<SEC-DOCUMENT>0000950123-20-009894.txt : 20201027
<SEC-HEADER>0000950123-20-009894.hdr.sgml : 20201027
<ACCEPTANCE-DATETIME>20200922152155
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950123-20-009894
CONFORMED SUBMISSION TYPE:	DRS
PUBLIC DOCUMENT COUNT:		71
FILED AS OF DATE:		20200922
<PUBLIC-REL-DATE>20201027
DATE AS OF CHANGE:		20200922

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PureTech Health plc
		CENTRAL INDEX KEY:			0001782999
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-03581
		FILM NUMBER:		201189502

	BUSINESS ADDRESS:	
		STREET 1:		6 TIDE STREET
		STREET 2:		SUITE 400
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		617-482-2333

	MAIL ADDRESS:	
		STREET 1:		6 TIDE STREET
		STREET 2:		SUITE 400
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>DRS</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission and all information herein remains strictly confidential. As confidentially submitted to the Securities and Exchange Commission on September 22, 2020. </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">20-F</FONT> </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>(Mark One) </B></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9746;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left"><B>REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>OR </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left"><B>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For the fiscal year ended
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>OR
</B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left"><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For the transition period from
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U> to
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>OR </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left"><B>SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date of event requiring this shell company report
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Commission file number [</B>&#9679;<B></B><B>] </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>PURETECH
HEALTH PLC </B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter and translation of Registrant&#146;s name into English) </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>England and Wales </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Jurisdiction of incorporation or organization) </B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>20 Farringdon Street, 8<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>London, EC4A 4AB, United Kingdom </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Daphne Zohar </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Chief
Executive Officer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>6 Tide Street, Suite 400 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Boston, Massachusetts 02210 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Tel: (617) <FONT STYLE="white-space:nowrap">482-2333</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, telephone, <FONT STYLE="white-space:nowrap">e-mail</FONT> and/or facsimile number and address of company contact person) </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities registered or to be registered pursuant to Section&nbsp;12(b)&nbsp;of the Act: </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of each class:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name of each exchange</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>on which registered:</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>American Depositary Shares, each representing [</B>&#9679;<B></B><B>] ordinary shares, par value &pound;0.01 per share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>The Nasdaq Capital Market</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Ordinary shares, par value &pound;0.01 per share*</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Listed not for trading, but only in connection with the registration of the American Depositary Shares, pursuant
to the requirements of the Securities&nbsp;&amp; Exchange Commission. </P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities registered or to be registered
pursuant to Section&nbsp;12(g)&nbsp;of the Act: None. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities for which there is a reporting obligation pursuant to
Section&nbsp;15(d)&nbsp;of the Act: None. </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate the number of
outstanding shares of each of the issuer&#146;s classes of capital or common stock as of the close of the period covered by the annual report: N/A. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&nbsp;405 of the Securities
Act.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this report is an annual or transition report, indicate
by check mark if the registrant is not required to file reports pursuant to Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of 1934.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange
Act of 1934 during the preceding 12&nbsp;months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to such filing requirements for the past
90&nbsp;days:&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp; &#9744;&nbsp;&nbsp;&nbsp;&nbsp; No&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&nbsp;405 of Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> (&#167;232.405 of this chapter) during the preceding 12&nbsp;months (or for such
shorter period that the registrant was required to submit such files):&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; and &#147;emerging growth company&#148; in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> of the Exchange Act.
</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Non-accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#134; provided pursuant to Section&nbsp;13(a)&nbsp;of the Exchange Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">The term &#147;new or revised financial accounting standard&#148; refers to any update issued by the Financial
Accounting Standards Board to its Accounting Standards Codification after April&nbsp;5, 2012. </P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the
registrant has filed a report on and attestation to its management&#146;s assessment of the effectiveness of its internal control over financial reporting under Section&nbsp;404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark which basis of accounting the registrant has
used to prepare the financial statements included in this filing: </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">U.S.&nbsp;GAAP&nbsp;&nbsp;&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;International&nbsp;Financial&nbsp;Reporting&nbsp;Standards&nbsp;as&nbsp;issued</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Other&nbsp;&nbsp;&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by&nbsp;the&nbsp;International&nbsp;Accounting&nbsp;Standards&nbsp;Board</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If &#147;Other&#148; has been checked in response to the previous question, indicate by check mark which financial statement
item the registrant has elected to follow.&nbsp;&nbsp;&nbsp;&nbsp;Item&nbsp;17&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp; Item 18&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If
this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> of the Exchange
Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp; No&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><A HREF="#rom68105_1">PART&nbsp;I</A></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_2">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_3">OFFER STATISTICS AND EXPECTED TIMETABLE</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;3.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_4">KEY INFORMATION</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;4.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_5">INFORMATION ON THE COMPANY</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;4A.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_6">UNRESOLVED STAFF COMMENTS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;5.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_7">OPERATING AND FINANCIAL REVIEW AND PROSPECTS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;6.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_8">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;7.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_9">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;8.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_10">FINANCIAL INFORMATION</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;9.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_11">THE OFFER AND LISTING</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;10.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_12">ADDITIONAL INFORMATION</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;11.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_13">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;12.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_14">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><A HREF="#rom68105_15">PART&nbsp;II</A></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;13.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_16">DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;14.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_17">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;15.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_18">CONTROLS AND PROCEDURES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;16.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_19">RESERVED</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;16A.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_20">AUDIT COMMITTEE FINANCIAL EXPERT</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;16B.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_21">CODE OF ETHICS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;16C.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_22">PRINCIPAL ACCOUNTANT FEES AND SERVICES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;16D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_23">EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;16E.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_24">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;16F.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_25">CHANGE IN REGISTRANT&#146;S CERTIFYING ACCOUNTANT</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;16G.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_26">CORPORATE GOVERNANCE</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;16H.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_27">MINE SAFETY DISCLOSURE</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><A HREF="#rom68105_28">PART&nbsp;III</A></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;17.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_29">FINANCIAL STATEMENTS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;18.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_30">FINANCIAL STATEMENTS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ITEM&nbsp;19.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#rom68105_31">EXHIBITS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">i</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Special Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This registration statement contains forward-looking statements that involve substantial risks and uncertainties. All statements contained in
this registration statement, other than statements of historical fact, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, are
forward-looking statements. The words &#147;anticipate,&#148; &#147;believe,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;target,&#148;
&#147;potential,&#148; &#147;would,&#148; &#147;could,&#148; &#147;should,&#148; &#147;continue&#148; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying
words. The forward-looking statements in this registration statement include, among other things, statements about: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to realize value from our Founded Entities, which may be impacted if we reduce our ownership to a
minority interest or otherwise cede control to other investors through contractual agreements or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success, cost and timing of our clinical development of our Wholly Owned Programs, including the progress of,
and results from, our preclinical and clinical trials of <FONT STYLE="white-space:nowrap">LYT-100,</FONT> <FONT STYLE="white-space:nowrap">LYT-200,</FONT> <FONT STYLE="white-space:nowrap">LYT-210,</FONT>
<FONT STYLE="white-space:nowrap">LYT-300,</FONT> our discovery programs (Glyph, Orasome and our meningeal lymphatics discovery research program) and other potential product candidates within our Wholly Owned Programs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain and maintain regulatory approval of our Wholly Owned product candidates, and any related
restrictions, limitations or warnings in the label of any of our Wholly Owned product candidates, if approved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to compete with companies currently marketing or engaged in the development of treatments for
indications that our Wholly Owned product candidates or those of our Founded Entities are designed to target; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans to pursue research and development of other future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential advantages of our Wholly Owned product candidates and those being developed by our Founded
Entities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate and degree of market acceptance and clinical utility of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of our collaborations and partnerships with third parties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates regarding the potential market opportunity for our Wholly Owned product candidates and those being
developed by our Founded Entities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our sales, marketing and distribution capabilities and strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to establish and maintain arrangements for manufacture of our Wholly Owned product candidates and
those being developed by our Founded Entities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our intellectual property position; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations related to the use of capital; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, including mitigation efforts and
economic effects, on any of the foregoing or other aspects of our business operations, including but not limited to our preclinical studies and future clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates regarding expenses, future revenues, capital requirements and needs for additional financing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of government laws and regulations; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our competitive position. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">ii</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not actually achieve the plans, intentions or expectations disclosed in our
forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make.
You should refer to the section of this annual report titled &#147;Item 3.D.&#151;Risk Factors&#148; for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking
statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this registration statement and the documents that we have filed as exhibits to the registration statement completely and with
the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This registration statement includes statistical and other industry and market data that we obtained from industry publications and research,
surveys and studies conducted by third parties. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the
accuracy or completeness of such information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">iii</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biotechnology company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating
diseases, including inflammatory and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The product candidates within our Wholly Owned Pipeline and
the products and product candidates being developed by our Founded Entities were initiated by our experienced research and development team and our extensive network of scientists, clinicians and industry leaders and consist of 24 products and
product candidates, of which 12 are clinical-stage and two have been cleared by the FDA and granted marketing authorization in the European Economic Area. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Founded Entities are comprised of our Controlled Founded Entities and our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities.
References in this registration statement to our &#147;Controlled Founded Entities&#148; refer to Follica, Incorporated, Vedanta Biosciences, Inc., Sonde Health, Inc. Alivio Therapeutics, Inc. and Entrega, Inc. References in this registration
statement to our <FONT STYLE="white-space:nowrap">&#147;Non-Controlled</FONT> Founded Entities&#148; refer to Gelesis, Inc., Akili Interactive Labs, Inc., Karuna Therapeutics, Inc. and Vor Biopharma Inc., and, for all periods prior to
December&nbsp;18, 2019, resTORbio, Inc. We formed each of our Founded Entities and have been involved in development efforts in varying degrees. In the case of each of our Controlled Founded Entities, we continue to maintain majority voting control.
With respect to our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities, we may benefit from appreciation in our investment as a shareholder of such companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom68105_1"></A>PART&nbsp;I </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_2"></A>ITEM&nbsp;1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Directors and Senior Management</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the names, ages as of September&nbsp;22, 2020 and positions of our senior management and directors: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="60%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NAME</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>AGE</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>POSITION</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Senior&nbsp;Management</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Bolen, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Scientific Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bharatt Chowrira, J.D.,&nbsp;Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President and Chief of Business and Strategy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Elenko, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Innovation Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joep Muijrers, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief of Portfolio Strategy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen Muniz, J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Operating Officer, Company Secretary, Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daphne Zohar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer, Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raju Kucherlapati, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John LaMattina, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Langer, Sc.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dame Marjorie Scardino<SUP STYLE="font-size:85%; vertical-align:top">(1)(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christopher Viehbacher<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chairman</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Audit Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Remuneration Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Nomination Committee. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Joseph Bolen, Ph.D.</I> has served
as our Chief Scientific Officer since October 2015. Prior to his appointment as Chief Scientific Officer, Dr.&nbsp;Bolen oversaw all aspects of research and development for Moderna Therapeutics as President and Chief Scientific Officer from July
2013 to October 2015. Previously, he was Chief Scientific Officer and Global Head of Oncology Research at Millennium: The Takeda Oncology Company. Prior to joining Millennium in 1999, Dr.&nbsp;Bolen held senior R&amp;D positions at Hoechst Marion
Roussel, Schering-Plough and Bristol-Myers Squibb. Dr.&nbsp;Bolen began his career at the National Institutes of Health, where he contributed to the discovery of a class of proteins known as tyrosine kinase oncogenes as key regulators of the immune
system. Dr.&nbsp;Bolen received a B.S. degree in Microbiology&nbsp;&amp; Chemistry and a Ph.D. in Immunology from the University of Nebraska and conducted his postdoctoral training in Molecular Virology at the Kansas State University Cancer Center.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Bharatt Chowrira, J.D., Ph.D.</I><B><I> </I></B>has served as our President and Chief of Business and Strategy since March 2017. Prior to joining
PureTech, Dr.&nbsp;Chowrira was the President of Synlogic, Inc., a biopharmaceutical company focused on developing synthetic microbiome-based therapeutics, from September 2015 to February 2017, where he oversaw and managed corporate and business
development, alliance management, financial, human resources, intellectual property and legal operations. Prior to that, Dr.&nbsp;Chowrira was the Chief Operating Officer of Auspex Pharmaceuticals, Inc. from October 2013 to July 2015, which was
acquired by Teva Pharmaceuticals Ltd. in the spring of 2015. Previously, he was President and Chief Executive Officer of Addex Therapeutics Ltd., a biotechnology company publicly-traded on the SIX Swiss Exchange, from August 2011 to July 2013. Prior
to that Dr.&nbsp;Chowrira held various leadership and management positions at Nektar Therapeutics (COO), Merck&nbsp;&amp; Co, or Merck (VP), Sirna Therapeutics (GC; acquired by Merck) and Ribozyme Pharmaceuticals (chief patent counsel).
Dr.&nbsp;Chowrira is currently a member of the board of directors of Vedanta Biosciences, Inc., or Vedanta. Dr.&nbsp;Chowrira received a J.D. from the University of Denver&#146;s Sturm College of Law, a Ph.D. in Molecular
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Biology from the University of Vermont College of Medicine, an M.S. in Molecular Biology from Illinois State University and a B.S. in Microbiology from the UAS, Bangalore, India. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Eric Elenko, Ph.D. </I>has served as our Chief Innovation Officer since June 2015 and held various other positions at PureTech prior thereto. While at
PureTech, Dr.&nbsp;Elenko has led the development of a number of programs, including Akili Interactive Labs, Gelesis, Karuna Therapeutics and Sonde Health. Dr.&nbsp;Elenko serves on the board of directors of Sonde and Alivio. Prior to joining
PureTech, Dr.&nbsp;Elenko was a consultant with McKinsey and Company from February 2002 to September 2005, where he advised senior executives of both Fortune 500 and specialty pharmaceutical companies on a range of issues such as product licensing,
mergers and acquisitions, research and development strategy and marketing. Dr.&nbsp;Elenko received a B.A. in Biology from Swarthmore College and his Ph.D. in Biomedical Sciences from University of California, San Diego. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Joep Muijrers, Ph.D. </I>has served as our Chief Portfolio Strategy since May 2020, and previously served as our Chief Financial Officer from April 2018 to
May 2020. Prior to joining PureTech, he was a Portfolio Manager and Partner at Life Science Partners, a specialist investor group with sole focus on investing in healthcare and life sciences, in The Netherlands and in Boston for 11 years. Prior to
joining LSP, he held the position of Director Corporate Finance and Capital Markets at Fortis Bank, currently part of ABN AMRO. Dr.&nbsp;Muijrers is currently a member of the board of directors of Alivio, Entrega, Follica and Sonde.
Dr.&nbsp;Muijrers received a master of science degree from the University of Nijmegen and a Ph.D. from EMBL Heidelberg. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stephen Muniz, J.D.</I> has
served as our Chief Operating Officer and a member of our board of directors since June 2015, and previously served as Executive Vice President of Legal, Finance and Operations since 2007. Prior to joining PureTech, Mr.&nbsp;Muniz was a Partner in
the Corporate Department of Locke Lord LLP, where he practiced law for ten years. Mr.&nbsp;Muniz&#146;s practice at Locke Lord LLP focused on the representation of life science venture funds as well as their portfolio companies in general corporate
matters and in investment and liquidity transactions. He was also a Kauffman Entrepreneur Fellow, a program sponsored by the Kauffman Foundation. Mr.&nbsp;Muniz also sits on the board of directors of Entrega, Follica and Alivio. Mr.&nbsp;Muniz
received a B.A. in Economics and Accounting from The College of the Holy Cross and a JD from the New England School of Law where he graduated summa cum laude. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Daphne Zohar</I> has served as our Chief Executive Officer and a member of our board of directors since our formation and UK main market listing in 2015 and
served as the founding Chief Executive Officer of a number of our Founded Entities. A successful entrepreneur, Ms.&nbsp;Zohar created PureTech, assembling a leading team and scientific network to help implement her vision for the company, and was a
key participant in fundraising, business development and establishing the underlying programs and platforms that have resulted in PureTech&#146;s substantial pipeline of 24 products and product candidates to date, including two products that have
been cleared by the U.S. Food and Drug Administration and granted marketing authorization in the European Economic Area, or EEA. Ms.&nbsp;Zohar has been recognized as a top leader and innovator in biotechnology by a number of sources, including
BioWorld, MIT&#146;s Technology Review, the Boston Globe, and Scientific American. She is an Editorial Advisor to Xconomy, a U.S. news company. Previously, Ms.&nbsp;Zohar has served on a number of private company boards. Ms.&nbsp;Zohar received a
Bachelor of Science degree from Northeastern University. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Raju Kucherlapati, Ph.D.</I><SUP STYLE="font-size:85%; vertical-align:top"> </SUP>has served as a member of our board of directors since 2014. He has been
the Paul C. Cabot Professor of Genetics and a professor of medicine at Harvard Medical School since 2001. Dr.&nbsp;Kucherlapati currently serves on the board of directors of Gelesis, Inc. and KEW Inc. He was a founder and former board member of
Abgenix, Cell Genesys and Millennium Pharmaceuticals. He is a fellow of the American Association for the Advancement of Science and a member of the Institute of Medicine of NAS. Dr.&nbsp;Kucherlapati received his Ph.D. from the University of
Illinois. He trained at Yale and has held faculty positions at Princeton University, University of Illinois College of Medicine and the Albert Einstein College of Medicine. He served on the editorial board of the New England Journal of Medicine and
was Editor in Chief of the journal Genomics. His </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
laboratory at Harvard Medical School is involved in cloning and characterization of human disease genes with a focus on human syndromes with a significant cardiovascular involvement, use of
genetic/genomic approaches to understand the biology of cancer and the generation and characterization of genetically modified mouse models for cancer and other human disorders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>John LaMattina, Ph.D.</I> has served as a member of our board of directors since 2009. Dr.&nbsp;LaMattina previously worked at Pfizer in different roles
from 1977 to 2007, including Vice President of U.S. Discovery Operations in 1993, Senior Vice President of Worldwide Discovery Operations in 1998, Senior Vice President of Worldwide Development in 1999, and President of Global Research and
Development from 2003 to 2007. Dr.&nbsp;LaMattina serves on the board of directors of Ligand Pharmaceuticals, Zafgen, Inc., Immunome Inc. and Vedanta and is Chairman of the board of directors of Alivio. He also serves on the Scientific Advisory
Board of Frequency Therapeutics and is a Trustee Associate of Boston College. During Dr.&nbsp;LaMattina&#146;s leadership tenure, Pfizer discovered and/or developed a number of important new medicines including Tarceva, Chantix, Zoloft, Selzentry
and Lyrica, along with a number of other medicines currently in late stage development for cancer, rheumatoid arthritis and pain. He is the author of numerous scientific publications and U.S. patents. Dr.&nbsp;LaMattina received the 1998 Boston
College Alumni Award of Excellence in Science and the 2004 American Diabetes Association Award for Leadership and Commitment in the Fight Against Diabetes. He was awarded an Honorary Doctor of Science degree from the University of New Hampshire in
2007. In 2010, he was the recipient of the American Chemical Society&#146;s Earle B. Barnes Award for Leadership in Chemical Research Management. He is the author of &#147;Devalued and Distrusted&#151;Can the Pharmaceutical Industry Restore its
Broken Image,&#148; &#147;Drug Truths: Dispelling the Myths About Pharma R&amp;D&#148; and an author of the Drug Truths blog at Forbes.com. Dr.&nbsp;LaMattina received a B.S. in Chemistry from Boston College and received a Ph.D. in Organic Chemistry
from the University of New Hampshire. He then moved on to Princeton University as a National Institutes of Health Postdoctoral Fellow in the laboratory of professor E. C. Taylor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Robert Langer, Sc.D.</I> has served as a member of our board of directors since our founding and is our <FONT STYLE="white-space:nowrap">co-founder.</FONT>
Dr.&nbsp;Langer has served as the David H. Koch Institute Professor at MIT since 2005. He served as a member of the FDA&#146;s Science Board from 1995 to 2002 and as its Chairman from 1999 to 2002. Dr.&nbsp;Langer serves on the board of directors of
Seer Bio, Abpro Bio, Frequency Therapeutics, Alivio Therapeutics, Entrega, Inc. and Moderna, Inc. Dr.&nbsp;Langer has received over 220 major awards, including the 2006 U.S. National Medal of Science, the Charles Stark Draper Prize in 2002 and the
2012 Priestley Medal. He is also the first engineer to ever receive the Gairdner Foundation International Award. Dr.&nbsp;Langer has received the Dickson Prize for Science, Heinz Award, Harvey Prize, John Fritz Award, General Motors Kettering Prize
for Cancer Research, Dan David Prize in Materials Science, Breakthough Prize in Life Sciences, National Medal of Science, National Medal of Technology and Innovation, Kyoto Prize, Wolf Prize, Albany Medical Center Prize in Medicine and Biomedical
Research and the <FONT STYLE="white-space:nowrap">Lemelson-MIT</FONT> prize. In 2006, he was inducted into the National Inventors Hall of Fame. In January 2015, Dr.&nbsp;Langer was awarded the 2015 Queen Elizabeth Prize for Engineering.
Dr.&nbsp;Langer received his bachelor&#146;s degree in Chemical Engineering from Cornell University and his Sc.D. in Chemical Engineering from MIT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dame Marjorie Scardino </I>has served as a member of our board of directors since 2015. She served as Chairman of The MacArthur Foundation from 2012 to
2017. Dame Scardino previously served as Chief Executive Officer of The Economist and as the Chief Executive Officer of Pearson plc, the world&#146;s leading education company and the owner of Penguin Books and The Financial Times Group. She is a
member of the <FONT STYLE="white-space:nowrap">non-profit</FONT> board of directors of Oxfam, The Royal College of Art and The Carter Center. She was previously a member of the board of directors of Twitter and International Airlines Group. Dame
Scardino has received a number of honorary degrees, and in 2003 was dubbed a Dame of the British Empire. She is also a member of the Royal Society of the Arts in the UK and the American Association of Arts and Sciences. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Christopher Viehbacher </I>has served as a member of our board of directors since 2015 and as Chairman since September 2019. He has been the managing
partner of Gurnet Point Capital since October 2014. Immediately prior to joining Gurnet Point Capital, Mr.&nbsp;Viehbacher served as the Chief Executive Officer and member of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
board of directors of Sanofi from December 2008 to October 2014. From 1993 to 2008, Mr.&nbsp;Viehbacher worked at GlaxoSmithKline in different roles, including ultimately President of its North
American pharmaceutical division. Mr.&nbsp;Viehbacher began his career with PricewaterhouseCoopers LLP and qualified as a Chartered Accountant. Mr.&nbsp;Viehbacher currently serves on the board of the directors of Vedanta Biosciences as Chairman,
Axcella Health Inc., Alladapt, BEFORE Brands, Corium, Crossover Health, Boston Pharmaceuticals, Zikani, York River Holdings and Gurnet Point Capital LLC. Mr.&nbsp;Viehbacher also serves on the Board of Trustees of Northeastern University and the
Board of Fellows of Stanford Medical School. Mr.&nbsp;Viehbacher has <FONT STYLE="white-space:nowrap">co-chaired</FONT> the Chief Executive Officer Roundtable on Neglected Diseases with Bill Gates and formerly chaired the Chief Executive Officer
Roundtable on Cancer. He was the Chairman of the Board of the Pharmaceutical Research and Manufacturers of America as well as President of the European Federation of Pharmaceutical Industries and Associations. At the World Economic Forum at Davos,
Mr.&nbsp;Viehbacher was a Chair of the Health Governors and <FONT STYLE="white-space:nowrap">co-chaired</FONT> an initiative to create a Global Charter for Healthy Living. He was also a member of the International Business Council.
Mr.&nbsp;Viehbacher has received the Pasteur Foundation Award for outstanding commitment to safeguarding and improving health worldwide. He has also received France&#146;s highest civilian honor, the L&acute;egion d&#146;Honneur. Mr.&nbsp;Viehbacher
received his bachelor&#146;s degree in Commerce from Queen&#146;s University in Ontario, Canada in 1983. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Advisers</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal United States legal adviser is Goodwin Procter LLP, located at 100 Northern Avenue, Boston, MA 02210 and our principal United
Kingdom legal adviser is DLA Piper LLP, located at 160 Aldersgate Street, London EC1A 4HT, United Kingdom. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Auditors</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">KPMG LLP has been our auditor since 2015. The address for KPMG LLP is 15 Canada Square, London E14 5GL, United Kingdom. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_3"></A>ITEM&nbsp;2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OFFER STATISTICS AND EXPECTED TIMETABLE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_4"></A>ITEM&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>KEY INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SELECTED FINANCIAL DATA </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We derived the selected consolidated financial data as of and for the years ended December&nbsp;31, 2019, 2018 and 2017 from our audited
consolidated financial statements included elsewhere in this Registration Statement on Form <FONT STYLE="white-space:nowrap">20-F.</FONT> We have derived the selected consolidated financial data as of and for the six months ended June&nbsp;30, 2020
and 2019 from our unaudited condensed consolidated financial statements included elsewhere in this Registration Statement on Form <FONT STYLE="white-space:nowrap">20-F.</FONT> The unaudited condensed consolidated financial statements have been
prepared on the same recognition and measurement basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly our financial position
as of June&nbsp;30, 2020 and the results of operations for the six months ended June&nbsp;30, 2020 and 2019. We present our consolidated financial statements in accordance with International Financial Reporting Standards, as issued by the
International Accounting Standards Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The summary consolidated financial data below should be read together with those consolidated
financial statements as well as the Item 5. &#147;Operating and Financial Review and Prospects.&#148; Our historical results for any prior period are not necessarily indicative of results to be expected in any future period, and our interim period
results are not necessarily indicative of results to be expected for a full year or any other interim period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidated Income Statement Data
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30, June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(in&nbsp;thousands,&nbsp;except&nbsp;per&nbsp;share&nbsp;data)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,688</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,371</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">650</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,465</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,955</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,119</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,377</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,885</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,379</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">432</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,807</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,748</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,535</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,844</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,387</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59,358</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,365</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(46,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,376</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,196</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85,848</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(77,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,672</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(38,250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,507</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Operating income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(135,399</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(104,019</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(115,420</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(52,782</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,317</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">264,409</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,730</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,016</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,395</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(37,863</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,615</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,334</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">276,910</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,375</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Loss realized on sale of investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,539</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Loss on impairment of intangible asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gain/(loss) on disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,060</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gain on loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">445,582</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,287</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(278</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Other income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>672,167</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,154</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>142,364</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>232,852</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>160,729</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Finance income/(costs):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Finance income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,362</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,358</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,032</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,383</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Finance income/(costs) &#150; subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,458</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,425</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Finance income/(costs) &#150; contractual</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,576</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,213</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Finance income/(costs) &#150; fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(46,475</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,631</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,735</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,866</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,978</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Net finance income/(costs)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,147</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,917</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(80,047</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,685</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(34,126</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Share of net gain/(loss) of associates accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,791</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,608</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,271</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Impairment of investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Income/(loss) before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>478,474</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(68,438</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,711</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>174,483</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>56,287</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112,409</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,383</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Net income/(loss) including <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,659</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(75,094</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>31,145</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Net (loss)/income attributable to the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(43,654</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>26,472</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>73,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Earnings/(loss) per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Basic earnings/(loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.49</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.11</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.43</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Diluted earnings/(loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.11</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.42</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidated Balance Sheet Data </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of</B><br><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of</B><br><B>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">132,360</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">117,051</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">72,649</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">340,120</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital <SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,643</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,978</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,832</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">941,178</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">441,763</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">339,846</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,105,523</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retained earnings/(accumulated deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">254,444</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(167,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(132,270</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">378,400</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650,398</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,972</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,600</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">766,879</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We define working capital as current assets less current liabilities. We rely on working capital to fund future
operations and advance our research and development activities. Our working capital as of December&nbsp;31, 2019, 2018 and 2017 is calculated as follows (in thousands): December&nbsp;31, 2019,
<FONT STYLE="white-space:nowrap">$168,845-$139,201=$29,643;</FONT> December&nbsp;31, 2018, $259,786&#150;$265,764=$(5,978); December&nbsp;31, 2017, <FONT STYLE="white-space:nowrap">$198,109-$273,862=$(75,753).</FONT> Our working capital as of
June&nbsp;30, 2020 is calculated as follows (in thousands): $346,871&#150;$156,039=$190,832. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CAPITALIZATION AND INDEBTEDNESS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth our cash and cash equivalents and shows our capitalization as of June&nbsp;30, 2020. You should read this table in
conjunction with our unaudited condensed consolidated financial statements included in this Registration Statement on Form <FONT STYLE="white-space:nowrap">20-F,</FONT> together with the accompanying notes and the other information appearing under
the heading &#147;Item 5. Operating and Financial Review and Prospects&#148;. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(in&nbsp;thousands, except share and per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">340,120</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shareholders&#146; equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital, nominal value &pound;0.01 par value per ordinary share; 285,512,461 shares issued
and outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,411</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,506</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share premium</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">288,225</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,776</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Accumulated deficit)/retained earnings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">378,400</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity attributable to the owners of the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>783,766</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity attributable to the <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,887</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Capitalization</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>766,879</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Capitalization and Indebtedness</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>768,334</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>REASONS FOR THE OFFER AND USE OF PROCEEDS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">6</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>D.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RISK FACTORS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Our business faces significant risks. You should carefully consider all of the information set forth in this registration statement,
including the following risk factors which we face and which are faced by our industry. Our business, financial condition or results of operations could be materially and adversely affected if any of these risks occurs. This registration statement
also contains forward-looking statements that involve risks and uncertainties. See &#147;Special Note Regarding Forward-Looking Statements.&#148; Our actual results could differ materially and adversely from those anticipated in these
forward-looking statements as a result of certain factors including the risks described below and elsewhere in this registration statement. See &#147;Special Note Regarding Forward-Looking Statements.&#148; </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to our Financial Position, Need for Additional Capital and Growth Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are a clinical-stage biopharmaceutical company and have incurred significant operating losses since our inception. We may continue to incur
significant operating losses for the foreseeable future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investment in biotechnology product development, as well as medical device development,
is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will be unable to demonstrate effectiveness or an acceptable safety profile, gain regulatory approval and
become commercially viable. To date, only two of our Founded Entities&#146; products, Gelesis&#146; Plenity and Akili&#146;s EndeavorRx, have received marketing clearance from the U.S. Food and Drug Administration, or the FDA. All of our Wholly
Owned Programs and the majority of our Founded Entities&#146; product candidates may require substantial additional development time, including extensive clinical research, and resources before we would be able to apply for or receive regulatory
clearances or approvals and begin generating revenue from product sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception, we have invested most of our resources in developing our
technology and product candidates, building our intellectual property portfolio, developing our supply chain, conducting business planning, raising capital and providing general and administrative support for these operations, including with respect
to our Founded Entities. We are not operationally profitable and have incurred losses in each year since our inception. Our operating losses for the years ended December&nbsp;31, 2017, 2018, and 2019 and the six months ended June&nbsp;30, 2020 were
$115.4&nbsp;million, $104.0&nbsp;million, $135.4&nbsp;million, and $52.8&nbsp;million, respectively. We have no products developed in our Wholly Owned Programs approved for commercial sale and have not generated any revenues from product sales, and
we and our Founded Entities have financed operations solely through the sale of equity securities, revenue from strategic alliances and government funding and, with respect to certain of our Founded Entities, debt financings. We continue to incur
significant research and development, or R&amp;D, and other expenses related to ongoing operations and expect to incur losses for the foreseeable future. We anticipate continued losses for the foreseeable future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to risks and uncertainties associated with the development of drugs, biologics and medical devices, we are unable to predict the timing or amount of our
expenses, or when we will be able to generate any meaningful revenue or achieve or maintain profitability, if ever. In addition, our expenses could increase beyond our current expectations if we are required by the FDA, the European Medicines
Agency, or the EMA, or other comparable foreign regulatory authorities to perform preclinical studies or clinical trials in addition to those that we currently anticipate, or if there are any delays in any of our or our future collaborators&#146;
clinical trials or the development of our existing product candidates and any other product candidates that we may identify. Even if our existing product candidates or any future product candidates that we may identify are approved for commercial
sale, we anticipate incurring significant costs associated with commercializing any approved product and ongoing compliance efforts. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>As of
June&nbsp;30, 2020 we had never generated revenue from our Wholly Owned Pipeline, and we may never be operationally profitable. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While Gelesis and
Akili have received marketing clearance for Plenity and EndeavorRx, respectively, from the FDA, we may never be able to develop or commercialize marketable products or achieve operational profitability. Revenue from the sale of any product candidate
for which regulatory clearance or approval is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obtained will be dependent, in part, upon the size of the markets in the territories for which we gain regulatory clearance or approval, the accepted price for the product, the ability to obtain
reimbursement at any price and whether we own the commercial rights for that territory. Our growth strategy depends on our ability to generate revenue. In addition, if the number of addressable patients is not as anticipated, the indication or
intended use cleared or approved by regulatory authorities is narrower than expected, or the reasonably accepted population for treatment is narrowed by competition, physician choice or treatment guidelines, we may not generate significant revenue
from sales of such products, even if cleared or approved. Even if we are able to generate revenue from the sale of any approved products, we may not become operationally profitable and may need to obtain additional funding to continue operations.
Even if we achieve operational profitability in the future, we may not be able to sustain profitability in subsequent periods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are unable to
achieve sustained profitability would depress the value of our company and could impair our ability to raise capital, expand our business, diversify our research and development pipeline, market our Wholly Owned product candidates, if cleared or
approved, and pursue or continue our operations. Our prior losses, combined with expected future losses, have had and may continue to have an adverse effect on our shareholders&#146; equity and working capital. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may require substantial additional funding to achieve our business goals. If we are unable to obtain this funding when needed and on acceptable
terms, we could be forced to delay, limit or terminate certain of our product development efforts. Certain of our Founded Entities will similarly require substantial additional funding to achieve their business goals. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently advancing a pipeline of four Wholly Owned product candidates, three of which are in preclinical development and one of which is conducting a
Phase 1 clinical trial. Our Controlled Founded Entities are advancing nine product candidates, including one that is expected to enter a Phase 3 study and three that are in Phase 2 development. Our
<FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities are advancing 10 products and product candidates, including two that are expected to enter Phase&nbsp;3/pivotal clinical trials and two
<FONT STYLE="white-space:nowrap">FDA-cleared</FONT> products. Developing biopharmaceutical products is expensive and time-consuming, and with respect to our Wholly Owned Programs, we expect to require substantial additional capital to conduct
research, preclinical studies and clinical trials for our current and future programs, establish pilot scale and commercial scale manufacturing processes and facilities, seek regulatory clearances and approvals for our Wholly Owned product
candidates and launch and commercialize any products for which we receive regulatory clearance or approval, including building our own commercial sales, marketing and distribution organization. With respect to our Founded Entities&#146; programs, we
anticipate that we will continue to fund a small portion of development costs by strategically participating in such companies&#146; financings when doing so would be in the interests of our shareholders. The form of any such participation may
include investment in public or private financings, collaboration and partnership arrangements and licensing arrangements, among others. Our management and strategic decision makers have not made decisions regarding the future allocation of certain
of our resources among our Founded Entities, but evaluate the needs and opportunities with respect to each of these Founded Entities routinely and on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT>
basis. In connection with any collaboration agreements relating to our Wholly Owned Programs, we are also responsible for the payments to third parties of expenses that may include milestone payments, license maintenance fees and royalties,
including in the case of certain of our agreements with academic institutions or other companies from whom intellectual property rights underlying their respective programs have been <FONT STYLE="white-space:nowrap">in-licensed</FONT> or acquired.
Because the outcome of any preclinical or clinical development and regulatory approval process is highly uncertain, we cannot reasonably estimate the actual amounts necessary to successfully complete the development, regulatory approval process and
potential commercialization of our Wholly Owned product candidates and any future product candidates we may identify. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, we had
cash, cash equivalents and short-term investments of $340.1&nbsp;million. However, our operating plan may change as a result of many factors currently unknown to us, and we may need to seek additional funds sooner than planned, through public or
private equity or debt financings, sales of assets or programs, other sources, such as strategic collaborations or license and development agreements, or a combination of these approaches. Even if we believe we have sufficient funds for our current
or future operating </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">8</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
plans, we may opportunistically seek additional capital if market conditions are favorable or if we have specific strategic considerations. Our spending will vary based on new and ongoing product
development and corporate activities. Any such additional fundraising efforts for us may divert our management from their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities, which may adversely
affect our ability to develop and commercialize product candidates that we may identify and pursue. Moreover, such financing may result in dilution to shareholders, imposition of debt covenants and repayment obligations, or other restrictions that
may affect our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our future funding requirements, both short-term and long-term, will depend on many factors, including, but not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the time and cost necessary to complete ongoing, planned and future unplanned clinical trials, including our
planned Phase 2 trial in serious respiratory complications that persist following the resolution of <FONT STYLE="white-space:nowrap">COVID-19</FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT>
trial in breast cancer-related, upper limb secondary lymphedema for <FONT STYLE="white-space:nowrap">LYT-100,</FONT> our anticipated Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">LYT-200,</FONT> and our anticipated <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> trial for <FONT STYLE="white-space:nowrap">LYT-300;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome, timing and cost of meeting regulatory requirements established by the FDA, the EMA and other
comparable foreign regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the progress, timing, scope and costs of our preclinical studies, clinical trials and other related activities
for our ongoing and planned clinical trials, and potential future clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of obtaining clinical and commercial supplies of raw materials and drug products for our Wholly Owned
product candidates, as applicable, and any other product candidates we may identify and develop; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to successfully identify and negotiate acceptable terms for third-party supply and contract
manufacturing agreements with contract manufacturing organizations, or CMOs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of commercialization activities for any of our Wholly Owned product candidates that receive marketing
approval, including the costs and timing of establishing product sales, marketing, distribution and manufacturing capabilities, or entering into strategic collaborations with third parties to leverage or access these capabilities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount and timing of sales and other revenues from our Wholly Owned product candidates, if approved,
including the sales price and the availability of coverage and adequate third-party reimbursement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cash requirements of our Founded Entities and our ability and willingness to provide them with financing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cash requirements of any future acquisitions or discovery of product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the time and cost necessary to respond to technological and market developments, including other products that
may compete with one or more of our Wholly Owned product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of acquiring, licensing or investing in intellectual property rights, products, product candidates and
businesses; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract, hire and retain qualified personnel as we expand research and development and establish a
commercial infrastructure; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of maintaining, expanding and protecting our intellectual property portfolio; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of operating as a public company in the United Kingdom and the United States and maintaining listings
on both the London Stock Exchange, or the LSE, and The Nasdaq Global Market, or Nasdaq. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot be certain that additional funding
will be available on acceptable terms, or at all. If adequate funds are not available to us on a timely basis, we may be required to delay, limit or terminate one or more research or development programs or the potential commercialization of any
approved products or be unable to expand </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">9</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
operations or otherwise capitalize on business opportunities, as desired, which could materially affect our business, prospects, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Raising additional capital may cause dilution to our existing shareholders, restrict our operations or require us to relinquish rights to current
product candidates or to any future product candidates on unfavorable terms. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect our expenses to increase in connection with our planned
operations. Unless and until we can generate a substantial amount of revenue from our Wholly Owned product candidates or royalties and other monetization events related to our Founded Entities, we expect to finance our future cash needs through a
combination of public and private equity offerings, debt financings, strategic partnerships, sales of assets and alliances and licensing arrangements. We, and indirectly, our shareholders, may bear the cost of issuing and servicing any such
securities and of entering into and maintaining any such strategic partnerships or other arrangements. Because any decision by us to issue debt or equity securities in the future will depend on market conditions and other factors beyond our control,
we cannot predict or estimate the amount, timing or nature of any future financing transactions. To the extent that we or our Founded Entities raise additional capital through the sale of equity or convertible debt securities, your ownership
interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a shareholder. The incurrence of additional indebtedness would result in increased fixed payment obligations and could involve
additional restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our
ability to conduct our business. Additionally, any future collaborations we enter into with third parties may provide capital in the near term, but limit our potential cash flow and revenue in the future. If we raise additional funds through
strategic partnerships and alliances and licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies or product candidates, or grant licenses or other rights on unfavorable terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if any of our Founded Entities raises funds through the issuance of equity securities, our shareholders&#146; indirect equity interest in such
Founded Entity could be substantially diminished. If any of our Founded Entities raises additional funds through collaboration and licensing arrangements, it may be necessary to relinquish some rights to our technologies or these product candidates
or grant licenses on terms that are not favorable to us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we engage in acquisitions or strategic partnerships, this may increase our capital
requirements, dilute our shareholders, cause us to incur debt or assume contingent liabilities and subject us to other risks. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may engage in
various acquisitions and strategic partnerships in the future, including licensing or acquiring complementary products, intellectual property rights, technologies or businesses. Any acquisition or strategic partnership may entail numerous risks,
including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased operating expenses and cash requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the assumption of indebtedness or contingent liabilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance of our equity securities which would result in dilution to our shareholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assimilation of operations, intellectual property, products and product candidates of an acquired company,
including difficulties associated with integrating new personnel; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the diversion of our management&#146;s attention from our existing product programs and initiatives in pursuing
such an acquisition or strategic partnership; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">retention of key employees, the loss of key personnel and uncertainties in our ability to maintain key business
relationships; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks and uncertainties associated with the other party to such a transaction, including the prospects of that
party and their existing products or product candidates and regulatory approvals; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to generate revenue from acquired intellectual property, technology and/or products sufficient to
meet our objectives or even to offset the associated transaction and maintenance costs. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">10</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if we undertake such a transaction, we may issue dilutive securities, assume or incur debt
obligations, incur large <FONT STYLE="white-space:nowrap">one-time</FONT> expenses and acquire intangible assets that could result in significant future amortization expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The failure to maintain our licenses and realize their benefits may harm our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acquired and <FONT STYLE="white-space:nowrap">in-licensed</FONT> certain of our technologies from third parties. We may in the future acquire, <FONT
STYLE="white-space:nowrap">in-license</FONT> or invest in additional technology that we believe would be beneficial to our business. We are subject to a number of risks associated with our acquisition,
<FONT STYLE="white-space:nowrap">in-license</FONT> or investment in technology, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">diversion of financial and managerial resources from existing operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">successfully negotiating a proposed acquisition, <FONT STYLE="white-space:nowrap">in-license</FONT> or investment
in a timely manner and at a price or on terms and conditions favorable to us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">successfully combining and integrating a potential acquisition into our existing business to fully realize the
benefits of such acquisition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of regulatory reviews on a proposed acquisition, <FONT STYLE="white-space:nowrap">in-license</FONT> or
investment; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome of any legal proceedings that may be instituted with respect to the proposed acquisition, <FONT
STYLE="white-space:nowrap">in-license</FONT> or investment. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we fail to properly evaluate potential acquisitions, <FONT
STYLE="white-space:nowrap">in-licenses,</FONT> investments or other transactions associated with the creation of new R&amp;D programs or the maintenance of existing ones, we might not achieve the anticipated benefits of any such transaction, we
might incur costs in excess of what we anticipate, and management resources and attention might be diverted from other necessary or valuable activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Founded Entities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ability
to realize value from our Founded Entities may be impacted if we reduce our ownership or otherwise cede control to other investors through contractual agreements or otherwise. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have a majority interest in our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities. Our interests may be further reduced as such
companies raise capital from third-party investors. In addition, we may agree to contractual arrangements for the funding of further developments by one or more of our Founded Entities. As a result, with respect to our
<FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities, we may not be able to exercise control over the affairs of such Founded Entity, including that Founded Entity&#146;s governance arrangements and access to management and
financial information. We are also party to agreements with certain of our Founded Entities that contain provisions which could force us to exit from that Founded Entity at a time and/or price determined by other investor(s) (for example, by the
exercise of drag-along rights). If we were forced to exit out of a Founded Entity, this could have a material adverse effect on our business, financial condition or results of operations and prospects. In addition, if the affairs of one or more
Founded Entities in which we hold a minority stake were to be conducted in a manner detrimental to our interests or intentions, our business, reputation and prospects may be adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As certain of our Founded Entities have completed equity financings, they have entered into certain agreements with the investors participating in such
financings, including us. We are party to voting agreements with Entrega, Inc., or Entrega, Sonde Health, Inc., or Sonde, and Vor Biopharma, Inc., or Vor, investors&#146; rights agreements with Akili Interactive Labs, Inc., or Akili, Karuna
Therapeutics, Inc., or Karuna, Follica, Incorporated, or Follica, Vedanta Biosciences, Inc., or Vedanta, Entrega, Sonde and Vor, and a stockholders&#146; agreement with Gelesis, pursuant to which we are subject to certain restrictions on the
transfer or sale of shares (e.g., <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights or drag-along, <FONT STYLE="white-space:nowrap">tag-along</FONT> rights or lock up agreements), and we may not be able freely to transfer our interest in
such Founded Entities or procure the sale of the entire issued share capital of one of such Founded Entities, similar to other investors who are party to these agreements. In addition, many of our Founded Entities have employee share plans which
further dilute our interest in such business. If the affairs of one or more of our Founded Entities were to be conducted in a manner detrimental to our interests or intentions or if we were unable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">11</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to realize our interest in a Founded Entity or suffer dilution of our shareholding, this could have a material adverse effect on our business, financial condition or results of operation and
prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our overall value may be dominated by a single or limited number of our Founded Entities. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A large proportion of our overall value may at any time reside in a small proportion of our Founded Entities. Accordingly, there is a risk that if one or more
of the intellectual property or commercial rights relevant to a valuable business were impaired, this would have a material adverse impact on our overall value. Furthermore, a large proportion of our overall revenue may at any time be the subject of
one, or a small number of, licensed technologies. Should the relevant licenses be terminated or expire this would be likely to have a material adverse effect on the revenue received by us. Any material adverse impact on the value of the business of
a Founded Entity could, in the situations described above, or otherwise, have a material adverse effect on our business, financial condition, trading performance and/or prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have limited information about and limited control or influence over our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While we maintain ownership of equity interests in our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities, we do not maintain
voting control or direct management and development efforts for these entities. Each of these entities are independently managed, and we do not control the clinical and regulatory development of these
<FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities&#146; product candidates. Any failure by our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities to adhere to regulatory requirements, initiate preclinical
studies and clinical trials on schedule or to obtain clearances or approvals for their product candidates could have an adverse effect on our business, financial condition, results of operation and prospects. The information included in this
registration statement about our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities is based on (i)&nbsp;our knowledge, which may in some cases be limited, (ii)&nbsp;information that is publicly available, including the public
filings of SEC reporting companies, such as Karuna, (iii)&nbsp;information provided to us by our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities. Where a date is provided, the information included in this registration
statement about our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities is as of that date and you should not assume that it is accurate as of any other date. As such, there may be developments at our <FONT
STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities of which we are unaware that could have an adverse effect on our business, financial condition, results of operation and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Founded Entities are difficult to value given that many of their product candidates are in the development stage. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investments in early-stage companies, particularly privately held entities, are inherently difficult to value since sales, cash flow and tangible asset values
are very limited, which makes the valuation highly dependent on expectations of future development, and any future significant revenues would only arise in the medium to longer terms and are uncertain. Equally, investments in companies just
commencing the commercial stage are also difficult to value since sales, cash flow and tangible assets are limited, they have only commenced initial receipts of revenues and valuations are still dependent on expectations of future development. There
can be no guarantee that our valuation of our Founded Entities will be considered to be correct in light of the early stage of development for many of these entities and their future performance. As a result, we may not realize the full value of our
ownership in such Founded Entities which could adversely affect our business and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain of our and our Founded
Entities&#146; products candidates represent novel therapeutic approaches and negative perception of any product candidate that we or they develop could adversely affect our ability to conduct our business, obtain regulatory approvals or identify
alternate regulatory pathways to market for such product candidate. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of our and our Founded Entities&#146; products candidates are
considered relatively new and novel therapeutic approaches. Our and their success will depend upon physicians who specialize in the treatment of diseases targeted by our and their product candidates, biologics or medical devices prescribing
potential treatments that involve the use of our and their product candidates in lieu of, or in addition to, existing treatments with which they are more familiar and for which greater clinical data may be available. Access will also depend on
consumer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">12</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acceptance and adoption of products that are commercialized. In addition, responses by the U.S., state or foreign governments to negative public perception or ethical concerns may result in new
legislation or regulations that could limit our or our Founded Entities&#146; ability to develop or commercialize any product candidates, obtain or maintain regulatory approval, identify alternate regulatory pathways to market or otherwise achieve
profitability. More restrictive statutory regimes, government regulations or negative public opinion would have an adverse effect on our business, financial condition, results of operations and prospects and may delay or impair the development and
commercialization of our or our Founded Entities&#146; product candidates or demand for any products we or they may develop. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For example, in the United
States and the European Union, no products to date have been approved specifically demonstrating an impact on the microbiome as part of their therapeutic effect. Vedanta is developing a pipeline of microbiome-derived modulators for immune and
infectious disease. Microbiome therapies may not be successfully developed or commercialized or gain the acceptance of the public or the medical community. Additionally, adverse events, or AEs, in <FONT STYLE="white-space:nowrap">non-IND</FONT>
human clinical studies and clinical trials of Vedanta&#146;s product candidates or in clinical trials of other companies developing similar products and the resulting publicity, as well as any other AEs in the field of the microbiome, could result
in a decrease in demand for any product that Vedanta may develop. Finally, the FDA, the EMA or other comparable foreign regulatory authorities may lack experience in evaluating the safety and efficacy of product candidates based on microbiome
therapeutics, which could result in a longer than expected regulatory review process, increase expected development costs and delay or prevent potential commercialization of product candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to the Clinical Development, Regulatory Review and Approval of our and our Founded Entities&#146; Product Candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Wholly Owned Programs and most of our Founded Entities&#146; product candidates are in preclinical or clinical development, which is a lengthy and
expensive process with uncertain outcomes and the potential for substantial delays. We cannot give any assurance that any of our and our Founded Entities&#146; product candidates will receive regulatory approval, which is necessary before they can
be commercialized. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before obtaining marketing approval from regulatory authorities for the sale of our or our Founded Entities&#146; product
candidates, we or our Founded Entities must conduct extensive clinical trials to demonstrate the safety and efficacy of the product candidates in humans. To date, we have focused substantially all of our efforts and financial resources on
identifying, acquiring, and developing product candidates, including conducting lead optimization, preclinical studies and clinical trials, and providing general and administrative support for these operations. To date, only two of our Founded
Entities&#146; product candidates, Gelesis&#146; Plenity and Akili&#146;s EndeavorRX, have received marketing clearance from the FDA, and we cannot be certain that any of our internal or our Founded Entities&#146; other product candidates will
receive regulatory clearance or approval, the timing of such clearance or approval, if received, or that clinical trials will progress as planned. Our or our Founded Entities&#146; inability to successfully complete preclinical and clinical
development could result in additional costs to us and negatively impact our ability to generate revenue. Our future success is dependent on our and our Founded Entities&#146; ability to successfully develop, obtain regulatory approval for, and then
successfully commercialize product candidates. We and our Founded Entities, with the exceptions of Gelesis and Akili, currently have no drugs approved or devices cleared or approved for sale and have not generated any revenue from sales of drugs or
devices. We cannot guarantee that we or our Founded Entities will be able in the future to develop or successfully commercialize any of our or their product candidates. Additionally, there is no FDA approved live biological therapeutic using a
defined cocktail of microbes, which could result in regulatory complexity in Vedanta&#146;s pipeline. There is also no approved drug therapy for lymphedema, which will require us to come to an agreement with the FDA on requirements for approval.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than Gelesis&#146; Plenity and Akili&#146;s EndeavorRx, all of our Wholly Owned Programs and our Founded Entities&#146; product candidates require
additional development; management of preclinical, clinical, and manufacturing activities; and/or regulatory clearances or approvals. In addition, we or our Founded Entities may need to obtain adequate manufacturing supply; build a commercial
organization; commence marketing efforts; and obtain coverage and reimbursement before we generate any significant revenue from commercial product </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">13</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sales, if ever. Many of our Wholly Owned Programs and our Founded Entities&#146; product candidates are in early-stage research or translational phases of development, and the risk of failure for
these programs is high. We cannot be certain that any of our Wholly Owned Programs or our Founded Entities&#146; product candidates will be successful in clinical trials or receive regulatory approval or clearance. Further, our Wholly Owned Programs
or our Founded Entities&#146; product candidates may not receive regulatory clearance or approval even if we believe they are successful in clinical trials. If we or our Founded Entities do not receive regulatory approval for our or their product
candidates, we may not be able to continue operations, which may result in dissolution, <FONT STYLE="white-space:nowrap">out-licensing</FONT> the technology or pursuing an alternative strategy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical development is uncertain. Our preclinical programs may experience delays or may never advance to clinical trials, which would adversely
affect our ability to obtain regulatory approvals or commercialize these programs on a timely basis or at all, which would have an adverse effect on our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All but one of our Wholly Owned product candidates, <FONT STYLE="white-space:nowrap">LYT-100,</FONT> are still in the preclinical stage, and their risk of
failure is high. Before we can commence clinical trials for a product candidate, we must complete extensive preclinical testing and studies that support our planned investigational new drug applications, or INDs, in the United States, or similar
applications in other jurisdictions. We cannot be certain of the timely completion or outcome of our preclinical testing and studies and cannot predict if the FDA or other regulatory authorities will accept our proposed clinical programs or if the
outcome of our preclinical testing and studies will ultimately support the further development of our programs. As a result, we cannot be sure that we will be able to submit INDs or similar applications for our preclinical programs on the timelines
we expect, if at all, and we cannot be sure that submission of INDs or similar applications will result in the FDA, the EMA or other regulatory authorities allowing clinical trials to begin. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical trials of our or our Founded Entities&#146; product candidates may be delayed, and certain programs may never advance in the clinic or may be
more costly to conduct than we anticipate, any of which can affect our ability to fund our company and would have a material adverse impact on our platform or our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clinical testing is expensive, time-consuming, and subject to uncertainty. We cannot guarantee that any of our planned clinical trials will be conducted as
planned or completed on schedule, if at all. Moreover, even if these trials are initiated or conducted on a timely basis, issues may arise that could result in the suspension or termination of such clinical trials. A failure of one or more clinical
trials can occur at any stage of testing, and our clinical trials may not be successful. Events that may prevent successful or timely initiation or completion of clinical trials include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">inability to generate sufficient preclinical, toxicology, or other<I> in vivo</I> or<I> in vitro</I> data to
support the initiation or continuation of clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in confirming target engagement, patient selection or other relevant biomarkers to be utilized in
preclinical and clinical product candidate development; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in reaching a consensus with regulatory agencies as to the design or implementation of our clinical
studies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in reaching agreement on acceptable terms with prospective contract research organizations, or CROs, and
clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in identifying, recruiting and training suitable clinical investigators; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in obtaining required Institutional Review Board, or IRB, approval at each clinical trial site;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">imposition of a temporary or permanent clinical hold by regulatory agencies for a number of reasons, including
after review of an IND or amendment, clinical trial application, or CTA, or amendment, investigational device exemption, or IDE, or supplement, or equivalent application or amendment; as a result of a new safety finding that presents unreasonable
risk to clinical trial participants; or a negative finding from an inspection of our clinical trial operations or study sites; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">14</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments in trials for other product candidates with the same targets or related modalities as our or our
Founded Entities&#146; product candidates conducted by competitors that raise regulatory or safety concerns about risk to patients of the treatment, or if the FDA finds that the investigational protocol or plan is clearly deficient to meet its
stated objectives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties in securing access to materials for the comparator arm of certain of our clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in identifying, recruiting and enrolling suitable patients to participate in clinical trials, and delays
caused by patients withdrawing from clinical trials or failing to return for post-treatment <FONT STYLE="white-space:nowrap">follow-up;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties in finding a sufficient number of trial sites, or trial sites deviating from trial protocol or
dropping out of a trial; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulty collaborating with patient groups and investigators; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by CROs, other third parties, or us to adhere to clinical trial requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to perform in accordance with the FDA&#146;s or any other regulatory authority&#146;s current good
clinical practices, or GCP, requirements, or regulatory guidelines in other countries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">occurrence of AEs or undesirable side effects or other unexpected characteristics associated with the product
candidate that are viewed to outweigh its potential benefits; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the standard of care on which a clinical development plan was based, which may require new or
additional trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of clinical trials of any product candidates that we may identify and pursue being greater than we
anticipate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinical trials of any product candidates that we may identify and pursue producing negative or inconclusive
results, which may result in our deciding, or regulators requiring us, to conduct additional clinical trials or abandon product development programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfer of manufacturing processes to larger-scale facilities operated by a CMO, or by us, and delays or
failures by our CMOs or us to make any necessary changes to such manufacturing process; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in manufacturing, testing, releasing, validating, or importing/exporting sufficient stable quantities of
product candidates that we may identify for use in clinical trials or the inability to do any of the foregoing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any inability to
successfully initiate or complete clinical trials could result in additional costs to us or impair our ability to generate revenue. In addition, if we make manufacturing or formulation changes to our Wholly Owned product candidates, we may be
required to or we may elect to conduct additional preclinical studies or clinical trials to bridge data obtained from our modified product candidates to data obtained from preclinical and clinical research conducted using earlier versions. Clinical
trial delays could also shorten any periods during which our products have patent protection and may allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize product candidates and
may harm our business and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We could also encounter delays if a clinical trial is suspended or terminated by us, by the data safety
monitoring board, or DSMB, or by the FDA, the EMA or other comparable foreign regulatory authorities, or if the IRBs of the institutions in which such trials are being conducted suspend or terminate the participation of their clinical investigators
and sites subject to their review. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols,
inspection of the clinical trial operations or trial site by the FDA, the EMA or other comparable foreign regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">15</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or adverse side effects, failure to demonstrate a benefit from using a product candidate, changes in governmental regulations or administrative actions or lack of adequate funding to continue the
clinical trial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and
receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA, the EMA or comparable foreign regulatory authorities. The FDA, the EMA or comparable foreign
regulatory authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA, the EMA or comparable foreign regulatory authority
may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications
by the FDA, the EMA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of one or more of our Wholly Owned or our Founded Entities&#146; product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delays in the initiation, conduct or completion of any clinical trial of our Wholly Owned product candidates will increase our costs, slow down the product
candidate development and approval process and delay or potentially jeopardize our ability to commence product sales and generate revenue. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical
trials may also ultimately lead to the denial of regulatory approval of our Wholly Owned or our Founded Entities&#146; product candidates. In the event we identify any additional product candidates to pursue, we cannot be sure that submission of an
IDE, IND, CTA, or equivalent application, as applicable, will result in the FDA, the EMA or comparable foreign regulatory authority allowing clinical trials to begin in a timely manner, if at all. Any of these events could have a material adverse
effect on our business, prospects, financial condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our clinical trials may fail to demonstrate substantial evidence
of the safety and effectiveness of product candidates that we may identify and pursue for their intended uses, which would prevent, delay or limit the scope of regulatory approval and potential commercialization. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before obtaining regulatory approvals for the commercial sale of any of our drug or biological product candidates, we must demonstrate through lengthy, complex
and expensive preclinical studies and clinical trials that the applicable product candidate is both safe and effective for use in each target indication, and in the case of our Wholly Owned and Founded Entities&#146; product candidates regulated as
biological products, that the product candidate is safe, pure, and potent for use in its targeted indication. Each product candidate must demonstrate an adequate risk versus benefit profile in its intended patient population and for its intended
use. Similarly, before obtaining regulatory clearances or approvals for the commercial sale of any of the device product candidates of our Founded Entities, our Founded Entities may be required to demonstrate through lengthy, complex and expensive
preclinical studies and clinical trials that the applicable product candidate meets the regulatory standard of clearance or approval&#151;for example, substantial equivalence or a reasonable assurance of safety or effectiveness, as
applicable&#151;for its intended use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure
can occur at any time during the clinical development process. Most product candidates that begin clinical trials are never approved by regulatory authorities for commercialization. We may be unable to design and execute a clinical trial to support
marketing approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot be certain that our clinical trials will be successful. Additionally, any safety concerns observed in any one of our
clinical trials in our targeted indications could limit the prospects for regulatory clearances or approval of our product candidates in those and other indications, which could have a material adverse effect on our business, financial condition and
results of operations. In addition, even if such clinical trials are successfully completed, we cannot guarantee that the FDA, the EMA or comparable foreign regulatory authorities will interpret the results as we do, and more trials could be
required before we submit our product candidates for clearance or approval. For example, the definition of clinical meaningfulness for outcome measures in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
lymphedema has not been firmly established by the FDA, introducing risk in evaluating and demonstrating the efficacy required to obtain FDA approval of
<FONT STYLE="white-space:nowrap">LYT-100.</FONT> As another example, while there is guidance regarding clinical meaningfulness for outcome measures in the context of acute <FONT STYLE="white-space:nowrap">COVID-19</FONT> treatments and potential
vaccines, there is no such guidance for treatment of complications that persist following the resolution of <FONT STYLE="white-space:nowrap">COVID-19.</FONT> Even if we believe that our and our Founded Entities&#146; clinical trials and preclinical
studies demonstrate the safety and efficacy of our and their product candidates, only the FDA and other comparable regulatory agencies may ultimately make such determination. No regulatory agency has made any such determination that any of our
Wholly Owned product candidates or those of our Founded Entities, except for Plenity and EndeavorRx, are safe or effective for use by the general public for any indication. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, we may utilize an &#147;open-label&#148; trial design for some of our future clinical trials. An open-label trial is one where both the patient
and investigator know whether the patient is receiving the test article or either an existing approved drug or placebo. Open-label trials are subject to various limitations that may exaggerate any therapeutic effect as patients in open-label studies
are aware that they are receiving treatment. Open-label trials may be subject to a &#147;patient bias&#148; where patients perceive their symptoms to have improved merely due to their awareness of receiving an experimental treatment. Patients
selected for early clinical studies often include the most severe sufferers and their symptoms may have been bound to improve notwithstanding the new treatment. In addition, open-label trials may be subject to an &#147;investigator bias&#148; where
those assessing and reviewing the physiological outcomes of the clinical trials are aware of which patients have received treatment and may interpret the information of the treated group more favorably given this knowledge. The opportunity for bias
in clinical trials as a result of open-label design may not be adequately handled and may cause any of our trials that utilize such design to fail or to be considered inadequate and additional trials may be necessary to support future marketing
applications. Moreover, results acceptable to support clearance or approval in one jurisdiction may be deemed inadequate by another regulatory authority to support regulatory clearance or approval in that other jurisdiction. To the extent that the
results of the trials are not satisfactory to the FDA, the EMA or comparable foreign regulatory authorities for support of a marketing application, we may be required to expend significant resources, which may not be available to us, to conduct
additional trials in support of potential clearance or approval of our Wholly Owned product candidates. Even if regulatory clearance or approval is secured for a product candidate, the terms of such approval may limit the scope and use of the
specific product candidate, which may also limit its commercial potential. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The results of early-stage clinical trials and preclinical studies may
not be predictive of future results. Initial data in clinical trials may not be indicative of results obtained when these trials are completed or in later stage trials. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The results of preclinical studies may not be predictive of the results of clinical trials, and the results of any early-stage clinical trials we commence may
not be predictive of the results of the later-stage clinical trials. The results of preclinical studies and clinical trials in one set of patients or disease indications, or from preclinical studies or clinical trials that we did not lead, may not
be predictive of those obtained in another. In some instances, there can be significant variability in safety or efficacy results between different clinical trials of the same product candidate due to numerous factors, including changes in trial
procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the dosing regimen and other clinical trial protocols and the rate of dropout among clinical trial participants. In addition,
preclinical and clinical data are often susceptible to various interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed
to obtain marketing approval. A number of companies in the pharmaceutical, biopharmaceutical and biotechnology industries have suffered significant setbacks in clinical development even after achieving promising results in earlier studies, and any
such setbacks in our clinical development could have a material adverse effect on our business and operating results. Even if early-stage clinical trials are successful, we may need to conduct additional clinical trials of our Wholly Owned product
candidates in additional patient populations or under different treatment conditions before we are able to seek approvals or clearances from the FDA, the EMA or other comparable foreign regulatory authorities to market and sell these product
candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">17</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Our failure to obtain marketing authorization for our Wholly Owned product candidates would substantially harm our business, prospects, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we encounter difficulties enrolling patients in clinical trials, our clinical development activities could be delayed or otherwise adversely
affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Identifying and qualifying trial participants to participate in clinical studies is critical to our success. The timing of our clinical
studies depends on the speed at which we can recruit trial participants to participate in testing our Wholly Owned product candidates. Delays in enrollment may result in increased costs or may affect the timing or outcome of the planned clinical
trials, which could prevent completion of these trials and adversely affect our ability to advance the development of our Wholly Owned product candidates. If trial participants are unwilling to participate in our studies because of negative
publicity from AEs in our trials or other trials of similar products, or those related to specific therapeutic area, or for other reasons, including competitive clinical studies for similar patient populations, the timeline for recruiting trial
participants, conducting studies, and obtaining regulatory approval of potential products may be delayed. We also may face delays as a result of unforeseen global circumstances, for example we have experienced temporary delays in certain of our
clinical development activities, including enrolling participants in certain of our clinical trials, as a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. Any delays could result in increased costs, delays in advancing our
product candidate development, delays in testing the effectiveness of our Wholly Owned product candidates, or termination of the clinical studies altogether. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may not be able to identify, recruit and enroll a sufficient number of trial participants, or those with required or desired characteristics to achieve
diversity in a study, to complete our clinical studies in a timely manner. Patient and subject enrollment is affected by factors including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and nature of a patient population; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patient eligibility criteria defined in the applicable clinical trial protocols, which may limit the patient
populations eligible for clinical trials to a greater extent than competing clinical trials for the same indication; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size of the study population required for analysis of the trial&#146;s primary endpoints;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the severity of the disease under investigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proximity of patients to a trial site; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inclusion and exclusion criteria for the trial in question; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the design of the trial protocol; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to recruit clinical trial investigators with the appropriate competencies and experience;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability and efficacy of approved medications or therapies for the disease or condition under
investigation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinicians&#146; and patients&#146; perceptions as to the potential advantages and side effects of the product
candidate being studied in relation to other available therapies and product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to obtain and maintain patient consents; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that patients enrolled in clinical trials will not complete such trials, for any reason.
</P></TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, our or our collaborators&#146; ability to successfully initiate, enroll and conduct a clinical trial outside the United
States is subject to numerous additional risks, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulty in establishing or managing relationships with CROs and physicians; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">differing standards for the conduct of clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">differing standards of care for patients with a particular disease; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">18</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an inability to locate qualified local consultants, physicians and partners; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential burden of complying with a variety of foreign laws, medical standards and regulatory requirements,
including the regulation of pharmaceutical and biotechnology products and treatments. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we have difficulty enrolling sufficient
numbers of patients to conduct clinical trials as planned, we may need to delay or terminate clinical trials, either of which would have an adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Use of our Wholly Owned product candidates or those being developed by our Founded Entities could be associated with side effects, AEs or other
properties or safety risks, which could delay or halt their clinical development, prevent their regulatory clearance or approval, cause us to suspend or discontinue clinical trials, abandon a product candidate, limit their commercial potential, if
cleared or approved, or result in other significant negative consequences that could severely harm our business, prospects, operating results and financial condition. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As is the case with pharmaceuticals generally, it is likely that there may be side effects and AEs associated with our and our Founded Entities&#146; drugs or
biologic product candidates&#146; use. Similarly, investigational devices may also be subject to side effects and AEs. Results of our clinical trials or those being conducted by Founded Entities could reveal a high and unacceptable severity and
prevalence of side effects or unexpected characteristics. Undesirable side effects caused by these product candidates could cause us, our Founded Entities or regulatory authorities to interrupt, delay or halt clinical trials and could result in a
more restrictive label or the delay or denial of regulatory clearance or approval by the FDA, the EMA or other comparable foreign regulatory authorities. The side effects related to the product candidate could affect patient recruitment or the
ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may harm our business, financial condition and prospects significantly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, if our Wholly Owned product candidates are associated with undesirable side effects in preclinical studies or clinical trials or have
characteristics that are unexpected, we may elect to abandon their development or limit their development to more narrow uses or subpopulations in which the undesirable side effects or other characteristics are less prevalent, less severe or more
acceptable from a risk-benefit perspective, which may limit the commercial expectations for the product candidate if approved. We may also be required to modify or terminate our study plans based on findings in our preclinical studies or clinical
trials. Many product candidates that initially show promise in early-stage testing may later be found to cause side effects that prevent further development. As we work to advance existing product candidates and to identify new product candidates,
we cannot be certain that later testing or trials of product candidates that initially showed promise in early testing will not be found to cause similar or different unacceptable side effects that prevent their further development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is possible that as we test our Wholly Owned product candidates in larger, longer and more extensive clinical trials, or as the use of these product
candidates becomes more widespread if they receive regulatory clearance or approval, illnesses, injuries, discomforts and other AEs that were observed in earlier trials, as well as conditions that did not occur or went undetected in previous trials,
will be reported by subjects. If such side effects become known later in development or upon approval, if any, such findings may harm our business, financial condition and prospects significantly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, adverse developments in clinical trials of pharmaceutical, biopharmaceutical or biotechnology products conducted by others may cause the FDA or
other regulatory oversight bodies to suspend or terminate our clinical trials or to change the requirements for approval of any of our Wholly Owned product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to side effects caused by the product candidate, the administration process or related procedures also can cause adverse side effects. If any such
AEs occur, our clinical trials could be suspended or terminated. If we are unable to demonstrate that any AEs were caused by the administration process or related procedures, the FDA, the European Commission, the EMA, or other regulatory authorities
could order us to cease further </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">19</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
development of, or deny clearance or approval of, a product candidate for any or all targeted indications. Even if we can demonstrate that all future serious adverse events, or SAEs, are not
product-related, such occurrences could affect patient recruitment or the ability of enrolled patients to complete the trial. Moreover, if we elect, or are required, to not initiate, delay, suspend or terminate any future clinical trial of any of
our Wholly Owned product candidates, the commercial prospects of such product candidates may be harmed and our ability to generate product revenues from any of these product candidates may be delayed or eliminated. Any of these occurrences may harm
our ability to develop other product candidates, and may harm our business, financial condition and prospects significantly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, if any of our
Wholly Owned product candidates receives marketing authorization, the FDA could impose contraindications or a boxed warning in the labeling of our product. For any of our drug or biologic product candidates receiving marketing authorization, the FDA
could require us to adopt a risk evaluation and mitigation strategy, or REMS, and could apply elements to assure safe use to ensure that the benefits of the product outweigh its risks, which may include, among other things, a Medication Guide
outlining the risks of the product for distribution to patients and a communication plan to health care practitioners. Furthermore, if we or others later identify undesirable side effects caused by our Wholly Owned product candidates once approved,
several potentially significant negative consequences could result, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may suspend or withdraw approvals of such product candidate, or seek an injunction against
its manufacture or distribution; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may require additional warnings on the label, including &#147;boxed&#148; warnings, or
issue safety alerts, Deal Healthcare Provider letters, press releases or other communications containing warnings or other safety information about the product; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be required by the FDA to implement a REMS for a marketed drug or biologic; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be required to change the way a product candidate is administered or conduct additional clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be subject to fines, injunctions or the imposition of civil or criminal penalties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we could be sued and held liable for harm caused to patients; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our reputation may suffer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any of these occurrences could prevent us from achieving or maintaining market acceptance of the particular product candidate, if approved, and may harm our
business, financial condition and prospects significantly. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if we complete the necessary preclinical studies and clinical trials, the marketing
approval process is expensive, time-consuming and uncertain and may prevent us from obtaining approvals for the potential commercialization of product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any product candidate we may develop and the activities associated with their development and potential commercialization, including their design, testing,
manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale and distribution, are subject to comprehensive regulation by the FDA, the EMA and other comparable foreign regulatory authorities. Failure to
obtain marketing authorization for a product candidate will prevent us from commercializing the product candidate in a given jurisdiction. For example, although Gelesis and Akili have received marketing clearance for Plenity and EndeavorRX,
respectively, from the FDA, we and our Founded Entities have not received clearance or approval to market any of our or their other product candidates from regulatory authorities in any jurisdiction and it is possible that none of the other product
candidates we and our Founded Entities may seek to develop in the future will ever obtain regulatory approval. We have no experience in filing and supporting the applications necessary to gain marketing authorizations and expect to rely on
third-party CROs or regulatory consultants to assist us in this process. Securing regulatory clearance or approval requires the submission of extensive preclinical and clinical data and supporting information to the various regulatory authorities
for each therapeutic indication to establish the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">20</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
product candidate&#146;s safety, purity, efficacy and potency. Securing regulatory clearance or approval also requires the submission of information about the product manufacturing process to,
and inspection of manufacturing facilities by, the relevant regulatory authority. Any product candidates we or our Founded Entities develop may not be effective, may be only moderately effective, or may prove to have undesirable or unintended side
effects, toxicities or other characteristics that may preclude our obtaining marketing clearance or approval or prevent or limit commercial use, if cleared or approved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The process of obtaining marketing authorizations, both in the United States and abroad, is expensive, may take many years if additional clinical trials are
required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Changes in marketing authorization policies during the development
period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an application. The FDA and comparable authorities in
other countries have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical or other studies. In addition,
varying interpretations of the data obtained from preclinical and clinical testing could delay, limit, or prevent marketing approval of a product candidate. Any marketing approval we ultimately obtain may be limited or subject to restrictions or
post-approval commitments that render the approved product not commercially viable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we experience delays in obtaining clearance or approval or if we
fail to obtain clearance or approval of any product candidates we may develop, the commercial prospects for those product candidates may be harmed, and our ability to generate revenues will be materially impaired. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if any current or future product candidate of ours receives regulatory clearance or approval, it may fail to achieve the degree of market
acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success, in which case we may not generate significant revenues or become profitable. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have never commercialized a product, and even if any current or future product candidate of ours is approved by the appropriate regulatory authorities for
marketing and sale, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. Physicians may be reluctant to take their patients off their current medications and
switch their treatment regimen. Further, patients often acclimate to the treatment regime that they are currently taking and do not want to switch unless their physicians recommend switching products or they are required to switch due to lack of
coverage and adequate reimbursement. In addition, even if we are able to demonstrate our Wholly Owned product candidates&#146; safety and efficacy to the FDA and other regulators, safety or efficacy concerns in the medical community may hinder
market acceptance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Efforts to educate the medical community and third-party payors on the benefits of our Wholly Owned product candidates may require
significant resources, including management time and financial resources, and may not be successful. The degree of market acceptance of our Wholly Owned product candidates, if approved for commercial sale, will depend on a number of factors,
including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the efficacy and safety of the product; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential advantages of the product compared to competitive therapies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prevalence and severity of any side effects; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the product is designated under physician treatment guidelines as a first-, second- or third-line
therapy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability, or the ability of any future collaborators, to offer the product for sale at competitive prices;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the product&#146;s convenience and ease of administration compared to alternative treatments;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">21</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the willingness of the target patient population to try, and of physicians to prescribe, the product;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations or warnings, including distribution or use restrictions contained in the product&#146;s approved
labeling; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the strength of sales, marketing and distribution support; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the standard of care for the targeted indications for the product; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">availability and adequacy of coverage and reimbursement from government payors, managed care plans and other
third-party payors. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales of medical products also depend on the willingness of physicians to prescribe the treatment, which is likely
to be based on a determination by these physicians that the products are safe, therapeutically effective and cost effective. In addition, the inclusion or exclusion of products from treatment guidelines established by various physician groups and
the viewpoints of influential physicians can affect the willingness of other physicians to prescribe the treatment. We cannot predict whether physicians, physicians&#146; organizations, hospitals, other healthcare providers, government agencies or
private insurers will determine that our product is safe, therapeutically effective and cost effective as compared with competing treatments. If any product candidates we develop do not achieve an adequate level of acceptance, we may not generate
significant product revenue, and we may not become profitable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any failure by any current or future product candidate of ours that obtains regulatory
approval to achieve market acceptance or commercial success would adversely affect our business prospects. In addition, any negative perception of one of our Founded Entities or any product candidates marketed or commercialized by them may adversely
affect our reputation in the marketplace or among industry participants and our business prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have conducted, and may continue to conduct
in the future, clinical trials for product candidates outside the United States, and the FDA, the EMA and comparable foreign regulatory authorities may not accept data from such trials. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have conducted clinical trials outside of the United States in the past, and may in the future choose to conduct one or more clinical trials outside the
United States, including in Europe. For example, we have conducted clinical trials for <FONT STYLE="white-space:nowrap">LYT-100</FONT> in Australia and currently plan to conduct future clinical trials for
<FONT STYLE="white-space:nowrap">LYT-100</FONT> in additional locations outside the United States, including without limitation Australia, Romania, Spain and the Phillipines. The acceptance of study data from clinical trials conducted outside the
United States or another jurisdiction by the FDA, the EMA or any comparable foreign regulatory authority may be subject to certain conditions or may not be accepted at all. In cases where data from foreign clinical trials are intended to serve as
the basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (i)&nbsp;the data are applicable to the U.S. population and U.S. medical practice; (ii)&nbsp;the
trials were performed by clinical investigators of recognized competence and pursuant to GCP regulations; and (iii)&nbsp;if necessary, the FDA is able to validate the data through an <FONT STYLE="white-space:nowrap">on-site</FONT> inspection or
other appropriate means. Additionally, the FDA&#146;s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory authorities have similar approval requirements. In
addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA, the EMA or any comparable foreign regulatory authority will accept data
from trials conducted outside of the United States or the applicable jurisdiction. If the FDA, the EMA or any comparable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly
and time-consuming and delay aspects of our business plan, and which may result in product candidates that we may develop not receiving approval or clearance for commercialization in the applicable jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">22</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to obtain regulatory clearance or approval in one or more jurisdictions for any
product candidates that we may identify and develop, our business could be substantially harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot commercialize a product until the
appropriate regulatory authorities have reviewed and cleared or approved the product candidate. Approval by the FDA, the EMA and comparable foreign regulatory authorities is lengthy and unpredictable, and depends upon numerous factors, including
substantial discretion of the regulatory authorities. Approval policies, regulations, or the type and amount of preclinical or clinical data necessary to gain approval may change during the course of a product candidate&#146;s development and may
vary among jurisdictions, which may cause delays in the approval or the decision not to approve an application. Gelesis and Akili have obtained marketing clearance from the FDA for Plenity and EndeavorRx, respectively, but we and our Founded
Entities have not obtained regulatory clearance or approval for any other product candidates, and it is possible that our current product candidates and any other product candidates which we and our Founded Entities may seek to develop in the future
will not ever obtain regulatory clearance or approval. We cannot be certain that any of our Wholly Owned or our Founded Entities&#146; product candidates will receive regulatory clearance or approval or be successfully commercialized even if we or
our Founded Entities receive regulatory clearance or approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Obtaining marketing approval is an extensive, lengthy, expensive and inherently uncertain
process, and regulatory authorities may delay, limit or deny clearance or approval of our Wholly Owned or our Founded Entities&#146; product candidates for many reasons, including but not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to demonstrate to the satisfaction of the FDA, the EMA or comparable foreign regulatory authorities
that the applicable product candidate is safe and effective as a treatment for our targeted indications or otherwise meets the applicable regulatory standards for approval; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA, the EMA or comparable foreign regulatory authorities may disagree with the design, endpoints or
implementation of our or our Founded Entities&#146; clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the population studied in the clinical program may not be sufficiently broad or representative to assure safety
or efficacy in the full population for which we or our Founded Entities seek approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA, the EMA or comparable foreign regulatory authorities may require additional preclinical studies or
clinical trials beyond those that we or our Founded Entities currently anticipate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA, the EMA or comparable foreign regulatory authorities may disagree with our or our Founded Entities&#146;
interpretation of data from preclinical studies or clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the data collected from clinical trials of product candidates that we may identify and pursue may not be
sufficient to support the submission of an NDA, biologics license application, or BLA, or other submission for regulatory approval in the United States or elsewhere; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as applicable, we or our Founded Entities may be unable to demonstrate to the FDA, the EMA or comparable foreign
regulatory authorities that a product candidate&#146;s risk-benefit ratio for its proposed indication is acceptable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA, the EMA or comparable foreign regulatory authorities may identify deficiencies in the manufacturing
processes, test procedures and specifications, or facilities of third-party manufacturers with which we or our Founded Entities contract for clinical and commercial supplies; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the clearance or approval policies or regulations of the FDA, the EMA or comparable foreign regulatory
authorities may change in a manner that renders the clinical trial design or data insufficient for clearance or approval. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The lengthy
approval process, as well as the unpredictability of the results of clinical trials and evolving regulatory requirements, may result in our or our Founded Entities&#146; failure to obtain regulatory approval to market product candidates that we or
our Founded Entities may pursue in the United States or elsewhere, which would significantly harm our or our Founded Entities&#146; business, prospects, financial condition and results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">23</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, clearance or approval by the FDA in the United States, if obtained, does not ensure approval by
regulatory authorities in other countries or jurisdictions. In order to market any products outside of the United States, we or our Founded Entities must establish and comply with numerous and varying regulatory requirements of other countries
regarding safety and effectiveness. Clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not mean that regulatory approval will be obtained in any
other country. Approval processes vary among countries and can involve additional product testing and validation and additional or different administrative review periods from those in the United States, including additional preclinical studies or
clinical trials, as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it
can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval. Seeking foreign regulatory approval could result in difficulties and costs for us or our Founded Entities
and require additional preclinical studies or clinical trials which could be costly and time-consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of our or our Founded Entities&#146;
products in those countries. The foreign regulatory approval process involves all of the risks associated with FDA approval. We do not have any product candidates approved for sale in international markets. If we or our Founded Entities fail to
comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approvals in international markets are delayed, our target market will be reduced and our ability to realize the full market
potential of our products will be harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interim, <FONT STYLE="white-space:nowrap">&#147;top-line,&#148;</FONT> and preliminary data from our
clinical trials that we announce or publish from time to time may change as more patient data become available or as additional analyses are conducted, and as the data are subject to audit and verification procedures that could result in material
changes in the final data. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, we may publish interim, <FONT STYLE="white-space:nowrap">&#147;top-line,&#148;</FONT> or preliminary
data from our clinical studies. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available.
Preliminary or <FONT STYLE="white-space:nowrap">&#147;top-line&#148;</FONT> data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published.
As a result, interim and preliminary data should be viewed with caution until the final data are available. Material adverse changes between preliminary, <FONT STYLE="white-space:nowrap">&#147;top-line,&#148;</FONT> or interim data and final data
could significantly harm our business prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates,
calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our
company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is the
material or otherwise appropriate information to include in our disclosure. Any information we determine not to disclose may ultimately be deemed significant by you or others with respect to future decisions, conclusions, views, activities or
otherwise regarding a particular product candidate or our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain of the product candidates being developed by us or our Founded Entities
are novel, complex and difficult to manufacture. We could experience manufacturing problems that result in delays in our development or commercialization programs or otherwise harm our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The manufacturing processes our CMOs use to produce our and our Founded Entities&#146; product candidates are complex and in certain cases novel. Several
factors could cause production interruptions, including inability to develop novel manufacturing processes, equipment malfunctions, facility contamination, raw material shortages or contamination, natural disasters, disruption in utility services,
human error or disruptions in the operations of our suppliers, including acquisition of the supplier by a third party or declaration of bankruptcy. For example, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">24</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Vedanta has its own proprietary GMP manufacturing facilities for certain product candidates, including VE303, VE800 and VE416. Creating defined consortia of live microbial therapeutics for these
product candidates is inherently complex, and therefore can be vulnerable to delays. The expertise required to manufacture these product candidates is unique to Vedanta, and as a result, it would be difficult and time consuming to find an
alternative CMO. In addition, manufacturing of clinical supply for <FONT STYLE="white-space:nowrap">LYT-100,</FONT> <FONT STYLE="white-space:nowrap">LYT-200,</FONT> and <FONT STYLE="white-space:nowrap">LYT-300</FONT> are dependent on third party
CMOs, and manufacturing such product candidates is inherently complex. As another example, we are advancing <FONT STYLE="white-space:nowrap">LYT-100</FONT> for potential treatment of complications that persist following the resolution of <FONT
STYLE="white-space:nowrap">COVID-19</FONT> infection. <FONT STYLE="white-space:nowrap">COVID-19</FONT> has been widespread, and any approved treatments related to <FONT STYLE="white-space:nowrap">COVID-19</FONT> could face issues manufacturing
sufficient quantities to meet demand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some of our and our Founded Entities&#146; product candidates include biologics, some of which have physical and
chemical properties that cannot be fully characterized. As a result, assays of the finished product may not be sufficient to ensure that the product is consistent from
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">lot-to-lot</FONT></FONT> or will perform in the intended manner. Accordingly, our CMOs must employ multiple steps to control the manufacturing process to assure that the process is
reproducible and the product candidate is made strictly and consistently in compliance with the process. Problems with the manufacturing process, even minor deviations from the normal process, could result in product defects or manufacturing
failures that result in lot failures, product recalls, product liability claims or insufficient inventory to conduct clinical trials or supply commercial markets. We or our Founded Entities may encounter problems achieving adequate quantities and
quality of clinical-grade materials that meet the FDA, the EMA or other applicable standards or specifications with consistent and acceptable production yields and costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the FDA, the EMA and other foreign regulatory authorities may require us or our Founded Entities to submit samples of any lot of any approved
product together with the protocols showing the results of applicable tests at any time. Under some circumstances, the FDA, the EMA or other foreign regulatory authorities may require that we or our Founded Entities not distribute a lot until the
agency authorizes its release. Slight deviations in the manufacturing process, including those affecting quality attributes and stability, may result in unacceptable changes in the product that could result in lot failures or product recalls. Lot
failures or product recalls could cause us or our Founded Entities to delay product launches or clinical trials, which could be costly to us and otherwise harm our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our CMOs also may encounter problems hiring and retaining the experienced scientific, quality assurance, quality-control and manufacturing personnel needed to
operate our manufacturing processes, which could result in delays in production or difficulties in maintaining compliance with applicable regulatory requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any problems in our CMOs&#146; manufacturing process or facilities could result in delays in planned clinical trials and increased costs, and could make us a
less attractive collaborator for potential partners, including larger biotechnology companies and academic research institutions, which could limit access to additional attractive development programs. Problems in our manufacturing process could
restrict our ability to meet potential future market demand for products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not currently have nor do we plan to acquire the infrastructure or
capability internally to manufacture our clinical drug supplies for use in the conduct of our clinical trials, and we lack the resources and the capability to manufacture pur wholly-owned product candidates on a clinical or commercial scale.
Instead, we rely on our third-party manufacturing partners for the production of the active pharmaceutical ingredient, or API, and drug formulation. The facilities used by our third-party manufacturers to manufacture our product candidates that we
may develop must be successfully inspected by the applicable regulatory authorities, including the FDA, after we submit our NDA to the FDA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are
currently completely dependent on our third-party manufacturers for the production of <FONT STYLE="white-space:nowrap">LYT-100</FONT> and <FONT STYLE="white-space:nowrap">LYT-200</FONT> in accordance with cGMPs, which include, among other things,
quality control, quality assurance and the maintenance of records and documentation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">25</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we have entered into agreements for the manufacture of clinical supplies of <FONT
STYLE="white-space:nowrap">LYT-100</FONT> and <FONT STYLE="white-space:nowrap">LYT-200,</FONT> our third-party manufacturers may not perform as agreed, may be unable to comply with these cGMP requirements and with FDA, state and foreign regulatory
requirements or may terminate its agreement with us. If any of our third-party manufacturers cannot successfully manufacture material that conforms to our specifications and the applicable regulatory authorities&#146; strict regulatory requirements,
or pass regulatory inspection, our NDA will not be approved. In addition, although we are ultimately responsible for ensuring product quality, we have no direct
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> control over our third-party manufacturers&#146; ability to maintain adequate quality control, quality assurance and qualified personnel. If our third-party
manufacturers are unable to satisfy the regulatory requirements for the manufacture of our products, or if our suppliers or third-party manufacturers decide they no longer want to manufacture our products, we may need to find alternative
manufacturing facilities, which would be time-consuming and significantly impact our ability to develop, obtain regulatory approval for or market our products. We might be unable to identify manufacturers for long-term clinical and commercial supply
on acceptable terms or at all. Manufacturers are subject to ongoing periodic announced and unannounced inspection by the FDA and other governmental authorities to ensure compliance with government regulations. Currently, our contract manufacturer
for the API for <FONT STYLE="white-space:nowrap">LYT-100</FONT> is located outside the United States and the FDA has recently increased the number of foreign drug manufacturers that it inspects as well as the frequency of such inspections. As a
result, our third-party manufacturers may be subject to increased scrutiny. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we were to experience an unexpected loss of supply for clinical
development or commercialization, we could experience delays in our ongoing or planned clinical trials as our third-party manufacturers would need to manufacture additional quantities of our clinical and commercial supply and we may not be able to
provide sufficient lead time to enable our third-party manufacturers to schedule a manufacturing slot, or to produce the necessary replacement quantities. This could result in delays in progressing our clinical development activities and achieving
regulatory approval for our products, which could materially harm our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The manufacture of pharmaceutical products is complex and requires
significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. We and our contract manufacturers must comply with cGMP regulations and guidelines. Manufacturers of pharmaceutical
products often encounter difficulties in production, particularly in scaling up and validating initial production. These problems include difficulties with production costs and yields, quality control, including stability of the product, quality
assurance testing, operator error, shortages of qualified personnel, as well as compliance with strictly enforced federal, state and foreign regulations. Furthermore, if microbial, viral or other contaminations are discovered in our products or in
the manufacturing facilities in which our products are made, such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination. We cannot assure you that any stability or other issues
relating to the manufacture of any of our products will not occur in the future. Additionally, our manufacturers may experience manufacturing difficulties due to resource constraints or as a result of labor disputes or unstable political
environments. If our manufacturers were to encounter any of these difficulties, or otherwise fail to comply with their contractual obligations, our ability to provide any product candidates to patients in clinical trials would be jeopardized. Any
delay or interruption in the supply of clinical trial supplies could delay the completion of clinical trials, increase the costs associated with maintaining clinical trial programs and, depending upon the period of delay, require us to commence new
clinical trials at additional expense or terminate clinical trials completely. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any adverse developments affecting clinical or commercial manufacturing of
our products may result in shipment delays, inventory shortages, lot failures, product withdrawals or recalls, or other interruptions in the supply of our products or product candidates. We may also have to take inventory write-offs and incur other
charges and expenses for products or product candidates that fail to meet specifications, undertake costly remediation efforts or seek more costly manufacturing alternatives. Accordingly, failures or difficulties faced at any level of our supply
chain could materially adversely affect our business and delay or impede the development and commercialization of any of our products or product candidates and could have a material adverse effect on our business, prospects, financial condition and
results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">26</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The complexity of a combination product that includes a drug or biologic and a medical device presents
additional, unique development and regulatory challenges, which may adversely impact our or our Founded Entities&#146; development plans and our or our Founded Entities&#146; ability to obtain regulatory approval of our Wholly Owned or our Founded
Entities&#146; product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We or our Founded Entities, such as Follica, may decide to pursue marketing authorization of a combination
product. A combination product includes, amongst other possibilities, any investigational drug, device, or biologic packaged separately that according to its proposed labeling is for use only with another individually specified investigational drug,
device, or biologic where both are required to achieve the intended use, indication, or effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Developing and obtaining regulatory approval for
combination products pose unique challenges because they involve components that are regulated under different types of regulatory requirements, and by different FDA centers. As a result, such products raise regulatory, policy and review management
challenges. For example, because divisions from both FDA&#146;s Center for Drug Evaluation and Research or Center for Biologics Evaluation and Research and FDA&#146;s Center for Devices and Radiological Health must review submissions concerning
product candidates that are combination products comprised of drug or biologics and devices, the regulatory review and approval process for these products may be lengthened. In addition, differences in regulatory pathways for each component of a
combination product can impact the regulatory processes for all aspects of product development and management, including clinical investigation, marketing applications, manufacturing and quality control, adverse event reporting, promotion and
advertising, user fees and post-approval modifications. Similarly, the device components of our Founded Entities&#146; product candidates will require any necessary clearances or approvals or other marketing authorizations in other jurisdictions,
which may prove challenging to obtain. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain modifications to our Founded Entities&#146; device products may require new 510(k) clearance or
other marketing authorizations and may require our Founded Entities to recall or cease marketing their products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis received marketing
clearance for Plenity from the FDA. Once a medical device is permitted to be legally marketed in the United States pursuant to a 510(k) clearance, <I>de novo </I>classification, or a premarket approval, or PMA, a manufacturer may be required to
notify the FDA of certain modifications to the<I> </I>device. Manufacturers determine in the first instance whether a change to a product requires a new premarket<I> </I>submission, but the FDA may review any manufacturer&#146;s decision. The FDA
may not agree with our Founded Entities&#146; decisions<I> </I>regarding whether new clearances or approvals are necessary. They may make modifications or add additional features in the future that they believe do not require a new 510(k) clearance,
<I>de novo </I>classification, or approval of a PMA or PMA amendments or supplements. If the FDA disagrees with their determinations and requires them to submit new 510(k) notifications, requests for <I>de novo </I>classification, or PMAs<I> </I>(or
PMA supplements or amendments) for modifications to their previously cleared or reclassified products for<I> </I>which they have concluded that new clearances or approvals are unnecessary, they may be required to cease<I> </I>marketing or to recall
the modified product until they obtain clearance or approval, and they may be subject to significant regulatory fines or penalties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The regulatory
landscape that will apply to development of therapeutic product candidates by us or our Founded Entities or collaborators is rigorous, complex, uncertain and subject to change, which could result in delays or termination of development of such
product candidates or unexpected costs in obtaining regulatory approvals. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We or our Founded Entities or collaborators may develop product
candidates that use genome or cell editing technologies. Regulatory requirements governing products created with genome editing technology or involving gene therapy treatment have changed frequently and will likely continue to change in the future.
Approvals by one regulatory agency may not be indicative of what any other regulatory agency may require for approval, and there is substantial, and sometimes uncoordinated, overlap in those responsible for regulation of gene therapy
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">27</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
products, cell therapy products and other products created with genome editing technology. For example, the FDA established the Office of Tissues and Advanced Therapies within its Center for
Biologics Evaluation and Research, or CBER, to consolidate the review of gene therapy and related products, and the Cellular, Tissue and Gene Therapies Advisory Committee to advise CBER on its review. These and other regulatory review agencies,
committees and advisory groups and the requirements and guidelines they promulgate may lengthen the regulatory review process, require us or our Founded Entities to perform additional preclinical studies or clinical trials, increase our or our
Founded Entities&#146; development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of these treatment candidates or lead to significant post-approval limitations or restrictions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, under the National Institutes of Health, or NIH, Guidelines for Research Involving Recombinant DNA Molecules, or NIH Guidelines,
supervision of human gene transfer trials includes evaluation and assessment by an institutional biosafety committee, or IBC, a local institutional committee that reviews and oversees research utilizing recombinant or synthetic nucleic acid
molecules at that institution. The IBC assesses the safety of the research and identifies any potential risk to public health or the environment, and such review may result in some delay before initiation of a clinical trial. While the NIH
Guidelines are not mandatory unless the research in question is being conducted at or sponsored by institutions receiving NIH funding of recombinant or synthetic nucleic acid molecule research, many companies and other institutions not otherwise
subject to the NIH Guidelines voluntarily follow them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the European Union, the EMA has a Committee for Advanced Therapies, or CAT, that is responsible
for assessing the quality, safety and efficacy of advanced therapy medicinal products. Advanced-therapy medical products include gene therapy medicine, somatic-cell therapy medicines and tissue-engineered medicines. The role of the CAT is to prepare
a draft opinion on an application for marketing authorization for a gene therapy medicinal candidate that is submitted to the EMA. In the European Union, the development and evaluation of a gene therapy medicinal product must be considered in the
context of the relevant European Union guidelines. The EMA may issue new guidelines concerning the development and marketing authorization for gene therapy medicinal products and require that we or our Founded Entities comply with these new
guidelines. Similarly complex regulatory environments exist in other jurisdictions in which we or our Founded Entities might consider seeking regulatory approvals for our Wholly Owned or our Founded Entities&#146; product candidates, further
complicating the regulatory landscape. As a result, the procedures and standards applied to gene therapy products and cell therapy products may be applied to any of our or our Founded Entities&#146; gene therapy or genome editing product candidates,
but that remains uncertain at this point. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in applicable regulatory guidelines may lengthen the regulatory review process for our Wholly Owned or
our Founded Entities&#146; product candidates, require additional studies or trials, increase development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of such product candidates,
or lead to significant post-approval limitations or restrictions. Additionally, adverse developments in clinical trials conducted by others of gene therapy products or products created using genome editing technology, or adverse public perception of
the field of genome editing, may cause the FDA, the EMA and other regulatory bodies to revise the requirements for approval of any product candidates we or our Founded Entities may develop or limit the use of products utilizing genome editing
technologies, either of which could materially harm our or our Founded Entities&#146; business. Furthermore, regulatory action or private litigation could result in expenses, delays or other impediments to our research programs or the development or
commercialization of current or future product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As we advance product candidates alone or with collaborators, we will be required to consult
with these regulatory and advisory groups and comply with all applicable guidelines, rules and regulations. If we fail to do so, we or our collaborators may be required to delay or terminate development of such product candidates. Delay or failure
to obtain, or unexpected costs in obtaining, the regulatory approval necessary to bring a product candidate to market could decrease our ability to generate sufficient product revenue to maintain our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">28</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not elect or be able to take advantage of any expedited development or regulatory review and
approval processes available to drug product candidates granted breakthrough therapy or fast track designation by the FDA. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to evaluate
and continue ongoing discussions with the FDA on regulatory strategies that could enable us or our Founded Entities to take advantage of expedited development pathways for certain of our Wholly Owned or our Founded Entities&#146; product candidates
in the future, although we cannot be certain that our Wholly Owned or our Founded Entities&#146; product candidates will qualify for any expedited development pathways or that regulatory authorities will grant, or allow us or our Founded Entities to
maintain, the relevant qualifying designations. Potential expedited development pathways that we could pursue include breakthrough therapy and fast track designation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Breakthrough therapy designation is intended to expedite the development and review of drug product candidates that are designed to treat serious or
life-threatening diseases when preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed
early in clinical development. The designation of a product candidate as a breakthrough therapy provides potential benefits that include more frequent meetings with FDA to discuss the development plan for the product candidate and ensure collection
of appropriate data needed to support approval; more frequent written correspondence from FDA about such things as the design of the proposed clinical trials and use of biomarkers; intensive guidance on an efficient drug development program,
beginning as early as Phase 1; organizational commitment involving senior managers; and eligibility for rolling review and priority review. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fast track
designation is designed for drug product candidates intended for the treatment of a serious or life-threatening disease or condition, where preclinical or clinical data demonstrate the potential to address an unmet medical need for this disease or
condition. Accordingly, even if we believe a particular product candidate is eligible for breakthrough therapy or fast track designation, we cannot assure you that the FDA would decide to grant it. Breakthrough therapy designation and fast track
designation do not change the standards for product approval, and there is no assurance that such designation or eligibility will result in expedited review or approval or that the approved indication will not be narrower than the indication covered
by the breakthrough therapy designation or fast track designation. Thus, even if we or our Founded Entities do receive breakthrough therapy or fast track designation, we or our Founded Entities may not experience a faster development process, review
or approval compared to conventional FDA procedures. The FDA may withdraw breakthrough therapy or fast track designation if it believes that the product no longer meets the qualifying criteria. Our business may be harmed if we are unable to avail
ourselves of these or any other expedited development and regulatory pathways. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we or our Founded Entities are unable to successfully validate,
develop and obtain regulatory approval for companion diagnostic tests for any future drug candidates that require or would commercially benefit from such tests, or experience significant delays in doing so, we or our Founded Entities may not realize
the full commercial potential of these drug candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the clinical development of our Wholly Owned or Founded Entities&#146;
product candidates for certain indications, we or our Founded Entities may work with collaborators to develop or obtain access to <I>in vitro</I> companion diagnostic tests to identify patient subsets within a disease category who may derive
selective and meaningful benefit from our drug candidates. For example, we may elect to develop companion diagnostics for <FONT STYLE="white-space:nowrap">LYT-200</FONT> and <FONT STYLE="white-space:nowrap">LYT-210.</FONT> To be successful, we, our
Founded Entities or our collaborators will need to address a number of scientific, technical, regulatory and logistical challenges. The FDA, the EMA and comparable foreign regulatory authorities regulate <I>in vitro</I> companion diagnostics as
medical devices and, under that regulatory framework, will likely require the conduct of clinical trials to demonstrate the safety and effectiveness of any diagnostics we or our Founded Entities may develop, which we expect will require separate
regulatory clearance or approval prior to commercialization. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">29</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We or our Founded Entities may rely on third parties for the design, development and manufacture of companion
diagnostic tests for our Wholly Owned or our Founded Entities&#146; product candidates that may require such tests. If we or our Founded Entities enter into such collaborative agreements, we will be dependent on the sustained cooperation and effort
of our future collaborators in developing and obtaining approval for these companion diagnostics. It may be necessary to resolve issues such as selectivity/specificity, analytical validation, reproducibility, or clinical validation of companion
diagnostics during the development and regulatory approval processes. Moreover, even if data from preclinical studies and early clinical trials appear to support development of a companion diagnostic for a product candidate, data generated in later
clinical trials may fail to support the analytical and clinical validation of the companion diagnostic. We, our Founded Entities and our future collaborators may encounter difficulties in developing, obtaining regulatory approval for, manufacturing
and commercializing companion diagnostics similar to those we face with respect to our Wholly Owned product candidates themselves, including issues with achieving regulatory clearance or approval, production of sufficient quantities at commercial
scale and with appropriate quality standards, and in gaining market acceptance. If we or our Founded Entities are unable to successfully develop companion diagnostics for these product candidates, or experience delays in doing so, the development of
these product candidates may be adversely affected, these product candidates may not obtain marketing approval, and we may not realize the full commercial potential of any of these product candidates that obtain marketing approval. As a result, our
business, results of operations and financial condition could be materially harmed. In addition, a diagnostic company with whom we or our Founded Entities contract may decide to discontinue selling or manufacturing the companion diagnostic test that
we anticipate using in connection with development and commercialization of our Wholly Owned or our Founded Entities&#146; product candidates or our relationship with such diagnostic company may otherwise terminate. We or our Founded Entities may
not be able to enter into arrangements with another diagnostic company to obtain supplies of an alternative diagnostic test for use in connection with the development and commercialization of our Wholly Owned or our Founded Entities&#146; product
candidates or do so on commercially reasonable terms, which could adversely affect and/or delay the development or commercialization of our or our Founded Entities&#146; therapeutic candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>For any approved product, we or our Founded Entities will be subject to ongoing regulatory obligations and continued regulatory review, which may result
in significant additional expense and we or our Founded Entities may be subject to penalties if we or our Founded Entities fail to comply with regulatory requirements or experience unanticipated problems with our Wholly Owned or our Founded
Entities&#146; product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis&#146; Plenity and Akili&#146;s EndeavorRx are, and any of our Wholly Owned or our Founded
Entities&#146; product candidates that are cleared or approved will be, subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies,
and submission of safety, efficacy and other post-market information, including both federal and state requirements in the United States and requirements of comparable foreign regulatory authorities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Manufacturers and manufacturers&#146; facilities are required to comply with extensive requirements imposed by the FDA, the EMA and other comparable foreign
regulatory authorities, including ensuring that quality control and manufacturing procedures conform to current good manufacturing practices, or cGMP, regulations. As such, we and our CMOs are subject to continual review and inspections to assess
compliance with cGMP and adherence to commitments made in any marketing clearance, such as for Plenity, and any future 510(k), premarket approval, or PMA, application, NDA, BLA or marketing authorization application, or MAA, or equivalent
application. We and our CMOs are also subject to requirements pertaining to the registration of our manufacturing facilities and the listing of our product and product candidates with the FDA; continued complaint, adverse event and malfunction
reporting; corrections and removals reporting; and labeling and promotional requirements. Accordingly, we and others with whom we work must continue to expend time, money, and effort in all areas of regulatory compliance, including manufacturing,
production and quality control. Gelesis&#146; and Akili&#146;s marketing clearance for Plenity and EndeavorRx, respectively, are and any regulatory clearances or approvals that we may receive for our Wholly Owned or our Founded Entities&#146;
product candidates will be, subject to limitations on the cleared or approved indicated uses for which the product may be marketed and promoted or to the conditions of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">30</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
approval. Any regulatory clearances or approvals that we may receive for our Wholly Owned product candidates may contain requirements for potentially costly post-marketing testing, such as Phase
4 clinical trials and surveillance to monitor the safety and efficacy of a drug product. We are required to report certain adverse reactions and production problems, if any, to the FDA, the EMA and other comparable foreign regulatory authorities.
Any new legislation addressing drug or medical safety issues could result in delays in product development or commercialization, or increased costs to assure compliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA and other agencies, including the U.S. Department of Justice, and for certain products, the Federal Trade Commission, closely regulate and monitor the
post-approval marketing, labeling, advertising and promotion of products to ensure that they are manufactured, marketed and distributed only for the cleared or approved indications and in accordance with the provisions of the approved label. We are,
and will be, required to comply with requirements concerning advertising and promotion for our Wholly Owned product candidates, if approved. For example, promotional communications with respect to prescription drugs and medical devices are subject
to a variety of legal and regulatory restrictions and must be consistent with the information in the product&#146;s label or labeling. We may not promote our products for indications or uses for which they do not have approval or clearance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holder of a cleared 510(k) or an approved NDA, BLA, PMA, MAA or equivalent marketing authorization must submit new or supplemental applications and obtain
approval for certain changes to the approved product, product labeling, or manufacturing process. For example, any modification to Plenity that would significantly affect its safety or effectiveness or that would constitute a major change in its
intended use would require a new 510(k) clearance or approval of PMA application. Delays in obtaining required clearances or approvals would harm our ability to introduce new or enhanced product in a timely manner, which in turn would harm our or
our Founded Entities&#146; future growth. Failure to submit a new or supplemental application and to obtain approval for certain changes prior to marketing the modified product may require a recall or to stop selling or distributing the marketed
product as modified, and may lead to significant enforcement actions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the European Economic Area, or the EEA, any medical devices will need to comply
with the Essential Requirements set forth in Medical Device Regulation. Compliance with these requirements is a prerequisite to be able to affix the CE mark to a product, without which a product cannot be marketed or sold in the EEA. To demonstrate
compliance with the Essential Requirements and obtain the right to affix the CE mark, we or our Founded Entities must undergo a conformity assessment procedure, which varies according to the type of medical device and its classification. The
conformity assessment procedure requires the intervention of a Notified Body, which is an organization designated by a competent authority of an EEA country to conduct conformity assessments. The Notified Body issues a CE Certificate of Conformity
following successful completion of a conformity assessment procedure and quality management system audit conducted in relation to the medical device and its manufacturer and their conformity with the Essential Requirements. This Certificate entitles
the manufacturer to affix the CE mark to its medical products after having prepared and signed a related EC Declaration of Conformity. In June 2020, Gelesis received a CE Mark for Plenity as a class III medical device indicated for weight loss in
overweight and obese adults with a Body Mass Index of <FONT STYLE="white-space:nowrap">25-40</FONT> kg/m2, when used in conjunction with diet and exercise. Also in June 2020, Akili received a CE Mark for EndeavorRx as a prescription-only digital
therapeutic software intended for the treatment of attention and inhibitory control deficits in paediatric patients with ADHD. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We or our Founded Entities
could also be required to conduct post-marketing clinical trials to verify the safety and efficacy of our or our Founded Entities&#146; products in general or in specific patient subsets. If original marketing approval of a drug or biologic was
obtained via an accelerated approval pathway, we or our Founded Entities could be required to conduct a successful post-marketing clinical trial to confirm clinical benefit for our or our Founded Entities&#146; products. An unsuccessful
post-marketing study or failure to complete such a study could result in the withdrawal of marketing approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a regulatory agency discovers
previously unknown problems with a product, such as AEs of unanticipated severity or frequency, or problems with the facility where the product is manufactured, or disagrees with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">31</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
promotion, marketing or labeling of a product, such regulatory agency may impose restrictions on that product or us, including requiring withdrawal of the product from the market. If we or our
Founded Entities fail to comply with applicable regulatory requirements, a regulatory agency or enforcement authority may, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue warning letters that would result in adverse publicity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impose civil or criminal penalties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">suspend or withdraw regulatory approvals; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">suspend any of our or our Founded Entities&#146; ongoing clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refuse to approve pending applications or supplements to approved applications submitted by us or our Founded
Entities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impose restrictions on our operations, including closing our CMOs&#146; facilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seize or detain products; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">require a product recall. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any government investigation of alleged violations of law could require us to expend significant time and resources in response, and could generate negative
publicity. Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenue from our products. If regulatory sanctions are applied or if regulatory clearance or
approval is withdrawn, the value of our company and our operating results will be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA&#146;s and other regulatory
authorities&#146; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory clearance or approval of our Wholly Owned or our Founded Entities&#146; product candidates. For example,
following new guidance from the FDA recognizing the need for access to certain <FONT STYLE="white-space:nowrap">low-risk</FONT> clinically-validated digital health devices for psychiatric conditions during the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, in April 2020 Akili announded that EndeavorRx <FONT STYLE="white-space:nowrap">(AKL-T01)</FONT> would be available for use by children with ADHD and their families </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in
the United States or abroad. For example, certain policies of the Trump administration may impact our business and industry. Namely, the Trump administration has taken several executive actions, including the issuance of a number of Executive
Orders, that could impose significant burdens on, or otherwise materially delay, the FDA&#146;s ability to engage in routine regulatory and oversight activities such as implementing statutes through rulemaking, issuance of guidance and review and
approval of marketing applications. If these executive actions impose constraints on the FDA&#146;s ability to engage in oversight and implementation activities in the normal course, our business may be negatively impacted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The FDA and other regulatory agencies actively enforce the laws and regulations prohibiting the promotion of
<FONT STYLE="white-space:nowrap">off-label</FONT> uses. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, for any of our Wholly Owned product candidates that are cleared or approved, we are
found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT> uses of those products, we may become subject to significant liability. The FDA and other regulatory agencies strictly regulate the promotional claims that may be
made about prescription products, if approved. In particular, while the FDA permits the dissemination of truthful and <FONT STYLE="white-space:nowrap">non-misleading</FONT> information about an approved product, a manufacturer may not promote a
product for uses that are not approved by the FDA or such other regulatory agencies as reflected in the product&#146;s approved labeling. If we are found to have promoted such <FONT STYLE="white-space:nowrap">off-label</FONT> uses, we may become
subject to significant liability. The federal government has levied large civil and criminal fines against companies for alleged improper promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> use and has enjoined several companies from
engaging in <FONT STYLE="white-space:nowrap">off-label</FONT> promotion. The FDA has also requested that companies enter into consent decrees, corporate integrity agreements or permanent injunctions under which specified
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">32</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
promotional conduct must be changed or curtailed. If we cannot successfully manage the promotion of our Wholly Owned product candidates, if approved, we could become subject to significant
liability, which would materially adversely affect our business and financial condition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our or our Founded Entities&#146; products must be
manufactured in accordance with federal, state and international regulations, and we or our Founded Entities could be forced to recall our or our Founded Entities&#146; medical devices or terminate production if we or our Founded Entities fail to
comply with these regulations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The methods used in, and the facilities used for, the manufacture of medical device products of our Founded
Entities, including Gelesis, Akili, Follica and Sonde, must comply with the FDA&#146;s cGMPs for medical devices, known as Quality System Regulation, or QSR, which is a complex regulatory scheme that covers the procedures and documentation of, among
other requirements, the design, testing, validation, verification, complaint handling, production, process controls, quality assurance, labeling, supplier evaluation, packaging, handling, storage, distribution, installation, servicing and shipping
of medical devices. Furthermore, we and our Founded Entities are required to verify that our suppliers maintain facilities, procedures and operations that comply with our quality standards and applicable regulatory requirements. The FDA enforces the
QSR through, among other oversight methods, periodic announced or unannounced inspections of medical device manufacturing facilities, which may include the facilities of subcontractors, suppliers or CMOs. Our and our Founded Entities&#146; products
are also subject to similar state regulations and various laws and regulations of foreign countries governing manufacturing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our or our Founded
Entities&#146; third-party manufacturers may not take the necessary steps to comply with applicable regulations or our or our Founded Entities&#146; specifications, which could cause delays in the delivery of our products. In addition, failure to
comply with applicable FDA requirements or later discovery of previously unknown problems with our or our Founded Entities&#146; products or manufacturing processes could result in, among other things: warning letters or untitled letters; customer
civil penalties; suspension or withdrawal of approvals or clearances; seizures or recalls of our or our Founded Entities&#146; products; total or partial suspension of production or distribution; administrative or judicially imposed sanctions; the
FDA&#146;s refusal to grant pending or future clearances or approvals for our or our Founded Entities&#146; products; clinical holds; refusal to permit the import or export of our or our Founded Entities&#146; products; and criminal prosecution of
us or our employees. Any of these actions could significantly and negatively impact supply of our or our Founded Entities&#146; products. If any of these events occurs, our reputation could be harmed, we could be exposed to product liability claims
and we or our Founded Entities could lose customers and suffer reduced revenue and increased costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Commercialization </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If, in the future, we are unable to establish sales and marketing capabilities or enter into agreements with third parties to sell and market any product
candidates we may develop, we may not be successful in commercializing those product candidates if and when they are approved. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have a
sales or marketing infrastructure or the capabilities for sale, marketing, or distribution of pharmaceutical products. To achieve commercial success for any approved product for which we retain sales and marketing responsibilities, we must either
develop a sales and marketing organization or outsource these functions to third parties. In the future, we may choose to build a focused sales, marketing, and commercial support infrastructure to market and sell our Wholly Owned product candidates,
if and when they are approved. We may also elect to enter into collaborations or strategic partnerships with third parties to engage in commercialization activities with respect to selected product candidates, indications or geographic territories,
including territories outside the United States, although there is no guarantee we will be able to enter into these arrangements even if the intent is to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are risks involved with both establishing our own commercial capabilities and entering into arrangements with third parties to perform these services.
For example, recruiting and training a sales force or reimbursement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">33</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
specialists is expensive and time consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing and
other commercialization capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or
reposition commercialization personnel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Factors that may inhibit our efforts to commercialize any approved product on our own include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to recruit and retain adequate numbers of effective sales, marketing, reimbursement, customer
service, medical affairs, and other support personnel; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability of sales personnel to obtain access to physicians or persuade adequate numbers of physicians to
prescribe any future approved products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement, and
other acceptance by payors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to price products at a sufficient price point to ensure an adequate and attractive level of
profitability; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restricted or closed distribution channels that make it difficult to distribute our products to segments of the
patient population; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lack of complementary products to be offered by sales personnel, which may put us at a competitive
disadvantage relative to companies with more extensive product lines; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unforeseen costs and expenses associated with creating an independent commercialization organization.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we enter into arrangements with third parties to perform sales, marketing, commercial support, and distribution services, our
product revenue or the profitability of product revenue may be lower than if we were to market and sell any products we may develop internally. In addition, we may not be successful in entering into arrangements with third parties to commercialize
our Wholly Owned product candidates or may be unable to do so on terms that are favorable to us or them. We may have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market
our products effectively or may expose us to legal and regulatory risk by not adhering to regulatory requirements and restrictions governing the sale and promotion of prescription drug products, including those restricting <FONT
STYLE="white-space:nowrap">off-label</FONT> promotion. If we do not establish commercialization capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our Wholly Owned
product candidates, if approved. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The insurance coverage and reimbursement status of newly-approved products is uncertain. Our Wholly Owned product
candidates may become subject to unfavorable pricing regulations, third-party coverage and reimbursement practices, or healthcare reform initiatives, which would harm our business. Failure to obtain or maintain coverage and adequate reimbursement
for new or current products could limit our ability to market those products and decrease our ability to generate revenue. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The regulations that
govern marketing approvals, pricing, coverage, and reimbursement for new drugs and other medical products vary widely from country to country. In the United States, healthcare reform legislation may significantly change the approval requirements in
ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a product before it can be marketed. In many countries, the pricing review period begins after marketing or
product licensing approval is granted. In some foreign markets, pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product in a particular country,
but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenue we are able to generate from the sale of the product in that country. Adverse pricing
limitations may hinder our ability to recoup our investment in one or more products or product candidates, even if any product candidates we may develop obtain marketing approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">34</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to successfully commercialize our products and product candidates also will depend in part on the
extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers, and other organizations. Government authorities and
third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. The availability of coverage and extent of reimbursement by governmental and
private payors is essential for most patients to be able to afford treatments such as gene therapy products. Sales of these or other product candidates that we may identify will depend substantially, both domestically and abroad, on the extent to
which the costs of our Wholly Owned product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health
coverage insurers and other third-party payors. If coverage and adequate reimbursement is not available, or is available only to limited levels, we may not be able to successfully commercialize our products or product candidates. Even if coverage is
provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment. A primary trend in the U.S. healthcare industry and elsewhere is cost
containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. In many countries, the prices of medical products are subject to varying
price control mechanisms as part of national health systems. In general, the prices of medicines under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for medicines, but monitor
and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our Wholly Owned product candidates. Accordingly, in markets outside the United States,
the reimbursement for products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is also significant uncertainty related to the insurance coverage and reimbursement of newly approved products and coverage may be more limited than the
purposes for which the medicine is approved by the FDA or comparable foreign regulatory authorities. In the United States, the principal decisions about reimbursement for new medicines are typically made by the Centers for Medicare&nbsp;&amp;
Medicaid Services, or CMS, an agency within the U.S. Department of Health and Human Services. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial
degree. No uniform policy of coverage and reimbursement for products exists among third-party payors and coverage and reimbursement levels for products can differ significantly from payor to payor. As a result, the coverage determination process is
often a time consuming and costly process that may require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or
obtained in the first instance. It is difficult to predict what CMS will decide with respect to reimbursement for fundamentally novel products such as ours, as there is no body of established practices and precedents for these new products.
Reimbursement agencies in Europe may be more conservative than CMS. For example, a number of cancer drugs have been approved for reimbursement in the United States and have not been approved for reimbursement in certain European countries. Moreover,
eligibility for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale, and distribution. Interim reimbursement levels for new drugs, if
applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for
lower cost drugs and may be incorporated into existing payments for other services. Our inability to promptly obtain coverage and profitable payment rates from both government-funded and private payors for any approved products we may develop could
have a material adverse effect on our operating results, our ability to raise capital needed to commercialize product candidates, and our overall financial condition. Further, due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic,
millions of individuals have lost/will be losing employer-based insurance coverage, which may adversely affect our ability to commercialize our products, As noted above, in the United States, we plan to have various programs to help patients afford
our products, including patient assistance programs and <FONT STYLE="white-space:nowrap">co-pay</FONT> coupon programs for eligible patients. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">35</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare
programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Our inability to promptly obtain coverage and profitable
reimbursement rates third-party payors for any approved products that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our overall financial condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Increasingly, third-party payors are requiring that pharmaceutical companies provide them with predetermined discounts from list prices and are challenging
the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, the level of reimbursement. Reimbursement may impact the demand for,
or the price of, any product or product candidate for which we obtain marketing approval. In order to obtain reimbursement, physicians may need to show that patients have superior treatment outcomes with our products compared to standard of care
drugs, including lower-priced generic versions of standard of care drugs. We expect to experience pricing pressures in connection with the sale of any of our Wholly Owned product candidates, due to the trend toward managed healthcare, the increasing
influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a
result, increasingly high barriers are being erected to the entry of new products. Additionally, we may develop companion diagnostic tests for use with our Wholly Owned or our Founded Entities&#146; product candidates. We, or our Founded Entities or
our collaborators may be required to obtain coverage and reimbursement for these tests separate and apart from the coverage and reimbursement we seek for our Wholly Owned or our Founded Entities&#146; product candidates, once approved. Even if we or
our Founded Entities obtain regulatory approval or clearance for such companion diagnostics, there is significant uncertainty regarding our ability to obtain coverage and adequate reimbursement for the same reasons applicable to our Wholly Owned or
our Founded Entities&#146; product candidates. Medicare reimbursement methodologies, whether under Part A, Part B, or clinical laboratory fee schedule may be amended from time to time, and we cannot predict what effect any change to these
methodologies would have on any product candidate or companion diagnostic for which we receive approval. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with healthcare laws,
we could face substantial penalties and our business, operations and financial conditions could be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthcare providers,
physicians and third-party payors in the United States and elsewhere play a primary role in the recommendation and prescription of pharmaceutical products. Arrangements with healthcare providers, third-party payors and customers can expose
pharmaceutical manufacturers to broadly applicable fraud and abuse and other healthcare laws and regulations, including, without limitation, the federal Anti-Kickback Statute and the federal False Claims Act, or the FCA, which may constrain the
business or financial arrangements and relationships through which such companies sell, market and distribute pharmaceutical products. In particular, the promotion, sales and marketing of healthcare items and services, as well as certain business
arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of ownership, pricing,
discounting, marketing and promotion, structuring and commission(s), certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course
of patient recruitment for clinical trials. The applicable federal and state healthcare laws and regulations laws that may affect our ability to operate include, but are not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully
soliciting, receiving, offering or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the
purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does not need to
have actual </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">36</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
knowledge of the statute or specific intent to violate it in order to have committed a violation. Violations are subject to civil and criminal fines and penalties for each violation, plus up to
three times the remuneration involved, imprisonment of up to ten years, and exclusion from government healthcare programs. In addition, the government may assert that a claim including items or services resulting from a violation of the federal
Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. The Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical manufacturers, on the one hand, and prescribers, purchasers and
formulary managers, on the other. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal civil and criminal false claims laws and civil monetary penalty laws, including the False Claims Act,
which impose criminal and civil penalties, including through civil &#147;qui tam&#148; or &#147;whistleblower&#148; actions, against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for
payment or approval from Medicare, Medicaid, or other federal health care programs that are false or fraudulent; knowingly making or causing a false statement material to a false or fraudulent claim or an obligation to pay money to the federal
government; or knowingly concealing or knowingly and improperly avoiding or decreasing such an obligation. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to
&#147;cause&#148; the submission of false or fraudulent claims. The FCA also permits a private individual acting as a &#147;whistleblower&#148; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any
monetary recovery. When an entity is determined to have violated the federal civil False Claims Act, the government may impose civil fines and penalties for each false claim, plus treble damages, and exclude the entity from participation in
Medicare, Medicaid and other federal healthcare programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional
federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the
money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material
fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity can be found
guilty of violating HIPAA without actual knowledge of the statute or specific intent to violate it; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal civil monetary penalties laws, which impose civil fines for, among other things, the offering or
transfer or remuneration to a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary&#146;s selection of a particular provider, practitioner, or supplier of services reimbursable
by Medicare or a state healthcare program, unless an exception applies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH,
and their respective implementing regulations, which impose, among other things, requirements on certain covered healthcare providers, health plans, and healthcare clearinghouses as well as their respective business associates that perform services
for them that involve the use, or disclosure of, individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization. HITECH also created
new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts
to enforce the federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal civil actions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Physician Payments Sunshine Act, created under the ACA, and its implementing regulations, which
require manufacturers of drugs, devices, biologicals and medical supplies for which </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">37</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
payment is available under Medicare, Medicaid or the Children&#146;s Health Insurance Program (with certain exceptions) to report annually to the U.S. Department of Health and Human Services, or
HHS, under the Open Payments Program, information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), and teaching hospitals, as well as ownership
and investment interests held by physicians and their immediate family members. Effective January&nbsp;1, 2022, these reporting obligations will extend to include transfers of value made to certain
<FONT STYLE="white-space:nowrap">non-physician</FONT> providers such as physician assistants and nurse practitioners; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and
activities that potentially harm consumers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal price reporting laws, which require manufacturers to calculate and report complex pricing metrics to
government programs, where such reported prices may be used in the calculation of reimbursement and/or discounts on approved products; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous state and foreign laws and regulations, such as state and foreign anti-kickback, false claims, consumer
protection and unfair competition laws which may apply to pharmaceutical business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims involving healthcare items or services
reimbursed by any third-party payer, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated
by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding pricing and marketing
information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; state and local laws requiring the registration of pharmaceutical sales
representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and are often not
<FONT STYLE="white-space:nowrap">pre-empted</FONT> by HIPAA, thus complicating compliance efforts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because of the breadth of these laws
and the narrowness of the statutory exceptions and regulatory safe harbors available, it is possible that some of our business activities, including compensation of physicians with stock or stock options, could, despite efforts to comply, be subject
to challenge under one or more of such laws. Additionally, FDA or foreign regulators may not agree that we have mitigated any risk of bias in our clinical trials due to payments or equity interests provided to investigators or institutions which
could limit a regulator&#146;s acceptance of those clinical trial data in support of a marketing application. Moreover, efforts to ensure that our business arrangements will comply with applicable healthcare laws may involve substantial costs. It is
possible that governmental and enforcement authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and
regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil,
criminal and administrative penalties, damages, disgorgement, monetary fines, exclusion from participation in Medicare, Medicaid and other federal healthcare programs, integrity and oversight agreements to resolve allegations of <FONT
STYLE="white-space:nowrap">non-compliance,</FONT> contractual damages, reputational harm, diminished profits and future earnings, and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our
business and our results of operations. In addition, the approval and commercialization of any of our Wholly Owned product candidates outside the United States will also likely subject us to foreign equivalents of the healthcare laws mentioned
above, among other foreign laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">38</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Failure to comply with health and data protection laws and regulations could lead to government
enforcement actions (which could include civil or criminal penalties), private litigation, and/or adverse publicity and could negatively affect our operating results and business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and any potential collaborators may be subject to federal, state, and foreign data protection laws and regulations (i.e., laws and regulations that address
privacy and data security). In the United States, numerous federal and state laws and regulations, including federal health information privacy laws, state data breach notification laws, state health information privacy laws, and federal and state
consumer protection laws (e.g., Section&nbsp;5 of the Federal Trade Commission Act), that govern the collection, use, disclosure and protection of health-related and other personal information could apply to our operations or the operations of our
collaborators. In addition, we may obtain health information from third parties (including research institutions from which we obtain clinical trial data) that are subject to privacy and security requirements under HIPAA, as amended by HITECH.
Depending on the facts and circumstances, we could be subject to civil, criminal, and administrative penalties if we knowingly obtain, use, or disclose individually identifiable health information maintained by a HIPAA-covered entity in a manner
that is not authorized or permitted by HIPAA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compliance with U.S. and international data protection laws and regulations, including the General Data
Protection Regulation 2016/679, or GDPR, in the European Union, could require us to take on more onerous obligations in our contracts, restrict our ability to collect, use and disclose data, or in some cases, impact our ability to operate in certain
jurisdictions. Failure to comply with these laws and regulations could result in government enforcement actions (which could include civil, criminal and administrative penalties), private litigation, and/or adverse publicity and could negatively
affect our operating results and business. Moreover, clinical trial subjects, employees and other individuals about whom we or our potential collaborators obtain personal information, as well as the providers who share this information with us, may
limit our ability to collect, use and disclose the information. Claims that we have violated individuals&#146; privacy rights, failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable,
could be expensive and time-consuming to defend and could result in adverse publicity that could harm our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Healthcare legislative measures
aimed at reducing healthcare costs may have a material adverse effect on our business and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The United States and many
foreign jurisdictions have enacted or proposed legislative and regulatory changes affecting the healthcare system that could prevent or delay marketing approval of our Wholly Owned or our Founded Entities&#146; product candidates or any future
product candidates, restrict or regulate post-approval activities and affect our or our Founded Entities&#146; ability to profitably sell any product for which we or our Founded Entities obtain marketing approval. Changes in regulations, statutes or
the interpretation of existing regulations could impact our or our Founded Entities&#146; business in the future by requiring, for example: (i)&nbsp;changes to our manufacturing arrangements; (ii)&nbsp;additions or modifications to product labeling;
(iii)&nbsp;the recall or discontinuation of our products; or (iv)&nbsp;additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States, there have been and continue to be a number of legislative initiatives and judicial challenges to contain healthcare costs. For example,
in March 2010, the ACA was passed, which substantially changed the way healthcare is financed by both governmental and private insurers, and significantly impacted the U.S. pharmaceutical industry. The ACA, among other things, subjects biological
products to potential competition by lower-cost biosimilars, addresses a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or
injected, increases the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program to individuals enrolled in Medicaid managed care organizations, establishes annual fees and taxes on
manufacturers of certain branded prescription drugs, and creates a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 50&nbsp;percent (increased to 70% as of 2019 pursuant to subsequent legislation) <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discounts off negotiated prices of applicable brand drugs to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">39</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#146;s outpatient drugs to be covered under Medicare Part D. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment methodologies may be subject to changes in healthcare legislation and regulatory challenges. For example, in order for a drug product to receive
federal reimbursement under the Medicaid or Medicare Part B programs or to be sold directly to U.S. government agencies, the manufacturer must extend discounts to entities eligible to participate in the 340B drug pricing program. For the 2018 and
2019 fiscal years, CMS altered the reimbursement formula from Average Sale Price (ASP) plus 6&nbsp;percent to ASP minus 22.5&nbsp;percent on specified covered outpatient drugs (&#147;SCODs&#148;), but did so without issuing a formal notice of
proposed rulemaking. On December&nbsp;27, 2018, the District Court for the District of Columbia invalidated that formula change, ruling the change was not an &#147;adjustment&#148; which was within the Secretary&#146;s discretion to make, but was
instead a fundamental change in the reimbursement calculation, and such a dramatic change was beyond the scope of the Secretary&#146;s authority. On July&nbsp;31, 2020, the Court of Appeals for the District of Columbia reversed the District
Court&#146;s decision, stating that HHS&#146;s decision to lower drug reimbursement rates for 340B hosptials rests on a reasonable interpretation of the Medicare statute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since its enactment, there have been numerous judicial, administrative, executive, and legislative challenges to certain aspects of the ACA, and we expect
there will be additional challenges and amendments to the ACA in the future. The Tax Cuts and Jobs Act of 2017, or the Tax Act, includes a provision that repealed effective January&nbsp;1, 2019 the <FONT STYLE="white-space:nowrap">tax-based</FONT>
shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#147;individual mandate.&#148; On December&nbsp;14, 2018, a U.S.
District Court Judge in the Northern District of Texas, or the Texas District Court Judge, ruled that the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the Tax Act, the
remaining provisions of the ACA are invalid as well. The Trump Administration and CMS have both stated that the ruling will have no immediate effect, and on December&nbsp;30, 2018 the Texas District Court Judge issued an order staying the judgment
pending appeal. On December&nbsp;18, 2019, the U.S. Court of Appeals for the 5th Circuit ruled that the individual mandate was unconstitutional but remanded the case back to the District Court to determine whether the remaining provisions of the ACA
are invalid as well. On March&nbsp;2, 2020, the U.S. Supreme Court granted the petitions for writs of certiorari to review the case, although it is unclear when a decision will be made or how the Supreme Court will rule. Litigation and legislation
over the ACA are likely to continue, with unpredictable and uncertain results. We will continue to evaluate the effect that the ACA and its possible repeal and replacement has on our business. According to the Congressional Budget Office, the repeal
of the individual mandate will cause 13&nbsp;million fewer Americans to be insured in 2027 and premiums in insurance markets may rise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since January
2017, President Trump has signed various Executive Orders designed to delay the implementation of certain provisions of the ACA or otherwise circumvent some of the requirements for health insurance mandated by the ACA. On January&nbsp;20, 2017,
President Trump signed an Executive Order directing federal agencies with authorities and responsibilities under the ACA to waive, defer, grant exemptions from, or delay the implementation of any provision of the ACA that would impose a fiscal
burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. On October&nbsp;13, 2017, President Trump signed an Executive Order
terminating the cost-sharing subsidies that reimburse insurers under the ACA. The Trump administration has concluded that cost-sharing reduction, or CSR, payments to insurance companies required under the ACA have not received necessary
appropriations from Congress and announced that it will discontinue these payments immediately until those appropriations are made. The loss of the CSR payments is expected to increase premiums on certain policies issued by qualified health plans
under the ACA. Several state Attorneys General filed suit to stop the administration from terminating the subsidies, but their request for a restraining order was denied by a federal judge in California on October&nbsp;25, 2017. On June&nbsp;14,
2018, U.S. Court of Appeals for the Federal Circuit ruled that the federal government was not required to pay more than $12&nbsp;billion in ACA risk corridor payments to third-party payors who argued were owed to them. This decision was appealed to
the U.S. Supreme Court, which on April&nbsp;27, 2020, reversed the U.S. Court of Appeals for the Federal Circuit&#146;s decision </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">40</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and remanded the case to the U.S. Court of Federal Claims, concluding the government has an obligation to pay these risk corridor payments under the relevant formula. The U.S. federal government
has since started sending third-party payors owed payments. It is not clear what effect this result will have on our business, but we will continue to monitor any developments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, on January&nbsp;22, 2018, President Trump signed a continuing resolution on appropriations for fiscal year 2018 that delayed the implementation of
certain <FONT STYLE="white-space:nowrap">ACA-mandated</FONT> fees, including the so called &#147;Cadillac&#148; tax on certain high cost employer-sponsored insurance plans, the annual fee imposed on certain health insurance providers based on market
share, and the medical device excise tax on <FONT STYLE="white-space:nowrap">non-exempt</FONT> medical devices. However, on December&nbsp;20, 2019, the U.S. President signed into law the Further Consolidated Appropriations Act (H.R. 1865), which
repeals the Cadillac tax, the health insurance provider tax, and the medical device excise tax. The Bipartisan Budget Act of 2018, also amended the ACA, effective January&nbsp;1, 2019, by increasing the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug plans, commonly referred to as the &#147;donut
hole.&#148; In December 2018, CMS issued a final rule permitting further collections and payments to and from certain ACA qualified health plans and health insurance issuers under the ACA risk adjustment program. Since then, the ACA risk adjustment
program payment parameters have been updated annually. In addition, CMS published a final rule on April&nbsp;25, 2019 that gave states greater flexibility, starting in 2020, in setting benchmarks for insurers in the individual and small group
marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. In August 2011, the Budget Control Act of 2011, among other things, resulted in aggregate reductions of Medicare payments to providers
of 2&nbsp;percent per fiscal year, which went into effect in 2013, and, due to subsequent legislative amendments, will remain in effect through 2030 unless additional Congressional action is taken. However, pursuant to the Coronavirus Aid, Relief
and Economic Security Act, or CARES Act, these Medicare sequester reductions will be suspended from May&nbsp;1, 2020 through December&nbsp;31, 2020 due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. The American Taxpayer Relief
Act of 2012 further reduced Medicare payments to several types of providers, including hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five
years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There has been increasing legislative and enforcement interest in the United States with respect to drug pricing practices. Specifically, there
have been several recent U.S. Congressional inquiries and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship
between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. At the federal level, the Trump administration&#146;s budget for fiscal year 2021 includes a $135&nbsp;billion allowance to
support legislative proposals seeking to reduce drug prices, increase competition, lower <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> drug costs for patients, and increase patient access to lower-cost
generic and biosimilar drugs. On March&nbsp;10, 2020, the Trump administration sent &#147;principles&#148; for drug pricing to Congress, calling for legislation that would, among other things, cap Medicare Part D beneficiary <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> pharmacy expenses, provide an option to cap Medicare Part D beneficiary monthly
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses, and place limits on pharmaceutical price increases. Additionally, the Trump administration released a &#147;Blueprint&#148; to lower drug prices
and reduce out of pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their
products and reduce the out of pocket costs of drug products paid by consumers. The U.S. Department of HHS, has already started the process of soliciting feedback on some of these measures and, at the same time, is immediately implementing others
under its existing authority. For example, in May 2019, CMS issued a final rule to allow Medicare Advantage Plans the option of using step therapy for Part B drugs beginning January&nbsp;1, 2020. This final rule codified CMS&#146;s policy change
that was effective January&nbsp;1, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, on May&nbsp;30, 2018, the Right to Try Act was signed into law. The law, among other things,
provides a federal framework for certain patients to access certain investigational new drug products that have completed a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">41</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without
obtaining FDA permission under the FDA expanded access program. There is no obligation for a drug manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act, but the manufacturer must develop an
internal policy and respond to patient requests according to that policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lastly, on July&nbsp;24, 2020, President Trump signed four Executive Orders
aimed at lowering drug prices. The Executive Orders direct the Secretary of the Department of Health and Human Services to: (1)&nbsp;eliminate protection under an Anti-Kickback Statute safe harbor for certain retrospective price reductions provided
by drug manufacturers to sponsors of Medicare Part D plans or pharmacy benefit managers that are not applied at the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale;</FONT></FONT> (2)&nbsp;allow the importation of
certain drugs from other countries through individual waivers, permit the <FONT STYLE="white-space:nowrap">re-importation</FONT> of insulin products, and prioritize finalization of FDA&#146;s December 2019 proposed rule to permit the importation of
drugs from Canada; (3)&nbsp;ensure that payment by the Medicare program for certain Medicare Part B drugs is not higher than the payment by other comparable countries (depending on whether pharmaceutical manufacturers agree to other measures); and
(4)&nbsp;allow certain <FONT STYLE="white-space:nowrap">low-income</FONT> individuals receiving insulin and epinephrine purchased by a Federally Qualified Health Center, or FQHC, as part of the 340B drug program to purchase those drugs at the
discounted price paid by the FQHC. On September&nbsp;13, 2020, President Trump signed an Executive Order directing HHS to implement a rulemaking plan to test a payment model, pursuant to which Medicare would pay, for certain high-cost prescription
drugs and biological products covered by Medicare Part B, no more than the most-favored-nation price (i.e., the lowest price) after adjustments, for a pharmaceutical product that the drug manufacturer sells in a member country of the Organization
for Economic Cooperation and Development that has a comparable <FONT STYLE="white-space:nowrap">per-capita</FONT> gross domestic product. Although a number of these, and other proposed measures will require authorization through additional
legislation to become effective, Congress and the current administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product
pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and
bulk purchasing. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other
healthcare programs. Furthermore, there has been increased interest by third-party payors and governmental authorities in reference pricing systems and publication of discounts and list prices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal and state levels directed at containing or
lowering the cost of healthcare. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our product. Such reforms could have an adverse
effect on anticipated revenue from product candidates that we may successfully develop and for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates. We cannot predict the
initiatives that may be adopted in the future. The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls
may adversely affect: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the demand for our Wholly Owned or our Founded Entities&#146; product candidates, if approved;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to receive or set a price that we believe is fair for our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to generate revenue and achieve or maintain profitability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of taxes that we are required to pay; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of capital. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">42</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect that the ACA, as well as other healthcare reform measures that may be adopted in the future, may
result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, lower reimbursement, and new payment methodologies. This could lower the price that we receive for any approved product. Any denial in
coverage or reduction in reimbursement from Medicare or other government-funded programs may result in a similar denial or reduction in payments from private payors, which may prevent us from being able to generate sufficient revenue, attain
profitability or commercialize our Wholly Owned or our Founded Entities&#146; product candidates, if approved. Litigation and legislative efforts to change or repeal the ACA are likely to continue, with unpredictable and uncertain results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We face significant competition in an environment of rapid technological and scientific change, and there is a possibility that our competitors may
achieve regulatory approval before us or develop therapies that are safer, more advanced or more effective than ours, which may negatively impact our ability to successfully market or commercialize any product candidates we may develop and
ultimately harm our financial condition. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The development and commercialization of new drug products is highly competitive. We may face competition
with respect to any product candidates that we seek to develop or commercialize in the future from major pharmaceutical companies, specialty pharmaceutical companies, and biotechnology companies worldwide. Potential competitors also include academic
institutions, government agencies, and other public and private research organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development, manufacturing, and commercialization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are a number of major pharmaceutical and biotechnology companies that are currently pursuing the development and commercialization of potential
medicines targeting the <FONT STYLE="white-space:nowrap">Brain-Immune-Gut.</FONT> If any of our competitors receive FDA approval before we do, our Wholly Owned product candidates would not be the first treatment on the market, and our market share
may be limited. In addition to competition from other companies targeting our target indications, any products we may develop may also face competition from other types of therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Many of our current or potential competitors, either alone or with their strategic partners, have: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">greater financial, technical, and human resources than we have at every stage of the discovery, development,
manufacture, and commercialization of products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">more extensive resources for preclinical testing, conducting clinical trials, obtaining regulatory approvals, and
in manufacturing, marketing, and selling drug products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">products that have been approved or are in late stages of development; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborative arrangements in our target markets with leading companies and research institutions.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among
a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in
recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Our
commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any products that we
may develop. Furthermore, currently approved products could be discovered to have application for treatment of our targeted disease indications or similar indications, which could give such products significant regulatory and market timing
advantages over our Wholly Owned product candidates. Our competitors may also obtain FDA, EMA or other comparable foreign regulatory approval for their products more rapidly than we may obtain approval for ours and may obtain orphan product
exclusivity from the FDA for indications that we are targeting, which could result in our competitors establishing a strong market position before we are able to enter the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">43</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
market. Additionally, products or technologies developed by our competitors may render our potential product candidates uneconomical or obsolete and we may not be successful in marketing any
product candidates we may develop against competitors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we could face litigation or other proceedings with respect to the scope, ownership,
validity and/or enforceability of our patents relating to our competitors&#146; products and our competitors may allege that our products infringe, misappropriate or otherwise violate their intellectual property. The availability of our
competitors&#146; products could limit the demand, and the price we are able to charge, for any products that we may develop and commercialize. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our
Wholly Owned or our Founded Entities&#146; product candidates for which we or our Founded Entities intend to seek approval as biologic products may face competition sooner than anticipated. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we or our Founded Entities are successful in achieving regulatory approval to commercialize any biologic product candidate we or our Founded Entities
develop alone or with collaborators, it may face competition from biosimilar products. In the United States, certain of our Wholly Owned and our Founded Entities&#146; product candidates are regulated by the FDA as biologic products subject to
approval under the BLA pathway. The Biologics Price Competition and Innovation Act of 2009, or BPCIA, created an abbreviated pathway for the approval of biosimilar and interchangeable biologic products following the approval of an original BLA. The
abbreviated regulatory pathway establishes legal authority for the FDA to review and approve biosimilar biologics, including the possible designation of a biosimilar as &#147;interchangeable&#148; based on its similarity to an existing brand
product. Under the BPCIA, an application for a biosimilar product may not be submitted until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made
effective by the FDA until 12 years after the reference product was first licensed by the FDA. During this <FONT STYLE="white-space:nowrap">12-year</FONT> period of exclusivity, another company may still market a competing version of the reference
product if the FDA approves a full BLA for the competing product containing the sponsor&#146;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of their product. The law is
complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty. While it is uncertain when such processes intended to implement BPCIA may be fully adopted
by the FDA, any such processes could have a material adverse effect on the future commercial prospects for biological product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that
any of our Wholly Owned or our Founded Entities&#146; product candidates that are approved as a biological product under a BLA should qualify for the <FONT STYLE="white-space:nowrap">12-year</FONT> period of exclusivity. However, there is a risk
that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider such product candidates to be reference products for competing products, potentially creating the opportunity for generic
competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. Moreover, the extent to which a biosimilar product, once approved, will be
substituted for any one of our, our Founded Entities&#146; or our collaborators&#146; reference products in a way that is similar to traditional generic substitution for <FONT STYLE="white-space:nowrap">non-biologic</FONT> products is not yet clear,
and will depend on a number of marketplace and regulatory factors that are still developing. If competitors are able to obtain marketing approval for biosimilars referencing any products that we or our Founded Entities develop alone or with
collaborators that may be approved, such products may become subject to competition from such biosimilars, with the attendant competitive pressure and potential adverse consequences. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Reliance on Third Parties </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are
currently party to and may seek to enter into additional collaborations, licenses and other similar arrangements and may not be successful in maintaining existing arrangements or entering into new ones, and even if we are, we may not realize the
benefits of such relationships. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently parties to license and collaboration agreements with a number of universities and pharmaceutical
companies and expect to enter into additional agreements as part of our business strategy. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">44</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
success of our current and any future collaboration arrangements will depend heavily on the efforts and activities of our collaborators. Collaborations are subject to numerous risks, which may
include risks that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may have significant discretion in determining the efforts and resources that they will apply to
collaborations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not pursue development and commercialization of our Wholly Owned product candidates or may
elect not to continue or renew development or commercialization programs based on clinical trial results, changes in their strategic focus due to their acquisition of competitive products or their internal development of competitive products,
availability of funding or other external factors, such as a business combination that diverts resources or creates competing priorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a
clinical trial, abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators could independently develop, or develop with third parties, products that compete directly or
indirectly with our products or product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a collaborator with marketing, manufacturing and distribution rights to one or more products may not commit
sufficient resources to or otherwise not perform satisfactorily in carrying out these activities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we could grant exclusive rights to our collaborators that would prevent us from collaborating with others;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual
property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disputes may arise between us and a collaborator that cause the delay or termination of the research, development
or commercialization of our current or future product candidates or that results in costly litigation or arbitration that diverts management attention and resources; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborations may be terminated, which may result in a need for additional capital to pursue further development
or commercialization of the applicable current or future product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may own or <FONT STYLE="white-space:nowrap">co-own</FONT> intellectual property covering products
that result from our collaboration with them, and in such cases, we would not have the exclusive right to develop or commercialize such intellectual property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disputes may arise with respect to the ownership of any intellectual property developed pursuant to our
collaborations; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a collaborator&#146;s sales and marketing activities or other operations may not be in compliance with applicable
laws resulting in civil or criminal proceedings. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, we may seek to enter into additional collaborations, joint ventures,
licenses and other similar arrangements for the development or commercialization of our Wholly Owned product candidates, due to capital costs required to develop or commercialize the product candidate or manufacturing constraints. We may not be
successful in our efforts to establish such collaborations for our Wholly Owned product candidates because our research and development pipeline may be insufficient, our Wholly Owned product candidates may be deemed to be at too early of a stage of
development for collaborative effort or third parties may not view our Wholly Owned product candidates as having the requisite potential to demonstrate safety and efficacy or significant commercial opportunity. In addition, we face significant
competition in seeking appropriate strategic partners, and the negotiation process can be time consuming and complex. Further, any future collaboration agreements may restrict us from entering into additional agreements with potential collaborators.
We cannot be certain that, following a strategic transaction or license, we will achieve an economic benefit that justifies such transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">45</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if we are successful in our efforts to establish such collaborations, the terms that we agree upon may
not be favorable to us, and we may not be able to maintain such collaborations if, for example, development or approval of a product candidate is delayed, the safety of a product candidate is questioned or sales of an approved product candidate are
unsatisfactory. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, any potential future collaborations may be terminable by our strategic partners, and we may not be able to adequately
protect our rights under these agreements. Furthermore, strategic partners may negotiate for certain rights to control decisions regarding the development and commercialization of our Wholly Owned product candidates, if approved, and may not conduct
those activities in the same manner as we do. Any termination of collaborations we enter into in the future, or any delay in entering into collaborations related to our Wholly Owned product candidates, could delay the development and
commercialization of our Wholly Owned product candidates and reduce their competitiveness if they reach the market, which could have a material adverse effect on our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Collaborative relationships with third parties could cause us to expend significant resources and give rise to substantial business risk with no
assurance of financial return. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We anticipate relying upon strategic collaborations for marketing and commercializing our existing product
candidates, and we may rely even more on strategic collaborations for R&amp;D of other product candidates or discoveries. We may sell product offerings through strategic partnerships with pharmaceutical and biotechnology companies. If we are unable
to establish or manage such strategic collaborations on terms favorable to us in the future, our R&amp;D efforts and potential to generate revenue may be limited. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we enter into R&amp;D collaborations during the early phases of product development, success will in part depend on the performance of research
collaborators. We will not directly control the amount or timing of resources devoted by research collaborators to activities related to product candidates. Research collaborators may not commit sufficient resources to our R&amp;D programs. If any
research collaborator fails to commit sufficient resources, the preclinical or clinical development programs related to the collaboration could be delayed or terminated. Also, collaborators may pursue existing or other development-stage products or
alternative technologies in preference to those being developed in collaboration with us. Finally, if we fail to make required milestone or royalty payments to collaborators or to observe other obligations in agreements with them, the collaborators
may have the right to terminate or stop performance of those agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Establishing strategic collaborations is difficult and time-consuming. Our
discussions with potential collaborators may not lead to the establishment of collaborations on favorable terms, if at all. Potential collaborators may reject collaborations based upon their assessment of our financial, regulatory or intellectual
property position. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators. Even if we successfully establish new
collaborations, these relationships may never result in the successful development or commercialization of product candidates or the generation of sales revenue. To the extent that we enter into collaborative arrangements, the related product
revenues are likely to be lower than if we directly marketed and sold products. Such collaborators may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a
collaboration could be more attractive than the one with us for any future product candidate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management of our relationships with collaborators will
require: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant time and effort from our management team; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">coordination of our marketing and R&amp;D programs with the marketing and R&amp;D priorities of our
collaborators; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">effective allocation of our resources to multiple projects. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">46</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to assist in conducting our clinical trials and some aspects of our research
and preclinical testing, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research, or testing. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently rely and expect to continue to rely on third parties, such as CROs, clinical data management organizations, medical institutions, and clinical
investigators, to conduct some aspects of research and preclinical testing and clinical trials. Any of these third parties may terminate their engagements with us or be unable to fulfill their contractual obligations. If any of our relationships
with these third parties terminate, we may not be able to enter into arrangements with alternative third parties on commercially reasonable terms, or at all. If we need to enter into alternative arrangements, it would delay product development
activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, although our reliance on these third parties for clinical development activities limits our control over these activities, we remain
responsible for ensuring that each of our trials is conducted in accordance with the applicable protocol, legal and regulatory requirements and scientific standards. For example, notwithstanding the obligations of a CRO for a trial of one of our
Wholly Owned product candidates, we remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires us to comply with
requirements, commonly referred to as Good Clinical Practices, or GCPs, for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and
confidentiality of trial participants are protected. The FDA enforces these GCPs through periodic inspections of trial sponsors, principal investigators, clinical trial sites and IRBs. If we or our third-party contractors fail to comply with
applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA may require us to perform additional clinical trials before approving our Wholly Owned product candidates, which would delay the regulatory
approval process. We cannot be certain that, upon inspection, the FDA will determine that any of our clinical trials comply with GCPs. We are also required to register certain clinical trials and post the results of completed clinical trials on a
government-sponsored database, ClinicalTrials.gov, within certain timeframes. NIH and FDA recently signaled the government&#146;s willingness to begin enforcing those requirements against <FONT STYLE="white-space:nowrap">non-compliant</FONT>
clinical trial sponsors. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, the third parties
conducting clinical trials on our behalf are not our employees, and except for remedies available to us under our agreements with such contractors, we cannot control whether or not they devote sufficient time, skill and resources to our ongoing
development programs. These contractors may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials or other drug or medical device development activities, which could
impede their ability to devote appropriate time to our clinical programs. If these third parties, including clinical investigators, do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical trials in
accordance with regulatory requirements or our stated protocols, we may not be able to obtain, or may be delayed in obtaining, regulatory approvals for our Wholly Owned product candidates. If that occurs, we will not be able to, or may be delayed in
our efforts to, successfully commercialize our Wholly Owned product candidates. In such an event, our financial results and the commercial prospects for any product candidates that we seek to develop could be harmed, our costs could increase and our
ability to generate revenues could be delayed, impaired or foreclosed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our or our Founded Entities&#146; use of third parties to manufacture our
Wholly Owned or our Founded Entities&#146; product candidates and other product candidates that we or our Founded Entities may develop for preclinical studies and clinical trials may increase the risk that we or our Founded Entities will not have
sufficient quantities of our or our Founded Entities&#146; product candidates, products, or necessary quantities of such materials on time or at an acceptable cost. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to certain of our Wholly Owned or our Founded Entities&#146; product candidates, we and certain of our Founded Entities do not currently have, nor
do we plan to acquire, the infrastructure or capability internally to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">47</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
manufacture drug supplies for our ongoing clinical trials or any future clinical trials that we or our Founded Entities may conduct, and we and our Funded Entities lack the resources to
manufacture any product candidates on a commercial scale. We rely, and expect to continue to rely, on third-party manufacturers to produce our and certain of our Founded Entities&#146; product candidates or other product candidates that we or our
Founded Entities may identify for clinical trials, as well as for commercial manufacture if any product candidates receive marketing authorization. Although we and our Founded Entities generally do not begin a clinical trial unless we or our Founded
Entities believe we have a sufficient supply of a product candidate to complete the trial, any significant delay or discontinuity in the supply of a product candidate, or the raw material components thereof, for an ongoing clinical trial due to the
need to replace a third-party manufacturer could considerably delay the clinical development and potential regulatory authorization of our Wholly Owned or our Founded Entities&#146; product candidates, which could harm our business and results of
operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We or our Founded Entities may be unable to identify and appropriately qualify third-party manufacturers or establish agreements with
third-party manufacturers or do so on acceptable terms. Even if we or our Founded Entities are able to establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reliance on the third party for sourcing of raw materials, components, and such other goods as may be required
for execution of its manufacturing processes and the oversight by the third party of its suppliers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reliance on the third party for regulatory compliance and quality assurance for the manufacturing activities each
performs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possible breach of the manufacturing agreement by the third party; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possible misappropriation of proprietary information, including trade secrets and <FONT
STYLE="white-space:nowrap">know-how;</FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possible termination or <FONT STYLE="white-space:nowrap">non-renewal</FONT> of the agreement by the third
party at a time that is costly or inconvenient for us or our Founded Entities. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, all of our CMOs are engaged with other
companies to supply and/or manufacture materials or products for such companies, which exposes our manufacturers to regulatory risks for the production of such materials and products. The facilities used by our contract manufacturers to manufacture
our drug, or medical device product candidates are subject to review by the FDA pursuant to inspections that will be conducted after we submit an NDA, BLA, PMA application or other marketing application to the FDA. We do not control the
manufacturing process of, and are to some extent dependent on, our contract manufacturing partners for compliance with the regulatory requirements, known as cGMP requirements for manufacture of drug, biologic and device products. If our contract
manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, we will not be able to secure or maintain regulatory authorization for our Wholly Owned or our
Founded Entities&#146; product candidates manufactured at these manufacturing facilities. In addition, we have no control over the ability of our contract manufacturers to maintain adequate quality control, quality assurance and qualified personnel.
If the FDA, the EMA or another comparable foreign regulatory agency does not approve these facilities for the manufacture of our Wholly Owned or our Founded Entities&#146; product candidates or if any agency withdraws its approval in the future, we
or our Founded Entities may need to find alternative manufacturing facilities, which would negatively impact our or our Founded Entities&#146; ability to develop, obtain regulatory authorization for or market our Wholly Owned or our Founded
Entities&#146; product candidates, if cleared or approved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Wholly Owned or our Founded Entities&#146; product candidates may compete with other
product candidates and marketed products for access to manufacturing facilities. Any performance failure on the part of our or our Founded Entities&#146; existing or future manufacturers could delay clinical development, marketing approval or
commercialization. Our and certain of our Founded Entities&#146; current and anticipated future dependence upon others for the manufacturing of our Wholly Owned or our Founded Entities&#146; product candidates may adversely
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">48</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
affect our future profit margins and our ability to commercialize any product candidates that receive marketing clearance or approval on a timely and competitive basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If the contract manufacturing facilities on which we and certain of our Founded Entities&#146; rely do not continue to meet regulatory requirements or
are unable to meet our or our Founded Entities&#146; supply demands, our business will be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All entities involved in the preparation of
product candidates for clinical trials or commercial sale, including our and certain of our Founded Entities&#146; existing CMOs for our Wholly Owned or our Founded Entities&#146; product candidates, are subject to extensive regulation. Components
of a finished drug or biologic product approved for commercial sale or used in late-stage clinical trials must be manufactured in accordance with cGMP, or similar regulatory requirements outside the United States. These regulations govern
manufacturing processes and procedures, including recordkeeping, and the implementation and operation of quality systems to control and assure the quality of investigational products and products approved for sale. Similarly, medical devices
manufactured under an IDE must be manufactured in accordance with select provisions the FDA QSR requirements, and devices cleared or approved by FDA for commercial sale must be manufactured in accordance with QSR. Poor control of production
processes can lead to the introduction of contaminants or to inadvertent changes in the properties or stability of Gelesis&#146; Plenity, Akili&#146;s EndeavorRx, our Founded Entities&#146; other product candidates or our Wholly Owned product
candidates. Our or our Founded Entities&#146; failure, or the failure of third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us or our Founded Entities, including clinical holds, fines,
injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, suspension of production, seizures or recalls of product candidates or marketed drugs or devices, operating restrictions and criminal prosecutions, any
of which could significantly and adversely affect clinical or commercial supplies of our Wholly Owned or our Founded Entities&#146; product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We or our CMOs must supply all necessary documentation, as applicable, in support of a marketing application, such as an NDA, BLA, PMA or MAA, on a timely
basis and must adhere to regulations enforced by the FDA and other regulatory agencies through their facilities inspection program. Some of our CMOs have never produced a commercially approved pharmaceutical product and therefore have not obtained
the requisite regulatory authority approvals to do so. The facilities and quality systems of some or all of our third-party contractors must pass a <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspection for compliance with the applicable
regulations as a condition of regulatory approval of our Wholly Owned or our Founded Entities&#146; product candidates or any of our other potential products. In addition, the regulatory authorities may, at any time, audit or inspect a manufacturing
facility involved with the preparation of our Wholly Owned or our Founded Entities&#146; product candidates or our other potential products or the associated quality systems for compliance with the regulations applicable to the activities being
conducted. Although we oversee the CMOs, we cannot control the manufacturing process of, and are completely dependent on, our CMO partners for compliance with the regulatory requirements. If these facilities do not pass a <FONT
STYLE="white-space:nowrap">pre-approval</FONT> plant inspection, regulatory approval of the products may not be granted or may be substantially delayed until any violations are corrected to the satisfaction of the regulatory authority, if ever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The regulatory authorities also may, at any time following clearance or approval of a product for sale, audit the manufacturing facilities of our third-party
contractors. If any such inspection or audit identifies a failure to comply with applicable regulations or if a violation of our product specifications or applicable regulations occurs independent of such an inspection or audit, we or the relevant
regulatory authority may require remedial measures that may be costly and/or time consuming for us or a third party to implement, and that may include the temporary or permanent suspension of a clinical study or commercial sales or the temporary or
permanent closure of a facility. Any such remedial measures imposed upon us or third parties with whom we contract could materially harm our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, if supply from one approved manufacturer is interrupted, an alternative manufacturer would need to be qualified. For drug and biologic products,
as applicable, an NDA, BLA supplement or MAA variation, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">49</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equivalent foreign regulatory filing, is also required, which could result in further delay. Similarly, for medical device, a new marketing application or supplement may be required. The
regulatory agencies may also require additional studies if a new manufacturer is relied upon for commercial production. Switching manufacturers may involve substantial costs and is likely to result in a delay in our desired clinical and commercial
timelines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These factors could cause us or our Founded Entities to incur higher costs and could cause the delay or termination of clinical trials,
regulatory submissions, required approvals, or commercialization of our Wholly Owned or our Founded Entities&#146; product candidates. Furthermore, if our or our Founded Entities&#146; suppliers fail to meet contractual requirements and we or our
Founded Entities are unable to secure one or more replacement suppliers capable of production at a substantially equivalent cost, our or our Founded Entities&#146; clinical trials may be delayed or we or our Founded Entities could lose potential
revenue. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have no sales, distribution, or marketing capabilities, and may invest significant financial and management resources to establish
these capabilities. If we are unable to establish such capabilities or enter into agreements with third parties to market and sell our future products, if approved, we may be unable to generate any revenues. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given our stage of development, we have no sales, distribution, or marketing capabilities. To successfully commercialize any products that may result from our
development programs, we will need to develop sales and marketing capabilities in the United States, Europe, and other regions, either on our own or with others. We may enter into strategic alliances with other entities to utilize their mature
marketing and distribution capabilities, but we may be unable to enter into marketing agreements on favorable terms, if at all. If our future strategic collaborators do not commit sufficient resources to commercialize our future products, if any,
and we are unable to develop the necessary marketing capabilities on our own, we may be unable to generate sufficient product revenue to sustain our business. We will be competing with many companies that currently have extensive and well-funded
marketing and sales operations. Without a significant internal team or the support of a third party to perform marketing and sales functions, we may be unable to compete successfully against these more established companies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Intellectual Property </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we
or our Founded Entities are unable to obtain and maintain sufficient intellectual property protection for our or our Founded Entities&#146; existing product candidates or any other product candidates that we or they may identify, or if the scope of
the intellectual property protection we or they currently have or obtain in the future is not sufficiently broad, our competitors could develop and commercialize product candidates similar or identical to ours, and our ability to successfully
commercialize our existing product candidates and any other product candidates that we or they may pursue may be impaired. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As is the case with
other pharmaceutical and biopharmaceutical companies, our success depends in large part on our ability to obtain and maintain protection of the intellectual property we may own solely and jointly with others, particularly patents, in the United
States and other countries with respect to our Wholly Owned or our Founded Entities&#146; product candidates and technology. We and our Founded Entities seek to protect our proprietary position by filing patent applications in the United States and
abroad related to our and our Founded Entities&#146; existing product candidates, our various proprietary technologies, and any other product candidates or technologies that we or they may identify. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Obtaining, maintaining and enforcing pharmaceutical and biopharmaceutical patents is costly, time consuming and complex, and we may not be able to file or
prosecute all necessary or desirable patent applications, or maintain, enforce or license patents that may issue from such patent applications, at a reasonable cost or in a timely manner. It is also possible that we could fail to identify patentable
aspects of our research and development output before it is too late to obtain patent protection. Although we take reasonable measures, we have systems in place to remind us of filing and prosecution deadlines, and we employ outside firms and rely
on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">50</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
outside counsel to monitor patent deadlines, we may miss or fail to meet a patent deadline, including in a foreign country, which could negatively impact our patent rights and harm our
competitive position, business, and prospects. We may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the rights to patents licensed to third parties. Therefore, these patents and
applications may not be prosecuted and enforced in a manner consistent with the best interests of our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The patent position of biotechnology and
pharmaceutical companies generally is highly uncertain, involves complex legal, technological and factual questions and has in recent years been the subject of much litigation. The standards that the United States Patent and Trademark Office, or the
USPTO, and its foreign counterparts use to grant patents are not always applied predictably or uniformly. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States, or vice versa. There
is no assurance that all potentially relevant prior art relating to our patents and patent applications has been found, which can prevent a patent from issuing from a pending application or later invalidate or narrow the scope of an issued patent.
For example, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing or, in some
cases, not at all. Therefore, we cannot know with certainty whether we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent protection of such inventions. As a
result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued that protect our Wholly Owned or our Founded
Entities&#146; product candidates, in whole or in part, or which effectively prevent others from commercializing competitive product candidates. Even if our patent applications issue as patents, they may not issue in a form that will provide us with
any meaningful protection, prevent competitors from competing with us or otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our patents by developing similar or alternative product candidates in a <FONT
STYLE="white-space:nowrap">non-infringing</FONT> manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the issuance of a patent is not conclusive as to its inventorship, scope, validity
or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held
unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical product candidates to ours, or limit the duration of the patent protection of our Wholly Owned or our Founded
Entities&#146; product candidates. For example, we may be subject to a third-party preissuance submission of prior art to the USPTO, or become involved in opposition, derivation, reexamination, inter partes review, post-grant review or interference
proceedings challenging our owned or licensed patent rights. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our Wholly Owned
or our Founded Entities&#146; product candidates and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize drugs without infringing third-party patent rights. In addition, if the breadth or
strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, our and our Founded Entities&#146; intellectual property rights may be subject to a reservation of rights by one or more third parties. We are
party to a license agreement with New York University related to certain intellectual property underlying our <FONT STYLE="white-space:nowrap">LYT-200</FONT> and <FONT STYLE="white-space:nowrap">LYT-210</FONT> product candidates which is subject to
certain rights of the government, including <FONT STYLE="white-space:nowrap">march-in</FONT> rights, to such intellectual property due to the fact that the research was funded at least in part by the U.S. government. Additionally, our Founded
Entities Akili, Follica, Vedanta, Sonde, Alivio and Vor, are party to license agreements with academic institutions pursuant to which such Founded Entities have <FONT STYLE="white-space:nowrap">in-licensed</FONT> certain intellectual property
underlying the product candidates <FONT STYLE="white-space:nowrap">AKL-T01,</FONT> <FONT STYLE="white-space:nowrap">AKL-T02,</FONT> <FONT STYLE="white-space:nowrap">AKL-T03,</FONT> <FONT STYLE="white-space:nowrap">AKL-T04,</FONT> <FONT
STYLE="white-space:nowrap">FOL-004,</FONT> VE303, Sonde, <FONT STYLE="white-space:nowrap">ALV-306,</FONT> <FONT STYLE="white-space:nowrap">ALV-304,</FONT> <FONT STYLE="white-space:nowrap">ALV-107</FONT> and VOR33. While these license agreements are
exclusive, they contain provisions pursuant to which the government has certain rights, including <FONT STYLE="white-space:nowrap">march-in</FONT> rights, to such patents and technologies due to the fact that the research was funded at
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">51</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
least in part by the U.S. government. When new technologies are developed with government funding, the government generally obtains certain rights in any resulting patents, including a <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> license authorizing the government to use the invention or to have others use the invention on its behalf. These rights may permit the government to disclose our information to third parties and to
exercise <FONT STYLE="white-space:nowrap">march-in</FONT> rights to use or allow third parties to use our technology. The government can exercise its <FONT STYLE="white-space:nowrap">march-in</FONT> rights if it determines that action is necessary
because we fail to achieve practical application of the government-funded technology, because action is necessary to alleviate health or safety needs, to meet requirements of federal regulations, or to give preference to U.S. industry. In addition,
our rights in such inventions may be subject to certain requirements to manufacture products embodying such inventions in the United States. Any exercise by the government of such rights or by any third party of its reserved rights could harm our
competitive position, business, financial condition, results of operations, and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our or our Founded Entities&#146; rights to develop and
commercialize our Wholly Owned or our Founded Entities&#146; product candidates are subject in part to the terms and conditions of licenses granted to us and our Founded Entities by others, and the patent protection, prosecution and enforcement for
some of our Wholly Owned or our Founded Entities&#146; product candidates may be dependent on our and our Founded Entities&#146; licensors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and
our Founded Entities currently are reliant upon licenses of certain intellectual property rights and proprietary technologies from third parties that are important or necessary to the development of our and our Founded Entities&#146; proprietary
technologies, including technologies related to our Wholly Owned and our Founded Entities&#146; product candidates. These licenses, and other licenses we and they may enter into in the future, may not provide adequate rights to use such intellectual
property and proprietary technologies in all relevant fields of use or in all territories in which we or our Founded Entities may wish to develop or commercialize technology and product candidates in the future. Licenses to additional third-party
proprietary technology or intellectual property rights that may be required for our or our Founded Entities&#146; development programs may not be available in the future or may not be available on commercially reasonable terms. In that event, we or
our Founded Entities may be required to expend significant time and resources to redesign our proprietary technology or product candidates or to develop or license replacement technology, which may not be feasible on a technical or commercial basis.
If we and our Founded Entities are unable to do so, we may not be able to develop and commercialize technology and product candidates in fields of use and territories for which we are not granted rights pursuant to such licenses, which could harm
our competitive position, business, financial condition, results of operations and prospects significantly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some circumstances, we and our Founded
Entities may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain and enforce the patents, covering technology that we or our Founded Entities license from third parties. In addition, some of
our or our Founded Entities&#146; agreements with our licensors require us to obtain consent from the licensor before we can enforce patent rights, and our licensor may withhold such consent or may not provide it on a timely basis. Therefore, we
cannot be certain that our licensors or collaborators will prosecute, maintain, enforce and defend such intellectual property rights in a manner consistent with the best interests of our business, including by taking reasonable measures to protect
the confidentiality of <FONT STYLE="white-space:nowrap">know-how</FONT> and trade secrets, or by paying all applicable prosecution and maintenance fees related to intellectual property registrations for any of our Wholly Owned or our Founded
Entities&#146; product candidates and proprietary technologies. We and our Founded Entities also cannot be certain that our licensors have drafted or prosecuted the patents and patent applications licensed to us in compliance with applicable laws
and regulations, which may affect the validity and enforceability of such patents or any patents that may issue from such applications. This could cause us to lose rights in any applicable intellectual property that we
<FONT STYLE="white-space:nowrap">in-license,</FONT> and as a result our ability to develop and commercialize product candidates may be adversely affected and we may be unable to prevent competitors from making, using and selling competing products.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, our or our Founded Entities&#146; licensors may own or control intellectual property that has not been licensed to us and, as a result, we
may be subject to claims, regardless of their merit, that we are infringing or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">52</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise violating the licensor&#146;s rights. In addition, while we cannot currently determine the amount of the royalty obligations we would be required to pay on sales of future products, if
any, the amounts may be significant. The amount of our and our Founded Entities&#146; future royalty obligations will depend on the technology and intellectual property we and our Founded Entities use in product candidates that we successfully
develop and commercialize, if any. Therefore, even if we or our Founded Entities successfully develop and commercialize product candidates, we may be unable to achieve or maintain profitability. In addition, we or our Founded Entities may seek to
obtain additional licenses from our licensors and, in connection with obtaining such licenses, we may agree to amend our existing licenses in a manner that may be more favorable to the licensors, including by agreeing to terms that could enable
third parties (potentially including our competitors) to receive licenses to a portion of the intellectual property rights that are subject to our or our Founded Entities&#146; existing licenses. Any of these events could have a material adverse
effect on our or our Founded Entities&#146; competitive position, business, financial conditions, results of operations, and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we or
our Founded Entities fail to comply with our obligations in the agreements under which we license intellectual property rights from third parties or these agreements are terminated or we or our Founded Entities otherwise experience disruptions to
our business relationships with our licensors, we could lose intellectual property rights that are important to our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are party to
various agreements that we depend on to develop our Wholly Owned or our Founded Entities&#146; product candidates and various proprietary technologies, and our rights to use currently licensed intellectual property, or intellectual property to be
licensed in the future, are or will be subject to the continuation of and our and our Founded Entities&#146; compliance with the terms of these agreements. For example, under certain of our and our Founded Entities&#146; license agreements we and
our Founded Entities are required to use commercially reasonable efforts to develop and commercialize product candidates covered by the licensed intellectual property rights, maintain the licensed intellectual property rights, and achieve certain
development milestones, each of which could result in termination in the event we or our Founded Entities fail to comply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In spite of our efforts, our or
our Founded Entities&#146; licensors might conclude that we have materially breached our obligations under such license agreements and might therefore terminate the license agreements, thereby removing or limiting our or our Founded Entities&#146;
ability to develop and commercialize products and technology covered by these license agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, disputes may arise regarding intellectual
property subject to a licensing agreement, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of rights granted under the license agreement and other interpretation-related issues;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which our Wholly Owned or our Founded Entities&#146; product candidates, technology and processes
infringe on intellectual property of the licensor that is not subject to the licensing agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sublicensing of patent and other rights under our or our Founded Entities&#146; collaborative development
relationships; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our and our Founded Entities&#146; diligence obligations under the license agreement and what activities satisfy
those diligence obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inventorship and ownership of inventions and <FONT STYLE="white-space:nowrap">know-how</FONT> resulting from
the joint creation or use of intellectual property by our and our Founded Entities&#146; licensors and us and our Founded Entities and our partners; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the priority of invention of patented technology. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, certain provisions in our and our Founded Entities&#146; license agreements may be susceptible to multiple interpretations. The resolution of any
contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the
agreement, either of which could have a material </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">53</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
adverse effect on our or our Founded Entities&#146; business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that we or our Founded
Entities have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates, which could have a
material adverse effect on our competitive position, business, financial conditions, results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Third-party claims of
intellectual property infringement may prevent or delay our development and commercialization efforts. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our commercial success depends in part on
our avoiding infringement of the patents and proprietary rights of third parties. However, our research, development and commercialization activities may be subject to claims that we infringe or otherwise violate patents or other intellectual
property rights owned or controlled by third parties. There is a substantial amount of litigation, both within and outside the United States, involving patent and other intellectual property rights in the biotechnology and pharmaceutical industries,
including patent infringement lawsuits, interferences, derivation, oppositions, inter partes review and post-grant review before the USPTO, and corresponding foreign patent offices. Numerous U.S. and foreign issued patents and pending patent
applications, which are owned by third parties, exist in the fields in which we are pursuing development candidates. Our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial
investments in patent portfolios and competing technologies, may have applied for or obtained or may in the future apply for or obtain, patents that will prevent, limit or otherwise interfere with our ability to make, use and sell, if approved, our
Wholly Owned or our Founded Entities&#146; product candidates. In addition, many companies in the biotechnology and pharmaceutical industries have employed intellectual property litigation as a means to gain an advantage over their competitors. As
the biotechnology and pharmaceutical industries expand and more patents are issued, and as we gain greater visibility and market exposure as a public company, the risk increases that our existing product candidates and any other product candidates
that we or our Founded Entities may identify may be subject to claims of infringement of the patent rights of third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There may be other
third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our or our Founded Entities&#146; existing product candidates and any other
product candidates that we or they may identify. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that our or our Founded Entities&#146; existing
product candidates and any other product candidates that we or they may identify may infringe. In addition, third parties may obtain patents in the future and claim that use of our or our Founded Entities&#146; technologies infringes upon these
patents. If any third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of our or our Founded Entities&#146; existing product candidates and any other product candidates that we or they may identify, any
molecules formed during the manufacturing process, or any final product itself, the holders of any such patents may be able to block our ability to commercialize such product candidate unless we obtained a license under the applicable patents, or
until such patents expire. Additionally, pending patent applications that have been published can, subject to certain limitations, be later amended in a manner that could cover our Wholly Owned or our Founded Entities&#146; product candidates.
Furthermore, the scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#146;s prosecution history and can involve other factors such as expert opinion. Our analysis of these issues,
including interpreting the relevance or the scope of claims in a patent or a pending application, determining applicability of such claims to our proprietary technologies or product candidates, predicting whether a third party&#146;s pending patent
application will issue with claims of relevant scope, and determining the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, which may negatively impact our or our Founded Entities&#146; ability
to develop and market our Wholly Owned or our Founded Entities&#146; product candidates. We do not always conduct independent reviews of pending patent applications of and patents issued to third parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Similarly, if any third-party patents were held by a court of competent jurisdiction to cover aspects of our or our Founded Entities&#146; formulations,
processes for manufacture or methods of use, including any combination </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">54</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
therapies, the holders of any such patents may be able to block our or our Founded Entities&#146; ability to develop and commercialize the applicable product candidate unless we obtained a
license or until such patent expires. In either case, such a license may not be available on commercially reasonable terms or at all, or it may be <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> which could result in our competitors gaining
access to the same intellectual property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Parties making claims against us or our Founded Entities may obtain injunctive or other equitable relief, which
could effectively block our ability to further develop and commercialize our or our Founded Entities&#146; existing product candidates and any other product candidates that we may identify. Defense of these claims, regardless of their merit, would
involve substantial litigation expense and would be a substantial diversion of management and employee resources from our business. In the event of a successful claim of infringement against us or our Founded Entities, we or our Founded Entities may
have to pay substantial damages, including treble damages and attorneys&#146; fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require
substantial time and monetary expenditure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Parties making claims against us or our Founded Entities may be able to sustain the costs of complex patent
litigation more effectively than we can because they have substantially greater resources. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or administrative proceedings, there
is a risk that some of our confidential information could be compromised by disclosure. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have material adverse effect on our ability to raise
additional funds or otherwise have a material adverse effect on our business, results of operations, financial condition and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Patent
terms may be inadequate to protect our competitive position on product candidates for an adequate amount of time. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patents have a limited lifespan.
In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> or international patent application filing date.
Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our Wholly Owned or our Founded Entities&#146; product candidates are obtained, once the patent life has expired, we
or our Founded Entities may be open to competition from competitive products, including generics or biosimilars. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such
candidates might expire before or shortly after such candidates are commercialized. As a result, our or our Founded Entities&#146; owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing
products similar or identical to ours. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we or our Founded Entities are not able to obtain patent term extension or
<FONT STYLE="white-space:nowrap">non-patent</FONT> exclusivity in the United States under the Hatch-Waxman Act and in foreign countries under similar legislation, thereby potentially extending the marketing exclusivity term of our Wholly Owned or
our Founded Entities&#146; product candidates, our business may be materially harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depending upon the timing, duration and specifics of FDA
marketing approval of our Wholly Owned or our Founded Entities&#146; product candidates, one of the U.S. patents covering each of such product candidates or the use thereof may be eligible for up to five years of patent term extension under the
Hatch-Waxman Act. The Hatch-Waxman Act allows a maximum of one patent to be extended per FDA approved product as compensation for the patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term
of a patent beyond a total of 14 years from the date of product approval and only those claims covering such approved drug product, a method for using it or a method for manufacturing it may be extended. Patent term extension also may be available
in certain foreign countries upon regulatory approval of our Wholly Owned or our Founded Entities&#146; product candidates. Nevertheless, we or our Founded Entities may not be granted patent term extension either in the United States or in any
foreign country because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise
failing to satisfy </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">55</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable requirements. Moreover, the term of extension, as well as the scope of patent protection during any such extension, afforded by the governmental authority could be less than we
request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we or our Founded Entities are unable to obtain patent term extension or restoration, or the term of any such extension is less than our
request, the period during which we will have the right to exclusively market our product may be shortened and our competitors may obtain approval of competing products following our patent expiration sooner, and our revenue could be reduced,
possibly materially. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, for certain of our and our Founded Entities&#146; licensed patents, we and our Founded Entities do not have the right to
control prosecution, including filing with the USPTO, a petition for patent term extension under the Hatch-Waxman Act. Thus, if one of our or our Founded Entities&#146; licensed patents is eligible for patent term extension under the Hatch-Waxman
Act, we may not be able to control whether a petition to obtain a patent term extension is filed with, or whether a patent term extension is obtained from, the USPTO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also, there are detailed rules and requirements regarding the patents that may be submitted to the FDA for listing in the Approved Drug Products with
Therapeutic Equivalence Evaluations, or the Orange Book. We or our Founded Entities may be unable to obtain patents covering our Wholly Owned or our Founded Entities&#146; product candidates that contain one or more claims that satisfy the
requirements for listing in the Orange Book. Even if we or our Founded Entities submit a patent for listing in the Orange Book, the FDA may decline to list the patent, or a manufacturer of generic drugs may challenge the listing. If or when one of
our Wholly Owned or our Founded Entities&#146; product candidates is approved and a patent covering that product candidate is not listed in the Orange Book, a manufacturer of generic drugs would not have to provide advance notice to us of any
abbreviated new drug application, or ANDA, filed with the FDA to obtain permission to sell a generic version of such product candidate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are
unable to protect the confidentiality of our trade secrets, the value of our technology could be materially adversely affected and our business would be harmed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our Founded Entities consider proprietary trade secrets, confidential <FONT STYLE="white-space:nowrap">know-how</FONT> and unpatented <FONT
STYLE="white-space:nowrap">know-how</FONT> to be important to our business. We and our Founded Entities may rely on trade secrets and confidential <FONT STYLE="white-space:nowrap">know-how</FONT> to protect our technology, especially where patent
protection is believed by us to be of limited value. However, trade secrets and confidential <FONT STYLE="white-space:nowrap">know-how</FONT> are difficult to protect, and we have limited control over the protection of trade secrets and confidential
<FONT STYLE="white-space:nowrap">know-how</FONT> used by our licensors, collaborators and suppliers. Because we have relied in the past on third parties to manufacture our Wholly Owned or our Founded Entities&#146; product candidates, because we may
continue to do so in the future, and because we expect to collaborate with third parties on the development of our current product candidates and any future product candidates we develop, we may, at times, share trade secrets with them. We also
conduct joint research and development programs that may require us to share trade secrets under the terms of our research and development partnerships or similar agreements. Under such circumstances, trade secrets and confidential <FONT
STYLE="white-space:nowrap">know-how</FONT> can be difficult to maintain as confidential. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our Founded Entities seek to protect our confidential
proprietary information, in part, by confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors and collaborators. These agreements are designed to protect our proprietary
information. However, we cannot be certain that such agreements have been entered into with all relevant parties, and we cannot be certain that our and our Founded Entities&#146; trade secrets and other confidential proprietary information will not
be disclosed or that competitors will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. For example, any of these parties may breach the agreements and disclose proprietary
information, including trade secrets, and we may not be able to obtain adequate remedies for such breaches. We and our Founded Entities also seek to preserve the integrity and confidentiality of our confidential proprietary information by
maintaining physical security of our premises and physical and electronic security of our information technology systems, but it is possible that these security </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">56</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
measures could be breached. If any of our or our Founded Entities&#146; confidential proprietary information were to be lawfully obtained or independently developed by a competitor, we or our
Founded Entities would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our or our Founded Entities&#146; products that we consider proprietary.
We or our Founded Entities may not be able to obtain adequate remedies in the event of such unauthorized use. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming, and
the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. Trade secrets will also over time be disseminated within the industry through independent
development, the publication of journal articles and the movement of personnel skilled in the art from company to company or academic to industry scientific positions. Though our or our Founded Entities&#146; agreements with third parties typically
restrict the ability of our advisors, employees, collaborators, licensors, suppliers, third-party contractors and consultants to publish data potentially relating to our trade secrets, our agreements may contain certain limited publication rights.
In addition, if any of our or our Founded Entities&#146; trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent such competitor from using that technology or information to compete
with us, which could harm our competitive position. Despite employing the contractual and other security precautions described above, the need to share trade secrets increases the risk that such trade secrets become known by our competitors, are
inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. If any of these events occurs or if we otherwise lose protection for our trade secrets, the value of such information may be greatly
reduced and our competitive position, business, financial condition, results of operations, and prospects would be harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our or our Founded
Entities&#146; trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our or our Founded Entities&#146; registered or unregistered trademarks or trade names may be challenged, infringed, circumvented or declared generic or
determined to be infringing on other marks. We and our Founded Entities may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential collaborators or customers in our markets of
interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark
infringement claims brought by owners of other trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term, if we and our Founded Entities are unable to establish name
recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. We and our Founded Entities may license our trademarks and trade names to third parties, such as
distributors. Though these license agreements may provide guidelines for how our or our Founded Entities&#146; trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks and tradenames by our licensees may
jeopardize our rights in or diminish the goodwill associated with our trademarks and trade names. Our or our Founded Entities&#146; efforts to enforce or protect our proprietary rights related to trademarks, trade names, trade secrets, domain names,
copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect our competitive position, business, financial condition, results of operations and prospects.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may become involved in lawsuits to protect or enforce our or our Founded Entities&#146; patents or other intellectual property, which could be
expensive, time consuming and unsuccessful. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Competitors may infringe our or our Founded Entities&#146; patents or other intellectual property. Our
and our Founded Entities&#146; ability to enforce our patent or other intellectual property rights depends on our ability to detect infringement. It may be difficult to detect infringers who do not advertise the components or methods that are used
in connection with their products and services. Moreover, it may be difficult or impossible to obtain </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">57</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
evidence of infringement in a competitor&#146;s or potential competitor&#146;s product or service. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded if
we were to prevail may not be commercially meaningful. If we were to initiate legal proceedings against a third party to enforce a patent covering one or more of our Wholly Owned or our Founded Entities&#146; product candidates, the defendant could
counterclaim that the patent covering our or our Founded Entities&#146; product candidate is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are
commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including subject matter eligibility, novelty, nonobviousness, written description or enablement. Grounds for an
unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. The outcome following legal assertions of
invalidity and unenforceability is unpredictable. Interference or derivation proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our or our Founded
Entities&#146; patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does
not offer us a license on commercially reasonable terms or at all, or if a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license is offered and our competitors gain access to the same technology. Our defense of litigation or interference or
derivation proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability
to raise the funds necessary to continue clinical trials, continue research programs, license necessary technology from third parties, or enter into development partnerships that would help us bring product candidates to market. Furthermore, because
of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our or our Founded Entities&#146; confidential information could be compromised by disclosure during this type of
litigation. There could also be public announcements of the results of hearings, motions, or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could adversely impact the price of
our ADSs. Furthermore, any of the foregoing could have a material adverse effect on our financial condition, results of operations, and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We and our Founded Entities may be subject to claims challenging the inventorship of our patents and other intellectual property. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our and our Founded Entities&#146; agreements with employees and our personnel policies provide that any inventions conceived by an individual in the course of
rendering services to us shall be our exclusive property. Although our policy is to have all such individuals complete these agreements, we may not obtain these agreements in all circumstances, and individuals with whom we have these agreements may
not comply with their terms. The assignment of intellectual property may not be automatic upon the creation of an invention and despite such agreement, such inventions may become assigned to third parties. In the event of unauthorized use or
disclosure of our trade secrets or proprietary information, these agreements, even if obtained, may not provide meaningful protection, particularly for our trade secrets or other confidential information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We, our Founded Entities or our licensors may be subject to claims that former employees, collaborators or other third parties have an interest in our owned
or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents, trade secrets, or other intellectual property as an inventor or <FONT STYLE="white-space:nowrap">co-inventor.</FONT> For example, we, our Founded Entities or our licensors may have
inventorship disputes arising from conflicting obligations of employees, consultants or others who are involved in developing our Wholly Owned or our Founded Entities&#146; product candidates. Litigation may be necessary to defend against these and
other claims challenging inventorship of our, our Founded Entities&#146; or our licensors&#146; ownership of our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents, trade secrets or other intellectual property. If we, our Founded
Entities or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our
Wholly Owned or our Founded Entities&#146; product candidates. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">58</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any of the foregoing could have a material adverse effect on our competitive position, business, financial
condition, results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Issued patents covering our Wholly Owned or our Founded Entities&#146; product candidates could be
found invalid or unenforceable if challenged in courts or patent offices. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we, our Founded Entities or one of our licensing partners initiated
legal proceedings against a third party to enforce a patent covering one or more of our Wholly Owned or our Founded Entities&#146; product candidates, the defendant could counterclaim that the patent covering the relevant product candidate is
invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several
statutory requirements, including subject matter eligibility, novelty, nonobviousness, written description or enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld
relevant information from the USPTO, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms
include <FONT STYLE="white-space:nowrap">re-examination,</FONT> post grant review, and equivalent proceedings in foreign jurisdictions (<I>e.g.</I>, opposition proceedings). Such proceedings could result in revocation or amendment to our or our
Founded Entities&#146; patents in such a way that they no longer cover our Wholly Owned or our Founded Entities&#146; product candidates. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the
validity question, for example, we cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or
unenforceability, we would lose at least part, and perhaps all, of the patent protection on our Wholly Owned or our Founded Entities&#146; product candidates. Such a loss of patent protection would have a material adverse impact on our business.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We or our Founded Entities may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed
confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As is common in the biotechnology and pharmaceutical industries, we and our Founded Entities employ individuals who were previously employed at universities or
other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we and our Founded Entities try to ensure that our employees, consultants and independent contractors do not use the proprietary
information or <FONT STYLE="white-space:nowrap">know-how</FONT> of others in their work for us, we or our Founded Entities may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used
or disclosed intellectual property, including trade secrets or other proprietary information, of any of our employee&#146;s former employer or other third parties. Litigation may be necessary to defend against these claims. If we or our Founded
Entities fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely impact our business. Even if we or our Founded Entities are successful in
defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and
maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Periodic maintenance fees, renewal fees, annuity fees and various other
governmental fees on patents and/or applications will be due to be paid to the USPTO and various governmental patent agencies outside of the United States in several stages over the lifetime of the patents and/or applications. We and our Founded
Entities have systems in place to remind us to pay these fees, and we and our Founded Entities employ outside firms and rely on outside counsel to pay these fees due to the USPTO and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> patent agencies.
However, we and our Founded Entities cannot guarantee that our licensors have similar systems and procedures in place to pay such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">59</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fees. In addition, the USPTO and various <FONT STYLE="white-space:nowrap">non-U.S.</FONT> governmental patent agencies require compliance with a number of procedural, documentary, fee payment and
other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply, and in many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance
with the applicable rules. However, there are situations in which <FONT STYLE="white-space:nowrap">non-compliance</FONT> can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights
in the relevant jurisdiction. In such an event, our competitors might be able to enter the market and this circumstance would have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to protect our intellectual property rights throughout the world. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing, prosecuting and defending patents on our Wholly Owned or our Founded Entities&#146; product candidates in all countries throughout the world would be
prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect or enforce intellectual
property rights to the same extent as federal and state laws in the United States. Consequently, we and our Founded Entities may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from
selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our and our Founded Entities&#146; technologies in jurisdictions where we have not obtained patent protection to
develop their own products and may also export infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with our or our Founded Entities&#146;
products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Many companies have
encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade
secrets, and other intellectual property protection, particularly those relating to biotechnology and pharmaceutical products, which could make it difficult for us to stop the infringement of our or our Founded Entities&#146; patents or marketing of
competing products in violation of our proprietary rights generally. Proceedings to enforce our or our Founded Entities&#146; patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert our efforts
and attention from other aspects of our business, could put our or our Founded Entities&#146; patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert
claims against us or our Founded Entities. We may not prevail in any lawsuits that we or our Founded Entities initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our
intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some jurisdictions including European Union countries, compulsory licensing laws compel patent owners to grant licenses to third parties. In addition, some
countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we, our Founded
Entities or any of our licensors are forced to grant a license to third parties under patents relevant to our or our Founded Entities&#146; business, or if we, our Founded Entities or our licensors are prevented from enforcing patent rights against
third parties, our competitive position may be substantially impaired in such jurisdictions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Changes in U.S. patent law could diminish the value of
patents in general, thereby impairing our and our Founded Entities&#146; ability to protect our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in either the patent laws or
interpretation of the patent laws in the United States could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. Assuming that other requirements for patentability
are met, prior to March 2013, in the United </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">60</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
States, the first to invent the claimed invention was entitled to a patent, while outside the United States, the first to file a patent application was entitled to the patent. After March 2013,
under the Leahy-Smith America Invents Act, or the America Invents Act, enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first
inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. A third party that files a patent application in the USPTO after March 2013, but
before us could therefore be awarded a patent covering an invention of ours even if we had made the invention before it was made by such third party. This will require us and our Founded Entities to be cognizant of the time from invention to filing
of a patent application and be diligent in filing patent applications, but circumstances could prevent us from promptly filing patent applications on our inventions. Since patent applications in the United States and most other countries are
confidential for a period of time after filing or until issuance, we cannot be certain that we, our Founded Entities or our licensors were the first to either (i)&nbsp;file any patent application related to our Wholly Owned or our Founded
Entities&#146; product candidates or (ii)&nbsp;invent any of the inventions claimed in our, our Founded Entities or our licensor&#146;s patents or patent applications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The America Invents Act also includes a number of significant changes that affect the way patent applications are prosecuted and also may affect patent
litigation. These include allowing third party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including post-grant review,
inter partes review, and derivation proceedings. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to invalidate a patent claim, a third party could
potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third party
may attempt to use the USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. Therefore, the America Invents Act and its implementation
could increase the uncertainties and costs surrounding the prosecution of our or our Founded Entities&#146; owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patent applications and the enforcement or defense of our or our Founded
Entities&#146; owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> issued patents, all of which could have a material adverse effect on our competitive position, business, financial condition, results of operations, and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the patent positions of companies in the development and commercialization of pharmaceuticals are particularly uncertain. Recent U.S. Supreme
Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the validity and
enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on
our existing patent portfolio and our ability to protect and enforce our intellectual property in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our or our Founded Entities&#146;
proprietary rights may not adequately protect our technologies and product candidates, and do not necessarily address all potential threats to our competitive advantage. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The degree of future protection afforded by our or our Founded Entities&#146; intellectual property rights is uncertain because intellectual property rights
have limitations, and may not adequately protect our or our Founded Entities&#146; business, or permit us to maintain our competitive advantage. The following examples are illustrative: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may be able to make products that are the same as or similar to our Wholly Owned or our Founded
Entities&#146; product candidates but that are not covered by the claims of the patents that we or our Founded Entities own or have exclusively licensed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others, including inventors or developers of our or our Founded Entities&#146; owned or <FONT
STYLE="white-space:nowrap">in-licensed</FONT> patented technologies who may become involved with competitors, may independently develop similar technologies that function as alternatives or replacements for any of our or our Founded Entities&#146;
technologies without infringing our intellectual property rights; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">61</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we, our Founded Entities or our licensors or our other collaboration partners might not have been the first to
conceive and reduce to practice the inventions covered by the patents or patent applications that we or our Founded Entities own or license or will own or license; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we, our Founded Entities or our licensors or our other collaboration partners might not have been the first to
file patent applications covering certain of the patents or patent applications that we or they own or have obtained a license, or will own or will have obtained a license; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we, our Founded Entities or our licensors may fail to meet obligations to the U.S. government with respect to <FONT
STYLE="white-space:nowrap">in-licensed</FONT> patents and patent applications funded by U.S. government grants, leading to the loss of patent rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that our or our Founded Entities&#146; pending patent applications will not result in issued
patents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that there are prior public disclosures that could invalidate our, our Founded Entities&#146; or
our licensors&#146; patents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issued patents that we or our Founded Entities own or exclusively license may not provide us with any competitive
advantage, or may be held invalid or unenforceable, as a result of legal challenges by our competitors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our or our Founded Entities&#146; competitors might conduct research and development activities in countries
where we do not have patent rights, or in countries where research and development safe harbor laws exist, and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ownership, validity or enforceability of our, our Founded Entities&#146; or our licensors&#146; patents or patent
applications may be challenged by third parties; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patents of third parties or pending or future applications of third parties, if issued, may have an adverse
effect on our business. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Business and Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The outbreak of, and the long term effects of the outbreak of, the novel strain of coronavirus, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> which causes&nbsp;COVID- 19, could adversely impact our business, including our clinical trials and preclinical studies. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Public health crises such as pandemics or other global emergencies could adversely impact our business. In December 2019, a novel strain of coronavirus, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> which causes coronavirus disease 2019, or <FONT STYLE="white-space:nowrap">COVID-19,</FONT> surfaced in Wuhan, China. Since
<FONT STYLE="white-space:nowrap">then,&nbsp;COVID-19</FONT> has spread globally. In response to the spread <FONT STYLE="white-space:nowrap">of&nbsp;COVID-19</FONT> and governmental
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">shelter-in-place</FONT></FONT> orders, we have encouraged our administrative employees to work outside of our offices and allowed staff in our laboratory facilities to operate under
applicable government orders and protocols designed to protect their health and safety. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of
<FONT STYLE="white-space:nowrap">the&nbsp;COVID-19</FONT> outbreak or&nbsp;any future&nbsp;pandemics, we have&nbsp;experienced,&nbsp;and may in the future experience,&nbsp;disruptions that severely impact our business, clinical trials&nbsp;and
preclinical studies, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays or difficulties in enrolling patients in our clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays or difficulties in clinical site initiation, including difficulties in recruiting clinical site
investigators and clinical site staff; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays or disruptions in <FONT STYLE="white-space:nowrap">non-clinical</FONT> experiments due to unforeseen
circumstances at contract research organizations, or CROs, and vendors along their supply chain; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">62</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased rates of patients withdrawing from our clinical trials following enrollment as a result of contracting <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> being forced to quarantine, or not accepting home health visits; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals
serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption of key clinical trial activities, such as clinical trial site data monitoring, due to limitations on
travel imposed or recommended by federal or state governments, employers and others or interruption of clinical trial subject visits and study procedures (particularly any procedures that may be deemed
<FONT STYLE="white-space:nowrap">non-essential),</FONT> which may impact the integrity of subject data and clinical study endpoints; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption or delays in the operations of the FDA and comparable foreign regulatory agencies, which may impact
review and approval timelines; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption of, or delays in receiving, supplies of our product candidates from our contract manufacturing
organizations due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations on employee resources that would otherwise be focused on the conduct of our preclinical studies and
clinical trials, including because of sickness of employees or their families, the desire of employees to avoid contact with large groups of people, an increased reliance on working from home or mass transit disruptions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These and other factors arising from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic could worsen in countries that are already afflicted <FONT
STYLE="white-space:nowrap">with&nbsp;COVID-19,</FONT> could continue to spread to additional countries, or could return to countries where the pandemic has been partially contained, each of which could further adversely impact our ability to conduct
clinical trials and our business generally, and could have a material adverse impact on our operations and financial condition and results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition,
the trading prices for biopharmaceutical companies have been highly volatile as a result of <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19</FONT> pandemic. As a result, if we require any further capital we may face difficulties raising capital
through sales of our common stock or such sales may be on unfavorable terms. The <FONT STYLE="white-space:nowrap">COVID-19</FONT> outbreak continues to rapidly evolve. The extent to which the outbreak may impact our business, preclinical studies and
clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the outbreak, travel restrictions and actions to contain
the outbreak or treat its impact, such as social distancing and quarantines or lock-downs in the United States and other countries, business closures or business disruptions and the effectiveness of actions taken in the United States and other
countries to contain and treat the disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent the COVID <FONT STYLE="white-space:nowrap">-19</FONT> pandemic adversely affects our business
and financial results, it may also have the effect of heightening many of the other risks described in this &#147;Risk Factors&#148; section, such as those relating to our clinical development operations, the supply chain for our ongoing and planned
clinical trials, and the availability of governmental and regulatory authorities to conduct inspections of our clinical trial sites, review materials submitted by us in support of our applications for regulatory approval and grant approval for our
product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful in our efforts to develop LYT-100 for the treatment of patients with respiratory complications that
persist following COVID-19. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to conduct a global, randomized, placebo-controlled Phase 2 trial to evaluate the efficacy, safety and
tolerability of LYT-100 in non-critical COVID-19 patients with respiratory complications. As currently designed, patients will receive treatment for up to three months and the trial is expected to enroll up to 168 patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The timing and success of this proposed clinical trial will depend on our ability to enroll patients in the trial. Many other companies are pursuing the
development of product candidates for the treatment of COVID-19, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">63</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
patient enrollment may be affected by availability of commercially available treatment. Our ability to enroll a sufficient number of patients could also be impacted by a decrease in COVID-19
hospitalization rates or a decrease in COVID-19 infection rate. Our inability to enroll a sufficient number of patients could result in significant delays or could require us to abandon the trial and development of LYT-100 for the treatment of these
patients altogether. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the rapidity of the onset of the COVID-19 pandemic, scientific and medical research on the SARS-CoV-2 virus is ongoing and
evolving. Results from ongoing clinical trials and discussions with regulatory authorities may raise new questions and require us to redesign proposed clinical trials, including revising proposed endpoints or adding new clinical trial sites or
cohorts of subjects. Any such developments could delay the development timeline for and materially increase the cost of LYT-100. Furthermore, we cannot be certain that the evidence that we believe suggests that LYT-100 may be beneficial to these
patients will be established in a clinical trial. The failure of LYT-100 to demonstrate safety and efficacy in these patients could negatively impact the perception of us and LYT-100 by investors and it is possible that unexpected safety issues
could occur in these COVID-19 patients. Any such safety issues could affect our development plans for LYT-100 in other indications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We attempt to
distribute our scientific, execution and financing risks across a variety of therapeutic areas, indications, programs and modalities that relate to the brain, immune system and gastrointestinal system and the interface between them. However, our
assessment of, and approach to, risk may not be comprehensive or effectively avoid delays or failures in one or more of our programs. Failures in one or more of our programs could adversely impact other programs and have a material adverse impact on
our business, results of operations and ability to fund our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are creating medicines for serious diseases involving the brain, immune
system and gastrointestinal, or BIG, system and the interface between those systems, or the BIG Axis. We have made investments in our Founded Entities, R&amp;D infrastructure, and clinical capabilities that have enabled us to establish the
underlying programs and platforms that have resulted in 24 products and product candidates that are being advanced within our Wholly Owned Programs or by our Founded Entities. Of these products and product candidates, 12 are clinical-stage, and two
have been cleared by the FDA and granted marketing authorization in the EEA. Our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities are advancing eight of these product candidates, including two that are expected to enter Phase
3/Pivotal studies, as well as two <FONT STYLE="white-space:nowrap">FDA-cleared</FONT> products. Our Controlled Founded Entities are advancing nine of these product candidates, including one that is expected to enter a Phase 3 study, and three that
are in Phase 2 development, and we are advancing four of these product candidates within our Wholly Owned Pipeline. As our and certain of our Founded Entities&#146; product candidates progress through clinical development, we or others may determine
that certain of our risk allocation decisions were incorrect or insufficient, that individual programs or our science in general has technology or biology risks that were unknown or underappreciated, or that we have allocated resources across our
programs in such a way that did not maximize potential value creation. All of these risks may relate to our current and future programs sharing similar science and infrastructure, and in the event material decisions in any of these areas turn out to
have been incorrect or under-optimized, we may experience a material adverse impact on our business and ability to fund our operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our
business is highly dependent on the clinical advancement of our programs and our success in identifying potential product candidates across the BIG Axis. Delay or failure to advance our programs could adversely impact our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are developing new medicines based on the lymphatic system, the BIG systems and the BIG Axis. Over time, our and our Founded Entities&#146; preclinical and
clinical work led us to identify potential synergies across target therapeutic indications in the BIG Axis, generating a broad portfolio of product candidates across multiple programs. Even if a particular program is successful in any phase of
development, such program could fail at a later phase of development, and other programs within the same therapeutic area may still fail at any phase of development including at phases where earlier programs in that therapeutic area were successful.
This may be a result of technical challenges unique to that program or due to biology risk, which is unique to every program. As </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">64</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
we progress our programs through clinical development, there may be new technical challenges that arise that cause an entire program or a group of programs within an area of focus in the BIG Axis
to fail. While we aim to segregate risk across programs, and in certain cases among our Founded Entities, there may be foreseen and unforeseen risks across our Wholly Owned Pipeline and programs being developed by our Founded Entities in whole or in
part. In addition, if any one or more of our clinical programs encounter safety, tolerability, or efficacy problems, developmental delays, regulatory issues, or other problems, our business could be significantly harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our future success depends on our ability to retain key employees, directors, consultants and advisors and to attract, retain and motivate qualified
personnel. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to compete in the highly competitive biotechnology industry depends upon our ability to attract and retain highly qualified
managerial, scientific and medical personnel. We are highly dependent on the management, research and development, clinical, financial and business development expertise of our executive officers, our directors, as well as the other members of our
scientific and clinical teams, including Daphne Zohar, our Chief Executive Officer, Bharatt Chowrira, our President and Chief of Business and Strategy, Stephen Muniz, our Chief Operating Officer, Joep Muijrers, our Chief of Portfolio Strategy, Eric
Elenko, our Chief Innovation Officer, and Joseph Bolen, Ph.D., our Chief Scientific Officer. The loss of the services of any of our executive officers and other key personnel, and our inability to find suitable replacements could result in delays in
product development and our financial condition and results of operations could be materially adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, each of our executive
officers may terminate their employment with us at any time. Recruiting and retaining qualified scientific and clinical personnel and, if we progress the development of our Wholly Owned Pipeline toward scaling up for commercialization, sales and
marketing personnel, will also be critical to our success. The loss of the services of our executive officers or other key employees could impede the achievement of research, development and commercialization objectives and seriously harm our
ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the
breadth of skills and experience required to successfully develop, gain regulatory approval for and commercialize our Wholly Owned product candidates. Competition to hire qualified personnel in our industry is intense, and we may be unable to hire,
train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. Furthermore, to the extent we hire personnel from competitors, we may be subject
to allegations that they have been improperly solicited or that they have divulged proprietary or other confidential information, or that their former employers own their research output. We also experience competition for the hiring of scientific
and clinical personnel from universities and research institutions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we rely on consultants and advisors, including scientific and clinical
advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other
entities that may limit their availability to us. If we are unable to continue to attract and retain high quality personnel, our ability to pursue our growth strategy will be limited. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will need to expand our organization and we may experience difficulties in managing this growth, which could disrupt our operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As we mature, we expect to expand our full-time employee base and to hire more consultants and contractors. Our management may need to divert a
disproportionate amount of its attention away from our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities and devote a substantial amount of time toward managing these growth activities. We may not
be able to effectively manage the expansion of our operations, which may result in weaknesses in our infrastructure, operational mistakes, loss of business opportunities, loss of employees and reduced productivity among
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">65</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
remaining employees. Our expected growth could require significant capital expenditures and may divert financial resources from other projects, such as the development of additional product
candidates. If our management is unable to effectively manage our growth, our expenses may increase more than expected, our ability to generate and/or grow revenues could be reduced, and we may not be able to implement our business strategy. Our
future financial performance and our ability to commercialize product candidates and compete effectively will depend, in part, on our ability to effectively manage any future growth. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because we are developing multiple programs and product candidates and are pursuing a variety of target indications and treatment modalities, we may
expend our limited resources to pursue a particular product candidate and fail to capitalize on development opportunities or product candidates that may be more profitable or for which there is a greater likelihood of success. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because we have limited financial and personnel resources, we may forgo or delay pursuit of opportunities with potential target indications or product
candidates that later prove to have greater commercial potential than our current and planned development programs and product candidates. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or
profitable market opportunities. Our spending on current and future research and development programs and other future product candidates for specific indications may not yield any commercially viable future product candidates. If we do not
accurately evaluate the commercial potential or target market for a particular product candidate, we may be required to relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in
which it would have been more advantageous for us to retain sole development and commercialization rights to such future product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, we may pursue additional <FONT STYLE="white-space:nowrap">in-licenses</FONT> or acquisitions of development-stage assets or programs, which
entails additional risk to us. For example, we recently acquired <FONT STYLE="white-space:nowrap">LYT-100,</FONT> which is our most advanced product candidate and to which we are investing significant resources for its development. Identifying,
selecting and acquiring promising product candidates requires substantial technical, financial and human resources expertise. Efforts to do so may not result in the actual acquisition or license of a successful product candidate, potentially
resulting in a diversion of our management&#146;s time and the expenditure of our resources with no resulting benefit. For example, if we are unable to identify programs that ultimately result in approved products, we may spend material amounts of
our capital and other resources evaluating, acquiring and developing products that ultimately do not provide a return on our investment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Product
liability lawsuits against us could cause us to incur substantial liabilities and could limit commercialization of any product candidates that we may develop. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We face an inherent risk of product liability exposure related to the testing of product candidates in human clinical trials and will face an even greater risk
if we commercially sell any products that we may develop. If we cannot successfully defend ourselves against claims that our Wholly Owned product candidates or medicines caused injuries, we could incur substantial liabilities. Regardless of merit or
eventual outcome, liability claims may result in: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decreased demand for any product candidates or medicines that we may develop; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injury to our reputation and significant negative media attention; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">withdrawal of clinical trial participants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant costs to defend the related litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">substantial monetary awards to trial participants or patients; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">loss of revenue; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to commercialize our Wholly Owned product candidates. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">66</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we maintain product liability insurance, including coverage for clinical trials that we sponsor, it
may not be adequate to cover all liabilities that we may incur. We anticipate that we will need to increase our insurance coverage as we commence additional clinical trials and if we successfully commercialize any product candidates. The market for
insurance coverage is increasingly expensive, and the costs of insurance coverage will increase as our clinical programs increase in size. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any
liability that may arise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The increasing use of social media platforms presents new risks and challenges. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Social media is increasingly being used to communicate about our and our Founded Entities&#146; clinical development programs and the diseases our therapeutics
are being developed to treat, and we intend to utilize appropriate social media in connection with our commercialization efforts following approval of our Wholly Owned product candidates. Social media practices in the biopharmaceutical industry
continue to evolve and regulations relating to such use are not always clear. This evolution creates uncertainty and risk of noncompliance with regulations applicable to our business. For example, patients may use social media channels to comment on
their experience in an ongoing blinded clinical study or to report an alleged adverse event. When such disclosures occur, there is a risk that we fail to monitor and comply with applicable adverse event reporting obligations or we may not be able to
defend our business or the public&#146;s legitimate interests in the face of the political and market pressures generated by social media due to restrictions on what we may say about our Wholly Owned product candidates. There is also a risk of
inappropriate disclosure of sensitive information or negative or inaccurate posts or comments about us on any social networking website. If any of these events were to occur or we otherwise fail to comply with applicable regulations, we could incur
liability, face regulatory actions or incur other harm to our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our and our Founded Entities&#146; employees, independent contractors,
consultants, commercial partners and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are exposed to the risk of fraud, misconduct or other illegal activity by our employees, independent contractors, consultants, commercial partners and
vendors as well as the employees, independent contractors, consultants, commercial partners and vendors of our Founded Entities. Misconduct by these parties could include intentional, reckless and negligent conduct that fails to: comply with the
laws of the FDA and comparable foreign regulatory authorities; provide true, complete and accurate information to the FDA and comparable foreign regulatory authorities; comply with manufacturing standards we have established; comply with healthcare
fraud and abuse laws in the United States and similar foreign fraudulent misconduct laws; or report financial information or data accurately or to disclose unauthorized activities. If we or our Founded Entities obtain FDA approval of our Wholly
Owned or our Founded Entities&#146; product candidates and begin commercializing those products in the United States, our potential exposure under such laws will increase significantly, and our costs associated with compliance with such laws are
also likely to increase. In particular, research, sales, marketing, education and other business arrangements in the healthcare industry are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices.
These laws and regulations may restrict or prohibit a wide range of pricing, discounting, educating, marketing and promotion, sales and commission, certain customer incentive programs and other business arrangements generally. Activities subject to
these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. It is not always possible to identify and
deter misconduct by employees and third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other
actions or lawsuits stemming from a failure to be in compliance with such laws. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on
our business, including the imposition of significant fines or other sanctions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">67</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Employee litigation and unfavorable publicity could negatively affect our future business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our employees may, from time to time, bring lawsuits against us regarding injury, creating a hostile work place, discrimination, wage and hour disputes, sexual
harassment, or other employment issues. In recent years, there has been an increase in the number of discrimination and harassment claims generally. Coupled with the expansion of social media platforms and similar devices that allow individuals
access to a broad audience, these claims have had a significant negative impact on some businesses. Certain companies that have faced employment- or harassment-related lawsuits have had to terminate management or other key personnel, and have
suffered reputational harm that has negatively impacted their business. If we were to face any employment-related claims, our business could be negatively affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could
harm our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory
procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce
hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from
our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with
such laws and regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we maintain workers&#146; compensation insurance to cover us for costs and expenses we may incur due to injuries to
our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against
us in connection with our storage or disposal of biological, hazardous or radioactive materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we may incur substantial costs in order to
comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or production efforts. Our failure to comply with these laws and regulations also
may result in substantial fines, penalties or other sanctions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unfavorable global economic conditions, including conditions resulting from the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, could adversely affect our business, financial condition or results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
ability to invest in and expand our business and meet our financial obligations, to attract and retain third-party contractors and collaboration partners and to raise additional capital depends on our operating and financial performance, which, in
turn, is subject to numerous factors, including the prevailing economic and political conditions and financial, business and other factors beyond our control, such as the rate of unemployment, the number of uninsured persons in the United States,
political influences and inflationary pressures. For example, an overall decrease in or loss of insurance coverage among individuals in the United States as a result of unemployment, underemployment or the repeal of certain provisions of the ACA,
may decrease the demand for healthcare services and pharmaceuticals. If fewer patients are seeking medical care because they do not have insurance coverage, we and our Founded Entities may experience difficulties in any eventual commercialization of
our Wholly Owned or our Founded Entities&#146; product candidates and our business, results of operations, financial condition and cash flows could be adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets upon which
pharmaceutical and biopharmaceutical companies such as us are dependent for sources of capital. In the past, global financial crises have caused extreme volatility and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">68</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
disruptions in the capital and credit markets. A severe or prolonged economic downturn could result in a variety of risks to our business, including a reduced ability to raise additional capital
when needed on acceptable terms, if at all, and weakened demand for our Wholly Owned product candidates. A weak or declining economy could also strain our suppliers, possibly resulting in supply disruption. Any of the foregoing could harm our
business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic has had, and will continue to have, an unfavorable impact on global economic conditions,
including a decrease in or loss of insurance coverage among individuals in the United States, an increase in unemployment, volatility in markets, and other negative impacts that have arisen or will arise over the course of the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cyber-attacks or other failures in our telecommunications or information technology systems,
or those of our collaborators, contract research organizations, third-party logistics providers, distributors or other contractors or consultants, could result in information theft, data corruption and significant disruption of our business
operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We, our collaborators, our CROs, third-party logistics providers, distributors and other contractors and consultants utilize
information technology, or IT, systems and networks to process, transmit and store electronic information in connection with our business activities. As use of digital technologies has increased, cyber incidents, including third parties gaining
access to employee accounts using stolen or inferred credentials, computer malware, viruses, spamming, phishing attacks or other means, and deliberate attacks and attempts to gain unauthorized access to computer systems and networks, have increased
in frequency and sophistication. These threats pose a risk to the security of our, our collaborators&#146;, our CROs&#146;, third-party logistics providers&#146;, distributors&#146; and other contractors&#146; and consultants&#146; systems and
networks, and the confidentiality, availability and integrity of our data. There can be no assurance that we will be successful in preventing cyber-attacks or successfully mitigating their effects. Similarly, there can be no assurance that our
collaborators, CROs, third-party logistics providers, distributors and other contractors and consultants will be successful in protecting our clinical and other data that is stored on their systems. Although to our knowledge we have not experienced
any such material system failure or material security breach to date, if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of development programs and business operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any cyber-attack, data breach or destruction or loss of data could result in a violation of applicable U.S. and international privacy, data protection and
other laws, and subject us to litigation and governmental investigations and proceedings by federal, state and local regulatory entities in the United States and by international regulatory entities, resulting in exposure to material civil and/or
criminal liability. Further, our general liability insurance and corporate risk program may not cover all potential claims to which we are exposed and may not be adequate to indemnify us for all liability that maybe imposed; and could have a
material adverse effect on our business and prospects. For example, the loss of clinical trial data from completed or ongoing clinical trials for any of our Wholly Owned or our Founded Entities&#146; product candidates could result in delays in our
development and regulatory approval efforts and significantly increase our costs to recover or reproduce the data. In addition, we may suffer reputational harm or face litigation or adverse regulatory action as a result of cyber-attacks or other
data security breaches and may incur significant additional expense to implement further data protection measures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Changes in funding for the FDA,
the SEC and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies
from performing normal functions on which the operation of our business may rely, which could negatively impact our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ability of the
FDA to review and approve new products or take action with respect to other regulatory matters can be affected by a variety of factors, including government budget and funding levels, ability to hire
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">69</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and retain key personnel and accept payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In
addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.
The priorities of the FDA may also influence the ability of the FDA to take action on regulatory matters, for example the FDA&#146;s budget and funding levels and ability to hire and retain key personnel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved, or for other actions to be taken, by
relevant government agencies, which would adversely affect our business. For example, over the last several years, including for 35 days beginning on December&nbsp;22, 2018, the U.S. government has shut down several times and certain regulatory
agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely
review and process our regulatory submissions, which could have a material adverse effect on our business. Similarly, a prolonged government shutdown could prevent the timely review of our patent applications by the USPTO, which could delay the
issuance of any U.S. patents to which we might otherwise be entitled. Further, in our operations as a public company, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly
capitalize and continue our operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We or the third parties upon whom we depend may be adversely affected by a natural disaster and our
business continuity and disaster recovery plans may not adequately protect us from a serious disaster. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Natural disasters could severely disrupt
our operations, and have a material adverse effect on our business, results of operations, financial condition and prospects. If a natural disaster, power outage or other event occurred that prevented us from using all or a significant portion of
our headquarters, that damaged critical infrastructure, such as the manufacturing facilities of our third-party CMOs, or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible for us to continue our business for a
substantial period of time. The disaster recovery and business continuity plans we have in place currently are limited and are unlikely to prove adequate in the event of a serious disaster or similar event. We may incur substantial expenses as a
result of the limited nature of our disaster recovery and business continuity plans, which, could have a material adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our International Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>As a
company based in the United Kingdom, we are subject to economic, political, regulatory and other risks associated with international operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a company based in the United Kingdom, our business is subject to risks associated with being organized outside of the United States. While the majority of
our operations are in the United States and our functional currency is the U.S. dollar, our future results could be harmed by a variety of international factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">economic weakness, including inflation, or political instability in particular
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> economies and markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">differing and changing regulatory requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties in compliance with different, complex and changing laws, regulations and court systems of multiple
jurisdictions and compliance with a wide variety of foreign laws, treaties and regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in a specific country&#146;s or region&#146;s political or economic environment, including, but not
limited to, the implications of one or more of the following occurring the decision of the United Kingdom: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">relating to the terms of the future trading arrangement between the United Kingdom and the European Union
following the expiry of the Brexit transition period on December&nbsp;31, 2020; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">70</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a second referendum on Scottish independence from the United Kingdom; and/or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a snap general election; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">negative consequences from changes in tax laws; </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our international operations may expose us to business, regulatory, political, operational, financial, pricing and reimbursement and economic risks
associated with doing business outside of the United States. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business strategy incorporates potential international expansion to target
patient populations outside the United States. If we or our Founded Entities receive regulatory approval for and commercialize any of our Wholly Owned or our Founded Entities&#146; product candidates in patient populations outside the United States,
we may hire sales representatives and conduct physician and patient association outreach activities outside of the United States. Doing business internationally involves a number of risks, including, but not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">multiple, conflicting, and changing laws and regulations such as privacy regulations, tax laws, export and import
restrictions, employment laws, regulatory requirements, and other governmental approvals, permits, and licenses; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by us to obtain and maintain regulatory approvals for the use of our products in various countries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additional potentially relevant third-party patent rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">complexities and difficulties in obtaining protection and enforcing our intellectual property;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties in staffing and managing foreign operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">complexities associated with managing multiple payor reimbursement regimes, government payors, or patient <FONT
STYLE="white-space:nowrap">self-pay</FONT> systems; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limits in our ability to penetrate international markets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">financial risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact of local
and regional financial crises on demand and payment for our products, and exposure to foreign currency exchange rate fluctuations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">natural disasters, political and economic instability, including wars, terrorism, and political unrest, outbreak
of disease, boycotts, curtailment of trade, and other business restrictions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain expenses including, among others, expenses for travel, translation, and insurance; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory and compliance risks that relate to maintaining accurate information and control over sales and
activities that may fall within the purview of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, its books and records provisions, or its anti-bribery provisions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any of these factors could significantly harm our potential international expansion and operations and, consequently, our results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European data collection is governed by restrictive regulations governing the use, processing and cross-border transfer of personal information.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event we decide to conduct clinical trials or continue to enroll subjects in our ongoing or future clinical trials in the European Union,
we may be subject to additional privacy restrictions. The collection and use of personal health data in the European Union is governed by the provisions of the General Data Protection Regulation (EU) 2016/679, or GDPR. This directive imposes several
requirements relating to the consent of the individuals to whom the personal data relates, the information provided to the individuals, notification of data processing obligations to the competent national data protection authorities and the
security and confidentiality of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">71</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the personal data. The GDPR also imposes strict rules on the transfer of personal data out of the European Union to the United States. Failure to comply with the requirements of the Data
Protection Directive, which governs the collection and use of personal health data in the European Union, the GDPR, and the related national data protection laws of the European Union Member States may result in fines and other administrative
penalties. The GDPR introduced new data protection requirements in the European Union and substantial fines for breaches of the data protection rules. The GDPR regulations may impose additional responsibility and liability in relation to personal
data that we process and we may be required to put in place additional mechanisms ensuring compliance with these and/or new data protection rules. This may be onerous and adversely affect our business, financial condition, prospects and results of
operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to the U.K. Bribery Act 2010, or the Bribery Act, the FCPA and other anti-corruption laws, as well as export control
laws, import and customs laws, trade and economic sanctions laws and other laws governing our operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our operations are subject to
anti-corruption laws, including the Bribery Act, the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. &#167;201, the U.S. Travel Act, and other anti-corruption laws that apply in countries where we do business. The Bribery Act, the
FCPA and these other laws generally prohibit us and our employees and intermediaries from authorizing, promising, offering, or providing, directly or indirectly, improper or prohibited payments, or anything else of value, to government officials or
other persons to obtain or retain business or gain some other business advantage. Under the Bribery Act, we may also be liable for failing to prevent a person associated with us from committing a bribery offense. In the future, we and our strategic
partners may operate in jurisdictions that pose a high risk of potential Bribery Act or FCPA violations, and we may participate in collaborations and relationships with third parties whose corrupt or illegal activities could potentially subject us
to liability under the Bribery Act, FCPA or local anti-corruption laws, even if we do not explicitly authorize or have actual knowledge of such activities. In addition, we cannot predict the nature, scope or effect of future regulatory requirements
to which our international operations might be subject or the manner in which existing laws might be administered or interpreted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are also subject to
other laws and regulations governing our international operations, including regulations administered by the governments of the United Kingdom and the United States, and authorities in the European Union, including applicable export control
regulations, economic sanctions and embargoes on certain countries and persons, anti-money laundering laws, import and customs requirements and currency exchange regulations, collectively referred to as the Trade Control laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no assurance that we will be completely effective in ensuring our compliance with all applicable anti-corruption laws, including the Bribery Act, the
FCPA or other legal requirements, including Trade Control laws. If we are not in compliance with the Bribery Act, the FCPA and other anti-corruption laws or Trade Control laws, we may be subject to criminal and civil penalties, disgorgement and
other sanctions and remedial measures, and legal expenses, which could have an adverse impact on our business, financial condition, results of operations and liquidity. Likewise, any investigation of any potential violations of the Bribery Act, the
FCPA, other anti-corruption laws or Trade Control laws by United Kingdom, United States or other authorities could also have an adverse impact on our reputation, our business, results of operations and financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The United Kingdom&#146;s withdrawal from the European Union may have a negative effect on global economic conditions, financial markets and our
business, which could reduce the price of our ADSs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;23, 2016, the United Kingdom held a referendum in which a majority of the
eligible members of the electorate voted for the United Kingdom to leave the European Union. The United Kingdom&#146;s withdrawal from the European Union is commonly referred to as Brexit. In October 2019, a withdrawal agreement, or the Withdrawal
Agreement, setting out the terms of the United Kingdom&#146;s exit from the European Union, and a political declaration on the framework for the future relationship between the United Kingdom and European Union was agreed between the UK and EU
governments. Under the terms of the EU Withdrawal Agreement, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">72</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
United Kingdom withdrew from membership of the European Union on 31&nbsp;January 2020 and entered into a &#145;transition period&#146; which is due to expire on 31&nbsp;December 2020, or the
Transition Period. During the Transition Period, the majority of rights and obligations associated with membership of the European Union continue to apply to the United Kingdom. The UK Government&#146;s intention is to negotiate a trade agreement
with the European Union during the Transition Period, but there is no guarantee that the terms of a trading agreement will be ratified by the UK Government or the European Union prior to the end of the transition period. On 12&nbsp;June 2020, the UK
Government announced that it would not seek to extend the transition period. As a result, the trading relationship between the United Kingdom and the European Union will be governed by WTO rules from 31&nbsp;December 2020 unless a trading
arrangement is agreed and ratified by both parties before that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These developments have had and may continue to have a significant adverse effect on
global economic conditions and the stability of global financial markets, and could significantly reduce global market liquidity and restrict the ability of key market participants to operate in certain financial markets. In particular, it could
also lead to a period of considerable uncertainty in relation to the U.K. financial and banking markets, as well as on the regulatory process in the United Kingdom and Europe. As a result of this uncertainty, global financial markets could
experience significant volatility, which could adversely affect the market price of our ADSs. Asset valuations, currency exchange rates and credit ratings may also be subject to increased market volatility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also face new regulatory costs and challenges that could have an adverse effect on our operations. Depending on the terms of the trading agreement to
be negotiated between the United Kingdom and the European Union, the United Kingdom could lose the benefits of global trade agreements negotiated by the European Union on behalf of its members, which may result in increased trade barriers that could
make our doing business in Europe more difficult. In addition, currency exchange rates in the pound sterling and the euro with respect to each other and the U.S. dollar have already been adversely affected by Brexit. Furthermore, at present, there
are no indications of the effect Brexit will have on the pathway to obtaining marketing approval for any of our Wholly Owned product candidates in the United Kingdom, or what, if any, role the EMA may have in the approval process. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Equity Securities and ADSs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We
do not know whether an active, liquid and orderly trading market will develop for our ADSs or what the market price of our ADSs will be. As a result, it may be difficult for you to sell your ADSs. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While our ordinary shares have traded on the LSE since 2015, the ADSs registered hereunder constitute the first opportunity to purchase our ADSs in the United
States, and no public market has previously existed for our ADSs or ordinary shares in the United States. We intend to apply to have our ADSs listed on Nasdaq, and we expect our ADSs to be quoted on Nasdaq, subject to completion of customary
procedures in the United States. Any delay in the commencement of trading of the ADSs on Nasdaq would impair the liquidity of the market for the ADSs and make it more difficult for holders to sell the ADSs. If the ADSs are listed and quoted on
Nasdaq, there can be no assurance that an active trading market for the ADSs will develop or be sustained after registration is completed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The
market price of our ADSs may be highly volatile, and you may not be able to resell your ADSs at or above the price that you pay for them. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
market price of our ADSs is likely to be volatile. The stock market in general, and the market for biopharmaceutical companies in particular, has experienced extreme volatility that has often been unrelated to the operating performance of particular
companies. As a result of this volatility, you may not be able to sell your ADSs at or above the purchase price. The market price for our ADSs may be influenced by many factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse results or delays in our preclinical studies or clinical trials; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">73</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reports of AEs or other negative results in clinical trials of third parties&#146; product candidates that target
our Wholly Owned or our Founded Entities&#146; product candidates&#146; target indications; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an inability for us to obtain additional funding on reasonable terms or at all; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any delay in filing an IND, BLA or NDA for our Wholly Owned or our Founded Entities&#146; product candidates and
any adverse development or perceived adverse development with respect to the FDA&#146;s review of that IND, BLA or NDA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to develop successfully and commercialize our Wholly Owned or our Founded Entities&#146; product
candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcements we make regarding our current product candidates, acquisition of potential new product candidates
and companies and/or <FONT STYLE="white-space:nowrap">in-licensing;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to maintain our or our Founded Entities&#146; existing license arrangements or enter into new licensing
and collaboration agreements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by us, our Founded Entities or our licensors to prosecute, maintain or enforce our intellectual property
rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in laws or regulations applicable to future products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">inability to obtain adequate clinical or commercial supply for our Wholly Owned or our Founded Entities&#146;
product candidates or the inability to do so at acceptable prices; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse regulatory decisions, including failure to reach agreement with applicable regulatory authorities on the
design or scope of our planned clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to obtain and maintain regulatory exclusivity for our Wholly Owned or our Founded Entities&#146; product
candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory approval or commercialization of new products or other methods of treating our target disease
indications by our competitors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to meet or exceed financial projections we may provide to the public or to the investment community;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">publication of research reports or comments by securities or industry analysts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the perception of the pharmaceutical and biotechnology industries by the public, legislatures, regulators and the
investment community; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcements of significant acquisitions, strategic partnerships, joint ventures or capital commitments by us,
our Founded Entities our strategic collaboration partners or our competitors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disputes or other developments relating to proprietary rights, including patents, litigation matters and our or
our Founded Entities&#146; ability to obtain patent protection for our technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions or departures of our key scientific or management personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant lawsuits, including patent or shareholder litigation, against us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the market valuations of similar companies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse developments relating to any of the above or additional factors with respect to our Founded Entities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales or potential sales of substantial amounts of our ADSs; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">trading volume of our ADSs. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, companies trading in the stock market in general, and Nasdaq, in particular, have experienced extreme price and volume fluctuations that have
often been unrelated or disproportionate to the operating </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">74</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
performance of these companies. Broad market and industry factors may negatively affect the market price of our ADSs, regardless of our actual operating performance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our ADS price and trading
volume could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The trading market for our ADSs and ordinary shares depends in part on the research and reports that securities or industry
analysts publish about us or our business. If no or few securities or industry analysts cover our company, the trading price for our ADSs and ordinary shares would be negatively impacted. If one or more of the analysts who covers us downgrades our
equity securities or publishes incorrect or unfavorable research about our business, the price of our ordinary shares and ADSs would likely decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us
regularly, or downgrades our securities, demand for our ordinary shares and ADSs could decrease, which could cause the price of our ordinary shares and ADSs or their trading volume to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future sales, or the possibility of future sales, of a substantial number of our securities could adversely affect the price of the shares and dilute
shareholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of our ADSs in the public market could occur at any time, subject to certain restrictions described
below. If our existing shareholders sell, or indicate an intent to sell, substantial amounts of our securities in the public market, the trading price of the ADSs could decline significantly and could decline below the original purchase price. As of
June&nbsp;30, 2020, we had 285,512,461 outstanding ordinary shares. Ordinary shares subject to outstanding options under our equity incentive plans and the ordinary shares reserved for future issuance under our equity incentive plans will become
eligible for sale in the public market in the future, subject to certain legal and contractual limitations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Holders of ADSs are not treated as
holders of our ordinary shares. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After purchasing an ADS, you will become a holder of ADSs with underlying ordinary shares in a company
incorporated under English law. Holders of ADSs are not treated as holders of our ordinary shares, unless they withdraw the ordinary shares underlying their ADSs in accordance with the deposit agreement and applicable laws and regulations. The
depositary is the holder of the ordinary shares underlying the ADSs. Holders of ADSs therefore do not have any rights as holders of our ordinary shares, other than the rights that they have pursuant to the deposit agreement. See &#147;Description of
American Depositary Shares.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Holders of ADSs may be subject to limitations on the transfer of their ADSs and the withdrawal of the underlying
ordinary shares. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ADSs are transferable on the books of the depositary. However, the depositary may close its books at any time or from time to
time when it deems expedient in connection with the performance of its duties. The depositary may refuse to deliver, transfer or register transfers of ADSs generally when our books or the books of the depositary are closed, or at any time if we or
the depositary think it is advisable to do so because of any requirement of law, government or governmental body, or under any provision of the deposit agreement, or for any other reason, subject to the right of ADS holders to cancel their ADSs and
withdraw the underlying ordinary shares. Temporary delays in the cancellation of your ADSs and withdrawal of the underlying ordinary shares may arise because the depositary has closed its transfer books or we have closed our transfer books, the
transfer of ordinary shares is blocked to permit voting at a shareholders&#146; meeting or we are paying a dividend on our ordinary shares. In addition, ADS holders may not be able to cancel their ADSs and withdraw the underlying ordinary shares
when they owe money for fees, taxes and similar charges and when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of ordinary shares or other deposited
securities. See &#147;Description of American Depositary Shares.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">75</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit
agreement, which could result in less favorable outcomes to the plaintiff(s) in any such action. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The deposit agreement governing the ADSs
representing our ordinary shares provides that, to the fullest extent permitted by law, holders and beneficial owners of ADSs irrevocably waive the right to a jury trial of any claim they may have against us or the depositary arising out of or
relating to the ADSs or the deposit agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this jury trial waiver provision is not permitted by applicable law, an action could proceed under the
terms of the deposit agreement with a jury trial. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable based on the facts and circumstances of that case in accordance
with the applicable state and federal law. To our knowledge, the enforceability of a contractual pre-dispute jury trial waiver in connection with claims arising under the federal securities laws has not been finally adjudicated by the United States
Supreme Court. However, we believe that a contractual <FONT STYLE="white-space:nowrap">pre-dispute</FONT> jury trial waiver provision is generally enforceable, including under the laws of the State of New York, which govern the deposit agreement, by
a federal or state court in the City of New York, which has <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction over matters arising under the deposit agreement. In determining whether to enforce a contractual <FONT
STYLE="white-space:nowrap">pre-dispute</FONT> jury trial waiver provision, courts will generally consider whether a party knowingly, intelligently and voluntarily waived the right to a jury trial. We believe that this is the case with respect to the
deposit agreement and the ADSs. It is advisable that you consult legal counsel regarding the jury waiver provision before entering into the deposit agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you or any other holders or beneficial owners of ADSs bring a claim against us or the depositary in connection with matters arising under the deposit
agreement or the ADSs, including claims under federal securities laws, you or such other holder or beneficial owner may not be entitled to a jury trial with respect to such claims, which may have the effect of limiting and discouraging lawsuits
against us and/or the depositary. If a lawsuit is brought against us and/or the depositary under the deposit agreement, it may be heard only by a judge or justice of the applicable trial court, which would be conducted according to different civil
procedures and may result in different outcomes than a trial by jury would have had, including results that could be less favorable to the plaintiff(s) in any such action, depending on, among other things, the nature of the claims, the judge or
justice hearing such claims, and the venue of the hearing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No condition, stipulation or provision of the deposit agreement or ADSs serves as a waiver by
any holder or beneficial owner of ADSs or by us or the depositary of compliance with the U.S. federal securities laws and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>One of our principal shareholders has a significant holding in the company which may give them influence in certain matters requiring approval by
shareholders, including approval of significant corporate transactions in certain circumstances. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, Invesco Asset
Management Limited, or Invesco, held approximately 29&nbsp;percent of our ordinary shares. Accordingly, Invesco may, as a practical matter, be able to influence certain matters requiring approval by shareholders, including approval of significant
corporate transactions in certain circumstances. Such concentration of ownership may also have the effect of delaying or preventing any future proposed change in control of the Company. The trading price of the ordinary shares could be adversely
affected if potential new investors are disinclined to invest in the Company because they perceive disadvantages to a large shareholding being concentrated in the hands of a single shareholder. The interests of Invesco and the investors that acquire
ADSs may not be aligned. Invesco may make acquisitions of, or investments in, other businesses in the same sectors as us or our Founded Entities. These businesses may be, or may become, competitors of us or our Founded Entities. In addition, funds
or other entities managed or advised by Invesco may be in direct competition with us or our Founded Entities on potential acquisitions of, or investments in, certain businesses. In addition, Invesco holds equity interests in certain of our Founded
Entities where they may exert direct influence. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">76</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>You will not have the same voting rights as the holders of our ordinary shares and may not receive
voting materials in time to be able to exercise your right to vote. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as described in this registration statement and the deposit agreement,
holders of the ADSs will not be able to exercise voting rights attaching to the ordinary shares represented by the ADSs. Under the terms of the deposit agreement, holders of the ADSs may instruct the depositary to vote the ordinary shares underlying
their ADSs. Otherwise, holders of ADSs will not be able to exercise their right to vote unless they withdraw the ordinary shares underlying their ADSs to vote them in person or by proxy in accordance with applicable laws and regulations and our
Articles of Association. Even so, ADS holders may not know about a meeting far enough in advance to withdraw those ordinary shares. If we ask for the instructions of holders of the ADSs, the depositary, upon timely notice from us, will notify ADS
holders of the upcoming vote and arrange to deliver our voting materials to them. Upon our request, the depositary will mail to holders a shareholder meeting notice that contains, among other things, a statement as to the manner in which voting
instructions may be given. We cannot guarantee that ADS holders will receive the voting materials in time to ensure that they can instruct the depositary to vote the ordinary shares underlying their ADSs. A shareholder is only entitled to
participate in, and vote at, the meeting of shareholders, provided that it holds our ordinary shares as of the record date set for such meeting and otherwise complies with our Articles of Association. In addition, the depositary&#146;s liability to
ADS holders for failing to execute voting instructions or for the manner of executing voting instructions is limited by the deposit agreement. As a result, holders of ADSs may not be able to exercise their right to give voting instructions or to
vote in person or by proxy and they may not have any recourse against the depositary or us if their ordinary shares are not voted as they have requested or if their shares cannot be voted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>You may not receive distributions on our ordinary shares represented by the ADSs or any value for them if it is illegal or impractical to make them
available to holders of ADSs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The depositary for the ADSs has agreed to pay to you any cash dividends or other distributions it or the custodian
receives on our ordinary shares or other deposited securities after deducting its fees and expenses. You will receive these distributions in proportion to the number of our ordinary shares your ADSs represent. However, in accordance with the
limitations set forth in the deposit agreement, it may be unlawful or impractical to make a distribution available to holders of ADSs. We have no obligation to take any other action to permit distribution on the ADSs, ordinary shares, rights or
anything else to holders of the ADSs. This means that you may not receive the distributions we make on our ordinary shares or any value from them if it is unlawful or impractical to make them available to you. These restrictions may have an adverse
effect on the value of your ADSs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because we do not have immediate plans to pay any cash dividends on our ADSs, capital appreciation, if any, may
be your sole source of gains and you may never receive a return on your investment. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under current English law, a company&#146;s accumulated
realized profits must exceed its accumulated realized losses (on a <FONT STYLE="white-space:nowrap">non-consolidated</FONT> basis) before dividends can be declared and paid. Therefore, we must have sufficient distributable profits before declaring
and paying a dividend. We have not paid dividends in the past on our ordinary shares. We have not announced any immediate plans to pay any cash dividends. As a result, capital appreciation, if any, on our ADSs will be your sole source of gains for
the foreseeable future, and you would suffer a loss on your investment if you were unable to sell your ADSs at or above the price that you initially paid for them. Investors seeking cash dividends should not purchase our ADSs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are an &#147;emerging growth company,&#148; and there are reduced disclosure requirements applicable to emerging growth companies. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; as defined in the SEC&#146;s rules and regulations and we will remain an emerging growth company until the
earlier to occur of (1)&nbsp;the last day of 2024, (2) the last day of the fiscal year in which we have total annual gross revenues of at least $1.07&nbsp;billion, (3)&nbsp;the last day of the fiscal year in which we are deemed to be a &#147;large
accelerated filer,&#148; under the rules of the U.S. Securities and Exchange Commission, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">77</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or SEC, which means the market value of our equity securities that is held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million as of the prior June 30th, and
(4)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt during the prior three-year period. For so long as we remain an emerging growth company, we are permitted and
intend to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley
Act, or Section&nbsp;404; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to comply with any requirement that has or may be adopted by the Public Company Accounting
Oversight Board, or PCAOB, regarding mandatory audit firm rotation or a supplement to the auditor&#146;s report providing additional information about the audit and the financial statements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">being permitted to provide only two years of audited financial statements in this initial registration statement,
in addition to any required unaudited interim financial statements, with correspondingly reduced &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; disclosure; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced disclosure obligations regarding executive compensation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exemption from the requirement to seek nonbinding advisory votes on executive compensation or golden parachute
arrangements. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may choose to take advantage of some, but not all, of the available exemptions. We have taken advantage of reduced
reporting burdens in this registration statement. In particular, we have not included all of the executive compensation information that would be required if we were not an emerging growth company. We cannot predict whether investors will find our
ADSs less attractive if we rely on certain or all of these exemptions. If some investors find our ADSs less attractive as a result, there may be a less active trading market for our ADSs and our ADS price may be more volatile. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the JOBS Act provides that an emerging growth company may take advantage of an extended transition period for complying with new or revised
accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We are considering whether we will take advantage of the extended
transition period for complying with new or revised accounting standards. Since IFRS makes no distinction between public and private companies for purposes of compliance with new or revised accounting standards, the requirements for our compliance
as a private company and as a public company are the same. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even after we no longer qualify as an emerging growth company, we may still qualify as a
&#147;smaller reporting company&#148; if the market value of our ordinary shares held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is below $250&nbsp;million (or $700&nbsp;million if our annual revenue is less than $100 million) as of
June&nbsp;30 in any given year, which would allow us to take advantage of many of the same exemptions from disclosure requirements, including reduced disclosure obligations regarding executive compensation in our periodic reports and proxy
statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are not, and do not intend to become, regulated as an &#147;investment company&#148; under the Investment Company Act of 1940, as
amended, or the 1940 Act and if we were deemed an &#147;investment company&#148; under the 1940 Act, applicable restrictions could make it impractical for us to continue our business as contemplated and could have a material adverse effect on our
business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 1940 Act and the rules thereunder contain detailed parameters for the organization and operation of investment companies. Among
other things, the 1940 Act and the rules thereunder limit or prohibit transactions with affiliates, impose limitations on the issuance of debt and equity securities and impose certain governance requirements. We have not been and do not intend to
become regulated as an investment company, and we intend to conduct our activities so that we will not be deemed to be an investment company under the 1940 Act. In order </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">78</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to ensure that we are not deemed to be an investment company, we may be limited in the assets that we may continue to own and, further, may need to dispose of or acquire certain assets at such
times or on such terms as may be less favorable to us than in the absence of such requirement. If anything were to happen which would cause us to be deemed to be an investment company under the 1940 Act (such as significant changes in the value of
our Founded Entities or a change in circumstance that results in a reclassification of our interests in our Founded Entities for purposes of the 1940 Act), the requirements imposed by the 1940 Act could make it impractical for us to continue our
business as currently conducted, which would materially adversely affect our business, results of operations and financial condition. In addition, if we were to become inadvertently subject to the 1940 Act, any violation of the 1940 Act could
subject us to material adverse consequences, including potentially significant regulatory penalties and the possibility that certain of our contracts could be deemed unenforceable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>As a foreign private issuer, we are exempt from a number of rules under the U.S. securities laws and are permitted to file less information with the SEC
than a U.S. company. This may limit the information available to holders of ADSs or our ordinary shares. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a &#147;foreign private
issuer,&#148; as defined in the SEC&#146;s rules and regulations and, consequently, we are not subject to all of the disclosure requirements applicable to public companies organized within the United States. For example, we are exempt from certain
rules under the Exchange Act, that regulate disclosure obligations and procedural requirements related to the solicitation of proxies, consents or authorizations applicable to a security registered under the Exchange Act, including the United States
proxy rules under Section&nbsp;14 of the Exchange Act. In addition, our officers and directors are exempt from the reporting and &#147;short-swing&#148; profit recovery provisions of Section&nbsp;16 of the Exchange Act and related rules with respect
to their purchases and sales of our securities. Moreover, while we currently make annual and semi-annual filings with respect to our listing on the LSE, we will not be required to file periodic reports and financial statements with the SEC as
frequently or as promptly as U.S. domestic issuers and will not be required to file quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or current reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> under the Exchange Act.
Accordingly, there will be less publicly available information concerning our company than there would be if we were not a foreign private issuer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>As a foreign private issuer, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ
significantly from Nasdaq corporate governance listing standards. These practices may afford less protection to shareholders than they would enjoy if we complied fully with corporate governance listing standards. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a foreign private issuer listed on Nasdaq, we will be subject to corporate governance listing standards. However, rules permit a foreign private issuer like
us to follow the corporate governance practices of its home country. Certain corporate governance practices in the United Kingdom, which is our home country, may differ significantly from corporate governance listing standards. For example, neither
the corporate laws of the United Kingdom nor our articles of association require a majority of our directors to be independent and we could include <FONT STYLE="white-space:nowrap">non-independent</FONT> directors as members of our nomination and
remuneration committee, though a majority is required, and our independent directors would not necessarily hold regularly scheduled meetings at which only independent directors are present. Currently, we intend to follow home country practice to the
maximum extent possible. Therefore, our shareholders may be afforded less protection than they otherwise would have under corporate governance listing standards applicable to U.S. domestic issuers. See &#147;Management.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may lose our foreign private issuer status in the future, which could result in significant additional cost and expense. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While we currently qualify as a foreign private issuer, the determination of foreign private issuer status is made annually on the last business day of an
issuer&#146;s most recently completed second fiscal quarter and, accordingly, the next determination will be made with respect to us on June&nbsp;30, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">79</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the future, we would lose our foreign private issuer status if we to fail to meet the requirements
necessary to maintain our foreign private issuer status as of the relevant determination date. For example, if more than 50&nbsp;percent of our securities are held by U.S. residents and more than 50&nbsp;percent of the members of our executive
committee or members of our board of directors are residents or citizens of the United States, we could lose our foreign private issuer status. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be significantly more than costs we incur as a foreign private issuer. If we are not a foreign private issuer, we will be required to file periodic
reports and registration statements on U.S. domestic issuer forms with the SEC, which are more detailed and extensive in certain respects than the forms available to a foreign private issuer. We would be required under current SEC rules to prepare
our financial statements in accordance with U.S. GAAP, rather than IFRS, and modify certain of our policies to comply with corporate governance practices associated with U.S. domestic issuers. Such conversion of our financial statements to U.S. GAAP
will involve significant time and cost. In addition, we may lose our ability to rely upon exemptions from certain corporate governance requirements on U.S. stock exchanges that are available to foreign private issuers such as the ones described
above and exemptions from procedural requirements related to the solicitation of proxies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will incur increased costs as a result of operating as
a U.S.-listed public company, and our management will be required to devote substantial time to new compliance initiatives. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a U.S. public
company, and particularly after we are no longer an emerging growth company, we will incur significant legal, accounting and other expenses that we did not incur as a public company listed on the LSE. In addition, the Sarbanes-Oxley Act of 2002, or
the Sarbanes-Oxley Act, and rules subsequently implemented by the SEC and Nasdaq have imposed various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance
practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some
activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;404, we will be required to furnish a report by our management on our internal control over financial reporting, including an
attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, while we remain an emerging growth company, we will not be required to include an attestation report on internal
control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section&nbsp;404 within the prescribed period, we will be engaged in a process to document and evaluate our internal control
over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of
internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal
control over financial reporting. Despite our efforts, there is a risk we will not be able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section&nbsp;404. This could result
in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to
maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, shareholders could lose confidence in our financial and other public reporting,
which would harm our business and the trading price of our ADSs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective internal controls over financial reporting are necessary for us to
provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">80</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted
in connection with Section&nbsp;404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may
require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information,
which could have a negative effect on the trading price of our ADSs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our management will be required to assess the effectiveness of these controls
annually. However, for as long as we are an emerging growth company, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to
Section&nbsp;404. We could be an emerging growth company for up to five years. An independent assessment of the effectiveness of our internal controls over financial reporting could detect problems that our management&#146;s assessment might not.
Undetected material weaknesses in our internal controls over financial reporting could lead to financial statement restatements and require us to incur the expense of remediation.<B><I> </I></B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>In connection with the audit of our consolidated financial statements in accordance with the standards of the PCAOB and U.S. securities laws, a material
weakness in our internal control over financial reporting was found to exist. If we fail to implement and maintain effective internal control over financial reporting, we may be unable to accurately report our results of operations, meet our
reporting obligations or prevent fraud. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have been a public company on the LSE with limited requirements to implement and test internal controls
under a UK framework. As such, we have not been subject to the internal control over financial reporting requirements of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, and the standards of the PCAOB and furthermore our independent
registered public accounting firm has not conducted an audit of our internal control over financial reporting in accordance with such rules. As a U.S. public company, Section&nbsp;404 of the Sarbanes-Oxley Act will require that our management assess
our internal control over financial reporting and include a report of management on our internal control over financial reporting in our annual report on <FONT STYLE="white-space:nowrap">Form&nbsp;20-F</FONT> beginning with our second annual report.
Although we have adhered to and will continue to adhere to all internal control requirements made relevant by the governance of the LSE, the requirements pertaining to the design and implementation of internal controls over financial reporting as
contemplated under the Sarbanes-Oxley Act had not been considered in the production of financial statements for the years ended December&nbsp;31, 2019, 2018 and 2017 for our annual report issued in the United Kingdom. In connection with the audits
of our consolidated financial statements as of and for each of the years ended December&nbsp;31, 2019, 2018 and 2017 conducted in connection with this registration statement, we and our independent registered public accounting firm identified a
material weakness in our internal control over financial reporting. A material weakness is a deficiency, or combination of control deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a
material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness relates to several significant deficiencies that were identified which, in aggregate, rise to the level of
a material weakness. These significant deficiencies relate to our process around accounting for costs attributed to individual projects, contract and consolidated review, segregation of duties, expense identification, allocation of employee stock
compensation expense, and tax provision relating to underlying investments and related party identification. We have taken steps to remediate the material weakness, including increasing the depth and experience within our accounting and finance
organization, designing and implementing improved processes and internal controls based on the COSO framework, and internally testing the effectiveness of our internal controls. As with any internal control framework, we cannot be certain that these
efforts will be sufficient to remediate our material weaknesses, prevent future material weaknesses or significant deficiencies from occurring. If we are unable to successfully remediate our existing or any future material weaknesses in our internal
control over financial reporting, or if we identify any additional material weaknesses, the accuracy and timing of our financial reporting may be adversely affected. In addition, investors could lose confidence in our reported financial information,
and we could be subject to regulatory scrutiny and to litigation from shareholders, which could have a material adverse effect on our business and the price of our ADSs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">81</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once we cease to be an &#147;emerging growth company&#148; as such term is defined in the JOBS Act, our
independent registered public accounting firm must attest to and report on the effectiveness of our internal control over financial reporting. Our independent registered public accounting firm, after conducting its own independent testing, may issue
a report that is adverse if it is not satisfied with our internal controls or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently from us. In addition, after we
become a public company in the U.S., our reporting obligations may place a significant strain on our management, operational and financial resources and systems for the foreseeable future. We may be unable to timely complete our evaluation testing
for internal control over financial reporting and any required remediation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we fail to achieve and maintain an effective internal control environment,
we could suffer material misstatements in our financial statements and fail to meet our reporting obligations, which would likely cause investors to lose confidence in our reported financial information. This could in turn limit our access to
capital markets, harm our results of operations, and lead to a decline in the trading price of our securities. Additionally, ineffective internal control over financial reporting could expose us to increased risk of fraud or misuse of corporate
assets and subject us to potential delisting from the stock exchange on which we list, regulatory investigations and civil or criminal sanctions. We may also be required to restate our financial statements from prior periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon completion of this registration, we will become subject to certain reporting requirements of the Exchange Act. Our disclosure controls and procedures are
designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized and reported within the time periods
specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the
objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented
by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error
or fraud may occur and not be detected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comprehensive tax reform legislation could adversely affect our business and financial condition.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017, the Tax Act was signed into law. The Tax Act, among other things, contains significant changes to corporate taxation,
including (i)&nbsp;reduction of the corporate tax rate from a top marginal rate of 35&nbsp;percent to a flat rate of 21&nbsp;percent, (ii)&nbsp;limitation of the tax deduction for interest expense to 30&nbsp;percent of adjusted earnings (except for
certain small businesses), (iii) limitation of the deduction for net operating losses to 80&nbsp;percent of current year taxable income in respect of net operating losses generated during or after 2018 and elimination of net operating loss
carrybacks, <FONT STYLE="white-space:nowrap">(iv)&nbsp;one-time</FONT> taxation of offshore earnings at reduced rates regardless of whether they are repatriated, (v)&nbsp;immediate deductions for certain new investments instead of deductions for
depreciation expense over time, and (vi)&nbsp;modifying or repealing many business deductions and credits. Any federal net operating loss incurred in 2018 and in future years may now be carried forward indefinitely pursuant to the Tax Act. It is
uncertain if and to what extent various states will conform to the newly enacted federal tax law. We will continue to examine the impact the Tax Act may have on our business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2020, the &#147;Coronavirus Aid, Relief, and Economic Security Act&#148; or the CARES Act was singed into law, which included certain changes
in tax law intended to stimulate the U.S. economy in light of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> coronavirus outbreak, including temporary beneficial changes to the treatment of net operating losses, interest deductibility
limitations and payroll tax matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">82</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are treated as a U.S. domestic corporation for U.S. federal income tax purposes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are treated as a U.S. domestic corporation for U.S. federal income tax purposes under Section&nbsp;7874(b) of the Internal Revenue Code of 1986, as amended,
or the Code. As a result, we are subject to U.S. income tax on our worldwide income and any dividends paid by us to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders (as defined in the discussion under &#147;Taxation in the United
States&#151;Tax Considerations for <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders&#148;) will be subject to U.S. federal income tax withholding at a 30&nbsp;percent rate or such lower rate as provided in an applicable treaty. Furthermore,
PureTech Health plc is also resident for tax purposes in the U.K. and subject to U.K. corporation tax on its worldwide income and gains. Consequently, we may be liable for both U.S. and U.K. income tax, which could have a material adverse effect on
our financial condition and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discussion of certain U.S. federal income tax risks is subject in its entirety to the summaries
set forth in &#147;Taxation in the United Kingdom&#148; and &#147;Taxation in the United States.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ability to use our net operating losses
to offset future taxable income may be subject to certain limitations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, we had U.S. federal and state net operating
loss carryforwards, or NOLs, of approximately $243.0&nbsp;million due to prior period losses, which, subject to the following discussion, are generally available to be carried forward to offset a portion of our future taxable income, if any, until
such NOLs are used or expire. In general, under Section&nbsp;382 of the Code, a corporation that undergoes an &#147;ownership change&#148; is subject to limitations on its ability to utilize its NOLs to offset future taxable income. Similar rules
may apply under state tax laws. Our existing NOLs may be subject to limitations arising from previous ownership changes, and if we undergo an ownership change, our ability to utilize NOLs could be further limited by Section&nbsp;382 of the Code.
Future changes in our stock ownership, some of which are outside of our control, could result in an ownership change under Section&nbsp;382 of the Code. Additionally, we may no longer be able to utilize losses of our Founded Entities that have been
deconsolidated or that will deconsolidate in the future. Furthermore, our ability to utilize NOLs of companies that we have acquired or may acquire in the future may be subject to limitations. In addition, under the Tax Act, the amount of post 2017
NOLs that we are permitted to deduct in any taxable year is limited to 80&nbsp;percent of our taxable income in such year, where taxable income is determined without regard to the NOL deduction itself. Federal NOLs generated after December&nbsp;31,
2017 are not subject to expiration and generally may not be carried back to prior taxable years, except that under the CARES Act, NOLs generated in 2018, 2019 and 2020 may be carried back five taxable years. There is also a risk that due to changes
under the Tax Act, regulatory changes, such as suspensions on the use of NOLs, or other unforeseen reasons, our existing NOLs could be unavailable to offset future income tax liabilities. For these reasons, we may not be able to realize a tax
benefit from the use of our NOLs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be unable to use net operating loss and tax credit carryforwards and certain <FONT
STYLE="white-space:nowrap">built-in</FONT> losses to reduce future U.K. tax liabilities. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a U.K. incorporated and tax resident entity, PureTech
Health plc is subject to U.K. corporate taxation on its <FONT STYLE="white-space:nowrap">tax-adjusted</FONT> trading profits. Due to the nature of our business, PureTech Health plc has generated losses since inception and therefore we have not paid
any U.K. corporation tax. Subject to numerous utilization criteria and restrictions (including those that limit the percentage of profits that can be reduced by carried forward losses and those that can restrict the use of carried forward losses
where there is a change of ownership of more than half the ordinary shares of the company and a major change in the nature, conduct or scale of the trade), we expect these to be eligible for carry forward and utilization against future U.K.
operating profits. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future changes to tax laws could materially adversely affect our company and reduce net returns to our shareholders.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The tax treatment of the company is subject to changes in tax laws, regulations and treaties, or the interpretation thereof, tax policy
initiatives and reforms under consideration and the practices of tax authorities in jurisdictions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">83</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in which we operate, as well as tax policy initiatives and reforms related to the Organisation for Economic <FONT STYLE="white-space:nowrap">Co-Operation</FONT> and Development&#146;s, or OECD,
Base Erosion and Profit Shifting, or BEPS, Project, the European Commission&#146;s state aid investigations and other initiatives. Such changes may include (but are not limited to) the taxation of operating income, investment income, dividends
received or (in the specific context of withholding tax) dividends paid. We are unable to predict what tax reform may be proposed or enacted in the future or what effect such changes would have on our business, but such changes, to the extent they
are brought into tax legislation, regulations, policies or practices, could affect our financial position and overall or effective tax rates in the future in countries where we have operations, reduce <FONT STYLE="white-space:nowrap">post-tax</FONT>
returns to our shareholders, and increase the complexity, burden and cost of tax compliance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax authorities may disagree with our positions and
conclusions regarding certain tax positions, resulting in unanticipated costs, taxes or <FONT STYLE="white-space:nowrap">non-realization</FONT> of expected benefits. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A tax authority may disagree with tax positions that we have taken, which could result in increased tax liabilities. For example, HM Revenue&nbsp;&amp;
Customs, or HMRC, the Internal Revenue Service or another tax authority could challenge our allocation of income by tax jurisdiction and the amounts paid between certain of our Founded Entities pursuant to our intercompany arrangements and transfer
pricing policies, including amounts paid with respect to our intellectual property development. Similarly, a tax authority could assert that we are subject to tax in a jurisdiction where we believe we have not established a taxable connection, often
referred to as a &#147;permanent establishment&#148; under international tax treaties, and such an assertion, if successful, could increase our expected tax liability in one or more jurisdictions. A tax authority may take the position that material
income tax liabilities, interest and penalties are payable by us, in which case, we expect that we might contest such assessment. Contesting such an assessment may be lengthy and costly and if we were unsuccessful in disputing the assessment, the
implications could increase our anticipated effective tax rate, where applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Shareholder protections found in provisions under the U.K. City
Code on Takeovers and Mergers, or the Takeover Code, will not apply if our securities are no longer admitted to trading on a regulated market or a multilateral trading facility in the United Kingdom or on any stock exchange in the Channel Islands or
the Isle of Man and our place of management and control is considered to change to outside the United Kingdom. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are registered as a public
limited company incorporated in England and Wales and have our ordinary shares admitted to trading on a regulated market in the United Kingdom (being the main market of the LSE). Accordingly, we are currently subject to the Takeover Code and, as a
result, our shareholders are entitled to the benefit of certain takeover offer protections provided under the Takeover Code. The Takeover Code provides a framework within which takeovers of companies are regulated and conducted. If, at the time of a
takeover offer, we have <FONT STYLE="white-space:nowrap">de-listed</FONT> from the main market of the LSE (and do not maintain a listing of securities on any other regulated market or a multilateral trading facility in the United Kingdom or on any
stock exhanage in the Channel Islands or the Isle of Man) and the Panel on Takeovers and Mergers determine that we do not have our place of central management and control in the United Kingdom, then the Takeover Code may not apply to us and our
shareholders would not be entitled to the benefit of the various protections that the Takeover Code affords. In particular, we would not be subject to the rules regarding mandatory takeover bids. The following is a brief summary of some of the most
important rules of the Takeover Code: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">when any person acquires, whether by a series of transactions over a period of time or not, an interest in shares
which (taken together with shares already held by that person and an interest in shares held or acquired by persons acting in concert with him or her) carry 30&nbsp;percent or more of the voting rights of a company that is subject to the Takeover
Code, that person is generally required to make a mandatory offer to all the holders of any class of equity share capital or other class of transferable securities carrying voting rights in that company to acquire the balance of their interests in
the company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">when any person who, together with persons acting in concert with him or her, is interested in shares
representing not less than 30&nbsp;percent but does not hold more than 50&nbsp;percent of the voting rights of a company that is subject to the Takeover Code, and such person, or any person acting in concert with
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">84</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
him or her, acquires an additional interest in shares which increases the percentage of shares carrying voting rights in which he or she is interested, then such person is generally required to
make a mandatory offer to all the holders of any class of equity share capital or other class of transferable securities carrying voting rights of that company to acquire the balance of their interests in the company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a mandatory offer triggered in the circumstances described in the two paragraphs above must be in cash (or be
accompanied by a cash alternative) and at not less than the highest price paid within the preceding 12 months to acquire any interest in shares in the company by the person required to make the offer or any person acting in concert with him or her;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in relation to a voluntary offer (i.e. any offer which is not a mandatory offer), when interests in shares
representing 10&nbsp;percent or more of the shares of a class have been acquired for cash by an offeror (i.e., a bidder) and any person acting in concert with it in the offer period and the previous 12 months, the offer must be in cash or include a
cash alternative for all shareholders of that class at not less than the highest price paid for any interest in shares of that class by the offeror and by any person acting in concert with it in that period. Further, if an offeror acquires for cash
any interest in shares during the offer period, a cash alternative must be made available at not less than the highest price paid for any interest in the shares of that class; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the offeror acquires an interest in shares in an offeree company (i.e., a target) at a price higher than the
value of the offer, the offer must be increased to not less than the highest price paid for the interest in shares so acquired; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the offeree company must obtain competent advice as to whether the terms of any offer are fair and reasonable and
the substance of such advice must be made known to all the shareholders, together with the opinion of the board of directors of the offeree company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">special or favorable deals for selected shareholders are not permitted, except in certain circumstances where
independent shareholder approval is given and the arrangements are regarded as fair and reasonable in the opinion of the financial adviser to the offeree; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all shareholders must be given the same information; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each document published in connection with an offer by or on behalf of the offeror or offeree must state that the
directors of the offeror or the offeree, as the case may be, accept responsibility for the information contained therein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">profit forecasts, quantified financial benefits statements and asset valuations must be made to specified
standards and must be reported on by professional advisers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">misleading, inaccurate or unsubstantiated statements made in documents or to the media must be publicly corrected
immediately; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actions during the course of an offer by the offeree company, which might frustrate the offer are generally
prohibited unless shareholders approve these plans. Frustrating actions would include, for example, lengthening the notice period for directors under their service contract or agreeing to sell off material parts of the target group;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">stringent and detailed requirements are laid down for the disclosure of dealings in relevant securities during an
offer, including the prompt disclosure of positions and dealing in relevant securities by the parties to an offer and any person who is interested (directly or indirectly) in 1&nbsp;percent or more of any class of relevant securities; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employees of both the offeror and the offeree company and the trustees of the offeree company&#146;s pension
scheme must be informed about an offer. In addition, the offeree company&#146;s employee representatives and pension scheme trustees have the right to have a separate opinion on the effects of the offer on employment appended to the offeree board of
directors&#146; circular or published on a website. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">85</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The rights of our shareholders may differ from the rights typically offered to shareholders of a U.S.
corporation. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are incorporated under the laws of England and Wales. The rights of holders of ordinary shares and, therefore, certain of the
rights of holders of ADSs, are governed by English law, including the provisions of the U.K. Companies Act, or the Companies Act, and by our Articles of Association. These rights differ in certain respects from the rights of shareholders in typical
U.S. corporations. See &#147;Description of Share Capital and Articles of Association&#151;Differences in Corporate Law&#148; in this registration statement for a description of the principal differences between the provisions of the Companies Act
applicable to us and, for example, the Delaware General Corporation Law relating to shareholders&#146; rights and protections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The principal differences
include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">under English law and our articles of association, each shareholder present at a meeting has only one vote when
voting by a show of hands unless demand is made for a vote on a poll, in which case each holder gets one vote per share owned. The Company usually conducts all of its shareholder votes on a poll. Under U.S. law, each shareholder typically is
entitled to one vote per share at all meetings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">under English law, it is only on a poll that the number of shares determines the number of votes a holder may
cast. You should be aware, however, that the voting rights of ADSs are also governed by the provisions of a deposit agreement with our depositary bank; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">under English law, subject to certain exceptions and disapplications, each shareholder generally has preemptive
rights to subscribe on a proportionate basis to any issuance of ordinary shares or rights to subscribe for, or to convert securities into, ordinary shares for cash. Under U.S. law, shareholders generally do not have preemptive rights unless
specifically granted in the certificate of incorporation or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">under English law and our articles of association, certain matters require the approval of 75&nbsp;percent of the
shareholders who vote (in person or by proxy) on the relevant resolution (or on a poll of shareholders representing 75&nbsp;percent of the ordinary shares voting (in person or by proxy)), including amendments to the articles of association. This may
make it more difficult for us to complete certain corporate transactions deemed advisable by our board of directors. Under U.S. law, generally only majority shareholder approval is required to amend the certificate of incorporation or to approve
other significant transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the United Kingdom, takeovers may be structured as takeover offers or as schemes of arrangement. Under English
law, for so long as we continue to be subject to the Takeover Code, a bidder seeking to acquire us by means of a takeover offer would need to make an offer for all of our outstanding ordinary shares/ADSs. If acceptances are not received for
90&nbsp;percent or more of the ordinary shares/ADSs under the offer, under English law, the bidder cannot complete a &#147;squeeze out&#148; to obtain 100&nbsp;percent control of us. Accordingly, acceptances of 90&nbsp;percent of our outstanding
ordinary shares/ADSs will likely be a condition in any takeover offer to acquire us, not 50&nbsp;percent as is more common in tender offers for corporations organized under Delaware law. By contrast, a scheme of arrangement, the successful
completion of which would result in a bidder obtaining 100&nbsp;percent control of us, requires the approval of a majority of shareholders voting at the meeting and representing 75&nbsp;percent of the ordinary shares voting for approval;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">under English law and our articles of association, shareholders and other persons whom we know or have reasonable
cause to believe are, or have been, interested in our shares may be required to disclose information regarding their interests in our shares upon our request, and the failure to provide the required information could result in the loss or
restriction of rights attaching to the shares, including prohibitions on certain transfers of the shares, withholding of dividends and loss of voting rights. Comparable provisions generally do not exist under U.S. law; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the quorum requirement for a shareholders&#146; meeting is a minimum of two shareholders entitled to vote at the
meeting and present in person or by proxy or, in the case of a shareholder which is a corporation, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">86</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
represented by a duly authorized officer. Under U.S. law, a majority of the shares eligible to vote must generally be present (in person or by proxy) at a shareholders&#146; meeting in order to
constitute a quorum. The minimum number of shares required for a quorum can be reduced pursuant to a provision in a company&#146;s certificate of incorporation or bylaws, but typically not below <FONT STYLE="white-space:nowrap">one-third</FONT> of
the shares entitled to vote at the meeting. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">87</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_5"></A>ITEM&nbsp;4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INFORMATION ON THE COMPANY </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>HISTORY AND DEVELOPMENT OF THE COMPANY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were incorporated and registered under the laws of England and Wales with the Registrar of Companies of England and Wales, United Kingdom in May 2015 as
&#147;PureTech Health plc.&#148; Our predecessor entity, PureTech Health LLC, or our Predecessor Entity, commenced formal operations and began engaging in initial sourcing activities in 2004, raising its first financing round greater than
$5&nbsp;million in the same year. The Predecessor Entity was acquired by PureTech Health plc on June&nbsp;18, 2015 in a reorganization completed in connection with our initial public offering on the London Stock Exchange. The Predecessor Entity is
now a wholly-owned subsidiary of PureTech Health plc. Our registered office is situated at 8th Floor, 20 Farringdon Street, London EC4A 4AB, United Kingdom, and our telephone number is +(1) 617 482 2333. Our U.S. operations are conducted by our
wholly-owned subsidiary PureTech Health LLC, a Delaware limited liability company. Our ordinary shares have traded on the main market of the London Stock Exchange, since June 2015. Our agent for service of process in the United States is PureTech
Health LLC located at 6 Tide Street, Suite 400, Boston, Massachusetts 02210 where our corporate headquarters and laboratories are located. Our website address is http://puretechhealth.com. The reference to our website is an inactive textual
reference only and information contained in, or that can be accessed through, our website or any other website cited in this registration statement is not part of hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless the context specifically indicates otherwise, references in this to our &#147;Wholly Owned Programs&#148; refer to
<FONT STYLE="white-space:nowrap">LYT-100,</FONT> <FONT STYLE="white-space:nowrap">LYT-200,</FONT> <FONT STYLE="white-space:nowrap">LYT-210</FONT> and <FONT STYLE="white-space:nowrap">LYT-300</FONT> as well as our three discovery platforms, and
&#147;Wholly Owned product candidates&#148; and &#147;Wholly Owned Pipeline&#148; refer to <FONT STYLE="white-space:nowrap">LYT-100,</FONT> <FONT STYLE="white-space:nowrap">LYT-200,</FONT> <FONT STYLE="white-space:nowrap">LYT-210</FONT> and <FONT
STYLE="white-space:nowrap">LYT-300.</FONT> References in this registration statement to our &#147;Founded Entities&#148; refer to the entities that we founded and in which we continue to hold equity. Our Founded Entities are comprised of our
Controlled Founded Entities and our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities. Anywhere our Founded Entities (or subsets thereof) are listed in this registration statement, we have ordered them by stage of development.
References in this registration statement to our &#147;Controlled Founded Entities&#148; refer to Follica, Incorporated, Vedanta Biosciences, Inc., Sonde Health, Inc., Alivio Therapeutics, Inc. and Entrega, Inc. References in this registration
statement to our <FONT STYLE="white-space:nowrap">&#147;Non-Controlled</FONT> Founded Entities&#148; refer to Gelesis, Inc., Karuna Therapeutics, Inc., Akili Interactive Labs, Inc., Vor Biopharma Inc., and, for all periods prior to December&nbsp;18,
2019, resTORbio, Inc. We formed each of our Founded Entities and have been involved in development efforts in varying degrees. In the case of each of our Controlled Founded Entities, we continue to maintain majority voting control. With respect to
our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities, we may benefit from appreciation in our investment as a shareholder of such companies. Additional information regarding the accounting treatment of our Founded Entities is
included under the heading &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and in our consolidated financial statements included in this registration statement. All references to our parent
entity refer to PureTech Health plc. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BUSINESS OVERVIEW </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biotechnology company
dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and
neuropsychological disorders, among others. The product candidates within our Wholly Owned Pipeline and the products and product candidates being developed by our Founded Entities were initiated by our experienced research and development team and
our extensive network of scientists, clinicians and industry leaders. These products and product candidates are protected by a growing intellectual property portfolio of more than 600 patents and patent applications, of which more than 200 are
issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We established the underlying programs and platforms that have resulted in 24 products and product candidates that are being advanced within our
Wholly Owned Programs or by our Founded Entities. Of these products and product candidates, 12 are clinical-stage and two have been cleared by the U.S. Food and Drug Administration, or FDA, and granted marketing authorization in the European
Economic Area, or EEA, and in other countries that recognize the CE Mark. Our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities are advancing eight of these product </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">88</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
candidates, including two that are expected to enter Phase 3/Pivotal studies, as well as two <FONT STYLE="white-space:nowrap">FDA-cleared</FONT> products. Our Controlled Founded Entities are
advancing nine of these product candidates, including one that is expected to enter a Phase 3 study and three that are in Phase 2 development, and we are advancing four of these product candidates within our Wholly Owned Pipeline. We and our Founded
Entities have relationships with several pharmaceutical companies or their investment arms to advance some of the underlying programs and platforms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All
of these underlying programs and platforms were initially identified or discovered and then advanced by our team through key validation points based on our unique insights into the biology of the <U>B</U>rain, <U>I</U>mmune and <U>G</U>ut, or BIG,
systems and the interface between those systems, which we refer to as the BIG Axis. The architectural framework supporting BIG Axis cross-talk is built on evidence highlighting the presence of 70&nbsp;percent of the entire immune cell population in
the gut, approximately 500&nbsp;million neurons innervating the gastrointestinal, or GI, tract, enteric neurons as part of the autonomic nervous system and key components such as the gut epithelial barrier, microbiome, metabolites and
neurotransmitters that play key roles in protecting and influencing the immune system and central nervous system, or CNS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are led by a proven and
seasoned management team of business leaders with significant experience in discovering and developing important new medicines, delivering them to market and maximizing shareholder value. Collectively, the members of our management team have
overseen research and development of products supporting 23 regulatory approvals and have been in the <FONT STYLE="white-space:nowrap">C-suite</FONT> of companies acquired for more than $13&nbsp;billion in the aggregate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our team, network and expertise in the BIG Axis enable us to identify and advance the latest scientific discoveries at the interface of the BIG systems. We
begin by collaborating with a cross-disciplinary group of experienced clinicians and the world&#146;s leading experts in brain, immune and gut biology in a discovery process that breaks down specific diseases and comprehensively identifies, reviews
and empirically tests unpublished scientific discoveries in a modality agnostic and unbiased way. Our model, which employs (1)&nbsp;this collaborative process leveraging our biological expertise in the BIG axis and our scientific network, (2)&nbsp;a
disciplined approach to program advancement, and (3)&nbsp;a capital efficient approach to driving clinical developments and value creation, has enabled us to rapidly convert these findings into valuable therapeutic product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Historically, we have developed these programs and product candidates with strategic allies, including equity partners who helped us to advance those programs
via our Founded Entities. As these programs have succeeded and our resources have grown, we have increasingly focused on our Wholly Owned Programs. Our Wholly Owned Programs are designed to harness key immunological and lymphatic system mechanisms.
They currently consist of <FONT STYLE="white-space:nowrap">LYT-100,</FONT> a clinical-stage product candidate we are pursuing for conditions involving inflammation and fibrosis and disorders of lymphatic flow,
<FONT STYLE="white-space:nowrap">LYT-200</FONT> and <FONT STYLE="white-space:nowrap">LYT-210,</FONT> two preclinical product candidates targeting foundational immunomodulatory mechanisms we are developing to treat cancer and other immunological
disorders, and <FONT STYLE="white-space:nowrap">LYT-300,</FONT> a preclinical product candidate we are developing for a range of neurological and neuropsychological conditions. Our Wholly Owned Programs also include three discovery programs: Glyph<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP>&#151;our synthetic lymphatic targeting chemistry platform&#151;and Orasome<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>&#151;our oral biotherapeutics platform&#151;both of which leverage
absorption of dietary lipids to traffic therapeutics via the lymphatic system, and our meningeal lymphatics discovery research program for treating neurodegenerative diseases. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of our Value </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below depicts the four
components of our value: (1)&nbsp;our Wholly Owned Pipeline, (2)&nbsp;Founded Entities that we have a controlling interest in or from which we are entitled to receive royalty payments, (3)&nbsp;Founded Entities where our interest is limited to our
equity ownership and (4)&nbsp;our available cash, cash equivalents and short-term investments at the parent level as of June 30, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">89</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hold majority voting control of our Controlled Founded Entities and continue to play a role in the
development of their product candidates through representation on their board of directors, with respect to Follica, Vedanta, Alivio and Sonde. Our board designees represent a majority of the members of the board of directors of Follica, Vedanta and
Alivio and a minority of the members of the board of directors of Sonde. With respect to our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities, we do not hold majority equity ownership and are not responsible for the
development or commercialization of their product candidates and <FONT STYLE="white-space:nowrap">FDA-cleared</FONT> products. Our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities have independent management teams, and we do
not control the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> development of their respective product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(1) Our Wholly Owned Pipeline</I></B>. We are focused on the advancement of our Wholly Owned Pipeline and delivering value to our shareholders by
driving our Wholly Owned Programs to key clinical and commercial milestones, while continuing cutting edge research and development efforts to discover and advance new product candidates. The table below includes a summary of our Wholly Owned
Programs and their development status. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(2) Founded Entities with Controlling Interest or Right to Receive Royalties.</I></B> The table below
summarizes, in order of development stage, the product candidates being developed by our Founded Entities in which we either have a controlling interest or the right to receive royalty payments. We established the underlying programs and platforms
that have resulted in the product candidates noted in the table and advanced them through key validation points. Each of these product candidates targets indications related to one or more of the BIG systems, and any value we realize from these
product candidates will be through the potential growth and realization of equity and royalty stakes highlighted in the table below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(3) Founded
Entities Limited to Equity Interest.</I></B><I> </I>We also hold equity ownership in our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities, Akili and Vor. The table below describes these entities, in order of development stage.
Our interest in the product candidates of these entities is limited to the potential appreciation of our equity interest in these entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(4)
Cash, Cash Equivalents and Short-Term Investments.</I></B> At the parent level, PureTech Health plc had cash, cash equivalents and short-term investments of $310.5 million at June 30, 2020, which does not reflect $101.6&nbsp;million in proceeds
received by PureTech in August 2020 from the sale of 1.3 million shares of Karuna common stock and excludes all other cash outflows from June 30, 2020, for total adjusted cash, cash equivalents and short-term investments of $412.1 million as of
August 26, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">90</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of our Value </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g20a27.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">91</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Note:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The table above does not include any discovery-stage programs which we consider to be an additional component
of our value, including Entrega, a Controlled Founded Entity. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Relevant ownership interests for Founded Entities were calculated on a diluted basis (as opposed to a voting
basis) as of June&nbsp;30, 2020, including outstanding shares, options and warrants, but excluding unallocated shares authorized to be issued pursuant to equity incentive plans. Ownership of Vor is based on the assumption that all future tranches of
the most recent financing round are funded. Karuna ownership is calculated on an outstanding voting share basis as of August&nbsp;26, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The letters next to the product candidates denote whether the product candidate is a&nbsp;pharmaceutical
product (P), biologic (B), or device (D). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">R</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">PureTech Health has a right to royalty payments as a percentage of net sales. For a description of these
agreements, see &#147;Business&#151;Overview.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">***</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These product candidates are regulated as devices and their development has been approximately equated to
phases of clinical development. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Important Safety Information: Plenity is contraindicated in patients who are pregnant or are allergic to
cellulose, citric acid, sodium stearyl fumarate, gelatine, or titanium dioxide. Plenity may alter the absorption of medications. Read Sections 6 and 8.3 of the Instructions for Use carefully. Avoid use in patients with the following conditions:
esophageal anatomic anomalies, including webs, diverticuli, and rings; suspected strictures (such as patients with Crohn&#146;s disease); or complications from prior GI surgery that could affect GI transit and motility. Use with caution in patients
with active GI conditions such as gastro-esophageal reflux disease, or GERD, ulcers or heartburn. The overall incidence of AEs in the Plenity group was no different than the placebo group. The most common side effects were diarrhea, distended
abdomen, infrequent bowel movements, and flatulence. For the safe and proper use of Plenity, U.S. Instructions for Use or the EU Instructions for Use. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#134;&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Contingent on FDA review of the research plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#134;&#134;&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Following the completion of a successful
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">End-of-Phase</FONT></FONT> 2 meeting with the U.S. FDA, Karuna remains on track to initiate the first Phase 3 trial in the EMERGENT program by the end of 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#135;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At the parent level, PureTech Health plc had cash equivalents and short-term investments of $310.5 million at
June 30, 2020, which does not reflect $101.6 million in proceeds received by PureTech in August 2020 from the sale of 1.3 million shares of Karuna common stock and excludes all other cash outflows from June 30, 2020, for total<B> </B>adjusted cash,
cash equivalents and short-term investments of $412.1 million as of August 26, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#135;&#135;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">PureTech Level Cash Reserves at June&nbsp;30, 2020 represent cash balances and short-term investments held at
PureTech Health LLC, PureTech Management, Inc., PureTech Health PLC, PureTech Securities Corporation of $284.2&nbsp;million and held at PureTech LYT Inc., our internal pipeline, of $26.3&nbsp;million, all of which are wholly owned entities of
PureTech, excluding cash balances and short-term investments of Controlled Founded Entities which are not wholly owned. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Model
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We employ the following process to identify and develop product candidates: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Step 1: A Collaborative Discovery Process Leveraging our Biological Expertise in the BIG Axis and our
Scientific Network</I></B><B>:</B> We collaborate with the world&#146;s leading domain experts on a disease-specific discovery theme through the lens of BIG Axis biology. We have proven our ability to efficiently leverage our cross-disciplinary
research and discovery efforts across multiple indications and potential therapeutic areas, reducing early development risk based on preliminary signals of activity in humans and promising tolerability profiles. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Step 2: A Disciplined Approach to Program Advancement</I></B><B>: </B>We employ a rigorous and disciplined
approach to research and development. The breadth and depth of our Wholly Owned Pipeline and our Founded Entities&#146; programs allow us to quickly pivot resources to the more promising therapeutic opportunities, strategically reallocate capital
across programs and terminate Wholly Owned Programs we choose not to pursue without adversely impacting the development of other programs. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">92</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Step 3: A Capital Efficient Approach to Driving Clinical Development and Value Creation</I></B><B>:</B> We
have financed our development efforts through strategic collaborations, pharmaceutical partnerships and public and private equity financings. We leverage shared resources, institutional knowledge and infrastructure between our earlier-stage Founded
Entities and development efforts within our Wholly Owned Programs to advance our programs efficiently prior to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept,</FONT></FONT> or POC. As part of our disciplined
capital management, we have been able to generate $359.9&nbsp;million in <FONT STYLE="white-space:nowrap">non-dilutive</FONT> funding as of August&nbsp;26, 2020 through the sales of portions of Founded Entity shares. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Pipeline Components and Expected Milestones Through 2021 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Through 2021, we anticipate many significant potential milestones across our Wholly Owned Programs and Founded Entities, including at least 10 clinical
readouts and at least 14 clinical study initiations and the full commercial rollout of two products. Of these, four clinical readouts and four clinical study initiations are anticipated within our Wholly Owned Programs. Additionally, we expect the
continued progress of discovery and preclinical programs, as well as the potential for additional strategic partnerships and transactions and the growth of value through our equity and royalty holdings in our Founded Entities. Our Wholly Owned
Programs and certain of our Founded Entities&#146; programs that contribute to our value are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Wholly Owned Programs Harnessing
Immunological and Lymphatic System Mechanisms: </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><FONT STYLE="white-space:nowrap">LYT-100,</FONT> Our Lead Clinical-Stage Product Candidate Targeting a Range
of Inflammatory, Fibrotic, Lymphatic Flow Disorders, and Other Related Indications:</B> We are advancing our wholly-owned product candidate <FONT STYLE="white-space:nowrap">LYT-100</FONT> for the potential treatment of conditions involving
inflammation and fibrosis and disorders of lymphatic flow, including lung dysfunction conditions (e.g., idiopathic pulmonary fibrosis, or IPF, unclassifiable interstitial lung diseases, or uILDs, and respiratory complications that persist following
the resolution of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> infection) and lymphedema. <FONT STYLE="white-space:nowrap">LYT-100</FONT> is currently
being evaluated in a multiple ascending dose Phase 1 clinical trial, which we expect data to readout in the second half of 2020. We intend to commence a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept,</FONT></FONT> or POC, study in patients with breast cancer related, upper limb secondary lymphedema in the second half of 2020, with topline results anticipated in
the second half of 2021. We also intend to commence a Phase 2 study in respiratory complications that persist following the resolution of <FONT STYLE="white-space:nowrap">COVID-19</FONT> infection in the third quarter of 2020, with a potential
readout in the second half of 2021. We also intend to explore the application of other potential new product candidates from our meningeal lymphatics platform for a range of neurodegenerative diseases. We are conducting a Phase 1 trial and plan to
conduct Phase 2 and POC trials for <FONT STYLE="white-space:nowrap">LYT-100</FONT> outside of the United States and are following the applicable regulatory requirements in this jurisdiction. We intend to file an IND with the FDA for <FONT
STYLE="white-space:nowrap">LYT-100</FONT> prior to initiating a trial in the United States. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><FONT STYLE="white-space:nowrap">LYT-200</FONT> and <FONT STYLE="white-space:nowrap">LYT-210,</FONT> Two
Preclinical Immuno-Oncology, or IO, Product Candidates Harnessing Key Immune Cell Trafficking and Programming Mechanisms:</B> The lymphatic system plays a crucial role in programming immune cells for precise functions and trafficking them to
specific tissues. By modulating immune cell trafficking and programming, we are developing product candidates for the treatment of cancer and other immunological disorders. We are advancing <FONT STYLE="white-space:nowrap">LYT-200,</FONT> targeting <FONT
STYLE="white-space:nowrap">galectin-9,</FONT> for a range of cancer indications, and <FONT STYLE="white-space:nowrap">LYT-210,</FONT> targeting immunomodulatory
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 (gamma <FONT STYLE="white-space:nowrap">delta-1)</FONT> T cells, for a range of cancer indications and autoimmune disorders. We intend to file an
Investigational New Drug Application, or IND, for <FONT STYLE="white-space:nowrap">LYT-200</FONT> and initiate a Phase 1 clinical trial in solid tumors in the second half of 2020. We also intend to advance additional preclinical and biomarker
studies for <FONT STYLE="white-space:nowrap">LYT-210</FONT> in 2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><FONT STYLE="white-space:nowrap">LYT-300,</FONT> Preclinical Product Candidate Developed Using our Glyph<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> Technology Platform, Targeting Neurological and Neuropsychological Conditions: </B>The most advanced product candidate from our Glyph technology platform is
<FONT STYLE="white-space:nowrap">LYT-300</FONT> (oral allopregnanolone), which is being evaluated in a preclinical setting for a range of neurological and neuropsychological conditions. We expect to initiate a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trial with <FONT STYLE="white-space:nowrap">LYT-300</FONT> by the end of 2021. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">93</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Our Discovery Platforms &#150; Glyph</B><B><SUP STYLE="font-size:85%; vertical-align:top">
</SUP></B><B>(Lymphatic Targeting Chemistry Platform) and Orasome</B><B><SUP STYLE="font-size:85%; vertical-align:top">TM</SUP></B><B> (Oral Biotherapeutics Platform) &#150; Leveraging Absorption of Dietary Lipids to Traffic Therapeutics via the
Lymphatic System:</B> We are harnessing the role of the lymphatic system in the absorption of dietary lipids to orally administer and traffic therapeutics via the lymphatic system. Our Glyph and Orasome technology platforms are based on this key
function of the lymphatic system. We also expect to advance additional product candidates from these platforms internally, and to potentially continue to broaden the platforms through strategic collaborations around
<FONT STYLE="white-space:nowrap">non-core</FONT> applications, beyond our existing discovery collaboration with a large pharmaceutical company. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain of Our Controlled Founded Entities: </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Follica: </B>Follica, Incorporated, or Follica, which is developing a regenerative biology platform designed
to treat androgenetic alopecia, epithelial aging and other medical conditions, is advancing <FONT STYLE="white-space:nowrap">FOL-004</FONT> for the treatment of hair loss in androgenetic alopecia. In December 2019, Follica announced topline results
from a safety and efficacy optimization study. Follica announced the completion of an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">End-of-Phase&nbsp;2</FONT></FONT> meeting with the FDA in June 2020, which supports the
progression into Phase 3 development. The initiation of a Phase 3 registration study is expected in the second half of 2020. We are party to a royalty agreement with Follica pursuant to which we are entitled to low single-digit royalties on
worldwide net sales of certain commercialized products and a percentage of any sublicense income for certain of its technologies within the range of mid single-digit and mid teen percentages. Our interest in Follica also includes our equity
ownership of 78.3&nbsp;percent at June&nbsp;30, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Vedanta:</B> Vedanta Biosciences, Inc., or Vedanta, which is developing a new category of therapies for
immune-mediated diseases based on a rationally-defined consortia of human microbiome-derived bacteria, expects topline data from a Phase 2 clinical trial for VE303 in high-risk <I>C.</I><I></I><I>&nbsp;difficile</I> infection, or CDI, in 2021;
topline data from a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-patient</FONT></FONT> clinical trial of VE800 in combination with Bristol-Myers Squibb&#146;s checkpoint inhibitor Opdivo<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (nivolumab) in patients with selected types of advanced or metastatic cancer in 2021; and topline data from a Phase 1/2 clinical trial for VE416 in food allergy in 2021. Vedanta announced topline
data from two Phase 1 studies in healthy volunteers of VE202, a product candidate being developed for inflammatory bowel disease, or IBD, in June 2020 and expects to advance VE202 into a Phase 2 study for IBD in 2021. Our interest in Vedanta is
limited to our equity ownership of 50.4&nbsp;percent at June&nbsp;30, 2020. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain of Our
<FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities: </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Gelesis:</B> Gelesis, Inc., or Gelesis, which is developing oral therapeutics based on a novel, superabsorbent
hydrogel technology platform to treat obesity and other chronic diseases related to the GI pathway, received clearance from the FDA in April 2019 and European marketing authorization in June 2020 to market and sell its lead product Plenity<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (formerly known as Gelesis100) as an aid for weight management in adults with a Body Mass Index, or BMI, of <FONT STYLE="white-space:nowrap">25-40</FONT> kg/m<SUP
STYLE="font-size:85%; vertical-align:top">2</SUP>, when used in conjunction with diet and exercise. Gelesis plans to bring Plenity to the U.S. first, where it is now available to a limited extent while Gelesis ramps up commercial operations and
inventory for a full launch in 2021. Gelesis plans to seek FDA input on the requirements for expanding the Plenity label for treating adolescents. Gelesis is also advancing a pipeline of product candidates focused on treating GI disorders. Gelesis
expects topline results from a Phase 2 study of Gelesis200 for weight management and glycemic control in adults with type 2 diabetes or <FONT STYLE="white-space:nowrap">pre-diabetes</FONT> in 2021, to initiate a Phase 2 study of GS300 in <FONT
STYLE="white-space:nowrap">non-alcoholic</FONT> steatohepatitis and <FONT STYLE="white-space:nowrap">non-alcoholic</FONT> fatty liver disease, or NASH/NAFLD, in the second half of 2020, and to initiate a Phase 3 study for GS500 in functional
constipation in the second half of 2020. We have entered into a royalty and sublicense income agreement with Gelesis, pursuant to which we are entitled to low single-digit royalties on the worldwide net sales of certain commercialized products, as
well as a low teen percentage of any income Gelesis receives from sublicensing certain of its technology. Our interest in Gelesis also includes our equity ownership of 21.0&nbsp;percent at June&nbsp;30, 2020. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">94</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Akili:</B> Akili Interactive Labs, Inc., or Akili, is pioneering the development of treatments designed to
have direct therapeutic activity, delivered not through a traditional pill but via a high-quality video game experience. Akili has a broad pipeline of programs to target cognitive dysfunction associated with medical conditions across neurology and
psychiatry. Akili received clearance from the FDA and European marketing authorization in June 2020 for EndeavorRx<SUP STYLE="font-size:85%; vertical-align:top">TM </SUP>(formerly known as <FONT STYLE="white-space:nowrap">AKL-T01)</FONT> as a
prescription treatment for children with ADHD. Delivered through a captivating video game experience, EndeavorRx is indicated to improve attention function as measured by computer-based testing in children ages
<FONT STYLE="white-space:nowrap">8-12</FONT> years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Akili expects that the EndeavorRx treatment will be available with a prescription to families soon. Our
interest in Akili is limited to our equity ownership of 34.0&nbsp;percent at June&nbsp;30, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Karuna:</B> Karuna Therapeutics, Inc., or Karuna, which is developing novel therapies with the potential to
transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, including schizophrenia and dementia-related psychosis, is developing KarXT, an investigational product candidate designed to selectively activate
muscarinic acetylcholine receptors in the brain. KarXT is Karuna&#146;s proprietary product candidate, which combines xanomeline, a muscarinic receptor agonist, with trospium chloride, an <FONT STYLE="white-space:nowrap">FDA-approved</FONT> and well
established muscarinic receptor antagonist that has been shown not to measurably cross the blood-brain barrier, to preferentially stimulate M1/M4 muscarinic receptors in the brain without stimulating muscarinic receptors in peripheral tissues in
order to achieve meaningful therapeutic benefit in patients with psychotic and cognitive disorders. In November 2019, Karuna announced topline results from <FONT STYLE="white-space:nowrap">EMERGENT-1,</FONT> its Phase 2 clinical trial of KarXT for
the treatment of acute psychosis in patients with schizophrenia, in which KarXT met the trial&#146;s primary endpoint with a statistically significant (p&lt;0.0001) and clinically meaningful 11.6 point mean reduction in total Positive and Negative
Syndrome Scale, or PANSS, over placebo at week five <FONT STYLE="white-space:nowrap">(-17.4</FONT> KarXT vs. <FONT STYLE="white-space:nowrap">-5.9</FONT> placebo), with similar discontinuation rates between KarXT (20 percent) and placebo (21
percent). The study enrolled 182 schizophrenia patients with acute psychosis, 90 of whom received KarXT. The number of discontinuations due to treatment emergent AEs were equal in the KarXT and placebo arms (n=2 in each group). One SAE was observed
in the KarXT treatment group, in which the patient discontinued treatment and subsequently sought hospital care for worsening psychosis, meeting the regulatory definition of an SAE. Karuna held an <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">End-of-Phase&nbsp;2</FONT></FONT> meeting with the FDA in June 2020, the outcome of which supports the progression of KarXT into Phase 3 development. Karuna plans to initiate two five-week inpatient trials evaluating the
efficacy and safety of KarXT for the treatment of acute psychosis in adults with schizophrenia. The first Phase 3 trial, <FONT STYLE="white-space:nowrap">EMERGENT-2,</FONT> is expected to commence by the end of 2020. Additionally, Karuna anticipates
topline results from a Phase 1b clinical trial in healthy volunteers to assess the safety and tolerability of KarXT by the end of 2020. This Phase 1b trial is designed to demonstrate safety and tolerability of KarXT in healthy elderly volunteers in
order to select the most appropriate dose to carry forward into future studies in patients with dementia-related psychosis. We have entered into an exclusive license agreement with Karuna pursuant to which we are entitled to receive low single-digit
royalties and up to $10.0&nbsp;million in milestone payments on worldwide net sales of any commercialized product covered by the granted license. Our interest in Karuna also includes our equity ownership of 12.8&nbsp;percent at August&nbsp;26, 2020.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">95</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The chart below depicts milestones that are anticipated to be achieved by our Wholly Owned Programs and our
Founded Entities&#146; products and product candidates through 2021 and our progress on previously declared milestones for 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g22v48.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Relevant ownership interests for Founded Entities were calculated on a diluted basis (as opposed to a voting
basis) as of June&nbsp;30, 2020, including outstanding shares, options and warrants, but excluding unallocated shares authorised to be issued pursuant to equity incentive plans. Ownership of Vor is based on the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">96</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
assumption that all future tranches of the Series B Financing are funded. Karuna ownership is calculated on an outstanding voting share basis as of August&nbsp;26, 2020 to account for our sale of
Karuna shares on August&nbsp;26, 2020. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Scientific Focus: The <U>B</U>rain-<U>I</U>mmune-<U>G</U>ut (BIG) Axis </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The product candidates being advanced within our Wholly Owned Programs and by our Founded Entities, and our work in these areas, in close collaboration with
leading academic and clinical experts, has led us to focus on the biological interplay among these three systems, which we refer to as the BIG Axis. The architectural framework supporting BIG Axis cross-talk is built on evidence highlighting the
presence of 70&nbsp;percent of the entire immune cell population in the gut, approximately 500&nbsp;million neurons innervating the GI tract, enteric neurons as part of the autonomic nervous system and key components such as the gut epithelial
barrier, microbiome, metabolites and neurotransmitters that play key roles in protecting and influencing the immune system and CNS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The brain, immune
system and gut lymphatic system form an interconnected adaptive network to respond to acute and chronic environmental change. Using the immune system to act as a bridge, the body relies on the bidirectional relationship between the gut and brain to
maintain normal homoeostasis. Dysregulation of immune signaling through gut inflammation, microbiome changes and a compromised intestinal barrier all contribute to a range of immunological, GI and neurology and neuropsychological disorders. We have
been at the forefront of research and development in the BIG Axis, including the role of <FONT STYLE="white-space:nowrap">gut-immune</FONT> transport, immune-microbial signaling, gut barrier dysfunction and repair and gut and inflammation selective
targeting strategies. In our Wholly Owned Programs, we are pursuing strategies to directly reach the immune system via the mesenteric lymph nodes, addressing lymphatic flow and vessel restoration disorders and targeting immunosuppressive and
pathogenic lymphocytes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recent scientific advances, including the work of our network of scientific collaborators, have uncovered the lymphatic system as
one of the most critical players in the BIG Axis. In addition to maintaining the balance of interstitial fluid that surrounds the body&#146;s cells, the lymphatic system plays a key role in conducting surveillance of the immune system through an
intricate network of vessels connecting the over 300 lymph nodes, serving as a &#147;superhighway&#148; for programming immune cells for specific functions and trafficking them to specific tissues. The mesenteric lymph node group around the
intestines serves as the primary interface between the gut and the immune system and for programming circulating adaptive immune cells. The recent discovery of meningeal lymphatics in the brain, an area once thought to have immune privilege, has
shed new light on neurodegenerative diseases and lymphatic vessel aging. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Through our scientific leadership in the BIG systems and the BIG Axis, we have
created the underlying programs and product candidates that have the potential to treat inflammatory and immunological conditions, intractable cancers, lymphatic and GI diseases and neurological and neuropsychological disorders, among others. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Model </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We employ the following process to identify
and develop product candidates: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Step 1: A Collaborative Discovery Process Leveraging our Biological Expertise in the BIG Axis and our
Scientific Network</I></B>: We collaborate with the world&#146;s leading domain experts on a disease-specific discovery theme through the lens of BIG Axis biology. All of our Wholly Owned Programs target one or more of the BIG systems and we
prioritize programs that have the potential to reduce early development risk based on preliminary signals of activity in humans and promising tolerability profiles. We have proven our ability to efficiently leverage our cross-disciplinary research
and discovery efforts across multiple indications and potential therapeutic areas. Our program collaborators and <FONT STYLE="white-space:nowrap">co-inventors</FONT> across our Wholly Owned Programs and Founded Entities&#146; programs include
leading </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">97</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
academic minds, recipients of major awards such as the Nobel Prize, the United States National Medal of Science, the Charles Stark Draper Prize and the Priestley Medal; members of prestigious
institutions such as the Howard Hughes Medical Institute, all three of the National Academies and world renowned academic institutions such as Harvard, MIT, Yale, Columbia, Johns Hopkins, Imperial College of London and Cornell, among others; and
former senior executives and board members at some of the world&#146;s largest pharmaceutical companies. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Step 2: A Disciplined Approach to Program Advancement</I></B>: We employ a rigorous and disciplined
approach to research and development. The breadth and depth of our Wholly Owned Pipeline and our Founded Entities&#146; programs allow us to quickly pivot resources to the more promising therapeutic opportunities, strategically reallocate capital
across programs and terminate Wholly Owned Programs we choose not to pursue without adversely impacting the development of other programs. We, through our internal resources and with our extensive expert network and collaboration partners, repeat
key academic work and conduct focused experiments both internally and externally to rapidly advance those that we believe hold the greatest promise and deprioritize less attractive programs. Collectively, these activities decrease the risk of any
individual program event negatively impacting our Wholly Owned Pipeline and enable us to preserve capital for the programs across our Wholly Owned Pipeline and Founded Entities that we believe have the greatest opportunity for value creation in
alignment with our shareholders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Step 3: A Capital Efficient Approach to Driving Clinical Development and Value Creation</I></B>: Our
management team has successfully driven these product candidates from early stage research and development, through POC and into clinical trials and has supported dedicated teams at our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded
Entities through pivotal trials and FDA clearance. We have financed our development efforts through strategic collaborations, pharmaceutical partnerships, <FONT STYLE="white-space:nowrap">non-dilutive</FONT> funding mechanisms, including through the
sale of our Founded Entities&#146; equity and through grants, and public and private equity financings. We leverage shared resources, institutional knowledge and infrastructure between our earlier-stage Founded Entities and development efforts
within our Wholly Owned Programs to advance our programs efficiently prior to POC. This approach has enabled the discovery and development of 24 products and product candidates to date, including two that have been cleared by the U.S. FDA and
granted marketing authorization in the EEA, between our Wholly Owned Programs and our Founded Entities, in which we retain equity ownership ranging from 78.6&nbsp;percent to 11.8&nbsp;percent. At the parent level, PureTech Health plc had cash
equivalents and short-term investments of $310.5 million at June 30, 2020, which does not reflect $101.6 million in proceeds received by PureTech in August 2020 from the sale of 1.3 million shares of Karuna common stock and excludes all other cash
outflows from June 30, 2020, for total<B> </B>adjusted cash, cash equivalents and short-term investments of $412.1 million as of August 26, 2020. From January&nbsp;1, 2017 to June&nbsp;30, 2020, our Founded Entities strengthened their collective
balance sheets by attracting $1.084&nbsp;billion in investments and <FONT STYLE="white-space:nowrap">non-dilutive</FONT> funding, including $997.6&nbsp;million from third parties. As part of our disciplined capital management, we have been able to
generate $359.9&nbsp;million in <FONT STYLE="white-space:nowrap">non-dilutive</FONT> funding, as of August&nbsp;26, 2020, through the sales of portions of Founded Entity shares. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">98</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Driving Development of Potential New Medicines and Accretion of Value Via Three Paths </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g71b00.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our goal is to identify, invent, develop and commercialize innovative new categories of therapeutics that are derived from
our deep understanding of the BIG Axis to address significant unmet medical needs. To achieve this goal, key components of our strategy include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Advancing Wholly Owned Programs Through Development and Commercialization, Including Pipeline
Expansion:</I></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Progressing <FONT STYLE="white-space:nowrap">LYT-100,</FONT>
<FONT STYLE="white-space:nowrap">LYT-200,</FONT> <FONT STYLE="white-space:nowrap">LYT-210</FONT> and <FONT STYLE="white-space:nowrap">LYT-300</FONT> through clinical studies:</I></B> We are developing novel classes of immunomodulatory drugs to treat
serious diseases, including lung dysfunction, oncology, lymphatic, neurological and neuropsychological disorders. In July 2019, we acquired <FONT STYLE="white-space:nowrap">LYT-100,</FONT> a small molecule product candidate that was well-tolerated
in a Phase 1 clinical trial in healthy volunteers and showed a desirable pharmacokinetic, or PK, profile suitable for oral administration. Due to <FONT STYLE="white-space:nowrap">LYT-100&#146;s</FONT> observed potent anti-fibrotic and
anti-inflammatory activity in preclinical models and encouraging Phase 1 clinical trial data, we are advancing our wholly-owned product candidate <FONT STYLE="white-space:nowrap">LYT-100</FONT> for the potential treatment of conditions involving
inflammation and fibrosis and disorders of lymphatic flow, including lung dysfunction conditions (e.g., IPF, uILDs and respiratory complications that persist following the resolution of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> infection) and lymphedema. <FONT STYLE="white-space:nowrap">LYT-100</FONT> is being studied in a multiple
ascending dose study, which we expect data to readout in the second half of 2020. We intend to commence a POC study in patients with breast cancer-related, upper limb secondary lymphedema in the second half of 2020, with topline results expected in
the second half of 2021. We also plan to commence a Phase 2 study in respiratory complications that persist following the resolution of <FONT STYLE="white-space:nowrap">COVID-19</FONT> infection in the third quarter of 2020, with topline results
expected in the second half of 2021. We are developing <FONT STYLE="white-space:nowrap">LYT-200,</FONT> an investigational, fully human, monoclonal antibody, or mAb, that is designed to target <FONT STYLE="white-space:nowrap">galectin-9,</FONT> a
protein that regulates immunosuppression and is prominently expressed in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">hard-to-treat</FONT></FONT> cancers such as colorectal cancer, or CRC, cholangiocarcinoma, or CCA, and
pancreatic cancer. We believe <FONT STYLE="white-space:nowrap">LYT-200</FONT> has shown preliminary </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">99</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
POC in both preclinical human and mouse cancer models. We plan to file an IND for <FONT STYLE="white-space:nowrap">LYT-200</FONT> and to initiate a Phase 1 study in solid tumors in the second
half of 2020. <FONT STYLE="white-space:nowrap">LYT-210</FONT> is an investigational, fully human, mAb targeting immunosuppressive or pathogenic <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells. We
are also developing <FONT STYLE="white-space:nowrap">LYT-300,</FONT> oral allopregnanolone, and evaluating its potential to address a range of neurological and neuropsychological conditions. We expect to initiate a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical study with <FONT STYLE="white-space:nowrap">LYT-300</FONT> by the end of 2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Harnessing our proprietary drug discovery and development capabilities to drive pipeline maturation and
expansion:</I></B> We are pioneering the development of therapeutic candidates by leveraging our unique insights into the lymphatic system and the BIG Axis. Our Wholly Owned Programs currently comprise four proprietary product candidates and three
innovative technology platforms. We intend to leverage our proprietary technology platforms, as well as our extensive network with world-leading scientists in immunology and lymphatics and major pharmaceutical companies, to generate and acquire
additional novel product candidates. To do so, we will rely on the track record of our team, which has been instrumental in the generation of 24 products and product candidates to date between our Wholly Owned Programs and our Founded Entities,
including two that have been cleared by the U.S. FDA and granted marketing authorization in the EEA, as well as our established internal identification and prioritization approach. We will continue to take advantage of our differentiated model to
manage the risk of any single program and quickly redeploy resources towards performing assets. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Maximizing the impact of our Wholly Owned product candidates by expanding development across multiple
indications</I></B><B>:</B><B><I> </I></B>We aim to focus our development efforts on product candidates that have the potential to treat multiple diseases and plan to develop them in additional indications where warranted. For example, we believe
that our product candidate <FONT STYLE="white-space:nowrap">LYT-100</FONT> has the potential to be evaluated in multiple fibrotic indications beyond our initial target indication of lymphedema, such as serious respiratory complications that persist
following the resolution of <FONT STYLE="white-space:nowrap">COVID-19,</FONT> IPF, uILD, and focal segmental glomerulosclerosis, or FSGS. We are initially developing our other internal product candidates,
<FONT STYLE="white-space:nowrap">LYT-200</FONT> and <FONT STYLE="white-space:nowrap">LYT-210,</FONT> for the treatment of certain cancers, including CCA, CRC and pancreatic cancers, among others, and we are evaluating
<FONT STYLE="white-space:nowrap">LYT-210</FONT> for the potential treatment of GI autoimmune diseases. Lastly, we are evaluating <FONT STYLE="white-space:nowrap">LYT-300</FONT> for a range of neurological and neuropsychological conditions.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Deriving Value from Equity Growth of Our Founded Entities:</I></B> Historically, we have pursued a variety
of strategic options to fund and drive the development of our Founded Entities&#146; product candidates, including private and public financings and multiple partnerships and collaborations with selected partners. In the preliminary stages of our
growth, we partnered with equity investors, pharmaceutical and biotechnology companies and government and <FONT STYLE="white-space:nowrap">non-governmental</FONT> organizations for certain of our Founded Entities which are now in advanced stages and
have the potential for near-term value creation with significant upside potential. Going forward, we intend to participate in private and public financings, enter into partnerships and collaborations, partner with equity investors, pharmaceutical
and biotechnology companies and government and <FONT STYLE="white-space:nowrap">non-governmental</FONT> organizations for certain of our Founded Entities and strategically monetize certain of our our equity holdings in our Founded Entities after
significant value creation has occurred, generating <FONT STYLE="white-space:nowrap">non-dilutive</FONT> financing. For example, in 2020, PureTech generated cash proceeds of $347.5&nbsp;million from the sale of equity in one of our Founded Entities,
which we intend to use to fund our operations and growth and to further expand and advance our clinical-stage Wholly Owned Pipeline, while still maintaining significant equity ownership to derive value from future growth of that entity. We may
create additional entities opportunistically based on future strategic imperatives. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Advancing Discovery Programs by Partnering <FONT STYLE="white-space:nowrap">Non-Core</FONT> Applications
via <FONT STYLE="white-space:nowrap">Non-Dilutive</FONT> Funding Sources, Including Partnerships and Grants, to Enable Retention of Value:</I></B> As we further develop our Wholly Owned Programs through key value inflection points, we may
opportunistically enter into strategic partnerships when we believe that such partnerships could add value to the development or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">100</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
potential commercialization of our Wholly Owned product candidates. We will also continue to pursue government grant funding and discovery partnerships that allow us to maintain most of the value
of our platforms while offsetting operational costs. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe this combination of development of our Wholly Owned Programs, Founded
Entity advancement and <FONT STYLE="white-space:nowrap">non-dilutive</FONT> partnerships and funding provides us with a unique and multi-pronged engine fueling potential future growth. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Focus on the Lymphatic System </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The lymphatic system
is a network of tissues and organs in the body that fulfills three essential functions: (1)&nbsp;maintaining the balance of the fluid that surrounds the body&#146;s cells, or interstitial fluid, (2)&nbsp;conducting surveillance of the immune system
and serving as a &#147;superhighway&#148; for immune cell trafficking and (3)&nbsp;absorbing dietary lipids through an intricate network of vessels in the intestinal tract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dysfunction of the lymphatic system is associated with numerous disease states, and we believe that restoring lymphatic function in various disease settings
can yield meaningful patient benefit. Our proprietary Wholly Owned Programs leverage these critical functions of the lymphatic system to produce product candidates with the potential to treat serious diseases: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Maintaining balance of fluids</I></B>: We are leveraging insights into the lymphatic system by developing
clinical-stage product candidate <FONT STYLE="white-space:nowrap">LYT-100</FONT> and several discovery-stage programs to address disorders involving impaired lymphatic flow and other conditions involving inflammation and fibrosis, such as lymphedema
and certain neurological disorders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Immune modulation</I></B>: The lymphatic system plays a crucial role in programming immune cells for
precise functions and trafficking them to specific tissues. By modulating immune cell trafficking and programming, we are developing product candidates for the treatment of cancer and immunological disorders. We are advancing <FONT
STYLE="white-space:nowrap">LYT-200,</FONT> our product candidate targeting <FONT STYLE="white-space:nowrap">galectin-9</FONT> in solid tumors and <FONT STYLE="white-space:nowrap">LYT-210,</FONT> our product candidate targeting immunosuppressive <FONT
STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells in solid tumors and autoimmune disorders, for a range of cancer indications and autoimmune disorders. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Driving therapeutics through lymphatics</I></B>: We are harnessing the role of the lymphatic system in the
absorption of dietary lipids to orally administer and traffic therapeutics via the lymphatic system where immune cells are programmed. <FONT STYLE="white-space:nowrap">LYT-300</FONT> and our Glyph (lymphatic targeting) and Orasome (oral
biotherapeutics) platforms are based on this key function of the lymphatic system. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">101</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Wholly Owned Programs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are advancing our Wholly Owned Programs that are designed to harness immunological and lymphatic system mechanisms for the treatment of lung dysfunction,
oncology, lymphatic, neurological and neuropsychological disorders. The following chart summarizes our Wholly Owned Programs and their current status: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PureTech&#146;s Wholly Owned Programs: Harnessing Key Immunological&nbsp;&amp;Lymphatic System Mechanisms </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g23d51.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">LYT-100:</FONT> Deupirfenidone, Our Most Advanced Wholly Owned Product Candidate for
the Potential Treatment of Conditions Involving Inflammation and Fibrosis and Disorders of Lymphatic Flow </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our lead wholly-owned product candidate, <FONT
STYLE="white-space:nowrap">LYT-100,</FONT> is being advanced for the potential treatment of conditions involving inflammation and fibrosis and disorders of lymphatic flow, including lung dysfunction conditions (e.g., IPF, uILDs and respiratory
complications that persist following the resolution of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> infection) and lymphedema. <FONT
STYLE="white-space:nowrap">LYT-100</FONT> (deupirfenidone) is a selectively deuterated form of pirfenidone, with anti-inflammatory, antioxidant and antifibrotic properties and superior PK properties and activity compared to pirfenidone. <FONT
STYLE="white-space:nowrap">LYT-100</FONT> shares pirfenidone&#146;s beneficial mechanism of action but is expected to be metabolized slower and with less variability between patients compared with pirfenidone. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pirfenidone is effective in slowing fibrotic pulmonary decline in IPF, has been granted &#147;breakthrough&#148; status in uILD, has shown activity in
investigational clinical studies in patients with FSGS as well as other indications and has demonstrated activity in a preclinical model of lymphedema and radiation-induced fibrosis. Deuteration of pirfenidone involves substitution of specific
hydrogens in a chemical structure for deuterium, a <FONT STYLE="white-space:nowrap">non-toxic,</FONT> naturally occurring form of hydrogen. A similar modification was determined by the FDA to create a new chemical entity. Deuteration of pirfenidone
improves the stability of the resulting drug, attenuates the breakdown of the drug&#146;s active metabolite and has shown a differentiated PK profile compared to <FONT STYLE="white-space:nowrap">non-deuterated</FONT> pirfenidone in clinical studies.
We believe this differentiated PK profile could enable potentially improved efficacy, less frequent dosing, improved tolerability, reduced interpatient variability in drug metabolism and reduced drug-drug interactions.
<FONT STYLE="white-space:nowrap">LYT-100</FONT> is extensively protected by composition of matter patents, as well as patents covering methods of use and process of manufacture for deupirfenidone as well as other claims. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">102</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">LYT-100</FONT> was originally developed by Auspex Pharmaceuticals, Inc., or
Auspex, for the treatment of IPF. We selected and acquired <FONT STYLE="white-space:nowrap">LYT-100</FONT> in July 2019 based on insights into the lymphatic system gained internally and via unpublished findings through our network of collaborators,
coupled with the relationships of our team members and their insights into the program previously developed at Auspex. These insights led us to an initial target indication of lymphedema, and we also believe that
<FONT STYLE="white-space:nowrap">LYT-100</FONT> has the potential to be evaluated in multiple fibrotic and inflammatory indications beyond our initial target indication of lymphedema, such as serious respiratory complications that persist following
the resolution of <FONT STYLE="white-space:nowrap">COVID-19</FONT> infection, IPF, interstitial lung diseases, and FSGS. Auspex was a leader in deuteration chemistry and was acquired by Teva Pharmaceutical Industries in 2015. Pursuant to an Asset
Purchase Agreement by and between Auspex and PureTech Health LLC, dated July&nbsp;15, 2019, Auspex assigned and transferred all patent claims, inventory, technology, contracts and related rights relating to
<FONT STYLE="white-space:nowrap">LYT-100</FONT> to&nbsp;us. As consideration, we paid an upfront payment, which we do not deem material. In addition, Auspex is eligible to receive milestone payments of approximately $84&nbsp;million in the aggregate
depending upon specified developmental, regulatory and commercial achievements. In addition, for ten years following the first commercial sale of any commercialized product containing <FONT STYLE="white-space:nowrap">LYT-100,</FONT> Auspex is
eligible to receive low to middle single-digit royalties on the worldwide net sales of such product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following our acquisition of <FONT
STYLE="white-space:nowrap">LYT-100,</FONT> we have conducted preclinical studies to validate the unpublished findings in a lymphedema model and initiated a multiple ascending dose and food effect Phase 1 clincial study trial, data from which we
expect to readout in the second half of 2020. We intend to progress <FONT STYLE="white-space:nowrap">LYT-100</FONT> for the potential treatment of respiratory conditions and secondary lymphedema, followed by other inflammatory, fibrotic and
lymphatic disorders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">103</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">LYT-100</FONT> for Respiratory Complications that Persist Following
COVID-19 Infection </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">COVID-19</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic has affected tens of millions of people around the world. The virus can be deadly and there are a
number of therapeutic approaches that target the acute phase of the disease. There is increasing data around the longer-term complications of <FONT STYLE="white-space:nowrap">COVID-19,</FONT> including preliminary data regarding respiratory issues
that persist. Survivors of the virus can have lung fibrosis that causes shortness of breath and other problems that could potentially last for years. In survivors, disease and invasive treatment both create fibrosis and the risk of persistently
diminished lung function. Lung fibrosis can reduce the function of the lung, as observed by changes in pulmonary function tests, and can cause difficulties with activities of daily living. Clinicians are already documenting rapid progression to lung
fibrosis in patients with <FONT STYLE="white-space:nowrap">COVID-19.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g04e96.jpg" ALT="LOGO">
</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; margin-right:0.50em; font-size:10pt; font-family:Times New Roman"><B>Figure X.</B> Lung CT of a COVID-19 patient. (A) Ground glass opacities (GGO) in the left lower lobe (arrow). (B)
Three weeks later, in the same lung zones, the disease has rapidly progressed and fibrotic changes are now evident (arrows). Figure from Spagnolo et al., 2020</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The potential for fibrosis-mediated lung damage and the unprecedented scale of the current pandemic creates an enormous public
health challenge: some patients who have recovered from the acute symptoms of <FONT STYLE="white-space:nowrap">COVID-19</FONT> have persistent pulmonary dysfunction. New therapeutic options are needed to address the underlying inflammation and
fibrotic mechanisms that lead to respiratory complications that persist following the resolution of <FONT STYLE="white-space:nowrap">COVID-19</FONT> infection. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The Role of Fibrosis and Inflammation in Respiratory Complications that Persist Following the Resolution of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> Infection </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
<FONT STYLE="white-space:nowrap">COVID-19,</FONT> as currently understood, the acute disease course can be modeled in three stages: first, an initial response mounted by the immune system to the virus; second, a secondary interferon-driven immune
response leading to lung tissue damage; and third, a final hyperinflammation in which an inflammatory macrophage response leads to aberrant lung tissue repair and ultimately fibrosis. As the disease progresses, patients with more
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">104</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
severe disease have an imbalanced macrophage population in lung tissue tilted toward inflammation and fibrosis. The immune system transitions from repelling the initial insult to repair, but
inflammation can lead instead to fibrosis (Figure X). Similar disease progression has been observed in patients with acute respiratory distress syndrome, or ARDS, undergoing mechanical ventilation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">COVID-19</FONT> post-acute injuries appear to mimic respiratory complications of other viral pneumonias like Severe Acute
Respiratory Syndrome, or SARS, and Middle East Respiratory Syndrome, or MERS. Up to one third of SARS and MERS survivors had abnormal pulmonary testing and lung imaging that persists for years. Post-acute injuries are hypothesized to be due to a
cascade of inflammation and fibrosis that begins during the acute phase of COVID-19 and continues after the infection resolves the post-acute sequelae of the disease. A high proportion of mild, moderate and severe
<FONT STYLE="white-space:nowrap">COVID-19</FONT> patients (up to 53 percent) already show signs of lung fibrosis at three weeks post symptom onset. Clinicians are also reporting lung fibrosis that persists beyond the acute infection, and of <FONT
STYLE="white-space:nowrap">COVID-19</FONT> patients with pneumonia, 44&nbsp;percent had fibrosis on CT imaging at 9 days post-discharge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fibrosis in the
lungs can impair lung capacity, pulmonary function, and gas exchange. In early studies of <FONT STYLE="white-space:nowrap">COVID-19</FONT> patients with lung fibrosis had higher rates of shortness of breath, or dyspnea, than those without fibrosis.
Emerging data from pulmonary function testing also suggest quantitative changes in <FONT STYLE="white-space:nowrap">COVID-19</FONT> survivors who were hospitalized. After discharge, <FONT STYLE="white-space:nowrap">COVID-19</FONT> patients had
reduced diffusing capacity of the lung for carbon monoxide percent predicted (DLCO percent), as well as other abnormal pulmonary function tests. The observed clinical time course of <FONT STYLE="white-space:nowrap">COVID-19</FONT> and its similarity
to SARS may suggest a limited window of recovery for the lungs, with no additional healing of fibrotic lesions or diffusing capacity after a year. Similarly, patients who survive the acute phase of ARDS may either suffer from lingering long-term
pulmonary complications or even develop progressive forms of pulmonary fibrosis. We believe resolving fibrosis is important for preventing post-acute complications, and there is likely a critical window of intervention in <FONT
STYLE="white-space:nowrap">COVID-19</FONT> and other viral pneumonias. There are no approved therapies for post-acute respiratory complications of pneumonia driven by this process, and given the scale of the ongoing pandemic, novel therapies are
urgently needed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Unmet Need </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">COVID-19</FONT> is causing a global crisis driven by acute illness and mortality. After the acute infection resolves, the persistent suffering by <FONT STYLE="white-space:nowrap">COVID-19</FONT> &#147;long-haulers&#148;
could lead to an unprecedented public health burden. Therapeutic options are needed for <FONT STYLE="white-space:nowrap">COVID-19</FONT> and subsequent respiratory viral outbreaks to blunt the inflammatory and fibrotic damage and prevent disability
related to lung injury. Hundreds of clinical trials of anti-viral, anti-inflammatory and immuno-modulatory and other drugs, such as hydroxychloroquine, anti-coagulants, vasodilators, anti-angiogenics and others, are under way in <FONT
STYLE="white-space:nowrap">COVID-19</FONT> patients. Very few, if any, of these trials are designed to test interventions for longer-term respiratory complications and sequelae of <FONT STYLE="white-space:nowrap">COVID-19</FONT> using
anti-inflammatory and antifibrotic agents. The inflammatory excess in <FONT STYLE="white-space:nowrap">COVID-19</FONT> patients has prompted investigations of anti-inflammatory drugs, but outside of dexamethasone in severe patients, there has been
limited success. Remdesivir, an anti-viral agent previously used for Ebola and other viral infections, has been shown to be effective in reducing the time of hospitalization from <FONT STYLE="white-space:nowrap">COVID-19.</FONT> Whether remdesivir
can prevent post-acute complications is unclear. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pharmacologic interventions are needed that targets both inflammation and fibrosis to disrupt the
molecular cascade that leads to lung fibrosis and potentially permanent loss of lung function. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>LYT-100 for respiratory complications that persist
following COVID-19 </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LYT-100 is designed to employ a multimodal mechanism of action that could potentially treat or prevent the respiratory
complications that persist following the resolution of COVID-19. Our pre-clinical data suggest that LYT-100 has antifibrotic and anti-inflammatory activity. LYT-100 has been observed in preclinical studies to reduce pro-inflammatory cytokines and
suppresse TGF-&szlig;, which is associated with downstream signaling related to fibrosis. LYT-100 (deupirfenidone) is a selectively deuterated form of pirfenidone. Pirfenidone has anti-inflammatory and anti-fibrotic properties. In animal models, it
treats acute and prevents long-term lung injury, and pirfenidone slows the progression of idiopathic pulmonary fibrosis (IPF) and has been approved for the treatment of IPF in the United States and other countries. LYT-100 may have differentiated
pharmacokinetic properties and activity compared to pirfenidone. LYT-100 is expected to be metabolized slower and with less </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">105</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
variability between patients compared with pirfenidone. These unique pharmacokinetic properties may improve the tolerability and activity of pirfenidone, while retaining the proven antifibrotic
and anti-inflammatory properties that could have the potential to treat COVID-19. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Relevant Data </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe LYT-100&#146;s potential clinical pharmacokinetics and mechanism of action make LYT-100 an attractive product candidate for addressing the
respiratory complications that persist following resolution of COVID-19. In preclinical studies, LYT-100 was observed to suppress IL-6 and TNF-&#945; in rodent lipopolysaccharide (LPS) pretreatment models, which we believe are relevant to the acute
inflammation and cytokine release triggered by COVID-19 infection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LYT-100 anti-fibrotic activity was also observed in the preclinical studies, which
could be relevant to the lung fibrosis that can affect COVID-19 survivors. COVID-19 patients can progress to respiratory distress and lung damage driven by pro-inflammatory and pro-fibrotic cytokines like TGF-&szlig;. TGF-&szlig; is considered a
master regulator of fibrosis (Meng et al., 2016). It is a pluripotent mediator of extracellular matrix production, which in excess can replace normal tissue with non-functioning scar tissue. The figure below illustrates results from an
<I>in&nbsp;vitro</I> model of fibrosis with primary mouse lung fibroblasts measuring TGF-&szlig; induced soluble collagen, on the primary components of fibrotic tissue. In this study, which predated the pandemic and did not relate to <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> TGF-&szlig; increased the level of soluble collagen by 20 percent (p=0.0185). LYT-100 inhibited this TGF-&szlig;-dependent increase by 36 percent (p=0.0001). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>In Vitro</I></B><B> Reduction of TGF-&szlig;1 Induced Soluble Collagen Production </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g02e55.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our Planned Continued Development </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2020, we announced plans for a global, randomized, placebo-controlled Phase 2 trial to evaluate the efficacy, safety and tolerability of LYT-100 in
non-critical COVID-19 patients with respiratory complications. The trial will initially be conducted outside of the United States, and will require appropriate notifications and authorizations in those jurisdictions. We will also submit an IND to
FDA, which, if approved, would allow us to enroll subjects in the United States. As currently designed and subject to review by regulatory authorities, patients will receive treatment for up to three months. The trial is expected to enroll up to 168
patients, with a primary endpoint measuring cardiopulmonary function. The trial is also currently planned to assess secondary endpoints of dyspnea and exploratory endpoints including pharmacokinetics, acute inflammatory biomarkers, imaging and
patient-reported outcomes. Subject to regulatory approval, this trial is expected to begin in the third quarter of 2020, with topline results expected in second half of 2021. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">LYT-100</FONT> for Lymphedema </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Lymphatic Disorders </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dysfunctions of the lymphatic system
have remained largely untreated or poorly addressed by current therapeutics. Diseases of the lymphatics include lymphedema, lymphatic and vascular malformations, GI </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">106</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
lymphangiectasia and others. Impaired lymphatic drainage in the tumor microenvironment can promote immune escape and considerably contribute towards lymphatic metastatic spread of cancer.
Additionally, we believe that neurodegenerative diseases, such as Alzheimer&#146;s disease, or AD, and Parkinson&#146;s disease, may be treated by correcting aging and inflammation related brain lymphatic dysfunction. There has been little progress
toward the development of meaningful treatments for lymphatic diseases, and there are currently no approved drug therapies that can treat disorders such as lymphedema. We are developing <FONT STYLE="white-space:nowrap">LYT-100</FONT> to target the
underlying fibrosis and inflammation affecting the lymphatic system to potentially improve lymphatic function and treat lymphedema. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lymphedema is a
chronic condition that afflicts millions of people globally and is characterized by severe swelling in parts of the body, typically the arms or legs, due to the <FONT STYLE="white-space:nowrap">build-up</FONT> of lymph fluid and inflammation,
fibrosis and adipose deposition. By conservative estimates, lymphedema afflicts approximately one million people in the United States. Lymph is a clear fluid collected from body tissues that transports fats and proteins from the small intestine,
removes bacteria, viruses, toxins and certain proteins from tissues and supplies white blood cells, specifically lymphocytes, to the bloodstream to help fight infections and other diseases. Secondary lymphedema is the most prevalent form of
lymphedema. Secondary lymphedema can develop after surgery, infection or trauma, and is frequently caused by cancer, cancer treatments such as radiation and chemotherapy, trauma or infections resulting in damage to or the removal of lymph nodes.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lymphedema is a serious disease with significant health consequences, including disfigurement. Lymphedema typically progresses through multiple stages,
with increased fibrosis, limb volume and tissue changes. Approximately one million people in the United States have lymphedema, including approximately 500,000 breast cancer survivors with secondary lymphedema. Each year, up to one in five of the
more than 250,000 Americans estimated to be diagnosed with breast cancer and that undergo surgery will develop secondary lymphedema. Beyond breast cancer, lymphedema can occur in up to 15&nbsp;percent of cancer survivors with malignancies ranging
from melanoma and sarcoma. A subset of lymphedema patients will also experience cellulitis, a bacterial skin infection that can enter through wounds in lymphedematous skin. Cellulitis often requires hospitalization and intravenous antibiotics to
treat, and approximately half of patients with cellulitis will have recurrent episodes. Rarely, patients with chronic lymphedema may develop lymphangiosarcoma, a rare malignant tumor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The International Society of Lymphology classifies a lymphedematos limb based on staging that describes the condition of the limb, as illustrated in the table
below. Within each clinical stage, clinicians use a measurement of limb swelling to capture disease severity described as mild, moderate or severe lymphedema. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CLINICAL STAGES OF
LYMPHEDEMA</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>STAGE I</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>STAGE II</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>STAGE III</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Symptoms</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Limb swelling, pitting edema, limb heaviness and discomfort</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Limb swelling, skin thickening, dermal fibrosis, fat deposition, <FONT STYLE="white-space:nowrap">non-pitting</FONT> edema</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Disfiguring limb swelling, hyperkeratosis, loss of skin elasticity, skin lesions and overgrowths, massive fibrosis and fat deposition, elephantiasis</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Additional clinical concerns</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">Lifelong need for compression therapy, chronic progression, repeated infections (cellulitis, lymphangitis), elephantine skin changes, development of lymphangiosarcoma</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As lymphedema progresses into later stages, the affected limb can acquire a &#147;woody texture&#148; due to fibrosis. In
addition to clinical staging, clinicians use a measurement of limb swelling to capture disease severity. For upper limb lymphedema, a relative limb volume of five to 20&nbsp;percent is considered mild, a relative limb volume of 20 to 40&nbsp;percent
is considered moderate and a relative limb volume greater than 40&nbsp;percent is considered severe. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">107</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Cancer treatments lead to new lymphedema patients each year, the majority of which will have mild lymphedema: over 70&nbsp;percent of patients with breast cancer related upper limb lymphedema
have mild to moderate lymphedema, while the remainder have moderate to severe lymphedema.&nbsp;We intend to initially evaluate <FONT STYLE="white-space:nowrap">LYT-100</FONT> in the more common mild to moderate lymphedema patient population. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The natural history of lymphedema is a chronic and progressive disorder, reflected in the increasing severity of limb swelling. The relative increase of limb
volume in the affected limb compared to the unaffected limb worsens over time. It has been observed in patients with mild lymphedema that approximately 48&nbsp;percent will progress to more severe stages during the first five years of <FONT
STYLE="white-space:nowrap">follow-up.</FONT> Because of the progressive nature of the disease, many patients will progress to the point where bandaging and compression are incapable of reducing limb volume. The potential loss of limb range of motion
and function, the risk of secondary infections and complications and the disfigurement result in physical and emotional suffering in patients. Secondary lymphedema is a lifelong disease and the affected population is increasing each year due to
improved survival of cancer patients, changes in patient and disease factors, including obesity, an aging population and increased use of radiation treatment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Current Standard of Care </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current standard of care
for lymphedema is management, primarily with compression and physical therapy to control swelling. These approaches are cumbersome, uncomfortable and <FONT STYLE="white-space:nowrap">non-curative,</FONT> and they do not address the underlying
disease, especially in patients with more severe lymphedema. Even with management, some patients will progress from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mild-to-moderate</FONT></FONT> lymphedema to more severe forms.
Referral to current treatment regimens does not predict reversal or stabilization of lymphedema. In later stages, patients may also seek ablative surgeries, including liposuction or debulking. These surgeries reduce volume but do not restore
lymphatic flow, and compression is still required to control swelling. There are currently no approved drug therapies that can treat the underlying causes of lymphedema. We believe the lack of treatments for lymphedema represents a major unmet
medical need. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The Role of Fibrosis and Inflammation in Lymphedema </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inflammation and fibrosis play important roles in the pathophysiology of secondary lymphedema. Lymphatic injury activates chronic immune responses that promote
fibrosis, reduce lymphatic flow and impair lymphatic formation. Targeting fibrosis in addition to inflammation may be a potentially effective way of ameliorating established lymphedema in patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The figure below depicts the feedback loop between inflammation and fibrosis driven lymphedema. The accumulation of TGF-&szlig;1 results in increased fibrosis
in tissue from patients with lymphedema. TGF-&szlig;1 is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation and apoptosis. TGF- &szlig;1 is a critical regulator of
fibrosis, and lymphedematous tissue has increased TGF-&szlig;1 staining. Inflammation is also present in lymphedematous limbs. Tissue samples from patients with lymphedema have increased presence of inflammatory cells. These cells can produce <FONT
STYLE="white-space:nowrap">pro-inflammatory</FONT> and <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> cytokines, including TGF-&szlig;1, to further the progression of lymphedema. The middle panel below shows lymphedema skin biopsy samples from
lymphedematous and normal limbs of patients. Lymphedema skin samples showed increased immune infiltrate as evidenced by elevated levels of CD45+ immune cells in immunohistochemical staining. As shown in the right panel below, lymphedema skin biopsy
samples from lymphedematous and normal limbs of patients show increased intracellular TGF-&szlig;1 staining in immunohistochemical staining. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">108</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Feedback Loop Driving Lymphedema </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g16m61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accumulation of collagen and fibrosis is seen in swelling associated with lymphedema. The figure below depicts the
accumulation of CD45+ cells in the mouse tail model of lymphedema on the left, and the increase in total tissue volume and accumulation of collagen on the right. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Accumulation of Collagen and Fibrosis in Mouse Lymphedema Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g17y82.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe targeting the chronic inflammation and fibrosis associated with lymphedema with an oral therapy could
potentially treat secondary lymphedema. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Preclinical Results </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In preclinical studies, <FONT STYLE="white-space:nowrap">LYT-100</FONT> showed greater anti-fibrotic and anti-inflammatory activity when compared to
pirfenidone. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inflammation was also monitored in an LPS induced preclinical rodent model. The figure below illustrates the plasma concentrations of <FONT
STYLE="white-space:nowrap">TNF-&#945;,</FONT> a <FONT STYLE="white-space:nowrap">pro-inflammatory</FONT> cytokine and biomarker of inflammation, 90 minutes <FONT STYLE="white-space:nowrap">post-LPS</FONT> injection. When 100 mg/kg doses of <FONT
STYLE="white-space:nowrap">LYT-100</FONT> were administered one hour prior to LPS, <FONT STYLE="white-space:nowrap">TNF-&#945;</FONT> levels were 70&nbsp;percent lower than those obtained using equivalent oral volumes of the vehicle control in this
study. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">109</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Preclinical Plasma Concentrations of
<FONT STYLE="white-space:nowrap">TNF-</FONT></B>&#945;<B></B><B> with <FONT STYLE="white-space:nowrap">LYT-100</FONT> versus Control </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g25p18.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, a functional analog of <FONT STYLE="white-space:nowrap">LYT-100</FONT> was tested by one of our academic
collaborators in a rodent tail model of lymphedema. In this model, the lymphatics draining the tail are surgically damaged, resulting in tail swelling, inflammation and fibrosis mimicking human limb lymphedema. In the figures shown below, a control
vehicle substance or a functional analog of <FONT STYLE="white-space:nowrap">LYT-100</FONT> was administered daily at a dose of 400&nbsp;mg/kg orally starting two weeks after surgery, when the tail has already begun the process of lymphedema (n=7
per group). <FONT STYLE="white-space:nowrap">LYT-100</FONT> treatment halted progression of lymphedema and reduced the overall volume of the lymphedematous tail. Control animals continued to have increases in tail volumes and have double the tail
volume by Week 4. In contrast, the <FONT STYLE="white-space:nowrap">LYT-100</FONT> group had a 71&nbsp;percent decrease in tail volume compared to control by Week 6, nearly returning the tail volume back to the presurgical baseline. Representative
tail images from both groups at 2 weeks and 6 weeks are shown below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">110</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">LYT-100</FONT> versus Control in Lymphedema Mouse Model
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g24k79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Fibroadipose Thickness Measured in Functional Analog of <FONT STYLE="white-space:nowrap">LYT-100</FONT>
versus Control </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>in Lymphedema Mouse Model </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Clinical Results </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">LYT-100</FONT> is being studied in a single dose crossover Phase&nbsp;1 clinical trial of 24 healthy volunteers to assess
safety and PK. The figure below illustrates single-dose PK at a 801&nbsp;mg dose of <FONT STYLE="white-space:nowrap">LYT-100</FONT> and 801 mg dose of pirfenidone over 24&nbsp;hours. <FONT STYLE="white-space:nowrap">LYT-100</FONT> has an
approximately 35&nbsp;percent increase in area under the curve systemic exposure and a 25&nbsp;percent increase in C<SUB STYLE="font-size:85%; vertical-align:bottom">Max</SUB> relative to pirfenidone in this study. These results demonstrate that <FONT
STYLE="white-space:nowrap">LYT-100</FONT> displays improved PK relative to pirfenidone and suggest the possibility of twice-daily dosing of <FONT STYLE="white-space:nowrap">LYT-100</FONT> in patients with lymphedema. In addition, <FONT
STYLE="white-space:nowrap">LYT-100</FONT> was well-tolerated and there were no SAEs observed in the Phase&nbsp;1 clinical trial of healthy volunteers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">111</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>24 Hour Single-Dose PK Profile of 801 mg of <FONT STYLE="white-space:nowrap">LYT-100</FONT>
versus 801 mg of Pirfenidone </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g91c90.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our Planned Continued Development </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2020, we announced the initiation of a multiple ascending dose study of <FONT STYLE="white-space:nowrap">LYT-100</FONT> to evaluate the safety,
tolerability and PK profile of <FONT STYLE="white-space:nowrap">LYT-100</FONT> in healthy volunteers. Results from this trial are anticipated the second half of 2020, and a subsequent POC trial in people with breast cancer-related, upper limb
secondary lymphedema is expected to begin in the second half of 2020 with topline results expected in the second half of 2021. For this POC study, we plan to recruit patients with
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mild-to-moderate</FONT></FONT> lymphedema of the arm. The primary endpoint of the patient study will be safety of <FONT STYLE="white-space:nowrap">LYT-100.</FONT> As secondary
endpoints, we will also study outcome measures of lymphedema, including relative limb volume, bioimpedance spectroscopy &#150; a measure of extracellular fluid change, tonometry, a measure of fibrosis, and serum levels of inflammatory and fibrotic
factors. The study may also examine patient reported outcomes using validated self-report instruments specific to <FONT STYLE="white-space:nowrap">upper-arm</FONT> lymphedema. The study will not evaluate statistical significance versus placebo, as
we expect to use data from the study to inform future clinical protocols, including future efficacy endpoints. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to pursue the foreign regulatory
approvals needed to conduct the anticipated studies. We may seek FDA approval of <FONT STYLE="white-space:nowrap">LYT-100</FONT> using Section&nbsp;505(b)(2) of the Federal Food, Drug, and Cosmetic Act, which allows the submission of an NDA that
relies in part on the FDA&#146;s prior findings regarding the safety and effectiveness of approved drugs, which, if we are able to use this pathway, could expedite the development program for <FONT STYLE="white-space:nowrap">LYT-100</FONT> by
potentially decreasing the overall scope of clinical data that we are required to present to support our application for the approval of <FONT STYLE="white-space:nowrap">LYT-100</FONT> in secondary lymphedema. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">LYT-100</FONT> and the Treatment of Other Fibrosis and Inflammation-Related Diseases </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fibrosis and inflammation are a common mechanism across several lung diseases. There are acute diseases with high mortality or that lead to long-term fibrosis;
chronic diseases linked to a specific cause, like a virus or autoimmune disease; and diseases like IPF, where the cause is less clear. In a large percentage of these various lung conditions, there are no approved treatments that address inflammation
and fibrosis of the lungs. Many of these diseases can increase the risk for worsening of lung fibrosis, and there is a clear unmet need to stop inflammation and fibrosis and to preserve lung function. Even in IPF, for which pirfenidone is approved,
high </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">112</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unmet need exists given pirfenidone&#146;s dosing schedule and unfavorable tolerability profile which often leads to dose reduction or treatment discontinuation. Despite these unmet needs,
pirfenidone sales peaked above $1&nbsp;billion in 2018 and 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to explore applications of <FONT STYLE="white-space:nowrap">LYT-100</FONT> where
the anti-inflammatory and anti-fibrotic activity of pirfenidone has demonstrated clinical and preclinical activity, including IPF where pirfenidone is already approved for use, and other ILDs. There are serious limitations in the clinical use of
pirfenidone in IPF and interstitial lung disease. Pirfenidone requires frequent dosing, which results in high peak to trough fluctuations in plasma concentrations, and side-effects leading to a &gt;25&nbsp;percent treatment discontinuation rate. In
Phase 3 studies, 77&nbsp;percent of patients taking pirfenidone had dose interruptions or reductions because of AEs. The real-world evidence of pirfenidone use also highlights tolerability issues: in a large, multinational post-marketing study,
73&nbsp;percent of patients experienced an AE, including 38&nbsp;percent with GI symptoms, leading to a high discontinuation rate. The most common AEs of pirfenidone included GI symptoms (nausea, diarrhea, dyspepsia, vomiting), fatigue, rash, and
photosensitivity reactions. Additionally, reversible elevations in liver enzymes were seen in a small proportion of patients, as were dizziness and weight loss. Thus, despite an intriguing mechanism of action, pirfenidone has PK shortcomings that
may limit its use in IPF and other ILDs. A therapeutic compound which improves upon metabolism and dose exposure of pirfenidone, while retaining or exceeding its efficacy, would be an attractive therapeutic option for interstitial lung diseases. <FONT
STYLE="white-space:nowrap">LYT-100</FONT> has demonstrated anti-fibrotic and anti-inflammatory activity with superior PK that has the potential for improved dosing, safety, and efficacy compared to pirfenidone. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because of our insight into how inflammation and fibrosis affect lymphatic flow, we also plan to explore the application of
<FONT STYLE="white-space:nowrap">LYT-100</FONT> in other lymphatic flow conditions. Millions of patients have lymphedema beyond breast cancer-related arm lymphedema and we believe <FONT STYLE="white-space:nowrap">LYT-100</FONT> may have potential to
target the underlying mechanisms of other forms of secondary or primary lymphedema. We may also explore the potential use of <FONT STYLE="white-space:nowrap">LYT-100</FONT> in other inflammatory and fibrotic diseases including FSGS, a rare,
progressive kidney disease that can lead to kidney failure and dialysis. An estimated more than 4,500 individuals in the United States develop FSGS every year, and there are no specific treatments designed to reduce fibrosis and inflammation in this
disease. Treatment with immunosuppression is symptomatic and often does not prevent relapse and progression to <FONT STYLE="white-space:nowrap">end-stage</FONT> renal disease. <FONT STYLE="white-space:nowrap">LYT-100&#146;s</FONT> anti-fibrotic
activity suggests the potential to target kidney fibrosis in FSGS and provide a novel treatment for this disorder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">LYT-100</FONT> and the Treatment of Brain and CNS Lymphatic-Related Disease </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The lymphatic system is an important part of the immune system, GI system and CNS. Loss of lymphatic flow can play a critical role in diseases of these
systems. We believe <FONT STYLE="white-space:nowrap">LYT-100,</FONT> if successfully developed and approved, has the potential to address serious diseases of lymphatic flow. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One of our academic collaborators discovered a functional lymphatic system in the meninges of the brain that forms the basis of our meningeal lymphatics
discovery research program. These meningeal lymphatics have been described as the &#147;brain drain,&#148; a route through which macromolecules are flushed from the brain in cerebrospinal fluid. Among the macromolecules that are drained via the
lymphatics are pathogenic macromolecules such as amyloid-beta and tau, which are both associated with AD pathology, as well as alpha-synuclein, which is associated with Parkinson&#146;s disease. Blocking the lymphatic flow increases levels of these
molecules in the brain. In animal models of AD, <FONT STYLE="white-space:nowrap">AD-associated</FONT> tauopathies and Parkinson&#146;s disease, blockade of meningeal lymphatic flow significantly exacerbated disease progression and severity and
improving flow through aged meningeal lymphatics improved cognitive brain function in these animal models. With aging, the lymphatic vessels that drain the brain become dysfunctional and no longer drain as efficiently. The &#147;lymphedematous
characteristics&#148; of meningeal lymphatic vessels in aged animals might be leading to inefficient clearance of pathologic macromolecules and potentially increase risk for neurodegenerative diseases. Restoration of lymphatic flow may then be a
novel class of therapies for neurodegeneration, and we believe that augmenting meningeal lymphatic vasculature function may potentially improve outcomes for a range of neurodegenerative and neuroinflammatory conditions that are not currently
effectively treated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">113</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are exploring multiple ways of altering lymphatic flow, both in the CNS and other parts of the body.
Starting with <FONT STYLE="white-space:nowrap">LYT-100,</FONT> we will continue to develop novel therapeutic candidates that target inflammation, fibrosis and other mechanisms that impair lymphatic flow. We also have ongoing discovery efforts to
explore new mechanisms with the goal to advance, <FONT STYLE="white-space:nowrap">in-license</FONT> and/or acquire assets that we can develop for diseases of lymphatic flow. We will use our network of collaborators and internal expertise in
lymphatics to actively discover and develop novel solutions for diseases of the lymphatic system, including rare lymphatic diseases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA and
corresponding regulatory authorities will ultimately review our clinical results and determine whether our Wholly Owned product candidates are safe and effective. No regulatory agency has made any such determination that <FONT
STYLE="white-space:nowrap">LYT-100</FONT> is safe or effective for use by the general public for any indication. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">LYT-200</FONT> &amp; <FONT STYLE="white-space:nowrap">LYT-210:</FONT> Targeting Immunosuppressive and Pathogenic
Lymphocytes to Treat Intractable Cancers and Immunological Disorders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hallmarks of cancer include dysregulated growth driven by both cellular oncogenes
as well as the intratumoral microenvironment and local and systemic failures of the immune system to recognize cancer and mount an anti-tumor response. In cancer, a complex interaction of the tumor, tumor microenvironment and immune cells creates an
immunosuppressive state, allowing cancer to evade the effects of many therapies as well as the attack of cytotoxic immune cells. Tumors can often express immunosuppressive factors, such as cell surface checkpoint molecules. For example, programmed
death-ligand 1, or <FONT STYLE="white-space:nowrap">PD-L1,</FONT> is a type of checkpoint overexpressed by cancer cells that suppress T&nbsp;cells, an important type of immune cell that normally responds to infections or cancer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A class of therapies known as checkpoint inhibitors has been developed to counteract tumor defenses against the immune system and includes therapies that
target programmed cell death protein 1, or <FONT STYLE="white-space:nowrap">PD-1,</FONT> <FONT STYLE="white-space:nowrap">PD-L1</FONT> and cytotoxic <FONT STYLE="white-space:nowrap">T-lymphocyte-associated</FONT> antigen 4, or <FONT
STYLE="white-space:nowrap">CTLA-4.</FONT> These marketed drugs have demonstrated encouraging clinical responses and durable benefit across a number of cancers and according to EvaluatePharma had sales exceeding $16&nbsp;billion in 2018.
Unfortunately, a great proportion of patients still do not respond or respond suboptimally to approved checkpoint inhibitors. In immunologically silent tumors such as pancreatic cancer, CRC and CCA, little, if any, efficacy has been seen to date
with any of these agents. In the United States, there are approximately 57,000 new pancreatic cancer patients, of which 50&nbsp;percent present with metastatic disease, approximately 146,000 new CRC patients, of which 35&nbsp;percent present with
metastatic disease, and approximately 8,000 new CCA patients, of which 50&nbsp;percent present with metastatic disease, per year, representing a significant patient population that has yet to receive benefit from any immuno-therapy agents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to identify assets with the potential to provide significant therapeutic benefit to cancer patients, we undertook a global, proactive search to
discover important new scientific insights and technologies that could address the challenge of multiple mechanisms of immunosuppression in current therapeutics. During this search, we employed the following criteria: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Aim to avoid targets where others were developing drugs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Address multiple pathways of immunosuppression via key immunological nodes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Attempt to develop therapies for solid tumors where existing treatments are limited, including solid tumors where
checkpoint inhibitors have failed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Identify targets where therapeutic intervention has the potential for both single-agent activity and the
potential to be used in combination with other immuno-oncology, and more broadly, other anti-cancer agents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Represent targets whose underlying biology enables them to have a favorable therapeutic window and a favorable
safety margin; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achieve significant preclinical validation; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">114</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Focus on targets whose higher levels are associated with aggressive diseases and poorer outcomes in people; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Focus on targets where mAbs could be effective. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on these criteria, and through our extensive network of advisors and collaborators, we identified two foundational immunosuppressive mechanisms
involving <FONT STYLE="white-space:nowrap">galectin-9</FONT> and immunosuppressive <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells, which are the basis of developing <FONT
STYLE="white-space:nowrap">LYT-200</FONT> and <FONT STYLE="white-space:nowrap">LYT-210,</FONT> respectively, and which fulfill the above criteria for a potentially clinically beneficial, novel immuno-oncology agent. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">LYT-200:</FONT> Our Immuno-oncology Product Candidate Targeting <FONT STYLE="white-space:nowrap">Galectin-9,</FONT> in
Development for the Treatment of Solid Tumors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">LYT-200</FONT> is a fully human IgG4 mAb that is designed to block <FONT
STYLE="white-space:nowrap">galectin-9,</FONT> which we are developing for the treatment of solid tumors, including pancreatic ductal adenocarcinoma, or PDAC, CRC and CCA, that do not respond to approved checkpoint inhibitors and have poor survival
rates. We anticipate filing an IND for <FONT STYLE="white-space:nowrap">LYT-200</FONT> and initiating a Phase 1 study in solid tumors in 2020, with results anticipated in 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe <FONT STYLE="white-space:nowrap">LYT-200</FONT> could meet the criteria that we set out in defining a potential immuno-oncology therapeutic
because: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">Galectin-9</FONT> promotes and facilitates multiple immunosuppressive pathways
by, for example, expanding regulatory T cells, shifting macrophages from the M1 to M2 phenotype, and inducing apoptosis of activated CD4<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> and
CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> T cells. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">High expression of <FONT STYLE="white-space:nowrap">galectin-9</FONT> is evident in tumors and in cancer
patients&#146; blood, and correlates with poor survival outcomes and aggressive disease in multiple solid tumor types. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In order to assess the effects of <FONT STYLE="white-space:nowrap">LYT-200</FONT> in murine models of cancer, a
mouse monoclonal antibody, which we refer to as <FONT STYLE="white-space:nowrap">mIgGI-200,</FONT> that targets the same epitope on <FONT STYLE="white-space:nowrap">galectin-9</FONT> was developed. A mouse IgG1 isotype has blocking function similar
to the human IgG4 isotype. Preclinical evidence we generated has confirmed that <FONT STYLE="white-space:nowrap">mIgG1-200</FONT> is efficacious in inhibiting tumor growth in pancreatic cancer (KPC) and melanoma (B16F10) mouse models of cancer. We
have used <FONT STYLE="white-space:nowrap">mIgG1-200</FONT> as single agent in both the pancreatic cancer (KPC) and the melanoma (B16F10) mouse models of cancer. In both of these models, compared to control we saw a significant tumor growth
reduction. Equally, in the KPC model we observed that administration of <FONT STYLE="white-space:nowrap">LYT-200</FONT> both as a single agent, and in combination with chemotherapy
<FONT STYLE="white-space:nowrap">(gemcitabine/nab-paclitaxel),</FONT> significantly prolonged survival of pancreatic tumor bearing mice, compared to control, while chemotherapy alone did not give a significant prolongation of survival compared to
control animals. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">LYT-200</FONT> also activated effector T cells in <I>ex vivo</I> models of
patient derived tumor organoids (PDOTs) in multiple tumor types (pancreatic cancer, colon cancer, cholangiocarcinoma, etc.). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">While elevated in the context of cancer, <FONT STYLE="white-space:nowrap">galectin-9</FONT> has low expression
under normal physiological conditions which indicates a potential safety window which has been further supported by the lack of tolerability concerns to date in our good laboratory practice, or GLP, studies with
<FONT STYLE="white-space:nowrap">LYT-200</FONT> even at extremely high doses, such as 300 mg/kg in <FONT STYLE="white-space:nowrap">non-human</FONT> primates (~100 mg/kg human equivalent dose). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Other companies, to our knowledge, do not have clinical development programs around <FONT
STYLE="white-space:nowrap">galectin-9</FONT> as a therapeutic target, and <FONT STYLE="white-space:nowrap">LYT-200</FONT> would represent a potentially innovative therapeutic. None of the other human galectins have been documented to play such a
global role in immunosuppression in the context of cancer which <FONT STYLE="white-space:nowrap">galectin-9</FONT> plays; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We believe that <FONT STYLE="white-space:nowrap">LYT-200</FONT> may be used as a single agent and safely in
combination with checkpoint inhibitors and other systemic cancer treatments. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">115</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Galectin-9</FONT> has a unique capacity to switch off a multitude of immune
mechanisms that would otherwise engage in fighting cancer; therefore, targeting this molecule has the potential to restore the immune system&#146;s ability to attack cancer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Galectin-9</FONT> functions through multiple pathways by binding to carbohydrate motifs on cell surface molecules and
receptors. It plays a critical regulatory role in immune cell response and homeostasis, and mediates immunoregulatory activities in several ways. Binding of <FONT STYLE="white-space:nowrap">galectin-9</FONT> to T cell immunoglobulin and mucin-domain
<FONT STYLE="white-space:nowrap">containing-3,</FONT> or <FONT STYLE="white-space:nowrap">TIM-3</FONT> for example, induces cell death of terminally differentiated <FONT STYLE="white-space:nowrap">TIM-3+&nbsp;T</FONT> helper cell, or Th1 and cluster
of differentiation, or CD, 8+&nbsp;T cells, as well as apoptosis of CD4+&nbsp;Th1 cells. <FONT STYLE="white-space:nowrap">Galectin-9</FONT> binds to CD44 and cooperates with transforming growth factor beta, or
<FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> to promote T&nbsp;regulatory, or Treg, cell differentiation. <FONT STYLE="white-space:nowrap">Galectin-9</FONT> also favors expansion of immunosuppressive myeloid derived suppressor cells, or
MDSCs, in the overall promotion of Th2/M2 differentiation, which ultimately favors tumor progression. <FONT STYLE="white-space:nowrap">Galectin-9</FONT> also functions to reduce the development of Th17 cells, and is immunomodulatory on tumor
associated macrophages. Taking all this into consideration, <FONT STYLE="white-space:nowrap">galectin-9</FONT> is considered a potent mediator of cancer-associated immunosuppression. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Galectin-9</FONT> Proposed Mechanism of Action </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g79y19.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Image adapted from J Mol Biol; 428 (16): 3266-3281; 2016 Treg = T regulatory cell; MDSC = myeloid derived suppressor cell;
M1/M2 = tumor associated macrophage (TAM)1 (immunoactive) and 2 (immunosuppressed) cell; Th1 = T helper1 cell </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">High levels of tissue and/or circulating <FONT
STYLE="white-space:nowrap">galectin-9</FONT> correlate with aggressive tumor features and adverse survival outcome in many tumor types. For example, <FONT STYLE="white-space:nowrap">galectin-9</FONT> levels are significantly increased in metastatic
melanoma patient plasma, correlating with Th2 systemic bias and less favorable <FONT STYLE="white-space:nowrap">two-year</FONT> clinical survival outcome. <FONT STYLE="white-space:nowrap">Galectin-9</FONT> is also highly expressed in human PDAC
compared with normal pancreas tissue and present on both tumor and intratumoral immune cells. Moreover, high serum concentration of <FONT STYLE="white-space:nowrap">galectin-9</FONT> may be able to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">116</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discriminate PDAC from benign pancreatic disease and healthy individuals and is potentially prognostic for stage IV patients. Plasma levels of <FONT STYLE="white-space:nowrap">galectin-9</FONT>
are associated with a worse overall and disease-free survival, as well as chemoresistance, in ovarian cancer patients. In gastric cancer, patients with <FONT STYLE="white-space:nowrap">galectin-9</FONT> positive tumors have significantly lower
overall and gastric cancer-specific mortalities. In yet another gastrointestinal tumor type, CRC, <FONT STYLE="white-space:nowrap">galectin-9</FONT> markedly inhibits the cytotoxicity of the gamma delta T cells towards colon cancer cells, indicating
its immune-suppressive mechanism of action. In muscle invasive bladder cancer, tumor-associated macrophages expressing <FONT STYLE="white-space:nowrap">galectin-9</FONT> are associated increasing numbers of Treg cells and decreasing numbers of CD8 T
and dendritic cells, indicating an immunosuppressed microenvironment, that in turn translates to increased tumor grade/stage and <FONT STYLE="white-space:nowrap">galectin-9</FONT> positive tumors with poor prognosis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In nasopharyngeal carcinoma, or NPC, significant increase in the expression of <FONT STYLE="white-space:nowrap">galectin-9</FONT> positive&nbsp;tumor cells,
with concomitant increase in Treg cells and decrease in CD8 T cells, is observed in recurrent tumor tissues, indicating that <FONT STYLE="white-space:nowrap">galectin-9</FONT> confers immunologic escape in NPC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">High <FONT STYLE="white-space:nowrap">galectin-9</FONT> expression is highly correlated with expression of immune checkpoint molecules, M2 tumor-associated
macrophages in the mesenchymal subtype of glioblastoma multiforme and in small cell lung cancer correlates with high levels of neuron specific enolase and shorter survival. In breast cancer, surface <FONT STYLE="white-space:nowrap">galectin-9</FONT>
protects carcinoma cells against cytotoxic T cell-induced death, while in <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer, or NSCLC, there is a <FONT STYLE="white-space:nowrap">co-expression</FONT> between <FONT
STYLE="white-space:nowrap">galectin-9</FONT> and <FONT STYLE="white-space:nowrap">PD-L1,</FONT> with high <FONT STYLE="white-space:nowrap">galectin-9</FONT> expression on immune cells correlating with early disease relapse. Moreover, early
accumulation of MDSCs expressing <FONT STYLE="white-space:nowrap">galectin-9</FONT> in NSCLC is associated with primary and secondary resistance to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> treatment.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Collectively, these data, across multiple solid tumor types, may support the use of <FONT STYLE="white-space:nowrap">LYT-200</FONT> in
relapsed/refractory, metastatic solid tumors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In basal physiological conditions, <FONT STYLE="white-space:nowrap">galectin-9</FONT> is weakly expressed
in most tissues, with some abundance in the thymus and kidney. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For example, the figure below illustrates the correlation between <FONT
STYLE="white-space:nowrap">galectin-9</FONT> messenger ribonucleic acid, or mRNA, levels and decreased overall survival in pancreatic cancer. As shown below, high mRNA levels of <FONT STYLE="white-space:nowrap">galectin-9</FONT> in pancreatic cancer
correlate to significantly shorter overall survival at five years, as represented by the red curve, compared to lower mRNA levels of <FONT STYLE="white-space:nowrap">galectin-9.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>mRNA Levels of <FONT STYLE="white-space:nowrap">Galectin-9</FONT> in Pancreatic Cancer </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g76o93.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">117</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The figure below shows immunohistochemistry, or IHC, expression of
<FONT STYLE="white-space:nowrap">galectin-9</FONT> in primary CRC and CRC liver metastasis. In staining of CRC samples with a reagent <FONT STYLE="white-space:nowrap">galectin-9</FONT> antibody, we observed high
<FONT STYLE="white-space:nowrap">galectin-9</FONT> expression at the cell membrane and in the cytoplasm, both at the site of the primary tumor and the metastatic deposit. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Observed <FONT STYLE="white-space:nowrap">Galectin-9</FONT> Expression in CRC </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g50h92.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, data below represents staining patterns of <FONT STYLE="white-space:nowrap">galectin-9</FONT> in pancreatic
cancer tissues, and we have observed the same IHC pattern in breast cancer and CCA as well. Namely, a variety of tumor types were assessed for the presence of <FONT STYLE="white-space:nowrap">galectin-9</FONT> using IHC of formalin-fixed,
paraffin-embedded, or FFPE tissue samples. Over 1,000 samples of breast cancer, 141 samples of PDAC, and 99 samples of intrahepatic CCA, with available clinicopathologic information, were examined. Figures below show that strong and moderate tumor
staining were associated with membranous expression of <FONT STYLE="white-space:nowrap">galectin-9</FONT> (p=0.004), and the tumors with strong expression correlated with worse outcomes. Strong <FONT STYLE="white-space:nowrap">galectin-9</FONT>
expression conferred worse relapse free survival (p=0.052) and worse overall survival (p=0.044) in CCA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">118</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Representative IHC Staining of <FONT STYLE="white-space:nowrap">Galectin-9</FONT> in CCA
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g11c37.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">119</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g94u40.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, we can detect <FONT STYLE="white-space:nowrap">galectin-9</FONT> levels in cancer patient blood which are
much higher than in healthy individuals. The figure below depicts blood serum samples from 14 healthy subjects, 14 CRC and five pancreatic cancer patients that were evaluated for <FONT STYLE="white-space:nowrap">galectin-9</FONT> levels. Serum <FONT
STYLE="white-space:nowrap">galectin-9</FONT> levels were measured using commercially available ELISA kits specifically for detection of human <FONT STYLE="white-space:nowrap">galectin-9.</FONT> The data show increased
<FONT STYLE="white-space:nowrap">galectin-9</FONT> levels in the serum of cancer patients compared to healthy subject controls. This assay indicates that <FONT STYLE="white-space:nowrap">galectin-9</FONT> overexpression occurs not only in cancer
tissues but also in the blood of cancer patients. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">120</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Serum <FONT STYLE="white-space:nowrap">Galectin-9</FONT> Levels in Various Populations
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g90w88.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Preclinical Results </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Specifically, the binding affinity of <FONT STYLE="white-space:nowrap">LYT-200</FONT> to the <FONT STYLE="white-space:nowrap">C-terminal</FONT> carbohydrate
domain 2, or CRD2 and the <FONT STYLE="white-space:nowrap">non-binding</FONT> CRD1 domains of mouse, rat, cynomolgus monkey and human <FONT STYLE="white-space:nowrap">galectin-9</FONT> was determined utilizing the Dynabead system (Invitrogen,
ThermoFisher Scientific). Studies were conducted to assess cross species affinity to the CRD2 domain of <FONT STYLE="white-space:nowrap">galectin-9.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">LYT-200</FONT> has been observed to have no cross-reactivity with other galectins, and exhibits good thermostability, storage
stability and the ability to be purified. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>K<SUB STYLE="font-size:85%; vertical-align:bottom">Dapp</SUB> (nM) of <FONT
STYLE="white-space:nowrap">LYT-200</FONT> to <FONT STYLE="white-space:nowrap">Galectin-9</FONT> Carbohydrate Domains </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="88%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="30%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Species</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B><FONT STYLE="white-space:nowrap">Galectin-9</FONT> Carbohydrate
Domain</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B><FONT STYLE="white-space:nowrap">LYT-200</FONT></B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Human</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">CRD1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">No binding</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Human</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">CRD2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.33 &plusmn; 0.07</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Mouse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">CRD2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.42 &plusmn; 0.04</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Rat</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">CRD2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1.28 &plusmn; 0.06</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Cynomolgus Monkey</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">CRD2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.31 &plusmn; 0.03</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The binding affinity of <FONT STYLE="white-space:nowrap">LYT-200</FONT> to CRD2 domain was similar and in the low nanomolar
range between human, mouse and monkey models and three to four times weaker in the rat model although still within low nanomolar range. <FONT STYLE="white-space:nowrap">LYT-200</FONT> and <FONT STYLE="white-space:nowrap">mIgG1-200</FONT> share the
same antibody variable region, and as a result have comparable binding affinities for the CRD2 domain of <FONT STYLE="white-space:nowrap">galectin-9</FONT> across the four species tested. Furthermore, both monoclonal antibodies are specific for the
CRD2 domain, as no binding was detected to the CRD1 domain of human <FONT STYLE="white-space:nowrap">galectin-9.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Binding affinity of <FONT
STYLE="white-space:nowrap">LYT-200</FONT> to cell surface <FONT STYLE="white-space:nowrap">galectin-9</FONT> was determined using human colon cancer cells (left panel; <FONT STYLE="white-space:nowrap">CRL-2134</FONT> cells) and a <FONT
STYLE="white-space:nowrap">galectin-9</FONT> negative cell line (right panel; <FONT STYLE="white-space:nowrap">HEK-293</FONT> cells). Based on these saturation curves, a cell-based K<SUB STYLE="font-size:85%; vertical-align:bottom">D</SUB> for <FONT
STYLE="white-space:nowrap">LYT-200</FONT> was determined to be 0.41 &plusmn; 0.07 nM. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">121</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Comparison of <FONT STYLE="white-space:nowrap">LYT-200</FONT> Binding to <FONT
STYLE="white-space:nowrap">CRL-2134</FONT> and <FONT STYLE="white-space:nowrap">HEK-293</FONT> Cells </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g91a12.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We next assessed the ability of <FONT STYLE="white-space:nowrap">LYT-200</FONT> to block interactions with <FONT
STYLE="white-space:nowrap">galectin-9</FONT> specific binding protein, CD206. CD206 is a receptor found on the surface of macrophages, and is a known binding protein/receptor for <FONT STYLE="white-space:nowrap">galectin-9.</FONT> An ELISA format
was used to first demonstrate that CD206 and <FONT STYLE="white-space:nowrap">galectin-9</FONT> are a receptor-ligand pair and secondly to show that the addition of <FONT STYLE="white-space:nowrap">LYT-200</FONT> could inhibit this interaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">LYT-200</FONT> Blocks <FONT STYLE="white-space:nowrap">CD206-Galectin-9</FONT> Interaction in a Dose
Dependent Manner </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g91o18.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These data indicate that <FONT STYLE="white-space:nowrap">LYT-200</FONT> has the ability to block a functional activity of <FONT
STYLE="white-space:nowrap">galectin-9,</FONT> namely, interaction with a specific binding partner/receptor, CD206. This assay demonstrates the desired and expected blocking function of <FONT STYLE="white-space:nowrap">LYT-200</FONT> as the fully
human IgG4 mAb. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We next observed that <FONT STYLE="white-space:nowrap">LYT-200</FONT> could protect T cells from
<FONT STYLE="white-space:nowrap">galectin-9</FONT> induced apoptosis, as illustrated in the figure below. The presence of <FONT STYLE="white-space:nowrap">galectin-9</FONT> (red square) significantly increased cell death compared to culture in the
absence of <FONT STYLE="white-space:nowrap">galectin-9</FONT> (black circle). The addition of <FONT STYLE="white-space:nowrap">LYT-200</FONT> to the culture of <FONT STYLE="white-space:nowrap">MOLM-13</FONT> cells in the presence of <FONT
STYLE="white-space:nowrap">galectin-9</FONT> (blue circle) significantly reduced the observed percentage of cell death in a dose dependent manner. The IC<SUB STYLE="font-size:85%; vertical-align:bottom">50 for this assay is approximately 60&nbsp;nM <FONT
STYLE="white-space:nowrap">galectin-9.</FONT> This assay supports the desired and expected functional activity of <FONT STYLE="white-space:nowrap">LYT-200</FONT> in blocking <FONT STYLE="white-space:nowrap">galectin-9</FONT> interactions on T cells
which results in T cell apoptosis as </SUB></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">122</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
well as a broad ability of <FONT STYLE="white-space:nowrap">LYT-200</FONT> to intercept <FONT STYLE="white-space:nowrap">galectin-9</FONT> - receptor interactions, since T cell death does not
occur through interactions with CD206. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">LYT-200</FONT> Protects
<FONT STYLE="white-space:nowrap">MOLM-13</FONT> T Cells from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Galectin-9-Mediate</FONT></FONT> Apoptosis </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g92o50.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ortothopic KPC mouse model is commonly used as a preclinical model for evaluating PDAC biology and therapeutic agent
efficacy. Our academic collaborator previously showed that blocking <FONT STYLE="white-space:nowrap">galectin-9</FONT> with a murine <FONT STYLE="white-space:nowrap">galectin-9</FONT> antibody demonstrated significantly extended survival in a mouse
KPC pancreatic cancer model. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Anti-PD-1</FONT></FONT> checkpoint inhibitors have previously proven ineffective in this xenograft model. As noted previously, to further characterize the
potential of <FONT STYLE="white-space:nowrap">LYT-200,</FONT> we created a mouse <FONT STYLE="white-space:nowrap">LYT-200,</FONT> or <FONT STYLE="white-space:nowrap">mIgG1-200,</FONT> by cloning the antigen binding domain of <FONT
STYLE="white-space:nowrap">LYT-200</FONT> into a murine antibody backbone. We confirmed this observation of single agent activity in the KPC mouse pancreatic cancer model illustrated in the figure below. We have also combined <FONT
STYLE="white-space:nowrap">mIgG1-200</FONT> with the standard of care for pancreatic cancer, (e.g., chemotherapy, <FONT STYLE="white-space:nowrap">gemcitabine/nab-paclitaxel)</FONT> in the KPC model and shown that both as a single agent and in
combination, <FONT STYLE="white-space:nowrap">mIgG1-200</FONT> extends the life of mice bearing pancreatic cancer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">123</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">LYT-200</FONT> Mouse mAb Activity in Orthotopic Pancreatic
Cancer KPC Model </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g93j24.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also observed clear improvement in survival of these animals treated with
<FONT STYLE="white-space:nowrap">LYT-200</FONT> mouse mAb, indicated as <FONT STYLE="white-space:nowrap">anti-galectin-9,</FONT> versus controls (p=0.005), as illustrated in the figure below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Targeting <FONT STYLE="white-space:nowrap">Galectin-9</FONT> and Survival in KPC Pancreatic Cancer Mouse Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g94x67.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">124</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Effect of <FONT STYLE="white-space:nowrap">LYT-200</FONT> on Survival of Mice Implanted
with Orthotopic Pancreatic Tumors </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Kaplan Meier Survival Curve </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g95k03.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Group 1: Untreated; Group 4: <FONT STYLE="white-space:nowrap">mIgG1-200</FONT> (200mg); Group 5: gemcitabine (50 mg/kg)
plus Abraxane (15 mg/kg); Group 6: Combination of <FONT STYLE="white-space:nowrap">mIgG1-200</FONT> and gemicitabine+Abraxane at same doses. A significant survival benefit was delivered by treatment with
<FONT STYLE="white-space:nowrap">mIgG1-200</FONT> alone, compared to the untreated controls (Group 4 versus Group 1: Hazard Ratio (HR)=0.348, 95%CI= (0.146, 0.83), p=0.017). The combination treatment provided an additional survival benefit over
untreated animals (Group 6 vs Group 1: HR=0.336, 95% CI= (0.14, 0.806), p=0.015) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Cox Regression Analysis: Groups 4, 5 &amp; 6 against
Group 1 </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Group</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">P-value</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>HR</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>HR(95%CI)</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.017</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.348</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(0.146,&nbsp;0.83)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>5</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.262</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.624</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(0.274,&nbsp;1.422)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.336</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(0.14, 0.806)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also explored the activity of <FONT STYLE="white-space:nowrap">mIgG1-200</FONT> in a B16F10 melanoma mouse model, a model
commonly used to assess the activity of checkpoint inhibitors. <FONT STYLE="white-space:nowrap">mIgG1-200</FONT> reduced mean tumor weights by ~50&nbsp;percent while an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> antibody reduced mean tumor weights by ~22&nbsp;percent. We also observed that when an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> antibody was used in conjunction with <FONT STYLE="white-space:nowrap">mIgG1-200,</FONT> there was doubling of cytotoxic T cells in the tumor in the melanoma
model. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One of the major challenges in oncology research is the translation from mouse models to humans, particularly in the case of immuno-oncology. To
address this concern, we tested <FONT STYLE="white-space:nowrap">LYT-200</FONT> in PDOT cultures that mimic human tumor physiology and tumor microenvironment content. PDOTs are tumor excisions from primary and metastatic
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">125</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sites from pancreatic adenocarcinoma, or PDAC, CRC, CCA, hepatocellular carcinoma and neuroendocrine tumors of the GI tract. Since the immune system within the tumor microenvironment is
suppressed, the aim of treating PDOTs was to assess <FONT STYLE="white-space:nowrap">LYT-200&#146;s</FONT> ability to induce T cell activation which would indicate that <FONT STYLE="white-space:nowrap">LYT-200</FONT> could show activity in humans.
We observed that <FONT STYLE="white-space:nowrap">LYT-200</FONT> potently and reproducibly activated T cells in 56&nbsp;percent of the samples tested (n=23), which we believe is indicative of a potential high response rate in cancer types which have
currently been unresponsive to checkpoint blockade or where response rates do not surpass 20&nbsp;percent. The figure below depicts a patient derived organoid system. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Illustration of PDOT System </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g96n79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We established PDOTs from tumor tissues surgically excised from cancer patients. Organoids containing the tumor
microenvironment were processed by flow cytometry to establish the percentage of <FONT STYLE="white-space:nowrap">galectin-9</FONT> positive cells. We treated organoids containing the tumor microenvironment with
<FONT STYLE="white-space:nowrap">LYT-200</FONT> and measured biomarkers of T cell activation such as <FONT STYLE="white-space:nowrap">TNF-&#945;,</FONT> interferon <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT>, or
IFN<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT> and CD44. The figure below is an example of data from 23 human tumor organoid samples. Positive response in the organoid model was defined as an increase of more than 20&nbsp;percent in at least two
of three measured T cell activation markers, TNF&#945;, IFN<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT> and CD44. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Examples
of</B><B><I> in vitro</I></B><B> T Cell Activation with <FONT STYLE="white-space:nowrap">LYT-200</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g97b86.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GLP toxicology studies were carried out in Sprague Dawley rats and cynomolgus monkeys. No safety pharmacology findings
attributed to <FONT STYLE="white-space:nowrap">LYT-200</FONT> at doses as high as 300 mg/kg/week were observed in either species. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">126</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our Planned Clinical Development </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> study of <FONT STYLE="white-space:nowrap">LYT-200</FONT> is
intended to evaluate the safety, tolerability, PK and pharmacodynamics, or PD, and identify the recommended Phase 2 dose, or RP2D, for <FONT STYLE="white-space:nowrap">LYT-200</FONT> further evaluation as a single agent. This trial is being designed
to permit inclusion of relevant drug combinations with <FONT STYLE="white-space:nowrap">LYT-200</FONT> in an expansion cohort setting for the treatment of certain solid tumors, including CCA, CRC and pancreatic cancer. We expect to file an IND and
initiate this trial in the second half of 2020, with results anticipated in 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">LYT-200</FONT> Clinical Trial
Design </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our planned clinical trial of <FONT STYLE="white-space:nowrap">LYT-200</FONT> is a Phase 1 open label
<FONT STYLE="white-space:nowrap">non-randomized</FONT> clinical trial of <FONT STYLE="white-space:nowrap">LYT-200</FONT> alone or in combination with chemotherapy or an approved
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> agent in relapsed/refractory metastatic patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to
initiate a clinical trial under a dose escalation with dose expansion protocol as per recent FDA guidelines. The dose finding part of the study will be open to all comers, metastatic cancer patients with solid tumors who have failed previous lines
of treatment. We intend to identify an RP2D of <FONT STYLE="white-space:nowrap">LYT-200</FONT> for further evaluation as a single agent and evaluate the safety of the RP2D in combination with chemotherapy and an approved checkpoint inhibitor. After
the tolerability and RP2D have been determined, we plan to proceed with expansion cohorts in pancreatic cancer, CRC and CCA as <FONT STYLE="white-space:nowrap">pre-planned</FONT> expansion cohort tumor types. We also plan to allow subjects with
other tumor types to enroll in expansion cohorts as well based on the results from the dose finding part of the trial. In the expansion cohort, we plan to assess progression free survival benefit in pancreatic cancer and effect of potential tumor
shrinkage in CRC and CCA. Throughout the study we plan to collect tumor tissue samples through biopsies as well as patient blood samples. These will be used to measure <FONT STYLE="white-space:nowrap">galectin-9</FONT> levels as well as many other
immunological and tumor biomarkers that could help us further tailor the clinical trial and identify patients that we believe have highest likelihood to benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA and corresponding regulatory authorities will ultimately review our clinical results and determine whether our Wholly Owned product candidates are
safe and effective. No regulatory agency has made any such determination that <FONT STYLE="white-space:nowrap">LYT-200</FONT> is safe or effective for use by the general public for any indication. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">LYT-210:</FONT> Our
</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><B></B><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT><B></B><B>1 T Cell Focused Product Candidate Targeting Immunosuppressive and Pathogenic
</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><B></B><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT><B></B><B>1 T Cells for Immuno-Oncology </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">LYT-210</FONT> is a fully human IgG1 mAb directed against the <FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 chain of T cells bearing
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>T cell receptors, or TCRs, we are designing for antibody-dependent cell-mediated cytotoxicity and antibody-dependent cellular phagocytosis, or ADCP. Similar
to <FONT STYLE="white-space:nowrap">LYT-200,</FONT> we believe that <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells represent an important new immuno-oncology target because they: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Activate multiple immunosuppressive pathways; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Have expression correlated with poor outcomes for multiple solid tumor types; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Have preclinical evidence that showed improvement in survival in the KPC pancreatic cancer mouse model where
approved checkpoint inhibitors are ineffective. We have since obtained data with anti-<FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 antibodies in PDOT systems; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">While elevated in the context of cancer, have low expression under normal physiological conditions which
indicates a potential safety window; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Represent an attractive target; to our knowledge, there are no other companies developing a therapeutic candidate
targeting immunosuppressive and pathogenic <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We believe are an amenable target against which to generate a mAb. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Different T cell subtypes with the focus on</I><B> </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT><I>T
cells </I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under normal physiological conditions, most T cells express the
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> TCR, whereas <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells express the
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> TCR. <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>&nbsp;T&nbsp;cells are further classified based on <FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> chain class, either <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1, <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>2
or <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>3 T cells. In healthy individuals, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">127</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
most abundant <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells are&nbsp;<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>2, which are typically found in the blood and are cytotoxic by function.&nbsp;<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells can also be found in the
blood but in much smaller numbers in healthy people. <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells are also present in mucosal membranes and skin in healthy people. In cancer patients,
immunosuppressive <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells become more abundant in tumors and blood than
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>2 T cells and create an immunosuppressive tumor microenvironment, as illustrated on the left side of the figure
below.&nbsp;<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>2 T cell cytotoxic functions are being evaluated by others as adoptive T cell therapeutics in early stage trials which is different from our
approach of targeting immunosuppressive <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are
targeting depletion of immunosuppressive, tumorigenic <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells rather than administration of cytotoxic <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>2&nbsp;T cells as a cell therapy. <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1&nbsp;T cells execute potent immunosuppressive function&nbsp;via multiple
mechanisms, as illustrated on the left side of the figure below, which facilitates cancer progression. We are designing <FONT STYLE="white-space:nowrap">LYT-210</FONT> to eliminate&nbsp;<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells, and thereby potentially relieve immunosuppression, which we believe could enable immune mediated cancer attack. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g98z25.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">128</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Elevated numbers of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1&nbsp;T cells have been observed in many cancer types, including but not limited to primary and metastatic breast, ovarian, colon and pancreatic cancers.
This T cell population promotes tumor growth through active suppression of anti-tumor immune responses. <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1&nbsp;T&nbsp;cells isolated from human tumors have
been shown to suppress naive and&nbsp;memory T cell effector functions, quell cancer cell cytotoxic activity of <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>2&nbsp;T&nbsp;cells, recruit tumor
infiltration of immune-suppressive macrophages, or tumor associated macrophages, or TAMS, and MDSCs, as well as inhibit antigen presentation activity of dendritic cells, or DCs. The figure below illustrates the impact of <FONT
STYLE="white-space:nowrap">pro-tumorigenic</FONT> <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells on tumor progression. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g43p64.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Image adapted from CellPress: REVIEW:
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T Cells: Unexpected Regulators of Cancer Development and Progression. DC = dendritic cell; TAM = tumor associated macrophage; MDSC = myeloid derived
suppressor cell; IL17 = interleukin 17 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The figure below demonstrates the presence of immunosuppressive <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells in patients with pancreatic adenocarcinoma. These cells are enriched in peripheral blood and expression of immunosuppression-related molecules on the <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cell surface is significantly increased, while the expression of killing function-related molecules and the activation of killing function-related signaling pathway in the
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>2 T cells are significantly decreased. In human cancers, <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T
cells infiltrate the tumor microenvironment and can be detected using IHC or flow cytometry as shown in the figure below. Frozen sections of human PDA and normal pancreas were stained using a mAb specific for TCR
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> or isotype control. Representative images and quantitative data are shown. The figure demonstrates that pancreatic cancers are enriched intratumorally for <FONT
STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells compared to normal pancreatic tissue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">129</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><B></B><B></B><FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT><B></B><B>1 T Cell Infiltration of Tumor Microenvironment </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g22w29.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Preclinical Results for Immuno-Oncology Indications </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Similar to <FONT STYLE="white-space:nowrap">LYT-200,</FONT> to better assess the potential activity of anti-<FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1
antibodies, we employed PDOTs from primary and metastatic tumors spanning various checkpoint inhibitor insensitive solid tumor types such as pancreatic, colorectal, cholangiocarcinoma, hepatocellular cancer and neuroendocrine tumors of the GI tract
in order to assess the prevalence of tumor-infiltrating <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells and the capacity of the antibodies to restore tumor-infiltrating immune cell effector
activity. Positive response in the organoid model is measured by an increase of more than 20&nbsp;percent in at least two out of three T cell activation markers. We observed positive response in approximately 63&nbsp;percent of the PDOTs we
analyzed, representing 30 patients, which we believe shows the potential of the approach to reactivate immunosuppressed T cells in the tumor microenvironment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The figure below is illustrative of data collected from 30 human tumor organoid samples from CRC and pancreatic cancer patients. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Examples of</B><B><I> in vitro</I></B><B> T Cell Activation with Antibodies Against
</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><B></B><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT><B></B><B>1 T Cells </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g68105g59m99.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g68105g35g68.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to assess the relevance of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells in the development and progression of pancreatic cancer, we assessed the survival of immunocompetent mice which have
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells (wild type) or mice which are knock outs for <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells in
a KPC mouse pancreatic model. In addition, there was an additional group of wild type mice treated with an antibody, <FONT STYLE="white-space:nowrap">UC3-10A6,</FONT> which functionally blocks immunosuppressive mouse
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As shown in the figure below, when pancreatic
cancers grow in the absence of <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells, represented by the red curve, or when mice with pancreatic cancer were treated with an antibody against
immunosuppressive <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells, represented by the grey curve, survival was greatly increased. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">130</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pancreatic Cancer Mouse Survival with
</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><B></B><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT><B></B><B> T Cell Depletion and Blockage </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g40n31.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to validate and expand these findings, we compared the growth of syngeneic subcutaneous melanoma, or B16F10, and
lung cancers in mouse strains with <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells (wild type) or without
<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells (<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> null) and evaluated the activity of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> and anti-CTLA4 mAbs within these groups. The results of these experiments showed increased anti-tumor activity of checkpoint blockade therapy in the absence of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to advance additional preclinical and biomarker
studies for <FONT STYLE="white-space:nowrap">LYT-210</FONT> in 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">LYT-210</FONT> for Autoimmune Disease:
Mucosa-infiltrating Pathogenic </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT><I>1 T cells </I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intraepithelial lymphocytes expressing <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 TCRs are tissue-resident T
cells that play a key role in homeostasis of the intestinal epithelium. It has been recently observed that chronic inflammation can permanently reconfigure the tissue-resident T cell compartment resulting in the repopulation of the GI mucosa with
pathogenic and cytotoxic <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1 T cells. Establishment of pathogenic <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>1
T cells along the GI tract tilts the gut environment towards a chronic inflammatory state, contributing to the pathophysiology of GI tract and inflammatory diseases, such as refractory celiac disease. We plan to conduct preclinical studies in animal
models of inflammatory diseases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA and corresponding regulatory authorities will ultimately review our clinical results and determine whether our
Wholly Owned product candidates are safe and effective. No regulatory agency has made any such determination that <FONT STYLE="white-space:nowrap">LYT-210</FONT> is safe or effective for use by the general public for any indication. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">LYT-300:</FONT> Oral Allopregnanolone in Development to Treat a Range of Neurological and Neuropsychological Conditions
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The CNS comprises an extensive and immensely complex framework made up of a multitude of cells that support its essential function of signaling and
transmitting information&#151;predominantly carried out by neurons. With billions of neurons within the CNS, this communication across the complex network is achieved by means of neurotransmitters that enable signals to be transferred at junctions
between neurons, or synapses. These signals transmitted between neurons might be inhibitory, excitatory or modulatory as it relates to the desired function to be achieved. Neurotransmitters communicate information between neurons via receptors that
are exquisitely designed for transmission of information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The major inhibitory neurotransmitter in the brain is gamma aminobutyric acid, or GABA, which
decreases activity in the nervous system and essential for maintaining normal physiological function. One of its modes of action is via the GABA<SUB STYLE="font-size:85%; vertical-align:bottom">A</SUB> receptor that is found on the membrane of
neurons. These receptors have also been </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">131</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
found on the membranes of immune cells suggesting a role for this biology across the Brain-Immune interface. GABA<SUB STYLE="font-size:85%; vertical-align:bottom">A</SUB> receptors play a
critical role in biology and their modulation has been the subject of several therapeutic efforts with the goal of having an impact across a range of neurological disorders. However, concerns around safety, challenging dosing regimens, and PK
limitations have hampered the development of meaningful drug candidates. Neurosteroids are a class of endogenous natural small molecules that play a crucial role in modulating neurotransmission. Importantly, as it relates to GABA<SUB
STYLE="font-size:85%; vertical-align:bottom">A</SUB> receptors, the neurosteroid allopregnanolone&#151;a positive allosteric modulator, through its action via the synaptic and extra-synaptic receptors&#151;is capable of having a profound impact on
GABA<SUB STYLE="font-size:85%; vertical-align:bottom">A</SUB> signaling. These compounds display significantly improved selectivity and capacity for modulation at these crucial sites, which might enable overcoming the challenges faced by approaches
that have been developed to date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Allopregnanolone, and neurosteroids in general as a class of potent endogenous natural small molecules, have been
recognized over the past three decades for their therapeutic potential to treat a range of neurological and neuropsychological conditions such as epileptic disorders, fragile X syndrome, fragile X tremor-associated syndrome, anxiety, depression,
essential tremor, and sleep disorders, among others. The major hurdles associated with the translation of these compounds have been: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The inability to create an oral formulation due to first pass metabolism by the liver </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The inability to administer them chronically to patients &#150; essential for treating CNS disorders
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The recent approval of Zulresso, a 60 hour IV infusion to treat post-partum depression, speaks to the challenges that limit the scope
of translation of this class of compounds to treat neurological and neuropsychological disorders. An oral form of alloprognanolone and other neurosteroids would enable the development of these natural molecules for treating a range of neurological
and neuropsychological conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inspired by the natural trafficking of fats via the lymphatics at the
<FONT STYLE="white-space:nowrap">gut-immune</FONT> interface, we have developed an oral lipid-prodrug version of allopregnanolone. By trafficking via the lymphatics, we are able to overcome the first pass metabolism by the liver and achieve
significant oral bioavailability of endogenous allopregnanolone in preclinical models. By utilizing our versatile small molecule lymphatic trafficking chemistry platform, we designed a multitude of lipid-prodrug molecules to control lymphatic
trafficking, systemic release, and hence oral bioavailability of the active endogenous compound. Importantly, by harnessing this approach we have developed a version of allopregnanolone that can be administered chronically to patients to treat a
range of neurological and neuropsychological conditions and built a robust intellectual property portfolio that enables protection of our proprietary composition of matter. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Preclinical Results </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We created a library of lipid
prodrugs of allopregnanolone and showed that orally dosing these prodrugs achieved therapeutically relevant plasma levels in small and large animal models. These studies, coupled with our other preclinical studies, support the possible utility of
this approach for converting natural allopregnanolone into an orally-dosed drug as well as for numerous other potential therapeutics with intrinsic hepatic metabolism liabilities and oral absorption limitations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We measured plasma levels of allopregnanolone after oral administration of lymphatic targeting prodrug of allopregnanolone or unmodified allopregnanolone in
preclinical models of dogs and <FONT STYLE="white-space:nowrap">non-human</FONT> primates. Male cynomolgus monkeys (figure below on the left) or dogs (figure on the right) were fed a standardized diet prior to drug administration. The figure below
shows dose-normalized blood concentration of free allopregnanolone over time in monkeys (n = 6) and dogs (n = 4) after oral administration of lipid prodrug compound in comparison with orally-administered allopregnanolone (error bars represent
standard error of measurement). Apparent bioavailability of free allopregnanolone versus intravenous, or IV, was calculated to be over 30&nbsp;percent in both species. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">132</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Allopregnanolone Oral Exposure </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g68105g01z16.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g68105g62g98.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This plasma exposure increase was confirmed to be due to lymphatic uptake. In the figure below, total allopregnanolone
concentration (including free and prodrug-associated) was measured in the mesenteric lymph duct of anaesthetized rodents following intraduodenal infusion of prodrug (n = 3) or parent allopregnanolone (n&nbsp;=&nbsp;2). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Allopregnanolone Lymphatic Uptake </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g37a85.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No drug-related adverse effects have been noted in preclinical studies to date. Formal safety studies are being pursued as
a part of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human-enabling</FONT></FONT> package of studies. To support these studies, dose escalation studies have been performed on rat and dog and dose proportionality
has been observed in both species. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our Planned Clinical Development </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The initial objective of the <FONT STYLE="white-space:nowrap">LYT-300</FONT> clinical program is to characterize the safety, tolerability, and PK behavior of
orally administered <FONT STYLE="white-space:nowrap">LYT-300</FONT> in a Phase 1 clinical trial in healthy volunteers. We expect to initiate a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical
study by the end of 2021. These studies may include exploratory endpoints such as beta wave power electroencephalography, or &szlig;-EEG, a marker of GABA<SUB STYLE="font-size:85%; vertical-align:bottom">A</SUB> target engagement. Data from these
initial studies will be used to define a range of future studies and planned indications, which could include those discussed in the above section on unmet needs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">133</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Discovery Platforms: Our Platforms Leveraging the Absorption of Dietary Lipids to Traffic Therapeutics Via
the Lymphatic System</B><B><I> </I></B><B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to our internal product candidates described above, we have two platforms designed to harness
the lymphatic system functions for immunology, oncology and CNS indications in discovery as discussed below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given our interest in the lymphatic system,
we sought out different approaches that could be taken to selectively traffic therapeutic molecules through the lymphatic system to target immune cells in the lymph nodes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Glyph<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>: Lymphatic Targeting Chemistry Platform </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are developing a synthetic lymphatic-targeting chemistry platform called Glyph, which employs the body&#146;s natural lipid absorption and transport process
to orally administer drugs via the lymphatic system. Consumed nutrients and orally-administered pharmaceuticals are initially absorbed by the small intestine mucosa, distributed to the liver by the portal vein before entering systemic circulation.
Importantly, many consumed dietary lipids, particularly triglycerides, enter systemic circulation by an alternate route. Triglycerides, which are composed of three fatty acid chains tethered to a <FONT STYLE="white-space:nowrap">3-carbon</FONT>
glycerol molecule, are absorbed by small intestine mucosal enterocytes where they are incorporated into large lipid-protein complexes, or chylomicrons, and released into the submucosa. Chylomicrons are too large to enter blood vessels and are
instead taken up by submucosal lymphatic vessels. Once in the lymphatic vessels, they are transported to mesenteric lymph nodes associated with the GI tract where they pass into larger lymphatic sinuses connected to the thoracic duct, then
transition to systemic circulation as illustrated in the figure below. This is in contrast to conventional systemic circulation via the gut and liver as shown in the figure below on the left. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Conventional Drug Circulation versus Lymphatic Systemic Circulation </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g08l96.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe this platform provides the following capabilities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Targeting the mesenteric lymph nodes</I>. This lymphatic targeting technology has important features
potentially offering meaningful advantages in the creation of orally-administered medicines, especially those that need to reach immune system drug targets present in the GI tract mucosa and submucosa, such as intestine-associated immune cells, or
in the mesenteric lymphatic vasculature, such as circulating immune cells, and mesenteric lymph nodes, such as lymph node stromal cells, antigen-presenting DCs and lymph node-associated immune cells. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Enhancing oral <FONT STYLE="white-space:nowrap">bio-availability</FONT> by bypassing first-pass
metabolism</I>. We believe this technology could provide a broadly applicable modular means to significantly enhance the bioavailability of orally-administered drugs that suffer from substantial first-pass liver metabolism or those drugs, especially
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">134</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
those utilized in drug combination therapies, that act as modulators (inducers and/or inhibitors) of drug-metabolizing systems in the liver. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have successfully extended our lymphatic targeting platform to encompass more than 20 molecules as well as a range of novel linker chemistries that have
demonstrated promising lymphatic targeting in preclinical studies. We expect to select product candidates from this and ongoing discovery work. In April 2019, we announced an alliance with Boehringer Ingelheim, which is initially focused on
evaluating the feasibility of applying our Glyph technology platform to one of its immuno-oncology product candidates. We retain all other applications of this technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our proprietary Glyph technology platform takes advantage of the fact that one of the triglyceride-associated fatty acids remains bound to dietary lipids
during intestinal absorption, chylomicron conversion, lymphatic vessel uptake and eventual transport into the circulatory system. Using a modular set of proprietary chemical entities, small molecule pharmaceutical compounds can be docked to
triglycerides where, following oral administration, the small molecule is directed into the mesenteric lymphatic system and on to systemic circulation. The point of original small molecule release from the triglyceride is governed by self-cleaving
chemical structures, with different release-timing features, that tether the small molecule to the module connected to the triglyceride. The figure below is a representation of the proprietary chemistry for the design of our lymphatic targeting
technology. The active pharmaceutical ingredient, or API, is meant to indicate an example of a pharmaceutical small molecule that is attached to the triglyceride, or Glyceride in the figure below, group using proprietary linker chemistry, or Linker
in the figure below, to create a prodrug of the API. The prodrug also includes a proprietary self-immolative or cleaving chemistry, or SI in the figure below, that can be tuned to release the API in its intact original form. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schematic Representation of Our Lymphatic Targeting Prodrug Technology </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g89r46.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Earlier efforts by scientists to create lipid-like prodrugs used strategies that coupled the small molecule drug directly
with a single fatty acid, which cannot be packaged by the GI into lymph-bound chylomicrons and therefore does not facilitate transport to the mesenteric lymph nodes. The figure below demonstrates our lymphatic targeting prodrugs, marked PTH Prodrug
in the figure below, demonstrated five-fold improved lymph transport as compared to conventional single fatty acid prodrugs, marked prodrug A through C in the figure below, or unmodified mycophenolic acid, or MPA, an immune-suppressive agent widely
used in solid organ transplant rejection therapy and the treatment of lupus autoimmunity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">135</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Lymphatic Uptake of Our Prodrug </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g89e29.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Targeting the Mesenteric Lymph Nodes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To demonstrate the mesenteric lymphatic targeting capability of the platform, prodrugs were created from MPA. Preclinical studies in rodent models conducted by
our collaborator and <FONT STYLE="white-space:nowrap">co-inventor,</FONT> which were independently repeated by us, demonstrated that lipid prodrugs of MPA were capable of achieving MPA concentrations in mesenteric lymph, mesenteric lymph nodes and
in mesenteric lymph node immune cells that were ten to <FONT STYLE="white-space:nowrap">100-fold</FONT> higher than observed with unmodified MPA. The figures below show the level of released MPA measured in lymph nodes (left) or lymphocytes within
mesenteric lymph fluid (right) at the time periods indicated following small intestine administration of MPA or MPA lipid prodrugs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">136</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the figure on the left below, dose-normalized MPA concentration in mesenteric lymph nodes following
intraduodenal infusion (over two hours) of MPA or MPA prodrug to anaesthetized, mesenteric lymph-duct intact rats (n = 3 for each time point, each drug). Our modified prodrug had a <FONT STYLE="white-space:nowrap">ten-fold</FONT> higher exposure as
calculated by area under the curve, or AUC, over eight hours. The panel on the right depicts dose-normalized mass of MPA and MPA derivatives in lymphocyte pellets separated from hourly collected mesenteric lymph samples following intraduodenal
infusion of formulations containing MPA or MPA prodrugs (PTH Prodrug). The measured prodrug was over <FONT STYLE="white-space:nowrap">100-fold</FONT> higher than free drug over the four-hour experiment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Drug Concentration With and Without Our Prodrug </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Measured in Lymph Nodes and in Lymph Fluids </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g68105g13o50.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g68105g78a08.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Enhancing Oral <FONT STYLE="white-space:nowrap">Bio-Availability</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As noted above, we believe this platform provides a broadly-applicable modular approach to enhance the bioavailability of orally-administered drugs that suffer
from substantial first-pass liver metabolism. To demonstrate the utility of our lipid prodrug platform in such cases, we chose allopregnanolone as the subject of our inquiry, which has resulted in the <FONT STYLE="white-space:nowrap">LYT-300</FONT>
program. However, this benefit can potentially be widely applied to nearly any therapeutic compatible with the synthetic approach which suffers from hepatic first-pass metabolism as has been shown by us and our collaborators with compounds such as
testosterone, buprenorphine, and multiple cannabinoids. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Orasome<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> Technology Platform: Designing
a Programmable and Scalable Approach for Oral Administration of Nucleic Acids and Other Biologics </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are developing a versatile and programmable oral
biotherapeutics platform, Orasome<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>, to enable administration of macromolecule therapeutic payloads, including antisense oligonucleotides, short interfering RNA, mRNA, modular expression vector
systems, peptides and nanoparticles that are otherwise administered exclusively by injection. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">137</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The figure below depicts the administration of oral biotherapeutics: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g21s21.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Orasome technology platform was inspired by the <I>in vivo</I> trafficking of ubiquitous, naturally occurring vesicles,
which are often referred to as exosomes, and we have engineered them for transport through the gastro-intestinal tract. Exosomes are a type of extracellular vesicle approximately ranging from 50nm to 150nm in diameter that are produced in the
endosomal compartment and secreted from most types of eukaryotic cells. We believe human cell-derived exosomes have attractive promise as vehicles for systemic drug delivery due to their likely observed tolerability over synthetic polymer-based
delivery technologies. However, the fragile nature of exosomes derived from human cells limits their usage for oral administration and the type of post-isolation manipulations that can be applied in order to optimize such vesicles for exogenous drug
cargo loading and storage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Orasome technology platform utilizes multiple vesicle components, including those isolated from milk. We have engineered
these vesicles, building on the naturally evolved architecture in mammals, to remain stable following oral consumption and transit through the upper GI tract. Orasome vesicles are readily amenable to manufacturing at scale and relatively low cost
based on the easily accessible and engineerable components. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our proprietary Orasome technology platform has the potential to transform the treatment
paradigm for diseases, such as rheumatoid arthritis, other autoimmune diseases, diabetes and cancer for which the standard of care often requires intravenous infusion or subcutaneous injection of monoclonal antibodies (e.g., anti-programmed <FONT
STYLE="white-space:nowrap">death-1,</FONT> anti-tumor necrosis factor) or therapeutic proteins/peptides <I>(e.g.</I>, glucagon-like <FONT STYLE="white-space:nowrap">peptide-1,</FONT> insulin, granulocyte colony-stimulating factor GCSF, Factor VIII
and IX, cytokines and erythropoietin, among others. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Orasome vesicles are currently constructed to transport macromolecular medicines to selected
mucosal cell types of the intestinal tract where the therapeutics act either directly in the GI tract, transit through the mucosa to the underlying lymphatic vascular network or, in the case of cargos that yield mRNAs, enable the body to produce its
own therapeutic proteins and peptides, such as antibodies within mucosal cells that are secreted into the mucosal lymphatic vascular network for subsequent systemic distribution. Using our Orasome technology platform, we believe it may be possible
for a patient to take an oral drug product that will permit their own GI tract cells to make virtually any type of therapeutic protein. We believe this approach also has the potential to provide a more convenient and significantly less expensive
means to deliver biological medicines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Within the context of the current <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, we believe our
Orasome technology platform has the potential to support oral administration of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-SARS-CoV-2</FONT></FONT> monoclonal antibodies or antibody combinations and vaccines to supply
passive immune therapies for infected individuals and passive immune protection for health care and first responder professionals. Thus, whether combating emerging epidemic/pandemic pathogens or other diseases where monoclonal antibody therapeutics
or vaccines offer significant clinical benefit, we believe our Orasome technology platform has the potential to transform the treatment of a range of clinical indications, while also lowering costs and simplifying administration of such
biotherapeutics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect preclinical <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> data in the
second half of 2020 and anticipates results from a <FONT STYLE="white-space:nowrap">non-human</FONT> primate <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> study in 2021. The <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> studies are designed to document the presence of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">138</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
therapeutic serum levels of biotherapeutics (peptides and proteins, such as antibodies) produced by the body following the oral administration designer payloads. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This work could lay the foundation for <FONT STYLE="white-space:nowrap">IND-enabling</FONT> clinical studies for one or more additional product candidates to
be included in our Wholly Owned Pipeline. We intend to leverage our proprietary technology platforms, as well as our extensive network with major pharmaceutical companies and world-leading scientists in immunology and lymphatics, to generate
additional novel product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Founded Entities&#146; Product Candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below summarizes the programs of our Founded Entities. We established the underlying programs and platforms that have resulted in the product
candidates being developed by our Founded Entities and advanced them through key validation points. Each of their product candidates targets indications related to one or more of the BIG systems, and any value we realize from these product
candidates will be through the potential growth and realization of equity and royalty stakes highlighted in the table below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">139</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hold majority voting control of our Controlled Founded Entities and continue to play a role in the
development of their product candidates, through representation on their board of directors, with respect to Follica, Vedanta, Alivio and Sonde. Our board designees represent a majority of the members of the board of directors of Follica, Vedanta
and Alivio and a minority of the members of the board of directors of Sonde. With respect to our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities, we do not hold majority equity ownership and are not responsible for
development or commercialization of their product candidates and <FONT STYLE="white-space:nowrap">FDA-cleared</FONT> products. Our <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities have independent management teams, and we do
not control the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> development of their respective product candidates. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g15b77.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Relevant ownership interests for Founded Entities were calculated on a diluted basis (as opposed to a voting
basis) as of June 30, 2020, including outstanding shares, options and warrants, but excluding unallocated shares authorized to be issued pursuant to equity incentive plans. Ownership of Vor is based on the assumption that all future tranches of the
most recent financing round are funded. Karuna ownership is calculated on an outstanding voting share basis as of August 26, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">R</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">PureTech Health has a right to royalty payments as a percentage of net sales. For a description of these
agreements, see &#147;Business Overview.&#148; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">140</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of these underlying programs and platforms across our Founded Entities were initially identified or
discovered and then advanced by our team through key validation points before being further developed by each respective Founded Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Founded
Entities are described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Founded Entities in which PureTech has a Controlling Interest or the Right to Receive Royalties, in Order of
Development Stage </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gelesis </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis is
developing oral therapeutics based on a novel, superabsorbent hydrogel technology platform to treat obesity and other chronic diseases related to the GI pathway. Gelesis&#146; proprietary approach is designed to act mechanically in the GI pathway to
potentially alter the course of chronic diseases. In April 2019, Gelesis received clearance from the FDA for its first product, Plenity<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (Gelesis100), an aid for weight management in adults
with a body mass index, or BMI, of <FONT STYLE="white-space:nowrap">25-40</FONT> kg/m<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>, when used in conjunction with diet and exercise. In June 2020, Gelesis received a CE Mark for Plenity as a
class III medical device indicated for weight loss in overweight and obese adults with a Body Mass Index, or BMI, of <FONT STYLE="white-space:nowrap">25-40</FONT> kg/m<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>, when used in conjunction
with diet and exercise, which allows Gelesis to market Plenity throughout the European Economic Area and in other countries that recognize the CE Mark. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given challenges associated with pharmacological and invasive surgical treatments for obesity, Gelesis designed an approach with an oral, <FONT
STYLE="white-space:nowrap">non-invasive,</FONT> <FONT STYLE="white-space:nowrap">non-systemic</FONT> mechanism of action and a highly favorable safety and efficacy profile. Gelesis&#146; product candidates work in the GI tract and pass through the
body without being absorbed. They are synthesized from two naturally derived building blocks (citric acid and cellulose) that form a novel, patent-protected three-dimensional structural composition and occupies volume in the stomach and small
intestine to promote satiety and fullness. Because Gelesis&#146; technology acts mechanically and is not systemically absorbed, the product candidates are treated as devices for regulatory approval purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis was incorporated in February 2006. The following chart summarizes Gelesis&#146; product and product candidates: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g37c32.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">141</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Important Safety Information: Plenity is contraindicated in patients who are pregnant or are allergic to
cellulose, citric acid, sodium stearyl fumarate, gelatin, or titanium dioxide. Plenity may alter the absorption of medications. Read Sections 6 and 8.3 of the Instructions for Use carefully. Avoid use in patients with the following conditions:
esophageal anatomic anomalies, including webs, diverticuli, and rings; suspected strictures (such as patients with Crohn&#146;s disease); or complications from prior GI surgery that could affect GI transit and motility. Use with caution in patients
with active GI conditions such as GERD, ulcers or heartburn. The overall incidence of AEs in the Plenity group was no different than the placebo group. The most common side effects were diarrhea, distended abdomen, infrequent bowel movements, and
flatulence. For the safe and proper use of Plenity, refer to&nbsp;U.S. Instructions for Use&nbsp;or the&nbsp;EU Instructions for Use. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Products are investigational and have not been cleared by the FDA for use in the United States.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">***</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Contingent of FDA review of the research plan. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Program Discovery Process by the PureTech Team </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were
interested in creating an effective and safe therapy for obesity given the tremendous need, significant health implications and failure of prior approaches to effectively engage and serve the breadth of the population affected. We consulted with
leading obesity experts to brainstorm on the characteristics of an ideal approach, which we decided was an orally-administered mechanically acting device, and we then conducted a worldwide search for compelling technologies meeting these criteria.
We identified and <FONT STYLE="white-space:nowrap">in-licensed</FONT> the core intellectual property from one of our academic collaborators in October 2008, and we subsequently <FONT STYLE="white-space:nowrap">co-invented</FONT> additional
intellectual property around a novel class of biocompatible, superabsorbent hydrogels. One of the core PureTech team members involved in the initial identification and development process subsequently assumed the role of chief executive officer of
Gelesis, and successfully attracted financing and built a strong development and commercial leadership team. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Gelesis advisory team is comprised of
leading experts in obesity and its related comorbidities, clinical research and development and advanced biomaterials, including Caroline Apovian, M.D., professor of Medicine and Pediatrics at Boston University School of Medicine; Louis J. Aronne,
M.D., FACP, director of the Comprehensive Weight Control Program at Weill Cornell Medicine; Arne Astrup, M.D., head of department of Nutrition, Exercise and Sports at University of Copenhagen; Ken Fujioka, M.D., director of the Nutrition and
Metabolic Research Center and the Center for Weight Management at the Scripps Clinic; James Hill, Ph.D., chairman, Department of Nutrition Sciences, director, Nutrition Obesity Research Center, University of Alabama; professor of Medicine and
Pediatrics, University of Colorado; Lee M. Kaplan, M.D., Ph.D., Director of the Obesity, Metabolism and Nutrition Institute at Massachusetts General Hospital; Bennett Shapiro, M.D., <FONT STYLE="white-space:nowrap">co-founder</FONT> and <FONT
STYLE="white-space:nowrap">non-executive</FONT> director at PureTech and former Executive Vice President of Research for Merck; and Angelo Tremblay, Ph.D., professor at Laval University. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Patient Need and Market Potential </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Excess weight is
growing rapidly in prevalence worldwide, with approximately 70&nbsp;percent of American adults struggling with overweight and obesity. Globally there are more than 1.9&nbsp;billion adults 18 years of age or older who are overweight and
600&nbsp;million who have obesity. Obesity-related conditions, such as heart disease, stroke, type 2 diabetes, NASH/NAFLD and certain types of cancer, are some of the leading causes of preventable death. Functional constipation and NASH/NAFLD affect
approximately 35&nbsp;million and 80 to 100&nbsp;million individuals, respectively, in the United States. Type 2 diabetes and prediabetes affect approximately 30&nbsp;million and 84&nbsp;million individuals, respectively, in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Current treatments for overweight and obese patients begin with lifestyle modification, such as diet and exercise. When healthy eating and physical activity
fail to produce the desired results, physicians may consider pharmaceutical therapies, device implantation or surgical treatments, such as gastric bypass and gastric banding (for patients with more severe obesity). These approaches are associated
with safety concerns, lifestyle impact, complexity of use, high cost and compliance issues that have limited their adoption. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">142</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development Status </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis received clearance from the FDA to market and sell its lead product Plenity as an aid for weight management in adults with a BMI of <FONT
STYLE="white-space:nowrap">25-40&nbsp;kg/m</FONT><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>, when used in conjunction with diet and exercise. Plenity is <FONT STYLE="white-space:nowrap">FDA-cleared</FONT> for the largest number of adults
struggling with overweight and obesity of any prescription weight-management aid and the only prescription weight management product to be cleared for use by overweight adults with a BMI as low as 25&nbsp;kg/m<SUP
STYLE="font-size:85%; vertical-align:top">2</SUP>, with or without comorbidities. Nearly 150&nbsp;million adults with excess weight in the United States fall within the BMI range included in the Plenity label. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis also received a CE Mark for Plenity as a class III medical device indicated for weight loss in overweight and obese adults with a Body Mass Index
(BMI) of <FONT STYLE="white-space:nowrap">25-40</FONT> kg/m<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>, when used in conjunction with diet and exercise. Gelesis will now be able to market Plenity throughout the European Economic Area and
in other countries that recognize the CE Mark. Gelesis plans to bring Plenity to the U.S. first, where it is now available to a limited extent while the company ramps up its commercial operations and inventory for a full launch in 2021. Gelesis also
plans to seek FDA input on the requirements for expanding the Plenity label for treating adolescents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis has a&nbsp;partnership with Ro,
a&nbsp;leading U.S. telehealth provider, to support the U.S. commercialization of Plenity. Gelesis also has a partnership with China Medical Systems Holdings Ltd., or CMS, for the commercialization of Plenty in China. Through the terms of the deal,
CMS will provide $35&nbsp;million upfront in a combination of licensing fees and equity investment, with the potential for an additional $388&nbsp;million in future milestone payments as well as royalties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Plenity was evaluated in a multicenter, double-blind, placebo-controlled pivotal study designed to assess change in body weight in 436 adults with overweight
or obesity (BMI&nbsp;<FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>&nbsp;27 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>&nbsp;40&nbsp;kg/m<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>) after six months of treatment. The study had two
predefined <FONT STYLE="white-space:nowrap">co-primary</FONT> endpoints: at least 35&nbsp;percent of patients taking Plenity achieving more than five percent weight loss (categorical endpoint) and placebo-adjusted weight loss with a
super-superiority margin of three percent. In addition, a prespecified analysis of simple superiority was also performed. The study met and exceeded the predefined categorical endpoint, with 59&nbsp;percent of adults in the treatment group achieving
weight loss of five percent or greater and losing on average 10&nbsp;percent of their weight (22&nbsp;pounds) and 3.5&nbsp;inches from their waists within six months. The study did not meet the three percent super-superiority endpoint but
demonstrated superiority of the Plenity treatment over the placebo group (&#150;6.4&nbsp;percent vs. &#150;4.4&nbsp;percent, P=0.0007). Plenity-treated individuals had twice the odds of achieving at least five percent weight loss as compared to
placebo (adjusted odds ratio:&nbsp;2.0,<I> </I>P=0.0008). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, 26&nbsp;percent of the adults who completed the treatment with Plenity were
&#147;super-responders,&#148; defined as achieving at least ten percent weight loss. These super-responders achieved an average of about 14&nbsp;percent weight loss or approximately 30&nbsp;pounds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The overall incidence of AEs in the Plenity treatment group was no different than placebo. The most common treatment related adverse events, or TRAEs, were GI
disorders (158 TRAEs in 84 (38&nbsp;percent) subjects in the Plenity arm, compared to 105 events in 58 (28&nbsp;percent) subjects receiving placebo), infections and infestations (two events in two (one percent) subjects with Plenity and one events
in one (one percent) subjects with placebo), and musculoskeletal and connective tissue disorders (three events in two (one percent) subjects with Plenity and 0&nbsp;in&nbsp;0 (0&nbsp;percent) subjects with placebo). There were no SAEs in the Plenity
treatment group, whereas there was one SAE in the placebo treatment group. For the safe and proper use of Plenity, refer to the Instructions for Use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
2020, Gelesis expects to initiate a Phase 2 study of GS300 in NASH/NAFLD and a Phase 3 study of GS500 in functional constipation. A pilot study of 40 individuals showed that a prototype of GS500 demonstrated a significant reduction in colonic
transit time, or CTT, in patients with functional constipation by approximately 16&nbsp;hours (approximately 31&nbsp;percent) compared to baseline (P=0.02 compared to placebo). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2021, Gelesis expects topline results from a Phase 2 study of Gelesis200 in weight management and glycemic control in adults with type 2 diabetes and
prediabetes. Data from a pilot study of Gelesis200 demonstrated that administration of Gelesis200 ten minutes prior to a meal increased fullness throughout the entire day (P=0.012). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">143</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis&#146; completed and ongoing studies have been approved by the applicable reviewing IRBs as
nonsignificant risk device studies. Gelesis also has ongoing discovery efforts to expand its pipeline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board designees represent a minority of the
members of the board of directors of Gelesis, and we do not control the clinical or regulatory development or commercialization of Gelesis&#146; products and product candidates. We have an interest in Gelesis&#146; product candidates through our
equity investment as well as our right to royalty payments as a percentage of net sales pursuant to a license agreement between us and Gelesis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Karuna </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna is developing novel therapies with
the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, including schizophrenia and dementia-related psychosis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KarXT combines xanomeline, a muscarinic receptor agonist that has demonstrated decreases in multiple psychotic symptoms and improvements in cognitive symptoms
in placebo-controlled human trials in schizophrenia and AD, and trospium chloride as further described below, an FDA approved and well-established muscarinic receptor antagonist that has been shown not to measurably cross the blood-brain barrier.
KarXT is designed to preferentially stimulate M1/M4 muscarinic receptors in the brain without stimulating muscarinic receptors in peripheral tissues in order to achieve meaningful therapeutic benefit in patients with psychotic and cognitive
disorders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Xanomeline was previously studied by Eli Lilly and Company, or Eli Lilly, in randomized, double-blind, placebo-controlled trials in
schizophrenia with acute psychosis and AD, demonstrating dose-dependent decreases in multiple psychotic symptoms and related behaviors, including hallucinations, delusions and agitation, as compared to patients on placebo in the treatment of
psychosis and improvements in symptoms as measured by both the Alzheimer&#146;s Disease Assessment Scale-Cognitive Subscale and the Clinician Interview-Based Impression of Change plus caregiver interview standards. To our knowledge, xanomeline is
the only muscarinic agonist that has demonstrated potential therapeutic benefit in humans in either schizophrenia or AD. Like all muscarinic receptor agonists studied to date, however, xanomeline&#146;s tolerability has been limited by side effects
arising from muscarinic receptor stimulation in peripheral tissues, leading to nausea, vomiting, diarrhea and increased salivation and sweating, collectively referred to as cholinergic AEs, or ChAEs, which led Eli Lilly to discontinue development of
xanomeline. By pairing xanomeline with trospium chloride, Karuna believes KarXT could potentially maintain efficacy of xanomeline while ameliorating its ChAEs. In November 2019, Karuna announced topline results from
<FONT STYLE="white-space:nowrap">EMERGENT-1,</FONT> its Phase&nbsp;2 clinical trial of KarXT for the treatment of acute psychosis in patients with schizophrenia, in which KarXT met the trial&#146;s primary endpoint with a statistically significant
(p&lt;0.0001) and clinically meaningful 11.6 point mean reduction in total PANSS scores over placebo at week five <FONT STYLE="white-space:nowrap">(-17.4</FONT> KarXT vs. <FONT STYLE="white-space:nowrap">-5.9</FONT> placebo), with similar
discontinuation rates between KarXT (20&nbsp;percent) and placebo (21&nbsp;percent). The study enrolled 182 schizophrenia patients with acute psychosis, 90 of whom received KarXT. The number of discontinuations due to treatment emergent AEs were
equal in the KarXT and placebo arms (n=2 in each group). One SAE was observed in the KarXT treatment group, in which the patient discontinued treatment and subsequently sought hospital care for worsening psychosis, meeting the regulatory definition
of an SAE. In Karuna&#146;s Phase 1 tolerability POC study, KarXT was better tolerated than xanomeline plus placebo and no SAEs were reported. In June 2020, Karuna announced next steps in the EMERGENT program, the clinical program evaluating KarXT
for the treatment of adults with schizophrenia, following the completion of a successful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">End-of-Phase</FONT></FONT> 2 meeting with the FDA. The outcome of the meeting supports the
progression of KarXT into Phase 3 development. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">144</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna was incorporated in July 2009. The following chart summarizes Karuna&#146;s product candidates: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g75h78.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Program Discovery Process by the PureTech Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were interested in developing a new approach to treat schizophrenia that was effective but did not have the debilitating side effects of the current class
of antipsychotics, realizing that any potential new approaches could have wider applicability. We engaged with a group of leading schizophrenia experts who were most excited about muscarinic agonists, pointing to the data generated by Eli Lilly with
xanomeline, which was not advanced at that time due to tolerability issues. We invented and broadly filed patents to cover the concept of combining a muscarinic receptor agonist with a peripherally acting antagonist, and we <FONT
STYLE="white-space:nowrap">in-licensed</FONT> xanomeline from Eli Lilly in May 2012. The core team member who was running this program at PureTech became Karuna&#146;s chief operating officer and we built a team of leading drug developers and
neuroscientists around him, including Steven Paul, M.D., an expert in CNS drug discovery and development. Karuna completed an IPO on the Nasdaq Global Market in July 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Paul was formerly executive vice president for science and technology and president of the Lilly Research Laboratories at Eli Lilly and was involved
in the original xanomeline work at Eli Lilly. Dr.&nbsp;Paul was also a <FONT STYLE="white-space:nowrap">co-founder</FONT> of Sage Therapeutics and Voyager Therapeutics, where he also served as chief executive officer, and the former scientific
director of the National Institute of Mental Health. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Patient Need and Market Potential </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Psychosis is a prominent and debilitating symptom that occurs in many neuropsychiatric disorders, including schizophrenia, dementia, bipolar disorder, major
depressive disorder and inflammatory neurological diseases, such as multiple sclerosis, but there are no existing medicines that sufficiently and safely treat psychosis and cognition impairments. There are approximately 2.7&nbsp;million adults
living with schizophrenia and about 8.4&nbsp;million people living with dementia in the United States, of which approximately 40&nbsp;percent are diagnosed with the disease, with around 1.2&nbsp;million experiencing symptoms of psychosis.
Antipsychotics are the mainstay therapy; however, drugs currently in use all rely on the same fundamental mechanism of action and, despite widespread use, the prognosis for patients remains poor. People with schizophrenia have a ten to fifteen year
reduction in life expectancy compared to the general population, struggle to maintain employment or live independently and are often unable to maintain meaningful interpersonal relationships. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Current antipsychotics only address psychosis, also known as positive symptoms, such as hallucinations and delusions, but despite treatment patients often
experience residual positive symptoms throughout their lives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">145</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
There are no approved treatments for the negative symptoms, such as apathy, reduced social drive and loss of motivation, or cognitive symptoms, such as changes in working memory and attention,
all of which currently lack any approved treatments. Current antipsychotics have modest efficacy in many patients and significant side effects. At least half of patients fail to adequately respond to current antipsychotic drugs. Additionally,
current treatments are often associated with severe side effects, including sedation, extrapyramidal side effects such as motor rigidity, tremors and slurred speech and significant weight gain resulting in the complications of diabetes,
hyperlipidemia, hypertension and cardiovascular disease. The clinical benefit of current antipsychotics is further limited by poor adherence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is an
unmet need for new treatments in schizophrenia that could address the positive, negative and cognitive symptoms and are free of the problematic safety issues with&nbsp;existing&nbsp;medicines. There are currently no approved treatments for
dementia-related psychosis associated with AD. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development Status </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2020, Karuna announced next steps in the EMERGENT program, the clinical program evaluating KarXT for the treatment of adults with schizophrenia,
following the completion of a successful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">End-of-Phase</FONT></FONT> 2 meeting with the FDA. The outcome of the meeting supports the progression of KarXT into Phase 3 development.
Karuna plans to initiate two five-week inpatient trials evaluating the efficacy and safety of KarXT for the treatment of acute psychosis in adults with schizophrenia. The first Phase 3 trial, <FONT STYLE="white-space:nowrap">EMERGENT-2,</FONT> is
expected to commence by the end of 2020. This five-week, 1:1 randomized, flexible-dose, double-blind, placebo-controlled, inpatient trial will enroll approximately 250 adults in the U.S. and evaluate the change in Positive and Negative Syndrome
Scale total score at Week 5 of KarXT versus placebo as the primary outcome measure. Details of the second efficacy trial, <FONT STYLE="white-space:nowrap">EMERGENT-3,</FONT> will be finalized by the end of 2020, with initiation expected in the first
half of 2021. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2019, Karuna announced topline results from a Phase 2 clinical trial of KarXT for the treatment of acute psychosis in patients
with schizophrenia, in which KarXT met the trial&#146;s primary endpoint with a statistically significant (p&lt;0.0001) and clinically meaningful 11.6 point mean reduction in total PANSS scores over placebo at week five <FONT
STYLE="white-space:nowrap">(-17.4</FONT> KarXT vs. <FONT STYLE="white-space:nowrap">-5.9</FONT> placebo). Karuna also observed a statistically significant 3.2 point mean reduction from baseline in the PANSS-positive subscale <FONT
STYLE="white-space:nowrap">(-5.6</FONT> KarXT v. <FONT STYLE="white-space:nowrap">-2.4</FONT> placebo) and a statistically significant 2.3 point mean reduction from baseline in the PANSS-negative subscale
<FONT STYLE="white-space:nowrap">(-3.2</FONT> KarXT v. <FONT STYLE="white-space:nowrap">-0.9</FONT> placebo) at week five (p&lt;0.0001 and p&lt;0.001, respectively). The total PANSS, PANSS-positive subscale, and the PANSS-negative subscale had
statistically significant separation at every assessment throughout the trial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The safety and tolerability of KarXT and dose selection for the Phase 2
clinical trial was supported by results from Karuna&#146;s two Phase 1 healthy volunteer studies in over 140 patients with KarXT. As disclosed in its public filings, Karuna observed in its first Phase 1 randomized, double-blind placebo-controlled
study that the addition of trospium to xanomeline was associated with clinically meaningful reductions in the rate of the most common treatment-emergent ChAEs than reported with xanomeline plus placebo, including nausea, vomiting, diarrhea and
excess sweating and salivation. The overall ChAE rate was 64&nbsp;percent on xanomeline plus placebo compared to 34&nbsp;percent on KarXT (p=0.016). The rate of ChAEs for volunteers receiving KarXT (34 percent) was similar to the rate observed in
volunteers receiving placebo during the <FONT STYLE="white-space:nowrap">lead-in</FONT> period (32 percent), suggesting that the tolerability of KarXT was more similar to the placebo <FONT STYLE="white-space:nowrap">lead-in</FONT> period than to
treatment with xanomeline plus placebo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna&#146;s second Phase 1 study was a randomized, double-blind, placebo-controlled multiple ascending dose
trial of KarXT. This trial evaluated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">twice-a-day</FONT></FONT> dosing of the proprietary KarXT <FONT STYLE="white-space:nowrap">co-formulation</FONT> containing fixed ratios of
xanomeline and trospium, rather than the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">three-times-a-day</FONT></FONT> dosing previously used with xanomeline. The study demonstrated tolerability at xanomeline dose levels
exceeding those shown in previous studies of xanomeline alone. The <FONT STYLE="white-space:nowrap">co-formulation</FONT> also achieved exposure levels equivalent to or higher than the separate dosage forms used previously. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">146</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna anticipates topline results from a Phase 1b clinical trial in healthy elderly volunteers to assess the
safety and tolerability of KarXT by the end of 2020. This Phase 1b trial is designed to demonstrate safety and tolerability of KarXT in healthy elderly volunteers in order to select the most appropriate dose to carry forward into future studies in
patients with dementia-related psychosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna has an&nbsp;exclusive license for xanomeline from Eli Lilly and has a&nbsp;patent portfolio more broadly
covering selective muscarinic targeting enabled by the KarXT approach. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna has an active IND on file with the FDA for KarXT. Karuna also has ongoing
discovery efforts to expand its pipeline. We do not control the clinical or regulatory development of Karuna&#146;s product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The disclosure
above is qualified in its entirety by reference to Karuna&#146;s public filings with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have any board designees on Karuna&#146;s board
of directors and we are not responsible for the development or commercialization of its product candidate. We have an interest in Karuna&#146;s product candidates through our equity interest as well as our right to royalty payments as a percentage
of net sales of any commercialized product covered by the granted license pursuant to a license agreement between us and Karuna. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Follica
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follica is developing a regenerative biology platform designed to treat androgenetic alopecia, epithelial aging and other medical indications.
Follica&#146;s approach is based on generating an &#147;embryonic window&#148; in adults via a series of skin disruptions, stimulating stem cells causing new hair follicles to grow. We believe that Follica&#146;s technology is the first observed to
create new follicles and hair, followed by the application of specific compounds to enhance the effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follica was incorporated in July 2005. The
following chart summarizes the progress of Follica&#146;s platform: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g33d00.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Program Discovery Process by the PureTech Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were interested in conditions of aging and focused on hair follicles given their importance in regulating human hair and skin rejuvenation across many
medical conditions. We engaged leading dermatologists and hair follicle experts and identified and <FONT STYLE="white-space:nowrap">in-licensed</FONT> intellectual property, or IP, from George Cotsarelis, M.D., the chair of the Department of
Dermatology at the University of Pennsylvania, on hair follicle neogenesis, or HFN, prior to its publication in the journal <I>Nature</I>. We translated the academic work into an <FONT STYLE="white-space:nowrap">in-office</FONT> procedure after
testing a number of modalities for initiating HFN, identified and <FONT STYLE="white-space:nowrap">co-invented</FONT> IP around modalities and drug compounds to enhance the newly formed hair follicles and helped conduct multiple POC studies to
prioritize HFN inducing modalities and prioritize potential drug compounds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follica&#146;s core technology and patent suite has been developed in
collaboration with leading researchers, building on the work of Dr.&nbsp;Cotsarelis. Follica&#146;s other key scientific advisors include Richard Rox Anderson, M.D., Chairman of the Wellman Center for Photomedicine at the Massachusetts General
Hospital, Ken Washenik, M.D., Ph.D., Medical Director of Bosley and the Executive Vice President of Scientific and Medical Development of the Aderans Research Institute. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">147</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Patient Need and Market Potential </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Androgenetic alopecia represents the most common form of hair loss in men and women, with an estimated 90&nbsp;million people who are eligible for treatment in
the United States alone. Only two drugs, both of which have demonstrated a 12&nbsp;percent increase of <FONT STYLE="white-space:nowrap">non-vellus</FONT> hair count over baseline for their primary endpoints, are currently approved for the treatment
of androgenetic alopecia. The most effective current approach for the treatment of hair loss is hair transplant surgery, comprising a range of invasive, expensive procedures for a subset of patients who have enough donor hair to be eligible. As a
result, Follica believes that there is significant unmet need for safe, effective, <FONT STYLE="white-space:nowrap">non-surgical</FONT> treatments which grow new hair. Follica&#146;s regenerative biology platform has potential applications beyond
hair growth to other aging-related conditions and wound healing, such as facial skin rejuvenation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development Status </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2019, Follica announced topline results from the safety and efficacy optimization study of its lead candidate to treat hair loss in male
androgenetic alopecia. The study was designed to select the optimal treatment regimen using Follica&#146;s proprietary device in combination with a topical drug and successfully met its primary endpoint. The selected treatment regimen demonstrated a
statistically significant 44&nbsp;percent improvement of <FONT STYLE="white-space:nowrap">non-vellus</FONT> (visible) hair count after three months of treatment compared to baseline (p &lt; 0.001, n = 19). Across all three treatment arms, the
overall improvement of <FONT STYLE="white-space:nowrap">non-vellus</FONT> hair count after three months of treatment was 29&nbsp;percent compared to baseline (p &lt; 0.001, n = 48), reflecting a clinical benefit across the entire study population
and a substantially improved outcome seen with the optimal treatment regimen. Additionally, a prespecified analysis comparing the 44&nbsp;percent change in <FONT STYLE="white-space:nowrap">non-vellus</FONT> hair count to a 12&nbsp;percent historical
benchmark set by approved pharmaceutical products established statistical significance (p = 0.005). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The study was an endpoint-blinded, randomized,
controlled study designed to establish therapeutic parameters for Follica&#146;s proprietary Follica Hair Follicle Neogenesis, or HFN, device in combination with a topical <FONT STYLE="white-space:nowrap">on-market</FONT> drug. The study involved a
less than five-minute <FONT STYLE="white-space:nowrap">in-office</FONT> experimental scalp procedure using the HFN and evaluated the optimal frequency and number of treatments across three arms. The study consisted of 48 men aged 18 to 40 who had
moderate grades of androgenetic alopecia as determined by the Hamilton Norwood <FONT STYLE="white-space:nowrap">III-IV</FONT> scale. The regimen was well tolerated across all treatment arms with no reported SAEs. No AEs were related to device
treatment. A single <FONT STYLE="white-space:nowrap">non-severe</FONT> event (headache) was determined to be related to use of the drug and is in line with minor side effects seen from treatment with the approved drug alone. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2020, Follica announced the completion of a successful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">End-of-Phase</FONT></FONT> 2
meeting with the FDA for its lead program to treat male androgenetic alopecia, which supports the progression into Phase 3 development. The initiation of a Phase 3 registration study in male androgenetic alopecia is expected in the second half of
2020. Follica has an active IND on file with the FDA for <FONT STYLE="white-space:nowrap">FOL-004.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the three previously conducted clinical
studies of patients with androgenetic alopecia, Follica demonstrated hair follicle neogenesis via biopsy following skin disruption, and hair growth through target area hair count. One of these studies demonstrated that skin disruption alone
generates not only new hair follicles but also terminal (visible, thick) hairs. Follica has been optimizing its device and conducting tests in androgenetic alopecia and other medical indications and is further developing and testing compounds that
enhance the newly formed follicles and hairs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follica has studied the potential for its proprietary device approach to address other regenerative
conditions, including female pattern hair loss and facial skin rejuvenation. Follica also has proprietary amplification compounds in development and ongoing discovery efforts to expand its pipeline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board designees represent a majority of the members of the board of directors of Follica, but Follica has its own independent management team. Our role in
the development of Follica&#146;s product candidates is through our representation on its board of directors and our role as a majority shareholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">148</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Vedanta Biosciences </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vedanta is developing a new category of therapies for immune-mediated diseases based on a rationally-defined consortia of human microbiome-derived bacteria.
The human microbiome is increasingly implicated in various immune-mediated diseases. Vedanta is a leader in the field with capabilities and deep expertise to discover, develop and manufacture live bacteria drugs. These include what is believed to be
a leading IP position with the largest collection of human microbiome-associated bacterial strains, a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies and facilities
for current good manufacturing practice, or cGMP, compliant manufacturing of rationally-defined bacterial consortia in powder form. All of this work has helped move the microbiome field beyond correlation to causation, and beyond fecal transplants
or fractions to defined, characterized biologic drugs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vedanta was incorporated in December 2010. The following chart summarizes Vedanta&#146;s product
candidates: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g59p99.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In 2017, Vedanta was awarded a grant of up to $5.4&nbsp;million from
<FONT STYLE="white-space:nowrap">CARB-X</FONT> for the development of VE303. In 2018, Vedanta and Bristol-Myers Squibb announced a partnership to evaluate VE800 with Bristol-Myers Squibb&#146;s checkpoint inhibitor Opdivo<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (nivolumab) in patients with selected types of advanced or metastatic cancer. As part of the agreement, BMS will supply nivolumab, and Vedanta will conduct the clinical trial.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Program Discovery Process by PureTech Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were interested in translating the crosstalk between the immune system and commensal microbes that live in our bodies into therapeutics to modulate a range
of immunological processes. We engaged with leading world-renowned experts in immunology, including Dr.&nbsp;Ruslan Medzhitov, professor of Immunobiology at Yale; Dr.&nbsp;Alexander Rudensky, a
<FONT STYLE="white-space:nowrap">tri-institutional</FONT> professor at the Memorial Sloan-Kettering Institute, the Rockefeller University, and Cornell University; Dr.&nbsp;Dan Littman, professor of Molecular Immunology at NYU; Dr.&nbsp;Brett Finlay,
professor at the University of British Columbia; and Dr.&nbsp;Kenya Honda, professor at the School of Medicine, Keio University. Drs.&nbsp;Honda and Rudensky demonstrated the role of the microbiota in inducing regulatory T cells and uncovered some
of the molecular mediators, known as short chain fatty acids. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We identified and <FONT STYLE="white-space:nowrap">in-licensed</FONT> intellectual property
from Dr.&nbsp;Honda when he was at Tokyo University in November 2011 before his seminal work was published in the journals <I>Science </I>and <I>Nature</I>. Based on Dr.&nbsp;Honda&#146;s work, we pioneered the concept of defined consortia of
microbes to modulate the immune system or treat bacterial infections. We played a critical role in the initial product development, initial experiments and planning of key clinical studies, business development and fundraising, and a core PureTech
team member who helped lead the identification and platform development is now the chief executive officer of Vedanta. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">149</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Patient Need and Market Potential </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Clostridioides Difficile Infection:</I> The Center for Disease Control and Prevention considers <I></I>CDI<I></I><I></I><I></I> one of the most urgent
bacterial threats. <I>C.</I><I></I><I>&nbsp;difficile</I> infections account for approximately 12,800 deaths each year in the United States alone and there are approximately 500,000 cases annually, of which 100,000 to 120,000 patients experience
recurrence. Existing interventions include antibiotics such as vancomycin or metronidazole, which have the undesirable side effect of damaging the gut microbiome and leaving patients vulnerable to
<FONT STYLE="white-space:nowrap">re-infection.</FONT> An alternative intervention, fecal transplantation, is an experimental procedure which is exceedingly difficult to standardize and scale and is fraught with potential safety issues. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Inflammatory Bowel Disease:</I> IBD is estimated to affect approximately three million people in the United States, and other autoimmune diseases affect
over 20&nbsp;million people in the United States. Many of the existing interventions are limited by toxicities and systemic immune suppression. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Allergies:</I> Food allergies are a growing U.S. public health concern and have an estimated annual economic cost near $25&nbsp;billion. Peanut allergies
specifically affect an estimated 2.5&nbsp;million people in the United States. Current treatment options primarily center around allergen avoidance. Desensitization regimens in development have limited efficacy, are risky, require treatment for life
and may not be cost-effective. Vedanta&#146;s product candidate, VE416, is being developed to safely induce permanent tolerance to food allergens including peanut allergy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Immuno-oncology:</I> Despite profound survival improvements in some patients, checkpoint inhibitors such as <FONT STYLE="white-space:nowrap">PD-1,</FONT> <FONT
STYLE="white-space:nowrap">PDL-1</FONT> and <FONT STYLE="white-space:nowrap">CTLA-4</FONT> are only effective in 20 to 30&nbsp;percent of patients. Common tumor types where checkpoint inhibitors are utilized include lung, bladder, skin, and renal
cancers. Vedanta&#146;s immuno-oncology product candidate, VE800, is designed to act in combination with approved checkpoint inhibitors and potentially other immunotherapies to safely improve their efficacy. Initial proposed indications include
advanced and metastatic MSS colorectal cancers, affecting more than 46,000 U.S. patients per year, gastric cancers, affecting more than 11,000 U.S. patients per year and melanoma, affecting more than 9,000 U.S. patients per year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The Microbiome Field: Moving Beyond Fecal Transplants and Fractions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unlike fecal transplants, which require use of donors and are untargeted, inherently variable procedures, Vedanta&#146;s approach is based on bacterial
consortia therapeutics, which are defined drug compositions produced from clonally isolated bacteria that can trigger targeted immune responses. Unlike single strain probiotics, defined consortia can robustly shift the composition of the gut
microbiota and provide colonization resistance against a range of intestinal infectious pathogens. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vedanta&#146;s novel product candidates are
administered as a lyophilized powder in a capsule dosage form, designed to have specific effects on the immune system, including restoring the balance of the microbiome in the gut to treat immune and infectious diseases and immunopotentiating
responses to treat cancer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development Status </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VE303, Vedanta&#146;s product candidate for the treatment of high risk CDI, is being studied in a Phase 2 clinical trial in patients at high risk of rCDI. The
trial was initiated in December 2018, and dose selection was based on the results from the Phase 1a/1b clinical trial in healthy volunteers, which showed that VE303 treatment resulted in rapid, durable, dose-dependent colonization and accelerated
gut microbiota restoration after antibiotics. Clinical results for the Phase&nbsp;2 clinical trial of VE303 are anticipated in 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VE202,
Vedanta&#146;s product candidate for IBD, was evaluated in two Phase 1 clinical trials in healthy volunteers. Vedanta announced positive topline data from these studies which showed that VE202 was generally well-tolerated at all doses and
demonstrated durable and dose-dependent colonization. The trial was conducted by Janssen Research&nbsp;&amp; Development, LLC, and a more complete study dataset and analyses will be submitted to a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">150</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
peer-reviewed journal. Vedanta has regained full rights to the program and will owe Janssen single-digit royalty payments on net sales of a commercialized product. Vedanta plans to take the
program forward into a Phase 2 study in 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VE416, Vedanta&#146;s product candidate for food allergy, is being evaluated in a Phase 1/2 investigator
sponsors trial at Mass General Hospital for Children for patients 12 years of age or older with a history of peanut allergy. The first patient was enrolled in July 2019 and will explore VE416 both as a monotherapy and in combination with an oral
peanut immunotherapy over the course of several months. Topline data from the Phase 1/2 clinical trial of VE416 in food allergy are expected in 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VE800, Vedanta&#146;s immuno-oncology product candidate, is being evaluated in a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-patient</FONT></FONT> clinical trial with Bristol-Myers Squibb&#146;s, or BMS, checkpoint inhibitor Opdivo<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>
(nivolumab) in patients with selected types of advanced or metastatic cancer. The trial was initiated in December 2019, and topline results are anticipated in 2021. As part of the agreement with BMS, Vedanta will conduct the clinical trial and BMS
will supply nivolumab. Active INDs or the foreign regulatory equivalent are on file for VE202, VE303, VE416, and VE800. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vedanta also has ongoing
discovery efforts to expands its pipeline, including VE707. VE707 is Vedanta&#146;s preclinical discovery program for the prevention of infection and reoccurrence of several multi-drug resistant organisms, or MDROs, including carbapenem-resistant
Enterobacteriaceae, or CRE, extended-spectrum beta lactamase producers, or ESBL, and vancomycin-resistant Enterococci, or VRE, which are some of the most common hospital-acquired infections. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board designees represent a majority of the members of the board of directors of Vedanta, but Vedanta has its own independent management team. Our role in
the development of Vedanta&#146;s product candidates is through our representation on its board of directors and our role as a majority shareholder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sonde </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sonde Health, Inc., or Sonde, is developing
a voice-based technology platform to measure health when a person speaks. Sonde&#146;s proprietary technology is designed to sense and analyze subtle changes in the voice to create a range of persistent brain, muscle and respiratory health
measurements that provide a more complete picture of health in just seconds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe Sonde&#146;s Vocal Biomarker program has demonstrated the
potential to screen and monitor for disease using information obtained from an individual&#146;s voice on commonly-owned devices, such as smartphones and smart speakers, and it has the potential to fundamentally change the way mental and physical
health is screened and monitored. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sonde was incorporated in February 2015. The following chart summarizes the progress of Sonde&#146;s platform: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g75x11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Program Discovery Process by the PureTech Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were interested in new ways to detect and quantify disease in a <FONT STYLE="white-space:nowrap">low-</FONT> to
<FONT STYLE="white-space:nowrap">no-burden</FONT> manner that could allow for more proactive and potentially effective interventions. We selected vocal features as leading source of health </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">151</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
data for this purpose, particularly given the evolving technology landscape where voice interactions with devices are rapidly increasing, and we identified and
<FONT STYLE="white-space:nowrap">in-licensed</FONT> proprietary technology from Thomas Quatieri, Ph.D., at MIT&#146;s Lincoln Laboratory in May 2016. Pursuant to an exclusive license agreement with Dr.&nbsp;Quatieri, we paid an upfront fee and are
obligated to pay annual license maintenance fees, both of which we deem immaterial. Pursuant to the agreement, we are also obligated to pay MIT a low single-digit running royalty of net sales of any commercialized product covered by the agreement
and a mid double-digit running royalty of net sales of any commercialized product of a party that we sublicense. MIT also is also eligible to receive milestone payments upon the achievement of specified development, regulatory and commercial
milestones up to $250,000. We developed additional, novel IP around this concept and helped advance the technology from an academic concept to a commercially-focused technology. A core PureTech team member who played a critical role in founding
Sonde is currently the chief operating officer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Patient Need and Market Potential </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The lag between onset of disease and accurate diagnosis and beginning of treatment can be measured in years for many high-burden health conditions, including
depression, AD, multiple sclerosis, Parkinson&#146;s disease and cardiovascular and respiratory diseases, to name just a&nbsp;few. Depression alone affects approximately 17&nbsp;million adults in the United States. Near-continuous health
information, powered by Sonde&#146;s technology, has the potential to improve screening, monitoring, and timeliness of treatment of high-cost conditions, broadly improving outcomes and care efficiency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Development of effective therapies for CNS diseases and disorders is hampered by the high cost and inherent variability of these diseases and the reference
diagnostic measures used to characterize them. Objective digital tools that can augment, and perhaps one day replace, the current clinical endpoints with novel measures that can be quantified with more meaningful accuracy and less burden can improve
patient enrollment and drug development for a&nbsp;range of important conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development Status </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of this registration statement, Sonde has collected voice data from over 50,000 subjects as a part of the ongoing validation of its platform,
and it has also initiated research and development to expand its proprietary technology into AD, respiratory and cardiovascular disease, as well as other health and wellness conditions. Sonde is collaborating with the University of New South Wales
and Black Dog Institute in Australia to create the first mobile device-based automatic assessment of depression from acoustic speech and has entered into collaborative partnerships with leading institutions, including UMass Memorial Medical Center,
Yale University, Partners Massachusetts General Hospital and multiple other <FONT STYLE="white-space:nowrap">ex-US</FONT> hospitals, clinics and academic medicine centers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2020, Sonde launched Sonde One for Respiratory, a new voice-enabled health detection and monitoring app, to potentially help employers improve
employee safety, meet government mandates and satisfy their own administrative needs as they reopen office doors in a <FONT STYLE="white-space:nowrap">COVID-19</FONT> environment. Leveraging the company&#146;s advanced vocal biomarker platform and
machine learning technology, Sonde One combines <FONT STYLE="white-space:nowrap">6-second</FONT> voice analysis, <FONT STYLE="white-space:nowrap">CDC-informed</FONT> <FONT STYLE="white-space:nowrap">COVID-19</FONT> questionnaire and body temperature
reporting in one app and is designed to give employees clear instructions about where they can work within one minute. Sonde partnered with corporate wellness solutions provider Wellworks for You to bring the health screening tool to market. SHI
International, a <FONT STYLE="white-space:nowrap">5,000-person</FONT> global provider of technology products and services, is the first enterprise to enrol. The company will begin implementing the Sonde One for Respiratory app in August, as it
gradually begins bringing employees back to the workplace. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sonde is also creating the first mobile device-based automatic assessment of depression, Sonde
One for Depression, a new voice-enabled health detection and monitoring app, to potentially help employers and payors improve engagement in services to address employee and patient behavioral health needs. Leveraging the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">152</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
company&#146;s advanced vocal biomarker platform and machine learning technology, Sonde One for Depression will also combine <FONT STYLE="white-space:nowrap">6-second</FONT> voice analysis with
validated self-report questions in one app and is designed to give employees a timely indication of how important measures of mental health and symptoms may be changing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sonde has ongoing discovery efforts to expand its pipeline. Sonde has obtained Institutional Review Board, or IRB, approval independently or in collaboration
with partner institutions that covers all past and ongoing human data collection for research in the United States and abroad. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have two board designee
on the board of directors of Sonde, but Sonde has its own independent management team. Our role in the development of Sonde&#146;s product candidates is through our representation on its board of directors and our role as a majority shareholder.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Alivio </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alivio is pioneering
inflammation-targeted disease immunomodulation, which involves selectively restoring immune homeostasis at inflamed sites in the body, while having minimal impact on the rest of the body&#146;s immune system, as a novel strategy to treat a range of
chronic and acute inflammatory disorders. This long sought-after approach has the potential to broadly enable new medicines to treat a&nbsp;range of chronic and acute inflammatory disorders, including enabling the use of drugs which were previously
limited by issues of systemic toxicity or PK. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To achieve the vision of selective immunomodulation, Alivio is developing a proprietary platform centered
on a class of self-assembling therapies that selectively bind to inflamed tissue. Alivio&#146;s platform has been validated in multiple labs using a range of animal models and indications. The platform is able to entrap a wide array of APIs,
including small molecules, biologics and nucleic acids. By selectively targeting API pharmacology to inflamed tissue, Alivio is developing product candidates that are designed to selectively treat autoimmune disease without having related systemic
toxicities. Alivio&#146;s pipeline includes candidates for IBD, pouchitis, and interstitial cystitis or bladder pain syndrome, or IC/BPS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alivio was
incorporated in December 2015. The following chart summarizes the progress of Alivio&#146;s platform: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g74q77.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">ALV-107</FONT> preclinical development until its IND filing was supported, in
part, by a $3.3M grant from the U.S. Department of Defense and in collaboration with Purdue Pharma LP (Imbrium Therapeutics). See &#147;Alivio&#151;Development Status&#148; for more information about Alivio&#146;s agreement with Purdue.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">153</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Program Discovery Process by the PureTech Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A key challenge in new drug development for autoimmune and inflammatory disease is that attractive drug targets are frequently expressed in both diseased and
normal tissue. Consequently, we were interested in identifying ways to address autoimmune disease in a targeted manner. We were inspired by a key observation, which is that pathologic inflammation frequently manifests at specific sites in tissues
and organs and is driven by dysfunctional immune signaling. However, traditional approaches act to broadly suppress the immune system throughout the body. This mismatch substantially limits the potential targets that can be pursued and frequently
results in narrow therapeutic windows. We worked with leading immunology experts and identified and <FONT STYLE="white-space:nowrap">in-licensed</FONT> a technology created by Alivio&#146;s <FONT STYLE="white-space:nowrap">co-founder</FONT> Jeffrey
Karp, Ph.D., professor of medicine at Harvard Medical School and Brigham and Women&#146;s Hospital, and Dr.&nbsp;Robert Langer, David H Koch Institute Professor at MIT, that was centered around this unique inflammation-targeting and
inflammation-responsive platform in May 2016. In addition to repeating key academic work and developing product candidates, Alivio continues to move those product candidates into the clinic while we oversee business development. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Patient Need and Market Potential </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Results in preclinical
models suggest the Alivio technology could be applied to diseases such as IBD, pouchitis, inflammatory arthritis, organ transplantation, and IC/BPS. These diseases collectively impact tens of millions of patients in the United States alone and have
limited treatment options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IC/BPS is a chronic bladder condition that consists of discomfort or pain in the bladder or surrounding pelvic region and is
often associated with frequent urination. It is estimated to affect four million to 12&nbsp;million people in the United States. Current treatments fail to control pain in many patients. Pouchitis is estimated to affect between 70,000 and 135,000
people in the U.S. IBD is estimated to affect approximately three million people in the United States. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development Status </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alivio expects to file an IND for <FONT STYLE="white-space:nowrap">ALV-306,</FONT> its lead product candidate, in pouchitis and initiate a clinical trial in
2021. Alivio also plans to file an IND for <FONT STYLE="white-space:nowrap">ALV-107</FONT> for IC/BPS in 2021 and an IND for <FONT STYLE="white-space:nowrap">ALV-304</FONT> for IBD in 2022. In December 2018, Alivio entered into a research
collaboration, option and license agreement with Imbrium Therapeutics L.P., an entity affiliated with Purdue Pharma LP, or Purdue, to advance Alivio&#146;s product candidate, <FONT STYLE="white-space:nowrap">ALV-107,</FONT> through clinical
development and commercialization. Under the terms of the agreement, Alivio is eligible to receive up to $14.8&nbsp;million in upfront and near-term license option exercise payments and is eligible to receive low single digit to low teens royalties
in tiers on product sales and over $260.0&nbsp;million in research and development milestones. Purdue does not currently have any ownership interest in <FONT STYLE="white-space:nowrap">ALV-107,</FONT> but does have an option to exercise for rights
to develop <FONT STYLE="white-space:nowrap">ALV-107</FONT> under the agreement. Purdue also has an option to collaborate on a limited number of additional compounds utilizing Alivio&#146;s inflammation-targeting technology, as well as an option to
invest in Alivio&#146;s next equity financing. Alivio is also evaluating the potential application of its proprietary platform to enable the oral administration of biologics in additional indications. Alivio also has ongoing discovery efforts to
expand its pipeline. We are evaluating the impact, if any, of the announced Chapter 11 bankruptcy by Purdue on this collaboration agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A majority
of the board of directors of Alivio are PureTech employees. These PureTech employees actively manage the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business activities of Alivio and together with
Alivio&#146;s Chief Executive Officer and the board of directors of Alivio, which is controlled by PureTech, direct the strategy and decision making in connection with the clinical and regulatory development of Alivio&#146;s product candidates. As a
result, we exert substantial control over the clinical and regulatory development of Alivio&#146;s product candidates. Additionally, Alivio&#146;s lab and office space is shared with our lab and office space. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">154</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Entrega </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Entrega is focused on the oral delivery of biologics, vaccines and other drugs that are otherwise not efficiently absorbed when taken orally. The vast majority
of biologic drugs, including peptides, proteins and other macromolecules, are currently administered by injection, which can present challenges for healthcare delivery and compliance with treatment regimes. Entrega believes oral administration thus
represents an ideal administration approach for this increasingly large class of therapies reshaping many areas of medicine, including the treatment of diabetes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Entrega&#146;s technology platform is an innovative approach to oral delivery which uses a&nbsp;proprietary, customizable hydrogel dosage form to control
local fluid microenvironments in the GI tract in an effort to both enhance absorption and reduce the variability of drug exposure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Entrega was
incorporated in December 2010. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Program Discovery Process by the PureTech Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were interested in enabling the oral administration of biologics, which has been a long-standing problem in drug development. We engaged with leading
experts in drug delivery, including Dr.&nbsp;Langer, and screened over 100 technologies and the initial platform was licensed from Samir Mitragotri, Ph.D., professor of chemical engineering at UC Santa Barbara. We later enhanced this platform with
IP developed by our team. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other scientific and business advisors include Colin Gardner, Ph.D., former chief scientific officer of Transform
Pharmaceuticals, former SVP of research and site head at Johnson&nbsp;&amp; Johnson and formerly VP of pharmaceutical R&amp;D at Merck&nbsp;&amp; Co., Inc., or Merck; Rodney Pearlman, Ph.D., formerly CEO of Nuon Therapeutics, President&nbsp;&amp;
CEO of Saegis Pharmaceuticals; and director of pharmaceutical R&amp;D at Genentech; Robert Armstrong, Ph.D., cofounder and chief executive officer of Boston Pharmaceuticals; and Mr.&nbsp;Howie Rosen, former president of ALZA. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development Status </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To&nbsp;validate its technology,
Entrega&nbsp;generated POC preclinical data demonstrating delivery of therapeutic peptides into the bloodstream of large animals. Entrega received $5&nbsp;million in equity and research funding from Eli Lilly to investigate the application of its
peptide delivery technology to certain Lilly therapeutic candidates. Entrega also has ongoing discovery efforts to expand its pipeline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The management
team of Entrega consists of PureTech employees, and a majority of the board of directors are PureTech designees. These PureTech employees actively manage the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT>
business activities of Entrega and together with the board of directors of Entrega, which is controlled by PureTech, direct the strategy and decision making in connection with the clinical and regulatory development of Entrega&#146;s product
candidates. As a result, we exert substantial control over the clinical and regulatory development of Entrega&#146;s product candidates. Additionally, Entrega&#146;s lab and office space is shared with our lab and office space. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Founded Entities in which PureTech has an Equity Interest, in Order of Development Stage </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Akili </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Akili is a leading digital therapeutics
company, combining scientific and clinical rigor with the ingenuity of the tech industry with a goal of changing how medicine is developed, delivered and experienced. Akili is pioneering the development of treatments designed to have direct
therapeutic activity, delivered not through a traditional pill but via a high-quality video game experience. Akili is evaluating a number of technologies and potential new digital medicines designed to target neural systems to improve associated
cognitive functions. In June 2020, Akili received clearance from the FDA for EndeavorRxTM <FONT STYLE="white-space:nowrap">(AKL-T01)</FONT> as a prescription treatment to improve </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">155</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
attention function in children with attention-deficit/hyperactivity disorder, or ADHD. Also in June 2020, Akili received a Conformit&eacute; Europ&eacute;enne, or CE Mark, certification for
EndeavorRx as a prescription-only digital therapeutic intended for the treatment of attention and inhibitory control deficits in pediatric patients with ADHD. Additionally, through a collaboration and development agreement with Shionogi, Akili is
pursuing regulatory approval in Japan for EndeavorRx. Akili has evaluated its platform technology in studies of various sizes across a variety of patient populations suffering from cognitive dysfunction, including adult ADHD, ASD, multiple
sclerosis, or MS, major depression disorder, or MDD, <FONT STYLE="white-space:nowrap">Parkinson&#146;s-related</FONT> mild cognitive impairment, or MCI, and traumatic brain injury, or TBI. Currently focused on the clinical study of the
company&#146;s patented Selective Stimulus Management Engine, or SSME<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>, core technology, Akili has conducted more than 30 clinical trials of SSME across a number of different diseases and
disorders. Akili is also developing complementary and integrated monitoring and measurement-based care applications, including Akili Care&#151;comprising a mobile tracking app (ADHD Insight<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>) and
personalized dashboard showing the child&#146;s EndeavorRx treatment and symptom/behavior tracking data and support and resources to help guide caregivers through their child&#146;s treatment experience. Akili was incorporated in February 2012. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following chart summarizes the current stage of product candidates that have been evaluated by Akili. Following the FDA clearance of EndeavorRx and the
evolving healthcare and mental health landscape, Akili is undergoing a pipeline prioritization strategic review which may result in a change in or the addition of product candidates and/or indications in the near term. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g99u33.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Program Discovery Process by the PureTech Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were interested in identifying novel approaches to measure and improve cognition in a safe and <FONT STYLE="white-space:nowrap">non-invasive</FONT> manner.
We engaged with leading neuroscientists and clinicians who had been studying the effects of video games on cognition and the underlying neural processes accessible by sensory stimulation, and we identified and
<FONT STYLE="white-space:nowrap">in-licensed</FONT> from UCSF the intellectual property invented by Dr.&nbsp;Adam Gazzaley, M.D., Ph.D., professor of neurology, psychiatry and physiology at UCSF and the inventor of this platform technology, in
October 2013 before his work was published as a cover story in the journal <I>Nature</I>. We then collaborated with Dr.&nbsp;Gazzaley to translate the underlying academic device into a medical intervention, including overseeing the initial product
development and design and the implementation of the initial POC studies. We helped to build development and commercial teams and raise funds, including from the investment arms of Amgen and Merck KGaA, Darmstadt, Germany as a part of Akili&#146;s
Series B financing round. One of the core PureTech team members who helped lead the identification and platform development is now the CEO of Akili. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">156</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Akili&#146;s <FONT STYLE="white-space:nowrap">FDA-cleared</FONT> product, EndeavorRx, is based on a platform
technology exclusively licensed from the University of California, San Francisco, or UCSF. The proprietary platform targets cognitive interference processing while also adapting difficulty automatically in real-time, allowing individuals of
wide-ranging ability levels to interact with the product in their homes without the need for physician calibration or additional hardware. Dr.&nbsp;Gazzaley currently serves as the chief scientific advisor and a board member of Akili. Daphne
Bavelier, Ph.D., associate professor in the Department of Brain and Cognitive Sciences at the University of Rochester and at the University of Geneva, is a <FONT STYLE="white-space:nowrap">co-founding</FONT> scientific advisor. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Patient Need and Market Potential </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cognitive dysfunction
is a key feature of many neuropsychiatric disorders, including ADHD, ASD, MS, MDD, MCI, TBI and AD. The treatment of the cognitive dysfunction associated with these conditions is only partially served, or not served at all, by currently available
medications or by <FONT STYLE="white-space:nowrap">in-person</FONT> behavioral therapy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are approximately 6.4&nbsp;million pediatric ADHD patients
in the United States and this market&#151;and other markets where Akili&#146;s cognitive dysfunction targeting products may address the cognitive dysfunction associated with neuropsychiatric disorders&#151;represent significant potential
opportunities for the company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Akili&#146;s Innovative Approach </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Akili&#146;s treatment is based on a patented technology that is designed to deploy sensory and motor stimuli that target and activate the neurological systems
known to play a key role in certain cognitive functions, including attentional control. Akili&#146;s approach aims to improve cognitive impairment and related symptoms through improving neural processing at the functional neurological level. The
treatment is delivered through an immersive video game, resulting in <FONT STYLE="white-space:nowrap">non-invasive,</FONT> patient-friendly medicine that can be used at home. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By combining high quality neurological and clinical science, and consumer-grade entertainment, Akili is seeking to produce a new type of medical product that
can potentially offer safe, effective, scalable and personalized treatments for patients across a range of neuropsychiatric conditions, and allow patients to experience medicine in a new way. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development Status </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Akili has evaluated its SSME
technology across a variety of patient populations, including pediatric and adult ADHD, ASD, MS, MDD, MCI and TBI. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2020, Akili announced that the
FDA has granted clearance for EndeavorRx as a prescription treatment for improving attention function in children with ADHD. Delivered through a captivating video game experience, EndeavorRx is indicated to improve attention function as measured by
computer-based testing in children ages <FONT STYLE="white-space:nowrap">8-12</FONT> years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Akili expects that the EndeavorRx treatment will be available
with a prescription to families soon. The FDA clearance followed the April announcement that ENDEAVOR<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> would be available for use for a limited time by children with ADHD and their families in
response to new guidance from the FDA recognizing the need for access to certain <FONT STYLE="white-space:nowrap">low-risk</FONT> clinically-validated digital health devices for psychiatric conditions, including ADHD, during the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. Also in June 2020, Akili announced that it had received approval to market EndeavorRx in Europe. Akili received a CE Mark certification for EndeavorRx as a prescription-only digital therapeutic
intended for the treatment of attention and inhibitory control deficits in pediatric patients with ADHD. The CE Mark approval enables the future marketing of EndeavorRx in European Economic Area member countries. With a near-term focus on launching
the EndeavorRx prescription treatment in the U.S. first, Akili is exploring expansion opportunities in Europe as part of its global strategy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">157</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Akili&#146;s EndeavorRx was evaluated in a multi-center, randomized, blinded, controlled pivotal study in 348
pediatric ADHD patients. In this study, <FONT STYLE="white-space:nowrap">AKL-T01</FONT> achieved its primary endpoint, showing a statistically significant change in the Attention Performance Index, a composite score of attention from the Test of
Variables of Attention, or T.O.V.A.<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, compared to an expectancy matched digital control (p=0.006). There were no SAEs or discontinuations. Of participants using EndeavorRx, 9.2 percent
experienced TRAEs which were mild and included frustration (2.8 percent) and headache (1.7 percent). Mean patient compliance with <FONT STYLE="white-space:nowrap">AKL-T01</FONT> was 83&nbsp;percent of instructed use. Subjective secondary outcome
measures, including the ADHD Rating Scale and the Impairment Rating Scale, showed statistically significant improvements in both the treatment and control groups and there was no statistically significant separation on those measures between groups.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2020, Akili announced that a study achieved its primary endpoint evaluating the effects of EndeavorRx in children with ADHD when used with and
without stimulant medication. The study achieved its predefined primary efficacy outcome, demonstrating a statistically significant improvement in the ADHD Impairment Rating Scale, or IRS, from baseline after one month of treatment (p&lt;0.001) in
both children taking stimulant medications and in those not taking stimulants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2019, Akili entered into a strategic partnership with Shionogi
for the development and commercialization of <FONT STYLE="white-space:nowrap">AKL-T01</FONT> and <FONT STYLE="white-space:nowrap">AKL-T02</FONT> (in development for children with ASD) in Japan and Taiwan. Under the terms of the agreement, Akili will
build and own the platform technology and received upfront payments totaling $20&nbsp;million with potential milestone payments for Japan and Taiwan commercialization of up to an additional $105&nbsp;million in addition to royalties. Akili and
Shionogi have initiated a clinical study in preparation for a regulatory submission in Japan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Akili is planning to build its own commercial distribution
platform for its digital therapeutic products to enable launch in a variety of commercial models. The company is building Akili Care, an integrated system for patient service, data processing, and distribution functions for its initial product
launch, to allow flexibility, learning, and iteration as it continues to invest in the delivery of digital therapeutic solutions to the market. Akili&#146;s Shionogi partnership is structured to enable the implementation of this localized platform
in Japan. Multiple IRBs have determined <FONT STYLE="white-space:nowrap">AKL-T01</FONT> to be a <FONT STYLE="white-space:nowrap">non-significant</FONT> risk device. Akili has obtained IRB approval independently or in collaboration with independent
clinical research institutions for all past and ongoing human data collection for clinical research in the United States. We do not control the clinical or regulatory development of Akili&#146;s product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have a direct interest in Akili&#146;s product or product candidates. Our interest in Akili&#146;s product and product candidates is limited to our
equity interest in Akili and any potential appreciation in the value of such equity interest, and we do not control the clinical or regulatory development of Akili&#146;s product candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vor Biopharma </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vor Biopharma, or Vor, is taking a
fundamentally novel approach for targeting cancer selectively by addressing the detrimental effects of <FONT STYLE="white-space:nowrap">on-target</FONT> toxicity to healthy tissue. Vor is developing engineered hematopoietic stem cells, or eHSCs, for
the treatment of hematological cancers. Vor&#146;s differentiated approach is designed to enable broad targeting of lineage antigens, which are attractive targets but face serious limitations, since they are expressed on both healthy cells and
cancerous cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vor&#146;s eHSCs do not display a particular antigen, therefore making these antigens tumor-specific and potentially safer to target
while protecting the healthy blood cells from depletion. This enables maximal targeted therapy doses to be administered without fear of <FONT STYLE="white-space:nowrap">on-target</FONT> toxicity. Vor&#146;s approach may also enable new targeted
therapies to be developed that otherwise would be too toxic to consider developing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vor&#146;s technology is enabled via gene editing of hematopoietic
stem cells, generating eHSCs which can be transplanted into patients as part of standard transplant procedures. Transplants can be performed prior to the targeted therapy or the targeted therapy can be used prior to the hematopoietic stem cell
transplantation. Vor is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">158</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
starting by editing CD33 expression, where CD33 is highly expressed in acute myeloid leukemia, or AML, and other myeloid leukemias. Vor&#146;s approach could potentially be expanded to other
antigens which are present in broad ranges of other hematological malignancies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vor&#146;s platform can potentially be used to improve the safety profile
of targeted therapies, such as antibody drug conjugates, bispecific antibodies, chimeric antigen receptor T&nbsp;cells, or <FONT STYLE="white-space:nowrap">CAR-T</FONT> cells, and others, expanding their reach beyond
<FONT STYLE="white-space:nowrap">B-cell</FONT> malignancies to other myeloid leukemias, such as AML, as well as enhancing the effectiveness of similar therapies. When combined with targeted therapies, this technology could potentially enable
transformative outcomes in patients with otherwise grim prognoses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vor was incorporated in December 2015. The following chart summarizes Vor&#146;s
product candidates: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105g85w28.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Program Discovery Process by the PureTech Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were interested in approaches to treat hematological malignancies that currently have poor response rates or poor adverse event profiles despite recent
advances in cell therapies and targeted therapies. We engaged leading hematological cancer specialists and we became aware of work from the laboratory of Vor Scientific Board chair Siddhartha Mukherjee, M.D., Ph.D., assistant professor of Medicine
at Columbia University and Pulitzer <FONT STYLE="white-space:nowrap">Prize-winning</FONT> author of <I>The Emperor of All Maladies</I>: <I>A Biography of Cancer. </I>Dr.&nbsp;Mukherjee pioneered the idea of genetically engineering stem cells to
eliminate a particular target such that healthy stem cells and progeny cells would be spared from targeted cancer therapy. We worked with Dr.&nbsp;Mukherjee on this IP, which we exclusively <FONT STYLE="white-space:nowrap">in-licensed</FONT> from
Columbia in April 2016, and on advancing this concept through critical POC experiments. We have filed additional intellectual property (both <FONT STYLE="white-space:nowrap">in-licensed</FONT> from Columbia and owned by Vor), assembling an excellent
research team and completing a round of fundraising. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2019, Bill Lundberg, M.D., was appointed to Vor&#146;s board of directors. In August 2019,
Robert Ang, MBBS, MBA, was appointed president and chief executive officer of Vor. In June 2020, Vor announced the appointment of Nathan Jorgensen, Ph.D., as chief financial officer, in July 2020, Vor announced the appointments of Daniella Beckman
and David Lubner to its board of directors and Christopher Slapak, M.D., as chief medical officer, and in August 2020, Vor announced the appointment of John King as chief commercial officer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Patient Need and Market Potential </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The prognosis for
relapsed and refractory blood-borne malignancies is very poor and can be measured in a few months, depending on patient-specific risk factors. For example, for acute myeloid leukemia, or AML, which affects approximately 60,000 patients at any one
time in the United States, only about 30&nbsp;percent of patients with active disease following a bone marrow transplant survive past 12 months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Targeted
therapies, such as <FONT STYLE="white-space:nowrap">CAR-T</FONT> cells and bispecific antibodies, antibody-drug conjugates, and conventional mAbs, have shown excellent outcomes, particularly in patients with certain hematologic malignancies
expressing B&nbsp;cell markers. However, these targeted therapies frequently target both cancer and normal cells, causing substantial toxicities and limiting their potential. There is a need for new strategies that can enable selectively targeting
cancer cells without impacting a patient&#146;s normal cells. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">159</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development Status </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vor&#146;s lead product candidate, VOR33, is a novel HSC therapy in development for AML consisting of donor-derived HSCs that are engineered to lack the cell
surface protein CD33. When removed from the cell surface, VOR33 eHSCs lack cell surface expression of CD33, do not appear to have any measurable changes to their biological function and have been shown to be highly resistant to attack from
CD33-targeted therapies. When infused into a patient, these eHSCs are designed to mature and differentiate into a full spectrum of healthy immune and blood cells that would be unaffected by the cancer treatment. This approach has the potential to
minimize targeted therapy toxicities and maximize the potency of anti-CD33 therapies for treating AML. Vor held a <FONT STYLE="white-space:nowrap">pre-IND</FONT> meeting with the FDA in January 2020 to gather important feedback to assemble the data
package necessary for a potential IND filing. The company expects to initiate a Phase 1 study of VOR33 in AML in 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2019, preclinical research
was published in the scientific journal <I>Proceedings of the National Academy of Sciences </I>supporting Vor&#146;s novel approach to treating cancer via engineered hematopoietic stem cells. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vor has achieved <I>ex vivo</I> POC for its technology and received validation of its technology in engineered humanized mouse models. Vor also has ongoing
discovery efforts to expand its pipeline. We do not control the clinical or regulatory development of Vor&#146;s product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have a
direct interest in Vor&#146;s product candidate. Our interest in Vor&#146;s product candidate is limited to our equity interest in Vor and any potential appreciation in the value of such equity interest and we do not control the clinical or
regulatory development of Vor&#146;s product candidate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently source most of our nonclinical and clinical compound supply through third-party contract manufacturing organizations, or CMOs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For clinical supply, we use CMOs who act in accordance with the FDA&#146;s GLP and current good manufacturing practices, cGMP, for the manufacture of drug
substance and product. Manufacturing of any product candidate is subject to extensive regulations that impose various procedural and documentation requirements, which govern recordkeeping, manufacturing processes and controls, personnel, quality
control and quality assurance, among others. We expect that all of our contract manufacturing organizations will manufacture our Wholly Owned product candidates under current Good Manufacturing Practice, or cGMP, conditions. cGMP is a regulatory
standard for the production of pharmaceuticals to be used in humans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe there are multiple sources for all of the
<FONT STYLE="white-space:nowrap">non-proprietary</FONT> materials required for the manufacture of our internal product candidates. Our manufacturing strategy enables us to more efficiently direct financial resources to the research, development, and
potential commercialization of product candidates rather than diverting resources to internally develop manufacturing facilities. As our Wholly Owned product candidates advance through development, we expect to enter into longer-term commercial
supply agreements with key suppliers and manufacturers to fulfill and secure the ongoing and planned preclinical, clinical, and, if our Wholly Owned product candidates are approved for marketing, our commercial supply needs for ourselves and our
collaborators. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Founded Entities independently manufacture or contract to manufacture their products and product candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sales and Marketing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have our own marketing,
sales or distribution capabilities. In order to commercialize our Wholly Owned product candidates if approved for commercial sale, we must either develop a sales and marketing infrastructure or collaborate with third parties that have sales and
marketing experience. We plan to directly commercialize our Wholly Owned product candidates in the United States and for some indications, we may also </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">160</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
directly commercialize our Wholly Owned product candidates in the European Union. In other markets or for certain indications outside the United States for which commercialization may be less
capital efficient for us, we may selectively pursue strategic collaborations with third parties in order to maximize the commercial potential of our Wholly Owned product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As our Founded Entities begin to commercialize product candidates approved for commercial sale, they will independently develop a sales and marketing
infrastructure or enter into collaborations with third parties to do so. We will not have control over or direct the sales and marketing efforts of our Founded Entities. As of the date of this registration statement, only one of our Founded
Entities, Gelesis, has a product cleared by the FDA and all sales and marketing efforts related to Gelesis&#146; planned U.S. launch of Plenity will be undertaken by Gelesis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We strive to protect the
proprietary technologies that we believe are important to our business, including pursuing and maintaining patent protection intended to cover novel platform technologies relating to our Wholly Owned Programs, our corresponding product candidates
and their methods of use, as well as other technologies that are important to our business. In addition to patent protection, we also rely on trade secrets to protect aspects of our business for which we do not consider patent protection
appropriate. The intellectual property covering the technologies, products and product candidates for the programs involving our subsidiaries are handled directly by our respective subsidiaries and we are not actively involved in the management of
subsidiary intellectual property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">LYT-100</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We acquired <FONT STYLE="white-space:nowrap">LYT-100</FONT> and all of the associated IP rights thereof, from Auspex. We are also obligated to make payments to
Auspex in connection with certain development, regulatory and sales milestones and pay royalties on sales of the product upon commercialization. We plan to advance <FONT STYLE="white-space:nowrap">LYT-100</FONT> for the treatment of various
lymphatic disorders, including lymphedema. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, the <FONT STYLE="white-space:nowrap">LYT-100</FONT> patent portfolio includes 31
active patents acquired, and one patent application licensed from Auspex. These patents and application provide broad coverage of compositions of matter, formulations and methods of use for deuterated pirfenidone, including the <FONT
STYLE="white-space:nowrap">LYT-100</FONT> deupirfenidone compound, comprising six issued U.S. patents, which are expected to expire in 2028, one U.S. patent application which if issued, is expected to expire in 2035, and 25 patents issued in 23
foreign jurisdictions, without taking into account any possible patent term extension or regulatory exclusivities. In addition, we have filed additional patent applications on deupirfenidone, including 14 pending U.S. patent applications and one
international PCT application directed to the use of deuterated pirfenidone, including <FONT STYLE="white-space:nowrap">LYT-100</FONT> deupirfenidone, for the treatment of a range of conditions involving inflammation and fibrosis and disorders of
lymphatic flow of lymphedema and other relevant disorders. Any issued patents claiming priority to these applications are expected to expire in 2039 through 2041, exclusive of possible patent term adjustments or extensions or other exclusivities.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">LYT-200</FONT> and <FONT STYLE="white-space:nowrap">LYT-210</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">LYT-200&nbsp;is</FONT> an investigational fully human mAb targeting <FONT STYLE="white-space:nowrap">galectin-9,</FONT>
a&nbsp;global immunosuppressor that facilitates a&nbsp;tumor-permissive microenvironment, for use in the treatment of solid tumors and other cancers. <FONT STYLE="white-space:nowrap">LYT-210&nbsp;is</FONT> an investigational fully human mAb
targeting <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T&nbsp;cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have broad intellectual property
coverage for these antibody-based immunotherapy technologies, including exclusive rights to nine families of patent filings that are exclusively licensed from or <FONT STYLE="white-space:nowrap">co-owned</FONT> with New York University which cover
antibodies that target immunosuppressive agents and mechanisms and methods of use for the treatment of solid tumors, such as pancreatic cancer, CRC, melanoma, gastric cancer, breast cancer and various other cancers, and one family of patent filings
that cover antibodies directed to <FONT STYLE="white-space:nowrap">pro-inflammatory</FONT> <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>T&nbsp;cells for use in the treatment of inflammatory conditions,
such as autoimmune disorders, for example, IBD, ulcerative colitis, Crohn&#146;s disease and celiac disease, among others. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">161</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We exclusively licensed and <FONT STYLE="white-space:nowrap">co-own</FONT> a patent portfolio of ten patent
families from New York University. As of June&nbsp;30, 2020, there are five families of intellectual property within this patent portfolio covering compositions of matter and methods of use for antibodies targeting
<FONT STYLE="white-space:nowrap">galectin-9,</FONT> including <FONT STYLE="white-space:nowrap">LYT-200,</FONT> which in total comprise two issued U.S. patents which are expected to expire in 2038, seven pending U.S. patent applications, which if
issued, are expected to expire 2037-2040, three international PCT applications, and 12 pending applications in foreign jurisdictions. There are two families covering compositions of matter and methods of use for antibodies targeting <FONT
STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>T&nbsp;cells, including <FONT STYLE="white-space:nowrap">LYT-210,</FONT> which are directed to the use of these antibodies for the treatment of cancer and <FONT
STYLE="white-space:nowrap">pro-inflammatory</FONT> and autoimmune disorders, which in total comprise one granted U.S. patent, one pending U.S. patent application and two international PCT applications. In addition, there are two additional families
of intellectual property covering compositions of matter and methods of use for related IO technologies, which in total comprise six patent applications in U.S. and foreign jurisdictions. Our issued patents and any patents issuing from pending
applications with respect to <FONT STYLE="white-space:nowrap">LYT-200</FONT> are expected to expire in between 2038 and 2040, any patents issuing from pending applications with respect to <FONT STYLE="white-space:nowrap">LYT-210</FONT> are expected
to expire in between 2039 and 2040, and our additional families of pending applications are expected to expire in 2037, all of which expiration dates are exclusive of possible patent term adjustments or extensions or other periods of exclusivity.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Oral Biotherapeutics Program </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have broad
intellectual property coverage for our Orasome technology platform. Our Orasome technology platform IP portfolio covers compositions of matter, methods of use and methods of treatment spanning various platform-based technologies, as well as various
broad classes of Orasome-formulated therapeutics, which include nucleic acid-based therapeutics (such as messenger RNA, short interfering RNA and antisense oligonucleotide-based approaches), small molecules, biologics (such as peptides, proteins and
antibodies), expression systems for biologics and other therapeutics for use in the treatment of a wide range of diseases and disorders, including various immunological disorders, such as cancers and inflammatory diseases. In addition, we licensed
patents and patent application on certain milk exosome technology of oral administration of biotherapeutics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, our Orasome
technology platform patent portfolio consists of ten U.S. and five foreign patent applications and one pending international PCT application in seven patent families. Any patents to issue from the patent applications are expected to expire in 2037
through 2041, exclusive of possible patent term adjustments or extensions or other forms of exclusivity. We exclusively licensed a patent portfolio consisting of two patent families from 3P Biotechnologies, Inc., based on certain milk exosome
technology originating from the University of Louisville. In addition, we exclusively licensed a patent portfolio consisting of two patent families from NuTech Ventures, based on certain milk exosome technology originating from the University of
Nebraska. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Glyph Technology Platform </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have broad
intellectual property coverage for our proprietary Glyph technology platform, which includes exclusively licensed and <FONT STYLE="white-space:nowrap">co-owned</FONT> patent applications, as well as company-owned patent applications. These patent
applications cover compositions of matter, methods of use and methods of treatment encompassing specific chemical modifications, including a wide range of novel linker chemistries, as well as various classes of lymphatic targeting therapeutics,
which include prodrugs for a large number of APIs, for use in the treatment of a wide range of diseases and disorders. The most advanced of these is <FONT STYLE="white-space:nowrap">LYT-300,</FONT> which is an oral form of <FONT
STYLE="white-space:nowrap">FDA-approved</FONT> allopregnanolone, a natural neurosteroid, that may be applicable to a range of neurological conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As
of June&nbsp;30, 2020, our Glyph technology platform IP portfolio consists of 19 patent families comprising 19 U.S. patent applications, four international PCT applications and 14 foreign patent applications. Of these, company-owned IP consists of
12 U.S. patent applications in nine patent families. We exclusively licensed and <FONT STYLE="white-space:nowrap">co-own</FONT> a patent portfolio of 10 patent families comprising 20 U.S. and foreign patent applications and four international PCT
applications from Monash University. Of these patent applications, <FONT STYLE="white-space:nowrap">LYT-300</FONT> is covered by two patent families comprising one international PCT application and two U.S. patent applications, all of which
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">162</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
are <FONT STYLE="white-space:nowrap">co-owned</FONT> with Monash University. Any patents to issue from the <FONT STYLE="white-space:nowrap">in-licensed</FONT> patent applications are expected to
expire in 2035-2036 and any issued patents from the <FONT STYLE="white-space:nowrap">co-owned</FONT> and company-owned patent applications are expected to expire in 2038-2041, exclusive of possible patent term adjustments or extensions or other
forms of exclusivity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Meningeal Lymphatics Discovery Research Program </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have broad intellectual property coverage around our meningeal lymphatics discovery research program, which includes exclusively licensed patent
applications covering compositions of matter, methods of use and methods of treatment encompassing its platform-based brain lymphatic technologies, including the identification of macromolecular targets, as well as various classes of brain lymphatic
targeting therapeutics for use in the treatment of a wide range of neurodegenerative and neuroinflammatory conditions, as well as various neuropathies and cancers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, our meningeal lymphatics discovery research program patent portfolio consists of eight patent families comprising eight U.S. patent
applications, two international PCT applications and five foreign patent applications exclusively licensed from the University of Virginia Licensing&nbsp;&amp; Ventures Group, and one family of one U.S. application exclusively owned by PureTech. Any
patents to issue from the <FONT STYLE="white-space:nowrap">in-licensed</FONT> patent applications are expected to expire in 2037 through 2041, exclusive of possible patent term adjustments or extensions or other forms of exclusivity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our commercial success depends in part upon our ability to obtain and maintain patent and other proprietary protection for commercially important
technologies, inventions <FONT STYLE="white-space:nowrap">and&nbsp;know-how&nbsp;related</FONT> to our business, defend and enforce our intellectual property rights, particularly our patent rights, preserve the confidentiality of our trade secrets
and operate without infringing valid and enforceable intellectual property rights of others. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The patent positions for biotechnology companies like us are
generally uncertain and can involve complex legal, scientific and factual issues. In addition, the coverage claimed in a patent application can be significantly reduced before a patent is issued, and its scope can be reinterpreted and even
challenged after issuance. As a result, we cannot guarantee that any of our technologies and product candidates will be protectable or remain protected by valid and enforceable patents. We cannot predict whether the patent applications we are
currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary protection from competitors. Any patents that we hold may be challenged, circumvented or
invalidated by third parties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Founded Entities&#146; Intellectual Property Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Founded Entities, other than Alivio and Entrega, maintain their own intellectual property portfolios and manage their intellectual property strategy. The
ownership percentages for each of our Founded Entities noted below, other than Karuna, are calculated on a diluted (as opposed to voting) basis, including outstanding shares, options and warrants, but excluding unallocated shares authorized to be
issued pursuant to equity incentive plans. Karuna ownership is shown on an outstanding share basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Gelesis </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, Gelesis&#146; platform has broad intellectual property coverage worldwide, including over 120&nbsp;patents and patent applications in
11&nbsp;families, several of which are issued in the United States and numerous foreign jurisdictions, including the EU, Canada, Japan, Russia and South Korea. The filings cover pharmaceutical composition of matter, methods of use, and methods of
making polymer hydrogels for use in weight management and glycemic control, as well as predicting weight loss and treating obesity, chronic constipation, NASH, NAFLD, and IBD. Gelesis&#146; issued patent and any patents issuing from pending
applications are expected to expire in 2027 through 2038, exclusive of possible patent term adjustments or extensions or other forms of exclusivity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">163</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own 21.0&nbsp;percent of Gelesis as of June&nbsp;30, 2020. Our board designees represent a minority of the
members of the board of directors of Gelesis and we are not responsible for the development or commercialization of its product candidates. We have an interest in Gelesis&#146; product candidates through our equity investment as well as our right to
royalty payments as a percentage of net sales pursuant to a license agreement between us and Gelesis. Gelesis maintains its own intellectual property portfolio and manages its intellectual property strategy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Karuna </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna has broad intellectual property coverage
worldwide, including, according to Karuna&#146;s annual report on Form 10-K filed March 24, 2020, two issued U.S. patents directed to an oral medicament comprising certain doses of xanomeline and/or the salt thereof in combination with certain doses
of trospium chloride and two issued U.S. patents directed to methods for treating central nervous system disorders using combinations of certain oral doses of xanomeline and/or the salt thereof and certain oral doses of trospium chloride. They also
have one issued patent in Canada and one in Europe, with other patent applications pending in the U.S., Europe, Hong Kong and Japan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own
12.8&nbsp;percent of Karuna as of August&nbsp;26, 2020 on an outstanding voting share basis. We do not have any board designees on Karuna&#146;s board of directors and we are not responsible for the development or commercialization of its product
candidate. We have an interest in Karuna&#146;s product candidates through our equity investment as well as our right to royalty payments as a percentage of net sales pursuant to a license agreement between us and Karuna. Karuna maintains its own
intellectual property portfolio and manages its intellectual property strategy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Follica </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June 30, 2020, Follica&#146;s regenerative biology program has broad worldwide intellectual property coverage, including over 16 pending patent
applications, and over 49 issued patents (of which 32 are design patents), in 10 families of patent filings, which are company-owned or exclusively licensed. The intellectual property covers composition of matter and methods of treatment including
combination therapies employing disruption approaches and active agents, as well as devices to promote hair follicle regeneration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own
78.3&nbsp;percent of Follica as of June&nbsp;30, 2020 and continue to play a role in the development of its product candidates through our majority representation on its board of directors. We also have an interest in Follica&#146;s product
candidates through our right to royalty payments as a percentage of net sales pursuant to a royalty agreement between us and Follica. Follica maintains its own intellectual property portfolio and manages its intellectual property strategy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Vedanta </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June 30, 2020, Vedanta has broad
intellectual property coverage worldwide, currently owning or having rights to more than 140 patent applications and issued patents in over 22 families of patent filings. Vedanta&#146;s IP estate positions the company as a leader in the microbiome
field. Vedanta&#146;s IP portfolio includes patents covering compositions and therapeutic uses of products containing microbiome bacteria belonging to Clostridium clusters IV and XIVa, which are among the most abundant colonizers of the human
intestine and play an important role in human health, including regulating inflammatory responses and other immune responses. The IP estate includes issued patents in the major pharmaceutical markets, including the United States, Europe and Japan.
These patents provide coverage through at least 2031, with priority filing dates as early as 2010. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own 50.4&nbsp;percent of Vedanta as of
June&nbsp;30, 2020 and continue to play a role in the development of its product candidates through our majority representation on its board of directors. Vedanta maintains its own intellectual property portfolio and manages its intellectual
property strategy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Sonde </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020,
Sonde has broad intellectual property coverage worldwide, currently owning or having exclusive rights to eight patent applications and 10 issued patents in five families of patent filings. Sonde has </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">164</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
filed several patent applications covering a number of facets of its technology in addition to the IP that was licensed from MIT. Sonde&#146;s issued patent and any patents issuing from pending
applications are expected to expire in 2031 through 2037, exclusive of possible patent term adjustments or extensions or other forms of exclusivity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
own 45.8&nbsp;percent of Sonde as of June&nbsp;30, 2020 and continue to play a role in the development of its product candidates through our representation on its board of directors. Sonde maintains its own intellectual property portfolio and
manages its intellectual property strategy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Alivio </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June 30, 2020, Alivio has broad intellectual property coverage in multiple countries, currently owning or having exclusive rights to 24&nbsp;patent
applications and six issued patents in nine families of patent filings. Alivio&#146;s IP estate covers composition of matter, novel formulations, and methods of using nanostructured gels for the delivery of therapeutic agents. Alivio&#146;s issued
patent and any patents issuing from pending applications are expected to expire in 2036 through 2039, exclusive of possible patent term adjustments or extensions or other forms of exclusivity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own 78.6&nbsp;percent of Alivio as of June&nbsp;30, 2020 and continue to play a role in the development of its product candidates. The management team of
Alivio consists of PureTech employees, and a majority of the board of directors are PureTech designees. These PureTech employees actively manage the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business
activities of Alivio and, together with the board of directors of Alivio, which is controlled by PureTech, direct the strategy and decision making in connection with the clinical and regulatory development of Alivio&#146;s product candidates. We
maintain Alivio&#146;s intellectual property portfolio and manage its intellectual property strategy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Entrega </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June 30, 2020, Entrega has broad intellectual property coverage worldwide, including 10 patent applications in six families of patent filings.
Entrega&#146;s patent portfolio covers oral drug devices, drug formulations, compositions of matter, methods of use and methods of making hydrogel dosage forms for delivery of active agents. Any patents issuing from pending applications are expected
to expire in 2033 through 2039, exclusive of possible patent term adjustments or extensions or other forms of exclusivity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own 72.9&nbsp;percent of
Entrega as of June&nbsp;30, 2020 and continue to play a role in the development of its product candidates. The management team of Entrega consists of PureTech employees, and a majority of the board of directors are PureTech designees. These PureTech
employees actively manage the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business activities of Entrega and, together with the board of directors of Entrega, which is controlled by PureTech, direct the
strategy and decision making in connection with the clinical and regulatory development of Entrega&#146;s product candidates. We maintain Entrega&#146;s intellectual property portfolio and manage its intellectual property strategy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Akili </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, Akili&#146;s IP
portfolio covers digital intervention that targets interference processing through a proprietary mechanism with adaptive algorithms to improve cognitive function and related symptoms associated with neurological and psychiatric conditions. The IP
estate also covers novel adaptive algorithms and reward structures invented by Akili to apply to various neural targeting algorithms. Akili owns or has exclusive rights to nine issued or granted patents and is actively pursuing additional patent
applications worldwide.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own 34.0&nbsp;percent of Akili as of June&nbsp;30, 2020. We do not have a direct interest in Akili&#146;s product candidates.
Our interest in Akili&#146;s product candidates is limited to our equity investment in Akili and we do not control the clinical or regulatory development of Akili&#146;s product candidates. Akili maintains its own intellectual property portfolio and
manages its intellectual property strategy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">165</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Vor </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As
of June&nbsp;30, 2020, Vor is pursuing broad intellectual property coverage worldwide to protect Vor&#146;s proprietary platform technology and product candidates, such as VOR33, with pending and granted claims to compositions of matter, methods of
use, related technologies, diagnostics and other complimentary inventions. Vor&#146;s worldwide IP portfolio includes over 40 patent applications in eight families, including three issued US patents. Vor&#146;s portfolio includes patents licensed
exclusively from Columbia University as well as patents owned by Vor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own 11.8&nbsp;percent of Vor as of June&nbsp;30, 2020, assuming all future
tranches of the most recent financing round are funded. We do not have a direct interest in Vor&#146;s product candidate. Our interest in Vor&#146;s product candidate is limited to our equity investment in Vor, and we do not control the clinical or
regulatory development of Vor&#146;s product candidate. Vor maintains its own intellectual property portfolio and manages its intellectual property strategy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>License Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Wholly Owned Programs
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a disciplined strategy to advance our Wholly Owned Programs and technologies through a combination of internal funding and <FONT
STYLE="white-space:nowrap">non-dilutive</FONT> funding from external collaborations, such as with other biopharmaceutical companies and grant funding organizations. Given the breadth of applications envisioned from our internal platform
technologies, we have a strategy to maximize the value of our Wholly Owned Programs through partnerships with other biopharmaceutical companies, that also serves to not only advance these technologies but also provide important external validation
for our technologies. In April 2019, we entered into a collaboration and license agreement with Boehringer Ingelheim, or BI, to evaluate the feasibility of applying our lGlyph technology platform to advance certain of BI&#146;s immuno-oncology
product candidates. Our proposed approach harnesses the gut&#146;s lipid transport mechanisms to enable oral administration and transport of drug candidates directly through the <FONT STYLE="white-space:nowrap">gut-draining</FONT> lymphatic
vasculature, also bypassing first pass metabolism in the liver. We plan to continue to partner with other biopharmaceutical companies to develop product candidates that we believe have promising utility in disease areas or patient populations that
are better served by resources of larger biopharmaceutical companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Another example of this strategy is the Research and License Agreement that we
entered into with New York University, or NYU, on March&nbsp;6, 2017, pursuant to which NYU granted to us an exclusive worldwide license to patents relating to <FONT STYLE="white-space:nowrap">LYT-200</FONT> and
<FONT STYLE="white-space:nowrap">LYT-210.</FONT> In connection with this agreement, we are required to pay an annual license fee in addition to milestone payments upon the achievement of certain clinical and commercial milestones, both of which we
deem immaterial. Additionally, for the term of this agreement, we are obligated to make low single digit royalty payments on the net sales of any commercialized product covered by the license granted under the agreement. In the event that we
sublicense any of the patent rights granted under the Research and License Agreement, we will be obligated to pay NYU a low teen percentage of any royalties received by such sublicensee, provided that such payments are capped at a low single digit
of net sales of any commercialized product by such sublicensee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have also entered into exclusive license agreements with each of Monash University,
University of Louisville, , Memorial Sloan Kettering Cancer Center and University of Virginia, pursuant to which we have <FONT STYLE="white-space:nowrap">in-licensed</FONT> certain early stage technology for our Wholly Owned Programs Pursuant to
these agreements, the universities are entitled to <FONT STYLE="white-space:nowrap">non-material</FONT> payments upon the achievement of certain specified development and sales based milestones. Additionally, the universities are entitled to low
single digit royalty payments on net sales of any products covered by their intellectual property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Founded Entities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Gelesis </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We entered into a Royalty and Sublicense Income
Agreement with Gelesis, dated December&nbsp;18, 2009, pursuant to which we are required to provide certain funding, management services and intellectual property relating to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">166</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
intellectual property. In exchange, Gelesis is required to pay us a royalty equal to 2&nbsp;percent of all net product sales and 10&nbsp;percent of gross sublicense income received on certain
food products as a result of developing hydrogel-based products that are covered by a licensed patent that has issued and has not been revoked or abandoned. The royalty rate is subject to customary downward adjustments in the event Gelesis is
required to pay third parties to obtain a license to intellectual property rights that are necessary for Gelesis to develop or commercialize our products. There are no milestone payment obligations under this agreement. Management services provided
by us include advisory services on corporate strategy, general and administrative support including office space, supplies and administrative support, payroll services and website development and support. Gelesis&#146; obligation to pay royalties to
us will terminate on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis upon termination or expiration of the underlying patents. To date, we have not received any royalty payments pursuant to
this agreement. We do not direct or control the development and commercialization of the intellectual property sublicensed pursuant to this agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Karuna </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We entered into an Exclusive Patent License
Agreement with Karuna, dated March&nbsp;4, 2011, pursuant to which we granted Karuna an exclusive license to patent rights relating to combinations of a muscarinic activator with a muscarinic inhibitor for the treatment of central nervous system
disorders. Karuna agreed to make milestone payments to us of up to an aggregate of $10&nbsp;million upon the achievement of specified development and regulatory milestones. In addition, for the term of this agreement Karuna is obligated to pay us
low single-digit running royalties on the worldwide net sales of any commercialized product covered by the licenses granted under this agreement. In the event that Karuna sublicenses any of the patent rights granted under this agreement, Karuna will
be obligated to pay us royalties within the range of 15&nbsp;percent to 25&nbsp;percent on any income received from the sublicensee, excluding royalties. Karuna may terminate this agreement for any reason with proper prior notice to us, provided
that it would lose its rights to the underlying patents as a result. Either party may terminate this agreement upon an uncured material breach by the other party. To date, we have not received any royalty payments pursuant to this agreement. We do
not direct or control the development and commercialization of the intellectual property licensed pursuant to this agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Follica </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We entered into an Exclusive Patent License Agreement with Follica, dated July&nbsp;16, 2008, pursuant to which we granted Follica an exclusive license to
patent rights relating to composition of matter and methods of treatment including combination therapies employing disruption approaches and active agents for the treatment of aging-related disorders and other medical indications. Pursuant to the
agreement, Follica is obligated to make milestone payments to us of up to an aggregate $1&nbsp;million upon the achievement of specified development and regulatory milestones. For the term of this agreement, Follica is obligated to pay to us low
single-digit running royalties on net sales of any commercialized product, process or service that would infringe a valid claim of patent rights but for the license granted pursuant to this agreement. Additionally, for ten years following the first
commercial sale of any commercialized product, process or service covered by the license granted under this agreement, Follica is obligated to pay us low single-digit <FONT STYLE="white-space:nowrap">know-how</FONT> royalties on net sales for use in
any country where such commercialized product, process or service is not covered by a valid claim of patent rights. In the event that Follica sublicenses any of the patents granted to it under this agreement, Follica will be obligated to pay us
royalties within the range of mid single-digit and mid teen percentages of any income received from the sublicensee. We may terminate this agreement upon written notice from Follica that it has conclusively abandoned all efforts with respect to the
development or commercialization of licensed products, processes and services. Either party may terminate this agreement upon an uncured material breach by the other party. To date, we have not received any royalty payments pursuant to this
agreement. We do not direct or control the development and commercialization of the intellectual property licensed pursuant to this agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We entered
into a Royalty Agreement with Follica, dated July&nbsp;23, 2013, pursuant to which Follica agreed to pay us a two percent royalty on net sales by Follica or its sublicensees of (i)&nbsp;products involving skin disruption using
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">167</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any mechanical, energy or chemical based approaches, applying compounds to the skin, or any other approaches to the treatment of hair follicles or other dermatological disorders commercialized by
Follica. (ii)&nbsp;processes involving such products, or (iii)&nbsp;services which use or incorporate any such product or process. In the event that Follica sublicenses the rights to any of these products, processes or services, Follica will be
obligated to pay us low teen royalties on any income received from the sublicensee. Either party may terminate this agreement upon an uncured material breach by the other party. To date, we have not received any royalty payments pursuant to this
agreement. We do not direct or control the development and commercialization of the intellectual property licensed pursuant to this agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The biotechnology and pharmaceutical
industries utilize rapidly advancing technologies and are characterized by intense competition. There is also a strong emphasis on intellectual property and proprietary products. We believe that expertise and capabilities across the BIG therapeutic
areas, technology, drug discovery and development provide us with a competitive advantage. However, we will continue to face competition from different sources including major pharmaceutical companies, biotechnology companies, academic institutions,
government agencies, and public and private research institutions. In addition, there are companies that are working on potential medicines targeting the <FONT STYLE="white-space:nowrap">Brain-Immune-Gut</FONT> and many companies that have approved
therapeutics for some of our target indications. For any products that we eventually commercialize, we will not only compete with existing therapies but also compete with new therapies that may become available in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the competition we will face from the parties described above, we face competition for certain of the product candidates we are developing
internally. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">LYT-100</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are aware of one current drug product candidate in development for secondary lymphedema. Herantis Pharma is developing Lymfactin, an adenoviral <FONT
STYLE="white-space:nowrap">VEGF-C</FONT> gene therapy used alongside lymph node transfer surgery to treat lymphedema. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The other current treatments for
lymphedema include durable medical goods, such as compression sleeves and garments, and surgical options, including liposuction and debulking. A novel investigational surgery, lymph node transfer, is also being tested. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">LYT-200</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although
we are not aware of any direct competitors targeting <FONT STYLE="white-space:nowrap">galectin-9,</FONT> if we are successful in developing <FONT STYLE="white-space:nowrap">LYT-200</FONT> as an immuno-oncology treatment we would expect to compete
with currently approved IO therapies and those that may be developed in the future. Current marketed IO products include <FONT STYLE="white-space:nowrap">CTLA-4,</FONT> such as BMS&#146; Yervoy, and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">PD-1/PD-L1,</FONT></FONT> such as BMS&#146; Opdivo, Merck&#146;s Keytruda and Genentech&#146;s Tecentriq, and T cell-engager immunotherapies, such as Amgen&#146;s Blincyto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the field of IPF, there are two approved drugs, pirfenidone (Esbriet), marketed by Roche, and nintedanib (Ofev), marketed by Boehringer Ingelheim. These
drugs have unfavorable tolerability profiles, leading to sustained unmet need for novel therapies. Other potential competitive product candidates in various stages of development include, but are not limited to, Galapagos NV&#146;s GLPS1690 in Phase
3 clinical trials, Fibrogen&#146;s pamrevlumab in Phase 3 clinical trials, Roche/Promedior, Inc.&#146;s <FONT STYLE="white-space:nowrap">PRM-151</FONT> which is expected to enter a Phase 3 trial in the second half of 2020, Liminal BioSciences&#146; <FONT
STYLE="white-space:nowrap">PBI-4050</FONT> is in Phase 2 clinical development, Pliant Therapeutics&#146; <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in Phase 2 clinical development, Kadmon Holding, Inc.&#146;s KD025 in Phase 2 clinical
development, BMS&#146; <FONT STYLE="white-space:nowrap">BMS-986278</FONT> in Phase 2 clinical development, BMS/Celgene&#146;s <FONT STYLE="white-space:nowrap">CC-90001</FONT> in Phase 2 clinical development, Galecto&#146;s GB0139 in Phase 2 clinical
development, Blade Therapeutics&#146;s <FONT STYLE="white-space:nowrap">BLD-2660</FONT> in Phase 1 clinical development and Avalyn&#146;s AP01 in Phase 1 clinical development. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">168</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the field of <FONT STYLE="white-space:nowrap">COVID-19,</FONT> there are numerous clinical trials for
prevention of <FONT STYLE="white-space:nowrap">COVID-19</FONT> using vaccines, or for acute treatment of <FONT STYLE="white-space:nowrap">COVID-19</FONT> using anti-viral and anti-inflammatory agents. However, we are only aware of investigator
sponsored trials that have been undertaken with pirfenidone and nintedanib for respiratory complications following <FONT STYLE="white-space:nowrap">COVID-19</FONT> infection. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">LYT-210</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the
best of our knowledge, there are no competitors in the space of immunosuppressive <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells. However, Gamma Delta Therapeutics, Gadeta, TC Biopharm, Adicet
Bio are developing <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cell based therapies at various stages of development. Lava Therapeutics is developing <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells engaging antibodies and ImCheck is developing antibodies to target affecting <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cell expansion in tissues.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">LYT-300</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
the field of GABA<SUB STYLE="font-size:85%; vertical-align:bottom">A </SUB>positive allosteric modulators, there is one approved drug, allopregnanolone (Zulresso), marketed by Sage Therapeutics. This drug is administered via a 60 hour IV infusion,
leading to sustained unmet need for novel therapies. Other potential competitive product candidates in various stages of development include, but are not limited to, Sage Therapeutics&#146;s SAGE-2017 (Zuranolone) in Phase 3 clinical development,
Marinus Pharmaceuticals&#146;s Ganaxolone in Phase 3 clinical development and Praxis&#146;s <FONT STYLE="white-space:nowrap">PRAX-114</FONT> in Phase 2 clinical development. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Programs </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not aware of any direct
competitors to our Glyph, Orasome and meningeal lymphatics platforms, but they may compete with new therapies that become available in the future to target the indications we are focused on. There are several exosome programs being developed but to
the best of our knowledge none of them are targeting oral delivery or using milk, thus differentiating our approach. Competitors developing exosomes or engineered exosomes to deliver payloads include Inc AstraZeneca plc, Capricor Therapeutics, Evox
Therapeutics Ltd, ArunA Biomedical Inc, ExoCoBio Inc, Codiak Biosciences, Inc. and Exopharm Ltd. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Government authorities in the United States, at the federal, state and local level, and in other countries and jurisdictions, including the European Union,
extensively regulate, among other things, the research, development, testing, manufacture, quality control, approval, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, post-approval monitoring and
reporting, and import and export of drugs, biological products and medical devices. The processes for obtaining regulatory approvals in the United States and in foreign countries and jurisdictions, along with subsequent compliance with applicable
statutes and regulations, require the expenditure of substantial time and financial resources. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Government Regulation of Drug and Biological
Products </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, or FDCA, and its implementing regulations and
biologics under the FDCA and the Public Health Service Act, or PHSA, and their implementing regulations. Both drugs and biologics also are subject to other federal, state and local statutes and regulations, such as those related to competition. The
process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, and local statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable
U.S. requirements at any time during the product development process, approval process or following approval may subject an applicant to administrative actions or judicial sanctions. These actions and sanctions could include, among other actions,
the FDA&#146;s refusal to approve pending applications, withdrawal of an approval, license revocation, a clinical hold, untitled or warning letters, voluntary or mandatory product recalls or market withdrawals, product seizures, total
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">169</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement and civil or criminal fines or penalties. Any agency or
judicial enforcement action could have a material adverse effect on our business, the market acceptance of our products and our reputation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Product
candidates must be approved by the FDA through either a new drug application, or NDA, or a biologics license application, or BLA, process before they may be legally marketed in the United States. The process generally involves the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">completion of nonclinical, or preclinical, laboratory tests, animal studies and formulation studies in compliance
with the FDA&#146;s GLP regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submission to the FDA of an investigational new drug application, or IND, which must take effect before human
clinical trials may begin; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval by an independent IRB representing each clinical site before each clinical trial may be initiated at
that site; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">performance of adequate and well-controlled human clinical trials in accordance with good clinical practices, or
GCPs, to establish the safety and efficacy of the proposed drug product for each indication; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparation and submission to the FDA of an NDA or BLA, and payment of user fees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a determination by the FDA within 60 days of its receipt of an NDA or BLA to accept the application for
substantive review; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">review of the product by an FDA advisory committee, where appropriate or if applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of one or more FDA <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspections of
the manufacturing facility or facilities where the drug or biologic will be produced to assess compliance with Current Good Manufacturing Practices, or cGMP, requirements to assure that the facilities, methods and controls are adequate to preserve
the drug or biologic&#146;s identity, strength, quality and purity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of potential FDA audits of clinical trial sites to assure compliance with GCPs and the
integrity of the clinical data; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FDA review and approval of the NDA, including consideration of the views of any FDA advisory committee, prior to
any commercial marketing or sale of the drug or biologic in the United States. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical Studies </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before testing any drug or biological product candidate in humans, the product candidate must undergo rigorous preclinical testing. Preclinical studies include
laboratory evaluation of product chemistry and formulation, as well as in vitro and animal studies to assess safety and in some cases to establish a rationale for therapeutic use. The conduct of preclinical studies is subject to federal and state
regulations and requirements, including GLP regulations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The IND and IRB Processes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An IND is an exemption from the FDCA that allows an unapproved drug or biological product to be shipped in interstate commerce for use in an investigational
clinical trial and a request for FDA authorization to administer such investigational drug or biological product to humans. Such authorization must be secured prior to interstate shipment and administration of the investigational drug or biological
product. In an IND, applicants must submit a protocol for each clinical trial and any subsequent protocol amendments. In addition, the results of the preclinical tests, manufacturing information, analytical data, any available clinical data or
literature and plans for clinical trials, among other things, are submitted to the FDA as part of an IND. Some long-term preclinical testing, such as animal tests of reproductive AEs and carcinogenicity, may continue after the IND is submitted. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">170</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA requires a <FONT STYLE="white-space:nowrap">30-day</FONT> waiting period after the filing of each IND
before clinical trials may begin. At any time during this <FONT STYLE="white-space:nowrap">30-day</FONT> period, the FDA may raise concerns or questions about the conduct of the trials as outlined in the IND and impose a clinical hold. In this case,
the IND sponsor and the FDA must resolve any outstanding concerns before clinical trials can begin. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following commencement of a clinical trial under an
IND, the FDA may also place a clinical hold or partial clinical hold on that trial due to safety concerns or <FONT STYLE="white-space:nowrap">non-compliance</FONT> with specific FDA requirements. A clinical hold is an order issued by the FDA to the
sponsor to delay a proposed clinical investigation or to suspend an ongoing investigation. A partial clinical hold is a delay or suspension of only part of the clinical work requested under the IND. No more than 30 days after imposition of a
clinical hold or partial clinical hold, the FDA will provide the sponsor a written explanation of the basis for the hold. Following issuance of a clinical hold or partial clinical hold, an investigation may only resume after the FDA has notified the
sponsor that the investigation may proceed. The FDA will base that determination on information provided by the sponsor correcting the deficiencies previously cited or otherwise satisfying the FDA that the investigation can proceed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A sponsor may choose, but is not required, to conduct a foreign clinical study under an IND. When a foreign clinical study is conducted under an IND, all FDA
IND requirements must be met unless waived. When the foreign clinical study is not conducted under an IND, the FDA may accept data from such study if the sponsor ensures that the study is conducted in accordance with GCP, including review and
approval by an independent ethics committee, or IEC, and informed consent from subjects. The FDA must also be able to validate the data from the study through an <FONT STYLE="white-space:nowrap">on-site</FONT> inspection if necessary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the foregoing IND requirements, an IRB representing each institution participating in the clinical trial must review and approve the plan for
any clinical trial before it commences at that institution, and the IRB must conduct continuing review of the study at least annually. The IRB must review and approve, among other things, the study protocol and informed consent information to be
provided to study subjects. An IRB must operate in compliance with FDA regulations. An IRB can suspend or terminate approval of a clinical trial at its institution, or an institution it represents, if the clinical trial is not being conducted in
accordance with the IRB&#146;s requirements or if the product candidate has been associated with unexpected serious harm to patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, some
trials are overseen by an independent group of qualified experts organized by the trial sponsor, often known as a data safety monitoring board or committee. This group provides authorization for whether or not a trial may move forward at designated
check points based on access that only the group maintains to available data from the study. Suspension or termination of development during any phase of clinical trials can occur if it is determined that the subjects or patients are being exposed
to an unacceptable health risk. Other reasons for suspension or termination may be made by us based on evolving business objectives and/or competitive climate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information about certain clinical trials must be submitted within specific timeframes to the NIH for public dissemination on its ClinicalTrials.gov website.
Information related to the product, patient population, phase of investigation, study sites and investigators and other aspects of the clinical trial is made public as part of the registration of the clinical trial. Although sponsors are obligated
to disclose the results of their clinical trials after completion, disclosure of the results can be delayed in some cases for up to two years after the date of completion of the trial. Failure to timely register a covered clinical study or to submit
study results as provided for in the law can give rise to civil monetary penalities and also prevent the <FONT STYLE="white-space:nowrap">non-compliant</FONT> party from receiving future frant funds from the federal government. The NIH&#146;s Final
Rule on ClinicalTrials.gov registration and reporting requirements became effective in 2017, and both NIH and FDA recently signaled the government&#146;s willingness to begin enforcing those requirements against
<FONT STYLE="white-space:nowrap">non-compliant</FONT> clinical trial sponsors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical Trials </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The clinical stage of development involves the administration of the investigational product to healthy volunteers or patients under the supervision of
qualified investigators, generally physicians not employed by or under the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">171</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
trial sponsor&#146;s control, in accordance with GCP requirements, which include the requirement that all research subjects provide their informed consent for their participation in any clinical
trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria, the parameters to be used to monitor subject safety and the
effectiveness criteria to be evaluated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Human clinical trials are typically conducted in three sequential phases, which may overlap or be combined: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase 1</I>. The drug is initially introduced into healthy human subjects or, in certain indications such as
cancer, patients with the target disease or condition and tested for safety, dosage tolerance, absorption, metabolism, distribution, excretion and, if possible, to gain an early indication of its effectiveness and to determine optimal dosage.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase 2</I>. The drug is administered to a limited patient population to identify possible adverse effects and
safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase 3</I>. The drug is administered to an expanded patient population, generally at geographically dispersed
clinical trial sites, in well-controlled clinical trials to generate enough data to evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit profile of the product and to provide adequate information for
the labeling of the product. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2018, the FDA released a draft guidance entitled &#147;Expansion Cohorts: Use in <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">First-In-Human</FONT></FONT> Clinical Trials to Expedite Development of Oncology Drugs and Biologics,&#148; which provides information for drug developers regarding the design and conduct
of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trials designed to expedite the clinical development of cancer drugs, including biological products, through multiple expansion cohort trials.
Expansion cohort trials are designed to expedite development by seamlessly proceeding from the initial determination of a potentially effective dose to individual cohorts that have trial objectives typical of Phase 2 trials, such as evaluation of
anti-tumor activity, or confirming the safety of a RP2D. Information to support the design of individual expansion cohorts are included in IND applications and assessed by FDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Post-approval trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial marketing approval. These trials are used to gain
additional experience from the treatment of patients in the intended therapeutic indication and are commonly intended to generate additional safety data regarding use of the product in a clinical setting. In certain instances, the FDA may mandate
the performance of Phase 4 clinical trials as a condition of approval of an NDA or BLA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Progress reports detailing the results of the clinical trials,
among other information, must be submitted at least annually to the FDA and written IND safety reports must be submitted to the FDA and the investigators 15 days after the trial sponsor determines the information qualifies for reporting for serious
and unexpected suspected AEs, findings from other studies or animal or <I>in vitro</I> testing that suggest a significant risk for human subjects and any clinically important increase in the rate of a serious suspected adverse reaction over that
listed in the protocol or investigator brochure. The sponsor must also notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction as soon as possible but in no case later than seven calendar days after the sponsor&#146;s
initial receipt of the information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Phase 1, Phase 2, Phase 3 and other types of clinical trials may not be completed successfully within any specified
period, if at all. The FDA or the sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research subjects or patients are being exposed to an unacceptable health risk. Similarly, an IRB can
suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#146;s requirements or if the drug or biologic has been associated with unexpected serious harm to patients.
Concurrent with clinical trials, companies usually complete additional animal studies and also must develop additional information about the chemistry and physical characteristics of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">172</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the drug or biologic as well as finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of
consistently producing quality batches of the product and, among other things, companies must develop methods for testing the identity, strength, quality and purity of the final product. Additionally, appropriate packaging must be selected and
tested and stability studies must be conducted to demonstrate that the product candidates do not undergo unacceptable deterioration over their shelf life. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>FDA Review Process </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following completion of the
clinical trials, data are analyzed to assess whether the investigational product is safe and effective for the proposed indicated use or uses. The results of preclinical studies and clinical trials are then submitted to the FDA as part of an NDA or
BLA, along with proposed labeling, chemistry and manufacturing information to ensure product quality and other relevant data. The NDA or BLA is a request for approval to market the drug or biologic for one or more specified indications and must
contain proof of safety and efficacy for a drug or safety, purity and potency for a biologic. The application may include both negative and ambiguous results of preclinical studies and clinical trials, as well as positive findings. Data may come
from company-sponsored clinical trials intended to test the safety and efficacy of a product&#146;s use or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be
sufficient in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of FDA. FDA approval of an NDA or BLA must be obtained before a drug or biologic may be marketed in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Prescription Drug User Fee Act, or PDUFA, as amended, each NDA or BLA must be accompanied by a user fee. FDA adjusts the PDUFA user fees on an
annual basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on NDAs or BLAs for products
designated as orphan drugs, unless the product also includes a <FONT STYLE="white-space:nowrap">non-orphan</FONT> indication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA reviews all
submitted NDAs and BLAs before it accepts them for filing, and may request additional information rather than accepting the NDA or BLA for filing. The FDA must make a decision on accepting an NDA or BLA for filing within 60 days of receipt, and such
decision could include a refusal to file by the FDA. Once the submission is accepted for filing, the FDA begins an <FONT STYLE="white-space:nowrap">in-depth</FONT> review of the NDA or BLA. Under the goals and policies agreed to by the FDA under
PDUFA, the FDA targets ten months, from the filing date, in which to complete its initial review of a new molecular entity NDA or original BLA and respond to the applicant, and six months from the filing date of a new molecular entity NDA or
original BLA designated for priority review. The FDA does not always meet its PDUFA goal dates for standard and priority NDAs or BLAs, and the review process is often extended by FDA requests for additional information or clarification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before approving an NDA or BLA, the FDA will conduct a <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspection of the manufacturing facilities for the
new product to determine whether they comply with cGMP requirements. The FDA will not approve the product unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent
production of the product within required specifications. The FDA also may audit data from clinical trials to ensure compliance with GCP requirements. Additionally, the FDA may refer applications for novel products or products which present
difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation and a recommendation as to whether the application should be approved and under what conditions,
if any. The FDA is not bound by recommendations of an advisory committee, but it considers such recommendations when making decisions on approval. The FDA likely will reanalyze the clinical trial data, including in connection with an advisory
committee meeting, which could result in extensive discussions between the FDA and the applicant during the review process. After the FDA evaluates an NDA or BLA, it will issue an approval letter or a Complete Response Letter. An approval letter
authorizes commercial marketing of the drug or biologic with specific prescribing information for specific indications. A Complete Response Letter indicates that the review </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">173</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cycle of the application is complete and the application will not be approved in its present form. A Complete Response Letter usually describes all of the specific deficiencies in the NDA or BLA
identified by the FDA. The Complete Response Letter may require the applicant to obtain additional clinical data, including the potential requirement to conduct additional pivotal clinical trial(s) and/or to complete other significant and
time-consuming requirements related to clinical trials, or to conduct additional preclinical studies or manufacturing activities. If a Complete Response Letter is issued, the applicant may either resubmit the NDA or BLA, addressing all of the
deficiencies identified in the letter, or withdraw the application or request an opportunity for a hearing. Even if such data and information are submitted, the FDA may decide that the NDA or BLA does not satisfy the criteria for approval. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Expedited Development and Review Programs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A
sponsor may seek to develop and obtain approval of its product candidates under programs designed to accelerate the development, FDA review and approval of new drugs and biologics that meet certain criteria. For example, the FDA has a fast track
program that is intended to expedite or facilitate the process for reviewing new drugs and biologics that are intended to treat a serious or life threatening disease or condition and demonstrate the potential to address unmet medical needs for the
condition. Fast track designation applies to both the product and the specific indication for which it is being studied. For a fast track-designated product, the FDA may consider sections of the NDA or BLA for review on a rolling basis before the
complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the application, the FDA agrees to accept sections of the application and determines that the schedule is acceptable and the sponsor pays any
required user fees upon submission of the first section of the application. The sponsor can request the FDA to designate the product for fast track status any time before receiving NDA or BLA approval, but ideally no later than the <FONT
STYLE="white-space:nowrap">pre-NDA</FONT> or <FONT STYLE="white-space:nowrap">pre-BLA</FONT> meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A product submitted to the FDA for marketing,
including under a fast track program, may be eligible for other types of FDA programs intended to expedite development or review, such as priority review and accelerated approval. Priority review means that, for a new molecular entity or original
BLA, the FDA sets a target date for FDA action on the marketing application at six months after accepting the application for filing as opposed to ten months. A product is eligible for priority review if it is designed to treat a serious or
life-threatening disease condition and, if approved, would provide a significant improvement in safety and effectiveness compared to available therapies. The FDA will attempt to direct additional resources to the evaluation of an application for a
new drug or biologic designated for priority review in an effort to facilitate the review. If criteria are not met for priority review, the application for a new molecular entity or original BLA is subject to the standard FDA review period of ten
months after FDA accepts the application for filing. Priority review designation does not change the scientific/medical standard for approval or the quality of evidence necessary to support approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A product may also be eligible for accelerated approval if it is designed to treat a serious or life-threatening disease or condition and demonstrates an
effect on either a surrogate endpoint that is reasonably likely to predict clinical benefit or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, or IMM, that is reasonably likely to predict an effect on
IMM or other clinical benefit, taking into account the severity, rarity, or prevalence of the disease or condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require that a sponsor of a drug or
biologic receiving accelerated approval perform adequate and well-controlled post-marketing clinical trials. In addition, the FDA currently requires as a condition for accelerated approval <FONT STYLE="white-space:nowrap">pre-approval</FONT> of
promotional materials, which could adversely impact the timing of the commercial launch of the product. FDA may withdraw approval of a drug or indication approved under accelerated approval if, for example, the confirmatory trial fails to verify the
predicted clinical benefit of the product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, a drug or biologic may be eligible for designation as a breakthrough therapy if the product is
intended, alone or in combination with one or more other drugs or biologics, to treat a serious or life-threatening condition and preliminary clinical evidence indicates that the product may demonstrate substantial improvement
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">174</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
over currently approved therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. If the FDA designates a
breakthrough therapy, it may take actions appropriate to expedite the development and review of the application, which may include holding meetings with the sponsor and the review team throughout the development of the therapy; providing timely
advice to, and interactive communication with, the sponsor regarding the development of the drug to ensure that the development program to gather the nonclinical and clinical data necessary for approval is as efficient as practicable; involving
senior managers and experienced review staff, as appropriate, in a collaborative, cross-disciplinary review; assigning a cross-disciplinary project lead for the FDA review team to facilitate an efficient review of the development program and to
serve as a scientific liaison between the review team and the sponsor; and considering alternative clinical trial designs when scientifically appropriate, which may result in smaller trials or more efficient trials that require less time to complete
and may minimize the number of patients exposed to a potentially less efficacious treatment. Breakthrough therapy designation comes with all of the benefits of fast track designation, which means that the sponsor may file sections of the BLA for
review on a rolling basis if certain conditions are satisfied, including an agreement with the FDA on the proposed schedule for submission of portions of the application and the payment of applicable user fees before the FDA may initiate a review.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification
or the time period for FDA review or approval may not be shortened. Furthermore, fast track designation, priority review, accelerated approval and breakthrough therapy designation do not change the standards for approval. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Post-Marketing Requirements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following approval of
a new product, the manufacturer and the approved product are subject to continuing regulation by the FDA, including, among other things, monitoring and record-keeping activities, reporting of adverse experiences, complying with promotion and
advertising requirements, which include restrictions on promoting products for unapproved uses or patient populations (known as <FONT STYLE="white-space:nowrap">&#147;off-label</FONT> use&#148;) and limitations on industry-sponsored scientific and
educational activities. Although physicians may prescribe legally available products for <FONT STYLE="white-space:nowrap">off-label</FONT> uses, manufacturers may not market or promote such uses. The FDA and other agencies actively enforce the laws
and regulations prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses, and a company that is found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT> uses may be subject to significant
liability, including investigation by federal and state authorities. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first use or first publication. Further, if there are any modifications to the drug
or biologic, including changes in indications, labeling or manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new NDA/BLA or NDA/BLA supplement, which may require the development of additional
data or preclinical studies and clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA may also place other conditions on approvals including the requirement for a Risk Evaluation and
Mitigation Strategy, or REMS, to assure the safe use of the product. If the FDA concludes a REMS is needed, the sponsor of the NDA or BLA must submit a proposed REMS. The FDA will not approve the NDA or BLA without an approved REMS, if required. A
REMS could include medication guides, physician communication plans or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. Any of these limitations on approval or marketing
could restrict the commercial promotion, distribution, prescription or dispensing of products. Product approvals may be withdrawn for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with regulatory standards or if problems occur following
initial marketing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FDA regulations require that products be manufactured in specific approved facilities and in accordance with cGMP regulations.
Manufacturers must comply with cGMP regulations that require, among other things, quality control and quality assurance, the maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP.
Manufacturers and other entities involved in the manufacture and distribution of approved drugs or biologics are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections
by the FDA and certain state agencies for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">175</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compliance with cGMP requirements and other laws. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain cGMP
compliance. The discovery of violative conditions, including failure to conform to cGMP regulations, could result in enforcement actions, and the discovery of problems with a product after approval may result in restrictions on a product,
manufacturer or holder of an approved NDA or BLA, including recall. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once an approval is granted, the FDA may issue enforcement letters or withdraw the
approval of the product if compliance with regulatory requirements and standards is not maintained or if problems occur after the drug or biologic reaches the market. Corrective action could delay drug or biologic distribution and require
significant time and financial expenditures. Later discovery of previously unknown problems with a drug or biologic, including AEs of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory
requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program.
Other potential consequences include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market
or voluntary product recalls; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning or untitled letters or holds on post-approval clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of
product approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention, or refusal to permit the import or export of products; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs and biologics may be promoted only
for the approved indications and in accordance with the provisions of the approved label. However, companies may share truthful and not misleading information that is otherwise consistent with a product&#146;s FDA approved labeling. The FDA and
other agencies actively enforce the laws and regulations prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses, and a company that is found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT>
uses may be subject to significant liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the distribution of prescription pharmaceutical products is subject to the Prescription Drug
Marketing Act, or PDMA, which regulates the distribution of drugs and drug samples at the federal level, and sets minimum standards for the registration and regulation of drug distributors by the states. Both the PDMA and state laws limit the
distribution of prescription pharmaceutical product samples and impose requirements to ensure accountability in distribution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Hatch-Waxman
Amendments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;505 of the FDCA describes three types of marketing applications that may be submitted to the FDA to request marketing
authorization for a new drug. A Section&nbsp;505(b)(1) NDA is an application that contains full reports of investigations of safety and efficacy. A 505(b)(2) NDA is an application that contains full reports of investigations of safety and efficacy
but where at least some of the information required for approval comes from investigations that were not conducted by or for the applicant and for which the applicant has not obtained a right of reference or use from the person by or for whom the
investigations were conducted. This regulatory pathway enables the applicant to rely, in part, on the FDA&#146;s prior findings of safety and efficacy for an existing product, or published literature, in support of its application.
Section&nbsp;505(j) establishes an abbreviated approval process for a generic version of approved drug products through the submission of an Abbreviated New Drug Application, or ANDA. An ANDA provides for marketing of a generic drug product that has
the same active ingredients, dosage form, strength, route of administration, labeling, performance characteristics and intended use, among other things, to a previously approved product, known as a reference listed drug, or RLD. ANDAs
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">176</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
are termed &#147;abbreviated&#148; because they are generally not required to include preclinical (animal) and clinical (human) data to establish safety and efficacy. Instead, generic applicants
must scientifically demonstrate that their product is bioequivalent to, or performs in the same manner as, the innovator drug through <I>in vitro</I>, <I>in vivo</I>, or other testing. The generic version must deliver the same amount of active
ingredients into a subject&#146;s bloodstream in the same amount of time as the innovator drug and can often be substituted by pharmacists under prescriptions written for the reference listed drug. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Patent</FONT> Exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Hatch-Waxman Amendments, the FDA may not approve (or in some cases accept) an ANDA or 505(b)(2) application until any applicable period of <FONT
STYLE="white-space:nowrap">non-patent</FONT> exclusivity for the RLD has expired. The FDCA provides a period of five years of <FONT STYLE="white-space:nowrap">non-patent</FONT> data exclusivity for a new drug containing a new chemical entity, or
NCE. For the purposes of this provision, an NCE is a drug that contains no active moiety that has previously been approved by the FDA in any other NDA. An active moiety is the molecule or ion responsible for the physiological or pharmacological
action of the drug substance. In cases where such NCE exclusivity has been granted, non 505(b)(2) NDA referencing the approved product or ANDA may be filed for substantive review by the FDA until the expiration of five years unless the submission is
accompanied by a Paragraph IV certification, which states the proposed 505(b)(2) or generic drug will not infringe one or more of the already approved product&#146;s listed patents or that such patents are invalid or unenforceable, in which case the
applicant may submit its application four years following the original product approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDCA also provides for a period of three years of
exclusivity for <FONT STYLE="white-space:nowrap">non-NCE</FONT> drugs if the NDA or a supplement to the NDA includes reports of one or more new clinical investigations, other than bioavailability or bioequivalence studies, that were conducted by or
for the applicant and are essential to the approval of the application or supplement. This three-year exclusivity period often protects changes to a previously approved drug product, such as a new dosage form, route of administration, combination or
indication, but it generally would not protect the original, unmodified product from generic competition. Unlike five-year NCE exclusivity, an award of three-year exclusivity does not block the FDA from accepting 505(b)(2) NDAs referencing the
approved drug product or ANDAs seeking approval for generic versions of the drug as of the date of approval of the original drug product; it only prevents FDA from approving such 505(b)(2) NDAs or ANDAs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Hatch-Waxman Patent Certification and the <FONT STYLE="white-space:nowrap">30-Month</FONT> Stay </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In seeking approval of an NDA or a supplement thereto, NDA sponsors are required to list with the FDA each patent with claims that cover the applicant&#146;s
product or an approved method of using the product. Upon approval, each of the patents listed by the NDA sponsor is published in the FDA&#146;s Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Upon
submission of an ANDA or 505(b)(2) NDA, an applicant is required to certify to the FDA concerning any patents listed for the RLD in the Orange Book that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no patent information on the drug product that is the subject of the application has been submitted to the FDA;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such patent has expired; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which such patent expires; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such patent is invalid, unenforceable or will not be infringed upon by the manufacture, use, or sale of the drug
product for which the application is submitted. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, the ANDA or 505(b)(2) NDA cannot be approved until all listed patents have
expired, except where the ANDA or 505(b)(2) NDA applicant challenges a listed patent through the last type of certification, also known as a paragraph IV certification. If the applicant does not challenge the listed patents or indicates that it is
not seeking approval of a patented method of use, the ANDA or 505(b)(2) NDA application will not be approved </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">177</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
until all of the listed patents claiming the referenced product have expired. If the ANDA or 505(b)(2) NDA applicant has provided a paragraph IV certification the applicant must send notice of
the paragraph IV certification to the NDA and patent holders once the application has been accepted for filing by the FDA. The NDA and patent holders may then initiate a patent infringement lawsuit in response to the notice of the paragraph IV
certification. If the paragraph IV certification is challenged by an NDA holder or the patent owner(s) asserts a patent challenge to the paragraph IV certification, the FDA may not approve that application until the earlier of 30 months from the
receipt of the notice of the paragraph IV certification, the expiration of the patent, when the infringement case concerning each such patent was favorably decided in the applicant&#146;s favor or settled, or such shorter or longer period as may be
ordered by a court. This prohibition is generally referred to as the <FONT STYLE="white-space:nowrap">30-month</FONT> stay. In instances where an ANDA or 505(b)(2) NDA applicant files a paragraph IV certification, the NDA holder or patent owner(s)
regularly take action to trigger the <FONT STYLE="white-space:nowrap">30-month</FONT> stay, recognizing that the related patent litigation may take many months or years to resolve. Thus, approval of an ANDA or 505(b)(2) NDA could be delayed for a
significant period of time depending on the patent certification the applicant makes and the reference drug sponsor&#146;s decision to initiate patent litigation. If the drug has NCE exclusivity and the ANDA or 505(b)(2) NDA is submitted four years
after approval, the <FONT STYLE="white-space:nowrap">30-month</FONT> stay is extended so that it expires seven and a half years after approval of the innovator drug, unless the patent expires or there is a decision in the infringement case that is
favorable to the ANDA or 505(b)(2) NDA applicant before then. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Patent Term Restoration and Extension </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depending upon the timing, duration and specifics of FDA approval of our future product candidates, some of our U.S. patents may be eligible for limited patent
term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, commonly referred to as the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit restoration of the patent term of up to five years as compensation for
patent term lost during the FDA regulatory review process. Patent-term restoration, however, cannot extend the remaining term of a patent beyond a total of 14 years from the product&#146;s approval date and only those claims covering such approved
drug product, a method for using it or a method for manufacturing it may be extended. The patent-term restoration period is generally <FONT STYLE="white-space:nowrap">one-half</FONT> the time between the effective date of an IND and the submission
date of an NDA or BLA plus the time between the submission date of an NDA or BLA and the approval of that application, except that the review period is reduced by any time during which the applicant failed to exercise due diligence. Only one patent
applicable to an approved drug is eligible for the extension and the application for the extension must be submitted prior to the expiration of the patent. The USPTO, in consultation with the FDA, reviews and approves the application for any patent
term extension or restoration. In the future, we may apply for restoration of patent term for our currently owned or licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and
other factors involved in the filing of the relevant NDA or BLA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Orphan Drug Designation and Exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biological product intended to treat a rare disease or condition, which is
generally a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States and for which there is no reasonable expectation that the cost of developing and making the
product available in the United States for this type of disease or condition will be recovered from sales of the product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orphan drug designation must be
requested before submitting an NDA or BLA. After the FDA grants orphan drug designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in
or shorten the duration of the regulatory review and approval process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a product that has orphan drug designation subsequently receives the first FDA
approval for the disease or condition for which it has such designation, the product is entitled to orphan drug exclusivity, which means that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">178</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the FDA may not approve any other applications to market the same drug for the same indication for seven years from the date of such approval, except in limited circumstances, such as a showing
of clinical superiority to the product with orphan exclusivity by means of greater effectiveness, greater safety or providing a major contribution to patient care or in instances of drug supply issues. Competitors, however, may receive approval of
either a different product for the same indication or the same product for a different indication but that could be used <FONT STYLE="white-space:nowrap">off-label</FONT> in the orphan indication. If an orphan designated product receives marketing
approval for an indication broader than what is designated, it may not be entitled to orphan exclusivity. Orphan drug status in the European Union has similar, but not identical, requirements and benefits. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Pediatric Information and Pediatric Exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Pediatric Research Equity Act, or PREA, certain NDAs and BLAs and certain supplements to an NDA or BLA must contain data to assess the safety and
efficacy of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for
submission of pediatric data or full or partial waivers. The Food and Drug Administration Safety and Innovation Act, or FDASIA, amended the FDCA to require that a sponsor who is planning to submit a marketing application for a drug that includes a
new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial Pediatric Study Plan, or PSP, within 60 days of an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-of-Phase</FONT></FONT> 2 meeting or, if there is no such meeting, as early as practicable before the initiation of the Phase 3 or Phase 2/3 study. The initial PSP must include an
outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any
request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach an agreement on the PSP. A sponsor can submit
amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials and/or other clinical development programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A drug or biologic product can also obtain pediatric market exclusivity in the United States. Pediatric exclusivity, if granted, adds six months to existing
exclusivity periods and patent terms. This <FONT STYLE="white-space:nowrap">six-month</FONT> exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric study
in accordance with an <FONT STYLE="white-space:nowrap">FDA-issued</FONT> &#147;Written Request&#148; for such a study. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Biosimilars and Exclusivity
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of our product candidates are regulated as biologics. An abbreviated approval pathway for biological products shown to be similar to, or
interchangeable with, an <FONT STYLE="white-space:nowrap">FDA-licensed</FONT> reference biological product was created by the Biologics Price Competition and Innovation Act of 2009, or BPCI Act, as part of the Affordable Care Act, or the ACA. This
amendment to the PHSA, in part, attempts to minimize duplicative testing. Biosimilarity, which requires that the biological product be highly similar to a biologic already licensed by the FDA pursuant to a BLA notwithstanding minor differences in
clinically inactive components and that there be no clinically meaningful differences between the product and the reference product in terms of safety, purity and potency, can be shown through analytical studies, animal studies and a clinical trial
or trials. Interchangeability requires that a biological product be biosimilar to the reference product and that the product can be expected to produce the same clinical results as the reference product in any given patient and, for products
administered multiple times to an individual, that the product and the reference product may be alternated or switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive
use of the reference biological product without such alternation or switch. Complexities associated with the larger, and often more complex, structure of biological products as compared to small molecule drugs, as well as the processes by which such
products are manufactured, pose significant hurdles to implementation that are still being worked out by the FDA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">179</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reference biological product is granted four and twelve year exclusivity periods from the time of first
licensure of the product. FDA will not accept an application for a biosimilar or interchangeable product based on the reference biological product until four years after the date of first licensure of the reference product, and FDA will not approve
an application for a biosimilar or interchangeable product based on the reference biological product until twelve years after the date of first licensure of the reference product. &#147;First licensure&#148; typically means the initial date the
particular product at issue was licensed in the United States. Date of first licensure does not include the date of licensure of (and a new period of exclusivity is not available for) a biological product if the licensure is for a supplement for the
biological product or for a subsequent application by the same sponsor or manufacturer of the biological product (or licensor, predecessor in interest, or other related entity) for a change (not including a modification to the structure of the
biological product) that results in a new indication, route of administration, dosing schedule, dosage form, delivery system, delivery device or strength, or for a modification to the structure of the biological product that does not result in a
change in safety, purity, or potency. Therefore, one must determine whether a new product includes a modification to the structure of a previously licensed product that results in a change in safety, purity, or potency to assess whether the
licensure of the new product is a first licensure that triggers its own period of exclusivity. Whether a subsequent application, if approved, warrants exclusivity as the &#147;first licensure&#148; of a biological product is determined on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis with data submitted by the sponsor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Government
Regulation of Medical Devices </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General Requirements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the FDCA, a medical device is an instrument, apparatus, implement, machine, contrivance, implant, <I>in vitro</I> reagent, or other similar or related
article, including any component part, or accessory which is: (i)&nbsp;recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them; (ii)&nbsp;intended for use in the diagnosis of disease or other
conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals; or (iii)&nbsp;intended to affect the structure or any function of the body of man or other animals, and which does not achieve any of its primary
intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States, medical devices are subject to extensive regulation by the FDA under the FDCA, and its implementing regulations, and certain other
federal and state statutes and regulations. The laws and regulations govern, among other things, the research and development, design, testing, manufacture, packaging, storage, recordkeeping, approval, labeling, promotion, post-approval monitoring
and reporting, distribution and import and export of medical devices. Failure to comply with applicable requirements may subject a device and/or its manufacturer to a variety of administrative sanctions, such as FDA refusal to approve pending
premarket applications, issuance of warning letters, mandatory product recalls, import detentions, civil monetary penalties, and/or judicial sanctions, such as product seizures, injunctions, and criminal prosecution. Unless an exemption applies,
medical devices require marketing clearance or approval from the FDA prior to commercial distribution. The two primary types of FDA marketing authorization applicable to a medical device are premarket notification, also called 510(k) clearance, and
premarket approval, or PMA approval; however, other devices may be commercialized after the FDA grants a <I>de novo </I>request. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The 510(k) Process
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the FDCA, medical devices are classified into one of three classes&#151;Class&nbsp;I, Class&nbsp;II or Class&nbsp;III&#151;depending on the
degree of risk associated with each medical device and the extent of control needed to provide reasonable assurances with respect to safety and effectiveness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Class&nbsp;I devices are those for which safety and effectiveness can be reasonably assured by adherence to a set of regulations, referred to as General
Controls, which require compliance with the applicable portions of the FDA&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">180</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Quality System Regulation, or QSR, which sets forth cGMP requirements for medical devices, facility registration and product listing, reporting of AEs and malfunctions, and appropriate, truthful
and <FONT STYLE="white-space:nowrap">non-misleading</FONT> labeling and promotional materials. Most Class&nbsp;I products are exempt from the premarket notification requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Class&nbsp;II devices are those that are subject to the General Controls, as well as Special Controls, which can include performance standards, guidelines and
post market surveillance. Most Class&nbsp;II devices are subject to premarket review and clearance by the FDA. Premarket review and clearance by the FDA for Class&nbsp;II devices is accomplished through the 510(k) premarket notification process.
Under the 510(k) process, the manufacturer must submit to the FDA a premarket notification, demonstrating that the device is &#147;substantially equivalent,&#148; as defined in the statute, to either: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a device that was legally marketed prior to May&nbsp;28, 1976, the date upon which the Medical Device Amendments
of 1976 were enacted, or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">another commercially available, similar device that was cleared through the 510(k) process.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To be &#147;substantially equivalent,&#148; the proposed device must have the same intended use as the predicate device, and either
have the same technological characteristics as the predicate device or have different technological characteristics and not raise different questions of safety or effectiveness than the predicate device. Clinical data are sometimes required to
support substantial equivalence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After a 510(k) notice is submitted, the FDA determines whether to accept it for substantive review. If it lacks
necessary information for substantive review, the FDA will refuse to accept the 510(k) notification. If it is accepted for filing, the FDA begins a substantive review. If the FDA agrees that the device is substantially equivalent, it will grant
clearance to commercially market the device. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The De Novo and PMA Processes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the FDA determines that the device is not &#147;substantially equivalent&#148; to a predicate device, or if the device is classified into Class&nbsp;III by
operation of law, the device sponsor must then fulfill the much more rigorous premarketing requirements of the PMA process, or seek classification of the device through the <I>de novo</I> process by submitting a <I>de novo</I> request. A
manufacturer can also submit a direct <I>de novo</I> request if the manufacturer is unable to identify an appropriate predicate device and the new device or new use of the device presents a moderate or low risk. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In response to a <I>de novo</I> request, FDA may classify the device into class I or II. Under the FDCA, FDA must make a classification determination for the
device that is the subject of the <I>de novo </I>request by written order within 120 days of the request. However, in accordance with the performance goals and procedures agreed to by FDA for the medical device user fee program in the Medical Device
User Fee Amendments of 2017, or MDUFA IV, FDA has committed to issuing a MDUFA decision within 150 FDA days of receipt of the submission for 60&nbsp;percent of <I>de novo </I>requests received in fiscal year 2020. During the pendency of FDA&#146;s
review, FDA may issue an additional information letter, which places the <I>de novo </I>request on hold and stops the review clock pending receipt of the additional information requested. In the event the <I>de novo</I> requestor does not provide
the requested information within 180 calendar days, FDA will consider the <I>de novo</I> request to be withdrawn. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If FDA determines that General Controls
or General Controls and Special Controls are insufficient to provide reasonable assurance of safety and effectiveness or the information and/or the data provided in the <I>de novo </I>request are insufficient to determine whether General Controls or
General Controls and Special Controls can provide a reasonable assurance of safety and effectiveness, FDA will decline the <I>de novo </I>request. If a <I>de novo </I>request is declined, FDA issues a written order to the <I>de novo </I>requestor
identifying the reasons for declining the <I>de novo</I> request and the device remains in class III and may not be marketed. The <I>de novo</I> requestor may submit a PMA or collect additional information to address the issues identified by FDA and
submit a new <I>de novo</I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">181</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I></I>request that includes the additional information. Alternatively, in the event FDA determines the data and information submitted demonstrate that General Controls or General and Special
Controls are adequate to provide reasonable assurance of safety and effectiveness, FDA will grant the <I>de novo </I>request. When FDA grants a <I>de novo</I> request, the device is granted marketing authorization and further can serve as a
predicate for future devices of that type, including for 510(k)s. In December 2018, the FDA issued proposed regulations to govern the <I>de novo</I> classification process, which include requirements beyond what has historically been required in
<I>de novo</I> submissions. If finalized, these regulations could further impact this path to market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Class&nbsp;III devices include devices deemed by
the FDA to pose the greatest risk such as life-supporting or life-sustaining devices, or implantable devices, in addition to those deemed not substantially equivalent following the 510(k) process. The safety and effectiveness of Class&nbsp;III
devices cannot be reasonably assured solely by the General Controls and Special Controls described above. Therefore, these devices are subject to the PMA application process, which is generally more costly and time consuming than the 510(k) process.
Through the PMA application process, the applicant must submit data and information demonstrating reasonable assurance of the safety and effectiveness of the device for its intended use to the FDA&#146;s satisfaction. Accordingly, a PMA application
typically includes, but is not limited to, extensive technical information regarding device design and development, preclinical and clinical study data, manufacturing information, labeling and financial disclosure information for the clinical
investigators in device studies. The PMA application must provide valid scientific evidence that demonstrates to the FDA&#146;s satisfaction reasonable assurance of the safety and effectiveness of the device for its intended use. Overall, the FDA
review of a PMA application generally takes between one and three years, but may take significantly longer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Exempt Devices </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a manufacturer&#146;s device falls into a generic category of Class&nbsp;I or Class&nbsp;II devices that FDA has exempted by regulation, a premarket
notification is not required before marketing the device in the United States. Manufacturers of such devices are required to register their establishments and list the generic category or classification name of their devices. Some 510(k)-exempt
devices are also exempt from QSR requirements, except for the QSR&#146;s complaint handling and recordkeeping requirements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT
STYLE="white-space:nowrap">Pre-Submission</FONT> Meetings </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA has mechanisms to provide companies with guidance prior to formal submission of
either a 510(k), <I>de novo </I>request or PMA. One such mechanism is the <FONT STYLE="white-space:nowrap">pre-submission</FONT> program in which a company has a <FONT STYLE="white-space:nowrap">&#147;pre-submission&#148;</FONT> meeting as outlined
in the FDA guidance document &#147;Requests for Feedback and Meetings for Medical Device Submissions: The <FONT STYLE="white-space:nowrap">Q-Submission</FONT> Program&#148; that was issued in May 2019. The main purpose of the <FONT
STYLE="white-space:nowrap">pre-submission</FONT> meeting is to provide companies with guidance from the FDA on matters of significance to product development and/or submission preparation. Prior to the
<FONT STYLE="white-space:nowrap">pre-submission</FONT> meeting, the company provides a briefing document to the FDA. The FDA is not obligated to follow the recommendations it provides to companies as a result of a
<FONT STYLE="white-space:nowrap">pre-submission</FONT> meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical Trials </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A clinical trial is almost always required to support a PMA application or <I>de novo</I> request and is sometimes required for a premarket notification. For
significant risk devices, the FDA regulations require that human clinical investigations conducted in the United States be approved via an investigational device exemption, or IDE, which must become effective before clinical testing may commence. A
significant risk device is one that presents a potential for serious risk to the health, safety or welfare of a subject and either is implanted, used in supporting or sustaining human life, substantially important in diagnosing, curing, mitigating
or treating disease or otherwise preventing impairment of human health, or otherwise presents a potential for serious risk to a subject. A nonsignificant risk device does not require FDA approval of an IDE; however, the clinical trial must still be
conducted in compliance with abbreviated IDE regulations, such as those relating to trial monitoring, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">182</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
informed consent, and labeling and record-keeping. In some cases, one or more smaller studies may precede a pivotal clinical trial intended to demonstrate the safety and effectiveness of the
investigational device. A <FONT STYLE="white-space:nowrap">30-day</FONT> waiting period after the submission of each IDE is required prior to the commencement of clinical testing in humans. If the FDA determines that there are deficiencies or other
concerns with an IDE that require modification, the FDA may permit a clinical trial to proceed under a conditional approval. If the FDA disapproves the IDE within this <FONT STYLE="white-space:nowrap">30-day</FONT> period, the clinical trial
proposed in the IDE may not begin. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An IDE application must be supported by appropriate data, such as animal and laboratory test results, showing that it
is safe to test the device in humans and that the testing protocol is scientifically sound. The IDE application must also include a description of product manufacturing and controls, and a proposed clinical trial protocol. FDA typically grants IDE
approval for a specified number of patients to be treated at specified study centers. During the study, the sponsor must comply with the FDA&#146;s IDE requirements for investigator selection, trial monitoring, reporting, and record keeping. The
investigators must obtain patient informed consent, rigorously follow the investigational plan and study protocol, control the disposition of investigational devices, and comply with all reporting and record keeping requirements. Certain IDE
requirements apply to all investigational devices, whether such devices are considered significant or nonsignificant risks. Prior to granting PMA approval, the FDA typically inspects the records relating to the conduct of the study and the clinical
data supporting the PMA application for compliance with IDE requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clinical trials must be conducted: (i)&nbsp;in compliance with federal
regulations, including those related to good clinical practices, or GCPs, which are intended to protect the rights and health of patients and to define the roles of clinical trial sponsors, investigators, and monitors; and (ii)&nbsp;under protocols
detailing the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. Clinical trials are typically conducted at geographically diverse clinical trial sites, and are designed to permit
FDA to evaluate the overall benefit-risk relationship of the device and to provide adequate information for the labeling of the device. Clinical trials for both significant and nonsignificant risk devices, must be approved by an IRB for each trial
site. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA may order the temporary, or permanent, discontinuation of a clinical trial at any time, or impose other sanctions, if it believes that the
clinical trial either is not being conducted in accordance with FDA requirements or presents an unacceptable risk to the clinical trial subjects. An IRB may also require the clinical trial at the site to be halted, either temporarily or permanently,
for failure to comply with the IRB&#146;s requirements, or may impose other conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the QSR does not fully apply to investigational devices,
the requirement for controls on design and development does apply. The sponsor also must manufacture the investigational device in conformity with the quality controls described in the IDE application and any conditions of IDE approval that FDA may
impose with respect to manufacturing. Investigational devices may only be distributed for use in an investigation, and must bear a label with the statement: &#147;CAUTION&#151;Investigational device. Limited by Federal law to investigational
use.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information about certain clinical trials must be submitted within specific timeframes to the NIH for public dissemination on its
ClinicalTrials.gov website. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Post-Marketing Requirements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After a device is placed on the market, numerous regulatory requirements apply. These include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">annual and updated establishment registration and device listing with the FDA; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the QSR requirements, which require manufacturers to follow stringent design, testing, control, documentation,
complaint handling and other quality assurance procedures during all aspects of the design and manufacturing process; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advertising and promotion requirements; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">183</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on sale, distribution or use of a device; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">labeling and marketing regulations, which require that promotion is truthful, not misleading, and provide
adequate directions for use and that all claims are substantiated, and also prohibit the promotion of products for unapproved or <FONT STYLE="white-space:nowrap">&#147;off-label&#148;</FONT> uses and impose other restrictions on labeling;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">medical device reporting regulations, which require that a manufacturer report to the FDA if a device it markets
may have caused or contributed to a death or serious injury, or has malfunctioned and the device or a similar device that it markets would be likely to cause or contribute to a death or serious injury, if the malfunction were to recur;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">correction, removal and recall reporting regulations, which require that manufacturers report to the FDA field
corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">complying with the federal law and regulations requiring Unique Device Identifiers on devices and also requiring
the submission of certain information about each device to the FDA&#146;s Global Unique Device Identification Database. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FDA enforces
these requirements by inspection and market surveillance. If the FDA finds a violation, it can institute a wide variety of enforcement actions, ranging from a public warning letter to more severe sanctions such as: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">warning letters, untitled letters, fines, injunctions, consent decrees, and civil penalties;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recall, withdrawals, or administrative detention or seizure of products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">operating restrictions, partial suspension or total shutdown of production; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusing or delating requests for 510(k) clearance or PMA approval of new products or modified products;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">withdrawing PMA approvals or 510(k) clearances already granted; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal to grant export or import approvals for marketing products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">criminal prosecution. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Discovery of previously unknown problems with a product or the failure to comply with applicable FDA requirements can have negative consequences, including
adverse publicity, judicial or administrative enforcement, warning letters from the FDA, mandated corrective advertising or communications with doctors, and civil or criminal penalties, among others. Newly discovered or developed safety or
effectiveness data may require changes to a product&#146;s approved labeling, including the addition of new warnings and contraindications, and also may require the implementation of other risk management measures. Also, new government requirements,
including those resulting from new legislation, may be established, or the FDA&#146;s policies may change, which could delay or prevent regulatory approval of products under development. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Device Modifications </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some changes to an approved
PMA device, including changes in indications, labeling, or manufacturing processes or facilities, require submission and FDA approval of a new PMA or PMA supplement, as appropriate, before the change can be implemented. Supplements to a PMA often
require the submission of the same type of information required for an original PMA, except that the supplement is generally limited to that information needed to support the proposed change from the product covered by the original PMA. The FDA uses
the same procedures and actions in reviewing PMA supplements as it does in reviewing original PMAs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Modifications to a device that received 510(k)
clearance may require a new 510(k) submission if those changes could significantly affect the safety or effectiveness of the device, or if the modifications represent a major </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">184</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
change in intended use. If the manufacturer determines that a modification could not substantially affect the safety or effectiveness of the device, it should document the changes and rationale
for not submitting a new 510(k). Though the manufacturer is responsible for the initial assessment, FDA may disagree, and later require the manufacturer to submit a 510(k) for the modified device. FDA could require the manufacturer to cease
marketing the modified device while the 510(k) notification is awaiting clearance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>European Union Drug Development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the European Union, our future products and product candidates also may be subject to extensive regulatory requirements. As in the United States, medicinal
products can be marketed only if a marketing authorization from the competent regulatory agencies has been obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Similar to the United States, the
various phases of preclinical and clinical research in the European Union are subject to significant regulatory controls. Although the EU Clinical Trials Directive 2001/20/EC has sought to harmonize the EU clinical trials regulatory framework,
setting out common rules for the control and authorization of clinical trials in the European Union, the EU Member States have transposed and applied the provisions of the Directive differently. This has led to significant variations in the Member
State regimes. Under the current regime, before a clinical trial can be initiated it must be approved in each of the EU countries where the trial is to be conducted by two distinct bodies: the National Competent Authority, or NCA, and one or more
Ethics Committees, or ECs. Under the current regime all suspected unexpected serious adverse reactions to the investigated drug that occur during the clinical trial have to be reported to the NCA and ECs of the Member State where they occurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2014, the EU passed the new Clinical Trials Regulation, (EU) No 536/2014, which will replace the current Clinical Trials Directive 2001/20/EC. To
ensure that the rules for clinical trials are harmonized throughout the European Union, the new EU clinical trials legislation was passed as a regulation that is directly applicable in all EU member states. All clinical trials performed in the
European Union are required to be conducted in accordance with the Clinical Trials Directive 2001/20/EC until the new Clinical Trials Regulation (EU) No 536/2014 becomes applicable. It is expected that the new Clinical Trials Regulation (EU) No
536/2014 will apply following confirmation of full functionality of the Clinical Trials Information System, or CTIS, the centralized European Union portal and database for clinical trials foreseen by the regulation, through an independent audit. The
regulation becomes applicable six months after the European Commission publishes notice of this confirmation with a three-year transition period. It will overhaul the current system of approvals for clinical trials in the European Union.
Specifically, the new regulation, which will be directly applicable in all member states, aims at simplifying and streamlining the approval of clinical trials in the European Union. For instance, the new Clinical Trials Regulation provides for a
streamlined application procedure via a single point and strictly defined deadlines for the assessment of clinical trial applications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European
Union Drug Marketing </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Much like the Anti-Kickback Statue prohibition in the United States, the provision of benefits or advantages to physicians to
induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the European Union and in the UK. The provision of benefits or advantages to physicians is governed by
national anti-bribery laws, such as the UK Bribery Act 2010. Infringement of these laws could result in substantial fines and imprisonment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payments made
to physicians in certain European Union Member States and in the UK must be publicly disclosed. Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#146;s employer, his or her competent
professional organization and/or the regulatory authorities of the individual EU Member States. These requirements are provided in the national laws, industry codes or professional codes of conduct, applicable in the EU Member States and in the UK.
Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">185</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Union Drug Review and Approval </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the European Economic Area, or EEA, which is comprised of the 27 Member States of the European Union (together with Norway), Iceland and Liechtenstein,
medicinal products can only be commercialized after obtaining a Marketing Authorization, or MA. There are two types of marketing authorizations. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Community MA is issued by the European Commission through the Centralized Procedure, based on the opinion of
the Committee for Medicinal Products for Human Use, or CHMP, of the EMA, and is valid throughout the entire territory of the EEA. The Centralized Procedure is mandatory for certain types of products, such as biotechnology medicinal products, orphan
medicinal products, advanced-therapy medicines such as gene-therapy, somatic cell-therapy or tissue-engineered medicines and medicinal products containing a new active substance indicated for the treatment of HIV, AIDS, cancer, neurodegenerative
disorders, diabetes, autoimmune and other immune dysfunctions and viral diseases. The Centralized Procedure is optional for products containing a new active substance not yet authorized in the EEA, or for products that constitute a significant
therapeutic, scientific or technical innovation or which are in the interest of public health in the European Union. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">National MAs, which are issued by the competent authorities of the Member States of the EEA and only cover their
respective territory, are available for products not falling within the mandatory scope of the Centralized Procedure. Where a product has already been authorized for marketing in a Member State of the EEA, this National MA can be recognized in
another Member States through the Mutual Recognition Procedure. If the product has not received a National MA in any Member State at the time of application, it can be approved simultaneously in various Member States through the Decentralized
Procedure. Under the Decentralized Procedure an identical dossier is submitted to the competent authorities of each of the Member States in which the MA is sought, one of which is selected by the applicant as the Reference Member State, or RMS. The
competent authority of the RMS prepares a draft assessment report, a draft summary of the product characteristics, or SPC, and a draft of the labeling and package leaflet, which are sent to the other Member States (referred to as the Member States
Concerned) for their approval. If the Member States Concerned raise no objections, based on a potential serious risk to public health, to the assessment, SPC, labeling, or packaging proposed by the RMS, the product is subsequently granted a national
MA in all the Member States (i.e., in the RMS and the Member States Concerned). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the above described procedures, before granting
the MA, the EMA or the competent authorities of the Member States of the EEA make an assessment of the risk-benefit balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Union New Chemical Entity Exclusivity </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
the European Union, new chemical entities, sometimes referred to as new active substances, qualify for eight years of data exclusivity upon marketing authorization and an additional two years of market exclusivity. The data exclusivity, if granted,
prevents regulatory authorities in the European Union from referencing the innovator&#146;s data to assess a generic application for eight years, after which generic marketing authorization can be submitted, and the innovator&#146;s data may be
referenced, but not approved for two years. The overall <FONT STYLE="white-space:nowrap">ten-year</FONT> period will be extended to a maximum of 11 years if, during the first eight years of those ten years, the marketing authorization holder obtains
an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are determined to bring a significant clinical benefit in comparison with currently approved therapies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Union Orphan Designation and Exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the European Union, the EMA&#146;s Committee for Orphan Medicinal Products grants orphan drug designation to promote the development of products that are
intended for the diagnosis, prevention or treatment of life-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">186</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
threatening or chronically debilitating conditions affecting not more than 5 in 10,000 persons in the European Union community (or where it is unlikely that the development of the medicine would
generate sufficient return to justify the investment) and for which no satisfactory method of diagnosis, prevention or treatment has been authorized (or, if a method exists, the product would be a significant benefit to those affected). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the European Union, orphan drug designation entitles a party to financial incentives such as reduction of fees or fee waivers and ten years of market
exclusivity is granted following medicinal product approval. This period may be reduced to six years if the orphan drug designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify
maintenance of market exclusivity. Additionally, marketing authorization may be granted to a similar product for the same indication at any time, if (i)&nbsp;the holder of the marketing authorization for the original orphan medicinal product
consents to a second orphan medicinal product application, (ii)&nbsp;the holder of the marketing authorization for the original orphan medicinal product cannot supply sufficient quantities of the orphan medicinal product, or (iii)&nbsp;the second
applicant can establish that the second medicinal product, although similar, is safer, more effective or otherwise clinically superior to the authorized orphan medicinal product. Orphan drug designation must be requested before submitting an
application for marketing approval. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Pediatric Investigation Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the EEA,
MAAs for new medicinal products not authorized have to include the results of studies conducted in the pediatric population, in compliance with a pediatric investigation plan, or PIP, agreed with the EMA&#146;s Pediatric Committee, or PDCO. The PIP
sets out the timing and measures proposed to generate data to support a pediatric indication of the drug for which marketing authorization is being sought. The PDCO can grant a deferral of the obligation to implement some or all of the measures of
the PIP until there are sufficient data to demonstrate the efficacy and safety of the product in adults. Further, the obligation to provide pediatric clinical trial data can be waived by the PDCO when this data is not needed or appropriate because
the product is likely to be ineffective or unsafe in children, the disease or condition for which the product is intended occurs only in adult populations, or when the product does not represent a significant therapeutic benefit over existing
treatments for pediatric patients. Once the marketing authorization is obtained in all Member States of the European Union and trial results are included in the product information, even when negative, the product is eligible for six months&#146;
supplementary protection certificate extension. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>European Union Device Development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the European Union, medical devices are regulated under the European Union Directive (93/42/EEC), also known as the Medical Device Directive, or the MDD.
Active Implantable Medical Devices are regulated under Directive 90/385/EEC, and <FONT STYLE="white-space:nowrap">In-Vitro</FONT> Diagnostic Devices under Directive 98/79/EC (the IVDD). An authorized third party, also called a Notified Body, must
approve products for CE marking (except lower risk, or &#147;Class&nbsp;1&#148;, medical devices) and conducts periodic inspections to ensure applicable regulatory requirements are met. The CE mark is contingent upon continued compliance to the
applicable regulations and the quality system requirements of the ISO 13485 standard. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The new European Medical Devices Regulation (2017/745), or the EU
MDR, and Regulation 2017/746 on <FONT STYLE="white-space:nowrap">In-Vitro</FONT> Diagnostic Devices, or the EU IVDR, which were published in May 2017 with a transition period until May&nbsp;26, 2021, replace the MDD and IVDD. Starting May&nbsp;26,
2021, the new EU MDR will apply and no new applications under the previous directives will be permitted. During the four-year transition period, companies need to update their technical documentation and other quality management system processes to
meet the new EU MDR (or, as applicable, IVDR) requirements. Under the new EU MDR requirements, CE certificates issued under the MDD or IVDD prior to May&nbsp;25, 2017 will remain valid in accordance with their term, beyond the expiration of the
transition period; however, certain limitations set forth in the EU MDR (or, as applicable, the EU IVDR), such as the need to use classifications that are different from the previous directives, would apply, as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">187</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
well as the requirements of the EU MDR (or, as applicable, EU IVDR) relating to post-market surveillance, vigilance and registration of economic operators and devices will apply in place of the
corresponding requirements of the MDD. CE certificates issued under the MDD or IVDD from May&nbsp;25, 2017 until May&nbsp;25, 2021 will remain valid in accordance with their term, but shall not exceed five years and shall become void after
May&nbsp;26, 2024. However, devices already placed on the market before May&nbsp;26, 2024 under the previous directives may continue to be made available until May&nbsp;26, 2026. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brexit and the Regulatory Framework in the United Kingdom </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;23, 2016, the electorate in the United Kingdom voted in favor of leaving the European Union, commonly referred to as &#147;Brexit&#148;. In
October 2019, a withdrawal agreement, or the Withdrawal Agreement, setting out the terms of the United Kingdom&#146;s exit from the European Union, and a political declaration on the framework for the future relationship between the United Kingdom
and European Union was agreed between the UK and EU governments. Under the terms of the EU Withdrawal Agreement, the United Kingdom withdrew from membership of the European Union on 31&nbsp;January 2020 and entered into a &#145;transition
period&#146; which is due to expire on 31&nbsp;December 2020. Since the regulatory framework for pharmaceutical products in the United Kingdom covering quality, safety and efficacy of pharmaceutical products, clinical trials, marketing
authorization, commercial sales and distribution of pharmaceutical products is derived from European Union directives and regulations, Brexit could materially impact the future regulatory regime which applies to products and the approval of product
candidates in the United Kingdom. It remains to be seen how, if at all, Brexit will impact regulatory requirements for product candidates and products in the United Kingdom. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>European and United Kingdom Data Collection Regulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event we decide to conduct clinical trials in the European Union and/or the United Kingdom, we may be subject to additional data protection
requirements. The collection and use of personal data (which includes health information) in the European Union is governed by the provisions of the General Data Protection Regulation 2016/679, or GDPR, and in the United Kingdom, after the
transition period, governed by the Data Protection Act 2018 (however, until the end of the transition period, the GDPR will continue to apply to the UK). The GDPR applies to any company established in the EEA and to companies established outside the
EEA that process personal data in connection with the offering of goods or services to data subjects in the EU or the monitoring of the behavior of data subjects in the European Union. The GDPR enhances data protection obligations for controllers of
personal data, including requiring controllers to: ensure legal bases they rely on to process personal data are aligned to the legal bases prescribed under the GDPR; individuals are informed as to what personal data is collected from them, how it is
used and how they can exercise certain rights in line with the increased disclosures; conduct data protection impact assessments for &#147;high risk&#148; processing; only retain personal data for as long as it is needed in line with the purpose it
was obtained; ensure an appropriate level of security in line with the nature and scope of the personal data being processed, and where there has been a personal data breach (i.e. a breach to security which had led to personal data being
compromised), notify the relevant supervisory authority and/or individuals affected; embed &#147;privacy by design&#148; practices into new technologies which involve the processing of personal data; enter into data processing terms and carry out
appropriate due diligence on any service provider which processes personal data on behalf of the controller (and therefore qualifying as a processor). The GDPR also imposes strict rules on the transfer of personal data outside of the EEA to
countries that do not ensure an adequate level of protection, like the U.S. Failure to comply with the requirements of the GDPR and the related national data protection laws of the EEA Member States may result in fines up to 20&nbsp;million Euros or
4&nbsp;percent of a company&#146;s global annual revenues for the preceding financial year, whichever is higher. Moreover, the GDPR grants data subjects the right to claim for material and <FONT STYLE="white-space:nowrap">non-material</FONT> damages
resulting from infringement of the GDPR. Given the breadth and depth of these data protection obligations, maintaining compliance with the GDPR will require significant time, resources and expense, and as an ongoing compliance measure we may be
required to put in place additional mechanisms which help to ensure our compliance with the data protection rules. This may be onerous and adversely affect our business, financial condition, results of operations and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">188</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rest of the World Regulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For other countries outside of the European Union and the United States, such as countries in Eastern Europe, Latin America or Asia, the requirements governing
the conduct of clinical trials, product licensing, pricing and reimbursement vary from country to country. Additionally, the clinical trials must be conducted in accordance with GCP requirements and the applicable regulatory requirements and the
ethical principles that have their origin in the Declaration of Helsinki. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we fail to comply with applicable foreign regulatory requirements, we may be
subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Laws and Regulations Governing International Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we further expand our operations outside of the United States, we must dedicate additional resources to comply with numerous laws and regulations in each
jurisdiction in which we plan to operate. The Foreign Corrupt Practices Act, or FCPA, prohibits any U.S. individual or business from paying, offering, authorizing payment or offering of anything of value, directly or indirectly, to any foreign
official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are
listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise
and maintain an adequate system of internal accounting controls for international operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compliance with the FCPA is expensive and difficult,
particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other
hospital employees are considered foreign officials. Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Various laws, regulations and executive orders also restrict the use and dissemination outside of the United States, or the sharing with certain <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. If we expand our presence outside of the United States, it
will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the United States, which could limit our growth
potential and increase our development costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The failure to comply with laws governing international business practices may result in substantial civil
and criminal penalties and suspension or debarment from government contracting. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#146;s accounting provisions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Healthcare and Privacy Laws and Regulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Manufacturing, sales, promotion and other activities following product approval are also subject to regulation by numerous regulatory authorities in the United
States in addition to the FDA, including the CMS, including the Office of Inspector General and Office for Civil Rights, other divisions of the Department of HHS, the Department of Justice, the Drug Enforcement Administration, the Consumer Product
Safety Commission, the Federal Trade Commission, the Occupational Safety&nbsp;&amp; Health Administration, the Environmental Protection Agency and state and local governments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthcare providers and third-party payors play a primary role in the recommendation and prescription of drug products and other medical items and services.
Arrangements with providers, consultants, third-party payors and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">189</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
customers are subject to broadly applicable fraud and abuse, anti-kickback, false claims laws, reporting of payments to physicians and teaching hospitals and patient privacy laws and regulations
and other healthcare laws and regulations that may constrain our business and/or financial arrangements. Restrictions under applicable federal and state healthcare and privacy laws and regulations, include the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute, which makes it illegal for any person, including a prescription drug
manufacturer (or a party acting on its behalf), to knowingly and willfully solicit, receive, offer or pay any remuneration (including any kickback, bribe or certain rebate), directly or indirectly, overtly or covertly, in cash or in kind, or in
return for, that is intended to induce or reward referrals, including the purchase, recommendation, order or prescription of a particular drug, for which payment may be made under a federal healthcare program, such as Medicare or Medicaid. A person
or entity need not have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation. Violations are subject to civil and criminal fines and penalties for each violation, plus up to
three times the remuneration involved, imprisonment, and exclusion from government healthcare programs. In addition, the government may assert that a claim that includes items or services resulting from a violation of the federal Anti-Kickback
Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal civil and criminal false claims laws, including the civil False Claims Act, or FCA, which prohibit
individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false, fictitious or fraudulent; knowingly making, using or causing to be made or
used, a false statement or record material to a false or fraudulent claim or obligation to pay or transmit money or property to the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay
money to the federal government. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the submission of false or fraudulent claims. The FCA also
permits a private individual acting as a &#147;whistleblower&#148; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. When an entity is determined to have violated the federal
civil False Claims Act, the government may impose civil fines and penalties for each false claim, plus treble damages, and exclude the entity from participation in Medicare, Medicaid and other federal healthcare programs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal civil monetary penalties laws, which impose civil fines for, among other things, the offering or
transfer or remuneration to a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary&#146;s selection of a particular provider, practitioner, or supplier of services reimbursable
by Medicare or a state health care program, unless an exception applies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which imposes civil and
criminal liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or knowingly and willfully falsifying, concealing or covering up by any trick or device a
material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services; similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge
of the statute or specific intent to violate it in order to have committed a violation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH
and their respective implementing regulations, including the Final Omnibus Rule published in January 2013, which impose requirements on certain covered healthcare providers, health plans, and healthcare clearinghouses as well as their respective
business associates that perform services for them that involve the use, or disclosure of, individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information. HITECH also
created new tiers of civil monetary penalties, amended HIPAA to make civil and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">190</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the
federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal civil actions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal transparency requirements known as the federal Physician Payments Sunshine Act, under the Patient
Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively the Affordable Care Act, which requires certain manufacturers of drugs, devices, biologics and medical supplies to report annually to
the Centers for Medicare&nbsp;&amp; Medicaid Services, or CMS, within the United States Department of Health and Human Services, or HHS, information related to payments and other transfers of value made by that entity to physicians (defined to
include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by the physicians described above and their immediate family members. Effective January&nbsp;1, 2022,
these reporting obligations will extend to include transfers of value made to certain <FONT STYLE="white-space:nowrap">non-physician</FONT> providers such as physician assistants and nurse practitioners. In addition, many states also require the
reporting of payments or other transfers of value. In addition, many states also require reporting of payments or other transfers of value, many of which differ from each other in significant ways, are often not
<FONT STYLE="white-space:nowrap">pre-empted,</FONT> and may have a more prohibitive effect than the Sunshine Act, thus further complicating compliance efforts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and
activities that potentially harm consumers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal price reporting laws, which require manufacturers to calculate and report complex pricing metrics to
government programs, where such reported prices may be used in the calculation of reimbursement and/or discounts on approved products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may
apply to healthcare items or services that are reimbursed by <FONT STYLE="white-space:nowrap">non-governmental</FONT> third-party payors, including private insurers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">many state laws govern the privacy of personal information in specified circumstances, for example, in California
the California Consumer Protection Act, or CCPA, which went into effect on January&nbsp;1, 2020, establishes a new privacy framework for covered businesses by creating an expanded definition of personal information, establishing new data privacy
rights for consumers in the State of California, imposing special rules on the collection of consumer data from minors, and creating a new and potentially severe statutory damages framework for violations of the CCPA and for businesses that fail to
implement reasonable security procedures and practices to prevent data breaches. While clinical trial data and information governed by HIPAA are currently exempt from the current version of the CCPA, other personal information may be applicable and
possible changes to the CCPA may broaden its scope; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">some state laws require pharmaceutical companies to comply with the industry&#146;s voluntary compliance
guidelines and the relevant compliance guidance promulgated by the federal government in addition to requiring manufacturers to report information related to payments to physicians and other healthcare providers, marketing expenditures, and pricing
information. Certain state and local laws require the registration of pharmaceutical sales and medical representatives. State and foreign laws, including for example the European Union General Data Protection Regulation, also govern the privacy and
security of personal data, including health information, in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Insurance Coverage </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States and markets in
other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Thus, even if a product
candidate is approved, sales of the product will depend, in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">191</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
part, on the extent to which third-party payors, including government health programs in the United States such as Medicare and Medicaid, commercial health insurers and managed care
organizations, provide coverage, and establish adequate reimbursement levels for, the product. In the United States, the principal decisions about reimbursement for new medicines are typically made by the Centers for Medicare&nbsp;&amp; Medicaid
Services, or CMS, an agency within the U.S. Department of Health and Human Services. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree.
No uniform policy of coverage and reimbursement for drug and other medical products exists among third-party payors. Therefore, coverage and reimbursement for drug and other medical products can differ significantly from payor to payor. The process
for determining whether a third-party payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are
increasingly challenging the prices charged, examining the medical necessity, and reviewing the cost-effectiveness of medical products and services and imposing controls to manage costs. Third-party payors may limit coverage to specific products on
an approved list, also known as a formulary, which might not include all of the approved products for a particular indication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to secure
coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic or other studies in order to demonstrate the medical necessity and cost-effectiveness of the product, in addition to
the costs required to obtain FDA or other comparable regulatory approvals. Additionally, companies may also need to provide discounts to purchasers, private health plans or government healthcare programs. Nonetheless, product candidates may not be
considered medically necessary or cost effective. A decision by a third-party payor not to cover a product could reduce physician utilization once the product is approved and have a material adverse effect on sales, our operations and financial
condition. Additionally, a third-party payor&#146;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#146;s determination to provide coverage for a product does not
assure that other payors will also provide coverage and reimbursement for the product, and the level of coverage and reimbursement can differ significantly from payor to payor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The containment of healthcare costs has become a priority of federal, state and foreign governments, and the prices of products have been a focus in this
effort. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products. Adoption of price controls and
cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#146;s revenue generated from the sale of any approved products. Coverage policies and
third-party payor reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which a company or its collaborators receive regulatory approval, less favorable coverage
policies and reimbursement rates may be implemented in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Current and Future Legislation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States and some foreign jurisdictions, there have been, and likely will continue to be, a number of legislative and regulatory changes and
proposed changes regarding the healthcare system directed at broadening the availability of healthcare, improving the quality of healthcare, and containing or lowering the cost of healthcare. For example, in March 2010, the United States Congress
enacted the Affordable Care Act, which, among other things, includes changes to the coverage and payment for products under government health care programs. The Affordable Care Act includes provisions of importance to our potential product
candidates that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">created an annual, nondeductible fee on any entity that manufactures or imports specified branded prescription
drugs and biologic products, apportioned among these entities according to their market share in certain government healthcare programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expanded eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid
coverage to certain individuals with income at or below 133&nbsp;percent of the federal poverty level, thereby potentially increasing a manufacturer&#146;s Medicaid rebate liability; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">192</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expanded manufacturers&#146; rebate liability under the Medicaid Drug Rebate Program by increasing the minimum
rebate for both branded and generic drugs and revising the definition of &#147;average manufacturer price,&#148; or AMP, for calculating and reporting Medicaid drug rebates on outpatient prescription drug prices; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are
calculated for drugs that are inhaled, infused, instilled, implanted or injected; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expanded the types of entities eligible for the 340B drug discount program; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">established the Medicare Part D coverage gap discount program by requiring manufacturers to provide a
50&nbsp;percent <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale-discount</FONT></FONT> (increased to 70% as of January&nbsp;1, 2019 pursuant to subsequent legislation) off the negotiated price of applicable brand
drugs to eligible beneficiaries during their coverage gap period as a condition for the manufacturers&#146; outpatient drugs to be covered under Medicare Part D; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct
comparative clinical effectiveness research, along with funding for such research. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since its enactment, there have been numerous
judicial, administrative, executive, and legislative challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. For example, since January 2017, President Trump has signed
various Executive Orders and other directives designed to delay the implementation of or otherwise circumvent certain provisions of the Affordable Care Act. While Congress has not passed comprehensive repeal legislation, it has enacted laws that
modify certain provisions of the Affordable Care Act such as removing penalties, starting January&nbsp;1, 2019, for not complying with the Affordable Care Act&#146;s individual mandate to carry health insurance, delaying the implementation of
certain Affordable Care <FONT STYLE="white-space:nowrap">Act-mandated</FONT> fees, and increasing the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discount that is owed by pharmaceutical manufacturers
who participate in Medicare Part D. On December&nbsp;14, 2018, a Texas U.S. District Court Judge ruled that the Affordable Care Act is unconstitutional in its entirety because the &#147;individual mandate&#148; was repealed by Congress as part of
the Tax Cuts and Jobs Act of 2017. On December&nbsp;18, 2019, the U.S. Court of Appeals for the 5th Circuit ruled that the individual mandate was unconstitutional but remanded the case back to the District Court to determine whether the remaining
provisions of the ACA are invalid as well. On March&nbsp;2, 2020, the U.S. Supreme Court granted the petitions for writs of certiorari to review the case, although it is unclear when a decision will be made or how the Supreme Court will rule. The
Trump administration and CMS, have stated that the ruling will have no immediate effect pending appeal of the decision. Litigation and legislation related to the ACA are likely to continue, with unpredictable and uncertain results. We will continue
to evaluate the effect that the ACA and its possible repeal and replacement has on our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other legislative changes have been proposed and adopted
in the United States since the Affordable Care Act was enacted. In August 2011, the Budget Control Act of 2011, among other things, included aggregate reductions of Medicare payments to providers of 2&nbsp;percent per fiscal year, which went into
effect in April 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2027 unless additional Congressional action is taken. However, pursuant to the Coronavirus Aid, Relief and Economic Security Act, or
CARES Act, these Medicare sequester reductions will be suspended from May&nbsp;1, 2020 through December&nbsp;31, 2020 due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. In January 2013, the American Taxpayer Relief Act of 2012 was
signed into law, which, among other things, further reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover
overpayments to providers from three to five years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory
initiatives. For example, CMS may develop new payment and delivery models, such as bundled payment models. In addition, recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their commercial
products, which has resulted in several Congressional inquiries and proposed and enacted state and federal legislation designed to, among other things, bring more transparency to product pricing, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">193</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for pharmaceutical products. At the federal level, the Trump
administration&#146;s budget for fiscal year 2021 includes a $135&nbsp;billion allowance to support legislative proposals seeking to reduce drug prices, increase competition, lower
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> drug costs for patients, and increase patient access to lower-cost generic and biosimilar drugs.. On March&nbsp;10, 2020, the Trump administration sent
&#147;principles&#148; for drug pricing to Congress, calling for legislation that would, among other things, cap Medicare Part D beneficiary <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> pharmacy
expenses, provide an option to cap Medicare Part D beneficiary monthly <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses, and place limits on pharmaceutical price increases. Additionally, on
July&nbsp;24, 2020, President Trump signed four Executive Orders aimed at lowering drug prices. The Executive Orders direct the Secretary of the Department of Health and Human Services to: (1)&nbsp;eliminate protection under an Anti-Kickback Statute
safe harbor for certain retrospective price reductions provided by drug manufacturers to sponsors of Medicare Part D plans or pharmacy benefit managers that are not applied at the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale;</FONT></FONT> (2)&nbsp;allow the importation of certain drugs from other countries through individual waivers, permit the
<FONT STYLE="white-space:nowrap">re-importation</FONT> of insulin products, and prioritize finalization of FDA&#146;s December 2019 proposed rule to permit the importation of drugs from Canada; (3)&nbsp;ensure that payment by the Medicare program
for certain Medicare Part B drugs is not higher than the payment by other comparable countries (depending on whether pharmaceutical manufacturers agree to other measures); and (4)&nbsp;allow certain <FONT STYLE="white-space:nowrap">low-income</FONT>
individuals receiving insulin and epinephrine purchased by a Federally Qualified Health Center, or FQHC, as part of the 340B drug program to purchase those drugs at the discounted price paid by the FQHC. On September&nbsp;13, 2020, President Trump
signed an Executive Order directing HHS to implement a rulemaking plan to test a payment model, pursuant to which Medicare would pay, for certain high-cost prescription drugs and biological products covered by Medicare Part B, no more than the
most-favored-nation price (i.e., the lowest price) after adjustments, for a pharmaceutical product that the drug manufacturer sells in a member country of the Organization for Economic Cooperation and Development that has a comparable <FONT
STYLE="white-space:nowrap">per-capita</FONT> gross domestic product. Although a number of these, and other proposed measures will require authorization through additional legislation to become effective, Congress and the current administration have
each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While some proposed measures may
require additional authorization to become effective, Congress and the Trump administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. Individual states in the United
States have also become increasingly active in passing legislation and implementing regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product
access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional healthcare authorities and individual hospitals are increasingly
using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. Furthermore, there has been increased interest by third party payors and governmental
authorities in reference pricing systems and publication of discounts and list prices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;30, 2018, the Right to Try Act was signed into law.
The law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain
circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a drug manufacturer to make its drug products available
to eligible patients as a result of the Right to Try Act, but the manufacturer must develop an internal policy and respond to patient requests according to that policy. Drug manufacturers who provide their investigational product under the Right to
Try Act are required to submit to FDA an annual summary of the use of their drug. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Outside the United States, ensuring coverage and adequate payment for a
product also involves challenges. Pricing of prescription pharmaceuticals is subject to government control in many countries. Pricing negotiations </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">194</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with government authorities can extend well beyond the receipt of regulatory approval for a product and may require a clinical trial that compares the cost-effectiveness of a product to other
available therapies. The conduct of such a clinical trial could be expensive and result in delays in commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the European Union, pricing
and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the
cost-effectiveness of a particular product candidate to currently available therapies or <FONT STYLE="white-space:nowrap">so-called</FONT> health technology assessments, in order to obtain reimbursement or pricing approval. For example, the European
Union provides options for its member states to restrict the range of products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. European Union member states may
approve a specific price for a product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other member states allow companies to fix their own prices for products,
but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. Recently, many countries in the European Union have increased the amount of discounts required on pharmaceuticals and these efforts could continue
as countries attempt to manage healthcare expenditures, especially in light of the severe fiscal and debt crises experienced by many countries in the European Union. The downward pressure on healthcare costs in general, particularly prescription
products, has become intense. As a result, increasingly high barriers are being erected to the entry of new products. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue
after reimbursement has been obtained. Reference pricing used by various European Union member states, and parallel trade, i.e., arbitrage between <FONT STYLE="white-space:nowrap">low-priced</FONT> and high-priced member states, can further reduce
prices. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any products, if approved in those countries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We lease approximately 50,858 square feet of
office and laboratory space in Boston, Massachusetts of which we sublease approximately 11,852 square feet to a third party. This facility serves as our corporate headquarters. Certain of our Founded Entities sublease space from us and reimburse us
at market rates. We also lease approximately 4,170 square feet of laboratory space in Boston, Massachusetts. We believe that our existing facilities are adequate to meet our current needs for the foreseeable future, and that suitable additional
alternative spaces will be available in the future on commercially reasonable terms if needed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of this registration statement, we were not party to any material legal matters or claims. In the future, we may become party to legal matters
and claims arising in the ordinary course of business, the resolution of which we do not anticipate would have a material adverse impact on our financial position, results of operations or cash flows. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C. ORGANIZATIONAL STRUCTURE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
June&nbsp;30, 2020, we had one significant subsidiary. The following table sets out for each of our principal subsidiaries, the country of incorporation, percentage ownership and voting interest held by us (directly or indirectly through
subsidiaries): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Country&nbsp;of&nbsp;incorporation</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;ownership<BR>and voting interest</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Main&nbsp;activity</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech Health LLC</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">United&nbsp;States</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Biotechnology</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">195</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>D. PROPERTY, PLANTS AND EQUIPMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We lease approximately 50,858 square feet of office and laboratory space in Boston, Massachusetts of which we sublease approximately 11,852
square feet to a third party. This facility serves as our corporate headquarters. Certain of our Founded Entities sublease space from us and reimburse us at market rates. We also lease approximately 4,170 square feet of laboratory space in Boston,
Massachusetts. We believe that our existing facilities are adequate to meet our current needs for the foreseeable future, and that suitable additional alternative spaces will be available in the future on commercially reasonable terms if needed.
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_6"></A>ITEM&nbsp;4A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>UNRESOLVED STAFF COMMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">196</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_7"></A>ITEM&nbsp;5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OPERATING AND FINANCIAL REVIEW AND PROSPECTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>You should read the following discussion and analysis together with &#147;Selected Consolidated Financial Data&#148; and our consolidated
financial statements, including the notes thereto, included elsewhere in this registration statement. Some of the information contained in this discussion and analysis or set forth elsewhere in this registration statement, including information with
respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the &#147;Risk Factors&#148;
section of this registration statement, our actual results could differ materially from the results described in or implied by these forward-looking statements. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Our audited consolidated financial statements as of and for the years ended December&nbsp;31, 2019, 2018 and 2017 have been prepared in
accordance with the International Financial Reporting Standards, International Accounting Standards, and Interpretations (collectively &#147;IFRS&#148;) as issued by the International Accounting Standards Board (&#147;IASB&#148;) as adopted by the
European Union (adopted IFRSs). </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following discussion contains references to the consolidated financial statements of PureTech
Health plc and its consolidated subsidiaries, or the Company. These financial statements consolidate the Company&#146;s subsidiaries and include the Company&#146;s interest in associates and investments held at fair value. Subsidiaries are those
entities over which the Company maintains control. Associates are those entities in which the Company does not have control for financial accounting purposes but maintains significant influence over the financial and operating policies. Where we
have neither control nor significant influence for financial accounting purposes, we recognize our holding in such entity as an investment at fair value. For purposes of our consolidated financial statements, each of our Founded Entities are
considered to be either a &#147;subsidiary&#148; or an &#147;associate&#148; depending on whether PureTech Health plc controls or maintains significant influence over the financial and operating policies of the respective entity at the respective
period end date. For additional information regarding the accounting treatment of these entities, see Note 1 of our consolidated financial statements included in this registration statement. For additional information regarding our operating
structure, see &#147;&#151;Basis of Presentation and Consolidation&#148; below. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>A. OPERATING RESULTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biotechnology company
dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases, and neurological
and neuropsychological disorders, among others. The product candidates within our Wholly Owned Programs and the products and product candidates being developed by our Founded Entities were initiated by our experienced research and development team
and our extensive network of scientists, clinicians and industry leaders. These product candidates are protected by a growing intellectual property portfolio of more than 600 patents and patent applications, of which more than 200 are issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception, we have devoted substantially all of our resources to conducting research and development of our Wholly Owned product candidates and
those being developed by our Founded Entities, <FONT STYLE="white-space:nowrap">in-licensing</FONT> and acquiring rights to our Wholly Owned and our Founded Entities&#146; product candidates, building our intellectual property portfolio and
providing general and administrative support for our operations. To date, we have raised a total of $439.3&nbsp;million from external funding sources such as major investment funds and other leading investors. We raised $196.0&nbsp;million when we
completed our initial public offering, or IPO, on the London Stock Exchange in June 2015, plus an additional $101.2&nbsp;million as a <FONT STYLE="white-space:nowrap">follow-on</FONT> offering that we completed in April 2018. Prior to our IPO, we
raised a total of $142.1&nbsp;million in consecutive private financing rounds. In the period from January 2017 through June 2020, our Founded Entities strengthened their collective balance sheets by attracting $1,084.2&nbsp;million in investments
and <FONT STYLE="white-space:nowrap">non-dilutive</FONT> funding, including $997.6&nbsp;million from third parties. The balance of the funding is between PureTech Health plc and its Founded Entities. For a description of our structure and
relationships with our Founded Entities, see &#147;PureTech Health plc Structure&#148; included elsewhere in this registration statement. As of June&nbsp;30, 2020, we had cash, cash equivalents and short-term investments of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">197</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
$340.1&nbsp;million, which included aggregate proceeds of $12.3&nbsp;million and $245.9&nbsp;million from our sales of resTORbio and Karuna shares, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Founded Entities, Gelesis, Inc., or Gelesis, and Akili Interactive Labs, Inc., or Akili in which we lost control in 2019 and 2018, respectively, have
products cleared for sale, but we and our Controlled Founded Entities have not generated any revenue from product sales. Our ability to generate product revenue sufficient to achieve profitability will depend heavily on the successful development
and eventual commercialization of one or more of our Wholly Owned or our Controlled Founded Entities&#146; product candidates, which may never occur. For the years ended December&nbsp;31, 2019, 2018 and 2017<I> </I>and the six months ended
June&nbsp;30, 2020, we recognized income of $366.1 million&nbsp;, incurred a loss of $70.7&nbsp;million, incurred a loss of $75.1&nbsp;million and recognized income of $123.7&nbsp;million, respectively. We had retained earnings as of June&nbsp;30,
2020 of $378.4&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have deconsolidated a number of our Founded Entities during the past three fiscal years, including resTORbio, Inc., or
resTORbio, in November 2017, Akili, in May 2018, Vor Biopharma Inc. and Karuna Therapeutics, Inc., or Karuna, during the first half of 2019 and Gelesis Inc., or Gelesis, during the second half of 2019. We expect this trend to continue into the
foreseeable future as our Founded Entities raise additional funding. Any deconsolidation affects our financials in the following manner: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ownership interest does not provide us with a controlling financial interest; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we no longer control the subsidiary&#146;s assets and liabilities and as a result we derecognize the assets,
liabilities and non controlling interests related to the subsidiary from our Consolidated Statements of Financial Position; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we record our non controlling financial interest in the Founded Entity at fair value; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the resulting amount of any gain or loss is recognized in our Consolidated Statements of Comprehensive
Income/Loss. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect our expenses to continue to increase substantially in connection with our ongoing development activities related
to our preclinical and clinical programs. In addition, upon the completion of the U.S. listing to which this registration statement relates, we expect to incur additional costs associated with operating as a public company in the United States. We
expect that our expenses and capital requirements will increase substantially in the near to <FONT STYLE="white-space:nowrap">mid-term</FONT> as we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continue our research and development efforts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek regulatory approvals for any product candidates that successfully complete clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add clinical, scientific, operational financial and management information systems and personnel, including
personnel to support our product development and potential future commercialization claims; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">operate as a U.S. public company. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we expect our internal research and development spend to increase in the foreseeable future as we may initiate clinical studies for <FONT
STYLE="white-space:nowrap">LYT-100,</FONT> <FONT STYLE="white-space:nowrap">LYT-200,</FONT> <FONT STYLE="white-space:nowrap">LYT-210</FONT> and <FONT STYLE="white-space:nowrap">LYT-300,</FONT> and as we continue to progress our programs related to
lymphatic targeting, oral biotherapeutics and brain and central nervous system lymphatics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, with respect to our Founded Entities&#146;
programs, we anticipate that we will continue to fund a small portion of development costs by strategically participating in such companies&#146; financings when doing so would be in the interests of our shareholders. The form of any such
participation may include investment in public or private financings, collaboration and partnership arrangements and licensing arrangements, among others. Our management and strategic decision makers have not made decisions regarding the future
allocation of our resources among our Founded Entities, but evaluate the needs and opportunities with respect to each of these Founded Entities routinely and on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">198</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result, we may need substantial additional funding to support our continuing operations and pursue our
growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of public or private equity or debt financings or other sources, which may include
monetization of certain of our interests in our Founded Entities and collaborations with third parties. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we
fail to raise capital or enter into such agreements as, and when needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our Wholly Owned product candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>License and Collaboration Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a
disciplined strategy to maximize the value of our Wholly Owned Pipeline, or Internal segment, and have partnered, and plan to continue to partner, product candidates that we believe have promising utility in disease areas or patient populations that
are better served by resources of larger biopharmaceutical companies. We are party to a collaboration and license agreement with Boehringer Ingelheim, or BI, to evaluate the feasibility of applying our lymphatic targeting technology to advance
certain of BI&#146;s IO product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See &#147;Business&#151;License Agreements&#148; for a detailed description of our collaboration agreements.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have also entered into exclusive license agreements with each of NYU, Monash University, University of Louisville, Memorial Sloan Kettering Cancer
Center and University of Virginia, pursuant to which we have <FONT STYLE="white-space:nowrap">in-licensed</FONT> certain early stage technology for our Wholly Owned Programs. Pursuant to these agreements, the universities are entitled to <FONT
STYLE="white-space:nowrap">non-material</FONT> payments upon the achievement of certain specified development and sales based milestones. Additionally, the universities are entitled to low single digit royalty payments on net sales of any products
covered by their intellectual property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">COVID-19</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2019, illnesses associated with <FONT STYLE="white-space:nowrap">COVID-19</FONT> were reported and the virus has since caused widespread and
significant disruption to daily life and economies across geographies. The World Health Organization has classified the outbreak as a pandemic. Our business, operations and financial condition and results has not been significantly impacted during
the six months ended June&nbsp;30, 2020 as a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. In response to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, we have taken swift action to ensure the safety of
our employees and other stakeholders. We continue to monitor the latest developments regarding the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our business, operations, and financial condition and results, and have made certain
assumptions regarding the pandemic for purposes of our operational planning and financial projections, including assumptions regarding the duration and severity of the pandemic and the global macroeconomic impact of the pandemic. Despite careful
tracking and planning, however, we are unable to accurately predict the extent of the impact of the pandemic on our business, operations, and financial condition and results in future periods due to the uncertainty of future developments. We are
focused on all aspects of our business and are implementing measures aimed at mitigating issues where possible including by using digital technology to assist operations for our R&amp;D and enabling functions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis of Presentation and Consolidation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our consolidated
financial information consolidates the financial information of PureTech Health plc, as well as its subsidiaries, and includes our interest in associates and investments held at fair value, and is reported in four operating segments as described
below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">199</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis for Segmentation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our directors are our strategic decision-makers. Our operating segments are based on the financial information provided to our directors at least quarterly for
the purposes of allocating resources and assessing performance. We have determined that each Founded Entity is representative of a single operating segment as our directors monitor the financial results at this level. When identifying the reportable
segments we have determined that it is appropriate to aggregate multiple operating segments into a single reportable segment given the high level of operational and financial similarities across the entities. We have identified four reportable
segments which are outlined below. Substantially all of our revenue and profit generating activities are generated within the United States and, accordingly, no geographical disclosures are provided. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Internal </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Internal segment (the &#147;Internal
segment&#148;), is advancing a pipeline fueled by recent discoveries in lymphatics and immune cell trafficking to modulate disease in a tissue-specific manner. These programs leverage the transport and biodistribution of various immune system
components for the targeted treatment of diseases with major unmet needs, including cancers, autoimmune diseases, and neuroimmune disorders. The Internal segment is comprised of the technologies that will be advanced through either PureTech Health
funding or <FONT STYLE="white-space:nowrap">non-dilutive</FONT> sources of financing in the near-term. The operational management of the Internal segment is conducted by the PureTech Health team, which is responsible for the strategy, business
development, and research and development. As of June&nbsp;30, 2020, this segment included PureTech LYT, Inc. (formerly Ariya Therapeutics Inc.) and PureTech LYT 100, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Controlled Founded Entities </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Controlled Founded
Entities segment (the &#147;Controlled Founded Entity segment&#148;) is comprised of our subsidiaries that are currently consolidated operational subsidiaries that either have, or have plans to hire, independent management teams and have previously
raised, or are currently in the process of raising, third-party dilutive capital. These subsidiaries have active research and development programs and either have entered into or plan to seek a strategic partnership with an equity or debt investment
partner, who will provide additional industry knowledge and access to networks, as well as additional funding to continue the pursued growth of the company. As of June&nbsp;30, 2020 , this segment included Alivio Therapeutics, Inc., Entrega, Inc.,
Follica, Incorporated, Sonde Health, Inc. and Vedanta Biosciences, Inc. This segment also included Commense Inc. for all periods presented through December&nbsp;31, 2019 (beginning in 2020, Commense Inc. was an inactive subsidiary). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities segment (the <FONT STYLE="white-space:nowrap">&#147;Non-Controlled</FONT> Founded
Entities segment&#148;) is comprised of the entities in respect of which PureTech Health (i)&nbsp;no longer holds majority voting control as a shareholder and (ii)&nbsp;no longer has the right to elect a majority of the members of the entity&#146;s
Board of Directors. Upon deconsolidation of an entity the segment disclosure is restated to reflect the change on a retrospective basis, as this constitutes a change in the composition of its reportable segments. As of June&nbsp;30, 2020, the <FONT
STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities segment included Akili Interactive Labs, Inc. (&#147;Akili&#148;), Vor Biopharma, Inc. (&#147;Vor&#148;), Karuna Therapeutics, Inc. (&#147;Karuna&#148;), and Gelesis, Inc.
(&#147;Gelesis&#148;). This segment also included resTORbio, Inc. (&#147;resTORbio&#148;) for all periods through December&nbsp;31, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities segment incorporates the operational results of the aforementioned entities to the date of deconsolidation. Following the date of deconsolidation, we account for our investment in
each entity at the parent level, and therefore the results associated with investment activity following the date of deconsolidation is included in the Parent Company and Other segment (the &#147;Parent Company and Other segment&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">200</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Parent Company and Other segment </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Parent Company and Other segment includes activities that are not directly attributable to the operating segments, such as the activities of the Parent,
corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. This segment also captures the accounting
for our holdings in entities for which control has been lost, which is inclusive of the following items: gain on deconsolidation, gain or loss on investments held at fair value, gain on loss of significant influence, and the share of net loss of
associates accounted for using the equity method. As of June&nbsp;30, 2020, this segment included PureTech Health plc, PureTech Health LLC, PureTech Management, Inc. and PureTech Securities Corp., as well as certain other dormant, inactive and shell
entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below summarizes the entities that comprised each of our segments as of June&nbsp;30, 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Internal Segment</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech LYT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech <FONT STYLE="white-space:nowrap">LYT-100,</FONT> Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Controlled Founded Entities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alivio Therapeutics, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica, Incorporated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde Health, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta Biosciences, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded
Entities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Akili Interactive Labs, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karuna Therapeutics, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vor Biopharma Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Parent Segment<SUP STYLE="font-size:85%; vertical-align:top">
(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Puretech Health plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech Health LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech Securities Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech Management, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes dormant, inactive and shell entities that are not listed here. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of Our Results of Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Revenue
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To date, we have not generated any revenue from product sales and we do not expect to generate any revenue from product sales for the foreseeable
future. We derive our revenue from the following: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Contract revenue. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We generate revenue primarily from licenses, services and collaboration agreements, including amounts that are recognized related to upfront payments,
milestone payments and amounts due to us for research and development services. In the future, revenue may include additional milestone payments and royalties on any net product sales under our collaborations. We expect that any revenue we generate
will fluctuate from period to period as a result of the timing and amount of license, research and development services and milestone and other payments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">201</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Grant Revenue. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Grant revenue is derived from grant awards that we receive from governmental agencies and <FONT STYLE="white-space:nowrap">non-profit</FONT> organizations for
certain qualified research and development expenses. We recognize grants from governmental agencies as grant income in the Consolidated Statement of Comprehensive Income/(Loss), gross of the expenditures that were related to obtaining the grant,
when there is reasonable assurance that we will comply with the conditions within the grant agreement and there is reasonable assurance that payments under the grants will be received. We evaluate the conditions of each grant as of each reporting
date to ensure that we have reasonable assurance of meeting the conditions of each grant arrangement and it is expected that the grant payment will be received as a result of meeting the necessary conditions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Research and Development
Expenses </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expenses consist primarily of costs incurred for our research activities, including our discovery efforts, and the
development of our Wholly Owned and our Founded Entities&#146; product candidates, which include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employee-related expenses, including salaries, related benefits and equity-based compensation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenses incurred in connection with the preclinical and clinical development of our Wholly Owned and our Founded
Entities&#146; product candidates, including our agreements with contract research organizations, or CROs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenses incurred under agreements with consultants who supplement our internal capabilities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of lab supplies and acquiring, developing and manufacturing preclinical study materials and clinical
trial materials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs related to compliance with regulatory requirements; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">facilities, depreciation and other expenses, which include direct and allocated expenses for rent and maintenance
of facilities, insurance and other operating costs. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expense all research costs in the periods in which they are incurred and
development costs are capitalized only if certain criteria are met. For the periods presented, we have not capitalized any development costs since we have not met the necessary criteria required for capitalization. Costs for certain development
activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our vendors and third-party service providers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development activities are central to our business model. Product candidates in later stages of clinical development generally have higher
development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We expect that our research and development expenses will continue to increase for the
foreseeable future in connection with our planned preclinical and clinical development activities in the near term and in the future. The successful development of our Wholly Owned and our Founded Entities&#146; product candidates is highly
uncertain. As such, at this time, we cannot reasonably estimate or know the nature, timing and estimated costs of the efforts that will be necessary to complete the remainder of the development of these product candidates. We are also unable to
predict when, if ever, material net cash inflows will commence from our Wholly Owned or our Founded Entities&#146; product candidates. This is due to the numerous risks and uncertainties associated with developing products, including the uncertainty
of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">progressing research and development of our product pipeline, including
<FONT STYLE="white-space:nowrap">LYT-100,</FONT> <FONT STYLE="white-space:nowrap">LYT-200,</FONT> <FONT STYLE="white-space:nowrap">LYT-210,</FONT> <FONT STYLE="white-space:nowrap">LYT-300</FONT> and our programs related to lymphatic targeting, oral
biotherapeutics and brain and central nervous system lymphatics and other potential product candidates within our Wholly Owned Programs; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">202</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing an appropriate safety profile with investigational new drug application enabling studies to advance
our preclinical programs into clinical development; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of our Founded Entities and their need for additional capital; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying new product candidates to add to our development pipeline; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">successful enrollment in, and the initiation and completion of, clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing, receipt and terms of any marketing approvals from applicable regulatory authorities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commercializing our Wholly Owned and our Founded Entities&#146; product candidates, if approved, whether alone or
in collaboration with others; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing commercial manufacturing capabilities or making arrangements with third-party manufacturers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">addressing any competing technological and market developments, as well as any changes in governmental
regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">negotiating favorable terms in any collaboration, licensing or other arrangements into which we may enter and
performing our obligations under such arrangements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintaining, protecting and expanding our portfolio of intellectual property rights, including patents, trade
secrets and <FONT STYLE="white-space:nowrap">know-how,</FONT> as well as obtaining and maintaining regulatory exclusivity for our Wholly Owned and our Founded Entities&#146; product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continued acceptable safety profile of our products, if any, following approval; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">attracting, hiring and retaining qualified personnel. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A change in the outcome of any of these variables with respect to the development of a product candidate could mean a significant change in the costs and
timing associated with the development of that product candidate. For example, the U.S. Food and Drug Administration, or FDA, the European Medicines Agency, or EMA, or another comparable foreign regulatory authority may require us to conduct
clinical trials beyond those that we anticipate will be required for the completion of clinical development of a product candidate, or we may experience significant trial delays due to patient enrollment or other reasons, in which case we would be
required to expend significant additional financial resources and time on the completion of clinical development. In addition, we may obtain unexpected results from our clinical trials and we may elect to discontinue, delay or modify clinical trials
of some product candidates or focus on others. Identifying potential product candidates and conducting preclinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes years to complete, and we may never
generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, our Wholly Owned and our Founded Entities&#146; product candidates, if approved, may not achieve commercial success. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and
administrative expenses consist primarily of salaries and other related costs, including stock-based compensation, for personnel in our executive, finance, corporate and business development and administrative functions. General and administrative
expenses also include professional fees for legal, patent, accounting, auditing, tax and consulting services, travel expenses and facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of
facilities and other operating costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect that our general and administrative expenses will increase in the future as we increase our general and
administrative headcount to support our continued research and development and potential commercialization of our portfolio of product candidates. We also expect to incur increased expenses associated with being a public company in the United
States, including costs of accounting, audit, information systems, legal, regulatory and tax compliance services, director and officer insurance costs and investor and public relations costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">203</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Total Other Income/(Loss) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Gain on Deconsolidation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon losing control of a
subsidiary, the assets and liabilities are derecognized along with any related <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest (&#147;NCI&#148;). Any interest retained in the former subsidiary is measured at fair value when control
is lost. Any resulting gain or loss is recognized as profit or loss in the Consolidated Statements of Comprehensive Income/(Loss). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Gain (Loss) on
Investments Held at Fair Value </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investments held at fair value include both unlisted and listed securities held by us, which include investments in
Akili, Gelesis, Karuna, Vor, ResTORbio (until its sale in 2020) and certain insignificant investments. Our ownership in Akili, Gelesis and Vor is in preferred shares and our ownership of Karuna was in preferred shares until its IPO in June 2019 when
such shares were converted into common shares. When Karuna&#146;s preferred shares converted into common shares, our equity interest in Karuna investment was removed from Investments Held at Fair Value and accounted for under the equity method as we
still retained significant influence in Karuna at such time. On December&nbsp;2, 2019 we lost significant influence in Karuna and, beginning on that date, we accounted for our investment in Karuna in accordance with IFRS 9 as an Investment Held at
Fair Value. We account for investments in preferred shares of our associates in accordance with IFRS 9 as Investments Held at Fair Value when the preferred shares do not provide access to returns underlying ownership interests. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Gain on Loss of Significant Influence </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gain on loss of
significant influence relates to the assessment in connection with our ability to exert significant influence over an investment in a <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entity. As of June&nbsp;30, 2020, only our common
share investment in Gelesis meets the scope of equity method accounting. For the years ended December&nbsp;31, 2019 and 2018, we recognized gains on loss of significant influence in Karuna and resTORbio, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Income (Expense) </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other income (expense) consists
primarily of gains and losses related to the sale of an asset and certain investments as well as <FONT STYLE="white-space:nowrap">sub-lease</FONT> income. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Finance Costs/Income </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finance costs consist of
loan interest expense and the changes in the fair value of certain liabilities associated with financing transactions. Finance income consists of interest income on funds invested in U.S. treasuries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Share of Net Gain (Loss) of Associates Accounted for Using the Equity Method, and Impairment of Investment in Associate </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Associates are accounted for using the equity method (equity accounted investees) and are initially recognized at cost, or if recognized upon deconsolidation
they are initially recorded at fair value at the date of deconsolidation. The consolidated financial statements include our share of the total comprehensive income and equity movements of equity accounted investees, from the date that significant
influence commences until the date that significant influence ceases. When the share of losses exceeds its net investment in the investee, the carrying amount is reduced to nil and recognition of further losses is discontinued except to the extent
that we have incurred legal or constructive obligations or made payments on behalf of an investee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We compare the recoverable amount of the investment to
its carrying amount on a <FONT STYLE="white-space:nowrap">go-forward</FONT> basis and determines the need for impairment and reversal of impairment losses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">204</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income Tax </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We must make certain estimates and judgments in determining income tax expense for financial statement purposes. The amount of taxes currently payable or
refundable is accrued, and deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their
respective tax bases. Deferred tax assets are also recognized for realizable loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using substantively enacted tax rates in effect for the year in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in income tax rates is recognized in our financial statements in the period that includes the substantive enactment date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table, which has
been derived from our audited financial statements for the years ended December&nbsp;31, 2019, 2018 and 2017 and our unaudited condensed consolidated financial statements for the six months ended June&nbsp;30, 2020 and 2019 included herein,
summarizes our results of operations for the periods indicated, together with the changes in those items in dollars: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended</B><br><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in&nbsp;thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B><br><B>(2018&nbsp;to&nbsp;2019)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change<BR>(2017&nbsp;to&nbsp;2018)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,688</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,371</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">650</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7,683</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,721</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,119</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,377</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,885</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,492</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,807</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,748</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,535</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10,941</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,213</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59,358</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,365</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(46,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,993</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,082</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85,848</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(77,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,672</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,445</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,730</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(135,399</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(104,019</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(115,420</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(31,380</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,401</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">264,409</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,730</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,016</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">222,679</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,286</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(37,863</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,615</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,334</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,248</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(91,949</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss realized on sale of investment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on impairment of intangible asset</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,060</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,060</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">445,582</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,287</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">435,295</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,287</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expenses)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(278</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">399</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(292</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>672,167</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,154</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>142,364</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>651,013</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(121,210</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net finance income/(costs)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,147</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,917</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(80,047</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(72,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>105,964</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net gain/(loss) of associates accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,791</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,608</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,281</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,118</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impairment of investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>478,474</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(68,438</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,711</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>546,911</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,273</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112,409</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,383</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(110,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,162</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net income/(loss) including <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,659</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(75,094</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>436,724</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,435</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net (loss)/income attributable to the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(43,654</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>26,472</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>464,798</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,126</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">205</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six&nbsp;Months&nbsp;Ended</B><br><B>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in&nbsp;thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,465</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,955</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,510</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,379</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">432</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">947</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,844</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,387</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,457</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,376</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,196</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,820</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(38,250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,507</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,257</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(52,782</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,317</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,534</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,395</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108,395</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">276,910</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,375</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224,535</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss realized on sale of investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,539</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,539</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on impairment of intangible asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">522</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>232,852</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>160,729</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>72,122</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net finance income/(costs)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,685</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(34,126</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>35,811</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net gain/(loss) of associates accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,271</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,271</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impairment of investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>174,483</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>56,287</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>118,196</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,633</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net income/(loss) including <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>31,145</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>92,563</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net (loss)/income attributable to the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>73,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>50,450</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December&nbsp;31, 2018 and 2017 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Total Revenue </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract Revenue:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,110</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,110</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,233</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,608</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Contract Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>16,371</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>650</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,721</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant Revenue:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,271</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,255</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,016</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">630</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(610</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Grant Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,377</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,885</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,492</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">206</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our total revenue was $20.7&nbsp;million for the year ended December&nbsp;31, 2018, an increase of
$18.2&nbsp;million, or 718.5&nbsp;percent compared to the year ended December&nbsp;31, 2017. The growth was attributable to increases of $13.6&nbsp;million in contract revenue and $3.0&nbsp;million in grant revenue in the Controlled Founded Entities
segment for the year ended December&nbsp;31, 2018, which was driven primarily by contract revenue earned under Vedanta&#146;s milestone-based JBI collaboration agreement and its <FONT STYLE="white-space:nowrap">CARB-X</FONT> grant agreement. The
growth was further attributable to an increase of $2.1&nbsp;million in revenue earned in the Internal segment under the Orasome collaboration and license agreement with Roche for the year ended December&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and Development Expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8,929</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,515</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,414</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,377</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,851</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,395</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,544</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,209</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,517</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Research and Development Expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(77,402</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(71,672</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,730</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our research and development expenses were $77.4&nbsp;million for the year ended December&nbsp;31, 2018, an increase of
$5.7&nbsp;million, or 8.0&nbsp;percent compared to the year ended December&nbsp;31, 2017. The change was attributable to increases of $7.4&nbsp;million in the Internal segment and $11.4&nbsp;million in the Controlled Founded entities segment for the
year ended December&nbsp;31, 2018, which were primarily due to increased headcount and increased clinical trial expense. The increases were offset partially by a decline of $11.5&nbsp;million owing to the deconsolidation of resTORbio during the year
ended December&nbsp;31, 2017 and the deconsolidation of Akili during the year ended December&nbsp;31, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses
</I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and Administrative Expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,498</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,096</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,212</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,671</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(459</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,385</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,064</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(679</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,270</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,146</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,124</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total General and Administrative Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(47,365</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,283</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,082</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our general and administrative expenses were $47.4&nbsp;million for the year ended December&nbsp;31, 2018, an increase of
$1.1&nbsp;million, or 2.3&nbsp;percent compared to the year ended December&nbsp;31, 2017. The change was attributable to increases of $1.1&nbsp;million in the Parent segment and $1.1&nbsp;million in the Internal segment, which were primarily due to
increased headcount and increased professional fees. The increases were partially offset by a decline of $0.7&nbsp;million in the <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities segment, primarily owing to the deconsolidation
of resTORbio during the year ended December&nbsp;31, 2017 and the deconsolidation of Akili during the year ended December&nbsp;31, 2018, as well as a decline of $0.5&nbsp;million in the Controlled Founded Entities segment for year ended
December&nbsp;31, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Total Other Income (Loss) </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total other income was $21.2&nbsp;million for the year ended December&nbsp;31, 2018, a decrease of $121.2&nbsp;million, or 85.1&nbsp;percent as compared to the
year ended December&nbsp;31, 2017. The decline was attributable to a $91.9&nbsp;million </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">207</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
increase in fair value accounting losses on certain investments held at fair value for the year ended December&nbsp;31, 2018 and a $43.3&nbsp;million decline in gain on deconsolidation as we
recognized a gain of $41.7&nbsp;million for the deconsolidation of Akili during the year ended December&nbsp;31, 2018 compared to a gain of $85.0&nbsp;million for the deconsolidation of resTORbio during the year ended December&nbsp;31, 2017. The
decline was partially offset by gains of $10.3&nbsp;million on loss of significant influence of resTORbio and $4.1&nbsp;million on disposal of assets for the year ended December&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Net Finance Income (Costs) </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net finance income was
$25.9&nbsp;million for the year ended December&nbsp;31, 2018, an increase of $106.0&nbsp;million in income, or 132.4&nbsp;percent as compared to the year ended December&nbsp;31, 2017. The income growth was attributable to a $103.8&nbsp;million
decline in the change in the fair value of our preferred shares, warrant and convertible note liabilities held by third parties for the year ended December&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Share of Net Gain (Loss) in Associates Accounted for Using the Equity Method, and Impairment of Investment in Associate </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The share of net loss in associates was $11.5&nbsp;million for the year ended year ended December&nbsp;31, 2018, a decline of $6.1&nbsp;million, or
34.7&nbsp;percent as compared to the year ended December&nbsp;31, 2017. The decline in share of associate net loss was attributable to the results of resTORbio for the year ended December&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Taxation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Income tax expense was $2.2&nbsp;million for
the year ended December&nbsp;31, 2018, a decrease of $2.2&nbsp;million, or 49.3&nbsp;percent as compared to the year ended December&nbsp;31, 2017. The decline in income tax expense was primarily attributable to the enactment of the Tax Cuts and Jobs
Act of 2017 by United States Congress in November 2017 and subsequent tax provision benefits realized for the year ended December&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December&nbsp;31, 2019 and 2018 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Total Revenue </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract Revenue:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,064</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,110</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,954</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,487</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,233</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,745</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Contract Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,688</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>16,371</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(7,683</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant Revenue:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(72</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,104</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,271</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,167</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Grant Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,119</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,377</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,258</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our total revenue was $9.8&nbsp;million for the year ended December&nbsp;31, 2019, a decrease of $10.9&nbsp;million, or
52.7&nbsp;percent compared to the year ended December&nbsp;31, 2018. The decline was attributable to decreases of $11.7&nbsp;million in contract revenue and $3.2&nbsp;million in grant revenue in the Controlled Founded Entities segment
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">208</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for the year ended December&nbsp;31, 2019, which was driven primarily by Vedanta&#146;s contract revenue earned under its milestone-based JBI collaboration agreement and grant revenue earned
pursuant to its <FONT STYLE="white-space:nowrap">CARB-X</FONT> agreement. The decline in Controlled Founded Entities segment&#146;s contract and grant revenues, was partially offset by a $4.0&nbsp;million increase in contract revenue in the Internal
segment, which was driven by increases in contract revenue earned under the Orasome collaboration and license agreement with Roche and the Lymphatic Targeting platform collaboration and license agreement with Boehringer Ingelheim entered into in
July 2019 for the year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and Development Expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(25,977</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8,929</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,048</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,780</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,850</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,555</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,851</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,536</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(156</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Research and Development Expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(85,848</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(77,402</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,446</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our research and development expenses were $85.8&nbsp;million for the year ended December&nbsp;31, 2019, an increase of
$8.4&nbsp;million, or 10.9&nbsp;percent compared to the year ended December&nbsp;31, 2018. The change was attributable to an increase of $17.0&nbsp;million in research and development expenses incurred by the Internal segment for the year ended
December&nbsp;31, 2019. In 2019, we continued to shift our focus towards the Internal segment, investing in research and development activities to advance a wholly owned pipeline of lymphatic system and related immuno-oncology programs. We
progressed <FONT STYLE="white-space:nowrap">LYT-100</FONT> to first patient dosing in 2020 and prepared for <FONT STYLE="white-space:nowrap">LYT-200</FONT> to begin a Phase 1 clinical study in solid tumors during the second half of 2020. Research
and development expenses in the Controlled Founded Entities segment also increased $5.9&nbsp;million, as Vedanta progressed its candidates VE202, VE303, VE416 and VE800 to meaningful milestones. The increases were partially offset by a decline of
$14.3&nbsp;million in the <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities segment owing to the deconsolidation of Akili during the year ended December&nbsp;31, 2018 and the deconsolidation of Vor, Karuna and Gelesis during
the year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and Administrative Expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,385</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,498</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">887</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,436</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,212</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,224</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,439</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,385</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,946</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,098</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,270</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,828</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total General and Administrative Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(59,358</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(47,365</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,993</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our general and administrative expenses were $59.4&nbsp;million for the year ended December&nbsp;31, 2019, an increase of
$12.0&nbsp;million, or 25.3&nbsp;percent compared to the year ended December&nbsp;31, 2018. The change was attributable to an increase of $12.8&nbsp;million in the Parent segment for the year ended December&nbsp;31, 2019, which was primarily driven
by increased professional fees incurred in the exploration of an ADR listing and increased <FONT STYLE="white-space:nowrap">non-cash</FONT> depreciation and amortization expenses incurred in the implementation of IFRS 16 <I>Leases</I> and the lease
we entered into during the year ended December&nbsp;31, 2019 for our new headquarters. Controlled Founded Entities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">209</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
segment&#146;s general and administrative expenses also increased $4.2&nbsp;million. The increases in the Internal and Controlled Founded Entities segment&#146;s were offset by the
deconsolidation of Akili during the year ended December&nbsp;31, 2018 and the deconsolidation of Vor, Karuna and Gelesis during the year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Total Other Income (Loss) </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total other income was
$672.2&nbsp;million for the year ended December&nbsp;31, 2019, an increase of $651.0&nbsp;million, as compared to the year ended December&nbsp;31, 2018. The growth was attributable to an increase of $435.3&nbsp;million in gain on loss of significant
influence for the year ended December&nbsp;31, 2019. For the year ended December&nbsp;31, 2019 we recognized a gain on loss of significant influence of $445.6&nbsp;million with respect to Karuna, while for the year ended December&nbsp;31, 2018 we
recognized a gain on loss of significant influence of $10.3&nbsp;million with respect to resTORbio. The growth was further attributable to an increase of $222.7&nbsp;million in gain on deconsolidation as we recognized a gain of $264.4&nbsp;million
for the deconsolidation of Vor, Karuna and Gelesis during the year ended December&nbsp;31, 2019, as compared to a gain of $41.7&nbsp;million for the deconsolidation of Akili during the year ended December&nbsp;31, 2018. The gains were partially
offset by a decline of $4.1&nbsp;million in income related to asset disposals and an increase in fair value accounting losses of $3.2&nbsp;million on certain investments held at fair value for the year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Net Finance Income (Costs) </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net finance costs were
$46.1&nbsp;million for the year ended December&nbsp;31, 2019, an increase of $72.1&nbsp;million in costs, or 278.1&nbsp;percent compared to net finance income of $25.9&nbsp;million for the year ended December&nbsp;31, 2018. The change was primarily
attributable to a $69.1&nbsp;million increase in the change in the fair value of our preferred shares, warrant and convertible note liabilities held by third parties for the year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Share of Net Gain (Loss) in Associates Accounted for Using the Equity Method, and Impairment of Investment in Associate </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The share of net income in associates was $30.8&nbsp;million for the year ended December&nbsp;31, 2019, an increase of $42.3&nbsp;million, or
368.0&nbsp;percent as compared to a net loss for the year ended December&nbsp;31, 2018. The change in associate income was attributable to the deconsolidation of Karuna and Gelesis and subsequent equity method accounting from the date of
deconsolidation to December&nbsp;31, 2019. We recorded equity method income of $37.1&nbsp;million with respect to Gelesis, which was partially offset by our share of net loss in Karuna of $6.3&nbsp;million for the year ended December&nbsp;31, 2019.
Additionally, we recorded an impairment charge of $42.9&nbsp;million for the year ended December&nbsp;31, 2019, related to our investment in common shares held in Gelesis. See Note 6 to the financial statements for the year ended December&nbsp;31,
2019 included elsewhere in this registration statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Taxation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Income tax expense was $112.4&nbsp;million for the year ended December&nbsp;31, 2019, an increase of $110.2&nbsp;million, or 4961.2&nbsp;percent as compared to
the year ended December&nbsp;31, 2018. The growth in income tax expense was primarily attributable to the gains realized on the loss of significant influence on Karuna for the year ended December&nbsp;31, 2019 and the gains recognized on
deconsolidation of Vor, Karuna and Gelesis during the year ended December&nbsp;31, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">210</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Six Months Ended June&nbsp;30, 2020 and June&nbsp;30, 2019 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Total Revenue </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract Revenue:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,916</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,479</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,436</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,549</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,262</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">287</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">213</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(213</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Contract Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,465</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,955</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,510</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant Revenue:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,379</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">418</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">961</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Grant Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,379</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>432</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>947</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our total revenue was $6.8&nbsp;million for the six months ended June&nbsp;30, 2020, an increase of $2.5&nbsp;million, or
56.0&nbsp;percent compared to the six months ended June&nbsp;30, 2019. The growth was attributable to an increase in Internal segment contract revenue of $1.4&nbsp;million, which was primarily driven by $2.4&nbsp;million earned under the Lymphatic
Targeting platform collaboration and license agreement with Boehringer Ingelheim entered into in July 2019, and was partially offset by a $1.0&nbsp;million decrease in revenue earned under the Orasome collaboration and license agreement with Roche
for the six months ended June&nbsp;30, 2020. The growth in contract revenue was further augmented by increases in Controlled Founded Entities segment&#146;s grant revenue of $1.0&nbsp;million, which was driven by $0.5&nbsp;million and
$0.4&nbsp;million increases in grant revenue earned by Alivio and Vedanta, respectively, for the six months ended June&nbsp;30, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Research and
Development Expenses </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and Development Expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(17,616</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10,757</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,859</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,594</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,534</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,061</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,555</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,555</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(662</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(621</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Research and Development Expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(38,250</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(45,507</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(7,257</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our research and development expenses were $38.3&nbsp;million for the six months ended June&nbsp;30, 2020, a decrease of
$7.3&nbsp;million, or 15.9&nbsp;percent as compared to the six months ended June&nbsp;30, 2019. The decrease was attributable to the deconsolidation of Vor and Karuna during the six months ended June&nbsp;30, 2019 and Gelesis during the six months
ended December&nbsp;31, 2019. The decline owing to deconsolidation was partially offset, primarily, by an increase of $6.9&nbsp;million in the Internal segment during the six months ended June&nbsp;30, 2020. We progressed <FONT
STYLE="white-space:nowrap">LYT-100</FONT> to first patient dosing in a Phase 1 multiple ascending dose study in March 2020 and plan for initiation of a proof of concept study for the treatment of breast cancer-related, upper limb secondary
lymphedema later in 2020. We also advanced <FONT STYLE="white-space:nowrap">LYT-100</FONT> towards first patient dosing in a Phase 1 trial which is anticipated to begin in Q3 2020 for the treatment of serious respiratory complications following the
resolution of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">211</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acute <FONT STYLE="white-space:nowrap">COVID-19.</FONT> Additionally, we further prepared <FONT STYLE="white-space:nowrap">LYT-200</FONT> for first patient dosing in its Phase 1 trial for solid
tumors which is anticipated to begin in 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and Administrative Expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal Segment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,495</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,157</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">338</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Controlled Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,229</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,391</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(161</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,439</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,439</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Company and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,652</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,210</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,442</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total General and Administrative Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(21,376</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(29,196</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(7,820</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our general and administrative expenses were $21.4&nbsp;million for the six months ended June&nbsp;30, 2020, a decrease of
$7.8&nbsp;million or 26.8&nbsp;percent as compared to the six months ended June&nbsp;30, 2019. The decrease was attributable to the decline in general and administrative expenses within the <FONT STYLE="white-space:nowrap">Non-Controlled</FONT>
Founded Entities segment owing to the deconsolidation of Vor and Karuna during the six months ended June&nbsp;30, 2019 and Gelesis during the six months ended December&nbsp;31, 2019. The decline was partially offset by growth of $2.4&nbsp;million in
the Parent segment, which was primarily driven by <FONT STYLE="white-space:nowrap">non-cash</FONT> increases of $1.5&nbsp;million in stock based compensation expense and $0.7&nbsp;million in depreciation expense for the six months ended
June&nbsp;30, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Total Other Income (Loss) </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total
other income was $232.9&nbsp;million for the six months ended June&nbsp;30, 2020, an increase of $72.1&nbsp;million, or 44.9&nbsp;percent as compared to the six months ended June&nbsp;30, 2019. The growth in other income was attributable to an
increase in fair value accounting gains of $224.5 on certain investments held at fair value, which was partially offset by a decline in gain on deconsolidation of $108.4&nbsp;million for the six months ended June&nbsp;30, 2020. During the six months
ended June&nbsp;30, 2019 we recognized a gain of $108.4&nbsp;million for the deconsolidation of Vor and Karuna, while during the six months ended June&nbsp;30, 2020 we recognized no deconsolidation related income or losses. The growth in other
income was further offset by $44.5&nbsp;million in realized losses owing to blockage discount on the sale of Karuna shares for the six months ended June&nbsp;30, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Net Finance Income (Costs) </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total net finance income was
$1.7&nbsp;million for the six months ended June&nbsp;30, 2020, as compared to net finance costs of $34.1&nbsp;million for the six months ended June&nbsp;30, 2019, an increase in income of $35.8&nbsp;million, or 104.9&nbsp;percent as compared to the
six months ended June&nbsp;30, 2019. The increase in finance income was primarily attributable to a $34.8&nbsp;million decline in losses resulting from the change in fair value of our subsidiary preferred shares, warrant and convertible note
liabilities held by third parties for the six months ended June&nbsp;30, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Share of Net Gain (Loss) in Associates Accounted for Using the Equity
Method, and Impairment of Investment in Associate </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The share of net loss in associates was $7.3&nbsp;million for the six months ended June&nbsp;30,
2020, an increase of $7.3&nbsp;million as compared to the six months ended June&nbsp;30, 2019. The growth in associate loss was attributable to the deconsolidation of Gelesis during the six months ended December&nbsp;31, 2019 and subsequent equity
method accounting for the six months ended June&nbsp;30, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Taxation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Income tax expense was $50.8&nbsp;million for the six months ended June&nbsp;30, 2020, an increase of $25.6&nbsp;million, or 102.0&nbsp;percent as compared to
the six months ended June&nbsp;30, 2019. The growth in income tax expense was </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">212</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
primarily attributable to fair value accounting gains on certain investments held at fair value for the six months ended June&nbsp;30, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Significant Judgments and Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our management&#146;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which we have prepared
in accordance with IFRS as issued by the IASB. In the preparation of these financial statements, we are required to make judgments, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from
other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates under different assumptions or conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our estimates and assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is
revised if the revision affects only that period or in the period of the revisions and future periods if the revision affects both current and future periods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While our significant accounting policies are described in more detail in the notes to our consolidated financial statements appearing at the end of this
registration statement, we believe the following accounting policies to be most critical to the judgments and estimates used in the preparation of our financial statements. See Note 1 to our consolidated financial statements for a further detailed
description of our significant accounting policies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial instruments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We account for our financial instruments according to IFRS 9. As such, when issuing preferred shares in our subsidiaries we determine the classification of
financial instruments in terms of liability or equity. Such determination involves significant judgement. These judgements include an assessment of whether the financial instruments include any embedded derivative features, whether they include
contractual obligations upon us to deliver cash or other financial assets or to exchange financial assets or financial liabilities with another party, and whether that obligation will be settled by exchanging a fixed amount of cash or other
financial assets for a fixed number of its own equity instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with IFRS 9 we carry certain investments in equity securities at fair
value as well as our subsidiary preferred share, convertible notes and warrant liabilities, all through profit and loss (FVTPL). Valuation of the aforementioned financial instruments (assets and liabilities) includes making significant estimates,
specifically determining the appropriate valuation methodology and making certain estimates of the future earnings potential of the subsidiary businesses, appropriate discount rate and earnings multiple to be applied, marketability and other
industry and company specific risk factors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revenue recognition: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We follow the five step model instituted by IFRS 15 to recognize revenue. This includes making certain judgements when determining the appropriate accounting
treatment of key customer contract. In particular, judgement is required to determine the performance obligations in a contract (if promised goods and services are distinct or not) and timing of revenue recognition (on delivery or over a period of
time). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For overtime recognition, we determine progress based on costs completed to total estimated contract costs. As such we need to make certain
estimates of costs to be incurred for meeting our obligations under the contract. The costs are for research and development activity and the estimation uncertainty is regarding the level of activity required to meet the performance obligation and
the timing in which that arises during the term of the contract. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">213</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements include the financial statements of the Company and the entities it controls. Based on the applicable accounting rules,
the Company controls an investee when it is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Therefore an assessment is required to
determine whether the Company has i) power over the investee; (ii)&nbsp;exposure, or rights, to variable returns from its involvement with the investee; and (iii)&nbsp;the ability to use its power over the investee to affect the amount of the
investor&#146;s returns. Judgement is required to perform such assessment and it requires that the Company consider, among others, activities that most significantly affect the returns of the investee, its voting shares, representation on the board,
rights to appoint management, investee dependence on the Company and other contributing factors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investment in Associates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When we do not control an investee but maintain significant influence over the financial and operating policies of the investee the investee is an associate.
Significant influence is presumed to exist when we hold 20&nbsp;percent or more of the voting power of an entity, unless it can be clearly demonstrated that this is not the case. We evaluate if we maintain significant influence over associates by
assessing if we have the power to participate in the financial and operating policy decisions of the associate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Associates are accounted for using the
equity method (equity accounted investees) and are initially recognized at cost, or if recognized upon deconsolidation they are initially recorded at fair value at the date of deconsolidation. The consolidated financial statements include our share
of the total comprehensive income and equity movements of equity accounted investees, from the date that significant influence commences until the date that significant influence ceases. When our share of losses exceeds its net investment in an
equity accounted investee, the carrying amount is reduced to zero and recognition of further losses is discontinued except to the extent that we have incurred legal or constructive obligations or made payments on behalf of an investee. To the extent
we hold interests in associates that are not providing access to returns underlying ownership interests and are more akin to debt like securities, the instrument held by PureTech is accounted for in accordance with IFRS 9. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Judgement is required in order to determine whether we have significant influence over financial and operating policies of investees. This judgement includes,
among others, an assessment whether we have representation on the board of directors of the investee, whether we participate in the policy making processes of the investee, whether there is any interchange of managerial personnel, whether there is
any essential technical information provided to the investee and if there are any transactions between us and the investee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Judgment is also required to
determine which instruments we hold in the investee form part of the investment in the associate, which is accounted for under IAS 28 and scoped out of IFRS 9, and which instruments are separate financial instruments that fall under the scope of
IFRS 9. This judgement includes an assessment of the characteristics of the financial instrument of the investee held by us and whether such financial instrument provides access to returns underlying an ownership interest. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We must make certain estimates and
judgments in determining income tax expense for financial statement purposes. The amount of taxes currently payable or refundable is accrued, and deferred tax assets and liabilities are recognized for the estimated future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets are also recognized for realizable loss and tax credit carryforwards. Deferred tax
assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is
recognized in income in the period that includes the enactment date. Net deferred tax assets are not recorded if we do not assess their realization as probable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">214</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We apply the provisions of the authoritative guidance on accounting for uncertainty in income taxes that was
issued by the IASB. Pursuant to this guidance, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical
merits of the position. The tax benefits recognized are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the tax benefit will be realized. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Share-based Payments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share-based payments
includes stock options, restricted stock units (&#147;RSUs&#148;) as well as service, market and performance-based RSU awards in which the expense is recognized based on the grant date fair value of these awards </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with IFRS 2, &#147;Share-based Payments,&#148; the fair value of the share option awards is estimated on the grant date using the Black-Scholes
option-valuation model which requires the input of certain assumptions, including the expected life of the share-based award, share price volatility, dividend yield and interest rate. The expected life and volatility are based on our historical data
for the purposes of the Black-Scholes option-valuation model. Expected life is based on the median expected term. Volatility is calculated by taking the weighted-average of the historical volatilities of our shares. We have not declared dividends
and we do not plan to pay any dividends in the future. The risk-free interest rate for periods in the expected life of the option is based on the U.S. Treasury constant maturities in effect at the time of the grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We recognize the estimated fair value of service, market and performance-based awards as share-based compensation expense over the vesting period based upon
its determination of whether it is probable that the performance targets will be achieved. We assess the probability of achieving the performance targets at each reporting period. Cumulative adjustments, if any, are recorded to reflect subsequent
changes in the estimated outcome of performance-related conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the performance-based awards is based on the Monte Carlo simulation
analysis utilizing a Geometric Brownian Motion process with 100,000 simulations to value those shares. The model considers share price volatility, risk-free rate and other covariance of comparable public companies and other market data to predict
distribution of relative share performance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For information on recent accounting pronouncements, see our consolidated financial statements and the related notes found elsewhere in this registration
statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Internal Control over Financial Reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the U.S. listing to which this registration statement relates, we have been a public company on the London Stock Exchang, or LSE, with limited
requirements to implement and test internal controls under a UK framework. As such, we have not been subject to the internal control over financial reporting requirements of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, and the
standards of the PCAOB and our independent registered public accounting firm has not conducted an audit of our internal control over financial reporting in accordance with such rules. As a U.S. public company, Section&nbsp;404 of the Sarbanes-Oxley
will require that our management assess our internal control over financial reporting and include a report of management on our internal control over financial reporting in our annual report on Form <FONT STYLE="white-space:nowrap">20-F</FONT>
beginning with our second annual report. Although we have adhered to and will continue to adhere to all internal control requirements made relevant by the governance of the LSE, the requirements pertaining to the design and implementation of
internal controls over financial reporting as contemplated under the Sarbanes-Oxley Act had not been considered in the production of financial statements for the years ended December&nbsp;31, 2019, 2018 and 2017 for our annual report issued in the
United Kingdom. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">215</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the audits of our consolidated financial statements as of and for each of the years ended
December&nbsp;31, 2019, 2018 and 2017 we and our independent registered public accounting firm identified a material weakness in our internal controls over financial reporting. SEC guidance defines a material weakness as a deficiency or combination
of deficiencies in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The material weakness relates to several significant deficiencies that were identified which, in aggregate, rise to the level of a material weakness. These
significant deficiencies relate to our process around accounting for costs attributed to individual projects, contract and consolidated review, segregation of duties, expense identification, allocation of employee stock compensation expense, and tax
provision relating to underlying investments and related party identification. We have taken steps to remediate the material weakness, including increasing the depth and experience within our accounting and finance organization, designing and
implementing improved processes and internal controls based on the COSO framework, and internally testing the effectiveness of our internal controls. As with any internal control framework, we cannot be certain that these efforts will be sufficient
to remediate our material weaknesses, prevent future material weaknesses or significant deficiencies from occurring. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>B. LIQUIDITY AND CAPITAL
RESOURCES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sources of Liquidity </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our
inception, we have not generated any revenue from product sales and have incurred significant operating losses. Our Wholly Owned Programs and most of the product candidates in our Founded Entities are at various phases of preclinical and clinical
development. We do not expect to generate significant revenue from sales of product candidates in our Wholly Owned Pipeline for several years, if at all. To date, PureTech Health plc and its predecessor entity has raised a total of
$439.3&nbsp;million from external funding sources such as major investment funds and other leading investors. We raised $196.0&nbsp;million when we completed our IPO on the London Stock Exchange in June 2015, plus an additional $101.2&nbsp;million
as a <FONT STYLE="white-space:nowrap">follow-on</FONT> offering that we completed in April 2018. Prior to our IPO, we raised a total of $142.1&nbsp;million in consecutive private financing rounds. In the period from January 2017 through June 2020,
our Founded Entities strengthened their collective balance sheets by attracting $1,084.2&nbsp;million in equity investments and <FONT STYLE="white-space:nowrap">non-dilutive</FONT> funding, including $997.6&nbsp;million from third parties. The
balance of the funding is between PureTech Health plc and its Founded Entities. For a description of our structure and relationships with our Founded Entities, see &#147;PureTech Health plc Structure&#148; included elsewhere in this registration
statement on Form <FONT STYLE="white-space:nowrap">20-F.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our cash flows may fluctuate and are difficult to forecast and will depend on many
factors. As of June&nbsp;30, 2020, we had cash, cash equivalents and short-term investments of $340.1&nbsp;million, which included aggregate proceeds of $12.3&nbsp;million and $245.9&nbsp;million from our sales of resTORbio and Karuna shares,
respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table
summarizes our cash flows for each of the periods presented: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended</B><br><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months&nbsp;Ended</B><br><B>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(in&nbsp;thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(98,156</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(72,796</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(88,685</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(56,098</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(55,326</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by/(used in) investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,659</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(39,645</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,682</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">266,052</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by/(used in) financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,910</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,887</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,696</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,405</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of exchange rates on cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(104</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,309</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">44,402</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,690</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">207,760</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,997</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">216</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Operating Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $72.8&nbsp;million for the year ended December&nbsp;31, 2018, as compared to $88.7&nbsp;million for the year ended
December&nbsp;31, 2017. The decline in outflows was primarily due to the $4.4&nbsp;million decrease in our operating loss and a decline of $4.5&nbsp;million in <FONT STYLE="white-space:nowrap">non-cash</FONT> items, which had no impact on the cash
used in operating activities, as well as increases of $5.6&nbsp;million in deferred revenues and $1.3&nbsp;million in other financial assets for the year ended December&nbsp;31, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $98.2&nbsp;million for the year ended December&nbsp;31, 2019, as compared to $72.8&nbsp;million for the year ended
December&nbsp;31, 2018. The increase in outflows was primarily due to our increased operating loss that resulted from increased research and development activities. In 2019, our income resulted from increased
<FONT STYLE="white-space:nowrap">non-cash</FONT> gains, that had no impact on the cash used in operating activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in operating
activities was $56.1&nbsp;million for the six months ended June&nbsp;30, 2020, as compared to $55.3&nbsp;million for the six months ended June&nbsp;30, 2019. Decreased outflows due to our lower operating loss were offset by the decline in deferred
revenues of $8.5&nbsp;million and increased outflows resulting from the decline in accounts payable and accrued expenses of $8.8&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investing Activities </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in investing
activities was $39.6&nbsp;million for the year ended December&nbsp;31, 2018, as compared to net cash provided by investing activities of $83.7&nbsp;million for the year ended December&nbsp;31, 2017. The increase in outflows was due to the purchase
of short-term investments of $166.5&nbsp;million, the derecognition of $13.4&nbsp;million in cash held at Akili which was deconsolidated during the year ended December&nbsp;31, 2018, the purchase of property and equipment of $4.4&nbsp;million, the
purchase of shares in resTORbio totaling $3.5&nbsp;million, which was offset by the maturity of short-term investments of $148.1&nbsp;million </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash
provided by investing activities was $63.7&nbsp;million for the year ended December&nbsp;31, 2019, as compared to outflows of $39.6&nbsp;million for the year ended December&nbsp;31, 2018. Cash provided by the maturity of short-term investments of
$174.0&nbsp;million was offset by the purchase of short-term investments of $69.5&nbsp;million as well as the purchase of fixed assets totaling $12.1&nbsp;million and the purchase of intangible assets totaling $0.4&nbsp;million. The inflow was
further offset by our investment in Gelesis convertible promissory notes totaling $6.5&nbsp;million and Gelesis Series 3 Growth preferred shares and Karuna Series B preferred shares totaling $15.2&nbsp;million. The inflow was further offset by the
derecognition of cash totaling $16.0&nbsp;million held by Vor, Karuna and Gelesis upon deconsolidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash provided by investing activities was
$266.1&nbsp;million for the six months ended June&nbsp;30, 2020, as compared to $37.0&nbsp;million for the six months ended June&nbsp;30, 2019. Increased inflows were largely attributable to proceeds attained from the sale of investments held at
fair value, Karuna and resTORbio, totaling $249.0&nbsp;million and to the maturity of investments in U.S. Treasuries with durations of less than two years which totaled $30.1&nbsp;million. The cash inflows were partially offset by the purchase of
fixed assets totaling $2.1&nbsp;million and the investment in Gelesis Series 3 Growth and Vor Series B preferred share financings totaling $10.6&nbsp;million and $0.5&nbsp;million, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Financing Activities </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash provided by financing
activities was $156.9&nbsp;million for the year ended December&nbsp;31, 2018, as compared to net inflows of $14.7&nbsp;million for the year ended December&nbsp;31, 2017. The net inflow was primarily attributable to aggregate proceeds of the issuance
of $139.6&nbsp;million received from the Vedanta Series C, Gelesis Series 2 Growth, Akili Series C and Karuna Series A preferred share financings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net
cash provided by financing activities was $49.9&nbsp;million for the year ended December&nbsp;31, 2019, as compared to $156.9&nbsp;million for the year ended December&nbsp;31, 2018. The net inflow was primarily attributable to aggregate
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">217</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proceeds of the issuance of $51.0&nbsp;million received from the Vedanta Series C and <FONT STYLE="white-space:nowrap">C-2,</FONT> Gelesis Series 2 Growth and Sonde Series <FONT
STYLE="white-space:nowrap">A-2</FONT> preferred share financings. Further inflows of $1.6&nbsp;million were attributable to the proceeds from the issuance of convertible notes by Karuna. The inflows were partially offset by payment of our lease
liability totaling $1.7&nbsp;million and $1.3&nbsp;million in tax payments related to the settlement of 2016 RSU awards granted to certain executives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in financing activities was $2.2&nbsp;million for the six months ended June&nbsp;30, 2020, as compared to net inflows of $33.4&nbsp;million for
the six months ended June&nbsp;30, 2019. The decline was primarily attributable to the $12.5&nbsp;million cash settlement of 2017 RSU awards granted to certain executives and the payment of our lease liability totaling $1.3&nbsp;million . The
outflows were partially offset by aggregate proceeds of $11.2&nbsp;million received from the Vedanta Series <FONT STYLE="white-space:nowrap">C-2</FONT> and Sonde Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred share financings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Funding Requirements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have incurred operating losses
since inception, and we have retained earnings of $378.4 million&nbsp;at June&nbsp;30, 2020. Based on our current plans, we believe our existing cash and cash equivalents and short-term investments will be sufficient to fund our operations and
capital expenditure requirements into at least 2024. We expect to incur substantial additional expenditures in the near term to support our ongoing activities. Additionally, we expect to incur additional costs as a result of operating as a U.S.
public company. We expect to continue to incur net losses for the foreseeable future. Our ability to fund our product development and clinical operations as well as commercialization of our Wholly Owned product candidates, will depend on the amount
and timing of cash received from planned financings. Our future capital requirements will depend on many factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs, timing and outcomes of clinical trials and regulatory reviews associated with our Wholly Owned product
candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of commercialization activities, including product marketing, sales and distribution;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of preparing, filing and prosecuting patent applications and maintaining, enforcing and defending
intellectual property-related claims; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the emergence of competing technologies and products and other adverse marketing developments;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect on our product development activities of actions taken by the FDA, EMA or other regulatory
authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our degree of success in commercializing our Wholly Owned product candidates, if and when approved; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and types of future products we develop and commercialize. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A change in the outcome of any of these or other variables with respect to the development of any of our Wholly Owned product candidates could significantly
change the costs and timing associated with the development of that product candidate. Further, our operating plans may change in the future, and we may need additional funds to meet operational needs and capital requirements associated with such
operating plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of
equity financings, debt financings, collaborations with other companies or other strategic transactions. We do not currently have any committed external source of funds. To the extent that we raise additional capital through the sale of equity or
convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing and preferred equity
financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If we raise
additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">218</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we
are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts or grant rights
to develop and market product candidates that we would otherwise prefer to develop and market ourselves. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, our operating plans may change, and we
may need additional funds to meet operational needs and capital requirements for clinical trials and other research and development activities. We currently have no credit facility or committed sources of capital. Because of the numerous risks and
uncertainties associated with the development and commercialization of our Wholly Owned product candidates, we are unable to estimate the amounts of increased capital outlays and operating expenditures associated with our current and anticipated
product development programs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and Qualitative Disclosures about Financial Risks </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Rate Sensitivity </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30,
2020, we had cash, cash equivalents and short-term investments of $340.1&nbsp;million. Our exposure to interest rate sensitivity is impacted by changes in the underlying U.K. and U.S. bank interest rates. We have not entered into investments for
trading or speculative purposes. Due to the conservative nature of our investment portfolio, which is predicated on capital preservation and investments in short duration, high-quality U.S. Treasury Bills and U.S. debt obligations and related money
market accounts we do not believe change in interest rates would have a material effect on the fair market value of our portfolio, and therefore we do not expect our operating results or cash flows to be significantly affected by changes in market
interest rates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Foreign Currency Exchange Risk </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain our consolidated financial statements in our functional currency, which is the U.S. dollar. Monetary assets and liabilities denominated in
currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet <FONT STYLE="white-space:nowrap">dates.&nbsp;Non-monetary&nbsp;assets</FONT> and liabilities denominated
in foreign currencies are translated into the functional currency at the exchange rates prevailing at the date of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income
(loss) for the respective periods. We recorded foreign currency losses of zero and $0.1&nbsp;million for the periods ended June&nbsp;30, 2020 and 2019, respectively, which are included in other expense in our Unaudited Condensed Consolidated
Statements of Comprehensive Income/(Loss). Translation adjustments are not included in determining net income (loss) but are included in our foreign exchange adjustment to other comprehensive loss, a component of shareholders&#146; equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not currently engage in currency hedging activities in order to reduce our currency exposure, but we may begin to do so in the future. Instruments that
may be used to hedge future risks include foreign currency forward and swap contracts. These instruments may be used to selectively manage risks, but there can be no assurance that we will be fully protected against material foreign currency
fluctuations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Controlled Founded Entity Investments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain investments in certain Controlled Founded Entities. Our investments in Controlled Founded Entities are eliminated as intercompany transactions upon
financial consolidation. We are however exposed to a preferred share liability owing to the terms of existing preferred shares and the ownership of Controlled Founded Entities preferred shares by third parties. The liability of preferred shares is
maintained at fair value through the profit and loss. Our strong cash position, budgeting and forecasting processes, as well as decision making and risk mitigation framework enable us to robustly monitor and support the business activities of the
Controlled Founded Entities to ensure no exposure to credit losses and ultimately dissolution or liquidation. Accordingly, we view exposure to third party preferred share liability as low. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">219</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entity Investments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain certain investments in <FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities which are deemed associates and accounted for under
the equity method. Our exposure to investments in associates in limited to the initial carrying amount upon recognition as an associate. We are not exposed to further contractual obligations or contingent liabilities beyond the value of initial
investment. As of June&nbsp;30, 2020, Gelesis was the only associate. The initial carrying amount of the investment in Gelesis as an associate was $16.4&nbsp;million. Accordingly, we view the risk as high. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Price Risk </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, we
held 4,739,897 common shares of Karuna. The fair value of our investment in the common stock of Karuna was $528.3&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The investment in Karuna
is exposed to fluctuations in the market price of these common shares. The effect of a 10.0&nbsp;percent adverse change in the market price of Karuna common shares as of June&nbsp;30, 2020 would have been a loss of approximately $52.8&nbsp;million
recognized as a component of Other income (expense) in our Consolidated Statements of Comprehensive Income/(Loss). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidity Risk </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not believe we will encounter difficulty in meeting the obligations associated with our financial liabilities that are settled by delivering cash or
another financial asset. While we believe our cash, cash equivalents and short-term investments do not contain excessive risk, we cannot provide absolute assurance that in the future our investments will not be subject to adverse changes or decline
in value based on market conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Credit Risk </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain an investment portfolio in accordance with our investment policy. The primary objectives of our investment policy are to preserve principal,
maintain proper liquidity and to meet operating needs. Although our investments are subject to credit risk, our investment policy specifies credit quality standards for our investments and limits the amount of credit exposure from any single issue,
issuer or type of investment. However, due to the conservative nature of our investments and relatively short duration, interest rate risk is mitigated. We do not own derivative financial instruments. Accordingly, we do not believe that there is any
material market risk exposure with respect to derivative or other financial instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Credit risk is also the risk of financial loss if a customer or
counterparty to a financial instrument fails to meet its contractual obligations. We assess the credit quality of customers on an ongoing basis, taking into account its financial position, past experience and other factors. The credit quality of
financial assets that are neither past due nor impaired can be assessed by reference to credit ratings (if available) or to historical information about counterparty default rates. We are also potentially subject to concentrations of credit risk in
its accounts receivable. Concentrations of credit risk with respect to receivables is owed to the limited number of companies comprising our customer base. Our exposure to credit losses is low, however, due to the credit quality of its larger
collaborative partners such as Boehringer Ingelheim and Eli Lilly. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>JOBS Act Exemptions and Foreign Private Issuer Status </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We qualify as an &#147;emerging growth company&#148; as defined in the U.S. Jumpstart Our Business Startups Act of 2012. An emerging growth company may take
advantage of specified reduced reporting and other requirements that are otherwise applicable generally to public companies. This includes an exemption from the auditor attestation requirement in the assessment of our internal control over financial
reporting pursuant to the Sarbanes-Oxley Act of 2002. We may take advantage of this exemption for up to five years or such earlier time </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">220</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that we are no longer an emerging growth company. We will cease to be an emerging growth company if we have more than $1.07&nbsp;billion in total annual gross revenue, have more than
$700.0&nbsp;million in market value of our ordinary shares held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> or issue more than $1.0&nbsp;billion of <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt over a three-year period.
We may choose to take advantage of some but not all of these provisions that allow for reduced reporting and other requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are considering
whether we will take advantage of the extended transition period provided under Section&nbsp;7(a)(2)(B) of the Securities Act of 1933, as amended, for complying with new or revised accounting standards. Since IFRS makes no distinction between public
and private companies for purposes of compliance with new or revised accounting standards, the requirements for our compliance as a private company and as a public company are the same. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon completion of the U.S. listing to which this registration statement relates, we will report under the Securities Exchange Act of 1934, as amended, or the
Exchange Act, as a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> company with foreign private issuer status. Even after we no longer qualify as an emerging growth company, as long as we qualify as a foreign private&nbsp;issuer under the Exchange
Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of
a security registered under the Exchange Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading
activities and liability for insiders who profit from trades made in a short period of time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> containing unaudited financial and other specified information, or current reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> upon the occurrence of specified significant events; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Regulation FD, which regulates selective disclosures of material information by issuers. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RESEARCH AND DEVELOPMENT, PATENTS AND LICENSES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a discussion of our research and development activities, see the sections of this registration statement titled &#147;Item
4.B.&#151;Business Overview&#148; and &#147;Item 5.A.&#151;Operating Results.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>D.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TREND INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a discussion of trends and uncertainties relating to our business, see the sections of this registration statement titled &#147;Item
5A.&#151;Operating Results.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>E.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">OFF-BALANCE</FONT> SHEET ARRANGEMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, our <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements consist of outstanding standby letters of
credit. We have no other <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements that have had, or are reasonably likely to have, a material current or future effect on our consolidated financial statements or changes in financial
condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">221</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>F.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TABULAR DISCLOSURE OF CONTRACTUAL OBLIGATIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations and Commitments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following
table summarizes our contractual commitments and obligations as of as of December&nbsp;31, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payments&nbsp;Due&nbsp;By&nbsp;Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;Than<BR>1 Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">1-3&nbsp;Years</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">3-5&nbsp;Years</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More<BR>Than&nbsp;5<BR>Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease obligations <SUP STYLE="font-size:85%; vertical-align:top">(1) (2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,843</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,929</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,964</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,305</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18,645</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">148,284</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">113,370</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,964</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,305</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18,645</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the minimum lease payments due under our operating leases for office and/or laboratory space. For a
more detailed description of our operating leases, see Note 21 to our consolidated financial statements found elsewhere in this document. We are subject to new lease accounting guidance as of January&nbsp;1, 2019. We recognized an asset and a
corresponding lease liability for an amount that is less than ten percent of our total consolidated assets. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts include lease commitments of Vedanta. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have certain payment obligations under various license and collaboration agreements. Under these agreements we are required to make milestone payments upon
successful completion and achievement of certain intellectual property, clinical, regulatory and sales milestones. The payment obligations under the license and collaboration agreements are contingent upon future events such as our achievement of
specified development, clinical, regulatory and commercial milestones, and we will be required to make development milestone payments and royalty payments in connection with the sale of products developed under these agreements. As the achievement
and timing of these future milestone payments are not probable or estimable, such amounts have not been included in our unaudited condensed consolidated financial statements as of and for the six months ended June&nbsp;30, 2020 and June&nbsp;30,
2019 and consolidated financial statements as of and for the years ended December&nbsp;31, 2019, 2018 and 2017, or in the contractual obligations table above. For additional information regarding certain of our license and collaboration agreements,
see &#147;&#151;License and Collaboration Agreements&#148; above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also enter into contracts in the normal course of business with CROs, contract
manufacturing organizations and other third parties for clinical trials, preclinical research studies and testing and manufacturing services. These contracts are cancellable by us upon prior written notice. Payments due upon cancellation consist
only of payments for services provided or expenses incurred, including noncancellable obligations of our service providers, up to the date of cancellation. These payments are not included in the preceding table as the amount and timing of such
payments are not known. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>G.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SAFE HARBOR </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This registration statement contains forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act and
Section&nbsp;21E of the Exchange Act and as defined in the Private Securities Litigation Reform Act of 1995. See &#147;Special Note with Respect to Forward Looking Statements&#148; included elsewhere in this registration statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">222</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_8"></A>ITEM&nbsp;6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DIRECTORS AND SENIOR MANAGEMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For information about our directors and senior management, see &#147;Item 1A. Identity of Directors, Senior Management and Advisers &#150;
Directors and Senior Management.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>COMPENSATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended
December&nbsp;31, 2019, we paid an aggregate of $4.94&nbsp;million in cash compensation and benefits to our executive officers, including those who serve as directors. For the year ended December&nbsp;31, 2019, we paid an aggregate of
$0.2&nbsp;million for pension, retirement and similar benefits for our executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding
compensation awarded to, earned by or paid to our Chief Executive Officer and Chief Operating Officer during 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NAME&nbsp;AND&nbsp;PRINCIPAL&nbsp;POSITION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>YEAR</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>SALARY<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>BONUS<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>STOCK<BR>AWARDS<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">&nbsp;(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>ALL&nbsp;OTHER<BR>COMPENSATION<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">&nbsp;(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TOTAL&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daphne Zohar</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">2019<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">601,960<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">601,960<BR></TD>
<TD NOWRAP VALIGN="top"><BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">2,101,401<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">33,536<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">3,338,857<BR></TD>
<TD NOWRAP VALIGN="top"><BR></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen Muniz, J.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Operating Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">2019<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">421,057<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">421,057<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">730,148<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">32,123<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">1,604,384<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reported in the &#147;Stock Awards&#148; column reflects the aggregate grant date fair value of
share-based compensation awarded during the year computed in accordance with the provisions of International Financial Reporting Standards (IASB), or IFRS 2, Share-Based Payment, based on maximum performance. See Notes 1 and 8 to our financial
statements appearing at the end of this registration statement regarding assumptions underlying the valuation of equity awards. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts reflect Company matching contributions to our 401(k) plan; medical, dental and disability insurance;
and parking reimbursement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at 2019 Year End </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding outstanding equity awards held by our executive officers as of December&nbsp;31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NAME</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER&nbsp;OF<BR>SECURITIES<BR>UNDERLYING<BR>UNEXERCISED<BR>OPTIONS<BR>EXERCISABLE<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER&nbsp;OF<BR>SECURITIES<BR>UNDERLYING<BR>UNEXERCISED<BR>OPTIONS<BR>UNEXERCISABLE<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>OPTION<BR>EXERCISE<BR>PRICE<BR>(&pound;/SHARE)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>OPTION<BR>EXPIRATION<BR>DATE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EQUITY<BR>INCENTIVE<BR>PLAN<BR>AWARDS:<BR>NUMBER&nbsp;OF<BR>UNEARNED<BR>SHARES,&nbsp;UNITS<BR>OR&nbsp;OTHER<BR>RIGHTS
THAT<BR>HAVE&nbsp;NOT<BR>VESTED&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EQUITY<BR>INCENTIVE<BR>PLAN AWARDS:<BR>MARKET&nbsp;OR<BR>PAYOUT&nbsp;VALUE<BR>OF&nbsp;UNEARNED<BR>SHARES,&nbsp;UNITS<BR>OR&nbsp;OTHER<BR>RIGHTS
THAT<BR>HAVE&nbsp;NOT<BR>VESTED&nbsp;($)<SUP STYLE="font-size:85%; vertical-align:top">&nbsp;(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daphne Zohar</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,362,393</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,726,710</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,035,628</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,353,179</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">644,668</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,709,810</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen Muniz, J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">455,039</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,912,720</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">346,644</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,457,090</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223,995</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">941,545</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Market value as of December&nbsp;31, 2019 is based on the closing price of our ordinary shares on
December&nbsp;31, 2019 of &pound;3.17 per share, at the conversion rate on such date of 1 GBP to 1.326 USD. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">223</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These restricted stock unit awards were granted on May&nbsp;19, 2017 and vest based on the achievement of the
following performance conditions over the performance period of January&nbsp;1, 2017 to December&nbsp;31, 2019: 50&nbsp;percent of the shares underlying the award will vest based on growth in TSR, 25&nbsp;percent of the shares underlying the award
will vest based on growth in NAV, and 25&nbsp;percent of the shares underlying the award will vest based on the achievement of strategic objectives. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These restricted stock unit awards were granted on June&nbsp;15, 2018 and vest based on the achievement of the
following performance conditions over the performance period of January&nbsp;1, 2018 to December&nbsp;31, 2020: 50&nbsp;percent of the shares underlying the award will vest based on growth in TSR, 12.5&nbsp;percent of the shares underlying the award
will vest based on relative TSR against the FTSE SmallCap Index (excluding Investment Trusts), 12.5&nbsp;percent of the shares underlying the award will vest based on relative TSR against the MSCI Europe Health Care Index, and 25&nbsp;percent of the
shares underlying the award will vest based on the achievement of strategic objectives. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These restricted stock unit awards were granted on December&nbsp;20, 2019 and vest based on the achievement of
the following performance conditions over the performance period of January&nbsp;1, 2019 to December&nbsp;31, 2021: 50&nbsp;percent of the shares underlying the award will vest based on growth in TSR, 12.5&nbsp;percent of the shares underlying the
award will vest based on relative TSR against the FTSE 250 Index, 12.5&nbsp;percent of the shares underlying the award will vest based on relative TSR against the MSCI Europe Health Care Index, and 25&nbsp;percent of the shares underlying the award
will vest based on the achievement of strategic objectives. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Employment Arrangements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into employment offer letters with each of our executive officers. Except as noted below, these employment arrangements provide for &#147;at
will&#148; employment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Daphne Zohar </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
entered into an amended and restated employment offer letter with Ms.&nbsp;Zohar in June 2015. Such offer letter provides for an annual base salary and an annual performance bonus equal to 50&nbsp;percent of her base salary at target and
100&nbsp;percent of her base salary at maximum performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event Ms.&nbsp;Zohar&#146;s employment is terminated by us without cause or she
resigns for good reason (as each such term is defined in her employment offer letter), she shall be entitled to receive salary continuation for the <FONT STYLE="white-space:nowrap">365-day</FONT> period following the termination of her employment,
subject to her execution of a release of claims in favor of us. Ms.&nbsp;Zohar must provide us with six months&#146; notice of any resignation of her employment without good reason, provided that we may elect to have her cease providing active
services during such period and continue to pay her base salary and benefits during such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Zohar is also subject to a <FONT
STYLE="white-space:nowrap">12-month</FONT> <FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stephen Muniz </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We entered into an amended and
restated employment offer letter with Mr.&nbsp;Muniz in June 2015. Such offer letter provides for an annual base salary and an annual performance bonus equal to 50&nbsp;percent of his base salary at target and 100&nbsp;percent of his base salary at
maximum performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event Mr.&nbsp;Muniz&#146;s employment is terminated by us without cause or he resigns for good reason (as each such term is
defined in his employment offer letter), he shall be entitled to receive salary continuation for the <FONT STYLE="white-space:nowrap">365-day</FONT> period following the termination of his employment, subject to his execution of a release of claims
in favor of us (provided that the Remuneration Committee may elect to reduce such severance period to a period of not less than 60 days if the period applicable to Mr.&nbsp;Muniz&#146;s <FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> restrictions are similarly reduced). In addition, Mr.&nbsp;Muniz must provide us with 60 days&#146; notice of any resignation of his employment without good reason, provided that we may elect to
have Mr.&nbsp;Muniz cease providing active services during such period and continue to pay him his base salary and benefits during such period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">224</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Muniz is also subject to a <FONT STYLE="white-space:nowrap">12-month</FONT> <FONT
STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement, subject to reduction as described above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Share Option and Other Compensation Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance Share Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2015, we adopted
the Performance Share Plan, or PSP. Participation in the PSP is open to the Executive Directors, senior managers and employees of, and other individuals providing services to, the Company and its subsidiaries. Awards may be granted in the form of
share options, share appreciation rights, restricted or unrestricted share awards, restricted share units and other share-based awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the PSP,
(i)&nbsp;in any ten year period, awards in respect of an aggregate of 10&nbsp;percent of the company&#146;s ordinary share capital from time to time may be subject to awards granted under the PSP (and any other share plan operated by the Company),
(ii) in any ten year period, no more than 5&nbsp;percent of the Company&#146;s ordinary share capital from time to time may be granted under awards under the PSP (and any other share plan operated by the Company) to the Company&#146;s directors,
executive officers, senior managers or senior service providers and (iii)&nbsp;no more than 22,724,800 ordinary shares may be issued pursuant to incentive stock options. Shares which are subject to awards which lapse or are released, cancelled or
surrendered, or which were granted pursuant to other share plans operated by the Company prior to its original initial public offering on the London Stock Exchange are not counted for purposes of these limits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum total market value of shares in which an award may be granted to any grantee in any fiscal year may not exceed 400&nbsp;percent of his or her
annual base salary for such year (or for the preceding year, if higher). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our remuneration committee has acted as administrator of the PSP. The
administrator has full power to select, from among the individuals eligible for awards, the individuals to whom awards will be granted, and to determine the specific terms and conditions of each award, subject to the provisions of our PSP Plan.
Vesting of awards may be tied to achievement of performance or other conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The PSP permits the granting of (1)&nbsp;options to purchase ordinary
shares intended to qualify as incentive stock options under Section&nbsp;422 of the Code and (2)&nbsp;options that do not so qualify. The option exercise price of each option is determined by the administrator but may not be less than
100&nbsp;percent of the fair market value of the ordinary shares on the date of grant in the case of incentive stock options and, in the case of nonqualified options, may be less than fair market value of the ordinary shares to the extent compliant
with Section&nbsp;409A of the Code. The administrator determines at what time or times each option may be exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The PSP permits the award of share
appreciation rights subject to such conditions and restrictions as it may determine. Share appreciation rights entitle the recipient to ordinary shares or a cash payment equal to the value of the appreciation in our share price over the exercise
price. The exercise price may not be less than 100&nbsp;percent of the fair market value of our ordinary shares on the date of grant. The term of each share appreciation right will be fixed by the administrator but may not exceed ten years from the
date of grant. The administrator will determine at what time or times each share appreciation right may be exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The PSP permits the award of
restricted ordinary shares and restricted share units to participants subject to such conditions and restrictions as it may determine. These conditions and restrictions may include the achievement of certain
<FONT STYLE="white-space:nowrap">pre-established</FONT> performance goals and/or continued employment with us through a specified period. The PSP also permits the award of other share-based awards in such amounts, on such terms and conditions, and
for such consideration as the administrator shall determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If there is a change of control of the Company (or certain other corporate events) the
number of ordinary shares over which awards will vest will normally be calculated by reference to the extent to which the performance conditions applicable to those awards have been satisfied and the time elapsed to the change of control event. Our
remuneration committee has discretion not to apply time <FONT STYLE="white-space:nowrap">pro-rating.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">225</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where appropriate, and with the consent of the acquiring company, participants may exchange awards so as to
operate over shares in the acquiring company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the occurrence of any demerger, reorganization, reconstruction or amalgamation, distribution or other
transaction of the Company which in the reasonable opinion of our remuneration committee may affect the value of any award, awards may be varied so as to preserve the overall value of the award. Such alteration may include amending the performance
condition and/or the terms on which an award vests, and may provide for immediate vesting on such event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No awards may be granted under the PSP after the
date that is ten years from its approval by our shareholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Annual Bonus Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our annual bonus program is intended to drive and reward our executive officers for meeting individual and/or corporate performance goals for a fiscal year.
Annual bonuses will be payable in cash, and may range between 50&nbsp;percent of base salary for the achievement of &#147;target&#148; goals and objectives and up to 100&nbsp;percent of base salary for the achievement of &#147;stretch&#148; goals
and objectives. For 2019, bonus targets were focused on (i)&nbsp;financial and strategic goals designed to incentivize the team to complete important deals, execute strategic partnerships and operate within our 2019 budget, (ii)&nbsp;clinical
development goals designed to incentivize the team to generate valuable clinical data in support of our programs, (iii)&nbsp;innovation goals designed to incentivize the team to create innovative programs, obtain patent protection for our
technologies, obtain publication of the technologies in top tier medical and science journals and establish state of the art laboratory and operations teams, and (iv)&nbsp;commercial goals designed to incentivize the team to take all steps necessary
to commercially launch products. The executives&#146; stretch goals for 2019 involved raising capital and entering into business development transactions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>401(k) Retirement Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We sponsor a 401(k) retirement
plan which is intended to be a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined contribution plan under Section&nbsp;401(k) of the Internal Revenue Code. In general, all of our employees are eligible to participate, beginning two months
after the commencement of their employment. The 401(k) plan includes a salary deferral arrangement pursuant to which participants may elect to reduce their current compensation by up to the statutorily prescribed limit and have the amount of the
reduction contributed to the 401(k) plan. We currently contribute to each employee&#146;s 401(k) account, in the first quarter of each year, 3&nbsp;percent of his or her eligible earnings from the prior year up to the statutorily prescribed limit.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Liability and Indemnification </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or controlling persons, we have been
informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Sales Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our directors and executive officers may adopt written plans, known as Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> plans, in which they will contract
with a broker to buy or sell our ordinary shares on a periodic basis. Under a Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> plan, a broker executes trades pursuant to parameters established by the director or officer when entering into the
plan, without further direction from the director or officer. The director or officer may amend or terminate the plan in some circumstances. Our directors and executive officers may also buy or sell additional shares outside of a Rule <FONT
STYLE="white-space:nowrap">10b5-1</FONT> plan when they are not in possession of material, nonpublic information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">226</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">NON-EMPLOYEE</FONT> DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding compensation earned by our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors during the year
ended December&nbsp;31, 2019. We also reimburse <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our board of directors for reasonable travel expenses. The compensation of our Chief Executive Officer and our Chief Operating Officer
are discussed above in &#147;Compensation of Executive Officers and Directors.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NAME</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>FEES&nbsp;EARNED&nbsp;OR<BR>PAID&nbsp;IN&nbsp;CASH($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TOTAL($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joichi Ito<SUP STYLE="font-size:85%; vertical-align:top"> (1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raju Kucherlapati, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John LaMattina, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Langer, Sc.D.<SUP STYLE="font-size:85%; vertical-align:top">&nbsp;(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dame Marjorie Scardino</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bennett Shapiro, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christopher Viehbacher</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Ito resigned from our board of directors in September 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Langer provides certain intellectual property know how and technology transfer services to Alivio and
Entrega related to certain know how underlying their programs, for which he was paid an aggregate of approximately $140,000 in the year ended December&nbsp;31, 2019. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently pay directors in accordance with the following <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policy. Such amounts are
subject to annual adjustment, as determined by the Remuneration Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each <FONT STYLE="white-space:nowrap">non-employee</FONT> director is paid an
annual retainer of $75,000 for their services on our board of directors, and the <FONT STYLE="white-space:nowrap">non-executive</FONT> chair of the board of directors receives an extra $50,000 for his contributions in leading our board of directors.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors also receive $5,000 annually if they serve on a committee of our board of directors,
and $10,000 annually if they chair the committee. Additionally, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors may receive an additional retainer of up to $20,000 per year for service on the board of one of our Founded Entities.
While these payments are initially made by us, we are reimbursed by the Founded Entity for such payments. Such cash retainers are paid quarterly, and may be <FONT STYLE="white-space:nowrap">pro-rated</FONT> based on the number of actual days served
by the director during such calendar quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amounts above also include fees for advisory services provided by certain of the directors to us beyond
the typical duties of a director. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BOARD PRACTICES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Composition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors currently
consists of seven members: the <FONT STYLE="white-space:nowrap">non-executive</FONT> chairman, four additional <FONT STYLE="white-space:nowrap">non-executive</FONT> directors and two executive directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a foreign private issuer, under the listing requirements and rules of the Nasdaq Global Market, we are not required to have independent directors on our
board of directors, except that our audit committee is required to consist fully of independent directors, subject to certain <FONT STYLE="white-space:nowrap">phase-in</FONT> schedules. However, our board of directors has determined that Christopher
Viehbacher, Dame Marjorie Scardino, Raju Kucherlapati, John LaMattina and Robert Langer do not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of director and that each of these
directors is &#147;independent&#148; as that term is defined under Nasdaq rules. There are no family relationships among any of our directors or senior management. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">227</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Governance and Committees of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Corporate Governance </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors is
responsible for overall corporate governance and for supervising the general affairs and business of our company and its subsidiaries. As a company listed on the main market of the London Stock Exchange, we are subject to the continuing requirements
of the Listing Rules as published by the Financial Conduct Authority in the United Kingdom from time to time. Our board of directors also adheres to the principles of the U.K. Corporate Governance Code in such respects as it considers appropriate
for our size and the nature of our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors is responsible for creating value for shareholders, providing entrepreneurial and
scientific leadership, approving our strategic objectives, ensuring that the necessary financial and human resources are in place to meet strategic objectives, overseeing our system of risk management and setting the values and standards for both
our business conduct and governance matters. All key operational and investment decisions are subject to board approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is a clear separation of
the roles of chief executive officer and <FONT STYLE="white-space:nowrap">non-executive</FONT> chairman. The chairman is responsible for the leadership and conduct of the board of directors and for ensuring effective communication with shareholders.
The chief executive officer is responsible for leading the execution of our strategy and the executive management of the company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of our directors
are subject to election by shareholders at the first annual general meeting after their appointment to our board of directors. Our board of directors has also adopted a policy that all directors will seek annual
<FONT STYLE="white-space:nowrap">re-election</FONT> by shareholders. The appointment of each of the <FONT STYLE="white-space:nowrap">non-executive</FONT> directors is therefore subject to <FONT STYLE="white-space:nowrap">re-election</FONT> at our
2021 annual general meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Corporate Governance Matters </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sarbanes-Oxley Act of 2002, as well as related rules subsequently implemented by the SEC, requires foreign private issuers, including our company, to
comply with various corporate governance practices. In addition, Nasdaq rules provide that foreign private issuers may follow home country practice in lieu of the Nasdaq corporate governance standards, subject to certain exceptions and except to the
extent that such exemptions would be contrary to U.S. federal securities laws. The home country practices followed by us in lieu of Nasdaq rules are described below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We do not intend to follow Nasdaq&#146;s quorum requirements applicable to meetings of shareholders. Such quorum
requirements are not required under U.K. law. In accordance with generally accepted business practice, our articles of association provide alternative quorum requirements that are generally applicable to meetings of shareholders.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We do not intend to follow Nasdaq&#146;s requirements that <FONT STYLE="white-space:nowrap">non-management</FONT>
directors meet on a regular basis without management present. Our board of directors may choose to meet in executive session at their discretion. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to take all actions necessary for us to maintain compliance as a foreign private issuer under the applicable corporate governance requirements of
the Sarbanes-Oxley Act of 2002, the rules adopted by the SEC and Nasdaq&#146;s listing standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because we are a foreign private issuer, our directors
and senior management are not subject to short-swing profit and insider trading reporting obligations under Section&nbsp;16 of the U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act. They will, however, be subject to the
obligations to report changes in share ownership under Section&nbsp;13 of the Exchange Act and related SEC rules. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">228</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Committees of the Board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors has established an audit committee, a nomination committee and a remuneration committee. Each of these committees operates under a
charter that has been approved by our board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Audit Committee </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of our audit committee are Mr.&nbsp;Viehbacher, Dr.&nbsp;Kucherlapati and Dame Scardino. Mr.&nbsp;Viehbacher is the chair of the audit committee.
Our audit committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appointing, approving the compensation of, and assessing the independence, objectivity and effectiveness of our
registered public accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the work of our independent registered public accounting firm, including through the receipt and
consideration of reports from that firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the integrity of our financial statements by reviewing and discussing with management and our
independent registered public accounting firm our annual and quarterly financial statements and related disclosures; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and monitoring our internal control over financial reporting, disclosure controls and procedures and
code of business conduct; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and monitoring the effectiveness of our internal audit function; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing our risk assessment and risk management policies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing policies regarding procedures for the receipt and retention of accounting related complaints and
concerns; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">meeting independently with our internal auditing staff, if any, our independent registered public accounting firm
and management; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving or ratifying any related person transactions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services, other than <I>de minimis</I> <FONT STYLE="white-space:nowrap">non-audit</FONT>
services, to be provided to us by our independent registered public accounting firm must be approved in advance by our audit committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of
directors has determined that Mr.&nbsp;Viehbacher is an &#147;audit committee financial expert&#148; as defined in Item 16A of Form <FONT STYLE="white-space:nowrap">20-F.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to satisfy the independence criteria for audit committee members set forth in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange
Act, each member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee, accept, directly or indirectly, any consulting, advisory,
or other compensatory fee from the listed company or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries. We believe that the composition of our audit committee will meet the requirements for
independence under current Nasdaq and SEC rules and regulations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Remuneration Committee </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of our remuneration committee are Dr.&nbsp;Kucherlapati and Dr.&nbsp;LaMattina. Dr.&nbsp;LaMattina is the chair of the remuneration committee. Our
remuneration committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving, or making recommendations to our board of directors with respect to, the compensation of
our directors and executive management; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing an evaluation of our executive management; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">229</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing and administering our employee share option scheme or equity incentive plans in operation from time to
time. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to satisfy the independence criteria for remuneration committee members set forth in Rule
<FONT STYLE="white-space:nowrap">10C-1</FONT> under the Exchange Act, all factors specifically relevant to determining whether a director has a relationship to such company which is material to that director&#146;s ability to be independent from
management in connection with the duties of a remuneration committee member must be considered, including, but not limited to: (1)&nbsp;the source of compensation of the director, including any consulting advisory or other compensatory fee paid by
such company to the director; and (2)&nbsp;whether the director is affiliated with the company or any of its subsidiaries or affiliates. We believe the composition of our remuneration committee will meet the requirements for independence under
current Nasdaq and SEC rules and regulations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Nomination Committee </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of our nomination committee are Dr.&nbsp;Langer and Dame Scardino. Dame Scardino is the chair of the nomination committee. Our nomination
committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying individuals qualified to become members of our board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending to our board of directors the persons to be nominated for election as directors and to each of our
board of directors&#146; committees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing a periodic evaluation of our board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to our board of directors with respect to our board leadership structure;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to our board of directors with respect to management succession planning;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to our board of directors corporate governance principles. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of our executive officers serves, or in the past year has served, as a member of the board of directors or compensation committee, or other committee
serving an equivalent function, of any other entity that has one or more of its executive officers serving as a member of our board of directors or our compensation committee. None of the members of our compensation committee is, or has ever been,
an officer or employee of our company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>D.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EMPLOYEES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, we had 61 full-time PureTech employees. 60 of our employees are based in the United States and one employee is based in the
Netherlands. All of our employees were engaged in administrative, management or research and development functions. These figures do not include individuals employed by our Founded Entities. One PureTech employee splits his time and work at our
Controlled Founded Entity Entrega. None of our employees is subject to a collective bargaining agreement or represented by a trade or labor union. We consider our relationship with our employees to be good. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>E.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SHARE OWNERSHIP </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For information regarding the share ownership of our directors and management, see &#147;Item 6.B.&#151;Compensation&#148; and &#147;Item
7.A.&#151;Major Shareholders&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">230</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_9"></A>ITEM&nbsp;7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MAJOR SHAREHOLDERS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information with respect to the beneficial ownership of our ordinary shares as of by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our executive officers; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person, or group of affiliated persons, who is known by us to beneficially own more than 3&nbsp;percent of
our outstanding ordinary shares. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The column entitled &#147;Percentage of Shares Beneficially Owned&#148; is based on a total
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares outstanding as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to our common
stock. Ordinary shares subject to options that are currently exercisable or exercisable within 60 days after&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;are considered outstanding and beneficially
owned by the person holding the options for the purpose of calculating the percentage ownership of that person but not for the purpose of calculating the percentage ownership of any other person. Except as otherwise noted, the persons and entities
in this table have sole voting and investment power with respect to all of the ordinary shares beneficially owned by them, subject to community property laws, where applicable. Except as otherwise set forth below, the address of the beneficial owner
is c/o PureTech Health, 6 Tide Street, Suite 400, Boston, Massachusetts 02210. The information in the table below is based on information known to us or ascertained by us from public filings made by the shareholders. We have also set forth below
information known to us regarding any significant change in the percentage ownership of our ordinary shares by any major shareholders during the past three years. The major shareholders listed below do not have voting rights with respect to their
ordinary shares that are different from the voting rights of other holders of our ordinary shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="26%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NAME&nbsp;OF&nbsp;BENEFICIAL&nbsp;OWNER</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>PERCENTAGE&nbsp;OF&nbsp;SHARES<BR>BENEFICIALLY&nbsp;OWNED</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>3 Percent&nbsp;Stockholders</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Invesco Asset Management Limited <SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Baillie Gifford&nbsp;&amp; Co <SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lansdowne Partners Limited <SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jupiter Asset Management Limited <SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recordati S.p.A. <SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Executive Officers and Directors</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daphne Zohar <SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen Muniz, J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raju Kucherlapati, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John LaMattina, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Langer, Sc.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marjorie Scardino</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christopher Viehbacher <SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than 1&nbsp;percent of our outstanding ordinary shares.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares beneficially held. The address for Invesco Asset Management Limited is c/o <FONT STYLE="white-space:nowrap">43-45</FONT> Portman Square, London
W1H GLY, United Kingdom. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares beneficially held. The address for Lansdowne Partners Limited is c/o 15 Davies Street, London W1K 3AG, United Kingdom. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares beneficially held. The address for Baillie Gifford&nbsp;&amp; Co. is c/o Calton Square, 1 Greenside Row, Edinburgh EH1 3AN, United Kingdom.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">231</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares beneficially held. The address for Jupiter Asset Management Limited is c/o 70 Victoria Street, London SW1E 65Q, United Kingdom.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares beneficially held. The address for Recordati S.p.A. is c/o Via Civitali, 1, 20148 Milano, Italy. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares held by the Zohar Family Trust I, a <FONT STYLE="white-space:nowrap">US-established</FONT> trust of which Ms.&nbsp;Zohar is a
beneficiary and trustee (ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares held by the Zohar Family Trust II, a U.S. established trust of which Ms.&nbsp;Zohar is a beneficiary (in the
event of her spouse&#146;s death) and trustee; (iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares held by Zohar LLC, a <FONT STYLE="white-space:nowrap">US-established</FONT> limited
liability company and (iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares held directly by Ms.&nbsp;Zohar. Ms.&nbsp;Zohar owns or has a beneficial interest in 100&nbsp;percent of the
share capital of Zohar LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All of Mr.&nbsp;Viehbacher&#146;s shareholding in the Company is held through his trust, Viehbacher 2015 GRAT
u/a/d 22&nbsp;May 2015. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To our knowledge, and other than changes in percentage ownership as a result of the shares issued in connection
with our initial public offering in the United Kingdom, there has been no significant change in the percentage ownership held by the major shareholders listed above in the last three years, except as described in &#147;Related Party
Transactions&#148; included in this registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not aware that the Company is directly owned or controlled by another corporation, any
foreign government or any other natural or legal person(s) severally or jointly. We are not aware of any arrangement, the operation of which may result in a change of control of the Company. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RELATED PARTY TRANSACTIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a description of related party transactions we have entered into with the beneficial owners of 3&nbsp;percent or more of our ordinary shares,
which are our only voting securities, senior management and members of our board of directors, since January&nbsp;1, 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreements with Our
Executive Officers and Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into employment agreements with our executive officers and director compensation agreements with our <FONT
STYLE="white-space:nowrap">non-executive</FONT> directors. See &#147;Compensation of Executive Officers and Directors.&#148; These agreements contain customary provisions and representations, including confidentiality,
<FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> undertakings by the executive officers. However, the enforceability of the <FONT STYLE="white-space:nowrap">non-competition</FONT>
provisions may be limited under applicable law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Invesco Relationship Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2015, we entered into a Relationship Agreement with Invesco Asset Management Limited, or Invesco, which came into force at the time our initial public
offering in the United Kingdom. The principal purpose of the Relationship Agreement is to ensure that the Company is capable at all times of carrying on its business independently of Invesco. If any person acquires control of our Company or we cease
to be admitted to the Official List, the Relationship Agreement may be terminated by Invesco. If Invesco, together with its associates, ceases to hold 30&nbsp;percent or more of the voting rights over our shares, the Relationship Agreement will
terminate save for certain specified provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Relationship Agreement provides that Invesco undertakes to use all reasonable endeavors to procure
that its associates and any person with whom it is acting in concert shall: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conduct all agreements, arrangements, transactions and relationships with any member of the Company on an
arm&#146;s length basis and on a normal commercial basis and in accordance with the related party transaction requirements of Chapter 11 of the Listing Rules; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">232</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not take any action that would have the effect of preventing us from complying with our obligations under the
Listing Rules of the Financial Conduct Authority or precluding or inhibiting us or any of our Founded Entities and other affiliates from carrying on its business independently of Invesco, its associates and any person with whom it is acting in
concert; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not propose or procure the proposal of a shareholder resolution which is intended to, or appears to be intended
to, circumvent the proper application of the Listing Rules of the Financial Conduct Authority; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not exercise any of its voting rights attaching to the shares held by it to procure any amendment to our Articles
of Association of which would be inconsistent with, undermine or breach any of the provisions of the Relationship Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms
of the Relationship Agreement enable us to carry on our business independently from Invesco and its affiliates, and ensure that all transactions and relationships between us and Invesco are, and will be, at arm&#146;s length and on a normal
commercial basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>resTORbio Series A Financing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From
March 2017 to October 2017, resTORbio issued and sold shares of its Series A preferred stock for aggregate proceeds of approximately $30.0&nbsp;million. PureTech Health LLC participated in such financing and invested $5.5&nbsp;million in March 2017,
$4.5&nbsp;million in August 2017 and $9.0&nbsp;million in October 2017. Our executive officer Bharatt Chowrira was elected to the board of directors of resTORbio in connection with this financing, but he was not compensated by us for his services on
the board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Karuna Convertible Promissory Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2017, Karuna issued a convertible promissory note, or the Initial August 2017 Note, to PureTech Health LLC in the principal amount of $345,819. On
the same date, Karuna issued a second convertible promissory note, or the Second August 2017 Note, and together with the Initial August 2017 Note, the 2017 Notes, to PureTech Health LLC in the principal amount of up to $6.5&nbsp;million. The Second
August 2017 Note was payable in installments, with $3.5&nbsp;million of the note drawn down upon execution of the note and an additional $3.0&nbsp;million drawn down upon Karuna&#146;s receipt of permission from the FDA to dose a second cohort in
its Phase 2 clinical trial and confirmation that a material adverse event had not occurred. This second draw down occurred in January 2018. In June 2018, Karuna issued an additional convertible promissory note to PureTech Health LLC in the principal
amount of $4.0&nbsp;million, or the 2018 Note. The 2017 Notes and the 2018 Note accrued interest at a rate of 10&nbsp;percent per year. The 2017 Notes converted at a 25&nbsp;percent discount in Karuna&#146;s Series A preferred stock financing, as
further described below, and the 2018 Notes converted at no discount. Our executive officers Bharatt Chowrira, Eric Elenko, and Stephen Muniz were the board of directors of Karuna at the time of this financing, but they were not compensated by us
for their services on the board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Entrega Series <FONT STYLE="white-space:nowrap">A-2</FONT> Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2017, Entrega issued and sold Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock for aggregate proceeds of $11.0&nbsp;million.
Approximately $8.4&nbsp;million of outstanding principal and interest on convertible promissory notes issued by Entrega to PureTech Health LLC converted into Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock in this financing in
accordance with their terms. Our directors Robert Langer and Stephen Muniz were on the board of directors of Entrega at the time of the financing but they were not compensated by us for their services on the board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>resTORbio Initial Public Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2018,
resTORbio closed its initial public offering of 6,516,667 shares of common stock at a public offering price of $15.00 per share, which included the exercise in full by the underwriters of their option to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">233</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchase up to 850,000 additional shares. The gross proceeds from the offering were $97.8&nbsp;million, before deducting underwriting discounts and commissions and estimated offering expenses.
PureTech Health LLC purchased 233,333 shares of resTORbio&#146;s common stock in the offering for an aggregate purchase price of $3.5&nbsp;million. Daphne Zohar, our executive officer and director, was a member of resTORbio&#146;s board of directors
at the time of the offering, but she was not compensated by us for her services on the board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gelesis Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2018, Gelesis issued and sold shares of preferred stock for aggregate proceeds of approximately $30&nbsp;million. PureTech Health LLC invested
$5&nbsp;million in the financing. Our directors Raju Kucherlapati, John LaMattina and Stephen Muniz were members of the board of directors at the time of this financing, but they were not compensated by us for their services on the board of
directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>UK Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2018, we completed
an offering in which we issued 45,000,000 ordinary shares at 160 pence per share, which were admitted to the premium listing segment of the Official List of the Financial Conduct Authority and are trading on the main market for listed securities of
the London Stock Exchange plc. The placing represented a discount of approximately 3.0&nbsp;percent to the closing price of the Company&#146;s ordinary shares on March&nbsp;12, 2018. We received gross proceeds of &pound;72&nbsp;million, or
$101.2&nbsp;million, in the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the aggregate cash purchase price of the ordinary shares purchased by our
5&nbsp;percent stockholders and their affiliates and the number of ordinary shares issued in consideration of such amounts. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NAME</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>CASH<BR>PURCHASE<BR>PRICE<BR>(GBP)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER<BR>OF<BR>ORDINARY<BR>SHARES</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Invesco Asset Management Limited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&pound;</TD>
<TD VALIGN="bottom" ALIGN="right">22,984,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,365,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lansdowne Partners Limited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&pound;</TD>
<TD VALIGN="bottom" ALIGN="right">7,194,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,496,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Baillie Gifford&nbsp;&amp; Co</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&pound;</TD>
<TD VALIGN="bottom" ALIGN="right">8,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jupiter Asset Management</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&pound;</TD>
<TD VALIGN="bottom" ALIGN="right">4,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,812,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&pound;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>42,678,101</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>26,673,813</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Karuna Series A Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2018, Karuna issued and sold Series A preferred stock for aggregate proceeds of approximately $42.1&nbsp;million. PureTech Health LLC participated in
the financing and invested $4.0&nbsp;million. Additionally, approximately $8.1&nbsp;million of outstanding principal and interest on convertible promissory notes issued by Karuna to PureTech Health LLC, including the 2017 Notes, converted into
Series A preferred stock in this financing in accordance with their terms. Our executive officers Stephen Muniz, Eric Elenko and Bharatt Chowrira were on Karuna&#146;s board of directors at the time of the financing but they were not compensated by
us for their services on the board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vedanta Series C Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2018 and May 2019, Vedanta Biosciences, Inc., or Vedanta, issued and sold shares of Series&nbsp;C preferred stock for aggregate proceeds of
approximately $45.5&nbsp;million. PureTech invested $5.0&nbsp;million in this financing. Our directors John LaMattina and Christopher Viehbacher and our executive officer Bharatt Chowrira were on the board of directors of Vedanta at the time of the
financing but they were not compensated by us for their services on the board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">234</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vor Series <FONT STYLE="white-space:nowrap">A-2</FONT> Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2019, Vor issued and sold shares of <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock for aggregate proceeds of approximately
$25.1&nbsp;million. PureTech Health LLC participated in such offering and invested $0.6&nbsp;million. Additionally, approximately $7.4&nbsp;million of outstanding principal and interest on convertible promissory notes issued by Vor to PureTech
Health LLC converted into <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock in this financing in accordance with their terms. In February 2020, Vor, issued and sold shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT>
preferred stock for aggregate proceeds of approximately $17.8&nbsp;million. PureTech Health LLC participated in such offering and invested $0.7&nbsp;million. Our executive officer Bharatt Chowrira was on Vor&#146;s board of directors at the time of
the financings but he was not compensated by us for his services on the board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Karuna Series B Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March and April 2019, Karuna issued and sold shares of Series B preferred stock for aggregate proceeds of approximately $82.1&nbsp;million. PureTech Health
LLC invested approximately $5.0&nbsp;million in the financing. Our executive officers Stephen Muniz, Eric Elenko and Bharatt Chowrira were on Karuna&#146;s board of directors at the time of the financing but they were not compensated by us for their
services on the board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sonde Series <FONT STYLE="white-space:nowrap">A-2</FONT> Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2019, Sonde issued and sold shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock for aggregate proceeds of $11.0&nbsp;million.
Approximately $5.8&nbsp;million of outstanding principal and interest on convertible promissory notes issued by Sonde to PureTech converted into Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock in this financing in accordance with
their terms. In August 2019, Sonde sold an additional 1,052,632 shares of its Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock for aggregate proceeds of $2.0&nbsp;million. In January 2020 and April 2020, Sonde sold additional
shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock for aggregate proceeds of $4.8&nbsp;million. Our executive officer Eric Elenko was on the board of directors of Sonde at the time of each of these financings, our executive
officer Daphne Zohar was on the on the board of directors of Sonde at the time of the April 2019 closing and our executive officer Joep Muijrers was on the board of directors of Sonde at the time of the August 2019 closing and both 2020 closings,
but they were not compensated by us for their services on the board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gelesis Issuance of Convertible Promissory Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2019, Gelesis issued a convertible note, or the Gelesis Note, to us in the principal amount of up to $6.5&nbsp;million. The Gelesis Note was payable
in installments, with $2.0&nbsp;million of the note drawn down upon execution of the note and an additional $3.3&nbsp;million and $1.2&nbsp;million drawn down on October&nbsp;7, 2019 and November&nbsp;5, 2019, respectively. Our director Raju
Kucherlapati was a member of Gelesis&#146;s board of directors at the time the Gelesis Note was issued, but he was not compensated by us for his services on the board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gelesis Series 3 Growth Preferred Stock Financing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
December 2019, Gelesis issued 2,973,270 shares of its Series 3 Growth Preferred Stock for aggregate proceeds of $50.1&nbsp;million, including approximately $10.9&nbsp;million of outstanding principal and interest on convertible promissory notes
issued by Gelesis, including the Gelesis Note, which converted into Series 3 Growth Preferred Stock in this financing in accordance with their terms. In addition to the 422,443 shares of Series 3 Growth Preferred Stock issued to us upon conversion
of the Gelesis Note, we also purchased 464,389 shares of Series 3 Growth Preferred Stock for an aggregate purchase price of $8.0&nbsp;million. In April 2020, Gelesis issued 818,990 shares of its Series 3 Growth Preferred Stock for aggregate proceeds
of $14.1&nbsp;million, of which we purchased 579,038 shares of Series 3 Growth Preferred Stock for an aggregate purchase price of $10.0&nbsp;million. In June 2020 and August 2020, Gelesis issued 2,316,154 shares of its Series 3 Growth Preferred
Stock for aggregate proceeds of $40.0&nbsp;million. Our director Raju Kucherlapati was a member of Gelesis&#146;s board of directors at the time of the financing, but he was not compensated by us for his services on the board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">235</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Follica <FONT STYLE="white-space:nowrap">A-3</FONT> Preferred Stock Note Conversion Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2019, $18.0&nbsp;million in combined principal and interest of Follica&#146;s convertible debt converted into 17,639,204 shares of Follica&#146;s
Series <FONT STYLE="white-space:nowrap">A-3</FONT> Preferred Stock and 14,200,044 shares of Follica&#146;s common stock pursuant to a Series <FONT STYLE="white-space:nowrap">A-3</FONT> Note Conversion Agreement between Follica and the noteholders.
We held $15.5&nbsp;million of the converted $18.0&nbsp;million in principal and interest. Our executive officers and board members Daphne Zohar and Stephen Muniz as well as our executive officer Joep Muijrers were on Follica&#146;s board of
directors at the time of the financing, but they were not compensated by us for their services on the board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vedanta Series <FONT
STYLE="white-space:nowrap">C-2</FONT> Financing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September 2019 and May 2020, Vedanta issued and sold shares of
<FONT STYLE="white-space:nowrap">Series&nbsp;C-2</FONT> preferred stock for aggregate proceeds of approximately $25.7&nbsp;million. Our directors John LaMattina and Christopher Viehbacher as well as our executive officer Bharatt Chowrira were on the
board of directors of Vedanta at the time of the financing, but they were not compensated by us for their services on the board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vor Series B
Preferred Stock Financing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2020, Vor Biopharma Inc., or Vor, issued and sold shares of Series&nbsp;B preferred stock for aggregate proceeds of
approximately $64.7&nbsp;million. PureTech Health LLC participated in such offering and invested $0.5&nbsp;million. Our executive officer Bharatt Chowrira was on Vor&#146;s board of directors at the time of the financings, but he was not compensated
by us for his services on the board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vedanta Issuance of Secured Promissory Note </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September 2020, Vedanta issued a secured promissory note, or the Vedanta Note, to Oxford Finance LLC in the principal amount of $15.0&nbsp;million. The
Vedanta Note is secured by Vedanta&#146;s intellectual property, inventory and equipment. Our directors John LaMattina and Christopher Viehbacher as well as our executive Bharatt Chowrira were on the board of directors of Vedanta at the time of the
financing, but they were not compensated by us for their services on the board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gelesis Sublease Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2019, we entered into a Sublease Agreement with Gelesis, pursuant to which we agreed to sublease certain office space in Boston, Massachusetts to
Gelesis for the remainder of the term of our primary lease. Pursuant to this agreement, Gelesis is responsible for all of our payment obligations under the lease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Patent License Agreement with Karuna </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2011, we
entered into an exclusive license agreement, or the Patent License Agreement, with Karuna, pursuant to which we granted Karuna an exclusive license to patents relating to combinations of a muscarinic activator with a muscarinic inhibitor for the
treatment of central nervous system disorders. In connection with the Patent License Agreement, Karuna has agreed to make milestone payments to us of up to an aggregate of $10&nbsp;million upon the achievement of specified developmental, regulatory
and commercial milestones. In addition, Karuna is obligated to pay us low single-digit royalties on the worldwide net sales of any commercialized product covered by the licenses granted under the Patent License Agreement. In the event that Karuna
sublicenses any of the patent rights granted under the Patent License Agreement, Karuna will be obligated to pay us royalties within the range of 15&nbsp;percent to 25&nbsp;percent on any income Karuna receives from the sublicensee, excluding
royalties. Karuna has not paid any fees to us to date pursuant to the Patent License Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Royalty and Sublicense Income Agreement with Gelesis
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We entered into a Royalty and Sublicense Income Agreement with Gelesis, dated December&nbsp;18, 2009, pursuant to which we are required to provide
certain funding, management services and intellectual property relating to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">236</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
intellectual property. In exchange, Gelesis is required to pay us a royalty equal to 2&nbsp;percent of all net product sales and 10&nbsp;percent of gross sublicense income received on certain
food products as a result of developing hydrogel-based products that are covered by a licensed patent that has issued and has not been revoked or abandoned. The royalty rate is subject to customary downward adjustments in the event Gelesis is
required to pay third parties to obtain a license to intellectual property rights that are necessary for Gelesis to develop or commercialize our products. There are no milestone payment obligations under this agreement. Management services provided
by us include advisory services on corporate strategy, general and administrative support including office space, supplies and administrative support, payroll services and website development and support. Gelesis&#146; obligation to pay royalties to
us will terminate on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis upon termination or expiration of the underlying patents. To date, we have not received any royalty payments pursuant to
this agreement. We do not direct or control the development and commercialization of the intellectual property sublicensed pursuant to this agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business Services Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were party to a business
services, personnel and information management agreement with each of Vor, Akili, resTORbio and Karuna until, with respect to Vor and Akili, the date on which we no longer controlled a majority of the equity of such entities, and with respect to
resTORbio and Karuna, the date of each such entity&#146;s initial public offering. Pursuant to such agreements, we provided each of these entities with strategic medical, clinical and scientific advice, in addition to providing certain operational
and administrative resources, and were reimbursed for such services. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting and Investors&#146; Rights Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are party to voting and investors&#146; rights agreements with certain of our Founded Entities as described below: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are party to an Amended and Restated Voting Agreement between Vor and certain of its investors, dated
June&nbsp;30, 2020. We held 42,656,404 shares of capital stock as of June&nbsp;30, 2020, each of which is entitled to one vote and which represents, in the aggregate, 16.4&nbsp;percent of the outstanding voting stock of Vor. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pursuant to an Amended and Restated Investors&#146; Rights Agreement, as amended, between Vedanta and certain of
its investors, dated December&nbsp;21, 2018, we are entitled to designate a total of four directors to Vedanta&#146;s board of directors, including (i)&nbsp;two directors for so long as PureTech Health LLC continues to hold a majority of
Vedanta&#146;s Series <FONT STYLE="white-space:nowrap">A-1</FONT> preferred stock, and (ii)&nbsp;two directors for so long as PureTech Health LLC continues to hold a majority of Vedanta&#146;s Series B preferred stock. We currently have four
designees as members of Vedanta&#146;s board of six directors and hold 5,635,020 shares of capital stock as of June&nbsp;30, 2020, each of which is entitled to one vote and which represents, in the aggregate, 59.9&nbsp;percent of the outstanding
voting stock of Vedanta. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pursuant to the Ninth Amended and Restated Stockholders Agreement, as amended, between Gelesis and certain of its
stockholders, dated December&nbsp;5, 2019, we are entitled to designate two directors to Gelesis&#146; board of directors for so long as PureTech Health LLC and its affiliates continue to hold at least 10&nbsp;percent of Gelesis&#146; capital stock
held by PureTech Health LLC on the date of the agreement. We currently have one designee as a member of Gelesis&#146; board of four directors and hold 5,173,142 shares of capital stock as of June&nbsp;30, 2020, each of which is entitled to one vote
and which represents, in the aggregate, 26.2&nbsp;percent of the outstanding voting stock of Gelesis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pursuant to a Voting Agreement between Sonde and certain of its investors, dated April&nbsp;9, 2019, we are
entitled to designate one director to Sonde&#146;s board of directors for so long as PureTech Health LLC and its affiliates continue to hold at least 1,000,000 shares of Sonde&#146;s Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred
stock. We currently have two designees as members of Sonde&#146;s board of five directors and hold 7,074,241 shares of capital stock as of June&nbsp;30, 2020, each of which is entitled to one vote and which represents, in the aggregate,
52.3&nbsp;percent of the outstanding voting stock of Sonde. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">237</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pursuant to a Voting Agreement between Entrega and certain of its investors, dated December&nbsp;18, 2017, we are
entitled to designate four directors to Entrega&#146;s board of directors. We currently have four designees as members of Entrega&#146;s board of six directors and hold 6,300,375 shares of capital stock as of June&nbsp;30, 2020, each of which is
entitled to one vote and which represents, in the aggregate, 83.1&nbsp;percent of the outstanding voting stock of Entrega. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pursuant to the Fifth Amended and Restated Voting Agreement between Follica and certain of its investors, dated
July&nbsp;19, 2019, we are entitled to designate one director to Follica&#146;s board of directors for so long as PureTech Health LLC and its affiliates continue to own at least 1,000,000 shares of Follica&#146;s common stock. We currently have
three designees as members of Follica&#146;s board of three directors and hold 37,993,501 shares of capital stock as of June&nbsp;30, 2020, each of which is entitled to one vote and which represents, in the aggregate, 85.4&nbsp;percent of the
outstanding voting stock of Follica. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreements with Founded Entities Restricting Sale of Shares in Connection with an Initial
Public Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are party to agreements containing market <FONT STYLE="white-space:nowrap">stand-off</FONT> provisions with certain of our Founded
Entities that restrict our ability to sell shares of such Founded Entities for 180 days after their initial public offerings as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Second Amended and Restated Investors&#146; Rights Agreement between Akili and the investor parties named
therein, dated May&nbsp;8, 2018; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Fifth Amended and Restated Investors&#146; Rights Agreement between Follica and the investor parties named
therein, dated July&nbsp;19, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amended and Restated Investors&#146; Rights Agreement between Vedanta, as amended, and the investor parties named
therein, dated December&nbsp;21, 2018; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Investors&#146; Rights Agreement between Entrega and the investor parties named therein, dated December&nbsp;18,
2017; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ninth Amended and Restated Stockholders Agreement between Gelesis and the stockholder parties named therein,
dated December&nbsp;5, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Investors&#146; Rights Agreement between Sonde and the investor parties named therein, dated April&nbsp;9, 2019;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amended and Restated Investors&#146; Rights Agreement between Vor and the investor parties named therein, dated
June&nbsp;30, 2020. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Family Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our chief executive officer, Daphne Zohar, and Yishai Zohar, the chief executive officer of Gelesis, one of our
<FONT STYLE="white-space:nowrap">Non-Controlled</FONT> Founded Entities, are husband and wife. As of June&nbsp;30, 2020, we held 26.2&nbsp;percent of Gelesis&#146; outstanding equity. Ms.&nbsp;Zohar does not have any direct interest in the share
capital of Gelesis. Ms.&nbsp;Zohar recuses herself from any and all material decisions with regard to Gelesis. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INTERESTS OF EXPERTS AND COUNSEL </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_10"></A>ITEM&nbsp;8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FINANCIAL INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CONSOLIDATED STATEMENTS AND OTHER FINANCIAL INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidated financial statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
audited consolidated financial statements for the fiscal years December&nbsp;31, 2019, 2018 and 2017 are included in Item 18 of this registration statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">238</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal proceedings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, we may become involved in legal, governmental or arbitration proceedings or be subject to claims arising in the ordinary
course of our business. We are not presently a party to any legal, governmental or arbitration proceeding. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management
resources and other factors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividend distribution policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid any dividends on our ordinary shares, and we currently do not plan to declare or pay dividends on our ordinary
shares in the foreseeable future. Under English law, we may only pay dividends if our accumulated realized profits, which have not been previously distributed or capitalized, exceed our accumulated realized losses, so far as such losses have not
been previously written off in a reduction or reorganization of capital. Therefore, we must have sufficient distributable profits before issuing a dividend. Distributable profits are determined at the holding company level and not on a consolidated
basis. Subject to such restrictions and to any restrictions set out in the Articles of Association, declaration and payment of cash dividends in the future, if any, will be at the discretion of our board of directors (and in the case of final
dividends, must be approved by our shareholders), and will depend upon such factors as results of operations, capital requirements, contractual restrictions, our overall financial condition or applicable laws and any other factors deemed relevant by
our board of directors. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SIGNIFICANT CHANGES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise disclosed in this registration statement, no significant change has occurred since the date of the most recent financial
statements included in this registration statement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_11"></A>ITEM&nbsp;9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>THE OFFER AND LISTING </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OFFER AND LISTING DETAILS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal trading market for our ordinary shares is the main market of the London Stock Exchange, where our ordinary shares have been
traded since June 2015 under the ticker code &#147;PRTC.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to apply to list the ADSs on the Nasdaq Global Market under the
symbol &#147;PRTC.&#148; For a description of the rights of our ADSs, see &#147;Item 12. Description of Securities Other Than Equity Securities &#150; D. American Depositary Shares.&#148; </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PLAN OF DISTRIBUTION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MARKETS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ordinary shares are trading on the London Stock Exchange. We are in the process of applying to have our ADSs listed on the Nasdaq Global
Market under the symbol &#147;PRTC.&#148; We make no representation that such application will be approved or that our ADSs will trade on such market either now or at any time in the future. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>D.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SELLING SHAREHOLDERS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>E.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DILUTION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">239</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>F.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXPENSES OF THE ISSUE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_12"></A>ITEM&nbsp;10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADDITIONAL INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SHARE CAPITAL </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Issued Share Capital </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our issued share capital as of
July&nbsp;31, 2020 is 285,647,414 ordinary shares with a par value of &pound;0.01 per ordinary share. Each issued ordinary share is fully paid. We currently have no deferred shares in our issued share capital. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ordinary Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of ordinary shares are
entitled to receive dividends in proportion to the number of ordinary shares held by them and according to the amount paid up on such ordinary shares during any portion or portions of the period in respect of which the dividend is paid. Holders of
ordinary shares are entitled, in proportion to the number of ordinary shares held by them and to the amounts paid up thereon, to share in any surplus in the event of our winding up. The holders of ordinary shares are entitled to receive notice of,
attend either in person or by proxy or, being a corporation, by a duly authorized representative, and vote at general meetings of shareholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Share
Register </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are required by the Companies Act 2006 to keep a register of our shareholders. Under English law, the ordinary shares are deemed to be
issued when the name of the shareholder is entered in our share register. The share register therefore is prima facie evidence of the identity of our shareholders, and the shares that they hold. The share register generally provides limited, or no,
information regarding the ultimate beneficial owners of our ordinary shares. Our share register is maintained by our registrar, Computershare Investor Services PLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As an ADS holder, we will not treat you as one of our shareholders and your name will therefore not be entered into our share register. The depositary will be
the holder of the shares underlying our ADSs. For discussion on our ADSs and ADS holder rights see &#147;Description of American Depository Shares&#148; in this registration statement. As an ADS holder, you have a right to receive the ordinary
shares underlying your ADSs as discussed at &#147;Description of American Depository Shares&#151;Your Right to Receive the Shares Underlying your ADSs&#148; in this registration statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Companies Act 2006, we must enter an allotment of shares in our share register as soon as practicable and in any event within two months of the
allotment. We are also required by the Companies Act 2006 to register a transfer of shares (or give the transferee notice of and reasons for refusal) as soon as practicable and in any event within two months of receiving notice of the transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We, any of our shareholders or any other affected person may apply to the court for rectification of the share register if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name of any person is wrongly entered in or omitted from our register of members; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there is a failure or unnecessary delay in amending the register of members to show the date a member ceased to
be a member. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Options </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the
PSP, awards of ordinary shares may be made to our directors, senior managers and employees of, and other individuals providing services to us and our subsidiaries up to a maximum authorized amount of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">240</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
22,724,800 ordinary shares. During the twelve months ended December&nbsp;31, 2019, we granted 3,634,183 stock option awards under the PSP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of our subsidiaries have also adopted stock option plans. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>History of Share Capital </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the dates
described below, the Company issued Ordinary Shares as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Issue Date or Period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Type of Issuance</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;Ordinary<br>Shares Issued</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;Shares<BR>after Issuance</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Consideration<BR>Received</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fiscal year ended December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exercise of stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,429,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fiscal year ended December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Follow-on</FONT> offering</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,429,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fiscal year ended December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exercise of stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,463,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fiscal year ended December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive RSU awards</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,493,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fiscal year ended December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Acquisition&nbsp;of&nbsp;Ariya Therapeutics, Inc. minority interest</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,126,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">284,620,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fiscal year ended December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive RSU awards</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">513,324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,133,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fiscal year ended December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exercise of stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,370,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Six months ended June&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exercise of stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,512,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We received a cash consideration for this issuance. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Prior to this issuance, we held a majority of the outstanding equity of Ariya Therapeutics, Inc., or Ariya. We
issued these shares in exchange for consideration consisting of 1,775,000 shares of Ariya&#146;s common stock and options to purchase 1,792,500 shares of Ariya&#146;s common stock, such that we owned 100% of Ariya following the transaction.&#148;
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ARTICLES OF ASSOCIATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Articles of Association </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Objects </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;31 of the Companies Act 2006 provides that the objects of a company are unrestricted unless any restrictions are set out in the articles. There
are no such restrictions in the Articles and our objects are therefore unrestricted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to any rights or restrictions attached to any shares, on a show of hands: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">every shareholder who is entitled to vote on the resolution and who is present in person has one vote;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">every proxy present who has be duly appointed by one or more shareholders entitled to vote on the resolution(s)
has one vote; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a proxy has one vote for and one vote against the resolution(s) if he has been duly appointed by more than one
shareholder entitled to vote on the resolution and either (i)&nbsp;is instructed by one or more of those shareholders to vote for the resolution and by one or more others to vote against it; or (ii)&nbsp;is instructed by one or more of those
shareholders to vote in one way and is given a discretion as to how to vote by one or more others (and wishes to use that discretion to vote in the other way); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to any rights or restrictions attached to any shares, on a poll every shareholder who is entitled to vote
on the resolutions and is present in person or by proxy shall have one vote for every share of which he is the holder; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">241</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where there are joint holders of a share, the vote of the senior who tenders a vote, whether in person or by
proxy, shall be accepted to the exclusion of the vote or votes of the other joint holder or holders. Seniority is determined by the order in which the names of the holders stand in the register; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unless the Board otherwise determines, a shareholder shall not be entitled to vote unless all calls or other sums
due and payable from him in respect of shares in our company have been paid. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the Companies Act 2006 and the Articles, we may by ordinary resolution declare dividends, but no such dividends shall exceed the amount recommended
by the Board. Subject to the Companies Act 2006, the Board may declare and pay such interim dividends (including any dividend payable at a fixed rate) as appear to the Board to be justified by the profits of our company available for distribution.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by the rights attached to shares, all dividends shall be declared and paid according to the amounts paid up or credited as
paid up (other than amounts paid in advance of calls) on the shares in respect of which the dividend is paid and shall be apportioned and paid proportionately to the amounts paid up on such shares during any portion or portions of the period in
respect of which the dividend is paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividends may be declared or paid in whatever currency the Board decides. Unless otherwise provided by the rights
attached to the shares, dividends shall not carry a right to receive interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All dividends unclaimed for a period of 12 years after having been
declared or becoming due for payment shall be forfeited and cease to remain owing by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may, with the authority of an ordinary resolution of
our company: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">offer holders of ordinary shares the right to elect to receive further ordinary shares, credited as fully paid,
instead of cash in respect of all or part of any dividend or dividends specified by the ordinary resolution; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">direct that payment of all or part of any dividend declared may be satisfied by the distribution of specific
assets. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no fixed or specified dates on which entitlements to dividends payable by us arise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Pre-emption</FONT> rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In certain circumstances, shareholders may have statutory <FONT STYLE="white-space:nowrap">pre-emption</FONT> rights under the Companies Act 2006 in respect of
the allotment of new shares in our company. These statutory <FONT STYLE="white-space:nowrap">pre-emption</FONT> rights would require us to offer new shares for allotment to existing shareholders on a pro rata basis before allotting them to other
persons. In such circumstances, the procedure for the exercise of such statutory <FONT STYLE="white-space:nowrap">pre-emption</FONT> rights would be set out in the documentation by which such shares would be offered to shareholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Distribution of assets on a <FONT STYLE="white-space:nowrap">winding-up</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On a winding up, a liquidator may, with the authority of a special resolution of our company and any other sanction required by law divide among the
shareholders in kind the whole or any part of the assets of our company, whether or not the assets consist of property of one kind or different kinds and may for such purposes set such value as he considers fair upon any one or more class or classes
of property and may determine how such division shall be carried out as between the Shareholders or different classes of Shareholders. The liquidator may, with the same authority, transfer any part of the assets to trustees on such trusts for the
benefit of shareholders as the liquidator, with the same authority, thinks fit and the liquidation may then be closed and our company dissolved, but so that no Shareholder shall be compelled to accept any shares or other property in respect of which
there is a liability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">242</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Transfer of shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Every transfer of shares which are in certificated form must be in writing in any usual form or in any form approved by the Board and shall be executed by or
on behalf of the transferor and (in the case of a transfer of a share which is not fully paid up) by or on behalf of the transferee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Every transfer of
shares which are in uncertificated form must be made by means of a relevant system (such as CREST). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may, in its absolute discretion and without
giving reason, refuse to register any transfer of certificated shares if: (a)&nbsp;it is in respect of a share which is not fully paid up (provided that, if such share is admitted to trading on a recognised investment exchange, the refusal does not
prevent dealings in our company&#146;s shares from taking place on an open and proper basis); (b) it is in respect of more than one class of share; (c)&nbsp;it is not duly stamped (if so required)or duly certified or otherwise shown to the
satisfaction of the Board to be exempt from stamp duty; or (d)&nbsp;it is not delivered for registration to the registered office of our company or such other place as the Board may from time to time determine, accompanied (except in the case of a
transfer by a recognized person (as defined in the Articles) where a certificate has not been issued) by the relevant share certificate and such other evidence as the Board may reasonably require to show the right of the transferor to make the
transfer and, if the transfer is signed by some other person on his behalf, the authority of that person to do so. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may, in its absolute
discretion and without giving reason, refuse to register any transfer or allotment of shares which is in favor of: (a)&nbsp;a child, bankrupt or person of unsound mind; or (b)&nbsp;more than four joint transferees </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restrictions on voting rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a member or any
person appearing to be interested in shares held by such a member has been duly served with a notice under section 793 of the Companies Act 2006 and has failed in relation to any shares (&#147;default shares&#148;) to give us the information thereby
required within 14 days from the date of the notice, then, unless the Board otherwise determines, the member shall not be entitled to vote or exercise any right conferred by membership in relation to meetings of our company in respect of such
default shares. Where the holding represents more than 0.25&nbsp;percent of the issued shares of that class (excluding any shares of that class held as treasury shares) then: (i)&nbsp;the payment of dividends may be withheld and such member shall
not be entitled to elect to receive shares instead of that dividend; and (ii)&nbsp;save for an excepted transfer as defined in the Articles) and subject to the requirements of the relevant system in relation to shares in uncertificated form, no
transfer of a default share shall be registered unless the member himself is not in default and the member proves to the satisfaction of the Board that no person in default is interested in the shares the subject of the transfer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Variation of class rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the
Companies Act 2006, all or any of the rights or privileges attached to any class of shares in our company may be varied or abrogated in such manner (if any) as may be provided by such rights, or, in the absence of any such provision, either with the
consent in writing of the holders of at least three-fourths of the nominal amount of the issued shares of that class or with the sanction of a special resolution passed at a separate meeting of such holders of shares of that class, but not
otherwise. The quorum at any such meeting (other than an adjourned meeting) is two persons holding or representing by proxy at least one third in nominal amount of the issued shares of the class in question. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The rights attached to any class of shares shall not, unless otherwise expressly provided in the rights attaching to such shares, be deemed to be varied or
abrogated by the creation or issue of shares ranking pari passu with or subsequent to them or by the purchase or redemption by us of any of our own shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">243</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Share capital, changes in capital and purchase of own shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the Companies Act 2006 and to the Articles, the power to allot and issue shares shall be exercised by the Board at such times and on such terms and
conditions as the Board may determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the Articles and to any rights attached to any existing shares, any share may be issued with such
rights or restrictions as we may from time to time determine by ordinary resolution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue redeemable shares and the Board may determine the
terms, conditions and manner of redemption of such shares, provided it does so before the shares are allotted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General meetings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may convene a general meeting whenever it thinks fit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Companies Act 2006, an annual general meeting shall be called on not less than 21 clear days&#146; notice. All other general meetings shall be
called by not less than 14 clear days&#146; notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The quorum for a general meeting is two shareholders present in person or by proxy and entitled to
vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board and, at any general meeting, the chairman of the meeting may make any arrangement and impose any requirement or restriction which it or
he considers appropriate to ensure the security or orderly conduct of the meeting. This may include requirements for evidence of identity to be produced by those attending, the searching of their personal property and the restriction of items which
may be taken into the meeting place. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Appointment of directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise determined by ordinary resolution, there shall be no maximum number of directors, but the number of directors shall not be less than two.
Subject to the Companies Act 2006 and the Articles, we may by ordinary resolution appoint any person who is willing to act as a director either as an additional director or to fill a vacancy. The Board may also appoint any person who is willing to
act as a director, subject to the Companies Act 2006 and the Articles. Any person appointed by the Board as a director will hold office only until conclusion of the next annual general meeting, unless he is
<FONT STYLE="white-space:nowrap">re-elected</FONT> during such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may appoint any director to hold any employment or executive office in
our company and may also revoke or terminate any such appointment (without prejudice to any claim for damages for breach of any service contract between the director and our company). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Retirement and removal of directors </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Articles
provide that at each annual general meeting of our company, <FONT STYLE="white-space:nowrap">one-third</FONT> of the directors who are subject to retirement by rotation or, if their number is not three, the number nearest to but not exceeding one
third shall retire from office unless there are fewer than three directors who are subject to retirement by rotation, in which case only one shall retire from office. However, in accordance with the U.K. Corporate Governance Code and best practice,
at each annual general meeting all of our directors retire from office and put themselves forward for <FONT STYLE="white-space:nowrap">re-election.</FONT> In addition, any director who has been a director at each of the preceding two annual general
meetings shall also retire. Each such director may, if eligible, offer himself for <FONT STYLE="white-space:nowrap">re-election.</FONT> If our company, at the meeting at which a director retires, does not fill the vacancy the retiring director
shall, if willing, be deemed to have been reappointed unless it is expressly resolved not to fill the vacancy or a resolution for the reappointment of the director is put to the meeting and lost. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Without prejudice to the provisions of the Companies Act 2006, our company may by ordinary resolution remove any director before the expiration of his period
of office and may by ordinary resolution appoint another director in his place. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">244</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Directors&#146; interests </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the Companies Act 2006 and provided that he has disclosed to the directors the nature and extent of any interest, a director is able to enter into
contracts or other arrangements with us, hold any other office (except auditor) with us or be a director, employee or otherwise interested in any company in which our company is interested. Such a director shall not be liable to account to us for
any profit, remuneration or other benefit realized by any such office, employment, contract, arrangement or proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Save as otherwise provided by the
Articles, a director shall not vote on, or be counted in the quorum in relation to, any resolution of the Board concerning any contract, arrangement, transaction or proposal to which our company is or is to be a party and in which he (together with
any person connected with him) is to his knowledge materially interested, directly or indirectly. Interests of which the director is not aware, interests which cannot reasonably be regarded as likely to give rise to a conflict of interest and
interests arising purely as a result of an interest in our company&#146;s shares, debentures or other securities are disregarded. However, a director can vote and be counted in the quorum where the resolution relates to any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the giving of any guarantee, security or indemnity in respect of (i)&nbsp;money lent or obligations incurred by
him or by any other person at the request of or for the benefit of our company or any of its subsidiary undertakings or (ii)&nbsp;a debt or obligation of our company or any of its subsidiary undertakings for which the director himself has assumed
responsibility in whole or in part under a guarantee or indemnity or by the giving of security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the participation of the director, in an offer of securities of our company or any of its subsidiary
undertakings, including participation in the underwriting or <FONT STYLE="white-space:nowrap">sub-underwriting</FONT> of the offer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a proposal involving another company in which he and any persons connected with him has a direct or indirect
interest of any kind, unless he and any persons connected with him hold an interest in shares representing one percent or more of either any class of equity share capital, or the voting rights, in such company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any arrangement for the benefit of employees of our company or of any of its subsidiary undertakings which does
not award the director any privilege or benefit not generally awarded to the employees to whom such arrangement relates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any proposal concerning the purchase or maintenance of any insurance policy under which he may benefit;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any proposal concerning indemnities in favor of directors or the funding of expenditure by one or more directors
on defending proceedings against such director(s). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A director shall not vote or be counted in the quorum on any resolution of the Board
concerning his own appointment (including fixing or varying the terms of his appointment or its termination) as the holder of any office or place of profit with our company or any company in which our company is interested. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may authorize any matter that would otherwise involve a Director breaching his duty under the Companies Act 2006 to avoid conflicts of interest,
provided that the interested director(s) do not vote or count in the quorum in relation to any resolution authorizing the matter. The Board may authorize the relevant matter on such terms as it may determine including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the interested director(s) may vote or be counted in the quorum in relation to any resolution relating to
the relevant matter; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exclusion of the interested director(s) from all information and discussion by our company of the relevant
matter; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the imposition of confidentiality obligations on the interested director(s). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">245</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An interested director must act in accordance with any terms determined by the Board. An authorization of a
relevant matter may also provide that where the interested director obtains information that is confidential to a third party (other than through his position as director) he will not be obliged to disclose it to our company or to use it in relation
to our company&#146;s affairs, if to do so would amount to a breach of that confidence. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Powers of the directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the Articles and to any directions given by special resolution of the Company, the business of the Company shall be managed by the Board, which may
exercise all the powers of the Company whether relating to the management of the business or not. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Differences in Corporate Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The applicable provisions of the Companies Act 2006 differ from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of
certain differences between the provisions of the Companies Act 2006 applicable to us and the Delaware General Corporation Law relating to shareholders&#146; rights and protections. This summary is not intended to be a complete discussion of the
respective rights and it is qualified in its entirety by reference to Delaware law and English law. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>ENGLAND&nbsp;AND&nbsp;WALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>DELAWARE</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the Companies Act 2006, a public limited company must have at least two directors and the number of directors may be fixed by or in the manner provided in a company&#146;s articles of association.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, a corporation must have at least one director and the number of directors shall be fixed by or in the manner provided in the bylaws.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the Companies Act 2006, shareholders may remove a director without cause by an ordinary resolution (which is passed by a simple majority of those voting in person or by proxy at a general meeting) irrespective of any
provisions of any service contract the director has with the company, provided 28 clear days&#146; notice of the resolution has been given to the company and its shareholders. On receipt of notice of an intended resolution to remove a director, the
company must forthwith send a copy of the notice to the director concerned. Certain other procedural requirements under the Companies Act 2006 must also be followed such as allowing the director to make representations against his or her removal
either at the meeting or in writing.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, any director or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except (a)&nbsp;unless the
certificate of incorporation provides otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b)&nbsp;in the case of a corporation having cumulative voting, if less
than the entire board of directors is to be removed, no director may be removed without cause if the votes cast against his removal would be sufficient to elect him if then cumulatively voted at an election of the entire board of directors, or, if
there are classes of directors, at an election of the class of directors of which he is a part.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">246</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>ENGLAND&nbsp;AND&nbsp;WALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>DELAWARE</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vacancies on the Board of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under English law, the procedure by which directors, other than a company&#146;s initial directors, are appointed is generally set out in a company&#146;s articles of association, provided that where two or more persons are
appointed as directors of a public limited company by resolution of the shareholders, resolutions appointing each director must be voted on individually.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, vacancies and newly created directorships may be filled by a majority of the directors then in office (even though less than a quorum) or by a sole remaining director unless (a)&nbsp;otherwise provided in the
certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> of the corporation or (b)&nbsp;the certificate of incorporation directs that a particular class of stock is to elect such director, in which case a majority of the other
directors elected by such class, or a sole remaining director elected by such class, will fill such vacancy.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual General Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the Companies Act 2006, a public limited company must hold an annual general meeting within the <FONT STYLE="white-space:nowrap">six-month</FONT> period following the company&#146;s annual accounting reference date.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, the annual meeting of stockholders shall be held at such place, on such date and at such time as may be designated from time to time by the board of directors or as provided in the certificate of incorporation or
by the bylaws.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Companies Act 2006, a general meeting of the shareholders of a public limited company may be called by the directors.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholders holding at least 5&nbsp;percent of the
<FONT STYLE="white-space:nowrap">paid-up</FONT> capital of the company carrying voting rights at general meetings can require the directors to call a general meeting and, if the directors fail to do so within 21 days (with the meeting to be held not
more than 28 days after the date of the notice),, may themselves convene a general meeting.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Under Delaware law, special meetings of the stockholders may be called by the board of directors or by such person or persons as may be
authorized by the certificate of incorporation or by the bylaws.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of General Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the Companies Act 2006, 21 clear days&#146; notice must be given for an annual general meeting and any resolutions to be proposed at the meeting. Subject to a company&#146;s articles of</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, unless otherwise provided in the certificate of incorporation or bylaws, written notice of any meeting of the stockholders must be given to each
stockholder</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">247</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>ENGLAND&nbsp;AND&nbsp;WALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>DELAWARE</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">association providing for a longer period, at least 14 clear days&#146; notice is required for any other general meeting. In addition, certain matters, such as the removal of directors or auditors, require special notice, which is
28 clear days&#146; notice. The shareholders of a company may in all cases consent to a shorter notice period, the proportion of shareholders&#146; consent required being 100&nbsp;percent of those entitled to attend and vote in the case of an annual
general meeting and, in the case of any other general meeting, a majority in number of the members having a right to attend and vote at the meeting, being a majority who together hold not less than 95&nbsp;percent in nominal value of the shares
giving a right to attend and vote at the meeting.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">entitled to vote at the meeting not less than ten nor more than 60&nbsp;days before the date of the meeting and shall specify the place, date, hour, and purpose or purposes of the meeting.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proxy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the Companies Act 2006, at any meeting of shareholders, a shareholder may designate another person to attend, speak and vote at the meeting on their behalf by proxy.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, at any meeting of stockholders, a stockholder may designate another person to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy
provides for a longer period. A director of a Delaware corporation may not issue a proxy representing the director&#146;s voting rights as a director.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Pre-emptive</FONT> Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the Companies Act 2006, &#147;equity securities&#148;, being (i)&nbsp;shares in the company other than shares that, with respect to dividends and capital, carry a right to participate only up to a specified amount in a
distribution (&#147;ordinary shares&#148;) or (ii)&nbsp;rights to subscribe for, or to convert securities into, ordinary shares, proposed to be allotted for cash must be offered first to the existing equity shareholders in the company in proportion
to the respective nominal value of their</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, shareholders have no preemptive rights to subscribe to additional issues of stock or to any security convertible into such stock unless, and except to the extent that, such rights are expressly provided for in
the certificate of incorporation.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">248</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>ENGLAND&nbsp;AND&nbsp;WALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>DELAWARE</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">holdings, unless an exception applies or a special resolution to the contrary has been passed by shareholders in a general meeting or the articles of association provide otherwise in each case in accordance with the provisions of
the Companies Act 2006.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authority to Allot</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the Companies Act 2006 the directors of a company must not allot shares or grant of rights to subscribe for or to convert any security into shares unless an exception applies or an ordinary resolution to the contrary has been
passed by shareholders in a general meeting or the articles of association provide otherwise in each case in accordance with the provisions of the Companies Act 2006.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, if the corporation&#146;s charter or certificate of incorporation so provides, the board of directors has the power to authorize the issuance of stock. It may authorize capital stock to be issued for
consideration consisting of cash, any tangible or intangible property or any benefit to the corporation or any combination thereof. It may determine the amount of such consideration by approving a formula. In the absence of actual fraud in the
transaction, the judgment of the directors as to the value of such consideration is conclusive.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liability of Directors and Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Companies Act 2006, any provision, whether contained in a company&#146;s articles of association or any contract or otherwise, that
purports to exempt a director of a company, to any extent, from any liability that would otherwise attach to him in connection with any negligence, default, breach of duty or breach of trust in relation to the company is void.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Any provision by which a company directly or indirectly provides an indemnity, to any
extent, for a director of the company or of an associated company against any liability attaching to him in connection with any negligence, default, breach of duty or breach of trust in relation to the company of which he is a director is also void
except as permitted by the Companies Act 2006, which provides</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Delaware law, a corporation&#146;s certificate of incorporation may include a provision eliminating or limiting the personal liability
of a director to the corporation and its stockholders for damages arising from a breach of fiduciary duty as a director. However, no provision can limit the liability of a director for:</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;any breach of the
director&#146;s duty of loyalty to the corporation or its stockholders;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;acts or omissions not in good faith or that involve intentional misconduct or a knowing violation
of law;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;intentional or
negligent payment of unlawful dividends or stock purchases or redemptions; or</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">249</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>ENGLAND&nbsp;AND&nbsp;WALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>DELAWARE</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">exceptions for the company to (a)&nbsp;purchase and maintain insurance against such liability; (b)&nbsp;provide a &#147;qualifying third party indemnity&#148; (being an indemnity against liability incurred by the director to a
person other than the company or an associated company or criminal proceedings in which he is not convicted); and (c)&nbsp;provide a &#147;qualifying pension scheme indemnity&#148; (being an indemnity against liability incurred in connection with
the company&#146;s activities as trustee of an occupational pension plan).</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;any
transaction from which the director derives an improper personal benefit.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Voting Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under English law, unless a poll is demanded by the shareholders of a company or is required by the chairman of the meeting or the
company&#146;s articles of association, shareholders shall vote on all resolutions on a show of hands. Under the Companies Act 2006, a poll may be demanded by (a)&nbsp;not fewer than five shareholders having the right to vote on the resolution;
(b)&nbsp;any shareholder(s) representing not less than 10&nbsp;percent of the total voting rights of all the shareholders having the right to vote on the resolution; or (c)&nbsp;any shareholder(s) holding shares in the company conferring a right to
vote on the resolution being shares on which an aggregate sum has been paid up equal to not less than 10&nbsp;percent of the total sum paid up on all the shares conferring that right. A company&#146;s articles of association may provide more
extensive rights for shareholders to call a poll.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Under English law, an ordinary
resolution is passed on a show of hands if it is approved by a simple majority (more than 50&nbsp;percent) of the votes cast by shareholders present (in person or by proxy)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Delaware law provides that, unless otherwise provided in the certificate of incorporation, each stockholder is entitled to one vote for each share of capital stock held by such
stockholder.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">250</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>ENGLAND&nbsp;AND&nbsp;WALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>DELAWARE</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">and entitled to vote. If a poll is demanded, an ordinary resolution is passed if it is approved by holders representing a simple majority of the total voting rights of shareholders present, in person or by proxy, who, being entitled
to vote, vote on the resolution. Special resolutions require the affirmative vote of not less than 75&nbsp;percent of the votes cast by shareholders present, in person or by proxy, at the meeting and entitled to vote.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shareholder Vote on Certain Transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Companies Act 2006 provides for schemes of arrangement, which are arrangements or compromises between a company and any class of
shareholders or creditors and used in certain types of reconstructions, amalgamations, capital reorganizations or takeovers. These arrangements require:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;the approval at a shareholders&#146; or creditors&#146; meeting convened by order of the court, of
a majority in number of shareholders or creditors representing 75&nbsp;percent in value of the capital held by, or debt owed to, the class of shareholders or creditors, or class thereof present and voting, either in person or by proxy; and</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;the approval of the
court.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, under Delaware law, unless the certificate of incorporation provides for the vote of a larger portion of the stock, completion of
a merger, consolidation, sale, lease or exchange of all or substantially all of a corporation&#146;s assets or dissolution requires:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;the approval of the board of directors; and</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;approval by the vote of the
holders of a majority of the outstanding stock or, if the certificate of incorporation provides for more or less than one vote per share, a majority of the votes of the outstanding stock of a corporation entitled to vote on the matter.</P></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Standard of Conduct for Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under English law, a director owes various statutory and fiduciary duties to the company, including:</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;to act in the way he
considers, in good faith, would be most likely to promote the success of the company for the benefit of its members as a whole;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;to avoid a situation in which he has, or can have, a direct</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Delaware law does not contain specific provisions setting forth the standard of conduct of a director. The scope of the fiduciary duties of directors is generally determined by the courts of the State of Delaware. In general,
directors have a duty to act without self-interest, on a well-informed basis and in a manner they reasonably believe to be in</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">251</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>ENGLAND&nbsp;AND&nbsp;WALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>DELAWARE</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.00em; font-size:10pt; font-family:Times New Roman">or indirect interest that conflicts, or possibly conflicts, with the interests of the company;</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;to act in accordance with the
company&#146;s constitution and only exercise his powers for the purposes for which they are conferred;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;to exercise independent judgment;</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;to exercise reasonable care,
skill and diligence;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;not
to accept benefits from a third party conferred by reason of his being a director or doing, or not doing, anything as a director; and</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;a duty to declare any interest that he has, whether directly or indirectly, in a proposed or
existing transaction or arrangement with the company.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the best interest of the stockholders.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors of a Delaware corporation owe fiduciary duties of care and loyalty to the corporation and to its shareholders. The duty of care generally requires
that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of all material information reasonably available regarding a significant
transaction. The duty of loyalty requires that a director act in a manner he reasonably believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. In general, but subject to
certain exceptions, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by
evidence of a breach of one of the fiduciary duties. Delaware courts have also imposed a heightened standard of conduct upon directors of a Delaware corporation who take any action designed to defeat a threatened change in control of the
corporation.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">In addition, under Delaware law, when the board of directors of a
Delaware corporation approves the sale or <FONT STYLE="white-space:nowrap">break-up</FONT> of a corporation, the board of directors may, in certain circumstances, have a duty to obtain the highest value reasonably available to the
shareholders.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Suits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under English law, generally, the company, rather than its</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, a stockholder may initiate a</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">252</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>ENGLAND&nbsp;AND&nbsp;WALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>DELAWARE</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">shareholders, is the proper claimant in an action in respect of a wrong done to the company or where there is an irregularity in the company&#146;s internal management. Notwithstanding this general position, the Companies Act 2006
provides that (i)&nbsp;a court may allow a shareholder to bring a derivative claim (that is, an action in respect of and on behalf of the company) in respect of a cause of action arising from a director&#146;s negligence, default, breach of duty or
breach of trust and (ii)&nbsp;a shareholder may bring a claim for a court order where the company&#146;s affairs have been or are being conducted in a manner that is unfairly prejudicial to some of its shareholders.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">derivative action to enforce a right of a corporation if the corporation fails to enforce the right itself. The complaint must:</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;state that the plaintiff was
a stockholder at the time of the transaction of which the plaintiff complains or that the plaintiffs shares thereafter devolved on the plaintiff by operation of law; and</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;allege with particularity the efforts made by the plaintiff to obtain the action the plaintiff
desires from the directors and the reasons for the plaintiff&#146;s failure to obtain the action; or</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;state the reasons for not making the effort.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Additionally, the plaintiff must remain a stockholder through the duration of the
derivative suit. The action will not be dismissed or compromised without the approval of the Delaware Court of Chancery.</P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MATERIAL CONTRACTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise set forth below or as otherwise disclosed in this registration statement, we are not currently, and have not been in the
last two years, party to any material contract, other than contracts entered into in the ordinary course of business. See the section titled &#147;License Agreements&#148; in Section&nbsp;4B herein. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>D.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXCHANGE CONTROLS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than certain economic sanctions which may be in place from time to time, there are currently no UK laws, decrees or regulations
restricting the import or export of capital or affecting the remittance of dividends or other payment to holders of ordinary shares who are <FONT STYLE="white-space:nowrap">non-residents</FONT> of the United Kingdom. Similarly, other than certain
economic sanctions which may be in force from time to time, there are no limitations relating only to nonresidents of the United Kingdom under English law or the Company&#146;s articles of association on the right to be a holder of, and to vote in
respect of, the ordinary shares. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>E.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TAXATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain United Kingdom Tax Considerations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following
is a general summary of certain U.K. tax considerations relating to the ownership and disposal of an ordinary share or ADS and does not address all possible tax consequences relating to an investment in an ordinary share or ADS. It is based on U.K.
tax law and generally published HM Revenue&nbsp;&amp; Customs, or HMRC, practice (which may not be binding on HMRC) as of the date of this registration statement, both of which are subject to change, possibly with retrospective effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">253</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Save as provided otherwise, this summary applies only to a person who is the absolute beneficial owner of an
ordinary share or ADS and who is resident (and, in the case of an individual, domiciled) in the United Kingdom for tax purposes and who is not resident for tax purposes in any other jurisdiction and does not have a permanent establishment or fixed
base in any other jurisdiction with which the holding of an ordinary share or ADS is connected (&#147;U.K. Holders&#148;). A person (a)&nbsp;who is not resident (or, if resident, is not domiciled) in the United Kingdom for tax purposes, including an
individual and company who trades in the United Kingdom through a branch, agency or permanent establishment in the United Kingdom to which an ordinary share or ADS is attributable, or (b)&nbsp;who is resident or otherwise subject to tax in a
jurisdiction outside the United Kingdom, is recommended to seek the advice of professional advisors in relation to their taxation obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
summary is for general information only and is not intended to be, nor should it be considered to be, legal or tax advice to any particular investor. It does not address all of the tax considerations that may be relevant to specific investors in
light of their particular circumstances or to investors subject to special treatment under U.K. tax law. In particular: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this summary only applies to an absolute beneficial owner of an ordinary share or ADS and any dividend paid in
respect of the ordinary share where the dividend is regarded for U.K. tax purposes as that person&#146;s own income (and not the income of some other person); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this summary: (a)&nbsp;only addresses the principal U.K. tax consequences for an investor who holds an ordinary
share or ADS as a capital asset, (b)&nbsp;does not address the tax consequences that may be relevant to certain special classes of investor such as a dealer, broker or trader in shares or securities and any other person who holds an ordinary share
or ADS otherwise than as an investment, (c)&nbsp;does not address the tax consequences for a holder that is a financial institution, insurance company, collective investment scheme, pension scheme, charity or
<FONT STYLE="white-space:nowrap">tax-exempt</FONT> organization, (d)&nbsp;assumes that a holder is not an officer or employee of the company (nor of any related company) and has not (and is not deemed to have) acquired the an ordinary share or ADS
by virtue of an office or employment, and (e)&nbsp;assumes that a holder does not control or hold (and is not deemed to control or hold), either alone or together with one or more associated or connected persons, directly or indirectly (including
through the holding of an ordinary share or ADS), an interest of 10&nbsp;percent or more in the issued share capital (or in any class thereof), voting power, rights to profits or capital of the company, and is not otherwise connected with the
company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary further assumes that a holder of an ordinary share or ADS is the beneficial owner of the underlying ordinary
share for U.K. direct tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">POTENTIAL INVESTORS IN THE ORDINARY SHARES OR ADSs SHOULD SATISFY THEMSELVES PRIOR TO INVESTING AS TO THE OVERALL TAX
CONSEQUENCES, INCLUDING, SPECIFICALLY, THE CONSEQUENCES UNDER U.K. TAX LAW AND HMRC PRACTICE OF THE ACQUISITION, OWNERSHIP AND DISPOSAL OF THE ORDINARY SHARES OR ADSs, IN THEIR OWN PARTICULAR CIRCUMSTANCES BY CONSULTING THEIR TAX ADVISERS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Taxation of Dividends </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Withholding Tax </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A dividend payment in respect of an ordinary share may be made without withholding or deduction for or on account of U.K. tax. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Income Tax </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A dividend received by individual U.K.
Holders may, depending on his or her particular circumstances, be subject to U.K. income tax on the gross amount of the dividend paid. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">254</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An individual holder of an ordinary share or ADS who is not a U.K. Holder will not be chargeable to U.K.
income tax on a dividend paid by the company, unless such holder carries on (whether solely or in partnership) a trade, profession or vocation in the United Kingdom through a permanent establishment in the United Kingdom to which the ordinary share
or ADS is attributable. In these circumstances, such holder may, depending on his or her individual circumstances, be chargeable to U.K. income tax on a dividend received from the company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All dividends received by a UK Holder from the Company or from other sources will form part of the UK Holder&#146;s total income for UK income tax purposes
and will constitute the top slice of that income. The rate of U.K. income tax that is chargeable on dividends received in the tax year 2020/2021 by (i)&nbsp;an additional rate taxpayer is 38.1&nbsp;percent, (ii)&nbsp;a higher rate taxpayer is
32.5&nbsp;percent, and (iii)&nbsp;a basic rate taxpayer is 7.5&nbsp;percent. A nil rate of income tax will apply to the first &pound;2,000 of taxable dividend income received by an individual U.K. Holder in a tax year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Corporation Tax </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.K. Holder within the charge to U.K.
corporation tax may be entitled to exemption from U.K. corporation tax in respect of dividend payments, provided the dividends qualify for exemption (which is likely) and certain conditions are met (including anti-avoidance conditions). If the
conditions for the exemption are not satisfied, or such U.K. Holder elects for an otherwise exempt dividend to be taxable, U.K. corporation tax will be chargeable on the gross amount of a dividend. If potential investors are in any doubt as to their
position, they should consult their own professional advisers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A corporate holder of an ordinary share or ADS that is not a U.K. Holder will not be
subject to U.K. corporation tax on a dividend received from the company, unless it carries on a trade in the United Kingdom through a permanent establishment to which the ordinary share or ADS is attributable. In these circumstances, such holder
may, depending on its individual circumstances and if the exemption from U.K. corporation tax discussed above does not apply, be chargeable to U.K. corporation tax on dividends received from the company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Taxation of Disposals </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>U.K. Holders </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A disposal or deemed disposal of an ordinary share or ADS by an individual U.K. Holder may, depending on his or her individual circumstances, give rise to a
chargeable gain or to an allowable loss for the purpose of U.K. capital gains tax. The principal factors that will determine the capital gains tax position on a disposal of an ordinary share or ADS are the extent to which the holder realizes any
other capital gains in the tax year in which the disposal is made, the extent to which the holder has incurred capital losses in that or any earlier tax year and the level of the annual exemption for <FONT STYLE="white-space:nowrap">tax-free</FONT>
gains in that tax year (the &#147;annual exemption&#148;). The annual exemption for the 2020/2021 tax year is &pound;12,500. If, after all allowable deductions, an individual U.K. Holder&#146;s total taxable income for the year exceeds the basic
rate income tax limit, a taxable capital gain accruing on a disposal of an ordinary share or an ADS is taxed at the rate of 20&nbsp;percent. In other cases, a taxable capital gain accruing on a disposal of an ordinary share or ADS may be taxed at
the rate of 10&nbsp;percent save to the extent that any capital gains exceed the unused basic rate tax band. In that case, the rate currently applicable to the excess would be 20&nbsp;percent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An individual U.K. Holder who ceases to be resident in the United Kingdom (or who fails to be regarded as resident in a territory outside the United Kingdom
for the purposes of double taxation relief) for a period of five tax years or less than five years and who disposes of an ordinary share or ADS during that period of temporary <FONT STYLE="white-space:nowrap">non-residence</FONT> may be liable to
U.K. capital gains tax on a chargeable gain accruing on such disposal on his or her return to the United Kingdom (or upon ceasing to be regarded as resident outside the United Kingdom for the purposes of double taxation relief) (subject to available
exemptions or reliefs). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A disposal (or deemed disposal) of an ordinary share or ADS by a corporate U.K. Holder may give rise to a chargeable gain or an
allowable loss for the purpose of U.K. corporation tax. Any gain or loss in respect of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">255</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
currency fluctuations over the period of holding an ordinary share or an ADS are also brought into account on a disposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-U.K.</FONT> Holders </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An individual holder who is not a U.K. Holder should not normally be liable to U.K. capital gains tax on capital gains realized on the disposal of an ordinary
share or ADS unless such holder carries on (whether solely or in partnership) a trade, profession or vocation in the United Kingdom through a permanent establishment in the United Kingdom to which the ordinary share or ADS is attributable. In these
circumstances, such holder may, depending on his or her individual circumstances, be chargeable to U.K. capital gains tax on chargeable gains arising from a disposal of his or her ordinary share or ADS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A corporate holder of an ordinary share or ADS that is not a U.K. Holder will not be liable for U.K. corporation tax on chargeable gains realized on the
disposal of an ordinary share or ADS unless: (i)&nbsp;it carries on a trade in the United Kingdom through a permanent establishment to which the ordinary share or ADS is attributable; or (ii)&nbsp;the corporate holder is disposing of an interest in
a company and that disposal is of an asset that derives 75&nbsp;percent or more of its gross asset value from UK land and that holder has a substantial indirect interest in UK land (broadly at least 25&nbsp;percent at any time during the previous
two years). In these circumstances, a disposal (or deemed disposal) of an ordinary share or ADS by such holder may give rise to a chargeable gain or an allowable loss for the purposes of U.K. corporation tax. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Inheritance Tax </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, for the purposes of the
Double Taxation Relief (Taxes on Estates of Deceased Persons and on Gifts) Treaty United States of America Order 1979 (S1 1979/1454) between the United States and the United Kingdom, an individual holder is domiciled at the time of their death or at
the time of a transfer made during their lifetime in the United States and is not a national of the United Kingdom, any ordinary share or ADS beneficially owned by that holder should not generally be subject to U.K. inheritance tax, provided that
any applicable United States federal gift or estate tax liability is paid, except where (i)&nbsp;the ordinary share or ADS is part of the business property of a U.K. permanent establishment or pertain to a U.K. fixed base used for the performance of
independent personal services; or (ii)&nbsp;the ordinary share or ADS is comprised in a settlement unless, at the time the settlement was made, the settlor was domiciled in the United States and not a national of the U.K. (in which case no charge to
U.K. inheritance tax should apply). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stamp Duty and Stamp Duty Reserve Tax </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stamp duty and stamp duty reserve tax, or SDRT, treatment of the issue, transfer and agreement to transfer an ordinary share outside a depositary receipt
system or a clearance service are discussed in the paragraphs under &#147;<I>General</I>&#148; below. The stamp duty and SDRT treatment of such transactions in relation to such systems are discussed in the paragraphs under &#147;<I>Depositary
Receipt Systems and Clearance Services</I>&#148; below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issue of an ordinary share or ADS does not give rise to a SDRT liability, according to the HM Revenue&nbsp;&amp; Customs practice and recent case law and
is not subject to stamp duty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A transfer of an ordinary share or ADS will generally be subject to stamp duty at the rate of 0.5&nbsp;percent of the
consideration given for the transfer (rounded up to the next &pound;5). An exemption from stamp duty is available on an instrument transferring an ordinary share or ADSs where the amount or value of the consideration is &pound;1,000 or less, and it
is certified on the instrument that the transaction effected does not form part of a larger transaction or series of transactions in respect of which the aggregate amount or value of the consideration exceeds &pound;1,000. The purchaser normally
pays the stamp duty. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">256</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An unconditional agreement to transfer an ordinary share or ADS will normally give rise to a charge to SDRT
at the rate of 0.5&nbsp;percent of the amount or value of the consideration payable for the transfer. SDRT is, in general, payable by the purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a
duly stamped transfer completing an agreement to transfer is produced within six years of the date on which the agreement is made (or, if the agreement is conditional, the date on which the agreement becomes unconditional) any SDRT already paid is
generally repayable, normally with interest, and any SDRT charge yet to be paid is cancelled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No stamp duty will, in practice, be payable on a written
instrument transferring an ordinary share or an ADS or on an unconditional agreement to transfer an ordinary share or an ADS if the instrument of transfer or the unconditional agreement to transfer is executed and remains at all times outside the
UK. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Depositary Receipt Systems and Clearance Services </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on current HMRC practice and recent case law in respect of the European Council Directives 69/335/EC and 2009/7/EC, on the Capital Duties Directive, no
SDRT is generally payable when shares are issued or transferred to a clearance service or depositary receipt system as an integral part of a raising of capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where an ordinary share or ADS is otherwise transferred (i)&nbsp;to, or to a nominee or an agent for, a person whose business is or includes the provision of
clearance services or (ii)&nbsp;to, or to a nominee or an agent for a person whose business is or includes issuing depositary receipts, stamp duty or SDRT will generally be payable at the higher rate of 1.5&nbsp;percent of the amount or value of the
consideration given or, in certain circumstances, the value of the shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is an exception from the 1.5&nbsp;percent charge on the transfer to, or
to a nominee or agent for, a clearance service where the clearance service has made and maintained an election under section 97A(1) of the Finance Act 1986, which has been approved by HM Revenue&nbsp;&amp; Customs. In these circumstances, SDRT at
the rate of 0.5&nbsp;percent of the amount or value of the consideration payable for the transfer will arise on any transfer of ordinary share into such an account and on subsequent agreements to transfer such shares within such account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any liability for stamp duty or SDRT in respect of a transfer into a clearance service or depositary receipt system, or in respect of a transfer within such a
service, which does arise will strictly be accountable by the clearance service or depositary receipt system operator or their nominee, as the case may be, but will, in practice, be borne by the participants in the clearance service or depositary
receipt system. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Taxation in the United States </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following summary of the material U.S. federal income tax consequences of the acquisition, ownership and disposition of our ordinary shares or ADSs is based upon current law and does not purport to be a comprehensive discussion of all the tax
considerations that may be relevant to a decision to purchase our ordinary shares or ADSs. This summary is based on current provisions of the Internal Revenue Code of 1986, as amended, or the Code, existing, final, temporary and proposed United
States Treasury Regulations, administrative rulings and judicial decisions, in each case as available on the date of this registration statement. All of the foregoing are subject to change, which change could apply retroactively and could affect the
tax consequences described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This section summarizes the material U.S. federal income tax consequences to U.S. holders and certain <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holders, each as defined below, of our ordinary shares or ADSs. This summary addresses only the U.S. federal income tax considerations for holders that acquire our ordinary shares or ADSs at their original
issuance and hold our ordinary shares or ADSs as capital assets. This summary does not address all U.S. federal income tax matters that may be relevant to a particular holder. <B>Each prospective investor should consult a professional tax</B>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">257</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>advisor with respect to the tax consequences of the acquisition, ownership or disposition of our ordinary shares or ADSs</B>. This summary does not address tax considerations applicable to a
holder of our ordinary shares or ADSs that may be subject to special tax rules including, without limitation, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">banks or other financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">insurance companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">dealers or traders in securities, currencies, or notional principal contracts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> entities, including an &#147;individual retirement
account&#148; or &#147;Roth IRA&#148; retirement plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulated investment companies or real estate investment trusts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;qualified foreign pension funds,&#148; or entities wholly owned by a &#147;qualified foreign pension
fund&#148;; persons who have elected to mark securities to market </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that hold the ordinary shares as part of a hedge, straddle, conversion, constructive sale or similar
transaction involving more than one position; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">holders (whether individuals, corporations or partnerships) that are treated as expatriates for some or all U.S.
federal income tax purposes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who acquired the ADSs as compensation for the performance of services; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons holding the ADSs in connection with a trade or business conducted outside of the United States;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">holders that own (or are deemed to own) 10&nbsp;percent or more of our ordinary shares or ADSs, by vote or value;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">holders that have a &#147;functional currency&#148; other than the U.S. dollar. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, this summary does not address any aspects of any U.S. state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax law, alternative minimum
tax, gift or estate consequences, the rules regarding qualified small business stock within the meaning of Section&nbsp;1202 of the Code, any election to apply <FONT STYLE="white-space:nowrap">Section&nbsp;1400Z-2</FONT> of the Code to gains
recognized with respect to our ordinary shares, any other U.S. federal tax other than the income tax or the indirect effects on the holders of equity interests in entities that own our ordinary shares or ADSs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this summary, a &#147;U.S. holder&#148; is a beneficial owner of ordinary shares or ADSs that is (or is treated as), for U.S. federal
income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is either a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation, or other entity that is treated as a corporation for U.S. federal income tax purposes, created or
organized in or under the laws of the United States or any state of the United States or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust, if a court within the United States is able to exercise primary supervision over its administration and
one or more U.S. persons have the authority to control all of the substantial decisions of such trust or has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a United States person. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a partnership holds ordinary shares or ADSs, the tax treatment of a partner will generally depend upon the status of the partner and upon the activities of
the partnership. This discussion does not address the tax treatment of partnerships or other entities that are pass-through entities for U.S. federal income tax purposes or persons that hold their ordinary shares or ADSs through partnerships or
other pass-through entities. A partner in a partnership or other pass-through entity that will hold our ordinary shares or ADSs should consult his, her or its tax advisor regarding the tax consequences of acquiring, holding and disposing of our
ordinary shares or ADSs through a partnership or other pass-through entity, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">258</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will not seek a ruling from the U.S. Internal Revenue Service, or IRS, with regard to the U.S. federal
income tax treatment of an investment in our ordinary shares or ADSs, and we cannot assure you that the IRS will agree with the conclusions set forth below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PERSONS CONSIDERING AN INVESTMENT IN ORDINARY SHARES OR ADSs SHOULD CONSULT THEIR TAX ADVISORS AS TO THE PARTICULAR TAX CONSEQUENCES APPLICABLE TO THEM
RELATING TO THE ACQUISITION, OWNERSHIP AND DISPOSITION OF THE ORDINARY SHARES OR ADSs, INCLUDING THE APPLICABILITY OF U.S. FEDERAL, STATE AND LOCAL TAX LAWS. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ownership of ADSs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For U.S. federal income tax
purposes, a holder of ADSs generally will be treated as the owner of the ordinary shares represented by such ADSs. Gain or loss will generally not be recognized on account of exchanges of ordinary shares for ADSs, or of ADSs for ordinary shares.
References to ordinary shares in the discussion below are deemed to include ADSs, unless context otherwise requires. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>F.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DIVIDENDS AND PAYING AGENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>G.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>STATEMENT BY EXPERTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of PureTech Health plc as of December&nbsp;31, 2019, 2018 and 2017, and for each of the years in the
three-year period ended December&nbsp;31, 2019, have been included herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of
said firm as experts in accounting and auditing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>H.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DOCUMENTS ON DISPLAY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When this registration statement on Form <FONT STYLE="white-space:nowrap">20-F</FONT> becomes effective, we will be subject to the information
reporting requirements of the Exchange Act applicable to foreign private issuers, and under those requirements will file reports with the SEC. The SEC also maintains a website at http://www.sec.gov from which filings may be accessed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a foreign private issuer, we will be exempt from the rules under the Exchange Act related to the furnishing and content of proxy
statements, and our officers, directors and principal shareholders will be exempt from the reporting and short-swing profit recovery provisions contained in Section&nbsp;16 of the Exchange Act. In addition, we will not be required under the Exchange
Act to file annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However, for so long as we are listed on Nasdaq, or any
other U.S. exchange, and are registered with the SEC, we will file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report on Form <FONT STYLE="white-space:nowrap">20-F</FONT>
containing financial statements audited by an independent registered public accounting firm. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUBSIDIARY INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For information about our subsidiaries, see the section entitled &#147;Organizational Structure&#148; under Item 4C of this registration
statement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_13"></A>ITEM&nbsp;11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For information about our quantitative and qualitative disclosures about market risk, see &#147;Item 5B. Operating and Financial Review and
Prospects&#151;Liquidity and Capital Resources&#148; under the <FONT STYLE="white-space:nowrap">sub-heading</FONT> &#147;Quantitative and Qualitative Disclosures about Financial Risks.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">259</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_14"></A>ITEM&nbsp;12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEBT SECURITIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>WARRANTS AND RIGHTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OTHER SECURITIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>D.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>AMERICAN DEPOSITARY SHARES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citibank, N.A. has agreed to act as the depositary bank for the American Depositary Shares. Citibank&#146;s depositary offices are located at 388 Greenwich
Street, New York, New York, 10013. American Depositary Shares are frequently referred to as &#147;ADSs&#148; and represent ownership interests in securities that are on deposit with the depositary bank. ADSs may be represented by certificates that
are commonly known as &#147;American Depositary Receipts&#148; or &#147;ADRs.&#148; The depositary bank typically appoints a custodian to safekeep the securities on deposit. In this case, the custodian is Citibank, N.A.&#151;London Branch, located
at Citigroup Centre Canary Wharf, London E14 5LB D. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will<B> </B>appoint Citibank as depositary bank pursuant to a deposit agreement. A copy of the
deposit agreement is on file with the SEC under cover of a Registration Statement on Form <FONT STYLE="white-space:nowrap">F-6.</FONT> You may obtain a copy of the deposit agreement from the SEC&#146;s Public Reference Room at 100 F Street, N.E.,
Washington, D.C. 20549 and from the SEC&#146;s website (www.sec.gov). Please refer to Registration Number <FONT STYLE="white-space:nowrap">333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
when retrieving such copy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are providing you with a summary description of the material terms of the ADSs and of your material rights as an owner of
ADSs. Please remember that summaries by their nature lack the precision of the information summarized and that the rights and obligations of an owner of ADSs will be determined by reference to the terms of the deposit agreement and not by this
summary. We urge you to review the deposit agreement in its entirety. The portions of this summary description that are italicized describe matters that may be relevant to the ownership of ADSs but that may not be contained in the deposit agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each ADS represents the right to receive, and to exercise the beneficial ownership interests in, ordinary<B> </B>shares that are on deposit with the
depositary bank and/or custodian. An ADS also represents the right to receive, and to exercise the beneficial interests in, any other property received by the depositary bank or the custodian on behalf of the owner of the ADS but that has not been
distributed to the owners of ADSs because of legal restrictions or practical considerations. We and the depositary bank may agree to change the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ADS-to-Share</FONT></FONT> ratio by
amending the deposit agreement. This amendment may give rise to, or change, the depositary fees payable by ADS owners. The custodian, the depositary bank and their respective nominees will hold all deposited property for the benefit of the holders
and beneficial owners of ADSs. The deposited property does not constitute the proprietary assets of the depositary bank, the custodian or their nominees. Beneficial ownership in the deposited property will under the terms of the deposit agreement be
vested in the beneficial owners of the ADSs. The depositary bank, the custodian and their respective nominees will be the record holders of the deposited property represented by the ADSs for the benefit of the holders and beneficial owners of the
corresponding ADSs. A beneficial owner of ADSs may or may not be the holder of ADSs. Beneficial owners of ADSs will be able to receive, and to exercise beneficial ownership interests in, the deposited property only through the registered holders of
the ADSs, the registered holders of the ADSs (on behalf of the applicable ADS owners) only through the depositary bank, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">260</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the depositary bank (on behalf of the owners of the corresponding ADSs) directly, or indirectly, through the custodian or their respective nominees, in each case upon the terms of the deposit
agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you become an owner of ADSs, you will become a party to the deposit agreement and therefore will be bound to its terms and to the terms of
any ADR that represents your ADSs. The deposit agreement and the ADR specify our rights and obligations as well as your rights and obligations as owner of ADSs and those of the depositary bank. As an ADS holder you appoint the depositary bank to act
on your behalf in certain circumstances. The deposit agreement and the ADRs are governed by New York law. However, our obligations to the holders of ordinary<B> </B>shares will continue to be governed by the laws of England and Wales, which may be
different from the laws of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, applicable laws and regulations may require you to satisfy reporting requirements and obtain
regulatory approvals in certain circumstances. You are solely responsible for complying with such reporting requirements and obtaining such approvals. Neither the depositary bank, the custodian, us or any of their or our respective agents or
affiliates shall be required to take any actions whatsoever on your behalf to satisfy such reporting requirements or obtain such regulatory approvals under applicable laws and regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>As an owner of ADSs, we will not treat you as one of our shareholders and you will not have direct shareholder rights. The depositary bank will hold on
your behalf the shareholder rights attached to the ordinary shares underlying your ADSs. As an owner of ADSs you will be able to exercise the shareholders rights for the ordinary shares represented by your ADSs through the depositary bank only to
the extent contemplated in the deposit agreement. To exercise any shareholder rights not contemplated in the deposit agreement you will, as an ADS owner, need to arrange for the cancellation of your ADSs and become a direct shareholder. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The manner in which you own the ADSs (e.g., in a brokerage account vs. as registered holder, or as holder of certificated vs. uncertificated ADSs) may affect
your rights and obligations, and the manner in which, and extent to which, the depositary bank&#146;s services are made available to you. As an owner of ADSs, you may hold your ADSs either by means of an ADR registered in your name, through a
brokerage or safekeeping account, or through an account established by the depositary bank in your name reflecting the registration of uncertificated ADSs directly on the books of the depositary bank (commonly referred to as the &#147;direct
registration system&#148; or &#147;DRS&#148;). The direct registration system reflects the uncertificated (book-entry) registration of ownership of ADSs by the depositary bank. Under the direct registration system, ownership of ADSs is evidenced by
periodic statements issued by the depositary bank to the holders of the ADSs. The direct registration system includes automated transfers between the depositary bank and The Depository Trust Company (&#147;DTC&#148;), the central book-entry clearing
and settlement system for equity securities in the United States. If you decide to hold your ADSs through your brokerage or safekeeping account, you must rely on the procedures of your broker or bank to assert your rights as ADS owner. Banks and
brokers typically hold securities such as the ADSs through clearing and settlement systems such as DTC. The procedures of such clearing and settlement systems may limit your ability to exercise your rights as an owner of ADSs. Please consult with
your broker or bank if you have any questions concerning these limitations and procedures. All ADSs held through DTC will be registered in the name of a nominee of DTC. This summary description assumes you have opted to own the ADSs directly by
means of an ADS registered in your name and, as such, we will refer to you as the &#147;holder.&#148; When we refer to &#147;you,&#148; we assume the reader owns ADSs and will own ADSs at the relevant time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The registration of the ordinary shares in the name of the depositary bank or the custodian shall, to the maximum extent permitted by applicable law, vest in
the depositary bank or the custodian the record ownership in the applicable ordinary shares with the beneficial ownership rights and interests in such ordinary shares being at all times vested with the beneficial owners of the ADSs representing the
ordinary<B> </B>shares. The depositary bank or the custodian shall at all times be entitled to exercise the beneficial ownership rights in all deposited property, in each case only on behalf of the holders and beneficial owners of the ADSs
representing the deposited property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">261</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends and Distributions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a holder of ADSs, you generally have the right to receive the distributions we make on the securities deposited with the custodian. Your receipt of these
distributions may be limited, however, by practical considerations and legal limitations. Holders of ADSs will receive such distributions under the terms of the deposit agreement in proportion to the number of ADSs held as of the specified record
date, after deduction of the applicable fees, taxes and expenses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions of Cash </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whenever we make a cash distribution for the securities on deposit with the custodian, we will deposit the funds with the custodian. Upon receipt of
confirmation of the deposit of the requisite funds, the depositary bank will arrange for the funds received in a currency other than U.S. dollars to be converted into U.S. dollars and for the distribution of the U.S. dollars to the holders, subject
to the laws and regulations of England and Wales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conversion into U.S. dollars will take place only if practicable and if the U.S. dollars are
transferable to the United States. The depositary bank will apply the same method for distributing the proceeds of the sale of any property (such as undistributed rights) held by the custodian in respect of securities on deposit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The distribution of cash will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement.
The depositary bank will hold any cash amounts it is unable to distribute in a <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing account for the benefit of the applicable holders and beneficial owners of ADSs until the distribution can be
effected or the funds that the depositary bank holds must be escheated as unclaimed property in accordance with the laws of the relevant states of the United States. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions of Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whenever we make a free
distribution of ordinary shares for the securities on deposit with the custodian, we will deposit the applicable number of ordinary shares with the custodian. Upon receipt of confirmation of such deposit, the depositary bank will either distribute
to holders new ADSs representing the ordinary shares deposited or modify the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ADS-to-ordinary</FONT></FONT> shares ratio, in which case each ADS you hold will represent rights and
interests in the additional ordinary shares so deposited. Only whole new ADSs will be distributed. Fractional entitlements will be sold and the proceeds of such sale will be distributed as in the case of a cash distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The distribution of new ADSs or the modification of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ADS-to-ordinary</FONT></FONT> shares
ratio upon a distribution of ordinary shares will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes or governmental charges, the depositary bank
may sell all or a portion of the new ordinary shares so distributed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No such distribution of new ADSs will be made if it would violate a law
(<I>e.g.</I>, the U.S. securities laws) or if it is not operationally practicable. If the depositary bank does not distribute new ADSs as described above, it may sell the ordinary shares received upon the terms described in the deposit agreement and
will distribute the proceeds of the sale as in the case of a distribution of cash. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions of Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whenever we intend to distribute rights to subscribe for additional ordinary shares, we will give prior notice to the depositary bank and we will assist the
depositary bank in determining whether it is lawful and reasonably practicable to distribute rights to subscribe for additional ADSs to holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
depositary bank will establish procedures to distribute rights to subscribe for additional ADSs to holders and to enable such holders to exercise such rights if it is lawful and reasonably practicable to make the rights
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">262</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
available to holders of ADSs, and if we provide all of the documentation contemplated in the deposit agreement (such as opinions to address the lawfulness of the transaction). You may have to pay
fees, expenses, taxes and other governmental charges to subscribe for the new ADSs upon the exercise of your rights. The depositary bank is not obligated to establish procedures to facilitate the distribution and exercise by holders of rights to
subscribe for new ordinary shares other than in the form of ADSs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The depositary bank will <I>not</I> distribute the rights to you if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We do not timely request that the rights be distributed to you or we request that the rights not be distributed
to you; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We fail to deliver satisfactory documents to the depositary bank; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">It is not reasonably practicable to distribute the rights. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The depositary bank will sell the rights that are not exercised or not distributed if such sale is lawful and reasonably practicable. The proceeds of such
sale will be distributed to holders as in the case of a cash distribution. If the depositary bank is unable to sell the rights, it will allow the rights to lapse. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Elective Distributions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whenever we intend to distribute
a dividend payable at the election of shareholders either in cash or in additional shares, we will give prior notice thereof to the depositary bank and will indicate whether we wish the elective distribution to be made available to you. In such
case, we will assist the depositary bank in determining whether such distribution is lawful and reasonably practicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The depositary bank will make the
election available to you only if it is reasonably practicable and if we have provided all of the documentation contemplated in the deposit agreement. In such case, the depositary bank will establish procedures to enable you to elect to receive
either cash or additional ADSs, in each case as described in the deposit agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the election is not made available to you, you will receive either
cash or additional ADSs, depending on what a shareholder in England and Wales<B> </B>would receive upon failing to make an election, as more fully described in the deposit agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Distributions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whenever we intend to distribute
property other than cash, ordinary<B> </B>shares or rights to subscribe for additional ordinary<B> </B>shares, we will notify the depositary bank in advance and will indicate whether we wish such distribution to be made to you. If so, we will assist
the depositary bank in determining whether such distribution to holders is lawful and reasonably practicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If it is reasonably practicable to
distribute such property to you and if we provide to the depositary bank all of the documentation contemplated in the deposit agreement, the depositary bank will distribute the property to the holders in a manner it deems practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The distribution will be made net of fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to
pay such taxes and governmental charges, the depositary bank may sell all or a portion of the property received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The depositary bank will <I>not</I>
distribute the property to you and will sell the property if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We do not request that the property be distributed to you or if we request that the property not be distributed
to you; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">263</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We do not deliver satisfactory documents to the depositary bank; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The depositary bank determines that all or a portion of the distribution to you is not reasonably practicable.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proceeds of such a sale will be distributed to holders as in the case of a cash distribution. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whenever we decide to redeem any of the
securities on deposit with the custodian, we will notify the depositary bank in advance. If it is practicable and if we provide all of the documentation contemplated in the deposit agreement, the depositary bank will provide notice of the redemption
to the holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The custodian will be instructed to surrender the shares being redeemed against payment of the applicable redemption price. The
depositary bank will convert into U.S. dollars, upon the terms of the deposit agreement, the redemption funds received in a currency other than U.S. dollars and will establish procedures to enable holders to receive the net proceeds from the
redemption upon surrender of their ADSs to the depositary bank. You may have to pay fees, expenses, taxes and other governmental charges upon the redemption of your ADSs. If less than all ADSs are being redeemed, the ADSs to be retired will be
selected by lot or on a <I>pro rata</I> basis, as the depositary bank may determine. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Changes Affecting Ordinary Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ordinary<B> </B>shares held on deposit for your ADSs may change from time to time. For example, there may be a change in nominal or par value, <FONT
STYLE="white-space:nowrap">split-up,</FONT> cancellation, consolidation or any other reclassification of such ordinary<B> </B>shares or a recapitalization, reorganization, merger, consolidation or sale of assets of the company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any such change were to occur, your ADSs would, to the extent permitted by law and the deposit agreement, represent the right to receive the property
received or exchanged in respect of the ordinary<B> </B>shares held on deposit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The depositary bank may in such circumstances deliver new ADSs to you,
amend the deposit agreement, the ADRs and the applicable Registration Statement(s) on Form <FONT STYLE="white-space:nowrap">F-6,</FONT> call for the exchange of your existing ADSs for new ADSs and take any other actions that are appropriate to
reflect as to the ADSs the change affecting the ordinary shares. If the depositary bank may not lawfully distribute such property to you, the depositary bank may sell such property and distribute the net proceeds to you as in the case of a cash
distribution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Issuance of ADSs upon Deposit of Ordinary Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon effectiveness of this registration statement, the ordinary<B> </B>shares will be deposited by us with the custodian. Upon receipt of confirmation of such
deposit, the depositary bank will issue ADSs to the underwriters named in the registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After the effectiveness of this registration
statement, the depositary bank may create ADSs on your behalf if you or your broker deposit ordinary<B> </B>shares with the custodian. The depositary bank will deliver these ADSs to the person you indicate only after you pay any applicable issuance
fees and any charges and taxes payable for the transfer of the ordinary<B> </B>shares to the custodian. Your ability to deposit ordinary<B> </B>shares and receive ADSs may be limited by U.S. and English legal considerations applicable at the time of
deposit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issuance of ADSs may be delayed until the depositary bank or the custodian receives confirmation that all required approvals have been given
and that the ordinary<B> </B>shares have been duly transferred to the custodian. The depositary bank will only issue ADSs in whole numbers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">264</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When you make a deposit of ordinary<B> </B>shares, you will be responsible for transferring good and valid
title to the depositary bank. As such, you will be deemed to represent and warrant that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The ordinary<B> </B>shares are duly authorized, validly issued, fully paid,
<FONT STYLE="white-space:nowrap">non-assessable</FONT> and legally obtained. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All preemptive (and similar) rights, if any, with respect to such ordinary<B> </B>shares have been validly waived
or exercised. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You are duly authorized to deposit the ordinary<B> </B>shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The ordinary<B> </B>shares presented for deposit are free and clear of any lien, encumbrance, security interest,
charge, mortgage or adverse claim, and are not, and the ADSs issuable upon such deposit will not be, &#147;restricted securities&#148; (as defined in the deposit agreement). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The ordinary<B> </B>shares presented for deposit have not been stripped of any rights or entitlements.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of the representations or warranties are incorrect in any way, we and the depositary bank may, at your cost and expense, take
any and all actions necessary to correct the consequences of the misrepresentations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer, Combination and Split Up of ADRs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As an ADR holder, you will be entitled to transfer, combine or split up your ADRs and the ADSs evidenced thereby. For transfers of ADRs, you will have to
surrender the ADRs to be transferred to the depositary bank and also must: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ensure that the surrendered ADR is properly endorsed or otherwise in proper form for transfer;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide such proof of identity and genuineness of signatures as the depositary bank deems appropriate;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide any transfer stamps required by the State of New York or the United States; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pay all applicable fees, charges, expenses, taxes and other government charges payable by ADR holders pursuant to
the terms of the deposit agreement, upon the transfer of ADRs. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To have your ADRs either combined or split up, you must surrender the
ADRs in question to the depositary bank with your request to have them combined or split up, and you must pay all applicable fees, charges and expenses payable by ADR holders, pursuant to the terms of the deposit agreement, upon a combination or
split up of ADRs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Withdrawal of Ordinary Shares Upon Cancellation of ADSs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a holder, you will be entitled to present your ADSs to the depositary bank for cancellation and then receive the corresponding number of underlying
ordinary<B> </B>shares<B> </B>at the custodian&#146;s offices. Your ability to withdraw the ordinary<B> </B>shares held in respect of the ADSs may be limited by U.S. and English law considerations applicable at the time of withdrawal. In order to
withdraw the ordinary<B> </B>shares represented by your ADSs, you will be required to pay to the depositary bank the fees for cancellation of ADSs and any charges and taxes payable upon the transfer of the ordinary shares. You assume the risk for
delivery of all funds and securities upon withdrawal. Once canceled, the ADSs will not have any rights under the deposit agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you hold ADSs
registered in your name, the depositary bank may ask you to provide proof of identity and genuineness of any signature and such other documents as the depositary bank may deem appropriate before it will cancel your ADSs. The withdrawal of the
ordinary<B> </B>shares represented by your ADSs may be delayed until the depositary bank receives satisfactory evidence of compliance with all applicable laws and regulations. Please keep in mind that the depositary bank will only accept ADSs for
cancellation that represent a whole number of securities on deposit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">265</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will have the right to withdraw the securities represented by your ADSs at any time except for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Temporary delays that may arise because (i)&nbsp;the transfer books for the ordinary<B> </B>shares or ADSs are
closed, or (ii)&nbsp;ordinary<B> </B>shares are immobilized on account of a shareholders&#146; meeting or a payment of dividends. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Obligations to pay fees, taxes and similar charges. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Restrictions imposed because of laws or regulations applicable to ADSs or the withdrawal of securities on
deposit. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The deposit agreement may not be modified to impair your right to withdraw the securities represented by your ADSs except to
comply with mandatory provisions of law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each holder and beneficial owner of ADSs agrees to provide such information as the company may request in a
disclosure notice given pursuant to the U.K. Companies Act 2006, as amended, or the Companies Act, or the Articles of Association. Each holder and beneficial owner of ADSs acknowledges that it understands that failure to comply with such request may
result in the imposition of sanctions against the holder of the ordinary shares in respect of which the <FONT STYLE="white-space:nowrap">non-complying</FONT> person is or was, or appears to be or has been, interested as provided in the Companies Act
and the Articles of Association which currently include, the withdrawal of the voting rights of such Shares and the imposition of restrictions on the rights to receive dividends on and to transfer such Shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a holder, you generally have the right
under the deposit agreement to instruct the depositary bank to exercise the voting rights for the ordinary shares represented by your ADSs. The voting rights of holders of ordinary shares are described in &#147;Description of Share Capital and
Articles of Association&#151;Articles of Association.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At our request, the depositary bank will distribute to you any notice of shareholders&#146;
meeting received from us together with information explaining how to instruct the depositary bank to exercise the voting rights of the securities represented by ADSs. In lieu of distributing such materials, the depositary bank may distribute to
holders of ADSs instructions on how to retrieve such materials upon request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the depositary bank timely receives voting instructions from a holder of
ADSs, it will endeavor to vote the securities (in person or by proxy) represented by the holder&#146;s ADSs as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In the event of voting by show of hands, the depositary bank will vote (or cause the custodian to vote) all
ordinary shares held on deposit at that time in accordance with the voting instructions received from a majority of holders of ADSs who provide timely voting instructions. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In the event of voting by poll, the depositary bank will vote (or cause the Custodian to vote) the ordinary
shares held on deposit in accordance with the voting instructions received from the holders of ADSs. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities for which no voting
instructions have been received will not be voted (except as otherwise contemplated in the deposit agreement).<B> </B>Please note that the ability of the depositary bank to carry out voting instructions may be limited by practical and legal
limitations and the terms of the securities on deposit. We cannot assure you that you will receive voting materials in time to enable you to return voting instructions to the depositary bank in a timely manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">266</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fees and Charges </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As an ADS holder, you will be required to pay the following fees under the terms of the deposit agreement: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>SERVICE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>FEES</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Issuance of ADSs (e.g., an issuance of ADS upon a deposit of ordinary shares,
upon a change in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ADS(s)-to-ordinary</FONT></FONT> share(s) ratio, or for any other reason), excluding ADS issuances as a result of distributions of ordinary shares)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Up to U.S.$0.05 per ADS issued</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Cancellation of ADSs (e.g., a cancellation of ADSs for delivery of deposited
property, upon a change in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ADS(s)-to-ordinary</FONT></FONT> share(s) ratio, or for any other reason)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Up to U.S.$0.05 per ADS cancelled</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Distribution of cash dividends or other cash distributions (e.g., upon a sale
of rights and other entitlements)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Up to U.S.$0.05 per ADS held</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Distribution of ADSs pursuant to (i)&nbsp;share dividends or other free share
distributions, or (ii)&nbsp;exercise of rights to purchase additional ADSs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Up to U.S.$0.05 per ADS held</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Distribution of securities other than ADSs or rights to purchase additional
ADSs (e.g., upon a <FONT STYLE="white-space:nowrap">spin-off)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Up to U.S.$0.05 per ADS held</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;ADS Services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Up to U.S.$0.05 per ADS held on the applicable record date(s) established by the depositary bank</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Registration of ADS transfers (e.g., upon a registration of the transfer of
registered ownership of ADSs, upon a transfer of ADSs into DTC and <I>vice versa</I>, or for any other reason)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Up to U.S.$0.05 per ADS (or fraction thereof) transferred</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Conversion of ADSs of one series for ADSs of another series (e.g., upon
conversion of partial entitlement ADSs for full entitlement ADSs, or upon conversion of restricted ADSs (each as defined in the deposit agreement) into freely transferable ADSs, and <I>vice versa</I>).</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Up to U.S.$0.05 per ADS (or fraction thereof) converted</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As an ADS holder you will also be responsible to pay certain charges such as: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">taxes (including applicable interest and penalties) and other governmental charges; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the registration fees as may from time to time be in effect for the registration of ordinary shares on the share
register and applicable to transfers of ordinary shares to or from the name of the custodian, the depositary bank or any nominees upon the making of deposits and withdrawals, respectively; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain cable, telex and facsimile transmission and delivery expenses; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fees, expenses, spreads, taxes and other charges of the depositary bank and/or service providers (which may
be a division, branch or affiliate of the depositary bank) in the conversion of foreign currency; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the reasonable and customary
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by the depositary bank in connection with compliance with exchange control regulations and other regulatory requirements applicable to
ordinary shares, ADSs and ADRs; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">267</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fees, charges, costs and expenses incurred by the depositary bank, the custodian, or any nominee in
connection with the ADR program. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ADS fees and charges for (i)&nbsp;the issuance of ADSs, and (ii)&nbsp;the cancellation of ADSs are
charged to the person for whom the ADSs are issued (in the case of ADS issuances) and to the person for whom ADSs are cancelled (in the case of ADS cancellations). In the case of ADSs issued by the depositary bank into DTC, the ADS issuance and
cancellation fees and charges may be deducted from distributions made through DTC, and may be charged to the DTC participant(s) receiving the ADSs being issued or the DTC participant(s) holding the ADSs being cancelled, as the case may be, on behalf
of the beneficial owner(s) and will be charged by the DTC participant(s) to the account of the applicable beneficial owner(s) in accordance with the procedures and practices of the DTC participants as in effect at the time. ADS fees and charges in
respect of distributions and the ADS service fee are charged to the holders as of the applicable ADS record date. In the case of distributions of cash, the amount of the applicable ADS fees and charges is deducted from the funds being distributed.
In the case of (i)&nbsp;distributions other than cash and (ii)&nbsp;the ADS service fee, holders as of the ADS record date will be invoiced for the amount of the ADS fees and charges and such ADS fees and charges may be deducted from distributions
made to holders of ADSs. For ADSs held through DTC, the ADS fees and charges for distributions other than cash and the ADS service fee may be deducted from distributions made through DTC, and may be charged to the DTC participants in accordance with
the procedures and practices prescribed by DTC and the DTC participants in turn charge the amount of such ADS fees and charges to the beneficial owners for whom they hold ADSs. In the case of (i)&nbsp;registration of ADS transfers, the ADS transfer
fee will be payable by the ADS Holder whose ADSs are being transferred or by the person to whom the ADSs are transferred, and (ii)&nbsp;conversion of ADSs of one series for ADSs of another series, the ADS conversion fee will be payable by the Holder
whose ADSs are converted or by the person to whom the converted ADSs are delivered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of refusal to pay the depositary bank fees, the
depositary bank may, under the terms of the deposit agreement, refuse the requested service until payment is received or may set off the amount of the depositary bank fees from any distribution to be made to the ADS holder. Certain depositary fees
and charges (such as the ADS services fee) may become payable shortly after the purchase of ADSs.<B> </B>Note that the fees and charges you may be required to pay may vary over time and may be changed by us and by the depositary bank. You will
receive prior notice of such changes. The depositary bank may reimburse us for certain expenses incurred by us in respect of the ADR program, by making available a portion of the ADS fees charged in respect of the ADR program or otherwise, upon such
terms and conditions as we and the depositary bank agree from time to time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendments and Termination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may agree with the depositary bank to modify the deposit agreement at any time without your consent. We undertake to give holders 30 days&#146; prior notice
of any modifications that would materially prejudice any of their substantial rights under the deposit agreement. We will not consider to be materially prejudicial to your substantial rights any modifications or supplements that are reasonably
necessary for the ADSs to be registered under the Securities Act or to be eligible for book-entry settlement, in each case without imposing or increasing the fees and charges you are required to pay. In addition, we may not be able to provide you
with prior notice of any modifications or supplements that are required to accommodate compliance with applicable provisions of law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be bound by
the modifications to the deposit agreement if you continue to hold your ADSs after the modifications to the deposit agreement become effective. The deposit agreement cannot be amended to prevent you from withdrawing the ordinary shares represented
by your ADSs (except as permitted by law). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have the right to direct the depositary bank to terminate the deposit agreement. Similarly, the depositary
bank may in certain circumstances on its own initiative terminate the deposit agreement. In either case, the depositary bank must give notice to the holders at least 30 days before termination. Until termination, your rights under the deposit
agreement will be unaffected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">268</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Termination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After termination, the depositary bank will continue to collect distributions received (but will not distribute any such property until you request the
cancellation of your ADSs) and may sell the securities held on deposit. After the sale, the depositary bank will hold the proceeds from such sale and any other funds then held for the holders of ADSs in a
<FONT STYLE="white-space:nowrap">non-interest</FONT> bearing account. At that point, the depositary bank will have no further obligations to holders other than to account for the funds then held for the holders of ADSs still outstanding (after
deduction of applicable fees, taxes and expenses). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with any termination of the deposit agreement, the depositary bank may make available to
owners of ADSs a means to withdraw the ordinary<B> </B>shares represented by ADSs and to direct the depositary of such ordinary<B> </B>shares into an unsponsored American depositary share program established by the depositary bank. The ability to
receive unsponsored American depositary shares upon termination of the deposit agreement would be subject to satisfaction of certain U.S. regulatory requirements applicable to the creation of unsponsored American depositary shares and the payment of
applicable depositary fees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Books of Depositary </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
depositary bank will maintain ADS holder records at its depositary office. You may inspect such records at such office during regular business hours but solely for the purpose of communicating with other holders in the interest of business matters
relating to the ADSs and the deposit agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The depositary bank will maintain in New York facilities to record and process the issuance,
cancellation, combination, <FONT STYLE="white-space:nowrap">split-up</FONT> and transfer of ADSs. These facilities may be closed from time to time, to the extent not prohibited by law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Obligations and Liabilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The deposit
agreement limits our obligations and the depositary bank&#146;s obligations to you. Please note the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We and the depositary bank are obligated only to take the actions specifically stated in the deposit agreement
without negligence or bad faith. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The depositary bank disclaims any liability for any failure to carry out voting instructions, for any manner in
which a vote is cast or for the effect of any vote, provided it acts in good faith and in accordance with the terms of the deposit agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The depositary bank disclaims any liability for any failure to determine the lawfulness or practicality of any
action, for the content of any document forwarded to you on our behalf or for the accuracy of any translation of such a document, for the investment risks associated with investing in ordinary shares, for the validity or worth of the ordinary<B>
</B>shares, for any tax consequences that result from the ownership of ADSs, for the credit-worthiness of any third party, for allowing any rights to lapse under the terms of the deposit agreement, for the timeliness of any of our notices or for our
failure to give notice. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We and the depositary bank will not be obligated to perform any act that is inconsistent with the terms of the
deposit agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We and the depositary bank disclaim any liability if we or the depositary bank are prevented or forbidden from or
subject to any civil or criminal penalty or restraint on account of, or delayed in, doing or performing any act or thing required by the terms of the deposit agreement, by reason of any provision, present or future of any law or regulation, or by
reason of present or future provision of any provision of our Articles of Association, or any provision of or governing the securities on deposit, or by reason of any act of God or war or other circumstances beyond our control.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">269</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We and the depositary bank disclaim any liability by reason of any exercise of, or failure to exercise, any
discretion provided for in the deposit agreement or in our Articles of Association or in any provisions of or governing the securities on deposit. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We and the depositary bank further disclaim any liability for any action or inaction in reliance on the advice or
information received from legal counsel, accountants, any person presenting Shares for deposit, any holder of ADSs or authorized representatives thereof, or any other person believed by either of us in good faith to be competent to give such advice
or information. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We and the depositary bank also disclaim liability for the inability by a holder to benefit from any
distribution, offering, right or other benefit that is made available to holders of ordinary<B> </B>shares but is not, under the terms of the deposit agreement, made available to you. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We and the depositary bank may rely without any liability upon any written notice, request or other document
believed to be genuine and to have been signed or presented by the proper parties. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We and the depositary bank also disclaim liability for any consequential or punitive damages for any breach of
the terms of the deposit agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">No disclaimer of any Securities Act liability is intended by any provision of the deposit agreement.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nothing in the deposit agreement gives rise to a partnership or joint venture, or establishes a fiduciary
relationship, among us, the depositary bank and you as ADS holder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nothing in the deposit agreement precludes Citibank, N.A. (or its affiliates) from engaging in transactions in
which parties adverse to us or the holders or beneficial owners of ADS have interests, and nothing in the deposit agreement obligates Citibank, N.A. to disclose those transactions, or any information obtained in the course of those transactions, to
us or to the holders or beneficial owners of ADS, or to account for any payment received as part of those transactions. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Taxes
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be responsible for the taxes and other governmental charges payable on the ADSs and the securities represented by the ADSs. We, the
depositary bank and the custodian may deduct from any distribution the taxes and governmental charges payable by holders and may sell any and all property on deposit to pay the taxes and governmental charges payable by holders. You will be liable
for any deficiency if the sale proceeds do not cover the taxes that are due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The depositary bank may refuse to issue ADSs, to deliver, transfer, split
and combine ADRs or to release securities on deposit until all taxes and charges are paid by the applicable holder. The depositary bank and the custodian may take reasonable administrative actions to obtain tax refunds and reduced tax withholding
for any distributions on your behalf. However, you may be required to provide to the depositary bank and to the custodian proof of taxpayer status and residence and such other information as the depositary bank and the custodian may require to
fulfill legal obligations. You are required to indemnify us, the depositary bank and the custodian for any claims with respect to taxes based on any tax benefit obtained for you. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Foreign Currency Conversion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The depositary bank will
arrange for the conversion of all foreign currency received into U.S. dollars if such conversion is practical, and it will distribute the U.S. dollars in accordance with the terms of the deposit agreement. You may have to pay fees and expenses
incurred in converting foreign currency, such as fees and expenses incurred in complying with currency exchange controls and other governmental requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">270</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the conversion of foreign currency is not practical or lawful, or if any required approvals are denied or
not obtainable at a reasonable cost or within a reasonable period, the depositary bank may take the following actions in its discretion: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Convert the foreign currency to the extent practical and lawful and distribute the U.S. dollars to the holders
for whom the conversion and distribution is lawful and practical. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Distribute the foreign currency to holders for whom the distribution is lawful and practical.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Hold the foreign currency (without liability for interest) for the applicable holders. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law/Waiver of Jury Trial </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The deposit
agreement, the ADRs, and the ADSs will be interpreted in accordance with the laws of the State of New York. The rights of holders of ordinary<B> </B>shares (including<B> </B>ordinary<B> </B>shares represented by ADSs) is governed by the laws of
England and Wales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AS A PARTY TO THE DEPOSIT AGREEMENT, YOU IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, YOUR RIGHT TO TRIAL
BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF, OR RELATING TO, THE DEPOSIT AGREEMENT OR THE ADRs, OR ANYTHING CONTAINED THEREIN AGAINST US AND/OR THE DEPOSITARY. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The deposit agreement provides that, to the extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or
the depositary arising out of or relating to our ordinary shares, the ADSs or the deposit agreement, including any claim under U.S. federal securities laws. If we or the depositary opposed a jury trial demand based on the waiver, the court would
determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with applicable case law. However, you will not be deemed, by agreeing to the terms of the deposit agreement, to have waived our or the
depositary&#146;s compliance with U.S. federal securities laws and the rules and regulations promulgated thereunder. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">271</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom68105_15"></A>PART&nbsp;II </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_16"></A>ITEM&nbsp;13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_17"></A>ITEM&nbsp;14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_18"></A>ITEM&nbsp;15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CONTROLS AND PROCEDURES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_19"></A>ITEM&nbsp;16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RESERVED </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_20"></A>ITEM&nbsp;16A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>AUDIT COMMITTEE FINANCIAL EXPERT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_21"></A>ITEM&nbsp;16B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CODE OF ETHICS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_22"></A>ITEM&nbsp;16C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PRINCIPAL ACCOUNTANT FEES AND SERVICES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_23"></A>ITEM&nbsp;16D.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_24"></A>ITEM&nbsp;16E.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_25"></A>ITEM&nbsp;16F.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CHANGE IN REGISTRANT&#146;S CERTIFYING ACCOUNTANT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_26"></A>ITEM&nbsp;16G.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CORPORATE GOVERNANCE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_27"></A>ITEM&nbsp;16H.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MINE SAFETY DISCLOSURE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">272</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom68105_28"></A>PART&nbsp;III </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_29"></A>ITEM&nbsp;17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FINANCIAL STATEMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have elected to furnish financial statements and related information specified in Item 18. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_30"></A>ITEM&nbsp;18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FINANCIAL STATEMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See pages <FONT STYLE="white-space:nowrap">F-1</FONT> through <FONT STYLE="white-space:nowrap">F-112</FONT> of this registration statement.
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B><A NAME="rom68105_31"></A>ITEM&nbsp;19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXHIBITS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Exhibits listed in the Exhibit Index at the end of this annual report are filed as Exhibits to this annual report. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">273</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="89%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>EXHIBIT<BR>NUMBER</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>DESCRIPTION&nbsp;OF&nbsp;EXHIBIT</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d68105dex31.htm">Articles of Association of the Registrant </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Deposit Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of American Depositary Receipt (included in Exhibit 4.1)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Performance Share Plan</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Incentive Stock Option Deed of Agreement under the Performance Share Plan</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Form of Nonstatutory Stock Option Deed of Agreement under the Performance Share Plan</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Restricted Share Units Agreement under the Performance Share Plan</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d68105dex105.htm">Lease Agreement, dated as of August&nbsp;10, 2018, by and between the Registrant and RBK&nbsp;1&nbsp;TENANT, LLC </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.6#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Deed of Indemnity between the Registrant and each of its directors and executive officers</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.7&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d68105dex107.htm">Asset Purchase Agreement, dated July&nbsp;15, 2019, by and between Auspex Pharmaceuticals, Inc. and PureTech Health LLC </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.8&#134;*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Exclusive Patent License Agreement, dated as of July&nbsp;16, 2008, by and between PureTech Ventures LLC and Follica, Incorporated</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.9&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d68105dex109.htm">Royalty Agreement, dated as of July&nbsp;23, 2013, by and between PureTech Ventures LLC and Follica, Incorporated </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d68105dex1010.htm">Royalty and Sublicense Income Agreement, dated as of December&nbsp;18, 2009, as amended on June&nbsp;28, 2012, by and between PureTech Ventures LLC, Gelesis, Inc. and Gelesis LP </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.11&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d68105dex1011.htm">Exclusive Patent License Agreement, dated as of March&nbsp;4, 2011, as amended on February&nbsp;1, 2013 and February&nbsp;25, 2015, by and between PureTech Ventures LLC and Karuna Pharmaceuticals, Inc.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d68105dex1012.htm">Relationship Agreement, dated as of June&nbsp;18, 2015, by and between PureTech Health PLC and Invesco Asset Management Limited </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.13*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ninth Amended and Restated Registration Rights Agreement, dated December&nbsp;5, 2019, between Gelesis, Inc. and the stockholders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.14*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ninth Amended and Restated Stockholders Agreement, dated December&nbsp;5, 2019, between Gelesis, Inc. and the stockholders and executives party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.15*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Second Amended and Restated Investors&#146; Rights Agreement, dated May&nbsp;8, 2018, between Akili Interactive Labs, Inc. and the stockholders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.16*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement, dated May&nbsp;8, 2018, between Akili Interactive Labs, Inc. and the investors party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.17*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Investors&#146; Rights Agreement, dated December&nbsp;21, 2018, as amended on April&nbsp;19, 2019, May&nbsp;3, 2019 and September&nbsp;11, 2019 by and among Vedanta Biosciences, Inc. and the stockholders party
thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.18*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fifth Amended and Restated Investors&#146; Rights Agreement, dated July&nbsp;19, 2019, by and among Follica, Incorporated and the investors party thereto</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">274</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>EXHIBIT<BR>NUMBER</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>DESCRIPTION&nbsp;OF&nbsp;EXHIBIT</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.19*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fifth Amended and Restated Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement, dated July&nbsp;19, 2019, by and among Follica, Incorporated and the investors and key holders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.20*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fifth Amended and Restated Voting Agreement, dated July&nbsp;19, 2019, between Follica, Incorporated and the stockholders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.21*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Voting Agreement, dated June&nbsp;30, 2020, between Vor Biopharma Inc. and the stockholders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.22*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Investors&#146; Rights Agreement, dated June&nbsp;30, 2020, by and between Vor Biopharma Inc. and the investors party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.23*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement, dated June&nbsp;30, 2020, by and between Vor Biopharma Inc. and the investors and key holders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.24*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Voting Agreement, dated April&nbsp;9, 2019, between Sonde Health, Inc. and the stockholders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.25*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Investors&#146; Rights Agreement, dated April&nbsp;9, 2019, by and between Sonde Health, Inc. and the investors party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.26&#134;*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement, dated April&nbsp;9, 2019, by and between Sonde Health, Inc. and the investors and key holders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.27&#134;*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Voting Agreement, dated December&nbsp;18, 2017, between Entrega, Inc. and the stockholders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.28&#134;*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Investors&#146; Rights Agreement, dated December&nbsp;18, 2017, by and between Entrega, Inc. and the investors party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.29&#134;*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement, dated December&nbsp;18, 2017, by and between Entrega, Inc. and the investors and key holders party thereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.30&#134;*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Research and License Agreement, dated March&nbsp;6, 2017, as amended on April&nbsp;23, 2018, August&nbsp;6, 2018, and May&nbsp;31, 2019, between PureTech LYT, Inc. and New York University</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>21.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subsidiaries of the Registrant</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of KPMG LLP, independent registered public accounting firm</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be filed by amendment. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">#</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indicates a management contract or any compensatory plan, contract or arrangement. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Portions of this exhibit (indicated by asterisks) have been omitted in accordance with the rules of the
Securities and Exchange Commission. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">275</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registrant hereby certifies that it meets all of the requirements for filing on <FONT STYLE="white-space:nowrap">Form&nbsp;20-F</FONT> and
that it has duly caused and authorized the undersigned to sign this registration statement on its behalf. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>PURETECH HEALTH PLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Daphne Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;Title: Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">276</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="index"></A>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Financial Statements as of and for the Years Ended December&nbsp;31, 2019, 2018
and 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_1">Report of KPMG LLP, Independent Registered Public Accounting
Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_2">Consolidated Statements of Comprehensive Income/(Loss) for the Years Ended December&nbsp;31,
 2019, 2018 and 2017</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_3">Consolidated Statements of Financial Position as of December&nbsp;
31, 2019 and 2018</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_4">Consolidated Statements of Changes in Equity for the Years Ended December&nbsp;31,
 2019, 2018 and 2017</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_5">Consolidated Statements of Cash Flows for the Years Ended December&nbsp;
31, 2019, 2018 and 2017</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_6">Notes to the Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Interim Financial Statements as of and for the Six Months Ended June&nbsp;30, 2020 and
2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_7">Unaudited Condensed Consolidated Statements of Income/(Loss) and Other Comprehensive
 Income/(Loss) for the Six Months Ended June&nbsp;30, 2020 and 2019</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_8">Unaudited Condensed Consolidated Statement of Financial Position as of June&nbsp;30,
 2020 and Condensed Consolidated Statement of Financial Position as of December&nbsp;31, 2019</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_9">Unaudited Condensed Consolidated Statements of Changes in Equity for the Six Months
Ended June&nbsp;30, 2020 and 2019</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_10">Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended
 June&nbsp;30, 2020 and 2019</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_11">Notes to the Unaudited Condensed Consolidated Financial
Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin68105_12"><B>Unaudited Pro Forma Consolidated Financial Information</B></A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_1"></A>Report of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Shareholders and Board of Directors of PureTech Health plc: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Opinion on the Consolidated Financial Statements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the accompanying consolidated statements of financial position of PureTech Health plc and subsidiaries (the &#147;Group&#148;) as of
December&nbsp;31, 2019 and 2018, the related consolidated statements of comprehensive income/(loss), changes in equity, and cash flows for each of the years in the three-year period ended December&nbsp;31, 2019, and the related notes (collectively,
the &#147;consolidated financial statements&#148;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Group as of December&nbsp;31, 2019 and 2018, and the results of its
operations and its cash flows for each of the years in the three-year period ended December&nbsp;31, 2019, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis for Opinion </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These consolidated financial
statements are the responsibility of the Group&#146;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Group in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the
consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our
audits provide a reasonable basis for our opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ KPMG LLP </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Group&#146;s auditor since 2015. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KPMG LLP
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">London, United Kingdom </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">22&nbsp;September 2020 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_2"></A>Consolidated Statements of Comprehensive Income/(Loss) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended December&nbsp;31, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Note</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,688</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,371</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,119</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,377</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,885</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,807</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,748</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,535</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(59,358</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,365</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(46,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(85,848</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(77,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,672</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(135,399</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(104,019</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(115,420</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>264,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,730</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,016</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(37,863</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,615</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,334</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on impairment of intangible asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(82</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,060</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>445,582</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,287</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>121</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(278</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other income/(expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>672,167</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,154</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,364</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,362</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,358</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,458</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;contractual</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,576</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,475</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,631</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,735</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net finance income/(costs)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,147</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,917</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(80,047</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net gain/(loss) of associates accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,791</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,608</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impairment of investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(42,938</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) before taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>478,474</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(68,438</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,711</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(112,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,383</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(Loss) for the year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,659</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other comprehensive income/(loss):</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Items that are or may be reclassified as profit or loss</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">408</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total other comprehensive income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(240</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,158</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) for the year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,055</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,899</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(72,936</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,472</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(55,079</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(101,566</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,659</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Comprehensive income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,134</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,894</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,630</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(55,079</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(101,566</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,055</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,899</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(72,936</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Earnings/(loss) per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">$</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">$</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings/(loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.49</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.11</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings/(loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.44</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.11</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_3"></A>Consolidated Statements of Financial Position </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as of December&nbsp;31, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Note</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Non-current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,323</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right of use asset, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22,383</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>625</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,080</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>714,905</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,755</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments in associates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,642</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease receivable&#151;long-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,082</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>142</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">449</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>99</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>772,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">181,977</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other receivables</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,977</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,328</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,946</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,380</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease receivable&#151;short-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>350</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,&nbsp;22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,124</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,199</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,088</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133,828</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>132,360</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,051</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>168,845</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">259,786</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>941,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">441,763</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity and liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,408</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,375</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share premium</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>287,962</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">278,385</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,506</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Translation reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(18,282</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,923</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retained earnings/(accumulated deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>254,444</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(167,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity attributable to the owners of the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>668,038</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275,507</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,&nbsp;18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,640</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>650,398</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,972</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Non-current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,220</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>115,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,428</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability, non-current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>34,914</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other long-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,516</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total non-current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>151,579</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,027</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,474</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,560</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability, current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,929</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other payables</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>19,842</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,875</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Subsidiary:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16, 17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,010</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,997</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,012</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15, 16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100,989</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,519</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>515</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">788</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>139,201</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">265,764</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>290,780</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">274,791</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total equity and liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>941,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">441,763</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_4"></A>Consolidated Statements of Changes in Equity </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended December&nbsp;31, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Share Capital</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Shares</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Share<BR>premium<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Merger<BR>reserve<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Translation<BR>reserve<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Other<BR>reserve<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Retained<BR>earnings/<BR>(accumulated<BR>deficit)<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<BR>Parent<BR>equity<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Non-controlling<BR>interests<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<BR>Equity<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Balance January&nbsp;1, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,387,951</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,609</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">181,658</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,506</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(184</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,412</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(160,335</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">177,666</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85,255</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92,411</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,472</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,472</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(101,566</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Foreign currency exchange</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">408</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">408</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">408</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized gain on investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>408</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28,222</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28,630</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(101,566</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(72,936</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Gain/(loss) arising from change in non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,449</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,433</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Exercise of share-based awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,745</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Subsidiary dividends</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(91</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(91</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(91</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Buyback of shares, net of tax</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(66</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(66</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(66</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Equity settled share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,782</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,782</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,067</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,849</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balance December&nbsp;31, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>237,429,696</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,679</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>181,588</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>224</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(132,270</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>209,905</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(150,305</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>59,600</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Adjustment for the initial application of IFRS&nbsp;9</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,525</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,525</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,719</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,244</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Adjusted balance as of January&nbsp;1, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>237,429,696</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,679</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>181,588</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>224</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(124,745</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>217,430</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(145,586</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>71,844</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,659</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Foreign currency exchange</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized gain/(loss) on investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(214</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(43,680</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(43,894</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(27,005</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,899</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Deconsolidation of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">619</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">615</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,168</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,783</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of placing shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">696</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96,797</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,493</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,493</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Exercise of share-based awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,171</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Subsidiary dividends to non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Equity settled share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,749</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,749</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,888</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,637</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>As at December&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>282,493,867</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,375</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>278,385</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,923</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(167,692</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>275,507</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(108,535</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>166,972</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Adjustment for the initial application of IFRS16</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>999</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>999</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>999</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Adjusted balance as of January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>282,493,867</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,375</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>278,385</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,923</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(166,693</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>276,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(108,535</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>167,971</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">421,144</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">421,144</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,079</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">366,065</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Foreign currency exchange</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,134</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(55,079</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,055</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,178</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,178</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Subsidiary note conversion and changes in NCI ownership interest</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,049</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,418</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Share Capital</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Shares</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Share<BR>premium<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Merger<BR>reserve<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Translation<BR>reserve<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Other<BR>reserve<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Retained<BR>earnings/<BR>(accumulated<BR>deficit)<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<BR>Parent<BR>equity<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Non-controlling<BR>interests<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<BR>Equity<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Exercise of share-based awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,090</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">499</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">504</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">504</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchase of subsidiary&#146;s non-controlling interest through issuance of shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,126,338</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,078</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(33,145</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,039</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,039</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Revaluation of deferred tax assets related to share-based awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,061</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,061</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,061</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Equity settled share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,785</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,785</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,683</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,468</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Vesting of restricted stock units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">513,324</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,280</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,280</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,280</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balance December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>285,370,619</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,408</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>287,962</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(18,282</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>254,444</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>668,038</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,640</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>650,398</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-6</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_5"></A>Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended December&nbsp;31, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Note</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Cash flows from operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,659</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Adjustments to reconcile net operating loss to net cash used in operating
activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Non-cash items:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,&nbsp;12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,665</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,778</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,099</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Impairment of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">637</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Impairment of investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>42,938</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Equity settled share-based payment expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,468</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,637</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,849</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">(Gain)/loss on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,863</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,307</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(57,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">(Gain)/loss on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(843</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">219</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(264,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,730</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85,016</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Gain on loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(445,582</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,287</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conversion of debt to equity</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">349</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>140</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from sale of assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Share of net (income)/loss of associate</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(30,791</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,491</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,608</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Non-cash share of net loss for deconsolidated subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,027</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>112,077</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,257</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Subsidiary research and development tax credit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Non-cash rent expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized (gain)/loss on foreign currency transactions</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(271</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">342</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Finance costs, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>46,229</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,446</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,797</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Changes in operating assets and liabilities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>747</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">467</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,672</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(48</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,327</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(25</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">774</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">168</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Deferred revenues</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>186</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,841</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(725</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,166</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,094</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,238</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,002</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Interest received</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,648</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Interest paid</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,495</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Net cash used in operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(98,156</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(72,796</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(88,685</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Cash flows from investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchase of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(12,138</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,365</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,091</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from sale of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchases of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(400</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(80</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchase of associate preferred shares held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5, 6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(13,670</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchase of investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,556</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Sale of investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,294</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchase of convertible note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,480</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cash derecognized upon loss of control over subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(16,036</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,390</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,340</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchases of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(69,541</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(166,452</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(147,203</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Receipt of payment for finance sub-lease</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>191</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from maturity of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>173,995</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">148,062</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">249,396</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Net cash provided by/(used in) investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>63,659</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(39,645</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,682</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Cash flows from financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from issuance of convertible notes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,606</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,147</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,616</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Payment of lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,678</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Repayment of long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(185</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(163</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Distribution to Tal shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(112</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>504</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from the issuance of shares and subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>51,048</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">152,030</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,400</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Vesting of restricted stock units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,280</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Buyback of shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(66</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Distribution to shareholders on dissolution of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,062</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Subsidiary dividend payments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(91</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Net cash provided by financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>49,910</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,887</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,696</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Effect of exchange rates on cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(104</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,309</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,402</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,690</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cash and cash equivalents at beginning of year</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>117,051</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,649</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,959</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Cash and cash equivalents at end of year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>132,360</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,051</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,649</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Supplemental disclosure of non-cash investment and financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchase of non controlling interest in consideration for issuance of shares and options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,106</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchase of intangible asset and investment held at fair value in consideration for issuance of
warrant liability and assumption of other long and short-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,894</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Leasehold improvements purchased through lease incentives (deducted from Right of Use
Asset)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,680</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conversion of subsidiary convertible note into preferred share liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,894</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,306</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conversion of subsidiary convertible note into subsidiary common stock (NCI)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,418</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Supplemental disclosure of cash paid for income taxes:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cash paid for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>176</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_6"></A>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Accounting policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Description of Business
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PureTech Health plc (&#147;PureTech,&#148; the &#147;Parent&#148; or the &#147;Company&#148;) is a public company incorporated, domiciled and
registered in the United Kingdom (&#147;UK&#148;). The registered number is 09582467 and the registered address is 8th Floor, 20 Farringdon Street, London EC4A 3AE, United Kingdom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PureTech&#146;s group financial statements consolidate those of the Company and its subsidiaries (together referred to as the &#147;Group&#148;). The Parent
company financial statements present financial information about the Company as a separate entity and not about its Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accounting policies set
out below have, unless otherwise stated, been applied consistently to all periods presented in these group financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis of
Presentation </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of the Group are presented for the years ended December&nbsp;31, 2019, 2018 and 2017. The
Group financial statements have been approved by the Directors on September 21, 2020 and are prepared in accordance with the International Financial Reporting Standards, International Accounting Standards, and Interpretations (collectively
&#147;IFRS&#148;) as issued by the International Accounting Standards Board (&#147;IASB&#148;) as adopted by the European Union (adopted IFRSs). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For
presentation of the Consolidated Statements of Comprehensive Income/(Loss), the Company uses a classification based on the function of expenses, rather than based on their nature, as it is more representative of the format used for internal
reporting and management purposes and is consistent with international practice. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis of Measurement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements are prepared on the historical cost basis except that the following assets and liabilities are stated at their fair
value: investments held at fair value and financial instruments classified as fair value through the profit or loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Use of Judgments and Estimates
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In preparing these consolidated financial statements, management has made judgements, estimates and assumptions that affect the application of the
Group&#146;s accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an on-going basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Significant estimation applied in determining the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Financial instruments valuations (Note 21): when estimating the fair value of subsidiary undertakings, subsidiary
preferred shares and investments carried at fair value through profit and loss (FVTPL) according to IFRS 9 at initial recognition and upon subsequent measurement. This includes determining the appropriate valuation methodology and making certain
estimates of the future earnings potential of the subsidiary businesses, appropriate discount rate and earnings multiple to be applied, marketability and other industry and company specific risk factors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Revenue recognition (Note 3): when estimating the costs to complete for overtime revenue recognition. This
includes making certain estimates of costs to be incurred relating to contracts with customers in </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-8</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
meeting the overtime performance obligation. The costs are for research and development activity and the estimation uncertainty is regarding the level of activity required to meet the performance
obligation and the timing in which that arises during the term of the contract. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Significant judgement is also applied in determining
the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Revenue recognition (Note 3): when determining the correct amount of revenue to be recognized. This includes
making certain judgements when determining the appropriate accounting treatment of key customer contract terms in accordance with the applicable accounting standards. In particular, judgement is required to determine the performance obligations in a
contract (if promised goods and services are distinct or not) and timing of revenue recognition (on delivery or over a period of time). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Subsidiary preferred shares liability classification (Note 21): when determining the classification of financial
instruments in terms of liability or equity. These judgements include an assessment of whether the financial instrument include any embedded derivative features, whether they include contractual obligations upon the Group to deliver cash or other
financial assets or to exchange financial assets or financial liabilities with another party, and whether that obligation will be settled by the Company exchanging a fixed amount of cash or other financial assets for a fixed number of its own equity
instruments. Further information about these critical judgements and estimates is included below under Financial Instruments. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">When the power to control the subsidiaries exists (please refer to Notes 5 and 6 and accounting policy below
Subsidiaries). This judgement includes an assessment of whether the Company has i) power over the investee; (ii)&nbsp;exposure, or rights, to variable returns from its involvement with the investee; and (iii)&nbsp;the ability to use its power over
the investee to affect the amount of the investor&#146;s returns. The Company considers among others its voting shares, representation on the board, rights to appoint management, investee dependence on the Company etc. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Whether the Company has significant influence over financial and operating policies of investees in order to
determine if the Company should account for its investment as an associate based on IAS 28 or based on IFRS 9, Financial Instruments (please refer to Note 5). This judgement includes, among others, an assessment whether the Company has
representation on the board of directors of the investee, whether the Company participates in the policy making processes of the investee, whether there is any interchange of managerial personnel, whether there is any essential technical information
provided to the investee and if there are any transactions between the Company and the investee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Upon determining that the Company does have significant influence over the financial and operating policies of an
investee, if the Company holds more than a single instrument issued by its equity-accounted investee, judgement is required to determine whether the additional instrument forms part of the investment in the associate, which is accounted for under
IAS 28 and scoped out of IFRS 9, or it is a separate financial instrument that falls in the scope of IFRS 9 (please refer to Notes 5 and 6). This judgement includes an assessment of the characteristics of the financial instrument of the investee
held by the Company and whether such financial instrument provides access to returns underlying an ownership interest. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Going
Concern </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After making inquiries and considering the impact of risks and opportunities on expected cash flows and based on the cash and cash
equivalents available to the Group as of December&nbsp;31, 2019, the Directors have a reasonable expectation that the Group had adequate cash to continue in operational existence into the first quarter of 2022 and, following the sale of 2,100,000
shares of Karuna common shares worth $200.9&nbsp;million on January&nbsp;22, 2020, the Group now has sufficient cash reserves to fund its operations into the first quarter of 2024, assuming broadly our expected level of required investments in
businesses and other operating expenditures. The financial statements have been prepared using the going concern basis of accounting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-9</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis of Consolidation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial information for each of the years ended December&nbsp;31, 2019, 2018 and 2017 comprises an aggregation of financial information of
the Company and the consolidated financial information of PureTech Health LLC (&#147;PureTech LLC&#148;). Intra-group balances and transactions, and any unrealized income and expenses arising from intra-group transactions, are eliminated. Unrealized
gains arising from transactions with equity-accounted investees are eliminated against the investment to the extent of the Group&#146;s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the
extent that there is no evidence of impairment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Subsidiaries </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in these financial statements, the term subsidiaries refers to entities that are controlled by the Group. Financial results of subsidiaries of the
Group as of December&nbsp;31, 2019 are reported within the Internal segment, Controlled Founded Entities segment or the Parent Company and Other segment (please refer to Note 4). Under applicable accounting rules, the Group controls an entity when
it is exposed to, or has the rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. In assessing control, the Group takes into consideration potential voting
rights and board interest and holding. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. Losses applicable to the non-controlling
interests in a subsidiary are allocated to the non-controlling interests even if doing so causes the non-controlling interests to have a deficit balance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-10</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A list of all current and former subsidiaries organized with respect to classification as of
December&nbsp;31, 2019 and the Group&#146;s total voting percentage, based on outstanding voting common and preferred shares as of December&nbsp;31, 2019, 2018 and 2017, is outlined below. All subsidiaries are domiciled within the United States and
conduct business activities solely within the United States, with the exception of Gelesis, S.r.l. which is domiciled in Italy. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center"><B>Voting percentage at December&nbsp;31, through the holdings in</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Common</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Preferred</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Common</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Preferred</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Subsidiary operating companies</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alivio Therapeutics, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>91.9</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92.0</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Calix Biosciences, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 2,10</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega, Inc. (indirectly held through Enlight)<SUP STYLE="font-size:85%; vertical-align:top">
1,2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>83.1</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83.1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83.1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica, Incorporated<SUP STYLE="font-size:85%; vertical-align:top"> 1,2,5</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>56.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.4</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79.2</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.4</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68.3</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Glyph Biosciences, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2,10</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97.3</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nybo Therapeutics, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2,10</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94.7</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech LYT (formerly Ariya Therapeutics, Inc.)<SUP STYLE="font-size:85%; vertical-align:top">
10</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech LYT-100</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech Management, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 3</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech Health LLC<SUP STYLE="font-size:85%; vertical-align:top"> 3</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde Health, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>64.1</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.4</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.4</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta Biosciences, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>61.8</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85.9</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta Biosciences Securities Corp. (indirectly held through Vedanta)<SUP
STYLE="font-size:85%; vertical-align:top"> 1,2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>61.8</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85.9</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Deconsolidated former subsidiary operating companies</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Akili Interactive Labs, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2,9</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>41.9</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.9</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61.8</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Akili Securities Corp. (indirectly held through Akili)<SUP
STYLE="font-size:85%; vertical-align:top"> 1,2,9</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>41.9</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.9</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61.8</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2,11</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20.2</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.4</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.7</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis, S.r.l. (indirectly held through Gelesis)<SUP STYLE="font-size:85%; vertical-align:top">
7,11</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20.2</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.4</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.7</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis, LLC (indirectly held through Gelesis)<SUP STYLE="font-size:85%; vertical-align:top">
1,8,11</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20.2</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.4</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.7</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis 2012, Inc. (held indirectly through
Gelesis)<SUP STYLE="font-size:85%; vertical-align:top"> 2,11</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20.2</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.4</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.7</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karuna Pharmaceuticals, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2,13</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28.4</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90.7</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vor Biopharma Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2,14</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>47.5</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93.2</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94.1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Nontrading holding companies</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Endra Holdings, LLC (held indirectly through
Enlight)<SUP STYLE="font-size:85%; vertical-align:top"> 2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>86.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ensof Holdings, LLC (held indirectly through
Enlight)<SUP STYLE="font-size:85%; vertical-align:top"> 2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>86.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech Securities Corp.<SUP STYLE="font-size:85%; vertical-align:top"> 2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Inactive subsidiaries</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Appeering, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commense Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 2,6</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>99.1</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99.1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enlight Biosciences, LLC<SUP STYLE="font-size:85%; vertical-align:top"> 2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>86.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ensof Biosystems, Inc. (held indirectly through Enlight)<SUP
STYLE="font-size:85%; vertical-align:top">&nbsp;1,2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>57.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57.7</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57.7</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.3</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Knode Inc. (indirectly held through Enlight)<SUP STYLE="font-size:85%; vertical-align:top">
2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>86.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86.0</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Libra Biosciences, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mandara Sciences, LLC<SUP STYLE="font-size:85%; vertical-align:top"> 2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>98.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98.3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Sync Project, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> 1,2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77.6</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tal Medical, Inc.<SUP STYLE="font-size:85%; vertical-align:top">&nbsp;1,2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64.5</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64.5</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The ownership percentage includes liability classified preferred shares, which results in the ownership
percentage not being the same as the ownership percentage used in allocations to non-controlling interests disclosed in Note 16. The allocation of losses/profits to the noncontrolling interest is based on the holdings
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-11</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
of subordinated stock that provide ownership rights in the subsidiaries. The ownership of liability classified preferred shares are quantified in Note 15. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Registered address is Corporation Trust Center, 1209 Orange St., Wilmington, DE 19801, USA.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Registered address is 2711 Centerville Rd., Suite 400, Wilmington, DE 19808, USA. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">4.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s interests in its subsidiaries are predominantly in the form of preferred shares, which have
a liquidation preference over the common stock, are convertible into common stock at the holder&#146;s discretion or upon certain liquidity events, are entitled to one vote per share on all matters submitted to shareholders for a vote and entitled
to receive dividends when and if declared, except in the case of Enlight, Mandara and PureTech Health LLC in which the holdings are membership interests in an LLC. The holders of common stock are entitled to one vote per share on all matters
submitted to shareholders for a vote and entitled to receive dividends when and if declared. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">5.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On July&nbsp;19, 2019, all of the outstanding notes, plus accrued interest, issued by Follica to PureTech
converted into 15,216,214 shares of Series A-3 Preferred Shares and 12,777,287 shares of common share pursuant to a Series A-3 Note Conversion Agreement between Follica and the noteholders. Please refer to Note 16. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">6.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Commense turned inactive during 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">7.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Registered address is Via Verde 188, 73021 Calmera (LE), Italy. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">8.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Registered address is 901 N. Market St., Suite 705, Wilmington, DE 19801, USA. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">9.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On May&nbsp;8, 2018, PureTech lost control of Akili, Akili was deconsolidated from the Group&#146;s financial
statements and is no longer considered a subsidiary. This results in only the profits and losses generated by Akili through the deconsolidation date being included in the Group&#146;s Consolidated Statement of Income/(Loss) and Other Comprehensive
Income/(Loss). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">10.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On July&nbsp;18, 2018, Calix Biopharma, Inc., Glyph Biosciences, Inc., and Nybo Therapeutics, Inc. merged into
Ariya Therapeutics, Inc. Thus, the Group no longer holds interest in Calix, Glyph and Nybo and owns 100&nbsp;per cent of Ariya as of December&nbsp;31, 2018. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">11.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2018, PureTech maintained control of Gelesis. On July&nbsp;1, 2019 PureTech lost
control of Gelesis and Gelesis was deconsolidated from the Group&#146;s financial statements, resulting in only the profits and losses generated by Gelesis through the deconsolidation date being included in the Group&#146;s Consolidated Statement of
Income/(Loss) and Other Comprehensive Income/(Loss). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">12.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All subsidiaries are registered in the United States (&#147;US&#148;) except for Gelesis, S.r.l., which is
registered in Italy. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">13.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On March&nbsp;15, 2019, PureTech lost control of Karuna, Karuna was deconsolidated from the Group&#146;s
financial statements and is no longer considered a subsidiary. This results in only the profits and losses generated by Karuna through the deconsolidation date being included in the Group&#146;s Consolidated Statement of Income/(Loss) and Other
Comprehensive Income/(Loss). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">14.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On February&nbsp;12, 2019, PureTech lost control of Vor, Vor was deconsolidated from the Group&#146;s financial
statements and is no longer considered a subsidiary. This results in only the profits and losses generated by Vor through the deconsolidation date being included in the Group&#146;s Consolidated Statement of Income/(Loss) and Other Comprehensive
Income/(Loss). </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change in subsidiary ownership and loss of control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in the Group&#146;s interest in a subsidiary that do not result in a loss of control are accounted for as equity transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where the Group loses control of a subsidiary, the assets and liabilities are derecognized along with any related non-controlling interest (&#147;NCI&#148;).
Any interest retained in the former subsidiary is measured at fair value when control is lost. Any resulting gain or loss is recognized as profit or loss in the Consolidated Statements of Comprehensive Income/(Loss). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Associates </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in these financial statements,
the term associates are those entities in which the Group has no control but maintains significant influence over the financial and operating policies. Significant influence is presumed to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-12</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exist when the Group holds between 20 and 50 percent of the voting power of an entity, unless it can be clearly demonstrated that this is not the case. The Group evaluates if it maintains
significant influence over associates by assessing if the Group has lost the power to participate in the financial and operating policy decisions of the associate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Application of the equity method to associates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Associates are accounted for using the equity method (equity accounted investees) and are initially recognized at cost, or if recognized upon deconsolidation
they are initially recorded at fair value at the date of deconsolidation. The consolidated financial statements include the Group&#146;s share of the total comprehensive income and equity movements of equity accounted investees, from the date that
significant influence commences until the date that significant influence ceases. When the Group&#146;s share of losses exceeds its investment in an equity accounted investee, including the Group&#146;s investments in other long-term interests, the
Group&#146;s carrying amount is reduced to nil and recognition of further losses is discontinued except to the extent that the Group has incurred legal or constructive obligations or made payments on behalf of an investee. To the extent the Group
holds interests in associates that are not providing access to returns underlying ownership interests and are more akin to debt like securities, the instrument held by PureTech is accounted for in accordance with IFRS 9. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change in Accounting Policy </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of January&nbsp;1,
2019, the Group has adopted new accounting policies for the accounting for leases. See updated accounting policy for leases (IFRS 16) below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group
has also adopted the amendments to IAS 28 Investments in Associates that addresses the dual application of IAS 28 and IFRS 9 (see below) when equity method losses are applied against Long-Term Investments (LTI), as defined in IAS 28. The amendments
provide the annual sequence in which both standards are to be applied in such a case. The amendment did not have an impact on the Group&#146;s financial statements as the Group has not yet had an investment in an associate where it applied the
equity method losses against a LTI. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of January&nbsp;1, 2018 the Group has adopted new accounting policies for financial instruments and revenue. See
updated accounting policies below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>IFRS 9, Financial Instruments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of January&nbsp;1, 2018, the Company adopted IFRS 9, Financial Instruments (&#147;IFRS 9&#148;), which replaced IAS 39, Financial Instruments: Recognition
and Measurement. IFRS 9 addresses the classification, measurement and recognition of financial assets and liabilities. IFRS 9 retains but simplifies the mixed measurement model and establishes three primary measurement categories for financial
assets: amortized cost, fair value through other comprehensive income (&#147;FVOCI&#148;), and fair value through the profit and loss statement (&#147;FVTPL&#148;). The basis of classification depends on the entity&#146;s business model and the
contractual cash flow characteristics of the entity&#146;s business model and of the financial asset. Investments in equity instruments are required to be measured at FVTPL with the irrevocable option at inception to present changes in fair value in
other comprehensive income. There is now a new expected credit losses model that replaces the incurred loss impairment model previously used in IAS 39. For financial liabilities there were no changes to classification and measurement except for the
recognition of changes in the Company&#146;s own credit risk in Other Comprehensive Income/(Loss) for liabilities designated at FVTPL. IFRS 9 relaxes the requirements for hedge effectiveness by replacing the bright line hedge effectiveness tests. It
requires an economic relationship between the hedged item and hedging instrument and for the hedged ratio to be the same as the one management uses for risk management purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contemporaneous documentation is still required but is different than what was prepared under IAS 39. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group reviewed the financial liabilities reported on its Consolidated Statements of Financial Position and completed an assessment between IAS 39 and IFRS
9 to identify any accounting changes. The financial liabilities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-13</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subject to this review were the Subsidiary notes payable, Derivative liability, Warrant liability, and Preferred share liability. Based on this assessment of the classification and measurement
model, impairment and interest income, the accounting impact on financial liabilities was determined not to be material. As part of the transition requirement, entities have the option upon implementation of the new standard to designate a financial
liability as measured at FVTPL. The Group re-assessed its financial liabilities and has elected not to split out embedded derivatives and retrospectively recorded changes in fair value of the entire financial liability instrument through the
statement of profit and loss, leading to changes in the carrying value of the instruments when looked at in the aggregate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group also reviewed the
financial assets reported on its Consolidated Statements of Financial Position and notes no changes in the application of IFRS 9. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group has applied
IFRS 9 retrospectively but has elected not to restate comparative information. As a result, the comparative information provided continues to be accounted for in accordance with the Group&#146;s previous accounting policy. The reclassification and
adjustment arising from the adoption of the new accounting policy has been recognized in the opening statement of financial position as of January&nbsp;1, 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Financial Liability</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>IAS&nbsp;39&nbsp;as&nbsp;of&nbsp;December&nbsp;31,<BR>2017</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cumulative&nbsp;Effect<BR>Adjustment to<BR>Accumulated&nbsp;Deficit</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>IFRS&nbsp;9&nbsp;As&nbsp;of&nbsp;January&nbsp;1,<BR>2018</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,455</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,435</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,890</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Derivative liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,263</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(114,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,095</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,095</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,051</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,584</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">215,635</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>254,864</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(12,244</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>242,620</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accounting policy (effective from January&nbsp;1, 2018) is as follows:</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Financial Instruments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Classification </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From January&nbsp;1, 2018, the Group classifies its financial assets in the following measurement categories: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Those to be measured subsequently at fair value (either through other comprehensive income, or through profit or
loss), and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Those to be measured at amortized cost. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The classification depends on the Group&#146;s business model for managing the financial assets and the contractual terms of the cash flows. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For assets measured at fair value, gains and losses will either be recorded in profit or loss or other comprehensive income. For investments in debt
instruments, this will depend on the business model in which the investment is held. For investments in equity instruments that are not held for trading, this will depend on whether the Group has made an irrevocable election at the time of initial
recognition to account for the equity investment at FVOCI. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Measurement </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At initial recognition, the Group measures a financial asset at its fair value plus, in the case of a financial asset not at FVTPL, transaction costs that are
directly attributable to the acquisition of the financial asset. Transaction costs of financial assets that are carried at FVTPL are expensed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-14</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Impairment </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group assesses on a forward-looking basis the expected credit losses associated with its debt instruments carried at amortized cost and FVOCI. The
impairment methodology applied depends on whether there has been a significant increase in credit risk. For trade receivables, the Group applies the simplified approach permitted by IFRS 9, which requires expected lifetime losses to be recognized
from initial recognition of the receivables. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group has reviewed the financial assets and liabilities and determined the following impact from the
adoption of the new standard: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Financial Assets </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Group&#146;s financial assets consist of cash and cash equivalents, trade and other receivables, debt and equity securities, other deposits and investments in associates&#146; preferred shares and promissory notes. The Group&#146;s financial assets
are classified into the following categories: investments held at fair value, trade and other receivables and cash and cash equivalents. The Group determines the classification of financial assets at initial recognition depending on the purpose for
which the financial assets were acquired. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investments held at fair value are non-derivative instruments that are designated in this category or not
classified in any other category. These financial assets are initially measured at fair value and subsequently re-measured at fair value at each reporting date. The Company elects if the gain or loss will be recognized in Other Comprehensive
Income/(Loss) or through profit and loss on an instrument by instrument basis. Financial assets that are recognized through FVOCI are presented in the Consolidated Statements of Financial Position as non-current assets, unless the Group intends to
dispose of them within 12 months after the end of the reporting period. The Company has elected to record the changes in fair values for most financial assets falling under this category through profit and loss. Please refer to Note 5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trade and other receivables are non-derivative financial assets with fixed and determinable payments that are not quoted on active markets. These financial
assets are carried at the amounts expected to be received less any allowance for doubtful debts. Provisions are made where there is evidence of a risk of nonpayment, taking into account aging, previous experience and economic conditions. When a
trade receivable is determined to be uncollectible, it is written off against the available provision and then to the Consolidated Statements of Comprehensive Income/(Loss). Trade and other receivables are included in current assets, unless
maturities are greater than 12 months after the end of the reporting period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Financial Liabilities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group&#146;s financial liabilities consist of trade and other payables, subsidiary notes payable, preferred shares, and warrant liability. Warrant
liabilities are initially recognized at fair value. After initial recognition, these financial liabilities are re-measured at FVTPL using an appropriate valuation technique. Subsidiary notes payable and subsidiary preferred shares without embedded
derivatives are accounted for at amortized cost. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The majority of the Group&#146;s subsidiaries have preferred shares and notes payable with embedded
derivatives, which are classified as current liabilities. These financial instruments are assessed under IFRS 9 to determine if the instrument qualifies to be accounted for under the FVTPL method. When the Group has preferred shares with embedded
derivatives that qualify for bifurcation, the Group has elected to account for the entire instrument as FVTPL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group derecognizes a financial
liability when its contractual obligations are discharged, cancelled or expire. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-15</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity Instruments Issued by the Group </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments issued by the Group are treated as equity only to the extent that they meet the following two conditions, in accordance with IAS 32: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">They include no contractual obligations upon the Group to deliver cash or other financial assets or to exchange
financial assets or financial liabilities with another party under conditions that are potentially unfavorable to the Group; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where the instrument will or may be settled in the Group&#146;s own equity instruments, it is either a
non-derivative that includes no obligation to deliver a variable number of the Group&#146;s own equity instruments or is a derivative that will be settled by the Group exchanging a fixed amount of cash or other financial assets for a fixed number of
its own equity instruments. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that this definition is not met, the financial instrument is classified as a financial
liability. Where the instrument so classified takes the legal form of the Group&#146;s own shares, the amounts presented in the financial information for share capital and merger reserve account exclude amounts in relation to those shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group subsequently measures all equity investments at fair value. Where the Group&#146;s management has elected to present fair value gains and losses on
equity investments in other comprehensive income, there is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment. Dividends from such investments continue to be recognized in
profit or loss as other income when the Group&#146;s right to receive payment is established. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in the fair value of financial assets at FVTPL are
recognized in other income/(expense) in the Consolidated Statements of Comprehensive Income/(Loss) as applicable. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other
changes in fair value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>IFRS 15, Revenue from Contracts with Customers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IFRS 15 establishes principles for reporting useful information to users of financial statements about the nature, amount, timing and uncertainty of revenue
and cash flows arising from an entity&#146;s contracts with customers. The standard establishes a five-step principle-based approach for revenue recognition and is based on the concept of recognizing an amount that reflects the consideration for
performance obligations only when they are satisfied and the control of goods or services is transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The majority of the Group&#146;s contract
revenue is generated from licenses, services, and collaboration arrangements. The Group adopted IFRS 15 with effect from January&nbsp;1, 2018 using the Modified Retrospective approach. The adoption of this standard did not have an impact to the
consolidated results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management reviewed contracts where the Group received consideration in order to determine whether or not they should be accounted
for in accordance with IFRS 15. To date, PureTech has entered into transactions that generate revenue and meet the scope of either IFRS 15 or IAS 20 Accounting for Government Grants. Contract revenue is recognized at either a point-in-time or over
time, depending on the nature of the services and existence of acceptance clauses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue generated by collaboration and service agreements is accounted
for under IFRS 15. The Group accounts for agreements that meet the definition of IFRS 15 by applying the following five step model: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Identify the contract(s) with a customer&#151;A contract with a customer exists when (i)&nbsp;the Group enters
into an enforceable contract with a customer that defines each party&#146;s rights regarding the goods or services to be transferred and identifies the payment terms related to those goods or services, (ii)&nbsp;the contract has commercial substance
and, (iii)&nbsp;the Group determines that collection of substantially all consideration for goods or services that are transferred is probable based on the customer&#146;s intent and ability to pay the promised consideration. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Identify the performance obligations in the contract&#151;Performance obligations promised in a contract are
identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the good or service either on its own or together with other resources that are readily
available from third parties or from the Group, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Determine the transaction price&#151;The transaction price is determined based on the consideration to which the
Group will be entitled in exchange for transferring goods or services to the customer. To the extent the transaction price includes variable consideration, the Group estimates the amount of variable consideration that should be included in the
transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Group&#146;s judgement, it is
probable that a significant future reversal of cumulative revenue under the contract will not occur. Determining the transaction price requires significant judgement, which is discussed by revenue category in further detail below.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Allocate the transaction price to the performance obligations in the contract&#151;If the contract contains a
single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation
based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct good or service that forms part of a single performance
obligation. The Group determines standalone selling price based on the price at which the performance obligation is sold separately. If the standalone selling price is not observable through past transactions, the Group estimates the standalone
selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Recognize revenue when (or as) the Group satisfies a performance obligation&#151;The Group satisfies performance
obligations either over time or at a point in time as discussed in further detail below. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised good or service to a customer.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue generated from services agreements (typically where licenses and related services were combined into one performance
obligation) is determined to be recognized over time when it can be determined that the services meet one of the following: (a)&nbsp;the customer simultaneously receives and consumes the benefits provided by the entity&#146;s performance as the
entity performs; (b)&nbsp;the entity&#146;s performance creates or enhances an asset that the customer controls as the asset is created or enhanced; or (c)&nbsp;the entity&#146;s performance does not create an asset with an alternative use to the
entity and the entity has an enforceable right to payment for performance completed to date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It was determined that the Group has contracts that meet
criteria (a), since the customer simultaneously receives and consumes the benefits provided by the Company&#146;s performance as the Company performs as well as one contract that meets criteria (b)&nbsp;above. Therefore revenue is recognized over
time using the input method based on labor hours, laboratory expenses and supplies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For cases where the entity does not have an enforceable right to
payment due to acceptance clauses, it was determined that costs incurred to fulfill the services are to be capitalized until acceptance is received for the milestone. This resulted in PureTech capitalizing service-related expenses as of
December&nbsp;31, 2017 and recognizing the consideration as revenue once acceptance was received during 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Grant Income </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes grants from governmental agencies as grant income in the Consolidated Statement of Comprehensive Income/(Loss), gross of the
expenditures that were related to obtaining the grant, when there is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-17</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reasonable assurance that the Company will comply with the conditions within the grant agreement and there is reasonable assurance that payments under the grants will be received. The Company
evaluates the conditions of each grant as of each reporting date to ensure that the Company has reasonable assurance of meeting the conditions of each grant arrangement and it is expected that the grant payment will be received as a result of
meeting the necessary conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company submits qualifying expenses for reimbursement for certain expenses after the Company has incurred the
research and development expense. The Company records an unbilled receivable upon incurring such expenses. Grant income is recognized in the Consolidated Statements of Comprehensive Income/(Loss) over the periods in which the Company recognizes the
related reimbursable expense for which the grant is intended to compensate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Functional and Presentation Currency </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These consolidated financial statements are presented in United States dollars (&#147;US dollars&#148;). The functional currency of virtually all members of
the Group is the US dollar. The assets and liabilities of a previously held subsidiary were translated to US dollars at the exchange rate prevailing on the balance sheet date and revenues and expenses were translated at the average exchange rate for
the period. Foreign exchange differences resulting from the translation of this subsidiary were reported in the Consolidated Statements of Comprehensive Income/(Loss) in Other Comprehensive Income/(Loss). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Foreign Currency </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transactions in foreign
currencies are translated to the respective functional currencies of Group entities at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are
retranslated to the functional currency at the foreign exchange rate ruling at that date. Foreign exchange differences arising on remeasurement are recognized in the Consolidated Statement of Comprehensive Income/(Loss) except for differences
arising on the retranslation of a financial liability designated as a hedge of the net investment in a foreign operation that is effective, or qualifying cash flow hedges, which are recognized directly in other comprehensive income. Non-monetary
assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated
at fair value are retranslated to the functional currency at foreign exchange rates ruling at the dates the fair value was determined. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash and
Cash Equivalents </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents include all highly liquid instruments with original maturities of three months or less. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Share Capital </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ordinary shares are classified as
equity. The Group is comprised of share capital, share premium, merger reserve, other reserve, translation reserve, and accumulated deficit. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Property and Equipment </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment is
stated at cost less accumulated depreciation and any accumulated impairment losses. Cost includes expenditures that are directly attributable to the acquisition of the asset. Assets under construction represent leasehold improvements and machinery
and equipment to be used in operations or research and development activities. When parts of an item of property and equipment have different useful lives, they are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-18</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accounted for as separate items (major components) of property and equipment. Depreciation is calculated using the straight-line method over the estimated useful life of the related asset: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="55%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory and manufacturing equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2&nbsp;-&nbsp;8 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment and software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">1&nbsp;-&nbsp;5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5&nbsp;-&nbsp;10 years, or the remaining term of the lease, if shorter</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intangible Assets </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intangible assets, which
include purchased patents and licenses with finite useful lives, are carried at historical cost less accumulated amortization, if amortization has commenced, and impairment losses. Intangible assets with finite lives are amortized from the time they
are available for use. Amortization is calculated using the straight-line method to allocate the costs of patents and licenses over their estimated useful lives, which is typically the remaining life of the underlying patents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development intangible assets, which are still under development and have accordingly not yet obtained marketing approval, are presented as
In-Process Research and Development (IPR&amp;D). IPR&amp;D is not amortized since it is not yet available for its intended use, but it is evaluated for potential impairment on an annual basis or more frequently when facts and circumstances warrant.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Impairment </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Impairment of Non-Financial
Assets </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group reviews the carrying amounts of its property and equipment and intangible assets at each reporting date to determine whether there
are indicators of impairment. If any such indicators of impairment exist, then an asset&#146;s recoverable amount is estimated. The recoverable amount is the higher of an asset&#146;s fair value less cost of disposal and value in use. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s IPR&amp;D intangible assets are not yet available for their intended use. As such, they are to be tested for impairment at least annually.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An impairment loss is recognized when an asset&#146;s carrying amount exceeds its recoverable amount. For the purposes of impairment testing, assets are
grouped at the lowest levels for which there are largely independent cash flows. If a non- financial asset instrument is impaired, an impairment loss is recognized in the Consolidated Statements of Comprehensive Income/(Loss). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investments in associates are considered impaired if, and only if, objective evidence indicates that one or more events, which occurred after the initial
recognition, have had an impact on the future cash flows from the net investment and that impact can be reliably estimated. If an impairment exists the Company measures an impairment by comparing the carrying value of the net investment in the
associate to its recoverable amount and recording any excess as an impairment loss. See Note 6 for impairment recorded in respect of investment in associate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Impairment of Financial Assets Carried at Fair Value </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Group&#146;s financial assets are carried at fair value through Other Comprehensive Income/(Loss) or through profit and loss, depending on the election taken for each instrument. Financial assets that carried at fair value through Other
Comprehensive Income/(Loss) are reviewed at each reporting period to assess whether there is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-19</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
objective evidence that the assets should be impaired. An impairment loss is recognized when there is a significant or prolonged decline in fair value below the instrument&#146;s cost. If an
instrument is impaired, the impairment loss is calculated and recognized in the Consolidated Statements of Comprehensive Income/(Loss). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Impairment of
Financial Assets Measured at Amortized Cost </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group assesses financial assets measured at amortized cost for impairment at each reporting period.
These financial assets are impaired if one or more loss events occur after initial recognition that impact the estimated future cash flows of the asset. An impairment loss is calculated as the difference between its carrying amount and the present
value of the estimated future cash flows discounted at the asset&#146;s original effective interest rate and is recognized in the Consolidated Statements of Comprehensive Income/(Loss). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Employee Benefits </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Short-Term Employee
Benefits </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Short-term employee benefit obligations are measured on an undiscounted basis and expensed as the related service is provided. A
liability is recognized for the amount expected to be paid if the Group has a present legal or constructive obligation due to past service provided by the employee, and the obligation can be estimated reliably. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Defined Contribution Plans </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A defined contribution
plan is a post-employment benefit plan under which an entity pays fixed contributions into a separate entity and has no legal or constructive obligation to pay further amounts. Obligations for contributions to defined contribution plans are
recognized as an employee benefit expense in the periods during which related services are rendered by employees. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in future payments is available. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Share-based Payments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share-based payment
arrangements, in which the Group receives goods or services as consideration for its own equity instruments, are accounted for as equity-settled share-based payment transactions in accordance with IFRS 2, regardless of how the equity instruments are
obtained by the Group. The grant date fair value of employee share-based payment awards is recognized as an expense with a corresponding increase in equity over the period that the employee is unconditionally entitled to the awards. The fair value
is measured using an option pricing model, which takes into account the terms and conditions of the options granted. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and non-market
vesting conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date. For share-based payment
awards with non-vesting and non-market performance conditions, the grant date fair value is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Development Costs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Expenditures on research
activities are recognized as incurred in the Consolidated Statements of Comprehensive Income/ (Loss). In accordance with IAS 38 development costs are capitalized only if the expenditure can be measured reliably, the product or process is technically
and commercially feasible, future economic benefits are probable, the Group intends to and has sufficient resources to complete development and to use or sell the asset, and it is able to measure reliably the expenditure attributable to the
intangible asset during its development. The point at which technical feasibility is determined to have been reached is when regulatory approval has been </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-20</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
received where applicable. Management determines that commercial viability has been reached when a clear market and pricing point have been identified, which may coincide with achieving recurring
sales. Otherwise, the development expenditure is recognized as incurred in the Consolidated Statements of Comprehensive Income/(Loss). As of balance sheet date the Group has not capitalized any development costs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provisions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A provision is recognized in the
Consolidated Statements of Financial Position when the Group has a present legal or constructive obligation due to a past event that can be reliably measured, and it is probable that an outflow of economic benefits will be required to settle the
obligation. Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects risks specific to the liability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Leases </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;1, 2019, the Group adopted
a new accounting standard for leases. The Group leases real estate and equipment for use in operations. These leases generally have lease terms of 1 to 10 years. We include options that are reasonably certain to be exercised as part of the
determination of the lease term. We determine if an arrangement is a lease at inception of the contract in accordance with guidance detailed in the new standard and we perform the lease classification test as of the lease commencement date. ROU
assets represent the Group&#146;s right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at
commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use the Group&#146;s estimated incremental borrowing rate based on information available at commencement
date in determining the present value of future payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group&#146;s operating leases impacted by IFRS 16 principally include leases from real
estate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Existing finance leases continue to be treated as finance leases. For existing operating leases, the Group has applied a modified retrospective
approach by measuring the right-of-use asset at an amount equal to the lease liability at the date of transition and therefore comparative information was not restated. Upon transition, the Group has applied the following practical expedients: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">excluding initial direct costs from the right-of-use assets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">using hindsight when assessing the lease term; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not reassessing whether a contract is or contains a lease; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not separating the lease components from the non-lease components in lease contracts. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group has elected to account for lease payments as an expense on a straight-line basis over the life of the lease for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Leases with a term of 12 months or less and containing no purchase options; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Leases where the underlying asset has a value of less than $5,000. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The lease liability was initially measured at the present value of the lease payments that were not paid at the transition date, discounted by using the rate
implicit in the lease, or if that rate was not readily determinable, the Group used its incremental borrowing rate. The right-of-use asset is depreciated on a straight-line basis and the lease liability will give rise to an interest charge. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-21</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial impact of adopting IFRS 16 on the Group was as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;1,&nbsp;2019<BR>$000&#146;s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right of use asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,353</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,995</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(999</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The cumulative impact resulted mainly from lease term extensions under IFRS 16 offset by the exclusion of short term leases
and leases of low value assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January and April 2019, the Company entered into additional leases that added substantially more right of use assets
and lease liabilities to the statement of financial position. This includes three different spaces for the Company and its consolidated subsidiaries, amounting to approximately $42 million of additional future lease commitments. In June and August
2019, the Company entered into two sublease agreements. Further information regarding the subleases, right of use asset and lease liability can be found in Note 20. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Finance Income and Finance Costs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finance income
is comprised of interest income on funds invested in US treasuries, which is recognized as it accrues in the Consolidated Statements of Comprehensive Income/(Loss) via the effective interest method. Finance costs comprise loan interest expenses and
the changes in the fair value of warrant and derivative liabilities associated with financing transactions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Taxation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tax on the profit or loss for the year comprises current and deferred income tax. In accordance with IAS 12, tax is recognized in the Consolidated Statements
of Comprehensive Income/(Loss) except to the extent that it relates to items recognized directly in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2019
and 2018, the Group filed a consolidated US income tax return which included all subsidiaries in which the Company owned greater than 80.0 percent of the vote and value. For the years ended December&nbsp;31, 2019 and 2018, the Group filed certain
consolidated state income tax returns which included all subsidiaries in which the Company owned greater than 50.0 percent of the vote and value. The remaining subsidiaries file separate US tax returns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Current income tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantially enacted at
the reporting date, and any adjustment to tax payable in respect of previous years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred tax is recognized due to temporary differences between the
carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax assets are recognized for unused tax losses, unused tax credits and deductible temporary differences to the extent
that it is probable that future taxable profits will be available against which they can be used. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will
be realized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, using tax rates
enacted or substantively enacted at the reporting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred income tax assets and liabilities are offset when there is a legally enforceable right
to offset current tax assets against current tax liabilities and when the deferred income tax assets and liabilities relate to income taxes levied by the same taxation authority on either the same taxable entity or different taxable entities where
there is an intention to settle the balances on a net basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-22</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred taxes are recognized in Consolidated Statements of Comprehensive Income/(Loss) except to the extent
that they relate to items recognized directly in equity or in other comprehensive income. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Deferred Revenue and Deferred Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred revenue includes amounts that are receivable or have been received per contractual terms but have not been recognized as revenue since performance has
not yet occurred or has not yet been completed. Deferred costs represent costs to fulfill a contract and include capitalized labor and research and development expenditures. The Company classifies non-current deferred revenue and deferred costs for
any transaction which is expected to be recognized beyond one year or one operating cycle. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fair Value Measurements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group&#146;s accounting policies require that its financial and non-financial assets and liabilities be measured at their fair value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing
the use of relevant observable inputs and minimizing the use of unobservable inputs. Fair values are categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability,
either directly (i.e. as prices) or indirectly (i.e. derived from prices). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group recognizes transfers between levels of the fair value hierarchy at the end of the reporting period during which the change
has occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The carrying amount of cash and cash equivalents, accounts receivable, short-term investments, restricted cash, deposits, accounts payable,
accrued expenses and other current liabilities in the Group&#146;s Consolidated Statements of Financial Position approximates their fair value because of the short maturities of these instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Segments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Operating segments are
reported in a manner that is consistent with the internal reporting provided to the chief operating decision maker (&#147;CODM&#148;). The CODM reviews discrete financial information for the operating segments in order to assess their performance
and is responsible for making decisions about resources allocated to the segments. The CODM has been identified as the Group&#146;s Directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Prior period reclassification </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2019
management identified that for the year ended December&nbsp;31, 2018, Gain/(loss) on investments held at fair value of $14.3 million was incorrectly classified as Finance costs&#151;subsidiary preferred shares. As a result, a prior year
reclassification has been made in the Consolidated Statement of Comprehensive Income/(Loss) for the year ended December&nbsp;31, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. New
Standards and Interpretations Not Yet Adopted </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A number of new standards, interpretations, and amendments to existing standards are effective for
annual periods commencing on or after January&nbsp;1, 2020 and have not been applied in preparing the consolidated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-23</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financial information. The Company&#146;s assessment of the impact of these new standards and interpretations is set out below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective January&nbsp;1, 2020 the definition of a &#147;business&#148; has been amended as an amendment to IFRS 3 Business Combinations. The amendments
include an election to use a concentration test. This is a simplified assessment that results in an asset acquisition if substantially all of the fair value of the gross assets is concentrated in a single identifiable asset or a group of similar
identifiable assets. If an entity chooses not to apply the concentration test, or fails the test, then the assessment focuses on the existence of an input and a substantive process applied to the input/s. These amendments are not expected to have an
impact on the Company&#146;s financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of its amendments to IAS 1 and IAS 8, the IASB has refined its definition of
&#145;material&#146; and issued practical guidance on applying the concept of materiality. These amendments are effective January&nbsp;1, 2020 and are not expected to have an impact on the Company&#146;s financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the other new standards, interpretations, and amendments are applicable to the Company&#146;s financial statements and therefore will not have an
impact on the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Revenue </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue recorded
in the Consolidated Statement of Comprehensive Income/(Loss) consists of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the years ended December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue (IAS 18 for 2017 and IFRS 15 for 2018 and 2019)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,688</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,371</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,119</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,377</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,885</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,807</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,748</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,535</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All amounts recorded in contract revenue were generated in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group adopted IFRS 15 effective 1&nbsp;January 2018, using the modified retrospective method and has only applied this method to contracts that were not
completed as of the effective date and all new contracts initiated on or after the effective date. Results for reporting periods beginning on or after January&nbsp;1, 2018 are presented under IFRS 15, while prior period amounts have not been
restated and continue to be recorded in accordance with the governing revenue recognition standard applicable to that period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the Company&#146;s
contracts as of December&nbsp;31, 2019 and 2018 were determined to have a single performance obligation which consists of a combined deliverable of license to intellectual property and research and development services. Therefore revenue is
recognized over time based on the inputs method which is a faithful depiction of the transfer of goods and services. Progress is measured based on costs incurred to date as compared to total projected costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-24</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Disaggregated Revenue </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group disaggregates contract revenue for reporting periods beginning on or after January&nbsp;1, 2018 in a manner that depicts how the nature, amount,
timing, and uncertainty of revenue and cash flows are affected by economic factors. The Group disaggregates revenue based on contract revenue or grant revenue, and further disaggregates contract revenue based on the transfer of control of the
underlying performance obligations. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Timing of revenue recognition&nbsp;*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transferred at a point in time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,415</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transferred over time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,688</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,956</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,688</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,371</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Customers over 10% of revenue*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Janssen Biotech, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BMEB Services LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,415</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roche Holding AG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,973</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eli Lilly and Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,433</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Boehringer Ingelheim International GMBH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,091</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Imbrium Therapeutics L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,013</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,510</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,415</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Required disclosure under IFRS 15 (not applicable to 2017) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An estimation uncertainty arises due to management&#146;s application of the inputs method in recognizing revenue overtime. In doing so, the total cost to
satisfy the performance obligation includes a significant estimate by management in its budgets and projected cash flows. The sensitivity of this calculation for the years ended December&nbsp;31, 2019 and 2018 is detailed below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the year ended December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Budgeted costs to complete</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>+10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)%&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(951</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>738</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the year ended December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Budgeted costs to complete</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(265</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">323</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contract Balances </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accounts receivables represent rights to consideration in exchange for products or services that have been transferred by the Group, when payment is
unconditional and only the passage of time is required before payment is due. Accounts receivables do not bear interest and are recorded at the invoiced amount. Accounts receivable are included within Trade and other receivables on the Consolidated
Statement of Financial Position. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-25</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contract liabilities represent the Group&#146;s obligation to transfer products or services to a customer for
which consideration has been received, or for which an amount of consideration is due from the customer. When applicable, contract assets and liabilities are reported on a net basis at the contract level, depending on the contracts position at the
end of each reporting period. Contract liabilities are included within deferred revenue on the Consolidated Statement of Financial Position. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Contract Balances*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,699</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue&#151;long term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,220</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue&#151;short term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,474</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,560</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Required disclosure under IFRS 15 (not applicable to 2017) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, $5.0 million of revenue was recognized on deferred revenue outstanding at December&nbsp;31, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Remaining performance obligations represent the transaction price of unsatisfied or partially satisfied performance obligations within contracts with an
original expected contract term that is greater than one year and for which fulfillment of the contract has started as of the end of the reporting period. The aggregate amount of transaction consideration allocated to remaining performance
obligations as of December&nbsp;31, 2019 was $7.6 million. The following table summarizes when the Group expects to recognize the remaining performance obligations as revenue. The Group will recognize revenue associated with these performance
obligations as transfer of control occurs: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;than<BR>1 Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Greater&nbsp;than<BR>1 Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remaining Performance Obligation*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,344</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,220</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,564</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Required disclosure under IFRS 15 (not applicable to 2017) </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cost to Fulfill a Contract </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contract fulfillment
costs include direct labor for professional services, payments made to third parties for intellectual property licenses and direct materials. Incremental costs incurred to fulfill our contracts are capitalized if these costs (i)&nbsp;relate directly
to the contract, (ii)&nbsp;are expected to generate resources that will be used to satisfy the Company&#146;s performance obligation under the contract, and (iii)&nbsp;are expected to be recovered through revenue generated under the contract. The
revenue associated with direct labor for professional services is recognized over time; therefore the costs associated are expensed as incurred. The payments made to third parties for intellectual property licenses are capitalized when paid and
recognized in line with associated revenue, whether this be over time or at a point in time. As of December&nbsp;31, 2018, the Group has capitalized $0.8 million of cost to fulfill which are included within Prepaid expenses and other current assets
as well as Other non-current assets on the Consolidated Statement of Financial Position. As of December&nbsp;31, 2019 the remaining unamortized balance was $0.3 million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Segment Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis for Segmentation
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors are the Group&#146;s strategic decision-makers. The Group&#146;s operating segments are reported based on the financial information
provided to the Directors at least quarterly for the purposes of allocating resources and assessing performance. The Group has determined that each entity is representative of a single operating segment as the Directors monitor the financial results
at this level. When identifying the reportable segments the Group </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-26</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has determined that it is appropriate to aggregate multiple operating segments into a single reportable segment given the high level of operational and financial similarities across the entities.
The Group has identified four reportable segments which are outlined below. Substantially, all of the revenue and profit generating activities of the Group are generated within the US and accordingly, no geographical disclosures are provided. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, the Company deconsolidated three of its subsidiaries which resulted in a change to the composition of its
reportable segments. The Company has revised the 2018 and 2017 financial information to conform to the presentation as of and for the period ending December&nbsp;31, 2019. The change in segments reflects how the Company&#146;s Board of Directors
reviews the Group&#146;s results, allocates resources and assesses performance. This change has been adjusted in both the current and the prior period in the tables below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Internal </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Internal segment (the &#147;Internal
segment&#148;), is advancing a pipeline fuelled by recent discoveries in lymphatics and immune cell trafficking to modulate disease in a tissue-specific manner. These programs leverage the transport and biodistribution of various immune system
components for the targeted treatment of diseases with major unmet needs, including cancers, autoimmune diseases, and neuroimmune disorders. The Internal segment is comprised of the technologies that will be advanced through either PureTech Health
funding or non-dilutive sources of financing in the near-term. The operational management of the Internal segment is conducted by the PureTech Health team, which is responsible for the strategy, business development, and research and development. As
of December&nbsp;31, 2019, this segment included PureTech LYT (formerly Ariya Therapeutics) and PureTech LYT 100. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Controlled Founded Entities
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Controlled Founded Entity segment (the &#147;Controlled Founded Entity segment&#148;) is comprised of the Group&#146;s subsidiaries that are
currently consolidated operational subsidiaries that either have, or have plans to hire, independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. These subsidiaries
have active research and development programs and either have entered into or plan to seek a strategic partnership with an equity or debt investment partner, who will provide additional industry knowledge and access to networks, as well as
additional funding to continue the pursued growth of the company. As of December&nbsp;31, 2019, this segment included Alivio Therapeutics, Inc., Commense Inc., Entrega Inc., Follica Incorporated, Sonde Health Inc., and Vedanta Biosciences, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Non-Controlled Founded Entities </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Non-Controlled Founded Entities segment (the &#147;Non-Controlled Founded Entities segment&#148;) is comprised of the entities in respect of which PureTech Health (i)&nbsp;no longer holds majority voting control as a shareholder and (ii)&nbsp;no
longer has the right to elect a majority of the members of the subsidiaries&#146; Board of Directors. Upon deconsolidation of an entity the segment disclosure is restated to reflect the change on a retrospective basis, as this constitutes a change
in the composition of its reportable segments. As of December&nbsp;31, 2019, the Non-Controlled Founded Entities segment included resTORbio, Inc. (&#147;resTORbio&#148;), Akili Interactive Labs, Inc. (&#147;Akili&#148;), Vor Biopharma Inc.
(&#147;Vor&#148;), Karuna Therapeutics, Inc. (&#147;Karuna&#148;), and Gelesis Inc. (&#147;Gelesis&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Non-Controlled Founded Entities segment
incorporates the operational results of the aforementioned entities to the date of deconsolidation. Following the date of deconsolidation, the Company accounts for its investment in each entity at the parent level, and therefore the results
associated with investment activity following the date of deconsolidation is included in the Parent Company and Other segment (the &#147;Parent Company and Other segment&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-27</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Parent Company and Other Segment </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Parent Company and Other segment includes activities that are not directly attributable to the operating segments, such as the activities of the Parent,
corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. This segment also captures the accounting
for the Company&#146;s holdings in entities for which control has been lost, which is inclusive of the following items: gain on deconsolidation, gain or loss on investments held at fair value, gain on loss of significant influence, and the share of
net loss of associates accounted for using the equity method. As of December&nbsp;31, 2019, this segment included PureTech Health plc, PureTech Health LLC, PureTech Management, Inc. and PureTech Securities Corp., as well as certain other dormant,
inactive and shell entities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-28</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Information About Reportable Segments: </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internal</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Controlled<BR>Founded<BR>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-Controlled<BR>Founded</B><br><B>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Parent<BR>Company<BR>&amp; Other</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Consolidated</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Comprehensive Loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,064</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>137</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,688</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,104</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,119</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,079</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,591</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>137</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,807</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,385</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(14,436</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10,439</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,098</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(59,358</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(25,977</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(42,780</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(15,555</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,536</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(85,848</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total operating expense</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(28,362</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(57,216</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(25,994</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(33,634</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(145,206</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>264,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>264,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(37,863</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(37,863</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(39</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(60</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(82</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>445,582</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>445,582</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>166</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(45</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>121</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>127</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>672,023</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>672,167</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net finance income/(costs)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(16,947</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(30,141</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>941</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,147</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net income/(loss) of associates accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,791</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,791</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impairment of investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(42,938</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(42,938</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) before taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(22,266</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(56,135</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>627,320</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>478,474</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) before taxes pre IFRS 9 fair value accounting, finance costs&#151;subsidiary
preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(21,889</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(48,996</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(21,873</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>640,298</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>547,540</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>107</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,564</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,458</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;IFRS 9 fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,294</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(28,737</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(444</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,475</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payment expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,678</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,543</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,242</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(14,468</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation of tangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(376</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,531</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(207</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,114</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,228</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of ROU assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(83</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,177</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,320</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Amortization of intangible assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(128</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(117</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(134</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(162</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(112,113</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(112,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) for the year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(22,266</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,579</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(56,297</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>515,207</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) for the year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(22,266</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(70,579</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(56,307</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>515,207</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,055</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(7,001</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(54,719</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,353</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>515,207</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,134</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(15,265</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(15,860</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(23,954</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(55,079</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Financial Position:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,614</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>41,612</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>881,952</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>941,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,076</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>132,935</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>145,768</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>290,779</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net assets/(liabilities)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,538</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(91,324</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>736,184</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>650,399</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-29</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internal</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Controlled<BR>Founded<BR>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-Controlled<BR>Founded</B><br><B>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Parent<BR>Company<BR>&amp; Other</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Consolidated</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consolidated Statements of Comprehensive Loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,110</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,233</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,371</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,271</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,377</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,195</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,504</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,748</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,498</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,212</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,385</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,270</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,365</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,929</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,851</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(77,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,427</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(46,236</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,962</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(124,768</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,730</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,730</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,615</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,615</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,054</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,054</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,287</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,287</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(405</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,051</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,154</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net finance income/(costs)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,341</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,945</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,631</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,918</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net income/(loss) of associate accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) before taxes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,232</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,297</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40,167</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,258</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(68,438</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Loss)/income before taxes pre IFRS 9 fair value accounting, finance costs&#151;subsidiary
preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,210</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,344</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(38,761</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,234</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,549</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;IFRS 9 fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,341</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,516</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,775</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,631</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payment expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,465</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,899</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,637</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation of tangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,823</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(390</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(256</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,476</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(270</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(381</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(185</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,454</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,206</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,239</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,239</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,659</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(240</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,454</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,420</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,239</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,213</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,899</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) attributable to:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,139</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,710</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,260</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,213</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,894</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,315</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,710</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,980</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consolidated Statements of Financial Position:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,984</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,603</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,934</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">387,240</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">441,761</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,366</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,992</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">202,161</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,731</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">274,788</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (liabilities)/assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,381</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,389</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(166,227</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">388,970</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,973</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-30</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internal</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Controlled<BR>Founded<BR>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-Controlled<BR>Founded</B><br><B>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Parent<BR>Company<BR>&amp; Other</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Consolidated</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consolidated Statements of Comprehensive Loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,255</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">630</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,885</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,880</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">630</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,535</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,671</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,064</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,146</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(46,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,515</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,395</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,209</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,672</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,917</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,224</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,459</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,355</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,955</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,016</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,016</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,334</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,334</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,364</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,364</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net finance income/(costs)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,583</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,495</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,053</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(80,047</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net income/(loss) of associate accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,608</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,608</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) before taxes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,927</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(132,324</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,479</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,711</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Loss)/income before taxes pre IAS 39 fair value accounting, finance costs&#151;subsidiary
preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,691</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(52,275</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,022</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,118</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,028</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(625</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;IAS 39 fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,652</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,078</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,735</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payment expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,722</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,844</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,849</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impairment of tangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(637</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(637</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation of tangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(833</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(373</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(411</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,617</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(459</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(57</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,411</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,383</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,842</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(132,381</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,067</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">408</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,158</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,434</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(132,381</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,817</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(72,936</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) attributable to:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(454</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,098</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,635</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,817</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,630</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,484</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,336</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(90,746</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(101,566</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Parent commences initiatives in theme-based technologies, raises capital for investment in new companies and existing
subsidiaries, provides other corporate shared services and support for all subsidiaries and manages the new program creation process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The activity
between the Parent and the reporting segments has been eliminated in consolidation. These elimination amounts are allocated to the subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
proportion of net assets shown above that is attributable to non-controlling interest is disclosed in Note 16. The Non-Controlled Founded Entities consist of the Company&#146;s minority interest holdings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-31</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Investments held at fair value </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investments held at fair value include both unlisted and listed securities held by PureTech. These investments, which include Akili, Vor, Karuna, Gelesis
(other than the investment in common shares&#151;please refer to Note 6), resTORbio and other insignificant investments, are initially measured at fair value and are subsequently re-measured at fair value at each reporting date. Interests in these
investments are accounted for as investments held at fair value, as shown below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000&#146;s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,351</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of Akili</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,748</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of investment to investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,297</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain&#151;comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss&#151;fair value through profit and loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,615</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018 and January&nbsp;1, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,755</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries (Vor, Karuna and Gelesis (Note 6))</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,571</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of Karuna investment to investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,006</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on Karuna investment at initial public offering
<SUP STYLE="font-size:85%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,633</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash purchase of Gelesis convertible notes (please refer to Note 6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,480</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash purchase of Gelesis preferred shares (please refer to Note 6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,020</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of Karuna investment at loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">557,243</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale of resTORbio shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss&#151;fair value through profit and
loss<SUP STYLE="font-size:85%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78,496</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>As of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>714,905</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The net amount of these two items is a loss of $37.9 million which is reported on the line Gain/(loss) on
investments held at fair value in the Consolidated Statements of Comprehensive Income/(Loss). </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vor </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vor was founded by PureTech through an initial Series A-1 Preferred Shares financing and raised funds through issuance of convertible notes. As of
December&nbsp;31, 2018, PureTech maintained control of Vor and the subsidiary&#146;s financial results were fully consolidated in the Group&#146;s consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;12, 2019, Vor completed a Series A-2 Preferred Shares financing round with PureTech and several new third party investors. The financing
provided for the purchase of 62,819,866 shares of Vor Series A-2 Preferred Shares at the purchase price of $0.40 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the issuance
of Series A-2 preferred shares to third-party investors, PureTech&#146;s ownership percentage and corresponding voting rights dropped from 79.5 percent to 47.5 percent, and PureTech simultaneously gave up control on Vor&#146;s Board of Directors,
both of which triggered a loss of control over the entity. As of February&nbsp;12, 2019, Vor was deconsolidated from the Group&#146;s financial statements, resulting in only the profits and losses generated by Vor through the deconsolidation date
being included in the Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). While the Company no longer controls Vor, it was concluded that PureTech still had significant influence over Vor by virtue of its large, albeit
minority, ownership stake and its continued representation on Vor&#146;s Board of Directors. PureTech still has the power to participate in the financial and operating policy decisions of the entity, although it does not control these policies.
During the year ended December&nbsp;31, 2019, the Company recognized a $6.4 million gain on the deconsolidation of Vor, which was recorded to the Gain on the deconsolidation of subsidiary line item in the Consolidated Statement of Income/(Loss) and
Other Comprehensive Income/(Loss). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As PureTech did not hold common shares in Vor upon deconsolidation and the preferred shares it holds do not have
equity-like features, the voting percentage attributable to common shares is nil. Therefore, PureTech had no </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-32</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
basis to account for its investment in Vor under IAS 28. The preferred shares held by PureTech fall under the guidance of IFRS 9 and will be treated as a financial asset held at fair value
through the Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). The fair value of the preferred shares at deconsolidation was $12.0 million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, the Company recognized a gain of $0.6 million that was recorded on the line item Gain/(loss) on investments held
at fair value within the Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). Please refer to Note 16 for information regarding the valuation of these instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Karuna </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna was founded by PureTech and raised funding
through Preferred Share financings as well as convertible note issuances. As of December&nbsp;31, 2018, PureTech maintained control of Karuna and Karuna&#146;s financial statements were fully consolidated in the Group&#146;s consolidated financial
statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;15, 2019, Karuna completed the closing of a Series B Preferred Share financing with PureTech and several new third party
investors. The financing provided for the purchase of 5,285,102 shares of Karuna Series B Preferred Shares at a purchase price of $15.14 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a
result of the issuance of the preferred shares to third-party investors, PureTech&#146;s ownership percentage and corresponding voting rights related to Karuna dropped from 70.9 percent to 44.3 percent, and PureTech simultaneously lost control over
Karuna&#146;s Board of Directors, both of which triggered a loss of control over the entity. As of March&nbsp;15, 2019, Karuna was deconsolidated from the Group&#146;s financial statements, resulting in only the profits and losses generated by
Karuna through the deconsolidation date being included in the Group&#146;s Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). At the date of deconsolidation, PureTech recorded a $102.0 million gain on the deconsolidation
of Karuna, which was recorded to the Gain on the deconsolidation of subsidiary line item in the Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). While the Company no longer controls Karuna, it was concluded that
PureTech still had significant influence over Karuna by virtue of its large, albeit minority, ownership stake and its continued representation on Karuna&#146;s Board of Directors. PureTech still had the power to participate in the financial and
operating policy decisions of the entity, although it did not control these policies. As PureTech had significant influence over Karuna, the entity was accounted for as an associate under IAS 28. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the date of deconsolidation, PureTech held both preferred and common shares in Karuna and a warrant issued by Karuna to PureTech. The preferred shares
and warrant held by PureTech fell under the guidance of IFRS 9 and were treated as financial assets held at fair value, and all movements to the value of preferred shares held by PureTech were recorded through the Consolidated Statement of
Income/(Loss) and Other Comprehensive Income/(Loss), in accordance with IFRS 9. The fair value of the preferred shares and warrant at deconsolidation was $72.4 million. Subsequent to deconsolidation, PureTech purchased an additional $5.0 million of
Karuna Series B Preferred shares, for a total fair value immediately following deconsolidation of $77.4&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to the immaterial investment in
common shares and overwhelmingly large losses by Karuna, the common share investment accounted for under the equity method was remeasured to nil immediately following both the deconsolidation and the exercise of the warrant in the first half of
2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;28, 2019, Karuna priced its IPO. PureTech&#146;s ownership percentage and corresponding voting rights related to Karuna dropped from
44.3 percent to 31.6 percent; however, PureTech retained significant influence due to its continued presence on the board and its large, albeit minority, equity stake in the company. Upon completion of the IPO, the Karuna preferred shares held by
PureTech converted to common shares. In light of PureTech&#146;s common share holdings in Karuna and corresponding voting rights, PureTech had re-established a basis to account for its investment in Karuna under IAS 28. The preferred shares
investment held at fair value </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-33</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
was therefore reclassified to investment in associate upon completion of the conversion. During the year ended December&nbsp;31, 2019 and up to June&nbsp;28, 2019, the Company recognized a gain
of $40.6&nbsp;million that was recorded on the line item Gain on investments held at fair value within the Consolidated Statement of Comprehensive Income/(Loss) related to the preferred shares that increased in value between the date of
deconsolidation and the date of Karuna&#146;s IPO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;2, 2019 it was concluded that the Company no longer exerted significant influence
over Karuna owing to the resignation of the PureTech designee from Karuna&#146;s board of directors, with PureTech retaining no ability to reappoint representation. Furthermore, PureTech is not involved in any manner, or has any influence, on the
management of Karuna, or on any of its decision making processes and has no ability to do so. As such, PureTech lost the power to participate in the financial and operating policy decisions of Karuna. As a result, Karuna is no longer deemed an
Associate and does not meet the scope of equity method accounting, resulting in the investment being accounted for as an investment held at fair value. As of December&nbsp;2, 2019 the Company&#146;s interest in Karuna was 28.4 percent. For the
period of June&nbsp;28, 2019 through December&nbsp;2, 2019, PureTech&#146;s investment in Karuna was subject to equity method accounting. In accordance with IAS 28, the Company&#146;s investment was adjusted by the share of losses generated by
Karuna (weighted average of 31.4 percent based on common stock ownership interest), which resulted in a net loss of associates accounted for using the equity method of $6.3 million during the year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon PureTech&#146;s loss of significant influence, the investment in Karuna was reclassified to an investment held at fair value. This change led PureTech to
recognize a gain on loss of significant influence of $445.6 million that was recorded to the Consolidated Statement of Income/(Loss) on the line item Gain on loss of significant influence during the year ended December&nbsp;31, 2019. The investment
in Karuna after the recording of the gain on loss of significant influence was $557.2 million, which was reclassified from Investments in associates to Investments held at fair value. Additionally, from December&nbsp;2, 2019 PureTech recorded a $0.7
million loss on the line item Gain/(loss) on investments held at fair value within the Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss) for the year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Akili </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;8, 2018, Akili completed the first
closing of a Series C Preferred Stock financing in which PureTech Health did not invest. As a result of the issuance of the preferred shares to third-party investors, following the first close of the Series C financing, PureTech&#146;s ownership
percentage and corresponding voting rights related to Akili dropped from 61.8 percent to 41.9 percent, triggering a loss of control over the entity. As of May 2018, Akili was deconsolidated from the Group&#146;s financial statements, resulting in
only the profits and losses generated by Akili through May 2018 being included in the Group&#146;s Consolidated Statements of Comprehensive Income/(Loss). As a result of the deconsolidation, PureTech recognized a $41.7 million gain on the
deconsolidation during the year ended December&nbsp;31, 2018, which was recorded to the Consolidated Statement of Comprehensive Income/(Loss) on the line item Gain on the deconsolidation of subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As PureTech did not hold common shares in Akili upon deconsolidation and the preferred shares it holds do not have equity-like features, the voting percentage
attributable to common shares is nil. Therefore, PureTech had no basis to account for its investment in Akili under IAS 28. The preferred shares held by PureTech Health fall under the guidance of IFRS 9 and will be treated as a financial asset held
at fair value and all movements to the value of PureTech&#146;s share in the preferred shares will be recorded through the Consolidated Statements of Comprehensive Income/(Loss), in accordance with IFRS 9. During the year ended December&nbsp;31,
2019 and 2018, the Company recognized a gain of $11.5 million and $12.7 million, respectively, that was recorded on the line item Loss on investments held at fair value within the Consolidated Statements of Comprehensive Income/(Loss). Please refer
to Note 16 for information regarding the valuation of these instruments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-34</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>resTORbio </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;26, 2018, resTORbio, Inc., closed its initial public offering. Prior to the resTORbio IPO, PureTech Health recorded a loss of $14.3 million
during the year ended December&nbsp;31, 2018 to the Consolidated Statement of Income/(Loss) within Gain/(Loss) on investments held at Fair Value to adjust the fair value related to its resTORbio Series A Preferred Share investment. Upon completion
of the public offering, the resTORbio Series A Preferred Shares held by PureTech Health converted to common shares. In light of PureTech&#146;s common shares holdings in resTORbio and corresponding voting rights, the preferred shares investment held
at fair value was reclassified to investment in associate upon the completion of the conversion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the period of January&nbsp;1, 2018 through
November&nbsp;5, 2018, PureTech&#146;s investment in resTORbio was subject to equity method accounting. In accordance with IAS 28, PureTech&#146;s investment was adjusted by the share of profits and losses generated by resTORbio (34.9 percent based
on common stock ownership interest), which resulted in a net loss of associates of $11.5 million accounted for using the equity method which was recorded to the Consolidated Statement of Income/(Loss) on the line item Share of net loss of associates
during the year ended December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of November&nbsp;6, 2018, it was that concluded the Company no longer exerted significant influence over
resTORbio, as PureTech lost the power to participate in the financial and operating policy decisions of resTORbio. As a result, resTORbio is no longer deemed an Associate and does not meet the scope of equity method accounting, resulting in the
investment being accounted for as an investment held at fair value. For the period of January&nbsp;1, 2018 through November&nbsp;5, 2018, PureTech&#146;s investment in resTORbio was subject to equity method accounting. In accordance with IAS 28,
PureTech&#146;s investment was adjusted by the share of profits and losses generated by resTORbio, that resulted a net loss of associates accounted for using the equity method of $11.5 million that was recorded to the Consolidated Statement of
Income/(Loss) on the line item Share of net loss of associates accounted for using the equity method during the year ended December&nbsp;31, 2018. This change led PureTech to recognize a gain on loss of significant influence of $10.3 million that
was recorded to the Consolidated Statement of Income/(Loss) on the line item Gain on loss of significant influence during the year ended December&nbsp;31, 2018. Additionally, PureTech recorded a loss of $33.0 million for the adjustment to fair value
in connection with its investment in resTORbio to the Consolidated Statement of Income/(Loss) on the line item Loss on financial asset during the year ended December&nbsp;31, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;15, 2019, resTORbio announced that top line data from the Protector 1 Phase 3 study evaluating the safety and efficacy of RTB101 in
preventing clinically symptomatic respiratory illness in adults age 65 and older, did not meet its primary endpoint and the Company has stopped the development of RTB101 in this indication. As a result of ceasing the development of RTB101,
resTORbio&#146;s share price witnessed a decline in price. In November and December 2019, PureTech Health sold 7,680,700 common shares of resTORbio for aggregate proceeds of $9.3 million. Immediately following the sale of common shares, PureTech
Health held 2,119,696 common shares, or 5.8 percent, of resTORbio. Additionally, PureTech recorded a loss of $71.9 million for the adjustment to fair value in connection with its investment in resTORbio to the Consolidated Statement of Income/(Loss)
on the line item Loss on financial asset during the year ended December&nbsp;31, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-35</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on deconsolidation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the gain on deconsolidation recognized by the Company: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year ended December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation of Akili</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation of Vor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,357</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation of Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>102,038</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation of resTORbio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,016</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation of Gelesis [Note 6]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>156,014</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total gain on deconsolidation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>264,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,730</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,016</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Investments in Associates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gelesis </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis was founded by PureTech and raised
funding through preferred shares financings as well as issuances of warrants and loans. As of December&nbsp;31, 2018, PureTech maintained control of Gelesis and the subsidiary&#146;s financial results were fully consolidated in the Group&#146;s
consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2019, the Gelesis Board of Directors was restructured, resulting in two of the three PureTech
representatives resigning from the Board with PureTech retaining no ability to reappoint directors to these board seats. As a result of this restructuring, PureTech lost control over Gelesis&#146; Board of Directors, which triggered a loss of
control over the entity. At the deconsolidation date, PureTech held a 25.2% voting interest in Gelesis. As of July&nbsp;1, 2019, Gelesis was deconsolidated from the Group&#146;s financial statements, resulting in only the profits and losses
generated by Gelesis through the deconsolidation date being included in the Group&#146;s Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). At the date of deconsolidation, PureTech recorded a $156.0 million gain on the
deconsolidation of Gelesis, which was recorded to the Gain on the deconsolidation of subsidiary line item in the Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). While the Company no longer controls Gelesis, it was
concluded that PureTech still has significant influence over Gelesis by virtue of its large, albeit minority, ownership stake and its continued representation on Gelesis&#146; Board of Directors. PureTech still has the power to participate in the
financial and operating policy decisions of the entity, although it does not control these policies. As PureTech is able to demonstrate that it has significant influence over Gelesis, the entity will be accounted for as an associate under IAS 28,
starting at the date of deconsolidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the date of deconsolidation, PureTech held shares of preferred shares and common shares of Gelesis and a
warrant issued by Gelesis to PureTech. PureTech&#146;s investment in common shares of Gelesis is subject to equity method accounting with an initial investment of $16.4 million. In accordance with IAS 28, PureTech&#146;s investment was adjusted by
the share of profits and losses generated by Gelesis subsequent to the date of deconsolidation. PureTech recognized its share in the net profit of Gelesis (weighted average of 49.8% based on common stock ownership interest) for the period from
deconsolidation date until December&nbsp;31, 2019 in the amount of $37.1&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preferred shares and warrant held by PureTech fall under the
guidance of IFRS 9 and will be treated as financial assets held at fair value and all movements to the value of PureTech&#146;s share in the preferred shares will be recorded through the Consolidated Statement of Income/(Loss) and Other
Comprehensive Income/(Loss), in accordance with IFRS 9. The fair value of the preferred shares and warrant at deconsolidation was $49.2 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During
the year ended December&nbsp;31, 2019, the Company recognized a loss of $18.7 million related to the preferred shares and warrants that was recorded on the line item Gain/(loss) on investments held at fair value
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-36</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
within the Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). This loss occurred as a result of the Gelesis Series 3 Growth financing, which was executed with terms
that resulted in a decrease in fair value across all other classes of preferred shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;12, 2019, Gelesis issued a convertible promissory
note to the Company in the amount of $2 million. On October&nbsp;7, 2019, Gelesis issued an amended and restated convertible note (the &#147;Gelesis Note&#148;) to the Company in the principal amount of up to $6.5 million. The Gelesis Note was
payable in installments, with $2.0 million of the note drawn down upon execution of the original note in August 2019 and an additional $3.3 million and $1.2 million drawn down on October&nbsp;7, 2019 and November&nbsp;5, 2019, respectively. The
Gelesis Note was convertible upon the occurrence of Gelesis&#146; next qualified equity financing, or at the demand of the Company at any date after December&nbsp;31, 2019. The Gelesis Note falls under the guidance of IFRS 9 and will be treated as a
financial asset held at fair and all movements to the value of the note will be recorded through the Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;5, 2019, Gelesis closed its Series 3 Growth Preferred Stock financing, at which point all outstanding principal and interest under the
Gelesis Note converted into shares of Series 3 Growth Preferred Stock. In addition to the shares issued upon conversion of the Gelesis Note, PureTech purchased $8 million of Series 3 Growth Preferred Stock in the December financing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Impairment loss </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the issuance of the Gelesis
Series 3 Preferred Shares at a higher valuation than the previous round with some favorable liquidation provisions primarily to PureTech and also to the other Series 3 preferred share investors, which resulted in adjustments to the fair values of
other preferred shares, warrant classes and Gelesis common stock, the Company assessed the investment in common shares held in Gelesis for impairment. Management compared the recoverable amount of the investment to its carrying amount as of
December&nbsp;31, 2019, which resulted in an impairment loss to the Investment in Gelesis. The recoverable amount was estimated based on the fair value of the Gelesis common shares held by PureTech, which are considered to be within Level 3 of the
fair value hierarchy. The costs of disposal are immaterial for the calculation of Gelesis investment&#146;s recoverable amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended
December&nbsp;31, 2019, the total fair value of common shares was determined utilizing a hybrid valuation approach with significant unobservable inputs within the PureTech valuation framework (refer to Note 16). The multi-scenario hybrid valuation
approach utilized the recent transaction method within an option pricing framework and an IPO scenario within a probability-weighted-expected return framework to determine the value allocation for the common share class of Gelesis. The fair value of
the common shares was determined as the calculated business enterprise value allocated to the outstanding common shares treated as call options within the OPM or the value of common shares within the PWERM. The PWERM maintained a 75.0 percent
probability of occurrence while the OPM maintained a 25.0 percent probability of occurrence. The probability weighted term to exit was 1.57 years. The discount rate utilized was 20.0 percent while the risk-free rate and volatility utilized were 1.62
percent and 56.0 percent, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The impairment loss amounted to $42.9 million and was recorded to Impairment of investment in associate within
the Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss) for the year ended December&nbsp;31, 2019. As of December&nbsp;31, 2019 the investment in Gelesis was $10.6 million, which is equal to the fair value of the common
shares held by PureTech. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-37</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the activity related to the investment in associates balance for the years
ended December&nbsp;31, 2019 and 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Investment in Associates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000&#146;s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">At January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment upon initial public offering of resTORbio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,210</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash investment in Associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,500</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net loss of resTORbio accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on loss of significant influence of resTORbio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,287</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of resTORbio investment upon loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,507</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>As of December&nbsp;31, 2018 and January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of Karuna investment at initial public offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,006</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment in Gelesis upon deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,444</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net loss of Karuna accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,345</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net profit of Gelesis accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,136</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impairment of investment in Gelesis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of investment upon loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(111,661</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>As of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,642</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the financial information of Gelesis as included in its own financial statements, adjusted for
fair value adjustments at deconsolidation and differences in accounting policies. The table also reconciles the summarized financial information to the carrying amount of the Company&#146;s interest in Gelesis. The information for the year ended
December&nbsp;31, 2019 includes the results of Gelesis only for the period July&nbsp;1, 2019 to December&nbsp;31, 2019, as Gelesis was consolidated prior to this period. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year ended December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Percentage ownership interest&#151;common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>49.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>369,336</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>40,079</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>82,406</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>216,852</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net assets (100%)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>110,157</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Group&#146;s share of net assets (49.3%)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>54,340</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share in associate&#146;s equity settled share based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(760</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment before impairment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>53,580</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impairment of investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(42,938</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investment in associate</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,642</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income from continuing operations (100%)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>74,573</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income (100%)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>74,573</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Group&#146;s share of total comprehensive income (49.8%)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,136</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-38</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Operating Expenses </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total operating expenses were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the years ending December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>59,358</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,365</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,283</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>85,848</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,402</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,672</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total operating expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>145,206</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,767</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,955</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The average number of persons employed by the Group during the year, analyzed by category, was as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the years ending December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>39</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>90</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>129</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate payroll costs of these persons were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the years ending December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>24,468</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,939</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,348</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,682</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,109</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,956</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>45,150</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,048</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,304</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Detailed operating expenses were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the years ending December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and wages</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>27,703</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,274</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,244</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Healthcare benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,511</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,465</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,699</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payroll taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,468</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,672</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,512</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,468</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,637</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,849</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total payroll costs</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>45,150</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,048</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,304</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other selling, general and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>34,890</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,426</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,935</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>65,166</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,293</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,716</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total other operating expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100,056</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,719</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,651</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total operating expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>145,206</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,767</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,955</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Auditors remuneration: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the years ended December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit of these financial statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>870</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">652</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">647</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit of the financial statements of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>290</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">254</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-related assurance services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>163</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-audit related services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>778</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,101</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,173</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-39</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please refer to Note 8 for further disclosures related to share-based payments and Note 24 for
management&#146;s remuneration disclosures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Share-based Payments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share-based payments includes stock options, restricted stock units (&#147;RSUs&#148;) and performance-based restricted share unit awards in which the expense
is recognized based on the grant date fair value of these awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Share-based Payment Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group share-based payment expense for the years ended December&nbsp;31, 2019, 2018 and 2017, were comprised of charges related to the PureTech Health plc
incentive stock and stock option issuances and subsidiary stock plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides the classification of the Group&#146;s consolidated
share-based payment expense as reflected in the Consolidated Statement of Income/(Loss): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the years ended December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,677</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,293</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,625</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,791</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,344</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,224</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,468</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,637</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,849</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There was no income tax benefit recognized for share-based payment arrangements during the periods presented due to existence
of operating losses for all issuing entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In conjunction with the acquisition of the remaining minority interests of Ariya Therapeutics Inc.
(&#147;Ariya&#148;) (Please refer to Note 18), PureTech Health exchanged Ayria stock options previously granted to the co-inventors and advisors of Ariya with stock options to purchase 2,147,295 of the Company&#146;s ordinary shares under the
PureTech Health Performance Share Plan. As this was an exchange of awards within the consolidated group, whereby the Company&#146;s stock options were replacing Ariya&#146;s stock options, the exchange is accounted for as a modification of the
original award and the incremental fair value on the date of the replacement is amortized over the remaining vesting period of the awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The
Performance Share Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2015, the Group adopted the Performance Stock Plan (&#147;PSP&#148;). Under the PSP and subsequent amendments,
awards of ordinary shares may be made to the Directors, senior managers and employees of, and other individuals providing services to the Company and its subsidiaries up to a maximum authorized amount of 10.0 percent of the total ordinary shares
outstanding. The shares have various vesting terms over a period of service between two and four years, provided the recipient remains continuously engaged as a service provider. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The share-based awards granted under the PSP are equity settled and expire 10 years from the grant date. As of the years ended December&nbsp;31, 2019, 2018
and 2017, the Company had issued share-based awards to purchase an aggregate of 5,409,751, 5,657,602 and 6,448,226 shares, respectively, under this plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>RSUs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the twelve months ended
December&nbsp;31, 2019, 2018 and 2017, the Company issued 1,775, 568, 2,860,782 and 4,648,084 performance based RSUs under the PSP, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each
RSU entitles the holder to one ordinary share on vesting and the RSU awards are based on a cliff vesting schedule over a three-year requisite service period in which the Company recognizes compensation expense on a
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-40</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
graded basis for the RSUs. Following vesting, each recipient will be required to make a payment of one pence per ordinary share on settlement of the RSUs. Vesting of the RSUs is subject to the
satisfaction of performance conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes the estimated fair value of performance-based awards as share-based compensation expense
over the performance period based upon its determination of whether it is probable that the performance targets will be achieved. The Company assesses the probability of achieving the performance targets at each reporting period. Cumulative
adjustments, if any, are recorded to reflect subsequent changes in the estimated outcome of performance-related conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the
performance-based awards is based on the Monte Carlo simulation analysis utilizing a Geometric Brownian Motion process with 100,000 simulations to value those shares. The model considers share price volatility, risk-free rate and other covariance of
comparable public companies and other market data to predict distribution of relative share performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The performance conditions attached to the 2019
RSU awards are based on the achievement of total shareholder return (&#147;TSR&#148;), with 50.0 percent of the shares under award vesting based on the achievement of absolute TSR targets, 12.5 percent of the shares under the award vesting based on
TSR as compared to the FTSE 250 Index, 12.5 percent of the shares under the award vesting based on TSR as compared to the MSCI Europe Health Care Index, and 25.0 percent of the shares under the award vesting based on the achievement of strategic
targets. The RSU award performance criteria have changed over time as the criteria is continually evaluated by the Group&#146;s Remuneration Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company incurred share-based payment expenses for performance based RSUs of $2.2 million, $2.3 million and $1.5 million for the twelve months ended
December&nbsp;31, 2019, 2018 and 2017, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Options </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the twelve months ended December&nbsp;31, 2019, 2018 and 2017, the Company granted 3,634,183, 2,796,820 and 1,800,142 stock option awards under the PSP,
respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the stock options awarded by the Company was estimated at the grant date using the Black-Scholes option valuation model,
considering the terms and conditions upon which options were granted, with the following weighted- average assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">At December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>35.68</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.18</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.92</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected terms (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5.81</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.85</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.79</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.96</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant date fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2.23</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.96</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.43</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share price at grant date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2.57</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.05</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company incurred share-based payment expense for the stock options of $9.2 million, $1.4 million and $0.6 million for the
twelve months ended December&nbsp;31, 2019, 2018 and 2017, respectively. The significant increase for the year ended December&nbsp;31, 2019, as compared to the year ended December&nbsp;31, 2018, is largely attributable to the amortization of share
based payments awarded to the Ariya founders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, 4,229,793 incentive options are exercisable with a weighted-average exercise
price of $1.42. Exercise prices ranged from $0.01 to $4.62. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-41</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>PureTech LLC Incentive Stock Issuance </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2015 and August 2014, the directors of PureTech Health LLC approved the issuance of shares to the management team, directors and advisors of PureTech
Health LLC, subject to vesting restrictions. The share-based awards granted under the 2016 PureTech LLC Incentive Stock Issuance Plan are equity settled and expire 10 years from the grant date. No additional shares will be granted under this
compensation arrangement. The fair value of the shares awarded was estimated as of the date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company incurred an expense of nil, $0.2
million, and $1.7 million in share-based payment expense for the twelve months ended December&nbsp;31, 2019, 2018 and 2017, respectively, related to PureTech Health LLC incentive compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2018, all shares related to the pre-IPO incentive compensation plan had fully vested. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Subsidiary Plans </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain subsidiaries of the
Group have adopted stock option plans. A summary of stock option activity by number of shares in these subsidiaries is presented in the following table: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Outstanding<BR>as of<BR>January&nbsp;1,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Granted<BR>During the<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercised<BR>During<BR>the Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Expired<BR>During<BR>the Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Forfeited<BR>During the<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Outstanding<BR>as of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,681,732</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(110,386</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,571,346</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&sup1;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alivio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,393,750</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,329,494</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,125</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(21,875</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,698,244</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech LYT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,180,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,180,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&sup2;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>540,416</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(540,416</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>914,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>58,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>972,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,229,452</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>79,588</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,309,040</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,949,927</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,949,927</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&sup1;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,806,504</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,829,004</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,373,750</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>154,193</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(77,843</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,450,100</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These shares represent the options outstanding on the date of deconsolidation of Karuna and Gelesis.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These shares represent the options outstanding on the date of exchange to PureTech stock options.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Outstanding<BR>as of<BR>January&nbsp;1,<BR>2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Granted<BR>During the<BR>Year</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Exercised<BR>During<BR>the Year</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expired<BR>During<BR>the Year</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Forfeited<BR>During the<BR>Year</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Outstanding<BR>as of<BR>December&nbsp;31,<BR>2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,728,232</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">953,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,681,732</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alivio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,393,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,393,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Akili</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,385,355</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,385,355</TD>
<TD NOWRAP VALIGN="bottom">)&sup1;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech LYT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,180,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,180,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">418,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,666</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,416</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">867,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,750</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">914,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,271,302</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,850</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,229,452</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">855,427</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,111,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,125</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,375</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,949,927</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Knode</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,500</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,663,806</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,750</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,630,806</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Sync Project</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,080,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,080,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,194,014</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">278,786</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,373,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These shares represent the options outstanding on the date of Akili&#146;s deconsolidation.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-42</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Outstanding<BR>as of<BR>January&nbsp;1,<BR>2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Granted<BR>During the<BR>Year</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Exercised<BR>During<BR>the Year</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expired<BR>During the<BR>Year</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Forfeited<BR>During the<BR>Year</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Outstanding<BR>as of<BR>December&nbsp;31,<BR>2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,489,031</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">297,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,299</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,728,232</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alivio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,393,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,393,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Akili</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,599,423</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">795,432</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,385,355</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech LYT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">418,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">821,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">867,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">449,505</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,119,283</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(190,059</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(107,427</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,271,302</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">742,677</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,750</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">855,427</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Knode</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,500</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,687</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,813</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,763,806</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,663,806</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Sync Project</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">850,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">230,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,080,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">882,250</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">359,764</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,438</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,562</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,194,014</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted average exercise prices for the options outstanding as of January&nbsp;1, 2019 were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Outstanding at January&nbsp;1, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-average</FONT><BR>exercise price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alivio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,393,750</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.03</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>914,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.71</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,229,452</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.92</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.12</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,373,750</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9.30</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted average exercise prices for the options granted for the years ended December&nbsp;31, 2019, 2018 and 2017 were as
follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the years ended December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Akili</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.55</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alivio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.49</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech LYT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.34</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.92</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.95</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.36</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.03</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.93</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.42</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.08</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.13</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sync</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.07</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>19.13</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.66</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.88</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-43</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted average exercise prices for options forfeited during the year ended December&nbsp;31, 2019 were
as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Forfeited during the year ended December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-average</FONT><BR>exercise price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,571,346</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7.48</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alivio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,875</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.49</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PureTech LYT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,180,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.01</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>540,416</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.13</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,949,927</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5.10</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>77,843</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.31</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted average exercise prices for options exercisable as of December&nbsp;31, 2019 were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Exercisable at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-average</FONT><BR>exercise price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise Price<BR>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alivio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,419,750</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.04</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">0.03&nbsp;-&nbsp;$0.49</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>882,062</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.60</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.03&nbsp;-&nbsp;$2.36</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,118,635</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.89</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.03&nbsp;-&nbsp;$1.40</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>191,405</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.18</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.13&nbsp;-&nbsp;$0.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,081,005</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7.05</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">0.02&nbsp;-&nbsp;$19.94</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Significant Subsidiary Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Vedanta 2010 Stock Incentive Plan </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2010, the Board of
Directors for Vedanta approved the 2010 Stock Incentive Plan (the &#147;Vedanta Plan&#148;). Through subsequent amendments, as of December&nbsp;31, 2019, it allowed for the issuance of 2,145,867 share-based compensation awards through incentive
share options, nonqualified share options, and restricted shares to employees, directors, and nonemployees providing services to Vedanta. At December&nbsp;31, 2019, 595,642 shares remained available for issuance under the Vedanta Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The options granted under Vedanta Plan are equity settled and expire 10 years from the grant date. Typically, the awards vest in four years but vesting
conditions can vary based on the discretion of Vedanta&#146;s Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options granted under the Vedanta Plan are exercisable at a price per
share not less than the fair market value of the underlying ordinary shares on the date of grant. The estimated fair value of options, including the effect of estimated forfeitures, is recognized over the options&#146; vesting period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the stock option grants has been estimated at the date of grant using the Black-Scholes option pricing model with the following range of
assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Assumption/Input</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected award life (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5.86-6.07</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.03-6.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.66-10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected award price volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">89.24%&nbsp;-&nbsp;95.46%</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">91.60%&nbsp;-&nbsp;92.56%</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">66.0%&nbsp;-&nbsp;76.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.73%&nbsp;-&nbsp;1.88%</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.65%&nbsp;-&nbsp;2.78%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.13%&nbsp;-&nbsp;2.37%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant date fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>$14.12&nbsp;-&nbsp;$15.61</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$11.21&nbsp;-&nbsp;$11.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$6.76&nbsp;-&nbsp;$9.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share price at grant date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>$18.71&nbsp;-&nbsp;$19.94</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$14.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$12.88</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-44</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vedanta incurred share-based compensation expense of $1.7 million, $2.1 million and $2.4&nbsp;million for the
years ended December&nbsp;31, 2019, 2018 and 2017, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Gelesis 2016 Stock Incentive Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September 2016, the Directors of Gelesis approved the 2016 Stock Incentive Plan (the &#147;2016 Gelesis Plan&#148;) which provides for the grant of
incentive stock options, nonqualified stock options, and restricted stock to employees, directors, and nonemployees providing services to Gelesis. At June&nbsp;30, 2019, 329,559 shares remained available for issuance under the Gelesis Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The options granted under the 2016 Gelesis Plan are equity settled and expire 10 years from the grant date. Typically, the awards vest in four years but
vesting conditions can vary based on the discretion of Gelesis Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options granted under the 2016 Gelesis Plan are exercisable at a price
per share not less than the fair market value of the underlying ordinary shares on the date of grant. The estimated fair value of options, including the effect of estimated forfeitures, is recognized over the options&#146; vesting period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the stock option grants has been estimated at the date of grant using the Black-Scholes option pricing model with the following weighted
average assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Assumption/Input</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected award life (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected award price volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64.58</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67.99</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.79</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant date fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.84</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.72</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share price at grant date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12.82</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11.56</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis used an average historical share price volatility based on an analysis of reported data for a peer group of comparable
companies which were selected based upon industry similarities. As there is not sufficient historical share exercise data to calculate the expected term of the options, Gelesis elected to use the &#147;simplified&#148; method for all options granted
at the money to value share option grants. Under this approach, the weighted average expected life is presumed to be the average of the vesting term and the contractual term of the option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis incurred share-based compensation expense of $2.4&nbsp;million for the six month period prior to deconsolidation ended June&nbsp;30, 2019 and $3.9
million and $4.2&nbsp;million for the years ended December&nbsp;31, 2018 and 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Karuna Pharmaceuticals, Inc. 2009 Stock Incentive Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2009, the Board of Directors for Karuna Pharmaceuticals, Inc. approved the 2009 Stock Incentive Plan (the &#147;Karuna 2009 Plan&#148;). It allowed for the
issuance of 1,000,000 share-based compensation awards through stock options, restricted stock units and other stock-based awards under the Karuna 2009 Plan to employees, officers, directors, consultants and advisors of Karuna. At March&nbsp;15,
2019, 106,865 shares remained available for issuance under the Karuna 2009 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The options granted under the Karuna 2009 Plan are equity settled and
expire 10 years from the grant date. Typically, the awards vest in four years but vesting conditions can vary based on the discretion of Karuna&#146;s Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options granted under the Karuna 2009 Plan are exercisable at a price per share not less than the fair market value of the underlying ordinary shares on the
date of grant. The estimated fair value of options, including the effect of estimated forfeitures, is recognized over the options&#146; vesting period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-45</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the stock option grants has been estimated at the date of grant using the Black-Scholes
option pricing model with the following weighted average assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Assumption/Input</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected award life (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected award price volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49.66</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.28</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.86</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.95</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant date fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.69</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.51</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share price at grant date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.40</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.08</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna incurred share-based compensation expense of $1.2&nbsp;million for the period prior to deconsolidation ended
March&nbsp;15, 2019 and $1.9&nbsp;million and $0.4&nbsp;million for the years ended December&nbsp;31, 2018 and 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Plans </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stock compensation expense under plans at other subsidiaries of the Group not including Gelesis, Vedanta and Karuna was $0.01 million, $0.8 million and
$1.0 million for the years ended December&nbsp;31, 2019, 2018 and 2017, respectively. The negative expense incurred during the year ended December&nbsp;31, 2019 was largely attributable to Commense forfeitures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Finance Cost, net </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table shows the
breakdown of finance income and costs: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the year ended December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Finance income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest from financial assets not at fair value through profit or loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,362</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,358</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total finance income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,362</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,358</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Finance costs</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contractual interest expense on convertible notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(149</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(388</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(400</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense on other borrowings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non cash interest expense on convertible notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(300</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest Expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,495</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on forgiveness of debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">289</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on extinguishment of derivatives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on foreign currency exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>68</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total finance income/(costs)&#151;contractual</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,576</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) from change in fair value of warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(11,890</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,847</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) from change in fair value of preferred shares and convertible debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(34,585</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,549</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(73,582</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total finance income/(costs)&#151;fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,475</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,631</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,735</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total finance income/(costs)&#151;subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,458</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total finance income/(costs)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(47,933</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,525</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(81,797</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Finance income/(costs), net</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,147</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,917</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(80,047</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-46</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Earnings/(Loss) per Share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The basic and diluted loss per share has been calculated by dividing the income/(loss) for the period attributable to ordinary shareholders by the weighted
average number of ordinary shares outstanding during the years ended December&nbsp;31, 2019, 2018 and 2017, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Earnings/(Loss) Attributable to
Owners of the Company: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Basic</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Diluted</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Basic<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Diluted<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Basic<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Diluted<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) for the year, attributable to the owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,472</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,472</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) attributable to ordinary shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>421,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,472</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,472</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Weighted-Average Number of Ordinary Shares: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Basic</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Diluted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Basic</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Diluted</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Basic</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Diluted</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued ordinary shares at January&nbsp;1,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>282,493,867</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>282,493,867</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">236,897,579</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">236,897,579</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232,712,542</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232,712,542</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of shares issued</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>932,600</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>932,600</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,950,688</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,950,688</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,819,846</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,819,846</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of dilutive shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,355,866</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,388,920</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average number of ordinary shareholders at December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>283,426,467</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>291,782,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">273,848,267</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">273,848,267</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">235,532,388</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238,921,308</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Earnings/(Loss) per Share: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Basic</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Diluted</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Basic<br>$</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Diluted<br>$</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Basic<br>$</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Diluted<br>$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted earnings/(loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.49</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.44</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.11</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.11</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Property and Equipment </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Cost</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Laboratory and<BR>Manufacturing<BR>Equipment&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Furniture and<BR>Fixtures&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Computer<BR>Equipment<BR>and&nbsp;Software&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Leasehold<BR>Improvements&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Construction<BR>in<BR>process&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,082</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">469</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,214</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,899</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,738</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions, net of transfers</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,586</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">477</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,070</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">171</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,331</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(261</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(260</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(556</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange differences</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(101</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,306</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">488</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,431</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,924</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,388</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions, net of transfers</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,374</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,126</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,494</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,649</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,818</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(183</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(168</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(405</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,076</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,190</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,157</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassifications</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange differences</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,385</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,452</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,508</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,656</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>646</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28,647</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-47</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Accumulated depreciation and<BR>impairment loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Laboratory and<BR>Manufacturing<BR>Equipment&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Furniture and<BR>Fixtures&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Computer<BR>Equipment<BR>and&nbsp;Software&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Leasehold<BR>Improvements&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Construction&nbsp;in<BR>process&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,360</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(175</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(534</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(807</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,032</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(60</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,088</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,476</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">210</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange differences</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(233</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(756</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,854</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,065</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,328</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(312</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,448</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,232</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">265</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,457</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">319</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,829</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassifications</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange differences</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,968</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(239</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,030</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,955</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(7,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Property and Equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Laboratory and<BR>Manufacturing<BR>Equipment&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Furniture and<BR>Fixtures&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Computer<BR>Equipment<BR>and&nbsp;Software&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Leasehold<BR>Improvements&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Construction&nbsp;in<BR>process&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,084</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">255</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">675</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,070</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,323</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,417</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,213</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>478</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,701</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>646</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation of property and equipment is included in the General and administrative expenses and Research and development
expenses line items in the Consolidated Statements of Comprehensive Income/(Loss). The Company recorded depreciation expense of $3.2 million, $2.5 million and $2.2 million for the years ended December&nbsp;31, 2019, 2018 and 2017, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Intangible Assets </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intangible assets consist of
licenses of intellectual property acquired by the Group through various agreements with third parties and are recorded at the value of cash and non-cash consideration transferred. Information regarding the cost and accumulated amortization of
intangible assets is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Licenses<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,018</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,067</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,842</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>625</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-48</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Licenses<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,709</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,987</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,104</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Intangible assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Licenses<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,080</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>625</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These intangible asset licenses represent in-process-research-and-development assets since they are still being developed and
are not ready for their intended use. As such, these assets are not yet amortized but tested for impairment annually. The Company tested such assets for impairment as of balance sheet date and concluded that none were impaired. During the year ended
December&nbsp;31, 2019, Vor, Karuna and Gelesis were deconsolidated and as such $2.7 million in net assets were derecognized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amortization expense is
included in the Research and development expenses line item in the accompanying Consolidated Statements of Comprehensive Income/(Loss). Amortization expense, recorded using the straight-line method, was approximately $0.1 million, $0.3 million and
$0.5 million for the years ended December&nbsp;31, 2019, 2018 and 2017 respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Other Financial Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other financial assets consist of restricted cash held, which represents amounts that are reserved as collateral against letters of credit with a bank that are
issued for the benefit of a landlord in lieu of a security deposit for office space leased by the Group. Information regarding restricted cash was as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,124</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,199</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total other financial assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,124</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,199</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Equity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total equity
for PureTech as of December&nbsp;31, 2019 and 2018 was as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">December&nbsp;31,<BR>2018<br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital, &pound;0.01 par value, issued and paid 285,370,619 and 282,493,867 as of
December&nbsp;31, 2019 and 2018, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,408</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,375</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,506</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share premium</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>287,962</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">278,385</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Translation reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other reserves</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(18,282</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,923</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retained earnings/(accumulated deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>254,444</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(167,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity attributable to owners of the Group</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>668,037</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275,507</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,640</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>650,397</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,972</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-49</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in share capital and share premium relate primarily to acquisition of Ariya non-controlling interest
and incentive options exercises during the period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders are entitled to vote on all matters submitted to shareholders for a vote. Each ordinary
share is entitled to one vote. Each ordinary share is entitled to receive dividends when and if declared by the Company&#146;s Directors. The Company has not declared any dividends in the past. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;18, 2015, the Company acquired the entire issued share capital of PureTech LLC in return for 159,648,387 Ordinary Shares. This was accounted for
as a common control transaction at cost. It was deemed that the share capital was issued in line with movements in share capital as shown prior to the transaction taking place. In addition, the merger reserve records amounts previously recorded as
share premium. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other reserves comprise the cumulative credit to share-based payment reserves corresponding to share-based payment expenses recognized
through Consolidated Statements of Comprehensive Income/(Loss). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Subsidiary Preferred Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IFRS 9 addresses the classification, measurement, and recognition of financial liabilities. Preferred shares issued by subsidiaries and affiliates often
contain redemption and conversion features that are assessed under IFRS 9 in conjunction with the host preferred share instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The subsidiary
preferred shares are convertible into ordinary shares of the subsidiaries at the option of the holder and mandatorily convertible into ordinary shares upon a subsidiary listing in a public market at a price above that specified in the
subsidiary&#146;s charter or upon the vote of the holders of subsidiary preferred shares specified in the charter. Under certain scenarios the number of ordinary shares receivable on conversion will change and therefore, a variable number of shares
will be issued. Because the possible conversion of the preferred shares is outside of the control of the Group, these have been classified as liabilities on the balance sheet and subsequently remeasured at fair value through the profit and loss.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preferred shares are entitled to vote with holders of common shares on an as converted basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group recognizes the preferred share balance upon the receipt of cash financing or upon the conversion of notes into preferred shares at the amount
received or carrying balance of any notes and derivatives converted into preferred shares. Preferred shares are not allocated a proportion of the subsidiary losses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The balance as of December&nbsp;31, 2019 and 2018 represents the fair value of the instruments for all subsidiary preferred shares except for Tal, which
represents the host instrument at amortized cost. The following summarizes the subsidiary preferred share balance: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,222</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,780</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,663</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,192</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,342</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,212</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Sync Project</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta Biosciences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>78,892</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,923</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total subsidiary preferred share balance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100,989</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,519</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, the total subsidiary preferred share balance decreased owing to the deconsolidation of Karuna
and Gelesis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-50</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As is customary, in the event of any voluntary or involuntary liquidation, dissolution or winding up of a
subsidiary, the holders of subsidiary preferred shares which are outstanding shall be entitled to be paid out of the assets of the subsidiary available for distribution to shareholders and before any payment shall be made to holders of ordinary
shares. A merger, acquisition, sale of voting control or other transaction of a subsidiary in which the shareholders of the subsidiary do not own a majority of the outstanding shares of the surviving company shall be deemed to be a liquidation
event. Additionally, a sale, lease, transfer or other disposition of all or substantially all of the assets of the subsidiary shall also be deemed a liquidation event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019 and 2018, the minimum liquidation preference reflects the amounts that would be payable to the subsidiary preferred holders upon
a liquidation event of the subsidiaries, which is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,216</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,216</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,405</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,895</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,301</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,343</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,250</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sync</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta Biosciences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>77,161</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,923</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total minimum liquidation preference</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>93,032</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147,900</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2018, Tal ceased operations and was in the process of liquidated. Therefore, the liquidation
preference shown above equals the cash on hand, as this will be paid out to existing investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, the minimum liquidation
preference decreased owing to the deconsolidation of Karuna and Gelesis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2019, 2018 and 2017, the Group recognized
the following changes in the value of subsidiary preferred shares: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">215,635</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of new preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,537</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of convertible notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,930</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Decrease in value of preferred shares measured at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,110</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale of The Sync Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,062</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,517</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2018 and January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>217,519</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of new preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,048</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of convertible notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,894</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in value of preferred shares measured at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,636</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,458</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(207,346</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash Distribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100,989</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-51</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2019 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
March&nbsp;15, 2019, Karuna was deconsolidated. As of deconsolidation, the fair value of Karuna&#146;s preferred share liability was $31.7 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
April&nbsp;4, 2019, Sonde Health issued and sold shares of Series A-2 preferred shares for aggregate proceeds of $11.1 million, of which $5.3 million was contributed by outside investors. Approximately $5.8 million of outstanding principal and
interest on convertible promissory notes issued by Sonde to PureTech converted into Series A-2 preferred shares in this financing in accordance with their terms. On August&nbsp;29, 2019, Sonde sold an additional 1,052,632 shares of its Series A-2
preferred shares for aggregate proceeds of $2.0 million. It has been determined that these shares are liability classified and contain a liability classified embedded derivative. This embedded derivative is a conversion feature which can result in
settlement in a variable number of shares. The instrument is not bifurcated and is measured in whole at fair value through the profit and loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April
2019, Gelesis completed further closings of its Series 2 Growth financing issuing 799,894 shares for proceeds of $10.2 million, of which $8.6 million was contributed by outside investors and $1.6 million was contributed by PureTech. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March and May 2019, Vedanta completed a second and third closing of its Series C preferred shares financing for aggregate proceeds of $18.7 million.
PureTech Health did not participate in either closing. It has been determined that these shares are liability classified and contain a liability classified embedded derivative. This embedded derivative is a conversion feature which can result in
settlement in a variable number of shares. The instrument is not bifurcated and is measured in whole at fair value through the profit and loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
July&nbsp;1, 2019, Gelesis was deconsolidated. As of deconsolidation, the fair value of Gelesis&#146; preferred share liability was $175.6 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
July&nbsp;19, 2019, all of the outstanding notes, plus accrued interest, issued by Follica converted into 17,639,204 shares of Series A-3 Preferred Shares and 14,200,044 shares of common share pursuant to a Series A-3 Note Conversion Agreement
between Follica and the noteholders. Third parties held 2,422,990 A-3 preferred shares following the conversion. It has been determined that these shares are liability classified and contain a liability classified embedded derivative. This embedded
derivative is a conversion feature which can result in settlement in a variable number of shares. The instrument is not bifurcated and is measured in whole at fair value through the profit and loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September 2019, Vedanta received $16.7 million from outside investors through the issuance of its Series C-2 preferred shares in two separate closings. The
issuances provided for the purchase of 711,772 Series C-2 shares at a purchase price of $23.28. PureTech Health did not participate in either closing. It has been determined that these shares are liability classified and contain a liability
classified embedded derivative. This embedded derivative is a conversion feature which can result in settlement in a variable number of shares. The instrument is not bifurcated and is measured in whole at fair value through the profit and loss. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2018 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2018, Gelesis received $16.8 million from
outside investors through the issuance of its Series 2 Growth preferred shares as part of a $30.0 million financing with multiple closings. It has been determined that these shares are liability classified and contain a liability classified embedded
derivative. This embedded derivative is a conversion feature which can result in settlement in a variable number of shares. The instrument is not bifurcated and is measured in whole at fair value through the profit and loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2018, Akili issued Series C preferred shares for aggregate proceeds of $55.0 million; PureTech Health did not participate in this financing. Upon
closing of Akili&#146;s Series C financing, the subsidiary was deconsolidated by PureTech Health (please refer to Note 3). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-52</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2018, Karuna issued Series A preferred shares for aggregate proceeds of $42.1 million, of which
$23.9 million came from outside investors. In conjunction with the August 2018 issuance of Series A preferred shares, $26.1 million of outstanding principal and accrued interest on notes payable converted, of which $7.9 million related to outside
investors. It has been determined that these shares are liability classified and contain a liability classified embedded derivative. The instrument is not bifurcated and is measured in whole at fair value through the profit and loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;21, 2018, Vedanta issued Series C preferred shares for aggregate proceeds of $26.7 million, of which $21.7 million came from outside
investors. It has been determined that these shares are liability classified and contain a liability classified embedded derivative. The instrument is not bifurcated and is measured in whole at fair value through the profit and loss. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Financial Instruments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group&#146;s financial
instruments consist of financial liabilities, including preferred shares, convertible notes, warrants and loans payable, as well as financial assets classified as assets held at fair value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subsidiary Preferred Shares Liability and Subsidiary Convertible Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the changes in the Group&#146;s subsidiary preferred shares and convertible note liabilities measured at fair value using
significant unobservable inputs (Level 3): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Subsidiary<BR>Preferred&nbsp;Shares<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Subsidiary<BR>Convertible&nbsp;Notes<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">215,635</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,343</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value at issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,537</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,824</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,930</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,581</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,517</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,066</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2018 and January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>217,519</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,458</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value at issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,048</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion to preferred</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,894</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,894</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion to common</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(207,346</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,017</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,636</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,389</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,458</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash distribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100,989</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>125</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For financial instruments measured at fair value under IFRS 9 the change in the fair value of the entire instrument is
reflected through profit and loss. The techniques used to determine fair value of the preferred shares and convertible notes included the market approach, the market backsolve approach and the discounted cash flow income approach. A market approach
uses prices and other relevant information generated by recent market transactions involving identical or comparable assets or liabilities. The discounted cash flow income approach, which represents a Level 3 approach, relies upon unobservable
inputs that are supported by little or no market activity and that are significant to determining the fair value of certain assets or liabilities. The market backsolve method is derived from the total equity that is implied by the most recent
financing round in which the only truly observable value indicator is the financing round and the economic rights and the allocation inputs are implied by the terms of the financing, while volatility and term are Management inputs within the option
pricing-method. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the years ended December&nbsp;31, 2019 and 2018, at each measurement date, the total fair value of preferred share, warrants and
convertible note instruments, including embedded conversion rights that are not bifurcated, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-53</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
was determined using an OPM, PWERM or with or without framework which consisted of a three-step process detailed below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">First, the total business enterprise value of each business within the Group was determined using a discounted cash flow income approach or market approach,
or market backsolve approach through a recent arm&#146;s length financing round. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Second, the principal methods that the Group applies for the allocation
of value are the Option Pricing Method (&#147;OPM&#148;) and the Probability-Weighted Expected Return Method (&#147;PWERM&#148;). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The OPM treats outstanding securities as call options on the enterprise&#146;s value or overall equity value. The
value of a security is based on the optionality over and above the value of securities that are senior in the capital structure (e.g. preferred shares), which takes into consideration the dilutive effects of subordinate securities. In the OPM, the
exercise price is based on a comparison with the overall equity value rather than per-share value. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The PWERM estimates the value of equity securities based on an analysis of various discrete future outcomes, such
as an IPO, merger or sale, dissolution, or continued operation as a private or public enterprise until a later exit date. The equity value today is based on the probability-weighted present values of expected future investment returns, considering
each of the possible outcomes available to the enterprise, as well as the rights of each security class. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Third, the fair value of the
preferred shares was determined as the calculated business enterprise value allocated to the outstanding preferred share classes treated as call options within the OPM or the value of preferred shares on a converted common share basis within the
PWERM. For convertible notes, the fair value of the instrument, including the embedded conversion right which was not bifurcated, was also calculated using a with or without method. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Quantitative information about the significant unobservable inputs used in the fair value measurement of the Group&#146;s embedded derivative liability
related to the subsidiary preferred shares designated as Level 3 is as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Option Pricing Model Inputs for Preferred Shares and Convertible Notes
Liabilities under IFRS 9 at December&nbsp;31, 2019: </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2">Measurement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Range of Values</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expiration Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Volatility</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Risk Free Rate</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Probability&nbsp;of<BR>IPO/M&amp;A</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0&nbsp;&#150;&nbsp;3.5&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.00%&nbsp;&#150;&nbsp;80.00%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.70%&nbsp;&#150;&nbsp;2.04%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.3&nbsp;&#150;&nbsp;2.5 years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45.00%&nbsp;&#150;&nbsp;85.00%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.47%&nbsp;&#150;&nbsp;2.60%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.7&nbsp;&#150;&nbsp;2.0 years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30.00%&nbsp;&#150;&nbsp;85.00%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.58%&nbsp;&#150;&nbsp;1.60%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65%/35%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Probability Weighted Expected Return Method Inputs for Preferred Shares and Convertible Notes Liabilities under IFRS 9 at
December&nbsp;31, 2019: </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Measurement Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Range of Values</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Time&nbsp;to&nbsp;Anticipated<BR>Exit Event</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Probability of<BR>IPO/M&amp;A/Dissolution&nbsp;Sale</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.37&nbsp;&#150;&nbsp;1.83&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.0%/50.0%/0.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.75&nbsp;&#150;&nbsp;1.00 years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.0%/50.0%/0.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-54</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Quantitative information about the significant unobservable inputs used in the fair value measurement of the
Group&#146;s convertible note liabilities designated as Level 3 for the year ended December&nbsp;31, 2018 is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Significant Unobservable Inputs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Range of Values</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">At Issuance</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time to next qualified equity financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00&nbsp;&#150;&nbsp;2.03&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.33&nbsp;&#150;&nbsp;1.50&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Implied discount rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.3%&nbsp;&#150;&nbsp;2,459.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.8%&nbsp;&#150;&nbsp;44.9%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Probability of a qualified financing or change of control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0%&nbsp;&#150;&nbsp;100.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95.0%&nbsp;&#150;&nbsp;100.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Valuation policies and procedures are regularly monitored by the Company&#146;s finance group. Fair value measurements,
including those categorized within Level 3, are prepared and reviewed on their issuance date and then on an annual basis and any third-party valuations are reviewed for reasonableness and compliance with the fair value measurements guidance under
IFRS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subsidiary Preferred Shares Sensitivity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following summarizes the sensitivity from the assumptions made by the Company in respect to the unobservable inputs used in the fair value measurement of the Group&#146;s preferred share liabilities, which do not qualify for bifurcation and are
recorded at fair value (Please refer to Note 15). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>Input</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Subsidiary&nbsp;Preferred&nbsp;Share&nbsp;Liability</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">As of December&nbsp;31,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Sensitivity&nbsp;Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Financial&nbsp;Liability<BR>Increase/&nbsp;(Decrease)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>$000s</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enterprise Value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-2%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,785</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,784</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-10%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>410</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(459</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time to Liquidity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-6 Months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>565</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+6&nbsp;Months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(501</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free Rate&sup1;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">-0.08%/-0.03%</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>565</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+0.02%/+0.05%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(501</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IPO/M&amp;A Event Probability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-10%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,167</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+10%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,162</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Risk-free rate is a function of the time to liquidity input assumption. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in fair value of preferred shares are recorded in Finance cost, net in the Consolidated Statements of Comprehensive Income/(Loss). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Assets Held at Fair Value </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>resTORbio
Valuation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ResTORbio (NASDAQ: TORC) is a listed entity on an active exchange and as such the fair value as of December&nbsp;31, 2019 was calculated
utilizing the quoted common share price. Please refer to Note 5 for further details. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Karuna Valuation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna (NASDAQ: KRTX) is a listed entity on an active exchange and as such the fair value as of December&nbsp;31, 2019 was calculated utilizing the quoted
common share price. Please refer to Note 5 for further details. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-55</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Akili, Gelesis and Vor Valuation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with IFRS 9, the Company accounts for its preferred share investments in Akili, Gelesis and Vor as financial assets held at fair value through
the profit and loss. During the year ended December&nbsp;31, 2019, the Company recorded its investment at fair value and recognized a gain of $48.8 million that was recorded to the Consolidated Statements of Comprehensive Income/(Loss) on the line
item Gain/(loss) on investments held at fair value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the changes in the Group&#146;s investments held at fair value using
significant unobservable inputs (Level 3): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$&#145;000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,449</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of Akili</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,748</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/ (Loss) on changes in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,966</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of note receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2018 and January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>85,163</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of Vor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,028</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,373</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of Gelesis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,170</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclass of Karuna to Associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,006</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(Loss) on changes in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,867</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of note receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,480</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of note receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,630</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>154,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Option Pricing Model and Probability Weighted Expected Return Method Inputs for Investments Held at Fair Value at
December&nbsp;31, 2019 and 2018: </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">PWERM (IPO Scenario) Measurement Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Range of Values</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Time&nbsp;to&nbsp;Anticipated<BR>Exit&nbsp;Event</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Probability<br>of IPO</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.50&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1&nbsp;&#151;&nbsp;3.0&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55.0%&nbsp;&#151;&nbsp;75.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">OPM (Long-term Exit Scenario) Measurement Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Range of Values</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expiration Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Volatility</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Risk Free Rate</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.56%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/31/2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.13&nbsp;&#151;&nbsp;3&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56.0%&nbsp;&#151;&nbsp;80.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.59%&nbsp;&#151;&nbsp;1.62%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-56</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summarizes the sensitivity from the assumptions made by the Company in respect to the
unobservable inputs used in the fair value measurement of the Group&#146;s investments held at fair value (please refer to Note 5): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Input</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Investments&nbsp;Held&nbsp;at&nbsp;Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Sensitivity&nbsp;Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial&nbsp;Asset<BR>Increase/&nbsp;(Decrease)</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enterprise Value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-2%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,947)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,947</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-10%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>131</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(143)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time to Liquidity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-6&nbsp;Months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,699</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+6&nbsp;Months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,711)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free Rate&sup1;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">-0.08%/-0.02%</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,699</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+0.10%/+0.16%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,711)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Risk-free rate is a function of the time to liquidity input assumption. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Warrants issued by the Group are classified as
liabilities, as they will be settled in a variable number of shares and are not fixed-for-fixed. The following table summarizes the changes in the Group&#146;s subsidiary warrant liabilities measured at fair value using significant unobservable
inputs (Level 3): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Subsidiary<BR>Warrant&nbsp;Liability<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,095</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,012</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant Issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,706</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis Deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,611</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,890</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,997</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2019, Gelesis amended their existing license and patent agreement with One S.r.l. As a result of the amendment Gelesis
issued One S.r.l. a warrant equal to 2.7 percent of as converted shares following the next financing round. The fair value of the warrant was $4.7 million at issuance. On July&nbsp;1, 2019, Gelesis deconsolidated and warrant liability of $21.6
million relating to Series A-1, A-3, A-4 and One S.r.l. warrants was derecognized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with various amendments to its 2010 Loan and Security
Agreement, Follica issued Series A-1 preferred share warrants at various dates in 2013 and 2014. Each of the warrants has an exercise price of $0.1425 and a contractual term of 10 years from the date of issuance. In 2017, in conjunction with the
issuance of convertible notes, the exercise price of the warrants was adjusted to $0.07 per share. The change in the fair value of the subsidiary warrants was recorded in finance costs, net in the Consolidated Statements of Comprehensive
Income/(Loss). The $8.0 million warrant liability at December&nbsp;31, 2019 is attributable to the outstanding Follica preferred share warrants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-57</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following weighted average assumptions were utilized by the Company with respect to determining the fair
value of the Follica warrants at December&nbsp;31, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Assumption/Input</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT><BR>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated fair value of the convertible preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise price of the warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summarizes the sensitivity from the assumptions made by the Company in respect to the unobservable inputs used
in the fair value measurement of the Group&#146;s warrant liabilities as of December&nbsp;31, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Input</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrant Liability</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Sensitivity&nbsp;Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial&nbsp;Liability<BR>Increase/&nbsp;(Decrease)<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enterprise Value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fair Value Measurement and Classification </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of financial instruments by category at December&nbsp;31, 2019 and 2018: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial<BR>Assets</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial<BR>Liabilities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 1</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 2</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 3</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US treasuries<SUP STYLE="font-size:85%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,088</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,088</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,088</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money Markets<SUP STYLE="font-size:85%; vertical-align:top">2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,586</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,586</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,586</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,905</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">560,460</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">154,445</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,905</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other receivables<SUP STYLE="font-size:85%; vertical-align:top">3</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>853,556</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>697,134</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,977</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>154,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>853,556</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial liabilities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>110,441</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>108,986</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>110,441</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Issued by governments and government agencies, as applicable, all of which are investment grade.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Issued by a diverse group of corporations, largely consisting of financial institutions, virtually all of which
are investment grade. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Outstanding receivables are owed primarily by corporations and government agencies, virtually all of which are
investment grade. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-58</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial<BR>Assets</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial<BR>Liabilities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 1</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 2</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 3</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US treasuries<SUP STYLE="font-size:85%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133,828</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133,828</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133,828</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificates of deposit<SUP STYLE="font-size:85%; vertical-align:top">2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,199</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,199</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,199</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other deposits<SUP STYLE="font-size:85%; vertical-align:top">2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,755</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,592</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,163</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,755</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loans and receivables:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other receivables<SUP STYLE="font-size:85%; vertical-align:top">3</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,328</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,328</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,328</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>307,210</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>218,420</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,627</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>85,163</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>307,210</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial liabilities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,012</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,012</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,012</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,519</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,519</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,519</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,010</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,010</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,010</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>242,541</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,010</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>230,531</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>242,541</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Issued by governments and government agencies, as applicable, all of which are investment grade.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Issued by a diverse group of corporations, largely consisting of financial institutions, virtually all of which
are investment grade. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Outstanding receivables are owed primarily by corporations and government agencies, virtually all of which are
investment grade. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Subsidiary Notes Payable </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The subsidiary notes payable are comprised of loans and convertible notes. During the years ended December&nbsp;31, 2019 and 2018, the financial instruments
for Knode and Appeering did not contain embedded derivatives and therefore these instruments continue to be held at amortised cost. The notes payable consist of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,330</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,552</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>125</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,458</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total subsidiary notes payable</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,010</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Loans </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2010,
Follica entered into a loan and security agreement with Lighthouse Capital Partners VI, L.P. The loans are secured by Follica&#146;s assets, including Follica&#146;s intellectual property. The outstanding loan balance totaled approximately $1.3
million as of each of December&nbsp;31, 2019 and 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2014, Gelesis entered into a grant and loan agreement with an Italian economic development
agency. Borrowings under the loan totaled &#128;1.1&nbsp;million as of December&nbsp;31, 2018 (approximately $1.3 million). Gelesis was required to make interest payments only in fiscal years 2014 and 2015, with principal and interest payments from
January 2017 through January 2024. As of Gelesis&#146; deconsolidation, $0.9 million in outstanding principal and interest remained and the outstanding balance was derecognized. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-59</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Convertible Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Convertible Notes outstanding were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Karuna<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Follica<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Knode<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Appeering<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,812</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,406</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,343</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross principal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,700</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,124</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,824</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(93</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,581</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,581</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 31, 2018 and January 1, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,838</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,495</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>50</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>75</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,458</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross principal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,607</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,607</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">817</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,389</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion to preferred</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,894</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,894</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion to common</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,017</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,017</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>50</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>75</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>125</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of the Group&#146;s subsidiaries have issued convertible promissory notes (&#147;Notes&#148;) to fund their operations
with an expectation of an eventual share-based award settlement of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Substantially all Notes become due and payable on or after either
December&nbsp;31 of the year of issuance or on the thirtieth day following a demand by the majority of Note holders and bear interest at a rate of either 8.0 percent (or 12.0 percent upon an Event of Default) or 10.0 percent (or 15.0 percent upon an
Event of Default). Interest is calculated based on actual days elapsed for a 360-day calendar year. Generally, the Notes cannot be prepaid without approval from the holders of a majority of the outstanding principle of a series of Notes. During the
years ended December&nbsp;31, 2019 and 2018, the Notes were assessed under IFRS 9 and the entire financial instruments are elected to be accounted for as FVTPL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes constitute complex hybrid instruments, which contain equity conversion features where holders may convert, generally at a discount, the outstanding
principal and accrued interest into shares of the subsidiary before maturity and redemption options upon a change of control of the respective subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The three key features are described below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Automatic conversion feature&#151;upon a Qualified Financing, as such term is defined in the applicable Note, the
unpaid principal and interest amounts are automatically converted into shares of the subsidiary issued in the Qualifying Financing at a conversion price equal to the price at which shares are sold in such Qualified Financing, less a discount. The
discounts range from 5.0 percent to 25.0 percent and some require the issuance of an equal number of ordinary shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Optional conversion feature&#151;upon a Non-Qualified Financing, holders may convert the outstanding principal
balance and unpaid interest to shares issued in the Non-Qualifying Financing at a conversion price equal to the price shares are sold in such Non-Qualified Financing, less a discount. The discounts range from 5.0 percent to 25.0 percent and some
require the issuance of an equal number of ordinary shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Change of control features&#151;The Notes also generally contain a put option such that, in the event of a Change
of Control transaction of the respective subsidiary prior to conversion or repayment of the Notes, the holders will be paid an amount equal to two or three times the outstanding principal balance plus any accrued and unpaid interest, in cash, on the
date of the Change of Control. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;15, 2019, Karuna was deconsolidated in conjunction with the closing of a Series B
Preferred Stock financing and the outstanding convertible note liability of $5.0&nbsp;million was derecognized. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-60</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2017 and September 2017, Follica received $0.5 million and $0.6 million, respectively, from an
existing third-party investor through the issuance of convertible notes. The notes bear interest at an annual rate of 10.0 percent, mature 30 days after demand by the holder, are convertible into equity upon a qualifying financing event, and require
payment of at least five times the outstanding principal and accrued interest upon a change of control transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;19, 2019, all of the
outstanding notes, plus accrued interest, issued by Follica converted into 17,639,204 shares of Series A-3 Preferred Stock and 14,200,044 shares of common shares pursuant to a Series A-3 Note Conversion Agreement between Follica and the noteholders.
Third parties held 2,422,990 A-3 preferred shares and 1,981,944 common shares following the conversion. The preferred shares are classified as financial liabilities at fair value through the profit and loss. The common shares are accounted for as
Non-controlling interests. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18. Non-Controlling Interest </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2019, the Company deconsolidated three of its subsidiaries which resulted in a change to the composition of its reportable segments. As such, the
Company has updated the following disclosures. Please refer to Note 4 &#147;Segment Information&#148; for further details regarding reportable segments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the changes in the equity classified non-controlling ownership interest in subsidiaries by reportable segment: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Internal<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Controlled<BR>Founded<BR>Entities<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Non-Controlled<BR>Founded<BR>Entities<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Parent<BR>Company &amp;<BR>Other&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2018*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,484</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,869</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,758</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">525</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(145,586</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of comprehensive loss*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,315</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,710</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,980</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiary*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,168</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,168</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity settled share-based payments*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,476</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,345</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,888</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018 and January&nbsp;1, 2019*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,799</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,103</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(73,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">592</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,264</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,079</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,178</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,178</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary note conversion and changes in NCI ownership interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,049</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,049</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity settled share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,683</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,683</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of minority interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,039</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,039</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(18,233</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>593</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,640</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the year ended December&nbsp;31, 2019, the Company deconsolidated three of its subsidiaries which
resulted in a change to the composition of its reportable segments. Consequently, the Company has revised the 2018 financial information to conform to the presentation as of and for the period ending December&nbsp;31, 2019. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-61</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following tables summarize the financial information related to the Group&#146;s subsidiaries with
material non-controlling interests, aggregated for interests in similar entities, and before intra group eliminations. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the year ended December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internal</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Controlled<BR>Founded<BR>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-Controlled<BR>Founded</B><br><B>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statement of Comprehensive Loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,078</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,968</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(24,289</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(26,250</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(47,905</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(24,289</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(26,250</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(47,915</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statement of Financial Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,614</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,290</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,510</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>50,554</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net assets/(liabilities)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,104</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(45,264</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the year ended December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Internal<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Controlled<BR>Founded<BR>Entities<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Non-Controlled<BR>Founded<br>Entities<br>$000s<SUP STYLE="font-size:85%; vertical-align:top">1</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Statement of Comprehensive Loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,195</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,504</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,454</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,206</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,239</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,454</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,420</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,453</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Statement of Financial Position</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,984</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,603</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,934</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,366</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,992</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">202,161</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,382</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,389</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(166,227</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Non-Controlled Founded Entities non-controlling interest calculation does not include equity method accounting,
fair value method accounting or the gain on the deconsolidation of subsidiary related to Vor, Karuna, Gelesis, resTORbio or Akili, which is recorded within PureTech Health, LLC. Please refer to Note&nbsp;5. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the year ended December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Internal<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Controlled<BR>Founded<BR>Entities<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Non-Controlled<BR>Founded<br>Entities<br>$000s<SUP STYLE="font-size:85%; vertical-align:top">1</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Statement of Comprehensive Loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,880</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">630</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,939</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,843</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(132,382</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">408</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,939</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,843</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(131,974</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Non-Controlled Founded Entities non-controlling interest calculation does not include equity method accounting,
fair value method accounting or the gain on the deconsolidation of subsidiary related to resTORbio or Akili, which is recorded within PureTech Health, LLC. Please refer to Note 5. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;19, 2019 PureTech and a third party investor converted their convertible debt in Follica to Follica Preferred shares (presented as liabilities)
and Follica common shares. The amount of convertible debt converted </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-62</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the third party investor into Follica common shares amounted to $2.4 million (see also Note 16). As a result of the conversion Follica NCI share (in Follica common stock) was reduced from 68%
to 19.9%, which resulted in a reduction in the NCI share in Follica&#146;s shareholders&#146; deficit of $20.1 million. The excess of the change in the book value of NCI ($20.1 million noted above) over the contribution made by NCI ($2.4 million)
amounted to $17.8 million and was recorded as a loss directly in shareholders&#146; equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2019 a subsidiary of the Company fully funded by the
Company ceased its operations and became inactive. This resulted in a change in the NCI share in the subsidiary deficit. As a result the Company recorded a loss directly in equity of $3.1 million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&nbsp;1, 2019, PureTech acquired the remaining 10.0 percent of minority non-controlling interests of PureTech LYT, Inc. (previously named Ariya
Therapeutics, Inc.), increasing its ownership from 90 percent to 100 percent. In consideration for the acquisition of minority interests, PureTech issued 2,126,338 shares of common shares. The fair value of the shares issued in consideration for the
minority non-controlling interest amounted to $9.1 million. The carrying amount of the non-controlling interest at the acquisition was a $24 million deficit and the excess of the consideration paid over the book value of the non-controlling interest
of approximately $33.1 million was recorded directly in shareholders&#146; equity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19. Trade and Other Payables </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information regarding Trade and other payables was as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade payables</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,098</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,644</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,744</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,231</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total trade and other payables</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>19,842</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,875</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20. Other Long-Term Liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information regarding Other long-term liabilities was as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,283</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease incentive obligation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">357</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">738</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other long-term liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,516</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please refer to Note 3 for a discussion of deferred revenue balances as of December&nbsp;31, 2019 and 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>21. Leases </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;1, 2019 the Company adopted
IFRS 16, which replaced IAS 17 for the annual period beginning on January&nbsp;1, 2019. Further discussion around the adoption of IFRS 16 is included in Note 1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-63</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The activity related to the Group&#146;s right of use asset and lease liability for the year ended
December&nbsp;31, 2019 is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Right&nbsp;of&nbsp;use&nbsp;asset,&nbsp;net</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adoption of IFRS 16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,353</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,353</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,434</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subleases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,580</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,237</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,587</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22,383</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Total&nbsp;lease&nbsp;liability</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adoption of IFRS 16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,995</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,995</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,305</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,173</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,495</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,779</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,843</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following reconciles operating lease commitments disclosed as at December&nbsp;31, 2018 to the lease liability recognized
at January&nbsp;1, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease commitments disclosed as at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,443</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discounted using the lessee&#146;s incremental borrowing rate at the date of initial
application</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(448</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Lease liability recognized at January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,995</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following details the short term and long-term portion of the lease liability as at December&nbsp;31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Total&nbsp;lease&nbsp;liability</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term Portion of Lease Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,929</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term Portion of Lease Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,914</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Lease Liability</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,843</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-64</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table details the future maturities of the lease liability, showing the undiscounted lease
payments to be received after the reporting date: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less than one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,257</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">One to two years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Two to three years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,603</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Three to four years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,071</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Four to five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,247</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">More than five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,494</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total undiscounted lease maturities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>50,080</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,237</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total lease liability</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,843</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additions in the period relate to three leases that were entered into by PureTech and its consolidated subsidiaries during the
year ended December&nbsp;31, 2019. Amounts were arrived at using the contractual minimal lease payments, present valued using the applicable incremental borrowing rate, which ranged from 5.49 percent to 6.58 percent. Rent expense related to
short-term leases which are not accounted for under IFRS 16 was $1.3 million for the year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended
December&nbsp;31, 2019, PureTech entered into a lease agreement for certain premises consisting of approximately 50,858 rentable square feet of space located at 6 Tide Street. The lease commenced on April&nbsp;26, 2019 (&#147;Commencement
Date&#148;) for an initial term consisting of ten years and three months and there is an option to extend for two consecutive periods of five years each. As of December&nbsp;31, 2019, the Company has not determined whether it will exercise these
extension options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;26, 2019, PureTech executed a sublease agreement with Gelesis. The lease is for the approximately 9,446 rentable square
feet located on the sixth floor of the Company&#146;s former offices at the 501 Boylston Street building. The sublessee obtained possession of the premises on June&nbsp;1, 2019 and the rent period term begins June&nbsp;1, 2019 and expires on
August&nbsp;31, 2025. The sublease was determined to be a finance lease and was reclassified from the right of use asset to a lease receivable at inception of the sublease. As of December&nbsp;31, 2019 the balances related to the sublease were as
follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="21%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Total&nbsp;lease&nbsp;receivable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term Portion of Lease Receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term Portion of Lease Receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,082</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Lease Liability</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,432</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-65</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table details the future maturities of the lease receivable, showing the undiscounted lease
payments to be received after the reporting date: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less than one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>485</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">One to two years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>494</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Two to three years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>504</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Three to four years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>513</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Four to five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>523</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">More than five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>353</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total undiscounted lease receivable</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,872</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unearned Finance income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>440</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net investment in the lease</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,432</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;6, 2019, PureTech executed a sublease agreement with Dewpoint Therapeutics, Inc. (&#147;Dewpoint&#148;). The
sublease is for approximately 11,852 rentable square feet located on the third floor of the 6 Tide Street building, where the Company&#146;s offices are currently located. Dewpoint obtained possession of the premises on September&nbsp;1, 2019 with a
rent period term that begins on September&nbsp;1, 2019 and expires on August&nbsp;31, 2021. The sublease was determined to be an operating lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rental
income recognized by the Company during the year ended December&nbsp;31, 2019 was $0.36 million. The following table details the future payments under the sublease, showing the undiscounted lease payments to be received after the reporting date:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less than one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,083</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">One to two years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>722</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,805</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the adoption of IFRS 16, minimum rental commitments under non-cancellable leases were payable as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Within one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,742</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Between one and five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,349</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">More than five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">352</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total minimum lease payments</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,443</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some property leases contain extension options exercisable by the Company before the end of the non-cancellable contract
period. The extension options held are exercisable only by the Company and not by the lessors. The Company assesses at lease commencement date whether it is reasonably certain to exercise the extension options. The Company reassesses whether it is
reasonably certain to exercise the options if there is a significant event or significant changes in circumstances within its control. The Company has estimated that the potential future lease payments, should it exercise the extension option, would
result in an increase in lease liability of $18.7 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, the Group reassessed the anticipated term of its
Tide Street lease due to uncertainty as to whether the two extension options provided for in the lease agreement will be exercised. It </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-66</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
was determined that there was sufficient uncertainty as to whether these options would be utilized, resulting in the useful life of the lease being adjusted from 20 years to 10 years. This
resulted in a decrease to the lease liability and right of use asset, as well as an increase to the minimum lease payments due within one year and between one and five years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2018, the Group determined that there were certain tenant improvement allowances that were originally classified as a
reduction to leasehold improvements rather than as a liability. The Company concluded that the impact of the change of a reclassification from property and equipment to other current and long-term liabilities was not material to the Consolidated
Financial Statements presented in the Annual Report of December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total rent expense under these leases was approximately $2.5 million and
$1.3 million during the years ended December&nbsp;31, 2018 and 2017, respectively. Rent expense is included in the General and administrative expenses line item in the Consolidated Statements of Comprehensive Income/(Loss). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>22. Capital and Financial Risk Management </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company&#146;s financial strategy policy is to support its strategic priorities, maintain investor and creditor confidence and sustain future development of the business through an appropriate mix of debt and equity. Management monitors the level of
capital deployed and available for deployment in subsidiary companies. The Directors seek to maintain a balance between the higher returns that might be possible with higher levels of deployed capital and the advantages and security afforded by a
sound capital position. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group&#146;s Directors have overall responsibility for establishment and oversight of its risk management framework. The
Group is exposed to certain risks through its normal course of operations. The Group&#146;s main objective in using financial instruments is to promote the development and commercialization of intellectual property through the raising and investing
of funds for this purpose. The Group&#146;s policies in calculating the nature, amount and timing of investments are determined by planned future investment activity. Due to the nature of activities and with the aim to maintain the investors&#146;
funds as secure and protected, the Group&#146;s policy is to hold any excess funds in highly liquid and readily available financial instruments and maintain insignificant exposure to other financial risks. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Credit Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group has exposure to the following
risks arising from financial instruments: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument
fails to meet its contractual obligations. Financial instruments that potentially subject the Group to concentrations of credit risk consist principally of cash and cash equivalents and trade and other receivables. The Group held the following
balances: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>132,360</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,051</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,088</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133,828</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>714,905</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,755</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other receivables</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,977</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,328</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>879,330</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">421,962</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group invests its excess cash in US Treasury Bills, US debt obligations and money market accounts, which the Group
believes are of high credit quality. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-67</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group assesses the credit quality of customers on an ongoing basis, taking into account its financial
position, past experience and other factors. The credit quality of financial assets that are neither past due nor impaired can be assessed by reference to credit ratings (if available) or to historical information about counterparty default rates.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aging of trade and other receivables that were not impaired at December&nbsp;31 is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neither past due or impaired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,977</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,328</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,977</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,328</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is also potentially subject to concentrations of credit risk in its accounts receivable. Concentrations of credit
risk with respect to receivables is owed to the limited number of companies comprising the Company&#146;s customer base. The Group&#146;s exposure to credit losses is low, however, owing largely to the credit quality of its larger collaborative
partners such as Roche, Boehringer Ingelheim and Eli Lilly. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Liquidity risk is the risk that the Group will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by
delivering cash or another financial asset. The Group actively manages its risk of a funds shortage by closely monitoring the maturity of its financial assets and liabilities and projected cash flows from operations, under both normal and stressed
conditions, without incurring unacceptable losses or risking damage to the Group&#146;s reputation. Due to the nature of these financial liabilities, the funds are available on demand to provide optimal financial flexibility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below summarizes the maturity profile of the Group&#146;s financial liabilities, including subsidiary preferred shares that have customary
liquidation preferences, as of December&nbsp;31, 2019 and 2018 based on contractual undiscounted payments: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Amount</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Within&nbsp;Three<BR>Months</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;to&nbsp;Twelve<BR>Months</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>One&nbsp;to&nbsp;Five<BR>Years</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Subsidiary notes payable</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Trade and other payables</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>19,842</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>19,842</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>19,842</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Warrants</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,997</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,997</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,997</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Subsidiary preferred shares (Note 15)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100,989</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100,989</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100,989</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>130,283</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>130,283</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>130,283</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Carrying<BR>Amount<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Within&nbsp;Three<BR>Months<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Three&nbsp;to&nbsp;Twelve<BR>Months<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">One&nbsp;to&nbsp;Five<BR>Years<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,010</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,010</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,010</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other payables</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,875</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,875</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,875</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,012</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,012</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,012</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary preferred shares (Note 15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,519</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,519</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,519</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">258,416</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">258,416</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">258,416</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-68</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the above financial liabilities, the Group is required to spend the following minimum amounts
under intellectual property license agreements: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2022</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Licenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,366</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,374</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,373</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">773</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,366</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,374</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,373</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>773</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Market risk
is due to changes in market prices, such as foreign exchange rates, interest rates and equity prices that affect the Group&#146;s income or the value of its financial instrument holdings. The objective of the Group&#146;s market risk management is
to manage and control market risk exposures within acceptable parameters, while optimizing its return. The Group maintains the exposure to market risk from such financial instruments to insignificant levels. The Group&#146;s exposure to changes in
interest rates has been determined to be insignificant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Controlled Founded Entity Investments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group maintains investments in certain Controlled Founded Entities. The Group&#146;s investments in Controlled Founded Entities are eliminated as
intercompany transactions upon financial consolidation. The Group is however exposed to a preferred share liability owing to the terms of existing preferred shares and the ownership of Controlled Founded Entities preferred shares by third parties.
The liability of preferred shares is maintained at fair value through the profit and loss. The Group&#146;s strong cash position, budgeting and forecasting processes, as well as decision making and risk mitigation framework enable the Group to
robustly monitor and support the business activities of the Controlled Founded Entities to ensure no exposure to credit losses and ultimately dissolution or liquidation. Accordingly, the Group views exposure to 3rd party preferred share liability as
low. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Non-Controlled Founded Entity Investments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Group maintains certain investments in Non-Controlled Founded Entities which are deemed associates and accounted for under the equity method (please refer to Note 1). The Group&#146;s exposure to investments in associates in limited to the initial
carrying amount upon recognition as an Associate. The Group is not exposed to further contractual obligations or contingent liabilities beyond the value of initial investment. As of December&nbsp;31, 2019, Gelesis was the only associate. The initial
carrying amount of the investment in Gelesis as an associate was $16.4 million. Accordingly, the Group views the risk as high. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Price Risk
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have an investment in common shares of Karuna and resTORbio, as described further in Note 5. As of December&nbsp;31, 2019 the fair value of our
investments in resTORbio and Karuna common shares was $3.2 million and $557.2 million, respectively. These investments are exposed to fluctuations in the market price of these common shares. The effect of a 10.0 percent adverse change in the market
price of resTORbio and Karuna common shares as of December&nbsp;31, 2019 would have been a loss of approximately $0.3 million and $55.7 million, respectively, recognized as a component of Other income (expense) in our Consolidated Statements of
Comprehensive Income/(Loss). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Foreign Exchange Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to Gelesis, prior to deconsolidation, certain grant revenues and the research and development costs associated with those grants are generated and
incurred in Euros. As such, the Group&#146;s certain results of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-69</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
operations and cash flows will be subject to fluctuations due to change in foreign currency exchange rates. Foreign currency transaction exposure arising from external trade flows is generally
not hedged. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Capital Risk Management </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group is
funded by equity and debt financing as well as grant and research collaboration income. Total capital is calculated as Total Equity as shown in the Consolidated Statements of Financial Position. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group&#146;s objectives when managing capital are to safeguard its ability to continue as a going concern in order to provide returns for shareholders and
benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital. To maintain or adjust the capital structure, the Group may issue new shares or incur new debt. The Group has some external debt and no
material externally imposed capital requirements. The Group&#146;s share capital is clearly set out in Note 15. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed in Note 15, certain of the
Group&#146;s subsidiaries have issued preferred shares that include the right to receive a payment in the event of any voluntary or involuntary liquidation, dissolution or winding up of a subsidiary, which shall be paid out of the assets of the
subsidiary available for distribution to shareholders and before any payment shall be made to holders of ordinary shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>23. Commitments and
Contingencies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gelesis is a party to a patent license and assignment agreement whereby it will be required to pay approximately $8.0 million upon the
achievement of certain milestones, pay royalties on future sales and/or a percentage of sublicense income. Gelesis accrued $6.6 million as potential expenses under the patent license and assignment agreement for the years ended December&nbsp;31,
2018 and 2017. During the year ended December&nbsp;31, 2019 Gelesis was deconsolidated. Therefore, there are no additional contingencies recorded related to Gelesis at December&nbsp;31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other members of the Group are also parties to certain licensing agreements that require milestone payments and/or royalties on future sales. None of these
payments have become due and the amounts of any future milestone or royalty payments cannot be reliably measured as of the date of the financial information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>24. Related Parties Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party
Subleases </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2019, PureTech executed sublease agreements with related parties Gelesis and Dewpoint Therapeutics. Please refer to Note 20 for
further details regarding the sublease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Management Personnel Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key management includes executive directors and members of the executive management team of the Group. The key management personnel compensation of the Group
was as follows for the years ended December&nbsp;31: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term employee benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,543</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,998</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,514</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,774</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,062</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,402</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,317</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,060</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,916</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wages and employee benefits include salaries, health care and other non-cash benefits. Share-based payments are generally
subject to vesting terms over future periods. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-70</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Convertible Notes Issued to Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain members of the Group have invested in convertible notes issued by the Group&#146;s subsidiaries. As of December&nbsp;31, 2019, 2018 and 2017, the
outstanding related party notes payable totaled $84 thousand, $79 thousand and $74 thousand, respectively, including principal and interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes
issued to related parties bear interest rates, maturity dates, discounts and other contractual terms that are the same as those issued to outside investors during the same issuances, as described in Note 17. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors&#146; and Senior Managers&#146; Shareholdings and Share Incentive Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors and senior managers hold beneficial interests in shares in the following businesses and sourcing companies as at December&nbsp;31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Directors</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Business Name (Share Class)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares held<BR>as of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>options held<BR>as of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Ownership<BR>Interest&sup1;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ms Daphne Zohar&sup2;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>59,443</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>939,086</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4.30</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dame Marjorie Scardino</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Bennett Shapiro</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Akili (Series A-2 Preferred)&sup3;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>33,088</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>24,009</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,840</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.01</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Series A-1 Preferred)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>23,418</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vedanta Biosciences (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.22</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vedanta Biosciences (Series B Preferred)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,202</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Robert Langer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Entrega (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>332,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4.09</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Alivio (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,575,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6.06</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Raju Kucherlapati</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Enlight (Class B Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr John LaMattina<SUP STYLE="font-size:85%; vertical-align:top">4</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Akili (Series A-2 Preferred)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,372</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis (Common)<SUP STYLE="font-size:85%; vertical-align:top">4</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>117,169</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.50</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis (Common)<SUP STYLE="font-size:85%; vertical-align:top">5</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis (Series A-1 Preferred)<SUP STYLE="font-size:85%; vertical-align:top">4</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>49,524</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta Biosciences (Common)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.22</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr Christopher Viehbacher</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr Stephen Muniz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)<SUP STYLE="font-size:85%; vertical-align:top">5</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Senior Managers:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Eric Elenko</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Joep Muijrers</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Bharatt Chowrira</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Karuna (Common)<SUP STYLE="font-size:85%; vertical-align:top">5</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.04</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Joseph Bolen</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vor (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>125,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ownership interests as of December&nbsp;31, 2019 are calculated on a diluted basis, including issued and
outstanding shares, warrants and options (and written commitments to issue options) but excluding unallocated shares authorized to be issued pursuant to equity incentive plans and any shares issuable upon conversion of outstanding convertible
promissory notes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Common shares and options held by Yishai Zohar, who is the husband of Ms.&nbsp;Zohar. Ms.&nbsp;Zohar does not
have any direct interest in the share capital of Gelesis. Ms Zohar recuses herself from any and all material decisions with regard to Gelesis. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares held through Dr Bennett Shapiro and Ms Fredericka F. Shapiro, Joint Tenants with Right of Survivorship.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-71</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">4.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr John and Ms Mary LaMattina hold 49,523 shares of common shares and 49,524 shares of Series A-1 preferred
shares in Gelesis. Individually, Dr LaMattina holds 12,642 shares of Gelesis and convertible notes issued by Appeering in the aggregate principal amount of $50,000. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">5.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Options to purchase the listed shares were granted in connection with the service on such founded entity&#146;s
Board of Directors and any value realized therefrom shall be assigned to PureTech Health, LLC. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors and senior managers hold
29,939,913 ordinary shares and 10.5 percent voting rights of the Company as of December&nbsp;31, 2019. This amount excludes options to purchase 2,909,344 ordinary shares. This amount also excludes 8,374,351 shares, which are issuable contingent to
the terms of performance based RSU awards granted to certain senior managers covering the financial years 2019, 2018 and 2017. Such shares will be issued to such senior managers in future periods provided that performance conditions are met and
certain of the shares will be withheld for payment of customary withholding taxes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>25. Taxation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tax on the profit or loss for the year comprises current and deferred income tax. Tax is recognized in the Consolidated Statements or Comprehensive
Income/(Loss) except to the extent that it relates to items recognized directly in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2019, 2018 and 2017, the
Group filed a consolidated US federal income tax return which included all subsidiaries in which the Company owned greater than 80% of the vote and value. For the years ended December&nbsp;31, 2019, 2018 and 2017, the Group filed certain
consolidated state income tax returns which included all subsidiaries in which the Company owned greater than 50% of the vote and value. The remaining subsidiaries file separate US tax returns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Current income tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantially enacted at
the reporting date, and any adjustment to tax payable in respect of previous years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred tax is recognized due to temporary differences between the
carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax assets are recognized for unused tax losses, unused tax credits and deductible temporary differences to the extent
that it is probable that future taxable profits will be available against which they can be used. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will
be realized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, using tax rates
enacted or substantively enacted at the reporting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred income tax assets and liabilities are offset when there is a legally enforceable right
to offset current tax assets against current tax liabilities and when the deferred income tax assets and liabilities relate to income taxes levied by the same taxation authority on either the same taxable entity or different taxable entities where
there is an intention to settle the balances on a net basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred taxes are recognized in Consolidated Statements of Comprehensive Income/(Loss)
except to the extent that they relate to items recognized directly in equity or in other comprehensive income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amounts recognized in Consolidated
Statements of Comprehensive Income/(Loss): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,659</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax expense/(benefit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>112,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,221</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,383</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) before taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>478,474</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(68,438</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,711</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-72</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recognized income tax expense/(benefit): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(123</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">358</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">496</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(109</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current income tax expense/(benefit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">498</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>83,776</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,034</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,255</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(311</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28,633</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred income tax expense/(benefit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>112,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,257</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total income tax expense/(benefit), recognized</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>112,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,221</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,383</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The tax expense of $112.4 million, $2.2 million and $4.4 million in 2019, 2018 and 2017, respectively, is primarily the result
of the establishment of a deferred tax liability for unrealized gains pertaining to our investments in Karuna, Vor, AZ Therapies, and Gelesis, and the remeasurement of existing deferred tax liabilities for unrealized gains pertaining to our
investments in resTORbio and Akili. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reconciliation of Effective Tax Rate </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group is primarily subject to taxation in the US A reconciliation of the US federal statutory tax rate to the effective tax rate is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average statutory rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>97,183</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,372</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.00</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,042</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.00</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effects of state tax rate in US</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22,111</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.77</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">376</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.53</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R&amp;D and orphan drug tax credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,321</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1.37</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,268</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.78</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,411</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.41</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payment measurement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>433</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.09</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,429</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5.01</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,531</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3.58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark-to-market adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,725</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.80</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,745</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.47</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,626</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19.27</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion on preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,231</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4.57</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(13,658</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2.95</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,688</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,397</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20.36</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark-to-market investment in subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,070</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal tax change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,741</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20.85</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax reform&#151;foreign earnings repatriation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">898</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.27</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income of partnerships not subject to tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.11</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recognition of deferred tax assets not previously recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,251</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1.35</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current year losses for which no deferred tax asset is recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,514</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.14</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,012</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19.01</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,762</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>674</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.15</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">854</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.25</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(460</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>112,410</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>24.29</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3.25</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6.20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group is also subject to taxation in the UK and exposed to state taxation in certain jurisdictions within the US. Changes
in corporate tax rates can change both the current tax expense (benefit) as well as the deferred tax expense (benefit). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-73</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Deferred Tax Assets and Liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred taxes have been recognized in the US jurisdiction in respect of the following items: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating tax losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>68,690</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,170</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital loss carryovers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,292</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,931</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,056</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment in subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">589</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,711</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,003</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,125</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,339</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,117</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,184</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>104,205</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,002</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment in subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(173,069</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROU asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,115</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other temporary differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,225</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(33,412</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(182,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(33,412</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities, net, recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>115,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,428</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets, net, recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(142</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(449</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets, net, not recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,099</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,569</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have recognized deferred tax assets related to entities in the US Federal and Massachusetts consolidated return groups due
to future reversals of existing taxable temporary differences that will be sufficient to recover the net deferred tax assets. Our remaining deferred tax assets have not been recognized because it is not probable that future taxable profits will be
available to support their realizability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There was movement in deferred tax recognized which impacted income tax expense of approximately $112.4
million, primarily related to the unrealized gains pertaining to our investments in resTORbio, Akili, Karuna, Vor, AZ Therapies, and Gelesis. The deferred tax liability related to the unrealized gains on these investments exceeds our available US
federal and state deferred tax assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company had US federal net operating losses carry forwards (&#147;NOLs&#148;) of approximately $243.0 million,
$238.1 million and $203.1 million as of December&nbsp;31, 2019, 2018 and 2017, respectively, which are available to offset future taxable income. These NOLs expire through 2037 with the exception of $126.6 million which is not subject to expiration.
The Company had US Federal research and development tax credits of approximately $7.4 million, $6.7 million and $4.4 million as of December&nbsp;31, 2019, 2018 and 2017, respectively, which are available to offset future taxes that expire at various
dates through 2039. The Company also had Federal Orphan Drug credits of approximately $3.7 million as of December&nbsp;31, 2019, which are available to offset future taxes that expire at various dates through 2039. These NOLs and credits are subject
to review and possible adjustment by the Internal Revenue Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company had Massachusetts net operating losses carry forwards (&#147;NOLs&#148;)
of approximately $273.0 million, $179.5 million and $116.1 million as of December&nbsp;31, 2019, 2018 and 2017, respectively, which are available to offset future taxable income. These NOLs expire at various dates beginning in 2024. The Company had
Massachusetts research and development tax credits of approximately $1.6 million, $1.3 million and $0.4 million as of December&nbsp;31, 2019 2018 and 2017, respectively, which are available to offset future taxes and expire at various dates through
2034. These NOLs and credits are subject to review and possible adjustment by the Massachusetts Department of Revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Utilization of the NOLs and
research and development credit carryforwards may be subject to a substantial annual limitation under Section&nbsp;382 of the Internal Revenue Code of 1986 due to ownership change limitations </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-74</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that have occurred previously or that could occur in the future. These ownership changes may limit the amount of NOL and research and development credit carryforwards that can be utilized
annually to offset future taxable income and tax, respectively. The Company notes that a 382 analysis was performed through December&nbsp;31, 2019. The results of this analysis concluded that certain net operating losses were subject to limitation
under Section&nbsp;382 of the Internal Revenue Code. None of the Company&#146;s tax attributes which are subject to a restrictive Section&nbsp;382 limitation have been recognized in the financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Uncertain Tax Positions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The changes to uncertain tax
positions from January&nbsp;1, 2018 through December&nbsp;31, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">US<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Foreign<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total&nbsp;$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross tax liabilities as of January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions based on tax provisions related to the current year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions to tax positions of prior years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reductions due to settlements with tax authorities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reductions for positions of prior years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross tax liabilities as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions based on tax provisions related to the current year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions to tax positions of prior years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reductions due to settlements with tax authorities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reductions for positions of prior years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Gross tax liabilities as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">US corporations are routinely subject to audit by federal and state tax authorities in the normal course of business. During
2019, the IRS completed an audit of Vedanta for the financial year ended December&nbsp;31, 2016 with no impact to the Group&#146;s financial condition, results of operations, or cash flows. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>26. Sale of assets </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2018, The Sync Project,
Inc. (&#147;Sync&#148;) entered into an asset purchase agreement with Bose Corporation for the sale of certain assets and liabilities. The total aggregate purchase price was $4.5 million, consisting of approximately $4.0 million paid at closing and
$0.5 million in cash deposited into escrow to be held for 12 months in order to secure the indemnification obligations of Sync after the closing date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PureTech Health derecognized certain assets and liabilities based on their historical costs. The excess of the consideration transferred over the historical
costs of the assets and liabilities resulted in a gain of approximately $4.0 million , which was recorded to the line item &#147;Gain on sale of assets&#148; on the accompanying Consolidated Statements Comprehensive Income/ (Loss) for the year ended
December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, as part of the derecognition, the Company and certain preferred shareholders received a cash distribution of
approximately $3.3 million during the year ended December&nbsp;31, 2018. During the year ended December&nbsp;31, 2019, certain preferred shareholders received further cash distributions of $0.1 million. As of December&nbsp;31, 2019, no remaining
third party obligations remained. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>27. Tal Merger Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2018, Tal Medical, Inc. (&#147;Tal&#148;) a subsidiary of the Group entered into an option agreement with a third
party, through which the third party was given the option to acquire substantially all of Tal&#146;s assets. The option was contingent on the third party raising gross proceeds of $15 million prior to January&nbsp;1, 2019 (the option expiration
date). Upon the expiration of the option all external investors, not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-75</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including PureTech, would be entitled to a distribution equal to the cash on hand on the date of expiration, and Tal&#146;s operations would wind down. As of December&nbsp;31, 2018, the minimum
gross proceeds were not raised, resulting in the option expiring. As a result, the preferred shares were adjusted to the cash distribution the external investors were entitled to, which totaled $0.1&nbsp;million, resulting in gain of $11 million
being recognized in Finance income/(costs)&#151;fair value accounting line of the Consolidated Statements of Comprehensive Income/(Loss) for the year ended December&nbsp;31, 2018. In 2019 a merger was executed between PureTech and Tal wherein
PureTech became the sole shareholder of Tal following the liquidation of all assets. In 2019, certain preferred shareholders received distributions of $0.1 million in connection with the merger. As of December&nbsp;31, 2019 Tal was an inactive
entity in the Group&#146;s Parent segment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>28. Subsequent Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has evaluated subsequent events after December&nbsp;31, 2019, the date of issuance of the Consolidated Financial Statements, and has not identified
any recordable or disclosable events not otherwise reported in these consolidated financial statements or notes thereto, except for the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
January&nbsp;6, 2020, Sonde effected the second tranche closing of its Series A-2 preferred share financing which initially closed on April&nbsp;4, 2019. The Company received an aggregate of $4.8 million in gross proceeds in the second tranche
closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;22, 2020, PureTech Health sold 2,100,000 common shares of Karuna for aggregate proceeds of $200.9 million. As of March&nbsp;13,
2020, PureTech Health held 5,295,397 common shares, or 20.3 percent, of Karuna. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;5, 2020, PureTech Health participated in the second
closing of Vor&#146;s Series A-2 preferred share financing which initially closed on February&nbsp;12, 2019. PureTech&#146;s participation totaled $0.7 million. Proceeds for the second closing totaled $17.8 million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2020, the World Health Organization declared the outbreak of a new Coronavirus, now known as COVID-19, a pandemic. The outbreak of the virus has
caused material disruptions to the global economy, including its health care system. Since the future course and duration of the COVID-19 outbreak are unknown, the Company is currently unable to determine whether the outbreak will have a negative
effect on the Company&#146;s results in 2020. To date, the Company has seen limited impact on its research and development activities and the operation of the Company more generally. If the pandemic continues to extended for a period of time such as
six months, the Company would potentially have milestones delayed; however the Company has sufficient capital to absorb any potential delays and continue operations in line with its going concern statement set forth in Note 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;1, 2020, PureTech Health participated in the second closing of Gelesis&#146; Series 3 Growth preferred share financing which initially closed on
December&nbsp;5, 2019. PureTech&#146;s participation totaled $10.0 million. Proceeds for the second closing totaled $14.1 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2020,
PureTech sold its remaining 2,119,696 resTORbio common shares, for aggregate proceeds of $3.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2020, Vedanta issued and sold shares
of Series C-2 preferred shares for aggregate proceeds of $6.5&nbsp;million, of which none was contributed by PureTech. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;26, 2020, PureTech
sold 555,500 Karuna common shares for aggregate proceeds of $45.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;30, 2020, PureTech participated in the 1st closing of
Vor&#146;s Series B Preferred Share financing. For consideration of $0.5&nbsp;million, PureTech received 961,538 shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-76</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;10, 2020, pursuant to its collaboration agreement with JSR Corporation, Vedanta issued 107,389
Series C-2 Preferred shares for $2.5&nbsp;million in aggregate proceeds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;26, 2020, PureTech sold 1,333,333 common shares of Karuna for
aggregate proceeds of $101.6&nbsp;million. Immediately subsequent to the disposal, PureTech continued to hold 3,406,564 common shares or 12.8 percent of total outstanding shares of Karuna. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Vedanta entered into a $15.0 million loan and security agreement with Oxford Finance LLC. The loan is secured by Vedanta&#146;s
assets, including equipment, inventory and intellectual property. The loan bears a floating interest rate of 7.73% plus the greater of (i)&nbsp;30 day U.S.&nbsp;Dollar LIBOR reported in the Wall Street Journal or (ii)&nbsp;0.17%. The loan matures
September 2025 and requires interest only payments for the initial 24 months. For loan consideration, Vedanta also issued Oxford Finance LLC 12,886 Series C-2 preferred share warrants with an exercise price of $23.28 per share, expiring September
2030. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-77</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_7"></A>Unaudited Condensed Consolidated Statements of Comprehensive
Income/(Loss) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the Six Months Ended June&nbsp;30 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Note</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s<BR>Restated *</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,465</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,955</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,379</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">432</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,844</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,387</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(21,376</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,196</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(38,250</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,507</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(52,782</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,317</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,395</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>276,910</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,375</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss realized on sale of investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(44,539</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>482</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other income/(expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>232,852</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,729</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,032</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,383</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;contractual</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,213</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,866</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,978</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,425</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net finance income/(costs)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,685</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,126</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net gain/(loss) of associates accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(7,271</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) before taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>174,483</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,287</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(50,775</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,145</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other comprehensive income/(loss):</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Items that are or may be reclassified as profit or loss</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total other comprehensive income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,063</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,506</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(249</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,145</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Comprehensive income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,424</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(249</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,063</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Earnings/(loss) per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.43</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.42</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to the unaudited condensed consolidated interim financial statements. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Restated as described in Note 2, primarily as a result of a re-assessment of the Company&#146;s accounting for
the deconsolidation of Karuna and for the asset acquisition by Gelesis. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-78</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_8"></A>Condensed Consolidated Statements of Financial Position as of the
Period Ended </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">Note</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>June&nbsp;30,&nbsp;2020</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>$000s</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">December&nbsp;31,&nbsp;2019</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unaudited</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Non-current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,583</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,455</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right of use asset, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,570</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,383</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>625</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>709,456</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,905</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments in associates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,371</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,642</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease receivable&#151;long-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,895</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,082</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>152</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>758,651</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">772,333</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other receivables</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,200</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,062</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,946</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease receivable&#151;short-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>365</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,124</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,124</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,088</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>340,120</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,360</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>346,871</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">168,845</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,105,523</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">941,178</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity and liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,411</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,408</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share premium</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>288,225</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">287,962</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,506</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(26,776</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,282</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retained earnings/(accumulated deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>378,400</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">254,444</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity attributable to the owners of the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>783,766</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">668,038</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,&nbsp;15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(16,887</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,640</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>766,879</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650,398</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Non-current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>251</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,220</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>148,418</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,445</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability, non-current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>33,935</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,914</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total non-current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>182,605</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,579</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,473</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,474</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability, current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,066</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,929</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other payables</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,802</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,750</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,912</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Subsidiary:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13, 14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,130</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12, 13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>111,238</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>963</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">515</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>156,039</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,201</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>338,644</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,780</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total equity and liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,105,522</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">941,178</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to the unaudited condensed consolidated interim financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-79</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_9"></A>Unaudited&nbsp;Condensed Consolidated Statements of Changes in
Equity </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Share Capital</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">Shares</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Share<BR>premium</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Merger<BR>reserve</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Translation<BR>reserve</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Other<BR>reserve</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Retained<BR>earnings/<BR>(accumulated<BR>deficit)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Total<BR>parent<BR>equity</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Non-</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">controlling<BR>interests</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Total<BR>equity</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Restated&nbsp;*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Restated *</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Restated<BR>*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Restated *</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Restated<BR>*</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>As at January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>282,493,867</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,375</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>278,385</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,923</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(166,693</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>276,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(108,535</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>167,971</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,506</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,506</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,145</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Foreign currency exchange</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(82</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>73,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>73,424</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(42,361</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>31,063</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Deconsolidation of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,584</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,584</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Equity settled share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,251</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,251</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,140</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,391</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(81</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balance June&nbsp;30, 2019 (unaudited)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>282,493,867</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,375</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>278,385</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(72</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>24,177</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(93,269</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>353,103</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(145,172</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>207,931</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Share Capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Shares</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Share<BR>premium<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Merger<BR>reserve<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Translation<BR>reserve<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Other<BR>reserve<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Retained<BR>earnings/<BR>(accumulated<BR>deficit)<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<BR>parent<BR>equity<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Non-<br>controlling<BR>interests<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<BR>equity<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balance as of January&nbsp;1, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>285,370,619</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,408</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>287,962</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(18,282</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>254,444</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>668,037</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,639</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>650,398</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net Income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,957</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,957</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(249</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,708</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(249</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Settlement of restricted stock units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,522</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,522</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,522</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Exercise of share-based awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,842</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">265</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">266</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Distributions</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Revaluation of deferred tax assets related to share-based awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(171</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(171</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(171</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Equity settled share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,200</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,200</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,005</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,206</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balance June&nbsp;30, 2020 (unaudited)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>285,512,461</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,411</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>288,225</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>138,506</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(26,776</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>378,400</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>783,766</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(16,887</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>766,878</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to the unaudited condensed consolidated interim financial statements. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Restated as described in Note 2, primarily as a result of a re-assessment of the Company&#146;s accounting for
the deconsolidation of Karuna and for the asset acquisition by Gelesis. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-80</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_10"></A>Unaudited Condensed Consolidated Statements of Cash Flows
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the Six Months Ended June&nbsp;30 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Note</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s<br>Restated&nbsp;*</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Cash flows from operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,145</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Adjustments to reconcile net income including non-controlling interest to net cash used in
operating activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Non-cash items:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,&nbsp;16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,182</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,858</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Equity settled share-based payment expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,206</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,391</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108,395</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">(Gain)/loss on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(276,910</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(52,375</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Loss realized on sale of investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>44,539</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Loss on associates accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,271</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Loss on disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Income taxes, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>50,775</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,277</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net finance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,686</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,125</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Changes in operating assets and liabilities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(80</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,581</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(28</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,538</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Deferred revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4,971</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,546</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,991</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,837</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>368</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">478</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Income taxes paid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(295</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Interest received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,004</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,878</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Interest paid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,200</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(948</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Net cash used in operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(56,098</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,326</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Cash flows from investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Purchase of property, plant and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,054</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,717</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Purchases of associates preferred shares held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10,650</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,650</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Purchases of investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,556</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash in subsidiary eliminated upon deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,379</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Purchases of short term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(39,693</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Proceeds from sale of investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>248,970</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Receipt of payment for finance sub-lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>171</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Proceeds from maturity of short term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,116</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,995</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Net cash provided by/(used in) investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>266,052</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Cash flows from financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Proceeds from issuance of convertible notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,607</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Repayment of long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(178</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Receipt of PPP loan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>68</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Issuance of preferred shares of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,250</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,478</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>266</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Payment of lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,256</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(502</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Repurchase of vested restricted share units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(12,522</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Net cash provided by financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,194</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,405</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Effect of exchange rates on cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>207,760</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,997</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents at beginning of year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>132,360</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,051</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Cash and cash equivalents at end of year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>340,120</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,048</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Supplemental disclosure of non-cash investment and financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Purchase of intangible asset and investment held at fair value in consideration for issuance of
warrant liability and assumption of other long and short-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,894</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Leasehold improvements purchased through lease incentives (deducted from Right of Use
Asset)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,680</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to the unaudited condensed consolidated interim financial statements. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Restated as described in Note 2, primarily as a result of a re-assessment of the Company&#146;s accounting for
the deconsolidation of Karuna and for the asset acquisition by Gelesis. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-81</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_11"></A>Notes to the Condensed Consolidated Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. General information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Description of Business
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PureTech Health plc (&#147;PureTech,&#148; the &#147;Parent&#148; or the &#147;Company&#148;) is a public company incorporated, domiciled and
registered in the United Kingdom (&#147;UK&#148;). The registered number is 09582467 and the registered address is 8th Floor, 20 Farringdon Street, London EC4A 3AE, United Kingdom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PureTech, which is comprised of PureTech Health plc and its Founded Entities, is a pre-clinical and clinical-stage biotherapeutics company dedicated to
discovering, developing and commercializing highly differentiated medicines for devastating diseases, including intractable cancers, lymphatic and gastrointestinal (GI) diseases, central nervous system (CNS) disorders and inflammatory and
immunological diseases, among others. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PureTech&#146;s Condensed Consolidated Financial Statements (&#147;interim financial statements&#148;) consolidate
those of the Company and its subsidiaries (together referred to as the &#147;Group&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accounting policies applied consistently to all periods
presented in these half-yearly Condensed Consolidated Financial Statements are the same as those applied by the Group in its Consolidated Financial Statements in its 2019 Annual Report and Accounts, with the exception of any new standards the Group
adopted as of January&nbsp;1, 2020, included below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Basis of accounting </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These interim financial statements have been prepared in accordance with International Accounting Standards (&#147;IAS&#148;) 34 Interim Financial Reporting
and should be read in conjunction with the Group&#146;s last Consolidated Financial Statements as of and for the year ended December&nbsp;31, 2019. They do not include all the information required for a complete set of IFRS financial statements.
However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group&#146;s financial position and performance since the last annual consolidated financial
information included in the annual report and accounts as of and for the year ended December&nbsp;31, 2019. Certain amounts in the Condensed Consolidated Financial Statements and accompanying notes may not add due to rounding. All percentages have
been calculated using unrounded amounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group has prepared trading and cash flow forecasts for the Group covering the period to the first quarter of
2024. After making inquiries and considering the impact of risks and opportunities on expected cash flows the Directors have a reasonable expectation that the Group has adequate cash to continue in operational existence for the foreseeable future.
For this reason, the Group has adopted the going concern basis in preparing the half-yearly results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These condensed financial statements were authorized
for issue by the Company&#146;s Board of Directors on August&nbsp;26, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>COVID-19 Pandemic </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2019, illnesses associated with COVID-19 were reported and the virus has since caused widespread and significant disruption to daily life and
economies across geographies. The World Health Organization has classified the outbreak as a pandemic. The Group&#146;s business, operations and financial condition and results has not been significantly impacted during the six months ended
June&nbsp;30, 2020. In response to the COVID-19 pandemic, PureTech has taken swift action to ensure the safety of its employees and other stakeholders. The Company is continuing to monitor the latest developments regarding the COVID-19 pandemic on
its business, operations, and financial condition and results, and has made certain assumptions regarding the pandemic for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-82</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purposes of its operational planning and financial projections, including assumptions regarding the duration and severity of the pandemic and the global macroeconomic impact of the pandemic.
Despite careful tracking and planning, however, PureTech is unable to accurately predict the extent of the impact of the pandemic on its business, operations, and financial condition and results in future periods due to the uncertainty of future
developments. The Company is focused on all aspects of its business and is implementing measures aimed at mitigating issues where possible including by using digital technology to assist operations for our R&amp;D and enabling functions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Significant Accounting policies </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There have been no
significant changes in the Group&#146;s accounting policies from those disclosed in our Consolidated Financial Statements as of and for the year ended December&nbsp;31, 2019. The significant accounting policies we use for half-year financial
reporting are disclosed in Note 1, Accounting policies of the accompanying notes to the Consolidated Financial Statements included in our 2019 Annual Report, in the below paragraph, and in the section below Adoption of New Accounting Standards. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amounts received as
part of research and collaboration agreements to participate in certain research and development activities that do not fall within the scope of IFRS 15 are recorded as a credit to the applicable costs in which the collaborating party is
participating, at the time the costs are incurred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Adoption of New Accounting Standards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There have been no recent new accounting standards that have had an impact on the Company&#146;s Condensed Consolidated Financial Statements. New accounting
standards not listed below were assessed and determined to be either not applicable or did not have a material impact on the Company&#146;s Condensed Consolidated Financial Statements or processes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We adopted the amendments to IAS 1, Presentation of Financial Statements, and IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors which
clarified the definition of &#145;materiality&#146; and how it should be applied. The amendments also improve the explanations of the definition and ensure consistency across all IFRS Standards. There was no impact on the Group&#146;s Condensed
Consolidated Financial Statements from the adoption of this new standard. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Prior period </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Primarily as a result of a re-assessment of the Company&#146;s accounting for the deconsolidation of Karuna and for the asset acquisition by Gelesis (which was
deconsolidated on July&nbsp;1, 2019), the Company has made certain restatements in its Condensed Consolidated Statement of Comprehensive Income, Condensed Consolidated Statements of Changes in Equity and its Condensed Consolidated Statement of Cash
Flows for the six months ended June&nbsp;30, 2019, as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Condensed Consolidated Statement of Comprehensive Income </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended June&nbsp;30, 2019, the Company deconsolidated two of its subsidiaries due to loss of control. The gain on deconsolidation was not
calculated in accordance with IFRS 10, predominantly since part of the gain was recognized in equity as opposed to Other income. An adjustment has been made in respect of the above, which resulted in an increase to Other income of $45.2 million,
against a direct decrease to the retained earnings account of $46.4 million, an increase to Other reserves of $3.8&nbsp;million and a decrease to Non-controlling interests of $2.6&nbsp;million. The impact of these adjustments on the Company&#146;s
consolidated comprehensive income for the period was an increase in income of $45.2 million to $31.1 million profit, rather </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-83</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
than a loss of $14.1 million as reported before. There was no impact on the opening balances at January&nbsp;1, 2019. The changes are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As<BR>Previously<BR>Reported</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjustment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As<BR>Restated</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,231</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,395</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other income/(expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,565</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,729</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) before taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,123</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,287</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,019</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,145</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,101</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,063</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,342</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,506</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,019</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,145</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Comprehensive income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,260</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,424</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,101</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,063</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Earnings per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">$</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">$</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">$</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-84</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Condensed Consolidated Statements of Changes in Equity </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the aforementioned adjustment in the application of IFRS 10, as well as an adjustment to the IFRS 16 implementation (which constituted primarily
a reclassification with the Deconsolidation of Subsidiaries line item, which did not impact the total retained earnings), the Company has made the following adjustments to the Condensed Consolidated Statements of Changes in Equity for the six months
ended June&nbsp;30, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Other&nbsp;reserve<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Retained<BR>earnings/(accumulated<BR>deficit)<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total&nbsp;parent<BR>equity <BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Non-<br>controlling<BR>interests <BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total&nbsp;equity<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>As previously reported</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment for the initial application of IFRS&nbsp;16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(642</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(642</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(642</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted balance as of January&nbsp;1, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,923</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(168,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">274,865</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,330</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,342</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,342</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,019</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) for the period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,342</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,260</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,101</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,794</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,621</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,827</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,189</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,015</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance June&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,380</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(92,371</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,203</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(142,567</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">207,635</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Adjustments</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment for the initial application of<BR>IFRS 16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,641</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,641</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,641</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted balance as of January&nbsp;1, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,641</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,641</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,641</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) for the period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,164</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,794</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,621</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,827</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,605</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(46,432</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(81</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance June&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,797</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,900</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,605</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">295</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>As Restated</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment for the initial application of<BR>IFRS 16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">999</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">999</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">999</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted balance as of January&nbsp;1, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,923</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(166,693</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">276,506</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">167,971</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,506</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,506</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,145</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) for the period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,506</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,424</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,063</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,584</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,584</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(81</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance June&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,177</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(93,269</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">353,103</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(145,172</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">207,931</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-85</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Condensed Consolidated Statement of Cash Flows </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has restated the Condensed Consolidated Statement of Cash Flows for the six months ended June&nbsp;30, 2019 to adjust mis-categorization of certain
line items (see below). These adjustments do not change the overall increase in cash and cash equivalents during the period, which remained constant. The impact is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;Previously&nbsp;Reported</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;Restated</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,844</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,326</TD>
<TD NOWRAP VALIGN="bottom">)<SUP STYLE="font-size:85%; vertical-align:top">(a)</SUP>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,512</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,487</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(b)</SUP>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,049</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,644</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,405</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(c)</SUP>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of exchange rates on cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,997</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,997</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The adjustments to net cash used in operating activities were primarily in relation to (1)&nbsp;changes made to
the treatment of an asset acquisition by Gelesis, which was mostly non-cash in nature for the six months ended June&nbsp;30, 2019, accounted for previously as if it were an actual cash outflow. The updated presentation reflects this change which is
to remove this transaction from both operating and investing activities, resulting in a $11.2 million increase in cash provided by investing activities against an increase in cash used in operating activities; (2)&nbsp;the sale of a short term
investment, which was previously inappropriately classified as an operating activity when this was an investing activity. This totaled $5.0 million and the appropriate classification has now been applied. As a result there was a $5.0 million
increase in cash used by operating activities and an increase in cash provided by investing activities; (3)&nbsp;changes made to the categorization of assets and liabilities that were disposed of in the deconsolidation of Karuna, resulting in a
$2.0&nbsp;million increase in cash used by operating activities and an increase in cash provided by investing activities; and (4)&nbsp;a removal of the loss on issuance of Gelesis preferred shares of $1.6&nbsp;million which was originally included
as a cash movement in financing activities. This change resulted in a $1.6&nbsp;million increase in cash used by operating activities and an increase in cash provided by financing activities. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As evidenced in footnote (a), the main adjustments to investing activities were the $11.2&nbsp;million increase
in cash provided by investing activities related to the Gelesis asset acquisition, the increase of $5.0&nbsp;million related to the sale of a short-term investment, as well as the increase of $2.0&nbsp;million related to the changes made to
categorization of assets and liabilities disposed of in the deconsolidation of Karuna. Also, $4.7 million was removed from financing activities to decrease net cash provided by financing activities, and from investing activities to increase net cash
provided by investing activities, that is to reflect the non-cash nature of the investment in the above mentioned asset acquisition by Gelesis in exchange for the issuance of warrants. Other changes of approximately $0.6&nbsp;million resulted from
an adjustment to correct purchases of property, plant and equipment. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The adjustment is the result of the $4.7&nbsp;million change mentioned in footnote (b)&nbsp;as well as an
adjustment for the payment of the lease liability of $0.5&nbsp;million, partially offset by the removal of the loss on issuance of Gelesis preferred shares described in footnote (a)&nbsp;of $1.6&nbsp;million. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please note that no changes will need to be made to the full year financials for 2019 reported on April&nbsp;9, 2020 as a result of the above mentioned
adjustments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-86</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Revenue </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue recorded in the Condensed Consolidated Statement of Comprehensive Income/(Loss) consists of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the six months ended June&nbsp;30,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,465</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,955</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,379</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">432</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,844</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,387</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All amounts recorded in contract revenue were generated in the United States. All of the Company&#146;s contracts as of
June&nbsp;30, 2020 and 2019 were determined to have a single performance obligation which consists of a combined deliverable of license to intellectual property and research and development services. Therefore revenue is recognized over time based
on the input method which the Company believes is a faithful depiction of the transfer of goods and services. Progress is measured based on costs incurred to date as compared to total projected costs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Disaggregated Revenue </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group disaggregates contract revenue
in a manner that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The Group disaggregates revenue based on contract revenue or grant revenue, and further disaggregates contract
revenue based on the transfer of control of the underlying performance obligations. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Timing of revenue recognition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transferred at a point in time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transferred over time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,465</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,955</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,465</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,955</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Customers over 10% of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roche Holding AG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,518</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,479</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eli Lilly and Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>339</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">765</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Boehringer Ingelheim International GMBH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,398</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Imbrium Therapeutics L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,148</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">457</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,403</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,701</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Segment Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the second half of 2019, the Company deconsolidated one of its subsidiaries which resulted in a change to the composition of its reportable segments.
Consequently, the Company revised the June&nbsp;30, 2019 financial information to conform to the presentation as of and for the period ending June&nbsp;30, 2020. The change in segments reflects how the Company&#146;s Board of Directors reviews the
Group&#146;s results, allocates resources and assesses performance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-87</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information About Reportable Segments: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internal</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Controlled<BR>Founded<BR>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-Controlled<BR>Founded<BR>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Parent<BR>Company &amp;<BR>Other</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Consolidated</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30, 2020 $000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Comprehensive Loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,916</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,549</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,465</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,379</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,379</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,916</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,928</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,844</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,495</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,229</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(13,652</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(21,376</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(20,594</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(40</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(38,250</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total operating income/(expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(15,195</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(23,895</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(13,692</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(52,782</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>276,910</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>276,910</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss realized on sale of investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(44,539</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(44,539</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>478</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>482</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>232,848</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>232,852</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net finance income/(costs)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,765</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(97</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,685</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net income/(loss) of associates accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(7,271</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(7,271</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) from continuing operations</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(15,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(22,127</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>211,788</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>174,483</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) before taxes pre IFRS 9 fair value accounting, finance costs&#151;subsidiary
preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(13,489</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(21,617</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>216,111</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>181,005</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;IFRS 9 fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,866</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,866</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payment expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,301</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,005</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,900</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(5,206</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation of tangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(388</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(784</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(782</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,955</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of ROU assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(586</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(641</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,227</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(50,774</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(50,775</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(15,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(22,128</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>161,014</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(15,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(22,128</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>161,014</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(15,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(21,873</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>161,008</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(254</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(249</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="20"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June 30, 2020 $000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Financial Position:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>35,905</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>42,960</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,026,657</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,105,522</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>42,222</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>156,024</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>140,398</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>338,644</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net assets/(liabilities)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,317</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(113,064</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>886,259</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>766,879</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-88</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internal</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Controlled<BR>Founded<BR>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-Controlled<BR>Founded<BR>Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Parent<BR>Company<BR>&amp; Other</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Consolidated</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30, 2019 $000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Comprehensive Loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,479</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,262</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">213</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,955</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">418</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">432</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,494</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,680</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">213</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,387</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,157</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,391</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,439</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,210</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,196</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,757</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,534</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,555</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(662</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,507</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total operating income/(expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,420</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,244</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,994</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,659</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,317</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation (restated)*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,395</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,395</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,375</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,375</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(39</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income/(expense) (restated)*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(39</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,751</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,729</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net finance income/(costs)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,099</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,126</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) from continuing operations (restated)*</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,382</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(56,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">149,207</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,287</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>(Loss)/income before taxes pre IFRS 9 fair value accounting, finance costs&#151;subsidiary
preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,285</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,874</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">152,205</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,939</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,564</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,425</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;IFRS 9 fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,297</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,737</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,978</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payment expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(786</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,543</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,059</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,391</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation of tangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(818</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(207</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(126</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of ROU assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(513</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(868</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,464</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(129</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(173</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,970</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) (restated)*</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,392</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(56,297</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,237</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,145</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,392</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(56,380</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,237</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,063</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive income/(loss) attributable to:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company (restated)*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,428</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,073</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,237</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,424</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,090</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,964</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,307</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="20"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December 31, 2019 $000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Financial Position:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,614</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,730</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">868,834</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">941,178</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,053</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146,054</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">134,673</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,780</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net (liabilities)/assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,561</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(91,324</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">734,161</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650,398</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 2 </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-89</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Investments held at fair value </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investments held at fair value include both unquoted nonpublic investments and quoted public investments held by PureTech. These investments, which include
Akili, Vor, Karuna, Gelesis (other than the investment in common shares), resTORbio and other insignificant investments, are initially measured at fair value and are subsequently re-measured at fair value at each reporting date. Interests in these
investments are accounted for as investments held at fair value, as shown below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000&#146;s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,905</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale of Karuna shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(245,922</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale of resTORbio shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,048</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss realised on sale of investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,539</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash purchase of Gelesis preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash purchase of Vor preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,150</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss)&#151;fair value through profit and loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">276,910</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>As of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>709,456</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gelesis </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;1,
2020, PureTech participated in the 2nd closing of Gelesis&#146;s Series 3 Growth Preferred Share financing. For consideration of $10.0 million, PureTech received 579,038 Series 3 Growth shares. During the six months ended June&nbsp;30, 2020, the
Company recognized a gain of $2.4&nbsp;million related to the preferred shares and warrants that was recorded in the line item Gain/(loss) on investments held at fair value within the Condensed Consolidated Statement of Income/(Loss) and Other
Comprehensive Income/(Loss). Please refer to Note 13 for information regarding the valuation of these instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vor </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;12, 2020, PureTech participated in the 2nd closing of Vor&#146;s Series A-2 Preferred Share financing. For consideration of $0.7&nbsp;million,
PureTech received 1,625,000 A-2 shares. On June&nbsp;30, 2020, PureTech participated in the 1st closing of Vor&#146;s Series B Preferred Share financing. For consideration of $0.5&nbsp;million, PureTech received 961,538 shares. Additionally, during
the six months ended June&nbsp;30, 2020 the Company recognized a fair value loss of $1.4&nbsp;million that was recorded in the line item Gain/(loss) on investments held at fair value within the Condensed Consolidated Statement of Income/(Loss) and
Other Comprehensive Income/(Loss). Please refer to Note 13 for information regarding the valuation of these instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Karuna </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;22, 2020, PureTech sold 2,100,000 shares of Karuna for aggregate proceeds of $200.9&nbsp;million. On May&nbsp;26, 2020, PureTech sold an
additional 555,500 Karuna common shares for aggregate proceeds of $45.0&nbsp;million. As a result of the sales, the Company recorded a loss of $44.3&nbsp;million attributable to blockage discount included in the sales price, to the line item Loss
Realized on Sale of Investment within the Condensed Consolidated Statement of Income/ (Loss) and Other Comprehensive Income/ (Loss). Additionally, during the six months ended June&nbsp;30, 2020 and 2019 the Company recognized a gain of
$261.4&nbsp;million and $40.6&nbsp;million, respectively that was recorded on the line item Gain/(loss) on investments held at fair value within the Condensed Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). As of
June&nbsp;30, 2020, PureTech continued to hold 4,739,897 Karuna common shares or 17.8&nbsp;per cent of total outstanding Karuna common shares. Please refer to Note 13 for information regarding the valuation of these instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Akili </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended June&nbsp;30, 2020 and
2019, the Company recognized a gain of $14.3&nbsp;million and a loss of $3.9&nbsp;million, respectively, that was recorded on the line item Gain/(loss) on investments held at fair value </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-90</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
within the Condensed Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). Please refer to Note 13 for information regarding the valuation of these instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>resTORbio </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2020, PureTech sold its remaining
2,119,696 resTORbio common shares, for aggregate proceeds of $3.0&nbsp;million. As a result of the sale, the Company recorded a loss of $0.2&nbsp;million attributable to blockage discount included in the sales price, to the line item Loss Realized
on Sale of Investment within the Condensed Consolidated Statement of Income/ (Loss) and Other Comprehensive Income/ (Loss). Additionally, during the six months ended June&nbsp;30, 2020 and 2019, the Company recognized a loss of $0.1&nbsp;million and
gain of $15.5&nbsp;million, respectively, that was recorded on the line item Gain/(loss) on investments held at fair value within the Condensed Consolidated Statement of Income/(Loss) and Other Comprehensive Income/(Loss). Please refer to Note 13
for information regarding the valuation of these instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on deconsolidation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the gain on deconsolidation recognized by the Company: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Six Months Ended June&nbsp;30</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$000s</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<BR>(restated)&nbsp;*<br>$000s</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation of Vor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,357</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation of Karuna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,038</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total gain on deconsolidation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>108,395</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 2 </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Share-based Payments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share-based payments includes
stock options, restricted stock units (&#147;RSUs&#148;) as well as service, market and performance-based RSU awards, all in which the expense is recognized based on the grant date fair value of the awards. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Share-based Payment Expense </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group&#146;s share-based
payment expense for the six months ended June&nbsp;30, 2020 and 2019, were comprised of charges related to the PureTech Health plc incentive stock and stock option issuances and subsidiary stock plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides the classification of the Group&#146;s consolidated share-based payment expense as reflected in the Condensed Consolidated
Statement of Income/(Loss): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Six months ended June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,522</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,847</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,684</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,544</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,206</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,391</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Performance Share Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2015, the Group adopted the Performance Stock Plan (&#147;PSP&#148;). Under the PSP and subsequent amendments, awards of ordinary shares may be made to
the Directors, senior managers and employees of, and other individuals providing services to the Company and its subsidiaries up to a maximum authorized amount of 10 percent of the total ordinary shares outstanding. The shares have various vesting
terms over a period of service between two and four years, provided the recipient remains continuously engaged as a service provider. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-91</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The share-based awards granted under the PSP are equity settled and expire 10 years from the grant date. As
of the six months ended June&nbsp;30, 2020, the Company had granted share-based awards of 8,592,307 stock options and 4,636,347 RSUs, net of forfeitures, exercises and issued RSU shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>RSUs </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended June&nbsp;30, 2020 and
2019, the Company issued no new service, market and performance based RSUs under the PSP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each RSU entitles the holder to one ordinary share on vesting
and the RSU awards are based on a cliff vesting schedule over a three-year requisite service period in which the Company recognizes compensation expense. Following vesting, each recipient will be required to make a payment of one pence per ordinary
share on settlement of the RSUs. Vesting of the RSUs is subject to the satisfaction of service, market and performance conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes
the estimated fair value of service, market and performance-based awards as share-based compensation expense over the vesting period based upon its determination of whether it is probable that the performance targets will be achieved. The Company
assesses the probability of achieving the performance targets at each reporting period. Cumulative adjustments, if any, are recorded to reflect subsequent changes in the estimated outcome of performance-related conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the market-based awards is based on the Monte Carlo simulation analysis utilizing a Geometric Brownian Motion process with 100,000
simulations to value those shares. The model considers share price volatility, risk-free rate and other covariance of comparable public companies and other market data to predict distribution of relative share performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The service, market and performance conditions attached to the 2019 RSU awards awarded in December 2019 are based on the achievement of total shareholder
return (&#147;TSR&#148;), with 50 percent of the shares under award vesting based on the achievement of absolute TSR targets, 12.5 percent of the shares under the award vesting based on TSR as compared to the FTSE 250 Index, 12.5 percent of the
shares under the award vesting based on TSR as compared to the MSCI Europe Health Care Index, and 25.0 percent of the shares under the award vesting based on the achievement of strategic targets. The RSU award criteria have changed over time as the
criteria is continually evaluated by the Group&#146;s Remuneration Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2017, the Company granted certain executives RSUs that vested based on
service, market and performance conditions. The vesting of all RSUs was achieved by December&nbsp;31, 2019 where all service, market and performance conditions were met. The remuneration committee of PureTech&#146;s board of directors approved the
achievement of the vesting conditions as of December&nbsp;31, 2019 and reached the decision to cash settle the 2017 RSUs. The settlement value was determined based on the 3 day average closing price of the shares. The settlement value was
$12.5&nbsp;million. The settlement value did not exceed the fair value at settlement date and as such the cash settlement was treated as an equity transaction, whereby the full repurchase cash settlement amount was charged to equity in Other
reserves. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company incurred share-based payment expenses for performance based RSUs of $2.7&nbsp;million and $1.3 million for the six months ended
June&nbsp;30, 2020 and 2019, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Options </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended June&nbsp;30, 2020 and 2019, the Company granted 665,392 and 1,274,388 stock option awards under the PSP, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-92</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the stock options awarded by the Company was estimated at the grant date using the
Black-Scholes option valuation model, considering the terms and conditions upon which options were granted, with the following weighted- average assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the six months ended June&nbsp;30,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>39.00&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36.00&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected terms (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5.65</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.75&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.25&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant date fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.11</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.89</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share price at grant date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2.97</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.49</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, 5,186,804 incentive options are exercisable with a weighted-average exercise price of $1.51.
Exercise prices ranged from $0.01 to $3.61. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company incurred share-based payment expenses for incentive options of $1.5&nbsp;million and $0.9 million
for the six months ended June&nbsp;30, 2020 and 2019, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Significant Subsidiary Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The subsidiaries incurred $1.0 million and $4.3 million in share-based payment expense for the six months ended June&nbsp;30, 2020 and 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Vedanta 2010 Stock Incentive Plan </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2010, the Board of
Directors for Vedanta approved the 2010 Stock Incentive Plan (the &#147;Vedanta Plan&#148;). Through subsequent amendments, as of June&nbsp;30, 2020, it allowed for the issuance of 2,145,867 share-based compensation awards through incentive share
options, nonqualified share options, and restricted shares to employees, directors, and nonemployees providing services to Vedanta. At June&nbsp;30, 2020, 380,723 shares remained available for issuance under the Vedanta Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The options granted under Vedanta Plan are equity settled and expire 10 years from the grant date. Typically, the awards vest in four years but vesting
conditions can vary based on the discretion of Vedanta&#146;s Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options granted under the Vedanta Plan are exercisable at a price per
share not less than the fair market value of the underlying ordinary shares on the date of grant. The estimated fair value of options, including the effect of estimated forfeitures, is recognized over the options&#146; vesting period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the stock option grants has been estimated at the date of grant using the Black-Scholes option pricing model, with the following
weighted-average assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">For the six months ended June&nbsp;30,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>78.24</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90.94</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected terms (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.79</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.88</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant date fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>13.13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share price at grant date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>19.59</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vedanta incurred share-based compensation expense of $0.8&nbsp;million for six months ended June&nbsp;30, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-93</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Subsidiary Plans </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stock-based compensation expense under plans at other subsidiaries of the Group not including Vedanta, was $0.2&nbsp;million for the six months ended
June&nbsp;30, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Finance Cost, net </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following table shows the breakdown of finance income and costs: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Finance income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest from financial assets not at fair value through profit or loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,032</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,383</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total finance income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,032</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,383</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Finance costs</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contractual interest expense on notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(140</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest Expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,200</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,032</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on foreign currency exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total finance income/(costs)&#151;contractual</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,213</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) from change in fair value of warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>867</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,664</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) from change in fair value of preferred share and convertible note liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>999</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,314</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total finance income/(costs)&#151;fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,866</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,978</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total finance income/(costs)&#151;subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,425</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Finance income/(costs), net</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,685</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,126</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Earnings/(Loss) per Share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic earnings/(loss) per share is computed by dividing the income/(loss) attributable to the Company and available to ordinary shareholders by the weighted
average number of ordinary shares. Dilutive earnings/loss per share is computed by dividing the income/(loss) attributable to the Company and available to ordinary shareholders by the sum of the weighted average number of ordinary shares and the
number of additional ordinary shares that would have been outstanding if the Company&#146;s outstanding potentially dilutive securities had been issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of basic and diluted earnings/(loss) per ordinary shares for the periods presented (in thousands, except for
shares and per share amounts): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<br>Restated *</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income/(loss) attributable to the owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,506</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average ordinary shares for basic earnings per ordinary share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>285,487,375</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,493,867</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of dilutive securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,170,249</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,167,815</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average ordinary shares for diluted earnings per ordinary share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>293,657,624</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,661,682</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings per ordinary share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.43</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings per ordinary share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.42</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 2 </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-94</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Property and Equipment </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Laboratory<BR>and<BR>Manufacturing<BR>Equipment<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Furniture<BR>and<br>Fixtures<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Computer<BR>Equipment<BR>and<br>Software<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Leasehold<BR>Improvements<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Construction<BR>in<br>process<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,306</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">488</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,431</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,924</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,388</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions, net of transfers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,374</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,126</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,494</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,649</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,819</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(183</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(168</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(406</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,076</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,190</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,158</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,385</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,452</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,508</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,656</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">645</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,647</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions, net of transfers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">829</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">818</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,098</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(345</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(385</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,849</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,452</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,519</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,054</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,465</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,338</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Accumulated depreciation and impairment loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Laboratory<BR>and<BR>Manufacturing<BR>Equipment<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Furniture<BR>and<br>Fixtures<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Computer<BR>Equipment<BR>and<br>Software<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Leasehold<BR>Improvements<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Construction<BR>in<br>process<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(233</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(756</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,854</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,065</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,328</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(312</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,448</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">265</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,457</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">319</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,830</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,968</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(239</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,030</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,955</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(761</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(157</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,955</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">345</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">385</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,378</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(347</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,145</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,885</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(8,755</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Property and Equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Laboratory&nbsp;and<BR>Manufacturing<BR>Equipment<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Furniture&nbsp;and<BR>Fixtures<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Computer<BR>Equipment&nbsp;and<br>Software<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Leasehold<BR>Improvements<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Construction&nbsp;in<BR>process<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December 31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,084</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">255</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">675</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,070</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,323</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,418</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,213</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">478</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,701</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">645</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,455</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,471</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,106</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>373</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,169</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,465</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,583</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation of property and equipment is included in the General and administrative expenses, and Research and development
expenses line items in the Condensed Consolidated Statements of Comprehensive Income/(Loss). The Company recorded depreciation expense of $2.0&nbsp;million and $1.2&nbsp;million for the six months ended June&nbsp;30, 2020 and 2019, respectively.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-95</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Intangible Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intangible assets consist of licenses of intellectual property acquired by the Group through various agreements with third parties, and are recorded at the
value of cash and non-cash consideration transferred. Information regarding the cost and accumulated amortization of intangible assets is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Licenses<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at 31&nbsp;December 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,067</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,842</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of 31&nbsp;December 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of 30&nbsp;June 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>625</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Accumulated amortisation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Licenses<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at 31&nbsp;December 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,987</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortisation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deconsolidation of subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,104</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of 31&nbsp;December 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of 30&nbsp;June 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Intangible assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Licenses<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of 31&nbsp;December 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of 30&nbsp;June 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>625</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These intangible asset licenses represent in-process-research-and-development assets since they are still being developed and
are not ready for their intended use. As such, these assets are not yet amortized but tested for impairment annually. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Equity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At June&nbsp;30, 2020 and December&nbsp;31, 2019, 285,512,461 and 285,370,619 common shares were outstanding, respectively, including all vested common shares
issued pursuant to PureTech Health LLC Incentive Compensation arrangements as detailed in Note 6. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Subsidiary Preferred Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IFRS 9 addresses the classification, measurement, and recognition of financial liabilities. Preferred shares issued by subsidiaries and affiliates often
contain redemption and conversion features that are assessed under IFRS 9 in conjunction with the host preferred share instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The subsidiary
preferred shares are redeemable upon the occurrence of a contingent event, other than full liquidation of the Company, that is not considered to be within the control of the Company. Therefore these subsidiary preferred shares are classified as
liabilities. These liabilities are measured at fair value through profit and loss. The preferred shares are convertible into ordinary shares of the subsidiaries at the option of the holder and mandatorily convertible into ordinary shares upon a
subsidiary listing in a public market at a price above that specified in the subsidiary&#146;s charter or upon the vote of the holders of subsidiary preferred shares specified in the charter. Under certain scenarios the number of ordinary shares
receivable on conversion will change and therefore, the number of shares that will be issued is not fixed. As such the conversion feature is considered to be an embedded derivative that normally would require bifurcation. However, since the
preferred share liabilities are measured in whole at fair value through profit and loss no bifurcation is required. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-96</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preferred shares are entitled to vote with holders of common shares on an as converted basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group recognizes the preferred share balance upon the receipt of cash financing or upon the conversion of notes into preferred shares at the amount
received or carrying balance of any notes and derivatives converted into preferred shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The balance as of June&nbsp;30, 2020 and December&nbsp;31,
2019 represents the fair value of the instruments for all subsidiary preferred shares. The following summarizes the subsidiary preferred share balance: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B>As of June&nbsp;30, 2020 and December&nbsp;31,
2019<B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,042</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,222</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,486</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,663</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,632</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,212</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta Biosciences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>85,079</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,892</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total subsidiary preferred share balance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>111,238</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As is customary, in the event of any voluntary or involuntary liquidation, dissolution or winding up of a subsidiary, the
holders of subsidiary preferred shares which are outstanding shall be entitled to be paid out of the assets of the subsidiary available for distribution to shareholders and before any payment shall be made to holders of ordinary shares. A merger,
acquisition, sale of voting control or other transaction of a subsidiary in which the shareholders of the subsidiary do not own a majority of the outstanding shares of the surviving company shall be deemed to be a liquidation event. Additionally, a
sale, lease, transfer or other disposition of all or substantially all of the assets of the subsidiary shall also be deemed a liquidation event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of
June&nbsp;30, 2020 and December&nbsp;31, 2019, the minimum liquidation preference reflects the amounts that would be payable to the subsidiary preferred holders upon a liquidation event of the subsidiaries, which is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B>As of June&nbsp;30, 2020 and December&nbsp;31,
2019<B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entrega</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,216</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,216</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Follica</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,405</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,405</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonde</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,250</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta Biosciences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>83,661</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,161</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total minimum liquidation preference</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>104,282</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,032</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, the minimum liquidation preference increased as compared to December&nbsp;31, 2019 owing to the
issuance of shares by Vedanta and Sonde. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the six months ended June&nbsp;30, 2020, the Group recognized the following changes in the value of
subsidiary preferred shares: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of new preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,250</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Decrease in value of preferred shares measured at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(999</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>111,238</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-97</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2020 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
January 2020 and April 2020, Sonde Health issued and sold shares of Series A-2 preferred shares for aggregate proceeds of $4.8&nbsp;million, of which none was contributed by PureTech. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2020, Vedanta issued and sold shares of Series C-2 preferred shares for aggregate proceeds of $6.5&nbsp;million, of which none was contributed by
PureTech. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Financial Instruments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Group&#146;s financial instruments consist of financial liabilities, including preferred shares, convertible notes, warrants and loans payable, as well as financial assets classified as assets held at fair value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fair Value Process </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For financial instruments measured at
fair value under IFRS 9, under the further guidance of IFRS 13, the change in the fair value of the entire instrument is reflected through profit and loss. The total business enterprise value and allocatable equity of each entity within the Group
was determined using a discounted cash flow income approach, replacement cost/asset approach, market scenario approach, or market backsolve approach through a recent arm&#146;s length financing round. The approaches, in order of best evidentiary
support, are detailed as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Valuation Method</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Market&#151;Backsolve</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The market backsolve approach benchmarks the original issue price (OIP) of the company&#146;s latest funding transaction as current value. This is based on the premise that the OIP is a result of rational negotiations and
comprehensive due diligence by sophisticated financial investors, inherently making it a fair market value. It first computes the value that can be allocated to each security such that the allocated value per share is exactly equal to the
OIP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Market&#151;Scenario</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The market scenario method is based on actual prices paid in mergers and acquisitions for similar public and private companies. Also referred to as guideline merged and acquired method (&#147;GMAC&#148;), the GMAC method generally
entails the development of revenue, earnings, or book value multiples based on the implied BEV of the target companies. In identifying the comparable publicly traded companies and similar transactions, financial and non-financial factors are usually
considered (e.g., business description, size, leverage, and profitability). These methods are most commonly employed when similar transactions exist in the market and/or a similar set of reasonably comparable public companies can be
identified.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Income Based&#151;DCF</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The income approach is used to estimate fair value based on the income streams, such as cash flows or earnings, that an asset or business can be expected to generate. The discounted cash flow (&#147;DCF&#148;) method involves
estimating the future cash flow of an asset or business for a certain discrete period and discounting to a present value. If the cash flow stream is expected to continue beyond the discrete period, the reversionary or terminal value is estimated and
discounted to present value. The discount rate selected is based on consideration of the risks inherent in the investment and market rates of return available from alternative investments of similar type and quality as of the valuation.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Asset/Cost</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The asset/cost approach considers reproduction or replacement cost as an indicator of value. The asset/cost approach is based on the assumption that a prudent investor would pay no more for an entity than the amount for which he
could replace or recreate it or an asset with similar utility. Historical costs are often used to estimate</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-98</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Valuation Method</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the current cost of replacing the entity valued. When using the cost approach to value a business enterprise, the equity value is calculated as the appraised fair market value of the individual assets that comprise the business less
the fair market value of the liabilities.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended June&nbsp;30, 2020 and year ended December&nbsp;31, 2019, at each measurement date, the total fair
value of preferred share, warrants and convertible note instruments, including embedded conversion rights that are not bifurcated, was determined using an option pricing model (&#147;OPM&#148;), probability-weighted expected return method
(&#147;PWERM&#148;) or Hybrid allocation framework. The methods are detailed as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Allocation Method</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OPM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The OPM model treats preferred stock as call options on the enterprise&#146;s equity value, with exercise prices based on the liquidation preferences of the preferred stock. Under this method, the shares have value only if the funds
available for distribution to shareholders exceed the value of the liquidation preferences at the time of a liquidity event (e.g., a merger, sale or IPO), assuming the company has funds available to make a liquidation preference meaningful and
collectible by the shareholders. The OPM begins with the current equity or enterprise value and estimates the future distribution of outcomes using a lognormal distribution around that current value.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PWERM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under a PWERM, the value of the preferred stock is estimated based upon an analysis of future values for the enterprise assuming various future outcomes. Share value is based upon the probability-weighted present value of expected
future investment returns, considering each of the possible future outcomes available to the enterprise, as well as the rights of each share class. Although the future outcomes considered in any given valuation model will vary based upon the
enterprise&#146;s facts and circumstances, common future outcomes modeled might include an initial public offering (&#147;IPO&#148;), merger or acquisition (&#147;M&amp;A&#148;), dissolution, or continued operation as a viable private
enterprise</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Hybrid</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The hybrid method (&#147;HM&#148;) is a combination of the PWERM and OPM. Under the hybrid method, multiple liquidity scenarios are weighted based on the probability of the scenarios occurrence, similar to the PWERM, while also
utilizing the OPM to estimate the allocation of value in one or more of the scenarios. The HM is used when the company is aware of one or more future exit opportunities that result in vastly different payout structures, such as M&amp;A as compared
to IPO. The HM is advantageous in these situations because it utilizes the framework of option pricing theory to model a continuous distribution of future outcomes and capture the option-like payoffs of the various share classes while also
explicitly considering future scenarios and the discontinuities in outcomes that early-stage companies experience.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Valuation policies and procedures are regularly monitored by the Company&#146;s finance group. Fair value measurements,
including those categorized within Level 3, are prepared and reviewed on their issuance date and then on an annual basis and any third-party valuations are reviewed for reasonableness and compliance with the fair value measurements guidance under
IFRS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COVID-19 Consideration </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At June&nbsp;30,
2020<I>, t</I>he Group assessed certain key assumptions within the valuation of its unquoted instruments and considered the impact of the COVID-19 pandemic on all unobservable inputs (Level 3). The assumptions considered with respect to COVID-19
included but were not limited to the following: exit scenarios and timing, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-99</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discount rates, revenue assumptions as well as volatilities. Additionally, the Group disclosed additional sensitivities with respect to COVID-19, increasing/ decreasing enterprise values by a
magnitude of 10.0&nbsp;per cent and increasing/ decreasing volatilities by a magnitude of 25.0&nbsp;per cent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subsidiary Preferred Shares Liability
and Subsidiary Convertible Notes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the changes in the Group&#146;s subsidiary preferred shares and convertible note
liabilities measured at fair value using significant unobservable inputs (Level 3): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Subsidiary&nbsp;Preferred<BR>Shares</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center">$000s</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Subsidiary&nbsp;Convertible<BR>Notes<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value at issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,250</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(999</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>111,238</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>125</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Quantitative information about the significant unobservable inputs used in the fair value measurement of the Group&#146;s
subsidiary preferred share liabilities designated as Level 3 is as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Option Pricing Model Inputs for Preferred Shares under IFRS 9 at
June&nbsp;30, 2020: </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Measurement Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="13" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Range of Values</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expiration&nbsp;Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Volatility</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Risk&nbsp;Free&nbsp;Rate</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Probability&nbsp;of<BR>IPO/M&amp;A</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">31/12/2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.7&nbsp;&#150;&nbsp;2.0&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30.00%&nbsp;&#150;&nbsp;85.00%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.58%&nbsp;&#150;&nbsp;1.60%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">65%/35%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">30/6/2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.4&nbsp;&#150;&nbsp;2.5&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35.00%&nbsp;&#150;&nbsp;85.00%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.16%&nbsp;&#150;&nbsp;0.17%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">65%/35%</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subsidiary Preferred Shares Sensitivity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summarizes the sensitivity from the assumptions made by the Company in respect to the unobservable inputs used in the fair value measurement of
the Group&#146;s preferred share liabilities, which are recorded at fair value (Please refer to Note 12). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Subsidiary Preferred Shares</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Input</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Sensitivity&nbsp;Range</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Financial&nbsp;Liability<BR>Increase/(Decrease)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>As of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enterprise Value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,932</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,989</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,702</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,679</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>751</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(791</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,630</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,091</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time to Liquidity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-6&nbsp;Months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>826</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+6&nbsp;Months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(679</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free Rate&sup1;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">-0.02%/-0.01</FONT></TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>826</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+0.02%/+0.03</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(679</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IPO/M&amp;A Event Probability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,241</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,212</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Risk-free rate is a function of the time to liquidity input assumption. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-100</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in fair value of preferred shares are recorded in Finance cost, net in the Condensed Consolidated
Statements of Comprehensive Income/(Loss). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Assets Held at Fair Value </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Level 1 Inputs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">resTORbio Valuation </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ResTORbio (NASDAQ: TORC) is a listed entity on an active exchange and as such the fair value during the six months ended June&nbsp;30, 2020 was calculated
utilizing the quoted common share price. Please refer to Note 5 for further details. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Karuna Valuation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna (NASDAQ: KRTX) is a listed entity on an active exchange and as such the fair value as of June&nbsp;30, 2020 was calculated utilizing the quoted common
share price. Please refer to Note 5 for further details. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Level 3 Inputs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Akili, Gelesis and Vor Valuation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with IFRS
9, the Company accounts for its preferred share investments in Akili, Gelesis and Vor as financial assets held at fair value through the profit and loss. During the six months ended June&nbsp;30, 2020, the Company recorded its investment at fair
value and recognized a gain of $15.4&nbsp;million that was recorded to the Condensed Consolidated Statements of Comprehensive Income/(Loss) on the line item Gain/(loss) on investments held at fair value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the changes in the Group&#146;s investments held at fair value using significant unobservable inputs (Level 3): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">154,445</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash purchase of Gelesis preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash purchase of Vor preferred shares (please refer to Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,150</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss)&#151;fair value through profit and loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,357</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>180,951</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Option Pricing Model and Probability Weighted Expected Return Method Inputs for Investments Held at Fair Value at
June&nbsp;30, 2020 and December&nbsp;31, 2019: </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">PWERM (IPO Scenario) Measurement Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Range of Values</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Time&nbsp;to&nbsp;Anticipated<BR>Exit Event</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Probability<BR>of&nbsp;IPO</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">31/12/2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1&#151;3.0&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55.0%&#151;75.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">30/6/2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1&#151;2.75&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55.0%&#151;75.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">OPM (Long-term Exit Scenario) Measurement Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Range of Values</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expiration&nbsp;Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Volatility</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Risk&nbsp;Free&nbsp;Rate</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">31/12/2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.13&#151;3&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56.0%&#151;80.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.59%&#151;1.62</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">30/6/2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.48&#151;3&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66.0%&#151;75.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.16%&#151;0.18</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-101</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summarizes the sensitivity from the assumptions made by the Company in respect to the
unobservable inputs used in the fair value measurement of the Group&#146;s investments held at fair value (Please refer to Note 5): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Investments Held at Fair Value</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Input</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Sensitivity&nbsp;Range</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Financial&nbsp;Asset&nbsp;Increase/<BR>(Decrease)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>As of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enterprise Value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,694</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,721</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(12,948</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>13,433</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(952</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,219</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,570</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,895</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time to Liquidity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-6&nbsp;Months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,570</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+6&nbsp;Months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(14,918</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free Rate&sup1;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">-0.01%/-0.00</FONT></TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,570</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+0.00%/+0.01</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(14,918</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Risk-free rate is a function of the time to liquidity input assumption. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subsidiary warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Warrants issued by subsidiaries
within the Group are classified as liabilities, as they will be settled in a variable number of shares and are not fixed-for-fixed. The following table summarizes the changes in the Group&#146;s subsidiary warrant liabilities measured at fair value
using significant unobservable inputs (Level 3): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="28%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Subsidiary&nbsp;Warrant&nbsp;Liability<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(867</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,130</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The $7.1&nbsp;million and $8.0&nbsp;million subsidiary warrant liability at June&nbsp;30, 2020 and December&nbsp;31, 2019,
respectively, is attributable to the outstanding Follica preferred share warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following weighted average assumptions were utilized by the
Company with respect to determining the fair value of the Follica warrants at June&nbsp;30, 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="21%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Assumption/Input</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Series&nbsp;A-1&nbsp;Warrants</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated fair value of the convertible preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.62</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise price of the warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.07</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-102</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summarizes the sensitivity from the assumptions made by the Company in respect to the
unobservable inputs used in the fair value measurement of the Group&#146;s warrant liabilities as of June&nbsp;30, 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrant Liability</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Input</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Sensitivity<BR>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial&nbsp;Liability<BR>Increase/(Decrease)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>As of 30 June 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enterprise Value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(108</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>108</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(530</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>525</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fair Value Measurement and Classification </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of financial instruments by category at June&nbsp;30, 2020 and December&nbsp;31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial<BR>Assets</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial<BR>Liabilities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 1</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 2</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 3</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money Markets<SUP STYLE="font-size:85%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302,020</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302,020</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302,020</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">709,456</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">528,504</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180,951</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">709,456</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other receivables&sup2;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,200</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,200</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,200</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,013,675</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>830,524</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,200</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>180,951</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,013,675</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial liabilities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,130</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,130</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,130</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,238</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,238</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,238</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>119,824</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>118,369</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>119,824</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Issued by a diverse group of corporations, largely consisting of financial institutions, virtually all of which
are investment grade. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Outstanding receivables are owed primarily by corporations and government agencies, virtually all of which are
investment grade. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial<BR>Assets</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financial<BR>Liabilities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 1</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 2</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level 3</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US treasuries<SUP STYLE="font-size:85%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,088</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,088</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,088</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money Markets<SUP STYLE="font-size:85%; vertical-align:top">2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,586</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,586</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,586</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,905</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">560,460</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">154,445</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,905</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade and other receivables&sup2;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&nbsp;&nbsp;&nbsp;853,556</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>697,134</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,977</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>154,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&nbsp;&nbsp;&nbsp;853,556</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial liabilities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,997</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,989</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>110,441</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>108,986</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>110,441</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-103</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Issued by governments and government agencies, as applicable, all of which are investment grade.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Issued by a diverse group of corporations, largely consisting of financial institutions, virtually all of which
are investment grade. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Outstanding receivables are owed primarily by corporations and government agencies, virtually all of which are
investment grade. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Subsidiary Notes Payable </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The subsidiary notes payable are comprised of loans made to, and convertible notes issued by, subsidiaries in the Group. As of June&nbsp;30, 2020 and
December&nbsp;31, 2019, the financial instruments for Knode and Appeering did not contain embedded derivatives and therefore these instruments continue to be held at amortized cost. The notes payable consist of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">As of</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30,&nbsp;2020</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">December&nbsp;31,&nbsp;2019<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,330</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,330</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>125</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total subsidiary notes payable</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Loans </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2010,
Follica entered into a loan and security agreement with Lighthouse Capital Partners VI, L.P. The loan is secured by Follica&#146;s assets, including Follica&#146;s intellectual property and bears interest at a rate of 12%. The outstanding loan
balance totaled approximately $1.3&nbsp;million as of each of June&nbsp;30, 2020 and December&nbsp;31, 2019, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Convertible Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of the Group&#146;s subsidiaries have issued convertible promissory notes (&#147;Notes&#148;) to fund their operations with an expectation of an
eventual share-based award settlement of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended June&nbsp;30, 2019, the Notes were assessed under IFRS 9 and the entire
financial instruments were elected to be accounted for as FVTPL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Convertible Notes outstanding were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Knode<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Appeering<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total<br>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>As of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>50</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>75</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>125</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Non-Controlling Interest </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the changes in the equity classified non-controlling ownership interest in subsidiaries by reportable segment during the six
months ended June&nbsp;30, 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Controlled</B><br><B>Founded&nbsp;Entities</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Parent</B><br><B>Company<BR>&amp; Other</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Non-controlling interest as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(18,233</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>593</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,639</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(249</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(249</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Distributions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of share-based awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity-settled share-based payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,005</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,005</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Non-controlling interest as of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,481</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>593</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(16,887</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-104</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Leases </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The activity related to the Group&#146;s right of use asset and lease liability for the six months ended June&nbsp;30, 2020 is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Right&nbsp;of&nbsp;use&nbsp;asset,&nbsp;net<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December 31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,383</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,227</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">414</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at June 30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,570</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;lease&nbsp;liability<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,843</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,456</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">414</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,001</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following details the short term and long-term portion of the lease liability for the six months ended June&nbsp;30, 2020:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;lease&nbsp;liability<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term Portion of Lease Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,066</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term Portion of Lease Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,935</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Lease Liability</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,001</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The sublease agreement with Gelesis was determined to be a finance lease. The rent period term began June&nbsp;1, 2019 and
expires on August&nbsp;31, 2025. As of June&nbsp;30, 2020 the balances related to the sublease, classified as a finance lease, were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="21%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;lease&nbsp;receivable<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term Portion of Lease Receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term Portion of Lease Receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,895</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Lease Receivable</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,261</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The sublease with Dewpoint Therapeutics was determined to be an operating lease. The rent period term began September&nbsp;1,
2019 and expires August&nbsp;31, 2021. Sublease income from operating lease recognized by the Company during the six months ended June&nbsp;30, 2020 was $0.5 million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Related Parties Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party
Sublease </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2019, PureTech executed a sublease agreement with related party Gelesis. Please refer to Note 16 for further details regarding the
sublease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-105</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Management Personnel Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key management includes executive directors and members of the executive management team of the Group. The key management personnel compensation of the Group
was as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020<BR>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019<BR>$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wages and short-term employee benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,266</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,449</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,222</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,586</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,488</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,035</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wages and employee benefits include salaries, health care and other non-cash benefits. Share-based payments are generally
subject to vesting terms over future periods. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Convertible Notes Issued to Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain members of the Group have invested in convertible notes issued by the Group&#146;s subsidiaries. As of June&nbsp;30, 2020 and December&nbsp;31, 2019,
the outstanding related party notes payable totaled approximately $0.1&nbsp;million in each period, including principal and interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes issued to
related parties bear interest rates, maturity dates, discounts and other contractual terms that are the same as those issued to outside investors during the same issuances, as described in Note 14. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors&#146; and Senior Managers&#146; Shareholdings and Share Incentive Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors and senior managers hold beneficial interests in shares in the following businesses and sourcing companies as at June&nbsp;30, 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Directors</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Business Name (Share Class)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of<BR>shares&nbsp;held&nbsp;as<BR>of June&nbsp;30,<BR>2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number of<BR>options&nbsp;held&nbsp;as<BR>of June&nbsp;30,<BR>2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Ownership<br>Interest&sup1;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ms Daphne Zohar&sup2;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,443</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">939,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dame Marjorie Scardino</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Bennett Shapiro&sup3;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Akili (Series A-2 Preferred)<SUP STYLE="font-size:85%; vertical-align:top">4</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Series A-1 Preferred)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vedanta Biosciences (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.22</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vedanta Biosciences (Series B Preferred)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Robert Langer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Entrega (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">332,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.24</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Alivio (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,575,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.19</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Raju Kucherlapati</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Enlight (Class B Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)<SUP STYLE="font-size:85%; vertical-align:top">6</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr John LaMattina<SUP STYLE="font-size:85%; vertical-align:top">5</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Akili (Series A-2 Preferred)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)<SUP STYLE="font-size:85%; vertical-align:top">5</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.50</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)<SUP STYLE="font-size:85%; vertical-align:top">6</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gelesis (Series A-1 Preferred)<SUP STYLE="font-size:85%; vertical-align:top">5</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vedanta Biosciences (Common)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.23</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr Christopher Viehbacher</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr Stephen Muniz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gelesis (Common)<SUP STYLE="font-size:85%; vertical-align:top">6</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Senior Managers:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Eric Elenko</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Joep Muijrers</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Bharatt Chowrira</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Karuna (Common)<SUP STYLE="font-size:85%; vertical-align:top">6</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.04</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr Joseph Bolen</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vor (Common)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.04</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-106</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ownership interests as of June&nbsp;30, 2020 are calculated on a diluted basis, including issued and
outstanding shares, warrants and options (and written commitments to issue options) but excluding unallocated shares authorized to be issued pursuant to equity incentive plans and any shares issuable upon conversion of outstanding convertible
promissory notes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Common shares and options held by Yishai Zohar, who is the husband of Ms.&nbsp;Zohar. Ms.&nbsp;Zohar does not
have any direct interest in the share capital of Gelesis. Ms Zohar recuses herself from any and all material decisions with regard to Gelesis. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Shapiro retired from PureTech&#146;s board of directors on June&nbsp;11, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">4.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares held through Dr Bennett Shapiro and Ms Fredericka F. Shapiro, Joint Tenants with Right of Survivorship.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">5.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr John and Ms Mary LaMattina hold 50,540 shares of common shares and 49,523 shares of Series A-1 preferred
shares in Gelesis. Individually, Dr LaMattina holds 3,579 shares and 63,050 options of Gelesis and convertible notes issued by Appeering in the aggregate principal amount of $50,000. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">6.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Options to purchase the listed shares were granted in connection with the service on such founded entity&#146;s
Board of Directors and any value realized therefrom shall be assigned to PureTech Health, LLC. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors and senior managers hold
27,315,840 ordinary shares and 9.6&nbsp;per cent voting rights of the Company as of June&nbsp;30, 2020. This amount excludes options to purchase 2,909,344 ordinary shares. This amount also excludes 4,636,347 shares, which are issuable contingent to
the terms set for the performance based RSU awards. Such shares will be issued to such senior managers in future periods provided that performance conditions are met and certain of the shares will be withheld for payment of customary withholding
taxes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18. Taxation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tax benefit/(expense) is
recognized based on management&#146;s best estimate of the weighted-average annual income tax rate expected for the full financial year multiplied by the pre-tax income of the interim reporting period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended June&nbsp;30, 2020 and 2019, the Group recorded a consolidated tax provision of $50.8&nbsp;million and $25.1 million,
respectively, which represented effective tax rates in continuing operations of 29.1% and 44.4%, respectively. The effective tax rate in the current period is primarily driven by the Company&#146;s earnings in the U.S. federal and state jurisdiction
in which it operates and is impacted by an increase in unrecorded deferred tax assets in respect of carry-forward losses in the Company&#146;s subsidiaries (as it is not probable that they will be realized). The change in the tax rate period over
period results from a lower increase in the 2020 interim period as compared to the 2019 interim period in the aforementioned unrecorded deferred tax assets due to deconsolidations and changes in ownership that occurred in 2019 and therefore impacted
the 2020 consolidated tax expenses.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19. Subsequent Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has evaluated subsequent events after June&nbsp;30, 2020, the date of issuance of the Condensed Consolidated Financial Statements, and has not
identified any recordable or disclosable events not otherwise reported in these Condensed Consolidated Financial Statements or notes thereto, except for the following: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;10, 2020, pursuant to its collaboration agreement with JSR Corporation, Vedanta issued 107,389 Series C-2 Preferred shares for $2.5&nbsp;million
in aggregate proceeds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;26, 2020, PureTech sold 1,333,333 common shares of Karuna for aggregate proceeds of $101.6&nbsp;million.
Immediately subsequent to the disposal, PureTech continued to hold 3,406,564 common shares or 12.8 percent of total outstanding shares of Karuna. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-107</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Vedanta entered into a $15.0 million loan and security agreement
with Oxford Finance LLC. The loan is secured by Vedanta&#146;s assets, including equipment, inventory and intellectual property. The loan bears a floating interest rate of 7.73% plus the greater of (i)&nbsp;30 day U.S.&nbsp;Dollar LIBOR reported in
the Wall Street Journal or (ii)&nbsp;0.17%. The loan matures September 2025 and requires interest only payments for the initial 24 months. For loan consideration, Vedanta also issued Oxford Finance LLC 12,886 Series C-2 preferred share warrants with
an exercise price of $23.28 per share, expiring September 2030. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-108</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin68105_12"></A>UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following unaudited pro forma consolidated financial information for the year ended December&nbsp;31, 2019 and related notes present the historical
consolidated financial statements of PureTech Health plc (&#147;PureTech,&#148; the &#147;Parent,&#148; &#147;Group,&#148; or the &#147;Company&#148;) and the deconsolidation of PureTech&#146;s former consolidated subsidiaries Gelesis, Inc.
(&#147;Gelesis&#148;), Vor Biopharma Inc. (&#147;Vor&#148;) and Karuna Therapeutics, Inc. (&#147;Karuna&#148;) as if the completion of all the aforementioned deconsolidations had occurred on January&nbsp;1, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vor </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;12, 2019, Vor completed a Series
A-2 Preferred Stock financing in which PureTech and several new third-party investors participated. As a result of the issuance of the preferred shares to third-party investors, PureTech&#146;s ownership percentage and corresponding voting rights
dropped from 79.5 percent to 47.5 percent, and PureTech simultaneously lost control over Vor&#146;s Board of Directors, both of which triggered a loss of control over the entity. As of February&nbsp;12, 2019, Vor was deconsolidated from the
Group&#146;s financial statements. As of such date of deconsolidation, PureTech held preferred shares in Vor and no common shares. The preferred shares held by PureTech fall under the guidance of IFRS 9 and are treated as a financial asset held at
fair value. All movements to the value of PureTech&#146;s investment in Vor&#146;s preferred stock are recorded through the Consolidated Statement of Comprehensive Income/(Loss). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Karuna </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;15, 2019, Karuna completed the
closing of a Series B Preferred Stock financing with PureTech and several new third-party investors. As a result of the issuance of the preferred shares to third-party investors, PureTech&#146;s ownership percentage and corresponding voting rights
dropped from 70.9 percent to 44.3 percent, and PureTech simultaneously lost control over Karuna&#146;s Board of Directors, both of which triggered a loss of control over the entity. As of March&nbsp;15, 2019, Karuna was deconsolidated from the
Group&#146;s financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While the Company no longer controlled Karuna pursuant to the deconsolidation, PureTech still had significant
influence over Karuna. PureTech&#146;s investment in common shares of Karuna that is subject to equity method accounting, was almost nil ($0 thousand) on January&nbsp;1, 2019 and until the date of conversion of Karuna preferred shares to common
shares at the end of June 2019 (See Note 5 to the annual consolidated financial statements included herein). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preferred shares and warrant held by
PureTech fall under the guidance of IFRS 9 and were treated as financial assets held at fair value through profit and loss. All movements to the value of PureTech&#146;s investment in Karuna&#146;s preferred stock and warrant were recorded through
the Consolidated Statement of Comprehensive Income/(Loss). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gelesis </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2019, the Gelesis Board of Directors was restructured, resulting in two of the three PureTech representatives on the board resigning. As a
result of this restructuring, PureTech lost control over Gelesis&#146;s Board of Directors, which triggered a loss of control over the entity. As of July&nbsp;1, 2019, Gelesis was deconsolidated from the Group&#146;s financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the date of deconsolidation, PureTech held shares of preferred stock and common stock of Gelesis and a warrant issued by Gelesis to PureTech. While the
Company no longer controls Gelesis, it was concluded that PureTech still has significant influence over Gelesis and therefore the investment in Gelesis is accounted for as an associate under IAS 28. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PureTech&#146;s investment in common shares of Gelesis is subject to equity method accounting. The preferred shares and warrant held by PureTech fall under
the guidance of IFRS 9 and are treated as financial assets held at fair value and all movements to the value of PureTech&#146;s investment in the preferred stock are recorded through the Consolidated Statement of Comprehensive Income/(Loss) in
accordance with IFRS 9. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-109</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Unaudited Pro Forma Consolidated Statement of Comprehensive Income/(Loss) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the year ended December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>PureTech<BR>Historical</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deconsolidation<BR>Pro Forma<BR>Adjustments</B><br><B>(a)</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR>Pro Forma<BR>Adjustments</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>PureTech<BR>Pro<BR>Forma<BR>Final</B><br><B>$000s</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,688</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,688</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,119</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,119</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,807</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,807</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59,358</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,181</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,177</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85,848</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,555</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,293</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(135,399</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,736</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(109,663</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deconsolidation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">264,409</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(264,409<B></B></TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;<B>(b)</B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(37,863</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,876<B></B></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;<B>(c)</B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,987</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on impairment of intangible asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain/(loss) on loss of significant influence</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">445,582</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">445,582</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income/(expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other income/(expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>672,167</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(258,533</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>413,634</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,362</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(93</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,269</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;subsidiary preferred shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,458</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,564</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;contractual</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,576</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(67</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,643</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income/(costs)&#151;fair value accounting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(46,475</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,737</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,738</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net finance income/(costs)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(46,147</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,141</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(16,006</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of net gain/(loss) of associates accounted for using the equity method</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,791</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,695<B></B></TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;<B>(d)</B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,096</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impairment of investment in associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,097<B></B></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;<B>(d)</B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,841</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) before taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>478,474</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>55,877</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(286,227</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>279,221</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112,409</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,320<B></B></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;<B>(e)</B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(84,927</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(Loss) for the year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>56,039</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(258,907</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>194,294</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other comprehensive income/(loss):</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Items that are or may be reclassified as profit or loss</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized gain/(loss) on investments held at fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total other comprehensive income/(loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive income/(loss) for the year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,055</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>56,039</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(258,907</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>194,284</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">421,144</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,085</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(227,811</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,419</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,079</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,954</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,125</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>56,039</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(227,811</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>194,294</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Comprehensive income/(loss) attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owners of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">421,134</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,085</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(227,811</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,409</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-controlling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,079</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,954</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,125</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>366,055</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>56,039</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(227,811</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>194,284</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Earnings/(loss) per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings/(loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.49</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.80</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings/(loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.77</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-110</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited pro forma consolidated financial information should be read in conjunction with
the notes hereto along with PureTech&#146;s most recent historical financial information included herein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis of Preparation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The unaudited pro forma financial information was prepared in accordance with Article 11 of Regulation S-X. Accordingly, the Company&#146;s historical
consolidated financial statements have been adjusted in the pro forma financial statements to give effect to pro forma events that are (i)&nbsp;directly attributable to the deconsolidations, (ii)&nbsp;expected to have a continuing impact on the
Group, and (iii)&nbsp;factually supportable. The unaudited pro forma consolidated financial information is presented for illustrative purposes only and does not purport to represent what the results of operations of PureTech would actually have been
had the deconsolidations occurred on January&nbsp;1, 2019, or to project the results of operations of PureTech for any future periods. The unaudited pro forma adjustments are based on available information and certain assumptions that
PureTech&#146;s management believes are reasonable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed financial information related to the deconsolidations is based on
the assumption that the deconsolidations took place as of January&nbsp;1, 2019 for purposes of the unaudited pro forma Consolidated Statement of Comprehensive Income/(Loss) for the year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pro Forma Adjustments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a)
Deconsolidation Adjustment </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deconsolidation adjustments removes the historical results of Gelesis, Karuna and Vor included in the
Consolidated Statement of Comprehensive Income/(Loss) for the year ended December&nbsp;31, 2019 to effectuate the deconsolidation of such entities as of January&nbsp;1, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Gain on Deconsolidation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of the result of the deconsolidations, the Company recognized a gain upon the deconsolidation of each entity in the Consolidated Statement
of Comprehensive Income/(Loss) for the year ended December&nbsp;31, 2019. The pro forma adjustment removes the gains that the Company recognized upon deconsolidation as they are not expected to have a continuing impact. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Fair Value Adjustments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of the date of deconsolidation, the Company held preferred shares in the deconsolidated entities, which fall under the guidance of IFRS 9
and are treated as financial assets held at fair value through profit and loss. The pro forma adjustments reflect the incremental amount of gain/loss that would be recorded had the deconsolidations occurred at January&nbsp;1, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-111</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been publicly filed with the Securities and
Exchange Commission </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and all information herein remains strictly confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(d) Equity Method Accounting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upon loss of control of Gelesis, the common shares of Gelesis held by the Company were subject to equity method accounting in accordance with
IAS 28. The pro forma adjustments reflect the incremental share of equity method losses that the Company should recognize, as well as the adjustment of the impairment loss on Gelesis equity method investment so that the pro forma investment as of
December&nbsp;31, 2019 would equal its net realizable value at that date, assuming that the deconsolidation of Gelesis occurred, and the investment in Gelesis common stock was accounted for under the equity method, beginning January&nbsp;1, 2019.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$000s</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Company&#146;s pro forma investment in Gelesis as of January&nbsp;1, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>13,042</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add: The Company&#146;s pro forma share of Gelesis net income for the year ended December&nbsp;31,
2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,441</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma Gelesis investment balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,483</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Company&#146;s pro forma share of Gelesis net income for the year ended December&nbsp;31,
2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,441</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: share of net income of Gelesis recorded in the Consolidated Statement of Comprehensive
Income/(Loss) for the year ended December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,136</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Incremental share of net loss to be included as an adjustment in this Unaudited Pro forma
Consolidated Statement of Comprehensive Income/(Loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(27,695</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net realizable value of investment in Gelesis accounted for under the equity method as of
December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,642</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma Gelesis investment balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,483</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma impairment loss for the year ended December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(11,841</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: impairment of Gelesis equity method investment recorded in the Consolidated Statement of
Comprehensive Income/(Loss) for the year ended December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(42,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reduction of impairment loss to be included as an adjustment in this Unaudited Pro forma
Consolidated Statement of Comprehensive Income/(Loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,097</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(e) Taxation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tax effect of the pro forma adjustments discussed in the notes above, assuming the deconsolidations occurred on January&nbsp;1,
2019, calculated at the applicable tax rate of each adjustment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">F-112</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>filename2.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DATED&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24&nbsp;JUNE 2015 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Company no. 09582467 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLES OF ASSOCIATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>of </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURETECH HEALTH PLC
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Incorporated on 9&nbsp;May 2015 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">As adopted by a special resolution passed on&nbsp;18 June 2015 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONTENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PRELIMINARY </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REGULATIONS AND ARTICLES NOT TO APPLY </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7 </TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">INTERPRETATION </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7 </TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LIMITED LIABILITY </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">LIMITED LIABILITY </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SHARE CAPITAL </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ALLOTMENT </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REDEEMABLE SHARES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWER TO ATTACH RIGHTS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VARIATION OF RIGHTS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">COMMISSIONS AND BROKERAGES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">TRUSTS NOT RECOGNISED </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RENUNCIATION </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ALTERATION OF SHARE CAPITAL </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NEW SHARES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">SUB-DIVISION</FONT> OF SHARES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">FRACTIONS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SHARE CERTIFICATES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RIGHT TO CERTIFICATES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REPLACEMENT CERTIFICATES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UNCERTIFICATED SHARES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">16.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">UNCERTIFICATED SHARES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LIEN</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">COMPANY&#146;S LIEN ON SHARES NOT FULLY PAID </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">18.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ENFORCEMENT OF LIEN BY SALE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">19.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">APPLICATION OF PROCEEDS OF SALE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CALLS ON SHARES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">20.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CALLS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWER TO MAKE DIFFERENT ARRANGEMENTS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">22.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">INTEREST ON CALLS; COSTS, CHARGES AND EXPENSES FOR <FONT STYLE="white-space:nowrap">NON-PAYMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PAYMENT IN ADVANCE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">24.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SUMS DUE ON ALLOTMENT TREATED AS CALLS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FORFEITURE </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">25.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE IF CALL NOT PAID </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">26.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">FORFEITURE FOR <FONT STYLE="white-space:nowrap">NON-COMPLIANCE</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">27.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE AFTER FORFEITURE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">28.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DISPOSAL OF FORFEITED SHARES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">LIABILITIES AND CLAIMS ON FORFEITURE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">30.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SURRENDER </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UNTRACED SHAREHOLDERS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">31.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWER OF SALE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">32.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">APPLICATION OF PROCEEDS OF SALE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TRANSFERS OF SHARES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">33.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">GENERAL PROVISIONS ABOUT TRANSFERS OF SHARES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">34.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">TRANSFERS OF UNCERTIFICATED SHARES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">35.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">TRANSFERS OF CERTIFICATED SHARES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">36.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RIGHT TO REFUSE REGISTRATION </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TRANSMISSION OF SHARES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">37.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ON DEATH </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">38.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ELECTION OF PERSON ENTITLED BY TRANSMISSION </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">39.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RIGHTS OF PERSON ENTITLED BY TRANSMISSION </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GENERAL MEETINGS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">40.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">GENERAL MEETINGS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NOTICE OF GENERAL MEETINGS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">41.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POSTPONEMENT OF GENERAL MEETINGS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">42.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">OMISSION TO SEND NOTICE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PROCEEDINGS AT GENERAL MEETINGS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">43.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">QUORUM </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">44.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PROCEDURE IF QUORUM NOT PRESENT </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">45.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CHAIRMAN </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">46.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DIRECTOR&#146;S RIGHT TO ATTEND AND SPEAK </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">47.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWER TO ADJOURN </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">48.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE OF ADJOURNED MEETING </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">49.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">BUSINESS AT ADJOURNED MEETING </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">50.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ATTENDANCE AND PARTICIPATION AT DIFFERENT PLACES AND BY ELECTRONIC MEANS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">51.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SECURITY ARRANGEMENTS AND ORDERLY CONDUCT </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">VOTING </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">52.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">METHOD OF VOTING </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">53.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PROCEDURE ON A POLL </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">54.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VOTES OF SHAREHOLDERS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">55.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RESTRICTION ON VOTING RIGHTS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">56.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VOTING BY PROXY </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">57.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RECEIPT OF PROXIES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">58. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">WHEN VOTES BY PROXY VALID THOUGH AUTHORITY REVOKED </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">59. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CORPORATE REPRESENTATIVES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">60. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">OBJECTIONS AND VALIDITY OF VOTES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">61. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AMENDMENTS TO RESOLUTIONS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">62. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CONFIDENTIAL INFORMATION </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CLASS MEETINGS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">63. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PROCEDURE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DISCLOSURE OF INTERESTS IN SHARES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">64. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SANCTIONS FOR <FONT STYLE="white-space:nowrap">NON-DISCLOSURE</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">65. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CESSATION OF SANCTIONS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">66. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SECTION&nbsp;793 NOTICES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">67. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">APPROVED DEPOSITARIES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">68. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DISCLOSURE OF INTERESTS - DEFINITIONS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">69. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SECTION&nbsp;794 </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NUMBER OF DIRECTORS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">70. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NUMBER OF DIRECTORS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ALTERNATE DIRECTORS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">71. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">APPOINTMENT </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">72. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REVOCATION OF APPOINTMENT </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">73. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PARTICIPATION IN BOARD MEETINGS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">74.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RESPONSIBILITY </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">75.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REMUNERATION AND EXPENSES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">POWERS OF THE BOARD </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">76.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWERS OF THE BOARD </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">77. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWERS OF DIRECTORS IF LESS THAN MINIMUM REQUIRED NUMBER </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">78.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">EXERCISE OF VOTING RIGHTS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">79. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CORPORATE SHAREHOLDERS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">80. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PROVISION FOR EMPLOYEES ON CESSATION OR TRANSFER OF BUSINESS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">81. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CHANGE OF NAME </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">82. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">OVERSEAS REGISTER </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">83. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">BORROWING POWERS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">84. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">LIMIT TO BORROWING POWERS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DELEGATION OF DIRECTORS&#146; POWERS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">85. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWERS OF EXECUTIVE DIRECTORS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">86. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DELEGATION TO COMMITTEES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">87. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">LOCAL AND DIVISIONAL MANAGEMENT </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">88. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWER OF ATTORNEY </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">89. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ASSOCIATE DIRECTORS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">APPOINTMENT AND RETIREMENT OF DIRECTORS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">90. </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWER OF THE COMPANY TO APPOINT DIRECTORS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">91.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWER OF THE BOARD TO APPOINT DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">92.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">APPOINTMENT OF EXECUTIVE DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">93.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ELIGIBILITY OF NEW DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">94.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VOTING ON RESOLUTION FOR APPOINTMENT</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">95.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RETIREMENT BY ROTATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">96.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DIRECTORS SUBJECT TO RETIREMENT</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">97.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POSITION OF RETIRING DIRECTOR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">98.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DEEMED REAPPOINTMENT</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">REMOVAL AND DISQUALIFICATION OF DIRECTORS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REMOVAL BY ORDINARY RESOLUTION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">100.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VACATION OF OFFICE BY DIRECTOR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">REMUNERATION OF <FONT STYLE="white-space:nowrap">NON-EXECUTIVE</FONT>
DIRECTORS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">101.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ORDINARY REMUNERATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">102.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ADDITIONAL REMUNERATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">REMUNERATION OF EXECUTIVE DIRECTORS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">103.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REMUNERATION OF EXECUTIVE DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DIRECTORS&#146; EXPENSES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">104.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DIRECTORS&#146; EXPENSES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DIRECTORS&#146; INTERESTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">105.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DIRECTORS&#146; PERMITTED INTERESTS AND VOTING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">106.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AUTHORISATION OF DIRECTORS&#146; CONFLICTS OF INTEREST</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">107.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PROVISIONS APPLICABLE TO DECLARATIONS OF INTEREST</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DIRECTORS&#146; GRATUITIES AND BENEFITS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">108.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DIRECTORS&#146; GRATUITIES AND BENEFITS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PROCEEDINGS OF THE BOARD AND COMMITTEES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">109.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">BOARD MEETINGS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">110.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE OF BOARD MEETINGS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">111.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">QUORUM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">112.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CHAIRMAN OF THE BOARD</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">113.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VOTING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">114.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PARTICIPATION BY TELEPHONE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">115.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RESOLUTION IN WRITING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">116.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VALIDITY OF PROCEEDINGS OF THE BOARD OR COMMITTEE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECRETARY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">117.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SECRETARY </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AUTHENTICATION OF DOCUMENTS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">118.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AUTHENTICATION OF DOCUMENTS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MINUTES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">119.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">MINUTES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEALS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">120.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SAFE CUSTODY </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">121.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">APPLICATION OF SEALS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">122.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SECURITIES SEAL </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CHEQUES, BILLS AND NOTES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">123.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CHEQUES, BILLS AND NOTES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DIVIDENDS AND OTHER PAYMENTS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">124.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DECLARATION OF DIVIDENDS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">125.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">INTERIM DIVIDENDS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">126.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ENTITLEMENT TO DIVIDENDS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">127.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">METHOD OF PAYMENT </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">128.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CURRENCY OF PAYMENT </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">129.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DIVIDENDS NOT TO BEAR INTEREST </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">130.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CALLS OR DEBTS MAY BE DEDUCTED FROM DIVIDENDS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">131.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">UNCLAIMED DIVIDENDS ETC </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">132.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">UNCASHED DIVIDENDS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">133.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PAYMENT OF DIVIDENDS IN KIND </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SCRIP DIVIDENDS AND DIVIDEND REINVESTMENT </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">134.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PAYMENT OF SCRIP DIVIDENDS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">135.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DIVIDEND REINVESTMENT GENERALLY </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CAPITALISATION OF PROFITS AND RESERVES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">136.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AUTHORITY TO CAPITALISE AND APPROPRIATION OF CAPITALISED SUMS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RECORD DATES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">137.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RECORD DATES </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ACCOUNTS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">138.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">INSPECTION OF ACCOUNTS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">139.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">COPY OF ACCOUNTS TO BE SENT TO SHAREHOLDERS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">140.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SUMMARY FINANCIAL STATEMENTS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NOTICES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">141.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICES TO BE IN WRITING </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">142.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SERVICE OF NOTICES, DOCUMENTS OR OTHER INFORMATION ON SHAREHOLDERS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">143.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE BY ADVERTISEMENT </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">144.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">EVIDENCE OF SERVICE ON SHAREHOLDERS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">145.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RECORD DATE FOR SERVICE ON SHAREHOLDERS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">146.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE BINDING ON TRANSFEREES ETC </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">147.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE IN CASE OF DEATH, BANKRUPTCY OR MENTAL DISORDER </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">148.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICES TO DIRECTORS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DESTRUCTION OF DOCUMENTS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">149.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DESTRUCTION OF DOCUMENTS </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WINDING UP </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">150.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWER TO PETITION </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">151.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">WINDING UP </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DIRECTORS&#146; INDEMNITY AND INSURANCE </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">152.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DIRECTORS&#146; INDEMNITY AND INSURANCE </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Company no. 09582467 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLES OF ASSOCIATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">of </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURETECH HEALTH PLC
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Adopted by a special resolution </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">passed on&nbsp;18 June&nbsp;2015 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRELIMINARY </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Regulations and articles not to apply </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">No regulations or articles set out in any statute, or in any statutory instrument or other subordinate legislation made under any statute,
concerning companies shall apply as regulations or articles of the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Interpretation </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In these articles, unless the context requires otherwise: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;Act&#148;</B> means the Companies Act 2006. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;Companies Acts&#148;</B> means every statute for the time being in force concerning companies (including any statutory instrument or
other subordinate legislation made under any such statute), so far as it applies to the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;address&#148;</B> includes a
number or address used for the purposes of sending or receiving notices, documents or information by electronic means and/or by means of a website. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;appointor&#148;</B> means, in relation to an alternate director, the director who has appointed him as his alternate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;approved depositary&#148;</B> means a custodian or other person (or a nominee for such custodian or other person) appointed pursuant
to an arrangement with the Company or otherwise: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to hold shares or any rights or interests in any shares; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to issue securities, documents of title or other documents which evidence the entitlement of the holder of them
to or to receive such shares, rights or interests held by the approved depositary, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">provided and to the extent that such
arrangements have been approved by the board for the purpose of these articles. The trustees (acting in their capacity as such) of any employees&#146; shares scheme established by the Company or any other scheme or arrangements principally for the
benefit of employees of the Company and/or its subsidiaries which has been approved by the Company in general meeting shall, unless the board decides otherwise, be treated as an approved depositary; as shall the managers (acting in their capacity as
such) of any investment or savings plan which the board has approved. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;articles&#148;</B> means these articles of association or
such other articles of association of the Company for the time being in force. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;auditors&#148;</B> means the auditors for the time being of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;board&#148;</B> means the board of directors for the time being of the Company or the directors present or deemed to be present at a
duly convened meeting of the directors or any committee at which a quorum is present. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;cash memorandum account&#148;</B> means an
account so designated by the Operator of the relevant system concerned. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;certificated share&#148;</B> means a share that is not an
uncertificated share, and references in these articles to a share being held in certificated form shall be construed accordingly. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;clear days&#148;</B> in relation to a period of notice means that period excluding the day when the notice is given or deemed to be
given and the day for which it is given or on which it is to take effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;committee&#148;</B> means a committee of the board.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;Company&#148;</B> means PureTech Health plc. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;company&#148;</B> includes any body corporate (not being a corporation sole) or association of persons, whether or not a company
within the meaning of the Companies Acts, other than the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;director&#148;</B> means a director for the time being of the
Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;dividend&#148;</B> includes bonus and any other distribution whether in cash or in specie. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;electronic form&#148;</B> and <B>&#147;electronic means&#148;</B> have the meanings given to them by section&nbsp;1168 of the Act.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;hard copy&#148;</B> and <B>&#147;hard copy form&#148;</B> have the meanings given to them by section&nbsp;1168 of the Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;holder&#148;</B> means, in relation to any share, the person whose name is entered in the register as the holder of that share and
includes two or more joint holders of that share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;office&#148;</B> means the registered office for the time being of the Company.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;Operator&#148;</B> means a person approved under the uncertificated securities rules as an operator of a relevant system. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;paid up&#148;</B> means paid up or credited as paid up. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;recognised investment exchange&#148;</B> means a recognised investment exchange within the meaning of the Financial Services and
Markets Act 2000 or any other stock exchange outside the United Kingdom on which the Company&#146;s shares are normally traded. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;recognised person&#148;</B> means a person to whom the Company is not required to send or supply a share certificate in accordance
with the provisions of the Companies Acts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;register&#148;</B> means the register of members of the Company to be kept pursuant to
the Companies Acts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;relevant system&#148;</B> means a relevant system (as defined in the uncertificated
securities rules) in which the Operator of the relevant system has permitted the shares or securities of the Company (or the relevant shares or securities) to be transferred. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;seal&#148;</B> means the common seal of the Company or any official or securities seal that the Company may have or may be permitted
to have under the Companies Acts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;secretary&#148;</B> means the secretary for the time being of the Company and includes any
assistant or deputy secretary and any person appointed by the board to perform the duties of the secretary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;share&#148;</B> means
a share in the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;shareholder&#148;</B> means a person who is a holder of a share. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;uncertificated securities rules&#148;</B> means any provision of the Companies Acts relating to the holding, evidencing of title to or
transfer of uncertificated shares, and any legislation, rules or other arrangements made under or by virtue of such provision. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;uncertificated share&#148;</B> means a share which is recorded in the register as being held in uncertificated form and title to which
may, by virtue of the uncertificated securities rules, be transferred by means of a relevant system, and references in these articles to a share being held in uncertificated form shall be construed accordingly. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;working day&#148;</B> means a day that is not a Saturday or Sunday, Christmas Day, Good Friday or any day that is a bank holiday under
the Banking and Financial Dealings Act 1971 (c80) in England and Wales. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;written&#148;</B> and <B>&#147;in writing&#148;</B>
includes any method of representing or reproducing words in a legible and <FONT STYLE="white-space:nowrap">non-transitory</FONT> form whether sent or supplied in electronic form or otherwise. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">References in these articles to a document being <B>&#147;signed&#148;</B> or to <B>&#147;signature&#148;</B>
include references to its being executed under hand or under seal or by any other method and, in the case of a communication in electronic form, such references are to its being authenticated as specified by the Companies Acts.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless the context requires otherwise, any word or expression contained in these articles and not defined above
shall have the same meaning as in the Companies Acts as in force on the date when these articles become binding on the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where these articles refer to a person entitled to a share by law, this means a person who has been noted in
the register as being entitled to a share as a result of the death or bankruptcy of a shareholder or some other event giving rise to the transmission of the share by operation of law. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">2.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Words which refer to the singular number only include the plural number, and vice versa. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">2.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Words which refer to one gender only include the other genders. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">2.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Words which refer to persons or people include companies. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">2.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where these articles refer to months or years, these are calendar months or years. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">2.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any headings in these articles are included for convenience only, and shall not affect the meaning of these
articles. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LIMITED LIABILITY </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Limited liability </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The liability of the members of the Company is limited to the amount, if any, unpaid on the shares held by them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHARE CAPITAL </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Allotment </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of the Companies Acts and these articles, the board shall have unconditional authority to allot (with or without
conferring rights of renunciation), grant options over, offer or otherwise deal with or dispose of any shares or rights to subscribe for or convert any security into shares to such persons (including directors) at such times and generally on such
terms and conditions as the board may determine. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Redeemable shares </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company may issue shares which are to be redeemed, or are liable to be redeemed at the option of the Company or the holder. The terms,
conditions and manner of redemption of any such shares may be determined by the board before the shares are allotted, or otherwise shall be set out in the articles. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power to attach rights </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to the articles, but without prejudice to the rights attached to any existing share, the Company may issue shares with such rights or
restrictions as may be determined by ordinary resolution. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Variation of rights </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">7.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of the Companies Acts, all or any of the rights or privileges attached to any class
of shares may be varied or abrogated in such manner (if any) as may be provided by such rights, or, in the absence of any such provision, either with the consent in writing of the holders of at least
<FONT STYLE="white-space:nowrap">three-fourths</FONT> of the nominal amount of the shares of that class (excluding any shares of that class held as treasury shares) or with the sanction of a special resolution passed at a separate meeting of the
holders of the shares of that class validly held in accordance with the provisions of these articles, but not otherwise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">7.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The rights attached to any class of shares shall not, unless otherwise expressly provided in the rights
attaching to such shares, be deemed to be varied or abrogated by the creation or issue of shares ranking pari passu with or subsequent to them or by the purchase or redemption by the Company of any of its own shares. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Commissions and brokerages </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">8.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may exercise all the powers conferred or permitted by the Companies Acts to pay commissions or
brokerages to any person who: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">8.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">subscribes, or agrees to subscribe, (whether absolutely or conditionally) for shares; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">8.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">procures, or agrees to procure, subscriptions (whether absolute or conditional) for shares.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">8.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such commission or brokerage may be satisfied by the payment of cash or the allotment of fully or partly paid
shares or by the grant of an option to call for an allotment of shares or by any combination of such methods. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Trusts not recognised </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Unless ordered by a court of competent jurisdiction or required by law, the Company shall not recognise any person as holding any share upon
any trust and shall not be bound by or be otherwise compelled to recognise (even if it has notice of it) any equitable, contingent, future, partial or other claim to or interest in any share other than an absolute right in the holder to the whole of
the share. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Renunciation </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of the Companies Acts and these articles, the board may, at any time after the allotment of shares but before any
person has been entered in the register as the holder, recognise a renunciation of those shares by the allottee in favour of some other person and may accord to any allottee of a share a right to effect such renunciation on, and subject to, such
terms and conditions as the board considers fit to impose. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ALTERATION OF SHARE CAPITAL </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>New shares </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to any special rights or restrictions attached to them by their terms of issue, all new shares shall be subject to the provisions of
these articles with reference to allotment, payment of calls, forfeiture, lien, transfer, transmission and otherwise. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Sub-division</FONT> of shares </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A resolution authorising the Company to <FONT STYLE="white-space:nowrap">sub-divide</FONT> its shares may also determine that, as between the
shares resulting from such <FONT STYLE="white-space:nowrap">sub-division,</FONT> any of them may have any preference or other advantage or deferred or qualified rights or be subject to any restriction as compared with the others. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Fractions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to any direction by the Company in general meeting, whenever, as the result of any consolidation or consolidation and division of
shares, any shareholders would become entitled to fractions of shares, the board may deal with such fractions as it shall determine. In particular, the board may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">13.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">arrange for the sale, for the best price reasonably obtainable, of the shares representing the fractions to any
person (including the Company) and distribute the net proceeds of the sale in due proportions amongst those shareholders; except that any amount otherwise due to a shareholder which is less than a minimum sum determined by the board from time to
time may be retained for the benefit of the Company, or distributed to an organisation which is a charity for the purposes of the law of England and Wales, Scotland or Northern Ireland. For this purpose, the board may: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">13.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the shares are held in certificated form, authorise any person to sign a transfer of the shares sold to the
purchaser of them or to his nominee; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">13.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the shares are held in uncertificated form, exercise any of the Company&#146;s powers under article 16.4 to
give effect to the sale, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and, in each case, authorise a person to enter the name of the purchaser or his nominee in the
register as the holder of the shares which have been sold. The purchaser shall not be bound to see to the application of the purchase monies, and title to the shares shall not be affected by any irregularity in or invalidity of the proceedings
relating to the sale. After the name of the purchaser or his nominee has been entered in the register in respect of such shares, the validity of the sale shall not be impeached by any person and the remedy of any person aggrieved by the sale shall
be in damages only and against the Company exclusively; or </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">13.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">subject to the provisions of the Companies Acts, allot to each such shareholder, credited as fully paid by way
of capitalisation, the minimum number of new shares required to round up his holding following the consolidation to a whole number (such allotment being deemed to have been effected immediately before consolidation). For such purpose, the board may:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">13.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">capitalise a sum equal to the aggregate nominal amount of the new shares to be allotted on that basis out of
any profits of the Company (whether or not they are available for distribution) which are not required for paying a preferential dividend, or any sum standing to the credit of any other reserve of the Company (including any share premium account,
capital redemption reserve or other undistributable reserve); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">13.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">appropriate and apply such sum in paying up in full the appropriate number of new shares for allotment and
distribution to such shareholders on that basis. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A board resolution capitalising any part of any profits or reserve in
accordance with this article&nbsp;13.2 shall have the same effect as if such capitalisation had been authorised by ordinary resolution of the Company in accordance with these articles and, in relation to any such capitalisation, the board may
exercise all the powers conferred on it by these articles without the need for such ordinary resolution. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHARE CERTIFICATES </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Right to certificates </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">14.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to these articles and unless the terms of allotment of the shares provide otherwise, every person, upon
becoming the holder of any shares in certificated form, shall be entitled, without charge, to one certificate for all the shares of any class registered in his name or, in the case of shares in certificated form of more than one class being
registered in his name, to a separate certificate for each class of shares so registered. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">14.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where a shareholder transfers part of his shares comprised in a certificate, he shall be entitled (without
charge) to one certificate for the balance of shares retained by him to the extent that the balance is to be held in certificated form. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">14.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such certificate(s) shall be despatched to the person so entitled within the time limits prescribed by the
Companies Acts (or, if earlier, within any prescribed time limit or within a time specified when the shares were issued). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">14.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall not be bound to issue more than one certificate in respect of shares in certificated form
held jointly by two or more persons. Delivery of a certificate to any one joint holder shall be sufficient delivery to all joint holders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">14.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company does not have to issue a certificate to a recognised person. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">14.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may deliver a certificate to a broker or agent who is acting for a person who is buying shares in
certificated form, or who is having the shares in certificated form transferred to him. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">14.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every certificate of shares shall specify the number and class and the distinguishing numbers (if any) of the
shares to which it relates and the amount paid up on them; and shall be issued under the seal, or bearing an imprint or representation of the seal or such other form of authentication as the board may determine, or in such other manner having the
same effect as if issued under the seal as the board may approve. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Replacement certificates </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">15.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a shareholder has two or more share certificates for shares of the same class, he may ask the Company for
these to be cancelled and replaced by a single new certificate. Provided that such shareholder pays such reasonable charge as the board may decide, the Company must comply with such a request. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">15.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A shareholder may ask the Company to cancel and replace a single share certificate with two or more
certificates, for the same total number of shares. The Company may comply with such request and may request that the shareholder pays such reasonable charge as the board may decide. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">15.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may cancel any certificate which is worn out, defaced, lost or destroyed and issue a replacement
certificate on such terms (if any) as to provision of evidence and indemnity (with or without security) and to payment of any exceptional <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred
by the Company as the board may decide, and upon delivery up of the original certificate (where it is worn out or defaced). </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNCERTIFICATED SHARES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Uncertificated shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject always to the uncertificated securities rules and to the facilities and requirements of the relevant
system concerned, the board may resolve that any class of shares can be held in uncertificated form and that title to such shares may be transferred by means of a relevant system; and the board may make arrangements for any class of shares to be
held and transferred in this form. The board may also resolve that shares of any class must cease to be held and transferred in uncertificated form. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In accordance with and subject to the uncertificated securities rules, shares held in uncertificated form may
be changed to become shares held in certificated form, and shares held in certificated form may be changed to become shares held in uncertificated form. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No provision of these articles shall apply to shares of any class held in uncertificated form to the extent
that it is in any respect inconsistent with: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the holding of shares of that class in uncertificated form; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the transfer of title to shares of that class by means of a relevant system; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any provision of the uncertificated securities rules, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and, without prejudice to the generality of this article, no provision of these articles shall apply or have effect to the extent that it is in
any respect inconsistent with the maintenance, keeping or entering up by the Operator, so long as that is permitted or required by the uncertificated securities rules, of an Operator register of securities in respect of that class of shares in
uncertificated form. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where any class of shares is a participating security and the Company is entitled under any provision of the
Companies Acts, the uncertificated securities rules or these articles to sell, transfer or otherwise dispose of, forfeit, <FONT STYLE="white-space:nowrap">re-allot,</FONT> accept the surrender of or otherwise enforce a lien over a share held in
uncertificated form, the Company shall be entitled, subject to the provisions of the Companies Acts, the uncertificated securities rules, these articles and the facilities and requirements of the relevant system: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to require the holder of that uncertificated share by notice to change that share into certificated form within
the period specified in the notice and to hold that share in certificated form for so long as required by the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to require the holder of that uncertificated share by notice to give any instructions necessary to transfer
title to that share by means of the relevant system within the period specified in the notice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.4.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to require the holder of that uncertificated share by notice to appoint any person to take any step, including
without limitation the giving of any instructions by means of the relevant system, necessary to transfer that share within the period specified in the notice; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.4.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to take any action that the board considers appropriate to achieve the sale, transfer, disposal, forfeiture, <FONT
STYLE="white-space:nowrap">re-allotment</FONT> or surrender of that share or otherwise to enforce a lien in respect of that share. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless the board otherwise determines, shares which a shareholder holds in uncertificated form shall be treated
as separate holdings from any shares which that shareholder holds in certificated form. However, shares held in uncertificated form shall not be treated as forming a class which is separate from certificated shares with the same rights.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless the board otherwise determines or the uncertificated securities rules otherwise require, any shares
issued or created out of or in respect of any uncertificated shares shall be uncertificated shares and any shares issued or created out of or in respect of any certificated shares shall be certificated shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">16.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall be entitled to assume that the entries on any record of securities maintained by it in
accordance with the uncertificated securities rules and regularly reconciled with the relevant Operator register are a complete and accurate reproduction of the particulars entered in the Operator register and shall accordingly not be liable in
respect of any act or thing done or omitted to be done by or on behalf of the Company in reliance on such assumption; in particular, any provision of these articles which requires or envisages that action will be taken in reliance on information
contained in the Operator register shall be construed to permit that action to be taken in reliance on information contained in any relevant record of securities (as so maintained and reconciled by the Company). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LIEN </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Company&#146;s lien on shares not fully paid </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">17.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall have a first and paramount lien on every share which is not fully paid up for any amount
payable in respect of such share, whether the due date for payment shall have arrived or not, and such lien shall apply to all dividends from time to time declared or other monies payable in respect of such share. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">17.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may at any time, either generally or in any particular case, waive any lien that has arisen or
declare any share to be wholly or partly exempt from the provisions of this article 17. Unless otherwise agreed with the transferee, the registration of a transfer of a share shall operate as a waiver of the Company&#146;s lien, if any, on such
share. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Enforcement of lien by sale </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">18.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to article 18.2, the Company may enforce its lien by selling, in such manner as the board may
determine, any share subject to it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">18.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall only be entitled to enforce its lien where: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">18.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the due date for payment of the amount in respect of which the lien exists has arrived; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">18.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">notice (stating, and demanding payment of, such amount and giving notice of the intention to sell in default of
such payment) has been served by the Company on the shareholder concerned (or to any person entitled to the share by law); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">18.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such payment is not made within 14 days of service of such notice. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">18.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To give effect to a sale in accordance with article 18.1, the board may: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">18.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the share is held in certificated form, authorise any person to sign as transferor a transfer of any share
to be sold. Such transfer shall be as effective as if it had been signed by the holder (or person, if any, entitled to the share by law); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">18.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the share is held in uncertificated form, exercise any of the Company&#146;s powers under article 16.4 to
give effect to the sale, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and, in each case, authorise a person to enter the name of the purchaser or his nominee in the
register as the holder of the share which has been sold. The purchaser shall not be bound to see to the application of the purchase monies; and the title to the share shall not be affected by any irregularity in or invalidity of the proceedings
relating to the sale. After the name of the purchaser or his nominee has been entered in the register in respect of such share, the validity of the sale shall not be impeached by any person and the remedy of any person aggrieved by the sale shall be
in damages only and against the Company exclusively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Application of proceeds of sale </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">19.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The net proceeds of a sale in accordance with article 18.1, after payment of the costs of the sale, shall be
applied by the Company in or towards satisfaction of the amount in respect of which the lien exists so far as the same is presently payable. Subject to article 19.2, any residue shall (subject to a like lien for sums not presently payable as existed
on the share before the sale) be paid to the shareholder (or to any person entitled to the share by law) immediately before the sale. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">19.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the share is held in certificated form, the Company need not pay to the shareholder any amount due in
accordance with the provisions of article 19.1 until the certificate for the share which is sold is surrendered to the Company for cancellation (or until an indemnity (with or without security) as to any lost or destroyed certificate is provided to
the Company in such form as the board may decide). </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALLS ON SHARES </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Calls </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">20.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the terms of allotment of shares and provided that any monies unpaid are not payable on a date fixed
in accordance with such terms of allotment, the board may make calls on the shareholders in respect of any monies unpaid on the shares or any class of shares held by them (whether in respect of nominal value or any premium). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">20.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board shall give 14 clear days&#146; notice to each shareholder concerned (or to any person entitled to the
shares by law) of the amount called on the shares and of when and where payment is to be made. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">20.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to article 20.2, each shareholder shall pay to the Company as required by the notice referred to in
that article the amount called on his shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">20.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A call may be required to be paid by instalments. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">20.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any time before receipt by the Company of any sum due under a call, the call may be revoked or payment
postponed in whole or in part as the board may determine. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">20.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A call shall be deemed to have been made at the time when the resolution of the board authorising such call was
passed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">20.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A person on whom a call is made shall remain liable jointly and severally with the successors in title to his
shares even though the shares in respect of which the call was made are subsequently transferred. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">20.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The joint holders of a share shall be jointly and severally liable for payment of all calls in respect of such
share. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>21.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power to make different arrangements </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to the terms of allotment of shares, on the issue of shares, the board may make different arrangements, as between the holders of such
shares, in the amount and the time of payment of calls. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Interest on calls; costs, charges and expenses for <FONT STYLE="white-space:nowrap">non-payment</FONT>
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">22.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the sum payable in respect of any call is not paid on or before the day appointed for payment, the person
from whom it is due and payable shall pay: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">22.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interest on the unpaid amount; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">22.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all costs, charges and expenses incurred by the Company by reason of such
<FONT STYLE="white-space:nowrap">non-payment.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">22.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The rate of interest payable may be fixed at the time of allotment of the shares or, if no rate is fixed, shall
be such rate (not exceeding, without the sanction of the Company given by ordinary resolution, 20&nbsp;per cent per annum) as the board may decide. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">22.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such interest is payable from (and including) the day appointed for payment until (but excluding) the day of
actual payment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">22.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may waive payment of the interest, costs, charges and expenses in whole or in part.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>23.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Payment in advance </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">23.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may, if it thinks fit, receive from any shareholder willing to advance the same all or any part of
the monies uncalled and unpaid on the shares held by him. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">23.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The liability on the shares in respect of which a payment in advance of calls is made shall be extinguished to
the extent of the amount so paid. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">23.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may pay interest on the monies paid in advance, or on so much of them as from time to time exceed
the amount of the calls then made on the shares in respect of which the advance has been made, at such rate (not exceeding, without the sanction of the Company given by ordinary resolution, 20&nbsp;per cent per annum) as the board may decide.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">23.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No part of any monies paid in advance of calls shall be included or taken into account in ascertaining the
amount of any dividend payable upon the shares in respect of which such advance has been made. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>24.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sums due on allotment treated as calls </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Any amount which becomes payable in respect of a share on allotment, or at any date fixed pursuant to the terms of allotment, whether in
respect of the nominal value of the share or by way of premium or as an instalment of a call, shall be deemed to be a call; and, in the case of <FONT STYLE="white-space:nowrap">non-payment</FONT> of any such amount, all the provisions of these
articles as to payment of interest, costs, charges and expenses, forfeiture or otherwise shall apply as if such sum had become due and payable by virtue of a call. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORFEITURE </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>25.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice if call not paid </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If a call remains unpaid after it has become due and payable, the board may at any time give written notice to such shareholder (or to any
person entitled to the shares by law) demanding payment. Such notice shall state: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">25.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a date, being not less than 14 clear days from the date of the notice, by which payment of the amount of the
call outstanding, any interest that may have accrued on that amount and all costs, charges and expenses incurred by the Company by reason of such <FONT STYLE="white-space:nowrap">non-payment</FONT> shall be made; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">25.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the place where payment is to be made; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">25.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that, if the notice is not complied with, the shares in respect of which the call was made will be liable to be
forfeited. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>26.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Forfeiture for <FONT STYLE="white-space:nowrap">non-compliance</FONT> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">26.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the notice referred to in article 25 is not complied with, any share in respect of which it was given may,
at any time before the payment required by the notice has been made, be forfeited by a resolution of the board to that effect. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">26.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Forfeiture shall be deemed to occur at the time of the passing of the board resolution referred to in article
26.1. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">26.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Forfeiture shall include all dividends declared or other monies payable in respect of the forfeited shares, but
not paid before the forfeiture. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>27.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice after forfeiture </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">27.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">When any share has been forfeited, notice of the forfeiture shall be served on the person who was, before
forfeiture, the holder (or the person, if any, entitled to the share by law); but no forfeiture shall be invalidated by any omission to give such notice. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">27.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An entry of the fact and date of forfeiture shall be made in the register. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>28.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Disposal of forfeited shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">28.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Until cancelled in accordance with the provisions of the Companies Acts, a forfeited share, together with all
rights attaching to it, shall be deemed to be the property of the Company and may be sold, <FONT STYLE="white-space:nowrap">re-allotted</FONT> or otherwise disposed of either to the person who was, before the forfeiture, the holder (or the person,
if any, entitled to the share by law) or to any other person. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">28.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such sale, <FONT STYLE="white-space:nowrap">re-allotment</FONT> or other disposal shall be made on such terms
and in such manner as the board may determine, including (but without limitation to the generality of the preceding wording) with or without any past or accruing dividends and, in the case of <FONT STYLE="white-space:nowrap">re-allotment,</FONT>
with or without any money paid up on it by the former holder being credited as paid up on it on <FONT STYLE="white-space:nowrap">re-allotment.</FONT> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">28.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where, for the purposes of its disposal, a forfeited share is to be transferred to any person, the board may:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">28.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the share is held in certificated form, authorise any person to sign as transferor a transfer of such share
to the transferee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">28.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the share is held in uncertificated form, exercise any of the Company&#146;s powers under article 16.4 to
give effect to the transfer. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">28.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may receive the subscription or purchase monies (if any) given for the share on its <FONT
STYLE="white-space:nowrap">re-allotment</FONT> or disposal, and may register the allottee or, as the case may be, transferee as the holder of the share. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">28.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may, at any time before any share so forfeited has been cancelled, sold, <FONT
STYLE="white-space:nowrap">re-allotted</FONT> or otherwise disposed of, annul the forfeiture on such conditions as it thinks fit. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">28.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A statutory declaration by a director or the secretary that a share has been forfeited on the date stated in
the declaration shall be conclusive evidence of the facts stated in it as against all persons claiming to be entitled to the share. The person to whom the share is <FONT STYLE="white-space:nowrap">re-allotted</FONT> or disposed of shall not be bound
to see to the application of the subscription or purchase monies (if any); and the title to the share shall not be affected by any irregularity in or invalidity of the proceedings relating to the forfeiture or
<FONT STYLE="white-space:nowrap">re-allotment</FONT> or disposal of the share. After the name of the allottee or, as the case may be, transferee has been entered in the register in respect of such share, the validity of the <FONT
STYLE="white-space:nowrap">re-allotment</FONT> or transfer shall not be impeached by any person and the remedy of any person aggrieved by the <FONT STYLE="white-space:nowrap">re-allotment</FONT> or transfer shall be in damages only and against the
Company exclusively. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>29.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Liabilities and claims on forfeiture </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">29.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any person whose shares have been forfeited shall cease to be a shareholder in respect of them and (if the
shares are held in certificated form) shall surrender to the Company for cancellation the certificate for the shares. However, he shall remain liable to pay, and shall immediately pay, to the Company: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">29.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all calls, interest, costs, charges and expenses owing on or in respect of such shares at the time of
forfeiture; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">29.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interest on such amounts. Such interest is payable from (and including) the day of actual forfeiture until (but
excluding) the day of payment. The rate of such interest may be fixed at the time of allotment of the shares or, if no rate is so fixed, shall be such rate (not exceeding, without the sanction of the Company given by ordinary resolution, 20&nbsp;per
cent per annum) as the board may decide, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and the board may, if it thinks fit, enforce payment of such amounts without
any allowance for the value of the shares at the time of forfeiture or for any subscription or purchase monies received on their <FONT STYLE="white-space:nowrap">re-allotment</FONT> or disposal. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">29.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Save for those rights and liabilities expressly saved by these articles or imposed (in the case of past
shareholders) by the Companies Acts, the forfeiture of a share shall involve the extinction at the time of forfeiture of all interest in and all claims and demands against the Company in respect of the share, and all other rights and liabilities
incidental to the share, as between the shareholder whose share is forfeited and the Company. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>30.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Surrender </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may accept the surrender of any share liable to be forfeited and, in such case, references in these articles to forfeiture shall
include surrender. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNTRACED SHAREHOLDERS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>31.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power of sale </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">31.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall be entitled to sell any share of a shareholder, or any share to which a person is entitled by
law, at the best price reasonably obtainable, provided that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">31.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for a period of not less than 12 years (during which at least three cash dividends (whether interim or final)
shall have been paid to shareholders of the class to which the shares concerned belong): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">31.1.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no cheque, warrant or money order sent by the Company through the post in a
<FONT STYLE="white-space:nowrap">pre-paid</FONT> envelope addressed to the shareholder, or to the person entitled to the share by law, at his address in the register (or other last known postal address given by such shareholder or person to which
cheques, warrants and money orders in respect of such share are to be sent) has been cashed; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">31.1.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all funds paid by any bank or other funds transfer system to such shareholder or person in accordance with
article 127.1 have been returned to the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">31.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at the expiration of such period of 12 years, the Company has given notice of its intention to sell such share
by advertisement in both a national newspaper and in a newspaper circulating in the area of the address referred to in article 31.1.1.1 above or the address at which services of notices may be effected in the manner authorised by these articles is
located; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">31.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company has not, during such period of 12 years or the further period of three months following the last of
such advertisements, received any communication in respect of such share from the shareholder or person entitled by law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">31.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If, during the period of not less than 12 years referred to in article 31.1 or during any period ending on the
date when all the requirements of articles 31.1.1 to 31.1.3 (inclusive) have been satisfied, any additional shares have been issued by way of a bonus issue in respect of those shares held at the beginning of, or previously so issued during, such
periods, and all the requirements of articles 31.1.2 and 31.1.3 have been satisfied in regard to such additional shares, the Company shall also be entitled to sell the additional shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">31.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To give effect to any such sale, the board may: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">31.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the share is held in certificated form, authorise any person to sign as transferor a transfer of such share
to the purchaser or his nominee. Such transfer shall be as effective as if it had been signed by the holder (or person, if any, entitled to the share by law); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">31.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the share is held in uncertificated form, exercise any of the Company&#146;s powers under article 16.4 to
give effect to the sale, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and, in each case, authorise a person to enter the name of the purchaser or his nominee in the
register as the holder of the share which has been sold. The purchaser shall not be bound to see to the application of the purchase monies; and the title to the share shall not be affected by any irregularity in or invalidity of the proceedings
relating to the sale. After the name of the purchaser or his nominee has been entered in the register in respect of such share, the validity of the sale shall not be impeached by any person and the remedy of any person aggrieved by the sale shall be
in damages only and against the Company exclusively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">31.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A statutory declaration by a director or the secretary that a share has been sold on the date stated in the
declaration shall be conclusive evidence of the facts stated in it as against all persons claiming to be entitled to the share. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>32.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Application of proceeds of sale </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company shall account to the shareholder or other person entitled to such share for the net proceeds of such sale by carrying all monies in
respect of that sale to a separate account. The Company shall be deemed to be a debtor and not a trustee in respect of that money for such shareholder or other person. Monies carried to such separate account may either be employed in the business of
the Company or invested in such investments as the board may from time to time think fit. No interest shall be payable in respect of such monies and the Company shall not be required to account for any money earned on them. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRANSFERS OF SHARES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>33.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>General provisions about transfers of shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">33.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of these articles, a shareholder may transfer all or any of his shares to another
person. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">33.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The transferor shall be deemed to remain the holder of any share transferred until the name of the transferee
is entered in the register in respect of it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">33.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee shall be charged by the Company for the registration of any transfer or any other change relating to or
affecting the title to any share or the right to transfer it or for making any other entry in the register. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>34.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Transfers of uncertificated shares </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Every transfer of shares which are in uncertificated form must be made by means of a relevant system. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>35.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Transfers of certificated shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">35.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every transfer of shares which are in certificated form must be in writing in any usual form or in any form
approved by the board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">35.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such transfer shall be signed by or on behalf of the transferor and (in the case of a transfer of a share which
is not fully paid up) by or on behalf of the transferee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">35.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company is entitled to retain any transfer which it registers. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>36.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Right to refuse registration </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">36.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may, in its absolute discretion and without giving any reason, refuse to register any transfer of
certificated shares if: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">36.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it is in respect of shares which are not fully paid up, provided that, if any of the class of shares which are
not fully paid up are admitted to trading on a recognised investment exchange, the board shall not refuse to register a transfer if this would stop dealings in that class taking place on an open and proper basis; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">36.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it is in respect of more than one class of shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">36.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it is not duly stamped or is not duly certified or otherwise shown to the satisfaction of the board to be
exempt from stamp duty; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">36.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it is not delivered for registration to the office or such other place as the board may from time to time
determine, accompanied (except in the case of a transfer by a recognised person where a certificate has not been issued) by the certificate for the shares to which it relates and such other evidence as the board may reasonably require to show the
right of the transferor to make the transfer and, if the transfer is signed by some other person on his behalf, the authority of that person to do so. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">36.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may, in its absolute discretion and without giving any reason, refuse to register any allotment or
transfer of shares which is in favour of: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">36.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a child, bankrupt or person of unsound mind; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">36.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">more than four joint allottees or transferees. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRANSMISSION OF SHARES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>37.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>On death </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">37.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The personal representatives of a deceased shareholder shall be the only persons recognised by the Company as
having any title to shares held by him alone or to which he alone is entitled; but, in the case of shares held by more than one person, only the survivor or survivors shall be recognised by the Company as being entitled to such shares.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">37.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nothing in these articles shall release the estate of a deceased shareholder from any liability in respect of
any share which had been held by him solely or jointly with another person. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>38.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Election of person entitled by transmission </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">38.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any person who is entitled to a share as a result of the death or bankruptcy of a shareholder or some other
event giving rise to the transmission of the share by operation of law may, on producing such evidence as the board may reasonably require, elect either to be registered as the holder or to have some person nominated by him registered as the holder.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">38.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the person so entitled elects to be registered himself, he shall give notice to the Company to that effect.
If he elects to have some other person registered, he shall do this: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">38.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the share is held in certificated form, by signing as transferor a transfer of the share to that person;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">38.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the share is held in uncertificated form, by a transfer by means of a relevant system (such as CREST).
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The provisions of these articles relating to the transfer of shares (including the right of the board to refuse
registration) shall apply to such notice or transfer (as the case may be) as if it were a transfer by the person previously entitled to the share. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>39.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Rights of person entitled by transmission </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">39.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">When a person becomes entitled to a share as a result of the death or bankruptcy of a shareholder or some other
event giving rise to the transmission of the share by operation of law, the rights of the holder in relation to that share shall cease. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">39.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The person so entitled to the share is entitled to any dividends and other monies payable in respect of the
share (even though he is not registered as the holder of the share). However, the board may: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">39.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">withhold payment of any dividend or other monies payable in respect of the share until such person has produced
such evidence of his entitlement as the board may reasonably require; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">39.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at any time give notice to such person requiring him to elect either to register himself or to transfer the
share. If such notice is not complied with within 60 days, the board may, after that time, withhold payment of all dividends and other monies payable in respect of the share until the requirements of the notice have been complied with.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">39.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless he is registered as the holder of the share, the person so entitled to the share is not entitled in
respect of it to receive notice of, or to exercise any rights conferred on shareholders in relation to, meetings of the Company or any separate meeting of the holders of any class of shares. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL MEETINGS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>40.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>General meetings </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">40.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may convene a general meeting of the Company whenever it thinks fit. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">40.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If, at any time, there are not sufficient directors within the United Kingdom capable of acting to form a
quorum, the directors in the United Kingdom capable of acting may convene a general meeting in the same manner as nearly as possible as that in which meetings may be convened by the board. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF GENERAL MEETINGS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>41.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Postponement of general meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If the board, in its absolute discretion, considers that it is impractical or undesirable for any reason to hold a general meeting on the date
or at the time or place specified in the notice calling the general meeting, it may postpone the meeting to another date, time and place. When a meeting is so postponed, notice of the date, time and place of the postponed meeting shall be placed in
at least one national newspaper in the United Kingdom. Notice of the business to be transacted at such postponed meeting shall not be required. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>42.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Omission to send notice </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The accidental omission to give any notice of a meeting, or to send or supply any document or other information relating to any meeting, to any
person entitled to receive the notice, document or other information, or the <FONT STYLE="white-space:nowrap">non-receipt</FONT> for any reason of any such notice, document or other information by that person, shall not invalidate the proceedings at
that meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROCEEDINGS AT GENERAL MEETINGS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>43.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Quorum </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">43.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No business shall be transacted at any general meeting unless a quorum is present. The absence of a quorum
shall not preclude the appointment of a chairman of the meeting in accordance with the provisions of these articles, which shall not be treated as part of the business of the meeting. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">43.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The quorum for a general meeting shall, for all purposes, be two shareholders present in person or by proxy and
entitled to vote (save that, in the case of the Company having only one shareholder, the quorum shall be one shareholder present in person or by proxy and entitled to vote). </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>44.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Procedure if quorum not present </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">44.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a quorum is not present within 15 minutes (or such longer interval as the chairman of the meeting in his
absolute discretion thinks fit) from the time appointed for the commencement of the meeting, or if, during a meeting, a quorum ceases to be present, the meeting, if convened by or on the requisition of shareholders, shall be dissolved. In any other
case, it shall stand adjourned to such date (being not less than 14 days nor more than 28 days later), time and place as the chairman of the meeting (or, in default, the board) shall appoint. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">44.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any such adjourned meeting the quorum shall be one shareholder present in person or by proxy and entitled to
vote. If a quorum is not present within 15 minutes (or such longer interval as the chairman of the meeting in his absolute discretion thinks fit) from the time appointed for the commencement of such adjourned meeting, or if, during the meeting, a
quorum ceases to be present, the adjourned meeting shall be dissolved. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">44.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall give not less than seven clear days&#146; notice of any such adjourned meeting.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>45.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Chairman </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">45.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The chairman (if any) of the board or, in his absence, the deputy chairman (if any) of the board or, in his
absence, some other director nominated by the directors, shall preside as chairman at every general meeting of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">45.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If neither the chairman (if any) nor the deputy chairman (if any) nor such other director is present within 15
minutes after the time appointed for the commencement of the meeting, or none of such persons is willing to act as such, the directors present shall select one of their number to be chairman of the meeting. If only one director is present and he is
willing to act, he shall be chairman of the meeting. In default, a shareholder may be elected to be chairman of the meeting by a resolution of the Company passed at the meeting. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">45.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The decision of the chairman of the meeting on points of order, matters of procedure or arising incidentally
out of the business of the meeting shall be final and conclusive, as shall be his determination, acting in good faith, whether any point or matter is of such a nature. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">45.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the avoidance of doubt, no provision of these articles restricts or excludes any of the powers or rights of
a chairman of a meeting which are given by law. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>46.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Director&#146;s right to attend and speak </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A director shall be entitled, even though he is not a shareholder, to attend and speak at any general meeting and at any separate meeting of
the holders of any class of shares or debentures of the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>47.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power to adjourn </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">47.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The chairman of the meeting may, with the consent of a meeting at which a quorum is present (and shall, if so
directed by the meeting), adjourn any meeting to another date, time and/or place or for an indefinite period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">47.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without prejudice to any other power which he may have under these articles or which is given by the general
law, the chairman of the meeting may, without the need for the consent of the meeting, interrupt or adjourn any meeting at which a quorum is present to another date, time and/or place or for an indefinite period if he is of the opinion that:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">47.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the shareholders wishing to attend cannot be conveniently accommodated in the place appointed for the meeting;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">47.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the conduct of persons present prevents or is likely to prevent the proper and orderly conduct of the meeting;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">47.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it has become necessary to ensure that the business of the meeting is properly considered and transacted.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>48.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice of adjourned meeting </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">48.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The provisions of this article 48 shall not apply to a meeting adjourned for lack of a quorum (see article 44).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">48.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall give not less than seven clear days&#146; notice of any meeting which is adjourned for 28
days or more or for an indefinite period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">48.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In all other cases, no person shall be entitled to receive notice of an adjourned meeting or of the business to
be transacted at the adjourned meeting. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>49.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Business at adjourned meeting </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The only business which shall be transacted at any adjourned meeting is that which might properly have been transacted at the meeting from
which the adjournment took place. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>50.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Attendance and participation at different places and by electronic means </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">50.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of any general meeting, the board may, notwithstanding the specification in the notice convening
the general meeting of the place at which the chairman of the meeting shall preside (<B>&#147;Principal Place&#148;</B>), make arrangements for simultaneous attendance and participation by electronic means allowing persons not present together at
the same place to attend, speak and vote at the meeting (including the use of satellite meeting places). The arrangements for simultaneous attendance and participation at any place at which persons are participating using electronic means may
include arrangements for controlling or regulating the level of attendance at any particular venue provided that such arrangements shall operate so that all shareholders and proxies are able to attend at one or other of the venues.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">50.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shareholders or proxies at the place or places at which persons are participating using electronic means
shall be counted in the quorum for, and be entitled to vote at, the general meeting in question, and that meeting shall be duly constituted and its proceedings valid if the chairman of the meeting is satisfied that adequate facilities are available
throughout the meeting to ensure that the shareholders or proxies attending at the places at which persons are participating using electronic means are able to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">50.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">participate in the business for which the meeting has been convened; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">50.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">see and hear all persons who speak (whether through the use of microphones, loud speakers, audiovisual
communication equipment or otherwise) in the Principal Place (and any other place at which persons are participating using electronic means). </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">For the purposes of all other provisions of these articles (unless the context requires otherwise), the shareholders and proxies shall be
treated as meeting at the Principal Place. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>51.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Security arrangements and orderly conduct </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board and, at any general meeting, the chairman of the meeting may make any arrangement and impose any requirement or restriction which it
or he (as appropriate) considers appropriate to ensure the security and orderly conduct of a general meeting including, without limitation, requirements for evidence of identity to be produced by those attending the meeting, the searching of their
personal property and the restriction of items which may be taken into the meeting place. The board and, at any general meeting, the chairman of the meeting is entitled to refuse entry to, or to eject, a person who refuses to comply with these
arrangements, requirements or restrictions or who disrupts the proper and orderly conduct of the meeting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VOTING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>52.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Method of voting </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">52.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any general meeting, a resolution put to the vote of the meeting shall be decided by a show of hands unless
before the show of hands, or before or immediately following the declaration of the result of the show of hands, a poll is duly demanded. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">52.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A poll may be demanded on any question by: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">52.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the chairman of the meeting; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">52.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not less than five shareholders present in person or by proxy and entitled to vote on the resolution;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">52.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a shareholder or shareholders present in person or by proxy representing in aggregate not less than 10&nbsp;per
cent of the total voting rights of all the shareholders having the right to vote on the resolution (excluding any voting rights attached to any shares held as treasury shares); or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">52.2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a shareholder or shareholders present in person or by proxy holding shares conferring a right to vote on the
resolution, being shares on which an aggregate sum has been paid up equal to not less than 10&nbsp;per cent of the total sum paid up on all the shares conferring that right (excluding shares held as treasury shares). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A demand by a proxy for a shareholder shall be deemed to be a demand by that shareholder.
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">52.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless a poll is so demanded and the demand is not withdrawn, a declaration by the chairman of the meeting that
the resolution has been carried, or carried by a particular majority, or lost or not carried by a particular majority, and an entry to that effect in the book containing the minutes of proceedings of the Company, shall be conclusive evidence of that
fact without proof of the number or proportion of the votes recorded in favour of or against such resolution. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>53.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Procedure on a poll </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">53.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a poll is properly demanded, it shall be taken in such manner as the chairman of the meeting directs. He may
appoint scrutineers, who need not also be shareholders, and may fix a date, time and place for declaring the result of the poll. The result of the poll shall be deemed to be the resolution of the meeting at which the poll was demanded.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">53.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any poll demanded on the election of a chairman of a meeting or on any question of adjournment shall be taken
at the meeting and without adjournment. A poll demanded on any other question shall be taken at such date, time and place as the chairman of the meeting directs, either at once or after an interval or adjournment (but not more than 30 days after the
date of the demand). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">53.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No notice need be given of a poll not taken immediately if the date, time and place at which it is to be taken
are announced at the meeting at which it is demanded. In any other case, at least seven clear days&#146; notice shall be given specifying the date, time and place at which the poll is to be taken. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">53.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The demand for a poll may be withdrawn, but only with the consent of the chairman of the meeting. A demand so
withdrawn shall validate the result (if any) of a show of hands declared before the demand was made. In the case of a poll demanded before the show of hands or the declaration of the result of it, the meeting shall continue as if the demand had not
been made. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">53.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The demand for a poll (other than on the election of the chairman of the meeting or on any question of
adjournment) shall not prevent the continuance of a meeting for the transaction of any business other than the question on which a poll has been demanded. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>54.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Votes of shareholders </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">54.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The voting rights set out in articles 54.2 and 54.3 are subject to any rights or restrictions as to voting upon
which any shares may have been issued or may for the time being be held. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">54.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On a show of hands: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">54.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">every shareholder who is entitled to vote on the resolution and who is present in person shall have one vote;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">54.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">every proxy present who has been duly appointed by one or more shareholders entitled to vote on the resolution
shall have one vote; except that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">54.2.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if a shareholder votes in person on a resolution then, as regards that resolution, his proxy shall have no
vote; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">54.2.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a proxy shall have one vote for and one vote against the resolution if he has been duly appointed by more than
one shareholder entitled to vote on the resolution and either: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is instructed by one or more of those shareholders to vote for the resolution and by one or more others to vote
against it; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is instructed by one or more of those shareholders to vote in one way and is given a discretion as to how to
vote by one or more others (and wishes to use that discretion to vote in the other way). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">54.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On a poll, every shareholder who is entitled to vote on the resolution and who is present in person or by a
duly appointed proxy shall have one vote for every share he holds. A shareholder entitled to more than one vote need not, if he votes on the poll (whether in person or by proxy), use all his votes or cast all the votes he uses in the same way.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">54.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of joint holders of a share, the vote of the senior who tenders a vote, whether in person or by
proxy, shall be accepted to the exclusion of the votes of the other joint holders. Seniority shall be determined by the order in which the names of the joint holders stand in the register. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">54.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A shareholder in respect of whom an order has been made by any court or official having jurisdiction (whether
in the United Kingdom or elsewhere) that he is or may be suffering from mental disorder or is otherwise incapable of running his affairs may vote, whether on a show of hands or on a poll, by his receiver, curator bonis or other person authorised for
that purpose and appointed by the court or official and any such receiver, curator bonis or other person may vote by proxy; provided, in each case, that evidence (to the satisfaction of the board) of the authority of the person claiming to exercise
the right to vote is received by the Company within the time limits prescribed by these articles for the receipt of appointments of proxy for use at the meeting, adjourned meeting or poll at which the right to vote is to be exercised.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">54.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purposes of determining which persons may attend and vote at a general meeting, and the number of votes
each such person has, the notice of the meeting may specify a date and time by which persons must be entered in the register in order to be entitled to attend and vote at the meeting. This date and time must not be more than 48 hours (excluding any
part of a day that is not a working day) before the time appointed for the commencement of the meeting. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>55.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Restriction on voting rights </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">55.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The provisions of article 64 shall apply to restrict the voting rights of a shareholder where a notice has been
given in accordance with section 793 of the Act in respect of shares held by him and the information required by such notice has not been given to the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">55.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless the board otherwise determines, no shareholder shall be entitled (in respect of any share held by him)
to be present or to vote, either in person or by proxy, at any general meeting or at any separate meeting of the holders of any class of shares or on any poll, or to exercise any other rights conferred on shareholders in relation to any such meeting
or poll, if any calls or other monies due and payable in respect of such share remain unpaid. Such restrictions shall cease to apply on payment of the amount outstanding and all costs, charges and expenses incurred by the Company by reason of such <FONT
STYLE="white-space:nowrap">non-payment.</FONT> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>56.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Voting by proxy </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">56.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The appointment of a proxy shall be: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">56.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in writing in the usual form, or in such other form as may be approved by the board; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">56.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">signed by the appointor or his duly authorised attorney or, if the appointor is a corporation, executed under
its seal or signed under the hand of its duly authorised officer or attorney or other person or persons authorised to sign it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">56.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to any contrary direction contained in the appointment of a proxy, a proxy may demand or join in
demanding a poll and, subject to the provisions of these articles, may speak at a general meeting and may vote on any resolution or amendment of a resolution put to, or any other business which may properly come before, the meeting for which it is
given, as the proxy thinks fit. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">56.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A proxy need not be a shareholder of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">56.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A shareholder may appoint more than one proxy to attend on the same occasion, provided that each proxy is
appointed to exercise the rights attached to a different share or shares held by such shareholder. Where a shareholder appoints more than one proxy, each such appointment shall specify the number of shares in respect of which each proxy is entitled
to exercise the related votes and the shareholder shall ensure that no proxy is appointed to exercise the votes which any other proxy has been appointed by that shareholder to exercise. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">56.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The appointment of a proxy shall not preclude a shareholder from attending and voting in person at the meeting
or any adjournment of it or on any poll. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">56.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The appointment of a proxy shall, unless the contrary is stated in it, be valid for any adjournment of the
meeting as well as for the meeting(s) to which it relates. No appointment of a proxy shall be valid after the expiry of 12 months from the date it is given. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>57.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Receipt of proxies </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">57.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In order to be valid, the appointment of a proxy must: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">57.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(in the case of an appointment of a proxy made in hard copy form) be received at the office (or at such other
place within the United Kingdom as may be specified by the Company for the receipt of appointments of proxy in hard copy form) by the relevant time, together with the relevant documents, if any; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">57.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(in the case of an appointment of a proxy made by electronic means or by means of a website) be received at the
address by the relevant time. Any relevant documents must also be received at the address or at the office by the relevant time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">57.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purposes of this article 57: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">57.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the <B>&#147;address&#148;</B> means the number or address which has been specified by the Company for the
purpose of receiving appointments of proxy by electronic means or by means of a website; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">57.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>&#147;relevant documents&#148;</B> means the power of attorney or other authority pursuant to which the
appointment of proxy is made, or a copy of such document certified by a notary or certified in some other way approved by the board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">57.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the <B>&#147;relevant time&#148;</B> shall be: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">57.2.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a meeting or adjourned meeting, 48 hours before the time appointed for the commencement of the
meeting or adjourned meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">57.2.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a poll taken more than 48 hours after it was demanded, 24 hours before the time appointed for
the taking of the poll; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">57.2.3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a poll taken after the end of a meeting or adjourned meeting but 48 hours or less after it was
demanded, before the end of the meeting at which it was demanded, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">or, in each case, such later time as the board may
determine. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">In calculating the periods referred to in this article&nbsp;57.2.3, no account shall be taken of any part of a day which is
not a working day. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>58.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>When votes by proxy valid though authority revoked </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A vote given or poll demanded by a proxy or a duly authorised representative of a corporation shall be valid even though the authority of the
person voting or demanding a poll has previously terminated unless notice in writing of the termination was received by the Company: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">58.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(in the case of a duly authorised representative of a corporation) at the office; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">58.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(where the appointment of the proxy was made in hard copy form) at the office (or such other place as is
specified for the receipt of appointments of proxy in hard copy form); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">58.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(where the appointment of the proxy was made by electronic means or by means of a website) at the address (as
defined in article 57.2.1), </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">in each case, by the relevant time (as defined in article&nbsp;57.2.3). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>59.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Corporate representatives </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">59.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A shareholder which is a corporation may, by resolution of its directors or other governing body, authorise
such person or persons as it thinks fit to act as its representative or representatives at any meeting of the Company or at any separate meeting of the holders of any class of shares. The provisions of the Companies Acts shall apply to determine the
powers that may be exercised at any such meeting by any person or persons so authorised. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">59.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The corporation shall, for the purposes of these articles, be deemed to be present in person at any such
meeting if any person or persons so authorised is or are present at it, and all references to attendance and voting in person shall be construed accordingly. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">59.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A director, the secretary or some person authorised for the purpose by the secretary may require any
representative to produce a certified copy of the resolution so authorising him before permitting him to exercise his powers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>60.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Objections and validity of votes </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">60.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No objection shall be raised to the qualification of any voter, or to the counting of, or failure to count, any
vote, except at the meeting or adjourned meeting at which the vote objected to is tendered or at which the error occurs. Any objection made in due time shall be referred to the chairman of the meeting and shall only vitiate the result of the voting
if, in the opinion of the chairman of the meeting, it is of sufficient magnitude to affect the decision of the meeting. The decision of the chairman of the meeting shall be final and conclusive. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">60.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall not be obliged to check that any proxy or corporate representative exercises the votes of the
appointing shareholder, either at all or in accordance with the voting instructions given. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">60.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No vote at any general meeting of the Company shall be declared or deemed invalid by virtue solely of any
failure by any proxy or corporate representative to vote in accordance with the voting instructions given to him by the appointing shareholder. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>61.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Amendments to resolutions </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">61.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No amendment to a special resolution (other than a clerical amendment to correct a patent error) may be
considered in any circumstances. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">61.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No amendment to an ordinary resolution (other than a clerical amendment to correct a patent error) may be
considered unless either: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">61.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at least two working days&#146; prior written notice of the amendment has been received by the Company; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">61.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the chairman of the meeting agrees otherwise. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">61.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If any amendment proposed to any resolution under consideration is ruled out of order by the chairman of the
meeting, the proceedings on the substantive resolution shall not be invalidated by any error in such ruling. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>62.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential information </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">No shareholder present at a general meeting, whether in person, by proxy or by representative, shall be entitled to require disclosure of or
any information about any detail of the Company&#146;s trading, or that may relate to the conduct of the business of the Company, if the board decides that it is in the interests of the Company to keep that information confidential. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CLASS MEETINGS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>63.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Procedure </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The provisions of these articles relating to general meetings of the Company or to the proceedings at general meetings shall apply to any
separate meeting of the holders of any class of shares, except that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">63.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no shareholder, other than a director, shall be entitled to notice of, or to attend, any such meeting unless he
is a holder of shares of that class; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">63.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the quorum at any such meeting (other than an adjourned meeting) shall be two persons present in person or by
proxy holding or representing by proxy at least <FONT STYLE="white-space:nowrap">one-third</FONT> in nominal value of the shares of that class (excluding any shares of that class held as treasury shares); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">63.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the quorum at any adjourned meeting shall be one person holding shares of that class who is present in person
or by proxy; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">63.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a poll may be demanded by any person holding shares of that class who is present in person or by proxy and
entitled to vote at the meeting. On a poll, every shareholder who is present in person or by proxy shall have one vote for every share of that class he holds. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DISCLOSURE OF INTERESTS IN SHARES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>64.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sanctions for <FONT STYLE="white-space:nowrap">non-disclosure</FONT> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">64.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where a shareholder, or any other person appearing to be interested in shares held by that shareholder, has:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">64.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">been issued with a notice pursuant to section 793 of the Act; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">64.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">failed in relation to any shares (<B>&#147;default shares&#148;</B>, which expression shall include any
additional shares which are issued in respect of such default shares) to give the Company the information required by that notice within the prescribed period from the date of service of the notice, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">then, unless the board otherwise determines, the sanctions set out in articles&nbsp;64.2 and 64.3 shall apply. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">64.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shareholder shall not be entitled in respect of the default shares and any other shares held by him to be
present or to vote (either in person or by representative or proxy) at any general meeting or at any separate meeting of the holders of any class of shares, or on any poll, or to exercise any other right conferred on shareholders in relation to any
such meeting or poll. The same restrictions shall apply to any transferee to whom any of such default shares are transferred, unless such transfer is an excepted transfer (as defined in article 68). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">64.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where the default shares represent at least 0.25&nbsp;per cent in nominal value of the shares of their class
(excluding any shares of that class held as treasury shares): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">64.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any dividend or other monies payable in respect of the default shares shall be withheld by the Company, which
shall not have any obligation to pay interest on it, and the shareholder shall not be entitled to elect, pursuant to articles 134 or 135, to receive shares instead of that dividend; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">64.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">save for an excepted transfer (as defined in article 68) and subject to the requirements of the relevant system
in relation to shares in uncertificated form, no transfer of a default share shall be registered unless: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">64.3.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the shareholder is not himself in default as regards supplying the information required; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">64.3.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the shareholder proves to the satisfaction of the board that no person in default as regards supplying such
information is interested in any of the shares which are the subject of the transfer. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>65.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Cessation of sanctions </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">65.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where the sanctions under article 64 apply in relation to any shares, they shall cease to have effect seven
days following the earlier of: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">65.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">receipt by the Company of notice that the shares have been transferred by means of an excepted transfer; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">65.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">receipt by the Company of the information required by the notice issued pursuant to section 793 of the Act.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">65.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may at any time give notice cancelling or suspending for a stated period the operation of the
sanctions under article 64 in whole or in part. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>66.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Section&nbsp;793 notices </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">66.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any notice issued pursuant to section 793 of the Act may treat certificated and uncertificated shares of a
holder as separate holdings and either apply only to certificated shares or to uncertificated shares or make different provision for certificated and uncertificated shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">66.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where, on the basis of information obtained from a shareholder in respect of any share held by him, the Company
issues a notice pursuant to section 793 of the Act to any other person, it shall, at the same time, send a copy of the notice to the shareholder. The accidental omission to do so, or the <FONT STYLE="white-space:nowrap">non-receipt</FONT> by the
shareholder of the copy, shall not invalidate or otherwise affect the application of article&nbsp;64. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>67.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Approved depositaries </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">67.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where a person who appears to be interested in shares has been served with a notice pursuant to section 793 of
the Act and the shares in which he appears to be interested are held by an approved depositary, the provisions of articles 64 to 66 (inclusive) shall be treated as applying only to the shares which are held by the approved depositary in which that
person appears to be interested and not (so far as that person&#146;s apparent interest is concerned) to any other shares held by the approved depositary. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">67.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">While the shareholder on which a notice pursuant to section 793 of the Act is served is an approved depositary,
the obligations of the approved depositary as a shareholder will be limited to disclosing to the Company any information relating to a person who appears to be interested in the shares held by it which has been recorded by it in accordance with the
arrangement under which it was appointed as an approved depositary. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>68.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Disclosure of interests - definitions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">For the purposes of articles&nbsp;64 to 67 (inclusive): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a person, other than the holder of a share, shall be treated as appearing to be interested in that share if:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the holder has informed the Company that the person is, or may be, so interested; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company (after taking account of any information obtained from the holder or, pursuant to a notice under
section 793 of the Act, from anyone else) knows or has reasonable cause to believe that the person is, or may be, so interested; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>&#147;interested&#148;</B> shall be construed in the same way as it is construed for the purpose of section
793 of the Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">reference to a person having failed to give the Company the information required by a notice, or being in
default as regards supplying such information, includes reference to his having failed or refused to give all or any part of it and reference to his having given information which he knows to be false in a material particular or having recklessly
given information which is false in a material particular; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the <B>&#147;prescribed period&#148;</B> means 14 days; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an <B>&#147;excepted transfer&#148;</B> means, in relation to any shares held by a shareholder:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a transfer pursuant to the acceptance of a takeover offer for the Company (within the meaning of the Act);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a transfer as a result of a sale made through a recognised investment exchange; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">68.5.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a transfer which is shown to the satisfaction of the board to be made as a result of a sale of the whole of the
beneficial interest in the shares to a person who is unconnected with the shareholder and with any other person appearing to be interested in the shares. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>69.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Section&nbsp;794 </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Nothing contained in these articles shall limit the powers of the Company under section&nbsp;794 of the Act. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NUMBER OF DIRECTORS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>70.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Number of directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Unless and until otherwise determined by the Company by ordinary resolution there shall be no maximum number of directors, but the number of
directors shall not be less than two. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ALTERNATE DIRECTORS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>71.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Appointment </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">71.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any director (other than an alternate director) may, by notice sent to or received at the office or at an
address specified by the Company for the purpose of communication by electronic means, or in any other manner approved by the board, appoint any other director or any other person who is approved by the board and is willing to act to be his
alternate. No appointment of an alternate director who is not already a director shall be effective until his consent to act as a director has been received at the office or at an address specified by the Company for the purpose of communication by
electronic means and his appointment has been approved by the board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">71.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An alternate director shall not be required to hold any shares. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>72.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Revocation of appointment </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">72.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A director may, at any time, by notice sent to or received at the office or at an address specified by the
Company for the purpose of communication by electronic means, revoke the appointment of his alternate director and, subject to the provisions of article 71, appoint another person in his place. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">72.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a director ceases to hold the office of director or if he dies, the appointment of his alternate director
shall then also cease. However, if any director retires but is reappointed at the meeting at which such retirement takes effect, any valid appointment of an alternate director which was in force immediately before his retirement shall continue to
operate after his reappointment as if he had not so retired. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">72.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The appointment of an alternate director shall cease on the happening of any event which, if he was a director
otherwise appointed, would cause him to vacate office. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>73.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Participation in board meetings </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">73.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every alternate director shall (subject to him giving to the Company an address at which notices may be served
on him) be entitled to receive notice of all meetings of the board and all committees of which his appointor is a member. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">73.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the absence from such meetings of his appointor, an alternate director shall be entitled to attend and vote
at such meetings and to exercise all the powers, rights, duties and authorities of his appointor. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">73.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A director acting as alternate director shall have, in addition to his own vote, a separate vote at board and
committee meetings for each director for whom he acts as alternate director; however, he shall count as only one director for the purpose of determining whether a quorum is present. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>74.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Responsibility </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Every person acting as an alternate director shall be deemed to be an officer of the Company, shall alone be responsible for his own acts and
defaults, and shall not be deemed to be the agent of his appointor. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>75.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Remuneration and expenses </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">An alternate director shall not be entitled as against the Company to any fees for his services as an alternate. An alternate director shall be
paid by the Company such expenses as might properly have been repaid to him if he had been a director. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWERS OF THE BOARD </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>76.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Powers of the board </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">76.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to these articles and to any directions given by special resolution of the Company, the business of the
Company shall be managed by the board which may exercise all the powers of the Company whether relating to the management of the business or not. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">76.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No alteration of these articles and no special resolution of the Company shall invalidate any prior act of the
board which would have been valid if such alteration had not been made or such special resolution had not been passed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">76.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The provisions contained elsewhere in these articles as to any specific power of the board shall not be deemed
to limit the general powers given by this article 76. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>77.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Powers of directors if less than minimum required number </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">77.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the number of directors is less than the minimum for the time being prescribed by these articles, the
remaining director or directors shall only act for the purpose of appointing an additional director or directors to make up such minimum or to convene a general meeting of the Company for the purpose of making such appointment. If there is no
director or if no director or directors are able or willing to act, then any two shareholders may summon a general meeting for the purpose of appointing directors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">77.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any additional director appointed by the remaining director or directors shall (subject to the provisions of
these articles and unless he is <FONT STYLE="white-space:nowrap">re-elected</FONT> during such meeting) hold office only until the dissolution of the annual general meeting of the Company next following such appointment. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>78.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exercise of voting rights </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may exercise or cause to be exercised the voting rights conferred by shares in any other company held or owned by the Company, or any
power of appointment to be exercised by the Company, in such manner and in all respects as it thinks fit (including the exercise of the voting rights or power of appointment in favour of the appointment of any director as a director or other officer
or employee of such company or in favour of the payment of remuneration to the directors, officers or employees of such company). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>79.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Corporate shareholders </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may at any time require a corporate shareholder to furnish any information, supported (if the board so requires) by a statutory
declaration, which it may consider necessary for the purpose of determining whether or not such shareholder is a close company within the meaning of section&nbsp;439 of the Corporation Tax Act 2010. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>80.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Provision for employees on cessation or transfer of business </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may resolve to exercise any power conferred on the Company by the Companies Acts to make provision for the benefit of any person
employed or formerly employed by the Company or any of its subsidiaries in connection with the cessation or the transfer to any person of the whole or part of the undertaking of the Company or that subsidiary. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>81.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Change of name </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company may change its name by resolution of the board. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>82.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Overseas register </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of the Companies Acts, the board may exercise the powers conferred on the Company with regard to the keeping of an
overseas or local or other register and may make and vary such regulations as it thinks fit in respect of the keeping of any such register. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>83.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Borrowing powers </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of the Companies Acts, the board may exercise all the powers of the Company:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to borrow money; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to mortgage or charge all or any part of the undertaking, property and assets (present or future) and uncalled
share capital of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to issue debentures and other securities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to give security, either outright or as collateral security for any debt, liability or obligation of the
Company or of any third party. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may exercise all the powers of the Company to borrow or raise money upon or by the issue or sale of
any debentures or securities on such terms as to time of repayment, rate of interest, price of issue or sale, payment of premium or bonus upon redemption or repayment or otherwise as it may determine, including (subject to the provisions of the
Companies Acts) a right for the holders of debentures or securities to exchange the same for shares of any class. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may confer upon any mortgagees or persons in whom any debenture or security is vested, such rights
and powers as it thinks necessary or expedient. It may vest any property of the Company in trustees for the purpose of securing any monies so borrowed or raised; and confer upon the trustees or any receiver to be appointed by them or by any
debenture holder such rights and powers as the board may think necessary or expedient in relation to: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the undertaking or property of the Company, or its management or realisation; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the making, receiving or enforcing of calls on the shareholders in respect of unpaid share capital,
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and otherwise, and may make and issue debentures to trustees for the purpose of further security, and any such trustees
may be remunerated. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">83.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may give security for the payment of any monies payable by the Company in the same manner as for the
payment of monies borrowed or raised, in which case such amount shall be deemed to be included as part of the borrowings for the purposes of article 84. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>84.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Limit to borrowing powers </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board shall restrict the borrowings of the Company and shall exercise all voting and other rights or powers
of control exercisable by the Company in relation to its subsidiary undertakings (if any) so as to procure (but as regards such subsidiary undertakings, only in so far as it can procure by such exercise) that the aggregate principal amount
outstanding in respect of all borrowings by the group (exclusive of any borrowings which are owed by one group company to another and after deducting cash deposited) shall not, at any time, without an ordinary resolution of the Company, exceed a sum
equal to two times the adjusted total of capital and reserves (or such higher limit as may be fixed from time to time by ordinary resolution). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No lender or other person dealing with the Company shall be concerned to see or enquire whether the limit
imposed by this article 84 is observed. No debt incurred or security given in respect of borrowings in excess of the limit imposed by this article 84 shall be invalid or ineffectual, except in the case of express notice to the lender or recipient of
the security at the time when the debt was incurred or security given that the limit had been or would be exceeded. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A report or certificate by the auditors as to the amount of the adjusted total of capital and reserves and as
to the aggregate amount of borrowings for the purposes of this article 84, or to the effect that the limit imposed by this article 84 has not been or will not be exceeded at any particular time or times, shall be conclusive evidence of such amount
or fact and binding on all concerned. Nevertheless, for the purposes of this article&nbsp;84, the board may, at any time, act in reliance on a bona fide estimate of the amount of the adjusted total of capital and reserves, and if, as a result, the
limit on borrowings set out in this article&nbsp;84 is inadvertently exceeded, an amount borrowed equal to the excess may be disregarded until the expiration of 90 days after the date on which, by reason of a determination of the auditors or
otherwise, the board became aware that such a situation has or may have arisen. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In this article 84: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>&#147;adjusted total of capital and reserves&#148;</B> means a sum equal to the aggregate of:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the amount paid up on the shares (including any shares held as treasury shares); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the amounts standing to the credit of the reserves of the group (whether distributable or undistributable, and
including retained earnings, share premium account, capital redemption reserve, revaluation reserve and unappropriated balance of grants (including investment grants)), after deducting any debit balance on retained earnings (other than any such
debit balance arising only on consolidation); </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">all as shown in the latest balance sheet, but after: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">making such adjustments as may be appropriate in respect of: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any variation in the amount paid up on the shares or the amount of the share premium account or the capital
redemption reserve of the Company since the date of the latest balance sheet; and so that, for this purpose, if any proposed allotment of shares by the Company for cash has been underwritten or agreed to be subscribed, then such shares shall be
deemed to have been allotted, and the amount (including the premium) of the subscription monies payable in respect of them (not being monies payable later than six months after the date of allotment) shall be deemed to have been paid up to the
extent so underwritten or agreed to be subscribed on the date when the issue of such shares was underwritten or agreed to be subscribed (or, in the event that such underwriting or agreement to subscribe was conditional, the date on which it became
unconditional); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any variation in the interests of the Company in its subsidiary undertakings since the date of the latest
balance sheet; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">excluding (so far as not already excluded): </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">amounts attributable to minority interests in group companies; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any sum set aside for taxation (other than deferred taxation); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.1.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deducting the amount of any distribution out of profits accrued up to and including the date of the latest
balance sheet declared, recommended or made by any group company to a person other than a group company (to the extent not provided for in the latest balance sheet); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.1.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">making such other adjustments (if any) as the board may consider appropriate or necessary and as are approved
by the auditors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>&#147;borrowings&#148;</B> shall be deemed to include the following (except in so far as otherwise taken
into account): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal amount of any debenture (whether secured or unsecured) of any group company owned otherwise than
by any group company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the nominal amount of any share (not being equity share capital) of any group company which is not owned within
the group; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the nominal amount of any share and the principal amount of any borrowings or other indebtedness, the
redemption or repayment of which is guaranteed or secured or is the subject of an indemnity given by any group company, but where the beneficial interest in the redemption or repayment of which is not owned within the group; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the outstanding amount raised by acceptances under any acceptance credit or bills facility opened on behalf of
and in favour of any group company by any bank or accepting house, not being acceptances of, or acceptance credits in relation to, trade bills for purchases of goods or services in the ordinary course of business and outstanding for six months or
less; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any fixed or minimum premium payable on final repayment of any borrowing or deemed borrowing (but so that any
premium payable on final repayment of an amount not to be taken into account as borrowings shall not be taken into account); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">amounts raised under any transaction (including, without limitation, forward sale or purchase agreements)
having the commercial effect of borrowings entered into to enable the financing of operations or capital requirements, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">but shall be deemed not to include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">borrowings made by a group company for the purpose of repaying the whole or any part of borrowings falling to
be taken into account for the purposes of this article 84 within six months of being first borrowed, pending their application for such purpose within such period; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">borrowings made by a group company for the purpose of financing any contract in respect of which any part of
the price receivable under such contract by that or another group company is guaranteed or insured by any government, governmental agency or body, or by a person (not being a group company) carrying on the business of providing credit insurance, up
to the amount not exceeding that part of the price receivable under the contract which is so guaranteed or insured; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such proportion of the borrowings of any group company which is not a
<FONT STYLE="white-space:nowrap">wholly-owned</FONT> subsidiary of the Company as that part of its paid up equity share capital which is not beneficially owned, directly or indirectly, by a group company bears to the whole of its paid up equity
share capital (but an equivalent proportion of borrowings from one such non <FONT STYLE="white-space:nowrap">wholly-owned</FONT> subsidiary by any other group company which would otherwise fall to be excluded shall nevertheless be included);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.10</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">borrowings of a company which was not a subsidiary undertaking at the date of the latest balance sheet, to the
extent that the borrowings do not exceed its borrowings outstanding on the date when it became a group company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.11</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any sum advanced or paid to any group company (or its agents or nominees) by customers of any group company as
unexpended customer receipts or progress payments pursuant to any contract between such customer and a group company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.12</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the amount of any monies held by any group company whether on deposit or current account or otherwise in
connection with any scheme for the benefit of employees or their dependants; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.4.2.13</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">sums which fall to be treated as borrowings by any group company by reason only of any current statement of
standard accounting practice or other accounting principle or practice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.4.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>&#147;cash deposited&#148;</B> means an amount equal to the aggregate for the time being outstanding of all
cash deposits or balances on each account of the group (whether current or otherwise) with any bank (not being a group company), the realisable value of certificates of deposit and securities of governments and companies or other readily realisable
deposits owned by any group company, except that (in the case of any such items owned by a group company which is not a <FONT STYLE="white-space:nowrap">wholly-owned</FONT> subsidiary) only that portion which is equal to the proportion of that
company&#146;s paid up equity share capital which is beneficially owned, directly or indirectly, by a group company shall be taken into account); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.4.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>&#147;group&#148;</B> means the Company and its subsidiary undertakings from time to time;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.4.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>&#147;group company&#148;</B> means any company in the group; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.4.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>&#147;latest balance sheet&#148;</B> means the consolidated balance sheet dealing with the state of affairs
of the Company and its subsidiary undertakings comprised in the latest group accounts prepared and approved by the board and on which the auditors have made their report pursuant to the Companies Acts. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">When the aggregate amount of borrowings required to be taken into account for the purposes of this article 84
on any particular day is being ascertained: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any of such monies denominated or repayable in a currency other than sterling shall be converted for the
purpose of calculating the sterling equivalent either: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.5.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at the rate of exchange used for the conversion of that currency in the latest balance sheet;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.5.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if no rate was so used, at the middle market rate prevailing in London at the close of business on the date of
that balance sheet; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">84.5.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where the repayment of such monies is expressly covered by a forward purchase contract, currency option, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">back-to-back</FONT></FONT> loan, swap or other arrangement taken out or entered into to reduce the risk associated with fluctuations in exchange rates, at the rate of exchange specified in
that document, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">but, if the amount in sterling resulting from conversion at that rate would be greater than that
resulting from conversion at the middle market rate prevailing in London at the close of business on the working day immediately preceding the day on which the calculation falls to be made, the latter rate shall apply instead; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">84.5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if, under the terms of any borrowing, the amount of money that would be required to discharge its principal
amount in full if it fell to be repaid (at the option of the borrower or by reason of default) on such date is less than the amount that would otherwise be taken into account in respect of that borrowing for the purpose of this article 84, the
amount of the borrowing to be taken into account shall be the lesser amount. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELEGATION OF DIRECTORS&#146; POWERS
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>85.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Powers of executive directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may from time to time delegate or entrust to and confer upon any director holding executive office (including a managing director)
such of its powers, authorities and discretions (with power to <FONT STYLE="white-space:nowrap">sub-delegate)</FONT> for such time, on such terms and subject to such conditions as it thinks fit. It may confer such powers either collaterally with, or
to the exclusion of and in substitution for, all or any of the powers of the board in that respect, and may from time to time revoke, withdraw, alter or vary all or any of such powers. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>86.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Delegation to committees </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">86.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may delegate any of its powers, authorities and discretions (with power to <FONT
STYLE="white-space:nowrap">sub-delegate)</FONT> (including powers or discretions relating to the remuneration of or benefits given to the directors) for such time, on such terms and subject to such conditions as it thinks fit to any committee
consisting of one or more directors and (if thought fit) one or more other persons (provided that a majority of the members of a committee shall be directors or alternate directors and no resolution of a committee shall be effective unless a
majority of those present when it was passed are directors or alternate directors). The board may confer such powers either collaterally with, or to the exclusion of and in substitution for, all or any of the powers of the board in that respect, and
may from time to time revoke, withdraw, alter or vary all or any of such powers, and discharge any such committee in whole or in part. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">86.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All committees shall, in the exercise of the powers delegated to them and in the transaction of business,
conform to any mode of proceedings and regulations which may be prescribed by the board. Subject to that, the proceedings of any committee shall be governed by such of these articles as regulate the proceedings of the board, so far as they are
capable of applying. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">86.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">References in these articles to committees include <FONT STYLE="white-space:nowrap">sub-committees</FONT>
permitted under these articles. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>87.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Local and divisional management </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">87.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may establish any local or divisional boards or agencies for managing any of the affairs of the
Company in any locality in relation to any business, either in the United Kingdom or elsewhere; and it may appoint any person to be a member of such local or divisional board, or a manager or agent, and may fix his remuneration.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">87.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may delegate to any local or divisional board, manager or agent so appointed any of its powers,
authorities and discretions (with power to <FONT STYLE="white-space:nowrap">sub-delegate)</FONT> and may authorise the members for the time being of any such local or divisional board, or any of them, to fill up any vacancies and to act even though
there are vacancies; and any such appointment or delegation may be made for such time, on such terms and subject to such conditions as the board thinks fit. The board may confer such powers either collaterally with, or to the exclusion of and in
substitution for, all or any of the powers of the board in that respect, and may from time to time revoke, withdraw, alter or vary all or any of such powers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">87.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to any terms and conditions expressly prescribed by the board, the proceedings of any local or
divisional board or agency with two or more members shall be governed by such of these articles as regulate the proceedings of the board, so far as they are capable of applying. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>88.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power of attorney </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may, by power of attorney or otherwise, appoint any person or persons to be the agent of the Company and may delegate to any such
person or persons any of its powers, authorities and discretions (with power to <FONT STYLE="white-space:nowrap">sub-delegate),</FONT> in each case for such purposes and for such time, on such terms (including, but not limited to, remuneration and
the protection and convenience of persons dealing with the agent) and subject to such conditions as it thinks fit. The board may confer such powers either collaterally with, or to the exclusion of and in substitution for, all or any of the powers of
the board in that respect, and may from time to time revoke, withdraw, alter or vary all or any of such powers. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>89.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Associate directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may appoint any person (not being a director) to any office or employment having a designation or title including the word
&#147;director&#148;, or attach to any existing office or employment with the Company such designation or title, and may terminate any such appointment or the use of such designation or title. The inclusion of the word &#147;director&#148; in the
designation or title of any such office or employment shall not imply that such person is, or is deemed to be, or is empowered in any respect to act as, a director of the Company for any of the purposes of the Companies Acts or these articles. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPOINTMENT AND RETIREMENT OF DIRECTORS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>90.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power of the Company to appoint directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of the Companies Acts and of these articles, the Company may by ordinary resolution appoint any person who is willing
to act as a director, either to fill a vacancy or as an addition to the existing board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>91.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power of the board to appoint directors </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">91.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without prejudice to the power of the Company to appoint any person to be a director pursuant to these articles
but subject to the provisions of the Companies Acts and of these articles, the board may, at any time, appoint any person who is willing to act as a director, either to fill a vacancy or as an addition to the existing board, but so that the total
number of directors shall not exceed any maximum number fixed in accordance with these articles. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">91.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any director so appointed shall, subject to the provisions of these articles, hold office only until the
dissolution of the annual general meeting of the Company next following such appointment (unless he is <FONT STYLE="white-space:nowrap">re-elected</FONT> during such meeting), save that if he was appointed after notice of such annual general meeting
was given, he shall hold office until the dissolution of the next following annual general meeting (unless he is <FONT STYLE="white-space:nowrap">re-elected</FONT> during such meeting). </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>92.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Appointment of executive directors </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">92.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of the Companies Acts, the board may from time to time appoint one or more of its
body to hold any employment or executive office (including that of chief executive and managing director) for such period and on such terms as the board may determine; and (without prejudice to any claim for damages for breach of any contract of
service between the director and the Company and to any claim which may arise by operation of law) the board may revoke or terminate any such appointment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">92.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A chief executive, managing director or other executive director who ceases to hold the office of director from
any cause shall automatically cease to be a managing or executive director immediately. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>93.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Eligibility of new directors </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">93.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No person, other than a director retiring (by rotation or otherwise), shall be eligible for appointment or
reappointment as a director at any general meeting, unless: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">93.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he is recommended by the board; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">93.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not less than seven nor more than 42 days before the date appointed for the meeting, notice by a shareholder
(other than the person to be proposed) entitled to attend and vote at the meeting of the intention to propose that person for appointment or reappointment, stating the particulars which would, if he were so appointed or reappointed, be required to
be included in the Company&#146;s register of directors, together with notice given by that person of his willingness to be appointed or reappointed, is given to the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">93.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A director shall not be required to hold any shares. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>94.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Voting on resolution for appointment </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A resolution for the appointment of two or more persons as directors by a single resolution shall be void unless an ordinary resolution that it
shall be so proposed has first been agreed to by the meeting without any vote being given against it. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>95.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Retirement by rotation </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">95.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At each annual general meeting of the Company, <FONT STYLE="white-space:nowrap">one-third</FONT> of the
directors who are subject to retirement by rotation or, if their number is not three or a multiple of three, the number nearest to but not exceeding <FONT STYLE="white-space:nowrap">one-third</FONT> shall retire from office but so that, if there are
fewer than three directors who are subject to retirement by rotation, one shall retire from office. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">95.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In addition to the directors required to retire by rotation under article 95.1 (as determined in accordance
with article 96), there shall also be required to retire by rotation any director who at an annual general meeting of the Company shall have been a director at each of the preceding two annual general meetings of the Company, provided that:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">95.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he was not appointed or reappointed at either such annual general meeting; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">95.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he has not otherwise ceased to be a director (whether by resignation, retirement, removal or otherwise) and
been reappointed by general meeting of the Company at or since either such annual general meeting. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>96.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Directors subject to retirement </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">96.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of the Companies Acts and of these articles, the directors subject to retire by
rotation at each annual general meeting shall: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">96.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">exclude any director appointed by the board pursuant to article 91.1 after the dissolution of the preceding
annual general meeting; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">96.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">include, so far as necessary to obtain the number required, first, any director who wishes to retire and not
offer himself for <FONT STYLE="white-space:nowrap">re-election,</FONT> and secondly, those directors who have been longest in office since their last appointment or reappointment. As between two or more directors who have been in office an equal
length of time, the director to retire shall, in default of agreement between them, be determined by lot. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">96.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The directors to retire on each occasion (both as to number and identity) shall be determined by the
composition of the board at the start of business on the date of the notice convening the annual general meeting, even though the number or identity of the directors after that time but before the close of the meeting may change.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>97.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Position of retiring director </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A director who retires at an annual general meeting may, if willing to act, be reappointed. If he is not reappointed or is not deemed to have
been reappointed, he shall retain office until the meeting appoints someone in his place or, if it does not do so, until the end of the meeting. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>98.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Deemed reappointment </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">At any general meeting at which a director retires by rotation, the Company may fill the vacancy. If it does not do so, the retiring director
shall, if willing, be deemed to have been reappointed, unless it is expressly resolved not to fill the vacancy or a resolution for the reappointment of the director is put to the vote of the meeting and lost. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REMOVAL AND DISQUALIFICATION OF DIRECTORS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>99.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Removal by ordinary resolution </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In addition to any power of removal conferred by the Companies Acts and without prejudice to any claim for damages which he may have for breach
of any contract of service between him and the Company and to any claim which may arise by operation of law, the Company may by ordinary resolution remove any director before the expiration of his period of office; and, subject to the provisions of
the Companies Acts and of these articles, the Company may by ordinary resolution appoint another person who is willing to act to be a director in his place. Any person so appointed shall be treated, for the purposes of determining the time at which
he or any other director is to retire, as if he had become a director on the day on which the person in whose place he is appointed was last appointed or reappointed a director. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>100.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Vacation of office by director </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without prejudice to the provisions for retirement by rotation contained in these articles, the office of a
director shall be vacated if: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he resigns by notice sent to or received at the office or at an address specified by the Company for the
purposes of communication by electronic means or tendered at a board meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he ceases to be a director by virtue of any provision of the Companies Acts, is removed from office pursuant to
these articles or becomes prohibited by law from being a director; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he becomes bankrupt or he makes any arrangement or composition with his creditors generally;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a registered medical practitioner who is treating him gives a written opinion to the Company stating that he
has become physically or mentally incapable of acting as a director and may remain so for more than three months and the board resolves that his office be vacated; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.1.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">both he and his alternate director (if any) appointed pursuant to the provisions of these articles have been
absent, without the permission of the board, from board meetings for six consecutive months, and the board resolves that his office be vacated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.1.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">his contract for his services as a director expires or is terminated for any reason and is neither renewed nor
a new contract granted within 14 days; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.1.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(without prejudice to any claim for damages which he may have for breach of any contract of service between him
and the Company and to any claim which may arise by operation of law) he is removed from office by a notice addressed to him at his last known address and signed by all his <FONT STYLE="white-space:nowrap">co-directors.</FONT> An alternate director
appointed by the director to whom such notice is being given and acting in his capacity as such shall not be required to sign such notice; and a director and any alternate director appointed by him and acting in his capacity as such shall constitute
a single director for this purpose, so that the signature of either of them on such notice shall be sufficient. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the office of a director is vacated for any reason, he shall cease to be a member of any committee.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">100.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A resolution of the board declaring a director to have vacated office under the terms of this article 100 shall
be conclusive as to the fact and grounds of vacation stated in the resolution. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REMUNERATION OF <FONT STYLE="white-space:nowrap">NON-EXECUTIVE</FONT> DIRECTORS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>101.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ordinary remuneration </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">101.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise determined by the Company by ordinary resolution, a director (other than an alternate
director) who does not hold executive office shall be paid for his services as a director fees at such rate (not exceeding &pound;125,000 per annum) as the board may decide. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">101.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The maximum aggregate level of fees stipulated by or in accordance with article 101.1 shall be increased on
each anniversary of the date of the adoption of these articles (or, if appropriate, the date upon which the maximum was last fixed by ordinary resolution in accordance with article 101.1) by the same percentage increase as the percentage increase in
the General Index of Retail Prices for all items (or such other comparable index as may be substituted for it from time to time before such anniversary) in the 12 months immediately preceding such date. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">101.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any fee payable pursuant to this article 101 shall be deemed to accrue from day to day and shall be distinct
from any salary, remuneration or other amounts payable to a director pursuant to other provisions of these articles. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>102.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Additional remuneration </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Any director who does not hold executive office and who serves on any committee or who devotes special attention to the business of the
Company, or who otherwise performs any services on behalf of the Company or its business which, in the opinion of the board, are outside the scope of the ordinary duties of a director, may (without prejudice to the provisions of article&nbsp;101) be
paid such reasonable additional remuneration for such services, whether by way of additional fees, salary, percentage of profits or otherwise, as the board may from time to time determine. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REMUNERATION OF EXECUTIVE DIRECTORS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>103.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Remuneration of executive directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The salary or remuneration of any director appointed to hold any employment or executive office in accordance with the provisions of these
articles shall be such as the board may from time to time determine, and may be either a fixed sum of money, or may altogether or in part be governed by business done or profits made or otherwise determined by the board. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS&#146; EXPENSES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>104.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Directors&#146; expenses </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Each director shall be entitled to be repaid all reasonable travelling, hotel and other expenses properly incurred by him in the performance of
his duties as director, including any expenses incurred in attending meetings of the board or of any committees or general meetings or separate meetings of the holders of any class of shares or debentures of the Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS&#146; INTERESTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>105.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Directors&#146; permitted interests and voting </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to compliance with article 107, a director, despite his office: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">may enter into or otherwise be interested in any transaction or arrangement with the Company or in which the
Company is otherwise (directly or indirectly) interested; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(except that of auditor or auditor of a subsidiary of the Company) may hold any other office or place of profit
under the Company in conjunction with the office of director and may act by himself or through his firm in a professional capacity to the Company and he or his firm shall be entitled to remuneration for professional services as if he were not a
director; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">may be a director or other officer of, or employed by, or a party to any transaction or arrangement with, or
otherwise interested in, any company promoted by the Company or in which the Company is otherwise (directly or indirectly) interested or as regards which the Company has any powers of appointment; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shall not be liable to account to the Company for any profit, remuneration or other benefit realised by any
such office, employment, transaction or arrangement and no such transaction or arrangement shall be avoided on the grounds of any such interest or benefit. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Save as provided in this article 105, a director shall not vote on, or be counted in the quorum in relation to,
any resolution of the directors concerning any contract, transaction or arrangement or any other proposal in which he (or any person connected with him as detailed in article 105.8) is interested. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of the Companies Acts, a director shall (in the absence of some other interest than
is set out below) be entitled to vote, and be counted in the quorum, in respect of any resolution concerning any contract, transaction or arrangement or any other proposal: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in which he has an interest of which he is not aware; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in which he has an interest which cannot reasonably be regarded as likely to give rise to a conflict of
interest; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in which he has an interest only by virtue of interests in shares, debentures or other securities of the
Company, or by reason of any other interest in or through the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">which involves the giving of any guarantee, security or indemnity in respect of: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">105.3.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">money lent or obligations incurred by him or by any other person at the request of or for the benefit of the
Company or any of its subsidiary undertakings; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">105.3.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a debt or obligation of the Company or any of its subsidiary undertakings for which he himself has assumed
responsibility in whole or in part, either alone or jointly with others, under a guarantee or indemnity or by the giving of security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.3.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">concerning an offer of shares or debentures or other securities of or by the Company or any of its subsidiary
undertakings in which offer he is or may be entitled to participate as a holder of securities; or in the underwriting or <FONT STYLE="white-space:nowrap">sub-underwriting</FONT> of which the director is to participate; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.3.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">concerning any other body corporate in which he (and any person connected with him) has a direct or indirect
interest of any kind (including an interest by holding any position, or by holding an interest in shares, in that body corporate), provided that he (and any person connected with him) does not hold an interest in shares (within the meaning set out
in sections 820 to 825 of the Act) representing one per cent or more of either any class of equity share capital, or the voting rights, in such body corporate (excluding any shares of that class, or any voting rights attached to shares, which are
held as treasury shares); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.3.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">relating to an arrangement for the benefit of the employees or former employees of the Company or any of its
subsidiary undertakings which does not award him any privilege or benefit not generally awarded to the employees or former employees to whom such arrangement relates; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.3.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">concerning: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">105.3.8.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">insurance which the Company proposes to maintain or purchase for the benefit of directors or for the benefit of
persons including directors; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">105.3.8.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">indemnities in favour of directors; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">105.3.8.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the funding of expenditure by one or more directors on defending proceedings against such director or them or
doing anything to enable such director or directors to avoid incurring such expenditure. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where proposals are under consideration concerning the appointment (including fixing or varying the terms of
appointment or its termination) of two or more directors to offices or places of profit with the Company or any company in which the Company is interested, such proposals may be divided and a separate resolution considered in relation to each
director. In such case, each of the directors concerned (if not otherwise debarred from voting under this article 105) shall be entitled to vote (and be counted in the quorum) in respect of each resolution, except that concerning his own
appointment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If any question arises at any meeting as to whether any interest of a director prevents him from voting or
being counted in a quorum, and such question is not resolved by his voluntarily agreeing to abstain from voting or being counted in the quorum, such question shall be referred to the chairman of the meeting. The chairman of the meeting&#146;s ruling
in relation to the director concerned (other than himself) shall be final and conclusive (except where it subsequently becomes apparent that the nature or extent of the interests of the director concerned have not been fairly disclosed).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If any question arises at any meeting as to whether any interest of the chairman of the meeting prevents him
from voting or being counted in a quorum, and such question is not resolved by his voluntarily agreeing to abstain from voting or being counted in the quorum, such question shall be decided by resolution of the directors or committee members present
at the meeting (excluding the chairman). The majority vote of the directors or committee members shall be final and conclusive (except where it subsequently becomes apparent that the nature or extent of the interests of the chairman of the meeting
have not been fairly disclosed). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of the Companies Acts, the Company may by ordinary resolution suspend or relax the
provisions of this article 105, either generally or in respect of any particular matter, or ratify any transaction not duly authorised by reason of a contravention of this article 105. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purposes of this article 105: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.8.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">sections 252 to 255 of the Act shall be applied to determine whether a person is connected with a director;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.8.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an interest of a person who is connected with a director shall be treated as an interest of the director;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.8.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in relation to an alternate, an interest of his appointor shall be treated as an interest of the alternate, in
addition to any interest which the alternate otherwise has; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">105.8.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">without prejudice to article 105.8.3, the provisions of this article 105 shall apply to an alternate director
as if he were a director otherwise appointed. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>106.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Authorisation of directors&#146; conflicts of interest </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purposes of this article 106 and article 107: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;Relevant Situation&#148;</B> means a situation or matter in which a director has a direct or indirect interest that conflicts, or
possibly may conflict, with the interests of the Company (including, without limitation, in relation to the exploitation of any property, information or opportunity, whether or not the Company could take advantage of it) but excludes (i)&nbsp;any
situation or matter which cannot reasonably be regarded as likely to give rise to a conflict of interest and (ii)&nbsp;any conflict of interest arising in relation to a transaction or arrangement with the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;Interested Director&#148;</B> means, in relation to any Relevant Situation, any director interested in that Relevant Situation; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">any reference to a conflict of interest includes a conflict of interest and duty and a conflict of duties. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The directors shall have the power to authorise any Relevant Situation on such terms as they determine. Such
authorisation shall be effective only if: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any requirement as to the quorum at the meeting of the directors at which the Relevant Situation is considered
is met without counting the Interested Director(s); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any resolution authorising the Relevant Situation was agreed to without the Interested Director(s) voting or
would have been agreed to if the votes of the Interested Director(s) had not been counted. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any terms determined by the directors under article 106.2 may be imposed at the time of authorisation or may be
imposed or varied subsequently and may include (without limitation): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">whether the Interested Director(s) may vote (or be counted in the quorum at a meeting) in relation to any
resolution relating to the Relevant Situation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the exclusion of the Interested Director(s) from all information and discussion by the Company of the Relevant
Situation; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(without prejudice to the general obligations of confidentiality) the application to the Interested Director(s)
of a strict duty of confidentiality to the Company for any confidential information of the Company in relation to the Relevant Situation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Interested Director must act in accordance with any terms determined by the directors under article 106.2.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except as specified in article 106.2, any proposal made to the directors and any authorisation by the directors
in relation to a Relevant Situation shall be dealt with in the same way as any other matter may be proposed to and resolved upon by the directors in accordance with the provisions of these articles. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any authorisation of a Relevant Situation given by the directors under article 106.2 may provide that, where
the Interested Director obtains (other than through his position as a director) information that is confidential to a third party, he will not be obliged to disclose it to the Company or to use it in relation to the Company&#146;s affairs in
circumstances where to do so would amount to a breach of that confidence. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">106.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A director shall not, by reason of his holding office as a director (or of the fiduciary relationship
established by holding that office), be liable to account to the Company for any remuneration, profit or other benefit resulting from any Relevant Situation authorised under article 106.2 and no contract shall be liable to be avoided on the grounds
of any director having any type of interest authorised under article 106.2, nor shall the receipt of any such remuneration, profit or other benefit constitute a breach of his duty under section 176 of the Act. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>107.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Provisions applicable to declarations of interest </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Interested Director shall declare the nature and extent of his interest in a Relevant Situation to the other
directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A director who is in any way (directly or indirectly) interested in any proposed transaction or arrangement
with the Company shall declare the nature and extent of his interest to the other directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A director who is in any way (directly or indirectly) interested in a transaction or arrangement that has been
entered into by the Company shall declare the nature and extent of his interest to the other directors unless the interest has been declared under article 107.2. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The declaration of interest must (in the case of article 107.3) and may, but need not (in the case of article
107.1 or 107.2) be made: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at a meeting of the directors; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by notice to the directors in accordance with section 184 or section 185 of the Act. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a declaration of interest proves to be, or becomes, inaccurate or incomplete, a further declaration must be
made. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any declaration of interest required by article 107.1 must be made as soon as is reasonably practicable.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any declaration of interest required by article 107.2 must be made before the Company enters into the
transaction or arrangement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any declaration of interest required by article 107.3 must be made as soon as is reasonably practicable.
Failure to comply with this requirement does not affect the underlying duty to make the declaration. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A declaration in relation to an interest of which the director is not aware is not required. For this purpose,
a director is treated as being aware of matters of which he ought reasonably to be aware. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.10</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A director need not declare an interest: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.10.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if it cannot reasonably be regarded as likely to give rise to a conflict of interest; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.10.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if, or to the extent that, the other directors are already aware of it (and for this purpose the other
directors are treated as aware of anything of which they ought reasonably to be aware); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">107.10.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if, or to the extent that, it concerns terms of his service contract that have been or are to be considered by
a meeting of the directors or by a committee of the directors appointed for the purpose under the articles. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS&#146; GRATUITIES AND BENEFITS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>108.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Directors&#146; gratuities and benefits </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">108.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may exercise all the powers of the Company to provide: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">108.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pensions or other retirement or superannuation benefits; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">108.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">death or disability benefits; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">108.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">other allowances or gratuities, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">by insurance or otherwise, for any person who is, or has at any time been, a director of or employed by or in the service of the Company or any
company which is a subsidiary company of the Company, or is allied to or associated with the Company or any such subsidiary, or any predecessor in business of the Company or any such subsidiary. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">108.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may also exercise the powers of the Company to extend these arrangements to any family member of such
person (including a spouse, civil partner, former spouse or former civil partner) or any person who is, or was, dependent on him. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">108.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For such purpose, the board may establish, maintain, subscribe and contribute to any scheme, trust or fund and
pay premiums. The board may procure any of these matters to be done by the Company, either alone or in conjunction with any other person. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">108.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any director or former director shall be entitled to receive and retain for his own benefit any pension or
other benefit provided under this article 108 and shall not be obliged to account for it to the Company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROCEEDINGS OF THE BOARD AND COMMITTEES </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>109.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Board meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of these articles, the board may meet for the despatch of business, adjourn and otherwise regulate its proceedings as
it thinks fit. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>110.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice of board meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Any director may, and the secretary at the request of a director shall, summon a board meeting at any time by notice (which need not be in
writing) served on the members of the board in accordance with the provisions of article&nbsp;148. A director may waive his entitlement to notice of any meeting, either prospectively or retrospectively and any retrospective waiver shall not affect
the validity of the meeting or of any business conducted at the meeting. A director will be treated as having waived his entitlement to notice unless he has supplied the Company with the information necessary to ensure that he receives notice of a
meeting before it takes place. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>111.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Quorum </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The quorum necessary for the transaction of business may be determined by the board and, until otherwise determined, shall be two directors. A
duly convened meeting of the board at which a quorum is present shall be competent to exercise all or any of the authorities, powers and discretions for the time being vested in or exercisable by the board. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>112.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Chairman of the board </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may appoint one of its body as chairman to preside at every board meeting at which he is present and one or more deputy chairmen, and
determine the period for which he is or they are to hold office (and may at any time remove him or them from office). If no such chairman of the board or deputy chairman is elected, or if at any meeting neither the chairman of the board nor a deputy
chairman is present within 15&nbsp;minutes of the time appointed for commencement of the meeting, the directors and (in the absence of their appointors) alternate directors present shall choose one of their number to be chairman of such meeting. In
the event of two or more deputy chairmen being present, the senior of them shall act as chairman of the meeting, seniority being determined by length of office since their last appointment or reappointment. As between two or more who have held
office an equal length of time, the deputy chairman to act as chairman of the meeting shall be decided by those directors and (in the absence of their appointors) alternate directors present. Any chairman of the board or deputy chairman may also
hold executive office in the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>113.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Voting </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Questions arising at any meeting shall be determined by a majority of votes. In the case of an equality of votes, the chairman of the meeting
shall have a second or casting vote. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>114.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Participation by telephone </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Provided that all persons participating in the meeting are able to hear and speak to each other throughout such meeting, any director,
directors or alternate may validly participate in a meeting of the board or a committee through the medium of one or more conference telephones or similar form of communications equipment. A person so participating shall be deemed to be present in
person at the meeting and shall accordingly be counted in a quorum and be entitled to vote. Subject to the provisions of the Companies Acts, all business </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
transacted in such manner by the board or a committee shall, for the purposes of these articles, be deemed to be validly and effectively transacted at a meeting of the board or a committee, even
though fewer than two directors are physically present at the same place. Such a meeting shall be deemed to take place where the largest group of those participating is assembled or, if there is no such group, where the chairman of the meeting then
is. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>115.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Resolution in writing </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A resolution in writing signed by all the directors who are at the relevant time entitled to receive notice of a board meeting and who would be
entitled to vote (and whose vote would have been counted) on the resolution at a board meeting (if that number is sufficient to constitute a quorum), or by all members of a committee, shall be as valid and effective for all purposes as a resolution
duly passed at a meeting of the board (or committee, as the case may be). The resolution in writing may consist of several documents in the same form, each signed by one or more of the directors concerned or members of the relevant committee. Such a
resolution need not be signed by an alternate director if it is signed by his appointor, and a resolution signed by an alternate need not also be signed by his appointor. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>116.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Validity of proceedings of the board or committee </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">All acts done by a meeting of the board, or of a committee, or by any person acting as a director, alternate director or member of a committee
shall, even though it is afterwards discovered that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">116.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">there was some defect in the appointment of any person or persons acting as such; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">116.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">they or any of them were or was disqualified from holding office or not entitled to vote, or had in any way
vacated their or his office, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">be as valid as if every such person had been duly appointed, and was duly qualified, and
had continued to be a director, alternate or member of a committee and entitled to vote. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECRETARY </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>117.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Secretary </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">117.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of the Companies Acts, the board shall appoint a secretary or joint secretaries and
shall have power to appoint one or more persons to be an assistant or deputy secretary at such remuneration and on such terms and conditions as it thinks fit. Without prejudice to any claim for damages which he may have for breach of any contract of
service between him and the Company and to any claim which may arise by operation of law, the board may from time to time remove any person so appointed from office and appoint another or others in his place. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">117.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any provision of the Companies Acts or of these articles requiring or authorising a thing to be done by or to a
director and the secretary shall not be satisfied by its being done by or to the same person acting both as director and as, or in the place of, the secretary. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">117.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Anything required or authorised to be done by or to the secretary may, if the office is vacant or there is for
any other reason no secretary capable of acting, be done by or to any assistant or deputy secretary or, if there be no assistant or deputy secretary capable of acting, by or to any officer of the Company authorised generally or specially in that
behalf by the board. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">117.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Persons dealing with the Company shall be entitled to assume that each joint secretary is entitled by himself
to do anything required or authorised to be done by the secretary. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUTHENTICATION OF DOCUMENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>118.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Authentication of documents </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">118.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any director or the secretary or any person appointed by the board for the purpose shall have power to
authenticate: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">118.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any documents affecting the constitution of the Company (including its articles of association);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">118.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any resolutions passed by the Company or the board or a committee; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">118.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any books, records, documents and accounts relating to the business of the Company, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and to certify copies of them or extracts from them as true copies or extracts, and any such authentication or certification shall be
conclusive and binding on all concerned. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">118.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If any books, records, documents and accounts are not kept at the office, the person who holds them shall be
deemed to be the person so appointed by the board for the purposes of article 118.1. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">118.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any books, records, documents and accounts which are held by the Company in electronic form may be
authenticated under this article 118 as if they were books, records, documents or accounts held in hard copy form. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MINUTES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>119.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Minutes </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">119.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board shall cause minutes to be made, in books kept for the purpose, of: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">119.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all appointments of officers made by the board; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">119.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all appointments of committees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">119.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the names of directors present at every meeting of the board, committees, the Company or the holders of any
class of shares or debentures of the Company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">119.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all orders, resolutions and proceedings of such meetings. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">119.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any such minutes, if purporting to be signed by the chairman of the meeting at which the proceedings were held,
or by the chairman of the next succeeding meeting, or the secretary, shall be sufficient evidence of the matters stated in such minutes. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SEALS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>120.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Safe custody </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board shall provide for the safe custody of every seal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>121.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Application of seals </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">121.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A seal shall only be used pursuant to the authority of a resolution of the board or of a committee.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">121.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may determine who shall sign any document to which a seal is affixed or which is intended to take
effect as if executed under seal (or, in the case of share certificates, on which the seal is printed), either generally or in relation to a particular document or type of document. The board may also determine, either generally or in any particular
case, that such signature may be dispensed with. Unless otherwise determined by the board: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">121.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">share certificates and, subject to the provisions of any document constituting the same, certificates issued in
respect of any debentures or other securities of the Company need not be signed; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">121.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">every other document to which a seal is affixed shall be signed by one director in the presence of a witness,
by one director and the secretary or by two directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">121.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nothing in these articles shall require the Company to issue under the seal any certificate or other document
which is not by law required to be so issued. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>122.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Securities seal </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Any seal which is to be used as a securities seal shall be used only for sealing securities issued by the Company, and documents creating or
evidencing securities so issued. Any such securities or documents sealed with the securities seal shall not be required to be signed. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CHEQUES, BILLS AND NOTES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>123.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Cheques, bills and notes </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The directors may draw, make, accept or endorse, or authorise any other person or persons to draw, make, accept or endorse, any cheques, bills
of exchange, promissory notes or other negotiable instruments, provided that every cheque, bill of exchange, promissory note or other negotiable instrument drawn, made, accepted or endorsed shall be signed by such persons or person as the directors
may appoint for the purpose. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIVIDENDS AND OTHER PAYMENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>124.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Declaration of dividends </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of the Companies Acts and of these articles, the Company may by ordinary resolution declare a dividend to be paid to
the shareholders according to their respective rights and interests in the profits of the Company, but no dividend shall exceed the amount recommended by the board. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>125.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Interim dividends </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">125.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of the Companies Acts, the board may, if it considers that the profits of the Company
available for distribution justify such payments: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">125.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">declare and pay interim dividends on shares of any class of such amounts and on such dates and for such periods
as it determines; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">125.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">declare and pay the fixed dividend on any class of shares carrying a fixed dividend on the dates prescribed for
the payment of such dividends. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">125.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If there is more than one class of shares, the board may pay interim dividends on shares which rank after
shares conferring preferred rights with regard to dividend as well as on shares with preferred rights, unless at the time of payment any preferential dividend is in arrears. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">125.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Provided that the board acts in good faith, it shall not incur any liability to the holders of shares
conferring preferred rights for any loss they may suffer by the lawful payment of any interim dividend on any shares ranking after those with preferred rights. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>126.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Entitlement to dividends </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">126.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The provisions of this article 126 shall apply unless these articles, the rights attached to any shares or the
terms of any shares provide otherwise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">126.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All dividends shall be declared and paid in proportions based on the amounts paid up on the nominal value of
the shares during any portion or portions of the period in respect of which the dividend is paid. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">126.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No amount paid up on a share in advance of a call shall be treated for the purpose of this article 126 as paid
up on the share. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">126.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the terms on which any share is allotted provide that such share shall be entitled to a dividend as if the
nominal value of it were fully paid or partly paid from a particular date (in the past or the future), then such share shall be entitled to a dividend on that basis. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>127.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Method of payment </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may pay any dividend, interest or other sum payable in respect of a share: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in cash or by cheque, warrant or money order; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by any bank or other funds transfer system; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in respect of shares in uncertificated form, where the Company is authorised to do so by or on behalf of the
holder or joint holders, by means of a relevant system (subject always to the facilities and requirements of that relevant system). Without prejudice to the generality of the preceding wording, such payment may include the sending by the Company or
by any person on its behalf of an instruction to the Operator of the relevant system to credit the cash memorandum account of the holder or joint holders or, if permitted by the Company, of such person as the holder or joint holders may direct in
writing; and/or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by such other means and to or through such person as the holder or joint holders may direct in writing.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every such cheque, warrant or money order may be sent: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by post to the registered address of the person entitled to it; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of joint holders (or of two or more persons being jointly entitled to a share as a result of the
death or bankruptcy of the holder or otherwise by operation of law), to the registered address of that person whose name stands first in the register (or, in the case of persons so entitled, if their names are not noted in the register, to such of
those persons whose surname is first alphabetically); or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to such person and address as the person or persons entitled may direct in writing. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Every cheque, warrant or money order is sent at the risk of the person entitled to the money represented by it. Without prejudice to the
generality of the preceding wording, if any such cheque, warrant or money order has or is alleged to have been lost, stolen or destroyed, the board may, if the person entitled to such cheque, warrant or money order requests it, issue a replacement
cheque, warrant or money order (subject to compliance with such conditions as to evidence and indemnity and the payment of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses of the Company in
connection with the request as the board thinks fit). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall have no responsibility for any sum lost or delayed in the course of transfer by or through
any bank or other funds transfer system (including the relevant system concerned) or when it has acted on any directions given in writing by the person or persons entitled to it. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The payment of the cheque, warrant or money order or the collection of funds from or transfer of funds by a
bank or other funds transfer system in accordance with article 127.1 or, in respect of shares in uncertificated form, the making of payment in accordance with the facilities and requirements of the relevant system concerned shall be a good discharge
to the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">127.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any joint holder or other person jointly entitled to any share may give an effective receipt for all dividends
and other monies paid in respect of such share. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>128.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Currency of payment </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">128.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise provided by these articles or the rights attached to any shares, a dividend or any other
monies payable in respect of a share may be declared or paid in whatever currency the board may decide. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">128.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may decide that a particular approved depositary should receive dividends in a currency other than
the currency in which it is declared and may make arrangements accordingly. In particular, where an approved depositary has elected or agreed to receive dividends in another currency, the board may in its discretion make arrangements with such
approved depositary for payment of dividends to be made to it for value on the date on which the relevant dividend is paid, or such later date as the board may determine. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">128.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that a dividend is to be paid in a currency other than the currency in which it was declared, the
rate of exchange to be used for conversion of the dividend shall be such market rate selected by the board as it shall consider appropriate as at the close of business on the last working day before: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">128.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a dividend declared by ordinary resolution in accordance with the provisions of article 124, the
date when the board announces their intention to recommend the particular dividend; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">128.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other case, the date when the board declares the particular dividend. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">128.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The decision of the board regarding the rate of exchange shall be final and conclusive. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>129.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Dividends not to bear interest </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">No dividend or other monies payable by the Company on or in respect of any share shall carry a right to receive interest from the Company,
unless otherwise provided by the rights attached to the shares. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>130.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Calls or debts may be deducted from dividends </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may deduct from any dividend or other monies payable to any person on or in respect of a share all such sums as may be due from him
to the Company on account of calls or otherwise in relation to shares. Monies deducted in this way may be used to pay such amounts owed to the Company in relation to such shares. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>131.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Unclaimed dividends etc </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">All unclaimed dividends, interest or other sums payable may be invested or otherwise made use of by the board for the benefit of the Company
until claimed. All dividends unclaimed for a period of 12&nbsp;years after having been declared or becoming due for payment shall be forfeited and cease to remain owing by the Company. The payment of any unclaimed dividend, interest or other sum
payable by the Company on or in respect of any share into a separate account shall not constitute the Company a trustee, and the Company shall not be liable to pay interest, in respect of it. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>132.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Uncashed dividends </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">132.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">on two consecutive occasions: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">132.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">cheques, warrants or money orders for dividends or other monies payable in respect of a share sent by the
Company to the person entitled to it are returned to the Company or left uncashed during the period for which they are valid; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">132.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any transfer by a bank or other funds transfer system has not been satisfied; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">132.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">following one such occasion, reasonable enquiries have failed to establish any new postal address of the
holder, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">the Company shall not be obliged to send or transfer any dividends or other monies payable in respect of that
share due to that person until he notifies the Company of an address to be used for the purpose. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>133.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Payment of dividends in kind </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">133.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without prejudice to any other provision of these articles, the board may, with the authority of an ordinary
resolution of the Company, direct that payment of all or part of any dividend declared may be satisfied by the distribution of specific assets (and, in particular, of paid up shares or debentures of any other company). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">133.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may settle any difficulty which arises in relation to the distribution, as it thinks fit; and, in
particular, may: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">133.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ignore fractions, or issue certificates for fractions, or authorise any person to sell and transfer fractions;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">133.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">fix the value for the distribution of such specific assets or any part of them; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">133.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine that cash payments may be made to any shareholders on the basis of the value so fixed in order to
secure equality of distribution; and/or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">133.2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">vest any such assets in trustees on trust for the persons entitled to the dividend. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCRIP DIVIDENDS AND DIVIDEND REINVESTMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>134.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Payment of scrip dividends </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without prejudice to any other provision of these articles, the board may, with the prior authority of an
ordinary resolution of the Company, offer holders of ordinary shares the right to elect to receive new ordinary shares, credited as fully paid, instead of cash in respect of all or part of any dividend or dividends specified by the ordinary
resolution. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may, in its absolute discretion, exclude or restrict the offer to elect to receive new shares where
it considers that this is necessary or desirable to comply with legal or practical problems under the laws of any territory, or the requirements of any recognised regulatory body or any stock exchange in any territory. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may offer holders the right to elect to receive new shares instead of cash for:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the next dividend; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all future dividends (if a scrip dividend alternative is made available) until such time as they notify the
Company that they no longer wish to receive new shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The following provisions shall apply where payment of a dividend is satisfied in accordance with article 134.1:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the ordinary resolution may specify a particular dividend or may relate to all or any dividends declared or
paid within a specified period; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a shareholder is entitled to such number of new shares whose total relevant value is as near as possible to the
cash amount (disregarding any associated tax credit) he would have received, but not in excess of it. For such purpose, the &#147;relevant value&#148; of an ordinary share shall be the average market value of such shares for the five dealing days
commencing, and including, the day when such shares are first quoted <FONT STYLE="white-space:nowrap">&#147;ex-dividend&#148;</FONT> or a later day chosen by the board. The &#147;average market value&#148; shall be calculated: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">134.4.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by reference to the middle market quotations for a fully paid ordinary share on the London Stock Exchange, as
published in the Daily Official List of the London Stock Exchange; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">134.4.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in such other manner as may be determined by or in accordance with the ordinary resolution.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.4.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the board may make such provisions as it considers necessary or expedient in relation to any offer to be made
pursuant to this article 134, including (but not limited to): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">134.4.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the giving of notice to shareholders of the right of election offered to them; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">134.4.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the provision of forms of election (whether in respect of a particular dividend or dividends generally);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">134.4.3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determining the procedure for making and revoking such elections; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">134.4.3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">specifying the place at which, and the latest time by which, forms of election and any other relevant documents
must be lodged in order to be effective; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">134.4.3.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">payment in cash to shareholders in respect of their fractional entitlements, provision for the accrual,
retention or accumulation of all or part of the benefit of fractional entitlements to or by the Company or to or by or on behalf of any shareholder or the application of any accrual, retention or accumulation to the allotment of fully paid shares to
any shareholder or any other provision for fractional entitlements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.4.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the relevant dividend (or that part of the dividend in respect of which a right of election has been offered)
shall not be declared or payable on shares in respect of which an election has been duly made (<B>&#147;elected shares&#148;</B>); instead, new shares shall be allotted to the holders of the elected shares on the basis of allotment calculated as
stated in article 134.4.2. For such purpose, the board may: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">134.4.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">resolve to capitalise a sum equal to the aggregate nominal amount of the new shares to be allotted on that
basis out of any profits of the Company (whether or not they are available for distribution) which are not required for paying any preferential dividend, or any sum standing to the credit of any other reserve of the Company (including any share
premium account, capital redemption reserve or other undistributable reserve); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">134.4.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">appropriate such sum in paying up in full the appropriate number of new shares for allotment and distribution
to the holders of the elected shares on such basis. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">A board resolution capitalising any part of any profits or reserve
in accordance with this article&nbsp;134.4.4 shall have the same effect as if such capitalisation had been authorised by ordinary resolution of the Company in accordance with these articles and, in relation to any such capitalisation, the board may
exercise all the powers conferred on it by these articles without the need for such ordinary resolution; and </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">134.4.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the new shares so allotted shall be allotted as at the record date for the dividend in respect of which the
right of election has been offered, and shall rank equally in all respects with each other and with the existing fully paid shares. Provided that they will not rank for any dividend or other distribution or other entitlement which has been declared,
made or paid by reference to such record date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>135.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Dividend reinvestment generally </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">135.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board may implement and maintain one or more share dividend or distribution reinvestment plans, including
or instead of offering scrip dividends in accordance with article 134. Any such plan may be suspended or terminated at any time by the board, in its absolute discretion. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">135.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The terms and conditions of any such plan shall be determined by the board in its absolute discretion, and it
may amend such terms and conditions as it thinks fit. In particular, the board may determine that any such plan shall only be available to certain shareholders, or to part of the dividends. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">135.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without prejudice to the provisions of article 135.2, the terms of any such plan may give shareholders the
right: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">135.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to elect to receive new fully paid shares instead of a cash amount; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">135.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to subscribe in cash for new shares, payable in full or by instalments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">135.3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to apply cash in paying up in full or by instalments any unpaid or partly paid shares held on the terms of the
plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">135.3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to apply cash in purchasing existing shares; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">135.3.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to accept any other option or participate in any other arrangements thought by the board to be appropriate.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">135.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To the extent that any provision of this article 135 relates to offers to elect to receive new shares instead
of a cash dividend, it shall be subject to the provisions of article 134 and of any ordinary resolution passed under article 134.1. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CAPITALISATION OF PROFITS AND RESERVES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>136.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Authority to capitalise and appropriation of capitalised sums </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the articles, the board may, if it is so authorised by an ordinary resolution of the Company:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">decide to capitalise any profits of the Company (whether or not they are available for distribution) which are
not required for paying a preferential dividend, or any sum standing to the credit of any other reserve of the Company (including any share premium account, capital redemption reserve or other undistributable reserve); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">appropriate any sum which it so decides to capitalise (a <B>&#147;capitalised sum&#148;</B>) to the persons who
would have been entitled to it if it were distributed by way of dividend (<B>&#147;persons entitled&#148;</B>) and in the same proportions as their entitlement to dividends (<B>&#147;relevant proportions&#148;</B>). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Capitalised sums must be applied on behalf of the persons entitled and in the relevant proportions.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any capitalised sum may be applied in paying up new shares of a nominal amount equal to the capitalised sum,
which are then allotted, credited as fully paid, to the persons entitled or as they may direct. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A capitalised sum which was appropriated from profits available for distribution may be applied:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in or towards paying up any amounts unpaid on existing shares held by the persons entitled (whether as to the
nominal value of the shares or any amount payable to the Company by way of premium); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in paying up new debentures or other securities of the Company of a nominal amount equal to the capitalised
sum, which are then allotted, credited as fully paid, to the persons entitled or as they may direct. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the articles, the board may: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">apply capitalised sums in accordance with articles 136.3 and 136.4 partly in one way and partly in another;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make such arrangements as it thinks fit where any difficulty arises with regard to any distribution of any
capitalised sum; and, in particular, in the case of shares, debentures or other securities becoming distributable under this article 136 in fractions, the board may decide that the benefit of fractional entitlements belongs to the Company, that
fractions are to be ignored, to make payments in cash in lieu of fractional entitlements, or otherwise deal with fractions as it thinks fit; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.5.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">authorise any person to enter into an agreement with the Company on behalf of all the persons entitled which is
binding on them in respect of the allotment of shares, debentures or other securities to them under this article 136; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.5.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">generally do all acts and things required to give effect to the ordinary resolution of the Company.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">136.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purposes of this article 136, unless the relevant ordinary resolution provides otherwise, if the
Company holds treasury shares of the relevant class at the record date for the capitalisation, it shall be treated as if it were entitled to receive the dividends in respect of those treasury shares which would have been payable if those treasury
shares had been held by a person other than the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECORD DATES </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>137.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Record dates </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">137.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Regardless of any other provision of these articles but without prejudice to the rights attached to any shares,
the Company or the board may fix any time on any date (the <B>&#147;record date&#148;</B>) as the time at which persons registered as the holders of shares, debentures or other securities of the Company shall be entitled to receive any dividend,
distribution, capitalisation, allotment or issue. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">137.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such record date may be on or at any time before the date on which such dividend, distribution, capitalisation,
allotment or issue is paid or made, and may be after any such dividend, distribution, capitalisation, allotment or issue is announced, declared or resolved. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACCOUNTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>138.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Inspection of accounts </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">138.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No shareholder (other than a shareholder who is a director or other officer) shall have any right to inspect
any accounting record or other document of the Company, unless: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">138.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he has such right pursuant to the Companies Acts or a proper court order; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">138.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he is authorised by the board; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">138.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he is authorised by an ordinary resolution of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>139.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Copy of accounts to be sent to shareholders </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to article 140, the Company shall send a copy of its annual accounts and reports for each financial year to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">139.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">every shareholder and every holder of debentures of the Company (whether or not such shareholder or holder is
entitled to receive notice of general meetings of the Company); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">139.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">every person who is entitled to receive notice of general meetings of the Company, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">in each case, as required by and in accordance with the Companies Acts. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>140.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Summary financial statements </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Where permitted by and in accordance with the Companies Acts, the Company may provide a summary financial statement instead of copies of the
annual accounts and reports required to be sent in accordance with article 139. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICES </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>141.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notices to be in writing </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Any notice to be given to or by any person pursuant to these articles shall be in writing, except that a notice convening a meeting of the
board or of a committee need not be in writing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>142.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Service of notices, documents or other information on shareholders </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any notice, document or other information may be served on or sent or supplied to any shareholder by the
Company: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">personally; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by sending it through the post in a prepaid envelope addressed to the shareholder at his registered address (or
at any other address in the United Kingdom notified for the purpose); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by delivering it by hand to or leaving it at that address in an envelope addressed to the shareholder;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by sending or supplying it by electronic means to an address notified by the shareholder to the Company for
that purpose; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.1.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by making it available on a website and notifying the shareholder of its availability in accordance with this
article 142; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.1.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by means of a relevant system; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.1.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by any other means authorised in writing by the relevant shareholder. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">However, article 142.1 shall not affect any provision of the Companies Acts requiring offers, notices or
documents to be served on or sent or supplied to a shareholder in a particular way. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to article 142.4, in the case of joint holders of a share, all notices, documents or other information
shall be served on or sent or supplied to the person named first in the register in respect of the joint holding. Notice so given shall be sufficient notice to all joint holders. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a shareholder (or, in the case of joint holders, the person first named in the register) has a registered
address outside the United Kingdom, but has notified the Company of a postal address within the United Kingdom at which notices, documents or other information may be given to him, he shall be entitled to have notices, documents and other
information given to him at that address. Otherwise, a shareholder (or joint holders) whose registered address is outside the United Kingdom shall not be entitled to receive any notice, document or other information from the Company.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of joint holders of a share, anything to be agreed or specified in relation to any notice, document
or other information to be served on or sent or supplied to them may be agreed or specified by any one of the joint holders and the agreement or specification of the senior shall be accepted to the exclusion of that of the other joint holders and,
for this purpose, seniority shall be determined by the order in which the names stand in the register in respect of the joint holding. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If, as a result of all or some of the notices, dividend warrants or other documents or information given, sent
or supplied by the Company to a shareholder being returned undelivered to the Company or other reasonable evidence, it is apparent that during a period of at least two consecutive years such documents or information have not been received by that
shareholder, then the Company shall no longer be obliged to give notices to that shareholder until he notifies the Company of a new registered address or postal address within the United Kingdom for the service of notices and the despatch or supply
of documents and other information, or shall have informed the Company of an address for the service of notices and the despatch or supply of documents and other information in electronic form. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any notice, document or other information to be given, sent or supplied to a shareholder shall be deemed to
have been duly given, sent or supplied to any shareholder who under article 142.4 or 142.6 or any other provision of these articles is not entitled to the same from the Company by exhibiting the same at the office. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">142.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may at any time and in its sole discretion choose to serve, send or supply notices, documents or
other information in hard copy form alone to some or all shareholders. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>143.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice by advertisement </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If there is a suspension or curtailment of postal services within the United Kingdom or some part of the United Kingdom, the Company need only
give notice of a general meeting to those shareholders with whom the Company can communicate by electronic means and who have provided the Company with an address for this purpose. The Company shall also advertise the notice in at least
one&nbsp;newspaper with a national circulation and make it available on its website from the date of such advertisement until the conclusion of the meeting or any adjournment of it. If at least six&nbsp;clear days prior to the meeting the sending or
supply of notices by post in hard copy form has again become generally possible, the Company shall send or supply confirmatory copies of the notice by post to those shareholders who would otherwise receive the notice in hard copy form. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>144.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Evidence of service on shareholders </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">144.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any notice, document or other information: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">144.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">addressed to a shareholder at his registered address or address for service in the United Kingdom shall, if
sent by post, be deemed to have been given: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">144.1.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(if prepaid as first class) 24 hours after it was posted; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">144.1.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(if prepaid as second class) 48 hours after it was posted </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">and it shall be sufficient to prove that the envelope containing such notice, document or information was properly addressed, prepaid and put
in the post; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">144.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not sent by post but addressed to a shareholder and delivered by hand to or left at a registered address or
address for service in the United Kingdom shall be deemed to have been given on the day it was so delivered or left; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">144.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">served, sent or supplied to a shareholder by electronic means shall be deemed to have been given on the day on
which it was sent and it shall be sufficient to show that such notice, document or information was properly addressed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">144.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">served, sent or supplied to a shareholder by publishing such notice, document or other information on a website
shall be deemed to have been given on the day on which the notice, document or other information was first made available on the website or, if later, when the recipient was given (or is deemed to have been given) notification of the fact that the
notice, document or other information was available on the website in accordance with the provisions of this article 144; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">144.1.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">served, sent or supplied to a shareholder by means of a relevant system shall be deemed to have been given when
the Company, or any participant in the relevant system acting on behalf of the Company, sends the instruction relating to the notice, document or other information; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">144.1.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">served, sent or supplied to a shareholder by any other means authorised in writing by the shareholder shall be
deemed to have been given when the Company has carried out the action it has been authorised to take for that purpose. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">144.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A shareholder present in person or by proxy at any meeting of the Company or of the holders of any class of
shares shall be deemed to have been given proper notice of the meeting and, if required, of the purposes for which it was called. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">144.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any notice or document exhibited at the office shall be deemed to have been served, sent or supplied on that
day when it was first so exhibited. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>145.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Record date for service on shareholders </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">For the purpose of serving, sending or supplying notices, documents or other information on shareholders, whether in accordance with the
Companies Acts, a provision in these articles or any other document, the Company may determine that only those persons entered in the register at the close of business on a day fixed by the Company are entitled to receive such notices, documents or
other information. This day must not be more than 14&nbsp;days before the day that the notice, document or information is served, sent or supplied. No change in the register after that time shall invalidate that service, sending or supply. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>146.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice binding on transferees etc </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Every person who, by operation of law, transfer or by any other means, becomes entitled to a share shall be bound by any notice in respect of
that share (other than a notice served by the Company under section&nbsp;793 of the Act) which, before his name is entered in the register, has been duly served on, sent or supplied to a person from whom he derives his title. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>147.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice in case of death, bankruptcy or mental disorder </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In the case of the death or bankruptcy of a shareholder or some other event giving rise to the transmission of a share by operation of law, the
Company may serve, send or supply a notice, document or other information to the person entitled as a result of such event as if he was the holder of the share. Such notice, document or other information shall be given by addressing it to him by
name or by the title of representative of the deceased or trustee of the bankrupt shareholder (or by any similar designation) at an address supplied for that purpose by the person claiming to be so entitled. Until such an address has been supplied,
a notice, document or other information may be served, sent or supplied in any manner in which this might have been done if the death, bankruptcy or other event had not occurred. Service, sending or supply in accordance with this article&nbsp;147
shall be deemed to be sufficient notice to all other persons interested in such share. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>148.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notices to directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company may give any notice, document or other information to a director: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">148.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">personally; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">148.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by word of mouth; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">148.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by sending it through the post in a prepaid envelope to the postal address given by him to the Company for this
purpose; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">148.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by delivering it by hand to or leaving it at that address in an envelope addressed to him; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">148.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by electronic means, to an address given by him to the Company for this purpose. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DESTRUCTION OF DOCUMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>149.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Destruction of documents </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Provided that it complies with the uncertificated securities rules in relation to shares held in uncertificated
form, the Company may destroy: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any share certificate which has been cancelled, after one year from the date of such cancellation;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any mandate for the payment of dividends or other monies or any variation or cancellation of the same or any
notification of change of name or address, after two years from the date such mandate, variation, cancellation or notification was recorded by the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any transfer of shares (including any documents sent to support a transfer and any documents constituting the
renunciation of an allotment of shares) which has been registered, after six years from the date of registration; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other document on the basis of which any entry in the register is made, after six years from the date an
entry in the register was first made in respect of it; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.1.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any instrument of proxy, after one year from the poll at which it was used or (if there was no poll) after one
month from the meeting to which it relates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It shall be presumed conclusively in favour of the Company that: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">every entry in the register purporting to have been made on the basis of a share transfer form or other
document so destroyed was duly and properly made; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">every share transfer form so destroyed was a valid and effective transfer duly and properly registered;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">every share certificate so destroyed was a valid certificate validly cancelled; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">every other document destroyed under this article 149 was a valid and effective document in accordance with the
recorded particulars of it in the books or records of the Company, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">provided always that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.2.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the provisions of this article 149 shall apply only to the destruction of a document in good faith and without
express notice to the Company that the preservation of such document was relevant to a claim; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.2.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">nothing contained in this article 149 shall be construed as imposing on the Company any liability in respect of
the destruction of any such document earlier than provided for in this article 149 or in any case where the conditions of this article 149 are not fulfilled; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">149.2.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">references in this article 149 to the destruction of any document include references to its disposal in any
manner. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WINDING UP </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>150.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power to petition </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The board may present a petition to the court in the name and on behalf of the Company for the Company to be wound up. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>151.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Winding up </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">151.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Company is wound up (whether the liquidation is voluntary, under supervision of the court or by the
court), the liquidator may, with the authority of a special resolution and any other sanction required by law, divide among the shareholders in kind the whole or any part of the assets of the Company. This applies whether or not the assets consist
of property of one kind or different kinds. For this purpose, the liquidator may set such value as he considers fair on any one or more class or classes of property, and may determine, on the basis of such valuation, how such division shall be
carried out as between shareholders or classes of shareholders; however, if any such division is otherwise than in accordance with the existing rights of shareholders, every shareholder shall have the same right of dissent and other ancillary rights
as if such resolution were a special resolution passed in accordance with section 110 of the Insolvency Act 1986. The liquidator may, with the same authority, transfer any part of the assets to trustees on such trusts for the benefit of shareholders
as the liquidator, with the same authority, thinks fit. The liquidation may then be closed and the Company dissolved. The liquidator shall not, however (except with the consent of the shareholder concerned), distribute to a shareholder any asset to
which there is attached a liability or potential liability for the owner. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">151.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The power of sale of a liquidator shall include a power to sell, wholly or in part, for shares or debentures or
other obligations of another company, whether it is already in existence or is about to be formed for the purposes of the sale. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS&#146; INDEMNITY AND INSURANCE </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>152.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Directors&#146; indemnity and insurance </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">To the extent permitted by the Companies Acts, the Company may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">152.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">indemnify any director of the Company or of any associated company against any liability;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">152.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">purchase and maintain insurance against any liability for any director of the Company or of any associated
company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>3
<FILENAME>filename3.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 1, SHEET 1 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 Tide Street
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Boston, Massachusetts </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(the
&#147;Building&#148;) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Located at Innovation Square (the &#147;Complex) </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Execution Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">August&nbsp;10, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tenant:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">PURETECH HEALTH LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">a Delaware limited liability company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mailing Address:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Prior to Term Commencement Date:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">501 Boylston Street, Suite 6102</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Boston, MA 02116</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Stephen M. Muniz</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">After the Term Commencement Date:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Innovation Square</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6 Tide Street, Suite 300 and Suite 400</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Boston, MA 02110-2412</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Stephen M. Muniz</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Landlord:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">RBK I TENANT, LLC, a Delaware limited liability company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mailing address:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">c/o Related Beal, 177 Milk Street, Boston, Massachusetts 02109</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Executive Vice President</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Premises: An area consisting of all of the rentable area on the fourth (4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) floor of the Building and a portion of the third
(3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor of the Building, substantially as shown on Lease Plan, Exhibit 2, together comprising the Total Rentable Area thereof.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Anticipated Commencement Date: April&nbsp;26, 2019.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Term or original Term: Eleven Lease Years (as defined below) consisting of ten (10)&nbsp;years and three (3)&nbsp;months (plus the partial month, if any, following the Term Commencement Date).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Improvement Allowance: Up to a maximum of $210.00 per square foot of Rentable Area in the Premises (e.g., $10,680,180.00 based on 50,858 rentable square feet), as provided in Article 4.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Supplemental Allowance: Up to a maximum of $.10 per square foot of Rentable Area in the Premises (e.g., $5,085.80 based on 50,858 rentable square feet), as provided in Article 4.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Use of Premises: Research and development, light manufacturing and ancillary and accessory uses thereto including office use, and for no other purposes, subject to Article 5
below.</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Yearly Rent / Monthly Rent:</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Rent&nbsp;per&nbsp;RSF</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Yearly Rent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Monthly Rent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71.00</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,610,918.00</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">300,909.83</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73.13</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,719,245.54</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">309,937.13</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75.32</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,830,624.56</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">319,218.71</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">77.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,945,563.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">328,796.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">79.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,062.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">338,671.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">82.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,186,121.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">348,843.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">84.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,311,741.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">359,311.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">87.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,440,920.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">370,076.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">89.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,574,168.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">381,180.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">92.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,711,485.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">392,623.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Year 11 (partial)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,852,870.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">404,405.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Abated Rent: Notwithstanding the Yearly Rent set forth above, so long as this Lease is in full force and effect
and Tenant is not in default under any of the terms and conditions of this Lease (beyond any applicable notice or Grace Period (as defined below)) at any time during the applicable Abated Rent Period, Tenant shall be entitled to an abatement of the
monthly installments of Yearly Rent (but not Additional Rent, if, as, and to the extent same is payable pursuant hereto), or a <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;free rent&#148; period, for the last calendar month of each of the
first (1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>) three (3)&nbsp;Lease Years (as defined below) of the Lease Term (the &#147;Abated Rent Period&#148;). </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="67%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Rent Payment Address:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c/o Related Beal</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;177 Milk Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Boston, Massachusetts&nbsp;02109</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Total Rentable Area:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">50,858 rentable square feet of space, consisting of the entire rentable area of the fourth (4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) floor of approximately 35,499 rentable square feet and approximately 15,359
rentable square feet of space on the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor of the Building and, subject to Article 7 below.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Total&nbsp;Rentable&nbsp;Area&nbsp;of&nbsp;Building:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">124,896 rentable square feet (approximate), subject to Article 5 below.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Electric current will be furnished to Tenant pursuant to Section&nbsp;8.1 below.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Operating Costs and Taxes:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Tenant&#146;s Proportionate Share: 40.72%, subject to Article 7 below.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 29.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Broker: JLL</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 29.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Letter of Credit Amount: $1,203,639.33, subject to Section&nbsp;29.13 below.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 29.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Parking Spaces: Up to thirty-four (34)&nbsp;parking spaces, subject to Article 7 and Section&nbsp;29.14 below.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Art. 29.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Option to Extend Term: Two (2)&nbsp;consecutive periods of five (5)&nbsp;years each, as provided in Section&nbsp;29.16.</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">REFERENCE DATA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DESCRIPTION OF DEMISED PREMISES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Demised Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Appurtenant Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exclusions and Reservations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roof Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roof Deck</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TERM OF LEASE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Habendum</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Declaration Fixing Term Commencement Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">READINESS FOR OCCUPANCY-ENTRY BY TENANT PRIOR TO TERM COMMENCEMENT DATE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Condition of Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Landlord&#146;s Work</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant&#146;s Early Entry</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant&#146;s Work</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conclusiveness of Landlord&#146;s Performance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">USE OF PREMISES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permitted Use</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prohibited Uses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Licenses and Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RENT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RENTABLE AREA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SERVICES FURNISHED BY LANDLORD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Electric Current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Water</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elevators, Heat and Cleaning</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Air Conditioning</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Heat and Air Conditioning Services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Air Conditioning Equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Landlord Repairs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interruption or Curtailment of Services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Energy Conservation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amentity Center</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TAXES AND OPERATING COSTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating Expense Share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Part Years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of Taking</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant Audit Right</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Survival</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CHANGES OR ALTERATIONS BY LANDLORD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FIXTURES, EQUIPMENT AND IMPROVEMENTS-REMOVAL BY TENANT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ALTERATIONS AND IMPROVEMENTS BY TENANT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">TENANT&#146;S CONTRACTORS-MECHANICS&#146; AND OTHER LIENS-STANDARD OF TENANT&#146;S PERFORMANCE-COMPLIANCE WITH LAWS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">REPAIRS BY TENANT-FLOOR LOAD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repairs by Tenant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Floor Load-Heavy Machinery</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INSURANCE, INDEMNIFICATION, EXONERATION AND EXCULPATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General Liability Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificates of Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property of Tenant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bursting of Pipes, etc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repairs and <FONT STYLE="white-space:nowrap">Alterations-No</FONT> Diminution of Rental
Value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Landlord&#146;s Indemnity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Landlord&#146;s Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">16.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ASSIGNMENT, MORTGAGING AND SUBLETTING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">16.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Generally</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">16.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reimbursement, Recapture and Excess Rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">16.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certain Transfers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MISCELLANEOUS COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rules and Regulations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access to Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accidents to Sanitary and Other Systems</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Signs, Blinds and Drapes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estoppel Certificate and Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prohibited Materials and Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Requirements of <FONT STYLE="white-space:nowrap">Law-Fines</FONT> and Penalties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant&#146;s Acts&#151;Effect on Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">18.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DAMAGE BY FIRE, ETC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">19.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WAIVER OF SUBROGATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">20.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CONDEMNATION-EMINENT DOMAIN</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DEFAULT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Limitation-Re-Entry-Termination</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intentionally Omitted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Damages-Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fees and Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Redemption</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Landlord&#146;s Remedies Not Exclusive</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grace Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Remedies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">22.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">END OF TERM-ABANDONED PROPERTY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SUBORDINATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">24.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">QUIET ENJOYMENT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">25.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ENTIRE AGREEMENT-WAIVER-SURRENDER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">25.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">25.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver by Landlord</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">25.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surrender</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">26.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INABILITY TO PERFORM-EXCULPATORY CLAUSE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">27.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BILLS AND NOTICES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">28.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PARTIES BOUND-SEIZING OF TITLE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Separability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Captions, etc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Broker</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Modifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Discrimination</FONT> and Equal Opportunity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governing Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignment of Rents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representation of Authority</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses Incurred by Landlord Upon Tenant Requests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Survival</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hazardous Materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patriot Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Letter of Credit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parking</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MBTA Pass Purchase Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant&#146;s Option to Extend the Term of the Lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Definition of Fair Market Rental Value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right of First Offer on Certain Space</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intentionally Omitted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Jury Trial</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 2 &#150; Lease Plan </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 3 &#150; Plan of Building and Land </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 4 &#150; Term
Commencement Date Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 5 &#150; Current Rules and Regulations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 6 &#150; Shared Conference Facilities Rules and Regulations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit <FONT STYLE="white-space:nowrap">6-1</FONT> &#150; Common Laboratory Facilities and Shared Conference Facilities </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 7 &#150; <FONT STYLE="white-space:nowrap">Non-Discrimination</FONT> and Equal Opportunity Covenants </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 8 &#150; Form of <FONT STYLE="white-space:nowrap">Non-Disturbance</FONT> and Attornment Agreement (EDIC) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 9 &#150; Form of Letter of Credit </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit <FONT
STYLE="white-space:nowrap">10-1</FONT> &#150; Base Building Plans </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit <FONT STYLE="white-space:nowrap">10-2</FONT> &#150; Base Building TI Matrix </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 11 &#150; Tenant&#146;s Signage </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 12 &#150;
Chemical Central Area&nbsp;&amp; Storage Quantities </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 13 &#150; Approved Hazardous Materials List (to be provided) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 14 &#150; Form of Notice of Lease </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 15 &#150;
Specific Tenant&#146;s Removable Property </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 16 &#150; Roof Exhibit </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 17 &#150; Phase II Preliminary Plan </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS LEASE made entered into on the Execution Date as stated in Exhibit 1 and between the
Landlord and the Tenant named in Exhibit 1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord does hereby demise and lease to Tenant, and Tenant does hereby hire and take from
Landlord, the premises hereinafter mentioned and described (hereinafter referred to as &#147;Premises&#148;), upon and subject to the covenants, agreements, terms, provisions and conditions of this Lease for the term hereinafter stated: </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>REFERENCE DATA </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each reference in this Lease to any of the terms and titles contained in any Exhibit attached to this Lease shall be deemed and construed to
incorporate the data stated under that term or title in such Exhibit. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DESCRIPTION OF DEMISED PREMISES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <B>Demised Premises</B><B>.</B> The Premises are that portion of the Building as described in Exhibit 1 (as the same may from time to time
be constituted after changes therein, additions thereto and eliminations therefrom pursuant to rights of Landlord hereinafter reserved) and is hereinafter referred to as the &#147;Building&#148;, substantially as shown hatched or outlined on the
Lease Plan (Exhibit 2) hereto attached and incorporated by reference as a part hereof. <B></B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <B>Appurtenant Rights.</B> Tenant shall
have, as appurtenant to the Premises, rights to use in common, with others entitled thereto, subject to the Rules and Regulations (as defined below) from time to time made by Landlord of which Tenant is given notice; (a)&nbsp;the Common Areas (as
defined below); (b) if any portion of the Premises include less than the entire rentable area of any floor, the common toilets and other common facilities of such floor; and (c)&nbsp;common loading dock facilities serving the Building; provided,
however, that Tenant&#146;s use of the loading dock facilities must be in compliance with all applicable Rules and Regulations, laws, regulations and ordinances and subject to reasonable notice and scheduling; and (d)&nbsp;subject to reasonable
notice and scheduling, access to and use of the Building&#146;s freight elevator,<B> </B>and no other appurtenant rights or easements, except as expressly provided in this Lease. Tenant shall also have the right to use in common with others entitled
thereto, and same shall be included in Tenant&#146;s Proportionate Share calculation by inclusion in the rentable area of the Premises, of the following shared laboratory facilities as provided herein: the laboratory waste and chemical storage areas
plumbed per the Base Building Plans (as defined below) for Tenant&#146;s acid neutralization system, all of which are both located on the first (1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>) floor (the &#147;Common Laboratory
Facilities&#148;) as shown on Exhibit <FONT STYLE="white-space:nowrap">6-1.</FONT> Landlord shall have the right to reasonably limit and allocate Tenant&#146;s utilization of the available Common Laboratory Facilities in proportion to percentage
that the Total Rentable Area of the Premises bears to the Total Rentable Area of the Building, from time to time, in a manner consistent with Schedule A to Exhibit <FONT STYLE="white-space:nowrap">6-1,</FONT> which shall exclude those portions of
the first (1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>) floor Landlord may use or reserve for present and future Building operations and uses. In addition, as part of the Common Laboratory Facilities, Tenant shall have the right to
access to up to five (5)&nbsp;watts of emergency generator capacity per square foot of the Premises dedicated to laboratory space (not to exceed 60% of the Premises for purposes of this sentence) from the emergency generator serving the Building,
from time to time. Tenant shall pay for its use of the Common Laboratory Facilities including, without limitation, utility usage therefor, in accordance with the provisions of Article 9 of this Lease relating to Tenant&#146;s Operating Expense
Share. In addition, Tenant shall have the right to use the conference facilities shown on Exhibit <FONT STYLE="white-space:nowrap">6-1</FONT> attached hereto (which use shall be subject to the rules and regulations attached hereto as Exhibit 6).
Tenant shall also have the right to use one hundred percent (100%) of the control zone(s) (i.e., chemical storage area or capacity available) on the fourth (4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) floor of the Building and
Tenant&#146;s proportionate share of the control zone(s) (i.e., chemical storage area or capacity available) located on the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor of the Building based on the rentable area of the
third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor portion of the Premises to the entire rentable area of the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor of the Building, which control zones shall be
for the exclusive to Tenant during the Term of this Lease. Notwithstanding anything to the contrary herein or in the Lease contained, Landlord has no obligation to allow any particular telecommunication service provider to have access to the
Building or to Tenant&#146;s Premises; provided, however, that Landlord shall not unreasonably prohibit access to Tenant&#146;s telecommunication service providers. If Landlord permits such access, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Landlord may condition such access upon the payment to Landlord by the service provider of reasonable fees assessed by Landlord. Landlord hereby agrees with Tenant that telecommunication service
provider relationships (including, without limitation, providing service providers with commercially reasonable Building infrastructure access and use) will have been secured and providing service to the Building as of the Term Commencement Date,
and Landlord shall maintain relationships (including, without limitation, providing service providers with commercially reasonable Building infrastructure access and use) therewith in a manner consistent with comparable first-class life science
buildings the Seaport District of Boston, Massachusetts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <B>Exclusions and Reservations.</B> All the perimeter walls of the Premises
except the inner surfaces thereof, any balconies (except to the extent same are shown as part of the Premises on the Lease Plan (Exhibit 2)), terraces or roofs adjacent to the Premises, and any space in or adjacent to the Premises used for shafts,
stacks, pipes, conduits, wires and appurtenant fixtures, fan rooms, ducts, electric or other utilities, sinks or other Building facilities, and the use thereof, as well as the right of access through the Premises for the purposes of operation,
maintenance, decoration and repair, are expressly excluded from the Premises and reserved to Landlord; provided, however, that if Landlord is required to access, maintain or replace any of the foregoing within the Premises, Landlord shall use
commercially reasonable efforts to minimize any interference with Tenant&#146;s occupancy rights hereunder arising out of such access, maintenance or replacement (including the advance notice and other requirements set forth in the Lease relating to
Landlord&#146;s entry into the Premises). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <B>Roof Rights.</B><B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;Tenant shall have the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> right, to install, operate and maintain, all in good order
and repair, alter and replace, certain supplemental HVAC and other equipment in a portion or portions of the (&#147;Roof&#148;) of the Building, including the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> right to use Building&#146;s chases,
risers and conduits for utilities and installations to serve the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment (collectively, <FONT STYLE="white-space:nowrap">&#147;Roof-top</FONT> Equipment&#148;), provided that Landlord shall have the
right to limit Tenant&#146;s use of the Building&#146;s chases, risers and conduits to Tenant&#146;s Proportionate Share of the available space thereof (i.e., space remaining after that used or reserved for Building operations). Tenant&#146;s use,
installation and operation of the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment (including the Building&#146;s chases, risers and conduits) shall be in compliance with all of the terms and conditions of this Lease, including but not
limited to Article 12, and all of the specifications relating thereto as reasonably promulgated by and amended by Landlord from time to time that are not inconsistent with the express rights granted Tenant hereunder, or with the approved Plans for
the Tenant Improvement Work (as those terms are defined below) or the approved plans for Tenant&#146;s <FONT STYLE="white-space:nowrap">Roof-Top</FONT> Equipment (the &#147;Specifications&#148;). Tenant acknowledges and agrees that the right granted
to Tenant hereunder is <FONT STYLE="white-space:nowrap">non-exclusive</FONT> provided, however, that at all times during the Term: (i)&nbsp;Tenant shall have access to the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment subject to
reasonable notice and, if appropriate such as in the case or work thereon, scheduling; and (ii)&nbsp;Landlord shall not install, and shall not permit the installation and/or operation by any other party of, any additional microwave dishes, satellite
dishes, antennae, towers and/or other structures or equipment on the Roof which interfere with Tenant&#146;s use of the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment that is then in place. Tenant&#146;s ability to use the Roof for its <FONT
STYLE="white-space:nowrap">Roof-top</FONT> Equipment as provided hereunder shall be in conjunction with Landlord and other Building tenants and occupants (including Tenant) and shall be equitably and proportionately distributed, from time to time,
among Landlord and such other tenants and occupants (including Tenant) (and Roof or other Building utility space may be used or reserved for Building operations) by Landlord in connection with such distribution and Tenant&#146;s share of the Roof
for the purposes of such distribution shall include that portion of the Roof available for Tenant&#146;s Roof Deck (as defined below) and any other portions of the Building affected thereby including but not limited to Building/Roof ingress and
egress, Roof penetrations, path(s) of travel, and Roof stair/elevator head house(s) installed by or on behalf of Tenant in connection therewith. Landlord shall use commercially reasonable efforts to accommodate Tenant&#146;s <FONT
STYLE="white-space:nowrap">Roof-top</FONT> Equipment requirements as provided herein, but Landlord shall have the right to reasonably limit and allocate Tenant&#146;s utilization of available and/or Roof or other Building utility space as aforesaid
including the right to use and reserve <FONT STYLE="white-space:nowrap">Roof-top(s)</FONT> and other Building utility space for future Building operations and other Building uses and operations. Pursuant to the terms and conditions hereof, Tenant
shall have the right to use the Roof provided the same shall be delivered in the condition set forth in the Base Building Plans (as defined below) without any further representation or warranty, express or implied, and without any obligation for
Landlord to perform any additional work in connection with Tenant&#146;s use thereof or provide services for the same, except as otherwise expressly set forth herein, including the completion of Landlord&#146;s Work and Landlord&#146;s maintenance,
repair and restoration obligations set forth in this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment installed by or on behalf
of Tenant shall be installed in the locations selected by Landlord, in its reasonable discretion, and Landlord shall have the right, to be exercised in good faith, to require Tenant to relocate the <FONT STYLE="white-space:nowrap">Roof-top</FONT>
Equipment from time to time, as provided in Subsection (d)&nbsp;below; provided, however, in no event shall Landlord require Tenant to so relocate its <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment at Tenant&#146;s cost for purposes
benefiting another Building tenant or occupant. Landlord and Tenant shall use commercially reasonable efforts to allocate Roof and other Building utility space provided to Tenant in such a way so as to minimize the likelihood of any such relocation
to certain <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment which efforts shall include indicating, upon review of Tenant&#146;s <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment plans, which equipment shall not need to be
relocated in the event of a relocation (provided, however, that Tenant acknowledges and agrees that the Roof Deck (as defined below) would most likely have to be disassembled, at Tenant&#146;s cost, in order to effect Roof Repairs (as defined
below)). Landlord makes no representation or warranty to Tenant that the Roof or other Building utility space will be satisfactory to Tenant when constructed in accordance with the Base Building Plans, provided Landlord shall use commercially
reasonable efforts to assist Tenant to locate a satisfactory location in the Building utility space and on the Roof. Prior to installing or replacing any <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment, Tenant shall submit to Landlord
plans and specifications for the installation thereof prepared by a licensed engineer reasonably satisfactory to Landlord (the &#147;Roof Plans&#148;) which Roof Plans shall be subject to the prior reasonable approval of Landlord (including, but not
limited to, location, size, design, and method of attachment to the Building of the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment shown thereon) in accordance with the approval standard therefor as provided in Article 12. The Roof Plans
shall be consistent with any applicable Rules and Regulations Specifications, and otherwise reasonably satisfactory to Landlord, and shall show the location of the installations of the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment, any
structural requirements and installations, and all related equipment and components on the Roof or Building utility space, the location and type of all piping, conduit, wiring, cabling, the manner in which same will be placed in or on and fastened
to the Roof or Building utility space and any other information requested by Landlord, in Landlord&#146;s reasonable discretion. Landlord shall have the right to require that any <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment not be
visible in a material manner from any location on the ground in the immediate vicinity of the Building and/or that the all such <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment be screened and sound attenuated in a manner satisfactory to
Landlord, in each case in Landlord&#146;s reasonable discretion and as may be required by applicable legal requirements and that all <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment be installed in such a way so as to allow maintenance and
repairs to the Roof (or other Building utility space) from time to time, all in Landlord&#146;s reasonable discretion. Landlord shall have the right to employ an engineer or other consultant to review the Roof Plans and the reasonable, actual <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> cost of such engineer or consultant shall be paid by Tenant to Landlord within thirty (30)&nbsp;days after Landlord&#146;s bill to Tenant therefor in reasonable
detail. After Landlord has approved the Roof Plans and prior to installing any <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment, and any related equipment, wiring, conduit, piping, or cabling, Tenant shall obtain and provide to Landlord,
except to the extent such <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment is being installed by Landlord as part of the Landlord&#146;s Work (as defined below) in which case Landlord shall obtain: (i)&nbsp;all required governmental and
quasi-governmental permits, licenses, special zoning variances and authorizations, as required by applicable laws, rules, ordinances, regulations and restrictions, all of which Tenant shall obtain at its own cost and expense (but with
Landlord&#146;s reasonable cooperation as provided in Article 12); and (ii)&nbsp;a policy or certificate of insurance evidencing such commercially reasonable insurance coverage as may be reasonably required by Landlord. Any alteration or
modification of the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment, or any associated piping, conduit, wiring, cabling, equipment (than a <I>de minimis</I> alteration or modification) after the Roof Plans have been approved shall require
Landlord&#146;s prior written approval, which shall not be unreasonably withheld, conditioned or delayed. Landlord makes no representation or warranty that Tenant will be permitted under applicable law to install the
<FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment on the Roof or Building utility space. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Installation and maintenance of the <FONT
STYLE="white-space:nowrap">Roof-top</FONT> Equipment, or any associated structural work, piping, conduit, wiring, cabling, and equipment shall be performed solely by contractors approved by Landlord, in its reasonable discretion. In connection with
Tenant&#146;s early entry into the Premises pursuant to this Lease, Landlord shall permit Tenant to coordinate conduit and piping installation work with Landlord&#146;s Work to coordinate roof penetrations and associated waterproofing work. Landlord
may require Tenant to use a roofing contractor selected by Landlord to perform any work that could damage, penetrate or alter the Roof and an electrician selected by Landlord to install any associated piping, conduit, wiring, cabling, equipment on
the Roof or in the Building. Landlord may require anyone going on the Roof to execute in advance a commercially reasonable liability waiver, provided, however, that such waiver shall not operate to alter or amend any terms of this Lease. Tenant
shall bear all costs and expenses incurred in connection with the installation, operation, maintenance, repair and/or removal of the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment (other than the application of the Improvement Allowance)
and Tenant agrees that Landlord shall not be responsible for, and, to the maximum extent this agreement may be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#146;s insurance
requirements hereunder and Article 15 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and Article 19, Tenant shall release, defend, indemnify and save Landlord harmless against and from any liability, loss, cost, expense, injury, damage, claim or suit resulting directly or
indirectly from the aforesaid installations, use of the Roof and the use, operation and/or removal of any of the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment and this indemnity and release shall survive the termination of this Lease.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Tenant acknowledges that Landlord may decide, in its reasonable discretion, from time to time, to repair or replace the Roof
(hereinafter &#147;Roof Repairs&#148;). Tenant is encouraged to design, install and maintain the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment in a manner that allows for Landlord to conduct Roof Repairs without any removal thereof
being required (e.g., using adequately framed, reinforced, sealed and elevated dunnage, curbing and/or roof framing) and Landlord shall reasonably cooperate with Tenant to accomplish this during the review and approval of Tenant&#146;s plans
therefor. If Tenant fails to design, install and maintain the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment in a manner that allows for Landlord to conduct Roof Repairs without any removal thereof being required and Landlord elects to
make Roof Repairs that will in Landlord&#146;s good faith determination require Tenant to temporarily relocate its <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment on the Roof, Tenant shall, upon Landlord&#146;s request and reasonable
notice and at Tenant&#146;s sole cost and expense, temporarily relocate the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment so that the Roof Repairs may be completed; Landlord and Tenant shall use commercially reasonable efforts to
cooperate in connection with such temporary relocation in order to minimize or mitigate the effect thereof, to no more than a <I>de minimis</I> amount, with respect to Tenant&#146;s use of and operation of its business in the Premises. Tenant
acknowledges and agrees that the Roof Deck would most likely have to be disassembled, at Tenant&#146;s cost, in order to effect any required Roof Repairs. If Landlord elects to make Roof Repairs that will in Landlord&#146;s good faith determination
require Tenant to temporarily relocate its <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment, Tenant shall, upon not less than forty-five (45)&nbsp;days prior written notice (or such shorter period as appropriate in the event of violation
of applicable law or an emergency situation) at Landlord&#146;s request, temporarily relocate the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment so that the Roof Repairs may be completed; Landlord and Tenant shall use commercially
reasonable efforts to cooperate in connection with such temporary relocation in order to minimize or mitigate the effect thereof, to no more than a <I>de minimis</I> amount, with respect to Tenant&#146;s use of and operation of its business in the
Premises. The cost of removing and reinstalling same shall be paid by Tenant or Landlord as provided above. To the maximum extent this agreement may be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15),
but subject to Tenant&#146;s insurance requirements hereunder and Article 15 and Article 19, Landlord shall not be liable to Tenant for any losses, liability, injury, damages, claim, suit, lost profits or other costs or expenses of any kind
whatsoever incurred by Tenant, or any invitee, licensee or agent of Tenant as the result of the Roof Repairs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) On the termination or
expiration of the Lease, Tenant shall remove the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment, and all associated conduit, wiring, cabling, equipment, and repair any damage caused thereby unless otherwise requested by Landlord or
unless, subject to Landlord&#146;s prior written approval, not to be unreasonably withheld, arranges for another tenant or occupant of the Building to agree to use such equipment and assume Tenant&#146;s obligations hereunder in writing reasonably
satisfactory to Landlord, and repair any damages caused thereby, at Tenant&#146;s sole cost and expense. If Tenant does not remove same on or before the date this Lease terminates or expires, Tenant hereby authorizes Landlord to remove and dispose
of same and associated conduit, wiring, cabling, equipment, and Tenant shall promptly reimburse Landlord for third party out of pocket costs and expenses it incurs in removing and disposing of same and repairing any damages caused thereby. Tenant
agrees that Landlord, pursuant to the immediately foregoing sentence, may dispose of the <FONT STYLE="white-space:nowrap">Roof-top</FONT> Equipment, and any associated conduit, wiring, cabling, and equipment in any manner selected by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant&#146;s right to operate and maintain the Roof-top Equipment hereunder shall automatically expire and terminate on the date that the Term of the Lease
expires or is otherwise terminated. This right to operate and maintain any Roof-top Equipment shall be suspended, at Landlord&#146;s option, if any of the following continue for more than five (5) business days after written notice from Landlord to
Tenant (or such longer period as is reasonable under the circumstances and proportionate to the interference or damage or interference being caused and so long as Tenant is diligently pursuing a cure): (a) the Roof-top Equipment is causing physical
damage to the Building or the Roof, (b) the Roof-top Equipment is materially interfering with the normal or customary transmission or receipt of signals from or to the Building with respect to transmission equipment located on the roof of the
Building prior to the installation of the Roof-top Equipment, or (c) the Roof-top Equipment is causing Landlord to be in violation any local, state or federal law, regulation or ordinance; provided, Tenant shall have the right to remedy any of the
foregoing circumstances to ensure the cessation of damage, material interference, or violation, as the case may be, to Landlord&#146;s reasonable satisfaction and thereupon Tenant may resume such use. Notwithstanding the foregoing, Landlord may
suspend such right prior to the expiration of the five (5) business day period (as extended) but after notice reasonable in the circumstances to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Tenant under any of the following circumstances: (x) if necessary to prevent civil or criminal liability of in connection therewith; (y) if necessary to prevent an imminent and material
interference of the conduct of business in the Building; or (z) if necessary to prevent injury to persons or imminent and material damage to the Building, Roof, other Building utility space or other property therein (which shall include but not be
limited to damage to or leaking of the roof membrane). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 <B>Roof Deck.</B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) Tenant shall have the exclusive license to use construct, maintain and use an outdoor roof deck space in the approximate location
shown on the Roof shown on Exhibit 16 attached hereto and incorporated herein (the &#147;Roof Deck&#148;), subject to the terms and conditions of this this Section&nbsp;2.5 and other applicable terms and conditions of this Lease including but not
limited to Articles 12 and 13 below and 2.5(c) above. Tenant&#146;s use of the Roof Deck shall in no event be used for a smoking area or other noxious or prohibited uses. All alterations and installations to the Roof Deck including, without
limitation, Building/Roof ingress and egress, Roof penetrations, path(s) of travel, Roof stair/elevator head house(s), electrical service, floor surfaces, planters, lighting, tables seating and/or other furniture, fixtures, plantings, finishes, and
personal property to be installed and used in connection with Tenant&#146;s use of the Roof Deck shall be constructed, installed, maintained, operated and, if applicable, modified and removed, in a good and first-class manner at all times and at
Tenant&#146;s sole cost and shall be subject to the approval of Landlord, which approval standard shall be the standard applicable to Alterations as set forth in Article 12, except that for purposes of such Article 12 approval standard,
Tenant&#146;s Roof Deck alterations or installations shall not be considered to adversely affect the Building&#146;s structure or systems solely by virtue of the fact that such alterations or installations may require roof penetrations or other
alterations to the structure of the roof and improvements thereon; and further Landlord agrees to reasonably cooperate, at no cost or expense (or delay to Landlord&#146;s Work) to Landlord, with Tenant as to modifications to Building/Roof stairhead
houses and Building common roof ingress and egress. In connection with the construction and use of the Roof Deck, Tenant shall obtain, maintain and provide to Landlord: (a)&nbsp;all required governmental and quasi-governmental permits, licenses,
special zoning variances and authorizations, as required by applicable Legal Requirements, all of which Tenant shall obtain at its own cost and expense (but with Landlord&#146;s reasonable cooperation as provided in Article 12); and (b)&nbsp;a
policy or certificate of insurance evidencing such insurance coverage as may be reasonably required by Landlord. Subject to the terms and conditions hereof, Tenant shall be responsible, at its sole cost and expense, for removing the Roof Deck and
repairing and restoring the Roof (and any other portions of the Building affected thereby including but not limited to Building/Roof ingress and egress, Roof penetrations, path(s) of travel, Roof stair/elevator head house(s) installed by or on
behalf of Tenant) at the expiration or termination of the Lease Term unless Landlord elects, in its sole discretion, for same to remain, which election shall be made in writing at least one hundred twenty (120)&nbsp;days prior to the expiration of
the Lease Term; provided such discussions may take place earlier. Notwithstanding the foregoing, so long as (v)&nbsp;Tenant is not otherwise in default, beyond any applicable Grace Period, under any of the terms and conditions of this Lease
including those relating to the surrender and yield up obligations under the Lease (other than those obligations relating solely to the removal of the Roof Deck); (x) the Roof Deck (including the use, maintenance and operation thereof) is then in
full compliance with all Legal Requirements, without the need for further work, updating, permits or approvals, and (y)&nbsp;Landlord has advised Tenant that Landlord or a new tenant of the Building is willing to assume the responsibility and
liability to maintain and operate the Roof Deck in accordance with all Legal Requirements (and the terms hereof) following the natural expiration of the Term of this Lease, then Landlord shall reimburse Tenant for fifty percent (50%) of the
certified hard costs actually incurred by Tenant in connection with the initial construction of the Roof Deck, up to a maximum reimbursement of $150,000.00, after deducting therefrom fifty percent (50%) of any of the costs and expenses of the
necessary and appropriate repairs and replacements to allow the Roof Deck to continue to be used and operated as provided herein to for an additional five (5)&nbsp;years of useful life; provided Landlord shall have the right to offset or deduct from
any reimbursement hereunder any amounts due and owing from Tenant under this Lease. At Landlord&#146;s request, Tenant shall provide reasonable <FONT STYLE="white-space:nowrap">back-up</FONT> and supporting materials evidencing the amount actually
incurred by Tenant in connection with the initial construction of the Roof Deck. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Without limiting other applicable provisions relating
to the use or occupancy of the Roof Deck: (i)&nbsp;Tenant also shall be responsible, at the Tenant&#146;s sole cost and expense, for furnishing, maintaining and replacing any and all tables, furniture, fixtures, plantings and personal property used
in connection with the Tenant&#146;s use of the Roof Deck and for stacking, removing, and otherwise securing the same whenever Tenant is not using same, during periods of extraordinary weather and for the removal and for storage thereof (within the
Premises (or <FONT STYLE="white-space:nowrap">off-site)),</FONT> and Landlord shall have no responsibility or liability therefor, or for any damage, vandalism, theft, or the like with respect thereof;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(ii) Tenant&#146;s use of the Roof Deck shall be at Tenant&#146;s sole risk and shall be conducted in compliance with all applicable laws and all governmental rules, regulations, permits and
approvals relating thereto; (iii)&nbsp;Tenant and its employees shall abide by, any and all commercially reasonable rules and regulations promulgated in writing by Landlord with respect to the foregoing or otherwise relative to Tenant&#146;s use of
the Roof Deck, including, without limitation, any such commercially reasonable rules and regulations affecting reasonable hours of operation, occupancy, and/or crowd and noise levels, etc., provided that in the case of any conflict between the
express provisions of this Lease and any such rules and regulations, the express provisions of this Lease shall control and Landlord acknowledges that Tenant may use the Roof Deck for Tenant functions and may include provision of beer, wine and
liquor in compliance with all state, municipal and other governmental laws, regulations, ordinances and rules with respect thereto; (iv)&nbsp;notwithstanding the exterior location of the Roof Deck, all provisions of this Lease applicable to the
Premises shall be applicable to the Roof Deck and the Roof Deck shall for all purposes hereunder be included and considered to be within the Premises, including Tenant&#146;s insurance and indemnity obligations, but excepting the purpose of
computing the Total Rentable Area of the Premises; and (v)&nbsp;to the maximum extent the following agreement may be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#146;s
insurance requirements hereunder and Article 15 and Article 19, Tenant will save Landlord, its agents and employees, harmless and will exonerate, defend and indemnify Landlord, its agents and employees, from and against any and all claims,
liabilities, losses, damages or penalties asserted by or on behalf of any person, firm, corporation or public authority arising from the Roof Deck including but not limited to Tenant&#146;s use, occupancy, construction, removal, operation or
maintenance thereof. No cooking, smoking, open flame, fire pits, space heaters or the like shall be permitted on Roof Deck, nor shall the walls, floors or railing systems thereof be painted or modified by the Tenant without the prior written
approval of Landlord, subject to the approval standard set forth in Article 12. Landlord shall have the right to access the Roof Deck from time to time for purposes allowed under this Lease, including the obligation to perform repair and
maintenances to the Building, to erect equipment thereon, for its use and the use of the tenants in the Building (e.g., to secure and access window washing equipment (e.g., davits), to clean and repair Roof drains (which must remain accessible), and
the like). Landlord, upon reasonable written notice (except in the case of emergency, Building maintenance and repair and the like) shall have the right to require that any and all tables, furniture, fixtures, plantings and personal property used in
connection with the Tenant&#146;s use of the Roof Deck not be visible in a material manner from any location on the ground in the immediate vicinity of the Building and/or that same be screened and sound attenuated in a manner reasonably
satisfactory to Landlord (but, as to Landlord&#146;s requirements therefor (as opposed to legal requirements imposed from time to time) Landlord shall not require Tenant to install any screening in addition to the screening approved by Landlord in
connection its approval of the plans for the Roof Deck), in each case in Landlord&#146;s reasonable discretion and as may be required by applicable legal requirements and that any and all tables, furniture, fixtures, plantings and personal property
used in connection with the Tenant&#146;s use of the Roof Deck be placed or installed in such a way so as to allow maintenance and repairs to the exterior of the Building from time to time, all in Landlord&#146;s reasonable discretion as set forth
above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In the event that Tenant&#146;s use of the Roof Deck fails to comply with Landlord&#146;s reasonable rules and regulations of
which Tenant was provided prior written notice or otherwise so fail to comply with the foregoing and all applicable provisions of this Lease, and such failure continues for five (5)&nbsp;or more business days after (or such shorter period in the
event of violation of applicable law or an emergency situation) written notice thereof is given by Landlord to Tenant, then, in any such event, and without limiting Landlord&#146;s other rights and remedies on account of the continuation thereof and
the resulting default by Tenant thereunder, Landlord shall have the right to take such steps as Landlord reasonably determines to be necessary to remedy such failure, including, without limitation, the right, exercisable by giving written notice
thereof to Tenant, immediately to suspend all of Tenant&#146;s rights hereunder to use the Roof Deck, until the facts and circumstances giving rise to such failure are resolved to the reasonable satisfaction of Landlord and Landlord and Tenant shall
work in good faith to resolve same. Any such suspension of Tenant&#146;s rights to use of the Roof Deck in accordance with the foregoing shall not affect this Lease insofar as it relates to the remainder of the Premises; and, without limitation, as
no Rent or other charges attributable to the use of the Roof Deck are imposed by the provisions of this Lease, any such suspension of Tenant&#146;s rights to use the Roof Deck shall not reduce or otherwise affect the Rent or any other charges and
obligations of Tenant pursuant to the provisions of this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TERM OF LEASE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 Definitions. As used in this Lease the words and terms which follow mean and include the following:<B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) &#147;Term Commencement Date&#148; &#150; shall mean the Substantial Completion Date (as defined in Article 4.2(h)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &#147;Complex&#148; shall mean all of the Building, the other buildings now or in the future, and the Common Areas serving such buildings
now or in the future, all located on the land (&#147;Land&#148;) shown outlined on Exhibit 3 to be known as Innovation Square (which shall include, without limitation, Phase I and Phase II). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &#147;Common Areas&#148; shall mean the common walkways, accessways, and parking facilities (&#147;Parking Facilities&#148;), located on
the land shown on Exhibit 3 (&#147;Land&#148;), a bicycle storage area, the common loading docks, freight elevator, lobbies, hallways, stairways and elevators of the Building, and common facilities (including, without limitation, conference rooms
and a fitness facility with showers/restrooms located within the Building and exclusive to the tenants of the Building (the conference rooms and fitness facility, collectively, the &#147;Amenity Center&#148;), subject to Section&nbsp;8.11 below,
which amenities shall be available for use during business days (as defined below) (except that the fitness facility and showers/restrooms shall be accessed using Building access cards), as the same may be changed, from time to time, including
without limitation, alleys, sidewalks and streets, lobbies, hallways, toilets, stairways, fan rooms, utility closets, shaftways, street entrances, elevators, wires, conduits, meters, pipes, ducts, vaults, and any other equipment, machinery,
apparatus, and fixtures wherever located on the Land, in the Building, the Complex, or in the Premises that either (i)&nbsp;serve the Premises as well as other parts of the Land, Building or Complex, or (ii)&nbsp;serve other parts of the Land,
Building or Complex but not the Premises as the same may be changed, from time to time, including without limitation, alleys, sidewalks, lobbies, hallways, toilets, stairways, fan rooms, utility closets, shaftways, street entrances, elevators,
wires, conduits, meters, pipes, ducts, vaults, and any other equipment, machinery, apparatus, and fixtures wherever located on the Land, in the Building, the Complex, or in the Premises that either (i)&nbsp;serve the Premises as well as other parts
of the Land, Building or Complex, or (ii)&nbsp;serve other parts of the Land, Building or Complex but not the Premises. It is understood and agreed that all use of the fitness center and its facilities shall be at the sole risk of Tenant and the
employees using same, and, to the maximum extent this agreement may be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#146;s insurance requirements hereunder and Article 15 and
Article 19, Tenant shall release, defend, indemnify and save Landlord harmless against and from any liability, loss, cost, expense, injury, damage, claim or suit resulting directly or indirectly from the use of the fitness center and this indemnity
and release shall survive the termination of this Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &#147;Lease Year&#148; shall mean each successive <FONT
STYLE="white-space:nowrap">12-month</FONT> period included in whole or in part in the Term of this Lease; the first Lease Year beginning on the Term Commencement Date and ending at midnight on the day before the first anniversary of the Term
Commencement Date (provided that if the Term Commencement Date is not the first day of a calendar month, the first Lease Year shall end at midnight on the last day of the calendar month which includes the first anniversary of the Term Commencement
Date). If the first or last Lease Year of the Term shall be greater or less than one full calendar year, the Yearly Rent for such Lease Year shall be increased or decreased, as the case may be, proportionately to the greater length of such Lease
Year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <B>Habendum.</B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>TO HAVE AND TO HOLD the Premises for a term of years commencing on the Term Commencement Date and ending at 11:59 p.m. on the last day
of the eleventh (11<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) Lease Year (which is a partial year) following the Term Commencement Date (as same may be extended in accordance with Section&nbsp;29.16 below) or on such earlier date upon
which said Term may expire or be terminated pursuant to any of the conditions of limitation or other provisions of this Lease or pursuant to law (which date for the termination of the terms hereof will hereafter be called &#147;Termination
Date&#148;). Notwithstanding the foregoing, if the Termination Date as stated in Exhibit 1 shall fall on other than the last day of a calendar month, said Termination Date shall be deemed to be the last day of the calendar month in which said
Termination Date occurs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <B>Declaration Fixing Term Commencement Date.</B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>Landlord and Tenant agree to execute a supplemental agreement confirming the actual Term Commencement Date and Termination Date, once
same are determined, in the form set forth at Exhibit 4 or as otherwise may be reasonably required by Landlord. Tenant agrees not to record the within Lease, but each party hereto agrees, on the written request of the other, to execute a <FONT
STYLE="white-space:nowrap">so-called</FONT> memorandum of lease or short form lease in in the form attached hereto as Exhibit 14. In no event shall such document set forth the rent or other charges payable by Tenant under this Lease; and any such
document shall expressly state that it is executed pursuant to the provisions contained in this Lease and is not intended to vary the terms and conditions of this Lease. If this Lease is terminated before the Term expires, then upon Landlord&#146;s
written request the parties shall execute, deliver and record an instrument acknowledging such fact and the date of termination of this Lease, and Tenant hereby appoints Landlord its
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> in its name and behalf to execute such instrument if Tenant shall fail to execute and deliver such instrument after Landlord&#146;s request therefor
within ten (10)&nbsp;business days, unless Tenant has notified Landlord of a good faith dispute with such instrument or the dates set forth therein prior thereto. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>READINESS FOR OCCUPANCY-ENTRY BY TENANT PRIOR TO TERM COMMENCEMENT DATE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <B>Condition of Premises</B><B>.</B> Subject to Landlord&#146;s obligation to complete Landlord&#146;s Work in the condition required by
this Lease (as defined below), Tenant shall accept the Premises, the Building and the Complex in their present &#147;as is&#148; condition, without representation or warranty, express or implied, in fact or in law, by Landlord and without recourse
to Landlord as to the nature, condition or usability thereof; and Tenant agrees that, except for Landlord&#146;s Work, Landlord has no work to perform in or on the Premises to prepare the Premises for Tenant&#146;s use and occupancy, and that any
and all work to be done in or on the Premises will be performed by Tenant at Tenant&#146;s sole cost and expense in accordance with the terms of this Lease. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <B>Landlord&#146;s Work.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions hereof, Landlord shall Substantially Complete (as defined below) the (i)&nbsp;Base Building Shell Work,
and (ii)&nbsp;Tenant Improvement Work (as those terms are more fully defined below) (collectively (i)&nbsp;and (ii), are &#147;Landlord&#146;s Work&#148;) in a good and workerlike manner, using new or
<FONT STYLE="white-space:nowrap">like-new)</FONT> designed and constructed in accordance with the Base Building Plans and Plans (as those terms are defined below), including but not limited to construction materials, design and finishes set forth
thereon, and otherwise in compliance with all legal requirements of general applicability to the Building (including without limitation the Americans with Disabilities Act and all governmental permits and approvals if and to the extent applicable to
Landlord&#146;s Work, which shall be obtained by Landlord). Landlord shall use commercially reasonable speed and diligence to Substantially Complete the Landlord&#146;s Work on or before the Anticipated Term Commencement Date, subject to delays
caused by Tenant Delays (as defined below) or event(s) of Force Majeure (as defined below), but, except as set forth in this Subsection (a), in no event shall Landlord be liable to Tenant for any failure to Substantially Complete the Landlord&#146;s
Work on any specified date, nor shall such failure give rise to any default or other remedies under this Lease or at law or equity, or otherwise affect the validity of this Lease or the obligations of Tenant hereunder. Notwithstanding the foregoing,
if the Substantial Completion Date (as hereinafter defined) has not occurred by the date that is thirty (30)&nbsp;days following the Anticipated Term Commencement Date, unless such delay is caused by Tenant Delays or an event of Force Majeure, then
Tenant shall be entitled to rent credit equal to one day&#146;s rent at the Yearly Rent per diem for each day following such thirtieth (30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day, until the earlier of (x)&nbsp;Landlord achieving
the Substantial Completion Date, or (y)&nbsp;the sixtieth (60<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day following the Anticipated Term Commencement Date as same may be extended as aforesaid; provided, however, that if the
Substantial Completion Date has not occurred by the date that is sixty (60)&nbsp;days following the Anticipated Term Commencement Date, unless such delay is caused by Tenant Delays or an event of Force Majeure, then Tenant shall then be entitled to
rent credit equal to two day&#146;s rent at the Yearly Rent per diem for each day following such sixtieth (60<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day, until Landlord achieves the Substantial Completion Date. The foregoing is
intended to be a liquidated reimbursement provision, and Tenant&#146;s sole remedy in such case (except as set forth in the following sentence), and not a penalty, and represents the parties&#146; good faith agreement as to an amount which shall
have been incurred by Tenant and which shall otherwise not be susceptible of exact ascertainment. In addition, if the Term Commencement Date does not occur on or before the date that is one hundred fifty (150)&nbsp;days after the Anticipated
Commencement Date, unless such delay is caused by Tenant Delays or an event of Force Majeure, (as same may be extended as aforesaid, the &#147;Termination Date&#148;), Tenant shall have the right to terminate this Lease by giving notice to Landlord
of Tenant&#146;s desire to do so before ten (10)&nbsp;business days after the Termination Date; and, upon the giving of such notice, the Term of this Lease shall, unless the Term Commencement Date occurs
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
within thirty (30)&nbsp;days after Landlord&#146;s receipt of such notice, immediately cease and come to an end as of the date that is 30 days after Landlord&#146;s receipt of such termination
notice from Tenant, and neither party shall have any further liability or obligation on the part of either party, except that Landlord shall, within ten (10)&nbsp;business days of the termination date, return to Tenant the Letter of Credit (as
hereinafter defined) and the first monthly of rent that Tenant has paid to Landlord in connection with its execution of this Lease pursuant to Section&nbsp;6 hereof. Notwithstanding anything to the contrary contained herein, the Anticipated Term
Commencement Date and the Termination Date shall be extended by any period of time that Landlord is delayed in the performance of Landlord&#146;s Work caused by Tenant Delays or an event of Force Majeure. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) As used herein, the term &#147;Base Building Shell Work&#148; shall refer to the base building core and shell work, in accordance with the
plans and specifications prepared by, among others, HDR, Inc. (&#147;Landlord&#146;s Architect&#148;) as currently referenced on Exhibit <FONT STYLE="white-space:nowrap">10-1</FONT> hereto (the &#147;Base Building Plans&#148;) as performed by
Landlord, at Landlord&#146;s sole cost, which includes the delivery of certain systems and conditions to the general quality of the design of the Building as shown on the Base Building Plans. Landlord has submitted the Base Building Plans to Tenant
and Tenant has approved the Base Building Plans. As used herein, the term &#147;Tenant Improvement Work&#148; shall mean the leasehold improvements to the Premises to be constructed within the Premises by Landlord in accordance with the Space Plans
(as defined below) and the Plans (as defined below) to be prepared in accordance with this Section&nbsp;4.2 and as detailed and further allocated in the Base Building and TI Matrix attached hereto as Exhibit
<FONT STYLE="white-space:nowrap">10-2,</FONT> and as further set forth and detailed in the Base Building Plans. Notwithstanding anything in this Section&nbsp;4.2 to the contrary, the bathrooms located within the Premises shall be part of the Base
Building Shell Work and shall be constructed with Building standard materials and finishes and in accordance with the Base Building Plans unless Tenant selects different finishes and materials for such bathrooms located on the fourth (4<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) floor of the Building by written notice to Landlord on or before August&nbsp;1, 2018 setting forth in detail such finishes and materials and, so long as such finishes and materials (and/or the
installation thereof) do not result in a long lead time or other delay in Landlord&#146;s ability to obtain a temporary certificate of occupancy for base building occupancy (or occupancy by any other tenant, to the extent the costs of such finishes
and materials (and/or the installation thereof) selected by Tenant that exceeds the cost of Building standard materials and finishes, such cost shall be included in the cost of the Tenant Improvement Work (as provided herein). Landlord and Tenant
shall reasonably and promptly cooperate and coordinate efforts in connection with the sharing of information as to the actual cost of the Base Building Shell Work bathroom finishes and as to the timing and cost of such Tenant-selected finishes. In
connection with the Tenant Improvement Work, Tenant agrees to use BR+A for Tenant&#146;s mechanical, electrical and plumbing engineer to ensure the efficient coordination of the Base Building Shell Work and the Tenant Improvement Work. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Tenant has prepared and provided to Landlord, and Landlord has approved, a space plan and outline specifications (the &#147;Space
Plans&#148;) for the layout of the Tenant Improvement Work within the Building. The Tenant Improvement Work shall be delivered in <FONT STYLE="white-space:nowrap">Turn-Key</FONT> Condition (as defined below). As used herein, <FONT
STYLE="white-space:nowrap">&#147;Turn-Key</FONT> Condition&#148; shall mean the condition required by the Base Building Plans and the final Plans, prepared and approved as provided below, but in no event shall the Tenant Improvement Work include
Tenant&#146;s furniture, trade fixtures, equipment, personal property, data or communications cabling, specialty or laboratory equipment except as may be expressly agreed in writing and set forth thereon. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Based upon the approved Space Plans, Tenant shall promptly prepare and provide to Landlord, for Landlord&#146;s approval as provided
herein, a complete set of plans and specifications sufficient to apply for and obtain a building permit for the construction of the Tenant Improvement Work (the &#147;Permit Set&#148;). The Permit Set must conform to the approved Space Plans, the
Base Building Shell Work and the Base Building Plans in all material respects and be limited to the general quality of the design shown therein. Landlord&#146;s approval of the Permit Set shall not be unreasonably withheld, conditioned or delayed as
long as same are not Material Changes. Within five (5)&nbsp;days of receipt, Landlord shall give Tenant written notice either (a)&nbsp;approving the Permit Set or (b)&nbsp;disapproving the Permit Set (with highlighted changes thereon and a detailed
list of the deficiencies in the Permit Set). If Landlord disapproves the Permit Set, then, within five (5)&nbsp;days after Landlord gives Tenant notice of such disapproval, Tenant shall revise the Permit Set and resubmit the Permit Set to Landlord
for approval. Within five (5)&nbsp;days after Tenant&#146;s resubmission to Landlord of the revised Permit Set, Landlord shall give Tenant notice either (I)&nbsp;approving the revised Permit Set or (II)&nbsp;disapproving the revised Permit Set, in
which case Landlord, in such written notice, shall provide Tenant with detailed direction as to the modifications required to be made for Landlord to grant Landlord&#146;s approval to the Permit Set. The foregoing iterative process (and timing) set
forth in this Section&nbsp;4.2(d) shall continue in good </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
faith until Landlord approves the Permit Set, which shall be the final Permit Set. Tenant hereby acknowledges and agrees that if Landlord and Tenant fail to approve the final Permit Set on or
prior to August&nbsp;31, 2018, for any reason whatsoever, then such failure shall be deemed to be a Tenant Delay (and Tenant shall be responsible for the cost and schedule impact therefor), unless caused solely by Landlord&#146;s failure to act
reasonably as aforesaid or to respond to any submittals as expressly required hereunder. In addition, Tenant acknowledges and agrees that if the City of Boston Inspectional Services Department (&#147;ISD&#148;) has not approved the final Permit Set
on or prior to September&nbsp;30, 2018, then such failure shall be deemed to be an Event of Force Majeure, unless such approval delay was caused by the failure of the Permit Set to be in such form as to quality and detail as typically required by
ISD in which event same shall be a Tenant Delay. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Based upon the approved Permit Set Tenant shall promptly prepare and provide to
Landlord, for Landlord&#146;s approval as provided herein, 100% construction drawings (representing a complete set of final plans and specifications), sufficient to permit the construction of the Tenant Improvement Work (the &#147;Plans&#148;). The
Plans must conform to the Permit Set, the Base Building Shell Work and the Base Building Plans in all material respects and be limited to the general quality of the design shown therein.. Landlord&#146;s approval of the Plans shall not be
unreasonably withheld, conditioned or delayed as long as same are not Material Changes. Within ten (10)&nbsp;days of receipt, Landlord shall give Tenant written notice either (a)&nbsp;approving the Plans or (b)&nbsp;disapproving the Plans (with
highlighted changes thereon and a detailed list of the deficiencies in the Plans). If Landlord disapproves the Plans, then, within five (5)&nbsp;days after Landlord gives Tenant notice of such disapproval, Tenant shall revise the Plans and resubmit
the Plans to Landlord for approval. Within five (5)&nbsp;days after Tenant&#146;s resubmission to Landlord of the revised Plans, Landlord shall give Tenant written notice either (I)&nbsp;approving the revised Plans or (II)&nbsp;disapproving the
revised Plans, in which case Landlord, in such notice, shall provide Tenant with detailed direction as to the modifications required to be made for Landlord to grant Landlord&#146;s approval to the Plans. The foregoing iterative process (and timing)
set forth in this Section&nbsp;4.2(e) shall continue in good faith until Landlord approves the Plans, which shall be the final Plans. Tenant hereby acknowledges and agrees that if Landlord and Tenant fail to approve the final Plans on or prior to
September&nbsp;22, 2018, for any reason whatsoever, then such failure shall be deemed to be a Tenant Delay (and Tenant shall be responsible for the cost and schedule impact therefor), unless caused solely by Landlord&#146;s failure to act reasonably
as aforesaid or to respond to any submittals as expressly required hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Promptly following Landlord&#146;s approval (but in any
event within twenty (20)&nbsp;days thereafter) of each of the Space Plans and the Permit Set, as the case may be, Landlord shall deliver to Tenant an estimate of the costs to complete Tenant Improvement Work, including a construction or project
management fee payable to Landlord of three percent (3.0%) of the hard costs of the Tenant Improvement Work, (each, an &#147;Estimate&#148;). Tenant shall review and approve same, subject to the terms hereof, within ten (10)&nbsp;days of submission;
provided, however, Tenant shall have the right, exercised promptly and in good faith, to discuss and request substitutions to value-engineer or cost-engineer aspects of the work set forth on the Space Plans and the Permit Set, as the case may be,
during the review and approval process for each set of plans as provided above, in order to adjust the budget of the Tenant Improvement Work, subject to the terms and conditions hereof, in which case Landlord and Tenant shall work diligently and in
good faith to complete such value-engineering iterative process and produce a mutually acceptable Estimate within such period, or such longer period as may be reasonably necessary. Throughout the approval process described above, each party shall
use commercially reasonable and diligent efforts to cooperate with the other and the other&#146;s architect and professionals in responding to questions or requests for information or submissions. Tenant understands and agrees, however, that changes
to the Space Plans, the Permit Set or the Plans that may be needed or desired by Tenant, and or the specification by Tenant of any components or finishes that are not building standard or as expressly depicted on the Space Plans, the Permit Set or
Plans, shall be subject to Landlord&#146;s prior written approval, which shall not be unreasonably withheld or delayed as long as same are not Material Changes. As used herein, the term &#147;Material Changes&#148; as used herein are
(i)&nbsp;changes that, individually or in the aggregate, modify the scope, cost or character of the Base Building Shell Work, except in any de minimis respect, or any material component thereof from that set forth in the Base Building Plans, or any
then existing permits and approvals obtained by Landlord in connection with Landlord&#146;s Work or the Building; (ii)&nbsp;changes that will, individually or in the aggregate, in Landlord&#146;s reasonable opinion, result in a likelihood of delay
in the Substantial Completion of Landlord&#146;s Work; (iii)&nbsp;adversely affect by more than a <I>de minimis</I> amount the Building&#146;s structure, roof, or exterior or any mechanical, electrical, plumbing, life safety or other Building
Systems (as hereinafter defined) or architectural design or use of the Building or Premises or otherwise involve changes to structural components of the Building or involves any changes or penetrations to the floor, roof, or exterior walls;
(iv)&nbsp;require any material modifications of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Building&#146;s mechanical, electrical, plumbing, fire or life-safety systems; (v)&nbsp;lessen the fair market value of the Landlord&#146;s Work, the Building or the Premises or any other
improvements in the Complex; and/or (vi)&nbsp;adversely affect the LEED certifiability of the Building or any improvements therein or any LEED or similar certifications previously obtained with respect to the Building or any improvements therein. If
Landlord approves such change request (whether a Material Change or not), then before commencing work on such requested change or upgrade, Landlord will submit to Tenant written estimates of the net cost thereof (taking into account the Improvement
Allowance applicable to the Tenant Improvement Work) and any increase in the time in performing Landlord&#146;s Work resulting therefrom. If Tenant shall fail to approve such estimates within ten (10)&nbsp;days after submission to Tenant, the
request shall be deemed withdrawn by Tenant and Landlord shall not be required to proceed with such work and may continue with Landlord&#146;s Work without further change relating thereto. If Tenant approves such estimates, the cost of such change
in the Tenant Improvement Work shall be added to, or deducted from, the budget for the Tenant Improvement Work and shall be paid in accordance with Section&nbsp;4.2(j), which shall include all applicable fees including, without limitation
construction management fee for hard costs set forth above, general contractor&#146;s fees or increase in general conditions. If any such Tenant&#146;s proposed request (whether a Material Change or not) increases the time required to complete
Landlord&#146;s Work then same shall be considered a Tenant Delay (as defined below) and no such work shall commence unless Tenant agrees that the Substantial Completion Date (and the Term Commencement Date) shall be deemed to have occurred as of
the date Landlord would have otherwise achieved Substantial Completion the Tenant Improvement Work, but for Tenant&#146;s request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)
Following the completion and approval of the applicable plans and final estimate, Landlord shall proceed to engage Tenant&#146;s design team and contractors, and to obtain all necessary permits and approvals for the construction of Landlord&#146;s
Work, to engage a contractor or construction manager to perform or supervise the construction and proceed to construct Landlord&#146;s Work at Landlord&#146;s sole cost and expense subject to the Improvement Allowance applicable to the Tenant
Improvement Work (and Tenant&#146;s obligation to pay any amounts in excess thereof as set forth below) and as otherwise set forth herein, in substantial conformance with the Plans and in accordance with Section&nbsp;4.2(a) above. Landlord reserves
the right to make changes and substitutions to the Base Building Plans and the Plans in connection with the construction of Landlord&#146;s Work, provided same do not materially adversely modify (i)&nbsp;the Tenant Improvement Work or the cost
thereof or the estimated time to construct and delivery same (except with respect to a Tenant Delay as provided herein), (ii) Tenant&#146;s access to or use of the Premises for the Permitted Use upon delivery thereof to Tenant, or (iii)&nbsp;the
specified utility and HVAC capacities specified in the Base Building Plans or the final Plans, and Tenant agrees to not unreasonably withhold or delay its consent to any changes that do not materially adversely modify the Plans. Landlord&#146;s Work
will be constructed by Consigli Construction Company (&#147;Contractor&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) The Tenant Improvement Work (and the applicable
components of Base Building Shell Work required for Tenant&#146;s use and occupancy of the Premises, including but not limited to all Common Laboratory Facilities and Common Areas necessary and appropriate for Tenant&#146;s use thereof for the
Permitted Use and the Amenity Center) shall be deemed &#147;Substantially Complete&#148; on the date (the &#147;Substantial Completion Date&#148;) as of which: (i)&nbsp;a completed or <FONT STYLE="white-space:nowrap">&#147;signed-off&#148;</FONT>
building permit or a certificate of occupancy (temporary or permanent) permitting the use of the Premises is available from the City of Boston Inspectional Services Department (the &#147;Certificate of Occupancy&#148;); provided, however, any
conditional Certificate of Occupancy shall not impose conditions relating to Landlord&#146;s obligations hereunder (e.g., Landlord&#146;s Work) that materially interfere with Tenant&#146;s use and occupancy of the Premises for the Permitted Use and
Landlord shall obtain an final Certificate of Occupancy for the Premises in the ordinary course (subject to Tenant completing any items of work or requirements that are not part of Landlord&#146;s Work); (ii) all Building Systems serving the
Premises are in good working order, condition, and repair; (iii)&nbsp;the Premises and the Common Areas serving the Premises are in compliance with all legal requirements of general applicability to the Complex (including without limitation the
Americans with Disabilities Act and all governmental permits and approvals if and to the extent so applicable, which shall be obtained by Landlord); and (iv)&nbsp;The Tenant Improvement Work (and the applicable components of Base Building Shell Work
required for Tenant&#146;s use and occupancy of the Premises) are substantially complete, except for the Punchlist Work (as hereinafter defined), which shall be set forth on the Punchlist (as hereinafter defined), subject only to the completion of
Punchlist Work (defined below). Notwithstanding the foregoing, if any delay in the Substantial Completion of the Landlord&#146;s Work by Landlord is due to Tenant Delays, then the Substantial Completion Date shall be deemed to be the date
Landlord&#146;s Work (or applicable portion thereof) would have been Substantially Complete, if not for such Tenant Delays, as reasonably determined by Landlord. &#147;Tenant Delays&#148; shall mean delays caused by: (i)
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
requirements of the Space Plans or Plans requested by Tenant that do not conform to Landlord&#146;s building standards for build out, or which contain long lead-time or <FONT
STYLE="white-space:nowrap">non-standard</FONT> items requested by Tenant; (ii)&nbsp;any Material Change in the Space Plans or Plans, once approved, requested by Tenant; (iii)&nbsp;any written request by Tenant for a delay in the commencement or
completion of Landlord&#146;s Work for any reason; or (iv)&nbsp;any other act or omission of Tenant or its employees, agents or contractors, including any failure by Tenant to timely respond to plan submissions and approvals for the Tenant
Improvement Work pursuant to the iterative process described in Sections 4.2(c) through (f), which reasonably inhibits the Landlord from timely completing the Landlord&#146;s Work, and which continues for more than three (3)&nbsp;business days
following Landlord&#146;s notice to Tenant thereof. To the extent any Tenant Delay causes or is likely to cause a delay in the issuance of Landlord&#146;s base Building Certificate of Occupancy or Temporary Certificate of Occupancy, Tenant
understands that such a Tenant Delay may result in a delay due to a necessary reallocation of Base Building Shell Work in order to obtain such base Building Certificate of Occupancy or Temporary Certificate of Occupancy for the Building and any such
delay hereunder resulting therefrom shall also be considered a Tenant Delay (e.g., the impact of a Tenant Delay would necessitate the rescheduling of component(s) of Landlord&#146;s Work to avoid a delay in the completion or performance of a
component of Base Building Shell Work necessary to obtain a Temporary Certificate of Occupancy inspection or <FONT STYLE="white-space:nowrap">sign-off</FONT> and such delay would be a Tenant Delay). For purposes hereof, &#147;Punchlist Work&#148; is
defined as minor or insubstantial incomplete work or details or defects of construction, decoration or mechanical adjustments that do not unreasonably interfere Tenant&#146;s ability to use or occupy the Premises for the Permitted Use. If as a
result of Tenant Delays the Substantial Complete Date is deemed to have occurred, but the Premises are not in fact actually ready for Tenant&#146;s occupancy, Tenant shall not (except with Landlord&#146;s consent not to be unreasonably withheld,
conditioned or delayed) be entitled to take possession of the Premises for the Permitted Use until the Premises are in fact actually ready for such occupancy. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Within fourteen (14)&nbsp;business days after the Term Commencement Date or earlier if practical, Landlord and Tenant shall confer and
create a specific list of any Punchlist Work remaining items of work with respect to the Tenant Improvement Work including those portions of Landlord&#146;s Work relating thereto including but not limited to the Base Building Shell Work (including
the Common Laboratory Facilities and Common Areas) (a &#147;Punchlist&#148;) which Punchlist Work shall be completed as soon as reasonably practicable, with Landlord endeavoring to complete same within thirty (30)&nbsp;days following the Substantial
Completion Date; provided, however, that if any item of Punchlist Work is not completed within forty-five (45)&nbsp;days of the creation of the Punchlist, Landlord shall provide Tenant with a detailed description of the item to be completed, reason
for such completion delay and the estimate of such completion. Subject to Landlord&#146;s continuing repair and maintenance obligations hereunder and to Section&nbsp;4.5 below and to Landlord&#146;s warranty obligations in this Section&nbsp;4.2(i),
except with respect to the items contained in the Punchlist or items that are not readily observable or hidden (i.e., latent) defects even upon exercise of reasonable diligence, Tenant shall be deemed satisfied with the Tenant Improvement Work
including those portions of Landlord&#146;s Work relating thereto, and Landlord shall be deemed to have completed all of its obligations under this Section&nbsp;4.2 and Tenant shall have no claim that Landlord has failed to perform in full its
obligations hereunder. In addition, Tenant shall have the benefit of the construction warranty with respect to defects to Landlord&#146;s Work brought to Landlord&#146;s attention within the Landlord&#146;s Warranty Period (as defined below).
Landlord shall warrant for a period of twelve (12)&nbsp;months after the Substantial Completion Date (or thereafter while Landlord has the benefit of a guarantee or warranty for such work) (&#147;Landlord&#146;s Warranty Period&#148;) that the
Tenant Improvement Work and the applicable components of the Base Building Shell Work relating thereto have been constructed in a good and workerlike manner and free of material defects. In addition, Landlord shall either assign, to the extent
assignable, the warranties and guaranties applicable to or for any appliances and equipment exclusively serving the Premises (and part of the Tenant Improvement Work) and/or use commercially reasonable and diligent efforts to enforce such warranties
and guaranties (and any other warranties and guaranties applicable to the Premises) in connection therewith for the benefit of Tenant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)
Landlord shall pay the costs and expenses incurred by Landlord in connection with the performance and completion of the Tenant Improvement Work in accordance with the Plans in an amount up to but in no event more than the Improvement Allowance as
set forth in Exhibit 1 above (the &#147;Improvement Allowance&#148;). The Improvement Allowance may not be used for any furniture, personal property, movable equipment, or data or telecommunications cabling. Landlord may include within the
Improvement Allowance all reasonable, third party, actual <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred by or on behalf of Landlord in connection with the Tenant Improvement
Work (but not the Base Building Shell Work, except as set forth in Exhibit <FONT STYLE="white-space:nowrap">10-2)</FONT> including without limitation, all design, review, permitting, bid preparation and bid review, construction, materials and
supplies, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including a construction or project management fee payable to Landlord of three percent (3%) of the hard costs of the Tenant Improvement Work; provided, however, that Landlord shall not charge
Tenant for any BR+A &#147;MEP&#148; review for the interface and interconnection of the Tenant Improvement Work with the Base Building Shell Work. Landlord shall use the Improvement Allowance to pay for, credit, and offset all of the hard and/or
soft costs and expenses in connection with the Tenant Improvement Work as aforesaid. Any costs of the Tenant Improvement Work that are in excess of the Improvement Allowance incurred by Landlord shall be the sole responsibility of Tenant and Tenant
shall be responsible for and promptly (but in no event longer than thirty (30)&nbsp;days after request therefor) pay directly or pay to Landlord for, as appropriate, and indemnify and reimburse Landlord for, from and against, any costs and expenses
for the Tenant Improvement Work in excess of the Improvement Allowance including, but not limited to, such costs resulting from Tenant&#146;s upgrades from building standard construction materials or Tenant&#146;s upgrades or changes to any of
Landlord&#146;s Work or the Plans or specifications relating thereto. To the extent the total costs and expenses of the Tenant Improvement Work are less than the Improvement Allowance, there shall be no credit, rebate or other payment to Tenant as a
result thereof. At Landlord&#146;s option, at any time following the completion and approval of the Plans, Landlord shall deliver to Tenant an estimate of the costs to complete the Tenant Improvement Work (the &#147;Estimate&#148;) and at least ten
(10)&nbsp;days prior to commencement of construction of the Tenant Improvement Work, Tenant shall pay, subject to a commercially reasonable escrow arrangement (with Landlord and Tenant acknowledging that East Boston Savings Bank is an acceptable
escrow agent therefor), as Additional Rent, the amount by which the Estimate exceeds the Improvement Allowance as set forth herein (the &#147;Excess Payment&#148;). The cost of the Tenant Improvement Work shall be disbursed and paid on a <I>pari
passu</I> basis with Landlord contributing its proportionate share of the Improvement Allowance and Tenant&#146;s contribution being deducted from the Excess Payment held in escrow. Within sixty (60)&nbsp;days (or such longer period as reasonably
necessary) of the Substantial Completion Date, defined below, Landlord shall provide Tenant with a statement setting forth the actual costs of Tenant Improvement Work and (i)&nbsp;if the actual costs are less than the sum of the Estimate and the
Excess Payment, Landlord shall credit such amount, up to a maximum of the Excess Payment, against future payments of Yearly Rent or (ii)&nbsp;if the actual costs are greater than the sum of the Estimate and the Excess Payment, Tenant shall pay to,
reimburse and/or indemnify, as the case may be, Landlord for or from the difference, as Additional Rent, within thirty (30)&nbsp;business days after the receipt of such statement. The completion of the Tenant Improvement Work shall be conducted on a
<FONT STYLE="white-space:nowrap">so-called</FONT> &#147;open book&#148; basis meaning that Landlord shall share and consult with Tenant, upon request, regarding the costs and expenses relating to the completion of the Tenant Improvement Work. In
connection with any materials or services to be provided directly by or on behalf of Tenant (as opposed to Landlord), Tenant shall make provision for written waivers of liens from all contractors, laborers and suppliers of materials for such work,
or other reasonably appropriate protective measures reasonably approved by Landlord. Upon reasonable notice of at least two (2)&nbsp;business days, Landlord shall permit Tenant to review Landlord&#146;s invoices and statements and books and records
relating to the completion of the Tenant Improvement Work. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Supplemental Allowance. Landlord will make available to Tenant an
additional allowance up to the amount as set forth in Exhibit 1 above (the &#147;Supplemental Allowance&#148;) for the payment of Tenant&#146;s <FONT STYLE="white-space:nowrap">fit-up</FONT> and space planning services relating to the Tenant
Improvement Work. The Supplemental Allowance shall be paid to Tenant in one (1)&nbsp;lump sum payment following Landlord&#146;s receipt of (a)&nbsp;paid third party invoices (with satisfactory evidence of payment and other supporting material) for
the design, engineering and/or project management services incurred by Tenant for the Tenant Improvement Work, and (b)&nbsp;if requested by Landlord, lien waivers reasonably satisfactory to Landlord from the project manager or any others performing
the work or supplying the labor or material. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Tenant hereby appoints Jeff Stevens as the authorized representative of Tenant for
purposes of dealing with Landlord and its agents with respect to all matters involving, directly or indirectly, the construction of the Tenant Improvement Work including, without limitation, change orders to the Space Plans or Plans (such person is
hereinafter referred to as &#147;Tenant&#146;s Representative&#148;). Landlord hereby appoints Chris Murphy, as the authorized representative of Landlord for purposes of dealing with Tenant and its agents with respect to all matters involving,
directly or indirectly, the construction of Base Building Shell Work, the Tenant Improvement Work, or the Space Plans, or the Plans (such person is hereinafter referred to as &#147;Landlord&#146;s Representative&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) All components of the Tenant Improvement Work shall be part of the Building, except only
for such items as Landlord advises in writing to Tenant that same shall be removed by Tenant on the termination of this Lease (such writing to be provided to Tenant at the time of Landlord&#146;s applicable approval of the plans and specifications
therefor) that same shall be removed by Tenant on the termination of this Lease (which items shall include, by way of example and not limitation internal staircases unless Landlord elects, in its sole discretion, for same to remain, which election
shall be made in writing at least one hundred twenty (120)&nbsp;days prior to the expiration of the Lease Term). Notwithstanding the forgoing, those items of personal property, trade fixtures and equipment to be set forth on Exhibit 15 attached
hereto, which may be updated from time to time to include such items, and those articles of personal property, including but not limited to copiers and computers; unattached laboratory and specialty equipment; unattached casework; bottle washers;
autoclaves; telecommunications equipment; cabling; and any equipment or utility connections necessary for the function of the foregoing, owned or installed by or for Tenant solely at its expense (i.e., and not paid for by the Improvement Allowance
or the Supplemental Allowance) in the Premises (&#147;Tenant&#146;s Removable Property&#148;) shall remain the property of Tenant and may be removed by Tenant at any time prior to the expiration or earlier termination of the Lease, subject to
Tenant&#146;s repair and restoration obligations in this Lease. For the purposes of clarity, Landlord and Tenant acknowledge and agree that any component of the Tenant Improvement Work or Tenant&#146;s Removable Property that is paid for by or on
behalf of Landlord (e.g., by way of the Improvement Allowance, the Supplemental Allowance, etc.) shall remain with the Building upon the termination or expiration of the Lease Term except to the extent advised by Landlord in writing at the time of
approval of the Plans including such component(s) to the contrary as set forth above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <B>Tenant&#146;s Early Entry.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provided that Tenant does not interfere with or delay the completion by Landlord or its agents or contractors of Landlord&#146;s Work, Tenant
shall have the right to enter the Premises up to thirty (30)&nbsp;days prior to the Anticipated Term Commencement Date for the purpose of installing furniture, trade fixtures, equipment, telecommunication equipment and cabling, and similar items and
such entry shall be made in compliance with, and subject to, all terms and conditions of this Lease (except as set forth herein) and the Rules and Regulations then in effect for the Building and shall be coordinated with Landlord&#146;s building
manager. Tenant shall be liable for any damages or delays caused by Tenant&#146;s activities at the Premises. Provided that Tenant has not begun operating its business from the Premises, and subject to all of the terms and conditions of the Lease,
the foregoing activity shall not constitute the delivery of possession of the Premises to Tenant and the Lease term shall not commence as a result of said activities. Prior to entering the Premises Tenant shall obtain all insurance it is required to
obtain by the Lease and shall provide certificates of said insurance to Landlord and shall have provided the Letter of Credit to Landlord. Tenant shall coordinate such entry with Landlord&#146;s building manager. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <B>Tenant</B><B>&#146;</B><B>s Work.</B><B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall perform, at its expense, and subject to the terms and conditions of this Lease, the work and installations (other than
Landlord&#146;s Work) necessary or desirable for Tenant to operate at the Premises (&#147;<U>Tenant&#146;s Work</U>&#148;). Tenant shall be liable for any damages or delays caused by Tenant&#146;s activities at the Premises in connection with
Tenant&#146;s Work. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <B>Conclusiveness of Landlord&#146;s Performance.</B> Subject to Section&nbsp;4.2(i) above and to Landlord&#146;s
maintenance and repair obligations hereunder, Tenant shall be conclusively deemed to have agreed that Landlord has performed all of its obligations under this Article 4 unless not later than the end of the first calendar month next beginning after
the Term Commencement Date Tenant shall give Landlord written notice specifying the respects in which Landlord has not performed any such obligation. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>USE OF PREMISES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <B>Permitted Use.</B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>Tenant shall during the Term hereof occupy and use the Premises only for the purposes as stated in Exhibit 1 and for no other purposes.
Service and utility areas (whether or not a part of the Premises) shall be used only for the particular purpose for which they were designed. Notwithstanding the foregoing, but subject to the other terms and provisions of this Lease, Tenant may,
with Landlord&#146;s prior written consent, which consent shall not be unreasonably withheld, conditioned, or delayed, install at its own cost and expense <FONT STYLE="white-space:nowrap">so-called</FONT>
<FONT STYLE="white-space:nowrap">hot-cold</FONT> water fountains, coffee makers </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and <FONT STYLE="white-space:nowrap">so-called</FONT> Dwyer refrigerator-sink-stove combinations for the preparation of beverages and foods (or such other installations as indicated on the Plans
for the Tenant Improvement Work), provided that no cooking, frying, etc., are carried on in the Premises to such extent as requires special exhaust venting, Tenant hereby acknowledging that the Building is not engineered to provide any such special
venting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, subject to the terms and conditions hereof (including the plan review process described above and Article 12 below), Tenant shall
have the right, at its sole risk, cost and liability, to construct and operate a vivarium in connection with its operations at the Premises. The vivarium permitted to be operated shall be located in the designated portion of the Premises as shown on
the Plans (or in subsequent plans for Alterations (as defined below)) and shall be used for biopharmaceutical research and development and for the handling, research, and testing of rodents only (the &#147;Permitted Animals&#148;) in connection
therewith, and for no other purpose or use. If Tenant proposes to use any animals other than the Permitted Animals in its operations, it shall first obtain the prior written consent of Landlord, which consent Landlord shall not unreasonably
withhold, condition, or delay. Animal testing, solely of Permitted Animals, shall be permitted subject to the following: (a)&nbsp;all testing shall be conducted in strict compliance with all applicable governmental rules and regulations and with
good scientific and medical practice; (b)&nbsp;all dead animals, any part thereof or any waste products related thereto, shall be disposed of, at Tenant&#146;s sole cost and expense, in strict compliance with all applicable governmental rules and
regulations and with good scientific and medical practice; (c)&nbsp;no odors, noises or any similar nuisance shall be permitted to emanate from or permeate beyond the Premises; and (d)&nbsp;Tenant&#146;s use of the vivarium shall not interfere with
the peaceable and quiet use and enjoyment by other tenants or occupants of the Building of their respective premises in the Building. Tenant shall procure and deliver to Landlord copies of all necessary permits and approvals necessary for the use
and operation of the vivarium and the keeping of Permitted Animals before allowing any actual Permitted Animals into the Premises and shall maintain such permits and approvals during the Lease term. Tenant shall defend, save harmless, exonerate and
indemnify Landlord from all injury, claim, loss or damage to any person or property occasioned by or growing out of the use and operation of the vivarium and the presence of the Permitted Animals in and about the Premises; provided, however, that
the foregoing indemnity and/or Subsection (d)&nbsp;shall not include or apply to acts of protest, objection, etc. by or on behalf of individuals or groups relating to Tenant&#146;s use of the vivarium otherwise in compliance with this provision.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <B></B><B>Prohibited Uses.</B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>Notwithstanding any other provision of this Lease, Tenant shall not use, or suffer or permit the use or occupancy of, or suffer or
permit anything to be done in or anything to be brought into or kept in or about the Premises or the Building or any part thereof (including, without limitation, any materials, appliances or equipment used in the construction or other preparation of
the Premises and furniture and carpeting): (a) which would violate any of the covenants, agreements, terms, provisions and conditions of this Lease or the Rules and Regulations; (b)&nbsp;for any unlawful purposes or in any unlawful manner;
(c)&nbsp;which, in the reasonable judgment of Landlord shall in any way (i)&nbsp;impair the appearance of the Building; or (ii)&nbsp;impair, interfere with or otherwise diminish the quality of any of the Building services or the proper and economic
heating, cleaning, ventilating, air conditioning or other servicing of the Building or Premises, or with the use or occupancy of any of the other areas of the Building, or occasion discomfort, inconvenience, or injury or damage to any occupants of
the Premises or other tenants or occupants of the Building; (iii)&nbsp;which is inconsistent with the maintenance of the Building as a comparable first-class life science buildings in the Seaport District of Boston, Massachusetts<B> </B>(including
laboratory); or (iv)&nbsp;which would violate any exclusive use or right granted by Landlord to any tenant or occupant of the Building in effect as of the date of this Lease and of which Landlord has provided Tenant prior written notice. As of the
date of this Lease, the current exclusive use rights granted in the Building are as follows (&#147;Current Exclusive&#148;): in no event shall Tenant or any party taking by or through Tenant use (or allow or allow the use of) the Premises (or any
portion thereof) for the primary and principal commercial business purpose of leasing, licensing or granting occupancy rights and licenses to unrelated, third party biotechnology or life science users or to similar third party users for service
extensions for third party manufacturing, diagnostics, vivarium, engineering electronics and/or medical services, including but not limited to commercial,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-service</FONT></FONT> incubator, accelerator, shared-community space, self-service and/or demonstration and pilot facilities, and any violation of the foregoing that does not
cease within ten (10)&nbsp;business days after written notice from Landlord shall constitute an incurable Event of Default hereunder; provided, however, that the foregoing shall not apply to (x)&nbsp;Tenant (or any party taking by or through Tenant)
using the Premises to conduct or perform third party testing, laboratory work or services for or with other parties, such as an independent testing firm or research company, (y)&nbsp;Tenant (or any party taking by or through Tenant) using the
Premises to perform research, diagnostics, manufacturing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or other related services for third parties on a contract or other basis, or (z)&nbsp;Tenant (or any party taking by or through Tenant) allowing the Premises to be used by their affiliates,
subsidiaries, clients, partners, venturers, spin-offs and the like to share laboratory or other space or services so long as the sharing of such space or services, as opposed to the relationship with such entities, is not the primary and principal
business of such tenant or occupant. Tenant shall not install or use any electrical or other equipment of any kind which causes any such impairment, interference, discomfort, inconvenience or injury to any other tenant or occupant of the Building.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <B>Licenses and Permits.</B> Tenant shall not cause or permit the Premises, the Building or the Complex to be used in any way that
violates any law, code, ordinance, restrictive covenant, encumbrance, governmental regulation, order, permit, approval, variance, covenants or restrictions of record or any provision of the Lease (each a &#147;Legal Requirement&#148;), interferes
with the rights of tenants of the Building, or constitutes a nuisance or waste. Tenant shall obtain, maintain and pay for all permits and approvals and shall promptly take all actions necessary to comply with all Legal Requirements, including,
without limitation, the Occupational Safety and Health Act, applicable to Tenant&#146;s use of the Premises, the Building or the Complex. Tenant shall maintain in full force and effect all certifications or permissions to provide its services
required by any authority having jurisdiction to authorize, franchise or regulate such services. Tenant shall be solely responsible for procuring and complying at all times with any and all necessary permits and approvals directly or indirectly
relating or incident to: the conduct of its activities on the Premises; its scientific experimentation, transportation, storage, handling, use and disposal of any chemical or radioactive or bacteriological or pathological substances or organisms or
other hazardous wastes or environmentally dangerous substances or materials or medical waste or animals or laboratory specimens. Within ten (10)&nbsp;days of a written request by Landlord, which request shall be made not more than once during each
period of twelve (12)&nbsp;consecutive months during the Term hereof, unless otherwise requested by any mortgagee of Landlord, Tenant shall furnish Landlord with copies of all such permits and approvals that Tenant possesses or has obtained together
with a certificate certifying that such permits are all of the permits that Tenant possesses or has obtained with respect to the Premises. Tenant shall promptly give written notice to Landlord of any written warnings or violations relative to the
above received from any federal, state or municipal agency or by any court of law and shall promptly cure the conditions causing any such violations. Tenant shall not be deemed to be in default of its obligations under the preceding sentence to
promptly cure any condition causing any such violation in the event that, in lieu of such cure, Tenant shall contest the validity of such violation by appellate or other proceedings permitted under applicable law, provided that: (a)&nbsp;any such
contest is made reasonably and in good faith, (b)&nbsp;Tenant makes provisions, including, without limitation, posting bond(s) or giving other security, reasonably acceptable to Landlord to protect Landlord, the Building and the Complex from any
liability, costs, damages or expenses arising in connection with such violation and failure to cure, (c)&nbsp;Tenant shall agree to indemnify, defend (with counsel reasonably acceptable to Landlord) and hold Landlord harmless from and against any
and all liability, costs, damages, or expenses arising in connection with such condition and/or violation, (d)&nbsp;Tenant shall promptly cure any violation in the event that its appeal of such violation is overruled or rejected, and
(e)&nbsp;Tenant&#146;s decision to delay such cure shall not, in Landlord&#146;s sole but good faith determination, be likely to result in any actual or threatened bodily injury, property damage, or any civil or criminal liability to Landlord, any
tenant or occupant of the Building or the Complex, or any other person or entity. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the Term of this Lease, the Yearly Rent and other charges due from Tenant hereunder, at the rate stated in Exhibit 1, shall be payable
by Tenant to Landlord by monthly payments, as stated in Exhibit 1, in advance and without notice or demand on the first day of each month for and in respect of such month. The rent and other charges reserved and covenanted to be paid under this
Lease shall accrue and commence on the Term Commencement Date, subject to the Abated Rent Period. Notwithstanding the provisions of the immediately preceding sentence, Tenant shall pay the first monthly installment of rent at least three
(3)&nbsp;months prior to the Term Commencement Date. If, by reason of any provisions of this Lease, the rent reserved hereunder shall commence or terminate on any day other than the first day of a calendar month, the rent for such calendar month
shall be prorated. The rent and all other amounts payable to Landlord under this Lease shall be payable to Landlord, or if Landlord shall so direct in writing, to Landlord&#146;s agent or nominee, in lawful money of the United States which shall be
legal tender for payment of all debts and dues, public and private, at the time of payment, at the Rent Payment Address set forth in Exhibit 1 or such place as Landlord may designate, and the rent and other charges in all circumstances shall be
payable without any setoff or deduction whatsoever, except as expressly provided in this Lease. <B></B>Rental and any other sums due hereunder not paid </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on or before the date due shall bear interest for each month or fraction thereof from the due date until paid computed at the annual rate of five percentage (5%) points over the <FONT
STYLE="white-space:nowrap">so-called</FONT> prime rate then currently from time to time charged to its most favored corporate customers by the largest national bank (N.A.) located in the city in which the Building is located, or at any applicable
lesser maximum legally permissible rate for debts of this nature. Notwithstanding the foregoing, Landlord shall waive the aforesaid interest charge as to any such late payment so long as Tenant is not otherwise in default of its obligations under
this Lease (beyond any applicable notice or cure period) and such payment is made within five (5)&nbsp;business days following any required written notice to Tenant that such payment is past due and Tenant has not been more than five
(5)&nbsp;business days late in paying any other amount due Landlord hereunder within the calendar year in which such late payment has occurred. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RENTABLE AREA </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total Rentable Area of the Premises and the Building are agreed to be the amounts set forth in Exhibit 1. Landlord shall have no right to
remeasure the Premises or the Building except for alterations to the Premises or the Building, as the case may be, that alter the rentable area thereof. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SERVICES FURNISHED BY LANDLORD </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 <B>Electric Current.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
The electrical service (e.g., lights, plugs, equipment, convenience outlets, and heating, <FONT STYLE="white-space:nowrap">air-conditioning,</FONT> ventilation fixtures and equipment initially installed in the Premises and all other systems
exclusively serving the Premises) serving the Premises originally demised hereunder shall be either separately metered or sub or check metered, as part of the Tenant Improvement Work, to measure Tenant&#146;s consumption of electricity. If such
electrical service is separately metered, Tenant shall pay directly to the utility supplier all directly billed electrical service charges before delinquency. If such electrical service is sub or check metered, Landlord shall calculate the
electrical service charge based on Tenant&#146;s actual usage of electricity and Tenant shall pay same to Landlord, as Additional Rent, within thirty (30)&nbsp;days of billing therefor. Landlord shall ensure that, upon delivery, the Premises shall
be supplied with electrical service consistent with that shown on Exhibit <FONT STYLE="white-space:nowrap">10-2</FONT> attached hereto throughout the Lease Term, subject to the terms and conditions hereof (e.g., event(s) of Force Majeure, casualty
or condemnation). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If such electrical service is sub or check metered, Landlord may elect to collect the electrical service charge due
hereunder in monthly estimated payments (as reasonably estimated by Landlord from time to time), due at the same time and in the same manner that it pays its monthly payments of Yearly Rent hereunder, estimated payments (i.e., based upon
Landlord&#146;s reasonable estimate) on account of Tenant&#146;s obligation to reimburse Landlord for electricity consumed in the Premises. Periodically after the Term Commencement Date, but in any event at least once in any twelve (12)&nbsp;month
period during the Term, Landlord shall determine the actual cost of electricity consumed by Tenant in the Premises (i.e., by reading Tenant&#146;s <FONT STYLE="white-space:nowrap">sub-meter</FONT> and by applying the applicable electric rate). If
the total of Tenant&#146;s estimated monthly payments on account of such period is less than the actual cost of electricity consumed in the Premises during such period, Tenant shall pay the difference to Landlord within thirty (30)&nbsp;days of
billing therefor. If the total of Tenant&#146;s estimated monthly payments on account of such period is greater than the actual cost of electricity consumed in the Premises during such period, Tenant may credit the difference against its next
installment of rental or other charges due hereunder, or may request that Landlord pay such amount to Tenant in which case Landlord shall so pay to Tenant within thirty (30)&nbsp;days after Tenant&#146;s written request therefor. After each
adjustment, as set forth in Paragraph (a)&nbsp;above, the amount of estimated monthly payments on account of Tenant&#146;s obligation to reimburse Landlord for electricity in the Premises shall be adjusted based upon the actual cost of electricity
consumed during the immediately preceding period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If Landlord is furnishing Tenant electric current hereunder, Landlord, at any time,
at its option and upon not less than sixty (60)&nbsp;days&#146; prior written notice to Tenant, may discontinue such furnishing of electric current to the Premises; and in such case Tenant shall contract with the company supplying electric current
for the purchase and obtaining by Tenant of electric current directly from such company. In the event Tenant itself contracts for electricity with the supplier, pursuant to Landlord&#146;s option as above stated, Landlord shall (i)&nbsp;permit its
risers, conduits and feeders to the extent available, suitable and safely capable, to be used for the purpose of enabling Tenant to purchase and obtain electric current directly from such company, (ii)&nbsp;without cost or charge to Tenant, make
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such alterations and additions to the electrical equipment and/or appliances in the Building as such company shall specify for the purpose of enabling Tenant to purchase and obtain electric
current directly from such company, and (iii)&nbsp;at Landlord&#146;s expense, furnish and install in or near the Premises any necessary metering equipment used in connection with measuring Tenant&#146;s consumption of electric current and Tenant,
at Tenant&#146;s expense, shall maintain and keep in repair such metering equipment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If Tenant shall require electric current for use
in the Premises in excess of the amount Landlord is required to deliver to the Premises and shown on Exhibit <FONT STYLE="white-space:nowrap">10-2</FONT> and if (i)&nbsp;in Landlord&#146;s reasonable judgment, Landlord&#146;s facilities are
inadequate for such excess requirements or (ii)&nbsp;such excess use shall result in an additional burden on the Building air conditioning system and additional cost to Landlord on account thereof, then, as the case may be, (x)&nbsp;Landlord, upon
written request and at the sole cost and expense of Tenant, will furnish and install such additional wire, conduits, feeders, switchboards and appurtenances as reasonably may be required to supply such additional requirements of Tenant if current
therefor be available to Landlord, provided that the same shall be permitted by applicable laws and insurance regulations and shall not cause damage to the Building or the Premises or cause or create a dangerous or hazardous condition or entail
excessive or unreasonable alterations or repairs or unreasonably interfere with or disturb other tenants or occupants of the Building or (y)&nbsp;Tenant shall reimburse Landlord for such additional cost, as aforesaid. Tenant acknowledges that it has
been provided with an opportunity to confirm that the electric current serving the Premises will be adequate to supply its proposed permitted uses of the Premises. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Landlord, at Tenant&#146;s expense and upon Tenant&#146;s written request, shall install all replacement lamps of types generally
commercially available (including, but not limited to, incandescent and fluorescent, but excluding specialty lamps and fixtures) used in the ancillary/accessory office portion(s) of the Premises (excluding laboratory portions thereof). Landlord
shall have the right to elect, upon reasonable written notice, to cease the installation of lamps hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To the maximum extent
this agreement may be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#146;s insurance requirements hereunder and Section&nbsp;15 and Article 19, Landlord shall not in any way
be liable or responsible to Tenant for any loss, damage or expense which Tenant may sustain or incur if the quantity, character, or supply of electrical energy is changed or is no longer available or suitable for Tenant&#146;s requirements, subject
to Section&nbsp;8.8 below. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Tenant agrees that it will not make any material alteration or material addition to the electrical
equipment and/or appliances in the Premises without the prior written consent of Landlord in each instance first obtained, which consent will not be unreasonably withheld, conditioned, or delayed, and using contractor(s) reasonably approved by
Landlord, which approval will not be unreasonably withheld, conditioned, or delayed, and will promptly advise Landlord of any other alteration or addition to such electrical equipment and/or appliances. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <B>Water</B><B>. </B>Landlord shall furnish hot and cold water for ordinary use for cleaning, toilet, lavatory and drinking purposes for
restrooms and facilities in the Common Areas. In addition, Landlord will stub an additional cold water line to the Premises (as part of the Base Building Shell Work) for Tenant&#146;s distribution and use within the Premises for ordinary use for
cleaning, toilet, lavatory and drinking purposes for restrooms and facilities therein (which distribution, heating, treatment, etc. shall be included in the scope (and cost) of Tenant Improvement Work as and to the extent set forth in the Plans). If
Tenant requires. uses or consumes water for any purpose other than for the aforementioned purposes in the Premises, Landlord shall install a water meter and thereby measure Tenant&#146;s water consumption for all purposes. Tenant shall pay the cost
of the meter and the cost of installation thereof and shall keep said meter and installation equipment in good working order and repair. Tenant agrees to pay for water consumed, as shown on said meter, together with the sewer charge based on said
meter charges, as and when bills are rendered, and on default in making such payment Landlord may pay such charges and collect the same from Tenant. All piping and other equipment and facilities for use of water outside the building core will be
installed as part of the Tenant Improvement Work and maintained by Landlord at Tenant&#146;s sole cost and expense; provided, however, that such piping and other equipment and facilities are used solely for Tenant&#146;s water usage (otherwise, such
maintenance shall be considered Operating Costs). Notwithstanding anything in this Lease to the contrary, if a water meter is installed as contemplated in this Section&nbsp;8.2, then there shall be an equitable reduction to the water service charges
included within Operating Costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <B>Elevators, Heat and Cleaning</B><B>.</B> Landlord shall: (a)&nbsp;provide necessary
elevator facilities (as provided in the Plans) substantially equivalent to those being furnished in comparable first-class research and development buildings located in the Seaport District of the City of Boston, Massachusetts (which shall be
automatically operated) on Mondays through Fridays, excepting Federal, Massachusetts and City of Boston legal holidays, from 7:00 a.m. to 7:00 p.m. and on Saturdays, excepting Federal, Massachusetts and City of Boston legal holidays, from 8:00 a.m.
to 3:00 p.m. (called &#147;business days&#148;) and have one (1)&nbsp;elevator in operation available for Tenant&#146;s use, <FONT STYLE="white-space:nowrap">non-exclusively,</FONT> together with others having business in the Building, at all other
times throughout the Term; (b)&nbsp;furnish heat, air conditioning and ventilation (substantially equivalent to that being furnished in comparable research and development buildings located in the Seaport District of the City of Boston,
Massachusetts) to the interior Common Areas of the Building during the foregoing times on business days; and (c)&nbsp;cause the interior Common Areas of the Building to be cleaned on Monday through Friday (excepting Federal, Massachusetts or City of
Boston legal holidays) in a manner consistent with cleaning standards generally prevailing in comparable research and development buildings located in the Seaport District of the City of Boston, Massachusetts. All costs and expenses incurred by
Landlord in connection with foregoing services shall be included as part of the Operating Costs (as defined below). Tenant shall be responsible, at its sole cost and expense, for providing cleaning and janitorial services to the Premises in a neat
and first-class manner consistent with the cleaning standards generally prevailing in comparable first-class life science buildings in the Seaport District of Boston, Massachusetts or as otherwise reasonably established by Landlord in writing from
time to time using an insured contractor or contractors selected by Tenant and reasonably approved in writing by Landlord and such provider shall not interfere with the use and operation of the Building or Land by Landlord or any other tenant or
occupant thereof. Tenant shall also cause all extermination of vermin in the Premises to be performed by companies reasonably approved by Landlord in writing and shall contract and utilize pest extermination services for the Premises as reasonably
necessary or as reasonably requested by Landlord in writing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 <B>Air Conditioning</B><B>.</B> Landlord shall provide Make Up Air
capacity capable of 2.0 CFM/sf of once thru air for the laboratory portion of the Premises and of approximately .5 CFM/sf for the office and <FONT STYLE="white-space:nowrap">non-laboratory</FONT> portions thereof. The ancillary office portion of the
Premises shall be served by heat pumps with code required make up air stubbed to the Premises in a location shown on the Base Building Plans as part of the Base Building Shell Work (with the heat pumps, connections, and distribution within the
Premises as part of the Tenant Improvement Work). The laboratory/office split of the Premises is anticipated to be 60% laboratory/40% ancillary office. Landlord shall provide a condenser water system for laboratory process cooling and office air
conditioning. Condenser water loop connections sized for 40 tons/floor of cooling and the hot water loop connections sized for reheat and/or radiation based upon make up air as outlined above. Condenser water and hot water loop to be stubbed to the
Premises in a location shown on the Plans as part of the Base Building Shell Work. Tenant agrees to lower and close the blinds or drapes when necessary because of the sun&#146;s position, whenever the air conditioning system is in operation, by
using good faith efforts to cause its employees and invitees to comply with such requirements and to cooperate fully with Landlord with regard to, and to abide by all the reasonable regulations and requirements which Landlord may prescribe for the
proper functioning and protection of the air conditioning system. Landlord shall provide such heat and air conditioning services to the laboratory portion of the Premises twenty-four (24)&nbsp;hours a day, seven (7)&nbsp;days a week during the Term,
and to the office and <FONT STYLE="white-space:nowrap">non-laboratory</FONT> portions of the Premises during business hours. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5
<B>Additional Heat and Air Conditioning Services.</B> Upon reasonable advance written notice from Tenant (meaning at least twenty-four (24)&nbsp;hours&#146; prior notice) of its requirements in that regard, Landlord shall furnish additional heat or
air conditioning services to the office and <FONT STYLE="white-space:nowrap">non-laboratory</FONT> portions of the Premises on days and at times other than as above provided. Tenant will pay to Landlord a reasonable charge for any such additional
heat or air conditioning service required by Tenant.<B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.6 <B>Additional Air Conditioning Equipment</B><B>.</B> In the event Tenant requires
additional air conditioning for equipment, machines, meeting or equipment rooms not installed as part of Landlord&#146;s Work or other purposes or uses, or because of specific climate control needs, occupancy or excess electrical loads, any
additional air conditioning units, chillers, condensers, compressors, ducts, piping and other equipment, such additional air conditioning equipment will be installed, but only if, in Landlord&#146;s reasonable judgment, the same will not cause
damage or injury to the Building or create a dangerous or hazardous condition or unreasonably interfere with or disturb other tenants. At Landlord&#146;s sole election, such equipment will either be installed: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by Landlord at Tenant&#146;s expense and Tenant shall reimburse Landlord in such an amount as will compensate it for the actual and
reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> cost incurred by it in operating, maintaining, repairing and replacing, if necessary, such additional air conditioning equipment. At
Landlord&#146;s election, such equipment shall (i)&nbsp;be maintained, repaired and replaced by Tenant at Tenant&#146;s sole cost and expense, and (ii)&nbsp;throughout the Term of this Lease, Tenant shall, at Tenant&#146;s sole cost and expense,
purchase and maintain a service contract for such equipment from a service provider approved by Landlord. Tenant shall obtain Landlord&#146;s prior written approval of both the form of service contract and of the service provider; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by Tenant, subject to Landlord&#146;s prior approval of Tenant&#146;s plans and specifications for such work (subject to the approval
standard for Alterations set forth in Article 12). In such event: (i)&nbsp;such equipment shall be maintained, repaired and replaced by Tenant at Tenant&#146;s sole cost and expense, and (ii)&nbsp;throughout the Term of this Lease, Tenant shall, at
Tenant&#146;s sole cost and expense, purchase and maintain a service contract for such equipment from a service provider approved by Landlord. Tenant shall obtain Landlord&#146;s prior written approval of both the form of service contract and of the
service provider. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.7 <B>Landlord Repairs.</B> Except as otherwise provided in Articles 18 and 20, and subject to Tenant&#146;s
obligations in Article 14, Landlord shall keep and maintain in good condition and repair the structural elements of the Building (including, without limitation, the Roof, exterior walls, structural floor slabs, columns, elevators and elevator
shafts, public stairways and corridors, footings, foundations, structural portions of load-bearing walls, structural floors and subfloors, and structural columns and beams), Common Areas, including the Amenity Center, (which shall be kept clean and
free of rubbish and debris), exterior windows, public lavatories, Common Laboratory Facilities, and all other common facilities, and the mechanical systems (including, without limitation, elevators, sanitary, plumbing, electrical, heating,
ventilation, air conditioning, generators, fire and life safety, and other systems) (collectively, the &#147;Building Systems&#148;) serving both the Building and the Common Areas, and the Building&#146;s emergency generator(s). Landlord shall keep
the paved portions of the Common Areas reasonably free of ice and snow. Landlord shall perform any of its obligations under this Section&nbsp;8.7 in a timely manner consistent with comparable first-class life science buildings in the Seaport
District of Boston, Massachusetts. Notwithstanding any other provision of this Lease, Landlord, for itself and its employees, agents and contractors, reserves the right to refuse to perform any repairs or services in any laboratory portion of the
Premises or any other portion which, pursuant to Tenant&#146;s safety guidelines, practices or custom or prudent industry practices, require any form of clothing or equipment other than safety glasses. In any such case, Tenant shall contract with
parties who are acceptable to Landlord, in Landlord&#146;s reasonable discretion, for all such repairs and services, which shall be paid for by Landlord and chargeable as Operating Costs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.8 <B>Interruption or Curtailment of Services.</B> When necessary by reason of accident or emergency, or for repairs, alterations,
replacements or improvements which in the reasonable judgment of Landlord are necessary to be made, or by reason of event(s) of Force Majeure, Landlord reserves the right to temporarily interrupt, curtail, stop or suspend (a)&nbsp;the furnishing of
heating, elevator, air conditioning, and cleaning services and (b)&nbsp;the operation of the plumbing and electric systems. Landlord shall exercise commercially reasonable and diligent efforts to promptly eliminate the cause of any such
interruption, curtailment, stoppage or suspension, but there shall be no diminution or abatement of rent or other compensation due from Landlord to Tenant hereunder, nor shall this Lease be affected or any of the Tenant&#146;s obligations hereunder
reduced, and the Landlord shall have no responsibility or liability for any such interruption, curtailment, stoppage, or suspension of services or systems. Notwithstanding the foregoing, Tenant shall be entitled to a proportionate abatement of
Yearly Rent in the event of a Landlord Service Interruption (as defined below). For the purposes hereof, a &#147;Landlord Service Interruption&#148; shall occur in the event (i)&nbsp;the Premises shall lack any service which Landlord is
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">required to provide or furnish hereunder (including but not limited to emergency generator service (per
Section 2.2 above)) thereby rendering the Premises or any material portion of the Premises untenantable for the entirety of the Landlord Service Interruption Cure Period (as defined below), (ii) such lack of service was not caused by Tenant, its
employees, contractors, invitees or agents or by a casualty (in which event Section 18 shall control); (iii) Tenant in fact ceases to use the entire Premises or any material portion of the Premises for the entirety of the Landlord Service
Interruption Cure Period (provided, however, that Tenant shall not be required to cease its use of the laboratory portion of the Premises if such cessation is impractical due to the nature of its business operations); and (iv) such interruption of
service was the result of causes, events or circumstances within the Landlord&#146;s reasonable control and the cure of such interruption is within Landlord&#146;s reasonable control. For the purposes hereof, the &#147;Landlord Service Interruption
Cure Period&#148; shall be defined as five (5) consecutive calendar days after Landlord&#146;s receipt of written notice from Tenant of the Landlord Service Interruption. Additionally, and notwithstanding anything contained herein to the contrary,
in the event that a Landlord Service Interruption lasts for one hundred twenty (120) consecutive days and Tenant has vacated 50% of the Rentable Area of the laboratory portion of the Premises or 50% of the Rentable Area of the office portion of the
Premises, then Tenant, upon not less than thirty (30) days prior written notice to Landlord, shall have the right to terminate this Lease effective as of the date of the Landlord Service Interruption and Landlord shall immediately refund to Tenant
any Yearly Rent and other payments paid by Tenant to Landlord prior to such termination; provided, however, if the Landlord Service Interruption giving rise to Tenant&#146;s termination hereunder is cured within such thirty (30) day period
Tenant&#146;s termination right hereunder shall be void and of no further force or effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.9 <B></B><B>Energy Conservation.</B>
Notwithstanding anything to the contrary in this Article 8 or in this Lease contained, Landlord may institute, and Tenant shall comply (and cause its employees, invitees, agents and contractors to comply) with, such policies, programs and measures
as may be necessary, required, or expedient for the conservation and/or preservation of energy or energy services, or as may be necessary or required to comply with applicable codes, rules regulations or standards<B> </B>including but not limited to
applying and reporting for the Building or any part thereto to seek or maintain certification und the U.S. EPA&#146;s Energy Start<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> rating system, the U.S. Green Building Council&#146;s
Leadership in Energy and Environmental Design (LEED) rating system or a similar system or standard. Landlord will use best efforts to obtain and shall diligently seek to achieve LEED Silver Certification using and meeting ASHRAE <FONT
STYLE="white-space:nowrap">90.1-2007.</FONT> If the Building is LEED certified, Landlord will provide Tenant with the Building&#146;s LEED scorecard and such other information as will establish the Building as having received LEED certification or
as seeking the same. Upon reasonable request, Tenant shall provide Landlord with the necessary information or, at Tenant&#146;s option, grant Landlord access to Tenant&#146;s account with any utility company or provider paid directly by Tenant for
utility services, so that Landlord can review the utility bills relating to the Premises in connection with any required energy reporting requirements to the City of Boston or other governmental agency or in connection with any third party energy
certification program (e.g., LEED certification). Regardless if Landlord obtains LEED certification for the Building, Tenant shall comply with LEED policies outlined, from time to time, for Green Cleaning and Integrated Pest Management provided such
policies are uniformly applied to all similarly situated tenants in the Building. In the event Tenant shall pursue certification for the Premises in connection with any Tenant work or Alterations under the LEED certification process for Commercial
Interiors (CI), Landlord will assist Tenant&#146;s efforts by providing documentation supporting points and prerequisite requirements related to the Building and the Building Systems; provided any costs and expenses relating thereto, including
construction materials or construction or building processes, products, procedures and protocols in connection with obtaining or maintaining such certification, or the applying and reporting therefor, shall be allocated to the costs and expenses for
the Tenant Improvement Work or to Tenant and not included in the cost of the Base Building Shell Work or Operating Costs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.10
<B></B><B>Access</B>. Subject to terms and conditions of this Lease, Landlord&#146;s Rules and Regulations and reasonable security requirements as the same may be amended from time to time and of which Tenant has received prior written notice,
Tenant shall have access to the Premises and all Common Areas and the Parking Facilities twenty-four (24)&nbsp;hours a day, seven (7)&nbsp;days a week. Subject to the terms and conditions of this Lease including but not limited to Section&nbsp;12,
Tenant shall have the right to install a card key or similar security access system to the Premises<B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.11 <B>Amentity Center</B><B>.</B> Landlord shall open, operate, and make available to
Tenant, from time to time, the Amenity Center in the Building unless and until same is otherwise provided elsewhere in the Complex; provided, however, that if all or any portion of the Amenity Center facilities are located in the Complex, rather
than the Building, or if all or any portion of the Amenity Center facilities are offered to tenants of the Complex, rather than just tenants of the Building, such Amenity Center facilities shall be opened, operated and scaled in such a way as to
offer reasonably comparable Amenity Center services (and access thereto) as offered prior to such change. With respect to the fitness center within the Amenity Center, it is understood and agreed that to the maximum extent the following agreement
may be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#146;s insurance requirements hereunder and Article 15 and Article 19, the use of the fitness center and its facilities
shall be at the sole risk of Tenant and the employees using same. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TAXES AND OPERATING COSTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <B>Definitions.</B> As used in this Article 9, the words and terms which follow mean and include the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) &#147;Operating Year&#148; shall mean a calendar year in which occurs any part of the Term of this Lease. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) &#147;Tenant&#146;s Proportionate Share&#148; shall be the figure as stated in Exhibit 1. Tenant&#146;s Proportionate Share is the ratio of
the Total Rentable Area of the Premises to the aggregate Total Rentable Area of the Building, as adjusted by Landlord from time to time in accordance with this Lease. Notwithstanding the foregoing, Landlord may equitably adjust Tenant&#146;s
Proportionate Share for all or part of any item of expense or cost reimbursable by Tenant that relates to a repair, replacement, or service that benefits only the Premises (or only a portion of the Building, in which case such adjustment shall be
made equitably between only those tenants occupying such portion of the Building). Further, Landlord may allocate the costs and expenses to maintain and repair the Common Laboratory Facilities based on the Total Rentable Area of the laboratory
portion of each tenant&#146;s premises to the Total Rentable Area of the portion of the Building dedicated to laboratory use. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
&#147;Taxes&#148; shall mean the real estate taxes and other taxes, levies and assessments imposed upon the Building, the Land and the Common Areas upon any personal property of Landlord used in the operation thereof, or Landlord&#146;s interest in
the Building, the Common Areas, or such personal property; charges, fees and assessments for transit, housing, police, fire or other governmental services or purported benefits to the Building and/or the Common Areas; service or user payments in
lieu of taxes; and any and all other taxes, levies, betterments, assessments and charges arising from the ownership, leasing, operating, use or occupancy of the Building, the Common Areas or based upon rentals derived therefrom, which are or shall
be imposed by Federal, State, Municipal or other authorities. For the purposes of this Lease, &#147;Taxes&#148; shall include any payment in lieu of taxes or any payments made under Chapter 121A of the Massachusetts General Laws or any similar law
and any payments to, for or relating in whole or in part to any business improvement district in which the Complex may be located. As of the Execution Date, &#147;Taxes&#148; shall not include any franchise, rental, income or profit tax, capital
levy or excise, provided, however, that any of the same and any other tax, excise, fee, levy, charge or assessment, however described, that may in the future be levied or assessed as a substitute for or an addition to, in whole or in part, any tax,
levy or assessment which would otherwise constitute &#147;Taxes,&#148; whether or not now customary or in the contemplation of the parties on the Execution Date of this Lease, shall constitute &#147;Taxes,&#148; but only to the extent calculated as
if the Land is the only real estate owned or leased by Landlord. &#147;Taxes&#148; shall also include expenses of tax abatement or other proceedings contesting assessments or levies. Notwithstanding the foregoing, Landlord shall have the right to
exclude from &#147;Taxes&#148;, from time to time, any portions of the Building, Land, Complex or Common Areas that are taxed or billed by the City of Boston or other applicable taxing authority as a separate tax parcel (e.g., <FONT
STYLE="white-space:nowrap">sub-parcel</FONT> or associate parcel) and to reincorporate such separate tax parcel in the event such separate tax treatment terminates and, in such event, equitably increase or decrease, as the case may be, Tenant&#146;s
Proportionate Share for purposes of invoicing Tenant for its Tax Share (as defined below). In addition, if applicable, Taxes shall be equitably allocated by Landlord, in Landlord&#146;s reasonable judgment, among the Building and any other
building(s) and improvements in the Complex. The parties acknowledge that, from time to time, Taxes may be based upon several separate tax bills affecting the Land and/or the Complex. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;Tax Period&#148; shall be any fiscal/tax period in respect of which Taxes are due
and payable to the appropriate governmental taxing authority, any portion of which period occurs during the Term of this Lease, the first such Period being the one in which the Term Commencement Date occurs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;Operating Costs&#148;: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Definition of Operating Costs. &#147;Operating Costs&#148; shall mean all costs incurred and expenditures of whatever
nature made by Landlord in the operation and management, for repair and replacements, cleaning and maintenance of the Land, Building, Complex and the Common Areas (including but not limited to the Parking Facilities serving same from time to time),
related equipment, facilities and appurtenances, elevators, cooling and heating equipment and the Common Laboratory Facilities (and services relating thereto). In the event that Landlord or Landlord&#146;s managers or agents perform services for the
benefit of the Building or Land <FONT STYLE="white-space:nowrap">off-site</FONT> which would otherwise be performed <FONT STYLE="white-space:nowrap">on-site</FONT> (e.g., accounting), the cost of such services shall be reasonably allocated among the
properties benefiting from such service and shall be included in Operating Costs. Landlord shall have the right but not the obligation, from time to time, to equitably allocate some or all of the Operating Costs among different tenants of the
Building or Complex (the &#147;Cost Pools&#148;). Such Cost Pools may include, but shall not be limited to, tenants that share particular systems or equipment, including Common Laboratory Facilities, or tenants that are similar users of particular
systems or equipment such as by way of example but not limitation office space tenants of the Building or Complex, laboratory tenants of the Building or Complex and retail space tenants of the Building or Complex. Operating Costs shall include,
without limitation, those categories of &#147;Specifically Included Operating Costs,&#148; as set forth below, but in no event shall Operating Costs include &#147;Excluded Costs,&#148; as hereinafter defined. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Definition of Excluded Costs. &#147;Excluded Costs&#148; shall be defined as mortgage charges; brokerage commissions;
salaries of executives and owners not directly employed in the management/operation of the Building, Complex and Land; the cost of work done by Landlord for a particular tenant for which Landlord has the right to be reimbursed by such tenant;
subject to Subparagraph (3)&nbsp;below, such portion of expenditures as are not properly chargeable against income; expenses incurred by Landlord to lease space to new tenants or to retain existing tenants including tenant improvement allowances,
construction costs, marketing costs, brokerage commissions and concessions and leasehold improvement costs, finders&#146; fees, attorneys&#146; fees and expenses; entertainment costs and travel expenses; attorneys&#146; fees incurred for services
that do not generally benefit the tenants of the Building or Complex, or incurred in connection with matters relating to the formation of Landlord as an entity and maintaining its continued existence as an entity, or incurred in connection with
lease negotiations or disputes with individual tenants, and other expenses and attorneys&#146; fees to resolve disputes, enforce or negotiate lease terms with prospective or existing tenants or in connection with any financing, sale or syndication
of the Building or Complex; accountants&#146; fees incurred in connection with disputes with individual tenants and/or the existence, maintenance or <FONT STYLE="white-space:nowrap">non-Building</FONT> related operations of the legal entity or
entities of which Landlord is comprised (without limitation, the foregoing shall not exclude the reasonable costs of preparing financial statements for Operating Costs); the cost of any special work or service performed for any tenant (including
Tenant) or licensee, such as after-hours HVAC service, which is billable to such tenant or licensee; the cost of any items for which Landlord is reimbursed by insurance, condemnation, licensees, tenants (other than through general operating expense
provisions) or otherwise; the cost of any additions, improvements, changes, replacements, painting, decorating, renovations and other items that are made to and solely benefitting areas of the Building or Complex that do not include Common Areas (or
common facilities), or that are made in order to prepare tenant space for a new tenant&#146;s occupancy, or the cost of any other work in any space leased to an existing or prospective tenant or other occupant of the Building or the Complex;
interest, principal, points and fees, amortization or other costs and expenses associated with any debt or amortization payments on any mortgage or deed to secure debt; any expenses for repairs, maintenance and replacements to the extent reimbursed
due to warranties and service contracts, any cost that Tenant or any other tenant at the Building or Complex pays for directly (either to Landlord or a third party); any cost that are reimbursed by a warranty that Landlord is required to obtain in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
connection with the Building or Complex pursuant to this Lease or that Landlord otherwise obtains in connection with the Building or Complex; salaries, bonuses, benefits, and employment taxes of
officers, executives of Landlord and administrative employees above the grade of property manager or building supervisor (and if a property manager or building supervisor or any personnel below such grades are shared with other buildings or has
other duties not related to the building containing the Premises, only the allocable portion of such person&#146;s or persons&#146; salary, bonuses and benefits shall be included in Operating Costs); Landlord&#146;s general overhead and
administrative expenses; any capital expenditures (except as otherwise provided in Subparagraph (3)&nbsp;below; any costs or expenses incurred in connection with services or other benefits (A)&nbsp;of a type not provided to Tenant (or provided to
Tenant at separate or additional charge) but that are provided to another tenant or occupant of the Building, or (B)&nbsp;that are available to all tenants of the Building, including Tenant, but are provided to other tenants or occupants of the
Building at a level substantially greater than that provided to Tenant (excluding those services or other benefits that Landlord makes available to all tenants at the same level, but with respect to which Tenant elects in its sole discretion to
receive at a lower level) without separate or additional charge, in which case such expenses shall be excluded from Operating Costs to the extent such expenses exceed the amount that would have been incurred to provide such services or other
benefits to such other tenant or occupant at the same level as such services or other benefits are provided to Tenant; expenses incurred by Landlord to the extent the same are chargeable and collected from any other tenant or occupant of the
Property, or to any third party; any fee or expenditure that is paid or payable to any affiliate of Landlord to the extent that such fee or expenditure is unreasonably inconsistent with fees charged by third-party property managers providing
reasonably comparable services in the Boston market; penalties, fines and other costs incurred due to violation by Landlord of any lease or any legal requirements applicable to the Building or Complex; provided the foregoing shall not include
compliance costs with respect to such legal requirements coming into force or effect from and after the Term Commencement Date, and any interest or penalties due for late payment by Landlord of any of the Operating Costs; costs and expenses incurred
by Landlord in connection with the repair of damage to the Building or Complex caused by fire or other casualty, insured or required to be insured against hereunder, other than the deductible amount under such insurance policies, or otherwise
recovered under its insurance policies; the cost of any item for which Landlord is reimbursed through condemnation awards; insurance premiums to the extent any unusual tenant activity causes Landlord&#146;s existing insurance premiums to increase or
requires Landlord to purchase additional insurance, but only to the extent such additional cost can be identified by the insurer and are not passed through by Landlord to a specific tenant; costs and expenses of investigating, monitoring and
remediating hazardous materials which were present on or beneath the surface of the Property and in violation of applicable Legal Requirements as of the Term Commencement Date or which were caused by Landlord, its agents, contractors, employees or
representatives; political contributions; and the costs of obtaining artwork. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) <U>Capital Expenditures</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Replacements</U>. If, during the Term of this Lease, Landlord shall replace any capital items or make any capital
expenditures (collectively called &#147;capital expenditures&#148;) the total amount of which is not properly includible in Operating Costs for the Operating Year in which they were made, there shall nevertheless be included in such Operating Costs
and in Operating Costs for each succeeding Operating Year the amount, if any, by which the Annual <FONT STYLE="white-space:nowrap">Charge-Off</FONT> (determined as hereinafter provided) of such capital expenditure (less insurance proceeds, if any,
collected by Landlord by reason of damage to, or destruction of the capital item being replaced) exceeds the Annual <FONT STYLE="white-space:nowrap">Charge-Off</FONT> of the capital expenditure for the item being replaced. Notwithstanding anything
in this Lease to the contrary, and excluding only capital expenditures on account of a casualty or changes in legal requirements (from and after the Term Commencement Date), Landlord shall not include any capital expenditures in Operating Costs for
the first five (5)&nbsp;Lease Years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>New Capital Items</U>. If a new capital item is acquired which does
not replace another capital item which was worn out, has become obsolete, etc., then there shall be included in Operating Costs for each Operating Year in which and after such capital expenditure is made the Annual
<FONT STYLE="white-space:nowrap">Charge-Off</FONT> of such capital expenditure. Notwithstanding anything in this Lease to the contrary, and excluding only capital expenditures on account of a casualty or changes in legal requirements (from and after
the Term Commencement Date), Landlord shall not include any capital expenditures in Operating Costs for the first five (5)&nbsp;Lease Years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <U>Annual <FONT STYLE="white-space:nowrap">Charge-Off</FONT></U>. &#147;Annual
<FONT STYLE="white-space:nowrap">Charge-Off&#148;</FONT> shall be defined as the annual amount of principal and interest payments which would be required to repay a loan (&#147;Capital Loan&#148;) in equal monthly installments over the Useful Life,
as hereinafter defined, of the capital item in question on a direct reduction basis at an annual interest rate equal to the Capital Interest Rate, as hereinafter defined, where the initial principal balance is the cost of the capital item in
question. Notwithstanding the foregoing, if Landlord reasonably concludes on the basis of engineering estimates that a particular capital expenditure will effect savings in Building operating expenses including, without limitation, energy-related
costs, and that such projected savings will, on an annual basis (&#147;Projected Annual Savings&#148;), exceed the Annual <FONT STYLE="white-space:nowrap">Charge-Off</FONT> of such capital expenditure computed as aforesaid, then and in such events,
the Annual <FONT STYLE="white-space:nowrap">Charge-Off</FONT> shall be increased to an amount equal to the Projected Annual Savings; and in such circumstances, the increased Annual <FONT STYLE="white-space:nowrap">Charge-Off</FONT> (in the amount of
the Projected Annual Savings) shall be made for such period of time as it would take to fully amortize the cost of the capital item in question, together with interest thereon at the Capital Interest Rate as aforesaid, in equal monthly payments,
each in the amount of <FONT STYLE="white-space:nowrap">one-twelfth</FONT> (1/12th) of the Projected Annual Savings, with such payments being applied first to interest and the balance to principal. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) <U>Useful Life</U>. &#147;Useful Life&#148; shall be reasonably determined by Landlord in accordance with generally
accepted accounting principles and practices in effect at the time of acquisition of the capital item. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <U>Capital
Interest Rate</U>. &#147;Capital Interest Rate&#148; shall be defined as an annual rate of either one percentage point over the AA Bond rate (Standard&nbsp;&amp; Poor&#146;s corporate composite or, if unavailable, its equivalent) as reported in the
financial press at the time the capital expenditure is made or, if the capital item is acquired through third-party financing, then the actual (including fluctuating) rate paid by Landlord in financing the acquisition of such capital item. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) <U>Applicable Capital Expenditures</U>. The Annual <FONT STYLE="white-space:nowrap">Charge-off</FONT> of Capital
Expenditures set forth in subsections (i)&nbsp;and (ii) above shall only be included as Operating Costs if said Capital Expenditures are, in Landlord&#146;s good faith belief, (a)&nbsp;reasonably anticipated to result in a reduction in (or minimize
increases in) Operating Costs, (b)&nbsp;required to comply with present or reasonably anticipated energy or similar conservation programs, (c)&nbsp;required under any governmental law or regulation enacted after or coming into applicability after
the date of this Lease, or (d)&nbsp;necessary to replace or maintain Building systems, life safety or improve security measures at the Property in a manner consistent with other comparable first-class life science buildings in the Seaport District
of Boston, Massachusetts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) <U>Specifically Included Categories of Operating Costs</U>. Unless expressly and
specifically excluded from Operating Costs under Subsection (2)&nbsp;above, Operating Costs shall include, but not be limited to, the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Taxes (other than real estate taxes): Sales, Federal Social Security, Unemployment and Old Age Taxes and contributions and
State Unemployment taxes and contributions accruing to and paid by the Landlord on account of all employees of Landlord and/or Landlord&#146;s managing agent, who are employed in, about or on account of the Building, Complex and Land, except that
taxes levied upon the net income of the Landlord and taxes withheld from employees, and &#147;Taxes&#148; as defined in Article 9.1(c) shall not be included herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Water: All charges and rates connected with water supplied to the Building
and related sewer use charges. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Heat and Air Conditioning: All charges connected with heat and air conditioning supplied to
the Building. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Wages: Wages and cost of all employee benefits of all employees of the Landlord and/or Landlord&#146;s
managing agent who are employed in, about or on account of the Building, Land and Complex. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Cleaning: The cost of labor
(including third party janitorial contracts), supplies, tools and material for cleaning the Building, Land and Complex. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Elevator Maintenance: All expenses for or on account of the upkeep and maintenance of all elevators in the Building. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Management Fee: The cost of professional management of the Building, Land and Complex, not to exceed three percent (3%) of the
then current Yearly Rent. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Administrative Costs: The cost of office expense for the management of the Building, Land and
Complex, including, without limitation, rent, business supplies and equipment and commercially reasonable costs associated with the Building&#146;s management office (either as rent or in the calculation of Total Rentable Area of the Building). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Electricity: The cost of all electric current for the operation of any machine, appliance or device used for the operation of
the Building, including the cost of electric current for the elevators, lights, air conditioning and heating, Common Laboratory Services, but not including electric current which is paid for directly to the utility by the user/tenant in the Building
or for which the user/tenant pays directly or reimburses Landlord. (If and so long as Tenant is billed directly by the electric utility for its own consumption as determined by its separate meter, or billed directly by Landlord as determined by a
check meter, then Operating Costs shall include only Building and public area electric current consumption and not any demised Premises electric current consumption.) Wherever separate metering is unlawful, prohibited by utility company regulation
or tariff or is otherwise impracticable, relevant consumption figures for the purposes of this Article 9 shall be determined by fair and reasonable allocations and engineering estimates made by Landlord. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Ground Rent: The ground rent payments and other charges, if any, due pursuant to the EDIC Lease (as defined below). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Shared or Easement Costs: The Building&#146;s share (as reasonably determined and allocated by the applicable agreement or
Landlord) of: (i)&nbsp;the costs incurred by Landlord in operating, maintaining, repairing, insuring and paying real estate taxes upon any shared facilities (including, without limitation, the common facilities from time to time serving the
Building, Land and Complex in common with other buildings or parcels of land), such as any accessways, sewer and other utility lines, amenities and the like; (ii)&nbsp;shuttle bus service (if and so long as Landlord provides for same); (iii) the
actual or imputed cost of the space occupied by <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">on-the-grounds</FONT></FONT> building attendant(s) and related personnel and the cost of administrative and or service personnel whose
duties are not limited solely to the Building, Land and Complex, as reasonably determined and allocated to the Building, Land and Complex by Landlord; and (iv)&nbsp;payments made by Landlord under any easement, license, operating agreement,
declaration, restrictive covenant, or instrument pertaining to the payment or sharing of costs among property owners, including but not limited to Boston Marine Industrial Park (&#147;BMIP&#148;) operating expenses, fees and charges for BMIP
park-wide snow removal, security, street lighting, landscaping and other services provided to tenants of the BMIP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Insurance, etc.: Fire, casualty, liability, rent loss and such other
insurance as may from time to time be required by lending institutions on comparable first-class life science buildings in the Seaport District of Boston, Massachusetts and all other expenses customarily incurred in connection with the operation and
maintenance of comparable first-class life science buildings in the Seaport District of Boston, Massachusetts including, without limitation, commercially reasonable insurance deductible amounts. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) <U><FONT STYLE="white-space:nowrap">Gross-Up</FONT> Provision</U>. Notwithstanding the foregoing, in determining the amount
of Operating Costs for any calendar year or any portion thereof falling within the Term, if less than ninety-five percent (95%) of the Rentable Area of the Building shall have been occupied by tenants at any time during the period in question, then,
at Landlord&#146;s election, Operating Costs for such period shall be adjusted to equal the amount Operating Costs would have been for such period had occupancy been ninety-five percent (95%) throughout such period. The extrapolation of Operating
Costs under this paragraph shall be performed by appropriately adjusting the cost of those components of Operating Costs that are impacted by changes in the occupancy of the Building. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <B>Tax Share.</B> Commencing as of the Term Commencement Date and continuing thereafter with respect to each Tax Period occurring during
the Term of the Lease, Tenant shall pay to Landlord, with respect to any Tax Period Tenant&#146;s Proportionate Share of Taxes for such Tax Period, such amount being hereinafter referred to as &#147;Tax Share&#148;. Tax Share shall be due when
billed by Landlord, but not earlier than sixty (60)&nbsp;days prior to the due date of any tax payment required by the taxing authority except as otherwise provided in the immediately following sentence. In implementation and not in limitation of
the foregoing, Tenant shall remit to Landlord pro rata monthly installments on account of projected Tax Share, calculated by Landlord on the basis of the most recent Tax data or budget available. If the total of such monthly remittances on account
of any Tax Period is greater than the actual Tax Share for such Tax Period, Landlord shall credit the difference against the next installment of rental or other charges due to Landlord hereunder, or if the Lease Term has expired or the Lease has
been terminated earlier, pay such amount to Tenant within thirty (30)&nbsp;days after the expiration or earlier termination of the Lease. If the total of such remittances is less than the actual Tax Share for such Tax Period, Tenant shall pay the
difference to Landlord within thirty (30)&nbsp;days of when billed therefor. Landlord shall endeavor to provide to Tenant not later than one hundred twenty (120)&nbsp;days after the end of each Tax Period a statement of the actual Taxes paid by
Landlord during that Tax Period and the amount, if any, of any amounts to be credited to Tenant or are required to be paid by Tenant, as provided in this paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Appropriate credit against Tax Share<B> </B>shall be given for any refund obtained by reason of a reduction in any Taxes by the Assessors or
the administrative, judicial or other governmental agency responsible therefor. The original computations, as well as reimbursement or payments of additional charges, if any, or allowances, if any, under the provisions of this Article 9.2 shall be
based on the original assessed valuations with adjustments to be made at a later date when the tax refund, if any, shall be paid to Landlord by the taxing authorities. Expenditures for legal fees and for other similar or dissimilar expenses incurred
in obtaining the tax refund may be charged against the tax refund before the adjustments are made for the Tax Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord has
obtained from the City of Boston the benefit of a seven (7)&nbsp;year Payment in Lieu of Taxes (PILOT) program that commenced as of Tax fiscal year 2017, and the payments thereunder shall be included in Taxes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <B>Operating Expense Share.</B><B> </B>Commencing as of the Term Commencement Date and continuing thereafter with respect to each Operating
Year occurring during the Term of the Lease, Tenant shall pay to Landlord, with respect to any Operating Year, Tenant&#146;s Proportionate Share of Operating Costs for such Operating Year, such sum being hereinafter referred to as &#147;Operating
Expense Share&#148;. In implementation and not in limitation of the foregoing, Tenant shall remit to Landlord pro rata monthly installments on account of projected Operating Expense Share, calculated by Landlord on the basis of the most recent
Operating Costs data or budget available. If the total of such monthly remittances on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
account of any Operating Year is greater than the actual Operating Expense Share for such Operating Year, Landlord shall credit the difference against the next installment of rent or other
charges due to Landlord hereunder, or if the Lease Term has expired or the Lease has been terminated earlier, pay such amount to Tenant within thirty (30)&nbsp;days after the expiration or earlier termination of the Lease. If the total of such
remittances is less than actual Operating Expense Share for such Operating Year, Tenant shall pay the difference to Landlord when billed therefor. Landlord shall endeavor to provide to Tenant not later than one hundred twenty (120)&nbsp;days after
the end of each Operating Year a statement of the actual Operating Costs paid by Landlord during that Operating Year and the amount, if any, of any amounts to be credited to Tenant or are required to be paid by Tenant, as provided in this paragraph.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <B>Part Years.</B> If the Term Commencement Date or the Termination Date occurs in the middle of an Operating Year or Tax Period,
Tenant shall be liable for only that portion of the Operating Expense or Tax Share, as the case may be, in respect of such Operating Year or Tax Period represented by a fraction, the numerator of which is the number of days of the herein Term which
falls within the Operating Year or Tax Period and the denominator of which is three hundred sixty-five (365), or the number of days in said Tax Period, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <B>Effect of Taking.</B> In the event of any taking of the Building or the land upon which it stands under circumstances whereby this Lease
shall not terminate under the provisions of Article 20 then, Tenant&#146;s Proportionate Building Share and Tenant&#146;s Proportionate Common Share shall be adjusted appropriately to reflect the proportion of the Premises and/or the Building
remaining after such taking. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6 <B>Tenant Audit Right.</B> Landlord shall permit Tenant, at Tenant&#146;s expense and during normal
business hours, but only one time with respect to any Operating Year, to review Landlord&#146;s invoices and statements relating to the Operating Costs for the applicable Operating Year for the purpose of verifying the Operating Costs and
Tenant&#146;s share thereof; provided that notice of Tenant&#146;s desire to so review is given to Landlord not later than ninety (90)&nbsp;days after Tenant receives an annual statement from Landlord, and provided that such review is thereafter
commenced and prosecuted by Tenant with due diligence. Any Operating Costs statement or accounting by Landlord shall be binding and conclusive upon Tenant unless (a)&nbsp;Tenant duly requests such review within such
<FONT STYLE="white-space:nowrap">90-day</FONT> period, and (b)&nbsp;within three (3)&nbsp;months after Landlord&#146;s delivery to Tenant of copies of, or access to, all such invoices and statements for the purposes of conducting such review, Tenant
shall notify Landlord in writing that Tenant disputes the correctness of such statement, specifying the particular respects in which the statement is claimed to be incorrect. Tenant shall have no right to conduct a review or to give Landlord notice
that it desires to conduct a review at any time Tenant is in default under the Lease beyond any applicable notice and cure period. The accountant conducting the review shall (i)&nbsp;be a qualified lease auditor reasonably approved by Landlord (such
approval not to be unreasonably withheld) having at least five (5)&nbsp;years applicable experience, and (ii)&nbsp;be compensated on an hourly basis and shall not be compensated based upon a percentage of overcharges it discovers. No subtenant shall
have any right to conduct a review, and no assignee shall conduct a review for any period during which such assignee was not in possession of the Premises. If Tenant&#146;s review reveals that Tenant has overpaid Operating Costs by more than five
percent (5%) of the actual Operating Costs, in the aggregate, that Landlord should have charged Tenant for the applicable Operating Year, then Landlord shall pay for the cost of Tenant&#146;s review. Tenant agrees that all information obtained from
any such Operating Costs review, including without limitation, the results of any Operating Costs review shall be kept strictly confidential by Tenant and shall not be disclosed to any other person or entity other than its accountants, lenders,
brokers and attorneys. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.7 <B>Survival. </B>Any obligations under this Article 9 which shall not have been paid at the expiration or
sooner termination of the Term of this Lease shall survive such expiration and shall be paid when and as the amount of same shall be determined to be due. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CHANGES OR ALTERATIONS BY LANDLORD </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord reserves the right, exercisable by itself or its nominee, but subject to the terms and provisions of this Lease, at any time and from
time to time without the same constituting an actual or constructive eviction and without incurring any liability to Tenant therefor or otherwise affecting Tenant&#146;s obligations under this Lease, to make such changes, alterations, additions,
improvements, repairs or replacements in or to: (a)&nbsp;the Building (including the Premises) and the fixtures and equipment thereof, (b)&nbsp;the street entrances, halls, passages, elevators, escalators, and stairways of the Building, and
(c)&nbsp;the Common Areas, and facilities located therein, as Landlord may deem necessary or desirable, and to change the arrangement and/or location of entrances or passageways, doors and doorways, and corridors, elevators, stairs, toilets, or
other public parts of the Building and/or the Common Areas, provided, however, that Landlord&#146;s access to the Premises shall be in accordance with Section&nbsp;17.2 below. Further, Landlord shall provide Tenant with reasonable prior notice
(which may be verbal to Landlord&#146;s employee contact within Tenant&#146;s premises) of any such work within the Premises, but not less than three (3)&nbsp;business days notice (for such work within the office portion thereof) and not less than
five (5)&nbsp;business days notice (for work within the laboratory portion thereof), except in the event of an emergency. Nothing contained in this Article 10 shall be deemed to relieve Tenant of any duty, obligation or liability of Tenant with
respect to making any repair, replacement or improvement or complying with any law, order or requirement of any governmental or other authority. Landlord reserves the right to adopt and at any time and from time to time upon reasonable prior written
notice to change the name or address of the Building, in which case Landlord shall reimburse Tenant for the cost to change its stationary, up to a maximum amount of $5,000 for each such change. Neither this Lease nor any use by Tenant shall give
Tenant any right or easement for the use of any door, passage, concourse, walkway or parking area within the Building or in the Common Areas, and the use of such doors, passages, concourses, walkways, parking areas and such conveniences may be
regulated or discontinued at any time and from time to time by Landlord upon reasonable prior written notice to Tenant, and without affecting the obligation of Tenant hereunder or incurring any liability to Tenant therefor, provided, however, that
access to the Premises, and use of the Parking Facilities, is at all times available in a commercially reasonable manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If at any time
any windows of the Premises are temporarily closed or darkened for any reason whatsoever including but not limited to, Landlord&#146;s own acts, Landlord shall not be liable for any damage Tenant may sustain thereby and Tenant shall not be entitled
to any compensation therefor nor abatements of rent nor shall the same release Tenant from its obligations hereunder nor constitute an eviction. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FIXTURES, EQUIPMENT AND IMPROVEMENTS-REMOVAL BY TENANT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Excluding Landlord&#146;s Work, which is subject to Section&nbsp;4.2(m) above, all fixtures, equipment, improvements and appurtenances attached
to or built into the Premises prior to or during the term, whether by Landlord at its expense or at the expense of Tenant (either or both) or by Tenant shall be and remain part of the Premises and shall not be removed by Tenant during or at the end
of the Term unless Landlord otherwise elects to require Tenant to remove such fixtures, equipment, improvements and appurtenances, in accordance with Articles 12 and/or 22 of the Lease. Excepting Tenant&#146;s Removable Property, all electric,
plumbing, heating and sprinkling systems, fixtures and outlets, vaults, paneling, molding, <FONT STYLE="white-space:nowrap">built-in</FONT> shelving, HVAC enclosures, cork, rubber, linoleum and composition floors, ventilating, silencing, air
conditioning and cooling equipment, fume hoods which penetrate the roof or plenum area, <FONT STYLE="white-space:nowrap">built-in</FONT> cold rooms, <FONT STYLE="white-space:nowrap">built-in</FONT> warm rooms,
<FONT STYLE="white-space:nowrap">walk-in</FONT> cold rooms, <FONT STYLE="white-space:nowrap">walk-in</FONT> warm rooms, chillers, <FONT STYLE="white-space:nowrap">built-in</FONT> plumbing, electrical and mechanical equipment and systems, and any
power generator and transfer switch shall be deemed to be included in such fixtures, equipment, improvements and appurtenances, whether or not attached to or built into the Premises, to the extent any of same were paid for by Landlord via the
Improvement Allowance or the Supplemental Allowance. Where not built into the Premises, all removable electric fixtures, and all telephone, data and other communication cabling and equipment, carpets, drinking or tap water facilities, furniture, or
trade fixtures or laboratory or business equipment or Tenant&#146;s inventory or stock in trade shall not be deemed to be included in such fixtures, equipment, improvements and appurtenances and may be, and upon the request of Landlord as provided
in this Lease, will be removed by Tenant upon the condition that such removal shall not materially damage the Premises or the Building and that the cost of repairing any damage to the Premises or the Building arising from installation or such
removal shall be paid by Tenant. The covenants of this Section shall survive the expiration or earlier termination of the Term. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ALTERATIONS AND IMPROVEMENTS BY TENANT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms and provisions of this Article 12 do not apply to the Tenant Improvement Work (except as to those specific references hereto
regarding Landlord&#146;s approval standard). Tenant shall make no alterations, decorations, installations, removals, utility installations, repairs additions or improvements (sometimes referred to herein collectively to as &#147;Alterations&#148;
or singly as an &#147;Alteration&#148;) in or to the Premises without Landlord&#146;s prior written consent and unless made by contractors or mechanics reasonably approved by Landlord. No Alterations or work shall be undertaken or begun by Tenant
until: (a)&nbsp;Landlord has approved written plans and specifications and a time schedule therefor; (b)&nbsp;Tenant has made provision for either written waivers of liens from all contractors, laborers and suppliers of materials for such
Alterations or work as permitted by Chapter 256 of the Massachusetts General Laws, the filing of lien bonds on behalf of such contractors, laborers and suppliers, or other appropriate protective measures approved by Landlord, as and to the extent
provided in Section&nbsp;13(b) below; and (c)&nbsp;Tenant has procured appropriate surety payment and performance bonds, as and to the extent provided in Section&nbsp;13(b) below. No amendments or additions to such plans and specifications (other
than a <I>de minimis</I> alteration or addition) shall be made without the prior written consent of Landlord. Landlord&#146;s consent and approval required in any instance under this Article 12 shall not be unreasonably withheld, conditioned or
delayed as to nonstructural Alterations (nonstructural Alterations being those that (X)&nbsp;do not adversely affect the Building&#146;s structure, roof or exterior, or the mechanical, electrical, plumbing, life safety or other Building Systems or
the architectural design or use of the Building or Premises, (Y)&nbsp;do not lessen the fair market value of the Building or the Premises, or (Z)&nbsp;do not adversely affect the LEED certifiability of the Building or any improvements therein or any
LEED or similar certifications previously obtained with respect to the Building or any improvements therein). With respect to Landlord&#146;s review of any plans or specifications for Alterations, or any amendments or modifications thereto, Landlord
shall approve (or deny) Tenant&#146;s initial submission within ten (10)&nbsp;business days, and any subsequent submittal within five (5)&nbsp;business days. If Landlord denies its approval to any such submittal, it shall provide a written
explanation as to the basis of such disapproval and the modifications thereto that Landlord would require in order to issue its approval. This process shall continue until Landlord has approved such plans or specifications. If Landlord fails to
approve or deny any such submittal in writing within the foregoing timeframes, then Tenant may send Landlord a second request for approval of such Alteration. If Landlord fails to respond to such second request for approval within five
(5)&nbsp;Business Days after its receipt of same, then Landlord shall be deemed to have approved such plans and specifications; <I>provided</I> <I>that there appears in </I><B><I>bold </I></B><B><I>type</I></B><I> on the exterior of the envelope
containing Tenant</I><I>&#146;</I><I>s second request, as well as on the top of the written request itself, the statement (in a reasonably large size font and in </I><B><I>bold</I></B><I>) that Landlord</I><I>&#146;</I><I>s failure to respond to the
request within five (5)</I><I></I><I>&nbsp;Business Days after receipt thereof shall be deemed approval of the within request</I>, provided, however, that in no event shall Landlord be deemed to have consented to any Alterations or Specialty
Alterations that are otherwise expressly prohibited by law. Landlord&#146;s approval is solely given for the benefit of Landlord and neither Tenant nor any third party shall have the right to rely upon Landlord&#146;s approval of Tenant&#146;s plans
for any purpose whatsoever. Without limiting the foregoing, Tenant shall be responsible for all elements of the design of Tenant&#146;s plans (including, without limitation, compliance with law, functionality of design, the structural integrity of
the design, the configuration of the Premises and the placement of Tenant&#146;s furniture, appliances and equipment), and Landlord&#146;s approval of Tenant&#146;s plans shall in no event relieve Tenant of the responsibility for such design.
Landlord shall have no liability or responsibility for any claim, injury or damage alleged to have been caused by the particular materials, whether building standard or <FONT STYLE="white-space:nowrap">non-building</FONT> standard, appliances or
equipment selected by Tenant in connection with any Alterations or work performed by or on behalf of Tenant in the Premises including, without limitation, furniture, carpeting, copiers, laser printers, computers and refrigerators. All Alterations
made by Tenant shall be made in accordance with plans and specifications which have been approved in writing by the Landlord, pursuant to a duly issued permit to the extent so required by any governmental entity, and in accordance with the
provisions of Section&nbsp;13(c) below, the provisions of this Lease and in a good and first-class workerlike manner using new or <FONT STYLE="white-space:nowrap">like-new</FONT> materials of same or better quality as base building standard
materials, finishes and colors, free of all liens and encumbrances. All such Alterations shall be done at Tenant&#146;s sole expense and at such times and in such manner as Landlord may from time to time reasonably designate in consultation with
Tenant. All Alterations shall be performed by a contractor or contractors selected by Tenant and reasonably approved in writing by Landlord. Tenant shall reimburse Landlord for any reasonable <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs it incurs in reviewing the plans therefor and in monitoring the construction of the Alterations. If Tenant shall make any Alterations, then Landlord may elect to require the Tenant at the
expiration or sooner termination of the Term of this Lease to restore the Premises to substantially the same condition as existed at the Term Commencement Date, provided, however, that Landlord shall be required to notify Tenant in writing of such
election simultaneously with Landlord&#146;s approval of such Alteration requiring consent hereunder. Tenant shall pay, as an additional charge, the entire increase in real estate taxes on the Building which shall, at any time after the Term
Commencement Date (and explicitly excluding Landlord&#146;s Work), results exclusively and directly from any Alteration to the Premises made by or for the account of Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, as a direct result of any Alterations made by Tenant, Landlord is obligated to comply
with the Americans With Disabilities Act or any other federal, state or local laws or regulations and such compliance requires Landlord to make any improvement or alteration to any portion of the Building or the Complex, as a condition to
Landlord&#146;s consent, Landlord shall have the right to require Tenant to pay to Landlord prior to the construction of any such Alteration by Tenant, the entire cost of any improvement or alteration Landlord is obligated to complete by such law or
regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting any of the terms hereof, Landlord will not be required to approve any Alteration requiring unusual expense
to readapt the Premises to normal research and/or laboratory<B> </B>use on lease termination or increasing the cost of construction, insurance or Taxes on the Building or of Landlord&#146;s services to the Premises, unless Tenant first gives
reasonable assurance or security reasonably acceptable to Landlord that such <FONT STYLE="white-space:nowrap">re-adaptation</FONT> will be made prior to such termination without expense to Landlord and makes provisions acceptable to Landlord for
payment of such increased cost. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing or anything to the contrary contained elsewhere in this Article 12, Tenant
shall have the right, without Landlord&#146; s consent, to make any Alteration that meets all of the following criteria (a &#147;Cosmetic Alteration&#148; ): (a) the Alteration is decorative in nature (such as paint, carpet or other wall or floor
finishes, movable partitions or other such work), (b) Tenant provides Landlord with not less than seven (7)&nbsp;business days&#146; advance written notice of the commencement of such Alteration (which notice shall include the name and contact
information for the contractor(s) performing work in connection therewith, required evidence of insurance and such other reasonable information as Landlord may reasonably require, if any), (c) such Alteration is a nonstructural Alteration (as
provided above), (d) the Alteration does not affect the exterior of the Building or Premises and/or is not located on the street level and visible from the exterior of the Building or Premises, and (e)&nbsp;the Alteration work does not require a
building permit or other governmental permit, or if a building permit is required, the Alteration work costs less than $100,000 in each instance. At the time Tenant notifies Landlord of any Cosmetic Alteration, Tenant shall give Landlord a copy of
Tenant&#146;s plans for the work. If the Cosmetic Alteration is of such a nature that formal plans will not be prepared for the work, Tenant shall provide Landlord with a reasonably specific description of the work. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TENANT&#146;S CONTRACTORS-MECHANICS&#146; AND OTHER LIENS-STANDARD OF TENANT&#146;S PERFORMANCE-COMPLIANCE
WITH LAWS </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever Tenant shall make any Alterations in or to the Premises &#150; whether such work be done prior to
or after the Term Commencement Date &#150; Tenant will strictly observe the following covenants and agreements: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Tenant agrees that it
will not, either directly or indirectly, use any contractors and/or material suppliers if Tenant has actual knowledge that their use will create any difficulty, whether in the nature of a labor dispute or otherwise, with other contractors and/or
labor engaged by Tenant or Landlord or others in the construction, maintenance and/or operation of the Building or any part thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
In no event shall any material or equipment be incorporated in or added to the Premises, so as to become a fixture or otherwise a part of the Building, in connection with any such Alteration which is subject to any lien, charge, mortgage or other
encumbrance of any kind whatsoever or is subject to any security interest or any form of title retention agreement. No installations or work shall be undertaken or begun by Tenant until (i)&nbsp;Tenant has made provision for written waiver of liens
from all contractors, laborers and suppliers of materials for such installations or work, and taken other appropriate protective measures approved by Landlord; and (ii)&nbsp;Tenant has procured appropriate surety payment and performance bonds (which
such bonds shall only be required for installation work that exceed $500,000) which shall name Landlord as an additional obligee and has filed lien bond(s) (in jurisdictions where available) on behalf of such contractors, laborers and suppliers. Any
mechanic&#146;s lien filed against the Premises or the Building for work claimed to have been done for, or materials claimed to have been furnished to, Tenant shall be discharged by Tenant within ten (10)&nbsp;days thereafter, at Tenant&#146;s
expense by filing the bond required by law or otherwise. If Tenant fails so to discharge any lien, Landlord may do so at Tenant&#146;s expense and Tenant shall reimburse Landlord for any reasonable expense or cost incurred by Landlord in so doing
within fifteen (15)&nbsp;days after rendition of a bill therefor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) All installations or work done by Tenant shall be at its own expense and shall at all
times comply with (i)&nbsp;laws, rules, orders and regulations of governmental authorities having jurisdiction thereof; (ii)&nbsp;orders, rules and regulations of any Board of Fire Underwriters, or any other body hereafter constituted exercising
similar functions, and governing insurance rating bureaus; (iii)&nbsp;Rules and Regulations of Landlord; and (iv)&nbsp;plans and specifications prepared by and at the expense of Tenant theretofore submitted to and approved by Landlord. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Tenant shall procure and deliver to Landlord copies of all necessary permits before undertaking any work in the Premises; do all of such
work in a good and workmanlike manner, employing materials of good quality and complying with all governmental requirements; and provide two (2)&nbsp;complete sets of <FONT STYLE="white-space:nowrap">as-built</FONT> plans (one (1)&nbsp;reproducible
CAD or BIM file) and specifications covering any such Alteration or work requiring a building permit; and defend, save harmless, exonerate and indemnify Landlord from all injury, loss or damage to any person or property occasioned by or growing out
of such work. Tenant shall cause contractors employed by Tenant to carry Worker&#146;s Compensation Insurance in accordance with statutory requirements, Automobile Liability Insurance and, naming Landlord as an additional insured, Builder&#146;s
Risk insurance, Commercial General Liability Insurance covering such contractors on or about the Premises in the amounts stated in Article 15 hereof or in such other reasonable amounts (which may be lower) as Landlord shall require and to submit
certificates evidencing such coverage to Landlord prior to the commencement of such work. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>REPAIRS BY TENANT-FLOOR LOAD </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.1 <B>Repairs by Tenant.</B> Tenant shall keep all and singular the Premises neat and clean (including periodic rug shampoo and waxing of
tiled floors and cleaning of blinds and drapes) and in such repair, order and condition as the same are in on the Term Commencement Date or may be put in during the Term hereof, reasonable use and wearing thereof and damage by fire or by other
casualty or condemnation excepted. For purposes of this Lease, the terms &#147;reasonable use and wearing&#148; and &#147;ordinary wear and use&#148; (as referred to in Article 22 herein) and terms of similar meaning constitute that normal, gradual
deterioration which occurs due to aging and ordinary use of the Premises despite reasonable and timely maintenance and repair, but in no event shall the aforementioned terms excuse Tenant from its duty to keep the Premises in good maintenance and
repair or otherwise usable, serviceable and tenantable as required in the Lease. Tenant shall be solely responsible for the proper maintenance of all equipment and appliances located within or exclusively serving the Premises, including, without
limitation, all specialty and/or laboratory equipment and refrigerators. <B></B>Tenant shall be responsible for janitorial services to be provided to any bathrooms located within the Premises. Tenant shall make, as and when needed as a result of
misuse by, or neglect or improper conduct of, Tenant or Tenant&#146;s servants, employees, agents, contractors, invitees, or licensees or otherwise, all repairs in and about the Premises necessary to preserve them in such repair, order and
condition, which repairs shall be in quality and class equal to the original work, subject to Article 19 below. Landlord may elect, at the expense of Tenant, to make any such repairs or to repair any damage or injury to the Building or the Premises
caused by moving property of Tenant in or out of the Building, or by installation or removal of furniture or other property into the Premises, or by misuse by, or neglect, or improper conduct of, Tenant or Tenant&#146;s servants, employees, agents,
contractors, or licensees, if Tenant fails to perform such work after written notice to Tenant and fails to commence to perform such work within twenty (20)&nbsp;business days thereafter and diligently prosecute the same to completion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.2 <B>Floor Load-Heavy Machinery.</B> Tenant shall not place a load upon any floor of the Premises exceeding the floor load per square foot
of area which such floor was designed to carry and which is allowed by law. Landlord reserves the right to reasonably prescribe the weight and position of all business machines and mechanical equipment, including safes, which shall be placed so as
to distribute the weight. Business machines and mechanical equipment shall be placed and maintained by Tenant at Tenant&#146;s expense in settings sufficient in Landlord&#146;s judgment to absorb and prevent vibration, noise and annoyance to other
tenants or occupants in the Building. Tenant shall not move any safe, heavy machinery, heavy equipment, freight, bulky matter, or fixtures into or out of the Building without Landlord&#146;s prior written consent, which consent shall not be
unreasonably withheld, conditioned or delayed. If such safe, machinery, equipment, freight, bulky matter </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or fixtures requires special handling, Tenant agrees to employ only persons holding a Master Rigger&#146;s
License to do said work, and that all work in connection therewith shall comply with applicable laws and regulations. Any such moving shall be at the sole risk and hazard of Tenant and Tenant will defend, indemnify and hold Landlord harmless against
and from any liability, loss, injury, claim or suit resulting directly or indirectly from such moving. Proper placement of all such business machines, etc., in the Premises shall be Tenant&#146;s responsibility. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INSURANCE, INDEMNIFICATION, EXONERATION AND EXCULPATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.1 <B>General Liability Insurance.</B> During the Term of this Lease, Tenant shall procure, and keep in force and pay for: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Commercial General Liability Insurance insuring Tenant on an occurrence basis against all claims and demands for personal injury liability
(including, without limitation, bodily injury, sickness, disease, and death) or damage to property (which may be in form no less broad than ISO CG 00 01 12 04 (or the then successor equivalent from time to time)) claimed to have occurred from and
after the time Tenant and/or its contractors enter the Premises in accordance with Article 4 of this Lease, of not less than Five Million ($5,000,000) Dollars (which such limit may be achieved by a combination of primary and excess policies) in the
event of personal injury to any number of persons or damage to property, arising out of any one occurrence, and contain the &#147;Amendment of the Pollution Exclusion&#148; for damage caused by heat, smoke or fumes from a hostile fire and include so
called &#147;host&#148; liquor liability coverage or other reasonably satisfactory liquor liability coverage as and to the extent Tenant serves beer, wine or liquor at the Premises or (Roof Deck). The policy shall not contain any intra-insured
exclusions as between insured persons or organizations, but shall include coverage for liability assumed under this Lease as an &#147;insured contract&#148; for the performance of Tenant&#146;s indemnity obligations under this Lease. Landlord may
from time to time during the Term increase the coverages required of Tenant under this subparagraph (a)&nbsp;to that customarily carried by office and laboratory tenants in comparable first-class life science buildings in the Seaport District of
Boston, Massachusetts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Workers&#146; Compensation in amounts required by the State in which the Building is located and
Employer&#146;s Liability insurance in the amount of $3,000,000.00 per occurrence (which such limit may be achieved by a combination of primary and excess policies). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) So called loss of income and extra expense insurance in amounts as will reimburse Tenant for direct or indirect loss of earnings
attributable to all peril commonly insured against by prudent lessees in the business of Tenant or attributable to prevention of access to the Premises as a result of such perils. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) So called &#147;Special Form&#148; insurance coverage for all of its contents, furniture, furnishings, equipment, Tenant improvements,
trade fixtures and personal property (including Tenant&#146;s Removable Property) located at the Premises providing protection in an amount equal to one hundred percent (100%) of the replacement cost basis of said items. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Automobile liability insurance covering owned, <FONT STYLE="white-space:nowrap">non-owned</FONT> and hired vehicles in an amount not less
than a combined single limit of $1,000,000.00 combined single limit. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Any other form or forms of insurance as Tenant or Landlord or any
mortgagees of Landlord may reasonably require from time to time in form, in amounts and for insurance risks against which a prudent tenant would protect itself. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.2 <B>Certificates of Insurance.</B> Such insurance shall be effected with insurers reasonably approved by Landlord, authorized to do
business in the State wherein the Building is situated under valid and enforceable policies wherein Tenant names Landlord, Landlord&#146;s managing agent and Landlord&#146;s Mortgagees as additional insureds with respect to Tenant&#146;s commercial
general liability policy and automobile liability policy. Such insurance shall provide that it shall not be canceled or <FONT STYLE="white-space:nowrap">non-renewed</FONT> without at least thirty (30)&nbsp;days&#146; prior written notice to each
insured named therein. On or before the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
time Tenant and/or its contractors enter the Premises in accordance with Articles 4 and 14 of this Lease and thereafter not less than thirty (30) days prior to the expiration date of each
expiring policy, original copies of the policies provided for in Article 15.1 or 13(d) issued by the respective insurers, or certificates of such policies setting forth in full the provisions thereof and issued by such insurers together with
evidence reasonably satisfactory to Landlord of the payment of all premiums for such policies, shall be delivered by Tenant to Landlord and certificates as aforesaid of such policies shall upon request of Landlord, be delivered by Tenant to the
holder of any mortgage affecting the Premises. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.3 <B></B><B>General.</B> To the maximum extent the following agreement may be made
effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#146;s insurance requirements hereunder and Article 15 and Article 19, Tenant will save Landlord, its agents and employees, harmless
and will exonerate, defend and indemnify Landlord, its agents and employees, from and against any and all claims, liabilities or penalties asserted by or on behalf of any person, firm, corporation or public authority arising from the Tenant&#146;s
breach of the Lease or: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) On account of or based upon any injury to person, or loss of or damage to property, sustained or occurring on
the Premises on account of or based upon the act, omission, fault, negligence or misconduct of any person whomsoever; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) On account of or
based upon any injury to person, or loss of or damage to property, sustained or occurring elsewhere (other than on the Premises) in or about the Building, Complex, Common Areas or Land (and, in particular, without limiting the generality of the
foregoing, on or about the elevators, stairways, public corridors, sidewalks, concourses, arcades, parking areas and facilities, malls, galleries, approaches, areaways, roof, or other appurtenances and facilities used in connection with the
Building, Complex, Land or Premises) arising out of the use or occupancy of the Building or Premises by the Tenant, or by any person claiming by, through or under Tenant, or on account of or based upon the act, omission, fault, negligence or
misconduct of Tenant, its agents, employees or contractors; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) On account of or based upon (including monies due on account of) any work
or thing whatsoever done (other than by Landlord or its contractors, or agents or employees of either) on the Premises during the Term of this Lease and during the period of time, if any, prior to the Term Commencement Date that Tenant accesses the
Premises; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Tenant&#146;s obligations under this Article 15.3 shall be insured either under the Commercial General Liability
Insurance required under Article 15.1, above, or by a contractual liability insurance rider or other coverage; and certificates of insurance in respect thereof shall be provided by Tenant to Landlord upon request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.4 <B>Property of Tenant.</B> In addition to and not in limitation of the foregoing, Tenant covenants and agrees that, to the maximum extent
this agreement may be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#146;s insurance requirements hereunder and Article 15 and Article 19, all merchandise, furniture, fixtures
and property, inventory, research, experiments, laboratory animals, products, specimens, samples, and/or scientific, business, accounting and other records of every kind, nature and description related or arising out of Tenant&#146;s leasehold
estate hereunder, which may be in or upon the Premises or Building, in the public corridors, or on the sidewalks, areaways and approaches adjacent thereto, and any income derived or derivable therefrom, shall be at the sole risk and hazard of
Tenant, and that if the whole or any part thereof shall be damaged, destroyed, stolen or removed from any cause or reason whatsoever, no part of said damage or loss shall be charged to, or borne by, Landlord. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.5 <B></B><B>Bursting of Pipes, etc.</B> To the maximum extent the following agreement may
be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#146;s insurance requirements hereunder and Article 15 and Article 19, Landlord shall not be liable for any injury or damage
to persons or property resulting from fire, explosion, falling plaster, steam, gas, air contaminants or emissions, electricity, electrical or electronic emanations or disturbance, water, rain or snow or leaks from any part of the Building or from
the pipes, appliances, equipment or plumbing works or from the roof, street or subsurface or from any other place or caused by dampness, vandalism, malicious mischief or by any other cause of whatever nature, unless caused by or due to the
negligence of Landlord, its agents, servants or employees, and then only after (a)&nbsp;notice to Landlord of the condition claimed to constitute negligence and (b)&nbsp;the expiration of a reasonable time after such notice has been received by
Landlord without Landlord having taken all reasonable and practicable means to cure or correct such condition; and pending such cure or correction by Landlord, Tenant shall take all reasonably prudent temporary measures and safeguards to prevent any
injury, loss or damage to persons or property. In no event shall Landlord be liable for any loss, the risk of which is covered by Tenant&#146;s insurance or is required to be so covered by this Lease; nor shall Landlord or its agents be liable for
any such damage caused by other tenants or persons in the Building or caused by operations in construction of any private, public, or quasi-public work; nor shall Landlord be liable for any latent defect in the Premises or in the Building, subject,
however, to Section&nbsp;4.2(i) and Landlord&#146;s maintenance and repair obligations hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.6 <B>Repairs and <FONT
STYLE="white-space:nowrap">Alterations-No</FONT> Diminution of Rental Value</B><B>.</B> Except as otherwise provided in Articles 18 or 20 or Section&nbsp;8.8, there shall be no allowance to Tenant for diminution of rental value and no liability on
the part of Landlord by reason of inconvenience, annoyance or injury to Tenant arising from any repairs, alterations, additions, replacements or improvements made by Landlord, or any related work, Tenant or others in or to any portion of the
Building or Premises or any property adjoining the Building, or in or to fixtures, appurtenances, or equipment thereof, or for failure of Landlord or others to make any repairs, alterations, additions or improvements in or to any portion of the
Building, or of the Premises, or in or to the fixtures, appurtenances or equipment thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.7 <B>Landlord</B><B>&#146;</B><B>s
Indemnity</B>. To the maximum extent this agreement may be made effective according to law (subject to M.G.L. c. 186, &#167;15), but subject to Article 19 below, Landlord shall indemnify and save harmless Tenant (together with its officers,
directors, stockholders, partners, beneficial owners, trustees, managers, members, employees, agents, contractors and attorneys) from and against all claims of whatever nature arising from the negligence or willful misconduct of Landlord, or
Landlord&#146;s contractors, invitees (excluding other tenants, occupants, licensees and/or users of the Building or Complex), agents, servants or employees (&#147;Landlord&#146;s Agents&#148;). Landlord&#146;s obligations hereunder shall include
any other matters for which Landlord has agreed to indemnify Tenant pursuant to any other provision of this Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.8
<B>Landlord</B><B>&#146;</B><B>s Insurance.</B><B> </B>During the Term of this Lease, Landlord shall obtain and keep in force (a) a policy of commercial general liability insurance providing coverage to Landlord with respect to liability arising out
of ownership, operation and management of the Building in an amount of not less than Five Million and 00/100 Dollars ($5,000,000.00) combined single limit which; (b) a policy or policies of insurance covering loss or damage to the Building,
including Base Building Shell Work and Tenant Improvement Work (excluding any Tenant&#146;s Removable Property and/or other Tenant furniture, trade fixtures, equipment, specialty equipment or other personal property) caused by any peril covered
under fire, extended coverage and &#147;Special Form&#148; insurance in an amount not less than the replacement cost value above the foundation walls, as reasonably determined by Landlord from time to time, subject to commercially reasonable
deductibles and retention, but in no event less coverage than the coverage that is consistent with that maintained by prudent owners of comparable first-class life science buildings in the Seaport District of Boston, Massachusetts; (c) workers&#146;
compensation in amounts required by the State in which the Building is located; and (d)<B> </B>such other insurance coverages and policies as Landlord determines in its sole but good faith judgment. Any such coverages may be effected directly and/or
through the use of blanket insurance coverage covering more than one location and may contain such commercially reasonable deductibles as Landlord may elect in its reasonable discretion. The cost of such insurance shall be included in Operating
Costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ASSIGNMENT, MORTGAGING AND SUBLETTING </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.1 <B>Generally.</B><B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any other provisions of this Lease, Tenant covenants and agrees that it will not assign this Lease or sublet (which term,
without limitation, shall include the granting of any concessions, licenses, occupancy rights, management arrangements and the like) the whole or any part of the Premises to anyone, other than a Permitted Transferee, as hereinafter defined, without,
in each instance, except as otherwise expressly set forth in this Article, having first received the express, written consent of Landlord, which consent shall not be unreasonably withheld, conditioned or delayed. A change in Tenant&#146;s name shall
not constitute an assignment or sublease hereunder, provided Tenant notifies Landlord in writing of such name change prior to making such change. Tenant shall not collaterally assign this Lease (or any portion thereof) or permit any assignment of
this Lease by mortgage, other encumbrance or operation of law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Without limitation, it shall not be unreasonable for Landlord to
withhold such approval from any assignment or subletting where, in Landlord&#146;s opinion: (i)&nbsp;the proposed assignee satisfies the Net Worth Test (as defined in Section&nbsp;16.3(c) below) or any sublessee of thirty percent (30%) or more of
the Premises does not have a financial standing and credit rating reasonably acceptable to Landlord taking into account Tenant&#146;s continuing liability hereunder; (ii)&nbsp;the proposed assignee or sublessee has a bad reputation in the community;
(iii)&nbsp;the business in which the proposed assignee or sublessee is engaged could detract from the Building, its value or the costs of ownership thereof; (iv)&nbsp;the rent to be paid by any proposed sublessee is less than ninety percent (90%) of
the then current fair market rent; (v)&nbsp;the proposed sublessee or assignee is a current tenant of, or a prospective tenant in formal discussions with Landlord regarding the leasing of space in (meaning such tenant has been shown space in the
Building (or any portion of the Complex owned or controlled by a Landlord Party (as defined below) and Landlord (or Landlord Party) and such person or entity, or their brokers, have exchanged a letter of intent, even if not letter of intent has been
executed); (vi) the use of the Premises by any sublessee or assignee (even though a permitted use hereunder) violates any exclusive use or other use restriction in existence as of the Term Commencement Date granted by Landlord in any other lease or
would otherwise cause Landlord to be in violation of its obligations under another lease or agreement to which Landlord is a party; (vii)&nbsp;if such assignment or subleasing is not approved of by the holder of any mortgage on the Building or Land
(if such approval is required); (viii) a proposed assignee&#146;s or subtenant&#146;s business will impose a burden on the Common Areas or other facilities serving the Building or the Land that is greater than the burden imposed by Tenant, in
Landlord&#146;s reasonable judgment; (ix)&nbsp;any guarantor of this Lease refuses to consent to the proposed transfer or to execute a written agreement reaffirming the guaranty; (x)&nbsp;Tenant is in default, beyond any applicable notice or Grace
Period, of any of its obligations under the Lease at the time of the request or at the time of the proposed assignment or sublease; (xi)&nbsp;if requested by Landlord, the assignee or subtenant refuses to sign a commercially reasonable <FONT
STYLE="white-space:nowrap">non-disturbance</FONT> and attornment agreement in favor of Landlord&#146;s lender; (xii)&nbsp;Landlord has sued or been sued by the proposed assignee or subtenant or has otherwise been involved in a legal dispute with the
proposed assignee or subtenant; (xiii)&nbsp;the assignee or subtenant is involved in a business which is not in keeping with the then current standards of the Building; (xiv)&nbsp;the assignment or sublease will result in there being more than four
(4)&nbsp;separately demised occupants (either Tenant or subtenants) of the fourth (4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) floor of the Premises or more than three (3)&nbsp;separately demised occupants (either Tenant or subtenants)
of the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor of the Premises, but in no event shall any assignment, subleasing or granting of occupancy rights result in a violation or breach of the Current Exclusive; or
(xv)&nbsp;the assignee or subtenant is a governmental or quasi-governmental entity or an agency, department or instrumentality of a governmental or quasi-governmental agency. In no event, however, shall Tenant assign this Lease or sublet the whole
or any part of the Premises to a proposed assignee or sublessee which has been judicially declared bankrupt or insolvent according to law, or with respect to which an assignment has been made of property for the benefit of creditors, or with respect
to which a receiver, guardian, conservator, trustee in involuntary bankruptcy or similar officer has been appointed to take charge of all or any substantial part of the proposed assignee&#146;s or sublessee&#146;s property by a court of competent
jurisdiction, or with respect to which a petition has been filed for reorganization under any provisions of the Bankruptcy Code now or hereafter enacted, or if a proposed assignee or sublessee has filed a petition for such reorganization, or for
arrangements under any provisions of the Bankruptcy Code now or hereafter enacted and providing a plan for a debtor to settle, satisfy or extend the time for the payment of debts. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Any request by Tenant for such consent shall set forth or be accompanied by, in detail reasonably satisfactory to Landlord, the
identification of the proposed assignee or sublessee, its financial condition, a list of Hazardous Materials (as defined below), certified by the proposed assignee or sublessee to be true and correct, which the proposed assignee or sublessee intends
to use, store, handle, treat, generate in or release or dispose of from the Premises, together with copies of all documents relating to such use, storage, handling, treatment, generation, release or disposal of Hazardous Materials by the proposed
assignee or subtenant in or about the Premises (if same is different from Tenant&#146;s then current Hazardous Materials activities), the nature of the proposed assignee&#146;s or sublessee&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business, their proposed use of the Premises and their business experience in the uses thereof and the terms on which the proposed assignment or subletting is to be made, including, without
limitation, a signed copy of all assignment or sublease documents, and clearly stating the rent or any other consideration to be paid in respect thereto, certificates of good standing (or certificates of qualification to do business in the
Commonwealth if such proposed assignee or sublessee is a foreign entity) of the proposed assignee or sublessee issued by the Secretary of the Commonwealth of Massachusetts; the filing with EDIC by the proposed assignee or subtenant of a statement
disclosing the identification of all parties who are required to be disclosed pursuant to Massachusetts General Laws, Chapter 7C, Section&nbsp;38, as having a beneficial interest, direct or indirect, in the Lease after the assignment or in the
Sublease as of the date of execution thereof, and a supplemental statement upon any change in such parties during the terms thereof within thirty (30)&nbsp;days of any such change, all in compliance with Massachusetts General Laws, Chapter 7C,
Section&nbsp;38, and any other information reasonably requested by Landlord (or EDIC); and such request shall be treated as Tenant&#146;s warranty to the best of Tenant&#146;s knowledge in respect of the information submitted therewith. If
requested, Landlord shall enter into a commercially reasonable <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement required by Tenant or any such proposed transferee with respect to any financial or other confidential information of
such Transferee to be provided to Landlord as required herein. Tenant&#146;s request shall not be deemed complete or submitted until all of the foregoing information has been received by Landlord. Landlord shall respond in writing to such written
request for consent within twenty (20)&nbsp;days following Landlord&#146;s receipt of all information, documentation and security required by Landlord with respect to such proposed sublease or assignment; provided EDIC approval, if required, may
take longer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Any assignee or sublessee hereunder shall comply with the <FONT STYLE="white-space:nowrap">Non-Discrimination</FONT> and
Equal Opportunity Covenants set forth in Section&nbsp;16.1 of the EDIC Lease and Employment of Boston Residents set forth in Section&nbsp;18.36 and Exhibit O of the EDIC Lease, which are restated in full in Exhibit 7 attached hereto, wherein the
term &#147;Tenant&#148; shall mean Tenant hereunder and &#147;Landlord&#148; shall mean the Landlord under the EDIC Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The
foregoing restrictions shall be binding on any assignee or sublessee to which Landlord has consented, provided, notwithstanding anything else contained in this Lease, Landlord&#146;s consent to any further assignment, subleasing or any <FONT
STYLE="white-space:nowrap">sub-subleasing</FONT> by any approved assignee or sublessee may be withheld by Landlord as provided in this Article 16. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Consent by Landlord to any subleasing shall not include consent to the assignment or transferring of any lease renewal, extension or other
option, first offer, first refusal or other rights granted hereunder, or any special privileges or extra services granted to tenant by separate agreement (written or oral), or by addendum or amendment of the Lease. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) In the case of any assignment of this Lease or subletting of the Premises, the Tenant named herein shall be and remain fully and primarily
liable for the obligations of Tenant hereunder, notwithstanding such assignment or subletting, including, without limitation, the obligation to pay the Yearly Rent and other amounts provided under this Lease, and the Tenant shall be deemed to have
waived all suretyship defenses. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) In addition to the foregoing, it shall be a condition of the validity of any such assignment or
subletting that the assignee or sublessee agrees directly with Landlord, in form satisfactory to Landlord, to be bound by all the obligations of Tenant hereunder, but excluding, in the case of a sublease, the obligation to pay Yearly Rent and other
amounts provided for under this Lease (except to the extent passed through to Subtenant pursuant to the sublease), the covenant regarding use and the covenant against further assignment and subletting (and that (i)&nbsp;any sublessee agree it will
not breach, or cause Landlord to breach, any of the provisions of the EDIC Lease applicable to the Premises; and (ii)&nbsp;subject to Section&nbsp;23(a) below, any sublease shall, in the event the EDIC Lease is terminated prior to the expiration of
such sublease, then at EDIC&#146;s option, the sublessee thereunder will either attorn to EDIC and waive any right the sublessee may have to terminate the sublease, or surrender possession thereunder as a result of the termination of the EDIC Lease,
and the sublease shall terminate simultaneously with the termination or expiration of the EDIC Lease; and (iii)&nbsp;that in the event any sublessee receives a written notice from EDIC stating that an Event of Default has occurred under the EDIC,
the sublessee shall thereafter be obligated to pay all rentals accruing under such sublease directly to EDIC or as EDIC may direct. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.2 <B>Reimbursement, Recapture and Excess Rent.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall, within thirty (30)&nbsp;days after receipt on an invoice therefor, reimburse Landlord for the reasonable, actual <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and expenses (including legal and administrative fees and costs) incurred by Landlord in processing any request to assign this Lease or to sublet all or any
portion of the Premises, whether or not Landlord agrees thereto, and if Tenant shall fail promptly so to reimburse Landlord, the same shall be a default in Tenant&#146;s monetary obligations under this Lease subject to the Monetary Grace Period, if
applicable, set forth in Section&nbsp;21.7 below. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If Tenant requests Landlord&#146;s consent to assign this Lease or sublet (or
otherwise grant occupancy rights in and to) all or more than fifty percent (50%)<B> </B>of the Total Rentable Area Premises, except in the case of a Permitted Transferee, Landlord shall have the option, exercisable by written notice to Tenant given
within twenty (20)&nbsp;days after Landlord&#146;s receipt of Tenant&#146;s completed request, to terminate this Lease as of the date specified in such notice from Landlord to Tenant, which termination shall not be effective less than sixty
(60)&nbsp;nor more than one hundred twenty (120)&nbsp;days after the date of such notice, as to the entire Premises in the case of a proposed assignment or subletting of the whole Premises, and as to the portion of the Premises to be sublet in the
case of a subletting of a portion. In the event of termination in respect of a portion of the Premises, the portion so eliminated shall be delivered to Landlord on the date specified in the manner provided in this Lease at the end of the Term and
thereafter, to the extent necessary in Landlord&#146;s reasonable judgment, Landlord, at its own cost and expense, may have access to and may make modification to the Premises (or portion thereof) to the extent reasonably necessary and in
consultation with Tenant so as to make such portion a self-contained rental unit with access to common areas, elevators and the like. Yearly Rent and the rentable floor area of the Premises (and any calculations based thereon) shall be adjusted
according to the extent of the Premises for which the Lease is terminated. Notwithstanding the foregoing, if Landlord exercises its foregoing recapture rights, then Tenant, upon written notice to Landlord, may revoke its request for Landlord&#146;s
consent to an assignment of this Lease or sublease of more than 50% of the Total Rentable Area of the Premises within ten (10)&nbsp;business days of its receipt of Landlord&#146;s termination notice, in which case this Lease shall not terminate and
shall remain in full force and effect with respect to the entire Lease, in the case of any assignment of this Lease, or to the portion of the Premises proposed by Tenant to be sublet in the case of a sublease of more than 50% of the Total Rentable
Area of the Premises. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Without limitation of the rights of Landlord hereunder in respect thereto, if there is any assignment of this
Lease by Tenant for consideration or a subletting of the whole of the Premises by Tenant at a rent which exceeds the rent payable hereunder by Tenant, or if there is a subletting of a portion of the Premises by Tenant at a rent in excess of the
subleased portion&#146;s pro rata share of the rent payable hereunder by Tenant, then Tenant shall pay to Landlord, as Additional Rent, within thirty (30)&nbsp;days after Tenant&#146;s receipt of the same, in the case of an assignment, fifty percent
(50%) of all of the consideration (or the cash equivalent thereof) therefor and in the case of a subletting, all of any such excess rent. For the purposes of this subsection, the term &#147;rent&#148; shall mean all Yearly Rent, Additional Rent or
other payments and/or consideration payable by one party to another for the use and occupancy of all or a portion of the Premises including, without limitation, key money, or bonus money paid by the assignee or subtenant to Tenant in connection with
such transaction and any payment in excess of fair market value for services rendered by Tenant to the assignee or subtenant or for assets, fixtures, inventory, equipment or furniture transferred by Tenant to the assignee or subtenant in connection
with any such transaction, but shall exclude any separate payments by Tenant for reasonable attorney&#146;s fees and broker&#146;s commissions and market-based tenant improvement costs to ready the Premises (or portion thereof) for such
transferee&#146;s occupancy, free rent periods, attorneys&#146; fees, and other such third party costs incurred by Tenant and relating to such transfer, such costs to be amortized ratably over the term of such transfer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything contained in this Article 16, Landlord will have the right to (i)&nbsp;negotiate directly with any proposed
assignee or sublessee of Tenant, and (ii)&nbsp;enter into a direct lease with any proposed assignee or sublessee of Tenant for any space in the Building or Complex, including the space covered by the proposed sublease or assignment, on such terms
and conditions as are mutually acceptable to the proposed assignee or sublessee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The following terms and conditions shall apply to any
subletting by Tenant of all or any part of the Premises and shall be deemed included in all subleases under this Lease whether or not expressly incorporated therein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Tenant hereby absolutely and unconditionally assigns and transfers to Landlord all of Tenant&#146;s interest in all rentals and income arising
from any sublease entered into by Tenant, and Landlord may collect such rent and income and apply same toward Tenant&#146;s obligations under this Lease; provided, however, that until a default </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
occurs in the performance of Tenant&#146;s obligations under this Lease, Tenant may receive, collect and enjoy the rents accruing under such sublease. Landlord shall not, by reason of this or any
other assignment of such rents to Landlord nor by reason of the collection of the rents from a subtenant, be deemed to have assumed or recognized any sublease or to be liable to the subtenant for any failure of Tenant to perform and comply with any
of Tenant&#146;s obligations to such subtenant under such sublease, including, but not limited to, Tenant&#146;s obligation to return any security deposit. Tenant hereby irrevocably authorizes and directs any such subtenant, upon receipt of a
written notice from Landlord (with copy to Tenant) stating that a default exists in the performance of Tenant&#146;s obligations under this Lease, to pay to Landlord the rents due as they become due under the sublease. Tenant agrees that such
subtenant shall have the right to rely upon any such statement and request from Landlord, and that such subtenant shall pay such rents to Landlord without any obligation or right to inquire as to whether such default exists and notwithstanding any
notice from or claim from Tenant to the contrary. In the event Tenant shall default in the performance of its obligations under this Lease or Landlord terminates this Lease by reason of a default of Tenant, Landlord at its option and without any
obligation to do so, may require any subtenant to attorn to Landlord, in which event Landlord shall undertake the obligations of Tenant under such sublease from the time of the exercise of said option to the termination of such sublease; provided,
however, Landlord shall not be liable for any prepaid rents or security deposit paid by such subtenant to Tenant, except to the extent actually received by Landlord, or for any other prior defaults of Tenant under such sublease. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.3 <B>Certain Transfers.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The provisions of this Section&nbsp;16.3(a) shall not be applicable so long as the Tenant is a corporation, the outstanding voting stock of
which is listed on a recognized security exchange, or if at least eighty percent (80%) of Tenant&#146;s ownership interests is owned by corporation or other entity, the voting stock of which is so listed. If at any time Tenant&#146;s interest in
this Lease is held by a corporation, trust, partnership, limited liability company or other entity, the transfer of more than fifty percent (50%) (or such lesser percentage which results in a change in the control of Tenant) of the voting stock,
beneficial interests, partnership interests, membership interests or other ownership interests of Tenant (whether at one time or in the aggregate) shall be deemed an assignment of this Lease, and shall require Landlord&#146;s prior written consent,
which consent shall not unreasonably with withheld, delayed or conditioned provided, however, it shall not be unreasonable for Landlord to withhold such approval for any of the reasons set forth in Section&nbsp;16.1(b). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) To enable Landlord to determine the ownership of Tenant, Tenant agrees to furnish to Landlord, from time to time promptly after
Landlord&#146;s request therefor, (i)&nbsp;if the first sentence of subsection 16.3(a) is applicable, proof of listing on a recognized security exchange, or (ii)&nbsp;if the first sentence of subsection 16.3(a) is not applicable, an accurate and
complete listing of the holders of its stock, beneficial interests, partnership interests, membership interests or other ownership interests therein as of such request and as of the date of this Lease. Landlord shall execute a commercially
reasonable <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement prior to Tenant&#146;s obligation to deliver such information, whereupon Landlord shall keep confidential any information received by Landlord pursuant to this
Section&nbsp;16.3(b), provided, however, that Landlord shall have the right to disclose any such information to existing or prospective mortgagees, or prospective purchasers of the Building, to the extent reasonably necessary or so requested
provided such mortgagees or purchasers agree to be bound by such <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
Notwithstanding any other provision of this Article 16, transactions with an entity (a &#147;Permitted Transferee&#148;) (i) into or with which Tenant is merged or consolidated, (ii)&nbsp;to which substantially all of Tenant&#146;s assets are
transferred as a going concern, or (iii)&nbsp;which controls or is controlled by Tenant or is under common control with Tenant, shall not be deemed to be an assignment or subletting within the meaning of this Article 16, provided that in any of such
events (i.e., (i), (ii) or (iii)) (1) Landlord receives prior written notice of any such transactions, except in the event where Tenant is contractually obligated to keep confidential such matters relating to the transaction with the Permitted
Transferee, in which case Tenant shall provide such notice to Landlord promptly after the closing of such transaction, (2)&nbsp;the assignee or subtenant agrees directly with Landlord, by written instrument in form satisfactory to Landlord, to be
bound by all the obligations of Tenant hereunder including, without limitation, the covenant against further assignment and subletting (excepting in the case of subleasing, as appropriately modified by the nature of the transaction (e.g., a
subtenant shall be obligated to pay only the rent required under such sublease), but in no way otherwise amending the terms and conditions of this Lease), (3) in no event shall Tenant be released from its obligations under this Lease, (4)&nbsp;any
such transfer or transaction is for a legitimate, regular business purpose of Tenant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other than a transfer of Tenant&#146;s interest in this Lease, (5)&nbsp;the involvement by Tenant or its assets in any transaction, or series of transactions (by way of merger, sale, acquisition,
financing, refinancing, transfer, leveraged <FONT STYLE="white-space:nowrap">buy-out</FONT> or otherwise) whether or not a formal assignment or hypothecation of this Lease or Tenant&#146;s assets occurs, will not result in a reduction of the
&#147;Net Worth&#148; of Tenant (or the successor to Tenant&#146;s interest in the Lease pursuant thereto) as hereinafter defined, by an amount equal to such Net Worth of Tenant as it is represented to Landlord at the time of the execution by
Landlord of this Lease, or as it exists immediately prior to said transaction or transactions constituting such reduction, at whichever time said Net Worth of Tenant was or is greater (the &#147;Net Worth Test&#148;), and (6)&nbsp;Landlord must
obtain any EDIC consent thereto as and to the extent provided in the EDIC Lease (defined below). &#147;Net Worth&#148; of Tenant for purposes of this section shall be the tangible net worth of Tenant (excluding any guarantors) established under
generally accepted accounting principles consistently applied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything in this Lease to the contrary, including this
Section&nbsp;16.3, Tenant shall have the right (without Landlord&#146;s consent but upon reasonable prior notice) to enter into licenses or other occupancy agreements to allow Tenant&#146;s Affiliates (as defined below), for so long as same remain a
Tenant&#146;s Affiliate, to use and occupy the Premises, provided that (A)&nbsp;such parties shall not be deemed to be subtenants or assignees of Tenant at the Premises, and (B)&nbsp;Tenant shall ensure that such parties comply with all terms and
conditions of this Lease. For purposes of the prior sentence, &#147;Tenant&#146;s Affiliate&#148; means any entity owned or controlled by Tenant (for so long as same remains so owned or controlled). In addition, any space occupied by a Tenant&#146;s
Affiliate shall be included as space occupied by Tenant for purposes of Tenant&#146;s additional benefits or rights under this Lease including, without limitation, Sections 17.4(a) (Signage), 29.16(a) (Option to Extend) and 29.18 (Right of First
Offer). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MISCELLANEOUS COVENANTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant covenants and agrees as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.1 <B>Rules and Regulations.</B> Tenant will faithfully observe and comply with the Rules and Regulations, if any, annexed hereto, including
without limitation the current rules and regulations, a copy of which are attached hereto as Exhibit 5 and such other and further reasonable Rules and Regulations as Landlord hereafter at any time or from time to time may make and may communicate in
writing to Tenant (the &#147;Rules and Regulations&#148;), which in the reasonable judgment of Landlord shall be necessary for the reputation, safety, care or appearance of the Building, or the preservation of good order therein, or the operation or
maintenance of the Building, or the equipment thereof, or the comfort of tenants or others in the Building, provided, however, that in the case of any conflict between the provisions of this Lease and any such regulations, the provisions of this
Lease shall control, and provided further that nothing contained in this Lease shall be construed to impose upon Landlord any duty or obligation to enforce the Rules and Regulations or the terms, covenants or conditions in any other lease as against
any other tenant and Landlord shall not be liable to Tenant for violation of the same by any other tenant or such other tenant&#146;s servants, employees, agents, contractors, visitors, invitees or licensees (provided, however, if Landlord enforces
the Rules and Regulations, it shall enforce them in a <FONT STYLE="white-space:nowrap">non-discriminatory</FONT> manner against all tenants in the Building). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.2 <B>Access to Premises.</B> Tenant shall upon reasonable prior notice from Landlord (except that no notice shall be required in emergency
situations): (a) permit Landlord to erect, use and maintain pipes, ducts and conduits in and through the Premises, provided the same do not materially reduce the floor area or materially adversely affect the appearance thereof; (b)&nbsp;upon
reasonable prior oral notice (except that no notice shall be required in emergency situations), permit Landlord and any mortgagee of the Building or the Building and Land or of the interest of Landlord therein, and any lessor under any ground or
underlying lease, and their representatives, to have access to and to enter upon the Premises at all reasonable hours for the purposes of inspection or of making repairs, replacements or improvements in or to the Premises or the Building or
equipment (including, without limitation, sanitary, electrical, heating, air conditioning or other systems) or of complying with all laws, orders and requirements of governmental or other authority or of exercising any right reserved to Landlord by
this Lease (including the right during the progress of any such repairs, replacements or improvements or while performing work and furnishing materials in connection with compliance with any such laws, orders or requirements to take upon or through,
or to keep and store within, the Premises all necessary materials, tools and equipment); and (c)&nbsp;permit Landlord, at reasonable times, to show the Premises during ordinary </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business hours to any existing or prospective mortgagee, ground lessor, space lessee, purchaser, or assignee of any mortgage, of the Building or of the Building and the land or of the interest of
Landlord therein, and during the period of twelve (12)&nbsp;months next preceding the Termination Date to any person contemplating the leasing of the Premises or any part thereof. Landlord and Tenant shall cooperate in good faith to schedule any
such access such that Tenant or a representative of Tenant may be personally present to open and permit an entry into the Premises and may accompany Landlord and its visitors, and further provided, except in the event of an emergency, Landlord shall
not access the vivarium without being accompanied by a representative of Tenant. If an excavation shall be made upon land adjacent to the Premises or shall be authorized to be made, Tenant shall afford to the person causing or authorized to cause
such excavation, license to enter upon the Premises for the purpose of doing such work as said person shall deem necessary to preserve the Building from injury or damage and to support the same by proper foundations without any claims for damages or
indemnity against Landlord, or diminution or abatement of rent. In exercising its right of entry hereunder, Landlord shall (i)&nbsp;use good faith, commercially reasonable efforts to minimize any interference with Tenant&#146;s use and occupancy of
the Premises or its business operations therein, (ii)&nbsp;not reduce (except to a de minimis extent) the number of usable square feet in the Premises, which means that, without limitation, any structures, facilities or improvements made by Landlord
and installed in the Premises shall, to the extent practical, be behind finished walls, above ceiling titles (if any) or against the underside of the roof deck or below any finished flooring, or (iii)&nbsp;create undue noise and vibration that
interferes with Tenant&#146;s use or occupancy of the Premises. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.3 <B>Accidents to Sanitary and Other Systems</B><B>.</B> Tenant shall
give to Landlord prompt notice of any fire or accident in the Premises or in the Building and of any damage to, or defective condition in, any part or appurtenance of the Building including, without limitation, sanitary, electrical, ventilation,
heating and air conditioning or other systems located in, or passing through, the Premises. Except as otherwise provided in Articles 18, 19 and 20, and subject to Tenant&#146;s obligations in Article 14, such damage or defective condition shall be
remedied by Landlord with commercially reasonable diligence, but if such damage or defective condition was caused by Tenant or by the employees, licensees, contractors or invitees of Tenant, the cost to remedy the same shall be paid by Tenant. In
addition, all reasonable costs incurred by Landlord in connection with the investigation of any notice given by Tenant shall be paid by Tenant if the reported damage or defective condition was caused by Tenant or by the employees, licensees,
contractors, or invitees of Tenant, subject to Article 19. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.4 <B>Signs, Blinds and Drapes. </B>(a)&nbsp;Signage. Subject to the
provisions of this Section&nbsp;17.4(a), and provided that (i)&nbsp;this Lease is still in full force and effect, and (ii)&nbsp;the Tenant originally named herein (including any Tenant Affiliate(s)) or a Permitted Transferee is leasing 100% of, and
occupying at least 75% of, the Rentable Area of the Premises for the principal and primary uses allowed hereunder, the Tenant originally named herein or a Permitted Transferee, as the case may be, shall have the signage rights set forth in this
Subsection (a)&nbsp;and (b) for the sole purpose of identifying Tenant or Permitted Transferee, as the case may be, subject to the terms and conditions hereof (collectively, &#147;Tenant Signage&#148;), at Tenant&#146;s sole cost and expense. All of
the Tenant Signage (including location, size, design, logo, color(s) and degree of illumination, if any, and method of attachment to the Building) shall be subject to the prior approval of Landlord (such approval not to be unreasonably withheld,
conditioned or delayed) and installed, maintained and operated in compliance with all applicable laws, rules, regulations, ordinances, and restrictions. If necessary, Landlord shall provide electrical service to the exterior portion of the Building
approximately where Tenant&#146;s Signage is to be located at Landlord&#146;s actual reasonable cost, reimbursed by Tenant. Tenant shall be responsible for obtaining and maintaining all necessary permits and approvals for all such Tenant Signage
(and Landlord shall reasonably cooperate with Tenant in connection therewith at no additional cost or liability to Landlord), along with all costs and expenses incurred by Landlord in connection therewith (including any taxes or assessments thereon
and the cost of providing and maintaining electrical service thereto). Tenant shall pay such amounts within thirty (30)&nbsp;days of Landlord&#146;s invoice therefor, provided, however, that Building standard signage in the building directory shall
be at Landlord&#146;s cost and expense. At the expiration of earlier termination of the Lease, or in the event the Tenant originally named herein or a Permitted Transferee ceases to lease 100% of, or occupy at least 75% of, the Rentable Area of the
Premises, all as provided above, (except for periods of casualty, restoration or remodeling), Landlord shall have the right, at Tenant&#146;s sole and reasonable cost and expense, to remove Tenant&#146;s Signage and repair and restore the Building
to the substantially the same condition existing prior to such installation, or at Landlord&#146;s election, Landlord shall require Tenant to so repair or restore. Subject to the provisions hereof, Landlord reserves the right to retain and grant
other parties signage rights in, on or about the Building. Except as expressly set forth in this Section&nbsp;17.4, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Tenant shall put no signs in any part of the Common Areas of the Building or Complex. Any signs or lettering in the public corridors or on the doors shall conform to Landlord&#146;s building
standard design. Neither Landlord&#146;s name, nor the name of the Building or Complex of which the Building is a part, or the name of any other structure erected therein shall be used without Landlord&#146;s consent, not to be unreasonably
withheld, conditioned, or delayed, in any advertising material (except on business stationery or as an address in advertising matter), nor shall any such name, as aforesaid, be used in any undignified, confusing, detrimental or misleading manner.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Exterior and Lobby Tenant Signage. Subject to Subsection (a)&nbsp;above, Tenant shall have the right to install and maintain, at
Tenant&#146;s sole cost and expense, the exterior Tenant Signage and lobby Tenant Signage as more particularly shown on Exhibit 11 (the &#147;Lobby Sign&#148;). So long as Tenant (including any Tenant Affiliate(s)) or a single Permitted Transferee
is leasing 100% of, and occupying substantially all of, the Rentable Area of the Premises for the principal and primary uses set forth in Exhibit 1, primarily for life science purposes, no other future tenant in the Building leasing less space than
Tenant shall receive more favorable (in terms of size or prominence of signage) exterior or lobby signage rights in or at the Building; provided, however, the foregoing restriction shall not apply to any tenant or occupant of the Building that has
its own exclusive Building entrance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Directory and Building Standard Signage. Tenant shall be entitled at no cost to Tenant to have
its name (and other Building standard information) inserted in any Building or Complex main directory so long as such directory is established and maintained by Landlord and to have Tenant&#146;s name in any lobby directory (if any) of any
multi-tenanted floor containing a portion of the Premises along with Building standard suite signage; provided, however, changes to such signage and directory(ies) required by changes in Tenant&#146;s name or expansion or as the result of a transfer
in accordance with Article 16 above, shall be at Tenant&#146;s sole cost and expense. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Blinds and Drapes. No signs or blinds may be put
on or in any window or elsewhere if visible from the exterior of the Building, nor may the building standard drapes or blinds be removed by Tenant. Tenant may hang its own drapes, provided that they shall not in any way interfere with the building
standard drapery or blinds or be visible from the exterior of the Building and that such drapes are so hung and installed that when drawn, the building standard drapery or blinds are automatically also drawn. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.5 <B></B><B>Estoppel Certificate and Financial Statements.</B> Tenant shall at any time and from time to time upon not less than twelve
(12)&nbsp;business days&#146; prior written notice by Landlord to Tenant, execute, acknowledge and deliver to Landlord a statement in writing certifying that this Lease is unmodified and in full force and effect (or if there have been modifications,
that the same is in full force and effect as modified and stating the modifications), and the dates to which the Yearly Rent and other charges have been paid in advance, if any, stating whether or not Landlord is in default in performance of any
covenant, agreement, term, provision or condition contained in this Lease and, if so, specifying each such default and such other facts as Landlord may reasonably request, it being intended that any such statement delivered pursuant hereto may be
relied upon by any prospective purchaser of the Building or of the Building and the land or of any interest of Landlord therein, any mortgagee or prospective mortgagee thereof, any lessor or prospective lessor thereof, any lessee or prospective
lessee thereof, or any prospective assignee of any mortgage thereof. Time is of the essence in respect of any such requested certificate, Tenant hereby acknowledging the importance of such certificates in mortgage financing arrangements, prospective
sale and the like. If Tenant fails to execute and deliver such statement within such <FONT STYLE="white-space:nowrap">12-business</FONT> day period, Landlord shall so notify Tenant in writing, and thereafter if Tenant does not execute and deliver
such statement to Landlord within three (3)&nbsp;business days, then Tenant hereby appoints Landlord Tenant&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> in its name and behalf to execute
such statement. If requested by Tenant, Landlord shall execute and deliver an estoppel certificate to Tenant on the same terms and conditions as this Section&nbsp;17.5 Within 120 days after the end of Tenant&#146;s fiscal years during the Term of
this Lease, Tenant agrees to furnish to Landlord copies of Tenant&#146;s most recent annual financial statements, audited if available (if such audited financial statement is not available, such financial statement may be certified by an officer
(vice president or higher) of Tenant). The financial statements shall be prepared in accordance with generally accepted accounting principles, consistently applied. The financial statements shall include a balance sheet and a statement of profit and
loss, and the annual financial statement shall also include a statement of changes in financial position and appropriate explanatory notes. Prior to the delivery of such financial statements, Landlord shall enter into a commercially reasonably <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> agreement, and Landlord may deliver the financial statements to any prospective or existing mortgagee or purchaser of the Building and/or Land provided that such mortgagee or purchaser also enter into
such <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.6 <B>Prohibited Materials and Property. </B>Except as otherwise expressly provided in
this Lease,<B> </B>Tenant shall not bring or permit to be brought or kept in or on the Premises or elsewhere in the Building (a)&nbsp;any inflammable, combustible or explosive fluid, material, chemical or substance including, without limitation, any
hazardous substances as defined under Massachusetts General Laws chapter 21E, the Federal Comprehensive Environmental Response Compensation and Liability Act (CERCLA), 42 USC &#167;9601 et seq., as amended, under Section&nbsp;3001 of the Federal
Resource Conservation and Recovery Act of 1976, as amended, or under any regulation of any governmental authority regulating environmental or health matters (except for standard office supplies stored in proper containers), (b) any materials,
appliances or equipment (including, without limitation, materials, appliances and equipment selected by Tenant for the construction or other preparation of the Premises and furniture and carpeting) which pose any danger to life, safety or health or
may cause damage, injury or death, or (c)&nbsp;any unique, unusually valuable, rare or exotic property, work of art or the like unless the same is fully insured under <FONT STYLE="white-space:nowrap">all-risk</FONT> coverage. Nor shall Tenant cause
or permit any potentially harmful air emissions, odors of cooking or other processes, or any unusual or other objectionable odors or emissions to emanate from or permeate the Premises. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.7 <B></B><B>Requirements of <FONT STYLE="white-space:nowrap">Law-Fines</FONT> and Penalties.</B> Tenant at its sole expense shall comply
with all laws, rules, orders and regulations, including, without limitation, all energy-related requirements, of Federal, State, County and Municipal Authorities and with any direction of any public officer or officers, pursuant to law, which shall
impose any duty upon Landlord or Tenant with respect to or arising out of Tenant&#146;s use or occupancy of the Premises. Tenant shall reimburse and compensate Landlord for all expenditures made by, or damages or fines sustained or incurred by,
Landlord due to nonperformance or noncompliance with or breach or failure to observe any item, covenant, or condition of this Lease upon Tenant&#146;s part to be kept, observed, performed or complied with. If Tenant receives notice of any violation
of law, ordinance, order or regulation applicable to the Premises, it shall give prompt notice thereof to Landlord. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.8
<B></B><B>Tenant&#146;s Acts&#151;Effect on Insurance.</B> Tenant shall not do or permit to be done any act or thing upon the Premises or elsewhere in the Building which will invalidate or be in conflict with any insurance policies covering the
Building and the fixtures and property therein; and shall not do, or permit to be done, any act or thing upon the Premises which shall subject Landlord to any liability or responsibility for injury to any person or persons or to property by reason
of any business or operation being carried on upon said Premises or for any other reason. Landlord represents and warrants to Tenant that the insurance policies covering the Building allow the Permitted Use without taking into account Tenant&#146;s
specific manner of use(s) thereunder. Tenant at its own expense shall comply with all rules, orders, regulations and requirements of the Board of Fire Underwriters, or any other similar body having jurisdiction, and shall not (a)&nbsp;do, or permit
anything to be done, in or upon the Premises, or bring or keep anything therein, except as now or hereafter permitted by the Fire Department, Board of Underwriters, Fire Insurance Rating Organization, or other authority having jurisdiction, and then
only in such quantity and manner of storage as will not increase the rate for any insurance applicable to the Building, or (b)&nbsp;use the Premises in a manner which shall increase such insurance rates on the Building, or on property located
therein, over that applicable when Tenant first took occupancy of the Premises hereunder. If by reason of the failure of Tenant to comply with the provisions hereof the insurance rate applicable to any policy of insurance shall at any time
thereafter be higher than it otherwise would be, the Tenant shall reimburse Landlord for that part of any insurance premiums thereafter paid by Landlord, which shall have been charged because of such failure by Tenant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.9 <B></B><B>Miscellaneous.</B> Tenant shall not suffer or permit the Premises or any fixtures, equipment or utilities therein or serving the
same, to be overloaded, damaged or defaced. Tenant shall not suffer or permit any employee, contractor, business invitee or visitor to violate any covenant, agreement or obligations of the Tenant under this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DAMAGE BY FIRE, ETC. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If the Premises or the Building are damaged in whole or in part by any fire or other casualty (a &#147;casualty&#148;), Tenant shall
promptly give notice thereof to the Landlord. Unless this Lease is terminated as provided herein, the Landlord, at its own expense (except for any insurance deductibles, which shall be deemed Operating Costs), and proceeding with due diligence and
all reasonable dispatch, but subject to delays related to any event(s) of Force Majeure, shall repair and reconstruct, and shall diligently prosecute the same to completion, the same so as to restore the Premises and Building (including, without
limitation, the Landlord&#146;s Work, but not any Alterations made by or for Tenant or any trade fixtures, equipment or personal property owned by Tenant) to substantially the same condition they were in prior to the casualty, subject to zoning,
building and other laws then in effect. Notwithstanding the foregoing, in no event shall Landlord be obligated either to repair or rebuild if the damage or destruction results from an uninsured casualty or if the costs of such repairing or
rebuilding exceeds the amount of the insurance proceeds (net of all costs and expenses incurred in obtaining same) received by Landlord on account thereof. Landlord shall not be liable for any inconvenience or annoyance to Tenant or injury to the
business of Tenant resulting from delays in repairing such damage. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Landlord shall, within forty-five (45)&nbsp;days after the
occurrence of a casualty, provide Tenant with a good faith estimate of the time required to repair the damage to the Premises or the Building, as provided herein (&#147;Estimate&#148;); if such estimate is for a period of more than two hundred
seventy (270)&nbsp;days from the occurrence of the casualty (or during the last eighteen (18)&nbsp;months of the term, for a period of more than ninety (90)&nbsp;days), the Premises shall be deemed &#147;substantially damaged&#148;. If the Premises
or the Building are substantially damaged, Landlord may elect to terminate this Lease by giving Tenant written notice of such termination within sixty (60)&nbsp;days of the date of such casualty; and if the Premises or the Building are substantially
damaged, and untenantable or inaccessible for the uses permitted under this Lease, then Tenant may terminate this Lease by giving Landlord written notice of such termination within thirty (30)&nbsp;days following Tenant&#146;s receipt of the
Estimate; provided that the parties shall cooperate in good faith to respond to inquiries regarding timing, etc. <B></B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For so long
as such damage results in material interference with the operation of Tenant&#146;s use of the Premises which material interference causes Tenant to be unable to use or access the Premises or any material portion thereof for the operation of its
business, the Yearly Rent payable by Tenant shall abate or be reduced proportionately for the period, commencing on the day following such material interference and continuing until the Premises has been substantially restored by Landlord, as
provided above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the Premises are damaged by a casualty, and the Lease is not terminated as provided herein, the Tenant, at its own
expense, and proceeding with all reasonable dispatch, shall repair and reconstruct all of the Alterations made to the Premises by Tenant, including and any trade fixtures, equipment or personal property of Tenant which shall have been damaged or
destroyed, but excluding those portions of Landlord&#146;s Work constituting leasehold improvements (as opposed to Tenant&#146;s furniture, trade fixtures, equipment, personal property, data or communications cabling, specialty or laboratory
equipment). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>WAIVER OF SUBROGATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In any case in which Tenant shall be obligated to pay to Landlord any loss, cost, damage, liability, or expense suffered or incurred by
Landlord, Landlord shall allow to Tenant as an offset against the amount thereof (i)&nbsp;the net proceeds of any insurance collected by Landlord for or on account of such loss, cost, damage, liability or expense, provided that the allowance of such
offset does not invalidate or prejudice the policy or policies under which such proceeds were payable, and (ii)&nbsp;if such loss, cost, damage, liability or expense shall have been caused by a peril against which Landlord has agreed to procure
insurance coverage under the terms of this Lease, the amount of such insurance coverage, whether or not actually procured by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
any case in which Landlord or Landlord&#146;s managing agent shall be obligated to pay to Tenant any loss, cost, damage, liability or expense suffered or incurred by Tenant, Tenant shall allow to Landlord or Landlord&#146;s managing agent, as the
case may be, as an offset against the amount thereof (i)&nbsp;the net proceeds of any insurance collected by Tenant for or on account of such loss, cost, damage, liability, or expense, provided that the allowance of such offset does not invalidate
the policy or policies under which such proceeds were payable and (ii)&nbsp;the amount of any loss, cost, damage, liability or expense caused by a peril covered by (or required to be covered by) fire insurance with the broadest form of property
insurance generally available on property in buildings of the type of the Building, whether or not actually procured by Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The parties hereto shall each procure an appropriate clause in, or endorsement on, any
property insurance policy covering the Premises and the Building and personal property, fixtures and equipment located thereon and therein required to be carried under this Lease, pursuant to which the insurance companies waive subrogation or
consent to a waiver of right of recovery in favor of either party, its respective agents or employees. Each party hereby agrees that it will not make any claim against or seek to recover from the other or its agents or employees for any loss or
damage to its property or the property of others resulting from fire or other perils covered by such property insurance (or that would have been covered by such insurance had it been so carried). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CONDEMNATION-EMINENT DOMAIN </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In the event of any condemnation or taking in any manner for public or quasi-public use, which shall be deemed to include a
voluntary conveyance in lieu of a taking (a &#147;taking&#148;) of the whole of the Building and Land, this Lease shall forthwith terminate as of the date when Tenant is required to vacate the Premises, and in such event, Yearly Rent and Additional
Rent shall be apportioned as of the date of termination. Landlord shall promptly notify Tenant of any written notice received by Landlord from any governmental authority with respect to any taking (including said voluntary conveyance) of the
Building or Land. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Unless this Lease is terminated as provided herein, the Landlord, at its own expense, and proceeding
with due diligence and all reasonable dispatch, but subject to delays due to Force Majeure, shall restore the remaining portion of the Premises (including those portions of Landlord&#146;s Work constituting leasehold improvements but not any
Alterations made by or for Tenant, or any trade fixtures, equipment or personal property owned by Tenant) and the necessary portions of the Building as nearly as practicable to the same condition as it was prior to such taking, subject to zoning and
building laws then in effect. Notwithstanding the foregoing, Landlord&#146;s obligation to restore the remaining portion of the Premises shall be limited to the extent of the condemnation proceeds (net of all costs and expenses incurred in
connection with same) received by Landlord on account thereof. Landlord shall not be liable for any inconvenience or annoyance to Tenant or injury to the business of Tenant resulting from delays in restoring the Premises. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In the event that only a part of the Premises or the Building shall be taken, then, if such taking is a substantial taking
(as hereinafter defined), either Landlord or Tenant may by delivery of notice in writing to the other within sixty (60)&nbsp;days following the date on which Landlord&#146;s title has been divested by such authority, terminate this Lease, effective
as of the date when Tenant is required to vacate any portion of the Premises or appurtenant rights so taken, or an earlier date if specified in such notice. A &#147;substantial taking&#148; shall mean a taking which: requires restoration and repair
of the remaining portion of the Building that cannot in the ordinary course be reasonably expected to be repaired within one hundred eighty (180)&nbsp;days; results in the loss of reasonable access to the Premises; results in the loss of more than
twenty-five percent (25%) of the Total Rentable Area of the Premises or more than ten percent (10%) of the portion of the Premises used for laboratory uses; or results in the loss of more than ten (10%) percent of the number of parking spaces
currently serving the Building or Complex and Landlord reasonably determines it is not practical to relocate such parking within the remaining Complex or on other property within <FONT STYLE="white-space:nowrap">one-half</FONT> of a mile of the
Property. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) If this Lease is not terminated as aforesaid, then this Lease shall continue in full force and effect,
provided if as a result of which there is material interference with the operation of Tenant&#146;s use of, or a reduction to, the Premises, then the Yearly Rent and Additional Rent payable by Tenant shall be justly and equitably abated and reduced
according to the nature and extent of the loss of use thereof suffered by Tenant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Landlord shall have and hereby
reserves and excepts, and Tenant hereby grants and assigns to Landlord, all rights to recover for damages to the Building, Land and Complex, and the leasehold interest hereby created (including any award made for the value of the estate vested by
this Lease in Tenant), and to compensation accrued or hereafter to accrue by reason of such taking, and by way of confirming the foregoing, Tenant hereby grants and assigns, and covenants with Landlord to grant and assign, to Landlord all rights to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such damages of compensation, exclusive of any portion of such award designated for Tenant&#146;s moving expenses or allocable to its personal property and equipment or allocable to any
Alterations (but excluding the Landlord&#146;s Work). Nothing contained herein shall be construed to prevent Tenant from prosecuting in any condemnation proceedings a separate claim for the value of any of Tenant&#146;s personal property and for
relocation expenses and business losses, provided that such action shall not affect the amount of compensation otherwise recoverable by Landlord from the taking authority. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>21.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEFAULT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.1 <B>Conditions of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Limitation-Re-Entry-Termination.</FONT></FONT></B> This
Lease and the herein Term and estate are, upon the condition that if (a)&nbsp;subject to Article 21.7, Tenant shall neglect or fail to perform or observe any of the Tenant&#146;s covenants or agreements herein, including (without limitation) the
covenants or agreements with regard to the payment when due of rent, additional charges, reimbursement for increase in Landlord&#146;s costs, or any other charge payable by Tenant to Landlord (all of which shall be considered as part of Yearly Rent
for the purposes of invoking Landlord&#146;s statutory or other rights and remedies in respect of payment defaults); or (b) [intentionally omitted]; or (c) [intentionally omitted]; or (d)&nbsp;Tenant shall make an assignment or trust mortgage, or
other conveyance or transfer of like nature, of all or a substantial part of its property for the benefit of its creditors, or (e)&nbsp;an attachment on mesne process, on execution or otherwise, or other legal process shall issue against Tenant or
its property and a sale of any of its assets shall be held thereunder; or (f)&nbsp;any judgment, final beyond appeal or any lien, attachment or the like shall be entered, recorded or filed against Tenant in any court, registry, etc. and Tenant shall
fail to pay such judgment within sixty (60)&nbsp;days after the judgment shall have become final beyond appeal or to discharge or secure by surety bond such lien, attachment, etc. within sixty (60)&nbsp;days of such entry, recording or filing, as
the case may be; or (g)&nbsp;the leasehold hereby created shall be taken on execution or by other process of law and shall not be revested in Tenant within sixty (60)&nbsp;days thereafter; or (h)&nbsp;a receiver, sequesterer, trustee or similar
officer shall be appointed by a court of competent jurisdiction to take charge of all or any part of Tenant&#146;s property and such appointment shall not be vacated within thirty (30)&nbsp;days; or (i)&nbsp;any proceeding shall be instituted by or
against Tenant pursuant to any of the provisions of any Act of Congress or State law relating to bankruptcy, reorganizations, arrangements, compositions or other relief from creditors, and, in the case of any proceeding instituted against it, if
Tenant shall fail to have such proceedings dismissed within sixty (60)&nbsp;days or if Tenant is adjudged bankrupt or insolvent as a result of any such proceeding, or (j)&nbsp;any event shall occur or any contingency shall arise whereby this Lease,
or the Term and estate thereby created, would (by operation of law or otherwise) devolve upon or pass to any person, firm or corporation other than Tenant, except as expressly permitted under Article 16 hereof&#151;then, and in any such event
Landlord may, by written notice to Tenant, elect to terminate this Lease; and thereupon (and without prejudice to any remedies which might otherwise be available for arrears of rent or other charges due hereunder or preceding breach of covenant or
agreement and without prejudice to Tenant&#146;s liability for damages as hereinafter stated), upon the giving of such notice, this Lease shall terminate as of the date specified therein as though that were the Termination Date as stated in
Section&nbsp;3.2. Without being taken or deemed to be guilty of any manner of trespass or conversion, and without being liable to indictment, prosecution or damages therefor, Landlord may enter into and upon the Premises (or any part thereof in the
name of the whole); repossess the same as of its former estate; and expel Tenant and those claiming under Tenant. The words <FONT STYLE="white-space:nowrap">&#147;re-entry&#148;</FONT> and <FONT STYLE="white-space:nowrap">&#147;re-enter&#148;</FONT>
as used in this Lease are not restricted to their technical legal meanings. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.2<B> Intentionally Omitted.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.3 <B>Damages-Termination.</B> Upon the termination of this Lease under the provisions of this Article 21, Tenant shall pay to Landlord the
rent and other charges due and payable by Tenant to Landlord up to the time of such termination, shall continue to be liable for any preceding breach of covenant, and in addition, shall pay to Landlord as damages, at the election of Landlord </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">either: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) the amount by which, at the time of the termination of this Lease (or at any time
thereafter if Landlord shall have initially elected damages under subparagraph (y), below), (i) the aggregate of the rent and other charges projected over the period commencing with such termination and ending on the Termination Date as stated in
Exhibit 1 discounted to present value at the Reference Rate exceeds (ii)&nbsp;the aggregate projected fair market rental value of the Premises for such period similarly discounted. As used herein, the term &#147;Reference Rate&#148; shall mean the
annual rate of five percentage (5%) points over the <FONT STYLE="white-space:nowrap">so-called</FONT> prime rate then currently from time to time charged to its most favored corporate customers by the largest national bank (N.A.) located in the city
in which the Building is located. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">or: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) amounts equal to the rent and other charges which would have been payable by Tenant had this Lease not been so terminated, payable upon the
due dates therefor specified herein following such termination and until the Termination Date as specified in Exhibit 1, provided, however, if Landlord shall <FONT STYLE="white-space:nowrap">re-let</FONT> the Premises during such period, that
Landlord shall credit Tenant with the net rents received by Landlord from such <FONT STYLE="white-space:nowrap">re-letting,</FONT> such net rents to be determined by first deducting from the gross rents as and when received by Landlord from such <FONT
STYLE="white-space:nowrap">re-letting</FONT> the expenses incurred or paid by Landlord in terminating this Lease, as well as the expenses of <FONT STYLE="white-space:nowrap">re-letting,</FONT> including altering and preparing the Premises for new
tenants, brokers&#146; commissions, and all other similar expenses properly chargeable against the Premises and the rental therefrom, it being understood that any such <FONT STYLE="white-space:nowrap">re-letting</FONT> may be for a period equal to
or shorter or longer than the remaining Term of this Lease; and provided, further, that (i)&nbsp;in no event shall Tenant be entitled to receive any excess of such net rents over the sums payable by Tenant to Landlord hereunder and (ii)&nbsp;in no
event shall Tenant be entitled in any suit for the collection of damages pursuant to this Subparagraph (y)&nbsp;to a credit in respect of any net rents from a <FONT STYLE="white-space:nowrap">re-letting</FONT> except to the extent that such net
rents are actually received by Landlord prior to the commencement of such suit. If the Premises or any part thereof should be <FONT STYLE="white-space:nowrap">re-let</FONT> in combination with other space, then proper apportionment on a square foot
area basis shall be made of the rent received from such <FONT STYLE="white-space:nowrap">re-letting</FONT> and of the expenses of <FONT STYLE="white-space:nowrap">re-letting.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In calculating the rent and other charges under Subparagraph (x), above, there shall be included, in addition to the Yearly Rent, Tax Share and
Operating Expense Share and all other considerations agreed to be paid or performed by Tenant, on the assumption that all such amounts and considerations would have remained constant (except as herein otherwise provided) for the balance of the full
Term hereby granted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Suit or suits for the recovery of such damages, or any installments thereof, may be brought by Landlord from time to
time at its election, and nothing contained herein shall be deemed to require Landlord to postpone suit until the date when the Term of this Lease would have expired if it had not been terminated hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing herein contained shall be construed as limiting or precluding the recovery by Landlord against Tenant of any sums or damages to which,
in addition to the damages particularly provided above, Landlord may lawfully be entitled by reason of any default hereunder on the part of Tenant. Notwithstanding anything to the contrary, Landlord shall be entitled to recover, in addition to the
rent and other charges under Subparagraph (x)&nbsp;or (y) above, any other amount necessary to compensate Landlord for all detriment proximately caused by Tenant&#146;s failure to perform its obligations under the Lease or which in the ordinary
course of things would be likely to result therefrom, including, but not limited to, the cost of recovering possession of the Premises, reasonable attorneys&#146; fees, any real estate commissions actually paid by Landlord and the unamortized value
of any free rent, reduced rent, tenant improvement allowance or other economic concessions provided by Landlord. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.4 <B>Fees and
Expenses.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If Landlord at any time is compelled to pay or elects to pay any sum of money, or do any act which will require the
payment of any sum of money, by reason of the failure of Tenant to comply with any provision hereof and in accordance with this Section&nbsp;21.4, or if Landlord is compelled to or does incur any expense, including reasonable attorneys&#146; fees,
in instituting, prosecuting, and/or defending any action or proceeding instituted by reason of any default of Tenant hereunder, Tenant shall pay to Landlord by way of reimbursement the actual and reasonable sum or sums so paid by Landlord with all
costs and damages, plus interest computed as provided in Article 6 hereof, within thirty (30)&nbsp;days after Tenant&#146;s receipt of an invoice therefor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Tenant shall pay Landlord&#146;s cost and expense, including reasonable attorneys&#146;
fees, incurred (i)&nbsp;in enforcing any obligation of Tenant under this Lease or (ii)&nbsp;as a result of Landlord, without its fault, being made party to any litigation pending by or against Tenant or any persons claiming through or under Tenant.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.5 <B>Waiver of Redemption.</B> Tenant does hereby waive and surrender all rights and privileges which it might have under or by reason
of any present or future law to redeem the Premises or to have a continuance of this Lease for the Term hereby demised after being dispossessed or ejected therefrom by process of law or under the terms of this Lease or after the termination of this
Lease as herein provided. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.6 <B>Landlord&#146;s Remedies Not Exclusive.</B> The specified remedies to which Landlord may resort
hereunder are cumulative and are not intended to be exclusive of any remedies or means of redress to which Landlord may at any time be lawfully entitled, and Landlord may invoke any remedy (including the remedy of specific performance) allowed at
law or in equity as if specific remedies were not herein provided for. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.7 <B></B><B>Grace Period.</B><B> </B>Notwithstanding anything to
the contrary in this Lease contained (except and unless such longer notice and cure periods are explicitly provided in this Lease), Landlord agrees not to take any action to terminate this Lease (a)&nbsp;for default by Tenant in the payment when due
of any sum of money, if Tenant shall cure such default within five (5)&nbsp;business days after written notice thereof is given by Landlord to Tenant (the &#147;Monetary Grace Period&#148;), provided, however, that no such notice need be given and
no such default in the payment of money shall be curable if on two (2)&nbsp;prior occasions within any twelve (12)&nbsp;month period there had been a default in the payment of money which had been cured after notice thereof had been given by
Landlord to Tenant as herein provided or (b)&nbsp;for default by Tenant in the performance of any covenant other than a covenant to pay a sum of money, if Tenant shall commence to cure such default within a period of thirty (30)&nbsp;days after
written notice thereof given by Landlord to Tenant and diligently prosecute the same to completion (the <FONT STYLE="white-space:nowrap">&#147;Non-Monetary</FONT> Grace Period&#148;; the Monetary Grace Period and the
<FONT STYLE="white-space:nowrap">Non-Monetary</FONT> Grace Period may be referred to as a &#147;Grace Period&#148;) and provided no Grace Period whatsoever shall be allowed to Tenant if the default is incurable. Notwithstanding the foregoing, Tenant
shall have no right to notice or the <FONT STYLE="white-space:nowrap">Non-Monetary</FONT> Grace Period relating to its failure to (v)&nbsp;maintain all insurance as required in Article 15 above; (w)&nbsp;deliver to Landlord the Letter of Credit as
required by Section&nbsp;29.13 below; (x)&nbsp;provide Landlord with Estoppel Certificates as required pursuant to Section&nbsp;17.5 above; (y)&nbsp;provide Landlord with subordination agreements as required pursuant to Article 23 below; or
(z)&nbsp;provide Landlord with the certificates of insurance required pursuant to Article 15 above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the
contrary in this Article 21.7 contained, except to the extent prohibited by applicable law, any statutory notice and grace periods provided to Tenant by law are hereby expressly waived by Tenant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.8 <B>Additional Remedies</B><B>. </B>In addition to the other rights and remedies provided for in this Lease, if Tenant defaults in the
performance of any obligation imposed on it by this Lease, and shall not cure such default within the period specified hereunder, including and applicable notice or Grace Period (as same may be extended as provided herein), then Landlord at any time
thereafter may cure such default for the account of Tenant. Any amount paid by Landlord in the exercise of its rights under this Subsection shall be reimbursed by Tenant (with interest thereon at the Interest Rate from and after the due date) within
thirty (30)&nbsp;days of invoice therefor, absent good faith dispute, failing which such amount may be offset against payments due from Landlord to Tenant until Landlord has been fully reimbursed. Notwithstanding the foregoing, Landlord may cure a
default of Tenant prior to the expiration of the applicable Grace Period but after a cure period as is reasonable under the circumstances (but in no event shall such cure period exceed two (2)&nbsp;consecutive days) and after such notice (which may
be verbal) to Tenant under any of the following circumstances: (w)&nbsp;if necessary to protect the interest of Landlord in the Premises or Building; (x)&nbsp;if necessary to prevent civil or criminal liability of Landlord; (y)&nbsp;if necessary to
prevent an imminent and material interruption of the conduct of business in the Building, or (z)&nbsp;if necessary to prevent injury to persons or damage to property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.9 <B>Additional Rent</B><B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All fees, costs and expenses, other than Yearly Rent, which Tenant assumes or agrees to pay and any other sum payable by Tenant pursuant to
this Lease, including, without limitation, Tenant&#146;s Tax Share and Tenant&#146;s Operating Expenses Share (both as hereinafter defined), shall be deemed &#147;Additional Rent.&#148; </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>END OF TERM-ABANDONED PROPERTY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the expiration or other termination of the Term of this Lease, Tenant shall peaceably quit and surrender to Landlord the Premises, broom
clean, in good order, repair and condition (except as provided herein and in Articles 8.7, 18 and 20) excepting only ordinary wear and use (as defined in Article 14.1 hereof) and damage by fire or other casualty for which, under other provisions of
this Lease, Tenant has no responsibility of repair or restoration, and free of all Hazardous Materials brought upon, kept, used, stored, handled, treated, generated in, or released or disposed of from, the Premises by Tenant or any party taking by
or through Tenant, including any assignee, subtenant, licensee, etc. and decommissioned as required pursuant to Section&nbsp;29.11 below. Tenant shall remove all of Tenant&#146;s Removable Property and its other personal property, including, without
limitation, all telecommunication, computer and other cabling installed by or on behalf of Tenant in the Premises or elsewhere in the Building (excluding any cabling installed by Landlord as part of Landlord&#146;s Work), and, to the extent
specified by Landlord in accordance with this Lease, any items of the Tenant Improvement Work Landlord has required to be removed in accordance with Section&nbsp;4.2(m), all Alterations made by Tenant (unless Landlord has not required removal of the
same in accordance with this Lease) and all partitions made by Tenant wholly within the Premises, and shall repair any damages to the Premises or the Building caused by their installation or by such removal to substantially the same condition as
prior to their installation. Tenant&#146;s obligation to observe or perform this covenant shall survive the expiration or other termination of the Term of this Lease. At least three (3)&nbsp;months prior to the surrender of the Premises, Tenant
shall deliver to Landlord a narrative description of the actions proposed (or required by any governmental authority) to be taken by Tenant in order to surrender the Premises (including any Alterations permitted by Landlord to remain in the
Premises) at the expiration or earlier termination of the Term, in the condition required by this Article 22 including the presence of Hazardous Materials used, stored, generated or disposed of therein (the &#147;Surrender Plan&#148;).<B> </B>Such
Surrender Plan shall be accompanied by a current listing of (a)&nbsp;all Hazardous Materials licenses and permits held by or on behalf of any Tenant with respect to the Premises, and (b)&nbsp;all Hazardous Materials used, stored, handled, treated,
generated, released or disposed of from the Premises, and shall be subject to the review and approval of Landlord&#146;s environmental consultant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant will remove any personal property from the Building and the Premises upon or prior to the expiration or termination of this Lease and
any such property which shall remain in the Building or the Premises thereafter shall be conclusively deemed to have been abandoned, and may either be retained by Landlord as its property or sold or otherwise disposed of in such manner as Landlord
may see fit. If any part thereof shall be sold, Landlord may receive and retain the proceeds of such sale and apply the same, at its option, against the reasonable expenses of the sale, the actual and reasonable <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> cost of moving and storage, any arrears of Yearly Rent, additional or other charges payable hereunder by Tenant to Landlord and any damages to which Landlord may be entitled under Article 21
hereof or pursuant to law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Tenant or anyone claiming under Tenant shall remain in possession of the Premises or any part thereof after
the expiration or prior termination of the Term of this Lease without any agreement in writing between Landlord and Tenant with respect thereto, then, prior to the acceptance of any payments for rent or use and occupancy by Landlord, the person
remaining in possession shall be deemed a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">tenant-at-sufferance.</FONT></FONT> Whereas the parties hereby acknowledge that Landlord may need the Premises after the expiration or prior
termination of the Term of the Lease for other tenants and that the damages which Landlord may suffer as the result of Tenant&#146;s holding-over cannot be determined as of the Execution Date hereof, in the event that Tenant so holds over, Tenant
shall pay to Landlord in addition to all rental and other charges due and accrued under the Lease prior to the date of termination, charges (based upon fair market rental value of the Premises) for use and occupation of the Premises thereafter and,
in addition to such sums and any and all other rights and remedies which Landlord may have at law or in equity, an additional use and occupancy charge in the amount of one hundred fifty percent (150%) of the Yearly Rent and other charges calculated
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(on a daily basis) at the highest rate payable under the terms of this Lease, but measured from the day on which Tenant&#146;s hold-over commenced and terminating on the day on which Tenant
vacates the Premises. In addition, Tenant shall save Landlord, its agents and employees, harmless and will exonerate, defend and indemnify Landlord, its agents and employees, from and against any and all damages which Landlord may suffer on account
of Tenant&#146;s hold-over in the Premises after the expiration or prior termination of the Term of the Lease; provided, however, in no event shall Tenant be liable for consequential damages as a result of such holdover unless and until Tenant
continues to holdover in all or any portion of the Premises from and after the date that is thirty (30)&nbsp;days following the expiration or early termination of this Lease or unless Landlord notifies Tenant prior to such expiration or termination
that Landlord has procured a tenant that is ready, willing and able to sign a lease for the Premises (or portion thereof), in either which event the foregoing prohibition shall be of no force or effect Landlord, Tenant shall be liable to Landlord
for any and all damages suffered by Landlord as a result of such holdover, including any lost rent or consequential, special and indirect damages (in each case, regardless of whether such damages are foreseeable). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>23.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUBORDINATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.1 This Lease, and all rights of Tenant hereunder, are subject and subordinate in all respects to that certain Ground Lease dated
November&nbsp;21, 2017 between Economic Development and Industrial Corporation of Boston (&#147;EDIC&#148;), as landlord, and Landlord, as tenant, the (&#147;EDIC Lease&#148;) as the same may be amended. Subject to the terms and conditions hereof
including Tenant&#146;s receipt of a commercially reasonable <FONT STYLE="white-space:nowrap">Non-Disturbance</FONT> Agreement as provided below, and subject to any mortgagee&#146;s or ground lessor&#146;s election as hereinafter provided for, this
Lease, and all rights of Tenant hereunder, are subject and subordinate in all respects to all matters of record (including, without limitation, deeds and land disposition agreements); other ground leases and/or underlying leases, as same may be
amended; and all mortgages, any of which may now or hereafter be placed on or affect such leases and/or the real property of which the Premises are a part, or any part of such real property, and/or Landlord&#146;s interest or estate therein, and to
each advance made and/or hereafter to be made under any such mortgages, and to all renewals, modifications, consolidations, replacements and extensions thereof and all substitutions therefor. This Article 23 shall be self-operative and no further
instrument or subordination shall be required, subject to the terms and conditions hereof including Tenant&#146;s receipt of a commercially reasonable <FONT STYLE="white-space:nowrap">Non-Disturbance</FONT> Agreement from all current and future
mortgagees as provided below, and subject to any mortgagee&#146;s or ground lessor&#146;s election as herein provided. In confirmation of such subordination, Tenant shall execute, acknowledge and deliver promptly any certificate or instrument that
Landlord and/or any current or future mortgagee and/or lessor under any ground or underlying lease and/or their respective successors in interest may request, subject to Landlord&#146;s, mortgagee&#146;s and ground lessor&#146;s right to do so for,
on behalf and in the name of Tenant under certain circumstances, as hereinafter provided. Tenant acknowledges that, where applicable, any consent or approval hereafter given by Landlord may be subject to the further consent or approval of such
mortgagee and/or ground lessor as and to the extent required under the applicable documents, instruments and agreements therewith; and the failure or refusal of such mortgagee and/or ground lessor to give such consent or approval shall,
notwithstanding anything to the contrary in this Lease contained, constitute reasonable justification for Landlord&#146;s withholding its consent or approval. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.2 Any such mortgagee or ground lessor may from time to time subordinate or revoke any such subordination of the mortgage or ground lease
held by it to this Lease. Such subordination or revocation, as the case may be, shall be effected by written notice to Tenant and by recording an instrument of subordination or of such revocation, as the case may be, with the appropriate registry of
deeds or land records and to be effective without any further act or deed on the part of Tenant. In confirmation of such subordination or of such revocation, as the case may be, Tenant shall execute, acknowledge and promptly deliver any commercially
reasonable certificate or instrument that Landlord, any mortgagee or ground lessor may request, subject to Landlord&#146;s, mortgagee&#146;s and ground lessor&#146;s right to do so for, on behalf and in the name of Tenant under certain
circumstances, as hereinafter provided. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.3 Without limitation of any of the provisions of this Lease, but subject to the terms and
conditions of any SNDA executed by Tenant and any ground lessor or mortgagee, if any ground lessor or mortgagee shall succeed to the interest of Landlord by reason of the exercise of its rights under such ground lease or mortgage (or the acceptance
of voluntary conveyance in lieu thereof) or any third party (including, without limitation, any foreclosure purchaser or mortgage receiver) shall succeed to such interest by reason of any such exercise or the expiration or sooner termination of such
ground lease, however caused, then such successor may at its election, upon notice and request to Tenant (which, in the case of a ground lease, shall be within thirty (30)&nbsp;days after such expiration or sooner termination), succeed to the
interest of Landlord under this Lease, provided, however, that such successor shall not: (i)&nbsp;be liable for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any previous act or omission of Landlord under this Lease unless it is of a continuing nature and an obligation of Landlord under this Lease; (ii)&nbsp;be subject to any offset, defense, or
counterclaim which shall theretofore have accrued to Tenant against Landlord; (iii)&nbsp;have any obligation with respect to any security deposit or letter of credit unless it, or any portion thereof, shall have been paid over or physically
delivered to such successor; or (iv)&nbsp;be bound by any previous modification of this Lease of which it did not receive notice, or by any previous payment of Yearly Rent for a period greater than one (1)&nbsp;month, made without such ground
lessor&#146;s or mortgagee&#146;s consent where such consent is required by applicable ground lease or mortgage documents. In the event of such succession to the interest of the Landlord&#151;and notwithstanding that any such mortgage or ground
lease may antedate this Lease&#151;the Tenant shall attorn to such successor and shall ipso facto be and become bound directly to such successor in interest to Landlord to perform and observe all the Tenant&#146;s obligations under this Lease
without the necessity of the execution of any further instrument and such successor shall have the benefit of all of Landlord&#146;s rights and protections hereunder, including, without limitation, under Section&nbsp;26(b). Nevertheless, Tenant
agrees at any time and from time to time during the Term hereof to execute a commercially reasonable instrument in confirmation of Tenant&#146;s agreement to attorn, as aforesaid, subject to Landlord&#146;s, mortgagee&#146;s and ground lessor&#146;s
right to do so for, on behalf and in the name of Tenant under certain circumstances, as hereinafter provided. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.4 The term
&#147;mortgage(s)&#148; as used in this Lease shall include any mortgage or deed of trust. The term &#147;mortgagee(s)&#148; as used in this Lease shall include any mortgagee or any trustee and beneficiary under a deed of trust or receiver appointed
under a mortgage or deed of trust. The term &#147;mortgagor(s)&#148; as used in this Lease shall include any mortgagor or any grantor under a deed of trust. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.5 Tenant shall not, by any act or omission, cause Landlord to be in violation of or in default under the EDIC Lease, or do or permit, any
act that is in violation of the EDIC Lease with respect to the Premises. At Tenant&#146;s request, Landlord shall deliver to Tenant an agreement <FONT STYLE="white-space:nowrap">(&#147;Non-Disturbance</FONT> Agreement&#148;) with respect to the EDIC
Lease substantially in the form attached hereto as Exhibit 8; provided, however<I>, </I>that if any Tenant requires a <FONT STYLE="white-space:nowrap">Non-Disturbance</FONT> Agreement in a form substantially different from the form attached hereto
as Exhibit 8 and EDIC agrees to negotiate such a different form with such Tenant, then Tenant shall reimburse Landlord and EDIC, as Additional Rent, for all reasonable, actual attorneys&#146; fees and expenses incurred by Landlord and EDIC in
connection with the preparation, review and negotiation of such a <FONT STYLE="white-space:nowrap">Non-Disturbance</FONT> Agreement, regardless of whether nor not such a <FONT STYLE="white-space:nowrap">Non-Disturbance</FONT> Agreement is finalized,
which payment shall be due and payable to EDIC within thirty (30)&nbsp;days after invoice therefor to Tenant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.6 Tenant hereby
irrevocably constitutes and appoints Landlord or any such mortgagee or ground lessor, and their respective successors in interest, acting singly, Tenant&#146;s
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> to execute and deliver any such certificate or instrument for, on behalf and in the name of Tenant, but only if Tenant fails to execute, acknowledge and
deliver any such certificate or instrument within ten (10)&nbsp;business days after Landlord or such mortgagee or such ground lessor has made written request therefor; provided that such request, or any second request, if applicable, contains the
following words in bold capital letters: THIS IS A NOTICE UNDER ARTICLE 23 OF THE LEASE. IF TENANT FAILS TO DELIVER A NONDISTURBANCE AGREEMENT AS REQUIRED UNDER SUCH ARTICLE WITHIN TEN (10)&nbsp;BUSINESS DAYS AFTER TENANT&#146;S RECEIPT OF THIS
LETTER, THEN TENANT HEREBY IRREVOCABLY CONSTITUTES AND APPOINTS LANDLORD OR ANY SUCH MORTGAGEE OR GROUND LESSOR, AND THEIR RESPECTIVE SUCCESSORS IN INTEREST, ACTING SINGLY, TENANT&#146;S <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">ATTORNEY-IN-FACT</FONT></FONT> TO EXECUTE AND DELIVER SUCH NONDISTURBANCE AGREEMENT, ON BEHALF AND IN THE NAME OF TENANT. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.7 Notwithstanding anything to the contrary contained in this Article 23, if all or part of Landlord&#146;s estate and interest in the real
property of which the Premises are a part shall be a leasehold estate held under a ground lease, then: (i)&nbsp;the foregoing subordination provisions of this Article 23 shall not apply to any mortgages of the fee interest in said real property to
which Landlord&#146;s leasehold estate is not otherwise subject and subordinate; and (ii)&nbsp;the provisions of this Article 23 shall in no way waive, abrogate or otherwise affect any agreement by any ground lessor (x)&nbsp;not to terminate this
Lease incident to any termination of such ground lease prior to its term expiring or (y)&nbsp;not to name or join Tenant in any action or proceeding by such ground lessor to recover possession of such real property or for any other relief. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.8 In the event of any failure by Landlord to perform, fulfill or observe any agreement by
Landlord herein, in no event will the Landlord be deemed to be in default under this Lease permitting Tenant to exercise any or all rights or remedies under this Lease until the Tenant shall have given written notice of such failure to any mortgagee
(ground lessor and/or trustee) of which Tenant shall have been advised and until a reasonable period of time shall have elapsed following the giving of such notice, during which such mortgagee (ground lessor and/or trustee) shall have the right, but
shall not be obligated, to remedy such failure, except Tenant&#146;s failure to simultaneously deliver such notice shall not constitute a default under this Lease; provided, however, such mortgagee (ground lessor and/or trustee) commences curative
action during such reasonable period and diligently prosecutes the same to completion. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>24.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>QUIET ENJOYMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord covenants that if, and so long as, Tenant keeps and performs each and every covenant, agreement, term, provision and condition herein
contained on the part and on behalf of Tenant to be kept and performed, Tenant shall quietly enjoy the Premises from and against the claims of all persons claiming by, through or under Landlord subject, nevertheless, to the covenants, agreements,
terms, provisions and conditions of this Lease and to the mortgages, ground leases and/or underlying leases to which this Lease is subject and subordinate, as hereinabove set forth and subject to the terms of the
<FONT STYLE="white-space:nowrap">Non-Disturbance</FONT> Agreement from EDIC and/or an SNDA from any mortgagee or other ground lessor, as hereinabove set forth. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>25.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ENTIRE AGREEMENT-WAIVER-SURRENDER </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25.1 <B>Entire Agreement.</B> This Lease and the Exhibits made a part hereof contain the entire and only agreement between the parties and any
and all statements and representations, written and oral, including previous correspondence and agreements between the parties hereto, are merged herein. Tenant acknowledges that all representations and statements upon which it relied in executing
this Lease are contained herein and that the Tenant in no way relied upon any other statements or representations, written or oral. Any executory agreement hereafter made shall be ineffective to change, modify, discharge or effect an abandonment of
this Lease in whole or in part unless such executory agreement is in writing and signed by the party against whom enforcement of the change, modification, discharge or abandonment is sought. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25.2 <B></B><B>Waiver by Landlord.</B> The failure of Landlord to seek redress for violation, or to insist upon the strict performance, of any
covenant or condition of this Lease, or any of the Rules and Regulations promulgated hereunder, shall not prevent a subsequent act, which would have originally constituted a violation, from having all the force and effect of an original violation.
The receipt by Landlord of rent with knowledge of the breach of any covenant of this Lease shall not be deemed a waiver of such breach. The failure of Landlord to enforce any of such Rules and Regulations against Tenant and/or any other tenant in
the Building shall not be deemed a waiver of any such Rules and Regulations. No provisions of this Lease shall be deemed to have been waived by Landlord unless such waiver be in writing signed by Landlord. No payment by Tenant or receipt by Landlord
of a lesser amount than the monthly rent herein stipulated shall be deemed to be other than on account of the stipulated rent, nor shall any endorsement or statement on any check or any letter accompanying any check or payment as rent be deemed an
accord and satisfaction, and Landlord may accept such check or payment without prejudice to Landlord&#146;s right to recover the balance of such rent or pursue any other remedy in this Lease provided. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25.3 <B>Surrender.</B> No act or thing done by Landlord during the Term hereby demised shall be deemed an acceptance of a surrender of the
Premises, and no agreement to accept such surrender shall be valid, unless in writing signed by Landlord. No employee of Landlord or of Landlord&#146;s agents shall have any power to accept the keys of the Premises prior to the termination of this
Lease. The delivery of keys to any employee of Landlord or of Landlord&#146;s agents shall not operate as a termination of the Lease or a surrender of the Premises. In the event that Tenant at any time desires to have Landlord underlet the Premises
for Tenant&#146;s account, Landlord or Landlord&#146;s agents are authorized to receive the keys for such purposes without releasing Tenant from any of the obligations under this Lease, and Tenant hereby relieves Landlord of any liability for loss
of or damage to any of Tenant&#146;s effects in connection with such underletting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>26.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INABILITY TO PERFORM-EXCULPATORY CLAUSE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26.1 Except as provided in Articles 4.1 and 4.2 hereof or as otherwise expressly otherwise provided in this Lease, this Lease and the
obligations of Tenant to pay rent hereunder and perform all the other covenants, agreements, terms, provisions and conditions hereunder on the part of Tenant to be performed shall in no way be affected, impaired or excused because Landlord is unable
to fulfill any of its obligations under this Lease or is unable to supply or is delayed in supplying any service expressly or impliedly to be supplied or is unable to make or is delayed in making any repairs, replacements, additions, alterations,
improvements or decorations or is unable to supply or is delayed in supplying any equipment or fixtures if Landlord is prevented or delayed from so doing in each case by reason of event(s) of Force Majeure. In each such instance of inability of
Landlord to perform, Landlord shall exercise reasonable diligence to promptly eliminate the cause of such inability to perform. As used in this Lease, an event or events of &#147;Force Majeure&#148; shall include strike or labor troubles, lockout,
breakdown, accident, order, preemption or regulation of or by any governmental authority or failure to supply or inability by the exercise of reasonable diligence to obtain supplies, parts or employees necessary to furnish such services or because
of war, civil commotion, or other emergency, or other extraordinary conditions of supply and demand, extraordinary weather conditions, <FONT STYLE="white-space:nowrap">so-called</FONT> acts of God, or for any other cause beyond the party&#146;s
reasonable control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26.2 Tenant shall neither assert nor seek to enforce any claim against Landlord, or Landlord&#146;s agents or
employees, or the assets of Landlord or of Landlord&#146;s agents or employees, for breach of this Lease or otherwise, other than against Landlord&#146;s interest in the Building of which the Premises are a part and in the uncollected rents, issues
and profits thereof and insurance or casualty proceeds therefrom, and Tenant agrees to look solely to such interest for the satisfaction of any liability of Landlord under this Lease, it being specifically agreed that in no event shall Landlord or
Landlord&#146;s agents or employees (or any of the officers, trustees, directors, partners, beneficiaries, joint venturers, members, stockholders or other principals or representatives, and the like, disclosed or undisclosed, thereof) ever be
personally liable for any such liability. This paragraph shall not limit any right that Tenant might otherwise have to obtain injunctive relief against Landlord or to take any other action which shall not involve the personal liability of Landlord
to respond in monetary damages from Landlord&#146;s assets other than the Landlord&#146;s interest in said real estate, as aforesaid. In no event shall Landlord or Landlord&#146;s agents or employees (or any of the officers, trustees, directors,
partners, beneficiaries, joint venturers, members, stockholders or other principals or representatives and the like, disclosed or undisclosed, thereof) ever be liable for consequential or incidental damages. Without limiting the foregoing, in no
event shall Landlord or Landlord&#146;s agents or employees (or any of the officers, trustees, directors, partners, beneficiaries, joint venturers, two managers, members, stockholders or other principals or representatives and the like, disclosed or
undisclosed, thereof) ever be liable for lost profits of Tenant. Without limiting the foregoing, but except to the extent arising from a violation of Tenant&#146;s obligations set forth in Article 22 or Article 29.11 hereof, in no event shall Tenant
or Tenant&#146;s agents or employees (or any of the officers, trustees, directors, partners, beneficiaries, joint venturers, two managers, members, stockholders or other principals or representatives and the like, disclosed or undisclosed, thereof)
ever be liable for lost profits or consequential damages of Landlord, and further, in no event shall any of the officers, trustees, directors, partners, beneficiaries, joint venturers, members, stockholders or other principals, agents or
representatives of Tenant, disclosed or undisclosed, ever be personally liable under this Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26.3 Landlord shall not be deemed to be
in default of its obligations under the Lease unless Tenant has given Landlord written notice of such default, and Landlord has failed to cure such default within thirty (30)&nbsp;days after Landlord receives such notice or such longer period of
time as Landlord may reasonably require to cure such default, provided that Landlord commences curative action within such period and diligently prosecutes the same to completion. Except as otherwise expressly provided in this Lease, in no event
shall Tenant have the right to terminate the Lease nor shall Tenant&#146;s obligation to pay Yearly Rent or other charges under this Lease abate based upon any default by Landlord of its obligations under the Lease. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>27.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BILLS AND NOTICES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice, consent, request, bill, demand or statement hereunder by either party to the other party shall be in writing and, if received at
Landlord&#146;s or Tenant&#146;s address, shall be deemed to have been duly given when either delivered or served personally or sent via overnight mail (via nationally recognized courier) or mailed by first-class mail postage paid certified or
registered mail return receipt requested, addressed to Landlord at its address as stated in Exhibit 1 with a copy to Landlord, c/o Related Beal, 177 Milk Street, Boston, Massachusetts 02109 Attn: Innovation
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Square General Manager and a copy of any such notices in the nature of a default, failure to perform or other legal notices to Sherin and Lodgen LLP, 101 Federal Street, Boston, Massachusetts
02110, ATTN: Robert M. Carney, and to Tenant at the Premises (or at Tenant&#146;s address as stated in Exhibit 1, if mailed prior to Tenant&#146;s occupancy of the Premises), and a copy of any such notices in the nature of a default, failure to
perform or other legal notices to Anderson&nbsp;&amp; Kreiger LLP, 50 Milk Street, 21<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> Floor, Boston, Massachusetts 02109 ATTN: David L. Wiener or if any address for notices shall have been duly
changed as hereinafter provided, if mailed as aforesaid to the party at such changed address. Either party may at any time change the address or specify an additional address for such notices, consents, requests, bills, demands or statements by
delivering or mailing, as aforesaid, to the other party a notice stating the change and setting forth the changed or additional address, provided such changed or additional address is within the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All bills and written statements for reimbursement or other payments or charges due from Tenant to Landlord hereunder shall be due and payable
in full thirty (30)&nbsp;days, unless herein otherwise provided, after submission thereof by Landlord to Tenant. Tenant&#146;s failure to make timely payment of any amounts indicated by such bills and statements, whether for work done by Landlord at
Tenant&#146;s written request, reimbursement provided for by this Lease or for any other sums properly owing by Tenant to Landlord provided for by this Lease, shall be treated as a default in the payment of rent and subject to such applicable Grace
Periods, in which event Landlord shall have all rights and remedies provided in this Lease for the nonpayment of rent. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>28.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PARTIES BOUND-SEIZING OF TITLE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The covenants, agreements, terms, provisions and conditions of this Lease shall bind and benefit the successors and assigns of the parties
hereto with the same effect as if mentioned in each instance where a party hereto is named or referred to, except that no violation of the provisions of Article 16 hereof shall operate to vest any rights in any successor or assignee of Tenant and
that the provisions of this Article 28 shall not be construed as modifying the conditions of limitation contained in Article 21 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, in connection with or as a consequence of the sale, transfer or other disposition of the real estate (land and/or Building, either or
both, as the case may be) of which the Premises are a part, Landlord ceases to be the owner of the reversionary interest in the Premises, Landlord shall be entirely freed and relieved from the performance and observance thereafter of all covenants
and obligations hereunder on the part of Landlord to be performed and observed, it being understood and agreed in such event (and it shall be deemed and construed as a covenant running with the land) that the person succeeding to Landlord&#146;s
ownership of said reversionary interest shall thereupon and thereafter assume, and perform and observe, any and all of such covenants and obligations of Landlord. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>29.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MISCELLANEOUS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.1 <B>Separability.</B> If any provision of this Lease or portion of such provision or the application thereof to any person or circumstance
is for any reason held invalid or unenforceable, the remainder of the Lease (or the remainder of such provision) and the application thereof to other persons or circumstances shall not be affected thereby. Time is of the essence of this Lease. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.2 <B>Captions, etc. </B>The captions are inserted only as a matter of convenience and for reference, and in no way define, limit or describe
the scope of this Lease nor the intent of any provisions thereof. References to &#147;State&#148; shall mean, where appropriate, the Commonwealth of Massachusetts. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.3 <B>Broker. </B>Landlord and Tenant represent and warrant that neither has directly or indirectly dealt, with respect to the leasing of the
Premises, with any broker nor has Tenant had its attention called to the Premises or other space to let in the Building, etc., by anyone other than the broker, person or firm, if any, designated in Exhibit 1. Landlord and Tenant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agree to defend, exonerate and save harmless and indemnify the other and anyone claiming by, through or under such party against any claims for a commission arising out of the execution and
delivery of this Lease or out of negotiations between Landlord and Tenant with respect to the leasing of other space in the Building, etc. Landlord shall be solely responsible for the payment of brokerage commissions to the broker, person or firm,
if any, designated in Exhibit 1 pursuant to a separate agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.4 <B>Modifications.</B> If in connection with obtaining financing for
the Building, a bank, insurance company, pension trust or other institutional lender shall request commercially reasonable modifications in this Lease as a condition to such financing, Tenant will not unreasonably withhold, delay or condition its
consent thereto, provided that such modifications do not increase the obligations of Tenant hereunder, diminish the rights of Tenant hereunder, or reduce the obligations of Landlord hereunder, or in any adversely affect the leasehold interest hereby
created. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.5 <B><FONT STYLE="white-space:nowrap">Non-Discrimination</FONT> and Equal Opportunity</B><B>.</B> To comply with the <FONT
STYLE="white-space:nowrap">Non-Discrimination</FONT> and Equal Opportunity Covenants set forth in Section&nbsp;16.1 of the EDIC Lease and Exhibit O of the EDIC Lease, which are restated in full in Exhibit 7 attached hereto, wherein the term
&#147;Tenant&#148; shall mean Tenant hereunder and &#147;Landlord&#148; shall mean the Landlord under the EDIC Lease. Landlord shall include or otherwise incorporate (e.g., by reference) the foregoing
<FONT STYLE="white-space:nowrap">Non-Discrimination</FONT> and Equal Opportunity Covenants in all future applicable Building tenant leases so long as such covenants are required of Landlord under the EDIC Lease or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.6 <B>Governing Law.</B> This Lease is made pursuant to, and shall be governed by, and construed in accordance with, the laws of the State
wherein the Building is situated and any applicable local municipal rules, regulations, <FONT STYLE="white-space:nowrap">by-laws,</FONT> ordinances and the like. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.7 <B>Assignment of Rents.</B> With reference to any assignment by Landlord of its interest in this Lease, or the rents payable hereunder,
conditional in nature or otherwise, which assignment is made to or held by a bank, trust company, insurance company or other institutional lender holding a mortgage or ground lease on the Building, Tenant agrees: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) that the execution thereof by Landlord and the acceptance thereof by such mortgagee and/or ground lessor shall never be deemed an
assumption by such mortgagee and/or ground lessor of any of the obligations of the Landlord hereunder, unless such mortgagee and/or ground lessor shall, by written notice sent to the Tenant, specifically otherwise elect; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) that, except as aforesaid, such mortgagee and/or ground lessor shall be treated as having assumed the Landlord&#146;s obligations hereunder
only upon foreclosure of such mortgagee&#146;s mortgage or deed of trust or termination of such ground lessor&#146;s ground lease and the taking of possession of the Premises after having given notice of its exercise of the option stated in Article
23 hereof to succeed to the interest of the Landlord under this Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.8 <B>Representation of Authority.</B> Each of Landlord and
Tenant warrants and represents to the other that the person executing this Lease on its behalf is duly authorized to do so. If Tenant is a corporation, Tenant hereby appoints the signatory whose name appears below on behalf of Tenant as
Tenant&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> for the purpose of executing this Lease for and on behalf of Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.9<B> Expenses Incurred by Landlord Upon Tenant Requests.</B> Subject to the terms and
provisions of this Lease governing the same, Tenant shall, upon demand, reimburse Landlord for all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses, including, without limitation,
legal fees, incurred by Landlord in connection with all requests by Tenant for consents, approvals or execution of collateral documentation related to this Lease, including, without limitation, costs incurred by Landlord in the review and approval
of Tenant&#146;s plans and specifications in connection with proposed Alterations to be made by Tenant to the Premises, requests by Tenant to sublet the Premises or assign its interest in the Lease, the execution by Landlord of estoppel certificates
requested by Tenant, and requests by Tenant for Landlord to execute waivers of Landlord&#146;s interest in Tenant&#146;s property in connection with third party financing by Tenant. Such costs shall be deemed to be Additional Rent under the Lease.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.10 <B>Survival.</B> Without limiting any other obligation of the Tenant which may survive the expiration or prior termination of the
Term of the Lease, all obligations on the part of Tenant to indemnify, defend, or hold Landlord harmless, as set forth in this Lease (including, without limitation, Tenant&#146;s obligations under Articles 13(d), 15.3, and 29.3) shall survive the
expiration or prior termination of the Term of the Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.11 <B>Hazardous Materials.</B> Landlord and Tenant agree as follows with
respect to the existence or use of &#147;Hazardous Material&#148; in or on the Premises, Building, Land and Complex. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Tenant, at its
sole cost and expense, shall comply with all laws, statutes, ordinances, rules and regulations of any local, state or federal governmental authority having jurisdiction concerning environmental, health and safety matters (collectively,
&#147;Environmental Laws&#148;), including, but not limited to, any discharge into the air, surface, water, sewers, soil or groundwater of any Hazardous Material (as defined below), whether within or outside the Premises within the Building, Land
and Complex. Tenant shall comply with all terms, conditions and guidelines contained in Tenant&#146;s MWRA permit and agrees to acknowledge such agreement to so comply in writing within ten (10)&nbsp;business days of written request of Landlord and
shall provide Landlord (and any applicable governmental authority) with a detailed description and guidelines of laboratory operating conditions pursuant to the MWRA permit. Notwithstanding the foregoing, nothing contained in this Lease requires, or
shall be construed to require, Tenant to incur any liability related to or arising from environmental conditions (i)&nbsp;for which the Landlord is responsible pursuant to the terms of this Lease, or (ii)&nbsp;which existed within the Premises or
the Building, Land and Complex prior to the date Tenant takes possession of, or enters, the Premises, provided, however, that if any such environmental condition was exacerbated by Tenant (or Tenant&#146;s contractors, subcontractors, agents,
subtenants, assigns, etc.), the cost (and any delays resulting therefrom) of the liability therefor and any such removal or remediation shall be equitably borne by Landlord and Tenant based upon the degree to which Tenant&#146;s (or such other
Tenant parties&#146;) actions have increased the cost of such removal or remediation. Tenant shall comply with all applicable Legal Requirements (including applicable zoning and building code requirements and Landlord&#146;s reasonable quantity
limitations to provide for multiple tenant use and compliance applicable to the Building area and/or the <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;control area&#148; therein, so long as such Landlord-imposed quantity limitations do not
decrease the areas Tenant is entitled to under Section&nbsp;2.2 in any material respect) pertaining to the transportation, storage, use or disposal of such Hazardous Materials. Tenant shall be required to adhere to and comply with all commercially
reasonable and uniformly imposed rules, regulations, restrictions and the like regarding the use and storage and quantities, including those as to allowable types, of Hazardous Materials and those that are allocated to Tenant by Landlord&#146;s
pursuant to the Chemical Central Area and Storage Quantities matrix, as updated from time to time, the current version of which is attached hereto as Exhibit 12. Subject to Tenant&#146;s compliance obligations set forth herein including quantity and
storage allocation requirements, Landlord consents to Tenant&#146;s use of the Permitted Materials listed in Exhibit 13, which may be updated from time to time by Tenant with Landlord&#146;s prior written consent, not to be unreasonably withheld,
conditioned or delayed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than the Permitted Materials, Tenant shall not cause or permit any Hazardous Material to be brought
upon, kept or used in or about the Premises or otherwise in, on or at the Building, Land and Complex by Tenant, its agents, employees, contractors or invitees, without the prior written consent of Landlord, except for Hazardous Materials which are
typically used in the operation of offices or laboratories, provided that such materials are stored, used and disposed of in strict compliance with all applicable Environmental Laws and with good scientific and medical practice. Within ten
(10)&nbsp;business days of Landlord&#146;s request, Tenant shall provide Landlord </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with a list of all Hazardous Materials, including quantities used and such other information as Landlord may reasonably request, used by Tenant in the Premises or otherwise in, at or under the
Building, Land and Complex. Notwithstanding the foregoing, with respect to any of Tenant&#146;s Hazardous Materials which Tenant does not properly handle, store or dispose of in compliance with all applicable Environmental Laws and good scientific
and medical practice, Tenant shall, upon five (5)&nbsp;business days&#146; prior written notice (or sooner if required by applicable Legal Requirements) from Landlord, no longer have the right to bring such material into the Premises, Building of
which the Premises is a part or the Land or Complex until Tenant has demonstrated, to Landlord&#146;s reasonable satisfaction, that Tenant has implemented programs to thereafter properly handle, store or dispose of such material. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As used herein, the term &#147;Hazardous Material&#148; means any hazardous or toxic substances, hazardous waste, environmental,
biological, chemical, radioactive substances, oil, petroleum products and any waste or substance, which because of its quantitative concentration, chemical, biological, radioactive, flammable, explosive, infectious or other characteristics,
constitutes or may reasonably be expected to constitute or contribute to a danger or hazard to public health, safety or welfare or to the environment, or that would trigger any employee or community <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;right-to-know&#148;</FONT></FONT> requirements adopted by any federal, state or local governing or regulatory body or which is or otherwise becomes regulated by any Environmental Law, including but not limited to the
Massachusetts &#147;Right to Know&#148; Law, Chapter 111F of the General Laws of Massachusetts, specifically including live organisms, viruses and fungi, Medical Waste (as defined below), and <FONT STYLE="white-space:nowrap">so-called</FONT>
&#147;biohazard&#148; materials. The term &#147;Hazardous Material&#148; includes, without limitation, any material or substance which is (i)&nbsp;designated as a &#147;hazardous substance&#148; pursuant to Section&nbsp;1311 of the Federal Water
Pollution Control Act (33 U.S.C. Section&nbsp;1317), (ii) defined as a &#147;hazardous waste&#148; pursuant to Section&nbsp;1004 of the Federal Resource Conservation and Recovery Act, 42 U.S.C. Section&nbsp;6901 et seq. (42 U.S.C.
Section&nbsp;6903), (iii) defined as a &#147;hazardous substance&#148; pursuant to Section&nbsp;101 of the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. Section&nbsp;9601 et seq. (42 U.S.C. Section&nbsp;9601), (iv)
defined as &#147;hazardous substance&#148; or &#147;oil&#148; under Chapter 21E of the General Laws of Massachusetts, or (v)&nbsp;a <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;biohazard&#148; or Medical Waste, or is contaminated with
blood or other bodily fluids; and &#147;Environmental Laws&#148; include, without limitation, the laws listed in the preceding clauses (i)&nbsp;through (iv). The term &#147;Medical Waste&#148; shall mean the types of waste described in any federal,
state or local laws, rules and regulations and any similar type of waste. Tenant shall not cause or permit any Medical Waste to be brought, kept or used in or about the Premises or the Project by Tenant, its employees, agents, contractors or
invitees except in strict compliance with all applicable Environmental Laws and with good scientific and medical practice. Tenant shall comply with all applicable and appropriate laboratory biosafety level criteria, requirements and recommendations
including specific &#147;BSL&#148; limitations, standards, practices, safety equipment and facility requirements for the applicable BSL level pursuant to the Center for Disease Control and otherwise consistent with good scientific and medical
practice (and in no event shall Tenant&#146;s use or occupancy involve activities that would qualify or be characterized or categorized as BSL 3 or BSL 4. Information can be found at:
https://www.cdc.gov/biosafety/publications/bmbl5/bmbl5_sect_iv.pdf. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Tenant shall procure and maintain at its sole expense such
additional insurance as may be necessary to comply with any requirement of any federal, state or local government agency with jurisdiction over Tenant&#146;s use, generation, or storage of Hazardous Materials at the Premises. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Prior to the expiration of this Lease (or within thirty (30)&nbsp;days after any earlier termination), Tenant shall clean and otherwise
decommission all interior surfaces (including floors, walls, ceilings, and counters), piping, supply lines, waste lines, acid neutralization system, and plumbing in and/or exclusively serving the Premises, and all exhaust or other ductwork in and/or
exclusively serving the Premises, in each case which has carried or released or been exposed to any Hazardous Material, and shall otherwise clean the Premises (to the point of ceiling penetration) so as to permit the report hereinafter called for by
this Section&nbsp;29.11(e) to be issued; provided, Tenant shall not be responsible for decommissioning obligations relating to any Hazardous Material or environmental condition which existed within the Premises or the Building, Land and Complex
prior to the date Tenant takes possession of, or enters, the Premises, unless the presence of such Hazardous Material or such environmental condition was exacerbated by Tenant (or Tenant&#146;s contractors, subcontractors, agents, subtenants,
assigns, etc.). Prior to the expiration of this Lease (or within thirty (30)&nbsp;days after any earlier termination), Tenant, at Tenant&#146;s expense, shall obtain for Landlord a report addressed to Landlord and Landlord&#146;s designees (and, at
Tenant&#146;s election, Tenant) by a reputable licensed environmental engineer or certified industrial hygienist that, in either case, is designated by Tenant and acceptable to Landlord in Landlord&#146;s reasonable discretion, which report shall be
based on the environmental engineer&#146;s or industrial hygienist&#146;s inspection of the Premises and shall show: that the Hazardous Materials, to the extent, if any, existing prior to such decommissioning, have been removed as necessary so that
the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interior surfaces of the Premises (including but not limited to floors, walls, ceilings, and counters), piping, supply lines, waste lines and plumbing, and all such exhaust or other ductwork in
and/or exclusively serving the Premises, may be reused by a subsequent tenant or disposed of in compliance with applicable Environmental Laws without taking any special precautions for Hazardous Materials, without incurring special costs or
undertaking special procedures for demolition, disposal, investigation, assessment, cleaning or removal of Hazardous Materials<I> </I>and without incurring regulatory compliance requirements or giving notice in connection with Hazardous Materials;
and that the Premises may be reoccupied for research or laboratory use, demolished or renovated without taking any special precautions for Hazardous Materials, without incurring special costs or undertaking special procedures for disposal,
investigation, assessment, cleaning or removal of Hazardous Materials and without incurring regulatory requirements or giving notice in connection with Environmental Substances. Further, for purposes of this Section: &#147;special costs&#148; or
&#147;special procedures&#148; shall mean costs or procedures, as the case may be, that would not be incurred but for the nature of the Hazardous Materials as Hazardous Materials instead of <FONT STYLE="white-space:nowrap">non-hazardous</FONT>
materials. The report shall include reasonable detail concerning the <FONT STYLE="white-space:nowrap">clean-up</FONT> location, the tests run and the analytic results. In addition, to the extent Tenant (or any party taking by or through Tenant)
used, stored, generated or disposed of any radioactive or radiological substances on or about the Premises, such decommissioning shall also be conducted in accordance with the regulations of the U.S. Nuclear Regulatory Commission and/or the
Massachusetts Department of Public Health for the control of radiation, and cause the Premises to be released for unrestricted use by the Radiation Control Program of the Massachusetts Department of Public Health for the control of radiation, and
deliver to Landlord the report of a certified industrial hygienist stating that he or she has examined the Premises (including visual inspection, Geiger counter evaluation and airborne and surface monitoring) and found no evidence that such portion
contains Hazardous Materials or is otherwise in violation of any Environmental Law. If Tenant fails to perform its obligations under this Section, without limiting any other right or remedy, Landlord may, on not less than ten (10)&nbsp;business
days&#146; prior written notice to Tenant perform such obligations at Tenant&#146;s expense, and Tenant shall promptly reimburse Landlord upon demand for all costs and expenses reasonably incurred together with an administrative charge of 10% of the
cost thereof. Tenant&#146;s obligations under this Section shall survive the expiration or earlier termination of this Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Prior to
the expiration of this Lease (or within thirty (30)&nbsp;days after any earlier termination), Tenant shall provide to Landlord a copy of its most current chemical waste removal manifest and a certification, based on the decommissioning report and
actual knowledge after due inquiry, from Tenant executed by an officer of Tenant that no Hazardous Materials or other potentially dangerous or harmful chemicals brought onto the Premises from and after the date that Tenant first took occupancy of
the Premises remain in the Premises. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Tenant hereby represents and warrants to Landlord that (i)&nbsp;neither Tenant nor any of its
legal predecessors has been required by any prior landlord, lender or governmental authority at any time to take remedial action in connection with Hazardous Materials contaminating a property which contamination was permitted by Tenant of such
predecessor or resulted from Tenant&#146;s or such predecessor&#146;s action or use of the property in question, and (ii)&nbsp;Tenant is not subject to any enforcement order issued by any governmental authority in connection with the use, storage,
handling, treatment, generation, release or disposal of Hazardous Materials (including, without limitation, any order related to the failure to make a required reporting to any governmental authority). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Landlord shall have the right to conduct annual tests of the Premises to determine whether any contamination of the Premises, the Building
or the Complex has occurred as a result of Tenant&#146;s use. Tenant shall be required to pay the reasonable out of pocket cost of such annual test of the Premises if there is violation of this Section&nbsp;29.11 or if contamination for which Tenant
is responsible under this Section&nbsp;29.11 is identified; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord,
Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant. In addition, at any reasonable time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct
appropriate tests of the Premises, the Building and the Complex to determine if contamination has occurred as a result of Tenant&#146;s use or occupancy of the Premises. In connection with such testing, upon the request of Landlord, Tenant shall
deliver to Landlord or its consultant such <FONT STYLE="white-space:nowrap">non-proprietary</FONT> information concerning the use of Hazardous Materials in, on or about the Premises by Tenant or any party taking by or through Tenant. If
contamination has occurred for which Tenant is liable under this Section&nbsp;29.11, Tenant shall pay all costs to conduct such tests; otherwise, such tests shall be paid for by Landlord. If no such contamination is found, Landlord shall pay the
costs of such tests. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Within ten (10)&nbsp;business days following Landlord&#146;s written request, Tenant
shall provide Landlord with any information requested by Landlord concerning the existence, use, generation or disposal of Hazardous Materials and/or Medical Waste at the Premises, including, but not limited to, the following information:
(a)&nbsp;the name, address and telephone number of the person or entity employed by Tenant to dispose of its Hazardous Materials and/or Medical Waste, including a copy of any contract with said person or entity, (b)&nbsp;all relevant information
relating to such materials (e.g., a list of each type of Hazardous Materials and/or Medical Waste used, stored, generated or disposed of by Tenant at the Premises and a description of how Tenant disposes of said Hazardous Materials and/or Medical
Waste, a copy of its most current materials list and applicable quantities thereof, applicable material safety data sheets ( MSDS) and safety data sheets (SDS) and transportation and removal manifests), (c) a copy of any laws, rules or regulations
in Tenant&#146;s possession relating to the disposal of the Hazardous Materials and/or Medical Waste generated by Tenant, and (d)&nbsp;copies of any licenses or permits obtained by Tenant in order to use, generate or dispose of Hazardous Materials
and/or Medical Waste, including any MWRA permits and approvals. Tenant shall also promptly provide to Landlord upon written request a copy of any notice, registration, application, permit, or license given to or received from any governmental
authority or private party, or persons entering or occupying the Premises, concerning the presence, release, exposure or disposal of any Hazardous Materials and/or Medical Waste in or about the Premises or the Complex. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) To the maximum extent this agreement may be made effective according to law (including the limitations set forth in M.G.L. c. 186,
&#167;15), but subject to Tenant&#146;s insurance requirements hereunder and Article 15 and Article 19, Tenant hereby covenants and agrees to indemnify, defend and hold Landlord and its employees, partners, agents, contractors, lenders and ground
lessors (said persons and entities are hereinafter collectively referred to as the &#147;Indemnified Parties&#148;) harmless from any and all liabilities, losses, costs, damages, claims, loss of rents, liens, judgments, penalties, fines, settlement
costs, investigation costs, the cost of consultants and experts, attorney&#146;s fees, court costs and other legal expenses, the effects of environmental contamination, the cost of environmental testing, the removal, remediation and/or abatement of
Hazardous Materials or Medical Waste), insurance policy deductibles and other expenses (collectively &#147;Losses&#148;) arising out of or related to an &#147;Indemnified Matter&#148; (as defined below). For purposes of this Section&nbsp;29.11(i),
an &#147;Indemnified Matter&#148; shall mean any matter for which one or more of the Indemnified Parties incurs liability or Losses if the liability or Losses arise out of or involve, directly or indirectly, (i)&nbsp;the presence of any Hazardous
Material or Medical Waste on or about the Premises (or the Complex), the presence of which is caused or permitted by Tenant or its employees, agents, contractors or invitees (all of said persons or entities are hereinafter collectively referred to
as &#147;Tenant Parties&#148;), (ii) Intentionally Omitted, (iii)&nbsp;Tenant&#146;s failure to perform any of its obligations under this Section&nbsp;29.11 or any other provision relating to Hazardous Materials, (iv)&nbsp;the existence, use or
disposal of any Hazardous Material or Medical Waste brought on to the Complex by a Tenant Party, or (v)&nbsp;any other matters for which Tenant has agreed to indemnify Landlord or any Indemnified Party pursuant to any other provision of this Lease
relating to Hazardous Materials. Tenant&#146;s obligations hereunder shall include, but shall not be limited to compensating the Indemnified Parties for Losses arising out of Indemnified Matters within thirty (30)&nbsp;days after written demand from
an Indemnified Party and providing a defense, with counsel reasonably satisfactory to the Indemnified Party, at Tenant&#146;s sole expense, within thirty (30)&nbsp;days after written demand from the Indemnified Party, of any claims, action or
proceeding arising out of or relating to an Indemnified Matter whether or not litigated or reduced to judgment and whether or not well founded. This indemnification of the Indemnified Parties by Tenant includes, without limitation, reasonable costs
incurred in connection with any investigation of site conditions or any cleanup, remedial, removal or restoration work required by any federal, state or local governmental agency or political subdivision because of Hazardous Material present in the
soil or ground water on or under the Premises based upon the circumstances identified herein. Without limiting the foregoing, if the presence of any Hazardous Material in the Building or otherwise in, on, at or under the Land or Complex caused by
Tenant or its agents, contractors employees results in any contamination of the Premises, Tenant shall promptly take all actions at its sole expense as are necessary to return the Premises to a condition which complies with all Environmental Laws
for the use of the Building as provided herein (or as then currently used); provided that Landlord&#146;s approval of such actions shall first be obtained, which approval shall not be unreasonably withheld, conditioned or delayed so long as such
actions, in Landlord&#146;s reasonable discretion, would not potentially have any materially adverse long-term or short-term effect on the Premises, and, in any event, Landlord shall not withhold its approval of any proposed actions which are
required by applicable Environmental Laws. The Indemnified Parties need not first pay any Losses to be indemnified hereunder. This indemnity is intended to apply to the fullest extent permitted by applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The provisions of this Section&nbsp;29.11 shall survive the expiration or termination of this Lease unless specifically waived in writing
by Landlord after said expiration or termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.12 <B>Patriot Act.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant represents and warrants to Landlord that, to Tenant&#146;s knowledge: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) Tenant is not in violation of any Anti-Terrorism Law </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) Tenant is not, as of the date hereof: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">conducting any business or engaging in any transaction or dealing with any Prohibited Person (as hereinafter
defined), including the making or receiving of any contribution of funds, goods or services to or for the benefit of any Prohibited Person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">dealing in, or otherwise engaging in any transaction relating to, any property or interests in property blocked
pursuant to Executive Order No.&nbsp;13224; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">engaging in or conspiring to engage in any transaction that evades or avoids, or has the purpose of evading or
avoiding, or attempts to violate any of the prohibitions set forth in, any Anti-Terrorism Law; and </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) Neither Tenant
nor any of its affiliates, officers, directors, shareholders, members or lease guarantor, as applicable, is a Prohibited Person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If at any
time any of these representations becomes false, then it shall be considered a material default under this Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used herein,
&#147;Anti-Terrorism Law&#148; is defined as any law relating to terrorism, anti-terrorism, money-laundering or anti-money laundering activities, including without limitation the United States Bank Secrecy Act, the United States Money Laundering
Control Act of 1986, Executive Order No.&nbsp;13224, and Title 3 of the USA Patriot Act, and any regulations promulgated under any of them. As used herein &#147;Executive Order No.&nbsp;13224&#148; is defined as Executive Order No.&nbsp;13224 on
Terrorist Financing effective September&nbsp;24, 2001, and relating to &#147;Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism&#148;, as may be amended from time to time.
&#147;Prohibited Person&#148; is defined as (i)&nbsp;a person or entity that is listed in the Annex to Executive Order No.&nbsp;13224, or a person or entity owned or controlled by an entity that is listed in the Annex to Executive Order
No.&nbsp;13224; (ii) a person or entity with whom Landlord is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law; or (iii)&nbsp;a person or entity that is named as a &#147;specially designated national and
blocked person&#148; on the most current list published by the U.S. Treasury Department Office of Foreign Assets Control at its official website, http://www.treas.gov/ofac/t11sdn.pdf or at any replacement website or other official publication of
such list. &#147;USA Patriot Act&#148; is defined as the &#147;Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001&#148; (Public Law
<FONT STYLE="white-space:nowrap">107-56),</FONT> as may be amended from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord represents and warrants to Tenant that, to
Landlord&#146;s knowledge: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) Landlord is not in violation of any Anti-Terrorism Law </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) Landlord is not, as of the date hereof: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">conducting any business or engaging in any transaction or dealing with any Prohibited Person (as hereinafter
defined), including the making or receiving of any contribution of funds, goods or services to or for the benefit of any Prohibited Person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">dealing in, or otherwise engaging in any transaction relating to, any property or interests in property blocked
pursuant to Executive Order No.&nbsp;13224; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">engaging in or conspiring to engage in any transaction that evades or avoids, or has the purpose of evading or
avoiding, or attempts to violate any of the prohibitions set forth in, any Anti-Terrorism Law; and </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) Neither Landlord
nor any of its affiliates, officers, directors, shareholders, members or lease guarantor, as applicable, is a Prohibited Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If at
any time any of these representations becomes false, then it shall be considered a material default under this Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.13 <B>Letter of
Credit.</B> In order to secure Tenant&#146;s obligations to Landlord under this Lease, Tenant shall deliver to Landlord, on the date that Tenant executes and delivers the Lease to Landlord, an Irrevocable Standby Letter of Credit (&#147;Letter of
Credit&#148;) which shall be (a)&nbsp;in the form attached hereto as Exhibit 9, (b) issued by a bank reasonably acceptable to Landlord, upon which presentment may be made in Boston, Massachusetts, (c)&nbsp;in an amount equal to the Letter of Credit
Amount (set for on Exhibit 1), and (d)&nbsp;for the period specified below, subject to extension in accordance with the terms of the Letter of Credit and as set forth herein. Landlord hereby approves Silicon Valley Bank and Wells Fargo as issuers of
the Letter of Credit. In addition, if the credit rating, as determined by any commercially recognized rating agency, Landlord reserves the right to require Tenant to replace the Letter of Credit from time to time with a similar letter of credit
issued by another bank satisfactory to Landlord. Tenant shall, on or before that date which is thirty (30)&nbsp;days prior to the expiration of the term of such Letter of Credit, deliver to Landlord a new Letter of Credit satisfying the foregoing
conditions (&#147;Substitute Letter of Credit&#148;) in lieu of the Letter of Credit then being held by Landlord. Such Letter of Credit shall be automatically renewable provided that if the issuer of such Letter of Credit gives notice of its
election not to renew such Letter of Credit for any additional period pursuant thereto, Tenant shall be required to deliver a Substitute Letter of Credit satisfying the conditions hereof, on or before the date thirty (30)&nbsp;days prior to the
expiration of the term of such Letter of Credit. Tenant agrees that it shall from time to time, as necessary, whether as a result of a draw on the Letter of Credit by Landlord pursuant to the terms hereof or as a result of the expiration of the
Letter of Credit then in effect, renew or replace the original and any subsequent Letter of Credit so that a Letter of Credit, in the amount required hereunder, is in effect throughout Term of this Lease, including any extensions thereof, or in the
event that Tenant remains in possession of the premises following the expiration of the term, or if Tenant has obligations hereunder to Landlord that remain unsatisfied following the expiration of the term (as may be extended), and for ninety
(90)&nbsp;days after the latest to occur of the foregoing (i.e., the expiration of the term (as may be extended), the date on which Tenant vacates and yields up the premises, etc.). If Tenant fails to furnish such renewal or replacement at least
thirty (30)&nbsp;days prior to the stated expiration date of the Letter of Credit then held by Landlord, Landlord may draw upon such Letter of Credit and hold the proceeds thereof (and such proceeds need not be segregated) as a security deposit
pursuant to the terms of this Article 29.13. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Letter of Credit (Substitute Letter of Credit or Additional Letter of Credit, as defined
herein, as the case may be) shall be held to ensure the full and timely performance of all of Tenant&#146;s obligations under this Lease and may be drawn upon by Landlord and applied from time to time against any outstanding obligations of Tenant
hereunder without notice or demand including, but not limited to, (a)&nbsp;any amount necessary to cure any default hereunder existing beyond any applicable notice or Grace Period (provided, however, that if any notice is prohibited, stayed or
barred by applicable law [e.g., pursuant to the provisions of the Federal Bankruptcy Code] without obtaining court, trustee or other party&#146;s approval (<I>e.g.</I>, relief from the automatic stay in the event of a bankruptcy), no notice shall be
required for Landlord to draw upon the Letter of Credit) or (b)&nbsp;if such default cannot reasonably be cured by the expenditure of money, to exercise all rights and remedies Landlord may have on account of such default, the amount which, in
Landlord&#146;s reasonable opinion, is necessary to satisfy Tenant&#146;s liability on account thereof. In the event of any such draw by the Landlord, Tenant shall, within fifteen (15)&nbsp;business days of written demand therefor, deliver to
Landlord an additional Letter of Credit satisfying the foregoing conditions or a new letter of credit in the full amount of the Letter of Credit required by this Section&nbsp;29.13 (&#147;Additional Letter of Credit&#148;), except that the amount of
such Additional Letter of Credit shall be the amount of such draw. In addition, in the event of a termination based upon the default of Tenant under the Lease, or a rejection of the Lease pursuant to the provisions of the Federal Bankruptcy Code,
Landlord shall have the right to draw upon the Letter of Credit (from time to time, if necessary) to cover the full amount of damages and other amounts due from Tenant to Landlord under the Lease. Any amounts so drawn shall, at Landlord&#146;s
election, be applied first to any unpaid rent and other charges which were due prior to the filing of the petition for protection under the Federal Bankruptcy Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon request of Landlord or any (prospective) purchaser or mortgagee of the Building, Tenant
shall, at its expense, cooperate with Landlord in obtaining an amendment to or replacement of any Letter of Credit which Landlord is then holding so that the amended or new Letter of Credit reflects the name of the new owner of the Building or
mortgagee, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that Landlord has not previously drawn upon any Letter of Credit, Substitute Letter of
Credit, Additional Letter of Credit or Security Proceeds (collectively &#147;Collateral&#148;) held by the Landlord, and to the extent that Tenant is not otherwise in default of its obligations under the Lease as of the termination date of the
Lease, Landlord shall return such Collateral to Tenant on the termination of the Term of the Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In no event shall the proceeds of any
Letter of Credit be deemed to be a prepayment of rent nor shall it be considered as a measure of liquidated damages. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the
foregoing, (x)&nbsp;based on Tenant&#146;s financial statements (provided in accordance with Section&nbsp;17.5) for either of Tenant&#146;s 2020 and 2021 fiscal years if such financial statements (including cash balances and anticipated proposed
uses of cash) demonstrate to Landlord&#146;s reasonable satisfaction that Tenant has sufficient cash, available for sale securities, or other cash equivalent to fund all operations and expenses through Tenant&#146;s fiscal year 2022, or (y)&nbsp;in
any event from and after the last day of calendar year 2022, (with such determinate date being the &#147;Reduction Date&#148;), and provided that: (i)&nbsp;Tenant has not been in default of any of its obligations under this Lease after the giving of
any applicable notice and the expiration of any applicable Grace Period prior to the Reduction Date, as hereinafter defined, in question, (ii)&nbsp;Tenant is, as of the Reduction Date, not in default of its obligation under the Lease beyond any
applicable notice or Grace Period (provided, however, that if there is no reduction of the Letter of Credit Amount based upon Tenant&#146;s failure to satisfy the condition set forth in this clause (ii), then Tenant may subsequently achieve a
reduction in the Letter of Credit Amount pursuant to this sentence at such time as Tenant cures such default and thereafter has a period of no less than nine (9)&nbsp;months without any subsequent default hereunder, so long as the Lease is then in
full force and effect and Tenant is otherwise then in full compliance with its obligations under the Lease), and (iii)&nbsp;the Lease is then in full force and effect, Landlord shall allow the Letter of Credit Amount to be reduced, upon written
request by Tenant, to Nine Hundred Two Thousand Seven Hundred Twenty-nine and 50/100 Dollars ($902,729.50). Tenant&#146;s request for such reduction shall include, if not already provided, reasonable supporting documentation verifying Tenant&#146;s
financial condition. Any reduction in the Letter of Credit shall be accomplished by Tenant providing Landlord with a substitute Letter of Credit in the reduced amount in exchange for the existing Letter of Credit(s) then held by Landlord,
substantially in the form of Exhibit 9 hereto or in another form reasonably acceptable to Landlord, and shall be effective as of the date the same is delivered by Tenant to Landlord. Landlord shall return the original Letter of Credit and any
applicable Cash Security to Tenant within five (5)&nbsp;days Landlord&#146;s receipt of the reduced Letter of Credit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall not
seek to enjoin, prevent, or otherwise interfere with Landlord&#146;s draw under the Letter of Credit (or any Substitute Letter of Credit or Additional Letter of Credit) even if such draw violates this Lease. Tenant acknowledges that the only effect
of a wrongful draw would be to substitute a cash Security Deposit for the Letter of Credit (or any Substitute Letter of Credit or Additional Letter of Credit), causing Tenant no legally recognizable damage. In the event of a wrongful draw, the
parties shall cooperate to allow Tenant to post a replacement the Letter of Credit (or any Substitute Letter of Credit or Additional Letter of Credit, as the case may be) simultaneously with the return to Tenant of the wrongfully drawn sums, and
Landlord shall upon request confirm in writing to the issuer of the Letter of Credit (or any Substitute Letter of Credit or Additional Letter of Credit) that Landlord&#146;s draw was erroneous. If Tenant receives a final determination from a court
of competent jurisdiction that is not subject to appeal that Landlord has made a &#147;wrongful&#148; draw, (i)&nbsp;Landlord shall pay Tenant interest upon the amount of such wrongful draw at the Reference Rate, and (ii)&nbsp;Tenant shall be
entitled to recover its reasonable attorney&#146;s fees in connection with such claim. For purposes of the immediately foregoing sentence, the term &#147;wrongful&#148; shall mean that Landlord had no reasonable basis to believe that it had the
right to make the draw </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.14 <B>Parking.</B> Commencing as of the Term Commencement Date and continuing thereafter
throughout the Term of the Lease, Tenant shall have the right to license up to the number of parking spaces set forth in Exhibit 1, above, in the Parking Facilities, and except for the Reserved Spaces (defined below) same will be unassigned and
available on a first come, first served basis, to which Tenant will have controlled access twenty-four (24)&nbsp;ours per day, seven (7)&nbsp;days per week, for an initial monthly rental of three hundred fifty and 00/100 Dollars ($350.00) per space
(&#147;Parking Rental&#148;). Five (5)&nbsp;of Tenant&#146; s parking spaces hereunder shall be reserved parking spaces, in the locations as shown on Exhibit 3, which shall not be relocated without the prior written consent of Tenant, not to be
unreasonably withheld, conditioned or delayed (the &#147;Reserved Spaces&#148;). Parking Rental rates shall be subject to increases equal to the prevailing market rate as established by Landlord from time to time. In the event that Tenant fails for
any reason to timely pay the Parking Rental (or any portion thereof) herein provided with respect to any parking space, Landlord shall have any rights or remedies at law or equity, be free to terminate such parking rights for such unpaid spaces and
lease such space to any other party, or person whatsoever and thereafter Tenant shall have no further rights hereunder with respect to such parking spaces or any other parking spaces on the property. Tenant may irrevocably surrender its rights to
any or all of the parking spaces, upon thirty (30)&nbsp;days written notice. Tenant shall have no right to sublet, assign, or otherwise transfer said parking passes except in connection with an assignment of this Lease or sublease of the Premises
which is permitted pursuant to the provisions of this Lease. At Landlord&#146;s election and at no cost to Tenant, Landlord may reasonably designate parking spaces for exclusive use by Tenant and other tenants of, and/or visitors to, the Building or
Complex and may install signage or implement a pass or sticker system to control parking use. Landlord shall have no liability to Tenant if such spaces are for any reason at any time unavailable for Tenant&#146;s exclusive use, provided Landlord
shall use commercially reasonable efforts to uniformly enforce parking rules and regulations at the Property, including Tenant&#146;s parking rights hereunder. Landlord reserves the right, from time to time, to change, alter, replace or relocate the
parking areas and facilities, or Tenant&#146;s parking spaces therein, serving the Building or Complex, which may include areas and facilities located on or reasonably adjacent (e.g., across street or way) to the Land or the Complex, and to
temporarily close portions thereof for maintenance and repairs as necessary; provided, however, (i)&nbsp;Landlord shall use commercially reasonable efforts to ensure that there be no unreasonable interference with Tenant&#146;s use and access to the
Premises, the Reserved Spaces, or the remainder of the parking spaces set forth in Exhibit 1; and (ii)&nbsp;Landlord shall provide at least two (2)&nbsp;weeks&#146; prior written notice (except in the case of an emergency, in which event notice
shall be provided as soon as reasonably practicable) to Tenant of any such closure. Neither Landlord nor any parking operator of the parking facilities will have any responsibility for loss or damage due to fire or theft or otherwise to any
automobile (or to any personal property therein) parked in the parking areas or facilities. Notwithstanding the foregoing, Tenant shall be entitled to a proportionate abatement of Parking Rental in the Parking Facilities (or portions thereof) are
unavailable to Tenant beyond three (3)&nbsp;consecutive business days so long as (i)&nbsp;such lack of availability was not caused by Tenant, its employees, contractors, invitees or agents or by a casualty (in which event Section&nbsp;18 shall
control); (ii) Landlord does not provide Tenant comparable temporary parking facilities; and (iii)&nbsp;such lack of availability was the result of causes, events or circumstances within the Landlord&#146;s reasonable control and the cure of such
unavailability is within Landlord&#146;s reasonable control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.15 <B></B><B>MBTA Pass Purchase Program</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant is encouraged to participate, and shall encourage its employees to participate, in any required, proscribed or recommended public transportation
programs including by way of example but not limited to providing employees with access to MBTA pass purchase programs, potential subsidies to full-time employees and <FONT STYLE="white-space:nowrap">pro-rata</FONT> subsidies to part-time employees,
posting and providing local train and bus schedules in addition to information as to where to purchase MBTA passes or Charlie Cards (online or a number of physical locations) and the like. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.16 <B>Tenant</B><B>&#146;</B><B>s Option to Extend the Term of the Lease.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) On the conditions, which conditions Landlord may waive, at its election, by written notice to Tenant at any time, that Tenant is not in
default of its covenants and obligations under the Lease beyond any applicable notice or Grace Period, and that the Tenant originally named herein or a Permitted Transferee is leasing 100% of, and occupying at least 50% of, the Rentable Area of the
Premises for the principal and primary uses allowed hereunder, both as of the time of option exercise and as of the commencement of the hereinafter described additional term, Tenant shall have the option (each, an &#147;Option&#148;) to extend the
Term of this Lease for two (2)&nbsp;additional five (5)&nbsp;year term (each, an &#147;Option Term&#148;), any such Option Term commencing as of the expiration of the then current Lease Term. The term &#147;Term&#148; as used in this Lease shall
mean the initial Term of this Lease, as the same may be extended by any Option Term. Tenant may exercise such Option to extend by giving Landlord written notice at least twelve (12) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
months prior to the expiration of the then current Lease Term. Upon the timely giving of such notice, the Term of this Lease shall be deemed extended upon all of the terms and conditions of this
Lease, except that Landlord shall have no obligation to construct or renovate the Premises and that the Yearly Rent during such Option Term shall be as hereinafter set forth. If Tenant fails to give timely notice, as aforesaid, Tenant shall have no
further right to extend the Term of this Lease, time being of the essence of this Article 29.16. If Tenant fails to timely exercise its rights hereunder, then within fifteen (15)&nbsp;days of Landlord&#146;s written request therefor, Tenant shall
execute and deliver to Landlord a certification, in recordable form, confirming the Tenant&#146;s failure to exercise (or waiver of) such right, and Tenant&#146;s failure to so execute and deliver such certification shall (without limiting
Landlord&#146;s remedies on account thereof) entitle Landlord to execute and deliver to any third party, and record, an affidavit confirming the failure or waiver, which affidavit shall be binding on Tenant and may be conclusively relied on by third
parties; provided that such request, or any second request, if applicable, contains the following words in bold capital letters: THIS IS A NOTICE UNDER ARTICLE 29.16 OF THE LEASE. IF TENANT FAILS TO DELIVER AN AFFIDAVIT AS REQUIRED UNDER SUCH
ARTICLE WITHIN FIFTEEN (15)&nbsp;DAYS AFTER TENANT&#146;S RECEIPT OF THIS LETTER, THEN TENANT HEREBY IRREVOCABLY CONSTITUTES AND APPOINTS LANDLORD, AND THEIR RESPECTIVE SUCCESSORS IN INTEREST, ACTING SINGLY, TENANT&#146;S <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ATTORNEY-IN-FACT</FONT></FONT> TO EXECUTE AND DELIVER SUCH AFFIDAVIT, ON BEHALF AND IN THE NAME OF TENANT. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Yearly Rent. The Yearly Rent during the Option Term shall be based upon the Fair Market Rental Value, as defined in Article 29.17, as of
the commencement of the additional term, of the Premises then demised to Tenant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Tenant shall have no further option to extend the
Term of the Lease other than the two (2)&nbsp;additional five (5)&nbsp;year Option Terms herein provided. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding the fact
that, upon Tenant&#146;s exercise of the herein Option to extend the Term of the Lease, such extension shall be self-executing, as aforesaid, the parties shall promptly execute a mutually agreeable lease amendment reflecting such Option Term after
Tenant exercises the herein Option, except that the Yearly Rent payable in respect of such Option Term may not be set forth in said amendment. Subsequently, after such Yearly Rent is determined, the parties shall execute a mutually agreeable written
agreement confirming the same. The execution of such lease amendment shall not be deemed to waive any of the conditions to Tenant&#146;s exercise of its rights under this Article 29.16, unless otherwise specifically provided in such lease amendment.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.17 <B>Definition of Fair Market Rental Value.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) &#147;Fair Market Rental Value&#148; shall be computed as of the date in question at the then current Yearly Rent, including provisions for
subsequent increases and other adjustments, for leases or agreements to lease then currently being executed in comparable space located in the Building, or if no such leases or agreements to lease are then currently being negotiated or executed in
the Building, the Fair Market Rental Value shall be determined by reference to leases or agreements to lease then currently being executed for comparable space located in the Building, the Complex or in first-class life science buildings in the
Seaport District of Boston, Massachusetts. In determining Fair Market Rental Value, all relevant factors shall be taken into account and given effect, including, without limitation: size, location and condition of Premises, lease term, including
renewal options, tenant&#146;s obligations with respect to operating expenses and taxes, tenant improvement allowances, condition of building, and services and amenities provided by the Landlord. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Dispute as to Fair Market Rental Value: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Landlord shall initially designate Fair Market Rental Value and Landlord shall furnish data in support of such designation. If Tenant disagrees
with Landlord&#146;s designation of a Fair Market Rental Value, Tenant shall notify Landlord, by written notice given within thirty (30)&nbsp;days after Tenant has been notified of Landlord&#146;s designation, of its disagreement whereupon the
parties shall negotiate in good faith to arrive at a mutually agreeable Fair Market Rental Value. If the parties are unable to agree within thirty (30)&nbsp;days after Tenant&#146;s notice to Landlord, the parties shall submit such Fair Market
Rental Value to arbitration. Fair Market Rental Value shall be submitted to arbitration as follows: Fair Market Rental Value shall be determined by impartial arbitrators, one to be chosen by the Landlord, one to be chosen by Tenant, and a third to
be selected, if necessary, as below provided. The unanimous written decision of the two first chosen, without selection and participation of a third arbitrator, or otherwise, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
written decision of a majority of three (3)&nbsp;arbitrators chosen and selected as aforesaid, shall be conclusive and binding upon Landlord and Tenant. Landlord and Tenant shall each notify the
other of its chosen arbitrator within ten (10)&nbsp;days following the call for arbitration and, unless such two arbitrators shall have reached a unanimous decision within thirty (30)&nbsp;days after their designation, they shall so notify the
President of the Boston Bar Association (or such organization as may succeed to said Boston Bar Association) and request him or her to select an impartial third arbitrator. All arbitrators shall have at least ten (10)&nbsp;years of professional
experience as a real estate broker dealing with first-class life science buildings in the Seaport District of Boston, Massachusetts, to determine Fair Market Rental Value as herein defined, and, with respect to the third arbitrator, shall not have
or within the three (3)&nbsp;prior years previously had a business relationship with either Landlord or Tenant. Such third arbitrator and the first two chosen shall, subject to commercial arbitration rules of the American Arbitration Association,
hear the parties and their evidence and render their decision within thirty (30)&nbsp;days following the conclusion of such hearing and notify Landlord and Tenant thereof. Landlord and Tenant shall each bear the expense of their own arbitrator, and
shall bear the expense of the third arbitrator (if any) equally. The decision of the arbitrators shall be binding and conclusive, and judgment upon the award or decision of the arbitrators may be entered in the appropriate court of law (as
identified on Exhibit 1); and the parties consent to the jurisdiction of such court and further agree that any process or notice of motion or other application to the Court or a Judge thereof may be served outside the Commonwealth of Massachusetts
by registered mail or by personal service, provided a reasonable time for appearance is allowed. If the dispute between the parties as to a Fair Market Rental Value has not been resolved before the commencement of Tenant&#146;s obligation to pay
rent based upon such Fair Market Rental Value, then Tenant shall pay Yearly Rent and other charges under the Lease in respect of the Premises in question based upon the Fair Market Rental Value designated by Landlord until either the agreement of
the parties as to the Fair Market Rental Value, or the decision of the arbitrators, as the case may be, at which time Tenant shall pay any underpayment of rent and other charges to Landlord, or Landlord shall refund any overpayment of rent and other
charges to Tenant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.18 <B>Right of First Offer on Certain Space.</B><B></B><B>&nbsp;</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Within the Building</U>. Tenant shall have the right of first offer to lease any space on the third (3<SUP
STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor, and any other space that is contiguous (i.e., adjacent to, either vertically or horizontally) to the Premises, in the Building that becomes available for occupancy (the &#147;Available
Space&#148;) during the Lease Term subject to and in accordance with the terms and conditions set forth in this Section&nbsp;29.18(a) and (b). If at any time from and after the Term Commencement Date prior to expiration of the Term any Available
Space shall become available, Landlord shall notify Tenant thereof in writing (&#147;Landlord&#146;s Available Space Notice&#148;), which notice shall include the anticipated estimated date upon which such Available Space shall become available for
occupancy by Tenant (the &#147;Anticipated Available Space Commencement Date&#148;) along with a floor plan showing the approximate rentable square footage thereof. Tenant shall have the right to lease all such Available Space described in
Landlord&#146;s Available Space Notice only by giving written notice to Landlord within fourteen (14)&nbsp;business days after Tenant receives Landlord&#146;s Available Space Notice, time being of the essence. If Tenant so elects to lease the
subject Available Space, such Available Space shall be leased upon the same terms and conditions contained in this Lease, except that: (x)&nbsp;the Yearly Rent for such space shall be equal to the Fair Market Rental Value therefor determined in
accordance with this Section&nbsp;29.17 above (made applicable hereto by such changes and modifications as are required given the application hereof,<I> mutatis mutandis</I>), and the subject Available Space shall be and become part of the Premises
hereunder upon the delivery of such Available Space to Tenant, (y)&nbsp;it is understood and agreed that the subject Available Space shall be leased by Tenant in its then <FONT STYLE="white-space:nowrap">&#147;as-is&#148;,</FONT> <FONT
STYLE="white-space:nowrap">&#147;where-is&#148;</FONT> condition, without warranty or representation by Landlord and Landlord shall have no obligation to complete any work to prepare the applicable Available Space for Tenant&#146;s use and occupancy
or provide any allowance or contribution therefor except as may be otherwise expressly described in Landlord&#146;s Available Space Notice, and (z)&nbsp;there shall be at least five (5)&nbsp;full Lease Years remaining in the Term from and after the
delivery of such Available Space (which five (5)&nbsp;Lease Year period may include Tenant&#146;s early exercise of any remaining extension term). Following such election by Tenant, and effective as of the delivery of the applicable Available Space
and for the balance of the Term and any extension thereof: (i)&nbsp;the &#147;Premises&#148;, as used in this Lease, shall include the applicable Available Space; (ii)&nbsp;the Total Rentable Floor Area of the Premises shall be increased to include
the rentable square footage of the applicable Available Space (and any Additional Rent, charges and expenses due under this Lease shall be <FONT STYLE="white-space:nowrap">re-calculated</FONT> to reflect the inclusion of the Available Space); (iii)
the annual Yearly Rent shall equal the sum of the then current Yearly Rent provided for in this Lease plus the Yearly Rent for the applicable Available Space as determined herein and (iv)&nbsp;the number of parking spaces provided in Exhibit 1 shall
be increased proportionate to the rentable square footage of the applicable Available Space. To confirm the inclusion of the subject Available Space as set forth above, Landlord shall prepare, and Tenant and Landlord shall promptly execute and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
deliver, a mutually agreeable amendment to this Lease reflecting the foregoing terms and incorporation of any Available Space. For the purposes hereof, space shall be deemed &#147;available for
occupancy&#148; only when and after the first (1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>) lease (including any extension periods) has expired or is due to expire within not less than six (6)&nbsp;months, and/or Landlord has elected
not to renew the lease of the present tenant, and any prior options, rights or rights to lease with respect to such Available Space have expired or been waived and Landlord is free to lease such space to third parties without restriction. For
clarity, Tenant understands that all vacant space in the Building as of the date hereof is not &#147;available for occupancy&#148; will only become &#147;available for occupancy&#148; from and after such space has been leased and such lease term has
expired and is not be extended with the tenant or occupant thereunder (including at Landlord&#146;s discretion beyond the existing terms and conditions of such lease) and Tenant&#146;s rights hereunder are subject to any extension rights, expansion
rights, options to lease or any rights of first negotiation, first offer or first refusal to lease granted to the tenants of such space and Landlord&#146;s right to extend such leases with such tenants, which are: one (1)&nbsp;building tenant has a
right of first offer to lease any space on the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) and fourth (4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) floors in the Building that becomes available for occupancy from
and after the expiration of the Lease Term (as same may be extended pursuant to Section&nbsp;29.16) or the termination of this Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
<U>Waiver</U>. If Tenant fails to timely exercise, or waives, any of its rights hereunder, the right(s) granted hereunder as to any applicable Available Space or Phase II Available Space, as the case may be, shall be deemed waived for all purposes
as to such Available Space or to the Phase II Available Space, as the case may be, and Landlord or Landlord Party, as the case may be, may lease the applicable Available Space or Phase II Available Space, as the case may be, to any party and upon
any terms free of any rights of Tenant; provided that (i)&nbsp;Tenant shall again have the right of first offer on any such space located on the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor of the Building when any
applicable lease entered into for such third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor space from and after such waiver (or deemed waiver) therefor expires and such third
(3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor space once again becomes available for occupancy hereunder, and (ii)&nbsp;the <FONT STYLE="white-space:nowrap">re-offer</FONT> requirement due to a Materially Different offer per
subsection (c)&nbsp;below. For clarity, except with respect to Available Space on the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor, Tenant&#146;s right of first offer on any other Available Space in the Building or space in
the Phase II Building, respectively, shall be a <FONT STYLE="white-space:nowrap">one-time</FONT> right, except as to a <FONT STYLE="white-space:nowrap">re-offer</FONT> requirement for due to a Materially Different offer per subsection
(c)&nbsp;below. Tenant, following such waiver and within fourteen (14)&nbsp;business days of Landlord&#146;s written request therefor, shall execute and deliver to Landlord a certification, in recordable form, confirming the waiver of such right,
and Tenant&#146;s failure to so execute and deliver such certification shall (without limiting Landlord&#146;s remedies on account thereof) entitle Landlord to execute and deliver to any third party, and record, an affidavit confirming the waiver,
which affidavit shall be binding on Tenant and may be conclusively relied on by third parties. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Within the Complex</U>. In the event
that Landlord, or an entity owning or controlling Landlord or owned or controlled by or under common control with Landlord, or a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successor-in-interest</FONT></FONT> or assignee of any
such party&#146;s rights in the Phase II EDIC Ground Lease (as defined below), (a &#147;Landlord Party&#148;) constructs and operates a building on Phase II of the Complex, as identified in Exhibit 17 (the &#147;Phase II Building&#148;), Tenant
shall have the right of first offer to lease certain space in the Phase II Building from the Landlord Party during the Lease Term subject to and in accordance with the terms and conditions set forth in this Section&nbsp;29.18(c). Landlord or such
Landlord Party shall provide Tenant written notice when the Phase II Building is complete or in the process of being substantially completed, whereupon Tenant&#146;s rights hereunder shall apply only if: (i)&nbsp;within fourteen (14)&nbsp;business
days of such notice, Tenant provides written notice to Landlord that Tenant desires to lease space in the Phase II Building (&#147;Tenant&#146;s Phase II Notice&#148;), which notice shall include Tenant&#146;s required Phase II Building space needs
(which shall in no event be less than 35,000 rentable square feet therein, except as expressly set forth below) and any other specific space or facility requirements consistent with the Phase II Building; (ii)&nbsp;the Phase II Building is complete
or in the process of being substantially completed by a Landlord Party and can reasonably accommodate Tenant&#146;s Phase II Building space needs set forth in Tenant&#146;s Phase II Notice; and (iii)&nbsp;Landlord has not leased (or otherwise
encumbered [e.g., put or call rights, expansion rights, etc.] by the lease) to a single tenant (including any such tenant&#146;s affiliates), all or such portion(s) of the Phase II Building such that there will not be available Phase II Building
space that will accommodate Tenant&#146;s Phase II Notice space needs. Subject to the foregoing conditions ((i), (ii) and (iii); provided, however, that with respect to Subsection (iii), if Subsections (i)&nbsp;and (ii) are satisfied, but less than
35,000 rentable square feet is available for occupancy in the Phase II Building (i.e., the remainder of the space is leased or otherwise encumbered to a single tenant or its affiliate, in accordance with the foregoing clause (ii)), such initial
lesser space shall be considered as Phase II Available Space and Landlord shall provide a Landlord&#146;s Phase II Available Space Notice [as those terms are defined below] for such lesser space for Tenant&#146;s
<FONT STYLE="white-space:nowrap">one-time</FONT> option hereunder), if at any time from and after the Term Commencement Date and prior to expiration of the Term (or unless Tenant&#146;s rights hereunder as to the Phase II Building are terminated as
provided herein), and so long as a Landlord Party owns or controls the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Phase II Building, any space consistent with Tenant&#146;s Phase II Notice becomes available for occupancy (as defined below) (&#147;Phase II Available Space&#148;), Landlord shall notify Tenant
thereof in writing (&#147;Landlord&#146;s Phase II Available Space Notice&#148;), which notice shall include Landlord&#146;s determination of the Fair Market Rental Value, the anticipated estimated date upon which such Phase II Available Space shall
become available for occupancy by Tenant (the &#147;Anticipated Phase II Available Space Commencement Date&#148;) along with a floor plan showing the approximate rentable square footage thereof. Tenant shall have the right to lease all such Phase II
Available Space described in Landlord&#146;s Phase II Available Space Notice only by giving written notice to Landlord within fourteen (14)&nbsp;business days after Tenant receives Landlord&#146;s Phase II Available Space Notice, time being of the
essence. If Tenant so elects to lease the subject Phase II Available Space, such Phase II Available Space shall be leased upon substantially similar terms and conditions contained in this Lease, and using a lease substantially similar to this Lease
with such changes and modifications as may be necessary to make such Phase II lease comport and be consistent with Phase II of the Complex provided that in any event: (x)&nbsp;the Yearly Rent for the Phase II Available Space shall be equal to the
Fair Market Rental Value therefor determined in accordance with Section&nbsp;29.17 above (made applicable hereto by such changes and modifications as are required given the application hereof,<I> mutatis mutandis,</I> to the Phase II Building), (y)
it is understood and agreed that the Phase II Available Space shall be leased by Tenant in its base building shell condition, without additional warranty or representation by Landlord and Landlord shall have no obligation to complete any work to
prepare the applicable Phase II Available Space for Tenant&#146;s use and occupancy or provide any allowance or contribution therefor, except to the extent same is expressly incorporated into the Fair Market Rental Value as provided above, and
(z)&nbsp;the term of the Phase II lease and this Lease shall be for at least seven (7)&nbsp;full Lease Years from and after the delivery of such Phase II Available Space (which seven (7)&nbsp;Lease Year period for this Lease may include
Tenant&#146;s early exercise of any remaining extension term). For the purposes hereof, Phase II Space shall be deemed &#147;available for occupancy&#148; and Tenant&#146;s rights hereunder shall continue only for so long as the conditions set forth
in (i), (ii) and (iii)&nbsp;continue to be satisfied; provided, however, that Landlord shall not lease space that would otherwise satisfy Tenant&#146;s required Phase II Building space needs as set forth in Tenant&#146;s Phase II Notice on economic
terms which are Materially Different (as defined below) than those contained in any original Landlord&#146;s Phase II Available Space Notice without Landlord <FONT STYLE="white-space:nowrap">re-offering</FONT> the Phase II Available Space to Tenant,
subject, however, to the terms hereof. For the purposes of this Section, &#147;Materially Different&#148; shall mean the total effective rent (as defined below) offered is less than ninety percent (90%) of the total effective rent set forth in the
original Landlord&#146;s Available Space Notice or Landlord&#146;s Phase II Available Space Notice, as the case may be. For the purposes of this Section, &#147;total effective rent&#148; shall mean the aggregate consideration payable by the tenant
under the proposed lease transaction, taking into account any applicable free rent, moving expenses, allowances or other inducement payments offered by Landlord, assumptions or buyouts of the tenant&#146;s obligations under other leases to be paid
or credited by Landlord, the anticipated cost of any leasehold improvements to be performed by Landlord at its expense, or provided as an allowance or incorporated into the rent, and the method by which the tenant&#146;s share of Operating Expenses
and Taxes are determined, pursuant to such proposed lease.<B> </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Mortgagee Rights, EDIC Rights, etc. Tenant acknowledges and agrees
that the Phase II Building would be constructed, if applicable, on that parcel of land consisting of approximately 98,200 square feet of land currently leased pursuant to that certain Ground Lease dated September&nbsp;14, 2015 between EDIC, as
landlord, and TS Partners LLC (currently a Landlord Party), as tenant, as amended by that certain First Amendment of Ground Lease dated November&nbsp;21, 2017, and the development option, rights and obligations contained therein (collectively, the
&#147;Phase II EDIC Ground Lease&#148;). As stated in Section&nbsp;29.18(c) above, Tenant&#146;s rights thereunder apply only for so long as a Landlord Party owns and controls the Phase II Building pursuant to the Phase II EDIC Ground Lease.
Tenant&#146;s unexercised rights with respect to the Phase II Building as set forth in Section&nbsp;29.18 shall at all times be subject and subordinate to the Phase II EDIC Ground Lease and any mortgage or deed of trust or similar instrument duly
recorded on Phase II of the Complex; provided that the any holder of such mortgagee, deed of trust or similar interest or Phase II EDIC Ground Lease ground lessor may from time to time subordinate or revoke any such subordination of the mortgage or
ground lease held by it to the rights herein. In the event a Landlord Party does not exercise, pursue or complete its development option or rights under the Phase II EDIC Ground Lease, or in the event the Phase II EDIC Ground Lease expires or is
terminated, Tenant&#146;s unexercised rights hereunder shall cease and be of no further force or effect. In addition, in the event of a foreclosure of any such mortgage or deed of trust or similar instrument, or the acquisition of title to the Phase
II Building by deed in lieu of foreclosure or trustee&#146;s sale or otherwise, Tenant&#146;s unexercised rights with respect to the Phase II Building as set forth in Section&nbsp;29.18 shall be terminated in the event of the expiration or
termination of the Phase II EDIC Ground Lease and/or a foreclosure. Tenant agrees at any time and from time to time during the Term hereof to execute a suitable instrument in confirmation of the foregoing, as aforesaid, and Tenant hereby irrevocably
constitutes and appoints Landlord or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such mortgagee, and their respective successors in interest, acting singly, Tenant&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> to
execute and deliver any such instrument for, on behalf and in the name of Tenant, but only if Tenant fails to execute, acknowledge and deliver any such certificate or instrument within ten (10)&nbsp;business days after Landlord or such mortgagee or
such ground lessor has made written request therefor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.19 <B>Intentionally Omitted</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.20 <B>Waiver of Jury Trial.</B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B></B><B>LANDLORD AND TENANT HEREBY WAIVE THEIR RESPECTIVE RIGHT TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, COUNTERCLAIM OR
CROSS-COMPLAINT IN ANY ACTION, PROCEEDING AND/OR HEARING BROUGHT BY EITHER LANDLORD AGAINST TENANT OR TENANT AGAINST LANDLORD ON ANY MATTER WHATSOEVER ARISING OUT OF, OR IN ANY WAY CONNECTED WITH, THIS LEASE, THE RELATIONSHIP OF LANDLORD AND TENANT,
TENANT</B><B>&#146;</B><B>S USE OR OCCUPANCY OF THE PREMISES, OR ANY CLAIM OF INJURY OR DAMAGE, OR THE ENFORCEMENT OF ANY REMEDY UNDER ANY LAW, STATUTE, OR REGULATION, EMERGENCY OR OTHERWISE, NOW OR HEREAFTER IN EFFECT.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Execution Page Follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF the parties hereto have executed this Indenture of Lease in multiple
copies, each to be considered an original hereof, as a sealed instrument on the day and year noted in Exhibit 1 as the Execution Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LANDLORD:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">TENANT:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>RBK I TENANT, LLC, </B>a Delaware limited liability company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PURETECH HEALTH LLC, </B>a Delaware limited</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">liability company</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kimberly Sherman Stamler</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen Muniz</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Kimberly Sherman Stamler</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stephen Muniz</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Its Authorized Signatory</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Operating Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Hereunto Duly Authorized</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 2 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">LEASE PLAN </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page144.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 3 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PLAN OF BUILDING AND LAND </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(PRELIMINARY) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page145.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 4 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TERM COMMENCEMENT DATE AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>PURETECH HEALTH LLC </B>(&#147;Tenant&#148;) hereby certifies that it has entered into a lease with <B>RBK I TENANT, LLC,
</B>(&#147;Landlord&#148;) dated _______________ (the &#147;Lease&#148;) and verifies the following information as of the ____ day of _____________, _____. Capitalized terms used, but not herein defined, shall have the meaning ascribed in the Lease:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address of Building:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of Rentable Square Feet:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">r.s.f.</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term Commencement Date:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rent Commencement Date:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Termination Date:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant&#146;s Proportionate Share:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial Yearly Rent:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Option to Extend:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial Letter of Credit Amount:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant acknowledges and agrees that all improvements Landlord is obligated to make to the Premises, if any,
have been completed to Tenant&#146;s satisfaction, that Tenant has accepted possession of the Premises, and that as of the date hereof, there exist no offsets or defenses to the obligations of Tenant under the Lease. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TENANT:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>LANDLORD:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PURETECH HEALTH LLC</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>RBK I TENANT, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Title: </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Its Authorized Signatory</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hereunto duly authorized</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 5 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CURRENT RULES AND REGULATIONS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant will review any <FONT STYLE="white-space:nowrap">non-binding</FONT> tenant manuals or information
provided prior to <FONT STYLE="white-space:nowrap">move-in</FONT> at Building and will provide referenced forms including emergency contacts, designated tenant representative, and card access requests and will notify Landlord when changes in
information occur. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The entrances, vestibules, passages, corridors, halls, elevators and stairways within the Common Areas shall
not be encumbered nor obstructed by Tenant, Tenant&#146;s agents, servants, employees, licensees or visitors, or be used by them for any purpose other than ingress or egress to and from the Premises. Landlord reserves the right to reasonably
restrict and regulate the use of aforementioned public areas of the Building by Tenant, Tenant&#146;s agents, employees, servants, licensees and visitors and by persons making deliveries to Tenant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After the conclusion of Tenant&#146;s initial move into the Premises, other movement in or out of the Building
of furniture or office equipment which requires the use of elevators or stairways or the movement through the main Building entrance shall be restricted to the after business hours reasonably designated by Landlord. All such movement shall be under
the supervision of Landlord and performed in the manner agreed upon between Tenant and Landlord, cooperating in good faith, by <FONT STYLE="white-space:nowrap">pre-arrangement</FONT> before performance. Such
<FONT STYLE="white-space:nowrap">pre-arrangement</FONT> initiated by Tenant will include the determination by Landlord and subject to Landlord&#146;s reasonable discretion, relating to the time, method, and routing of the items&#146; movement, as
well as reasonable limitations imposed by safety, appearance or other reasonable concerns which may include the prohibition of equipment or any other item from being brought into the Building, as well as the method of the items&#146; movement
through the Building. Tenant shall assume with its contractors, all risk as to damage caused by any such movement or property being moved or injury to persons or public engaged or not engaged in such movement, including equipment, property, and
personnel of Landlord if damaged or injured as a result of Tenant or its contractor&#146;s negligent or willful acts in connection with such Tenant arranged moving from the time of entering the property to the completion of work. Landlord shall not
be liable for the acts of any person engaged in, or any damage or loss to any of said property or persons resulting from any act in connection with such moving performed by Tenant arrangement, except relating to Landlord&#146;s or its agent&#146;s
or contractor&#146;s negligence or misconduct. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After the conclusion of Tenant <FONT STYLE="white-space:nowrap">move-in,</FONT> all deliveries, inclusive of
packages, office supplies, etc., must be made via the freight elevator during normal Building operating hours as set forth in the Lease. Landlord&#146;s written approval must be obtained for any delivery made after business hours and Tenant will be
responsible for the expense of the security attendant who monitors access to the Building during the period of such delivery. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant shall not permit the parking or standing of delivery vehicles to interfere with the use of any driveway,
walk, parking area or other Common Areas. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No hand trucks or delivery dollies, except those equipped with rubber tires and padded side guards, shall be
used in any of the Common Areas of the Building, either by Tenant or by jobbers or others in the delivery or receipt of merchandise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All deliveries to the Tenant must be accepted or rejected by Tenant. The Landlord and its agents or employees
will not accept, sign for, or hold Tenant mail, packages, or deliveries. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant shall not make, or permit to be made, any unseemly or unreasonably disturbing noises, odors, or
vibrations to emanate from Premises or otherwise unreasonably disturb or interfere with the occupancy of the Building whether by the use of any equipment, musical instrument, radio, television, talking machine, unmusical noise, whistling, singing,
or in any other way. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No additional locks, or security devices will be installed without prior notification and approval by Landlord.
New locks or rekeying must be coordinated with Landlord and keyed on building master system. Upon <FONT STYLE="white-space:nowrap">move-in</FONT> all doors with locksets will be keyed to building master system and Tenant will be given 2 keys by
Landlord. Additional keys may be requested in advance and at an additional reasonable charge to Tenant. Upon termination of Lease, Tenant will return 2 keys to each lock, and further will disclose any previously approved and installed security
devices including combination locks, punch codes to doors and vaults. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After the initial <FONT STYLE="white-space:nowrap">move-in,</FONT> for which the distribution of access cards
will be provided at no cost to Tenant, Tenant agrees to pay a reasonable amount fixed by Landlord from time to time, for each building access card issued by Landlord to Tenant for access to Building during
<FONT STYLE="white-space:nowrap">non-business</FONT> hours. Such expense is presently $20.00 per card. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Landlord specifically reserves the right to exclude from the Building during
<FONT STYLE="white-space:nowrap">non-business</FONT> hours, such as before 8:00 a.m. and after 6:00 p.m. on weekdays, on Saturdays and Sundays, and Building recognized holidays, all persons not permitted entry by utilizing card access, telephone
access system, or previous arrangement with the management office. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant shall be responsible for persons it authorizes to have access to the Building during <FONT
STYLE="white-space:nowrap">non-business</FONT> hours and shall be liable for and shall coordinate which persons should have access cards issued. Tenant shall keep access card records current and properly identified by employee name.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Landlord shall not be required to permit entrance to Tenant&#146;s Premises or offices by use of pass keys
controlled by Landlord to any person at any time except as may be expressly requested in writing by Tenant. It is recommended that Tenant inform Tenant employees of these lockout procedures. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All service requests of Tenant required of Landlord shall be administered through Building management office.
Tenants will not contract independently with employees and agents of Landlord without the coordination of the management office, nor shall Tenant request employees or agents of Landlord to receive or carry messages for or to any Tenant or other
person. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">None of the entries, passages, doors, elevators, elevator doors, hallways, or stairways or other Common Areas
shall be blocked or obstructed, nor shall any rubbish, litter, trash, or material of any nature be placed, emptied, or thrown into these areas, nor shall such areas be used at any time except for ingress and egress by Tenant, Tenant&#146;s agents,
employees, or invitees. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No boxes, crates, pallets, or other such materials shall be stored in building hallways or other Common Areas.
When Tenant must dispose of crates, boxes, etc., it will be the responsibility of Tenant to dispose of same prior to, or normal Building operating hours, so as to avoid having such debris visible or being moved in the Common Areas during normal
business hours. If such items are desired to be removed as part of evening janitorial service, the reasonable expense of such will be borne by Tenant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Tenant shall cooperate with Landlord&#146;s employees in keeping the Common Areas neat and clean.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The water and wash closets, drains and other plumbing fixtures shall not be used for any purposes other than
those for which they were constructed, and no sweepings, rubbish, rags, or other substances shall be thrown or placed therein. Damages or maintenance expense resulting from any misuse of fixtures or disposal of the above by Tenant, its servants,
employees, agents, visitors, or licensees, shall be borne by Tenant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise provided for in this Lease, Tenant shall not mark, paint, drill into, or in any way deface any
part of the Premises or the Building, except for Tenant&#146;s interior design components and furnishings in the Premises or the approved signage. Other than for initial <FONT STYLE="white-space:nowrap">move-in,</FONT> no boring, cutting, or
stringing for wires shall be permitted without the prior written consent of Landlord and as Landlord may direct. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise provided in this Lease, neither Tenant, nor its servants, employees, agents, visitors, or
licensees, shall at any time bring or keep upon the Premises any flammable, combustible, or explosive fluid, chemical or substance (including Christmas trees and ornaments) except such items as may be incidentally used, provided Tenant notifies
Landlord of the location thereof and makes adequate provision for safe storage. No space heaters or fans shall be operated or located in the Premises, other than UL approved or Landlord installed appliances. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except as otherwise expressly provided in the Lease, no bicycles, vehicles, or animals, except with respect to
Tenant&#146;s vivarium and those used by the disabled, shall be brought into or kept in or about the Premises or Building; provided, however, Landlord shall provide a bicycle storage area in the Building in a manner generally consistent with or
customary for comparable life science buildings in the Seaport District of Boston, Massachusetts. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant will not locate furnishings or cabinets directly adjacent to mechanical or electrical panels, HVAC
equipment or other mechanical equipment so as to prevent personnel from servicing such units or equipment as routine or emergency access may require. Reasonable
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> cost of moving such furnishings for Landlord&#146;s access will be borne by Tenant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No space in the Premises or Building shall be used for lodging, sleeping, storage of money in excess of $300,
or storage of drugs or medicine not typically found of quality or quantity in First Aid supply kits or for other legal purposes, subject to the terms and conditions of the Lease. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant shall not place, install or operate on the Premises or in any part of the Building, any engine, stove,
or machinery, or conduct mechanical operations or cook thereon or therein except Tenants microwave, refrigerator, office, laboratory, and communication equipment, except as otherwise provided in the Lease. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant must obtain prior written approval, which shall be at Landlord&#146;s sole discretion, for installation
of window shades, blinds, drapes, or any other window treatment of any kind whatsoever which would be visible from exterior of building other than Landlord supplied. Landlord will approve all internal lighting that may be visible from the exterior
of the Building and shall have the right to change any unapproved lighting, without notice to Tenant, at Tenant&#146;s expense. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant will coordinate with Landlord all Tenant arranged contractors, and installation technicians, rendering
any construction or installation service to Tenant before performance of any such service. This provision shall apply to all work performed in the Building by Tenant arranged contractors including the installation of telephones, telegraph equipment,
electrical devices and attachments, and the installation of any nature affecting the floors, walls, woodwork, trim, windows, ceiling, equipment (other than Tenant&#146;s office equipment), or any other physical portion of the Building.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant shall (unless impossible due to the nature of such required repairs), at its expense, provide artificial
light for the employees of Landlord while making repairs or providing services in said Premises regardless of whether occurring during business or <FONT STYLE="white-space:nowrap">non-business</FONT> hours after lease commencement date.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Smoking is prohibited in common entrances, vestibules, passages, corridors, halls, elevators, stairways, and
toilet rooms of the Building. Tenant is responsible for informing all of its vendors, service providers, agents, employees, licensees, and visitors of this policy. Landlord reserves the right to request that any person(s) engaged in the act of
smoking (in the Common Areas recited above), at this or her choice, either cease smoking or leave the Common Areas of the Building immediately. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">29.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Canvassing, soliciting, and peddling in the Building and parking facilities is prohibited. Landlord and Tenant
shall cooperate to prevent same. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">30.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except as otherwise provided in this Lease, Tenant shall restrict parking by Tenant, its employees, service
providers, agents, and visitors to parking areas designated by Landlord and shall comply with reasonable parking rules and regulations as may be posted and distributed from time to time and of which Tenant perceives prior written notice (which may
include email notice). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">31.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant will evacuate the Premises and Building in the event of emergency or catastrophe notification; whether
practice drill, false alarm, or actual occurrence. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">32.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant will notify Landlord of any incidents, accidents, injuries, or hazards which Tenant is aware of, which
occur, or are present in Premises or Building. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">33.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant will be requested to participate in recycling and other expense reduction programs offered by Building.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord reserves the right to rescind any of these rules and make such other and further reasonable rules and regulations as in
Landlord&#146;s judgment shall from time to time be needed for the safety, protection, care and cleanliness of the Building, the operation thereof, the preservation of good order therein, and the protection and comfort of its Tenants, their agents,
employees, and invitees, which rules when made and written notice (which may include email) thereof given to a Tenant shall be binding upon Tenant in the manner as if originally prescribed, provided that such rules and regulations do not conflict
with Tenant&#146;s rights under the Lease in any material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord desires to maintain high standards of environmental comfort and convenience
for the Tenants of Building. It will be appreciated if any undesirable conditions, lack of courtesy or attention are reported directly to the management. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 6 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CURRENT SHARED CONFERENCE FACILITIES RULES AND REGULATIONS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reservations for the conference facilities must be scheduled at least two (2)&nbsp;hours in advance via the
Building&#146;s work order system (e.g., Angus Work Order System). Reservations will be scheduled on a first-come, first-served basis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Projector available upon request, subject to availability. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The conference facilities must be left clean after each use. Trash and recyclable items must be placed in the
appropriate trash container/ recycle bin. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant is responsible to push the chairs into the table after each use. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant is responsible to erase any white board or other media after each use. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant is responsible to turn the lights off after each use. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No items may be stored in the conference facilities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Landlord reserves the right to amend, revise or modify these Rules and Regulations from <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time.</FONT></FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord desires to maintain high standards of
comfort and convenience for the Tenants of Building. It will be appreciated if any undesirable conditions, lack of courtesy or attention are reported directly to the management. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT <FONT STYLE="white-space:nowrap">6-1</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COMMON LABORATORY FACILITIES and SHARED CONFERENCE FACILITIES </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page152.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE A TO EXHIBIT <FONT STYLE="white-space:nowrap">6-1</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 OF 2 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Distributions/allocations
below relate to Tenant only; references to other tenant parties are not applicable) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page153.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE A TO EXHIBIT <FONT STYLE="white-space:nowrap">6-1</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 OF 2 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Distributions/allocations
below relate to Tenant only; references to other tenant parties are not applicable) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page154.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 7 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">NON-DISCRIMINATION</FONT> AND EQUAL OPPORTUNITY COVENANTS and EMPLOYMENT OF BOSTON RESIDENTS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">NON-DISCRIMINATION</FONT> AND EQUAL OPPORTUNITY COVENANTS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Section 16.1 of EDIC Lease) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to its
exercise of all rights and privileges granted herein, Tenant agrees that Tenant, its successors in interest, subtenants, licensees, managers, operators and assigns shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) Not discriminate against any person, employee, or applicant for employment because of that person&#146;s membership in any legally
protected class, including, but not limited to their race, color, gender, religion, creed, national origin, ancestry, age being greater than forty years, sex, sexual orientation, disability, genetic information, or
<FONT STYLE="white-space:nowrap">Vietnam-era</FONT> veteran status in the use of the Premises, including the hiring and discharging of employees, the provision or use of services, the selection of suppliers and contractors, in the subleasing or
refusing to sublease any portion of the Premises or providing or refusing to provide any services or use of any facility. In addition, Tenant, its successors in interest, Subtenants, licensees, managers, operators, and assigns shall not discriminate
against any person, employee, or applicant for employment who is a member of, or applies to perform service in, or has an obligation to perform service in a uniformed military service of the United States, including the National Guard, on the basis
of that membership, application or obligation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) Conspicuously post notices to employees and prospective employees setting forth the
Fair Employee Practices Law of the Commonwealth of Massachusetts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) Comply with all applicable federal, state and local laws, rules,
regulations and orders and Landlord<B> </B>rules and orders (provided that, with respect to Landlord rules and orders, copies of such rules and orders have been provided to Tenant) pertaining to Civil Rights and Equal Opportunity, including but not
limited to Executive Orders 11246 and 11478 as amended, unless otherwise exempt therefrom. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Noncompliance </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-compliance</FONT> by Tenant, any subtenant, their respective successors in interest and assigns, or any of their
respective agents, employees, licensees or operators, with this Exhibit shall constitute a default under this Lease, provided that Landlord has notified Tenant of such noncompliance in writing and Tenant has failed to cure such <FONT
STYLE="white-space:nowrap">non-compliance</FONT> within twenty (20)&nbsp;days after Tenant&#146;s receipt of Landlord&#146;s notice. Tenant shall indemnify and hold harmless Landlord from any claims and demands of third persons resulting from <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with any of the provisions of this Exhibit. This Exhibit shall survive the expiration or earlier termination of this Lease. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EMPLOYMENT OF BOSTON RESIDENTS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Section 18.36 and Exhibit O from EDIC Lease) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant understands that the Premises are being leased to Tenant as part of an overall program to provide jobs for unemployed and underemployed persons in the
City, all within the intent and purposes of Chapter 1097 of the Acts of 1971, as amended, and of the Economic Development Plan for the RFMP. To that end, Tenant agrees to include in any Sublease of the Premises provisions substantially the same as
those entitled &#147;Employment of Local Labor&#148; set forth in <B>Exhibit O</B> hereto and further agrees to be bound by such provisions as though set forth in this section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Employment of Boston Residents</U>. Tenant understands that the Premises are being leased to Tenant, in part, as part of an overall program to provide jobs
for unemployed and underemployed persons in the City of Boston (the &#147;City&#148;) all within the intent and purposes of Chapter 1097 of the Acts of 1971, as amended (the &#147;Act&#148;) and of the Economic Development Plan (the
&#147;EDP&#148;), approved by the Boston City Council and Mayor of Boston under an Order effective July&nbsp;6, 1976 and amended by Order effective March&nbsp;10, 1980. In hiring for new positions and vacancies within its workforce for its business
operations at the Premises, Tenant agrees to use commercially reasonable efforts to fill at least fifty percent (50%) of these positions with residents of the City. Tenant shall also use commercially reasonable efforts to fill at least twenty-five
percent (25%) of new and vacant positions with minorities, and at least ten percent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(10%) of such positions with women. Tenant agrees to use commercially reasonable efforts (i)&nbsp;to offer to the fullest practicable extent employment to qualified and trained persons from among
graduates of any training program of the City and (ii)&nbsp;to cooperate with Landlord and with Landlord&#146;s designee(s), in their efforts to obtain employment for qualified residents of the City. For purposes hereof, any one person may satisfy
more than one of the above categories. For purposes hereof, jobs shall include all job openings, whether full-time or created by attrition or expansion. Tenant shall obligate its sublessees and assignees to comply with this <U>Exhibit O</U>.
Reference herein to &#147;employees&#148; shall include, but not be limited to, administration and supervisory personnel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this
<U>Exhibit O</U>, in hiring new employees for employment at the Premises, &#147;commercially reasonable efforts&#148; shall mean: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
Tenant advertises in a daily Boston newspaper (whether online (such as indeed.com or in print) which advertisement encourages minorities, women and City residents to apply for the open position; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Tenant advertises in at least two weekly or <FONT STYLE="white-space:nowrap">bi-weekly</FONT> newspapers which circulate in Boston or one
or more of its neighborhoods (newspapers to be chosen by Tenant) which advertisement encourages minorities, women and City residents to apply for the open position; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Tenant keeps on file all advertisements, resumes and responses to its advertisements and other recruitment efforts and provides Landlord
with copies of same upon request by Landlord; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Whenever Tenant operates <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">on-the-job</FONT></FONT> training programs, Tenant agrees to use commercially reasonable efforts to include in these programs unskilled or semi-skilled City residents (and to recruit women and minorities for these
programs) who, in the Tenant&#146;s judgment, can be expected to benefit from this training and perform the jobs in question. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Hiring Procedures</U>.
Tenant shall notify Landlord or Landlord&#146;s designee of each position that is to be filled at the Premises by Tenant during the Term of this Lease. However, nothing contained herein shall be construed as requiring the Tenant to hire any employee
who does not meet Tenant&#146;s standards and qualifications for employment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Tenant&#146;s Records Available to Landlord</U>. Tenant shall submit
and shall cause Tenant&#146;s Subtenants to submit annual employment reports to Landlord or Landlord&#146;s designee, such report to be substantially in the form designated from time to time by Landlord, showing the increase or decrease in total
employment since the last reporting period and detailing the number of City residents, women, and minorities who comprise Tenant&#146;s or Tenant&#146;s Subtenants&#146; workforce at the Premises, and a schedule of the positions that have been
filled (including residence of employees and salaries) during the previous year and a projection of the availability of future jobs and salaries to be created during the succeeding reporting period. Tenant shall make available for Landlord&#146;s
inspection at reasonable times all records of Tenant reasonably necessary to review and ascertain compliance with the provisions of this <U>Exhibit O</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>Employment of Contractors and <FONT STYLE="white-space:nowrap">Sub-Contractors</FONT></U>. Whenever possible, Tenant shall engage independent contractors
and <FONT STYLE="white-space:nowrap">sub-contractors</FONT> who are based in and whose employees are primarily City residents. Tenant shall also pursue bids from minority and women owned and operated enterprises (M/WBEs). Any labor or other
agreements, contracts or arrangements to the contrary notwithstanding, Tenant shall pay at least such minimum wages as required by law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U>Qualified
Employees</U>. Nothing contained herein shall be construed as requiring Tenant, its contractors, or <FONT STYLE="white-space:nowrap">sub-contractors,</FONT> assignees or subtenants to hire any employee who does not meet their standards and
qualifications for employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The provisions of this <U>Exhibit O</U> shall be subject to all applicable local, state and federal laws now or hereafter
in effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 8 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">RECORDING REQUESTED BY</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AND WHEN RECORDED MAIL TO:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U><FONT STYLE="white-space:nowrap">NON-DISTURBANCE</FONT> AND ATTORNMENT AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For use with Commercial Leases </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">THIS <B><FONT STYLE="white-space:nowrap">NON-DISTURBANCE</FONT> AND ATTORNMENT AGREEMENT</B> <B>(&#147;Agreement&#148;) </B>is made to be
effective as of the <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>day of
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2018, between <B>ECONOMIC</B><B> DEVELOPMENT AND INDUSTRIAL CORPORATION OF BOSTON</B>,<B> </B>d/b/a<B> BOSTON PLANNING
AND DEVELOPMENT AGENCY</B>, and its successors and assigns <B>(&#147;Ground Lessor&#148;), </B>and<B> </B><B>PURETECH HEALTH LLC</B><B> (</B><B>&#147;</B><B>Subtenant</B><B>&#148;</B><B>).</B> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>BACKGROUND: </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">RBK I Tenant LLC (the <B>&#147;Tenant&#148;), </B>is the lessee under the following lease with Ground Lessor:
that certain Ground Lease between Tenant and Ground Lessor, dated as of November&nbsp;21, 2017 (the <B>&#147;Lease&#148;), </B>relating to the property described in <B><U>Exhibit A</U></B> attached to this Agreement and by this reference made a pan
of this Agreement (the <B>&#147;Property&#148;). </B>Ground Lessor has agreed to lease the Property to Tenant for the Term, as described in the Lease, with one option to renew for an Extended Term. Tenant has agreed to, <I>inter alia, </I>make Rent
payments and Tenant Improvements, according to the provisions of the Lease. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subtenant is the sublessee under the following sublease with Tenant: that certain Sublease between Subtenant
and Tenant, dated as<B> </B>of _______________ ___, 2018 (the &#147;Sublease&#148;), relating to the Property. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>AGREEMENT: </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For and in
consideration of the mutual covenants contained in this Agreement, the sum of Ten Dollars ($10.00) and other good and valuable considerations, the receipt and sufficiency of which are acknowledged, and notwithstanding anything in the Lease to the
contrary, the parties agree as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">1. <U>Definitions.</U> All capitalized terms used but not otherwise defined<B> </B>herein shall
have the meaning ascribed thereto in the Ground Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Nondisturbance.</U></B> If Ground Lessor terminates the Lease and takes possession of the Property, so
long as no default of Subtenant exists after the expiration of any notice and cure period under the Sublease, then Ground Lessor agrees as follows: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ground Lessor will not terminate, impair or disturb the possession of Subtenant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Sublease will continue in full force and effect as a direct Sublease between Ground Lessor and Subtenant,
upon and subject to <U>all</U> of the terms, covenants and conditions of the Sublease, for the balance of the term of the Sublease. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Attornment.</U></B> If Ground Lessor takes possession of the Property by termination of the Lease
with Tenant or otherwise, then Subtenant agrees as follows: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subtenant will perform and observe its obligations under the Sublease. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subtenant will attorn to and recognize the Ground Lessor under the Sublease for the remainder of the term of
the Sublease, such attornment to be automatic and self-operative. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subtenant will execute and deliver upon request of Ground Lessor an appropriate agreement of attornment to
Ground Lessor. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Protection of Ground Lessor.</U></B> Subtenant agrees that Ground Lessor, upon taking possession
of the Property after termination of the Lease, will not be liable for, subject to or bound by any of the following: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">claims, offsets or defenses which Subtenant might have against Ground Lessor; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">acts or omissions of Ground Lessor; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">rent or additional rent which Subtenant might have paid for more than the current month; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any security deposit or other prepaid charge paid to Ground Lessor; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">construction or completion of any improvements for Subtenant&#146;s use and occupancy; provided, however, that
(A)&nbsp;if Ground Lessor elects not to complete any portion of the Tenant Improvement Work (as that term is defined in the Sublease) or fund any undisbursed portion of the Improvement Allowance (as that term is defined in the Sublease), then
Subtenant may offset from any rent due under the Sublease Subtenant&#146;s actual costs (documented through paid third party invoices (with satisfactory evidence of payment and other supporting material)) in completing the Tenant Improvement Work up
to the amount of the Improvement Allowance not paid to Subtenant, and (B)&nbsp;if Ground Lessor elects not to complete any portion of the Base Building Shell Work (as that term is defined in the Sublease), then Subtenant may terminate the Sublease
upon at least thirty (30)&nbsp;days prior written notice to Ground Lessor; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">warranties of any nature whatsoever, including any warranties respecting use,<B> </B>compliance with zoning,
hazardous wastes or environmental laws, Ground Lessor&#146;s title, Ground Lessor&#146;s authority, habitability, fitness for purpose or possession; or amendments or modifications of the Sublease made without its written consent<B>.</B>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Ground Lessor Exculpation.</U></B> Subtenant will look solely to Ground Lessor&#146;s interest in
the Property for the payment and discharge of any obligation or liability imposed upon Ground Lessor under the Lease. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Estoppel.</U></B> To the best of Subtenant&#146;s knowledge, there does not exist any default, claim,
controversy or dispute under the Lease. Subtenant has not commenced any action against Tenant nor sent or received any notice to terminate the Sublease. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Notice to Ground Lessor</U></B><U>.</U> Subtenant agrees that it will deliver to Ground Lessor a copy of
all notices of default or termination received by it under the terms of the Sublease. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Invalidity.</U></B> If any portion of this Agreement is held invalid or inoperative, then all of the
remaining portions will remain in full force and effect, and, so far as is reasonable and possible, effect will be given to the intent manifested by the portion or portions held to be invalid or inoperative. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Governing Law.</U></B> This Agreement will be governed by and construed in accordance with the laws of
the State where the Property is located. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Notices.</U></B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All notices, demands and other communications (&#147;Notices&#148;) under or concerning this Agreement must be
in writing. Each Notice shall be addressed to the intended recipient at its address set forth in this Agreement, and will be deemed given on the earliest to occur of (1)&nbsp;the date when the Notice is received by the addressee; (2)&nbsp;the first
Business Day after the Notice is delivered to a recognized overnight courier service, with arrangements made for payment of charges for next Business Day delivery; or (3)&nbsp;the third Business Day after the Notice is deposited in the United States
mail with postage prepaid, certified mail, return receipt requested. The term &#147;Business Day&#148; means any day other than a Saturday, a Sunday or any other day on which Ground Lessor is not open for business. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any party to this Agreement may change the address to which Notices intended for it are to be directed by means
of Notice given to the other party in accordance with this Section. Each party agrees that it will not refuse or reject delivery of any Notice given in accordance with this Section, that it will acknowledge, in writing, the receipt of any Notice
upon request by the other party and that any Notice rejected or refused by it will be deemed for purposes of this Section to have been received by the rejecting party on the date so refused or rejected, as conclusively established by the records of
the U.S. Postal Service or the courier service. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any Notice, if given to Ground Lessor, must be addressed as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Economic Development and Industrial Corporation of Boston </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">One City Hall Square, 9<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Boston, MA 02201-1007 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Director </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With a copy
to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Economic Development and Industrial Corporation of Boston </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">One City Hall Square, 9<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Boston, MA 02201-1007 Attention: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">General Counsel </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Any Notice, if
given to Subtenant, must be addressed as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Prior to Term Commencement Date (as defined in the Sublease): </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">501 Boylston Street, Suite 6102 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Boston, MA 02116 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attn: Stephen
M. Muniz </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">After the Term Commencement Date (as defined in the Sublease): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Innovation Square </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">6 Tide
Street, Suite 300 and Suite 400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Boston, MA 02110-2412 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attn: Stephen M. Muniz </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">With a
copy to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Anderson&nbsp;&amp; Kreiger LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">50 Milk Street, 21<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Boston, MA 02109 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attn: David
L. Wiener, Esq. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Successors and Assigns.</U></B> This Agreement will be binding upon and inure to the benefit of the
parties to this Agreement and their respective heirs, legal representatives, successors, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-title</FONT></FONT> and assigns. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Counterparts.</U></B> This Agreement may be executed in any number of counterparts, all of which when
taken together will constitute one and the same instrument. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of page intentionally left blank; signatures
follow] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><U>GROUND LESSOR</U>:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ECONOMIC DEVELOPMENT AND</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">INDUSTRIAL CORPORATION OF BOSTON</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Brian P. Golden</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &nbsp;&nbsp;Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><U>SUBTENANT</U>:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PURETECH HEALTH LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EDIC ACKNOWLEDGMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMMONWEALTH OF MASSACHUSETTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COUNTY OF SUFFOLK
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On __________________ before me, ______________________________, Notary Public, personally appeared Brian P. Golden, who proved to me
on the basis of satisfactory evidence to be the person whose name is subscribed to the within instrument, which was _______________________ , and acknowledged to me that he executed the same in his authorized capacity voluntarily and for its stated
purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WITNESS my hand and official seal. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Signature of Notary Public</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:56%; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Seal) </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SUBTENANT ACKNOWLEDGMENT </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMMONWEALTH
OF MASSACHUSETTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COUNTY OF _________________ </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On _________________________ before me, _________________________, Notary Public, personally appeared _______________________ , who proved to
me on the basis of satisfactory evidence to be the person whose name is subscribed to the within instrument, which was ______________________________________, and acknowledged to me that he/she executed the same in his/her authorized capacity
voluntarily and for its stated purpose. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">WITNESS my hand and official seal,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature of Notary Public</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:56%; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Seal) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A TO <FONT STYLE="white-space:nowrap">NON-DISTURBANCE</FONT> AGREEMENT
</U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DESCRIPTION OF THE LAND </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 9 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF LETTER OF CREDIT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I<B>RREVOCABLE STANDBY
LETTER OF CREDIT NO. </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATE: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BENEFICIARY: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RBK I TENANT, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Related Beal </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">177 Milk Street, Boston, Massachusetts 02109 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">APPLICANT:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AS &#147;TENANT&#148;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AMOUNT: US $_______________ (___________________________________________________ AND 00/100 U.S. DOLLARS) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXPIRATION DATE: ______________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LOCATION: AT OUR COUNTERS IN
BOSTON, MASSACHUSETTS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DEAR SIR/MADAM: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WE HEREBY ESTABLISH
OUR IRREVOCABLE STANDBY LETTER OF CREDIT NO. ____________ IN YOUR FAVOR AVAILABLE BY YOUR DRAFT DRAWN ON US AT SIGHT IN THE FORM OF EXHIBIT &#147;B&#148; ATTACHED AND ACCOMPANIED BY THE FOLLOWING DOCUMENTS: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. THE ORIGINAL OF THIS LETTER OF CREDIT AND ALL AMENDMENT(S), IF ANY. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. A DATED CERTIFICATION FROM THE BENEFICIARY SIGNED BY AN AUTHORIZED OFFICER OR AGENT, FOLLOWED BY ITS DESIGNATED TITLE, STATING THE FOLLOWING: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(A) &#147;THE AMOUNT REPRESENTS FUNDS DUE AND OWING TO US FROM APPLICANT PURSUANT TO THAT CERTAIN LEASE BY AND BETWEEN BENEFICIARY, AS
LANDLORD, AND APPLICANT, AS TENANT.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OR </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(B) &#147;WE HEREBY CERTIFY THAT WE HAVE RECEIVED NOTICE FROM __________________ BANK THAT LETTER OF CREDIT NO. _______________WILL NOT BE
RENEWED, AND THAT WE HAVE NOT RECEIVED A REPLACEMENT OF THIS LETTER OF CREDIT FROM APPLICANT SATISFACTORY TO US AT LEAST THIRTY (30)&nbsp;DAYS PRIOR TO THE EXPIRATION DATE OF THIS LETTER OF CREDIT.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PAGE 1 OF 3 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IRREVOCABLE STANDBY LETTER OF CREDIT NO._______________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATED </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE LEASE AGREEMENT MENTIONED ABOVE IS FOR IDENTIFICATION
PURPOSES ONLY AND IT IS NOT INTENDED THAT SAID LEASE AGREEMENT BE INCORPORATED HEREIN OR FORM PART OF THIS LETTER OF CREDIT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OUR OBLIGATION UNDER THIS
CREDIT SHALL NOT BE AFFECTED BY ANY CIRCUMSTANCES, CLAIM OR DEFENSE, REAL OR PERSONAL, OF ANY PARTY AS TO THE ENFORCEABILITY OF THE LEASE BETWEEN YOU AND TENANT, IT BEING UNDERSTOOD THAT OUR OBLIGATION SHALL BE THAT OF A PRIMARY OBLIGOR AND NOT THAT
OF A SURETY, GUARANTOR OR ACCOMMODATION MAKER. IF YOU DELIVER THE WRITTEN CERTIFICATE REFERENCED ABOVE TO US, (I)&nbsp;WE SHALL HAVE NO OBLIGATION TO DETERMINE WHETHER ANY OF THE STATEMENTS THEREIN ARE TRUE, (II)&nbsp;OUR OBLIGATIONS HEREUNDER SHALL
NOT BE AFFECTED IN ANY MANNER WHATSOEVER IF THE STATEMENTS MADE IN SUCH CERTIFICATE ARE UNTRUE IN WHOLE OR IN PART, AND (III)&nbsp;OUR OBLIGATIONS HEREUNDER SHALL NOT BE AFFECTED IN ANY MANNER WHATSOEVER IF TENANT DELIVERS INSTRUCTIONS OR
CORRESPONDENCE TO WHICH EITHER (A)&nbsp;DENIES THE TRUTH OF THE STATEMENT SET FORTH IN THE CERTIFICATE REFERRED TO ABOVE, OR (B)&nbsp;INSTRUCTS US NOT TO PAY BENEFICIARY ON THIS CREDIT FOR ANY REASON WHATSOEVER. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PARTIAL AND MULTIPLE DRAWS ARE ALLOWED. EXCEPT AS EXPRESSLY SET FORTH HEREIN, THIS LETTER OF CREDIT MUST ACCOMPANY ANY DRAWINGS HEREUNDER FOR ENDORSEMENT OF
THE DRAWING AMOUNT AND WILL BE RETURNED TO THE BENEFICIARY UNLESS IT IS FULLY UTILIZED. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DRAFT(S) AND DOCUMENTS MUST INDICATE THE NUMBER AND DATE OF THIS
LETTER OF CREDIT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS LETTER OF CREDIT SHALL BE AUTOMATICALLY EXTENDED FOR AN ADDITIONAL PERIOD OF ONE YEAR, WITHOUT AMENDMENT, FROM THE PRESENT OR EACH
FUTURE EXPIRATION DATE UNLESS AT LEAST SIXTY (60)&nbsp;DAYS PRIOR TO THE THEN CURRENT EXPIRATION DATE WE NOTIFY YOU BY REGISTERED MAIL/OVERNIGHT COURIER SERVICE AT THE ABOVE ADDRESSES THAT THIS LETTER OF CREDIT WILL NOT BE EXTENDED BEYOND THE
CURRENT EXPIRATION DATE. IN NO EVENT SHALL THIS LETTER OF CREDIT BE AUTOMATICALLY EXTENDED BEYOND SIX (6)&nbsp;MONTHS BEYOND LEASE EXPIRATION. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS
LETTER OF CREDIT MAY BE TRANSFERRED WITHOUT COST TO THE BENEFICIARY, ONE OR MORE TIMES BUT IN EACH INSTANCE TO A SINGLE BENEFICIARY AND ONLY IN THE FULL AMOUNT AVAILABLE TO BE DRAWN UNDER THE LETTER OF CREDIT AT THE TIME OF THE TRANSFER AND ONLY BY
THE ISSUING BANK UPON OUR RECEIPT OF THE ATTACHED &#147;EXHIBIT A&#148; DULY COMPLETED AND EXECUTED BY THE BENEFICIARY AND ACCOMPANIED BY THE ORIGINAL LETTER OF CREDIT AND ALL AMENDMENTS, IF ANY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL DEMANDS FOR PAYMENT SHALL BE MADE BY PRESENTATION OF THE ORIGINAL APPROPRIATE DOCUMENTS PRIOR TO 10:00 A.M. E.S.T. TIME, ON A BUSINESS DAY AT OUR OFFICE
(THE &#147;BANK&#146;S OFFICE&#148;) AT: __________________________________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BOSTON, MASSACHUSETTS _______, ATTENTION: _______________________ OR BY
FACSIMILE TRANSMISSION AT: (___) ____-______; AND SIMULTANEOUSLY UNDER TELEPHONE ADVICE TO: (___) _____-_______, ATTENTION: _________________ WITH ORIGINALS TO FOLLOW BY OVERNIGHT COURIER SERVICE. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PAYMENT AGAINST CONFORMING PRESENTATIONS HEREUNDER SHALL BE MADE BY BANK DURING NORMAL BUSINESS HOURS OF THE
BANK&#146;S OFFICE WITHIN ONE (1)&nbsp;BUSINESS DAY AFTER PRESENTATION. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WE HEREBY AGREE WITH THE DRAWERS, ENDORSERS AND BONAFIDE HOLDERS THAT THE DRAFTS
DRAWN UNDER AND IN ACCORDANCE WITH THE TERMS AND CONDITIONS OF THIS LETTER OF CREDIT SHALL BE DULY HONORED UPON PRESENTATION TO THE DRAWEE, IF NEGOTIATED ON OR BEFORE THE EXPIRATION DATE OF THIS CREDIT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PAGE 2 OF 3 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS CREDIT IS SUBJECT TO THE INTERNATIONAL STANDBY PRACTICES 1998 (ISP98) INTERNATIONAL CHAMBER OF
COMMERCE, PUBLICATION NO. 600. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">AUTHORIZED SIGNATURE</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">AUTHORIZED SIGNATURE</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PAGE 3 OF 3 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT &#147;A&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATE: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TO: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="97%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">RE: STANDBY LETTER OF CREDIT</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NO. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ISSUED
BY</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">ATTN:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">L/C AMOUNT:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LADIES AND GENTLEMEN: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED, THE UNDERSIGNED BENEFICIARY HEREBY IRREVOCABLY TRANSFERS TO: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(NAME OF TRANSFEREE) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ADDRESS) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL RIGHTS OF THE UNDERSIGNED BENEFICIARY TO DRAW UNDER THE ABOVE LETTER OF CREDIT UP TO ITS AVAILABLE AMOUNT AS SHOWN ABOVE AS OF THE DATE OF THIS TRANSFER.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BY THIS TRANSFER, ALL RIGHTS OF THE UNDERSIGNED BENEFICIARY IN SUCH LETTER OF CREDIT ARE TRANSFERRED TO THE TRANSFEREE. TRANSFEREE SHALL HAVE THE SOLE
RIGHTS AS BENEFICIARY THEREOF, INCLUDING SOLE RIGHTS RELATING TO ANY AMENDMENTS, WHETHER INCREASES OR EXTENSIONS OR OTHER AMENDMENTS, AND WHETHER NOW EXISTING OR HEREAFTER MADE. ALL AMENDMENTS ARE TO BE ADVISED DIRECT TO THE TRANSFEREE WITHOUT
NECESSITY OF ANY CONSENT OF OR NOTICE TO THE UNDERSIGNED BENEFICIARY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE ORIGINAL OF SUCH LETTER OF CREDIT IS RETURNED HEREWITH, AND WE ASK YOU TO
ENDORSE THE TRANSFER ON THE REVERSE THEREOF, AND FORWARD IT DIRECTLY TO THE TRANSFEREE WITH YOUR CUSTOMARY NOTICE OF TRANSFER. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SINCERELY, </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">(BENEFICIARY&#146;S NAME)</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SIGNATURE OF BENEFICIARY </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SIGNATURE AUTHENTICATED </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(NAME OF BANK) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;AUTHORIZED SIGNATURE </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT &#147;B&#148; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DATE: _____________</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">REF. NO. __________________&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>A</B>T SIGHT OF THIS DRAFT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>P</B>AY TO THE ORDER OF ___________________________________________________________________________ US$ __________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">US DOLLARS _________________________________________________________________________________________________________ </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DRAWN UNDER _______________ BANK, BOSTON, MASSACHUSETTS, STANDBY LETTER OF CREDIT NUMBER NO. _______________________ DATED __________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>T</B>O: _______________ BANK </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;________________ </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;________________, MA _____</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(BENEFICIARY&#146;S
NAME)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Authorized Signature</B></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT <FONT STYLE="white-space:nowrap">10-1</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BASE BUILDING PLANS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[LOG OF PLANS
ATTACHED] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page170.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT <FONT STYLE="white-space:nowrap">10-2</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BASE BUILDING TI MATRIX </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Innovation Square</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Base Building and T.l. Matrix</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>3/6/18</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="right">


<IMG SRC="g68105page171.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Responsibility Allocation</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><I>Description:</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Landlord<BR>Base&nbsp;Building</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Tenant</I></B><br><B><I>Improvement</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Heating, Ventilation, Air Conditioning</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">High Efficiency Chilled Water Plant Sized for Ashrae 1%</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cooling Tower supported by Emergency Generator</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Condenser Water Pipe Risers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Central High Efficiency condensing hot water, gas fired, boiler plant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hot Water Pipe Risers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vertical Supply Air Duct Distribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Horizontal Supply Air Duct Distribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Make Up Air Volume will provide 2 CFM per SF of once thru air to the lab portion of the
Tenant&#146;s Premises and Office Portion of the Tenant Premises to be served by either heat pumps or fan coil units with code required make up air (Lab/Office Split of the premises is anticipated to be 60% Lab/40% Office).</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hot water piping within Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Building Management System (BMS) for common areas and Landlord Infrastructure, which includes
Rooftop MUA, General Exhaust, Heat Pumps and Condenser Water Loop that support common areas.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant BMS (compatible with Landlord&#146;s system) within Tenant Premises and Tenant
Infrastructure, which includes but is not limited to Dedicated MUA Units, Dedicated Boiler, hot water/chilled water pumps, Server Room HVAC if required, etc.)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supply air duct distribution system including but not limited to; heat pumps, fan coils, VAV
boxes, equipment connections, insulation, air terminals, dampers, hangers, etc. within Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Process Condenser water system</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhaust air vertical chaseways</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General exhaust fans (EAHU&#146;s) and heat recovery system* </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhaust air vertical duct with connection on each floor *</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shaft space for (2)&nbsp;future 14&#148; round lab exhausts per floor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Future dedicated 14&#148; lab exhaust vertical/horizontal in shaft and on floor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restroom exhaust for restrooms within Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ventilation system for Base Building electrical closets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ventilation system for electrical closets within Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sound attenuation for all rooftop base building equipment to comply with City/Town Noise Ordinance
as needed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merrimack Pharmaceuticals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rooftop Mechanical Penthouse Space (Based on Tenant Proportionate Share of Building) for
Tenant&#146;s Equipment.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant Server Room HVAC (if needed)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Plumbing</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Domestic water service with backflow prevention and Base Building risers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Domestic water distribution within Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant Metering and <FONT STYLE="white-space:nowrap">sub-metering</FONT> at Tenant
connection</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sanitary waste and vent service risers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab waste vertical chase and sleeve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">pH Neutralization system, including but not limited to the tank system, individual test ports,
monitoring alarms, etc.*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waste piping within the Premises and from Premises to Common pH Waste room on 1st floor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non potable Hot water generation for Tenant Use</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab air compressor system for Tenant Use</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compressed air pipe distribution in Tenant Premises for specific points of use</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab vacuum system for Tenant Use</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab vacuum pipe distribution in Tenant Premises for specific points of use</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tepid water generator</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tepid water pipe distribution in Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RODI water generator and water pipe distribution in Tenant Premises for specific points of
use</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Manifolds, piping, and other requirements including cylinders, not specifically mentioned
above</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Core Restroom plumbing fixtures compliant with accessibility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wall Hydrants in core areas as required by code.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Storm Drainage Systems</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hot Water Generation and Distribution for Core Restrooms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Innovation Square</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Base Building and
T.l. Matrix</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>3/6/18</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g68105page171.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Responsibility Allocation</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><I>Description:</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Landlord<BR>Base&nbsp;Building</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Tenant</I></B><br><B><I>Improvement</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Electrical</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Electrical utility service to elevated switchgear on ground floor main electrical
vault</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">480/277 3 Phase, 4 Wire Bus Duct Allocation of bus power for Tenant use (exclusing power for base
building systems): 10 watts/ per RSF of Lab and 6 watts/RSF of Office</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Double Ended Switchboards Located in Main Electrical Room</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Generator for Tenant Use including sound attenuation sized for 5 Watts per square foot of Lab
RSF</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Standby power distribution within Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lighting and power distribution for Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Energenix <FONT STYLE="white-space:nowrap">Sub-Meter</FONT> for disconnect (if not a direct
utility meter)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common area life safety emergency lighting/signage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant Premises life safety emergency lighting/signage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant panels and transformers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All <FONT STYLE="white-space:nowrap">distribution/tie-in&#146;s</FONT> from generators to
tenant premises*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Natural Gas</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Natural gas service to building and piping to base building equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Natural gas service and pressure regulator for Tenant equipment stubbed to ground floor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Natural gas piping from Tenant meter to Tenant Premises or Tenant equipment areas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Natural gas pipe distribution within Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Natural gas pressure regulator vent pipe riser from valve location through roof as
needed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Fire Protection</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fire Service entrance including fire department connection, alarm valve, and flow
protection</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Primary distribution of wet sprinkler system to Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All run outs, drop heads, and related equipment within Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Modification of sprinkler piping and head locations to suite Tenant layout and hazard
index</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fire extinguisher cabinets at common areas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fire extinguisher cabinets in Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Base Building fire alarm system with devices in common areas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fire alarm sub panels and devices for Tenant Premises with integration into Base Building
system</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alteration to fire alarm system to facilitate Tenant program, subject to Landlord review and
approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Egress Stair Sprinkler Distribution and Sprinkler Heads</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Common Areas</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accessible Main Entrance with Vestibule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Main Common Lobby Area</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Upper Level elevator lobbies on floor with multiple tenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Area restrooms, ADA compliant, finished to a first class standard.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Janitors closets in common areas, finished</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Electrical closets in common areas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IDF connected to secondary demarcation room, finished</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Primary demarcation room</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loading Dock area</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Doors, frames, and hardware at common areas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Two (2)&nbsp;hydraulic passenger elevators with a 3,500 lb. capacity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">One (1)&nbsp;hydraulic freight elevator with a 5,000 lb. capacity linking loading dock with Tenant
floors and rooftop Mech PH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Building Common Area Signage&#151;Interior and Exterior</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bike storage located on 1st floor of the building</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fitness Center located on 1st floor of the building</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conference Center located on 1st floor of the building</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Space is provided for Tenant pH Neutralization systems on the first floor of the
building.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant pH Neutralization system and all associated equipment, piping, test ports, <FONT
STYLE="white-space:nowrap">tie-in&#146;s.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Innovation Square</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Base Building and
T.l. Matrix</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>3/6/18</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="right">


<IMG SRC="g68105page171.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Responsibility Allocation</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><I>Description:</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Landlord<BR>Base&nbsp;Building</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Tenant</I></B><br><B><I>Improvement</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Tenant Areas</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Floor skimming to accept carpet/VCT/sheet vinyl/epoxy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant signage to be approved by Landlord such approval not to be unreasonably withheld. Landlord
to cooperate with Tenant in obtaining building signage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inside face of exterior walls - slab-to-slab insulation with vapor barrier.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finishes at inside face of exterior walls, will be provided as base building but construction will
be coordinated with interior <FONT STYLE="white-space:nowrap">fit-out</FONT> (i.e. the interior face of the exterior wall will be finished in conjunction with any required MEP or other services and devices that would need to be in the wall)</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Electrical closets within Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tel/data rooms for interconnection with Tenant tel/data</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant kitchen areas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Partitions, ceilings, flooring, painting, finishes, doors, frames, hardware, millwork, casework,
etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fixed or moveable casework</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory Equipment including but not limited to biosafety cabinets, autoclaves, glass washers,
incubators, freezers, etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chemical Fume Hoods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shaft enclosures for Base Building systems&#146; risers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">An area for two (2)&nbsp;direct exhaust risers per floor. The exhaust shafts are common area but
accessible to each floor.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furnish and install Building standard blinds for all exterior windows</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interior Window Treatments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walls finished and prepared to receive Tenant finish on Tenant side of Base Building Rooms and
shafts.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Telephone / Data</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underground local exchange carrier service to primary demarcation room at a to be coordinated with
Tenant location.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Service from primary demarcation room to secondary demarcation room</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intermediate distribution frame rooms in Tenant Premises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pathways from secondary demarcation room to intermediate distribution frame rooms, where
applicable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant tel/data rooms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pathways from secondary demarcation room directly into Tenant tel/data rooms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tel/data cabling from secondary demarcation room to intermediate distribution frame rooms</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tel/data cabling from secondary demarcation room to Tenant tel/data rooms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fiber optic service for Tenant use</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tel/data infrastructure including but not limited to servers, computers, phone systems, switches,
routers, MUX panels, equipment racks, ladder racks, etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provisioning of circuits and service from service providers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audio visual systems and support</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Station cabling from Tenant tel/data room to all Tenant locations, within the suite and exterior
to the suite, if needed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Riser Closets and Cable Sleeves through Floor Slabs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Structure</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steel Framed Slab on Grade Structure with Moment Frame and Composite Steel and Sealed concrete
floors and roofs fireproofed.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Typical Load Capacity of 100 LBS per square foot. 2 Structural Bays shall be upgraded to 150 lbs.
per Sq. Ft. and 2 Structural Bays shall be upgraded to 125 lbs. per Sq. Ft. and Penthouse Floor Structure shall be 150 lbs. per square foot.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Structural enhancements for specific tenant load requirements subject to Landlord review and
approval.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Floor to floor heights of 15 ft.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Utility risers for Tenant utilities, subject to Landlord review and approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capacity in structure to accommodate tenant dunnage and roof equipment.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dunnage at roof for base building equipment including grates or walk pads</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dunnage at roof for tenant equipment including grates or walk pads.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Framed openings for base building supply air and general exhaust shafts.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Framed openings for additional tenant shafts and risers (above Landlord Number)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21&#146; Column Bays in predetermined Lab Areas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous metal items such as brackets or supports and concrete housekeeping pads required for
tenant-supplied equipment.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Innovation Square </B><I></I><B></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Base
Building and T.l. Matrix </B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>3/6/18</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="right">


<IMG SRC="g68105page171.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Responsibility Allocation</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><I>Description:</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Landlord<BR>Base&nbsp;Building</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Tenant</I></B><br><B><I>Improvement</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Roofing&nbsp;&amp; Exterior</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EDPM Rubber Roofing System or similar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roof penetrations for Base Building equipment/systems</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roof penetrations for Tenant equipment/systems</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walkway pads for Base Building equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walkway pads for Tenant equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roofing alterations due to Tenant changes subject to Landlord review and approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Building exterior consisting of <FONT STYLE="white-space:nowrap">Pre-cast</FONT> Concrete and
glass curtain/window wall</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aluminum frames and insulated windows</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Main Building entrances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loading Dock doors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conduit for Card access at Building entries and elevators</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant card access into or within Tenant Premises on separate Tenant installed and managed
system</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant video camera coverage of Tenant Premises on separate Tenant installed and managed
system</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Landlord to provide Base Building card access system for all common entry doors and a video
surveillance systems for all common areas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Site Work</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Perimeter sidewalks, street curbs, miscellaneous site furnishings, landscaping, parking and
exterior lighting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone service to main demarcation room from local exchange carrier</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Domestic sanitary sewer connection to street</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roof storm drainage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eversource primary electrical service</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">National Grid gas service</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Domestic water service to Building (BWSC)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">On site parking lot to include 84 spaces, provided to tenants based on their <I>%</I> share of the
building at Market Rates. Tenant shall pay the cost of its parking directly.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LEED Silver Certifiable Base Building (actual certification will be coordinated with Tenant
Work)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fire Protection water service to Building</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><I>*</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>HVAC: Manifolded general exhaust system including heat recovery and vertical ductwork from Tenant space
to rooftop equipment; Electrical: power to ph neutralization systems, and panels for standby power ot floor electrical closet; Plumbing: vent piping from ph neutralization room to roof; all to be purchased and installed by Landlord with the costs
allocated to the Tenant based on their proportionate shore of the building. </I></B></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 11 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TENANT&#146;S SIGNAGE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms and
conditions of the Lease including but not limited to Section&nbsp;17.4(a), the Tenant originally named herein or a Permitted Transferee shall have the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> right, at its sole cost and expense, to
maintain (a)&nbsp;one (1) branded lobby sign in the location to be mutually determined prior to the Term Commencement Date; and (b)&nbsp;one (1) branded exterior sign on the fa&ccedil;ade of the at both main Building entrances for the purpose of
identifying Tenant or Permitted Transferee in the locations as approximately shown on Schedule 1 attached hereto, which Tenant Signage (including size, design, logo, color(s) and degree of illumination, if any, and actual location in or on the
Building) shall be subject to the prior written approval of Landlord, not to be unreasonably withheld or delayed, and installed and maintained in compliance with all applicable Legal Requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(1 of 2) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page176.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(2 of 2) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page177.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 12 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CHEMICAL CENTRAL AREA&nbsp;&amp; STORAGE QUANTITIES </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page178.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page179.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 13 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">APPROVED HAZARDOUS MATERIALS LIST </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[TO BE ATTACHED &#147;COPY OF ONE EXAMPLE OF CHEMICAL LISTING AJB 2018.XLS&#148;] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 14 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF NOTICE OF LEASE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NOTICE OF
SUBLEASE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;Notice is hereby given pursuant to Chapter 183, Section&nbsp;4 of the General Laws, of a sublease upon the following
terms: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="70%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="6">


<IMG SRC="g68105page181.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Sublandlord:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">RBK I TENANT, LLC, a Delaware limited liability company</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subtenant:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Date of Sublease Execution:</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">PURETECH HEALTH LLC, a Delaware limited liability company ____________ ___, 2018</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Premises:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approximately 50,858 rentable square feet of space, consisting of the entire rentable area of the fourth (4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) floor of approximately 35,499 rentable square feet and approximately
15,359 rentable square feet of space on the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) floor of the Building, as more fully described in the Sublease, located on land known as 6 Tide Street, Suffolk County, MA
(&#147;Building&#148;). The land on which the Premises and Building are located is more particularly shown on Exhibit A attached hereto and incorporated herein, and is leased to Sublandlord pursuant to that certain Ground Lease by and between the
Economic Development and Industrial Corporation of Boston, d/b/a Boston Planning&nbsp;&amp; Development Agency, as landlord, and Sublandlord, as tenant, as evidenced by a Notice of Ground Lease dated November&nbsp;21, 2017 and recorded at the
Suffolk County Registry of Deeds at Book 58836, Page 106.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Initial Sublease</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Expiration Date:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11:59 p.m. on the last day of the eleventh (11th) Lease Year (a partial year consisting of three (3)&nbsp;months) following the Term Commencement Date (as defined in the Sublease)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Extension Options:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Two (2)&nbsp;extension options of five (5)&nbsp;years each. An affidavit signed by the Landlord and recorded with the Suffolk County Registry of Deeds shall be conclusive in favor of any person acting in reliance thereon, without
necessity of further inquiry, as to whether such option has been exercised by Tenant or has lapsed unexercised, or has been waived or terminated.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Right of First Offer:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subject to and in accordance with the terms and conditions of Section&nbsp;29.18 of the Sublease, the Subtenant has a right of first offer to lease any other space that is contiguous to the Premises in the Building, and certain
space in the Phase II Building (as defined and further described in the Sublease).</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This Notice of Sublease has been executed merely to give notice of the Sublease, and all of the terms,
conditions and covenants thereof which are incorporated herein by reference. The parties hereto do not intend this Notice of Sublease to modify or amend the terms, conditions and covenants of the Sublease. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Pages Follow] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Executed as an instrument under seal this ____ day of __________, 2018. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>SUBLANDLORD:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RBK I TENANT, LLC,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware limited liability
company</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">STATE/COMMONWEALTH OF __________________ </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">__________, ss.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">_________________, 2018</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On this day, before me, the undersigned notary public, personally appeared ___________________, proved to me through
satisfactory evidence of identification, which was _______________________, to be the person whose name is signed on the preceding or attached document, and acknowledged to me that he signed it voluntarily for its stated purpose, as said
_____________________ of RBK I TENANT, LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">___________________________(official signature and seal of notary) My commission expires
__________________________________ </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>SUBTENANT:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PURETECH HEALTH LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Delaware limited liability company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">COMMONWEALTH OF MASSACHUSETTS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">__________, ss.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">_________________, 2018</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On this day, before me, the undersigned notary public, personally appeared _______________________, proved to me through
satisfactory evidence of identification, which was _______________________, to be the person whose name is signed on the preceding or attached document, and acknowledged to me that he signed it voluntarily for its stated purpose, as said
__________________ of PURETECH HEALTH LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">___________________________(official signature and seal of notary) My commission expires
__________________________________ </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LEGAL DESCRIPTION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">I.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Description of the Land</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Premises is shown as &#147;Sub Phase II&#148; on a certain plan entitled &#147;Lease Plan of Land&#148; for the project &#147;Lease Parcel, 6 Tide Street,
Boston, MA&#148;, dated November 9, 2017, and prepared by Allen &amp; Major Associates, Inc. (the &#147;Premises Plan&#148;), to be recorded with the Suffolk County Registry of Deeds. The legal description of the entire Premises as shown the
Premises Plan is as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A certain lease area located in the City of Boston, County of Suffolk. Commonwealth of Massachusetts bounded
and described as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Beginning at a point shown as P.O.B. on the Premises Plan, said point being the easterly most corner of the
proposed lease area to be described hereafter; thence </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">S31&deg;28&#146;l 1W</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Two hundred fifty-eight and fifteen hundredths feet (258.15&#146;) to a point; thence</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">N58&deg;31&#146;49W</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Three hundred five and ninety-nine hundredths feet (305.99&#146;) to a point; thence</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">N31&deg;16&#146;51E</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Two hundred forty and forty-two hundredths feet (240.42&#146;) to a point of curvature; thence</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Northeasterly</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Along an arc to the right having a radius of twenty and no hundredths feet (20.00&#146;), an arc length of thirty and fifty-five hundredths feet (30.55&#146;), a chord length of twenty-seven and sixty-seven hundredths feet
(27.67&#146;) and a chord bearing of N75&deg;02&#146;30E to a point of tangency; thence</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">S61&deg;H&#146;51E</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Two hundred seventy-two and twenty-eight hundredths feet (272.28) to a point of curvature; thence</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Southeasterly</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Along an arc to the right having a radius of fifteen and no hundredths feet (15.00&#146;), an arc length of twenty-four and twenty-six hundredths feet (24.26&#146;), a chord length of twenty one and seventy hundredths feet
(21.70&#146;) and a chord bearing of S14&deg;51&#146;50E to a point of tangency, being the point of beginning.</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The above described lease area contains an area of 81,591 square feet, more or less. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 15 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SPECIFIC TENANT&#146;S REMOVABLE PROPERTY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[TO BE PROVIDED BY TENANT AND REASONABLY APPROVED BY LANDLORD POST-EXECUTION AND <FONT STYLE="white-space:nowrap">PRE-ENTRY]</FONT> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 16 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ROOF EXHIBIT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(see attached) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page188.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 17 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PHASE II PRELIMINARY PLAN </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g68105page189.jpg" ALT="LOGO">
 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>4
<FILENAME>filename4.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.7 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED (INDICATED BY: [ *** ]) FROM THE EXHIBIT BECAUSE IT IS BOTH (I)&nbsp;NOT MATERIAL AND (II)&nbsp;WOULD
LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSET PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>by and between </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUSPEX
PHARMACEUTICALS, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURETECH HEALTH LLC </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>July&nbsp;15, 2019 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Table of Contents </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article I INTERPRETATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Defined Terms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article II PURCHASE AND TRANSFER OF ASSETS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Transfer of Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Transferred Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Assumption of Certain Liabilities and Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Purchase Price for Transferred Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Milestones</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Royalties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">VAT; Withholding and Similar Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Records</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Audit</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Blocked Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interest Due</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Diligence</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Certain Costs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article III CLOSING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article IV REPRESENTATIONS AND WARRANTIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Representations and Warranties of Auspex</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Representations and Warranties of Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article V ADDITIONAL AGREEMENTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Condition of the Transferred Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Regulatory Commitments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Further Action; Consents; Filings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Bulk Transfer Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Support</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Payments from Third Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Resale Exemption Certificates and Transfer Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Payments Under Transferred Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Patent Challenge; Covenant Not to Sue</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article VI INDEMNIFICATION AND LIMITATIONS OF LIABILITY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification by Auspex</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification by Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Procedure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Survival</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Certain Limitations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Exclusive Remedy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article VII CONFIDENTIAL INFORMATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ownership of Certain Confidential Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Protection of Confidential Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Permitted Use</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authorized Disclosure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Excluded Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Obligations Upon Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Rights Upon Unauthorized Use or Disclosure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article VIII MISCELLANEOUS PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Successors and Assigns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Press Releases; Disclosures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Schedules</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amendments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Submission to Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Waiver of Jury Trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Third Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SCHEDULES AND EXHIBITS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSET PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <B>ASSET PURCHASE AGREEMENT</B> (this &#147;<B>Agreement</B>&#148;) is entered into as of July&nbsp;15, 2019 (the &#147;<B>Effective
Date</B>&#148;), by and between <B>AUSPEX PHARMACEUTICALS, INC.</B>, a Delaware corporation (&#147;<B>Auspex</B>&#148;) and <B>PURETECH HEALTH LLC</B>, a Delaware limited liability company (&#147;<B>Purchaser</B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BACKGROUND </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Auspex is
a wholly-owned subsidiary of Teva Pharmaceuticals USA, Inc., and is in the business of researching, developing, manufacturing or having made, as the case may be, compounds intended for pharmaceutical use. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. Auspex owns certain assets and rights, and is subject to certain liabilities, relating to the Compound and the Product (as such terms are
defined below). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. Auspex desires to sell (or to cause to be sold), and Purchaser desires to purchase, certain rights and assets related
to the Compound and the Product, and Purchaser is willing to assume certain liabilities related to the Compound and the Product, in each case upon the terms and subject to the conditions set forth herein and in the Ancillary Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE</B>, in consideration of the premises and mutual covenants herein contained and for other good and valuable consideration
(the receipt and sufficiency of which is hereby acknowledged), the parties hereto hereby agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INTERPRETATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1. <U>Defined Terms</U>. For the purposes of this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Action</B>&#148; means any claim, action, suit, arbitration, complaint, inquiry, audit, proceeding or investigation, in each case, by
or before any applicable Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means any Person that controls, is controlled by, or is
under common control with the applicable Person. For purposes of this definition, &#147;control&#148; shall mean: (i)&nbsp;in the case of corporate entities, direct or indirect ownership of fifty percent (50%)&nbsp;or more of the stock or shares
entitled to vote for the election of directors, or otherwise having the power to control or direct the affairs of such Person; and (ii)&nbsp;in the case of <FONT STYLE="white-space:nowrap">non-corporate</FONT> entities, direct or indirect ownership
of 50% or more of the equity interest or the power to direct the management and policies of such non corporate entities. Affiliates of Purchaser shall include any company that (i)&nbsp;fits the definition in the first two sentences of this paragraph
and (ii)&nbsp;to which Purchaser grants, or under the circumstances would be deemed to require to grant, a license or sublicense, as applicable, of Purchaser&#146;s rights under this Agreement. Except as stated in the previous sentence, Affiliates
of Purchaser shall not include (i)&nbsp;any other companies that are controlled by Purchaser or (ii)&nbsp;any companies that are under common control with Purchaser. However, nothing in this paragraph shall be interpreted as granting the right to
Purchaser to be released from its obligations under this Agreement by inter-company transactions within Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Ancillary Agreements</B>&#148; means the Assignment and Assumption Agreement, the
Bill of Sale, the IP Assignment and the Neuland Assignment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Annual Report</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.12</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Laws</B>&#148; means, in respect of any Person, property, transaction, event
or course of conduct, all applicable laws, statutes, regulations, rules, bylaws, ordinances, codes, official directives, orders, rulings, judgments or decrees of any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Assignment and Assumption Agreement</B>&#148; means the assignment and assumption agreement substantially in the form of <U>Exhibit
A</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Assumed Liabilities</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Auspex Indemnitees</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Auspex&#146;s knowledge</B>&#148; means the actual knowledge, after reasonable inquiry, of Stephen Trusko and Brian Shanahan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Auspex Technology</B>&#148; means, to the extent exclusively related to the Compound or a Product, any and all current and future
issued patents, patent applications or other patent rights, unpatented inventions, <FONT STYLE="white-space:nowrap">know-how,</FONT> <FONT STYLE="white-space:nowrap">show-how,</FONT> trade secrets, trademarks, copyrights and other information owned
or controlled by Auspex or its Affiliates necessary to exploit the Compound or a Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Bill of Sale</B>&#148; means the bill
of sale in the form attached hereto as <U>Exhibit B</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means any day, other than Friday, Saturday,
Sunday or any statutory holiday in the State of New York or Israel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Calendar Quarter</B>&#148; means each three (3)&nbsp;month
period commencing January&nbsp;1, April&nbsp;1, July&nbsp;1 or October&nbsp;1 during the Royalty Term, <U>provided</U>, <U>however</U>, that (a)&nbsp;the first Calendar Quarter of the Royalty Term shall extend from the first day of the Royalty Term
to the end of the first full Calendar Quarter thereafter, and the last Calendar Quarter of the Royalty Term shall end on the last day of the Royalty Term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Calendar Year</B>&#148;<B> </B>means the period beginning on the 1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> of
January and ending on the 31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> of December of the same calendar year during the Royalty Term, <U>provided</U>, <U>however</U>, that (a)&nbsp;the first Calendar Year of the Royalty Term shall
commence on the first day of the Royalty Term and end on December&nbsp;31 of the same calendar year as the first day of the Royalty Term, and (b)&nbsp;the last Calendar Year of the Royalty Term shall commence on January&nbsp;1 of the calendar year
in which the Royalty Term ends and end on the last day of the Royalty Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Claim Notice</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.3(a)(i)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Claims</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Closing Date</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Combination Product</B>&#148;<B></B> means a Product comprising a pharmaceutical
formulation containing as an active ingredient Compound and one or more other therapeutically active ingredients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Commercially Reasonable Efforts</B>&#148;<B> </B>means, with respect to the efforts to be expended by a Party with respect to
any objective under this Agreement, reasonable, diligent, good-faith efforts to accomplish such objective as such Party would normally use to accomplish a similar objective under similar circumstances exercising reasonable business judgment; it
being understood and agreed that, such efforts shall be substantially equivalent to those efforts and resources commonly used by such Party for a product owned by it or to which it has rights, which product is at a similar stage in its development
stage or product life and is of similar market potential as the Product, taking into account factors including but not limited to efficacy, safety, approved labeling, the competitiveness of alternative products in the marketplace, the patent and
other proprietary position of the product, the likelihood of Product Approval given the regulatory structure involved, the profitability, and other relevant factors commonly considered in similar circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Compound</B>&#148; means deuterated pirfenidone, also known as <FONT STYLE="white-space:nowrap">SD-560,</FONT> and salts, solvates,
enantiomers, isomers, modifications, prodrugs, or metabolites, of deuterated pirfenidone. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>[***]</B>&#148; has the meaning set
forth in <U>Section</U><U></U><U>&nbsp;2.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Confidential Information</B>&#148; means any and all information or material
that, at any time before, on or after the date hereof, has been or is provided or communicated to the Receiving Party by or on behalf of the Disclosing Party pursuant to any of the Transaction Documents in connection with the Transactions or any
discussions, due diligence or negotiations with respect thereto; any data, ideas, concepts or techniques contained therein; and any modifications or derivations therefrom; <U>provided</U>, <U>however</U>, that following the Closing notwithstanding
the foregoing or anything else to the contrary, any <FONT STYLE="white-space:nowrap">non-public</FONT> information and materials included in and relating solely to the Transferred Assets shall constitute Confidential Information of Purchaser and not
Confidential Information of Auspex (and Purchaser shall be deemed to be the Disclosing Party, and Auspex the Receiving Party, of such information). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Contracts</B>&#148; means any agreement, contract, commitment or other instrument or arrangements that are in writing and signed on
behalf of Auspex or its Affiliates (i)&nbsp;by which the Transferred Assets are bound or affected or (ii)&nbsp;to which Auspex or its Affiliates is a party or by which it is bound relating to the Transferred Assets, in each case as amended,
supplemented, waived or otherwise modified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>CPA Representatives</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.9</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Debarred Entity</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.1(h)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Disclosing Party</B>&#148; means the Party disclosing Confidential Information.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Encumbrance</B>&#148; means any lien, mortgage, charge, pledge, security interest, hypothecation, condition, prior assignment,
option, warrant, license, lease, sublease, right to possession, encumbrance, claim, servitude, easement, encroachment, equitable interest, or any right or restriction, which affects, by way of a conflicting ownership interest or otherwise, the
right, title, use or interest in or to any particular property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Excluded Assets</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Excluded Liabilities</B>&#148; mean Liabilities arising out of or in connection with or
related to the Transferred Assets that are not Assumed Liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FDA</B>&#148; means the U.S. Food and Drug Administration,
including all agencies under its control, and any successor agency thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;First Commercial Sale&#148; </B>means, with respect
to a Product in any country, the first sale of such Product to a Third Party in such country for distribution, use or consumption after Product Approval has been obtained for such Product in such country. Sales for purposes of testing the Product in
a clinical trial shall not be deemed a First Commercial Sale. For clarity, First Commercial Sale shall be determined on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Product</FONT></FONT> and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">region-by-region)</FONT></FONT> basis, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Fundamental Reps</B>&#148; means the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;4.1(a)</U>
(<I>Organization</I>), <U>Section</U><U></U><U>&nbsp;4.1(b)</U> (<I>Corporate Authority</I>), <U>Section</U><U></U><U>&nbsp;4.1(f)</U> (<I>Title to Transferred Assets</I>), <U>Section</U><U></U><U>&nbsp;4.1(p)</U> (<I>No Brokers</I>),
<U>Section</U><U></U><U>&nbsp;4.2(a)</U> (<I>Organization</I>), <U>Section</U><U></U><U>&nbsp;4.2(b)</U> (<I>Limited Liability Company Authority</I>) and <U>Section</U><U></U><U>&nbsp;4.2(h)</U> (<I>No Brokers</I>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>GAAP</B>&#148; means United States generally accepted accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Generic Product</B>&#148;<B> </B>means, with respect to a particular Product or Combination Product and a particular country,
(i)&nbsp;any pharmaceutical product (other than the Product or Combination Product, as applicable) that contains the same active ingredient(s) in a comparable quality and quantity as such Product or Combination Product, as applicable, irrespective
of its pharmaceutical form, and is approved under an Abbreviated New Drug Application (ANDA) or any similar abbreviated route of approval in such country. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>GMP</B>&#148; means then-current good manufacturing practices as required by Applicable Laws and the rules and regulations of the
applicable Regulatory Authority where Auspex or any of its Affiliates makes or has made the Compound or the Product and the jurisdictions where the Compound or Product is manufactured, as applicable to the manufacture, packaging, handling, storage
and control of the Compound or the Product in the applicable jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148; means any
(i)&nbsp;federal, provincial, state, regional, municipal, local or other government, domestic or foreign; (ii)&nbsp;governmental or quasi-governmental authority of any nature (including any agency, branch, department, commission, board, court or
tribunal); (iii)&nbsp;body exercising any administrative, executive, judicial, legislative, police, regulatory, expropriation or taxing authority, domestic or foreign; or (iv)&nbsp;self-regulatory organization or stock exchange having jurisdiction
in the relevant circumstances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>IND</B>&#148;<B> </B>means an Investigational New Drug Application, Clinical
Study Application, Clinical Trial Exemption, or similar application or submission for approval to conduct human clinical investigations filed with or submitted to a Regulatory Authority in conformance with the requirements of such Regulatory
Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indemnitee</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indemnitor</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Inventory</B>&#148; means the entire inventory of the Compound and the Product, including the
<FONT STYLE="white-space:nowrap">non-GMP</FONT> and GMP materials, owned or held for use by Auspex or any of its Affiliates on the Effective Date, as set forth on <U>Schedule</U><U></U><U>&nbsp;1.1(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>IP Assignment</B>&#148; means the Intellectual Property Assignment Agreement in the form attached hereto as <U>Exhibit C</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Liabilities</B>&#148; means, with respect to any Person, any liabilities or obligations of such Person of any kind, character or
description. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;Licensed Patent&#148; </B>means (a)&nbsp;the continuation patent application with the claims set forth on
<U>Schedule B</U>, [***]; (b) reissues, substitutions, confirmations, registrations, validations, <FONT STYLE="white-space:nowrap">re-examinations,</FONT> additions, continuations, continued prosecution applications,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> or divisions of or to the continuation patent application set forth on <U>Schedule B</U>; (c)&nbsp;any other patent application claiming priority
to the continuation patent application set forth on <U>Schedule B</U>; and (d)&nbsp;extension, renewal or restoration of any of the foregoing by existing or future extension, renewal or restoration mechanisms, including supplementary protection
certificates or the equivalent thereof, in all cases with respect to subparts (a), (b), (c) and (d)&nbsp;above, only to the extent related to the Compound or the Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Licensed Patent Rights</B>&#148; means (a)&nbsp;the Licensed Patent and (b)&nbsp;any foreign patents or patent equivalents to the
Licensed Patent that result from the filing by Auspex of divisional applications in accordance with the provisions of Section&nbsp;2.2(d) hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Losses</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Material Adverse Effect</B>&#148; means, with respect to Auspex, any change, effect, event, circumstance, occurrence or state of
facts that is materially adverse to (a)&nbsp;the value of the Transferred Assets, taken as a whole, or (b)&nbsp;the ability of Auspex to consummate the Transactions, <U>provided</U> that none of the following changes, effects, events, circumstances,
occurrences or states of facts shall be deemed, either alone or in combination, to constitute a Material Adverse Effect, or be taken into account in determining whether there has been or would reasonably be expected to be a Material Adverse
Effect:&nbsp;(i)&nbsp;changes or effects in the general business, economic, social, political or legal conditions or the securities, syndicated loan, credit or financial markets; (ii)&nbsp;changes or proposed changes in Applicable Law or GAAP (or
any applicable accounting standards in any jurisdiction outside the United States) or the enforcement thereof; (iii)&nbsp;changes to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Applicable Laws, that generally affect the pharmaceutical industry; (iv)&nbsp;changes or effects that arise out of or are attributable to the commencement, occurrence, continuation or
intensification of any war, sabotage, armed hostilities or acts of terrorism; (v)&nbsp;earthquakes, hurricanes or other natural disasters; (vi)&nbsp;failure to meet projections, estimates, plans or forecasts; (vii)&nbsp;changes or effects that arise
out of or are attributable to the negotiation, execution, announcement or pendency of the Transactions or the performance of and compliance with the terms of this Agreement, including any litigation, any reduction in revenues or income, any loss of
customers or any disruption in supplier, distributor or similar relationships; (viii)&nbsp;any labor strikes, labor stoppages or loss of employees; (ix)&nbsp;currency fluctuations; (x)&nbsp;changes or effects that arise out of or are attributable to
actions or omissions of Purchaser or any of its Affiliates or actions or omissions of Auspex or any of its Affiliates and consented to by Purchaser or any of its Affiliates; or (xi)&nbsp;any matter disclosed in the Schedules to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Material Contracts</B>&#148; means material Contracts (x)&nbsp;by which any of the Transferred Assets are bound or affected or
(y)&nbsp;to which Auspex or its Affiliates is a party or by which it is bound relating to the Transferred Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Milestone Events</B>&#148;<B> </B>has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Milestone Payments</B>&#148;<B> </B>has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Net Sales</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Neuland Assignment Agreement</B>&#148;<B></B> means the Assignment Agreement in the form attached hereto as <U>Exhibit E</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Nonassigned Contract</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Notice Period</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.3(a)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Parties</B>&#148; means, collectively, the signatories to this Agreement and &#147;<B>Party</B>&#148; means any one of them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>[***] Agreement</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Patents</B>&#148;<B> </B>means the patents and patent applications set forth on <U>Schedule A</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Periodic Reports</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.6(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Encumbrances</B>&#148; means any (i)&nbsp;Encumbrance for Taxes not yet due, delinquent or which are being contested in
good faith by appropriate proceedings; or (ii)&nbsp;Encumbrance caused by Applicable Law for amounts not material or overdue that does not or would not be reasonably expected to materially detract from the current value of, or interfere with, the
present use and enjoyment of any Transferred Asset subject thereto or affected thereby; (iii)&nbsp;mechanics&#146;, materialmens&#146;, carriers&#146;, workmens&#146;, warehousemens&#146;, repairmens&#146;, landlords&#146; or other like Encumbrances
and security obligations that are incurred in the ordinary course of business and are not delinquent; and (iv)&nbsp;all Encumbrances approved in writing by Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means an individual, a general or limited partnership, a
corporation, a trust, a joint venture, an unincorporated organization, a limited liability entity, any other business or legal entity and any Governmental Authority or Regulatory Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Product</B>&#148; means, any finished pharmaceutical product containing the Compound. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Product Approval</B>&#148; means, as applicable, on a jurisdiction by jurisdiction basis, with respect to a given Product, any and
all approvals, licenses, registrations or authorizations of the applicable Regulatory Authority necessary for the development, manufacture, packaging, labeling, storage, import, export, marketing, distribution, sale, use and/or intended use of such
Product and reimbursement, if applicable, in and for the relevant jurisdiction, including any Regulatory Application. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Product
Business</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.1(g)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Product IND</B>&#148; means the IND
for the Product as set forth on <U>Schedule B</U>, together with all amendments, modifications, supplements and updates thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Indemnitees</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchase Price</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.4</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Receiving Party</B>&#148; means the Party receiving Confidential Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Regulatory Applications</B>&#148; means any and all applications, submissions or other filings with a Regulatory Authority seeking
approval to make and/or have made, or market, distribute, sell, develop, manufacture, package, label, store, import, export, register and/or use the Compound or a Product, in each case as set forth on <U>Schedule B</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Regulatory Authority</B>&#148; means any Governmental Authority (whether federal, state, municipal, local or other) regulating the
development, manufacture, packaging, labeling, storage, import, export, marketing, distribution, sale, registration, use and/or intended use of the Compound or a given Product in any country in the Territory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Regulatory Commitments</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;0</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Regulatory Documentation</B>&#148; means (i)&nbsp;all correspondence and submissions between Auspex and (A)&nbsp;the FDA or any other
applicable Regulatory Authority with respect to Regulatory Applications and Product Approvals for the Compound or a Product, including any reports, filings, or notices submitted to FDA or other Regulatory Authority to support, maintain or obtain the
Product IND or any other Regulatory Applications or Product Approvals; (ii)&nbsp;the annual and periodic reports relating to the Product IND or any other Regulatory Applications for the Products which have been filed by or on behalf of Auspex with
the FDA or other Regulatory Authority, and adverse event reports pertaining to the Compound or any Product, in each case to the extent in the possession or control of Auspex or any of its Representatives; (iii)&nbsp;all <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> data, animal data, clinical data, and laboratory records, data and information exclusively related to the development and commercialization of the Compound or any Product, and any other records and data
concerning <FONT STYLE="white-space:nowrap">pre-clinical</FONT> or clinical studies conducted with respect to the Compound or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Product; and (iv)&nbsp;any other regulatory applications, submissions, notifications, communications, correspondence, registrations, approvals, drug master files (DMFs) and/or other filings made
to, received from or otherwise conducted with a Regulatory Authority in order to make, have made, develop, manufacture, package, label, store, import, export, market, distribute, sell, register and/or use a Product in a particular country or
jurisdiction, including all Regulatory Applications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Regulatory Fees</B>&#148; means any and all fees and charges imposed or
assessed by any Regulatory Authority in connection with the development, manufacture, packaging, labeling, storage, import, export, marketing, distribution, sale, registration, use and/or intended use of a given Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Representatives</B>&#148; means, with respect to a Person, such Person&#146;s Affiliates and its and its Affiliates&#146; respective
officers, employees, agents, attorneys, consultants, subcontractors, advisors and other representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Response
Notice</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.3(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Royalties</B>&#148;<B> </B>has
the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.6(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Royalty Term</B>&#148;<B> </B>means, on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Product</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, the period commencing on the First Commercial
Sale of such Product in such country and continuing until ten (10) years from the date of First Commercial Sale of such Product in such country. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Sales Projections</B>&#148;<B> </B>has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.6(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Shared Assets</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax(es)</B>&#148; means any and all taxes, levies, tariffs, imposts, duties or other charges in the nature of a tax (together with
any and all interest, penalties, additions to tax and additional amounts imposed with respect thereto) imposed by any Governmental Authority, including income, estimated income, gross receipts, profits, business, license, occupation, franchise,
capital stock, real or personal property, sales, use, transfer, value added, employment or unemployment, social security, disability, alternative or add on minimum, customs, excise, stamp, environmental and withholding taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Taxing Authority</B>&#148; means any Governmental Authority, exercising any authority to impose, regulate or administer the
imposition of Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Return</B>&#148; shall mean any return, report, declaration, information return, statement or other
document filed or required to be filed with any Taxing Authority in connection with the determination, assessment or collection of any Tax or the administration of any Applicable Laws relating to any Tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Territory</B>&#148; means all of the countries in the world, and their territories and possessions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>TGA</B>&#148;<B> </B>means the Australian Therapeutic Goods Administration, including all agencies under its control, and any
successor agency thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Third Party</B>&#148; means any Person other than Purchaser, Auspex and their
respective Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Third Party Claim</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transaction Documents</B>&#148; means this Agreement and the Ancillary Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transactions</B>&#148; means, collectively, the transactions contemplated by this Agreement and the Ancillary Agreements, including
the purchase and sale of the Transferred Assets and the assumption of the Assumed Liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transfer Taxes</B>&#148; means
all documentary, sales, use, stamp, registration and other such Taxes (and fees) together with all penalties and interest associated therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transferred Assets</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transferred Contracts</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)(vi)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transferred IP Rights</B>&#148; means (i)&nbsp;the Transferred Patent Rights and (ii)&nbsp;Auspex&#146;s intellectual property rights
in the Auspex Technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transferred Patent Rights</B>&#148; means the Patents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Upfront Payment</B>&#148;<B> </B>has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.4</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>U.S.</B>&#148; means the United States of America and its territories, districts, commonwealths and possessions, including the
Commonwealth of Puerto Rico. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2. <U>Interpretation</U>. Unless the context otherwise requires, in this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>References to this Agreement</U>. &#147;Agreement&#148;, &#147;this Agreement&#148;, &#147;the Agreement&#148;, &#147;hereto&#148;,
&#147;hereof&#148;, &#147;herein&#148;, &#147;hereby&#148;, &#147;hereunder&#148; and similar expressions mean or refer to this Agreement and, as applicable, any Exhibits, Ancillary Agreements, Annexes and Schedules attached to it as amended from
time to time and any written agreement or instrument supplemental hereto. Unless otherwise specified, expressions such as &#147;Article&#148; and &#147;Section&#148; followed by a number or letter mean and refer to the specified Article or Section
or other provision of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Headings and Table of Contents</U>. The inclusion of headings and a table of contents is for
convenience of reference only and shall not affect the construction or interpretation hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Gender and Number</U>. Except where
the context requires otherwise, words importing the singular include the plural and vice versa and words importing gender include all genders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Including</U>. Where the word &#147;including&#148; or &#147;includes&#148; is used, it means including or includes &#147;without
limitation&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Or</U>. The word &#147;or&#148; is not exclusive. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>No Strict Construction</U>. The language used in this Agreement is the language chosen by the Parties to express their mutual intent,
and no rule of strict construction shall be applied against any party proposing any such language. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Statutory References</U>. A
reference to a statute includes all rules and regulations made pursuant to such statute and, unless expressly provided otherwise, the provisions of any statute, rule or regulation which amends, supplements or supersedes any such statute, rule or
regulation in force at the time of the signature of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Currency</U>. Except where expressly provided otherwise herein,
all amounts referred to in this Agreement are expressed in United States Dollars. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Time Periods</U>. Except where expressly provided
otherwise herein, time periods within or following which any payment is to be made or act is to be done shall be calculated by excluding the day on which the period commences and including the day on which the period ends and by extending the period
to the following Business Day if the last day of the period is not a Business Day. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PURCHASE AND TRANSFER OF ASSETS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1. <U>Transfer of Assets</U>. At the Closing and upon the terms and subject to the conditions of this Agreement, Auspex shall assign,
transfer, convey and deliver to Purchaser, and Purchaser shall acquire and accept, all right, title and interest of Auspex in, to and under the Transferred Assets, free and clear of all Encumbrances other than Permitted Encumbrances. In order to
effectuate the assignment, transfer and conveyance of the Transferred Assets, at the Closing, the Parties shall duly execute and deliver the Assignment and Assumption Agreement, the Bill of Sale, the IP Assignment and the Neuland Assignment
Agreement contemplated herein. As of the Closing Date, Auspex will initiate the transfer to Purchaser of the Inventory and all other materials, documents and electronic copies of all data, records and information included in the Transferred Assets,
which transfer shall be completed within [***] thereafter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2. <U>Transferred Assets</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The term &#147;<B>Transferred Assets</B>&#148; means the following assets of Auspex and its Affiliates: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Product IND and any other Regulatory Applications; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Regulatory Documentation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the Inventory; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) the
Transferred IP Rights; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) the Auspex Technology; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) the Contracts set forth on <U>Schedule</U><U></U><U>&nbsp;2.2(a)(vi)</U> (the &#147;<B>Transferred Contracts</B>&#148;); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) all claims, counterclaims, defenses, causes of action, rights under express or implied warranties, rights of recovery, rights of <FONT
STYLE="white-space:nowrap">set-off,</FONT> rights of subrogation and all other rights of any kind against any Third Party to the extent relating to the Assumed Liabilities or Transferred Assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, the Transferred Assets do not include any other assets any kind, nature, character or description (whether
real, personal or mixed, whether tangible or intangible, whether absolute, accrued, contingent, fixed or otherwise, and wherever situated) that are not expressly included within the definition of Transferred Assets (the &#147;<B>Excluded
Assets</B>&#148;), including without limitation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any Contracts of Auspex or rights therein or thereunder, other than the Transferred
Contracts; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any licenses, permits, registrations, certificates or other authorizations, consents, clearances or approvals of Auspex
and its Affiliates, other than as set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;(A) the corporate books and records
of Auspex and its Affiliates to the extent not related to the Products, the Transferred Assets or any Assumed Liabilities, (B)&nbsp;all personnel records, (C)&nbsp;any attorney work product, attorney client communications and other items protected
by attorney client or similar privilege to the extent relating to the Transactions, (D)&nbsp;Tax Returns, Tax information, and Tax records related to Auspex or its Affiliates, (E)&nbsp;any documents that were received from Third Parties in
connection with their proposed acquisition of the Transferred Assets or the Compound or Products or that were prepared by Auspex or any of its Affiliates in connection therewith and (F)&nbsp;any market research data compiled by or on behalf of
Auspex, clinical timelines and budgets, commercial forecasts, target product profiles (to the extent not included in the IND, Regulatory Applications or other Regulatory Documentation), in each case regardless of whether or not related to the
Compound or the Product; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) any current and prior insurance policies of Auspex and its Affiliates and all rights of any nature with
respect thereto, including all insurance recoveries thereunder and rights to assert claims with respect to any such insurance recoveries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) any intellectual property rights of Auspex or its Affiliates, other than (x)&nbsp;the Transferred IP Rights and (y)&nbsp;any intellectual
property rights included in the Auspex Technology; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) any rights, claims and credits of Auspex or any of its Affiliates relating to any
Excluded Asset or any Excluded Liability; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) any rights that could be construed to interfere with, hinder or compromise Auspex&#146;s
ability to institute or maintain any claim, action, suit or proceeding against a third party for infringement of patents owned or licensed by Auspex or its Affiliates (other than the Patents); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) any other assets, properties or rights of Auspex or any of its Affiliates other than
the Transferred Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, the Parties acknowledge and agree that the [***] Agreement dated as of [***] (the
&#147;<B>[***] Agreement</B>&#148;) between Auspex Pharmaceuticals, Inc. and [***] is an Excluded Asset and is not being transferred or assigned to Purchaser by Auspex or any Affiliate of Auspex that is party thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Purchaser acknowledges and agrees that Auspex may retain for archival purposes and for purposes of complying with Applicable Laws and for
legal and regulatory purposes as a manufacturer of the Compound or Products, copies of all or any part of the documentation that Auspex delivers to Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;2.2(a)</U>. Auspex agrees to treat such copies as
Purchaser&#146;s Confidential Information in accordance with <U>Article VII</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Parties acknowledge that Auspex or its Affiliates
own or control the Licensed Patent and may own or control Confidential Information, trade secrets, processes, <FONT STYLE="white-space:nowrap">know-how,</FONT> technology, data and other intellectual property rights and information (whether or not
confidential) that is used in connection with both the Compound and the Products and the business of Auspex or its Affiliates with respect to compounds or products other than the Compound or the Products, and that is not included in the Transferred
Assets (all of the foregoing, including the Licensed Patent, collectively, &#147;<B>Shared Assets</B>&#148;). Nothing in this Agreement shall be deemed to create or effect a transfer of any right, title or interest in any Shared Asset, except that
Auspex hereby grants, and shall cause its Affiliates to grant, Purchaser a <FONT STYLE="white-space:nowrap">paid-up,</FONT> <FONT STYLE="white-space:nowrap">non-exclusive</FONT> (or, in the case of the Licensed Patent Rights, exclusive), perpetual,
irrevocable and assignable license, with the right to grant sublicenses, to practice, use and exploit the Shared Assets solely to the extent necessary to develop, make, have made, distribute, sell, offer for sale and use the Compound and/or the
Products. Promptly after the discovery of any Shared Assets, Auspex will provide Purchaser written notice identifying such Shared Asset(s). To the extent Auspex desires to extend the Licensed Patent Rights beyond the Licensed Patent to include
foreign equivalent patents and patent applications to the Licensed Patent published, pending or allowed by the respective patent authorities identified on <U>Schedule 2.2(d)</U>, Puretech shall have [***] following the Closing within which to notify
Auspex in writing that it desires to have the Licensed Patent Rights extended to any such patents or patent applications. Within [***] of receipt by Auspex of Puretech&#146;s timely written notice, Auspex shall cause to be filed, at Puretech&#146;s
expense, divisional applications with respect to such patents and patent applications to create foreign equivalent patents or patent applications to the Licensed Patent, and such divisionals shall be included in the Licensed Patent Rights. Purchaser
has the right, but not the obligation, at its sole expense, to prosecute, maintain and enforce the Licensed Patent Rights. Teva hereby covenants to refrain from filing any further claims covering the Compound with respect to the patent family
including [***] or any other patent application claiming priority anywhere in the world. Auspex and Purchaser will discuss in good faith general patent strategy, and in furtherance of that obligation, Puretech will provide copies of any submissions
planned to be filed with patent authorities to Auspex sufficiently in advance to provide Auspex with reasonable time to review and provide feedback to Puretech, which feedback Puretech take under consideration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) (i) Notwithstanding anything to the contrary in this Agreement, this Agreement shall not
constitute an agreement to assign or transfer any such Transferred Contract that is not assignable or transferable without the consent of any Person, other than Auspex, Purchaser or any of their respective Affiliates, to the extent that such consent
shall not have been given, or required hereunder, prior to the Closing (each, a &#147;<B>Nonassigned</B><B> Contract</B>&#148;); <U>provided</U>, <U>however</U>, that Auspex shall use, both prior to and for [***] after the Closing, commercially
reasonable efforts to obtain, and Purchaser shall use its commercially reasonable efforts to assist and cooperate with Auspex in connection therewith, all necessary consents to the assignment and transfer of each Nonassigned Contract;
<U>provided</U>, <U>further</U>, that none of Auspex, Purchaser or any of their respective Affiliates shall be required to commence any litigation or offer or grant any accommodation (financial or otherwise) to any third party in connection with
such efforts. With respect to any Nonassigned Contract, for a period beginning on the Closing Date and ending on the earlier of (i)&nbsp;the time such requisite consent is obtained and such Nonassigned Contract is transferred and assigned to
Purchaser and (ii)&nbsp;the date that is [***] after the Closing Date, Auspex shall use commercially reasonable efforts to provide to Purchaser substantially comparable benefits thereof and shall enforce, at the request of and for the benefit of
Purchaser, and at the expense of Auspex, any rights of Auspex arising thereunder against any Person, including the right to seek any available remedies or to elect to terminate in accordance with the terms thereof upon the advice of Purchaser. As a
condition to Auspex providing Purchaser with benefits of any Nonassigned Contract, Purchaser shall perform, at the direction of Auspex, the obligations of Auspex thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Auspex provides no assurances to Purchaser that any consent, authorization, approval or waiver of a Third Party contemplated by this
<U>Section</U><U></U><U>&nbsp;2.2(e)</U> will be granted. Subject to compliance by Auspex with the provisions of this <U>Section</U><U></U><U>&nbsp;2.2(e)</U>, the Parties acknowledge and agree that neither Auspex nor its Affiliates shall be
obligated to obtain any such authorization, approval, consent or waiver hereunder and neither (i)&nbsp;the failure to so actually obtain any such authorization, approval, consent or waiver in connection with the consummation of the Transactions in
and of itself nor (ii)&nbsp;any default or termination or any lawsuit, action, claim, proceeding or investigation commenced or threatened by or on behalf of any Person to the extent arising out of any such failure to so actually obtain any such
authorization, approval, consent or waiver in connection with the consummation of the Transactions in and of itself shall be deemed a breach of any representation, warranty or covenant of Auspex contained in this Agreement to cause any condition to
Purchaser&#146;s obligations to close the Transactions to be deemed not satisfied. Under no circumstances shall the Purchase Price be reduced or Auspex or its Affiliates be subject to any liability on account of the failure to obtain any such
authorization, approval, consent or waiver. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3. <U>Assumption of Certain Liabilities and Obligations</U>. Purchaser assumes
responsibility for and will pay, perform and/or otherwise discharge when due those Liabilities (including any Liabilities arising in respect of Taxes) arising out of or in connection with or related to the Transferred Assets from and after the
Closing Date as set forth in <U>Schedule 2.3</U> (collectively, the &#147;<B>Assumed Liabilities</B>&#148;), including all liabilities and expenses arising from the assignment of the Transferred IP Rights hereunder, and following the Closing Date,
the ownership and use of the Transferred IP Rights and the filing, prosecution, maintenance and enforcement of the Licensed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Patent Rights. For the avoidance of doubt, the Parties hereby acknowledge and agree that any and all current and future Liabilities of Auspex or any of its Affiliates under the [***] Agreement
will be Excluded Liabilities, including that Auspex and its Affiliates shall retain the obligation to pay to [***] as provided in [***] of the [***] Agreement with respect to which Auspex shall retain and may apply against such payment obligation
[***]. The Periodic Reports furnished to Auspex by Purchaser with respect to sales of Product pursuant to <U>Section</U><U></U><U>&nbsp;2.6(e)</U> shall be in form and substance sufficient to enable Auspex [***] under the [***] Agreement in a timely
manner. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4. <U>Purchase Price for Transferred Assets</U>. On the terms and subject to the conditions set forth herein, in consideration
for the sale and transfer of the Transferred Assets to Purchaser, in addition to the assumption of the Assumed Liabilities, Purchaser shall pay to an account designated by Auspex, (i)&nbsp;on the Closing Date, an aggregate <FONT
STYLE="white-space:nowrap">one-time,</FONT> <FONT STYLE="white-space:nowrap">non-refundable</FONT> payment in the amount of [***] (the &#147;<B>Upfront Payment</B>&#148;), (ii) the Milestone Payments as and when due and payable pursuant to
<U>Section</U><U></U><U>&nbsp;2.5</U>; and (iii)&nbsp;the Royalties as and when due and payable pursuant to <U>Section</U><U></U><U>&nbsp;2.6</U> (collectively, the &#147;<B>Purchase Price</B>&#148;), in each case by wire transfer of immediately
available funds into an account designated by Auspex in writing, which designation shall be made for the Upfront Payment not less than [***] prior to the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5. <U>Milestones</U>. As a part of the consideration for Auspex&#146;s sale of the Transferred Assets to Purchaser hereunder, Purchaser shall
pay to Auspex the following <FONT STYLE="white-space:nowrap">one-time</FONT> milestone payments (the &#147;<B>Milestone Payments</B>&#148;) upon the first achievement of each of the events set forth on the table below (the &#147;<B>Milestone
Events</B>&#148;) by the Product. Purchaser shall pay the relevant Milestone Payment within [***] of such achievement by Purchaser, its Affiliates or licensees. Such payments shall be <FONT STYLE="white-space:nowrap">non-refundable</FONT> and <FONT
STYLE="white-space:nowrap">non-creditable.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Milestone&nbsp;Payment</B><br><B>(in US Dollars)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6. <U>Royalties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As a part of the consideration for Auspex&#146;s sale of Transferred Assets to Purchaser hereunder, Purchaser shall pay to Auspex royalties
(&#147;<B>Royalties</B>&#148;) at the graduated royalty rates specified in the table below with respect to the aggregate annual worldwide Net Sales of all Products by Purchaser and its Affiliates and licensees in the Territory in a Calendar Year
during the Royalty Term: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Royalties</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Royalty&nbsp;Rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of Calendar Year Net Sales less than or equal to $[***]:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]%&nbsp;of&nbsp;Net&nbsp;Sales</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of Calendar Year Net Sales &gt; $[***] and <U>&lt;</U> $[***]:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]%&nbsp;of&nbsp;Net&nbsp;Sales</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of Calendar Year Net Sales &gt; $[***]:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]%&nbsp;of&nbsp;Net&nbsp;Sales</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Upon sale by a Third Party of a Generic Product in a country, the Royalty due to Auspex will be reduced by
[***] for sales of Product made in that country, for as long as the Generic Product is sold in such country. If for any reason the sale of Generic Product in the country ceases, Purchaser shall resume paying Auspex the full Royalty without the
offset set forth herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If it is necessary for Purchaser to obtain a license under intellectual property rights of a Third Party in a
particular country in order to research, develop, manufacture, have manufactured, market, make use, offer for sale, sell, export and import for sale, or otherwise commercialize the Product in that country respecting which a Royalty is payable to
Auspex hereunder, then, in that event, the Royalty payments payable to Auspex under this <U>Section</U><U></U><U>&nbsp;2.6</U> respecting the sale of the Product in such country to which the Third Party intellectual property rights apply shall be
reduced by an amount equal to [***] of any royalties paid to such Third Party in consideration for such rights relating to such Product. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In no event shall the cumulative reductions under <U>Sections 2.6(b)</U> and <U>2.6(c)</U> reduce the royalties otherwise due to Auspex by
more than [***] in any Calendar Year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) No later than [***] of the Calendar Quarter in which Purchaser plans to conduct the
First Commercial Sale of a Product in any country in the Territory, Purchaser shall deliver to Auspex, for the purposes of informing Auspex&#146; financial planning, a <FONT STYLE="white-space:nowrap">non-binding,</FONT> good-faith rolling sales
forecast of the Product for the next [***] (the &#147;<B>Sales Projections</B>&#148;). With respect to the Sales Projections, Purchaser shall have the right to provide <FONT STYLE="white-space:nowrap">pan-European</FONT> Union sales forecasts rather
than <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> forecasts. Within [***] after the end of each Calendar Quarter commencing from the First Commercial Sale of a Product, Purchaser shall furnish
Auspex with a quarterly report (&#147;<B>Periodic Report</B>&#148;) detailing, at a minimum, the following information for the applicable Calendar Quarter, each listed by Product and by country of sale: (i)&nbsp;gross amounts invoiced for all sales
of Products for which Royalties are owed Auspex hereunder for such Calendar Quarter, (ii)&nbsp;deductions by type taken from Net Sales as specified in <U>Section</U><U></U><U>&nbsp;1.1</U>, (iii) Net Sales, (iv)&nbsp;Royalties and Milestone Payments
owed to Auspex, listed by category, (v)&nbsp;the currency in which the sales were made, including the computations for any applicable currency conversions pursuant to <U>Section</U><U></U><U>&nbsp;2.6(g)</U>, (vi) all other data enabling the
Royalties payable to be calculated accurately, and (vii)&nbsp;a detailed summary of progress against each development and commercial Milestone, an estimate of the timing of the achievement of the next development and commercial Milestone and
applicable Sales Projections on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis. Once the First Commercial Sale of a Product has occurred, Periodic Reports shall be provided to Auspex
whether or not Royalties or Milestone Payments are payable for a particular Calendar Quarter. In addition to the foregoing, upon Auspex&#146;s reasonable request, Purchaser shall provide to Auspex such other information as may be reasonably
requested by Auspex, and shall otherwise cooperate with Auspex as reasonably necessary, to enable Auspex to verify Purchaser&#146;s compliance with the payment and related obligations under this Agreement, including verification of the calculation
of amounts due to Auspex under this Agreement and of all financial information provided or required to be provided in the reports. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) On
the date prescribed for the submission of each Periodic Report, Purchaser shall pay the Royalties due to Auspex for the reported period. All payments under this Agreement shall be computed and paid in United States Dollars. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) With respect to Net Sales invoiced in United States Dollars, the Net Sales and the amounts due to Auspex hereunder shall be expressed in
United States Dollars. With respect to Net Sales invoiced in a currency other than United States Dollars, the Net Sales shall be expressed in the domestic currency of the entity making the sale, together with the United States Dollars equivalent,
calculated based on the average conversion rate existing in the United States (as reported in The Wall Street Journal) for the Calendar Quarter for which remittance is made for Royalties. For purposes of calculating the Net Sales thresholds set
forth in <U>Section</U><U></U><U>&nbsp;2.6</U>, the aggregate Net Sales with respect to each Calendar Quarter within a Calendar Year shall be calculated based on the currency exchange rates for the Calendar Quarter in which such Net Sales occurred,
in a manner consistent with the exchange rate procedures set forth in the immediately preceding sentence. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7. <U>VAT; Withholding and
Similar Taxes</U>. All amounts to be paid to Auspex pursuant to this Agreement are exclusive of any applicable taxes, including value added tax. Purchaser shall add taxes if and as required by law, to all such amounts. If applicable Laws require
that taxes be withheld from any amounts due to Auspex under this Agreement, Purchaser shall gross up its payments to Auspex by any such amount. Auspex shall cooperate with Purchaser in claiming exemptions from such deductions or a reduced
withholding tax rate as allowable under any agreement or treaty from time to time in effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8. <U>Records</U>. Purchaser shall keep, and shall require its Affiliates and licensees to
keep, books of account that are complete and correct in all material respects and in accordance with GAAP enabling the Royalties and Milestone Payments, and all corresponding deductions, to be calculated accurately. Purchaser shall, and shall
require and cause its Affiliates and licensees to, retain the such books of account for [***] after the end of each Calendar Year during the Royalty Term and, if this Agreement is terminated for any reason whatsoever, for [***] after the end of the
calendar year in which such termination becomes effective, and shall be kept at each of their principal place of business and shall be open for inspection and audit in accordance with <U>Section</U><U></U><U>&nbsp;2.9</U> below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9. <U>Audit</U>. Auspex shall be entitled to appoint, at its sole expense, a certified public accountant or other professional as appropriate
and reasonably acceptable to Purchaser (the &#147;<B>CPA Representatives</B>&#148;) to inspect, not more than once a Calendar Year, during normal business hours Purchaser&#146;s and its Affiliates&#146; books and records contemplated by
<U>Section</U><U></U><U>&nbsp;2.8</U> above, including all books of account, records and other relevant documentation to the extent relevant or necessary for the sole purpose of verifying compliance with the payment and related obligations under
this Agreement, the calculation of amounts due to Auspex under this Agreement and of all financial information required to be provided in the Periodic Reports, provided that Auspex shall coordinate such inspection with Purchaser or its Affiliate (as
the case may be) reasonably in advance. In addition, Auspex may require that Purchaser, through the CPA Representatives, inspect, at Auspex&#146;s expense, during normal business hours the books and records contemplated by
<U>Section</U><U></U><U>&nbsp;2.8</U> above, including all applicable books of account, records and other relevant documentation of any licensees, not more than once a Calendar Year, to the extent relevant or necessary for the sole purpose of
verifying the compliance with the payment obligations under this Agreement, the calculation of amounts due to Auspex under this Agreement and of all financial information provided in the Periodic Reports, and Purchaser shall use its commercially
reasonable efforts to cause such inspection to be performed. Prior to making any inspection or audit pursuant to this <U>Section</U><U></U><U>&nbsp;2.9</U>, the CPA Representatives shall sign a confidential agreement in form and substance reasonably
acceptable to Purchaser. The Parties shall reconcile any underpayment or overpayment within [***] after the CPA Representatives deliver the results of the audit to Auspex and Purchaser. The results of such inspection, if any, shall be binding on
both Parties. Any underpayment shall be subject to interest in accordance with the terms of <U>Section</U><U></U><U>&nbsp;2.11</U>, below. Any overpayments shall be fully creditable against amounts payable in subsequent payment periods during the
Royalty Term, or if such overpayments are identified following the Royalty Term, then such overpayments shall be refunded within [***] of receipt of the corresponding audit results. In the event that any inspection of Purchaser aforesaid reveals any
underpayment by Purchaser to Auspex in respect of any Calendar Quarter of this Agreement in an amount exceeding [***] of the amount actually paid by Purchaser to Auspex in respect of such Calendar Quarter, then Purchaser shall pay the reasonable <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> cost of such inspection. Any underpayments or overpayments under this <U>Section</U><U></U><U>&nbsp;2.9</U> shall be subject to the currency exchange provisions
set forth in <U>Section</U><U></U><U>&nbsp;2.6(g)</U> as applied to the Calendar Quarter during which the payment obligations giving rise to such underpayment or overpayment were incurred by Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10. <U>Blocked Payments</U>. In the event that, by reason of Applicable Law in any
country, it becomes impossible or illegal for Purchaser to transfer, or have transferred on its behalf, payments owed Auspex hereunder, Purchaser shall promptly notify Auspex of the conditions preventing such transfer and such payments shall be
deposited in local currency in the relevant country to the credit of Auspex in a recognized banking institution designated by Auspex or, if none is designated by Auspex within a period of [***], in a recognized banking institution selected by
Purchaser, as the case may be, and identified in a written notice given to Auspex. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11. <U>Interest Due</U>. Any sum of money due to
Auspex which is not duly paid on time shall bear interest from the due date of payment until the actual date of payment at the rate of [***], or the maximum applicable legal rate, if less, computed for the actual number of days the payment was past
due. If the LIBOR rate is no longer published, the Parties will agree upon another internationally recognized rate which has historically been substantially equivalent to the one (1)&nbsp;month LIBOR rate and utilize such rate retroactively to such
time as the rate was no longer available. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.12. <U>Diligence</U>. Purchaser shall use Commercially Reasonable Efforts, at Purchaser&#146;s
sole expense and in its sole discretion, to develop, obtain regulatory approval for, and commercialize the Product in at least one of (i)&nbsp;the U.S., (ii) one or more countries of the EU or (iii)&nbsp;Japan. Purchaser shall deliver to Auspex no
later than the end of the first calendar quarter of each calendar year until FDA approval for the first Product a summary of its development efforts for the prior twelve (12)&nbsp;months (each such report, an &#147;<B>Annual Report</B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.13. <U>Certain Costs</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
All costs and fees associated with transferring to Purchaser or one of its Affiliates the Transferred IP Rights conveyed to Purchaser hereunder shall be borne by Purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All costs and expenses associated with removing and moving any Transferred Asset to a location designated by Purchaser shall be borne and
paid solely by Purchaser when due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CLOSING </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.
<U>Closing</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Closing shall take place simultaneously with the execution of this Agreement (the &#147;<B>Closing Date</B>&#148;)
at the offices of Sills Cummis&nbsp;&amp; Gross P.C., One Riverfront Plaza, Newark, New Jersey 07102 (including any Persons connected by remote access to the Closing). The Closing shall be deemed to occur and be effective as of 12:01 am on the
Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At the Closing, Auspex shall deliver, or cause to be delivered, to Purchaser (and/or its Affiliates in the case of
<U>Section</U><U></U><U>&nbsp;3.1(b</U><U>)(</U><U>ii)</U>) the instruments and documents set forth below: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) executed Ancillary Agreements, each dated as of the Closing Date, with the Neuland
Assignment Agreement countersigned by Neuland Laboratories Limited; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Transferred Assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At the Closing, Purchaser shall deliver to Auspex (i)&nbsp;the Upfront Payment, by wire transfer in accordance with
<U>Section</U><U></U><U>&nbsp;2.4</U> and (ii)&nbsp;the instruments and documents set forth below: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) executed Ancillary Agreements,
each dated as of the Closing Date. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1. <U>Representations and Warranties of </U><U>Auspex</U>. Auspex hereby represents, warrants and covenants to Purchaser as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Organization</U>. Auspex is a corporation duly organized, validly existing and in good standing under the laws of the State of
Delaware. Auspex is authorized to do business under the laws of all jurisdictions in it is required to be so authorized, except as would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Corporate Authority</U>. Auspex has the corporate authority to enter into this Agreement and to perform its obligations hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>No Conflict</U>. Except as set forth on <U>Schedule</U><U></U><U>&nbsp;4.1(c)</U>, neither the execution and delivery of this Agreement
or the Ancillary Agreements by Auspex , nor the performance by Auspex hereunder and/or thereunder will (i)&nbsp;conflict with or result in any violation or breach of, or constitute (with or without due notice or lapse of time or both) a default
under any of the terms or conditions of its certificate or articles of incorporation or bylaws, or any note, bond, mortgage, indenture, license, Contract or other instrument or obligation to which it or any of its Affiliates is a Party or by which
it or any of its Affiliates or any of their respective properties or assets may be bound, (ii)&nbsp;violate any statute, law, rule, regulation, writ, injunction, judgment, order or decree of any court, administrative agency or Governmental Authority
binding on it or any of its Affiliates or any of their respective properties or assets, or (iii)&nbsp;result in the imposition or creation of any Encumbrance other than a Permitted Encumbrance upon any Transferred Asset. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Governmental Authorization</U>. Except as set forth on <U>Schedule</U><U></U><U>&nbsp;4.1(d)</U>, the execution and delivery of this
Agreement and the other Transaction Documents by Auspex, and the consummation of the Transactions by Auspex, do not require any consent or approval of, or any notice to or other filing with, any Governmental Authority, except for consents,
approvals, notices and filings the failure of which to obtain would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Legal and Binding Nature</U>. This Agreement is, and each Ancillary Agreement signed at Closing will be, a legal, valid and binding
agreement of Auspex enforceable in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar laws and equitable principles related to or limiting creditors&#146; rights generally and
by general principles of equity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Title to Transferred Assets</U>. Auspex has good and valid title to all of the
Transferred Assets free and clear of all Encumbrances, other than Permitted Encumbrances. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Litigation, etc.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except as set forth on <U>Schedule</U><U></U><U>&nbsp;4.1(g)</U>, as of the date hereof, there is no material litigation pending or, to
Auspex&#146;s knowledge, threatened against Auspex before any Governmental Authority, and to Auspex&#146;s knowledge, there are no material investigations, inquiries, audits, examinations or findings of deficiency or noncompliance pending or
threatened by or before any Governmental Authority, in each case, that (A)&nbsp;involves or otherwise relates to the Compound or the Product, including the development, packaging, labeling, storage, import, export, use, marketing, distribution and
sale of the Product in the Territory and the manufacture of the Compound or the Products (the &#147;<B>Product Business</B>&#148;) or the Transferred Assets; or (B)&nbsp;challenges or, if resolved against Auspex or any of its Affiliates, would
prevent, delay or make illegal the transactions contemplated by this Agreement. There is no order or judgment of a Governmental Authority to which Auspex or any of its Affiliates is subject that involves or otherwise relates to the Product Business
or the Transferred Assets or that prevents, delays or makes illegal the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Neither Auspex
nor any of its Affiliates has, in the [***] prior to the date hereof, received any written notice, claim or complaint from any other Person alleging a violation of, or failure to comply with, or any Liability under, any Applicable Laws relating to
the Product Business or the Transferred Assets as a result of Auspex&#146;s or any of its Affiliates&#146; operation of the Product Business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Debarred Entities</U>. Auspex has not used, and is not currently using, in any capacity, in connection with the performance of
Auspex&#146;s duties or obligations hereunder, the services of any Person that has been debarred or subject to debarment under 21 U.S.C. &#167;&nbsp;335(a) or (b)&nbsp;or otherwise disqualified or suspended from performing services or subject to any
restrictions or sanctions by the FDA (a &#147;<B>Debarred Entity</B>&#148;). Auspex further represents that neither Auspex nor any of its officers, employees or Affiliates providing services in connection with the performance of Auspex&#146;s
obligations hereunder have been (i)&nbsp;threatened to be debarred, or (ii)&nbsp;convicted of a crime for which a Person can be debarred under 21 U.S.C. &#167;&nbsp;335(a) or (b). Auspex shall immediately notify Purchaser in writing if either Auspex
or any Person who is performing services on its behalf hereunder is or becomes a Debarred Entity or if any action, claim, investigation, or other legal or administrative proceeding is pending or, to the best of Auspex&#146;s knowledge, threatened,
that would make Auspex or any Person performing services hereunder a Debarred Entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Conduct of the Product Business</U>. During
the prior [***], the Product Business has been (i)&nbsp;exclusively managed by Auspex or its Affiliates; and (ii)&nbsp;under Auspex&#146;s or its Affiliates&#146; exclusive control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Status of Transferred Assets</U>. The Transferred Assets and the Shared Assets are
all of the legal rights and assets owned or controlled by Auspex as of the Effective Date which relate to the development, manufacture and use of the Compound and the development, manufacture, use, marketing, distribution and sale of the Products in
the Territory. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Contracts</U>. Auspex has made available to Purchaser true and complete copies of all Material Contracts. Except as
disclosed in <U>Schedule</U><U></U><U>&nbsp;4.1(k)</U>, (a)&nbsp;each Material Contract is valid and binding in all material respects on and, to Auspex&#146;s knowledge, the other party thereto, and is in full force and effect in accordance with its
terms, subject to bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or similar laws affecting creditors&#146; rights generally or by general principles of equity (regardless of whether enforcement is sought in a proceeding in
equity or law), and (b)&nbsp;neither Auspex nor, to Auspex&#146;s knowledge, any other party thereto is in material breach of, or material default under, any Material Contract, and no event has occurred that, with the giving of notice or lapse of
time or both, would constitute a material breach or material default thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Compliance with Law</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Auspex and its Affiliates, with respect to the operation of the Product Business or the ownership of and use of the Transferred Assets,
are in compliance in all material respects with all Applicable Laws in each country in the Territory in which such activities are being conducted, including (i)&nbsp;any Applicable Laws governing the research, development, approval, manufacture,
pricing, pharmacovigilance, recordkeeping or Marketing of drugs and the purchase or prescription of or reimbursement for drugs by any Governmental Authority, private health plan or entity, or individual; and (ii)&nbsp;all Applicable Laws regulating
the pharmaceutical industry, including the federal Anti Kickback Statute (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(b)),</FONT> the criminal False Claims Act (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(a)),</FONT>
the civil False Claims Act (31 U.S.C. &#167;&#167; 3729 <I>et seq</I>.), the Civil Monetary Penalties Law (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7a),</FONT> the federal Physician Payment Sunshine Act (42 U.S.C.&#167; <FONT
STYLE="white-space:nowrap">1320a-7h)</FONT> and similar state laws, the federal health care program exclusion laws (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7),</FONT> the Controlled Substances Act (21 U.S.C. &#167; 801 <I>et
seq</I>.), the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. &#167; 1320d <I>et seq</I>.) as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. &#167;&#167; 17921 <I>et seq</I>.),
the Foreign Corrupt Practices Act (15 U.S.C. &#167;&#167; <FONT STYLE="white-space:nowrap">78dd-1</FONT> <I>et seq</I>.), and the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of
2010, in each case except for such noncompliance that would not reasonably be expected to have a material adverse effect on the Product Business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Auspex and its Affiliates possess, and are in compliance in all material respects with, all material approvals, licenses and other
authorizations from applicable Governmental Authorities (other than Product Approvals, which are the subject of <U>Section</U><U></U><U>&nbsp;4.1(l)(i)</U>) necessary for the conduct of the Product Business as it is currently conducted and the
ownership of or use of the Transferred Assets. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Neither Auspex nor any of its Affiliates have made any voluntary or involuntary
self-disclosure to any Governmental Authority or representative thereof regarding any material <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any Applicable Law applicable to the Compound, the Products or the Transferred Assets, which <FONT
STYLE="white-space:nowrap">non-compliance</FONT> remains uncured. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Regulatory Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) All INDs and other Regulatory Applications relating to the Compound and/or the Products are listed on <U>Schedule B</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) During the past [***], neither Auspex nor any of its Affiliates has received any written notice that the FDA or any other Governmental
Authority or Regulatory Authority has commenced, or threatened to initiate, any action to enjoin production at any facility at which the Compound or any Product is manufactured. During the past [***], Auspex and its Affiliates have not failed to pay
any Regulatory Fees or timely file with the applicable Governmental Authority or Regulatory Authority any required filings, declarations, listings, registrations, reports or submissions that are material to the development and manufacture of the
Compound and/or the Products as currently conducted in each country in the Territory, including adverse event reports. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Intellectual
Property</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Auspex has the right to transfer the Transferred IP Rights and to license to Purchaser the Licensed Patent Rights and
the intellectual property rights included in the Shared Assets. None of the Transferred IP Rights, Licensed Patent Rights or intellectual property rights included in the Shared Assets is in the possession, custody, or control of any Third Party.
Other than the Transferred IP Rights, the Licensed Patent Rights and the intellectual property rights included in the Shared Assets, neither Auspex nor any of its Affiliates has any material intellectual property rights necessary to market,
distribute and sell the Products in the Territory or to manufacture, make or have made the Compound or the Products in the Territory. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) To Auspex&#146;s knowledge,&nbsp;no Third Party has interfered with, infringed upon, misappropriated, or otherwise come into conflict
with any of the Transferred IP Rights or the Licensed Patent Rights in any material respect. Neither Auspex nor any of its Affiliates has received any charge, complaint, claim, demand, or notice alleging any such material interference, infringement,
misappropriation, or violation in the Territory (including any claim that Auspex or any of its Affiliates must license any intellectual property rights of any Third Party or refrain from using Transferred IP Rights or the Products). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Neither Auspex nor any of its Affiliates owns, holds or controls any trademarks, copy-rights or domain names which relate to or cover
the Compound or any Product. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <U>Taxes</U>. Neither Auspex nor any of its Affiliates has any Liability for Taxes for which Purchaser
would reasonably be expected to become liable or that would reasonably be expected to adversely affect (i)&nbsp;the Transferred Assets; and (ii)&nbsp;Purchaser&#146;s right to use or enjoy (free and clear of any Encumbrances, including liens for
Taxes) any Transferred Asset, the Compound or any Product. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) <U>No Brokers</U>. Neither Auspex nor any of its Affiliates has any
liability or obligation to pay any fees or commissions to any broker, finder or other agent with respect to this Agreement for which Purchaser could become liable or obligated or which could result in an Encumbrance being filed against any
Transferred Asset. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) <U>No Additional Representations</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except for the representations and warranties expressly set forth in this Agreement or any certificate or instrument delivered hereunder,
Auspex and each of its Affiliates expressly disclaim any representations or warranties of any kind or nature, express or implied, including any representations or warranties as to Auspex or its Affiliates, as applicable, their respective businesses
and affairs or the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Without limiting the generality of the foregoing, and except as
expressly set forth in this <U>Section</U><U></U><U>&nbsp;4.1</U>, neither Auspex, nor its Affiliates, nor any of their employees, officers, directors or equityholders, has made, and shall not be deemed to have made, any representations or
warranties in the materials relating to the business and affairs of Auspex or its Affiliates, as applicable, that have been made available to Purchaser, including due diligence materials, or in any presentation of the business and affairs of Auspex
or its Affiliates, as applicable, by the management of Auspex or its Affiliates, as applicable, or others in connection with the transactions contemplated hereby, and no statement contained in any of such materials or made in any such presentation
shall be deemed a representation or warranty hereunder or otherwise or deemed to be relied upon by Purchaser in executing, delivering and performing this Agreement and the transactions contemplated hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2. <U>Representations and Warranties of Purchaser</U>. Purchaser hereby represents, warrants and covenants to Auspex as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Organization</U>. Purchaser is a limited liability company duly organized, validly existing and, if applicable, in good standing under
the laws of the State of Delaware. Purchaser is authorized to do business under the laws of all jurisdictions in which it is required to be so authorized, except as would not, individually or in the aggregate, have a material and adverse effect on
the ability of Purchaser to consummate the Transactions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Limited Liability Company Authority</U>. Purchaser has the limited
liability company authority to enter into this Agreement and to perform its obligations hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No Conflict</U>. Neither the
execution and delivery of this Agreement by Purchaser nor its performance hereunder will (i)&nbsp;conflict with or result in any violation or breach of, or constitute (with or without due notice or lapse of time or both) a default under any of the
terms or conditions of its certificate of incorporation or bylaws, or under any note, bond, mortgage, indenture, license, agreement or other instrument or obligation to which it is a Party or by which it or any of its properties or assets may be
bound, or (ii)&nbsp;violate any statute, law, rule, regulation, writ, injunction, judgment, order or decree of any court, administrative agency or Governmental Authority binding on it or any of its properties or assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Governmental Authorization</U>. Except as set forth on <U>Schedule</U><U></U><U>&nbsp;4.2(d)</U>, the execution and delivery of this
Agreement and the other Transaction Documents by Purchaser, and the consummation of the Transactions by Purchaser, do not require any consent or approval of, or any notice to or other filing with, any Governmental Authority, except for consents,
approvals, notices and filings the failure of which to obtain would not, individually or in the aggregate, have a material and adverse effect on the ability of Purchaser to consummate the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Legal and Binding Nature</U>. This Agreement is a legal, valid and binding agreement
of Purchaser, enforceable in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar laws and equitable principles related to or limiting creditors&#146; rights generally and by
general principles of equity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Litigation</U>. There is no suit, claim, action, investigation or proceeding pending or, to the
knowledge of Purchaser, threatened against Purchaser or any of its Affiliates which if adversely determined would materially interfere with the ability of Purchaser to perform its obligations hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Debarred Entities</U>. Purchaser has not, is not currently and will not in the future use, in any capacity, in connection with the
performance of its duties or obligations hereunder, the services of any Debarred Entity. Purchaser further represents that neither Purchaser nor any of its officers, employees or Affiliates have been (i)&nbsp;threatened to be debarred, or
(ii)&nbsp;convicted of a crime for which a person can be debarred under 21 U.S.C. &#167; 335(a) or (b). Purchaser shall immediately notify Auspex in writing if either Purchaser or any Person who is performing services on its behalf hereunder is or
becomes a Debarred Entity or if any action, claim, investigation, or other legal or administrative proceeding is pending or, to the best of Purchaser&#146;s knowledge, threatened, that would make Purchaser or any Person performing services hereunder
a Debarred Entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>No Brokers</U>. Neither Purchaser nor any of its Affiliates has any liability or obligation to pay any fees or
commissions to any broker, finder or other agent with respect to this Agreement for which Auspex could become liable or obligated or which could result in an Encumbrance being filed against any Transferred Asset. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Inspection; No Other Representations</U>. Purchaser has undertaken such investigation and has been provided with and has evaluated such
documents and information as it has deemed necessary to enable it to make an informed and intelligent decision with respect to the execution, delivery and performance of this Agreement and the transactions contemplated hereby. Purchaser acknowledges
and agrees that it is relying exclusively on the representations set forth in <U>Section</U><U></U><U>&nbsp;4.1</U> and its own examination and investigation of the Compound and the Products and that it is not relying on any other statements or
documents. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ADDITIONAL AGREEMENTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1. <U>Condition of the Transferred Assets.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the Closing, Purchaser and its Representatives will have made all inspections and investigations relating to the Compound, the
Products and the Transferred Assets deemed necessary or desirable by Purchaser. Except as specifically set forth in this Agreement, Purchaser acknowledges and agrees that (a)&nbsp;it is purchasing the Transferred Assets based on the results of such
inspections and investigations, and not on any representation or warranty of Auspex or any of its Affiliates not expressly set forth in this Agreement or the Ancillary Agreements and (b)&nbsp;the Transferred Assets are sold &#147;as is, where
is&#148; and Purchaser accepts the Transferred Assets </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in the condition that they are in and at the place where they are located on the Closing Date. In light of such inspections and investigations, and the representations and warranties expressly
made to Purchaser by Auspex in this Agreement and the certificates and other documents delivered pursuant hereto, PURCHASER AGREES THAT THE REPRESENTATIONS AND WARRANTIES GIVEN HEREIN BY AUSPEX ARE IN LIEU OF, AND PURCHASER HEREBY EXPRESSLY WAIVES
ALL RIGHTS TO, ANY IMPLIED WARRANTIES THAT MAY OTHERWISE BE APPLICABLE BECAUSE OF THE PROVISIONS OF THE UNIFORM COMMERCIAL CODE OR ANY OTHER LAWS, INCLUDING THE WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Any claims Purchaser may have for breach of representation or warranty shall be based solely on the representations and warranties of
Auspex expressly set forth in this Agreement and the Ancillary Agreements and the certificates and other documents delivered pursuant hereto or thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2. <U>Regulatory Commitments.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">From and after the Closing Date, Purchaser will assume control of, and responsibility for, all costs and liabilities arising from or related to
any commitments or obligations to any Governmental Authority involving the Compound and/or Products (&#147;<B>Regulatory Commitments</B>&#148;) only to the extent arising from or relating to events occurring after the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3. <U>Further Action; Consents; Filings</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Upon the terms and subject to the conditions hereof, each of Purchaser and Auspex will use commercially reasonable efforts to (i)&nbsp;obtain
from the requisite Governmental Authorities any consents, licenses, permits, waivers, approvals, authorizations or orders required to be obtained or made in connection with the authorization, execution and delivery of this Agreement and the
consummation of the transactions contemplated by this Agreement and (ii)&nbsp;make all necessary filings, and thereafter make any other advisable submissions, with respect to this Agreement and the transactions contemplated by this Agreement
required under any Applicable Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4. <U>Bulk Transfer Laws</U>. Purchaser hereby waives compliance by Auspex with the provisions of
any so called &#147;bulk transfer law&#148; of any jurisdiction in connection with the transfer of the Transferred Assets to Purchaser, it being understood that any Liabilities arising out of the failure of Auspex to comply with the requirements of
any provisions of any <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;bulk transfer law&#148; of any jurisdiction shall be treated as Excluded Liabilities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5. <U>Insurance</U>. As of the Closing Date, the coverage under all insurance policies of Auspex and its Affiliates shall continue in force
only for the benefit of Auspex and its Affiliates, and not for the benefit of Purchaser or any of its Representatives. As of the Closing Date, Purchaser agrees to arrange for its own insurance policies with respect to the Transferred Assets covering
all periods and agrees not to seek, through any means, to benefit from any of Auspex&#146;s or its Affiliates&#146; insurance policies which may provide coverage for claims relating in any way to the Transferred Assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6. <U>Support</U>. Following the Closing, Purchaser and its Affiliates, on the one hand,
and Auspex, on the other hand, shall reasonably cooperate with each other in the defense or settlement of any Liabilities or lawsuits involving the Transferred Assets, the Compound, the Products, this Agreement or the Ancillary Agreements, in each
case for which the other Party has responsibility under this Agreement, by providing the other Party and such other Party&#146;s legal counsel reasonable access to employees, records, documents, data, equipment, facilities, products, parts,
prototypes and other information relating primarily to the Transferred Assets, the Compound or the Products, as such other Party may reasonably request, to the extent maintained or under the possession or control of the requested Party;
<U>provided</U>, <U>however</U>, that such access shall not unreasonably interfere with the business of Purchaser or Auspex, or any of their respective Affiliates; <U>provided</U>, <U>further</U>, that either Party may restrict the foregoing access
to the extent that (a)&nbsp;such restriction is required by Applicable Law, (b)&nbsp;such access or provision of information would reasonably be expected to result in a violation of confidentiality obligations to a third party or (c)&nbsp;disclosure
of any such information would result in the loss or waiver of the attorney-client privilege. The requesting Party shall reimburse the other Party for reasonable
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses paid by the other Party to Third Parties in performing its obligations under this <U>Section</U><U></U><U>&nbsp;5.6</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7. <U>Payments from Third Parties</U><U>.</U> In the event that, on or after the Closing Date, either Party shall receive any payments or
other funds that are rightly due and payable to the other pursuant to the terms of this Agreement or any of the other Transaction Documents, then the Party receiving such funds shall promptly forward such funds to the proper Party. The Parties
acknowledge and agree that there is no right of offset regarding such payments and a Party may not withhold funds received from Third Parties for the account of the other Party in the event there is a dispute regarding any other issue under any of
the Transaction Documents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8. <U>Resale Exemption Certificates and Transfer Taxes</U>. At the Closing (or within such reasonable time
thereafter as may be necessary to perfect the resale or other exemption certificates), Purchaser shall deliver to Auspex fully completed and executed resale exemption certificates or other applicable exemption certificates for all jurisdictions
identified by Auspex prior to Closing as jurisdictions in which inventory is to be transferred and for which resale exemption certificates are necessary to comply with Applicable Laws; <U>provided</U> that if any such exemption certificates are not
available in a jurisdiction or not sufficient to avoid the imposition of sales or use Taxes, such Taxes shall be equally shared between the Parties. Auspex and Purchaser further agree that any Transfer Taxes (and related interest and penalty) other
than those described in the preceding sentence assessed by any jurisdiction in connection with the transactions contemplated by this Agreement shall be shared equally between the Parties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9. <U>Payments </U><U>Under</U><U> Transferred Contracts</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If Auspex or its Affiliates receives any deposit or payment prior to the Closing that relates to obligations under any Transferred Contract
to be performed or satisfied after the Closing by Purchaser, then Auspex shall pay to Purchaser, within [***] following the Closing Date, an amount equal to the portion of such deposit or payment in advance that relates to such obligations to be
performed after the Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If Auspex or its Affiliates receives any good or service prior to the Closing under any Transferred
Contract that is billed to Purchaser after the Closing, upon request and presentation of reasonable supporting documentation, Auspex shall reimburse Purchaser for the amount of such payment within [***] following the date of such request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If Auspex or its Affiliates makes any deposit or payment prior to the Closing in respect
of supplies of goods not received prior to the Closing under any Transferred Contract, Purchaser shall reimburse to Auspex or its Affiliate, within [***] following the Closing Date, an amount equal to the portion of such deposit or payment that
relates to the goods to be received after the Closing by Purchaser. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10. <U>No Patent Challenge; Covenant Not to Sue</U>. Notwithstanding
anything to the contrary contained in this Agreement or otherwise, Auspex on behalf of itself and its Affiliates covenants and agrees (i)&nbsp;not to challenge or contest the validity or enforceability of any of the intellectual property rights
(including the Patents) included in the Transferred Assets and (ii)&nbsp;not to assert any claim or initiate any legal or other action against Purchaser or its Affiliates based on any intellectual property rights or other technology now owned or
hereafter acquired by Auspex or its Affiliates to prohibit or otherwise adversely affect the continued development or commercialization of any Products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11. <U>Further Assurances</U>. Each Party agrees, from and after the Closing, upon the reasonable request of the other Party, and at the
expense of the requesting Party, to make, execute and deliver any or all documents or instruments of any kind or character, and to perform all such other actions, that may be necessary or proper and reasonable to effectuate, confirm, perform or
carry out the terms and provisions of this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INDEMNIFICATION AND LIMITATIONS OF LIABILITY </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1. <U>Indemnification by </U><U>Auspex</U>. Subject to the limitations set forth herein, including <U>Sections</U><U></U><U>&nbsp;6.4</U>
and <U>6.5</U>, Auspex shall indemnify and hold harmless each of Purchaser and its Affiliates, and the directors, officers, stockholders, employees and agents of such entities and the successors and assigns of any of the foregoing (the
&#147;<B>Purchaser Indemnitees</B>&#148;), from and against any and all losses, Liabilities, damages, penalties, fines, costs and expenses (including reasonable attorneys&#146; fees) (&#147;<B>Losses</B>&#148;) from any claims, Actions, suits or
proceedings (&#147;<B>Claims</B>&#148;), including those brought by a Third Party (a &#147;<B>Third Party Claim</B>&#148;) incurred by any Purchaser Indemnitee, arising from, or occurring as a result of (i)&nbsp;any breach by Auspex of any of its
representations and warranties set forth in this Agreement other than Fundamental Reps; (ii)&nbsp;any breach by Auspex of any Fundamental Reps; (iii)&nbsp;any breach by Auspex of its covenants set forth this Agreement; or (iv)&nbsp;any and all
Excluded Liabilities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2. <U>Indemnification by Purchaser</U>. Subject to the limitations set forth herein, including
<U>Sections</U><U></U><U>&nbsp;6.4</U> and <U>6.5</U>, Purchaser shall indemnify and hold harmless each of Auspex and its Affiliates and the directors, officers, shareholders, employees and agents of such entities and the successors and assigns of
any of the foregoing (the &#147;<B>Auspex</B><B> Indemnitees</B>&#148;), from and against any and all Losses (including Losses arising from Claims, including Third Party Claims) incurred by any Auspex Indemnitee, arising from, or occurring as a
result of: (i)&nbsp;any breach by Purchaser of its representations and warranties other than Fundamental Reps set forth in this Agreement; (ii)&nbsp;any breach by Purchaser of any Fundamental Reps; (iii)&nbsp;any breach by Purchaser of its covenants
set forth this Agreement; or (iv)&nbsp;any and all Assumed Liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3. <U>Procedure</U>. All Claims for indemnification under this <U>Article VI</U> shall be
asserted and resolved as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event that any Person entitled to indemnification hereunder (the
&#147;<B>Indemnitee</B>&#148;) has a Claim against any Party obligated to provide indemnification pursuant to <U>Sections</U><U></U><U>&nbsp;6.1</U> or <U>6.2</U> (the &#147;<B>Indemnitor</B>&#148;) arising from a Third Party Claim, the following
provisions shall apply: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Indemnitee shall with reasonable promptness notify the Indemnitor of such Third Party Claim, specifying
the nature of such Third Party Claim and the amount or the estimated amount thereof to the extent then feasible (which estimate shall not be conclusive of the final amount of such Third Party Claim) (the &#147;<B>Claim Notice</B>&#148;). The
Indemnitee&#146;s failure to give reasonably prompt notice as required by this <U>Section</U><U></U><U>&nbsp;6.3</U> of any Third Party Claim which may give rise to a right of indemnification hereunder shall not relieve the Indemnitor of any
liability which the Indemnitor may have to the Indemnitee, except to the extent the failure to give such notice materially and adversely prejudiced the Indemnitor. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) If any Indemnitee asserts a Third Party Claim, the Indemnitor shall, within [***] from delivery of the Claim Notice (the &#147;<B>Notice
Period</B>&#148;), notify the Indemnitee (A)&nbsp;whether or not such Indemnitor disputes the liability to the Indemnitee hereunder with respect to such Third Party Claim and (B)&nbsp;if such Indemnitor does not dispute such liability, whether or
not the Indemnitor desires, at the sole cost and expense of the Indemnitor, to defend against such Third Party Claim, <U>provided</U> that, upon prior written notice to the Indemnitor, the Indemnitee is hereby authorized (but not obligated) prior to
and during the Notice Period to file any motion, answer or other pleading and to take any other action which the Indemnitee reasonably shall deem necessary to protect the Indemnitee&#146;s interests. If, and for so long as, (w)&nbsp;the Indemnitor
notifies the Indemnitee within the Notice Period that the Indemnitor does not dispute the Indemnitor&#146;s obligation to indemnify hereunder and desires to defend the Indemnitee against such Third Party Claim, (x)&nbsp;the Third Party Claim does
not (1)&nbsp;seek equitable relief or any other <FONT STYLE="white-space:nowrap">non-monetary</FONT> remedy against the Indemnitee or (2)&nbsp;involve any Governmental Authority as a party thereto and (y)&nbsp;an adverse resolution of the Third
Party Claim would not have a material adverse effect on the goodwill or reputation of any Indemnitee or the business, operations or future conduct of any Indemnitee, then except as hereinafter provided, such Indemnitor shall have the right to defend
against such Third Party Claim by appropriate proceedings with legal counsel reasonably acceptable to the Indemnitee, which proceedings shall be promptly settled or diligently prosecuted by such Party to a final conclusion; <U>provided</U> that,
unless the Indemnitee otherwise agrees in writing, the Indemnitor may not settle any matter (in whole or in part) unless such settlement (I)&nbsp;includes a complete and unconditional release of the Indemnitee and its Affiliates in respect of the
Third Party Claim, (II)&nbsp;involves no admission of wrongdoing by the Indemnitee or its Affiliates and (III)&nbsp;excludes any injunctive or <FONT STYLE="white-space:nowrap">non-monetary</FONT> relief applicable to the Indemnitee or its
Affiliates. If the Indemnitee desires to participate in, but not control, any such defense or settlement the Indemnitee may do so at its sole cost and expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) If (A)&nbsp;the Indemnitor elects not to defend the Indemnitee against such Third
Party Claim, or fails to promptly settle or diligently defend such Third Party Claim, or (B)&nbsp;the terms of this Agreement do not permit the Indemnitor to defend the Indemnitee against such Third Party Claim, or (C)&nbsp;the Indemnitee reasonably
believes upon the advice of counsel that there are issues that raise actual or potential conflicts of interest between the Indemnitor and the Indemnitee, or (D)&nbsp;the Indemnitee has different or additional defenses available to it, then the
Indemnitee, without waiving any rights against the Indemnitor, may settle or defend against any such Third Party Claim in the Indemnitee&#146;s sole and absolute discretion and the Indemnitee shall be entitled to recover from the Indemnitor the
amount of any settlement or judgment and, on an ongoing basis, all Losses of the Indemnitee with respect thereto, including interest from the date such Losses were incurred; <U>provided</U>, <U>however</U>, that the Indemnitor shall not be required
to indemnify the Indemnitee hereunder for any Losses incurred as a result of a settlement of such Third Party Claim if the Indemnitee did not obtain the Indemnitor&#146;s written consent to such settlement (which consent shall not be unreasonably
conditioned, withheld, delayed or denied). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to any Claim for indemnification not involving a Third Party Claim, within
[***] after receipt of a Claim Notice that does not involve a Third Party, the Indemnitor shall by written notice (the &#147;<B>Response Notice</B>&#148;) to the Indemnitee either (i)&nbsp;concede liability in whole as to the claimed amount,
(ii)&nbsp;deny liability in whole as to such claimed amount or (iii)&nbsp;concede liability in part and deny liability in part as to such claimed amount. If the Parties are not able to resolve any dispute over such a claim within [***] after the
receipt of a Response Notice denying liability in whole or in part, such Dispute shall be subject to the decision of a neutral arbiter agreeable to both Parties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4. <U>Survival</U>. If the Closing shall have occurred, all covenants, agreements, warranties and representations made herein or in any
certificate or other document delivered pursuant hereto shall survive the Closing. Notwithstanding the foregoing, all representations, warranties, covenants and agreements made herein or in any certificate or other document delivered pursuant
hereto, and all indemnification obligations under <U>Section</U><U></U><U>&nbsp;6.1</U> and <U>Section</U><U></U><U>&nbsp;6.2</U>, with respect to any such representations, warranties, covenants and agreements, shall (a)&nbsp;in the case of any such
representations or warranties other than Fundamental Reps, terminate and expire on, and no action or proceeding seeking damages or other relief for breach of any thereof or for any misrepresentation or inaccuracy with respect thereto, shall be
commenced after, the date that is [***] after the Closing Date; <U>provided</U>, <U>however</U>, that such an action or proceeding may be commenced after such date if prior to such date a claim for indemnification with respect thereto shall have
been made, with reasonable specificity, by written notice given in accordance with <U>Section</U><U></U><U>&nbsp;6.3</U>; (b)&nbsp;in the case of Fundamental Reps, survive until [***] after the latest date such representation or warranty is allowed
to survive by the applicable statute of limitations; and (c)&nbsp;in the case of any such covenants or agreements, terminate and expire on, and no action or proceeding seeking damages or other relief for breach of any thereof shall be commenced
after, the date that is [***] after the last date on which such covenant or agreement is to be performed; <U>provided</U>, <U>however</U>, that such an action or proceeding may be commenced after such date if prior to such date a claim for
indemnification with respect thereto shall have been made, with reasonable specificity, by written notice given in accordance with <U>Section</U><U></U><U>&nbsp;6.3</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5. <U>Certain Limitations</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding the other provisions of this <U>Article VI</U>, neither Party shall have&#151;except for Losses arising from Third Party
Claims, which are excluded from the limitations contained in this paragraph&#151;indemnification obligations for Losses under <U>Section</U><U></U><U>&nbsp;6.1</U> or <U>Section</U><U></U><U>&nbsp;6.2</U>, as applicable, in excess of the aggregate
amount of Purchase Price paid or payable by Purchaser to Auspex under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The amount which the Indemnitor is required to
pay to, for or on behalf of the Indemnitee pursuant to this <U>Article VI</U> shall be reduced by any foreign, federal, state, provincial or local income Tax benefit actually realized to the Indemnitee or any of its Affiliates applicable to the
indemnifiable damages in the Tax year the damages are incurred or in the immediately following Tax year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In the event any Losses by
any Indemnitee are covered by insurance or any indemnity, contribution or other similar right against a Third Party, such Indemnitee agrees to use commercially reasonable efforts to seek recovery under such insurance or indemnity, contribution or
similar right; <U>provided</U>, <U>however</U>, such Indemnitee shall have no obligations to commence any litigation to seek any such recovery. If the Indemnitee receives any insurance proceeds or other amounts in respect of the matter giving rise
to any Claim of the Indemnitee, the Indemnitor&#146;s indemnification obligation with respect to the Claim shall be reduced by the amount of any such insurance proceeds and other amounts actually received by the Indemnitee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.6. <U>Exclusive Remedy</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This <U>Article VI</U> provides the exclusive means by which a Party may assert and remedy Claims under or with respect to this Agreement
except for equitable relief as may be necessary for specific performance of this Agreement. Each Party hereby waives and releases any other remedies or claims that it may have against the other Party (or any of its Affiliates) with respect to the
matters arising out of or in connection with this Agreement or relating to the Compound, the Products or the Transferred Assets, except that nothing herein shall limit the remedy of any Party hereto for fraud. With respect to any Losses arising
under this Agreement, Purchaser agrees that it shall only seek such Losses from Auspex, and Purchaser hereby waives the right to seek Losses from or equitable remedies, such as injunctive relief, against any Affiliate of Auspex or any director,
officer or employee of Auspex (or any of its Affiliates). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Any payment made by Purchaser as the Indemnitor pursuant to this <U>Article
VI</U> will constitute a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">dollar-for-dollar</FONT></FONT> decrease of the Purchase Price and any payment made by Auspex as the Indemnitor pursuant to this <U>Article VI</U> will
constitute a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">dollar-for-dollar</FONT></FONT> increase of the Purchase Price. Each Party shall within a reasonable time, if necessary, request all amendments to its current or past Tax
Returns to reflect such increase or decrease. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONFIDENTIAL INFORMATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1. <U>Ownership of Certain Confidential Information</U>. Ownership of any <FONT STYLE="white-space:nowrap">non-public</FONT> information and
materials included in the Transferred Assets shall be governed by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2. <U>Protection of Confidential Information</U>. For [***] following the Closing Date,
each Party shall treat all Confidential Information of the other Party in accordance with the requirements of this <U>Article VII</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3. <U>Permitted Use</U>. Confidential Information of the Disclosing Party shall be kept strictly confidential by the Receiving Party and,
except as expressly permitted herein, shall not be disclosed to any third Person by the Receiving Party in any manner whatsoever, in whole or in part, without first obtaining the other Party&#146;s prior written consent to such disclosure. The
standard of care required of each Party in protecting the confidentiality of the other Party&#146;s Confidential Information shall be at least the same as the standard of care that the Receiving Party uses in protecting its own confidential and
trade secret information, but in no event shall either Party use less than a reasonable standard of care. Except as expressly provided herein, Confidential Information may be used by the Receiving Party only for the purpose of performing this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4. <U>Authorized Disclosure</U>. Each Party may disclose the other Party&#146;s Confidential Information (a)&nbsp;to its
Representatives who reasonably need to know such information for the purposes of advising or assisting in connection with the performance of this Agreement; <U>provided</U> that, prior to disclosure of any Confidential Information hereunder to any
Representative, the Receiving Party shall inform such Representative of the proprietary nature of the Confidential Information and its obligations to protect such information hereunder; (b)&nbsp;to any Person required by a valid order of a court of
competent jurisdiction or other governmental body of a country or any political subdivision thereof of competent jurisdiction; <U>provided</U> that the Receiving Party shall first have given notice to the Disclosing Party of such requirement so that
the Disclosing Party may seek, with the reasonable cooperation of the Receiving Party, a reasonable opportunity to quash such order or to obtain a protective order requiring that the Confidential Information and/or documents that are the subject of
such order be held in confidence by such court or governmental body or, if disclosed, be used only for the purposes for which the order was issued; and (c)&nbsp;as otherwise required by law or regulation, in the opinion of counsel to the Receiving
Party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5. <U>Excluded Information</U>. Notwithstanding any provision herein to the contrary, the requirements of this <U>Article VII</U>
shall not apply to any information of either Party which (a)&nbsp;at the time of disclosure hereunder is available to the public; (b)&nbsp;after the date of disclosure hereunder becomes generally available to the public, except through a breach of
this <U>Article VII</U> by the Receiving Party or its Representatives; (c)&nbsp;is independently developed by the employees or agents of the Receiving Party or its Affiliates without use of or reference to the Confidential Information as
demonstrated by written evidence; or (d)&nbsp;is received from a third Person without restriction and without breach of any agreement between such third Person and the Disclosing Party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6. <U>Obligations </U><U>Upon</U><U> Termination</U>. Upon any termination of this Agreement, each Party shall immediately discontinue use of
any Confidential Information of the other Party and cause all Confidential Information of the other Party in its possession to be returned to the Disclosing Party or destroyed; <U>provided</U>, <U>however</U>, that each Party shall be entitled to
(a)&nbsp;use such Confidential Information for the performance of any of its outstanding obligations hereunder and (b)&nbsp;retain one copy of such Confidential Information for its record keeping purposes; <U>provided</U>, <U>further</U>, that such
Party shall continue to be subject to its obligations hereunder with respect to such Confidential Information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.7. <U>Rights </U><U>Upon</U><U> Unauthorized Use or Disclosure</U>. Each Party agrees that
the unauthorized use or disclosure of any information by the Receiving Party in violation of this Agreement will cause severe and irreparable damage to the Disclosing Party. In the event of any violation of this <U>Article VII</U>, the Disclosing
Party is authorized and entitled to obtain from any court of competent jurisdiction injunctive relief, whether preliminary or permanent, without the necessity of proving irreparable harm or monetary damages, as well as any other relief permitted by
Applicable Law. The Receiving Party agrees to waive any requirement that the Disclosing Party post a material bond as a condition for obtaining any such relief. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS PROVISIONS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1. <U>Successors and Assigns</U>. Neither Party to this Agreement may assign any of its rights or obligations under this Agreement,
including by sale of stock, operation of law in connection with a merger or sale of substantially all of the assets, without the prior written consent of the other Party, except that (a)&nbsp;Auspex may, without such consent, assign its rights or
obligations to an Affiliate and (b)&nbsp;Purchaser may, without such consent, assign its rights to acquire the Transferred Assets hereunder, in whole or in part, to one or more of its Affiliates; <U>provided</U>, <U>however</U>, that no such
assignment by Purchaser or Auspex, as applicable, shall relieve Purchaser or Auspex of any of their obligations hereunder. Any permitted assignee shall assume all obligations of its assignor under this Agreement. Any purported assignment in
violation of this <U>Section</U><U></U><U>&nbsp;8.1</U> shall be null and void. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2. <U>Specific Performance</U>. The Parties acknowledge
that the failure to comply with a covenant or obligation contained in this Agreement may give rise to irreparable injury to a Party inadequately compensable in damages. Accordingly, a Party may seek to enforce the performance of this Agreement by
injunction or specific performance upon application to a court of competent jurisdiction without proof of actual damage (and without requirement of posting a bond or other security). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3. <U>Press Releases; Disclosures</U>. Neither Party shall disclose the existence of this Agreement or issue any press release, publicity or
other form of public written disclosure relating to this Agreement without the prior written consent of the other Party or as otherwise required by Applicable Law. For releases or announcements required by Applicable Laws, the Party making the
release or announcement shall, before making any such release or announcement, afford the other Party a reasonable opportunity to review and comment. Any copy of this Agreement to be filed with the Securities and Exchange Commission or any other
Governmental Authority shall be redacted to the fullest extent permitted by Applicable Laws and to the reasonable satisfaction of the Parties; <U>provided</U>, <U>however</U>, in the event that the Securities and Exchange Commission or other
Governmental Authority, as applicable, objects to the redaction of any portion of this Agreement after the initial submission, the filing Party shall inform the other Party of the objections and shall in good faith respond to the objections in an
effort to limit the disclosure required by the Securities and Exchange Commission or Governmental Authority, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4. <U>Schedules</U><U>.</U> The disclosure of any matter in any Schedule to this Agreement
shall be deemed to be a disclosure for the purposes of the Section or subsection of this Agreement to which it corresponds in number and each other Section and subsection of this Agreement to the extent such disclosure is reasonably apparent on the
face thereof to be relevant to such other Section or subsection. The disclosure of any matter in any Schedule to this Agreement shall expressly not be deemed to constitute an admission by any Party, or to otherwise imply, that any such matter is
material for the purposes of this Agreement, could reasonably be expected to have a Material Adverse Effect or would not, individually or in the aggregate, have a material and adverse effect on the ability of Purchaser to consummate the
Transactions, as applicable, or is required to be disclosed under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5. <U>Expenses</U>. Except as otherwise expressly
provided in this Agreement, whether or not the Transactions are consummated, all costs and expenses incurred in connection with this Agreement and the Transactions shall be borne by the Party incurring such expenses. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.6. <U>Severability</U>. Should any part or provision of this Agreement be held unenforceable or in conflict with Applicable Law, the invalid
or unenforceable part or provision shall, <U>provided</U> that it does not go to the essence of this Agreement, be replaced with a revision which accomplishes, to the extent possible, the original commercial purpose of such part or provision in a
valid and enforceable manner, and the balance of this Agreement shall remain in full force and effect and binding upon the Parties hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.7. <U>Waiver</U>. No waiver of a breach or default hereunder shall be considered valid unless in writing and signed by the Party giving such
waiver and no such waiver shall be deemed a waiver of any subsequent breach or default of the same or similar nature. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.8.
<U>Amendments</U>. This Agreement may not be amended or modified except in writing except in writing executed by duly authorized representative of the Parties. No waiver of any of the provisions of this Agreement shall be deemed to or shall
constitute a waiver of any other provision hereof (whether or not similar). No delay on the part of any Party in exercising any right, power or privilege hereunder shall operate as a waiver thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.9. <U>Governing Law</U>. This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York without
giving effect to the principles of conflict of laws thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.10. <U>Submission to Jurisdiction</U>. Each of the Parties hereby
irrevocably and unconditionally consents to submit to the exclusive jurisdiction of the federal and state courts located in the City and County of New York, NY for any litigation arising out of or relating to this Agreement and the transactions
contemplated hereby (and agrees not to commence any litigation relating hereto or thereto except in such courts), and further agrees that service of any process, summons, notice or document by U.S. registered mail to its respective address set forth
in this Agreement shall be effective service of process for any litigation brought against it in any such court. Each of the Parties hereto hereby irrevocably and unconditionally waives any objection to the laying of venue of any litigation arising
out of this Agreement or the transactions contemplated hereby in the federal and state courts located in the City and County of New York, NY and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court
that any such litigation brought in any such court has been brought in an inconvenient forum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.11. <U>Waiver of Jury Trial</U>. THE PARTIES WAIVE ANY RIGHT THEY MAY HAVE TO A TRIAL BY
JURY IN RESPECT OF ANY ACTION, PROCEEDING OR LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.12. <U>Third Party Beneficiaries</U>. No Section of this Agreement is intended to confer upon any Person other than the Parties any rights or
remedies hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.13. <U>Counterparts</U>. This Agreement may be executed in one or more counterparts, each of which shall be deemed
an original but all of which, taken together, shall constitute one and the same instrument. This Agreement may be delivered by facsimile transmission or other form of electronic delivery, and receipt of such facsimile copy or electronic delivery of
any Party&#146;s signature shall be considered to be receipt of an original copy thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.14. <U>Notices</U>. Each notice, demand or
other communication to be given or made hereunder shall be made in writing and may be made by facsimile transmission. Any notice, request, demand or other communication required or permitted hereunder shall be in writing and shall be deemed to have
been given (a)&nbsp;if delivered or sent by facsimile transmission, upon receipt, (b)&nbsp;if sent by registered or certified mail, upon the sooner of the date on which receipt is acknowledged or the expiration of [***] after deposit in United
States post office facilities properly addressed with postage prepaid or (c)&nbsp;if sent by overnight courier, the Business Day following the date it is sent. All notices to a party will be sent to the addresses set forth below or to such other
address or Person as such party may designate by notice to each other party hereunder: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to Purchaser:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">PureTech Health LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">6 Tide Street, 4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Boston, MA 02110</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Attention: President</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Fax: (617) <FONT STYLE="white-space:nowrap">482-3337</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">With a copy (which shall not constitute notice) to:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ira A. Rosenberg, Esq.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Sills Cummis&nbsp;&amp;
Gross P.C.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">One Riverfront Plaza</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Newark, NJ 07102</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Fax: (973) <FONT STYLE="white-space:nowrap">643-6500</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to Auspex:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Auspex Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Teva Pharmaceuticals</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">400 Interpace
Parkway</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Parsippany, NJ 07054</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Attention: General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">973-658-6056</FONT></FONT></TD></TR></TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Teva Pharmaceuticals</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">41 Moores Road</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Frazer, PA 19035</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Attention: Alliance Management</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All notices required hereunder shall be deemed received (i)&nbsp;the same Business Day if delivered personally,
(ii)&nbsp;[***] after being sent overnight by a reputable national overnight courier, (iii)&nbsp;[***] after being sent by registered or certified mail, postage prepaid, return receipt requested and (iv)&nbsp;the same Business Day if sent prior to
5:00 p.m. Eastern Time by confirmed facsimile transmission, otherwise the immediately following Business Day. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.15. <U>Entire
Agreement</U>. This Agreement (including all exhibits and schedules) constitutes the entire agreement between the Parties with respect to its subject matter and supersedes all prior agreements, arrangements, dealings or writings between the Parties.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[The remainder of this page intentionally left blank] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B> the Parties hereto have executed this Agreement as of the date
first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PURETECH HEALTH LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bharat Chowrira</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Bharat Chowrira</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AUSPEX PHARMACEUTICALS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Tushar Shah</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Tushar Shah</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Sr. Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen P. Trusko</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Stephen P. Trusko</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Sr. Director, Business Development</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE C </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 1.1(a) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 2.2(a)(vi) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 2.2(d) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 2.3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.1(c) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.1(d) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.1(g) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.1(k) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.2(d) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>[***] </U></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT D </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>5
<FILENAME>filename5.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.9</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.9 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED (INDICATED BY: [***]) FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE
COMPETITIVE HARM IF PUBLICLY DISCLOSED. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ROYALTY AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This ROYALTY AGREEMENT (the &#147;<U>Agreement</U>&#148;), dated as of July 23, 2013, is by and among (i) PureTech Ventures, LLC, a Delaware
limited liability company (&#147;<U>PureTech</U>&#148;), and (ii)&nbsp;Follica, Incorporated, a Delaware corporation (the &#147;<U>Company</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, PureTech is required to provide certain management services and intellectual property as set forth in the Management and Overhead
Services Agreement dated on or about the date hereof by and between the Company and PureTech; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, PureTech will receive certain
consideration for such management services and intellectual property, including the potential royalty payments set forth herein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE, in consideration of the mutual promises hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1. </B>DEFINITIONS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1&nbsp;&nbsp;&nbsp;&nbsp; &#147;<U>Affiliate</U>&#148; shall mean any legal entity (such as a corporation, partnership, or limited liability
company) that is controlled by a Party. For purposes of this definition, the term &#147;control&#148;:, means as to such entity, direct or indirect ownership of (i)&nbsp;more than fifty percent (50%) in the aggregate of the voting power of all
outstanding shares entitled to vote at a general election of directors of such entity, (ii)&nbsp;more than fifty percent (50%) of the equity interests in such entity, or (iii)&nbsp;more than fifty percent (50%) of the assets of such entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Product</U>&#148; shall mean any product that involves (i)&nbsp;disrupting the skin using any mechanical,
energy or chemical based approaches, (ii)&nbsp;applying compounds to the skin through the propelling of particles, or (iii)&nbsp;any other approaches to the treatment of hair follicles or other dermatological disorders commercialized by the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Process</U>&#148; shall mean any process that involves (i)&nbsp;disrupting the skin using any
mechanical, energy or chemical based approaches (ii)&nbsp;applying compounds to the skin through the propelling of particles or (iii)&nbsp;any other approaches to the treatment of hair follicles or dermatological disorders commercialized by the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4&nbsp;&nbsp;&nbsp;&nbsp;&#148;<U>Service</U>&#148; shall mean the performance of a service for a third party, which
performance uses or incorporates a Product or Process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5&nbsp;&nbsp;&nbsp;&nbsp;&#148;<U>Net Sales</U>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Reporting Period</U>&#148; shall begin on the first day of each calendar quarter and end on the last day
of such calendar quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.7&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Sublicensee</U>&#148; shall mean any
<FONT STYLE="white-space:nowrap">non-Affiliate</FONT> sublicensee of the rights granted by the Company enabling the commercialization of one or more Products, Processes or Services. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">l.8&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Sublicense Income</U>&#148; shall mean all consideration
received by the Company or any of its Affiliates from Sublicensees in exchange for the sublicensing of rights (i)&nbsp;to research, develop, make, have made, use, offer for sale, sell, lease, import or otherwise exploit Products in in the Territory,
(ii)&nbsp;to research, develop, use, have used, perform or otherwise exploit Processes in the Territory or (iii)&nbsp;to develop, offer to sell, sell, have sold or otherwise exploit Services in the Territory, but specifically excluding royalties
that are calculated as a percentage of Sublicensee sales. Sublicensing Income includes, without limitation, upfront payments, milestone payments, license maintenance fees, research and development funding and equity investments (whether in the form
of stock purchase, options, warrants, convertible debt or other forms) paid directly or indirectly to the Company (or any of its Affiliates) from (or on behalf of) any Sublicensee. Notwithstanding the foregoing, Sublicense Income shall not include
amounts paid to the Company by or on behalf of a sublicensee in connection with a sublicensing transaction as an equity investment in the Company (whether in the form of stock purchase, options, warrants or other forms) to the extent that the amount
of such investment (calculated in case of options, warrants and the like as if exercised and including all amounts due on exercise) does not involve any premium over fair market value of the equity investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.9&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Term</U>&#148; shall mean the term of this Agreement, which shall commence on the Effective Date and shall
remain in effect until the expiration of the royalty obligation set forth in Section&nbsp;2.1, unless earlier terminated in accordance with the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.10 &#147;<U>Territory</U>&#148; shall mean worldwide. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2.</B> ROYALTIES AND PAYMENT TERMS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Royalty and Sublicense Income</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Royalties</U>. The Company shall pay to PureTech a royalty on Net Sales by the Company, its Affiliates and
Sublicensees of Products, Processes and Services equal to [***] of Net Sales by the Company, its Affiliates and Sublicensees. Such royalty shall commence upon the first commercial sale of such Product, Process or Service in such country and shall
terminate on the [***] anniversary thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Time of Payment</U>. Royalties arising under this
Section&nbsp;2.1 shall be payable for each Reporting Period and shall be due to PureTech within [***] of the end of each Reporting Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Sharing of Sublicense Income</U>. The Company shall pay PureTech [***] of all Sublicense Income received by the
Company or Affiliates. Such amount shall be payable for each Reporting Period and shall be due to PureTech within [***] of the end of each Reporting Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Payments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Payment</U>. All payments under this Agreement shall be made payable to PureTech and sent to the
address identified in Section&nbsp;10.1. Each payment should reference this Agreement and identify the obligation under this Agreement that the payment satisfies. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Payments in U.S.</U> Dollars. All payments due under this
Agreement shall be payable in United States dollars. Conversion of foreign currency to U.S. dollars shall be made at the conversion rate existing in the United States (as reported in <U>The Wall Street Journal</U>) for the last working day of the
calendar quarter of the applicable Reporting Period. Such payments shall be without deduction of exchange, collection, or other charges. Each Party is solely responsible for timely and properly filing and payment of its own taxes of any kind and in
any jurisdiction. All payments under this Agreement shall be made in full without any deduction or withholding for or on<I> </I>account of any tax unless such deduction or withholding is required by applicable governmental laws, tax treaty, or
regulations. Any tax required to be withheld by the Company under the laws of any foreign country for the account of PureTech shall be promptly paid by the Company for and on behalf of PureTech to the appropriate governmental authority, and the
Company shall furnish PureTech with proof of payment of such tax together with official or other appropriate evidence issued by the applicable government authority. Any such tax actually paid on PureTech&#146;s behalf shall be deducted from royalty
payments due PureTech. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Late Payments.</U> Any payments by the Company that are not paid on or before the
date such payments are due under this Agreement shall bear interest, to the extent permitted by law, at two percentage points above the Prime Rate of interest as reported in <U>The Wall Street Journal</U> on the date payment is due. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>3.</B> REPORTS AND RECORD KEEPING. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Frequency of Reports.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Before First Commercial Sale.</U> Prior to the first commercial sale of any Product or first commercial
performance of any Process or Service, the Company shall deliver reports to PureTech annually, within [***] of the end of each calendar year, containing information concerning the progress of research and development pertaining to the Product,
Process and Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Upon First Commercial Sale of a Product or Commercial Performance of a Process or
Service.</U> The Company shall report to PureTech the date of first commercial sale of a Product and the date of first commercial performance of a Process or Service within [***] of occurrence in each country. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>After First Commercial Sale.</U> After the first commercial sale of a Product, a Process or a Service, the
Company shall deliver reports to PureTech within [***] of the end of each Reporting Period, containing information concerning the immediately preceding Reporting Period, as further described in Section&nbsp;3.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Content of Reports and Payments.</U> Each report delivered by the Company to PureTech shall contain at least the
following information for the immediately preceding Reporting Period: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;the number of Products sold, leased or
distributed by the Company, its Affiliates and Sublicensees to independent third parties in each country, and, if applicable, the number of Processes and Services sold by the Company, its Affiliates and Sublicensees in each country; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;a description of Processes performed by the Company, its
Affiliates and Sublicensees in each country as may be pertinent to a royalty accounting hereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;the gross
price charged by the Company, its Affiliates and Sublicensees for each Product and, if applicable, the gross price charged for each Process and Service performed by the Company, its Affiliates and Sublicensees in each country; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;the calculation of Net Sales for the applicable Reporting Period in each country, including a listing of applicable
deductions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;the total royalty payable on Net Sales in U.S. dollars, together with the exchange rates used for
conversion; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;the amount of Sublicense Income received by the Company from each Sublicensee and the amount due
to PureTech from such Sublicense Income, including an itemized breakdown of the sources of income comprising the Sublicense Income; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;the number of sublicenses entered into for Products and/or Processes and/or Services for which amounts are due to
PureTech under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If no amounts are due to PureTech for any Reporting Period, the report shall so state. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statements.</U> On or before the [***] following the close of the Company&#146;s fiscal year, the
Company shall provide PureTech with the Company&#146;s financial statements for the preceding fiscal year including, at a minimum, a balance sheet and an income statement, certified by the Company&#146;s treasurer or chief financial officer or by an
independent auditor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Record Keeping.</U> The Company shall maintain, shall cause its Affiliates, and shall
require its Sublicensees to maintain, complete and accurate &#145;records relating to the rights and obligations under this Agreement and any amounts payable to PureTech in relation to this Agreement, which records shall contain sufficient
information to permit PureTech to confirm the accuracy of any reports delivered to PureTech and compliance in other respects with this Agreement. The relevant party shall retain such records for at least [***] following the end of the calendar year
to which they pertain, during which time PureTech, or PureTech&#146;s appointed agents, shall have the right, at PureTech&#146;s expense, to inspect such records during normal business hours upon minimum advance notice of [***] to verify any reports
and payments made or compliance in other respects under this Agreement. Any person inspecting the books and records of the Company on behalf of PureTech pursuant to this Section&nbsp;3.4 shall enter into a customary confidentiality agreement with
the Company covering the receipt of confidential information from the Company. In the event that any audit performed under this Section&nbsp;3.4 reveals an underpayment in excess of [***], the Company shall bear the full cost of such audit. Any
auditor shall report to PureTech only the amount of any underpayment or overpayment to PureTech or that the payments made by the Company were correct. The Company shall remit any amounts due to PureTech within [***] of receiving the report of the
auditor. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4.</B> INDEMNIFICATION </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Indemnity.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>By the Company.</U> The Company shall indemnify, defend, and hold harmless PureTech and its members, directors,
officers, employees, agents and Affiliates and their respective successors, heirs and assigns (the <U>&#147;PureTech Indemnitees&#148;),</U> against any liability, damage, loss, or expense (including reasonable attorneys fees and expenses) incurred
by or imposed upon any of the PureTech Indemnitees in connection with any third party claims, suits, actions, demands or judgments arising out of any theory of liability (including without limitation actions in the form of tort, warranty, or strict
liability and regardless of whether such action has any factual basis) (a <U>&#147;Loss&#148;)</U> (i) concerning any product, process, or service that is made, used, sold, imported, or performed pursuant to any right or license granted under this
Agreement or (ii)&nbsp;due to a breach of this Agreement by the Company; provided, however, that the foregoing indemnification shall not apply to any Loss to the extent such Loss is caused by the breach of this Agreement or the negligence or willful
misconduct of a PureTech Indemnitee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>By PureTech.</U> PureTech shall indemnify, defend, and hold harmless
the Company and its directors, officers, employees, agents and Affiliates and their respective successors, heirs and assigns (the <U>&#147;Company lndemnitees&#148;)</U>, against any Loss due to a breach of this Agreement by the PureTech; provided,
however, that the foregoing indemnification shall not apply to any Loss to the extent such Loss is caused by the breach of this Agreement or the negligence or willful misconduct of a Company Indemnitee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Procedures.</U> A party seeking indemnification pursuant to Section&nbsp;4.1 shall provide the indemnifying
Party with prompt written notice of any claim, suit, action, demand, or judgment for which indemnification is sought under this Agreement. The indemnifying Party, at its own expense, shall provide attorneys reasonably acceptable to the indemnified
party to defend against any such claim. The indemnified party shall cooperate fully with the indemnifying Party in such defense and will permit the indemnifying Party to conduct and control such defense and the disposition of such claim, suit, or
action (including all decisions relative to litigation, appeal, and settlement); provided, however, that any indemnified party spall have the right to retain its own counsel, at the expense of the indemnifying Party, if representation of such
indemnified party by the counsel retained by the indemnifying Party would be inappropriate because of actual legal conflicts between such indemnified party and any other party represented by such counsel. The indemnifying Party agrees to keep the
other Party informed of the progress in the defense and disposition of such claim and to consult with such Party with regard to any proposed settlement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>5.</B> REPRESENTATIONS, WARRANTIES AND COVENANTS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties by each Party.</U> Each of PureTech and the Company, with respect to itself,
represents, warrants and covenants to the other that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;it is a corporation or entity duly organized and validly
existing under the laws of the state or jurisdiction of its incorporation; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;the execution, delivery, and performance of this Agreement has
been duly authorized by all requisite corporate or other action and does not require any shareholder or member action or approval; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;it has the full right, power, and authority to enter into and deliver this Agreement, and that the execution of
this Agreement creates a valid and binding Agreement enforceable against it in accordance with its terms; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;the
execution, delivery, and performance of this Agreement and its compliance with the terms and provisions hereof does not, and will not, conflict with or result in a breach of any of the terms or provisions of, or constitute a default under (i)&nbsp;a
loan agreement, guaranty, financing agreement, agreement affecting a product or other agreement or instrument binding or affecting it or its property; (ii)&nbsp;the provisions of its charter or operative documents or
<FONT STYLE="white-space:nowrap">by-laws;</FONT> or (iii)&nbsp;any order, writ, injunction, or decree of any court or governmental authority entered against it or by which any of its property is bound; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;to its knowledge, there are no existing or threatened actions, suits or claims pending against it with respect to
its right to enter into and perform its obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>No Inconsistent Agreements.</U> Neither Party has in
effect and after the Effective Date neither Party shall enter into any oral or written agreement or arrangement that would be inconsistent with its obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6.</B> ASSIGNMENT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither Party may assign
this Agreement without the written consent of the other Party, which consent shall not be unreasonably withheld or delayed. Notwithstanding the foregoing, upon written notice to the other Party, either Party may assign this Agreement to a successor
to its business:(whether by merger, a sale or other transfer of all or substantially all of its assets, a sale of a controlling interest of its capital stock, or otherwise) which agrees in writing to assume its obligations hereunder. This Agreement
will be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7.</B>
COVENANTS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Laws.</U> The Company shall comply in all material respects with all commercially
material applicable local, state, federal, and foreign laws and regulations relating to the development, manufacture, use, and sale of Products, Processes and Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Export Control.</U> The Company and its Affiliates and Sublicensees shall comply with all United States laws and
regulations controlling the export of certain commodities and technical data, including without limitation all Export Administration Regulations of the United States Department of Commerce. Among other things, these laws and regulations prohibit or
require license for the export of certain types of commodities and technical data to specified countries. The Company hereby gives written assurance that it will comply with, and will require its Affiliates and Sublicensees to comply with, all
United </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
States export control laws and regulations, that it bears sole responsibility for any violation of such laws and regulations by itself or its Affiliates or Sublicensees, and that it will
indemnify, defend, and hold PureTech harmless (in accordance with Section&nbsp;4) for the consequences of any such violation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3&nbsp;&nbsp;&nbsp;&nbsp;<U><FONT STYLE="white-space:nowrap">Non-Use</FONT> of PureTech Name.</U> The Company and its Affiliates and
Sublicensees shall not use the name of PureTech or any variation, adaptation, or abbreviation thereof, or of any of it employees, or agents, or any trademark owned by PureTech, or any terms of this Agreement in any promotional material or other
public announcement or disclosure without the prior written consent of PureTech, except as may be required by law, stock exchange rule or other securities trading system rule. The Company shall be entitled to factually identify PureTech as its
licensor under this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>8. </B>TERMINATION. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Voluntary Termination.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;PureTech shall have the right to terminate this Agreement, for any reason, at any time upon at least [***] prior
written notice to the Company, such notice to state the date upon which such termination is to be effective. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Termination for Default.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Nonpayment</U>. In the event the Company fails to pay any amounts due and payable to PureTech hereunder, and
fails to make such payment within [***] after receiving written notice (by certified US mail) of such failure, PureTech may terminate this Agreement immediately upon written notice to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Material Breach by the Company.</U> In the event the Company commits a material breach of its obligations under
this Agreement, except for breach as described in Section&nbsp;8.2(a), and fails to cure that breach within [***] after receiving written notice thereof (by certified US mail), PureTech may terminate this Agreement immediately upon written notice to
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Material Breach by PureTech.</U> In the event PureTech commits a material breach of its
obligations under this Agreement and fails to cure that breach within [***] after receiving written notice thereof (by certified US mail), the Company may terminate this Agreement immediately upon written notice to PureTech. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Effect of Termination.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival</U>. The following provisions shall survive the expiration or termination of this Agreement: Articles 1
and 9, and Sections 3.2 (to the extent requiring a final report and payment) and 3.4. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9. </B>DISPUTE RESOLUTION. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Mandatory Procedures.</U> The Parties agree that any dispute arising out of or
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
relating to this Agreement shall be resolved solely by means of the procedures set forth in this Article, and that such procedures constitute legally binding obligations that are an essential
provision of this Agreement. If either Party fails to observe the procedures of this Article, as may be modified by their written agreement, the other Party may bring an action for specific performance of these procedures in any court of competent
jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Equitable Remedies</U>. Although the procedures specified in this Article are the sole and
&middot;exclusive procedures for the resolution of disputes arising out of or relating to this Agreement, either Party may seek a preliminary injunction or other provisional equitable relief if, in its reasonable judgment, such action is necessary
to avoid irreparable harm to itself or to preserve its rights under this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">9.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Dispute Resolution
Procedures</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Negotiation</U>. In the event of any dispute arising out of or relating to this Agreement,
the affected Party shall notify the other Party, and the Parties shall attempt in good faith to resolve the matter within [***] after the date of such notice (the <U>&#147;Notice Date</U>&#148;). Any disputes not resolved by good faith discussions
shall be referred to senior executives of each Party, who shall meet at a mutually acceptable time and location within [***] after the Notice Date and attempt to negotiate a settlement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Arbitration</U>. If the matter remains unresolved within [***] after the Notice Date, or if the senior
executives fail to meet within [***] after the Notice Date, either Party shall be entitled to submit the matter to binding arbitration under the commercial arbitration rules of the American Arbitration Association. Any such arbitration shall be
conducted by a panel of three arbitrators (the &#147;<U>Arbitration Panel</U>&#148;) and shall be conducted in Boston, Massachusetts. PureTech on the one hand, and the Company on the other, shall each appoint one arbitrator, and the third arbitrator
shall be appointed by the two arbitrators appointed by PureTech and the Company. The Arbitration Panel shall have the authority to grant specific performance and to allocate between the parties the costs of arbitration in such equitable manner as it
shall determine. Judgments upon the award so rendered may be entered in any court having jurisdiction or application may be made to such court for judicial acceptance of any award and an order of enforcement, as the case may be. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>10. </B>MISCELLANEOUS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice</U>. Any notices required or permitted under this Agreement shall be in writing, shall specifically
refer to this Agreement, and shall be sent by hand, recognized national overnight courier, confirmed facsimile transmission, or registered or certified mail, postage prepaid, return receipt requested, to the following addresses or facsimile numbers
of the parties: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="72%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If to PureTech:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Daphne Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">PureTech Ventures, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">500 Boylston Street, Suite 1600</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Boston, Massachusetts 02116</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fax: 617.482.3337</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If to the Company:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Follica, Incorporated</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">500 Boylston Street, Suite 1600</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Boston, Massachusetts 02116</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fax: 617.482.3337.</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All notices under this Agreement shall be deemed effective upon receipt. A party may change
its contact information immediately upon written notice to the other party in the manner provided in this Section&nbsp;10.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. This Agreement and all disputes arising out of or related to this Agreement, or the
performance, enforcement, breach or termination hereof, and any remedies relating thereto, shall be construed, governed, interpreted and applied in accordance with the laws of the Commonwealth of Massachusetts, U.S.A., without regard to conflict of
laws principles, except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent shall have been granted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Force Majeure</U>. Neither party will be responsible for delays resulting from causes beyond the reasonable
control of such party, including without limitation fire, explosion, flood, war, strike, or riot, provided that the nonperforming party uses commercially reasonable efforts to avoid or remove such causes of nonperformance and continues performance
under this Agreement with reasonable dispatch whenever such causes are removed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Waiver</U>.
This Agreement may be amended, supplemented, or otherwise modified only by means of a written instrument signed by both Parties. Any waiver of any rights or failure to act in a specific instance shall relate only to such instance and shall not be
construed as an agreement to waive any rights or fail to act in any other instance, whether or not similar. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. In the event that any provision of this Agreement shall be held invalid or unenforceable for
any reason, such invalidity or unenforceability shall not affect any other provision of this Agreement, and the parties shall negotiate in good faith to modify the Agreement to preserve (to the extent possible) their original intent. If the Parties
fail to reach a modified agreement within [***] after the relevant provision is held invalid or unenforceable, then the dispute shall be resolved in accordance with the procedures set forth in Article 13. While the dispute is pending resolution,
this Agreement shall be construed as if such provision were deleted by agreement of the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.6&nbsp;&nbsp;&nbsp;&nbsp;<U>Binding
Effect</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their respective permitted successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.7&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>. All headings are for convenience only and shall not affect the meaning of any provision of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.8&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement</U>. This Agreement constitutes the entire agreement between the parties with
respect to its subject matter and supersedes all prior agreements or understandings between the parties relating to its subject matter. For the avoidance of doubt, this Agreement shall not supersede the Exclusive Patent License Agreement dated as of
July&nbsp;16, 2008 by and between PureTech and the Company, which agreement shall remain in full force and effect. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly
authorized representatives. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PURETECH VENTURES LLC</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">FOLLICA, INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daphne Zohar</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daphne Zohar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Daphne Zohar</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Daphne Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Partner</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Interim President and CEO</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>6
<FILENAME>filename6.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.10</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.10 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ROYALTY AND SUBLICENSE INCOME AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This ROYALTY ASSIGNMENT AGREEMENT (the &#147;<U>Agreement</U>&#148;), dated as of December&nbsp;18, 2009, is by and among (i)&nbsp;PureTech Ventures, LLC, a
Delaware limited liability company, (&#147;<U>PureTech</U>&#148;), (ii)&nbsp;Gelesis, Inc., a Delaware corporation, (&#147;<U>Gelesis-US</U>&#148;) and (iii)&nbsp;Gelesis LP (formerly AML-Dienstein B. V.), a Bermudan limited partnership
(&#147;<U>Gelesis-Bermuda</U>&#148; and collectively with Gelesis-US, &#147;<U>Gelesis</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, PureTech is required to provide certain
funding, management services and intellectual property as set forth in (i)&nbsp;the Note Purchase Agreement dated on or about the date hereof by and between Gelesis-US and PureTech and (ii)&nbsp;the Management and Overhead Services Agreement dated
on or about the date hereof by and between Gelesis-US and PureTech; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, PureTech will receive certain consideration for such funding, management
services and intellectual property, including the potential royalty payments and sublicense payments set forth herein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration
of the mutual promises hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. Reference is made to that certain Patent License and Assignment Agreement dated December&nbsp;9, 2009 (the &#147;<U>License
Agreement</U>&#148;) by and among Gelesis-Bermuda, One S. R. L., Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino. All capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Royalties</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Gelesis shall pay to PureTech, during
the applicable term described in Section&nbsp;2(b) below, earned royalties at the following rates: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Type of Licensed Product</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Rate</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">A royalty on all Net Sales by Gelesis-Bermuda, its affiliates or any Sublicensee of Licensed
Products that are not FoodProducts:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">A royalty on all Net Sales by Gelesis-Bermuda or its affiliates of Licensed Products that are Food
Products:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the manufacture, use, lease, or sale of any Licensed Product is covered by more than one of the Valid Claims under the
Patent Rights in the Field, or any patents in the Improvements or Food IP, <U>multiple</U> royalties shall <U>not</U> be due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) The Parties hereby
agree that should intellectual property rights owned by a third party pose as an obstacle to the development or commercialization of any Licensed Product that is not a Food Product (the &#147;<U>Blocking IP</U>&#148;), Gelesis-Bermuda or an
applicable affiliate of Gelesis-Bermuda shall, after consulting in good faith with PureTech, seek a potential settlement solution with the Blocking IP holder and the royalty rates for Licensed Products that are not Food Products set forth in
Section&nbsp;2(a) shall be reduced by the amount of such consideration paid for the rights to such Blocking IP; provided, however that in no case shall the royalty rates for Licensed Products that are not Food Products set forth in Section&nbsp;2(a)
be reduced by more than fifty percent (50%)&nbsp;as a result of the application of this Section&nbsp;2(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) The obligation of Gelesis to pay royalties
pursuant to Section&nbsp;2(a) shall terminate on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis concurrently with (i)&nbsp;the expiration or termination of the applicable Valid Claim under
the Patent Rights in the country in which the Licensed Product is sold, or (ii)&nbsp;the withdrawal, cancellation, or disclaiming of the applicable Valid Claim under the Patent Rights in the country in which the Licensed Product is sold. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Sublicense Income</U>. Gelesis shall pay to PureTech ten percent (10%)&nbsp;of Sublicense Income
received by Gelesis and its affiliates on Food Products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>Reports and Payments</U>. Following the commencement of Gelesis&#146;s obligations to pay
any royalties pursuant to Section&nbsp;2, Gelesis shall deliver to PureTech within sixty (60)&nbsp;days after the end of each calendar quarter a written report showing its computation of royalties due under this Agreement for such calendar quarter.
Simultaneously with the delivery of each such report, Gelesis shall tender payment of all amounts shown to be due thereon. The royalty payments due on sales in currencies other than U.S. dollars shall be calculated using the appropriate exchange
rate for such currency quoted by the relevant Government Authority as published by the Wall Street Journal on the last business day of the calendar quarter to which such report relates. All amounts due under this Agreement shall be paid to PureTech
in U.S. dollars by wire transfer to an account in a bank designated by PureTech, or in such other form and/or manner as PureTech may reasonably request. During the term of this Agreement, PureTech, at its cost, shall have the right from time to time
(not to exceed once during each calendar year) to engage a certified public accountant, reasonably acceptable to Gelesis, to inspect, during normal business hours, upon reasonable advance notice (not less than one week), and subject to a written
obligation of confidentiality acceptable to Gelesis, such books, records and other supporting data of Gelesis as may be necessary to verify Gelesis&#146;s computation of royalties due under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U>Withholding Taxes</U>. All payments made by Gelesis to PureTech shall be net of withholding taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U>Miscellaneous</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Transfers of Rights under this
Agreement</U>. This Agreement, and the rights and obligations of each party hereunder, may not be assigned by any party without the prior written consent of each of PureTech and Gelesis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>Successors and Assigns</U>. The provisions of this Agreement shall inure to the benefit of, and be binding upon, the respective successors, permitted
assigns, heirs, executors, and administrators of the parties hereto and shall inure to the benefit of and be enforceable by each party hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c)
<U>Notices</U>. Any notice, demand, request or delivery required or permitted to be given pursuant to the terms of this Agreement shall be in writing and shall be deemed given (i)&nbsp;when delivered personally or when sent by facsimile transmission
and confirmed by telephone or electronic transmission report (with a hard copy to follow by mail), (ii)&nbsp;on the next business day after timely delivery to a generally recognized receipted overnight courier (such as FedEx) and (iii)&nbsp;on the
third business day after deposit in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid), addressed to the party at such party&#146;s address as set forth on the signature pages hereto or as subsequently modified
by written notice delivered as provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the laws
of the State of Delaware and the laws of the United States applicable therein (without giving effect to any choice or conflict of laws provision or rule that would cause the application of the laws of any other jurisdiction) and shall be treated in
all respects as a Delaware contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) <U>Waivers and Amendments</U>. Except as otherwise expressly set forth in this Agreement, any term of this
Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only by written agreement of PureTech, Gelesis-US and Gelesis-Bermuda.
No waivers of or exceptions to any term, condition or provision of this Agreement, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) <U>Delays or Omissions</U>. No delay on the part of any party in exercising any right, power, remedy or privilege hereunder shall operate as a waiver
thereof nor shall any waiver on the part of any party of any such right, power, remedy or privilege, nor any single or partial exercise of any such right, power, remedy or privilege, preclude any further exercise thereof or the exercise of any other
such right, power, remedy or privilege. All remedies, either under this Agreement, by law, or otherwise afforded to the parties, shall be cumulative and not alternative. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) <U>Titles and Subtitles</U>. The titles of the sections and subsections of this Agreement are for
convenience of reference, only and are not to be considered in construing this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) <U>Entire Agreement</U>. This Agreement embodies the entire
agreement and understanding among the parties with respect to the subject matter hereof and related transactions, and supersedes all prior agreements and understandings among the parties, written or oral, with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <U>Counterparts</U>. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(j) <U>Severability</U>. If any provision of this Agreement shall be held to be illegal, invalid or
unenforceable, such illegality, invalidity or unenforceability shall attach only to such provision and shall not in any manner affect or render illegal, invalid or unenforceable any other provision of this Agreement, and this Agreement shall be
carried out as if any such illegal, invalid or unenforceable provision were not contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(k)
<U><FONT STYLE="white-space:nowrap">Non-Impairment</FONT></U>. No amendment, waiver or termination of the License Agreement following the date hereof shall have any effect on the terms of this Agreement unless such amendment, waiver or termination
is approved in writing by PureTech. In addition, each of Gelesis-US and Gelesis-Bermuda agree not to, through any reorganization, recapitalization, reclassification, transfer of assets, consolidation, merger, dissolution, issue or sale of securities
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by such party, but will at all times in good faith assist in the carrying out of all the provisions of this
Agreement and in the taking of all such action as may be necessary or appropriate in order to protect the rights described herein against impairment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Remainder of Page Intentionally Left Blank</I>]<I> </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have executed this Royalty and Sublicense Income Agreement as of the date
first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GELESIS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Yishai Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">222 Berkeley Street, Suite 1040</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston,
Massachusetts 02116</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Fax: 617. 482. 2333</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GELESIS, LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Yishai Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">222 Berkeley Street, Suite 1040</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston,
Massachusetts 02116</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Fax: 617. 482. 2333</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PURETECH VENTURES, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Daphne Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">222 Berkeley Street, Suite 1040</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston,
Massachusetts 02116</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Fax: 617. 482. 2333</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 1 TO ROYALTY AND SUBLICENSE INCOME AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;1 (&#147;<U>Amendment No.</U><U></U><U>&nbsp;1</U>&#148;) to the Royalty and Sublicense Income Agreement dated as of December&nbsp;18,
2009 (the &#147;<U>Agreement</U>&#148;) by and among Gelesis, Inc, a Delaware corporation (&#147;<U>Gelesis-US</U>&#148;), Gelesis IP L. P., a Bermudan limited partnership (&#147;Gelesis<U>-Bermuda</U>&#148;), and PureTech Ventures, LLC, a Delaware
limited liability company (&#147;<U>PureTech</U>&#148;), is entered into on this 28th day of June, 2012 by and among Gelesis-US, Gelesis-Bermuda, PureTech, and Gelesis, LLC, a Delaware limited liability company (&#147;<U>Gelesis. LLC</U>&#148;).
This Amendment No.&nbsp;1 shall not become binding and shall have no effect unless and until Gelesis, Inc. enters into a License and Collaboration Agreement (the &#147;<U>Gelesis/AZ Agreement</U>&#148;) with AstraZeneca AB
(&#147;<U>AstraZeneca</U>&#148;) substantially in the form attached hereto as Exhibit A. The date on which the Gelesis/AZ Agreement is signed shall be the effective date (the &#147;<U>Amendment No.</U><U></U><U>&nbsp;1 Effective Date</U>&#148;) of
this Amendment No.&nbsp;1. For purposes hereof, all capitalized terms used herein but not defined herein shall have the meanings given to them in the Master Agreement and License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;6(e) of the Agreement and Section&nbsp;9. 9 of the License Agreement, Gelesis-US, Gelesis-Bermuda, Gelesis, LLC, and PureTech hereby
agree as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. The parties hereby agree that Gelesis-US and Gelesis-Bermuda hereby assign to Gelesis, LLC, and Gelesis, LLC hereby accepts and
assumes, all rights, interests, and obligations under this Agreement. All references to &#147;Gelesis-US&#148;, &#147;Gelesis-Bemuda&#148;, and &#147;Gelesis&#148; in the Agreement shall hereafter be deemed to refer to Gelesis, LLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. Section&nbsp;2 of the License Agreement is hereby deleted and replaced its their entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;2. In the event that, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, one or more patents
are issued by the patent authority in that country and contain a Valid Claim, Gelesis LLC shall pay to PureTech Ventures, LLC two percent (2%)&nbsp;of Net Sales of such Licensed Product during the Calendar Year. For the avoidance of doubt there is
no increase to the royalty for more than one Valid Claim. In the event that, on a <FONT STYLE="white-space:nowrap">country-by</FONT> country basis, there is no Valid Claim, Gelesis LLC shall pay to PureTech five percent (5%)&nbsp;of any royalty paid
to Gelesis, LLC by AstraZeneca pursuant to Section&nbsp;10. 5. 2 (i. e. Royalty Scenario 2) of the Gelesis/AZ Agreement. The royalties referred to in Section&nbsp;2 shall (i)&nbsp;be paid to PureTech within thirty (30)&nbsp;days following receipt of
such royalty by Gelesis, LLC from AstraZenca and (b)&nbsp;be subject to all of the same adjustments as the royalties payable to Gelesis, LLC under the AstraZeneca Agreement.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Solely for purposes of this Section&nbsp;1 of this Amendment No.&nbsp;1, all capitalized terms shall have the meanings ascribed to them in the Gelesis/AZ
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. In the event that the Gelesis/AZ Agreement is terminated, PureTech may request in writing that the Amendments set forth in Section&nbsp;2
of this Amendment No.&nbsp;1 be terminated. In such event, the amendment set forth in Section&nbsp;2 of this Amendment No.&nbsp;1 shall terminate and be of no further force or effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. The Agreement (including Amendment No.&nbsp;1) are hereby confirmed and continue in all other respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of Page Intentionally Blank.] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Amendment No to be executed by their duly authorized
representatives as of the Amendment No, 1 Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GELESIS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Yishai Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Yishai Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GELESIS LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Yishai Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Yishai Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GELESIS IP L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Yishai Zohar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PURETECH VENTURES, LLC:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Stephen Muniz</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stephen Muniz</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Partner</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>7
<FILENAME>filename7.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.11</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.11 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED (INDICATED BY: [ *** ]) FROM THE EXHIBIT BECAUSE IT IS BOTH (I)&nbsp;NOT MATERIAL AND (II)&nbsp;WOULD LIKELY
CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXCLUSIVE PATENT LICENSE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>by and between </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURETECH VENTURES LLC </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KARUNA
PHARMACEUTICALS, INC. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED (INDICATED BY: [ *** ]) FROM THE EXHIBIT BECAUSE IT IS BOTH
(I)&nbsp;NOT MATERIAL AND (II)&nbsp;WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXCLUSIVE PATENT LICENSE AGREEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement, effective as of the date set forth above the signatures of the parties below (the &#147;<U>Effective Date</U>&#148;), is between
PureTech Ventures LLC, a Delaware limited liability company (&#147;<U>PureTech</U>&#148;), and Karuna Pharmaceuticals, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;). PureTech and the Company are sometimes referred to herein
individually as a &#147;Party&#148; and collectively as the &#147;Parties.&#148; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RECITALS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, PureTech is the owner of certain Patent Rights (as later defined herein) and has the right to grant licenses under said Patent Rights; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, PureTech desires to have the Patent Rights developed and commercialized by the Company and is willing to grant a license thereunder; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company desires to obtain a license under the Patent Rights and PureTech is willing to grant the same to the Company upon the terms and
conditions hereinafter set forth. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, PureTech and the Company hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>1<B></B>.<B> DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.1
&#147;<U>Affiliate</U>&#148; shall mean any legal entity (such as a corporation, partnership, or limited liability company) that is controlled by a Party. For purposes of this definition, the term &#147;control&#148; means as to such entity, direct
or indirect ownership of (i)&nbsp;more than fifty percent (50%)&nbsp;in the aggregate of the voting power of all outstanding shares entitled to vote at a general election of directors of such entity, (H)&nbsp;more than fifty percent (50%)&nbsp;of
the equity interests in such entity, or (iii)&nbsp;more than fifty percent (50%)&nbsp;of the assets of such entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.2 &#147;<U>Field</U>&#148; shall
mean all uses and applications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.3 &#147;<U>Licensed Product</U>&#148; shall mean any product that cannot be manufactured, used, leased or sold, in
whole or in part, without infringing one or more Valid Claims under the Patent Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.4 &#147;<U>Net Sales</U>&#148; means [ *** ]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[ *** ] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.5 &#147;<U>Patent Rights</U>&#148; shall mean all of
PureTech&#146;s right, title and interest in: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) the United States patent applications listed on <U>Appendix A</U>, their foreign counterparts, and the
resulting patents; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) any divisionals, continuations,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuation-in-part</FONT></FONT> applications, continued prosecution applications, or any other application claiming priority to one or more of the patent applications listed on
<U>Appendix A</U> to the extent the claims are directed to subject matter specifically described in the patent applications listed on <U>Appendix A</U>, and the resulting patents; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) any patents resulting from reissues, reexaminations, extensions, or restorations (and their relevant international equivalents) of the patents described
in (a)&nbsp;and (b)&nbsp;above. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.6 &#147;<U>Reporting Period</U>&#148; shall begin on the first day of each calendar quarter and end on the
last day of such calendar quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.7 &#147;<U>Sublicense Income</U>&#148; shall mean all consideration received by the Company or any of its Affiliates
from Sublicensees in exchange for the sublicensing of rights granted to the Company pursuant to Article 2 herein, but specifically excluding royalties. Sublicensing Income includes, without limitation, upfront payments, milestone payments, license
maintenance fees, research and development funding (subject to (a), below) and equity investments (whether in the form of stock purchase, options, warrants, convertible debt or other forms) (subject to (a), below) paid directly or indirectly to the
Company (or any of its Affiliates) from (or on behalf of) any Sublicensee. Notwithstanding the foregoing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) funding of activities directly in
furtherance of Licensed Product research and clinical, regulatory and manufacturing process development are excluded from Sublicense Income; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)
Sublicense Income shall not include amounts paid to the Company as an equity investment in the Company or any of its Affiliates (whether in the form of stock purchase, options, warrants or other forms) to the extent that the amount of such
investment (calculated in case of options, warrants and the like as if exercised and including all amounts due on exercise) does not involve any premium over fair market value of the equity investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To avoid any doubt, Sublicensing Income extends to and includes consideration that is paid on the basis of rights (including covenants not to sue) under any
intellectual property licensed to the Company pursuant to Article 2 of this Agreement even if the Company structures its grant of rights to the Sublicensee so that the grant of rights under the Patent Rights formally occurs in a separate written
agreement from the grant of rights under other intellectual property of the Company relating to the Licensed Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.8 &#147;<U>Sublicensee</U>&#148;
shall mean any <FONT STYLE="white-space:nowrap">non-Affiliate</FONT> sublicensee of the rights granted the Company under Section&nbsp;2.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.9
&#147;<U>Term</U>&#148; shall mean the term of this Agreement, which shall commence on the Effective Date and shall remain in effect until the expiration or abandonment of all issued patents and filed patent applications within the Patent Rights,
unless earlier terminated in accordance with the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.10 &#147;<U>Territory</U>&#148; shall mean worldwide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.11 &#147;<U>Valid Claim</U>&#148; shall mean a claim of any filed patent application included within the Patent Rights which has not been held finally
revoked, unenforceable or invalid by a decision of a court or other governmental agency of competent jurisdiction and which (i)&nbsp;has not been admitted to be invalid or unenforceable through reissue or disclaimer or otherwise, (ii)&nbsp;has not
been withdrawn or abandoned, or (iii)&nbsp;has not been lost through an interference proceeding. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>2.<B> GRANT OF RIGHTS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.1 <U>License Grants</U>. Subject to the terms of this Agreement, PureTech hereby grants to the Company for the Term a royalty-bearing exclusive license
(even as against PureTech) under the Patent Rights to research, develop, make, have made, use, offer for sale, sell, lease, import and otherwise exploit Licensed Products in the Field in the Territory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.2 <U>Sublicenses</U>. The Company shall have the right to grant sublicenses of its rights hereunder. The Company shall incorporate terms and conditions into
such sublicense agreements sufficient to enable the Company to comply with this Agreement. Within [ *** ] following the execution thereof, the Company shall furnish PureTech with a fully signed photocopy of any sublicense agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.3 <U>No Additional Rights</U>. Nothing in this Agreement shall be construed to confer any rights upon the Company by implication, estoppel or otherwise as
to any technology or patent rights of PureTech or any other entity other than the Patent Rights, regardless of whether such technology or patent rights shall be dominant or subordinate to any Patent Rights. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.4 <U>Due Diligence Obligations</U>. The Company shall use diligent efforts, and shall cause its Affiliates
and any Sublicensees to use diligent efforts, to develop Licensed Products and to introduce Licensed Products into the commercial market; thereafter, the Company and its Affiliates and any Sublicensees shall maximize the commercial sales of such
Licensed Products. Specifically, the Company and its Affiliates and any Sublicensees shall fulfill the following obligations: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Within [ *** ] of the
Effective Date, the Company shall initiate, defined as first dosing of patient, a trial using a Licensed Product where the primary outcome measure is a statistically significant separation by a Licensed Product from placebo on the positive and
negative symptom scale (PANSS) or equivalent scale that has previously been used as a primary endpoint for U.S. Food and Drug Administration registration for the treatment of schizophrenia and the total number of patients that will enroll in the
study is greater than [ *** ]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) At any time prior to approval of a Licensed Product by the U.S. Food and Drug Administration, the Company shall not,
for any consecutive [ *** ] period, fail to initiate, defined as first dosing of patient, a human clinical study with a Licensed Product or make a regulatory submission to the U.S. Food and Drug Administration, the European Medicines Evaluation
Agency, or the Japanese Ministry of Health and Welfare seeking the marketing of a License Product for the treatment of a disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) The Company shall
not (i)&nbsp;become insolvent; (ii)&nbsp;make an assignment for the benefit of creditors; (iii)&nbsp;have a bona fide petition in bankruptcy filed for or against it, which petition is withdrawn or dismissed within [ *** ] of its filing; or
(iv)&nbsp;cease operations (at an activity level sufficient for the continued development of Products) for more than one [ *** ]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that
PureTech determines that the Company (or an Affiliate or Sublicensee) has failed to fulfill its obligations under this Section&nbsp;2.4, then PureTech may treat such failure as a material breach in accordance with Section&nbsp;11.2(b). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>3.<B> ROYALTIES AND PAYMENT TERMS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.1 <U>Consideration for Grant of Rights</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Running
Royalties</U>. The Company shall pay to PureTech a running royalty of [ *** ] of annual Net Sales by the Company, its Affiliates and any Sublicensees. Running royalties shall be payable for each Reporting Period and shall be due to PureTech within [
*** ] of the end of each Reporting Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>Milestone Payments</U>. The Company shall pay to PureTech the following milestone payments in
connection with the achievement of the following events by the Company, any of its Affiliates or any Sublicensee (each such event is hereafter referred to as a &#147;<U>Milestone</U>&#148;): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) [ *** ] within [ *** ] following the commencement of a Phase III Clinical Trial of a Licensed Product; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) [ *** ] within [ *** ] following approval by the U.S. Food and Drug Administration, or any successor thereto, to offer for sale and sell (including any
necessary price approvals) any Licensed Product; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) [ *** ] within [ *** ] following approval by the European Medicines Evaluation Agency or any other
European regulatory authority, or any successor thereto, to offer for sale and sell (including any necessary price approvals) any Licensed Product; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv) [ *** ] within [ *** ] following approval by the Japanese Ministry of Health and Welfare or, any successor entity to offer for sale and sell (including
any necessary price approvals) any Licensed Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <U>Sharing of Sublicense Income</U>. The Company shall pay PureTech [ *** ] all Sublicense
Income received by the Company or its Affiliates, excluding running royalties on Net Sales of Sublicensees. Such amount shall he payable for each Reporting Period and shall be due to PureTech within [ *** ] of the end of each Reporting Period. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.2 <U>Payments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Method of Payment</U>. All payments under this Agreement shall be made payable to PureTech and sent to the address identified in Section&nbsp;13.1.
Each payment should reference this Agreement and identify the obligation under this Agreement that the payment satisfies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>Payments in U.S.
Dollars</U>. All payments due under this Agreement shall be payable in United States dollars. Conversion of foreign currency to U.S. dollars shall be made at the conversion rate existing in the United States (as reported in <U>The Wall Street
Journal</U>) for the last working day of the calendar quarter of the applicable Reporting Period. Such payments shall be without deduction of exchange, collection or other charges. Each Party is solely responsible for timely and properly filing and
payment of its own taxes of any kind and in any jurisdiction. All payments under this Agreement shall be made in full without any deduction or withholding for or on account of any tax unless such deduction or withholding is required by applicable
governmental laws, tax treaty, or regulations. Any tax required to be withheld by the Company under the laws of any foreign country for the account of PureTech shall be promptly paid by the Company for and on behalf of PureTech to the appropriate
governmental authority, and the Company shall use its best efforts to furnish PureTech with proof of payment of such tax together with official or other appropriate evidence issued by the applicable government authority. Any such tax actually paid
on PureTech&#146;s behalf shall be deducted from royalty payments due PureTech. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <U>Late Payments</U>. Any payments by the Company that are not paid
on or before the date <B>s</B>uch payments are due under this Agreement shall bear interest, to the extent permitted by law, at [ *** ] above the Prime Rate of interest as reported in <U>The Wall Street Journal</U> on the date payment is due. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>4.<B> REPORTS AND RECORD KEEPING. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.1 <U>Frequency of Reports</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Before First
Commercial Sale</U>. Prior to the first commercial sale of any Licensed Product, the Company shall deliver reports to PureTech annually, within [ *** ] the end of each calendar year, containing information concerning the progress of research and
development pertaining to the Licensed Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>Upon First Commercial Sale</U>. The Company shall report to PureTech the date of first commercial
sale of a Licensed Product within [ *** ] of occurrence thereof in each country. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <U>After First Commercial Sale</U>. After the first commercial sale
of a Licensed Product, the Company shall deliver reports to PureTech within [ *** ] of the end of each Reporting Period, containing information concerning the immediately preceding Reporting Period, as further described in Section&nbsp;4.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.2 <U>Content of Reports and Payments</U>. Each report delivered by the Company to PureTech shall contain at least the following information for the
immediately preceding Reporting Period: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) the number of Licensed Products sold, leased or distributed by the Company, its Affiliates and any
Sublicensees to independent third parties in each country; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) the gross price charged by the Company, its Affiliates and any Sublicensees for each
Licensed Product; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) the calculation of Net Sales for the applicable Reporting Period in each country, including a listing of applicable deductions;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) the total royalty payable on Net Sales in U.S. dollars, together with the exchange rates used for conversion; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) the amount of Sublicense Income received by the Company from each Sublicensee and the amount due to PureTech from such Sublicense Income, including an
itemized breakdown of the sources of income comprising the Sublicense Income; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) the number of sublicenses entered into for the Patent Rights and/or
Licensed Products. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If no amounts are due to PureTech for any Reporting Period, the report shall so state. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.3 <U>Financial Statements</U>. On or before the [ *** ] following the close of the Company&#146;s fiscal year, the Company shall provide PureTech with the
Company&#146;s financial statements for the preceding fiscal year including, at a minimum, a balance sheet and an income statement, certified by the Company&#146;s treasurer or chief financial officer or by an independent auditor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.4 <U>Record Keeping</U>. The Company shall maintain, and shall require its Affiliates and any Sublicensees to maintain, complete and accurate records
relating to research and development under this Agreement and any amounts payable to PureTech in relation to this Agreement, which records shall contain sufficient information to permit PureTech to confirm the accuracy of any reports delivered to
PureTech and compliance in other respects with this Agreement. The relevant party shall retain such records for at least [ *** ] following the end of the calendar year to which they pertain, during which time PureTech, or PureTech&#146;s appointed
agents, shall have the right, at PureTech&#146;s expense, to inspect such records during normal business hours upon minimum advance notice of [ *** ] to verify any reports and payments made or compliance in other respects under this Agreement. Any
person inspecting the books and records of the Company on behalf of PureTech pursuant to this Section&nbsp;4.4 shall enter into a confidentiality agreement with the Company in its standard form covering the receipt of confidential information from
the Company. In the event that any audit performed under this Section reveals an underpayment in excess of [ *** ] the Company shall bear the full cost of such audit. Any auditor shall report to PureTech only the amount of any underpayment or
overpayment to PureTech or that the payments made by the Company were correct. The auditor shall deliver a copy of its audit report to the Company at the same time it remits such audit report to PureTech. The Company shall remit any amounts due to
PureTech. and PureTech shall refund any overpayment to the Company, within [ *** ] of receiving the report of the auditor. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>5.
<B>PATENT PROSECUTION. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.1 <U>Responsibility for Patent Rights</U>. The Company shall prepare, file, diligently prosecute and maintain all of the
Patent Rights. PureTech shall have reasonable opportunities to advise the Company with respect to such preparation, filing, prosecution and maintenance and PureTech arid the Company shall cooperate with each other (any each other&#146;s respective
legal counsel) in such filing, prosecution and maintenance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.2 <U>Payment of Expenses</U>. Payment of all fees and costs, including attorneys fees,
incurred after the Effective Date relating to the filing, prosecution and maintenance of the Patent Rights shall be the responsibility of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.3 <U>Reversion of Patent Rights</U>. In its sole discretion, the Company may elect not to prosecute certain of the Patent Rights (including rights in
certain countries or territories) if and only if the Company shall notify PureTech of such decision within [ *** ] prior to any filing deadline in respect of such Patent Rights; provided however that it the Company elects not to prosecute such
Patent Rights, such Patent Rights shall revert to PureTech and shall automatically be excluded from the definition of &#147;Patent Rights&#148; hereunder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>6.<B> INFRINGEMENT. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.1
<U>Notification of Infringement</U>. Each Party agrees to provide written notice to the other Party promptly after becoming aware of any infringement of the Patent Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.2 <U>Right to Prosecute Infringements</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Company
Right to Prosecute</U>. So long as the Company remains the exclusive licensee of the Patent Rights in the Field in the Territory, the Company, to the extent permitted by law, shall have the right, under its own control and at its own expense, to
prosecute any third party infringement of the Patent Rights in the Field in the Territory, subject to Section&nbsp;6.4. If required by law, PureTech shall permit any action under this Section&nbsp;6.2 to be brought in its name, including being
joined as a party-plaintiff, provided that the Company shall hold PureTech harmless from, and indemnify PureTech against, any costs, expenses, or liability that PureTech incurs in connection with such action. Prior to commencing any such action, the
Company shall consult with PureTech and shall consider the views </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of PureTech regarding the advisability of the proposed action and its effects. The Company shall not enter into any settlement, consent judgment, or other voluntary final disposition of any
infringement action under this Section&nbsp;6.2 which admits the invalidity or unenforceability of any Patent Rights without the prior written consent of PureTech. If the Company does not take commercially reasonable steps to abate the infringement
of such Patent Rights within [ *** ] from any infringement notice from PureTech, based upon the Company&#146;s determination that such action would be commercially unreasonable and the Company provides PureTech its reasons therefor in writing, then
the Company shall not have the obligation to take any such action or institute any proceeding. In this regard, the Company shall be entitled to use its reasonable commercial discretion in determining (a)&nbsp;whether to contact and/or institute any
action or proceeding against an alleged infringer; (b)&nbsp;the timing of any contact with an alleged infringer or action or proceeding to be instituted against an alleged infringer; (c)&nbsp;the location of any action or proceeding to be instituted
against an alleged infringer; and (d)&nbsp;if there is more than one alleged infringer, which alleged infringer to contact regarding its alleged infringement or against which any action or proceeding is to be brought. It is further understood and
agreed that, during such time as the Company is pursuing any action or proceeding against one alleged infringer, the Company shall have no obligation to contact or pursue additional alleged infringers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>PureTech Right to Prosecute</U>. In the event that the Company is unsuccessful in persuading the alleged infringer to desist or fails to have initiated
an infringement action within the time provided in Section&nbsp;6.2(a) above and the infringement is open, obvious and financially material, PureTech shall have the right, at its sole discretion, to prosecute such infringement under its sole control
and at its sole expense, and any recovery obtained shall belong to PureTech. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.3 <U>Declaratory Judgment Actions</U>. In the event that a declaratory
judgment action is brought against PureTech or the Company by a third party alleging invalidity, unenforceability, or <FONT STYLE="white-space:nowrap">non-infringement</FONT> of the Patent Rights, PureTech, at its option, shall have the right within
[ *** ] commencement of such action to take over the sole defense of the action at its own expense. If PureTech does not exercise this right, the Company may take over the sole defense of the action at the Company&#146;s sole expense, subject to
Section&nbsp;6.4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.4 <U>Recovery</U>. Any recovery obtained in an action brought by the Company under Sections 6.2 or 6.3 shall be distributed as
follows: (i)&nbsp;each Party shall be reimbursed [ *** ] for any expenses incurred in the action from the proceeds of such action or settlement, (ii)&nbsp;as to ordinary damages, such amount shall be treated as Net Sales, and the Company shall pay
to PureTech based upon such amount a reasonable approximation of the royalties and other amounts that the Company would have paid to PureTech if the Company had sold the infringing products, processes and services rather than the infringer, and
(iii)&nbsp;as to special or punitive damages, the parties shall share equally in any award. Any recovery obtained in an action brought by PureTech under Sections 6.2 or 6.3 shall be distributed as follows: (i)&nbsp;each Party shall be reimbursed [
*** ] for any expenses incurred in the action from the proceeds of such action or settlement and all remaining amounts shall be shared [ *** ] to PureTech and&nbsp;[ *** ] to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.5 <U>Cooperation</U>. Each party agrees to cooperate in any action under this Article which is controlled by the other party, provided that the controlling
party reimburses the cooperating party promptly for any costs and expenses incurred by the cooperating party in connection with providing such assistance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.6 <U>Right to Sublicense</U>. So long as the Company remains the exclusive licensee of the Patent Rights in the Field in the Territory, the Company shall
have the sole right to sublicense any alleged infringer in the Field in the Territory for use of the Patent Rights in accordance with the terms and conditions of this Agreement relating to sublicenses. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7. <B>INDEMNIFICATION</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.1 <U>Indemnity</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>By the Company</U>. The Company shall indemnify, defend, and hold harmless PureTech and its members, directors, officers, employees, agents and
Affiliates and their respective successors, heirs and assigns (the &#147;<U>PureTech Indemnitees</U>&#148;), against any liability, damage, loss, or expense (including reasonable attorneys fees and expenses) incurred by or imposed upon any of the
PureTech Indemnitees in connection with any third party claims, suits, actions, demands or judgments arising out of any theory of liability (including without limitation actions in the form of tort, warranty, or strict liability and regardless of
whether such action has any factual basis) (a &#147;<U>Loss</U>&#148;) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(i)&nbsp;concerning any product, process or service that is made, used, sold, imported or performed pursuant to any right or license granted under this Agreement or (ii)&nbsp;due to a breach of
this Agreement by the Company; provided, however, that the foregoing indemnification shall not apply to any Loss to the extent such Loss is caused by the breach of this Agreement or the gross negligence or willful misconduct of a PureTech
Indemnitee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.2 <U>Procedures</U>. A party seeking indemnification pursuant to Section&nbsp;7.1 shall provide the indemnifying Party with prompt written
notice of any claim, suit, action, demand, or judgment for which indemnification is sought under this Agreement. The indemnifying Party, at its own expense, shall provide attorneys reasonably acceptable to the indemnified party to defend against any
such claim. The indemnified party shall cooperate fully with the indemnifying Party in such defense and shall permit the indemnifying Party to conduct and control such defense and the disposition of such claim, suit, or action (including all
decisions relative to litigation, appeal, and settlement); provided, however, that any indemnified party shall have the right to retain its own counsel, at the expense of the indemnifying Party, if representation of such indemnified party by the
counsel retained by the indemnifying Party would be inappropriate because of actual legal conflicts between such indemnified party and any other party represented by such counsel. The indemnifying Party agrees to keep the other Party informed of the
progress in the defense and disposition of such claim and to consult with such Party with regard to any proposed settlement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.3 <U>Insurance</U>.
Beginning at such time as any such product, process or service is being commercially distributed, sold, leased or otherwise transferred, or performed or used, by the Company, an Affiliate or any Sublicensee, the Company shall, at its sole cost and
expense, procure and maintain commercial general liability insurance in amounts not less than [ *** ] per incident and [ *** ] annual aggregate and naming the Indemnitees as additional insureds. Such commercial general liability insurance shall
provide (i)&nbsp;product liability coverage and (ii)&nbsp;broad form contractual liability coverage for Company&#146;s indemnification under Section&nbsp;7.1 of this Agreement. If Company elects to self-insure all or part of the limits described
above (including deductibles or retentions which are in excess of [ *** ] annual aggregate) such self-insurance program must be acceptable to the PureTech. The minimum amounts of insurance coverage required under this Section&nbsp;7.3 shall not be
construed to create a limit of the Company&#146;s liability with respect to its indemnification under Section&nbsp;7.1 of this Agreement. The Company shall provide PureTech with written evidence of such insurance upon request of PureTech. The
Company shall provide PureTech with written notice at least [ *** ] prior to the cancellation, <FONT STYLE="white-space:nowrap">non-renewal</FONT> or material change in such insurance; if the Company does obtain replacement insurance providing
comparable coverage prior to the expiration of such [ *** ] period. PureTech shall have the right to terminate this Agreement effective at the end of such [ *** ] period without notice or any additional waiting periods. The Company shall maintain
such commercial general liability insurance beyond the expiration or termination of this Agreement during (i)&nbsp;the period that any such product, process, or service is being commercially distributed, sold, leased or otherwise transferred, or
performed or used (other than for the purpose of obtaining regulatory approvals), by the Company or by a licensee, affiliate or agent of Company and (ii)&nbsp;a reasonable period after the period referred to in (i)&nbsp;above which in no event shall
be less than [ *** ] This section 7.3 shall survive expiration or termination of this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8. <B>REPRESENTATIONS, WARRANTIES AND
COVENANTS</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.1 <U>Representations and Warranties by each Party</U>. Each of PureTech and the Company, with respect to itself, represents, warrants and
covenants to the other that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) it is a corporation or entity duly organized and validly existing under the laws of the state or jurisdiction of its
incorporation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) the execution, delivery and performance of this Agreement has been duly authorized by all requisite corporate or other action and does
not require any shareholder or member action or approval; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) it has the full right, power, and authority to enter into and deliver this Agreement, and
that the execution of this Agreement creates a valid and binding Agreement enforceable against it in accordance with its terms; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) the execution,
delivery, and performance of this Agreement and its compliance with the terms and provisions hereof does not, and will not, conflict with or result in a breach of any of the terms or provisions of, or constitute a default under (i)&nbsp;a loan
agreement, guaranty, financing agreement, agreement affecting a product or other agreement or instrument binding or affecting it or its property; (ii)&nbsp;the provisions of its charter or operative documents or
<FONT STYLE="white-space:nowrap">by-laws;</FONT> or (iii)&nbsp;any order, writ, injunction, or decree of any court or governmental authority entered against it or by which any of its property is bound; and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) to its knowledge, there are no existing or threatened actions, suits or claims pending against it with
respect to its right to enter into and perform its obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.2 <U>No Further Representations or Warranties; Damages</U>. EXCEPT
AS MAY OTHERWISE BE EXPRESSLY SET FORTH IN THIS AGREEMENT, PURETECH MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING (A)&nbsp;THE PATENT RIGHTS, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY, FITNESS FOR
A PARTICULAR PURPOSE, NONINFRINGEMENT, VALIDITY OF PATENT RIGHTS CLAIMS, WHETHER ISSUED OR PENDING, (2)&nbsp;THE ABSENCE OF LATENT OR OTHER DEFECTS, WHETHER OR NOT DISCOVERABLE, (3)&nbsp;REGARDING THE VALIDITY OR SCOPE OF THE PATENT RIGHTS OR
(4)&nbsp;THAT THE EXPLOITATION OF THE PATENT RIGHTS OR ANY LICENSED PRODUCT WILL NOT INFRINGE ANY PATENTS OR OTHER INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN NO EVENT SHALL EITHER PARTY, ITS MEMBERS, DIRECTORS, OFFICERS, EMPLOYEES, AGENTS OR AFFILIATES BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES OF ANY
KIND, INCLUDING ECONOMIC DAMAGES FOR INJURY TO PROPERTY AND LOST PROFITS, REGARDLESS OF WHETHER SUCH PARTY SHALL BE ADVISED, SHALL HAVE OTHER REASON TO KNOW, OR IN FACT SHALL KNOW OF THE POSSIBILITY OF THE FOREGOING. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9. <B>ASSIGNMENT.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither Party may assign
this Agreement without the written consent of the other Party, which consent shall not be unreasonably withheld or delayed. Notwithstanding the foregoing, upon written notice to the other Party, either Party may assign this Agreement to a successor
to its business (whether by merger, a sale or other transfer of all or substantially all of its assets, a sale of a controlling interest of its capital stock, or otherwise) which agrees in writing to assume its obligations hereunder. This Agreement
will be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10.
<B>COVENANTS</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.1 <U>Compliance with Laws</U>. The Company and its Affiliates and any Sublicensees shall comply in all material respects with all
commercially material applicable local, state, federal, and foreign laws and regulations relating to the development, manufacture, use, and sale of Licensed Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.2 <U>Export Control</U>. The Company and its Affiliates and any Sublicensees shall comply with all United States laws and regulations controlling the
export of certain commodities and technical data, including without limitation all Export Administration Regulations of the United States Department of Commerce. Among other things, these laws and regulations prohibit or require a license for the
export of certain types of commodities and technical data to specified countries. The Company hereby gives written assurance that it will comply with, and will require its Affiliates and any Sublicensees to comply with, all United States export
control laws and regulations, that it bears sole responsibility for any violation of such laws and regulations by itself or its Affiliates or any Sublicensees, and that it will indemnify, defend, and hold PureTech harmless (in accordance with
Section&nbsp;7) for the consequences of any such violation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.3 <U><FONT STYLE="white-space:nowrap">Non-Use</FONT> of PureTech Name</U>. The Company and
its Affiliates and any Sublicensees shall not use the name of PureTech or any variation, adaptation, or abbreviation thereof, or of any of its employees, or agents, or any trademark owned by PureTech, or any terms of this Agreement in any
promotional material or other public announcement or disclosure without the prior written consent of PureTech, except as may be required by law, stock exchange rule or other securities trading system rule. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.4 <U>Marking of Licensed Products</U>. To the extent commercially feasible and consistent with prevailing
business practices, the Company shall mark, and shall cause its Affiliates and any Sublicensees to mark, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that
applies to such Licensed Product. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11. <B>TERMINATION</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.1 <U>Voluntary Termination by the Company</U>. The Company shall have the right to terminate this Agreement, for any reason, from time to time upon at
least [ *** ] prior written notice to PureTech, such notice to state the date at least [ *** ] in the future upon which termination is to be effective. Within [ *** ] following such termination effective date, the Company shall pay to PureTech all
amounts due to PureTech through such termination effective date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.2 <U>Termination for Default</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Nonpayment</U>. In the event the Company fails to pay any amounts due and payable to PureTech hereunder, and fails to make such payments within [ *** ]
after receiving written notice (by certified US mail) of such failure, PureTech may terminate this Agreement immediately upon written notice to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>Material Breach by the Company</U>. In the event the Company commits a material breach of its obligations under this Agreement, including a breach of
any of the obligations set forth in Section&nbsp;2.4 and not including for a breach as described in Section&nbsp;11.2(a), and fails to cure that breach within [ *** ] after receiving written notice thereof (by certified US mail), PureTech may
terminate this Agreement immediately upon written notice to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <U>Material Breach by PureTech</U>. In the event PureTech commits a material
breach of its obligations under this Agreement and fails to cure that breach within [ *** ] after receiving written notice thereof (by certified US mail), the Company may terminate this Agreement immediately upon written notice to PureTech. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.3 <U>Effect of Termination</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Survival</U>. The
following provisions shall survive the expiration or termination of this Agreement: Articles 1, 3 (to the extent necessary to satisfy Section&nbsp;11.3(b) and (c)), (4 to the extent necessary to provide final reports), 7, 9, 10, 11, 12 and 13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>Inventory</U>. Upon the early termination of this Agreement, the Company and its Affiliates and any Sublicensees may complete and sell any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">work-in-progress</FONT></FONT> and inventory of Licensed Products that exist as of the Effective Date of termination, provided that (i)&nbsp;the Company pays PureTech the applicable running
royalty or other amounts due on such sales of Licensed Products in accordance with the terms and conditions of this Agreement, and (ii)&nbsp;the Company and its Affiliates and any Sublicensees shall complete and sell all <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">work-in-progress</FONT></FONT> and inventory of Licensed Products within six (6)&nbsp;months after the Effective Date of termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <U><FONT STYLE="white-space:nowrap">Pre-termination</FONT> Obligations</U>. In no event shall termination of this Agreement release the Company, its
Affiliates, or any Sublicensees from the obligation to pay any amounts that became due on or before the effective date of such termination. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12. <B>DISPUTE RESOLUTION.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.1
<U>Mandatory Procedures</U>. The Parties agree that any dispute arising out of or relating to this Agreement shall be resolved solely by means of the procedures set forth in this Article, and that such procedures constitute legally binding
obligations that are an essential provision of this Agreement. If either Party fails to observe the procedures of this Article, as may be modified by their written agreement, the other Party may bring an action for specific performance of these
procedures in any court of competent jurisdiction. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.2 <U>Equitable Remedies</U>. Although the procedures specified in this Article are the sole and exclusive
procedures for the resolution of disputes arising out of or relating to this Agreement, either Party may seek a preliminary injunction or other provisional equitable relief if, in its reasonable judgment, such action is necessary to avoid
irreparable harm to itself or to preserve its rights under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.3 <U>Dispute Resolution Procedures</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Negotiation</U>. In the event of any dispute arising out of or relating to this Agreement, the affected Party shall notify the other Party, and the
Parties shall attempt in good faith to resolve the matter within [ *** ] after the date of such notice (the &#147;<U>Notice Date</U>&#148;). Any disputes not resolved by good faith discussions shall be referred to senior executives of each Party,
who shall meet at a mutually acceptable time and location within [ *** ] after the Notice Date and attempt to negotiate a settlement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)
<U>Arbitration</U>. If the matter remains unresolved within [ *** ] after the Notice Date, or if the senior executives fail to meet within [ *** ] after the Notice Date, either Party shall be entitled to submit the matter to binding arbitration
under the commercial arbitration rules of the American Arbitration Association. Any such arbitration shall be conducted by a panel of three arbitrators (the &#147;<U>Arbitration Panel</U>&#148;) and shall be conducted in Boston, Massachusetts.
PureTech on the one hand, and the Company on the other, shall each appoint one arbitrator, and the third arbitrator shall be appointed by the two arbitrators appointed by PureTech and the Company. The Arbitration Panel shall have the authority to
grant specific performance and to allocate between the parties the costs of arbitration in such equitable manner as it shall determine. Judgments upon the award so rendered may be entered in any court having jurisdiction or application may be made
to such court for judicial acceptance of any award and an order of enforcement, as the case may be. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13. <B>MISCELLANEOUS.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.1 <U>Notice</U>. Any notices required or permitted under this Agreement shall be in writing, shall specifically refer to this Agreement, and shall be sent
by hand, recognized national overnight courier, confirmed facsimile transmission or registered or certified mail, postage prepaid, return receipt requested, to the following addresses or facsimile numbers of the parties: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If to PureTech: Daphne Zohar </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PureTech Ventures, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">500 Boylston Street, Suite 1400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts 02116 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel: 617.482.2333 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fax: 617.482.3337 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If to the Company: President </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuna Pharmaceuticals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">500 Boylston Street, Suite 1040 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts 02116 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel: 617.482.2333 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fax: 617.482.3337 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All notices under this Agreement shall be deemed effective upon receipt. A party may change its contact information immediately upon written notice to the
other party in the manner provided in this Section&nbsp;13.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.2 <U>Governing Law</U>. This Agreement and all disputes arising out of or related to
this Agreement, or the performance, enforcement, breach or termination hereof, and any remedies relating thereto, shall be construed, governed, interpreted and applied in accordance with the laws of the Commonwealth of Massachusetts, U.S.A., without
regard to conflict of laws principles, except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent shall have been granted. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.3 <U>Force Majeure</U>. Neither party will be responsible for delays resulting from causes beyond the
reasonable control of such party, including without limitation fire, explosion, flood, war, strike, or riot, provided that the nonperforming party uses commercially reasonable efforts to avoid or remove such causes of nonperformance and continues
performance under this Agreement with reasonable dispatch whenever such causes are removed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.4 <U>Amendment and Waiver</U>. This Agreement may be
amended, supplemented, or otherwise modified only by means of a written instrument signed by both Parties. Any waiver of any rights or failure to act in a specific instance shall relate only to such instance and shall not be construed as an
agreement to waive any rights or fail to act in any other instance, whether or not similar. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.5 <U>Severability</U>. In the event that any provision of
this Agreement shall be held invalid or unenforceable for any reason, such invalidity or unenforceability shall not affect any other provision of this Agreement, and the parties shall negotiate in good faith to modify the Agreement to preserve (to
the extent possible) their original intent. If the Parties fail to reach a modified agreement within thirty (30)&nbsp;days after the relevant provision is held invalid or unenforceable, then the dispute shall be resolved in accordance with the
procedures set forth in Article 13. While the dispute is pending resolution, this Agreement shall be construed as if such provision were deleted by agreement of the parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.6 <U>Binding Effect</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their respective permitted successors and
assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.7 <U>Headings</U>. All headings are for convenience only and shall not affect the meaning of any provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.8 <U>Entire Agreement</U>. This Agreement constitutes the entire agreement between the parties with respect to its subject matter and supersedes all prior
agreements or understandings between the parties relating to its subject matter. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized
representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Effective Date of this Agreement is March&nbsp;4, 2011. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PURETECH VENTURES LLC</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">KARUNA PHARMACEUTICALS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daphne Zohar</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund Harrigan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Daphne Zohar</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Edmund Harrigan MD</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Partner</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED (INDICATED BY: [ *** ]) FROM THE EXHIBIT BECAUSE IT IS BOTH
(I)&nbsp;NOT MATERIAL AND (II)&nbsp;WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 1 TO EXCLUSIVE PATENT
LICENSE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;1 (&#147;<U>Amendment No.</U><U></U><U>&nbsp;1</U>&#148;) to the Exclusive Patent License Agreement dated
as of March&nbsp;1, 2011 (the &#147;<U>Agreement</U>&#148;) by and among PureTech Ventures, LLC, (the &#147;<U>Company</U>&#148;), and Karuna Pharmaceuticals, Inc. (the &#147;licensee&#148;) is entered into on this 1st day of February, 2013 (the
&#147;<U>Amendment No.</U><U></U><U>&nbsp;1 Effective Date</U>&#148;). For purposes hereof, all capitalized terms used herein but not defined herein shall have the meanings given to them in the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;13.4 of the Agreement, the Company and the Licensee hereby agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. Section&nbsp;2.4 of the Agreement is hereby deleted and replaced in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Due Diligence Obligations</U>. The Company shall use diligent efforts, and shall cause its Affiliates and any Sublicensees to use diligent efforts, to
develop Licensed Products and to introduce Licensed Products into the commercial market; thereafter, the Company and its Affiliates and any Sublicensees shall maximize the commercial sales of such Licensed Products. Specifically, the Company and its
Affiliates and any Sublicensees shall fulfill the following obligations: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Within [ *** ] of the Amendment No.&nbsp;1 Effective Date, the Company shall initiate, defined as first dosing
of patient, a trial using a Licensed Product. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any time prior to approval of a Licensed Product by the U.S. Food and Drug Administration, the Company shall
not, for any consecutive [ *** ] period, fail to initiate, defined as first dosing of patient, a human clinical study with a Licensed Product or make a regulatory submission to the U.S. Food and Drug Administration, the European Medicines Evaluation
Agency, or the Japanese Ministry of Health and Welfare seeking the marketing of a License Product for the treatment of a disease. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall not (i)&nbsp;become insolvent; (ii)&nbsp;make an assignment for the benefit of creditors; or
(iii)&nbsp;have a bona fide petition in bankruptcy filed for or against it, which petition is withdrawn or dismissed within [ *** ] of its filing. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that PureTech determines that the Company (or an Affiliate or Sublicensee) has failed to fulfill its obligations under this Section&nbsp;2.4,
then PureTech may treat such failure as a material breach in accordance with Section&nbsp;11.2(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. The parties agree that the Agreement is in full
force and effect as of the Amendment No.&nbsp;1 Effective Date, as amended as set forth above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Amendment
No.&nbsp;1 to be executed by their duly authorized representatives as of the Amendment No.&nbsp;1 Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Karuna Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Eric Elenko</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Eric Elenko</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PureTech Ventures, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Stephen Muniz</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stephen Muniz</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Partner</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED (INDICATED BY: [ *** ]) FROM THE EXHIBIT BECAUSE IT IS BOTH
(I)&nbsp;NOT MATERIAL AND (II)&nbsp;WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 2 TO EXCLUSIVE PATENT
LICENSE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;2 (&#147;<U>Amendment No.</U><U></U><U>&nbsp;2</U>&#148;) to the Exclusive Patent License Agreement dated
as of March&nbsp;4, 2011 (the &#147;<U>Agreement</U>&#148;) by and among PureTech Ventures, LLC (the &#147;<U>Company</U>&#148;), and Karuna Pharmaceuticals, Inc. (the &#147;licensee&#148;) is entered into on this 25th day of February, 2015 (the
<U>&#147;Amendment No.</U><U></U><U>&nbsp;2 Effective Date&#148;</U>). For purposes hereof, all capitalized terms used herein but not defined herein shall have the meanings given to them in the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;13.4 of the Agreement, the Company and the Licensee hereby agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. Section&nbsp;2.4 of the Agreement, which was first amended by Amendment No.&nbsp;1 to Exclusive License Agreement dated February&nbsp;1, 2013
(&#147;<U>Amendment No.</U><U></U><U>&nbsp;1</U>&#148;), which Amendment No.&nbsp;1 deleted and replaced Section&nbsp;2.4 in its entirety is hereby deleted and replaced in its entirety a second time to read as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Due Diligence Obligations</U>. The Company shall use diligent efforts, and shall cause its Affiliates and any Sublicensees to use diligent efforts, to
develop Licensed Products and to introduce Licensed Products into the commercial market; thereafter, the Company and its Affiliates and any Sublicensees shall maximize the commercial sales of such Licensed Products. Specifically, the Company and its
Affiliates and any Sublicensees shall fulfill the following obligations: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Within [ *** ] of the Amendment No.&nbsp;2 Effective Date, the Company shall initiate, defined as first dosing
of patient, a trial using a Licensed Product. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any time prior to approval of a Licensed Product by the U.S. Food and Drug Administration, the Company shall
not, for any consecutive [ *** ] period, fail to initiate, defined as first dosing of patient, a human clinical study with a Licensed Product or make a regulatory submission to the U.S. Food and Drug Administration, the European Medicines Agency, or
the Japanese Ministry of Health, Labour and Welfare seeking the marketing of a Licensed Product for the treatment of a disease. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall not (i)&nbsp;become insolvent; (ii)&nbsp;make an assignment for the benefit of creditors; or
(iii)&nbsp;have a bona fide petition in bankruptcy filed for or against it, which petition is withdrawn or dismissed within [ *** ] of its filing. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that PureTech determines that the Company (or an Affiliate or Sublicensee) has failed to fulfill its obligations under this Section&nbsp;2.4,
then PureTech may treat such failure as a material breach in accordance with Section&nbsp;11.2(b).&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. The parties agree that the Agreement is in
full force and effect as of the Amendment No.&nbsp;2 Effective Date, as amended as set forth above. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Amendment No.&nbsp;2 to be executed by their duly
authorized representatives as of the Amendment No.&nbsp;2 Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Karuna Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Eric Elenko</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Eric Elenko</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PureTech Ventures, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Stephen Muniz</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stephen Muniz</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Partner</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED (INDICATED BY: [ *** ]) FROM THE EXHIBIT BECAUSE IT IS BOTH
(I)&nbsp;NOT MATERIAL AND (II)&nbsp;WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 3 TO EXCLUSIVE PATENT
LICENSE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;3 (&#147;<U>Amendment No.</U><U></U><U>&nbsp;3</U>&#148;) to the Exclusive Patent License Agreement dated
as of March&nbsp;4, 2011 (the &#147;<U>Agreement</U>&#148;) by and among PureTech Health LLC (f/k/a PureTech Ventures, LLC) (&#147;<U>PureTech</U>&#148;), and Karuna Pharmaceuticals, Inc. (the &#147;<U>Company</U>&#148;), as previously amended by
Amendment No.&nbsp;1 to Exclusive License Agreement dated February&nbsp;1, 2013 (&#147;<U>Amendment No.</U><U></U><U>&nbsp;1</U>&#148;) and Amendment No.&nbsp;2 to Exclusive License Agreement dated February&nbsp;25, 2015 (&#147;<U>Amendment
No.</U><U></U><U>&nbsp;2</U>&#148;), is entered into effective as of July&nbsp;31, 2015 (the &#147;<U>Amendment No.</U><U></U><U>&nbsp;3 Effective Date</U>&#148;). For purposes hereof, all capitalized terms used herein but not defined herein shall
have the meanings given to them in the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;13.4 of the Agreement, PureTech and the Company hereby agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. Section&nbsp;5.3 of the Agreement, as amended pursuant to Amendment 1 and Amendment 2, is hereby deleted and replaced in its entirety to read as follows:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;5.3 <U>Reversion of Patent Rights</U>. The Company may elect not to prosecute certain of the Patent Rights (including rights in certain countries or
territories). If (i)&nbsp;the Company has elected not to prosecute any such Patent Rights, and (ii)&nbsp;any third party with a binding contractual right to prosecute such Patent Rights on behalf of the Company has waived or otherwise affirmatively
elected not to exercise such right, then the Company may notify PureTech of the same and upon such notice such Patent Rights shall automatically revert to PureTech and be excluded from the definition of &#147;Patent Rights&#148; hereunder.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. PureTech and the Company agree that the Agreement, as amended by Amendment No.&nbsp;1 and Amendment No.&nbsp;2, is in full force and effect as of the
Amendment No.&nbsp;3 Effective Date as amended as set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned parties have caused this Amendment No.&nbsp;3 to
be executed by their duly authorized representatives as of the Amendment No.&nbsp;3 Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">KARUNA PHARMACEUTICALS, INC.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Eric Elenko</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Eric Elenko</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PURETECH HEALTH LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Stephen Muniz</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stephen Muniz</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">EVP, Legal, Finance&nbsp;&amp; Operations</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>8
<FILENAME>filename8.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.12</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.12 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATED&nbsp;18 June 2015 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(1) PURETECH HEALTH PLC
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- and- </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(2) INVESCO ASSET
MANAGEMENT LIMITED </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(ACTING AS AGENT FOR AND ON BEHALF OF ITS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DISCRETIONARY MANAGED CLIENTS) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RELATIONSHIP AGREEMENT </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONTENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">DEFINITIONS AND INTERPRETATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CONDITION PRECEDENT</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CONDUCT OF TRANSACTIONS AND RELATIONSHIPS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">INFORMATION COVENANT</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">5.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CONFIDENTIAL INFORMATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">6.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">ANNOUNCEMENTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">7.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">OVERRIDING OBLIGATIONS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">8.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">TERMINATION OF DEED</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">9.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">VARIATION, WAIYER AND CONSENT</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">FURTHER ASSURANCE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">11.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">ASSIGNMENT</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">12.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">SEVERABILITY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">13.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">ENTIRE AGREEMENT</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">14.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">GOVERNING LAW AND JURISDICTION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">15.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">NOTICES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">16.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">COUNTERPARTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">17.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">COSTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">18.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">NOPARTNERSHIPORAGENCY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">19.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">THIRD PARTY RIGHTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS DEED </B>is made on </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">18 June 2015 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BETWEEN: </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(1)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PURETECH HEALTH PLC, </B>a company incorporated in England and Wales with company number 09582467, whose
registered office is at 5th Floor, 6 St Andrew Street, London EC4A 3AE, United Kingdom <B>(&#147;Company&#148;); </B>and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(2)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INVESCO ASSET MANAGEMENT LIMITED,</B> a company incorporated in England and Wales with company number
00949417, whose registered office is at Perpetual Park, Perpetual Park Drive, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Henley-On-Thames,</FONT></FONT> Oxfordshire, RG9 IHH United Kingdom <B>(&#147; Shareholder&#148;).</B>
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RECITALS: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Application has been made or will be made by the Company for all of the Ordinary Shares to be admitted to the
Official List and to be admitted to trading on the main market for listed securities of the London Stock Exchange <B>(&#147;Admission&#148;).</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is expected that upon Admission the Shareholder will exercise or control on its own or together with certain
of its associates, and together with any person with whom they are acting in concert (or deemed to be acting in concert), more than 30&nbsp;per cent. of the votes able to be cast on all or substantially all matters at general meetings of the
Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">C</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In contemplation of Admission, the Company and the Shareholder have agreed to enter into this Deed to record
the current and future basis of the Shareholder&#146;s relationship with the Company as a Controlling Shareholder so that the Company can demonstrate that there are appropriate measures in place to regulate their relationship and to deliver
effective independence. Furthermore, the Company wishes to enter into this Deed with the Shareholder pursuant to LR 6.1.4BR which includes a requirement for the Company, as a company with a Controlling Shareholder admitted to listing on the premium
listing segment of the Official List, to have in place a written and legally binding agreement with such Controlling Shareholder containing certain provisions intended to ensure that the independence of the Company is safeguarded.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IT IS AGREED: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEFINITIONS AND INTERPRETATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Definitions</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">In this Deed, the following words, expressions and abbreviations shall have the following meanings (except where the context otherwise
requires): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;acting in concert&#148; </B>means acting together with another entity (or a number of entities) to control or exercise
30&nbsp;per cent. or more of the votes able to be cast on all or substantially all matters at general meetings of the Company as referred to in the context of Chapter 6 of the Listing Rules and the definition of &#147;controlling shareholder&#148;
in the Listing Rules; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Admission&#148; </B>shall have the meaning ascribed to it in recital A of this Deed; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Announcements&#148; </B>means any press announcement by the Company in connection with Admission; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Articles&#148; </B>mean the articles of association of the Company as amended from
time to time; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Associate&#148; </B>means any legal or natural person which falls within the definition of an Associate in the
Listing Rules; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Business Day&#148; </B>means any day (other than a Saturday or Sunday or public holiday) on which banks generally
are open in the City of London for the transaction of normal banking <B>business;</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;CJA&#148; </B>means the Criminal Justice
Act 1993; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Companies Law&#148; </B>means the Companies Act 2006; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Company Group&#148; </B>means the Company, its subsidiary undertakings and its operating companies from time to time and references to
a &#147;member of the Company Group&#148; shall be construed accordingly; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Confidential Information&#148; </B>has the meaning set
out in clause 5.4; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Controlling Shareholder&#148; </B>has the meaning given to the definition of &#147;controlling
shareholder&#148; in the Listing Rules; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Disclosure and Transparency Rules&#148; </B>means the rules made by the FCA relating to
the disclosure of information pursuant to Part VI of the FSMA; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;FCA&#148; </B>means the UK Financial Conduct Authority or its
successor in respect of the regulation of listed companies and securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;FSMA&#148; </B>means the Financial Services and
Markets Act 2000 (as amended from time to time); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Invesco Funds&#148; </B>means Invesco Perpetual Income Fund, Invesco Perpetual
High Income Fund, Invesco Perpetual UK Equity Pension Fund, Invesco Perpetual UK Strategic Income Fund and Invesco Perpetual Distribution Fund; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Listing Rules&#148; </B>means the listing rules made by the FCA pursuant to Part VI of the FSMA; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;London Stock Exchange&#148; </B>means the London Stock Exchange pie; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Minimum Interest&#148; </B>means an interest of 30&nbsp;per cent or more of the issued share capital of the Company (or which carries
30&nbsp;per cent or more of the aggregate Voting Rights in the Company from time to time); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Official List&#148; </B>means the
official list maintained by the FCA; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Ordinary Share&#148; </B>means an ordinary share in the capital of the Company having the
rights set out in the A11icles; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Prospectus&#148; </B>means the document prepared by the Company in connection with Admission and
to be approved by the FCA in accordance with the Listing Rules; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Prospectus Rules&#148; </B>means the prospectus rules made by the
FCA pursuant to Part VI of the FSMA; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;subsidiary undertaking&#148; </B>means, in relation to a company, any subsidiary
undertaking of such company as defined in section 1162 of the Companies Act 2006 and &#147;subsidiaries&#148; shall mean all subsidiary undertakings of such company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Takeover Code&#148; </B>means the City Code on Takeovers and Mergers or any successor code or other regime (whether statutory or <FONT
STYLE="white-space:nowrap">non-statutory)</FONT> governing the conduct of takeovers and mergers in the United Kingdom; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;undertaking&#148; means a company, body corporate, partnership, joint venture or other </B>economic enterprise (whether or not a body
corporate) carrying on a business (whether or not for profit); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>&#147;Voting Rights&#148; </B>means, in relation to any undertaking,
voting rights attaching to securities of the relevant undertaking which are generally exercisable at meetings of security holders of the relevant undertaking. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Interpretation</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">In this Deed (except where the context otherwise requires): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">clause and paragraph headings and any table of contents are inserted for ease of reference only and shall not
affect construction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any reference to a <B>&#147;party&#148; </B>is to a party to this Deed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any reference to a recital or clause is to the relevant recital or clause to this Deed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any reference to <B>&#147;include&#148; </B>or <B>&#147;including&#148; </B>(or any similar term) is not to be
construed as implying any limitation and general words introduced by the word <B>&#147;other&#148; </B>(or any similar term) shall not be given a restrictive meaning by reason of the fact that they are preceded by words indicating a particular class
of acts, matters or things; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any reference to a person shall include any individual, firm, body corporate, <B>association, joint venture,
partnership, government, state or agency of state, in </B>each case whether or not having a separate legal personality. Reference to a company shall be construed so as to include any company, corporation or other body corporate wherever and however
incorporated or established; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">references to the Prospectus Rules, the Listing Rules, the Disclosure and Transparency Rules, the Companies
Law, the Takeover Code, the CJA and the FSMA and to any statutes or statutory provisions include any code, regulation, statute or statutory provision which amends, extends, consolidates or replaces the same, or which has been amended, extended,
consolidated or replaced by the same, and shall include any orders, regulations, instruments or other subordinate legislation made under the relevant statute or statutory provision; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any reference to a deed or other document or any provisions thereof is a reference thereto as it is in force
for the time being and from time to time as amended, supplemented, novated, or replaced; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all representations, warranties, covenants, undertakings and obligations in this Deed given to or enforceable
by the Shareholder shall be deemed also to have been given to and be enforceable separately by each of the Invesco Funds and/or by the Shareholder on behalf of the Invesco Funds. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any reference to <B>&#147;writing&#148; </B>or <B>&#147;written&#148; </B>includes any method of reproducing
words or text in a legible and <FONT STYLE="white-space:nowrap">non-transitory</FONT> form but, for the avoidance of doubt, shall not include email; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">1.2.10</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">references to times of the day are to the time in London in the United Kingdom. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CONDITION PRECEDENT </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Deed conditional upon Admission</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">This Deed is conditional upon, and shall come into force on, Admission (the <B>&#147;Condition Precedent&#148;).</B> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Long stop date</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">In the event that Admission has not occurred on or before 30&nbsp;June 2015 (or such later date as is agreed between the parties in writing),
this Deed shall be null and void and of no further force or effect and no party shall have any claim in respect of this Deed against any other party for costs, damages, compensation or otherwise. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CONDUCT OF TRANSACTIONS AND RELATIONSHIPS </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shareholder shall and shall procure that each of its Associates and any person with whom they are acting in
concert shall: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make and conduct all transactions, agreements and relationships with the Company and any other member of the
Company Group at arm&#146;s length and on normal commercial terms (and the parties hereby acknowledge that this Deed has been concluded on such a basis); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not take any action that would, or would be reasonably likely to, have the effect of preventing the Company or
any other member of the Company Group from complying with its obligations under the Listing Rules; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not propose or procure the proposal of a shareholder resolution which is intended or appears to be intended to
circumvent the proper application of the Listing Rules; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not exercise any of its voting or other rights and powers: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">3.1.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to procure or propose, or vote in favour of, any resolution for any amendment to the Articles of the Company
which would be inconsistent with, undermine or breach any of the provisions of this Deed or the Listing Rules or would be contrary to the principle of the independence of the Company from the Shareholder and its <B>Associates; or</B>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">3.1.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in a manner which would be inconsistent with, or breach any of the provisions of, this Deed, the Listing Rules
or the Disclosure and Transparency Rules. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where any obligations that the Company is in the future required to impose on the Controlling Shareholder (or
its Associates or persons with whom it is acting in concert) to ensure that the Listing Rules (if amended) are complied with in full are not satisfied under the terms of this Deed, the parties agree to negotiate in good faith to amend the terms of
this Deed to give effect to the Listing Rules (as amended). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nothing in this Deed is intended to prevent the Shareholder, any of its Associates or persons with whom it is
acting in concert, from acquiring or disposing of any securities of the Company (save to the extent otherwise required by law or regulation). </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INFORMATION COVENANT </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shareholder acknowledges that, pursuant to Listing Rule 9.8.4R(l4), the Company will be required to include
in each annual financial report certain statements made by the Board confirming that amongst other things: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">4.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company has entered into all agreements required under Listing Rule 9.2.2AR; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">4.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company has complied with the independence provisions set out in Clauses 3. I. I to 3.1.4 above throughout
the accounting period covered by the annual financial report, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">or else to confirm that the FCA has been notified and to
include statements to the effect that such agreements have not been entered into and/or complied with and a description of the reasons therefor to enable shareholders to evaluate the impact of <FONT STYLE="white-space:nowrap">non-compliance,</FONT>
as the case may be. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shareholder covenants to provide all information (as to the compliance of itself and/or any member of the
Shareholder group with the requirements of Clause 3.1) within a reasonable timeframe that may be reasonably requested by or on behalf of the Board in order to support the statements required to be made by the Board as described in Clause 4.1.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CONFIDENTIAL INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shareholder shall ensure that any Confidential Information (as hereinafter defined) which it acquires in
connection with this Deed shall be treated as confidential by it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the exceptions stated in clause 5.3, the Shareholder shall not disclose or use Confidential
Information for any purpose whatsoever other than for the purposes of properly performing its obligations under this Deed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Confidential Information shall be maintained as confidential by the Shareholder and may only be disclosed:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to such of its Associates and its or their respective employees, officers, directors and/or members who
reasonably require such disclosure (on the basis that such person(s) are required to comply with this clause 5.3 as if they were subject to these obligations); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to its legal, accounting, insurance and other professional advisers (on the basis that such person(s) are
required to comply with this clause 5 as if they were subject to these obligations); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the tax or VAT authorities, any regulatory authority, and any other governmental or public authority or
officer, but only to the extent that such persons require such disclosure for the proper discharge of their functions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where required, in connection with any legal proceedings; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.3.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in compliance with any law or regulation, or if required by or for the purpose of listing, or maintaining a
listing of securities on, or complying with the rules of any stock exchange. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purpose of this Deed, <B>&#147;Confidential Information&#148; </B>means any information of a secret,
price sensitive or confidential nature acquired from and concerning the Company Group from time to time or its affairs, whether in written or oral form, save that the Shareholder shall not be obliged to maintain in confidence any such information if
the information: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">was in the possession of or was known to the Shareholder prior to its receipt from the Company (other than
through a breach of this clause 5); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is independently developed or acquired by the Shareholder without the utilisation of such Confidential
Information; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.4.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is or becomes public knowledge without the fault of the Shareholder; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.4.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is or becomes available to the Shareholder from a source other than the Company. in circumstances where the
Shareholder concerned is not aware that disclosure has been made in breach of an obligation of confidentiality. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shareholder agrees and unde1takes to the Company that it will procure so far as 1t 1s reasonably able that
its permitted disclosees as set out in clause 5.3 treat all Confidential Information which comes into the possession of such persons as confidential. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INSIDE INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shareholder acknowledges that the information disclosed to it by or on behalf of the Company or any other
member of the Company Group may be inside information in relation to the Ordinary Shares for the purposes of the CJA and/or the FSMA and accordingly the Shareholder undertakes that it shall not (and shall use all reasonable endeavours to procure
that none of its Associates or any person with whom it is acting in concert shall not): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deal in securities that are price affected securities (as defined in the CJA) in relation to such inside
information, encourage another person to deal in price affected securities or disclose the information except as permitted by the CJA, in each case before the inside information is made public; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deal or attempt to deal in a qualifying investment or related investment (as defined in the FSMA) on the basis
of such inside information; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">engage in behaviour based on any such inside information which would amount to market abuse for the purposes of
the FSMA; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">otherwise breach the requirements of any laws, rules and regulations in relation to dealings in the
Company&#146;s securities which apply to the Shareholder, any of its Associates or any person with whom it is acting in concert. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ANNOUNCEMENTS</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Except for (i)&nbsp;the Prospectus and any preliminary or supplementary documents thereto; (ii)&nbsp;any Announcements; and (iii)&nbsp;the
documents relating to the Admission and identified in the Prospectus (or any preliminary or supplementary documents thereto) as to be made available on display by the Company pursuant to the Prospectus Rules, no party shall make, and shall use all
reasonable endeavours to procure that none of such party&#146;s Associates makes, any announcement or publish any circular in connection with the existence or the subject matter of this Deed or referring to any other party without the prior written
approval of the other party. This shall not affect any announcement or circular required by law or any regulatory body or the rules of the London Stock Exchange, but a party with an obligation to make an announcement or issue a circular shall
consult with the other party insofar as is reasonably practicable as to the content, timing and manner of such an announcement or circular before complying with such an obligation. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OVERRIDING OBLIGATIONS</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>8.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>For the avoidance of doubt, the obligations of each of the parties pursuant to this Deed shall at all
times be subject to all relevant legal and regulatory requirements and obligations of the United Kingdom, including, without limitation, the obligations of the parties in the United Kingdom or elsewhere including, without limitation, the
requirements of the Disclosure and Transparency Rules, the Listing Rules, the Prospectus Rules, the Companies Law, the Takeover Code, the FCA, the CJA, the FSMA and the London Stock Exchange. Each party shall act in accordance with each of such
requirements and obligations applicable to it and no party shall be required to take any action in breach of any such requirement or obligation applicable to it. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>8.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>In the event of any conflict between the prov1s10ns of this Deed and the Articles, the provisions of
this Deed shall prevail as between the parties to the extent permitted by applicable law and regulation. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TERMINATION OF DEED</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>9.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Deed shall come into force upon satisfaction of the Condition Precedent and shall continue in full force
and effect for so long as the Shareholder, any of its Associates and any person with whom it is acting in conceit, in aggregate hold a Minimum Interest or is othe1wise a Controlling Shareholder, save that the termination and cessation of this Deed
shall not relieve any party from any liability or obligation in respect of any matters, unde1takings or conditions which shall not have been done, observed or performed by that party prior to such <B>termination</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Deed shall terminate immediately upon the cancellation of Admission whereupon, other than in relation to
any <FONT STYLE="white-space:nowrap">pre-existing</FONT> breach of any provision of this Deed, no party shall have any rights or obligations under this Deed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shareholder may terminate this Deed immediately at any time by notice to the Company if the Company has a
receiver, administrative receiver, administrator or manager appointed over the whole or the majority of it or its assets or business, makes any composition or arrangement with its creditors or an order or resolution is made for its dissolution or
liquidation (other than for the purpose of solvent amalgamation or reconstruction), or takes or suffers any similar or analogous procedure, action or event in consequence of debt in any jurisdiction. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Clauses I, 4, 6, 9.4 and 10 to 20 shall survive the termination of this Deed for any reason.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>VARIATION, WAIVER AND CONSENT</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>10.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>No variation or waiver of any provision or condition of this Deed shall be effective unless it is in
writing and signed by or on behalf of each of the parties (or, in the case of a waiver, by or on behalf of the party waiving compliance). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>10.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Unless expressly agreed, no variation or waiver of any provision or condition of this Deed shall
constitute a general variation or waiver of any provision or condition of this Deed, nor shall it affect any rights, obligations or liabilities under or pursuant to this Deed which have already accrued up to the date of variation or waiver, and the
rights and obligations of the parties under or pursuant to this Deed shall remain in full force and effect, except and only to the extent that they are so varied or waived. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>10.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Any consent granted under this Deed shall be effective only if given in writing and signed by the
consenting party and then only in the instance and for the purpose for which it was given. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FURTHER ASSURANCE</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">At any time after the date of this Deed, the Shareholder shall, and shall procure that any necessary third party shall, execute such documents
and do such acts and things as the Company may reasonably require for the purpose of giving the Company the full benefit of all the provisions of this Deed in relation to the obligations of the Shareholder. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ASSIGNMENT</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">The rights and benefits of this Deed (together with any cause of action arising in connection with any of them) may not be assigned by any
party to any other person without the prior written consent of the other party. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SEVERABILITY</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>13.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Each provision of this Deed is severable and distinct from the others. The Shareholder and the Company
intend that every such provision shall be and remain valid and enforceable to the fullest extent permitted by law. If any such provision is or at any time becomes to any extent invalid, illegal or unenforceable under any enactment or rule of law, it
shall to that extent be deemed not to form part of this Deed but (except to that extent in the case of that provision) it and all other provisions of this Deed shall continue in full force and effect. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>13.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>In particular, but without prejudice to the generality of the foregoing, the provisions of clause 3 are
believed by both the Shareholder and the Company to be reasonable and legitimate to protect the interests of the Company. If any such provision is subsequently judged to be invalid or unenforceable, but would have been enforceable had it been
subject to some restriction in duration or geographical scope, then the provision will take effect subject to such restriction. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ENTIRE AGREEMENT</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>14.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>This Deed together with the Articles constitutes the entire agreement and supersedes any previous
agreements between the parties relating to its subject matter. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>14.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Each party acknowledges and agrees that no representations were made which are not set out in this Deed
but that, if any were made, it has not relied on, or been induced to enter into this Deed by, any information, statements, warranties or representations of any description, whether written or oral, made, supplied or given by or on behalf of the
other party in relation to the subject matter of this Deed or otherwise. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>GOVERNING LAW AND JURISDICTION</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>15.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>This Deed and any dispute or claim arising out of or in connection with this Deed, its subject matter or
formation (including any <FONT STYLE="white-space:nowrap">non-contractual</FONT> dispute or claim) are governed by and shall be construed in accordance with English Law. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>15.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Each party irrevocably agrees that the courts of England and Wales shall have exclusive jurisdiction to
settle any dispute or claim arising out of or in connection with this Deed, its subject matter or formation (including any <FONT STYLE="white-space:nowrap">non-contractual</FONT> dispute or claim). </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NOTICES</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>16.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Method of serving notice </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Any notice, demand or other communication <B>(&#147;Notice&#148;) </B>to be given by one party to any other party under this Deed shall be in
the English language in writing and signed by or on behalf of the party giving it. It shall be served by sending it by fax to the number set out in clause 16.2 and marked for the attention of the relevant addressee set out in clause 16.2 (or as
otherwise notified from time to time in accordance with the provisions of this clause I6.1), provided always that a copy of such Notice shall also be sent by email for information purposes only. Any notice so served by fax (and copied by email)
shall be deemed to have been duly given: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">16.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of fax, at the time of transmission; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">16.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of email, at the expiration of two hours after the time the email was <B>sent,</B>
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">provided that in each case where delivery by fax or email occurs after 6.00 p.m. on a Business Day or on a day which is
not a Business Day, service shall be deemed to occur at 9.00 a.m. on the next following Business Day. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>16.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Addresses for service </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">The fax number and email address of the parties for the purpose of clause 16.1 are as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Company:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">PureTech Health plc, Attention of Stephen Muniz</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fax:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+] 617 482 3337</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">sm@puretechhealth.com</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Shareholder:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Invesco Asset Management Limited, Attention of Charles Henderson</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fax:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+44(0) 1491416000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Charles_Henderson@invescoperpetual.co.uk</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>16.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Changes of details </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">A pa11y may notify any other party to this Deed of a change to its name, fax number or email for the purposes of clause 16.1 provided that,
such notice shall only be effective on: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">16.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date specified in the notice as the date on which the change is to take place; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">16.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if no date is specified or the date specified is less than five Business Days after the date on which notice is
given, the date following five Business Days after notice of any change has been given. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>16.4</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Proof of service </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">In proving such service it shall be sufficient to prove that (i)&nbsp;the fax transmission was made and a fax confirmation report was received,
and/or (ii)&nbsp;in the case of email, that such email was properly addressed. For the avoidance of doubt, no notice or other communications to any party may be delivered by email only. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>COUNTERPARTS</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">This Deed may be executed in any number of counterpat1s and by the parties to it on separate counterparts and each such counterpart shall
constitute an original of this Deed but all of which together constitute one and the same instrument. This Deed shall not be effective until each pat1y has executed at least one counterpart. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>COSTS</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Each party shall be responsible for its own legal, accountancy and other costs, charges and expenses incurred in connection with the
negotiation, preparation, execution and implementation by it of this Deed and any document referred to in it. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NO PARTNERSHIP OR AGENCY</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">No provision of this Deed creates a partnership between the parties or makes a party the agent of the other pai1ies for any purpose. A party
has no authority to bind, to contract in the name of or to create a liability for the other parties <B>in </B>any way or for any purpose and no party shall hold itself out as having authority to do the same. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>THIRD PARTY RIGHTS</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Save as set out in Clause 1.2.8, the operation of the Contracts (Rights of Third Parties) Act 1999 is hereby excluded in relation to this Deed
and a person who is not a Party to this Deed shall have no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any of its <B>terms.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS </B>of which this Deed has been executed and has been delivered on the date which appears above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executed as a deed by
<B>PURETECH</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HEALTH PLC </B>by a director in the presence&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">of a
witness:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Signature: /s/ Stephen Muniz</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name (block capitals): STEPHEN MUNIZ</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:9.50em; font-size:10pt; font-family:Times New Roman"><B>Director</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Witness signature /s/ Caroline Magor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Witness name (block capitals) CAROLINE MAGOR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Witness address: DLA Piper UK LLP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; font-size:10pt; font-family:Times New Roman">3 Noble Street</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; font-size:10pt; font-family:Times New Roman">London EC2V 7EE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executed as a deed by <B>INVESCO ASSET</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)<BR><B>MANAGEMENT
LIMITED </B>acting as agent&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)<BR></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">for and on behalf of its discretionary
managed&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)<BR></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">clients by a director in the presence of
a&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">witness:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Signature: /s/ Graeme Proudfoot</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name (block capitals): Graeme Proudfoot</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:9.50em; font-size:10pt; font-family:Times New Roman"><B>Director</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Witness signature: /s/ Beverly Young</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Witness name: Beverly Young</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(block capitals)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Witness address: 125 London Wall</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; font-size:10pt; font-family:Times New Roman">London, EC2Y SAS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>12 </B></P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g68105g01z16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g01z16.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2#"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (*:^@U@X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              0$   $A          $
M                     0             !(0   0$
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   0$     4F=H=&QO;F<
M  $A    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   $!     %)G:'1L;VYG   !(0    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ C@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M 0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87
MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W
MAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B$P4R@9$4
MH;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B
M\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>W
MQ__:  P# 0 "$0,1 #\ ZGK69;7]9:FOR+#C5#$W,KNMHKH===;2Q^9]GK>S
M);U"STZ:JK?YOT?TWH4W>JNL7 ]=M;C?7"AF20YWJXSL.\ASW4BZTMN8]]]^
M/5MN</2K91ZOV:K^7_.;'UCZME]-;?FGJE./1BN8&X5-++KG;W55_K/KY%#G
M>^S^;H^S?HO\-8DIZ9)#H];T6?:-INVCU#7(9NCW[-WNV;D1)2DD'&R69-7J
MU@AN][/=H9K>ZEW_ $JT9)2DDDDE*22224I))))2DDDDE*22224I))))2DDD
MDE/_T.CZL_-/UM#*Z_4(^Q;36PY(JK]6[=?E5V8EC<-[_P!894_$RZ/]-=]!
M5_K*1@]=+FOK8_(-=]CFT>JX5E]6(W]%F93J\N_U?S.G8C,BJO\ X6RGUY_6
M6FQ_UMP\AKZ/2QOL@O<^H.-1NR'5X_KDX]S[_M5E=E&+LR:/L5WZ?]#_ #SY
M?7![*_K!@V9EPHQA4W[,7VEH^T>J=_I54Y_2K6V>ELWW.^U5_P#!U_X=)=;K
MWUEOZ1DVU?8_4J;A6955SK T/LKMQ\;[/L&]]=;?MM3[+G_]:KL5'#^NV5=U
M-F#?AL:RNXX>8^NQSW"\?;MKL6KTMUV/MZ6_Z7IY'Z?^;_1?I>FOPL/)DY-%
M=VZM])]1H=-=FWUJ3N_P5OI5^HS\_8@4=#Z-C6T7X^#CU78K#5CV,K:'5L<7
M%S*GANYC7>I9_P!NV_Z5Z2%NB.#^GAXD!UV00' M,&^X^YCPU[/[:L79#JK:
M:_3<_P!9Q;N:6PV!N]^YS7?1'YF] Z/_ $(_\?D?^?[D7)_I.)_QCO\ SW8@
M?X+H@$Z]C_T6PG5:LV_;K6E\U-K8YM<#0N+VN]WTO\$K*(017V _:I))))"D
MDDDE*22224I))))2DDDDE*22224__]'I>O.J_P"=6/;>?4;BC$VO:Y]7V5U]
MUM#77V4TV>LSJ+]E%=3G[*_2_3^A3?ZJM=:P<L=99EUWXU5^2QN/C.?E6XEC
MFL<;6X]E%;<AG4-M]F[]%]BM].[T?^$4>N8E+_K'@WVYN%1;-'V9N0YK<EA9
M:]U[<*IP_6OVBQ[<3])_1OYZC]*J'USP:\OZPX!?2X;*V_I7"YS+@7V-=AL;
MBXV595?76Y]OJU646?IO^!KLI27L0\X^+ZF9:R:F;K[X].OVC=;;M>]_HU?G
M>^U_IL_PB#3U?I5]M--&;CVVY+#9CL9:QSK&"0;:6-=NLK]C_>Q#Z]TZSJG1
MLOI]3V,?DUEC76-W-G^4W^5_I&_I*OYVO](N>Z;]2^HXW4J,JV^D4^J,FX,+
MW6ML:.H-KJJOM&_(]O5/TV9D_K-ME7O_ )_]&D/1]&_H1_X_(_\ /]R+D_TG
M$_XQW_GNQ!Z&W9T\,W.?MNR!N>9<8ON]SW?G.0^J'J/VO 9ABL5OL>+['ZN8
M-AAU+-S=[MOJ)LC0[ZC;S9,4;E5@:2UEH/DDFJR<=W5<C';:TWLIJ+Z@?<!-
MNKF_]<8KJR&8U&%U@7-&Y]U;*;KG&7N<XVV566/_ .L^E_VTS^;8M8)1)UON
M591$&/#9!C'?O6JZ222<QJ22224PM#RPBMP:_LYPW ?V98LHX77G]"S,2_,9
M9U*ZFYF/D5@TACWM<VAV^OW-]-Q9[V5^Q:MOJ>F?2V[^VZ8Y_DK.8[ZPLZ5>
MZYF-;U0,><=E!<*B_P!WH[S?^9_-[TN']*]M*O\ 8N$R(F-#4@W0XO3_ %_F
M<FSZM==KR*[,;J5A &Y[GW7[6V'(Q;=M6,^R]KZ*L"G+J_37?I;+_?\ H[/T
M,<[HGUONH(Q^HM%E3<H,_26L]4Y=N1M?8^N?L_[.Q'XEF%^CO]._?3^CKK]5
M568'^,+%R+=F0,FNJKT*;'/8?4+0TT91HMAE=K[&MKS=[OYC[4_'_6'T*SD
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( .D!!@,!$0 "$0$#$0'_Q  >  $  @$% 0$             " D' 0($
M!08* __$ $L0   & 0,# @,#" 4)!@<   $" P0%!@< "!$)$B$3,11!415A
M<187(C*!D:&Q(S=WT? *)3,U4EB8M\$8)[/3UN%)66)RB++7_\0 '0$!  ("
M P$!              $&!0<" P0("?_$ %01  $# P$%! 8$!@T)"0$   $
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MOS:-A+XX7?RDDL0L'95)NMH':OS,'2 $CZ_@G1\.NO&[?IYQ<?"[,-NL3$Y
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M3(I,].&Q14[7<HEB,V43,R328JXJ+4?:8YVJ(5]1RQF1!&0CE[#8/RS7D")
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M<V2GJ6:.AJZ9\51&X-(>0"%X>,RK8\?2C2IYS1C8[XYPFTK>4X5%RVH]E,8
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M)]L;N,N6/HZ"X0R5+IK@]S97M,8#8WEN-XNR)8W;N2X8W3C QC08R\.$.JD
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M;469D8@D_DUU7QP2:NOL^[ZRB@KMAW$[H)?)>R_<+:MR-]M\7N[W<;IL(7G
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M@Y70(@_DI9E'13"1]9H9^J1(BRA%F!EU+-B\C!2MB8[E*(YCX:<AZX_9IDL
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%B)HB_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g68105g02e55.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g02e55.jpg
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M 0$! 0'_P  1" #1 7X# 1$  A$! Q$!_\0 '@ !  (" P$! 0
M  @)!PH#!08$ @'_Q !)$   !@(!  8$"0@* 00#   " P0%!@<  0@)$105
M5942$U35%A<A4U:3E-/4&3$X.7G1TM8B05=U=I:7M;:X&"9"47$C)37_Q  <
M 0$!  (# 0$              0(& P<(!03_Q !/$0 " 0$$!04(#@D# P4
M     1$A C%1D0,$06'1!082<;$6-7.!E*&T\ <3%R(R-E-45722L\'4%5)R
MDY72T]7A%#-")33Q(R9$LN+_V@ , P$  A$#$0 _ -_C & , 8 P!@# & ,
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M*B6V[17(:VE](5;<G1H0ZM)54S\VK>'S76G(2<FZO>:<G$B(E4=*&";M*Y1
M(C)0)G(^*R<B-B:U$7+"ZOFQBK-(:JU:HT^E*5(ZG5W4;F8-HK!QC & , 8
MP!@# & , JYZ8V\;6X[<%)C:-+3-Q@,^;K8XXL**2M:=M5+$[1,;]KJ*29"
MEV1."+93M'GAR:SQ#2B-+)5F#3F$GA+- ,K"3M0ZJ+7_ -6R)/2Y<EN:G#*V
M:ZF=!.4@G<$Y@5E)>&=95P%$QG-=5\Z)DZI57'ZUT*M6VC7'[DC2ID[:O85R
MQ7'QBA6EBAOT<K$,8RL*S:3FG1:M/?9VKKNCUGP?(VM^85<<UNC)XU)^DFY8
M(6GEM%KVCUS.4=24&3IOE/&/C+$Y1N5UT6^TB\FM K*G2=VDDM0R,R2I4^GM
M2@C9,?2DI"DP*THM/H6:.5,[7=?LV7$KN;O-F7RW@QRCM_HTN0?&R=2?CA ;
M/=+AF3PY.DU<H(CA-<R.2.)$.0Q/1C(5;H-M.SX\GFY(XF0L"%2ZMRY*4-"<
M)9L^^LJTFDVDMDRTIJKNKS7E;/,;F5S*.K_B\T5KR6F=-NC-T,%H](E-I5#H
MQ6[L_6Q<]7UG"'QE9IH*:PZ2H"84XNASLK>V>/(6;O$;RJ">,8$K:%",K-E.
M94^_LV55TEPW1WW1,[T8@E/23<X)1;CU<S5?CK#(I1LKZ%>+'T-'X?7YM768
MW=(!4#%8U[J)P>\1=SF^W/3F^";H:M898SZC#8F#V0D;@,"\@56%$1>K;FLK
MHMI;8BE:5R-P_!PC & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , AVU</8VW\T;5YCJ98XN;C:_'2%\=':NU#4E R(V.'RM^E'?A;P!7M<I
M5NNWX]N4H!I"B"2"0FEJ!C'L(19][T=DSFH_!$ N.70T.%!69Q+?EO,:Q['J
M#@K+[:>N+U+/59P1E*B49N:.S1CE<<FD]9E 9!8;FE-DS6HCTE<$K;IE0LBI
MH2LFB'PX]",G;E6J).U'2>,5IA7Q>:)^<'>'<7X4\2*RXD-\F56A&:W#.0 D
M4G8FY H?BYQ94OLA06X,A![@WE@0+)::VDAT<<$XA"2I'H!I@@ $M6NE:=IJ
M)CS*""ED=&[:%Y\F>7^WV=ET_P 5+MD7"AW=8S%HQ#']TNF/\>4!,A=X>B<1
MN9+Q4 &Z:L;8@5O)3(M&_,3X[D(D.S0)71 +TDE9VM=+Q3=UX^+Q.[#!@, 8
M P!@# & , 8 P"&_/;B$AYS\9Y9QS<+!=JM+DDEKB4I9PR,3;)7%F<JVL&-V
M$UB*97=2E;EH%3A&DR0\"H[U823S![+-]'U0Q;+Z+E0[[[JIK9&)@Z6\ ;4N
M2(\>V7DCS"D]URCCKS>J#F5%9INEZRK@]>53[4Y(FJI5K! @M3.%F<W%Y=W=
M5+!EJGTD:W2())R5,GT6PW<&OQ+TKX24IJDYU;,_7-Q)9;CY4\,N4BZ9.C(\
M<.%'(-0Q1)(U)%;;-]W_ %DDK1R"[.9RHI4T:CB1(%U0[1IE?;E ]IE&B"]:
M,P2:-8QYCW?(#CS%;TX[7[QY*,30!JOVI[&JM[D<;8VW:UJ)L2(N\252 MO#
MV),Z.#80[F+""59Y85!A023#BP#$+0)PT\&GDRMKDMT/"2\H=0T?@_)N8TR_
M5-PXD7 ^;29%7$1G1=L<=YG%(S%9<S*&60+DI4+E#D1'CE2"3LJY8>TC=E)0
M$BKU"8T(R5N)I,M6HFYJ6O%CC%Z/,2SH/:_=KG:IA$^0U@PZDG%RX3/ML42*
M'1"0'68]\!8FEA%$'DV@LVE?X6W"CC<VI)HWL[.J-D!Y2E4G7-9AR72 %;:5
MU8M)/]J^EU]2\S!@, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M;*Z&.Z2NXE;8_0K-UEQY6BV3<W!I*K$ICK>M$4Z."$LH)SB4BV@)4HC5 %A
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M,E936R$M^V2#R&)15>J<7-@6*S!'%(FZL[7+K$N*1MO)J8(, 8 P!@# & ,
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M.D5_18F/]^PO_DS?F]>QS\:M3^KZ[Z-;-?YS]Y]/X30??6#7*ST<=7C & ,
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M_&X [P<O 5GVQK_&X [P<O 5GVQK_&X [P<O 5GVQK_&X [P<O 5GVQK_&X
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M9HK&&-"$843-'H\W)FAE:483!F&!2MS:C3(TX1F#'HDD&A#$+K%L0]!@# &
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MWQTN J;7]'Y&[VXY0S336=YS!@9&Z02Q_L%=W,CL9<UD,"DIX.?&YV5,G8Y
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M6OV=7]'T1"C-V/@C & , 8 P!@$Y^CH$$'*2*[$((=?!V9?*+>M:_P#X"O\
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M/%R1R\5.FVYJ+U6Z,*WTV;9IW5J\/I4DD+U+^-+!7=3JRY"UJ=L40>BZ><[
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M0M\&A<#PM,L4.SDW-9$=7[3O!SBO1(BT8E*H@HP2'AO\6)[O & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@%)LGZ&QM?[OM6X <BEIS1(;-M#D+3E6RJC*QE\)K#DQ::(]&JN*P0*]H
M5O(KXO@.<A#3L1L@TILK0A^5E,JP0P .$CCYH,^E2(4T3<N86Q83MC>63<2N
M.C/Q-X[5AQ\8I*Y3%%7;2YIU$J=FUI95;^]2&1/$ND;H6PL*=,R1YN5R%_=#
M6>.-!(6Z/-.T+*C$:G0EFC&+<N7M)&8(5?<IW#D/#WZ"O2V 1*WI,99=AZIV
MRZ[XZW'.4G%ZN'>*.3.Z/L^K=BM24;N6TW]E=$,)CZU,.IHJ,"^7O!PFEO*-
MBTA%4;U2M;_-=XG^*BK&Z6D]+2JHT?&]JYA%2YFCG"BMX(SV51E>JJ5F5)5_
M) H[.<;2F*VK!O=,OT3B,IM!Z<(HHG52R%JE((\944'D;>L*8'(69EN(<NDR
MGN3:F85Z='5S59JF- S7CE+ RF@F*;2F/0=36T3+<YW G&X$L/9&=HM17!$L
M,J2KE%/SBV8C2".Q'Z,(%JF6227.TEOQ7,IA-I"IX\%MB<25%=]WBJVYO_"Z
MLEI]=.TM?Z^@C[/XR3"IV]0V,.TUAJ=Q)>"(E+7)D0K))&2'=,(2=T)87@Y:
MU%N*<0B5P$@5)0MEFAWL0] H(=!FB$F<$A!._1] HUM&H&'J#K0O2-TO(T+T
MA>D+744'T=;T'^EO7I;M-J><?@R5V-93^*.'LSYXLA\G,]ZXI@\UP%<5D^([
M,^>+(?)S/>N*8/-<!7%9/B.S/GBR'R<SWKBF#S7 5Q63XCLSYXLA\G,]ZXI@
M\UP%<5D^([,^>+(?)S/>N*8/-<!7%9/B.S/GBR'R<SWKBF#S7 5Q63XCLSYX
MLA\G,]ZXI@\UP%<5D^([,^>+(?)S/>N*8/-<!7%9/B.S/GBR'R<SWKBF#S7
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MLA\G,]ZXI@\UP%<5D^([,^>+(?)S/>N*8/-<!7%9/B.S/GBR'R<SWKBF#S7
M5Q63XCLSYXLA\G,]ZXI@\UP%<5D^([,^>+(?)S/>N*8/-<!7%9/B.S/GBR'R
M<SWKBF#S7 5Q63XG8I@*0%:"J/+4'=8M[,*(VF!L.]_T=>JV<HWK>M?)O?K-
M]?Y^K60M=O9'XLY\ 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g68105g04e96.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g04e96.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2LL4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *Q"^$0)#A"24T$!       0!P!6@ #&R5'' (   (/_AP"4  (4E(Q,3
M<U-S(< @4 'TUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@X0DE-!"
M4      ! :<&^3(HF#5^SQ',L7)UX'.$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0&
MH            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  T     $  @
M#0     0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@             #'P   SX          0
M                     !              ,^   #'P
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG   #'P    !29VAT;&]N9P
M   SX    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P   Q\     4F=H=&QO;F<   ,^     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    %.$))300,     "
M"R     0   *    ":   !X  !(,   ""6 !@  ?_8_^T #$%D;V)E7T--
M+_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q
M,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"P
MT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,#
MP,# P,# P,# P,# P,# S_P  1" ": * # 2(  A$! Q$!_]T !  *_\0!/P
M   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M/YWIU[:V_OK5Q#7]IK;6W:UH=SR21RY4?6:Q
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$!_\  $0@!<0%_ P$1  (1 0,1 ?_$ !\    & P$! 0
M       &!P@)"@,$!0(!"__$ '40  (" @$"! 0# P,($ \"'P$" P0%!A$'
M$@ ($R$)%"(Q%4%1%B,R"F%Q%Q@D,W*!D;$E)S0U-T)255:7H;*WP=36&1HF
M-CE#6'-UA96TM='P1$A78G1V>+.VU>$I4X*'HCA%1D=48V1E=X.$DI/"P\;3
M_\0 &P$! 0$!  ,!              $" P0%!@?_Q  X$0 ! P($!00#  $#
M!0 " P$! !$A,4%187'P H&1H;$#P='A!!+Q,@4B<@830H*R(U(4%6)#_]H
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M+.AY4V8V' +)XB8 88"*F_71U+GIVDZ=T]P\>N:!J^'U#!QJJ_A^$IQUA,5
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M8A+]EX6G6-:]6IB<?ZJTZ5*H*U6E1:J(X*,5>. (B!O%Z[M0X34SHD."! S
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MK3?,VC:@9X)J%U(IK@D,DL<;U)":LYJVH J12(O9*&:-"GV'RS'*7,/20J\
M&<C\RP887@&"+#GPZ//9%U1HXSH7U=S44_4S&4EKZ5M-EI(UWK%5:\;+ALA+
M-'$9-LQ4"=B6'X.?IQF7Z[T<SV0PPW]:@BRA#,;'M =X&/25)AM&II^_R>-0
M%P'DMU$/LRGW:6(?D?N70<>X) !\5 6MB"DQGB@DBDAL003UYX9:MNI8C66M
M;J3QM%9J6(F!26&Q [12QN"'1B#]N?!;X@X!@11\K8FW(*ES\;CX?O\ 4)WR
M+KSTWQ,_]3+=YW%M(HF>+!9 .YEQ]F5?X9,=WQP1RRK_ &3BWH3L[3162"Y^
M5")T;_T2-<_\<?\ H'*>"+]-C0NEFF='\3>TW2:$=;'MG,IE,K>>,"_G\U=N
M2R7<MDY5!:69F8QUHF;LJUUCBB"_7S'R?M,XT>G."5TX>&'J]/[0'OF)1Q^Z
ML O)(;[?K[D\<D'DGV''^#\_%V%NT3I'?/%&+6<.<C8=['=\C7*F7CV]1QP3
M$IY[@26;O(Y*JO'N>WQ-W%/,]B<9Y$D%@3$5H]1>^<-=DB?G3\XV7\I?2V0:
M18BI]1-_$^ TT1JC-AX:D1:]LDD05RT6(25/DT"=DF2FK@D)$_-?XWNDJ .>
MI.@Y'QDJM&<S.SYO+9+;\UF)[^;S%^WFLAL.?O?,Y#-Y:<M8N6+/S+V+N4M6
MVDE0+Z$JR,YCD"Q^PF.OT_2+7JM0WZBI+:2.>%S2I98,7@9MTNFE@[6M86Y$
MMB_)C<QE)->QL%"L1):OPY#)<XH1U*P^<N13VX;?IP2?)Q3-VPK*C7Y:[VLV
M.*&#<7$9O(_VX8Q1GIXVF7&RY%<#B[J7\%K=),'K]NK7>&#-6&N<V<[#$RL\
MJYG*6+%U)+7I3#&?(QS"-HEA54WCSS:@[&$#AWAP] P9F+"I>UK@KG7(4KW+
MF'D96^5ECJ3/#,'1,C7KK7OQ*ZDB4):6:)Y(N(F:,]DCH 2YFT1!V+16J29:
MY!(?_$ESYY@O9UK12V:EVM=2*!)*$M:6%):M05O6J,OIO+4>$UKOJNBM:6S#
M9%QN];0F1V4GC-B,"\4+ 1$BO*=,"\N"0P#Q6*PX<6]EM7LE/E'R66R>3IM=
MFD+E+%0CYJ9V20UZ-'$8]\?6JA7[(XVBJTHD5JH2"-%7P>":$.+&S_;.:5JL
MT_V@.'+6=QC#WO+X,C-CTSV_[.(Z51\[L&=LJ8,;B4ITFFG:M#4ACIPQ5XJ]
M.O6BC@JQU(Z\->*&&.*,!%Y!W9]:NXT9RT0V$O"D"\$3&8BI#X:RT%2M>7OX
M;.3R'X;M'6ZS+BJ /S"Z)C9 ]^QWJ08<ME8V58*TT95;$-2-II."@F[/J-UG
M?M;Z<QS7'SCKI2S*9G1NG^#UK$8[6]6Q5+ :]C(D@JX[&5TKUXPBJH/9'P99
M6[1W22F1V8]SNYX'BJ(_9;0L=EJ4L#P1RB>!HIX+,(LUK*%&62&S#(KQ2),C
M=D@8%>TE2I X\$?>_*A$\Y_P\<:U/8^I?13'-A,W1:;)Y_I[1K(F#R=>..66
M]>U^G$JPT+\:)ZBTZ\82;F4Q(LC@>)4'L1G0BD\^<JOW88X6F**)#IYONW=*
M[D^1U+:MBU7*6K=$9+\%MRX]A0JS.]^OZBS*U?*3HHI17HH%L5H9;"Q6XC(Y
M$$%C<EL&PRDP\,PJM$$@.7PH)+3=P&))O6CD\P6+FZYW:,CG-CDCFM5LYL4>
M0VN_F,]D<O=:9[&.P;WZT&5OSYG*M+'1CMY(Q489@)LC<JP R>*/X#6(?'&K
MG1"&'^,W+0V+"(8.,;&45)89A&'[F](V#6]:6+M1'01S!0 I42^C+&W"\$,2
M'[??Q##.P,@&PP@Z?>.@7#7!!.-7- )&4EC"/U2#'8'8LSC#-%>J8S(W*8>9
M(VL-\JS11H5C,ZQ3R-*C3-ZJ5U>,R%T0*/% :)YWSVTK'$Y8Q(/DQRCV4T'D
M2\_G433\W@?+GU(VZKM?3;=EKZWJ5[8YH,ED-)R4KA,?@ZF<L)\U+K-B=4HU
M8I+%BOCK)K-C94@$R-??>_XLLI6MII25[LDTBH&FD8HRJ 7C[0O+\ <NA'8Q
M8!N..[D@$2-\[==5O@)?)MVTOX#E/L#_ ' /()5E[>?;GG@GD$DG]/;[^!AN
ME>;\FZ.MD OA9AJ\R[SIK*:5YN_*_A?,QT^FQT<%:IU'UFM9M:%GY%B#RSD&
M>36LE*>#)B\LZ^G&)2R4KC+8151YRRHCX^QY"P1^IR=R8GEB)$4@L%(K\#WI
MS-TH^'?TTT:UCK.'MX??>MOSN(MQF*;%7K?5S<+5S']A [8ZMF62.(#E?3"E
M692&-62SQ2RBT_E? _\ I>O0\\_^^SU3]?\ X%O5?]/?\_R]_;P43-O@9>3R
M#R^>5BKU;VC")3ZH^8(5MIM6;,;+DL;TY1$?2<%VL1\M%?B:;9K4?8LCR9.I
M'/W"G$L<>F9\5\-BM\ <OAOEKRD.IKIF+%8UX4<\,1P!P./<$\\  ??G@$$_
M<>*M<3N &%<LWY5<9W"2_P TOGEP?E(Z-V-?U;!U<UUKWH,^L1VU2;%:C@:,
M8A&U9RJ5<Y)*N3E]7'T98UIWLJJ-=+UJ)C9O>XT=<P)YU=AWI3Z5:[*[E=ZC
M9+==WZE]1:]_;]CAR>7EM;9'M.7R&QYV.>%HS<MXC&68: G[IHL7.UV*M7>&
M*K+7KX]D*S>/6*O6K5*&#[@6H_,-J_-$6_9LRIB,=#7L5HL9#:B'S"QQVY9<
MK.]NW-#*M*M<KTK*R*(*IGL1)$#,CCYB3NC%JNSOB36TC066@P<FX!%X=B)J
M>HAUI#'332M'7AF;M!C B5W?@A5,<8C# IPHY4*') )/MXK;Y-ME'Q8G2@C3
M1J0U*[.1U7:J)5[^$RD$;1>K7]>"8"2MR"#&J\.48$E@%4\>Y/V'B,7?!P]2
M+14/B[GP-_MPXN^6)=[4-&18-Q?G8I[ZO:2#M-B!F52Z5P1#0$*1$00 J(F0
MJR+!ZGTCD@KAQ6[",N[58FE2H8'%^K$'.=/)%F!=UJKF<NL-R&IG[&$[H_3B
MI8^U8QM"[ZTGI30H,?)6I^H0/_=2")H@RF16"(]&X;L9S]V609D ]Z5-^9G*
M@:3WX8'EM@WC;,MUQV^O')B]%RRX73L39B)-[;TK1SV<Y8+2%?3UVI9C2HKJ
MYDR5P2#CY8%G.;$Y_P =O9"S1-SAI!Q>PK&=D3!8I<?2"A>UY0'<D$>_'LOL
M..0J^_L/?G]? =.ZRNO^O'/'_M]_OXJ+YX(O7 /VY^W)]OM_?Y]^?O\ EX(L
MB/VK]F)Y^D>_#??GG[CV' X']/Y>Y%G[OT*D?<=S#@<_S=O^'G[\_?[\$46'
MQ9<)A['E=V'(V[#0WZ6:P<N/K+"72Y8L9.G L:2@@0O$3ZY8AN4#HOUL.3;T
MWME0[Q6RK6]-;,)VC#8Z[8L5JF:MQ83(?*XILO8-3*#Y65:^.2S7EM6B'7Y5
M(W[C8[.0P8@EOB:M   (AW?QB&-:,_?%W,:9LS1T)+NO9[4,Y8ACL5I7ARN&
MSF&R#+'.)XBKP9&C/5C53"R)!+ Z E"><R[ F*O-JZFC.*DM=  0\S5B3-GA
MVJU6:I5KKX;GG Z>>:K1\CI/4N5\3UXU+%03Y&*A96$;E@*:1PVMQPV.DYK6
M;->3LEV/$1*7J%_G:X6FY]&AYQP?W^0ZSQ<+&L8^8WJG ]3-!GT[,)+!,EW!
MY6)KF&RM;ZJUN MPR<\\Q3PN0L]>4^I$Q[3RC(QJ<,FMH]KVPD,$TSS!="].
M\R?1W>.BN\U89<+NF'LU*-N9 YPN=->5,3F(9 RL@KSR>G9*,I>K-,A!Y!!"
M,'9@U_JM<S$2OSQ,YT:VOR^>:W8>C>ZT9L?L.@[1M>!M1S(4]>&KBLN*=Z$D
M 2UKU0PVJ\REEDAE1E)!'@LK]+W+L!E,B?8D9"X/I/M[VI??C] /Z>!]N?;Q
MD.\M2EVFL5!BPJNP@1=B.@&)]^:PX['S9&W'!$3]9'?)P2L:@DLQ'/OVC['V
M[B..?%@V<C''II(3B/ZS>P^G[^$K5:M%CZU>E6#!44!W;M!X^[RLS-[,Y_G^
MD<\'M4>*N),YG9WWD*JYYY>N0Z[^8K9[\-EFTS2YY]&U)('++/BL/=FCR66A
M4F)?6S&2-NPDG>O$"5$=^R/D3G8X'I=Q?4+?"" 2 YU-*]78B[80[*;+5GFE
M6H+*5Q,R5_G)(7L>CZCI$\IKQ)$)!& )1"C+WDA2Q(;QF'-@(:&K+B6#@3%:
M/)T'8@UZ5AWH[88+/#!-$RQ0J7$[BI+:2*5Z[I./WD<D[QCTHUA)$D7 9E5B
MZD<^ $TBA@!W8B&SFD!\E"PJ'XJU]\(@%ROM"JL=S%G&V.+KVFEB>S'%#2B-
M2R7K2R6)!.A5:\)M64EK1K73A"9&''BTEX#@N^(>I.&@JZR&EWL0'K<.='UR
M6:"&:]8O32WJXFJQO=<3R01RW$,R@?)B-6BGL+).)WJGM<U1/,.[T3$3WB(+
M33-^<B'EI*T"S!CB'K9C )R%7>P8+MYV66Y+3LK5L8ZG/01L?%+ :\7[L]M@
MUIC!"EZ$71,387TW!D$;LTB>[Z[M,_Y$$"<\80,'QD'" 3+&]Q(+(Q]->EVV
M]8^H6N]-NG^*L9#.;/9-?T99I)*U"JBI+<RF3M-$RQ4,=&KV9K#+&0/3A53)
MV%U20X!;RTUY!Z(?]ID/8.2S2P$80SM/2S=Y:/)-TZ\L6IQI2KU=OWVQS;RN
MZ9#%U%NO9,*=^/PZA9):="M(&%;F5YW/[V1U9^Q=+F=CI/;0TI1Q$4&8D/JV
M\=.D)(//?')(@)]^Y5)<'@ ]IY[0/<CQ,6^C?WDHC_J0CMQR1]JJ]9BW8."S
M*> K'\^>206)YX7WXX'BHCFW" '@ >PY!X/M[@#@$G^C].>3QX(B%L]&.<O/
M&H8B-DD#*.&/U\%N2>Y2">0PX( Y'!/B7>:;C9DY(JRGQ!^A>,Z0]78L]@H#
M#KG4FE?SJ588D]#&YV&RL6:HP+]$:5Y?7K7H1SW0M9=(U[$#>!Z@P1[XTM+P
MS+7"2:0TU(',7&<:T3)]!S6OZ]MF+FW#$5<AJ]F_C\;MT4E:.?(PZM<MPG.S
M8<2=RP97Y#U)*EZ)'F1XE2NZ>J[^(&/*):M-"2(THSK7$09!G)YOR8R<=:*U
MUDZ88+IGU!LT3E<-N>II+'ENG-'%9(Q2[9H-V2WD</MVUWJ[67P@R..K!\M5
MMSQYV8J5JP8Z@*UM+KFT4\V\'EBQY=>W>FM4>S6U9[;+%V_GLNLSW;(NU,;6
M@2.JEAITA%:ECZ_,6.K5Z4LB1-,S-/'66/U+,X[_ !'T%(S@B&&;Z/!=MAA#
M$Q)R-69Z#"LRL,>=O+?KS8YGI3XIJ\]$K([V*EG'".9;*OZ,#*\=F S*BQJ(
MCPBDE>YJ^CS8]6KN%/U 8V>2\-2V-*ZM:V+T!ZNT_,/Y>]*ZCQ*@S5C&)CMD
MJ%BTE+;,$JT,Y$?X3VVI4_$:ZD?56N1<^_N3@SYM8UHL@GAXA+%VQZY7]T9F
M1XN.[Z Z=PX(/!)]O?D]O ]^".?J]Q^15VWW?)=007: ,FN:903=W7DHI8-R
M.2H[OOR .."#S[%?U'!Y(XX/'@,A CIADA >6FK\@&P^]%*CY8XXDZ/:^T4$
M,!FN9V:;T42-9K$F9NM/9<)P&GL2%I9Y6Y>65F=RS$DT;&"Y&IR)'0YJ(?X_
MOEJL>;7I/Y,^B?,D6$S7G0U3-;E<C#$TM+UKI/U:S6R2AA[1RV:-1L=5<\!;
MEVL7/9R047=QN,QFOXC'XC$014L7B,?3Q6,HPCA*E#'UXZE*M&/<"."M%'$G
MO_"@Y'C()-FYO6\B:0SCHNCGA#-H2[4?(XQ:Z[&"QAR5^,2<K"C>M,2" 8P?
MJY8<=H8GCGC@CD>_C67\6#<O4TOF;;T59OSA]4SU5\P/4;999[<./HYRUJ>L
M2TSWU4U?7OF,7#%&A$4I-ZU#->[HI1%WVY!,C !O$.#M'DQ@7JS'V6N'( W:
M >K:&V5"FHO 65%($9=E2%9'(E?D$A5B'<X9V/>(U [GYX)'!\1B>3,[SG47
MJ")83AH$5<N:L(!9S9CW.%2EQ\OVB4NHVV0XVW7^>%&24V*,EJ>H\P8H>T?*
M.DZ,Z<E&+KVL"/NO'B[OI0TV5CB,D1=X&)NV#*?CH[Y:^DN#PU.=NG6"^9$2
M2/)8ER-R7O\ H_C:W;E)(()8$$'W/L/;Q5G8W89F\)9=JZ5=)\SCA4RFJXRE
M!%$T,5BF%$D/TL!V0NXY Y^WK(0../?V!% IYU.C&@Z-EK.;T#/T[RQV$7+8
M5HWJW*PF^F.TM6<D6JH<B&:>C/9CA=@)E1"&\0AV)M.]T?4:!9Z3CNZ8)"BV
MHK<$U&H&FHPU:LRT+-J2E$DTTEFQ2A2]7K)9G<F.Q9MQV%B@:3Y:.%N"3F(Q
MUBD17DR"]G-!9S>K!GSR9U9?^&7J,N&\L/3EZ52::'+Y?;<O9G,#*.;.TY*J
M9>YN5D9*M.O$"&<?1_-X>6J1]Y6/L\,O-=Z@!X->[2LR0I&I12W  4'A0">.
M>1Q[\_K_ #_F/OXJBYTL)[A]@?TX/\([CR?SY/YGG\_OX(L2Q%N2WT\ D<<$
M?KQ[$@ D\ \_KX(O+*R@\@^_ /VXY'' )'/Y?I_-_. 1>@Z\@<D<#M[^>?8^
MS'@_8'\OYOTY\$7N,KSP$)[>6![B>2/;[#VX/YCWYXX\$4)WQD>IT-/1-!Z3
MP20I;V;+R[5D)O4[7AQ6OAX*T;Q\-VPV\G9C(/!/=38*" P\.3J\-1]E\1#V
M4$N"P%K7I+^P-N4&#RVMX6/9L+5P^2:UE;V7.6J5,35H34'>"M:@,DV8R'K2
M1RX^C0=)XA9FBA,K-.A^EL\3Q #M(L&SC1@V+N5IW;5G-9&[GK1GL7<S>GOW
M[%II)#8R5V=K&3GM6FC"O+:M2O8!1I%XE^ME8A?$-A9ZN,XQ<6:7'-9%:/&>
M0STF/"5/0]RR_33:=2W[I_GLOJ^[:Q8_&Z>4QRT+"XO.XVXPIUZ,]?(0RS8Z
M]1"&]%D*DD4OKW<98KV*@6::X8C,/2_5C6J.2)H!GR9@0)I&5(5J[RE><O1O
M.3T2V7'9^G#J75_5I<=+L6K55:3#3W;"B$[;K3/Q)C\;GD6<7<5,"F/R%<10
MS2Q&)F!CL1TQ]U*-Y&ZA=.W5:K+-6G/,E>22)B ."5Y4, "/XE]QSS_3XNQ/
MG974?[N&:L>4$96.BK7_ !PO)^EG<NDOG1U.J@M5[3=+.J]6M$0\XL:_G9=)
MVJ8IQW.[16=>O2..XO\ A/U,9&"SOV\[*Y@%P 0Y#N'PZT5ES)+WY?)CC@&_
M=)(]@H]:0 #_ %1)_,$<'W_+GP\G"#JQPDS>*E;)_4",,K8WU"436,2:5(VW
M4K/<4%%8?P0C^#W^_+DECP/T!^WBKF2^;0^,G%(1YP.IEKHSY=NHN]12-5RU
MK"/KVIM(&C:3-[%(<31EC;V8O DENZ.U22M8L/920T4 <SCT%*]\G*J26K ,
MH[HI)_2,9(E=H6G;O#RR>N4<AI^9"':.3^(=W?[\1[?.M=O1;9@[@$VK!L07
MOK@;MLYW'58[DEO&V*L>/GAK7,;1M7*LN36G941QHT,/<TT\,L<B32&*(N5-
MA4C1E'@1TC \I!RUA4$P*G]B\4Q9KUZZ/L:_E,GJV06Y%+:@@RM)Z61H)(JC
M.8:\C0S4K<#QSH].=585Y)XF*R1K8AC#1JWB"UH;7"&%@]B+@!.)B2PD5,-W
MFS6O:O#%H2VDBCD-"O+%'$L=IX2E*N[.7AC:O"\IK=W< 1$;%CN+3@&0DJDL
MUP8?E-I<XPH(@B7X2)%,L<!+:7]<UZ[DP.;==XU9)I8YJY]22)?4)C#EP\+L
MT?\ ;2I,?>R*&*>&8E\R!,9GX:RW)!,@W%2PEFY\]%T4GB:%79XI)RP@6*59
MF>(21/-\XKR*:H$<D91(G8EIC&S*H(;P@V-[$9FK79CCS63K FQ:S<33D2Y<
M8E2W_"$K5#UAZFW7:)K%/IS5@IK($><K>V"J+%H>KZDT;!:ZQ2M$ZH?7]-U9
M.SBC;U^>JQQ9N]Z,]8W+NK"<7+@R,.X!>U0>#P!R"2.??N/W]C[#CD^WBJ+%
M+"&/*<<,1]/V"_J>2?R/WX_O?IX(M.K6:G>^=K]T;M$T4R< )*I92#P1P&#
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MA1QRI_,Y?B8V9WC.9/,,(S$+1_4AJ9.U,I:M&!)J%ABB>"/EE(=D]10SR1!
MP!6>("0(\D3A642J\4@/UP-P" ,DL<WQMB8; D.\"L_4@07Q%HK#L<#06K0T
MZK16YDI97GKC&8&EF=HN&\TD435L35EL5TM/"%D06K0IU)Q#(RH)VEC106#7
MA[6&($/09>YH!.($5J29HX/85+C3,EW?P_,L^)\W/1NP+<=N'(YG,XH6TE+P
MV$RF!S%8E5=^](WG!;ZHT8E0& 8<>+A#UD:7Y1AI"AD49F<7P>;"C5F8 5F3
M<*[OD_FHU5HVAAY( ?M9![GE1POT\<<^Y]ON/NZGI];'6\!%(JX>9C.(IGWY
M&)(_$ZP/W(FX!X]_['E/L/S/ZG^;Q(%&#8P)FK0[@\@%OC(8AYB.:4;3P6S^
M>+*.%GM,O;Q]):VX/\_\(X_]0'BC9B<ZEX;#XY&U:!WL;B4MNENL6W8B<\ U
MFN6??VY^5QMNQW#V(Y7M''=^?''Y\510+_&PR5A\_P"675I)H?FJ_3[;]MM*
MY!8S[7M->")BOT_5)#B>T,5Y/!7CQ#E\TGN'M[/1LS$&8PKRU4&;58#7N7[=
MJC7A2RU1<36]1\E-E*U5IJJO591'6IE)2\^3L6>Z)DEAAAGG8(K$ZQ)N=:Y"
M*8+1L Y9V+U+6-FB-GF2V8DHTH(Z4,-II,C+<R</KI;NUYVKQTJ<H$BU_DZX
MBL=R1P1M-+-WSF;THPL?(YB,+BY,1I1V-X>&31@<"6(M:CUO5HA3L%U+V'5=
M$RNHXBK2LZYE5?([1#*I>:6_EZ$V#%W&Y%V>QKERK3F?'BSB!!->$UB'(_-5
MBD4=?XL6/>E\(L[9(FP+Y-#69IJ'MBX=,,>+>0BK:]':BJ4K.2%V5IF(JJRU
M'A]>T5):6.K"I:-(R#$[3"&/ND8/'S#2QB&U,EJEHS6N(4(K (M.%V>@')F6
MC!+3,Z%_6:NBR"/ZHH)NV1&7GMG@N=K=Y6>2%XV;D-&K*Q[U07$L"7'\F>\P
M;:-+ FFIMBXC!BTL%,7Y0/AQ:MUMZ0ZOU/ZF[1GL32S]Z6_AL%JC5:[9;7Z\
MTE21,QD;L=F>G/-<JN8SC:\1>JQ6012B.044;#?/7PN9XI)&[0S4LXH=5-9T
MSZ.Z%T9UVAK72O4,3K.-QX[EJ4E]*6]*R!);F5OR>I;R>0D'!:Y>EGG) C5E
MC"J*LH\9*#:K,L$N/BK598F)E>2T9TFC(]XC&L*\$'@@D,P_A! )\$73J5,E
M(G-^W"IX)9*<!0GCD<%Y"67WYY,:J>!SS]^2+<%6*OR(@3W'EF+?4QXX]RW+
M'[?<D\ <?ESX(OG/L 3[ _G]@/O]Q[\'D\^WY#[_ )$2&];=XFUS2MKR.)@-
MZUKVO9G-B#Z3'8M8W&VK=>H[=O!0O /44<??MY!!\%<^2J#9K(9O;L_D<UD/
MF<IF]CRES)W'@K2V+-S)9&Q):L-'%#')+(6FE/;&B2=B=JJ.Q?:8]#B]:\\%
ML%HP]G#C,FM*M24_#R]:AL?3WICO'6WJ91QV&T7"X*OB>GVBY+$X3"2=2M]6
MX)<'ELI4,%?*Y(X+(=EF.Q>$E_T5N68XDJ0,95LQK[_?-8+/1IUY"T2V*8MM
M1V#(9*[LFSPO9RVR7)\K;RLM6(0Y=Y2@9ZC1K\J(4*A/3B*BNJ"*81L"@DZ$
M'"Q/\);FUM#]7R:*5:27,9 QABBX0)+!=XX9T#$F&4J!)&RE1 %1HQ&1W*R,
MCJ$<!A[<@H=PSG-S3"CD/>DRM-_M84%:5%?\FAYS8B$9Z&K9C,1^A7UVQVX&
M.:',93'X;*S)\SZ\_"9V]&+6,K7DDXKQL@IK.B#E964L:SQ+>=7%H.>867 D
M,2<6CH;R^;0(=U7DH3):-YN/+;F75D>KU>TY)XD5>X4K^0AI67DG!93'\G=D
M,J]@$2"4,W/! Y-TI4OU;=(2"YO8TIB)ZOAFK@W42]@6RF/QFMY!,I2PM2S6
M:S'VA/7GR5FU)!&PXC>. 3!%DC[E8+[<<'BK*0;J!$@2C8( 8EX'X((("EP3
M^88,#P/<>_//ZPEN<#,VTU,*\(+AJB4_SRSCCH]K@Y_]TYKV]CQSF+OY_I^G
M]'B[WL*&I13\V-=K6DZ[ HY#;A59OT"18C+/(3[_ &],,#[?I[CPWO>*;Z_2
M:=@I4L82KV$(65H_I"+PREE)*GD<<#D?FW ]^3X"43 OC>9X8KHKT0U.I+Q!
M2ZD79*M=E!B,&OZ'CXK+NK<K(LUO*=\D9Y,C2L >3SX*T-.1?Y??)5Z-,U3"
M9J3'V]JV/5X8,W;R'3S]C<Q-L>)VO6'S>%M2Z5N]5+&'.).H8[8VQ<5FY%F9
M+&-@>5LA1^2L).T9YO:['PX-57: S5I!,.XB,(A%'$:,4W1=#W.[3T/8),HV
M$CR&P/+^&X//1W6IQ8[9GJK:FQ^,LV(WBER0CD6A%/!D&BDJLS- ]\7J<6%7
M>CBDVNKQ%V+RS&+&I#\Q\7V^H'2C<.DNUWM-ZC8:WJN:IUFO5&R%&U/B-C@:
M5'I7-6RU".>EF<#E*KK-C<_4>:C*&4S-69RL1F'5J!R*49PV.%,'[D@\J"UZ
MQE:J+=Y6J^M39H9I%LBP/EI*=JNDC0I$(S8CBE>>.!$$:UG=0DWJ/VK*S,XA
MA#1B8[T @L&I" /)9KDN#+S5B]'?DOIRR3QUZTYFKW:D]9Z.13(WH*=."'B2
M2#\*]"S7>V/2B:A9B>C!$S,EN"T7CEAI;%K<]V49IKDUKEY9J/S$+GU[<V/D
M26M?C[K]6878*LER*58K5B0M3OK)6JQS3R)#5M.*_P S4*RP!)2RLBQQBTW<
M$O-#B>SL56!!<-F)9ACA!BI<2MFX(GA2:25%N"2"P*\[>LMNI)$4%KDQ"$UX
M)(W@F#\JSNB$CAN*6AXO);7H.2@N";'JXH#5V&!LE$Z6]5.H/0K=-5ZH:-D1
MB\_26=,=?>%),5E\<;#T,AAK]#TXH+F-EB@^0N5E4_6J3P2I*(I5GLXAVC*'
MT#Y%"Q+.3(,L[' W=WM<D*T)Y??,KA^NG2S ;[#3CQF4R2S4<YAZ%N"ZN'S]
M)EBO4W!E6>""1V2S1^90324YH6['/+'7=93@==8A7MJ[F83DOW-R2C>[(1S_
M  DGCD@ $$C[>";W](]F>*="RGEE4=RD^ZEO8+[>Y/YCV/(]_;[>"+G3GL C
M]QP.3_1^0/YDCC\_<?J>?8B0OKOU]Z?= =5FSVZ92,W#!SB-;H2PS9W.79D+
MUZM.EWATB)[&LWYE2I2A+22RDA8W(JS'F"ZX[AYA=USF[;9(XHQO#6P.+A;F
MKA:!,YH86BL8*!TC5Y[MDKWSRF6>1P67B<X:K_.3&58QG3^>]$UB6&%Y D[,
M@#EI&C+/VJ&X9QV\F;@$_1P"S #N/)\#]F,-_&(T7(L : &M7_CL[ @DE=?"
M:5EMHV? :]BXYLADMDR0KQ/!6EM0/2B$EBS?$T1>"6I4H5[=V\&D!JP0NMM(
M^QR#,S4N-;_.IO42#+ &.<%P<NHH#EQ,@E&[>R,F-:#Y.'(6(H(82ZU8J9GF
MC@8'F7TDD"*8D[9'$;*R*P4CPQ+_  !VL.1YN%HJ,#66!$N(P>F",.F;/E-(
MN9O)8-8AE;^M9O 8NV8!*,=-ET2I/D:$=F$,UR.J9XJ4LM=1'8D2QZ:E%"K]
M6T?K%[4R <4B(:O"U#)?>J=KY!L5EM[\Y7EXHY&[-9OS[]5ER5F2=9YTH8ZC
MDKN1M32!Y$BF6I%8DFC]F9G]0J&9@6#WB-#S%\Q11F!P83S&L&QNT%G"MI[]
MI>-Q&:S&&J^G-1X2:G(X#.8+%>.:N'8*Q+HLBJ"63GV8 \GQ=PL]DVZ@!#EX
M(V]RKV%' 'MVPS@GWXX^Q!_/G[_?QDA@8/*29>XQ)QQJNC@\+.Q+.Y+8O7)N
MB537*\:YC:)X^Y.W,6ZX4AO9(YIBR_?CGDK]0Y (/(Y'M;G;;W5<TIVF2Q?M
MGB5D<*EI<G5Y+\@O9Q-^./@=H_B)/ Y_XO%15]_C=VG;S1:%6QUI7IX_H3K6
M-K%"&CBD.8S\EN.-NY0DC">-FD61?3*JI^I ?$.H%NO,8%KX*BH>C[QC&%"E
M;]0^JUAF8E:_9S-"O*1PB-&E 7DDJH 4.'4=S,[E^"-YMEULW5EH-#7K!F0X
MPB2>0(JL06&<5ECKPQM"D@L3SVU43.;$DD2L'DC2"*&!A$K5_6FE=6(AE=D0
MRK'W(PPKK0M$%4_[26F8O,R8J":5F5]=6CDC[DD^4#+:BBM$F*:.,LI5P85C
M:)F1NSUT[4'/J>S,?"XKC:&:*%A ,74L8#T+%C0UF2\FQ&D9+0CNP6)+9@6T
MV1KJDB10QB*E*)H[(XJ15*WRE:=JDBE*T9]W[&,9(\&MO"(BLQ<MB!B6)<!Z
MZX.P Q+7SR8#7<WL&;PVI8".GD,ELFR8S"1U'JQ22Q69+AIX_(Q7IZK&ACI'
MN,]HUK*I8BB'SBE8X6\4,S#D6\=8,OG*$P*O$.P@D4Y2S-"N7]'>GPZ5=+NG
MO3>:T+;:5J&$UZ2VA;TK%NE41KUF$.798;-^2S/&@/:@D';POMXJPMG,]8>D
MNK[=CM&S74S1\3NF3$7RNJY'9L55SLK3\>@HQ\TZ3)).2/1AE"33#^U(_(\-
M=[^T2G13(XY0JQ)(X!YY;W''L>0/;W/ ')_I!(L$A?Z).WA@3R1]ASRI''()
M/^#_ '?!%S+V5IXU"]F158 *D?LTSG\PJKR??]6'"GV//V\$1;K7[NPVC!$D
ME6F2.]^Y2Y0?QENWZOJ'L/L./R]BWAO=M]2[MK0=>OT+&.NU?7@N12P64?AU
MGAFC>*:&9)"Z2)+$\B2+]/<K'AE([O!%6HZX>2'=-9\VT?23IY@<X=.W'+19
MO3]CBHW;>.UW6+,@L9HSWE$L$!U$+<0),ZRRJE,^YF3F-+W/C#+'755X8X30
M.7@SFP:K4-5R?.WD=GI;/B]-U#3=YP'1GHAC_P"I_@+EO4\Z-6S>9@JP1[3M
MTF?:E'1L99[\;T'M6)IF"51,LW,]@*G?]MSJ)J@ -2V/4;Y2F &>;TU)2*>(
MM+>AAE'J1>M9A6(SS*8^+ (BC;MY:-WC16''<I&0(FSPUY^,6U6Q3B L)+"F
M4X$S6MR ,'K0PV$,0DEKI+$?1;]S+(L?IMQ*.^8!WEC9@ )$"OVQJOL!F!#4
M?&)%,7-#C *H!(+FK4FYG"1@VCU<MTIWFG3@R$>1:*&SD;SY&^6"QT+TIDL6
MA%8JH8:SB&Q)W=DZ^HD7(23D<C0W#;TKBL<08WM73>6"<5Y=]GU[+^:'HM1P
MV/CJSQ[KCII(8WDLU@U:G:L3&G/.6F-:-XC)6]1_4C5.&DG")(U6594PPD-.
M .>)"9 Q*\$<2./J'O[@#W_0_F/OX(M'=X$GQB,SLGHNTD8]B)'*E2.?;@=H
MYXY//L..?!@:AU06(-4_+RT*R='M:5@P(GS)^H<$@Y:X0>/T(((_4<<>&JAJ
M5R_,K$9]2PR<@<Y]OOQ]VP673CGD'D\_E_C\3^]-[L3$M:M\X>S"H DJ"=>>
M221P[J3P?O\ Z4#V X''Z^+HBC=^.9/,M/RUU6M5A!FHMYVJ$/+Z<,4.1@U>
MM'--*6X7B&%D+?4>P<*"P \+8>RM3KSV579=K$ER.(R3VQ*STHI#ZCI9CD0P
MGT193MDB[) T/K1(Z?N7XC<(1)Y:$'N16<+56V#9WH0&<!VP$DD-5P2P3A=R
MT+J3U8Z98SS(Z[H.8R6KX/#XS3NKFST*+6&J[=J5:/!P;?DHO4DG;'[/@Z>#
MEO9FI5;'QYZ#*QY&9)2&D2S@<C!TW]C(9PY@<BQK3G#W@&BU-6ZU9_\ 8?.:
M!N.>RN^Z/C]6R63U74LI3PM_#:OM]I,?7PF5QF6S:W[^&Q5*W;F_%L;K9Q;7
MW6$0_N6E< ]RY'W/2.6:$9$2P!J=QF2:FR#22/,\LLC>M+WKW/$2GS#LWUM&
MJ*RQB5C]".SA1^H]O%T5$,X/P"[]G>+V(G>S%G"O=>/6Z.1QV%3T_ETSEG&9
M7./)Z$9N?B&3QN+P]6SS>6RU:"*G##6J"")EEFC>627[?SP0<,I6>I:A> XI
MEF[6F5P[/KL6,A+,Q60AR3*[2#N5U "OVD<,W+'GE3QV^PAOW:IPH07-!HMA
ML*N(<BY(TCG851\Q&\3PZ-M>E-JFHY>QLV0PN3DVO)XVQ9WC U]=BG6/%:WF
MX,E7&'P606>23,46Q]N"_(L/K<?+1%;E6#!(?SROY6" .(U R?XYL"+L71'K
M2B*2%%LVL>\DO;':61F2!6B;U@8N)I@).0UB>L4$<2]PK<AF\0BM6:Y^7I)<
M]X:FM1Q2*7.$!F,Q,_\ L4\'R9>8Q_+[U$LT\S;?)=-MP6MC<^M<S1MCLB)8
MX,;MU6M*CR^E1E>2"_!*L$UG&RLW;ZT<2@'&VH].<BD'( 9XL1!9C6K7SF1U
M,JT)JDUM*.(N6(7>KGL?!/CYXXS)!<KVX4LPS0R@$,)(&292?J"L&X'/C7C^
M?:RNSF[-G"/7M=YJ.L;V#/8X$,=+NX>6QWQ^D(H?=O5D9 @5B3]^2**?K3\3
M3#X:_>T[H]3L=4=\M7K&&Q=JABKW[)U,BTS5X.R6G#^(;%94K(\=#&B*O.8^
M]\@(>Y6;W]*@/)@3G3Y<5:JB7ZP9+J=?SU/=NI]XY#:-U@R&6N3W)JN4;&7(
M,@]"QKTM6:S/9UR:A72*2QA+4"V:L5NOQ$$XLLW&PII1<R_HNS2] I.J-'1L
MW2T.OU6;7IMC<R6\,^<GUG'UZD5>T\26X<:MJ2S5KBVUR!;T\D$>0>8F%)IO
MSN58+.;9Q+\XT$Y)!)?3K\KD$9%,:L9 4#1#GE9(V#/&54 ]T1 Y'*LR$@^+
MOLVW=7AN18=<B''EHH4^GI5HTOE[Z29;S$;A2KWMBZF8S+Z+T#TVS7LQOE),
MK71,]O.4KV((7AQM+%.:T$?8PM17T"2\9*)Q(&3OUK/1"7-& M?, ^ (NRX&
M2V#HY@^D>4O]1,@F\[KL#3872^EG3G :5K6I:'<HS06VV+:]NQ>+J;3;NPTK
M=5$QL*8XY)'M0<R5XEE@$MNN0W[J,].^RP;75R$S&&U11;MH8N7N^7GCK-2R
M)A3'O:!C$L:6ZEMIWKQ%Q7CDGC[B?4>3N5) J1 H2"^RTU;!;+R/V>Q#26%0
MTG6':2RD=^$YAOQCSI]-Y8X)Y1C=:ZBY>-F1C*SU=(R=2-B5 [F66[$H$7TJ
M2H/U$DA02]WW2L!8XGF@- (C=\U:7WJ[#+L^44MW"F*M%SRH)DQU."K(03R?
MXZ[,#P/< $<^*HFOP]QV$]RE"T]N1>X@'L>*<I]_8\J0>1X@?F(DM>+&VI%*
MNNG_ (1EU>^D)5,99;U<DC($_P E<E]) YD+V96[CQPP/+!>>"..#^7O5S6:
M?.PZ_DM>R<A54HYW'22CDL?160QV2" >1Z+R<GCV!]@>.?!%!'\7/!S?U2="
MVUWEL4LSC=BQ$$X5G';BLFMN-.1W>QKW^]5Y[2JGA>/<2<'K]=4]E#;.L0[E
M#J .&!#_ $<N#Q]V8?4.XKP .!^7V%6PX<$9X&8<DC__ %G3!:;@!0"Y"GCA
M3P6]NT >Z\\+[\@<\?J/$PMOPK0$W@3+%Q4Y0S-F"T8V7CZ%E<J>WE Q7M[>
M![H3]8[.0JAN/<'CD#P;M#4'V6V)5@DT9C+M-Z&[R6#Q4,^_0P.2S-JOC<-#
M/<OWY/2K011?O@O+2SR/ZRJM>O6@CELW;<TD=>M5CELSR)%$SK&?G$C0V8CF
MTLS7G[:":ABP834N;4@:%>L<UG%68K!LRPW*K-:CDK6(942>%F:/T[%<RPLR
MS<.LBL\8[5<%P1S0UB^[=?:S"&7M/L:AG@/-,JD68O)=YBMDW;RA6>H^_/<V
M#,=-(=RQ]J7#PPKG,MC-$JKDZT31VI(*MO)R8B2O#'-WPQ6U$9?B0,3=[U_B
MR0Q;#>\**O3NW3W(=4-YW#J=KW5GIYFL?LFP9';+&4W;=:>E;7B1D[QR$=;+
M879F@R-S)XF*S%%VZL^PUWCKI)CI7CX1"KPTYB&H9<=;P*PIX>@WQ"?+]?\
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M"AQ,:TC+PG\<X"%3*6149)FC X6.$(92%'J*&)\(DTM7!WBF/+!:)X@*R2[
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M;&VXGD^<2Q$MEKB!9(98XYZTBCE3>^_;QBBF"\@G1B3I]TUL=9MHJ20[1O%
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M!55H:7U'QNH[-WNM/#P[%#!^(3W_ $__ %?\'\_@_P#P>J.'C _W>CZG^WU
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M8!=W7A^M^!Z?J>L/5X@\$$2Q(O!$-D+S9&6!\MYEZO[,9^SC.D'GM\N,)S&
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M#]2!S_.?$%<7JS]9(<4F7#@1 I_6'(+.* &[19L(F;+.E:61B""S$^R@,6/
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MQ%F=F("JH+$D #W'@B[P\P_0$_;KCT@]OO\ Y9>F>Q_,?Y]?<?GX(OA\P_0
M??KET?'Y>_4O2_Y__P!=?S>"(?UP_0#_ .#ET?\ <\?Z)>F??_RUX(A_7#]
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MQD<A<4)9O69(8U41PK+(*L2+[JJ5P4B6-.XJ%"$1CD* %]TFC-CN,0<(.2,
M0X.!&;93->M;::Q@\L/J0<#U.\)VGV],LIY5F1>Y"4*DCL7W/OX&;L2&!OON
M)HI0AP[$P:8;TNA(%4\%E/N5 ,L7)/((/;(1]2D\$$%"&)]R3V-*5<:^\O\
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M9B*>.A58X8P2!W,PY;CD,1W'EF/O_$_NW!Y X][L*+M<<@%N"">>[[,HY(#
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MV;M#GD+-<=_']6>+#"#:[T>CR+3DK@FL8F/%XZ-%4>I(B!G_ --Z?$?"J_)
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M*T5>$H1R%;EF[BJL0;WOG10D^7'RW]7NJ%[$1:UT\R$U"U:6:39WOVX<;Z<
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ME:E,^1O4\?/)&D]6"O%+>GI/:L^B+9HU [+,!'-:AA4^BDK!&AB &P-J7S!
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M((\G@<E0FI7Z%[9M>O8K,RPT93+DK-4]OB3Y^OGD@W+?64XHY^4?J/T[Z-Y
MY7IIY>=!AZK9.>/ #+09C><G:RE+.UJ]FMCM-L;3G]LM8JR1ZT>4->O!%9A%
M&6S>6M)-55W?&E]_00DGEO?VI[MYZ2Z'UAT7,Z;U5TVCN>KYFI!/DM;R]R::
M>KD&B]57QN;AG-K#9G'F26.GE<;8J68W+&)X8IG!8M:W\G<!2B)G0/RN="_+
MW%:7I!TNQ.AP7ZL*Y&\]^WGMNR[.QG%7.[%F+%O-RXZG*GJ18X3QXR6SQ-Z;
M]BDU$Z 7+0#01V)0$/9VQ&3T$4@?0$A41(IYX8.6_B'<1RI\$WO#NF4>9#S#
MS= .I'2+%_(ZM=UKJ+;>'8QG-C7!Y2K&F0CQ[VL%>DCGQU#Y*%K.6M39E/D[
M<-2;'BQ3FGK2^&>]_ 1.'Z?=0]!ZL89MIZ<[9K^YZ[\W8Q8RN"R/X@D.2H,8
M[5"U"Q9JUV(LDKP310-)'(DL:O%(KR$3;_B#[O>Z?>4+K3D<8LKW,]@Z6FO*
M.%^5QVW92G@LW/VA^Y#'C+-N)0.Q1-84E@>1X*@.13GU]E5+US.4Y-AQ!&O4
M+-:.Y#)G*J97(@9=H+$[+W7($$^)8XN2""/L@FIB2$RS"8O(ICZ[Q<:4E]"J
MP%?8XB)G4TF[.X_1/,'E-:Q.2QEKRT=!]^I13BW-^VNB/D<@Q$CUJKRWZENE
M;,QCL!8RLP#2@&)5DE7A+&'RUL7BKY-1,&XN;GD:1#7.;,BG:U;"/MF3GU*W
MC\+D9A7>UK.K6S?R.N93)P/<EP,4"1BK7PJB5UJY$/,:]:L:.1[;,[.]QWUW
M=1X'.M ^'0^TREJZ(T<ML&?U_2E@K9O8MYV+&5:=.GJ^NSY;!6&GK2;+:DR$
M21S14;."-NO13L6OCI6MY%5IRI'+)/@>^>\3:*SEB\/0PL&OX&CW0TL%56"E
M1#M8,>+P%-*./+S.G9)9EE9;$KL>Z6=BY[_?BHE,I5K,RUEK0R2W;[K3I5V=
M$GL6IW6*&)BJ RGU0?5F/*JH8@@!F#>]A$^'I_4AQ^L4J$,%F!:;V:[&V6^8
MLS1694FNLC\-$ER57L0Q=J".%T58T4!0T1$;KQ";&HPP!U43Y$5R&XX9YL?D
M%B4%@5#&0H02".0/T\$3.,96L+@8H+ D0MC;#PR$=H<JCQ31MW<\,DKADX8
MA^22#P";WW35_B:= ,OYG/*_@:>OY[%8R_JV?Z9;CC9-ACRD\#5,IJ&2UO,X
M['+A*63R,=B:22M;]""K/%,U25 1(RN)ARW3'1JIOW54O<.AG4ZILV\X/'8E
M]OLZ?L-O7-F.J4[]H4+V/C]@]26A1OQ4)*\<5BE9>I'6MPJDB][+QX7ISO\
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M(=OGGP$LF#NXQ-?S&HYBQ7;#6<<5RF.R\$HK9VOE[&067)V&^>J(9\;:E%6
MB5*5>LLTI>%C%&+X8_9%CF'5G$R&?(M3207BSRB/*MF*09!GC@>6:.PC"=G6
M"9G,GS ]F>.,2([A68R%4"@2$<L8B7? D3)H6UHPG!EH4(9PSFK8T)#=9:!*
MZ#M5MY.6]D<C#:#QI$[0K%*;4$:%(&-:/M26)C&AD0M#8:/DO"&!9E?JYEQ,
M&!-#R*R&F[OR$30D$>QK<R5M>Q69P&?RPE4;!K\-+.1XAJ\D)RN"CO5X,E/
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M,J[@,UY-L/FRH+,9=P?-P?:)1PZ :CU)Z@:3J'2#J%8RF.P?2'8-VS>N=/M
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M<%GBE7T9&(]Q]#D@ \#[@5$9*>V6'?ULG2%FTJA%S.-%>+)O$">$N12 0Y)
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M8]SSD(63Y2M/&$':T=1HF5XPP<-\NY9/5X4$)VEN5/T@<^).]_S$W+?'4"9
MI?$)ZJ1MVDVP(W4@=I"2U&L*JDCU'CD9NUNT^I[MX/WW9_A%PI-LS3/))%AL
M&IE<=BPXX3%6=0>UI522.0GGO4S1]W;W-V<*2'/;\]-ABU'V7*R!O6Q.'$C
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M#=O  _=*I3M/L>3XJ-IS('.6WR2:YOXV6/@65=8Z;9&O(04JR2ZCK^,92O)
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M8MQ?\N+_ .2NM^'_ (\/_P!!=^G_ )F7^X7_ 'OC0_RXO_7PJ:<&O#X6*3^
M?W1_Q#Q;G0>>)8_\/_;V6'QCA_SXN?D+7%_AP\O!6:#^VK_[?IXV:<^'R%G@
M_P AS\%-%V/_ #\S/_A;(?\ G4WBKK<:'SPKA^"X\53J?*'@HN_JW^?]#^BW
.._P"9S^"WPUX=>+P%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g68105g08l96.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g08l96.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1Z^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'J*^>$(X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              .$   (;          $
M                     0             "&P   .$
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   .$     4F=H=&QO;F<
M  (;    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   #A     %)G:'1L;VYG   "&P    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 0P"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MWV. +&/?[BRNJJL
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M6;,3OB[[]4^/U?%WZ NJ[<=_%-W+93N$53FS)MB")P%BO-]?OLNY/#R+B.R
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M?80,(F$2B)!,(<_X9>?(<:IVMT>3ZE[!N >E9]%*-$1HB-$5!'@!'[@$?O\
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M&?P*B;(B1$$R$+*#2W9\GS\/)UK7+'TQ]JMGN3*ZR<!< D&*M7>C&-<@7!M
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M(Z(C1$<!]VB(X#[O]/?^?SHB-$5. ^X/T:(J\!]VB*G ?<'Z/N]OT:(L"HE
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M<)N6RZ9P R:B2Z1SD.!@'GN ? #Y#[M^CECE9SL4K9(R+M+2"#V$;^CRKO\
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M#;M8 18ZD$KOVLPM#1HB-$1HBYWEEH#_ !U;6@P?X2 O$."#!?'_ %6$H @
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MA:OG/">5.FR[73Y@QZDJ<)8:<U5.PTQEMX1"&[#V4\;K$ZG0'7C:Z9V .\>
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MM^!J8WEU3*6.AED<76DBAS@Y^OL=/UZLNX< <P']22;1C.5(901,J@_*H(F
M_<;8]EHW-'F"Y022;DDDW))WDDZF_&^\GI2G0*' <@ CQY'@ Y'[^-+#H'F"
MA8?AD/6%<$D@5,4"** F3U%"%$PID.< [C%3,8QB%,(@43&$  1$16%[V%[6
MO;6PN0.P$DVW:GI7K;?LAFT[8!)#=H[() !(;>P)  )M<@ '0!9A*40X$I1#
MGG@0#CG[_P NI7E' ?<'Z U%AT#S!$<!]P?H#2PZ!Y@B. ^X/T!I8= \P1'
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M$A[;&WC-^,)+VS3_ ,1L;_[^<P?_ 'MW4/Y@ /R 'W:P.60!A%/8 7J,3)L
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M1/BB<#?][4Q9S;-DZ-DD#Y6VNU[7;G)4D$T2E(F4"D(4"$(4 *0A2AP4I2%
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MP3LS6E[N1(4VEIO=IL@(NIIQ'$,4S-@BU,V161(JF)# (:D=^_Q(GKDOW/R
M '@  . #CQP''@0#Y#R/CQSXT19-$1HB-$1HBH(\"'M\_P H_=QHBM[A[N!
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MYJ8.0<+V>Y#&F)PX[%2K_5L0HGZLL=,P'3[DV_)5% $*C6M8T,: UK0&M
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M%/%4$,%16U+8VQO<)"><D$SRXG4W)'38JO 0$.0'D-9=;*JZ(C1$:(N [J@
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M&19(QQ4J1#_A F"0(JN;,^:INYUTZ*4"B=RH_55*L93DXG)]KD=$2R/3+P(
M !R''Y?// C[\?=]WRT10Z/I)Z9*_O#Z9%Y:!Z4BQN$^W!8OV5#$;6JC.T@$
MX?:X3.4XD#GQZ@B'N/,&XN0>!MNTT-_.O3/?LZG-MU6<"/7JN"]?Z27>['-D
M=8Y,1I/;JLX/G"?(]@G;W*^-$NXOL($"76X[O]\/ ^W&!RSKA#!]S6XD&VX
MXA5$@6Z3K>ZZCRSM#<_UH _Y$R>>FY.4<$<3?K))T '   *:OBZ,;PV.*'$M
M4RI-HRH5Y@W33#M3*BUB6:*92%#P4 *0"E /  7C6?7+%O@@ AP(<A]PZ(N
M[IL.PF?-NV9,/3S9-S'7[']D@#)J$*IPY<1RQV2A"G P>H1XF@<H@'< AR \
MZ(HU'T73*LI U[=;L\LSE493#.2'4Q#-'!S=R$>J^=04J5%(XCV$%ZV:JB4@
M%+^V";CR/)1\V[O8\5*0RZ) QI=14^N^SZ@D.[\&P,,[V^B;D(H" )A>C_M
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M2P@OVG$$#:.BE&I$$A.#>_/(_/Y 'O\ FUTM?3RR:(C1$:(N ;J^?UM&?_<
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M=%!P)7!"$%,>2Z(I_+9!!NW10;I$2013(DDDF4"IIII!V$(0H< 4I2E H
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M\>\06 3>^B#HZ$O;1$:(C1$D/+[E-ON/VQ>NNF05'61TD?4,4HJJGJ3OL1(
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MBX!5NHHD8BB@=+6\9)Z575$R1TO<IV"3D\)Y0DW4KA5U(KF&.0?R20RE<DF
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MT^]'BW\&I9H&/DG,/*,74?(1$@J@0)&.=LWZ*#I([-\5RV*)TQ!0B0* <0.
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M=)Q*$@L80$1X,95R<?'W^. 'C1.^J<(   . _P!/QB/N(_C'1%8I^Y\!S^<
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M2-R<.X\W,6$XB3G@HB(%'NX$1 "\\@ <$4R(A" 4"E .WV "B( )0#@.?O\
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MDC-$Q+VZK*R%]+]&O1?ZN]U^B+BR+<PF-:##N_\ 9,93:TP<!P(<+M89DBJ
M<B/@%"F#\0@(>=%*WW1$:(HWGTI>&>RG3.CG;1)15.#W$XYDW_IE$WHLSU7(
MD>*ZG AVI@X>MTNX1[0562#W$-$MZD[1TW9^/L^P[:7-1:R2[)U@?&Y$SHG[
MR=[:LQ[=8G(< !DUDCIG+Y$#%'N\\Z*!\I]1*6NH<2!SXXY\B/L4/<1$1$
M  !\B(!\Q$-%*8DZJO6RPOL@K4IB[%3]AF#=/8VJL55J-7%!EV=5D9 AVK.4
MLSJ/*H0'#=P=,[:"0.:1<J%*4X($'NT1)TZ#?3?REA]3)F_;=F@X7W);C2O'
MT5&S9".)BIUBQJDFI&0>JJBJJRF;"JHDW%D0Y%(R);$8*@ K'12\N%VD'H*]
M,]^W\IOQIW7#6*Z=G'9M;L/9!C4YBDY)D,\U"R1ZI4SE6C)S)]Z9+G3!4ITR
M.&PG(Y9*]O*#Q)!8@D,0#%P.63_4F$G7:J<2)ZR,1J1\6GKWKJ7+1?V_5O\
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MF**B3LOQJQ%4P-Z@ T(L[$I>Y%,Q^ U2J*JGIF&2>>"&%NIFF>6 Z7( XVU
MMOMH=ZHSRP4\1DJ*F.G8+N,L\L4;-EN]K";!Q=O;M$FQ!7E[2>EG,6JS2/4A
MZ@>>Y??1>,6R*+R&Q1574O<(MK8X-X@]8,I=[:4^]_&0:SM&1CJ[&Q+&OHD5
M!R=-ZB8J08>;,5"<,J\2H"_$FTSVM,=(-IQU +6AP.T+:@[P-2L!+FG"Y,%K
M,>PQ\F*TE#)/'+%0,,DSI(VLO"T.WNC<\EQ V2T%UR+A2.L*7;<-E;(<G9;7
M5(6 VSV6ELG=3K$]&-4+6R>.$&Q#L)=HHB5P<HJ)2'K)O#&:_#"S,U1;)G,G
MK$8168_BF)RU%7310Y=JZ".6GIJJ*(5$<SB#LS6822!H]LA+1L@BSB2<3@=;
MF;%\3J:RMHZ:FRI68=#+0TU1&!B#9)&Q[7/- O=SN<YQKR6AI:6-:38;YDW;
MM/7C*^*[_7\I62D5S':'H.J+!*K-H2<("YUB JW;+MVR13I'*W5%1!8IFY2D
M(4H:O\0P&:LQ'#JRGQ"2CIZ  "EA\2.6Q%@0VS0" !8-L+;N"O\ %LMSXCB^
M"XC!C%=AU/A+WNEP^D<8X*H$DAKF,+0 !H1LVM8'I";.K58-I2FTBP8BW@96
MDL24+-\E'46)L$"U6D;!]?*NDEV:C!B@R?@J@U4]-5X=RR4:)I#RH(CP ;..
MO1;5OZ?+Q[5%TVX8"QQ0NO/M-P)@.PR-VH&W_$U>4/<7OI&?3"+.LSEO=R,C
M\.BT(B=TE*-?VLJ*1$@521!,I@[1=^_?1-_EW?&IZA.>P.>>>/G^7W#V\?=^
M+C1%=HB/]/\ 3_3^<=$4-KJ,KITGZ1OL=M$V/PT5-PU';M'"P=B)U#)R\2 )
MG-R!@%X3TQ$  04'LYX$-0>JWE13( '@. $  >>/LB'G[Q,/< ?_ +Q>=2B\
M6Q6:"J,+(V.T3<37H"(:K/9.8FGR$;&Q[1N0RBSAV\=G10123(4QC'4.0!]B
M^? D4.3JI]4:[]1ZVI],OIHQ<SD-"_R2,)ES*D21RTAY."%<$).$8/Q*W3CZ
M>D)TUK+8GBA$'[(IXYFFH1<Y7,='?N!WULE[7UTW;CKJ+=>IZO,G%LH[)JAT
M_P#I,T/;S6%F\E*PE\JDU?;0DU(U6ME^FTYEU8)E8"$*H=%-7T8B*]<RBJ4+
M&Q[<RABDXUH'*42,N"V\5\!U -OL%3>U[ZVXKD7+;ID>4C?[*4!\K1.X>8@'
MU;EZ^^OIQ(]0[IE89@:E\+'YRQ90J_<<13"H(I*NI).$;&?54[T_:JT0GB-&
M_I+%4*1%^V:K*"! 4,&Q98%LO8-UX=2G_P"TU;UE#[5<O"PTPB@'D%.SS^77
MK29>D+UFFD,UC]BG4#<OL0[B,8N"4RO6F\%781UP9LU"M(Z.FI)T!TF$TBF"
M:2+URH5E*) 18C@IA$NL]W[V6QJ4RT?-GS9!XS<(NVCE(B[=PV5370714*!T
MU4%DQ%)9-0@@<ITSB E'D.0X'1%X5S?(L*?:G[E0"-V5>F72Z@B!0*DC'.5#
MF$Q@$G:!2^1$ [0 1'D>.2*)#]%A:K2=UZC%V0 1AYK)]6;,EB (MUE#S&0)
M,02/SVF$J#E$P  <@0X#\_!%,)T1&B(T1)1RM_?*;9O^.R5_U1=ZUG$?X_R]
M^37?Z,Y=8RG_ &,>5#_JO_KJ!*NULRY.C1$:(K1(41$1#GD  ?N\"(_SC_-]
MVB)%.-A+AS<OD;%:P TJ.6T#98H)3CZ;1&P 8C*[P;(/LD*=18J$J5NF7D$U
M1,'!1U&GG[_$B6L7]R'^GS_'J45VB+F>8<H5;"6+LAY>O#TD?4<:T^P72P.S
MF*'IQ=?C5I)PF0!$.]=S\.#=LF \J.%$4@ 14 !(H76P;:S?NO!NFREOIWHN
MIQ]MLJ%H>UW$^+Q>/&]<DC,E#@RKD>W]0R9:_ -2H'G3HF*K+3J[D72RQA=
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MX^)'KTC9/<]/5JONU*E&B(T14$> $>.?Q!\]$7$ZC=)Z6S1E6EO5TCP55KU
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MOZB)/C[+95TB&<()+#W*$B(\P?#L&_>( 0GJ&Y4.8PD[>OS=[73EX  !P'@
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M/MK@_*)&Z/'V.:\QEU#%*R1A+'[8D<S1P-R =@-;:P)-ND_('+V)J#.&%8O
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MS+=PF!;XU..*N58##W>J10I^?(F$?.B+J@))E*4I2@!2AVE / %#VX  X#@
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M]=@\M-72O(J'-JHZ]]2)V.&PW:=,VG<P[3@ '"]@#:1"@98$T@5$ 5,5,#"
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MQMHQY(E*C;ZV0"E4%0RC0I9%DB(&$7S)+@H"/EW[W3OW]7QWT2HJG:H2[5F
MMU9?(R<!98EC-0[Y Q?2<Q\BW3<-C\=W<0_8H4JI!*)DE ,D8H'*( 1>L[:M
M'S9RS?-F[UF[16:O6;E%-PW<-%TCHKHKMU2&(LBJFH=)4BA3$514.!BB0P%
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M[B19-$1HB-$1HB-$1HB-$1HBP.O[@K_P!_[->7B[2.HKTS1[?RAZS9)?V:@
M8*B^/\*]YB$?S9<NW'_UAU@LM$G"8B?Y53B1/:,1J1HNI<L_V_UO\QY._P!C
M\"2I]9]<K1HB-$1HBYYEER9GC.]NRRT1!&;5>97":GVOQT+%BDQ6.#^4:"FJ
M#ABUX]9PD*9@.D0P"' CJXI1>IIQ8F\T>C39Q\<7L;ML>O:%ND*C4&T$QT'V
M-^IW#Q3J=#NW[CV'<MRCQ[F[4W>0XF;ICWIE["'Y)R)BE$ X(<1$R8?(.0
MX'FVOYRYWEU._J^556^]:>F-F[=[T;MWQ;EZ.I4H'G@>/?Y<CP'/XQX'C\O
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M("@,.U(#D2+XP>,QC!\0H\>BBV:8-\#Q41M(;'32.',U1:+-'@CKESB" "2
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M7+M"T$HBJJC:#P2&EYCDNT[<; ;*;1+[:L#]0R]NX7,^WJ.M>')?;I3&U-W
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M6X#Z2_:KK1;A$0S6%,C-8^D89]]3,<GSU2P[7V436WS_ (1%PE:WJ2R4@8P
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M+N=L22;AQ2E\;;_L#[O=H&)=O%IWLP6U7'K#$C+&^3:8HQ<Q-Y1GHI,Z/UE
MS;9HX3<QD@F)%"""A.P .F=,P&\7U12Y@.,4T\%=31X.UA%12R1-+Y+D[3G/
ML':B]@" -;"P6N8/BG)G3\GV,X5BN7,1K<^U%2#@V,1UA91T]/\ R0Z':V2]
MA]_M AYT-A<%&G['/TRO\+K02("(B)BF=NA$! 1 >>([CD>.>?GSSK/]-MDM
M!LW8T;L_MONT7,G7O8BSF@-=H!J-^HW]IN>%] C]CGZ9(B(CUHI#Y<?]UN_
MA\__  ;R/XO/CW#C1>5\;OIL],!^F9N[ZRZ[ULH0Q%T7:JZZ1B'$I1**:L88
MAN>?)3%-S[_(=$2"]WFV';KL[DL;S.V#=EE#+]7NY'*\IF"A G&TNIS3&06:
M(PDJM%LV#M>;;D2)*'8G727&.=MW"!1(H(Z(I"_0!ZD^X24W!3>PC<G?'>4V
M2=36M.(;U)KJ/Y<S)F@V>? GE5S&=/8IY&KI.8\CD5%D3F43[^PH!HBF.D\A
MS[\_/GGGCGS_ $?FT17Z(C1$:(C1$:(C1$FK=M@F,W%8*N^-'I@;R$G'&=UV
M2 QDSQMCCA^,AW8*$'N!,CU)(JY \*MS*I&^R<0UA,Q81%C>$U-!+M R-:Z)
MS#9S)6.#F$'A<BQZB5TKDCS_ %?)GG[ <V4]GP454V+$:<M$C:K#:@B&L@YL
MZ.<Z)[G1W][(UCAJ 0T]T;MJ4I4CWK.>0&"Z4ZA)SF.*:T>'44*T+%/SM+E+
MH$.84S'<2+/ZF1<@'=Z:$@7D2K:YKR6Y9DHFU>+5S7F8S5-)1@N)8V)E27U!
M UU;478UU]6MUN;KZU_=H<K=)C?L#D#+T[),.=2T&9L9D8T!\SJVE,F#TDSA
MO;%22"K<S[J2 NOL"S^92=H@/<(B!0+Y^[Q_2'/'X]=EUUUWG=P&^WFZ[KX
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M?#K/_KN8%%50!,4AG2H-S"0W': $'GQQ**7AV 4.0_P?(!^(.!X_+R'@??\
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MXE=UDOJH_J6U!"PHW&@UB,6D8Q[#D>LCM5XJQ1"C%5NDXCR']$@-S#ZBQ%'
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MG*L@8R8%,4O< EXT[W[Z_(G1?]BE2RDY%0;):1FI)A$L&Y147>R+QNS:(IE
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M9M(!?R*@](/90/\ [#;0''W6U[_4?/WU'N992U_><^O34./QM*G_ -L/EO\
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M Y3FX H.CO=+=G?OYSQU4JO;#L]V\[.Z QQQM_QQ!T:":I$([=M&J2L[-JE
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M-,W[?V"57<YJLEJ/;E+%8LKHQ\TW.[A*XM(-G,3!)-DV+$OQR8+ #P\F<H<
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ME]0!'P)0&PE^\>  /;@ Y^1%4>KGT:>[TOV(=#X@?!4?B(?N$W)A !#\(.X
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M6!RU_%%-_=\3_P!:5:ZERS_;_6_S'D[_ &/P)*IUGURM&B(T1&B+GF6F@O\
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MN6?[?ZW^8\G?['X$E3ZV!<K1HB-$1HBYUEUD$EB[(,>,$VL_QM0GVH5QZ_\
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M]*;8]M$F 4B%AK&>=?'KB$PC,JU^NQQFQ AVTVY:-TWBSHRATFAEB)F(J!#
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C 'S\?BUG%G!IU]JKHB-$1HB-$1HB-$1HB-$1HB-$1HB__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g68105g11c37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g11c37.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3$24&AO=&]S:&]P(#,N,  X0DE-! 0
M    ,/:^$E-#A"24T$!       0!P!6@ #&R5'' (   (/_AP"4  (4E(Q,3
M<U-S(< @4 'TUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@X0DE-!"
M4      ! :<&^3(HF#5^SQ',L7)UX'.$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0&
MN            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  W     $  @
M#<     0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@             $8   !"<          0
M                     !              0G   $8
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG   $8     !29VAT;&]N9P
M  !"<    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P  !&      4F=H=&QO;F<   0G     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    %.$))300,     "
M:8     0   )@   "@   !R  !'0   "9\ !@  ?_8_^T #$%D;V)E7T--
M+_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q
M,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"P
MT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,#
MP,# P,# P,# P,# P,# S_P  1" "@ )@# 2(  A$! Q$!_]T !  *_\0!/P
M   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MO_ +R._J Q<RF[93;B^A6Z@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M=6*W2>8W+WVI&O'L(:_VG5++I!#*>?M' (O=B2U!85D9UF%#=J7]MG.RBRV
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ME7ZL:9'XNZD5A)0PI(&?X9DX.1[_ .OCY-Z/P=TLMJ5Z[Z8 (474 &1Q+9D
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MVZIHT!A T*8"YE,NIAVF,.?<JN_$KKAQUFR4W<%PM+2V$)42(!TZ4@",@;^
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MP/MX-.?Y_'*^0Z!#LMUGO0::QK1$G?0<EHTN^9]*<,W0-/&N:TV=<K=!]A6
MKJDO65Y]IF3$]XL.$'_M[;,8N+-1U./% G*1),X,)$D8,QM'WJ$]:W#J2TF
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M$S3@:S.4X04U;:&XC6R) _@#;QSQX)B PI%]JSVZ@^7+GN/$:P(_N=<])H_
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M4>Q:3$2 =5MD!C)]XFS=6I:6U-GWN:?$$_\ '&Y^M=?>GTVU.-J@%( 5. "
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M&"RRL*X8?[L:Y\Y:=,L_3:N'+A"E-@8!QJQM!'?P#QV%5/5+IM3UHS;+!>!
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M*$@@ $ "-1.2-AR3B8HN\7H7J4S)J1?[C"\V%1/WM2ZT.\G(IE9)-(&K,3A
M#7O%41)\DQ.D4Y916: :+G]U2[\R5,7G@AQE12-(.G3G;MS_ ,<XQ;(894I+
MI0>/<H>X8'!, 9S/R (I9YK8YEOY&*1KG1UGJ:,C(XSQ:1D$F6RE_G,'NCJU
M4=JXC93]\E8L%X$"$P9Q<GAGH^\I;+H6,K)2%,O682M14XA) !R29X!_;$G[
MFH:VGVKQ*FTA;"R9).$_S3 $8(X'!B8$WQ?TN/04Q7Q3@.)GH#9M+K=K*>C5
M=)MYL9Q_5RW,8#'B47#F1D;6HMIIL)J+FJJLI@/05]N'T#\+NI3T\,!HH2CW
M*41E1R(DSJF9SMP=R>"_%*(ZB7@H.*4@)@<*)CC8?3(!B (J8!C7/9[V1=I2
M2QHD^BJ%-6=EV5E5#X/JFFP7[_WZ.KV+6YHOHZL!A>.R$5S/8S&N%$IMYU+C
MC?HI+8.M8G29P1( !B9W,XW@XBN92TIPK"AIT@*PHP.X@D]@0(P/-1 ]A>\?
M?)Q26076G1@^8C[7]M0HC-@MU(+: (0+V,#.U _G#B!5@5PIG47=0<&=7./*
M2+.0=M_6>4]<,*'IJ*@,DG: 2(WQ&,3VQ73V[H8L@VVLJ6H!&=, $< 1F9,^
M=XV64P5&QU29D?9*M0"QPV4SY<YV4:<1ER_+&*+PXT$'UR64EG5DMF-LABPX
MUUG#L)VPY=&0ANWO'F7$6ZD+0  %2!([QB1$YG/G%1ENNVJ%LZ@0LDD@P0"9
M(DF8 ,8G^]2#?%^DYGS=\_(TFG;Z);2&D[49F)&1"&'O(NB]0H4Z*I@PT$%E
MG+#.0KFN)81MHK_;95RSMC</N6[:EJ2K2V$)3IV&Y,F). <Y@_!F$PA#SJ&B
M$R=:BKE0 )&! S''G:J3?GAK6V@+#\_L>[H:WS9)EX]&VXMI43FFMLH=URB3
M2J:D NP"+0!+2!R?P"A0Z5O#6#"VF@GY]^)+UV[*DNI<2VR@J2HC]8Q@8WTF
M1F>WGO/PY:AA;3@4T%.^THG*3D G,[8S,23%/5\/RO@UX>1SWYOZ;HN^E[7&
M(\MM<]IE^HI3Y6N90A3OIZI"(<F(  +H%O[HF$"Q!2N7&ULJ#&!EWU8=)>Z%
MT^VM;@N:[IQ(U^ID(B"921!C'ZIP"9YJ)UL=>OGG+0-ANW:4H)4C^:"8.K'
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M:)&-^QB-R'G%\IQGNK#S+. $:G,:5P<,IN5\HJLBP_BEBH:#"WMVB_BDK/@
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MK'/7AS"_+U;#%L-&<'(NNT0?0CD=.M+D/*DKZ*RV&D-MH;0D)"$$@#*@3J@
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MJW(V=""'C2[K.[(R^Y_#-P/]4",E$@F)((, >(DDX.P@YWK/Q/;:NF+7K 4
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MV(!!D3P^;[^F*OVR0">$^1[/6!A>>\5),HW;VLU0 EUXY]%(G%.CA55GV93
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M\EQ<PYD[DP)43(*HCCA-*9UK>=+<L]2DC^'K@+!)).V,D3MO,3M4:]LNIIO
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M+E?T'CBMBAZ3QRH: AO_ %_G^<^:4K"_9_'05N)<G>I^<!)_2KPQ?.6I>XS
MRW?E,(5VKAL4=:U@-JB#Z[:K J4=I]A4+*YT1LY./>J5DNO6O*<YK%.!T7I&
M!0[E])=!'BW6PSBK6.9.9M*U$56<.9#N6,FMB1S6MX&%=TZQ2T@+]V0!?*O,
M>/\ /\-*&7J_E2?8!>>M_1<&KW[* -B[#LM?G0=@PK9VWTK; LR4RJ=EUL+A
M2:@9T@V1+L&OKH[9*FR,?:4I]+I,UCD;/3:UXDS&<2"6'N=!HF@"1(I!J_\
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MW^=\_P "KU2<'U]9HG&/\V(UQ2$[>A[WVWTS%<TQ%NN86E0\VR'GB2@JQC;
M(@-@"N1J5:I]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI
M1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI
M1]*4?2E'TI1W_+OZ?\OI2J>?2_A5\EM5_4TQGRA#VTR_#U$/-RU< O5[,D]\
MW QF8VJ?>>>U8&_R+8_WME?6FV@3N70:STG KV%E))&CJO:9+%%24K*\"^'_
M +WYK_4*^1/R>U:O']\0]>"W2SS3" >B[!RR\2:2[YQ%WOE6:9]_L[C/Y0GY
MDS2>B+<V( 1B#\KEJ!37ENLV)5:E13_I,?$+Y/8GQTK;>A96CQ^GT#X;KO++
M\8R]&])>[?TGUZS2[1R#Z[ZMD]OET</+=1E<LW3^=4*P"M,;:MHL&J8#9M!E
M@?I2E7ZQ_3(]Z[\ OA;\<O'2TM&K\>_MK0?)+#F^ONLXK]BW++Q1UD-=H(^E
MZ3S[V#IIJ#UQN%Z(F_F\1<+&*>EGF^9_2)<O,5_G;^G^?%*<[Y,_"3Y9['9?
M"'3^1NLMHM)X-C,'CMWM/9_6.:E/6<@T>+:ZC7%8=AX*<VU.O;*<^X'&]2\[
MW'B&_=,#ADNE#[CF#,492G!TWQ.^3$OZF^:^3N+C@QO%2 50V^:[7<U:W2RS
MR[S9OE",QYIC/]#RS7>;,CM/<E:E@ ^Z.?*'(M#K7-</7O&,/U4K7[;X;?(I
MO\:_6_.@B,MI7FE^>6]^1MWG#OT?393)^R>!.O=B_0/]"6KW:)$Z;Y$?69&^
M@9@!6@>()F!59A[07EVC:<7^?Y%*25O]/?V;8?'?X6>+>K%YW2K?*/D9[-Z?
MZYCZ/2=LU0I/(]SY_P#*!=YIXQGM<Q#2ZGT)!Y<=ZEY;A:9/A4H[?-Y,DB:^
ME8.*FDI5B?PX\Y]+\C^)/QL\I]C;QT'J_F_B/F>']#=Q>&Z:+779;)*DKT[F
MB9UTL'GY)P=UG&QU<"S_ -WY1'.6V3[]*56RY_IU^O;WX]?"7QCTO^W]&/XO
MK?DB[]G6]WFC'7OP_0_-O>T7G%5)Z^H W15K==O,0P,".D-0OX!895$FQ917
M8I5H/QDPN]P'QF\+\W]>90T7I./\7\[QOHS:38K00=Z]%C5*;4'2='0K,<\/
M:C&729&0@2?RS\B^$;+)<^E*JN\Z^!_R1\.^*7QI\T\IPGC 7H7QH^<&I]V(
MR8OJ>BR>(]@\W:OO7@@"CM8O\S<'Y=];F_2,^67GS<CHQJ(X[\2+(PJ\7E2E
M-_Z'_3/^2_HWQ#^'/BFC8Y<[>>&_%?Y2X+=6C>E:Q>GM]RW_ (W+/^)Z)4X"
M$!8/0,IZ>.KTE+=J-3?G25J_0"+[V:\2-:E.PE^ OR1S/QB^8GB.4TZE:3ZM
M[1X;Z7YDD9^K;Z"K093,><_&7_V@O/M1NA0W.SQ8_O>X\Z]F4Z1XHH=%WU^A
MFZLX0LAPS!L4KWN_I_\ M6P^'&9^/FXIS:E>V^;F(]M;^/9WUC;MLIY-\91O
M;$^S=^ 9/TNQ7F-/H 5.($:C4 A*LRDK,>&9'.P$RZY41+S/^9C^F/W^*5;A
MD>:9<YT&6OQR3/>=Y==DUWG#E=IKF;%^)%5;4Z#:9NQ*''+TYL@<)<KG%X_D
M\&MF99Q7*C@]WM*7_P!*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*
M4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*
M4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*5QWG._X=Y^OTI1R/.?KW
MG/T[W_/OTI7/TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2
ME'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2
ME'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2
ME'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2
ME'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2
ME'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2
ME'TI1]*4F2]GD@#R59NG0!L0X<F6 2V I,%AT>LJ,R!["(W4QD-=41'ME<>2
MILA;'O83C+N.H!6DD Q.2)^V]9!"B)"21W GQ_6DY+V/R>L-D?;Z9@:PE'8_
MRA?=:BX.NC/M$:^G6]._8+R<B1^1^]V'Z]NJ_3]?N0_7%UUMA(6\XAI"C 4X
MH)!/@DBLFV775EMMM:U@24I25$#?@=L_&=J;^GY=?%DD80T;Y'>&$!G6SH#*
MH]5Q%PY5U<;IV4CW5NY5VW5P'(E.J$I3C&FWLH\Y7/\ 2.;^R285=VR<@"7D
M9)\D@=JWCI]\HPFTN5'PRX>8X3WQ\UD%?+#XP F$+C/D/XF*>)/E901'J&+H
M*&G*NNWD+Z+'4;:Y]JMJLYR4>?K797/G^K./>CU"Q'_[Y;=A_&;S^Y/[5D.F
M]0,Q97)C>&7/K_+QSVYK;/?DC\?<LM5.=/[=Y1G5+RF=Z5D[]!RBP%M37VKD
M[EI1C6FDRN';Z?W3HE9'GWJN][^ED/W>F_LD@%5U;ID2)=1D?4BL$6-XX2$6
MMPLI,$):62#C>$\2)[<TCEGS6^'CIX!F$_RF^/372-3N+%B!=[#@#'+!E(C@
ML0 EH[^PPDSI7>#\&IIG=V[OV_V?O_P^@OK11A-TP21(_BH,_94UZKI]\B=5
MI<) !))96  -R24P(Y[4YSKVKR'.5RNT'J'GR*F-5M\K7&QSRRN-(]?+;[>S
M,84Q[537WEEMG.]A7"7)3E'G?U^B[ZT0K2JYMTD"2%.I!^V<<S6"+2Z<$MV[
MS@F)0VI0G: 4@R?&](@7Y:?%XX(AD'\BO#S%PA XI1XOJ>(N$'*+ID0*/=?!
MYVNNXBB$[::YRC.VJ,K(<E#G>_7@ZA9&?_EVV)F'D';ZBMJNG7Z<JLKE(VRR
MX/ZI_?:ED@]Q\:U2OKS,^K>=Z%+$F(<VZ399YHNB9. UD!)%@L;Z.$SK,%G&
MGMG+.P)HG^W]MM?[LDWMFJ2FZ8(F)#J(GD3J@GXK4NTNFU!+ENZA1$A*D*2H
MCO!$QYKO?[;XZ-:301ZIYU1<&7)>;3=M,Y5:(="4H3#(A8QC*DJ,X3C(>SD;
M>2A*/8<ESO.%7MHG>YMP!O+J/V$F?[UDFRO%)"TVMP4'90:64_\ ZM,?O6^C
MZ'A)Q'G#8YB4#+(U"2X\6=X3;+OZ<KH[^7^EMDN_KSD(?K+O>=_P[^G?K:AY
MEQ(4AQ"DG904"#\&<UI++J206U@C<%)!'[;^-ZUUGK?F%3.*6WT+%UMY\_6"
MN>F2\82YW]_.=B'^=^1WGZUV?X\K_3_9S_R_;W]/?5;F-:9[2/\ (\[4#3I$
MA"H[P8I$-OE+\:T&@.R3SWWQQ3JEDZZV6<8^D8\%XOLMJC=5 Q44XK-&G93*
M-M<;:8]E7*,^?K&7.]CB_LRLH_-6^M)TE/JHU!6<$$@SC;OBMXL;U2 X+2X*
M#LL,K*3\*"8/W_H:[ZCY1?&W$-0$6S]\\<R;IIWO%JC1^E8U*S/['[_>_AA,
M7(Y)/Z?BD_KRFN?>?CW][_A7/L<EWMJTG4Y<L($3)=3$;3N,3BL6[.[=,-6S
M[AR(0TM1D;B #L,_&=J[T?)[XY%=<\&]V\@(_MU;%P_[3Z/D;?X13+\?]K-M
MR#>7\<!W\L7]"R_LT=_(H_2S]+8?KBW?V3H*F[JW6A/ZE)=20,3G@??:LE6%
MZA02NTN$*5 2%-+253M$I$SXK3Q^7_Q4F.>77\D/#;!5-$"6Q-?JF)G0L'L(
MK$K(.LB[[ 6B95M0\;KY0K[=9"KDOWRY'N(ZE8JG3=VRHWAY!_I->GIU^DI"
MK.Y&K],L.#5\2G/T^=JR5WRS^+SFB9*?Y$>*-AJZ(DV$+?3\6=16/*R54;[+
M!G5D(T]LA*'+.]Y#LH]C^OZ\_3ZVB\M%83<L*,$PEU!P/@G&=Z\-A>C>U?'R
MVH?3(W\?[UN,S\D_CUM.MXY#W+R33RS] 9+Z*#T/)MII1F,)V $-(@-;Y TF
MPKE,2PGE4"(<[.J4H_X_7J+JW<U>F\TYI)U:'$G3'?)['YK%=E=M1ZEL^B8C
M4TL3.T2*UZ#Y4?&C5+3W.8]^\;T*A70Q*9-$GI6.:+P!4_")-B## 7-] U"R
M(A4C[;IPK$X-?TB5?V;/VX*OK-.%75N"(D%Y B9\^.U>FRO  ?RK\*,)/I+@
MD[ &,D[".<5HTGS-^(^F;AY_.?)SP)Z]8QOF F4>NX)BT.K&YSI-@@(;^XDB
M _[H]NE55*-?Z\Y+O.]Y^N:+NV<,-W#*S$^QQ*L>=)-%65X@$KM7T@8)+2P!
MMN2/-;AE\KOC$G8D)VOR&\46-Q2P@"59_IV,%84&LN1DO$M#O=5WUDGQG#H=
M$X1M(Y./VH3_ %Y^N/YVSU%/YIC4#!3ZB 1X()WKT6%Z4ZA:7!3W#*R/_P#F
ML@7Y1?&XZRBH+WKQTRPFU?0-6-Z3CKID7-J;R%=-,(.>RMM8T"DW UPYV955
M%UE')PKEWGIO+0"?S+,3I_ZB3DXC!WG$=Z?D+[;\I<3&J/27,=XB:Z<^4WQJ
M[I;L9_I]\<_NZ@/C&[+_ .DK'?W!4!*$+(FV*..>GP%E797/A$J.5=C.'>2[
MR7/UQ7?V;9A=U;I.Q"GD B=L23GS%>"QO#$6MP9VAI9G,<)[UYB?*SXR'L;T
MX/R$\5+;"V]H*6#>GXNY@/=^L8_9N#K=2(KL_=*//V3KC+]91YSG>]Y^N)ZA
M8B/_ )=M!V_C(W[#)S'$S69Z;U!/ZK*Y3\LN#^J:U4_F1\2ZJK+[?DSX+4/4
M50#;?9ZWA(U5FE=E$8.R?7O[:R;^PLY31/O++.PER$>]CW]"^HV39]]W;)$3
MEY QWB=NY!Q0=.OU1ILKHDX ##A/V"9[?<=ZRR?EW\5@BI@F?)#PP4RN%<YB
M$>JX>DB,;9QKJEVF;R-G.6SG&%??V_I.4N1C^O>_I]>)ZGT]:=2+ZU4G.0\@
MC'PKCFO3TSJ28)L+L [$L.#^J1X\^*]F'RQ^+ZCD.M_D/XHJY9"5E?67IV,"
MY97 ;\V<X=(<PY*$0^\*E+G>\X/WEW>_;[R7T_U/I_M_^;:^_"/XS<J/_B-4
MGZ#O]//]-Z@=K*Y,3,,N$",F3IQCO3GX+T7 >IYL38^:;;*^@9,^TJ@+38Q^
MKTJ$N\&^8QM(S9.48#=:(17.@FNN^4Z+H2KLY&?.\^I:'&W4ZFUI6DR-25!0
MP8.1Y%1G&G&5EMU"VUB)0M)2H2)$@P<BEG]9UKH^E*Z?OC_C_K1_S_3_ +_U
M_P"GZ_KW_P /I2N.3YW_ "ES_G_V9?\ Z_\ Z_Q_Y?2E<QLCWO\ GS_A^GZ\
M_;^O_3]>_P"/_#_#_/\ Q^E*.SY_P['O_#G^/_'_ )?X<[]>=O\ 8G]^/K2C
MDX]Y^O91_7_C^G?\.?X_X?Y_IW_SY]>SQ_G^?\=Q2C[D?U_3]W.?]?U[_P"G
M_#]/\?U_7Z4KG]\?\/T_Q_7_ (_K'GZ?^'>\[_W_ .'._3_/-*Y_='_GS_SY
M]*4?KS_GS_S^E*.RCS_.4>?]>\^E*Z]LAS_#]W/^[].=[S_E_GS_  _S_P"_
MG_+Z\DSMCO(Q]*5SR?/T_7G>=_Z=YS_U[]>TKK^__']/]3]?^7[^_K_Y?L_7
M_C]*5V_?#_\ %'_SY_\ 7_'Z\) W_P".V^U*Y_='_P#%S_SY_E_Q_P"/U[2N
MO;(1_P >RY_C_P"/^?\ E_E^O_G]*5V_='_#_'G^//UY_C_GSZ4KKV?.=_3_
M #_Z=CS_ /1V7.__ */I2CEG.]_SY_E^O?U[SG>?I_S_ ,?T_P"7_'_#_C]*
M5SR4>_\ 'GZ\_P ^?KS_  []>2)C_/\ /%*/WQ_X2CW_ ,>?I_G^G^?^/_'G
M>?\ 7Z]I7'W(_P"/^,?^'^/.][_G_E^O^'/^/_?_ (?\>\^E*.3YWO>=[SG?
M^'._X?K_ -_/\>\[_P"O_=]*5V_7G_/G_G]*4?KS_GS_ ,^?3_/]J4?NC_SY
M_P"?/I2C]T?^?/\ S^D_OBE'Z\[_ )=YW_Q^E*^:KY[_ "%U.#^<.I\WQ+]=
M@USE3C6'H#ZU3=JSF-HN'!,#)$41LX*K(_C(K4,#282E81(#O*Y?K7 OD>JW
M_4?]5M;!HLIM"M)<7)#B J,G&-MYYP)%=KT>QLCTA=[=%PN N>BA !"RG]4S
M.., ?.<)GY':GQ;##>5Y;VKU=/G-!MQF&AUG<QG![#W,!V%TDL3ZEVHB4*
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M :G) DG8XQ &<3YBI;'20^RIW])'$#<"2./ VP9SRF6^!]/U/H22[21]&ND
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MVON$.7%V\NV(T*0I(!)C>=CC&)$@_$2-K:V[*S;U ET.I*C!U!.9UF)@;?(
MK:+/ ?;/C^@9;_Q5SM%-9;.MX<$,&654V(*3TIA%3O#LS(U +EBV<BB>JQ;A
MQ&(M=E1O*0!;+=27+_IS:EE"U:0%&4E28.8/: )^N,17OJV/4G$MKTR4Y3J
M@@2<=R9.3]1Q++QS;<^32#*]]16!9#W'&RH>HF-,944-A":Y#7-0$D6-\S$T
M;"I#5BM[+(2NA)C3"DJ,^!WG3>IJN0DKD$@0"(DJ!D%([>/FJJ^L1:%2[:5(
M!,@F4X$[[<\QF(&!4@?9?0/"O' 4\_0:KJ2CI?81@K),[F)Y$8WVQCVP FJ0
M\;.0[.9;8FD.<K*^S)G^V?8R;FX9M=6LA*E"=/ G,QWSB?OBH##3]TH0-7N.
M!M\3MI[<SGY@'O\ ^H;Y>O8MK\QD=QH,QE2U<GCF=2;I(:NOI3P@.M<>QJC>
M*X 45C**6$PV["HPOB[EI@(U)7/GKJ7'E--,!21 0HKRL2)TDS(&^3MB*OD=
M$N/1"E)4)!$JG,3,XDYWG:*GW\&/D7GOD,S]?9YE(:J5HO\ 1U*F^\HR0I<7
MZO1'1J&63K@ H(#@/SA] LI$D7DQ)-_;7,'G;CIMTNX_,!:- ;6D!/8*!/C&
M.WVJEZC:"U]$>H%J6E14)D@@@?;?D[=ZJY^5OAJ9M\__ )%^F^H8P%OYI7E/
M)SE^K1J'KG3(VBGSE>N81/C4-;RGE$ZUK<0="*RHL! O(T=4Q.3K'YGJ?3%W
M?7%.AJ6TH9E1PE6E(E(QF ,C.X$",]1TV]2UT2V:;?+;OK/A2?!48^9!,=I^
MT=GF]^,RS_2CY5G6F24-,P"$C]#<%9?'A*B3;)#3LT0EQ0&<(U:Y<-9W/N@4
M2Z(XC^FH@E&ZC0/ K!QGIJF+RU= :N$J4&TB % 3I, 3D;',SM BI[;/4%.,
M7"27&@D%3@DQS&,P1F0#O,GFNCTK6TZ[Y"K8JO0PLIY5Y=XN7I,M_(/7I2-K
MTA:%IC9!*JA!^&'/SRZ@Y2NB26(6-.DH,(M=&KO&NJN(_+VGO.E25ZQI]J %
M&"K(SMN#,$S-=.PVVEM3ZA[PH)4H;!).DJ,3  ]QVV(IU/C&]& ^1>J]^X<3
MB/-/!/.=-+1,*IQ7@;K9M["%ZG-BT E\ZZ%$X:%:^_91RI<58M)*JC)DNLMF
M=+#]HA5V^%)6CW!(!A1 F1L3XC<D3O47JIM;I#=L@)>4X4H64D:C,$P9$"1/
MQ/D5OOC=L5>G^3/G^B^1#,'7W>ELGB;#L![AAE*SO8,F:%JM;IQ*2!!X'**\
MW*!!/"J[6Y?2#292<46[^CE*NJBXN/<'7-0D :9SGM!)' GB=\>I)6.DK9MD
MN(2TWH5J,G8) \[R%"=O(J='R"W)'IEGI7QDSN39#SVGFUUS341JS&=EJ=*2
MFS[/$DL)UJ83Y>=,$3)C$6$UBRZS7Q/K.& Y4+UW6W[BYBR2U+2F9U@3R-R,
MF<?. =\<ET=BWMTMWJE)2\P]H4%]\G5'B9D\\SM _)_'/7IWJILI>$>:>AK\
MM9W/>?Z00)CH'_HLZJ8K3;Z*F)=J?\)OPH'*L3/TH8'Q7%Q7W#=O7RY55EZ#
MVAAU*'= 0$Z3J5C(3P8)XSOCBNH3U4.:PZCU+92I+HCTTB0=*@1)VR< ]QN,
MWP;P798G+A[?Y(#@E-LMM>T^?XI2VYN#HEEBLIW-?1FJ\UKU2ML:HSVCZ8=A
M4!Y5Q%!G KG*>[[?IMU;(<?]?U'C)+2TJ4M)\* @2!,1C(W@"/==5M'D^@RV
ME"9@K2("AM(SPJ1O$> 99OU3PPCY+[]\LT;=GZ%ZCK 3AJ3,Z_8)%ZTLM+8O
MQ&A'I&$9?P"7(3KZ<)E9+0NE)5_\9;99V!AL]/Y=;OJ/NMC\RW[DM:DE*T3(
MF,$P1(P>U2$WRK*V!0$^BHR"1J)<5()'R<R) F#$ 5H?0\WY]YKI?5%'=P)'
MT#+Y=KXO_<^F#C&9X9B4$9[*%;:$@*"2K#6!$B*JR#44AOWJI4&C0(AHNT--
M,NMW"BXZI"2R4R"@G,*!V(R<C],UOM'+BZ?MW A*65%,J,)"D@Y($"3&1&YW
M.,87A;9WHT>O\"S.4'U96ND@CKGTVI<L]EHY%F'5G], N3_G*;JKSOM],O;2
MK(A61!2JK)ME5R-99^HXA5L"HH.#@P9)( .1)/;.!$\6?4FFFUFY6L)#8&F"
M))Q WG)('  R8 $.EZ0U]_\  &N/^/\ YF&W5>:\SK#?^S>RBJJM[_,NMN4X
M.SB;*AT=LB@1^?K1%KB(5=5<BIW*"'$R;+Z+V73+>N>D=.:9MVCH>!U*;(&D
M@$G48WW$$I(@Y2$YYQE-KU.\7<W:@VXTI"64+,I6. $R-1)Y )S$2:K2U6YS
MV]T*'R;^%7MFF^_<_2^D,BF][E[ML^/80@<3>6SOHE*P6NB3*7VXAU&F4"7T
MPLI(Y/GVUWCR7;ELE*DC2H+*<E2HC!D'!Q^H@\1CI@AALH0M*?3A7M2DC9)(
M) &PD=X)XFKU/E7\@-GE<'X7A\=90AV^K\NR>W,^P!8+62_(#5"73+A22M.L
MD,_)L+"LY7)<,,'*!JRPJFB-W97_ %Q^TL6$VY])_P!(^IQJ]@!^T<9\5Q?3
M.E6]S?7CCON92M>C<@0HD3 @8SOF?N@?._>M[N_ /5WS4WS@GV?(^=.U\CXK
MV(AKR!.2?Y\&8]V>KH ,IX2N4U6)#@;U@QX7YJTH2IGQ?]5UAU!URV<6Z0E;
MK:EA8W*I()GD8C&P,XC$J_Z>RU<VR6T_P=:03D8F=S&QWG;O&:0WQ']<=9"D
M' :0[.LA#DR]BP$.C]D91I@42ZPW*GLKIEI+K]7G5[3.Z.5RA342G[]LN-Y@
M'^Z:.EW3[]SZ3JW7$ZC(,1IDQ$#, <_,U(ZU8MMV_P"8MQZ9T@E4GW'DDD?]
MV<<3B #2O^.'Q<5^)^I[58;#%.5$"'9/E N8:@+-@$*Y6W'\:'F+:!+AREL-
M$.E606E\)HRG;#"[: 0>AD[E],2W=W-T6RW"5-3)S)UDS$3_ "_6)P*C*ZF^
M;"WMRL:% A9W 4I9P># WV(WCFF*^67R.\_TGM[3%;Y"SED_,QXHB6PJ0<RU
MHZI #.I5/GN6B+2#CL9H=%35287$N@<JXF+2V^XRN2VNNW%=0*D!8"6&9@D0
M=)G$GB(QDG:0:M[.V_)6[3I;4I=PHF2"5!.H\8!2K!3 V4#B:C?\6-/NO$_5
M7FPR6@,/YUS4I/1YZNH#,;Q!QD SU(;.1WX0TZ%:W]+^$CUGD*2;P!J[UE[6
MCM]=T)Y3=T0N6V5:TDR/=G28.(P#]N:G]?:2_:(*0/4:0D"<A,Q P"#)C&^0
M!FKB?EQZ_GO%QA,<F*E9M=COE=Q:Q&?#-M>U4@T-F,)OZQV2Z!43 0ZX@4KV
M [&FE>'*19%!$Y7?4G6;);7Y%1]0CW$$3S,]@#/^T;\[TNQ=O6W1>%26TDZ5
M)E)C( !/83!SSWJ$?I>VII#T&XJQ>75\R-)]!?C]42')5PW]SST+IR$*E5FW
MK793XLIQPK0YZ"&X*T_EQ@;;[42*I;KZ'EW+VA<C4 ""9G(\@' P!N.U6S5N
MV6RRTY<A*?:"M7MA,[;[C?),P)&X9<;T'U8T+)**C[5@_HNG!]!SY:@BZ2[/
MZNO[H#T"V#1%8,/_ +F=74871*T0=8F,$H$_0ODA]"[AX6\#6I+KFL-MJ (U
MF(C&Q,X&)GS4D6Z$O%82WH:9 45IWB,\C8'(^/BQ:7@1GOGG"OR/FCONK7;-
MN2H<:RTR!91-UVC86C.S8.*M!32U++JZ):&NN[,A131.(E]O[_KHD= 5<6*
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M\\W9V#T4*X%?9+,5AIQ;XKI<AVA?.RV%]=5/U87;*;!"+*Y3ZKCJ=27$?_9
M(TI3DCL3,1 [5HM+A%\Z[U%A(:0TJ'&QC7).8_\ QWQ,XVBHLKOC=LZ?"''N
MRNT5MC\;OA<O=)+?PK4I<WEDIU!B6N-EH509<!]-=8R,+4G$7"3^P2P7='&
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M5$+,LRA4 SK72&8_QAM*BIT7"M=QD5P.X9?&*Z#&"^%^[\\'5?E@J%J&E6J
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M+%U94PQJ2.V*KBX3;AL%[U%:1"E2EH#]93 $D QF1L(S)CNH:6\VH!AQN3
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MZETFQ7EXRS.#)&MK[:$G'%:^5#,T<0/\59GA0![;H56$.;O]VKGG[6QN@O\
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M=<1K->OK_( A4NS@\\T(R%96D )5ME-#H4F^QNEIII7D0P5@@A2B=(4?;)V
MB! D8 VS$15S:**GTI0DJ4A!2HP "!/  [#YG<":L:RZ0.'G_G4"TN0?^V9#
M)OO-HC^E/ENXU"U(("?I,2<QJ%M#B^OO-#$&>4#@+'5X_8=',$_<M;W]0PPA
M@6*D.A+GH%QPK]PT@$09!"3XC;]^<6LOW%ZEQ)2E#P*4P4C!R(V(Q&<D?6F^
MUI>=]D^')6^&R7F" CTO)Z! [.'S=3JU:=@T6E4XE@K$<KS7XN<9M0A!EH=#
M!@WB04K7KB&E\RSK:F[]-=L^\ZZA:UNJTJ !,)!C) & 9C?,<"K6T66NHLH1
MK+*FT%23,"0)5!QQ&(D2=MZ_OBO_ 'OB_.G/FVL.-3-MU1J/S^M$Y#%9H53Y
M&*F7U]?%<I/H?(KYM"0E51=^;6C:V@>(L':68L*;2E;+?IG2E1$B8G3('(C$
M#F<G )!N'$)_,*>2!Z:6]1)$*"I[;D#@[XSYR,=\1/DAZR8J1W>5K\:X7:30
MAH&QFJGQ(.HO3D.B=@UJZ':;(%C.80X<@Y#%B<MK64J3^B%E=VFR%P4 A"&V
M])6I( .-TG,[;DB2G)\:O]29M$./!;CBG)2@$DQC2-((@9$]\YV$_6__ $F?
M--7Y'\+<+B-MJ$^OU .EWIKARAL^\KD6TU!QTP1KNUT]NBOY=^+]W[%';.51
MEVFO_L\^G=!MQ;=.;;2 $ZED1L0I14#VR"-L3-?+?Q!="\ZH^^)]R6DF<F4M
MI!S G(Q5E7U<U2UQ+GZ\[S_GSO/_ -'TI5/*SX^>@B_+7U7WOT,O,7J -1I!
MO'T2TPYB?^$[@(L(?ORS8P@LM%7UFATYT"F\+\J_IEE\9P'[5 :MGOSA?N0%
M-)5+6F1@F!,"# SM@YJV-U;IL@RR#ZBD$.ZX,&(.D1C?Y(,_+B^B)SH^=OJV
MHLQ]+SSQR8\W4"@U9*EDASW2[3B;Z*N$?AVLF$[!Z:*+Z85CE1O&CV_G/K;U
M!2'6;QQHA*DH.Q .!@$#!)R,SW[UIM?5]>S;6%%)7O&!,3C^YCSX@M\+!E7K
MN,U^3MNH&<H4KI<1H!UI7!+ -E505TC1?R5QL3'JOGWAD]#*-T?XV/3Z>D#D
M4_MYCI"?S@4VM3@7N5),:<D&0<8X WB=R">BZL#9J0M(!08(P)(@#D3N#)SQ
M3F=^#WKOH&AS9_IOM(3O.91D.;F31LE!(XGRBR=D3")*BD/*#;.5B%0M^U?1
M.X6JO[5?VX_=LG.E6[;B7$N'<ZRKW*S/$X'P/CQ7_P"K%;92AF=H D:B)Y X
M[3S]\'WOP+6>B95DJ\ZVZ37W".!BSJ]6 S6)A0N,A;FXJO:<"9P/HH .GU<M
MC-D$&RX4/^,"19R=.I734OKAIX/ F%!X$E"=@ =@0.P[\U(M>H)90KU&5-'"
MI;5I"MLQ@YQDQ,8.U*#QDCR_XP_&K/XKT6HD=% (T\V&SJK*H[0[TA[*P]@*
M?81%2G^Z9<Q&A="-X*T:J?:X%4UA]EZV^CAIA9E*E&0<@Y@Y,F"-@.,B#41Q
M#_5;ARYMY3H3(,01N,D9).Q)^N-EANE'F'LGG9?CV=*SL51$%CGSHX30+3D+
M5H7REG0]R;(=Q9UHM1BV%Q-7#3!C_'7UC4W@RO[;1FKJ"'E.-H&AM0(T@" "
M,>W;/!'W[>-V;EH$N.@N$&51(),R23,GP,@=HQ4%E#7Y#>3>JF^-L''H'MCS
MB56:PAG?,V?,*(:P&H-!%7:(C0%4YP1/)@!2Y?SX/"HG@G;^2F,5R?,/V+P<
M";<J4E2H*52I*022=L_&<&)WJ]-Q;NL)7<:6PA,@*PI6  .ZM^_?8;RU8_$_
M=>YHEU?ONKNS=0T92GEL*Y8V6I!B X=9CQ96W%(Z6AU/":&1=2!K%:&1>.KE
M&^"YH/>(Z/ZC*4.+44QE"ITYR(,S'8; 'ZU2+ZLAMP*8:"-!.EP#?SR))G-/
M_P";^>?'OXE9-5F@9*//0&QWX E35\R9NGS>?"384=9MRB'#8G[YI,AQ*>0%
M'C=9"I<-"/(56EC9VUBE3;*$(*X*SR?)))Y)YVB.]0;J[N;]\N+<45"!M/?$
M 9C;8]SC-;#'Z%[ZJV?#,,)0!YRK**KA%V&XZ=J&5!XMB1PDK, "'K7!\#D=
M(KE<F K,D&FJ0U0'32[);0: =D**TE,#>#(/)&T\]H,Q4,)DJU9()!,G/V/F
MO5GIWU>]7(1,\Z78O/T<I:;!<U5K$Q+A^MI' ZV3G1X<V"65'6D"L!R9U]T
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M+V42K,JV0]NN9Y5VJ2M;'*32H H572(-,'F"1;*CG"QRH246QG8!7+NT""2
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M2?/TJKN+5%ZA]Y"_12H$9B=B)D&/IMF !%293YW,94YC\P_2,T)=N""=-/.
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MGDD"T]LK%L[!_P#TQ 1<Z2I8D+48C@3(YX)@3OG%5W4&!U1T?DP4Z=P-,*@
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MKN6D4K8=^[W[1LSY0<+V,.P[VJDD.5TH2W>GL7=N2\T !J 5(U:8(@'?L?G
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MRHIRUJ\[L;1Y1!:<G3]V%@W:_P!*Y"])C;<7.[[<JH]_?^/"$OUZ<DH3.F$
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MU T=BU],V;4HAKOO7-#-\ZR05-4Z>5(4+]Q0LL?'S_,K.,90I 5PML."5+
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ME,')(=BX0,P:?>E*V<3&8M ,_P T<5WV@<FA7191'7:MW$+"R4%!!"DR/;)
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M6M"5H;!W@P0I48R?Z0*B#\T\MG_,O1&/G/B-UK'"(\GY\/H<?2V@?R.M 7[
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M.^H( /[_ #4U/JZJHKB7^7?^G?\ T^E*IZ8^$^A5>T_(78K7).4BQ8:IAAQ
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M'EC303S9JVD**O1.-*SAD,58Z55S'2(R'*3KC0'$\G.E?&JHR MQU,)_6_\
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MHL:ZOO6?[(VJP.N59]08NT!2%@&-MCG&><^>/K6FZZ>[:86D@#<[^,;$=_\
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M-Q)+#E=!-U=]TKJU2NU]-16/5A(4D*!44B 3.V1F(F37M_\ Q[=9&P7 )P0
M0!OMQ\"EKM!7OK%BSXG8%7H]-#S;2$Q&T^A0+S+(4)@^K^/%)P$B6W<^Z(F_
M8E=8D4$UFW@I*#_X\-=<%7WCZNHW*V6D^FE)@ @ &)E4_P V),3/!D21E8L_
MZ8VFY*](=G7[LQQYB8QCSYM@7?'C,.<[YT+_ *1-!)Q@L9G\<Q#L;UW8A_S[
M4Z"#M!DZ#:8ST<.7L_XIB(QH[!W 0J^+#HG(2LFK6V4PFW<<;]5,$**@0,;
M@QJ(@GSC>*I7;M]%RZZEIQ25:E)(!TJ$X)F=IGC$X--9I?Z<6!O>Z!KBW+).
M$\#N(&0W71.14NJIC]4V7UV??)L6B64<_42/*HR_4F<I=NOG;=C>=->2$EAT
M%24@MJD$:AD?UQV!.]9VO6&E)]-]K45*()( TQC(/ZC_ )WJLS$[#V#X>_(0
MI3O:FC3&=NH2[+, "4QHHS[NZP>_1Y\>WH]I7\9^J9S<>-V#!@/$N4>EV6=L
MMJ[*YN#<$71*[PSK7MK  "<;#$ @?78&KJYMVG[4%E(TY,@SW ^,$GL"#%2D
M(\:#Q;\;VS!L*MH,Q<IFNXF47<,4MSFR//X;OUL(D+ZN-3%C4$\FB$IC&42*
M:]J+C9)?1.=LFFG"^ '"Y'JIS[9,&1O/:-C4!J[6I'Y4HRD0A4 #MDF<2/B/
M.#O+?*VN-(Q.S\VU,MCL<FV?:!,C8"YN#GH!O&)#>EO0B-16Z,US2P'_ (X>
M[HLJ)1_+M*^^*NZ+"NF0TXBZL!*3"'$I$E!,@^V8$?;Z"M[%P%AQJZ!2$I.E
M2MI&-XW( SC@3DR^/B^"U*GR+)BM55PGJROAVE$S=S BQ**UT>E+TXAK1S Z
MLPY5E&NCN',!O,O(T(RN^N]7V7ZCT]-9(4AI"5X4$I5G_P PDQ@[Y((VGO7/
MWJDJ4X4'4G$*G&T1.VY/ /G)JR?P)@.RJU9(L@+Z8LA!9&K[*YT$&AQ.$8PY
MV-=<^_A'T$ 3G=^ZWMXU]<Y<E5+G9H6M7M4F G">T8B!'@&>_FJ]P) 1!!,&
M3XQ']Z^9S^KYH&>2^9K31,*P]#A "_/IZS('W6D5M%', NY930/&%D1#AI2/
M8*K8]I*H9]J;B3E<#SOU\[_$3C:.ML>HO2$AO$09@$F?,]C ,8,&OH_X9;<>
MZ(\AM *M3D+D'=2H$1CL<CCS2P9(\Y\5F-VV2D,=?X3\CWV*3C^@PV;[^;\<
M1:#&1O"V:K*#B,5N@G<[GPRLU94NF$9<O8&S_'#OG*SO%-V;5N^@^RY(*<RJ
M".YF2<D\GL:KFD&\6ZTL_P 2V44+1IY3@[;1G$3$@\SJOE1C&GLGQV]F-PJ'
MFB](1;)"]7/!!X*GY= 5*6G5:=2(*,8R#!V"2ZYG_%2&K(IO+-#Y BL4.SZA
M=6CJ%B%*;UL),I?!R2F!.@A6W;5F#$34GI"ST^_;2'(#^M(2J0D*$'W;X5('
M;FJXY_'KP#:>:XM$5[=I/#6]K-NUL<WXR]B@W[W^3#5/+; 8+TG T1!8JL0^
M@^:V=AQ,EQ$> 3H/GSB&K90])^4-Q"-0 U':4G&1,[S@"#,UTR[B^;6Z^T6G
MB?:I"%P4 G!P#/D00))^%MZ;YCZOYX=LL&3Z>1H<WJ@\KM]8X?%QQ+W1#4JF
M@.=T74 W&M$V4Z[J%3:2QW2(>2NM[<,W*FKL5@JYM5NVP5Z;12DH7!.I"CM
M4F9Q$;',<UL!8N0V_P"G+H5[TX)"B)$J@"1G)' S@3D_&/?;(;U_)(?&_4X$
MJ_0VN2NTR1ACUME&6/RE#& Y[7K.F\B)F?BF/:7-E#(7O$IHW+8TMX]H'\Z4
M[<6]T466MA'J@.@$D+4K5J5$2 8(W,#L9)U=6M[95FIRY;!6E*=*C!G)P )
M@3 C!.<Q'@E\=6![MWJ?<M7'/XKQ[)[AWZ:R5<.@];+Z23 W=2V=CT^BC3.'
MM@X\F_.&&,8'54?D4T%55V>&P_\ DW%R^YZDNDD$23D&#W)C&TSG<&O5]0'Y
M!JVM4#URAM*-Q ( D' B/G8YP9DEY!\CT?K^N5#*<,XSOG%%\0T^?>Z>AW_(
M9O%TE-G>E>A5<HXL6 M*T]23]M3.\G35WS-A&K_;62V;MI3H6TV(MU2$D#,
MC)^VXB<;57W-F\RTI*UGUU) <"1$$P9VS[2"1\[34$_<,6V]-*^30BSTFH(R
M6BLRN ISBF/5X^!SJ\,;F3H#2<KLG'06):;7.A"F5V#JPJ[[7^_VV3@W#S%T
MZM\I2ETK4/2&4F-4$@XU0,#M@@YBQ95^2M[9LZEH*2%+4?<F8!@]A/.2#G:*
M;OP#V_Y#X%P_O=;76/WVR<JE0ZUB"EHXS9E=U?%!"7K9L)?V@I\U7L6I%@91
MEHM95,R!Y0B,3'2MQAY#3:0V'C"U[D:CDG&0!P -^]3[UBV<84Z275-)*D@B
M-DR(^QS$S&,8L_=Z+58DO;+H^\>5>;>I; ')Z3/I709J;C%7>"V[L 4SNJ#%
MU144^L)T C-LJ6-V0@8*@V^JRR?*[PM(#*P'@E2"!.?=$<?7^T3!KFVE(6X2
MJV*@2<A>DB,R0$F. 0#F<=C!"[UVCSEOH\/F<ZDVCS;7@9XPY1V+K/KPW*V_
M]80)>+KF )=Q!%;F!%(:G2B#R#NL.L_?9>95LW#GJ*90GU221$@""#)G23L/
MK@;XJY-HDM)N7'RTE*9T:,@@3DE0&P !@0.(-30S /EWQ),+=V7729Z4.#][
MIF)]'\M&!=+L+.Y_'4WK"&_6_HF@*D8N5AVJ"XCT\67GWW=ONNL6_5L$EQ#.
MIQU,Z20 T<@& DA6Q(F! \&*IUT=2]-(=*6VB"L"3(VDDR!OB.5 <YA)Z_O=
M/OATK7UC% N-<;JI9WQG#3TQ:HL_+ZJ5*B7]RVB0[5)@$-/L:&AE-O[)CCV3
MG9977=V,^X_<7-J'@4@NMR =P5201',DY&WWJ<S;M6MM<+MW/_M.0N"2% $R
M)G;&)D8R)%.5[#E,/H]=#^ZF!/G*M!Y)B,WJ/+XZVMEF,L"D6 :4.U*130*V
MF1(AP=1<7RR@AD<!<4QJIF316/-ZFPTNX<#;X0$)]K?IDP0D#<* V@[#?)S6
MCIS[R;-E2F?56M2E*>48U>\DB D$$$#^>/DS#:^-^_X/XX[K5>B8^UGH8FKJ
M\BHS:D\$G,+QOS1SET]^/=$QW:?**7]%9(EEQ(1M\R"RZKNE7?59TZZ1;NK#
MB/5T_I5(0? !(,$XQQ'(J;?6-QU%I.@H:20-:MQG,=SG!. 2!-)]+Z \]>U'
MJ^]T#$%MW)'R4+,U4 "(B60ZH":&4?EDW<:%R9A,S+:TX]MI]\%AE-)'VHTQ
MJ\=:<O%.WKCR&$),(;7!*@,2/<G3,$C! C!R1638M[%IJP;96XI0U+<0B05$
M X@'3&!)@_TIC=AJO4?-L_YZ1GKVH/G^X4Y'4M\\YKH,Q[Y-<4R94@ZI0R[>
ML?$6'#'UTJ+XVD?[3A0E,(PA;]0VW;A3\J<]T@)@$I(!]HQSSSC8'FP4&2V2
M&PI03NI02I,B"=)&XC/NWSBI&_*+SM%?YWY9K/**3UF:V6BK#!R1A79KU!ZI
M%62(.2N9-&0(_P"4+W@%<K2!&5\%?[NA_GED?LM^IV2;9NV>2DEQ[3ZZ8_0"
M0"59V@R1,XV!R*3I]ZXX[=,N$'TR0V)C48, $[ $0!R9WWJ07QX\P\VUGG7M
MA.;+U5WI2/7:M<N@@SF?EF3L9<J'98@MGE#^S<3)TYJ1D!*U(80R0L!/Q"*H
MC66WR\M;5BXLKDLO?_)0M20"D**@-,$G?.8 G&_:O;^[<9O+7UD!+*FT+4F<
MA9D$9XVD]]P8R\GPX]Z_F?+=!DE(@?CFZ<.4NQYK7I2Q."VI(^Q4VQA%K "O
M1C,@:1E]L*.SII&$92*!G>0O(61M.BNLVJ7D7K:5J+2AJ4H B4]BF-DB84.<
M#-5'66'G%M*MG5AM2D_PT()"1W5!@DR2,',;G?:['XX^>?*A5K>/-GYAYKN<
M#L7311O_ "YC<;_'4].$;,TVSR\'X+,+LX!\KM?Q(KL(+[.[@D;2QA2=CMCT
MQYA;WYAILD A( 4HRH#,$ 9/?'[UI1U._LGT'T7W&T(T*!)3   U209G''&8
MBI!8[X3^,>38C/):]H+Z.XZ5W3\:Z54MU\#SAZ# ;\\N4NJBUBL080CJR-[0
MM]:NNA2#]H+DOULG6-K9=,4GUE!TOIEM&D)"IVF20.\S/.8BH=Q?7=ZLJ:24
M 8F=2@,\C<P<DQQ @177V+;9]"\R.3R&S]#!T#UF_P CS^UZ7Z_S#$GA!KLZ
MRS#\Q,8NAD._D-40H)]0Q02UH;8<)"OIH?*=GYU#:ULMVSBDO^P*9&K02#E6
M,".<1,>:\39NO)]0OM!30*E)>,$@00$R0%'@[F(YS3.>S>:OMYA6%N@+81[A
M\<!N/.YL6[ K0W[EF429K4.KI$SRL&T%-E*[6\-'VP/22T/*#3>64Q*A717/
M2T7'KA;A<6PE2T!?N6GDI*00=H$Y[8FK6UOC9^DIL!'J+2A<#!QOC]0SF)XY
MJ+GQO^.&(]/%]=SZC3<EH5;=4+D2%AXMR-7JMD'>D6/KCF,:B6@YG$)*521;
M0P'DS.MY*X.\;KRB%T_IR;Q00E2&CI &HB9!(@"9X /@\$U:]1ZBNS;#GIE:
M-8*AKTE4@'L=QQM(S3.,>^M>-+=/D7E>,?C/%-V' ]$?J3PVF*>K[QJFH%ZY
MHP4L4^KQZXVI4N&@83,:B<"V9;E68123N_+N],N'"IZ5# 6A,XC=)'_:9[;G
M@S6HW%OU1ID)!;"?XBD X)QJF"/$'/\ M]6/]&M$LSWP4P2U6=>?37L/2;KK
MKR[#YUEWZ]E,D;\VV,)D<HLEV'W>540G+DI0'HCWE4/H/15+58-*6O625D*)
M)P5$\_.?-?-^OI2GJERA*0A*-"0D1  2.V,S//S5J'U;535Q+_+O_3O_ *?2
ME4O?-KU<[SK9YE0 EPUK?4Z+>EB%:*LYTJBM2V!4L0I\%+5]HT;Q<5VRJ-<+
M^J>4'<D3$;\HVBCZL^Q:E#BFU+)!)&D$3SP<'Y[& <5?])8<N$* 48&!DP,X
M)@S (QVC@5$+S+YK>9'-5G9>6[3S@/&CZ+3ZJ[$UI- H/Y^XZ1:Q@&>..>0C
M:6F6-;5*^-;,:T7H_9_@0M)IB]/ZW;*:4E+*6M2H4(2!$$Y&Y)( C^F:L[SI
M%ZI8=+P<(2D)U D@#@',1 )5,>=J;WU'V[S[>D1,\W\#5X^6E,SFAGJWRLY?
MI]$*?9^M]X&>4PG!9(.[EI)!A)1-Q5UAU8\!I73)G"OGTWBDLV:=#LZE 8,2
M00('COYF#G.TM%VZ5.73Y2([G3(F 0=IG>>3OBMC\<O%M[I_37&G4:%0A48Y
MBTMT_P#,+V)]"*NP:G@*A2([5 P(*)L.H+L-O*H.&M6\)Y;398-&R+96%ZF]
M"EON-I"O<A16 " #,XGL8[$1,FI5Y>V?Y0!"&E'(!$2<;8,G(@CL<P:LC]T;
M^G^:>3,W?GK@<_0)R!#:@&*@O2%3#)_&I)_CLXLF*S<_P]$R"Q%=!%A$NUV<
ME=9R,?U[*^NC;VG\$)6Z! R"3B<&29[^17*V%HFZN_XGL;)*@8 203 WB,9V
M!F#6I^/_ +3=\@,Y#'>Q>1WNF(MI%)&@9XHNKS_0=3R!_<>.)HUW[TC2WAE<
MAUQ7>72) ,E7.JP*8X<:T4F]M4+O;8+6I>B%)!*021KDC,Y)$ #8")!VWJ5V
M5SIMKCTVQ,Z5$"1@ B0) X$<33EX_P +\$\5>,M1Y]YNL0Z=_"%1/48EY15]
M5MT:+JQ*KCK1UXW;;*R&/5](5-DJ_O6]OESDN2V>GVULX'$(0@*_2!@2(V@@
M\>!!/>H]Q?OOM:7'"O20)422KX'UWF<<8K?N] 258*GJMN%>6VDR#S7#! ;W
M-E=E4Z)2+'(Y=1 <8:-I/*R>TSIY*R=1/Z1B1HO9"D0M0DX2$X.8R9 S)P1\
M]Z6[1(+BNQDQR1 \$S$Y_P!CL]JJU?$#%?192V1]RYH$\( NA,YQ&V%0]_WR
MBV2GOZ6@\($A+\BR5EM\2.7#WT<ING(<<],)+:82)F03F,GC?Z;8P*U!M(45
M$9!D#;YR/VX\U$3WCV7ROR1!G?*]-A'W9N,J'2G6W 6M%R0 .J@22RTWC>E\
M1?4-76+30NG9]J(-X9%T9W<HG0]1OK5B5OC0J2ELD),G$J!3P"8@P,R35MT^
MRNGUJ4P5*2D!6G4 ))/M ,9,F"9B!WTUY^*YSRWY#^-^@8E<RI9Y'3NC*;BU
M\V*\P72T5KKH'70/IK@(UYP)8? N4"^7?:GTJLH?M]'95L@7]BA:G3H=!",C
M _3B>^<D#;':O+EPV5Z5+;AYH)*DJW)_4?.T9W.<1-8'A?P*Q?AVAEOR_4C-
MEJ$ZYHKR+W0JEXZK,5-;>0F4R#ZQ_!>/J*9V5+.UQ6+Z/RC+8A]L-&^SKL.C
MM=/>4XE2G%DJ]P&1N9)VP,2/,@';7U#K*[Q 2 $ CW)!C.WF( 'VGD5+S90-
M08K;%9Y>%6I1Y?2=S>?0K.6'MF3.CK(^XH:K["R^^T^O[D!*:.0LB5;^EU=L
MK.2FWBE^DI9258(($&29!(YC??Q(JNMP5.(]P 'ZC(!R!_MM/TJMSXJ>5>L!
M]>;'VODD6!SB"=23+?\ O""-EKN_G4,V=R%V-RZC^.C2*4K8PDUX6,Q!K&-"
MM77+0^3MNG)*KAU:"64I6L)3C^*!*3.>8. ?[5U-UU'2;9JVTEU2PVI1 /L4
M2G3/U[YSXK3?&K%8/Y-HMWGL1JCL?[=Y0W),UCK-GL[<YH&SSD*!#C;!G!1=
M%Y]2:@0V"ABOZ!Q96/6'&-,*HY=+6+K\P$%;;UL?TJ496!^G3,23.,"(D36S
MJ@78"V4^&EVSV-2!D2 2?I))GSW%-> +?OFNF\N]9S(]'RL\X(@6@O)X9F@O
M<$Z4>ZI@N((LN,@:ZN4_FVKNE0OO; <B0)>/(=C)?M:>2Z\XE:/3>0<A9TJ<
MF9(D;;R<;R :\+?HMLNM.%RV?!)4D_HB""1@C$<8^A-9*CV;]/?OC0X?8Q3A
M&>9SJM,XR&;A3?4,?-NXB^UD 2.C165<@R)I 5U6,3J%O#3>W=!J'MAC>W3&
MJVN6F_:PZ&[H #V()@+C8@D_<;UDTPXAB[9+A4EY,LJ$E1.<8D@F.00<")IV
M?FSYBK3;+OJ63\_5L;7RN+1FPA>G(2=,&Z%(^H:=';[[ZKA+^EE4W!P&N(I)
M^[SD"B+X9W:F$OMN)0VIMU04C1I/ZDX&>Y.9_22#S6FQ+ZVE,N%<MI4%F#!W
MR."?KVQ-1(])6!D\PVK6:8W,L?04H-;>W)<XI5JN?=#2,%TF MW_ /3^%).5
MWJ^3L'H@'RL>HBJ7VNVK*V[E+A:92ERV3J4J!^D1[C$9.)WV\UI]Z0MI*R09
M5DD'&(F1N9$B3CZ"3OR4\MQ?BGH7Q(3^>6B-"0G0>C=W?=+-8.Q$1(IP;8XZ
MJ[[ W3I_DK!N6#1&#%[TJ==GXHTQZBYMS^80ZT\HK)22(()!R1CC,'&)(DYK
M=9.*?M;M+Z-!"M+9,9@P/J8),3,<@8T'F7M//)O3/;)A# $];JG!=-_3;JFZ
M%#53_<5-X]H MI4!P8VD"R",O_,+ $7E5D=^Q:"#J><+2'R0$J@@Z,+XF.01
M(QMN>*W!E3S3"4DJ(4"4J'MP>3.Q3M.ROO36H=1Z+WSWU+Y"YAOK1QU02IPK
M-97< 7-)\TL.FBYO\P* ]"UC_LXP.OHY*P@HKMD@0B+8QPM>G-*MS<J==:42
M5)*E$PN"8TQB8DQ.#(%2;BZTW#%N&FU^T)4$)!@0=_Y1 Y!_J:F/@?7_ )';
MGX>^I;B&B[YVV7=:I[]4ZJD.?B%7 D3 K:+;&D1>$,5RD]A&E-<CYVUG$:VL
MC[4Z:KYO2[NX2S<./+4XFW6I"53(( WA7'$Y)[YBJKJ%K;B\8:9; _, $A*=
M.YC;Q'[Q'-,7Z'LO$OD)\> Q_5M39#W;SS'$R ]+>CCJM%N+ :*KR5Q]>;J@
MKZS< B#J[>TE?K7&WMH_!2"BU5&-PZBYMC>MM%MQHE22<*4<X)' C;,D3DU)
MM$.V]T+8%2V7"4N:I 208P#@CX,SGYDC\:%MKKX^^24FM6Z._0><K$F915O!
M^QO7+-9^&*R*[0OC)N,M3=2+Z8W#= I4D7 7V2Z7:97?6"C<6B''6Q*T29@@
M&/,;$9X!YWJFO VS>O!MU6E"B-C&^"!/&#,D?2I<-,4H36NM'G$RFEN8JISP
M5C!A<GK9M*:;H# TGU](Z,7(:FN))52_I<Q>4_<G;31R'=;UL&@2VV"5:3H!
M D@R220H$DP9(^O%1F7RK4E2BI(4<F?/'._T'S6(IHQGEPN"PAI@X%F]<Z #
M+J6)<3X.CK+M-N#UPUM\8E$VCCT'VUSNL["(JZF=?82YWMLQ+P*T:DE!6AM
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M@P-LF-QY\&G/T/QM:OO$\\QLH%RPG,]#4KE>QK[E].,^?:(ZXQ.0LO#^^M8
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M4?S5_P#3?457#9_*I0RE.E2O6;U& 8.D+R,Q@@D#,G%2!^*.G"U<!N27R?8
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MM 7TWB*5@X( [(]BU+D4QME$3L:)PMOGT-UT[JUVAEHV2&RAM*5N>LT"5<F
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M55?9TS\J=D:KXV3*!:H6W;-)2VI1(3  $@ F#DS& (W[U4W5VJZNB^M<'$$
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M6MN.9N,:4J]1^4Z#/;KR_';C,H4VC9ZU95A_$?5=WC]67M<_FH-'0.#OS7'
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M6P%LLA5/I-/>QC=+Z>EQU>N0@G>(W$)\1,)&-Y^F3CLI"2/<0#^XVV&.<B/
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MEI-;!BV#J_4QQ_'K+BEEO2HEK>GPG?#DX]JIY[:KEMQGTS+0)&\Q(S(VB><
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M7Y@%4C("AMN2).\$"?FI"7C>)92H$>DA0R1F<C'C81QS&:=?U3$ODF(,U_\
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MF!Y\;; 3.:QI8>G!4 6HS=:XOJ@0N@W(8 N-F53(TIL*JF[T #*PI;RV=M%
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M1PV#%RT='L"D=.6'%C$Y:E!OO!6L9_8)[.$AZ[9]$^Y9[U*_;O$E@(T*1MJ
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MS;QS5.GOICFE_GM, );6X7GDZOH][XDVUE>>L# 9Q#IG9 *%Q8YD@R!"QHU
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MIH(N0@#*T :1N<<=Y$^=I$\*+4,-"E!'*S@%#@*I??81^I=4N0X+ 28]2_\
M()&D6291693741<+3;W]MG6%7>Q@1L"51J3L<@ _]V>1V_WK6I02K0J0J-B.
M9B/Z_;[;A/.@D08],0*2ON^^62+9^W[=MY1'9VRC*,[>#R%MA>+<-7^_E5L_
MVVPA?SO99#'ZCSR>WS'?XV/:M2SJC1[H.8S&,P?/S_>=P+.=M'Y-/*ZF-4/T
M)!E9R_O(3C'MTAI]A7TJ$/\ 6E7;1&O[_(_KVF/>1_;Z%)48$&)X)C;?&/\
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M+J]4$*C>!\ X,\<#^\VR?!>K\GSW5:BP@*\[9[+^X&4%KX;1 B&3S* &0HS
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M6$A-3;H6#?D*S"E2L&Q=;^]=4,Q&H2'A70*[&F-7:(VPJ^I7YYYMM"4@*4
MMQ/\V8D3.3.TD@9Q6IU+39 @A)D@Y$]O^!P.^U9SY9L?.]FAL9!4K"1EI2S+
ME6#U44N[A0^] KMM5-1Q;+;XRI#.6,VZRM;?R%(14Y5U3^I+*_S++VM$^HLK
MD&5#VQM!YC<^?G5ZD9V@2)&.PYSO@]\QVE6O#QW,5^+ZCD_,=5-ZS23%*#90
M>&CZ=N4'4P1$*G:YR6JE]_\ ,NE6#>8%>+,L6<!X_<+)K4$6Z7?XI2-D$9(G
MQOSCG'8UDI/J%(3,* ))$9(WX@3/P?I3 2\'=1R3KU'!+!,\A,<,%JC'%\0%
MF7$721+AR!E@N=7KNK%\4T65@SS^1MAS^0M_;>-:/5V<T]>!L,N7A"5@:5A)
M,3D F1L#L<9^:UK+9>2%3* 21&(Q!C@D\;B?NT6-.NC_ "8F>OQ1>16DH<G8
MQU8U(QQ>B<67@LT1)"BGMJ^JTRXR^JT$:HDL6C]P796$SE]3X=M%V[3KQ>2I
M4J*4GV)(P5*GD$=MB,<YN!MQ6I(.,Y(D8^DB9\^=XX$]5=)F2 G D9;,M\>7
MK1RZ+"SQLZ^X/ ( CSNI:>R'9-/TK)"TS"]=(V-M"S\X:FEASM%'E^S;J0M\
M$*T?](C<C(5 V$'^AYK0TLJ<]):O83\F9Y'F,QWQO EUY5Z3F/DZBT^.UP@C
M)+@2E@VD?+#+E5RC9'HP=-5W-1A;VMUFA5S87L")<KO!+MH'D.RIZ3,"GM])
M0%(2HNA:E$:3I*=P%*G&-\3]JW7*%L*$924DC,D0../&\YQV$6M9XGN_&=.T
M59XK6;K+ZI8I5@O-#JNZ)3,=G.TA<LL36DH3$=--@O[T=EKZ\<2<Y2I)O&[(
M:R]1>M+"  04MELQ_P!RI&/&=Q(/UK0C4X4+U" 02 ,DR(G?;G:-MJWC,1SC
M7.F\V]/]2>LR=<3+2)]M<B1:G38(.[]_:+ T(B K/&*L\XG"$*KEU_[A!(V_
MC&RMF5"F7:W>@N,7+R1K* E(PDHE7?\ 3C?>,QQ4]3[.I"ELI4E(@&1JD"9T
MG;8B9Q$;DFM&M2>FAJO6$^U3Y?2-6X@%OF&MRRYL@0;)+>$0P:1N7&R_&!T@
M; J\-T<*6'0T76V7#JZAXRC"E9ZM>-]12U=-*T!825Z9DS^K<^[,P3\<U/<M
M+1YA5PPXE*P!"9 ^02,P-^W>L#Q-KH?'5R7T->)%4Q%8(2=LG>6_RX5:>\9B
M,9G<Q>/*;&$05OV^?8MHHOFZA*S][* E5-W97Z"XID*B'6PMH#)@ &3_ -I\
M9XSG'.QI2XG<J44;<YSL3&=YX@Q5FVR]2\ST.:ZE>%BOQM[_ !PN:QT[(9IY
MI;K^#,0PLW_,EKJF#T"P?C#DQ6@5E10=$1K S::[?JA?8"D+0]*41[HF3D$$
M;$@$"8_>*]9U-*"DY.(WTS\^).?M2C86H/,0$D@5AE6&>=X&XJ#'<:#BMC0H
MEP.\M-2&P+X T#6WB,F?+Y<I8CA=)%LFT),JUH2EA!DJ($F-_)SW'SGZ447'
MU%*X!W)&^28&V=N\1)%*_'C"KQ6HBA2<N7R<D,![#; NC-*])70X+9*9#76]
MI7?F-;JNR+KI*@:*3. _XGXQ%@.I6F1/(B-C_;P?VVK,)#>5&)Y$;?WD<<[#
M::]]MCPM:BX!:66KO )%:+V"HJP8X0\']LHR&MC&==U9=7W!S*;J^0($)[V,
M>7UU2CDE4(4D:9((!.^V_CYYP#MDEY(<!4"I(R9$B09  _?YC&]0?BX]O\HT
MD<YO[-+MLE3CMEO]UH,L4Q&C_!Y]A0L4BK'I-T3@+N)AZFS)&! 5C,TTV:]M
MP<;GY,>UL5+:<2XXN2HD*"N3M/@PHG/<9 J8IUIQQ"VT@&1[5;<S(F3QSV[Y
M;[XTYM+YU\FW_HHRIRU\XU^X\\7^=L3>W[+M;'T(P"@SN?+OFX;*T2@Z%@[8
MLUE.0;6;2NPB@'\,;E;TQA]B[NTO**TB=*B2K<@C.3$;@P,G,[6'4W$OV5N&
M@$+2R"Z! _253.W@[>!7T40_3]O/T_X_KW_]/U?5RM=OI2NEG?TKG_G_ -F7
M^7^?^7?\?H=CSX[TKY[+FVB:_P"B\H%[A7N07,7B\W<G2I9LU^?4'?CB=$))
M(N)+8L)#U!GWV%RHHE*_[U'1+N!5TEPME0A3FE6HA24F8!P9V\C'><C?JVFE
MH2G^%+80G)4-R!IC;&XV.T#M3.M%VM2^E)63I^NK5&5.14N?78'4WV<+UVF#
M#.#_ )X6S1+5H[2E#0QZ,(Q@NOY9:UA;2+]F,("VG'%>GJUL"/3!V!D<\CZ2
M-]Q4I#C*6PK3"U'(W. 1F-_)^FQ,)^AQH,6AURVI()_"GLAUFC$NSS42D6^R
MD8"^T;A;(@)FL"SDDG2RKF%)D&U!-410R":9E3W;4/?EV[=S2^$%6D'$(2%+
MR!((P(W,SF"*P;<#:UZT M+!*E?]I.>V9,[<C(IX\6*Q6JUN MA2>QB=:3EZ
M=XW%"+*!&_!+9T*V:>R;3J_B.!%B].PK)G:L@2@:U?A3(+NS9?\ 6>2V5!7H
M) !4- "TRDGR<;'>*B.H2ALKT*$DZ4B)WP2!QQ.X' %&B0KF"3*4M-AJB-6F
M1A96W;8D6L4!D_9T1#D:UHG1<L,_&M7FAB%%]LLI[&L9H1]RRJ^=?U!NT?4\
MIY(6K3_U!WQWD3&.^*GV1?1Z2HU$G5I48@1"<>0,B,'8"125QA.'444JD6G?
M6:M?(E+0O?I+H<I&!G30:[7I,C4VB,S *M,/7LGJBZ$X7WB64Q4GBEU:+<M:
M&TM#TPDA.J,F($G _?QV%>.A]:G->!OHYVG'>-L=CM3A[AV.)KP4"2G(,.>@
M4OG%[6PE@_S9FD$%^^?210%<18&JN'@6S80[4'$><1EU,IUE=/\ J;=,MW#K
M"TJRW[5$;$#P,F1^T1)K2TYZ25A0. =.<S$;$ S(X.28$;TRWIWHF*R;6>9P
M$^ :IQG\_5J=9EZY7P76-$42U2S)+3[RF%TXTU"&GA*X6]KK:U77#7,XQ_"B
M.)TNJ89!<*(U #&HC,$QD$9[9 J2PAXMJ=?" V3[42)*?_(3';C?FI!9U#5Y
MICRWZ1!<)N]$1$S.,M<TGI1U)[NNVNAZ;74'(A.I*M9EM&=HWZ?@+2*>,BJH
M7F##VC!-L@)*D!US.E:YT9!VD\[8/F(JM63<NJ4IIS0V(!2DQCB8QVG$]\BD
M1Z+G]_JIH;&K[\=ZH:M<[O7I-6666%Y!*WOZ.WY)0];B@YAF) =FGJYU::>$
M>+>8M#E+\.)=T6G%!X:R6U"4[I/MB#C_ /EW@]J];0EP*#:8*3&),SWQQ F9
M[=XQMU$=II2\UF56<$I67*C8GZC,0<J!RCF=<X-#1QSUYQQY2VPT'.$C7SKH
M,LOK[5935(67/&ZN'W?RZ X0LE(42O&3 P4B1O/_ !%NFW9M[=+JBG7 *MCS
M'!$1!QWF,Q&>U\0"J(2:5V*N=:BS0C6-KE"NLB_JM9PF*ZMVK J[*0T"K1K)
MCWN0JQQ?VL87T7<@KORMNE.!Q?KKEI*DE04(.<8!WR.^XVK4[?#2E#(2%.B
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M69/M!.),3V.>1)F.U:3*F:*UIG$F7BG/*S,BGLUJ[4-E.=F#TA] @+*EL!N
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MCV6,)WPIHY7=6*GVU*6ZZVFV290%$R!N9SB3]YY-:O:XTTTVDEQ0,F1&#/\
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MT4RV\"XTY@#"2=CS]L$F!YP23-7T%C6LRCLP,7K$FA0>7$6NUG"PP6@:W\J
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MYF/?O5H>+Z1A-C<$N(EOF64;+Y#.!QD,W /'00EY?>! EN%LLFX*GWI$F!]
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M-M8-;_V1HGO2+)Q7\$N.2?:0D$)*@ $C&0 ",YC]M:?4;,N+&HRHF-SODQ!
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MU?&:9$^H($59C[E<3"GZNR-]7]NN'=]YI=E U;$ZY;=$JZL2$[?J-K-K<ED
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M\J2(C.Q@:M\9B-N=ZN6&C;A+@7J<3,=B3NDD[ X$")WS->N)6XW+,T!Q@SL
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M,*H\'_?S]O(MOU*VZDA1*5MA)*4I=P20#!['&>X&1C!DOV#MCI2W+FL E>Y
M,8&<;SGGL<4G>,\-DT#[T&E0Z;2CL+LXBML9UQ;#S:U?CM"6@S1;?8NKK"%I
M_BZ+:+C:_P F48U62I[=9:V#1N ZR5:DJ9DI)[S&DXXQD0-P-YA7+BK<@N<
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M%WY'2.]7CBASC$K\$:5O8SG=-4\X0%MH3*2= &,<@B()[8 SL.-"H_48*4@
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MAMO4-?L2H@E."0#D?!@GZP(&138LFI2S-\D#$A5/S^^^9OGL%[L1?7QKPD*
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MR+6]HCQ: PM_G?M'0O9N&E(OZ=FK^\-7Q>:$,+.$_P!)=MNFFZM7O45^E1+
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M>J8-(WA4KVHK&HFN!72@GTB>&A\_#E^LJ)TT]E5R51?/M.-K47RVD@A#(.!
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M>]X)F%P6L3$+B'T>161D5/M]_;#^"KBQ?UKCML1:K+KB62'$)4L0=S 'G;Q
MX[5KO%7*6T-%TD+.GM "LS! Q@'(_J*1O==G-P7I]P@#BEFJ6%OQ!&3H<D[L
M5LYC]J*H5#D2@.N"-E)H(7/I?+P^BUT0,A.RV*A"5)>6ILA?J)*4F3'O'G!'
M\VQ[;"MZU.(2TC4E4-D'R.W<Y C/;Z8]R/2:ST 2W.<@75DO0<M1@\DR7#X\
M/\>\0.;_ ((P*IMJ:)7B;^<A=:R"A5.R,J(UR)OK_=;I=_\ E,*:/N3&J.$@
M '>1W$;_ %%1@--L^%B=??SJB(/.!F-I[0_W?)]%#V#1:,JJW+8NJ@'TB]<O
M;Q*;'^G'!?OOS(MI:RX(C+H#P+'TSI+Q6'Y5BR-2^(HP\1L[NT2;Q5X2%J<;
M_A $*A4Z?TDGMO'BHK5SHM$VJ4D N*UF"0-]^<\1!V/.(_\ L?GZ#6TJ'@S-
MFU]<I-5Z:HX9^U?/AE+ *]< GHLNII;5Q?C0A;V<!.#&V0NLG1;PJNZ5)?"[
MTNMH!<6MQ*S&R2C<2, 8\@F9@U;].2VDCUR&VMB21XTJ[_[8&36ESWG?H^)8
MX\O^X$BTV>;%V6PS<V!])FJ&8GB1,-C381)=.P=+&7!*N5CQ,>2C]V)M]LI2
MDM-=04VVIUPD)$J2F3X(^8W^3]-3SUFKU$M)'ZB KD9,#8<D<XR1D5-?)8E+
M1\>]-T>8C2_T!NP?<;0I-DZ9:<C2%WK1+%:[EI$"E(PH*@:$29PCP,@B^=(T
M[I2N6K=I=C!!UE](SD@ ?.J ([Y,X(KG[IUQNY$+ 03"9@@SF"!/?SC YJ)F
M!=[G<,3VF.00&U83AJ3K!QQADU4AE==E<E!6><L163<TXBJ^F\XJX<FRB^P>
M!!=7;;+O%WS27V[8H@)A&H'!@1O':28DC<9Q4]3"PRM[=9*9$^"3 G)W_P V
M7JU:L9O=$'ZB8/B0<P:+Z6:;U3:%G$^?645B9^@70FUFYT'3 QDP()D#1"0P
M$:^V62G5$FB0IUI 4X"D$*( C. (SGGSGSN(R0I(2K0?=(/C5MMC:=@ 8\4C
M[0:]@Q',69LST[.; >XK FYL5::KS>?0#AV9,=@QBRER(MO.T'!FS'Z*7)E5
M;TNTB;"B%"XZ]=O+!;46TF9@@*@Y B)\8C)^*LVPW:A!0I.H[CYGR8WF#MXK
M(JZIV_H>M%1Y[,)WF!7B2=&/%[Q"^O:WU0%O9F6WTTB\2RL!8RA8GKE30'5"
M=E?W>72KVAED(AUHZ9,0"<G&^\B"3L>16#KCH&M*P4DQ F"9F .8F#VVK=?R
M:)TX/IT0/;@[.+E;."S.G2R>@;%# U9SJ5N+.+)[5&[[T)_C*K:AX3N(8T#_
M &K2(X!A"E'T3.DF1N4YP"">QCGZ162G5-H!(*58D# \P/$^0)^*3/G&62YW
MR/9M/07H?KHQ9SY6C?"99R5N\7"9!%I2I1=GZ:VCO\/A?VARE]%5=LN6RME;
M941V<1^R;#DK1ZB7)3K'\NCL1)R) P<XJ2BX=4$K0K049"3SF<9C?/D8^,]Z
MGP&=U*OB'.I;]]D$RQIFRGKQLN<GJUJJBTFB+:LJM@P*OHJIO/':#3&G&%L2
MH?I"Z473F4)>.II24 PG4%:2G(,D1W,23DB?&=TMU;&H*25DF1L1G,C8GYXD
MG8PZCC^?8I9>C)A6?5>N6*"0DP)J[B[),42]M!JP=:"VZZMD'=<;"Z5P$?UG
M;"VZ?;>_A_CVR@6;A3C33*CI  C>.-QG;MODYJK]34VEI:DDR9GC()]WW^V9
MFFBS?F7H#-FGOM)5OE']C17O":B26?.3,;F'C?AG3O()%= DF<,63M#[32'+
MO:I\CWD?JL6+Q=U^:U(&D@_EP" F.8/,??&>*LM5OZ!:4I2%@0%1[3J!V,'O
ML2.\\TN<WGR<W,-UI-"]%&'U[ICMA+F-;0HV*VN]2A-?Z.-M-\5UBD<2T5*:
M/P:@VW\"V5TJXE1NQU%IUF'6RAU0G49E1)DJYB>03 X[U5_EG$.!;:O41R#N
M3Y,@0(Q$\<FE-L<EM_19J=-B]SW9?DT3%%9OR;!I9['T@D,$DJD]P0,F9DVG
M!:[:X5Q*E1^-RLO\>N=\(]FTV7E*4\\'#A&?:E1G3CMDC?C)&:D..E""@6[2
M$J/N//\ ^1QS&(_;:L P;3M=?"6>4[%5Y^+68!,1EG U>=TPKP:#1[H#*S#)
MV)[51M=\E-308VP4XRV$AX#DRC5.=0XT?56Y+J<0"95J'_$8V)-1 6R"TA,$
MY4HY'8CD'XS@#B:R1@U?HOGK!?Z3M\R_#;4]/\M;@Q;U)JQZZ)K0[7[VKOX!
MLH&4A7&=#*Y_KVDQN["-M==9MP^FH+(;6M7MU9(D^<Q'.(/(Q$<K6E92B5)3
M@QL?GB8\YP#M6D3Y^.1'0,FI;'KOH2?\]FFL/)N&R[L<9D$Y%SS;H!&6C9H!
M30RPK*RSAJQ^,^0I$C=]B3^66X@)4Z%(&92HP2<&1(_>3CO7@=*"?X8U 1F
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M[G)Z30YY(X\^;.3U12M)52R%<5-T[C/DDB,X616@P,5D$#4'$#R9 7P+M5T
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MLM L5:*]+&G3PHBK6+5)-EW("V-";Q[V7\737=(O[CJ=[=)NVT!@#0DQ!T3
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M_'%$WV+Y=-T\X2T'%)4W&)&D$_;:=YG>:QN&?<AEHAU2(!5&"1B"<8@8R1)
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M9\7HXDW*E# $ZQ2V2\C"TY@&8M@E,NH(<1K%83/HV"P0H/7*SJ5/M1JB1F2
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M 0,2.W(S\$Q6YU"?RY)("PG[[P.3@XY$GC>KFJO^QS_Q_P ?U_7]?\?\^_\
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M9(K9[?UQPB \]<Y7$Y-GFWTP+WIJ1KG+<^RCPD5890RSM$8'?GV+[6G#;0N
M?C$*0I$F0CR8THUS;%+>I*R7)"2 ,3$D:@()/<$P3!QMZTD%PA4 P#)Q@\ _
M3B9,3X1?GVX%NW,?[UQH^#:M+3V'E5-9H.Z1ZCJ$RH22E+>61-N/HVRLNJTB
ML<3M(U5-]=4)SHZ/&N5U&Y:+=D&B%+)*R24X$'!,=YQ/;;(V_E676U.Z].C9
M1X[[2?B ,R2.[F8K44:%<\:Y9;I#+,MOM"YT2XH(E X+T8W9 M!+XL0U+%LF
M"E?V-/Y(%ES\.<3 #9"&TVSFHO$3"U!/I)]ZU?R[#D">V)VXK4MD@>T%0/N
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M&/"Z":ITV+ Z=Z'J(0I2$H4=)(.Y,9@1F1&2 /FHCI?4\&5+&OA8W3I^G/
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M8;A93<CW.00#$]N"<'><UID%9<2K6VO"4Y"DG$@@Q)&=QM I,['8CS8,!X.
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M[ZHA_HL6,R5)K<:^%_5T9V6+[-EHXREPHO0?TJ""D2(4")@D2>>PWVWT%M8
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MA.TOFY>"%O285YP(I68BHIX&P$MJ !7N9,H(;;Q+*C282I[=&6Q;=,M4VK"
MX]ZA6IPPI2 53"3X/<@QX,B07 \275:4@@#<X&"8QW!YSF.SN:M/<MMV F\
M[CMR46I18_7-HTWU#)U"%*.[*$,R#L-H*K8M:&'XD>37E6$4WW&JRUXM ]=4
MPBXU.NH&I6I0E9 (!(Y VG< CMYK8IU"&TH"B4*G:9)&<_&.\_$UB*]YX]+8
MT/(H-KH+QES\M@724)41=?EA":J69:,&A?0;)ORNVX:^07+RZ*@RB K3(RE*
MX]!Y8%JIUDK6A6A"7!J28DDI VX!C!($Q4-*M*4N!)4DG2G ,&2 >(@#<B<<
M 12,]$UWGOK.67F$=9*Z'*\U[F:;QWJL%T;@ZJ](> U(-)S<[I/E4F^?KJ7+
MG8RF5(T3BYV3IXQK$BY:2\TTY_$:("DA2M)4/;!(R1B>WB!4V)TJ5!0<F/U)
MGL![3$&0<'8'D1)S;K,>0ZO(6CL0LODC4S9F RB18PI68CI5@] 9IEB8LBW7
MW$A&-*:>_I^1^\>)-'.2Y=&_M7BWTXJN&@5K?#:%'?61(F1.DY.J">,S4);9
M=>4&2=(!R(G&8 F"3V[X&U2)S^L^/^O:9)G!-MMW_#C'*5N<?9FFD8*X@^HF
MO25M%<""%C:ZVX"X,Y>2.8<+5^MW.W5]A%<6Q6VVZ\+912%:?3=]T'3.""21
M!B#/?SK"G$J4A(5I4<ZMLYQG(\F(-/\ ;+&IU^3ZF#H386"H?3TW :MN6UMC
M@]$)-2?,%S$X.Y>UNL)$B5,@@H("X2)?)55_<*[1W5O;N,J;45(9N82E42KU
M4F2DD3 @@R#_ +5-8<6%I2LA2DIE(D1IG:(G!.-QN!P*67Q-^-OQRR.8U.TE
MGN6O-K8 O>UZ*^<Q#[5Q!0_["8-(PK>=[V=UG&Q=[4DRL?\ )H(Y33WL8RF&
MT(0R52&QZ8 ()4 -SS]\;<XK;<75R24I*6PD @A VV[_ $X_>IX9_8>?8K59
M[)7V+<^9?I<H@5*ZQI<_-B5:'Q)0N%&JM_02/[IU57V0HJ'F.3WMD(0G*S>U
M:J0V5-B$H/OD"=( F#^\#CB9-4[CRU:M1U:I!.020=SWXC;SFK 8_P#9Y_\
M7_'ZRJ/7;Z4KI9_]G/\ 7_'G[)?KS_G_ *O?KP['X->C<?/S7S&#^;*B4W.8
MXFM>HK79XQF/7J:;U1MJL*H>"I5,&=>@%5IVQ8,R.L[RNF+E$9W?;G.^RSYZ
MMNV:1)63[P=,1[9DC4,'>1GN#C%?0D.N/+)5F$ 8)X! QG8Q_3::3HK/4.VJ
ME;+5RR]PZRQ2L/DUE4UT]DK:K&T#ERFF:D8&(\S!JJ[KZ2)RKF3(>$)PY&&]
M9H<<-PV-;:2"&P<$SD$1W'?:8J2FX*&BTH$*R2HB#]Q F!O'&")I&NW>DR.D
MQ.&9&,'/G SLC0/MN+GEQM*_[WV&1:/^;*[_ "$6C9=;WH8Q36CMDPJ>#QG;
M]R'UDX\MOTVPSZ3*EI4H]AF>, F),\CXKU+*%H6Z'-3P22@=U ;?.=^P.>\@
MVFDS6LW37&Y A^@1$@9Y6DIXLH"S X:Z@XNL8I)?P&=-5;1TW(G9.R!-+Z50
M\1+*%8X]UDLO70<]$E#"$!* F!K$$&3,F#&1$_L($ML)0MU/_P @J)6#,))Q
M@0<$ &#WGS329OB_)60QV(2%-!VC5@ZT#39E]9LB3+H7BE1,8,*_X]7GPC?W
M06"<#[RF4NE?=EV1%]FBVLV&62MZ ZHDP51,&-N^,8VR<F*F*N%/I(22I(&!
M&TF<3MOG.^TUX'T6J>BX_&I$Q75Z L_;9I""U*R%VL:@M)*[517)!4-65;DS
MDCR_TBMC*H6^'WK@X<YN%XBW0L)2"520-HQ,#$F)C:!'N-1UVZW2C48]."!.
M\&=))^H@9&TCAR@4>B)QP7F88Y?GDJE]779:BRA:&K:5V6LK A7%=IAIU!LJ
M8C2X*O/ML;U&RGVFF5-G(]N+BY6/34EH%944E69.=.)($XQ.#\5FM2&$J6Y[
MI3"COI3B2#@ ^2"8S3BBOB%=-FXD@UN^79["K4>D5K%K"=MU0H1:6EHC&LIZ
M2^-:+)RH:A%?NZ(2NA;9&-AU/[^L;:<0PA*U(UIRHI).TP8))).)X G$BN?6
M^TIQ>B=)42#&Y.\20-]S,\032E584 1)G7*CEW-*&O;J%UY.03E2S,KHWL\P
MS-SQPI-=C3-Y\R:J 1S*@2TGLB:ZZY2_%CH*"MM:P25@D$1&H\'R",;Y)[#'
MJE0ZE3D!) V!.Y& (Q(!)C$B/G;'D^@Z$#=YYB5W&J*[1!L9O% L[=5Q7P2B
M7[;  +QQR#X7CW7%UT5C6@#]L&&)B/&,):V7!;J"W65DF)"@-(B<X ,@'/CM
M6QQ"7UE#:C! &H0-]^9XQ.\<\-;O6.;UV;\HT<2[=]Z2FL.BHT<Q.14'EUES
M3EWZ?)?MK;5*9$RFPG-93 JDH&'>M?W<LM.EBZ;=<6HH*4G88R>PV@3 ^GBM
M08<:):D'29!G@XP<_4 XP17MS-,L0PEZ/7=1IP<I%E4DS6;H9L;#8V#066=I
MXPD?6I5JNV&=J,'HM(E5&V9;"5,Y_I8BX;4A%L@!"G HSG&"8)//GD'G-:!;
MK4=:_P"4[2#/8':(P,<;&126<U:N6BM?IPJU" !8.]U;!(# Q^6<YA:92-A^
M$4UOF#J2*%-7&MQ?8F%T<$I5#T<'J^JL!RZ*V<Z08*L1 .-(."1WYBI:0TV@
MN%(U0<?0$@Y!WF 3SW-+'TXQ5B!<[J=5"4Y;+^-SV>F\3LWS98Q+HNZ[-_A5
M8-U:J^Q2G0F\_&+IA4^Y=&18,X6Q-FW3MK:M6P62IQ(*) F83@$P,GG[YK1:
M(>?<="$H4$H"BI1Q!,QG),&,<3&331W(8[+/KG64M8I]2A%NNH[IT5&*4>B-
M5XT%52J2X\@Q<P4A A$0[>MM95-OS^<L&F;139R JZ0M92@!*'",G"@8 CM$
M2!/[U.3;*DZI2$B3IS@@\;':(SO63F#Q_2;LCI-CA=/DM$E.KXQ:Q5R_LPIR
M$$<"..TY!A0)RNF[M(\#65%U?96UKB1Y_IPCZW.,+M6M27$*"I]I@_RDD;YQ
MVWG8&*CJ>;6L(!( , P09&\_[;3P8%*_)ZS8TG;/J35R'N20*!&FM76+!%^@
M#O%LD "C[.D9PO:S*_D;B$T1>T2_,LJ+OE=7]^,A<-DG2'4E12(A,* $$$?8
M '/UK)33:U(,$ 1J/!G;S.Q';&]*R[V<G.Z%57O6%05B^+A64E:U47%^E%+J
M:X-;T68J:D"7PD(6)9;3.FML(;7?^+VS[\J_JF<O$JODK2\E*@0-)) U0 8Y
M[Q/)R.:F(LHMG-%NM0!G7'U!&Y@Q(VS,>77PKS'DKB45+>P],[L9-3,X]MH2
MR$J;'BC I%L4O%5? @&%TEX7Y\[S+F!<*ZSZ^"C<NM6;Y:WBRVI*WD9WE,<
M$G/;;&?)J NS"$!Q:8\;'$"22"!F)D_O6X1W>A;?+D/=JO+RR,D]9:AS =-8
M3D8I4><1^4R+6O'P,R;Q":D311]ZP0J2^TQ9"CG8<JDN/J<M_4<0%N>KZ91N
M<#)@B-]\QS.]1+=IH/G2H@*!))CB)$3([?2-]\@++,UM8MBU6":$A-:E@.(M
MK&A:JF[H<8@T4G$%75C$65W%6?;LY(>-(H]M,JK(6=TW)4V$*2J1I$H$$=L
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M\F0AXO[:Y:;,I0H(;P<%0GD9!\CDDS^U:S>K;7"3*<<R0(&TR 21)QOWIO\
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MY>'RX:J%<-UNV98=9-T!ZJR\5K)"@N/TQDG< 1L1-9GUG%'4WML #MGOG/\
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ME*$2'EN HCT**Z1K"265@=,ONKK;[;0@JXVSB#R=?847Q*M6'DLI="D%9<
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MG_\ )'ZRK74#_DS\X_.?BQ\@?C;X5Z"AT5M/R36>I7)O0@I#QRV*<^?3PZY
MHV?9TSFM%]$U6^SV&SCN=T J=DYSJ0FN5CX>VA2M1W^HO\<,S\:?C/\ )7V%
MUH/,TWR<\CSWL.6R8>4UOI>A0Y@[ (_1=<T>C^>9IZ6)E/-43\&W;[HU<NS*
M2JT2\\L3\\.JQ7I,\ ? BE][9\X_B_\ 'O4Y['>E>@.AG>CS^0U8\LMY]OM\
MF3YGT+:B><X!]KM)B<P_SN+4[G;%_P!N9 _5M$XVB8C&TJ[">AD=K\)CO]I_
MI7E+'4_*3Q+%_(#"?&?5/M>F]0]-^]1A/S?,O1*\%I'%&9T.RLS"[U7^UO\
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MD/7KH^>+7R'3ZA[Z6\@=3;_(9S%Y_)M7+T(68Y?5PY!%-W/L2A-28_\ 0/\
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MZ9MBW1WG^^T6858KT=6GUJ-MGF3/#/GX(K(*RN=_VITW6*5C^L?*SP#Q+U#
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MGI3@BQ2I$X3X;^(K\Y\=[LGJ-6[SWAGM?I?R=\Q;T:+/-0WVI]Q6>R0>2:L
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M$U00LM!,RJT^]2G>^/?A&-^-7E"+QW F: _*YYON'0)6H,!8.YE[_>Z?T1U
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M[JLW&M]A^;7COS0UNM4>3UY1!%GY2=\>S)>>K,21O--.E,YI\%' H:F:1@8
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ME'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E><O\ MQ_\/_7OTI7I]*5X]_\ WO\
M\[G_ /=]*5[?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*
M4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*4?2E'TI1]*
(4?2E'TI7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g68105g13o50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g13o50.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3%.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ,3*^$EE#A"24T$!       0!P!6@ #&R5'' (   ('_QP"4  (<G(R,S
M W,C@< @4 'TUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@X0DE-!"
M4      !"I>VKQVS7F1B!1.-MQH?9].$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%
M>            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  7@    $  @
M!>     0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@             !!0   0\          0
M                     !              $/   !!0
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG   !!0    !29VAT;&]N9P
M   0\    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P   04     4F=H=&QO;F<   $/     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    $.$))300,     "
M;3     0   *    ":   !X  !(,   ":W !@  ?_8_^(,6$E#0U]04D]&24
MQ%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$
MU31E0     245#('-21T(               $  /;6  $     TRU(4" @
M
M 18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @
M0    4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9
M   E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'
M5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P
M@,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&
M,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G
M-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C
M$
M       %A96B        #S40 !     1;,6%E:(
M!865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M       "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96
M,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                  9&5S8P
M     N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2
M!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;V
MQO=7(@<W!A8V4@+2!S4D="                             &1E<V,
M      +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-B
MTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6
MX@245#-C$Y-C8M,BXQ                                  !V:65W
M     3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4
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M$!R0'1 =D!X0'I ?(!^@(# @P"% (= B8"+P(X D$"2P)4 ET"9P)Q GH"A
M*. I@"H@*L K8"P0++ M4"X +K O4#  ,+ Q8#(0,M S@#0P-/ UH#9@-R W
MX#B@.6 Z(#K@.Z \<#TP/@ ^P#^00&!!,$( 0M!#L$2 15!&,$<01^!(P$F@
M2H!+8$Q 33!.$$\ 3^!0T%' 4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?
M8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L &T0;C!O4'!P<9!RL'/0=/!V$'=
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ML*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,#
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M'JL
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! ?_  !$( 0L!%0,!$0 "$0$#$0'_Q  >  $  00# 0$
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M(G")PBT1^TTS>:"M4)T_6V?BGK/+=A9K5J/E,5/[M%5V+90R[IR=ZZ;LUO\
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M1ZBZ&?\ &5>H#"..H!@3- K0-.JR4FNMHP.14.Y,3X& H\V(@[&1,CS_ -H
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M$HM)L7\G R(G^U"S!L"8HF3,!1((& 0]>4<Z2Y[C<B7'28YZ"WK15:UK0 !
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M\GX]L+"'8OS&'?OWJ+J)D#KK$V(%TH1/0%$Q1$ 'GV.%\:/"B^>&\-QX>?\
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ML*%3L;UUW'MG3Z1=24_%L)>:E9*3=K/G[Z2D73<Z[IPNY75.8QS#H!  \
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M()V6S1-.H)CW3RW%Y\H\UZ_LR[;2+NG?YVC8 QIA^+[F31Q)8_NL=:U)E<I
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MLDC1*A'/,>SJCULLA,*J2#LJJ\\S0%,VV#8R*9B@(?MJ8*'[BE$H\_;N%?\
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MZU1I#G/IEM6F;.HES@2#)[T$6<+=#<CG<T9:;<W=94!:X:5 &EHCQD\H,G2
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M_P!F+"TX&+\Z,$^XMA8)]M?NB2)2B6&O<,42MI9DL!?<IO#A].9@;O16T4I
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M!Y^[S^(?,/AY^'/'+I5%5RFB0RBQBI)D*)SG4.4A2$ -F.8QM 4I?]X1'0"
M@/"**F6^M/IWPY(# 6:^L'UM,01:T^M$4L-E>G[1%))&.C2KJ@93T 3=H!OC
M1%@!WU!=7><T"(8!P(6@UJ2!5 U_S0Z&+61;J )#.H^KMA%ZN8"F[TRKF2]
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MT(ET8=")N:M-CF;G<9AP&@.AB_F9YR9NLG Y@9+&[,,3KI-I'2+?1;!2AHH
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MU<=RA7)XB"CU#BSCT&8(B1)(AP 3#OGA<?7IXG%U:]&EV+*M4O(F2;W)G<[
M>9FX[&#*UK3:!>+^6L6]2MFZ:":92D31*D0I2$*4A2D I"CL2]A1[13'SX$1
M'8CL!#6N567T\(G")PBX[@WKSO\  ?N\^FM>?7TX1<\(G")PB<(O*DXR.F&3
MR+E6+:2C)%!9H_CWB*;EH[;.""DL@NW6(**J:I#&(H14IRG*.AX18DQ=T[8/
MPFZF'N*\75&@O9XP#*O:_$(-'#TH'%4J*C@@^_!J139@9IJ%;@8=@F/@ (LU
M%+W:$P$'M\>"AH1\@.A P@&A$>X.W0#L WH!X15O3TX1.$3A%P)@#UWZZ]!^
M/X!_[?'A$ 0$-AY#A%SPB<(G")PBI*!\1$ #T#R "/Q'P.@-Y^ CVZ\B CPB
MHK"!4')1]014'0;,.O=F\ (!Y$ #\P ^SYUL//"*%G09^]?D/]/66OQ\SQ1#
MQ^ _]/4!Y)VZ#[E5:")G=Q/DHT>U@Q:XO50PK8X2X8RBKO3[Y+ITRD9>]\-+
MR&_L]8D8%U%*)HMW9FTG&,W:TM&/U&JB3([8IUU6Y-JEIE<^HUC6AQ=3Q#8)
M @.H5!FD]T98+KGX5JUP:TN<2 *E R 23%9I#8 ).8PW2TW(%U%SV-C ;#=\
MC7";M^'0M=*HU6PZ\H^)490 ,QJKIXHC<+!+R+"/_+[A\LZ69M'C9)R@FV9I
M(E<&]WVEO2:*=%VYJNINZL%-I9<:C.1,&"=;JM4'M&-<,KJ J B1WNV<*@N#
M#LHU G+H5NMRG@#%6:D_<Y)J+6S)_DU:) '+EZU$(]PK[Y5N!V#IN81.I]HQ
M_P \ T & !$.1 Y("1H2)L8Y+'.)>B7IIP=;$+MC#&$=5[,BT59$E&TE,N%"
MM5O"J0H/9%VV$3!_O@D!]>.X!$>/+^?RJQ>3)Y<OET^?T4L>%*<(@^@^-_=\
M_NX14>T1WLH@/J/:8=#OUU]LHE$?0?A\?/"+GL'1@T!1, @(E -#L- /D=]P
M?'SH?OX1:S;9#=86 7%]EL10.+K]7KED-&891\H2=;V!BC-K-V;I1P=LY*V,
MA'D)[]329=EWVB/P*+\Y68BO.N\Y"F*TZ?@V5,1 26\1 QM>![7GQ$?/GTT(
M^.%*J?2>O'^!]/G]"W?YSA$^D]>/\#Z?/Z%N_P YPB?2>O'^!]/G]"W?YSA$
M^D]>/\$Z?/Z%N_SG"*R%KGU^)7QA40JF#%8U[!O)92T$"VE8-7;91--"+.F#
M\3'6<%,=0@ZT)2:$0'QPBO?Z3UX_P/I\_H6X/[/IH_\ ,?Q'A$^D]>/\#Z?/
MZ%N_SG")])Z\?X'T^?T+=_G.$3Z3UX_P/I\_H6[_ #G"+H+GKO 1'Z)T^^HB
M.BW#11U\=//C\O/GX<(L:4'(GM!+E)WUC)T3"573I]I/7HQY(_6A1&SM",F[
MDLW&%*\VFU%1P+<?>&[A41/X  \""(G<3Y?.W@;^*&0)=8$V_P!A/J-)A9.!
MSUXZ\-.GS^C;Q_M%Y_[>G")])Z\?X'T^?T+=_G.$3Z3UX_P/I\_H6[_.<(GT
MGKQ_@?3Y_0MW^<X1>7-2_7I&Q,E((1. 7[EBR<.D6* 6LJ[Q1%(RB;1$QW?:
M55P8O83N, "(AY#UX4$QL3X+RZ5:>OJT5>&GY"N8(KSV49D=N(1\-J.[C5#[
M S9<4WG;WDUL0 3:WH3?*)O'KYZ*?NKH^E==X@ E:=/@@(>O;;O^CSDHGTGK
MQ_@?3Y_0MW^<X1/I/7C_  /I\_H6[_.<(N/I77AO0M.GSTV.BVX!T'R_VS?\
MP<(L?WN]^T!J2M73C*7A&REG["SAWRL>-J*6$9N#:4E77O'9A%NAZJ 4!-KR
M <)R];%7X*G7:<ARBSZ?A*;N[@*2W%!7[(EV E?$,7O$"C^< " " @'IPGG'
M4+('2IB"V88QF]K]XE(B6M4_<[5=II>!;K-HAL[L[_Z8=@P2<G5<"@U H%*H
MJH8R@F$1UZ<(H ^V'K,')XRQ38&EUL%<RQ!7*79XF@JM6R7"PW67LE<>0\U$
MQ%?7*HB:01@W+YXTE5033C5"I+** "?:.3RX5&ADYBRK80):*50O )T)9F&P
MN+K6F<H+I:#+2TN$@.#@6F.CH.A-K+$7LFZW5F^3<BKJC:J3=:1CNEXW8X;N
MM-0J=H@:E% X>HV>8=-D@0LKBP2CV06&3265!(Q1;&$ON^T-QE';U:;\XQ+J
M+JE._P"@:=/*UHF(!%S$@F^JQ+9;1SRZK1%9G:P0*@J5,Y<9@F3&6UA T6_
M/ !^ <JI7/")PB<(G")PBX'T'QOP/CY_=PBUP=5?5/E^B91@,*8!IU9L]Y&C
M6#*%D<V]TX;Q+6I5PQ$UF3$6PB=27?*G]VV W[63M#N'X\R#GES[0RF 7NU
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MN4;+E?--.P]TQX\R'=NI3IT>M\C(7FHE8!6<<.[+'.618>QA*IBSD%IV'4<
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M(T;9SST6^@8%"#,D5>(1.W6;G(W*LF)C?9,<Y1#8B(9,SL#Q!(-;,!:[3RY
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D!H!T5" "Z+7)^JOLOQ^XP@'X<A%VX1.$3A$X1.$3A$X1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g68105g15b77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g15b77.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3! 4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ,"2^$C)#A"24T$!       0!P!6@ #&R5'' (   ('_QP"4  (<G(R,S
M W,C@< @4 'TUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@X0DE-!"
M4      !"I>VKQVS7F1B!1.-MQH?9].$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0&
M0            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  H     $  @
M"@     0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@             #UP   Z$          0
M                     !              .A   #UP
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG   #UP    !29VAT;&]N9P
M   Z$    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P   ]<     4F=H=&QO;F<   .A     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    $.$))300,     "
M7&     0   )<   "@   !R  !'0   "6J !@  ?_8_^T #$%D;V)E7T--
M+_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q
M,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"P
MT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,#
MP,# P,# P,# P,# P,# S_P  1" "@ )<# 2(  A$! Q$!_]T !  *_\0!/P
M   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M6CT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! ?_  !$( DX"+0,!$0 "$0$#$0'_Q  ?   ! P4! 0$
M!08' 0(#! @)"@O_Q !W$  !! (! @(%!@@'"0H%!2$% @,$!@$'"  1$B$3
M%!4Q00D6%U%582)QD925T=35"A@R5H&3H2,E6)>QTM/6\!HD,S1"4E1EDL$F
M0Y;A\1DG*#8X1$5(8F-D<G:"LN0U1E.$PC=79G6%AK.TM\5T>(.'H[7#_\0
M'@$!  $% 0$! 0            $" P0%!@<("0K_Q !)$0 ! P($ P8$! 4#
M @4# @<!  (1 R$$$C%!!5%A!A,B<8'PD:&QT0<4,L$C0E+A\0@5DC-3%B1B
M<H(7&$,F--)55F.#A*+_V@ , P$  A$#$0 _ /:7^$Z^J)X@Z(]<],IO^,D.
MRG#/@PI3GT7['QGOE:<X\.4I\_C]6<=;;@AG& [9'?4#:1OS_>+=1F=L>GQ(
M&NW]_1?$1[5]#^##9]"COCME:E.+\L_\[';&//WX[=O?CMV\^NP%5S9:- 3&
MUYGUO!]+K&."8]OB+6DSFF28N-8TB>F][K*D\11CLF2YY^_O\/?Y?RO=CX?C
M^OJ#B'C:9Z$WMUM/[?&S^2P]/5TYOZ1RYR!S'G&R'CA-Q'@7+=[Y[?R%J0GM
MCX9QC.,Y]_;OW^'5!K.J#*1 UTC3U/-5#"X9MX=(C40+1$WGX"]S)A:S10@U
MG.6YTMOR\LIDOISC/?OY90YCMC[\^[RSG&?=U%Q<C6_G\-/2%<#,*\%K@0 #
M<3K/76(Y7,[);C7*QQD^%!9]Q/;"<HD91*;SC&<>7A?2ORSC';/NSV\L*]_0
MF3L/)6W87!D0'.]1IU$#7H00E)-NC2\X27KHB;C.$XR['9='R<=N^<YP['=2
MC.<Y[>:FU9_I]\YG"-1:UH'T&EN:L5<%6I^)A :8B77 %QS/(_X6ZTW0R&.V
M9!4"\K.58PXVDE$QG.<]\96AM#Z4]_<K.,YQCOV]WG6VJ\"!!Y3'R%I^?TBW
MEQ=."3G _E!.DB1Z@QMJ.BWXE$=G.8R*L :?&SG&?2MR,M/H1YX[JCO8P]XL
M8SYI2G_)YSWSP1(UM&D^G+EUWU5JKQ!E)IS43W@)&87#;\^>\1J/-2*+U<$R
MWC$R9+G.Y3X599RTRU]?EA:59SCOW\\YQG/EY=^_5BKC'TW V%K:VTT(VMZ7
M6@Q''<0'Y6#PS^ETS(.T6@>=N5E<0TX.2E3L&9+BXSCR2ZVW(;[X\\)SEM*<
MX[Y^OO\ B\NC,>7%I>9OY3/2Q'PU'-7Z7'ZK!F<T!X!,7)$21:2+B+G0Z[J)
M['1S->[ONHQ+@Y5E*9<9>76D_5Z1.,86UG'EC.%8QVS\>WGUEMQ--\"8BPT&
MNORCSY<]UA>)87%,#GN9WT D&T;&;\]["VTR65G.,=LX7GQ*\\XSC&>WP]_D
MG\?;.?AU0YP),'6\VY]2!SWYK8MTS2(B+$CE$$"XC3HL><X[^:\=_+X]L_V>
M7]OX\XZMP9S3-P=.742WYQSA7@TN;(W!_J/,:D?7185X=[_W/.%=_?W<3CMG
M^C./?U,--R0/(B_4W._PZV4!I;O/*X,?"?>RR9_ 3A7;'?MYXROQ8[]OJQWS
MGS[>[OU(=E-MI .8'Y$^]%2QK7..8R()MKKKH ?3Z*Q*7W'/#VSG.>V<8SC*
MLX^'X&$XSG/GGXX[]\]L]NJN],&#<3 @3YZ&3\28ZJ<]/#D^( N! )-A(F]]
M (.]@+B$Y!59+%'%=VG8D1O"5RI\IM3$:.SC.?&M;B\8\6<8QV2A/?*N_EU;
M[]T:C2^D_+W,1JL"OB</,@BI5V#;WU,3Z;1I(3GB38C[[57KF%-1)+N&R1;/
MX,PBAG/9[LKP84S&\.%9;:QVSG"LY\7NQU23,S-_K;Y?8#JL6JTTZ3L94\)+
M9;TM>\1TD6W!"DN63#5$2U(?\DMI] +@)SGQ2%-]TJ<5C&4JPVE6/$ZXO./$
MI><85G/?M9>Y^8Q!&TWN1Y:_L#>ZY^C1J8^J7N!R.?.AT!CSDQ\"#H"H L-D
M(V*>N:0D..=\>!EE.?"RRTG'X+;>//'A3W]_APKZ\=33<YP.: 0?<['T^J['
M"85F&IAK=\LCD6S ZGG\- $WLJSGOWSG/?/?SSW[_7WS[_\ ;\EQ97N.>GOT
M5,9SWQVSV\_=WSV_]'4.T/D?HIDZ20.4F%>I6/#V[XSG/U>[X?[8ZL*%C[>+
MR]W?.,9S]V<]L]9%.V6\ZWTYSKR^:D:C]^6_R6\XO#?9IM.$XPGLM??/=?UX
M^[W]O/[_ ,75]P: 7 G.!($[CWY"WK9?9Q'^38:SMTM\5K+^&/KQG_*G/_=U
M8S.=^J;:295=/0CF8^A_96MQU*5XLISG&<]^V/?YY[X^_P!WW>_RQUD!K@!:
MP%S(Y>^NEKH_2QZ&QB.FNO4!*2&L-]\Y3GRQW[8QGMY>[OG/P_R?Y):UQ<V1
M>1L0!?W?EZS;D $";[G^VWUWL(-'I*FDXPWA.%K\O+ZOCV\L=\^_'U_BZ5:F
M6VGGI]1'S!V"EK,U[[Z:^_+]DG*5E259SWSG'G]^<_C\L?=V[=8+G%Y\SOST
M]\M%<[O(ZX,P('GN//EM<:Z84ISC/?R\\8_M[9[?T>[/5)$&.2E7]0B.B(Z(
MCHBKC/;X=_+M[^W^3HI!@[QO$3\^L*F?#W[)\L=_+&<X[^?UY_'T564NN"(/
M.VEM+Q[TT5,)SWSGP_BSCMGOYY\_+RQGW??T]^_?DJ2"(G=5PC'?R]_W=_+\
MO;&/[.JF@$WY3]%;?H//]BMEM"D9[]O?V[X^['O\N^,^>?/X=7^O[B?O\E;@
MQ,&.>RM>7WSX<=^WBROOG';W]L8Q]?EC'U?]W4*^W3[ZF^AOKK)Y\I6!27,>
M24]\_?Y8[>?Q_P!OR]8]M_I/[A2(WGT_NJ8PY[E([?7G&?+']/5UK6D DZ\Y
MG6-K?/YH8FTQUU5W;Z\XQ_;_ ),9ZKRM;^DSZ']T@<_B#^TK+Z)6$9<2I.<8
M[8\L^?G\.W?W]_AT4@\A?_Y2=.15J4Y\>._?OWSCW9SGRQ[_ /;/4$$B!K:/
MBJ'D^+F =[3H-23>+39216WD2JX?&JQ^&VN-/0E6<Y[^C7E+N<8^&4HPGO[^
MV/CVQVQEX;*XAKS>(G:?>GS$+4XJU=K@(,B2182?+41RL#?20T8SWJ4S.6\^
M'"<*2K&?PL92M?O[9_Y6,>6,X\\>?;O[NKM,]WX9L9MO$[G>=@2MAF-5I( @
M"X&LGD=(]>6Z=##KS:<.M_AM_!2%8SG'?/?SQCSQG.>_?';MC^CK-# X!P@E
MW*-1:3 W6MK4&ODZ$VW,GT]\H6U*(X5 ?SG.<*RC",8SW\U+SVQA.,^[.,^>
M>^<=0YI#2\\_C:?EH3<20%ATL*6U@;0!:)^H C2=O4V352WAM/I'/Y:DXRE.
M,]E8SCW95C.,>7OSCM]?QZQ6G.XD:203Y](.VAG7;1;APAK0=1/GUWVW6/*L
MJSA2O?XN^?/.?+RQCSS[_+'W?=U<C*#RRZ^4D_7[J@7('-2+K-&'3DEM7X27
M(;V%)\\8QGMY8S]_?&/CG/\ 1U@XI_@$G_&TS]M>I!.HXV6&B6C4$2#RF-YB
M!]+7ND"ZQULV4@CPJ2E2V\M]_BE3:?+'GY>?Q^'E]_:YAG33ML2= =)UO8>E
M]EE\+=2.# :?% !W$W!@@$B(TYZ6-F\PCS[^_P &5=_K\\>_O]7?Z_K^OK)$
MQET\,W\S]Y](68^^EI ^@!]-QZ+77X<+SG.?/X?T^?\ W]4NN&^4?"WOS1#B
ML>@5_P#)9_M[8_[NH?L.;8\K%5L$.(Z?9)*O)6?Q]_+[_/K%N-+FY$:S,P%>
M<9)(W^T+%A"LYQCNI6>RO?V^.,?5_M[^W5.9\Z'>;7.QUG6;Q,:JX8+3$>FU
MY]--XD]5/=!-MQ0"8B4I;_#>0ZA/?'I<K7W[YSCOXO+*D^7E[_Z(J423GBTC
MSTZ7MN0)N!&BX[C&'JLQ-.JQ]O.(&M]H$'?D-932NU8P#F1R,1WTD2<G+J^^
M,+]7>7GQ>CSV]^,Y]WX^V>V<=30<7/>#H  #?4 ;]!RO;HMQPGB+ZW\)YDM:
M<X,$&3(-R3)!!-C$>29#[27,)?2E/INV?2-X[83E.?+';[_+SQ\.WO[]7*DM
M,,TGKS'7IZ 7((6U(ESCJ9Z:1TY#F9Z%)*6E^+.,^/Q>+'X&/=CQ9QC&<9[]
ML8QG./CY8ZLG,;&PZVT'V_?DK^62!U!=Y$7)VN#]U)5)KB7%NG"BDQQXW*UM
M*<SA2'9+?GA6<9[^)MC'96,]\)RO.$]\YRGM;+?$.=MS\!YS!^6LK3<4Q8+3
MA\-)[QI8X$;$7T),#D!UV2B3?A(6FPFVE/LJ4O%?"N.Y2J9WSW02DXQW6VPI
M64N)[^'TR<>!'?"4]2K&#P[R&8=H_AN -4@& 9N?,R;: 1IM&929*(R79LM2
M5.+[=TI[X0TC';"$-X]Z6T)\*<8[]_//?IDG^73IY#3?9;RBT89Q:V.6O+:V
MYZQ\;#3CH4XZE&$^]2<Y\N^,83GSSGOWS]>/K[]^V.JV,$D$1'*-#Y>FXDVY
M+)K',P$@ ENACF>>GW@%/R"ER-5K++\:4XF/CQK'N[KRAQ;[^,=^WEZ/*,9S
MY_RNJ:A[PEG(1'J?6_+K;4+4N!-=I!WOUL>7*/..H7U=?P6=*DB.;F,JPK&9
MW'3*>RL]L8S&W=Y8[X[]OCVSC&>^<]:CM%9O#QE!FGB'7(&M1@W\O[E9[=!\
M]#UV\Y]5T)_"@,_^P^T)Y8SWY+0,9[_5]%VR_P#S8\NM5P>V*M;P'3S"R22
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M8F !)TU&_G'7T.R\C-(?).\B-]ZEU'O2O7CCO1=;;O/V2JT0IMK;D>A27[8
MM12I0Z7F"3#O2BUKM!,.1S5PU8S89I&%"D2I.8"TMM/;#$<0;1J.I%F9],-+
MS3AS79FM=8B8 ! .D'353#8_2) )F(\C.P&]MNMNE^)OR1[=VK_/H7R)O6NM
M9[7XLA5U4#7;1MH)5*W6[O-'N3XVQ=ED409;L75+D"3 ?K%D8E,#C!1F?'FM
M/-0WX*[>(XD&NPYIL);4+7&VK=,HB?A/3S@93<@'Z^9MI:#H1Z+;T7\G#2=T
M$ODUZK;:[0=35_D/*WD_=-MA>1!<]8MY#=86"NP7(%7IMGH4.JT*T-)G*BU$
M562UO3=H,^:4E>S'!,=F6JX]U,XQS9.7NQ2&2!3)O,@RX&(,BY@S8HYC' B(
M,\O[V,6MYF=F5M?@K5]7@_E,L *EJ;;X;CB<HTBF;,IW)*SRIFEPEPV04"CJ
MP_3@E,+ MF7QH:S'K-[K]LLM:DT@M'DR&GR4M*VL76<0=4=@@7NI,J-=WHR"
M'0""<SI@$@D$  "))5!HMV.UK1M$6/QM&NN\+F?DDN6H?4\O9TS&J?G(,UJU
MN0QH%G98E[DB'U4['S,S>BNI\-H)1 C4+Q27D8EN$V4-/,.#TSF7XK=UO%<*
M[$=R9#9#14D1.^H'EM)4!CA$"-(N+?VZ=1K=:U1^2GY"6?5U/V82V3Q>US,V
M)K]W:6OM7;5Y 5.A[:N>O51'B$*V@ZD:PW%R&(PF7)42<2,P(S;*5.3G(;2<
M.=4.XEAA5-/)4@&"YK9@S F-B+V!Y[E1E=L/B?W^'SY0O,]]A;#KS3JF_2,N
M.-+]$XV\WE3:\HSEIYIQUIYO.4]T.M.+;<3G"VU90K&>MCE#@"+2 1RCX3I\
MU!!&HC_ ^\^JP]L_5W_%Y_Y._536Y9O,J()T!*IU4BV&EXRXC*NV,I[]U9^.
M>_?'?W>['E^+J0<I!B8,Q$_)0[])\C_GT3VIBVL&VHKBNR2C3T)6<^2,9>;S
MA&?//;.<+QC&,9\^^<>[JZ!D'? [B6CK(\^4P-+VT6NQ@AA<0 X WMYW_>VA
MG=(!R(H>7F1G<>%R.XIM6.WA_";SX//O_P KOGQ=_OSV^'5;[D.T,$B(ZZ<S
M TBWR&7@ZC'42V!< C<SN--YU.XO?0A//-9QA+N<I4K"LX5GLG&.^?CC.,8[
M>7?W?'J_AZS@XRX[0"-/A!@>4D;$*FK3#0' B#)@><6N8]\DX)C+4J!&D(?Q
ME.%K;?3A.,^!>/#X/%C.?/*L]\8S[LYQYY^K*>]SVW(B+:"+:FTP?D.JPFU(
M>9 Y@V-MYWU^EHLD9Q*E+SG&,JQCR3GMW[XQVQ\?/MW^&>_OZQVV\+;6).OE
MM.Q'4GR$7G5 YXM?K\;CGS'764(9><7C';"<Y[)\L=L9SYXQV\\8\_+&<>74
MEI(<))&A%[FTV]3?HJJA:P!P$1)WVO)G3]H-KKI*BU^,-B0E9PGT\I.%R7LH
MPI?9S'GC&<Y[XPGZN_W?'K3XI^9Q;,DS Y7%N<]8\MIXGB&,SXA[#);<0=Y,
M#;:]OIMI[.KD*1&R59[(>C.H;[ISC&7F\^7X6.WEG'9/G]7O\^V.LK!%U6 #
M (#2-B3&O(_&?)97"<26U'4P(9!<&SN2+_68Y]5"K4+&%92C"DY4GMGQ]NV>
M_GV3G'EGOG\?XO?UO3A18YKR)$B08,<I_?T72?F&?S$@_P"8^0U6DZ-5WSGL
MK.<*SCS3GS_%GMGR^_R_%]5#L&XQE<(CX3\O\B]KT]^TZ>NICERUO;;>%8L<
MI+.?'VPGOC/;*?/';/GGMC/N_)\,YZMOPKN=QI.XO<;G7YVM"N"O>1J;:_<=
M/IS"37!^<Y5VQ[_^5Y_=VSC'PZQGX8@S)'D8\H!G7RZJ\VO:"&]";&]IL?J.
MO**I'Y3VSCOC./+OGSQY_7CR_P G;X=^W?HRAF-_6_VGZ[&RK:_-I!\C?;I'
MS'WDVB,-+2\PM&%.,>-:<=L84GQ8SWSC&/OQ\.^<=_Q]36EK8N),<Y%Y!/\
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M7ZZ=;S-]9$]("\^=5\LM1T+Y/GDAKF1=8<W;IOG/K3>%&H4N"?\ 26JI54@
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ML +0?W5%+QG';"<9[_'.?=[_ #QC'Q^KO_Z;C33 DU& \BZ"/3W8JDR[:!U
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M_P!L]Y3%Q4$BXL=?@52Z2T@1)YSM/+SNKLY\&<?\KX]LY3COY_'.,^7XO/\
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MPHO&.ZDL]O%WQVPG.>_;/U9_VS[NL>I7  )L)V+=;WL1"N-HO!TM&XWMO?\
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M,B%2T5KC4.0/<'Y@IF+FQSED&3(\6.LI :7-=C)A9>ELL)?4ZKP89G?]P_\
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MH>\&KB?(GZ$J<@Y#Z]+'[;7T5<?PAS@.G'X'!*RIQGXHK>F<>?W=G/?C/O\
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MWP4=VQLM ;!URZ&WD%BQ_"&N R?)/!&RXQ[^V*YIK'__ $Z$/.KB?-Q0
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M->[R=A&2AU#39DD5BN"5L$"!=##""LR6AYXBVPRW.5)2VG.)SB3;7]M"1O\
M$>9M P2>ON?<7Z)W6#7/RB=IUE)U.?X[<F"U:*705?[$0*:0VV5M5ILM= S:
MO5G[!9"H*<1F0:K7B9(57QK+D:'!C37DJ9?<RVZU.<#:T=!Y^7Q,VT2>@W^?
M[B?IR4)_Q-.7_P#@I\DO\1FS_P#5?J<XY'Y?=0NQ=5<5.44/A)S!KDOC;OR)
M8#VV^(D\*"DZ>V'',&(()KD6DY+%#':ZB<0C!\E!?M.3$8>:'*)#_6ULJEQ\
M.4 ^*;Q)^<]=?=T3ZTU8.7&KZGIJ#9/DU]J;0V%QH(G2G';9=AU=R"$2J)),
M6.7=H;%EJX(7&!W\=6;S-D6JN0R/LQ<:6^] (R2@M3,5@3+IZCY1*6]/._Q_
MLIC%<IOE)QW'IG0<G@YN8LG&M+?195\FZ;W FS3#UF++C0-@N>AJ*64V.MZR
MGG=5C4I7F.Y7RGK#G@6PJ*^<<QM.D;>_JGOW[^&@<-8Y;_*$UW8=NNS_ ,GO
MN(\.O6T^2FP[)6CNI]LEV5">1HW5<*94!4HOKXC#@QZ9(U,#E!R$T,58GLS9
MT&8&;;2P\FE%%UKW5\H/=+OK:[G>$O(W$[7V[]K[B5D)KW<]9FG&=H5FE4Y=
M7?F@*1 9BMA:[2HT!9'$"3%/()$6"P-P;)DCI,7VCWU_M];/?O1*1;=G-B18
M,$ZS\FYM&A FKWN&\LU"GZ@VZ&!.S=N\91G&J:LC$A46-"E%H ^!)O$PO%@#
MVS-D*D&4C!4-]>52BELAR&Y1_1'$EP?D^-_S=[R+ENU0^20U;OAJLZX [ XR
M:4XYQ3\**. PA-[*& =0MLF4%L8Q,0$02+?BO/PWR ^7$[;^MQST^5XYI[]^
M_HN&> '%#E)5^<G#^QV7C9OZOUX#R4TL7.'CFF]B" P<4/V$ ED"A4G/KK$$
M</A16G9,R;,D-1HS#;CS[J&T*5BX'0V"+W'2_P /HBY1(\-^7BR1)2.*O)%:
M53Y2TJ3H[9RDJ2MY:DY2I-8RE6,XSY9QG.,^_'ET:X 09UV]A%J?Q-.7_P#@
MI\DO\1FS_P#5?JK..1^7W1'\33E__@I\DO\ $9L__5?IG'(_+[HC^)IR_P#\
M%/DE_B,V?_JOTSCD?E]T1_$TY?\ ^"GR2_Q&;/\ ]5^F<<C\ONB/XFG+_P#P
M4^27^(S9_P#JOTSCD?E]T1_$TY?_ ."GR2_Q&;/_ -5^F<<C\ONB/XFG+_\
MP4^27^(S9_\ JOTSCD?E]T1_$TY?_P""GR2_Q&;/_P!5^F<<C\ONB/XFG+__
M  4^27^(S9_^J_3..1^7W1'\33E__@I\DO\ $9L__5?IG'(_+[HC^)IR_P#\
M%/DE_B,V?_JOTSCD?E]T1_$TY?\ ^"GR2_Q&;/\ ]5^F<<C\ONB/XFG+_P#P
M4^27^(S9_P#JOTSCD?E]T1_$TY?_ ."GR2_Q&;/_ -5^F<<C\ONB/XFG+_\
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M]^MY@)^]_@I+&<MQ!H]8JL'W#KDM9Z@.;,6VN##U*GGJL(>::D-%+&'BRG2
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M)CL5IX]+B#(#$9Y3K&GSOMRV^B*8%<$Z5.A[(&F8UXR)OME*6*((II6]:Y$
MFS6IZ1JPB.(@JA81U=O$=R+3DFV&+>&)#X4XG(:9%^)IV3,?$?#W!@_/I!-
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MW:A$R+'U9F"#&$BHPU/"MN6L01:H;F]R"+V?-?:J>G8"6!!&2'F6.02K,;;
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MKT0B7&,RW+0+KI0O55!6I4E"GB46PQA\F*F*A<A+N,*:[.Y[]3[Y^_81:/\
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M=:O:$(E.!/H'M$QOJ#\>$@6ELBT1VM.%VR=@D40"<2=L2P1+3+9JXW<-VBS
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M -^)KUJ(@W#,D5\3A-37AEDJQ#8U3BVFSZWV[K4JJET4757),3:56UW7T&Y
M.5;;$5FFP(O7S$U:YAAZ+.=+2T0(E?"0QPJ,1*)KAA[1EVB:.W2^.9M5V,D9
M0OV).2$)P#%^VY?9].M# *_UV=9LP[%M8K)A15$QH-4RK5WYRU*QP(I864(H
M]-?)_P":UKAX!2]A'Y-K;J% H]:MN(H.NSJ"_3JUH6FP=E-2'GY3"IP85HR*
M5D#(L-S)'YQ$@[3'JO?+A-_V]^_WF_>G%$5M/&O8D78KM!H&OX=&AC*@D?,(
M!(,JB6\)9ZJ2K;&;6%K<(K+>"CZH2FV.M7.6Y5U/#::]4#,R2:D$4:S?D\P+
MB1#C%Z@3Y((8+#C&K=0$60.J#]&E=UC:%3Q,:W@D2Y),73JH4 N9D-1P!B(8
M8+Q+@!,.AHA%/N>/ -&I+)I^O6I@;DM>8^PH)#(6#);"SQ=_#W46.?KXZ>*1
M+$0R-=C!Y#$2<'<<@-/LQ9 ]QMK#)/?V4(6;@G3I>*++>V#$;.T2$+&T_%MK
M3!6L3"D$_M@I*<L%=AVBMDCT:<&W!9!&!HJR@ID&7#&FHQ3"H\B \13P.X[X
MK)+3Q6J6V'6FM8:]GZP.#V*<+2-M%+*$J>=)1PT.'/'1*+/=*4N(VU+A1RT:
M($*%H#8_!1 4\'(HAC<,)R?F2:@[BPY8M;#:;5M:F/F%#?$P=:TVD;6H0@18
MA3%F9^=%LD5W<MGE/W*$2KX9PR/K4Z/2V1T4V(L)%1?!V!%U6 UJ!V+(%2P5
MC FHMW76Y35N#+$ZPIFL$$*:;K-OJANJVI,*F02<(RT6(AEO2Y FS52UU];P
MMTB<.NN&=)HDK:$!9R 5%WL)LX-'=8J\,=L06'W3925HNB3MW<)EL'%K*/X9
MKS@FM5".F(.:5:(]Q+QHI>"1+U,XS*JVP0>V[=L;YQVX,XJ')?BUF+4@$T.U
M08VNJ_!2,6<,+A$H\-MPF4)^TG\&34]Y$2 $#LBPPXB04\8(8:H4FI6?;+/S
M:ULW>JYKW"ZX,"/0ZE;]9676T,6<GR#4GYQ643"LLPG-L$9(:"65 @,LU@-E
M$^5-(L+'$2/ J$ !3=GJ'$XD>]!9IV;4QM@8FU3:%3JU;M ](9)H8W%L"(-8
M!DZN??FS((V2A+96O6(0^\/?(H]G_)VZ[?HM4H$S8ECC5>M4FTT%I280UHA)
M#6BQ7^PK=Q/EO266B,%JZR(J'GH<MJ1D4W+E1%ID/QDD72ECU'<;C6->R".R
MQ*MG:[MLR[5R[PM?H:IZYA>M6BE38DC7ZK:]*D"54NYEX47'SZ]I-&<0CBBK
MT9ET0^1<\AN <(#'UZQ!VJ0;?I6:,T1L<*M/ +P1'TS7&GM=RA@&S5>U@4@!
MUT@:B:<MP$P-N%2)P+%*'XK+,\.%/PB)+A_)]# % B44/LT?7PP]NM5YY\=0
MY(==DUU5P%HKP()L)P7L(:[<K(.D6G-BA$)DF'K7%G%"B<C44M*B<8@18D_)
MYA7A2 CFT49@@A&M(X\3!J4R !,VK6LRE%PUEVQ5(E[Q7+I+4NH)@QI@,3K^
MZ(KMD,CIUW,3VJ\6"D4JTCB(O7]ZIMWJMV!5MVMC)39H;4J%-J42YDB63;A2
M%8HP._QPYJDYG'I9P*%M0:U7,'8((TBQLJ2TL_!L)$X=Q\9)&T7;W%#[$?I5
M?VQ&#L;"AIK"#)N*4""LUX?==8V%L\%S2+VV!1!&^TSPZ_5MIP,#GQ:E&G1B
M3Y4BAY7R?^NGX]U%3;9!^;-CM10M'EQ:I#8OT'-LVN+VG;P1F_234W!1L@=@
MM" >1=>JTB! >CKLN+J9A#2$<BPB^"86&!!AP>QJF#L 2<)99NU,UXY5+K%K
M@02*'CI06P@MBQ[ ,O66(B9LPU)*E=:$LDG&)FGG@OJ0Q@BE36O$QK6>RPU[
M%[ E)A#(]@43%"P<P 4N,HY@BVU$O1 9:L5FU5\+Z^S/"M%:-(N(DN-A*'7R
M)7/3U>01-8IP<I<TY0R2["'G* 5<34+#"L]*AV%P]7:U?2NP!4FL)R<&QJG8
M&2]E,1"!F:-M\&1$G1Y$<,.-08)5LBUCW!]-@I^L:L6V $-.:@KYG7-&58]9
M1BP1C4YH!6:XH(< L6T9[9O3$>H I_ST42B@9))$U#^NE@B#@!"_L?WY_;JB
MQ6/Y/G65JE?WWL]C;$/@MVU\F$$PQHR+/9VX1V$^&E9SEF0PQ*UF)VSL@56\
M)B+@S$VAV3.B>"*S#61)0+@7@ 5(G1.QJV!+7(YIV?M%59U%#%P+8+T1?A>P
M*!$#,3;H9FU\T_.BEA=K/E2MO22%&\LUP54O9 /(\BFBP\;'+"0V?%=OCT6C
M;1OE&V:2JZ*U'66AW&H%-6R93C-K46P\^#*#M5#(406D3'F")9TS/>+EH[84
M2%(N?XOR>HP3K^#K@1LX>#&-Q@-3<R,H4L2Y:Z!5ZS9 8(5>$BMA#GKG;A#E
M@DV:"2FR&=9LV,=!++T\ZG!%N<1.BP\%D%].1=-1-MEQX&2^1:M3KE?EJA6*
M&4UW7->*??"B+?7X;YT$S7&CM4>L[ELJ0TV_ATU2;&F# 3'(K /!>+6A.I95
M6VP]BU:>C6613;"4I\0P#EE;5L4S?7R1NNP[&)>)#F8MA+A&AT(\-4YXXA1!
M%#D94-\BE*D\505+W8>W$DT),.FSI2Z.))TN%FX1+D<IXNEFI<>Z-%40(E;F
M#!\J6T%&TT<9CSRDR)FVR*UB-6F2)'"\285?#2\5O8+J#WM'7A^NG)];C$QD
M$OKO9.P-F!U%A$4R/=/ R4G84T.2&Q#028H='1+$FQA)]N7$(FA&X'UI@+9!
MCVP2TF9:[#8;:<*+KH]M;EEM^J]Q:ZL<F#$;F);A#G9^Y#]E%C<OR,C&X,,)
MF9+9<=(=$4H&^,48UL^@;$5<93#-& :X$Y"9!MO.%)&L8VU(8B;[544:3":G
M,;8-9)1<#):EO#A3D6:RE,J/((HVTSP?IVE+K438NS!SZ*P)J$QUD[2X;]S>
MLU.U4$TW&/B+1FP+C@*]-K(2'*EAXU8F&FC2Y2(5RCA)\P!((GD/XFZ^&ZYM
M(F@8I(:]7&\E;[+VTUK\(0+EB$C=RMTQ!MF6$(@"]J"P2[$0(_&<MD*2_#@(
M=9EP9B&L,D39.<$ZWLTU9;)NR]6&[3[C&MRCPZESKCJ"N>U;94*IKA<D= JE
M[DF\BA6OZ?% P0-FLMJCNRK%<R,^1*9-01H4B[-HX E5J?5ZX8/R;45 UT(&
M)6:8QB)+L,\4,BP)AR5%2_)3&DEGXZY\AA,E]+3TA:$O.8QXU$3JZ(ODO_A@
M+JF^ ?'YU&/$IOEQ75H[X]V4:GVBYC.4YQGQ82I.%^'MG*LX[=NA^G/WR1?%
M?\GY6W[5R5$V\$T9E3HK)Z<^GV>PR/#RSD*;$D2,D$RE>MJ8;ER'($5N!%7E
M>,./+9]5]!,CW[]WV*+Z??G83PPV.D$WVA[[66O12,K2I*TYQA36?$I.? K'
M=/ASGLI&5X3Y9[=3'OW[^"*=$W&EWNF%:T*/P:B_2JU@W<3Q<W[ !4RO1G8(
MEHN2+QV)4M,<F6)C PL>-A$9YHO.@BH Z=+=3'ZB-_?)%YD<@]MIJLG4_''C
M_M6B7SD#R<O,;7U!M,,G:H@6DNWDN)HT.P6J0:J86P"\0'GFEPUM@Y"%=\S(
MN)J694=:==_KO[^*+R(X.:6C9Y^Z HX;<-!V_9I12:;$%:-,OL(0#M-(=)V:
M*&/R[]0ZB44ZM%=E2UH$#9S3RY[&4S4S%/):D>_[HON>F6MZ0?L947)$"*Z5
MH#ER(SS*I[8N'( H+%#Y%218LK,?D.A\#\.)B0)#LB5AM*F_'XE]1[Z3K/Q\
MT4=C=D''PEV>K9_63=9'PZG=;9;[!62%@KX\=5+&->#N0HQ:I2;(I$H\7A#2
M0]JJN)GM+=]:2B$RJ0W/OW[_ &11I6SC$I%]D+D50S"JH(86)F*M'9#AY0\O
M8A5?ASP$2.%$+<DND3<!4I^; 'RL8;D/2E+?:PGI[]^_V4;CX_M^_O;4(FKQ
M4\E@[MATD/@7[7T26BC1Z&.B;"53+Y9&K-#*AR8NFPZ^Q+\3;4J+B/9GB0@4
MM;*!\*1%0RU&WO\ ;7TU4I;?L%XH&*.2$))/QY@YZ*]"9;=D>J,J4Q,CQYO@
M](E*TMO.>%2DX:<6E:>^%94K,^_O:?\ "C[>[F/V2:]ME$.R.%"%?#0RN$Y]
M.^^*C-$WH[O93J/&WVSGT^%JRI2NZW,YSESOWSCJ#/O;Z6^:E=-\1;F',<GM
M5)CQ7ATB48(,PDQ5+Q#E1W !9QMM:%NXPVKPXSX_1X5C*T>%:<Y[9Z>701R]
M-O[(OHT3W[8[^_\ %V_L^'4HJ]$1T1'1$=$1T1'1% W),;L QJ*R"M8#R1&X
M$)%<C16@MAFU<TP+7: RK#/#E1]^U7*R2'@4$I<. WLFDX*.M^SG#\5J6M#Q
M%YWT[1'.*+7F2A*X[(&7\#BFA:;(/;M)F*TP+SM7?>;*3MU83?[2$M\EG6-C
MU5F5,N'SRL3BA ]H66G6$+(F=$4A4?4>^:UK;D:X*H>RA5SV&0T\T%9M^\%7
M&^%5 JK4*UL:QAKD,W(**0,,O1+"0JP"1MNA+)LLQ8K9&D1BF((DB;!/0>_C
M^D>- 79M;V/=[5K;?.X+/;&8)G0]^OK-!-#MXA]:R7I'(RTWNAG5PP5LHPF>
MR3L5HLPIAM2&"<MX>\3Z(G#<-<\LY+I*N:_#[0KM9(1R)BMD_I&UM4TU02KA
MQ;-6!J')!4.X0@X>Q1=[-UZ[^IT8 WK084FP;:'*0YHZ2T-(FAR$U[R0H-6W
M$9HY#>+<*O52VE@]Q:WV?*C9FO&-!9#Q:$% E[N<LL+<&=V8^=D/8C]3];B"
MV'GF]AXC.MTQTBW/H=YBR;P%)"S6YJYJM5B=FTVGRMK#[=>==HR;JC\QW:]@
M)[O;AW8*5:BV6>-&2"V]V 0B6V#CUN.\^S@>1)-/T=S(LFR2KM\F[<K&N+%:
M:"7-C!'("SCL#,BZ]R/1=(M7*C=^7:V1JN0.6G3*8S@-[7C9KV'&FKUG46 >
M(J"*<R&K=FR0/'TQM[4CG(N=7^/&:#L;7Q$MK8G,';=+#*4^5O<M>PK&&J)E
MN8Z$L%;,V,49(V"%[5;>"CBPTL:5&(D+0.BKG0=\W2W6;5-W$M'[B.*!"H:7
MQHNFN PA&C->TE;<B^6:/!Y62GAQ>OF@C3K*(*2F6XA"8*P)*D\./?OV$46/
M<7^0 NPF4@ZB*DUD=R9V3R<K$23<!(]4J\77<=L<C^@5'F*>"0VM>ML6>=,2
MG,WVKL"<S$BN%X9AMDB0ZYQVY<VBM;4KNQ9FU$UXY7MGRZ=7"F\#:5R3IK3%
M7J]>KIK"=][8GRJVN_P;(09"'+Z9K#\<@V4*BQF"98''(IDG\<MR6W0]&UO>
M'#5CN]-Y"4Z[3K,3V!(;"60)77(A<-9XH$=9/4@=9KSN18K.KV&L"D&ZQ.+0
MA)1!1@X3>_>B+?U'J#D&Y=Z)+O,O<-=UX#>KY&PU^Q[\,60T7OH*D%(]ALDD
MJ"V :F$]:6JW/UR4#H4@DT)QD,5E&:%7AQB6)E$477WCGR&<O6SKK7V]LQR5
MG8.PPQ6B[48C-N!XV_\ ;5O!@)]><WQIMUL=,J5RJA)&*Y<Z.7C01Q,0]:H3
MN9%7L!%+6]- [8VC_%BM60CSM\U;4SCEC]E[&(H% [H;8UQ!EN,K(&Q;-I<Q
M AW*+&,E1Q&6A"\R''&I4B&MXBCPSQ\Y,YQ0(,$OMVR+L%&)B-K,V7>5FF4N
M"2L+=O@V";%E0-W BPTRV,*"&PD*+K[9]3<R-&,BOHV+(,VXH16VZE[SAO\
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M]I!1%4>8/F1CIRA:RM95JSE(MZ(&:ZY&(WB?#@A;3K"JQI8IJO$P-RM;Y0E
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MVK()VQ&&0@*('UYB4<'28MO-!DVB1Z*U!Y0802/$5+5R]VGIB]\B5W6WTJP
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MNO/0'5"N9/&Q;F75<&M,Y<SG*E.9#5[*\JS[\Y5[ [^[&,?=VZG_ .C6,_\
MYQ1]:+3]7'Y)_P#=[PO?LEC/,8VD.O\ 3>_5*L/G-H0?G"H/"W5$-6.V<9CP
M0C6<9Q[E8R@$G.%8SVSWQ_E\^@_!K&3/^\T=XB@W6?\ WQ\O+DH_^[SA?_\
M2>+/_P#MLTV!\6GP\PG+_P"J+ZR]'A/\5&@J0CPX2G+@[.,>''9'9.1.>V$]
MNV/P>V/+&?+/?H?P=Q0+&/XS0:ZH"6%U#]0!RN(<"6C*=<Q!M(E2/]7?"BX
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M+\+\?G[^B(R+DJ\7B,3E>/&<*[Q0N?%C.,8SA7<5YXSC&,9QGOWQC'U8Z(C
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M#_PCQN-\ 0/#&E9EM.1^<ZKU?\$@?_JIV' 'B/&:9OR%&N9$V]1UZKZTV?\
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MBM%7FB?&CN3VZ;[L0-2KR)UI CV0026.EU2'9U2!YCZ'M,[D@N3$ECKK<X;
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MIAZ1Q6$&)H/8V6U:P:ZI2HU+^%[LH: 3+G"P*DNE53Z1J;4)!",Q#QM(-6"
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M/?'>WQRJ7<)XD#$/X:X$ 6(SM'46,Z1=<G^'E.G1[<=F&-(J.I\8PWBBYO4
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MJ?!$EK@J'L%+VN->,U)VN.53%ZH#EG#^$#7;[4I'SI@#[M6WCLB8!OT]UB7
M(5]4$V/C$L)E1'7Q>%_8_NB9^?DUA:)C;D/:KR1C>O&:"D;+IZ)#&$?1=%ID
MLPC#%FAQV7)EMKM(O28;<=,6,FK-!8W@?DY/Q")?N/#FQU08)MU'+XN-OIUH
MV+;!%9A5&O-^WR^QN1FK]W1G2,:R;(I00M'IC.O\BG(!"VUUXZEYLB.-UX@.
MAQ'R+9B<.+=<^-],UG:+.#H]F;'<F6[/&8J$,P*98Y)C=HCY@V$'%V]D8+>J
MN-A0I&8<,]91"EB9(6,2F1WXU@;(MJV<"TG]GV/8D;8J685N*SL':?)A;('
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M8Y&C5E_%W#6X0.RQFQU\&(+/O^F(O2/'NQ^+'W=$5>B(Z(CHB\"?X1/*?B<
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MV^V>?+AS EL"$JX#37"8P_DD]8G7AID&*#0=7RH$:I5I*[-<($=HR45.(D4
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M?!:@JU//?]"S :5A.%/(V@QA?I'G9#^?"AOLMY7OZTM3CU:I5=4+ &D0&!Q
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M4RUD_P G;IQQY?$9)K?)6^$F:1&U>5.:XO\ I"U,S)%'J3-A:I%0@,0S(2+
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M0Z"6.6D5(, H[3LF=#B2\0WE-#&'2V%8?PXWG"L.0$90E*D]UY1A><)5G/4
M9X#;YG-:-OU.#3\))5+CE:7'83RM_A<+4+EMQVO 2'8?F$:KPF>-IDZ/(.61
MYAQ4F]R8\*OC'6FY[F6Y<R=+BP6,^-3;\AY#37X7?'6QJ\,K8?$BD^HRF2&.
M[R2&^)H=RO -Q$S,3$*Q^:IBF:E]Q&A-R"/D9UMJN.-6_*[<6-M;AFZ<KNF+
M%DX/GG8,B4B_^L(PH!/0.EO>@0EO&$)><1E:,2%*8SG+;O9Q*TXS,7P-]/#M
MKNQV&Q+3!+:9)=3)B ^PB03SL#&Y5@<08YX:&&?,'2_/2.D;Z(WI\L!P^T#O
M"TZ*NNJ;7%L%9K0^T9,/6V3&#3A\X=')KPEQI$QZ(J*P^KTCLA&(N<L.X].A
M2<-]:JE3H/K,HU<71P^:PJ5)+09L#<:W.JR?S%1SFL92J5"_1K=><G:-="=M
M@2'1J[Y5[AAMF)%G5VL(:B3O$U"D3-E1X[$R:E4!M$6*J1)COOY==GLH2ZF/
MA&<=EI\7C1C/5?\ A%IPQQ#.,\.J0PO#&YB]T G*UDG,X[-!),AL25A5,>^G
MB/RS\%7:!^I]@T WFVH ))GEO*Y,Y$_+[<7N,^QRNO=A\1=S0LQDNN@STBX1
M(<*R14K4AF?"A*=?FM0)?@RN,\M+BO I.76F<YSV\VQ/$JC,37PE'!5,4_#N
MROREE $&?$WO(G2(UUMLL[OZ#69@3%["+:1KKJ-QTZ<F2/X5'Q#CJRE7"#<J
M\^_NC;5>PGP9[Y3GOE&,XSGM_)\.,XZV5.J'-!+2VVAV( MK/R6,,<QVC' 3
M D7-XYC:ZTD?PK3AXK/H\<'-SY7G.<=L[8 >+O[L8QG"<XSGX8[8SVS\,Y\N
MKOA(S2=^8%OKUMT5PXDCQ970!,@6TG6;$<I^"ZMXK?PA;A;R6LEMK930EHTN
M[7:H1LHV7?\ ; I:+3)&9\4D"&9B99<411&\4MS+BO W';<<SC.$9SUM.#\-
M?QFO5PU"O3I5*=%]?)4/_4;3!<X-B?TMDD[1<&+86.XU1P5)M6JRH0YP:#$@
M%VDP3K%A:=)D* H/\*"XC3G&FOXENW&U.2,-KPWM4+)RU&RM3>).4M-^?=:>
MWH?^%SC.%9PG"L=^=K8UC:KJ/=N+&BJ'.( %1S&EP8)@DF)#[#PVFY%]_$Z3
M*+*IIU"'!I@ 9CF@B;Z7%] )7H>;^5[XT@.*VM^4Q#CU?&P.R;:5J0ZJKO++
M)6!)%+GH=F29KZFV'8[N!ZU)2TQA:?&G&/'V[YV6%HNQ/!,+Q60VC7>]PHV-
M1AIN>PO<X?J:,DR"1$'FM3B>U.%PTY\+B#>+ $6@ZR3<&VHD]%#FI/EW^*&X
MMETW6E:XT;(9GW*RC*Y$)2K^/5$B.$$R^\M]AM_,E;3"XBD^C2C&7494XE>,
M)PE5W#X9^)K4J+" ZKI.D'0SOT&_60IP7::AC7!C,)B&DZDY2!;G,<Q!C3SC
MK/CG\I5QXY%\DFN-HG2-KK!Q4:6IVTDKKZ\#;*14O+P%2W&=9D.3'\19B6<8
M4C"G(^6^V5*QGK,?PC$L;C'ES,N# +CLXFWAD#3<G6\+I:Q[FG1J.%JQ:&@V
M,.N9B>41Z[+V&:U/1%H\60J_?GWDR_N\OKG_ -'EY=:H7 )G0;D?15'['XB5
MD^B6A_8JOTD7_;^D#K\3]U"/HEH?V*K])%_V_I Z_$_=$?1+0_L57Z2+_M_2
M!U^)^Z(^B6A_8JOTD7_;^D#K\3]T1]$M#^Q5?I(O^W]('7XG[HCZ):']BJ_2
M1?\ ;^D#K\3]T1]$M#^Q5?I(O^W]('7XG[HCZ):']BJ_21?]OZ0.OQ/W1'T2
MT/[%5^DB_P"W]('7XG[HCZ):']BJ_21?]OZ0.OQ/W1'T2T/[%5^DB_[?T@=?
MB?NB/HEH?V*K])%_V_I Z_$_=$?1+0_L57Z2+_M_2!U^)^Z(^B6A_8JOTD7_
M &_I Z_$_=%3.HZ%GWA5]LXQWQ[3+8QGMGOC/_'N_?'P[9]_;/P[=3"*GT1T
M+MG^\SG?OWPKVH6[XSWSGOC_ '[VQGSSYX[>><YQVSGOTCW[^B*N=1T+OWP&
M<QGMC'?!,MW\OOS.SGM_3W[^>,XSVS@BMQJ*@X[8P%7C&,=L8]IE>V.^,X_!
MQZ[^#CMG.,>'MV3G*?=GHBO^B2@YQVR$5G_\IEL9S]>,YQ.QWQG';';/?OVQ
MXO%T]_%%;]$5![8Q[%7Y8SV_OD5]^<8QA7_'>_BQC'EGW_R<YSE24JPC]_GJ
MB/HCH.<=LA5YSY>>29;WXSW[_P#'NV,]_CCMGS5COV5G'1%3Z(J#G';(5>??
M_P"_,M_1_P"]W?OCWXSC.//"<Y[Y2G.$>Y**N-1T+'?^\SGG[^Q,KC.<?#&<
M^N]\XQ[\8[]L9]V,=U>(B/HCH7?.?8R^^<YSC^^17R[_ %=IN/NSG&>^,YQC
M.<=\8STCV;HC.HZ%GRP&<QCZO:9;/W_].^O'?S[YQ\,XQGMT1'T14+.<9R&<
MSV[]O[Z%<9[YSXO+.)N,I\^V<^'P]_=_)_!Z(JYU)0LY[J#.*\NWF3+?=[O]
M_>6.^,9[8[8\L>7O[O?OXHC&HZ#CQ?WE7Y]^W]\RWEY93Y9]>[]NWEVQG&,]
ML=\9[8[(]^]?5%7Z):']BJ_21;_NGXZB!U^)^Z(^B6A_8JOTD7_;^D#K\3]T
M1]$M#^Q5?I(O^W]('7XG[HCZ):']BJ_21?\ ;^D#K\3]T1]$M#^Q5?I(O^W]
M('7XG[HCZ):']BJ_21?]OZ0.OQ/W1'T2T/[%5^DB_P"W]('7XG[HCZ):']BJ
M_21?]OZ0.OQ/W1'T2T/[%5^DB_[?T@=?B?NB/HEH?V*K])%_V_I Z_$_=$?1
M+0_L57Z2+_M_2!U^)^Z(^B6A_8JOTD7_ &_I Z_$_=$?1+0_L57Z2+_M_2!U
M^)^Z(^B6A_8JOTD7_;^D#K\3]T1]$M#^Q5?I(O\ M_2!U^)^Z(^B6A_8JOTD
M7_;^D#K\3]T1]$M#^Q5?I(O^W]('7XG[HCZ):']BJ_21?]OZ0.OQ/W1'T2T/
M[%5^DB_[?T@=?B?NB/HEH?V*K])%_P!OZ0.OQ/W1'T2T/[%5^DB_[?T@=?B?
MNB/HEH?V*K])%_V_I Z_$_=$?1+0_L57Z2+_ +?T@=?B?NB/HEH?V*K])%_V
M_I Z_$_=$?1+0_L57Z2+_M_2!U^)^Z(^B6A_8JOTD7_;^D#K\3]T1]$M#^Q5
M?I(O^W]('7XG[HG.#JP2MQGH@:)F)'??S)=;4_)D^)[+;;65X7)>=<QW0VC&
M<85V\N_;J0(1<V<QH'MO4,P E>&,GI$L3AW/?.&_6PQ-.7.V.W\CQ95C'Q7A
M.,]L9[]7<.\,J-JN FG+F@[F8&^ON0J'C,"S^H$7GIRZ?1>%$.F$J[2B6O0*
M"-E?I]RX]"8CB([22,H-2]KTY^1-EXBH0TM,$3!F3IJD(2E#;+JLI[=O%E8?
MB3\=Q!XQ(RAN4#_XM;'(7:.0WDJQC,,RC@F/ICQ.)) DG]1OM%M+QU*^>G@(
MPZ!^4&MT&>[#<??LNXY3#D-WT[32)=KCS,M*7C&,)6I+BG'4^?@5W2K/BQG&
M-UB7FG0?3<PNIN<US?\ V^(SUL0#;4A8;FTVT:=07J'PD"Y!,:C8"->MI4[<
MW^1^LM2?*4;:8N>GJGLTJ8TCKB",F6@=7IS=>:D#RKA&9%;L3;[*D9:S%3)1
M 9]H.)[I0I:4+:QS^*K8:G&)IT@^I29X1 C--B1S$VL1RT*Z_LW@\(YT8QP8
M*@S&= TF^N]C&T^2Y8NV_M.;S@[FCU8*%"6G3E$J16O62L1&&89P44L-0$V&
MIM3842'(G) JEQBC<N2TN4,C#<-CGXL',V$[S?'NT>-PC>'5B\T1B\33HU6Z
MN[N6BHT :N+9:S8N(T"ZD8?@SF\3K4J)K4," X5H!:'XH&DV22;@_JMI.62"
M%.-TV _L335*E[^UN'W=1&K=:AK<^6T.-6L?0X5=<7#E@+%!<:LC#\$[9(;S
M$54M_P!57XW'XSJ64M9W=##XC&5'XAKVU*(HYN[>2UQ(:"2+<HWTY66!AZ'9
MIC",=AGUSB06X84\Q=1K$G*XY3&6^\R/-?/]<>+>W8D%5X#:XM\RH3R)Q<3,
M$,<+9!"H$U*(J3I%(U$%$A<5^.[GT+S_ *+'I,3/5WFW&DX&$KMQ#JE!DYZ=
MG"/YM2&WN 09,:1S"XWB7#<1P^J]I9+*CG.8 +ADG*3H2<L3O/D0H6EB&(3<
MI$Z$6BRH\Y<94%<)UAW#<1/HYN<R'$)PRN._A25XPTO+3F,)=PCOYTAU=M5@
M: 1E><Q-\V: ,H!GJ9^.JUC:3YS&F8)#M#Y&9L1 O)CU"ZX^3]Q"=Y-9R1B^
MUXD/5>XYS<2:RI_#LUC6%A<2]Z+"7,*RW(5Z1"<XPI7=.5>?BSUW786D*G%2
MUPR!^!XC_'%^Y(P[LNQU@:#70+F>V5(NX,,@R..-P0!%BT]^TB3N"1RC3S3_
M *5J'<X[5=>=@AH->K>RL5>R>LUVPT<C.G"YQIP4S**^.PJ=KDI,Q'HW0Y)(
MYYA;$?!6.RK'=/(X'L;B<?QAG$\7AZN,H43493JU):QC:N8$VC1I=!(U=&FE
MCB%3%,=4H#$TW-RY<KC!G*V&9F@N<-"2""<Q(U7MCN33NVK=P+X]\20E>(F=
MHP]K;+)S)UA(@0<L0H4W;3>'3%G(%XM-B.$ <U<Y<I@Y)@3DP4>R7YC>._7I
MV-[,"AP; 8'A].FS#4&%E,%[0\]Z232B/U-<\APTM()WY?$8PT&&G6H2 0[,
M&/>UHL7.&I/,@;2+'2".*/%3=/'797&^9L"LZ\@1T[YBR2EEKVTM77LR86[4
M[-*$19$2IV@R63%B2(DU*76XK8QM/G)?]87XU<2WLAQCAO:(]HJV,Q57"-PX
MI-P0<UN#D  A@ SE_,.:!I!C7JN 8T8DT^%]WAJ+'14_,%CFO#9!\.<220?*
M2! 75/R5NR6;M\J9K23ZH1&$CAXL7(M1VHJQ<Z-F 9G-3H,3*5S8C$DC*F/N
MOR7?$S"2RSAE#^'EN[*GB:^)H<6<]H:TX*H0#_*!4%K?T@D""9Z[>E\9HX>C
M3X<VF_.17HQ!C,"QP!Y"2[;22OOM:_D)_I^KZ\_5_P"GZ^N:]_%8*R=$1T1'
M1$=$1T1'1%SCRMNEQU_I4W8]?NSF;<JT:MKHMP8S7)!3#5SVO2*:32*;M[;M
M724<%'YK8YX\VX,C3%,R93;C3*D*(H(+[_V-JAP37K&/G&YXX?2K);6=J&*-
M!V.:'[&V@O6XD!0H&I D.CF2]><9<-34)PI4CVM70CSK,PJ]-'D4 T3F_MV=
M/J84E&J1,Y>(U3A"2I^3BJTD 1,ZAXYW:82M,D8*G%6ASA?8UJ9AOQ)3;:))
M .,7$DMXCOQB+I$/RR(%.4%>TA'$54O5+"BQ"46P$7*J<&VRMT$1L"8.9=-P
M Z;7&6,(XR[/J8HG71\2:#S+MWM^82J@@B2-%<LK9?[K7:A:ZR.%C+%0FS]8
M*12#UC,6HM J5=MAR,X[6!6:]6R(]@VZP]6;G'I!2= :$V&KYL< T]'$D4%L
M<[]P/VB+&%4RBVS&Q*MHTY0:N LPEMZAXV( Y$W4S$V84LY>GQF[4P'U.(K^
M0L8PPA)?VC-@,+1&DPI!$\#G/F[#VS B)I%"[B$CT @5#8N8"? $C=RF-2 -
M4ELV9DK!II@45)WR\Q)Q:!9V ,F=J@[ &&UY)1W8I%?&YG;5]NE!)&H4.K$6
MJ'FU.0+=<Q#E<&R*=G;3ENALVJD$+;"D$[<W2A$D*)>)27JC":L>3*2,X%-&
MND3)C?**W$C1@U]^8E7:BV09L2U!08.V2"!FNC]9W2PTN;5]FYFUYYD2>L4@
M8Q+9BC$19 V0-M(5$F6\#7/DD3EE\ZMI#"MU %J)JR"3UM9-.0K.N3=[%#BV
M41NZ9J&,(A41<JOH?F6&I(VFC)I)&.B,2EQ046,@3\Y\R!1%.YSE03&<K*?H
M2$#!%*Q9+.0H9:P-S"L O7+=%TZ8W&U#?08B#8!Y^2'&1F7QU18L<,/$,"IY
M^R"2D]JL*(HO-<R]N"["%%P-/ 3\8M,VF:1F)>*U7FVJ/K';6-2O,OF=A6BE
MCE6<Q*3FQ.N0&20^O,30X6;'E.%$%^B*-CGRAFTX6Q*UKT)J6E6$CL*DM;&J
M:1]^'0YU5"XE[13(K6QH]P(TP6-LZ(NM)/=< YGT4E=G\(B0Q3)+ADB4K3\H
M%M"OSJTAC3 *<SL>]F=9TP=!NXL@8"V8,]JY+Y&W$Y! )0I8AWZ19(V(T MZ
MHA H&&-C#TIFSL>RR)?L7-W;$ %DFUK[7H(HTP#%,5@I;'[03.6\A7[]:"4<
M:;H\LEKL6!& =?$B\PO9[Z($C1D]Q)0Y&L89BL6,B9]/YZ7]R).V3;0P!_7:
MY*[@\-%2'&YE(U,Y4>'IPT5+R<"WW3D^E0-\6JT/SVGA,.0,!DH[\9Y+@M8\
MBF;C+R]V=O:W1Q=DTLB@5R=&L\;$N3=:<X=#'*W#"$%19];D6ANXSX\^,<:P
MI4:F14#6UB"C\R:,/,2HQ%"%;Y[;*'ZXUF;MXFC6HZ>I](NLXU2+'EBK.Q[E
MK#>A](:ZORP,S%<G!CNIV"QQ8?,=N&&(O.M8RV%DQ#9$\(O-/9R]M;%UFL9K
M!F;2X@X?@^2/E(&MYQ0*$W#<K02#FT0WBTATN&J=< -BI3BFZR:"WB8N27:#
M*BSR)/G_ "B%@%E-?V<U0:B&U+;8UQ.6QLE:B;>U=7U'7IG60*SVNSUGV1[.
M<'1GME1['(RS*C8%5,8U/D.SEEF502*8MD<KKUKY.OU3*728! UI&9NJWU8Y
M;9\:T88&6B@5R30Z/!C#7FC5D<5?&V$$9+WJF#L,<%1!D)/-SQI%S9:>?^TA
M@ 2*!#*46/FJ;LH=+M4IHK#:J>RJSH796\@;,\?.8%C+!ZP)IPEEZO4]-E;@
M0"\0O8K %D$8@%XB=.G.7^ZU0"DG8OT?VF3$V*Q"(Q1[SU>FD*M:M_V#0=<"
MZH$,C''K$5K\BI2[59'; 3G.3G#P,3#?&M$4.PR+43SLWZNN$K9]%FI$C(T#
MU]N-FWW!4]N.[QUM'(UMMWP@,,ONMA:?+JKBFE1\**FHI5IO$05)@DB*7-_\
MM+C0+# BU$36F! 25H$M8X)N>ZN]W(5MJR'F)0'7(3$=0\E+CB:J0@ORWI#;
MN)4J9)CKC^P,M$2)CC^=FU,U8!;+%J&L5H#.<#6,V=<O]7M6!5"-A!!ML@JI
M:VLU\OSC4!HEZ,G:(%<+L1(:QAQ56]F3IF1!$T+Y\H9L6DUMFR"Z10#L1K9!
MC6"A-JO$X!<#1ANH;&OHNPB&!54>@*J>(=/BUQU28"YZ9#-C(J<?=">J$B)S
M6KGMM&HFK57/H,BW0MJR19']A/5NYU4 -/CPMVD52.QKU6PK94);YE49AN9*
M'Y:/.)+D@%=1EMX["GK(E=GD_NLUKK>MI&E]2-FZB3XU.U# "1-LE<" ]O-4
MTF<AGI"VXLQPNP.LSN4*5E;/JRH1F-B,S-;@1(O?9$^F.4]\L-5VX\)#TT<:
M%Z.VIM6@281(A8,UV30CYVHQ0>S!RX\3$8U/)#6"4>*/>0TXY LP-2'7 :B1
M"43!G\R]V!A0%J+K.H7 L9-2:L/EC;,-!P)<VG:EKFRKB9)SKC8*D"%LFW+#
MB!7!L0M-F0!H4W9)>"<6&L6T1,]GGCL^[7RKTVI5VC !UBN>N'XMAESI99+M
M4F;K#:LOU=] MR+)($(DPN@9'NXZ!#IDLN..*I16\ &QUIE1-X\_E'W1/W>?
M.NQZHVI::-7Z55KB*$0[2*@3Y)LY77V+U6J,'O2@)9\D)RZ2:5 )I;)RJ6!L
MH,#'G!O6K2]8Y!"ICY1-(OS@VOFQ'ZJ@+K*ND=4;NI&K[[F2;*+G7Q%BN-H&
M.2=9BY\+TN1[@6L]IZISCLR%-D&UPI>6ZYG!8B7+GSGV3K^EQKB=H&OB#F!V
MI<$*J*M1R.=61WD((FJR4%YE!7\.TBAQ&XN;_8G8N'5BP]\L$&% CU9 \B1)
M3W/7:D2U6.F0]14ZW%* >M,2V'JOL>LBJ@8"5TW50*W:V7V#8J8MDRT_85.F
M(2$6!(><V*K[GII!B.0:(M1GGYM_(ZG#<:8JY6\7>F4W9P]H-=QT&IB:G:];
M3;_@$5.7TM0HV;+$]F$H&9[$G$58N/-L:!#C0>:.P1&K>:6X3CU=$6@;KN-8
MK@>L+3!"PV1@%K^H"!=]Y3I]GG#H$>=]*;8JVCAH)@J/*%0A&1+]N1XZVX,O
MVP1/ODUS1M6HKZ5H50#UHM'R!O(A^PNNDFIM1OPGCWL/>%<3,28BC UC7,BU
M,8E5<JR;,N,+(ME[$7 *D#P\XBPG>;MS$2!,)FMZV4JZ76=2:L^5N)."JI/
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M(XVIZ5(FQX\5I#BO18P_XNRU8PGK$Q-:I1=2[L FJ[)!)M#2;"1KKOO:"LW
M4*-=U1M:IW;*=)U4.,7(@ $[ZZ1>\GG\9 /ECONR<E.0@DKM:W10JW5XP%$R
M6P@V&\IZ*TJ'"CQU-/0V$NK6RVPE]QQS'A2K"UYSC.HI5,2S$U\\"H70T7 (
MCK>8@@"!8QR745L/@WX2@6.#V]V'!S8NZ X@S&AD0+\[0O<;A_I:I:AJ<?8$
MYB"7V?=8N"$@Z^VW)DUX7/QAY@:)D2$K>8E/1<,.&B#:DRI4E;D)+N8;'>1Z
MAV>X929AJ6*Q([ZK5ES>\N&7ME @R9$R8@0())7G7&<57-=]&B13IML0P'Q
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ML^;!05-!;"L-JG[QV4W>6T; /O31DRUS9MV7<5 +T=M2?70I_'L*P.2!T8G
M<BB1[<-^Z*TKQWX(J*&RQRP5]N57)Y\6:1-Y$6V/"J$[8B;1DY7WA;NQ&QU7
M9LS5DMN4@TQ1[<A,XAZK%\#>/0D4FE=*<5Z^[(MECEAAT1)@+9XK]CVN>8K%
M=)+NH+;\4E6!Q6VIKU539KI1A-R,X 11K%Q="ONF4%8*Y[3I-;>G^%KU75O%
M6K6>#?:U9QK1DA<;G7:Y*7O"R%A42^W<_P"W+R!I@DG=9P0+:3AOTOM8%6(,
M4DK$B9!S!:9FRV'2)R:_V_QBMU^L3M%V)2S-[V'&A02T1NQ*<?LS-)-WJBL0
MA8TA(3!EOBC%8NPV9$!,9F9;'ND)[*X3P^6^117(TAPAK@*?>"1&O.AZEF#K
MZ1:36Y;0>36V:A8JE<P^L(Q4A="3PV-6K#3@!$'KN"\C Z2HC&%AD?.,NP3(
ME7.F>(0VJQA'MW-<K-F# MJ5X+]--]K2(HND1&[.SL.GA%W6!+K3T=I"3EML
M0&$,E%7O33K9*EO*=5T174FB\1KK1N/[U6.2)5$<5\Z=& 3&S-D"(5Q=AV)=
MZBETT^V6. 0OTD<:;S81LJR"#<F#$4AZ(MH1(1A1$TMQ<<^*.R()ZTN[#&5
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M3A<7GUP?*.H"9=R=E^R"+7G\##9@PB.7N.MRP$16S=7%P2%&/+,VH&7L6Q;
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ML^2^9D2BLJ>J-ER21;=%XK[)HO(:I8% 1YO6\7DML3DX5V3/"U=A0]=YI>Y
M ^B4^8Q?95D8@"&-@A(2V)5'98=EXL\V-.2-+,(B$3],\'[,9L=VF,;"!UVL
MV38KUQ'5L(*L$E8I)F3M)%G+C2]C/G3M<L4V'M"63C!P19G7\.YQR-E%U4)F
MRD8K9$TJE\G6R*.CS1RQT^82'5N@59[Q8VO=)!(;1-I:6OD8A)D;7VA?%!O:
M,/4LD*T)KD82-&M$A[;CIA 1E:R+H %QA/5A>G7Q=DIQIW7,?9@ M!MU2G%
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MSG.(9C.<X[9_O1-QCW]\>6&,8\N^<?B_I[D67VRS_P!"+_HF=_H>B(]LL_\
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M9],O+?A](YC&>?XI@^TW&ZM*G4H8K$%SHP[Z=-[:+2\DN?F9E B9=4)R@:D
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ME$F([AHG$E16"*+S'.GCG&?MHK; HI07Q]P?IKP39-98'F"P:NT?66QBMMG
MB[;;[=8KOTK@XV<*]HR?7\NR($-]Q3[+!$]&>9&A4'[;7)^2 <(&07C2[*6J
MY6)73<JLM;8BGVHTE\6W G"1\325VA#R*I;C)=X0J%!84R\)D$R),B<T^*QD
ML9JD O%*G1;:8C59C5UB27/F$6<94)53!A$)7/DV87<KC$K4\/)A0ULEB9++
M2GHT8O+C$1(Y4Z]ET[7UJ*:BNTP5LRY[KH[H1FDK-64(C4LRYQ;,1L=90/5,
M:A%6=<.R94*2EE]A2X ^4F22:C1%D2I*Y=<;Z_:8],1@@R9G5<7>*?%A4B:W
MB]"2!NHUZO2J.SB*U++NE;'LBNB:[*S%B02DXQ+6)FR(T$M)BI]_?DB9)SG#
MQRU;9[/KB[ R>LXD$-7K,A@[5V:VV=$6BNM6&R%)5:F-CB,;%4CSAH^UQ)\+
M)3) @W$CP)CJ<XR12&1Y,:;ER3<7YKFSP4=#VE@@28I$Z9%--ZXM5+IUZ<!I
M<&9'EZZ/+V$:JQ6.>0&@HT =@L\_,"PYA,41+B-QZ@-:>HN]*E68ULJ1\K1:
M35,Q0,"(4AQKIL8+K#U")'FQO%$CAC1-6)8N(K#,O YYJ&MU#K#RB*(W.66G
M!])U%LJSZBL 4#O'6EVV@6D-TZ&:)5&MT1NHO&9MZCB8;[KHQD?88L]97*WH
M[4,6A+:'GY$!E;W[]_V)QW7E=QBHUGV!1K<,?&V(2H:8/B"-#1&7;\3[@#IX
MTLPF:PPV29?L]A!,C3![,"(0CDH!D/,FBGFI^2)9V7R#H5"N.EZ\2U@:)P;A
M2S=X"FWJN_&GTN$(*T"N JR-JSH60?3>+);+[3:Z*JR8P-V).>0F=+BOQF8J
MB+<'\A..LW!;*8"84_.*'6;.+G41^$6A/WK9-ETS6JK8XBAN7$O1;S4#@*<.
M?4_&&18C)#NH5,AR72)0&[FTP2":EM(^D'GD[-::@ZR'QM8S7K,_4H;8XFFQ
M,@8HY\J%HXZ*1%%G9+T>*F"U+@O.0FY*VVT$44*Y=\>0C)&">I,H8W2#&P"+
M(NOT:5:% XNMBY^-;[J^T) I' (8Z(&>/JG1ICLQV/)3'3E19;$*212S4MZ:
MBL)VTTVOUDB0(1)%S(6Y-1H!ZPA&<UZR7BMM/6F6,KR6_;=IEZXLB0T%^-,=
M*RA\>#!FD'B(%18B0M5;_P!';DMH*IT&JQI$D$SLX=)61KHH:_1#6N'M223%
M:3#PS)Q'D3X6WZ\30L5*S&CJ8D0IJFR.'&&")NYY-:/(2Z\!JFMCEM#G=ZD]
M8$)PK7:7@0RZ@ZWL.P%[ AA(]_)<@->UT8&RX<"(NU1WI<&:Z.;C$1F29%JQ
MN;W&8<&OUN@0;0B54BMMC;0@ =:DB-IKB*37ZA8[8:MT8%%EO>S0XF]U!,Z4
M[(DR6YQA YQA)$>4BCB)\TGDMQCM1R^4&G%:X_-UB)OLTR+'"A^(CHJFF,!]
MDX#0XF'5R4!K%&8@'8ZH\7UR:J-(BI(Q^TM)$C1^5_'R=+&GI8JQP3CPS)3+
MY[69478@U'8K\&]-W(PX1'M30=(37939Q)"6[']$]$G0%PFS\!T>T1*AWFYI
MFJ@S10W%V-!EU4>;.6VKN:WM+EPJ57 A@%@(6^QUUB"J:/K"!EKKCS1+#;F'
MGBGJ+;69HTRR.(MF7S5T\.A4$L49O @#LVX!Z-3;$7I)H8#+GK#8Q]2 -1YD
MUME3[1BP$6H,7$1F1+989DF"$2""0V3>(FM&^4)X].AU6*7(O@6N^S&2K!X]
MKVS"1,N/.HI7901$67+B(2X_8*6 L!P2C.$IS&"3\3EPE^K(D$76M$N@O8-3
M"7(+'*Q19Z-F7#9-#)(DAAG#SK*7%Q).,95'?4TIZ#.C+D#RD%R,2%RY@Z7%
MEOD3OZ(CHB\UOE+ZFY9],@&6IK4,@/MKA$5A>5)S+)1Z^66Q#2[CPI;5*3Z9
MGNK&4?W3Q)\+B<*SXG^.?9QO:'L=W1:W\W@L1^>P[Y('>4FPY@\)+B^G+0(_
M5E)(_4.\_#GM([LWVIP6()'Y;&$X'$AV@H5_U220 0X @R1S.H7G+I/D6@_K
M^$N?(<S8 R_8QII6?1JQ,83E+$J2MU24->N-X2IU:LYQB3B2G/?*,]>)]B\6
M_BG A2K$NQ?"^ZP=1L /<R[:54-L2'-: ^8<UX= C7H?Q!X.W@7:9[\+E'#N
M,=YQ+"56DEC6O/>.I.) #:@+B0UN9@TSVE,>R<M"=ON)'6])/,#<00C1">7B
M8=D2)DAHW @F!@]_#>/"U$&SG,IE(1A_UMA*LI2WXE9V^)P/B<R2' "(YG4&
M8N+:00=#8+08#'"6/-VD&0;$7Y @<R9V'*RAK<<S>FUJ)3MK:4IQ N5IFRGJ
M[*:*SH+%>MX*YR@H>U02C+\GUN+%"%T1##!UJ$ZV+>#O14.9PMV/G*P?9#%<
M4P[W&E+'N#6U'"<KKEKI-BPGPN!(\+I ):%N:?&J>&?KDF+"--YTCY@&0=3$
M 765RCU('VR=9U@\7BT>,Q:)-AKI*$0 -0Y0QR4],%HDO#BY=X0A,F4;CP@^
M9,)O#<F1'0P[&6]H<=^'V-HYWN;3%,/R/>QKO " "08 !$3-FMUM"Z+!]I<,
M\,:*I)<YK"UH&>7'*#^J; S/ZB1 &PUN+5^/!*[28NQ;&R6E:YEV38QN).=4
M]'39;Y<YUJGQO1X5_=DB)1),>>]A28R) :2A+R6%81UYWCL!B>*=J,/7H89[
M^'<'=1&%H/![LC!LITR\-8#?$5F"I#B"YAO!U]-;CL/POLSB:9KTF<1XZ.XK
M.INE]/#O+R0\.@A^4P"V1.ME[%5CEA43$2*]+(I@R'V\.8;[.Y:4C'X>5M^-
MM#F&\XPK&%93E"O"K*5K0A2\?2'9WCAX@<F.H5*.)+&A\4B*>4@ -9/B@1EN
MT "(MKX+Q7"#!,=^6J,J,IDPXDYG@;"Q!<8\0L.I4@,;F#OMIDLDVEL/=UH<
M2M6490I6>RN^,=DISG/AQE7AQC/=/OZZ^CPY]2H:M)I>TMJL@@@L#IEQD<O%
M/.XM=:JIB:8#,I:U[V@OO #P(T,FTD&UHY+D'D_L*.+16=S5*>ENV:ZGQ%3,
MIPKQ2@,EU2$I?3VSEUB/,=]"XA..V816;W4K"$]_%/Q/['8S#5>$]L>$TZC,
M?P^M197JL#B7X=QRL<2T$> @TW D LJ&T:>L?ASV@PM0<0[*XUX=PO&8=U7#
M,J.8S+BH<77SR<V8EL9KMD@3?E_F1OO66P7M57I16;B4Y4)9((-\2FTK=5*?
M>EQ)+;L&5A;T=YEV#)_NJ$H[N84AM"FI&>4_$AN,XW6X#BL)AC5IXOA@.)J.
M!:*;C6 J B6NBFX7R&3DD2->L_#E_P#LK>.<,?4HBFS&N87=ZT@LJL=!:3J?
M"UHD "3<6<F'IGD7:"QJ]3R \$@7-!PS F!DNHP\DNW+E)2N$^Z.A-K'QX;C
M;,B%GQOBGH\>*K$AE"IBO+:F#P7!:&*>QE3%XJOWA>*V':RG2R4V.NTU'%I:
M[,6._36ID.%P0NXQU!V(HX'#TLM&A3J.=6[A[7EU-SC+GD$&2TD0 ?$2"8@K
MQ>^5&%3=PF0-G?FK(EZTR;&/164^G4J"89B/X=0SZ3&,9BR(RD*0WWRG&49Q
MA*>ZD^Q_@?Q5_ _S[*S,K.+UL/BGUC%.*U U69=+,?3>(%H @DZ+GOQ$[.TN
M)\/X?6I/+WX*D^F&B^?O*;0"YNA+7-!;H;Q;=P_(FZ7N8SF[Q,NTJP"5A6-E
M W)32)SKSLC'J)*+ %M,.QHLAB:TM]UY]K$MY"4MY94PXQG*%>TCM9PO$]L>
M%</9@JSJ]3B 92>ZGE#"0XU*Q<VJYKJ1(8&D-;)(=K$^;X[LQQ' ]A.+XW$8
MVBYK<#%2E3.:6A[&L:,U,/:X29#C  (T"_2S9_X)/EC'\KRQ_P#)9^_/G]?U
MY[Y[8]V/=6@ 0  +V'.;_/\ NOG8DDDGV!8>5MOFF_;:Q#N  K79\DE#B%H+
MD-R8'(R1):&I2D.,S1Q&)G#T2;$>;;D1W<>-&76TH?:>84XRN5"YX5Q UB\3
MAFIL^X$3#Q:(9NQ.4<CLR-IRQEG%W(-C84<<*@CB$8-90@HB/B@X5>82S'?$
M24R@9(J,GD3T.<;]26:\4'9]CIU?-[-UR;P? ;$F@*ZFYOS6JU8*I%:*GX@:
M-.FP80RRD%P827(\>'-9'S([:'82,J(M#/&;6ZM@UG9[C1A^WU@F:,M3I!5;
MK1DH7</+CS#[2H_CGN5]NSFXE<0R]$8&0),>!AIZ&.&1X1%T-CRQC&?AC'1%
M7HBCC:0ZGDZPQ%O4MV& 3:Z!-0\RY(:7BP"[]62E00MR,T\XF.];(85B3XT8
MC9CN.XF.L1,OOMD7(]9XT\6[:5LVS*5L5RQ8@VZPV @5J.PZP7K]0LA+9M-W
MH?\ 3NA8DB#[1^>E3KQN;(MSY@RP%RV&=FIKS8N%!(F<%U3P@N8-RLA=M0RU
M'?+LZN'UO&S(#-4+;.<TZ H[12GS)&&/G1?G-0'Q )+]<+EP7@(/R&Q.+5B?
M.01.;8_'[B08,D=E7#94&M)L1 =:2Y3.S:R$%&VSAVOSZXXT6(8=F# \ZU:_
M%OP<5LL'9M4T(^&..V 0U)#X(M"-ICC5&O.IQ8>[UP9'I.X2)1BL6>QNQ+/<
M=D4+6=;UX*JH&.8DC$V ,$&,5BS'H(^&6:EGP%9FMJ3CUC'1$J6+77"$AZ&V
M#=C:OUU4Q-HH;%I&Z[V'K^DZZL]GHEF=VG00]Y'#'VA<@B.+N%+ T.9D#")H
M62)),Y*#$L(BD66%IKBE+J=4I3VXF+'699&R4?68V;MZOS&6/%KNXZB(Z\I?
MJ+L;!J57JI>[$.=2][:N^)SH]1\T02(%QHA$B6&D\*I$ZFP%;8!LV1_95DK5
M"GUO9 8N9$;7W!L2/OM<.*W#R7@Q3I"RU!4X&/L4!X/*"-RJ[*@%81;U*61;
M=9&<2S.SFGQ>[RLFY:PVM7ZM8A!F_+%C+IOBM5*6-%-D_;$ ?#OEW$U6XK'3
M %&GO Q^7PXXD C$:O7F C]D_=;9ZI\6Z?2QT:9OLC6:U7]E$ZI6;",V<+<@
MZM-G*B<24UA'*LPR(&H G*C+-N/(N:,E8+<@=+18XY*%4I \BV7M8<1JF*'P
MQNR1NM88D@=&U,BSL097HL:=?*AKPX_!K$ZS./A[1"73JY2ID8>I-C"2PSDN
M*:CDX4\E%61(VL./W$2]AY]4UC='C]?JDF<%O&O05MBQXC5T#2;E446>X5&/
M @%:]8!\N396 28D2OU*3B '(#*_,@ :R_#(M;8>JN&=UL5HL-DVZ%&S1 :H
MURPST[$J&*U5B%6LVO2-=D%EG892KLVQ9>@4&([7[(J;%E1X</QUK*R+LF61
M/8+J?CH9J4?6-8V-8AR]=F]S,.SXMU?'W54>TEG#&ZA<F<>BKDF*M.E7*!@R
M;'Q'6@[LD)+"V(66BP)S1$VA5MX@A D <&G7F*-&;,J&W*T"AZVW(X2-V BI
MJK5$K0 *:&X;O=)EK&L0XI&FP#U>2C#$EXHU'DQW72>_?OZIO5+CMQ&VJIFK
MT^Q[ ?@BJJ0]K4-R=:*PEB0Y2]@\>I=@M@:R5P381%YA5$]9:;($$713L1$
M.7DUE,Z' +/$6S8:5PIVI;35;>VA$'W?6FU3-6>4NR#QGLS<%^,:WV-,K 5-
MU#RJC=;3')4*FRF0$*)9\@9&'(DN#&+.-ICD3VIVH^).J8I!\3L4'$C:AO%:
MM-HFG]L"9RJ7:1@VW5NO,7>:1)9=$+DQ+R;BLQK$^Q+(2'(BLN.OL)4LBU9-
M!X@GJ,"MI&^#!=(W(8@'JH:L-XCU)BVEI^Z7^00V. Q9,BI4F3+V#+<F1Q;+
M"IC@I21>&/1*2O)%KT4%Q,J,8M7PVU9@:K4W8E2RU6;;;WJW4JULFK7@_#9;
M"*L<$*R5-VJ^:]/.F8Z21Q1&6+F*!I'""F$3B+3M&J.)P8J]/.;ZCT\Q3+0U
MBL2).Z*D%E:?,D#INZ9K%=9+.>CA1SAZ.4-R0%N9L"R,0"@+Z)=3!H"QR)V#
M>*''2=$]D5(\:B(."[ .-HK=];DS+I3I8RGT/8%;.2%*(2B(*PR*/7(]O(0W
M(9V-8V):XIX3-)$&GB*)+2'X+P)%BUY8IENGQ,SV7KF-B4_;!NJ XPO>FSCC
MF+C9 %-FUJGUO&S[;?!TDE8S8<3D-'RKVBD.-P1P1/JD5KB?L-E[4IG%DVW+
MD_/<)7R>[=>7%ES,.OQ/F)< VJ[[::#5 4U0B&-<BDI^OR\ZP$?02[&3*E)"
MI!GI[]_%$FL:MXK B%IM;O).0U; =N*-[&OI#>=/39(<@Y5Z96"M#MI!Q+,*
ML0Y8/3-<RU%CPJ_:ALVM%38<V.+2#<U\B5[AJ;AQ93D+5%CLPLQ9MQSQ1@14
M(ER<(FCC0^V[-Y"1R$>.&7)EC:R9=.;#5(*S<Q0=AK3[U53,E>LL199%ND]=
M\7&8>P2CN[( *JQKVJ22A1-M54;4M4;>F7,;L!TF,<6YX -YDWH<Q8V0MLG%
MXD:?+*PQ@"*+.F!Y(B2B5(XQ1ZBBG3MSVFILZ1M=^,E[F3O;U;*0S6WR1YBZ
M,V*UV(;' F6K9*OQ<9#:0F1ZI+*0WZV[ -BPT\<11N'TIP7?L>N9E>V++ $M
MHT>1M71PMBTHK;4.O3K#J4U%N]5BE@T,E-*-6P=J696F=A/62?!>'0ZT$%-5
MEL]7%D4AW+6O%<=>XUVL/(?YF;&54OFJ0L$C==1"V4Y6ZOF<%MC)%XPI4K*Y
M\RK*CVH@.3"EAC%,1("R:T4#3G<D3@O6H>*MU;= FMB@8).HJLVRUI8V#57B
M-:8V/LJE[=DVTD)L&3(U0*7<JG69X2590TX%B/X&6DOXD,NX(GOK"A:"+T9G
M46O=CPKY7*@>I^Q,"1FQ MP+!22=A*W)6S)*>.>F&,P['8L-$&7BS[S!D1&;
M1!=RWF0^^1+$SB?JTC1 &NB&+%,KM9U=L73HG#IK*)S-#V<P&AV 8[*C18_I
MI$:  $P!!%:/78D>)AQYZ7+>D272)G?Q'M4L&;2?&&[Z')6K%];D*'&Q&(4.
M+LVZ@K_>(N!,VN31)]FPV&OQ/:/SU@VIR6'<57I#CH2*+@CR)ZS.*.J)-=H-
M:CPS(J%J^AXU]09 HW)B3JT,CG:!:!1:#(RAU&3X*QZRJ!<1+?8=B,/P'F'X
M$F#,D15D3:SPNU2HF,+K(WC,Z.1KINQOXLR<+V!8*ILDSMP"=NV,#<8FSA]]
MLMC,M-!_88U39EP:X/4+&@H0DBD>9Q_J#XG50J 2M->5IV!&"U M7CK@XUBN
M)%CPI.M$I^8[ZI(FP#10Y@LXPB(5PN&Q*&$ALM&'\$3!>X7Z5D2+9*>A6'+]
MT [+K9Q2;!*PEP9MG)+-P1&3Z+M&>?\ :DK,!Y'=4'.4>CPKP8[D6VOB#JS#
MUQ]4EW0<-V&!N%>OH,;:I<$3;X-Q)WTN^Z::8CXEKE!INS+BH&J+-BLQT$HN
M9S!%T&"<'$2?4>%&BZO)D2B%?S?E37B\F;"V'& 6, _*,B]5!GGV:DD#!J0M
M,$;IFA10L((#%C@R1;JQL.,Y,?4HBTR_"+3U@*68V;?MQ$O:BL6<1**.QH9)
ML5! 7ZK1*LU/&B8,R4#CUW9MR#19)=\G98 Z=!AP+#&B@P;(TBAR_P#R>HR?
M7"U6UG>B56B7^-8 6TSA5U_)\Q5+%4J/1Y0&O1*LU7:@!!HK6OJO%77A=7%,
MNS08HE"*BG%6-BS$72X_C=7:V+V0-J9ZRP(5]$WN'!KQ$LJ;4:D1V),)&+.1
M#"(T:#*D>U+"2?+J:-D3&0^%R1M66 %SID-\B:.ON&^O*I7AL&US[#LBQ9U^
MK75GL5K-2I#UBK<FF"*1*".MQ41,L!XP45E@6A*\E6W9Y,F3*E39&:4?(HPV
MYP6<NHB8(JFQC(^9=QEDJFV;Y:YQ,OL2TTBQ!:K7<UI@L*=$AL!1X>I"FT"U
M HLZ42AQ37SDB39=I^=)%)QWA/IX]*H\E]RV0L4,=2A8UH<=985-A:ZOK>S*
M8Q/GO"Y!=AD3<V62TR,$)!HEF]!#@VV.>'#A\2*1*S/#_5$(+7 PE^X!<U'%
M956RHJSRHI@5)J&K+1IX!-8F885AR1#IUO+I6E]IV/+)9CRY;#R&UQW2*6=2
M:EJ>EJ4/H=,CNLA($TR4SE],%IV26L)B8>-D%Q1, 6'@JGE2$N5B &%BQ$+#
MF(XT="B(2Q@BE#HB.B+S?^4H(Y&:EI<E.<X6B_I\">^,9<<36+%EM"<JSC"5
M>//BPK.>V/1YSG"L8SCKF.TU!E?!4Z51N9@JESI ,C*ZT&UR=>86-BGEE-I#
MS3)J,.<6+,I+IN)&FPWNOE^/6Z77C=@(#7\($[#&D8TS$?QI1%.9_P!])?0A
M/?*%KFO(D(1X$91')/IQ_P %WZ^5<;@?_"';!E9@#>&\7?WA$96,[VH0ZF8)
M [E[@1L&/&ER/=^'XX=O_P /:F'(S\9[. AL$.K5<,UF<5- 2,C7"Q,Q)$J/
M./I?,[;!66X\K+#0$\A&5R/1*0EYUJ+.\#:,9QA6'8F7,>/N[G+C;CGGCOUW
MV)P;0XO#3FJ-:X3) %1N8">1$$3Y#2#Y/A<06.<PD_PW%FI EA((.\@ZR-8@
MKVO^3</3C='VG M"6?HXF6.PC-=2'5N8D+;KXUIJ\-0>Z$>$>N9#>?%/-)]+
MD@Q8EH4KNSC'H_9!E2G@']^&!I<2 1<0(!'./(Z&948NH7U YKB\&)C2/+I?
M:T@)>YR0RX?BD=QI[^[V; F>;.+2SW()J6)$?&RY+C,=2U8)N#/6<@XBG5M9
MBQY*XZ'DP/0NX_;-S\)V;QWY5C78C$!Y80&YFAP>WO +Z"Y@"(MUZ/L@S#U>
M-X4XLEN%IUZ1>3.7*'-<0Z),V(@@C8V@+QPH&S1\W3 BHLBK03W*X#V)I^@E
M1[&/90_3-_,Q+E9Y)&<[(9<?L8@D#M( %$1A32*ML$NYAU"A[*%^4]EL7@:'
M"*6&J81C^*.Q1:ZIW;8[AY%0DF+D&6#,"9<Z]H73]HVU<5QC$8S#5'4L*7M:
MQN<EH[EK6-?EN 'B\@:B][KH*?R8@;$W!OJTU"\;'J@.\:X11=9V875]C^WZ
M/8,;$J-H<88&&+M,E?A#694"6U0&0E6%I)B67QD>(3D.N]E^?PK>(8JLQE6@
MW$4*=&D]M,'\N^G!<<MFP2#%B3UT6B.&K##TV/=WE2C6-4206U&N!M>-XB3/
MZN04MU[DS2)[FP\N5:_DX^X<IH),TRR A&!M<J5*A49>R8U=]&6=)GKIMJ1.
MOY&(%)B6<&JR*@IL)3"YZ7M]A.TK*%&OD87]\!3SN:!.6@*1J$;&H\%WAL23
M&\:I_"WE]/Q#,XA[@"ZSJCLX;I;*('EH %$1SE8Z>U58JK+!W&/><Z.U_KC6
M-_&CHL 43< 6"EE-GCK"0]92VAJL636]M)U>W-3?20FYYV'+<:C-#'&N4XMV
MPK5N$8OAK:#Q7&'8,,33%2E4>:@-5M2;$-9.4WVDB('2<([.N9C\)BA5IP'.
MSEU1S',):[NS:)!EN:-"0W<IJU[DR%C[6B;(V#7[UMN51M.Z=JVO!EJ(07HD
M?%EKH&C;WL+I:PMVR'F-;$5FP5]EM@6N;;6[4;/L383T/)-'+T^TN$P=>M7Q
MV&%?#G 8;!T<*^DS)2\+3B:[!!RO+HO?400;NZ"OP7&5L/0HX6NW#UJN*Q3L
M97I5G9GEM6H_"B) AS0"W38$;J*MD6JF4H>\)I@@.)JP^?8Y%)7@ R(LJJT3
M(HB"G)[F)+^&WHXWT:"45AWT*ID;+B5Y0O&%>/\ :,T.+XQC.&844L%7K.JF
MN]CA4JA@+N[<\R3F<#3B]IGDO4NR.&Q='#Y\=B:CCEHM>SO,T/ID2S*3$.<
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MA@O:3+[+:&U-_@.R7O2*[^%UO&<83Z[P?\-."<3PHJ5L7BVUG#Q-IMIY&S,
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M$FR['9-32VII\$AJLJ[OFR-4$;5[(7U#?R%BHQO6B7G2-D32=X)#180"2"@
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M).$GBCV*L:"RB+ 0W!S4"4[VL0*7N5-(5+4]VD1&=,JC'(A:PR=ZQ+=KBI2
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M3;:>41%KG>3U%:V#\TUSY#%/'B"IJ>.K\!;K9/V8EM3D=V(+;D3B><-*7AJ
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MK-D1"$"E2*LG-AP19K+S:,59VY0[%J5^ON59LZ%P7CVZ#:XJ[R.X]HY(QQ.
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M475:S*@=7J$#+1_AO+<AWL8(]02+K4XGB>&QK<=7!9AGUFM#Z39EY!&4-BP
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M^=%<292LB?KVWN"Y&/B>ZNJS8+:H]T@SVM;W%T9.,G %*RQ&KLQBJ9@G+U*
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M.90YB/EY+:L6WXNCA,CZSVL#W9&ESB)=<P#I, ZZ7.Q5BOAZF(9EI@ES3F@
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M'BF'&I1RNRD !T 1U]+@[B2 E5'?&H=3Q.'>M#NI+[OZ]<L==5>]%+P,(W>
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MA\0<"K(:N@0@)QX."&C(+(UN 15N_#S7-^H(W6Y4O<(]=';/V!M;*$8I!?)
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M1+2>&MC;+<HM!N5%D*LTJ'4I:V!UG:O!TK8_9PM:$&)GK0L>P-CI N$3%K?
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MJ&PQ]$37INRPTD"\@Q$!ID6,P5'"L5VBXA7[["4NZPF)$![X[NI38\"S3:H
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MSB?"Z?%:#</6_2U^<08T$ G33>#Y+*PV*?A7.=3_ %.:6CH#KH0;P%XEWO\
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M[VD&<NY@3;4FT$[OAO8?C_$<0,,,([#V'BKMR1),7)$B-0)(,;:\W[0Y-DY
MT6W0U(%X)95B5+DX1(FL]EX4WZ##2G&,-9;1E3B^^7,9SE.$X[XSCYQ[>?ZD
MN*\?I?ENR7?< :XN95>\-&)J-)%V.ME,22;F9RD KTWLO^&6'H8PGC8I8D-<
M2&R[)9H$99%PZT3$";WAHZDY 643.--6XLX6CSH\N>T])>6XJ#(3E:&E1\.8
M\F<K[84UCP(\*\>%/C;5XN/[$_CCVE[+8W'#BF,QG$L-Q+#5&MJXFHY[L-7(
M<WO&7,',[,V6@'>;+<=K>P'#<3^0?PFA1P[F5&MJL;8/:UX:XV\68-MXIN9%
MKJ#3%QM1\].?F&YRR$F=A(Y&9>4LHPO"'<J7X_28[K:<2G"&DX4VE&.R?"K'
M?R;BG:'B?%<=B.*8[&XS$XBOB*M5E:I7>TM:7DM:QK8:WNP0)%S )@B%W.#X
M5P?A^ HT6X/#$,:T5 YC2YQ#8U#="<Q(^6R=X+;>T:P13"9LTF;*8EI1F%+<
MD2(/J;:.^'%(5E3>6,)4K*TXRASLG*<>'.4];_@_XF=M>!5*-; =H.(LI4'-
MC"U:]2K2>,P'=ECLP&8  .(D;D3*U?%.R79SBE"LYN PU!]6F6M>UI:YM1QL
MX$3&6YB!:^T+K^B<FZR>%F)MFC+KL<&Y'C/3UK7(CSWG58:3F.TEE+S?I5]U
M^B4E7A;SC.5X[9QCZW[%?ZE^#8JC5PW;'#/X)6PU&B68AKC7.+>6"8&0!F=V
MTN !OHO$^TGX;8SAM?#,P%08YN):7%H8 *3>9()/AM).]UMF>5.M Q62+=60
MDYAM)=>D16<+1E#C2'6\LM*RAYWOAQ.,]D_'OVSA.>MCC/\ 5%V2HXM]'"\-
MXCC<,) Q-'PA_6'L$ ]"9UG1,+^%':#$X9E<=RR0(8XB1!(,P2 1%ITT,2E7
M7O)6DW6RBP<.(1B229!,2!ZPC&<+4M*E,*=1^ MK+OASX<9PK&,_@Y6K.._6
M=V0_U%<&[3=H<!V>/!>(82MQC&'#82J^'-:V)8:H#8 <&R?TD"1NL3C?X<<1
MX)@*N/K5F/IX:D*E40+/D AL$Z9KZZB-"NQ&L=VTYSC'?S\\X\\X[^6<]_CG
MWY^_SZ^CAI?Y?+Y+SPV)'(Q=9.V/JQ^3'4J$=L?5C\F.B([8^K'Y,=$1VQ]6
M/R8Z(CMCZL?DQT1';'U8_)CHBL4IM'\K*4^7?SQ\,9QC.?=]^.B(PMK/NRGW
M=_=\/R?[=\?7T14PXUG'?NGM]><=O\N/C\/K^'1$9<:QCOG*>V,=_=\/R?[9
MSC'OST15\3?W?]G/XOJ_+]7QZ(J>D9[]O$GOG.,8QV^O^CZ\XQG/NQG.,9[9
M5CN1'I&>V<^)/;'O\O[/=[_N]_1%7QM^?FGRQWSY?#MW^K\OU>[W]$5,+:SC
MOC*<XSY]^WY/A\?A]?PZ(C+C./>I/N[^6._E\?=C/N^./?CX]$1Z5GMW\2<X
M^['?_)C\GU_#HBKA;6<=\93V[YQ[OCCW_#X9\OQ^7OZ(C*VL>?=/Y/O[?5]?
M1%3TC7UX_P"SG^WR\OZ>B*GI6?/'B3WQ[_+/Q_H]WG[_ '?DZ(KO&WY>:?/W
M8[>?Y.W?_P WG[NB(\;7?MW3C/U9QVS^3.,9Z(CQM>?FGR]_N[8_I]W1%3+C
M.,8SG*>V<]L>7OS]7N]_1%7QM=N_=/;'EW[>7?OV[=^W;W^7Y/KQT14RXUCM
MWRGS]WE[_P 7E_MGR]_1%7QMY^*?C\/J[]_A]V>B*F7&L9QC.4X[^7N^.>^,
M8SGMVQG/;/;&>W?HBKXVNW?NG.///?&._ECWY\L=$5/2->7FGS[YQY9\^WO[
M>7G_ .?'UXZ(JY6UCWYQ]_X.?+\?EY?T]$5/&U]:?CCW?5_1T15\;7;OW3V\
MO/..WO\ =\/C\/K^'1%3+C6,]LY3W[=^W;S[>?P[=_/PY[?7V\NB(](UY^:?
M+/;/;'?SS[O=CHB/2-?6GX_#ZO?Y]OA_Y_=T1'I&O/S3Y>_R\NV<=^_?MV[=
MOC[NB(RXSCOC.4X[8[Y\O+\O;M_1W[^>/KQW(CTC/?MXD]_J[?DQ[O?GWXQ[
M\X\\8Z(JX6WG/;NGO]7;S_)V[]$1XVOK3^3\?W?=_MWQT14](UCS[I[=^WN^
M.?A[O]O?[NB(RXUCWY3CR[^[X9^/N\^B(](UW[=\=_+R\.>_G[O+M\>V<8^O
M/ECHBKA;6?/&4^_MYX[>?].,?'RS]6?+/GT1'B;^[ZO=W_[OAVSW^KHBIZ1K
M'ORG']'XO=Y>?OQCR[^>>WO\NB(](U\,IS\/+'?ZNWNQ\>^.WU]\=O?T1'I&
MO/\ "1Y8[^7;/E]V<>6?Z/Q=$1Z5GS_"3Y=^_E[NV.^?A_MG&<>_&>B*]/@5
MCOC&,_T=O[,X[]$5>V/JQ^3'1$=L?5C\F.B([8^K'Y,=$1E*<^]*<_CQCHBX
M4YV./-42F>@5G"EW=M"_"XEONS@(46[Y9QE*\90E6<HS]_WYZ^:?]3K6O[&\
M.S /#>+M.0@Q/=1-M2)MRWTA>J?A) [15W$?IP-9P']1#Z5M#K:_2%Y@K+N$
M'QJHZDOL07XS27V<J>0XYZ9M65O,N^F3Z?*$I3X$IRC\'&,84GRS\!_E^YI.
M.7_JYR7.EQ )= DFP M%CYG3Z%&6CAZN01^9IEY$-D.<UQ(:2+27&?U3J-D^
M[S8''$BL80G,-AOQ1EMJP['<=BLNMY0XVII&$+4ZI6%I2GMY9PO.>^.K&"PK
M&U'U+$$Y@1(((D"+V$;$QU$P<#AS<O? NR3)=  +PZXNT R!I!%R.2:J?;<>
M,@9(<8]GR8V2F(J5H;::2TI:GDK;RI"4Y\:<*4WGOA24I<1\>LJ:;ZPJ1-6F
M6AKR9( ))<T&1:3XCMOLLRG4I3FID=Y3>!/B)( T<9)@Z0#<F%IQK@32$56F
M3*(8E*<*;99:==<D*>RA:FT.8?\ 0-N*S^"EWMA2,)QG/?.<=78J-[PLKUFL
MJ NJ8<5*C:%1X%GNI ]V:DW:^)DSJJ_R^"=BFXPX>D<0(#'E@FDZT.!,S! =
MKK!LDY)QV*U)'#U8:C/*9Q,AK6MUI]_"$I\2/2XPA4CNK/IL)RE:E>)64Y_E
M*I?AFYZ=4,(?(DN.:]M-6Z'761/19#VM>_O'O!>#.9HR:6_E\MYTD0G@.=;D
MP#$=:GUJC*P]'C,-M9Q'>=6MY33&7,Y6AA*48R_E'=6,Y4G&,=^W6'7;EKBI
MD!=.4&#(%K@".4G<3Z+7UJ^3$-.Q!!Y'03S)Y&8.MEKULOE4O$:?%CN9?Q)B
M87AO/B7%3Z7#;F,XSV2M+B/"[V[>FQAKOY^ZNO2>YK2YYJ-+I+""00!;3R@3
M_=5XK*/$'00T$-ZN$FYTG8'2^I$%/*D7!*Q[B9DA:VSY)I;K;N?^!BQ8:&$H
M<1E6,8PPXK"D)4I64HPGOCT?;J:+!68:3O T78UH-M9 !G74[E*3A7:YI8 8
M9),F8!V,?$ ZW3J#GHB)L\EEV*]'E+<4A]><-)RPZQ(;2MS"DY<\2,LN+2G'
M?TKGDKMWZL5,.X$4FDY7.!F^@(F">I$P!Z%8]=E5SFTVEWZ2<HM.F:(U&EXV
M*3G"WHZ7+BY5'>?(EF'EH;6M&'/0]_1(>1CM^$I&<*\&/ GT:L*SGX]7*=!P
MQ;G39^0.DDR&0(&:29 @W.I  &DL:S\[2?5;#:=)S'7)\#@T.U)UWRVF1JF_
M)A$1L:/-F+DJD$,3,I;>2A3C>4QU890W(<4M6?"F*F.EO'EWQC..V>_;,%5S
MW5*0<6L:# !BY!M)S:1:P\EET\;1>Y].F'-8RP +HM;0VM/G)\U+VBH^&MU:
ML?;<>S'D%HBUYSG*FDOH0XC+6.ZLX7C*WD9SG&,X2I2L8[>77HOX+NJ,_$[L
MD07M:[C#6!I.8910JC,,TD3-R(MU7+]M*[G]D>.LJ',3A'.&;8]Y3 C?00"3
M>W,KW#:_X-/]/U>_OGZO]ONZ_442  9)C>"?6 !/D%\GK)U*([X^OW^[HB.^
M/KZ(COC/NSC/1$=$1T1<^\G+=<:CJ*P9UP)L!K9%I>&46APJLT'=.LV&WD8X
M5)Z%FQS1M;9Q3QTDA<I+MA(P R8H!Y,^4VRO/<B\\0.Z>5JI82GPA-N:V-1@
M\O7Q45L*#&(-6"WUBK\BC=8M%EDT4X_57R.R P#4A&PJ&V O7QTVP9C0L^LQ
MH,ELB=L+D_NT[*%VHPN-INA; A5XS#M5MHEA)M:TI)0QR.S5W+($FF1P]%@M
M<?7VM8DZ3.9%2(4R[PQ$AAR?*KK2">_+W?WI(FV]Y;U"ZZTU<Q8D#KZVV?31
M.VWD?=6;##KU3L:K9H2%,$3WEHD#@9% RV6Z(%D7>#@>(+(CJ/E!(B-8YR2+
M4WQR<VI4^-&J]A46-.&['O5.E'8\:VZ^APX9 Z,ICAML 6%QKI8'0)FSE,LM
M5NH4]W9=DMDM;8&N/(C*FV@:]^_-%$7\9WD'/O4&W(G90U5=;[>NUXX_0->'
MWI@VITG9&B\"C"S:9.7R5DV%J*=>+3KB*]#0M^>>5!%QRS( SCHB2[MS&Y/@
M"=4CQ*^-9,D=?VFP6NCE=?SLSZ^0(<?MD;@HT@=$&60I938T3:1U&UO:+&3A
M4VK2;2Y/IH1PQ:I<C(HBG6G;UWE]+0K6NPK'7@HB'="8A-U5JPREK9<I=1X^
MV<51 PV-8GF:X1PC:5\2DZB67PF#2O:\J&["KUM3DBB )R6Y6PZU$L;HP=.@
M.J"TV-79&N;5,) GY7$:H[O*['*%W;"^:L386\/V,%) >AA.$HG@"I(X/QER
M9)$YSF]]U6SC_>BM/M\2S607NC<FNJKL:CT\H,04J]9TG>K)5[)"!QRQ*'/F
M.62(-9CD\/RZV9D9C$1@]#<H<AHB=NI]W;CML[:M%)6@?8Y$#2LZQ4:V4FL(
MF8$DV  QD,0M[LLO%,A[?89)3!\($D5<S5+U#C2R=*M^8@0L,61<_,\ON18A
M52K]8FPKRXQJ*'%-R;#K^1DIF_HXV-;4'6M,>N6&<2)U\C<(BP$TF>31VC)F
M45JM8"%)5:(6ATB?FUN4?)'6-R(U(,2J=WLPYZ^"W:-+UV:%E(==K-9J)(3M
M^>8!$#&, R&#%ALSHJ& ELD((22##*]?K=B??>GNWOT1-4KR/Y3AR,6S,V77
MYL>5IXP5"FB<F7M5QAJMV9KMAV[*LLBH1,.OUFLS!@\[/&!R=&&MRXMHD3V:
M_B:AHBD.O[^WW:MCZ+!6FRUZLJ);&ID2=5Z14[23&[=U^3UML8P4V4/MAL8#
MEC*BW9((,5.[@/84(M!BQT%)7SMJ,N21(UNW_ON1MJ5&'GO1N"7K:((ZD8I-
MK9BT=H?RVT!KZG'K380DG$^Q.6K5)2RW,>Q$CQD/@CA>5#AF ",M+(F^-Y?<
MGY\*CPX;&N%R)1.[Q2]]L$ L/UQ>;0!7K)5;UYKDS4X%UG6=%C1;+*F.EP!3
M]CYEAIU7:IN;%3;(L@1-B[\WN2 J_6B$ <K+5%&RBTEO!>AK;O4=ZNFK:)(4
M,2)39$TMZ\3UQ:X0 T:Z[(J=SMM?PS-1FC'[G7*PR1=3ZAWQO>^W_;PJV"::
M!"5\9M-P;1VLVIG9=.S6+$L3KPA8(6*[''QHFP*VG-E0Y,L:'2/K,:33,SQP
M\NY$(H0K/(CEXL53+++R$6&F2I*2-4=U;8'"^1M>VMH"@.1G;%-LLB:F58P&
MT;>==(RH+CS2ZK F1L/1FCBGR).3R;YE M?B;P5C5^RSBXBN2'*V.U!8!RQ,
MBR<:K5N<A)6IFQ$9\MBKVJJ-5AF-EEE4ALO(B3E**M0<)<OGT12!+Y0;\L-P
MM\^BXK\[6U6MX9 -4:@EB:=B58KNZE:[2Z,LV#+$=$-%3-FCT8X,@3HL]4>
M7;>]AL2VB!$V2/)WE(1CCX=1E5U\F4@,E[;-7JD_*1J.X,ZOWU<CVCBD!T_&
MR7/5\[KVC"9A22]#(QVC#ZYPYGYTUE;!$L2>3?)$&4L8 XL"X4K$D<]3DMZS
M-QL;SL9FJ:9M:-5USL;>;"DA_P!(=F%M3H3A8F[%%).RV/4ZI:T/O?)$CU3E
M+N6-M..>N5GB-TQX;K"'M2IR:(;$A-"E;"5Y!0S%8*V%<E;$FRP#P/5M=FE)
MR&9>8Q(.0DC8XZY5QYLBCTIS'Y* :4+M3<1YNY6<;1K\JLG]?S6:[*AXX_\
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MXM:P-MX"VN'JF]W&UZ-=&3S[^4V&J6.LU,<6)$I"S\&/=%!B@]-AC1Y:GO\
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M%35>*8,$$41<3!H^6K\*5"AO,QGU>;K:\]$6SBHU7$T62Q6@."(-))(4A@1
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M?7%/;S$A.L0YF1KBYD=]<Z:J01,U7$/2#;0+ T+8@$VK@*36:T=KEYN8&R
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M>+]_B^Y< )MZC7;E<";[2KV)[-5<+P__ '$P6EK2!>?%&]M)$VC:Q*^KQO\
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MP,K2E*_[M$5EQQC*?$I*59RKLGOUL.S'$.)XOC=+"8G$OQ%%S'&H77R&Q#;
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M2/)^Z7W5TQN1<H(N!QXILNXU,30[%7@9C?YXF-QL"ME2&(,0HS-J483.DPX
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M68=6+&(I1A<U@NQ,$LH<#R$2(^2)8L_*^ST>[5D%;M)V0*%(U,(?L[_SGHQ
MI37+'MP3J@)(E-C+)*A&QA"0<'&FVPKTLHQ!Q*3.@PYK,>#*(FK!Y]ULU:3=
M'K&J[?9[) LM3 !F EEUU- 62/< NZC< L/N#-I757V($;0]NBFVAI0M[/(R
MQD!+\F3[1;@D6.L\_:O>HU!,5O7%XB4[:@2-8Z!=C.:HX/.0(&Z=.:4M,*4
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M9_46V$7H>T1+V*E PD6YE@E-' J'8E6;$FE2+".)KEC=A@V1X&%+45E%8QB
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M1(%;N<U9#7=G/UVH3@6QB1^&T?G YN)C1@H130-=XM:]K,':]5@?-OT3[=*
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MRG;SKX ^$RS2ZXMROD#N=/&ABUW= M1^!KY"P$8SEAO %TB>M3$\3MIV>TB
M 1DA9K7$G'+$+;DV]L6)(1;*,*$"0B6,(.TBB;%EGA0"\$,U(B#V--?9 7DL
MG+J1Y?!$PC;7 R:!SK\V,0@10L&@+=4?#[@@RC(G:YNR'S;L,:U$C%-LTBS&
MZ';+A-/Q47&FLOT@U<G"<5NK22X\BW1=EX=W2S+UZ]4)==,CKOL;7P$B:@6F
MEREVP1>PMXL\RC69J<..QEE;O88]@"W&O3(2'2*76(QH?)E0H$XB1!NPN$%K
M):XTD+ 36*]6:]#QK0X(%W0-1F %LFZ_##*=B\5Z3&]&)O\ )OU.B/4JUS6@
M]I;=%M&A4MI\!B81._86E>*9\92=SF$2(U,$%C#S'S4=NJE[((WIVR5A@>B#
M5G'+=:Y=@*WFPQF1H*.0<O<6Q/B9L4[79C$3HB:H+97"*8%)[.$ Y,5HN',V
MU\$T)MC :,]32L@ZRU'"QYBM64:\6^=JB-8 XI^35K=?VP, C.8G>@D89(ER
M(_P=)-FB9*-6ZYAILW2K,%+ES889)CD4;2K4N?8 (\RY6##S@>L;5A,W(BQ-
M+UZM![##>+A((B;%AD6Q8;7PC<("+/8834<\8L1N:U!ETO:<*RRRX\)JRO%H
MEPI" D<\H1.%Q=+1XP*Z $5ZPS<ZUG#8! K,K,Q\B9MNQP-:JE5I!.L%;0+O
M=GKM'B5^-'VQ*L ;&QK3"T4Q3KT0*S8)S7M'?))=J$W5MV)UX)+AU8L!$THG
M-JS@F(13MC=7&-FQR%O69N79M0?.\'%>FB+T6FCYDJX!*#;P=+>EBYB+J?9N
MDJMT:6(IBK&=&D#@.K18L5NQCX$\B8^K0G#[8UU/T[7FNLRB%'CU#:L@VJM6
M\0":G6J?. P!L$J3Q#2R7KA'4,058M?RVX:*L5J8H3. Q2E7?BB'OW_9%T>Q
MQ_T_%KKM18H@5%:>(""C@;*)+D-<X#4!E"$/J0Y)4I:X%/#"P+&%*RC$&&UA
M2%.XRYDB=E'UW4]<BW0U3@284262DF2,@D7,V,T8,2VV([Y4Y8[(1+6$Z15%
MB0H*)I<G-DM#X, >RZW"@PX[)$^.B(Z(H1W:=57@ J4AS",/FVX_BPK*>WBA
M2U^'OC/_ "LHQG&,YSWSY8[J\LTY@V ]N=QLUK209V(@@VWVZ)(;>8B=?7]O
M->9.\/E&^-_')Z0/VGM0:,LC$5,KYG!T2[';EMN9;]%X@H=B8]"R[AQ"FEDE
M067$9RZAQ3*7'$[? <%Q^/ ?3HO93)-W"( )!_5>+2"9$VF%A5N(X:E:9>T$
MNC0\K;1\9F19>16UOX3;I2G3Y(S7NB=LV]YEY331.T%*S2QDA+?B3AUMJ#+M
M9/#:E)1E"9$*(YE.<J<\"O"CK=#LI6I.::]497 VD B(L8@@F?VL9C&=Q)U1
MH[NGII(D0;:F!ISY;W7&Y/\ A,/(4W8TX$ZYUK4Z^].PQ 'H>,G2"6EQ\>'V
MO/()1&>PTZM*L8&1A2W%(RA2U-Y]$O?X'L[P3O*+<47N:Y[657!P&5A%W#23
M,$;>JU]?$<4RE])X&6]H](L=1,>LSJNO>*_-)/,'4.VXNT[*S9KNUM"UR#T6
M6\E&4 2:&)-0P*CMX1B&.&B<9'0V(K2&HV8CN/ G+\A3_C7;KNJ'&L5@Z#?_
M "=%KF8<N!E]-H'CFTDC4W-^:]@[%&KA,%A>(TWYL;7K4FO#3^G,0)D$BT@Z
M!H\@N)]E6Z_4NPDVZK8@K$:N1Y;X*.W!&RYS:'<)0MQ^$8C/19+\=:E.-3&,
M.)0I.%.MX4KP8\VHBA7?4J!EJ<D]1K)$:6M?8GFO<<+CL0:V'9B*\&L&Q+HD
MVOK UMR\,05P;/W]LRPG_12I<%;K<AYR3F4%B1LID/+1ER:B4P3=QXU.*=\+
M+#+,1EOPNJ1C"\9Q9Q6"X?D9BA3=)F3F=J;V@\^EKPNDQ7$C1I=UAJ]-V*:,
MI8""( /BBYF #9POY0NS..V_Z31+'*V1?GXY<C4(2VX+H^>[%0"E9BR_$5'/
MI_NSQR&XTRZ.GY[M0)J6W([3R\)<1'#L91P&,IU68<N,L[L%I=(,&03)N=;Z
M':%R?'W8KBW"JV&JX\8:@YCA6J-J923!S-$7 F08 D^0EZUO^$;$@VH2M%W(
M',;1)QCTN+ LR) P=<"M:B34.#&BWLZ + /G<,I;RZ63!B1Y"<J7)AY>SXE_
M2.$P_!J_"\)CZU4X?&OI>*E$_I@Q%S)!N"(^:^2<?2Q>'QN(P>'BIA:%4M;6
M=<UB22YP(,$#SN3J=_0/BM_",.$5W&1JQL$S>=%',OXQ%=OH116ORDJ88:0E
M!ZG/'5QU84W_ '51,6/;1C.%^E4CQ9QJ:V%-<@X;&->XFU,Q);/D 2.7)5T:
MG<C^,UQ($9@# Z^NG+Y+V8UIRTU5N<7@WJC:5-V(,PTT^[)J=D'EUQFW^ZF5
M3(K#ZIL'TF$KRA,QAA?9.<^'&,9RG%KX7%85H%2FXM<?UY1 W)F($;[VZ%95
M.J*GZ2T#D=8Z:3/3G%U([NSW,=O]\YSG&,YSXG.^<?A93VSC.>^,]TYQV^O'
MQ^.)!YSYQ^T?NKIG:/4Q^Q3IU]?W"MWKD!;J\^LSTIRG.?+.,-.KQY85YX[I
M\NV,X^O&._2.I]^SUOK8*5W"GW8[?#R]W;W>7NZE$W+; L!$ 4BU8I""V%R&
MXD02(P/:<&-.PM"VL386'6%O0W\(5'E8:>;?0T[EV.K#S:.Y%P9G@J5EL4\M
MG:IJK'ZWMD'L5-9K;08WK\:(C;5K^T+#60Z[O6#EP3+L!0'F01LS1L40*$9+
M:BC,D</@#V"*1;;QAL%WV2]8S9NJ*H]KLVK+OL&L+&D"$Z6?U+ -P!8D1*D+
M;@/URRHF <FT%(?I8T<+/B,Q9OM_+XHB;M,X;D]?;;I%]I5RBU.K!2MEG66C
M /;T000@S,6:,#%0X2R3L&>V_$,BI=EEV%J?(<L0>;8 OL^=8B:L/7W[_P H
MN\\>6,8^K&.B*O1%S;RMJTRXZB6"'7H=K6>O9&C"L6YE'8C; MVN[RUS8TQX
M:2 <_ DG#&!.0M>@SQ$N"2.$1X^:J+&DN2F2*#J]Q*UJ8CKV'0MS77)NUC#+
M!/8H5^A%L69JWE]@F+Q.Q$EU2=6X[MK-; *2\X&#8T8,Z)#L V(4-@A'($68
MSP#TH;K RHO%+"H& <NKP&!-35ST(=,M]VUIL*,J8-L%?*"CT:LFM55O$$38
MH90:5'.$HEDA&$24J:(DE[A5H'7I81M$L:JX#YK"0T*Q%YFJN/8L5)C!+99+
M*!F0<(U8Q'U])CE[G/BND*(FNSB:$#I4V6_8&$FW"*0)/#?6[[P:>JU6]I 3
M3T72T7*98+#2Z]%H=OUXV2=4L,KQFEBKF0EY6E28/M&+!6F"F-ZQ&><O?UE%
M$E'XSSZWNA^MV6\AX>N<:>W[4]:T&#;V"]KE5W;=HUB0V!<'8#^L:O+#KAFQ
MS#LIM^Z; @1RMP8CC,"!C4,<T1/ YP1U/:J<NG6>UVL]#]LO6:3)F)ISOK!I
M>K:;K"%,F"W:TZ#DQ84*D!3[(J<,DB9Y7UM@I"G I*A""(!ZUT:U4J;0Z/N
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M6.C/:PO'S-/Q:[;(E%XZJ 8-5\S6RPF?ED%IW6]F]B6"!.&E(UF)*G0I(LC
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M+8'WER,Y=)H.P7+V8!"MRI)C,><P4(FGK+B*/3:-CS]Z[2R<W-NNSZRVF?!
M;""(1T5[0-TH)H!ZK)1KK7KQ""Z8$A1=IGL4X&RQ -1AL)+)'&3DXBVX'R;.
MJ@@(N"I5ZL%!DF-8V/2[A^DT718&Q+U#;8<.,8JA(G!U8U)LTQ]T17IT>V65
M9:QQ989MZ//847L:S1%T;?./ BW[$8VL+V%;*5<Q0:HB1! *Q4YT4+*I^-D#
MXQ;$"R5XS%E2"E?VW=:\2B3V9$#$>;"GP(T$L,CD,$2$;XF:W,T^MTC)^S01
M58TE<]'1'8\T2N?)KU\(T(H9/S798U]#MB7.H ^1'<99:%I62)H]F+0N$B&1
M1-.^3JU4;<VF\7V#L.>3V<(BAB=@CJI8^W"E#KTU?@A=NX#ZFU:2QX'*2_7H
M$^S%33$:HN)K[4)J&UGQ/W120!X8Z9KUXO5R$P1C,*_1;5%+ F:9K9F5%Q=*
M["JM@:&;$CTYO:4$<^,8>1$$L71,"&LC(BM-9%M0AL$B0QW"JIME?G!8=K[#
MMI-I=5BPI)?%%@M1!U-^8Z 8AIH'4!+3[>&Z*,5,DR$R9TV00+.*D(;>A,0W
MOX?W1:3G"/4,2Y6TL"L"ZQ8SMFD[0#2Q5(U(FT56UO[,![,E'6KW*U_(O-A@
M+NPM2_FY;K*: >S2\D.H<[!'5Y 0BE//'$4[6[=7)FP[>0E6[:6O]Q3CLJ/4
M&R[%UU](UY/;E,1Q]<AB503T[78F87AJ%Y:9R0)-B,C&%06X1%$9O@!J Y I
MT:4<*SIM&JNLZO5Y5C :YNT%B+K*#M@2/G3JS<:<;JY>68&;@LT<F[*%.MPW
MH86>$0+F17WI9$U=V\,=!FJV(UY>MK$J0%V4:FT@)7WHNJAX:T6BQ:OI]'A#
MJO4"=)S48]Q'UO5V2=/?KU=CSJY(FV5VML#XSD1@>11]-X:ZGN,!>Q-W;H&V
MKZ+=U\HK9K A($ZQL^O]7-W;8MZ-;%'%PMJU[(!V$LS6QLD-<&KM".QZ8="&
M%U,A!E18Q-1%*1KA#JRSO 4#]KW ()BV4!>@P"NAM9!06;[K+7@S3J;-$'C=
M>PH0]F."#",RZP):&U1!-AQT>&CQGUQNB*?M0<> ^DS1R?4[Y;EU^V29)FPU
M$DBJOB#%OEQH(Y-FR217V+%"DL!!(T8R+&%H85Q,-$U^ _-=D/.$4'UC@)2Z
M5<IFS:]MS84#8:W@$B#=5C=92C33M=A[+"-3S<N;0Y"[L9(A=N6\1.,W5=@E
M(;R%4.2/<#LMND2Q:^(&IMI+VX)D[(N+\XP4LL<LX"+5Z$:UO:[Q,U/LI9 1
M/A!$2H!Z%-J%5M =)3,QE,&QRHTN-+$S(<=F(UZ_6R) W%Q6HD 5>)M3NC5/
ML.S1CFMJY!.E!@:MUXX<9UC%JQ*M^I54P6Q8=?NZA#6ZF!F<89*FH#@\G,@#
MW&"(:470,S3 0_KJL4@5:YH.MTI>M3>IRP-@8Z9JCNO8 [(6>]DW"(CC3,],
M?+<N,6&/H<A39:<+:?6R_#(N>(/R=VH(3Y E(M)0P5L88L+L]FL%*TP;M9LH
M5B6J Y88%N):VD&Z@10S9E9;B4B: %86(&/1X$=UPPLH1.XSP-TE8YC:['/M
M)5E5;W-69PU\B.9B%X>Z"5O(3YDYE@8UZ6?38^PK^+ICZ,H;A#[@:P5;,2'8
M[L8BTG^!&H)E/74RY)#["XIY"7A&O=+4T:Z1+&=66,69)5*H:Y!TZQ2@IS4-
M9FM,6@&:'F&I!<2<A$P3\07!(L0;B/JX18A=9K.T)];-!Y&J+Y=Z?3*QINHP
M;J.U[N"P[+UM++U:LZ_&0*\(S;6;0#?G5**#(V4='DL'"A$M!P40]^_BB>QC
MB'1RA".;C76XACHRP[+LH,M#<K,AT/9=E;QHN^Y<UJ(0 2X$KV)<:"''#()"
M-(8? RB,0HB=.>CSXQ$ITS5NN.,4NX[++[%)M1[=$ B;N4N$FOQX9:Z$]C7F
MSMV+.!PD=ZB?METVT9A, 1>&0;>98P6""14QTX>(NMT*PM"%ISW2M*5)S]>%
M8QG&?Z<9[]$5W1$=$1T1>#O\(#Y4;%XJ\0*?8-82(XNT7[;<*@M61U/I)M9A
M2:;<#<PF%0K.(R3"V0^8<27*2\W!];<F-L.2F8Z<;_LUA*.+XDWOFA[:;#4R
MD _I< 1?74R-]M%@\0<YM#PD@ET6G<<A[\M1^<CL;?UT,'R\B18"$Z<4DO2R
M9"1+D2)Q.?(EI?FRYTR0X[+FR)#ZENNR)+ZWW',Y<6ZOOCKL.(=H7X.N,-A&
MAM)AR0&M!UAPS"':EP$6;$B; Z^C@6U6"I4:,Q!,SK!@.RP1/.;GXJ%R-I)3
MWEN29+CZU]\K4ZKQ9RI6<Y\7=7B[JQW\LY\\>[&?+/?08CB-6O5S5,S9T F#
M-S<':-QSM 6:RED:&@"#J(%H^&QTGX)PC9RWH+[F5JQ)PE*4N?AY]"M'B>9?
M2E'9:U=U.)5C&>^4K1G&>V,8ZVF'J.J4:A:<SLCM9,90+7$Q?6_/FL9])I?%
M0D-,BQ.]MIZCXQ8K[5MV!M:[#^1YXT_*.\(]64NGW3CO10@+D%2:0(@AGK%4
MP$2)4-R#K-*&QVB)@I1;6.1>PAP[Z],17)YLK)5*P7>6KS7B_#!Q7$.;B:KA
M6:7M8\F2,Q,"=<H.TBWP75\(XK4X0UHI-[RC#?"=@)DCD7 D:;PI:^2(J>L/
ME)N!/-0E%UY66=E6:W6+5]7M-^#P29&IG4:OKQFKR8!J,U(GP8 JQ'DE<R!B
M8DO+BENK85Z-M*=)0[-T<%A\5AY#ZM4&*D D6,08)WV-HU)LNAXCVLKXG'8#
M%4#4I4:&0OI-<X BTR 0#H1I(Y'5>'/)?EKKSC)Q-L7R<>[N(H_7?,/7FU7K
M#9-S38+"SDB#@_DQ',"2[(?,\VS8@F6ZL.)PS\NJ3:FIF?$SF5C$6/J3P?%U
M.%#!'",;4%=W\>6RZD#8D3-QJ-C&476[':7!4.-.XJ>)5ZN'J8<M.$RN!94=
M3-A(B0Z"TB3N7!=Q?+3T_5^J_D</DP=BZSUY4ZK:=D5C4[1ZRA0L00<.QKQH
M!FY'W#TZ&A$TM)*'DH+R%$I$EULAA:\*3E;F%]!A^"X,4L,'4&&K08R'&+.9
M'H1-S)ON>7+UNT>+;7XD]F(JNHXMSRQCS(:UV8  3X792ULB+3R"CG^$U<>]
M&:.UK\G#/U#J>A:VFG->7&OF9%-K@NNN&Q@8#K2:*;..C8\919\?)*$Y#4X@
MJ3.]+/E+4^MR0M6>@HO=F#"0&B!E.EK <HY_+9<R/%XS^IQ+KZC-\M.JU_DN
M= Z'M/R!'RGFW;;J?7=NV36;%M;(.]F*R+*6P#BC:BUK9ZFR$/2HRR0=(0^7
M)EH:1C\='K4Z4XZISQJ3U<>_N<13>V'93-I@[P8@P/M95.EP().GGM^XU\RO
MG/TYRYOVH[N!M]**3:T;"/1WH)8++D0"32FW,+RVN0A?:3#>PGT<F#)]+$DL
MJ4T^TZA:\9Z:EQVAB)P^*H!U)S.[=E%PUWA=,C2#:+D!:VIA'#,ZDZ'"2TV'
MB&AU!Y3?XK['_D]_E6Z-S%;>US9E1*IO $*]H/",94P,N8R-AI,LN!])W2W/
MB)6VLJ'2XM:$*7/A8Q#0\Q#TG$<'0#C5PU0-I6(9$$#>0&CK,3$6D65[#57V
MIUCXK#/! F#,ZBW2)-HDKT+&7?9@CF9PF76"\W&NK#L*^5#:(!EN(J)+06UX
M:(4LS(<=:S+0X)L89$=*(SZ$J;(N>F2ZCP)1B4GX*E@\0VL6OQ-4QAGDB!<$
MB(D&+;;A7*U=M&KAZ%275*I(!HC-3-_YW$>&!$[BYYKZ&VO^#Q[O^5V[?5A6
M<>?O\_K^_K"]^]5?Y[<KS;99.B(Z(CHB.B(Z(CHB@3DEJE[=&L)%'C#ZN4F8
MM^L[;#@W%O*@$EV@[)JEW?B2W4"3CL-1"  F#&9K0J<J.Y-2IR.XQEW'1%QE
M0^ #-7*4K!2%J^578#&L)]^$10RUQK=;:1+Y R2%HGPI(1N&<)RW-K5142><
M2N6YBNS$2%,,18"'R+7K_#':E2GT^Q5W&G1AFAD:<TH2-*V46+VS- T+=]!.
M;<V$4CTIZ2,V=9(VW6#,V*T*MZI#U9=%DKW-:+Q"%?(N:F^#]]/&J]IZ52*D
M_*I])E@[9NXU7;)$^<PB9IC7M AT^.>E5G 8]1XQ,,10$'";$:.1XK66K!3:
M=F&[/LY%V?=N(EF(:9,:?J4;5J*N0WO=-AM5*>.%#ZW!H%EE60@+K@1!766P
MQ-8)!S!: 1D-#*0YB1&8*B@=@K,TFU9!Y$WRO"2P':=QNKUC3K.S$M4\?*SH
M^]&3+1"3(,(!7;0]HGOA7)%=FRB(8Y!U59!TH<4EB/PK*TMU4IIV>C)%'A?@
M1L:=MVV[#BHTJP!)H,0U4MB+&!5O85<C;HU3L>GTRZ!:UJ42H< C5+7<RD''
MSAK;LQZ>9D&(Z' +[M-CD3>H7R<UZJY6(;D?0F,GIV=L.VM)K&#B&Z77;A?]
M#78<$ITN934R5I$1]2'*^F O(2&U$L4:4B2I#4N$Z1/X5P$)D)U(8NP;3<BK
M54I5LV:MPH,\X+VY.K&K-]T=_;]Z%F*O#@KVC;3.V@$\Q!EHL'J<6ORWY%WL
M$M0F-!(F+J3Y/[=E0MM5M5OMNKI942!HP2TG #C\>9=W*5O30NTAI:;$AZQK
M1%<^!7-4G@.9=NM>PC9:PGE&,V &-(2 (XB>C?$K8MXVML:Y+KM!U]&C<A2U
MQ@7#*BB;_M.K)L^ICT4%9$, ,1FJD-33RI&NOIL)5$TXT#;R%K^(!0P3(G</
MX:W(;IV#0)[&J=@RQ^U=&;#D5NX.&FJ/91FJ=.:SUR8 F'\U<V_%67,4>?.%
MREUTU#C0Y0Z01%S%M2Q2R*-Y/ ;:3U?30GSNKBU.**,6(Y()O61;XHZ3XR;2
MX_0:(!JS]<(0)]'KSERK!,,>(V* 3:!!)0?-63*:@D7"*<-G\0[#?Y.K%#"]
M3IH0/JV!3-L4Z F;*"64OKL"1FZ(;!3&1 K+(76FQ#YXWZ9X,*?(BG8++0N$
MMAN(T1-[1?$;9NLN16=SGRFM7&,ZNV'KB2_7668Q&Q9LAW5I6FSB0@?KBI3<
MKJ8O7*PY239K_?BIZ43?+BB%4&+;JH\B8VMN"FQ*_K7?U(M,W5R,[OKVI8$P
M9741T5AX_2C9N5=#!$57M7:W"1H=M%3!<>%!@UB7/AQH<<(8-'4C6#LPB;6Q
M>)![6RS-BB4:G[,H4NZ&5@],#:K8S-/CA3UCY$'@C!RLU>G6.6/'55_;82:#
M2 J)X8/M(Q.9WS<#J1> A$\- \&+7KUO65OD%*[0MA0&J(U:[94QX)[84*K!
M.&= T+-I<<F=K=H $F8&S:8Q;&0I9!VJYBPH!3P2#49G"")ID^'FW86X8*QH
MFB6&3&@7"]8W@7E3Q=IV781?+3CUOBN53<\L!1HXP"1R J!:DUTE7!UJBQQ0
ME1(8  B(K-601-/_ -3KWD0L)DZ7L.F8A,E+Y!*:+!%R8TG +=E$VL"BU2>M
MG4\&VF6@=OV%!.32YV_F!DP8)APQ%+KTP8V^4(G78^$5WK+Q:77<UEJ[[$O]
M6&L7>J"S"C<&KV"3MRL;6CVTG'!P<0 \/3FQ"!*N%B5A] ]L '70C0[,M -1
M,BZ%W_Q!,;5NDPO5+ !K]0)Z9LU.(TZ9'FM0I&PA=&V)1-0V/P0([T;(BNB]
MMV]9I+C2Y[<NO4=\6TXH7E*2+GVS_)][$.F9$QA_4[;<239)!,U$)&1=KWO%
M/;I";.C!MNSY6OK$.'PPX.$Y7(4A0_8L7$X8,(-A4A)/S8#$4MZ*X<V[5-\J
MMADJH<>-7SY&UO7 4;L!S9,X03U>W06="R"!.J@V9NJ:T;RFX@YGM6! ]:"5
MX?#UL!=A9*I(N8:OQ&V5>3&PXD#6FOZL'^;^K*7;"5UK;M>,[D,4:U;P+G;C
M9)]QU%=1*;M*DW2GFREHK=6V2"+LME!U7V]@A/;*4LB=P'Y,TS$H;X^QR-2G
M=B-:IDT4;>'AQ*5-B'A_&S26GJB?23G \DV&P-VU>5ND)3.5R RB(XH-\9MI
MQ4<BFG5O"J[TJO[Y"3+RT*/[3H5[I<':H"S%IUH+SK:7/DAUWLM?Q5*HV,LM
M:8)Q(L=]=OO11S*261=AKT&2D6DGOWS^*8D+@Y=0%:#R80G70U^K%+79GZ8(
ML9BS!;(Z7 4H%@"TE.M:% @P6I%97LH6/&UL=G&UJMKF41FDVHMB*%2*- 'R
M?>R;'0]>D"@36-*PBD5(4>T0#/F:]24'F-<"J_+VF3+.:S/OL[<:),/)(0V*
MFY/9@=A\;:'M-A=AF$4F7CY/<^9+2;&%)4A^=.L]B/VX=-ES!;NUQTZ[3C@&
MMW^T2J5=WI$8((FM3X\DM6;E'BV@- ]$(?;D.E8SW[T163/D\;"^,EN"CU*
MW"6ET7'MN'CAFQP*6]Q%,Z(72L6>0('GIU?:OQ ;8%#<.CH+U=',S&F!YV)"
MALO?FB?%8X;VX5NRK;66 U=6A87YN3A=0H=M,B0VKUUM-FQ,J=(CM:LA23E9
MN4@M%(V%Q!+7P_!&?8UDJ=9H[\*,A'RNG/JI0Y'\8[MR&,CRGTHDM;LTRAN+
MU]!JJ*T788W#*L0NR(M5C=MM#,R?9-=E5"H10!"IR*S:781"X1WI0^.1::>(
MN<'^!&TI<79*I-FUU)+[1MN[+R2(3YMF(RZD1V8'Y&!QE+JQ%ZO)?QK]I6Y0
M!HB'Q''9@V0/;S,=!B59FUP2*6+]P]M%NUY7*C(DU$W@&0W@0ECI9TS7H)9>
MS-S!=F5YA)=-0MK3&!L(7F,4;-5"T 9)!3<$E6K-7WY\-\B0=B\,-A7O7V@:
MT3.TT[(U;3K74#M<Q.:HE4Q)LKU?6%NE;=K6M"D%%DH4 "X(%J!T?7KY-HR4
MG "VN<2%CU/?OT1(-QX*7DE](\0>?H=KK5DNP]RIU>Y1XJL5_6TJ5L*^6D,@
MQ8M>;0@"C9#;NQ915<D=4)+DRE5L(!@FZJ6RV<%$34$\#MW5ZI,@(EKUB6(%
M-/"M06(B3*VR"F)&AZOXLT^5:A:6ZP0=+2Y)KC\:\(*=[):]F6882<-^M#9H
M:816P?D_MD2-IE=EV'&E"3DNWTJS.C6X\>'$*%*I=;N:S:TQ0NH0,>OF5 KW
M-P/AS_GX=;+B<>TMBE$GY)(21:,G@A8]=4:%8DPZ9:;("22>O$.N BY,GM&K
M8@Z,CQ==V%$4 X?L-'FNZO.Q[("C#[!-37C;[U>J5K,OKK)(B3RW"K:>W^)0
M?58^M:PULV8MO*BS,5(J,P*BT5.X]CW0[K4U6O;VJ+/81D:L +$M^=6H5>T_
M<9_KL%B0;HJA9*JS2+JC;7$LCLW:+.SUR*3$L\"M<:0(*PS8DF58ZRC56U;_
M ''9Z0A;(O,J'#NU1O"ZNTB'*BX,IS/'GD11KN5*(N;9GR>.P+F+5 V0_I\F
MV)T0G4-:C(D6&PQ&SP#3936%5OSBB]0&^S"*"\MFT89A1Y4VK*2B.+)%R(]H
MG-;SY_./LB=#' .TCKV3(A&M/A:[*.B)-/M(I@K V#I84'Y W[<SK>KX3%8<
M#1)=B%6IBJDH\<M7X<9R43FR7+ -0H*9(EW0W \AKR3K;-[:HECC4.UA#Q=I
MPK/M,.\%JSK:]5.!L:4!GT6KBA-W(V&V0#DIN?\ .XU#]D,2)FR;+.@AD#"+
M,<X-G[/<DES$+4R18_;3&P")+$6<2L6X84GDQ2]XQG=GPIE81!9-:TJ=:+T"
MAXP5MS,MNSE'(\^E"'WQ+Q%Z?8=:[=O'CR\O=G'N[?7CX=_Z/Z,]$5V76\>]
M>/?V]_Q^K/U9\\>6?KQ]>.B*OC3_ ,['O[?T]^W;M[_?GM^/HBNZ(OE=_A9+
MSL?@YHA;2\^+/)X;C.4Y[=DYU5LWSQG'NSCO]W?^C/?=<">YF+>YA@BBX3YN
M;U'NVX6-B8R1$W&OR'/D3Z<U^=>0?6J6XXK*LJSX58[YSV[X<QGMGZ\>6/Y7
M?R]W;/;J,34<:[G.<2XU'&QU!=,@<K\R !YI3!+0 +#]OJ?OM*6\M^EC(?3C
MNKMV5\,8RG/;MG_+]?U=_=UF":E-K[9B ";&(TCEOL9A4@^)P.HL!O%S]+GX
M<@O3WY-.1\FFB?R S\H_]).!WT6?^L;\P%6K"<WK*R&27K/S14A_-@4U[&Q5
MDV'.:CAU)3VYA2$Q.UEU3%TPT4'.9+@'$$B6S!%B8!M8Q(YJJ*=0^( Q>-@=
MB ;R+Q$W.B]"?D,/E4M!<-Q')GC)S'FG7>*F]:T2+CFTU\G;V!MJ>$RZQ;*[
M. !H\V0N'LNG38L*:\TPJ%')UZ B3EIHBY):QL91SY*E*"\07F-(N2>H/(6/
M,F]5)TRTFP!(S<M8-M]=?DGM\E)\KOQH^3[X2?*":R V.X5G<ELVA>-A<38,
MVEN65!IDS31-1U\S8IC3<JNP)M>F H,^U,FGHT"1!=<4.40=]/'3AU*;G%N@
M(!!F>D'29_OZ7&P)\6M[D6\MOEYI ^5;^4_X$_*?\"-:7>UZZGT'Y2ZD&J[7
MFHH,#/R"AUU)%EV]KD7Q<9N(>UH7'N3RM3KI22_8ZU:I'H&V$QUE"A2EM&LT
MR7C+%A>()C2=XF)TZ:5Z:;=+?,*,/E3/E..,/*?Y+;Y-KBUJ Q:B6X-!UC7,
M3;0DE5B <75)VNM-1=9SXR#DQ&(!K)LUEX@%>!O3V,"6<O$7($MUB&NT6NIN
M)-[WY1Y=3?E<>LV,$B2"#H-.7301 \Y7M1OCY3'^#R?*"Z9T'%YH'+X6L>JJ
M*AH15%5;?0 [2CIBO Q]J&9(ZY8C@S4G,D%&;B2E3R,!U4=B3'4RV^YC,97D
MYA87^)N-]X@6N)V*C?SV^R\=N'_RF'"WCO\ )._*>\,O;6Q!]QW?L;<$_CF!
M*U:65FV2B[%IM-HU0]OV =Z0&'-@HU77.MV"<B&UZ%3:Q2B4E[U5(EV:2;C[
M:&)F9^^Z+YFX><Y?:[?%:>WQSYYQCR[9SY=LX[>?;/EV^.,7*)\<FY((UYB#
MM'2_2RD?'7Y*6]1;;MFE=LU#:U*(2(-DHA\8?&.M./MI<7"F,^L0I*V7$9]2
M(Q%R($YE>%HD1)3["D*2YGJ^*DOR.@MT(,S>Q'("\:&-A!5JHP.:0+&-O>O[
MK]#+A;R0U5R>M'&?8=",HE)*;&J<[ ST;KLL"=98>P9KY'*,83'G#HTUYI[*
MU>!QE;3V,*0ZWU9QV (.'<6#)3)J-.LS>_, 7$Q'Q*P'U6AU -_73K,I$/()
MAX(),09\-C>_I'T_-8[(3CS\N^//OW\LYQY]_=GZ_AW]W5A;(=.I^-U?T4HZ
M(CHB.B(Z(CHBYHY9Q[L_IV4O7Q:_!K%#O6H)SDK6HY9:UN5V)MZC/V^/'&L@
M+++G#U51!ETW$A"I#T@.U-8?0[ <F1GR+AVI[8YGSVVG=B-[#J R1:Q<384J
MEZ3M-WMFN)'L79DAP?KX1/X[ @UQI$VW!Z%7910%(WI)%@RD@UG8\6$8CV0,
M3W[A*A0KS"KA^THJY_;DL-=]F;.9@,D=;C+%&UX!C\B-%UVOEZY),5(B1:@D
MM9VS:):%"L!(M5F 8=PI7Q0Z'5B,J01*#6P^7#,N&&GXVK,,CC\BO5J,C341
M-?V<!B<A=ITFV6?9MR#T&&+H!03HP)2[[3W0A?6XJR%R<:<%&W".;8K40B90
M/:G+BO5&IL%7=O1",<* #[&8/:?>FPZ+1O96N8+&Q*3:C5,DD=F;M(K)6"0_
M0)1[8)(C:%R [FN4R@F!YLB:@O=_,8F'9.UF3LVT5AZZ6>H%M@2=6E0MJA5F
MI;CY<UL-.11JKH#::85J<'U#38:Y(CZ0?)Q1Y.))+C*LX5;*"R+H726U^42Q
MF\U;7!7RUFZSKPG9ZK(KFKC=0 R++$4<5#I]"K5XU51SQ4\N.@>AJ/FX[C$F
M7HC9)PS5'C3%,9(H/ ;4YX%P]MD8^EN"JDC=Z6FLYEZ:BOD-C/56J\9CFL*:
M8?L?'C5,N5!/G[9NROXCU?7-'M1J.%FP19>7-JSAYTB7['M?D=68W(/9!XUN
M0.6H_''<A5H69U+*A:OHU[#;*D?,YK7;CE8#U[:\MRDCX9*$_-*7,I/CR)2?
M;D1HK( BR)SN;/Y6YDS&1,K=)( P:6WILT3T$Q -;;RNRT^*1'[RAKU<+3J8
M"(BSK1&#'G0.HE%@\1NQKGEL0,13)%!7TB<_*70R-?K'TK$C==U99Y=5+W75
MMKM9ZX7=#^TUFDGHXSCN5&SSH8@,K3.OFBFR]>!S\9T'+2.V(.L#?=[^**7"
MT[E</W(PU./;ZL]?JIG-5#28U#AP %X"$-I</[1--V7--H0"O(G":W9]P5H8
M>BNUT>Y6Z@;@RUSIT"XOD7[>]/91:_''9W+F\;S+N[& ;E@:_@:&MMEK2KM0
MCM9BM7L\1J2&*L7\&EM-5XA8 2 3V0P%X/=YXA):QMC-AVT22]-&(D:?LWGK
M7PU3@O8OY=HM5*):++>9VI'8QT!=K)JN&=(T&-7-=\>MG/2:C O,<Q$+L2:"
MJQ EIAULWL\%/EPB#Q%.FK[SR]*;]$T>]#3$2BC2%C=LUH;UXD74BHH&.,V4
M=@%9)@-M3BCS&U-45AAG$QF>X2U5L%$=62 VV]B+G8EL3E_%N!*WL.;IE&(%
M&CO6FMVC61>L:AHER@B.3$^>&IY5->K58NU9'3X6M4XLDTM:%EDJK#1"^S$'
M!P\2_M_?;WT18\[!Y)7^SPV@5YY%GZ+1N0\(;,L\/4'S)NTRE"[/PF.K#7>G
MC]8A4-1\Q;?N5Y_VE2@Y$E6H9QUS&:X++(6]^_?FBD;16RN5=^W!6&-@@=Q#
M-?QK[3[ RJU4<[5,#Q]@U%R?BVJKV69%TUI\5," [.(U,M(J=](0X5928-V-
MLFTR)X:0T1-N=>OE P(B%9P\B^WL],IPTRS0;!J.I@Z\U:K#6>3*90.>5%4$
M?88,.L%*%I:9$8>,LST%K:XR>G$!%PKXL:3W[]V25=MA\P#NJSD&05WB.23J
MVR$U0WKK3%VF['-W2.UKMNL5"ZKF<>-2GZ<(>25O4D5=*UK[7S./4(4=%SGS
M :_G2]^_=^B*30EVY.2 NY!Q_&XQ]@%A;?\ 196(6IR[P"P"$V?+\2VR-A(J
MSI&->8TM<P"&IZK?%]>J3$ U$IDJ.[BQY(F@4V5SI##13ZF=@F(%FA5$S:RS
MFK6!YC62)UIW6*GBZ; J&AMHF";RF:]J)HS#-:SV>:&C;%/L:VP HDP8 D4W
M:7V)R>G[A0!V)"LIVND=4BS"7HFN[+1:%7[<BFTF:[%(DK?IRJS)9<O8Y9]2
M7!>T"TJ"J?)KYG5%*DU*45FD7+>=F<THAJ6='N;ZF,G@&D8FQI-AT[: ,36U
MKQ7^0):\UW4]?!\>-K1[/7XMT:H5?+W$-K&^RY0%ZN,E;Z^Q,&VV"1+S.XN;
MD:#8UG!=O,'*Z7*&T6%G65DI>M!\=K6^[I# >&&MVL-?&GAXTZ/I/I725VVO
M7#!)@'+S<ZS.LL6L0R+&UN#E\>3M63K*W[=N(;6#NZ"-159=#5JL6/8!JH5G
MBV:U_KN\A9.J@Q(.T;G7;;D1<0-7:;<SD&.Y/&SH.*ZA;9%OUW;'-$U16'M@
M*VA46RCD=F[3Z'I&TVC8-%L\C7E[(2*S5 93CK4()>@R;Q"J85!ZNP-IR0;*
MW,KW(^P<B6,$1.(>2Y'5<[1)12R\D1E6.\=>+L&_$!6KY^RRE+-Q 6Y%WXF!
MKY'6]XE2]F$KFQK4%L*,4'VJP0:]991DF%1!$P#=9(G+L:W<F!D'1.P78NZ(
MUF(<<KO!NU1UU2_:H.-LPW;-'1AQZT!&=<;.S7K") 2KH>C1'PUF>$1Q-@&
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M?"D9CHB/,QB*3MA\KM1T;8<:BV6A7<H2N%5U>\3*!M8G;;$(@-EN[*C  KR
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MX_<-]4V*<U$W THWM:UT6V);>MVMQ@J8=XSV@/?&60HZG52MU.O1!Y?([YT
MX$$?#3$DIA"H@E&&\,$4VF*'IPK=9K0_==H$QMD6X<0.:MH]V 1ZW9K^4I\\
MG ,$U" DN\#7#]4JF3#X)FWAZ%;6JZF46K9AP@7R7(D\-4]35JE6_C7:.1]A
MN 3&I)M2G +<7U$,):]UZ#&CJ81F8,4K7--P-EM0[* BR)5VDEI"G'1\N/%1
MAR<[((H?*Z*X?F;L6UK"V2>9N[#:=D%FHC@.WA@PFTS#5QKJ["];J#<=7M V
M =?E,4P%;6'VH%8KP8L*AX)#Q!]1$J)T%PXJ]=UQHTM=94L49GUJQ:^'GK)!
MDM65-1TY;J2!>%6)(=D>1:%4 8:-HGP"*2H\J*%'4D(CKL!,TB?FP>.^C=F$
M]3[)L^R[4<S64ZYA5JVPR=(.1#Y#4%AE;2!'YUO71S$JN/23%;F$KD0IYRD@
M+CB#$&V-@@J!7HL(BP#^-W'R#IK8 /&R52*/L^VAK?9;ZX1U"R+EFJ9.&28N
M78HZBQ-2GFTR*LVS:_G53[%*MN&9^+M)//(2XP1(\SC'18H_2>L-?[J+TX-0
M"VW=DRVQEBI6=@6*K[<&W9!U8UEZL2@:*LX<NI!S$]JM,,B(33. )$>6'0"4
M<B1%:EX;VT*L/6]F0P0_3%@(LKM$ M3"0:LHV2"KK<NF,GMA52TT69!*B!=5
MD1WHF)MI#28@N6//C9DAQV2163-/<69%^OU_'[M+AMCU6WA@B[#626MXMFH5
MJ?$-DAH 8S$UY(?O4Z;5K_@8-3L"'LLD% V%P55)0;&,HC$3XW#QRU[LRAVM
MFJ[+> &H6Q95CE7/-I%R6*K<7DTP)86ILU$*5@>6A!J[$]1C$%YE03\IJ213
M*CN^IY(FZYQ6XR/+D$C&VC)R;MZ=,M$DJ0V#0V)>QK3'KFT*Q-N@N0&KXM#Q
M."&VX=:0U3T#ZX&R-K&8(2$V+RB418JWJ'BULBO%KTK;!F^QMOQ188WL,_8:
MR,3L>6<+4BV!4,98JE=JTL@Y"UY5 $,360\2*V%&RA\D5DZJ?,R18]NZ#X=G
ML3M:EKP%UK6]B2*]JTUI_7)RA5.MV*V1%7(I1L3*[ KDTJ M(@J^?-"\"YX*
M 9(!XS=H'V%@8R/R1*>S.+VG]FU:_G*K=(RG-MRYXLC<<7R$R*KGI6]4QC]B
MIA$&.><^=]0@Z%KA8!#]K0T1S,$PY/*PHJNX\BW-^A^,3Y0"W>-OD-7O,5H3
M6WX%0+C( RX4Z@OE=NBZI-7+K%B;>AUU.N;"=<AU.4%/I$^O!YTIP79(XTF1
M0R4XP:]<C2+;G;H^%Q'H]<OMI.20ETAD5N39O'RU:0MYXTRS3I#$ X(I1Z;/
M?/Q;D\&3@,+'.:DBGO:=J)/I[^*)!VEQ_P"%-KC"5V[:.T9%<N *!M0:; 5V
M)8ZP I-KVI8-M@K-,V5$TS84:JIDF[&#$YXB7N%3&'!<)F/=I9V#6A[XXBZ9
MO8;CC'LM4W78]A6"#BE*331D49XYXPF8T*[LV/)C/#(=5)V(B9KGSEOD65%#
M2V6BO="&84Z1'@9R1,?4O%7C+9A5@C:].W^,-CU)K6%TJ1VOCZK:XLG.JHFM
M(1VR#[[K,+MFL6*9KSV0Y BIE Z@:;C#+0U6)TAY<Y\BW]C_ "?=,.F#UYI5
MYN=6V$9-0)48YE5.1D+ (;@U=M2WYCE8E&S:; 44]J\1'J#EY.6V)56X\,"&
M8'U5+@C!$ZP? #1XDI<C*9UP(/;05;26UD$54IZ1LBVW< 5JUFNQT['I,:TA
MCA (33#P,HIZH4R-@4&7&JC2QZ,J(K&N .I'YUI)66X;1NDV]+#+O+MC+4]&
M+6BNM4:,%9G-5ZD &AK$&!0!L##5=0$3+8(F7)WK4M^%)@$4M'>-%5MNJ(>H
MKI<=A6\/"D.OM6$N3KS%IRS[+) X4!4D+6!05N&,#DU086(P)B0[ZJS/)29Y
M5XA/G$3(MW!_3UT?,O%YURPD](ER2D=@D%7'D.2*#K"A1>S4RO2\-^RF]/4*
MSCE-^!SYS"7O7USJZ0G5U\BPD.#6G#M</5>S3;78AUI&TT39?3JJ-?P9@TC9
MK^U1K#@VDU"J@!J)I]]8XF@"&$M. <(BP6X$]/M/)$C2^!&L2,]P\7OFTCEN
M6]AE-P/O:U.F(];S5*Q37:?$@%M:3*M$#/B:75I"RD>NMW1LT)]N1K6P4)&9
M1$B?%/XAZ\I,.XB1EFV!,KMIU>YIH=6B9<&Z&H>N%3++/8K]*;B5N#+:S#?M
MA1,8I9IMF+YB-"QTF?('B!\6.1:=4X9ZPJEJH5JCG[\5SJHM:#&L01@N#=!4
M9V]J(R;S$%-0*X/)SX=L)D&BQ!-B*&Y(V0-'0:Q* @D2A$LBZXZ(DDF6BC64
M.R<)\#CF&DX<E#XF/'E*E8QAPA,ALJSV0K.$H<4YGMG/@[8SG$$@"20!UM]4
M24BSP%XPIJ-A>._EE!6N*QGMGMWQE)O/?^CO]7OZ3.E_*Z7W!!Y'5;C9U3N.
M[8N6O&?=E$T"K';'EGSP9[9\_J^KJJ'<CTL?91:ZK3%0XME45Q+K??QM*)5U
M+B>V.^>Z%&\*3C'GWRK&,>6<]^WGU.5W]+O@?LBM^=,;/96(Z\X^K!.MY_\
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MLD"7>+".D!S3X M/-ZLVP!K8PE&M]@H4C$^WF:,/JT2 S=:N=JBR\@P@2D[
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M0D^L V (C58-4NEI U=<>4;:^G/R3ZB3D264N)QE/GE*T9QGQ-N(SX7$*_\
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M@HY-$)L&Q2DV0')#ZIEQ==6Z\LB9LE#[9&T%R<JK."A^0PEP1AA@J1G%H.6
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M/N+1@4Y"R/(M\_Q(V'K^'8;K*UOJ ;3WMBS;.1T/JJ5LZ\5&P@S4/B%7T@C
ML!I;VY*$39&C[@7L[ '6QY$:).!)< V*'/LZ81$WM??)\6^VZ\@%+=6M=B;"
M3;+2!(:QR+/)FU2MDZ!R "C:HMLE67B$,?%N6Q=<6-0R:PS+4U48I@V/BVNK
MAA/1%UWL;C%L2[6ZF%W'-?E$#JAI<#,NE@-6!=RUY*UW:"I[8J: )14B$$]
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MJI8*OK@U+R8UOE-24,5+JDH:T!K@XBH:X"[R)E4%A)/4VOZX@/5QD_4=/M)
MC2[;("2:6NQ$S4F[:*LU>1)V&L'(-V9!75MO:66KM;21;L,PP7/C");E<!MH
MH1+4"GZWARRC>OIY\B2M1N6;M:*EK>V4HIKRT&@NJ*Z@I3B*20VO12[0J)B/
M4"99#%)AK$P!1E[]^_-%T)NWC=?=BZTTQ7Z17-74RS:UF)EQ J[3*)ZXI"TL
M168<< ,.Z8LGSR@AL1F8XR1&!Z@N(J*VM5*NU!?EO]$4%5W@?M*N7X <BDZ
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M6S",.>R6<N\H-'-U2MQ2+1N$#E9).1*C926]B-:"[XUNG6A2J! <EZXUBO\
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MT2"-FE #$2Y>VAM=]+5F)<']CY^DHKKCL+DK32\RNG#FS@E)J)?9T.\;"?K
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M&\Q[3!4\C;=CS)!'YX"-5:YVZ2BVNJ@]?38 X0P!NA,.Q/$W,]*EG@4=M0E
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M8.@WJ7/UV%("J/L$[3#!9-M>KUCB+/[DVMK36;(BC+K1V-8&(;5%%NW8O(N
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ML&6J:J7"FU0%*AR\D0<>LD<R(SL!33RI]=B1 $Q3J%YDA8L<6_Z2 PU&P16
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MI5Y\;)D:?U4_)#.A'A,E[7M3<?%.UEK+%:=&.+$J7!<KS"E,!%QEM*%LYRU
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DISQY:RM*<Y]-(<QCP^)7;*/#XL9_"[]L8Q$#KOH2-?(HO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g68105g16m61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g16m61.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1.N4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $Y*^4! X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              '@   (6          $
M                     0             "%@   '@
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   '@     4F=H=&QO;F<
M  (6    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   !X     %)G:'1L;VYG   "%@    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ ) "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M 0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                          #_X3_Y:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(P
M+3 Y+3(P5#$P.C,U*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @
M/'AM<#I#<F5A=&]R5&]O;#Y04V-R:7!T-2YD;&P@5F5R<VEO;B U+C(N,CPO
M>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R
M,"TP.2TR,%0Q,3HS.3HT.2LP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @
M(" @(#QX;7 Z365T861A=&%$871E/C(P,C M,#DM,C!4,3$Z,SDZ-#DK,#4Z
M,S \+WAM<#I-971A9&%T841A=&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N
M/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @
M(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\B
M/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%C<F]B870@1&ES=&EL;&5R(#$P
M+C$N,38@*%=I;F1O=W,I/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L
M96UE;G1S+S$N,2\B/@H@(" @(" @(" \9&,Z=&ET;&4^"B @(" @(" @(" @
M(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X
M+61E9F%U;'0B/DUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@\+W)D
M9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I
M=&QE/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D9CI3
M97$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^4E(Q,3<U-S(\+W)D9CIL:3X*
M(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^
M"B @(" @(" @(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@
M(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO
M;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS
M.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S
M;W5R8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(CX*(" @
M(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#I"03(V04)!-C W1D)%
M03$Q.$(W13DS044X-3@V,T1$,SPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @
M(" @/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#I".#(V04)!-C W1D)%03$Q
M.$(W13DS044X-3@V,T1$,SPO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @
M/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.D(X,C9!0D$V,#=&
M0D5!,3$X0C=%.3-!13@U.#8S1$0S/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT
M240^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F
M.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V
M960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN
M<W1A;F-E240^>&UP+FEI9#I".#(V04)!-C W1D)%03$Q.$(W13DS044X-3@V
M,T1$,SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.G=H96X^,C R,"TP.2TR,%0Q,3HS.3HT-"LP-3HS,#PO<W1%=G0Z=VAE
M;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O
M8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E
M;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T
M.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED
M.D(Y,C9!0D$V,#=&0D5!,3$X0C=%.3-!13@U.#8S1$0S/"]S=$5V=#II;G-T
M86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 Y
M+3(P5#$Q.C,Y.C0Y*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V
M("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z86-T:6]N/F-O;G9E<G1E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N
M9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE
M=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z86-T:6]N/F1E<FEV960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^8V]N=F5R=&5D
M(&9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G
M92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V
M960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN
M<W1A;F-E240^>&UP+FEI9#I"03(V04)!-C W1D)%03$Q.$(W13DS044X-3@V
M,T1$,SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.G=H96X^,C R,"TP.2TR,%0Q,3HS.3HT.2LP-3HS,#PO<W1%=G0Z=VAE
M;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O
M8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E
M;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T
M.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @
M(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#I".3(V
M04)!-C W1D)%03$Q.$(W13DS044X-3@V,T1$,SPO<W12968Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#I".#(V
M04)!-C W1D)%03$Q.$(W13DS044X-3@V,T1$,SPO<W12968Z9&]C=6UE;G1)
M1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N
M9&ED.D(X,C9!0D$V,#=&0D5!,3$X0C=%.3-!13@U.#8S1$0S/"]S=%)E9CIO
M<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R
M;VT^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP:&]T;W-H
M;W ](FAT=' Z+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @
M(" @(" \<&AO=&]S:&]P.D-O;&]R36]D93XT/"]P:&]T;W-H;W Z0V]L;W)-
M;V1E/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\
M+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M/#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_;
M $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( 'D"' ,!$0 "$0$#$0'_Q  >
M   ! P4! 0              !@<( @,$!0D!"O_$ %,0  $$ 0,"!  &# H)
M @4%  ,! @0%!@ '$1(3"!0A,146(C)!40D7(U-687%RDK'1TR0S-U1U@9&4
ME;(80G."H;.TP?!2P@HE-&*3-4-TP_'_Q  ; 0$  @,! 0
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M0T;!, GIZ_W2.73NM\>_PUO3R8IX>(.,,OC!O&BG9%A608I+-!IJZ''B$O\
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M& GE3$5[1L^[DZW.(G3G?KZTI$Q/CWV/PBEZ;9ZL+F\K-UM)C94O)8F3.A]
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M4^&V^\>6YM;1I]M<XYB\4^6&Q=,"GPR+D4@8(#SCG"*CEECE27,64!Y!)7I
M(Q".[CFN6/7^_C;T ,Z:>O7?RBF1+?93AVYM[EY+25?31YCN^(4%$.&*6'C]
M13-K(1XHB=!(T)2$*UJ,1S!J16.Y<NGUUC;Y'RI'6]XUMKZY6%M*7MIXA,SQ
M(JR+&QQ[+:"'78_<75S1Q$:*H'DX31XU2?RY""21!L&QW-<KN^L8R(=O5RNI
M'J9^MZ7V]>KWVY&G*V%W6S/<R7:QLC@0ZZ3B-?'K<GCQXY1M;D]A)\]$%'(1
M$10"HW!4S6JJH=RKIT_G_= >?(?7X6MOSJ33?;ZO?T]5X]?H5?7CZN?HXTJ:
M/;GCV<J)PG/O[]2\<JOKZ>G'/LOXU*F7X5\ R<&3MS297DAT;*^;&&>3U#),
M)*$X#4BB5.MS&N=U*5R=*+Z)Z(NE*Z%L^8WGWX^GCZ_Q>G'U?BTI5>E*;#)D
M_P#F:^OM&CK^7E.>/^/[/Q579[2W(?Q\:]!PM4,&-2I7TO2>U$KY#UXUTLZN
M?P'VHTE?(>O&F=7/X#[4:2OD/7C3.KG\!]J-)7R'KQIG5S^ ^U<C_$YX,MV]
MW-W-\<IHXE'(Q;<;']D:>"V3=^0/)9A.20Y^3AE#8SNQQ/KQ&&#AZNE*J,3C
MGE?<<(]H,#@>'<,8=6L.85SB#JTA @*?:4EB+;K.L&.8->%XSP'&\0QW$GFD
M([/%-X!IL]H9AAY*GYO89 ;" =-J1,[[';DY-V*JVC8?B"[=4/BAKMS**L-;
M/(RKP!F.@AV X4$B.[4F1<B[SH2.Y(Y.\KE5>%L)]J<,G!EM3SR,4]P4X$P@
M#-B ZI2LQF\((@F?=&41I54^RV(_&)6AEE6$;XPQBB"L0G#]D I"9%B%I"E0
M1:YO33;C> ?Q/W>V-)MW78OAL_HE;\RTL8V1P(=G36>>9E+N\8D.L)P"(E4Z
MO,U\]E:%ED&2B#87T55N83VDX,WBW<5VSTJ_*0$]FHH4C"X=+;Z0D&1[UCF]
MPF3$51Q7LYQ5[!!@LM0%<14HA:04KQ>(+C*PHB-"/T95ITF0861/L<VY626Y
MK[,<?QRRMYF[OADO)<V1E!R3%V_V_P 'IJ#<VL\R)&*CK*=#E-\LWA;(*L<\
MB)Z)I/M5@6<K#2W>R_+>,I0KLY/XE[$K<PPGF&BF"--@+ ;E>RN+>*EO(1)Q
MO#'!"U066F\K\7-BZ% @VN)&U*2?]C[SLNY1(T/'L89LPSQ6;<;J@QA;TRQ/
MB+C^R+L,R<;Z]W+BRIN8*L@D)Q.FQ:[SA557\:TI]IL-^&)SO?B3P+%8)<(,
MC%/\26\R9&BOPX09U 5'?N_]K8P8A(*&@PCC>%QJ/ZAA6%8X<AMP$?M+REDI
M( )$P2(I%8-]CZWVVSPG$OB?18,F;QMD_&-@F7-M+^1*JLCM-T,WB6>SU5;*
MBM)/J*S'8[(BHC@CID8@$5S4?U6L3[4<.QF)?&(<>2P>(\"?20W[R</A&.QX
MAD,Y4#\0/>21[Q).E:,+[,<3PN&;.&2RA[\!QO#OE2C#OXU[ML,5Y[.*0QD2
MA0G*/=!UIO\ &OL>'B$@*:ZN]OL9NA5GB7\.>]-'@EEF%4YDC'L'PJTQ7<>M
M;)@1&U%3*GSR5L^+' )6'@A& KEDB(5^]WVIX6X'&VWGLYX+Q;AKI#9@JQ>+
M4XR5),2I+=@5:;'+K6P_LMQ(A+R\+AT]GQ7@W$$H<?2I24M-AEVX 2E*U(*A
M$2#[UQ2A?X O$94TU 2UPC#MUX[L<\3V*!PBXSA]57X7>;L;PY9FN%;FP)KQ
M.%/DQL?NZZ-.C"8R=!)!8&,1$:JIJ/M)PA;CB48K$84(=X9B?Q#+)<5B6<'P
M_"X9[".)!A)+C2B@$P0HD@P:VK]F.)) )PF$Q/:#B[/9+Q.489S'\4Q>,:?2
M1,@(>2%Q!0$H -Z4-]]CCWJG0]PI,XM#EV=K3>#VLP+.)U^>/.27L]%QZ+N7
M/Y?RZN)8,KI"1E>A"V;%X>Y.M434W[5<-'X8!)9PQ/'/Q#"$)/N8Q:EX6#%B
MA2X)_L,Q!M6]WV6Q\XI[*RO$ <#_  [J7E%Q:\$A+6(D$VE+1L#<"3>:[HUX
M2 @00&7J,&'&$9W*NZBC"QA%Y7U7EZ+[^_O[+KYRL)<6XI*B1G6!F$$0HB#W
M?S7T1"B&V\Y][LT$B#:0+=PK+U'O)L ".?HUM"S%C;N'VHTE?(>O&ISJY_ ?
M:C25\AZ\:9U<_@/M5;?G#_*G^;1$]I<0;?,5@LRAPG7(9^%/2+^*9^:FK2=!
MW#Y5Y%6I[S\ZN:FHHTI1I2C2E'*<\?3QS_5I2C2E8%C AV44L*< 4F+(8\9@
M%8CQD8]$:YKD<G'JB^_HJ>Z:4J">[_A@+'6;D.W[%,'AYY%#U+W6+ZO<Z$YW
MHYJ+S]R<O/'''.E*A1(C2(<@L66$L>2%RM, [7-*Q[5X<CFN1%:J*BIQQQ]*
M>^E*P9<2-/C'A3 CD19(GAD ,B.$83TZ7"(U?=KT547U3CWU!MYW[O#6E:-F
M)8TQBB'2UXQ^>AV2L6.U/X= 8$,*6]/5.]''%CL$[GY+0-^A$TUD6]<_0I6%
M(P#"YD)\"5C=6:&6*R*^.Z.G2Z,"62>P:KRCV#',(^4CF.8]JO(]KD56KIN/
M&WAO?X]8C>H(!U /?7M=@.&5'7\&8W5P>X&='=Y>.C7.99"A1IPGJJJKF3 U
MT!LQRJJE;%3J<KD5=-+S:;SZZB_3OJ8'*LUN)8RAH)VTE:AJT=&""5H&H^(/
M'%F-H!A>WGI'5/GS%B)ZH-DHOJJ.<J32L.3@F&3(;H$C&ZH\)WPROE21FN$U
M,CE,G7G2U%^02SEHR5)>B\DDL"1%ZDYU'RCQ^D>M(NK!#MAM\"&^"'$:5(JS
M@6+@I&5S"3H\?R8)3WJ_N/.V)U <1[U51HYCN4]-32LI^WN$OGUMH_&:@EC3
MAC K)3HS5)$#'9T 8SA>VJ@Z58)7M(X;>AK%1$](TMZO)/JPY4K;Q<<HH3X!
M857#C$K!R1U[Q!Z71!37,=+8%4XZ4DJ)CC(GSU:WGCC4TK=(K515]OI7E.5]
M./H^GT^A/Q\>NE*<+;_;'*-Q;)D.CAO6*US6S+(S7-A11N7ESGD5$1Z\>PV+
M[IQS].HO.]YO.EHTW^]Z5TJVNV5QC;>,UT4'GKM[&^:MY+4<1%Z41PXK53@(
MD7GA4^4J*B*Y4U-*>WCCCCCCUY^OV_\ .?ZM*5[I2C2E&E*-*4:4HTI1[:4J
MCN,_]2:4JI4147TY]%_X_P!GO^5-*4R.Z>RF,;DQ'E,)E;>A8J1;4 D:_JZ>
M49*:WCNC5?=>.KCGZ=*5S5S[;7*=NK!\*]A.2.KE\G8A1SHDP?*HBM*B*UJI
MQSVGJCDX]E]-*4VDR'$L(Q8DR,&7%.-&'CG&A@EXX7I>QR*BISPO#D72E(BH
MV]I8%QF-Y->6\L,T\A&LUM& ((%)5)+^#J( T9T_!L8L^>5K7*YQ"RU<[EO1
MQ&O3O%]_X/\ ND?&E<M-4N(4CJV&YY942>1SHXW*Z77HWR,MRJB\R(B#8C'*
MJN'T-Z%3I;Q._EW;^CX4]>5(S$-JL+PRG=45M1#DC.MEYV7,C!)*FCM;B5>&
M')*K>2,\W.5HD5.'=EG<1W2G"H  F!K2IL,7QVW4KK2FKIKC2 3".DQAD>Z3
M%%V &<]6=7?"%>SU*O2@E0?S?32IJRS#\6&2(\>/5+'04<V$YD(#?*(^1YQ6
M@Z6(@VME?PAJ<(UKN7(B.]=*5>3&L=;:)>-J*]MPT?:^$TBA25T(U&\M,C>6
MO8-$9U(G5VT1O4C=*5?=0TSS^86MA*92R3*58XNONS&HR67U:O622QJ-.YW\
M:B)U=7&H/?\ "?.VGEJ;Z0K"CX?BL2'+KXM!4!ASS-/+B,A [$DS'(]A3#5B
MM>K'(BLYY1JIRUJ>VIJ  -!%;:)6U\)9)(42/&?,*V3,> 31.DE1J,:0SFM:
MI7-&UK&N7E4:U$3T33K4UNZVMGV\L$"MB%GRSO:P4:.-Q'O<Y>$1$3E45O/J
MJ^B>JKZ>RE3PV?\ #$*!Y7(L^:V3+3H-$H4=R$*M5'M68Y$^Z.1.%42*B<^G
M//II3UZ^%33BQ010C#'$P(AL:P8QM1K!L:G#6L:U$1J(G'I[_6JKRNE*R=*4
M:4I&Y%&I8D:=>W<X=975D,TRQL9,AL>)#@PPE+)DR#$5& ''&-3',]>@;/5>
M$3UB 3,#R]>M(O-MC&O8=!0V 0>@)WTYZFW/N K07,G"<?KOA:[OZ^MKO,0X
MZ39M@$,99,XOEX8$>YW'=D/5 @#\\A..$76 ;3SZ&(U_UM\:V?F.(YCRK-KH
MV+V\*-:5EO#FULR*";%F1YPBQS1)3&O!(89'=+AFZNL)$]'(OHJIRB.S3H/*
MWH=]3^8OQM-[^732U^9WK-6DHT5/X<Q.7<(JRA</<B<O8GRO5R)\]/=$7GCC
MCF>S3U^&VFU/S'$<QY#YQZTJQ-@XW71R2["TC0XHVM>4\F:  AL(1!C(0A'H
MUHW%>T:/Y1JO<C4555$T[-/W._3R[IZU'YCB.8JW @XU9!;)@60)07.,QI02
MAD:KH[E:3A>I.OLJBH]Z<HU??VY5D2=0"=),^K;5/YB^   D<CO>QC8 Z'GO
M-;(6-U4AO<#(<5GT$89I&HJ+Z\.8JISSZ\>OJFH+:"02)(G76^IG4'NB@XEB
M!;W0!M$ GJ!$G3RJ[\4X*IZ$+POK\Y?RI]&@:0-!TT$^<>=0>(X@ZD0=HMY5
M#SQM^*3:?P/;(7>\>XKY4_RY1U>-8Q$.,=GE>0RE>D.JAH1WHUR(XDD[ON46
M.(A7^C4378X+P1_C>,:P>&AL).9UP@Y6FIA1)VS6B>?*J/$?:'\N84^[$&4-
MIB96;@<]9(MK%@;U\]5%XB?LQOV0 ^1;T^$S'8^U6QM+83&X;6SI577NR0%<
M4K$CLFV@4)?S"-$ULYL?^"@DJL8)7M:WCZ,>#>P_L\$8/BRE8K&KR.NK$K"%
MY1)&4_TQ)!$@V(-HKR)XW[5\5)Q. 4C#X9!5D#@$NH!(@3LH"_/0ZWZ$?8Q?
MLCF3[^Y[DWA)\6>+%VV\5.!BED8&1'^#(^;PZP;3V+4KWM&R'>5\5S9WE@=8
M+&L<Z=%>Y6%:GF_:?V2PO#L.SQGA#G;\)Q(*G$E7:%OM%D95&\@KF9_3:9((
M';X-[58W$+<X?CTAK&(LT(@*3ES$I$6&721$ >/=!N*PG(CD(9OTHG6O+?HX
MY^M$1$5??T]577A$M(%P",UR;29O),29UUKT/YB^?VW@&UCETMR!F!MM1\4X
M7WPOU?.7V^K3LD#0#6=!J-#IJ.=/S!__ )?+G$_(>0K&/04\56MD2V1U>JM&
MISC%W'NZ41&H144BHJL]&\JGMQZZGLTB+=P\9)\X^>IF@X@^(_2(,V$&;WG8
MP2+56+':DZ)V9"EX1%<HS-=QRG4B+TJO3U(J*G/T+ZKPNG9HO;6?,F?GSFI_
M,7YGW=X$"!MRJ\N*0%_URHJ^R=Q%X^CCV]?J3V_)J<@YGX?:H_,'QI \*H3&
M:U7J-"N>YO"O:CT5S>I.6HY/=O4GJG*(B_DYTR)ZT_,<1S%7/BK"7U0AD_%W
M.43\G"<<:CLTG6_E]J?F.(YBO4Q:"U6JA"J]JHJ=3N4]UX_'SZ?_ .\)QD$)
M3H.N@^U/S%^"#!!!'G2E&WI:C>45$X1%3Z41$3^WT_K]]950.I/,DZSK5S2E
M&E*-*4:4I/6%,Z7=TUPEC8QDJ@S@>0CR7#KYZS_+HJSXR)Q(?'2-U1G*J=I7
MD7_7TI6^8O//Y4_+[)[_ %+I2O7*U/G*GXN=*5;(K'I\]$1.>?Z_;G\7IZZ4
MI@MU=A\7W% Z7%4%-D34^18A%R,R_P#HEC8K5<U5]5<B*[GW7C2E1T=X.<@9
M[YE2MX3EW5$F(Y>?=57I3A$3T:GTI[:4KQO@YOE3Y.9T;_3GA(TISN.??A$Y
MX7GCU3CUXTI5I/")<-5R/S>@:YCT$1?+2T1".].EW*>_"JBHOKQ^+2E5KX/K
MMC%*_-:-@D:BJ]T>6UG2YB/Y<Y4X:WA_NO">O'TZ7V"C-O=$F.ZEAJ0._P"5
M6!>$6S.K&1L]QPSB(Y1M$PY".:Q/E(QK%5RHB^_I^+\6IR*2,Q#@!_<"!<3Y
M].50"#N">0Y>?/I66SP:Y$J>F94:MZ45.(<QJ+ROU*GHK5;Q[_C^KB*FJ_\
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M1CCH!FD")7,&K&H_N\6,-@L1C<R&65N2"/=GW!(]]6T#2)B3?0UK6\AH**S
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M4*($1 M)\(VCZ29K:T"K--]+G30[R#RL#2E%7U, 99-G&AR;AIXCQ&H;,ZQ
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M$5I\E=%C7W7*18D!IEBL5$4C7KUI4UE6!O'G+M;*#*KBR49=XE+B7,-D0-7
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M_35=)%'&C  KX]-!#61G&[+&(4R1XS&.([E5]?7CTU\R>?<Q#CCKBE$K<=4
MI2E1F<4HQF)U)D\S>O7M--LH2VVE*4I2D>ZD)F$@$D) $SK2O1$3T1$1/7T3
MT]UY7^U?5?QZU0!H(W\>=;*@?XO-\MT=B\EPW*,0IEO\)J\+S3(\[J%CK_#1
MUN08%61!PYK6]0[84*YMI4&"CNJ>L=XV-<K>$5!G:_\ L?#6:CW(\6'BDA9'
M5$LMG\6D5K)=;&D31PKSX1AQ)LO%HUD2+)\HX36$'D:R.6D:Q!TIN\Y5?R")
M$Q/.WEZZ^%3Z]>O.D=4^,_Q1YLS$LBQ7#:8U+'FW4RZ)"J+Y:F[KPU]65U"I
M9,-) ;:J.:6$4R,KX<DO*/5%'T:G[\[\^^L022!'?X2+'H;'Y$7&?>^-+Q(W
MUQ=Q,=P=N+T5+9,4EA)QVUE3)034UD1E'TN;W(LP=D".UDTL97)W&-+$:CFJ
MY4WVMU^<?21'>*6,;QC;^Q\4R*QD814"M\>'CB%Q^?"NPY *!*%5)(O2294*
M!06!+=\J0L*".=&(P@',1'KU(U2_A;OZ^K=U=.\'O9.48=B^1S(4BNE7E#56
MLB#*CEBR8AI\(,DL<\8R(4) D(X;AO3J;T\*J^ZJFE5I2C2E&E*-*4:4ID-_
M]TK/9K;FPSZNQF=EWP7;X['L:JN9))+!26M]7UMO;"#$!(,9:>!(D63V(-6N
M9&5KW#:Y7HIZ\Z8#PJ>)#<_>BS*'/,+HJ2OML$QS<&FDXY*NS$Q^/DLJ>.)B
M&5I<UM<T63QH44%B5D1QQ.#+8JHQ.GJB;QT!^)]>A4 SL>XB_J+TXV],BJK[
MN/9RHSN]7P1R"R6M89SX;7+WFL$J*3K:C4<O:=R1J='"N:FNC@TJ2VXI&Y -
MS.^^L7TYGF:P<"%94JW)@??SU,]8M3%VDRMRX,5L<,&YF7;9)*BGNP1X\Z:!
MJ=J1&CBFHQXQ%;RBBYZ7MX5?1-2Z5A 5*4C,1<3-A8:WUWG307K8VDI)2A1!
M@$C-SL "#O\ 3QK5OVTRVDBTL&#DLW;J.&,^<.E%,2: K6%:CX/EI!>AXU9U
M1VQ6E8)&.1PT7H1=50Z%*("" 9SJ5<0-QL-[C7E622020!F!]V;F3;>VDR2+
M&E^V1\%X]9^2*.6UL(LB/%7MC.)SD>A&Q3$1Z*1'.ZE[B*C'<*C7(BHNU]63
M#E.&.8")(,&VH!&\QI$7W@U#:2IT%V HDB+0=[QKH(,2(FD/&L[$K($6LCY'
M(KXL536$0L$,^<DJ((G?+'[+X;Y4B2]6M8Y!/8X37.0*JU'-KMEX#,5%I.0+
M7"05.$D#OF\SJ (FMA#942Y*PE7NWV%X .HFWT@S2@P]UUDJ0"W-?)ASS"GB
M@U:HD,CX5IY4Z-LH@U(=EG%:% $5YF/8KU1PV+PUME" I"EKQ/:Y@4I3E(#8
M,&__ #0(G47D7OK=< 6E*&R .8'('30QRC3X;6ZH,>R?$KG#Y=9&(D=LV#-A
M2HKSQXQ.%2(20]Q&D(HC*A>&$15=Z]2/X5, R0A2&G0TX;A6DV@@WNG?*9!V
M%A0N)"@XM"EI L$6(5^XCE 5XDTVLIN]F';AXU?8-4SLXADC? %W!LK4]?CF
M)T0*D$M'D;,F.#(<6=&&"#+2&2:%);H@VS$(KF:NQ:;;RXH%_$!8/:- AL#*
MJY M(,<B1;OWA:7@5)6AD!))[0&5;%-QJ8)@\N5ZFON^>.+:NTF6;AQ!QHE=
M+(K"JT(#"D1R\=]5&C@=72-KG(Q'(O6]J(BMU.'0MQU+3*"MUP*0TB\E:DJR
M C6Q$]XZ556I*<V94"_O"P.]CX2*Y>>'2!+L=YMS)P+%D^HB.FUEV]QG(HB3
MHX+6$2'(1O;,<PY*B(QO6C%8)1N1%77K/:3&.KPW#FE-*:<.%P[BS)&12$*;
M(3LD+4"2+&1)V-<WAS:$J?<2HJS+((.GO&9ZGK>\]U26RWXO9$&=AUJ IV.$
M^3$#*CM,O8'*48R$<9G"J:0USR#:G\4T:HJ.5JIX)3JEEQE4I;4,RKGWR-E"
M?>!S'69M7I6V4MI#J%'-9-B=#!)$#I'TB:3JK9OD5YJ^JC-,E=.Q0\@<F$ =
M2OR4),'$DR6E/(Y8U1A<-R(]'HCD358.OPE#:$@2$!Q205)0)@ ZC00! $6C
M?.&E J65*5$Y<Q]Y4@R9L3._C6SE8>3X4Q2#;7C+6"6+*=9CE5BH_F-%$QKP
M1Q,D19)Y)4ZB]Y1-$W^*4B^V:F%I6 IWM$K$K!)5 L;DV Z @6%M16(Q 6@D
M-E"P0D" D$&Q,3<W_5&LC2D!NP^MA44B%7S'0PULV 2'<3XXQ2XKBR!M<.''
ME1T81.GD47L+UN54&B)PG%ALX<J0RM8*)_4LA610_1&8F-8!G06MK@A+R%=L
MVDDA*@ B0J#J 1&@VWOSJ.WBQPVFQW#L9S9:Y9DZ)/K(9)<UR#EOJ[XK8[DD
MD57GG.9(.TP *]SPN51C5K6JJ^X]E<6]A'W&4NEUHI5",Q*<H!(3E)@#GJ+Q
M%</BS3>*0TLH(>"KJ(N-U&=0;V/21M5W$/#IC6.[56>1QK*U;.D1964&5X&0
MUDM9#CR0!#W7%58S7/[*&>]"/5'?(3W3=AO:+%XC'G#*3EC&=DA(D94K5D(0
M)L,IN+==2*T8C ,M85#K9SJ*%9UJNJ2+ D^\8-[F!:(@UT:\$Y+0^R5+*MSD
MD3)LJ=.X,O)@1Y0X;X\8O_W"&K3)POJU[5]EUR?:9;*^+OI:"4EH(0M*0!*D
MI,D@1>3>QDCE%;^'S^%1,DR1)GI;X3KH=-ZF9K@5=HTI1I2C2E6C^HU3UX7A
M%XY]OZO7^SU^K2E0DPO9S.\:\0,O*@8Y21,";,R<PK&5D^37-V<UN8<V/.BQ
MK+))D*$U[#)"/%2H8@312*$@@.$KWH4]>OA67:FE&W1O0!I%D!B7)2R9AR-9
M#43GN<K7J]_R7!Y4BJUJ*_A.?HU1<6XEV4@$!4RJ^6(,P>4 \X%NEA 06QG4
M09( G7<#7F+6B;TUT[!+&'OW?;K4.=-=3Y#BM=BV28.6G H;.XC/>.MO@V:.
M<5H4KW.A>30;T(]J.0C/5NJS36'3BUO(A*W#"W/[%S(-B(,S GX0:N?B4JP+
M&#[)04'U+DV*0FY@@STZULSUT.+;,IA7<$<Z^?.=\!6-NZ*I(<5HTGDJ8_04
MK5CM5B/$,H0#<]SFHQ_KK<M;><M@Y8-BFQWG2 !/.M8"UMNKRCLQ&547GH=[
MQM<V@Z4M*;)J=8=CBRQ(<B3%B$IY+8MQ'98U[21.$A]]2++87AR% IE>[J<-
M_"JB*N27T(S2JZK&^LP+WO$VF9T'30$J*0YE=(!"H+8BQN#;3_?0X&VNV -M
M,-Q_"L56YL85,VV(V1D5XZ^O3LN)TNUE$EG(KS2BC(=8S6/8P: 8U4^6B,U
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MS,D<ID:5MQ/X(Y0PAPNI@*42<A(N+:6! (Z2:7%+C;*RR,Q&-LRV]A5MCDL
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MA/W.>?\ %>?'*R]5[(.5XY7LO]>/;G[MZ\?1]6GYQCO^AY?S3\KPG[G//_\
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M?OBI*01! .^@/C>:5'BFL)D+PX9O('5'L[$]!#B@K(7:[Q9TXD.,,87#Z@=
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M0[&'%G2H\V"1TU&G)Y([6L$D/J>)A3(I$9R55X1?153T7:AQUM>$QJFR6T.
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M)E:PI1DW,FYN:E'$.'-#*R"A$  --=DB ( "$ )  L!6R^*%U_-F?WAG[W6
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M7$5B-7E41:&9:2%(RA0,W!B-XCU%JV)A.H)$ &)D"PF-.^ /C4 =Z]J+W;;
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MC\<T6Q2:0:-BB<:9$L*R>1W2!S1H!L0)#QNIQD0KGHZ.BHWJ5BI[TB"I+D(
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MQ,$="O*I0N<QK#-<UNJW8(4%!<&?>!(N%"8B^M]1<#8FK Q;J<G9J$I.BU&
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M8_W_ /C]:523YSO]H']2ZE6A[C\JC<=Q^::K7V7\]_Z]8G]'@GZ5-5I\]O\
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MW_-I4*T/<?E7C/G+^5O_ "]*FLCZ'?D9^I-8H_2/'YFE>?1_N_\ OUE2K/\
MK._V;_\ F-TI5UWLGY3?J?I2J&?/%_O_ /+'I2O0_.;^0_\ S]8_W_\ C]:Q
M_L_\?I5;/9OYS?\ DIK*LJML]_\ ==_D;J$Z#N'RJ5:GO/SH7Z?SF_\ MUBC
M0]_T%#HGN^IH?[._.=_G76=8[CN/S35 _GM_+K!.J^_ZFMBM$=WT%5+_ !R_
MGC_6[6=854+Y[ORK_P"[2E5%]F?GK^M=8K_2?#YBB=5>/_T%4-_B7_G)^MNI
@3H.X?*I5J>\_.JD^<[\YWZC:FHJZ/YB?E=_F72E?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g68105g17y82.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g17y82.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[19F4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %DJ^5P8X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              ,\   ("          $
M                     0             " @   ,\
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   ,\     4F=H=&QO;F<
M  ("    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   #/     %)G:'1L;VYG   " @    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 0 "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M)<7&??NW=_Y:2FVG4*JJZ:Q74W:P20
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      #_X3_\
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X]
M(N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M
M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!8
M35 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z
M,C<@(" @(" @("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W
M=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS
M.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @
M(#QP9&8Z4')O9'5C97(^06-R;V)A="!$:7-T:6QL97(@,3 N,2XQ-B H5VEN
M9&]W<RD\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^
M"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @
M(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(^
M"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^4%-C<FEP=#4N9&QL(%9E<G-I
M;VX@-2XR+C(\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I-;V1I
M9GE$871E/C(P,C M,#DM,C!4,3$Z-3$Z,S@K,#4Z,S \+WAM<#I-;V1I9GE$
M871E/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C R,"TP.2TR,%0Q,#HS
M-3HS,BLP-3HS,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z365T
M861A=&%$871E/C(P,C M,#DM,C!4,3$Z-3$Z,S@K,#4Z,S \+WAM<#I-971A
M9&%T841A=&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F
M.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/@H@(" @(" @
M(" \9&,Z=&ET;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @
M(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/DUI8W)O<V]F="!7
M;W)D("T@4'5R951E8V@@+F1O8W@\+W)D9CIL:3X*(" @(" @(" @(" @/"]R
M9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @(" \9&,Z8W)E
M871O<CX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D^4E(Q,3<U-S(\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q
M/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @(#QD8SIF;W)M870^
M:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" \+W)D9CI$97-C<FEP=&EO
M;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @
M(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @
M(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M<U1Y<&4O4F5S;W5R8V52968C(CX*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E
M240^>&UP+FEI9#I"1#(V04)!-C W1D)%03$Q.$(W13DS044X-3@V,T1$,SPO
M>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^
M>&UP+F1I9#I"0C(V04)!-C W1D)%03$Q.$(W13DS044X-3@V,T1$,SPO>&UP
M34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE
M;G1)1#YX;7 N9&ED.D)",C9!0D$V,#=&0D5!,3$X0C=%.3-!13@U.#8S1$0S
M/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I(
M:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I"0C(V
M04)!-C W1D)%03$Q.$(W13DS044X-3@V,T1$,SPO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TP.2TR,%0Q
M,3HU,3HS,RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D)#,C9!0D$V,#=&0D5!,3$X0C=%
M.3-!13@U.#8S1$0S/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 Y+3(P5#$Q.C4Q.C,X*S U.C,P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F
M='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^
M+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE
M=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@
M:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD
M+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T
M97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I"1#(V
M04)!-C W1D)%03$Q.$(W13DS044X-3@V,T1$,SPO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TP.2TR,%0Q
M,3HU,3HS."LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @
M(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F
M.FEN<W1A;F-E240^>&UP+FEI9#I"0S(V04)!-C W1D)%03$Q.$(W13DS044X
M-3@V,T1$,SPO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F
M.F1O8W5M96YT240^>&UP+F1I9#I"0C(V04)!-C W1D)%03$Q.$(W13DS044X
M-3@V,T1$,SPO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F
M.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.D)",C9!0D$V,#=&0D5!,3$X
M0C=%.3-!13@U.#8S1$0S/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @
M(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(#PO<F1F.D1E<V-R
M:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@
M(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N<RYA9&]B92YC
M;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @(" @(" \<&AO=&]S:&]P.D-O;&]R
M36]D93XT/"]P:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_;
M $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M ?_  !$( -$"!P,!$0 "$0$#$0'_Q  ?  $  00# 0$!            " (&
M!PD! P4$"@O_Q !@$   !@(! P(# P0)#0D-"0 ! @,$!08 !Q$($B$3,0D4
M014B418R87$*%QDC@9&AL? D-CA"5G=X@IBRM+;7&"4G,S0W4F)S)BA#1$A5
M<G:2EL'4U4976&1EM\?1\?_$ !T! 0 " @,! 0             %!@$$ @,'
M" G_Q !!$0 !! $# @0$! 4# @4#!0 !  (#$00%(3$2008346$B<8'P!Q0R
MH2.1L<'1%5+A)/$(%C-"8A=#DB4T4V-R_]H # ,!  (1 Q$ /P#]_&$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3"+J7$2HJB B @F<0$/</NC]X..!Y+[^//
MCQYPB@G\.Z\W'8.@I&>O%GG+9-)[@V]#DE;!(N)1^6,A[I(LXQ@#ER<3D9L6
MB:;=FW+R1!(H)@   !A%/'")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBZE_P#B%O\ LE/\PV$6NSX7
MG]C1+?W\-V_Z^2>$6QC")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(OD<&[2*G$BA_3(8X)I"(J*B0!/V%Y$I>XW':0HG(41, &'M#"+3;
M8=T[HE=D[7-:V&W]<1<Q2ZFLYC'WV?%06O*FGLDD0[D(60A9]\N1_(P8)A,S
MY0:JB==TJ5&-:$X#&_;[]?L]_9%-WIQV%7$H"^1SS8+"4K41M"WQ>OY6PW!O
M)NGE-;.&X1XL9J6D%G,W$HJ'72CY(SETFY3[BE=G @ 7**54?*1LJW!U%OF4
MDS$3)E=,'2#UOR7CO(1=N=1$3IB(=Y!,)@ 2^1]\(O5*'  'D./Q'G^7^G'M
MA%SA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB814G'@HB'D>/'Z_Y?YA_4/L)%"'JGZS8CIF?KQ3FE/+6]2UO
M*W\#)3T?#-SKDGF55K%?;%<-W#MY(62>>BV[FZ $8-T17.*IC>F!%D/IDW=9
M]Y:^EIN\41IKB\5V>E:M::M&V="XQ;&1CTDU?ZBGT(Z)%R4Z2Z8K(N8MDZ:K
M H@J4PE QEW_ $18$^%Y_8T2W]_#=O\ KY)X1;&,(F$3")A$PB81,(F$6MOX
M@77^YZ#&6M;(^T3>]OT^X.I]"UR]&=(&>4=E"&AS$?NXX[5RL_3?%E%13Y.T
M:HJ-3IKO2>JGQS8WK-77O5C^O/\ 53>BZ*[673-$X@\EMEQ!/J >1ML=E\_3
M/\6?H7ZJEV,1KO=,+$7%ZD@<U'O9T:I9$EU1 HL")OEC1[MTFJ/8"#%^L<?^
MCS[/*D#02V^0?F/7T^]APNK-T3.P33V"4;T<<F8GT)Z18VW/.^U\K9.DJFHF
M11-0%$S@ D4 0,4X&#D!*8OW1*(#R @(@(>PB&<%$[]P0>X.Q!]".Q'==N$3
M"*RZW?*/<G4TRJ=PK%G>5V05BI]I SL9+NH220'A9C*-V+E=9@[3.'!T7:95
M2B!@[0X$,(K>V=M_76H:^\L-_MD+7FC9FZ=H-9&38,Y"2^42.N=M%-G;A!=\
MY4(F8H(I!X\F,)2%,8.3&%[@T#]N%W0X\TYJ*-SC=;??]+7YMK_^R3*-KESL
M1@EK5+:]M5GTV.KZ'KYZJ1O#0R0+)*O-F7MVJ[CE9=9R""JD758=PS9IF4;!
M*KJD]<W8]L,9'5, >2#6U 6-O?O^_<6=OA/.RWXL.F09&4^5L9F>&VV)[@.M
MFP/Z'$C??8BN%KEVK\;?XN&V7+U'6,)J_3<.JW2>-$J?4_RBD6C-<AU"-',_
M<5I-!>1%(A14*T9H 40'L I>,X.FAC871Q_F'>@/].!>]B_W5ZP?PBU TW,R
M8(Y'T0UUAS;W#7#_ '-W!L<D@@=LL?"Y^)-\2+;G7UHS2O4/N1U9J)9GEH1L
M5<<5FJL0?)L:/89-@H=U&0[1=$J$DR:.2F0=BH8$OWTH"8P9ILS73/Z'8A@!
M) <0. =C?O8'R]=UJ>(O .-HND9^8Z3JGP.AA+;Z7.DL=0&VQ=5>Q7[7P\
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M[+IVN/KLVJC',36Z<7MY:JQ*(ID:,RR+D6:+5-0PF2 $2BF7@O<!2AQ0M/\
M!'AWPEBZCG:'X=T?_4IG2SSY4>!'#-DR.<9'%\A8YU]3B21O9L;J5B\0ZEGR
M8[<O+S&LC>&- <0 QIZ0 !M0 %\BA7NI[;-Z:)C4;-M3]-V]M;*+8(\6<>LH
M>+0=@^$AB+QL:FQ.N?L$ICE,9 1$G/';G#2]2P\]CLC5<!N%E0N/4V(.Z&L'
M!??2T#;>A56>ZEWZQF1Y+1#F.)'!Z6W7%7ON-J'<\4%!F:OUNJZ[6GC1#PKB
M+2*V2^8CG!4R@R$R78<RK<@"D?@QS\@(JG'U!-Y'FV0:/B9,?YJ++C=#*!40
M>"X]8NA\5CTVW%W:[?\ S-EL>Y\T9<6N+7.W!< ?U< ?%SZ>MJ.-^DEEI=O=
M&]=C#OP*5FLNR2!-5!9#U.WE%,G(%  X4.8"E$?/'G-J'2V8X,0(Z7]SN:-4
M ZR=[]36]V%9M,\41YQ;">N,$#]3OA%M%BKKN=QMW4U^B>T6FY;&I\1+*"6O
MN9)DU?-S'373*JY42:$X2.4$@232.8R@"( <0#G]$#K\<6GX.3-%;IA$XQFZ
MJA8]QZ5[?):FNXD6=)N]K0#T6 TV >21R>][\[E;FM:].,UJ3J[AI%1Y"SU>
M>H3,G **$.UDX%NK$OD'0M$D^6X "JGH)-0X(5!4XE_- ,\ZU'Q%'JOA&>#^
M+#,QV/'(&@%DKFN827.Y^)WQGW&YXNH8N S!UB!@)=U1S.%\;WOSSP/K\UM9
M#G@.0X'@.0_ ?J&>8JW??WPN<(F$3")A%\QQ\CP "(#[\A[B//@!\^W//MX#
MD/TD6LW8.CMW; NZUR0HD?6G<!#,F3B'_*^'?5&Y_85I;3,2PI[!(Y%ZRBZ1
M27?2#B;1:&7>'214* %,($5^5'?&H.GMY>HO?^R*-J2\; OUBV.E19ZR,EI&
M'A+"J@,81TXC_F&"[M5- RCI1JNJ@8XAV*"(#P]?\?=HK>^&98X.WZFW99JS
M*-)J F^K+=S^)EF"GK,Y!DL[@?1<MU> [TE #DIN YQ]_P"46R#")A$PB81=
M)A.!_ \A[\?@' ?3CDW=]X  /(& !]N<(HY43JFU=L/8KK6T M8BRQ5KDUAI
M>1K[UA6+4ZU],%@K>WK$VL4&LNO#R1CD,1,2F=-VSMVU!1!JL<I%)$HB)0$0
MX'SS^OGZ<_3\/T<81581,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$5)^>T>!X_3^ <^1_@#G"+4CUJ;.6UKN#6N]J$MJ+8$W4
M*[;M=JZ_V+;7%2592"LN521GJU(KH#%%DFQR&BIA-V<JQFR3<K<QRE4#"+/W
M0(P.EI:P6)5W0R*WJ_W*XJ5K6LD[EJ=3%9IT*ZE;BWSI-(%SLS]QGJK5,K,S
MI0_R_P!P>1??W_-%;/PO/[&B6_OX;M_U\D\(MC&$3")A$PB81,(F$3"+2+\8
MVMS$["Z=<Q<*YE$(\;Q\^J@J"1&J2Q:QVE4%02E[CB4P@3GU!]/P AGKWX49
M,<$VK![RT/;B;#N/^HWXW/I7';M=;U\$_E]K%GOM=]^/YW_SI!FJ!-UE%NLA
M'KO4'K-#U)2.;JNDT%#%*!T'RJ*?Y[<3@F(&-QW_ %_'V./,AR"6N>(Z) 8X
M@2$#T-EM$;BB1OO:JP-G=P[$>Q%BN#6XY]!OR:^&&[FI5T2,9>1??OH+*MTN
M3,0.B8IU%@[!$4DN0[P-R( 'CVSL<W<.ZV,B&[3U;2$5M[G8_7TV626GAMD
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MO1CJ?IE\1JT^J^$C@$920.K#*/$F99R-:/I"-^8;MR**A_7?^G/^*[;\K)!
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MYD8Q9&R4#1<T$@RD,-;$C?Z%2V-GZ)BEH<Y\N0PD!SXW=0VH4!33?8D.W-;
MF[8F;73^H":L2YY*LJ0L!.,PJD12WBKZSF5#[_VT^?%49QS=$_ G,DD+@?8H
MJD'-O%Q\O0H8(NF;SLF%_P";GR14!!XB:*,G&U"AON2M3(EBSIC,"(XH/BCB
M;L[??KZA1/:[=[5ZW12R$DRW$[:YPZR,#WG>R2D++1-CJDE%I?,+"NB40^V#
MO&I035=)//2],W'IJ%'M'6S2(GXG5BSGS2&L:)6/QLMDIZ0!8_A^4[<#I:;
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MRV4B<=0-MU.FPDI:*^TJ/$,KNTE)]R9>>2@(U"^,4(!-A2"R:RP.F[EI*6M
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MA#Z^?U^??"()0Y*''CS[^?I].?8!^H!X'Z\X1:_?AX?UB=07^%_O,/X >0/
M?P81;!<(F$3")A%C[9$GLF)KXNM5TZGWFT?/-B#"7>_RNMH7[.$BIG3P;+#Z
M\V<[(]:G*B+9E^3 I.14+ZL@T!,/4(M1VE.E7K4T_P!0$[N4VM.FB<A#+;#=
MU"L--^WJOV..5V-9I&RS2=SO@=,LJ:[MVCB6?D;M6-6J7VNZ^R['<7-DM,(S
MEAP+'8;#;?;G?^W;U3[^:W,UU><=0,.XLT;'0]C7C6:L[$Q$RXL,5&2QT"&D
M&$=/.X6N.IEDT="J@VDW%?A57J)".#Q;$R@MD\HO9PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(N!]AYXX_3Y#^40PBU"_$:
MO,I5]A:L28Z3H.R;*UK4D[TQ-V[1\CM>68;CF++&P$82$L+9$S&DMZS#'<6R
M4.\.W)+)IIH@^23;F$'W]_?]5CT^_P#O_P WV4B>@AY*K:6LT5((5ETE7MCW
M6*:6FH:M3U%#W15)]WREC3JJ _(J+N98SQ-><8]S68,G\V4QN3G-BQ]/K_;?
MZ#<?.D(V[GY5U;^G58[[6*]B-E^,';?59U;R\'M7IB:(2ING13?>TF[G['K$
M-)E70+?74B919==BO(*O&CE,3(*1[^/73'D"KEX[3;T0RXX?.9@>:UQIV0"\
MEK/5HOI#JK_V@E?2'X>>$-(SM&T[4FZ<\ZH))?,R9<MX!8Q[2T.B;((@T<VV
M,$51(4T^EZPQS"ZRT^QAI)"N6"OUYFY7G4%H]Q*3,:11O)2)6::@J-CJ%(V(
M4.2*O%"$*JHH!<N.B^<Z)TA8Z(MJKNQOML?H2:W_ *6'\0=-AR<)F,1#U-:>
MIH:QUD@ _%1._8 ['BE/IY%5R< B:*JAG"Z9B>N= P_*J.3%1$S@R#?L A!-
M[ (.2E 3**#P(Y>,363!TC(!<T  VT;M]@ !>WH02.%\L:YX'G\PRX+VL+"9
M2QH!#BW?X@[JV-  <<[5:\?5D]L#2;^Q0T(QA;;$6$2*.4["P"Q1_P RER!'
M+862B:[0XI=XBW<..T##R"7< <2F;#IFLQ12F<P/91J,B,UL:K9M75D<?(4:
M%EX6HX\ABDT_K((M[FNZ31%D41SZ5MQQNK4GM-RZ,ZTV=0]FR>CKO-Q5AJ-I
M=56J0+C\I(.2>,99L6+9VJ,DX>#E(9\U25BI \5,K?U=(-P3*9V5P7RW\3/P
MC\(_B\W2,3Q=!E:GB:#.[/QXF94D;OXC#')$Z;'EAE?'(P %A<8Q0=T=8:1(
MZ1XHSO#IG;BQOA_,6*Z6R ^@#96/K8WZ@]QRHB;*Z7T)-XC;IA>T[#NH%>-D
M+[LVU*6^Q_)O5!!<K"=DE&$=4&[XW8=:(K\=&Q@@'I@T G!<](\!>#?!?X>X
MPP_"GAW2M"@ (>-.QF122 @ ^;.0[(G.UDR2/MQ<X'J>XG7S-:RM3GZ\S)FG
M<6])+Y'7T4!T[%H'?>R?5W"PHXUJZJDT[8/S-R*()(N52(MT554#'X6*)Q2
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MMZ[C7EA+OO<B,M,D*5-[+,AO4@99NHNFF)S&33'A+N-P4P%]N1'+YH^A'4\
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M/O\ 7R'/Z^!X_5XP1?<CY&EBA=]_5<^F7QQR''@.!_1_%[\&#\#!SF5E5AX
M _#")A$PB814C^<7_&_FPBU^?#P_K$Z@O\+_ 'I_IL#A%L%PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$5)B@;CGSP//Z_ AP/XAYYX_$ 'Z818>M6C]*V!Q
M*3-LUY3)1Q)B=:9?348T6!V0R94E!>J.0])0AB 4#E6Y(<H"40$!XQ5_?U_L
MGW_->U4M2ZTI4BI,U"E5VOR*S55B:0B&"39=1DNJDJJV,H3R**AV[<YB@/:/
MI)\?FX19(*4"^WZ/X. ^GX?41_2(CA%SA$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(NES_R=;_LCC_$41^GG^+S^&8/ROV]47YCNE/9K&'IUI@3PC1Z*.]=U
M*K*G<$*MR%V?F$Y" 8#)@ &[2E$ [QY$0$,]9\/83IM+;*)G1N- ,#+!%<&M
M]^"?EW)51U;RVYI)CL]-"Q?\A=U_W'HI[L;U2 BE'1X9-L^<>F05A7 5$P$I
MA+W\&\@4 $.TH@(\^?'&;$N)FES6"=W0';-Z=@37(]/H*(WH<1C6XX<28+LT
M2";KVL>^Y&_LCW>D*T20CU/549L44@3(F/:BH)B\@4W(\""8B''GP(\CP.<6
M:-D.+G%S"7V#8W(OMMMMWYY]%LAV&P![8Y@6#J:230(.VQ XW/<;>FRN^ Z@
M ;,5%UU4SLQ(D11J5VF440#GTR@03B!3"82B<> [Q  YS3F\/2/?^EO4*HF]
MN+[>^P/SVI;'^H,8T$&;<41TW?\ 0 &M_P"5+TVNXH*81DE$2NV+59$G"Y5D
M!464(*8 0R*:A3D23$QC 8/O'Y$1$??.J73)X".J..7>QM>QVKB[-5W'IZKE
MCQG)<7MD="0.[B1P!P?GOL._=?#2=J/8E5W'+R2?RKIPN+5!8._M:E,F?]\[
MSB &.)1%(.?(CSY'W[<S3F3Q-?'$6R- ^(  V01>P_G8K8<!:EC'F?YV1(QK
MS\0:T/%<_3B_7GV*\^S[:ET8VP+QLQPC,+*I.VYC<MFY)!9!@0W<H8>")DY7
M,D00#U>3_G" @QM-QWO@$F-9@KRW=.Y+=]S1!-COV[4MQUM#ZR7T^^JF@;&[
M YH;[<T=@K2-UC;+U.V<M'9H^[,VK,WV8C*$6(X5.W12Y)\^V$H]IP-V 0XB
M &Y'WSO?X4TK4W&4,GP'DDN$726;WPQVP)L&N-AZ%;4.1G8]11O9E- V\SX"
M*'J-S7'UY],OP?7M*2R\8U6UZFW7=LTEW79( JFBJJB"A2I 503G2[S 3O$.
M?KYR/D\!1L9*_P#U D1\ A@)WK<$?+OZKIEU^>&4,=B#IWNG&S1KO]/ER12U
MV]5'4U?-O]3FK='MD8B#80>N+/L.4E4FSF5<K._MB#9':H)-^_E(J0J"F @!
MR]H%5\#QDEX<Q\72,S4<0 S":&-PZGM80]@>6[]6P^(WR/V7%V8_.PX\EPHA
MQH $"C]=^P[\[K.]?IUW+*1-AK]Z0,_!D;Y,ZD(DT%H!0(9N1!OZ/>)#+J'%
M3W$?3'R/(AFUD3XW1)%D:>#$';@9!>'<@]6Y[=C?MN5W1N=,\0Q9+V2\W=@5
M[<'<[V.02LH6A38D:U60<;!D%7L@1--TU(Z0%.3=-SD%Z@5$A ,@D)^\R0%*
M;@! AQ$ XS0Q&8$S@]NGX\0C)<QQ!MG4+&Y-DWSN+)^BZB[(@#(I<M^0TN<'
MAQL[&]G7MZ @>JQZF#ZRM91]*MS ,,],5L3TET5FC_M*9NN@F!">H)N X.4
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MOQ1W'&Z]=I^QMMA*RZT6'4OK]("(@X:R 04XNV=$[Q34 A$DA.0R9P$# 8?
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MT4J93"4W>F RP]BH'*!O4+P(^0'P.;3/&VLQNZF#%'&QA)XO_P"8];^]NO\
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MAA*)P !'Q[!B+Q!GQLD;4$GF?J,D9>>VXMU=OY+K&GXC9/,;%TO'!#B.]_\
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M6H-S,D5ZK.HQLM]K.8YNL_\ 60+L<A45OFE%2JI 0@)G*( 4 ]R*[#?#0Z<
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MYC'MFL\?LBRA5H:QLK?KR&M4HY+66;&-:1<K6JI89NMNF,E/0XS#I-\.?O\
M?[^FZ;W_ ')OYW9Y]-R/;@+*G4^QL5FG9NOK,9A\\DNDS:_[7\5#1ZDA)25V
M=@S97)*-BP341?3C9F>D(Q;)5)94%GZR+=-,KI<7&#\K[=O7?[]D_M]WZ_\
M=8&?-M^O31LM2F6\I^OTAE8#T*;OVO)F!O#&2'7M%5L#)"#F*?6Y91@:PM)Q
MC7C2<"09)TF[9P!Y)@1@LIG[O^7W]%BN.^_O8V(W)/\ 3^NZ]?8&S>J&R2DA
M+5&.W1"ZQ7G&K47SC5&S("W-G#35=258C%5QII^WWT\.^O9[29^[6I9XA20:
MMF<C,QD<HDV<X/WO7]%E2<T0\NRFV7WY2F<*R$AH^AR&R#JL3QQR[("4>M8\
M)".%-/[-EEJ:1FNX9J-VI^!$RC)J?N03"^]7[)]_=*:P>P<?@'TX_DX#C]7
M<?AF47.$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$7SC_P :/\'^<AA%4'L'_HH?YXX1<'_\+_Z"G^8GA%H]^%7_ &0/7'_Z
M^K__ +A[1PBWAE]C_P#;!_GEPBP5L_\ YSM$_P#K78O]5W&$6<A_-)_VIO\
K,/A%7_X$O^+_ )P818,UU_SB[M_]9:]_JZWPBSSA$PB81,(F$3")A%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g68105g20a27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g20a27.jpg
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M &2/I63M%@?>DY_O4G0\?9///AD,])U,^(]S[RKM^G(Y)=O7.<_=?N_SS_\
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M??\ ;E<E/]^*\?\ +/6KZK;_ ,0U_H)^E.V<_A#_ $$?V:/U1WGW_;E<E/\
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M*<^R3G&<93A6<K5CYH3WSVP.OAN1 )!$B=._+CTYQKE7+N\22T"A/M+S!(,
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M RU$G.?$1F3[HKF7US*>Q2?O&"K2$G(CA!(R,9 <B:2;27>B9)16EH^,$O\
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MS.8D*"@(*1"E$@J*8!)((B)$'B._K4ZY\N-'[)T'NLI(VGI,=;;IXVFK=S*
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M (ESCGNY99\^4TE2*;!:SGV=I"YSC&?1Q;R/\.&UX[_/MZ_5CZ^K^Q_! )B
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M\INO=\N-94E>4*\\A7IE24J].V>^,>O4>O78,A]8//V9^58UMH7&^A*H.\)
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M-@,K89L6;UI.%M.8FAETWMTQ@SUJ_AUO<[[Z[4MLN6-GOJ:M67KA-LTFY==
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MCOU08#_+>$?UE9_\>I^SL0'_ *#>?[*]^#?OJQOTVIG[;JQ_'XK_ "OI^J#
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MQL<K;%N2JTG6LDS[I/3L^2++P2=_*"8<*P&=:DB#9JNJV98X5=*E")"W 1^
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M[O.=3/=K&L9\J959Y[0GH1&;:*W6UY(W@*'U_!J]KDK,6>N6K9>L*(#;;"V
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MBDV5SB3';W&Z+E>)7-_B=LV&7>Q[%5G<C"F]TJ26&=TDMK)4_'N4>J CU</
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M*BY3Y2)C3Q@BGSYPCO#<AYRM&&"+"T/:/_DE.$K!1C&$['X3C +S(+J]M?\
M!XVU6[(>9(BZOMAKZZ&\"G\@I@R.SN6R%;4WAO!G97F-WEE"%G<3@7I*P)*(
M[-R998Q]ADQG#G:"#O-JE*V^P==.VB!/JX ]L \ ;([9U,.<;QKOECKK#?MX
MVXM.R6/+%@[+@Q4_%7V!66IKLUI<J*A$Q$N(KH.M8BYB.+VUSA&&XEM-B.&I
MNML]C+52!LOZ:=EPCM&MN=AW6X9M]K+=D>N.M6>Y<+N$*=:2E]+K2M5*K9-M
M9.M7MU:X5:W19P+'7@3BVPN+%6ZO9_:!"I6[@SJSV"%O[S:6U!"R6RA=:<.8
MW[.@EQ%^<:CM..A^.G(LRUVDAY./-F7QJY*Q,)SG,;.<K&P)Y)&4X3G$^!G+
M6947&JP^D)V;OK':1:&D+78^B_TH7R#VU@])+_HI]*S $EDG>M;>XNDD $7-
ML8[9DY'&R3BC#^%@K(3<;6[)6ZO8?1EV>V&Q[DQO:/.M,F9EIT?<6=:5%$,B
M+B.(TXR&I88RT5W=I$4ZO%WXWWC"_;1-\:'EL^=^30Y+Z\%Y,81EV$Q"=<=:
M0Z+=D1V,;K5BBQQVUNL"OK' ;&^1>>D#T?V:U?J@]%FT&]VC'I&]'+[>\X]L
MX\XH7SK5B5L-L+4XVE=JMUI-T+?4_A[K6(6]QB-Q;J8V;VD?2/L[:[#HW5[,
M;3H5"48HA([!"WX<6X$I4H/!"UK2%V5VRQG&Y-6LNTK+5LMBRCF(S&I><FI6
M(WD6)+(7YQH;<(8:OV.,O8]Z:E?K3OO B0A<;HI5BR\694E[!\5VQQ7!RFRO
M5!IO8K_"%V*;:@V5Z#O6MCMQ8VJMR5_EFWO95VMBZ"SK$6:;1:5(O;/!;.]E
M]@;ZL=]&^.J7(N+<B'G\!?>&\0GV%(]I.X^@A6Y2*?*OB:H$U_(MRJP)+E4:
MFO6&<N;6XC[#%Q)$LOJC:$.:ZB45UI+3&>&Q4$5OLO15L!W/><2!,O.?9_!'
MMI!@]ALT[C7V597MZG8S:'LRK;+T*[3V;+KU[L9M?;OK#UYLH^&EVK2;I3C:
MV5-62NU[2R?K'B5^C"S>W&*(L/7'V&#C>&[T8'MUA3ZTH8QS!7&TE#&+H*TO
M.%D)4E85<)W-Q] Z"&W8VC]+[ MC8F 7EU*E6_8AT./<F!0!VPB:U).'FQ$"
M4\<:J@NQ$A\F2J!":E18<HC,GN1ILZ3->E_K? ,&:P2P1:(2PEY]PWF(&T0_
M;V#F)W*&SB-QA]@]<W*,,M;N[2[>>HV[G8H??>>5VEP^^\[\;Q&^7?7"GE%P
MMMI[&V#ZFW+A-HT5"V:N+E#31NG662AGMW$[Y;;;;&ZTVVVBN]5Y);*V-91>
MOX&BJ[!MAP<;M@8U=R^QJI1"=2H,:A/F)4!RZ:2KEVGV(1:-FU<1#B0:=(J^
M&)!<] ND@F#(UC';@<\N[IWQ\>!KGS/#/X>XZGW#ZTIZPY$&=Q9G&ZWJBB#J
MA6KY1:+LU^U7U@<?C['L$"GRS"ZBQ]#' %N&55BYUQ@ =GG@9/8,K,T< %C9
M442T=BIGSI\_/*G+?N3NOZO=3&OTT,U9;77+AJT%/B>:D#L^[; O>OZNS:Q\
M(S8F+(^'KA39P:4DL]7H8PV6^)0*V5G2!QR4+>?/GK0GI)$?74^X^%(]NYG:
M_& %F:C4+;=S>*+ V*T.8A#!+0ZIS:_K\]&-G2D\AER%!C1MMU.#+9$0SIIF
M24)/1P\@2*-DH4@9QIG'Q\^8I.4CE/PG/Q'F:?X?D#KPW3I]HJ(J2L<!/:UK
MI>,0%X#H!V?9-CKD5^J3FXK4]R+<*LY9A,^TB<1\M#R4^ P_/PXY*DPHC\?A
M21\OC$?,5']BYB5:'QEW3R-JM"LDA&G=/$-P#Z;<,#*I/M%=E:WQLRJ/QB A
M^W-@Q]M#J:9SF;$R>#26Y3)JMQI,=$=Z8S G7SYC+K2<B8.0G/R?K4!6?Q#7
M'SEV&5#CN3M(&G;,I6O<1M@S[/IW8]N*7*GT:\10M(TIL+53&Q[)L C*L1.5
M6Z]D&.K! !1S%XL6P*F(4,>DH^1.7#S^(B:3\_P!TUG/2.&<5(')_F"WQHN1
ML,4T4*NE.CZEN5_+D0%U#+ODD+1*!L"ZRR)+6T>JDV@^JHY>K"-<NW^ZVZNM
MYOM_""J[5[%'9*2V0$QGJ8T.N7'Q/NJ"8,1PG4#+GW::]8TIA%_$1LU5)8&V
M[CZ)QBK638]5V%$INX&+A88!/5;5D)VL[K2I*UR$.7*A4ZM"ZR>O-ZN<;4P>
MNKO0&O!56NRMRA*1$<>7#G!^O'A4S\R/ D=_?RGOJU7&3?$OD)7KS+L^OQ="
MME MP*JV,$,M*KZ%=S;=0:TW$ FC;/)JE,D3?:TS;(,<7BOUZ)D>;BF1\=XD
M-1#)SA$>8.I&?A0&9\]?D:LL]!@R&L1WX<5]A/?RLO1V7&L>;/?/9M:%(QWS
MZY[)]<^N?7J*FOCT"#(B9'R(41^!E#;>83T9EV)EMK*5--YC+0IG*&U(0IM&
M4>5&4)RG&,IQV4KXH</6^B2N!"7);>S(;D*BL*?;?4TRRI]#N6\N(>4S'CM9
M<2K"\M,,MY5Y&D82I2#+I-6G&:V?DB&5$JA-,DZZII^7&A#BQ\=*$%#&!,:0
MT)E&GA1 J-8,384DG @&CT0?*BL'C#<Y2*<&8,',E4W,.+F8M#+:Y>8[.9*V
MXZW'(Z%/Y1[52&%NNK93E>4M+<<4C"<K5G*E>\Q8V?/WCL9]IE*G.[+>?:*0
MY[5"E]T_?Y0[^N)RKOE+GW^.RO7I2L"Q@USO[0?!<[O,2<^>)'5WD1<M9C/Y
M\S>>[T?+#&6'<_?LY9:RVI/LT=E*\Y$"LLN1LC!^8[N&<.L9A1LLNXC)81'P
MXU[+R+Q'1&C)9PI.<-)CL);\N&F\)4K<2RTE7G2TVE?ZY]^E"<*_75(4[]]C
M'?\ 75-MJ<]?OU(1E7?*4YPI6)B'$C=_=HL:/YG)#RO8,-->9V6[AZ4[GV:4
M]W)+V,.R%Y^^>=QAQS*E8QGI2MGI2CI2CI2CI2CI2CI2CI2CI2CI2DB: #$2
MH4Y.&Q91>NY(*!D'6_-)&*+1<0B68B^_ZWF9$QB._P"F?.WCR^G5TN.)0XVE
M:@AW=[1(.2]Q6\C>''=5F.1JBFT*4A:D@K;WMQ1&:=\;JMT\-X9'G2OU2KT=
M*4=*4=*4=*57KDKQ^&<D:(+HQ6R3JO'&6J#:4$!\".0>=>@B38I,13$E^.A+
M3B#3CRG<+RM*F$)PG.%JSCYAZ6/1E:>E;9RTV=O,5N<':M,9ML83=6MLU=.+
M7;V=_9A@MNN-I"%)OU+*PHD%L  A1(]7L?M4]LAB;V)L6;5ZMZQ=L2TZZII*
M4NOVSY<"D)62H&V"0F((43,@31[]2CIO[L%F_DN*_P"4^OSS^POP'^?.+_U1
M9?\ -U])_7QQ#^0+/_;7_P#@T?J4=-_=@LW\EQ7_ "GT_87X#_/G%_ZHLO\
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MV\<PM5RIIO%;.V"6V,9MW1<!0)6VMD^KCQ%]MY=WYOB]:9N7Z\5P=X7;@O<
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M%/L!87Q< RCA$N2.MSH%[ _!]U5+->BQZ?M0BTWA,2Y.!6)R<5&ZL/XQ-4>
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MI1>=-',Q)16?4JW(*.S%A1V8ZE-9CBWQ[C0(XQC5%4;@QG<.-L8C2,^9I,(
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M6[33]W\<V+ NVK?9FT-W:*6VXV]@N%A+:V1<>L]H4N24VR[=+#^X5%#]U:)
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M63KCMIB1LKIZS:2PTRIU-S=+N58;NVRBVA3+;*KF]M@5NNB2@'=&ZM3?.O\
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M/*CP(951#WF- E/60G)(QDJRB;+6U*=_T0WEQ7#:])VWC5KB-L-J<;6YB?J
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M[6VS(]<<;L]RX5<(4ZRD/!UE6HE5J+6R=:O+JUPJUNRU@>..@G%]@\7WMU6
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MQ5C"!^W\,#:F%8ELKC)]M9P2Z-PDW&&..@;]K<*MB4G>2$N)WE^?TI=JCI4
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MWB#ENZIQHV[SR74*5R6L!]%:U/=I@MS;H:<<9"GKG'.U=<;NA:AMNR1=KO\
MM%N$PTJU2X@)7VJ4%"@&M Y >(@38AOC[/+E>_RW8<:.U6].9GYRW/*"L37A
MN0F"$4,^4#%!L,]*C,A)Y"&["A$)$G*&E<6V])G^%)>-L.6V*N/>LOK8::1A
M.PAN3N7-Y9BX7:&P%TS8.7=A>6K&)/,MX?<W-NXQ;W3KL(.Z[LMZ)F%.)=M$
M([)M+BU*N\?[*%-LO=FE[UCLG+A+-PR\Y:MK5<M-.)<<:0B5!<A[F\0R8#D&
M6]A#DK;)"H,49\*TP[-F1"<"X%%6!3L<&\/%UB&-I)@DNPG)HP3.%8;+B99
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M%P^I67DNQ'925XD2I#CG$5Z1MJEV#.&*O&#:,8<]A3:/4K4*%D_@V"X XV7
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M/ =?@3S1+;>I!KKF=B<4-B9<S(B[ETU*CX5*FZVFRE9+/,B<.P68+KLN(TY
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M:U.)?0X;=KV;D+8<7<J1N$.O+5;,F5>R"@C<+:EH5B5@5HIQ"DN7*$I;4RI
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MQI]-?\S/_B#9?^^J]5^NCL)_+H_JW%_[OH_2"\M/W)E_RVUU_2[I^QI]-?\
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ML:?37_,S_P"(-E_[ZI^NCL)_+H_JW%_[OH_2"\M/W)E_RVUU_2[I^QI]-?\
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MAIBYL-(04EQ!BV9DB:SEMS#!EA"Y&\^Q>+O,?M+O +.]QJ]LT7OI&]'-DL'
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M:&S6.AM2TB M2/4MTJ R"B) R!K]'_JCV:*@LX]@6\ 0%?:EAO ',@'MY )
MD3!BA6DMZK5E:]1;94M6$X4I5!N"E9PA&6T8RK(G.<X0WG*$XSG[U&<IQV3Z
M=2?1]Z2%$J5L1MNI1 !)V:QXDA*2E()-E) 22D Z)) RRJ!M'LR  ,>P( 3
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M+HK]=8*DH0]X^?=@$"K8,*U+?964+N"Q)4D@;!2_-7 &$)B6,QX4EQNZ&G'
MX6VUK#2.U=*$*4&VPI*"XX4@A"-]:$;ZH3O+2F94 :+<;;* M:$%Q8;;"U)2
M7'"E2PA )&^LI0M02F5;J5&(22(_LF^-'4V%/(V_<VJ*H/%6(E4"D^R;$J *
M$-M@82@\8K$^44,16(=B$@G&S1(+(<;)01+B",J,U#4E[.RUAV(/J2ABQO'E
M+:0^A+5J^XI;+BRVV\D(02II;@+:' "A2P4@E65:[M_8LI4IZ\M&DH<4RM3M
MPRVE+J$=HMI14L!+B$$+4@D*2@[Q &=? >^M&6>BF=H5O<^I[#K.NRWH%@V(
M#V+3RU%!3HZ(+DB$9ML Q( #);#908MZ--(,/-((P5+0E,N/EPYAV(,W#=H[
M87C5VZ IJU<M7T7#B25 *;94@.+!*%@%*2"4JC[I@W?V+K"[IJ]M'+9LE+EP
MW<,K8;4-TD+>2LMI("DDA2@1O)G42YI.QM>PX6"4N]TV*.54G[^DA)LX1B$J
MB14QE2;KB4[.2QFI1TS8:G[)ASX.RF7&RY-3A]K*\0M;E2MQ-N^I7;"VW0RX
M5>L&8M]T)GMCNJAJ.T,'V<C64W-N$[Q?9">Q-QO%U 3V B7Y*H[$2)<G<$B5
M9BEP"?!6D,,L=8-";'7C4-@B&/ 24,N&+#Y*,.1IPPH/>D09\.0WG"V)45]U
MAU&<*;6I.<9ZQN-.,N+:>;6TZVHI<;<0I#B%#(I6A0"DJ!R(4 1Q%7;<0ZA+
MC2T.-K 4AQM06A:3HI*DDI4#P()!J#>3/(*#QMH0N]3ZQ+M;).V0*JD=#)LB
MG679PDX53,5)>AS4+;;0%6SEG#25*5(2O#F,-Y2KY9Z6O2;;>BG9NTVCNL(?
MQEN[QFVP<6K%VW9K0NXL\0O ^77&'TJ2@6!;+80"2Z%;P"2%>OV.V5<VOQ1_
M#&KU%BIFQ=OB\XRI]*DM/VS!;"$N-D$FY"M[>( 01!F11?\ 57ZU^XN<_EG
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M$YL(6MF7*F,Y:=Q'-L-.R=]UJZ<N]H+*]V?M+S&;RT3>^D?T<62P<&](>#$
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M]5X'7W5(3<M.@"V<89=LULI2IMH70<BP8"E+><0E3UVXTA*GC-^=)40OK77
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M&8W>X*NYM<(VB9P^][3"-H<3P5QMJV9VD5;-M&X>;2L6ZW'FV'-U<(^6X_M
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MU/M]@\;=].\V7&E$EM9&J"217SS$K"XPJ_N\-NP@75D^Y;OAM7:(#C1A82L
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M/29+S4>-':<?D2'W$,L,,,HRXZ\\ZYE+;333:5+<<6I*$(3E2LX3C.>I )(
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M>'_J@VDV:1=6V(KO'+B]+=ULU</(8=8M+9NRN67GKVV;;N"U>VVTM+6U*[+
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M3A*TR9&%8SAYS"KG_ [QTM(8/I/EAM"FT,G KPM(;6'4K0AO[>W$H6EYX*2
M$J#KH((<7-1Z:L/"BL;*0M1"E+&(,[Q4DH*5%7V?)*2V@@DR"A!'W1&7]2\N
MWG<<_3$K]H\Q'C.K^B1;SNQH><9B1W%?3/NMB+E.,QVE9RVQG&/9)3VQU?\
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MF\2YD\_(:%K@\L=S3DI[JPUFZDFGL(QW^6,KSW],>F._\/5V_4U']P:$Y9M
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M5YX+SCR\JMX+RK'WJ<7<LK.<]_EVPY^#T^W\'5O5K:8[%J?\Q/TJOK!XD ]
MDGG_  ?/'*:>\+Q!^;U<C)(G.56Z)1"2UE8\2[>2N<-8SWPB5+1EW./)C/\
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M6R&XXN"RR/:)-?#H)!;T770^];"X"8+SE\6RM*"H),'>4EO/>)_>IS.9UJ2
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M.+3''K9M'A@_$=H_$N\ZRN.])=N5LEJ;44W6M;,(V7Z)QV:\;&E\UHL2K->
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M^!/%A%=%CX+\]V$<FRT1&=E=S=GUPH=0E%JLPDH"BH2?9G01$S!))X54(1[
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M(-;#MLY^<8?DS\2%*E!')#[JHHK+241V\I1AY7;OUF%NTE:UC>E;*629U0D
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M]IZYC6YEJ.PBT"0Y"1!EBRZF8D1+WN9%N!)<BQI,F"[+8;?3C?MVGU!9"T.
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M,]^WS_%COWQ]?6+M#.1)XS)/PCKGTGNK/H1[CEKUCWS^?6EP,$EEU/NX6F+
MAHRY.(2/-B/%3GTPG&<8[NR'%=D,QF^[CJ\X3C*4XRI)3F>6]F-!$YB!).>0
MS@@F.M%*![Q!S(SR@Y<--9X\>"F7L,=,!@&#;=C#6O*N7(<QA$DI+PCRJD/^
M7OEMM*?O&FO-G*4)3YLY5Z]5+AS!'>)X@ :GCK,#X9UB""5%2A)RW1J!.N7P
M^&=,[*\Y[>97^//X_7Z\_+OG[?GU':'3/2,_$3$9 _"L^Z=-8[N/&)$9>,:U
M]1A2UI2A.595G"48QWRI2L]L83C'SSWSZ=NWKG'?Y] HGB9C3*! UF#R X0>
M0JI!&1U[YCS'A%+9A>&<1A2>WD'-Y0[V]4JEN*R[(5\OOO*M>6TJ]<Y2A./3
MMU*E<)/'3+NU'RX9]*@9G+CE[Y/']$&:0\KQCZL^OKCY?+^'K%5@DGB,CUR/
M'A7SSX^S/^#\_2IW#S'Q^E'GQ]F?\'Y^E-P\Q\?I1Y\?9G_!^?I3</,?'Z5\
MSG"NW;&?GZ_;V]/JQ]7X?P=6"B)ZCX\ZC<B9(&67(ZY28SKN)M[Q99%AY#>'
M]LK3=IY$4/6/%G1O%G6^WZ"U8\5B+?;!IJX&"FQI >M5R]S:U8@=MJTV%7HC
M]J<$RS,5A8P\-@C66<KUK>R!M[IMQ+2ENN.J;61.YVB $G>*0H%)$PF8X&2:
MR%9*DP2 E(*@#K!S@ P9ZQU%;NU?$NT78*OXH(36E1V:$,<U>0/'C=6FI1VM
M4D6*JCVKMC#-AVQO9#(V]EO<)TXFW.4,77F[.P7?7B66=#9E/H8)LW$FT[12
M"+=EYIT)*BH]HE24%$I2" "F9(B(@Y5!6GVX!S4%#(<-9S[]*[U(J]('[>Y5
M>('M;CIO#1NQ-E\$;HO:>T;+M;25PX;QY,W6%4K@5O15QH=@/6#8MIOZ0%?'
MBQTV2/8BM-DW&A;Q4N*93RRM9;9M4.MN(3<@MH"' ^?:)_*A20$I3*CD"3.?
MLC++ !4L@@[IDS*=!]V,S/7W5^?(+XD6E1NQ?"0M[U3VDL;P&I@ZN[=CM"*F
MJ;9YL2Q)+N.ZX;7<T,$XJHV,MH79I-3>R]V2IE+?ZYCJ&U<*+].\B;I6\WFJ
M!_GG=RGDD*[ZQ=HG\GD?8U^&DD\N,4C[#YX<;=K\-N7G'6RU_=H2X[,Y^;(Y
MM:--A0]&EUMW%Q"XK FF[4]]MJ"0',(5*)323U3BVA+D]<)F+,S'COKEW2PZ
MBYMWDELI1;(MW0HJWO9S*D0F#)R3O$=0.$[X*5#,$J*DGE)T.O>??[XB\/[E
M;H30U#YE:@Y#"MM/4KE9I<7K5BQ:;&5 U:*N5"G)1>/*>%72PUD6] EXEJ;=
MDHGOR(ZHZ6TCWTR5/Q+W=NZ\MAQG<EE94 X2$D$ $2@*SD:=:JA0E0,^WEE!
MB3U(J[5&\1[@C;2W"OD=R5UOR=7RLX+ZIUYJZI5K5,G7&=+;>9TO+)$M4';0
M9L1.):ZC+8,$7B=K8$!Y[#JG,,PVR,1M$'.FY872 ^TTIHLOK4LJ5O!;>]&^
M("85D  9X<#-6WA*5*"MY(C*(,:&9$9G/AW@URMJ7)]$KGM5>9FRA,K+;O+D
M#R8O8"I,QI$WV&-Q0]H68-6(Y2:,B2)*6L3((5HD1'QWG<1DS)T5M3LA&RNW
M*;93*2/W$M F8S1N G(F)U@&.$U284%G^%)''(YY9?G(-=.]6>,($KGB*\A^
M0VP37)&U<2MU#]S H6E'2\$_*&@]@P/8UJ-.UP<V-&URA(>2VA,N'!L*V8D5
MZ0D>_)PM;+NHJS)M6VD]DEY!0KM"" 2DF1O!!7G.1W<XSBKAP!:E'>W2# G3
MEE(&7?W5(O'+QA-05GC)QUU'M*^<V-2VGC"%L52C#^+<G5<6G;[J3A!<^E-7
M$G=Y^#FO[  1B.)G3P$0TV[ ^(3V7Y$R;"A"8=LUJ==4A+"P^H*EW?"FE?OH
MW1NK!.8!Z" =27$PD$J&Z",@,QPU,@_HF*AX-X@?"?DIHZCZGY^4GD[/EZ7Y
M);FWQ0YNG"U,L\C9];W==R>P[?K?:IZU&*68C%9U@*/0Y=VKB(Y*6/PN9$<!
MD5=EY/5[AETKM5-?E&D,JW@4[BFT!(6@#>D  $ Y"0(($T[1,0YO9$G@,C.1
MTRS[]#-3QQ;\332FNM#W[1IUGD=PPU3&Y%67<^C)_%ZPUB[6D?KNR1TQ)6E+
MFO<Q5R<80REE)./=43ILR4<DH6Y"&"Q^89.CMFZIQ+@+5PLM!#G;2E)4)]M/
M9Z99;I^-8^W3! [0 *WD[B03&?LPK+KS&>@J!MR^*9J&_P"E/$"U_%KN[#]P
MY1WOCN4UG8]E$:W=WHM9T<5%)4K:%G44#S\')046ET-$ 5@V.AR76!#LY,.$
MDG(RMVBTN6ROR82RET.!OV?:<!^X.4G,J()S,22*QG>=2ZE14D.*04E1$I"3
MH2.)B8&0TD9&DODYXMP+=_!'5NB:K4[O6N21"#I2K<F]FS6 3=1V)2^-R[HO
M4\0,_#L$TR3*RB)T%8[+(,5P*VR3#J@QEDHB6)6:-VJF[A;BE)+0+BFD9RE3
MN[OR"D@" 0(4<LZS$#LT@03"$K42/:" 0G,ZF8F>NN=6LW[XW>KMR4G8-_'7
MOG53]S;%T^S2'./%9LFL*_Q>JNQ'ZW$K9>YP[DTHCLLO39;<=PI(IKX*%*,3
MYA&+(GBFYC)&!@18N)4E!#!;0O>#A"RZI,R$Q]T*'/0==#8N"2?:F(CV=V8
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MCL!_"->O=O"S_=%Y]?[R_'K_ )]^K'&W"".Q1GU5]:=@/X1\!7C,/PLL]_\
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MO;,++;&),_:KG%I'BH?B:G<3S/P^E1G\/\+/]T;GU_O,<>O^?;I]JN?Q2/\
M253<',_#Z4?#_"S_ '1N?7^\QQZ_Y]NGVJY_%(_TE4W!S/P^E?<0/"SQGO\
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M$D%!-R43USX\$:1N,;<'^)1I$R=/<:=@/X1^%1IF/X6N?GL?GWV^S&E^//\
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M8HB))HK98<.+%-92V]7V%7W4V6BP:6T6IYE@?%#FB3M?4IN/>&#7*=R=X_\
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MKL8[8?'U_8"Z9'('WQU^03I!5C9-@18P44:(,Y(0ZZ:"681,#91-4JX&-?\
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MS]('(> I1[9W]E<_NU?GZ0.0\!2CVSO[*Y_=J_/T@<AX"E'MG?V5S^[5^?I
MY#P%*/;._LKG]VK\_2!R'@*4>V=_97/[M7Y^D#D/ 4H]L[^RN?W:OS]('(>
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MQWUM/;^-BBT R3P=79!YY)U]A$SY\?P,=V5(&OZ,X_$3WTHC.'-. M0)6O\
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M<:E*<9<985'=2ZVG"DM*2M*\H7G&<=$@C(YQIY\\1I%4)!S&4Z^/GH<LAI5
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M5JFT6O6T#<NXZ2-L4;9MBKCL>OZ^MMQ"4T>XT[78E9%9(@Q,99\<A\QW<!K
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MT#N MN^EZJ]KN)4/I$'9H!Z=53!5:","SK:LB)G7F2<^\$'Y\XZ57=TS, :
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M!$C%?EF18^L# $5,3\/@0?C%)5?X!L!5_P"B-J/E&"(RP5ZP(FU&21F+KMG
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M^&1O]O._C0G_ )9UXNOL,#KXGZU$.U+2=HY+5+ ,2/)"KKLX+1[/-*VBQQ"
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MTM?#(W^WG?QH3_RSI2!U\3]:/AD;_;SOXT)_Y9TI Z^)^M'PR-_MYW\:$_\
M+.E('7Q/UH^&1O\ ;SOXT)_Y9TI Z^)^M<CZMXAIY^^\A0UYI0ZL5W0A;=\
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MY<I[*4<D+SCMGUQVPO&,X5C"L9]%)3G&<8^ ;?W8O=I;NX#:FDJ9M4I0L@J
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M & K)LX7LVDC0U?8?+P3X[1%"T\B?9CZU#2BX3> =F>C@P,R 5@.OU^T@;T
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M&78\2?5*T5C-M% 0N9%F3GUU\^>/.H@9=-.'D=-*Q-<;M&,H9;:UK74)8?\
M.UG#<O*T0?8Q8V*W[3,K+F:5B-"A1L4-2\TO$>'%8P!PU&90A)Y_IY]_76D#
MEY\ZCCG.IIXR-7:_EWB)LB15AKMU@^1<4XI+_M6Y;0N>"8*YAX>P.=.Q@)4H
M B'W8:S<0"2GA(T]H7,D1'(J8X^?/Y^=:Q746L3@E (O1Z\0#M&+?86A\F V
MN,V<OL@]+N)9M'IY)]AF6<_-(2DYPZY-)R)B%(DX;=;4@<J:2^-&AWGH[\G6
M-;F+CL3V,XGM2Y[4Q1:'9AQF<58FRGV31@X,NEO%G3A=N:9-BK0?&%9\R 7G
M1WYD^?=]!ETJ('+SG]3WS62O\>=85:]5Z_ 0RH!.K";I "P?]!RX;!78<BKN
M7*WR"$Z%*M$^W'H=- ")I6?8I+3@R,^W[GB5.FRY$5-3?TI1TI1TI1TI1TI1
MTI7Q24K2I*L84E6,I4G..^%)SCMG&<?7C.,YQG'V=*5%Y/2>I# T0((Z]JT@
M=7P0:L 8^!;#'P,!7L+0#%!WH^&GQD02T](CP$0G6,QHLN;$;4F--EM/*B!Y
M^7=TIM1.-FGF9=JED*>(.9M1RMF7(Y(0#8AA8].IOT JM> 1@HH0W#KX*I/F
M 46))Q-E2!%DL(8C.FA22QJ$Z=*0//='R^&6E*C''O1T9F'':U31LQH =ZOQ
MHSM>@2(_P1\8D*\+D,2&G6ID-P0E0Q3,Q#Z?<7Y<;'9J9+2\J8X^>/U-9Q>A
M].!B0@P,UU6(I8')3-@$TP$N3\S69<B?$G$);RG'S$X;.ERI@>887.DAI<AZ
M0*=AO.+7E)Y^?('A40.0\\>_K4M]*FCI2CI2CI2CI2OPN;VYZ[@A[ZU +KL,
M#1Q!@+=E2FWXC)Z:IJ'$6E$W),BB*PUAB2U*94A$5#2<L*6[E["DYZX#EZ^\
M_:N%'8MK)2E)G>W3J22=1QT@ G@)]6UAEJ&WFB_VZT*1VA283Q(@03T,_ S5
MW^,6I*V+A-;KNWNEKV3=)#ED'S9;+3L6N122LRTR(4!*6AZ#<Y;JI4@DF)[Q
M RY[I 7'RF4]*^B8/8=I;-7-T ZM>\IK?]I*$20E201(7*3*M[3A7A\7>4EY
M5O;0AE$S$[Q4%*23O YY!.4:]1 N&3?HUG&SZU:PX(V%-PG8!,67B1IT(E&E
M8]B_%>C/H4TYYL+QGMA&76\XPZVK#J$K3UKII+J%-.@.(4DIW%P1NQD!O#*(
M!D& 0-=*YK*7FG67FU%#S0A#R%*#@25;ZM" =X2D[P)W5* ,D&J]U[0]%XCA
MV&N-6LZV%KECE&"$I,DF7(%A99Y(Y,V+!+$I!(JX*F1(HI3,)Z>YY7XJU*4Z
MM:7,\;#MF+!V]?NP5^L(2C=0XJ4!L!0AM.Z-W-,'//V>45U;[:"[:M[>UA@,
M.+6EP!79%"G%#>=5).\D$2K@3QY5]W+LFYE[=10AE^!]'O>X"#8E^0EEX@<L
M82PJ9B2E3EI:CPA0F(^^H>YCVF9<B)-E/8QY6$=[#K%0Q<+=6#9BT<:["/97
MVOLE+@CVE02!I'6L>(8A;,X,;.S2A=R+UMU=XVJ25-*'Y1E8C=0LYQ)*M)@B
M*J\Y.+.Q>3]5UQ=J'9694/4ETF5JY#Y;;LZR%!VQG=:M#"8^*.Q+:*40=+S(
M44]^:P:#8>LC[#CH5QU$#<N<$8OL4N+.ZOG;!A>'S8H0SVELN[82[V8<X-F'
M%;JH!(( 4(,\K]4EXW@K-NADNO-75TY<W2W$MK0Q<)8#@02E*E[W8) ]I6Z=
M00JJE<Y^#-OL5;K&PZG'C59_3FJ(->-LC)306.9 U94LJ3D,0QP=+>)B(KQ%
MX<CWV'&9?>4VMK#"O3I7^#IQ$X(IMT=MA-O;L..K,E264HT*"F2 E11, $Q$
M UQ<$Q!>'?:;;BR48K=+>+0'LJ4Z3"G$*W@1!2-,TI YSS<KU#Y-:+K5 W%4
MSQ(T_N46NN1*.(/7>%9;,'L=7(EFFB49N*':F06PS'Q>'-'%9[$.2W$>BOIE
MPW<1N\^]=6EJ+AAHXDZD*1ZKO'?7OMK)4"(W5(&\K+,%.A)SO<LV&()<L'4)
MMVV%!SUL,LI0VM#R1[) /WEF"E286E2@3F#5BX(9^;Q;V<>28D$9)0QQOD%8
MQ4I*-&4M):VF92I>2:Y<G+$=$N*W"Q+5.S$;9<B9>6MOSY^4XQ=+O4EQ]E2%
MMO--!#LJ<;24SN.*,;Q3, P( .5>UP"T19W ;0X5)>MUK*D0E"]V E2 D )3
MEF!,G/I7[IO!4=CN>'3I),6.S&9CS=@1DML,MM-96S>SZ75HRWG*7FU.^?V4
MG.$JD,X;>6A"UJ0GD8D9N$G<[/\ (, (&@]@5E(W7'A,_E5G68F,IR^6E=6.
MM"E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E
M'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E
M'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E?SM>1U
M->L?*/1IRNA"RJ78LWL>\/EIFEQP5^+6A@MQ:WDYDQ!8^PJ::EQD9]S;=G.S
M5OMY(+F+<\4[<NBTEM#UX[8(4I-HPD^L*42 $J3J$F3O$P #)@2:]HM-C9OW
MCH2&'[H!Q:E+'Y=2)(]DF4P8&8 )X$S'4NC;/A XJ:<PK"%55F(,D(;E-.^R
MS#%Q74MK2E:O9NR''7);F',(PIO&<H;4AQ"L_5<,OE"W884VZRE-NRHLNP5L
M[[:5J0%)R(2I1(B8,ZC,^*OV>T67%:N$J!R@R9)RX=W&3K4R"Z=4K3:N.&;Q
M<[A3J1NJ:!*&KF*FBHZZW,C7W?.J<(&R"8F>.C I&QV..X4T^0C2O=)]\']Y
M<6-.;4SJ7EZZ;A10K)!(3Q]G=202/'@,HX2*E#24M[L20$SEF<@>\9\M8[ZE
M[;06)4=_S>,6;O/=KM1.09S]IMY>",/%P[VLP5W*#620NN/P8Y23EZ7$A2L!
M<M0X:'YKC,QV,EE_-;XF^TA;H([12=W> )@[Q@D @D0H93GS'#GW%DT]N)6/
M9"BJ"<SE[0!(R.4YY1S@"N4O)[4Y[<-9IDBOYKP.SS-JZ5NY6/K?8RW-E-Z/
MLVQ NOYMU0V] A2R]552K>HC!ERF469(+X/<I8!@ TF:WM.XJ3;J[+M6[G>:
M ?3[,J1!),&4G7I.ATFEK:N,NB"CU<=I#6L!>@S$$1KG.<&G5QIUS:=4B(\:
MK2+A?1%H'5@^2.;$V/$E.AK C9W+,>4E','ABDXIXS6>A1!YLPT4%PZ:S6;.
M4=CS\61MH=%GBSC:NTN7G'%0N-^5'-*"-T[V1WEE,$$$D"4E,F,0L&[QL)T4
ME0(3HG=,S.4>UN^Z)SJ9=Q';!M/4&QJE7K!IMIF\5R;KFIW*5>HK54L%TOH0
MP/#5<7(=@?$V3\?+3L@HR:%AXH*(X/G&9L"$9#/SNRC:#<4E90YO!*MY.["M
MT1),D2,P)!,G3,&.8G!_R@4%-I *8S,$@" #F8RG01I RKC2+XO@-1;>U/.$
MWK<-XDZSV7;J+9ZQ:W9I^J5)L)4KJ"E2A4F $8C0H2;".$B(K\=M4=4>4RG+
M6$^3R=NSQ@W#EN^AX!"4JEMX%24!39$A($R)"<C$'+*L-U;[S-U;.,MA3@$J
M; 3OPM),R=XR1/M#.,Q4(%0UJU1JCD?3[LPQVE;1T<BMHAO2Y*I5-?D;9?%8
M;2^Y#?BS8T1?PYQ;2L);]S0XA:F,^T3XK&D+;5=*6IM07>H<2IK[I0K3+-4_
MPAKSKU6!N(4ZP0"E+5FXV<L@4P.$B)Y=W6OW/^!]-S,\.G4:<17(C4"P[)',
M-.X=P[EN+>#.,N.8>6XO'G>4[[/&,X1[##64)2G.$XY%\K??G=W8;;$3.B!Q
M_3WUD4(4H3O>T<])_1IUUKK=UIU%'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2
ME'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2
ME'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E'2
ME'2E'2E'2E'2E'2E&<]L9S]GKTI7\_EFC\C7#@L[''[[$QQTE;SE<&:Z<0%*
M-JPI.(1%1.G$2ZX:<N/+0VR38RV^\Y);<1(RAUO;LK*PP]QQ=N@-]NH%\SOJ
M7' K5*AS@$> SFZN7KN%/!*EI&2Y*3 C@"!'7IKF85X_W9ZA-+L2]0[E-?2%
M],R')31[(KW!E#:$2!Z,(K[;2777D9D*F3Y_9]"L-Y]GEM27RKA-K<.Y+=2[
M[:5?>B1NI!B8@ '4:STK80#=L(,I0IF$$*($P"01,3]Z,C$C(\:ETYRHY0LZ
MJU7JUSC@]-KFI2UGDUI=@TS<CQPR O9,E-V'2+GF,9P++U"Y1RZH9T,R&=<S
M[@#+AI(FRUX,<@ZSCS2MYP[P43F(R&8 @$3RF2#U(DU*6"")4,Y!.\,O9.GO
M$@QR$:RYH^Q=MV:]2MAAM%[CKTN-&$M#:Y?!.R=AOAV/H*Y2)0U%I."AQ\P(
MA0?:M5YHS-G%!8WX9"F%C:H:R$G;MU)4-Q9@$3ED9!!&1$S,SD!6E<I4D!28
M49/AQ)&4<--=>=862F\((8)!&Z2)Q+*"!4^HQ]F)U3?5;!E46C'PQ\#1I\O$
MYNMN!$X "Z]/)PZS#N<^GQ_HJ_:E!G%Q<YU-L$DA2A)G=S"=[G$93)U,<=9G
M"E3@B0)RD]/'3XY1RA;K]SY#A1XV%]RH^_F%&"P)B5ZAMN8)H6,>W5[^$*CG
ML/PW@EG&[]V, L<%"&E2@<^%&B2(,B(N5(@--095'+,3/LYR!E!2#/.>D%+5
M(($](RXZQGG)GGXSD@'MBBFF!\/B=7?HJ+- K36Z0[J3;CU?K%SK^9GNER'$
M,VOZ:E#DUJ9[H:9MEML8(U @!AQ(+(@ Q$>$+:#JZK>(@G>S*<I21$0,HW0.
M)U-4WE?Q:>8!2<B)SF9DSG,]-*:K0_:[LZQEI.JMB^_VFR'K44S&H=K9C)*6
M,G*+$,1&7![KC,5,J6ZF.RX\\XVUY$J=<SA2\[C+Z&4A&]DGJ)RC,^Z#//7A
M6LXVMPE11F>'#AI&7=W>/.OECJ7=YRWP'X.K=L3X5E6!++CQ-:W5_$&30FRP
MZ-B1)CB5(S[\B\37F$.);[9ANXSEW&5>36O[D.+:SE!4"H S!1IW @Y\>6M=
M/#):2M)&ZK<6F>:5D$Z@Z1IR!TK]C?@IP"%.X"4 ):1!ZM&F;ILQZ2(L04P*
M)1_;6\AG#BX1&(U);8DY2J1'7Y<M/-.)=96MM:59U;]2%7"E-D%)0WF(.>Z)
MTZY<Z!95)(,[QX'GJ>IKK%\9&_UPK\GE?S/6G4R.O@?I1\9&_P!<*_)Y7\ST
MI(Z^!^E'QD;_ %PK\GE?S/2DCKX'Z4?&1O\ 7"OR>5_,]*2.O@?I1\9&_P!<
M*_)Y7\STI(Z^!^E'QD;_ %PK\GE?S/2DCKX'Z4?&1O\ 7"OR>5_,]*2.O@?I
M1\9&_P!<*_)Y7\STI(Z^!^E'QD;_ %PK\GE?S/2DCKX'Z4?&1O\ 7"OR>5_,
M]*2.O@?I1\9&_P!<*_)Y7\STI(Z^!^E'QD;_ %PK\GE?S/2DCKX'Z4?&1O\
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M5I"D[RO;02%*&]O"$P .'M;LELXWA5E?V&%6-DM%QV=TVVDI40I!4-]!<)2
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ML"DE9BI@'7%DHP&%1!-#E6^:]=[E5&SD',R! >CO1,279@1KSX<O?Q[JB3,
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M_JJV'Q;9UU2',:V4;3B>!J007G;>X6/64!4_>]H I3!TRB34"Z[V*?M$_;Y
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M4![.<C^AOH[V6V:VKP[:3#;79' 7,4?PMY.&7M]AMMV5JM*"KMF7UM?D[@D
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MEC;6-E:EQM(WWWVFD,N +C=*OW.%J(.\0;#^%-RPVA+YL\M>+FQ]N\@]DU?
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M&4Q,OIEO82B/Y\I0SYL9:3GMY<=;-B^BX:6M"U+ >=1*E;Q!0J"F9.0Y<*R
M*W&RJ)4A*I$00=#EK//CQSJ=/A<+]C<_*97\]UN4JL_(?=\'2<K60N*#R1G7
MS8=!KY(@2S8D@P-1/[*HM$L)'$T:Q(:DV?&+M%77 +\B'B6B.5,.N/Q03PTC
M($SYZ_ #Y<Z@F(R_-YG\>%14%Y(6AK4.T[A;  >)L2KTZHW>JT>+$1[C.$[*
MCD6=>H@6"N;8V")OJ3AD43&P9#!/7TV<L<AXL$J DN.-]#Y[^/ >>-,XSR_
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MA>X/L5R S6GFHZ434,*@3J^D;/%RX.24]X80&2HD\5*EOS!LF+*7E[I2*:-
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M4L<E,%6<QL8:Z4I#QJ;5:61D9.M-?XCA"+!@-'Q3:YAD26BRILZ,4&-8&^2
M1CS21&8Q.BI:DLRB$V0VZEV4^MQ40.0Y:<.52!TJ:.E*.E*.E*.E*.E*.E*.
ME*.E*;[]3JLK(]4JLU^2H27DV 4I\,.>R,/3)SI.8;'Y<C*S#+RR3SQ"22C>
MSF/SGG9;KRY#BW,J5MQ@02'D<J('%15"&)443F,/B,9%QIN6538X[+3*<PF)
M:H["I3,;V3<C+#.74KRVCRJ4J]*4=*4=*4=*4=*4S-C_ /<\OO;&<Y^AEH]$
MXSE6?](YWIC&/7.?LQCUSGY=61DM)_I)Z<1QJJ_NJ_S3\C7\G;<$\,?U77)2
M$_$K/4RZ83#[:V7G6<D)[J\12#;B?:M.8C^S2UA;2<>9"NV5*PK+?;NW=VY1
M<*5^302I25*$*'" 3KF- 9UKFX(Q^URUN#MB/9,$ZD&%(T5GD"N>$:S5,S)"
M=";E-/,(:D)4XF1AM?WR%9],XRMO",9QCS)QG&,]LY[XSCY];1N2;=#K94!F
M2 M43H#,F#TB/?IF?;626U[A)B2&VQ(SRR2.9 @Y1KSNAPOX#;CYHQ9I^EV6
M,#8&6&")P2-LO8$Y>2Q*=2V\?C3<R81&-&&SBN0<,62L3M- V^WA11093#R8
MO+&(NH<WRXXDI.^%#[X(.J5&"# R(( (R/*AL&G$E!;;4D@@MJ$H5O#,*'$&
M<Y&ASFOU Z:C'^,=Z8U7:JY#KLT%6 N4Y*OQI(V,P.%X'B%#$PWI<F6DBN+G
MVS[TN.PIEK!."DE!(PI;O48Q W-D#!NG0X0I:U$J 4H'VU!4J&XH$%<@C,01
M->;O<-0UB;L%VT:6D.H0D-=B7$-D$M@I.Y]TI*6XG50,YW*LG(V-8QZALX[E
M#$>,XW(^'Y>BQ,.*;\WD\Z,X5]YA7WJ<)=QGMCLOS8QVV[8-L.!82E)4M)$1
M'4 \>&<F.Z:YUT\[=,.-;ZEA"5)*I$*U D" ,N0$\2<JY3<_JLC9^A0]6KE2
MFVN:.-E;%):&E&X$V>S+RS)6/S.(1Y&(:G_=V,1Y;J)D:,[F0ZZ,>4I*>M;$
M'7U76/7@Q9Q*KW"VK.VLW&DNV[#EFR6P_NA32G)(WNR[5"%P!E)KJ8(PEBTP
M6S^S4397EQ>75PE]:%O-W:@X&R5%:4&#F0@[DZ#*G;P*$ ]A2)E@OD0P!J
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M+F/@)@W'NO<D.G:H>HL-X?+OE/"V$J8^Y'?YIB78';9K:!-I0NN)G2Y&LS.
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M-]*QP*2C>"DG@H$@D$ R*E6\@@*3!(DA1"2,XSF.6NE'Q6=_7SN/_P!AB?\
M$[GK/N9:^(CQUJG:=/C^:C):;C_Y?<^WT@Q?YS_#\NJ$08,DQ,)2I64QP$:\
MR#5DJ!^\=T<SF//G/.M.;9DCFLR)YMJ&QCOW>E,0&&\9QC*LX\SCZ<=\8QG/
M;OW[8^77,Q'&,+PADW.*8A9X=;^UV;MY<-VX=W$E2]P.%),1'4Z3G6RS;7%P
MX6K9ERX7 *0PA3L@D1)0"$F#)"HB"-<J29NPPXX.FP3;1$8".)0IHFIJ J(_
MA?FRGV+J'E)=SG"<JPEO*E93A2NV,)SGKA8CMYLEA.")VDOL<L6L$< #5^EW
MM6WG9(4PTEH*6XXC+> 3 WAGSVK?",3NKLV%O97#EX(ECLU)6)YA0'Z?&D0/
MN:EGNV!M[%NK4O#:6G408CRUYQWQAMJ6ZPIS"OJ4C&4Y^W&?3KSV!>F;T:;1
M98?M;A*5EU++;5Y<"R=<<60E"0BY#9"E*( !@R171O=E-H<//[9PF\0@)*EN
M)96M* !),I!WH GV9GAJ*?B2\M>,*006I*L=TJQ"B9QG&?EG'9W/?&?MQZ?A
MZ^FMN(=0VM"@M+J=]M;1#K3B3]U2'6Y0H$9Y'3/O\^1NDA1"2%%)2H$+$#52
M")2"<LXSTDY49+S,?.>[]7_RA%SZY[_8YGM^_P!OX/7JQ4 8WDR("@504SI(
M(RD$$2<ZKU!2=8]H"8Y D$GI2O#P1F,8?04RA.5*3Y50(^<_>_/Y.9QU8@I)
M!GWB/?4),@'2>!U%;7NA3^R^/XO8_G.HJ:BC:.R2VKVZ](=JMXND.PG!5<1*
MIL;7/<<8.EQP4+#EP+=?ZD8GN$)9'VV,UT<<Q!@0"1$KD?#BY>6H<O/UJ**K
MR^UE;=>;.V;$-EX-8U2B&NQ.3HM,>D.K*Q\/!Q[:@]N+#P5CG/+CP)M,O$^I
M72J3ID!N\UZK-3HCSRHD9]//GKE6U6N5E+M)$$*'_2C$RQA'2XGV,6@'(DM]
M%Q+49D5%(U6\V ?/Q).!Y*$VH9*G:[B-O1&"=T@$I"1^%)'GKIX\#IUJTGNA
M3/R+X_B]C^<Z5-'NA3^R^/XO8_G.E*/="G]E\?Q>Q_.=*4F0*RT*E&9PSX6.
MFV,BT8L$R !'0Y1TLR*&@V2AB1'2VZ3(M! P@.W-FK?DH%BAH]+N(D&*RTI4
M6;_W0$XXZKL.VKM(LAD.!D@!L>NTNN0#=RLYVU6$75J[7:J%DDQC14V6-&(4
M:-$7/BMX0IV0\^U'8=<1($F/G4$P)^51S5]^:N?C;SL>MQ!8VNIZWH?(VX2Z
M12ZLU.VP/V+KDB4IQ.ON_&AJ[9<R5)UL- ,O69T5G$6'50[9=8V*UD>Z'AEW
M>>E 09CH>^1E\*5*ORAIMZK6R[;1<7:Z!=:1*@\Z[6*F+*OW2===<5':8L-1
M8K!OVQ6?"JE\J3YV032%"A'S&,SRS4(<7FCT'+A//+SI21GQCD/ESJ!$^)EQ
M^:"L6@D0V"(J#-<+'+);I50KLROTXD+$[C.,U(Q*"6LL^7/'1.AMCSZV1H\6
MW4HU&A '8EN4BY5%1I'=T'$Z9B>&?SY4WA]3P'0]?S<ZL%I4MJ;D33YVYJM4
MJSA-_+"X]F(%JUJ\^9L)34I]YJI/';/1CUVK-KS2S$+,ZH3H5M/,UR8GN/>&
M%8\J/'&=#P^$]]!!F(,Y'\]61]T*?V7Q_%['\YU%33)V7<F]5ZYOVSK#.(3
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MV=L6F7K)E\.ER[3<N-()6RK?9"U*A1"E)3V<$[JCG&=?,-HT73^(K6ZRZO>
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M@Z(*[*+O<7*2>O=U&Q;H'E.&! 7.S([20T@/:C#8V:1):EMX] JX(K)X>EB
M1+!H0PG ER$GIX#Z4W?Z2O&O!?<!K5ZIXO=H(TU9V0+MVBA-)[;([*E,T(4(
M.%KE9S<&V"=7F!H^E8 R8JGF!D]^[.2AS%)'E+$HO5@B3T\!]*;O])7C3'/<
MRM8"9,14,#OLH$79K8+E6#)X/ A/U6C"M\R+5?:_&DV_)$N%%&N/UM#8&SH@
M(^48F"CH,:5%S83DU)Z> ^E-W^DKQI7LG*BF"(L7,2O[K8GD+I2:.-Q:[''!
M"2)P_L/5=+M@6//$G+1.:L%%';4&GYL&<(AC"SPPN"&&W" @]D.D]/ ?2F[_
M $E>-(5!YK:;OS5<%AE[;,WFRB@ZA5.JUP!&))FUN_1R-;:D+D$+>"?#R*63
ML/NTLOLF!KL/8H0<Z5ITNP0PY%49)Z> ^E-W^DKQH)\E; ]6.,1JJ4>Y$2/(
MO5%@VFX*FVK=9IVF1P;.K5_!Y4'4^FMIV60IY[9K+4HX6KE<!"E"<LSYK4TI
M B*2>G@/I3=_I*\:DT7R+U00/#:[)(;A%R[!*/-5&=,(NJ$749606U#AJRUJ
M1%.2)GT?CHT[<(;*K!  F9+SM<FMAO@UC&%'DGIX#Z4W?Z2O&FV&Y7:JL;M<
MC 1G(4G.OLZR#-70&Y@J(_M E2++BL7N'5725XA0X&:9,5B88EW:541\H:EY
M\!,-/19<:.D]/ ?2F[_25XTQ=;<Y]+;!KM6EMKVTFW6.HZQ*XJ 2W#"\M5XV
M;'U:D;K6%@A90)B&7B%]O5(4JQW8#2*3(7\:>;L:,5NQMB4GIX#Z4W?Z2O&E
M&P\ESL:G:6L==H5\EE-O6K;5>77B5HV^;)59C5Q6PC5OSA.GM3[<L\N<2^!H
MS-89KK0@%(D.QY!Z2EJ.]-2>G@/I3=_I*\:<!WE#6 9.!6L5/>!6ROV^J4M]
M<:R1A-9D%"&TM*ZHN\@,0LQL+8WX=".[WHS[R#M1KDL^B<[#&,)E"K-BNI/3
MP'TIN_TE>-:.IN6VOMC,"6C([;E0+64K51E+B9M.3\:\L61K22)!FNNP"#4]
M@<!E;WJ$PW'/C Q<=5DS;)+',M0B<(<D]/ ?2F[_ $E>-3AMC:>M]-6?6U3N
M%DOV">T;"+K8#,*Y#D>[S35PI]$&/21Y>S"3A2._9KU7H;S=3$V6>.B/3"Y.
M%"#P)4]M)Z> ^E-W^DKQJ,M<\J-+[-N=$HP0GMX::V($#G@+9ZPB(;[<&RU(
MU?JHLD#BW.?:XC%EI(-^QP2B:\\"@,SP@>PE@ME."P<I)Z> ^E-W^DKQK;QR
M3UT_97Z:.$<@BEHF7&XT:C!HI 3'?V><UW9MCU:_?0V24NXX?#A529JB[39D
MN]S*4DH)'1IM;2<^*#FI*3T\!]*;O])7C26$Y-T,_IZS[RC(V9 U^!V/5*>*
M)$K9*S(MU8MWT"E";R&'#7IY"!'(C+W$D0 %BC!RZ),148R@.EU3\=)Z> ^E
M-W^DKQKU#Y/40Q\='@:SR(FV>L1&Y]KKC\R&U*I0HM7J;9:C8;:]!MI-#%?M
M0N_UB6P[7468W7X;AR7;@-?:JEF^%)/3P'TIN_TE>-; GDWK0J$U(]$1N0O<
M-RHO<2F46O&T2"A4_J\V& W\/#*'SU9 MH#/E9):(1,D@L4E7@A2:C+,_$,5
M+2>G@/I3=_I*\:CC77.?2U\K].?0K;7TRM=-U28330-N%EYF;UM4/JLB-UG!
MP2LU>,1BD&5MZJPG+1= %)HS^&S;F+&R]7;!%%)/3P'TIN_TE>-/Z/R0KD>C
M:PNQ\-M6"YL\G9 8JGC+5-)VULZ/V_5M-UP*EB2X*")G&K+<0:2BR9P4.K_M
MY"G9\V%#DST)/3P'TIN_TE>-:NU.2X6@4'7M^ U#<5OAWY=]BNCLW:$%)5$M
MKN&36<!'XJBY)R>649#%*W&35<6$<\4B9D-DG!+T4A(2>G@/I3=_I*\:UY/+
M?50PY'$G<;=!8D/"A<M!:U"ATFM6%>SMTZHL0JS$9]KBTE3HBU:5/1 T"H7*
MWV6\Y<=72ZZ;CQ$R)*3T\!]*;O\ 25XTK;8Y/:YTE:=B@]BM;3%!M?P*@2^E
M#.P*LB+88-BK%SMIF0'%FKH#*R7*D+I<Y,L+%CS+589<EF/4*Z=6A?=)Z> ^
ME-W^DKQI@E>9]"JCT5-]#[5I,'[H6_*W*,%KFMX63I.A4<@&CM[J*H$F3/*.
M/%M)#@TJMV.!3Y<>3>ATT/,L0:(R3*)/3P'TIN_TE>-6VU)9*CN:FLW6JG;Z
MQ 44,A)4.=<(TZ1"* B+XV?'P4JI^R58O'RXSB1$*5NQ&P\V(^R]%(.YRXAM
M)Z> ^E-W^DKQJ3?H9'_;!<?Y4%/YWI)Z> ^E-W^DKQH^AD?]L%Q_E04_G>DG
MIX#Z4W?Z2O&CZ&1_VP7'^5!3^=Z2>G@/I3=_I*\:/H9'_;!<?Y4%/YWI)Z>
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MHTP %K-TF52JQU*<H&_\0-A7.I:-%Z:CR*+=EV";1[:NO/CZM<C]$#VC7!9
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M0!-'DT9=5.G@(S7@F52W7VV:Q!!S*ZI3UU/?^(DS;=MU'3*7BN[&NE=2&O\
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MZFJ17)=A""!QN6$F$!;D]<0E/:D5.!I$3=J@ZQ;3'_OP/=-8W+I+:22DDR
M..O,<#EIK3D%>.?Q"*3"K,;P_32H&?=$LF7MX3')@E0R1.F!!E)4[4E2Z:%J
M)$H2,4D=4IP 923,^8<J X(6E/2U0O!6D"1>J(CC; 9\C^V3 Y$\> K4N<2[
M!M*DLAQQ1_<R[N0(DDJ#:\^0W<^=1_?/&6XD0[E6KH2XI[/<&5Z 5;8U%%W2
M#;IMJ+GJOLZHF;9>I3FNWK':[&9$;=N[Q.SV0J9L\HJ15.299;F'8AJB,'0L
M3ZVH?_>\_P#X\>>=4ML3=N,S:!">)#Y7X?D$@]<Q%+52_1(>@Z&<:.4[@?<J
M_);=EKQ&B<F)CPK,20U-;B!F1D[7$R(/JP+),O)K%-%MP:C6YIDH0#!8<V:\
M_G(,#21_TL_[/PZ?EY^&M= /@_O3X^1EQF*^TO\ 1(7'C7MCGVZJ>'_9(-A(
M?25*2,WDF0/9%,7&P(M=N@UF+8->%(5/&6>RLQ3A\758X<<8)01TJ?%?=&P<
MQQP)(TN_%@#_ /'FI[9/(^Z.G.#\.%>T?HD+C/'JUYI@WPU1 &L;+ 3ZM?A-
M7VG5ZHU; ),>3$RQIEZN:;%RI32QY@M&9<4_B1$00EKB.L./K6J/L1/&\\&)
M_P#QW7S!J.W3R.DQ.>L?G_2*;./T0UQ?5$Q#<\/.UO.NE9I@@:D\IK'*M9^0
M3%#@16';+E)I#MLMX$N"#A@9>L6@T7KA4*&#B2 J2/$CXT9]B)X79.O_ */&
MG_MC4]LDY *D\X^II6G_ *(BXOE6C3DKPY)+"[!:R]\)S1F_$AR2[P<(50L0
MN4,F(UF/(B[6HS1J@;B6$5+A%QANNBC R9$*1D2NK_8*>-X?]G_^O]*GM1!,
M&._YQ,>>^MNG_HC_ (\4$\W8J?X?EA"%&1\>!C,?DG/?'.KCA1%;2<DA)FNY
M 27<)%< A0!"\RA[]R)A!L041/2H#6&.H^PAIZV=)_Z/ST_Q_?/XU';IY'W_
M )I^,5+V/T5G3L^GZ2>R?[_(W_BU+GH,"'&[C_V'_P!:H[<?P36RU^BJZ@[W
M[<*+)CM_\'@;GT^W_N38].I^P4P?VX<O_P!6_P#K_A&DG.K%T#4?$G\*S9_1
M4],1CNYPNLB<8QWSVWJ-SG&/K^>J$_+T^OI]@I_RP_[/_P#7YU >!X9<R?#A
MQ@UH._HK6E-]\HX565S'?TSG>XQ/?'R[Y[:G7V]?3MZ]55@:0,KLDSH;<#_\
M>>&?*<IIVR>7Q_-6OG]%=4_&,9_226/MG_X/8W[._P"Y'UC^QTDP+HR-?R'_
M -:H[<?P3XBC'Z*[IV<]OTDED_W^QG_-)T.#) GUH_ZC_P"L:=N/X)\17K_H
MKBG_ -I)8_\ ?[&_\T?5?LA/^5?^X/\ Q:=N/X)\11G]%<T_&,Y_226/T_\
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M ]_1R@F0>7 Y9'W\J^J_14-*2RIW])A9<Y3COY?NY#,8S]?]5]RO/;^YST.
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M$\*V<.89^K^JQG'X\_5W]/Q_BZD&/?EWCE0"=2"9D1P[NFE)\M_*OO<*^?\
M58^KM]7U?+USZ_X?GUC6K@,IY'3\<ZJHQ(ZYGY=.6G+2DU7]3G/U9QCM_#_Z
MNM<$[Y!T/#W953AUS_"/QK'E6<XQCT].K!(!)SSI7U']5C]__%GJ%_=/N^8I
M6;K#2OBOEG\6?\74IU'>/G2L&,]O7'6<B<C2ON,YQGO_ )Y_'TI7K"_7UQCM
MGY]L>O\ CZ4K(E*<^N.V/K[]\_Y]_P '4C43SI6RA+>.W=7?.>W_ *?GCT_X
MOMZR I$\(X\3]1^F!E60)$">.G'A.?@=(/":S>=O"5>7OG/ESVQ\_7..^/7[
M?P]7X'W_  \/F*;P @&>0 (.?4D_6M/RISCU]59\O;YXSC/S^?U_Y_;UB4$S
M.9)G+D>O$1R^D''6/&.RL^F>_?/?.<X[?X,^N/WL]4(G6#\:5Z[XQZ]OK^SO
MW_'C'3I^'F/=2O6%=L=LIQ\^_K_GG'R_S^?>P409URC@,O#SX0K,C"',Y[^B
ML8],?/O_ .KY_P"??K("%3[O,_AR]X%TQGSX#](B>6O=E2E&4Y$4P^RK*7$N
M-N8\OSSY5]LYQGZOK^7;/?\ %U;ETCAEETHI((,@0=03KKPTG.=>X"GK=.ZL
MHFX[8S-CQ)??'IAQQ]&,.8QV],^56',9_#C.>WICJZR#! UUST,00?T<1'&M
M=AR9"<RE2DD:P H0/?\ "(I$$%?9]D2<87C.<8QE7?NGMY.V,9QCOZ8[X[=\
M8^WHA4$3)'7O&L\*SK02)( &>0X:Y]<C[N0BG:A_.&G9#&5*;0GS83YO-C&<
M]\XSZ=E9QC.>^._WOU9[8^>7@2,P/QTYUB4D$C.)UYG093EYXTWLYSC&5*QG
MSK5G*N^/7/F5\_7Y?/\ A[^N.L:@ )SF29[N$Y'F9XQ/&L@B. ^>0.7#(_09
MYUASC&/EWSE7K\^_;O\ /'UY[_P?O>N,T))^52WF23ENSKQZCR:>E'"R)A5D
MBG'D8@N9SG*DY_7',]OO4]^W?T]?3\'?TSUK7"]U)TSXSIP/#AU\<JYN(W&X
MDHF=[300,^,9]XZ4Y-D@G</1RC32EHPVAE[RISW;^^[XRK&.V/GGYY^>?GV]
M.RV6%MI2-1,",SF9\!]16##;@$%N0(T&0'&1IIT)S)XSG&S4;.,Y[XRGTSE.
M<X^?KV[_ +^?\6?WMX( ,Y_G]T5V"9/RZ#E26[$7EW*LISZ9QW^>?EG\?V=8
M]T\09[IGCK/'3*I2J$D:S.8/2.OSKTJ,O+3B?+GU3CMZ9QZ>N,?7\OX>ADY[
MI  CCUSTG+SK4!1^,GKF#[M.%(;\-?FS]ZK/;Z_\?^+Y]OS]5X3PJTI(,Y'.
M-<AKW'/YZC2L;4%>5X\Z5=O3OZ9QZ=^V?KQZ]_W_ /!T"1,P,Y]_3GGYXU*=
M#!)@0)D1RXD>_AGPJ8J6F7B F.TO&6D+6I:%9[9PG"L92E.,Y],=\]_3MWS\
M^J.-RD+C3/B($SSX\_F8KC8@ ' HC/=@$<Y/#0"8\*Q['BLY1!(I:0V[E?N[
MBTXQC+B/GC"L_7V^7VY].^<]4943(G,'0>[/2?SS[K8<XI04DDD0(GNF3W"?
MC49/L8D(;^]RK';.$YQ_L$YSZ_//?/RQ\\_@_'F(D@1'.>?PCGT^75!S$Z G
MX\XU\/A6G"%O2ID:&VRZ\MU[#?9M/?'=6<83WSC&<8QC.<9[JSVQZY5W[9[U
M5 &@Z3GGG'D:=U'5I0@YC+/40 #QYZ_GFII>9AB(+(2,YB#"9;S+L!%ORI6J
M.WYT.1F%J_JI9!S*F8R<*\R&%I<5CR>USG"DA2B0 =W2)&9$GW\N.1B,HY""
M7UJ6H$[OLM@\"K28S( &>1DY'I$18V\4<3';1B,*B^9,$>UG/L66\9SE*U_[
M)UY??.7'',K<RK&>ZNW;MF!F0>F66<'-723J#H1UKK--A(S$DCVCEQ,S\QEI
M&?1&?C>7V>>WEPK&?7'UXQVSW^O[>_S^O'VYZDI!C(?'ARCP\.45DA*M.7#\
M>>G&/B*WH;7?#3",9<=DR6HZ,8]>_F6G&.^/EG'FSC'?ZL9^SMT/AX=>_P"7
MXU567&8!F)G/+A(C("/=&E.V5.;<OHIMI&,,PRX>$SCURG#<:5%0G"?3M][G
MOCZ\Y]>^?EU5*CG/[W4C61/X <JJT=TC,D$@YY:GB3///0?&?ZP^G,]]1:KS
M]NMZ/G^&L"^O#OYO/'FZY_XS6_7%;8X;Q6>7G)CDB!UYM^P\#^/6AR'P#4Q8
MWJ]+[>\B,24:'KM35D),19I.M$I%?E%YA:!/E!0-<,51$:K&9LT@2?I[( RD
MYSF1%4(42<X TZ^>([LN-37X+W-'<W,GCI=R.]W1Y^^:EV9+UV_L,..@#!][
M'X!BC,2=)CAX\0&HZ/5.>CD'PL*! EC70DW,)N5*DO2"@ <M")[JE))&<2,O
M/GG733>'_<5V_P#[EVP/^"9;J6_W1O\ ST_^(5:OY)5DSWL!W'U8,$_\$U_U
MZ]DA,)$ZD#X@9==*T5?>5Q]HY^^D['?OZ=^^?LZR D:&/EY^-5 G(5FQCT]?
M7Z_7ZO\ 'U< DSH.8_??+7NI).I/C-9&L*]?GV[YQC'S_#W[?B_P=OP]9*R)
M'M$C3..7=YZ5N)QC&,>G;/;'?T]>E7CO\37K#BT=O(I6,ISY\*QW[]^^,^7&
M?WOEV_#Z]*$3P'OSS[OST^*]9W6EH8EN+QC/;"%95G&>_IC'FSCMZ_;ZY_!U
M:9$* 5W\N(]_G.(T+BV"TE24B8!G0C4QF=//&1,40IE<5"\JSA/F]%8S]?IC
M&>_XL^O?/KW^7?K5>MP<TI G/@# X$:2<OEPKANM0HB/:B"/B3KPD:1TK<<(
M>9KLK.,I[*QZ^N,H^OOCMVSCU]>_?';Z^L2&=TD[L'NSGF>6IB/TXFVB%A4&
M0> CKWGR34(6$77WY;KL0I&@OK6K+C+K:\,XSZ=\H4WCMC'_ +MGT[YS]76W
M[(GD-=3F-,XSUYY1I7?MW70D MDP#G/N]WN,Z\LVTBM$WTJS#]W()SCMCW62
MVM7KG/924YRA>?3[<>OKCUQC'>H7D9,GA/XQQ[_'.:V>W$F01/\ "! '377G
MKX"E(-0SA&4VF1&7!C^;R.N/=\*QC&<=\)3G[Y6585Z?+OZ_+MU"EQ,C@1KE
MWY\^%8'[M"$E0^]!R'<3GS@>Z8STCKGP2X-A>3L3=$DKMX)H^EZ'USC9ENMA
MNIE;9&S7HTAQ@G(7""SX4].8#$9Z:\IAJ<\ZVC#3492_+WY-W=*0I"$I*RY[
M"4 QF21H00<S' 'W5R$(-^MU:W0VAAO?45)*_9E7[U)!T]\9 4@<E-':8UQ&
MI OCWREK_*ZT7(W*"OU'7^J]@UDX)?PW$0(]C&/-/.GI)Z;(<@P1XAER9A^/
MVRVOVK6,WM6W%*4X\P6D)A6\M:"")DS$1"9)G+499U46C0<;+#Z7R500EI:-
MW,1(5J"?"-:Y];9X[\BM?7>M5?8N@MS:_MNP9T.#1:O==6W:KG[O/GS(P^%"
MJH<V$AD+'-E3YT. U$#QYC[DV7'AI:S)>;:5OA]A84IIUM24IE10L$)B09*3
M"0 -Z51TE->A;0IIM*-TA664:Y<)&LZZ9^^D(WJ/;,*!;@V=7[%0[J!*IFX&
MU4JRXSK*3,G.CVT;#Q\,_P!1JO>X[@U/TD^'9S,9<BI[OMK1@5M2CVTGM)W"
M5)]L1^\S]O@9&1D3TJE)*E*W<P8,@R .<Z2>8STSRA6<XE\IVJW8KD]QIW\U
M4*>'A'[9:'M/[": 5D$1')+P#1XPY7D#Q0F6)=;*QB,Y]B&\,6B>AY41:7<Q
MZPPDA(>:*E&$G?0=X@@$  SKE DSIG60)/%*HU, \C!_'.G%QTX@[TY'GJ7]
M#=:;-?UE8]HT?6%CW0)UM;;+KC7\VYV8+7<D;/8AD!(.&@/DY%GS8<LR/<RP
MIE*WHWO3+N8>NFV4JE;8<"%+#94 M6ZDD!(USC*0>DZ5*4@JB%$2,P# GGW=
M*=^R^"V_:[R2WSQNU#KO97(T[H&Y&JG9C.HM77"SX4R)F/Q&C<\-78ECE@89
M%R,]B(W/E+\[C:V&7GG$YQU5-XTIEIYQ2&@ZF0E:T@B<H!4!,:R!WB!0I.\4
MI$[LZ _',GIKT%0+1-![VVE;SVOM:Z5VQL.^U9L@[9J52M>6ZSVNMMBI.89-
M9ZNA!$TL(Q FX]RF?$(D?,>9Y8COED*2UFZGVD)2HN(0A1R47$@*[E$Y^Z0-
M34>TK@21P ^GT^53URXX<V#B&,XT2[):FS\_D9QQHG(3 ;-<G5PA0DW59!E=
M',,SYTQZ:6!OCW6)TWV(W"WO,VH?'6VK&:VMT+@O!*2.R=4WO;P(7N_O]! ,
MB/O$C/I62-P#>X@'CQX=XCH/C5Q:OX8NCX'&_CER(Y!^(#KSCI%Y,5RU6.B5
M*R:5V+<YBV*8>;!6!CXK4"4QAQ4%V:(?<<DPQV'$E&FXZ'\L/K1A5?O%YYIF
MS6]V*@E2DNI3J"1D493!XG2K@)"0HJW0=!'TJB]JXPVLGLJ\57C$Q=^6^OZK
M8ZW6!NV]2ZBV&Z!L96T#XT@1"2%R*(E09,@360#"Q)53<\O)%R7A[+S2D]MM
M+Z0VE;^[;K4DJ+;CB92$F#GE(B"2!E(!JHS,""! D3KRB/A)J4N.WAP<K.1^
MX-BZ-$Z\L&M=@ZJH!K8%U$[8I^Q:N^&C#8.)XFNSH,.F&3 ^TW1KVJ:0-)C8
M+-B<CR/=)F&VLKZQO7K#+2'2M*T+6$)+:D&9U()4 0G]]!]GB*L$DF (.IX1
MU.6I^.?*G'KCPYMB[=$\:P]),6=&Y-_;DOFH#.M[?I#;]7K^HY5$./@RUBM6
MSOHT4!F8 94:3+O RN#)AG7S428U9(;#\1U&*N7J&R_O)26VFT.)6EUM1="P
M" E$@B9]DDD*X'.JA)(3,S)R(C0QRX#/+3C3.V-P/MFG:=R\G[7L=BJNQN*F
MT*KKG-*CZ6VJ2J>QXEEM;U;;NT#;$H$(K%)J\^"TW9Z.[=H@R9L,).'KKT?+
MTM",8/6PXMGLX*76RJ>T1*"!O;FY)WE#16[.Z09JA01O$R"E7(QF=0?E5<+5
MQMY#T77X;;-WT/N2H:LL>(6:_LBT:RN@&B&D$D)<&J%VPJ%B@9R"2,X<'+C3
MW$SF^ZXF7D)SG&5+K:Y0AQ"G=2D+259'D#.0\*J4JU(.<YP?/CK64IQBY(A-
M9P]U&>/^Z1.G)\>)+A[5)ZLN\'74J'/4VV/FQ[M*!M5QV%/==;;A3$$51YCJ
MTM1G75Y\O5 ^V5% >1V@_>!Q.\3.@2#((Y0?=2"!)2?\Z#S\.E3%P2X;%><>
MY3FG@U[':[EA=67W9ZCI(#(L,=^/18<26\(3!BDA3C;Q%,O#;4S,E:(V494M
MA["L8Q1^X[! 6I)6"M*"-[=^].<P=(FB$[Y(F(!.DZ</C4#Z%UG%W-N?6>J2
M5B(5*!L"X!JM+LPFDV/9!(&R5DICK)0:'3VG[3;9,;"O.T# LN$YZL>QBH4Y
MG&.LSJT-MK6$A12)"2K=!CAO*!2.\U"1) TGD"?@,S4D3N(.^S=_N]0TWJ'=
M>ZP59VY>=/A+?3]);*PW:+'27R4B0.4!^!2R==M3E:'_ $I*T0NI-GK0MQW)
MJ&RF)(=Q N& E*EK;;)0E925)E(4!G.0(DP%#)7"9%3NF3 )$D A)SCSIPIB
M63C5R*IM)([*M^A=RU778BQS:>6O=CUE= E/%VP:3="D:R2LA,+%#P3T$RP^
M'EB94QJ?'*L/CG6$3&764V%PPI6XEU"E$2$A0*B")D 9D1GW9U$&)@QS@QXU
M?6M>$QM_:^Q+!1= V<AL%FF<20O*:VV"YZ5W5JF,Q),,2W8FG:R-*4X\2M5W
ML.84].NR<9J#6-C)#GW*^3\@2;Y=95^A+86M(25/%I(#B%Y"/RA((  D;PDE
M,B=:OV9*MT9Y3)!'#3C[N=4;JW%ODO>*_;;92N/&[[=5J%-)C+Q8ZSJB]' =
M0)!>^3(ZS%1@&5!!SPZ4J65A$WXTD:A*ES6F$)4K&55PVDA*GFP5 %(*D D'
M0C/CP(UX50)4<PDQGG!C+6DW6/'G=^Y!IVP:QU!L^^5.HN1_IO;J5KZU6VN4
MF*_C#JYUI+@A<P>$CQXGM)[JB4J(E,)AZ4I2([3CJ"GD-D!;B03F$J6$E4<@
M3)Y9 YY:T"2= 2!J8)CPJ7>:O#VS\/\ EQ?^(Z;)C;-II4^@"X)FM5J>.>M1
M/8-&J-S%CA%93+-$53L.6Z,$8B,RID@A-8PN.WA4EN.@Q<H>92\4E 4%$@JW
M@D)4I)))@1[,S @5*D[JBG6(]\B=/?3AY3>'CR:XE[8UUIJZ4XE<;?M:I@;/
M06]<UB_FH]IE&8<>9.IP%HM3@)0Y=:I[Y!BVX"&'$' DN?"9>>7[RRI9F]:=
M0I:24A"H5O*2((T4?:("5<"=8-"D@@:D@:3G.<>ZJX;4TMN?1AJ)6MV:FV3J
M.P3X>", 'LVCV:C%9X[S^3W^# LXL9*EP_:?K>949IQC#J<M97Y\9QC*W<H<
M@H4AP:$I4%9G+.#WQ)TFA"ADH'/21\I_#6K]<4/#NUWOSBO=^6^X>7%-XP:U
MI.Z4:2??M.L;A?L3K%)J=<M8Z0VY422)K"9[)]R(W'4*=0TL:ZZ[+3A]MM.%
M^]4R\AE%MVRE-[^2PDP"0=4D& F9GC5@D*!5(3!@S)S^?N^<U7;=_&6D5W:]
M)U3Q,WBUSB(74&B9&>U)J3880RS9<SRK"Z=!IYF--L1TDV+'L&U2A45V/B)-
M]GVPN+(5C(TZM2%N/M"V"5 ?E'$E,$:[V0 G*))TYU!1! 2=^=(&?A^/?4:G
M.+/)FL&1U<LO'?>8"P&;6JAA@9C4U]'%C%W1!9*JIXD?* M2B5HP+?8)? (3
M3Y3(Y]F=B+F*ZVZK.'+=0)2\T0$[Q4'$D!.@4?:@#>C/(3E52E0,%)F8T.O3
MG3%^Y5M%L5>K"K7%]0!U>6A MF&U5"P)$:Z-DBC@,>%O1+([$.HE9YIEX/"'
M6!X?,E%&71[#+DMM;6+)4D*2.T1^4!*$[PWEI F4C]\ ,R4R ,]*0<S!@9$Q
MD.&?*NG,[PDMV6:]\GZQH8R<VU6>+VMJYL I8++H[>&IK-L*<?K@NP9U[0];
M'Z67LCU_0DCG P&;<$)/C6FSPV0H;-C+5JC$6TH84ZD-E]:D )=:<" %;N^I
M84!N<R 8.1SK.$Q(&>Z-=TC7AIYB35-R6A]WSQ=!JGW&=J)O=K@LEJ33W=>6
MY%LNE8+QYL\-8JA7U!\&+,#G-C2[D$J%B38$EB#/=8D+;BOY;V^V:*5+#B-U
M"H6K?&ZDZ0HS (E,@Z3F)BM!*%-W2D@$!Q,I &1,_,@3,#,"#K2OPUXN'.6/
M*C7'%A-@1K6Q; -V<"^;L "82569M7J]BLDV.3K^)8F<J3A==?%O1%RHCT22
M]YGL9RPME=+A]+#"KB-]* E0"50%!2D@0H2(.]/$$>-;N[O*2)@'OD&"=.&G
MNY95O@^*_(T[<CM0UOI/<>U1D.X7J@B[#0-57FR";)/UZ3D#3SPEX((*1GW!
MB6F9!*(Q+DNB&I+"9JD>=M2LJ;QD!)6\TT%(25)6X@%(6 4[TP=" # G45B<
M;4<TI4HC,$#B==!KQRSS\9,U%X>_)C=6H>3>Y*Y2RL(/Q9E@1-WJIJK7YFZV
M"P%"<F =K%*$#:>2BD;+KR,S'.[%#%R(2;50)(82F-*;F-IQC=O&6W665+!]
M8WBA84@H2!!2I1WA"5R4H(!"E CAE*4K*2J(*8D09DZB(X?O@=!K4#Q^->_Y
M6LU[KAZ.V])TZRAUU_:S&M[B]KEEIE_,9]YRZH#*KB([,I*HKKZB6&6I./=U
MK2]]YUG+C(<#0?:#A_Q7:([2=1[&]O=P(GCG4$**20#W@99=1EKT]]3)4=%;
MCCZ\1?%:DV4W1V0,6W2+JNBVA%4;K$XJV#@V-=B6*P'^!S#3B1$0M[WF#))J
M]Q9?7)[MXYE\M.^$!Q!()24A29WLS!3,R-8U@SRKS6((>*U++;BD) )44*W4
MI*B)*AE$P 28)CC2_N'2>[-;4,=<]C:6VM1J;:<1XU>M=QUW;:W6CCDEE4J*
M@6<,B80R>Y)BMKE1D1I*UR(J52&<+9QY\6PQ:%+(WT+*092%I*X@IT!W@).I
M&1B<ZFQMGT.(<6TXA)DA2T+"2"G*"0!F)B#/$B,ZC,WQDY#56E ]DV3C_N>N
MZ[L.1;0*]F]6W<533*S:V6@R1EDGA& \Y1AV0RV)]VF.?$W'6T0O;J4G&>PE
M^U4YV:7FBM,[R X@J3 D[R0HD;N<B,H,UZ$AR"8,'0P>9&66??RTZ2ERTX,;
MGX;2=4M;?"L-Q]O:OK>S0)04+MT88)78<353-?6*79ZQ6VXFRZBW&CNW&KP_
MB&0;142MV8YB:CM%M=6UX'NQ4):=6VI)W"3NY!Q&ZI4M+_>+,;T'+*H*5MP"
M-8/'*8]F8$$2)&<$\:IK)9C);RA.4I5WSWSG'U>F.W?/U8[=_EG&>^<X^761
M02,@<YSGZY#SK4@DYD0($9S[XCC/?E2.IAC.59SY<^N?7T]?Q>F?\/5('(>
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MNCS+SE/?/Q_&,]T^N.V?7Y9^S,G$[. .UT/!"L]<S(]U43;.=HI1  ,9[Z.
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M8,Y_S]>GVC:_PU?Z"OI4%I9T@'A[:0/_ !>>%9V_!/\ $Y0K.?TJ]M]4]O\
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MK+]J6/\ '?[B_P"S6\6UP8"3T*D_VJV$^"WXF?;/?BU;?XZJ'U_@^D'^+O\
MO=3]J6,3VX_T%S_X:QEE>1"0-9&^G+W[W$5@7X*_B:Y^7%FVY^O_ +-5#Y^O
M_OP8ZC[4L?X[_<<_LU<M*@P!]T@>TGZUI+\%+Q.,Y[XXKV[/U?\ 9RG_ &Y]
M?^V'_P!/4'%+/*'>/\%6GA(]XRXU53*R1 3$1]Y.7QKSGP4?$Y[=L\5[:K&/
MJR<I_P#2''^?\'3[4L\_RO\ NDF>FOGXNQ<T.Z0/Z8Z\)'/G3RI/@I^)#%*)
MFE>,UIAIC)6MG"S-55YW%IRC_P!K.KQ][CLKU_#C'5',3LR/9=,_YJN?1/+B
M#I''35NK>X6UN-H"B=0%H$<_O*C,#/A.6E9+EX,?B5393:QW&&V24XCX;4XD
MU4D^J5YSV^_/XSZXS^'OU*<2L@@#M03$'V%ZY_T1SCX"IM;5Y#<+0$JRR*T&
M.)^ZHY_6F7%\%#Q-TR&<O<6+9AGSIRYG)NGY^][X[]T_2#.<_A_%VZJ,3M 9
M[4\ONK]W[TY><JSJ9=*8 3(D#VT\3KJ/=G^-+MB\&GQ/YY.0]$XOW),1'LV(
MJ$'ZBVE+##:&D83C%B1G"5>7*NV<X[95^'/3[4M!/Y0G/.$JS/2!/>1TX55N
MV<2 %!/,G>2<Y)S]KNT.LFF^OP4_$_=5G+G%NWK^S*C]17GU^S*K#G.,?@[^
MOI]G6-6*6Q@]H>_<7GRD;IC+QJ_8+_HSG^_3$>.?>:Q?J)_B>=_]:Q;<=OEG
MX[4,X]<?^$&._P"?[.V,]1]J6XU<4H#AN*^$IRTIZNL'()SYJ0)\%3XQ7S/@
MF^)W_:L6W&,9[X_T\I_?/?Y]O]4/;'X/K],?9T&*6W%PF#J4*SF>29US_34]
M@N-$_P"D,H]^<\:<QKP8_$YFCP$9OB_<%Y@#<,/H^.U'&$N^V<5COWL.,*5A
M&4]U8[XS]O?J_P!HV8 5V@DC/V5@]WW3[IX<<JPHM7 I1*$#>)@[R-(Z'CYU
MK1 ^"QXG<4V'D.\7;<RRR4'/.N9L-00E#;4ME:UK5](L=DH2G*LJSGTQC.>J
MJQ*TB X<_P"@L\.@X<CD:S!A04D[J8!3^^28 UC,?#CIE7]';60H@"UMKX&7
M8S%+!J/4Q1.,I:'%1R X# B36%.-J6VYEF2RZWE;:UH5E/F0I2<XSGS2R%+6
MH&05*(/,$DSGG6S3XZK2CI2DXQ_V)*?_ %.F_P#WL[TI7\=WV[_[,[_?%_GZ
M4J?M@\9=]:Q(-![53ENFO@)"SD050ME0V,>K  7%%39Y6\@]=V.TE:!%CQ#8
MV0I5VA@%+;?6IM*_=9?L%*CH=K;:1=UQ@30;^4?::G/NLCJM8IKK3 R-!FDG
MG&XT!U:&A\,H,ESG%8PB)&(P7W\MM2XZW%*<F-$[R54*Y?&]97YZJ6]=G^C)
M6.!*2/C<6F!ZV?LY:!!8:<)/5X.'MU>G2;)B'@ IHAY6"3KL2<W&4I5 \<=^
M65S4C0O7=D0K?%K*TK462SD.O-WFPA1]+*D6!+U@G"V6QS([8=.F-'YZX=?E
ML&FU0RDCW0AB(I7F3QUWFW:$5 7225R*N&:]7&IFM3 +:=5=L%JE!X( (W>=
M;E[527"Q"?808](]%@5*CD"L&!+:8ER&V<J5[M7&[D'2JTJXV75]T'U=HP_7
M)AQJ$HE %V*(B4[,KQMT6]-^!'H+4-]R<%,X@DX3:6URHK*7V,NJ5"TUDF,F
MRQQ%F>/(#Y4B%/@36Y$2;"FQ'5L2HDN*_AM^-*C/MN,R([S:'674+;<0E:<I
MPI6K[=_]F=_OB_S]*5=KF+AN1MS14:8^MN%(XD<&6IBLOJ92F,]QCU*B2M;O
MF3AK&&E+4IW*L>3U7G..W?I2KH[8XN\#]G[@V53N/&X!>NA.F[T;K5J($+T+
M:H]HIC5RVN.&6^C'=K[ =*W0H$$5G7PZQ3*O.D5^T$[L.GTX-'A*S[PI4<6O
MBGQ(UKKB_;="\APVX26K]CP:>G4-A/!0?W06VY>J8<YYE='N<>SJKIF-L*W&
M*]9*T9R^EC5)1N0.E,$;/)UXI4K63A5PKV);-OG*CR2H6G*Q5.4FQ-)T:B";
M^(M"SE!HE]KU6J=FQ8=B7EO,XKM^N&"=F!W-HXQKR#)K[OLX+E>=L1:CJ56W
M>O'3C/3-&$#U(VH3QN&ELDB92LDKEJ^SHLT"1N-NBQZ])70;];12+C7@16.8
M6_49LX.2 5Z<9E0H;Y-YD$I4(GH<-' S5)E$6,@Q)Y=<@1D@JEAI)*0-A::X
MS2H0]Z=A&)3L&)*(3Y,6(XZJ/'D39;S3:')+REJ547V[_P"S._WQ?Y^E*/;O
M_LSO]\7^?I2CV[_[,[_?%_GZ4H]N_P#LSO\ ?%_GZ4H]N_\ LSO]\7^?I2CV
M[_[,[_?%_GZ4H]N_^S._WQ?Y^E*/;O\ [,[_ 'Q?Y^E*/;O_ +,[_?%_GZ4H
M]N_^S._WQ?Y^E*/;O_LSO]\7^?I2CV[_ .S._P!\7^?I2CV[_P"S._WQ?Y^E
M*/;O_LSO]\7^?I2CV[_[,[_?%_GZ4H]N_P#LSO\ ?%_GZ4H]N_\ LSO]\7^?
MI2CV[_[,[_?%_GZ4H]N_^S._WQ?Y^E*/;O\ [,[_ 'Q?Y^E*/;O_ +,[_?%_
MGZ4H]N_^S._WQ?Y^E*/;O_LSO]\7^?I2K'V/B9R4J]>IUHGZT-D15[C4N37F
MZB7K]\-]MC:_QM:@1C]8I!JPV6GDKIK7#UYK FWB 10W6(9$N/AOPQA!V,I4
M60M9;6))"+':^V%/196#4JN+A5.R2DGXM<\V+#)"*8@.8*L <H7@T]!R^V+\
MBO?E,>7/92EJ!I/=!43 ,C-=W8A%+2!; B+"$3Y)LPV;BSI@DB(KC*%V$J"G
MM#9J(]B'BY(%<IGW'XCB:ZS'<4I5F<>-^0!=;+2M975MBY-UE^HPDCWGC]IB
MW&+<IM<GURL,K<LAL:1C:_MZ\DAHJ3 AJ#.,SY,5Z6/;EJ5'A.G7L*%B60S5
MK:)KL\A($P3Y,&8@!9A6&I],L9$*RHK4&00BJBRDR(;+ZY+"HS^'6TY9<PE2
MFO[=_P#9G?[XO\_2E'MW_P!F=_OB_P _2E'MW_V9W^^+_/TI1[=_]F=_OB_S
M]*4>W?\ V9W^^+_/TI1[=_\ 9G?[XO\ /TI1[=_]F=_OB_S]*4>W?_9G?[XO
M\_2E'MW_ -F=_OB_S]*4>W?_ &9W^^+_ #]*4>W?_9G?[XO\_2E'MW_V9W^^
M+_/TI1[=_P#9G?[XO\_2E'MW_P!F=_OB_P _2E'MW_V9W^^+_/TI1[=_]F=_
MOB_S]*4>W?\ V9W^^+_/TI1[=_\ 9G?[XO\ /TI1[=_]F=_OB_S]*4>W?_9G
M?[XO\_2E;<!][WZ%^O._]=QO_;%_LR/P]*5_8HZ4HZ4HZ4I.,?\ 8DI_]3IO
M_P![.]*5_'8Z4KI2'\4_DI"V':-AG$U^ZOF'J"1JM8M1?94JJ:Q,:PRZ[2Y%
M&'#]@#I#0&'+DRY9JA'IIR@6IY]OZ25DDF"/Q$4I9%>*WO"O3:41K.N]25Z?
M4K-3+D0DC6]EX7=++4+AQPNCLVSHD[(D-(AV6?QAH8\\%KZ 890<E98X^# E
MS(,X<I3DJ'C!;]I8NOBQ>M=-R,! ,$:_,(M;0ERR1D.$X]@P5I8RK9J6:B1$
ML\9];RF!U 9J8%,]RP3XPN+.D Y5?4J*3OB2[>/7WC5L9ZD:ZBV'C/L(AM&O
M^ZR-E+A6ZX%JEIJFD9-ACS-B2U5\4Z+T=4GX@#6;M##B9\T[)$0X.9L=$-2E
MR/XH^]AIA9</7JPRM^S&[?/18[EO;8\TP>,C=&"D2CMDV;M^X6\V@)$T#4&:
MZT2L$C 5@B>B0<LPW1<<4I3VUWXJ=U"W"J$[KK*E3Z=32MTL,&I@46B0T<?L
M6O\ 9M28IUDQ:KF7@$:E/G7T;+*DYD&?:1N:N**AIJBC<G$Y2N5YDP4L)<J?
M-SI)0T<)3C!<E,<R]+(E"<IV;/G2G5??.R9<M]V0^XKU6ZXI6?7/2E)O2E=N
MWJ7H^V[ #N[*#:9MUV'<3?#/CU"G[]W/.T7KUW7I?CS1(^Y[?#M\+8VJE$;W
M41K%3;K5:5:YKTH8=LQJ!3;:0 QH<=2FQ!XB>&N>B1+3!YESQ0,[L0:%$U,I
M8*$-ML"D&=S1]<-6 TDN.C.!G!51K.Q-FDVS(^+B'5BFJ7YBFTV63)4I7@)P
M\\.\Q4!MOD\LIP3XW-U>2<K#^T=)2;)2!UQUCI6Z6>C'AQ"'7"EG.UHW?MDU
MZ5L< &@5L*=U?FH6.FP#1<G-K*E;5#XP^',JD5*U7#=BEM[1UI6L/5Z;R U3
M&V5JF\6+D3Q5KTDWD0!K[X05'IFK=A[B<.!]ALE"%JKU(MMO:J^N'A3,^M*4
MGVCB?PUJFEXG(&7?HME$"$58:S7ZSM^D!0>Q+;K[2O"&Z;*H FO%)EHV=8+A
M?;1OW:@:RF]?D706E2M38F&JX.#.LAXBE5;V7- $N$5&(U0)(K-6G\YN44VM
MUR64<.2@ &5J+C&^("R33S$5TO(%CUQX+Q-V-'<GN,*E+8:4[E"5*HQTI1TI
M1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI
M1TI74"B>*CMG7*1J*QIW14;WJD:;H>R9$D;L<E,VV+T!H%SCCJ>7:5D]DS85
M?(56ARB4M*M<P*5#+V,K-('H96)B(.BJ4J9\6O=LL/"#&M6Z>,-XB'XALLJ1
MN(1;CS9C8U-VM#:7L"O[;%;"#1 ETH5<F#X0"U#8[0Q!4$PF,*,SHSBE:6O?
M%!V$$S?D; I 2ZPK+K#6U#!C8UAV, 2+>U-K&F:CJC2C(6_#+*, $*U6)QZR
MQ:Z9&RYMS,S"$)V&'ES0KRE:Q+Q5]XV"4>D6;7^J#*;FB7'O+3#>R*^NQ0IS
M?(9F1%ASJYL443J&,1^1UJ99=ITT&XAJNU>,O+L!5FA6-2HAY#\^]S\F:E9:
M;L(93(HNT7.O7J9BO1+'$Q!.5V^<G=@M*%125F+08K)$MRJO40JXY&D$)H^O
MT_VL_)"(<GGE*H_TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1
MTI1TI1TI1TI1TI6W _Z^A?\ TW&_^[(Z4K^Q;TI1TI1TI6-UM#K3K3B<+;<;
M6VXA6.Z5H6G*5)5CZ\*3G.,X^S/2E<RL^%#X;V,9[<,-"YS_ .!$+.?G^/I6
M)*C(DY=>ZOSL?HB[A-H'B]QYT7MSC=HS6NJ6<[9)TB]R:C3!;*RC-AJ\DS7,
MDG'XDM"(\)^JEF6594SGVQ+",9<\_9/2P]+*E+#K:7#'L!4Z\@)$\^)R.1X4
M?4I.[NDC,;T1IIQSZ=20,C$\,>&?'PGRPT1RVS2*V!L6\Z(*U&4UT/?BU(#'
M8'&2MJBW"5'<*0&!2G,*'B$N9G2HR&8OMLL/>V7E#FABRVK5^T=@M6ZVUAY"
M01"PHA)4%:*T.9&6<1G7I,!L/M.VOF$-H>O$N)5;K,J.Y$D)W?WL3.4#+3A0
M?9C>PM56<I1[L!A5RUUYUL89"R@%5D3X<R&VIN<N7F&/>82_(EXSEMEIYQ#;
M2FT86K&/:+RLEIQM+B=TH6/8)*23 S/C$Z'/*N7=,JMWEVZT;CK1W7$YC.<C
M! (T.6E/_C9KZX<@=C#JHLP J=7B.8)W:XE0-7BC*V :<1A_N_)%MLNDY7F3
M&%PO:>=^2OVB_+%9DO-:&+XA:X:P%J&\\L[K;*(*B50$*6G>WMR8WE0!!DQF
M:ZFS^"/XS=]F06K1"@NXN5@I2AI)':[BR-S>")*4DYY"*_1SK?2'"NVN-@*E
MHVLG! D>B'*OANJB78LZ6/8PRM[WJ4TT]+?*26TMM2&(RF93[RLL9PC&5]?,
M;K%\8#CR_7G&6B'%( 6D;A5]Q&8@<=T9DF0,X%?=[/9?99QNT0G![=Y84VTM
M3C;F^\!D78"A*5Q]X:GCK7YY>6DL91N2&X:C48%=#UP'=YPH4)A5JOIC"D#F
MF(\L<UA8M2L>[SO>&G4Y6K.'6U8[]NW;ZML^E3V$8>Y>2NY6VHO+=$.*_*.!
M)(@$'=W8D"0!SS^#;6-VMMM#BS&'I::M&GPAEMG-MO=9:#B4QO1#N_(DD*W@
M0"(K]\W!SPL.$A?AOQ@.;;XG:;M&S;'HO6-GO1X]2ASAHC9;/4QI\HZ34TVR
MC$MN014PZA+2,(RSY/+][WSD?"4NN)3 2%*W0! @&,@<X&E<1N2W)!WI3KJ!
M"OH)USXU:A/A1>&]G/;/"_0G?Y_]I$+'V?5WZQ5"]Y.<QT([\\ZD QX8_A^7
M=P:2MO$;25@GB:_7*@-EDZ?$D/0JQ30<"LU8(PO*L90/ @!@\0.8QZ1X41AE
M/WJ,=*))(SY_2H!W3P"\+C1P6#8K)P'U,7!ON.X(DPE,I4:(&;;E#8+#<AVT
MVFM8*&B\TM%AUJHUOXY<+1+1*C5\"1>BO(3,3Y\_3G4DQY\^&IX321^DF\)/
M,'>99OA%J&0%T$.?(V@M'UP*<B6%N"+,3B3-+[D4.&GAY  7K+RI"!T=ZQP)
M,*(_(CMXFJBD@_#XZ1SIGQ>)OA3+L<JGE/#JI@"S#7I0PT.)Z[H3S :R(5-^
M&UZ64$78F->>,LM@9#!P?)FU0,B]4*-;#]=)6>'!3,>?.?Z#&E)UR.7=G.G'
MYQJ*MDWX4GAKRX,5MKAMH.2,PIV?!;;J$1Z#A9!F*EZ;%0EY4?S38\2%AV2S
MCO)9C1<*6M#+/EBII?>\,/P^7ZD/H;W$32+E.%6(Q;AU<73XF14*S'Q@,,:-
MQXWF\J"!,76@$"6_C/F=C"83>?1E/2E5ED\)_!Z@V6\58AQ(T*-F:Z.5H%:R
M)/7\,> 'JM08V9@EDGIC[(QX#!Q6+,+.%D2/=PIRNFA4_P!C('OX2J"0-3YS
M^AI;JO /PEKE="%#!<.=!R3PT*=/OI^A]=7&6-KMQFT8D[&7'+/R)*XYZ ^Q
M,0U&5D.I4>(?R)*R6!SBID<ZW:QX?OA VX.3.!>,G%:1! 5R%:[*XD36'FJR
M!FCWR221R;#)2AD2#&C1)V)A!$YX='='SVU3,YB/92I7@AX?_A"C0=8M#_%C
MC2JJVLY8J_!M#=5$_1^#/J5;NUHLOQLF[(:CAV04#7MIBEE35-N#BP]0V:TQ
M)PXEI^%)^GGPK7_2(>#1A#;B^/W$1M#@6=84K>'5UE*1 SXS\1E/*=EHPPJ#
M]'+'[W%?RW+C_1X][5A/P4G[J@\J4VJ_PW\%ZQ896QQOXLCFYILS7PZC(6L#
MG#L\#<RU"(Y$17"BIK\5NR"'8J);T:.RZW+@.I5VD*2U,'EYU_3RJ)'/SI^C
MG3S@^'[X/),183X[CEQ,GA:FY#:LA.&*K\F&&=)OJBBFYSS,M:6EF9&,,A4=
M\J,N.,)%XEYD,>TBIG7IK30K/#/P8;1$@S8O&WBR/8,6N53*]@N&J\)ZQFXT
MBMPD-AF$E7G7V9T^X56 ,4^B,Z0EV6MMQ67$V, LDI/T\^-:@KB!X+9@#(/0
M^-G&+*(Z"F,C%5@+DK(E!@D$_/@#V&ICL8K(Q")0FX;XR7,'E)DAN**G37%)
M[S!Y=?PJ)'/C'O\ QK<M7##P::.=#5RW\7N.5<)&AE;-(R8I$0?!'B+:!V18
M09(J2E+:@Q(LF%JBY-NYQ(=<ARHD-$MMEHA&?7%)\^/T^E.61P*\&R)-F#I7
M'[B%'G0#<&M2XKT*LMNLGR/Q?$(1E*IV/-/?77K UB.C*EMO@3<=W"'A!!N,
MJ:P0^"G@RSWQ<6)H+B"])-+4@7&]QK:)$M27\QL>5ER:AUM+DG+<=A3R6TR'
MY,-EC+CDZ&E]!Y>?(-1(Y^?/S',5Z1P/\&QVO$[5&X\<2Y@ /%9F$2$(2!EM
MQF)<Y@7 RMMB4X]YRA&5#A"6\-Y<*29T!L>F1F=$]LJ:2!?"GP8"D$:0_2[\
M3QK)@9*-BFBXJM0)<T)%@$"JBJ8;A',B-'=&B#,YEF<W%GJ8"&\KAH6')HBH
M/+I[^50#/GX]W7IEE3OF>'AX0@\=5RT_C1Q3A#;M);A5*;*# H[%@E.28\'#
M Q;LI'O+C<^7$'R$IQWBD)4:#)]E+D,LK5,QK34>X4^"E'B#Y[VD.&Z(A:3(
MABWLL5C*2,F-FO86U"2F=E<G+JK?3TPU,I6F>JX5%,%4A5H X(*3'ORK=:X,
M>#"_[YB-H3A_+5 &AR\I$*%6YJTCK!BLY!R6VXLUY<G!9-UIBA[<9+STI-QJ
M:F6UXL@7,Y3SXUNC> _@W&335=$<?.(1,X^P)D1QD"'69<N0R>BUZ:%7';8G
M+]O@G"M]1F0L-96I^+:ZQ(1C+-A#KF*4NE_#?\),#48%^,\7>+8RDE8HR:+M
M,L %:!DXAF.B8)D#B*I'NTYHC#6F7#7%6[B1%[R6_,PE2\*4T2/![P6A#!*4
M4T9PW@1@\](PG)E,U5J/#G*BV";F.Z^HAAK*FHM3MC\A:%J;BHJMF]Y6UFOE
M\0U*0G.'7@N?$"8R-QQXL3I8ZEN7N/[L&K"(IH-&E;'AD&0Q"84B#Y)(3(U1
M>$EXC\J*D8@-)>F/,L1YKD28/GW?45$CS[_H:69'!_P9([LA"N/7$=;(\DL0
M7F(B5),4*1Q(F0&8I);Q5IU#LLN/( HJ8S4G+AP>0$JPB8/G-1XI-+X'P^?!
M\M)D97JWQOXG'#ID:V7%"!8FOS2) <Z/063)B1&):WG\(%NL$GVT(R]&@28D
MN0VU'EQG'5)',>-(4O@]X,40<@E^E^XBR&'WR,2"EB'5<*(S1D01,D183D@E
M'C+4XQ8JSF+(=D,P97THK&69:D6$0N8J9'.O4[@[X+XMDB^6T)P_%)$361I9
M,^)5V%#B3\,]/]PE9R04WB4S%JMJ<E(:6XF+]%[)A]2,@BONJE,R?Q,\&>(3
M'"8_$[C\4E$K.>J+7N=1K49,<O5Y.U(-@S.29-"GX@\?/T];X39-UG$(J_@?
MD(\38<FO0)@^?=]142//GF([\JDZ/X?/@^S*^8M<+C;Q2FUL 7B #!J$%!S!
M\$V0<'-#!3DB-)=0N>5<+BDB8K7M'BN28_(Y,G$R/ER*2/"9]U)"N#'@P)<G
MM8T-P]<<&0!1.:AB+6)&68)SZ-_!Y&/83G/;))XN=.7"2Q[5R0W;JLXVA2+$
M'5-5,C6<N=)T[A)X. K7E1V85XO<:AE>OM#9V/3H\^JAHQJQUF0$''F'A(MR
M9AV;)>C& \)IEA:T/&# D2T\N<3@,R$9QQTJ)@3TFLR>#O@Y*=>@9XR<6T'F
M99:&JL."Z>V?RZ&.E@$K"H:C6&F7%2@1F0S$DR6"&8HDMEV(U*$%8L)4S[^%
M;T?@IX,\Q41N!Q]XC$'2!.0%'LP1M=E.SRL=(/.8$1+,Q6'GI"K15VH.4Y]E
M/>L];9A./N'Q*9BE>7N!W@_Q1=/)S^+/&84J\5ZM6T$+,U^MAC"JQ:9(V' /
M2X!0G$7'%QY)6)'GR<K6EJ4O$)G$B:XQ&>1'R\*3/S\:\Q>#7@OSL1LQ-#</
M7\2U3$,^2)6N_M!\1F=,;=QF;C,9UB)(8>4W(PTM27480E2U83T@\J2.=+KO
MAZ>#^Q# D)'&_B9&@6F+#FUJ9*&UR-&L$(@ZXQ F!GGYK;9*+-=:<3$D0U/,
MR?+A3*UI4G.51(J,?TIW@J-V'Z-2^-G&:!/1-F09$F75@J T1<65:XS;LHZW
M-=$M-2DTJQRTIQ,5('Q!TAPXP)<CRFHZDC\^49SEWY&G%:N$O@W4B\JUW:^,
M'&T!9&&AKTY!6F0H X8V8%FS(Q1 I+6S"8Q+&5TU-[I=<Q%BP)$N=F+%0I_"
MIIUM^'AX1LN!:IXCBSQ?.MTF6B!:6A .N2'0LQPA(%)8(*=(L1XBLDH9 ?A<
MF0TTH@,)CT.*G#Y<=I2F^SP?\%J1$CSF-%\.7H4LA@7&E-QZNN._.5&&RTM-
M.IGY0I"V3(;*)&,^[+<+BF$/*?(PFWT'EU]W.HD<QK'OY=]9V>"W@Q2'1K$?
M0O#YYXP877Q+342LK<)&$/ &/<H*4SLYE+6[:ZNEIQG"V'L60"MEU;9<>J0J
M?/GPK0L?"/P:JJD)(+\:^+B1]@C Y8XG#KX$A$7&LY:C!ZY*6B'->F_#S3VQ
M:M,BEVHCH=@7/;)$"$**_"7+5!(&O&G>3\.OPB X6;8BG&?BG"!#B,$1-+OA
M@*8$<J2#P+# '+DXEY;]]E@"@\XQ&2K+JP\MDGA/N2O;X5/X5&Q7AWX-X6IV
M&[D.)>A&ZR OEBULDG&H(\@T<ME6KD^S%8(/ Z5+4\CW,26C0WI^!V)TP<YF
M,ER#+%SI\P?/6HD">D_#/Y?6GJ'X"^#G8)-?@AN.O$LE.M+\J+7X,077WIA2
M5#<6U(C18R):G5OX=;6VTWE.%25X[1?;>9/>(/+I[^5 0?G[N=:,;@MX-<@A
M.$N<<^*@\F.L-JJTR 8KX@-*9-4J4_#LL=3)-Z*K#(Z1&D(S-SVAR/8N9BOO
M80KLI(\^_P"AK7K?!WP;+==(U KG&SBV6LI *..AXD.O!7D'(Q"=?H&8@=:)
M2E3B@]W6=Q>*#6V\2H<02_*4A3+,E4='GP^HI(F.-9\\%O!L8F%!A+CIQ,#%
M0K]F9*BBD"J,$(*:F5-B2STIAHH_B/A+M<-2&8SRVYZHHPCEZ&Q(%E(\)21\
M_AY\P:P@N#G@V6"MNVR)QMXL1035BL=7Q-) @,%+Q>L3[7#F,1T.S/,_[ZQ2
M;(8#I;PIXF$'.DHS*F4KPA4^?"M6M\+/!9M@YLF&T!Q,<CJ"E;&XU-!AQDZ(
M!"-F7RA:>/(OQ9H^#$B5X[/6_-880H>')ST95$@2GFI@\C42.8J=$>$QX:S:
MTK1PKT$E:%)6A6*1#QE*DYQE*L9\_IG&<8SC\/45-=#NE*.E*.E*^*^6?Q9_
MQ=*4SE9[)SG'X/\ 'TK7&9 YU#F\] Z9Y,ZW+ZAWUKT%L[7)V2/F$:O8&Y.8
MKDT3*;FC9T:5!DPR0Z="DMX<8FC9L26A*G&?;>Q>>;7(6M!E*MWWQGWY_+E6
MSNH4(4DDSE'+E''/.JXA^"O%+C)K2XN<<] :ZU=.5"20(SZR"1DZ5@PUMO2!
M\VP3W9IV2-0AM4Y(UT@J"B6RB4B/B1W<5HXF7+JU5O2I: I0R)*NH$&-9UUF
M-:[>S[QM,38*5EIMY2&ED'=W0<B59YS &G&,Q-?F"Y%\8-&;0Y$2;C?ZBB5*
M.GF$SG(CDY2R[C;^(L=,J V\Y%<<4G/D2K,53[BTIPG.%N*SGY:,>Q=BZ39H
M6>R4X4!()!0D'=R)$3,DYC@<H@?J)>PF 7F$_:1995<)M0ZM:D@AQ13O#(9J
M) )$C*3J#2[NK0.J=29L&AZQ5H-&IS2X$I3@#SP2$Z5,%-/L>^F(CK4R7/2N
M2ZO#ZY2GO;J5E:T=NV>?B]_?MXDK>?4LL*S0X21*2%0")XF #E$QQK<V;P/#
M+C F%(L6;<7B'&E*2D(5(!0I2A UUD=)STV^)^MW"VQJ+JV ]9S6;391,1TC
M:;,?MA%J(V\A+J(KIV?.^'0V(J7599BX0UE?WSJEX3A6(M'KG',2M;=Q"6TA
MP$[H(2=TS#D:IB>[/7*>GB6$X;L9LWBM\V2XL6CKS;MPH*4A\I/9)9,DCVB8
MSY:1-=R[1X3?AT;FW7=+#L;BQ03=@9))*/DX<FS5M9,G-PP6GD#46LGPT(Q,
MG$)#\B;()1Y3LGVJFG5J9[(Z^\(46F&DIA(2D)A,@#=A(C(1H#IR[J_#[SR[
MJY>>6K>6\LNK4=>T<EQR9SG>4>F6O$]<($.(-AQ1X^*U#'P(L>%!AQ6D,QXD
M.(TEB-&8:;QA#3,=E"&FFT8PE#:$I3C&,8QU@*BK-6:LY/?$\!RG]%94K2D0
M?P_-6SG"L)4K.<95C&>W;'IVQZ_+[?G_ (.@S(RB2!E^>:PK7O\ #SX_.G")
M5E4-.<_/VCG^/'10@D#A'RJ4:'O_  %,+9NH:?MN"V,N"K"H:L2?KA0>%LYP
M!"L55MC4%BSU:PQ14V,R4#'&!D%F5AU"2$=IIUH;/@HFSTRHJ\>9---'&#1,
M5%W8#ZZ!5>%LD5@%?!U,9538%I"IKMHK.!A:-5U"4NQ4C[>8E-X;RVXT:P..
MM.(+"A\R.J('+R,_G2@KC]K>149U+*PS1T27GV8R<E&K$7G&SM@M@R0$*V J
M:S*00D%$!9<@,+4AYJ('%9CCQD2+%@#FHC\*F//Y]??4DU&J!*-60E0K<5R&
M"KP]@8,C.R9$QUJ+'3V3[65+=>DR'5JRI;CKSBE+6I6>^,=L84IQ]*51&\<;
M.'F(!*Q6UP2U%FRRDRZEH9R-[Y;#5WNC5QAVFXR@L=9&25KEI*3CU0LC2X&*
M R8,&!<H1!;5-A3GYUY14$ YGA/D^8IW:(JG'$G<"6Q]4;"^G5I:K-I#&I:K
M+"G/NA]FWI6URAR8*9@CEI8.6*8Y.#FHT5D/(@+7&'*?;:4IL9X^8R^%!&HS
MU^)S\2/I6I2-*<>*+KV]D:MLS,/7E[I4;69&V0KU4!X@9 9BOU%J5#N02 -2
M1MZ),U ^ ?MI6RF0TAJ#7@#PL,PT#Z=(^LTZS(]T#P_'ZUJ3],<7TZI<U8<V
M!7UTNC6<WL2<N5:M>!FZT:V\.NC31(G"$BA%6$B3+^R#QJJBY0*,!D2Y0]B#
M!E@X[ I23,Z3^$<YZ?HJ($1KQ\9Y1UC\U-=SC+QA<@PK7)O<\,%I-B/@HY:7
M+H--#B=@/SKL+*SQ<IRD!(X:<]:;R9-1:_571>O"%L:&FHM5F2,R%STD>?PZ
MCGP-3 /NR\.$]#RT(I5J>IN+ZAEUNC6QIY2*Z6VKI^[W.TV@<$BRKA9]MIM>
MPQRY3X>O TFU[*B.0HGP&*R&95[8,%BY8;:::9Z<-8]VOAGRIE,SS&?R]T&D
M/4- U3!I5R'F^0U<L@J=:]8T.I2!<@)2W=7$-(&ES=4TL7#L<\Y,DV2NV,/D
MF*@7)LY+/PQT-DNQ;(:R!(RGIIKRSU/3AW<(IIQZ2>D\^69SGJ3208X^:>$$
M 1"E\A:_4QH;;8LMMF6?L%7/&K?946K4-[8I,XHHL'%5B<9DZ7'.O#F0J3N5
MSY<X6_&$-%Z]86?+@8UR&>?<#SGE3+GQ$Z9G+XP,HCG2@OC3Q4F1&!#NT"4(
M=3A<<JJNF;;38LFM :.T$!SC&8]GK6;+51KF12$V:Q0) ;X^P79;*DYH:#2X
MX))SZZ^_N\8Z=]  (@\/&(S_  G\T2U<*CQY,VRA2[!?6(A"V4U=:I335G&,
M@K:+JH6[:R9^'EEQ'HDP]#B\C[",@P81AB48G'HK[(PFH#G,%G!Y:'W_ */A
M3+X2#W<>7'CSIN57CGQE%F"Q6L6R%@CFW6_'MP5JJ XP!MML8N=1N(QNR5H<
M-M[QJ6<WG/=]WL)\L9KUF-U2!7W L1L4'<21^?EES[AX4RZ:GH9.1T[P/#C3
M!E<7..-.F$DV[<<2%KK8@0*2*T8V?UG3 MW<KLQJU13BIE?#57" <)\&,LK#
M-,9KZ??8)685*$P1"0(92> SRYF.&6?Z.$4/4Y9S,9]_=GW\:<R>.W&.O,D(
M3^S8HAD!)II;8D5BS:MJ<8OELY5C>MG[[ KM8 0PZ$3JR!:KTL3&J\BT-8Q\
M6E6*4^B1A/+SEGYX<(I YG4<>LCSQXR<Z1JWJ_C!,J<8B VS:O@.P*!B/*&2
MYPA$[9U;##+-+@GIU$.TCXE8XX!K8Y\N^+'UO%2(/%(R+96S4$2*A#TG0\/P
MR_ 2=<M:0-1.>>I[_P 3EIGF*E!O7^A7@.OA,';R6HE-E&]50B _8=1;D6=N
M^E:W:[%J8FIF+D?$19I5:K#T6KTN'5BX0$/A@:7]'ZPZX+>CW?FI[^G#/A!]
M_P :TP^C-#5ZP#Q)"Z&IEQB6.M#1OTML@T><,DJ0[HO8%:!"(_PD+'L4< )U
M%JYMY02)-DOP&S"S\^;8R9DEU),_FH(&4SWQ.4?++K439T1QOJ1BR4>S[V>B
M9"BQQ(/6IYZDL#-95"M">/%0F1[5D^#+@B,JSRJ3K3$V)LA,F 7BF7$U:L1'
M7#!61,G7O$]3/AK40,QW$#H(U'NIR6WC-H$5JY-2@[)@T\>@,-I$&UV*W#?.
M*&"2>B*J^\*EQ"-::CW$0[Q\H(RNE,R5LAKK%=?)B3.9#X5Z,SEKT'O^IJ8
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M$Q+)UFDG3QU4:OD:\.'D;,'JA<U8%3#AV5:C<)$F1$*V!;,9AJ.,^>O'WZT
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M(+KX./8)<-ZP$\0FGY"?/UYG/6IT\Z=U1Y5^"U+ YK8BOW*LO0*,9IJS(CZ
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MPID(JS[BE.S:_:H5E"N##5@D)%.9+\:Y9O,=#<6NC9TPK!T]LU*IA,+*EO\
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M:76_<RJ1[)LBBQ;%=$Z]V365!"! F6K7P5)^9;P\<CD[>;'V:%^^U^PT0?
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M<\^O'62>>D'3CTIT%]*\IXI(;,KFR\D&EFJ[8"D,_L^_)&)-Q[7L]\RO,$?
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M'[X\R6UFE-.KQ_L<)0[V5W5\\=\8Q^'[):0M?M+4A"8T$E1/*-!E]:SK9"3
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MH+!I&5#?>_\ 0_O/MOO.E)'/R-:W#=QIM=<KR#5L<@-6M@O(K\]V0^L01:!
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M!*M_M51,*42H$@",B3QY'ISB]VE1EAK]>J0*QI:O>SPE:%MW.ZX1)D1WC<2
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M'QC$A'7P=IY5Z';>Z8M7K1A^[0M_-+A82%>KI1D"IX2 HDA,04G>BL:RI((
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M2W)PS&;=<><:B1_:9:C-+>=4AI*<9<5]4XYBUMC6)W.(VEJW9,/* 1;MD*"
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M.O#+H<\_S<(J027#V&1U6-UZBQTT42%;!VOL,<4$ZF%-U,02VK3MH4^9"!T
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MRY$DTXZRU%3IY]WAK$3RRFD:\^?A\CI,QSJ9JCPD>UR?J]VHMMI0RUTZ-9I
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M"+3C>2)%&5)R0LYR.W!?(9RO[_*5$);+<1MS/G1"CQ8V<Y]GYLY4E1*1)(S
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MTCE^'" ?Q(XFD:<P9^HZ\0,LA2=%X8;6C///#MH0*P3F:VB4F+:P1R^*/4K
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MD1+3JF_OTMJ5E/WV,=60G?6A),;RDIG6-X@3&4Q/.GNGH-3T&M?B_G_HD7<
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MJ=A^(1%D!R1QTI&BP)*R@]MPB*0E[SE!S;D^ F1$0M[$)L>T4IM&*K4M&2D
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M.T8M9/D@/NOQP<$//RD"RLX-[]"^*Q(,I^0.]\B^^-L^\->>HP1!44B[!4D
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M_P 2I2\A0/L*'_M ?_Q8K25^BB>3./\ W'?3^?\ [)K]Z?\ \2Z?8:?\J/\
MJA_Q:@O $ ()/+?$_P#@IW%/T2;S*KA8"'MW$ZA5"791 6R!6;-)VB#D%JM8
MF,2P-F%,%),-P@!-P\XF""\7#H\E&SA^')>:^_ZJG!4+DINPH!2DJW6P84DP
M08=U'$&"*JY<)0%'LU& 3!6!SXE$>_Y5-EM\=OGU60MS._I.:VJ%K:O5NV[$
M64C[/!JIM7N$H?"JU@.,$23,J()L,DL,0'G.,8CD$SXCT9;C+[;F<#>&-+*
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MYXM,T<L(A]_"XM[L+92G70?5U$I4IY!6OM%04.H"MYZ  $.@IB#!WA5@!)
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M4=#+!C4B,*%3VV[$:P7QH>6'+;>>N/6%/N"Y;4IQ* 1O]FD @( B(2#NQ,B
M(A0 2J G="04Y#A$\9.>LCWS3'Y&<9]&44UXDFV6:/QA@ZKV;LWP[;#P^EU>
M9I$CY]?3]Q46%M0QK"KUR7+,T:K%AY)T5;WF1%=A62-DG'D)*P89);$(>6M%
MJWO.EQMNZ#P5OY*"%% 43DHB)3F8Z&JJ$%1@ %2".[G[_G7H96N#.P.0G,J#
M?ZEQYKM<X(<X;=RSBY@UK78M&Z>,X_7UX>):&#M01K<2^@&-JT[7R1E1D?$Q
MF1UZ(CH(^1#?<B8K^V$-,[I=)N6.QB5'<=*T@+.?L$H)!/3.IA)*I &ZK>X
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M!$C@1H>1R,C*O2I<)&D\N'RU]W<<YJ2M[;TV?R3VI:MT[CL+=HV)<UBLG3#
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MLSF)C,0,SGPFL:4*=SY6_P"JS]ZGY]O-GTQ_ASC/V9_%Z=5((URG.K%0")Y
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M\>,?&M'7Z<XO])QC&>V+A6^WIGY?&H7;J",S$1W@?#**SI2>T3D8WQW1//\
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M\"7O;C8KBL^5*D*6I7?M]\G"<>G?Y=_G^/MU<P4IX<LY^/F-*\]<(W7E 9\
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MJ5$ 9Y\A45]_S_S_ ,'6(F> '("E'44KRK"L]O+G&/M[X[_BZG+C/A/XBI!
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MX038GVZ&N0F==-X\IU2'%CLW%/(0$H0IL@)5NA+J%E86(!4%IC7(95.XD)!
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MRK^$2G/C&]/=DD0?)XG:,X$\8;<&XBZ9L6H-IV>P<M>)ESY%G^:P>]FA^O\
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M$C>' F3F9.I&IDZ'/W5-6B*[XKI8?9MS<:@//HN)W0^2<N&T],"=_E(.TIT
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M)-S+V5EK:1'GH\VP%L*??4V5*/2B#2I#RFI*,O.95*K=A0 4RVL)^ZE2$E(
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MVF4FUN62@R11"0"?GVF2L8\0$RI R<N'[',L?(>A2,NQG5M*CU6UW2/5V %
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M[@$*W@25$G++AE1*04I]D%)"BI1^\%2=[/H9[Z8.L^$.M;A5>/V_AFD-;F=
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MPVK8@QK?./D1%PA+NK,4E[04)LAYX)>6'E+2PXP[ <6YOMD?E4;Q2DJ3Q)(
M$'=,9D6T$I!2D%04/N@9C[I@2!EIGRUKC-SGE4_7W,JH<?-70@HD!QR!:4T!
M>C%?0U&5L;;5)A"F-UW>S/Q\XR1/3]C$+.!E37G5Y5  0&VDL--H8;Z#"UJM
MU.N$DNEUUO>SW$&=Q(R@ )"5 :9S-87&FRH)W1D$I/"2,YRC.3RX5VAWNUI;
M3=LWW<X^@-!;0-%/&:H7&T?]U>HINT !INX:*"'K +#P7"L1EUO,Z)*P.?*Y
M)CQ$PK,*PX;9MD:1@<]M;KB6QVKB FQ6Z2A6Z2M+B@G.3J-=V"1P(RK)V+6^
MH[B"2Z,RD$@$&0)!Y3G(GK3R8I.G6-,;3X]%Z;00/%?5OCCW376S346+'CS]
M;Z(*M4]ZOV(]=5S\F:_&)&R\34*=C2I:)4;7R&:ZHDEL6N:B4N.*<2[OK4^O
M#PIL$_?<2I<@)T, %>[J5R1]Z#1QE"DALI ;#X*C$$ 0201F"8"9$>R>.441
M\1W3U<IO%VZV_>/%?1?%3< ;ENNA\98.G!HFL%-R<=,@;').'C 838"R;S7@
MCD2J3!NV9\=$@@2*('8)=B;D9_<LGY?0A+[CS2V-Y_M"5;CTC[I*1!.8*! X
MD& :E:(01"4$*.X (]D"(($[V8!!,'A(SIX:8TONSF#P.\//5G!C8,NIYUCM
MO>D3E&FK7(I62>MMFV_8,0YK';VT!=1D+N1"NMT5MH=6[C##E(591'D#G)@]
M#4MZ/#KK%O=7B[E!5OMM&W"DI4%H"(6A)(W4G>S@P2,X)@&Z$K6V@ @1O;^<
M$&<IC7+S&EOAVX+30O'</ZJ%$1$*+L[C]#:Y!F6ZA6VXFSKY4>#%KL^+;6;.
M7KR+%!!%;"D=/41JD\*.N$J)B20P7C984K6[-*\,2X026WH9E2I0E5PE.Z4@
M[L@2,P2)RBKF0X<QFD@B!).[D3R'7W5P*X"U/D#;>=^IZOQ=LP.C;D,S[A !
M7NR0ALX/2 9"DV:+>+:^V3A$66I8>F2K ^*D18JC#9;,' %Q@TN \CM8@6A;
MNJ>"E-P@E*205G>24IRT!5$B8C4Q6LSO%"=P@*R WLDCV2)ZY3IG/N%?I6L=
M3VS7XMSXQA@6W,[.J?AX\A-3<9-T;0L8G.]>1MR([,I-TV;*J215F.FZ\W\&
MD2A^LJ?*-R;= IZ)\1R0F2],A1O/!;96EPEL(5<MK=;0G\FTD)*4@@I ,1*E
M%(2508C.M4..)>[,H7OBV=2RMPIWWU]JA2]R%$@!)(0G[P3,F3%1PG3G)7;^
MXIE.KNU[U2 NGN&OA\XY^M:@E5Z3R:VGR3UI5;%.!Z@JERF&0TF+=<1GDHNI
MHQ<X-;KZVXA2U1RLB./AXS]HRVW)0E9<N;OU7?GL&V5E(+JD@$;O\ )29SW2
M,ZZ@WB0,Q"4E?\+>B0._G)_ U]X9[.UR2\07;QV^VBL<;>8O(#>&[)6Y./1R
MHWH_8@FCP&@+,;H6O@&R:G526K'I%B.R(VYMM%Y=K%3+(5UY4!8D4W/>?@$5
MRAP6B$I!>MFFFPV\%(2DN%Y(6M2%*#F0EI W2$A:E$P)  ;\Z*).6>8 YP1U
M.DP.&5?FSXR;<H7''>MN.$[3L.P4YFJ[AI(>W:AMI+6+UF28J%JKU6./1#E)
M/&EAC<N0-GC1A42&)5HG)%6$FTZ]7Y 29VKAM;[*0$H"]YM92XD+W84E2A(4
M!($@D$A0E((WI&)!.]F3 ! C+A X?/37A!^[<Y&U&^\7=;ZB'3M\/6JN[BVW
M="T>^;F;N]60#M('4D,"XZ,1KBM))RERZS8,#64$HRZS.0?+._$T79F&"AMA
M2'UN$-;I;;2"AO=,I+D@>VJ,BF<CO"!ENYY. &>1)URS\Z:?"*.X5G&>^?7O
M\_WOEUM5@"B#)SG7W:5Y7COW5CYJQV\OR_?SCY8_!Z_+J.&DY<,Q\8U\**UG
MGPXCOY5--0C2(U8<<\N$^\R9JVE=N_9&8V?*K\2L_+_%C/IU@F7 #Q),<<YC
M7IK&?+*:Y=RH+N0!J 9F.(D C/,08U'6H?(.9RYY,]N^/-WSCMW[JSG.?3\.
M?GZ8[=O3MW[=9%Z ?#E[^/69UKIH$*2#R]VF7T&?B:=5,=1$R9*+]?=!;R<(
M^I:W_P!;PG'V9SC_  =OGWZ;V0RGA',</,9YQ6)TDP-059SR'R\8YTC9/J:Q
ME$:)%91C^IRIE*G4JQZ]\.)QC*<=_LS^_P#+IVD#AR$ZGAE(.?'7Q(FK@",Y
M,]3QC4$9_#CD)I*D%"$GOA^6XXGZDKS][C'U8[=_EC'I]?6,O02(F"8XQW9C
MN_-5Q/ 3U@R/#S.=:>7,]L?+&>^,=_M^7RS]?SS]6/K_  XZGMLIXSIEIW<-
M.9U[J@ \\Q.HS$9\LN '/QIYZ_FKCVL6E2L^Q=?6A:?JSG#+KB.W?/?OAS">
MWU8Q\NJD[Q(U&8/<9(TR@"0?I6*X1OH()G^"9ZE/'CK'?KG6O+N5A5/?E,DI
M$=S+KN<>R<5CR_?JSC&,8],XQ\NW;MGMZ>G?'0#=F(ZC7W:]QURD@&#-5:MT
M)3D(R&0)Y:"(//H<Z?>M]DW%F_416"KKV6[C6%H4_C#F<*0;@J3GME7KGS8Q
MW_%\NJY)43"9F0 "<AF!$'X:_&KIMVU+2")WE)&O,\\R/&>-?UCJ>XMZHU9U
M>>ZW:X$<7G[5K&15*S^_G.<]>,7]]7^<KYFNG$9#AE3CZK2CI2F=L4..L.OK
MT ,1_?!)RFV<.4B>V?C^]#B82="G1_;Q76)+'MXS[K7MH[S+[?F\[+K;B4KQ
M9)(4DC4*!'>#4IU'>/G7X^YGAC\'E3)3BM(]UJDOJ5G[I.W<=U*=7G.>V+]C
M&.^<Y],8QC'U8ZZ7K]V/\;_[MK^Q61=LR(A&LS[2^G]*L./#'X/8^6D?_&3M
MW^GW61&(7DD=ME$_N;6N7]"J>KL_P/\ >5_:K[^ID\'_ -Q+_P 9.W?Z?=67
M?W>Z?RO+_%M<Q_0IZNS_  /]Y7]JO.?#&X/9[]](_/Y_],G;OU__ &?=8?7[
MO^-_]VU_8IZNS_ _WE?VJ/U,7@YG&<YTACOWQ_WR=N_9G_W_ +\&.GK]WKVW
M^XW\MR*L+9G=G<SD_OE\$D_PN=&/#'X/8^6D?K[_ /=)V[\_Y?=/M"[_ ([_
M -VU_8J.P:R&[H9'M*U\:5R/AI<)I$,4P[I7S-1XKB6D8V/MI"4X<>5E><^2
M^)\ZU=DXRXYYG/*E"?-Y4)QB3?W<_NO ?XMKD/Z%5%LR)A&I)/M+U.?\*DC]
M3$X.9QZZ0^6<8Q_TRMO?+MG_ -__ /S_ '^H]?N_XW_W;7]BK=@T8]C3JKZT
MH2?#-X1N0X+2]*=VV$.8:3]TC;>/+A3KB\X[ION%*[J5G/WV<_/M\NV.AQ"[
M/^-_]VU_8UZZU46S()(1J9/M+.?<516FUX8_![#C6<:1QW]JG/KLG;N<>F4Y
MQWQF_9QG'VXSCMGZ\9Z@7]W$]KF0"?R;6O\ H5<6[/L^QQC[RM,OZ74TO6'P
MU>%!"7A4O2^7?9QV6VT8V/MIIIM"$_>I;99OC;2,8SZYPE&.^?7/?/KT]>NO
MXWC/W&\R.?L9T%LQ)5N02E2B0I8SF)R5R'=2"CPR.#Z<]DZ34G#B,I7A.R]O
MI\Z<J\V4J[7_ !W3E24JRG/IG*<9[=\8ZQ^O714)=UWC^YM\U?T*R"V8(!*)
MD GVU\O\ZO7ZF'P;_<0^?_P2MO?T_P"K^N7,D]IKK[#?#_LT]58_B_\ >7_:
MK?&>&7PABSF7V-)^1UO#OD7]TC;B_+YF5ISG"5WU2>_;/IG..Z<]E)SC.,9P
M%]=!63NH/[QL_P 'FBGJMN1'9Y9'[Z^&G[ZD_P#4Q^#R6UIQI->$J4G*DXV9
MN#RJRC*DHRI/W0/*K*$J5A.<XSG'F5VSCOGJIOKK="NUS  G<;GA_0Z"@MF8
MC<RDY;RA^^/)5?<^&)P<RG",Z15E"5*4E'W3-P>5*E83A2L)^Z!VQE6$IPK.
M,8SG"4XSZ8QVMZY<Z]IF=3N-YQI^\JWJ[/\  SY[RI\=ZO/ZF#P:_</_ /&7
MM_\ I_T]=N?XW_<;_L4]79_@?[RO[5>L^&)P<RE*<Z25E*._D3G9FX,I3YL]
MU>7&=@=D^;/KGMC'?/KGUZ>NW/\ &?[C?]BGJ[/\#_>5_:HSX8G!U24H5I)6
M4H[X0G.S-P92C"L^96$XSL#LGS*]<]L8[Y]<^O3UVY_C/]QO^Q3U=G^!_O*_
MM5Y<\,;@]G.,YTDI6?*E/=6R]OJSY4)2A"<95?\ .<)0E.$I3\DIQC&,8QC&
M.JJOKH%(#NIS]AOF/Z'6JJMF2#[&@/[Y?]JO&?#&X/8^6D?JQG_NE;>^?;_P
M^ZN,0NP" ]E.G9M<@?X',FL1MV0<D< ?O+Y _P *C]3'X/=^_P!Q'U_W2=N_
MXOI]VZL<0O"9[;/_ *MK^Q4>KL_P/]Y7UHSX8_![/STC_P",G;O]/NK+O[N1
M^5X?Q;7,_P!"GJ[/\#_>5_:J8>/_ (='"VH[DH%G%:) RB8(THF/9LU@N]U!
MXFQ8,QR*].J]RLYZLEL1GL(DQVBPB:RQ+:8EM-HDQV'6\2[VZ6DI4Z=U0@PE
M"3'^<E(4.L$2,M*%AH20C, D9J.?<3%(>W^!O%/;VT]A;1V1K&5:KY?;@?M-
MLL,S8FTH[Y4V7)2)4V5[F/NT,;!8RZO*(HX;#AC1\5#,(?#BPF&([9N]N6DI
M0AS=2@0D!#9@#J4$D]229SF:DL-$DE,DYGVE?6H[_4R>#_[B7_C)V[_3[K93
M?W<#\KP_BVO[%1ZNS_ _WE?VJL'H/A'QAU7'WBQ0]9J!,[,X_;!U1=F\W;8A
M5)F@6V?69=A IP:MI'X7DC(""W,E0WP\W&]UPB&2CH=?2[K.WERZ4[[F]V;@
M<1[#8A:)"5>R@3 )R5(STJ0RV)A,2(^\K0Q/[[H*K_CPQ^#Z\8PO2:E80GRH
MQG9>W\X0G*E+RE./I_\ >XRM2E9QCMC*E*5GUSG.9-]='5W_ '&^[^!RRJZ;
M=E4RB8B/:7UY*KVQX8W!W#R,_<03GRNHSC"]D;<6G/9?R4A=]4A:<]NV4K2I
M*L=\*QG&<XZH+ZZ)4"[D#'W&QSXA$U;U5C^+_P!Y?]JK]W[C/HHORLUMM.5K
M@*S;] 5RN =+Y%/E0=6UL'UZ'*6*E#JMKX(0'Z_'Q:V?GRS8UO%87[(N[@BK
M*YC;3R,7;.!MQ&][*RM2Y )43()4H@J,@1F?F:CL6MT*W?: @$%0@;W(&/A5
M:8'"3C(JE6JJ+UQ)<#V6Y.["LGM;[LITM8[FL?,'M'K!8W+BJQ&Y4&*6.8$M
MDRLJ*&?L5FEB8\*793KY#*+JX!!#D%*=Q/L(A*9!@#=@20)@28$Z",#UJPM2
M$J1*4DJ WUC.-3"@3J8F8DQJ:AM/AG\)67'W&M,/-N/H6T\M&SMP)4ZT]C/M
MFW<XV!C+B'?DXE7?"\>BL9ZOZ]=?QOO*&R<M,RB9ZZ^%7[!I)(2B()C-7U\Z
MUASX8W!Y.'$ITEG"5Y1YDXV7M_RJ[=\X\R?I_P!L]L^N.^/3/R[=8TWUUO?N
MO[T?O&YX<=R<^/.K*8:*4^SK,^TK@<N-"/#'X/XPIO&DU8;<\OM$)V7M]*5^
M3OE'FQB_XPKRY]4]^_;.<]OGUD]>NIGM3ES0V?FBI%LQ"?8U)!]I>>O]+H*^
M_J8/!K]P_P#\9>W_ .G_ %/K]W_&_P#NVO[%6]58_B_]Y?\ :KU^IA\&\?\
M>0_\96WOZ?\ 5?7;H_XW_<;_ +%/56/XO_>7_:KS^IB<'&\X<1I'*%H4E2%I
MV7M_"DJ2K&4J3G%_[XSC..^,X]<9]<=6]?N_XW_W;7]BBK=K=/L<OWRN8_I5
MX_4Q>#F<+SG2/?.>W?/W2MO>OK_X?]1Z]="/RNDQ[#?'7]Y5/5F-R=S/_.7S
MC^%7Q/AB<'.^,?<0_P#&3M[O_#]/N_\ GV^74F_NSD7?_=M_V*A-NR2 4<_W
MRN1_I5ESX8O!U/WR=(YPI.<92K&RMO8SC.,^F<9^G_IG'U9QZXZKZ[=#_&_[
MC?\ 8JZK9@ D-YC^DL\>JHJR/%#@AQ*T_NFO;/HFEP42[TR,1L=5,6$Q;+VR
M"L0MI) 381P:^6"R@F#P8@PP0#&<#,D@\]EJ:-E193:'4T<NKAP%"W"4J!W@
M$I3.F1*4I,&3(F#Q!RJBF&D;A2@ DB<U'EP)(GKK4"'?#BX:6HX:M%CU%*,6
M&R%B1XZ7G;.V^].*F3$U\@3(S'LW[&794V;)?DR',XQE;KJU=L=^KB\N0  Y
M 2  -QN   !EN<@._C5TVS! )1F9,[RQQZ*I'_4Q.#F59Q]Q'/;&/3_IE;?_
M  ?7]/\ O]?V]5]>NBLCM<HG[C?3^A5A;, SN9_YRS\U5O0/#-X1Q79"F-*>
M12HDAE6?ND;<7W;>:4AQ.<+OJL??)SG'?MYD_-.<9]>I3B%W*AVVA$>PWE!,
M1[%45;LQ.YJ2#[2LQ)R/M9Z<:TU^&-P>7A&5Z36O*480GS;,W KRI2G.4I3W
MV!GRIQGUPE/;&/7MCUZDWUU(/:\?X#?(G^!S\Q5DVS,?<U&?M+SR_P ZO<?P
MS^$L=2LQ]+NL9=;6P[EK9FWV\N,.]L.,N>2_X\[3F,8PMM7=*\>BL9ZR>OW8
MF'=$@_N;1S.[S1UK$&&AHGXJ^M;+GAJ\*I,QF1)TT])>:;AQVW9&S=OOK1'@
M1F(<&.E3M_7G$>'$CQXD5C_J4>*PS':0AEM",!B-X-'@-?\ %,\3)R[/B<SU
MJ2RV<BGXJ[N=..+X<'#!)]<_&FN\O+RN[RMA[67\\Y[]D*O*F\8]<^F$8QCY
M8Z'$;TR"],Z_DVL^'\76%=I;J;*"W*=TB-]8R@C4*D^/76I):X <2&F4Y:U.
MMM3:\+;4W?\ 9Z%H6A6%)6A:;IA25)5C&4YQG&4YQC..W;K4-W<=I/:<0?N(
MZ?T:T?LJPWM[L/:&<]J]KSCM(J'"OAK<*9LZ7*E:7R](><<6Z[G8^V4J6I6?
M,I6<(OB4^92LYSG/;OG.<]^M[[0NPH /9$21V;7(_P!#H*Z*;9E A*($S]Y9
MS]ZC6ECPS>$6/EI/_P 9&W/Z>]4^TKW^._\ =M?\.K%EHZI_WE?6O6?#/X29
MQVSI3T^S[H^V_P"GG4G$KW+\MJ/XMKF?_5T#+0)(3F?Z2OK6%?AE\(>V/^DG
M]?[I&W/Z>_@ZE.(WI(!>_P#=M<O^KJ>R;_@_%7UK!^ID\'_W$O\ QD[=_I]U
M*<0NY7^6X_Q;7"?Z%5]79_@?[ROK7I'AD\'_ #8_Z27_ (R=N_9]GT^[=0O$
M+P*$/</XMKK_ $*D,-#]YIU5]:E.-X=?#= 5B(C3B$QVX^4H;Q?=G^B<(\OJ
MOZ:^T5GRY[9RI6<YSZYSG/KU1-_=[P/:\1^\;Y\MR*U#86A>WRU[7/M'?X/+
M?CX5%K_AD\(%NK4O27?.<_/[I.W<?A^6+]C'U_9U*L0O,ORVD_XMKF1_ Y 5
MMEAHZHT$?>5IXUN1?#0X2,PIK#6E<H:>PUAU.-D;;^_PE7?'=6;[E6/7Y]LX
M[_7WZ@7]W!_*Z"1[#?,#^!53:L',HG_M+_M5H?J8O!W*<J^XCZ]_W2MO?7G'
M?T^GW;J/7[LZN_\ NV_EN>?<*R"W9W#[&AR]I<#3AO1QKU^IB<'/+W^XA_L>
M_P#W2MO?/MW_ &_]4-[=03VO G[C?]BKBU8@'<S@?OU\O\ZON/##X-YQC.=(
M>N<8]?NE;>[_ /#_ *"]NB!^5X#]XW_8J1;,#1'^^OY;U;POPS.$,2?'D1])
MX;>9<[MK^Z1MM?ESEO*>_E<OJDYSVSG'JG/^#'5D7UUO?NO[X?O&^0U]C/WU
MC7:L*2243G_#7P5_G5H9\,7@ZK*E*TCW5E>?7[I.WL?/.._ROV,=\]_G\_P]
M3Z_=_P ;_P"[:_L50,-)T1_O*/S53BIGAE<(&+E5'6M)^1QJS G&U8V3MW/E
M6@K%4E7;-^SC/96,9[9QG&?EG&<=1Z_=Z]KK_0;_ +'ARX5;L&@0H(SUG>5K
M)SUZ5^P<5%8A"QL.,CV4:) AQ8[?F6OV;#$=MII'G<4MQ?D;0E/F<6I:NW=2
0E*SG.>:2223J3)[S6.O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g68105g21s21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g21s21.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1/:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $[Z^4%0X0DE-!"4      !                      .$))300Z
M  $S    $     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!
M     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y"
M:71B;V]L      MP<FEN=&5R3F%M951%6%0    H %P 7 !, $L 0P!- %<
M5 !0 %( 3@ P #0 +@!A ', +@!A &0 +@!R '( 9  N &, ;P!M %P 3 !+
M $, 30!7 %0 4 !2 $X ,P X       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M @.__C4  @ ".$))300F       .             #^    X0DE-! T
M  0    >.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@             !]0  !V0          0
M                       !              =D   !]0
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   !]0    !29VAT;&]N
M9P  !V0    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   ?4     4F=H=&QO;F<   =D     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    (.$))300,
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M/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M   !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3
M(G&!,@84D:&Q0B,D
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M4E5B>)BWU_$E)C5#5.$V1%-R=H*#A+.VPO_$ !T! 0 !!0$! 0
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M%#2UI6OU5E5R%Z*6NJ:VD@=HS93#B1LY3THPJP%>/?SDEB=HRQ*CCN<#@<8
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MT 50<8SG.G*_4F=P" Q=L%R[>\<Y=V)>1SGWI')9OD!@=W'Y\_X?K_)55/\
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M+*3W:::-99G;U9Y7=W/<LQ)Y-9AS J1JBOHKF''M?6)#(2C'R>M?N)Z1D?'
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MW@$>!0N<'G:05QZKY @U\X:>XM;O9<#WH+BXAF4Y7[R*YDWC)SC>I5\C/NR
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M !Q7>Y?LCU%'V8@.BS'2X<"LF&.+J-NIOP6DM/:D5<'TS[52VMGN)<P)/##
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MXE*R%21'#]\KBW1F&YAU9)V2-EYM8VY-[J$EUM:;VF&XCC0LT,(DLK:$.@8
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MV2R)SCPMKS>*K6^OYEBMKFWU&YM+D+*9K>66(K(9K:4I&[02)*IBS'N!!5N
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M'#.&B8U]L7'4I@L^1@JRGC@C]?\ CC'/%2\!P1YC@9'X@?S]?(U;6'\O]O\
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M^7ECD@D_O]?YI^7V7\OY?=/Y_P"]/R^_%>?+T/?D=_7@^G\#WXI_R?\ Y_\
MR\\4]>_^[Y_CBHO[BV4&*P-X5$U3-%=!DYK$4$#D6PTVSNA9Q,_25T*+[Y'S
MF/:0>0UJPU50-87)[X*ZN+(A]')^7G]*=2.)6GG<1P0*9IY&X"1)@LQ/F3\*
M+W=RJ*"S '\QF:CQN*R&/BF;/%D\OG\S%.C?8DT5#4AU3)6M7[M21@C7^U?R
M1?"_=.>-W/?&><X^N3CC@CU QZ\"OGV_G-S=75R1@W-Q+.P[X,TC2GGZMBM<
M7[2/*J1GNN-K##Y6KN;;,G3-;Y=\=R%#9UZ/5$^S(I*0]&^5\(\GPGW<O-N\
M(SXGO;8D>_''.@X_Y-BCXQYGJJ3GR&:Y)X_MLQ:?=@?W<DMNY^4J]1,^> 87
M \LM]*S/T*:O\=Z2?0RS(\G&:>UJFQ*Y%DCKK/X;X)ZM_-(WE6%E#$OY+]*]
M$7RQ>1GBR#HZJ)0,)<VZ29'F\>8GY]=L:$C(QD'@$9>%+CK:482V6M;B1,>8
MCDQ,I^FZ1P#ZKBKA/D?$K)8W.9)&]KXY&^4<Q[7>YCFN\(J.:YOE'(OE%1%3
MS]N:J._'H3W^6?+^7X5+2DKM93AE;(()!!&,$<\$'!&//GUK8YUYK!MID:F[
MA)'()=#]':M'DC?]-<!(D%@/*UBK\,B3-^5(7^U[89HG*U$<U5G(F+Q1NP(+
M*#R,9P2I(^1(.".*ZKI5ZNH6%O<A@79 LP!'NSI[LH(';WP2!_A(K-N5U(TX
MI3BE.*5K6W6@&S7J"O\ LB'^UFRDIP$HTGN4>687\+K?$WQK\BLC@T2DS>SQ
M(V)K6-\*Y7<V>. 7ESH.FEB/:-,OXB5(W(9[C1[L=SC.V)< C&6!/!Q4>)S9
M>'?%.H[1M@UO2[M2X.UEM++Q):,,C!QU ^2/)& .15H?5-V?HNHND-3O<>R.
M705L^?CJI)Q(3:ULAU]6CN2T;+*QL5:;!))72E1>^:!YT4L/Q/1I,.!H=E!?
M:BEO=,JPB"[DDW-(I'1MI74@1*TC,CJLA11EE1@ QPC9CECT1&'<RSV\0$?3
MWLLLR(P1I66)6920K2,(PQ!9E7+#YPM[VUW=2>J'?]FD7IV([-SVVQF3*'GB
M_";2Z@UF9IP=-)""56 G48+\= PJJ)ER1!M**6/*0'(?3OLI-"\6?:)H'AWQ
M#:/=>'4U>33](M]-T^%]0N;:UL6OM0OKV.X1742WYDCE,=Z\L<<*K)')' 9H
MY85^H_ _V47GB7[-[C2=.\4-8:=K?B"75]5NH=-TZ]NM0FL+"WL(;*6:&>XB
MT^.PNH$NK9;6>XFF/M5N;KV6Y6>MG^:[M[&['].1>D[5##CU6.[&FEQY2"V
MY*"+688,.7Y"T?\ C P=3V<?,%=2&64UE )46!Q+K6,IR]#ECLM0\/MJ]C&U
MO#J?A<:I+;AT=8G"W]_!R"-CB72H"\:JB(YD6,",J!\\W5F?#7VCVOA=[@77
ML/B9]&]I92KW(2XM-,NP%& 5DBO[D$'<2NW<6.6;8CT%))^ ;42:-(9J[M;L
M2N=&DB2>8:_0DUXLWE&L5K2!PV3QL<GED;VM]ST1'NQ]7;>UB^,!M/MSWSSF
M1N?/)#!B#VW8R>]:IIZ"-]00$G^W%QD;>'M;4XQDY"L&3/GMS@9P)UY$U)5A
M78..'W66L*"5T$1+_875E$CM+A#M1%60*>8=71NE@5ZN@*9%*.0X6:=HQ(I"
MQ$12&F7S:=>1W(#,G,<R(VQI('XD57PVUL89"590ZJ61URIP[^T6]M9(&VY.
M&C9EW!95Y1B,C(S[K $-M9MK*V&&DGN[H?7":JPT.6$95[ 3V0:3-G$)$'=Q
M03#!CV8!ZHV*&=4*!@:05'$/-%-7O(<S\2K+"S^A?#7BBQ-E#9W[F;3I"S6E
MW&A=[8L'D:"6(99DRDCE8RSHRS! >E-%#P/Q/X3NWNI;RR39>#:+NT=PB7!7
M:B7$$S JDN&CC)E BD4Q=1E+0RS5R-MNUH6J 1U[N&D-:C59#G[ R)ZJJ-1T
M!8490,[%>Y$CEC*=&_RBH[VK]MRBCT!CUEU33BIRQ+7D$;#S]Y)#'*K8[@QY
M R.>]<^FM]>1NE^SM1#$@#_R=<2?B'A,MNPW# ;K[6 !R,\91U[T%J]C>5]_
MV37R5U'"0PD/'^YYMUH3(9AE'@M8*SZMH=9"20&CZH20VZMC9JVHA$:59"AS
M1^K^+;*QM9+31I%DN&0HU\/<MK-&#AWA>81F6?8K[9W6*WMXUEGW[8I'28T+
MP5>7EREUK$31VP=7]CD.^ZOV1U9(YD@:1;>S60QE[=7EN;B3IPNH$D2'?!T?
MUX7BZ(BQNA_I;Z^6*64!5C5::NC;Y%K'M@EG'^N<][RK:>,@MTQ;VP?6SAA
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M&.%^%580)H,\5]4T-K38VC^%%$R=4S[%41[=V&;[Q7+,X!8DJ B[<%1[RL)
MCI(:IXNE,+[%@#M(9-Y7( Z31[%C!P%W,9&W$AV]QPT3RH_GD R]-W?@6 Q3
MI&)H77TQ*1/^+Z2D!/FG<U6L57ME(>.&U(D>[YYDC1CI%8Q=UO/'/AE9/$G@
MO]HI_P )=-TRV-SI;Q2JYCU5+2>WDBF9/9Y0L$O4D42]2+:2Z*I#'2]&\,:U
M/=:'XB6T8Z/>ZJSPWB2HP3]D"]6<31!^O&S3F.&(F+$G4PK$Y ^AWT\5\X/7
M4<TZ3-2SO;H^%"!0 9EA80RN1SQ*]TD0[I)*^2163S2G*KE>;\)#I!8/GKQ/
M*LFJ;5VYAMK>-MKR2+N*F7 >4 M@2@955C\H]R@.WT[H$9CT]<Y]^:9QN1(S
MC=LY2,D*3LR06+\Y?:Q*+.?-=J:IQ2G%*<4KCEE0@BDFDN]@X8\Q4[_'GV0C
MQNEE=X_7VL8Y?'].*I=UC1Y'.$C5G8^BJ"S'\ ":TO;C76/8FYLMA,3.1;&S
MRUXN;'E)L&#UT1)-9$$I2-6O%M8#BH\M!!70)3,&E*M8+XTN^NSC+LQ9>E9(
MZQF4":Z=N"J;.H Q4EA'%$!(P'#/P5S@UPC5+V?5-0,BR?VFY8B2W#-)TH/?
M1(>HIZ:/#O%LJ0I[.=TDOM$LEQ<2R3-DNFZI ADMAH;HN.3ZM/J8?GKA"W^Q
MTCJT,AKD8ULS%DC--^IM9'N5\IB>](HX]KF3F.S#V\0&W<AQ/(.Q:64<Y;N4
M0K&H.%4XW&:LM&ABC5%02$'?N(W9<@;F4-G )]X,Q:3)R6[8[+1=84;8$3\'
M#'=!%)##((-$'/##(QD<T#)A612(/-&QL4PZJZ&:)J1RQ/8B(EOVJZ3(:5YD
M;EXIR9D<?1RV"#V92'&<@^1N7>G1A"K1(RA2-I0#"D!64$88*0-K , 1P01B
MJS&1F45T-7SF%ML:8\8NN_"XF1RV:2-D(BF>'$4$\I+189XH09)1H0;ZMLI*
MF00*M#,GD+>6.-T<9]CO5,9C8ENC(I4,A8*WO0L5>-^"89 6(/N5JP!L;J.,
MRR=*1U,21*-Q8$'!52K.202@+((Y8Y6A=$B5GV^=.[J/L7KV@TOU Y)<T#P[
M*0994:\X%ZP23/@(A'*#D-A2"P<"7!$2&A;1YFJYGO=5(AC=XVQN1BIQSR#^
MCYCT)'-=NT2__:6FP7#,C2C?#.4)(,L+%"Q4A6C,J[9NFZAXQ(%.<;C)W**E
MJ<4IQ2G%*<4J!O4?N?W&ZQM)HTC^JT,S,V.^>58!88[&&=QLA<T<!944,@,)
M <;P C#4++%^"%G\1(]R%.I(JY('+,PP"JJ"S,,D#( ..>_?C)J!\1ZD^FZ<
M9(I&AFGE2"*=)&B,&5:627JH#+&5BB=8WA5I5F:,H%YD35WDLG^\1;:( ^4F
MLB?,=+9M!^F4!RN0=(PQ)V%5R-0E9@J$?Y3PAJ^HG^08=HT(4]F:=96>XE57
M@C=8K: ,5#L!D!@I!,:+AY7&UI"Z*,9)''+6V_:D\A:5I;9)-RG:5)<C& N7
MC**Q(C(9U*1D%4VJC6@K>HL]! D[*,(@ES(?G/,&C./)</Y=%(4>6V8HB2-Z
MJL;I)7)%[O; D3&M8W#:YO''$\D:^4<+=&-1P/=2/:J@CC)R2.Y).3MT6EQJ
M@*Q#@ %@N2=IX)9LLQ^;$D#M@8J--UUW (R4^F#&'/A)DL5&9'\8EA*YBJ5&
MH\:-CA--]D#OJH$@E*F@A$/G=6$GQ351W)=EBO&WJ?<2X..M;MR%;>,-)$.S
MHY(VEBN" #$:CIR$%MJ=0,75PN&#G.[A< ER!N)P7*A7;ILX./=(=B1X#?5U
M\RP)EKK8D"LT"3-='4_1F!#*A*3#RO$IE?7"O*8(HK*\H^D!@DDK4D@(;)H7
M>*6VEP9[$L=QX)A#X9,D88*6#)[S$+YA2,6/#VJ_LZ^$CRLQA=8;HL-L/LSB
M,-]X#LA B'7C0J8F>WC1GA4HZ[B?S_+EBNXTXI3BE.*4XI3BE8A9M;-M<I _
MPJ#TVMM8T5//B<>7-U;7I^J.2"[):B_;^%[T_7F=$2NGWK#]^>RA//=6%W,0
M?4;K=#]0*CYL-J5@I_<MM0G'R=&LH 1\]ERX^A-5D]6A\TG4G?) D_M(K^M;
M'-5*JQLGT]O'26?86G58E8_YD3,55$2QOM7WO@?$U/+O/,R ^SZ<[XP3;:G>
MR'CF(V[:79')X&+R>X4C!X8$\'B_I,27_C#0[9SNCD\0>&-,5<L#U#JEOJNH
MKE&5^=/AMF4JRL&4A&#<U\F%_*)-&KS6OS-4=JWV6AM'&$ R5,$&0'GC^KM
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M>-@9%7WASD\XX[C'G^?&,8Y\JZ;IDUHD>)5^\+9SC(V!1MVD$$$-G.0<@CT
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MK#+>+.AF6 M*TZ9'3I7#FDPB^_XHY7,:B\4K)>*53?UC0DKFL<3",&7'#?\
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MNC/B(G%J@_J9(18G2D3+[FQQQ1M3RC5DFDC:Z5_MBA8YTLKVQ,>J8$API/.
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MLI$C]D0[HJZKL"_J30D49HLLA4%"VF#FYN(8T\UBD6YF?L-J+$SIN.<YD>,
M#.<X!N7>L1!<=16+':J@,&;W2V I3J$X 4A49@SIE=A++%N2H+.^TB9X:.QO
MKNZFD/(:L,,A<3;YJ2SQQ,-BGKH:^R;].'72$++-G:9ZF*PN5P:V$E&ID9;I
MHDBM;<".UB;N2H&W!Y#L6^]ED]WWP5! SMB["UN+V]7[J28MDPQ$*TA,X5L*
M71H=DY*?>MDVL.7PY"%]RF#RD&)R=-FX%C>\$=SS9XUF<TJR+FD,LBO>0^4B
M1)S9YWL>1))-\:L:]RJWPEMB6)8]R23]3_+Z>5=TTVR6PLH+48+(&:5EW8>>
M5C),X+EG(:1V(W,3C )XK+^>5G4XI3BE.*4XI5(.[>H?4'VULK01-+G:GJJE
ME'L,W2B3L4R_3\"^FL ;8*:I^2:X/++NZYAMAH(,Y4@RTQX]'8V,1TS,N.6"
M)%95<W 8'<3[JX;D#!&0R\$8R<GE>#4AK5MX9OO!T]BEE=W'B27,L=R[K%%;
M3Q3,46)VD>$P3VA-O)&]H\CM-/NG@"PNM&Y2+7(6+?IQ#J^WSUK(*</-"V 0
MF0@9X[A9XSI)[!L)*PL4VLA5MU7&4KS6R%1(8.?C3QI#O(0R65SMR(_[R&13
MP1G $R$XVL"DB%@2NX!?FQVETR??'%(J+-LE0*4".0R[2LFZ0/[H$L']\I@+
MAF]Y'FP+N8!()XCHK,*<*-7%QLKC+=D/@:0G_24PY[VHC(GQ^TJ 2=)VI'(/
M&LL"RQYM6Y,5Q;2)_P!:=+>0 <'J1SM'@C/.TLHY() .)V+6X65OO "@RX;)
M*C!;W@BL1V*G<JX8$$#C,9[G8%[5AN=#2Q!#>JQ618TJ,NG) UT\X@HS8YHJ
MY/(Y$91%Q.$][1"!1P"H#&%MO01QVL@E+QW5TI^YAA&^*-\X$DDAPLC+W2*,
M-EMI+KM*F*OM1]I9[>)FDD&05AR74KDD'*[$*[6R)&0L48*C!@PD_P!-/7J]
MA:2KMY FS9>CG9:&G-8K*RU\,&G"E%DDC98/CM"&J")12J/71T0)MD:PII-(
MZTS=C6\;I)@W%PV^<G)=%)W;'R.'=@&=0Q"XV\'=F:\)Z2U]/&\L:R1)(MQ=
MR$'INHV21+E@)6:YD 46Q(A2VC>20-N@$^U3EJNPTXI3BE.*4XI3BE1L/7S:
MQFUN(71@B:?/MR%/,CUFFE$I2-7 R]D]K61QP'EWQ$U=!#(1\E:.(<\B.8]X
M04L\JV1T^!@9)+.Z-].N JJ]PMDQMADY+1);*LK,%Q,SQA2L0DDA4A>_&IW"
MD11WUH-/MFR68QVSWZ"[.  $FDNF:%5+DP)'*7#2F*+QZ]M&7C[2[2!1UM*S
M&F#PN5KE'KB\P&= (UR(U71CFEV7A?"-6225S43RO&J0FV$-ONW"&:_C8@8#
M2QWDD;/C)P6C2+S/ 4$\4TB<71GNMNWVB'3I44G)2"2QBE2/.!D)+)/S@ EF
MP*DOD34U4(8#$=57744N(S6._!^M[0K50+F"9)HW0S6&EM+*T+$(@LSBJZ1]
MZ03<4\X-C 52RN#?6I5R@C0BYT]M/H]X(UDC$T(CF#P[FC!F02E<2(FX$.5D
M5D*/EE]]#S8;5F\3PM?WC3W!N5%L[76P3-'8J+&$DQ.P&R*VC$3A^J%5&8K*
M&QTX.CN:NCVW578)\EAJZ/$Z&SS^G)CB'7LG"CA/"9I7H,.* S5T<Q(=3V%6
MUL,(PEH75:$0&JI=?25PV9#%&]Y87MJNR&2^MEEA4D^R7)E5ND-Q9NC( SVK
MN2S(KQ,SR02.8NYE=;'4;.Z)>6.PNVCE8 &[MUA=>J=H5>M'E4N50 !V20*B
M31J,XCK2-)7]A#0/B@G-MH @Y)_>D+C:BBH8_J2/C1TC&.LX)1WNC:]S1QHY
M&L>]?CY29DM)=+=@SI' TCJI&X1SW%R=BD\$B%E89(!=F!('-! ]Y#JZ*51I
M;A(XRV2IDM[6U&^3 ) ,R%#C<1&BL,D[:TT^HWT&WG:OJ8ONW0NQ&TV/[(TO
M7VPV]#9);&ZK*Z/JP^HJ2JG%%#$14KHR#,+&$'=$_2K7 V]O(ZMO5CSSZGO/
MA/[08-)\)VVC2::9[W2K;4K&PN8NC'9W=KJT<MS'-?)(K3@A-0ZDEN@DZLD$
M0ZMONN1+P+QAX,GU'Q7<:K'?+#:ZM-8WE[!*))+JSNM-D2TG@M'0B%P)-.V1
MW#E D4LGW,VRW:/HM]0YD[3]K7QG5/J$L<S+=ZB/6+17E?6870O#@N*,^Q;2
M15,9A@-8VJM+V<][C!)H[.)7&Z+1-I\I7<FG7WY2(I]N]MS!P%8@#G'&02#W
MSSWSGGJ-J3L@4SVP?IILW(6= S9"YP0#AL  YX' QNKL.O4ML??YS7T_2_JX
MORZZ"TM1Q]7N!"J@AFKJ+:=!K"L*96PVY00<D< =3,WZ;+VY T0?PED6\Y&.
M2RL&$4[$9'O,,<[N2,#/ [#.T\8SG$A'L8%3-;+POPH=V%*YP1N(&?/S7)Y&
M*LR#WOV66:T!OIJ[)KITK93WFW)M3!1S3IG[>X&JA;.M2UE:<2:)74;Y+$"O
M$&L"C623N=#1,TUIYY#C[EAQDY(XRI.,_P"+A5] <GL.9".-.?OD(#8R ?-P
MK-SSC&6[G@#C).V?\%JC=94O/L\O=8T^,LD=U)H&PQV3AH7M9&>D+')(@L\G
MRCMF?%'!,4(6^NFL:I0;4_%D<LKY4J=QRK$9'<#MY>?S\LYJ5A R,$,,#D#C
M@$XY\QY_T-9L> ':UYM8? TD&P$E#*@D3^&4<B-T4K%5/R5T;E1%3PYJ_P 3
M5143F&_EV[]O7U_#U_6)6.*.9'BEC26&1"DD4BATD1AADD0\,K X((P>?PK+
MVYU]U7B,069)UQ6;<_1:7$YRAJ]/HK( 2#36UX/09VP38SPW5UCXJQ;)737%
M%#/;_2C1 5@I1LPPTV!*$1&P@ !'89R2?H?7(],DXR3B9\*:'::?>%=+#64K
MQN9KKJW%S-[-$AD-N@GF?,*E=R6X*1ESOD)QN6'7];5%% LFY]+KM,YBJL5C
MC?47>;-D:*YJ^\J?NV^ZM+KT;^:, )M61HU/:]%5&\Q%EC/_ "?/'8$^OU_7
MXXWV2&_8CHZL%'.%EMQ!VQ^[:I.">WO%5SWR*E#I_+Z"FL]3:H 3D.O[@2@C
MR/7IW8-EV6?3V84MU)H-#/>V!%D+0LOH3:2O9C,Y>WV;K5H'VX9D1MW8#LLR
MLK-[H(QQR"#QVR/Z=O3SK(C$B1(L\JW,P9RTJPK$O3.W9&  ID*X9S*ZH[;]
MAR$4F?QC# GND#(F&>]OL<Z"1T;O8JH[PKFJBN1'-1?;Y\>4:OA/"<M@D=B1
M]#C^54210S#;,B2 '< ZAAD<9 (."0>_USGRYOX[=_I:V"?;_P#%2^?*?EY_
MC\+_ #_3Q_-.>[W_ ,3?^L?]:LBRLA_]%M_+GI)CZ\*#Q^/G1+^Z\_\ VK8)
MY5?M]7+X\_S^S_/G^?Y^/U_3C>_^)O\ UC_K3V&T XM;?U)$2C.?JH_ESY9P
M:Z/5S37F7NJC16]M!0W=>73GE1VYE7*R(^":%ZAV8\\,X)\;?DE"+&FB*&(@
M^H&>R4='MI>?I*TCR;43XF9C@9[ \]SD!0.22 H)(JN*RMFF1(K6W>8'<L2P
MHS$+CWMFTDKDC=QCW@#\6*T(=M?LM_6#L+^SR0?JK;L>G+*QBE^'LG5;B>]%
M"&-84-%:9P*LM:"ZL:U\43QRQ[6N&.*@:2@]1[TBANB4, 0200""#D$'D$'L
M01@@UL5M?Z5#MF338X;E5]UX(8D'O+@E7.UT# G(*D@'!+8K;IZ8_3GC?2WU
M)2=58R4BPB#F(MM#H#(HX+#4::P9"VSNRX(Y)8Q6RM&&# !BEE8!6!A!N(*D
MAD+GMDY.:C+NZ>[F:9\ GW57)*H@)P!D#MDY)')).!Y<'J P.OZU,/L"Q0 1
M=[W3.6::1$*&+"WN3?N?,03.]D,,+$\JZ65[6-3[JJ)QM9V554N[;0BJ-SL>
M,*JC))/& .2?(&N%>,BJZ]JA8A5#P99L* /8[?DDX  \SP!R,54KU-=VZO:U
M.:R7I?)U?81K])#=]@6W4]-M[@&3KREC*ANZZG[*PN;T8@]C^.E9R*Z QI-A
MO(J.<TFFKUBAL)A^K_9GHOA]-;NI?&RV-I"=.FBTF'69+*.$:M(T)ADNK"_N
M;9'06BWC6QO^GIS7"(LSES$K<-\<W6LRV%NOAI;N[?VR)M0_9@N6N&L$CE+K
M!-9PSW !G$(G-BDEX(B>F AD80L^I[&T_2K<5ZI.IO51;6U%I[?;]>;K'=;/
MN+TO %6>BJ,U2;:ML4/LJ32OJ@"K P?16)-S&"1F671,A[R3IGC*7PSI?C*6
M3P>+,V$VEV4>H06$HGTU-79 ]ZNG2QK'%);I(L8#6RK:F5I_9XTBVHMWP[X7
MU36O"D?_  FFO;>\BU.[DL'NT6WO6TM6"6SWL<XFFAED5Y6,=P7G6-(>J[MN
M=Y0]/5]B^GH=%D*_I_UFZ(&VT,1\$D?401+A&QU:!EVTC&_A7PBF%P 5R0.>
M3/"UD!Y;0(W$Q0Z-KK_M*2"=X^BT:-"6 8!EW;TSO)Y!,A&,9!SY"MET?P=:
M6<<T*:A)()"LNTR0LRL,(_PQ+Q@)GCOC![U<'JWO'/!]L5X_^0OU3U;ZVIUM
MO7D:'K<,)EQ;YC(:/1VF=!&C.6(PLBKJIH*0\"S)JK6^*KJ5I<)%A7_60<5L
MJ2(^\G!.!D'C:<?,#G_<*V'3?#EO9W\%W'<R2-"S$*6C*G=%(G(" \ [L YX
M/I5G)_6P.T \X/TO>KXWZ*6>%@W^1N&O)+DBN%I87PP6FH"F8,5.L9<),\43
M&U\CB)6QO&+A'S:W*ICZ<[S_ ,L5EJQ(>JNW.N@LP)031V':F/EQ_P"\!-T9
MIAB!:,64DMQ25$- (782.E9)"R^KH9AX)DD:JE3OQ2J3^L3L.@#H1NL+NR'I
MZ"^9GM!V7=D(LCJSK=N^S-%8UX D;G$'V^M>:51!##BE.B@4TN1D:0QOY)6T
M$RVLMQ'$TCW+2:; Q*I!#[3%TKNYGE?$<8MK>X#1;W0-,ZL28XI%/EH\4FJV
M\3RJO[/0:QTE!DN;FYLNK=:9:00(=\B7%W9'VIU5BL$;0J%FN877F>FBUEMJ
MI+&<* 6*S[D[NMX8QWPRPQFZ6XMM 2U"1Y9ASY*XN6[J$L1Y9!["*+ZP;_-Y
M(UYF7+![6;8RE8[:"&-U!"S6]K?26Z2J#V$P,4C_ /I V>214;-#[/JD".7+
MR,LTD<I!DM[JYT>UFDA<C',(69$4@E(71"25S7J]8_:]YFLO5]68093-SVI;
MYK'-F88@GX/6[.];GQFN>S_.$+TJPW(0SX'02 4=3K=#$2TG/CB&ZT0MS>6F
MG,S)#<2!]0E4D-!IL0>:[V$ _P!HN+>">&U&4S+E@X9%#;_X>M%M;34_$\ZJ
MZZ-;7#Z3;2('6^UX1I'I^]6(1K/3+V[T^\U $2[TDMK9X6BNI)(H0WE32^GC
M4]-;'J@8@DS!YN?H*VK)?92C[M<_9T^D*SQSW1QA)/8TUSV)MQK>.!6#ZC.U
MWL<VMFLAR9C7([E],FU001+<65Q:ZG!!"P6/]CZI*FFW5KP"(X;>2+3!;(1]
MPT: ;4>0-&^";NTU35+OPU?W4K6.M)?V]Q?7"233VOB;2+.YU6PU2/<RO/-<
M;]0M+]MS>U6M]<N0]Q%:R17],T=9K^KK/34[II*R\QEH>*TB%PQD23U)*N$,
M%D5)!+ 2;WAFAR^)A389AI4;)$Y$Q=+D6>ZT^6,G;)<VS+N&"N94)# _"RG(
M93\)!![&H+Q!9S:?%K%C<A>M:P7L,FQA)&Y2*0!XI%]V6*48DAE0[9(V21"5
M8&M97>O9Q>/[\M;G/ L*UU7M:6V=6RUMB\*^'S,-?24P3K$=P]>/(%G9.SY[
M(FP.B92"Z..Z6 @<5PQ,W;.(X9HF6>8M'8VL-O!&9)IH+JT]JO#""C*9\W:M
M;H&7JRV$<3,JN6%26/MEI;RM-:6MONU:\GOKJ>.&"SN[/4/9+(W.9%E%HS:9
M;K=2K&XBAU">1 SJBUM8R>C"U^8SVJKF3Q Z*FK;H: J-T)8\5D)$6T4N%R(
M^ L;Y5'*@>B/A(CDB>B.8J)!SQ=":6'>LG3D9!(G*2*"=LB'S21<.A\U8&K<
M$IFACE*-$SH"\3XWQ2=I(I,<"2)PT;CR=2/*JM>H6P238U5<VWG$D%S<,B5L
M1)\/UC;2V)]TD@D8B"'1>^H@A27\1@E%=\C$AD?/&K?CG_:AU%E;0M,359K)
MI41VLX9[R)KY9)YB(Y((K<07<!DMX5.Z_M7B<$(DTC(J]:^SFW!6]N3:I-M8
MJ)F2)^@5C3WE=I-\3A9'P!#('!R2JJ<RGZ= X8^I\];HL,ANHDL='9EQ.5[B
MBCSYXQUF53K)&2"UHX->H\9DD0K1$&B9"V)(F=T^R#3H-.^S[P]TBDDMY;->
MW5PIR;F>61D$LG]HN@L@@CAB:-)W2(Q]- @7:-,\5SO/KM\&RJP.L$2'@1HB
M@[5^[B)7>SL&*!FW;CDFIRYTRM=KHM/1UVESMY06\#":RXJS0#8)/'M? 3 ^
M-Z^5_NN9Y1['?FQ[6N3[HG(_5;"UU33+_3KV-9;6]M)[:>-L8:.6-E;D\ C.
MX']T@'RJ_:SR6US!<0L5EAE21&'<,K C\^Q'F#BM>?0]_!)I.MKDN8TZQ.)'
MJY;&&6P:TF:SJ;0$E]@XDX6!12R8ARWAH)8R3'($6V*!T<A+?@O["KZVT[[4
M)+4/=3R7#M";A&U!UE,ZW$:^TRW-Y%;)$PEBD>VBM[QKB?H78Z++)*_;?&EO
M)/X=Z@6*-(QOZ9$ *[&B8]-8XG=F&QD60R0JD?4B/4]U:V2S?Z*7_BW_ /17
MGZ"5PNJ]>D#[^DOTN_\ J[=)_P#NUS/%*L3Q2G%*H'W/C9Z[3W@Q9#HA;HMM
MYFGBMKA'NDF*DL)GJ]) 3CK&ANF.)56RN@#JIQW$F0).V"7X7^V_PS>^&?&@
M\6Q/(UK=W4%U:P6J:;:K+.S3M+)<SEK2^N;NUD)6-VG:WL["21Y[F%94@F[-
MX.U&+4-)_9C "2*-XI7D-Q*50!%18T DACBE3X@$ZDDX41QN59DL?U-W%4[H
M""FN2!J??U@@[;V@(E2)Q$J-CB?:4KY8AF6=61.[V+,'&J"%K("1'%-&C7?3
M?V<_:7HOCG2K<K=0V^NP01+J>ERNJ3I/M5))(58()HS,6C?I ]&=7A8 JI;G
MFO\ AV[T:Y<B-Y+%W<VURJDH4R2JN<L4;8 PWG+(0X/)Q+]E:5M,"196QX=9
M7"L20DX\F$02!BN:QKI9YWLB8CGO8QGN<BO>]K&^7.:B]&NKJVLH)+J\N(;6
MVA7=+/<2)##&I(4%Y)"J+EB%&3RQ"C)(%0$44DSK%#&\LC'"I&I=V(&3A5!)
MP 2<#@ D\5KQ[=["C[3V )0,DC.N<<+*516BQG1-MM"9&HI5X2,@3Y8J2 (F
M(&G.>K)7G.L(DA%E=!/)\(_;Q]H\/C75+7PMH3SW&DVP#+>6\-T\37\DL4:R
MW2P6\TT-K.\D-K:7.T,DR75NWLUQ<VTE=J\%:"^CVDNI782.[E)5HI&C5E@5
M6;9$7E1'E0*TLL0R&C,<@,B(Z5<?J#(39/+N4N0MYMV7^*R1&ROEF!&</ .#
M7^7,@:UL \*2JU@0"ME(D;,)%.V3W?5WV5^$&\&>$+'3)9+B2XF_M<PNIC/+
M!UD4I:F7HVRND R$86=F=K 26T4@<5S'Q+JO[7U26X546- (DZ:[%<H3NEV[
MI""YP6S--R"5E=2#4J\Z/6OTXI3BE.*4XI6);3#9CL"EEH=560V0,GRNB]Z>
MV<668>822869$5T;I!2)QIV*CX"A9YA2X9QII87^JS*P92593D$'!!'F#6%?
MZ?::E ;>[B$B9+(02KQL59"\;CE24=D8<JZ,T<BLC,II!?\ HPOP#_EQ6N#*
MIV#',@J;UC1)8)VAMAIY4*CJ[1\DHDD;'RO&FJQ'DJ\QM>CB"8I+S20S9,]N
MCOG/50F)SZ[@ON,3D\E1CRQYZ#=^!9A)FUG@GB"RA5GS;R*>F%@+,D4ZNRD
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M]?>D*+M"MTA'9,WJWZG/>P.CF&O/4C!K9MA0F4I!4@ASZN.Q"DKZ4O07-,0
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M&-D37S3.5\LST8UJ.EE>JODD=Y>]RJYRJJ^>*]+,V-S%L *,DG"J,*HSV '
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MRTZ2XD#+-J1:"TWA@5LX75KJYC#8QUIECM(95RK(FH1G!%=&EN)9)619I-L
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M<4IQ2G%*<4J)>[]]KNM.NSM7A>O#NU-6S087/U.(KK%M1/9/V6ZSF/).DM)
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M .&_+/[.N/\ I+'_ .)Z;_WNI?VV'_!=_P#N%]_W:G^7'&_^8NX?_9\[Z_\
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M"OXZ R4><[3YZN4KV=18?3!&6NLU/[.3'5]AUWTH);=<)66.H^>QU @AH_\
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' XI3BE?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g68105g22v48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g22v48.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X9"&:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C8M8S V-R W.2XQ
M-3<W-#<L(#(P,34O,#,O,S M,C,Z-# Z-#(@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX
M;7!'26UG/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(@H@
M(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B"B @(" @
M(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.FEL
M;'5S=')A=&]R/2)H='1P.B\O;G,N861O8F4N8V]M+VEL;'5S=')A=&]R+S$N
M,"\B"B @(" @(" @(" @('AM;&YS.GAM<%109STB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W0O<&<O(@H@(" @(" @(" @("!X;6QN<SIS=$1I;3TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+T1I;65N<VEO;G,C
M(@H@(" @(" @(" @("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @(" @(" @("!X;6QN<SIX;7!'
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R\B"B @(" @(" @(" @
M('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @
M(" @(" @(#QD8SIF;W)M870^87!P;&EC871I;VXO<&]S='-C<FEP=#PO9&,Z
M9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET;&4^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U
M;'0B/E!R:6YT/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @
M(" @(" @/"]D8SIT:71L93X*(" @(" @(" @/&1C.F1E<V-R:7!T:6]N/@H@
M(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X
M;6PZ;&%N9STB>"UR97!A:7(B/D9I;&4@3F%M93H@(" @(" @(" @(" @("!G
M,C)V-#@N86DF(WA!.U5S97)N86UE.B @(" @(" @(" @(" @<G(V,#DT.# F
M(WA!.TQO8V%L(%1I;64Z(" @(" @(" @(" @(#(R+5-E<"TR,#(P(# S.C R
M.C(S)B-X03M%4U0@5&EM93H@(" @(" @(" @(" @(#(Q+5-E<"TR,#(P(#$W
M.C,R.C(S)B-X03M38W)I<'0@5F5R<VEO;CH@(" @(" @(" R+C8F(WA!.TEL
M;'5S=')A=&]R(%9E<G-I;VXZ(" @(#$Y+C N,"8C>$$[1W)A<&AI8R!T>7!E
M.B @(" @(" @("!&;&]W($-H87)T)B-X03LF(WA!.^* HB T($--64L@8FQA
M8VL@;V)J96-T<R!C:&%N9V5D('1O(&=R87ES8V%L92XF(WA!.R8C>$$[5&AE
M(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z
M)B-X03L@(" @(" @(" @2&5L=F5T:6-A+4)O;&0F(WA!.R @(" @(" @("!(
M96QV971I8V$F(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!C;VQO<G,@87)E('!R
M97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($--64LF(WA!
M.R @(" @(" @("!";&%C:R8C>$$[)B-X03LM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF(WA!.SPO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z9&5S8W)I<'1I
M;VX^"B @(" @(" @(#QX;7 Z365T861A=&%$871E/C(P,C M,#DM,C)4,#,Z
M,#(Z-30K,#4Z,S \+WAM<#I-971A9&%T841A=&4^"B @(" @(" @(#QX;7 Z
M36]D:69Y1&%T93XR,#(P+3 Y+3(R5# S.C R.C4T*S U.C,P/"]X;7 Z36]D
M:69Y1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&5$871E/C(P,C M,#DM,C)4
M,#,Z,#(Z-30K,#4Z,S \+WAM<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP
M.D-R96%T;W)4;V]L/D%D;V)E($EL;'5S=')A=&]R($-#(#(P,34@*%=I;F1O
M=W,I/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z5&AU;6)N86EL
M<SX*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \>&UP1TEM9SIW:61T:#XR,#@\+WAM<$=);6<Z=VED=&@^"B @(" @(" @
M(" @(" @(" @(#QX;7!'26UG.FAE:6=H=#XR-38\+WAM<$=);6<Z:&5I9VAT
M/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIF;W)M870^2E!%1SPO>&UP
M1TEM9SIF;W)M870^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.FEM86=E
M/B\Y:B\T04%14VM:2E)G04)!9T5!:%%#1D%!1"\W44%S54=H=F1'.7IA1SEW
M241-=4U!0311:VQ.02LP04%!04%!0D%!:&1#:T%!14$F(WA!.T%10T8P2U%!
M05%!0B\K-$%$:T9K8C)*;$%'5$%!04%!068O8D%)44%"9U%%0D%514)G549"
M9VM'0E%92D-W9T="9V=,1$%O2T-W;TLF(WA!.T1"04U$07=-1$%W441!-%!%
M03A/1$)-5$9"451%>'=B1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.1$$P645"
M05E':%521E)O9DAX.&8F(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%46="04%$
M44%W15(F(WA!.T%!25)!44U2068O14%A24%!04%(05%%0D%114%!04%!04%!
M04%!449!=TE'05%!2$-!:TM#=T5!06=)1$%114)!445!04%!04%!04$F(WA!
M.T%104-!=U%&0F=C24-1;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N34)!9TU2
M0D%!1DE227A15D5'13)%:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T2&A->%II
M.$-2>6=V16Q1>E)4:W%+>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)24IO34I#
M:&=::$I21E)Q4S!6=$Y62T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7,7AD6&PY
M5UHR:'!A;71S8E<U=EDS4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.
M:F\K0VLU4U9L<&59;5HF(WA!.W%B;DHR96XU2VIP2U=M<#9I<'%Q=7-R839V
M;U)!04E#05%)1$)1545"45E%0T%-1&)114%!:$5$0D-%4TU514954DYH26=:
M>&=:17DF(WA!.V]B2'=&34A2-%-.0T962FEC=D5Z2D121&=H85-5>5=I63=,
M0T(S4%-.94I%9WAD56MW9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y9W F(WA!
M.S K4'IH2E-K=$U453504FQD65=6<&)81C%E6#%2;%IM9&]A5W!R8D<Q=6(R
M4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$;$I75VPU
M:5IM<'5C;EHV9FMQ3VMP86%N<4MM<7$V>71R<2MV+V%!07=$05%!0T5135)!
M1#A!5#AJ95=V375G6#)P5#9H-58Q;#4F(WA!.V)T;&=3-'1R3U8S5S%D;2MS
M:5!L2D1'2%EC3U!.2D9.3TI&0V%Q5V(X=$)A2U)(+T%#>3%50C=M,W5E0S90
M8FE/:TUQ:#%+2S9*.%8F(WA!.W9(5'!4;3AM=U9Q67$X-3$W>41R,7HU:6QV
M9$,X<C8Q8C)5.7)+6EDW<7HY37)C4$$V=4DQ:$1+14Q%8V$W-'%Y<GDO<#=A
M9#52<TXF(WA!.TIU=DEE<S-D-T1*3DY/2F1/5V4S17-K855M551T2GIF,4E%
M5V=33F946FQ)6F='2W))-3E2<W!P,750*U9C-G0Y87-B:R]O5C5D2VHF(WA!
M.V%+1S%A34%2=6Y*>49J:UHS4D4R0F]W<%5R:7)Y:E9F>2\X04YK*V\V,4IP
M6&Q,57)05'!L6F)'1C=764]5*W-O>6-X.&%H*T%Q=U@F(WA!.S1F1&)&56LO
M-59J*UEV.$$Q3%=P9CE)<W8O3D]+2&8X<7@O35@O<5=T4R\V4EIF*V%C5E)E
M:R]L>C4R='13=')J55!*,G V:%EX4TLF(WA!.S%X6F5J4$0V<4$W<#9I2U=3
M=FE-5E1Z>E U5S$S5DQA5U!39GEZ=F1%;6QN4UEZ4DQD5%565$Y607-I9D1Y
M5U=/=D5G5E-V2#1Q2W$F(WA!.WAJ+VQ74#5I+W=$571A;"\P:7DO.# T<3<O
M;%=0-6DO.5,Q<5@O4TQ,+WI4:7%*;B],5#AW;7-R5D(U8C%)<VYQ8V@Y5FPR
M<3(S-T\F(WA!.TM53B]Y<D@X>&8X07%7=%,O=T-K5U@O;6Y&1'8K5EDO;4PO
M,4Q7<&8Y27-V+TY/2W!Z-5DX:BMA9$UU,VXQ8GE$<4]S<"LW34U4<&,F(WA!
M.U%Q:%-66&-K3$<T9FY'<DI2:%%6<C)X5E,X>"M1=DYM;V%J-BMJ*U).43!7
M>4,X5G-L4S9U9'=X4$EY4W)Y2DE)0B]Z1TMP6"]W07$F(WA!.W@O35@O<5=T
M4R\V4EIF.$%M;D955G!V-6$O;49(8T]Z*U<Y4U940F-+0V)76'$P1'%O*WHS
M2G!I<48O-59J*UEV+U5T86PO,&EY+S@F(WA!.S T<3<O;%=0-6DO.5,Q<5@O
M4TQ,+W=!,#1Q:CE&+TPS>FQ:,VAM,4AY5G%7<%%E;$EQ,GAI=4E12D=1:4]1
M<VEK;F<Q1S0Y*VU+<'HF(WA!.S5M.&]8=7!X>71P4#5:879O,3%)5UI84U=E
M94E->&HO04XQ3F)R.$E#4%%+=S-F=U960W)&+SA!;%=0-6DO.$%5=&%L+W="
M27-V.$$F(WA!.WI4:7)V*U99+VU,+T%.4S%Q6"]33$PO>E1I<C%N+VY(1'EH
M-7$P5'ID<4YZ<2MK6&5N,CAM;G1(2$QC=W9%<D]:;VIX0EE$96=*>%8F(WA!
M.S=E,6QR1E135G%6,B]E2$989E5T6B\S-C,O27<T<3<V;')0*R]7+S5'2$98
M9E5T6B]W0BMT+WE-3TMU*W!A>B]!3#EB+VM98U9D.5,F(WA!.S%N+V9R9CA!
M27<T<3<V;')0*R]7+W=#4FAX5DIV35!L,WHQ9FTS+U$O;48Y1T59:SEC3$9&
M8RMQ5T$Y4"LY*WIW25!4<EA&57!8>6@F(WA!.RMB46UL-2MC>3!5:51E;59S
M-$8Y2C(T*VQ24U<U<6YX9%=(8G)I<3)(>5@K8G%%1B]08E,W55E(5#=C8CAG
M86II-"]:,GA6=%!*,S4F(WA!.W1I-&-T-3),46-A278Q2T1L>4Q%:S=%9$9O
M3RM+<#EO1V@K8W)+>$U/<C9Y,G(S6$YM1C-W5S(K03!O;D--;&1V2$95>2MP
M87HO=C$F(WA!.W8K4FAX5C,Q3%=F.2MT+WE-3TMU*W!A>B]V,78K4FAX5C,Q
M3%=F.$%F<F8X:D1I<G9Q5W,O=T,O5R\U1TA&6&95=%HO,S8S+T%#34\F(WA!
M.TMR-$Q05FQM:EHU5TM"9U=(36Y92&9&55902DE*5T%99V5&8U95+U9L+VYB
M-WIH5C-Q>2]Z=#DU>%8S<7DO>G0Y-7A6,W%Y+WIT.34F(WA!.WA6,W%Y+WIT
M.35X5EAT6&1N4$II9'4U=TLQ<68V5BMQ2#E&:4$S;DIE4#%R;C995W9X12MN
M.%913V<O5FEQ5'I$.'=X15)!,FM.3'DF(WA!.T)6;D9Y<3A4>'%P04Q'<2](
M=EAF8EE5,U94,C K="]6669R;G O5RM#*W8V3F94-3 K3&AY*TQJ6'!81E9T
M+SEF*W%V*VIZ14QV-&8F(WA!.U0Y9FM9-F-H>35C4&DK>E=N=FEQ5#9#=FYS
M5'AT-6=B5$1#65=%>5=!;D)765-%;WE'5W15361!=TY+2$95+WA6-59Q+VQU
M-#%*-&XF(WA!.RMT,SEL-E-Y2GAS-41%1SE294Y82$9Q;&5Q*T)Z;CAC<%(O
M:$(Y-&1N24$Y85-A-3AL86YA,GIM,'9.678U;E521T]3.4U20SAW-6,F(WA!
M.U-"2SAH>&]0;69%;DPT-6)/.%EG9C%7<W=R:U-F:6=O+TQ0;64S<T9K-#9Z
M2E!#-WHK:2MO2S=-63!Q:49H1U%Y=7=#.&%5-S5:>%(F(WA!.TIQ;R\V47-+
M3F1F;6\S+VPO=T$T4U0S16MD=')1+W56:FIH,4M&15E+3TI:96-F=VUI,6)F
M8VY$17=!+V@O,&A5.%AN+W!K9&$V2#4F(WA!.VYV8CDT8BLQ,4]Y=%(Y63E'
M.5,O:F%N<4UE4#=U3D9.84@T3U9E22]#16I'275.13DS0U5G16YE+VUN15!L
M2V%+-$UW=F13649L8C F(WA!.U=M67AG2VY$:48T.417<#DX;T]74B]H2'EB
M0D%D-2MB25AT-2]W0DAW1# R<4IP4U)X4&19.&=92&=',U4O;UI#431J-V@K
M;&A';RLF(WA!.U9D8G1':2MP4V%V<6%Z>4]*=S$V:UEI5U%P53!D4&E#:%1X
M564O:FU4:GE8>D59+S5P87!2<FM39FEL>F574$YV<'9#261B2V5S07,F(WA!
M.W<Q4D))54-/964V,$,X;4$T.64K.4M:8GA1+V\O=T-K3$-P968K;58U3DDX
M-&XQ6FAP*W%#5W!K4T)D4VHT1FUQ-5%%<#A+9WI-;R\F(WA!.S%%*V522$(O
M4B\P:%-E3'HO=T)-;U,K5R]/33 W1U,S,6A&2TEI96QQ55%65%%L>G5L95%)
M<'EP=4<V9&-L>%$O;R\V46]Q6&XO<&PF(WA!.VQL-64X,E1Z5W-5,7!R9')B
M6$1*2E!0*VLQ6F]L5F$O141'2$Y42GA)<E=I:D=::4%A-%18.4%R14AZ+T%.
M33E".'0V5%!P-S).<U@F(WA!.W5,;%EP;%!R,THU>45'5&QU=U924F$P1S-4
M35-(1DQ+1%9B:'5L46=29E)M,7@O9DYM*V1C<#169&ER<U9D:7)S5E8W4#=B
M9DQ!<F4F(WA!.W O<%@V;V8P5TE$96-L-"]7=69P:&$O150V9GA6039$.5=+
M<%!-4'I$15)%1&%1,'9)1E=C6$MR>%!'<6M!<V%R.&4Y9#ET:%1D5E F(WA!
M.V)4-C,Y5F@K=65N.6(T3#8O;S$Y4&Y4-'5(3#1U3F5L8U97,R]W0F8K<78K
M:GI%3'8T9E0Y9FM9-F-H>35C4&DK>E=N=FEQ5#9#=FXF(WA!.W-4>'0U9V)4
M1$-95T5Y5T%N0E=94T5O>4=7=%5-9$%W3DM(1E4O>%8U<'%E<5AL:%I09&5J
M9#-F07%0471685-5.&U!*T9+:71+,5 F(WA!.W1N3W=%<$=R<C-U,&M10F1-
M4VXQ-WI2.5EV2E9K,7!9-V525#E71VYO,T]0-&Q#=VM0>6%R9D574&(R>D]%
M0E$K;B]41GAJ22MF>5@F(WA!.U%A>C5V:&ID3&UF5THU25)'1V505#1H>EE"
M<&XT55EG:&Q(<#E.;7!417AJ,'(O5$9)2C@O:T9'-C$O>F1A5W1W2C=J5C)A
M,&IC>5@F(WA!.V%A9$9W9&Y:5U9K57E(*S=6<4AT<V0X26=#96XK;4M$26IV
M*U%62'9F3VMK<%9D4C%643!Z=D5Y869$=T522'=)>%IT=W!&83EX*T0F(WA!
M.U52,V8V67):."]K12]W0D,Q5%=85T]#.$8Y2DY+2EIH8WEW*VEI<'I(0TIG
M1',T5F=096A.8WAC,%-.=V9T='5X;G8K-6M$>5A8-E F(WA!.VA02U1L-G-T
M9'I7;D=/;5%*;'=$;GI0-D=1031J-V@K;#5V<E!M6'IH2F8S56QL2G)L:F%X
M8U5J9T=L>%1+>FAW:$MU.&=:=RLU03(F(WA!.WI.>#1X479H2B]R;'@U4TXW
M5U!G,BMU96,Q9VUC6$=T:VHQ1U)6,'1#=TI):E9E3$XX6$9J-FDP3S0K5TAH
M:B]!168Y3U9S*V8K;%@F(WA!.UA/<V5E3%9,8VTW,6DT-$M05SE04V\R36A7
M44UX,FM(1&MK9U-N*U-49T59;G4O,#55:RMF*VQ#:W9M3'IK>6]$9#9V1$Q)
M2D=I:FTF(WA!.S!U3E=C<'IM-$%E;V9I.4]%<'0O341H-$DK6"MN2T])*V8X
M07!1<$A79GI!;F=H84LY,6TS:TI7171*<$-F83-,4T]O:V-Q;31Q47 F(WA!
M.W!4661C4$1!9#,K;DLS3'HO=T)+.4<X=3,Q-6-Z5VIY3&-X:U-X<31U1DM/
M,C8Q67%$5&5U66M225I"=C%(,W0U;W=0=5IP8V8S>EHF(WA!.W9(6$ME1EA9
M<3=&6%EQ-T9697HK,C-Y=TLS<61Z9C(Y;UIB1WHK=EA(2E%T=C9I>%9"3D-X
M9#EQ3#%0-%EQ:W,R=65C-'E1;FQG4VTF(WA!.VA9370O0T8K,4=!=GA+<#55
M9'ED<69$,5!,6E90-U-3-&QT65I,:4@V=F-/:71,0GE$.$=)<58U1%IQ2&%O
M>%9B9GI88TYQ.&QP8B\F(WA!.T%&=318:G=G3&E,:T-W1&9'=TE&1G%C5E-F
M4618.#)8:SA9,6910G!51'=S>G-,=4LU84]:6D-!:D)!=%9A3VI";"M2>%90
M.%9E6E0F(WA!.S8Y-6U38W!$1$Y,1G9353-82&]P22M%,4\W04PY3V%+3U$Q
M=DTO83=%>#,K:TE196%03TIN=31V<45W.4=.6'1N3C4X37I.5W%%,&\F(WA!
M.VQ#4&9*8U=W4&E(-V8Q<V$O;VA94$TO;G=30E<P,7EN3D5:,79X.6MR>6ME
M:$A25RM%1'%F8D1X:B]62F9A=D-F-6\K>%A4>D@U>% F(WA!.W!&<DM647DQ
M;$@Q,$5O,4%A0V=O,CE2,7=C9BLR2#=5.% X05)(,DMC;FUF>G%T94]M>E!3
M=E,K459&2D-+5G Q-$HO=U@K4V-E4"\F(WA!.T%'=R]A=D0O0452.6DR6'I0
M-351,&HP,E-51U1J6#8K<3!J3E!J,T(V5DY2-UEE368V<$PW56-*+VUJ-T4K
M='16,6584F)3931E5S(F(WA!.W5P2&LY84@Q:351.$EZ=S5Q84YX2D]1>5I:
M0TEQ4D\U,S,X;55906YC1&M0,'-F=69.6&YY3RMK:6@P;5=A,%-12DAC+W!"
M14QO82\F(WA!.W905$EQ05!!;754:DU%8C5$9GA9:V(O45!S5VYZ6"M90594
M*VE*1W%R;'%A:6=)6F58055P4VHX5C<W5CES94EF-F]F=%=J+T%$0CDF(WA!
M.VEV1#5N.#9.355L,#9A3TU2:'A+3#5'0F-X0G94<'-F-WEQ5BMN05HW9C-H
M*S%01"]22#)+36YM>GHT<5%&3DAN9&Y2;6U8.4E2:C F(WA!.S)#,4,Q4#)Q
M;F%U2&E(*W%N-U559C5G*WAQ-#@Q*V9O>DM)9$EM;D--=VI986A';DU":'A/
M.6%60E!8=SDX4DEF-F]F=%=J+T%$0CDF(WA!.VEF95AD6#$R-F5Z8E5"3&%4
M=DU&;'1F6$UY9T-4:5!J1D%W6F%(<#-P:UE:6F5)04I%:7@S<&Q!8TI.049M
M5G@O9DYM.&1E<#169&DF(WA!.W)S5F1I<G-65C=0-V)F3$%R97 S3B]B,FAL
M<V)0-CEC8VQ#,B]Q3$9513!,1C,R;W95+VAI<51T<F9N1EI/2"M'9S0T=3-Q
M3&91.&$F(WA!.V=*=U0T;%9U5&-M<G118V5P<G-Q;G1P2F-3,G--;'A$.5AU
M2%)7;&<U0BM$159+.&AS,41T55EQ='8U<G5',653,'0O<F1W=DAH05@F(WA!
M.T58249G1RM.9U%+3%4T<6LK9S9V-7-V2C1X<2MG1%-O2&A:;EE88U9Y,&-Y
M>45"1T-"87$P9$=$3#AJ:7%F-'$X.74Y63%I3S-D-UDF(WA!.VUE8T0Y,T-7
M15E9*S=%3E0W<S4K3V523SAQ1'-Z:D9B0DM8.#%E9&=J<W5K1FEV4&=V,75%
M1G5*9FHK>E%C=4MF3&PW8C-C62]W0E4F(WA!.RMX<C14+TXK,7-E879/;$EY
M9$E98VA'6D(Y86AQ:&5V361.+U1O4&Y88DAJ2"MQ9EEV1"]!169T85!M=GIR
M>F]U:G1W.5@P*U)U;T$F(WA!.V94,G),44$W8FYA=&1V9DAJ2"MQ9EEV0V8U
M=C)R0C5R.#E'>5-B.41C8FMT4U,R3C-#4W%J;%5H=W9%:SA6<"]R8C!P:#1X
M9CDU.6DF(WA!.SA*+VTO86ID3#AX*V%,;6%:8BMY87=I4E5-36AM:6U,<WDQ
M9&5+1#1E0C(V-S58:WEK1#!Z=C1-;W=V;D=K-695<C1714PK<652;&PF(WA!
M.T)/,U%,2%1T-S1$;FYW03,Q4#9&1T]0161V>'5K;"\U:C@Q=WIL3$]X*W1X
M52M'6#9X2$9V=UIT,5I446-W<2]46'1V2T=3>'9/=F<F(WA!.VE52T\P54\S
M;7)Z<TI:1D=K1FM73FYJ:T8S1#A4:&E&:F]6<4]3,$YE9S9:3&I(*W%F66IH
M4#A!3BLQ=B]&6&Y0:U(K:5=O2#1H=G(F(WA!.U5.0VY*4GHV5BMY>D=N*U14
M=4UE368V<#EI.% Y2#=6:65B4%!*;%)',%5Q:DTT950V,T-1;U9156%G5W U
M=%5E,DAJ2"MQ9EEV0V8F(WA!.S5V,G):4$YV;G1667)O:&MB9VIO0F1W06-M
M-&@T>5-/<3%9,39%1'A/4$=0.54K>&5%+WIF=%I.<'5P,SAL-V%R2DE2>FMJ
M1'!S97(F(WA!.T-O<E1+.%=A4FU"9E5-<#1X=VYB;WEI-"]V;7IE=755.$MU
M>%8R2W5X5C)+<3EN.71V;&=6=E4Y449H84<U*W)4,U9'5E)$87@K<DDF(WA!
M.U-X;TM,56)E2C=9<6LP,VY1>%9$841R1$U"6&EL<4AQ=DM.46%Q-5AF,6$P
M<E=I=%5#;39Q9E=L>#E:=%EB:C!P26974E@Y1UIE16DF(WA!.V-H6&DV-S!9
M9'AI<3(O=7I:,G(S06=L=65(2#EZ079/43AM0R]#<$ER4W14-UEQ:RMG*V)(
M,65E3TTV3'%E;7!,0S!Q>3,Y=C9)1$HF(WA!.TE536)G3356>5!I5W5X1TMP
M+VEQ:#E2<V8K5V5,+V=&+W!L9FA1-V@X;5A(3'9D.5)S9BM794PO04E"9C99
M*T9$=4AY6&IL,W4K;S(F(WA!.U O3%!&+W=#+W="369#:#-$-4QX>3<S9E5B
M2"]!2EHT=BM!6"MM4&A1-V@X;#0U9#=V<4YJ+WEZ>&8X04%,+U1(=V]D=RM3
M.&-U.3,F(WA!.S%'>"\U6C1V*T%8*VU0:%$W:#AL-#5D-TAV3V,Y>EE78U1A
M8F%X>7I5:UI,9C1%1'0X2#=42W=8-3!Z0S%L4DU12VE.*VYU8VI"6G8F(WA!
M.W%W,79-9FY!4U5':7A-;DXQ-65T05!H0V-K9C="-G0X0DAB<G5->&5+2#@W
M+UET=%,W=G184#5I.#-E:T=44EEV53E5;U5A841A3&PF(WA!.WA%;3!E-7 X
M6$@X831I568U,RMX5%(W=G1A8GI,-70T<58P2E-X-3%";71H5&E#53,T;C=7
M=SEJ-V(T,T@K95 Y2W1(*V(Y<FPX>64F(WA!.V)J-C%D1&I89UI"1%=E,RM-
M3%0P>6%)95!09C59,T@K9B]S5F\O>F9T5TXU;3@U8U=+-D1(5EII9T)N='9I
M:$%R-F=O;E9J<T90,#0F(WA!.S-$*V8O<U563"MB.7%:*UAT8SAW6%=R5W-D
M-W!A,E5,3W!-;D]#43%R1U%T15=U-61X5W8W4'5-;$-1-&A5<C-(.$Y,24=J
M67)B=EHF(WA!.S-C9C-Z6G58054X2W5X5C)+=7A6,DMQ.6XY='9L9U9#*UI.
M4G5D4# Y3&DS=7)',&(Q;S!E6%5P1$A$>%DP2VAG4CA:+UIX5FE).#,F(WA!
M.V5B43!(4%<O2U-H23!E*T%U6FEA=$EP<DA6>%)04F130S,W4DA9-%9:<&]&
M,64S96E73C%E=F)Y6&1X0DA,33EM959U5V11,S=P=50F(WA!.SAK,S)023$V
M-$921B]D;7IT6'5"0DQC.$]0-VU"96-H-4U&*T934E=L86XR>%9*.4(X,E!Q
M.#AC6C!853E.4U=&<%9L=C=F,%%'4U$F(WA!.V]9,T%:>7)K9D5T9&E-5E0O
M1EAM,G)F;4IR1VY%9U=6-V4P24@K:5=Y4V163%8S2S=#;%!N;7!X-3AS:#E5
M4C<S3FQJ9T]H55EV>DXF(WA!.S%L-5=4.4<V:6ER2S!83G)644-65FU,:F8W
M0C0W3C-*1U,X8DHO4&EJ9V@O3DQ6>BM:*W-1>',T,'I56E-R=7!33S%J6G%)
M,T1M1DPF(WA!.T$X5U R9F)F<&E-=54O>'@O2'=5=V@O3DMO,S5K-G5T>6M"
M,"LO4$YM55-I,55X:FEG97)-1'-$6&E09D(T,E=V<FEV0D0K859%+VTF(WA!
M.VQQ=VAA5398<616570V67-G6$Y(-%5!0DEQ96\S-F(T9D9Y+WHT3'=1+VUY
M6'AF;61Q:EAZ5V-L;&5X3W!+<DDQ=6Y":C%8:E%L=FDF(WA!.S=62%DO=T%P
M;VY,;'$K2TLX14QQ:6HO35=Q95I:.4AG;# S-FY*9BMT26]..&A-46I#;U0O
M9&IL6&9+=GI(1D5(2G9U96<X;5AH,%,F(WA!.TDK6#973F%L<EAN:7IG5V1X
M;WE*-F]1,6AN8V-:2D]+8DEP8FQ1:C(V.7--2EEP1V=$.&]R251'.2]E;'-0
M-6=A>$DS25A7:5!"3$,F(WA!.UI,6C%T<FMC:D-5.6-S94I!5VY0:C-R>#8W
M-6%C42]M;B]9<T]-.2\S="\T-SAX3&%W;5-44D9N;$TP66-16%)J859*;&=5
M065N54LF(WA!.TAA:D=U+V)92$AW-#,Y2BM55C1J,VHW5FMN-6<V,S9546IN
M,%E4>4=(9#=7-D,X5V]*1%%O<E9,>E)C4C=M=E19*T-0-7 O,E T-S$F(WA!
M.S1Z,R]!2'$K;&5C+TUT+W%C.6Y&3F\P<D,S:V4S5DQA-5%'4VET2'ED,31S
M;T1Q5S1M=2M2>5%J1TYM2C4O,%5X2DIQ+W9:4F].-34F(WA!.W!/=%=Y,SA7
M;F961VQ58W)A3FA+4#-J8U0X46]0:#1D3SEC<7@U35IK2T<Y:F]'56]Y;S,S
M96)03&HK*V).>31+;FA6,DMU>%8R2W4F(WA!.WA66',O='0X<T-P8F8S=6TS
M>4Q$9E=+6%558VEY3$A+1F11-D=Q='A9159",T=+<&1B85@U4G1N;&5,47)9
M3DTS3BM323E0:%)+2T<F(WA!.U4X1C1X2CA+,$<S5$-Q83(R<E=L<F)X,C%T
M84Q"8G=Q16AH:C1O:4MO;T965D%!04A964964# X;BLK5"]W048O6FEQ2#%$
M>E5L;%DF(WA!.S-&,SE3;75F<3AB4V96-V-E<$TO158T>'!T>5DY:&ER2$QF
M.#,T<&QL2CAR83E%,%1O9U-3>DE,:#(T;#!)2EAI;E9Q:V)D2S<P5E,F(WA!
M.W50.$%-;E,R5#%$-4<Q,5EY>4E!8E0T-G9Y,TMC+W-J:G5F=G!T5VHX<FHW
M;3-X<&0V<W8U:#93,6<Q-G9K<E=Y<6QG,$)T07,S=VTF(WA!.TU616)30715
M>F)C82]:8G--9GEU4'52-#!U.5-J+TUV4EA#+S@V5')Y1FA7:E=,0VYX8V%(
M-'5V9C59+VQC9F-V:E,W,4]8.'ID358F(WA!.VE&.&EA-GER5W!.;5)7:E4K
M14)M<G18=S=D<6M0-5A(+TY4-#!U.69,*UI7;$M113AJ-C8U24Q%+U4V04)8
M2VXY=C=20S%59#EU;5 F(WA!.S582#-,-#!U.69D9FU2;V1T3D9#,VLW5VYA
M6F556E<Q1D-F449W54981EA#,5AJ+T%$2U(R>"]+-"LU9D=N,W)H*UEU;%1A
M9F-33#4F(WA!.U$Q6FUT3&HP4'%Q=R]'6&M13T<T:'516&AW3$5J874Q8U1P
M8UI&579I>3<Q0B]Z1S!C5R]R3#5),35M-4MV<$<P8TY1<GI*;TA046(F(WA!
M.V8V,C-V:V9Y94QU6'@U.3=,8F584EIR94MB.4=T1C9Q2R]P>4UY=79)5C1S
M2S=%9#A0-5!&,TPT."LY8W-E:$PY;E1L6'(P66IQ86XF(WA!.S=Z:61*:C=K
M94Y,=EAF-VAF*U=$+V@R>"]*-'4U4&IZ-S-F-VAF.$%L9R\T9'-F>65,=5AX
M-3DV<F$O;VHV>D8V9&QW9FUV0G5B1V@F(WA!.W)S8TDP=4U'=T5(3DDW5VU6
M>"]F3FPW5W T5F1I<G-69&ER<U96-U W8F9,07$S57)J4SE/<W!R-CA6571O
M0GEK6EEZ23%#86)):7,F(WA!.S='<#9!67%X,E0X>5!)16)53C%Y1DII>G)A
M,T1+=C%F;5I/4D52<%0P;BMF13!W<7E7>F)4-WDQ:'4W6D5E,VY26DEN-&-A
M<7=Q1%(F(WA!.V=$,'=+;S9R9C9,<%9S;'IF.$E96&QJ9U)V5$QK>51-16I5
M2VES,WA-861-5E%/;F5:+TLR;S9M*VTR8V=K=3!537EM0U)&,UAN44\F(WA!
M.S9+<&)I959!96U+<#$Y5W1V.3E*+W=!0TU6965A=#4W,6DP:%-7>C!E,'5X
M>2]F:'!"0G=4=3E8<414=G5->5I985IM3$@W9C@V-W@F(WA!.S=G0V93=$UT
M-U8R<$A+.3E!2$M#44HV;D%S<#1L87-+94AU37)%0BM#>'!5=5!Z:C%32S)L
M;%A23DY:;S=G,B]%,SEU;V]&<GE,13 F(WA!.T(R*W=D.&5!9F=H85=X+VY(
M<DQZ1TUA1G!H*T%L2V%H8FMT249*0T)2-'5P5W9S5&IW9FEW=$PP+T]3*V5/
M3F\Y2C!X<$AL84PP>&8F(WA!.U<U4$5-9U9W45-$>40Y3W1A1'5-94%F9W)3
M86%0*UEM=C-L9G)V;"LR<VQ*0FED2FMU15I#0V5654EP,G!T=EA*>'A7>455
M-F)Z5D\F(WA!.TQA3U@V;F(X;F0P231M;$9#:V0O.')$-$%T94)3+WAF8V8X
M04Q(8F8X0V8V-&9!0V5!24A5+WI+<SE,.4@V+T9B42]71S11,6IK8FLF(WA!
M.S-H.$YF2$),1D5C>6=X05$P,S5U-DY#6$5G=&Q-865Q+W=#-6Q.1C1O,61H
M-%-R=#$S>5!"1'9245=W9FTO;W,K;TIP.%%T:F531VDF(WA!.U)M1UI14U)5
M9D511B](15%H9%=T0D]F.%@S2"]!0W@R,R]!;BMU5#A!375!26EW.#!Z>C,Q
M=D-B4S-54WEO:%I63E)Y64-O,W=3=V<F(WA!.T,P1TQ)-VHK*V)-6F=P-%9D
M:7)S5F1I<G-65C=0-V)F3$%Q2#$S>DQO;6<R-EA'<EA1=%EN-3A'2W4Y9E1J
M858V0D99-TEH3TMP3F4F(WA!.V9M9#5"9W1Z9#-/;W%)8F1Y4%5-13=&6#50
M0V%!4FLQ-4MY-V9Q>'!5.#!,6#E*,3=4;SE3,&UF-GI:4VMH2F5,<%5J<CA,
M:%<O1$8F(WA!.U945F19,#=3<EI,;2]L.4=&-5DT16)I>FMY5$U%:E5+9UIV
M:5DP-EEQ9W1/.#1E6'12,4XY3G,W;'!,=$9$37!I;%)D,34P1'5Q<5<F(WA!
M.S1N;%%(<&EQ8S1Q:U0K4SE$9$=2,&1K645-<&%O24]X0D)'5RM.2FQX1D%3
M9FQ:-4=L0T-44S18165Y07AX:T%5<%%F1#!W94HU0D8F(WA!.W)N+TQ$>5,V
M;$@P,D9K6G5B2U5J24Q'=GA%8V5U-3-X.%$Y=U<R=BM66"M383AH<&M18BM9
M26=0,G5854Q8-U<O=T$X9D508T9T<5 F(WA!.SAR4$DX85)O;6U256DT.$-5
M46M&44%$57%46#12=FHT;FM&=$=W*U)V3#A#;$E9;6I5;7!65V]+,' R2&=-
M27I%2C1K9S@X5W P5W<F(WA!.W1H<&1J.69L9'!'.4-36# K>4%K3V1S<WAZ
M2G-P0DQ&0G$R=6PV1%%99VY+5F546%9.;$)-5&)C=&Y);V4V,3<U6F-M5S9Z
M.4\V>$@F(WA!.T$P,7IO555#27%S.6)T83=P5F=#4W$W4#A/-T%(<FIC:U=5
M32]M*V1O3&%3,C R,&UA-3E/9RMV2GA"6E=-;GA":4<Y3FMP.%!89G<F(WA!
M.W=C6E<S42MA-RLU8TQ:85)A,T\W07%L.&AB:7 K,U%&='5*42]W0WE'26M4
M>5=Y:DQN5CED:F=,=V%$1E!-2$LK:V)R,#9P=%)G>$PF(WA!.V5*<40T66)K
M;F1(95AT5C%E8GI,85<Y>&]I5S%P-FM25SE&=T@K26Q35CE-2&QS>'!8,G=3
M2F]O3G948FHK*V)-3G)5.$MU>%8R2W4F(WA!.WA6,DMQ.6XY='9L9U97=DQU
M,W,W4V$W=5@Y3S-T,&%36C9%.%515EDP04HV67%X:%!Z5CAH=DDV2G%24$%2
M1FU%1GAX<E!'6EEX6# F(WA!.RMP4E-F-V-A5FQG24E"2%$W:D952'%U<V%D
M<%9S;'IF>2MJ0SAS8T-.>%IY6DIM0U)Q1E%-,WA-861-5E%7;F5C4$PR;S9M
M*VTR9'DF(WA!.S!L,FEH;55X4V]U-C@V0C-65DQC5'EO1#!X5D]C5F5A,S,U
M=4Q9>DY$8V5K2D9+0FQ71V0V1U%K2CEK:V9%5G X.'E$:F=/<%IK0F\F(WA!
M.V9M.4%W46@T1'IK849F,U4O=T)T9612,3=E;3(O5&)(=S1D-C!&,%@U='AY
M;'=J,C5A4&@V:6U+649F5D)+0F=4544P-DA(=S1D-C F(WA!.T9&9GIM=$=U
M2DQD6DE43$-65U5#1S1O<&1G<6=T,#-*>#1)9#9+1&\O=T$U-TM266U384%I
M6GA(1V92=4XR2EE5*RM.=#AE0TAE;6<F(WA!.W-I+T]U>6M73FQK:7!),T)A
M=UA!,TI10W1E9U!R2E0U-$]#2&5554=5-DQ082MB=$YJ=G)O07AO83(W4F-O
M=U5K5E=Q43%4:51W9E0F(WA!.S%8;'E2=CA!9S=29C5:4"M$+W-W94Y*94ER
M6G9*1V=44G1&3$<X:V)F85)M<40X=U)G3V%3.%)1=B]+=%!*=2\K-"M0-&E3
M9F=48W0F(WA!.U=P*WHS-70Y-7=E269*1G%L="M8;FQ7,F)N8E=A=TU">$12
M:%5.2TM+5E5$86E,.7<X35)L251X26HO0C)I+WEY9CA!0B\R6DQX<$PF(WA!
M.WA&56<X<6%40E!(3D=*3V-40C!Q,5)65%591&UK5C1I:7)J*RMB2VU+;FA6
M,DMU>%8R2W5X5EAS+W1T.'-#<3$U9#(Y;F%46&1Y+W F(WA!.S(Y=6I35%!1
M;FEI0W)'9T)05$973DHK85AK3BM81%9!,T%X0G%1,T=X;FI-,&8X075V.$%A
M4E-F,3<T,')+9U%10T]H,T=+;U!69%DF(WA!.S W4W):3&TO;#E'1C59-$5B
M:7IK>51-16I52V=:=FE9,#99<6=T3S@T95AT4C%..4YS-VQP3'1&1$UP:6Q2
M9#$U,$1U<7%7-&YL44@F(WA!.W!I<6,T<3AQ;'4T26\R:VMH44EO<7@O94AB
M-D=Z649U4V,K9"],4WAM4FE&44MR;7-6>4-&:V-O:#0O82M*:'1T:T]-9#=(
M:4-P4#4F(WA!.W<X=7=13E!+>7)#;DUT2C9D=U9(<'5%8F-D*U1!92]B2&I(
M96UW<5 U<3!&2D1'-TER0B]43E9N03550G!5-V1'+WIO8U!'3SEB0VTF(WA!
M.U!/4&QW:$<U;T9D5EI72UA!56@Y,494=%=M.4]T3CA(1T\Y94E):E0O34=J
M6#AR>%=F<'E3;VE3>4I35E=66DLX95%9:6A.3V@S=V<F(WA!.V<X:6],4#A!
M>55Y=%E4:TE%+V4Y1G(O2U!%;DM-+TYH3FM754U867$W1EA9<3=&6%EQ9V)J
M*SEF+U!T:7)$1"M89CA!<$UK<2M:9&0F(WA!.U=*-&QI14%V;DMQ46]5=4-W
M63AJ4W9Z<CE"5DE.6#!4>G-N<3)L;$)R5GI"07$R,$8T;717.$UK>5)&<%9N
M265);%AD;3E.<2]S9UDF(WA!.W%H-VY19D\V34I)8DQ86E9K5U)7:4=U5S!8
M<#AG44=!5E9"97-R3E5L=#%(=&EQ23!4>70U='5R=3!T.51B6#E.=&]66FYV
M1')C3G<F(WA!.U,Q1F-)-DI'0SE73$Q8=%0S>%9L3VDK4VIP97!R96I89%9V
M230Q6D5S<G$U.5,S-'18-U-C4E5R6#132U5&359:6EHO8F(U6496<GDF(WA!
M.S=T-T\P;74W;"]4=#=D1VMM96A01D5&5TY!0V5M2W-B2#5N*U)I9V-A;%9#
M555-24QI:$UK9G)+2RMN+T%#1W9T:E-S<$)"04DV2&,F(WA!.UEQ9SE6,6I4
M=$MT:W5B*U@P65AL:F=2=4Q/5$I-=U-.47%";2M*:E1P:7%#,#=Z:#5E,4A5
M,S R>G57:W4P54UY;4M61C-8;E%/-G$F(WA!.W!B:656065M2W!Z:7%2+S1/
M,%@K5U0O9R]W0WI,=D=K>31I-R]",FDO=T%S;B]"+S)9*TY*94EU+W=!2&%,
M+TQ*+W=F.6U0:E-8:4PF(WA!.W8X2&%,+TQ*+W=!2"]::C0P;#1I-R]",FDO
M>7EF.$@O04=9*TY*94EU+W=D;W8X04Q*+W=F.6U0:E-8:4M8-CEE5"M6<D92
M;SES='HF(WA!.TI.-FMG9VU9:FLV0E%Q:'%Q1G)8=FAI3T]Y56ID:3!V-7 K
M9&]K1'DK6%E65&Y%<G0Y655H5FM!.5)T;7(K-UDP.2MU2GAE4T]&<40F(WA!
M.S@T3EIL4V-M>7-!-&]B44QD;S9Z8VUO;31F-$]61%1B=&HT62]"5VQ&9GIM
M,7E53S!&:G P9U-627%F6$5";S5P>6(T:GA09W S3D0F(WA!.V<T0BM#=$Y8
M2#4P-GA%67E,3%1J13!R2DQ+,3=%<6]N3FQ6.3,S3$--;FHQ,DDW63A!+T)#
M,'9T9GIE.#$S8SEZ1&$V3EIZ4&))<G4F(WA!.W$S4W-1>DEX.4YU2EI68FUN
M2'(W-&I'1"]A=$HW;UAN>GI*9F%O;'!E-F)$85%S.&%I44U8-4(U1U1A:F1E
M241B.4LU231T:6YH6E0F(WA!.W%&,V%7,&=A-6UJ9U=2>$A'6D=#0FY98DM/
M4D974%E::G-%<%!N1'EK1DQ(5W)%249$;'IC>$)E2DE!4$QL5'%2.30X8TMU
M9GIL-5(F(WA!.U-'2V0Y8G-"0D]Z<$1,.5IH-$TP64)C0G564&A$0W9H565/
M2W)O+TYV;&%263)45TQ)<DUX5T4O5TEV:EI70T5,.%AX9D513G-65U F(WA!
M.S5Y.&]29T8Y8G-&56=%36)M14QU07<S-54S5F=2-&I&5GEE8B]+5'E'3DYB
M<T=K5F=R24QQ17-'2C1G14)U<&)B1E4W,'EE0S126C0F(WA!.TI&;6=M45-2
M4WAK36IO,4-R2W<R24DS0D="55A04$9B=U-4>71X:6E6;FMA:$Y&559*;TXK
M;4MP0EEF;48U4C%#6DEB2RMA958R5E$F(WA!.VEW6$916&Q-2VQV,V9W:C%&
M2S%/,DMS:7A61#,K;S)D:$-S,3-*-F-4345$.%=98VTV5C1G,"M:>%9+9$4X
M.6579&)V5%HV8F-V3DPF(WA!.W=34D,P33!A3W)X:59E3'5I<51W64=N6$95
M*WA6:"\K3614+T%..5%F.$,O+TY78DPX;DAZ9%HK9&XS0DQ.6B]-6'I"<#13
M5TQ48F4F(WA!.S1T44,Q>F-.2W-#>$%/9W%F56-6*T9M8G(R<#-Y=65M:4\O
M-6AS>#9Q574W-49*<&9Z;CAW<D\X83946F-2>4-/.2]!;DIO-&DX:3 F(WA!
M.S5M;D9Q1#5(:V%$2W9#:BM*0G4X5U@T:593-"]/3%A9<'%$5&)"<EES23%N
M*W91:7-V34LP655V.7!6-4=N=%1%-&\O:5%137-V>$4F(WA!.V]J4U!Z63$V
M*W8X039M*VU7>554:S!S539404U'2W5P0U X07-5,W!7:$E(=FMO65EK,78X
M=VEE95%&-V9)<V<O=T%9-FXO=G%$+V<F(WA!.U@O-7%Y+SA!2G@X,T@O3WHW
M9V<Y6C%A92]S-%IP;TDU2EDR;$5A2U=52#153DLX=35X:F=%4V%T;4Y:24%(
M6FEC=6]A.%)#<#AU=WDF(WA!.TI*5#9W<'5X.$%*545#=C(V8VU08EEE2G=C
M174W-U$R+VY0369)+W)39CA!5$=L,C%T3'@X=F%81E!B<GE&<W0U8G)T2&--
M<#,O6D,F(WA!.TXX9%-.:5-/=58P0C K,$UH;FPK26QE,G(V8TAK9&9,*VU%
M>51M2#%0<FQU3V-K67)#2$YA.&EY,#0W;%1H;V0S,FAF2&PK26Q3:S$F(WA!
M.V)Y,DEH2$1O3VQ4:'!$1$1%='IA9T]12D1T5F@O35!E:B]E4%0S9F%&.&%F
M-&E5>C O57)H;&MN<V9,;'9X9552*W)$8WA594U/4&HF(WA!.TI5.7959'5*
M.$0T-4]-4V51*S!)3W%)-6MF27-G.'(S5C%C,V1O.3=P9S K9C$P<$8V=G)B
M97!12&MR57)15GE29V5%,W1S>"]/4TTF(WA!.V="4D(X:7IJ5F1.,#8O9%DW
M-C%H=3!I:U=72EHT,6M#>4M+2S9H9V%-2VUH>E=U66QQ*U502U-X*VUU:5=!
M:G!49TQ71VQ/46%L3U F(WA!.SAW0BME1E=Z-5,X<6Q5539.66Q9,V%734<R
M:&]S:C U=5!H,EIU0S%096=X5EHO9S-Y;C8X8S0P:3!%:U%94C!H44MP6C%C
M<T5!-#@F(WA!.W5303AQ5CDX5F-02FYL1&=%3VE71$M&5F9I=&]72D-,=U5%
M;%-44F1S5F%L.&QE5#53>E-A2%E->C U=#E7:'$S16=G35%U-'%O,D\F(WA!
M.TMP.7!L=D)B>')B,CAA=W=2245I:6I52VE+=$%Q<6]O04%/9T="5D@Y4%$O
M-S9B-WAI<G8P.40O04PV8C=X:7)V,#E$+W9P=G9'2W4F(WA!.R]4,% K*VTK
M.%EQ-SE042\W-F(W>&ER=C Y1"]!3#9B-WAI<50O561$+S-X3"]W95I0-7%B
M:2]L24U/=G9Z1B]+0D9A0S5U6EI!>#0F(WA!.U!%67 S0F\W26%G>%5.1VIB
M-W1U,D$V<5(W:VI344AE;V8T=R]).6Y89$]C;D-:83(X;%0V:UI#='9$,4U9
M22M7,D1X>C-$-4UV>30F(WA!.S=Z.#)P=D]V-4@R-D9::C93:&EZ4G9A>DM1
M-&MA<%I41%5.-FMB9%)7=5!J;G5(>5@X=4\X+TY%>F5C+WEF<TM826-R23-+
M3DAI:6LF(WA!.TQ-94U5:DE'5U!W;6ER53 K-#!2<4I$=5%D3D4X-RMA3#!8
M>G@K5T]T6$U6<G Q>DQ.8U1Y3D9$1U)+=DIL4G!E<DE!4&=1='5F8G(F(WA!
M.W1K=GI5,E U4T1*>F$V2UDQ:CE#6&ER1F@X9F1G068K2310>DTW=% U5T95
M="MO-D@O=FE8+V<X4#5Q85!Y:T5V:SAO95):6FI.2G F(WA!.T-.27ES:FMH
M4&E6,C5S1T9+3E9V:3,W-4$U:C-$-4YG=VIV4'I66E!,6&LR4VYQ85=R.%=%
M:3AG:&\V+UI95EAQ2S=(1#0U-V@X:V4F(WA!.T%/."].86YL8GE59T%84VQ!
M0D)555-I,$-J-%)48BLW6' T1$(T>#=H.&PX060U*V%V86%,-5ES-$)B,FQM
M.$5#;&ES56)"5D)9;&HF(WA!.U%!94IY43%-:'-+67DP,%-B3F]Y>7-T1T8S
M0UDT6E))<G%52F5O0D)Q35IA;5I&3$A3=T)T3TQJ*RMB361Y56DX>657=C U
M1D)(*VPF(WA!.V12,'8P1UIU5VTS2#%D;C5!0VIN:3-)0VTR1E=/*V%03$]U
M=R]O,71);3%N551&1D9A6$-287%L;T%K5&-V<DUV<4DS<7EU9&UP,4<F(WA!
M.S)+<V9':R]M335U241P*W1X4EA$1S1%-#$V,4QX=5E80F=4.3 Q27EZ.%)T
M<U%'-UEQ>4Q34$I'<%AM:7AR<75R-C596%1Z1U=A,B\F(WA!.U--9'=115HQ
M5E!74TI1,&-I;FM6<#=D<U9:9'!7;B]O-U1O3$PV>E!E96=V2#9Z9'8V<S<W
M:S%D-DQY4#!9<6U6;CET=FQG5E0Q1V8F(WA!.U-.3W1X8UAC87!%6%-)1DE7
M:U!+4F=Q:FI'<DXQ4&AT,WA627)Z>B]!4&PW6G)#6G)Y3&QC54554U%3>5-%
M=$=*5DAP<$=Z1&MJ07(F(WA!.U5B.4)V:7))<F%/=W5B84LT:6A1>'I)<VE%
M;T%E3$-O-V4K2V]45W12,$Q28DTS;6])2310:3-30G!4.$5B4VYA3E=0,DDR
M3RM+;T0F(WA!.U)03G9K-U<W;&)B5&Y75UIK5U%+,79*1U!I45-C951O<3AU
M1$%K5GA64#A!-FYA9C<T:B]!3T)8*VU+<T]F>D1+:6PS:'1L4F1Y>&HF(WA!
M.T%!*VMN3DM.9FM08S4O-6%#46%J*UIO:'5)67)#,S O54$Y1$UY>C(X4FHU
M4$=%,F1V:35,25-T3W1!3RM:34TR56DU8F8U<&%P630F(WA!.T1L=CA52DPK
M85=T3&-016UI5T)#;%92;79B4E-Z=$-:3TA(:WA"2D%#*TE03&)*:DQ0=B]!
M3FA*:G=$=2LP3VTO3E<O4S9-4V%:<'(F(WA!.W=H02]Q+UAB5E13<6PO9TIR
M4EDR-3$X4&YI37,V-2\W07)W4C=V.$%:0E<P>CAZ<C8U=D5T-VI48D=#3C%J
M4#%L6C=E4D]B9W1X*T8F(WA!.W1Z>$9A2U-D>#(K3$)03DU#=V(O04TP<D=%
M4V%0,W-G9S@P<F-C+W$T=$IV4UEP2C9A<3-&:#%6<4A9*S)9<W1B;$A-9EDS
M1%1W4$HF(WA!.VM/9WEP9E<X:VLX15!*6#1J:6=',4%C>G1*;FQK:5-82'HT
M>$4W2G Y5'10.3A2+SA#=CE->3)L,S%/,"]W0CA2+SA!07(O5$989E4F(WA!
M.S=4+V9%9CA!=TLO,'A6,S%/,"\S>$@O=TLO,'A6,S%/,"\S>$@O=TLO=T)-
M5F)7,71L64US2T)H=4-&04EX5DEF32]M6%)F3#9*8S8F(WA!.W1/8F5'85%1
M>$99-5I3>CA3.4]-4W4S,E9*-EE64U)0>E0X:'9*2$=U<59E6&@V82MH8T-V
M<2MM539X.2]75#<O631Q=E@X>E!*1%$F(WA!.T=C86PK-E5)4R]O6$$O=E!4
M-&8W<C9N,3 R.2]9,%955B].9GE#.'!I6%9#6$-2>7-"8C-/>51C0D=39E-P
M=C9Q+V9I<6TO-7=F;#(F(WA!.VE&;C%59T%S<E9T<G%O2S!"-40P<6HW438T
M<7)(.#%025ET;G54<61)15)*5V8V=F,O66MB:7 O=38W;D975S9.93)T.6)2
M6&QQ+W$F(WA!.S(Q>$=S<TUG0D%:1V]63D11-VI!<4YU<FU',71P8FUD=4U-
M0TY*2W="86EQ2VLP545N8G=X5FI59C5N95(U0W%R<4HU4$UL<W%M,W4F(WA!
M.U%F5FMD-#%7:&HW=D5W<C R>'!7531Q9TYC,3-43D5S9G(R<%-.1F)E;VM2
M9%5E4VI33497;U%-85906$952G!N;DQY+W%E;T=W<W(F(WA!.VAP2G=I>4M4
M2$EQ3W)X:55C2%I1<%!"9U-+,4@P67%N5TMP4R]L9E)856\X2EI',DML:5%F
M;T]99S!7368R=#,U:5-%+W=#5F8K55 F(WA!.RMR6D)S14$K0F5K6C5)3VXW
M2C-(:&LO>3AE."]-<V9&4&PX;#0X:65605=),#9)1FE#,49'-4%#9VYB<T9!
M>"],4C=Z.'EV:6YY*U,F(WA!.V@O>7)F>55*27!"<%5+=D-X84IL6&E14W9!
M.4\S14%5-F)$=WE89T1V4'I8>$0U2W$K469+2W%%6%1946=P4E%I9T1I04)T
M5'-":V8F(WA!.WDP93@O37(T<#AV:W$R=FMV>3%A1U$R=&ML=5IM-7I'26-/
M8FXY<'5.2VXS3T-7:V=E9&XT;$EZ4TA*4S%/6#E">'=P64M&5V-U>C@F(WA!
M.S9T=79%0VTO=FU.;FPK6$%%3W)B:DAI6'AD1TMY9FUL<6E,8T@Y1#-Z;4-9
M=VA6=%-42E)G=D]0-#DP3F$X=D1%86I)9C1O2D]/4&0F(WA!.TI$>69M-7$P
M8TU-;C9!,4IX34-A2F%62VM->3!:5$ER3#EM=30V15EF1WEF>F]).$]09$I&
M2BM:*W!T2UDO,%9E<G5W1'1A;FEE35HF(WA!.VMR6&XS-#A26#EO:DEN55I0
M-3!%*T9(=6MH-69Z8W9O6&A76%-,.51/,&%X+W=#:49J*SAJ.5)V:%9Y,S=S
M8E!T54AX>5%Z6E-,-&\F(WA!.TE/3TAD2F1&*V$K<'4Q=W P6%5%34%5:FQ:
M;6MG6C%4.3)1-4)P>C5(,G(T641N>6)E<4,K2$AU:VY8;#=Z<G%/<DQA4W9A
M>5=A6$4F(WA!.V=2<F4V:4U5>6IN>$Y6-4Y3=E5:16%U9FE#2DU4=4]42319
M.$I/-TIR:BLK8DYO-&%G:T5-8GE32D=Q4U1%3DLV9T%U44%O3$5D4T8F(WA!
M.T%'*T95=#AW869R=#E"8G@V4G%V-DID6F<Y>D])63=H;FE#:T=.5FQ"545M
M;GAD<U931F9,6#5K35IF53@U3$=0:%-)<' Y<SE1<7 F(WA!.U=1:'501FU9
M4#A.4T)81E=3-E!95#)6:$1$9'IR9#-Q<E,T=D9I4T0Q6$Q&,EEX<#A+,5II
M9FYI<4]X5EAS+W1T.'-#<3DQ8W<R='0F(WA!.TQC>G1X:&=2<$I704Q55E)5
M;6EG:S=E1TMS6E0X,&9)<G-I1%4V33AY5S9Q,$9W<$US:GE2;W4X639V0S0K
M:D=L6E9I<4$Q>EAD33 F(WA!.U-X*W9A;$DP5G0V:5)&,5(U2TY)=U9A:$%X
M<%4Y8U91;6UE8W9,*W V9V)#>75':VY#3$EP36-I;S9V1TI2=V1L0VLX1T))
M<E5F4FDF(WA!.W%D67%W4%=03VYM83%S+U8P-G=J,4<U-4%F5G5A=V9#97)C
M,TI',VAM;W@V-E)0<4E!.3%U8DQ49T195VQ,9FU2-3EI:657-3!#,V<F(WA!
M.VEI.5%Y>5!E4F5M1E)#>7E&>4)24U)1,4<S6'1L-#%6-T-8*WA,6#10;#EQ
M050X-F1C*W(K=$I9-F5I;4U-=BLU2S%O>FU8:'="2E4F(WA!.V8S64UL5%1P
M>#8U335*,WHO=T)G5U!$2'4O,E%2;B]+,TY81$MP=')%37%(-GEV,38S<D9-
M6#1P0W<U9%='.69O>5!J5#<O.6E5.$4F(WA!.V9W43-"*UHS;E<T,#DW;3 P
M3T,U;45Y<$A$2&1X8UI)5U%T-C9Y8G!X3&9#04-E+VAG;'%31%)L6"MA9FMK
M67)(3#=55&$O;4(U-&TF(WA!.W4W94]846\W93-9,'5:,FYJ8C O,V%S84M.
M,R]!2&I&9'8U83DX:DQ6,$0V9U0W:7E'0WIY*S%.-R]62G)Y,VAK=4DP9&QE
M4E8K,$LF(WA!.T-I2'-C>$TR8WII1$E$<BMH=6AJ15-A45!Q>"\W-50W,R\U
M<7I(-&@S1#=F,71T96%4>2M:=49Y,$$P4S=:4DE),6U%8D9'*T5S5T(F(WA!
M.T5L94EP4W!(6&)-9UEH5C-(-6QQ37HS1G$R.#!I-&I6>&]6.4=70TAH3$-5
M64(S-&(Q;' X4#)M.$)I8U%(5TAZ2VE:-W!,5C@R>'0F(WA!.V)#-$=H,SE#
M:VMN<&TS8U-F=3)P>#1'4W9**W%J=W@X15AZ:#AY=D@U4RM385=E;U(S54AQ
M+U5Z0CA43#9C=V1(*T5K5G!Z3WAP55HF(WA!.U1/;VUT:C@R8V0K.4@V9$MH
M,4,Q06A15FUJ,T)F8C1H-'1K.$UH>'@R-FIV4FM(<$\O4FQL>"]F3FY13W-5
M.$MU>%8R2W5X5C)+<3DF(WA!.VXY='9L9U98=7!Z8C(P<S1J96(P:UHO4VE(
M2U(K27)X445I<DAT:7)(13@W5'5G9&9,=7)Q1$E)=4UL<T9A<&PY27113S-W
M069(>2\F(WA!.VQW<7EF07%!,7I6;C!U>"MT2EDS3V](,45J3G9:;TI*84]W
M0F9J56)+3GII<44P>GI,3&9A9V)5-E)F,FM80EAJ=3=I2&A'>&%-4T8F(WA!
M.T1U5U5R>31M;W!Y1TMP,6EQ5B\T83!J+T%(,C,O0G0O6$U4.&II-VTO=T1-
M5%=4959.1&UI94=A,SE32U)3:VMB:W-R2W=O47=/>$(F(WA!.T=),%=-8FHW
M,$A02D%J.'1V239J:75J5V]&2U5%4U5P46EN5'=9+V9L;F=$=FPX>7@X42M8
M>5A39FPU-4UK.6(Q3DMT,RMS34AN-5(F(WA!.W%F55IA.%=E;RM):7!P6$@X
M=DAV4'I+*TMF3#5);3$X;2M88E-->#)L;W1V1V%%<$8X0S%!0VI:869S<4)K
M2F%3175D;C1S:&YK3U,F(WA!.W0O:')34#A!9F)F.$<S.6-(-4A&,THO3513
M;GI$6C)M;GA7-E%W.&Q9>4U1>%EM;T,Y2T5::#9Z1DA'26=$=B]!14XR0UIL
M6DQ">C4F(WA!.S!4-FY(8T1Y.7%.6D-6.44R,&=K5VQD,U@Q1%%F1#)R,4=6
M94%,-7<K6EHK264V6'E7;GIU;VQH:E!L=E4V5$)32D)B3598:T%4>G F(WA!
M.TQ694YD.7-F04AF1#5L9D4X<&9*5R]X9$AX56Y1<CA&<%!4-"]6,W%!5T,X
M>E-4-U!F-5E00DAF1#5L4&EE579K<'8U>E9B9'!V.$$F(WA!.T0R<$5+2RMM
M3&1I-4EK-%5#*W)7=C=8*W)V:#A!9#A0;55E2C53*U,V6'IJ2$A)<V8V03%&
M>7=C9W)B=58K0G!&;U0V;$%7.4]Q*WHF(WA!.TPT-$)H2&9$-6Q0:655=FMM
M,VQ(6')85U9S8BM#>F4S:6QN54ES-$MY9D1*>$IO2&-D4FA%3T1+26UU63<P
M1UA&06YD;FQX+V9.;3@F(WA!.V1E<#169&ER<U9D:7)S5E8W4#=B9DQ!<79D
M5&TS='!:>$<X,W!)>BML14]5:CA26&EG2D974&)&5TQR*UE%:&Q21SAS-C1Q
M=DUK06,F(WA!.S)I:T%U.&E&,G!)85)R-F13,V=W.&-66EII<4$Q>E9N,'5X
M*W1*63-/;T@Q16I.=EIO2DIA3W="9FI58DM.>FEQ13!Z>DQ,9F%G8E4F(WA!
M.S929C)K6$)8:G4W:4AH1WAA35-&1'5757)Y-&UO<'E'2W Q:7)S5F1I<G-6
M9&ER<U9D:7)(=DYS:6],56U*6E0K.&]'3$0K6"M5<FTF(WA!.W0W44E(1%DW
M+W="1&QA66,S;EDX>65B:C91+W=F179.4UI'3BMH0TY59T-G8C1T9T0Y3UDO
M1&@O;D0U4R]7,C-K-W9T0V<O;G$X1G@F(WA!.T9B2F]T:3EX=CEB9R]356%Y
M=T)557574FU"4$9I>3=F>3$V2$I$0D-R+S-S=C%O.%-8-$E5,C@O,V%#4G!D
M1S Y47-F3T=M<5)%4%8F(WA!.U$T<5=D3TDT<W!R42]A2&)$*UAH*TEY+U=J
M>$IF9VAB2BM9>G@S>G=Y85):43)Q<S9,4$YQ545B16]/.%IL<5!I;T\O5W1A
M9%0K5VHF(WA!.UAN+U9L*W1F1DXO=$-9,C-M6%<W:4I*;V9,<T5S16E"-#5O
M-S%74G%L:%)31TE/=UAF,WEU54U13D4O6DPY8DE3;68W46Y8;&)5<BLF(WA!
M.S=L='!.4C!I4%1,:WIO0D-*:D]13U%O,TI7-#5'4$%-:U)':G5/+SEA5'A'
M2G9B-4TU=5 W-7,S:G(Q4$-R<U9D:7)S5F1I<79:+V(F(WA!.V(U6493=GI8
M-6YM,%)B35<Q=$)D>C-5=G!E:E!E=U=204MK<58Y8BLX3$U/259D.%99-5HO
M;6QQ17-C:C-7:U=D<G=A04M$<DYJ2E8F(WA!.UI!4%9C*VU31E=.<$DK=C)G
M-FYB1%-S<CAR-C=*<E=L<F1Z=WA7=#!(:VIN=%EB;4LX15I2,E%6;&@K1W T
M,7 R-EE&4G5P,WHR5F\F(WA!.V)H3%=7.%E01VYO5S1$3V958TE7;U-.;$1C
M:C=$1E5P,$QZ6E!Q;#,Y6&PP4%5T3U5O:D-E-VA#4FQM:D1S;%%X24LQ-#%)
M<%59<7DF(WA!.T1&5T=F-'4Q6'=I+S1%+S%Z6B]L265B<2]W0350>5-N569Z
M03@U=UA$>#)7:7!E4DMP6EHO5VII5FIX0E911UET56UO3E)193ED<7 F(WA!
M.V%903=!;C1T<V134TYY0CA#:S!N-3 K64DU8GE..5!S03EQ>DM!9%)T45-&
M3$Q6=U=R2#A15F0K-UI8-&-E-R]!1U%B9D5L,R]W0W@F(WA!.TLV,2]/8EA*
M8C9/1U=Y<TEB3V%:;V]R=U@Y<S1:5B]A5D%W3&)L9FA(:FE-8V(U9C=)24]3
M5F,O.6E59D@K62]N=#%L66%"1CA#2UDF(WA!.R]W1%-O:GIF9U,V8F1#<V<T
M5E!Z>68U9BMJ.7)%-FHK:U!K539T=D]/=5!B>%!01D9$37E+6EE2.%E2:4MS
M=DE%8W%(8757:E-2<' F(WA!.T]S;F923V1+85!83%IP3E%J5C)H8W)(>$Q,
M445!;F]C=TY:<$U:24)&=61P3E1-9VQ'+S1D,&(O04I:+RM(9B]!2G%Z0R]*
M674W-U,F(WA!.S5F:GHW,$=F279L07IV8TA38F,S16Y,;DYX*TYU66\Q5W)5
M.&@Q>7HX=D-Q,RM:+U=X.%4O9T)4:R],>GE02TM3-DIA3TM!56%-2%DF(WA!
M.T)603,Y:U5F45!$15E)*V9Z4#8P94EF3#5",&XU96532EA-:VUI,G)Y1B]5
M3'1'0U,U+V%Q92]V:4U%9E U;CEA*TEF3#5"1U%E5F8F(WA!.TPY=D-K1G9:
M<D1$1T]-8U5:6E9594%514%:03941U1:2#)L:TTX:#%6;W1",&U+4DI%9V\V
M14UP-75A14=O-FY'3VMX9S)".39N4$TF(WA!.VER8G50-S5S>5=P5'=Q-T98
M67$W1EA9<7(R9C(R*U="54AR.6AO<%0Y2E@K;69P3U,S0W%K4W=I-6LK,D-#
M:UIQ2W%45W958C1Q>&DF(WA!.S1V.$%Y;F%7075O+TDY-TU:5$I(.5AI,&Q7
M;#0X45!I56HT56-20E%$-$-O030T5EI2-6%S3DYG<T9U-TQ4,C!X=%%!=4HW
M4C$T3VHF(WA!.WE69&Q:2VM+47IT541V9U98,7)66DY-<WIC4C)&>G%$9D93
M0S!26&LK1TYN,T1-=EAH>$AU4FEQ6&%&-7-N,5<W3G9,;V5P86-N0E<F(WA!
M.U<T=DE1:UI:;W<U5%II459R>#-&2SDX5EI":7%79C1:,%0O;&TO-&54+VUR
M3"]Z32LY>"]Y=5!U9"]H;E)0.$%L;2\T950O;7)(.'HF(WA!.U!V6#AR:C=K
M=FLO3&IY3$HV<&LP4S%9>G-(;4I49#)"-59F9C1J53DX9V-P.'9K1W=9;VIV
M*UIB+W=#5F0K4U%52S908G%9,C5O5E4F(WA!.W%68FM(<4-#3W)+0V9(2'A:
M9F="9D-J-2]-;S)0>7)O16-A>'@R9U-.04921EIW04)S04%',D=41V]N,W-$
M<&](<#DV-R]$3VEF.$$F(WA!.TQ.+W<X;B].5U U;69E:CAR:C=K2'%K;S!.
M25DY4&I616Y,=$E'-4YU=D5$<69F3F1R.5A/3D]B<&1.0VE'37<K9E!/5%-Z
M3$QO,&,F(WA!.V%*5#!P0E!'=VMQ5W)18D5505=T934Y<6Y'3W,O<$0O045P
M8G9!.'9T56)B.'=F3S Y<DA)9$1J9W5'6C%L:&MM6#1!=DE+,TMN>#@F(WA!
M.VEO-F1J6$I(5E5F<4AY+V%G66(V9F%G0BMB,VU$-&=B1W<Y5&E"2$8Y9G0K
M5%1E;5=E2'(Y<%=O4&MA*S)794Q0=CA!.6E74$%/-S<F(WA!.U%I+RM6:RMC
M2G):<FI4.4AT-S90<$=9<G5+:D5C07=Q9&AX2F8O9V9F87,V:V<P6E8O;6QK
M358X:#EQ*V8X=V905514<W5G>'EW>'(F(WA!.U=,:&-2.#-)-#$K13E/<'!V
M,BM723%D+WA$+U-L5&@X=G14=E-03E=U6%8T<TXS8E(R-G1-:V$X5S4X,%EG
M1G1Q8V1Y9'-H2%=336\F(WA!.V=%1R]*:V-!;VQK9'@O9DYM,&-.5'=Q-T98
M67$W1EA9<7(R9C(R*U="5C)O,W=S8D]3-DU%,7E)-F9U8EI$3$MA:T0T54A7
M;&%N1E4F(WA!.VUK.#9+;6YM.$=I874T0DDK<G):=#9X1F%"=4)),D\O=4MB
M,'%+<7-G:F-V1W)L1$=704I2<6-L<4]H;U-+:C)/2V],5W16:S!Y>DXF(WA!
M.WA(65A/;TXX5DE,4D9E5#19,F9C37DY94A%935'2W!D;UAM>6968G,R.'5H
M-FQP>6-&6F)I.&A#4FQM:D1L3FU*0E=V2&-5<C-X5FLF(WA!.T=+=7A6,DMU
M>%8R2W5X5C)+<V8X,E-);C%8;$=S;&95<'DU8F9:+VQ+-7)E,$-"=S=8>B]!
M14]8<%)Z63DV.%@O3$Y(.3AN+T%$6&TF(WA!.W0T>#-$-V8Q=59W;G9D-CA8
M+TQ.2#DX;B].95!'3S1F8BMT944Y-T<W83<X=G102T8X<4Y&3$,S27EV845C
M;6M*0DM0>E!):U)Q5TXF(WA!.V9#=2MW>7I+6#@V4"MM4#8R9T%D>"M15%!1
M9%0P-C=S1$QA85=,1TPQ2D9A,VM2;VU$:&IZ2E9823-A=2M5-7939#90>% V
M,GI(=4XF(WA!.W)(>51(,31V*U=A4#<U4"MA.'$T>#-$-V8Q<RM%.39),#9A
M339H86=7.&%K>7!19WE62'A$>&),34UH>'@R2$UD+S8R1U%(:$\O4FPF(WA!
M.V1X+V9.;E%/=%4X2W5X5C)+=7A6,DMQ.6XY='9L9U9B<D=Q2%1,13-1<S=M
M*TED149V6GAI5U4K;S14;'A*56-6<E9J6%E9<6Q59FXF(WA!.TIN6&MD0C%D
M45=I56-R658O96M#=$$Y84HK,S1F9&EQ9#)&,SEC<V],<C!:8F8Q,%=4,$QH
M945Q8VA8:DET5'A99'AI<7DO=FUT1FDF(WA!.UE7<SDP2DA+34QD5EEO06I0
M>EE&;"M(-&%B5DY30E1&57(P6'I7*W%8;C%C-DIQ9&A'558Q=4PR,T556DQ)
M2D]'>G-W2VAQ1V\K,54F(WA!.V1C5E1Y4FES8DU/;T))*V=9:%=$+W=#33E9
M.$EV*T)0.6-Y+T%I,F-)9"]J4%=00TPO9U0O6$AW27)W:#,K33E9.$EV*T)0
M.6-F06DF(WA!.W9#1G,S;FI726]N:S1)+T)3,T)%2EDP1F%+3U<U>$]'2SA)
M4V8O;&)/=&-69CE$,VY!;WIK+U9T=U9R.%!(,4]65'@R<#=E3U$X3U F(WA!
M.V-554<Q+TYN5GI(8E K:6)W9E=4>#1M,%E.2%)L6#DT3V9W:C1Q+TE(2'<T
M.7A79VA:=GI*=3E384%83VE8;39C,4PR>F]%-5-#36@F(WA!.VE*0G8K,50K
M6$MS;6QX-4LT9U=C2FU02E%4>G)Y=%1C3F].,4=/1'E#3F]8.5%H0414:4I4
M4FTU9D-$-%I6+THK1"MA9G1:94Y*<'8F(WA!.T]Z<7I$+T0Y,GEJ;5%Y=W5A
M:$=#;B]D,60V,5AX1U X;C1F-7 K,69':VY),4E%02]666A8<V95+W=#83AN
M+TIM1'4K,'-V1FPS="\F(WA!.W!%9CAS,%@S>68X04YE4#AM64\W-U-V:7DW
M,V9P168X<S!8,WEF.$%.95 X;5E/-S=3=FEY-S!4<&0K1S%/,%@V=D5V2V%-
M5DAQ5D8F(WA!.UA(:35X+VLW1$AC1&-E6E),2DEJ;7I3-"]V;7=/37 T5F1I
M<G-69&ER<U96-U W8F9,07%I,G0R-G-636(Q0G R-V94:7)8-F1T+SDF(WA!
M.SEV.$%H+UA&6&9P,C,O,S(O=T-(.6-69"MN8F8O9F(O04EF,7A6,S9D="\Y
M.78X06@O6$961S@X>F%F8E=C.7IC<397,$5B>5104W0F(WA!.T524WI':3%0
M461S5F5F4"MA4#5+>&U66DHU23)H67AY;SA.-G)+=W)65U5Q0T0X2GEZ>%ID
M-TQI2TEU+WI#+TM',6E%:VIU47A+;T4F(WA!.U<U8FMY<$<U554R*WIC2C%0
M9C).2'A:9#8X4E=79C5J+VLW9&]8:&QB:7!K<GE7-4<P56)4360K,W!O5R]$
M<G1J-'-U.65)<5HO33<F(WA!.SAM07=";69I95@W=W!D0F%Q;V5L4T\V-VIT
M:C0P=3EE27%R+T%*:2]L0DA!,#AR>4I':$%*360R5#A8<4944E%D;45$;C9.
M.&9&;#,F(WA!.W)X1C!(-6EF;$102&1Y>$Y+,$9I9VMU6G94=2M)1%!W;TYQ
M:SAU=R]R:C0P=3EE26]:+WI5+TID241+,&MO;W!F:#9D,U@T5S1L83 F(WA!
M.S0Q1&)D9G=X.%=8979%5UE142M62C1)-31R3C)I;%501S-/4596:%5':&%V
M5$0T<W4Y2$565#9L-5DO-5E8+S5'4#A!.#$T*TQ,=E@F(WA!.VE,=G%8;&HO
M04I96"]W0U)J+SA!3F50:7DW,31I-S9L-5DO-5E8+S5'4#A!.#$T*TQ,=EAI
M3'9Q6&QJ+T%*65@O=T-2:B\X04YE4&DF(WA!.WDW,31I<3)L<#5D5S9H84MZ
M6EI1-FU.:3=M:D%I:#-B>'=(3$DY5C1I;71X+V9.;&%&4$-R<U9D:7)S5F1I
M<79:+V)B-5E&46PU<5@F(WA!.VQA>G5V<3$W95=6=F1&9E4Y0V%72DI/2G%E
M6$9I1%0T1S,Y:FEQ2"]!35)E4F8X07$V-F(Y;FXO04PP=V99-$-4;#ER<'=)
M879H=FDF(WA!.W)T4#$O=T%N-FIQ03 K=W5)8G4T84UZ25E636M4;W T<U5M
M54=*=4I.0T$Q4C-X5D@S>F%(65%F5TPU-V4Q9W%&.5=:;&I8:V5G<7@F(WA!
M.T%Q8U953%154$LY-61T6C)T>F%4,V%)2DAT-#-2<$92:%5&:T(U0W9V:7%0
M*V\R9BLK52LT67%X1%903W5N5T9L2F1F;U=A-SE0:BLF(WA!.S1T44I*5S5-
M1BM&84-T2S%0=&U83%-%0S<K>'<T87-%,59F1DMH*V%M;4=+,FM0;&)5,2MS
M>4Y%56$S06%-<59(2U%D;&)N<U)8;V8F(WA!.T1)94(W+VLR94]03#5R;U!Z
M4C R5S%L=40U6#%+27AG:U%344%34'@T;6E+2S%*-6)B.6IJ-$AV*U-N3U!,
M-7%0+TLR=$TK=%$R-3@F(WA!.W V;T1.>$MU8F1E24150DQB,4A'=GAB8EE0
M0CDO=T%K*TU+-F9.168X<DTP,'1':#AS86A354U35$%+3'AA4F%.-&-V4W%0
M6FPX8U F(WA!.V=(>BM34'I!.'9M,6]V-6<V4&4S:&A4>7)E865W:%5E=F-W
M2D-H4U!D22MA.'9S*V]A3#(S=W@P-4IR8V9"13E304PR4'A:;&\X.6HF(WA!
M.W%51'EI,%=,9S-':&]A-U8X0FM-,DQG3DTX3UAJ1C!J+W%.;B]V;%!U1U5T
M>G9Q3FXO=FQ0=4=+=2MO,F8K*U4K-%EQ-S9J6B]W0RLF(WA!.U4K-%EQ-S9J
M6B\W-50W:&ER83)6;W)";&E53415141O4FEQ2'50-S5S5E4X2W5X5C)+=7A6
M,DMQ.6XY='9L9U91,5A49DQ40U<X,6$F(WA!.S%S:4=667!R;39J:4Y5<596
M1V519%!J24%0:C<T<6Q(;R]L9$)*2VY$431P27%*3W1,4E=89VIQ<75/,T9&
M8T%(<T0W-'%Y2WAS3$,F(WA!.WAT>$)9,CA6<F(Q3$-+0D9J4W)'<%!&44)5
M;D963%95,&0W9%8Q6F)D<EE/<DE,;TE5.5)F:55J,4YU47!567%G3DUU4$IK
M;7%3=V$F(WA!.UDR;G1Q8TE$>7!B*VHV>6AK041(:#A8,DM$-5EQ;F5+=D]*
M,C!Y1T8U<#)A2T=.4S!K:G5I<7%J8VMK:6='56IT,&Y942LQ9V5Y05 F(WA!
M.S1M2W<K569Y>6=#>556;G1G:4Y/,3%2:#962%AL4FQ!249$,#9E,E%(85 K
M,6XW5S0V32]Z+W-$<'9,=C584S@W6C-2:4=30V%,-C0F(WA!.U,S2D]24D<K
M4&Q8-U(X8U X;U@O04I-+TUO+TIN*V8Y9U5X-6(O2V599V@T-5,W*VA56'I0
M5U-8;5%P4'%(-#(U3E1V:64P4#EQ4'HF(WA!.TLO;$0O<6XR0E9F4F9Y='5"
M3$TX:U1I-6Q+4T]B,W),4C9O2W8X3&-:5RM%94]%.6]M+S=O+V%G85 X03)Z
M-T%Y3WAJ,%I):$9A>5 F(WA!.TEG2$IA4W))94I*<'9U86)51T@K5VI(*T0W
M5T(W2T5J.5-E5UAM2%1T1# O;DQ267!P:6]A5U)52$MI9TM#4C%B;'--<7ED
M<&Y*4D4F(WA!.U<W1F]2:G-C5&%F;68U9F1G<7I11FU(2E8K<U(Q24QC2VHO
M6B]$.#ES9V183"M95WIW0B]/0V]N-6DV3S5!4F]72D-S07,V16M/84DF(WA!
M.V1V-74S:F<O3WDO;4@X9D)0-6-F>F=P4R]M:#5E:35E<&-7-F-&3'-$8W@Q
M0VAU0DY004YT.#A),6-J+T%!2#AF0DAG1"MC1WHK6B\F(WA!.VPU5%$S1G-#
M1D1M='I&.6MR>D1F3&@X6'DS=V9N2F9Z1"M09VYW0B]/0S0O;5AO439Y=V9T
M9CA!2'A(*W<S1G8K0EDP4'9J*V-L+TTF(WA!.U T*T,K05 U=U9D3B]-3%)D
M4G8T<DLQ;&=M;FQ+14I(8U)U=U8V569I=3E+3EA*4C%C<D%-0TQ.24]%5GI4
M=30O=FUZ3F-D5'=Q-T8F(WA!.UA9<3=&6%EQ<C)F,C(K5T)54DY"0E!'67 T
M,6QJ3D-58T)L2D)Q3FHT159X5DPU4$LO;&U6;F%84TQ*,FM*85%T8GA%<U="
M1$9Q<G4F(WA!.U-(25!Z3TMP;4%!2T1P:7%Y84-#6E%K,&%Y2T-'0W5!=W%.
M=V%(=4U643EV;RMK5S@S<C(Y:F)W>C%R-G-C4TLY95!$-U%!4#)25#4F(WA!
M.UEQ:3A6679*-5DP-E)':FML9#0R1D=2:U5G9SEI0V,Q=S=/03533&Q(5DAU
M478X06=0>3-742MH2%=8*SDO8U)F1G1X*TQX,C)Y9C4F(WA!.TTO>C5-9DA(
M.#!.9C1".',K<S O,650,3-B;3AV;U)C>7="5W!B<E=J15DO:WHO4&MV:FHK
M849L<BM89FQA,6A-3G9B2DA%>BMO>4,F(WA!.T=/:%E';TIR-&1V1'1H;'!*
M13):;$%Z069W:'-E469+=GAX:3-H*TIV5FM4,$ED,V(Y<VEN53 V-"]K>B]0
M:VYX>"].0TMT+TMU:U(F(WA!.U)J-G,U4TYG0U!44D%#3S,R8VA,45AZ:U5J
M53%Y0W!C95=.3'5,9$E*,DUQ235K061%66-I04%A2'<T-4EA1VA1:U5(55AZ
M0T0O=TPF(WA!.S5::B]!2&AH:E1H>5!0,$EH5&ME8FUV=7=Q8V9Y6B]N>5AX
M>"].0RM0>5@U95%Q:V%)<&I!2W%S55$T:F]T04]N5&)(.&MF-7A8>"\F(WA!
M.TE+9BM"4$Q$>49Z0D4P:3!6;3E#27-+14]!5#@O:2](1"M44#@K4RM/4#5O
M5U X06PU-5-A4D]D<D-85D=21DU%6#DS>%9#05!$:48F(WA!.U@U8EDO;$IF
M>C5,-'<O;6AD2BM8=FQA4E-K;')%-DAL5E=T-%-0:EE/,GA(9&=#9F9(.&UF
M-3AL.&-F>E%I3D\X;&589%!V64QY,6<F(WA!.U-+84%R=V1)66M92W10:$1,
M=4)244U),&AS17E*,U%C=W)K1U%/,$QU5W%W<C=$*W5::E%P>5!A>&]8:V-O
M9S9S,4%".4I/2W)Q464F(WA!.TQF8U V-'$V:TAI,S-$*W5+=7!"-'0Y=R]R
M:7)Q465,9F-0-C1Q<E=V<#AZ>$IR5'941E54:7)S5F1I<G-69&ER<U91;C%.
M+S5H:7(F(WA!.W9Q8B]!37=X5C,Q3B]W0UE9<3 Q:7I+5DI"0D9#3BMH>%9I
M4"]+;5!)2'%'4395;DEO:U(O9EA.0VM954E+97!48F=U*T<Q5C5F>6PF(WA!
M.SAK>6]Q4S9C<V=694,X-7)H:48T.&5P978R9'-B5EEV-5%E4T521FHP.$HV
M5SA43%!C5E5J:%%I<FYC96EN6'=X=%8P2#53*U0T=$@F(WA!.T=K1S!A4WDY
M3#!N4G U+VI":U-::3-&,4A)>5)+,5)4=T<R,DYQ:&TO2E1Y2'AP1%E',V)K
M:F,T-34V+T%Y4%-J3WDO1C93,3)R.4\F(WA!.RM.<7)39FLY-45K;D4W-E=P
M;41M55-E=&-!:'EZ3U1T2B]--5 K,$UB5EEV-4TK46A08GHO;S)S=')W1G4W
M6$XP,T52;FMG,VQ/>6XF(WA!.V]-8E96+S561C5(1FU,26%99W11>G5)4DQ0
M>#5396QZ4#(O,G9Q,&8S935Q3%9D1BM5=FMM25-"9$]5<$Q%<TUK8GI81&]9
M,$U:56,F(WA!.TAD;"\T.30Y-E902$1A;V1F>5@X9W%94W5M54YU45EI3&TV
M,DMK<W8K-V0V16UL8V)6969Y9#AI3DUK># R<W-A0TY(3GAC:VA183 F(WA!
M.R]V4'AX=%5Y.'8X035F95A03#!S:W5J,F=T<$I%151N,5IP2V](3#!P23=G
M9D5X3T)5-RMP=CA!>D1&6&95,R]!2FAI<G9Q8B]W07<F(WA!.WA65F=G84YI
M4U%A:6TR2W$R2W5X5C)+<U!V=% P6G(R-&%454-K:E-U6%0P;5!%;&I55CES
M;4\Q<V-04V5M,U@Y5%%E>EI33CDV23 F(WA!.VDP,'5'85HW9E5#-RMI-$HY
M3FPT:6TW5E!H9U!A34TS<$-9844T:GA&:E9H95)0<'1U9% O35AL1#9G14PS
M8U5C:W%Y96A+94TS3F\F(WA!.S5E2E W,FMV6F5T2UE'-4U"9%AG<S%)+TU+
M,%=M,&QW,$9N475)-75F2&LY079)8W=.-D-/;%-/4GA62F]R=6-855!P9FUF
M1D=406XF(WA!.TY*<F%+:WIN;E-D1$Y*>$--,WA55&%I.6%9;U1M+W5:,3%A
M15,K9EE,659J2#%666)C0C9S+W=C:358:S=C86)C<4DQ3FDR2V]85&(F(WA!
M.WAY;TQF;5!$9"]U<F<S1&E',E53:U5P3$0X4E5#2'8V9%909F5U2U9&,'5R
M:5A4-6]F>DI34#!K270R.4M%3$HV:T-+:7EG>4-.-4\F(WA!.U(Y44(Q-4=U
M,VII<DMT0S%Z4TEO,U-B>DY:-FU:<%0Y6$EL9U5R57%H:EAI-T9V,VID>E56
M<#191E)2.#8K5&=G:T]U-F8V6E@Q4%4F(WA!.RMT43A/2$QH>4QC<54U9D0X
M.%945S)U8F$V9U,T='!5;G0U4GEJ;6I93VI!.3%:86=J1E50<2MQ5RML86).
M<49W<G9$04%85TEC;DXF(WA!.U=#+T-T4EAR:7%22#AZ4$HO;TY)=#0P:G!+
M8EHT56EK6FA/3FI'4T8T5D)06&QX.399859A4'I3.&QC,5(W,3!C;S!J03(X
M-4,X0S8F(WA!.W-P6E5:95%-3#E$*WIT,G=5<6-A1C5L,%18;TI*.4IU9G)-
M55A!3W=2,' V:V%Y<#ET5C9O-% Y=4MP:DI,1D=&36IQ9UIG:6QI0E8F(WA!
M.VU.04)8=6-663-R3W)E96)A859.33!+2RMI4C9X4VTU:FHU>&E.>G@T<W<T
M<UA65D1F-5A48F165#!4>E U<'5P;$=Q95@T.4]T*V(F(WA!.R]72GAQ1G9/
M245J16Y)=44V;%=206%D3V8K4V-66E5R2WEH;$E+:U9"1S1)3TMU>%8R2W5X
M5C)+=7A6,DMU>%9H.3EQ55-8,7=H,&<F(WA!.U-L6EA":W$O>%59+T8P-S1F
M>4]+5S4V=#1N2W5A23!7+U-7-&Q69$M%2D5,=%5C:GEP5#1.>"LQ9R]+63AE
M.&5B1V-I4G55;F96-T<F(WA!.U<Q4G15.&<S4')M:3-%2S)C5C!O:CE#46=O
M>7)6-DM$2'A+<G4S2'9U5W!6+U-8;#,V<D=X.&HS=D5+;VEH1VU1:W)'27!F
M5$9#448F(WA!.V]I;$]0-TIC3#-/2W!:*VPY02MS5S1N+T%#,G5J>71G65I9
M.4UJ:TUC2E8V=W96131-17%05$)/-7 S>%9.<FI5=$9J,5-*62]*3C$F(WA!
M.TTU35E&-$Q#3F5*4'%!2&UW1D92961D-FIK0E0T<U953DXQ8E(R14)I.&A8
M9&]05'5$6F<V9D1'55913V%0,$545&1H56AS5F%F5G0F(WA!.TI72T]4+T%L
M>E%N,4QU33)#;#%E3T9*1DU15D=%:$=Y06MR=4YU;4MS;W-F3#-L>5,Q:6XO
M46QR8E!/175(:&$R:%8P:TE6=FIO=C(F(WA!.S%+:F9X1T)842M49DM53G,Y
M=$AO,6M,95$Q94DR.&)+9FI-;T9#<#)6,DQ+3V<W67%M;'9B,CET0W-&=D5K
M34MF66EJ54MO<6$W2TLF(WA!.T%9<7!A<%DO6#E0=4Q,-GA0869714UF,6TQ
M9C U-"M7,TM.-DAI=S=';4MS6#%(.'-R0R\Y8W9R5W)X3F-2=$1+.%9Y<755
M9%E%6E,F(WA!.WAJ3$YY5S%7=DEM=%<X8V)65S!B.'4W3%-T6515,#%F5DQR
M,'!:-30W2S9U1FMT;&MU45$U15E2854U1VTO9D975C1Q9S5.2G1:9%8F(WA!
M.VDQ2U%U.#A%6FIH:EIY66M*2G))<UHK15-52EAM3BM/,U1&5T8K6E!,53DY
M<D9X2V9+<5AT=3AI:#=N-CA595I*9E-74C%4;D=):6<F(WA!.VE5.38X9'%(
M<593,GHX;71*1D-T-S5%161%4S)9<'%X6FQT>4)'96I,>31X>E-C=6Q3=3,W
M2D-R,4-/3DDT,6I155)!1E5E04=W=TLF(WA!.W5X5C)+=7A6,DMV+S)1/3T\
M+WAM<$=);6<Z:6UA9V4^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO>&UP.E1H=6UB;F%I;',^
M"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z8F-C-39A8C<M
M,38R,"UF-S0R+3@W8F(M9F$P9C%D8C(P-3AF/"]X;7!-33I);G-T86YC94E$
M/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX;7 N9&ED.F)C8S4V86(W
M+3$V,C M9C<T,BTX-V)B+69A,&8Q9&(R,#4X9CPO>&UP34TZ1&]C=6UE;G1)
M1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C5$
M,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X/"]X;7!-33I/<FEG:6YA
M;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I296YD:71I;VY#;&%S<SYD
M969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S<SX*(" @(" @(" @/'AM<$U-
M.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#IC9F(S86,X8RUC-S5E
M+3$V-# M8F%D-2UF9#5D934Y,C Y9#4\+W-T4F5F.FEN<W1A;F-E240^"B @
M(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z8V9B,V%C.&,M
M8S<U92TQ-C0P+6)A9#4M9F0U9&4U.3(P.60U/"]S=%)E9CID;V-U;65N=$E$
M/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z
M-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+W-T4F5F.F]R:6=I
M;F%L1&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.G)E;F1I=&EO;D-L
M87-S/F1E9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \
M+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*
M(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-#@Q938R83 M,39B
M92UB9#1D+3@T.38M865E.3<W8S)B9C5D/"]S=$5V=#II;G-T86YC94E$/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 Y+3(R5# S.C R
M.C R*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#0R R,#$U("A7
M:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @
M(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z8F-C-39A8C<M,38R,"UF-S0R
M+3@W8F(M9F$P9C%D8C(P-3AF/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 Y+3(R5# S.C R.C4T*S U
M.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F
M='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#0R R,#$U("A7:6YD;W=S
M*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X
M;7!-33I(:7-T;W)Y/@H@(" @(" @(" \:6QL=7-T<F%T;W(Z4W1A<G1U<%!R
M;V9I;&4^4')I;G0\+VEL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE/@H@(" @
M(" @(" \>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^1F%L<V4\+WAM<%10
M9SI(87-6:7-I8FQE3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.DAA<U9I
M<VEB;&54<F%N<W!A<F5N8WD^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE5')A
M;G-P87)E;F-Y/@H@(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z
M3E!A9V5S/@H@(" @(" @(" \>&UP5%!G.DUA>%!A9V53:7IE(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T1&EM.G<^-C$R+C P
M,# P,#PO<W1$:6TZ=SX*(" @(" @(" @(" @/'-T1&EM.F@^-SDR+C P,# P
M,#PO<W1$:6TZ:#X*(" @(" @(" @(" @/'-T1&EM.G5N:70^4&]I;G1S/"]S
M=$1I;3IU;FET/@H@(" @(" @(" \+WAM<%109SI-87A086=E4VEZ93X*(" @
M(" @(" @/'AM<%109SI&;VYT<SX*(" @(" @(" @(" @/')D9CI"86<^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$YA;64^2&5L=F5T:6-A
M/"]S=$9N=#IF;VYT3F%M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O
M;G1&86UI;'D^2&5L=F5T:6-A/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z9F]N=$9A8V4^365D:75M/"]S=$9N=#IF;VYT
M1F%C93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G14>7!E/E1Y<&4@
M,3PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV
M97)S:6]N4W1R:6YG/C P,2XP,# \+W-T1FYT.G9E<G-I;VY3=')I;F<^"B @
M(" @(" @(" @(" @(" @(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T1FYT
M.F-O;7!O<VET93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&:6QE
M3F%M93Y(5E]?7U]?7RY01D([($A67U]?7U]?+E!&33PO<W1&;G0Z9F]N=$9I
M;&5.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IF;VYT3F%M93Y(96QV971I8V$M0F]L9#PO<W1&
M;G0Z9F]N=$YA;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%M
M:6QY/DAE;'9E=&EC83PO<W1&;G0Z9F]N=$9A;6EL>3X*(" @(" @(" @(" @
M(" @(" @/'-T1FYT.F9O;G1&86-E/D)O;&0\+W-T1FYT.F9O;G1&86-E/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=%1Y<&4^5'EP92 Q/"]S=$9N
M=#IF;VYT5'EP93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3
M=')I;F<^,# Q+C P,#PO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S
M:71E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/DA6
M0E]?7U]?+E!&0CL@2%9"7U]?7U\N4$9-/"]S=$9N=#IF;VYT1FEL94YA;64^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI"
M86<^"B @(" @(" @(#PO>&UP5%!G.D9O;G1S/@H@(" @(" @(" \>&UP5%!G
M.E!L871E3F%M97,^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @
M(" @(" \<F1F.FQI/D-Y86X\+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:3Y-86=E;G1A/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^
M665L;&]W/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0FQA8VL\
M+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM
M<%109SI0;&%T94YA;65S/@H@(" @(" @(" \>&UP5%!G.E-W871C:$=R;W5P
M<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \>&UP1SIG<F]U<$YA;64^1&5F875L="!3=V%T8V@@1W)O=7 \+WAM<$<Z
M9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<%1Y<&4^
M,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G.E-W871C
M:$=R;W5P<SX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!9&]B92!01$8@;&EB
M<F%R>2 Q,"XP,3PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$97-C<FEP
M=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@"M (I P$1
M  (1 0,1 ?_$ !\  0 " @,! 0$!           &!P4( P0) @$*"__$ &$0
M  (" @(  0<%"0P$"0H""P0% P8! @ '"!$2$Q07E=0)%1885B%455>4EM'2
MTQDB-%-8<Y*3E[/5US$W474C-4%TD::TMM8D)28R.#EQ>+6W-F%R,T1%4G:C
ML;+%@?_$ !P! 0 " P$! 0             !! (#!08'"/_$ &$1  (! P$#
M! P)" ,-!P,"!P$" P $$1(%$R$&,4%1%!46(E5AD92AT=/P%U-4<8&3E=+A
M!R,R4E:2L<$DU/$8,S0V0G)S=*.ELK.T)28U0V35Y3=BM8*%HL)$Q ACI/_:
M  P# 0 "$0,1 #\ \H/E,_\ WB7CC_\ FM[X_P#N58^*5J11 06EWIJQG%I.
MM8VJO L()-]XXY@2VX8Y<6\D>\<D>D@\DFFV^DFF^FN<[:[ZYQC;"E>[GB>Z
M-^39L/:_B-Z\I8!-%8>$XKQ86VW9\/"^[)P'U&Z][7ZHZXZBZQ:F=_WB^@6;
MLL,UQV#):NP:$$BJ!:O9(P6IGWJVPFJE8HKY*/HX.1?N/=^[;&0)7KXQJU21
M:]?;6KQF:53J.J]A W#PDZ:!G9TI9;E^>F*T:+.PS]Q$\D:TPNSY:5M*I4B[
MR^2OZ597SL&TT&T.NM.I:^'V< [;3%I6=(ZNN-&&\/@]206EN2R:R1&VE3V5
M<;NW4;6,@TL*N,"ZV5JD5GD0J537?G@4Z%Z4Z>\7DXG7_B(QV5U8IZM<=?D]
MG6"@"FB5HSO6_P#6#[M$:MT$HLQIUGV E0UQTF*NM:K<JG1T%O675M0G*KF^
M4KQ1XI6Z:K_W==]_^=/J3_[&]U\4K2SBE?T(6'P[^ *\B^&7PR J*_4>_NX>
MFO!W:TMEZT%[,ANH5HO?AFQV#V?KV;9[_?'73]BSV->V-;7TZM4:D+WR5RR^
M;I2Q-(Y@BE*K^N?)?=!+\].UCN#MCLSKWL7M:U^'6AFJ"8::,#0K?V;U%KVS
MV GM89@<CX9HJ)4N.LZNAA#E:PW5VBU>Z2R*CT[=2EDZ8\-7AKK/C=IN.G.N
M.Z'?2G3G0_;%'?=[K.^:QV93K?W#VATQU[;^L[<I!L70DKL&D);987U?(+ZC
MI%BE*.!:/EF@L$U=A4JQ[M\D9X=ZG=8J[6.TN[>YSEW7]KLPO7'6R !;V#W?
M C['Z,H:KL;I!WV#1ZI3&G73!/VM;^Q66$LW9"195NK64@G:#=>Q<OZ8I6LW
MBB\)?AJJGAR"N_6YUN2]I]9]+=-VNU:DM:>RJG8^G8/?G=75A9IJY)8+AA5?
M0@:I6VS(JI7=]0Y%^F DXA<>VEJ:*5Y \4K=%Q_[N[KO_P"='N;_ .QW0W%*
MTNXI3BE.*4XI3BE.*4XI5D=3=8.NX+L%1T3BI5T@A78WI]BO=C"JE20(*C76
MEJL3AT[.\[6$<!(G.GA""'.<-S-1E"-:S<' @$*5N4Q^2\\52O5Q$6#UO$W6
MOXUBU!+V761FEKK>UFZPJ4W9M:D,(&4D=9A.NX^O-#[,S:*MPPG)K2=?JNK5
MH)2J5\2?)C>)+: QBL/ZE?(":VKL77]F2]D+"D7<DC=/VN[$KO5)$HPY-@LV
MH71_:>LZUD(CBA+JN LEY)?U:-XI7GAQ2G%*<4IQ2G%*<4IQ2MTWW_NZ^J?_
M )T_$!_]C?#1Q2M+.*4XI3BE.*4XI3BE.*4XI6_ZOY-SOYLC2VR"P]+1TLA$
MU>76Z;=J)":QU!LGKG7UH*2=IL5T1VR1]NN[5Z_'A!306&/YYL<**8F%LN<A
MKE*QEI^3H\25/3O3'<'60]@J-ZUH5WH4G;5$#M]$.([%N/4RUW=-6;@"MUNM
M-[_0[&C7M&5CADS!$N?EB"5IVF<G*5J[W+U1;>B>V>R.E[YHNCNO5=UL=!M<
M:@W#)7'8*LT)3MM%[#$4.#1-31)M8"L11XFCQK)C37&V,<4JM>*4XI3BE.*4
MXI6U/@4_]MWP<?\ S4^'K_[N5#BE4!>O_P ;W+_^:K#_ /5S.*5%>*4XI3BE
M.*4XI3BE6_TITQ8.\K6=5D-CH=0T4U\ZSNK-V1; J?5E"@(Q:KQ(0P)T)+,,
M-;.%*M>K3KV;,HD_27 >H(QQ@BE;8LODOO%.AQ+!9Q.M*HZ6VL^O6>N67LZK
MJ6]+1K.T;WTL9V9:]B"?FE=UIIV;UI=*K#8H&AA)92H<P-5.L=(36:E1^P?)
MU]^UU'>W\[;J-@/3*61V8L7J>S49KOLGK)?U;3^ZV_8?7"7.L3!O54_5U\K%
MM-+<P5\R6$PQ.N!/L:9TF7J5I2]K=@K!(85D1MD!;%*CL@ KA>4M(-K]G4AO
MJV\%A+BADG4OD; %PG81:["LEA@IPDLPT\4FRE87BE.*4XI3BE.*4XI3BE.*
M5O#\IG_[Q+QQ_P#S6]\?_<JQ\4K9/P+/J@MZ!=B4FX>#JC]X_6-KAW;#'QA*
M.LFB!UX6=*3F/*:M"]FIFYCU)I<<6.;LNG].ZZ]Q6(4BG8KHQ>0H=Q%*O:+H
MCY,)7TI0+T^MO6%@[!&Z\M]SL58K?>TZH:\OS/")W-VH@K!2F3L=O>JJ:I\0
MM8Z_ZJ&0,*!U@[7L'&M5ET[0A<U^_.%*SZ?KSY-ZEU;O2Y=>']).F3CI#Q/0
MCC=@=]+#VO5-EN'@%IUAZ<J'3]!LALI7;1YGB O'9]/AM>\3^UT2VT2KA3.$
M5C!ADMJE6TSZ_P#DUC[/XACU5W\.!ZWM5_W-3&79MH[KJ*-M2S3O%OUPIHBW
MK+JY.L)"!HQ7A[$.[#U[DI%$8[KB"+4E";10@?1!HI6)*Z;^2;!E:]?[.NEU
ME8M=F\(MEMUH'[EK;FZ40;'9/BJI7:=:Z\?#=T=G"1I3@D70!'8@2;L2V^J5
MCLLKLYB4D05A(50%*\:/&Q5>A:9WLP1^'677Z#15*DDM@1+76;NA47HNO!S7
M!95K34>R>X4K6O1,]LSAZP]IWZ58026GFM#79=@C92LZJ_\ =UWW_P"=/J3_
M .QO=?%*EW@&:4U:?X@]?GGI>L]^G=+0"^&*R^(/7KZ/J]1V!KV=U\3<\3,^
MVA2^KJ]=&'4<%\ H]@OFHJ->UGEC'9+7Y24K12O2<KJ[Y++O.[VC?LWM/J/K
MCLH=7U_U_=;;UQ;@Z-TS8N\[IT/U86^[/H->4#+ZCKU31.Y.O^\%]S;U!4NJ
M!Y_9U88J@]D?T;]84JN*+U?\DC?&5."L#$#K&ON5E [(.L&W=C@JQB3VOQ-=
MLT@SI)ZF=-\JE0B;IU?UH_LSB39=9Z^$=-<6-B6)R9Y=5*Z]EZH^2Q27&F(Q
MA5S3-O[_ *'4KO'%XBJT,JZTHHW5]!MUW+K3*M=J]FTEK6+#>/G^HK+*_P"Z
MW:>OX<OT)W94!R9?<ZZI4LOE%^37K]0M?2PS3IEV.XNG?EMK=YKO:0\-BZK:
MK/ 12KY15@SM3>^R5UH4N/$@@(Z\65HWM?N6@QO'-CKM;N5LL$\%@$4K/>(K
MH?P)+>ONS._1?9DS$L9/B)>=;WL/N9.M8V2Z=6W#KY=U!3.N>D$N!*_?JA=]
MF=@0]BMD=59K:VGBPZ/.J9 PTEF4KPM[J['7]N]IW3LI7U]3>JP[BUPXUZ_Z
M]#(7TJM3RBC1F"5P J8D@)9.9$0="+,21N/DK:'8B?.GI=U*V <?^[NZ[_\
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MKM^W=YWF^T1U?T1ET['N5R?6DQY;JQ]*)ZO:I4*I^51J/FR@-]Z/4=-A*WN
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M3'\D=?\ VQ>(/_-GBE/W!3Y)C^2.O_MB\0?^;/%*?N"GR3'\D=?_ &Q>(/\
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M*%,G.>/S=7TU\A?)^]++JPOI876O3T%25&6-BOKN.NTFR@5A<*^TJ=L81@R
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M/"S/.I!^8\:R'(& C(VJ^.(_P51S$J>>?H((KG^N0P^Y_P"@0/W?]'_I#/\
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M*4=$3<,1E9$9@5",\;QE#\FEWNMQ5(F-DM3$9$X>FL1\=0O-1SE5D25=6\2
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M*IE04&,,@;43(H "GCP."5!RC3QUO$N!,M;KUZ#\X+8'"_$^@6-CU19(X8C
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M9;%IL>3%!/O,*@:G2^KS2ZA@B[%FY'A_?8MS\LORE0!#V'9S*XF96MK$3C3
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MZ2NM48J^;WJW02\@-A[0 ?23&K)MXAK@G,^=EERLU,RD4EBBQSR[UUH_74>
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M=)R9LZYQ2XV]<[0MG2*9+W:*W%G:ONFMM]V?/,\VZD.[09EO')D5@L2NN2J
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M[V&#<+I53NYI\DO)K'9:_)Q]A:*C-*V),&\^EXU[7&G6>L[QCV$6>G2PY\[
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MM/JQZZ>V;M7[>6/\OW_1QW:\K?VAVIYT].Y[8G@RT^K'KI[9NU?MY8_R_?\
M1QW:\K?VAVIYT].Y[8G@RT^K'KI[9NU?MY8_R_?]''=KRM_:':GG3T[GMB>#
M+3ZL>NGMF[5^WEC_ "_?]''=KRM_:':GG3T[GMB>#+3ZL>NGMF[5^WEC_+]_
MT<=VO*W]H=J>=/3N>V)X,M/JQZZ>V;M7[>6/\OW_ $<=VO*W]H=J>=/3N>V)
MX,M/JQZZ>V;M7[>6/\OW_1QW:\K?VAVIYT].Y[8G@RT^K'KK9"A7^Z,>B.T+
M"=96Q3M2?I&M9S$[;%A:9A4[9T'E\GETUSM-+G.,?\LFW^WGT[D_RAVW<_D^
MY5[1GVI>2W]I<JEK=O,S3P*4LB5C<\5&9'/#]8]=>1VILO9T/*?8UI%9P);3
MQ$S0JF(Y#JG&67I.%7R"M;_;-VK]O+'^7[_HY\Q[M>5O[0[4\Z>O7=SVQ/!E
MI]6/73VS=J_;RQ_E^_Z..[7E;^T.U/.GIW/;$\&6GU8]=/;-VK]O+'^7[_HX
M[M>5O[0[4\Z>G<]L3P9:?5CUT]LW:OV\L?Y?O^CCNUY6_M#M3SIZ=SVQ/!EI
M]6/73VS=J_;RQ_E^_P"CCNUY6_M#M3SIZ=SVQ/!EI]6/73VS=J_;RQ_E^_Z.
M.[7E;^T.U/.GIW/;$\&6GU8]=/;-VK]O+'^7[_HX[M>5O[0[4\Z>G<]L3P9:
M?5CUT]LW:OV\L?Y?O^CCNUY6_M#M3SIZ=SVQ/!EI]6/73VS=J_;RQ_E^_P"C
MCNUY6_M#M3SIZ=SVQ/!EI]6/73VS=J_;RQ_E^_Z..[7E;^T.U/.GIW/;$\&6
MGU8]=/;-VK]O+'^7[_HX[M>5O[0[4\Z>G<]L3P9:?5CUT]LW:OV\L?Y?O^CC
MNUY6_M#M3SIZ=SVQ/!EI]6/73VS=J_;RQ_E^_P"CCNUY6_M#M3SIZ=SVQ/!E
MI]6/73VS=J_;RQ_E^_Z..[7E;^T.U/.GIW/;$\&6GU8]=/;-VK]O+'^7[_HX
M[M>5O[0[4\Z>G<]L3P9:?5CUT]LW:OV\L?Y?O^CCNUY6_M#M3SIZ=SVQ/!EI
M]6/77>6=Q=HS,ET4MZL6\<IPD<FFQV^==]-R(]=]=L>3[N-M<YQG'^S/+%IR
MTY5O=6RMM_:;*UQ"K*;ER&4R*"".D$$@CJK5/R?V*L,S+LRT#+%(P(C&00A(
M//T$5ZO%?P8C^8F_N]N?L"OAM4=Q5>G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4I
MQ2G%*<4IQ2G%*<4J^.*L4XI6ADM [G>=1OJBMKE[Z\[6H?:'8%QZT[)DL/6Q
MZQH-<.U+S+YZ:(>YV0@D&?JVWFB%)^P*NH'#G)"F!#^?4BV<![^_OY:CW]^?
MYQZ<5+T7AG4T?MQO<.MJ5U[6Y5?3%!JE"O%CK(]M/ N:AM?%MD:MM8'B"YMV
M[.DLJ^K=V*:S ,["/M&.P<'8#('Y.>'.><Y\8X8_GCJICCS<,#'BY\X]%4,V
MZ<[;;6^T65KU-V&77)^RW)5GZ\6=@4<<+MJHZK^ZAD%EP^8=TR3F/XKI;NO;
M>F3V +KL7K&BUE13D4EO:4Q'DAPQUDCR<WB'S<YS48/CX'(\?/PX$\,XQD<!
MPXU:'ADZJ[QHUP6%]K99LW8%)[!5=G=D3VD)HE[CLKZXT5KU2Q2IXG1;H3'5
M]&46NG'R6.N57U<MOOM7\/PVI[ <<=']GO\ /S<^3S #T\_3QY_4/6< =.]O
M(K*G%*<4IQ2M*>U^IKZ=V%=K&L26F]==V&7H1A8NOH;W'F>XP5-CW,/=*Y7
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M=,*&AN5LS@Z2GR1^SX3U7$T%MTK\<T)H[*8FI+B-JE/:R2I ;2?%IL,E1[R
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MHFVTLDH^ID<<9V=]Y!-\XUT*TTUESMN/OMG&NL^N,Q;9SC&-LYSP9+H DO.
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MM,;@QO,(#&RRM&D33LRQL S?FE+J%!+C&@,2 37,"1[YIH]T'5#(&#('9Q&
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MP6ZMVX"5 =;Q@,2A9T_35 P!D*\QT!N/"NQI=*CO%Z7:RHX,:[J8I8RV8@1
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M_?[_ -/_ +NIY?!Y_L;_ /7C]/&?R+]5[_OWUT_[_?\ I_\ =U/+X//]C?\
MZ\?IXS^1?JO?]^^NG_?[_P!/_NZGE\'G^QO_ ->/T\9_(OU7O^_?73_O]_Z?
M_=U/+X//]C?_ *\?IXS^1?JO?]^^NG_?[_T_^[J>7P>?[&__ %X_3QG\B_5>
M_P"_?73_ +_?^G_W=3R^#S_8W_Z\?IXS^1?JO?\ ?OKI_P!_O_3_ .[J>7P>
M?[&__7C]/&?R+]5[_OWUT_[_ '_I_P#=U/+X//\ 8W_Z\?IXS^1?JO?]^^NG
M_?[_ -/_ +NIY?!Y_L;_ /7C]/&?R+]5[_OWUT_[_?\ I_\ =U/+X//]C?\
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MJA:PKEM M39XZ(; 5P0146**Y.<"F*QGO[^_S\*C/B/O[]-5AKXX>IYTVMD
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M-T1TT5@U('UEV58!Q,9#MBY/[1D69F2*-88HY<M/$YE25[1(WMUA>5IHV%[
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MN)R-W*OYK<E)#O),%U$8CM6T>V8S=">9I@8+CL=G[$&F<.>QR!%''^DC=]O
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M\LLCG+/)(Q9W8])9B2?&:O(B1(D<:A$C5411P"JH"JH\0  %;<=>?^S9V_\
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MP,R]_(2)2.\C@H=D\2PSE;/-76YD#1K4<6*.8!,*M2:1%UJ"[@)(8RFDABD
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MZB*<KG&GY^ X<<=&??Q\*:3S\/%X^&>G'1Z?%DCFF\;E]L_9CH'KUW3E'55
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MPK:?BIIQ2G%*\?O%7_KVNG\U6?\ NHDY]-Y._P#@]K\]Q_U,U=ZR_P &B_\
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MVA,#!]1:25F64JD653>LJ()'W>$4-I32VL6ZR%B&7=EBRE"#DEG)#%57@-6
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M0!RN,C,63QYW?!!((DZGPD=:%I=X*S903MA+6)H6T)K]5N8^,TWJU?T4=53
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M )Y_VY_VY^YCBE.*4XI3BE.*4XI3R8\OE\GW?NX\O_+Y,^3RX_\ ^^3'E_\
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M*\=1$'M$11,UBV[SMBU&D*'QK.H)*94TM+=2NIRQ#99]0P%" 8.DF(Z?Z5&
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M:7CZY%F5W&M2JB,P$*V6+NJL)8PLK)V3%I+%UYLJ6E$IRP<%AD$#3H."<DD
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M$?S$W]WMQ2J.XJO3BE4QU[XANF>U75EKU OBRQN:;MYEI!@%;![HI?\ R';
M[&5FO"@@)VC9KI]1=I<D;BG"%ZQ9&(BEWDJ1SCGI5B6BW5FE)&=CM;L!$D3#
M:EM&)\V(X 1=IX!M9Y_-QO)K%F<D>+SL:9QY\T>,_P#K8Y%*[*6PIK"#"Q3G
MQEB$$LA(),Z3#;RD*&!:MC'H.7% 1GU8X$J#;?T7H]\1>FBVD@WCDW$8YZ5E
M,$C[0^L:SP[#^;MMZ?$NF8?-U\N-MO2XV\SS=<Z[>=GSO)CR9\O^C/%*_,E"
MZXVSDD?&-)]1M\YFCQC0G?.F-!]LYV\FL^^98\:Q9\DFV9-,8USY^OE4K!66
MX5>G"KSK0\7HPVCQ16EY)\V(HBGKX^-8G61[^3./63V$L8D.-O-T]-OC7?;7
M'ESA2NVAL:"TJ$[^M.E3Y)8$RZQ(FR@\9@O<(7 T9BIRM+%DEA,5LA)HB03H
M-]QB89-)(9-]=L9XI6*JM]IUX5ENZG8EKU0$XL" AF%-G(6&U5:&);"+$1)K
M'$1A4U7' E$C;2B8G$(UTGWQ%OG$X(X8XTJ3;EBQXUSN2/IC?3TFF=YH]<;Q
M_O,>DU\NV/.T\LD?[_'EU_?Z?=_?:^6*5]2D#P>3T\\,/G>=YOI9=(_.\R.2
M7;R>?MCR^;%%+)MY/]$<<F^?)KIMG"E82TVRMTFM/;C:W(**KUE2<]?NSI?,
M!5IU@NYQ[ J33&^VHXHD>Y$NVNNV<1:YVQC/W/* SP%*QR;L*D6(XU<ALZAP
M2NR]T/V6E:F"!SU>R,:?9 B6,&-U\+%!:%#1$X6R%:GKF2\P8L:+>"3&K'O[
M^YI7?66^L.6MD1JW:\UM4&X""R@0SX]83NFE>56M<M*UVQKC!9E<>*7$$<>9
M,[A'02_\NV-9P?+_ "YZ5(^12G%*<4J^.*L4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE.*5YU=]WGJ-+VK95MIZ9Q;7@\:3)K_-W<I_7L3(%<PV/FX0
M>0>#U422 3RZ;Y]+Z#TV_DWDVQCV^QK/:4NSH)+?:IMH6,NB'L2*71B:0-W[
M,&.I@S<1PS@<U=:UCG:!"EQNU.K";I'QW[ ]\3GB03XLU3WM.Z#_ ).NO]I5
MB^$YU.U^V/#A\P@^_5C=7/RO_81^NGM.Z#_DZZ_VE6+X3CM?MCPX?,(/OTW5
MS\K_ -A'ZZ>T[H/^3KK_ &E6+X3CM?MCPX?,(/OTW5S\K_V$?KI[3N@_Y.NO
M]I5B^$X[7[8\.'S"#[]-U<_*_P#81^NGM.Z#_DZZ_P!I5B^$X[7[8\.'S"#[
M]-U<_*_]A'ZZ>T[H/^3KK_:58OA..U^V/#A\P@^_3=7/RO\ V$?KI[3N@_Y.
MNO\ :58OA..U^V/#A\P@^_3=7/RO_81^NGM.Z#_DZZ_VE6+X3CM?MCPX?,(/
MOTW5S\K_ -A'ZZ>T[H/^3KK_ &E6+X3CM?MCPX?,(/OTW5S\K_V$?KI[3N@_
MY.NO]I5B^$X[7[8\.'S"#[]-U<_*_P#81^NGM.Z#_DZZ_P!I5B^$X[7[8\.'
MS"#[]-U<_*_]A'ZZ>T[H/^3KK_:58OA..U^V/#A\P@^_3=7/RO\ V$?KI[3N
M@_Y.NO\ :58OA..U^V/#A\P@^_3=7/RO_81^NGM.Z#_DZZ_VE6+X3CM?MCPX
M?,(/OTW5S\K_ -A'ZZ>T[H/^3KK_ &E6+X3CM?MCPX?,(/OTW5S\K_V$?KI[
M3N@_Y.NO]I5B^$X[7[8\.'S"#[]-U<_*_P#81^NMS_"W8Z18DMLFI%!Q0AAF
MB^,\7%A86#YPGW$FVBG]*?%%L-Z&/&T?HX\9UD\[SMLXSKCGE>4,%W!+;"[O
M.S&:-RC;A(- U %<(3JR>.3S='/7/O5D5H]Y+O25;!T*F!D9&%)SGQUM/SSU
M4:<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4K@*_@Q'\Q-_=[<4J
MCN*KTXI6C?9O@TS?]>RIH[G5R);[XCJ_XA8Z[V!UEB_]<2R(^@:ET/FCWND_
M32N9OJ7,5:VOJPKYYKF5-OTK97J!N*SZ1KEG&,<.&.L\^21S>_32M5J_\F&^
MF>7>)WV2F7*@L5JLTV[246)]VW>J^E\,'0G34IM^NNEQ79EJ6UBZ^LKZ/K39
M-KMI;8%EQUL^\>^BW9J](/3@<2W1T\]3GAC'OPYNKQ_/S<!5@M_DQ4+GY[+F
M[5D!L;/+(99=%-!%!N=44/9_$Y(_75FP[6D@U5LVC\18V"9AMHQYY^O5I!P)
MV&D,**=7'./3\W#F\7'Q'%1Y?+X_?Z>-6%6/ K3JQT%6NC;;8Z4RK(7?%.[9
M>K]*(4!U_9/FNP(YLT >BVSL"XC*UMNV6P L!M7;!6<X;,C=:W/*T("G@MDY
M\1'7SY]?N.%3GTC'OQ_MZ16N3CY+:OL*-;?5.\JA$+:;B'V"#>FW7;:P";!X
M [6A"L=H".[HUHEXNLXO;AWK%U8(1D+X)>)"TJ)FNZN='(;&,#/#'CZ^K..G
M'C^:A\?/[]%79M\GP>QN)#JQ]OJG=5A[!M%T55F3JS6,Z0*[>(S?Q'6E'9W$
MU]*4O<&/S6M9#*"JB(,5%.)(4I8DC$8.@MPQC'$'GYL# Q_'T>.G-S=7\1Q]
M_P"RN7PT> R'HGM*D]F*NT:@_'I74R7IQJMKG5^$9ED(I]-K% RP->,>P[I#
M6Y-IZ?"\?)JHI13LK/.9*]/-SB:.<6R",8R<YZ>L?/XO%Y:CW]_16#'^3*HP
M"^T:K+#2OG=DEH2A!,PZ>5&(5<=*\3?:7B.9)+"A'M04EEHW8$78"+K:]5 9
MM7?GJL4V&65MYC,=8D:O%P^?CS8X''S^7FI[_34'.^2ZZU+A#3VSLJD-GFX)
M:\2)IU6BSJ (^ZU\1]+#KM13L+F64DI*6U]QJ+C1:G"6;"BAZ4J2&$XY@"+:
M$,ZCT#F Z^L<_DQ]//3R^7\*V1[:\#=2[ENG7%ONKE$_]GU:ZCK7S=9^OUUH
MPW&ZX[(#O-AVV*:NMO4H>Q5$)M->AY&-BU5LR]S]W@DLRJ> V/*3P..<8YO%
MSBGO[^_\*H'3Y,9UI49*%GOX.2L2=>;57;:;J<F5_FS2^%!3X49;#AGMVC@/
M5#'7D"BTBU7*K<Z)GZ^MDM<H<XLP4Z^;AS<P!P.GQ>.F<^_T_P ZX[W\G(WU
M:1LJ4[ZM>"-.[7-U-JEPZC'(IH56MW=US[G8QW!#%>@XNQL5W>U:4P=:-+4_
MG:LJDT4>R[=?F.8&Z\\Q X^(>+AS>FF>&/?AGUUP0_)5@PD=>RS=T2.H:.?5
MR-@WM'<;09TK_77A[HF&M:E0=G5\VKW%?)T'"72K'J6U'J*6X,ZYNF>X C:&
MM? C'.#Z2?%X_1XZG.,8YQT^_57KES"HIQ2G%*OCBK%.*5J'X@N\KOURXL@5
M4FIJ9?0>H"^XK$;<JT]L\EF60OR4I*NO0)+C3]TJZIPKMVO8%LDUMF]=7V&L
M3#U5C(5Z J?7[_-]/\JCWYL_-[^HU7@/B=[*9W!BNU(ZL0URU,+,BZC9OEYD
MZ-TR2W&KU:#72\H>R&<#RVP_.K$-AU3;Z=T>\)O6ZVD*+,2)"1;BW#Q^CR8^
M?I]%,GQ8X8^GR>3'T]5=0^.3LCZ/[6$BJTH?U"\O>E&R)@*\5M@>PDU#["N1
M?8;.3%A9")^O$AU&DJ]FK(NUCW$8BVLQ3VBY75T2=Z..CCG\??H^:F>OH^?R
M^+F/7XB:WPZ<NKJ]4\QE8HU/SVCO'9%$9&H!RPT3@KKR_6.D;NE(1S!L6N@:
M?,."B5!#9M(D8[G)LMFOJ&&),'AZ/2,U-6IQ2G%*<4IQ2M(%GB%[=F1RV;%:
MZ[L58G[9\/\ 21K6LGMU>1Y5]L=IK.O;H'4?G45H7VEO1-'=>F1=DBQT2B]@
M9?&'I088JF0N?21CWX_3U<>CG%0"3[\#\W7PZ>8FLYVEWYV'7.RS*5U^AJ%C
MP('5TP")G,7%9+/=+X@[F8(I5+'1T H!KZ!MU5&O>PG"32GCSV\K+FM_0O?1
MR]_F^?R_AQH3\WS=9XX&<^+J_";=,]X[W]PQIEK@#27Y0(?N0B!6-=AB=:V4
ML LC/9U"0\J01<)MB0#D4M?;;*Q2ZSQ-8+!::R[0V$J* ]?OU_QZ"?GK8WBI
MIQ2G%*\?O%7_ *]KI_-5G_NHDY]-Y._^#VOSW'_4S5WK+_!HO_U_\QZUXYVZ
MM55_8'8DU':U8+11NXCL<DX>HX\T,!NS&=[4Z\HAAE*F@#B@E.M$>YLQ&_\
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MRYWWS)7XLZ*=_.V\X3/G9\K)Z_']/748'4*D29*FKBH%%7E*Q"D5CZ"+$Z8
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M6S=B32M$EFA(B24$M( RNJM@#>ZLHLD1;( _.* 20P&20VCL56)?T58'CQ#
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MN].5*N\; X(.&1E89!((S@](KOLH;GSPYB"5(Z.!4@CRU#->E>LXH<CC5O<
M?3(^P<"QY8E<2B0>#U7TM?C7-Q=*Y,4/G>!E,APNE;13$:--S-29\2:>Q+<#
M CTCA@*\BA<#'>!7&[)'!BFDMDZLY.<-TGZOS8+#'^;@][X\8STYKNZ=2==1
ME"&1U<2(@)H [&WB)8QZZ-5;9N\7G;Q:&:Q33B,WK8B':?23&NAFPODR)%!!
M%D+6 %2(P"K*XP6'?*S.K$9P2&=B,YQG'-@5.[08PHX$$<_."2#S]!)/TU!R
M*G1.N^PEUKD-L(>S(%YLN0@ZFG(HV,\=:4L#\J@=2#F+QA'HI7+MXPCFD^9Y
M0=B)@ATP2W1NH+>=9,NNM7T1J"R!CNU9M*Y9G;O%4X+'B"2 @7 JB.&[X9#=
MZ.(R=()P.)8X ' GHY@,8W9]T/80 J_@LZ%=1%R]578U!]R6Y.1NJ]3=A Z\
M76C8C[6(<JMM1"(3Z2L3MY62S!BWR' 3EP7LI (\D"%56,(TJZD>.'2(S&09
M RRQ*4!8]\H*]\,LQ-@9X( %P6&0RIP&D]\"&7AQSD<.(K**W/2==C76Y4N
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MS4<.OHZNGJ_&I=UG\H'I=KI7JC/3E$.ULM($<!3NZ5RA;IZS8C^LD*);7X+
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M"<3OWV1%:^QRY:Z)KH1VI,TW(<W="-HSQNF5LT ]>J4-.D*8!+E500GQ,YK
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M_P"$<?"1RU\.2>9;-_J=.Y/D_P"#E\XN_P"L5M]X:;Y;;VGM!-L;[MYU[("
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M *7$#@'#%)8V TL#5--HV,KF..ZA:02;HH'&K>:G73@X)[Z.1<CAE&&<J:D
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M_D6W?-;#_P!SIW![8^/V=]=<?U2GUNNMOP-=?=J3_P 1<?#)R7^1;=\UL/\
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M)B/6./73&,::XQQM]-Q_.R\22?SC<2Q)8GCQ+$DG/.2<\YJ_NT_43A@#O1P
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M)CY9-YG=>RI]:#I_\.,?<+7X;CN$Y2?)(?.[?VE/A Y,?+)O,[KV5/K0=/\
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MS,V ,L23Q)-<^?9&RKJ5I[K9FS[F=].N:>RMII7TJ$75))$SMI50JY)PH &
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M$,DDQ31'QD=KQER<8*+V:X9",2:%U'!=6S77G24-%NIMDP?$4)\T-HQ!H(H
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M7&2P&M-(;4H.">]()P,C/$4UI@'4HU#4N2!D<^0.<\XYJZ1':E "1KWI]G4
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MI@#&<:1@8.34[I<YX_I:L9&,Z@W5GG Z>:L#-X<J3-@73+6SX@6KUH*@;>=
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M?@.-"]7I/KIK;K] ]5/:I??P_O[O4_ <:%ZO2?736W7Z!ZJ>U2^_A_?W>I^
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MTXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE8B]=9VE_:FS==
M'N&9L)F':4R.*3.(0!1]_.CVQG.O_"0[XQY?]./)G_EYL5P !Q]S\]9LI))
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M;- &'^2.',>&>?//FC7Y.'KMS83K2=2<[.6CD]\SF'[ M@@[%DQM/7%U(D,
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MFT )!&+=]=SD;/U12%(U,LL@6(JR6[++QKRQ:H(ZX\3)UZ6JR;.!"ZPW>E,
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MV MON)A^PX[CN5?[.[8\PN/9T[?;%\*6/G,7WJ>R3L_[ 6WW$P_8<=QW*O\
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MY^NHKKR_*%*JP^8U*YT>3<ZNL\5-P]$>H4A.+%6NR.F.J^P7EFH&S>T'=95
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M-U^*K'G\5'2@S" "=]9HM2>Q6?5$3>3K+L^.LYO2>\A=9L%/TKDI^E;]4B[
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M8'+EB;)"&3!]_H]8ID$X'5G/1P.*P[/QJ=*PJ$[JN[7JZ+GC;J=4O85OK3L
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ME*4#2!H) WV!]%,>R.L3)%1CW^G-2WK;PJ]1]46@"VT\)^,T7J%ZN'0RQ,#
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M?Q\W#G!'CZS4O-\"2@^"(N?LVQ:6;)F'Q;@<(L>$JT W"J6A"=MO'8\6V16
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MU)E/!8ZB^/A2]EV)+&N<+[8J;]AO;)KH-*+<];_5 H*UZHVK]EGSE::KSO7
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MJ:D5^\-/4O9;=\YM:JP3S6<. >P@*KQ<Z^B<F!)3:XL?,J^C>@)3;&J1GSK
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AG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g68105g22w29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g22w29.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[16\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %:"^538X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              ($   )5          $
M                     0             "50   ($
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   ($     4F=H=&QO;F<
M  )5    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   "!     %)G:'1L;VYG   "50    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ (P"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MQ__:  P# 0 "$0,1 #\ ](ZAGG#-<-:0\.)+B0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0'_P  1" "# ET# 1$  A$! Q$!_\0 '@   0,% 0$
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MQY=$7%0#6([;:5[PEJ2T4%]?7U_;'(^OG^VPQ\^Q39V3L[('Z#1!/V) 62-
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M/M0ZMAE^.S'5IQI*R]9E;G:A#;"EE7WWOKZBU]W*DVZ&7[=YH)/@%$J4J 0
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M/<*6W I*D!.R-_'5UZ\6;AVU@:'D:B>24>4 8SR3F9]Y$]N_<,I*V'%H(X0
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MU!203VIUY^XZR/7Z_,'ZVK4@G8D?'WXY^/;BD9_HS]5__P"4/5__ ,O<?_\
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MS'J9D28GODGU*8S#T[XWE<:TATV1N16,GIW&(]C%47FT,R$H2PVM84E;D(!
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MO)\86[-KHR1';+]G&4$R'D ]SZP-:!.M'>AOK@W5NZSTCJ'B.E8\%SRDR9&
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MCWV#*92"^B1'"NP_E)4I0UX\=:,"TZA>J99<-A;*1J?MG283< Y2B< $Q\A
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MWV:/M '\@)UO?A6:Z1=*4=*4=*4=*4=*4=*4=*4=*4=*4:'QKQ^G2E0_S/\
M^_,X>_\ FQSW_P!O"Z4J8'2E'2E'2E'2E<T/[1>ASY_$</R;#O3]C/-57CUA
M)7D]O(RN_P 4S/!*I\!2K?'W<8C.7<^N2E#:KB+!=]SL;2X([B4!(5@^T_4'
M\JA/_9_R<GS5_P!5>62N.^,(V*8M6Y9AE%G5-FV:YAEK;)QJ-8&BC2,OC+?3
M7)<=>7-6AR*X9+*8RXZUH20K/U]?F<T_''L612XKBZ(+<D27,>K6H;<H)DP$
M3)$(&+([DI46H[;A[Y"F^U1;V$Z^.OI*5)?9:*X *4G!A02$B4$\KB!DD]YR
M*YNLSIDP3!['.-O3;&\>]:3*.-<9Y 5)I>11"R.__#&FV2TPA%+"L_<]Q,Z)
M'(5+2XXLAI;YTK0\GQU>:O;BU2EVSEBV#H"T*)\9: /PZOPP<^4R#,<Q1*@V
M4A8UN3Y'");1W,3 X]9]LK3':_(UXVQATBM%9=093%=7&UA*DPUQ(G:M$EB.
MKR^P(Z2@J!4 HI*DDCJM=+MDN+NDN%UI4J64$)5).Q(YDQG;.T5E!<+A0-R9
MQCUQ$8Y!R<TEL3]4?%][EF48:N3-K\AQ*VCXW*D3Z=Z!%N9?<6?^:=H2'8R'
M6UMJ[TI4E*4E)[==6+C[/WIMK:Y0$.L7+:KA(2]*D(/F&HS(5&<<S K4K6RI
M:'0,K,$C)R3@G.TR=YS(DTD>4/4?P=QI,;8SJ+)8DW4M]<= JS-B1(S)#<FV
M=:"@64,J<"^]Q/9]P0#L6['[/]4O;>+,I#;200/%*7'%*ES1J$J(),1CV)%5
MVGD)N%K#*M(3$?RF!E0]1D[9I38+F]&SE4&)C[]IE,9$%%I%OY;';7&)8Q$2
MX@C@ND);$=2>U*3VI42I"03OJK=VRE6[BKCP[9U9+2D),J*T*TF1R93SO $B
MK *UPX 0G\21&!(U#RC$F<D<_"MKRG)R;)Z/,H>-S!$NK>DM857,*4D1)LB&
MN.PMPE0]MK\SACD=R4J*%+\@GK2P0U;JME.C4EM;8)(_%I(\Q$8,B2#WP,U@
M*7)45F%DD@JF09D?#@' ,'$341, @9KP?Q=:#/F[[)(4K*E2<>KI4N-/O0E3
M*"ZAZ6HHCM1PI$F2PS[O:IGM*D%?7I;I5EU;J*$V*FFG0T$N*!6E)4-Y28DS
MO& 28.<:*EN5$X)P#, $;>T;>@$#&7B<K:7GOC^M38UE@BBG.1;*&Z^ F36O
M0)"4J#BB2CM:4T&RR%%"EI!T= ]<PJ5TB[=#:P;E(4TI*?*A:,I"M(X()(GC
M?<U(@K3#Z5(+:P$&0%:%$Q&1@C:8F1.T59F6-0[?'$8K9J=ET;BT1V[II?T]
MA61H_P#@3(8/>W-BJ4E$5]Q"VUH 05).UGK##JDN&Z1I2XL&6A&E2E&>" #,
MG(,DXQ K"EZ"4D!39P5'.)@Q(/Y9]<$4XF-,4TV#%J4S64LU$*,_!5'EQ6Y4
M9IE"6>Z3$4KO?@.! (4.UU#FP@'9ZJ77WE"E.J2M+CCB@OR%2/-_*#L%3C !
MC\XEN-LDGR/MDR@X0IL'8# U0-M63@UXV?,O']'$N2[EU$TFB8#3K0E-I=^H
M6HI"'4("E*6I[\H 2H)V._Y'6XZ7>+4V?N[A2Z=1)!P.V2(CG8S2W>#BR$E6
MGPS 7((Q.1L#N1WWXJ-7,68<.<FQ^);;-\G_  N/)L)\6JFPK,Q?I)ZUAI(D
MI90EMQEYPI;<4\@%L+!"@='KL=-M+^P/4F[)L*(2TMW6G4I2)R&U9*5>Q$X,
M@5.%K6VA(!AL$21G<R#(.?RQVBND?I*X2QE-2Q<1(+#&/T[SD2F:3WK382UD
M/2[14AU3A?5(#B5(='@C?:0-:\']I^KO!:V,^,\K4ZE1,MQY0D"3IP#B<<S4
M[(*RHJ!2E)($ 9_MG$]QGOT0@UD. "(T="-CM*_RE1 )T-Z!UUXA2E*RHD\Q
M. ?2K?$<5[RG$L-..[">P ?F![/E/C2?/W&M??8ZUI60"D([O&AOS_(Z\?P.
MM#^&ATI7DHJ.G$$]J>[:0C:COY(/\]GX\GQTI22S*-)ET<XQ8Z'9(C/I:0\C
M8+RD -DI'YM)!&@-)\[/R>K%LI*7VRLJ2D+$D&('/MQFM5S!TQ,1ZGL/;)GZ
M-<C^8&LGQ2GRMJVL\5Q_,;#]UQI96$=AE:KA]21(0\% -(6E'N,P2\0EQ:RL
MJV>OI_2UM/+9<9;N;BU;"?\ $$A1+:FP0$:1,X.5P 8$&>:2E("VFWCX205%
M*T@$N$R5 [:2"=,CCWQ 3@R?QMPY:R;#G',YE%FM%D%@TQ#O*H2XD5RT<[VW
M:^6U&6B9'<V7(P0Z4,!0!45#KV'5&KSJ2$IZ19H>M';<ZBV^$K4IK=)2I04G
M( D842>2:A4X4#0DN(2%&% %28X@D&(&Z9 &T ;2+L+/F#*.6GJ>UI,(N^"9
M$9NRJ,ILH0$M$9UEN0R][DM"5AYU9+;S( 3[?QX&CQ6F^G,]/\1*KQCJP*D+
MMFU*@K!((.A6E0&\[P)F:RL/A"G$W+:E ""I*01$\F3R.,B .:D=<.Q;3";[
M%*T4>,N9/3OXW276//."95D-'^^5[*BA 2H@@^SV.!/<$;\=<-E!%RA]2WW1
M;K%P\RZGRK,D%*R<YB$G*1R:...E#2WBC*0"M"LP,"4" 8]0"<>U-;Q#Z=[/
MA^GFPI^3IRF;>.,W2C%:G"KC:95';760Y;KL@.*3W+FN$-^X\5'6M$W[[K#7
M4"HFW-LEL>$95#A"5:O,L >4RF!D#C.Q:W%/)4TI)MFVT%: @))49DJ2D '!
M DB3ZQ-*7T<5G.=!Z@+"OY.N*VUQ>QR2UL,.:C+"I<&.*VR2VQ[?:DL,"&IL
M%*RHE?N=^P0!S/M>[T=[I%FJR9<3<) 2Z1,%2<E1(W.3F?WJTWI4[J2DI"D@
MC5[F2!&!,&!@< P37:P#QH'M)V/'W()2DGP/E('G6]?'7S"1O,R0,;3O^\G/
MYU9[>^?D:X#Q<XGU/(7*,R;8M-8_A?*6?NMQ9U,)TR0Z_E\QY<?'5. I9EI0
M7E(<#C9:4MQY?PDGZET6P0YT&S#3:OO%UXJ5+2OP@IL.O:0[I*=: ?*-4G(
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MP+BV=4V*7/)N*HL)<FK<D0@S*?KPQ+<4Z'H$\QUMA<5_V6)"J^0%(4A>E)(
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M(0K23V[Z]ITL7=A=W]^;1VZ0$%MPM.G2DI&DRA1TI G=(G&9K1%PE)2R7%L
MK40GPO$"I.24D$"9!G)/I4FV<*DV6"-8[:38[:X\:)6SIL=<95>'8[+:%=I]
MYI+9;*0H,A12X-)6C7CKC?>THNRZTTX%+6IP-ZE$RHS$SL=H$ <5666T*\5P
M MH4=1*4^:3O!GT&DX'ZM?R5A5/5XA58BQR+08]EDFR:L,:=RBT$"/?K;(2_
M6^["<1)AQWF@"TXPZDMK"$CP#UT+.YNWKERY38W#S+8+=V&6D+4V@G"H<'F$
MR%#)C)X-8*V H"6=*H<!65 @*!P-. .!$C>.0-_16/.^$\89&[9+9O,AJQ8O
MX/&C6;=M(9C".4Q:J9<M,H<F1UR!WQ&BI4A#*DAYQ:B3U7=3TFXOF_#:6VRX
MH)N"M(;D_P#G$MCRMDB 0!'EGO4L%Q;99=;T*.E6E:ES&X))*B)V!P)VWIUO
M1/EO).<WF.9%RO3.0<B3DTNNJ9#M8NJ6]7HHY[DE7TCGYC_>5>TAX>'$ :'S
MUP/MFQ86S;;/3EZF9UJ.HGS3!'R !XGXU:;;6VZ0M>N 8@RD#,#TV)'N8Q%=
MB/R_X@#O\JM;\D>-DCS^NB?MKY^W7SC8' $21\!@U:_;\N?W^IKY>LY1<Y[S
MCG_&U!.,1P\I\GKGO,A\B8B9DKD1Z$[V/,!+S$92GV707%Z=<2E  5W?<_LR
M&;3[-VES<A)TM#3K"5!/\5PF"K8**P3Z"N+=N*UJ#0\T$Z1 )"B<G&50(G?,
M<4]7#>68/P-#EU%)4U[_ "1;6\YJZFS(EA$D+K8TH1:R$PAU $IT-Q@J0&@@
M.OZ6X%* /6W5K*YZP]X[RE(Z>VVD(0C2$:HUE<#8$+3D8W,956C%QH04A*=>
MHZU$#4%0, GS1Z;;@1BIG8KGK+<*-DN=V\FK4N7(5]+: L3)DP/$K?@,D)<,
M$CVTLJ [?E.]#QY*XLB7%V]DRT^ @2ZU&A(D_P -S'XPD222!!&*LLN+<F5(
M$JW4),B(,J@\\1F>])+F;+*JF5-R^PR_\5LY,%U_$,44MV$XY*4A3S D(:5W
M>U[NO=? 2>T #SYZL]*MWG$BT:LDM-ZQ]X?C5D')22# C@;FMGTH!!+I6N)
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M3$1DMSK:+-7:QQ'4[W>8A4TA7<$*)5O6^M>L6CYZ;?.-KRVPH.I082HD""H
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M]N:YD\J\B8_RXS,HK+%ZG+<2ENMNNP+Q@/1IS;+O<RI,<O-EQI+B \.]2E*
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MN,^.BU6A33YU%:C) 4(*B1O@0)B  /6I+NW8M7/!*/%6V-!4D#2H@_B$?WK
MSN%P@UE8R*]LQ/OX%4MYS&&[-#[L&OBI07"JNAGZQ*DI0GVVD!*W/(5_BUU:
MLW^LEA=NRA"+=;F@7*4E*EE0Y7 R)B9.8 JFFV0-1=!:*X4C4,Z (.F()!@\
M9[Q-;"ZY?P+,>-+7%JZ[R' F,JHYN/4]Q1MFJR+&3.C*BQ[2F1)2Z(<UM:TN
M152F"GW1OPK9ZY]Q]GK];ZU$I6M$+6O"ED[_ (R 9 />>>U7+>Z8M5!0TN$)
MTA*P"#.Y@SL8B?3(S4.>->#N/.$,3F8M8<K9MS#D:8LUUC(>49$VUMI$F6YW
MORY\EIYMMQUD$(::CH$1HZ<+87O?HK-5^&K=IM!;;;4$NNDRXO.P*AJ2F!D
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M4IM8<.A*7$  P4+G5),C<8[;TGO3O@?TV:Y#R?;\A7%K@45*(^&\>3H[28=
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M>Y9'E!^=?;X^?N1_LZUY4"< CTWS\Q&/C2D]ERB<;OMDZ_"9W:=_E/\ =UZ
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M<C%PA4ZI60Z&&% DA@_]+[:U-@%1/53JO2K?J@<>1:W3;;2] OT(0&TXDAU
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M;87'!0A(>:6OO2TDI/:GP/CKDV[/AW:'5(9=<"_XRT.%2EI!F%$DE0SSB2.
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M,$#&<['N1SVJ$ :^V").2).X'O$3N/>D!:V<2\DU%2G)&TB$TN?,)5'C+?\
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MB:\@DZ/OZ _U@#\)!U^O6)'<4J_]H:#_ ,^4_P#ZSA?]OUFE'[0T'_GRG_\
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MH&WDH42M1W@R0#&)!'O(W/'K4JIC%@X4/*2E!>*9CMC[Y24)!2I06>Y*%/\
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MV]?F>.4"FYUTG%<EK2GLNZZ*TMN=7+"7T%16@+;!)5G/'ZQ6M]&O+_JZIZG
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MD$'2<$D[Q/Y32!8])'J<L+O'KK).*[IZ?2!UMRZCYOCDJT?CNM^VXPA#T]+
M:DC\JD$#VD;  )WU:'VVZ6E"T,VCS:#E*= 2 HF9$$R=YGDR"*U^[O!!05!:
M5+2HA1G*=C,]CW[[P*>N@X.Y\I[V+:*X4OEL1F)A:::RS#VEHF&.6H6E?BZO
M<:; "E)4  OYW]N5=?:RS6RI"6']2UI,P#,%1. 0 3[D@0/;<,*<7J>. -,)
M@RF,=LCC:8C8TH%87ZM($M5Q2\&!JW+R?+^58NEB2THI#SLH(L2"^ZAMM)[0
ME*BCX&NJ:^M=,6E7\)_6H 3.?Z8]CO5AII*"6RXHVY4"IO!&)]-4YSD#TVJM
MKQSZJ;I$M%IQO=2(EF\)L^J.0XJJ,"AH-L0F4FR2GV4.H':M2O&@2"2"-6.O
M=+:3I-O<H6DRA03J(F2HE1(S&GT]JLJ\!M84P/*#"@<CT F?^D<[?D--6<,>
MH>(PXV[PG;E^&I\5<E&5XF\D?4-A7ON,N6(6T\VX2T$%12EML!.DG75W_>>P
M*0G3=$*D.#0D3$$3!.\G:._I5%QM3MSXRR58$S &!Z1)G([GO A,(X+]4+35
MC"D<+2IC%BE2WWI.58HM*U+6''$_3IL0I!6L>%]W:V=*2 0.K8^U72AX92U<
M)+9E("1VQ/MV,@Q!P:T>:=<40#*,$ D ))$';G@Y-)>O])7-$&W:R-W@N[?F
M>\77JV-F.(L-?O-MO-KD&T*)#"V%*"FEMGO"BDJWHB5[[<6*V%,MHN0HQ*RU
MKVY ! $\1B1L*PTR\%#6H);&0!F9WG?: -N*<AGA/G>#:SG*OT^6-=2F.E,:
M"SFF)J?D/E)&W'7;+MB(;4=MI2I04=I&O.^>G[4V90@NFZ6\E1A1MY"1 V&J
M,R>.\["+"T'6"@PF?,!'!QN,^OM@UH8W!7J4^HB6$G@:Q"X34IL58SK%UMRG
M75DM29<]-B"E3:/B,VT$E7GW#X'6A^U%D5Z2J\#9()(M4X(SCS9/&9&_-6BM
M!&KPTJ<B"3.PVGN,9QS[5NL7X?\ 4576+;MEZ;DLLLR53C*A9KC+LIZ24=B0
MX%692^%-E39)2DH2=#1&^I+G[2].4@(;>O'"OR*"F$(2E R"/^MB-]Y)JI#A
M62=( RD@\\[YV&WY\5G7/#'J OL@E6QX6O:QI22B,RSE&(/-!OMV X@VR2GL
M5M*$I 45$*4HC?6]K]J>GVS26@V^XH9*BE*<$9P".<<["J3]JXX2H*@DG."8
M/$1C.21S6;2<3^I'&V7(%7P[:2JQS?OMV&1XFX](<D*7[Q6K\3"6V$)<4D-;
M45)5KR-'J.X^TG2W]*G&KE"TJD*0 3M^$^;TF2#,1CG9AAYI0*E%:1!"2/PJ
M[C$XB-\ [DYIMFN!/53 R*MOZG@N+!>;>F?6ICY5C;43V)3[B$!F$JP6A:4Q
M&V&E)_Q%9"TJ[4GNM*^U?1W+9UAXWR@4:4I\-,@SC(4-L^TU=*$J4EPH 6 1
M(D$@B(,;\'X9[5'*MP#U5^G_ ";F*CM?3OCMA(]3GJ"R/*N,YEQR[A%7*E2;
MG"\=8?IH]6[/;=>LXS6,64EJ,V1N$I*2H'O/7#M?M#;L*7"+I3:GBXH*2C4L
MJ"1)R2)"$F," )BJMQ:^.L*G2=,3$D&9CY 9D9$9%.=&P#UQS9;TJP]+$6R>
M2W&C3HL7F/CUIB"U$?3*W&^GM"['E/J0VHAT);2I"6SMM&NNDO[7V926V+:X
M1 403 !,1!!)B9/;?CB%/3RD@E>H8!Q!@1/;B.V];*]E^KG$8[.06GINI:.A
M6J'C^K/F3C0UTJVM;'Z&'#3*-TD,3IB);<%E+2_=7*" $)!)ZH_[S,%*@JT>
M+FM)"YC B=C!!4)@XP!.TV'+4&0@Z4%,%),@Q^8D;D1M2B;Q_P!;C59 K(OI
M'8B4D)T.1Q&YAX^6YW![W !+<MN_V7$=R5,_F2I"BK>_C97VGMU+4Z;5XNK/
MF5( [;  ':9(]M_-&FS@!)(TI!CG.V,GX?#;:K(^,>L-R*]!B>D5;'TBWWH;
MM=S3QRM^ 9:#[JI'?:.%82L[;2L) 'P"0-9/VK25()M7%_@"TJTA*D@YB "D
MB/?::T'3_/,@B#$$XWQ$CG;&<"(-(C*^&O6KR9AN-\90?3#38[ >SW&;O)\Q
MM.5, O'(L.HO(MA*E!JNFKF&0VRRL(99!/=X3KSU0ZAUMGJ'C%33R7' E+15
M_P M"!A2?+'XAMS(JTTR6B(5*0#*>_;B>\YKZ!ZQAR-#A1UZ[V(<9ISR%?G:
M90VH@C?@J"M'[@;V=[/G0(_0>V/W^N*L5LNLTHZ4HZ4HZ4JAWHZ^?M_,?;^1
M^_2E8[TAJ.@N/OM,M@H25O.(;0DJ(UM:R$[43H>?.Q]^E*:F_P"<N.,7SYCC
M7(<A8J<JFXE99O7Q9K3K$>PQVFW^*RZ^:I(C2W8"4ER3%:<5(;;_ #^V4^>E
M*YZ\[?VAMJ>/WG^'<*RVFG92ZXGC?/\ +<;?&*9M!JY0.0#%EM*4IR\9K6Y,
MVE@VB8:;7V5!A2_CI0_7-,;'].F;\S\@3,XA7MMG]EDM1A_,OIWYWMT231XI
M?XW[$?(^+LII(Q$&#76<CW9,<JC.NDJFLE?>PC:L1\<#/?X?&IM0?0KPY)MK
MS/>1H)^HR";7YO<8U M9%;C&*YNY4)@YG/H9<5R*ZFIR7VVS:P7@B+(,<2%H
M#KJU%]?7^G]\_7U^7-2ZXXR'CR]HFV>-)U%+QZF=35(9QY+*(,-V.A.F$ICI
M0E*PWV*4I22I] ]TD^25*<?I2CI2J'X/\CTI4#/[0O&N2[C@.1><<2<AF-X+
M>P,NSG!\6FIKKSD/ *Q#ZLCQ:LL4@KASW8JC+B*;6@NJC?3E8+F^E8.,]M_;
M]_:H*<!>C!7.^ \A\O4)C\2XQRK18;DG"&#5N33,KF8)FF(E<B!G-_<.R)+,
M7(K9Y"8-]5UKKC*65O(>*G0=/KZ_2D'''IQ\-OKXS,7!?35S-RKEN$\D>KJ;
M@ZYV 8O?8K08'@2Y4^NFC((!I[NZR.]F-1'94BUA K;K8C!CQ2\M*G7%H"NE
M9YDY/K]<U/+&<:H<%QFHQ?&X**O'\<K6:ZIKF>Y2(<"$V0TPV%E2E!ML:3M1
M4? _DI4:^+/5?0<D9O-QA]BDQR%-FV=?ARIF20'L@O9=-:3*B:S+H&E&16N/
M2*^8[!;?6')##25%""MO;Z^OK'-8D';/]OK\Q4O.E9HZ4HZ4HZ4JF@?!'@?]
MQ_\ H'2E4[$[WKS_ -Y.OY;)\?'D]8B/UW-*"A)^1\Z^Y^WQ]_CQ\?!^_6:4
M=J?T_P!I_P!V]=*53VT:UKP?D;)W_'R?G^/6" =^1'8Q[C-*NT- ?IK7D_;X
M^_G^9WT @ #8"!SMZG)^-*M+:#\I'^T?[M>?'S\]('8?*DGO]?1/SJO8GSX'
MGY_CTTI[#Y"DGOMMZ4=B0 -?!!'SX(UY_P!GG]?D[)/6:4!*0  / ! V23H_
MQ))_KO?3:E':G]/MKY/_ +_\C\C[=(W]:4WN2\G\<X9-<KLIS;&L?G-LL2%0
M[FYAPI"&9)6F,^IN4\VX&GEH4A"PDA1! 4?'3:E*^+85\Z U;0IL:37O1Q):
MG,O)?AN1^PJ#R'VRII;02"HK2KM &R3YUB!,\FE-8KU \'IEB$KE3!1-2_\
M2JBJR*L#_P!5[GM^Q[?U'<ESW#VA"AY5H:)ZS&_KO2O/FWFNBX6X_=SB=7S\
MD7)E5U5C=#1F.NSR:[MW6V*JMKE27F(B3+<<23)<?2RTUW/+/8GI6#&_;Z^-
M-GP3ZA<VY%RR\P7DKB5[C;(JVM:O*^;69/49SBMI6./^PY$_:&E/T\*]A*2#
M/JI"4K;!26G'DD*ZQ [#XYK/?W]>WUM^LU+5(!2#H>00?'R"3O\ H3LZ!U^G
M6:5=H?Q^0?DCR#O[']?D?!^#XZ4CZDT=H_0?\?'\M?;]!XZ5B/?'J?S[_&@
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M!\:5(7E'DIOC"BB7:\/SC,OJ9B8?X;@6-S\GMF>]IQP2)$* VXXW'0$!"G%
M=SA"4["5=( V %*27%W/#'*-S-IVN,N6\*7"BJE_7<@8%<8Q7R0MP(]F++GM
M(0Z^"ORTGSVH6HC21UFE00]1'JVR:-S/R+QACG,4'ABLXKJ*M3DYC I/(=SD
M>26U>FR8%E!BE?X1B<-MUE-A,+:']*<4AU';UB ?@?49_M_IS0_7U/\ IS71
M#@?*\@SKB?",JRQW'9.16]%#E64[%)PGT$]];:=S:M]))3%E?],EA:BN.5EI
M9*DD](YS\S^DQ3Z^OKVIWNT'6Q\?'\/^/M^GVZ0)!Y&U*M[$?^3KQKQL>/Z'
MK-*KVI_3?C7G9\#[>=_U_7[_ !T^OG2CM3H)T-#6A_(:'^0Z4JA0@CR!]A^A
M\[ &QY^_V.^L0.P^0I7.OUP\?YEF7)WHFL\1QVUNH^%<[Y!?9'+JVD.NT=:Y
MQIE,"//<6X0Q']R?+CL,O/%+(?=90LI20I I!,D9@C&)F)!@CMZUF2,#:03\
M 0..)]._%<@N)\1]8U#0\V8OQ_3\O97967'T9=]GEY S#!^0*N1%S2(O+,:M
ML7R=RRQ*VY(L\07?&EO,!N%U:W@PEF$TGZ8+1]2?7G'?;8;5KZ^O;U^._)VC
MMO6[Y1X0R+D/&,M5QAAW/TCTSXWE?I[RRPH\T_:]G*%YSCV:17.0;3&H5G_\
M8WZ^OI'(JK$-(5#58,RGH?ELD9DS,F8B9.U#\QD;3F)S\(QG?CF3$K'?4HUR
MQFG U0K/APK@-1E_/F-<@//6 FY"UD.,RCAW&K4QT_5/RJ6XG2W)$%P!89CP
MDE*E I&(S/IW,[^^!]8Y29';DX[;1O\ E^IJ->&8GZCK/CR!+],$'U!4_*+_
M  ?F+'.EARNS?HKYF32EH- WCC%ZF-'E9(E0FN0DT"T,_1EM#RP\4=8($&9B
M.YV^=9D[C$8]C\/2??@QFIC_ -EY@_+N-YWGD_)<USNXPN3@]%%L\>RCCG-\
M3J8G(#<I"["7#M,\N9\Z9;H8]]BQ9J(Z:A:%H>;<WVCK/ W@;;_7P-8S/]O[
M^W$;CV[6!*0=@?P^3_N)U_W>/CK-9J[I2CI2CI2CI2J*^#_+QKYV? _V]*4P
M_J1X<3SUPER!Q6B^N,6F911/QZG(**S?J;.GNXX3(J9C4V*I+[*69[,=3P0H
MEQ@N(T>[PK!V,=JXM5OIC]8G*?%6(+Q#/H%ER7P1F9I['#N>X$^'9PYL):JN
M^1BO)=-#4]=8IEM&7E_AUQ4R67DO,$V3;C0[F?K.?R^NU9KHUQKZ&JS'V\ C
MY7G64W6&X%<,YMC/%,M53)QW%<N?;4M]B->(@L7%K2U\A^1^&0I:@A"% .J=
M![>L 8B2?<Y^=/KZ]ZFXEJAPRA>$&#'JZ.FBR9(A5<,(1'92IR3(2S"B-DE;
MBRXX$M-%2U*(2DDCK-*C:QRG2>HJOY'XFKX%MBJ;G%+&!56=L[$AVT]F6PY'
M<L$42)#MO5Q6O<0IE=Q%@N2?)9;4W^<*;_6_M32>E3&>9,4RVJJ,IJ\C@&)C
M]S Y718UE7 PAW)*R7&@XG9\=2(+#+DV!95;#C^U+DN,Q%!%BXU._=*4^OK/
M[=O6.BO2E'2E'2E>+D=AQIQIUM"VG&UM.-K'<A;:TE*T*2K8*5))"DD$$$['
MGI2DYB6&8O@M.S08E30J*EC.R9$:MKVU,1&');RWY"FFPHI1[KSBUD)T 5'M
M2!XZ4I$Q><.+YN<IXXA9=5R<O<#Q16,N%Q*WF$][T1N6A*HJYC*05N14.&0@
M!16V"-]*4S=5.]1$SFAUFPC-6&'5DQUJ08C*<;PZMJGBKV3]?9LR[_,LA4V4
ME2:R!6TL3?[V8Z=#H?3--SG$?6P/IS'RFM=$](%14<C/Y-C^0,5>'3^0ZSE>
M?BQH6)%NWF5=V*4JKR54E+T"DGOM-/3:U$1TJ4N2&UH$ES2E34Z4HZ4HZ4HZ
M4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4KEYG/#N$\E^M'GF=R!@T#+(-7Z
M9\0;HE7E>N=6L3Y$S)_J'8B'$F.JP:]J*I"FR9,?:5-%"O)5C$\3O'/;'PFG
MP]"S%L?2;QW76#;J)T>JN:^/$NFY/<VPW83F(464V[N0J*EKVT%/8I2H_P"4
M;.NE9VXCX1OSZ^],6[Z7_40K(U6*.,/[/LP%6XE"4K N0Q>F()?NAU3XAF+^
M*^WI??WAOZG9![=CI6,XP/GQS&*77K]X_N\FX-PN6B!9S*WC[.L,RO-J["#+
M9M3C50\VU=G'FVO9EE$1M2W([:"F2B,@>V4N#N*LGZBF[]+SO'MAZD[2Q],4
M:^A\%HXV#6>EY.0C%Y>?/V,9=**YG(2MS]H&(GU(MWHRPDMJ29#BW05=*Q'O
M^7[?/X_+J>D #0UKS\'?W.SO]2?)_COYZ5FKNE*.E*.E*.E*.E*.E*.E*.E*
M.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*26>5DJZPO+:B E*Y]KC-[60D*4A <E
MSZR3&C-^ZX4H;[WG$)[UJ"$D@J^ 0I^7]ZY^K].?)PXQ_L^L:9H8C=GP-F>%
MW7(L=$^"ANFBT^#9!36+S#@>")I18ST-E,1:W7/=+G<E6RK$&?GSP3(X]NU9
MD?"4\=L<1W_<D5-KE/C!OE"BC4IS?/\  Q&F":;+CK(OV9MI!#9!BOS1%E)=
MCJV2H%'V.R3^9.:Q2.XKX#9XLN)=RWRSS1G9E1/I16<BYP<FJ&"5I5[\2)^&
MQ0W)V/;+R7 $H*@4$%1Z4J,V5\4<O\2<^<P<N\6\4T/,M5SKC]5"LH<W)Z7&
M+7%[RIK$5#;=B]=M*:F8G.90EZ<J N3); 5VP)'Y4I5CGW].W<_I4G/2[Q/;
M\*\*XC@&038LV[KF)$RU%<5*JX4VS?5,?K:M2TH4:^O6X8L0^VRE3386AEM*
MNT*S4@^E*.E*.E*.E*" ?G['?]?^//\ /1^0.E*M[$ZUK8\?))^!H;V3LZ\$
MGRH>#L=*57M2-^/!))'V)/D['QYUY\>=G]3M2J!"1\ C^15O^IWLC^'QO^?2
ME'8G>]?I]S\#R!\_ /G7QOSK?2E4]M ^$@?IK8U_+] /L!H#[:Z4JX) ^!_Q
M_P!_W_7[]*57I2CI2CI2CI2CI2CI2J=J?T&_U^_]3\D_QWOI2J!"1\ ??^?G
MYV?G9^Y^3^O2E:3)(MO*Q^ZC8[,9K;UZLFMT\Z0PF5'B62F%B$^]&6I*'FVW
M^PJ0HC:=Z(Z4J%/IS@<O)M:K(;RYRG(8%T,DQ+E^HRJP_)0YI2R%.U]_BT-8
M;3$I[**ZPPN%7GZ?Z>6R\E!?9>65/;XU+_$^/,+P@V"\6QRKII%M->L+67#C
MI^ML9<AQ3KCLV:Z7)<DEQ14A+KJD-^ TE"4I 4I9A(!V/DC7R=:\:\;UXUX\
M>/.OD[4JO2E'2E'2E'2E4(^?GR/L2/\ +R-'^(U_/I2H=UGI>AU^4YFMNU16
MXG99]6\HX0[4@,Y%BN6N'>311(?C.,/4ER\I:BV7%K:;6IA"4H(4%*F $;2
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@>/GY/CQL_<_)'@G72E7:_G_F>E*.E*.E*.E*.E*__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g68105g23d51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g23d51.jpg
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M 0$! 0$!_\  $0@!30') P$1  (1 0,1 ?_$ !X  0 !! ,! 0
M   ' P4&" ($"0H!_\0 31   00" @ $ @4(" ((!00#!0(#! 8!!P ($1(3
M%!57%A<9EM0)&"$B(Y75UB1455:2E)?3,3,E,CA1=Y&V\$%"87&!)C188F2A
MI?_$ !T! 0 !!0$! 0             ! @,$!08'" G_Q !9$0 " @$# @,!
M" X&"0(#!0D" P$$!0 &$1(3!Q0A,147(B-!46'P%AA4559Q@9&4E:'2T]4R
MD['!T=0()%)35Y:CUN$S\24T-C="8G5VM+4F-42"1:2R_]H # ,!  (1 Q$
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MME%N2#WYKSO#2-6D>VO:+:--KO4 _P!C#U"A#NNS,O9E^UEL77-)<J<1IW4
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MI-,D8U) :FLKK5++,'!ST/6,0OGNQE9;JY63 6]'QTLM")URFU<L-#A1+\,
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M,-!R5.<L+4E$_J]O>LZ-L$XE$-O2VFX=\EVAFQAA462\_5(PUT9-,69V>B;
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M,Q)#TQ$+G-!/Y/G3H"KVJFA;#?8("SZ-V7U_Q&41"2GQ%*V;JGKMJ C*@RY
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MX=5Z+LS_ $:[6UJ%^BW>*7OFTK,;>SF.P9XW.[9W#67V5W:ELLK:7;QUNO\
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M/U5A_P#N#6;[R^[/NK!_IES^7:?:B]>?[M[:^[E5_G?C[;[PP^]>]/U5A_\
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M:J,]FM>SB$$>'A64ZJR51RW:[F"XH50W:<:(UEPL$HL^6>AQY%N!Y2MHM5+
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MR#L]EN/0<:<OV-E2:](U<_NMF_1Z2H1@NN@N:HBR+K])<MICIB,J"K:3:\H
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M66YF:7'N<&S@"]MBW([4;9+E"+G-I)]JRTLF6*C)*[!!%E9S@Z;)-35%XL/
MTFZZB%-&'!,^$S*QPNT=^KP"L_7R^,O9M6>R.#S3G4L_8V_DEY; 6[UVHXLE
M6IW+!5;#<A8FZE'E+9F*'U,A2LH6Z.AS.W2R)XYE*U7H'CJM^@L+&.7DJI4\
MBFNAP14:]*H:L*RX0;.\F!EBW5WJ80:E<'VZ4$76RB: Y*L8Q.HAIV6]=)JP
M1:O:;LH^R5^,(!2@DN4!/$WA<*,;L4L[8,2$K)26!<>27(+>[3'>-TX\L5<C
M;1NRE0=DU,B]F?L%CKN,V-E:V4QJJ6.=CW.QN2MG3KJOY1V1R?=@K;0IK;=L
M$>BL[!\Q%M/NK 4W3GG55CCEQ91;W!3;4MF^R%E86:J1>PZU1=:KT3V@-Y@A
M41WM6]J8P>S:ZBVD3(B5T'&UG7C1KXO-)N18%*W=/VS*L2130M3TN2]&)N L
M#VG5/(:BIF-RG\NX@(R=H>,J:66VNG,4FHQ>/5M+&7[_ )ZQ<--; >(-G>CL
MF-(*<FYK%6RQT50*6""1>+F2<5AM9O8YV*>6.C8!ENR>8MUZTUUI@VY#;BL$
M%27D^!6 FF+4M(>F2.5R P/=GJ#NVD6O9KHX#0)K@"K3J@0'MG;PZ8-RI=;W
M"UMXDN:;S6(?GB&)S7P<?$P.0L'$7F9(D&YJY"G[%;QK3C)QE7&[9>6-P]G!
MVJHY'<)WL@YV*WR&][9/R$XBOU)OV0\E63%6"QR2ES&9!\MEM;=AG;\TZUE5
MC:NJOJ;-7&C7K %O 3@40NO%UD0RNJ>^YG=F++([8#67 =-LC=H1.)M.,D=<
MD)QBN1JX')(;V*4@UDN JGT@R&:8JC()8QDXE9Q$B83L*K:(?EPEOL5J)@J4
M;DXB?&"E%G!W[6U;-F]BDXRC;$=TVZ^)NXW#^Z?D07A5XZ:89""R M?;R<YJ
MBQU<F+Q2?-VQ;?/9+^WD*Z<NE5>V=NPF2Q"&W$6KT58L2=XK,.*M,5I$$U(H
MO$&])VS[*9#($=PHJ"86?C6B\-ULUJTV%C,VP8/;3(UG7[75FV9T<30QXI40
MP&M<C/M @H!%$D8D=^&PX/\ ^B4;*/'-,6Z%F-I% XJ_L_(4%+S52L,-VGC,
MSAA"RJEMRK2E-^AF6_$T*6-32M)4Q"BK?ZD.+/A\<IL*G,QS<KYJM9,J+FS(
M9BU1N$2C?E'/AB+%$/C++[1O4PA84-^/FWUSMS]&UUPE&H#C]@@(U'"L<EZX
MO8!E16FH"1]::KM?Q7L_1$E/:9C+-D<DCS#KB9N1PT:DE+2K&Q?C;[E%B[:M
MLFS)UQV2C*N//,C'W:FQ*T5L4&+QD8N?<2U9 %%?M3;R2S.'^5JU!M.&;MS8
M7G(MI+*P%5LYYE,!QXS90_<+)9<*W:\U$WDJ(CBLJ%52&)7W6NE(3KKT'MC]
M$!];&EZ(NT1:]4:W6G8\FQ"\Q3DFL7/8-O@$"D8_2;2AA.%7UX>R\$4(M0O
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M0!EE;"F?C.I@0K0LGD291!IY*HIRZBGFK%R5DK44,@^W"4NI.,AAZJ\&05V
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MK&,,JJI(S,E21$4S,D13,S,\S/.H8^MW;'S/V']];)_$^<']FV\_PNW/^O\
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M;>?X7;G_ %_E?\WI[@8+[RXG]74_X.GUN[8^9^P_OK9/XGQ]FV\_PNW/^O\
M*_YO3W P7WEQ/ZNI_P '3ZW=L?,_8?WULG\3X^S;>?X7;G_7^5_S>GN!@OO+
MB?U=3_@Z?6[MCYG[#^^MD_B?'V;;S_"[<_Z_RO\ F]/<#!?>7$_JZG_!T^MW
M;'S/V']];)_$^/LVWG^%VY_U_E?\WI[@8+[RXG]74_X.GUN[8^9^P_OK9/XG
MQ]FV\_PNW/\ K_*_YO3W P7WEQ/ZNI_P=/K=VQ\S]A_?6R?Q/C[-MY_A=N?]
M?Y7_ #>GN!@OO+B?U=3_ (.GUN[8^9^P_OK9/XGQ]FV\_P +MS_K_*_YO3W
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MSQF1QM>I>,/.P!JLHO.-D2Q:5KK2\29"VP>42=*]?<,/5AIR-'CR]@ZG(2K
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M?-=^_";4[T]RG61-QY4?3/8)BW0*=QXWIX98JUCGLY.L$S\3*SF(]L;71I+
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M0*M=S&5P1HJ4&"9)Q$I.JVQ!6*MLC489 %5!I@ZN-NVT+O\ K+6<A6%<]LY
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MK/8*YA-;MI,(J-[!P<NV!TQ#[++@Q3PO"X\]J1''R'F(;T;S)6EI,<^FLP2
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MPA[,++B:]C_X!<*P-_\ \;C3B/;QZ_/KKMZQUJU$B#VM>T=N! ,Q['!A-U,
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MOZYE'G\V(OZ<?TC./2__ +\>9K=4AYA'7"?,R/=7U17]G?D>KF$\^G=XZ/\
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MREDY&10NRDHEPFNP<.'K X I7JL?[@$CLJROKJDQ$>P$>P$[V$JVNSX3#.[
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M\QDS8MI6V22I=(#$ *HFP';L221"$GYA?Q;^M9=Y<0MG4$0.K0XK'@MBQJA
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MN/M4O"7[FS_ZZ9_ T]]_>?\ O\?^@+_?T^S7ZR_U&[?>UW\%Q]JEX2_<V?\
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M7GB+;PIHT,6Z\Y%3%?Q(5B(_(S'E89XZ]M+<F-6#+N(M)Z\QE\ *H[;;,Y?
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M%EE551AX[&Y+(A)V<!8.9%NSMY)*)*QA;!3*J-YL%"8(9@H'55*I1B4P\T\
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MR?U<+;!*-D 8YY=/R>%YB7"YGZ!8@M-KK],*,4HU0/HX*V+K%;O6XAJF?2J
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MXPV.8'$0Y2G#J<4;M5OJ-5=7-M'7&TS7,.Q=]Z$E-96_9M%V=Y:9MIJ\)3[
MIA]Y:6$MX5C-35*JJNU;=&Y@JN"N!F<YA,,1/R_A9F'E!I\2?#9P23,MX=Y9
MDQ8S&'KRQ5);&3 0$2,2!FTZ[E/1D'9!!4<??O1"J6[:2XZ6;6W0$\#3W+3&
M)72NL@9>8A\+UYC/*AK\SL2PD:M*%AGF[,\$LVS!X65*':]NPP@[Z-;[3:$M
M(^)+C5#8<1Y#;MCKC.&$&9*'F7VDK2ZXGH\)MJ]N?)VL.ZG18.6/'Y;=E:@U
MU3;&X*ED^C%>,/AOF*R7*PFYTL$#RN+7VXNN%BV!!"1QK+^5KXJJJ\MU@2IC
M9IX=MD =E<<Y0\W-D[IHM8L[^),9D:ELNJ:X2)"4_!B?26G4X=3AB8S"L$3,
MM@;FS6J5!&13UQ+#AD05\?LCXN'!9GEI$6$PAV0IG&<)0E"?!./T_5&"P57!
MU(4N8M7WKJSELRVO43DL[=JU$T_=+*LJ(KA8NM4A<&V0CB(@8](]?(LA?=?=
M)E':KK)T4Z0,<=:@AKF/\K4%S&$I &PI$(+VSS/KK+N;O6#IQIIQIIQIIQII
MQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQII
MQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIK1BZ?D]=!WRW6:ZG
M)%]29MATI8BJ8-B@1X>"!>8].EXBL+!OK9CX??7Z3:GG5(1Y4Y<5G'CGYYSW
M^C)X;;CS>6S^1/<47\UD;F4N17RB%(BS>>=AT)7- Y!?<870$F<B/$24S'.O
M2L=XJ[HQ="GCJPXSR]&LFHCN5&&SM(6*PZRBP,$72,=4P,1,\SQ'LUC/V9/6
M[^L['^] [^7N:G[4OPI_V]T?KBO_ "W69[\>[_\ 9Q/Z$S_-:?9D];OZSL?[
MT#OY>X^U+\*?]O='ZXK_ ,MT]^/=_P#LXG]"9_FM/LR>MW]9V/\ >@=_+W'V
MI?A3_M[H_7%?^6Z>_'N__9Q/Z$S_ #6GV9/6[^L['^] [^7N/M2_"G_;W1^N
M*_\ +=/?CW?_ +.)_0F?YK3[,GK=_6=C_>@=_+W'VI?A3_M[H_7%?^6Z>_'N
M_P#V<3^A,_S6GV9/6[^L['^] [^7N/M2_"G_ &]T?KBO_+=/?CW?_LXG]"9_
MFM/LR>MW]9V/]Z!W\O<?:E^%/^WNC]<5_P"6Z>_'N_\ V<3^A,_S6GV9/6[^
ML['^] [^7N/M2_"G_;W1^N*_\MT]^/=_^SB?T)G^:UG&O.A6CM969BTUU^Z2
M)2(9$7-&G"P8P$,AS$-T>6#&!DJNY:F#B$-]QB0UYFW,8SAQEYIU"'$]!MC_
M $<?#S:667F,4>=-PHM4[%7(7:-['WZ-Y!UKM"]4?C)6^K:0PEM#D#]A+8!B
M)1K<MXG;ES-,J5R,>*Y8EZVUD/KV:]BNP6HL5W!:ZEN4P8("]8]L$)#,Q,F#
MNLFOA$>H-C"-PAR]?%ILRCF$G&'S-; $%*]YK]@A,'272NOWFUKCXK=B^--M
M1E888DM-H;2CK:OA-MJDO"#4M9Q#]LW7OV_>'(+9?Q6-LS/?VTNTZJT[FVC&
M97&*RGGQ!4PM;1$1@=,W>.5>5^7*H,7E4+7DJ\UB&O<M*X[>4)2V@*,H,Q!3
M;J>7DCCJ()F2YI*ZMZQ;&R1(U=F"0&+:B\TYH,8;AN:PLBW?7(R=;RO8N2JX
M.-/96X5KZGYU=>RX[A@5&2M2>4%X0;2BHVE6++4*R\T.X<$%&\*#VCE9/N6F
M[5=Y<G8NK?.2*[C)98Q;.HH734)3&IC>>9EP/;%.PPJ,XW(38KRP<S3B.E09
M<.Y 6VUQB(1:@56PXB2><Q$QV"?6+5Y7%U8DL&FAM\?A&3(:$08@BX5X'Y2J
M/LFM,1(+3M6O:UH2Y,+5]\?#(N>*R V4I2LYN6_"3:-R,^IJ[XU-QLKWK]%%
ME=>I7W#5F)5NO$@FN!X?<<D,&^[C65D6BY*U4=,SJ$[RS2)QY@5<G8P65Z]A
MBB:YF-;$P>'N$QA1>QD1,PM%L7,5$\*<$1'%>3ULUN0(&"!=)HSFV52/4]@0
MB,R$H9L9F"VEL6?N$",-BQY%P$J2AX=:Q"0YIAY"59E.)QY>76^%6U;-F]9N
MC?O^[6&7A=S5[3T34W2NN$!4R6<K*JI4W.4I@3JYFE%'(+,1F7%$<:H#=V74
MJNI$UZ_D;QWL4Q2V0[$DV9E]6@TVF84'Q,BZB^;%<AF8Z(YF=?L'KA08DRL$
MWYEF+EJ]6YU*($S1*$0E7NDS6W&45+8J'!:8EP#CV7$MC5DHN2<7T6G,$5O>
MHZXK>%FVT/Q-MC\M=NXS%6,!9MW[:+3MQ;?L"01A-T"=2$9RC6 H&K-M,VT]
ML#BU+.HR-W;E&+N)%=.NBU<5D5)KI8H,9D5R)3>Q,PZ64+#2B9="3[)]11VH
M&8&*0KK1KD*S24#I%J8E:Y-S"%+*J/*>+A !!S*IFN\$7HSD@EKQYI3D3Z.&
M5$?2B.*99F-X2WE%%/PGVM0#;\569A;MK9!]G 7)R)'=Q^-LE,OVO%HU$VWM
M=@22?<J\5KH24K6\($)&7;ORUB<CW1I$O+UUJR*(K0*+-I4<+RW:$X!&6$HA
MGFZT)Y9'42YY*)E:ET6J:["JKE,#L@06210LV*BNR5PHLLS.>(STP&)#SS8^
M&N6^ZM@="Q''PTJ]*)&8;QA'.RP.WL-MBA.+P-%>-QWF[ET::3:5=+[U@[5F
M*ZVL8-9!.89+JUX551$]"$K#X.M)D,E=RMB+>0L%:L]E")>8A##774*5=T@$
M9:R%B,$UG4UG')F4^NLMYNM8.G&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&
MFG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&
MFG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&
MFG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&
MFG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&FG&
MFG&FG&FG&FG&FG&FG&FO&SMS9.R] L'=N_Z],;;.T=[557UI#IE8D665-H]B
MLFL"3U(W'IV*,SF:.* ]C$&Z]LY%5]%V0#LD&\E)4=6K4L$6FNYLGLCV7*$Y
M@4-98]6S VY%^L,<&U;8$EM"TBC=VM+ZYKZK.?EEW(=@![>T4?N5]-2946$S
M8*N',6:FNPZ-'*/QVFI0ZW]F=^;,MEC@;-55:+"CSZO\0"*H%CFF-=64CME5
M33J(L\/+NPU%;-6?+!BG;%.%EQ!:,O8K-:+T&P#1@9IK ^TY^="VYV?9@WG?
M(G;(SK_JJ=U-J>N;ONB*)-;BD)W+F&R.UO5"Z-7W5<^W1:'$N;-_KQ:NI!89
M^F+L2LMRY#+35K)=J^RE"MT('&JS5A]>[[AB0-;BJW=+'>+N6_.AWW1QN($Z
M_647ZE!9J=9HY5DKK4_9W]2!YTVS6?6,'5$R@P,M-59_;G>L:L0" W9E-.Q)
M%#O]NQ>8_6W9,87)W37*=JDU4^K,8&NT.+)G+:9N%V])H20=OK":>]K?TLW\
M6:)*::R"_=J>W !B^#&M;C:]*U=8J\)V!:R-5(RJ_! [NV362FM;'62<DO"
MEF=0:6<L@'<9IZ6Y6Q>Q98:X%TB*>%.5^6TU2#=I^ST6JVC;USQ4(.L-,:WU
M;LO8,6!K"W(F7>@$]Y;HK6U;Z#-3S+"X;U6Z^ZT$[7'5NO +#"+&RV&@MB,5
M,Q7"<YIJ1]C;][1T_25*M=AIU/UT>L4FDSK#9B\S$B.)9MU>/VPQ1XHF1'?K
ME.LU*DLB*0FU[5LX&AVLI#EPXQ</9K34QSC36JMA[A=G:G6]H'H1(VY<;//
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M33C33C33C33C33C33C33C33C35D>K8&18QUO?$P7;.("&:V,.KCH43@@;%/
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M ^;1,3+MFQ[/NT&[7)J]W=ZX>SNP%Z6H_"$"(]1K"X<6=7<DYQQ5/@XFN?\
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MQ<F/9ISZ<_7\>L2SW-TN^X30$3?K4@8Y8%^O5M=VLU'*"J=$@D+O9 #D8?\
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M1X5'%!&[52T19%Z2Q.I-H(5XFR V8V&9OE-9F1\K7&JMA;KE=4N%%2S-$RP
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MP=B!'AUTPNUV<J0GMT5NHB3D/X< L PM7 XD3"<^WZ8X_)]?3UTXC^S]G/\
M?//I_9K;3D:G3C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C3
M3C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C3
%3C37_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g68105g24k79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g24k79.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1["4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'J:^>$8X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8             !-    =H          $
M                     0             ':   !-
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P  !-      4F=H=&QO;F<
M  =H    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   30     %)G:'1L;VYG   ':     -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ : "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M5-<^NJD5W B6[V,]6@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MS2_B$3^-HB>D= ]\TOXA$_C:(GI'0/?-+^(1/XVB)Z1T#WS2_B$3^-HB>D=
M]\TOXA$_C:(GI'0/?-+^(1/XVB)Z1T#WS2_B$3^-HB>D= ]\TOXA$_C:(GI'
M0/?-+^(1/XVB)Z1T#WS2_B$3^-HB>D= ]\TOXA$_C:(GI'0/?-+^(1/XVB)Z
M1T#WS2_B$3^-HB>D= ]\TOXA$_C:(GI'0/?-+^(1/XVB)Z1T#WS2_B$3^-HB
M>D= ]\TOXA$_C:(GI'0/?-+^(1/XVB)Z1T#WS2_B$3^-HB>D= ]\TOXA$_C:
M(GI'0/?-+^(1/XVB)Z1T#WS2_B$3^-HB>D= ]\TOXA$_C:(GI'0/?-+^(1/X
MVB)Z1T#WS2_B$3^-HB>D= ]\TOXA$_C:(GI'0/?-+^(1/XVB)Z1T#WS2_B$3
M^-HB>D= ]\TOXA$_C:(GI'0/?-+^(1/XVB)Z1T#WS2_B$3^-HB>D= ]\TOXA
M$_C:(NUBN4>2ZAB/5*>^\X>5MIJ9&<<6<$D(0AU2E$ $D 'H"?9HBFNB)HB:
M(FB)HB:(FB+BH$I('0GZ?S'_ *-$6CI[LE-XK?[-BZNS^VFXR'ML:C?F[6XU
MZWGO12MJ)+U3J6W^Y5[7%>E>VV@6^QN13Y5*$]RJT^BU:OL7,M53H<2J4Y5,
M88K3P8(I-3>R&WYO'A$O+A*XA.-^EWW0*-4=IKHX6;@VIX6]LM@T<,M\;15J
M97J)<-&MVR*LJGW>Q.F+@,3J?4GZ>X(C504Q.:FU)R8V19F\ W M<G"-(WYW
M&W>WXJG$UQ(<3-[T&\=X=Y*A8]#VVB51FSK;CVG9=N4&Q[=F3Z50J3;]':?
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MLQ=Z[1[=<*5-?E\+G$1M_?K=O72A6Z-HW;=E%JD?<"37)TX5&B16)!%ZIT^
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M_)8_^I\N_L2?= [<;W%O!_\ =SMU]@Z>9ON?ORC*_P"N\W_MJ>=.F;^2Q_\
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MQ]=T1<'*)3FD*<=EU5M"05*6NO5=*$I2,E2E&< D =220 -$4KJ"+?IM%GW
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M<I%;JECW,N(Y 7<%I3ZE#DRK>K2H+SL-53I3L68J,XM@O%M:DDBK? ^89^?
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MRE'!. *5*R< $G\P!.B+$O@T_P![W_\ ]\6Y_P#A5O56VD<H_P#"%9VOK_\
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M1=3TAB,VMZ0\VPRTDK<==6EMIM \5+<60A"1[2H@#4M:YQ#6@N<3 :T$DDZ
M 7)[ H<YK07.<&M:"2YQ   U))@ #B2L2-T^//A%V=3);O+?6Q55*(5H>H5L
MU,7E7T.I'^1=I%J(J\R,YDX_PMN.D$*YE#E44]SRGH\VTSLM.!V>S 4GP1B,
M72\@P^Z?QA6QAH,>+:L+N=UU3,MN-E<K#O*<YPCWML:.#><;6F0(+,**NX;B
M]0L %R0+K6[NIVZ^S]%#\3:':2];ZEIYDMU2[JC3K&HI5X(>99BIN:KRF<GF
M+<B)2G5 <O,C/,GU#*?N?<ZK0_.\ZP.7LD%U' TJN85HMZ+GU/)*+''FUU9H
M[3 70<QZ9\NIDLRG*<5C'08J8RK3PC/]9M.EY2^HV(,/=0<>';@ANYQ\]H7Q
M0[;[A,6[MC(M?927:%R(OF?9NW%3GT5%EFE3$W&FL7U<[-3CL,II0F)D/TQZ
MER0A*O)DH?Y<^A9-T<]&NR69Y:[%9JW%Y[3QF&=E]/'YI2IX@X[K6>3'#X#"
MNH%[C5+"QM5E9M_2);*Z1FFV^W6TF!QS:&!-#*7X>L,6<#E[GT!A13>:S:^,
MKMKFF.KWM\MJ43: &DP93L%V@G&[PG[7;?0ZSMH;KV%11HR+$DW=9-3HM*>M
M]UUYQAJW]P:'%B1I)[TOA"JKYZ?0L+0XWZO(G+M%T;; [8YKF3\/FWDFT)KN
M.8MP6/I5ZS<0 &DXK+J[JCJ<-W!%(8<$0[>!,G'DFW6U^S.7X*G5P?7Y/U9&
M";C<$^E2=2<YS@,-C*0H]9Z0=\=]:)<"!  V@[.]MSPVWHF'!W4MB\]H*N\4
M-OS5,"][2;6KE3S"JT..S7D)*R<]_:R&VTX4M\IYBGR?.N@7:G []3)\7@<Z
MH-!+6%QP&,/9U6(<_#.M$$8R7$P&VOZ/E73#D6*#69IA,5E=3>W75&?AV%$\
M=^FVGB6R=0,*\-$#>)F-I6V6^VS6\T 5':O<ZR;\8#:7'F[;N"G5&=$2L# G
MTQI_SE3W.H!:G1([J3ZJD!61KR3-=G\\R)_5YQE./RYT[H=BL-5ITGG_ $58
MMZFJ/\ZF]P.LKTG+<\R?.&[V69E@\:0-YU.A78ZLP6/WRA(K4]1\=C5=@$'J
M-<.N531$T1-$31%:K?< [(;R9 /_ %*MP_'_ ,$:OKF-GO\ '^1_]<99_MM!
M<5GO^(\Y_P"JLQ_V2LL1>RF_ZPK8?_O2^?\ ]3+SUW/I@_\ .)M%_KY?_P#:
ML"NL]&G^\K)N['?_ ''%GY[K8?KS1=[31$T1-$31$T1-$31$T1-$31$T1-$3
M1$T1-$31$T1-$31$T1-$31$T1-$31$T18#=H-8>V\C9:]=\MV=]N(K9';_8O
M9[>VI77-X?K]EV=4YU NBSVX-4K#D.)"EKK%Y6LS3A,VTDE;!HER35R4E8D+
MY"+S6\&VYFU+W%WPYTBDU'_9#,6NU+?^UK'IS'%QNY1*1P_/W4BW(NY#]L;G
M1Y]:?55@K;J2U>KEA,1G*W<%MO19,!I466U)T1>TH> _,-$6F/\ V01>=^6+
MV3?%'5]OYE5IT^=%V[MFX9U$F.TZHL61=6YUH6_>+#=0:!5!8JE#J$JC3I)P
MVF!4I*73W:E D7FBW"K5#V"X4>TQX=[>X9K1X1]R:_M3P87MN$]PW\15S;O[
M+5WAROS=BSK'E3Y9D2W*?:VX[]OUE^!>U5B*B"^*/7:G4G8S%,6F358]L>O^
M]%O7[,W;C:;AY[5#M >'[A2A4R@\,,+AYX4MPY%G6G5Y%6L>V=W*]2:A#=E4
MKGGU"/#JEUVBVQ7*L67W'*@ONY3SA"&D(E%Z(]$4K>J$MIUQM%&J,A"%82\T
MY3$MN# /,@/5%IW&3CUVD'(/3&"2+J\YS?<%5_M:/]J:(GG.;[@JO]K1_M31
M$\YS?<%5_M:/]J:(GG.;[@JO]K1_M31$\YS?<%5_M:/]J:(GG.;[@JO]K1_M
M31$\YS?<%5_M:/\ :FB)YSF^X*K_ &M'^U-$3SG-]P57^UH_VIHB><YON"J_
MVM'^U-$3SG-]P57^UH_VIHB><YON"J_VM'^U-$3SG-]P57^UH_VIHB><YON"
MJ_VM'^U-$3SG-]P57^UH_P!J:(GG.;[@JO\ :T?[4T1/.<WW!5?[6C_:FB)Y
MSF^X*K_:T?[4T1/.<WW!5?[6C_:FB)YSF^X*K_:T?[4T1/.<WW!5?[6C_:FB
M+57VQ7EDO@YJ%42BOT"7;>X-G5F#*BU"'%[Z2ZN=0EQI*H$R1)<CJBUB2]W2
M2P"^S'67L-]T[ZET.5VLV\RS"U,/AL11S'#YAA*S<31;6#&,P=7&A](..ZVJ
M*N#IM#R'?>W5&@ N#F^>]*%(OV0QV(;6K4:F"Q&"Q%,T:CJ>^Y^)IX,LJEOI
M.IFGBGNW0YOWQK'$D-+79 <,5QVQL1PA[*Q:F_7YT)%F1IL235*C3*C6JQ/K
MLF579;3'/,CRY#;,NI/--%<5"8D-#*7W"$!U?3MK,PJ9GM)G6-JT<-AWOQ]:
MCU.$I]3AV-PA&#I[E/>=NES*#75(,.J.>X 3 [-LU@69?D.586G5KUVMP=.M
MUN(?UE9SL4#BZ@<^!+6/K.:RTMIM:TDD2;SV_>E#X@+%KT.?:5:CTE<SS;.;
M:GTX%#L<QJA%DQ9STB"2ZRKN'5I\G4AMQ'(YWK2QS=>^FWKLN<TO(M>>[C?Z
M5:NL<1W"5PKTF51+AW!LZTYD<J?J-->NFVZY>DY] .5RJ)1JK4+@?=2GU&FD
MTY#+0(0TVV%X/9\IV+VKSPL.5Y!F>)IOC=Q!PSZ&%,D 'RK$]3AXN+];&O)=
M>S+:W9O*BX8_.<#2J,G>HLK"OB!$V.'PXJU@;1'5B]N2PBW-[<OAWMQI^/ME
M8&X>Y5205)9DU!JGV/;KOWP#@FSGJK70G(20A=M-$I425(4.4^HY3T [3XHL
M?F^89;E-(P7,IN?F.*;<2#3I=3AIB8+<6^_ KS_,NF3(Z!<S+,!C<R>)A]4L
MP6',3<.(Q%>-##L-3L=008PQJ/:B=H5Q&2WJ7PX[.&@1'7>Y3)L.PZSN+58A
M<&$IFW%6X4NW(G*E:5*D.42"A '>*4A'-CO5+HEZ-=F6-K;3YV<0X NW<QS&
MEEM%^[J:>&P]2EB' D69UU4GXLDF%T^KTC[=9]4=1R'+NI:21_@_ U,=6;.G
M65JS:[&D ?&%&F ?9+E\ 7:B\3;C50WUW#JM"HT]3;DB#?NY*YZ6&%X4LQ;#
MM.5,HL9Y() AR$TC[U*%K:2$*%CTD]$^R0=3V>RIF,KTP6MJ97E5.EO. @=9
MC\=U%9X)MUC75Q!)$Z&&["](FT</SG&OH4GD.W<TS!]7=:2)ZO"4/*!3(O\
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M(158"UKVLW"2E*93))4;1K   Y\DGV 9)]@US&SO^^#(AQ.<99_MM!<5GO\
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M<\/9Z>8X@D2]X>*;G'??B:KFNIGK^0]'.>[3XD9SM9BL3AZ-8BH:=<EV9XD
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MDBNSHB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB(1GQT1?
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MQT_X@MYO_P"J'<__ /*+.UWOIM_WQ9%_[I93_P#7QRZ?T3?XCS?_ -X\P_\
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M=/VWL5:(U.MNBOMD=U7)L:-%?RFH,Q+@>4ZL^GYUM[L3T98)^0;)8'"X[,F
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MT-+\QZC]:)Y)7/?,7X0/M#2_,>H_6B>25SWS%^$#[0TOS'J/UHGDE<]\Q?A
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MND;[1*#:C$"/=M9V^JE)IMQ.3H<2KS8D!F73+;J#E:J$65.;#4>!,:2ZMU"
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M"];2&XGD3T]$?RE3BHS1E!PK=2KU97?A(*1ZB01TQEYYP9%GN'?3?IPX7)Y
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M>W;3@D&V.'O(Z?[[MC_UA_;X:Q>7_<\&?\(;3V$_M&.^;R53U/34?X+DU_\
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M:O#X4G)!\KMCV>/_ ,H/]?9JXK_<^$2,?M+'_18SYO)I^E1N=-'Y-DWKP/\
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MJAS./8 0I/0#P)P-7+Q$"1W=_=:U['52 0!]$</KXWUYB54<5PL! 4E 2HI
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MH*/K=22"K(!&0<#(*@(!!&Z3?U&-->R\3:"2JD V((^>W,WY\;W/>IDBL\P
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MMH;;0J.^B6TVD\W(L+4I!Z)/0A:N4*!!',"D@]? ?-9KAH!:0X7 (O/*.8X
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M(EO._+2-;-PU)S@T577,7IP!,:R[6\Q].LU8[9.&X'FCM0^2TH=XA%R1V>J
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M\4VVZ)T&3&+FSR'FT2&7&%*1]T6^^5Q*74IYFR 4Y'0XZ'(&/GJO_%.]Z0(
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MZF$%(M8V3&[.KBX^E:1/,P><#VK.:N]#8#K @P"1>2;1H"8$V @P  9<BJ7
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M;M.J!IP--=[)D18[:/54HK4H+4,E2TI^^7U!",!M8& YAA7$%C7R1J&'TKD
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MW GM0LK[ZU:8Z%D**%1ODWE)Y5\S^0GG<)2A16L.%7+ZYQ@&7X5IDDG0"&D
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MN56B1'$(0WSLSJG-!9 ='=J2B"T7 V'"KUGVRZKE2XKE!"LU+"8\$C<IAA:
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MN^IJ !?D=9Y@ZQKRCP"KJD;*P0@I;HM)'.DAQ*:>RAW#BP'"E?<)<"7.8\Q
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MU;0;87-;\B_*G7;8EQJE#$R;0 Z$<M8D(3+6S!;<3SA32W4-A#C9(5Y2HC(
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M>"7WYN)^H4SZYI\!NWG\CE/]9#[!/A<V2YYG\B;]NOA[9S@D4"#7-PR#T(]
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M^KL78W%IC45V$W3Z<S!?47'X2(D=N(ZK*3EV-W0:6O#;9RM))Y$C.$C$'$U
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MT^?CV=FD(:RVE+:"[WA*\);2H#F2",%2BH'!5]Z,A2\9S@'4[\ "00!SM,Q
M/'ES%[S*MU8)-HF9-CH=/ "^HD+BFJH?"TJ7W?K<ZPC 6GEZX"BK \ ,*&/#
M()&3C-0NC>!%Y(@^-]!;M_5!I@7$6XS'@!H+S/?SE?77Y"R5A9+/.VH)SCNV
MTY4">GK*(('3IT&1J23(+8($&(T M$<#W'MX!5W0+'6X)Y]@[+<-.5EWB8MI
M#:0X%)+2BL G*\\R #@9"0!S8 '0C/7)%A4(  OK,\?$C3EQ'9QC<!DQ!D $
MZ3SU [YX\-2I4N8$K3RO<JUA1"4J3S #F0H\JL@D]$Y)Z9'@#JDN&ES!';P[
M"#IK?0>%PTF;1$:F._@=?8N*)JE%*G'6T!"P@ JY2"1DJ(R,D(P!D\I\<8SJ
M0\V,F>1$>N.7=W<U?<$$1,ZZ'3@)^KO7;,F$EQ"EA+13E#A6E*E<I*4 8 SS
M$DGQ ZDG(U8NO//C!!-^<F=!-C MJ48T#A!&L=PY6XQVKA)E)[I#2E H0PTL
MJRGY4\Q')S????GPS@)'WV1UDND:C21IS,7X]NMXB1*D"#)!F3K/<>R\3IQC
MDI2JIEI*B2$9 2KE<"B4A)!0GQY@.;',3U.!UQK :X!().@OPN;<1IR-M;7*
MR;A/+G?@?5(/O*Y-OASNE!00,<BC@Y(*P5=?#JD^P]?' 2KK(=) @V -XT[;
MWX?-:%);$^VTQXQ/>8 UO-E&L/H09&.5(!Y@5$I(2.8)3]\1DE0  P3X_.#&
M_)<3','61<1,:B=!S! T41IKVC4R;Z6U'M$'FN]J<VMP(0L96%)YBD #'CT/
M0<P3@'H<^.JAP)@$W!U,WGE,6D@>JUD+#>1;6WZ[V,>'%1KDSD2QZX.>916D
M$J ]=*0/'*<843T((R!TSK*YX#6P)_C. X'@)/,\.$W0-F8FP&O/M]OTGGTI
M?<<[DI(7ZY*0>GCZJ<!0Z]<G)3D #&!J-X. X\;ZW/'G%S?CII*L!!=P$7U/
M;PCAVDCF50VYMWS;!VSW(OBFQ!/G618MXW9$@K25HF2[=M^H5:/%4E!#BD29
M$)MAP(6%J0XH(4"=6I#?J-;H"\-Y""0(TXW&A'#OFI9CC8D-)$]@)[#SM9>;
M7LT-V=R=L=S>%#>OB,VGI5Y7EVF--ONA4CBB7OA=U[[EM52(Z_?4&T*[MA4(
M$2P["V\?9HE.I]NT2QU2)-$9I\1VN5 OI>I3'.8QC*C*]*B^/)=TFD&M8PM,
M"=X7<Z3<NB9,6 *XC#5"VI3J/;O=?Z._-P3<@-T#3! '(:+/;M#^.7?WA,WL
M=L*SG*!5*7O/PK5U/#?09E @2:I-XN8^[EI6'2*2Y.=6VY6Z7*HE_P!$K"[>
M>YFTII4]];B8Y66]7#8>G6I-+@1U=8"LYITHNIO<Z=0(-,P1_&%B00-NM6J4
MJM3=)])GWH.%NL#F- $1KO@\)#29''"YSMC-^U[.;^;_ -,HMHU>W]DM@N%^
MRIMHU"@RO)&.,G>:XWZ7?:K@G492:XBW+ C0IJ)5H4]UJ4^^(3#;S4B>A;5S
ME](U*5)Y=-6K7=O;Q$X>F ZF&DD#>>V"'1S,2(5/+*@:YXW8%*F"T:=<YU]"
M="1:9X")O&?RM7$[LMLOQ3UG<"A4G>JJ[96_M%4]F-ZI/#QO+P^V3<EQ[J71
M"LZMV?=5D7K3Z=6Z@-NZE-%6B2;:6S)N:D,ML+4S-E!<8<!0=5H,ID4@XU>M
MI]:RJ\,I EK@YIMOZ7L#J)4,QE5K*F\-\M#=QX8YC0YQ@AP-Y'(6+8XB^,?&
M!QE;^[N\$_%UM?OH3N/;VWE0X7]Q;,W\HO#YNGP^4JYD5?>.TF;NL"39>YL"
M"])K5HU)IE5*J5**4U:D.>4RVQ)Y@UFHX>E3Q.&?2BF7]>QU(UF58 I/+7AS
M.!:8(F 9Y+'5K5'T*K*DN#>K<U_5/8#Z8D'>,R'">X@CMS8LWM .-;>#A+W?
MXK-E*';U;<K6_P!2]J;!V.M[;J1?NY7#GMI0JBFD7Q?-]6C'J% N7=#=U<'R
M:Y(FV\"=$I4"G56+/:<J$(O,0-1V'PM+%-P]7>;][=5?5=4%-E:H0=UK706L
M8#Z&\X$[P@@'=6R*U=^'-=D.&\U@IM!<:;19SG-WFDNTL()%P=5G_P!G?Q(7
MOQ$[9;@5*_\ <[;3=BK6)N75+-BW/8]BWUM%>+5-CPH,V/3-Y-GK]@,3-N=P
MHBI+AD4RAU.N6]-IJX;\&HNNM2'G]7&4J=&JS=94:UU-KH>YCV3)NRHP@.:0
M!,-%Q)C4[6#JOJTW%[F$M<6V:6D<2'--P;D23PMR&?SKA=*E$'E'+A2L\V >
M7)!\21C_ -.-:ACXQ +!)U]*1:;B(/:=.Y<@R !$29L-.XVTM(TUTU4ELRRK
MC3O.;W\WI3;"[8\VHG^51N8S$LMH+9C=[Y2!S ^MW/)_VWMUW#*(\A;'\I4/
M@=V"3Q)'N%U7-3.+=-R&-![Y=(\/5WK*/7)KC4T1>:RR-ZK0V@[4#B]CW?58
MM%CWO7'*13Y\]]F-!$ZGR*9-##[SSC8;6\VXH,JR4]XGE5@'.O2>F?&>1]$7
M10]S98[$5VO=P9^"5R"XR(!$R>SU] Z+,*_%=(W2,VF-Y]-F^&B[G XVFT[H
MU)%K#OY+?!9=WPJK3HLZGS&)L.2EIQE^,\AYE3;C0/.AQI2D+2KICE)3CV_-
M\]8+'LJ-94HOWVF""US2.1@@F>WM[5[5B\&XDMJ4W,< 1#FEI$F1,P1\]Q"N
M7&JZ2 0L'+@!(P,**0>H!P3@]1GP\,^ YJCCRT6,RXDGE:T=\7/81K=<-5P1
M!.[:&S83:=3>PT@]MU,V:DTKH5=02%9&,?G\<9'AU_/^/=9F#8EQ/&8@@1/,
M]A.OKT&L["U&_4;'PUXJ)3,;]JDD>&01X^S)Z 9P<>PX\?GS-QU.->/&Y'??
M7C%UBZIX)$:3[.'>N0EM'P(.?  C/AGY\GV^S5QC:1(&\#,\".7?V^KM4=6\
M3+2(YA=J7FU '.,DC\V/GUE;B*;A.\V.\?,84%KAJTCP*^%] P 02?Z_#\Q_
MT^T=.G74.Q#!^,WLDB_AP/>5&Z>1]2ZE/H"N8GIC.>I \1^(#'4Y^?6)V(I"
M27MTFW(>OQ4[KIC=,]Q4,9;7CWB<$8!'4?.<'Q_T=/FZZP'&4^' D'0Z#MCW
M]1R]2Z39T #6QF_,<A/O:&<G-( P>8G(2 >F<_/CP\23CH ?'V:E7'-@#6)O
M8]\<;<3)(Y1=9&47$F0&BP,<(GUGP$65.3:_&CI)=>82@*()[U 4E8&>["20
MHJ((./$ @^&-<8[$@2!$#B2)'A<\C<6GO6XS#000'3''0]IY=W;V%4>N\(KL
MA"6I;',04\H6TH*QGG 4H@ H21S'&$G(*<==:QQ(>X .:2+1(D^V_"3?AX[
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M5Q>C%-IG=):USA%KD[P#B3!;!B;DC7L^5;*X6JZDS%U'%SW"6AYI,;,GA#W
M 3O$BW+58V6EVKW$'26)%-O"Q;5OEU"G'X]27Y9:U21'6TCN83_FF,_3Y*>^
M;<=4\FF1G2TZ6E.%2$@ZS<VQU)L/%*L#)#BUU-P!-@2QNZ>,>B'&;N,+L>*Z
M/\L>0^ACZN&:1!9NMJL)$RYI>YKP3:1O/OV$J1UOM'.)*\JLU48K-N[;T=+2
MH+-+HJ6)KHDN1)#Z)\BJ5J*[-EO//AI 8A&"U%;2@!I;R7W7,)S3'UW#=+*5
MH;U8]*=TW]*7.D\# %H!F3PU;9O+,$"S?J8NIO &H\N8V+2W<8\MW8OO.F>$
M65J)G'=Q2LRWYL/=2M(=E+B/LQ'13NX[DMTMZ1SHGQWHE/84IJI-H7-:;>D%
M7<17#WC8&R<3C0T#KJV\;E^H$Q;=D"?QHB8XVMQE3+\$"6^3TX#RV/2WA$@$
M02YQT)$V$S>5&1>U$XI:<RI*MPX,M,AIA$9RIVO;+,8NIBQPMZ3,=HT9UN&W
M(@STO/S),-OO)K"0ZZM"$.9*&*QY;!Q! FP-.DXN  %R&MD<+$W)!M"TJN78
M&;4CO"1 >\@'P=$[I'XI,"UK*F:]VI7%>Y$I3B+TCPU5)U:F)$*TZ%&>68<:
M:[)B^32*4M;45UQN,T7UMF64]ZIIB.E;:#F-7%$&<0[0D%K6L=RX B"?I[UC
M9@<(#'5B=(+WVY_%<.TBVI&JLK<?']Q65QYB*YN]=]//</",NF0X=/"#*I=,
M<;++<.GPA,FMR^]:7Y4_%?0IYY"4J8DN1]8P:L0:U4VM+YBU[Q.\9@.%A!,7
M*RC"X9E^I828M$W#C/;I&E]!J)%-R>-?BC9F1/)=\KOJ,=+TAIY;56<9<=$B
M5.!0Z\VN*'Y(<<2A* E3P;BA*)P SJK=YP(>^H(!!(>]I)(T(:X$SQ)-AIV[
M-/#X0&'T&0='1O$>%YGD=.40%UO<;G%8'7FI&]]W QZ@RE:&:LT5Q_*6F6HS
M12GUW70J5)[M"9+R4.(A=\^@MH7K$ZG4=(;6KL$<*CAZ0F")D\[&W9HMUF!P
M+@'=13W2)!+;F"9L# F1PBT1<S5]/[0_BPM]\2D[Q5V6ELAEUFJQ*%-CI=>,
M-YR*VS,@EMAYE#\@--PT.I#;3?=\JF@V;"IB&D;N)J@B1-G-DB)@MCGWFX5S
ME> <8.'IMDRTM+@3'-TDQ(D6 X197%HW:O\ %3!D-O3*[0ZNT)"7.XJ=M0QS
MQ&XTQU#!736X* B43"<+K+9DJ6RXPF6!Y3%74U<<UY/E33S)IM=,:0)#0#Q(
M&]PF"4&2Y>\.#F.9#2994=KS&\7:7$ ;LWC19#6IVU5]0VD1KSVSM^I*;!3Y
M73JG+I<F4770RTM$)QEUB,@E!6HK6O*2G)2L+2,C,=CFP'"E5-PX^E3]$<(#
M2.P@$\Y6N[9O#O)-*N]A_BO <;2-Z9WKWO XV*RJL3MB^'^Y%-0[HIEY65.D
MN-LI2NF-U>-SJ;"D<BJ;*=>")"@M$=M##[[@2%J "R&Y9FOI.94IU1!^-3BJ
MV+"?1.\!-KWYC2=*OLWB:7I,J4GM,V)+3W0;$V[!RU*SHL/BTX?[[EM0[>W/
MH$Z>E"$OP'Y#U/FQW72E*&'&9[<93<AQ:T@, J425 )/*3K;9C<,YP!J[IB8
M?+2)XG@+W-QJ#'!<94RW&T@'/H/+3HYHWFF+DB)D0/&T2LD*?76IJ$*C/MR&
M2EPH(6AP**DY"@H*4"G!RD#U>I\"#CD:51I:/2]$BQ= GCV2#V\?6M9U(@F1
M!T,B+QV6X> ]M2,RB\RTI2T#E4$$)Z'Q)"N8'H0D8 P,="3X'5R0_=@B)([0
M1<FT\"/9QTQ;L$SQN9^:TVX#Z%'O"*\Q-AR6FW8LALQGV'D)=1*COH+;T5UI
MP+;6V\@E+K:DJ0MLE*_5YLY)AIBQ;!)'QID>K4=D\N%2V8) )O(X$=MC[^"P
M8V<[-G@_V"W1I&[NW5C7&Q<%H"YCMM1;AW(OJ[+#V@7>J7S=RMI[%N"NU"W+
M'7< D2&YKE+A!UIF1(C0%0X[JFCNOQE6K2-,N;#A-1S6M#ZFZ!&^X7=&@N+@
MZFZUF85C'[\.BY8W>=NML) !L XR387MH KS;T<-&R^_=Y[#[C[D6X]6[KX<
MKYD;C;73FZC)@LTJYG&F6"]4(\=0;J\)+T*G3VX$K+":C3H,O!<CA)U6XJI0
M9493< VLTLJ3'Q0>'(S8'D3H5G.';5>RH_\ >W;S8YP)G0$'N(,7 5LJ%P"<
M*%M[;\0^U0VQC5.PN*?<"M[G;P6S5ZK49,2JW377(+SKU%=COQ)MLPZ9-I\>
MIT!FBRHCM!J(<GTU]A]25(L_&8@&@_?W7T6-8PP 6M;,2.,[Q!+I)%BI;A*/
MWQ@;+*CBYP-SO$ '=M:(M$1P5/VIV>'"U:NV>YNT59INY&ZMG;NT6CV_?%.W
MEWBW,W-?E42V77)-KTJAS;DN:4NUVK8DNJF4.9;**558$Q+,A%1*XL<M'XZJ
M:E*J'M94I%SF=73I4V[[K.+PUHWY&H)(GM"EF#IACFD.<VH()?4+CNC0-WW$
MM,DDQ$$3R5$#LS>%YS:6\]FZW+WKN^TMQJA8TNXY-\;[;F7M741MLZVW7['I
M-&J=T5ZJLT"D42I-K+<.D0HJY49UR+-??94A+5?.&(<^E5!I!U/?AK*3&M&^
MTM)(  )()%^9(UO<8&AN5&>FYK]P$NJ%SB6G>#03P%N//D%.KS[/#A3W NK=
MJZ:Y;5W0*MO%<5C7U=?HIN!=-HQZ7N;MXP85J[MV:JWIU/EV5N7"AJD1I5SV
M_+B/U=F7,166)_E+N8IX_$,%,%S2*8>QI+&D]6\@OIU"=[>IDW#386(LC\%1
M<7$!P%0AQ )@/8(:X1H[A+8D7,Q*O7P[\,^T?#'0[IHVV$2Y'7[YNF1>U_7=
M?-YW1N'?U^7=)C1Z>NO7==]V5*IUBJ3TP(D.&R%OM1F660IIA#STIQ['B*[\
M34:^H1NL :QC6M:UK03$-:&B#X:=ZR4:+*#'-8TW])SG$N+G$!H<7.))L+7M
MH+:9$I4I1</,DIY$E(ZXY1@8!ZDX\<GITUCWH#@3-K"3H>SA',Q'S91;=($D
MDC4Z\)[+Z#UZJE;*KU:5OZNA&K5'S(FTA)32#,D>;4R.X;S($/G[@/%65=YR
M<V3G.NWY)^X6FT&I4[]0.>D >^O5\U_=9/.FP_\ B*RZURZXU-$7AM[0VK1*
M/Q];X29;\J*D[HU9#<F'R!]IQ5/I:1A;C+K;><D]XI;!;Y2M#[:TI.O2.FNB
MZMT,]&#6\*E=Q/+\#Q !CB)-QJNH]#!:.E+I##N+! YN&/I0./.+V6S+ACWM
MNVF6/2H\&^)R_)&$H:9DA;/18YD@N*#,);/183(3WW.XI"EA RXGXF:W&81X
M\EK56.:2-VF][67<'3&^&DDD_B[T67V!B<'A,528_$81CG%MWP=YT"-&F28C
M^*(BY*RK9XK=VZ<H(B56).Y5<J1-C1E(*E*(0M:W$I5R+5E >/*D$$I'=XUR
M-'.LWIF'5Q(($/8US9U)#A&\1$$08-]->(J;-Y35!+J!9;\5S@(N;=MM)':)
M$*LHG&!NBVTN1(@T62T@J<*D,I0VLI2!CF92X0.9) )^^<6A(*DC!VCM!FC9
M._3(,N]*E TCAP,SXD :+0J;*Y82&MZP?B@2X@ 3 !)$$<>$R0ILQQR74T\&
M9=K07E,-I\I2VE]M;*@E*UO*S+3SL]VI"P6V^5*'BI1 95K;I;1YB #4I4G#
MD YL&TDG?TB#8#C!D6UCL9@S.Y6<TNF#,S$"P GG(),\+%<U\>-296E,FTV6
M^5(<2EB<YG"@%(]=16AY12I(4A"U%*RH]4(6H9&[0X[5U-D-L '/L9C4AS3W
M3-EA=LA0@AM;>))$E@ X@VD$=_JDA2E[M&XL5;R7;6:"FB&^5,]\ R%O-H[E
M2E0T-!X+?80TSW_>K4Z@E"$*!.1FT>,,S08")U>1<F"9#2#V:3866)VQS#'W
M\ZQ>F-(O!#IOV@#4776_VD$.&V0NSW'Y*2>:/&GJ>4E*PT4*4XF.6>;+S20@
M. E*DY3T.+_LBQ+2!U(DZ#?<ZQ_[-B=>)XWE8W;(TS^_M+1>=WEJ(#IL1QW;
MWX"+1U[M1J]!5)%-L=A3;"<8=?E2'BX&&Y3I4PVE#BF4M.82MMI9*P"4@%:6
M<#L^QAD4VM(BX<#,D3 )AQB0/BZSP"ENRN&#@'5=))AK?7,FQXR>RQF:9I/:
M0;DU^IJB.*HM#2MM#L5L0$D8=>=0EB6]-EK:+@98=D*++H46UMD%I2"@ZU7.
M<S D5& @2T;C1:]C+G6@&=+'2UMRGLM@"0"'..] A]^\ "8O$6'K"N=N)Q7[
MHNV0^W3JS3J7*F, HJ5/8Y)2RL+*A&>$M92V484ZIA+3@2GF$@(6I+FM1S[,
M<632?NLXAS&%KC>(WBXBUR2 #8B2==FILMEV'FH.LJ1$L>YNZT:G>AC3KIZ7
M.RTY7]OQ?R*S,??ORNSJ@U*6@IF5F34GBX[+D%U327:C(20\T[%9=PQSMB.P
MIAQ#B$%K?H.<\2^26B3O$NWG$NDW)!FP@_&(!!M"XRM3ITSN4F,#;AI8T- W
M8L="8!U/L%U8"5Q!;I,*6]&O:OJEOH<[SRBJU!MA#A99<2A@&2ZA33CR7><!
M*E%Y;*I"&VV2IS9;1INN6 .#9L7"=3( (TX =OAJD F";0"  #RO8=@B2=)D
M3?H<XD=VH"7 SN#<")28[L>46;AJ3)0XI3C"E*!F.+0DN1(3K);7W>5*(+:_
ME%RR@P'=TU())+FSJ)D'2!!%XUXBIIM<3(XC5K;@@@<)$&;P# '"ZI\\6>\C
MKK#[FZ5TB4E]J*H1;AK#*G6W7 EQI;<><TH M37O6YFTI=:8*'2EI94;2IB2
M]KB"#!#R(GL$]D2!'/18^J:V0YH!<):8:0#  X03QN><V78_QI;^TP!<?=R[
M>^4@,\IKE026'6F&1WR&VY:F''.^BH40M#G,5NJY7N]5SFTC?<#H,"=XSK;C
MS%[1P3JZ))EC3!L V 9[QV7(.LKI9X_N(V%':#6[-PAGF;=0E=3=<<4TE;:%
M!1>;>:5EAP>4!04XAUM2TJ2[E.KLPI!.^ZI!)GT]3S][WFRAE/#BSJ0T.@(B
M^O>.R9G0KBKCWXB)[D=Y.]-T-O/M);6EFJOM1$*9AR.\;<0TIN0XXZX\EY7?
MN%Q2RSW7=XYDXW88[Q =5$DZ57"03 !((X7B8Y\EE%"@;"FPD _BB.$$\"9M
MZN94HF<>/$)_A:*EOG=#9$=*H:&ZC(1'="'EN-I0[%Y.Z7W4=;3RG%E;Q4D/
M-%*N\2.')@!U4"3,/(W=)L-;WY^J]^II-@]2RTS8"9)M<\HB>_1434^+O>.0
MD(>W<W!E?Y-"P_=-6+CG*ZTA:5*\M/*EU"'02T%-M=ZXEI:4*"-4=A03!+C$
M_OC_ -*;?-8#1;@:R 6TJ8) N:8,6X&X/<9O[*!J/$9>=444S[KNF8ER,EA]
ME=7G*1\JRVP2YF25AIQR2L!25=ZY\JM)#A*55;@J8)&Z(.LDF1:P#B8'/@;6
M.JVVOH[MV[I:X$ AI).NH%HMKPUT5!3MUZK.=<5&\YR5=VDE$JH.O-)2M?E2
M^1*BI0 ,HNIPA)[Y#84DCD6);AJ+!!+ T$@ Q8DP9WCK;Q]:S4G-<T$- ,B'
M B9TB!<<!>YXB%+TW'=M=?0W1Z'/ERD!:/DV)$T<L<RPREU:$.+2KOF0H.A+
M:#WF$)*_7)S:%)H+ZE,#6 1-AP /#D#-IM,'/ON$\!S[._L'/GZIW2MN.("O
M2N[HE@W,2M7.0FA26FGBEGN^KLMN*VI(*N1/*^TZVMOO486APZPNQ>!:PNZP
M'>$B+DB]H!-[<38=BH:O:UI!!)L2Z;<Y()-])<!PLKO6_P %G%)<JFPW;"Z:
ME[G(<GU-F+W392I"4NL,%]X)Y.<**4)>"ECG"%G(IYQPT2RG4<6R=W<!)WHT
MOQY2 LAKTV1+Q//Z.0Y7 FT$WB[-'[+SB-K"T^6UBCTYMPK!;0Y5I?=\[^4<
MP1#CI<9,=0[TEY0[U"1RDDN)@Y@ZH#NX2H;@ASMT6!F\ P0.-QI!,PL)QM!O
MQJP(N3$$=I,$\!/._>%=>'V/&Z]2\G5-W%:;04<A9\RRN[2"VXEM#?>U1/>I
M2I92.=*$J2M9"4J"0#,7B8.Y@VB0!Z;^W40P:P.$SV75'9IAA#7/J$ Z ET1
MI,C3M![[2J]@=C-5'6U^6[ESTOO*:"RBAQU=T\ESON[82[4'%K:)YT<RUH)"
MN<A);2WJ#B<:7 FE1'80Z>=Y !(.@B1II=5.9X=IWFM>3(/ZKCLX\.U5=3>Q
M2I:UAN=N;=#Z&AEQ"8]*;6%\B0XI)+#X!<6$J!2$% "<]XD%*\C78YYC=H@:
MSNN@ ZVD$S;L$0(T4^=:+2'"F\FY&^X1<G1LV$F0;Q<J>M=B;9BR>\W&N\]X
MI20&S1AR IY>;D-**24D9/5*<X1@)&I QH,CJ;F0"USAQG4\K:1;0:&3G%,2
M!3-[D@VF!I<@6X1<SS79+[$FPVDH=B7[?'-R^NM4FD++JFTI',LBE-A))0<H
M QZV>?.2!\N^,.JOJ#3(';\4M( TB;WUL5+,Z9<&GPL";GD#+A.A,@\-%0%8
M[$!X!4J@[M5EA*E.AJ//I<64I*E<N$+=C2(H4HD$J<0RT"!T3@CE@5,=^-3H
M$3;=#KD0;R>WM[9XY1F]"2#3<+$PUP C7P,6U)!B5;5_L==\[4J")UL[HTV5
MW,EE8[VGSZ?-8;2KG4XA^-)F%3K:@E: A; 5A9*FU@%=*E>L&;KL()N/1=OB
M3J2 R1K-IDV[1M4LWPI))<Z"-'01.A!)''CV7XK9MPM;/;_;)6VU;E?NJ95<
M*5)<F^DETU)"PCUDEB#5%*C0TA.0H15\KI2EY8+KBT(X8>5LJO=3WV!P)&[O
MAMB3N@ [@$S?=X1,+??CLGQ #:M!KBV&C[W1N/1 .^0'$SV\8TNL\Z3<6Y'>
M->43&7XZ^5!#[8<YAC )48ZEXY1A1"TJSCJ%94<[<1F0)BHXL.A=I>;AQ:"3
MSD <>Q<=7\PN:=RG4:X7A@ O>?QR+&(CM-U<1J0\[&2IQ1YN8]YRCE0I>/6[
MM))/+G) R>4$#FURE&I4+07@G>D&#8EHO$P0/5($7 777;F^0V0 [T"=0)D
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M7V5N!)DI<,A02WS<Q0G608G#N(+7 &QN'-UDWG0SH._56!:9<#O$& TN#@#
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M2FL/4MUWD(883&3RQ'D@*4"IQE"F(Y<>'>7-&J8C"8AN]#231K$-+@ 8):
M( $ZD V)E8O.6!8TCRNB>9ZT$D"?1D3.LS;B/24AG\*'%$]$E(IMJ7,908[M
MN,(ODC"RF.R6PW*DR&6RA,N.VHJ"&4JY#WC'*L%+R?%3(PU<%L[L,(.@DR1
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M3%W#8<1B1$8?-PTGR*2F5%>;80A:&T)>6X_&2[5V$Q ZS>HO!IT>N?,$-HN
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MU$E*H\13K+*%J"@A)23K.I.@NZMX>6D'T729_&-N#CI,D3H97(,QV'-^NI.
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M32Z1-O"TD$N>#'+RJD?6(/A*W6,L)3T2 $@#KC!Z=.HP.O3ITZ#PUX73I-:
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M@#.?5R 0<$=2-:XIADD0)MQY<+?/] 5B7&#O$3$R9/;^K70ZJ4.V_@@N-MH
MYE!)1DJ!)R.H!&<!/48R,]=8^K@R; S$CAK8F>5[7"N+VEQDV)![;CQ%S:1,
M*7L49"W&4E"4\[JL#E ];! *<#[W/*?'JO &3G56@[P!;\_*>=SZ_8(@FQ )
MD6-^T"XXR9&I^:(2?1X[JREQA <#J0G"3DE.#S 8 P#@],'/7H,@XZM-KW7
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M2/@<_P"R.L/_ ,=_9&GP7;?_ .3&8?SL-]NGP@;'?G["?S,3[3U%O%?#VD?
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M0D)-+(\ 3G'CC6+X%^E-SA.Q.;M;;C@R3%A_"P-+G06BZS-Z3-@Q).TV7Z
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22UV$P[FDC#5H)!ID6X6LO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g68105g25p18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g25p18.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1IZ4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &EZ^9U X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              -    $2          $
M                     0             !$@   -
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   -      4F=H=&QO;F<
M  $2    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   #0     %)G:'1L;VYG   !$@    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ >0"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MDZ2E))(
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_  !$( -(!%0,!$0 "$0$#$0'_Q  >  $  00# 0$
M        "0$&!P@"! 4#"O_$ %@0   & @$" @4$"@P+!0D   $" P0%!@ '
M$0@A$C$3%!5!40DB<9$6%QDR-T)A=8*Q&",V5W:!E:&TM<'1-598<G.3EK+"
MU/ D)292MC,T0TAB8Y2STO_$ !P! 0 # 0$! 0$            ! @,$!0<&
M"/_$ $P1  (! P($ @4(!0@+  $%  $" P $$1(A!1,Q02)1%#)A<8$&(T*1
MH;'!\!925<+1%21R@I*4TN$'%S-#5&*3LM/B\24U15-SL__:  P# 0 "$0,1
M #\ _?QBE,4IBE,4KB/8#"'// CYCY\>[GR_BQ2M#;QO'J"BNI,^HH>CT1I2
MY/6UEL5,G9:R23B8L=DB02!/VH@S:H-:W!M5%1!8@^U';LA!,"K0.X8PEI(.
M*.R"&>V:'T<,VI'A>;0\[[XW7Q+&FEQC=B",[.JIZ$R$2I-,\5PH4*Z,L/-5
M$VSDG"M*VI,'8#>M12]7W562R6FEL[-J*TMZA$S-U<;1C-?6%C4[*TJ[,SNS
MZZKS!2\N </X=VF>(6O#>868JJB54D**I%&^6BU26]S>M!_-+.1(S\]HFXA#
M/*D,5RD>";8!F)CU I-L5&D,:V-L'GAM(W47-^0D2C>.QFC0RR+-)@K*)$V"
M@@QMLQ5B%J\T>N?:QGQ-C'CZK]JR8DW])B*66'E?LO866,H$?=OLA=V,)@6[
MR,<K218]2&0KR2B2+?UE*36%44T])(GC%Y%KUW#6M]?66H%0MM8SM!RYXE\?
M/D*/EERBL% 5P=0CD!S%IQ$MO):V]^6.MFN+J9H6-ML T,!"$$[OJ;459,58
MRG6GU/-I]YK-21U@M>(36+/J!DK(2DV M>?4&1@7,\A0FL26WF5:6)-5FHP5
MLZDDHB#0Y7X0150.V&=) XC+M)'P&Z-GQ*%&"R7\@:VCCDLYPKK%'(9IW9!%
M*R"-%61]1*PUNK^C"%U1N+Q%N$F0D\C3J$CWH.G!.(3'&^C)DD&$,>FI<=5W
M$VP]=T2^%:F8)W*GUVT>HF4%46?MZ(:28MA.(B)Q0.Y%/QCP(^$1$"\^'-[N
M 6UU<VZOS%AGEC1\8U(KL$)&3@E<9 . <@;8%<:ZL . )%RD@4@J)8R4E"L-
MF42*P5MBRX8@$X&0\YZM3%*8I3%*8I3%*8I3%*8I3%*^2JA4P\1S$*0H>(QC
M&\'A ._B$>0 "%XY,(CP !BE6T\M4"V8O'X2K-VVC63J1?%C5S2#A-FW3,NN
MN5K'^M/5P(F B!&[=57Q\%*F81  RFFCABDEE.(D5VE< MH5$9B<*&8],8 )
M/WV2,R2(J^LS*BCVNRKG? P!GJ<5C5CU"ZBDZIK2ZQUT:/:SN*7BX#6S]HRF
M'"UIEIA-VHU8L6"3 TDB<C>,D'4@H^:-R0[9D[=2RC)LV<+$UD1HKJ*S(_G+
MQ32HFH%.1!:-?3S&0$H42UC,JN3XV*1H2TJAZ8)AEG.1%#((I&*D%)3<"S5"
M-CK:X)BT@;9+$> Z>U;=\:BH=8>W.R[!KK:M1EAKM6DY9@_"<;1=CM$XQK4-
M%R00H22K%9Y.2C5BH+I%%)F"P*O3MTDQ<$S+J&M0,LU[/':V^,Z9994:2-4)
M.G+("W]'!S@UHL;L9AC2UO;W$\ZGZ"6B2R3DC&<(L3:MLY4[[$5<9-F4A9>#
M296-E)(V%&8<Q4E$J'F(19&!*W-+*K3\<5W#,09%6)XR/GJ'I#^D!(3B@X$L
MG;4I!"Q1+*S';P<SEJVK8'YP:#N-\^5$C9PSHI;$T<# ?1EECD=$*]5+)$SJ
M-B<#;!VZ:VW==(RM2@_LOBG$A>T)YU508KGE&4LA6$VKBPJ)2<<5:.0"-(]1
M]8];>-O )C 4IA25*65R>:=AR;?TF;40"L)E6-6P2-0UOH\.=\;8J K,G,49
M FC@.,MB:19F2/8;L5A<XWW!&VU7A 6BNV1LJ\K\[$SK1-<[=1W$2;.5;D<)
M#X5$#+L5EDR*I#\TZ9A X#YB(Y(!P& .EP65M\-O@XSV]VWU[T[E3C*X';."
M 03CJ3D[GW=JN,! 0Y#N Y-33%*8I3%*8I3%*8I3%*8I3%*\YZ^:,DQ7>O&[
M)N51)(RSEPFW1*HLJ5%$AE5#$#QK*J)II$ >5%3$2+R8_ T)RRJ-V8L$4'=B
MHRP [E55S@ [ GM4@'<@$@;D^7YS\*[Y! Q"F*/B*)0$!YYY 0\P'W@/QRPS
MC<8/<5%5X#OV#OY]O/Z?CDTK".R]#:ZVH_6DK;&RBLBI59ZE%D(BQV"NOD:]
M92 27:M7<!)1R[59<A0!.024(^;<B+59,1$1YY84DBO(3J1;V..&=D.EWCCD
M$BJK @AM0()&Y!QT-;)<.AMF4*3;3//$3G*RE#$<G&ZZ"<+TU 'KC& (WY/C
MIXC8&"K9C;=DXNM&$D&G.[WW'-N(^+,F5%Y7&[N4NKQY]B\@D4"2M<.L,/)@
M)P>M%@.H [L5U<QHT?"1HR/&KI*D14Q12*P(DCB95=$;*J_B R*Q3,8E568"
M4L0 S#DLQ8M-#I($<[ZCKE4:R-B3624>D70R-TDKTG47'M&2CO9Z\.:?L*E+
M1.>++!KR["B#*?8DPGU8A-&,=6%I#DF5V:*+=1Z9-(I2BSNMVLKM+Z;S>?),
M=<JK,R22PQ2,-44,DBB1XT(1G&HKG>K%C_-L *;5;=86C\+:;4N;?65P7,)D
MDY6HYCUMIP6-6*3H"Z:THEK$#7+>J#*0,[3F%]F[(6L:\8+46 5!Y8SVGVZ]
MHB<<<T<E1W+U:IIL#JL@BBMS"F,@D.KC!(#"0, T=R7:-GDNHSX+F8\J+YV5
M6;YF+Q?-@!([.9B25:9TD#QD(T#('"\DKO$,R3-A?I32L1EV)W+B(>-A(V/B
M8EFC'1D4R;1L<P:IE0;,F+%$C9HU;I)?-30002(DDF4?"4A0* =N L[M*[RN
MS-)*[R.S$EF>1B[LQ.22S,6.=\FLU4(JHHPJJ%4>048 ^ %>IE:M3%*8I3%*
M8I3%*8I3%*8I3%*MRVQKF8K4[%,_1^MR,3(-&WIE#I) LNV.FF*AR<F*0#F#
MQ"!##Q\/>I4?O2_TO[+U/?Y*P74]>4B'U9D(80BY1\\64<O%V1B"9NM&M \!
MTTU05$JYQ*8P\=Q-S5P&4J<>+8Y[+]+ZURN""I)!(R%(A,AE.2,/K+ X;96
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M&U4GWGL^$EETZU&2GH4998JJC-)4Q7:[1%=Z1$6Z1E<LQY1G1@X:UG2VEU9
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MNRQ[>*F(PQ@#EN]8MUW+=L=,0[D(NH4!X !'.F6,*Y\:OGJ58L#ML,^SL?\
M[7&C9U#'0X#8QJ\R/+)SD$>7>K]+QX0X#@./(<K5Z^0H%$1'GCGW<=N//C%*
M V2]Y0$1\Q^/O_Z#R_)E2JD $;#M2J"V3Y'CMR//D'GQQY_QC]&-"[C PVY]
MN.E3DGJ?S[?/XT]6)SW[AY<<!P.3@9SW'0Y/:@)'2ON7C@/"' !R !QQY#QY
M9-15<4IBE,4IBE,4IBE:R=8'X KE_IZ[_P"I(K%0W0^X_=6P\'_@6'_-<?\
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MIQL0"-Z]^/BX^*9MHZ,:(,&#-%-NU9M$DT&S=!(H%32113*5--,A0 "E*4
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MC%G&3EF+M+G7G7M([.,,-+,2N#4ZWYD4NH\R&,11/T*($$>!_4 0DY8J "2
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M,R2RM('B)5DD8QJO/*!'UE79I67ER%QU5<BOTM,.09M_$8#F]$GXC@ @!C>
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M8' \6&KF1Q,"LDBZXD(PTJ$ AT!.2N21GN5[54X"22 ADA8I,P]6)U(!5VW
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M!LB6,BW^IK;(986"R>D!8[B(W"/R^5$TNIXD<3OL^?5DN2"F(D 13$  2"(
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M!A0*4! Q@YXKII@%:'',6:$*^G5Z.&V:?2?"Y0$E01U."#71;A"YYCE5Y;G
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M*SC[_#\:E>Q6E,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4KY'1
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M4Y2' # !R??<!\X #D>V*5<=>L,1:HAC/0+Y"2B9) KIB];"847"!^Y%$S&
MHB4P=P'PAR&*5[>*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2OD=4"B(=A$.
M./J]X_3P&1OOG& "<Y_#'W9IY==S@>_\[^ZN9#>(H#\>>W//'<>.?XLFGO\
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M?;CD1'@!R,^PYU8'P!).>PVQYT.1V/0G[L?7G:N(*)"'(E*)N"B(]@$P"!0
MW;N(<B!1$>Q>! 1#PCD]?/H#UQU]W?SIW(\CB@J(!QP7GD> #R'Q"'(%$!$.
M!'MQSP' \B(<9!QVR?ZQZ[^WMC?RICX;9W[CKG[_ *JH"J(ASZ,?,P<\=OF\
M@/?GW" \_ ._EQRQ[\?TCY#V^\?#;(-1GRWWQ]IWW[;9'P[T,JD7G]K$>/@
M<C^0 $?/@.>_N[^_&VV<Y) ]8G&<[G?IMVIGK[,[9ZX&0![3L/?[-ZY 9$0
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MYXV/E6,4]N]<JD]:*JG7Z1L384)$;&LI&Z4@M;(ZM6A1R\0C4WS?U%1BF]6
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M]3&T8QQL-FRJ#$C:OU^]/8I^E6-PE=K.(.ORCZ))[0EM91E*5,H];MDS"2V
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M9W*],[E<U>I=4:N;0Y&HU* 2B$91.TD2*F)F:,JU75D49<I04$A54UE%'7I
M\).5#J&#@1RA8H8F8Z1:QS+$6.#'',ACE'DNM696&6V)WR:A5 ,I1?%=-$9]
M.6YIC*Z,MC4=.!CP]@/5%:N1KWHFL+A^];QE?;A0B3%B.]E(:UP,6HT;2JBT
MO)0SB5;1T5<8=*6(<ZI(4)N-(ZY\!#''PC4HRP+,48".&"%<@F2)2H:U/).)
MOI 1R!/'D(&(;%:$%G>W#AFD:4'EG/,(7^<HDJAE+A-0E0-E0&+!,$C(NIF^
ML;\O:-@0EKD962/<(Z8FUG<5-T9]"I0S "5NOR%>G46$LUB6S!<[E SQLBA)
MBZ7>HE%$Y +<HT,5O.=:Q<V[N&DR!SYI8?1I3,N0(I(XA"!$V" J2$ N28,B
M2S311JC:K>UCBC&[1PJ_/0JX'SBRR<Q]::A_NQG1MDN4AM+6=>P&DT*7-O+>
MA&Q$^!G;1RM8$H$5G\7'N2)+"=T,>9RJX;MR%.J7THF @^,,*AB.4 5S,EPS
M9QKFMHL+(0 0&C$:DG&RJ#[XYQ8 <PE5BEMD4D>%+G49$QN/&-0/?8Y([74R
MNM*F6#+B8C2MIQ(S5FQE3EC73U-0RS $%(R3(V=>%QZ$Z8(K-@(MV!$BHF 3
M2R%\H1G(4^$[Z9=$J@#R=74C!)(8$ YHH>-E."K1-*%;&,-;.R2Z"#D\ME))
M., !NG2WZ[KC5.HSR4Q 0<#4EID2(O9%P\6)XTT!4=ILFZTF[7+'L$?VQ9"-
M9&;L6H"=3U4/+',<1Z&8*ADSRR =;X #LP\3X"DKJQH&6VRU9Z%;Q:0W+B.&
M(QRXO"&W.="YT9"YU8'< 5X\G0=(R-SB=ER$14%K@Y4:.(J<6?D\4@X0240C
M7J347:4=*OT4.6S.049N73<H))-G12-B%+,8>%F" Q'#:UWU*'R'P#Z@?JS+
MC6Q<G)9B=97D,161G:-"8E+ E<HW," M@!EU%F0="R]0 19CC0VI+_N6<V],
M*05UE_8=;KB,4=0CE*ON:RZD7:"CGU-_Z%TH=P]].5G)QXIM72":J/[:/C"E
MO\Q'<LBZY)KE9@Q.H0JELD+1JI! R4,@;(.7QMIR5RQE%M!)LEO%*FD[%WFE
MU&0L,D>%2F,$$*N-R:^C>!Z9);8]TD4HRFGO]14;,;DNY469^SG$W$@"1UFR
MRK>(]>>1*OHC2;=N9V=(RK8SH %0 J@4PLRDM%++<0:0207U1B9 .Q8LH"]-
MP 2,U#ZN:I;(E2&*?.#E80Y",<YVUC.=S@#N0*NR\U2K7;7S_558LE;K1W3!
ML=FS!G&V!NA'I*D<$(K!*O4%EF2Y2A^W(NVCDA3 HU=(*%(H5+JD)+$9ADC.
MER1CEC!4E?$K !L$%64KDD#.496//A.F56(Z*#KSAB3D8+G)&E@<;=C6#]<T
M?0_3I4IFRV"VT^1=LK,26E+$S0*W;0TU+%2AD46<<E+6"0:>G*<C8ZC^0?N3
M@(F6<]NVTDP(LT'AP)8HG.,YX@X:1 %4)HF9=UQJV!);N"2/)-*Q 9TC8JW@
M CLT94?2Q8G1G(8  D[ 5EUA1^G6/F9:S-(F@H3=@8NQEW*K]L(JL9,@#(B5
M@Y>G:,$WY3AZ\HS;M3.0,'K1C"(YF5TQO;JH,;MIE0DE?6TX#>QA@*" 2 1O
MO4*Q9A(K%70"4$$!M2IJ+L!WT#.H@;=2.AQQ<^EOIZL,=!U2+95:J(N[)6+.
MY9-53.WEI90#Y.09QGC<2I7P,3"0"-CLUA(T3,(M4@^:7)',-Q#*22+64R[$
MYYAB:(-)L<,,YR2"%W.^U:"4K;SI@@74+0Y(SA)&5FT^8.=_,[@=ZSM$2NI=
M15:480SZLUNM5-A(3$FQ8/$5CQS1N)UI%^]1(X<R*RO*8F=.''I5C'#A8WC#
M(,RB-I6($,8&7&- 4D[[;8+$@ 9).X!SM5(7>18U!,DL@1 3N6(R%WW!TX(Z
M C)&Q&<CU>SPUQ@8BS5YXC(P<]&M):*D$#>))VP?()N&JY.P"4%$5"F$AP*H
M0>2'(4Y3 &SHT;O&ZD,C,IZ$$J<9!!W!/0]QOTQG%'610Z$,K#((^X^T=_X;
MU<&5JU,4IBE,4IBE,4IBE=54H\*" AQQR)>1#MQP(\!P(]_QOC[^/*K#((/4
MA@ ,9.1VSWQ\*D9R#VSW\\[?C6D>B'=\I[FS:XM6C]BI,)O8MRDBW/TM!=TQ
M2$FG@K-7CD4;LI/$:JHB)#D4KPN0Y$HI  \A2!1)8VD,A(:"S$+"4$+E9)3I
M &KZ+#&PW[]";W#D7EU,N")KD2*T74+RXTRQ;&&U*00I(P1OVJZ.G;2">KYO
M;D@I .(X9B[2*-1,\D$GXMJ&5LT>,(Z$1*Y<C%0H2[F562CO^R*%5,*AD? 5
M$0OJ_F-O$I,LPB83L_AD=U>1(%<D$,L$!"1-J)TELX)J)0KW/.&$3EHJ(F2D
M;%M4Y'3_ &I"L^%V8,H&#D]G4- VC7=9V.$9/8R@6EYLN[SC-W.0B5L9'AI:
MQ.'C)<8Z,L44F4'S0Q3I":3(JW Y2K(F,42Y"AUM>&Q *OH]K'%,@;<,DLAP
MI!(*Z& 4$G8X.#FJROKN>(2YU<V4-$Q]4 6T*>W8.AZ9P !C;%?&Y:AE'^T-
M:6UI!0ZDPC 7&*O5XBXJ.AW3A:0KI(Z,*L95RYES,S._$#5BD[D$T!+R(EY
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MJ',3R0F$1K\[;E%5"NL[1Z&4G*9UA@=6U8B'IGW38'UME)'1\@BUF*3&M'D
MXK^DJQ"KV6*N+29%E!1%;G7SJ5*9@FN#"<NL[(2#ON15PW PI9K'RTB"XD98
M[WAMQ;A].8X(@R2(44K'$8LAM$8?PC)<G J9,.P+,AD%MQ&W<Y)5EDC#Q?..
M6ED+NI UZ5#D *.HS#'=)<K(NFTU+:6B@>OKYLZ7D DT*JL\+7YBIK-*TW?$
M3D7+51C[3!!)",**R+5RF18R21"%7#%E,<**A#.O#[]&+$D&[DNC-;%@1O(5
M_P!G( QB.&!4[5$0CUL6RJO+PMUQ@'1$JK=HV6QH*Y65=M8R!GK5@5+IAW:P
MGH(MX@=KR*SIE20@):I'T0Y849*$(*3R*DK'<F,E>JV5L<J2QPI3Y=N^;CPF
M8JQ *'3$RNSF0\N1I?2'<Y$,HDMH5"2#!>5TD5UDYBX?5@.%S5;SQ%GA\2+&
MZ+$".:66XDTE3G1RVC9&4EU950J0, -?SOI5NP0D*+#6+!.P2TYOQ.[OCFK9
MWTO!6UI8/L5;3KI5\HI*1KUXM&J-&*AW#9FX,1RJU:<'$G/,!)97$+)@R?)U
M(&BATJIX@G$8IM* G1S/1U;#%QI&5!)V/2DHBN8IP580\<LIH](]:S6T2"=F
M& =!D,AP=]LD#)J1C04,YKNGM;5]]6%::_A*7 14A6U4HQ(\5(,(]NU?(&+"
MNGD6(J.D57!3LW*B:A%0/P0WB(7OO'66\N)$8.DCLZE<X56.I4((&EE5@C!<
MJ"I"LRA6/EVL8A@CB"E2@TMG'B9?"[J1G*.RED)PQ1E) )(&8LYZWIBE,4IB
ME,4IBE,4KK*>?Z?]HY0^NON_C4'8''D:^)OO"_YX_P#!EZL.C>[\17T#S_3-
M^H<5%?)/[T?\X_ZU,JOTOZ1_"C=%^'_>:X#YA])OUHX/KC^BWWI4=Q[C]ZU4
MW_";^S)[CW'[UJW8^\?<U?57R+_H#_\ ZE,J?77W?QJ*^8 'C'L'<AN?R]AQ
M_O!_0/\ W"JMZO\ 6;__ #%?0WWQO\\W^ZIENY]P_&K#U5^/W+7R#S)_FF_W
M!R&]4_#[Q2K:L%-J%I=1:]GJE;L:T2<[N+6GH.+EU8UV15(Q'4>I(-7!V;@@
M@ E6;"FH40 0, @&4Z3J1L='4;'8DC?KL=Q[=ZD;QX.XUML=Q]7P'U5<?A*!
M"% I0*"0@!0    #@   XX      #MP'&)-Y(R=SECD^>V]1^?JZ?55M25+I
MT[)L)R<J=9F9N%$5(:8E8&+D96)4,(<GC)!XU6=L#CP')FJR1AX[CDQ$JY92
M5;21J4X.#@$9&^"-L5>3=$!W (P#N!X6/3IUWJYT2E 2"!0 3$[B   CV+YC
M[_X\E.GP_%JKDG&23CI[/=7U. ? //\ X2XZC?R3[ZA>_P#7_&N!@#YG;X_\
M62V^K._ASOY^+?WU/T0.V3]PKYE /$?M^,7]2N/I_P!7\:BJG /VSL'WQ/=_
M]] ?U]_IR&_&/_OI72D(Z/?BQ,^8LWIF+OUUB9VU0<F9O$T5$2.VHK$.+=R1
M)99(BZ(D5*FJJ0#@50P#5=I01L1*Q!&Q!-JP)!ZC()!QU!(Z$U)W5P=P8T!!
MW! G! ([@$ C/0@'J!7>(  !@    67   .. *J8 #Z     ]P  !VS6J@G'
M7NWWG^)KF?R3^@?UJ8P/*AZ'W'[JX@ <&[!V,'';R^:/E\,H -+;=Y/^YJA?
M6C_/85SX#T@=OQC?J,/Z^^4^C_6_"I[GW#[S51 /$ \!SZ(?UAFO<>X_A4UQ
M$ \(]O<?_<#,LG5U^E]QVI7$ #T8]O<'^Z/]P?5EWZ?'^-2O5?>/O%"@'I%.
MP>9O^+(;H?Z7[HJ.Y_HG[&7%?=#[\_Z?^_EP!EMN_P" JS?1_HC\:[635:8I
#7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g68105g33d00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g33d00.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1_D4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '\B^@38X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              ,T   -%          $
M                     0             #10   ,T
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   ,T     4F=H=&QO;F<
M  -%    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   #-     %)G:'1L;VYG   #10    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M     #A"24T$$0       0$ .$))3004       $    !#A"24T$#      5
M:0    $   "@    )P   >   $D@   530 8  '_V/_B#%A)0T-?4%)/1DE,
M10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$  &%C<W!-
M4T94     $E%0R!S4D="               !  #VU@ !     -,M2% @(
M
M$6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M    %')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0
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M
M      !865H@        \U$  0    $6S%A96B
M6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M       DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C
M+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                 &1E<V,
M    +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@
M<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L
M;W5R('-P86-E("T@<U)'0@                            !D97-C
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0                                  =FEE=P
M    $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %
M  !7'^=M96%S          $                        "CP    )S:6<@
M     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #<
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M&(H8KQC5&/H9(!E%&6L9D1FW&=T:!!H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MM(E@Z6]JER2?2!1Y6?JAP%0"IQ@G8F@Z5Q^>B.\E@\P@NO<Z+'GBR3W<EMP
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MY/;"&V]*K0CYP 0ZB/7<.T=MQ'?G:3GS--R>"2?AW.P$[>ON'(G.*L7A(NI
M%4CJXCP\*@9,:<AMX]WLV%;6<,U$0NW@\?"(GB:8E;;Y6;5PASD0Y8U].=ME
M?K)[ID%E:W\0LBV=2\?%*BM%(V S$46ZJ!FIWPG311+KSNKW(M^E/1XO<-!
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MO(MI=)':&9T4O*2@9AQ<*GF3N:[.GV6C23W5TZV!CDM--E>&18V"R7$+-.(
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M3TZ35=%&G7$,E^XN8M726S9Y9+=<&5X)(X>#$<AD4-QG=B0"<;5E=C3]7%Y
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MG.CW@8#JQ>GBQ[XDQ1 9SMC<]V3R&._XSY2@1K-JX)SYB !D8VD8CN]>2>X
M_-I]87.%N)VL<(638GC9HW"I['KALA\0Y&J\V\N<3E:DV6D)3(.IG$M:J<>R
M2O"62T7Z3PZL-88Q8ZCP6<R)GQ'3).Y$+G1[G6+23H]<ZK)=ZEU]O=*%$753
M")D621F)1800 2N).'D 2*H.\&H6^G7(UF'3C:6(@G@/6B5G5MPB1CTQ*0&
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M>;H(;AN B [#U$ $,3%$S>FJ,!N,@$ [=^-OL&1FH20E\R$XSR8DX4^^4'F
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M+*^P7((R5(YC?)!V\;TBECN[RV%M)')P6-E;DJ#PK-#$D; Y#88>]/%S8\(
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M.EFY$@46EBI["5!,=<WHOI[6&EI)+@WMX[W]W)G)::Y<LR,P]+$2MP("<K@
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M3BXN4*Y')!B7-1[+.H</.6+731IDHUA:RWQ>BE",;"J1ZT@[!(QZKF/6DO\
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MZE/XE/)6,7?UO[_]%%:_>_3M?O?B:U^LR_<IV6VGQM<_J4_B4\E8Q=_6_O\
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MI=C)&RVT/R\N/ .?40#\U43^A7<5&VVXP;^&_78<4ULN_9TZ6WM 2AN'00V
M!VVVUB?*_>Y4'1K0$]_G$H_\,Y(QDYWV%#Y+[?F-5N#@$>G;PL=]M_RF-_
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MS4+^Q].W#RG_ *7ZG],?=IV;=#_BL?K+C[]/9?\ $Y[\%H^:A?V/IVX>4_\
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MS4+^Q].W#RG_ *7ZG],?=IV;=#_BL?K+C[]/9?\ $Y[\%H^:A?V/IVX>4_\
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M,&5"& R<D['(Y ':O5H?A%,AV!'$V3[=@)A4^&KB1L,S4,"9!1OJDI>G4ZE
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MVQ> ELN=,GA*%&CE!%N'8$'@>XCXE7((&2V5!S@X[N=:+;58)PZLKHR]>R
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M&P=>SJ.VF/D]H/+GRS67$N^"#@9(!!./DS5)0QBF'8 Z!O\ B\P[ '4=R[]
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M4II2FE*:4II2FE*:4II2FE*:4KAQX5(P)Y%Q<8VQ0&HSHB(AR@<1E&0!L;F
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MMR;*.34K&$;QMYML$"SFJMPUUF>9%;NSR4H3+MS90CE4C6P/$/6F\7X?1D+
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M,<B\4 R+)VZ;)M7:X>);KJJ@9/58>5WR*FUFU);>QS!,MM(HT=>.,LQ3TD$
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M.7RZ[A<YW"JAS*5]W,B [;I@)MA\VX[[[#^?8W7X#=PZ4J)13W "\NX[AL
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M@#X@, "'PAOVZB?9"1L> [C8^_'?SK'\Y_4Q ]0R=AX?-4Y0 /&@   ;J#L
M  ;^WZ[=FMG?CN &!X;M6>  , #<_L%5UBE -P* "!0$!   =]R]=_SC\H]X
MZFHH0 Z!L&PB<1#8-A$"@("(=X" "'<(!W:4JF/ZQ+O\/4 Z_F  ^(-*5$
M5MA#H*91$.\0 =A_-I2I%NG4.W=,-_/L)""(?$(]1TI4Q^B8B'0=S=0Z#^(8
M>WX^OQ]=*572  4Z  =3]@=X@(_6(C\8B.E*^K2E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
6I32E-*4TI32E-*4TI32E-*4TI7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g68105g35g68.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g35g68.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2N"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *V:^$1$#A"24T$!       0!P!6@ #&R5'' (   ('_QP"4  (<G(R,S
M W,C@< @4 'TUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@X0DE-!"
M4      !"I>VKQVS7F1B!1.-MQH?9].$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%
M>            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  7@    $  @
M!>     0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@              ]    /@          0
M                     !              #X    ]
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG    ]     !29VAT;&]N9P
M   /@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P   /0     4F=H=&QO;F<   #X     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    $.$))300,     "
M$(     0   *    "=   !X  !)F   "#L !@  ?_8_^(,6$E#0U]04D]&24
MQ%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$
MU31E0     245#('-21T(               $  /;6  $     TRU(4" @
M
M 18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @
M0    4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9
M   E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'
M5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P
M@,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&
M,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G
M-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C
M$
M       %A96B        #S40 !     1;,6%E:(
M!865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M       "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96
M,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                  9&5S8P
M     N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2
M!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;V
MQO=7(@<W!A8V4@+2!S4D="                             &1E<V,
M      +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-B
MTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6
MX@245#-C$Y-C8M,BXQ                                  !V:65W
M     3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4
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M$!R0'1 =D!X0'I ?(!^@(# @P"% (= B8"+P(X D$"2P)4 ET"9P)Q GH"A
M*. I@"H@*L K8"P0++ M4"X +K O4#  ,+ Q8#(0,M S@#0P-/ UH#9@-R W
MX#B@.6 Z(#K@.Z \<#TP/@ ^P#^00&!!,$( 0M!#L$2 15!&,$<01^!(P$F@
M2H!+8$Q 33!.$$\ 3^!0T%' 4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?
M8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L &T0;C!O4'!P<9!RL'/0=/!V$'=
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ML*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,#
MP,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0
MP,# P,# P,# P,# P,# P,# P,# P,# P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0'_P  1" #Y /T# 1$  A$! Q$!_\0 'P !  $#!0$!
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M$+OX_C[>+^\2/XPU&20/=1)VSV*B*/P ;=LQLCF[8*D]1^J#PSH38YK)X/\
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MUNI=FX<VX;1Y7TP&$4Y$M/,/TH+1D=,F,8E=(?M"?BZ %8XC8J1CLYLSM#@
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M3'<'L=2_A;1FM)^@Q@Y%S<.(_P"EUPX'?;E,]E<UK^Y91JO%QREM-S@XC <
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M_#'! _BB[7 YR"($KE'8]<RCZY]<?+7L:_J[1'TNJ1OGE/WJMZBB0!ZMN,3
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M&%;.TRR=<T[QU!@N:0+&/;B&.:YI:1$$>UL<3[43MP1X-7AFCJ.$C:X=2?\
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M.,'H!K3[KB&_NWR'NITMF-I.+"9W!#79&!@@1GN5VNSX4TO3Q[#&!T-!<:;
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MWEJEU*J3'2IV1)D*42I6&^5"4@:9J^L7VNW=2]U"KZVH\\K&-Q3H4Q]6E1:
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M4Z7]VB?"@/R(RZS,$"E-+0G/G3YA2OR(K*<NO+"5*Y$%*4J40"18:4+B=O\
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M_9C.RIFK3!+>=G.-VE[0?MV_P*XO\-.SO_&UMD?I?5K>G_2VO7J*_P#P:O\
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MN*P[_JGW?>%/'"L/]DOP_P#SWBV_/_62 /\ )K"\0XT6_P#ZBM]K"5>Z&?\
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MIV!#IRHHFP6:12Y3\YJ#4&ZI&3$J\AL5*CNB6TCSWHCJ_/8"F?+1SJ62*/\
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M-$31$T1-$31$T1:*. 3D#'4DD  9ZY)R ,=SWQVZXT18/W;3=T-V][/T)K-
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*B:(FB)HB:(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g68105g37a85.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g37a85.jpg
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M:D\.QHU,KMS@\# _R@Y(WP<Y/&_EL/16U_'6V"$N4JDLR&SF^I-7=W0*"V_
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M&56.0CK-N0D#&"1XH0:EI<[!L';1Z8; &A!8:T=-W#W1%%=+?8IP<$X.!R?
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M;[:.Y,LVV49*%U7>S!55EENKN5",$@\@D;<<^"\ONGIAQQ]RC<'1+&,Z3$M
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M1T;JYUX-1<::EE9#,*KO)#TQB*@KZAKW=#I"QDE/32QN>(V/>YC7ES6L<2
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M<,<[FR,O>Q.[1?8^@NC3([;/]W\;3R!!]-<__P![0TM8NV-?_O.=$U-OI_\
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MF#Z RZ;O8:&<RN30A\+UU&/(D=/*/R<==#M-&#@0Z:*L]-&^Z>F"@\G&PR<
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9!QG_ ,6 3]/X[JT;Q53Q$\1/$3Q$\1?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g68105g37c32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g37c32.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1A>4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &$*^8A X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              H\   7^          $
M                     0             %_@   H\
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   H\     4F=H=&QO;F<
M  7^    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   */     %)G:'1L;VYG   %_@    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M     #A"24T$$0       0$ .$))3004       $    !#A"24T$#      -
MY     $   "@    1    >   '^    -R  8  '_V/_M  Q!9&]B95]#30 "
M_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3
M%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-
M#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,_\  $0@ 1 "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M[>/_ *"CVC^\7QZSJ68'Q3FYCF0-;++&NG\[VLML;_TE']I=2_[EY7_;MO\
MY)>P5=0ZM;:RM@: ]Q&ZS$R& " YKCNLV_O*\QO5]IWV8Y?)B*W@1!V?X4_X
M3;N_D?YZ7W@#] ?;_P"@H]D_O%\1_:74O^YF5_V[;_Y)+]I=2_[EY7_;MO\
MY)>UN;T
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_  !$( 0,"70,!$0 "$0$#$0'_Q  ?  $  00# 0$!
M        !P$%!@@"! D#"@O_Q !M$   !@$! @<)"P<&!@P*"P$! @,$!08'
M  @1"1(3%"&3T14Q45-45Y&2TA87&1I!4F&4E]35"A@B<8&5EC5SH;&R\",G
M,C-6P20E-#<X0D=5=H>VTR8Y1%AD97>#M=9C9G5X@H2%HK3A\<7_Q  < 0$
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M>D6?N*?/3XQ)PG_G+QK]D5+^X:>:_HK^:OO?&^2H\X?2?TFR]RC^>J_&(^%
M\Y6-OLBIGW#3S7]%?S5][XWR5/G"Z4>D6?N4?ST^,1\*!YRL;?9%3/N&GFOZ
M*_FK[WQODIYPNE'I%G[E'\]/C$?"@><K&WV14S[AIYK^BOYJ^]\;Y*><+I1Z
M19^Y1_/3XQ'PH'G*QM]D5,^X:>:_HK^:OO?&^2GG"Z4>D6?N4?ST^,1\*!YR
ML;?9%3/N&GFOZ*_FK[WQODIYPNE'I%G[E'\]/C$?"@><K&WV14S[AIYK^BOY
MJ^]\;Y*><+I1Z19^Y1_/3XQ'PH'G*QM]D5,^X:>:_HK^:OO?&^2GG"Z4>D6?
MN4?ST^,1\*!YRL;?9%3/N&GFOZ*_FK[WQODIYPNE'I%G[E'\]/C$?"@><K&W
MV14S[AIYK^BOYJ^]\;Y*><+I1Z19^Y1_/3XQ'PH'G*QM]D5,^X:>:_HK^:OO
M?&^2GG"Z4>D6?N4?ST^,1\*!YRL;?9%3/N&GFOZ*_FK[WQODIYPNE'I%G[E'
M\]/C$?"@><K&WV14S[AIYK^BOYJ^]\;Y*><+I1Z19^Y1_/3XQ'PH'G*QM]D5
M,^X:>:_HK^:OO?&^2GG"Z4>D6?N4?ST^,2<)^'?R5C8/^J*E_<-/-?T5_-7W
MOC?)3SA])QVW-F/_ ,E'\]2?F'A_^$EI]MBXB"R'CU!F[QIA:S+)JXGI[HYI
M:[8?I-QG52G5:"<$UYJ:D%T40$J;9%1-ND4J21"A1X=^#;HS<02/)%?,RW5Y
M$,7C?D0W4\2#:)02$C )_P 1&K;)K?>?A!Z112Z(YK4*(;5R#:)G,UNDK'\H
MG\ICG? .P &!49?&'>%(!,BPY#Q^**I@314+A>H""BAAXI2)F%EQ%#&, E I
M!$>, @(= [K7FSZ(AG7%WJ0:F7RXZE'BPQL.[) 'K&*KG\(/2@ ,9( IV#>1
M#2S=P4YP=^[<CO\ 5\P_*)N$^$-WOE8W ?E ^(*80P?0(<R,'T]_Y=WR:S'X
M,.BC $17V#V?CC>W\C<>L4'X1.DN".?:Y[RUDF1MW];&/[[:Y?&(^% \Y6-O
MLBIGW#4^:_HK^:OO?&^2I\X72CTFS]RC^>J?&).$_P!^[WR\:[__ &14S[AI
MYK^BOYJ^]\;Y*CSA])_2;/W%,>W7C]54'\HEX3\!(7WRL;"8Y@*4I<14H3&$
MP@  4!8@(B(B   =\1 /EU!_!AT4 R8[T =I-ZP _64IYQ.DPP/*+,DD 8LX
MP=^S'6.<G:MI-C?AXMO;,><8K#F2<D8\:AEJO6['F-YXF-JC%H5?-EA@'B.'
M9>2%-LD@^AW>0"0E<EF#\P,CL)MT[551,R363XW'?P=< L.'R7]I%>-Y')#<
M7$9NRQFLHY%:\5,QDJX@UNC#)RFP/?U.#]/..7=\EI=3VJ^51RV\+BW51%>2
M1L+5CIU @S:%(/5.3D=QUDD?RA?A38B2?P\K?L?1TI%OG4;),'>'J>BZ8OV3
MA1J\9ND5(XITG#5RDJ@NF<"F353.0P )1 .LGX,^B<B(Z)>,DBJR,+YB&5AD
M,/LQG(W'97*;\(?2E'9'GLU96*LILDR"#@@]8;J>W./NS77^,2<)_P!_WR\:
M[O#[T5+^X:V>:_HK^:OO?&^2I\X?2?M\ILL>/D4?ST^,2<)_YR\:_9%2_N&G
MFOZ*_FK[WQODIYP^D_I-E[E'\]5^,1\*!YRL;?9%3/N&GFOZ*_FK[WQODJ?.
M%TH](L_<H_GI\8CX3_SE8V^R*F?<-/-?T5_-7WOC?)3SA])_2;/W*/YZ?&(^
M$_\ .5C;[(J9]PT\U_17\U?>^-\E!^$/I/Z39D>JRC^>MP=GGAQ.$%S?AS:?
M@T+W1$\_XQHD=G7%SE#&=4!G9Z#C]VX)F^EGAC-#-'DPSI\JWR)#N$D0D.94
MBP,TSG(Y*GK@<7_!_P!'N&WW")#'=CAEW</87A:ZWAN;A?Q&8N0K"+FJT<HS
MIZR$D=_8X?TWX_?V?$XA+:CB%M E[:E;90)H("3>0A.LID$1$J$]8A' VK3P
M/RB7A/A[V2\;;@Z-XXBI8"(AT#O#F)@#I >\8P> ==_S7]%?S5][X_R5Q1^$
M3I1C>YLP.XFR3?P[6&Y&Y':#L:K\8EX3[SEXU^R*E_<-/-?T5_-7WOC?)4^<
M/I/Z39G[K*,_R>J_&(^% '_E*QM]D5,^X:>:_HK^:OO?&^2I\X72CTBS]Q3Y
MZ?&(^$_\Y6-OLBIGW#3S7]%?S5][XWR4\X?2?TFS]RC^>J?&).$_\Y>-?LBI
M?W#3S7]%?S5][XWR5'G#Z3^DV7N4?SU0WY1-PGQ0$1R7C;<'@Q%2]_?W=&]@
M(?KW_)O^7=IYK^BGYJ^]\?Y:'\(G2;!_&;,^L6D8QOV[%ON_7VC:MP<N<.-P
M@I]E[9TVC\4WRA-&4R\M>#L\QB^,ZK*)PF=J:NI:XB<04>-#*1T5DW%T]"2L
M7&I<9@VEJI;$&0AS==!OYZQZ ]'?IOB/"+U+LLB17_#6%V5YUC(ICD0E4 9[
M:X1E9MG8.F5 W;L7?3GCYX78<2M);4!WFLK]1;I(L%Y&W,A?+$%1/;R*0,$!
MHGV&<#3\/RB7A/C &[)6->GI_P!Z*F;_ -7^X1#H[VO0^:_HI^:OO?6^2N0/
MPB=)B/\ 6+/.^_D<9.,D;@-CV4'\HDX3\._DK&WV14S[AIYK^BOYJ^]\;Y*C
MSA])Q_VFS]Q3^>O^^WLJOQB/A0/.5C;[(J9]PT\U_17\U?>^-\E3YPNE'I-G
M[E'\]/C$G"?][WRL;;_![T5+^X:>:_HK^:OO?&^2GG#Z3]GE-GGP\BC^>N/Q
MB7A/@'=[Y>-OLAIG]?,-VGFOZ*_FK[WQODJ/.'TG](L_<4Q[=6*^R/Y11PG2
M2J2BV1<:.$DU$U%&XXEIY <$(<#&;F.FS(H0JY0%(QTS%4(!Q,F(' !UB_X+
MNBY1PD=^KZ6TD7A)#8.,!E"DY_VMO&I'X1>DHTDS6;@,"P%HB]7(SN"V!C8[
M9.<9&01M-MC<.)PBN(\M1SO&F1*&GAG,./*+G'#'/\75"2=-:%D6'*^/7'DF
MLQ,L^DZ#;6MIQU+N' BY4E:B\4<B*QSB/&X#^#_HY?VDHO(KP7]E=36%\BW9
M73<6S%3(%4, DZ%)H\8&E^KM73XQTWZ16ETAM;BU-G>6\-]9LUH&/(G4GEY8
M@EX) \3DD$LFX!K57XQ'PG_G*QM]D5,^X:[?FOZ*_FK[WQODKF></I/Z39^Y
M1_/5!_*).%  !'WRL;= "/\ O0TP?Z.8AO\ U;PW^$-/-?T5_-7WOC_)3SA=
M)\?ZQ:'[K*//ZNMVU]_C#'"F#N N0:#QC (E V$JJ'& !#>) Y@(G*'&)^D4
M.+^F4=^X>G1YM^AQ#8:YZA"OF^(TL20%.0,$X_O!J1T_Z5GM:'LR/Q#!T^)W
MV[@3XD5U_C$G"A!Q^-D;'@<F/$.8<.4TJ9#[SAQ3GYB8"F$4S !3<4V\!Z!X
MH[MGFRZ)Y5>7>ZF!*?CK=8 9)7"G;<$^&1X[X^</I."<RVQ"DAAY*!@]V3@X
M&Q\#ZC0GY1+PH!B@/ODXVZ=_3[T5,W]\0\@W?T:S\U_17\U?>^O\E2/PA])R
MHQ/9@_\ P:-W]A)89]@H/Y1+PGY1#?DK&W2(!O\ >BI?RB #_P"0?3IYK^BN
MWV5\=QMY:^__ ,E0?PA]*,'\8L^P_P#8HQ_]9[/N_P"$EVO\H!X2B*H&*+ Q
MR+CM.3MD=<',RJ?%%/.DLI#VQY$,112.S$C?DV:)"*%2*4%#[SF_3WB-*W_!
MKT9DNK^)X[W1;O;K&!>'($ENDC D)DG6203W'&,8-69>G_21;:SD$]HKRK.7
M)LT(8I+I&QD(!"X&P'?D9[(V^,1\*!YRL;?9%3/N&KOFOZ*_FK[WQODJOYPN
ME'I%G[E'\]/C$G"?AW\E8U_;B*F?< T\U_17\U?>^-\E2/PA])QVW%F>X?B2
M#_ZZ#^40\*&0!,?)&. *4Q2&XV'::7<<Y3&(4P\S$2F,4IC% 0WF*41 -W3K
M%?P8]$V( 6[.02 +ULD#8D8!) .Q., ['&:Q\XG2@8)FM ">^S3^6<G[AOXX
M[:H/Y1+PG_0/OE8U#?WO\45,_P!;#^O67FOZ*_FK[WQODJ3^$/I/Z19@'_N2
M;?\ S=@]?9WU7XQ'PH'G*QM]D5,^X:>:_HK^:OO?&^2@_"'TGSO<69]7D2#_
M .NJ#^42<*" %,.1\<<4YC 01Q#3"E/Q!W'XHFC]Q@*;>4>*._> ]/2 C'FP
MZ)DD".])7&H>6ME<^(T9'JSC/<<5!_"'TG!SSK3!.Q-JJC]6000-]L]Q S51
M_*).$_W[O?*QJ ^#WHJ9_K8#J?-?T5_-7WOC?)4G\(?2?.UQ9CU>11G_ .NG
MQB/A0/.5C;[(J9]PT\U_17\U?>^-\E/.%TH](L_<H_GI\8CX4#SE8V^R*F?<
M-/-?T5[HK[WUQ_\ 0:></I1Z19G_ /)1C_ZC7ZR.!4VN\W;:^QV_S)GV;AY^
M\(9@NM.2?0==C:PS+"0<15';%N,;%I)-A637EG@G<B455BG(4X[DRAKXWTXX
M)8\ XV+'AXE%N;."?$KL["21Y@W6;<C"*/#(/?FOJW0SB][QK@_EE^T;3BYD
MBS&@C70J1,O5&V<L<G;)]6*_+%^4&P*]IX5F4K+19%N[L5"P;!M5G/*<U2=2
M\<2.;JKBD4ZG(I*N2J*\F0ZG)E-Q2''<4?K_ .#>58.AIG92PAN.(3%1VORR
M'TKZSIP,[9\:^8?A#C,W2A8E.&DM+%!G\D%WD +=O?\ =^NM.MHG@K=HS 3M
MRD#FN7AE$1%WF[1(':3V(E:Q%T.W5ZDR,RZC\]0V,7\S5[#8K5!QM"ME53GH
M.]O72C6L/)!P@)3]?A/3;AG$E.M)+5S)#%'A5O5D>>.298@]GS]$BQQ2-*L@
M3DA09"F=N)Q/HK?\/.1)'.HCEED)7R9HDAD2)G870A=E>1PD;1A^:6'++=\1
MU3@]MJVQ9#K>.7^.351Y.OH=H]L%CLU/9U:JC)W>#QXNSLTVG8%F4=;8>W6*
M(@93&IEQR8G,OFT,G4CRSENS5NS]*^"PVLMT+HS: Y2%(I.;+IC>8&->7EHF
M1&*3C,+ %@Y49JG%T>XM+<I;&#0695:1VC5(LR)&1(^2%D5I%#19Y@8XTYV.
M-2.Q%M+MK++5R.QM(3(QDS!Q2<JRF*\VB'"%HB,B6.M3RKF2EVG<BNR=6Q/D
M.UNYB<",CZW7JO)R-I<PJ*91-N'27@YC$KW)C^SE?ENCZR\)@26)0JMS)5EN
M88E1-1D9P$U'.-+<#XD)"@MV<AT4NK+HQ*)FC=B=D1E@=]3Z455.HC )Z=VV
M.,U8_K>)IVQM*H5_F3)UTQ-5:K#WRIS]K+:J5)UB*=IR+"&EGJ*49,2-F8IP
MLRS=/HQ9J+20<NVK"=K;B8SMND'#[N6]BA,V+&TBOIIFBD2-K:9&F 4N%(=1
M&0RD JP*'=6 PEX/>PI:22A,WEU-:1(DBR/SH71"#H+;$R#2VX(Q@]E93:]B
MVS-\BQF*<0Y7Q!G^_J2EHKUBKE#L4G4EJI;JO-P];?0+MYF2!QO&S2<Q/SC&
M(I4I6W\HUNDF#AA!)KO$TD5Z\722 6C7U_8WO#+3$<L,MPJ3+/#<*7B93:\\
MH50%YEDT<I<9)WQOFX')Y3'9V5W;<1N"98WCA,L/*EA8)(C^5(FH:V"Q&-FY
MAV45CR>P]M4*1-3F"8DEB1MU/%)PYE;)247"*,["7&P1<G9&"ME3?TF!7A<?
MWN4&QW5M7X%LTIEG5=R3?N'(@VW?67@NJ9#>:6A1GD!AF)P'2-U3$9YD@>:(
M<M,N#)'MAE)P^@N**(F%J^)7"(P>,+JTR.&;K910L4C:I J]1LL,5,=@X,K:
M0A+I5J.R:5^<5L2];1?6AI.PS*BUA*<IVSY;!6DK9+23&*=*,7.TECJJ%;QR
MSA2QVE^VB:6-G=2L8FXYL?3/AAM;FY?FQB!5$<3(S2ROKOXU5452P##A\DC%
ML<M Q?&"1=?HMQ))X81RG,I!=UD7E(H2S+,92=.-5[&@WRS$! Q8"L9@.#MV
MD;-<Y:LQC*FI0D=9<HU U[F,BTR%JO=G%4#D*RRC>2*\F2S]56L<%C*W2=02
MM\+ A-L(QU*E40A&$G*,;$O2[A,,6MI+AIC%:R/:1P2/*@NFAC1@0NAU22XC
M5RA?22 <,54Z(^CW$I9N6BQB+F7,:W+2QI$6MEF=\L2&0LD,C*K@%@K'8 D:
M[Y2V?,SX5B*C-Y0HTI4HF]M5'-8=O'D._([.A%P$ZO&OBQ$E(+0,ZV@K569M
MQ7I]*,GD(>PPDHK'$8RK%=?JV'%^'\3DGCLKE9VMF"SJ P*$DJ/RE&5U)(H9
M2R,Z. Q*L*YUYPV^L$A>[MWA6X!:)F&S* #^IM+(VDX(5U;&&%0VD(\;OB/0
M.X!WCT[M=.JBG).=\ XSOZNS[OA6V\OCJ4S!E?90Q-!O6$;-Y0HN L=0TE*\
MX"+CI:[S)*U'/Y'FB+AUS%H[DDG#SFR"[CFR2O(HJ*"4AN#%=K967%[QU++:
M3WDY5>UA%!$^!G;)P=^X'L.:Z"6SW=SPRU1@&N4MX%+?DJ99M&H['L!SX8![
MS7UDMA#:FC@KS@,7N%X:VEYS7IM.UT=*)4B%*5-Y(:6*P.'%E2"B5U[CVMV"
MY(35]"M1W<.!G%SN"*0TFDUQ'2?@HYRFZTR6P EBY4Q8/S1 8X\1GFN)V6+3
M'J.ID[F4G<>!<4!B9;9BDQS%)KCTLHC:82-USH4Q(TFJ30NE6W&D@2!D?@WM
MI>B68M6CJ[&W1T#(D@\EXB<@8:KM#G8T$4(U*RVJ7A(I],/);(D!6XJ)07!_
M89\QF-9;S@*IG&M:]+N%W*-+(S09>-5C9)))2SF<'[.*-F 5+=I'8X$:DF0C
MMK?<]'>(6[B-%6;(<EU<",!!$,:R0K.S3HBH"69ME#9(&*8TV"]HG)D:VL#.
M"K<%6GV/[KD2/GIN]TPC>7C*)$UB;FZXV8QTY(2#.^!'7.J/6M,G&T--\PG6
M4HY;MHU070;KKI3PFV<Q:YYIDNH;26.*&3,;3B?#NK("8P]LZ<Q=2:P5#$JP
M&JVX#Q"X42<N..-[>2XCD>6(+((C%K0$,<2!)HW"$:M+*V!JWZCK8%VL$YM.
M#C<1S$HN\N$Q3(LJ<Q4F;]T^B9.\19))]"/; G+5ZOR[S'%V;0-DL#:.KD\]
MKDK'PDQ)/&@I'E>E/!C$LDEVL9,$<[@I*RJ)(X9-"NL9621%GB,D:9>,.K2*
MH()-T?XJ'9$MBX$CQJV8M]#RH6(+%U5VAE6-F4*[QN QTX.N>2,;7;$ML?T?
M($$:N6F.90<FX8%DHJ8;+Q%G@X^RUR8C9B#>R4+,1$[7Y:,F(B6B)!Y'R$<_
M;N6KE5)0#:Z]E>V]_;I<VT@>)RZYPRE7C=HW1E=5=61U92K*"",8KG75O/:2
MO#.G+E41LRY4Y25!)&^02"'1E96&Q5@02#FL!WCX1](ZMU5IO'PCZ1TI3>/A
M'TCI2F\?"/I'2E-X^$?2.E*;Q\(^D=*4WCX1](Z4IO'PCZ1TI3>/A'TCI2F\
M?"/I'2E-X^$?2.E*;Q\(^D=*4WCX1](Z4IO$>^(C^W2E3QM#[O=_!<;?Q?>1
MV:!_1Z#;PV=,:;MP^'Y/3X=<K@P!M9"V<"_XEG&QWXC>=A[MQ[,BNCQ' N4S
MN#96(QZ_(H@#ZR"1C[O"O7["NVKL_5K#.S;1\IY]L5CQW4<:8=H5MV96M5RB
MNPI.2Z]MC-<NV'.[6:3BF-3CWL!A].3BVTOCZ9?W^8=2"5>0;)-@640\+?='
M^*S<6XI-;\,$<TUU<W,/%%N8,2VTG"'@CLBNHL1)=%&99@L2A-3 YP?7V?&>
M'Q<.L(;F_,D<-O;P3<.-O.5CN1Q,7$MV),!=26H=%,3,Y9M."IJ)G.1N#9E8
MW&DHTK](A+^RI.2HJ3/.U3,%QH!L@NZO%I4K(&7C)56$M$DC(V=O./G-2K:&
M6VD=)RJ3].;8UYHA5V]B"PZ8(+J-I;MX'ELM/*N+&&X%NDC>40V+%C%&3$%"
MRRFV+ !3&6S(VB6ZZ,-Y*Z10QRJEZ'+PWTL//92;::Z&!,PU@EHXO*55L$,$
MP@Q>%R!P;S>&K498JC7GG=>_OH*URM6I&4&DG5:[;+/M 05TR-'I629D^>TN
ML4*SX"LN'*0$U/WZ+LV/99O8Q:*O)=U<+,EGTL=YGAN+B,);\R(2W5J5F>**
MR>VM<0JJ"X>>&[CO9U18GBG70,$*E>.YZ.(D23PH^J4K,T<%P'2.66]6:=2[
MLSQ1026KVD66F5H2S#(R\A0^7>"F5]RA76&XMHU3VC(E2SNYD^1@F6V%JYEJ
MK(L; WK4+0YN.L<7:,%0TFRN==7R/799*\6"8DV%+EWJ<9+(5'L.FJRS$7TK
MAN%2L%5H"AO);9M2B5G22.6.[=.05C:,11H Z@L#92[Z)M%$39HI'$%$C$3E
MEM8KB/&8V73)'+:@F4%U;FN=*L,,;+$7_9/I&)\#;1\CC^BTK.$S>+#(15;J
M\<HXBF$9LYKY'OU#O#&NLI*8D*Z?,5]L6%\2NG5B9HMC1V++S-K@JE)OWQ=X
MMN-W%Y?<*6[N;CA\4$4<D]S(7F;Z2CMHKF%Y2%#BRA6ZN8].VJ>(*1U16HW'
M"H+6TX@;>**]DFED$,496%8^'O</!.(]3E?*I6M8'5L;0RG?.:\>HZ<F(F:8
M62-DG;&<C)-G-1\JBN(2#678O$Y%E)I+](E=MWJ2;HBH[S%5*!MV\->\>%)(
M6@=<PR1&%T.Y*,NG!.^<@[Y[.T[YKQZ2/'*DJ-B1)$E5AMAT8,I&1@ $#M[.
M[QK>#A H>*LF2J7M0U..;Q],VP\>QV<"-6"92L8;*1W[RI9_JZ?$ J931&88
M*UR;9("E%*"GX(>*'* (^?Z,R/';7'"+C>YX'<&R+D@\RU;,EA(#G)_$GB4Y
MWU(<C.]=OC\*R3P\4B %OQ2%;E N.K<_Z*]4@ 8TW"38QMATQCL$+;*^S;9]
MJS*R>)ZE,)0LJ-1N=R.Y-6KK<G:T?1X!Y8Y)C$53'==M=SL,V\:,E$8J)@*_
M)/WSPZ:"*!C'U>XYQB+@=@U_+&94$T$.@2QP F>58@6FF*Q1JI<,6=@-L9R1
M5+A/#).+7B6D3A',<TI)CDE!6&-I&7EQ*TK$@841C46(P< UL/G?@S]H+"45
M-38.*ID)E6[99JS8"U*37C9^(;5Z%Q#-C-/Z?=&U4MJ3<"YIJL78(Y*OGEJ-
M,H23&ZLX4J;9PYY'#NF7#.(2Q0E9K1I[=)X6G"N'#-=ADUQ:X00+.8HVO$J:
M63/=T^(=&.(V,4LFJ*Y6"=X93$2CC2+=F<QR:&T9N8D(TZD<Z9 IJ%9_8JVF
MZS#V>QS6,U6M<J5>A+5*V%"[8]D8!W"6-M:7<,XJLW'6QU%WIT];TBX*A$TI
MU/2Z'N8G2.F*!XQT"?03I-P262&-+W,D\CQ)'RYQ()(V5'#IRPT8#/&-4BHO
M77K=89I2<#XK$LCR6SK'$B2,YD33H=2RE3JQ(2JMA4).58=U8Q=]ES.>,KG1
M*#DJF&H%@R.[38UGW4V2IQD+SP)<(*1:3]D-.'KU3?5N5WL[E&VB1B).FJAQ
M;.SBAW .ZWX[PR]M;N[L[@W,5FK&801NTA(1G540J&<R!2(RO5<[JQ7K5HN.
M$W]K/;V]U ;>6Z*K#S615.IPF6920H0D<S.#'_B[-\?V@L,SVSQF&]X7LLQ7
MY^;H$NC$2$U5';I]79%9:+828.8=Z[:,7#M@HC()<BY4:(<N!!4(0$S$$;7"
M[^/BEA;7\4<D4=RA=(YAB5 &*D.,D9R#V>%:N(6<O#[R>SE>-Y+9Q&S1,6C9
MM*ME&(!(P1N1D;#N%7+9DS;);.>>L79JCFH2:=$M3)_/02O%,VM-.>@>'N]0
M>D4WIJ,;94)*<KSPB@"46\DH/0)0,&KC7#TXIPN]L9#IY\#".0;&*9,/!(I[
MC'*JN#W:=ZV<*O7X?Q"TO5RQ@G4NO:&B;J3(<[?:1%UW.,;]P(RK;%PO&8#V
MB;]1JN[[K8Y?+15^Q-.$$5"6##>286.OV+YD%MVY596EV&';R!B]!)1L^2'B
MF2,0NG@'$'XCPNUN)@5N8P]K?)MU;NT/(N2.['-1B",94@]G9LXS9BPXC-#"
M<V[JMQ:-N2;2X42P$DC.I8G16SOJR"=M\[V--B&^[:4ED%C2+&TKPX[:4YS)
M<I2,GY ?.0N]C&M1JC>#Q72KQ.H1L>\#G=@FWT6WAH*)Y:3DW[5H@LJ2KTAZ
M1P]'DM7G@><73S(@6:W@T\B)I6/,N62(E@ JQEM;LP1 6(!M<%X'/QM[I(IE
MA%K'$S,T,TQ/.E$0PD"/)^5EG8C"('9\*K$77+W!X;0V)3U94R%-ND+:31S,
MECJ=ZJR=?@9N7L>2JY&,K$\L<K N(.$E%<46^0B[S,LHVCR#./<D;3XOF,BS
M:86/2KAM\+D'RFV>!6E$,L+F1XTBMI',9C5ED93=1(T::I%)4F,!ERO.CW$+
M7D8Y5PDY1!)%*NA9'DN(U1^8R,FOR:1U9U56"D*<J0,#EMAK:OA@0+*8<GFS
MESD)#%C",&:J*LU-WES(P42A&UJ#0L*TU9XY23LU>:!9J]'R=6*I,QXFF2E<
M$WV%Z2\#E**E^IS:F]=@DH2.$(\A:1^7IC(1'81OID(1B%&G%:9.!<7C74]E
M(H\H%H,E1JF+*H5%U:WZSJ,HA4$KN,BL49[.5UBLPL<*Y+=QN+K/(L8U^Q6D
MTI6],YTEBAT)>F-Z<?%D?=0NR][!]&LJDYK2C^'DWD@D"DJT22<*)9/QZV;A
M+\7L8WOX$+:DBQ&R:">8TG/Y8C6/!:0L,JH)TDC!A.$W,=^G#KO%G/)@ 2AY
M =0)C5>4IUF7!$>G(+, 2-\QWE[&TWAO*.1<265Y#2%BQE>+309U_7GAW\$^
MEJG-/(1\ZAWJB#95RP6<LE%&ZBS=NOR9B@N@BJ!TR]&PO$XA9VU[&K1QW,2S
M(D@TN%D 8:AG8X.3VC?M.QJA=V[6=S/:N0SVTKV[%#E#RV_*4X'5+9W.^3CQ
MK<;89!;,D)GS8I=K$4/M#T(UKQ"W6/N*UVD<((25VQRFU44 Z3=Q>ZN-_P 6
M', $5=.;G%% YS-4D5.#TD'D,O#>D"Y_Y,N5@O " 6X=?NEO.3G8\F5H+@#'
M_5G&3@5V>!9O4O\ @K8_Y0MS-:G_ &;^Q5IX,>'-B$T!P.R0"O/94#$4.4Q1
M3,4PE,00$IBF#H,40'<("4=X" @ [PZ0 >C7J@01D=AW&-Q@[C?OVKSQ[3W;
MD'M[0=^W?M\?XUZ38)X,S+.?MGYAM!UB\U2&KTE(6UFWCI^M9+-&(!2+!6X&
M6+*Y#BZ1)XTKDQ(K69HK5*W/6Z,L%N,W>-8!@\<H'3+X[B?3&SX7Q63A<UK<
M2/&D;%TDMW#/+&TJ&.W+B<Q@(1).BLD>"2, X]/P_HO=<0X>O$HKB-$E,BHD
MD<Y&F-UC?7<,C11/EE"1,P=R>KDXJ$['L.;2];LEMK1Z$UE7=3K,Y=CNHFYT
M-VC8J97G-Y)+6*F))V<75Q[G$QW>E)F"JZ$Q9J_[E)UO/0T<ZBGB"-Z#I3P>
M:&VE-RT?E,JVX5X9@(YY!$ZI(3& @;RB'2['0_,32W6 JC)P'B<<L\0@#M!%
M),Q1T;5%&959XP&+/CE2EE4%EY;:@-) Y!L&[6JMJ<TE+#<LO:V-=C;,^@V]
MDHSEZQ:S,J2$AXF0%"T*),;K+S"B43%8X=&1R!)R9R,6597<J%3-/UJX%RQ.
M;Y>4;HV:N8Y IF0%G*DH-4:KDM*N41068@ D#P#BYD:,6;F00+<E 4++$YTJ
M7&1I<MI41$"1F( 4DXK!\8;/TOE3&V9<@0]RK$<[PM6%[G8Z9+QUJ)+.ZRTD
M82)<2999I7G52BUG,G/,XV"CYB?92<[*I.V#5H04T55[5[QA;*[X=:R02R1\
M1F$$<Z",QK*ZL8UT&42NV$,CE(R%B(;).0-%KPZ6[MKRX26)'LH^<\+*=30J
MP0NKC[, 2G #,"Q.G<X)UX+WP[_?^378KF5Z&%,?//!^J(B//+_L.9&YP7C;
MC.7&S;M"2Z;<Z9!_256;X\SFV;JE*;<DV;Y?7, D(B!3^4Q]%]* 1M:](H &
MWV'%+%&P0#WSVFE=B"3!G!Q7I"QO^ %=FN>"3#3D=8\/O74X)[Q#>DG.#@3^
M%>>@ ;] H<;>(=&X!Z1 1W_1O\.O5*-@-\_$GV_Y]O?7F\?'^./YT$#\41_2
M$-W3Q1 1#H[P]\ 'I#H,'RAO#IT;=3]V-NT9'9C!P>_!'9N1BIW&<YP.T#.X
M/W>([-Z_0G9.$QJ=_P PY 853:$R)L_UN.V7E,78BS6[NVT7:(J+O,B]V;GS
M]S7,>04=-2F(TS1^-[I"NE*-7&#*;Y5-64541=-SK?+4Z)7-K:132\-MN*22
M<2\JN>'""PMY?)PUV-+WH<"Z)$J2!96!5@@ & !]$EZ2V]Q>2I'>W'#X5X>+
M:VON;>31K,4LR>7;!&:U4<J6)C$"&!8L3G-8QE/:SV$KSB?:RH1+3<G-YVF'
MDQ<7-N0Q42.K+G(^'J?C9/%=MLR8%&QP<SE;(M2RQ.G-5XR781D5GA^2\J1+
MQ@^,SW6/!>DMK?\ !K@6\ M>%:(>2UV9)1:WUQ*+J*-1B)UM;>2V0-(P#/9A
MXM8<UHNN*\!GL^*0-+.USQ-G;FK BQ\ZTAC\FGE9CSD-Q/'=,1$N EV#, $R
M/!00,7O;P*!A(&X0Z1#P;AZ=^X1Z.C7TT# QC !(]6W]YKP1[CW$ @^.0#G?
M??.:!O'<(B/^4 =/T]NG]_"I&-M_\0V[L=YJ:\@_[TN!/_LG(H?M#($IO#^G
MIUS+/_7^*_\ FVO_ *9?A5NX_P!5L/\ P7'W?ZPU0EO'PCZ1UTZI4WB._>(C
MT"'?\(;M",@CQ&* X.?"OT)5G,.QKER5ML/)7NIW7WXI62V@)FH9)H]T@ZKB
M:6P7L!YLJ4)"WF16+'$N4NIEJ<B'4%'XX=3HS+&"3%NY2E99E#F^5W%CQZRB
M21;:6V\@4V275M=6[3WRWO'()<Q+VP@6H"L;D*H+=8:037T**[X)=NT9F@N?
M*V-W)#=0SHED]IP>XCTRE=/-#W3Y18)%9QNI5L :^62^\&<Z=QAH:JT].K)9
M:K,AEV("C9E"[W"J(RF"5;,ZV=)I.5B8>@TIXWB\YG;P=]>L)U*,GV$>%=4D
M58!]4.I#:]+QS \MP\BV<T=D[W=GR(69;W1]((%>2YN1JL\30:XR\;YD5-6N
MA+<=&7T:(X(U-W&UV@AOG::+%KK:Q<.!#!)IN@$G99P6&O4 H2^ES!P;D)#O
M =8]Q);<ANX&=3L<I%XVR^QQJ_M<?@[:*=TU]C>$F%HJ;K<,\RR;9F@K,WFV
ML:J\D6EODDV+6I.Y267U'AG2Z1HU\KXA#$DHY:/?V1N%B:\L0_E<J9CDD%J;
MYXRC/H3DIJ:116XWO1J-9/Q:SFF*,'*6UV8.:EI=F,VZLRLL9N!8HY8+EC,V
M!&3B0??TX*\LG76*M3@I^HH9)@R]PYRG9A=P]0QU;L[P$SE1>HL%3I&BG3?%
M;BS!$M60J.DG)&96C9U.MHT2U_HWIBRLZRS1SF(E9(IK)))IHK"5+;RB1GZ^
M;@1<TXP=1R/RJW^7=%5V,$3QM<H60PW(2.!IH#.8@"/^H601KG42O>V 8'VI
MJ#LSP&PUC>X8VA,91-XLUFV;DZVK'R3E[EQ[$DPQEI3:#=V]4]@E&+R(?9>3
MJLG'D8M4W57BG]5K5A)#2Z7N>C[W ;OBLW2.\@O)+QH[=.(I,'#>1:O*K468
M@0QJ(2(5F4Y9A(R.R$JV32XQ!PV/@=M+;+;B6:6R>$@CRLJ;>X-X9FUG6O.,
M)4!5Y:NB-AABO(K>/A'TCKW]>,IO'PCZ1TI7] /\FD_\7-(_3M#Y)$?U^YO'
MVOS?^%,YZ4 XQ_R99_\ ZIZ_0'X-3GHZVV,<0G'ZA!:U^?'\H7G'E:X5*9L$
M;R02,#C_  E.,3+I<LB#V*B0>LQ52XQ.52!P@F*J?')QR;R\8.-O#Z1^#2)9
MNB A?\B:[OT<@]8(^$.DD$ [Y'=W]M>!_"*YBZ4+(N-26=E(,]FI'E(SZL@9
MQ7DQ*[5.7IJ;S[8I"79*RVT>L1;(#H6CA0S7D<I1&8&Z55!P_6[A-V]QA62J
M#<!=HI1Y5&92"*HK%]A'P.PCCX9$J:1PL?8&,!"[>2R6A:7 ZY:*60DC#:\$
M'<BO(-Q:[>2_E:0E^($&?(U8_&%N=,>6S&JR*"@!.,8[26&PB?"=[1P6(]@=
M1F*9)%W-K7>8K+VA(A5I_*KO(M:RQ(9=EXYI)-72U_D;]4X.:>O&T@T@E$V8
MQ*=?2AG#B./S3T/X5RN6LE^C*BPQRI=XDBM5A>!;)#RB!:+')(H0@OOJ,A8D
MUT5Z4<0UJSQVCKJ>62)K<&.6X:5)O*W&K)N.9&K:LA.X*%&D]<G"8[1)6#%B
M,;BPYTWC%2=?J4<1D;G#,:CF''Z53MK@LP5%]6O<+G?(]3,@Q:QLGW+DVKDD
MHE,M.ZBL'H=PLR-()+Y20S1(MUI6WFDDM9FFA(CRL@EM(Y%9M2Y&G0%VK$])
M^(&-$*6;;()2UJNJ=42YBY4S:R9(S%<NG8CXQ@@Y+:_WO:9O%ZK]-KA82D4M
MCCC(EKR5CP<>UT:D>DR]R"K&EHN 18OS,DH--W3*[)LBO6CV;0DV)GBDXLHZ
M=\OU+?@EI;R7$O-O+A[JSAL[@W=QSQ,D)DP[@HN7<2NK;A-) 55 Q5"XXK<3
MQ0Q!(H%M[J:ZA\F7D\EY1'A4"YRJM$N QR!OJ) K8RO\)QGJIY%;Y2JE)V?Z
ME;^YLZE+2=/PW7Z@ZLEDL]LJ5WL%XL$E5UX>=?V.5L-(@#/&A)=O4UXCNQ7U
M*P:!L$Y&/^3+T,X7-:-8R7/%9+=GCD19+YI!"8X9(5CB25'180)#A=)8X4ER
MR(1TH^E-_%<I=QP<.CG5'1GCLDC,A>1)3([(ZN9"Z G?2,D8(8BL90X17:%0
M<*+%"B*H.HZE0LI'.*H9:/F:]3*QF>E)UN22-*@JI$3]3SYD>#L8H+-Y!ZUD
MF:K![%/8])V;>>B?#"  ]TK*9I$E65!(DTTEI,9%81 !HI;*%XCC )<,I5L#
M2O2/B"L6^Q;*0(R/$61UACNHBK R9TR)=2*^,,1C#*0#64N.% VC';UF=U#X
MD<03/F($IJM$4/43EA(S9SCZP52+[N%<\2K.-E?#TS!HIR"21)*&DT9,DI#S
M;Z+&N.A?"0K!9+U)7SKN4G03DMY8)23R2C&=+^Y20LI*KHT88:JL?6OB6I<Q
MVKQQXY<;Q,8X])M#'I37G[(V5NT>'&&4DY5BA[C_ (4_::E(B#@)!KC)Q"PM
MHL-K5BBU"0:Q\T]M54R[1[ VDF+.R(,V[>6JN;+O'R+N$;Q,R_<K1LP^E7,X
MR-*.8'0KA"RRRB2]#RI%&Q$R900R6\L1C;E%@4>UA8!VDC!U 1JN!4-TKXDT
M<496V*Q/(^\1^U:5+B*3F@. =<=S("R!'!(R[:16MFT!M69:VEFU)0RC(L9!
M2BQ2,5&N6*4D@=]R$+ 5XDC(H/9628MWQX>L0S59.OLX&+55;+2*L:I*R$D^
M=]7A/ ;#@KW+V:L&NFU2%Q#E1K>0JC1PQMAI'9VU,QR%4'0JJO.XEQB[XJMN
MMT5(ME*I@N<Y5$+'6[ $K&BD*%!T@D%B2=<4?\L/U#KM5S4[3]W^8K:FV7V>
MQ7D/9?RA53,T[1C;'>"+]6SR#7GS )^GR2MAB!?LP6;BZ9A(1S;G+<%TA71X
MZ8*)\;C!Q(;6.]M.*6DI817%S<PN4QJT20QH^,C&=+8';^KONF9[:6QN8SB2
M".WD3(R-4<C.N0""1D9[?54AH\(MM!IMBQSA.A2,,M%52N2\*_JJBL;8JM5,
M)WS9^)6YM(DJDX6C)O&V2+5&S@L7,?(*2"[*6C9&-=LTQU2;HCPIM9U78=VD
M<2+,BO&\EU#>&5"(O]*)H4TZLHJ#05;42+Z=([]-&%MV"+&AC>(M'(D=M):*
MD@U@LAAE?4!I+.=8((%7^R<)EGVY$>1]NK.%[/5'[5)L\H$[C9O(T9T>/>T:
M1KZ[B!7ECIK#7'F.ZZ>-9*K'B7+928BYN-EXB4<QY]<70[A<&'@GXA#<*>I<
MQW*K.HTW*L!((MA*+EA+I4,=*%&1D!;:_2?B$H*21V;PG4&@:W+0_EQ.AT&7
M=HS"FC4Q4#4I5E9@>(\)OM)C 4*L ECLD)CJH62E04>E5'*#)2'M-&IU D^6
M8(3:3".5/$T&K2":-;:P,82PLWLT>.5<34V21+T.X4D]S<K)>\^YF29Y6N%9
MPR32S AC%KRS2NCEV=BA #]5<8GI/Q)HK:#%JD=M')"BI =/+DBBA8<OF!,A
M(D*E= 5E#:=V!HYX3C:9=3"UB.?'I+&]D7[F8L25,21FK##+R62)>'J$T\3D
M0!:KU.2RK;'M=:MDVTB57N(C,2DNTKT,W9RO0[A"+RU-WRUC58T,ZXCDQ;I)
M<*.7@3RQ6L22MNA&HHB%V8R>E'$RQ?, 8L2SK&59XP\\D<#G7DPQ27$KHN<@
MM@LRJH&G>4\J6C,%F8VRX&8'EHVD8YQ^T&-9BR;!7L7T"O8VK!543+N!.])6
MZM$%?.@. /'Q'#L$D 6!$G>L;"'A\+00%RAGN+@:SDZKJ9YYAM@8$C]38[#?
M!-<6ZNI;R433%2XBABRJX!6&&.!,C)[$C49\1MC-1MJ[5:FE*:4II2FE*:4I
MI2FE*:4II2FE*:4II2FE*GG:'Z;_  (;A'?A+9G+T#N'<;9VQF COW#W@'?W
MM<G@V3:2*._B'$1^H\1O!X'O(/9W5T.)?ZR@_P"Y6)__ ,*'[_#_ (UZ6XK/
ML'.MEW9*P[DZEQB^8-H90(*T9+J\)4XBPXN6D-L"4JY[[;,O2.1%7E?>06'X
MIZTCJ+,8>FZ^_C)"(L<A84&:0MC>0NTZ2KQOC'$;.Z:.PX<A9+6669XKDIPS
MFI#'9"/0Y>=ES.MP'C=&3EDUZ>T?@'T1PVSNX%>]OW9'N8TB26U5K\QF9[HR
M:UT0HQ6(P.IR&9EW M$/L>;!MIK5'L;/.E^IONLSZ&.7YK%D[!TPQJ-=89%?
M4QQ'6(5(6C3#&?LE:CDLE0EZ:PTG1H")L+"+G89ZPB96WN!Z0=)XKBXC;AD$
MXBX?Y4KQVUVK<UX!,K*5D>-HH)"UNUN'$\C(SJQUA! X-P"2"WF%]+"\E\UM
MEI[=QRUG:/2P(#+))&%N%ET\E5DTL#@M4I8YV1=CJQU1*GWVQEQ(Z]\6,;S*
M3O,^SM?,G,:]9#[.J[N.>9&AZNM5^4@!G[TK%J1$#674>49.,MT>HLPE&"-.
MYXWQV*X-S#KN<6K,@6SNX+-Y5'$T5VM9"7&LI 3U^MIC9=RCFU;\)X0\)@G=
M8#Y5EP]W:2W:1L+'*>4(-'4$DQ&E"!N&W#BL(@]C_8YL5)@7L3DN==+RS$M]
M@,8*Y?P) 9-L#^5P-@FXFQD7+4_06,3&O8>SW;(;KG<[6"1"[*BO:VTK+&V.
M)&;-8?C_ !Z.Z&JW2,8:WDG\DXA):0+'Q"]C%P;19RQU0PJ-I!("X)D:-0!H
M3@O!WB!2<R'2D\=L+FS2YFUV=FXA\H9-(Q+-*[94A@@ 7))&05/8KV3:-B)3
M*=AR13K#<7=.VDXTM#D<VXJR)!"(;,VU18\93:;6J5NN*Q5VI^0L;4&+24C+
M1?:S8+/8(@T+)-GCUK!HXR](.-75\;-;6:*U6?A<B316%S;.P%_PU9AEI9#+
M;2Q3S$%XXVY>1(G5+#-."\*@L5NVN87G,5^3"]Y;S@R+8<0>$,HCCT21S10Z
M@KR!G*E&[0?%2L5J:NEFK]1K3%:4L-KGHJMP4:@417?S<Z_1C8MBB4P!O.Y?
MN46Q-^[](X;M_1O^B33QV\$UQ(=,4*2RRL<@(D:L[MOC90I\,_?7B(XGFE2&
M-=4LLBQI&.TO(^D*, @;G [@<+BMS.$ M$$GF2'P)1))"1QILD4:)V=*P\:;
MR,Y^QU!9[)Y?O#=,H\B?W;YEF+S.HN2@"B\.I$)*'4YN3=P>C$+FQDXE<*4N
MN-74W$9E<$/'%(=-G#@YZL5HL0QG"N7QL179Z02IY9'80$&WX5;16"$$XDDC
M77<RCN/,NGF8-ME0O:3BM7L7Y7MV(9:PSE+=-V<G9:%=\<OG*Z*BJB%?R!7W
M=9GU&"B+ALJUDRQCY<8]Z4XBT= FMR:@%$@]F]L;>_CBCN 66&YM[I ",&6V
ME65 ZLK*\9*X="!D'8@UR[6[ELWDDA(#2P36[$@Y$<Z&-RC*RE7"G*MOCLQO
MD31C7;.S-BNKP51K:U7>Q5?=9%?M3V6N(6%P\=Y0EL6S-J&6)(.3LI5!P]P_
M3Q1;/VKA $0ET'23M.2/R7.N^CO#[R9YY.<DCBW!,#K"JFV6Z2/1&J80$7DI
M;=B6"8(P<W[;CEY:0)!%RV5.>/ME:0MSS;,^IBX).JTA()!( .YR09MLO"F[
M4EHDKA+O'%,9R-TQ.;"\DXCXVS 5.C&=9"="R50D+=((6-=$V3+&+ ;N2TL8
MIVC S45'LK'7XR:0YEOT*X/;BVTFY8VMT+M"94&9 (MCIA!7+0HVJ(Q2'+HS
M,CLINS=*^*3<_48%\HMO)7"Q, L9+YT@R$N0LC*.:77\F0*LB*PUNVD-J;*V
MU3:HRY9;D&$A.Q[.014<QJ#]JD_?R[P9"8FG#1[*2;=H_EWG)JNFD*2)K[0C
M=NVAX.,:I@CKK<'X#8\$BGALU;1<.S.7"E@@!$4((5=2QJQ&M]3G=F+,=N=Q
M+C-YQ66&>[8<R%5"E,@EP<M)DDD,YW*IH0#JJH48,<9<RE:,U9$LV4+J=@>T
M6YTS>2XQ3,8^.Y9C%L(A#FK05W)D2\TCF_' 5C\97E% $./Q0O6%E%PZTBLX
M"QBA#!-9RP#,6P3C?!8^'W52N[J6\N)+B;!DD(+$# )"A<XW[@._MJ1MDS!@
M[1VT!C;$SN1""K,U-J2V0K,?]%O4L85./>6O)5L=*B D11KM)A9R2(*@E(J[
M1:M@,"BZ>JO'.(?1G"[N\4%YD016L0W:>[G80VT2K_B+S.@(&X&3W5;X18GB
M7$+6T+!(WE#3R$;1VT:F2XD)P<!(8V(\6P.W%-K'.)=HC:"R7E5BP"%K$U,)
MPV/:V0I4T:GBVIQK*H8UJ:")!%%$E>I$' QBA4 (D9PW763*4%1TX'P\\-X5
M:6C'5,L;27$G^)[FY)FNG)R=1:9W.3VCV4XM??2'$;JZ *Q.XCMT.,QVL2+%
M%'@;#$:+V9W[ZPFE9FO&/J/D[']6D"1\'EM"GM;:NF5PE+BWI$[[HH5.-D&S
MMN=F4TB93GY3$7*[;;FX@F B<-UUPVVO+JRNKA!(UBT[PHX5HR\T:1$NK!@V
ME0S 8&'P>S-:+>_N;6&ZMX7*)>")9F4L)"L+ET"L"-/6QG?)&1D=M;&8]X0;
M/N-6=680):,Y:4^MX[JL2C+5A=T88K%Z66T:N<[QO,,W[.43+FJZ**3<0YCI
MEF]"$E(1_$2<.V=ZY5UT5X;=M</(URK7,MQ-)RY55>9<FT,F$,;*4_$H0(V#
M(09 ZNKZ1T;?I#Q"V$.@Q.;>."./FJS=2W\J"@L'##(O)=UPZD(492HQ(1N%
M7VLTY.U3<=,U.)F;ED2E90FWS&"?*-U+50)6DS=?=)UZ1G)"HF63DL?5XR\V
MYKR]K".5FZ^SL#.M3<A#+U/J/P,K"D@NI8X+>6VC5YURL<O/# .L2L %G951
M2D0 !,98 U9'2SBRO-)&T$;SS)/(RQ$Y>,Q%>JSE=N4O6QS"<DOUC4-UO;7R
MK6-HQ+:?:P]*D\CL89S"03>>96>7A:TBXK)JFG(P#EU;36]C8HV,6=.86T'M
M;BP1$T[5GF$BA*I,W36\_1GA[<(^A0]REISQ.Q1X4E=M8D*.1!RFB8@!HC"4
M9>H04)4U%X]>+Q/Z5Y=N]SRC&JR([1IE#&&0\P2HZJ=2RK*)%<!PVK>M7+-.
M#9K#-V 8V/AC34F]E#1,0,F>,9*/G!W*C9HI-R<U,*((F4,1)23EY)\J4 .Z
M>.%S'4-W((>1#%#S&D$,:QAW6-6D"@!2ZQ(D:D !0(T1, 84=E<F:0S2O)H5
M3([N44N54L2QT\QW<C.?RF9L8W)R3OGL8%7PGC/:.VTW(D:R.,:B;!^"W:@
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M]OH$83))*(:J>Y^4:QB,[ LI;7&FZ&\(FEAF+7:-#/'<*J2QZ.9$EJB;-"V
MJV<."FACUPS%6"KTX^E'$8HY(56W9)8&@8O'(7".UTSC6LRE@WE4@PV0HPP7
M6 :[:?"E[52+-M%(RU93AFE!98_0B@9V0Y",HR<;V.)E$Y-2U&GFJ\-+M^6B
MJRPEF>.F39S(QC>E)14I),7>L]!^!G.I;EF-RUR&:6,X9UT.A7D\LJRE@SF/
MRANJ3/E01L'2SBP"@/$ +<6Y41N,HI!5@_.Y@*%5TQZC .M]D<D5J_CK:(N6
M+J1D&EU:%H95\BP]BKLG?)*F1;[)$37+E$IP-SKT);@,@[)"6B&2YB\C99*6
M:Q1G#V1K24),OWTFY[=UP>VN[BTN)IKPFS:&2.$7!%N\ENYEA>6'&EG1SJUK
MH+#"R:U4"N1;\2FMH+B"-(/QE)(WE>!&G5)0!*B3;-HDP,JX<#)*X;K&!0 1
M'<7OF_1#_P#%T;_V;]^NH?#QVV[=_#[NVN?OW?V._P#A7H3-@7 >P!6J[QN:
M9"VWKT6_S9?T2O6FS?@N2DZY1V*Q3<5=)ID',J]ML0!TI.T,6U]<#G*?<GY2
M'/$^D\\A(>TX!:BVB(&WTE?+&\YR<@M;VJJJD8*F=E(VU5Z)P.']'8HL_C'&
MIQ/)D==;&R9EAP< CF719QL W)R&P0#@FPU7L?V3*UF;76(QS9K,TQ1>9'"]
M.R_96E4Q9<LSLT8WW+P%TF9.Q5&'3:*Q:ECD8>.F[-!0LY9XZ#AI)Z=N_.S=
M6NDLMY!P^)[=[N&%KN%.(7%@ADO(+$AN=);*JNPDUZ 66)BL98@:L5JX#%;3
M7S>4);._D\KV<-Y(([6:\! 2*=FD13&R%B Q0,ZJ&.Y)])XG9;V/LL09PR].
M8CPE>X+(N?7UCIFRQEC'CME*D9--CN,C(JMV[*-LL=:=U>C!<LNW'N*I8B1[
MI['72&@+5&P%=>2$7XZ7CG&^'2EN&I?\3MI(>')'-Q:VN02KMQ-Y)9$@6-UF
ME$4,1<H69#'(\;/I!]+'PG@U]&3>2VMA.DO$&FCX;/ ZAU'#UBBCYLKH8(S)
M/* 'QJUJK*H;3#P;$6QW6L%T?*]MS'+ST\XQG>;U9:11,Z8H/(3SJ/PZUR/1
MHZ*!YC%\\Q[*R-A!_1K)7Y!GD\[.90<Q\18'TQ#R$<I>'2/I!)Q"YLH;%8T6
MYMH(I[CAUVH@UW8MYW.BX(N41#S(Y"8"RX8IH(%5?H'@R65O<37;%VM[B:6"
M*^MGU%;4W$ ),*\EWT,CQXEPP*AR1D9,[V$-B>KTRBW&WYJG)-S*XX=3]GJ=
M#V@L/32ZUH4O6RA 0JL397F(&XQ,<YK>=,C2K^N/ZK-/FSG&KYU'6B6AXN6<
M.,5Z3=(9;BYMH[-5Y5V\<%Q/PZZ1)8H[;B#MKB6X<LW-M8E21)8LK,-40U**
MR^@>"PQVLTUV=36W,N+>"\MI&CE::RC33(T*:0(;F9G0Q%LQ$AL DV2-V$=D
M,MQIM>?YNFI:K/[-ER)F\GQN;<"0[%]*T:3VAV-4Q+"4"6BW-HAKG:TL68T=
MMLD/W<_279,G,.;UM!.5K"LPDZ3\=$%U-%9*98;: 1VLEE>.XYJ61EOI9T*1
M-%"\\X%LJ)+B ZF;#:<(NC_!Q+:PM>MRGEG62Z2ZM(T72]PL5HD!#.LL@@A;
MGL=!,X^S(*UY?YYJ-*HF9,B4[',U+S](K=KE8NMRL\\JTC,.8UHH0J:,G)4F
M1E:E)OF2HK,'$G7GIHR1.V%\@@R(X!DW]MPJXNKOA]I<7L:PW4L>N5(PZH"6
M.,)*JR("N#I==0SC.QSY?B$,$%]/#:RO)!'-B,MHSIV.,H61M))!93OC5L#7
M>R#_ +TN _IB<C#^T<@28C_7K"S_ -?XMX\RT_\ 3+_QK&X_U2P_\%Q_ZAZA
M'74JE32E?I'I6'N#O?;/E5OLPUPREDQ785G,7R-2<62*(]'.KS9@?[0D1M '
M8N9(6YKJQL\2]Q,**Q!4]TCV-BS1RDAQ4M?(KGB'29>)30(]^UH./+>I*8I"
M%L8^(-8O8*W6!@;4DV-.G0&.0*^FV]IT?>QAGD-HMQ]"FTDAYZ!O+GLTNTOB
M2RXD0"2$;_Z3  PN:C;/^R#L'.J[?YZ$RVS8S6,Z)D%G#Q6,K?A*.6L4C&YS
MVR$H')%VC)):"B+(R=P="Q%5E:_CM6GNT8:P5YU"-E^ZM6A9+=8](.DL$EM&
MUF\\=[/;F9[U;U^4AX?PLR00M&"82'GN)2[B0,ZN&4:69=%[P7@#Q3N+R)3:
MVKI'';26V)76]XFJ3S*TBZ^HD*E8RA *XU9"FP26QAL$UD;_  #7)JLFQN>%
M<;SU0M=PSGBQY<<2R"NT[C:F9%O$O6Z?425*43C<73,G<6M<A;9=$Y6F5N\A
M"6IRI+Q%HJ]@=(>DMQRY7LBD<-[=QS11<.N1!=(MA-+;0<V8O,-<\>@S-%%I
ME:,,%7"G0_!>!0B2-+D/S[*UDAE>[@$EJS7L4=Q((XE$.4A<R"-I928E9ESI
M)&.--A78=-,NXV>S)<*[(2\SCZK,JR7/&![*\Q^^N$SM*QBMIMUL@J$I7+?!
M*P&)<87M*'KR%5>P\5DMI!S4\963@Y]2R.DO2-P3'8P2I&L\SR'A]]%Y5%"M
MFQAMTDE#0S"6XGMRSABY@,@3 *-J^@>"*V'NY(S(T< 3RRTD:UEE\J(DF*)B
M6(PPPRZ5"E.?HYF2"---L/9_V?,)U+!\AA;)]AR-,7:J,Y:XO7]BQU.UQVJY
MIM"G.ZU7CZHX1M=1:HV*>LU9=UV[1CMRW<UXR:%F?RK>P1,/V>C?%^+<3GXB
MG$K..SBMI0MJJQW*OHU,A65YAHD<"-7+1D;N<J%*$\?C?#>&V$-D;"ZDN9)H
M]5P6Y)C#:4;,(B)9%U.RE9>MU<9R&4:':];7G::4K^@)^32?^+FD?_O#9)_[
M.8_U^;OPI?\ 2=?_ ,,L_P#]4]??_P &G_1U_P#\1N/_ /1:UH#PSG!-;9VU
MWMP63-&$J95IVB26/<>P39_*7VKUYYW2@(E5G(H*1LQ(-'9"IJB IJ@F9)4A
M@,0XB!@+Z/H/TUZ/\#X#'8<1N+B.Y6YN92L=K+*NB5P4.M!C) W'=7$Z:=$^
M-<:XT;RPMXI8?)((@S75M$VN,R%NI+*CX&H;D '.V0*\H_B_W"5#_P F5'']
M65Z"/_\ V^S7K_.;T1]+N_<)_A7E/-WTF[[6$??>68]A,^_ZJK\7]X2KS8TC
M[5Z#^-Z><WHCZ7=^X3_"GF\Z2^C0>^6?_P"XI\7^X2KS8TC[5Z#^-Z><WHCZ
M7=^X3_"GF[Z2^C0?JO+,_P#_ $53XO\ <)2/>QE1Q_ZUZ#^-Z><WHCZ7=^X3
M_"GF[Z3>BPC[[NT'\YZ?%_N$I\V5'^U>@_C>GG-Z(^EW?N$_PIYN^DWHL/OE
MGC]9\HP/UT'\G^X2D._C*CA^O*]!_&]/.;T1]+N_<)_A3S=])O183]UW:'^4
MYI\7^X2GS94?[5Z#^-Z><WHCZ7=^X3_"GF[Z3>BP_?Y7:8]O/Q5?B_O"5>;&
MD?:O0?QO3SF]$?2[OW"?X4\WG27T:#WRS_\ W%/B_O"5>;&D?:O0?QO3SF]$
M?2[OW"?X4\WG27T:#WRS_P#W%5+P '"6$, EQA1AZ!W@;+-")Z-TP??^W=\F
M[?IYS>B(!/EET .W-A<]YVQA6_CCU4'X/>DZG(M(&[B/+;0']6)CGL/;BI=R
M#P"_"47I''Z\/B>G)I5K&50IKX7F6L=I&5E*\D]0>K-0)/J<=D=18 044!)4
MX%$QD4P$ U1M/PC=%[?GA[NY;FW$DZE+&XP%=(P =0!#=7?:M\_0'I+*(@MI
M!A(E0DW=MNRL^2,2=AU?>/;B.OB[W"?>:RA_:]C_ /&]7/.=T3])N_<IOA6C
MS=])_18/>[;^I3XN]PGWFLH?VO8__&]/.=T3])N_<IOA3S=])_18/>[;^I3X
MN]PGWFLH?VO8_P#QO3SG=$_2;OW*;X4\W?2?T6#WNV_J4^+O<)]YK*']KV/_
M ,;T\YW1/TF[]RF^%/-WTG]%@][MOZE/B[W"?>:RA_:]C_\ &]/.=T3])N_<
MIOA3S=])_18/>[;^I3XN]PGWFLH?VO8__&]/.=T3])N_<IOA3S=])_18/>[;
M^I3XN]PGWFLH?VO8_P#QO3SG=$_2;OW*;X4\W?2?T6#WNV_J4^+O<)]YK*']
MKV/_ ,;T\YW1/TF[]RF^%/-WTG]%@][MOZE/B[W"?>:RA_:]C_\ &]/.=T3]
M)N_<IOA3S=])_18/>[;^I3XN]PGWFLH?VO8__&]/.=T3])N_<IOA3S=])_18
M/>[;^I3XN]PGWFLH?VO8_P#QO3SG=$_2;OW*;X4\W?2?T6#WNV_J4^+O<)]Y
MK*']KV/_ ,;T\YW1/TF[]RF^%/-WTG]%@][MOZE/B[W"?>:RA_:]C_\ &]/.
M=T3])N_<IOA3S=])_18/>[;^I3XN]PGWFLH?VO8__&]/.=T3])N_<IOA3S=]
M)_18/>[;^I3XN]PGWFLH?VO8_P#QO3SG=$_2;OW*;X4\W?2?T6#WNV_J4^+O
M<)]YK*']KV/_ ,;T\YW1/TF[]RF^%/-WTG]%@][MOZE/B[W"?>:RA_:]C_\
M&]/.=T3])N_<IOA3S=])_18/>[;^I3XN]PGWFLH?VO8__&]/.=T3])N_<IOA
M3S=])_18/>[;^I3XN]PGWFLH0?KR]C_=_1-;_1H?PG=$^ZYN_<9C\*>;OI/Z
M+![W;?U*DK*? (<)?>+5&S45B6E-VC/'>(JFJ5[EW'B:XR5"Q53Z1+K)D2G5
MB&9KRD \68J"H155FHW562;JF.@G1L/PC=%K6%HY+JY9FGN9@5L;C'V]S-.
M<J,8$@4[]H.]6;GH#TEGE$BVD  @@A -Y;=L,*Q$X$G8V-0W[\=N<1Q\7@X3
MX  !Q701W"83"&7<?!QQ$>@1$)OIXO> /3J[YS>B9Q^,W7:2?Q";).V#V=J@
M8'J\=C5?S>=)O1(.[_M=M^OMD/;Z\_KS3XO%PH&\-V+*%NW  @.7L?;A[^\1
M#NUN'>(B/R=/ZM2/PG=$\;W5WG_X&;?^6,_P]=/-YTGW_%8,[?\ :[;M':?]
M)OG_ -\U3XO%PG_Z7^*RB=(  ?XX* />WB&_?-?3\FGG-Z);XNKS<;_B4_\
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M?@'R]\ FNGO]X=_AUVO.;T2SDW-X/NLI_P"(V%<KS=])QV6L&?$W=L1^H&3
MJH_D\/"?&  -BRB& .G<.7L>@'&^0?T9@H]'3NW" [A'>(Z@_A-Z*$8\KO"
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M]U7^JS_X3J?JMTA_15U[$^>GT7Q'T.?]@U3\_+9"\]U7^K3_ .$Z?57I"?\
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M?<FP\3C[N*!^+Q=P' H 7C &_B@ =X-VL?./9ZM0X5,#C /.BU ??R\[]_\
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MQN[5&E1N<6N5E8M([EV+&20LV&*C P3@ZK*<-D>/5)###.U];7+\H@1<N!D
M5532.K$I4 C=CG P"/30@"!0 >^ % >G?W@#H_4 [_Z_EUP@, 9[< ''9MX5
MWN\^!.1_#^\# \*YZFE-*5'UB(B:34$ZPIFY)']$$^-_Q>_OY0O]6E*L7)-O
M*3=0'_?:4IR3;RDW4!_WVE*<DV\I-U(?]]IW8[CVCNWV.WK&U,D=A_L]O\A[
M*<DV\J-U(?\ ?:4\!W 8 \ <@@> P2,>L^-5!)MO_P!TC\O?0 0Z>_T<K\NI
M!(((P2,XR<#?8[]VU1CM(V)!!/>0>T$]I#=A!R#G<&L*F,9T"?M];OTS!1\C
M;J<D\2K$ZZ:F4=Q!9!%5!R=JF+GFXN!1<.D6[E9%5PT2>OB,U4 >O.6VI<3Q
MPRVZ2GR>8?;1=8:NP@$YZP!"G!SN%SG2,78N(7D-K<V4%V8K:].98PAR?R0R
MDX["$4,-\A5]6,TY)MW^<CO^A  ^3=X[HZ!XO1\G1N -:MP.TX(QVY) /?WG
M?O-5 YW*E@#@]I&< ;D;=^3N.TYR:<DV\I-U ?\ ?:BH_OV]M.2;>4FZ@/\
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M=Y2CX0 ?#\GAUP:[U5TI32E-*5^2_;V_X7F;O^DT;_V:A=?H/H?_ -&^%_\
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M,SZ(&6)5.7D 4#M(Y/$;V:SEMBB1M$1*TA9@KDHT4:@,3A$629#*S;)'J?!
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M5C8,=)"AV*@@G?J]P&,RPMM,X/LT:T8PU57Q^Z7G2XZK\$C3GL8SL3*NW,:
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MMV_9MGV8]GCW54-HK9KW=.<<(_YH5P_QE4?I1 !$5@W3([T@ IMZG^3T#T]
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M.)&*B<(/]3N3N8^*P]D-P"JR#&"=J@'MQCK#!)R=AOI&!^7_ +&3@Y)WP!5
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ME-*5E$G,Q%<Q_-V&?XH04!!3LS-"8$A+W)C$'KV1XY5SI(&*#-NMQBK*II&
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M2NKAZ8FM%T+S')@^VABY40CE.5C**P8,,TDM^%R&0O.H+7"EOQV0&*Y.O[-
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M&&Y9P)D0$%!6D888.7YAY($IT\_E[^17+9'D_%HL9@O.KS %4'&-,X[\9[_
M^H?^+_[VV/7V&A2<RX@"D6%[@E";,5D3NNE2&LMR8!>*Y_L1<+9L^6H7 A.5
M$".S0A7*N])03F"0Q!+]I:4RMRF);EK=E!J$$I++R.+VX Y4V5$C =@'5Q\0
M,L<GNQG;8 ]@*[[]Y[,=E9=0J%:;U;8*CTR(!.SBOR\;&-SMI%.F%F$BKFLD
M<Y>E%K:]G6VHG5[H0"Z[H:^+T^Y-RHL5*=TWEY;VMO+=7,I>%AAY""GEG+P-
M#JN6M.,VQ  ET@3  G SHU3SQ6\322D%57&,[MN=@-]^\'?/</']$>$,>/\
M%F-JW2)&=>6!U#LB)J.W*RJK5H9415/$08.A4?(5R),864 T?NGKMG%I-FIW
M1R(ID3^07]REY>3W"0K"DC#"* I(48UN%55,CX#R,H :1F( %>'N95FF>1$"
M*QR%'\_O)W\/#'94M:J5HII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2L!N6
M3Z'CV5HL/=+3#UI_DFT'I=)0EG16HV&T%K\[9^XS)0^Y('1X6MRSI(%CI)K*
MMTF22AGSQDV<;HK>>=97AADE6!!),T:,PBC+*@=R =*EV5<G;) K1-<0P-$D
MLL<;SORH%D=5,LFEGT)D@LVE2<"HE):]F.:-.2#')^-9,VT+RD("L=DJ#>%R
M$XAX5Q3EXVH UG%"R#]E','D8Z;UCC.DW;5P*Y0>)*B7>8^(#0I@N MD-8#0
MN!"&D68,X*]52Y#9? .H8VJL)>'MJ?GVY-\1'J6:,\XK&8],>&.HA"1U<L,C
MLK5>MXFX/_+T]CG(+&;1B[<\"LY'I4.OF.STRQ3<?1 JMAKLX]I#>ZL7,O#U
M]7'4-)*H2<8X:-G$'(KR2)5D9 2]![GCEFMS"R'0RRP3NULDRAIA)#+$93&P
M4L)BO5;_ !#3N03STM."W;03HXU_9SPA9VA9U@99HY.4'!90T8?<?X23@ YD
M.H[-6QI7JW%9DJEG M7K\Y8<CN<O-=H&Z.X>>4=JUXL\_O&00O2K*XUQ!6BU
M])VUM,M*0[8815)8A0=S!'NF7B'%FD>TD202,D=N;5["-9%P)"G+B:$.KE9W
M*NJAL,,?X0-\5CPM%%VC1F-6DF\J%XSQG68]>J0RE-&84V)T@J1G46S\96\[
M'#V\%VJYC-1(&U5K&5DD1;ES#885N]Q-C69MI;!-J8C864K6RU9"6;3[U221
MK$DVG5V<6Y [U=C$\A"VW%A >%I9.R^4JN%M [>53+&%C,XB#:V4H%0ME2Q
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M<!A!#<XELQF1C#$3(4-N[N=AI::2#6X'5 8J 0%QL4WV?8UMB2!Q*C/.4X^
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MMO,<I3&'<NH ;S" B.X   WCW@#4GM/WX]E8@ @$@$X[ZN_((>)2ZLG9J*G
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M"6<<=9[JY[11U7"96KM6.F:_.,V\=9JY*('.FO&3L6FNZ!H[(<A@**;APV6
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MJR=FE,#P'L%.00\2EU9.S2F!X#V"G((>)2ZLG9I3 \![!3D$/$I=63LTI@>
M]@IR"'B4NK)V:4P/ >P4Y!#Q*75D[-*8'@/8*<@AXE+JR=FE,#P'L%.00\2E
MU9.S2F!X#V"G((>)2ZLG9I3 \![!3D$/$I=63LTI@> ]@IR"'B4NK)V:4P/
M>P4Y!#Q*75D[-*8'@/8*<@AXE+JR=FE,#P'L%.00\2EU9.S2F!X#V"H>L&>,
M"U6\DQE9<NXFK^1U619).@S=]J$7=E(X[)S($?IU9]*(3AF9V#)X^(Y!B*!F
M;1TZ!3D6ZIR[EM;N1.=';RO!ULR+'(5ZIPQ#!=)"G()!P#L=SMH>[M8I!"\\
M22G&(RZA]_R>KG(R.S;?; QO4IQ[N+E&3618*L'C!\W0=LGC11NY:O&;E(B[
M9VU<(B9)=NX14(JBLD8Z:J9BJ)G,0Q3#I.Q(.Q':#L1]X[1^NMX"D9 !!["
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M9#%5F.%!8[G !)P!J.PR=E!/W"H8HHRVE1D#)P!D[#VG8>NKH5) P ((H](
M(AQ";PW_ "#^C^L.D [VHJ0!X#V?SV&#ZJY<@AXE+JR=FE3@> ]@KF0A"!N(
M4I \!0 H;^]OW!N#?N  W]_H#P:5-1S9OY54_F4?[(Z4K']*4TI50#?_ '[_
M /?^GY-/#NSX_>!_F/[!IW@#<L< #M[,^SUTW;N_N]/0'TB/>T.RZB0$QDN3
MA0-QDDXP,C'W[=]1D:BN0&!"Z2<,6). !WDX)'J!/8#5/V@/>#OAWQ^3]8;P
M#=X1Z-^X=T@$[@$CN(!(/;N",@@8.2"0-LXR,SGPW/9@$$@[=4CN8DX"G!)R
M!G!IWMWT[]W?[X=\/UA\H?)T;^@0U P<D';J;X;!U_DD;;@^/9ZZ;Y([QJ["
MISI(#8(.#C.^^:;P^00'_7W^]X>]_?<.[(*Q ." 20"P*C*C)&2!V5B649W!
M( 8@$%@#V' .?O[QWT[VL:R[::4II2I,@U")Q#8QQW  K=/ZW*H=']_!J6_*
M/K; ^\G:L0<+D]@7)^X#)_@*NG.4?G?JZ!Z>_P![Y![P]'?UCD#[L9SX#?X'
MV8.]9?\ M^O&<>S?[JKSE$!W";<(;M^\![P[MW]?R?3X!TS_ !]1Q[>S]?W^
M!IVY'>-B#L?8: Y1'< &Z1Z0#<._<.[IW?M#Z>G?WM3Z^[QJ,C)'>.T=X_5V
M_P *Y&73*.X3;A_5^W=O[V_=TC]'3WM!OMW^'?\ V>ZI_EVY[B/$&N/.4?G=
MX>*.\! =_@Z=W3_?O;M1D#^_Y^'ZZC.=_''\?A_[4YRCOW<?I'Y-PB.[HZ>@
M!Z.G?^KI[PAO9'=OVC;Q':,]F>S;MW'=4Y'B/NR,_?CMQZ^ROH10J@")1W@
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M!Z]4(YY#GW%K+:E1*8R7UE.6^O*(Y02?DC"R$%HS_B7?U5T+:[BN@YB$@T:
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M<?O[N,QR"/2S7!P&N-"BX69'"Q-<F% !,V@QPJPP-9?L.FTX#8V;AXS(=*Q
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M5S?!A.$7,D3G0H7+10&!7V[RK$MXMOMO5BTX=;V;*T)<E5E1=9R526?GE1D
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MS\+5V5:A9M\P/:BXO)%RLVEK*8N7CFB8D\F.6.W+%9T)-L)7:-@0Q?2SER@
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MC\FD(EXQ>1X4!N0NJ9!EH07F4"7'8A(8]P-%M+Y]&%DQ(S*IUGM7M&Y&^/\
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<:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g68105g40n31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g40n31.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[13:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %+Z^4Q X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              -P   (%          $
M                     0             "!0   -P
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   -P     4F=H=&QO;F<
M  (%    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   #<     %)G:'1L;VYG   "!0    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 1 "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M 0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87
MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W
MAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B$P4R@9$4
MH;%"(\$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_  !$( .$"$ ,!$0 "$0$#$0'_Q  >  $   <! 0$
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M^(@/Z.G;XTSX+Q?P'GKGW]B]A-_*_P"#]W_M4SX+Q?P VKZ%^[_VZ9\%XOX
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M^X#")M )1Z;$.NP\@Z]AZ@;>]"'I0I/0"@% * 4 H!0"@% * 4 H!0"@% *
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M7 O#U[1'@N^97&-MX[_".V\R?+AK?3=I_*GND9$^[>] Y=N2F\$%5 +R@4!
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M I )V$1WKO\ #T]*T5*WQLE?ML;+OOY;B:J!0"@)#D ^MB(: 0Z:WUUU =;
M0UL-4%O>M6M=="!4RD$1#>QUOKZ?5K_+Y[J:I7=[7S7S=>RW.A+)ZYZ:W>BM
MON3B4![['ZQ']]++K\7\19+1)$.4 [!K[1_?2RZ_%_$MD]5<E.79=;'J)0[B
M/<0 >^_(:67%^+^)$DFFDLNI'/KV@3YG$L>%21?N463%EQB89=.W;@Y2(M6R
M SQUECG, @0B:93',8>P /J 5K&TN7VCM?[X<,R;;OTO7PV>?7D\K>3]V]!K
M_:_2YE>_H;VOALEF[UF#]]W;O\+;8DS=B(#?2R/: "/-RC\M,M" #H1 ?%'0
M[\AZZ\NM;+\V%O\ \JXO^"N'.7%'A*TOQ<7BHFGS[K'J.;\1:Z9(L[ZS3K$
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M=* KA1$0 1T CY .]?#8=!$.PZZ;W0$AE!*(AH/\$.HB;0;'H =.H@  ([$
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M(18M4H]U=#A=)FRM.>LYNV!&,CF1C?)MR)I22JSU5H9^X63 6@K.SH(;*EH
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MX#R@(AJV\WB ]QZQL/WW_@E  ]/*K;7J5_-+WCGGR.G90T !Z?7^WK4!&@%
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M$0Z[$ [?#7?]72@([[#K0==['6O3[_T4!+SA]0  ".^@AOML._7I]] 3@.P
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M=G15^6[)RG?MS74;\UIIGA0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M/:$E<,K:S)\^5G81!TO(M3P-P-4$DF?**QDY1Y%(Q#OD$Q!(5L]7\3FYD^<
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M1QS(H[9:)1/YN^UMUUO.<,,,-U###"GPAA3\4EP15*A10"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * T=S7Q&9ABLRIX(
MX=<5V]DJ^8BPTLEWR]O"Z%+7MVWK>?RCN*MV.1<MTEEW,Y<+^-DDVJ)B@BB@
MT475$4TQ*(<\\[S,_#;FYAQ"8<M7*C:&=VV[F3SD3<=KR"A%7]JW;:%Q2EH7
M;;SQ5/Z"QXNX863026+HJZ!$E@ "J%  -/>)$P#[1+@.$/YMM9N#7K_<N&[:
MZ#KKOTT.N@4!T]H!0"@% * 4!*)@ ===]>WPT._T_KH"(" AL.WZ_B'PH"-
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M<\W,BT H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MCENJ'B)+@'B)].4=T!5P#0:[_=^P #]% * 4 H!0'F8@"(FZ[T #H V)0'8
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M.V6*H7F*=(>8B@$$IM (4!=!"<I@ "Z* FZ:  [" & -B/-OF#>_^YB4#;$
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M 00S66MK7?'6]K;\B][H]H1!2,7B]O@;'DKF6^,GVFM?3:U2S\!9K>UK:9N
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MJ55%?D6(8M")W[LGVFRU"B@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * E$!$0] Z@'8.8.VQ#KH=@.M"&R@/P$#E=Q(<(^3LE<:.%[_M1FQ#!\
M\YQW/\0;@[YHV>GFN'N3O*Y\6(_)2QBKS",W-75#,WXIIG*V:6P@*H<H:*(_
M#?V]7Q)>(/A"R1D'C8Q)DRUH]F;"TNWLB2S@=:3;-GA[@P\YNM[89D8XY@6?
M$>*SL4BX.D0Y4B0B)A-V !>7KGKW;S7W-? =<T7G7--^QG"+CSBIB,S3(75;
ML_/Y8?XYF,>7$X8I,WD5<4:+UDUF;9*[3!^BYBA5?"@*C8R8&,42ASRN;GPW
M[[.NZH)]AG(7\&C#V=R0&+C6!?N$+;O:X<9PUM29I+Y793>.INX9UV9\@S4,
M>/D&LY*$*[(8SILFF.@!\>==R[2:>#X_7?P?N=;>\ %WW9P_6ICR;X?L5X]C
M;JXJL:9#OS%&/+GFWZ,3B2WYAJ253NJ\)JXS#<USEB >&=_@W\F-Q35(S9(N
M3D!0 U6BUT>>7#1>Q9KM*QD3A5S_ &;&W+P]VKP^8IXE^$%G=X9"LJQ\@W&2
MW[H@+;N8LH6Y,563<AY5FO;4I9MRN2W+9DN[:KMU[2DGUK?*S%TT9E -,EHK
M<<\N/5YM<,WL;[/'AUR?@=OF5W=D!(8NQY?5RV[(8JP)(Y/D<NKXMC(B"+'S
MJ@W=(&6*D%TR8A($@&+Q^QADFZ2*;Q9114X@N=_O?GX(Z2T** 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
$!0'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g68105g43p64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g43p64.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2?04&AO=&]S:&]P(#,N,  X0DE-! 0
M    )[2^$!9#A"24T$!       0!P!6@ #&R5'' (   ('_QP"4  (<G(R,S
M W,C@< @4 'TUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@X0DE-!"
M4      !"I>VKQVS7F1B!1.-MQH?9].$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0&
M*@           *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E0    $  @
M"5     0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@             "80   V           0
M                     !              -@   "80
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG   "80    !29VAT;&]N9P
M   V     &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P   F$     4F=H=&QO;F<   -@     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    '.$))300,     !
MU6     0   *    !Q   !X   T^   !TZ !@  ?_8_^T #$%D;V)E7T--
M+_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q
M,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"P
MT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,#
MP,# P,# P,# P,# P,# S_P  1" !Q * # 2(  A$! Q$!_]T !  *_\0!/P
M   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M?+L
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! ?_  !$( 8@"+0,!$0 "$0$#$0'_Q  ?  $  @(" P$!
M!P@&"00% 0(* PO_Q !&$  !!0 !! $# @0#!@0$ @L$ 0(#!08'  @1$A,4
M(3$)%18B05$C87$7)#*!D;$*&*'10E+P\24SP>$9)C1#@I)38G+_Q  = 0$
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MT>'1R7L#$BCE6-26-F2PYGQOON9$T8DQL4R B5\;%BBF<%'3B94^8K3D^;)
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M*"H8_*GE44=T2/)-=T;L6":U-28D<&"(U8-(S<BU422*'$'L(HZ%]FR2*-#
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MZ^7FV7*65U4%XN9"241S7P&"]^:NK/OKQ#+^(]KQV94F]6B0"*XD=T;OP?\
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MRO\ AJJ+U,86Q[AFL D)B5CT\@(%&^PO9)Z)HU?GJZU;-J^"?B'=1ZD6$\,
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M?NF!&9LF"HZL%:)5/8D>*K_E+=4/K4?!+CYCK&F1)R#<>4J<4D)( "FSQ!-
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MY.T7KO8$RAB :[X!JM;JK%]C5N^%YL.'/A7<SD12*67&,H'X;FY(!:B2A*D
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M6P9U+823#06]1:10#-)CA*@40P>4> D65T7EKF/:]=7=<;*V:5%R@LD;D@2
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MFG333IIITTTZ::=--.FFG337'6;[K_,K45?'E43PU$545454^_GQ_5/"??\
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M4D=+BP@"D&D.E_;6SCQ/:Z25*Y!V2-1Z1/17.D8JJJK\X_'/\4-^VG<=WV[
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MEK7*Y+WLO\.MUSY%;/'X* %6<5ZDA4FSX(5#]S=$CJ^M73:O@+<LEDFSN&)
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M&Q)$?UUW/99L*)YHI/7"'YQ79'?8(]P:H$$639(/?;'F0S)'.2.94!JY!2;
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ME=2MTW)2"0*IKZ/?76IGM-(!;<-5FGT@L<9MIF&F6(J1JWV^0=R3^C'(C_\
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M>R!R)OH =FAU[7UJ#'P)\3_B1BKMDUM)P69J$0'_ #%KZ6NR:-?76B7O/_\
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M6H-\_P!(^\'1[9?:61PA 1LHS(O56L,)8S_#1J)YSN3#*PS(WYXVKNK[-D=
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M65X88Y"QXU)WZ0\EE!OOV]P ;(JJZ'M^[W=9L>>G<.<FA5A VSFLI,5=5T,
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MGZ'H]:LID."=WG:N&X[CN41<0%*ULB96A>RST<XS8FJHS3X5(A#8YS2&K]/
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M)DL8L?&?HQEV568ATJBJTM4#J4VS9]S^(\QIL>),@JJC)EDF5&\JJCD:8<5
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MS*CFN?)'ZM:J6K V49D+2GP%!% '[]D@_P!N_P!NM1<CB.!0CT: H'L$$'H
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MN$N4_P ?C[82]3_M_?[_ .?6#;S6?@__ .9B_P"<\8U*9_\ ^8YI^N'D?_\
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M1L^SD\M1K?5R>/5%;X3SIP0[!C94E;/GHU[_ %U[7"4,:-&%5& 8!0 *;OV
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MGFDCCB1I)9G5$C46S,Q"HH \DDU]O<UX_FZ?K+=\ _=]W;:RUSATQ?'/'_\
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MKVZYTTZ::=--.FFOSE=ZL<O^2^?LJ_;POGQX5/OX_']//Y^W3Z>_8\_2^_\
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MIIITTTZ::=--.FFO#E1J*J_A/[=--=1=7M7GJJSO+DR&OJ*>O,M+,\ARL@$
M 'D**)E=_2.&"*21Z_=?5J^$\_;I[@5Y_3_O?^7OK)#%)D2QP0HTDLLBQ1HH
MMGD<@*JCW))H?W\=Z_F[_J+=U',7?UW2\@;[(9K9;;CK$W4M)Q_2T-):6=-3
MY&B.BACEDC@CD%:9>**IY[_/U$TA2Q*U&0QL;9MNC,$8=48K8455W8)))ZZ
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M"_4DT]RO5J-1&,Q;EF+E3K,@*E5"A3] 6(_S)'T\4>Q6F4E>4 OQ"GYE!NK
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M'HWPZ*%CI&(Y\#D6-J>57U:OGY"Q?XCYN/N"O'DY%>N$+ER$4\BH^H_3LW]
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MXE3V;'\B(Y W)YD\-61KF*J=>X_!'P$8IH-PW-2TK4R1<238['1(H@UT;O\
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MX08Y,8,)S8_C*?))%$JK!]J?\<;MC&?',?%I4<N0K"Q?M8-4?->; J]2WP_
M\"9!D)]*2(HO*^)+-[75\?<^W*O)&LWY"S&$EYFM+RK4@DJOIK%-7>(XB68B
MXOBQU!JX4'<YL8U6 -)-)$C/1%G:]6>WW3YM_BU\<X>V8.#MN3/%!G9^4N9&
MQ;Q!4T:K]?F:0,:ZI3XUB&''G.T<;2RXN*K>N\:-9E)XJ!QNA98V/9">O?G
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M'R(\F&.:)@R2*&%>U^VI+ZQZSZ=--.FFG333IIITTTZ::_.541BJJ*O^2?\
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M32$6-J5ZJH3IIX!H(/5)7,]Y(W^<Y.1L\!4B1<E4-R10I*AR'6PI>5KI0/(
M^8FR=77U"S$@>PHFO)%FJ_\ 'D=$#5ML!B0<%F*_. DE'-&>2698G2_*;9VE
M@3*;961+D1&-E,,GFF6*-&Q0M>D,:)&QOBMY$YR9I)F54YL2$4$*BCI5 /=
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M98_E^4KQ()8DT;XJP)(%@&NZ&1?JTVN2Y*I]=A[01A[LAPER)OP$9,Z&&AT
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M,F.K0Y+(0075J4=?*. 6B!\WGEWUJ$_A_%-%L$"S)2 <HR;[Y$DM9\@] 62
M1T?<YYWL?KJ\<]HW.07#T'&I>]K(] )D]+K!M$VMDI[LXSZ!7U]0E0<EJ%3S
M/@EL5<:+,3$XF,/R^"-Y.C#\!YJ[1B;QES%(,Q4DBC2,NXC9PO8!!LBR!Y'O
M^4C7,GQECR;GF;5C8[.^&SQR2DG@TD:%C71'&Z6[HDT"/.M0N4Y![D>[C]5_
MMC&KN1;RML*GE(O<WIC+,@>MJ,%A!2[_ %&>!K89X!5 N*@.?//#;&K)XK%\
MLS)?61>O2OCCX?VCX:^#<7\%!S,L2AY901*V3(L3)VU\5;YB0.EZ^YU1?@W=
M-PWWXCS)LN>3C&SM&C<5"1J[CB%0 % !V6%^ 2*U]$'<'^KMVK]MUS %NK'4
M&4W\7"Y"QU=%4#'4=22I @MK83O<9"436TLAHZGSBC2.5&%/%CG0:1CO*A\!
M?$*[<VYS8RP0B&/(]-W!F*RHS+\@[%JA(!HBQ?1UZ"OQMLDNYC;()S/*91$9
M$7^4K6 06/=@U?[FNNMGE+=5]_3UEY3G#V57< A6E79"2,E$/K;""(L$T6:/
MS',.6++'/!+&KF21R->QRHY.J805)#"B"5(/1!!H@CR.]7"[/78J['8_N/MW
MKN>FN=.FFNBTI*!45N8KD:@=78E*OGU\? )+*CO/]/'KY5?PGY7K',0L4C?\
ML;]_3Y3]Q^O^ZULX2>KF8D?L^5CH>KL-*@(K]#K^;AV3;>LE_5A)U%^<-&9>
M:WF%:>>QG;$Z?3W#K9*Z$=\GA)+ M\LL8T?AJS32)$Q/=6^:9\ E1NK2OX.3
M,Q+=<K+TOD#NP.N_IWKZ8_\ Q'12K\$IA8Z'AC8&"IC +$0PIC))0-D!41K(
M/L39(L?4C4X#_;%@[+&NN3 Z*V._=*LX7_>5S]\',Z2,Q@+Y8VS*V3W@+%>]
MKI87R(DC7(U4^F=HW%L&>/.51'*H8*AHLRD5?S GNZ( ( 'CLZ_-'.C8/D8+
M.>,\BY E]B!7% #\MBJI>R?8ZQ#)_ICD7FK$TO-'*M??X^E)&+3.9ZD(KI]%
M")*R9@US:&V$JU=<Y8T:6.'%--/%[Q1SPM<CDW-T^*CD$QXN,8WD4J68H0H/
M70 '??FAUW8UMX>TKZ9GFR %6C\C$DB^[)H1BAY-M9(&KZZ/F_&TMC!CAIBQ
MZ=!W5]G: ARN#K (H/A;#71(L3BB%B8T<-K71P1>6R2/5D:M=57QV,;2H!ZX
MMOG'?*K!)\?,>SU^_P!).')CDE6#F/PI^1^+<3P\'B P)%=+VI(KVNXE-N./
M[34BW/'-NTJH'8*&L#_G&MJ@D:")L<=A$0[ZJ*>6/[OD?ZQ3OC<^)9&O]NL^
M(T[P*9E#2)8KB  !8]@ ?:[!(!_36ANB8L&4ZXDA]'BIB')F;D>SV6+$CL&R
M0#V*U^&_!I]_&%4[(.+94#)XEDI;V)2(H_YOYY1I?#98)/158V>"1DD:/<C7
MIY5.I';\EL21I8E])VZY@DT37=-\HKS0!\6?(U$933R(G.1I0O\ 0>[3^I:'
M=-V#Q[![K4MYA_$/;]QI9KQ3QYG,@<<U)#4JAGN-LRV,D^G=9&S?*86T;WD=
M&V:9[8D<[XD\NZB,N')RLEILW*,D0)=49N(]B*"U1J@?MUX\V?%W:-<&*'$Q
MH\?*<K$96-D72V2WD+7(#JS1)L6NDW]278P\&<-ZN3D"W4ON*[FX(QB:'ZR)
MR<<\0UA329(IH872?&9H7?'Y21L#O#VP(USH)7K+;&?Q^0S+'(N!B&BX4E7F
M%J0& O@H%M1JR/8"_JG^!GP#-#N ^*\^1!@[4K?AXBKWDY4JV\J,S!I":O\
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M8)I:O*W2 Q.^T$-R#;!REL:D:/GK()G1L<YZM\?_ (G[5CXVXG/Q?^#E3$V
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M$6>__KJ,R\>7$G(DXOZ; @E05=6!XM1^I/=^Z^036K?/V--GZF)18H84A'\
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MY7RB=5N?(FRI&FR)#+*YLN>R>R1_K_G[^=5V6:7(<RS,7=O))L]DGS[]D_\
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MN5/FK;&8&WAL&58V6#EKPP66!0HIFW!B8>,!GXX&5D33QY'I @*%AH2,H)(
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MG22HGHQJHB^?LMW3TT=(8$NOZ1U1_L!X'GW()/6O*LIIRK9#OR9V))-M1Z)
ML$4/K8\CZ :D^SPQ]761&B,=',Z-CI&)Y:YZ.1$<B^%3V:J)X<Q45KD54543
MK(WS#BP%^;('T/N?%@_3R #?D1OJ2$B3C3$=D'LUY^Y/?7GVUD&* HKNML*O
M0DPT=I703FBE7'O*'/".WY21/;YX)EA^".1P<SY'PL<V:(B-GI!))H9)EQC&
M8D+@M9(HU9Z_6N@1]/U U)X*[?G),N5)^%G@4E)R3Q<^0I^X'BO)!NB;'5Y:
MQ_B>*[DH6AY'"5D9/C1SC3?N>GE;(Z,=:]K7MG8.LC$C;*.BI(KFHQZM\JNZ
MSOP1P#SDI2H'06O-"O(K[UU]!J/..KPY$K3B(0]QSD$B0!K52.^[%UU7OUXB
M7N>XDUO.?!NCXF(O[4;,7L5>4'%&UQ:55G4R_/5&AA$.>P9X\G\L[!E'^=DD
MK7*V7UD0F#!%*F2J@R+1)Z#&CR(OZV!UV!Y]JU>/@?\ B3N_P/ON-O""+<\3
MT%@GVZ6FBFA++ZD)5[4B5 4-^S6;[O2MQUSYS]^GYR2'D.<A;G6<=SDR19_4
M,:2?(D0WLGB%Y7L04Q858A505,ZP!<JN$<9 B/ZF#B1YD)?#*\P!ZBC^H^_(
M5T13?8W1^WON_?!WP?\ QMVS_P!3_P -OP>Q_%2$2;S\+N\<<<L[/R=@B%:5
MV#LA%FP0 ""=;P^/N^S.\YX!NDXNH+C8 33$4O[M#$^NH [EC&I,";9F_"J%
M ++#*:#'&I,+'L\L]G(G4(<0P3\'3YI""#T*%F@1UW?7?_?7S9\1;3OGP]EO
MM&^0_A,F)6!C/(<RMJQ%FR/-$UUY\:X0E%5<8U#+G0(MK#IM1%:[2UD^1B_N
M6A7XR;*%R)YC"KFH@U4*Y_I'$UJ*OLY>I;;X1-.8FXAU0O&#X9QTJ_H;J^_%
M]UJHB02\/4%(00:_I /0[Z\#OZ]==ZUO\\\B:'CWFFR.XJWNC,IX[2NFH0YK
MRPLZXZ*9HK9*4ZM-GE&.',F?(%,.^)R.9.WXU:Y$5MO?"CEP4_$Q1H\L;"<@
M !?3!(:QWV1=^>]8V(@R%7'8LA)(H?,+ LV?!O\ -[BNJZULVY'XC7'&Y3D6
MFK(J6/355*)NL[&ST 'CNQX9R6-&^S8W5EI(GQ+ZHY(OE8Y$553KSV*2-WE<
M-Q6%W"L/+"-BJGS1M0/W)KK4IG138ZQQ@$F9(Y@#=J[("P\D]&Z)-^WZ1A!V
M%<;<K7:6%UMMW55#S'/M<;5DAP12R)*Y9H1KA['G B2O:B*V%GR-:JHR1/*.
M2<D^)\^/$*1(C<5H,Q['L*%&['U(/BO<C4Q,:#(F6,R-&01RI+)!KD++]=^>
MC1]M;;<5Q_D>*<7G\=C:L"AS-!71A556"U&0"CM\O=\CE3S+//(]\Y)$JOE(
MFD?-*]7.=UYY-DY&;,[S%FD9OFY7['PM^P^G0\WWKTB+%@P<:-8R%0)8^8$]
M]DM5?,3V3_H* I9S_HWW7(;6Y\&"[ERF5E&-B<+&1"/<7YT2A0R2JQSTEAKQ
MY"_I62Q*K)(7R*C7M8^>P(&6#BX-J>0 !OV!'CS^]?;KNH;GE1S9#E3:F-8F
M)'N"S&K\>% -]7[4:Q?C<7;AV8FA+21UF JR0Q$P(L<#E1WAL0Y+)89&(CGL
M<R1&QN\^BO8J*K=F5(IU,<RLG*U)[!/?D'V/8^]=^#J,Q<O_  V9)8$$A5^=
M$!N@>[Z]^SXJ_MXOE7:&#G3,6.7.&KP=E4BE25A!,*.KC/,*A3I)"USIAE\%
ML:8'Y<C'N@)B?-"YOK6)<6;8<Q<G^8V(\B@A3Q:K# GKR#57Y\ ]]^R;#O<>
M[XR!@$E4 E5(HT*L>:^X'VUJGY3XMVF5+KLOHJR$1M!$P*22(1 2+R9CWDMC
MSOA\C9TC'<Z=%=*GSQMD]',5/A7T[;-RPLR-LG'D+-D'E1?FL/R@,9K\ FEZ
M'RGLBOF%E@D8'@[*.('R]6UG^G]/+'P?%WJM%)O-M4\@93-\)%;"DNK[3U5=
M"+1O(&L+&$BPB2PAL:B))('5TL#9D/),:OH*QW^)'X8JSF1AX3X61/O Q988
MH'<F4(RQE02I20CER!KB$ %FS[D;$TEQJ5)Y\AQKOH577BK'GL=_4F]B7.FC
MUF<'@%G+9#HZI59D5T ,8E,%JK&.00*:7/@$D$7(]2][KF(,B0-YJC(00K/5
MB=4/:$VZ8F1[3%DE1<@PLSS30J>15960>FTE>GR52$'2CZPF\;E'MF.F7EL"
MBE5X==E@>)(!L@5=&K/70\?-)SEVO\W\-_4Z#D+-SV^7M#IIO]HM,V:TS%@:
M=-]1(IY:Q(14E$S3.5HUI"/Y>CHHY)?C3KZ.V??]HW5(X]OR4258UXX4I$>1
M&BV!P4FI%0+7*,FO)5=0.)N6+GKZD+JU@DLOGOOYELUW]; \ GQKN>W/OMYO
M[4"(ZRLLK+=\-E3>='QA9V4LC10W*Q)K#!FDR21T-O#$U'L%1&U=@UB0$MC]
MFS1X=Z^$-G^(F$\D,6)N\:G\+N442\V8BA'E* #-&QH%BP=;Y"Z(+/QOQD#1
M%V*%2*![7H]CR"1=T0*\#SK=/QSW'4.H[?=MS+Q%J1M?GI2$.%@D&C989G56
M)@]>9#KJQ[7FAW%"V9)'"&/^EF^*,@61XKVOZ\<;X>GPM^AVW>%&,'9@\JC^
M7D1AN:M'[5*:OW%L2 25UY3O$&3MG+'X7 C<U?B#R9J)/CRH8BO ^O6JE\B\
MB\A80>CY-R',>PAVGU+K"8<K26)U>7/$]Q+X[*FE)6L)JBU8C" 5'5C!W>K'
M,6)%ZM>X[5C3Q38;PQQPI'QB7BHLCPZL!8)%6; ZOLFM1<<\L2+D1R,)"RO0
M8AK7YAU=?,211OEX(HWK:QO=HN\[;N)N<C:S]JLM'FZ/068*,5(!"BHXHCVQ
M-<B.8++.DTHS5^_PNB:JN155?'H>*9N5MTI]6+&9^+5^;@":[OOL GR>_!U<
M<S%]1=NS.)CES(3ZJCH*R@D%0* MA8 JKKM0-2'A^ZRYK.(M)5CSLM];G#LY
M2YB.:1T<LSM4*UU'5V-C+_A1_!(]CW'^KTBK6M61$E;YZAWVF!\TR54(Y,T8
M ()7]O?NQ56+'6IB/XGR8-D2%;_Q$S?AX?)(5BR@V;JNN[Z ->.J3\A6G*&2
MU-O==Q=M]&C)&DPQC$3V57/&2QRC1444:N^ND>UKV,E1JN5K'/FE1$]EMFU8
MD><@CPTX!%"_*E$<00.7@^P!![!_75*W/)S8<IAO3F25K:KY#YCR!L-1'=@#
MHCH:_'B'D;@GFW:LXZJ+2^S>XL829* '3U3 1]$HD+IR(:@N*:>#ZP>!/F4*
M=(YGQJY84>K7>-K<L#)VV'UIUM!T7'](OR00.AT>O%=CHUK8BMF3F.)@&87"
MK?E)[H$@D*;  #"CT+U+6)Y7VG8]S]0YO<>D_;]R\96U%W:JUS&8K9F3K75.
MD?+]XTJB(X1JNUCD8CH84$G:_P",14ZI6[8:9D!RXV!95['5T 3V!WV??]QK
MT7X3SY\.23;\T<'Y6HLD$-P"E3?CR  !V"/87O0A>V:%CXWHL;T:^.1CO9LC
M7>'(]JHOCU?Y\IX7POE%3RG50\>WVK_+_+7I/GQKD=--.FFG333IIITTTZ::
M=--.FFG333IIITTTZ::=--.FFG333IIKU5C53U\?;_U_/G\_Z]<$ ]D7IHUJ
M-3PGGQ_FOGKG3][_ +?] ->RIYZ:>=>OJGCPGE/LB>?/W\)]OST\^>]< 4*U
MZ_$U/[_]?'_+[>%^_P#K^?O_ %ZXH?Y5]O[?;7/@5K%=EA<EO\^?F-E1 Z&B
ML(U8576$22PO5&N1DD:HK9("(O970D0OCGA?X?%(QWWZR1R/$W*-BIZ\?:NJ
M\$=#HZQ20QRIPD4.OGYN]:YC/TW<IG-Y#K>,-01GJ^-SI$HKB2ZM&B/61?$0
MDT%J&V85J*J>MA 20Q45OU+V(UK9;&WJ: W)'ZPJN*D*WZ@]^#[5[=?45K</
MAF'+Y&&;T"U'H#CV?<"KH>._W.IGH>(<9BM]0V'+/*N>M+B>86'!X@XJNSE?
M+<P2/5IXM:=:S66FN&N<BAQN]X Y6K+$/).K'M[9.?N&XPOZ.-+Z*VTDB1NZ
MJH\J[ 4O7D_2R*[.FW;)MFT3IZL\<F0P'IJ[A68D'Y@I[)\_47?G6I?];7EJ
M6KY+[>.-@U)-?]5"5!5!N_W@G1:ZP(S5+ZPK[-D)@DBBD'<GM,Y\CXX?\5[5
MZ]?_ (1;;%_A^[[QDP(T8FC@C=E^9&CX/\A\(2S?0^WFNO/_ .)F:[[EM^U0
M2L&7%DFD2R5/J%EH_4TOUH=U=]_/A?T?#%9Q3J,5S;G:/5<JG[8JYJWCG$D6
M>!RI,@E4(.+<51 ;BRK.X)6:P! .+#JV-&;)&23:3,&]5R\6/<=X9LEH\+$$
M%0SLUR2,1:GP*\4.K^8V05[H&)E96+@L<3E*X"I*KCY"4H. M"^_J1T.O).J
M7Y'BOB6[Y*CP+,[N3S+.NOR*EM!KA5(EL*>N(MXX'CFY"U>@Q<($PJR-DDFB
M(>/)[_%\WB*SL,8,D2IN*-$QXORC]3BK$A)+OSRZL'QU]]3>W;G//BLWX%Y)
ME0\8PY1#36Q"D,; /N>N/BP!K8KVDF8/M<Y8YLALM/O9<#G>$;EMW '/#;D4
MVLTNAQ^;DE" 'FIJZ[6O#ETT(Y,@P$E@"QSTC&>L;4UOBW:,C_"]MQ<1DR<N
M?*@FR(TC"%H KR*9/<@LOS $#]AKMM&Y#-DS)9XOPL#(T"Q-+R/J\D+'VH@4
M!U0^Y-"K?+N0Y+Y4>1S#QP2!<\435.IM*36C6#J^QN65IZ@#0P9.UB'TT4@>
MJJQ)SYYZY@8RURE,-E6,?YM.?(7XC.'C?X:8VQ,>5)9N5*LP1E$<0 7BMK0
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M]G'/5QVPL43HY7OK7MA_G8K)-/XK@FGVK!G=),*C&L<T+E&*EEX>J:%$J5#
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MM_37Q&BIUYB[:"*3_:+3T "<G\9U@[PZ[?$#!QM*O,RB1L&74.>.Z0H.5?\
M\4D:CGN2=6J^X?"GQ+F84KX>=!(V/(Y,4@"\E0D\8VY,HXUT&!- *"M=CZ?_
M (:_Q?VG:\6+X9WO=X/P<6-%%CS2,>,;+2O%(20 E&EX@W7$@#Q\[!O=ASSP
M[26>=H^1--20TT1%>N:T:SE34DXSE:M;&#9N0L!(9(_I6B-?\;6N<R)/5&-;
M>=RP-IRL=LQHU8LC$JE#TV9; :B.S=L?F[[!-4;9\7? ?\./B99-W&)A2/-!
MZHS<.4P"<]LS.(1V_?3-9()-] '[7^UCD#-9OLMX0Y4DXZKL+R;R)QW77NB;
M(#(ERIDLL\*%?56;I;2&.V5LEB-$LWK#!-,Z-C&>B.^5/C3>8MGFRHHICS]2
MH4#GY1T"&Z7P+ ]_E[[LZ^8_B$;7\+C(AVN-8UMO38GE+P X@<V[Y.UD&KX\
MB>QJ#KG9Z+8V9-@=96+('2N>J0$$N1/"K]D8Q[?9WW7[N]GJJ?S/<OWZ^;-^
M^+A#,9LC,>V<\@LA+>3THL===GW/7TUY9&V?N\TDC-*L=GI"_'KJJ'9->Y!/
MCD3YUX!I2;I[CLYJK,6ZKI(W+,$:2/8 2K]XW.7V83"BO\.;(URQO7\*[^FS
ML_Q!F9#>OM^89BI5BJN0Z6.N2GP  3Y(-6.KUV.V,[&3%SIX,J%@6X/(K*PJ
MN:'YZOL$T#9H]=6.H-_J^2<X5D-L3(=M\>"2?1W38U1;BG9\"%*;ZN;\MB%(
M@\S9(VJX@12$=$LK55?=_@?XIEW)SC3/>4H/,]!2!U1[)#CS0'[FM2>1E9>\
M8$F'N(7_ !';T,N//Q^2:.OF:P2Y8  W]";NK-4;?C+ <N_58'=G%YB\$L"S
M*.\ *%!T%47,GL5 )]6U8#PBXXF?.'.ST<B-GC6*;PJ_0&R;QFX,7&*BS WS
M)XLOB@:L-=7UVI(LT-4]HQ*Z"4_,;Y.HL!@"?!*V+]B171\^9AX4[5N#NVXD
MW0U!1UYKK(-\5KM]B8(5<QU[_+I*ZF9'% -3U\Z>GU;!$5Y;6,9/,]C$;UDR
MMQR<LN<EXT!/RJI8 ]_UD@611]O[^V\D<*5'$SRD@<Z'9_\ BB#EYNB23T:J
MKUENSTIO)9V5Q.*9!5 V]S"(-I115'EF;"Y9##JHA6M^LBK!XI9DL6*X?ZQL
M<<:N=&[Q&AAC)/.)'?JZL%#]:%_6K% U?GO6T%ERLK'PFACA"#D/DX.P)"T[
M5;%3['R0.P*JL6TW?;=QYR=%QUN\5H*:ELGR5]1RS9WDI$-U8(Y(3#+J8E'1
MP2H:JHY455CB<UZL^/RJ67:?QJX39\&1$LE M"\8ME'7%&]Z!%<Z!\]:XD;;
M7S1C?AG5@S S%P!\M@LP%T&HMT!0/D^=9-P?/?[OO<8/QQ:%7?#_ !MQ =F-
M%< F.,R<SSBQ2:;/PEAHM89?0%?(=/$SY9PQV/61[$>C'Q^^9>.NU&64(N5/
MD\P0M,*';59I0; [['5=G6_BXIR=TCAAIHHL=A*$/)"E.*Y4#\P90%XCNR#T
M:LWW@UH2<#;/-%-_WDS]LKJ)J+ZRDG6%L(,!!$J*CGN8^7U7U3RU&))ZKZ^O
M4%M[DS1Y*OQ)INKL,O8OZ*2;/^76NNZ)Z$)Q>/\ PV_E$=7&W(=$5^5?E;Q5
M77C6/\!=BG;_ (S:5_(!L5UK=74QQ$4Q.YMF75;GK%L">Q-/7H+"(TUDOM],
M:0R:<;RBP/C?Y>LAOWQ)O65!'C.P6$ K4)99&%@"V-&J^]'K[Z[_  ]M6W/,
M99).3J P]8((PX -4O+E\PZY55>":&KQ6ET$ QS)"8XYE1?54<C7(J(OEWE?
M"IZHBN5?Y?5$5RJGA>JM!B2NMKS*$6[D'HGW[\@'OL^/K[V#*S8(#Q9P)&'%
M$!^9C1JJH^/M[5^FH;NO_2)XJ_4#XQY&Y,JBA\9S1>Z2VM.,]V)7C0 6-94"
M"U,%7I1QAXY;:ENSJXPH>PF<XX1282AY7P*D;[AL_P#$3.V+*@VS*8YFRK&D
M4T/J>I)C\Q9D@9^(5EY<C$/Y9X@!@0&%FV;&D;;XY9+$CO.Z\@0W!II"H((N
MBI%=GKVZK7RM<)]Z7>%^C_SW8=M7, UED<"W51U^WKR*M]L=79\\N*&?98-M
M@0+46J#C(^QJ)D:Z*5CI(9U5Z>J7OXDR-LWS;(\PR8^3"D17 S"W!U0@D1M8
M)(CL QBR@^H4:QY.UPSR>KR>*4D F,\>7B^0JB;][NR3YU]_/:7Q[PG)A,_S
M5QJ:3NC^4J$'0NY2TRQ'ZN^KK*+YV1-*]/6IKV*J-93UR0!P>GHY)7-]NOGK
M/ER6F>&=B?28J I)2O(J_((JC7C^^IC;\#&P8@L"46[=V YL?<FO?V/G4A\\
M\6Q\AY0]0(&OTM8-+/4+[(SZN6%?GC">_P!?*/?(U/I9%<C63+X>US'N:O;;
M\Z3#DJ[B/D ]CSWV0.O[G]0#K2WW9X=TQF!'\Y5^1O%$#KQ9\_\ @5UK7GE.
M5,=Q&PT'D@I,+=C$/C,'U#/V?PKO1J2/^L6-'LD5$1LD7RCN<OALKD1?%RBG
MQ\V$%IN'R**L U0-$ _F'N!]*OZ^5G;,S:<AC^':1BQ',*S!K/$GP*!JQ]>N
MM=HSN5=RCHP^.NW:C7DK4$O<AI]?',+@\F.KF_+<;'30P."#&B8Y[XP15)N+
M%['C"#M<KI&Z<\^)A*SE_7) KYN3#NJ'*K%^PZ!'VU-8VW;GN4D<8C&+!=M0
M="; )) 6N7L;]N[J];#>*N*C\97Q&;"_BV6PF192+5@+:VJK%>QC7 YZK]YW
M!!L<UW^\SSD6!*R/<3.K?CBCJV7FR93'Y0B4/E'O75D&Z-'V.K]MNS8^W@%2
MTDH!'J/1(L@D+0  M030\^^II1JM3PBHJ(GA//\ ?S_DB?\ TB?Y]:6I?OO_
M "U[]-<Z=--.FFG333IIITTTZ::=--.FFG333IIITTTZ::=--.FFG333IIIT
MTTZ::=--.FFO"JB?E43^OW5$^W]^N+'U&FN//(C6HYKVM\>5555JIZIX5455
M141%\>%7[?W]D\*O3Z&B5L UV;/Y2![U7MKJQH'L U8L@"AY\]?I_NOCE_7&
M[QM%H^=J7BG(;C^(^#L7;YBCY6R@"D#4[[*Q+C_?A+XF%()RX2:YTXPUF"2W
M]MDA*;7S#6 [B%]S^ MIVY-BFGGA<;K.[\)5:F&.>^*4:5B :-!K]]>3_%N7
MN4V\1)$[+MT:4L;*O%\@?U$$<F'*_%BJJ_)H1S5E#+W3$U7*?)]/QU8 RU,!
M>)PF9DU4-555X381HKG1-T&:_?= P-@OA6VMD*UWO+97-H3*1%#Z?AMNF3@X
MV%M.-+#C")D>>7(4.RT0_;GF&NJ%AC?CVUYS+_A>-EYF7EROD9YD4JBQ$PAP
MUH!8,9 [+$#H=GZZ[3=]Q/ V:V=?KLLFD@M:F.!@QQ$U)671!GT* 7)L5F#]
M<ZI)O_D(D,=4CC$"P&F!@FA1S-D3>3 S'VR#;<_(1@)"]LX9A&K @$N2MB@I
M)JF!'1 K3BR?0W')S(X&'XB-BT:)Q4R,&#4R(&JV-<2O@#\O6I?QG$^IYDP$
M?<Y2QY?C#(.-/N&ZB[++AIP71F'TD<8R6"VMY;71+:DOZ(0>,ZQ>/#]0U8QE
M:1'%9^^[3#+B;9B0/NF<L\<9QHCQD>)2!ZIEC'IHH:U8V#:]>VLT.TY\2Y&X
M2.<+'=>/XAF/R&R?15)"S,2*< !K!/9[ @;NFY4Q-=PEB<,_DB_Y#*Y3/+8F
MAK9ODJ*G2UFAM,J^N!S=A5Q6C4K17P//AGM1IYV&0%B#I!('\W8YN;'E94_X
M/&VXID#&BQUE]7)>*55+LS@LI7D!= FV !Z).U#A2RMC@Y.1F11Q/DF6565
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M;G'A[EC2-C\4Q8Y8I0"7LY#APRKV:(5E/T'%? &M7X@Q3OVVG+P $)/!50!
M?3 4D*!=] GKSW0.M>',EG5V7=G26FGR$^OH.,.+<EI<;A;&B(N*F6T,;4
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MP.QJ>.^/D[D/ 5E#R34Z.K(- WMH#H:V"$"@!U6)BT,9)V=_9X9X3ES4>/+
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M-0+$\0 0>Q7WU#_^GI]PG7,SYD3()5Y<;@TD#O0MN*DJ./$$=T2WO6H;X)Y
MO.:]GF>'<_B-?6UYM1+49Y:"SAM(:^*LJ9G4X)#K&@B@%#4<!(U-M+Z&-D,;
MYISGMCDD21P,G<DCQ=M?=(L3&7'<\O0+D% 3TY)?E?V8L?K>N^Z?#NV1++F"
M"3,S9\B*21#*L2@N0K&,$?*%[:O H#7-YCX:PO9CRZG)6XTUARULL:>%<Y.E
M,KP\M0U9A T)0-LK!+'2+HCZ]Y*&4I#"!*=QPXYDPQ\$:CK4-ZV&*2--[WC<
M1E_AP6EP0I"N0\G FSR5I%*TG3*RFQV+V]KW3+Q95V/:]J?&>0E6SY9Q(1T3
M\A% J *L$WW5G7V/_P#A\.2^3N1>W'FIVYNS;K-YCF\JFX\_<HH8K6OJ+'*4
M6IL@RU9YD\(=?QRQPS22O$>^87Y',B1&^2?$T./#N58R"..:,92QCI8TE"E8
MJOH*#T!=#W!K7HVP-.^WJ<B3G(28RQ[LK8Y>!^;[COS>OH"C7RU%55=_FJ>/
M_I/\_P#[=5T&[^Q(^NIW7E[?9/'E4_/W3_/\^?\ [IUSKBZ_WX_7Z:BWE;C@
M#DK*&T!CVC%^CY:NP5GN@IC89&1J]C7,=(-*CW1DPM>Q58Y'L<DL;')LXF2^
M+,DBDT&7F :Y*&!93^H%?]=:&XX$6XX[PN%)*MZ;$7Q<@A6'Z$W^OZ:T;<PV
M6Q[?M@+G.1PH:<<@B1U)>3%QQ5]R- OF.8&P<Y()GM3T>^!7Q%0>&_- URI(
M^]X>[09*"B5( 475]^WC_P"/U%==_7R#>OAG)QY"?F860.(/$U5D$$>?^GWU
M/_$W*W;^>2%?%8C#2[XB=)&ZN"BJ)[&-&L1$D_<(Q9)D*D\HJSM?[.\^/;RG
MV[Y;9.7*2<R0Q(ACX&4UU[&S=>W=7XO77 D7 QBLFVK)(DH=9PJDJI'9"D>;
M[NO)'V.I7YQY=S[\/8U6?/'N=;>,=74M*+*CY)K V-T;)CY&HZ( $1KW$E&&
M.A@B:Q$=(KWM:[1@Q"GJ'D%!4@&Z)L$V!]/)OQW7OWLYN?#D1QCR0ZR.A'$T
M&![NN_\ ,'[6-=EA.7;7,9#,X>A2N9G<_0"5$L#:=DHA<[(D_<)EGL)72RLG
M*DG?X2*)'^RN1?NGB/;9,<AGDD/ DAJKL,:/[&R.QWK</QGD0QC%QX(_25.%
M.OR_?D3T>5FQUY^FH\V&:XZO9FV4U-<@'22S36#<A8NIHB5D8WX_0.>&U#@<
MU6)_+''%!^%=&BR.D93<_P#AUL.3(S8Z/%([%F*J0&![OS0L_M7=79,,V=MF
M2Y;*Q'C9F)D;"=HU8FJ*J2P6N[X #_XZSJLXCX2J..[+D;%#7.DU- 9!%,3K
MRI##J,N?PY&2 >L=8Q480Q!"XX9(GQRM?$0LGA6X]J^$-KVG<$Y8RO*&Y([G
MF35 4/%_]NO/5CDV?93LF1N>TQMEY$8'"3()D>,^#T>K L D$6"11[-:!,Z;
MRO2;G- :<W-IIH7C$G /5TP%DQSW1.*&>YKB!5F<YIHCG,66!7M:[W\]>O[3
ME#"R1D- K% "BD=*![*/%]@ $>W?UU0\F*8F-/6*>JJ7Q8\1??S 7X/9JR/8
M'H"%,3^G%L[G>T-WS-N,I<8/-%1&+09^&U_<]%]![25@<Y)DK8JD#ZJ,,@QD
M3)YI(8I1$5C)DF9.;E\8+-CMBP8Q224<>9 H=_,Q'N:\439Z\"M;F'L<I99Y
MYU,4=L0K@F3Y2%!Z^46;/(@BK(ZK5]?V^SUUO;X+)Q?4R5-;/9[.W<V:0.DJ
M7122M!^1DD4G[G;#QR"U@H[Y'P^'%2-8*QGM3\S+Q\/T[):20T$NCV1U7TL]
M^/>NZ)F-MVC,W'UI(SQAA#-R*W9"FN)[NQ0 [L_0:AZ_VKBBQ(VU*:5P51>
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M=Q.)J-,&-# %80A5L5N3($J5\)C$^9\BT46XQA\M%G*%N#M_+ XN5MV/%""
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M8QJ(B-:B)UR22;))/U)L_P!SH !T  /H!6N<U/#43\?G^C4_JO\ 1OV_Z?\
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M3G\6,4*DGTXHC2A_?M000*)LW VQ[=^*.*NW#>\<;SD76\H'ZK5T.ZM;^EG
MS^>H['*06@HH&0J=!7WAI )8UP2TVR.DIIRT@!^*O @!@\]<GX*W#)PLK<9$
MP\-_P[\(94"2!!Q)#DU;, 19/1JCXU&R?'6-+EP8V*C31QR-SR8SU(S<%8*E
MTH!X]5\UV3T=1MP9WOZ?B+/<N]OM-PIJ^70.<]):[7ARA_A^$RCN:'E"(8P@
MG4B#+/&<9G((OIEC<092UIK3FV$PRTB/G\\P]WFQ,D8D>'!F139'J(<=3)-'
M+"%A$%<2%#O$"6L,+KG0.O0)\"/,PQ*0F+D11"(),W!!$].T@]RP0L5Z(Z)
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M8?\ 3H_KKJDL;WQ8'Z41V?\ /_S_ 'UD+V(Y457>'(B?9/'W5%\IX1?[*O\
MZ_E.NG?U_P#.LFJ(\X=AO&7+>RAY JM-J>*]"6Z2/4MQCZM*C:HYD<0TMY26
M@A8/[F/ZN;':5\0A\R2JA,Q/K'ZR&/N.1CKQ4\@+Z)/0^_U%F^_WL:B,_9L+
M/[FC4&U^<=-TP/Z=D5]>Z'7FO^7_ $D^W/-;@/9[7?<K;^::P]Q<WHMC^RYR
MQ.D<I<8DU=0Q54]A"V,>56USBG030,F;*/(QJ^F23=,J44*'N2+/0]_IY]S_
M -M<0;/@8R@!%85X;C9/M55?CH&[UM7IZ.FRM.%3T-<#34U2)&)7UP4$08
M<+$1L,$,3610PQM;Y\>$1$157[_=8UF9SR8V3Y)]_P#34LBHBA4 51X \#]/
MMKNF+Y:GV\?T\?V\?;\?_?S^47PO7&NVO;IIKB%G"@CS%&$#BCP)YDG)FC@@
MC\N1J?)+*YL;$5RHB*YR*OG[-5?"*HMT+L_3SK@D $GP-?K#(LJ*J^/'V5%;
M^/"^?M_GX\?=4^WGRB?=%1'CH^VN"+H@]UU]Q]#]O]-?MTUVTZ::=--.FFG3
M33IIITTTZ::=--.FFG333IIITTTZ::=--.FFG333IIITTTZ::=--.FFG333I
MIITTTZ::=--.FFG333IIITTTZ::=--.FFN%.Y/9S55$^WG[_ )1$:GGPGEJ_
M^OC^ZHOWZZ$D..OEH\C]*[ /_0>>S^[JJ!^8GH'W'5D =FOU\_MKY0OUO.>=
M&SETOC6M/E=%08^JCJJQD[X($/NOK)B#WL^1(_D>BPQK/Z>[1X?1/D3T9)]3
M_P '/AO&E^&Y-S.(KY&1/*@R90##&JJO$K(U@"R00;[L?37S?_%#XF_"_$F/
MAG*D2* 1%H8#;L;LATZ-FQQ) #$T#T:T.7=CRYS/^V<79*MV>D,P/'%'-R.?
MGJ6WT5KG,[FJVGSY#F! 0GF?,=:S"TE) L*I]46(LD,8@Y/I>L_<\7X:A7:O
M\1Q<:?)D=WRF(2*+G;,4Z')NSQH$GLBP3J)VC#D^(<N3=5Q,J>& CTL>52T\
MO$D(9#1"1@!25L?058J]/)'!-'VEWV#V=;D-'QY)R-VLX/EO)8S7R%S7W'6J
M,B$IN2!5(.&#+ENZ&2)E@V4V!EI60Z8LU_T\M:T@2D_#F]8WQ)BY.W[KE#)C
MP=UGC?,@)!FA12V+R%D",TQ< =T!Y[%Y^)8,S;<+&&'COCRS!;5CWR;OL#KH
MV!].0[)&JH]I5EP-R1R3RCMN4<_7Z37<<7-$3QZ5<NC-SIMS? Z8DR*^ *+'
M!M",]'2Q7E7"0Z2)QDT#2ARV) QN$XBY.]A</*!VQ0O.)"57D#RH&C2D^.K"
MFK%:;6DL^U^GE0G&E926DJ^36"SFZ_,U_P!ZH]WE=E:"RVME+7/]@)#2I!'*
MCV*H\D[Y8U])))9/54<GJDKW2HWQ\KE?Y<MIDC6)V1&#1@@H%HB,%1R0$ !N
M+7V!W?75#4P/6AQXVCG67TP%!KP + -GS=&Z\$#7/DS!O(^G@X_H:PVZI?82
M*$&0P- M_9_31&&6]L$Z7Z=N9IVH\6II[>:,9/BL+.\"FG^B>/'E5E9A/2H@
MY=B_!"]=63V>A=D^/&M4))*'RLBP$0]=^+'R@V!V!V?'0[H'4EZ#BR?BR:KS
MX=]E1+BUL ZRPSF4:T$<!Q\CA8B)9@HQJXNN4ULX'U;(VC3%#D,'D,B@4CK(
M)4Q(GD56"!'<!AQ)4 L;4T5+"S3 58NC=:V#N<6;))'B1B)H 22?JO9 8@]D
M]$@GOQYUD7)6_H.,;,K%8FOS:I22SU15Q;Y^FN[J^+&^80T^Q)N@C7Q0GRN(
M\50WP5XPTB#L%<C9'3[6W[/A[MBG)S<MD>:_20.0%) H 7]Q]>P;[)JG;G\1
M;MCY\@CC+1QL;''R 3V22>R.[/==$GLZZ3BW<X"]WN5,NL5@,)JZ=E> ZUHL
MG  [9Y4:P5I%>TFN#.M K6N"(<UM>/(RE(HX/C$# ;63Q%4W?MLSOA-9,C&Y
M3PY/,%OS!684*JA8/^?VU,8.?%\5 1916.2%E9E!KF$-D,/<&O<&O'75V@[X
MLSB,QS-R5REG]#5!4U12VO%&.PM42/-8R6VNSLE7<V5H-&KV- K:V*U1)I6M
M;+8,B@B9*]T2LHVVKNFZY^!C[DKB!$DR$G((Y-S0JI)OQ5?K5?75^P(-MQDS
M,C$E3U@T<?IJ0>E# = ?KXKH]:TWZFS=ZR.545?"JB>?9?*JJ??^957\+^?N
MJ(BKY\>5OF26 "@=*@/0%$M0(H6.B1UY [KO61;(#V0\Q)8>*OYB/V(^_P#?
MQ MJ:V>5S'/\>55/LY/*^4<[Q]_PBHGV3_DJ_P!.M2*-7?YCTQ_W]@>_84//
MW'9V*I9(\&S]*]K^I^U_;QJ]_(_Z8&T!X^I+*CU*VO)]_78A];@2 :^LB/NM
M80K2:$.V+N&L26M815HA<XPPY+YYR&R1""32=;[X&//'))C@JL2RMZEDJ50+
M3D<!08E^KM0M&BU",R=V6,)D+'^*C#B-N-\D?NP5![X'N^NS] +U#:+':KC[
M;7>(V=033:3,6Y=-=5A/J]PIH4[H)&)-$Z2 B)RM:^$B"22 F)S)H9'QO:_K
M!A(!(C2@FC0-4./RT?'BCY]P?H=;(R$RX3(KCBZBFL'A8/\ +('@J1W=$7_;
M<[IINVK!]JW 6DQ_%K<]S/896W' U>OKV9O3\B3V$\\U]8@RGF@4-Z#5W<4(
M&=N2))OI*5[HP9?*V$TTGD8NV@[C/N*KDHT3PX<48!:"?@G#Q1#%"6:[_-8-
M,!JN9<>XC)Q3MVXJS&>'\3&.B(3ZA8D$5QY*BD=7^HO5/]]W*[W/' XJ?CJG
MI+$;#94*YWW&%QG[!3]"52B$Z*2PG&N)%OV06$KX""Z_0L"<3 3\#2!V#.ZJ
M.Q[AEXD<^//LZR0DMZ<DF*C3H#=%I';L &U(\+6M[?-D?(EBRH-U*2A;9%)4
M>+( 7Y>1H@V/?^]>\Y>\[:+2OAS.^O[F>09YL,:UV_C&%&8JI-)8&#4UE7U8
MD"/3ZL\HYM:+'[23&0PM61-J7,CQIHYC'()VZC10[(H)KOB2JCKWZ)H&C5]8
M]LR\K%,?K2#TQ32>H+->;4D$GR:\=&^7C5F<")W3:+(0\E#UX&QP@\QH<V@K
M]U23Q#$54RP6 ;H+BTK3G&0R*QZ"PCR3$02P%CQD"RLG6X;-O.5 WK/B+../
M]* ,EF_F([X_J#5CP?-,WO8XT'&?<UA##B U@LWT'MV0?N>^]1SSKR+L=?B[
M&JJQ@AAAHAH;RVL;^CB!ID/*06"4^-EE-8*A!?M + ("2640J1#PRR/8U<?Q
M+\929D#;7AXXFS\E7$4"G\@7B&9SRL@!U_:P+/0R_#'P;*N0,C(?U,%:E#JH
M^?@>0% >37@BJ [(UL6[,=)8<%=NO&U*)=T:Z39696ES>?L*13RM%6T-(-2B
MV]?!8C$2"B:,#-6.G?0SS#&.A,*(<+],L3INGP[LN!@;7!!NL<>#,L(QY=R/
MRB2:8&7Y"#?,22E;%5Q7NQUD^,=RS<K=B-K$TD6/%&D\",1Q"%;Y+5= $$V2
M.Q?'7ISCRD1OLB-)5.%MM5\EP#9 6UY3T3(S+2^L;2,]]A;EUX;*Q$L6Q%2M
MD4D5XLJ30-9)%-)97S9=GPIC#C'<<:<EH)\,BW0*%7U5))6/BHH>>5W[:J$>
M$-QS(GRYAC>F#&5G#>FOJ,3:,JW(3ROKOR1[ZW-_^'\[1^+.,1]9S.?K[?7<
MY#98OCG_ ':XJBN.JS+:/22[W138J"MA0TZ0^^>&$87=D23CA5%>\006,^;S
M\P?&K9J9<>/DR1.!ZF747)@CY-,R@$@  50JZ/L//T1\)OM\N-)/BH5)?T S
M*%=HX@ C,:NVJV]K\^QU]/<2(K/PGE%5%^R?E/LO]_\ 3_EU2%[4=$=#HCL>
MVK>?)^EFOT]O.HKYBX6XOYTR)6'Y6Q.?VV9.=[R5]V#$0X:=K')$=6E+ZEUE
MB.Y4>/85TPYL#T1T4S>I3:MZW;8<R+/V?.GP<F-@2T+T)5%DQ2H;CEC?PR2*
MRD?3R(O=MDVK?,5\/=<&+,@<$@.HYQ,>A)%("LD3B[#QLK7]B0=<!7'?=OV,
M/0_ADZ_[K>V<)5D.X;UUK(7S;QU41,?-(G'&N)?#!JJJN'B2,/,6J26+V+ +
M6MFG^0I/1FW+X2^/>*;S#C?"GQ/(>'^-8BF/:=QD<<0=PQEY_AI68AWR(J4=
MN: K7G#[=\5_ ER;1+D?%'PY';?X1D'EN.#&I+L<3(I?655!58N+$]*JV.6L
MJ[N.2Z'N'_3BY2VV1SY?[=LZ/.@193D_/VN?7]Q9R9FJ4[.:^HL:V0MM<VS;
M+5VT@P1XI0:D2USCH'1NEJ&#MDNS_%>/M^3-#D>AD.#-CRK/%*/2<K-!(OE2
M"KJ6"\;%@>!<9]T3>?AB7/Q()H6F@0B'(5H98V610\<@8CBRL2IHFZ-$]:I#
M@<]J>U;G?FG=VO;WVL=MFPX*[/\ ESDO(\>=K%!=5><[I:B86JLY+"]MIL]A
M:XZNXMT&9%JCZ>>ECUM2=K ;2&Q!H;-K;C=81;CAPQ1Y65F)F[A!'+DYSH#M
M[I:LI:Y"/Q ;Y&Y!&X@?76D&S,+*EFFQX,8XF%*\4&&CO^/#@$,% !*P5;*%
MY"S[>,RXO[J_U$;OC?D\JWR[9+O2\,47*/$FJY%@[9,4Z'27^PR%-/F>.*+$
M\_[(#69@W.Z8P[C8[DM:9[]+5U=+K-;;?Q!#$/ADV_85R((W_%1>EER09#0F
M>5&B1"R/*7QT:.0R !S"K(8V9@ 1WD3<MZ;&FDB_"R!\6.>(2\(W21V 9$42
ML60J24#D%2 &/1&N,WEWG'FFE[6:2^YQW>2Y+X_[\<YA>2:_8\%Y[C7?C!V7
M#NHWE-GN0LP/<WN(LRGUCY)*Z^Q1+<M<T]]3V<(DEO4CV9/9,/'Q%W$KBK/'
M+M1FB:'+66/F)EC)C98PU+8Y)RY*ZL22I.N&S),HX(ER6QI(]P$4B2PB.0!H
MS(H90S*P)%6+'9%=:RVQYMY]_:.,N:]_L<MR)12=[W+7'N-XV=Q9CO&1I>(J
M[NJ"K;BIT\H)M\S<W(6.JZ5^@K'U\X5,A@837RWEU.=A;;\)<I\)%]$_@<>3
MU7F<W),L',$5QH*[&CY*D$D^<OX_-7'7-DD&0B9,Z".-!16%Y"ANOS&@!XZ(
M]R-8WS!R#W):_L;YQM]?W4<6W5QR+V]<7\[Y,'!YBKS_ "/QD'IM;6R:?,1T
MD9U@+;\:/ D#S-'K[4R35QVS-".824K W"Y]OQ\&+?L1!MV6D4>;/C2^M;QR
M!(7(\HO\RR"U?+QXT 0==<K(S9]GR'_Q#'>1X89D]*DFB,DR#B&Y4H - D>2
M156#L,[JN2MUPOP9A:ZGY2L*_D_6ZK'<95FMIN(1^3-QLM%85-B79KB^. [*
MHS NKLAJ2QN!R;N0C&T8HI[SJTN)@\+H#;,5,S,E#P*T*Q23%9ISC0Q\6 !F
MEZ8Q@'M059O;P1J8S\F3$PX.$U2EXH0Z0F:60,MDHBD*'Y5;45NAWUK5]2=Z
M7>ANN.Z:EH>4J'%[C+<C]Y.:T^MUG%>%MK[24?;KQUEN0LN->Y7+ZJYQ-#J+
M$VUESNB?G+D@&&NE,<P(&_AC=762;9MKQ)Y/6@EEA.-M4B+#D^HG+.EX3.DI
M <Q*H=D# L!Q+$@C5=CWG<LJ*$0SQ12B7<%=YH*?ABQEHTDC+=2N> 8K\H -
M=^>3W%\\\]\^\&\YZTSE+CSCKCWC^M[9**WX8)R0Y%ANCN7LEQ)R;8Z1^ML[
MI-#23RV>S=2<<UE7')7'19\YMNRXGG;('QMV#MN-GXD(QYLHRMFR#*,UJGHF
M18X3&HX@J%J8,!;=K0J^V?F[CE8.3*\\.,43&C_"*A$CB8+RF#$\AR8VGD!0
M0>Z.ML/>CM>:L7P1:VO;X@;^29]#D:D**1<C+H9:>UOP1M"W!T^]O,UC-)R
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M9/O#=Z!Z$2$!&YC+5-A=:=$4LMP5'7 %K'*42\ )LL\JNV1N.YSRP.V;DM-
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MN2>['F;-XS7:FRY=I-CD]S:\=QV&FXR+U0''7%E!GZ<\9]Y9'>-" '8#6[!
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MIDC+$ DD,6+M[+1^H([MVY0YW^-[9-!"/PF)%*BK1KG(%!%*#2!5%]W8% @
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M)Q4SC82KAHGQOR)3=\[E>5()VSS2V\/43N*+^#B_!G$_!KB0%F8(LYR:_F@
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M 0B0+,D1S#N7I9!=:?\ #GDSA&+D5:V/3'D$"Q5:KCP?G^3"N*>87B;BSV%
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M)#ZWI?(#8 2_S*%Y79N1R$BR,0''7,E1<_ :1)N0"!'5Y/25J<@!JD)%<N7
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MD?&9DE82/,[(BA M@C@S-?7$6?(K,NZ 3/CKC339"L_*%)84,:H@8V2R@]D
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MN/)BD;+&I8JH)8DLP) %D<INI".&Q)Y'QX(9LG@\0$0D 8<>;@RD*>3*@!4
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M]O\ XU5%1$\JB)]D7PGC[^?**J?A51>/N.5CJK(![]_8^+_W6G?8ZH^"//\
M>O\ 0Z^:7]7W@SN&JN:,SW$XC4V>AQ(@5:-)C*L^P=948(L?[5?-;0HBA&59
MC;)D@]C#[E"6Q<$TT3(X8C(?>?X7[ML,N%_@^7B10;E!(V5#FR=)+;"HRQKD
M?%(000"/8Z\;^.]NW3%W5MY@RI'Q,C&&+^'LD8YX$&4H00J_U%O(JQ7DU?\
MT^*CBG.9?NDY2[BL7#9Z8.JBS6?Y=T^@L;TS-U]^)-%!GL3D[9CJS/WT4K')
MH;*AE#)L1XP([(A86$I)L?&/XV?XAPFV[+D6")_6?&1J4L/FEL T(K'R@TK!
M5JO;7V7,AC^'9</<($GER0T<>0OS<^1 #M[F5310*+XV2:ZUJSYLOJR7D?':
M+0Z.Q/$QQ==89V&HLV1T5M%23_441HY<<,CB1JXV%D_P1.9%).+*'8QM5"8G
M>DX>5M6\[?-'C;FT<Y13)!:",Y"BN3JIY $D E>B5(-ZHA@SMJRR,K;Q)!85
M)$9C((B*4+:@50[OL,Q[\'7,Q.2K[&\UO(/;=HP^,;^XI67?-^ZU-G;*^FR\
M%X/&729;X(+9TM;:F$Q&KE!3:R$NP; Q7(+5,.!A1MLFT+/D9^,-QS<UT@V[
M.CF62"!>+GM&/*,IQ!)5:H$$DD V!=YDRIH(]OG&+%CHTLF(Z\7E<\%OG&*8
MT5 4D,!?L.\4Y$J9^:<WBK.:2 7@6G27_9_0V-Q14&WYNO5M'@7>QN*F$Y"J
M*MT-Y736T8T+)+/0@2 TV?4:K96V;ZV\&=G<I,E'3$AE49.X1C\\H8TH 5&5
M21P'$BQ;#R-6/%GPI9FESYUDRR @QX^W2/B 5*_F#%2*!'(FJ/TO]VV5^7;Q
M3;\JA,!=6YW-W5=<8P<<YT588/"T%0(YYH(8)ZSZ0D*P*K6D3%!UY4<,DI\'
MRG,FL[=MPQL?%PLE4FP1(GHSK1F6,\ "8J/=&@[?,&5J-]- 9OPWBP;A-F84
MQFFGA<C&D#!UNR%/9/D]COV\=#6EOEGD^PYJ[CLQQ'1$+6,T5M/ ?9ABQM&S
M](.P@NQNYX16(LHM2",29(*Q&RE,&2")4GF8B]OB+XCB1\; V?)D,\B*9><S
MN&M5)ZM@GFJZ /7&M8/AOX7F:&?*W&&..-&;@T8)D!+$@]$,*ZN_ ^UZFO;]
MMNKR]]0B<@W63V6NREF#+D+,WZ^*X.-#AC*"=#76\8A!D@X*BD"!6SRK:..4
M)E6+',L4C<*X6+E1PQ[S 8I+Y8^8LOKQK./RF1.0*_-1NCX/TO4G V?M^5)D
M;-()(@CB>$A2\D2D<E52K&Z)L@@@UV#9,17T>_QM?H \]::*JR]M"^"\J13R
MW0#1SLC4F"Q@8L<:QQRH\%MS\$+R((OIRG023/$ZZ3X^=MY>";C*DB$I/%;P
MR1]LBWVL=*.1440OGS6K#M^[X6\XZ1($ARL9SZN/(0)8V\,6LAAV2I%4#?7G
M4M9_/=Q%WV^77-(G).MN<KE2)<Q4YBY=>;*!*S/P!_6QP36!<L>;I*V Z 2!
M*Q4<V1'1?"&,QI#.VW8[QPR/CY;8\Q0R&/'*F)F^8A&[+<B%)/5 =V=;N3MN
MW9Y"96-!/*"%57(YWV>5'Q7L;_N-0-G>W70=P-UB+;DBKWM5@]W:WF8H]32W
MP5/3&ZNOI+*Q%K8RK\8W_="; - 3#X9"A!IY'C*]A<4D:1^Y[?F[LY_'[IF>
MFJJ'6!82U$=+\H!'1!L]D=D>^M+&Q]LVQWAP,''?/6F]"4S&-3= D,Q!!]S5
M#OVK79X3/X;MWGYMXYI:/6<?[:[P8%B3:['?@ZFV-HZO79R2IJ!:7,T\-2$-
M>6A85HLD]D7<ELJA0A@H@C2730>%L^V;9G3L/Q60L>,[*V:H7E.>@J\6XD="
M@>^^QKMEY&^9V*HECQ,1ADHI_P /<NPBH\R05%D$ -^U?>(LQWQ<N8QQ4=5'
M'7$2QS5ED746#02"!(YHW3#F%U];!,:%\XT1'Q++/')+#"1Z/5D;FV?'S4!C
MEBV/%+1\)!)),KL[*I!41709K/MT ;[(.HN;X<RYD5AO.0Q/J6) Y;IE" @L
M2!Q)HU?GR -26%WK6QP4DA>IHTM)8D:R I^[DG9*K53T=,-AR(?5CO*/='*K
M47U\*Y&IXL6+\7,N/-CX^Q1K/+VZI,D8-=4Q"FP1T?:B15'N!?X R,B7U)MQ
MY+=\@[AAW9I>2FQY NB:^VLAXVX,@Y6BS_+O,=$WDFLVL=B_$9W,#%TF>IKD
M.SEK''Z*[2VS]OI;4.X#F#9CQ\P1&<]$G<18!/\ CGJD>RS;_N$TV^.PQE?K
M;<-6F]*.NFD<\0JT!TGCH\B#U*Y>X#X:@CQ=H1%R57^;N&8XB]1B.UBCI^3
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MQ5B32O(M@OQXW0H@J;!.J,<"<9;CEKMJY6JL<,#C#=T#B8*RYOB[.MQ=U;M
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M3:CL=WJI?XMM6P1I$V63+)-(6(4,"&/:EK('D >_GH@:C#D7,[3C&DIBN0H
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MU_#RJY#,61B+8&P*5K)/&PHOZYORERCP[V^7$5%IJ,+E7EX8.+)2;R^K&$;
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M7:H03- &3UBC$2.GS,I*-?:IVP\5[5N+=LC;<KU(]E;-W:8%(,GH01$GBA(
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M?Y.XPMWPAQS:Y'0TN8SEWGS\O6%5ME1XJTO;O)5I \L#FH/G+;3Z*PJ/C])
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MR2.F@J10AYB)9298G3RO>LONV_;MO@P1NN;+F?X= <;%:6B\<!H\&>N<E$*
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M!PG/J1*L[@%&)97#+?BLHS<N>6*:(9,<<.)#DR1RE&8K#G2I*.48X,7C3ME
M#+0H&SJ+>;.>.Y<[_8C;F\UC<3\<=P%-S+W#971[GN/F[8:>,.UVU"O$7'4?
M(I7"W,PTLF<XG+H;R/C-HU )H[&[OK8UMP\,>OCS8V%MZ',C6 9<^&T&&R18
M@S&950E\GTER8N):4&-Y@[!>B%%DZPY&;GD8DC2B"+-$N0CRS&$(S&A 7,,@
M^5"&1"JLY)MN@NM\';-?[?3=O_$=]R-=9_1;NVPF?-U&@RL=DS/7MK.#$Z>X
MJ6W&?RMBT.S3T.8I.;I/;YU?%6B0NCB;3,]8H\K(6%)(X@[<$E 211_RL 2
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M4ZDW(V8'?\Q;A%<D2BQJ4?"Z0440*Q0HFT940EF.;GY*#T\%&7T8 4'(^D@
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M\DTKPAWM=",^61\+&.>Y5Y,DI;EZC\A9!Y'HMY([L$CKJM<"&( J(TXD $
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MOF5DQD'A\F'B,P8D)"" Q!/&R!0/5T 9? ^$Y,J+T\<2;+AP2$>E7J9>4%(
M:7((!/(@,4OB""1=]_:!QAVO9;,]M>=[>.4WU?,,2\:4. Y0TUY205Y/*4U5
MGA: ZZOH8)I2GE&P#(@\TUB2>%$R!D1WO$U[?(WS)OQLF=CN^+,\C2(T#<3'
M9)I2!T*/CQV0/OZ0F+&,6/$F5<F-$"?S@&#55$^]G_,_3K5+N3/T;>V6Y[;)
M>VOM_?<=K^;DVIN]EO,"UFEMC[^U!9564]R_:$6I=LO[9&P:M?/9-?6)%&P=
M?@4B B:VCXKWC9LF7.Q)BV5-%Z322?FHM9/OV2;)/ZG43NOPUM>[QQ8^7$/0
M@D$B(OY?NI/1H 50\78H]ZX7&'Z$_P"G!@^.Z[$:+@T;EFXC,%M-%R1R9>7E
MMO=A:0,7YG7=G7'50C:,I[WNER5>$'F%1R(^K>]J/ZC<W=MQW+(ER<V=I99G
M9VMBP[)('?TLBAU].NM26)MN%@PQP8D2QQQ*%3@ .EZ]O-U9/DF[O6V?*93/
M8?/TV2R5)4YK+YVN'J*&@HP1ZVIJ*L*-D(8%> +%$.(*/$Q&1PPL:QB(GA%7
MRJQWO?O]=;VLCZ::>//_ -?G_7^_335&^Z?LVJ.<;"HY2X[T9/#_ ')8-KR<
M!S#GH_C.\#HKH<OLPXXW,U.--D<L1E8:V=1XY97"M6.4D4FZ?"OQE-L(FVW<
M<6/>?AK/^7/VC)):,%J7\5B$D+CY:+?IS#L-Q^84"*1\4?!N/O<D6Z;?.^U?
M$6"+PMT@Z+!0Q&/E*H+38[,1R0]@75AB#A_;+WCVFDV17;GW,YP;B/N=SHS?
M_P ']U;CN6:N..5[-AQ;;E2-_= YQXG$GU#U4VK<DK/$K1BF";?Q/\&0XN$/
MB/X8G?=OAG)8'U>CE[5*Y!.)ND2V(RK$K%+R*2 'Q5MI_#/QE-/EM\.?$L2;
M9\18H"\#0Q]R0 \<G"D)%\T4.\7%:NT+=JNPR)Z+X3RJ_;^7_)$3[*JJOY5/
MM]O^?7GJD$GYA[ C[^]=>!Y\Z]#H@"P1Y]_'Z]W^W?\ ;O7(Z[Z:=--.FFG3
M36,$Y#.%ZBMVA%%33ZNGK+*DJM)/7"RWM;271-69<U(-H^%QHM?:%4M22<'!
M/&,7/6 3$1R/%B5O;DP4K9XGLC74HI;D1V#=_H*_W[_MUK)^NNNVG333IIIT
MTTZ::=--.FFN"=7"GJ&\D<>>2O+:<$^>%DJBEMAG'0F!SVN=#.D!)$*2Q*R3
MXII8_;TD>CN0Q6Z]P5_8]]_V^_=:ZLH:K]C8_P!_]JURV-5K&M=]U1$1?[*O
M_1/^W7!%]:[:QRXR.<O+G/:&VH*:TO,E.>7E[<^N$+LLZ5:U\M59DTAL\,A%
M;/85D\U>9(&^)Y04LHLRNAD<U>>3*I \'L@>3_O[?]M="@+<B!7M]>ZO_2_^
MNLE;Y1K47\^$\^/LGGQ_;KJ#8!/N+_OKOXZ'@>->>N=-.FFB_A?_ -/X_P"?
M336.6&7IK8ZGL[.IJK"QSQDUC0'FA#E%TIY 1=<0953SPO> 5-7G& 2$"K',
M\,H@=[UBF>Q>RNP! ) (['C[^Q_R_N-="BE@Q]NZKW[[_P"_7>LA8U6M1J^%
M5//X^R?=57_E^?QUT!OZC]?.N^O;KG33IIITTTZ::=--.FFG333IIITTTZ::
M=--.FFG333IIITTTZ::=--.FFN/[2_?RJ)]OM_P_G^G]U\_G[?\ IY_/5KH\
M>CUX[^E]&_(_UUQW^MG^P[^W^[\G7NCE\*JN\JGA/"(G_%_7^G]?Q_DB>?S]
MNN2:^O9H?[Z^GWT'TONK/@?^/8C7NKD\IX>WPGY3RB^47RB?Y_G_ *^%3I?R
M@GZ G7.O7W1R)ZO1/"_=5\>?'W\_Y?T_Z= ;]J_O_P!0-/'D_P"GO_O[G3W9
MY_X_'C^WA47_ -%Z7=CL'OR/\_N-/W_\?;7OY3QY\_;^Z]<Z:\^47\+YZ::\
M>S?_ )D_M^4_*_A/^?E.N":^OFNO^OVTUZJ]OGQY^Z??PG]?_K_5/O\ GKD]
M"SX\?O\ [/\ OO7 (NKL^?V]OM[C7OTUSK\W.\+X]VM\)Y\+X\JGC\??_/\
M[]=&+6:OQ]/>_P#MI8^OCS]M>6JJJO\ ,CD3[?;Q^?SY^W^7_;KL+[OV)^W7
M6FO?KG3151/RJ)_KTTU^*CPN\JYB.\JJ_=7+]U7V5?NO]5^_VZXH7?O5>3X_
MO7_73VKVN_WN_P!?^FO9K8XD]4\-1?Z*[\__ -R_]?[KY5?OYZ?:S=#L]GZ
MD^YZ_P M<="_ 'V  _L/K>OTZYUSKPJHB*J_A.N":!/T%Z:]6R-7[^S/"_A/
M9//Y\?W_ +HO]/\ MT!ONC^^N+'U&NLN*&CT58?3:"HK;RFM!Y!;.IMPQ[*L
ML!94\2C&@&1S"%#R)]I(9XGQ/;]G-5/MUV1FC<.C%'%TZDAA?FF!L>3X(UPZ
MK(I5U5U-6K %31ZL'JP?M=ZZG)8/$8&E@S>$R&9QF=%=(\:AR='69ZE'=*Y[
MY70U=0,(#$LLDCY)59 U9)'.D?[.<JKP?FOD2Q)))8VQ)\DD]D_Z:[ 50'0
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M)_JJ)_E_W^W337A'-7\.:O\ HJ+_ $1?[_V5%_T5/[]/'G7 (/@@_II[-_\
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D.FFG333IIITTTZ::=--.FFG333IIITTTZ::=--.FFG337__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g68105g50h92.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g50h92.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2+44&AO=&]S:&]P(#,N,  X0DE-! 0
M    (KB^B(@X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              /(   '8          $
M                     0             !V    /(
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   /(     4F=H=&QO;F<
M  '8    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   #R     %)G:'1L;VYG   !V     -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 4@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M[7M:UALV^_V>]_Y]B88UK>O1>)7TM5;NGOQ7-S#6TW$?:+,:O:UU
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M-&M?/L(=;%D3K"8"#!B"(>5+DF$"-' )O)Y3G*J#"P:>R/(X;$3\NZX2 +.
M-= )( !)/ '.J^=>_J"X-IO5%9IQ5R=2[LTI:V-.A%2+C$::5> GDL9! I/$
M,G]7PWH(B(J,D?OU1&_ADF:*-K* V3^@D?%'(R,XR*YJ[(VKA0S^V_'D?_:Q
MC^ZN\0COM;->M2%-.SC.%=628WE#AF.PF4U,!3,3B&8YSSGEH%?7G)-(]5W<
MQ."M3JK)O/5C=#@ANWN4\CZ5XKZ&Z^F9XH.P@D=P^HY^I^W'R/WO4/<C&6/D
M#;^^S')<6L9<X4<5+57P'PYD2*GDB";&='B+'C&5><@40JGF\W".1S4:G44T
M[]J;?;;2+>% !*XB1)8K]UF;L#.>T]PS=4.!JP@3N<L0 ,UX K(HXS_+SS>E
MY76D6\+/@W5XVXD%@QK*/!%6EA2*^O8]R.)*7S/D21E(C7*&2\B%C\%1J!XI
MUY?_ -ND<\D5A%*^J["3+$G"MW=O:30R![<"R=><2.40X'Z:P ,7D')YLU8R
M2/C39?1T5I*Q_+7K>S)F.O#%""HM;B-6F+\AR-25CL:2R'/C?R48ULF,]HQ/
M1K6JQ=E7K-*YEC5HW;<$,CE0K 59"D_IHXP:-7S6IZ:(@,38YR3\G]-71O@8
M^FD[F&.ZT'RAZP+.O?C+G@4+(Y#5KZR 2'%4A);@G">0<QOD/&S@B@031LV:
M_DOM-O"\<C[F5TDCL-V,1WXL71]Q (!)^OBM2G<=B)4:O0))(![?=];(! P*
M&?'@)%,(;F,HU-79Y-C'QX['9%6+#!92::8!SI@!&'/,]OR%F\SQW.!)>1JM
M5NSV]4]M$D4AW>_V4C[:4&/;VQ2.A=."GN[NXD$T  !7&K#[@1Q*(C&>\=S=
MP!IB?TC%\!>.":JS0XV.88Y,HK6NJRR;"RKSQH;EU"'<U%=+<(84:6)5SG0G
MS-GD1LHD 2 CJ]$3FTNR1]3,NU.WGB[XPS,>Q')<042"64][4>X#N]P.I-HO
MK^V3M R 5&/!%C@G)KFQXUU8'E5T\<&B?!Q+&X10RHM]$KJV4V,PZJ]R289A
M*KF$,-S/&*:B-]J]"NW5J>(>H03;4?F4W*NSL89Y2Q8QW6'))[>[N\\W5YUZ
MFV2Q2@QL)%9.WM]I 8L2*&:QC&?FAIYZ6DGRL?DQ\2S:2V&^4]P;";"B3&QU
M:=JE@QPO9&<@1;.$UY$4:-_"[(BK?VTJ46E[GBHK:$]Y'@$WW$5=BZSD9TLW
M "5$\:+(,ARJAC9)(N@Q\7X^_&M19WV%8CD5:MV6D_CR=#,E":0$<"QL8\5$
M60&-/:,C!B<N[W1D>K%];"7^KJ6*.;LD='=-E%)W,KGVJM85P3>1X JQ= Z\
M&I%6,#WT/H3_ $)KSSQY\:D;IEW,ZF:6N^?29VR5C]B'SQ,,RJQ#-K(\EJ?<
M"(9[B&@@)^4;&5B(OO9J^NK$74FC4PQ%)F!M2CLXIL@&^*&* JJ( &HFV3N?
M>H10/<P !L6><XSD_?CQ9GIEWK:=Y)&K(N?S(6!7<YT6.TLV8S^'Y<V2C6L%
M%LI'#Q,,1=@^9>+DW7R-_'3?;;OUV$3(R2]I:AQ0-9(XS\X_IJC+MS&U*>\?
M(X_G?V^?OJ9\22"8 <J*<4F.<;"A. C2@*)Z*K""(Q581CD7=KV;M<FRHJHO
M5L&[-@B\5XK_ %^=5R*YUD]>M&CHT:.C1HZ-&CHT:.C1HZ-&CHT:.C1HZ-&C
MHT:.C1HZ-&CHT:.C1HZ-&N!%5K'*F^^W[)NJ;KMNB;+NJ;[HFR[K^R_CH-^/
MZZ-,;K;W&:0]N^,'RO5C-JS&X3 O+#@/*V3>6[V\N(:FH"KYTU[WH@_((21Q
MJO\ ->)$5>EG4NK]/Z3"\^^W"Q(@!:O<^2%%(+))+  5YLXSIAT_I6_ZI,L.
MSV\DK.X3N *HMB[9^   3_3R-54:@_6DTMKM-KC.\.I?FD-*GUV,4,JV!(R(
M[X:C8VTOJ>"5[JB$9I@E'&\[Y+^7#R\D^[YCOO\ U'GW,CP](VOIQ#N'YC<,
M ST">Z,8K@"JQ9K UOMM_P"G4RRQKO\ <>D0 \R*"4 -X206 0:YOYR>/-)W
MC]VN?=U=K_%V6M:R952+MD(*292LCU\J2U\"$BDD%8GPD]@ QBE8Q>+MMEZ^
M9S]2WO4MU,^_GFF:V[4,SR+1O@.6 QS5?[?3=OTO9]'V\$.TB5D8*)'"*+J\
MN0!W78PQ)X\ZBG39==VX:P633YME3T\4I(<*0>22+!10\'-BB(G^'5Q$1Q%'
MQ0A/N7[O:45VT(D[=L&,DN#W?I7-L37P+.>"/J!IO/(88.[(4J".T\$50\\\
M?]QCU<?20QG3WMSTLRK-,FU"Q4>1Y?BT#,KZB2[B/G8_108)Y2BM C(C8IW+
MP>B&1QW<D9Z<JIU]8_#74MKTM6[MQ$8HH<M8)D94(56.+MC0# F[H7KX_P#C
M"/?=3W$*#9;EKD95E56:NY@+O)H\XQP*\ZHY[N^ZO).Z'7_.,PB&GRL)EQYV
M+T\!!.'$;CL>44()*NXC8C)3N!D<>.QWM%\RK[Z^9=<ZDW4^I3;EB[,CF0QD
MVJQ&NU:-^P7:C@>!7/U+H?2HND](VL/9&9HU#.Y1>^24BNUVY?MNE!LB\'SJ
M)&+8C$KK\=;->2.V0$WPWG50H]KEW<PCUW\@T8X?V[JB-4GK95ZHI.KF7'!]
MI('DV*/QY/&/-UJW+'N6A",4/;R;!('[Y)JJ R+P=/H]M9:1X JFKF@+&(H9
M"[-^.[X81,:0('(K21"RT*YO-JM*F[G;K[Z:>BLLVWGVX5)H 0[2*!&<#F\&
M\@ V!]=+3,8MKN(II7>&8@HK.S3KF\$DL*QC!P<59UAX;91X]PLN;5,\JVTT
M8<?K!ADH <OS+'*)CP'"CQ$*IO J>1Z2$>42*Q52INY"%F;TQW ^V(**%\D#
MC!^@J[QG5B$R")MN))&$HM)68EA_]23W# (Q0&/OJR/M9T+R#5Z@JLLS/3>7
M'Q,=BM)A\2'"F(_*9*2GFE'G2I#/@_'D.<U3288QM:/9454142=.F;F?T]SZ
M4Q6<GLPPLT"*(XO@\<V#9H+=UU'9[6239[7>(LD"T[.U%CD9.6-#%$_&#0&K
MK,"TFK]*J&-DN>9@;!,4QV-!2HP=UA65./XV"O1S06%I(CL 0LD['LDGARB%
M UZ->J(J[];38[%=O% VZG2.8\JQ7N/D]W).?K?CGC ;OJ!WDQCV6T.Z-V9V
M3U)#S5.WNY^3X&?&HMZ]?5DTFQ04FET9GV^H-ACQPQC7D)3'HBS3N,%AXL]I
M&MG1Q3)C!/\ $Q6H, TWV8B)<WWXODB,FWV0, V^V+/+91BQ\EU():ZHV2!Q
MQJ;IGX%FE#2=1,7=,?X<:J"!CP.%X\?;G.HWZ1?6UUEP_42%BFK^$ SW#+.P
M8-]Q51W5V3T466=[8[6MCH2+8R1L>!7U\F.R0UI6?XMJ-3:7\+_CSJLS=G4/
M0W>W&>\'T]WGX5O:U#.6QJ7K_P"".EQ0]^S:?:;FK(;W[+C-R466S@  <_&=
M7^:$]UVC'<3!(_3O+ OO(@ADM<0N$2JRRH4C4<GRJB2]QC@7?9)D)QXCD_!V
MKZ3ZAT[KG3NJ7^3W2.RD=\+L$FCY%$$^_(\6*H^=?->I=$ZCTMJW4#*",2Q_
MQ(B#FP5P+L5?S5^-293\)O\ VZ<Z5:.C1HZ-&CHT:.C1HZ-&CHT:.C1HZ-&C
MHT:.C1HZ-&CHT::[4[5G%M*Z:1;9#,;YFB(^%5!<Q9T\C&JK1B8JJK&.79%*
M]$:F^Z;K]JPRSK$0#R>!]? UZ52YH:HTUP[LM4]:3FJ[S!;JJP.9;1X]/6X_
M9LGQ)L9)2C?+NUCAC/1X>+2.0KCA1%XHK$3UX]$[J-FCWT<79?J1N 2?':+&
M>?WU;BJ$GN ):J/GDX'FOW^<\U&NYDUU%FXB*_)I45!/+<&GVLZ3B6-L"-B-
MXUKWDA13HU$>,8!-5'?=ONJJM62)4V3ECM(4LJLB[5#N9B;R&[0X!XY -_;5
MA2\DJJ6)L%LG'@_7( \\8KQ;DR*FUO\ (,,N\<OA"PN%#L["TD%:=J3"R(B)
M"DA*,R1T'%(YQGN.CFM^U.*/1=E^W6)89MN=M(TY>%E?N(0AG_P#_"&4CN[<
M%B;LG/HD @%A@L#DV#9-?N*^!QSC23LWR/CV)*V'=6RR99@R,GFVRPUA0%1S
MBRL?<T4MS ."U$X0 !\BM3DJOY*K:!UC?^-)%MT1740@ @FS0F(_7G/NNU
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M4"J(DR6=A%9(0@A\%$X+'#3^EJ(K>K9G,^VCB:1V,"A(E9B0BC("@_I%L2
M "2>=0JC(Q[Q@MP1RN.+'E@3\4:QID=9LJR3#9=4<>F,74YD[*P0VQX45BIC
M-43XR,LCL:SYIRN.A'%>)P_'LUSGKNJ]9S>,5>1?3J1MK-4B@"V -$G-M]3?
M]:TYZ=%!N)'1]V-IVK8"V <<X(\<U=UB\ZCIA$?46LU*S6]J\:/,)J0,\9\:
M]&.,^@?&&\$4B"=Y'F J?RA/=Y542-YNW3BBC\WOMS%%T^5$5854(Q OM/N-
M&@++,21BR2>;TZD791QQ]LYG:*W+H*+#P&L63\$Y\#ZR(KJ*9B.)P]/\NSZO
MH9*HRP*,%K3CL3C,?RDCBCS7-(D=%W"WQM:1BIZVV3IWTR7<;,NSH)412MFF
M%\YO%\&_M0R=(MYZ>[D[XXF+$4& L@7==P%U]">?&;TL,L,*ZKX%9 F8Y*Q*
M+6E@7E_/E,C7U0V2)K0EC3SC*C7/8OVO'*C\GHU&N7UU))-+NHY54.PGYB4D
M(X4F[4&F^U8KG@Z@BC2)@'202<*6&:&,D@GGX-4/C3?X_ISBM[65%%\ZYD$I
M+$R1YLR5*L!W$/;_ '4[FY_^&<-409%56KNU45WM>N].F,<SRQ0J![4*N@'8
M4':0"?T_6OCZ8L;QG:,!R "IKM(KZD@<G'F_M6G6)A..6-%&P8T=SAT\@,NM
M8^29Q@2XYO)&*QRFYN03U3QB5>/!..R;=-8>I3IN6D*H$<%6[11%^!5'@>#G
MCZ:4^BP'=W$+D%<^3=?RY^]FM/)HIW*:[:#Y)$KWV[<KT] C6VN+68E&$(5(
MB.ET\E6FD1):BW7QH\<9SF[E:]=DZ;0;[9K&\=%9NX&^,M?[&S]OGSJK+ S>
MY10%X P.,"AS_?%'5UNB'</IOKW2%M\(N6/FU[W!O<>G.0%S3R!N\;TD155K
MGQ5<BH.:%JQ2K^$1_P!J7E#=B,2"'%J0;_G_ #'C][NJ9!!HX/\ ?%Z?=O[I
MONJ+[V7=$541=ORJIZ5%V7]E3;ULB=US7+HT:.C1HZ-&CHT:.C1HZ-&CHT:.
MC1HZ-&CHT:.C1HZ-&CHT:Z3$8-CE>[@UJ;N?NC48U%^YRN56\41-U557TGOK
MC$*"Q(4#))X'W^GS_IKH!8A5!))H <D_ ^NF.O-8ZTDEL/&UBV5<X!WRLG;-
M8ZD 4:$5 1S-54F\G!<UQ@/02*T@F*\B_;F>H?B/;0.VWVKB7<@HI91WQKW,
M%-5?<1W<@8R;QIOM^DS$++N(V$087'961QX[<BC=$\CM#<ZHW^IOVN7V<:.6
M&LU*^\U#S3#[HUI=SQ6-I/6=A1FE8>G)115YQ28T2. PEBA8_P"*Z4X[BD(?
MG@>J)N=Y(DV\5)4].:,S(14<BN""ZT+;'9?(!KP =Y^'NIQ[2>3;QR+M(9$[
M$@8'W,HNRU5=K=_0CC7EPKJZ=_%,V**M..I'#?.G_,69M\@A!R$:1AVM(-R<
M$&K'(F_%J*BO3K'GHB2M/(\Q0KW&(75DFL41@@DDC']*WK]6>&#;[4*7:1P7
ME([D*_J >[#"P!1^A%<:40L<DRL<AVLJK.L9;>:R2Y0H 2E<UR1Q2!O*TJ1B
MJ-SF/5CD<B(BILNW5:+I:[1!(Q[R6;WGW&C8H?/('W/ &=6).I&=A KJ@*#^
M&L84$@Y!I?D7XX/[H>#&\T@T*4>0*NBED-<]&(D6*J(Y_C7R(-#(QZIMQ0GO
M9$1%ZB@VC%IFLJ7[J88(!YJLBQCXS7G4DNZM$5K81U[6HK@@51!L<G.?Z6I<
M1_BVJ#>$I,JM!@R..Z/9N#-.)9E=QX?&D#:5KO'Q3[1R.341-D3=$Z7$,&,%
M&.,&_:*4]IP2!61R."+YSIE',!&)2YDM;5&8MV$CD X!!LXX\\8<NNKSX^.L
MJXH?FQIXS.48'F"1'\&*@W_?X#-3=#/:]/O<NVRJB=0^D$W;S,JLDBE6# 95
M1@&^0#?CY%<:B&X::(0*[!U8-@^1?NY![KJSR?GQIV<EP^RKHF-3#UPA'%3B
M<L@S&OD-_5QE;!5['*FQT3@YP=^7%4V1$])S:[="^YDM>V8>E$*Q'(/\2#A3
MG) [C\\WXEW@[1$"?4!MCY-&ZO!H_P#?(K63!Q^TI+V&YRJRGF5X03+ <HC*
M\D)%CS)315Y&()Q7/^=%>]KN3RE\#E5H6(C/<)+%!#MT8LQ_4;(LC-F[R>!>
M:P-4HS%NI'W3(G? ::(JIHDD94_4G[?YVP=LW9]@N<@Q;42QJ+7&V9 ,%5 I
MQ8]818UG4-D$BR;*650_'9*LS$D*,[S(\\)@51_QFHSKUL^B;Z18=S/):R;D
M+(6:PRWPY\@?!Q1^=*=_^((-K++M-K1W$:F1"I'HHY!_A)_A"U1"X%FJXU93
MK/W28EVKZ,U\6UB5M!-I8D>FPS!02:Z3?@BP!M@,LI0@<5*LQXTV:$37(KMD
M0R];#KO5X>EQ;7I^RW"2,E^G(L8[EX&" "#]N?Z'%]&Z+N.N=0?<SJR0RFY)
M6OWY%@F\T,Y-9QS1\UG<!WE:Z=R-C*#E>438U ;YD6JQODR.Q:^RLT'(-9"C
M?R^?Z>@D!%4+B!#XFL<UI7MZRD[322[9MS)(21_^8S$\_4GQC'CYJS]+V.RV
M'3DW$73HH5[2")?356')PPHBON,C(!U&5[6TQ@1:GX[718D:(P2(H1'&.3S?
M*CC"K?YLUSF&:C]G(]K7?E$VH;R/<-,P8L7D7L:-B>UU%T&'D$_(/-V21JU!
M/ L"M3M(I]K^5Y! )LKD$"J\T!K?8U17=I8%$^."1:5;V7E!*6<C7&'/,JO9
M(,-Q2%FJG%&-.KE-LU"+Z1.K(V<L4<4L7IQ+-?;W +XSQ@T<<?85Q6;=QR/-
MZBLX4#]7N _8V /BOZ:>/'J/6"/=.U*Q&QGXL; 99;"1:X_9285N%\<HT$X=
M@(8"-DMYIQ#\A4\:<43CLBWORV\BC@WT4HBG1C[HF*/0O'<M, 39P3_KI>T_
M36F_(3PB:+< =H=%<+>, B@<X%#YU>=V4_68I+:;#TL[GK-M?9@-"IZO4MWC
M$*?)>WQ.=D<<*!& ;'HU'VS%^][G*<3O9.OHGX=_'R.R[+JX93A4WK' /_\
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ME/&CUD;B"-&1Q(5?%8-K%-XD1$7R.ZTO6/X'3Q!!&(!>VC61E[2)G![F!/\
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M@_56(Z[SVQNW?IEM2&G%/3 +7E+2I-6/Y2-59,*4S9R-$Q1(WCN]"*XVJ?\
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MUK:I&E6!Y$N0A9#A$YO#%9OQ9'8W;@P0T1$XHY=W*JK!N=VR($A!#<  FQG
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M*YR>> P<<Y&24<1[1\T7BY-LOU#<2;WJ#M%MHU@)C1V "]X6-$+'/-H1]@,
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MI-G8A82:ZOO016HB BV!9"RF(1?M>-Y-MCIU1ZYLQL]UN]O"RG92[0[B)UE
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MA$^YF>'TC!)*TS"=9 >R)>.WNX&< '-5]]-VZ=^4C>:2<Q2R9C5"/;7D6#8
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MTM++L!5OSS6$L;K*;*E%+($LDRN:<X7$1!B*5CE>?\<_7/=R-5*,TD\\*NP
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M$\UDD6!5 $??3/\ 8[EF7:R9'<V&>8?C)=0].9E-8AO<A>VOD#BVG)D6Z?B
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M(SG4 0]C&^;/W.0/!'T_K=$'3>:J8G%,"SRZNRLI+?\ P<Z%6QY*B8.)%4"
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M('SX% ZRFVV<V^GEW':38+W[LFL4< T +P1J4<G$Y51+OPBFP:O%,O?'?2?
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MT!&")D[%Z0<J <Q6.5 P;4RBB&DM=]CVH\KA/5J*/WNF=Z[U[;2[1H.FRK$
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M:4R.-*0<%H7)#,URIOY5=LF[_"/7>S>[7;3S/>],L4J%5].*95+1#O !N0(
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ML23P<7R&UZ_,LQ/>29$]O=@ A1S0I1GSVWY.:U:>3(?U3% Q+R+5W<&0]E=
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M?8VG;3D$J:,ILMQ1[72#R-/C3GG-85P7#+#&][7?'(Q/GSB)-W<H"I*BMVV
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M(<$!?&5&.)(^!(EQBO57Q6.1/&Z'?[Z+:[DR&:0S%N_<;25FG!>^2Z'"6?\
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M"SE5<:++C-J@Q)8;>$1BE*9[V1%@&CG7BUCXI&.:YJHJ/;(;ZW9UQ8XBDA9
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MR?=2)QWN,4A22 RFA$14<,88B-"=C>#AJBNVY+OU\_VN^,<,O>OIB/;>@$
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M[WD<AVJW9?M3VO\ ;JKN8O5[%#JK,P5>XTN<DD_3'T^W(EB--S59_D>*^O\
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MCT+9CW$DY!-&\ CZ8U&)D#JZ#O"D%N^A@'CZYK%G_;MT\P\NB^#R(^07MED
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M$M@(V/<PY"X.5S9%8TE\'T=QS3Z5"MK:KJ7*%9!!R9$>",+FL5Y8T:;,<Y/
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M/+,LKQ.)&/E$8AX87[$HICGJY!2XSFH42JY50)$]/3[=D7\:79.J-'MO3?\
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MIS,7QL$Y^^VW6?ZC^(';_P#5/2&6- 6CE=G>9I@N!_$(!0G))6[S]=:O\/\
M2HMPK=3ZFWJS$AQ X';$S>YO8<$*< &OI6I8?3#[JLZT2[@\-TAC44(M+J'D
M%917H[&,1+>MC*Y!Q3P99$8J\8[E>4BL\94V54:B)UD?P_&^VZAO%97*H\TC
MNR,Q1E\*#C+7DGZ@\ZUGXLV,&_Z+'N!*>[:[8/$$D(!<T A48[:S0^,"AKU]
MX^#&ZJMEZ@AD3'PV0)ED<,<A)0%5R>29+'&&KFE.GA\>PD]<%5&HJJG7U?HF
MT$I_,1V'9J])\"VQ]2<W=CBJU\4ZAO)4638NJ*(V2V50K'L  ]P^?K?U^2FR
M:YX8>/BEU*NXDW%LR.6-5O?4D&$L]CGMC"ED.B?%.IA[ 0C4W*W9'-W5>F'4
M-UN>G;UMEO8UG+'*1]@5:(HV";^1]OWU'MMH=S%))MHW69."[98"B:^21S1Q
MY(&E9G6END.N=(2KSG&,>S2L4"*KS("4H4&]Y@>$\<BN$\)V/<-Z/5$*B*B-
M3UUV7;=-ZD+>*.4D8>@#GQ]>#_8SXVN^ZATU[VTLL \HP]M_OXNKU4UW/?34
M[,Z)BQEQZ5AI,H+*+4EH&%(.-=HSY1["PB^(HSPU*<+DCHYA. I#1(G!%ZQ?
M7.BMMX?R^W)FA/CL ? (OU1GSXXK6TZ+^).JSS=S/'(3F42.0)<_XQP!]O'V
M&JPS?2/M<AFCG:8ZUX%?3<=6); K8I5$3^8\1&DF1XZFD#>\+2FYJ%4\8G[*
MNZ;X#9=+>@PCE)Y[^RB3P: %^+Q@8\:WF\_%>V">GO=KN=HX.25'IX//<POG
MZ4< ?6-^?:2]PNC5A<Z>VF!6<"*&WG7^09XQ9"5&0RGPDARX&+.>) 6 XH1H
MQDA'/*Y6^0F[^'5\].VR[-FW*.HBL0 ("T&.9F-,HH8K.!XUY3J*3;F+\KN8
MVC<5V%@ !>.+-\6<8OGC4?,-[K-1ZNWKUFJ/)(^,6$RKJ[.VJH9<AH2F&6.*
M.![AC?$*@A\127(Q5\KG-1'-3=3NX)-O#/N=H\RPF+TF0.Y5O_D 7 7/QY(^
MY:10[?<NT6[&W>2/_DE%NR18[EHALBLWD57(&MRA;#5.-9Y19.%*F799#9,R
MYM3?)J9%<=728T0#R(.4LF,7SK$3[E\7)B_;MU7V6T1T=YF"R@#TWY8G.,CR
M<FLYYSFQN]Z89Q#&DRI"!_!6/M23P0S#(&#9LU].1)/M(["9/<EAU[D6/97#
MHZ"MF,QN7*\,YLF1?1D9(<E<Z/M%<]SW^-IC.4;E14>J;*G6GV&QD@@+2)ZC
MM^A3=-\43?/^?[$H.L]:6+<K%==R@L@H ?0FKP>;'@X.-/+:_37S"LL)]9ET
MNNHVVIY-12/MR)Y[UH@KXI)9T!71X1%:/SMC2>+N"JWDJKZJ[J.2"8!X_3:<
M]H0 TH^1CZ^1]_J0=42: /MV,H0V>Y:HYOYL> ?MX&F>U/\ IZ:RXI45N U]
MYCU[1VAB6,_)AR7I&K:QT=I20&15:IGNC/9R0JJHWNW5-D:O5:;=[;;@HVWG
M$T:,!V$$/?DF\8_SQJSMYXMR_K=S1T?T/VU>/)(P:_87R=6H]BV9'T@TZIM'
MQ5T(L>-(F'D3$E@? OU>U G/ ,)K7.,[DWYD?BKF(J-WW7T]V,6ZAZ%N>I)&
M\\#'TI(BKF:#O%@L5M>T<62!5<ZSG6/RN\ZPNW9I(S^7]K,@JU-X).0UT&'C
M/VJV[V-.X&A>IEW;4=)^A8GE=S89-#D1I*J.);V1"$M&$1KE:]SU(\H$5GDX
ME1$7=O6.FW\DA"=K22@=J8 6EL)8Y]E #QB]:S80":%#*W?$B*#XX"@T17 Q
M\5D#G25[+-,B=QVONB<9AZZR@GU$IDF-F26.EV-95RFV=LY( D5Z)$A1#N60
M5!BXMXJJ<57J_P! Z9O>H]7Z:N[-SG=I*J-5M'%ERZC [45RO-D GG$'6.H;
M+I?2^IF*-RS;5XUE8GL5Y4[$[39O)XOD$\ :]Z8&-&$0VHB-8QK6HB;(B(FR
M(B?LFWX3]DZ_3JCM  X  %? P/Z:_.1))))LDDD_))LG7;UW7-8<N,&9&E1)
M#&$CR0FCF&]$5A G$HRL>U45'M>BN&]JHJ<5<FVW7#D'ZC_/1J@;7[#;C3N;
MG%-C#  M,=L9)JX<MBH \"-)$<+-D5$:"16->@GHJHW?FU'>T56@B3>,NZ_Y
M2L;)& DH+*X'R&- 7]^#J]&G\->T9 !!R2"0*^Y K'^M:C9D=5C=TS'M7:>U
M!2Y $$>ML;(#E)&LZUZN;^GV_C16$!'D<U%((S>,YZM4C6KLB\[5II3#M33Q
MR%@I\Q ^V[) L"\?75R*8I$Z;@AU. 30[0;%#YH?:\^ #IQK!MO+I)UE'.$\
M]J0"U@QF_DDV.Q6*KP+L]I1.(-_!.#VHU=TWVZNRS"!(P%"RQ.>_S9JF)-<#
M/@ZKQ('D:G_AV0E#':":-CSCC!^NE#4 @%<>(%!#%*<1]J!=G1G2I+>1>35W
M413?<NRHU$V1-D7UU$VX6<$3OWH$[0JC-&PI.2;-UC(/TSH:*2*7U%%!<@<!
MA9S=FK%<7G42]6M'J:GGDR&LD5M?7-E<[E\G=%43W;@0+V.5-G.](Q&_:J\E
M_LBMXI(NU(&(-C^&V2M']-DV*SX)\ $8+?:;KU499D"%>#W7YR<@ $_7^FFB
MQ0V+R\K@PZR*.(YT[XLF*4#1/D/(B(DD#G[J4)$7FPB*UJ_E%WZ;;;_B"Q#U
MU(B P?*K\W0-@6;)Q?\ *'="!E)0 ,>6^:^1P3^^!\#4S[F9"AMC49DDB<P
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MYF4LJ7D Y@T4DB!'GSO,=T5BM1VT<WI@VH151$1,]UKK.XZO/M8X[BZ9!)_
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M]-U?=LY]&(P[92+"EC3MW$W; LM4:LF]8G\<]>BFV$?3(13O.))3VT0BJ&5
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MR8;\0PRS=5B7822.RBRX8@8-G%U0&>:^^-:'HLL2=/F?>!-OM1(6<E;DE!P
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M(-R1,!(I#IVFP%+>;H\7>0 3@XU9S(@S6/B_N +'_P L5Q5?7#IK*PM:$$\
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MZ/[_ &\_^?'.J>?J-]D-SK/.B:G:>V=-16$N'"H-1VV<ET9L^B"5[(UO$:I
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MFC*1T:*K[*SM+.222*LC&XO868HHX/F$CH7F0X!/VRPP?A<F+;O!O=]/V(D
M+M+Z?<*C]'O<@*+;+C"FU\ZRO?+^))7:OR>WA!:9WD!0( >WM)](,Q;M';8R
M15GFD3-^YK7[ZR26.":80<O[?_I\8[)&'4S,Z%#"U8[FV1I@HMKBFGB%!&6C
MP C7D9:W!_C2)D-"+N8RR:T+C<_B$=/VL:RPK^>H/) D99(^Z@ ULWO%WV]H
M[3[B25 U2AZ&VXW%+(B[:V"[B618E)"D^Y%8XL8]QOBQW"K:M(^UWLGI],,;
MP.AT!P.%BF.U"5-?BN68L(UC&CQ4:.5/ER)89=C+E2W*X\VU(4J29#G&=)1=
MML[%/L]W/-U":)VF8$JLQ;M%?]/M/:*^$P:P ,M/_P!9;+MVNWF<11$L)MD5
M",Y%=Q6P+HD>YZ/SIN\CT*[1\?\ UJ\KNPBGR6+BAA0#3Z&OJ2#DUI/LD65=
M7NG-)/!!'[,1D=Q1HURHY43?IMMWZ/N(V_,IMX@87=N\R >T$A2WI^TM0 /R
M1C7H[WKL15H^K;OO9E]KF-:+$#)4RG%_'T%#6RTNT@^FWD-E-SC%- ,<B9+4
MR@0C0+"KGK$2W5B/%6QHTN>:A.=J[<QM56->FVW)%1%OK?A?:"#<3[,[>:96
MDA64V&[30(9;!O!4$@\8.IYMU^*V,L)ZGN'VP 62<,:"M1-@*I%?>C?@'+M9
M]K!D]E4S<?CU^$Z$Z/U,.9#O,FRVUKP&/7B&X,>%0U%?)8. QCF.\KY3=F,5
M&C"551.II_Q+T:7I\D0W!VDN/3A10W<!7^(%&%9JE:\>+NIMNDSQ[V.7TINJ
MR.Q/;%EBS>6PP!)()).!G.=03M^\+M;Q";CTE_=5318>,2U$M9IW79 V!:L>
M_P 4R-8QF5DN#8/D(UOG<-([V*G,)QHO6/'XGAV;[Q-HQW/YN)8Y&W))>+MP
M7A) [1\)5?+55ZW_ /#/6MV%:7I&ZCD5S(0=SM'[@,A37:>WY(!L\"AI2ZP_
M4UTQQFBQB;I#,9J$TX4%#4<>;5S+G();5^ *=*/ '%K*L,DS4G$:=YN WC\?
MV\NJ6Y_$4$T<9VB2K,A3OD)16*L+D86V.T7@=UXL@C,VT_!G49WG?J06(2'O
M]%6!"]M$BK )N_ ^2,$:JX[C\OUEUXQF?/U+OY*Y)BN0GC9?05=M GX'2Q+Q
MPK/&H]0R&4)) F@(1BS3EG&F*A57QL 9[4'5)MOO=M$\4\K1S2&.&28L[N1D
M?P[4BJKDC/TUJND;<=,G=-OM8UA](/ZJ@*[M8]DA(<'/#*5JZJM529'IU./D
MLVKJ8QC2(HUMY8XP4CH(,81Y;2*U%>\",C%>=1[*K6!3R,&YZHU4T<Q':FXE
ME:K;O*1&\X_2_P!N>;R;(T\7=1R)W2"1+( IG8'R?(XS7-_%<]F 7^M>!6F)
MT^&:G9AATN79FFF%CN06T($&-)/'57G#',0!9)7,(<D%&(YS$>+P(]ZHDL74
MMSMZ2&-70H=N%EC[SWT<VIC]G%L1P3P3KK[*"19/SD<#Q1_X6[75A7%R!V^?
M)'.K4= /J/Y)IMFUYC/<F^DR#'GP)*3,X_AR.'/9\V!'%)H(LF351V%L22;$
M#XTLUG%))44E7-DC46SYTZ[O-Q"\$S2[ER*B0$QQPW7Z(@'YR33C^EG/=1_"
MVS CW?1__:RN(6D(8*@$UW[2P![30N_=CC42;RJB:X3B9I2VDIU83(SVT^G#
M,:*>R%)M)+'U@):,:,YB))C2D1R"007EW/S\3'0="VK[K>MN)&C9XVE!B<>D
MC^E\VS,"><FQDT1RXZIU%.G[>/:-4;S5Z4\<(D@<X-F0,I%\'!.,?.M;6:?:
M-4606TRR@VU="@6=%-H*V2$\BODN\D-DX<TTR4$\(:RFC5J."ORT\JL)'\:/
M7W,=W-U.*':Q3F1VM70%VCC_ .N,K96O 8,#@XO,&V:9.GRS3S;<R(*:4]H/
MJ'(4+9P<9!/C&35VFB>JN5XTRCL;W/A$Q*51J6E2LI+:RQJ.,@A0F5TR0"$1
MCYL-HU,0J.^#!@!9)//"QI&HVZ-O?R,[/N/44K,Z.) %D]]BS8)]I!P0>[.1
MK,=9VD>XC[?RT;2-35&"UDUFU(%63GY^G:=(36[Z@NGV$R#5,<),_OZTK$=D
M),.I[2G@%4CE#%K3R+FN+)$Q$_WX"$ YNRKS141SQOQ/&\S PF$-BA.R75Y[
MF1KO)P / &,TMG^&YY=NH3<I$&.4-L5P!G(NLG@"LC)PA;'OOP+433N9DTVN
MLZBYQXYO/''CN-VL>2Y6^$D9:J5*, 4=[$YM&R0KA-7@Q[G(CD@EW2+LY-Y)
MO%/K;DH-D-UZ<B*@OO#A&[@?CL7[^-31]'W$._AVBQ=\4T1D;<'/:RC](CR&
M[A=DL" >#9UB:8?5AT6R8C,%U'P?QQX[HD&KMH=)3O:\45FQG%CLL5DQB#&U
MJH*-(*9J(YK8S_35BVW5YT,$NV3T6#>V0/WFK !]ZDD_4$>.!HW'X:F E*S0
MMW]UQ%BMY-T;/W&.+N]3TR+2[1WO,Q*%<:49O2&Q56D_4H8ID=MA#L"@&A8[
M*R9#9:5\D[!N&%\9Q'([GR NR.6[U+;;?JX;>3S!=R%HP,H21V HL#W4>XY%
M*+\#2C9]1WOX>/HOMF:$2&IT!?M%\=A0@T//<"?.EUV5_3ZQ?2_5RPU +99!
M80\6DQ3U]?<("3 +<.CO9$/%E ;&89(/W2)#"06D'(4*$*1[E<UM^!NB-)O7
MW\\92'9'LB+*6]:8CM!!P%"**-!K8,;%XJ_BS\3/N=DNVA9"V\]\S! DBQ^$
M- G((!R.TG .#JZ4;6M8B-VV_P E<O\ W<JN7_FO^GKK[$!0 ^/J3_4YU\R_
MF/N;/\]<_P#Y_P#/_GK]NNZ-'1HT=&C7!S.6^Z_G=-E153BOIS53=-T5J)_H
M[[OQ]O1HU7_WC:4JL-^IU)$YK%$.+DXXS"/,X3G"!'LE$)R;O:CFAE%X;L$T
M)=W+RXK]W!S*N3>17^N?KX\F^=30D!J)H$9YQGD5^U^=5:9Q97%!3DLJJ/'E
MV '-D#BRE<P,J*%%>>.)XPJYDI1*A0(\">141BN3^I5C2#VA_8#\'N.>2 <C
M[XR,U>+VWBMI%/N)#,I^1S0^/L>+-9TE<PF6I:V/F %G6%=_#AVW&(">]Y[4
M,M0[DBKR>,$N$-\AS$9OY%9XT0?YZL0R1+$Z2*A;U4>&;TBU*O ;W@60:[KH
M$C&HLE^TKVDX.2PS^P O[ ?'.E!@^-8C*Q6L'1L60"16J*),GL>ZQ&!Z*]H)
M3RM$1S@N51HCT51JU417)T3S/N8_3D(*]U@J, #X!^P%V#C4BJL19E)+6<DT
M?OGQ]K''Q82%302)%=9X]>5PXZQK0S!*B#".4'RH0,O@[[B/1/;E8J<U3?=J
MJO5=(XX94(]]I=55?8^X'P1X^_.O9<R$DFB2/%DWCY^@SBN/C3MLQREL*IL>
M3#&510UB/1L5-W*)NS3AF%:QHT5J)Y$\O)R\FI_2BK83<RPMWP2M$I':RV2&
M%FQ_A(Q@ #Q\&M1.HPH -UD&K\V+P#SSX/C38Y?7/!/H;:BH:"PL<8.$@_F0
M4+*+'$BH\ "M(PPW$:BM1PD14_.[TVW4LGK;Y&]1XR/<2"I O/E+!^['!O Q
MJ[!)Z>TGC8%A(O8/!2R3?U'/M(&#^H:7V-YB7)::_F&J"5LLG($6K&PI/(QH
M%%(*D=Z(QB(17,3=/_MHY>3W*Y;TX*)( YDL4>X"^,9\G(X \$638IA.^2*@
M?9V@&_U51H_ !JQQX%#.HMV0J>AN,RK*^SATQ+NH8>3-<=HR0;U0K&K)')7O
M)#<%X5))&Q1O>)S.(W(]%ZS&PE&WZP/46HV6@I)%ELXQBK/S9K/G6BG1I]E'
MZ@ =5:V;W7[F &2/%#S8OG(U)ZO'$QFJ=%2!')?7E6"YMW00M2':2QQ(H)97
MR5$T))QD$,0TD#:JAXO_ *N3$T[AT!ECHHC,W;QV@L6(O(Y/Q@WQI "3.G;[
M@+6N,YR/BP#S0.;YS&/*TO['*\2;#Q>)94]D2P,'+:1DL\BE/6R7J-DLS6$2
M*9P(M;%>W9PT>DD;&.8/=]W9[S:2;'>;II1ZZM2PM[PY5%3VDD!<WCM:R+NB
M )&@D1EC8=ILD-@_J/<3VDFR :LG- \4-;_5W3S"=4Z*+5V$>4RQG("5!))C
M2VRZ^W'%:T9#A&K^(6%*P@QN&Q[U&YHV[M7CE>I=)?=;8;M$"EJ()(JKN^T>
M.?D&O@#37I?4FV6Y[>Y9(T;W(?;9(&>X ^*\$?4:B!J_CNIFC6 XUE<?'29T
M&!'6NMCV3TC1V8W$&ULRQBU'RFSTLQQR;1G-><B[%5XFJU43/0)+T^>/</((
MG [%D5;*V3BNXJ:NZ(^EYQH5DCZDTZ1@(\[6$!!KVC()"WP0<"K'-#321>X+
M$-0*.&F.TWZ.Z+XTEK:3$@B 8+%&]LF5)$JH(RJ[PC8UTQJN1?$]$:JZ-.N;
MMX92)49P.Q95CIB" 06%GW"Z.0*_<Z7_ / VV\JK)&2M'@D6#8/_ % 7]S>0
M+\IR?W%90W(8%-@6%6-XZ5*A0;*[QUAKI8L0TAD="H0B^)SD>JHK7QPM(Q/O
M<)45.ED?4>H[B9(]UN;C5NZ*X^T]]\#WB\UD7SD'&KHZ-M(XI905CQW$&BQ:
MOT\WSG&/GG4T-8H.4U&.X-"%<1,9KI<EDZ^)"(\%G(/%8R2&O<L$:@A-DR'?
M^)A4A7JQJHB>U5-=L.M].Z>-P=Y#-N]]N(OR\;%_42$,,N%*'W#-"U-6>XZR
MHVDVZE=HI/31,FUL$BSQW"_.0<><$:;:6;]:>6-=%CM>]?/$?.F2IP#<A[>.
M.,<E0@\Z_AKR"<B*BJUJ^E72OMHK=8IYE86%8-$(W?/<!4EJ.0+48JP,BVB2
M$*K2-'VDCN4@!J-6<*;X\\#QKD?0##-2,8E5&H&'0F0[R#(JGQ4(DYLV(1KF
M".-%D$^*1J_S I'>QX7JA&(KV\NJ DW*L#MI'8@V[D%:OA>PEKY.;%D77%VG
M:,QF,NT@'ER#S@#Z?USR:TSFDF495V":HX]I'W!VE]D';EE#G4&ANL]FU7KI
MO86RC*/3W4$SVE6)">U$'3W)R.AL&CD4G#S>+81O*W3F1 JF4*TQ-!F95(!"
MFBO)X)^FLO([).1EE[B #CM\<D$D?L"2,9YCS]4#16\T/UDPCO\ =#6Q&W.-
M7-'+SBEA"62VZIHS6M'EDQK7OB'KY(',I;7@YJ2*X\66QS60SO(=/ :-MNZN
MJ*,LY/:6HA:7'-F_=CBM1S+8[P<C) 'DUF[.!FCCZG@:?#NZU&H-;>W;0#Z@
M^B,4-A9:(9;2YOD H<A&VL/$99AXWJ7@ED7Q&>"1&68*5,4S4&&HAI8BC>"2
M'EV% \IVT[D;=R0J* ,H13'!NL5^FA=7R!79%25&(=0ZEB#=&NVS],$5=WGD
M#5K6$Y-,N]-,"RE]I5%L\IKJ:RJ+"M&:PA'I[=PKZ)$"\HB$*:72"6.\Q$&U
M\DHD8GWJC+NX;:KO5*!A$(A$B.V>X !G#!5_5C #40<\WQ3)+&V.X\,Y.?D6
M*-9NOV%D<V\]FG;_ %P#0M>LEIR R690%I,,^8QPY%?C]F8$ZQE.B._E /,/
M'C"CO:CE:$)E:YP9'%2%6164GN!;O5N+!'%6QQ\WF[K5<DTJD?H[AG).>"?@
M<?ZZL68S@FVZKZ1/RNWK]_N5R[JFW+W[7W^57J77G7/HT:.C1HZ-&CHT:.C1
MHZ-&N+F\DV_'M%1??I4]I^%3_P!=O[HO1KA .#K0Y-C=-EE!;XUD,$-K1WL&
M16VE?)1WBEQ)8W!,%SF*US$>QZHCFHCF.V<UR.1%3PR!E[2!VGD4/]01C^_@
MR1R/$ZR(2K*0002/VM2#1&#G(YQJJ?5WLQ!I==S-0=%07>4_X6-7V6G=M+_6
MW":=&-B2:=UCS&B2#L%'D/FLD$CO,>0*8$:^!N!_$/X>7>[O:=NXF3;AU$Y5
M4:E8CFBMYK..<_&MMT;\01Q[6:"=(HYK>:&7U)45FC4L$9>Y[+UV@_\ 6XH&
MCI,Y51=M?:5A1M5^YS+*#)LPH80/%@>-OBE?3RK0X7? K:-DE;4Q"3R-67;$
M%#0;PJ1K7QU<$E?<Q]%Z%LGVN\ZA+O(WD+0[%2@1W4=]/08X(#*#7O ' S9@
M;K/XAW4+=/V";9S&S2[YRXC 6-F/O*]JAE# , U]V0#>H=9Q];?L:T?,/.#Z
M5:E8%\F?!EY!=5%+CH[2ZCC:184.>,MNR18J>&QAX45I7/4+W-"XHWL-TJAZ
M]'U+?;78]-Z:\&ZB"R+Z<Y4J&)),Z_E^V-%4%PQ=KJB 3JYO?PQO-GLI]WU#
MK'3G5X_T2L6=BC"UVY.9'- !0BCN)&+.H#P47ZLV2YAWE=X>HS](.PC33-(=
M3I]V_P!LR9#S;41\)\5]58:IEH([VA@R4E1Y8,<@29Y2N,\CWBCQ5FV#7JG4
M-CTZ200MMFZK(BC=[O\ YA5<6NUD\2*/:Q'Z19HF[4;/I_4=W)#MI-A(^VDB
M>6';]AB9U[6*23"PY4,%<+R2H&%R/1[HT?16SQ_"['0+7#"V:;T-+!@4V$UD
MVL6OJ:6NB,B1*R/75T^FM*T488QA^-;191$7='#<JL\=:%-@5AZA_P 3].7N
M9I%W $RO88'U"73)+ !PM76+K7F9=U%&VPW'1'[U+*)XHI$-9(I;86!FRXL#
M@ FG_E99*EK&.. "04D8R0LBQ4J3(;AIMP#,KIP1L!((FZ.8Z1NG%'H16[JV
MY/U?92K&8FVS2 /_ !(I%0T$:SV&-@2 #C]N2-+UV+JO;))+&.\=VVG5@C@M
MVA6 8&E8]UB[(SR=51=Q7U*M!].?U/$9V3Y)E.15MF?RNAUF/7DFKD*5['P2
MH']-K8489!N&YI;*48+&HCE(OY^>]2_$[[N23;;8R^DBF(R&6,>H5(-!?0&
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MRF+8S*J)7@&%9'RZ]R&:.N*)) 9I2QX3WN&*/+-)E*,-D0MLH)=[%)+MY=F
M>[;/Z1>(_P"%2PER>; .?\)TGWF^+;@;- A$_P"K;^E4BR^).WN'<+QV^W.+
MYI@=:=64N8::;XU-+B6E&G]<*KH,=08X3K>3'3QDO<EM7I83;>QEE$]SXIR^
M-PMFK]SW.6D.H0[W\QNM[;2RL'C;L[%C XL"^\FN1V7=$#@-HMG/!Z9BCD>2
M3/<R A>+M"<FL5W"OKJ%V2Y++R"NB1,7-%;/5K(" FR3# ,B.4?R%-/$R) "
MY%WV:=[6-W<QB+OO!U ;;<!=T[L=NN"50(V+%]O<21\FQ]AQJWM6EBFF4QQE
MJ-(8>T C_P#2SQ\#YY(U)^D[4-5Y6B%MJ9"#%L:^MLO'+E5"2K.I,"(S:5(2
M4N[GQXI$:[R/$,;]MT=QV3I6NWF>,RA(Y-LOJ&,2*R2N76@2]N4[,&^Q[P,
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MZGY#3 # IZ-JC5IR1V)9DBC+=A6V0 ]YP;.:KZ$9-Y^E4?"2LBL$( 8YQ\'
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M!%(E(CDCA_,E[6-:KFJC&_A.F[S1@B;<E%B:J[*I >2$S=G_ .0/R:&EY)P
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M8T:[.C1HZ-&CHT:.C1HZ-&CHT:.C1KXJ[)NOX3\_Z?\ )%Z-&OB.WW7;9/\
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M, [X3G(UHR.X^03T(YJD14797;]0;2O6*D]H)++?^'G ^E_.*\?'N1A(BT;
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MCW)NUAWCN\L$99FL-V@$#R,#R;\_7G7/S#BNRT%&P#B_'\AC[?SU-:!V=Z2
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M'1HT=&C1T:-'1HT=&C1T:-?')R14_O\ ]O\ /_5/RG^?1HUU*)=_2HB*OO\
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MIQWW5?\ 7HT:^*5J;_G=-DV5%3=57BU-UVVW=]J*[9%=NF_I>C1H4C4;NO\
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M3R'?Z;Y)C%)6S(MEBAZ''&0687E[+B761JV_AVTZ.C8SXUL0B&7KNN?>N/\
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MRR'C48=I N+5"MM9U4]'>.H-9^8SK!*P<4<QY'$D#(15<IHUEZLZ%XP[MCU
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M:4EI-.\6JWZ'X_88II"Z%6! [3S'+JFK,<MJ?&7(BK70[&CKZVKEC%LI8<$
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M84T9WRL=C21SH]2WQ,%X(L:6(4B*@>#XIAL(%[',:J&C6YP/0+1;2[ 9NDN
M:9X?C&F]HMDMMAT"FBNI+I]R'A;EO8LEAUNY%F)J"G2;0DN1)&C6&*]K6HTT
M:1>F/9QVMZ,5V6U>E>A&FN"P,]KG467 H,;BQG7M$5"M=0S#D4QDH6H<OAI
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CCBAP*^'&A0H@&\ 18D4+ 1HXF;KQ&$+&#8FZ[-:GOHT:_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g68105g59m99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g59m99.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1OP4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &]2^<20X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              /(   $D          $
M                     0             !)    /(
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   /(     4F=H=&QO;F<
M  $D    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   #R     %)G:'1L;VYG   !)     -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ A0"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M6.][SOU /\VSZ/[OO0_^=?UG[]8R_P#/']RZQW^*'-<XN=U>LN<9<?LYY/\
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M^]S['^H#54&U?2I^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         /_A/_QH='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(CX*(" @(" @(" @/'AM<#I#<F5A=&5$871E/C(P,C M
M,#DM,C!4,3(Z,#DZ-#(K,#4Z,S \+WAM<#I#<F5A=&5$871E/@H@(" @(" @
M(" \>&UP.D-R96%T;W)4;V]L/E!38W)I<'0U+F1L;"!697)S:6]N(#4N,BXR
M/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR
M,#(P+3 Y+3(P5#$R.C$Q.C,T*S U.C,P/"]X;7 Z36]D:69Y1&%T93X*(" @
M(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,"TP.2TR,%0Q,CHQ,3HS-"LP
M-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I
M;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @
M(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS
M+R(^"B @(" @(" @(#QP9&8Z4')O9'5C97(^06-R;V)A="!$:7-T:6QL97(@
M,3 N,2XQ-B H5VEN9&]W<RD\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z
M1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T
M/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O
M96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @
M(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<]
M(G@M9&5F875L="(^36EC<F]S;V9T(%=O<F0@+2!0=7)E5&5C:" N9&]C>#PO
M<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z
M=&ET;&4^"B @(" @(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @(" \<F1F
M.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:3YR<C(S,#<R.#PO<F1F.FQI
M/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E871O
M<CX*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M870^
M"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL
M;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]2
M97-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B/@H@
M(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.C<U,#DS1#)%,$)&
M0D5!,3%"03A!1$0T-$,V,S U-#0S/"]X;7!-33I);G-T86YC94E$/@H@(" @
M(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX;7 N9&ED.C<S,#DS1#)%,$)&0D5!
M,3%"03A!1$0T-$,V,S U-#0S/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @
M(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z-S,P.3-$,D4P
M0D9"14$Q,4)!.$%$1#0T0S8S,#4T-#,\+WAM<$U-.D]R:6=I;F%L1&]C=6UE
M;G1)1#X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR
M9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS
M879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M:6YS=&%N8V5)1#YX;7 N:6ED.C<S,#DS1#)%,$)&0D5!,3%"03A!1$0T-$,V
M,S U-#0S/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z=VAE;CXR,#(P+3 Y+3(P5#$R.C$Q.C$X*S U.C,P/"]S=$5V=#IW
M:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!
M9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!
M9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%
M=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I
M;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI
M:60Z-S0P.3-$,D4P0D9"14$Q,4)!.$%$1#0T0S8S,#4T-#,\+W-T179T.FEN
M<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M
M,#DM,C!4,3(Z,3$Z,S0K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#
M4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO
M=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A
M;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T
M960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM
M86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS
M879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M:6YS=&%N8V5)1#YX;7 N:6ED.C<U,#DS1#)%,$)&0D5!,3%"03A!1$0T-$,V
M,S U-#0S/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z=VAE;CXR,#(P+3 Y+3(P5#$R.C$Q.C,T*S U.C,P/"]S=$5V=#IW
M:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!
M9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!
M9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%
M=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @
M(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.C<T
M,#DS1#)%,$)&0D5!,3%"03A!1$0T-$,V,S U-#0S/"]S=%)E9CII;G-T86YC
M94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.C<S
M,#DS1#)%,$)&0D5!,3%"03A!1$0T-$,V,S U-#0S/"]S=%)E9CID;V-U;65N
M=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/GAM
M<"YD:60Z-S,P.3-$,D4P0D9"14$Q,4)!.$%$1#0T0S8S,#4T-#,\+W-T4F5F
M.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/"]X;7!-33I$97)I=F5D
M1G)O;3X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S
M8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!H;W1O
M<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W O,2XP+R(^"B @
M(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-;V1E/C0\+W!H;W1O<VAO<#I#;VQO
M<DUO9&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^
M"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ ]P$J P$1  (1 0,1 ?_$
M !\  0  !04!               "!@<("0$#! 4+"O_$ & 0  $# P($ P,'
M!08.#0T   $" P0%!A$ !P@2(3$)$T$4(E$*%18R87&!(Y&QP? 7&4)2H=$8
M&B0E)B<I,SEVE+6V\30U.$9B9&:"E;*TU.$V1$5'2%16='62EJ*C_\0 '0$!
M  $% 0$!              $#! 4&!P(("?_$ %81  $# @0#! <$! @(# <
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MJK;X7AU*C<]Y]*\%4O>T&D64J>6BYQC*9,M!@DZ&3*S#J3'5JA?3#(@2-G2
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M6BL ?77-:) <^G58T.J!LYLHR-EQ[@TU!DFY-I:P'.IL&8'+D (Y3,$@;@"
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M0ZA5_:#B!IHT[^[R^N<2?!Z\2D=3PF[G@],$0J?D'\)Y_EUZ&/8;/_.Z0_\
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M '+?PZ)Z+^,+_B.ROL-QE]*KB^#5VTZU>DQK&W%*L"ZD_*USI>T- >1E!<1
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M5)@$W5U_QAN/R59C]LU:YG6G7$)C)K=-I<.)4WF$)"'"B6TVPM#X!;2X2&G
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M4!\XMI96^63S)Y9+@/,MX#F<;4YET_POAK[8K&J*%<.,0UH:-X:?9;!!.F@
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M6YC%3CRFTIZJ2I#7MB'%')0 A025)4/= &,!<4[)U0TZE"M3J[Y*8D:R,PU
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MU.?7NPNQ3N/P_P 6W:+3*-#JL>31)LI]N6F2E#CYGH0D^T,E'(I+:6>13B2
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M: Q$#+7-NZV?E@%[<S7,+B!+C3[V29R@NRQ)4Q !63[H 'O 'N<'L0.V$\V
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MO/Y//\IOSO*YO+\WE'F>7S@+Y.?/)S *Y<<P!R-$6YHBH+: (XA-YR>QLC:
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M*\J\BU[4N"XW)E)IZ*/2Y515.K;CK5(BIBI6ZI^>XP0^B(D)475-$N@'"!T
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MP:^4%]%C7[S\"0A.%X^(2#^9P_JT4KS??%B/]T+XH3WSN1/.#V_V+%]-?07
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M?Z39_KMT\]/Q6(R.Y!Q\0QQ\Y$@^[YK)3X1&?Z/K:<<IP+?W*]",8L2MD')
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M&IQHU496ZT8CKC9-]?CS$^8^?395@HVW5-X8;49OVKN,7AN;7ZA;=G0ZI4I
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A&"(E 201CM@]!W^(_BY]0.G08 ]2*/1$T1-$31$T1?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g68105g59p99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g59p99.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[19B4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %D:^5P(X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              <0   1#          $
M                     0             $0P   <0
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   <0     4F=H=&QO;F<
M  1#    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   '$     %)G:'1L;VYG   $0P    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 0@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MU]Y'8_:P^QXC[/[7Q:]^ "W[+<]X
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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MF%4;;=[?WUM#G<]E[GOB4K[GK[3U]7=:WU=?5KKZOT]6NO\ 1D')&,$CO_\
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M+,0VS >*."=WA)$RB*3,8V-@="U8<S^ S9AGCMY!E"5EE>..($!\E'>:)5F
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M84A!F K==6,IQ?+X>GDGTFU2<EKFS,VFW1)!8W&G3/92.V.AYQA$X(Z,LBL
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MXI-@(9L*"1W+/A^_OK!M1@:WY*FZ C=W65O4H!<7&T<HQC;$=R[Y4WD%5RV
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M6A,<DD-[+E(3%;AUB80#E@5NQ<57EO%)#!8Z7"DDT,I$5O/'CD7-M=11]FZ
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MY86UO^#O9.7>);\^YBF+6L4*&2*$O+=(%A)3$DI.#[%)+98[R\N^;9FY,%K
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M\,XD8]\6C:<%!]GKNJ2$NONW16EK$>O4"YZ=[5W3_!>'@.@DU:_)/\KU73D
M0_\ Z9+FXD&/:;?)[A6A^>05PJ8I6Z<9T^>D/$SW1HE19X94'T58R@@<<\=.
MG7!7&DF;QS-3TW!66X4Y%M; DK20[83@I2:B503[\:V,*,D/;;CCW"?AW37C
MU5&C/,UAKAKJY"P>M*MS''')##/R=RP@1*R1OS ')8EN@':37]1233&#CEZ2
ML"VUL6F]69K>261)9H><%:4F5@SIRR5 48P<V; ?*><UP-.LM/3QKP/)>,_#
M1G!!-I/J=S:N0?'TG0;SQQ+1PL[$<B12BDR<!?Y@IX";&EX 6P"0]@BX6/DP
M5/OZLO"MC+/%.;K45Y-\NHB%9H.0URES;W2.8WMGV[9+:-0T;)(8B\;2,K #
M:CXGOHH)(1;6+<RS:Q,S13"9;=[>>V=0Z7"[MT=PY*R*Z"14D5%9239<9\LW
MTL($D]VNPO&=>8DN+H'BXI,23S4U.NL5:7G)JLVXGD4CF@GE:2LE?)L<PQ$Q
M<M?#^/! 3'!$43;:E]UJ/P-H\BJLLEW*5O)+P%Q8&,&9(TE@6U%B+-(I!$C.
MZ6RW190QN:V5XSU:-F,:6T8:UCM2$:^#D1,[Q3&X-Z;II(S(X1'G:V"G'(KY
MYTCFNVT+C3FWBN'$@B*[SW$4F&N9<D(<_,!"T*\1M_AG*Z2-)""!$/S46.Q)
M+D )5M^.6\P.T(0I!;?DMQ80W-W87DC2"73GN'@"LH1C<V[VT@E!5BP$;DIM
M9"' )+#*GQV"]EM[:]M4$9COTACF+ABZB"=9T,9#  ET 8LK@J2  <$5!F[6
MI4SXYHTYR=R#1^.*T.LNPWVW5VG0@R$[5MZ5LDN)#@IWK6M]2.T&-[<5O_10
MC2EJWI*=[U1<W$=I;7%U*=L5O#+/(?<D2-(Q^%35UM ]S<06T8W23S1PH![6
MD<(/VGK^BMB^GC>(*[=*CE%BGOM$4#C8J"X-XW6,K2@G>/\ @JMQ/$M6D ])
MTE&FYV-J#=B?6E.MD&RY1;O=/$.K5S.'K>2#2+0S@BYNA)J%T& #"YU&5[V9
M6Q[8WG,0]@6-5'0 5T==G2?5+H0D-;VQ2QMB/FFWL8TM(F'_ 'B0B0G^,SEC
MU)K4'.U7(JY^ N=[WT;N1V>5.-701K@)4>1J?'G'>%4[BQ>3./K-QQ+R\81"
MRL+) V"(A[2=)5N28/1J-GA8XYX<U@=P-_1U'3[?4[4V=T&:!IK6=U780YM+
MJ&[2-Q(DB-$\D"I*A7MQ%U!4D,-VPO[C3;CUJV*B80W,*LV[LK=6\ML[J4=&
M61$E9HF#=F0*Q# %3>-$Z??/M(J,A4GRH&^;EYSEBPRUHY(U:K;<961YCXC%
MX6LZI.<)MC"CVP:>&PY Z+'>=#E4]]-=DH_2(Q.A<<.Z=/.DX62WY<=G$D5K
MR88$6QO3?P[(Q"=I:=B)-I 9.BA6[=;L&OW\,+0DQS[WNY'EN>;-,[7EH+.3
M>YF&[;"!R]P)5^I+* M;$$?+ ](-ZQ14^SQ7T?HX:"HM\X_B*A&0_+X- $A.
M1)D6=GF"*4QS0F FH@8YDMJ#H=@#EN+8:*DR8$.AI@PX2.B>8."M-Y3QF\U)
MFDN+:Y>=WL6N6DM8S'&1<&PYD;E2IDN8F2\=T61KGF-([](\8:@9%D%KIZA(
M+BW2%4O%@5+EQ)(#"+W8Z!@0D$@>U1&,8@V*BIKWTB.GUS?THZ]PK5N7QJQ-
MP/"3$8Q%Q Q7(0L);?!4/ UT9ZRUQR_DUF&?=K]>#B#'.,(;COMK#YA1.G)-
MYLYGI:9PYI^D2ZA-9&6.34&=G<BV:2#?)+*1%+ZN)9 )96D7UQ[HJ0H!V J>
M?J.OWVJ1V45V(GCL0@1%-P$EV)'$#)&;AHT)CB5&-JEON!)/;(85;TF^D;+]
M*#D)CD>>XXXQXSDV8"*KFX3B<2\1=4\&P;/8H5@&$NE[O3=>!AXE D)$0%5>
M@JM$1  8<9 B:;6MW;TK3$TFV-K'=7=VID>7F7K6[S;I#ND+206]OS6=RTCR
M3"29W9F>1LC&IJ>I/JEP+F2VM;5A&L>RT6=(MJ#"!4FGGY:HF$2.(QQ(BA4C
M7'777.G7.IBE;Z=)QC7&G1EZ%7!2]Z\,R-)N?2FN25*[M8DCT@)B/C:-&I2I
M2ECMIXHXVI5AVWW#.GG;2X]I#C7>'W/'M*/K6JZ[J ^8EQ!H\'3&4TV-GN'/
MO/KMW<19ZX$(&<Y4=W4\VVF:-8'&YH9M4E]X:_=5@7W@>J6\$GZ3*>\ $Z%Y
MY#7"K8I/2FYC&Z/4)T8X6RF5GBZ*MUWN,D'69:RPIMS+O@%7CY2)O#0<\B"L
MD!'M50%V%CBH-*@B"Y-QX@K1+:&.;]J;(ZE)JLD2RW;P6\"-*D4BP+;/,Z/;
MEH^9%(QG82,).T%0 +@YZ/VUO%T]-,25HK5)IYF6)Y4:9IUB5DG"R<N2-1$N
MQ3'V26R3GIN!6?E<.D76;4W<FZ!P+,3@=VOW(D,3-4^Y/O5RX<@G<9R!\O7S
M@N1 )6-W$O\ %5>9C0VY!0$C%R%B@K<+:(*75&L<27@W3)83!ZSJ,<;6]M:R
M".>$"6"V6[14E5K9D?F"\E+MLW*ZQ20&&2,,>Q%Q=J,4W.]7L))!//<H9(9S
MRY[AK5B\96Y5EV&TC"KN*LC21S++&^T=]+^5YZ3% $H8E9JO$HFJ'9+S8QS"
M&>7#I:5_*%&6:*L,"F;+Y>=EZ)7'6+260F,X?.XU45)1L#*2Q$F?#B$)Q/P7
MI5R;DS37C>LQ6\14>I*B>K/"\4IC6R$=S*#"%WWRW>U'E1 BN168>+]2MQ;B
M*&S7U>2>0,1>%W]8659(]YO-\$9$I.VS-L69(V<NR*:HWCGI\<O<;\U\K<_,
M57BVZ<A<KRN[$5(<DUZP7=RFVH>3>E(6T4F9EK:NW#2T$X^X(TBQV6S1=@C5
M>#[O&VH;K;WT+GAVRNK"STTRW<%K9H(E2UDCMQ/"4"20W")"(2DH 9N5%$\;
M]N!X6ZUHV^OWEM>W=^(K6>XNW$A:YCDG,,JL6CE@=YC,'C)P.;+*DB]F=)1T
MK25]YPE]XA[>E.D.N/.[TE*-;<=6IQ>])3K24ZVI6]Z2G6DIU\VM:UK6L[H
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M>A_\1T^17BO\=T'];O\ ]V4_.A]'_P"RG+W\/T[_ #[C[\#T9?D?C?Z+T/\
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M)$#-D3X(:D1T1K&:%KD/NY48C*LT$;1ES@]D#+%=P(1G &%!PI/5KN7((2N
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M0%Q($5,(0JE Q4;^6S%VCW=^QF+9'?AF7.TD&1A0L6[62P8C<=N\+M#;>[<
M![,9 .,@&NWD7@^D<HGPTC:%6#1,1&OPCO@B?/AVIR")FJ_828.PM!+;1*Q1
M$Q6(<M\5S2-/)9(#=4L \X4A%<20A@FS#,&&Y0VU@K*&3/S6"N1G^@]X!!XD
M<@MNZ#;T)&Y<JV&]XRHR/;U'<37@ =&/A\"-:A_ !9T:V&*$L.3EY$YDED)O
MBUH51:7WM]H>8;X;H*4.KWM>M19&M;ZI O3DC=SD[MP!R3D*H()YV<=.F>?+
MW>U@?8*P((@,!3@ #!)Q@<O&1GK_ ))!UZX'7O.?(5T3>'RHM,3."VFTC;AY
M6 ?<L]QGY@HF'F*I.T<D!Q]\S2F1VZK/.10S86A4L[C8>1UI4N!J0<SZY/G*
ME$.X-V$51N#K)G '4[U#'.>]A\TXK'J\9&#N;H5[3$DAE*$')_DG QCN![QF
MIG+\/!'TR#J ]EL#JX*_4>_L3=E,(M$B4=2[S"7) ).B"0FVPC6X?P..P#V,
M2*:>;,'#>='6R3 3D2,Y5>U')'M4! !)&T>1@'J-V[KDGN)Z])&(% H8]'1\
MMVB2KJ^#U'0XQTP![!TP8E+=%CBZ9&(#)<M[8J)C4]6QQ[2>EBB2:N08+E I
MZDL.Z=9AFS;E6X<YX=QLQA@ 54#'MA03Y$:[,7DRD$;,[=KDH#S!RFA D_E8
MC=@#T.3N.6 (B;>,]#NQG<O:/8.]9,K[NVH/7/3*_-)%<+%T8:1.M:ZCI?M\
MIN7!NLU+%$S4Q=*[:GZ7X[Q,D^X4(*R9;(CCJFU(R5T&_N-IT4J#AP0=.CE!
MDNY%/<,#:8U7LK&Z"3EL!@G"-+(X7(R[;F)Z@F@0^TY.0Q/4L&*[P?9EPBJ3
M@X484#H1LGFK5],4IBE,4IBE?RK=(3_;YSA_WO\ )?\ XTFL_&CTG_\ 27Z0
M_P#USQ;_ //ZA7W!PE_S5X9_]/Z-_P#'6U5!G@U>04Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*5Z4,&Y(3$4 R>S%O'20(;4F0[MAB.<)*:9;/?>3O2F61
M%+T0XZG>MMH;4O6];UUYLV<9EO+2)9%A:6Y@C$SG:D1>5%$C'V*A.YC[ ":I
MN&"6\[E&E"0RL8U&YI J,2BK[6<#:![2<5M:XW9;9941\B\JC=*&B;3J)ET.
M-" \GA1X_=,-D&;WV9VROA=UL>0>7N/G@-)'([GOG<,^S2E[?W8CF8Z7QKIF
M!!,O*1=96* [5>??L.I-'G%RS\BYA"HV'(->' VUI;EXQZ]PQ?#\+$06?39)
M7&XH@&X6ROC,2KS(9"S+D*<X(\N(<1,<GU2!$CKE#CD \W\+FC/L1%C@R'6Q
M92:AX[7][L+M2F")..=[Z[$22&9/7?&4*T]2D\,C3:S8VL,-_ CQ<1</21;+
M6[M7:))+FV@#@^KB7EO+"Q:2&["7 S&IQ)HGC6+3+FX>2SF82:+K*.&FMKA5
M9XX99""-^T,L<@P)8B8^C$5Q;=KM4@GY2)&.O71LO1B6K!77EH79^,[*XA.]
M[:4K:D!3<9KO?@Z5[E04N%WL8I7?ULNKR#9V-J9H8I=3X0U*0>M6C<MK_1[X
MP#)1M^V.^A4#9<[.1- 1&V&.%EBXNYQ%,T=CQ)8KFWN%W"VU.V#$ -[9()23
MOBR)(G[:C:"*_3P(J(C(CCCD27U8.)Y_3QW#O,(+*GRJF00XG2ARM;VI]J):
M*7I%BKZMMNC/-J*#Z_\ 1VSF6&""&#2-6F6ZT*Y667A_B"*,,UB7V!@P+%UL
MTE.+ZT.)3*O,A.2"8QR2RR2ZCI\1M]5@*QZQH\C;4NU7)RAQM:9DZVTXW*5.
MUQC.<PT"8FYB-X_OLBBN\T5;0;W$G*8I7<Q]U%96EV#BI69;4K9"BDH816IG
M6].BO;T%((2]MY+TI8I[BYCTO4Y1:<0V+1MH>M(R"/455T:TAN+A9.T\BB,:
M=<940=(YP.I6*R100R7]A&;C1;L,NK:6Z$R63,"L\L4)'9"$L;F+JK@;TR,&
MN0S]CM%A(L==932>DK1N_HM%7VT@:.Y0!%;4@X\$;2DCOS+@;;OAV.4ZH.>%
M?;* 4GK5O4HVN[V[:\LT&G<8:8&%[9!$CBUN-&87$T0+A6N>6LAOXV8I>(P,
M !W@F6VM;=+:X)O>&[[!MKK<SRZ8[8,<<C=66+>R\B0#? R[9/9C$C9,5@>7
MY4XNAQWHUYC0/.7!LBVIP%E@E2M&244!\RWJVHE:W 5(;697#&^[>:V!IUE%
M4,L:1RZWHMO&T+(D?$O#4R+R%1R^Z:"+>K-8<TYM5 ::RE57?,8S4Y(G9HM+
MU.9EE#%]#UR-CS&*@;8I7P=MSM $F2$N%)"D28)X(77JI7W3XYB1O?1FO9VF
MYF$<<:5:>-+4IION]M;5_=@SL<G3.PY'2% 3,>IH<K^^6RMS -I8VK2QQS:I
MP?J4F)[=N6=0T?4/5^NP[BD5]"BKMN=GJ\]N1&V&R%?PBZN DKQV'$MBAY,P
M#"TU*TW'&[&"\$N3NCR)(I1N7H#6^71CZ([]KBA%\M.PM^XAKTC'6+AH]U)P
M]@DAB=).<;+2OO;@=4<[M""X$G:M%R3;JT:0(VVIWZ9]#?H.DXACAU3C..VU
M+A"REAO.%U=9([S5%?ER,)4)WV^B=&$UG+V[NY#,NV!=T_JWC;CU;"62#0C-
M8:W<Q26VMA#&UO;,I* QE<B2^Z$K.O2*(J#F0D+]9$(0TA#;:$MMMI2AM"$Z
M2A"$:TE*$)3K6DI2G6M)3K6M:UK6M:ZM9]RJJHJHBJB(H5$4!555 "JJC "J
M   !@ 8%>AB2Q+,26))))))).223U))ZDGJ37+)5BF*4Q2F*4Q2F*4Q2F*4Q
M2J-YM/Y7#WQP/Q4@I1$A=91NUJ'CHXQK<!&\:\@3T6#(&R@$B+ QLW>8FH0!
MDTD=)+#4IL81\<DIIU&Q;B$F4S8P(P4ZD'<98E) !!9EC:1@N<$C)R!BJI3(
M-G+SDN=W0$;0CD D@[07"@GOP3CKU&CI7+O3:$H,)((J]JD+@4M<D^$)QY,M
MM!&AQG'CDE4YQHCA5M\\=V6E[7X%;C0:M$NQ<;)CZYMEY2$CUV/?$%@96&]!
M'T7)E7)!:7$BXGP#M5 VXNP9@>0JL0NF9;L(#L8OU/1"1D!,J?P8]K,1@ $*
MWX4D -R\>NE\W:IZ5(URV,P91:N/.!A<1:DX>H<A@Q?2+DWZUQ[&O0KH%JKQ
MML#XG@YBZI9EGRZY(Q+9MOC&7DV""R8['8BCDDB1R"9\,\1-J TIR"CA.>RQ
MY4!@<1MC:TM]R&8_A,%5S^#R$<"8E47';!81@MU[)^>/G"82EYZ5D_<>.8"3
MAK_4X^*Y!+DN2#*C277(A<&URQQT-5X@2R+@I4.?K[]"E[2].>!GBGEB D$3
M1 KT::VS!8[-$E8-&Y,0$0DD&[>89>82@8%6$@3;NP,D;<@@T+W#,BL)% ?+
ME$.,<U-HW;>HV%MV.F 2V,5).;B.4SN2+LWQJ_S?$Z@86.>EGF0>0"*S;@9
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M(,9;,DEE?LAX)Z)89[29[?5;IM1LR%O-,ELXHYU(ZOR?X03(LBAFMI-H288
M(.<([I[VQNU37'ELXVK-5N3HZ"*$6;;#MTNY)4M:F5,6%<0WWH:68;5X$-:8
M?8*+WV%WO)?4PK$/V4NKB]N-*ON$=(LK]HTDTN637+G[6Z@&9B&6\;3U"PSH
MA]4G56CFDQ$=K'%)?139&TAU&TUF\NK-6*WZ)81^NV9& 0;<7!W-$Q_#H65D
M4;QE<D8<'\H!=+#&V2%#XBC >7*H44LWC>6L1XALU%BIVHA59<\$J(DY@9.M
MNN1&AM.$#(V2$X0AQ.M0M?LI];NXKNV3@FPAUZRD<OH]QJ]U'+<P(FYO4_\
MD_F37B'):TY>]HAS8V;)43G]$^GV\EO,^O3R:3=(@348;.)TAE<X NAZQLBA
M;H!,7PKG:X7&:Q-_*,R9U(&O%?XUB91N")'$Y+K#MD*%L]52\2@=$L"'N,6F
M2@WG%:'2:YL90YJVQR6DZ[ZXU7]]??RZ='J-KPAITWJS*FL6;:S<I=V09E47
M$4?J!$UF2PC,YV;)V6)E[08R'HA@2^:QN-9GB,ZLVFW0LXVM;K:I8PN_/'+G
M4 ML&X,@+*>X'TYOY0TB DJQ/OT&-E>'K6MMH:^0LV:6;#%K:WMZ)L,1X-[W
M'S4>[I2RH[MBW7A$+?"40I"VTW7/V5=Y:S6=TW"=C/P_>L%34[;5+F2:WD,1
M=K:[M_4=D5Y$P)DMN<6,7X5&8=!"#T1QSQ74 U>>+6+4$M8S6D2),@; FMY>
M?ND@D7HLFP .0KX[Z[?[?LY#W3Q1N-"J\*!80.T\>7P6U&FTBR.D=7@YTJ6W
M%-)$C7W%H'-+9V0J,)TI)36F5(?WG[Z;4[?4?4-0X4TBVBNH'?2M477+E],N
MW.WDL]R=/4);,6V3SJ']7D!5T/4B/R3VTUD+NSU:\F>WDVZA8-8QI?6RKGF;
M81<$O( "R(P7FJ04.>E=4-T^;H?)VFB2W%,)7.5X?K>KU8EK08/$W%AI&W5B
MPTPY%([Y)',:T3!HTPL.89<0IDI&NO>D'V4FM237VF3\&:=::Y;D&TLY]9N4
M@U!01F.WG;3P3/,I#V2!&2[#+L=<J6S-Z*+".*UOHM<N;G2YLBXN8;&-IK,G
MH'FA%P0L4;96<E@\)!RAP:P(_P"4)M]AJ<N;6^)(Q_D"G/EZNG',E89$.>9C
MV'-MJDZZ-J(67+MQ^VWDS8BAF2X[:4;4VO3K&GJH?LJ=8N[&>2TX+L&U73WD
M&HZ1+JUTET(D<IS;./[7\RXY(1S>1E$>VP"V0<U9)Z)+&WNX8[G79UT^\5/4
M]1CLX7@+L,\NY8W(2$R97D/N*RYZ$8.$G\HK++J41R%5.,HVRU1AP(._!M6(
MMJT4>1><TE[MT:B+=97$$]UIJ)F7'61"R>H=[L[RMMH2_96ZBVGV^K6/!^GW
M=BO)CU2-=8N1>:9.YP_-B6P93:O\VVNV*)-)^#*I(0M(O1%;^MS:?=ZU/;79
MYCV#FSC-K?1J"5Y<AN%83+C,L #,B]H%EZUN5PQTA:ES"(._&NC,*E$.E0+K
M).WQ949I"G"0-K6VTH*S1"$.>&*^_P!T2V.C4D&LH+M.PO>7HV]+VB^D%3 %
MAT_47#2V=N+CG1WL 3F/'%(\<134;1 QO-.8-+'"HNXFEMV=HO7W$W!]]PZY
M+[YH8RJ3LT?+>"1CM5F4,V^UF..1<C",QY+A) O,V!SV_7B%,4IBE,4IBE,4
MIBE,4IBE,4IBE4M/=(;B"KS5F@K#:GX<JGO&"6*0/K%O'K4?(Q],9Y$,A=7!
M<!JIF6!FD/MV;=> FBIM<5W;[8"]M.I1>MM,ZHRH&YF"@#Q[R&DY0;9NWA3)
MV-Q4*#T)JHSQ*6#,1LR&)5]H(7>1NV[2P3M;02=O7& :FX_(W'I::\H6]TTE
M-M=,8JJF+/"/:LS\>XED]FO[;.5X9>!>6EHQJ.[2L5U26WTH7O6L@8I1NS'(
M-@!?*,-@/<6Z=D'V9QGV5+F(<8=#NSM[0[6._'7KCVX[J[!>0*&<S#D W:HF
M,6&1)AX!\6R0Q#,Y+!*6DR+AW&35HDY$13;B20@E/DL*0O3K2-I5K6#'(-P,
M;@J S HPVJ>XMD= ?83@&LAT."'4ACA2&!W$=X'7J?T"ND[D:AQEKW1C[= "
MW!%5DKR_6W9(;4N)3H@H0$^RG!Z7MT"&9+-8'0>;IA@EW1*15O;",[QD12,G
M,",4WB/?CLF1@2$!]K8&<#) QG&1G!D0-L+*&VE]N>NU<98CV 9'4UY=+Y=X
MZY#DY6'I]D:EY*&:V08-N/EX[O@S<B;#%%QCLK'@L38<=-QLA RY<*[(#0\\
M"7!RCH<L.Z&G,D,L8#.N QP#E3UP&P=I.TE2& ;!92&&5(-%D1R0K9(ZGH1T
MR1D9 # $%21G# @X/2L>*YLX@FR) :+Y,I!;L9:&Z23M-DBFV5VUR*BYM-=!
M)>);&E);47-1A*PXQTQUOM:&'$H(0ZRWDV\ZXS%(,IS!V"3LRR[R ,A<JPR<
M=QK EB;.)$.&V'M#YV =H]YPP/3/?695.7>+;PW".5'D*G6!5E'D#*^-'6",
M>.F1(HPR/DBHV.[0D\P<$V/.&*>9&6VRZ(_I:M=[5O6'@FCW;XG780&)4X4L
M 0"<8!(8$ GVCWUE9(WQM=3NSMPPR<$@X'>>H(JQ,JJ=,4JGR_ULK]X>_F*Q
M2L?%*8I3%*8I5;<Q6:W4OBR_7"B0@-EME4J\M8X:NR*BDC3KL(,N2(B$K"6V
M2@N1"&)$CEM[5I$@\*IQMUK2VEW6Z1R311RN4C=PC.,$KNZ!NO3 )!/Z,]1W
MU7*SI&[HH9U4L%.>UCJ1T]I ('Z<=]?-6S?*%<H3#5 L7$''T).43E>U\H1_
M'DLJG<BW^;FJGQ?7..-R5EW 4<L4_LYMYL]NKZ7T,:%""K(A!2M$R"VF>NFE
M0@R)/*RRPI"TJ\R&)5>9Y=J;I!C(C1'P3DER!G SH-?2-L:) T<CR!#LD=F6
M-8]S;4ZX+LZYQ@!03WXKV;-\I 2NU])BF\;URB6>8Z//%3=M<;G+-(P1-@L]
M<M**]RDWN''"D94& J7?D,PS#[+9ECEDM-.R41"R(LZF*:2-EF\KRHMU/R\J
M@8*CH6@.X[06DQVCG"#^*6!2LM?]JX5%1C!'NZL5)96VR=,$[4/0>UC[0"&J
M\N&^EQ,<G=)SD[@Z1KL'7X2G!2C5<+=;N#=CL,G6!Z2]8RV#"8'5*D(UM5S'
M4L "=;F803P,44U)IGGD0>M<6"P6<-P'9V<J7 Y>Q5<RA 0&YBM^#Z$J58[L
M$;>U=%<M)<20E0JH#M.'W,5V;B#MV$=L=-P8#:<-N.W>C.;6Y3%*8I3%*8I4
M]J7ZF5^\Z_E(Q2M0>/\ I+\G2M$J]RLM, DI+DDG3%!JXT)^3V,[D&MVN[3A
M)5\DN0^0FY@$:L58S4>4NGU1\R7V$P]'BAR!!<+T)+6$.Z+(0(AF1]W-/5TC
M4",11%27<9&]P%SU)&&U$GD9%<H"9/F*!L'169LN7?(PIP=B]<#'7(1W3AA)
MYVI:K_'DT6+R<87#<6$24[&Q3D[/1$Y0J_.BVP;LQKE,C0Y#D*)V!)-JL;\H
M,!*.:C!'E1#$N;3V7?NE4&$!IMJLVU661E*GIO8B,Y7L[21U(#%0NU.S"'\(
M=L>6 W,"BMN[]H!<8(W9 .!W9S9WI@+I71XHG-EJIC!<O9JU8+3,4R#ERWC@
MXRI1Q\K9? +4?$6(V:>C0PT=V6^/'5@-+FS['::Y%:2:HMB9+F2W1^B.B!V4
M $R$*NXEE"@D]V2Y[D1CTK+7.R%)63JREBH)R HRVT ,6(_J4=[,!UJN(SI\
MF^,!U<*XKL%JE77;;(0<308>T3LJ36*1;K-7IXH@>&A[,K4VM@.L^" S&X:
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MU-6OE-64Q2F*4Q2F*4Q2F*4Q2F*4Q2OY5ND)_M\YP_[W^2__ !I-9^-'I/\
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MT9$\PVXFE&PDIB1QM)SDK@]DG)R1C.3[ZP8HR23&A+##$HI+ 8P"<=0,#O\
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MK>]J5O>][WO>][WO>:K65D[,[VEJS,2S,UO$S,S')9B4)))))))))R:M$\X
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M@WX V_/<87=G'4XK2-X C-RV)5&;O&TE8FEVYSGYJGKMQFNYKIX1%>'%#OU
ME46%)O),?,C4B;K%A'AC./5<GO:8E 7IP2>A4V +BZ53#2$W' 0TK)EI"@Y.
M81%3Y,1C[7,Y)BD4KB(J9 Z%A+RAD':58J95W!26 &6"Y4'/KBK@.IW9<'85
M;;LYARPSN4-RR%)&"3@$X)$H8Z:D4X\5'O\ #_(X<TB<C*S'1+LCQZZY*STC
MR5QIQDL-DL:Y/!",Q\IRU3Y0LP]X=E44Y*;$T2;']D?AZ@>\3Q%=K.QQ+V56
M*67)!0$Y6&0 #)R!G -9];7..6^=P0#*'+%XX^\-C ,JDDGNSC.*\&0Z?]#B
MJ*5>9#CR]BH$BXZR>+:Y'C]RT&U22KI=D;G8>&&N1!4WH4..DDR@$0@PJ$:"
M<DYSP9#K;D%27396D$8DCZDIOQ)L#A@NUFY?9SN!!. V=J[FZ5@WJ!-Y1QV0
MVW*;BI4MD /UQ@@@9(QDX7K7H-=-R'BXJX2UOXXM,:'1+I=*K:CH<^NR@4*W
M'<M<D<4<>N/-O2X,D>;>YCCHQEUJ) ."KI9C*Y8YF+WX0U@V#%D5)4)DCC=
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M:XY4-HBXA,FW0&3-@,C%H8"+:76)V6'?%':VY+S+;KNT[[6\]:NHX4AE=F8
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M")"P"$-K3(7>/$9(4AC("NY2K!@!N=2 2 78!B4!3:=V5U.5T;^1O%4*M2'
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MVQGR$>IE^XQ2G;&?(1ZF7[C%*=L9\A'J9?N,4KDDII77U)?^;]/6*4G]/_\
M)G77^C_FQ2JG+_6ROWA[^8K%*Q\4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4J>
MU+]3*_>=?RD8I4KQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2J?+_6ROWA[^8K
M%*Q\4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4J>U+]3*_>=?RD8I4KQ2F*4Q2F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5\<K'\J%:H.PSL(WQ)7R$0\S*1:"%
MVB1;6^B/.?$2\I"8I6D*=TSI:D:4K2=JWK6]ZUUY\):K]F!K.G:IJ6GKP1ID
MJV%_>6:RMK%TK2+:W$D D919$*7"!BH) )P":^@;/T*V=U:6MR=?N4-Q;03E
M!81$*9HED*@FY!(4M@' SC.*\;\ZM;/V/5W^*Y+^D9H??FZU^8NE_35W]1K9
M^0ZR_.&Z^CXOK-/SJUL_8]7?XKDOZ1C[\W6OS%TOZ:N_J-/D.LOSANOH^+ZS
M3\ZM;/V/5W^*Y+^D8^_-UK\Q=+^FKOZC3Y#K+\X;KZ/B^LT_.K6S]CU=_BN2
M_I&/OS=:_,72_IJ[^HT^0ZR_.&Z^CXOK-/SJUL_8]7?XKDOZ1C[\W6OS%TOZ
M:N_J-/D.LOSANOH^+ZS3\ZM;/V/5W^*Y+^D8^_-UK\Q=+^FKOZC3Y#K+\X;K
MZ/B^LT_.K6S]CU=_BN2_I&/OS=:_,72_IJ[^HT^0ZR_.&Z^CXOK-6!1_E*Y6
M?DQHVU<:PU.8L(A3-.L1T]);K1T\P[L9 4M(.13:0@-E;0P4<SW_ + I25E-
MH:<2O7=TC[+?4KZ1([[@_3M.2[CF6PNY=5NQ9R74;!%CGF:Q CM]Y"S7";Q
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M23397BBCMKMMNY[:2X$S);SR@J+-G)AG8A#(F2R?0@ \&4"$DHTP60CCQV3
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M>M RMG:RMC&<$'&1D9Q[P01[P<U(,C4JP9.3C86..EYF0!B8F,$(/DI23+'
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M3A&V =IR5(!WA< *6SW@@@D$=.E3AKIFT#<ZW6RZ-RC&RXY$0BR#'15/2FG
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M(2OTV)KD=7#"7:ZNNM,P1L45$@1P8EOKMQM92X.X@AMJ@H078E,* K,SLY8
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M2TC.S;LR<9(Q,L4=/.3,J>N?.>D80 M1LSLXK3FC-)=2B4E$F#=7'0<P@
M*%4* &4!0H 488C"X'=_)7#D1=>P#G.<DG.2"2V2=QR <G)_M.<R+Z/?#,.R
M\R#0HI.R6FF2RBB)20D361CZK)!M'RD@>5)'(CWZ/3V8Q)93VHR.K,+#@:&B
M8\8)O#7,[=\AZ9P % &0X.   ,B20G &6=F/:)-!#$HP$'L[\DG!4C))).-B
MXR>@4 = !5RY15M?R2\@?^OEV_[763_ZR;GXE\3_ /.7B'_SS5O]_N*^\-)_
MT5IG_E]E_NT51'.'70IBE,4IBE,4IBE,4K8+CUR:JU)-M*AQKYQ=+FN0G*=$
M[YW9,#U*3J-L+0ZU;4"<L7??HBPBL[0(4RH8IU&^\[1YWH)N+/2)+TQKJFBS
MS26VM::/GVI[/(NE5FS'.8R6MKZ-"MNP,;L&(#>-:F(;J_6U#/8ZI$BSZ7?8
M[$_3\);E@,/&& $UNY!=6WJ" 34N(8K]:@PJY8C";MT=+L2\_2+PTRIZ=XSG
M'%;V\CO6]./QI8+SNT3\/MEIF;8;>* 2M[1#6==TM+.WCM+IGU+A/49'?3-2
M5"USH]P9%Y@"[V> Q,^V]MPJ"^52\!9NHT%:XN9WN;=4LN(K) M]8E@L&IP
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M>][Z]_/FB=+TQB6;3K$L222;2W)))R228\DD]23U)K8%U=  "YN  , ":0
M=P W= *X^+==^H(7V6#[C,?:K2_R;8?J=O\ X=/6[O\ &;C_ %TG]ZGBW7?J
M"%]E@^XQ]JM+_)MA^IV_^'3UN[_&;C_72?WJ>+==^H(7V6#[C'VJTO\ )MA^
MIV_^'3UN[_&;C_72?WJ>+==^H(7V6#[C'VJTO\FV'ZG;_P"'3UN[_&;C_72?
MWJ>+==^H(7V6#[C'VJTO\FV'ZG;_ .'3UN[_ !FX_P!=)_>IXMUWZ@A?98/N
M,?:K2_R;8?J=O_AT];N_QFX_UTG]ZGBW7?J"%]E@^XQ]JM+_ ";8?J=O_AT]
M;N_QFX_UTG]ZNUN"A&4NH9AXII+Z-M/I;CQ&TO-[Z^MMU*6=:<1OKWUH7K:=
M]>_F^?)+ING(&"V%DH888+:P ,#WA@(QD'W'I6#<W+8S<3G!R,RR'!]XRW0_
MI%-04)IA0NH>*T,M>G%#ZCQ-,*<UU=2U-:9[WM>NK74K:=JUU:ZMYG[7:>%*
M"PLPI.2OJL&TD=Q*[,$CWXS3UFYW;O6)]V,;N;)NQ[L[LX_11<%".M-,.0\4
MXPQW7>&5QXBVF>[WUK[TVIG:&^ZW\ZNXUKNM_/OKP=.T\JJFQLRJYVJ;6 JN
M>IV@I@9/?COH+FY!)%Q.">\B60$X[LG=DX_37-<+#NNMD.1,:X^SI"6GE@"K
M=:2WO>V]-N*:VM&D;WO:-)5K2=[WM/5O!T^P)5C8V990 I-M"2H7YH4E,@#V
M8[O96!<7 !43S!3G($K@'/?D;L'/MS7ZF'B$$;+1%QR2U=>U%)!&20K:M=RK
M>W]-:=WW2?\ 1WUJ^?7S;^;,C3[ /S!96@?KVQ;0[^HP>ULSU'0]>ZAN+@KM
M,\Q4=RF5]H_JW8K@W!PC*7D,P\4T@A&VR$MQXB$OHWU]:'DI9UIU&^O?6E>E
M:^??S?/O,#3M/7<%L;-0PPP%K -P]S83J/T'(K)N;DXS<3G:<KF60X([B,MT
M(]XK\U!0FF-C:AHK0REZ=4/J.$TQMS6NK3FVN\][VO6OFTO:>ZUKYNO'VNT_
M:4]0L]A.XKZK!M+=V2NS&<=,XS3UFYW;O6)]V,;N;)NQ[L[LX_162Q'1XVV=
MC AC['0MMC; S+6V4.[3MU#/>T)[VAS:4[6E'<Z7M*=JUOJUED=I:PE6AMK>
M)E#!3'#'&5#?."E5! ; W 8!QUJ#32N"'ED<,02&=F!([B02<D9.">ZLS-BJ
MZ8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%
M*8I3%*8I3%*JTF-D%DD*2&0I*GW5)WII?5M.W%;UO7S?HWK?7K%*Z/!<C]")
M_P"$O[L4IX+D?H1/_"7]V*4\%R/T(G_A+^[%*>"Y'Z$3_P )?W8I3P7(_0B?
M^$O[L4IX+D?H1/\ PE_=BE/!<C]")_X2_NQ2G@N1^A$_\)?W8I3P7(_0B?\
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FF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g68105g62g98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g62g98.jpg
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M"G5<5(X/,S6L1+ZY-A&BZ*WP*JT6*-UDT\:D.>9.<]^0>77B?>JT"@Z(A1I
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MC(W!I\L[*OC+>!S&30QJ_?/'+AK%RRX)ONF,3;MD29/4^WQS]_'TK44\Z 4
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M[M9NR9H*+[:Y4V2;()YV]*6F,9E245)0QF&CIH:6)SS(Z."-L;#(X-:7EK0
M7%K&@GGAH'<%ROJ35>I=8U[+KJJ^W34-RBI8Z*.NN]9-75+*2*2::*F9+.][
MVPQRU$\C8P0T/ED<!E[B<WYZECZ<(G")PB<(G")PB<(G")PB<(G")PB<(G")
MPB<(G")PBA9WQ@=83JE1"ET6%34 JN%6E7\YG*?8K(;>B)T"$DEV#B 6>VD,
M@C05V*-*%TG\<T)OW3%I/@\1)NPA]NP5#/7S\%+<YX9SW8Y@^"AOX2]+T=4V
MUSHT#<O2RS0#*O\ KU5S['4-[%"K@N[JEO:X\+=E][14F[196Q;H,^P:'Q3=
M5<2X(U^8D+ Z5?R OJ.*7$G&0<\>9/?W#/(?'B2M%W%2GB1N)?5Q#M"8N;L3
M3XVVG9.YPG2JV@]4U^7H_:OK(9H!<47'0=+=CG9C6RG]8E"<:1["]C4BT;!G
M6VOM$'[B/.RG+1G QPX$C)SG/B,XR.0'+OXJ^6") 4(1#4(L)( (PC%8\E'
M1847!%0H%,0ST$"28,^BV/!B X?JW9O11MNW+CG**K0DBD\163U*A:9[-T9*
M+\BD(CD7M#:L5HA:<0LYXHXA8V? I?M!]"A*-QR2QPD5"INA8F<[Q2PV6Z1%
M+;2204!JZ2>#=WS)P4@X[@>&.*J##=(^Y$"ZZ%:35BP2U)'V=\-^LNAEB2UD
M?@\0#]<2T%)]@F;282,21/Y<3V'BH=VAE>BCFO=)-*3\AK8*U7C#0=*E3 4I
M)&<]'9'CG'P[^O!3VZ@UM&*K[1=](Q$E)0H*4DG7HQOM+IY.;$*Y?%JE4=/?
M0>L"12<V@P]MMGW(.W((AA2'I:"6#%IIHAJ49]RL6X4*,O<U13?JM? E'?9-
MQ+JZ.UZUWTVSJIAW9*6D!:>RVQG&=5LN9(EA';7/KPKG3.GY7ERR:C/\176,
M<#44<M(W_:K1Y(W'CO3#'?G&%MG82UK=L.SJM> Z.R:HMVII@X9;V&E7G4D^
M^#P,8AM3S(#]4L#M[AE?CIXGHE0@))/35--.<W:FGIIC&NNFFEXV-KIIKKCR
MQKKKKC&-<8^C&,8QCD:= %JB X 5=T '0"Z5JG;>YS]HUQ>XESG:>T"YSB<E
MSG;/]+DDD\R222>\J3O+XM2KK\?\H)L><1&CJ;AT;D3T3&+(E\E8SD,WU;;-
M)(TC"46DD?1?X6054Q@4=:MR;39NHCOHZ1TVVVVUQZ>:FVLUE33VNW4T,SHX
M*RHF;51C=W9FP"":$.R"?S<K0]N"#O +]*_W-/2VG[WM!UU?;K:Z>LN^E;):
MJC3U?(91/:IKNZ\6JY/IS'(QN:RW32TDPD;(UT+W  $Y4RO"'N2S[WZ;!+ M
MZ9%IY,G,_G8M>0&LMLOE!XQ^V28-=O=&[9'V39/?;5/R2QMY;9]6=L_3S(MG
MUQKKKIV.KN%3)55)JZJ,RR[N\6,<T,;]4-&&@G'!:*^FQH726SO;I<=-:)L5
M%IVQ0Z;T[5QVV@[7R=E35TLCZF8=M+-)ORO <[+R,C@ K/>9NN24X1.$3A$X
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%7IXDH2:EJ?JI]7S28JRF*]EZ9E
MC,C6,9BTRMN/MA1(IH3.59%YZXTK\W*FPYTZ;/V$U9&A"L+>2SW ,]DV 'LR
MD'!]1''Q] )]F/2MA=13UDG$)]FPY5V=D^[96,X$[=D*9J*H566JVA[W[$/3
MJF+QK0^FXRDTR>W.X>;#-D0^HW+?#]]A8A]1]OXX4-^UGB02J@.RN:?*3+K'
M2D6T/[Q$+OV%<RIK*K%1*]6;1N\)<,3=#Y=$F&E5C;<A<>ZY$QH(%8,G+S\N
M]8(K1\R\AH25%(;D< 3PSP].,<CW<?P5J%23(O8U55E84@AY6O3\[KZ&3(W
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M,P"[?!)(P%;7U_[.]F;"HRHIW*>G=@/I'+ZXATC,OPT]I*/BRI P!8OG)88
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M_P#GK7_6*?+O<G[%'8+/_P"=]2/_ .]EN/,=H_;/3_\ 0M6?V:3RVJ_5%?\
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M_'I;O]//A.'4^P?%8%5?8+Q!K7K6!6:/Z5];(BQG\1 2]I%Y[W<MN/3:/-I
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M/GZ>W_V<=;?N?9_XP\)N#J?=\$^?I[?_ &<=;?N?9_XP\)N#J?=\$^?I[?\
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K!<J/CS=OE%==-JXZW8QMZO/.(A9_G]&N<_KN'./KQ_EPH<P $\?D^A?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g68105g71b00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g71b00.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2'^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (>*^AG0X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              :L   *Y          $
M                     0             "N0   :L
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   :L     4F=H=&QO;F<
M  *Y    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   &K     %)G:'1L;VYG   "N0    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M     #A"24T$$0       0$ .$))3004       $    !3A"24T$#      7
MA     $   "@    8@   >   +?    7:  8  '_V/_M  Q!9&]B95]#30 "
M_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3
M%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-
M#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,_\  $0@ 8@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M++[FMTT%MA/_ )\3.S<YSG%V1:26\FVS@?!ZUQA9'JM+^BX8WN;5IE,#=1]
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MT119)^H&)Z+@--0@PF5UXS*ZF-KKK+F5UL :UK6N<UC&,;[6M8T(T"9C4\E
MK^T5-+!4'#<X@[HT+B[P\U+U,C_0CP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MF? $B\[7F)QHOZ0U085W/B6 FWD0+\^4>[,#Q:_$^-W+SBY3 !$>XIU40#[
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M_1T<G1$:J*-8#43!)BX$CISM\1*2V>.3233V[E=4IG:(*=9PT8@J% 2B'M!
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M$2E,41*8!\A#R  \^,,BZM6D&+D3<VD1!@\XC?GO!EQ"BM3+G52 D 2"" 2
M =ID;^6QWBPA;)9)XX*NL90PJ&(K[4IA,)C"(B<PCL!,80$1,'81'8?7.CF*
MB@J#91I@C8 1L1R[ORQ.EDJ%2@G9K3LHB !R%I!O$";]<;,J=S-"1KDY"@JY
M7/U;$H"(=]Z  +L/(==]^[UXVJ=8A(8*X)DB ).^\6@\B3OOOCDYW)5:M80R
MZ  " 0MAXW&XFX\S8'&4-ULDG+-$HPZ_QCK*L (&$!(4@>T4$W<"E*4I V)N
MP=NX;[U9JHM0JHI+)!M VY_E\\45,E0R]-GJ1-[DBQM  !ON>@%[6G#+GY-S
M*24NJJN8ZH.W B581,8.M43 4VQUHA1 FO3IUZ"'%5,D*P0*L,0 5D"8]PMT
MM[<='((*5&D5T@-$F)),"2>9D[<A-AAJMF3F1>I1S5 [IVN82D21*([ ! #*
M&U^ F #L3&[ 'F.^*GJ&2"-1N!%Y'D!MY]<;N9S8H4F>I 33%@2#(V WN-A'
M46PHSS-%"5/&I(%*5@FV9E-K76J1$IE#=)M:-[14X;W^"&P[#Q)76H0HIP -
M,$Z;B\P>I//PGGBGAV9%6EJ*QKUN9M #$P+;"+6,V@VQAHQ#E9R+<J"Y3I?2
M.!43'* " :'J !((F[] %,(CH==PX@U322EE,P+38>(%O8+^S&:W$Z=-6 >F
M =A8D@3:VTS(W&YML70G  91$CM4B!42%3% $4S.E */5U#^[D(0P@(@'M!
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MC;;8S'EYQUM3+U"H@$+)F1:.<W\+WY^9QBKS$E(H-TD5VB*R:"BRH.GB:!@
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M">HQ&I(G1I[H&H$F;^\"(.]O$FP4'!EP(!4AZ +TF$PAH! P;\OHCL [=A,
MZZB[ >UK:@)! 4:8@2+W]MX%MS,'<8K !4N8-U  ,#I<^SW'?&(9V!!,58Z
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M0=( L!M,020?"<-@ZS@O3H"@4W3Y&$0+ON(B(:   !\]]MAHHB/$07$:E[K
M7+$@;\]R3\N>-Y)'K4R 0HDO<3,F#R\ ;1N<5F< LCT*JIJ&$3@E],"]DPV(
M ?J$#F /I#LH 77L][TIP+H5T]I3J%BVD @-W2)N=XL#;>UYD3(T$D0X9B%7
MK$ 7@VM&KG$@6(.![0R@%]F4 [?2-U=0>7<0V "._,-@';O[^(AM0&E"# D2
M6Z WOL>OG>,9URHTTV)(!N6@=01,6VVM%QBPHLH(:3 Q0#?6?WZ[B !KMO\
M5Y]NW&&DBWA,";<_IRY>.)$%E@H1!N(F!^5HWCK>)Q:)(%*( D90#]P(41$.
MHP"&_I>6O0X](@4!ZNH-=)XBM3!" D.0=(-B=,!@.L2)/($3XY&@'U2QF(O?
M?:?+E,W\,*[>1*4P@Z*)PV4H"  0X"(B B;S$ [; .HW8=['MQ>M3O0ZS \B
M&^N\;F.9 O!A+0$/JDD3(GH.?/H18X4O;&$Q@14,)"@(B4QO,IA^B(B : 1#
M6Q -#^?@*PFR]T26G<"X6YOT,S\\:JU!(5J8$$ZS&PY=(ZR9F,6#G5'J.!3
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MCE,AP_,UJ34%!JU*ZGMD&GQ0@6M((N)Q-LGEZ-13H96:M75;+ITHX5#I*P0
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M4)Q*JM/,+IJ('74I 900-)D6@@-,$$\_AU::JU) XN=)8V)DCO>0,P!M'0@
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M5(^O1A=."!;715+ 0CA<#29_:&,OTJ.2R^@N*-%"H-!6T):B #I4"(4D1IV
M@D;#'2%2B0Q-4*=9[[L5F 9-^9( D";V$8V''\P>>9;)-6R;=LR99N5RJR16
M-8MUIR%<;#;JTDH?J2+7[%,3+J6AR)N51,0K!T@/6J90B/MCB7C5/"LFF6:*
M67IT&)U4110(Q.Y("BXDF\VF!.VCQ5<Q7RFO+YVI3K*\J15;M#%X!F193$#S
M( O@Y3S-F#)MQ"QV[)>2+1.U%4)"JSMEN]FGIFLO4)-27]O R<K(N7D.LI,+
M'E2J1[ALI\K**2G6#XYQ/9E.&4<M3=*=.EI<,_<I#2X, (8$%8.D;@ S&V&3
M-8T<D^9KBI5<E98&HS:A)!?D01+<YL;21IE&SW)[=W%W?6JR.[P]EGMH7N;N
M;F%[8YM2SD912Q*V-5PI+K6!23 )!294>&DCR!Q>G=&=G%0;5H4U44=*"BM/
MLPG9D(%"@!  (  &F!..E6C068J M5&8BF20=88F8WFY;K+6L1)&6Y]^8YQ@
MJG8*C,C7"JLH.YYFNEFR'6[Y?XK(&4G><E*R]O$-D^8;69-*WQCEW6$7YDGR
M9U)9V]?/)07ZJOM$^4O!\BF<;,NE)T:EEDH*U)=-!LN'@TP0+A3 *Q8#2()C
M?IU@JL.UJ+J4E?7 ?M+&T";Q<R.\9OC0,1F7,%>H\MBR#S1DR$QG8#*N9['$
M1?;=&4"=%X9('!IBG,YAK7I,S@4T2+G?1ZRBH))>T'I13*/2?)9-LPE>JE!J
MX12M<TAVBK TJK%9 ,\B/>+Y%8J%76P# $B&4$F-,B(D@F\&+[7.'_)3_-/"
MXRJ&49&_YG88IO+R,QY3+&ZO]L&"GG. U8U]7:JP*%AZRM<2JRL<[J,<HW(S
MJ:[A):O"R.4ZI-5*/"GKUZ=(4#60EZB/EPQ%2N62HVM@+N%:;DD2&W,XUTY8
M)4?40%"LIW5H:#($"96;7D7@8O4."YL,U0%[G*5*YAR%!Q&4Z%=,@/6URG73
M,N9<CSCZIX^ND\5_.%^/9#LM@=OH6*MJZ3J>^-.ET5))!)5952+?H^@]%*ZT
MA5>E52@6I*!V.7IAGI P0B)3 .B8A8 [IQBFS&7:3I*P2K"[L0LP(N1R,WD&
M^$#,]LYE'.19RN\P]^R=:,CXWDI>@3;#+%TL5[G*B^K\D[93-4,O8I>:%JU8
M2B#M%TU9.Q9_&R"=-,XG!4;\CEJ"4NWR*4*=#,**A:G2 #ZUE25@3)B;2#
MDR(UZ;9K4SZ616:F=RR.L@"=P58*!'(R"( .?/9NS5DB!+5)W,F6K P&&K];
M<T6?R)=IFL2M=J;P7=9@F,#)S;N.^2ZU(&4D("MBDLQB7:BCF&;LU0,7A2R6
M3RSJ[TZ*U$K/7,T4635$57#-'>@*#,D@[C8Z25JV3J+1S=1ZM*VE^\Q07E7!
M@E1;2PF.8)@E8NBW-O-8UNU[R+*9JEL6!E2NU'(#W(5HM3R)<YC0IC]W4V%H
M@['+KKKW%E18IXE"O91BN[CH!H:/;2"+84TCQI/P],P*>5HY5:YI5'6**!C0
MU@.4TA@H#Z)&JYB;P<;I:F4.@EB6U2X)5E.J(@F&TS!%XVC;&MY7-^7K?5:W
MCNU95R19*'2SH+4ZD6"]VR7J535;)J-&ZU8K4A*.H>!59I**((*P[1 Z!5#(
ME.4IC%&^AELB*M0T\K06M4M4840KN&)!U, "3O),B9F3?%A9& IC62L *VON
M@P-C-S(V$[F1<'<=,YT^8^M9#Q_?++EV\9D0Q=>:[?86BYLNEKR?CUW.5 J[
M6#-)56US3^)54CF+E[&QSE)!%_%-73A.,>M>L2\:;\#X:PS:)1I4NU1PST@J
M5!+22K+&DLPY;QOC"&K3=HJL2HE Q)@ 6'>D$1L#:_*V-[\W?BC9ZYN'%&5"
M-B,#MZ)*9*FV9<067)368F)[+;)C#WV2G;;:[K9[6Z;3=?CVM>5@FTTU@$8
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M<\0IYY,KD?PJY8L%[?0]ZX5K3I," #>;SB5),N:9J!:"(*KIR9M"^JP)TM+
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M>D;1'+S'6XP[&C@[A-1V14QDG1RK$0$1'XNH8!^,(@4P")"@L(J% .D-*"
M!2Z-6203I)@[")T]0-[ S>TSTG'E\W37+U!1B6NH*B"0(()(G4=*Z2;[;7$9
M/M3_ ,$?S?\ U/&)?Q]W\,:E^C^\_3![4_\ !'\W_P!3PE_'W?PPOT?WGZ8
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MZ^P9&M;_ #]OR?EX][Z<2.#J#SS""/:M_A^?L\MZ-?\ .M.=Q2K>ZWT^YQ]
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MTZ!:FI+(:>8)52=(%PP#&9 $Q()F-;O!6;:(O N+'BS(U/6GY]:!@E+/5++
M$F)R->"PE8:)6E8YB60DF#HAX]['-3*O&KOZ+MN0X'3+TJ>9RI0U,MF*3M3T
MLY7,(X5;W;3$ B8N-I)MBOB2TSEBIHL!40$J4=@Q"FP4"-08@W  (TBXPOYR
MIN2\8RC6HY&I5GHC]P*THTA[G!2]>DW44J<@-GR#*99,G*S0ZACI)NDV_LCB
M04P4ZNXUY3,96J&;*O1KCM'+'6*I42+%KD=X7 C;GOCD<(R!R]<U'IU%9D7N
M.I0#5,OI,;@ @WL>>&C&X7S6W;UN=7Q/E)O$7ANNE1I9>@VUM&79VY;_ .Y&
MU.?*1@-;.Z<(*%4;MX-1ZJL4>M,#](".%SV33,.%KT&J4=9KC4NJG8J=4'NZ
M1JEK05DW&/09JG1I-1.@S4JTQ, ZN\ (, 2# U"9WYX2VN#\T/E%6T=B'+3U
MX:6L5>%!I0[<Z5&>I[91[;H$01AC+&EJFT36=66*.B+N":$46D6Z*"9CER,[
MD0M;3FZ(*J&;_::=@YA-1F;L;2+XWDIDJYT'40\2WK:02+002!!,7'.-\<$P
M9GTMN:8X'"66B9%4C!FF]!/CBY?=NZB.@##+MJL, ><5B@3V<7Q8X['9 $%
M  $V*?$<J<NE49O+JB%@S?B*1741! ,P.D&QL<35'[)2%=""3 :Y9@08$ Q!
MYC:3.*HG!.?+*[DXR!PCE2;DX:Q+5.:C8C&ESE'T3:VC!>3=5>3:L84RT?8V
MT<T>/EHEVBG((,FZ[PZ"+8BI^,_C\JRD_B\I!&J]9+J(46U 68Q-P"8D3B 1
MV#$E]Y(EIY6L.0%]C;8Q.$9AB?,$S7IJVQ&(\CR]0J3IZVM]JBJ):7M:K#QJ
M!3R+6Q3;2)6B85PQ Q0D&\DY:JH )17(GHPDP<_EDJY>BU2C-26 [50S=I&G
M3.\EE (%[3O::+J9%TLUV9MR01)4:KP09]T=!C8]LY9,GQ-GHM,J$!-9BM%_
MQ%2\RQ\)B^F9#L,S%U^Z1+29;LI.%?4^.EGK^#(Z2;3$Q!M9BH*.E@-#V:3;
M*IN%,+Q+*M3S%2KIH+1S.8H&I6JJ%+4G"AC<@23S(\Q(Q-0#W13>1J902UF@
M$*(N0+FUHDB0(PP*WA+-=S6>HU;$.4[0ZBYYU5))"M8^N,\O&6QNT=OWU7?I
MQ<2Y486)HQ8O'JT.[(G*(LV3MPNT230<G+)\[E5*G,9JA3+J:E,FJ)8.8+"6
M%KP#<21L9Q%-51F#A@%F" 29,R+1O<QR.T@$XUVM\>BW:J2P.8^2C'9VRJ"B
M2C9TT<LSG04;.$52)K(.$%"F371.FFHFJ02F22,!DB[#5%J("K&T:66X*Q"R
M;@R-CSWZ@0KJ*],TVD&-(D7(L 2#>#&Q)._GA;>D9S+0TXB@5)ZAT$FV[=/H
M'VHC_P#&B:1.D/8.#")G0)@!471Q5 .HW5Q"FM) "2208-KB?5C8%9(%Y@]3
MCFY9CDJO85G<JQ(H,UQ&P1B9@K;0#,K80!&$R-F)F'^5TH*=E8YM8HT\/8&\
M;(NF*<W#&?LI8\1+HM5DTY.+-)1D:_-'O"JM!>,&3HR(KM45"9[->T!![T^$
M@W[PMO?I,$]<=-474"3)M%Y,C;?^-Q: 1A.$I3', [3'SV(B "(B83; .VQ,
M(B)AV8P[$PB(;XLB&;>;&]SN?ATMBT"&8[DP3/K$GQZ;<H&,ALD8%2*" ])!
M'0^8&'RUW\_?YAY<9Z>'W?$*A-UD; WW'*?#V;6/,RH& #J  =BF* &+H!$=
MAW'?GY#Z!W'Z^)"6<"(!@$@[<C;I'PGVU#5/@">H$"1$;?3F3MCO \)3P;Y+
MQ-,<Y:OK3F(:X80QGD!A2U(QQBE;(0S*DA7F\Z61([2R-2PCRD!<S7XD5M(!
M^X@J+W9A3'Q?'_2C]"9M*"Y49E6IFI_*]DVHL5M*5  !R@]"9$XR."GB9-3M
M10*=T,$UD7WB0;B1<1<D;P.V_P#J3J8]>?"-_P#Q9G8?_G['CA_ZQ#_U4W_F
MT_\ [? ^B+C?B)'GEQ]<']2=2_\ =WQW_P"+,[_[>N'^L0_]5-_YQ/\ ^WP_
M5)O^L?\ _7'UPQ\G?!;I7&^-\@9#/SOL)<E$I-JN1HDG+B[8'E"UB"?S8QQ7
MPYQ>@R,]!B+8KL6;H&XJ@L+9?H]D>RC_ *0&JU:5/]&%>TJ)3U?BT;3K<*&*
M_AY,3M(!-IQBIZ*FC2J5CGBW9TWJ1V$:M +!9U<XBPF\Q:_G2Y1.4G,7.IF>
MNX3PI FE[%,E^/S4RY36"N4RM)*I(R=ILD@0IRL8IA\92(D4X&</G)T6;,B[
MM8B(^SXAQ+)\+RS9S-.%9EU4T$:G9KP@)WY^ !DV&/,9'(5N(9I553,DP;!0
M" "T R2!S([Q "\\?03\.SD*Q/R 6L,28\2^6K ZQ"TDLAY!D&R:,U>+0>:A
M2/9 X *GQ"'14*9*'A6ZRB$:V*7VBCAX=PY5^(\7XSFN-9AZM8E,MK(HTYM;
MNV,"2!%QN2;7@?3^&\,I<-IPEZC*NMMX(DS?8$G8$\L=O)2%*4Q3"!0 3&Z0
M'ML?I;$?>(CL==^^_4>.2 %&A3?E,G'2F3J/+KOX\XC:/I&+Q/P2_P#)#^8.
M)C83OSQG?;;E@/KI'?<-@ A]H@'#&"8]X_._PQ@.&31YH%D$E3I";H!4A3]
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M/WSRQXMNE+@TY#(4=5+O8GF/305S7QE;W=1LR<6M$W&4E(,R+AHZE(QO;&4
MK(P[=TNU ZC1RV+T!D*[%J=.H:S!%:HBJ3IU@&""!-B!(WZ'ESVSV6314J 4
M@S,H<P)*[\R(G^<.5CMA_I<U7+^I69:VHY CCP,7+M81XJE"V)5\YDY-%S(,
MDXJ#1AOEJ>;2$?'R4JU?PD?(Q[N)C)*51=KQ\>\<(ZCY7,K465: I73<05,0
M=@(V@W!CKC:IYO+,"%J*02#JD]XD2".LCG$=+VQGI<R6!)26>UI/(-:?/&,1
M'V!=("/58\(I^C N6KE&2!@:+>*D;6BNOW35HY5>13*<BWLD@T;/6JJ\OP^9
M66TMW2;\P;P(,=VV]Y-H,XQ^)RSRH9#>)$>!D'J)M'3&>_SGA6%FXJN/;A#-
MY9],R-49I)LI%R1O+1LE\CNV#Z2:,5F4*0DL;Y(!Q*O&3)S+$6BD%W+U%=).
M0R6>J!66E4(*ZPH![T"25 F8'>A00(GNP,1.;R*:J9J4]2GLRQ([I.X)-P>4
MM$W\91:YGGEWMIS6*!N=?=C7&22;>349RK I8RZRT=&MEX<SYBS+,1]@FT(R
M.:OHDC]J\D$B,VRHKB*00?+YP*0R."T'8VT28-Y!"@VL0,32KE"T(Z$K,3!)
MU6)$S(),#H;#QNS/,9@&LV>Y5R8O4%$6"BL'CZXM5V4D0D8V8,X:3D2+OB1X
M1[Q\U86" ?NHUHZ=R*3.39/E&P)+"(V+E\TZB$=I763$G09(,P8$7DG<QO&*
MWKY:FY4N@)&D#4+L" 1',W(\N=B<5M.9[ KMU*1GS@1C=W 58]REFLA'S46:
M-KZ49%S*SI<).,:I$?,8F=@W[Z"3,:=C6<S%'>QK0LBU!6!RM?5K"L9,6YEM
MHZ FX)L;7DB;%S>7C066P/(  +),VO;D"?+EA,3YI>7&539K)W^&>BM%3TVF
M'R-.G68QU9.\2L*LJBI"F<P:T8^CG<4Y;3*,>[";;#!%;#,"5B:?X/.")1P'
M*A02%U2+1_.Z^PF<0&;R<M#H2@8M?8V G>),1//G<1B/N;;EL91L'(2&2(PK
M.V(2"D4DK!64[IR2*GY"I.VKV,+!J/XYZA9XQY5DXV7:LWCFR(EA4&QY)9!L
M?*9'/,SZ*%0*C"&! !U+(&]Q%Y$@@B^V(G-Y/2"U9&U!NX;GN[V\"""#M&V'
M'C[-F"[_ '-]!42RQ,O;9"O1,RZ0:1\JB61@&K!A(LQ0?NV#:*=FCHZWQ3EW
M',G:K^-3FFGRFT0!R4AX9C*YG+R*J.K"?6]8&XO/4@R1(WOBVAFLOF 5I,I!
MY#:^XVW%IYXWRG',$RZ;M4B%.<-D*0I"") ZBFZ0+T@8HD 0-KJ#780[:UP[
M&YD$3\=_@?B?'%_9K<1]/#:UON8$9 -BBIUF*'4 'Z>^]=0[$-CW#Z0]0"&A
MZ@WOSWB2-C&)6-K&.5OR]N+9F#<YRJG;)&5 O3[0>GJ -B(E PE$VA'N(;T(
MB/;C,M_./OZ[XP44Q(%O 8 BV %( -42@0X*D(!""4BH&Z@4* E$ 4ZN_M
M#&#L81#MQCM&%AKZ>_Q/+&.S69B]M^HV/GBW%PL9"I+(1;1)FBX?RDFLFEU=
M*C^:DG<O*.C=0F$57LD^=.UAWH55CB   ZX8E !D"/O[^P(5.&,X.&&#AAB
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MD5-"!O8F,/[@<-DZ1*01ZAXBHTC6I)'.9)1B-CT!O>#.W/&IELP:#=AF#-0
ME6:_: ")!)WO<<N4@&$\I0'0KA[00[>T2Z2A]A]=Q'W>>AWOOV"R9,[^,\QR
M/O\ \K8WF,P5,3)ZQ>W.>L7\N<Y1#  :+H2^0 4-Z -=Q >_5OZM]M^?"?;R
MQ B;FYYSSWM\?(['J*C"H?H*@F=5<Y@2232*)E3#ZB4I?I&T'< #S["'&=1
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MM>>A  T/YM^F]AQE=0@$<MY^$??OPBQBQY=)\?\ (SBD"*=.O43 )MB'D'D
M" _5^;MQ+& #:>0@]9,?3KB_PQG!PQB\[6ZS\(Q243"'T@ !WZ#OM[^,0#N!
M[0,9Q2)1*(B3S'>]C]8CVWV -CW_ /?QF -A&,$MR$^?^>*B]7;8:[?2[[[_
M %  Z#_;\N+R+6YGWVQD>-L5<9PP<,,'##!PPP<,,'##!PPQ ;//[^!?XNH_
M_+CSB#[#S^1Q--SY?,8GSQ/$,'##!PPP<,,="GPD)(%O"ZR0!NWL\J884_Y7
M1=V@@7S[=0=M]_?H?+CU?H1WN/Y:3'[',@^?9GI',>XWQRN-6R%3_CIQX2T3
M\=ORQ\ZTR8*)G54#:9"] $+YG$>P%$N@[;$.HW<1#\_'W-]B=P 3 F28L+7C
MK[,>-:5! W*,3X6!L/+G)]AC&7,+G785\[D>M4K)PF5$#=BH)NC@W*8?,W0'
M64O5Y$*&N-=")0G:#;E )&W.+\R;>W&GP\!:V8 L-2DGG)66N!$GV23(Y8IA
MP%BW>6!P;H*V.5I%E4*!@5?KD./64H_A)M$BF5,(#_OATB;*)@,&088L3$>K
M.VH@WC:!!]I&(Y@FM7_"B2&[]2+0@.W_ 'B8\I\L-\79PZM'.<QS&.<ZH]9Q
M.8=B(F/LVQ$1WH0UO8=^,J2HW)G>?XSCI4J 0 S @"!81:  "186 B_3%@R@
MFV(I^8#LPCY=A[['_8?+A-YY[XN%N9L;B(V(&T\S'+SOO?8,%I1R5@T(95=;
MMV$"$3+_ &:BBAAZ2)IE$3&,;IT " ;$>&X*@2S;>$;S;:]Y/L.*\QFERU)W
M?N\EF^H] !N9C;W]56:E6;)DG6(,1,S05ZY1\0H&^4WA>W6"FPVV1$1*D4W5
MO\(=>M*:KJ8(F[0+P=K':1M$<S>PYF2R]2O7_%9F0395,_LT@Q?JPY\@>1.&
MN7]S$!45#MV#8  A^4!'[>P!]0<7;&QVV//SY8[]HA5D   @R(M%MCMXS',#
M&,=-(PB)E^K8B(Z*;8B/U[[^?#$CJ@0(OMTWY$ #S^N+8"U*&AZC?P?\_EV^
MOU'A.WCB)UGD1Y6^?\.F*?C;=/10:D,8.Y14.<=AOOHI2COL/EZ^_AS^_P N
MGW&'9.9)8@$08D]-Y\['W8OH*O'IQ19,"KJ"&_9I)*&'9MZ$PE$0)H1^EU]
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M76!>Y$09)',">B(J]<H+ 3JZ  $M$!,O4 "4- /44!WKSZN^_/8ZXDK&Q$7
M.UQ('A>Q'2Q\<=2F$K*& LPU7)OJ .X/B.=N0PKMYAX8A@]IH"E[?N9.^^W<
M.G0?E\_3BQ7:]_W29@>&*ZF70&(!D&(Z08W-_(3AW2,FZ=52#$RFS-WK] -I
MIB!@Z@.!#; -%$ WK0Z[" @'8=92=]5]1$6\X]L@<KP>D>:RE%1Q#,)RTHRF
M]ID6O\2=Y\\/>D6UP6N.XR08 _21]J1%R9(#%VI[,I6RA0#8]1P#H-VZ0#0@
M/IJULBU>IV^LC0 (BQBPV,"]K@P?9CF\6R 3-"JE0(7 )ID$0!,M.HD=383Y
M8N)UEE.Q,T[^+LX20&092:8.%E$F[C]R$KA0Z)Q$""<ZRP"4G20YDS (@4^R
MQ%3L@::@R65222+^J=R=B>>\7QKT\[6HLE-&:H"&HEA>!J"V,21 4B8VL#C7
M-UE5R*M2J5TK%)N0$47)4B-D70I%Z#+ +?I2.13744!544 ! 3!O6]HU'4*&
M6RVU$>?3EOS\KX[_  VG420:Q<M!(+$D&8OJO(VD #:9C#)&7V "9DTT/EI,
MY0WOOWWLWD'<1[COR[\7JP(LJB9.QGQOO[<>C7+DJ"*KWW[P/2UIY=>N*#2:
M1PT9JW#OY 0^O3ZQ_7Y<9GP7XS[Y^_;C/X=AL[>=OG'T]V,<Z[=38BV !-Y"
M4YB@&_\ B]^VO3ZN_NXP2(-AL=I^I_+%FAP!)) './?;[_/' JMQ(4@_1$IA
M$# /4 %$!#IZ=!Z^>AU]7 %8D[7D@_Y<]CSZ8DLEIW$'K<@$"3Y=1/ONN5N:
M9QRKR-?',M!RR8H2"1@W[$P"!4'J7G^[MSFV Z#K)U;UQ6  TF2C>L=ST!WO
M%N5Q<8Y&=R=1BM>D--6F25( !(BZG8P1.\7/,$X3YZ'7A78ME#@X;K%%=B]3
M,!T7;4WTR+$$/30])R@(G*?L)1\^)'NG23OZI',<C,7.P)V%O$XV\EG%KII8
MZ:@)5D)NA%HVY\MOEA !P :TB)0#7T@Z@$1 /(0_G#?ZN!,"VX[UXZWM8CGR
M\!C?()%H]M_OX^$8YZC*%$2&*76^P_A!KU]>X?9[_3A -^9&\;6W!@'_ "Y8
MR1(@@?F/E\L+YU%)2#$?.0KYM;[_ +K%+JE* :$0 R;-=0H  ZZ$EA]$_I1Y
M&/60GD/5V]L$V @ 3X8Y6D97,D?]'F21/2H@YC>6!/\ 9',G&-7E$U)=J8W2
MF<A554]:$IC@D8R)1W^";K*F;L(B7IZ $?,+%[Q4^9'GRM[)WCSL1MYT%LNP
M%P0 9BVPFT[ ^70<PD"LL90YG&Q4,J905#?A>T$PB(]7J8VQV(ZWY[X@LE3)
M,S?K,R1,B9ZVWQ?051E@%.P B(!Y7$B-_#KCW8?!+Q$W+9S6#V_?VK.Q#L B
M..HX=B'O'OO[-^NN/DWI\3^D<K(WRBF?^\?#G(/CCN<)$)4\=!^$?+'K1X\'
MCL8.&&#AA@X88C2R_P"%)/?Q1I?])(KAAB2:?X ?:;_&'AABOAA@X88.&&#A
MA@X88.&&#AA@X88.&&#AA@X88.&&#AA@X88.&&#AA@X88.&&#AA@X88.&&#A
MA@X88.&&#AAB V>?W\"_Q=1_^7'G$'V'G\CB:;GR^8Q/GB>(8.&&#AA@X88Z
M&OA'1#+>%]D<A V)LI8:UO\ XMV9^>NX ._U\>K]!Y;T@RX G]EF9 W]1Y Y
M2(_/')XV=.0J&)[R;<C/B-]_#'SKW:2I5TD6Z9E"G B8&#U,8='( :["(#V'
M7<0[".@X^XNQ'<@C5;5[Y  O/COM Z^'[5=!U]QH-S$00(]HO(C?V \S:($D
MRLDA]NLU*E'MTR" E%9 !35]! 2BN*QA$/00'?8!&+*B, IEAI"[&\P3RL2?
M#%>6*TZ;5-:KK)J,6@B#<"W01[L8TZI[06L6BIUH1":J)C%$!34?*F*+M0@!
M]$0*H4I"G[[!$A@[#Q J#^\"5M(B"; CF#\[GGBS+4E8MF6>'JM,']U5'=!
M@3!DQU .$003(.M@)A[=1AV ^\>WJ/IY>\/KE !C6#8;VO[!N?D;#'0!8BSK
M:-OR\?? YXOL8YY+.2,V28F55T)1./21,NQZE5#; "$3 !,8QNP%#7GVX@6'
M(CV[;QUM]-IQK9C-4J*G4XU=1>38!1UG[ZX69-\RAVAX2$6*Y45^A+S/T4RO
MCAV.@UZ?I@S(8#%^D)3*B&_(H;%"3': @$PP$3,R"!<BPCQ\QC4HY6MG7%;-
M. J7H4QNFK<L++JLIZCI>S+.!U #1RZ !WT!T@/IW -AV[=P]=;[\9(,0&$
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MMTVDKF7E%$S=,J;1^RMV8EG*)2 (E2626P@W*NV !UKVR:B?;V?T=AQG]?\
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M;:$ $H]P$0T._+SV&@, _P#JC]>NVVI>OP.W6?SZ8"3T]_U ^&. 7V&P(([
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M:-ND B(GX^&+*%*BIUKI(Y@:8$[2.1'B!MTPF?NHE.*B(F%<Q"D)U%*'D(Z
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MC T$P2#,[ 3(O8P>G7>9W Q54RM%P9*L#: JW.^XZ0/=:,+C:TF:]/LG"Q!
MP 42'.4>LH[T&O71#=0 (#V$.VAU,O2"Q>02)F-N4CF(/E'F<:=3A^6*-" [
MR=()%CS.P Z?'#IL%U>@X(NJ[%5H^;-%T0<E3=I%%1N0JR:97*:R9 *LFJ
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MCLRL(5IG?EKYC^9Z-01HC]T:IQ>"'^26YZ0J8]N;FF',^GCTZ;>PBO'!%#*
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MH&+9D336&()GF08 DDC8\K]")F\VN<S-90F7:N%H$L4U43=[ @D ]+V !B3
MFV^&5<F?.9A/D^Q7E.JY23YC*;B[(F-<N+UV=I5>=4G)]9"UL)N:JSQS-S48
M>/@A774C17=.W)_BZ)RMW"RA6O>3TAHCAE;B%;)/1%%JM&K3#A]-6EW7$BQ
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M2DBD:8E0XEM0&P-R%))Y1N;@S5R3X0E:P[$<S-BRGSAU^%A.7_+E'PO NF.
MK':7&5KGD?$L9D^J,85A"W=5[7DY!Y*)P!G<X5=HS007LK]VBD0D>;E4O2FO
M6:BM'AFMJU.I4TFM30(E)BK&2+D"6*S(801^\)-E:":R&"A(!(5]R"1IL-_5
M,6@VW@\2/@W5V+D;%4S\X^.YK)6$9S#T=S:T2%QG<6I,&1.8WK.(B;!7+/.R
MT;!Y81KDM+1R5GC61JB=FT44<(.E#HMF3_-/TGJ.*;GAI%*N*_X5Q60]N<NN
MJH2@DH".\"0TS;8Q)J! &DJ=@X@DBX$BP#7(!(-B=HF'#)>!+DRFP5<N>4\\
M5O'E'3M7,3$9?LQ<>R5C5P_4L$!9QA;R\BT;4P>6:,RT6HRIJNP3/%N407BB
M(*S19$PMXMZ74W+I0R?[0K1% M4 6I5J$:D!@@0#<C5 OSQ<F7$!F15!)!/K
M,L$7"BQ\;B+GE>2&5/"]Y",3Q'/!3%>8,T<UQ%BWDKM:&;,@8\R%)R^&)/*]
MGED;8K'5RKR#5'(;G)$"FP6C8E!D5O #(-XI=^S=L7CU327TBXE4JY:H<E %
M;B2FFM18JLM)T5=9('[,W)F+@Q< 3_"T1J[PB"?4;3+D%N1Z]=NA#8ZS!\..
MXASUY Y$W^7*2A'XNB)R^V+.KV&FV]<B,70=!890?70*HDJYF57QZH];'6J*
M+Y3_ ,=J&CDYXS),9);T#>D&G@R\1;+S#:.Q+:2M8N$T*38@N(,6Y^?-_#::
MVI4 &J'[O=*]XZX D&!(Y[@@2".Q#D_\+SE.J.29'+F<\X4GF1Y7YCE.RUF_
M"\HIB_+U7C;3(XQL436+X^O%/K=MA+C"CCE=\P60K[.RG5NK6Q-',8^:&BG+
M4W!XCQWB6<H"AE\HV4KK5RZ5V5T;LQ6946&!@DLZB !IF381CH)3HL#J.RLP
MTHXU%5)((@%>I!F^WAYO+3(1\E9['(0C%G%0;Z?EG<-&1WQ_Y/CHEP^<K1K!
M@66=/)4C-@R.@U9_*3MX_30)[)PY75]HX4]M1:IH <WTJ"QDABJ@'QWWFXO%
MH)U5:#N2+$<I$1M O-^4VF^R !SD.!B[*)=B E.8.X:_@Z'>]:,'TBB'8! P
MZEU.W,1]B/9/T%$<'5)@<P+R1RF_^7CA?: W?^V7D0.F5ND"KEXCH#J (@4B
M1TQ$I%%53:*!P #@ "( .A'BP0TEA879AT,V@V+$D7\#;&FY9"JT;ZK!3:+\
MCO '6TQ)VC!,N9PJ<C1%)LF*A^GH+KV28&['55'9A$ UU'T &-L0T(ZXQ)(@
M ++6%Y@& 2?=RN>4C%P5A3"/)=H)%C).^UN<@'D?+'NR^"3B3[VGFPZ3BH8<
M\UGJ4'8]8ACJ- 1*)M" ;#T#6@]=[X^2^G@_]HY5M_\ 90"9YAIMM:^.]PD$
M4W4B"ND0( '=6UOCRZ8]:W'AL=?!PPP<,,'##$:67_"DGOXHTO\ I)%<,,23
M3_ #[3?XP\,,5\,,'##!PPP<,,'##!PPP<,,'##!PPP<,,'##!PPP<,,'##!
MPPP<,,'##!PPP<,,'##!PPP<,,'##!PPP<,,0&SS^_@7^+J/_P N/.(/L//Y
M'$TW/E\QB=IG)0V!P .D>QQ'0"8H^X '6@V(AO>@'T$!&0U$&QYQ%_;L/9.^
M*R0L20)ZG[^_'$0<J^(1R4X.E5X'+/,YANESC4PINXB2ND6M)LU2G*F9%ZPC
MU'CIDL50X%.DZ224*.^H@!WXWJ7#L]6 9,K6(.QT&^\]>F-.IQ')4R0V8I@_
M\0/TGKMMA]X;YN>6?F'.JEA+-^-<F.6R0KKL*G;H>2E$40_"64BDW/R@5),0
M#VBPMO8I]10%39M<5U\EG<LH>KEJJ+>2RD7$6GJ)$^8&)4LYD\P2*=>FY!B
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M>A\O/@8D=_P]4_?69\KSC>:M5!$TB3 V;W$&#^6\[3BM5DT2(BL:0]J14!.
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MW,4&-K[:/A^5VQ.K-BE*N1[%R6.A!BY1\J6129, 9OF:"+1)JT03+OK4> 9
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M^S^D)S@/09-/H W4F0PB'TA*4PAU#H-\8),!5!-QMSO%HY<_N<;+5U#!V.D
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MQ.YM%]:0;.MM;4PM]QA'Z,+'K.%V;$C6-FT84A&ZSIVJ10(LJRAW"IG"JHF
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M-Q;[&Q7CS9ORM9LC0S1PFJ10:\VCX:I13XI5!$IDI0M;.\;*)E*"J)BK&[G
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ML1$=CW[[$P[WOWB(\960+GW\O;]],;:J5-]HY&>EK3/LG%9"B8P  "/V!O\
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MD+4IJQN.X3J!5I  :  9,3)&J\]K-?RG&.L5_.).BSC#1=0:6*W14<_8S2\
M[4KC.Q.H@ZL:Y=-UWA&;]JLT23<'!X@Z9+-E%4'2"RGGFHZ*O9K<:RJDC3J
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M/:#4&@@*"!(F1.0&8@ D2"8TBU]B21RN2=NF&0AR.B]QG"SD;D]1UEVR<O\
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M_4G]_P#[MJG?X!I?_M2XX'^L%?\ JP_WZ_\ HXE^IS_TT?W'_P"^P?U)_?\
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M8/B9\R9N?ESQ@TT('=%O ?3X[WY7Q1\AQ_T@^*,^DYT5%2@T1 %#MBE!J<X
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M2FGO Q()+ G>!8<^N/&<5X#F^(9GM:;HH')V80LB+!2I&_,^ F^(#F^"N<T
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M5RS+3!9V@[22)&KUHTZ0)N0#$L)%C$;CN$5?I%$!WH1'J*81$#;#1BB(" "
M& PZ,)^H>P 7CML038&#!)U;D3'=Y%3$'KM;&JE(H6 $ D018$#:038W(
M&USC 5 FME NQ,;J$  !$1Z@$1$.XB.S;$?/8^\>(;$D6))DBQ,[DG<SSG?G
MC874&!GO $R#>^GG8WC?GA'6Z"&V4 (8O44I@["&Q'8!KOKZ@\P'7;C$ $&
M" 8/,#G!Y#KC9IJ9#$WY&\B>AWD]!O&$9ST&*;0%*(:V';Z6A[>7U>7;O[^*
MBW($@=!($]8FWV=\;:$J0 2 .0)@6-_J<-ER8J1A FB% 1T! T'<HE-H"@
M(@80'ZA'?;?$!"V6UR3IM<Q.W,C?J.HQMTX4#38R22-YZDCF;>>^$18W4<1
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M(_\ *''\:)A#[1$1WZCL>/D?^D  <1R4?T9^G^\<G;Q)_P \=K@/\C6._?\
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MOS#MO[021L8\=MS8$2#?\QBLHPV$6@;&(GE]\L*K>5.B)2E$0$W81V&O>'J
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MKTG[>K4X>*H.8H $QWE""()$Q)LQ 8;P+-B#R<VCU&]B*B2/5^Y%4-M0A
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MG/WO?&G58=FQ)YF_C/V/$>>/=%\%# 0Y;N:?8:_KYUL?_P G\?\ T<?(?](
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M\MN< ;GVX7R&]O .D'0J"C'+HNT_:&,9$YE/C! 1* ]7[G[0I!,.@*4!Z=;
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M?SA[3"S]>?7'JXX\'CO8.&&#AA@X88C2R_X4D]_%&E_TDBN&&))I_@!]IO\
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M7^]7_'BD>97ET*'4/,'A4==]?.K1]CKT_P#C[U]_EZ^7$?PF;_HN8_N*G^'
M5Z)/\L/[Q/J9\KSXXX#F>Y;P']_["?\ A5HG[;#U^OC/X/-G;*YD_P#@5?\
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M0 1 >K0@.^(&IW(*BQ,)-XO!-MO,#'-XNX/#*Q6+E@ #UBXCD!/YV(P_LND
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MJ:52L,AFBE1J@%(,,Y2(/?= 5$VM,$RP!O[(Y1.\13K!94 %HJ*-+%IN(VV
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MPPP<,,'##!PPP<,,'##!PPP<,,'##!PPP<,,'##!PPP<,,0&SS^_@7^+J/\
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MZO6W$+,M58:NR$D]<RC^*CCMF"TLJ=VJV4<GZAA6X?DZXS%*KDLNQK.K,&I
MLY0@$DB20% ',#;ECMU"U&LCI4=7#Z&"L9!8$P-]F V+6F]S"$KS+\QPS)GZ
M^=<MNG\ADR.S$ZDE\AVP[U;+#)LO&L<D.%32P.%+LSC'+N+;6HRIIA!FNHU(
M^(V7%,ZKPS)4PM'\-1[)Z1HZ@JJ5INY<TP-PNH0(,=T<@,79I79"Q: %;O$F
M0XGO3>7!7=KD2?'$BK1S#9TQD[5R#C7,&3Z#=KFU=LKE;J;>+#6K':FD\HH_
MEV]AF(:3824RA)OU5WD@F]7<IO'2I7*Q3J]S:U/A>3<U:-:A0S%*BRE5<I4"
MW[IT$R8.Q.VYOCPWHW6K/Q'-0S4VTNXLP# L%U&(N9VU"UR(%M.K\T/-%89\
M\D\S_F:4GY*^PN2U'[G(]T=2[O)4)!?<I WQ5\>84<+VR&K '@&-@.H,DQB!
M/'MW2;,1*;;7A?#T.D93++*FFH6B!"U&,@1.I20"8 O<"YGV-6HM+54J5GD
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M"Y&YRHV.F\9<LEQY@H&$O\+9YRS4C%%JO,/#7*'J4 ZE;C(3$;!/VC&P-H&
M2>R$VX52<@QBT'*CHQ$1.<)YFCPHU:.9S-'+-4HZ$1G0$([%51>\)+,Q&D@&
MX-Q)C:1V0:FJ@D]UUN%E!-UW@"(!F_E>?^!_%MRIA;E C>6^M8?QXL_JE3RG
M U;(2MFO\,HBTRJ$E VJP3N-(:898XN]V:Q4])Q$9;;3"R4Y'1ZHH-'"*8N
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M^VOKUE/(5RR7<I1)LC)6O(-DFK?9'J+1$J#5%S+V!W(OE4FR12IHI"X!,B9
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MGUZ<4BTU#@G LVLS+JL7*9VKES-13H^UX] R?N_0ZKPZA6JU<W4II6MV1J1
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MU8C;O)M6#F)(X?)JMQB8U=K-*O$:%.J@;-TLFM2@<QF*2ELW2_9:0$B:BAF
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M7JHB^H0?$_7I?IX[P?'$S'*!3%$VQ#H*;J$VP\@T&A$ T8?,==PWY#@BH))
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MUM#FU6=NBXI]0>7ZP0T0UD++:&M29*&1<33>HUUG*V620]N46[=&-BWCIXX
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M+QQ1[0I1./24!$P]NLI=@("(B4![Z\@'8$UHP['7<9B2"><WB1SU 'X[\_
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MA42F0>X!?<D@ 23$P>?B <-Y9,O28->9A-O8]8& /,#?A!Y%V&]!TD   "@
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M6)@DFT6\HY8WGD)):8QK7Y0"]0$(T.L8H  =:29@%02E#V8*;.IU& H&.!Q
M^PT :-*FBUJX%-0:K:R56[1WK@SX&P DQ$G'C>#NU'C>8HAFT_M:2K,KHU:@
M!UVW,1L,1T,4W8!(&DR%*31 +H2AH3;* ?3'6C& =G+L#; Q@'H% RB54D
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MXWHIO6J %J10]Z0=,]X^$@6%HL.8) .,UBJV3<D.,CHYRF2,!$UR'4(L!@T
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MBM4S'=*@WMPEHT+(WN8Q;9K7&%1@)MA*MG-A,I(QRPO6EF?S'#LB:V7S57*
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M&1)G.9ST<3ANG+4J3:ZF4=5>K^UIN*B-7(I#+&01J#DY@ J)""2IEE,IQO\
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MTM#]O??I^7RXP3<7YQ\#_#[.*GB^TEO"\CYG"D!AT(CU>X![B(&#L  '<!V
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MTF%E<,C 6$,)!.P]86Z7\L2)0(=WA1)LJ ^W*8Q$TQ[' A3'T;I$Q=!V#OL
M[!]G&DQ*9NFH!&I7N)_FL3R]MC$1;?'AV<9?C]5E(AJMB"2!*[& >9/OCQ&@
M58I0H +A9DU$_< 6>)E. >OT4C*:$![B&A$=CVWOCHG5&Z@02)86VD "9-_>
M1[?;_C24&A*CV%Q3<@&!-SRO!V@;X6*M365C?K-"2Y !%$RZRA$%@33Z1 .D
M5%P3*/6(Z*8A3AZ@7N'%)< >N8$R8(%CS)/Y3MY8Y_$^,U<G0IMV))9HW ),
M3R!V ,J;S?R6R140PE35TJ95B%.*PO3+ L958@&*"::0 4I!%/K+[30& !$1
M  Z@XD#J(0 $$!M1(DVD >0)@@]8FV.96SN<S&37-74E1"E=,:B+EHEA<$0(
M-I PT;8JJS=@1FI\5]L ^U213334+[,  !]J  J!1*4H&*)_I& -E$.#@J2(
MB1>(GQBTQL3RYG'5X4KU: -?4Q(M+,09N1!M8[6(CQPRC+.3";K54/U#WZE#
M#OS'>A-Z^?Z^*K\R>7,B8Z@&#[K8[:4*  (43X+T\8,[_<XJ(X=)@)2*J$ V
M@,4BIR;]0 0 VA#UUW]!XS,<R)CF1Y8RU.D3WA>T%ATY#8C\K8L[4$1'OV$1
M'RV'?OL?,//0[T/?AUZ\_P"/MQ,+36T00(L#.V^*@,<1[_6/8>X:WW\Q]P[_
M "^[C*P3N/@8M.,JJ,0 9\]MNL"/L<\5[. E[CL=:WOO[M;XD1ICF3X"/&?"
M#>XQ)E ($*09DKRVCR]N,YJNHDY3,1,%#GZ")]1>H -U%$IT]@/TB]A Q>X=
M]=N!LT@3MN)!\1'E;VXU\P@9#:T$V -N?L,Q]-Q5(&7</'BRICG/\86]J<PB
M8W5[0VOPM&$V@'O]0]^P\8,L23O)O,P 3R$QX^,7YFNBJBB@6(TK8$D;<NA&
MW@8Z82S"(!L-ZUY^F]AV_6/;B)\>6\\N7\,;"@<]@>L 6/S Q;ZS:WOM[]!K
MN&P]/4._V=^&+-*]/'<[==\7"B(@&_<._P X:_S\,5L "8ZB/<9^6,M/92"(
M]MAV$>V][UK[=_EXN7;W?D,7+LL[6P^JU_O#KZW "'UA[,G</>'<._EQB0')
M)L18]=L>6XQ:O)L(%S[<.70CY (\3D'8@XX\CJ/>,<Z'W#^8>&$CJ/>,<" @
M&Q 0 /J'C!B#Y'Z8:EZCWC%15 !,0Z1UVT(!L=^@ZT._M[^7<!#?$ RQ&PM<
M 7-KQ!'C/SC%4RTBT^,&!$\_GCMP\)GPPKEX@^:&BEA6DZ5@*G;GKM<4B*MI
M&QA%R#!#[DJ4J!05/+NUGB97TP4"M(9L593VJD@9DT7\GZ2>D5+AV7J4TTU*
MU6:80D-IYZJ@-XOR$SX D=[@_"JG$*X-Z=--)+D$ W,JINLDCKL!MS^DS3:U
M%TVJ5VHPA71(:L0L97XDCY\^E'I(R'9(1[ CN3DUW4C(N2M6Z0+/G[EP]=J=
M3ATNLNHHH;XR]4UG:JWK5&+&T7)DVV'D+#:T1CZ;3IBDBTQL@"CGM]/\\+AD
MR!U&,4#"8XB'T=B'?S_4'?S[!KBOU@1'./<1?W?3$_OXS^=_/%'0 !_8B  /
MT>@==^X:^B ;V("/D/GOUXEA VBW3' I_1*;I#7X(AK\F_+R'R'ZNWD';!@V
M)/,\SM];?8QBPV'0;<I@>[[WQ2"11,;:?4.O4H"'8= /?L(=O+^CO$R.^+DC
MNKSGI/Q&T1XX6)((F/#\C?KAJW>S-Z12;?<UV)WR-1J]@LBS%)1-NJ\)!1CN
M1.S17.11- SDK8R)%CD,FF90%#D,4HAQ9EJ+YFO2HE0CUJE.F&D,%[1@+\SI
M9B2"1S$7C%=>L*-&K6,E*2.Y78MH$D#S(@&"/&V.L?"?B66^^KX$G<M\I&0,
M'XGYGG,/$X4RZYR5C;(5;G[#9X=U/U&(L$75WB-EIIK.P:JIQ*D]$H*B_$&+
MIH@!%W#?TF<]&Z5$YM,MQ6EG<SD!_M&63*9BD]-01K(<H P0$$P>H)F >!E>
M/5:IH/6X;5RU'. G+UGKT76I ) *@RLQ:;<Q86D%4^?;E[#'6/KKF'(V*<)2
M.3)FWPM3K%@R_0[$$PM4;G+4U4\/98&36A9@RZ\6DNZ28+**P[QT:%DA3DF#
MI,G*/"LVU5_PR5<U1%-'-5*-5%0L 2&5Q:.1B^\0<=*GQ*BU(-7"96J:K(*1
MK4JC-I/K$TSS$=8Y\\;KD>93 $3E"!PI)9@QRRRU9F*$C7\>N;;#IVV78ND%
M'39=C"&=?'')'34IEVX)I^T<):.W*H0Q!-K#(9]LNU>GEZKHK%7J%#I73ZTF
M([LWVV\!&P<]E>W%(U:89EU! PD@P 0)G<6W.-=TO/?)C7;;E7'V.LEX.B;K
M!RUHR5F"K56;K3.::S;H >W&Y7".C52.5)10$"N+!+.R+.^A$YWBO[D;IVJ^
M3XO57+UZU#-U::TJ-'+N^ID%*--"FA8]U($(H@'D)@'7HYSA=)JM&G6H4RU2
MI4KJ@4$U3>J6L-3BY9K[&=C#NI%_Y:,?1%0H>/;/BNFP<]3+!ENFU:L.X&#B
M)&B.9 L]9;]#1S'XLR-7EI:R%E96=*0K-1],F<.5SKN#'&JK1S]6I5?,TJ]2
MJK=E4+EW97!"!9/>!!( 7<2!M$VTZ^1I!$H5:5-3-550!0RM+%R% L;DMX$\
MK)D9SF\J4]0+-E2"YA<22^.:9+,H.W79A=H1W7*W+R4@TB(YA,22+LS=@X>2
M4@S8-B.#$(NY7!),XJ'*/!.&\1J5:=&GD\PU2JCM204V)<TU+/:QL 3%R "2
M1N3<2R*(U1LS1T4W578,IC60J3<BYV)B3L)&.*KSC\JUYAG=BIN?L6V:$86"
M"JCJ5A;9$/V"%EM;]:(K4*#A!4R0OYV306CHQL*@G>/DET$BBHD=,F*G#N(T
M] J9.M2[0,VIEBR3J,7G3 +DV QA>(</8OIS%(FBRADD @5++?EJN!M)$<K1
MQY@N>W).)LV7;#6,>4VTY[/C;%%=R_?++#Y9QMC]*O52PO;&R2,C$7E1B\FU
MVX5>15.WA5GKHX@1,S=(3I=75X=P"EGLA1SU7BE/*MF<V^2I4VRF8</6HF2O
M:(K4UDN$EH@\Q8XYO$..5,GG*^6I\/>NN6RZYAF7,4D/95!!.AAJ(  8@$DQ
MZL"R]BOQ&L(Y'D960D#ACK&\5RXXEYC'61[_ #,7 Q+&NY7E[%#,X.8:+B"<
M9(PKJO*HO%U9!9LZ<.4D&A!$I3*4YST?SF41F**]7\;F,GH0:BU3+!&).Q(A
MA!L1LOA;E>.97-5-,LH&5HURS" !59D \M0 /(D @\\.&Y>)%R44MKB:1?<P
M./Y&&S7-3$)1;' SD=+5MVM!)KJ2LA*3K=<L9$QS!RBC&"X=KD57DGC-FV;.
MEE@,6K+^C_%:XS+C*.IR]%:U;6K(W9$Z0R R6ZV\Y@#%M?CG#:&@OFD.IV5=
M)E2XTRKD2%,LLAC-[2,:JP)XIG+_ )?K>7\G6R7IF&\-8UR(KCR"R;=,KT!:
M/N[I)V];E?\ R(QD#R]4!X5F1]$M)TGM)>-=MY..4<,#@N&WQ'T9SN0K96A3
MJ5,U7K4$S#9:E1JMV25 "@9PA!:#$R8\9&-;(^D&6SB5ZM6FN61*K4J=5W0%
M] U-I60T!3) %K[D'$J+5SB\JU';TN0MN?\ $\ QR)%(3=#<R=TA&[>VQ"TB
MTBD9.O'.Z LHT/*2#*.!9L*@ [723,7K'9>6O"^(.U6F,G66K1;374T[HP(4
M*\[7,+,$\MP,=!^)\/1:;G-TVIU0.S.H029)8#>_,@1$@X;"7/SR4N&<B^:\
MTF##MH=>+;2ROSB5DI6+B:DW,)&(N@.]+T'>RS-RQ0)HQSK(G(4O2!N)?HCB
M2ZM>2S"K!-J+=T"Y\!/.PN3-P,8_2>2( 7-4BPT@?M%$S(!,F2+F#L(YC#^=
M\TO+DQRU$X(<YHQBAF">;LGL5C92W0I+?((R3 TFP.A!B\!VJ9\P K]F4I?:
M.$!241*8%2":G\!G30?-+E*QII(+%84!2 3-I%CSM'06M.=RJUQE^UI%JD-
M(U:C!F_/H3S/7$A"IAT>0"/7ON Z 0* _1$2]^XB(#LP[[=7;MJ@D:00!((
M VM(%_/IY;8V6 N1<2&VZ&9GY^9YXK*BF E-KN.RB/3Z .]#VWH1T.QWW'?$
M54J%4GF3/Y#RWY#GB7[S,0)*@3%[;D6^'AX7N>R1 W9,NPUTAT@!0$1WV[
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M2*E*I:8XJKFIVR1;)K.$[*O$ZAR+YKLGINM;+JJEE?70:JHUJ59QIJTRUI#
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MOUE*WX<@R57*Y;31#EZ@5N^@J,Q<, QL0QE2""L@@B+;8H\E, LK%025-@#
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MI<[CH1[B+[G9L9(8 DMN5F^Q)F/C[]Q2:44%(B/6F1!+JZ$4DBI@!C!H5.H
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MO.8Y^SG?$-'<86DO([R\R><^-NML>[SX)*(%Y:^;0H]C#GNM:#U'6/([8_8
M]A'RW]'>^W'R;T^/_M+*CIE0IBXG4;3MRY'>V^.OPWU&$B01L0>2CD3S!^XQ
MZU^/"8Z>#AA@X88!'0"/N[\,,1I9?\*2<'S V(TND0[@.[)%:[^\=]@\Q[Z\
MAX88DFG^!^4X?E Q@$/R#V'AABOAA@X88.&&#AA@X88.&&#AA@X88.&&#AA@
MX88.&&#AA@X88.&&#AA@X88.&&#AA@X88.&&#AA@X88.&&#RX88@/G@!-F\H
M@&P^;N/#?EW^7'GOUQ![B/&;F.O7$T,$^70GF.F)\<3Q#!PPP<,,'##$0^<O
MD[Q7SR82F\ 9E>VYA2)R?KU@=NZ++,(*Q$>5B42E8PK=])P\\Q*B+E(I7)%(
MQ4ZJ0B0BB9M'#=X;Q#,<+S29S+=F*R2%+KJ7O @R)$R#X7QKYK*TLU3%.IJB
M03!BX@B/;UF1OCIU5^"]>'&L42J6_FET.A$"Y+H8=P'?KB<?7CTC>GG'-2J1
MDR'F?V!F5$SZ_CC13@^54$2YD]1'Y3\1&VV^"?X+3X;1_P *W<U'O[9-H0?_
M )I?Z>'Z\<9.Z9/^X;>]_P"5CGTWQ+]$94'9O(D$?E/WY8L_U+'X;/\ ;?S4
M?X3*";]8XDV/$?UVXS_,R7]Q4_\ 6QD<*RH$ -[Q],5_U+-X;.M#<.:G_"90
M _7\T>P_/OZ^,CTWXR(ME+<NR>/_ +NV'Z)RO0_#Z8 ^"R^&P __ %W\U8_4
M;*%%$/S#B;B7Z\<9/[F3_N6_]7$1P?* R WP^F+J?P67PV3; +;S3:UWZLF4
M0?> :_K3A[_]M<8_7CC%_P!GD?;0?_U1@W",HPB&'D0/ERY8S5_@MOAQN 1!
M6X<T1@;HE02_KE4/8)EZM!WQ,( (;[:]=COOP/ISQJW<R-HC_9WY?^-'\ !B
MI. Y%"2%>29;O+)/GIOTORY8QOZEC\-WUM_-((>N\F4/8A]8_-+O\O >G'&"
M >SR-_\ _'J3_P#?B<6_H?*?UXZ2/D!\L6U?@L7AM 78VWFE#N'X.3J)O]>)
M!#[>W&#Z;\8(LF2!ZB@UO_U<9_1.4')O?BQ_4L?AK^MNYJ?\)U"_S8D#B/Z[
M<:_FY(GQHU/E5QD\)RIW#>_ 'P6'PV#" !;^:KN/;^N?0P .W?\ ^=((C_-Q
MD>F_&A^YDAY4'/CSJSO^0B,97A>56>ZQGQ_A]\L9CSX+9X<3A-HDM<N:8$6B
M7L&Z:63:,F!2]0G.<_\ 6H$#JG,/48XE#8[[:XR?3?C)CNY,1_\  ;X_M1SQ
M0G \BCO4TL6<R23SY7()B+0(MC -\%A\-<P][AS5"7U <G4+S_P2?9YCQC]=
MN,C]W)$]#0>/=VI\3:TQ:V+OT5E=N\/(Q^6 /@L'AK%V!;=S4@!@T/\ 7-H7
M?N _BE#TW^?A^N_&N:9$>5!^>^]7V<]SA^B<K_6]IG[\8B<9"OP6KPW5DT4C
MV[FF]FW3%)("Y-H8"!#F$Y]C\TP]Q$?/\GD'$CZ;\9( TY.W2@POUM5GW$>>
M*UX-E%8L-<DR22+D1X6%MABLOP6WPW2@(%N/-3W_ /HG40.X>0CK$VOM[?F\
MN,?KOQG^9D3_ /T[S\*PO[(\,2/!\F3)4S[/ISYXY4^"W^&^J %/<.:@0#7_
M ,\ZB;$0[=Q^:;?8-@'Z^)'TXXR?W,C_ '#_ )=M'NCRQ@<&R0,A"#U$#Y<^
M>,0?@L?ALB.PMW-0 ^O]<ZACO_\ ))]OY^(GTVXR?W,C_<./RK8E^B,IT;WX
MN%^"O>&V<H"%QYJ0#?E\YU#UV^KYI/7U\O=P_7?C4:=.2 GE0?YUK>-[VQ-.
M&Y90RPY! MJL)G:T\N=ARP\V?P9_P]6-=<55.T\R9XM4JQ#F5R%25'@ H(B<
M2+_-@!"#L=@((]A\M=N(_KKQ@ #1DR2TR:'F=RQ;XVY8Y#>B?#'S9SA-?M2Q
M814@26U00  0-NI&][X8W]2O^&L/G<.:L?\ \)]#_G'$HB'Y!XR?3;C)_=R7
M_EV'Y5<=4<)RH$ ,/;\]\']2O>&K_;=S5_X4*)_V2\8_77C/3)_W#_\ K8?H
MK*_U_P"T<']2O>&K_;=S5_X4*)_V2\/UUXSTR?\ </\ ^MA^BLK_ %_[1QP'
MP5[PU0'86_FK^P<GT+0_;_6D'A^NW&?YN3Z?R#?^K\=\/T5EOZVT;XJ_J6#P
MUP$!+<.:PI@'93%RA1"B ^@@8N)BF#7IHP:WQG]=N,],IO::+6__ %1S/UO?
M&&X3EB".]?Q'S!$>$$>&%B2^"X^'%,*MUG=MYH/:MFJ+0IDLDT-+VB2/X K
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M^&T!@Z+AS4E'7T1')M!,'O#938B$!\NX#L//S 1WC]=N,J9 RD;1V+;DB/\
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96Y3C[0.HP@4 #!$]/:)^F,@QU]ACZX__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g68105g74q77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g74q77.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[17(4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %:R^54@X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              >@   3J          $
M                     0             $Z@   >@
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   >@     4F=H=&QO;F<
M  3J    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   'H     %)G:'1L;VYG   $Z@    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ /@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MQ__:  P# 0 "$0,1 #\ Q\KJ-7V[(%N?GUN;?<'BMY<TGP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #K ET# 1$  A$! Q$!_\0
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M0H*3P0@S)31$4F)TX?$8-D-%5G.$EK*SPU-R=975Y&22I*72U.+_V@ , P$
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MMH.T23'H'9.0;BTLTE7#<:FT0=.GKA)5TM T[X/^E;B"5IM.):.\O8/5O+P
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MDVKON=3Y-^D?V!_OEY^95?CUU+^\5^[6GY-/C^>E*^<"'^R;5WW.I\F_2/[
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MFK-MT_72DWLI_N_".>/+J_[E.J>5^=K>:)WY^>]^7=SMUK6MWU)'P<='D/\
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M(V(9\$*"016%M!U-5=I((X4601'NW,"MF&986VJ7W,.[M5F *GG<0I&;M><
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M@?#\*<[^>_KO3)\S[S63 \A[A3G?SW]=Z9/F?>:8'D/<*<[^>_KO3)\S[S3
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M[N,C.,7Q:UE6F7T:/;;"*:29;F 6_;G3? 5E+A).Z"=BJ3D@YY',8S#A7WQ
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M[[#:O*1W5.AVTW O]R+;CQUW')$^VQKJ(IE)$ST.]:;(()*#I(^&,6P9-W;
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M-W9.D]J=4CGBM[E6M9)8!;=IG=D)"H9\NXP5'BKY]6''TW;SH5BO4,=TMC)
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MT4.I#TR:\NK>WNC*TI[4[2@]UVW"2*2-A+N##@]S(Y#>+;K5WEN"5[^VW/\
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M;EPZ-OM7T_>_[9U>WKM>WYJH?A&Z1_>K8^FTN_P,)!^VJ?$+J?()M%P/*>U
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M[)'_ )]I^=_7NJGQ"72G?-S;?:MJ'[^4^4;I+]ZM]UO/R:?$3J?]DC_S[/\
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MN),+,8.8R6)*DD'VYS@U7HOJR-%B2U"I&YF54NXEVR$ "0!)^'7 .X#=X<@
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M@'=RTF1R":PFQZ!+I3>5NKPY-L;<K<L;[7U#?E;S<_AYW\O/\OYZZ)?A&Z1
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MV;'T>O.?P!JGQ"72FV[[\.3>]OEM;:^H.?+Y?_IYW_J[Z?*-TE^]7^RTN_\
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M +*19[<=["W&7G.[8]*P+G8TH*;,;SJ/;"U_,RR0)V$5CXMG-R(1K',0;%^
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MXNB1!Q>R#%BA=1T[6O9)NDIG?JU<JLV0JLQ +$*"<*.2QQG  Y)\![:M9E0
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M9 CLVU59FY]4*2WJ@EN ,^J 2>. "3P*,Z(-SNJKQZS,%'K$*O)('+$ >9(
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MU(A:$\: B-[E:B]>;/E$S1E95X&E3[B/4=1Z=QHUOV\QC".I]:L=W:LO&2,
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MSQ<XYIVR%ZNUXU360R2<M[1 ,NV62<M;+7RK>WB'U+AU 8,,'G<"YS[Y'/\
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M8#-ZR9RHYK(F@DL'F$,KB:)M[ G,"=[?%MY"@]P85<JW]_(&*LMIT>'$$A%
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M#ZP?L_O>WV5RR1=96OC=RG>U^7/_ #;S7M?_ (:AY_A_ YH-P]H]OL/M&/\
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M>.[FM)HK:9@L<SKA7+;\8]HSL;&0 =K8)*D5GBU&QGN)+6&ZBDN(@3)$I.5
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M;_0X]U<JK2E*5',E_I);]&A^YC5P^:W^'\:M/SE_Q?A5NW[N^_D\O_7YJ8
M+Y!9MJ*JERP/S2/#Q'./9]-5'K$A,%5&79CM"GV@\'P/&<C/D*T(#0$W3Z1*
M3R-_PXZQ4C!#>\,PBNZ$-2Z,^"0EJR>S8?,W#O=:9K#8[G:YW!S#5&HIPEG*
M&>QF"T4:Q]M&>V'R'HTK0GIE8EO;CU=/=GM&EOFE9BQ)!M<I!';*5YE[A4(0
MV#C%><QI-\9I6-I;L'OTV7(BL3;HG;&")]AD>X(/K0F/>'(4L<EAOO\ )_B_
M]MK7]=K7_-7F_P!7'T>5>C#P'.>!R!@'Z0.,9\O95U17^<._T.'[]*K6BK=^
M^N*/1T6GPS74^WD:FK/>G%3+6:1C68<H$68!)B*):]UCB]9<.NS#1B.E(J:2
M.@0H,;&")0.Y(*VW3$@\?RP8=O:6>DWMQ ;J&Q@@-II\1D2XG+K)Z.[2W04W
M\068LC)*6[D:$J!;LS 'B+J[U.SBF6"6^GG%W>RA6@@ [9F18H,^AR;XE5BT
M8&UBN[,@4#;-^V-S\2L*&%IQ(=Z;&U_"C>PN(IDP< -!Q"=81''4!<VTU'#D
M1;;7)V1O0NWT%G#F1R@THY</F41CH*&&X<=DCJ0'8=I8Z=/)'%%;0SND6GF1
M3>3Q&3TIS'<L6:X4;K?:,!2 =^XH<\2+J]U&**6:2XFA#R7ZQ[;6WEVFV0>C
M@*MLS$3G) /(";06+8J#@^^N/W:Q.71LC(O@W'I'PZF,Q8\/')8G-G^)GA9P
ME@7:D#9B>$DG#V,N);<?8,4"YSB:2A36R;R$L=8-9O@)P>R38Z';)'. )V6\
M@9U>2+L1XOFADM9G&JQSNK18)"V+2L-LHD$9:L!O-<N6D@+&&-[*95D2.43.
M[68DCG16TLVZ.9<J-UX(PPVA"PP?1B^R>*\<WDCO7D]G34%$H8VV3XS<Z2A"
MA?=Q6-ZAX'F(\;-7;K7@U[=S(<I;LIN67C[4%*+Y#%10U^'1B*30=?+;Z+)V
MS*D)>>X:,KZ7,%L8S/JO^Z07!#! EN55\J2P\=QS19]9C#]J5\6UN)"?1H2U
MVZQZ?N61Q&&&_=/DQJ''//JC&5O"]OO;LTXJ,M=S;94J/-GNLM]S";:N.:@'
MP@)J>7Q#<FKHC"([$)PG$@Q";!4H:=,+IO%Y'+5BV1"TK=%_$YV("@VMU+3[
M:'3%NX+=(U%U;01W"W7>:X66S::1I(>ZPC;NJWS40#_=XW*Q;9Z??7$^I-!)
M</(.Q<O)$UL(A"T=WVXPL@4,X[6%]9C_ ,[V@#:O7-5TE*4I2E*4I2E13M2%
M 91A!Y"6)*A".L)P.V!'C:&":BK-TV&EHX?'Y(*W\&X;2:$R.415UAE;-1!(
MU<BSPN28L<\,\$LB%XHUW^DIV63)"ME@R9(\,.%*DC&X#D5'N4C*I+(YC[$@
ME#@*2."&'K<;2I(;Z#QSBL=M/Z<X0)@->[$UA !GBO8.41D;,P0"S@ V+,B#
MJ*;PC#B$#IAB,Q&QQV8>1N7.6$,8L8]G)VBH\VSN?!%!S"5/=ZI&^R>:0/;E
MUV1E=Z,JM;R";:/7<*70LY)P1@D'F)%9Z8VXQPIF5AEG!(?+K.K1$M@(7".0
M@VEAR/8;JRX/N%W '((XEK*.,A1*3CY<3LP*&QQ 0?%(%D1#@*;9FFIN'-!+
M,Z>:AQ4:(A@XM@>.LV#%NS,DD75AU35"Z2&YF9NVZ!BD>'BE8LZL"F)69@&=
MW5I'*H6<E5JX:=IP0QB",1B16V;B-DB+M5EVD&( 9"*I50-V!AB*N0OPU\/L
MBBR\)?P8#E'3"T2?I#1SXB)7[5 ![89$"0(D&*,BHE['1C-NS8D0CUH[P:V4
M366SP7<>%M74-0CD[QGE+*LB,Q"DL+@CO!U(\'/+AQCP(&1FKGL+"2/L&*+:
MS1LH!QM,.1&8R" "@! *^&3SGBK2%Z"X5]1*ZU:B(7'XJ@!D:$8UXV9N9&J&
M#2<F3GDD8L? 8/W0=@^>%9O.,!JYK!/%1])U0#!?PY48-4R27VJ7+3-)--*S
MAI)F<+O9&6-6(. 2H2*,8 P%1<G !&-++38!#''#'&L16.%$8A4(9R"0#@%F
M=SDD$ECC.37NY<&O#4J#U]'<=4QQL#U<U*#H0-'Y%!S<0).%&YPV!<>+R+7,
MY'#)EHT*%HY(<BP,D_;-W3U@NN@DIA;^D[\O-*US(7GQW&8ARVU.V#E@<,J9
M4,N& ) -9!IMD$C00(%AW",<^J&;N$>JP!4L=VU@1GV9%2'M;1.K=X V,<VM
M$1LS#C".94<U(7>(9,WJH]V(<YHNQ[QH]Q0(!R!$,69=H["8#$7PDHV=CG;A
MLI&M[BXM2[02F-I JNR@ N$8.N_.02K*I4XX901R*SSVL%RHCGC$B#/JDGC(
M ."#D9 P?$$$C&#BK)(\(/#D6E4DFC_5$76D,N#$ 4@=V2?I-W;(L!9Q8LLW
M%HOTQ LL5C ]E'"9X4P9'2 -HV%.R2K!NFWQD+J-^D4<*7<L:1,K($VK@H_<
M4'@LR+)ZZHS%58Y4!N:COI=A)*\TEM'(\BE'+AF&"G;)4;MJ,8\HS*NYUP&)
M %?8YX4]!O"5RKG7 -9YF/N+7LKF24:/&-I3)9JF@1'9D,AQ&S:3S.6E6>;Y
MHNHSSDIMLUS29DG;=8=2OSG-RQ!V[B0N\[46-0' #* J(" <':,C-7#3+$'(
MMT!&[@<KZS.Y]1LJ3OD<AFRR[C@C->S!>'+3>MX=*(!$8.)91&:V=X2\.1S(
M2-.3HOA",?<M#[J2OB[XLPR -VX)$>]<K,F@=!$8U019)XH6LEOKR:6*9[B3
MNP$&!U(4PD2&7,04 (>X2Y('SR6K)#8VD$4D,=O&(I<]U2-W<!4)AR?G ( @
M'@%X Q7RZDX9-(:+)&C.K8$-BIF2-&C"0&479@D9-L!M\;"&)<L:)$R!%F"0
MPLRC[5VX50 #[YCPZ;)DJJWSK<W]Y=QQQ3W#R11%FBC;E8V<EG9!X*SL2S$8
M#$DL#5MO86=J[RP0)'+*%661?G2*@ 16)R2J* %!)V@8&!Q7A8\('#EA()A)
M\=5QRQB=BYB&DJG,K=@X'[#14;SS$8%N3N&CKR9(K+8R<I'6 HD=S555*.G2
MJBF65QU&_9(HVNI2L)C,>-H8=DYBR^W>PC/S0S$  *   *#3[(/)(+=-TH<2
M9R582</A,A5W#QP 3[2:]>0\+NBI5/!NS)!KH 4FXIBQ'M#;C!]WHBF9 <'<
M/!V#[ 42* V!4FT F23%V7!H/W28I\SQ64ME1=0ODA:!+F18F9F900#EY%E?
M:P 9!)(JO($(5R/6!H^GV4D@E>WC9P%7D<$*C1KN'@Q5&8*6R0#@''%=B?#)
MH]'.ZB6O06"F48QA>>=K$.><5PAUM?XAK_[(?S>T,QPC_7_W[L>.-[YW7M96
MK#>71SF=SEMY_P#6;Q)N_P P!L>>?.GH%H""L"*=O;SC/ZL(8PGC[$.W/U<8
MR#]$BX;M,RR6PJ<2*$#B<FUY@#3B;]5R5238I18E@:BR;T>W(HC#N,7-86-1
MOQ\S)W F?]EA-V9#FXN2\NHXY8DE*I,6[@&<$.-K\$\%QP2N!_T:J]C:R/%(
M\2EH=O;)\1M^:#C&X*>5#9VGD'SG!2_)/._?W897[K<[]V-_):UKWO?S6M:_
M/S7J*3@$\G )X!)X\@.2?(#DU+^K^/A]M:1-L:0VL9V#N*2@M,FW )W,G]Y)
M!,57&,>W1'W)PAF'F((G@JKB E@/M;=^YQ0O@X5SZK]K>^61<6X_.[KSX,>N
M-1ZOZRU6QZ.O)-/GUV[E-E#ZMMK=E+<W"0:E:2%F[=Y$&#RC'!DWHH#21M]!
M=/\ 56B6VE:)97&NPQ3VUE&MO>=N19-*F$2=ZUE18SZ3;SD$9SZI+9RH4K9:
M?#=O[ DP:,8E*LS#2.V<0K8Q,;CAF\ Y#5$L].;,#JK9(9H?Y-89@7?7<-4L
M? HWLJ(>(W&\JOP._"69(HQTSJ+7!MS-9W\RJZ-:B+!TF_C+ K(5(A5RI0D%
M%)A)DCV;=8],O"[-J%I''+.HN-/1IS&)U 'Z5MI.TIC=L;C#C=G#@[QN?Y67
M#=N)^VCS5#54Q QTX>4\7ALL\_'>@)?=VV4M+8V2<O&ZQJ($E,;DWH_%1HBG
MA;LKE6Q8>T(/:Q? [\(MP;01=)ZK:VUY=&-("1W>G[PRC,\1[_<-FV!([DG:
MAVMEXD<W2]:]/HTSMJUG+/#;XDECBE"ZU!C"PW,1B(6Z3@+<Y."%/*EA6VSA
M]T$%TV'7>+79$M@RE!BML&4L&SA@WD9=E@XMB^2&J.5V["^5W"V;A1G@W\8.
MU%GKE.ZBUL$ON#X+/@NT[X/=.WLT-WU%?0Q_IK4X8RD-S*I)401N6[2H&97>
M/MFX8M)(,D*/$NJ.J+SJ*XC1S)%IMD7CTVS>3N>C0EBQ5I,*96/&"PP@ "@"
MLC,<.KESY\_);ER\UKV\O._/GSYWKUD+@GG@^SV#ZOKKE:[*NI2E*4I2E*4I
M2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I
M2E*4I5N2V)@)S&))#)6-;FHO+@):,R,,Z\+9J5!'6"XPN.<W0516L@^'N7#5
M6Z*J2MDULKIJ89\LK55F1UD0E74Y5AX@@@@_9BK7175D895N"#[1[1]OM^CC
MVU'!OAXT[(\AV1N!@268C966X!:KI!QFN.V6HS5'JR]BO9UBJU*JL%EF:ET,
ML&RC951'-ODGGEC>0EY=Q[^W.Z=R%;>4#P>%6WA"/# 8 @\D%149[&TDV!X$
M;MSM<QYSE)F7:7!\R"0<8X)'MKP=1<*VC-%$<RVL(0A'R=PF$8;$'9F329Z,
MC."S9Q:-@W<L.'',?C^;AB/76"@U1XQ=4</47:J9L6F2%;F]N[M=EQ.9%WM)
MC8J$LPP6<H%+ODGUGSP2 .2:I;6%K9MOMXMC;0H)9GVJ/[J;R=B_]%<#@9S7
M3EPG:(SV')]I*0Q568S99\O,'"\IFJP&3J$HUA#GWCV&*R7*&%$W,732"YHO
M(^LC9FBCBGAAFBEGA<VH7K100&?,=NJK""BYC56+KL;&Y2')?.>6.2#5/T=9
M]V6;L^O.Q>4EW(<LNQMRYVD%/5QC@8QX59>7 7PL>)@8%OK' :QCATM)@ZP6
M73\"7;'3807&B))60!)8/.O5\XV$$1QIB^(N41D>&L@8U)H+;)-<<JZOJ2F0
MBY),P5)]\<;B5%9G56!7'$K&0D<EL^TY&#]"Z;B-1; ")I'BQ)*#&\H"NZMO
MSDH GC@+P.#BKXB7"KI*"[#>;5BL9*"9R16S<DBN$WG[IF4=Y1]K%>VE8^_E
M3J.$WV$?8LQJ;U\)7=8)-&JF*UG+=%;##+?W<\,=O+(K0Q B-!%&NS<S.P5E
M4$*SN[[?-CYU(BL+6&9YXXV663&]NY(0P487*EB"57"AO'  / %9$XVY8VMS
MY\K6MS\_*W+GY;^7Z[_742IE5I2E*5',E_I);]&A^YC5P^:W^'\:M/SE_P 7
MX5;*R"3E!5LY1P7;N4E$5T%<,5$ED5<<DE4E,,K7QRPSPRRPSQRM>V6.5\;V
MO;*]KT5I$*.BMN#C;M 8^) /T>P_7X55E1U='?:A3# L4!R,X)'B#GP/!\<\
M5^>O36MM/0GC@) (["]1:WQB?$<=:1:+NN%[B=F$F((YYX.$I,"W@\E*>HP+
MPFL^?9L'MX[F'BZB.;1FHOB@B[5]0O9[N70.[))=7+C3%C=EU.RB2,,QS$;'
M;WW11PP#>MCUFKS2Q@M8M<"1I:PHVI&18QIM].[N$SO6[:0VZ%]NXG& QW8Y
MK]#'E_Q_?7EY\3QCD\'Q'T&O3/?]OC]N/;5U17^<._T.'[]4I6)^7'IK )%9
M9-)Y$-J0^/Q#:NT=:E"]M:S<^)9,=527*.&9P6+BHZHQ$QASGX-VBNZ5R4RM
MB^;L_&&0HBJAN1H-X\R0026\TCVUM<*@N80Q]*B$T<<:%@7<*?611Q[?$ Z4
MZW:)%)/,LL2+<36VXP2,,V[]N1W8+A4!! 8X\,8.#5O;EW!P:;8:R!OM^!.=
MDB-02=(:.=&]-RV1B2TD+3<;J,R+UH1RCRK:<+LI\38P29BXRN023)WP'E6S
MA!&_4MMK/6+=HFMIEA>ZW [+J-)4[4(N%,Z!LPJL;=Y'DV\<KA@12XOM*G64
M7"&6.VV,"8':.3NOV=D#;=LKF3$;*A)R0#XU]TJXZM216/R1G$@LHN>BPDBD
M "R:"RZ$1(R8B2HM"6P0/+'P'$ XE<%;O<T9)&ASIP_$N!1=A=OFL"-8C[HM
M%O)GBDF>$13O&SLLT4TZ";)AE>$2=Q4E*^K(P .0W]Y<V2ZS:0QRK!'-W($<
M"-X9(X7:(*9(TE*;"\:D[E4DC! \&QVL>D'TGX9J *)S<K)G*Z W)O =5[0E
MX9<\59R M&XTQ*M(GC960R 5&BRHT4M@@X66'.^5L$,4%UK?T'>R(95$:Q8D
M/Z^ZMXFV1E!))M,H9D0R+N900 ?:0<9!K=BK%&+M(-N!%;S.I9]^V,D)A7;M
ML%5N6QX8Y-HP7?7 1J47*-Y003'8,QFI7/&5S()KLH(>%7C_ $*]XOE\R&*
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M:]-K<):(N]YC$Y0(6*!@V I!(X.?P)J%^D; 7"V8NX&NW)58!+&'W ;BI&2
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M<W["XZSULUNI;P5GRK?%EX7+%+M'A,\,;PS\-'P8*)BW66D@V[[)EQ=AU)(
M(C]&,C)DC,BH8_\ I5F'1_4I[&-'N@+E2UN2$VR@>(5]P3<#QMSOS@;<UZH_
MB-TL5/LHPPV/&W!HHQ1)B6EG"N&!ABOCAFFY$/5$,&!9*^.?.^0YTYOAX->V
M=L;MG'@I5K\+?P<7M[#I]KU?I4EW<A3!$&E43!L%1'+)$L#$@^'<)SD8!&*P
M2=+]00PRW$NE720P,R3OM![+*<;957+1G/&&')X'-34FK93EECE;+#*W/&^/
M?:]OS9>2_=RO>]O/:WY[^BJX958$$, RE3D%2,AL\<$>T9'(Y-:$@@X(P02"
M".01XC'L(/C7=5U*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*CF2_
MTDM^C0_<QJX?-;_#^-6GYR_XOPJWK?+^;ES_ #6YVMS_ *K?KJTE<98E,< 8
MW%CSG&,XR!GV'ZJJQ8<*H?(\2=H7/UXR1X>!&/:?&M!(=Y$Q/2,D41M\!$D*
M<2!%F3T6SV]Q.,]GED50MW[CB+>0]&;)Z/>ZR<9()/U@[B%*@<XTW3;6D.<G
M2PC^/I3F:3IA>Y(HB72&N$OFBT]K<(KNHL$;;Z8MSP1ECE2?FX]:O.8Q"O4V
M54%FU!HI-.2;4%N6E[8<7[>L+9K;P.U!M*^.2<5OU_Q_CRUYH#D ^8S7HX\!
M[/H'@/JSS[ZNJ*_SAW^AP_?JM*B5CIOAUG",J=CX^(.MR1/9L3E*S0Y(,DU2
MDDG(Z1;+#N+H%<+(NW$XC#!P_30\%D/=C<F++)HUS<M5);75[ 8T,DJ$""6,
M$#@+$ZPD$@A5[<C -\T@GDDBM>+2PF#D1(P8SPR$%L,7D5YE;! 9S)&I;Q8,
M/*NB9<)/#K/6JK:20516]BIHV@1$S"=1@Z-,R&<FME&B@211B3!SH)^_F,D.
MDU78<DQ<8-2KP(@HF 6S&5=#JE_  (KGU" VQQ')&=L0B&4D1D=>VJC!!!P&
M^=S2;3;&4DRVRET+88;D92TAE)4HRE3O)8D8/./# KX ?#'PQ:=B]U14'%Q*
M*0S&,2O)RO(I0HP!I:H+R::QDJY=$CKG--I%B<EDA6UE5,FN:+Y5L_P<,6S1
MLW27]]=2LSS,\T^Z+@*"YE C,855"X8!5  !X! ]M433]/M(@JPI%#"%DP6.
MU1$QD5V9F))C)9@Q.%]N17? =+\.&2GC2#P[P'B28QN7-GZ]YRT9KRD;#U<X
MV?$.3KE%G(&"$7GSELF]$YDX^HY?OQSK+,X&=MQU9[R_\)YWW%&A(#QLXC9@
MK1/C)3UH.0P5O4SX-S2&TT_@PPIA664,594#H&*NN[:KD"4\C();QR./&$<#
MW"R)F$6FPS679)##L0-HYX*;;%R!L7<:A:>MQ)K.)*2S.*/I&A D$(:XE!,*
M[D1"-M6P4B4>,6J*2>0:SJ?;DB]);9*&C?U8C(8VE67;W"@D""2-7 5L!@",
M'QM_1&FB6-Q:IOC99%.7V!UC:/<$#E"=KLI+*<@E6SC%<GW ;PID8N-A[O5Z
MV801V5,?X.?;,;F46#6+"81<&I)FTR2DKJ,/H@""QLU%'9=>-'PPMBP."B#=
MLEAB.KZD2&-W(2"2.$QN,S7&[&S&X3.\BMC*LS;2 2*N&D:<  +5!C !W/D#
MMK%MSNSM,:*C+G!  (X%3!&]#:DB!QI(XU"V <NP>RL@Q<-'12R#1U-T(VUD
M^;8?F^S'(I$F\1CB.+7!IBU8)C$\1J+.RSJR\5[NYD4H\SLK! P)'/;+E,G&
M3@R.<YR=QSG-2$LK6-E9($4KNQ@' WA0W!)!R$4<CC'%2YCACA:UL;6M:UN5
MO\>>_/OO\M1_;GV^=2@ . ,#R%<J4I2E81\:)*6@UN&\]#<2=R8'<&RC%\A[
M1=\@GF/X->*IP(S*LTL%47+&\DP"8)-WJ>;5P4S&H=3-RHVPOM-+2"22=+@J
M(VC@7DX)!OK0/M(((/:,G*G.W.*U6JM.L<+6^[N!IRI"[AN6UG9-V>,&0)PP
M()QFM=1O;O&@)>0$X8V)+YW*82XEIZ/Q\=K,1%@&T);->"G+:<4UC*!H )GB
MH+8;0L3C,7S1<-#=LW"(TB6(R9BT(9= +;1.W*L<,213OL:22Y=WLXH=4DMV
MN(SN!):V",RL'3)#!0!QH&NM8#QN\KO+#ZT:+ BI=/-ID<Z0$;5 Q<!P"&1L
MJ4X)%23H;>O&)M$3K<<:VT*3;G-N'FY:>1" K2,HK%0&FR$^?0LPC*-#ZP ,
M%<9JQ;@,WD<B1,Z-$OG$6?EEINSL5QC7MKH]K)=&.!W,5G&R0S2=A.])=10K
M(A2_N7?,+L^TRJK, X6.+BL]I=:Q<I:AIPBRW+J\T47><1K:/,T;J]G;HA64
M(O<"^:^LY)$3QO?G$?LF(Z_(3S:,VS>P[B(D(*12&-:_#MM>3X=(^&#<3T/!
M\DUM>10QF!PV"/$@7 .8PL!*8D7E8$4:.'I.Q"'\)4MCI<4Q6"&!H[B")D22
MY<36YCO88YY7"W%PA)B,H#I.\<H&^-$ P8J7VHR1 S3SB2">57DAM0T4V^UE
M>"-=T,3+ME$>Y3&6C)"/*Q8D6DUW9OO5$@V466E.Q'+F\>RS#D\M7QTDKJEA
M+8SP"(,F<=<%X\D!CT*9VDTY4>.RC.3!1+L*_/%8\?*"2K9Q=+9:7<"$Q+:I
MVV5"#<2$7(5M3=CGO(S.5@MXU561G)&'&^J1WVI0-+O-VPVDL?1E/8+^@1Q\
MB)O5!EF=B0P&#E"1SEGP"[;W1MJ1;/V3LYN4*2NW#YKL&/7> B$8921]!>)3
MCEC I]XL<QR(-6YHU&!,/?FE&D4C-G.) >_Q !F3E@Q0UVO6EA:2>CVKQI M
M[N)242F-9+.T=TWB25B(Y#(.9'*D%"Q(R=CH5W?W2&>Z61I3:/MWH8A(RW5P
MBL4"1X+1+&2-BY!SM'->!$^+#B$":+2W(^F9':Q 3*(J$G,+(:1=:T5CLXVY
M"<X\"U0.?.1S):06U_Q"%H/%W1!@V4)#(\?)H2\J<)#>V(T:PLYKLVL<'HF^
M*1HI'NC*-MNYE,S* 602VJN2K9 <;E"@X!=1O(+07<LS78$\:O$EF(G43CM+
M'DD*_:N"N67!VG#EL;C&VU-V<5"A?BTTP8VY,2/P7TF;,Q^:ZSUL,8+0DA"D
M8&H_(E4'NO 9T%()>FYD[EID,>[,B4M9.U'L%>P^T>78NIEM::4?T7.MO"HD
MG"3^DW."XD-P%(*W+J4C55SB&%XV4=S?W%)B3WFI[]1MGGE8I$9(O1X!ZNP6
MHR5-LIW$O(>9I58$[2 N%K>8;<0V4B3M-)(_!%)J/'QZ$KP(>K#I0D-Z36&
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M/WY9WY^3R\\N_GU;<^?/GR[^??5-JDYP,_CG'B/ GCQ.3[S51QX$^S')XQX
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M[-O;%[J26:WTDEO7=0R&2[9SX>.%&'RO'0ZW<"6YME'<FBDFP]Q.$@5%N-5
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MJ1['P)&;#,.5QGD"IOX,.+^<<3A8XI)M.+:ZC+V*AYYKT]<LY>9&HZ9*E!N
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MW,R8:S.\=CY6,-B[@PRE1:L0EE;2QA+>UEC<R)OEDV1!R(U66;MQ*Y8A^TJ
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MKC?RVY_7W_)R^6E*IU<?+RMYO\>JJ8'^GM\/+^O#P\*?Z4ZF/FM?Z^_R_73
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MU@M_YD1WV@.?N?5?_#-O_P#T M/_ 'BN/_TFGR&1?^DK?_EG_P"\I\:P6_\
M,B.^T!S]SZ?^&;?_ /H!:?\ O%<?_I-/D,B_])6__+/_ -Y6:G"=Q/O.)<5,
M23J&-H=>*D1;+!% ZJ;[=XQ:NELE<\U1(J[>Z/9KVZML5K*>$Y]?&^/*_P!!
M? K\+L_PLV6MW4^A1:(=(GM(%$6H-?\ ?[T;RDD/;6QCQL ^:0=P.>"*\RZY
MZ/3HZ]M;5-1_2(N8C+W/1UM@OK 855N+C<!G.<K[1CR[]@<9^N]9E)\A*XIL
M!M'-<28C"I#.6S.).8WE+QNFD=ZJ &#3&8XR]99>"KIY($W,59@+%[W'N2[>
MV-W%>YUQ%2>UXC](.D 3A/9\+Q3DCEPS$75/,T?#NVQ%,0JU7\-EA9DX\:K(
MC$DWMV^3@@LDS;65752PS4KO&<1&DS%XOB.V;#'64S)9B(SBF=:=<P23>BQO
M9&B>=\,[JK$3@5@T\)BGB]>F0[5IDLN48X+J538.[PL"D:<31B<YG<A2BR\Y
M-"( '8FB$=A:!#(7>1$F;TN)</\ !R^1>-Q,?C29^92!4<2PC\:*9#W5DE*^
M(MQ-:% JF$36V8&,7 $O$QEL\D3)%T/+8V,66&+M<\K+W?M58\>;/FB>&:X]
MZ%*L7R;=X/=(IJ5\X[BDX?"[L2P%;@UZ1?'G.3,*S9RD8NY)NNT"F:231+%;
MFIVMV> -6"M[XHD'$@ (LE5U#8O%TI5JH\9_#VL&A9:T['67G+K7#(: Q6;K
MR(<ZVC8%E'$CHUHNXL-LTM(P_P (5O#K( \GK;!XKBHZ9XN%*]62\7/#_&8E
MC,U-D1PT*7(8BA[>/$V1,F4(9.(VW[,.9671NOR^%\6<>'SS2:YM9$"7274P
M-"NV*5DECEUL;9>3G;G2E5I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*5@1Q
M*\&<7X@-A(3@UL=[$W3*,#H_XM;#1SQ.[5B0+O$GN2KI^T5QNLH540ZG4RPM
M=#&^&5\LL[6^:_A:^ ?0_A*ZHAZ@U#JZ70[B+2;73C9I;V<X,5O/=S)<%KB[
M@= [7#QX"%,H,-G->D](?"'J/2FFRZ=::9#>1S7DEV7D:4'>\4,14!%8958@
M0003G!XJ K=%] +Y=7^&TKU[)V5OC>/A;Y63OC;*V>5O'//J=6]LNO?\F^/Y
M5K\N^O,3_LA],;BORC7(94WE3IVGDA",AB!J/"D<ACZOTUUA^&S6O$=/V8&<
M<3W>,^T#U1CZ1[/=5+=%]K^]DKVW>3O9;*^*-[1\)>RN5K\KXI7\=<E,K7O:
MU[8<[\^[E5!_LB=+L$*_"1.PD.(RNFV!WGR3&H^L?H7)JGRVZT,YT"S&.3^O
MN^!YGU:X_%@:^M92]]WDK62RMBI?Q"$Y)Y7O>UL5+^.?R,KWM>UK7[[WM>UK
M<[53_P $7I8;L_"3-ZG#_P#!UAZA\F_X1]7[<57Y;-;X_P" +/GP_7W?_P#C
M68G"_P -03AQ&RP<%F3F7VE#X6^<*NV3-C=E=BV<II8X8M7;OPF*^#G+*^>>
M>/=ACU;7MSO7O?P/?!3IOP6V>LVVG=02Z^NK36D\K206\"VQBC=%"BWFGR7$
MC-EF ("X4X)/GG6G5MSU?>6UW<Z?#I[6\;1A(7E<,,@[LR@$<CD #&?:<$>L
M7X2M.''&^"A *V6E/$!8ZE)9OD'BZLTC;.0ZFC>GGPZ'2-<"J1&C\8W&D'R+
M1^L42\<$2BJV*S!S@/2]IKC:C.=\ NK]@3E&=%IA/4W24_BFR/$V6$$,@D9%
M#91'96)5&,Y-"3B@/M3R-M1AUX&79%CL?<. I BHSQ:XMU*\^/\ 1YZF &XV
M=3ELY?K1PR%)HBWS> 9QNP^-2*.2J/1@)&4H0D#@\=%&X[=Z@Q@+&,9V<G#K
MS!=-\NP=#5*R%V!HYO-9/G, ^PIYKB1OH>I 3Q.#.8ZB[.1/Q@Y*M&2B\@CI
M]8.2$/B!9<-(8ZH(-CLRS[))[DI9KFU4J',.!C6WPJ!2ES--DO\ *(EMHE88
M)>E(\NPC7\,SV6E]BLTW5XS8T;2.'9:J82=R8J9*CEA IHQ((L,BK8HI5E,^
M >/#]A^,F>PI@GKQ^$@:<DBN7P7S(2(]K-;47P2Q>$\XE=TRCZ2.FXV](HA'
MHPF]*O"Z>;S$4Y9LQZE>>!Z,?1,=&LPXZ13[Q:-P9X#DU[P=5^VZ\DB<JDMK
MG+0G ZLC,2T2;J&6BA*[1HF2?)@D!-FP.X=2O>$='EK*/L%&H*?;$$/'XYY'
MI"78,]9MW\FB+Q/6*64;+X)Z\LRR33MJ:,>#-M&C6288KF$<"^+=RR1'*5G[
MCCU<;8V\EK<J4JM*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2M/W' *=D=Z8
MX@1!Q8J[U0R9'V"[59Q&MEPQ(X><%(2)6[&XP93D??K$0BB5[KJ*/4+HYH.D
M6N#SX6_VC+34[GX08#I-GJLDIZ7MH[I;:">6VU&U6ZU!KBVB*0R1)>0H1(C$
M[RS(%&\1K)[C\',]I'H$D=XUB$.L,\%Q(\:W=A=&"V6*=U:17EL7P5E3';!#
M9!W,5P[9A)-BXA[T=F5;O>QY#-3;'*"L[-(\)30>(O=2[?;J"LVWA41Z]V#%
MZJ@O;JO<,[*+A%T[#/ (]/ZD_L,B6VLK(,IHFH26]VT21KO[FDZHK0A9&4'M
MH[DJA9LI)!)F/NFN]),5V&-F\1>,:K8)<6ZO+,I#1WVDRY!52ZB22-&.5PI
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..4I2E*4I2E*4I2E*__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g68105g75h78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g75h78.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1>:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %WZ^8!0X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              I4   7S          $
M                     0             %\P   I4
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   I4     4F=H=&QO;F<
M  7S    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   *5     %)G:'1L;VYG   %\P    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 10"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MFE]Y(Z _:CV(]R^'_P#-[ZR_^5F9_P!MO2_YO?67_P K,S_MMZ]P22^\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M-CA$14=(<G:#A++Q*$-&56)DA96EPL;'_\0 '0$!  (# 0$! 0
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M]FWJ%Q<+?WRI(X1;NX51S7R )G4+@'Q 8P.F!Y,5#'NLY4W_ /&5/=P<8?\
MA=)MP#UQ_P J]'[JZ'<%E_<K3]'3_!6F+F[/8\G;CK)*.OST]UK*.FONF3O0
M!&VX?;C)- N  $0$?930!T'HWZ];6H[AL<$]QV>!D9Y$?:.I'O>GSXJ!=7)&
M>:P'9UF<?J)!K7[J^4M>+[I<\U'73_AA)=^@Z"(#[)Z" =D!TTW]%.X;+^XV
MGZ/'].=N,=#U[.E3W3=' $K'/9B9C\?]:M(Y9RF&@^Z7/=-!$1&7R;0  =!$
M1]DPTZ_3^?HZ7<-CC)LK0#X[>/X__I^+QX\O94&[N1VRM^>?[:H.6<I@(_\
M&7/-P\4?^%\E'00 !$-?90-^@A3N&Q';9V8ZD?[.G:/C"D?0:GNFZR1S')';
MB9SY/C^.J>ZUE/OESSYWR7UK3N&Q_N=G^CI_@J>Z+O\ M'_.O]M/=:RGWRYY
M\[Y+ZUIW#8_W.S_1T_P4[HN_[1_SK_;3W6LI]\N>?.^2^M:=PV/]SL_T=/\
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MS0+<V\4$$G\GS2PRR]&EE+W"@1\N0,'3<Y96P1G!Y[&L+L?8;)\D LD$P@$
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M!)<01%Q;ZC!:M,LI0*(^7))*Z##,B^ ZC)$<9GV,=G-5'Y#+8/*;WA_LCT7
ME@BN2L'P6,8NM<H:[26R7SXJ6)4Q\MB[H\E!#$*5J=VJ5HE;.IN5.4J>W)I9
M3<^G\2:LKQPW4;(C&=Q<7%G?7<]VT;1HT,6QBL#Q)EV/*DC(==J1*&>M>]T?
M3PDDT4G-=0B,$FL8XH&97/,EYGA2@L B['+J4)=I-^*GR/; >QG!9XWPETDR
MF6.\D7;/BP]X59G@$E;\8I7;:1R#B_*:H2G+%$59)JP'1J,Q)^-]G88T@TMT
MI3&6GN#0M3.SIH/Q3Q!=VXF6/N54_E4,D=E=1-.$TVWN;7*M<.;=A*\R I(2
M7C)V9!4=#^0='MY6A,QN&D-B0_=5NRV[27TUO<#P(E25518BT;QG:'P7/:<8
MDFQ'LD(82U3%]RU+UA*7$CED2XIDR=BE-[L+DBV:UN9'-'CE'?$WQTQXBQ]D
MQ(GP?*4<T2RYT>7Y>4I:?8MR1JV$.J_$VNF66&&Q@W"\C@&^SO\ -FIU%;5!
M<MS0MRUQ;2+<QO$T(C7HP?<'//&AZ.J12S7;A1;-.0ES:@WA%DUPY@0(S0K!
M<*;=U?>TDF%0IV#SIVF<<1#$6><G8V@4B4RV&Q.2GH8Q)%JQK<7!S9#TZ5>@
MN<'%F3I6M>N3$J[4:M6WID:-0H3&'$H45MX)2?7:/>7%_IEG>7<:QW,\1:55
M5E&X.R]%<EP#@$!F/0BO-7MM%:7T\$+M)'&S!9&*EG'@L"2!UZ. 2#@D'IV5
M!==.L%*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E4N_HW?F']U.VE9"[5NGOB\SZ
M='NAR'_:KJYVC?\ PJT^1_\ N/6Q?_[=-_Q#_P!M*AN*21QADGC<P: 3^RD4
M?F>2MO/";E"07%A<DCJAM4D6&%7G)Q5)"N7)M-*N,*X]EIE@W<8-V:-989HG
M)6.2*2-ROO@KJ5.T8.6P21T/4=A%:RRR031S1A2\?AKO!*[E92H8#M!..F1\
MHZ&O7O:"SKPA.%TOMIR/@3%^%XAD=UDUBAL@T3:RXN]9)E4^P_G>6R)^,C<[
MDCTAR;)%F)<;&GWR%Y1K2H@V')V%H0@)R\CP&EZ;PK?,UO:ZO=7UQ9HHD:XE
M99>3';W%A%"JS6\2&VC%S/MY0Z2XYA=1MKUVI7NOV*EY]/M[2WN&+!K>$;3=
M-+#>/('AGD>.21XH-W-;=RU\$')QB_D'A!,]95]LI$ZCN-90<_*69[CBM^B;
MW)GB!21C@Q6/"IK$7V3RE\?G67'1IN;RSY)D%SGKB2Y-+8\MMZ!S:&]2E[5G
MPII5@$Y%S=1B(2).RSHBW<<LC3M!<JFR-(5E*E$@6+*;E<,K,K<RZU^^N^8;
MB*WD,O*:,O&-UM)'$L(G@D=VDYAC4J7D,F&VN"K*I$DS;;)VU(6H+GSDT0/'
MJ?+&.,C6 V1YI8[2I05M,&LT^E^7PBXR=XD".62IW98U+&>4%D(&&./L?:4L
M<:F>]N,:1U(-$X<N!+:+<W%Q)9W5M(TDTKL(&TPM#!9++(B1&&.*1HG@#.\L
M<C,Q?J];,VL:S 1<-##;+/;W.P1B+$IO5YDMQLR^Z61XUE+D (X&Q ,@1G.=
MM[:5?X$Q1N5*XVOC[[@9QPZ098J<WE<KQX7[3H9<N<6$J9.;=").A2XC8VPC
MFD=B!;BEM6R9Q87=7*1D2_:M^'-$ANIYXFF5QJ=M>X9$C7G!);J..-Q"K3QR
M->M*^99","-614"C5N-;U-X(8Y50(;*2S3H6#18BB=UC+%5E46Z1*%11[Y]I
MW GOLV[3&7MHZ#N3;#8>Y)L6X:V9L*XQGCH]'M:Z3F0^(3R&(BYM(7!"2PHU
M"F:964P!M7&)FIV=#FY@AB=>N.!K7.!U--T:QTFYC>YGB-[?:O?75O' LBP\
M^X@G*0JAW[%M[83E0[A<RRE0 5 O>ZG=ZE!B*.3N6STZQM)&D93((HY8E:>0
M^"6,UUR02JLP"Q!B0&(\Z@#?H(Z?'T_NUU^2O6UPA@ =>F!U-9E[ (KQVI\?
MIN*D,B*]IR,@R]8Y7'6-(8%5XUEA>=CW.\DLR^U.DQ/=+5J<>(/%<$Z*^P;3
MK2K@X'$^P:/<9)$_-M#8[>KMJ NH38JHZ$[K@1A@.IC+UU-$.-5MQM'+:.Y%
MV6QM[C[FE%R7\6%B+,#UP57Q5AH.HA:(CK=I^%IT<8+A"[3HZX;_ (]:[_;U
MR"3VX\OC%<B,Y4]<]3U\O9\U #K[]W8Z?^SHZ>MV*5+MM Z%L],#]]?03C,G
M@Z34&Q;A.9XLC#WDG($%P),9K*4<821YF8%"QOE#AD91.,J#EY;;*W"1($R-
ML"$K\4Q8F-.O-7:Z3KC2[$8_E]V>+&GXAO[>^N(;"TN+Z.WB:227F%%A6)8+
M80*T(CD+,;E+@[T#*$!R1[NV[W!%HUG+:Q-<7,5H]S)"QC6%GEEYQFN#,_-W
M(J@1/ H1@&$A("U";7L!;,TBQUDO)B7+CTPLZ#"L,R? FUQR]C1WE[/)73#\
M1RA)L?2E@MQW'6Z5G"J?7:/,KY?*L4'E*VE27:P/M[))+VW=/%>LQW=E9M9I
M+*;RYM+F06EXD<BI=3V\<T$O-9HE!$1DW)=-AU)9"Z9U4T#2Y+>\N>Z76-+>
M&>V4W5JS(\EO"SPR((E9FW2N%WO&Q>/)+ ,HNB:\'AL>1U1F-41M 2@6>*8U
MC<N@K$GG,'>)XAN>2,UV.,GR.TN&.899:W,SKC6(I5T/;!:TYC?D%I>&?*#^
MC=HF,DUX>+]?F6P4:9![O=O#-,8;E('5.YQLMF$LS/(3+*1*S,'$)5H(R'V9
MIN'-'B[J(OY,V]HDT4:O$\F[W0;YEY:;%/+3,0)VF0%)&!3=@)CEJPJZ[&FT
MLY.L0*'.<8G.%#8O-'64?T8A(W=W;'>/Q.&VI45UJBT6\];*'Y0K=S3TJEF1
MI4C*4C5GN_K;R345XBTD),5TZ:&]2:S$38,D<$96263:"02X"+B/:5;)).%\
MY;K9/I&HL\:F]26WY%P7PPCE;EE5C!(R2I9F\+P2HVKC)PT_OV*[U<T9  )R
M0!D^4^6M=NG%'773C6[PZ0'\+3I$ TZ==]3XC\W\?K_CQ5?/3'BS]8'[ZSCF
MUHG\'U@4Z9CQ9"CVB<TM^%@M#18?B,8Q#5V4;5O&TNMC[?E92SW1"\L;B3WY
MTRA;=<!J8 KS=J O%&HBW'N+:99OJ.!T%ZLTRV^WL',-IO,V1[T0'/6NO,,\
M/61G!,JW]VMF ?"[D$41F+=<[!,P6/'0,)/GP9UXV_L[_#OKT=<I?>K\@^JL
MS-@!IQ.\;5F/4^<&]A=,7I(SFE\DR&2H"G9G.,C.#,ER2/WGLQ\AB93XJ3R=
MI95#6Q7R=@!\=2D30#LA%8!]G!XFDO8M&N&T]IENVEM8XF@8QRC?=P*^V0*Y
MCW1LR&0(Y0,6V-C%=30UM7U:!;W;W,$N&??G8"EK,R%E#*T@60*>4&7F$;=P
MSFL])=#]@C:4Q\ZNV*8<=BA^=\E/S!%I!>[Q;$24QXQ[LMMTS=WN20%_D67T
M\4QQ-I^T+4+9&F[(U]K*Z.YCO[;U7-[XX?Y2*\XIT:Y@BOIVOE2V26:)UN+[
M(N-3:&%$N(Q:[KB&%E#2O&!(J*!&I)(]!/#H.JP2/:Q/ SW3)%F18$W1:>KL
MSPL)S'$\P\"-)/ =B1(0NVNTFG!M[*; KR&TH<V/)<@9L#I<DQJQPRU"%L-9
M9D@=\],<@:I?.$V'T#TZH1]S*&N$=0*\<8U;594P-;'.>-SDJB@2/%#QEKKB
MT>33X"KZ@MO(1;7:SR)MMO"BA[I91A+J3:XFE5Q$&$!4/MF7AG2E:Y5;QVDC
MLS/&)+BW,:R+W5'L9^YPY)Y2 (8%P6&)@V#)C#M"[*V&L.9CV:(?@66IL[+L
MBO;)8[M>0I(QI\;38TQWAQ3"[VR*(J84Z17'<]/>'EL>4ZIT*61MN9EQR3)#
MBJ!<:Q=S2M=U'4++6I]3MVTN.U68I)!')W5%M#Y#1S121M=1@!@RH1(S(I@4
M]#RM0TNRL[C2X;*9;YIS")1,RBW9V:/*%T>-DA<L4PW5%5L/(3D13P@D,@F/
M-H4V%P*.,C&7'X+"FJ8.41:U+' )ID5O;3$<WFN.&-:O<53= 7=](4(HY>8:
M2#LF:;Y$4B0EO=J)/N\)W<]]I*SSSRSF2ZNN4+@YN;>WYN;>"Y?:ADG$3*[N
M$ &0@+8S6IQ%!#::D;=8HEY<%NLO<X(MVN#&O/D@4N^V(N/ 4L<CP@1DJ,'Z
M]+7+K(+9249&2;3& #L0DEJ<F6YBQ[;"TRC7F2F0FR5M*0I'32T0%D5A>*=[
M P!)N:3'"U0 D776W<W6UMFT?4EO.EJ;.XYY'5E40N08QG!=<!D Z[P/'@';
MTLW":E9FT_G3=0%<C(+B0)M8>.-@6#].@5B1@9'2;0R?'"7/.:DV(#[U&*B,
MISXG'!MX6?API/*W:R-WE<41"]'<T<SYD9>(&FI0),.LL-OOLMOI'=)TK3S>
M "[-E;<\ 8(E6)0^?C/0GRMGY*Q:B+<7]Z+,CN9KENYR.N$5F /R%2 #V].O
M49J&@NTX]P"-NE@CN -^@:Z::Z!J(?\ RZ:Z .,G)& 3T^(9Q\_96MDJJ[B>
MC#)':1GKXQXOF'R5[)837;#L4V/,,MV8,:,<VS1F.6Y0CR)<BB:8]]9U[1/8
M"WQ"22G)H988%4'CT?0+G8Z^-78OEY,Y;KE24UX8BD]YQGY[JB<22\0Z@]A=
MRPZ?I]K9RO&TI6-]UK.\D<=N+:3G32-$ D@FCY3["%;)SZZQ.A0Z-9+=P1SW
M]W-=1;^5B2+9/$B.T_.5HT"L6"")^;@C=&5W"9KN#VV/\LYKERN*Y+/QUC)V
M<LO$IV<W,6/"5D%D3'GG+N.(RXQ]OMQJY62''K@SPMC=4D7=5,94M*%_;$1V
M67=:ZL/LOH#BW7K&QMDFM4NKA3;!IA8W865&LK.Y<RYN%6.XS<3!YLR*6C9N
MYE7)&Z= TB[O9S'<"VMV[H98VO( 8G%Y=P(4)A9I8\0Q,(28V59 #<,=I-F0
MO@\=CV3$XH>W#.4K0-<KPH=,GR+F3^ H\EO\Y1KL(IW=!%F-1 %,>9HFU(,D
M3.1H3D#_ )-3R!M@3@W+Y;#W%JEU\>S7'%VOQF^2/3+=VM]0%JDW(O#;);$W
M.T3R-,&,CM!'&^V&( R@HDFY V&'AO19!9N;UHN98BY:$26[7',#1 \J/:Z)
M&I,C=7DW+&ZDH=P3$_9.QQCE_,VFF>71[&DNQRR0/*:9IRO-'QK8Y)$Y(S8Y
MRHX8L>4;8&1&]Q9XR_2=I9E[K(8Q%,A*KY2V0K']BE.W3=:4[=O7;V\C70Y8
M9[R&ZFGLWDMK="UO<1O-"+J&0M 1(\<3/L1YX!R5DF/\V*Y.EVUNQU..>*VD
MMT@N52>9@LT#B.8PR &9-BM(L8RL4QW%$'1\GSHW" "'_*M"\1_*&\.-K\FO
M%'>.\!T'2O7YS@^4 _+GK^_!^,5Y^+W@/EZ_2!].>W/QUJL_IV_^E;^\*5=N
MP_(?JJ<99_WO>%?_ %_SG_L>'ZYMM_\ $M2_X=A_T3UM2?[%9?\ 'OO^J.H,
MKI5K56W774-=0#K!J/8Z/E\%*JY 4D@GLZ#MKW$V8LN[=Y?O-O8K9F9,@0E]
M7QMZA$CC$:BS'DO/>,MC%X5.I4#?)\N<U*,M@QA>58F*]D&AG7*R&AE(/5OA
M:),5?^=ZOI_#A;7 ^KS6]Q&LD4L$LTTEIIUWK2A1+%:I$&YES_2$<DB#K[TY
MQ['3+K6RNCA-.MYH9'66&=8(^Z+VVTA]_*EF9BJI;!=JL55LA,.QRJXN9/VF
M]I)+CJ.MDQQ9ALC%[RC!GPDF1Q]OE;#C!=!XH44[.N+UC?,G\$LK;VO*J=V>
ME4Q42:]IE;J2XHTK1)62RUKZ>GZ+HIN9)+6^ON[48?RB6E>.2[YLC[(KG?"@
M=-UJRQK"4+10E79XW(//NM2U)X8DGM+5;1UC-B!'&ZVG*""22 Q.W+8"Y#2,
MVX[W#!E;%7!%^$)VPI9)%3C!H;!E:YID:C:4?FB/8^<?8U7*,?3]DV@Y[EY]
M3EO@WVJ'V00-F<YQ>G4HF MG:BF>.-,>*-L+,F;A?0;:-5N+FZ7F+_)\3SW2
M[UAN('L;6U7*8 B25EM]X9S(Q,KR9(J5U[5Y7Q'!%E"M[*L5O@-+#+'?7,Y*
M@9R\:BX PN$Z!5( C!1P@FT0OQH&)#4<*&*7X[-QT(DQ5P%U]K:R-QB(7F%K
M >1+O5W-D19[+%UJ6XCGMRDWD+@/M+*V$X7T>.Z-YS)PZW*SN>Z5V+.DLDH7
MWH 4&0^,..PGQUJCB&_Y(MV5'18.YU]S96Y9C*,?!Z#HL9R,@$YSBI5R;PC"
M_+6SOER"3K&H..8,SC(&MYR80J:FZ.Q^*23::;-J1UCT384[-<\)V\N?(W&X
M&QWD+PIL/DCBX&/MZ!&RQUNU+/A06>KV=W;7FW3[*-)%LB',LLZ6+Z?'-*XE
MY981/DLL2[L*NWHSOMR\0FYTVYM[BVW7MX2&N3M5(XY+U+N2&)%C'3F1@^&Q
M;JWA]0#Y;U[.O/54.GY!'P (TJKDA&(Z$"OHMX G_P [#_T<$?\ _9:_.N/>
MW2ODO?KM*]5PF25OB>I/<N?HGKPRVA0M'/><0'BW .9<HB("(?UV?!LZ!#7?
MKIT](_&->YT_#:?99 .;: X[1_-1D=.SM[/D^*O+WA/=MUDD?ZW,,GMQS&SC
MXSU'3RGI40#K<(B.@C=<-PCQ@ 1 1UX@B @(V!OTM$>N.HB&FFYXR3XR3\Q\
M1QC([>A\IK"0A_I$>$6Z9';CI\@P,>/'2@  " A;;J'1K< @%O6M !$1 +1W
MVZ"&@[Z=,YVC]?9XAV] .T>//7)J<(.QCUSGM/Q#J0>P9 ^4TZXW<6SCB(W<
M?4-0$1WZ!KQ1U#4-]HCH/34YZDX&2<Y(Z_9T[.S./'5B5[,],YQCY>F<9P,]
M!G'Q9ZU41N'?^"%P[QN#BVW".\.,/%$ UT'B]&F@ &G3K'C)[">I(Z$G &3C
MQX 'R "JG82#N(P>F"P\H SU/08'0CH!34=W1H    (VW!:/&MN&ZWC".@B-
MH:]/7Z^@A.?B&/$",@=0>F<X/2IR.N)'R0 <DGH"#V$?$/CIKJ(:VV?@\8;0
M#BV@%P]%VEN@"-@;K-=>*'QZB,'!QD#P3E>F,'K@C&.H!(!\0^4DLC((?!&0
M"!V9)([ ,XZ8SV8^.@_]$1 +0MU$!&W3I&T==0$=+;1'74;;0#7I$9SGMP>F
M!T[/D^,] 3Y!5!@DJ>B#&W &>G9V@GZ:T@ 6@ 6VV  6VVZ?@"&MG1<.NNMV
M@B&HZ[AWZT!QV #L\IR1V$Y)R<=/)@GI5AM!SO.<^3Q>3J#\Y^KIBHAJ(CV1
MZ]_&T#L (W#NU$1_.(Z;M "/XQXA\GQ9Z_/TZ5(V DYZGXL =<X  Z=:J(B%
M@@&\>3O  #>/X0VZ] ]@ T[ ].[HGQ$=O1L =O48/ZLX^/MZ5&[P@0"1G.0#
MTRO4GY-I/_X-3SM3W:[3FT>'X-UMV>LPZVW<7=ID22\4=!WAH(B.@[]0W[MU
M<[23G2=,!&1_)]GX) .,0)@?*.WITSGIVBMS42IU'4.H_P!LN,$9ZXF<9^PG
MYJ@8=!#0;"A#=INLW:#KN'K=C3HT'HZ-.CGR@'Q]0#CY/)X^SRFM3P!GKU.<
M''82",CH.SM'B! -4#0-P6%\4=XV#Q1M&[74;M!$=!$>G30.C0 IGXACMQXB
M3VG'9U\>*97!&[P2=Q3'@ECVL1CJV/'XCUQXJ=;32S3C<8-0L'3HW -VHZ;N
MBF?D^@'YNO[Z@[3VNQQ@#/7 'B'3H/)Y*#TC< 6VWC_R[;@ >GK@(B [OP0U
M = U --1J#U)/83XQT.?+Y/U=/%BG@X #' 79V>+(/B P<CY_EZU41$0TTL"
MT.@+>* !\0:;]!$1$=1'>-23GQ #R =GR?%\794Y3<6SU/3L/0=.G9GQ>6M.
M@_%X0^VHJV]?+^H_930?B\(?;2F]?+^H_930?B\(?;2F]?+^H_930?B\(?;2
MF]?+^H_930?B\(?;2F]?+^H_930?B\(?;2F]?+^H_930?B\(?;2F]?+^H_93
M0?B\(?;2F]?+^H_930?B\(?;2F]?+^H_930?B\(?;2F]?+^H_930?B\(?;2F
M]?+^H_930?B\(?;2F]?+^H_930?B\(?;2F]?+^H_96F\!XEVF@CQ;M  0$1'
M0=P &HB(]@ $>P%0W8?D/U5(8$@ ]20!T/:?FK(/:J'7:,S1;T:9"D(AKN'0
M55PZ[]-0UZ!#<-<[1<_R7:#L!1FZD ^%(Y^+IUS^^MG4,"_N 3T#Y!\I*)^K
M^,U -MHCNUMM'\H=X &@@(" #KH.OQ;M=_173QD$=,^4Y*_/CM'SCIGJ*TV=
M<KVG!!. ?$1TZ XSY<''DKU=EO"P9HDN1<I2='<MC,-DN.\DQ'&\0B P^%.N
M/I;/X"S00C(SC-(;#8](9W*6)&UW"B?9*J5R1*C.YDU/C;:%]YOAHN"+**TA
MCW1RW(OH;B\FF$KK<6\-S)/W.D4DK+%$W,\..,*K,H8C)KU+\57;W$LA#+";
M.:"WA0I$89I((XA.TD<2M+(.4%1GR45MN0H)%]O'"P%/[O&U1^-IQ$RF/$*?
M&J%VQMD6*Q2<P%86\8'>5[CB29ABE6\1UE?O<25,KK'I"KDJ2UAR')$2&U)>
M8]J)7JIP,T(F,=[;2[KUKGN>XM[J2UN1BZ$8NH!=K$7A%SA'B6,^Y)G<"<9V
MXJ69H@T,L92T$#2V\D N8B&MV<VTC6Q<+*;?+QRO(2)748/4<2SA7#FK&-T)
MB6.)C&)&EQBOQ^R3\K)]ELB:5ZW'48@A,HM<6Z(LZD75/='S'0U2B%M4&GK-
M4UR&^P+ZNW!$CW<EQ-=6\D,EZER8'MG$03FB1XPIE8$'+* V1T3.0&W5'%2K
M;K%%:S)*ML]N;@N Y<Q&)9<;"H?P4.5&!DXV@C;S\A\*M&YXEG"!'B;(>.29
M@,GO]F<79>:8M+BB'_,NTYE=3"U[T;C9Y3+,>/MFT6D0R]C!MLO>'?'3(]6C
M8)Q*=NBWX+N+=XI&O;2X,:01\NYM99HHS%9Z?;FXA"W$31W$<EE[A(""L<K
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MZ;[S3VYVF^8=_P"FK;[E3JS:7X/IWTEV?R+3VMFI^=%EZ.F^\T]N=IOF'?\
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MHT6&WA9MZDIRMDFQ-BYZ-DR9<Y)(J/L;,'":IW''2N4!DXM&AS4[F.C!*'W
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M1U^,"X=K9U$$W<X+;P))%EEA?8>668;H7= JD.GA945UD4X1":R)$OE+?@Y
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M'L#X!ID>4?2*9'E'TBF@]@? -,CRCZ13(\H^D4T'L#X!ID>4?2* @G ()/0
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M(*L5QMV^$KN-I;(C(^6)O$-H[#43;I'"E>.YJ]6Q&81FUN;E,NCSFZ1&>O\
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MXT])Z7_DE.I";/']?<U_.&"_V<4]L/QM\'<-?H6I?YM3VHOL<?#7&GI/2_\
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MH_<-01GYNH_@$4JQ2\9X^),=C28)#B39 Y$/#\<5&F6PUZ=DKJ8^I75UNM1
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MI2E>>4AX/2)JYKEC(\)RMD'%\ZS4YY0/R#)H58TM[F_,N16.$H&YB6+;""W
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M8Y/ $822WMW0!;B6Z1@CQLN^.>:1XWQE-VU<)X-8#I-B4V"-U\,ON2::-LM
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MDB"SA)\&WMD[$C7M/3<[$NQ)-?TWP-P+H'L?:%;Z%H%L(HHPK7=TX!N]1N<
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MU;%*4I2E*4I2E=6^?Z$>/]5N'^R'5E@_GX?^+'_UK6O=#-K<@9)-O,, 9/\
M-MV#QGXJ^(?B\:P WZ" 7 (#IT](= ] Z];HTUTKZ?P/X"%1GW- <]!V ]/C
M'8>WYL=?B#*%+R!LA3+*R/G!1PPCDBGB*<R-U$60,=<^3K6CD0^/]8/N5GWM
MY!^O[:P[8_Z_ZF_P4Y$/C_6#[E-Y\@_7]M-L?]?]3?X:<B'Q_K!]RF\^0?K^
MVFV/^O\ J;_#3D0^/]8/N4WGR#]?VTVQ_P!?]3?X:<B'Q_K!]RF\^0?K^VFV
M/^O^IO\ #3D0^/\ 6#[E-Y\@_7]M-L?]?]3?X:<B'Q_K!]RF\^0?K^VFV/\
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MZ"TB,A"G)2IBBB$Z<DM.02278222238!9111)86EE%EEVVV%EV6VV66VA;:
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ML[Z?Q^K'U=/DZ4JO$LW?@ANZ*4K52E16N4J;%BH+%!UH J46@ &7@ !:=>
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MIS8C4.MR5GY_R?B&E/X^FJ\S2#_X,1XJS[M*504B,-XIB _]E9V!'\GL!2E
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M;TZ&LFN:C*_,9HE<",*RHN1RXDMT.2#G=&J[L@Y*^%NR24>AZ>D?+"2%3O+
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MQR'*3F^[-$P6D3&)X5V_6A9)L01TV3H4S9#$F3,Q8A,@C+)AB\A]C9*:U/\
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M:H223GKRYLB-E94>(>$#*W6L[M@K&62\8X]RT1E".S.,N\UVA\EY"8T.1)+
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M!)Y?E^*>%-*XMTF?2M8@YL+JSPSH$[IM)PIV7%L^"5D3/O1X,JY20,I(KV_
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<'@3^CTI6JTH0Z3CK_CN&P-/U"[ \(#^^E*__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g68105g75x11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g75x11.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1-"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $R:^20(X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              4(   5[          $
M                     0             %>P   4(
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   4(     4F=H=&QO;F<
M  5[    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   %"     %)G:'1L;VYG   %>P    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M     #A"24T$$0       0$ .$))3004       $    !#A"24T$#      (
MR     $   "@    )0   >   $5@   (K  8  '_V/_M  Q!9&]B95]#30 "
M_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3
M%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-
M#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,_\  $0@ )0"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! ?_  !$( (L"70,!$0 "$0$#$0'_Q  >  $  00# 0$
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MWW"/FB#UF\_>*>_7B?SK+]%;>QJTW#1\*& <^V#?MV\-XA X[ 0+O#C#O^)
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MZS>?O%/?KQ/YUE^BMO8U0>&BX4/=S[85]#\O>''?ZJ1S_1IWO^$1_DB#G_\
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M*U<1+RY.'S1=XW6:Q\FBDLO43A'6H8RT,VGVZ33227$4<]V4MX3K2:E&MO\
M!$,5@0Q#DN"H Y,:VOQ'IDQ9I4OI3';HB2/';[[B3W*ET]S,O/:))R)O!9\
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M3>/6/UCI3 \@] J1\/"(Y9Q=O$1_])5"Z?\ [IB]4M2_WOO?_MIO_P &K=;
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M84,4MW:0.NY7,N]%N@^'11N4KD@'&5EPU-<I;W$DL2VD\L^V6*1F*R);W$P
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M[NZG:)'EY)M#P,@_K]A:1<+QIH?2V<#32A[N(3!VCC^!1EE:(2(DTDC,W0,
M(EFP<%R@="TGA?5NBGE*(Z6TKQ\LIO<R('VMT:IM195R9F1CS$>XHY&([46Q
MV_V7:!B2<L-ZK-NNMXO^><?W2'I[PLM 4J<PE-4B E(@LV=NR</9E*7LTE'3
M:(,^]R+B)0<P\C+1L@V?K6]%UY=9N;Z*&VDBM[>+3Y899U$<TT=\DT@DV!Y
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MZ4P/(/0*;QZQ^L=*8'D'H%-X]8_6.E,#R#T"F\>L?K'2F!Y!Z!3>/6/UCI3
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M17CXYC!X@XBLTN[F(WE[-=WMNP>33;KH6":;:.\!AD<M;(9I7'P"8E9'/2(
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M'.1CG5 ^#%9J#> ;4F*0XW,80H%M =W/T"$N'/S[AWCS@(@/-J>^]8=GN/,
M<Y(G3.?GZ/GX_'^CMIWLK_L]TK;!&&Q"P/Z#N/R8'B.#XA5?DQ>:]Q0#:DQ2
M %W;@^(-N$-X;@ >>8W<8  .?=O .;?NU([KUARSH\W+'_'H>P<C@Q]OB[>P
M"LN]I?D?[XVX.-O]$QRH\62V1R[<=I[:!\&,S;Q@,;:HQ88 ,)N+\0;=NWB
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M-IAE.=C!L#,N,\N6>7EJ\GP5[.A0  VL,4!Q=Q0$*%<M_P"* %W[QEQ'Q<P
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MSD5%$$$I7%.X[PS\&JWNLW)<M=VI@N+0#4]-3)FC@+V/P&IVZ\WLY03)M(3
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M=?Q&W\T34^(_./V-6)_&7_6_970:BLJ:?QZ>WTT_L.1\A'8?G%.C=^3H_)H
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M=I2G%+^]+]0=FF!Y/X_@FE.*7]Z7Z@[-*4XA/WA?\T/IZNOGT_\ ?]/(9]
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M@7_IFG?*X_\ \[=9]:?[:=Y7N4?Z/^'/4(_OT_ ?V3_X"J-_(%_Z9IWRN/\
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M8Q:ZIP3%;O<+0BW))"J0YD$>)D>..+V+LW$&HLTL MIF:;)E@4 ".7*GI H
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MA*(L5H^6D(J0;29ZS<*WD8<]9MND59RD8D;=(D,T$#L $PN6GC9.D*%EW=C
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M@\[I.S=6;>3B$F+PKXM<Q+:6MQ*90_1EU<);ON545BFT[AM9 Q V@D5[B/0
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M8H-I9$WD$D*?&2QMV.DM:W#2-<%X8Y1)!'L16W]52T:21E4 EU5VV+A4)\N
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M?OI$ '2/,/.(?1OU^YNX?+&O<^TU2ZAA>:B2">8#74H4_)D@CY@?%SK^7/\
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:TI32E-*4TI32E-*4TI32E-*4TI32E-*5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g68105g76o93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g76o93.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1HB4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &@:^9F(X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              1H   %5          $
M                     0             !50   1H
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   1H     4F=H=&QO;F<
M  %5    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   $:     %)G:'1L;VYG   !50    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ A "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M;+9T;J>1
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$!_\  $0@!( %< P$1  (1 0,1 ?_$ !X  0 !! ,! 0
M       ( 0(%!P,$!@D*_\0 8!   0,$ 0," @0&"PD*"@L  0(#!  %!A$'
M$B$Q"$$34105(F$7,G&!D;4)%A@C-UAWEZ&QU20X0E3!T=+3\"5#4E-EDY25
MEN$F)R@T-8*%DL+4,T1&55=B9')UAO'_Q  ; 0$!  ,! 0$
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M'2%$)!H4V4G\4>?'N"#^<'O^F@*T H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H")]SP"Z1/5-C6<VO&VF<=:X\
MR.)=KQ%9CM!V[R9#*V67^A"5NR'$)5\-2NKN?(IWWW]QJ3EF7R#;.4<2YWQW
MBC)LMM8Q'*N/+KB\8PVLBMTB>^4VR[-,/N!E5NEOL)^D+2X%HBN=10D[ #;L
MIN^]3?7I5P'(N.N%L=L&61FH&03)M_R&Z6R.H*;M;F17R?=T6UI:?LK,1J4V
MT]TDIZ^HI5JB5 0$_9,_3"3Z5O43G_'-QY$G9^; _?H]LBYI>OJLMF?'?NS:
M+6J8(BX+<)+KJXY;* UU(2 %$"1.T3KDF]N[A6_$]\-#)<^%39<;@CI!13&D
MHK).%5M5[+NK2R-<\ Y%ZS,4R/CW/+4_C/*_#JN$\)9R*Q8^B- NUI-ML:GF
MX<)I;ZD_683TIEK^"E<HA(3H!('E*FP3$U#&HHH/RQK:HE9]'8]\7@IN$F0.
M*1-@DSZPR(IB>K&T[N&+;1VK7+-DX>,?V07@OD&[9#:IMTGXA(L#MLCR6<BM
M=UAN-2IS25.,2UJA%F,J,\KX*G%K2RM0Z@>G1KV,&B3:3K3;?Z]^5"=,22Q,
MC,2HSJ7X\EEM]AY"@M+K+R0XVXE2>Q2M"@I)'E)% =B@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@*: [:% 4*4
MG6P#H$#\A\T *4GR!_MK_,/T4!'WU7I3^YJYQ.M'\&>5^.V_]RI'8_=W/:H\
MN=$^3=&%9IK---/<UDUQ1HWA/C#,K7@/'^3<>WJQV&)D/&F"IN5ME6Q4G^Z(
M-D:0)310M*4J?2Y]L'SL]1)K7/"39<^9,P\4,"F+6B2358FZU>=77/8U5G<8
M;Q'HG$:)P6CM/:/QV/FX"+$/#SY.*ADN"&;%66G6%MJ&%J!7R6PQ=\M=DQ;-
MU8IG@XPFHY68EV[)BS:(]MN$J0B*EB&Y*<43\924E/PP"@I4D%)*M&L58G$X
M;&2Y6)Q,N*":K042B3;5KNOGSR-E!X=T=IS0>E-)Z"T-I.1'HYR8X7%-4^5'
M*BA;FN9JI4U73)JF>RVR/21FKLK$;YQG?9KO[;>,+]<,=>AS5],Q^P,OD6.X
M1PL!QR Y$*6VGT[1]@)*B=5O++)MK8WF]I^:*JJFJ.%M-;J;-F61,$=P#\P/
M]NU"E: 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@.O)4M+2RT4I<Z
M%%!<V&PH))!7H[Z4D;5KOKW\4!JFQ\T\;W*])Q!?(F&RLS1(=@R++;[M',D3
M6EJ!C(C.N%P/A( 6V25 [T!N@-MI))/N-#1]O??Y_F/R:H##Y!D%FQ>URKYD
M%UA66T0&U/3;C<9#46'&:!2.MUYU24)VHI0D;ZB5]@=4!P67)K#DMF8R&P7J
M!=[++:4]'NMOE,R(#C*2"MP/MJ+8#82H*45;0 2=;H# 6OE#CZ\V^\W.TYMC
MEQMV/..M7R;%NL5^/:5LG]\3.=#G2P6_Q5]9 ZMA/?P!E;#FF+9-9#DE@R.T
MWBP@.K5=[?/COV]I+()?*Y*%EM"60"5]:@4COK5 >>R/E'"K);+7-=S7%+?^
MV!Y+./2KG=&$1+HXISX9;B]+R%25$A0"FE:"@!OVH#8L9T.M(6'$.A2$J#C2
MNII:5)2H+0K9ZD*))0=G:?<T!V* 4 H!0"@% * C[ZK_ .]JYR_DSRS]5/U'
MEYP^J!F?3R!^ CB4^_X/\5[^_P#Z)B?Y.U4BR7)'B>>.$86?FQ9/:[3;).68
MO>(MTB";IAN<RRK]\COR0"I.PD?#)[=0[[[5I])Z/EXN*7,U6YLIJ.'5LXJ;
M&U?R]C]!\%>,9WAZ'2& Q&+Q4G16E,).PL]2(88XI44<.K!'! [;76M;97L1
MUS#/G<:RSC#U"+QB3;+999]\XUY-B60"<MFWS'$?0[G+:B(^+/8A3VT_#<4%
MJ9;4H) &ZR\'/>*@3:<$4N+4BAS55:[Y;,UMJ:#Q%H9:%Q\,A3HL1+Q4B5BI
M,V-*&.8I\+CA<25:-J[5KTV$EH_JOX-?D0HR\Q;CN3I,>$PN5"FQF/I4E:6V
MFR\ZREI'6M24(*E:*B!6:[-K<<ZN*HZ73S7!DD4*"D(4D]25)2H*!!"@0"""
M.QV.^QV/FA2Z@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!T;C_ .9R
MSW_\UD:T=$'X2]E/_P";1[??KO\ (#X_\6>GOD7D6:Y,_:9QWB^.Q.9[YD#O
M(+3<AOD5Z+;+ZF6&F2EM*TJEEH1%.+66_@.KT"-4'WV=[O.W,D'ZF,*]3=[Y
M!MTWB:YY7&Q9JV1VI;-FOEJMT94I+ZBXI3$PAY:E-EL%:0=Z5O1(J;N^O#ZT
M)G5/+U/1^J^,N/QIP[*S>-*N6%V'D?!)G*T=:'+@ARRL0W6I#UW9C _3H+%W
M4PY-0E*F5Z;4H%)W1WS[Y>52[N'S-2\<SX+O!_J%MO&C4VUV3-\ASZ;PU:6(
M\J$7[''@03/=LS"NE42(])$U<9I(0"7-- ;JCOONW*A&">G"+U"7<.*,?N,?
MC^R8?@+'-D6W6R=#:FS8UY0[=&)S!0A5PFQVT.JN:T!:UM]G5&A&ENKDM_>?
M0];/N&23\-Y;8]/G'>0WK@_,LB6W*_:RE5H=CVZ'8TINS=C@S%-+9BSI* V^
MME!ZC\0)^V=T#KLH^\O/?:G$U!D3LBV<=<,7VZXE&M$][C'(L/L>)\AVNY7%
M-MDQ[E(3;[I8'H*7DM9 \I2$)#X0XI*0H.#N:#:LJ<G6JO\ 3Y6SM]M>!H60
MV[A_CB%E1<.0Q\0LJ+M\;J#PE_1&U+0X%DK2IL* *5$D; 42H&A3;U * 4 H
M!0"@% 1]]5_][5SE_)GEGZJ?J/+SA]4#->GC^ ?B7^3_ !;]4Q*I(<ER7H;?
M=;"PH*) ZAOM^+\CVUL$'OO8WW/<#0M6FFE5I\+<;V-%V+#[!C/)=SM=KAK:
M@9'8I%_N4&0Y]*@.W(71#*GVXSO4TTI25D+"4 *WW)]L*"5#*Q,W4=YLIS(H
M;T3<Q)Q)95V5SR5SKL?C\1I3PWA9V,U)D[1^D8,'AYRA2FJ0\+%%#+F3*.*-
M0N&L*;=%E3)>6]4O'$W+>!^0,?P?$[3<,JE6.4NQ]28%O,*Z1D*E0)Z):T('
M7#E,MNA*3\0_B@[T*S3D7?.[VM[7M;SSVFK_ -CMYAY;YE]..*Y!R]:H<7++
M*J=B=XN42='D*O%[QFYSK/=7G8;92Y 6E<:.$I?"?B(<#PVE740)ZC1 (.P0
M-'YCY_GH"M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!0@'R ?;N/;Y4
M!QLL,1TE##+3""I2RAEM#:2M9VI92@)!4H]U*(V3W))H#ET/D* Z\J)%FQW8
MDR.Q*C/H+;T>0TV\RZV2"6W6G$J;<02!M*TE)]Q0'68M%JC-Q6H]N@L-P4+;
MA-LQ&&D1&W""M$9+;:4L(40.I+00DZ&P="@+(]CLT1F5'BVJW1F)JUN3&F(4
M9EN6X[LN+DH;:2A]:R3UJ<2HKV>HG9H#GAVVWV^,F% @Q(<1/5TQ8L9F/'3U
MDE0#+2$-@*)/4 D;]Z X)-DLTQ,9$JU6V0B&X'8B'X,5U$9T'J#D=+C2@RL'
MN%MA*@3O>Z R02$D=(2$A.NPT?/]0_K- 74 H!0"@.'K.R#]G7D%6U=/LH=)
MV-GW4 !\]4!7JT"I1Z0!H]1 )WV!))2A/Y 03^B@.4;T-^==_P OZ3_6?RF@
M(^^J_P#O:N<OY,\L_53]1Y></J@9KT\?P#\2_P G^+?JF)5)#DN2]#<^A\A^
MBA33V>8!*OUXCY%:<LO6+72#:9=MW:A&6W*BN/"7^^MO,K45(>0D)^&H$@^^
MM5A8K#.9%#-@F1RXX(7#2")PJ)-N)J*CO?@]YTNA-.2L!AIVC\3HS!:2PV(Q
M4K$.'%.*%03(8'*JHE7.")_F>5$\DD=?A?(I^2X,RY>KN;Q=(5SNEJGRW$-,
MOONP):VD"0RD)2A:FPDG2 5#MM6Z^<!,<W#OXD7YE,CA;<5&Z14:;K54RSI3
M)JB/KQ=H^5H[3$4O"X;^&PL[#X:?*EP1.9+A^-*AC:@C57%#6+95[U5U<>KW
MQSRIP%DN<<@<.7O%[CQMDR+UF66X+G-Q^IK7CN2%F-)E7RP76,R6XL2>Q#=3
M+B2^F.AY1>;5\196,Y6VU6SE]3F&J15;I6B=8=5UJ[TMGNI:E+4/7^DKUC<8
M^K;"Y]_PJZVYJ]X]=YF-Y-CR+Q;YDR)>+3#M[]T?@H9DK>DV=#UQ^"S<EH#2
M^A'2"5 BATJTG5)M)[R7Z=E().R0.^BG?W]))(_(3L4!6@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% =*<ZN-%DR6PI:F([S
MJ6_M$K6VVMQ*$]/GJ4D)U\NW;Q0'R)L&3\AP7L,]03O*677"^9?S?/P:ZX/+
MN9<PT8PY-7!:M42Q!'T>-)@)2'TS&6_I/6#U'6Z>7GR_N^G$E'L=.C6_*V_/
M;S-B^NC*.0E9OQUAF#/<B7]B19<EO]\P+BR_1\4R=_ZMB+5;K],O4GH0;-;)
MI97*@(<+LD$ (^0-W7&MN5ZU^7]KRO\ 2GEMXS7T_P#'%_R'(7\CR%ZS.1[Y
M<GTH;G"YV^9*AR;?<4A"4KN=N# A7!]I/0]-9>>22""'T+WT(N>K?GOEMGBC
MG;$F_3#R'(L2,0RFU(S9K),2^IW;>J&XRY?&8:Y*;DN,A"UO?1U-%U+21L=0
M.@)E>GC?X!^)-]C^#[%=C8.C]41-C8['7C8[?*A%DN2-T4*=":VMU"T-]0)0
MI/4V3U)41VV 0#L^=_X/8]C2UJI.F\L+U8E%L3JUL?'FMFZW&L!XG%OJ.QS*
MN4/VOY7CZ;'?X\^Z6U,FQ*)3+F'3<6/T/_"$M"4A*I'0#U?;WKQRZP>EY4_&
MN7,EQ2IL,<4J!WAA<43<+4-&H8KUJJ.MV[-G[7,\3?X?:1T?X<_C]$:0_C,%
M.D2\:H,?! HH)*AABG.)85Q1RXM76AEQ1/534-71L['H[1R5>\'S'">:C;+T
M+%=Y]AE6NXQ%29+S%P493K5Y3,^.U*BRF'%(CH4'$AM9;V$[WZ>'HM*?"F2]
M)S$YN&FS$OS.***&*)_"JVZM*#+-;$LD8_\ C!AO",.D-%:0\(X2;+PVE-'2
M\1,<424G7A4,,QPP0J&#XNM$W,C4$#BB3<2SI"#)K!P%^Q&<Y7GF*SQK2O O
M5GR6Q!S7'(K5GB9%@N8Y$D1;+>\5CJ9CIA8(XJU,0+Q;V)###<Q27U-K4.H]
M)\N_,_&J).V5Z7UFJO*NWB]M$W7,^M?"WJ$XHY^QV'?^-,QL>0AV Q.F6RV7
M>#.G6I#Q<;#%Q;B270PZ'6EMK'VE-K2I"CL$ 57OY^6PWD/ WY^_7^0 ?H%
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M*OQ'CY[T'?7OYGW A!X0XHDNH>D!AKXSS:>AMUWH'6XA&STH6K:DIV= @;-
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M.1.7>..)+=%NW)>;8]A<"=*$.'(OUQ8A)E22"H,QVE=3SKF@=AD.A*25*4D
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M'XD_D^Q7]4Q*%R-TT H!0"@% * 4!TY45B4R_'?3UM/LNH=0?"D.(*%C?MU
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M]5X[:&5R;WD$Y+2W&X%MC-!U3CBPA2W'-=$9E*W73TB@/:\<9FGD+ L0S=J
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M*E=ID6EAQ(.P3[]/C?OKN>WYS7W?;F>1R#W[@]_;^H_?0"@% * 4 H!0"@%
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MW0N,BP6.@@@G0PPQ_P"7,@FPN&-5AB44N*)76_T/95D&L% * 4 H!0"@% *
M4 H!0"@% * 4 H!0'4FR3&BR9 22(\=V01X*@TA:RD#1.STZ\;&]B@/EE9.6
M^;HDS$><KER.JXXEE_+<SCU[BLVJUQ[+;+"Y+7"A2XES2@7%=T:<2EQY;KH2
MK\4)&]T)?AGRMQSRX4R\B3'JE&76ZQ-Y0SSNKA7#;%!ER)QM-GA7/),CORT=
M-EMD15R3(2^S(DE#9MT&,J9+V4-J0>HU&Z<>7?L4VEZ>;UR#D7#>"7CE.+]&
MSB?:$/W9!BBWOOM_2'A;9\J"@]$"=.MB8TR5"2=L..EHA!24B]?/^R!$3U:^
MJ2!'XDYTP17$/-:W&\/R>Q'(6L$FJQO;D)UA-R%S6ZA"K5HESZ6E)!;Z5!.E
M=IG;*ZV6SKW2I&VGD_EZ5Z[B8/IX(/ _$A'@\?8J1V(/>T1#W! (/S!%4*R2
MW)&Z*%% * 4 H!0"@% * 4 H 1L$'P>QH#@,=.SH]C[$;_2=]SXT==@!O=+W
MN[[._J2G!5V.EU\_/9S+DLMI3H(0?O*$[)^9_P"[5?.K"ZMPPMUSU57SWE*A
MIL#\1O\ ,@ ?H.]?IIJ0?TP_M7L"OPV_^+1_[J?\U-2#^F']J]@4^$T?+;9_
M]1/^:FI!_3#^U>Q:M9-KS+5,-J! 2E((T0$)&^X/?6M[UK1W_6"U8?Z8>B]B
M5BK76:R>>U5H_GFKK>>><QZU,W)^\)A1S<7X28CLKH(<7'84XZTTK[1!;0M:
MU:&B2K1WK=1RY:;BU($Z17U4\T^5<[U=?.YD?Q6(>'EX/XL3D03HIT,%:4F1
M.&L6LJNO"E-MC4WIX &,9$0D=\QOVU)"0%:EK';73V'@#78=MFL'1K;DS*N%
MTFQ_Z85"L\_/RX+?U_CR)1:4P=-5TT3@*N&!0MOX,-7%3_5%O=S?O6-Z V?D
M.Y_HVG\V]_UUL;]O['$%4JZM[&B-=M@^?O';V/@G[]4!=0"@% * 4 H!0"@%
M * 4 H!0"@% * XU-)6E:' %I6"%)([$*!2H:)/90.B/% 0^M7HRPBT\A(R]
MO+<TDXS#R"9E]FXSEW3X^%6;+9W47KY"@+1U?%2M1=9CNK7':=^VE&Z$U56K
MJ^#=5SH=#E7T@3N4[K@]^F<Y\E6>\8%*NLVSR(1LTB,J7<G%J:F2+;-@/P'Y
MEN:66($E^.ZY'2 MKH='70-5VO9\N?=D2AP+%[GB&*6;'KQEMZSBYVQA;4K*
M<C^CKO%U=6ZXY\>7]$:8CA8"_ACH:!^&D)! UH4U=ZK4Z]-?.)!/;C7*R1LZ
M.K5(T.Y/SV3_ (1&R.]1_5>J#NFMYG/3L!^ CB1&]D<?8KW/<D?5,7N?&]Z[
M_?5(LER1N;J[Z^SOW'5W'YM=_P ^J%+J 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@.K)2M0T@$]B"1K8"@4GIWH=7CW/Y/G(DVFEM37G2W=2JB:;V<.5[7=*9+/
MR(UXW@O,F'&\0L<O>$.6F=>I]TBINMNN7TUM,YY3OPGEQY:6W%))_& '4>_8
M:%:J3A<9AH7#)F2W#%'%'%K0WJ[[6^&3O0[_ $CIOPIIAX6?C\#I:'$R,)(P
ML7\)BI,,N+X$"A<;^)*;K%G1)*%6;;N9"S9/R9;^1[5AN9G&)L.[VF9<8TNQ
M,S8[[#T1P)*%HEOO@H4-[4" .Q/C5>D$[%RYT,F<X'KK644,-*).C6YKJZ6N
MS$QNB?#V*\/8O3.B8-(R(\%C<-AHX,;-E38HW/NG!%*A@24*3LTVVZ)HD8@!
M*0 =CVUX_-[>=]_>MD<474 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"/O
MJO\ [VKG+^3/+/U4_4>7G#ZH'4XJRB'A7IAP3++@P\[!QWB>PW>6W'Z2^ZS"
ML4=YQMKKT/B+"=)V>G:N_8;-(LER7H68'ZB;+EEG9R:]6V)B>-RX\63#NT_(
M[1/23,!,=B4U!)7!=6D;_N@@>1O8H*[[=]_W/:M\[<3..SV!G-B#UK@JN5P0
MJ5T?1H21U?&4I:0A8*05!+:EK*1U!)212OL4K$YTXHFO6]AC-+3UW1@28?Q7
M'6$+84GK;<<<>:0VP'D_:8^.MLO @MA0(V!UQS[Q(;:N[)S.VJA)N2;0AT)D
ME4B>H*4&8388+DW["%K^)%2ZUTI*BX$C="5]*\UWO*S.=>-;4J=]<9-;+:B)
M<V+6V5R?CNR'G[>Q<^OZ,RVI]EMN*^VMU;B.AI*DJ=6VE0-._3T^G(5WJG3C
MWY\S+0>8>-KEDC>)0,NL\J_O**&8#,CXBG7DQFYICH=0A3"I'T-U$@,ATN*;
M.TI(T2*;*!V =:^X^U 5H!0"@% * 4 H!0"@% * M4GJWX\=M[[$>#K>NVS[
M?IIMX?/OK\KN^_[["SHT1L;[I^\#0[]C]_?>A0E*YT;WT]ZD?LJ=;9YVP=:W
M&T)&+7U/4IQ*5*/63TI"ND#MY\GQVK638J8^0FW1017B=E^9?-^C6RYVVCTX
MO!.FH(56NE='Q4A3;_+ WDM]*5KR1O5NX1>A(#\<CI&OW]I.AKP03O?;9W\_
M?S6P<V6G1QPVXG&J5-:34J;1JJ>I%?Y%_P!81?=YC\S[1_\ BJ?%EO*.%^9?
M@S?TIG[(O8K]813_ +^Q^=]H?UJHYLM9QPKFQ\&;^E,_9%[#ZPB>\B./RR&O
M]*JIDMY1P]4/A3?TIC_[(OJD/K"'_C,;_I#7^E5UX/ZH?W+W)\*=^C-_8P;A
M$]I#!_(^T?\ XJ:\']</[E[E^%-_2F+_ +(OHF/K"*?]_8_Y]H?UJJ.9+6<<
M/5#X,W]*9^R+V'UA%_X]C_GV?].I\65_7#U'P9OZ4S]D7L/K"+_Q['_/L_Z=
M/BROZX>H^#-_2F?LB]A]81?^/8_Y]G_3I\65_7#U'P9OZ4S]D7L#<(@\OQQ^
M60S_ *=/BRW_ -<'G$EZCX,W]*9^R+V*?6$4D!+\=1.] 2&MG7R 4?Z="K\2
M!Y1P/?\ F1'*FK.7,7_9%[&&C9?8Y=[EX\Q-9<ND)AN3)CH=:4IIEY72VL@+
MWI1]AL]]D:KX6(DN9\)1PN-*K2:=,E>F5?H94S1V-E8.5CIF&G086;''+ES8
MH&H(HX%6))[Z-9T/2)7UDZ! &NY]]^*]C"+Z 4 H!0"@% * C[ZK_P"]JYR_
MDSRS]5/U'EYP^J!@N/<5>S;THXEB4>0B&_DG#]GL[4MQ)6VRN;8(["7'$[^T
M&RKLD#N >_<52+)<EZ&JXOI@RB5Q/,XCEMX7C]MNEJ@6:YY#88KXNTJ/#[J>
M"'E*::D*5HI< ^P"0#W[B[+^=/H:^A>D/-<AO&66_([I:K?8[8FV1,<GQ8.I
ME\,6T_5WQ[@E/2GZ,TA">M"2>MTE1^14\K[/GS[VC9VO3+R/:WWT;NW+-F[\
M+S"DV:=$Q8W6!-;>"&)6+VY,)I,*,PM#1BS"D+4E8)222?  $O?=2W#/Y][S
M%N^D/*E6J\PF;M8(S#EW9FXO:&TRVXF)OL(EI<O5HDA9?9F.?2_B*B+4ICI1
M\()Z=$2^^W+Z_;9F*6HK6HN!WFO23FMLNDO)H.:VN]9'<;?/L$YV^VT.Q)%O
MO6-6RR7*XJ920E%T8EVTS(JT@)6E:V%'I4C5OPV^MOEG\A3Z/:]WIY9;SUF
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MZM^'+WR4OB^WWB<Y>?K%^S1[LNUS6L:G7R("95DAWQQE,)^YLI25*CH<.QH
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M-&=E+G!3[C;2DMK>7LN=/6KN2*HO:^S:JM[G6J^YM,\;>M\Z_P#*0P$'W_\
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M/<$D=J OZT[T.^ALZ]N^AL?EW^36SVH"A=2!O1U[GV'S[_=OQ0%I7OJ4E6]
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M&[3K>TJ/=9*2VL&*Q)4#,UU.NI*BRTL@4%;NS]^[=IG)8O5SSCGCD+!L-Q+
MXW)MF.:NYL_?KM*C8PW'PZYJMZV["ZAM<V0[/5\,;6PE$8$J>^&G=!7EQOYF
M"NGK7YNOT"5DO'N 8>O'L.XC9Y-S]O(+H^U/$J'?KG9KS9K N,AV/,/^Y;[M
MOF+<0T2$=2NC9H$Z^O??U-<97S+ZDKOE^>W"S7>RJM3O.O"</CRP?6,B*8D?
M*\+CWEVTWE?PDI%J6W+1)N*6UN*>D _ 2ZD[!72?*W,E=^]Y;$M^>]5=E2O
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MO3Y3K\WJ5)DN.%3RR0#04SXF,1Z4^(&LJ_;@S:;DU=3(PV:N.B]3TVI5RP.
M+5CET-N^(6/IT6W)1&==4%&0VVTASL@&FU.N5_[DHK\<SIY=Z2>(\R8N+4V/
MDMJ=NV27/*+E*QS*KW8I,VX7GH%S9DKM\IEMZ#+2GH>B.-+;4DD=J%I4[5J]
M/-CLN9\=3;0Q M>"\5669#P_&8J7?B,7>XI2Q*N<EUP*#B_HJ @*^(XM;A4X
ML!1)IO[^62&[AWGF\D212"-@^ ?L]]]M>_C1^?S^9H"Z@% * 4 H!0"@% *
+4 H!0"@% * __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g68105g78a08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g78a08.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2DP4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *12^$%%CA"24T$!       0!P!6@ #&R5'' (   ('_QP"4  (<G(R,S
M W,C@< @4 'TUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@X0DE-!"
M4      !"I>VKQVS7F1B!1.-MQH?9].$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%
M>            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  7@    $  @
M!>     0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@              \0   2(          0
M                     !              $B    \0
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG    \0    !29VAT;&]N9P
M   2(    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P   /$     4F=H=&QO;F<   $B     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    $.$))300,     !
MZV     0   *    "%   !X   ^6   !Z: !@  ?_8_^T #$%D;V)E7T--
M+_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q
M,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"P
MT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,#
MP,# P,# P,# P,# P,# S_P  1" "% * # 2(  A$! Q$!_]T !  *_\0!/P
M   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M_TBMYO\RW_ (VG_P ^UI2%2(4Y_4\VJOJ6*P^L?0)?>*MVP,<U^QU[&.&P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\4-%1F*"A)66U?_$ !L! 0 " P$!               #! $"!0<&_\0 1!$
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M/=/U5_HH^C6_K]\[;Q_1W;_[WZ0>Y^W]*0>Z?JK_ $4?1K?U^^=MX_H[M_\
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M[!KY;VLX$W[/WUG;MZT^\V35RIIU25.LJ<)!:<*?#K3&0.T598<+J5*)!A1
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MO1W8LO>*-M%7@\BP):M:Y:3G;+(55," %>+-2:[U&*$$^2 HW25(50"=@-R
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MC-'(N_5SG\(&ZAE. (8=*?GK4RHR#%7H*F\;'4.052D(ND8YB<\&.4I3")B
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M6;+1J[+N&;N<;N<E(/GTW.1..DX-K+O',?++N18GLOCNT&/BE(F!BJG1 A@
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MV!\!3%]FO41 ZB8" JK%(4?<YU I)+]N8.E%VAPGL$LK$GH # DX)('D=DK
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MV;76^;I76+V$C3)>;80;^WR+%:(L:E118/'U<:WI)E(>QO$:) H#E,JI42N
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M%1<5%5E2>&FIP0#\]) U:!4&U!)T@J!(C<$YR<D=L1G!S4"C+J"H$JTG,X!
MQC(Q]=J6'TFN:\1W6^-65!S!(8XSABV+LU$E$K-B*T7.G2<!9R(J2;/Q&+$R
M97:2A$SMG[18>D!$O/&J;K!=#N8YK'(4(W 652/KZ_4U:9=+1;(SRW"L"/\
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MV*).GX3'I4>)8'PPA3%\=(XLHB5$=+^M.:DG6(D(!=T41.F\4C :BV6= *8
M"QBBL <#U (]MCXIG,TKLRV$L23=3BZ)+XVI$E2H8R1HFJO:S$N(&,,EW2,R
MC5&HM6@E'XHHE$.1'OSK"AJ5K5E41.Q^HB,2*5GT7$QT''M(N'8LXN,8(IMF
M<>Q;HM6C5!,.A-%!!N0B*21"]BI)@ =NP!K-*3JY_MY\0?5B6ZA_\8V_)^#2
ME.[I2C2E&E*-*4:4HTI48YBDGT-C&\2L8Z5:/V5>DEFKA(.I5%8K<W"B? &$
M#$#D2\!R ]]#L8WZ4J :)MNJ5DIU7GY2T9$6DIN#CI5^H%RE$P4=/FY'#@Y2
M$,4B93*J',1,H!T%X+Q[HZ5B/R3'TFN]C2DM,;Y]L-9AIZSOX>0QVPEEF$_-
MN9A))\G,JM <M?6#&,W$Z E3/Y=P$0[:?GY]OK6?SUV_3^>>D-Z'Y?/R^7/;
M\W&E*UTI2Z[I?O12'\H*M_OQII2I^;%#P4A$W "FEP''?D"%YX$>W EY WU>
M?;2L)V'H/TK%:]2(FMSMNGV!UA>720:2<J50XF(59G'I1Z/JP>92^"D3GC_C
MI6?SZUFA0#OW#N/(\>0"(!S^7S_'S\=*5NTI1I2C2E&E*-*5M/\ <&_@F_0.
ME*5[)7[9?;YVY_S#D[MV[_K2"^?;2E0AO<"2-D';2$'3F=UL'TJM0PC"3Z B
MXE_[(:>'89$RABIE;1 \.3\\G,( 5,0,8-?:^RFCW'VA#MTY:,FUMN<XU_>*
M:YRM;:/_ "<'@';4:J7$:V8 4YJ5H0=CM))_\3I.?E45[=#5X-V[WU&5E+U9
M@H,DG=,E.@6&&E)PD@0%H&NG'AJ2.AC<HIH-0Z40X*H(GY#70XX'_P#IE!6V
MW9V_O[?NG#Q >;8TKA]^-W'CXE:LR9V(HS_?N>+F*T^)R=CJ^ ?Y3GRF)Q5L
M9 \Q[@(\@(? .!'X?#]/ Z\X3L/G^I_/.K=))OR^]74/YW,:_P!JXO6U*=I'
M]B2_BR?U0TK*MSZG]:KJ])XKCQ3:U+1%^I]RO#VRW.EUW&L!CN63@;J;*TG*
M"G2'=;FES$0B7<?(D,Y,_4(LFFW*H)TE"E$HP+"BIKD?WQ<0;;.[FHYQ.,@G
MY"L@ H<U?W80HK)'2#/7J)[]<=:KJ]%D4D3EBOR&96^<9G+%VI]LC:/,9AO\
M3>VM11H]B6B+E3(0T6Q8$9O4CECUWLD/BC) )2E'A#O;80ZMA]]L^!5O:NOB
M),$\L"2?\8)S/?L:@=<90ZRRK+J7[IIK(^" N8Z2-O6!YV?;NMEC;='.8QMT
M=FG(N#K;BM^\?0UGQL>+0E'J3X$S+1LFO(I*I+QAS$*<[0>4#&+[Y>1'4(&E
MU+ASX2(V)B>O;/F?EM/KEI3<3*I[QI\AGH?D9WJ!<.^C*L>)\SR.<$MYN=[=
M9+(_8.K@VL+:JK,[''QQA.WA%%$V'K$;$E,85!:LU$4_$]\"AR&MD**4.M$
MMNJU 3D'.V.@G:M" 5!69';'F>^_YVJV<@"'QZNWW?;O]7F(CQ\QTK-;]*5U
MCNDDR&.91("$[*&!8O"??N ^7?@0'CL/X.PBI6TSQ$I/$,HD1,P )5#J@!1
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M0%Y,1&-C@3!QT'85E%M9-&^^K%#A!FS07<8GNWCK)()(N%^';40%PNF/B*"
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MEL0V+'EK2Q55+#,-F%@CV4K*NIIK&*P%".\5(:9>QB$V<CU^'+,ZR1R$[I*
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MZCGE>M-_<91E$VSE^PD"7MSX8N++'RK-R@^CI)3P^RK)9N !R <?'1"$(^
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MTE,\KCO!K.[U>#HS:WRV0*%0E,A7*H-;6RH4%:Y3V>[LKMHHU675;L3>KI%
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M>'J4+_BKENX%,+7Q!JYXA<&+F_>##LVMLDB4LMI(RD">IBJA*M+86(.E!TQ
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M ,F.<Y')CX?&-MR0<D>D$8Q,=2:O;QQU?0"E]0 !OHQ"=10\BF]GM^2AQQV
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MFE*]3/S*GR.$<@LK](.8JFN:H\1L,BT(55=I'G;@"JR*9R]!U"AQP4PB4?\
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M54$U7J144"#T>\( ,#8FX UJ2KD*4"DP?B$S&=A$R)$^=3*+GNZ@!K3K&,*
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MT<,D[&W HHH+N !(B)Q+YCP,30 ND@Q/NRQ,#!USY_3:<U845&W5I44@OI!
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M,('GZ(8QJ*;UV63R1;U!ZD0L,@W4ZF?B%!V<X%19<*)*&'V)CEIXV1:K=M+
M<0MD\1OWR3=<1N5%.BQM?X@SI44*_A $$P23SU'2S$\U2E>!LB6T F%:L1)D
MD$]^PJ]'&_/T I8B/(C6(41'CCDPQZ B/' >8_\ U'SUY#>1[Y=Q$>\OP!B!
MS%0#DY P?.KZ1"4C_P 1Z;=/+MY5FNJU;4NNZ7[T4A_*"K?[\::4KP]WOA_J
M8,Q>.F99#Z!R0+(%YZW"1FQ04;IB'?Q%B\IEZ0$>3<#KN^S&/:#A1"H/OC43
MD!4G28Z0<_+O5=\PPK$^$?+;-5/W@\;]B3"QK7%.ZFD9YBLF(L)P0 8()L6S
MU\[_ "%>BMN$/7'W"ZC8'1033(N #U+'/KTBQY@XEQ0VCXN E%Z>)<7N9*G5
M+9=/N-IKE6EH:00DF28Z U5/]TR("00"4C8F3XCMZI]3G%?0"AQX9> X#X=^
M1\@\Q^(_7\N ^&O&00=MOG]IKI5RZS2C2E(IO^"OCB*#&U2,O&5XN0*R:46@
MA6"57; =QRR9^ !E14>"(-^DI1$04$.0\]?7^Q0?5Q=T6R&7'_<;G0FX@-),
M#]X2K *-YGI]:]T0&TA0/+4L!6GXIQ &=HFE4KOK?ZH+:^:1=HTJ/,_F/H)A
M%ET>+"U,(5X!+19ND!$9]^/0H8#=*A2N#%.)AZAU]"\EO]B^T090J\>2TW^T
M.+.F0Y<AU)Y%L2-18;^$08, P($0@'GM:2$-QX$@P2,3J'^(G'H<U<@@  4>
M/+L/'RY#X^7?CCX<_FUY:@X\]SB-R<[9GKZ5>K5;GIY#S*!AX^?;@ ^7<PAS
MSVX >VBOY$YVQ&9Z'L?N*=4CN8^QK\N_TJ-PN#;TB&X5"3L4VVK\7FJ90K==
MAI9XB^LDBO(DZUU 16**#!(H%35(/ F*4"EX#D->^)N;JW:]F3<W;C'"V[+@
MBK+A?#U%%SQ/B%TW;<T7(1 -L@ZE/A8.OF@'M7)T@HN5%L*67+@%XCQ("0@H
MTJ.1&HF1MVW-?9VBY<.=M>P=9]>%:#'FJ<@K9+$4QUI@\,-8CP?Q46<PBM[1
M?E-ZHB8.MP A[@<B A\^VA(XY[:A'#_>EI>;3;,2 VVZEY>AQP$$!MHD_?K4
MKF&+8ZY20.8N25D8&,D[3,]P#WIB=N@RAMP]:%O6XVB4'[%[_P"@]2'H"U+L
M#/B>-9;0)  Y7DR(%7*14!5[F%4WB".N-QSE#@3H+ZKV]_:3?O=TD:;9*^6J
M+5@&1I9R#I@#IC%3-QSO# :Y8* 0=>HD25#/3/TJTQ,>>>_P^Y'N(=Q[B/UA
MQ^'SUYXGX1\_U-6Z2;?E]ZNH?SN8U_M7%ZVI3M(_L27\63^J&E95N?4_K5>7
MI,*?/VK;.^>0DE7FB%$O-'R-/1EMG@K5;M%?J,H#][6I68%5$J+62/X9ND5
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MDDF(.#OB-J?;9",L; <#[>8LXR8]K3XR$='=/J#%Q[5<B+9KT !/"1'@@=(
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MK^S&TT) BP6$7( N\Z^WA-0Y7$!_<=A#7U'LGR3Q"Y%PZZTQ^S[DNEDPX4P
M4IC)*IB!^DFH7QX08R%"#V\Q.)V_XFDUJR;(FY'!YF+-Q<)$]UFC7K,KH>MI
M*6@(-X"M3K8F$O\ F>**)DB$:D\ @HAU&$YA$/J+B3[.\7#Q]T93:,&RX8T8
M+;'O#>E^Z"<EUX^,ZC,=*K@ O-J@%423&Y QTZ3$^7?%7+IEZ0'R[\?7W#D!
M'GZ]>7#,XC,#T'^\XZ5>K14> #R[@/GY<=OEW_)\=%1L>N)'G_6*=?,9'RK\
MLCTH7ACZ2C="6&6$9S[+<J:5G9 >8ZGQ(R*8&39B?[6#]PIW#@!4X/RGYF#7
MNUL0+K@J['6.(?LWV?3>\1N?^SX-8\JW"E6X5X0_<:?!I25?NSMUYHD-7(WE
M+RB@&-1.D$D'K $GZ3M7VO1O(;>?1TJ-Z:.1)HL.L,%"*=(L33!JVQ]5E90Q
MQ*0K!@<PN5CG$>DA>  3=.N+"CQKVX"KP6S*E(+]VC"ELA]R4-C_ !O#8#)5
MY44=+=G#<@H)*1G3'4>9GJ,Z>Y-,!M]&)_5=NC+6-W=[\?'#TMVLZ0*&K+%\
M#P!)6*X(E*V(WB/>2.DV 0*  *AA/SKD<;#H]F0$LHM++]I)]TMB0;E;>A7]
MH?,ZB7.FK(,G;%6&Y+Q6K*BB).($S"1V&PCIM@9M:3#@ '@.Y>X_$1YXX'X^
M6O.4[#Y[;;G:K1W,;=*27?E]ZNH?SN8U_M7%ZVI3M(_L27\63^J&E95N?4_K
M577I8E*JXVP@PL%TQ_ .(V^TRYMJAD6?1A(#)[:GRHR+VA/E!6(JNUFDC%3$
MA"F0.X31(Y#PP,&JZDJ*V""2&G$J<3_B3(@$XCI 'VJ1LZ0X9@EM02>RBD@$
M>8)&X_44L7H]+'%[F,[,<^8^Q+C3 M-QSC]Y19J'Q[8:Q(O[[+R3I%9$\Q'U
MH_0E%0:3<QX=P_2*X5];5*0P^&)=7T.0RZ",+(3M@!!\.<1I$B9S-5EH',;A
M7B2G4<[:HF1.9)S':"=C7-Z1/)L*?)>*LLXRS1&XJO>&[':*/*.K1BJRWB.F
MD7)4%G\-ZFQ9'\-L4Y4U22"!@*H(B!5. $-5 DI>"I(24DD#&>GF9_0]-ZM2
M"PH8D+$&!@^7]#U!\J:3T>&?+MG!C?5;AE*F9*/"NF*+12I8SG\=IQI%0$1*
MX).$(,F)_@= !!/R'ZIR!H20,SDYG^D8Q]ZK!1*B.@F/K'K_ ,U9YK2MZ-*4
M:4JO+>#@S->2+91[9B^ PS?8N$@['7I>E9=@T':*:\XF!$+!"RYTG!VJB' )
MNVA4N7"8 '/( (1:05/2G^\1H2O_  CJ!'3??ZSO*%CEM)@ I5J<C^+.)[$9
MVD1&VU29LCV[S.U[;S3<26":;3LU#>OO)%9@"R40U<R3Q9\I'Q":XB9*.8BO
MX#9/G@"E#C@.P2[  G5 B<R?M_*M%K#BRM*0VA7PMC9,3,3)SON>M15)8\J-
M9](-1;5#1RK:<MF*;>I./#OW[D'AV[M 4_#;+N%6K4I1$>0;(HA\P'C2M:L6
M#R#\&E*-*5Q#SU&X !$>K@!'L/9(._Y]*52A2BH$RON?<UA+V-9T<IVP;GEJ
M?*H:&QW3/946*S"M^L]+0+#)%\02BVZSE,)55^KI*4?5;@J_9?LZ+D\^V5PR
MW]UX7;G][?WG.>"%/@2KE(^)<D"=HF!13RPJX5*PO4L2!M"C,>1VZ#&Y.*>G
M8FI&*[=ZTI"R#R5B3R<^9A)2!U#OGZ RCC]=NCJE(<RBW F$3%*(\^0!VU\E
M[9!P<>N0ZA+;@1;AQM$%"%<M/A3&(&!(G/U%BWCE)(S(W(@D?G;%.4'/'<.!
MU\O4U5\^D%W7XPVS8Q14R#D6R8U>VERHPK=@K3,KMZG)H(J.4DC>*U<H(H+"
MD*:RJI *"8F]X!$!#ZOV0X'=\:OW56]K:W3%DE"[I%ZYRK?E+5I4=>M'B2DG
M^(9]*KW#Z&$2I1U*$)"1F3@&3C?\WA=?1P;V<:[K\,Y&A:YE^Q97O]1KKQ]?
MG<TV123AW#M%ZU2812S1HW;*(%Z$3F$AE3 <X@80$!+KI^U?!D\/XG:W-LU8
M-</<O46]N;!_GI4XUR5.!PZUDE*BH#X8]1)TMG@XA22HJ= 5J2H1 ),=-BDB
M=MZA"X.W9-N9&UQB&=JNBU LZF-L6U_CZ/X]JI'CL)3)UR$G#8\JX1,=TS5=
MB51)T")6J9G/4H'U%NE)X^M5HZ;.R%_;GB7%;D0[>74-<OAUF%PH,:3RW @
M%07*O%-0N:@R$K3J<*B&V\Z$I"B"5$9ZX)P">U7F8X$PT"EB;CJ&L0@FXY$
M$8] 1 .>X '/  /< #@?+7D5Z0;R[(F#<OQ/3]XH?3J/(U?3A*0#/A3/K D?
M(R/E6::K5M2Z;HP.?$[],I#J#[>JXE(D4YSF_P ]->1X(41 "]S"/D  (C\-
M*5XF[P"_J8,P^*D9=+Z!27C(I\BHLEZL7Q$2B'!A.J4.DH (=Q#SUW?9:?\
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ME: Q,:O-9NPR$<SD719,DF8JY9 I56Y(Q*'2<.1!)(Y!57<( 0QA,1/J,F<
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MDW'Q$2+G*!0KA"N=<:C^Z=M%(  $\V2$YWR, 3\NM7A= 63%O$Z+Y+ZI$^&
M#G<1F8Q$3TJ>]@6'[WAG;E6*YDYHPC;U*2$W9[!#QQ_%9PKV>D%GYHM)0 ("
M@M"K%34/[Q3J%$0$0X$=F[=-JTW;-K+B&4Z4%2B2@*E1&K*E $G*C,X%5GWS
M<NKN(T%SXDZ1_#(P(D$@3(S49[BO1^.,PY)8Y:H^<<GXOO*"+UHY?1MFFG;$
MD:ZX%2/BHP9-NTC43'X.<$$B\\!SJ;;:HNN?L!_M41!Z-O<'P'&^O,PAP' C
M)RPB(? 1$)C@1^8AK$#L/H*5@&2?1%9"S#4Y*BY,W?Y0N51E@*$A!S#R579.
M>@P&+UI^UP'W3D >Q@$#>]SR(B-^QXE?<-N?>[*X<8N.4ID. A6EI:"VI"4K
M"DI24&#I GK-8*4J !S!D>1]9G^72EBIG^3]06VGVK?-M>7)ZIY+CXQ\I75(
MM25BQ>2*K55N9HX=)3!E ;.&[AP0X\B(@)B?<CQJ1/&.)HL'^%INW$V-RZV\
M_;@@)><:67&UN*C62E9)RHCU&*U4V@J#A3*TC!E4]]IC[?SJ>VGH@\FS]<<M
MK-NUR<W<6QRSLUQA&\E,FC7UG%)H=T[7*$N0':A'#=-,%52B*A$4P.4>-;M<
M;XFRZP\W<P[;6Z;1A9:94IMA&K2@%39F-2I4969RHXK8H09E(.HRJ!$D]3$2
M<SGK4A5OT6F9*G%-X:M[U\MQ,6V$YD&C-]*HHD%01,<0*67#L8QA,)>P<]^-
M4[R[N.(/JN;QSG/JTRX4I23I$#"$I$]S$DY,FL)2E(TI 2.@&,?+;Y5[_P#T
M;6X+CC]73F3Y?^DI;_\ V-58'8?05M4+YC]"G,;@XAM 9GW19"R%#LE%%6K&
MPN)-T@B=4AB'.F'M<# 8Q#&+SU /?MWX'72L.+<1X8BX;L;E=LBZ1HN @(_>
MI.(45))'2""".A%:K;0X!KDE.V2(^BA/S![;5#52]![9]JD:#;:AF:Q54;I8
MX&'OS:-=S$6BK4G;TB<[(&%*7,+ATR:*'=((GY3643,54#@/&HW.(7CMNS:K
M=)8MWE7#+:4-HT/+C4YJ2E*BI6D$E1,D:CDDG(2 2H#Q%.B3GPF9$$_ID]ZG
M5KZ&^Y,&TXU9;NLKH-;0R1C; @G)38EDX]OXP)L'8>V0 [-+QUBE;\ F('-R
M4_481ON>T?&'5VRW+L+5:/>\,$V]MX'H2D.$<J%J 2(*PJ(QN9U2TV H:<*(
M)!D@D" <JE,"/ACOO4H,_1H9\8-6[)IOES&BU:(IMVR))&5*1%!$@)I)$ LN
M  4A"@4O;R#7$62XHK7"E*R20))B),#?N>NYS6]=G_HV]P?G^KJS+_\ R<O^
MCVSQK6!V'T%*73-7H*&NXJ1B);-NXR[9(DJ^@LUA7EC/).UXYNY_[PDU.:7Y
M3*K_ *8 (=6NK8<9XCPQ!18W'(25+5AII1"EHT**5+;4I)*<>$COO6JFVU_&
M)/I^I!$^AQUK":IZ$.U8$C(O&.!LY6>L8QO,N\#)\='NI9D@BQ,R651>H-B2
MQB.72[LB*!RJF$GAG,(!SQQ&.*WZ5VC@?(79...VR@VU+;KJM;CA\'C6I6ZE
MZC&) FA0F"(P1!&TB(V!_-ZFT_H=;LX<KNU=WN47#ARSAXY=1>1EEA4CH!RD
M\AF0@:6-RU8.D4W#=+GH Y2CQ\[*?:#BR4I2FY2$H4\L)%M:A.M\*#JU ,^)
M:@HPI4J2<@@B:P&VP00-AI&^!,P!)&^?.I2#T;.X,/+?5F4/P2<N'X^ F #D
M?,>W<>1'D1YUQCDR0">Y%;Q&W_&-AY5J/HVMP0^>^G,H^8=Y*6'L(E'S]L"/
M(" "'ET]Q >1'C$ 3@9 GY3TVZG.Y!(VI2IY?_R?ZH9]N;?(69<Z6G(%U9,2
M1[2R6(DJZDT6:1>@C<BQI@!\(I#'+Y<@!N0'L AU+;C'$;-+";>Y+8M4N)MX
M0T2T'2HN%"E(*@M6HC7.L" D@ 1C2F21N<'$3]S]<&N>C>AGR3CUPTPY3MPU
MRK&!X"/1LT E'2$NF9I=?7#"IX#$TL=$A$D@*Y(X#[;X@B/4 <:#C'$Q<*N_
M?'E7"K=5L75E*U%E4R@ZTD$F?B(U#HH5@(2D!('A!D"2?+J3]"8Z^=2PEZ'N
M[_3%#(?ZKS*"UV;E B5D</99Q)HD!,R)4TG*DQU$2!(Q@\,/=]X>W?6YXYQ,
M\/7PKWA(L5P%LH8MT:H4%^)Q#27"=0R2LDC!,$BL<M&K7'C[R>FV)C[=JDS_
M *-G<$'EOIS*'/'W,E+%#M\1 )@.1^L>_8/EKDD F2!, ; "!,  "!N=A6]
M^C:W _'?3F81X$ #VC+G#@>QN0&8, <AV[@/("(?/6( Z".Q (D;2D@@D;@D
M2#MO2DKN?^3BXAO][D<GW7+$]9;[*O59.0LLDWDEY%U(K'%4[@RHS?!3J*&/
MR8"!P8X&  $.==A''N+MW-M=INU>\6;;35JZ4MK4PVPV&FPT%-D((;2E*E)
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MT[X+,[B+AFJ3]RP:]#J2.GXX]:740]>W?%V25#0I-DRZ@(\,NEPMG4,R(3)
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MN9SU(!6*HJ<ZI7(D1+R<.+%JA%FLAQ?,?:X7>K0F1I<?"5EE&DB2-B0#)D#
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g68105g79y19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g79y19.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2,*4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (NZ^B4(X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8             !-\   =1          $
M                     0             '40  !-\
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P  !-\     4F=H=&QO;F<
M  =1    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   3?     %)G:'1L;VYG   '40    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M     #A"24T$$0       0$ .$))3004       $    !3A"24T$#      8
MCP    $   "@    :P   >   ,B@   8<P 8  '_V/_M  Q!9&]B95]#30 "
M_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3
M%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-
M#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,_\  $0@ :P"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MK+7L?7_.+ELUMM%E[;R/4%A%CB".3O:_^I;NW)^*(,CX*;U'4;\>/0RQ8XD
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M2W-R:\8Y#ME/JN#=SHW;6[ESGUB_QA],Z6\X?3P.H9Q!TK,U,_XVRO>Y[O\
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MZ1OZ;Z'J?X57_P!.^QYR&_9_3?\ HG-))<QPV>KZ8<_VU^S;;7_VVGS,Q F
M!G$:6UIQ,9<,A7EM_>:?6NEX/4*[
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@!CP)7 P$1  (1 0,1 ?_$ !\  0 " @(# 0$            '" 8)!0H!
M @0#"__$ $,0  $$ @$# P,"! ,' P$( P,! @0%!@< "!$2$Q0A"14Q(D$6
M(U%A%S)Q"B0S0H&1\!@E4K$T0T1BH='A\5.2P?_$ !T! 0 " P$! 0$
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M',F% @B%E+8S!A"4JO4<<)!KZ;R?*%*]41@O%PD:YW=4\.%'*85N57*[F*C
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MK;K+%UEEVN7%+]O5;66 Y09BZ?K<C&YU%_"':,*I%>K;@..C-(A?P\H7>@_
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M/2!&1&HG@C4>I7IXC<]4<KO'MR_HFU2J$%B&PQ;!:1V)+-SGR>/@#C!K$5/
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MI>/:P!#6[I(K89>0:F[H#TUU+:#Z?*75_5!MO'MR9AC%C+@XSDE)%M5E0,'
M&,&AHKV]N619^46E>@Y"?>)%=#.D0D:$8MB^)[\T;U-?Z3J>IO>:/92V$$R!
MIXI#& ]R2QDEBBB+)"CY!*!R"P9@J;MHD= LM2L-/2VU.[CNY8V(B>,2$I
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M$:9[7#>C9K^%:@8$F%I)VW7<FYD1V7'#;'96P1AEX)/! J.C,3/ZI5WC/C+
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M)\+)*>5"QL\)CB3 7TL$PD>G-$&QY)0[ D=\=C'/,UC6N5/#6]PC1J\$ZM,
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MM0]S;"8IGW!1G<G@@E@I7!.2 <#P0<&M$J=QQR0#Q['X/^O_ $K)ZJ@O\++
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M (VJXA3&*YHQ"8U%<\CW-8U$57*B< $G &2> !Y)^*_0"Q"J"S,0JJ 268\
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MT0QG1HQ+:U*K(-4&01KT"29($LAPB,C#.1CFI+&\73%62XRRR/Z%&-P"C+$
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M#B0*VO P$< 1-1J*J-3R*5_;R-(*XASE5Q3$>1SG+5G=G9G=BS,268G))/\
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MW--2-,[<+EF&%5U#GDAMVS%0PVBAPB&(X=U'JW_\.-(;, RP&T;F1R.GMCO
M)RA>_K_16I27NGRVKYD>Q*@EY!EXVR(RA/(**'4A@5(49(.2-:565MR9R>?M
MQC(^WMCY^X!J+4$+(V0*ZK&&.&33'<,A0O A;&8CE\I+?)'A5'(P9&-5$:]"
M*_LO=.6<,8E>60L3O!(R#B,>P!'/DGGGV^*](>4(P ,,H(\G/Q[>X/S[^,U5
MS*[P;<C;7M_]BE1A"%9-.]&N=/ US9;Q>LC1F&]6()O;MZCT551'=UY-6\0%
MLSDAE=GV,",*KGTGD<'DN<C'/(-;BD!6#-C<Q. ?!)&"/8@\$@^<X:L/RS.
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M>Q^V/>OL;6.E].ALUT^ULXX[..,Q) B ($V[<G )+8SSYR<D^U3_ *Q^J?\
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M<QK H*+3N*T8*H1POEM."&$*2D17E:] M]/'I.H7&H73)<2!52,E(XP(T))
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MW?\ R@C"$C8,8Y; &[CP#@8P"#S5O,4IOXRVQCD&J:0T+&Y@+[(9PQO6/#%
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M^:WNKN\A5L9A^G3?  A_1#(?RL ^2S>0>#P263"M&D3$9YWL-_@9)4>KGGC
MX]\>)OUO@.1;1DPL;Q2OI-;U+*X\O*\SQVHK)=E%D-40(T42)$97!O[)KRJ
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M&X;VXX&$*\C12HB,,:MF6DA\R(4[$_F.*25Y%<I7>7=6.TSU#=RQF.\BCO'
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M?V/FLMQU_P!*68+R:Y!,?Y4MA+<L?' $2$#D>6(7V)'M?/5'0-FUR2%/V]D
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MJ<K.NV,=A=J]OE;:=)"L99F[<D9&]0SDL5(<8!/!R/&,98;GO6;HZYE0Q9?
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MR),](S#>H<4=D=9#"$>;PCEA;[J_1-KV5K?Q"]F7 ADW0RK&W!<I*J,-P)"
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M#9-1%<B%K)DL;E8]$=W8_P 8._T?4-.]5Q 3%[31,)8CGQET)"GD9#[2,@$
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M?2HY .WW^,9/.5YCTV[(CL6/E&2Y1D]*^7]Q8%Y$(L62]/UR(\A@5?$DJU/
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M,_I8': >2Q4\DBKMX. M]O; &#<P,"KLGWEA),X0Q1H=3&+,<<KRO&B"]48
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MHSZNU( ?RS790P_"-73\*.EE*-66#ZR35G@1R=I)YIHI0LE">YJDCA,KF/\
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M:!WBF@AO))V,P("JK(0&C<J75BGV&XNBW9N] 8J8X++19K"[DBF1989)+41
M18+$LK\K*@(# .3P,X%U.?37RBCTYAV"Z?P>%UT4L3:TC.,VP7K<W'EEWF3(
MDC'(]+7KJC;;)53+P:/!GPP3<AHR>K!R*&4XBM(YOMI&SI75<4M]/<7UP>G7
M:R%M;W'3]A$D!(G:5_K;(K(MP65F6&48>)L8(&",&I=.2Q6D4%G#_&XQ=&:>
M#6;R5Y@#&J)])=!X>PH8;I8R2LH.""00?PI03OHX?2HSNXSJ1B1=KR+;-,O^
MR8AYP\-A;4VS;JVGQ;$VE &0:BPVO; $Q[8@O7B4,H@0ACN$UM-_$3JJ*ZGO
M=7@65HHK:VL+ 7+9GG,:B*.28C/KEE=Y7 Y"G!;/(ZG^"GX>RZ[KVC=,W+K'
M%/<W6JZS-  8[6QMU-S=+$&V@@0Q1VL7S(Z[58<5T+]9:)WSUU[BR2JUU ;=
M6[GR\ISO-,EL5K\8QJ+8SR./=Y/>E87PD6,\Q&08$4,JWN):E9 A'41W!YMT
MOI-U>E8X5[LS9DED<;54NQ9Y)7^2S'@!F8X"CWKZW_%_\1M$Z6MQ+?S+;PLJ
M6MC86J;I)%A0)%;VT2[56.*) "3LBC4 ,Z96NQW].?Z:%/T5;:G[@R#9UQM*
M5<Z_L<+DT5!72\,JXTJV/!ES+-3I96I+^OB28(UK8%K7Q50K&3G>VD-9X=>T
M[I^XL)4F6^42J KQ"%NVPW#=&S%\E#@8)3.<%0#R?A/K3\4[;JZSET^XZ?[<
M'>[T%PUVCW$+*76)T41 +(%8L0)7 #,ASN8G:O*R2;$(Y$]6,%7*K%*5J(C?
M+](7O:OBKVIXIW[HC^W=O;Y1+A&K#])#?;D8( R!D9XP<'WX//%<.F96WY!#
M;B,D<D9])P/GWVG .<>U3YIK=M=C!Y:S[2"PA(;X[22YH1/CHY45WB0RI^AJ
MHYWCY(U.ZKY)V7F.[M%NT5) <!UDP%)W$>Q YY&!D<X /WK8TS4)=-G>:$\M
M$\)\C;NQD@^>,>/!]^#4O7N_<59$)%#>PTE'!ZK7L*PYB,(B]EBB;Y.,]RK\
MF[>@Q'(J$<_LB:Z:=&KAQN"JV0N,#R>">2 ..#YXK<GUB>2%HT!WL,-(5X4'
M@[<D#=R<GP!R><"JMUNC\9VS,LR6>*ULJ!8I+?9SCU\>1:S F&K#DEV[A+->
M[T"()J..K0"\ B8T349S:+  %I70D@*%<KZL\8 (PQ(]O/!]JQV&J:Q:R0+I
M]W?*MJYG2&.[NDMDVMOD/;BE145R2TG;9"Q.XG=AAIG^H!]+G)-.XOD&X=?K
M$RK75=*]Y<BA0WP<DQ6LE$&QDBTK@(^!<U\8YD$:VJVQ) &.8>?7M#ZD@4CI
M.K"2X6RNI2VX[(YFVYW@^C+C!&X A@^<'D$8P?N#\)/Q>35[JQZ?U^_NU2[A
MBM+>#4YC?+%><K$]CJLN+SLR )')9:A).%W+);3 JZ2:D-.=2FZ^D'(I.5:E
MNJ\M7:.&F289DU:"_P 'RH AE&-MS325;Z4H0BE''N*J17W$8;R,#-01""=,
MZII,%W&O=#K(@/9N(V,4R?LR_J7(#,IW(Q !!P*ZMUST/I.N6QCU"V2<+O[,
MY0=R(D>SX)\8.TG'R/>NSWT2=4FB^K_4M3N#(< V+@R!O+?%-AX5@^<+<X["
MR:ECB+8MA-FUD2W^UVX9M?:5@4MP3XT:8@SR'()'/HEQ;:M&)(H;RWD:-MJM
M+"J.5(RAW#*DGD$X SSQXKX.ZPZ?T'I/J273+ZRN)(&C2Y@N8)04EBD9EP8F
MPZM&RE6"2D>",Y!%K=B2M4T=+#3IVHHE;36K65-C?5ZRC9#/C0CL=,KK:RM'
MGLTG!F+.4P9)G#*]D8S'O&K'+ZT^.[52;YV:8,?02HC0#(!0(0K C^8'QD<<
MDTG7)-/EF5=+AC2T1%+.BL)969 S"5I/S04;T[#QD9P>*@W?5?2X[KV#D%3&
MR"\QRIN:Z?DOWAB"D*V4&1& ,0$&I$B0YY@-,<CW>H\K53Q8B=[MTM*J7\O<
M9(Y9;9XX&'@,'5CD@?J9%/D8&TX^:JU]V R&,2R1@AI XP2<?I S^E6QN)/J
MQS[U0&=03-TYI10HM-.QVK=+B(&)!B'9:'$R0UXYOJ>DB5,0"_SW6TEK59Z*
MK#$4S6N;/:EJB0(T4<BSR<[V)!2//ZE< X=B/Y 2#_,?(KPD88]YE$*(OI4^
MEG^,9Q@GV;)^QS6Z7(69/D6#V;<EN0V6/B@- $=E40)Y))P,8QBL)Z0I*.&0
M;"K+>\KFG1%\7O\ )6<VDMK4B2/M*!*&$J$L5(?.=RYP?V(Y]_D[1N[^?9))
M+O16 3>D3%CP"N2N[&.'R2IR0168Z@QKIZW7#J(46ZM,)V#]OBBM:))<98]I
M/ -OOYU2Z6QSY+Y"JXB1D.TL?NYJ1"C$I%XEJWX>:2)Y)3#+"C2,0\$OI(+,
MPRK!]I(SXP//G Q?],L.G=9[:0RW&GWPC59;8.FV1PN7DA+JPD!(8@*^54<H
M !G\]L8!KW6<2[;C3;&ZO:AZ176]S,')/#<8PV2&1(P QH@""<UXV'6,Z4C6
MO\3H-S&I8NENC-*TR1;V.WWS2#$<L[=UE0L.57"HK$KD$*&QX.,9@]?LM,L9
MS:6O>GGMWQ-<7,H?#,N[:J(%C4KP"W;+CD%O J/L]%6:@P^KS+8;#%6SC1W4
M-34N!/M;R5+'ZH(D$"D&/U?11YSF.088P!D,1_Z6-?U'1[!]5N7MK+:7C+&>
M27*1P!2 S2-M)VY8 ;069B%  YJ O[>:QBADND"I<()($0AWE5LD8 (()\G/
M@#P>!5<<+^H/KF)EL##,\P.]US7V<T5?!RN3;0K:JAGDF:".[(@#C0I59%>5
MS&R+ "38T3S0AD0+"F9-7W3]W9@LLL=QM4L44;'(4;F"$NRD@<JI.6Y]6>#@
MM9XG!5HWC;.-S,3CX+KM!Q\E>1SZ6(YMWDH?XHFK&>)J^S.K@2&M[H-R=G@.
M(H_S_E\F.1RHY/%S5^45(+"D>I<@Y!!\$'CD$>/;G'/SX'AY'$A96*,K95D)
M5@5.596'(8?J# _!'@5F%UIRBSS6L394B]QS#<AA.G5N0NNFL#5VQ::8:#]U
M4T47K0K*QC##-D"C0Y8RR#O<,8W%<1U<349;.[FL3#+=1+(6@V9,T:MAE0[L
MJR#(7U$;0,#@8KH2Z7;:MHUKK+74&FW!B*79D*BUGDB<QO,P'J260+O8)NW$
M\@GDT6WEBLK,2TF'0M@8MEV#UY8IK V,W4B>=T=XQN)&<C&1EBO*]KHA%D,8
M6+W*SR=(;V2G=8_B(=!M;BWM])ODU&:!EL;J<PFRBG8,O=D4CN,8!F1(E!WR
M(@;T,2:Q>1?13=NWN;6\65$9;FVERH1\9;MXR".0 Q W#U#G:?VN+#9%=61,
M=Q/%Y4FG@000:H%(6NAUL:" 311@L$:5&;#:$;&,02M1&HW]/FW]7/AV\T7J
M.]N[F26XGO6FFEFDO))-\MQ)-(TDDTVYMPE=CF0N>6\';@B:FU74&B2"&-HX
MU143M*Q3:H'C;PO(_F))/G<3FO74FK\@H,F?L784B(.W TPZ:HB&28VN66-X
M339TIJ(+W(0%. ,>,IF=R$(Z0]?!J63ISIO^&W<=]>2#N19$$<>9&C:53'+<
M2LH(+I$SK'&JMR=Y.0%J/L[1XKDWUTPWIN,2,RD[V4KOD;]*X&0J@D^K)Q@
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MU<>0KL9$900 Q8LR<<9Y V\97D>6VT.Z>KC+LE^M5TJ6F%'1,BRB;E&2YXX
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MI#Z/AMA_43]N1D5_,>;4[J]NKIKF7T2S75]<J"(^_*TDEPQEVC+*96+[, 9
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MN3J+VMDNZ,ZI1P;.73XG0P)-1C8AF/!<L9Y52?=2!(H7@FV2$6,Q4[265[%
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M/*>Z.R%10@Q)3F+,+(L[%\B:6I=3Z=>:Q>PW6K&ZAE@@$=G;%6BMH(]V\M%
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MR010(]2G,,37/22T:YAL]8TJ\N&*06NH6EQ,X5G*Q0SH\C!$#,Q"@D*H)/@
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M-X8VM[E5:WCMKGZH"]$K)(%$JI'+O5EW!9W\$]]#'96]S'?:G#?K>3M"\,*
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M5F]._P +$J_I15SZ4!R HX\DY/GH6CPV<=BS)+'$4PPC/ZYG8C<[$ 9('N?
M 4<#)COJ$S2EL<6G:^"=DJUS-6T$2 ! R)3A'(W[A/=%<1KD@5,1IIL^6]$"
M%@VA1SY!@B)LV%HT969Q@@$A<X\C&XY^1_<YXR*BM4U)95,$&&"N"\F>!M.=
M@\DL2,>!\#.#5 ,WS;4F!9FJ;"V "%-0K!E%[&SM@U0T[-&.RDUL24.$X0&(
MQ6&7S&UO9PF?"):H-,OYX._':R=AN5D;:G< !.8PQ!<9/L,$D$''-54S*I$:
MN"WP!R.>?Z_;SP./-6WJ:O%,APN%EN"7M9=5DH"R*F^H[!DV!,\/,3U#,B$3
M]8R>82M11R8I4>PC1%8K4T,8=HI$(\B2.11XQR&5@1X/'!4^ 36=3+"%F21E
M8,"CHY#*P; 9&4@@J?G!'N,U;K3^:8KMO6,ZBV/%AY#-Q54^[QKJ.RQ>>"XQ
M4J[%BE&IBG'Z;X"RVN<=Y8[3&/YR%Y2-4M9]+U))+!I+=;G#6Y@=HRK$@/""
MI! 5L':W&TCC X[#TYK27VDM)=R9ELEV73R8RRA=R2G'G>G!(\N"//%:R-LZ
MMC5N:7LBNGARO7TU[1U.MRP?9Y!2.$I$8RHRD$UB$&)RL6/7A#"*20KD%.=Y
MN4O1-/U*X6WA$[!+M4'=N$&X.V!EI8CE78CABP//.!@"HV+K:S2[=)HI4M]S
M".8'N' .U3)$J[@N 2=A8\CC&2?SU=@&TZ!\JCPO#I6DXF31A!R>[MK:/*R&
M<Q6F:!DJ)&LIUMY@C39!H5<CHT,CE8KW@D*\Q,E[>6U]MENF_B!@W-:)M1(8
MVP-VT[>V.44&0AV&"!E0 -N?K738F>%#=O.-@*=AHB0^#RTH4@;6+ !-S<*O
M)W")]_Z<R?5V35-7EF=S+?#\H 8.-9C5I)B.D"B(\H\<MQ-*0]9,@A<24L5Y
MG_>FODS"%))9(:DOTK>Z?J,DX>U":DN[M6LR#8 H+2O"^ DK$>"<L%7('''.
MNJC=75^+^>XBDM7B58'M^!# '8QHZMAT(+$R"3D.WJ/()J]JO9>;ZZZA<1P'
M'KB?FF)YKDM;A^085.(2XQ_):6_D#A2E?437'B!E0@%=-;+$-CQCC&#(4L,A
MQ/E-:T^V:":=A]+-;PR7,4Z,8Y;>2%2ZL'&6PQ 3&3NR"#D B(L[J2.>,0R9
M<311JR$@N'8  E?<!C@Y]!Y.!5ENJWZ,F'9^"YRWIWR.)K;(BQI,I,!O!29^
M"VMAY/,C*ZT84UIB8Y+G>*"9'MZV.J(V/%B [^GJ]-?BS<V+0V^O6[7T <+]
M= 52\B0@ -+%@17)'DMF)VSR7(]75H;IE4"8DX!W,N,, ",E> "1CQQ]A75-
MV_B/4]T'[PKLOE5.1:MV'@^0)]KR2KD@L*21+"GJE@@O*LDJFMXL^%V6;322
MN=*KCJV9"4)4[]IO=7T3J+2$DM)K?4[22,I<VS@K(L4G@2P/MEB96!V/A2K@
M-&^Y.-]3;7\.$998I-T;$#*[AE2C CTL",,#@@@'V!KMK_30^LGK_J7URL3:
M^58KK':=#_NMK'F6T2HQS('!BL*697.M#(*#+(C2F96F,OKC1Z07$)'.$7SG
MUET+;V4@O]))N]-D4O*CL#<V+@M^7,PP9(P/_-7D#F0+FHQI;S2]\:23&- 7
M15R^5/NB$,3C!#  L,\\$9M%8:9R/Z@.TJC(\CDR:SI1Q*Q%8O*SQ8;>5I"D
MCD#@UOZ&]\)]<;4LK9$)&LP"6#6H7UY$J)SV^O8K*W%A;.K2+Q(Z-N5&(P<-
MR"P V\'QR1G@>](TN>_NY-6U"-D$C PQR@!V53D%EP, ^>1GG&.,UN&K:VOI
MZ^'55,*+6UE=&!"KZ^" 46'"AQA-#&BQ8P6L$". 3&#$(;&L&QJ-:B(B)RL^
M?-78  8   \ < ?TK[>*_:<4IQ2HNV]MK%--X'E^<9),CE_A7#<OS0..!L:V
M-?Y)$PR@G9#9P,?AV$J-[V<Z'!(UJ-7T@N>Q\AXA>3TW+&QGO[F"WA4COW$%
MN92CF*)KB5(8VE90=J[W'GD^!DUJWEY#96\T\K ]F":?MAE$DBP1M(XC5B-S
M;5/V'N0.:@O8_6-BFK-;Y;M#*\1OH^.TE!J&QQD;+[!!V.>7NY"QX6/XG3PY
MF412T]C6V4V!&N)^4MI:AL,TNW@2YU=5V!P2%IH4]Y=P64,\1EDDODF/;N2E
MM'8;C+-(1"0Z.BLT:P&63<!&RJ[(&T;C6(;6VENI8G6...T:/\VV#3O>8$<2
M!YEV,K, [2]M,;G4LJL1[:%ZOL>WK=;/@Q<4-B%'J"7'H<VRRZSS6=I21<O;
M3T-W<4<-<:RJWER*JGC7S([LR*"+C-E.KK2/53I:14*3\U+0YM-CLV:<7$E^
M#);01VUVDA@WR(DK=Z"-5:0QY^GR9XU>,R(I:EAK$=^]T!"84LR(YYI)[5XQ
M,%1I(U,4SEE0/COX$+LKA';&3:(N7XF"JAWQ\GQT-'8">:!<ENJT=5.".+(G
M$+#L7R6PY(AP8DJ8\@3/:R+&D2'*@0D>V)$$QD:(0RF52 T8C<R*254!D W
MEF50"!RRCR14H9H0BR&6,1L"5<R+L8 %B5;.T@*I8D$\ GP#1,MQ1TRHKDR?
M'EL,@B?<*& EU6K,NX"B4Z3:B*DGU[*(H6N-[F$PP?2:I//P15X[$VUW[,NR
M)MLC=M]L;?Y7;&$;[,0?M3O0[D3NQ[I%W1KO7<Z_YD&<LOW4$5Y7+<52S#2K
MDV/I<R)<F!'J5NJU+,\Z$ 4J9"# ]S[HLN)%."3)C,$XP &$8K&#(QSG9FV&
M3M2]L*&+]MM@5B55BV-H5F! )."00.13NQ;@G=CWDE0F]=Q90"RA<Y) () &
M0",^:@FFZH<#S*URFEUV"5FME@6\ZK1.=1H=MBM43';F= J+&PR5&7E]!);8
M[3AN0QRMJQR+JTL(=G"I*FQ+")Y;\FDW4"027)6!+G3I-2MV9)G$L:O(B19C
MB8)+(8R07(CC5D:1U#"M%-3MYFE2W!G:"^2QG"O$IC=@A:3UR*7C0/@[079E
M941BIJ>?XHQG[R?'/XBHOXAC1/?R:'[O7_>8\'Q:[WAZOW'OA1?%S7>X(!H>
MSFKY]E3D?V9>V)NU)VF.T2[&[9;.-H?&TG/& <YK>[L6\Q]R/N!=QCWKO"_Y
MBF=P7[D8J"M>=3N#[>CX/;ZNC2LOQC+L[V5@%CD$>VQ: W$;/69<J@V,ZUJ)
MUZ&\L85U;8L:'1BH(%K8$@V=;?SH,*D(>:"0N])N;$W"7C+;RP6UI<K$R3,9
MDN^R45)$C,2-&LP,G==%#H\2EI1MK1M]4@O%MWM TT4T]Q T@>).TUMW0S,C
MR"1@[1801J[%761@L9+"=HN38W/F6U;"R"CF6%#V2]@1;:!(F4OFUSVI;10R
M'GKE<QCWM]XP/=K'.3X:JI'M%*JQNT<BI*"8G9&"R <$QL0 X!X.TFMX2Q,S
MHLD;-'_B*'4M'_[P#E?_ *@*CZ#A^A\FS_\ Q!K<9U+D.TJRO@N_C:%3X?;9
M]754Z+WK%_B0$>1D42OF0B=X*^]'&D12?[NKPN^=EYM1AM1;/-?163NV+=I;
MB.U>1#AQV2PA9U;]0VE@WG!)K L-A+<?4+%:272*OYZI"\ZHPRA[@!D"L/TG
M< 1XR *D.[R3'<9CAEY'?4N/Q)$@<./)N[2#51SRRM<X44)IYP#+)(UCW# Q
MSBO1CE:U4:O;6CBEF)6**25@"Q$:,Y"CRQ"@D >Y/ K/)+%$ 99(XPQV@R.J
M L?"@L0"3\#FOPM<MQ2C<K+O)L>IWH*(96VMU6U[D#/D$B03*V7)"OI390BQ
MHA.WA)D"($*O(QS4_4AFE_PH99.6'HC=^4 +#T@\J""P]@03@&CS11_KEC3P
M?6ZKPQ(4\D?J(('R00/%?%F.;8]@]-*MKRSKXKAPK&575\BP@PYUX>M@FGDK
M:<,LX5G3RA Y!1P>;U5S55$;W7G[!;RW#A(T8C*AW",RQ!V"AY"H(503R3@5
MYFGB@0O(ZCTLRJ656D**6*H&(W,0. /]JXG4.QJ[<&JM:[8IX$ZKJ-FX'B.?
MU599^W6RKZ[+Z"OOX4*>L4IXJS8L>P&&4L<Q0>NQ_I$>SQ<N2]M'L+R[L965
MY+.YGM9'3.QW@E:)F7< VUF0D9 .#R :\V=REY:VUVBLB7,$-PJ/C>JS1K(J
MMM)7< P!P2,^"16N;ZF>0GI/\, M<YL>=$R="*BKV\PS,?5GE^WPA.[?CY7N
MG?G+/Q%=DM]/QG:TDP/G;NVH5S_0,..<$^V:YQ^)<C);:;R1&TDX;X+;4*\?
ML"./GXK4L:T28BN1R/\ )47NB_NB_P!E_/X[I\)\I^>WSQ.[?((S\^ 2/'S[
M?TR//[UPFZEW,5/)S[#'W_K\? P3GS6>X'&$-9=@7LA'*D4"N7LK6HB$,Y%_
M97]VL5?Z-7Y3]Z#U#,SO%:J<*%,T@S^IMQ6,$$8. I8>W/SR+9TC B?47S@;
MBPMXL_RJ 'E9>"5W9"$^2!P>>9K@'B#;YD(Q$1.Z]W(B(GQ^_=._9?V^/GM\
M=N1-I;H#ES[9!)&!Q_0\\@?(^]7Y9XU7)( \^>!_8?Z'W'BHKS_(HGDX,5Z.
M<CE1%:J*B=NZ*OQ\]OC_ +)\(J)S7U%XR<1X(!Y('N?;QCY)&/[>T!J=VC,0
M#D Y_<^X'!R?^7WYK!=>3SMSFG03G>$Y9<*2B=D:6.^(8ZM<U/A484 R,7\M
M<BJB_*]\O3<TB:W9JC$"<2PR<\-&87?!]CAT1N>00"".<P=I,6OH@#P[,A^Z
ME'+>?N%(_8<U9JP8-0*G9/POS_7_ $5/W7^J=D_*?VYU>-?&=W \XQ@_W\>Q
M\^?[S5P$*$?TR0#X^Y_?]@<'P:K766J83U:=,>80B.!*B;6I*Z20*JUY:J_(
M2ALX[WIV1!'@V)A$5WZ?%W9R]E7O=>BYV@UJTP<+)*J'GG\Q'0C YR<C'!\C
M/S6KTE,UKU-:A"0DDJHWOD2AHR!GGD$#[_N..U-SZ KZ&IQ2HYD;9P"-M6MT
MF3(H;MFVN#7&R(V+"52SAX927=-CLN[E^"*R)&+<7D2'!20X;YSP6#HS2,@2
M7#W1IUZ=-DU?L.-.BO(=/:Y. ANYH9ITA0>7810L[[0=@*;L;USHG4K(:BFD
M]]#J$EG)?BV&2XM(IHX&E? PBF6550,07(?:"$?$B]T_JG_=.:5;U.Z+^%1?
M^O%*\\4IQ2M*OU$=0]36";;HNJWI8)E,FX3%?X6S^!BXDM;!D&$7O$.:A<*4
MZTJ#QU&LIHH1T@2(+9K_ $O-##NW35[H\UG+HVM]M8&G^HM9),QJDC#:ZF=&
M4Q'@%2V%8%@Q\5T3I+4-!N-/FT#J$1+ ;OZRREE+1(LLB)%,AN(R&A++&C!B
M0A 8,<[0=-<C%>MOKZV;6U-CCN;Y%;L(.OF9#D]'98_AN&0F^+9$RUG2($2O
M@C$-BE=&"A+*>YGH0HDB0]HUO(U'IOIRR<6DMM@Y(CMY4N)[A\>GU!B<%L!F
M?"J/O@5T%M7Z5Z5TUH["6U"G,BV]I.MU<74N,*TC[G<Y  +R,$51Q@X!NCJW
MZHNVOIS8U;='?73TO7&'9SJS%K4?3UM'5<*?.T;U XK12VQX$D5U*?+-BE_(
M'(2?:AFG.1T@I 38E-/(*.:A=/=.:CUUKYMK5MGU$CW.H7<B,\5C 269Y,8!
M)_PK>,LID?"@@ D?..M:SVFNM0NAOGN)I)5C#<R/(Y8*I.3M4'D[?2H&?:M+
MF7=6^4=2>^,QS"=B]KE <TDQYQ"Q;.5&'@;I)$DSS29<F-)C.I<?A/,!@"/@
MQY HJ.B%:XJ#3OT?1EOH6E/'+JD-E)8R.EK"\=NZ:G:HJK'*421;A)[F7E64
M.$&%D5N&'0M%_$V_N=6Z3T#I321J.GMIVG1:O D-Q'<Q7L@ U-UFPL4<6GKN
MN&F96BGR6,IRNWM.?1CGY-9]+>23;/(!WV+.VQD\;!%;8Q[%:^KAU]+'O(C?
M0.<D(#LJ;<R!PI*!*TICRA"6)+C%)\_=;PPPZXXCB,3O;02S*4V R2*6#J,#
M(>+ML6'#'GSFM?KQ]-DZEOGTV2&6/T+<M R-%]8!B<?EDH'!"]U0S8EW@DGF
MMNG*A5.IQ2G%*<4K"-E5I+C7N;U00^X-88I?Q Q_CN8QZN4,0^R_N][FHGRG
M9?GO\<RP,$GA<^$EC8_LK@G_ &K+ P6>%FQA98V.?& X)SXXP*T&?0?TQEVO
M+_J_RG,<UQ^ZL<CS6FBQL:I_5-+IZYUIE5O%L;([R*,2S#39E?'AB'V:M8<R
MO1A!-6W=92;KFT3.]>R\T<@)P4FD)"8/\RA02P)!W#'@YNO74QDO;-.XDZ""
M2:*="V'CGD!52&YW*$&XY();*DY-=BKE,JBU^,@ )0#Q9(A2(\D) 'CG8TH3
MA*Q1E"43T5A!$&YS"#>US'L<K7-5JJB_H)4AE)5@058'!!'(((Y!!Y!'@T\^
M:T.[_P#HF3]N[-N<DP7JQRG2&LK[(@VLS5>":VQR-6P:=IQF-CM+*C6M=!KX
MGAZX()1TO_M[#>; &*USB=(B_$-H-'M].BT2S2]BB[<VJ&9WFN'VE>_)')&X
M$[*?7()-S')+8(585M&5[EIWN'9"VY(2BA8^<A5((.P?!&.3QR:VVYSTOZ#V
MAA--KW9.KL3S;%Z&EK<?KH-Y7-(\%74Q&PX<1DN,Z/,8 0FJJ!9(:)'N<]&(
MY>_*#!?WMJS/;74\!<LS]N1E5BWZBR@[3GWR/]:LMKJ%]9*Z6EW<6R2 ATAF
M=$<'C#(I"M^Y!/WS52>HCZ<'1A;:8LA5&F*G5MOKB+7YC@NQ=*A%@6U\&O\
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M))(W&6P1,21RK,0C<@LF.2202,KYXR,CC.35(N$"':Z.L<;LIB! 8*&*D$G
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M1AH<+7^*LGRFG/3Q*NI.GIR9=A+@&AEF%5R 8VN97R)"D<[L!C7O<1!%*Q\
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MO/T]%='[0AZ9T/&,8_AUL&Q[>K9OSQP=V<^]?@ZMZK#[QU%K.<YYU*Z89_\
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MQ5UW,?8W+L=HZRF=;3WN(YTRR=71HZS92N*1?7DJ0B*1_9R>3N]?9W?&]V?
MP-S%L > ,DX ^!Q5=9F?&YF; P-Q)P/@9)P/M7X;#S:JUOA&3YU>>K]JQ>HE
MVTQH6/(5[([%5@V,8U[E<4JC$BHU4;Y^;D\6KS+;6[W5Q#;QXWS.$7/ !/N?
ML!D_TK9L;.74+RVLH=HEN9DA0L<*"YQDGX R3CGCCFM/_3GU=]1'6#U(7V*8
M/FF-ZUQ/6T&@RW+,?E4,:Z?8XG=7-A7Q8<-DF,V7-M)J5TF/(GI:0(M0YT24
MH9;G)"+;-9T?3-$LH5E2XN+VY0F*57*1(R\,7\K@'.V,*6."2P49-ZZJZ?T'
MIJRM[7_C[K5[A#(ESW$CM0H;:Y>/:<C.0D:8<<%Y/Y3MSH]H8%D><YCK2ER:
MML,ZP"'0V&7XV$CON5+!R84HU',DB>QC71K!L&6@C <4;2@*$CF%8K.5!X9$
M2.1T94F#-$Y'#A6*,5/V8$'[BN?/#+$L3R1NBS)W(F92HDC#M&70D ,N]&7(
MR,J1Y%9_S'6.OBLJZ%;U\ZJL8[)5?91)$&;&*BJ.1$EB>"0$B(J+X%$]S'=E
M1>RKV5%^>?JLRLK*2K*0RL"058'(((Y!!&01R#7X0""" 0000?!!X(/V(K2W
ME/TA.D77?5#A?5O&V;>Z>I<5L0SK'7QKNEAX=DEP)ATBAG9#DCS6@ZMZ/_WR
MH4TA\F,,L8<J-#*4/+O==<]2ZO8'3KEA=L(NVUPD)%R8$.5$G8"AQ&68B1P=
MI8G&XEJTK;18%E+VL$K%292D8>14  #-C#LJX W<@8\^!C=/"?"+$C&KGQBP
M2@$2&6&\1(A8I!M>!\8@%4+P/$K'!<)5&X:M5BJU45:/6]5!.L[H?QSJ8EXW
MFTZ\RX\O7TD.3,UG7S8;L3V/;4#F3J.NOX%H[V"N21'8 ;S(Z.Y'-0@V+YE6
MU=/=6:CH$5S:6IA2"^5H9IC"K7,$<P[<Q@E7;(FY/(#@94'!QBM8V%G/>VES
M=!RD$T3NJ^I65'#>J,^E\<\' /CSR*J_3?Z,LXPC9._MT;ZU-65<S9L^,W&A
MY[:R<TS:$UE@>1="].R4]=74TYP:P@?3APC.6''C0@"KHS7R/WJ+5;:ZCLK6
MQNIY8K=#W1L[5OW""JF-0%R0K.K #M@'TY9G8WWJG6[:^CTZUL+Z[GBM8<2A
MU$,/<VA5*(@0;PA9"%41QKZ4R6<UNN1$1$1$1$1.R(B=D1/Z(B?")RJ52Z\\
M4J#^H/IUU)U0:TO-4;DQ6)D^*78V_#_]WM:><)?.+<4%H-JRJFVAD1"1YD5S
M7+V41FE \@GY[:YFM)DN+=S'+&<JP\'Y5AX93[@\']P#4EI.K:AHE]#J.F7#
MVUU P*NA]+KGU1RI^F2)QP\;94CX.".FUUY?3(W9].G)X>[]/9-D68:8@6*&
MJ\^KP^VS#6,N43V8(&:)#:^+)K9B2DKPWXXX:Z=[AT*Q@@4J(3J_3O4MKJZG
M3M3CC$KC!1O\*<#)_+R=PD'ZMN2PQN4G;Z?H[IOKC0_Q!TZ?ICJNQM));J Q
MW%G<)NLM112K;X QW1S1NJR!-XEC*B2"0[6:.,M._5#V;A<-(68PGY:9J#2/
M8T[(T&=,5O?],V$%8T+W"M[(DB$T+"?@D9%7SY.7G3K-F33+A IY-O=.P"<9
M_*G568@G^67QG(? Q7'.O/\ ]&NREN&O^B;V"T@E+-)I&IS3&& [<@V5Z$FE
M,9(/Y-T'* C;<8&UMV'0A(ZC>NX]UFU_<9)H;4./V$2/&A'H"2<QSJ.\?JO+
M16<T*XY55R+X@/,5+B>QZN1M>'N&0G/];O+K2I!;M].T[*QS%,DPB(./S HQ
MO(P<9Q_F&:XM+^&;:+<K;ZS-;2RJ-[065P)U7DC;+*F%#''Z5R0/<'@;]\'U
MIA6NX7M,5HHD$Q6,;.M2HLN\M7L:UOK6US*4MC8%7Q:O>1(>QBHB"8-B-:E+
MFGFN'+S2-(Q)/).!GV4>%'P!5DMK2VLXA#:PQPQJ,;8U"Y^[$<L3Y)8DD\UG
M?,-;%%3NBI_7XXI6F#K-TWF^J[FRV=BM<^WUW.LUGSX\-A'OH)$UQ"2@S ,:
M\@8*R$4T:>O>,CC-C&>$J":>SZ;J8*1Q2-B6,! 6.!(F<YW$\,HXP1R",9YS
M0-=Z?(EGN8D#6]P2[*@R\,I7DD<YC8C)(/I)Y4#+"., ROI_V1"K,ER_'-<W
M-[5K$1;7(J*DL+6"6,QOIA+*FQB2&DBN1$&PSGM%XHX:-7\6Z.\F,02.XG2,
MCE(YY$3+>1M#8Y/GW.3R>#7.VMY()=K0!R"<%HPQX_H21X(!R!4ST>U+';.6
MR]<Z(JA93?1Q,9=7K4<+#<.A(BHR1D%P$)8T1$8UB0:>,A+6Q5/3A1$ ,YQ1
M=YJ,%FF78%^=L:G+,<?&>03^IF.<\G)Q4UIFBZAJLF(T,,+?XDS@JJJ",@<>
M0,;549X'@9(XS$[:NU[N2PJ<[N7RL@K<6OQ+?2(+8SBY!,\8PU@UK'&6"$ 6
M%BP(B%>X06D]:0604Q'9,R7EI#)$.)&A=ESP$+;F!YQQX/OGCCP<$4<.DZC>
M13,1V!=P(VWDR@-'&W]2 WO@'(\ U5W-.FBUMLZB[*P?.LGPK("E9(ERZ<8I
ML68=$1KIA8<IXT80PD\)(VO4$OY<82O5ZNLUOJ<JVGT4B))  =BR#!1222BM
MC.,DE>05]L @56^_);3?41 F4'=N!(+'WW8X8$YSG/W]JN_TO8!C>I#9%>-'
M-O<VSHS)6>YGDCQ'N\ED,&]D9CT",4:MKX*E*2!65X0Q@$<\KE*<CR<@=:26
M\AB16*1VS9@A3(5#G)89SN9\ .S9R!C 515@T#5BEW-//&C23ADF9P&RC<!5
MX&U4)#+C^<%LXP!Q7515S-K6FHM8XL\;[RWVEB]N\;C((9JW%UFY*>))>O8;
M@G?4L7P.\;/-G='H[]+HJ)_H+9YYBVP,I*#]1(. 0,@Y)88!(X!)Y&*EY8AK
M-^MG:A#+V)@LK'"+N7)!(!( &2, X8@<9S7,T^N^LM)$NGI\#PZG"#U&AR3,
M\TC#KR.81C?Y%=C0+^S.YXW.()Q8X8R^'@\S55>V.;J"SP,(9\^ 8]N/W+'V
M/QD_Z5LV?16J(QWW"6R@X.U^YNY\J!]C_-MY'!'FIKQWI L<C1\G?.>FS1"'
M";^&<2!.Q2@<T:>2QK&>*<^[LX[GKXE#'/4QI(QM9( 4)9 "1%UKMQ,AB@06
M\9!'!W/@^=IP N1P<#_4"K1I_2-C:2BXN'>]G!R#(<1Y&""4R=Q!' 8[0/;Y
MO"  8P11P#8$(!#"$0VHP8A":C!C&QJ(UK&-1&M:U$1K41$1$1$Y!5;/'BOU
MXI3BE.*4XI3BE.*5X5$7MW3\<4IXI_1/_/\ _O\ ?\\4IXI\_'Y_/%*=D^/C
M\?C^W%*=D_HG_;BE>>*5X\4_I_?X^/\ Z<4IXI_3^_\ 7_S_ /O^J\4KPO@B
M_/9%_/RO_7\K_P"=O[<4S_W_ -_[_P!/-8K&SC$I6:VFNXU[7'S6EQVHRVVQ
MP1E?9U^.9!86U536\L2,5H(EG8T-S$AN>1''+63/!BM Y4S&"98$NFC86[RR
M0),<!&EB2-Y$4YR2B2QEN,#<,GD5B$\)F:W$BF=(TE>/^98Y&=$<^P#,C@<Y
M)4\5Q.T]GX;IG ,DV;GU@:KP_$H@9UY81H$ZT/$C29L6N$\=?6QY4Z2KY<V.
M-61XY'-1ZD<B,8YR>[.TGO[F&TME#SSL4C5F5 6"LQ!=R%7A3R2,G@<D"O%U
M=0V<$MS<,5AA4-(P5G(!(4>E06.20, ?Z5R6;YK4X#B=KF=U$O9U52QQ2I47
M&<=N\LOBC/*!$8E=CN.0+.[LRH62-Q!08)R""TL@C6A"4C/%O ]S-'!&8U>4
ME5::6."(8!)+RRLD:# \LPR< 9)KW/,MO$\SB1DC&6$4;RR$9 ],<:L[G)&0
MJG R3P#4?Q>H+7$[(LEQ6M+DEK=8?M>ATOE$>IP[*;,5)F^28949]6LLI<&I
M/&B8ZF-7E5*GY:<H\;K94P5?.LX\YWH+LMIMVD4,SB*..XLY;^$R3Q(9+>&>
M2V<HK."TO=B=4@4&5PNY5*Y(UAJ%NTLL*=QWANH[.4)#*PCGEA2=-S*C!8^W
M(A:9B(U)"LV[BI$P_-L3V!3.R'#KRNR*D;;Y!0?=*PRR(:V^*7UEC&10&&1K
M6O-47]1954OP\AI*AG:Q[VM1RZT]O-:R=JXC:&3MQ2['&UNW-&LT3D>PDB='
M7Y5@:V89X;A.Y!(LL>^2/>ARN^*1HI%S\I(C(?NIK*T[=OCMV_MS#_W_ &K+
M7!91C=3F..7>*WT9DVFR&KFU%G%(G=IX4^.2,=G]G>!%5CORUZ-<GRG,<L23
M120R*&CE1HW4^&5P5(/V(.*QRQ)/%)#*H>.5&C=3X9'!5@?L02*ZO>Q=7V^D
MMHY/KF[81RTMB5:J:5GILM*8Q%+66(5:B,5DJ(X)7-'V01'% K6N"]K?E[J?
M2)-$U:XM2I$9<O Q!_,@<EHV'CV&&/LP93S7RKU-H\NA:Y/:RJ>R9&DMY&'$
MD,AS&ZD\<8*L!G# C.0<YC5-K[.$Z#8Q@384H?HR8TD;" ,Q>W=',7]T7LK'
MHJ/8[L]KFN1J\AB(YT:.15='&&5N0P/M\@_!!##VY&:W+&12J@@8'!YQGXY&
M#GQSP1_4Y]0:$PB87U8MC>UHG+W]J*6"6)B+^&B?-$0S&)_RM4C^WX[_ !W6
M%EZ8L)F+))<0CD[49&49.<#<I8?;)/ QDXJ=CT^&XP3+(H/) V$^2!@X!_ON
M^23R:EC&-7X+C!&28-:LV>Q$5D^W*L\XW=O\X!/1(P'=_E'#"CV]^R/^>;ME
MH&F6+B6* RSC.)KH]YEP1AD0CMHV>0P0,"20<>9*WTZQMB'V"23V>7#%2.#M
M4 (IX\[<^<&L]=&&3]7DB_NO?^O[_/X7M^/[?CXY,D'WP<\\C'[8\_T_?[UO
M;%<>D@CX\_;]Q4;[%O*[%L=L[:P.,$:%%-)*1[D8UK!L5?\ ,J_E5_2UOY55
M1$[*J+S/$FXJ N"V ![9/OC^O]\_;$+JCB.$JN"[_EK\[FX (]_.2,9_ODV1
M^ESTU915R<GZK=F5QJF]V15K2:TQRPCD%8TF!%E!FGO9HBC8^),RHT:*2-&=
MW<RIC ,JM]\K$[MT;HC:=:?53KMGN4 5#Y2+((+<#U/@$CV &>20.B=$:"VE
MV9O)UQ/=1J$5AADASNRP/*M(>=O!"@9Y.!N5Y=:O=:TOJ7_3MI/J":NI,>7/
M+W!,ZP&39W&!36RIDS"Y-I81!QSQ<MQAAF@EBD, ($>\B,;<TS'G=%65&-)K
MY-]Z"ZXEZ*U":8V45[97RQ17J!52\6.-F9&MK@@E=I8L8'S#*P4OM95D2C]<
M=&1]7V,4:W<EI>69D>S9BSVC/(%#+<0 @'<%"B= 98@6VAU9HVZ06;]$NV=&
M=36 ].O4A2V>KUS+/<8QA,S#"^\4,['+[(85+(R_$;!"1:[)($44ITE!#E@.
M$K%B6(X,II ,^M+3JK3=6T"[UW0IH]16VM+F<6Q<Q3)/!;R3_272%6DMI6"!
M>4<'<&C,B[6;Y>NNF]1TK6K;1=:CDL'GNH(?J"O<B:&:>.$W5N^Y([F-=Y;T
M/C<O;DV/N"]R'2GT,?I_:G@P'7^N+3<F0QD8\][LW(;2;'D'1J-*K<:HY%+C
M:17O1SQQI==/</R[/.54\E^7M6_%_K74G<07T6DP-D+!I\$:LH)XS<SB:X+8
MX)61 ?917TAI?X5=(Z>JF>TEU2<8S+?3.5)QR!;P&*#:3D[760\X+$5L$Q#I
M)Z6\!$$6&=.FDL;]!C&#-5:PPV-+\6*BL\YK:=9A'-5$5'%.]R*B?J^.4JZZ
MEZBO23=:[J]QGDB34;ME_HAEVC]@ *M]MTYT_: "VT32H<<933[4,?W?M;C^
MY)-31!Q?&JMC15F/4E<)KD>T<&J@Q&-<B=D<C(X!M1R)\(Y$[HG9$7LG(I[B
M>0YDGF<GR7D=B?ZLQ-2B6]O&,1P0QCX2)%']E45S(PB%W](0Q^2^3D8QK45W
M;MW5&HGSV^._Y[(B?MS$23Y)/[UE  &  !]J_3GY7[3BE<-D&.T&5T]ACV3T
MM5D5#;1B0[2FNZ^+:5=A%*WQ)'F09HC1I(7M7LX91N:O].Z<]1N\3K+$[QR(
MP9)$9D=&'AD=2&5@1D%2"#S7X0""" 01@@C((^"#P1]C4$:>Z0.F/0%S/R+3
MFD=?8!D%DLA95Y140!VZLF=O= CV4ATB9"BR$:U#1(1H\4C6M:X*M:U$E-0U
M[6M5C2+4M5U"^BC*F.*ZNIIHU95VJP1W*[@I*AL;@"1GDUABM;:!BT,$,3'R
MR1JIP?(R " ?@<59#D36>G?BE1IMK9-!JS ,BS.[R3$<;%709 ZRPS2]C8_C
MI;XHR#J:^=9R'(T23)R#C^ D?(?W<T0U?VYN:?:27UY!;10W,X>2/NK:0M/.
ML!D5971%!R55CM+87=@$XK%-*(HG<LBD*=O<8(I?!*J6/C)'MSC-=!/(J_JI
M^H)UGW5=A.#X%L;:^5KDN1'6KK:>!'P6NQQ\<=)L'.+YE<.AI:2Y: V.XQ42
M)Y[N6T@)D^1(E$2*+Z<U+5]'Z!&E6,E@;?3([=WMNW=22ZVLQ4".ZG5B"EN7
MDD M@Y#,78J@#PK2[>WN-56XD%PSS&0"160"SVY(>) #G>!M/<* 8Q@GAJMW
MTX_17^H+U&;%M[GJ=I\*Z36Z\DQ+O#<V7%]<[@)E.412M!$BQ=?CMI&.)1I!
M4LJ=.L)+',F"KR AR3(9!<AZKZFTZ_99K*>:[N))DE>:1621$7DHSM'&3N&U
M"@4KA?43GFTZ1;&QFCDDC!B0 &$-M$@SD!MI(PIY ((\@ #DQMUCZ.!T;]5N
M&[$WCC^UZ2@J,A;:FMM;V-CCD3+HH)\>7+F8]=UT65$CI.DM:=(\=J2Z@LE0
M(D<C6H+8#VE_8/=Z=/9O+-"T5S:78RT+$$*X3(9'Y(R%*.PWKDDUVF[ETJ\L
MY-1TBXL2UU:&"\L;Z,DVTY!'=1$ ".,G! :)FPZG(P.TMK+ZH?3UD73;B_49
ML3[WIRAS&PNX.'8AF0)!,XR:MHYJ5Z7E51-B@LY=7**QZ-LB1!PU43W))(QX
MG$JNF='Z[K5[+9:39O>M!M[\Z%8[6$L,A99Y&$:O\)N[A&2%(!-<>U*\M-,9
MEGN8VP<+V_47./Y%') /IW8"Y&,U$&V_JE](NQ.G7<!X,;9^5JN/'QRLQ''M
M>W]K=9IEMTUL6@Q?%R0(TF&:WDVAZY'^_/ !#%(%)DO:'R5)*^Z(ZKZ9N(;N
M[TXLML/K&>VFCN%2"%@7DD$;&2- ,@L\8\,1D*:_-(ZDLH;VTO+>0-+;74,D
M<3@QF5T<.(@6&TE@,, 2 #SYQ6OW7^JNK;I;V'2;0Q[46P:/)KG%XPC0H=0/
M(DDU5XP4YV'Y/_#+L@I9UA6SF-]2N%*E%C6$5TF ]&F:4L[<7^@Z_911W-U%
M$8VW!97$,T3X ;8&*G:RC&064Y\DKFOH2]U'HSJ^P@;4+U+5X&W@22BUNH20
M"\0W K,A]PG<!.""#YVA?3[T#N.AV!NKJ@WQ D8_F^Z86/459C5@@F74;'Z*
MRN[LEO<0@=ATK[.?=H"NHR+[V'7UPS6 (4J6Z(&D]07UE</:VFG+FTL(3$LO
M($KL<L4#>HJN  Q +DLPRNTGF'5VI:7?WEG;Z/&5L-+LUL892"._M=G:10V&
MV98 ,X#.VYMH4J*VG<KU5.G=/ZIS\SCY_L3_ +"E=.GZR/7:/%?J!:GZ=]B8
M=FVS-58Y%E9)=:SUW<32VF79'9Q"5VN\8M:.CDAM+.GF6K!Y)D&-,E09&21R
M4\ SCTSYD25;+)[:WL+=$N&@-TS/?7$0(GCCC)VP*?U*&)]1!&% (Y=A5PL=
M4TZST[3[%99K=+N>6;7;NT&+QH8VQ%9(VX.(F&#(%9 5P<DNPKLL="T;> NF
MS!IG4!1P\-SBX^X7%?KJ)#KH9=9X3.DJ["<#M&U0Q0GWE#CS(;+ID=B @61Y
M-5'58U>%5K]]);R74SVJ%(-V(P2=S*H"[V!)PTF-[*"0I. 3C)KFI3VMS?7,
MUE:BSM&D(MX,DLL2X5&<EG!D< .X4E59BHSC)M]S4K2IQ2G%*<4IQ2N$R3&L
M?S"CM,9RFFK,AQZ[AFK[>EN80+&LLH,AJL-%FPI3"1Y 2,54<PC')^Z=E1%3
MTCM&RNC%'0AE920RL#D$$<@@\@BO<<DD,B2Q.\4L;!XY(V*.CJ<JRLI!5@>0
M000:TU7_ -#3I39U"8ENO7@9>$XS63TF93IQ!OM,%NRM<4K9-0DN2^=CY/6<
M)2P0%/6$&Q6#C1^[599X>K]7CLYK224S=Q"J3L<31_U7 <#P-PS\DBKS%^(G
M4(TZ;3[B?ZHR*5BNY"1<Q ^067TR+C.-RAN3EB,8W,T5!2XQ5PZ7'ZN#3U5>
M <:' KHPHL6.$;48Q@PA:UB(C6HG?LJK^55555Y6'=I&+NS.S'+,Q)))]R3S
M5&DD>5VDD=G=CEF8EF)^Y-<OSS7BG%*<4K\S!#($\)Q#,$K58016-(,C')V<
MQ['HK7-<GPYKD5%3X5%3BGGS6O\ V9],?I,V?F \TGXED6*SS37SKNLP#,K_
M  _'\D*1SB.^\4E5+' 3N1?)7UPJ\JM[L4GBJIS<CO[N)=B2G'MD9(_K_P!<
M\X]N#'2Z5I\S]R2VC9LYSCSSG_7WQC-71P/7F$:PQV%B>O\ %Z7$L>@,:R/6
M4D$,("N:QK%D2%&GJS)A4:U9$Z80\R2_N20<CW*Y=5W>1B[L78^68Y/_ -@/
M8#@#@<5O1QI$@2-%1%X"J  /V JM/4;TMP]FL3+,&%75&P8AG2'FDO(")>C5
M%5T:29K3)&.K^[V&0/ID(]72/E$?R7TW5I++\N3=) 1@ 'U1'Y3/!'RIX\XP
M:K.N=-0:I_Q$ 2"\!.YB"$G!]I,>'SC$@!;'!S6OZ;-V_KYY*/*<8LL=FB1W
MHMMX15A2FC\$4M?9Q62:V>%'$'Y+#F2%&KVL>C7^34M,&H6\Z[HIUX'J5MJL
MN>.06')^Q(^_BN;WV@7=E(%N+2;!X5XE,J-C/*LF2/;AE7WKG,,O-LWT]3"H
M+RTBM(P;08W16]FCG=T1J2#1X#F1AHY45Y'*T8_+N]Z(O?GJ2^MTYEN(L#(/
MK4GSGPI).1G( XXY(X..'0K^8CZ:QNV)_F:-XU'/LSX7W]V'G/C-7%T3H#.6
M[)%NO:DA*>564\JIPC7L,S)*U?W%C13\BRJ> I(LNY)%4D*LJXCCQ*D!I,DD
MN3-D-;$JVJZF+L]F'B$,"6((WE?TD D8 /R 3CVKI/3?3QTI3<W1#7LB[=H(
M*Q(0,KN'#,><D<#P/-7IY"5;*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4I
MQ2G%*<4K3;]1.Y6HW+B,FYVUCN-8]%T_;2*S6^S=W[<Z6,/OLA7*%]SE.M=W
MZYF.HKG<-96B!!!K_+<?R$L:M)6W%5%$"?:*2]]+1=VQG6*QFFF:^0/=V6G6
M.M7$4(A.(;S3;L"2.P=\L;J"2$,PDCD8[4 IG4<FR]A9[R**-;-]EK=7UWI4
M,DIFYFM;ZW)1[U5PHMY8Y"%VNB^IB*W7FQ</QS86VNH&[%O77VR]@?34T/E.
M)T$K.Y<#><F<2[V=19Y,K*>X>N'R<@PZB7'KK,,ACX(6%@L8T_/FT%-8V,]9
M<I%:7$MM8Z8G\.N[.UZMU&"XE%L'TU1VK66V222,"=(KAUFB@B-R&N2%MNY(
MB+MCY+F&*XNM0?ZZVNKCINQGAC:X*W[,7N(9F5'S$7B3MO-(+<K;@M<=N-F;
M-=]@[(+/PWK<P;&\SKWZMMNB[$<WBUFM>I#:/5EBS<UJ-VU=#<93C>Q=B4T
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M+6[@:*5"3M;.",L \9QAT)!PPRGD9'./GRZT[5=%N6M+N!TDBS@'@,F2-\;
M!9%.WTLIQP?@@9YCVV*@K6M]ZSLG9?EZ]OGY3]_A._[+_P#I\KS"B.OE3D^_
M/]<X'V'QSP.,XV[;598QET=?8<9_;QD#Y_Z5(479%8;P8"8!Y'_"-0S>_?\
M?OV<O]/S^5_=>Z_&PHXY'D^.?]L>/'DD>^<BI'^,C[\_)QY_?Q]C\?8UG5):
MV5S)BU]9#EVEA.>T$*!71C3)TT[^ZM#%BA80IGKV5RH-CE:Q'E?XC8YS=FUM
M)[R9;>U@>>9R L42;V)S@$C@ #/+'  Y) \2EG<W%XR16T4DTK_I2)6=F)^
M,G'^9OTJ!EB .+C:IZ&3Y?>5>:=0<89J.GDBGT&J$.&7!L9PNQ8UOGI8Y"1Y
MPXQ%5T+%@ED0$(P<FW/*)VKX_7NF>B4L&2]U4)+=+S%; AXH.<@N1E9)/L,H
MI_26.2>AZ'TB(I8]0U<+)<H=T%H"'B@/L\I&5EE/G&61,C#$YK:(,0PC8((V
M"$)C1C&-K6#&-C4:QC&-1&M8QJ(UK6HB-:B(B(B<Z)5\KWXI3BE0EO?IVU#U
M)8>S"=O8?79/5Q)\>XHYQ&>VOL7O811G@WV+W@/"QH[:(80WMDPC#;(&U8LP
M<F&0L<DMHVN:IH%T;O2[N2VD=&BF0>N"XA=2KPW$#9CEC921M9<J3O0JX#"*
MU?1-,UVV%KJ=JEQ&KB2%SZ9K>52"LMO,N'BD4@<J<,/2ZLI*F:AL],;!^3G^
M#6M\W]O)W9.WD[LB(KE_*JB(G=5[(GXY$U* 8 'P,5[\5^TXI3BE.*4XI7Q6
M-E75$,UA:SX=9 CM1TB;/DAAQ -54:CC29#QA$U7*B(KWM157MS] +$  DGP
M "2??P* $\ 9/P*H-U5=:!-*V5+2XC6T]Q7V58^TN=A&R&C3&<5 ,[QDCS7%
MF(Q;!0L;($!RD(41Q.$%W;]5AT;1$U-)I'ED5XV"1VT<4AEG) .5?845 3M8
MDC:022*LVA:#%J\%Q*;F;ZB)ML%C;VLLTUR2I(8R@=J&(-Z7=R=@]6.16J7I
MN^MSD.R^J?,M.5> YQL_6.)X)=Y'DNV95?48QB%';QIE:&D93V8X$1]A56)Y
M,RG_ -Z"^QF3T$>%$2KA3;%)&XZ9:2ZBL+2WN$N3AF<AI+=X@H+=MEW-)(K'
M:0J@9XS\174<$.@E8I8IA*" SY#6[LR@A(I<XDVG<LD@ 0%?3G/,%=2?U0>K
MK=G4%B_31T]0<#@6F<WPZ'&(T39>)+,R"02#)GF R''M!MJ @%'.!TO+[&(4
M\N.)E=7C*4?J]-T/HOICI_39]:ZJLM4EB@4M^= \:C+*B,ENNZ612Q7UE41-
MWK8$USV?4;_4)%M[*2)2Q/I0X  !/JE/\^!P%."02!QQL:TQT1]4&S3[<UAU
MI2,=G].6R-,8/!@8_CF2>MF6*[?@VMXZYO,9NH3Y+ZZ9&K93"'N'.41228,.
M$$X8LQR\ZUCJ33DN;:_Z8%SIM[!+>0M(8XXUFL9<]I)$RZL"C=IX6WIZ#)NW
M, )FST^4120WVR='*. 69BKJ #@D#'(SD8X.,8%7\T%TN=,W0)J7(*_4.%P\
M.QV!"D9%FV439![O-,OE5T57$M,JRFT(>WO;!S!J.& \EL.,XB1Z^)%$Y!\J
MTMQJ.N7\7?GFO;VZDB@C::1G9F9A'&@+$[5!(  X4?:I+$-M$2 L44:ECM
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MF&XNK<?&8Y0/V+J"/ZEJSK"/I<:UQN4*3>;#RW(&L15>"- JJ?NY?\OA(?\
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M8\BV-$:60X/K*U&#0TF3)<(;'RI!Y+BF)\]RN))'<*J!W9@B\*NXD[5'L!G
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M@Q]U$15S]1:^^NRVY[9BBMD<*I(+,\C NYQ]E55&3P">,X&.PLC:+)N8.\C
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M(Y(P3P>.35XJ"AJ,7HZ?&L?KXU318_5P*6FK(8T%$KJNKBBA5\&,)/@<>+%
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M($YI 2(Y2"*QR.8]S51><1EAEMY9()XI()HG:.6&5&CEC=20R2(X#(RD8*L
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MA4K (8Z/D$*1^OU;86FF=0ZC8V,1AM8&@$49>1RH>U@D<%Y7=R2[L3N;C.
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MC%LJJP0L2.< *![*/ &00N,8Q[< #WH0!/ 1CO!))/# G+%V;C))R><G/VK
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MCV3&*Q581W=JMN>D_@^K.LNMWJB,$$V=D"2PR21)=,%(SQD11Y\X?P:T+CJ
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MQ^*,<V3-L:>IL33I<BQ+Z9#3T85?41(C6QQQT$G8#$\V*I41-DZ%?MN*PPR
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M.R=_PB<ICW@7E?4<@9///OR?]"<_)QQ7<+30)9 "RE54848X"G& J@>D8XP
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M1[!+.XQ'&#D@ #'<=AG"KR<Y) %2L"C+715.$#2>#>ZN*S]*_P!T1JHJ(O\
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MW,6^Z5,9;&"11^E/II !G"J<$XP1SP1GV&!]N3ZW;+!JEW$X#=Z3OQ$G: &
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M)%M0M/(8WWSBI<NGM<MEA&E7EP$N%5GLVE/$T( 62!7)_P 1#S&&_4A8 X4
M8IK&[ECDOXHBT22I'.1@"*23+*S*3PC KRHVJ3E@,C.M.UO\BR1&5U'26V2R
M@(KQ4=&+UY341/U$,'NP<5C4^3R9+QA"W]12-:BKRPW$PAADF90D"(2SED0
M #C+LJ@GQP2221R:T$03.B--AF8  ACSXXP&)/N./'N0:W<_2^P>5K.^PS$L
MHFUL"]R3,,IRV=7ED>J\.60L5E);45"A$'[B+#KI]9!/9@1(\^SK+ET09A"0
MSN)]5WYNOJ9@FV.XN(U3)SA8EV@YQZB0HW$'&3C]^D]'0HNK6P,BEH+6?;G:
M&<,O XS@XW.5_P O))(KL.<H5=<IQ2G%*<4KPJ]D5?Z<4K3IUI[BK+/8#:Z
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M<Q7*QC.[I)&(YC6HW]#?+M^E7/Y1@\URZ0J))97;;'#'&SN[  A%C"EC[ \
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M\-S+I\*J<(C^\J= @LDS2/417A&)6\V)YMZ*W='I8%,;#C&0Q8K[ @\D>YR
M<D[?;N8)'2W:[-NH=3((K>57#*"5ECW[%2,YRV[>6+ !.08SSB!U/UMM&KL8
MVCC]SBMBZ;)B49L7AU^6T Q ?(.,,0UHU]WC\8:,:IHKTM!*]C8[9'DQO,I-
ML\2R3;@W. &;8<<L0JCSCD'])R,8I(]U#;I;_43285BL*$1RE1&7?;$5:8!5
M5BNQW0@#8!X.6X?ICJ M,4@,BV609'.MW0Y!J/6T&X$VMAS98FV,R"&%*-(N
M;"0([Y,^TR.=&%'.US6! $*.=MV5A>ZI.J:9:27*$;E:+:R<\]R5BP6.,Y
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MR174&15%K90Z>@R"=5PYT<MK7TN5"F'QNRLJQ">_KHEX*NL'U9)T>.DQ(,Q
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MQC$B,7)8MDG.6/2;")45868I=I?=R2:>69[J-2B32S2R/+*RH=BB1V4* -N
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,4IQ2G%*<4IQ2O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g68105g85w28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g85w28.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1*(4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $FR^1Q8X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              -$   06          $
M                     0             $%@   -$
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   -$     4F=H=&QO;F<
M  06    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   #1     %)G:'1L;VYG   $%@    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M     #A"24T$$0       0$ .$))3004       $    !#A"24T$#      (
M#@    $   "@    (    >   #P    '\@ 8  '_V/_M  Q!9&]B95]#30 "
M_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3
M%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-
M#@T0#@X0% X.#A04#@X.#A01# P,# P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M^2[I;]'=_>W_ )Z?'_J;Z1;?=(_Q*><8<S3]-<0_1)"_>>GR7=+?H[O[V_\
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MFN(?HDA?O/3Y+NEOT=W][?\ GH.O^I@?^46WW.+_ !D/]U ]T8<S01$OOSQ
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M$A0F]/(' ')X R3BL-+TJZU>3L6\D,7;@DF=YY3&FQ"/G, 0H4,%P%.1@Y+
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MD^%Q<!?'W$C'VUK7!EMB:!F_#][G0.G T7*V-KE+G;I^$6)%UFX1$U*'13(
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M.X_V0[S" :\YI+!+[J1WP$748F9B<  65L? 8/'!]GAQ5A>KNM=)4;"6L90
MQ(Y]/NB,<@>/V^&#X5Z*9YY,RV+*+EJ;H/$0ZRGD'"D3C>P6S'S[AWR)BZ'?
MLLF24#$0C"G99GIR4Q]:YLCVS,?\414@=90B3HJRK-P@HAKSFG]>"XOK>VNM
M.2"VGN+Q(KJWO8KAU6T$Q+S6J#OPIB/)9E&<YR1X^DN^D8[6TFN8KTO)!%9R
MR6TMG-$O=NNTL*),P[4I[CODQ\JOD& Q!)?EU<;2%LFJ(?A[N25OKK5!6<A$
MI&KBO#*/)56&B(R04+.G;L9JR2+=4E7KZ[DD];4DA>5J.E6.Z^O0GJSI\VRW
M2ZC$D<C=J)@)$[CX#>HKQAS&%*M/*!LB_P"<*XJA^+VLB62$:;))-$,W"++&
M!$"3P6'B\CA#L)W.&.U6(!. 5WA$XG+=0+5E2OX3OTE1Z*M:&EEF BDVBK%Q
M101+>U$89ZNVL,FA23+$);G,/$/FU;,18LRLQ%!R"79)U'HJ7D-FU\GI4J1&
M%,_FV:7/;S.0%5F(*QH6!D_J@DC&J+2;^2V>\CM66**23<6!#)V3^=(!(+"-
MLK(0I4*29 "!F5F8N5WF:C6V1Q]B]*YYPMK?)L'CJ&][F/8NOURQO)3AXJ/$
M1(M(Z7?Y'D94+3"U^T.6ZU8&MG:O(V,+-M;"9](EKK:EL>L[2XC=[XV]A%'#
M),6[S22 #4'L@C0K&<!V4N7#@@-\Q@3(+"XZ:N8B([2*2XD[H0_F3'$S368N
MG*R&0J9%1@NS;@A, DJJC0;S@CSK5H;);W(F/K]5)6B8RJF4XIFRKT):X:?J
M]ON4?28B4=V%C=&*$9#N91Z>/;2%<871^K.(IPKV%8"HM(-;)>I-.G-DUI<V
MUQ%<WTEBQDGDC[3QP-,S!6C.3L09R8QM8-O\%/(="O8FNA-$+=H+:.Z&U797
MCFD6&-BQ\4#$Y(WL'PFT D'+:EPE<P3!&4,83],P_E+&^3Y4]H7H%DAU8]C(
M1CN#K3EW<6\A.)22L=29>OU1\[=65A;7L%)0D6LX4DFS0I#B3GN=<Z9U*TNT
MN+FPN;*WQZ4'D9]_YP+"5BPS3!FXC>(;'. N<UG%I&M65U;"*SN[>ZD;^CW
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M;>2ZO(+:$,':]@CA91@KW) P)P/6*[>3QC'CC.93\SG)52RMQQ\1EMI1D)"
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MQ(D]O K2)'"I#3!P=QDS@*  ?6)BW \?O#)_@=X2HV5K:XR%<\1CPPL(?%E
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MR<L=.IN2,KO74[CI #9DF('B1/@>03J4LPR!-2;]Q-SSD\X_DI2#9O&TN+B
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MV;0,G<2.3@G%>?X@41$1$VXCN.Y!#J/RCN _W]^O7G'M)/GD$?O/!KSW<V@
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ME.%"X/J\\9Q@^6/*J]HOYP]H_:'N,!S )"^@I  -@+\FPZ!B"3EL^1W$;1Y
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M),BG?['4+MYPN".1[?#S]OLXJHG+N @.PEZ (!W%^#W=0_GU;26SC QCW_\
MI_&AD4D'. N,#GR]IQ7IYR^44\+4CBDXZI=,&Z^ ,<*8WP@Y7V*1WQ'9T:R%
M6I[J/ 2[N7-(J1+5;WI&YBKLP2C7?;1('A2>+ZID-_>:7TY'ZTE[<1W=\H)
M&FVK%ILD?I658R#Y$XP<D>IT&)K2WU/5Y!M]%MC;61(\=1G&R$\XPRJ7;(&
M,9SGGS%[8 8>V)CCZ>V4P_G]YC"<=^T81W$3=YA$1W]?M!M0!%& H"A"I 4
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MU.^-HCB CVLJ8VYDW=W^L4X)UM>^8AA.S_X6L57\ .\=0&?:#P],(56FITF
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MN 3ZYXV#YZG&?6'E]M-3^_WCP/U4_5CW'Q'N--*5W-_\H0_YY+_OETI6W"F
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MU6U9TTI32E:_M'^<0_Z&E_XB^LE_K?[I_P *Q;^K_O#_ !K%]8UE50Z#^_\
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M@J<JITU%2^ (J(9P0O/.(D]9Y,A%X!X!..<#R]HS]>*TW$J00O*Y 1 "2<@
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M/"A)O9IJY6<M4XD6\A8V.J3Z;%>"VC3OW44<0F8*[1(DG<9%1U92)BJJQ(.
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M^=0;QRO'K5MSTL+AH2;^3;#)'(H>$R$%)S<?FSWT5,N2&RCMM\&\ /: H"
M COT#KW;B/?_ /Y^O;7E*]8. /\ "N6E332E?,MVMS]D Z$ZC^P=O3_LZZCP
M(/CQX<D>WPQY_7[N:8SQ[>/+_' ^WBO!OBD/!)<0F9GL2V>S,D@E%-LH8Q?
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M96$BZGT\MO.1;KL4-?6JD97:29002L+#:WYF3#>Q#J3;*UPH8EGTS7MZEW?
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MZ5]B6Q!<_P!49<X0<#D^=6EHT_Y5U&.69I(UAM&B7&$17$N0H]I(&6QDX /
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M<DMA93'=-9VDS9W9EMHI"6_M9=6(/ASX^RMBS3)\R61,C!VNRY'LX(XKAXK
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M9I_JGT"Q)3YA-I!E,?V2$]7S^:!C/VQWY^?STOK?._./ZWU\\_KJH,JZ!UE
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MNO\ 9Z4IY0;>M7YNO]GI2GE!MZU?FZ_V>E*>4&WK5^;K_9Z4IY0;>M7YNO\
M9Z4K6&5L6XLSA4G=#RW2X/(%+>OH^2=5JSQ*DC$N)")=)O(QXJV43V%=@[33
M<M#@("BX236(('* ZW6UW=V,XN;2>2"0*5WPG#X)YP1S@C@CG/(P16BXMK>\
MA:&YACFB+#*2@;"1X9!X]X/M]_AJ0W!SPGJ42+Q@M@3&3O'T)97%RAZB\J+=
M[#QMG<HD;.YEDW>-US).GS8A6ST2& CML MW*:Z(B0.@:QJIN)+K\H7GI$J=
MLR[BI$8R>VV, C<<C/ZB,9KF&E:<D*V@L[5;<-W!$/FA_$L#GS_K8(SC'(\>
M<AP?<*\ODM',DE@W'KC*"$C7)=&[!6S)3B4E4&,9&5=V1TB0@>$@(Z&BF,6'
M@^PT;,&Z*1033* 2-7U0VPLS>7'H@5@L+L"%,CL\AY).78ECCS8FI.E:<9A<
M^B0>D C,J<9V (@]48X557GP4  ^5;^C:]4XNS3EP9PS)O:;%%P<+.3Z$>J2
M3E8JMK2[B"CWCD$NTLTB5IZ858HC^:@I)/#%ZK&WXNY)VUA9Y&2-F90YR 7Q
MN(P!XA5S]0S78(D5VF5(U:0!6*')(3P#>8QN) /M/ZLI\H-O6K\W7^SUC6=/
M*#;UJ_-U_L]*4\H-O6K\W7^STI7V (" "'<( (>CH/R#UTI7RJK)$4 IEB)F
M$!  ,8"]1 -AZCN(;@&X[=! .@ZT//!$VV6>.-G.0LDJJW_^02#CZOMJ0"<X
M!.#CP/N\/;XBN1'"'9_.72WW'?=4G^KJ'3Y-8^EP<_GH, \'OQ\CV_.IM<>*
MO^I&_@:Y^,-_^/1_^*3^+3TN#]-!_P#/B_FIM;^P_P#Y&_A3QAO_ ,>C_P#%
M)_%IZ7!^F@_^?%_-3:W]A_\ R-_"N!W*'9'9=+]8*EW#Y>AM]O7J#=V_B9X
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MI=6$FY"NVJ\VU(D>];*5-K"&,I;%];L;"P6I"Y6"VW^X9!G)EE7 JD:$I;I
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MH_)OK(#!SQGP)P!QY#V\<>=35?!@!0 !$O:W$1+T'<NX]!#NW$=Q]._IU#<
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A32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g68105g89e29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g89e29.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2=24&AO=&]S:&]P(#,N,  X0DE-! 0
M    )S:^$ .#A"24T$!       0!P!6@ #&R5'' (   ('_QP"4  (<G(R,S
M W,C@< @4 'TUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@X0DE-!"
M4      !"I>VKQVS7F1B!1.-MQH?9].$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%
M>            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  7@    $  @
M!>     0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@              WP   0T          0
M                     !              $-    WP
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG    WP    !29VAT;&]N9P
M   0T    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P   -\     4F=H=&QO;F<   $-     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    $.$))300,     !
MS8     0   *    "%   !X   ^6   !R\ !@  ?_8_^T #$%D;V)E7T--
M+_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q
M,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"P
MT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,#
MP,# P,# P,# P,# P,# S_P  1" "% * # 2(  A$! Q$!_]T !  *_\0!/P
M   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MT+[>D4F3?=D9!,$FRYX$@[I]*@TTM_[;5NBBG'H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! ?_  !$( .0!$P,!$0 "$0$#$0'_Q  >   " @(# 0$
M            " <) P8!! 4""O_$ %80   & 0,# 00%!@D(" (+  $" P0%
M!@< "!$2(3$3"11!4147(F%Q%C(X>(&1&"-8EJ&QM]CP)"8S0E)WP=$G-T1&
M8I*T\4=()2@T-516<G2&F+;_Q  < 0$  04! 0               0(#! 4&
M!PC_Q !4$0 ! P,# 04%!@,% P@&"@,! @,1  0A!1(Q0083(E%A%'&!D:$'
M(S*QT? 50L$D,U+A\0@68B4T-39#<G6")E-DLK.U%S=45G-T=H62M)6CI/_:
M  P# 0 "$0,1 #\ _?QI2C2E&E*-*4:4HTI1I2C2E1UE>;DZSC/(]EAE@:R]
M=H=PG8MR=(CE-&0B*](OV*PMURF;KE2=-TE#HK$534 O09)1,Q@%2D?VGUK.
MV<MMN%<OVW>EN"CK+D:@05KFF->I>SUG"-9"50]=="+:R6U:4?HLR&'I23=R
M+U< _P!(X5-R89GT'U_6HC_B/T_2IDL6*[G56[9Y9=^NXB$9O9&.AVSF6@-E
M3%%Q)RSM%A&,$%G.TQ)(73QXNDDV0*85G"PE(DF<PAJZRP]<*4BW9=>6AM;J
MT,MK=4EI *EN*2@**4) )4LPE(!*B ":I4M#<%;B4A1"1O4E()/0$[9/I->^
M7 V51 .=[NYLINPF*%5V8&Z1$1[<_P $@>W/(%[^ _9JR%)C^4^LG/KS592?
M-0^ _3I6H7"BSU :M7]X]H9G*G1[Q;W9J_M338W76;EQT]?H-W4OM2:(++ 3
M[7I)',?I'GI^.HWH"MI*=Q!4$E7BVB 5 3) ) )R 2.)H$J()&X@$ D $ F8
M!(3R8,#DP8X-:M(EBHAXVCI3VG.3(V1?MV[IDQD)78,S=NFKL@*-'+9LXVN)
MK+MW29BJ-U4DSIKD,4Z1CE, ZJD;E)@;D&%IDRD^2Q,I/H8- E1VD%1"A*2
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M #2V8_W1])'D/K^M(/F?I^E'U!Y7_EN;G?YI;,?[H^DCR'U_6D'S/T_2ODV
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M\4E+X7KD]=5!?)VE.O4Z*?O%21T[(MFDF\1@Y6.8F5=KIM$7ID$ED6JRH!8
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MB8!$CI(D#CBJH/,&#@&.3Y5\X_RGCK*D:YFL<W2O7>(:.?<73^MR;>49H.A
M#BV54;'.4JP%'JX,;D ^[C4U%2*'@/P#_'?2E<& HATF\&[<:4I6[GLNVPY
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MVI2XZ% Q^(+]*IM7%O,I<6A*-V0$KWR" >N1[O6IO6#D"AW[B/S_ &"/ AR
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M6JJ@\?%/YBDQVN?];.]7]85A_930==9VC_Z-[(_^ J_^9WU8%E_?:C_^</\
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MY#X"(<_-2L)6#<JH+@0@+?ZROIEZS?B?@#?T_P#+2E1QG8>,(9C'Y8KR%_\
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M0.H,]!0@$H*YX( &,=!GJ>IZX.)JT<.> Y\\!S^/QU-17.E*T*RY#I%0F*U
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MZ'K\_=5]1 X* <<<!XX  #[@ O;@/A\>..>_.E*^M*4:4KY,<I1X,/'[!_K
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ME?<YS)$HC<WTW5&CV*(KCXJY7C=RZLCEY(IS41Y_ 'I_KS[C5YA2@4H%#P4
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M8F1%:IH%+SR"X5[&K5(E1) 2VI()!&-P B#P#-65@'  'C@ #]VK-9%<Z4K
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MZPQ<A"OYFZT^II5]*NRC-S]*U]@$@5)VY*\6='.YX+EH1_977&W@0H6KJT"
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MC4^F0)F 2!,1P('&/2IQB0# @2 8$S&9ZF??632E?)B%-^<'(_ >1 0Y\\"
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MFSQI%1L(WKQB'358+G6D%'9Q6,5<OI"0,YQ)"$*4 E06M"@!@+;4D*$R28F
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M8O5F@ SHK+2\S"1TV\S[6$*G:U&M;BC,(%JQB4'CPH1;)DJLF1SR11=4RAE
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M./(?2EI@>'<D;"VA(V]%)4K!415W!-V,  F$<1;@.1X#OC)03=@^(!,=@$!
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MT)S-D$D#&%(A2A2TVED*#<I"R2H#KNC</.%$21Q),152E*6$A1*M@ 3/0 0
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MD0@[=,/G "@'Z3M@$I@Z1#DH#MN 2@(#R   =(<%X  XU>VB !A($;0!M@"
M#()X'G/G4#Y9)D$]?+R]PB.!6):Y[LC=(?P<\/#P(]C[G)[IY-QV$3;;3=A
M.P !@ZB@/ "7[4Q@@$@'H  !@C$ >9.9(F!C%)/^9R>IY5)'3\)'ZQ!@[<ON
M+SK0V>0:CM<HD%"/):?AR1]OW"34%.%=U^6=0[Y=1BWV^OTP:N'3159@X]X
MSEJHFN9)$Q_3*@1&>F9()C D@@GYTXGB#F   "3)(   )ZD<]9YJ:"7?=F0.
M"[<L/B CR/5N=L)N1^?)MN B(_MTCIR/(YZSUS]:?+Y ?D/KS4-9]W1;C=O&
M++-ERY;6Z5.UVJI-%G\71]PDY8+.Z*\>H,B!'1*NWR-3<BDJN11;EV02(%4.
M &,4"F!('  &,#$QZB#[\_UI)]?H1SY$>IZ>?6*F-*\[L^!$-N>'RCSQVW.V
M'MP !W VV\ 'D  >Y XYX  Z0TCGU_?[ZU$ \@8].>,_T^%<'O&[(#=7\'/#
M@&'XCN=GBCY$0\[;3"(<CSP(\<^0'0@'Y1P#'NF1/P_*@ $QB>8)!/.#Z9\^
MIQ6I.\R;H6=NAZ0IMKQC])S<++331XAN2G%8=!I#+L&SA%T\_@[)&0>G/((F
M:H @<JJ9%3"J0Q0T  !!S[P!/IX0!_7'-3Y1[HZ#GSGCH!@GD9)K;DKONT*4
M0_@YX>YY^T!-SUB .>//(;<2\\^1^R7@>0X'R( "8 $YP(J(\P#ZD#D\X  '
MG@ 9H/=]VHF+QMTP^' #W'<Y8C!]WG;>;]P"'[=" >0#[QY4XP,#!QC^GE^Q
MS4-8QW1[C,JVK,U0@MKU*C)#!^0$<;V9U8]PTW%1DS-.*M VT']2<I;?W2DU
M!%86%DU/(+),% D4'K0&@$0!9=')GGT&/08X],_E3K(QY#<HCT.9@^N2),'-
M3.6[;LBAP&W+#W'''Z3E@#^K;>'?YC\1[CR/?2),Y^<>?E'G^E3[A'6/4\\D
MY^)K5KSF3=)0J9;;Q*;:,7OHRG5F?M4BSA]R<X]EW;"O13N7=M(EFKMT1([D
M'"#-1)DV,NB5=R=),RR93"8$#/NZDD_"9_3Z4\N8!DCH8\XR?AYUT<<9SW/Y
M,H-.R'![9\:1\1=JY%6>,86+<A.Q4\T9S+-)\W;R\>GMX>ILY%!-8$G34CE=
M-!8ITR*G* &%'O\ F1^44_+\O0>@_6MT&\;LC<E-MSPX'/P+N?L'4(__ -;@
M$!^\! ?EQI ]?F9'N,R/A3]_OS^-1'D_<SN-Q._QM'3VU^D2CC*&0X'&T&>M
M;AIR50CIJPK^BTDK$HKM^9C'0+8P@9_(I ]50)W!JKW#0" !),1R=Q@=,SBH
M^ $_X9 F9F$@9YR>)C@U+B=XW9AV_@Z8@'@..!W.V(0\\B/4;;>7JYY+TB7J
M* <AU (<:;1T^DC],>E3)//^9XY@1/F1R29FN5;QNQZ#"?;GAXI2@)C".YRP
M"7@ 'GKYVX"(% /M"8H"(<?FF#DHMH/.?>58^O/3/G\:9Z?$8@CUD&?.,<?
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MQWD<JV<'1;F5]$@ #@1^?[]_I429QGSDD"1YX]<'K/I4H4B SC8MP$5E/)U
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M%-!0SA+JB HGT2"8ZQ JX6EA"7"(0L.E)_Q%I(40#[R ?7'G#XLS>L0%  2
M8A3 '("8.H"FX,(=N0Y^T!?L]7(]S<CJ\00I22/PJ*00<&(S\<_*K0,A)'!2
M%?$DX^0!Z\\YKL+=12")3#S\S" @ <"(B("( /CQ\?';GD()B/4Q[I!CYF .
M<D8J?/\ ?SP<>?ESTJNIUNSSK#;EZWA!]M .E&W.6GTF628[,,%).$L?U5T1
MN:]S552I23^.BEE9)@FPC'<T"PN7Z[=LNZ]R>*$FV*'RX%+#1;:#IW _S*4E
M"<QE6U4<921&*AS>@(,2%+[N9_$I(!<*?-*-R 3G)]1%BJ)A4* \ ';N(=A^
M8>.P@(>?'[]0/>#[JD_N?/K]:C+-62F6'L8W7)LC'/)=E2J^^GEHMB<Q'3_W
M0H FT24!%P" KJG(0[@R"B;=,3KJE%-,VK3[R6&^\5^$*0DGRW*"9]()J];L
MJN'4LI_$N8^ )^. <<GI2][1]TQ=Q?Y;Q3G'D=CV6I(U=X\95^]0V1ZX_97-
MB[DF2[6SUZ+BHLLFBHR=(S$."*CEDL*2SA0?>$PUE+;*4A8(*"ZXU/'B;"3*
M3D*!"AQ$>O7&"QWBVC(6A"%@]"E94!(Y2?"3!GRIU!2*(]^X<@(!V  X#L'8
M $>.1'OSW\\\!JW5=9/&E*-*4:4HTI1I2C2E&E*-*4:4HTI70>I%71624 PD
M5342,!>.3%.00XY^'/(@'/<?'PU0H;DD#GQ =.A3])^8^4@P0?4'Y&<>?UJK
MVC;+<G,+UA"%N-CIZF%-LN<LFY\Q66OMI%&X2\[?H_)\5$URR$<&,R1CJPRR
M[;2+.&P I)'3A@#H%)R)J;5M#32$N)E2+;V=.>3 0EPF 9[L*!1)!*R>0*KN
M5J==6L&0XZ'2<2,"4\\;I,\XCSFTY/CH+QSQT@(<AP/ ]PY#X#QY#X#JX  (
M'$D_,D_UJW6)4!$W8!'@0#D!^?'V?ZA'CN)>0#SJ(D_'/NVG(ZR9B1Y<\TS/
MNB/?.?IQZU VW/&LQB6CRM8G';-Z[D,@W^V)JLNOT4V-KM$A-,41 X<@LBW=
M$36*'V04*;I[<:PM,MUVEA:VKAE3#0:DB)"9@P) D9('!K+OWTW-V]<)P'EE
M<#^4GH/01CTB<XJ?S\])N.P\#K/K$I'=WV,,Z90:T*'Q8>%?U-G,2+W(U6EK
M1*T\+4P&-70B(Q>7AP,Z/%%D5$G4BP'A-Z1 K=4P)G,.K*DE3H.2G8I)$RD[
MA!W)X) @@<3!YBJ@J$P )D'=U$$&!Y3$'S$BF1PI7']0Q;2JO(56L4A> A48
MDM4IJRJ]9@FL>=1JP81"RQ2K*-4V"3<1.H'6*IE.1'R-\F23YG   "0  $I
M@  # & ,#%4Y.223 DGDD"))Y)@"2223DFI)<% W)>X#TEX'CD.YC ("'<!
M2B81#_P@(:I(D0#!P9'.#(^!@CYU(]<CRJM_.VUS,F8\H0ZTG)XXE*/7\GT[
M(M!NTI&OT,DXG804G!REFJ5;.T4]SD$K<O"*LUI-QTF)%2KEJL0QB)CJRR'D
ME1*R@AQZ"D05M.I4 A1Z!!4HC;$XG!BJU]U"0E,@H3O2K_&"3N&/*!!XJR1
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M/A?I:M65FPC99D#$CHG4O!RK=U(MI%A+(IJ@46:K)8@HO#B$$*WH6E4;-Y&
M3N4DI"@3P4R?>"0:K24;7$K1OWA 'B(@)<2X9CF2A/N(!'%:=LVV[6/;U0;3
M#6B9BGLO=<DW?)+B#K:;E"H4S\LI]]-)U*J-G1CJH0T.F[*V2#@A#J$44(0A
M3@4+JUH4EE"9^Y92UDS(3^&!TVIA.,8JRD*!<*BD[U[Q @@D#=)Z[E2KWFG
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M!W'P'@>W;GL/?GOVXXU.3U@YQSC@3TF<C_6J>F..D<>[X5VBE OCY  <_#L
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MIMGKQRXMH! *4]RZV @CP&4SX:BZ6AQ%MLW)*;&Q;6"09>:L>Z=\0@G[YM7
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M SDB#^7]*CFT8[KUILU(M<S[ZY>T)[(2=?8E723BDY239F8&DG;4J'J.7C)
MQOHY47!0:JF,J!3J"(ZQBX4.%0 E++822.-[@"NO48]U7#E(2>%*!5YG:8 G
MRS,>?IBI(:?F%'YD ?P[B' "/?CL'D1\>=9'"BGI 5\3!/\ [QCR%43.2!B1
;CR&/R GSKN:JI1I2C2E&E*-*4:4HTI1I2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>g68105g89r46.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g89r46.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1.^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $Z*^4"8X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              *P   'S          $
M                     0             !\P   *P
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   *P     4F=H=&QO;F<
M  'S    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   "L     %)G:'1L;VYG   !\P    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ -P"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M 0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%05%A$P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M,F%Q@9$7(T*AL='P)%/2,S14<Y*BLL'3&"4F57*3X35#16+Q_\0 &P$! 0$
M P$!              $" P0%!@?_Q !!$0 " 0$%!@4"! 0""04      1$A
M C%!4? #87&!D:$$$K'!T07A$S)2\10B0I)3TA4C,U1B<H*3HB0E-$3"_]H
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M=$!ZA_S#B%DNB ]0_P"8<0LET0'J'_,.(62Z(#U#_F'$+)=$!ZA_S#B%DNB
M]0_YAQ"R71 >H?\ ,.(62Z(#U#_F'$+)=$!ZA_S#B%DNB ]0_P"8<0LET0'J
M'_,.(62Z(#U#_F'$+)=$!ZA_S#B%DNB ]0_YAQ"R71 >H?\ ,.(62Z(#U#_F
M'$+)=$!ZA_S#B%DNB ]0_P"8<0LET0'J'_,.(62Z(#U#_F'$+)=$!ZA_S#B%
MDNB ]0_YAQ"R71 ^R1S"=+9A'8COS^_$+)4NI<"_R@8 P!@# & , 8 P!@#
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M2'%L^0(Y0[B&_&0WIJ%[B' # ;N 0UH1 OL 8 P!@# & , 8 P!@# & , J
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MNMZP"FA^@_R'  @(>X"'[\ I@%>TWT' &A^@_P AP!H?H/\ (< :'Z#_ "'
M&A^@_P AP!H0]P$/X8!%UM__ %4?^I2_\(9QV\.?L>7XW_:K_E1B_M[9QG3*
M@(;_ !" !O>Q'0!O?D3#X)[B/J:'LWW]IM:&IN?GGGC5M;RJTTYGC..L#5&]
M\N\3PW4=Q=7)GDNF1-IC8&UU]>MR,H1"4"5Y 7J2U19F R0(MW,P$"\)'M72
MR#A\)$"1Z3DZY3*6;ZUI#WW0[7#.*IW17+M+SI36K;K,12'#AOCEA?M@8 *
ME*(@4#C^ 1 ! "[)WB40 P@8Y3AWZ 1[0*8B>@ V3;=]5*OC*D+&JI1447MG
M#8_7Y[_C]?W_ +<&0/G6_.O;?G7[OI@%1$1'8B(CK6Q]]>?&_IY'^8_7 *8
MP57KBO4SJC>7#H1\CZ:?GY_K;_Q$?YYSV;EP7H=_P7Y]IS]42ME/0& , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# +-U_9_U]< M
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M4BVJ4JH\=6WE:>BJM^G%I:P,M7(1"O5473MFFN"]DD&:<M-/56#X\=#,P 5
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M8B+=\Y\%/G,<T7>-T>2/0<KMDE'*/;6R'*!5#%,)!*?\1>PV@'0AYV. :_\
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M , 8 P!@# & , 8 P!@# +-U_9_U]< L\ 8!4!$/8?;Q@#8ZU^W?\< ;$/\
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M24V:\K5"8\'HC & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@%FZ_L_P"OK@%G@# & , 8 _B/C]O^O _,/8?G@'5ST9]]PDQ#^N#8
M92+?Q_Q D[_1^,:*M@5[0$.[TQ.40 YB$/\ \EW 8Y3%#]H-+NG?H1XXZ<;1
MQ!:Z6,>UE...G>:X*LB[.*.S<7Q:9EN+)3]+9)0SYT5BY1<<<KE*P2(<BPSB
MY_4*5H0I0QG6EAS-YS"'L!NX?8WG?DOR,'D=>1$ -\A = &L H([]]>-Z_"
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M#O)5,GQ#EP#ZK1PO5%A/\605RF$2*F 0P2OBZ<.!M^B4")@0-@!-$ !'>@*
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M ;,.OJ(B(^_N/S]Q_@(A@%0( " [$=!H-CO7U']X_,< Y8 P"A@ P" ^P_3
M*=H;WY]_[O.@_P#I#>]?76 .PN]_L /X /\ B/@!'Z!H-8!42@("'R_P\:\?
M3_/ *=H#]?;^_P"O[_VX!3TR^^O/CSOSL/8?WA\L KVEWO7D1 1_;KV_EX']
MX;P#E@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MU6?EG!IUW&D,6+4:(BH]<MFYP^_58<3I+GU3< T)2-;V'E&KB^FZM=;K 1,
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M5%45#$. E.!3?@, E-Y# .UV&Q#Z>_\ ' & , 8 P!@# & , 8 P!@# & ,
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ML1 !'6O<?D @'O\ V1UY #>V <R'[OW['?CV^>A\^X@/RWH0'Y!@'$5#  &
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MU3<<"[EEDG]0D)^TT6!;FJS9B9U'O96JL(H)V-=/':[&TQ2UB;NDV3PJO?\
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M[A#W/^L80 1-Y#0"/S#0=NOF&_.  :IE$!  V4H%+LH"!2AK\)0U^$HZ#N*
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M39I)V5HB"BQ#@5["=9?8R9IUR\(O)ZSPQD[.U;5>PM*U,6%_ +MH1-\X>N6
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M=_3NDOIK;.FTU",E;&YK,DBK$NW=K<SI*M\ Y</VD/% 5RH2.CV3]PM((L!
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M_GF*,]>*L_J<1<[;+NY!6OR,A?\ E.HW+E*K\E.*MR[97[Y3](&%794Z"HL
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2!@# & , 8 P!@# & , 8!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>g68105g90w88.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g90w88.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[19V4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %EJ^5R(X0DE-! 0      $ < 5H  QLE1QP"   "@  < E  "')R,CDT
M,38U' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0)&C6/Q&MV21\,%=N<M2D0#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              4    (C          $
M                     0             "(P   4
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   4      4F=H=&QO;F<
M  (C    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   %      %)G:'1L;VYG   "(P    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 7@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M@^UK'!I!+G D!HG01/\ U22F'J6FQS&-:=D222.?@P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                _^$__&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M P$!              $"!08'"@,("0L$_\0 :1    4# 0(&" \(#P0'!P4
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MG[DOA#]B@&3]R7PA^Q0#)^Y+X0_8H!D_<E\(?L4 R?N2^$/V* 9/W)?"'[%
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MYQH37AYI>U3]= * XS)@8VT(CD<?!LAGU/P"(B(T!^5Q&1[M1-5RR:+J(_\
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M9[\XWE'8[C87?F)D"43&(*D72C&*"Q,"11%FV353-M"42E.1,#@8Q1. "40
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M=[JMR)<5=3'8=$>M5TDW;9F=@B[(5<J@4).[% * 4 H!0"@% * 4 H!0"@%
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M-3OM0"@% * 4 H!0"@% * 4 H!0"@% * 4!PJ"!1SSCD! ,9'F'(@&<AD $
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MXSC.!'X1#!@#!BY ;?\ PYWB X'.!#HP.,CN$<!D=D $0W@% 1 V0Y@SOYC
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MR7U(@1V=^1*<<CD1'8R(^^.UC',&X '   B(;J ;'_";HW^H$?T"?9QVB[.
MY\4!+Q8AOP;/O@3 ]H! % R',&.;&X #- 3;(B @)1'(8W 4.8<[PXS&,CT
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M'X'QW+=FX69M^S7C=JX4;M 6X@7:Y4CG0; NH)TT 75(4AEE-L$PP(E,'J1
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MB1^UWT?_ )(A\]7!_FM.V*F=N_58+\,.UVAMI?6HW\2/VN^C_P#)$/GJX/\
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M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"4_K#?DF^@:
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MT'R=- 8@T,()].68[@Q=.I&[F#/ID79C   <Y1WCG!1 -DHX : S)0"@% *
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M7#=,QC.)2%4!&K__ "1/0MGS=IX0-.3)@,(_]:2 @8-P_P#>UMG&! #%$O\
M% H 7=C.-_I+#>\AX5)+HE<.V&IZ&N;MF<ETM:I,JLUG.U4G6>=T57%OVU:D
MRR_>,HC++536B;E4K<_+6N"2%(P;NO\ TA7[R9_=7SV?^$_.;?[W/]X !L^N
M_JQ_6 Y#X0WT5EE45-"M:2[IG_A$V_WN?[Q?NI0 -W.1$,@$+:."B!3%R%HP
MH@(;11$I]HYLG#.T.R<Q3"0H5UJY)=!0CIJ2R6/I];656NFH]A/\.Q&DL6Q)
MJE:F=NJFM+O$:5E%2CZ'2;++5K=$0",VMSJJ192+"P;NO_2%=EDS^ZOGL_\
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M0KLJ6)_%]MHZ[^VUO,?90C0DV)?V/8\:L]4]?3NER(E/8$(4HG$0R/W1->T
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MZS%+=[7/\3_[K2YAJ+FD53G&Z\FI5$K^9F_B4O8D_ +XJPYF1Q*7L2?@%\5
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M%0#B4O8D_ +XJ <2E[$GX!?%0#B4O8D_ +XJ <2E[$GX!?%0#B4O8D_ +XJ
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MTA^^77[\]9O\)=*:S%+=[7/\3KUK2YAZ,[[ISC;_ &FB#-]8<S H!0"@% *
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M1WCN ,%<"/\ 5\&_ 4'+Y$5>8P2T?O2\):7,6'>B8=#;=+L"LR 1*%_72('
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M(X#F#(\P>]0$] * 4 H!0"@% * 4 H!0"@% 0$0 ,B. H!M!C.0QV_DS]%
M$!YA"@(T H!0"@% * 4 H!0"@% * 4 H!0%IW[]XMZ?%.X_U.\KE0/?L'PJ'
MZ9@X=(^#X[@<5T#9\UZX/W^F_P"<Y+^^K5Z30W>\/XMC[!YU1/PL1PE>D>%,
MKD$B@% * 4!NF>@:_@-0GQZO?ZP2-4HOZ:]7O%U'>JN2X5Y/66YX9%=(T>RE
M:>-O"@% * 4 H!0"@% * 4 H"4_K1^3Z0J&K%WEY@:%?HK/XP;A+?&JW?J!:
M-7TO3?%[<UP:)ZPBRCE]#7]=+PN'ZO@SSUK8IT(4 H!0"@-B[]CQ_P *VO\
M^;^#^L36JY>Z(\%W.\8Q'JKPW]>#\+4[Q>X];=FU@7G/^4']@M54+0I:UO\
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M0D4 H!0"@% * 4 H" F*'.8 ^$0#Z: C0#_7^OTA0$,@&X1#._=D.C C^@!
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M?!\=P.*Z!L^:]<'[_3?\YR7]]6KTFAN]X?Q;'V#SJB?A8CA*](\*97()% *
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M3 B+*O"I]*TTTJ:8UHGF"3"(B)N-(TU*J:2JGAL(U(%"&K%WEYC?.]">$/\
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M"7_F,;@KDN#>/0SB)_V_&]07\\K7AL <1/\ M^-Z@OYY0#B)_P!OQO4%_/*
M<1/^WXWJ"_GE .(G_;\;U!?SR@'$3_M^-Z@OYY0#B)_V_&]07\\H!Q$_[?C>
MH+^>4 XB?]OQO4%_/* <1/\ M^-Z@OYY0#B)_P!OQO4%_/* <1/^WXWJ"_GE
M 6I?B$]]P]Y[3^.V?N4N+:V6*P&QR0\S@1=F !QG B4V!WX'FKE0/?L'PJ'Z
M9@X=(=X1W XGH6SYN\[D)R;R8=KE-^!C%#!1-V6MD=D<" =H,9#?T\_I,X^
MAI)^RQ9*I%=KFN/!@4\[(A4T^(K1$[);K5%3]MXF"2R1;*DG-+)E,KD$"@%
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M?>Z:Y>Z(\%W/<8Q'JKS<-_W@I:K4]/Y.<2JG7V6[SF;4)49_U7^W1H#M;Q[
M7R/J2X_\6&  !W?"/-555E5+%7OS7V2+0):UOU>:S[2;B)_V_&]07\\J"1Q$
M_P"WXWJ"_GE .(G_ &_&]07\\H!Q$_[?C>H+^>4 XB?]OQO4%_/* _<S(_("
MG9R[9<1$O%=CH'0V0#:V]O;65VL^IV<;.,#G.0P!^R@% * I3^'BI$Y%9"*8
M2"B1=E)1VR;.5$B[0&V4S+IG,&3  [)1* B&=XAN B\B8V203;OH]F[12.4Z
M2+ILBNFB)2F !(10A@3QZHH;.! !V/6CB@(K1[)=H$<HR;*L.)(F#)1LB=J!
M"!ZE+L4Q!1*4I0]24"@!1QLX$I: E0C&#=F,>W8-$66R).PD6R*;44U2&!0@
MH$(5(Y3E,;:*8N#F'*F1$1$ PB8Z,(=*.CV; BAA.<C1JBW(<PFR)C<20HF$
M.??D,@ !@    J9>;F'/2(@ "/O[MV__ %OS0$U * 4 H!0"@.LG#/\ P4>$
M#^:R[?U6O79[BM=MSO&\%TS)UN['6K=!Q3&] V?.YZ1^ /I-7HBSW'\QYS,%
M V>X3^'F4C0"@% * 4(:L7>7F-\_T)[\7MP;/B]=W^)5Z50J^O\ &#='X^"Z
ML@B\-Z[6'<YXF,ZPCCT1K7AL 4 H!0"@% * 4 H!0"@% 6G?OWBWI\4[C_4[
MRN5 ]^P?"H?IF#ATCX/CN!Q70-GS7K@_?Z;_ )SDO[ZM7I-#=[P_BV/L'G5$
M_"Q'"5Z1X4RN02* 4 H!0&Z9Z!K^ U"?'J]_K!(U2B_IKU>\74=ZJY+A7D]9
M;GAD5TC1[*5IXV\* 4 H!0"@% * 4 H!0"@)3^M'Y/I"H:L7>7F!H5^BL_C!
MN$M\:K=^H%HU?2]-\7MS7!HGK"+*.7T-?UTO"X?J^#//6MBG0A0"@% * V+O
MV/'_  K:_P#YOX/ZQ-:KE[HCP7<[QC$>JO#?UX/PM3O%[CUMV;6!><_Y0?V"
MU50M"EK6_P"Q":A(H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'63AG_@H
M\('\UEV_JM>NSW%:[;G>-X+IF3K=V.M6Z#BF-Z!L^=STC\ ?2:O1%GN/YCSF
M8*!L]PG\/,I&@% * 4 H0U8N\O,;Y_H3WXO;@V?%Z[O\2KTJA5]?XP;H_'P7
M5D$7AO7:P[G/$QG6$<>B-:\-@"@% * 4 H!0"@% * 4 H"T[]^\6]/BG<?ZG
M>5RH'OV#X5#],P<.D?!\=P.*Z!L^:]<'[_3?\YR7]]6KTFAN]X?Q;'V#SJB?
MA8CA*](\*97()% * 4 H#=,] U_ :A/CU>_U@D:I1?TUZO>+J.]5<EPKR>LM
MSPR*Z1H]E*T\;>% * 4 H!0"@% * 4 H!0$I_6C\GTA4-6+O+S T*_16?Q@W
M"6^-5N_4"T:OI>F^+VYK@T3UA%E'+Z&OZZ7A</U?!GGK6Q3H0H!0"@% ;%W[
M'C_A6U__ #?P?UB:U7+W1'@NYWC&(]5>&_KP?A:G>+W'K;LVL"\Y_P H/[!:
MJH6A2UK?]B$U"10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@.LG#/_  4>
M$#^:R[?U6O79[BM=MSO&\%TS)UN['6K=!Q3&] V?.YZ1^ /I-7HBSW'\QYS,
M% V>X3^'F4C0"@% * 4(:L7>7F-\_P!">_%[<&SXO7=_B5>E4*OK_&#='X^"
MZL@B\-Z[6'<YXF,ZPCCT1K7AL 4 H!0"@% * 4 H!0"@% 6G?OWBWI\4[C_4
M[RN5 ]^P?"H?IF#ATCX/CN!Q70-GS7K@_?Z;_G.2_OJU>DT-WO#^+8^P>=43
M\+$<)7I'A3*Y!(H!0"@% ;IGH&OX#4)\>KW^L$C5*+^FO5[Q=1WJKDN%>3UE
MN>&172-'LI6GC;PH!0"@% * 4 H!0"@% * E/ZT?D^D*AJQ=Y>8&A7Z*S^,&
MX2WQJMWZ@6C5]+TWQ>W-<&B>L(LHY?0U_72\+A^KX,\]:V*="% * 4 H#8N_
M8\?\*VO_ .;^#^L36JY>Z(\%W.\8Q'JKPW]>#\+4[Q>X];=FU@7G/^4']@M5
M4+0I:UO^Q":A(H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'63AG_@H\('
M\UEV_JM>NSW%:[;G>-X+IF3K=V.M6Z#BF-Z!L^=STC\ ?2:O1%GN/YCSF8*!
ML]PG\/,I&@% * 4 H0U8N\O,;Y_H3WXO;@V?%Z[O\2KTJA5]?XP;H_'P75D$
M7AO7:P[G/$QG6$<>B-:\-@"@% * 4 H!0"@% * 4 H"T[]^\6]/BG<?ZG>5R
MH'OV#X5#],P<.D?!\=P.*Z!L^:]<'[_3?\YR7]]6KTFAN]X?Q;'V#SJB?A8C
MA*](\*97()% * 4 H#=,] U_ :A/CU>_U@D:I1?TUZO>+J.]5<EPKR>LMSPR
M*Z1H]E*T\;>% * 4 H!0"@% * 4 H!0$I_6C\GTA4-6+O+S T*_16?Q@W"6^
M-5N_4"T:OI>F^+VYK@T3UA%E'+Z&OZZ7A</U?!GGK6Q3H0H!0"@% ;%W['C_
M (5M?_S?P?UB:U7+W1'@NYWC&(]5>&_KP?A:G>+W'K;LVL"\Y_R@_L%JJA:%
M+6M_V(34)% * 4 H!0"@% * 4!@W4[4U[9UT6Y;K.5L6 "7B)>8<S-^R:L;&
M(HQKJ-8E:HJ$=,BG<.7$FAL$X\PB)!]1S4!R2VH%PM8VP8N&"U[BN_4)\\:Q
MLA'OGH6:TCF$?(2[RX161%PZ>L6\>U;,V[%JZ06?RD@W2!^S2*J];OS_ "SY
MANY^GTE$<ZP3T$A=4#/V_%+7] SEI0$2UB7[M*WKC-?*B24!,)G=-W,A$L6Z
MW*)IMH*,BY;!!2'8:\@)FW&$W<]SR>3V!=RN:R3!RS],IV+@+HMZ\;K;WF2Q
M[Z80:3Z0@U+@@I6VU'P,'23=QV/(QKMI)"NZ1?QQA24,Y1=*-WB+E(P)MU1.
MW2 RZF(" X#&_< @(&QT"("(B&>< '& Z* Y* 4 H!0"@% =9.&?^"CP@?S6
M7;^JUZ[/<5KMN=XW@NF9.MW8ZU;H.*8WH&SYW/2/P!])J]$6>X_F/.9@H&SW
M"?P\RD: 4 H!0"A#5B[R\QOG^A/?B]N#9\7KN_Q*O2J%7U_C!NC\?!=601>&
M]=K#N<\3&=81QZ(UKPV * 4 H!0"@% * 4 H!0"@+3OW[Q;T^*=Q_J=Y7*@>
M_8/A4/TS!PZ1\'QW XKH&SYKUP?O]-_SG)?WU:O2:&[WA_%L?8/.J)^%B.$K
MTCPIE<@D4 H!0"@-TST#7\!J$^/5[_6"1JE%_37J]XNH[U5R7"O)ZRW/#(KI
M&CV4K3QMX4 H!0"@% * 4 H!0"@% 2G]:/R?2%0U8N\O,#0K]%9_&#<);XU6
M[]0+1J^EZ;XO;FN#1/6$64<OH:_KI>%P_5\&>>M;%.A"@% * 4!L7?L>/^%;
M7_\ -_!_6)K5<O=$>"[G>,8CU5X;^O!^%J=XO<>MNS:P+SG_ "@_L%JJA:%+
M6M_V(34)% * 4 H!0"@% * 4!B2^11C+I@;C7TS=WF+.)E8U">AR13V;@Q?+
M,U562<?)KL [ DRMBE<.T'QE4U4T$S-C(**J)L.<N0G'9[?)^1AN'LB[[8+9
M=\M[7='",U"U%FW5B,EHU:6@[/OXCTJ;>.!1TC%'E&,JG'3D@P2?D:I@]E&S
M5RX[%;BJ/G?E4M5OILW2>8M"\KJD[HU-;VT_C7B-Q::R%L6I)KLDIF5A;%6?
M+28K\4X791\C+$N&?Y-0.\,03HQAG:[8RZZ:0G//&9"ADK@O+4Z,O)S;$U:T
M);%LR,2S"X!CDY"1E9MRDH_XAK'/)$I&+1NT:D*Y6625<+@KA'8 BAPS_KBS
MW#.0@*@"4QAV3%$H[(B4V\,")1+^Z$,(Y'.UNQ0%,"&:!D#.)3(;OWWE,XY^
MAT   9]2 !@ H"/(S+VQ*?.\KYU0#D9E[8E/G>5\ZH!R,R]L2GSO*^=4 Y&9
M>V)3YWE?.J <C,O;$I\[ROG5 =:.&5$LT^"KP@#E7D1,32R[C "DI)J$W1:W
MKB&<B4?@, A[PUV>XK7;<[QM!VV?#,VV9VU'6KL=:MT$ODJ-Q;"WC]E9\]#G
MYP'H$!W\PB;<//D=P<X[0=K?7HBSW*U_XC>/$Q+R2Q(4"9L7<1A*YSG[_'+.
MR4A0^A0"@% 0$<8]\<<X!]//\'./1BA\M+)/*E=56&<EMWK3>Z]"DC&[CT/O
M@W+*K/RB>W;M'",D_13#&I-Z .RDBX(0F\0 <%#M=-4*OK?&#=)9WQ!V*JIX
M-@L*UEXKUL^T*YR=ND1<_P#4(W.7HQ>AO(S+VQ*?.\KYU6O#8 Y&9>V)3YWE
M?.J <C,O;$I\[ROG5 .1F7MB4^=Y7SJ@'(S+VQ*?.\KYU0#D9E[8E/G>5\ZH
M!R,R]L2GSO*^=4 Y&9>V)3YWE?.J <C,O;$I\[ROG5 .1F7MB4^=Y7SJ@'(S
M+VQ*?.\KYU0#D9E[8E/G>5\ZH"U+[AV06/>0@XD\A:EQ"&9:3,&0B'F,E,Y,
M40[8& 2CS" AD*Y4#W[!\*A^F8.)2'>$;P2)Z%L^;Q.@ 3TV4=KU,I( 7(@8
MP@#M;.T8^\1S^G?TUZ3.%FXAI?N,>1- M2;DMZ6!%/.Q\DWT1-)_K3Q5G.2J
MC3RNNN=4Y2Q%+KD'R* 4 H!0&YUZ!]'(NN _"*F5?IYO>] V47[UJ3)+BD,X
M(@NF00Y\9#M52J_K5=N^E;J?1^"Q5AW6YO5VEPKRFLMU5+]=BDLE_BM684SE
M4>QG(S+VQ*?.\IYW6G#;PY&9>V)3YWE?.J <C,O;$I\[ROG5 .1F7MB4^=Y7
MSJ@'(S+VQ*?.\KYU0#D9E[8E/G>5\ZH!R,R]L2GSO*^=4 Y&9>V)3YWE?.J
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MQ<F51:.$W!V@IHJ$2()SS]!G,5 *4QCF I2 )C']2!0*&_:,81$H%QS].[-
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MO"][XE(9U(LH4T!"QL"R>-&#-!PX%Q(OU5'CQXY7=R \64P%430101;D!/C
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M2E+GGV2@&?AP 4!-0"@% * 4 H ( /Z!#Y!Y_P!- 2[)>Y#]'OY_U^CFH"8
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MHSSP9[J';F@% * 4 H!0"@*1<!C$@9LQ3"0Q8B2,4Y1$#%,#)80, A@0$H@
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M;P<M*XNXI.Z&D,\(^E4I=$S923=*1C TZF*4LM%QYS"BS</BB/'JI@8PB.0
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MG9V0H#);NPK2?6,;35U#-E;-&WD[7&%$#=C%A&[8C)!KM@;; 46R:((J"?C
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M^K0LB L5O-,K<;*-&T]<DM=,D114RPJ3,T=-617(8V (504BG*0-Q1#!<\]
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M: I\UP8=)IR&A8-U%R*+2#5NGL)6/EW;%V9K>;T7]QQCIPWP+B-DG8@HNU4
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M=_/S^_0$: 4 H!0"@% * 4!*!2AS!VNWT9QS]K(X_P#P% -@H[A#M=O?C @
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G!$K9DR:(AA)NV;D]0BDF40*4I=V QN   !)6* 4 H!0"@% * __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>g68105g91a12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g91a12.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2C$4&AO=&]S:&]P(#,N,  X0DE-! 0
M    **B^$$"#A"24T$!       0!P!6@ #&R5'' (   *  !P"4  (<G(R.3
M0Q-C4< @4 'TUI8W)O<V]F="!7;W)D("T@4'5R951E8V@@+F1O8W@X0DE-!"
M4      ! D:-8_$:W9)'PP5VYRU*1 .$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'
M#@           *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !#@    $  @
M$.     0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@             "/@   [(          0
M                     !              .R   "/@
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG   "/@    !29VAT;&]N9P
M   [(    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P   CX     4F=H=&QO;F<   .R     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    $.$))300,     !
MY)     0   *    !A   !X   M>   !XM !@  ?_8_^(,6$E#0U]04D]&24
MQ%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$
MU31E0     245#('-21T(               $  /;6  $     TRU(4" @
M
M 18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @
M0    4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9
M   E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'
M5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P
M@,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&
M,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G
M-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C
M$
M       %A96B        #S40 !     1;,6%E:(
M!865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M       "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96
M,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                  9&5S8P
M     N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2
M!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;V
MQO=7(@<W!A8V4@+2!S4D="                             &1E<V,
M      +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-B
MTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6
MX@245#-C$Y-C8M,BXQ                                  !V:65W
M     3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4
M   %<?YVUE87,          0                        */     G-I9R
M      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #( -P
M [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *
MD K@"R +< O #! ,8 RP#0 -4 VP#@ .4 ZP#P /8 ^P$! 0<!#0$3 1D!'P
M$E 2L!,@$X 3X!10%, 5(!60%@ 6<!;@%U 7P!@P&+ 9(!F@&A :D!L0&Y <
M$!R0'1 =D!X0'I ?(!^@(# @P"% (= B8"+P(X D$"2P)4 ET"9P)Q GH"A
M*. I@"H@*L K8"P0++ M4"X +K O4#  ,+ Q8#(0,M S@#0P-/ UH#9@-R W
MX#B@.6 Z(#K@.Z \<#TP/@ ^P#^00&!!,$( 0M!#L$2 15!&,$<01^!(P$F@
M2H!+8$Q 33!.$$\ 3^!0T%' 4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?
M8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L &T0;C!O4'!P<9!RL'/0=/!V$'=
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M5+Q<C&1L;#QT''O\@]R+S).LFYRCC*M\LVR[;,-<RUS37
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #, 5 # 1$  A$! Q$!_\0
M'@   0,% 0$               4'" ($!@D* P'_Q !7$   !0,# @$&!1 '
M! <)   ! @,$!08'$0 ((1(Q$PD4(D%1<14W87>W%A@R-#58=7:!D96AM+7!
MUQ<C.$*QT? D)5+Q&4-$1F6"X2<S-D578V>7I__$ !T! 0 !!0$! 0
M       ! @,&!P@%! G_Q !'$0 ! P($ P8$ P<" P<$ P !  (1 R$$!3%!
M$E%A!A-Q@9'P!R*AL10RP14C0E+1X?&2TB5BDP@D,T-38W(6-'.R@J+"_]H
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M68%A 1K)&.4EJDE7+10D4W1632(L(86*H"3X?4=)'WM<<UG&V*N[B7EJ*_\
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MY;2BL0H@41 QB  X' \#@BI^M_F?/AC/KQMQ?PB!/$\P^J*S?GO1_P ?FO\
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MHYI5]U5XH+7_ %'QTN=Q*TCTR$1;E%JRCU8.+BP*YD42.FJRXD709>$2F/9
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MC?W7_.E1?T-V_P!%*DQHB-$6K+?B[\ZNY9:* >H6%)U[+@0!Y [I6*CNH>_
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MGY] I!(TWZ3/NX]5(O8(N(V+7;=(897(N(D(9["M4[UT&/8!@6Z@#U!P'&,
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M$1HB-$1HBC[NO_LT7U^:VM/W$\U!T\V_<(GM@ON+$_@R/_8T-2B4C]@]_P#
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M@64^-_=?\Z5%_0W;_12I,:(J3=O>( 'O$<?Q_-H?3^Z+1I<5P5W?J_CTP_\
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M0D)'-^GIP7)HY$@!@ $.DP%)@0X$!'UCK<M9W>8O$N>9.'+C3V+0'$W\=]X
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M^>/7YK=)\M9_$^N:.3X9LVJUWLC0DBG(OZ>MTRX".!$ ^R .1 0#&"B(!VY
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M31L@;PHQNT,;G(J,@\T5$V?6!T3 / >WG4LJN/$#I,F(B]['>>4Z77A5I>X
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M2:;P!.^^P,W'(7/ZI6V02!J?WQWL@#K$1;UY9.@*N23$1 73VG)R0II?I V
M$Z#11J)ND!$I5>HV . C@WQ"HN=EV K%IAM=[>+01P\6W0].96YO@W6#,9F%
M$N'ST&. DW J"\"((ZS/D5NPUJ!=#HT1&B(T1&B(T1&B(T11]W7_ -FB^OS6
MUI^XGFH.GFW[A$]L%]Q8G\&1_P"QH:E$I'[![_X#HBCKM6^*-'\>;G_2)4NB
M*0ZH8],.^.G]?Y_;JU5) $;F_E>_3FBYI?*%.QG/*/4)$"<3A2UJ7TH(9 0(
MH***14QY]$YB30F*']X.0XSK=/P];W>68RJ?RO#:8)CA@.T-IDGQ\%H7XL5>
M]Q6688$DT<15JEO_ ,J32#X0".IY0$CG !+QD1$0,'8,9*7/ ]@# @ <\A\F
ML@>?^\/(T =Q>1,QYP?[+5+)+Q(@AAG?^(Z1,ZK-;1CX=25>SXRX8P\@4F0#
M(I"JQ, !VY$G4.,\CR/(:^ND[NVL;M)O?4G[<A'31?'C\*7/>Z_Y&N D022-
MSU\P(/-/3M;D$* \H"E&,B$CXZ]UAZA4DF[<B:#:6JVWU0Q[]"26*B4A#O$(
M*7?(BN?J66!8#&,;IY\#X@X>F_LYAL0&AU6CCVM<X6<*;J3[$Q<2&D@S<;0L
M]^$6-K4^T]?"NJN%'$96]P:3\KJK:S#($V=PG\VAGBU6]5(Y3$ >H,B(_P![
M/(B(X <]^W''?@ [!HX$$2#(73\$1(@P#"]=2B-$1HB-$1HB-$1HB-$1HB-$
M1HB-$3#7Q^W;)_/G1G[LJ710=/-OW"0+*?&_NO\ G2HOZ&[?Z*5)C1$V=YY$
M8BTMR9/JZ 8T15#DQNP]*4*],.!X#/;N(!WR.B+EMNLJK(UEM5M^G_[B-82M
MPY),2]1!"GX)*,C#&[^B+R44#)B@ &*7G(B&MO\ P\H]U1KXDD_/3L=#J0&Q
M8V(Z&ZTO\5,>'-P^"!!X1)!$V<&N%]A]+[1=YS#WP(CSWQG@!]7R#GV!K*JW
MS8ESP) '#L8,7F=(:?Z:0M-4V26$B 1 &GS DFT\4@2=K;FZ5J*>A%U_#' P
MIHS;-[$.,B/AF7*3SI@)L\=9E4S(E'OE4P!WTH-)>\&2 01?0&_C;S_K;Q5(
ML<" 8>' @[.N?&XTZ;VO)U3'6.. 'D ]@?W0[CV+C7H.$'R'V$_4+PGCA<X=
M>8\IC<"W3P7GJ%2C1%7]D3IQG B.,>H?R^_L&K6)!JTJ=,"[7EWE(/W/TV5Z
MG$.GI'G(^F\=-(6(6VFBT/OGVU5 )>EM<"!N/:9VJ)NE-1ZYCF-918J@(AU&
M*-.N44"9'!G(@0!$PCKQ^V5$XSLY7X0YWX(,KD@0&@ AQ(M:!<ZVO*S[X8X\
M8/M'@J!,?BGOPYF+\7S-@DZEQ  !C<6DK?H'8,^S6A%U8C1$:(C1$:(C1$:(
MC1%'W=?_ &:+Z_-;6G[B>:@Z>;?N$3VP7W%B?P9'_L:&I1*1^P>_^ Z(HZ[5
MOBC1_'FY_P!(E2Z(I$+!D@A^7'R!WS^?5NH.( :C36-8A%RX[F)0M5^4RN\Z
M)_6ITC;J$BBF .KPCO%FC18O<0#'P;@X<#GIX'(XWOV/I&CV>I&!%4DS>Y%S
MUD&2 ;'6;KG+XC5>^S[A!![KBTB6@" -;6(;'GI*7,8Z0 /^LP'K' &+[/\
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M!)=-R4! 1*!NH.# 8 Z0PU/NL@RRF6\+@'2#+2"YC""0;C4["0"N0^T5;O\
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M_P Z5%_0W;_12I,:@B1!NB@#Y0>1Z+:V^IDJF#U+=:G2J)@;TEF4*UDYEZ4
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M023M G:"#:4\@AC5X&?TOJ.:\DB/UMH>2-2H7T._^OS?E[:@DBX,  S&I4@
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M0U]2I6!)-1[R20((+W$&UM"-^9W3W!S^O]09U\2H-OI]3"\<@<W4''2(@)1
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MRJ4VU>XIDO:RE2:#H8[ILB\2.1OSO"Y)K&M7JUJC6-/'5JF0Z0?F(%YGH;Z
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M*A"Y.F!R&QP/W8'$TZ-/@XN*2+DB2+S,ZR+$$>*\'$8=_>]XPAP ,@@@!TR
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M39+T+=RV=1MU'E/UA%3;1%=9JLXB!6D6J3IN/2NV66:)*D(NB(@"J)C JF.
M.4N>;)SW+ !\S >4AOG^:#M'D;*IO9;,G$2U\@Q IO/UZ:[*])<J@U7#MLG4
M+<[F/(BH_0!N^,LT3<$4.@=PD#;K0*L1)0Z1E2@50I#F((])M#GN7"+T[B0
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MC PR_B=Q.J5(@DD;3)\/KK'%Y=VQS>O5Q.+PPJ.J.<*4TB&L82XM D B&D>
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MHZ?!:/BW+1!VRC4484$T%DV .ERE<J9*12Q013;HI()%*1)$A4TR$*!"$(0
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M=$05,A?L2@'KX]OK'WCZQ[CZQ'1%7HB-$5 )D <@4,@(CGD>1X$>1[Z(JBE
MH8*& _US[_E[Z(ONB+X8H& 2F ! >X#HBH!),..@OY0 >^1P'L#D<AZ\CG.1
MT1>G;MHB-$7PQ0, @(9 >X:(J0(0H & P " 9YP ]PR/.,<>[CMI[_NB^AT@
M   @  & #/8/SZ)(&IA?<A[0_.&F_P"NR2.:I.1,_P!F!38P(9]7L$.?E[A[
M<9T1? 33  P >H,YY$0]HYY'UCGD1Y[Z(O3(>W42#H045!R$4  ,&<" AS^7
M''<! ,"'80R';4HOI2E3*!2\%+P "/;UXYTD<^OES159#OGCVZ(OF0]H?GT1
M4F3(?/44!R&!_@/O]@^[V!HB^E(4OV)0#N/' <]^.WZO=HBJT1&B*@$R@;J
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M,6S 5F5Z#FMP5*F8>):]H/%()F1M'(1JOT5R+&-P-;-Z3\/6IBMF=2LUO 7
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M+,52J.(:3(9,] (,3XIS;@4C=F)JY_<I&ZSIQ:J#IUT[E+*MZ$B),U0@PA7
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M@ ! !' "'<! ,YYU6VP$<OO=" =0#XB?NO(R1#FR(#Z0G P (@ AT]&,>SI
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B.)E5ECB80 I0P4H!HB<'1$:(C1$:(C1$:(C1$:(C1%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>g68105g91c90.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g91c90.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[19,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %C"^5H X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]       $@ U     0 M    !@
M     3A"24T#]P      '   _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #-0    8              4,   &K          $
M                 0             !JP   4,
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   4,     4F=H=&QO;F<   &K
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   %#     %)G:'1L;VYG   !JP    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $    !3A"24T$#      ,7
M  $   "@    >0   >   .+@   ,0  8  '_V/_M  Q!9&]B95]#30 !_^X
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MYW_K?^C5I0LJK@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  +" %& ; ! 1$ _\0
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MA!2D%)".W>L\H*3O7T.M?30\%(V0 ?(/U\FJZ4I2E*4I2E*5\J^2I<&T7&;
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M23TCR/%0O]+]XM%[Y(]3TJS3X=QBM<CV:*X_#=2\RB7#M<OXB(I8 ")#9/\
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M04+_ %!&AWK[>UZ3\V@H'N?D5HI)  /A8()&QI('<G=5-+!!3UA13V'S!2M
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M(JGX,IJ6VS*BVJ47([SL9QSVW&_+K"RA6SM6OI-)O?0GJ\@:)[ $CMU !2P
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MEKC*R>X1GW%?'Y9D5QO2PI:FE-;2&D]+:1H G:B -#J42HD;T=$G8V K1^8
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M++T:TR398PEK"E;DQV8WLO\ 2M20\AP)4M*4J,AD?H22020"2D[3L]STGO\
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ME"0E*0-: ^GW\D[^NSLD_4G9JJE*4I2E6YEF.6O+,?NN/7EA,FV7:%(ARV5
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MN%RN-OY$X^FM6/DG'QU1UN=;=GRR$V0XO'<D;9)6ZU*;2ZS GJ]QRW2WDO\
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M05TJ4"1]=UULY+SY8V@U?,&L&4)2YWD8[=2Q)<9$AILJ$64AMM+B4.*<*/<
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MM:]^H[FVQ7S%<?D^F/)G)F73)T*WNL97C3L9AV!!=N#RICHF=+"%,LJ2VI9
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M..R$1Y3S#LA+TQ2)>F8W0R07%$ *("M5=IY<Y^[_ /TUWDCZ;S+&000.Y[3
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MM"D*V36QU4BW0GUH]M;\9EY;>M="W4!Q22"2=I4H@DDDD$DD]Z]U*4I2E*5
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B%Q(&P$D;&R00E*PC6R3VZ02"=$]_Z^JE*4I2E*4I2E?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>g68105g91o18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g91o18.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1ER4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &5:^9(8X0DE-! 0      $ < 5H  QLE1QP"   "@  < E  "')R,CDT
M,38U' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0)&C6/Q&MV21\,%=N<M2D0#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              O<   1H          $
M                     0             $:    O<
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   O<     4F=H=&QO;F<
M  1H    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   +W     %)G:'1L;VYG   $:     -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ ; "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M/(WX%OV/$?8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MH;?A)S-"L?'1_\0 ' $!  $% 0$               8! P0%!P((_\0 1Q$
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MBU)!*@D7M%*"BSBA>F]>T6:#1@!>F]:WKU"+6_3>M;UZ_3KUP#ZX P!@# &
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M X&H$[7[P7E8 P!@# *4/PA[]$?TW^]Z&_F&JS +H6O\VMW["D_AR\ WV ,
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MS_PWA?3^/79C1_6[O]!1_O,CU_CT)<9%3)& , 8 P!@# & , 8 P!@# & ,
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M-&4M)O\ 37"9*T]&-ZX(FIB<HHWIUQ;FCD9KKM.U'1TPLUP6*%B8\A"E"(9
M +I< ZRW32'/$BD<0:97&W260\#2;+8NW/C8MD46+?DQBUB,D;(F5&N3(!Z1
ME&JVD3FF3!<4Q1BA'LXH AZ V<6L:OIRH?4D)G4.F*N+N(F>3)8K)F60J(Z[
M@V/0VM]):%JPQH<0;+'H2%P"G5!]@7J5KV=^@"(V+7T_V\Z@<ZATUW''(QFD
M.HE)F61[8G@GU^&:GG\3K5GXK<BO9%\*@6_ *B]AW[96O3?H!4%^$/?HC^F_
MWO0W\PU68!="U_FUN_84G\.7@&^P!@# .C6%"2; C:B-G2B:Q "@](HV]0"2
M*XI)2=I#M':*3/*((CR4Y^P_!JB@A]D\G8BQ;UK>9>#F/ R8Y,<;"RW&,H^1
MGXT,O&DYKI4I4S^%RCO<9/>GW^2/$X=<>ERG'NGN$G&7;Y;7?3^?OZ>FRKGG
M"X*TK19*WBTKOZPDTFBMIW]"1H98S7Y8M<[CT4MN91:.'_'6:OG>(N#@VQIK
M:OC"Y*\&B1+@J_C 4R@M0F)Z7XCX?DN2AC4\7PGA;&Q<KC.!S5/$NX+C^2\_
M*XK#R<E.%W(4Y5==F3;;TPE2E.OHZ7)-2>LQKZJG-VW94Y1NR:_CADV0Z87S
MA'35;B^F,4MIO7?;)C$]X<DCV/2FZXVSB![7M!D:"21C8=@'LL7M:D3(U[#[
M(]>@O77^'UUO?IK8=[B;\$>*UIQX7(M3UIX]F-E=VDTO\FNMWM/Y;^:,M9V(
MWKSX)^TNJ'IZKXDNZ^:]4>CL'3O-\J,"3&K]IA]4##L04K59T+7*MZT+V-[^
M*IGHQ2'6A?X=^T5K?K]&]>N:Z_PWXBQMO)X'F*(K7QV\;F0CMK:U*5"C^WO]
M=78Y./+]&^F7X6P?^$OO6SUPM_8SFL3V2\-9S,!.8J&[E+THVL"4H(AFJ1KP
MF[2A3E!"(1AVS?@P!"(0A:UK?IJI4W*SR'3;&YR4%5*N:MZGV456X];;^2UW
M?9>I=4HM=2DG'6]IIK7OOTT0ZH&;0U=T5V"G1RR,JE#O9%6_BDA,^M:@YT^!
MHN!E';;BRE0QK=%&D'%&[3:,^#,*, /T$ >@R[GL/,KX#PE*>)E1C5QW*.V4
ML>Z,:M\WG27F-PU#:E%KJ:VI)K::,/'MKE?EJ-D&Y75N*4XMM+&I3TD^^M-/
MV::?=$V\AIFC -HO-,)1+#BMZ"82E4&@WO7KZ#+*$,._3ZMZ]=?3K?U_5^O/
M4%U3@GZ.44U[IM;_ &;^H,)F)^5KLLV^RYP.:1;;_+ 0VM7HS4%CVDA\28Y<
M\.+>A)3:3>B<XM1*7CVUI0]*C0'E!&;OX K8?LS*_);X/7!/"6'E>1B_:^2I
M7V_)ZHY=V)3798Y=>Y1<<6K5;^!-/2^)G.ZN?Y"6;'<ZM63KHDG5'^;5KUZ=
M]KKEW[^OH9N&M;UK7K].\^,%_P W^QG1#7*@8 P!@# & , 8 P!@# & , 8
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M_P!?I]<XXNR_A_N-X:Y4# & ,IM;:^: RH& , 8 P!@# & , 8 P!@# & ,
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M_P!&\*8T?UNW_P!O1_O,@EOO7KK>O\]>G_7IZ9%3)(D6!R3%W.5K;5IJ1.=
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M]%DZKJIQ[J5=E;4X27O%[/,XQG&4)Q4X26I1DDXR7LT^S_O,(VZ>W>IJ.O\
MEM?US;[TV1;G2UKCA]-HGEJC,O50V,J'YVC.V4IWE[(^/#NA3L"9,U("7Y>Y
MZ;4:<DIN^*A*+]G[/X7P5X7YO@<3D.0XBFS*\1<7Q&7R\Z;<G#CF9,::LGSW
M5B74U4V3OE*RR5$*W9*4G9U[>^<Y?+9^)F74TW:KQ+\BNB,X0L<(.;CT.4XR
ME)*,4H[;UKL9DG.EFMUP4=5=BM\G:I>.302-+W=\:#49B91)-M*4$E),*0!
MF1K$CX!>E6MP"2-H%1)J7:<G96RP_(7B#C;.(YOE..LQK<18V=DUTT7*Q2CC
M>=-XTE*S<K(3H<)0L;EYD6I=3WLZ#C71OQZ;8S4U.N$G*.M.3BNKT[)I[VOD
M^Q[7FG+XP!@# & , 8 P!@# & , 8 P!@# & , 8 WOT^G> 8^_DELU<T]!<
MV==<R7YP?8,IH)OOBG7BA>F;RC$&8'%]D:J%ZE$B@LJT[')8[;$ -:$$?>R'
M!,2K0LDC/;SSD_XP,3*0(J<Y\?\ 0G8D[@]RO%K<.EMN_(W!NWKU@_,$Y*LM
MKIS_ $3U7'8A!(5"GUD^'3G3FXU[6O=;6=%BA"WJDZ! [ISW%9\9;3 ,K/ &
M , 8!2A^$/?HC^F_WO0W\PU68!="U_FUN_84G\.7@&^P!@# & , 8 P!@# &
M , 8 P!@# &\-;!5!>7"_)3WU%0Q[M1D+7&VL^7@_6(,XIRUN6/!$1T_E.#K
MHMP $P\#TI/<=;)T2'XP:,6];UOTUU+A?&_BRCPSSD:><S8+BZ>$Q^/TZV\2
MF65*B5=3=>U%TPC7\3D^E+3]]-D<9Q]F73*>+5*5KR++&U+XY)1>Y+JTWM_<
MM]]$C)%SD\T^[J[0Y. UQ=Y"W$ F%'+#C6^J;<3MA*,DH_X,DW1<%L\38@+;
M&ZQ42984X:"G2S-J>TP"%C?':/$-7+4PXSQ4[<JGS)RQ.<@HSY7B96.<G';7
M^7\9YLW99Q]DHRK>YX=M,MPGF2QI4MVXG3"6DIT2;5-VDDF_5UVI+2L2?4NU
MBDDG'W&E+MA]Y14V0QG3BU.C0X'Q^:0F1)?Q9,H!+4&@Z=(K+6<0S!('-$(0
M1E&E#/;G1$8G=&A8N;5:94;I.9X?,X3*CC9/EVU6UQOPL['EYN'R&)/^;RL6
MY+5E<UV:DHSKFIU6QKLA**R*;HW0ZH[C)/IG"2U.N:]833[IKY/TDM2BW%IO
MV+-471@# & , 8 P!@# & , 8 P!@# & , 8!IOT]-^OU?\ 7T?\?JP#"FZ1
MZ#Y7F5=7M-X_XHN8[+&_>1!]Y'X=3SH'QT^\^A9L^*TG0EM3AI;5B%>SLBUY
MB<4& " Y >[*U;8E6O)(R%1J4"XOPN%IJ_7]D\UR[DKF[D^^Z#L^O$5K-O*Q
M+T"J;%9)U7R>5UQ,41DB5KGCX_IL.>4*E,K4^TG+ 3OXND--.3E@7GX P!@#
M *4/PA[]$?TW^]Z&_F&JS +H6O\ -K=^PI/X<O -]@# & , 8 P!@# & , 8
M P!@# & , B?;HP_*=Y%_P 6O_O7M^O7ZJY(WO7K]7_6_P#+>2CBOZ->+/7_
M #%Z+?\ G"Q?+\3%M_6L5[7Z.1\U\XPU^.]/T)7^NM_[=?Y_7K>O]_U9%S*(
MR6W0RMXEB2[:A=$T'O6/MPD(7(P)A<5M)@3%*#$M=6PB2%B.=(T-6;HUJ?DH
M-R6'+!;<&,\P@2YI<I%Q?.1IQ)\-RU4L[@LBSK=:T\OBLB3BI<CQ-DVE5DJ"
MU;1-K%RX+HOBI*%M>-=CN4U=3+R[XIK?]2Z/=^5<M=X[>U)?'!MN+[M/L%%W
MVRW*A?VQ6RN4#M" KRF2SZKD1A I'"7HPL1J46U"?>T3_&GQ,#;C%9:SC.9Y
M V#"<080K*6H4ECFN#NX:=%D;J\[C,^$K^,Y3'36/F4)ZEN,M3HR:)?R>5BW
M*-U%O:2<)0G)CY,<A23BZ[JI=%U,OTZY?+>NTH22W"<=QFO1[32]\S2&2, 8
M P!@# & , 8 P!@# & , 8 P!@#Z\ I9AO@XYBA76S;U.DLN^7-MBES3[HVN
M.=GF8,JNAJYO:R]@,E5AQF-ZC9;L2I&N3-[LU-YCULEN<VU",9RM$F)0E@2V
MX;X8:N-$=R/CK<=C]"W+T+8!%C7'<MI#:BY#)'5K9DL;C;*V-;,F(1,<6B[$
MD A9&C1Z\23X=4$M4!'M(A1 3PP!@# & 4H?A#WZ(_IO][T-_,-5F 70M?YM
M;OV%)_#EX!OL 8 P!@# & , 8 P!@# & , 8 P!@$8'GBGD>0O+A(GWG&GG9
M\=G!<ZN;LO@C I7KG)S/,5."Y4I-1"-.5+5!IARD\8MF'&&#&,6]BWO))3XQ
M\58]->/1XAY>JBJN%5=5>=?"$*ZTHUPC&,TE&$4E&*[)))+1BRP<.<G.>-1*
M3;;E*N+EM^KVUO;^;]7\R1S0T-; U-K&R($K4SLZ!(UM38A) F1-[<@(+2HD
M2-.7H)9"9*F*+(()+"$!918 !UH(=:R/6VV7VVWW63MNNG*VVVR3E999-N4Y
MSF]RE*4FY2E)MMMO9DI**22226DEV22]$D<C]>>/X^A4CC<E$?E@]MEL5PY)
MX/?L-:5;=$9H,"LUF?6LX8E0X%9S0@4)#9;7CDM]#SVX9Y3FQ+]A?8TN;G0D
M0E&^XCFWAU6<5R%<L[@<RV%F7A[CY]%J^!9_&76*<<3D*H-I6=+KOKW1D0LJ
M>H8UU'7)75-5Y$(M0GWZ9I_]W=%-==;??3[QDDX.+VS?4??""U@/D7D#*HK^
MXX#M&CLVKGA02<YQU8K+]I&\,JTK?Q:3P9_T Q5%Y:V;&B<4VA)58&]Z1N34
MC\\UPEG%.C)HOAR'#Y_7/C.4IBXU9,(M=5-T&E+&SL??1E8EBC.N7Q1ZZ95V
MS]47^:I0FO+OKTKJF]N+?I*+_KUSUN$UVDNSU)22D!FC+XP!@# & , 8 P!@
M# & , 8 P!@# & 8T7X0;T_;E!IJT8DW0%V\N4;*:.Z/?R+/HMJ5$/DPZAA[
M(Q*J&IZ5S]M9'MV@D1E1ZEY5*C6W\4&O9J02-0\MR4@UP0@2H\-/4LMZM2=2
MS5LM>;W?SPVS>I45-6!/8^N95Z:6+*9BRR\8%&U;HW-3F_0J&3820+,[.*,2
MLY>[/.MK%Y7P2T\"[7 /BH/*2D'*3AZ+)3E&'G&"WZ! 44#9A@Q;_5H  B%O
M_9K *K>8_,3RGUA(7IMKJ,]"L,1883.+#6W'8])R2%TF9$J\&(,E=$5F+#5$
M>6%IP%*CTX"3Q"4$H5XM: -(:7H#O_&WE*Y4[EF\CKNFEUBM4N9H<CLYA:K.
MKJ0UZ98]2.3P)A;;8K<3V2 ,G@:YWT!$2YE[3*P&GD;4-Y(3/:"!&G\(>_1'
M]-_O>AOYAJLP"Z%K_-K=^PI/X<O -]@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# ,57RJ=MWS1O="-!6;M'(ZIJJ-1Q5&'PJ,MYS\I;I<P%+))%I$XG:'N
M11%T6B)7"C[J4H1(W)$@=&\*1S2$K _3WY+?!7 \WX(G9R563D1Y3*RHY-$L
MFQ41MQ,B5>/EXU2TL?+KK3K^T5.,YURG59UUR<2$\[RF7A\C&%#KAY==<HRZ
M$YM33ZJYRW\=;>I=#6E))K36RY3QL=AG=64'&7&?/R(^\&]*[+9PS@8Q1CXX
MU'2Q_;X[)H\VB !,Z1M2A0%-)STSB4H"Y V.S8J&G<$IQ&N0_E%\(KPMS^37
M@461X2R5,,*YY"RNBY8M%F1C7V;<ZLF,YNU4W=,Y46U6P4H24B0\1GO.Q*[+
M6OM&F[(J+@M=4E&44_6#2UU)M;W%OJVBQ;.?FU& , 8 P!@# & , 8 P!@#
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MBV/86]'K8Q:UH0]Z3%ZV(6@ZT'6Q;^G>M:UK6]_1K6L Y# & , 8 P!@# &
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M[HR)3;JNAY61!;E#NX3BM+S:9M)3K;:[?I0>XS6TFY.Y'#*& , 8 P!@# &
M, 8 P!@# & :;^G6_3Z_]_I@&(1V!9B]IZVC-9/7FZH6H>@HE*NF7U!/Y9RO
M0<J%2U=NDB@)T6Y_?)O)GTES@LDC)1*T"#8 D.-BD&J5[EH'XD3Z, M/\0%Y
M3*T%?4T&FWD';O(DY51+:T2I[2B]30>N((PI9A$%KYIFBCO!7MX03/1AA0RW
MM2K"B4,KL@.;@EG%BT<("ZG & :>FM?5K6O^& :^FM?5K6L I0_"'OT1_3?[
MWH;^8:K, NA:_P VMW["D_AR\ WV , 8 P!@# & , 8 P!@# & , 8 P!@#
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M3KI!!*P=XA:]7I)G')T[G(R$JEV?9$C.VU;3/21"[-!49WK:3;:O;EBP"]7
M& , 8!2A^$/?HC^F_P![T-_,-5F 70M?YM;OV%)_#EX!OL 8 P!@# & , 8
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MH6O\VMW["D_AR\ WV , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & :;UZZ^GZOU_J_7_U_P#& ?S:[ILFBXK,;[ZF
MBW4A-/\ E-#YAK>@*.?/$UD:E97_ "LZ.C[ !NKG#!_&H\?7T42JAF#-^)'.
M)*!K UIA@;R24F@,OSPOUCP95]-V:V\8]*BZWE[[,VZ2],7PZRE=*);.+.=&
MLP:9P?A*RRRFA,-*6N-9VI.)8:20<H-<G5V<CE+@>!<S@# & , I0_"'OT1_
M3?[WH;^8:K, NA:_S:W?L*3^'+P#?8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#P!SY/Y:>G)P>'CFVA79W=
M5JIR='1RJ&OUSBY.*TX:E8O7K54?-4K%BM088>I5*#3#SSC!FFC&,0A; [_
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M '%K<2P$#6 ?20^9B(-%\RR#-G/5AOO/-;=80CB.S>I")3#4<?BO0T[5H&M
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MCH!?=*N0-M? JQG9')3+$J0EH>D[M(AS)ECHT(D:I&(KXV<0F&!EAX P!@#
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M-V6W+(KIC9VQOC:QK<AKOCA;H4D("::!EC_3_GK_ );_ /\ < UP!@# & ,
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MC'Q'5]=3FRIW8S%%9=.K8>-)J[I" J@FC?[.?8HCDD8E,_\ Q9O1)"*+19S
MYG",,5"+4!( C5 4B*O-OTU#.;KS0/M=4?8G4=?^0IA\<]66'#?RP:.=K-G\
MH,/V18*N/+'ISE2%%%"$2@F31ELF!_QMR5-H43R@3FG_  (&]F?FXZ)Y[J3M
MRM+LKNFYEVCRGT+2W.L.<8*"7QJEK.<.BTQSA7$Y<HV[O#U*V%&QM"%U<Y)'
MTTH.,=A)4Z- Y,NU1AZ8"POQ]]L7]:72O9'#O6;952F_.1%5:/.[%I5MDT<@
M-DP&UHPEDC&X%1&6O4F=H\]LH521,Z:_*!6C7;<"=)4J3XF:-4!^9KY&#(YV
MGU; UBI$Q<L^/3EA/<?4\J(CRJ1RUWL.;H=R^*QB,%HU&C4;=$*T9G>1NY"=
M$K<7]W=4#:3\5(1#&L YBH/,SP[?]I0VE*PF\X_+FUX(]S>FW*7U-8,.@]H$
ML$>52)Z;H3+9"R-[3(G%A2(UH7<M$?\ $@*FYP0I'!4K(^"$!1WR#^$-=,SC
MD3O2VNBX?4K?:],4@T7%S,FB,<D#-')LBE%FR#G]L#(VA;+'I>Z)VFYB(^C7
MA;7)L.5(%BI+H:,?P2L($FN4/,)U?)>,ZJ[ Z;:*M:VN.>1)5R%TO'85%75C
M2,E>RA(Q0M@FK.J<Y/(%#>[U_:$A:EK^5LU6CD,>.6("RFU042O !E#:^G6M
M_P">M8!K@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & 5:^9WERX.S/'3?'.M#,S7(+2GAU;F1MI>7UNC;<JU&K1ALI=?AWA
MV-(0)/@FAF7'%_#&!^&-  @OU,,#K='W^J_8]@XCCVV/**YS* UET[PM3M-4
MRT0\;*]V?%.G&6RGY.KC\;TE8BRH2BCJ,U46^.*1.E5B"M]AO)4F'[$:$KT%
M4'Y\07'5A<6TC?<%LN'1>&O4^[$Z"MJ.HHJM97!(KKJ9/R 4 /4',FO@$IQ+
M"A)2$M!VPG,Z4DE%LD@( EA ZYS_ ,>7A ?,#WSU[)V1J1T=?U'T7!:X?TDB
M;%3TO?X1'8HVR(E;'R#1N;24E4M*W2=6L) 2IT L9.Q:&'6 0KZ;\;O=/*?-
M]C5;XM+BZ+N^Q>F'9F8[5L'J/I=B=WVFZ\C")^&<"DU[RU1@,<E$Y/D9K2Z/
MI 7)4UMC<6J0 2.I;<X) /)C/&GVA9'CHK6@VKE>D.4+8XHZ0I;H[G.(H+J3
M66T7_(Z\"Y+9FNM6=MS<G,9YE-G!P.5JGU6G$G5.GP)(@M3/HL;>!U^<^'7L
M?J"H^ZNAK69*TIWLCIKI6@NC:MI!-.]3:%PU'S*W*&>)P.7V2UMR= L=Y@T.
MKVD/=VI$:UH%86I6H$F+5+4[8!9=XVN3NFF'JCMGR!=>P.(4O;/6PZJBL?HN
M&SQ'9Q%>0*IHHACB4]]G+8A;VAX>I"<WHE&RVLC1*4I(8:;LHQ9I*E @Q85#
MV.Y]@>?KDJ.MR9?8O?G&4#N'GC3PX)6A%*"B*ODU%/3/^.EY@$:0IAGKBC1+
M1*#"RVY L0J3] 3C :8![L^^/#HU1+?!<[-41C12#A>H)?#NA1E2AB(%''E[
MYTC=?IDS$5\,$<G3G3!O7D'J&?1Y82O^_F"^!-T/ *PJQ\!W68(]XMV^9-D?
MC::LG^?0?NJ/-TXCJY&]48U==K>I:U:$YR0\TN5@=7;105B%L&8I:EHV\PW0
M/BRCV /0[1X;ONH/&)-N([+8VEHMSMWR],JBKD#&_MLBWJ#S2TXI9/Y7''M1
MIP$06&$UO)GY[).V UH0HA&+?@?;#@&8>'7IK6OI^C6M?3Z^OT:_7Z^N_7_/
MUWO> :X P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & =.7UY!'2;1ZR7*'QQ=8,3:7M@C$U5,Z$Z4,+')1
MHC) SM+X,G;BA:WHUM;C7- 0H E6&H4AAY0QIRA! [C@# .K/$'ATAD,2EC]
M%V)XDT"5.RZ$OSDV)%KM$UK\U',3TKCRY048H:53JRJ%#2O/1#)-4MQYZ,T8
=B#C"Q =IP!@# & , 8 P!@# & , 8 P!@# /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>g68105g92o50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g92o50.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1C44&AO=&]S:&]P(#,N,  X0DE-! 0
M    &+B^8R@X0DE-! 0      $ < 5H  QLE1QP"   "@  < E  "')R,CDT
M,38U' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0)&C6/Q&MV21\,%=N<M2D0#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              J(   4'          $
M                     0             %!P   J(
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   J(     4F=H=&QO;F<
M  4'    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   *B     %)G:'1L;VYG   %!P    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 5 "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M]-KZ3#4][ Z/1]9E=SMOK[MW_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MLKXK0;:Y4V-+B8 #;(6I0!66F&E-^HV66<(PHT( )?8 P!@# & , 8 P!@#
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MDDDAA!9))1980@+**+"$LLL =   (0AUH.M:T!L&8 P!@# & , 8 P!@# &
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ME=7?UA. ; V , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MW:=5\\(%YO>?7T7X1Y6M+IZ6Q]7+$%?)&),VQ9$XI&8Z12>7R9GAT6:37A<
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MG"PMKQW:V::SB/+)[2,=/JL'!NQHY<-4\=SMLQ9RC-2\%&:34ODO:KEK7,D
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M#LM)MM-Z?PXYGU9]N_P,6Q59MRG-MXUDX^-+A-1<FWX.47<GK\M?WYMHXD&
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M;U^6\C7V79S@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M$')Q@O[12*5&*;DHQ4I?;22;_P";2[?_ %.XSY%0P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , JZ\C?;G2W(0ZC+H/B6V.J$LYF<7
M;Y4_U\C2/C;%F,V3HF^1L*II2/38]MTM=V55L^&/[@2;"B%X3A2)02E2':$!
M^GCGLCJSIZ\YDT6'PW:/)]"1FJ$3DV/]W'1T,\D]MJ9<6E,9FA-&)4[MID3*
MAXC%HS1M92TAV3C"<X?)4I4X@+/, 8 P#7Y^'M_=3Y"OYI75W]83@&P-@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , JD\R];S2U^+5L.AU=7/<*<^XZ0<Y[4E#.@V&>V95
MK-834Y6'#BI"2[LRE@;7.-IUABAU3*#3"%29"6(C1!QRE.!''Q)47S-5EIV8
M]T9X[>T^-GEVKI,W/,UZ:F+Q)XG+6PN3-IVHO&@.-X6D24_$KB .9AY;4V&[
M0(E18EWIL24SQ?'\7_@%].>@8 P#7Y^'M_=3Y"OYI75W]83@&P-@# & , 8
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M- V6\ 8 P#7Y^'M_=3Y"OYI75W]83@&P-@# & , 8 P!@# & , 8 P!@# &
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MA&>N@(7(?+OQ>KI.5W>LD-F,""&6Q'Z*>:RD=.6,S7F*X9>VH7J'U\V5"K8
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M# & , 8 P!@# & , 8 P!@# & :_/P]O[J?(5_-*ZN_K"< V!L 8 P!@# &
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M'C#K>@[P"-G(E-=N6!XY[!(XFM=OY#G%C]Y=+W#4LHM6K]+4FN<I9;,T<&A
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M59I:A&0!<X48 XHLXH6AEFE@,+&'?J$8# Z$ 0=_WZ$'>MZW_?K> ?> , 8
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MD2^(*83?*_G)V.:+2(:H^U/"N5Q$M(-&Z+XV?)4! 9$W-2TXL",\OZ;8%N6
M, 8 P!@# & , 8 P!@# & , 8 P!@# .!!"/6PBUH0=_GK?XZW_EO7]^O\L
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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& , 8!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>g68105g93j24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g93j24.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1I$4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &BB^9I8X0DE-! 0      $ < 5H  QLE1QP"   "@  < E  "')R,CDT
M,38U' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0)&C6/Q&MV21\,%=N<M2D0#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M         $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!7
M@           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M     %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C
M4FQT                4V-L(%5N=$8C4')C0%D            08W)O<%=H
M96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,
M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              3D   #)          $
M                     0              R0   3D
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   3D     4F=H=&QO;F<
M  #)    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   $Y     %)G:'1L;VYG    R0    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ H !G P$B  (1 0,1 ?_=  0 !__$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M 0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87
MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W
MAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B$P4R@9$4
MH;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B
M\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>W
MQ__:  P# 0 "$0,1 #\ ]522224CO+VT6.K!-@:XL#8DF/;MW0W_ #E@8]W6
M?3J]USK@3Z,L=LL,M];[2ZRNJQC*Z]WI>M]G_2?S7J_HET:22G-Z:_,=B6P7
MV.#OU=V4"QQ&UA?ZK=C7MVY'K,_FT?#R<FRZ['R6,;92&.FMQ((?N_?:SZ.Q
M6U2Q_P#E3,_J4_\ HU)3=226;UO(R**\84/LK]6_T[#0QEEFWT[K/T3+FO9]
M*MOYB2G23+/V]9LZ;0=S*LPL:<EN@.[;[A59%U-3]_[U.17_ -6JG4\;+LS:
M',JL>[;2,:P'2I[;?4S'W$':WU,;8W_AMEE'^$V6)3MIUAOIRK>LLR&56@N>
MQ[+W AK,<5/9?CO#OHV.R';O2V>_]#;_ (']%?Z119CX7HV;Y;;?!L<7O+3=
M:ZI[GN+G.WUECTE-U))))3__T/3;<[&JM])Y=OT$!CW#7CW,8YJL+G^OUY#L
MZDAIV;=M>TNFPN,645_HWMHNV?I/7W?^H]#J74GX3V-#&D.:7;GE_#-;(9CT
MY#_8WZ=C]C$E.@D@XF0W)QV7MB'C\T[AH8^E#?\ J49)2E2Q_P#E3,_J4_\
MHU752Q_^5,S^I3_Z-24E;GXCLQV$'_K#1);M<!PU^T6;?3<_8]K]F_>A/S,3
M)Q+[&MLMKK!WL#'L>Z!NV5[Q4YVY'^R4>MZ^S]+)=ND\EK:G']W^;8QJXKIW
MUV8_ZX7?5JKI;*,9]UN.75^VW=6';LFVIC6M]"QK/^V_TB(!*GH\>[IV1DMI
M;BO:RP -M<1M]0UMRO0VML<_=]GLW[\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M.8QX>7[?#'J=KJ>K_=C %7#6_P#@>,5;UKMG,W0V_1AMC/DB:TRMMEG$;@V
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M\\\D\GVX]_IS][C_ #O.@'II\^YY\GD\^?\ UY/]9X]] 5*0?_3Z?,?H/ST
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M0]? ; /D\\#@ @?U^/GQXY_K\^=:N>\5" "#R3QSQS]#_P"?X^Y X.@+] -
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M L*FOQBP[*B:JY<;;AREV9,5J$H.DI?5)4OTPPE#BU<_Q%)YXC<)O@(GOO\
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M8/\ ISPS^^=U-5T?S2"9X/(!^HYU06+<0VA2W%)0A(*E*40E*4I!42I2B$I
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M$TVK>"0;VHHZI.._EAMZ+*GV,VI:1,RB]-:^NM%S;+]4Q2HEGUE%W0$R- -
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M!<6Q6;*QJJJ+#E2^]7>?6=:;2I0*_O$<@$DDC0'?4HX/)//CCGY\?+]'ZO\
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M,F\L2[)5WN)^,E$N>B%DE"#P1R0? &G??J#)>@&@&@&@&@*'GY>_!X]N.?'
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MJVKAI4XXI#+?)+CKSQ+K\A]Q3C\A]PEQQYU1*B- =ST T T T T T T T T
MT T T T T T T T T T T T!3D?7Y\?K^F@(D=8V^\_979_);C#;:F;SMI,$
M18S[L*QLZ>IE2FX]EE+>,J=5-N(]*PY\2[':BO-K'EQ)0E6@[[]R!M1;V&_>
M0XCL%U076&[TT&XM2]F^PW4+M@F)CN0TE[3MMR'6I<:B<0K'[JN]1!8EPD-,
M*'JQ931)4G0F>#7PU]G[9^IM@VPP%.WV-5M-)M'LENF(;$2VRZQ8B-WF1+B)
M+3$RYDQ6&?CIB60AI;[@[E]G>1SR2+[F2M - - - - - - - - - - - - -
M - - - - - - - - 8?WNWFQ+8C ;+/<N18R8,63#KX=33153KJ]N+)]$>!3
MU,)!"Y4V8ZKA+:/(;0XH\!/.@-#FY$W ]Z,EW)WKRK;K=+.-OMRWFHF%9EBM
M98(W9V!SW&J\P'\.R'$&G>&:QZ<D/Q5DEN4P\KXELH4D@->\^GW_ "S91T*=
M+6&[>81BVZ]]MW&QO>.^I5-W,M2I27&X\@A3<E%0\X8E+8V+(0]9L0VFDB2I
M2>#QH#8N@$$\\\D GZ?@."/?ZD>YY_'0')H!H!H!H!H!H!H!H!H!H!H!H!H!
MH!H!H!H!H!H!H!H#XV0WU1B]';9'?6$>KI:.!+M+6QE.):CPH$)AQ^5(><40
M$H::;4LGWY3XY/C0=^A _;_JYV^ZD]C[_>?"\"7N SB6X<VMP?$4I:=R*58U
M%R*2IR*1720EZF]8O2I[4A]L>G6\R&R2M' 'Y,$Z8=V(/53FV[=AF#>,[+WH
MH<SKMN:)THFV6XTBG3!R9S)'$<,NUT8H0F$E"29"RIQ9Y2-2%,Z\1WWW^]AS
M?@@#GCR/;SXYY!)\D\^20/H-4'-H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H
M!H!H!H!H"QP@())  X))(  ^:B3R/NCE7M\M :R?M',OW0E;19'M_MSLGN3N
M6Q<TL>^B7^"1J^YJ7[JANX]E'PO(:IN:+255Y"(2JZR#,1;7PLIQ#J@A1Y#A
MWCI'EB?#V VVVFW_ )6WG4]L'9W.Q&Y%.:G'][<&J:XT\6UE4\!N+<X+N#AL
MIM#$6YJI!4B':M,-S4LLL]SSS;J5)$42WC.7+O%?IS.T]K[OW#[@?CYX)'/G
MR$D@\$GE1)/GY"G-H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H#
MAD-I>:6RM)4VZA;;@!()0M"@H CR"02!X]^!R"00!K)RW9_J]Z<KK(9/2E<P
MMW]O]Q;:49&W&[^33$SMI<BOI"TG+\0R5]+[MEA=>_*%A<X?.69A98<;I76R
M"AQWWQ'+CKPSQ^W#EPG_ +>8I)Q?'X"+I--+S*=!@/YKD%/4QJAO(LA1$:9F
MV;D>,@%1<<;4EOU5K4VREM*2 2D!QYG?= - - - - - - - - - - - ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>g68105g94u40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g94u40.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1JZ4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &IZ^:!0X0DE-! 0      $ < 5H  QLE1QP"   "#_X< E  "%)2,3$W
M-3<R' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0&G!ODR*)@U?L\1S+%R=>!SA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8             !$    ;)          $
M                     0             &R0  !$
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P  !$      4F=H=&QO;F<
M  ;)    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   1      %)G:'1L;VYG   &R0    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 9 "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M:*HDMW_Z-)36ZOTWKM^<W+Z9GC&:RK8VAX)87GU=UKV^YCOI4[=U?_I.ZO\
M8/KBRW97U"DTDN.\L!<WZ;]6O8_=N=8UC*]_Z+TOI_X&W6BXB?M%FOE7_P"D
M4HN_[D6?=7_Z124YG[-^M5M31?U.MEK;:WM=2S:-@J?5?6YKF_I-^0]MWO\
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M_I?3]#V*_.;_ -RC_P!MM_O2G-_[E'_MMO\ >DIS[^D_6AU3Z:>KM#7DRXU
M/#7>MOVV-]S?I8WI;-GH_IO^!6^.%GSF?]RC_P!MM_O3SF?]RC_VVW^])3H)
M+/G,_P"Y1_[;;_>E5;E,RJ6/N]5EI<"TL#8AN\$%I24__]#U1P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M"+RPTS3])M-\LS>I&CY25<Q=2CG,G*LHM-9^T8JRGB6YTT6SI^T(*XE(LLB
MB8/$I**;>B[PDY-):O0Y'4^Z:=MK4&K-TQC@]?JNW:+3;]6&]H6CXN42C+M
M,+%%,9!,KU=F64(SD$4W+=H\=IE<%5*BLLF!5!]RBX2<9?*BVGYGFN&FGK/*
M=U=:,E%Q(L&A3'=/&K<A45'!CKN$D2E02+X2JYC*'*!44RB!CJCT3(4>IC '
M4<@D\596+18>=%I%BE&>)(X\X*NVY&((*  D7%V90&X(F 0$JOC/ , @(&'J
M&-,GKR!["2#!1H#]-ZT48BB+@'I'")F@H 43BL#@#^)%("@)A4\/P  !$3=
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M%)XM14Y$DSB/@G4.5,HB<P *^=N/+T_2#Z ?,A0,Y!XU%L01 [@'"7B2" @
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MDT'+A$BY5"IK*D IS=)Q<)2@[-Q;B[:767',\1>]%2TNKV)"SR2, 8 P!@#
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M^T[*NDDI2<+):**E\99Z7:2TSOH[//NN[#R,;LZERQDM>7&%L'':=WN@ZT]
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MRWJ^+E)6LW&\=U.RR4<K)NUM"0]VZ#V[6.9E^[(FEP5D9<7.;')S6G,TUCB
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MRQ7:=>JUFG4EZV5Z7V.&5O)63+49Q/8P!@# & , 8 P!@# & , 8 P!@# &
M?G)M][N/9H]J!R_Y%;6T7NO:'&SFW3M,25<VSI+7DMM!]KN\:FJ?P2>T*XP,
M&524CFTP .I..>B*+8Z1XDC--\8LN,1%-J-.I2:S==UHRMFTU\F_)2;MEHO.
M>IJ[IS4ODP=-PO:V=][7.^C6J>;1 -5X5;5[1"O=K)RDM&HKQH!/EFCIYUQ
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M/OQ;TY ]@  >KN^^/3\']?R8!G & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M_BI;S_H7@FSZN]>T?5YZU^*'EI_%2WG_ $+P+/J[U[1]7GK7XH>6G\5+>?\
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MHF.HHH80*0A"@)CG,(%*4!$1  $< ^-25C$G31BJ_9I/GZ:JS)DHY1*[=I(
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M# & , J5O?[.?%K[K[=^C1]@B6C['ZB1<$GRO0$63P  1$6K@   ZB/]A/W
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M@W, >[X04X>_[]$''BN?XTVE_.8?^[#Q&N.V]LO_ )Z/TX=L>B=_\;^YA_\
MU!3_ .@F/%<_QIM+^<PZ_P#\Q#V)=_;O;7]/7T4%ZAZ*)#XX-S?P@I_]!._[
M_4,>*Y_C3:7\YA_[L/$:ROMK;/7?'1;[^@?K8]%$AU$?3#N?O]?^^"G=_P""
MA^WVX\5S_&FTOYS#_P!V)\1Q_'6V>K]_1R_Z?U6'HH?_ !O[F_A!4/Z"X\5U
M/QIM+^<P_P#=B/$?^V]M/_GDUYTZ/M'HHD/5Z8=SB ^P;!3_ .@G7\N/%<_Q
MIM+^<P_]V'B-?CK;*?/PZ/HMA[KO0]%$A\<&Y^GN^$%/Z?/]8G7K\PX\5U+6
M\:;2MK]DP_\ =AXC7X[VTWP?AROWNA?TH>BB0^.#<W3W?""G_G^ G4/O#_+C
MQ7/\:;2_G,-].%:[TQXC5OMWME/JQT5;NH>ICT4/_C?W-_""H?T%QXKG^--I
M?SF'_NR'B/\ VYMK^G__  CT4/\ XW]S?P@I_P#07'BN?XTVE_.8?^[#Q'_M
MO;2ZO#DO51L/10_^-_<W\(*A_07'BN?XTVGYZF&^C"I>@>(_]N;:_IW_ ,(]
M%$A\<&YOX04_\WP$Z?D^?'BN?XTVGYJF&^G"OT6'B-7^W>V4OSY>FU!7\Z'H
MHD/7Z8-S=??\(*?][_R$Z?DQXKJ?C3:7\YA_[L/$:O\ ;O;27+PY6?/+H+>C
MO,>BM^ CUW#N<1^6?I_Y@H?3[^/%=3+^%-IJW*IADWY_!7YN0>PKZ;9VXNS&
MT\^_#/Z#C64-,U'8E08!?[W9XV>A[<9]'6Q_ /FA%8D(%5DZ;#%UJ&<HN$S/
M'!#&%PHFH142F2$P%,'BG0JX3'82'AV+KTZU/%=)3Q+HRBW3C2<'%TZ%.47%
MR;^59\4^%>GAZ^SMK[.HPVAM'%4L71Q[K4\97IU8IT(4)4I4U&C2M).4KMMW
M4GD38/K]?7Y<V3Z;N\VGHR[LC& , 8 P"->,/VQ/,K[N:)^AV(P"]6 , 8 P
M"I6]_LY\6ONOMWZ-'V"):/L?J)%P2, =>O\ 7[W\F+\.7T@C+67^!L#V_P!U
M6\__ %Z/YO5FMM6R> LK?P;A+Y<=S/MMI<X4-:V=[UIOOD[^G+S$FYDG<8!I
M['Z_K1^Y>F__ %MJRC3^V&*_-\-_6K&91^VF,_-L-_:5S<,O&F, 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8!J7%CZU]G?OA=[_2)+X!9W & , 8 P!T ?
M6 #@&.@>X/9[/=ZOP>S .N.A_;)\R/W<ZF^AZO9'%]B]<@3[D@8 P!A*[LM7
MD@1!MVJ7&Q$U]+49O7'TY1=@L+@$;:):0@XR29HP%B@W+4).,AI]RU<E"=*Y
M1'S8NFJ+<R1C)>'X8;6Q\9@\-X;2QKJPHXW"3PRJ8>/2SIRE4ISO*,G%-14'
M'5*[Y%7%4JT^AG1<-^E5WW&=U&2LU:ZS3SY'&^?.2'J]&^G>O3I]ENW^L/8'
M740^SN#J'7KT]6='A_@YDHX[:5UFKX2C%/-W3;K+AIPR2/&]C]71PSZNDJ>;
M[GKST[3FM9W>W6B1OD#=JS 5J<H\Y$Q9R5NROK/&2+68KL=/MG9'DC7*RY;K
MI^7*-%FPL%" *!52+F\8)2<=J8'"86E@<1@J]:O1QM*=1.O3C2E%PJ.#2C&4
MX[MU=-2SSNLCWAJ]2K*M"K"$)T9J#W)2E%[T5)-.6>CM>_ E?,<M# & , 8
MP!@# & , 8 P!@# (UL/V3=;?<?8'WO[#6/^[,^NK[1V=U4L?ES^+H^K4Q,;
M?QWL:SM\1M._6MW"9>_(DK- VQ@# & , C7C#]L3S*]WGS1/T.Q'3^7 +U8
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M9</63-F'T=3[W/\ 1E["]=<UWH8Z.I][G^C+V"ZYKO0_)\H^H/GQT=3[W/\
M0E[ Y16;:[T.[V" _-_7Y!SS*,HNTHN+Y233])-T]'<9 & , 8 P!@# & ,
M8!&MA^R=K;[C[!_Z&L90K?;'9_Y+'_V=$Q,;]N]C?D-I^K"$E9?-L8 P!@#
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M[>WEP(<8- E_P=90P![@?V$ _!YYZ9W_ '4[>6:Q\N7V.BO52//@&%^])_\
M%/Z)(S]3#H+KU]&4-U_^/L/\\Y'[J=OWOX=+E\BD\O/2S['D/ <)]Y7Z53ZQ
MX_4O: $>HZQA.O7VO[#[?7ZIG\V3^ZG;N?[_ )?S6'_[5B'L_!O)T5YI3NNS
MRG8US2M3K]%W#R%JU1CAA:VU)J"1;0R3Z1=,&C^2J4R,BX9HR#QYY*=\+1J9
MUY.*95SH)J*%%0/"RSMO%5\;LC8>*Q515<14>.C.KT<(2DHUO(C+<BDU"/R>
M5WKJ^.$IPHXG%TZ:<81Z!I;S:O)+>>;;U:[]+%G<^6-(8 P!@# & , 8 P!@
M$:V'[)VMON/L'_H:QE"M]L=G_DL?_9T3$QOV[V-^0VGZL(25E\VQ@# & , C
M7C#]L3S*^[FB?H=B, O5@'57VHFP=_:7H=-V?H_8F_VDB^LC:@)ZLTC4-!RR
M4[(/HRPVMS;K5:MSZXO1JS'P\%6)%@W!B9-O*2SF&AD62DG+(+8!8?L]]O6;
M?'#K2.W+A*V><L5U@)N3?RUQ;UEO8WQ6]PL<:S7D!I=/H=0=%,P8M08R-9K#
M*"E(\&LE%.YEDZ1FY "Q?I;U9YCGK-Z2:%\&ZM++P%GL'PPKOF2N3K5=%LYA
M)Z5\Y>0Q$NW<N6[=:-D%V[Q)==%)1$JBJ93 0/O)9-?>/%A5(Y%$CRFVU"*$
M,!B'(?6;XQ3D.41*8IBB!BB B @/4.H=^"'H^QDE8)& ,+-I<P0VV?V&K778
MBYJ%;)R.L$K 2,9)P0UE1HLBUJ<)%.$SDD;'&NT5T'K!PF=-1J4IB^ HF<Y#
M .;$J=#$X3!)8W#4JE*G4A4I59R4XMUJDU>T7%K=E'-/5VYE9;U.I5?1S<92
M4XR2WON(P::R;ONMW[S8F.P@7G8> E*;<:XYGCOTHQW,H0(L5UXY@M).&YE8
MF>E%D51:-UE$Q5;$2.*8D%4IA*4W">S[4*U>GBL+75#H]^G3G)S4:D]Q22E&
M*:4LGG?/2UVO:JMSC'=DMY2LY1W5>.>E[Z=:7TR%W>S,Y9^_L.PP#2%?LE,O
MW"2'^L4?E)_;"'YI/^U11:7C.&7_ -/J_K6'-WRZ7A@# & , 8 P!@# & ,
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M(>[+YMC & , >O (VXP_;$<RODG=$_ET[$?HP"]. =6':C[1^#FK(.F5>Y[
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MMEK3ETK-:7DM;9^8MECGDYR%KDB26F[D_L,F^ T#$-/*'2@QK!M&BT3*!:3
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M35GXZX1$VFYC+]:XN0:2T5?]K;ON4:_82#-TP=,;!M&UOFJK8R)EXY,J<-'
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MWJ'7IU[_ %?]WO\ EZ>KVX!UQ4,>O)7F3\EYU+^73U>_[,CCYE]/[03]D@8
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M94QKM0;X*=*_9TM-_03(/K'Y1Z_AS&DK-]OG74^OF6EHNQ>_ QD$C & , 8
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M/*G*E3Z13WU5J.6\VTU9<];$V#Z_?_7YQS:-XQ@# (UXP_;$\RONYHKZ'8C
M+U8!@2E-_A%*/S@ _GP#/0 ]0=, 8!4K>_V<^+7W7V[]&C[!$M'V/U$BX)&
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M677IUF]9=UL^:378\UZ#1NGFFFGHU>S[TGWI# & , 8 P!@# & , 8 P!@#
M& , U+BQ]:^SOWPN]_I$E\ L[@# & , J+L'@;Q%VKMI#>.P-$T>S;-3>P4B
M]L#]DX\389&J@D%4DK=!HND8"XR56\G:FK;^T1DN[@E&C12*5:*-6YDP+<@4
M   Z!W  ?)W!T[@]0?>P!T#W!^ , ZXZ']LGS(_=SJ;Z'J]D<7V+UL$^Y(&
M, 8 P!@# & , 8 P!@$(<DD&[G16RTG**2Z?F BP)KIE53!5K),'3=7P#@)?
M&(.447")^GA)K))J$$#D*(;GP;EN[:P+3:>_42Z[T:B:?4XMWM9]94Q_S6KP
MMNO_ -<2<#>L?G]_7^O]?FS%G\N?7.3Y7S>9:6:78C&>21@# & , 8 P!ZL
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MBRY+N0LN2[D:/LX3&US? $1'_>=9/6/7U1#P?;^'*N.^9XA?ZJ677P*>T$O
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M'8/)25BMH1\;'-EGD@_=Z?V:@U9-&Z9E7#IRL>K^ DW02*9590W0I$R&,(@
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M&WG2E&-*G5WO+;FI/I.+M96LKJV_9=-@8!&O&'[8GF5]W-$_0[$8!>K & ,
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MW<T5]#L1@%ZL 8 P!@%2M[_9SXM?=?;OT:/L$2T?8_42+@D8 P!@# & , 8
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M@B6C['ZB1L$C & , 8 P!@# & , 8!%>R0_MYI?Y-L__ /,=EYI[/^P[3?\
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M=>6M3:C%>DT:Q;#>UZTU^FIS55395.LVB(=UB&+*L:U//?W]V#?9_7&R*KR
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M0?XU:7_/. /JW.''LY2Z#_&K2P__ )@< \#\X.&J8%$_*?0!/",4@>'M>E%
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M[OZ^OU8!GJ'O#W>OV^[ 'A![_9UZ"( /3N]G7N]8!W]._%_>S]WY@9QJ!@#
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M.JK#5:7=)[2ZCWT@U9"6EQ0=HS,0V8JNDW7FQ2N.S=8M"?-/HNHAL!S':_\
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M(+SF]1C8WSS*L8SSA(N# 1NP8^6KH>5O5SF*5%JW\8NJ8P%(F81 , YKU^K
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M1I+5 QLS'/IJM&F4%W406P1;5RJ^AC2K9LY<1I9%!N+Y!NLLV\:FDH8H&P8
MP!@# & <(PLU<E9B>KT7/PLC/U4\:E9X1A*L7DO7%)ED63B$YV-;KJ/(A24C
MCDD(XD@BW,^9&*[:@J@(*8 D;+78B4@(.5GH:,FK6Y?,JO$2$HQ92EC>1<<X
MF))I Q[E=-W,.8^):.I1\A'HN56D<V</G!4VR*BI0.;P!@# & , 8 P!@# &
M , 8 P!@# (;VIL#9=)=5Q#7^B;/N-"6.[+-/*]<]=5-*K$049$;*/DKU8X%
M>2!Z1PZ53+#IO3(E8*E< F==J577V7@-FXV.(>T-N8;8\J2AT,,1@MI8MXK>
M4W)0> PV(C2Z-Q@GTSAO=(G&ZC-JMB*U>DX=#A*F)WF]]PJT*?1I6LWTU2&]
MO7=E&]MUWM=7C!SO+D.DC,J-^%>QG:K"8;,(Q FW=!HFG8Q8)85YULHO?TTF
M+9H+&. [&1,WDE1FFXHMC@S?BWTX[%^#SE14OAEL^"J495*DGLC;[5"JG2W:
M$E'9[<Y2WZC4Z:E370RO);\+UWB\;:=MEUVXS48KPG!K?CY5YKXZR2M')V?E
MZ7C*WU+[LY )+3J:/#?83E*,BF;Z(7)MC129;'(.'<,@ZAFA%;X12/<,&TA)
MOE7<J5HQ72@7*+9=5P]C4G/F.QM@-4'+X88"+J5:D*J\4;=?@].,*TH5IM8"
MU2-25.E!0I;\XNO%RBHPJ.,^%8SR[;,K>3%2C^^<(M^3<$X+XZ\7%2D[RLGN
M-)W<4_67=W((SAHD;AGL,B*]?>2CAT.V=$"1G,MXV0>-:RHF%]\:J\?OFK**
M3D42'B4%Y-%RX=ILVSM9(]C; W92_=A@&XXB%*,%LG;MYT95*<)8E/P"RA3A
M*=5TV^E:IN,8N<H)O"L;=+Q77LX.3?A.#LI)2:I_9\VVHQWODK>NW9.V6&[N
M03IQ6TGG#/8<:C+R)6DXY6VSHARG5&1GR+891ZFTOJJLH@5HHK(BVA2/7GBF
MYFX(BZ432,J;&V!".)</AA@*KHT]^A&.R-O1>*GN2ET4'/ 15)[RC3WJSA"\
MMZ^ZFQ'%8QN">S*T=Z5IMXG"-4XW2WG:LW)6;=H7=E97>1\([WY&!#@_^HCV
M0,D,F9F,&&X./_E)6)6I%BRPO?2#YO% [@QF8-2N!>@H053(@@)5!Z>)/@[T
MNY^[39_1]%O]-XGV_N[^];HMSQ?TBEN^5O..Y;+>N>?"\;NW\55][>MN>$X/
MY-K[V]T]M7:VO'1,]LKO3D2R=S*##A3L:8;1\JHRBWS?;V@FJ<]'D6>)DF6R
M+W8"+A@W52;M5RLY)-N_*5^DF9N"B#DJ<4MB?!Z<:,JGPSV?1E4I*=6$MC[?
MFZ%1J#=&4H;/<9R3E);]-RIO<;4K2BW,L7C4YI;+K249-1:Q.#6_&[M))UKI
M-).TK2SM:Z93GB-8GD]S#[1IIO",BZKR-<6C6;K5,#L$8Z66B.([[15"5J#&
MH&1?D;SE"C-S'V^ELE2GR0P[C8)I5.4D =&BSD^8K1A3K5J=*JJ]*G5J0IUX
MPG3C7A&;C"K&%51JPC4BE-1J0C.*DE**::+\'*4(2E!TY2C%R@VI.$FDW!RB
MW&3B[IN+:=KIM%)C=H+?J[PFH6U]*/Z+I23A^,#+?<;QLH53@)6DT^ E.3#>
MA1#N>O%\$CA[19Z.BK/2J[2-;5B$L#.3D7+M%_!Q,9 NT.9Z-^NG(5]HGF-R
MZ@(*]UK3T'OGF_QVUC:MPR\K5J[&4@7W9UQ%YK_@66WT;8]'K\[>;M4(*K1L
MM<:78(Q^I).H9NV0G9>*E8Y[^_\ AGY@3+6.56U)/8=5T=M/FYI?5]]I_'71
M^X8K8U0JE&F]9<KY:;W7M&D[/-!QMT2CI2?@TZYKNHU]*(T].TR<C;CLX]@C
M'DM!GJD*H!I%:W-N"%B*N_DMOR]N?3_;77SC_*(7J UI/F1UA';'V35H&'AB
M*4IJO5WD=!U>"3B):!-'2#$C=4T<LW*]="L!]VM^7?*>+?:$GE+A,\CI'97(
MWM)M$FTPTB]&T!>ZQW&2[;])J-2OVA6&IC2&OQHS4L/!R4K+VN-I$E%2[MU(
MP"$L1&=P#G>5CC<4I3;=R5V?I=G N-I\1-J\5VW"?8-\KUHVF.UK3=91Q0AU
M1(ZF:[2I%XG]OH#",[)$L9.(/7HB%JEBF+ T:U>>0B@+;;,?<F--\+=(0-=G
MD[7R*AX/1%(O"K6TZ^@KMLN<C(F%0VI'ZML6WHN7UFOM&RHQ-B>U1*^Q_F.;
M< X9K/8A\\:2S$#JULO,7=+B@<Z.0&K^2>STW&NNSBXQ[CU839.OM3P9X?8"
M]TY70]T4L.M!J+J :3C^7ULWC+6C$OW;)R]3=DAY9:!95-*' ESD!R@Y7Z85
MYMPD%R#E)^^<-](Z>Y":LK5LUOJ%JGRF;[3MM^E)>J2<?"4B.E%Z6U^#T/Q_
MH)]8/ZS<F-T.I,6JT6^8EXV.3 W5QRFY&1&X-GJO-S.5*Q1>U-XY\5HW7#^H
MZM)%J:GWMH+CY;[%6IR:8U!M:W4Q5;?MJ=>U*<C9Z+E4UHANPL:]G8&5:$>?
M37]H)*X9\C-[;YW#2E[#NJAS=2:T'D &WM?UF;TI(QI=FU[=K"O:B<:I&OH.
M]G26O%-:!:9&<D;"\!8%FU'4DW;.;?6"&7 ]>[^1^ZZ9R3V=KJ5OMRJU!LS&
MWU305DU=':4NM+87V!XF2>W)/7&WX^<K,CMW6F[FDE%SNW*78'GPCT];-:-Z
MU7'<7&V1XN:6 JN[YF[BU9Q5XXS53WT\MMWKO$OL[MFWFKS]9HC]P\^J"W-5
MZ#8;#LJ]S:1).?:7JNH6JJ4VOZ^AVEO@Y>NS-PNMK6-+0;@QY DAER)WR.US
MTN"W,E66%C[86^\69E]$:^T\62D]1'X8CMZ.9++*T<Z+JWP=JA&:<3<GR#Z7
M=,Q1CK)\(HYLT8) 1N?F!R&D*-K2T*[?CU+<SX^]L "MO5H.HG$L[MG"_<J=
M%U?> ,I2Q:1<E,04,V4V! 02$32[$Z(5PE7(P&K0&X$B3',GD+KTUGCI7=$)
M9D'O&KLTM].)RUQNI*A(5$_)3D-=-3[WC-=*>9JW572SZF5=K):UB]D.+"$=
M=WY4WT_(1#QK$H =D7#2W[$O6O[Q9=@;/AMHMG6Y-F-=<2\4\UN^>LM2LI]5
M/7;*VJ:O8LZVA<E:^9M(R[7PSR"31[&&EF4-+JR$0S MY@# & , 8!IMLL%E
M@S1P5ZBRET!V=<KTT;,UZ)\UE3% $CKA/2+ 7(. 55$A6GCC$!N<% *)T@/C
M[5VAM+ RPRV?L+%;:5:4U7EAL;LW"+"*+IJ,JGC#%8=U%44YN*H*HX]%+?W=
MZ&]PKU:U/<Z+#3Q&]?>W*E&GN6M9OI:D-Z]W\F[23OP3UA:\[#3*^%+2MC7,
MW>)H-"DMU"(,BU.+KPWZ1E+ 4K9-($6XF0=BBY-Y8F":9A17\7EU-N?"&,<0
MX? K:51TJ\:=&*VO\'HO$T6ZN]B(.6TDJ<(;E)NG5W*TNGCNP>Y4W>#Q.+6_
M;9]5[LDHI8C"^7%[UYJ]562LLI6D]Y663MYJW?8!#OBDTU8E2-F:#AJH6UT4
MH2#I4[,JS!(IIX#H*MBN'2AUW0)-E 8*E25.9=J"WJ6V]OQEB%'X&[2FJ5&G
M4HR6U=@)8FK.5%3H04MHITY4HU*LY5*RA2DL/)0G)U*2E/A&*O)+ 5'NQ4HO
MPC#+?DW&\%>JFG'>E=RM'R'9N\;X+>-@F.@!M,6(A%8]PZ64&V4,?)GJ2+I1
M&,.0)\3J+.5$6Z!'*13LTSO$SJK$227.G"VW\(&Z=_@9M)*6&J5IR\;?!]]%
M7A"K*&%<?&.]*=6<*=.-6"=&+K1E.<8PJ.)8C%-Q7@%5)P<FW7PODR2DU3:Z
M;5M1CO*\%O)N5E*QO>-@JFC06TQ8FP/'0H/C'MM$4");@JD0'C@$9XXNDQ3.
MHL"+$%W %0,04_&'2*=3VY\()O"JI\#-I4E6JN&(;VML":P=-3C'IJFYM%NL
MG%RFH8=5*EH..[>4;EB,4W"^SZL=Z5I/I\*^C5TMYVJ^4K-NT=YV3RNTGZ O
MFQQ:&7]"%E\I!T"(,1N&OP4,W%(QQ> L-A\G\ J@ B*(J>4"8P'!,4P$P>%M
M[X1NBZG[B-J*JJRIJ@]L?!W?=)P<G7W_ !GT6ZI?%]'O])=[V[NYD/$XO=OX
MNK;V];=\(PGR;-[]^FM:]E;Y5WI97/)U>]BHJO2-])V-XFW<BBU63M]!1+((
M HJ4':1'%@3403$A$U 2=%27Z+%**8&*H!?57;GPBA*NJ?P*VE5C3K='1FMK
M_!^"Q-/>J+IX1GM%2I1M&,MRLH5+5(IQ34DIEB<4G.VSZLE%VBU7PJZ17?E+
M>K+=2LG:6Z[25E=-+KJXMSBLMSE[1^.W4VBH'?8RVHU=(1U[*T? VXB.-'4P
M\&2B$.\0\\4MEO0^X!VB-4?!'GO"AV\V]36"%,E]-0J5*M"E4JT98:K4IPG4
MP\Y4YSH3E%.=*<Z4ITIRIR;BYTYRIR:O"4HM-VXMN,7*+A)QBY0;4G%M)N+<
M6XMQ>3:;3:R91MUV@=]K/"2L[6TF_H>D)>O\8[YOR*XY:_J5?EZ76XN-Y,(T
M.(F)^ZWTQ#.*#8/-=JJ</1=<UF&L19.R'692,'%0,5((]CT2#?N0[_0_,OEM
M&PEXK6I(7>W,'B=JNX[>EY2LU^,H"$OP&F;O!/1L=KI.Q:57YBZWFEUFD1LQ
M<:58(ARO8E(Q-NA,R47)L )?KW*O:CV_5/1FTN;^E]7WBK\;]6;F@]K5*K4.
M=UGRGFI#?&TZ%L9".C[HA&.IZ(AJKKND0S^%T_+T><3M^UEI^%D%H%*K1!P-
M+B=S;?@XE.3D-O2UL>RO;8+Z#?-+U7]:3Y&VKD]BOJG%0,,BO26ZU9<,8"-B
M@AYB#%A+1YV0/(UTV7>2"SL#D:#RXY20\EHN>4N\QR%?;$Y8=HYQW]##6)T?
M1%+K#<;Y#DE):C+"6A2%I[>'V&9+3%?K[F9E;9$T=_$33US,P"<J1*P !L_*
M!]M^1JLWR?VOI1G6RWCB?N;B\KPGV-?*Y;-FOMD76YIN:$?4[_4;7:U,O=EV
M^C'14).5MD\BUXR*;UB:DYUFC69UFV G'<-EY#<<.$_#Y@ZV@I%;MC]F\!-'
M;<MJT;7+82VK[$VIJ;3NW2.C6B-DB+K2K>R3\BVFX\[*6))(M9!-\"0N45SR
M_8"L\1RTY*4^ZU<)#;<MM2.B>THY \-W=+D*AJJ,=;"UU6^-NVMV4QQ)/ZI2
M(*1;;0AK95Z[6(R5JRE<K<E7TBM)VF2T\\<3RP$*'[2/D[1=,ZRW^UNL-NR#
MWEV<FUN5EL@'-*K3.&XQ;>H%MTY J @G38Z!LCK4\ YVS:8&SU78<Q8+N#S4
M,FNE<VKE&R-T0.#6Y%NM"\Q^0\7!\G*[-PN_-J\'=;67DU8Y/35>^!\//\:.
M3UZKKMW9:]JZ>T_%R-JO%1J5&KUBL6JY&+/'W&,@W2+BPNXVSF M;6]Q<H93
M<VEM>VWFK2&]?9<+]F<@]G7K4>N]:6>AWR<TER U_5%YZ-?6&GN9=&K6^@3,
MQ'7Q.K"Q0\Y ^D]<N:R5&.5*!3K8'-KDG:?2MK='?5B6KC33O90[KK=\BZSJ
MNGVM^7DGRR9:LVP5M&P,/.$K.O\ 85*19VF%J5BD):]5>.D$6LU8DVLA)0)
M.P757)O:NT.6=EIL?R)U-7HS4G(V[:4OW&>WR-6](]MU[':P3F*1>*C68[7,
M9?\ X8VA^K$;6;7!O?'NJW6N'ME@BTQF_A L$>!(^^]\[3UURWUW4WMFN$)H
M2X'TYKYK-:Q:Z>MR55W!LFW7.(9Q&^J;;X)WM> K&R&R-7A=6;)US(O*Q"VE
MA--KY >;^KU0#JUAN<F_-8\":WL&'Y'2UNW-6^,FX>1ECKEGJ.NY*2?2$?R:
M2JD;8K];IE@P;%H\@5I8J)'4"E5\EW<35@6=M9^!A(.%\T@6PW!R0WA4]O<K
MXBD[6C:L%1YH]F)K"!>I4+5SYX>@\F)34=9V+6YIZZJ_G"Q$+'WF87KDQ*/E
MK%!E8L&S*8(P;N4'(&*7R,W9/\D=7:GG]NA/LH+F9S?X^KV62I.GS7![6:!Q
MA<;6H4XJ]94)E'0EMJ<A/%ACO*Q$P$;8Z^P:M;7#S!G<FJ_ @>E<\>6D;H75
M^Q)'==4NEQVWV4FU>6"A+Y7=7TZI5G<6LK]HZLL)2NKP,%6P1;S\/MB:1?0E
MOFY6NN[9#UWR'X,12\JR5 [7^'&PMA;*E>04_8MM1NS]:H[+@&6BR@_U(]MD
M)13:QI+VPI7LFIF+9@SEU-I.K\RA4Y=1.27J<5".SL2E6"4E@+OX P!@# &
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7-=!%^C&I,V#4"]V , 8 P!@# & ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>g68105g94x67.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g94x67.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[14N4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %1*^4Y0X0DE-! 0      $ < 5H  QLE1QP"   "@  < E  "')R,CDT
M,38U' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0)&C6/Q&MV21\,%=N<M2D0#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              +P   &_          $
M                     0             !OP   +P
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   +P     4F=H=&QO;F<
M  &_    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   "\     %)G:'1L;VYG   !OP    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M     #A"24T$$0       0$ .$))3004       $    !#A"24T$#      *
MM     $   "@    0P   >   'V@   *F  8  '_V/_M  Q!9&]B95]#30 "
M_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3
M%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-
M#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,_\  $0@ 0P"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M\K,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! ?_  !$( , !R0,!$0 "$0$#$0'_Q  >  $  0,% 0
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M2#Q__@*PR/M^M98/]5HNBA2[YT1-!V^8-!]']@HB41*(E$2B)1$HB41*(J
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M+>+Z2.%CTDF:/&3D&V1;ID2;H(608B"2*90(FFF5(W0FFF0H$(F4 *0H 4H
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M ! ?,?,! 0,/?N;8 /4/?8;WOO0 -% 5^/U)Y)]YYOGJAYZD_4_?R513(("
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M/H$1'_4$V#T-I\J^_L?):J(MI0QP, %$-#K8=NKOO8@ ]Q'R /(/MA'YH[_
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M#0-T-!Y?O2?Y/M?91$]5;=]((AL-=DDP[?\ X_0/T@'NI0\NO7WHGAII@!"
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MKGGER#E)E]<C-6-C<988.S;E@[DE(1(R9G5FJJ=:Z$>FNH/6(BHH< $""(#
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M;XD;)-IL![0X _->B2;(H)$11(1))-,J1$TRE3(1,@:*0A"@!2E*712E*
M=@"L5D\DDGN3U)7L  4  .P'0?!;]%*41*(E$2B)1$HB41*(E$2B)1$HB41*
M(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$5##HH
MB ;$ \J'W>[\^?P1; ."B'F&P'1M#L 'O[O+R =#W#>A^5VH;';^7"*@N  -
M[)KM\H3 !>XZ\Q$ 'OK6O.@Y[&^>*-\>[Y*+'!) :>AOJ>U=OQ[_ %W0/O?E
MY=A#?<=;'SUVUW_$(=ZBQ]_E\?<I3K'6]>P>W?8Z\^GMY?.(=ZGX)TZJGBE]
MY1$! H@!@[";[7Z?G[:]OD C0WV\_P!+^@1:^KWZ#N :WWWO7X_9K5$6JB)1
M$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E
M$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HBTG#91#>MZ#>M^
M8A[.^_[>7G4'H?@4\OB#]%A%R)D_(F-''.#!!+KN UUWGE6PF^&GJTJY6EH>
M'S^#!-;ZGG)U16:H6^N2Y569&X=#$K), *76J[;%P\?)9H>>(&>#'CY0S6<;
M'G"!:2X]07ES2!1(%5N7(9.7/C?M7$$[G3396,,0N!:YC<LBPVCRUE58()LG
M@"EY6T<@Y)4Q3A?BW,7S<Z^3+.Y(O+#R#=!I=X2YG]D8W%6Y74I(/P/ZVHC*
MQ0,_&5.(IKI'%/8@8:S3XF'ZSGZK%CM&#)IT;\:,-MHR9W-CC:T@6ZC9X''4
MBEXAR<@P8VFR2N&5#FR-E<''>8(09"XM!X!:0*O@=>REIOZ3A^JX5R(G;%A_
M6%:Y"#'X'-?C8^6U44Y4L*O=I++*B9 \0E(>)U-_A#X24;IF5*U$3 4=8^BS
M '8[I<CUX1&9I9BR'"#C%XC8C.=M./3^#CD]BMK]O.W"5K(#BAXBVNF+<DM!
MIT@B+"*':W4>"7#HN;>WI+91C,Y;N6SK7Q])XAPE<IK8NM2<OYI#Y)N]S'(-
M7=PO;#M8Y3)OVL2B[(5%-^^CU)-=%PBR(J=, 'S%Z,#P\./(=F,S,^/Q8?#Q
M2_$A:7[&>L9&X;"]W0AKF &W/ ',R>D%29#XV0G$Q91'(73-&1(-H<YT,+0X
M.#?>Z_(<THVC>;3^W>7F<\:X_7<9(R-F]]Q[' F/Y^6<1MK1<#,8X<W%=-V2
M3MP"C:!@X^$*XDG:3--61EI%)-DU9.%SZ+G?H4<FD:=E3_\ #8V)^T1GY$31
M+->-+X=!A+;!>6M!W< DCR6"+5W_ +2S88;FDRG8#L2*4F.-L<D>Z1[G@..Y
MM7MH[CU\U/-\<Z\C1'(.[\,V[:F*V[BP)FT85W"9!R 6R+UR$2?814C(SN-&
M<JS2B9>&CTY!9HW5<RC15X^8N6Y$P.0.K0@T/&EP(,QS\UWK$4TH=CXS9\?'
M#'N;$S(D;)N8Z0-Z%E GDTMV?6,B+*?C># UT)8'MFF,<DS21N?C-\-PE:T<
MDES?DLH;5T=P@@L9'PSJI)J&3ZRG$@G* F #$$Q3@01$HF()BFT!B")1W7+7
MR1TISAR""=I(- T>W^ZZ &Z\BUI!]YYKY?#XKF5*E*(E$2B)1$HB41*(E$2B
M)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*
M(E$2B)1$HB41*(E$2B)1$HB41*(J&WH==Q\] .MZ[ZW[-T16,Y;X8,<H<J<.
M<CANGX,98X8.$KCL[X/%9&\Y)@5X%H2+ET#HB:)[<-)R!T@4;K&,91,2&3Z1
MU=X>MOQ-+S=.\)SW3EW@S77@MD<PS -H[O$V $V*!)HJIR=*9/GXV<7T(6M:
M^+9_S'1M?LD+]W!:7 M&TT6U8!7&B>$\:PYAW?R@<70+F&N>T?@A+'@,/#08
MW.[9)Q<U=(R'K!BG<2<<D1 Y2-RJE, F%00[5+]9>[18-):Q['12M>[($G+V
M,=OB8!MMNP]]Q]U<*&:4QNJ3:B7@B6-S!%MH-+VALANS>ZNP!YZGE0?;WHWY
M.RK@-$6A<&$T<8&O9:[TG-QX$MBZ,OL&SV1^%7]O-KRDW!XAPV.[,J#.4D()
MW),DE.DAS&(0P6#_ $D9+#NFAS7Y7A&(M&H2-PW$,V-D="UK7V!U:'BQQN')
M6DW0GQ2%L<L'JQD$@#\</R&\\M$I>6NZ"MS0!=5W6Y</HX9!E>60'N-9W"<?
M:&3;I-=\L.1L$P&0KZM"6?)H(S9+,GG[YO&F8R!6J3ALRN&*DT8YT=<4 .@L
M*!(B](X_5\=F3#GNFQH3#_P^H20X^0P'='XT+FR$%AO^!P!ZN!Y!F30WB>=\
M$N.V'(E;.62XT;Y(G@543@T#PSU+2!=D6.J])?7H[&=W3V:[RCKU8VY?EWOL
M,7-AJ]H^V&C><Q)>F%896.A)$#M56Z4A"3"IU6\W ,"1K%U OY&(!,$5DQ2Q
M8WI&Z"+#QI('RXL3LIN; 9>,N+,E;)(WEI#7#;P]VZ^X';*_16NDR9A(T2O.
M,[&>&;!$Z",L(.VR6O/) '%#JN'G'@GE7.CJ?C+PRMCB=M*]#V\_DEKGQ2E.
M7[C>38-8U&<2PQ>/PNR=6W%23B.-(QB,N25>PKY\Z.D[71-X->L+7<3"C;X>
M/FQ31QRQ!N+F-@Q,EDA);ZYC.BF$KFW1+2W<*/7IXR=(RLEYWY&,6OVN?*_'
M+\J-S3>V"7<W;&[HYA'0GS*R50,*G PD1"HN%W241&LHU)PZ4%1RNFR;I-RJ
MN%1[J*J@EUJ&$.YS#[*YJ5YEE?*0&[WN>6M  &Z^!5  6>@'P5\UNUC67>UK
M19%WMKD_&O._??*[JO"]I1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)
91$HB41*(E$2B)1$HB41*(E$2B)1$HB__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>g68105g95k03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g95k03.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1N\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &Z"^<'(X0DE-! 0      $ < 5H  QLE1QP"   "@  < E  "')R,CDT
M,38U' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0)&C6/Q&MV21\,%=N<M2D0#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8             !,4   4@          $
M                     0             %(   !,4
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P  !,4     4F=H=&QO;F<
M  4@    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   3%     %)G:'1L;VYG   %(     -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ E0"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MG&Z;K6$6R_?L_2-V,<\V?S/Z'U$B8'Y)<7X?]U)49
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                _^$__&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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ML[2VQG2$HL+$_\0 ' $! 0 # 0$! 0            $#! 4& @<(_\0 8Q$
M 0,!!04$!P(&"0X+!P4  0 "$2$#!#%!404287'P(H&1H083L<'1X?$4,A4C
M)#1"4@<6%S,U5%5B<R5$15-R='6#DI2RM-+4"#9#5X*3E:.ST^,F)S=EEL+#
M1V-DA*+_V@ , P$  A$#$0 _ /OX@B01((D$2")!$@B01=2=7F72O%KOO%:F
M6^EQK=4#;NS= 5&QL5"'ID19SS4#N]D.*Q>>9,!ATQA24B0N3&))9-^V"9+;
M'RLE9?SL=1._8/EQ&.>?ZJ'4&P(1E[S[<5\;P_6'^2?BGRLM9C,.=6&HG=]V
MTG-RG"':(P\U=YL4('=[A!0=,M9^]#Y;#43C/W;2!_VPAUX#EB1&O?U/BF\V
MI!'7A*#IEK/ @&K'41^&T8>H[;U#MW8&$<3X_'#NA-YM*B>1Z"!IEK,,8U8Z
MB=WW;1^OQP#U[81Q([_=AY)O-J"0>X_.>:P&F6L\#G5AJ)SG[MHQ[!-SU;(J
M;PU$<B?/+E"S\K+6?"VZL-1&[B>T?M.$.W/H@F\(H0*Z'V4/>@Z9:S][^ZQU
M$8S]VT@#MYO'#V@ <L2(U[^I\4WFU@B>7TGD@Z9:SP(!JQU$?AM&'J.V]0[=
MV!A'$^/QP[H3>;2HGD>@@:9:S#'[K#43GG>T8]OC@$/2.8O767BF\VLD'N/S
ME8#3+6>!SJPU$YS]VT8]@FYZMD$WAJ(Y$^>7*%GY66L^%MU8:B-W$]H_:<(=
MN?1!-X10@5T/LH>]!TRUG[W]UCJ(QG[MI ';S>.'M  Y8D1KW]3XIO-K!$\O
MI/)!TRUGMQJQU$[ONVC]8';?0 ]<7KK3NA-YM*B>1'MP\4#3+688_=8:B<\[
MVC'M\< AZ1S#KK+Q3>;62#W'YRL!IEK/ _NL-1._[MHQ[!-]0X@F\-1'(GSR
MY0L_*RUGPMNK#41NXGM'[3A#MSZ()O"*$"NA]E#WH.F6LQX/[K#43@!^[:0!
MZO'#Z@#ES$B->_J?%-YM8(GE])Y(.F6L]N-6.HG=]VD?3O [;Z ''3%ZZT[H
M3>;2HGD1[</% TRUF&/W6.HG/]^T8]OC@$/3M],.NLO%-YM9(/<?G*P&F6L\
M#^ZPU$[_ +MHQ[!-]0X@F\-1'(GSRY0L_*RUGPMNK#41NXGM'[3A#MSZ()O"
M*$"NA]E#WI\K+6> _=8:B=_W:2 /_P [UACE&'76:;S:U&&A^4\ED-,U9RS!
M-+JPU$9E'(9>D0AG'& FB$W1CC&"F\-1QH>AYKV!TWUSD,:L-06W>'E1OV?_
M ,QQR\\%=YNOM0=-U<\6K'4%D-V71NP/5/ZX)OMU\C\$^5NK@<?NL=0>T,['
M1NV<V0G#/HR$$WVZ^10--]<XR.K'4%GD!T;MW+MGQV_H)OMU\BL?*W5SM_=8
MZ@L<7T4;MO,.9_U<\$WVZ^17XS:9ZUGFX<VK'4/PAWA*\H@ ,;OWILH!Z,03
M>;KY'X+P#3+6>!_=8:B=_P!VT8]@F^H<03>&HCD3YY<H6?E9:SR&=6.HG=CZ
M^) Y>(3A >C9RXV03>;%"!70^RA[U@=,M9X^RQU$XSGZ]I)?4=LZ1#TPZZS3
M>;J)C$CZ3R61TRUGMQJPU$;ONVC]8'!R?HW0ZZT[H3>;2HGD1[</% TRUF&/
MW6&HG/\ ?M&/;XX!#T[>*'767BF\VLD'N/SE8^5EK/WPCJPU$[_NVD'CY!.]
M0^D8=:>R$WFB*B.1]V')9'3+6>0SJQU$;L?7M)S\IPAWW03>;%"!70X\J'O6
M!TRUGC'RV.HC?]VT@>H[=SB'IB1&O>9]J;S=1AIEUDL_*RUGMQJQU$[ONVC]
M8'!WXH1SZYX=T)O-,20>X^_!8#3+6>S]UCJ)SM_NVD'</+XX!#T^B+UUEXIO
M-K)'@?;4%9^5EK/WPCJPU$[_ +MI![!.]0[>48D4BOC7R3>:(J(Y'W8<D'3+
M6>0SJQU$;L?7M)S\IPAWW14WFQ0@5T./*A[UP]1:;ZX;Z=J%Q3ZL]0\JEN8G
M=>F&9Z1\ %")O4*21GE T1FE TN41#=-+LW#F$1]2?:@<#@<M/.32%931_5=
M35KIGLS5%7O*FH*E>*):U+R]K)9)53HMX$Q9JU1+)[P#CQD"<S@B(<(1'C@O
MK7A\ ?>K,01((D$01  R.P @BJ_;C6'8B[%T[NVBH>J%3M4MD$2==7;F+0X)
MZ0))G#@KI6:K#B9&9\.8E8&-M0DMZDV=F<R%"%:!9Y)DH$6D[9^% TG7/J=3
M3R%_K6C6TZCZGN!2%P;H6^J:W5KKHT31Q)ZVI*GM3<&IT:&G*^9VMH3*'Y0L
M85B@H&$DUVS[C+G- BV#IPUUV/U/50\T/1*2YM'ULT4RV5R51]XK9U7:BI7^
M@GE4:B:J[I5HJ]"@5U%1RY:2<C(?VR0Y#,I*,*X832C!%<N"+JIH;[9GJ=YK
M 6E';_?NHN_1!": <3[!CX>,*^NP<#MYMH]^N"TB7 D"DF<JR?DL"(;A'&WG
M#M#IY8L9^/6:K6O$08),4R%:RG"EW9]?K]N>>(OKU;IF3,Q,9X:PL!, 9 ?0
M.1'/K@JZS<<3.?W<.9P\RG" !YA#.<C@/1R]NV">K<1]Z1 @;LTRJ/>909I<
M9#;Q;Q ?T[X(UCX(#H$UIG3*IR&2SPI1X^<-HAVP4:QP)#20>4'S/%8":40V
M]0Y'K$8(;-T@R9D0=V*Y8P@3 &0'T#D1SZX(ZS=F9C^;AWX>U.%* AR#R".S
MIEY_7!7<?'WC$4$32(RF*1C"SF4=N>;>(>T.6"-LWP0#2:B!C34\ @C+NR'7
M[0W=<%!9O#J$AT:##G*SF7=D!XM^<]>_N$()P$H;-T[Q-168&5:5]BQF67C[
M1'\^((6.(J9'('#B#DF9<YR'_.]FZ"OJWQ$TC081SG#O6<9V^H1QV8@L1+F2
M)CPKU&"SC,$[33.![CU@FS=Z]OK@G:H[C0TQ'T3&.7TB(^N"2YP.8%<DQMSM
MZQQU;H('./9!X133X+&,_H$0]4$#G-D QKAUDLXS!)<TS@37+7Y)CB]>WUP0
M[U''N-.*8QR^D1'UP27.!S KDL8X_:..K=! YQ[(/"*:?!,9_0(AZH('.;(!
MC7#K)9QF"2YIG FN6OR3'%Z]OK@AWJ./<:<4QCE](B/K@DN<#F!7)8QQ^T<=
M6Z"!SCV0>$4T^"8S^@1#U00.<V0#&N'62SC,$ES3.!-<M?DF.+U[?7!#O4<>
MXTXIC'+Z1$?7!)<X',"N2QCC]HXZMT$#G'L@\(II\$QG] B'J@DN;(F-<%G&
M8)VFF<"<Z)CB]>WUP0[U''N-.*8QR^D1'UP27.XQR6,!W$<=6[].V"!SCV0>
M$4T^"8S^@1#U027-D3&N"SC,$[33.!.=%'*QV4=5WQ5J+G_N.L&"SV1)J=#[
M5"M#/V)=BOB(VAU3G!!9AB[G[@K<052")!%B8< ([^_0,$70VNK%YN#KEUAT
M92]F]1].%W4T^26BHBXK[I\N;3-JU=<L:928X&?)%6,*:G"&H\R8!05 <L+;
M70R894BHZ82P,(J/7TM+?C73IST^::+<:>;W6NN;IBTT:@6BY3A=NW516ZI%
M76-5:?:HLY3]O:"KYY;D5,5^+W5CJE5&KZ67KFF5DE!U$T"I9\$79UID>ZDU
M(:SZ5OZW61O+:6@K3Z5&FU#NZWMME4EJJ@>;B.51K7!QI1D8ZK0('%\9:>;S
M"%TU3-I9]/*5:@U,A5FFESP1=GUX&^Z[G0+RCLF_4K3=QC (%B=JT0*W.G$\
MTIH">#@C12&*3))RN%+)XJ2899\#LWP1=2NEEMOJU^$&U1)]0-34%559#9&U
M$Z5PMXU.#0S%M4SM4'BB#T[D22HF6RG2FS3F $\HES%RA/[T0@AJ(Y^8XT/?
M1=JX!LP/)MZ1W]?3T06GO5((!,P''$ &G@H-7B>XJAN326T=:3:7@%0"L/K!
M O<&\U%P1 2TY3>4<;*HX>,3S $G!X0".<1GL#=P^;TVU=901%BYC'%Q^[VG
MP(DB:SI@NC<G7-KYOC;>TLMUW9L'L:_>QQ>"V# $0*R9Q6J96G5KCX9V.$,<
M=.U)GH /<@8$-W%[8W?6;'&%AM$?X^RSJ0(B#\(J%U/7>CAI]FVG3+UUA&5?
MNQC3E.(QSY)U:CCZ=+';,;!IVI QR_ZC#.WBR._?QQ?6['/_ "&T:83;V/N%
M<!SH@MO1S 7;:>G[]=X)[AAQ,>V,"TZMAR'GG8[.1V>;M2  XW8'W(../&W;
MQ\[UNQ\/L^T8_I['+#+HUXIZ[T<!_-MJ#CZZ[D]])G456?)6K8!^&EC@'&^6
MG:D''3E(.1W[<!O"'K=C@_O&T3_C['WY\4-KZ.#&Z[3C^FN\UP@;N&N%9SQ"
MTZM0WUG8X=N=E.U((_\ TF #FP(;H>LV.,+#:/=;V0]PIPYZIZWT<-?LNT^9
MMK",!/Z/**5KWO).K;:/GI8X=F\:=J3/HE]R!MP&P>P8>MV/CZC:,_T]C\(R
M$ZBG)Z[T<(I==ITR-K=Z<?NQB:\*\$\DZM1Q].=CMF-@T[4@8#_!-N1XLCOW
M[X>MV.?^0VC3";>Q]PK@.=$%MZ.8?9MIZ4MKO!/^3AQ(Y2GDK5L.0\]+'!RA
MYN5( #Z?<@X#DV]8P];L?#U&T0/Z>QI'=/AG5/7>C@/YKM,'7UUWD:SV:'A7
MC&*>2=6P"'TZ6-#9C(4[4FS_ .%$1'H#= 6FR)@6.T).9M[&.9G08G%/6^CF
M'V7:9.7XV[]T=FDUX @SJN-;"M6CFD]UR5A8Z0 4JD_ &G:ESE*H-3C,/[#V
MA.)8S &W8(!OV1JW2_;'O=@+;[+M%GXVVL]T7BR_Y&U?9[U:P[=F,%]O/H[9
MN#3=MI1N@SZZ[SVA(K!!H<)F*TP4.NA5.K*VU(J*K-J.R#I*0Y-+=[CE8:E(
MFFF=5Q2*4SQ@HP#!(F^,$,B$P2X$-HX^[>];&L+*TMC=]HG= )BWL6S)#1A.
MJX^V]L^CFQ]G6M^^P;3MQ9VEA9[@M[N/WZU99[P$"K0\DB3G0D+8,K3JUF"6
M8*UL>(#++-@:=J7'OI0FQM29[=N(SFTV.#^;[1!@?UQ9$ D Y]U,BNMZ[T<G
M\UVD-X P+:PH#49'(XDUTT_-2@U;$)U1P5G8WYPG4*,#3U2@$WB"IS."&$N<
M"$G%MVQ6VFQR0#8;2J0*6]CRD9Z9^^0?Z..<&_9=IU< 8M;O0$Q4[M.4Y8Y&
M?60K5^N%:VDZOJ@EL(J!V*<Y'4IF Z5K]U-SNX-LQB*50$I\I)LJ20P)3999
MI1F$-N(U]HW>SNU\M[&R+O5L+=S?(-I#FL=VB*$]HX4HN?MJZV%ROUXL+#>-
ME9EFX+0@O =9L>0XAH::NH1E (D+:\:*X^]62 >!Y\D[YXX(73%* @Q3X9I!
M4NI  ;.,9^203> %&@$#'/")P[^](*!P$RT$DS)^B03>K) / \^200NF*0!6
M.@D%2ZD !LXQGY)! X 4:)C'/#DD% X"9:"29D_1()O5D@'@>?)((73%( K'
M02"I=2  V<8S\D@@< *-$QCGAR2"@<!,M!),R?HD$WJR0#P//DD$+IBD 5CH
M)!4NI  ;.,9^200. %&B8QSPY)!0.%9:'$YGZ)!-ZLD2,@<!7KBG+!"Z8I %
M8Z"05+] &\OIUDGIX_;G'L@@< *-$QCGAR2"@<*RT.)S/T2";U9(D9 X"O7%
M1VL?@?5_Q5J+\D+(+8LB#PD&@PQU'P[U"M#7V)=BOB(V_P!(Z"RC/B?<%;>"
MJ01((D$2")@.0((D$2"+JJH;[9GJ=^\!:7T?1NHOT03('4D>$'WJ^@; ]7-S
M>C9Q[8+4):3+B008  H8./#EX0LX#D""@<":DM&45UZR6!#//S#NZ>D.*"F\
M*"3$SO34X\-2F W8V=D%2X 0TETS4T(0  .( Z.X00. $R28%#.-)RR3 <@=
M4$!!DES@9H!A'/Y)@!W@ ^B"!P)J2T<)Z]G>F QC <P<4%"X4$F)$NFL9Z=!
M,!NQL[(*EP AI+IFIH0@ '( = 00%H .\XF,#,3&'C\5G <@?GSOSV<>V"^K
M,@NDDS-!B(I'G11FDPRT#N^N3MQ9V XJ0] CCLW8Q'+V-2XQ4C[3>R))_C-K
MKECAWFBW;\(M*DB&66'%@(XTPJ(K3-:8U4;+0KA#&RI:0#&-V'U(/_\ 8/3&
MS?OS2VY-_P!-J\5Z9P?1N]5)'VBY5.?Y78T]QI@K%R 'BR\8^I%!U22AMYPQ
MMYXW#\#WD E>H>8&&+6C2A;(7JN. ;7+(?W.<,\^4AWK@TPYM8[3:]X66[QO
MM )-6S.56X< 9\.Y:*TO?P'42(;O&5,  /$/G0\_FQQX -O%'3VS_"-XK_:Y
M&7[U9^>>E.2['I$&_A2^2(;^35$3'V>QU$X^,\U8'D[>H?;B.6O/R''M4$12
MN?)._-!"11HP!Q]M(XI!): =TDS2M,CP2"#<$&23&&4QAAK*04&Z9+B0230?
M3FG<8*DM<ZL@1$CGR2"$B T8 R3X\.*026@'=),TK3(\$@@W1!DS&&4QR2"@
MW3)<2"2:#Z<T[C!4EKG5D"(D<^200D0&C &2?'AQ2"2T [I)FE:9'@D$&Z(,
MF8PRF.204&Z9+B0230?3FD%26N=60(B1SY)!"1 :, 9)\>'%()+0#NDF:5ID
M>"00;H@R9C#*8Y)!.RZ2XD'(#NX=:)!"6N-: 9C$UY>7FD$)$!HP!DGQX<4@
MK+6SNDF=?IUP3;V]F?S=P@H-T09,QAE,<D@G9=)<2#D!W<.M$@A+7&M ,QB:
M\O+S4=K'X'5?\5:B_)"R"SV0&51!B<<=,>^%%-#X2RZ3K%!*(@'F$TC[T,AD
M9)A'B'C$0]D!7YK,K6P1((D$2")!$@B01((NJJAL?-,]3OW@+2X_#=1>R"5@
M:2?&*^Y7U#:'?\X^N"TRT.)(B :UK,UC7NHD%-T./9(CB8UUY)ZOU8]N8)NB
M@_2SQC,Z<D@A:&@[QKE!D?!((&Q5T1 /CA,=2D% PF2"(DBIKEEW^W1(*[H<
M>R1'$QKKR2"%HH/TI@XQ7#'N2"%H:#O&N4&1\$@@9@3$1.-8B>N_-.."^[)O
M:D8 F-3$'"F/6!49I/ZT#C=Y2=^ORBISV]/%TQRMB@_8:S/VF]Q&$?:;7Z95
M.:W+\"7@3^A9XG^8(IRPQ' 8K3&JC^"%=PLA+YRTAU^7DN1ZL"/HV<FU?OS2
MVY-_TVKQ?IF(]&[UA(O%R\#>['H3FK%R?4RN<HKHSXN7._G$>+IC</N'L$+U
M+P(BM&B,<=T1@O6<?K<Y?WN</_HSH-^\WF/:ON[MA[2:2YO^DVG?,<<%HC2]
MD+'42&\/&5/M <@(^=#R. Y1CI[9_A*\<K.=?WJS\O?"[7I$)VG>QF!=A7+\
MFN_PB>[56"]L<M>>W070W3.1!PS]Z>KM[[X(6B@_2F#C%<,>Y((6[H.\>4:X
MZ=5S2"!F!,1B=<)Z\D@H&DR01 .?T2"I:"Z&^>LPD$+0 !^D3QB*]:I!"W=!
MWCRC7'3JN:00,P)B,3KA/7DD% TF2"(!S^B05W070W(5G68ZR2"%H  _2)XQ
M%>M4@A;N@[QY1KCIU7-((&8$Q&)UPGKR2"@:3)!$ Y_1(*[H+H;D*SK,=9)!
M"T  ?I$\8BO6J00MW0=X\HUQTZKFD$#,"8C$ZX3UY)!-V9+2(X]W#BD$+03#
M<1C.&,=9)!"T  ?I$\8BO6J05W0/O'E$_#K-,_F[<04#,"8C$ZX3UY)!-V9+
M2(X]W#BD$+03#<1C.&,=9*.UA\#ZN'DI6HA_ZH606:S$4-:'S/C@5"]#4PCI
M+L3M$/I#;-F1XA-#U!!9U;:")!$@B01((D$2")!%U54-]LSU._> M+^7*B@A
MRX$GQ$*^@#D,]^?;[8+2<T[U*S6<JGKX+,%"T@P*\@D$W3 .N45S^"00-,$F
MD90D$#2> UA(*0:T)@Q0)!4M(,"O()!"T@ YDQ$<T@@:8)-(RA((&DD8@'.$
M@ONS!W^1CA0A1FD_K0(?[Y._:Y*AQZ.;CS'*V+6XS$1>;W3/\YM:D=# 56[?
MR2\",666 T8T=1/(!:9U5%*Y[,O9B)&<X'I'JF5TJ)-@5*F5,\I#)BB91P$Q
MDX2C+( B #,(!D(VK\YHNKP]S6->ZQ87N^ZW>M[( NX P>.!HO%^F37GT;O6
MZTN<+Q<W;H!GLWNR<8BLT$<J DPO;EO@[A(7^TM=$!\45G+<E /WDN,")O'G
M.W'-LQ'K?P#8T_JWLO#.TM)[X80#Y:+T1O+H!-TO6 DAG#AO" ,_%>W3]Z$M
M5U$XT&NHJL*0?#*1=*A2^<:(HA*L;R"YDYON<XN>;A'2&FE@,@@'O1$<\4?%
M\V$ZZ7)NT&7VYWVP%ZL[L\75[G/L[1W::7@M;#:&2"5ENUX:Z\,LC96UD]T.
M;ZQL!P#@" 8-8'SJO4TN_P !U$A_NE3"/(/TTO0 (#WX^2-3;,?A&\9SZLS_
M (JS[O+C4X=[TC!_"=\%:?9Q$8Q86'#(4. D>-@8Y:\\6D&!6DX)WSQ00M(
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MP#?1F\B )VS=R0!B#96I [XDC"=%@;/X2NPD@^J.9 )WA4C,C"8QY!>>E[^
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MY2\$X<H"3I)R35@?L8LV68N<P)P$(+X+7D@;E!!BG55^9]44TED$Q34+&G+
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M7A\$[^KN$$EM!E^MF:'AJD$):!#>U,U(@CR2"#< G$P*$9TG+)((-PR22#-
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M@:8),B!-1BF0SC(9Y.."!I)&(!SA!$ WB =,%(,F 3!C!(*EI!@5I."00M(
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M [!'DCE-V18LWQ9WJ]6+'O?:&S9:.#0Y[R]T1&+B>Z.[=%[#C)#9AHJ"1#1
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MO^;_ /K)^Y3:_P MV?\ V>[_ 'Q/]$JTQ_-$?OQTM_\ X9P_:/:_Q]O^;_\
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M( ) J!(&2E8B ;Q .F/A:$.$@30D4GW)!""TP"32:?)((08#I,DQ&><<<DR
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M=34I+PXF22#C4S2D\8A:#0:3=+#4?<%4V::K -RF[*%6V754(;-VZ2'W,;7
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M%.[GYE;0DED*DD+DED++DEEDDDE"622220 EEEDEE )99990 )990
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MRXI!(!,- G.28QC7Y*.UA\#ZO^*M1?DA9!9K.E*" 28D]U?'50K0T.=)=BA
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M HT3&.>')(*!P$RT$DS)^B03>K) / \^200NF*0!6.@D%2ZD !LXQGY)! X
M4:)C'/#DD% X"9:"29D_1()O5D@'@>?)((73%( K'02"I=2  V<8S\D@@< *
M-$QCGAR2"@=C+0XG,]W#@D$WJR1(R!P%>N*00NF*0!6.@D%2_0!O+Z)Z>^=W
ML@@< *-$QCGAR2"@=C+0XG,]W#@D$WJR1(R!P%>N*CM8? ^K_BK47Y(6>R"V
M+*N%)!II7'G.4*$Z&?L2K%?$5N_IG0648NY^X+K0\+KIAU*WLN?9RKJ&TNU%
MKCL:P4)4M..NGRE];=3:)%M&74<*A0+D%X5M24\K:Y+A)%-,ES4H2R+UQTU-
MF$'N"-(7([KE E5N#3QX->G[LZ%K)64\)7;BF[PW9H8ZJG-M=72M7ZL+BV@:
M'&OZDJ&W-$4OJ-;%3!<Y<\6XHA=3=(+JQ::B1'OBIE,GG6.B.4E6I(NT.TUM
MT-H;<4C;-KJ:N:P;*,:"F1MJ*Y55N5<URXH$QILR,:CJ]YG,=ZA7)4YA:*5T
M=3E#BH3)B!7*E2D#5!I%L2")!$@B01((NJJAOMF>IW9_L 6E]  ]U&/L@AP\
M8'&%?3;S=77Q[.V"TSN$DF008B)!@XGFL[>+U9]H04[)->R.%=>')8V^GLZM
MN[IZH)+:#+];,T/#59V\>.K'M&"$M AO:F:D01Y+&WFQT=6W/L@@W )Q,"A&
M=)RR3;Q8ZL^T((-PR22#- !2.?R6=O%ZL^T()V2:]D1E77*.N*;<<6>SVP4)
M;092)=G&>0Z";>/'5CVC!4EH$-[4S4B"/)8V\V.CJVY]D$&X #))C BDQAAK
M\4V\6.K/M""#<,DD@S0 4CG\EGH[>_YN6"=DNKV1&0Q[H3;WV![8*$MH,I$N
MSC/(=!-O'CJQ[1@J=P Q6=1A3$46-O-CH]N?9^>"#< !DDQ@128PPU^*;>+'
M5GVA!0;IDDD5H!].M%H;4&.*?H7[Z-(]JH0#MSNCT'HY'VJ_3GLJ_#"L"RDP
M?#&BQ7OM6-B!0?:;,Z#$QIC!]^2WZ;M,G$-V1V;N3'?UQP#4\.&G"8P[EL6D
M3!H9$TK$8SGD5QCH BWKMPX2*.;>3. #M'&_OMC!>A^2WJ13[/:SWL,4SD+/
M81O-B2"6Q,9$2/,8TY+\FC8SI-FSR=+@-F/[6'/;G,?-S_-+G_16/M$=>Q9"
M0+Q,5#Z]Q)^"IO:ACJAULM;9PI%N;G9RI:[5;OQS<YN8M)2I(353H6;(6M!.
MJED.#(C+*)(A-G]\ ;(V/2JPO-M?;L^ZV=G;6EVM+E;FRM+0V37-;8!KP'[C
MR#O5'9(IJ:8/3RZ;0O&TMGWG9]C8WFWN%[N5Z=86UJ;O9OLA=K,&+7<?#L@-
MV#)!(-3OGSEO;M$+5TIM_P"$4!'CQ_<+BZ(Y/VC;(J=E783IM$:"/ZUQC'Y%
M<(7GTG([.P-GD$X':XG_ %.NI\=5R-#UQ4;]4=44M5-)HZ9=::3-:L10/H/J
M5:F=)>$5-*:"-%XDPH0'QDG G =_"VYC)<;[;WBWO-UO%U;=[6[-LK0EEN;9
MKV6H)%39V>Z1!I$D":9_6S=IWR^7S:%PVA<+.Y6]PL[O: 65Z%[L[1EXJV#Z
MJSW"W](8"D3*VGW_ #\?ZHZ2ZIW6R,3QRIB*+&WFQT>W/L_/!!N  R28P(I,
M<DV\6/3M]H=Q@H-TR22*T ^G6BSMXH*]DNK0<,ZXQ&GU3U]7Y\04.[0#":G/
M/@L;>/LV>T8*G< ,5G484Q%$V\V.CVY]GYX(-P &23&!%)CDFWBQU9]H04&Z
M9))%: ?3K19V\4%>R75H.&=<8C3ZIZ^K\^(*'=H!A-3GGP6-O'V!CVC!4[@!
MBLZC"F(HFWFQT>W/L_/!!N  R28P(I,<DV\6.K/M""#=,DF- !3+AUHL[>*"
M2TFM ,P*FO+3+S3;Z>K\\%#NT PFISSX+&WC[ Q[1@K+!AVN?T3;S='Z<^G=
MS<\$&X #))C BDQR3;Q8ZL^T()V#),C0#NX<UG;Q026DUH!F!4UY:9>:CM8!
MFCJOXQ\U:B_)"P-@;8==?)9[(#*H@QXY\.,1WPH3H9^Q*L5\16[^F=!91B[G
M[@K<052")!$@B01((D$2"+JJH;[9GJ=^\#:7'X;J/V ,$.' $GRJKZP6F6R2
M0:3769K%$@IN@GLF@U[^";<\W?=VYS!-T4$]K/3 G3DD$+0T'>-:Q%13N2"!
MM)<:1EC7N2"@;,P1$Q7Z)!-T$]DTBLZ^"00M @3VI@Z5[N205+0!4UK$8>Q(
M(&4!)$1-,<)T2"@:3)!$ Y_1(*[LNAIYSK,:)Z._?H@H6@0)[4P=*]W)(*EL
M EQY1K&=$@@90$D1$TQPG1(*!I,D$0#G]%H74'\'Z%SQW1I$.G]E#QYY]G''
MH/1P?E5^_P %7X<*V<F=,!58;X!ZFQ K%ZLSX$@^TK?IOU68.<=O1@.V. 1!
M(TZZRTHMEX!,C$D#@*>RE."XQU^MRW_](IV\X$SX#M'UQKWK\UO0K6[VO^@>
M[//S6>P!#FS @M%#2I%:C&@]Z_)HQY&2!Q W2].!3"/<>/U_-S_-+G_16/D1
MUY\%D(_*).!>9\3AW=8+16E<.%9AK 0QBK;@B.!SM&KG,0]<VSMW1W=KG\MM
M!'_(W6O^):?:<<PNKZ1?PB\M@D6-V@F<KO9#EG6DS&A5B EX(8 1X\ .!R/.
M.,X''*'HCF2:5('!<'?DD0"<R21&7):=I< "]%T!R(YIZC\9'EE'.<<>,[_4
M.WCW6FV-IQ_:+G/^2_7C&"X-SD^DFWB<?L>S1   PQPGO*W)'77;<T5)..'.
M,Z<$_3V04## )P\\)TXA._?J@H&%TD1 .>GAQ"=^^/;!7=EVZT^.LQ&";LYW
M;X*%H$">T3W17@D%2V 2X\HUC.B?I[((&& 3AYX3IQ"=^_5!0,+I(B <]/#B
M$SZ\!SP5W9=NM/CK,1@F[.=V^"A:! GM$]T5X)!4M@$N/*-8SHGZ>R"!A@$X
M>>$Z<0D$#)DM-!KW<-2F?7@.>";H)AIKG.&,:?)-WH@H6@0)[1/=%>"05W /
MO'E%?<L9X_1Z<X]<$## )P\\)TXA9@F[,[I$#7'+AQ3OWQ[8)N@F&FN<X8QI
M\E':Q^!]7_%6HOR.L@LUD(H8H#[?FH3H9^Q*L5\16[^F=!9AB[G[@K<052")
M!$@B01((D$2"+JJH;[9GJ='_ ( +2]KW40>K,$. X$DZ01"OK!:1#@:34S28
MJ<T@I#@:3AE/6200AU#62>,]42";KB"3E.,RD$ <:5B,YA()VA($T.4Q*02'
M TG#*>LD@A#J$XD\9GH)!-UQ!)RG&92" .-*QQF$@G:$@30Y3$I!(<# QC*<
M$@A#J$XD\9GH)!(<029IK/DD$ <:5CC,)!.T) FARF)6A=08 -/T+]]&D0ZE
M0B&STQZ#T<K>K]PV3?O$V>'&@P6*]RVQL1G]JLL-)/AB*@2M^F[#)@YQ[,9Z
MQ&. <3Y\\UL6@.],TD #,4I3 &E8S7&.N0;UV-XI%'4!,X^WV1@O4FZWH:W>
MU\F$#)9[N3O-H1!&.9)'/3S7Y-'UF1@._P FR@(\7]K"._ ;-OH[1^;G^:7.
M/[38^T+(0?M!T+_"I%3W+16E<<V9:1_];;A<7%YVN0AUXR _F&.YM>/MUI44
ML+J(G,V33[#7BNIZ22-H/ Q]5=9C*+M9_+N5BHY:\[!:1CE,3KA\EINF #Y-
M-T-N?I>HX>D>".1QT9] <@1R+L8VQM/7[/<X_P EX/D5QKE_QDV]_>FS?8>M
M3B5N2.NNTX$DZ 37EEX)!0!QI7OF!I/N2"0X4$]TPD$(<#G,324@A#J$XD\9
MGH)!(<029IK/DD$ <:5@ZS$)!.T) FARF)2"$.!SF)I*00AT F<8&,YI!(<0
M9FE:SY)! '&E8.LQ"02' D">,3UFD$(<#C4Z3/>D$(= )G&!C.:05#7'&>^4
M@H XT$@'G"02' D">,3UFD$(<#C4Z3/>H[6/P/J_'\5:BS^!U@^O$.N:SV4T
MF<S7GC7AW]RA.AG[$JQ7Q%;OZ9T%F&+N?N"MQ!5((D$2")!$@B01((NJJAOM
MF>IW[P%I>/\ W[J, 'T9@AP U)!Y0/!7U@M+><TD 8DZUK\D@H"YAI3G(^"0
M23.]'E31((2YU2,)J >^4@F\2-V,A@#-$@@<6R!WS/6200%S#2G.1\$@DF=Z
M,Q!K$CZ)!"2[+#0%()O.(W1I&<]0D$#BV0.^9ZR2" EIG,Z\\<D@H29WHS'*
MGT2"I<YW=I/FD$WG$;HTC.>H2"!Q;('?,]9*N^I9Q3M%&TH[K)5/N!KN122U
M>:E2GJS$R219P3%,Y*>0PWQ18C*)DP23!++D1#$>E]%[)]M?;W8V99OVNS;Y
M9V;7O:P.>;.C=YQ#9(PDY%8;V=VPLGN!AEYLW.(!)B<2W=, :@S[N8.U(68*
M$)E%8R)RC#BB /4-CB0G Q1/*64$YTZ>0LL##)@D":<<<*8,S!MQ@'HSMMT[
MMR#B X[K;6R)<&P3 ;:.-!)P Y+,;Y<S46I$D"39O #B: D@B3I\XV\Y32S-
MBN?&0G1GSRCG8,DQ$TTLP"'%-*,HAS" B&P8\W>H^RWN,1=[8 Q,$,<'>8TR
MA;EE >T"34$F")D@C,F8)TE>#1]9T08VS-LH8SQBE$ #I'8&[:. &/FY1]DN
M9R]19&<I !->!Q7T3^/,X!\QPD_/$ZPJ96"O?;.B+;%4Q5+ZL9GULJZNRUS<
M>QNPFIQ.JEQ.)F&:1)-)-(85/+.7/)--+/+,$P#@1CT^T=G7NWO)MK&S%HRT
MLKN6N%I8C>#+%K3B\''$1)C00O4;8V5?KW?OM%A9MM+&TL+KNO\ 66(!BP8'
M2-[>W@609!(( -,-S!J:LF/^O$X1#;GR&\!S;O<G/OQCEXXTOP3?P:V('^.L
MA_\ ?YX KE?@#:(D-L&@9S;6$SG5UH#UBM*H=4MCJ?N[<!P=JO4I4+JQTN6W
M*!IY^,D53I91!3)),6WB&2A'$P"(B&T<  ;>,W9=^N^UK_:6MB6MM+&[-8[>
M;VBP.#P(.[0D&F62\LS9=]N7I%MBTO-@;.RM[I<!96A(+7E@AV[!,[I!#@8@
MY4A;/;=8.G9W4F(F^OA-6%$>Z)DPL3Y(:!'"&7QP%F()!FDX0"'"#(9 0XAC
MI65RO%NXLL[,.<!.[ZRS! U,D4KP7;NUPMKY:.L; -?:L9ZTV9<UKPPG=#X<
MX=F:#"25.J6OM:JLG]%2]/566M?W$I4>@;3D"Y"<L*12R3JYDTRH@N0T4\AD
MDQLDLPS2RS@(@ 9&/JVV=?;"S=:VMB6V=F6[[@]C@W>-)W"Z Z#!.=,<-B\[
M&OUVL;2WM+ BRL]T/>+2S>&AY@26$Q)(J8&E86W $!#(<?MVQI'$KCN>6DB(
M-09&A^(68+X!<TSGQ'&?<D$))(=X&*)!"YSN[2?-._7!-YQ&[W<>HX)S\O?V
MP0.+9 SQGK@D$!<TSGC4=9I!"22'>!BB00N<[NTGS3OUP3><1N]W'J."00.<
MV1KB".N"00%S3.!X]:Z)!"28=$:&*)!"YSLIC0'NU3 =N?3G/K@F\XC=[N/4
M<$@@<6R/(]<D@@+FF<"=1UY*.UC\#ZOYZ5J+T?0A8/Z(=<EL61G&*@]]<*^.
MO<H3H9^Q*L5\16[^F=!91B[G[@K<052")!$$0 !$=@ &1'D ((JH43K;TUW!
MO%4]AJ9N#.;<NE"GM0L;'6EZOIYF>$]-F>+?U%'5>_,+;25<D,V)S'(VCWM[
MD1DE'GJ!+)(-GD(N$LQK_P!*.H"Y"FU%J[G _P!9R-SD\-*=92E9TZS5BTM"
ML4;DYV]JFI*>::9N(@2&2SG&*Z)=GU/[BDG7@8**2<^4BN5!$@BZJJ&^V9ZG
M?O 6EXL[GNH\!S9'$$.'$DCE0*^L%I[T$R 2"8.E>207R'5EP#N??IS3OWZ8
M)O5P$#]&D8<N]((730 -!F0./<D%=Z!0 & )Z&:04#@)EH))F3W==Z00.K+@
M'<^_3FD$+I(H(!!W<NBD$+J0! SPKY)!7> %&@$#'/")P[^](*!P$RT$DS)[
MNN]()O5D@.R@]9)!"Z2*" 0=W+HI!4NI  ;.,9^200. %&B8QSPY)!0. F6@
MDF9/T7YF%%F@,II91LH[!D.+D-+F#;LF+,":0=^0R&R*"15I+30RTD&AD5!"
M^VVAJ(!#C%8H,J16%H/4FB02V1KP94+>'[ 2S!-*A2R#+,"LK$TLTI(32S ,
MH#D!V"&Z/0^C%I:?AZX@VEI]^UD>L>!)8<>U! K2(7S?VM-RMY H&"( @E[3
MC&0P(Y\]TJL>1!'./H,4&<#QH)=F!VX# [QR <L>8OG[Q?3GZN\TI7[^<<L-
M=%NV='MU)9CPW<:_SAIXKS9Y0%J;AV;4:<0R&WZE* ;^+CW;>@8^+F2+G=1/
M];V?FW#EAX!8K>TW;5PBLFLQ0DTP\_?$>R*!!-,,\[>W&3S?OIYT".::8<B(
MS333$C--,.=HB(B,;0>\8.=I]X_%?(O5J/TGY_INSZR6/)S;C'DUL_!R/_(9
M'KAOO_6=_E'XH;U:G]-_(O)]J_.9I:IOWS2TSS!NFF:T CS!F9/-LZ.*!<XY
MFG\YQ]I*&\.<X$R<!VG3%<C$]%:?,;FR2^R4)&MLE#Y&Y@#+(VH9)1^BIWOA
MEE3@'"#'!S@1#&!Y(Y.^X;<9VG0=GOD;QK^,)KK43P.&"X9M'CTLLRUY$[$:
M<<2+P^,(^Z<.1J"N-N E2%7GT\3$(T9$_E>OP"<A*G(GP-,DB,HSE%238'@@
M [<<>-D>GNI<=G[4DN,-NQ.\XND"T<(KA(',3&2]W<WO=LK;.\YSB&76!O$"
MML_+( M'##@K 2_O0V[,!CU]PXL1S3B>97G'O!<Z6"9(QF*ZQU4KRB+XWJR0
M#P//DD$+IBD 5CH)!4NI  ;.,9^200. %&B8QSPY)!0. F6@DF9/T2";U9(!
MX'GR2"%TQ2 *QT$@J74@ -G&,_)((' "C1,8YX<D@H'8RT.)S/=PX)!-ZLD2
M,@<!7KBD$+IBD 5CH)!4OT ;R^B;>7C[,[NK9VP0. %&B8QSPY)!0.QEH<3F
M>[AP2";U9(D9 X"O7%1VL/@?5_Q5J+\D+/9!;%E!J!%#32N(X]RA.AG[$JQ7
MQ%;OZ9T%E&+N?N"MQ!5((D$7C.(2RS"(9  $1#&<^C;GHVP1?.^[WIHC6)JG
MK)(R%5E03O8Z@+WVATG6S6V:NY2CE4]QZLI5UINX5UJCJQ50"&@&*EG9K4*J
M>H!FEJ==Y42@55BXYJ<50,I)%Z>FFIFV_MT_!7T';RWEPJ5JG112UP7;46FJ
MZV%4V^36T)766?;6I**D=WEF;*9J-<OK=P1\)%1CL_(O<1/E24V=* G 1?1=
M!%K>[-UJ/LK0KS<6NU#DEIEAD*G<#6AE=JA<  XR4HN5.TLB->Y*IIIY@ 92
M$TXRAMFP&1 BZD]+E]+>Z@/"$ZI*QMJJ>UC&ELC:EJ/.?Z8?J36 M)=W\XR2
M1NJ) VKC"0D-DP?*G\5-,(RRSB,@A!0F!A,2?+K+Y=JD%J=DDDP(,1(K&9IF
MD%!NN->S3"E?)./K]G?TP3LR&Y?K2*T)QC5((=UH@0Z9J8D>"00;H$T)@4)&
M<<$@@#3))BN$@42"#=<:]FF%*^200[M&C"1VI&![N/DD$.Z! @S-9!(\D@J
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M:F#I7NY)!4M@$N/*-8SHD$#* DB(FF.$Z)!0-)D@B <_HL>CT=QQVA!4-&\
MTX5,\#RZU6BM2H8LA78<7N%,&WD%87ZPCT'HQ_#]P-"#:6@..!LWGR E2_&;
MG;TF?5DQH'-!&L"2>&.$K<BH@X6,1 N<909BQX6!XF^79G.WC#MCS%\(%A?6
MSC9WD5::DETY0,:33"L8[UD.TUU8[$9S]V3H,"9-*5PE>++GR2W9 0_82<
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MM,R:SB((-*$=\K4!.F*S1,Q4Y;$\@),TDT@354^3R!XH0X 32BJ&6:67@@'
M$!EP&! 0V1UK7TFVS:MM+-]O=W,M0YKP;E=JM?1^#!5PIG6LU*QBZ71L$,>(
MK^^6E *C]+V9:1"VH%',!1(ER)CY92B# DE!:HQ+*67-XL)<3!C@X#?OZX\<
M-B[-#FM%E:B7-  M[4- W@( +G "2: 4& G#HMO-HZ2-T81V09<&D!Q)$DD"
M23-22M16*0R51;A \/QZQQ=#7ZK4IBL]6=XR9.@J!:D1E3#+. <!.F*D*D
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M/V9]7'!#AP!)\JJ^L%I%LFE1->!FO54@INR>S49^?)((6X#]+,9:_#-(*[H
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M?/Q2"!PWI<) P'>L8X^/&,]^_7!4OTG&O+QQ68*.<(AHB<:"M*I!7>: (':
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M/DU%D.CYS!$&GV$=[(T#TMJ(?^Q@B#3[".]D:!XMK:CW<GU&")YOL(!@&1H
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M[GTP#!:2@&<*<N4ZHRFYTN$Q W4^G\D5PY-Y!"%?5C?[G?EB,DI,H7F$%RR
M1<PIT^6$6W-37J661M$KO(C*D)27:56WHY1<U*263(F+*35X:S3U407(GDD3
MR2%.LDLI$DI0 !<H2@1>R=8FR"DFYZ919RU:A/>X)0O00?;VDC2;O!*W3L\H
M70*,:)BZ_"5H-,:Y0JN5V &TR="'[%FF*$BV Q,3)2[(STU33.UT]3E/-:!D
M8&!C;TC2RL;*U)2D+6T-#4@)3H6UK;41!"- @1$$I$:4DI.G*+)+DDE(N5@B
101((D$2")!$@B01((D$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>g68105g96n79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g96n79.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[10<4&AO=&]S:&]P(#,N,  X0DE-! 0
M    % "^42 X0DE-! 0      $ < 5H  QLE1QP"   "@  < E  "')R,CDT
M,38U' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0)&C6/Q&MV21\,%=N<M2D0#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              *X   )P          $
M                     0             "<    *X
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   *X     4F=H=&QO;F<
M  )P    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   "N     %)G:'1L;VYG   "<     -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ +0"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M 0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                     /_A/_QH
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB
M[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE
M=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-
M4"!#;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR
M-R @(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W
M+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z
M>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*(" @(" @(" @
M/'AM<#I#<F5A=&]R5&]O;#Y04V-R:7!T-2YD;&P@5F5R<VEO;B U+C(N,CPO
M>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R
M,"TP.2TR,%0Q,CHS.3HS,BLP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @
M(" @(#QX;7 Z0W)E871E1&%T93XR,#(P+3 Y+3(P5#$R.C,W.C4Y*S U.C,P
M/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^
M,C R,"TP.2TR,%0Q,CHS.3HS,BLP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*
M(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I
M;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QP9&8Z4')O9'5C
M97(^06-R;V)A="!$:7-T:6QL97(@,3 N,2XQ-B H5VEN9&]W<RD\+W!D9CI0
M<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C
M/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @
M(#QD8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^36EC<F]S;V9T(%=O
M<F0@+2!0=7)E5&5C:" N9&]C>#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @(" @(#QD8SIC<F5A
M=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D
M9CIL:3YR<C(Y-#$V-3PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^
M"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @(" @(" @/&1C.F9O<FUA=#YI
M;6%G92]E<'-F/"]D8SIF;W)M870^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N
M/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @
M(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(*(" @(" @(" @
M(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S
M5'EP92]297-O=7)C95)E9B,B/@H@(" @(" @(" \>&UP34TZ26YS=&%N8V5)
M1#YX;7 N:6ED.D9"-D$W-S-",3!&0D5!,3$X,S Q1#DV0T$P-#4T,45!/"]X
M;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX
M;7 N9&ED.D,W0D8W-S4Y,#E&0D5!,3$X,S Q1#DV0T$P-#4T,45!/"]X;7!-
M33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N
M=$E$/GAM<"YD:60Z0S="1C<W-3DP.49"14$Q,3@S,#%$.39#03 T-30Q14$\
M+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DAI
M<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D,W0D8W
M-S4Y,#E&0D5!,3$X,S Q1#DV0T$P-#4T,45!/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 Y+3(P5#$R
M.C,Y.C(Y*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T
M:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#II;G-T86YC94E$/GAM<"YI:60Z1D$V03<W,T(Q,$9"14$Q,3@S,#%$
M.39#03 T-30Q14$\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IW:&5N/C(P,C M,#DM,C!4,3(Z,SDZ,S(K,#4Z,S \+W-T
M179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G
M96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T
M=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO
M/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S
M=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T
M97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I
M;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N
M861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E
M<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D9"-D$W
M-S-",3!&0D5!,3$X,S Q1#DV0T$P-#4T,45!/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 Y+3(P5#$R
M.C,Y.C,R*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @
M/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z
M:6YS=&%N8V5)1#YX;7 N:6ED.D9!-D$W-S-",3!&0D5!,3$X,S Q1#DV0T$P
M-#4T,45!/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z
M9&]C=6UE;G1)1#YX;7 N9&ED.D,W0D8W-S4Y,#E&0D5!,3$X,S Q1#DV0T$P
M-#4T,45!/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z
M;W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z0S="1C<W-3DP.49"14$Q,3@S
M,#%$.39#03 T-30Q14$\+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @
M(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @/"]R9&8Z1&5S8W)I
M<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @
M(" @(" @(" @('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]P:&]T;W-H;W O,2XP+R(^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-
M;V1E/C0\+W!H;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E<V-R
M:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
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M%0D6(S)A<9&!H212L? 7,T+!-$-38G+1&"7A8__$ !P! 0 " P$! 0
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M9N$0@(#U$1$@B(CY)2)45!%$Y527PB>5X^=.? +$G&!R3] !DD^P[GQS7A(
M))  Y))P/U)[#ZU1O<7]H9Z;]N+Z?C4K)+C*;:J?./:-850RLAC5TAOZ7HTF
MQ85JN5]AS^&^VU(=<;<0FS;$A7GL;'T)K]];0W9^!T^"X!,/[SO(;.:4>#'!
M*W5(/C\/#>& YKCK_P!>>G[">2W$EU>S0'_B%TZUFO8[?'.)I(@54D> 21['
MQ*^Q_JJV9]0:2F]N<K&7:5[2/6&/6L1RGOHC1*J"\[63!!\V>1).ZPIMIX52
M\IJ!KWI37/3AC?5+0I#)GIW$$D=S;R=L#J1;MK <X.WZDU9:+ZHT3U "--OD
MEF7/4M75X;F/'??#*%D&,@$X(^HJQ0.*JISY3I157CSRJHB<<(O//*<?'ROX
MXUS@Y (Y!&0?Y8'_ )Y]^XKH/)'D'!'^^?T_K7UZN%Z5\E_8D15^4^Q>/RO*
M\?[:]I1%7E?*JG'GA1X%?Q\(O^?]M*4\K]R'GS_Z/\?"_P!_O_?2E!Y\HJJO
M_P"2<+_E$1%3^W/'W7RB(I6[2E/NOS_M_M]_\_Z:4II2FE*:4II2FE*:4II2
MFE*:4II2FE*:4II2N*X\@NBVK@HI(2H/4"%THJ"1=)+U&@*2*O2B((JJ$O4@
MH6.>3W&._D 9X)..,CW]C]Z5$>\^^6$["XJ&9;@IE 4)35A.RL9P[(<P=ADD
M1^64F?$QJNLY,." 1G.J<^T$4#)IDG$=/A9-K:S7LH@@"F0Y_-)'&.._,A X
M^U8NX1"Y&0,<<Y_E_G?'>N]V[W/QK<W%*_,L=.WC4UH1#$'):*TQ2T$D7I )
M5+D,.NM(ANIP;*.Q4[K9"8*0ERGES:SVDSV\H&] <NK+(O!(."@VG:1SCCL3
M]2N' 8 C(!P<YYS@\_R_0UE09#4..C';N*PWS=)AMD)L-QYQX0[A,@VCR&KH
MA]:@@*:CRJ#]TU!)" =C[2!\Q7CDXR3C S[]O P:%@-W(R,''W!QQ]QCW)SC
MC%:+D=.*2$6WK$**ZW'DH4Z(BL/N"1BR\/<Y:=(6SZ1/Z_!%VB$5XQP_.%8X
M&[.UORGR,)@^,XS]<<5GYQC!'<$X/ZYQC^G\Z[]%Y1%_*(OGCG_7CQ_CQ^->
MUY]ZUTI32E-*4TI32E-*4TI32E-*4TI75W=>EK4V-<KSL=9D5U@)#'_GQW#%
M>U(9_P#^S#J ZUSX4P'GQSKU2%92>0",CGD9Y''//;(Y%>-DJP4X;!P>.#C@
M\\<'WXJ/-H]P6=P<;<D&;:7V-6CV'YBPVK?;CYC20X:9"RQT\*4=N<^Z+3BB
M!& <J(]*"N^Z@:"7&"(Y<R0Y'>)FR@SSR$'DY.>>:TV\PF3)_.A"OX^; !.,
M  %NV./&3XE?4>M]-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI5<]^=]$VBAUL2NJ_P!?R>[5S]-KU=]O&99:\.2YKB 9BT)*@B
MI'PO'''F1!;M,W<*H[D_YC_I[&KC2=*;4I'+.(H8AEW/;[ ]O?SX/MS3^1ZK
M=_8[RV2TV*E ;/N'6>WFHJMJJ%VBFH:N-KT^.ZL=?'E&^>=2A:0L-HE7?V_-
MD_<#('U_F/:ND7T]H[%XUNY7DB&7,;(WOP1S@<?YVKN;OU2;K7T^NO\ "(-9
M48^M.RU-K;>+[QS]9$W&;+N26W6>A(DH%8:!..ML$<45[@<8"VB5,RN$/ODY
M'Z=OM].]1$T33+2.6/5+HJZW 1;F(B.+ '(_%SWSD]_OQSFNRGJJNK;+9N';
ML2\=JGGZYZRI;-AT:]LFXA",MN6S)>+H%$<#MN]:(IJ(*B$8IKR2T5HEFM2T
MJ!Q$Y S^)MW#)' W 9P./;C-0]2TO3UMQ=:3="Y0.$DCZL<K+G '* 8Y/G/G
MCS6_<'U8Y=&MGF-N\6A6%/"<-M;.W?>;_4R;X0BBM,,GT,D2D@&KBF2(AB*C
MX7R.T5A^)*$)X"G@\_?VYK=9>G[5DC-_=20RR_,J1["%&.-V[DKR"V,'';GF
MIJ]/6^DS>6LO/U7''\=N<:G185BTCJR8,SW;*/,2(3ZM-'TJ(.=U@PZVN4ZB
M1-:9X>BP7<#D'D?3]?/Z<>*K-8TDZ5*BB83QRC<CX"G;]A],=\'O5D=:*IZ:
M4II2FE*:4II2FE*VESQPB\*JHG/XY5.?]M*52;]H)FF283Z9,RDXQ-?KK&]L
ML9Q1VVCD3;U77Y)D%=56$MIT."9=2)+>;;=0A5LR145%3E.M]%0PR:ZDT\ N
MEL+2_P!02V/(GELK*>ZA3&1D=2-<KSD BN3]:SSPZ#<);RFW>ZFM+,W QF)+
MJZA@D8$\!@DC8)XSCZXCC978?;;%MM8==71:QA(U:TK\AUEER3:RG&D.1,EO
M$A./N27#)Q2)PTX)4'QRB_CR^O;K]J#:IZP]3Z[</J$K2RI;7%S*L5DBRG99
MV\*O&MN;5<1J8T20B++L6YK[1I^GV7I""PTC2=,MA;PQ0]>86\;371=/Q+B6
M0JSRF=B9%WL5&<KM%>7>ZZL[)^K?;[)]M"*'8)E6-A+K*A4:"6U:6D>%/K38
M9X$VK",\:DQTJ"/=MQ 0A0D_9W_X=K[4O57['M8LO45U-J-OI=[K%EI6H7SR
M2.]G:QL]N4EE^=S:N.F'9G! !)K\U?M5CLO3W[2]+N-"CB@DO4L+B_M(%5-D
MTLZJZ%4&T&>,AY%P#X   KW3]36>91M_L==Y5BD]C'[E^UP&BD9/.@+91,$H
M\QS7',:R?.9L%#:&3'PG'[BTR(P>=;B@M6CDUT(82#'DK&&&:_AMY]_2+S =
M-U1I6AM9YXX0[!PAN7B6!7*D*TJG:<8/U=F81-(!N81.^,$A3@G<5!!*Q\.X
MR"45L<D52G*,XO:9S$]O*KULV-Y1W6ZU%6W>Y<5G;MF_Q&KL\%S.X+&[#)OT
MM_"YK=E:T,"3$ :F+8PXKJQY!$K[$@KB.)'W3'1XXI$@OF2V9KEXIVB$)#"+
M<MP##U&.]7*/N3Y3L??7/.L991?(VZ2TSD*Q@65^F2TB[$"R$*%1@7W%CG:0
M%BW<7UH;GX#BE!AU=F-MDZ0MU0JDWS9P];"OS+"*[(:: ,".Y417Z%R\L';*
M753+2(C4/IJY,J-%;,T;;EV>DV]]=P.T,<'4MR9+ 3&/;<M',5XGQ*(0L:RL
MFXN'. 2N!6J]NGMK2X$4[W$Q;\"5(E/3&^ LCNN8F*AV0$*,CZ@FO2VBQS>7
M(J[="!ENX$>C@9-/!_;>_P (@1X^0XM1.LMNB;@7<>RA.SD\"J383HHIN<M)
M]/3SI>TC2U"0N\\+2_&"23=',>H>F$,84A0H(R.3P#R,FT42&:5B0('6(1+Q
MO0[,2,<C.2>02, \@8Q5<-C=PL^VQ]*.X&_6X.?YWO9:U=1F60M4U\WC$(HP
MX9*N8K%;5.T-%4!'8L1B,N3Y<\92,*)O"0-MJ"S;Y(9[VPM+>VMK,3+8;I4D
ME8,UXD'4ZA=WQT<LX"J"S,5S@ #3&K1-=LT\LXCDN55&0?*L!F*[510S%]JJ
M#D@X '+9J--W_P!HQEFT=3MJ%CMGCF7769CETRYE[=YC,S#$8M=C$W&XH1*+
M(*RB<"7D5@UDC+[<&V9JHC!0I0ORT F2.7::#%=SW*I=3Q100PL/B[802L99
M;R(2A6<*T(^%W2.K$@2QX .X5IDOQ''&_3W&5P.'WJ@V0L5+(,EB92HP"/EW
M$@,M35Z)=Y]P-VW=QW\TN9-G'K'X#E/&E08D-^ S*N\LC]ET([#)=UN+7PH[
MH.]:H<8E0E4B(M&L6,%G';K&$ZI9EE:,R%&VP6S*PWGLY=V^7@$D9Q@"1%*T
MDCY!0#.$;&X9>0<D  \ 8QV YR235_17E$7GG^OY_MJBJ16NE*:4II2FE*:4
MII2FE*:4II2FE*:4II2H'R/8JAR/?? M^I.2YG$R';[$<JPVMQBOO'XV%6D'
M+9$.3*L+VA >S/M(10A"!*,T5E"%4X5MOB5#>R06>H6:11.M\8-TK@&2+X=B
MP$9_AW$Y)\C([-QK>/>\;EF_#'"^"<\9]\9X[?T%9%O)AD_<':W.L*JI$6'8
M9/C5C41)$SJ2&P_*95L7)*MBI]D5Y5Q %5YZN%\\ZCQ.(YHI&&55P2".XSG&
M./;W_P"M;&Y5E[9!QWP,\?7P3]\#GWI+9^G+?*=EUO H,AVXD;<7&YN&;BS;
M)VVOERN&M#3,5L^C9KV*UZM)B0]#;<C2"L6T,#-3C(8<:N4OK(1.TT=TLR17
M<4(4*8V^))96;<,CI[MO!P$QBM!ZPDVKTWA:.!>2,J(BQ/ YRQ)R?ZUC6+_L
M_P!_'+2CR&.>+,9-3S-LK<;EB7=^Z"[QG,IUOF=LT1+TK/R+'9+=.Y+<#NRV
M6DA2U6*(KK:VN*8C"J9B9[@,#''D0/IHM($!VYRETO7X(.X[@<U@;7<6=F_$
M80;B"2&,5X;D''8?AGIC&#C^8Q?$O0#FK6YNW=]F0;;OXG@64LV&4'63,CG7
M6]Z11R>7 S7<.#/C,5XY16S[:&D.$LBV;4GK$RG>UC0(P[SKL2PRI%\2)9;1
M(;?E4CL&10&$!7#*'[%B0S X<L>:P>U9FWL=S&0EFR07!D@))"X7.P3*, 8#
M^^#7KDP\TXT!,.@XU_*!-$#C:HWU-D D'T\-JVHKQRHFA(2<IPG+@L1EA@GG
M'W&<^.#X[<5-QCC&,<8]L<8K47P=4VP> G&^GN !@1ARBJBD@JJAU<*J=0IR
MB+QXYU[SQD8R,TKE)\)S^-*4TI32E-*4TI32E-*4TI32E;31%%47\I^4\]2<
M<JGE$YXY7[)RNG^?RI5!?1O/A'N?ZPZ6L*04"NWXO[-_O&I@.07&29HS="TG
MP "-17\"B^$Z45...;_64 M-%?NS6*9/T$-N0/KC>W?GGZ53:8S-<ZHI)VI=
M84'L ))@,?3Y5_E[U?S5!5S32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*
M4TI32E-*4TI32E1!N/O3A6V+D>+D$R0[93 )V-55[!RIIM)RB.D (J,MJ2*/
M4ZHHO'//CQLCA>4Y7L.#D\?R\G[><"IUEIUU?D]!/D!P78X4?KY\']:\V-R-
MV:O.=RW,AG^_AP74@UE S91'$8CM*3:$#KH$H,.2#5Q0<(>A"+ZE3E-3VAGC
MML1;-YYR/S9.?E.<\X[^W(\FNIGTS4;+0;N"S6W:Z92962?#,I.X#'/900<>
M"><\5+-M45,DF[9BJ_0Z9FGD1K9ZQ?:%)\UR/Q'6.A.J)$)<O*]]'2VO2JHJ
MHBUULDKW"A59NF<R EO?!SM4^,]O[X-<9HJ7MOJ23.L]O#)CXMI)5C5L]]AE
M;G//;N".!Q6$;>16EC64AB"S9P:')'YLFF4P%R;&?@H:I&)P@:,F7Q5SMF7!
M][KY5$14DWT4LC(KC:Z *\9R 6.1\V.1WSD#M5UZKMKJZ:VF@*S0],75Q"#D
MS9P-RG\K#D\C@CC %5$W"B5&XN47^2/2:^D8IS>DQ*^8$%FRBP93S#AXU)&M
MG3(LL6)=<$MLG'Q?,7E:=;Z1%"B:QZEN/1UYZ:TF'0KW4H_4NI"QN;JR,MS;
MZ;,D8$-^Q-N"$E#LLC.4A"*"C[L@QM(A>VM[E=BHTA67L "IY51AL;@?S <@
M>*G;9&WCW^VUY5RX-K/R*JR!YFKO)\PW2=;=$9ANR%.%!8B1V%,FV(S+;P!%
M% %T^>=6^NV[1W:L%:-I(X7CBAB*QIAE4D-O?>Y WLVX  GY0,BJ6[74KBZ(
M3XB6Y611"7+")%## 7&U=@  .<_;FIUVNWHQO9N=ER7C$R1$N),!V!'JXROO
MR)\5MUB<X()P@, !@*NEQRX@BBKRYQ'DA>4PA3\VS+9]SYX!)XYP/ &*[>]T
MV\U-+!0 )X;<).6)" @ DC'< !CY\#[VDV[]3FVVXEQ'QZ!,GU-]*Y2)6W40
MXI2C$4(VX\A5*.\XB? H2$JJJ"BKK1+:RQ@G *K^8Y^X.!WX_P QFJ2^T+4=
M/3JSQJ8L9$B,&P!G)8#M@8R>W-6,1>%3E27^_E4Y7CA43X5%^_*^.-1ZJ*^F
ME*:4II2FE*:4II_G\J5&F[NV&-[P[=9/MSE+!.TN30%AR#;)0?BO"8O1)L9Q
M%Y;DPY3;4A@T\BX"*FI^EZE/I%_;:A;8,MN^0K?DD1P4DB<>4DC9D<#NI(J!
MJFG0:K8W-A<@]*X3;N'YD<$-'(O;YHW"L/J*\GK3:+UY;4QBPS#Z['=S,=B<
M5]%E;4^-$M4K@3MQ"MJ^6XT(/QHX@V^X"N(X8]P143357+^R+]C.O:K-K,NK
MZ[Z:2]G:[U+T]9DO8/<RN9;E;>8J[Q0SN68HA&P,0O;FI'J[]JFC646FV]CH
M^N&*/X6UU><".YCMD&VW:>(G$DL8 !8CG;DUE'IL]!.>CN;"WI]1UE!G7U1.
M;MZ#%H$I)[#=LV?<8GVDMM!9)(AH!1HC0=(.#RJFHHNOK6J>K]!T;TW!Z.]"
MV1LM*AMC;&?8(M\)4APBY9V>4L3++(VY\Y[<5R.C>CM7OM=?U1ZMNTN]1DE%
MP81AL3(P,39&U56/'RQIE?>O7.57P;.%+K+.%%L*Z='>BS8,YAJ5#F1) DT]
M&E17P-E^.^VK@.,N@;9MFH$*@7&OE*EE*,I*LHSD$@AA@ @CSC.#7U(=V\ Y
M  ]CP>1SSGG[U&Q;"[)GC28:6U&WRXFEDES^[G[J4R4RVPMJT-DM>D3VQ3A:
M)6QE$VKP@O2AH/":EB]NQ*DXN9^M&K*DO5<NJL"K*&))VL"01V(^PK PPE'0
MQ1E)"ID4HN'*8VEACDK@;3W&.,5F4;",/A4,+%X>+T,3&ZY&!@4,:KAL5$-(
MKB/1_;5[3(1659=1'0(&A(7?XG/6JKK2TTKRB=Y9&F!)$K.Q?)X)W$Y[$C[$
MCM601%3IJBJF,;0H"XX\ 8\"LD1EM.> 1.4X7Y\I^%_/^O\ ;6H  8' SGC_
M #^?OYK+'.?TKJ8^-T$6I=H8U-6,TC[,J.]4MPV!KGF)RN+,9=A]'8<:E*ZX
ML@"!1=5PU-"ZEY]/)!.25  )). H 7'MM"@#VQQ7F!S_ /(L3CC)8DL>/<DY
MK""V1V=*JI*(MKL"*FQJ<Y9X_5%BM,4"FL7G$=>FUL58:LPY+K@B3KK  ;BB
M/6I=(\23>79=I/B9^HZ"-W$KAFC48"$ALE0.,=JPZ4>T+TTV@[@NT;<Y!SCM
MG@8XXP .!69T^+8WCRR%H:*JIUEJ)2EK8,>&L@A<>=%7E8 .XHN2'S13Y5">
M<5/)ESI:21P \CN!@C<S-C"J@QDG^%%7["LPH!R!R?/GN3_<D_K7?(B)\?\
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M:4II2FE*:4II2FE*X\AY([3KY*JBRV;IHB=2]+:*1(B?\R\HB)\^/'*Z4')
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M2R*19RIZ0;+$FXB--PX+[BA)??;,!<8>AL$])]PZX:)[?M.*8O*.JE)K@,&
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MX\\_CRG&O#G&1GCV[GQ_G!I7E9OC4^J"T]35?O=@^%^[VXV.L\?QB/7%D%K
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M6H1P8<9C*#][ZEN:7.1()49#"'C;>EBC(58-D1K86K+R2A0L2"3GSX6W5"O
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M#@;67 ]ML-N4B2-7)"6UM;!MQ)(@:0[ASSD.6SW+,^>YKG5'[/'/Y]CDF09
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M&W$B"K>IL'J+4+69)XMF]?@ "8U?_P"GJXAX/ W23-+)QAV&6)P,QGL+>19
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M;W5K.VU6^)&%33K:Y,0O+A5C(2&!"[XPJGFIOQ_<BBE4@JEG/&OL0"2]$8D
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M44/)($JLAJ?=<E.RW&R5DH\>,VX^YVG$$W%Z4! 155=;(@YD!C&7'(YQV_\
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MNR[FM42%+<VZ.&ZS31I DL*H%:9G61E8O@9R#M; VY\8?MM(K)6;6F,3[C?
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M+$8Q*X"@YB"$%52I_H<GC6#=5<U=VE;90X2-,O=M78<F*XJR&E(6S!P>",G
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MTJRR5:ZFS^*SW&QQ':0*!UG"%W9E1""P8>W-_92SI!IT\=TZ.LE]=SPD16L
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ML,"KCK@,@B )&\8-BBFYTMBIF7"*;A]("JJI$2"G)<)JH RW!)_A"X\\=O/
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M%K9>I&M$O=4MV:,PI+:N\"-%<.'*0G?F'<5!P<'XY8_LIT_3[:32G]8>H?\
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M6NL3ZE,IMYG<W %G(I(B3:Q"LZX\#&<'MQ@'M"U_(8*VEV<5MPID1J+'DR(
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MX !P<CW%5MW"&WS+.,@@9K9V\1\(@_HD*OFK(2<:$P,=Z0K':Y59SK3:<HH
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M-OOR2;A21+DF8SC@-B1]0(9*BKPNMT$37=Y;6D;F.XN)DCB))96)=0<H01M
M)9F(P #GD U7^H?4-CHD4U_/-.I_%F6V3YEEV /(DB$9 ?  /'/.#Q4>Y#2^
MI.+M>6\,:^H8M/[#]48P^3"<=5:CI5]$EV??0TG%%0'3%M.R)FH\%XYI=._:
M'Z.N/55EZ:/I^^N-)OM9_<">K8KU82VJJYB9O@@K-\(;A&C !.Y<M[&N/U*7
MUNFD7/JFWU#2[>:UTXZFWIR2P9P;#B58Y;X.#UFB*L^T;0S'D>.TVBS!_<>G
MK\EDQR%IRM65&I!>4V_<LM.J\!$*JARI#PN$Z\YR2 B ""*<)UGJ#3AHNH:A
MIZLTC6MQ+&)64@NN6*/XPI!RHS^7;SCFNTTW65U3TGI^OV]LJSZG91W3QHQ8
MB61<RI$W<)&^Y #G 4 FK2V=<'[@)DHW,-J5RG%:++2(/**HLJA?Q$517MGY
MY55Y5$ZN-<?\1,5/(R7' //!P/?[=NX^^>"FU[5 C7*7)#;C&T&<!2)2NW;D
M9)"@L/+$^_$=X7MQ)R_=_$?T9\JYRIF1<@ERVD7EB/&)M]QI%'A!1WRSP7/A
M>$X^-7$DS"V 8Y9P >>>01[^P!..WWR:^FSZEMT/JSC+W4:6Z@8R/PP3D>^3
MWQ]P,&O70$X 4_ HG]^$^?\ 7YU65P-:]0\\<IS^.4Y\?/\ C3(]Z4Y3\I_E
M-*4ZA_*?Y32E.H?^9/\ *:4IU#\=2<_CE/Z__I?\+KS(]QQWY_SV/\J4Y3\I
M_E-,CW'/;ZTIU#_S)_E->TK551/E43^^E*:4II2J;^K[ +7*L1I\BI(B2YF(
M67OY+(-]4ERN-@VY*M=**2]"\.*(I_Z5ZDX^)-JX5]K' <;3VQSP>_;(R/IW
MSQ70^G+Q+>[:"7'3NT,&2, ,W"DD]AGL>W^]8,(W"R1<?DT%6L%(TT>A2DO]
MGMBHJ/#@+]7($I?"=2<*B+SQJ,]G,ID"-A=P\X# GP<\_7CBN>N_3.M03W,=
MM%&UM<32G>9(\J#NRPPHY )8#C)';FLWS7,9-9M^$2)$L,FL<<QPW%A4L-V;
M9V!P(A..,Q(32JXZJ""J+:)P9(*BG6O&IL211(IN2VPD&38NY]F?FV <LY7.
M #DG !SBNLTC2+C;#9PFW6_F46UM+>3""S^+GQ'!\3<$!(H>JR=60GY$W-GY
M>*"Y7E<2QRG&GMJ;S+(TC(G*Z+GV-V4B<W62H* #-BL^K?%&:U(T=IPHG2VT
M\L@1ZB,B+4R]FTZ26V_=JEYOBV::;9*5%GM&U"K'"R#D[T&%/)!.<=[Z'T3U
MO8:-ZG3]IT-C%IT&GA_3BS)ILFHQ>I8;LREM.O+!>I)ID^&39/),##*&C:-8
MPM74VXQ)B6#!(T!(HBB)PJKPO"KY^502Y_V7X^=4\@7)(QV[^/'M_7N!GV%<
MOJ%TR,S>Q.#X')XR!G)_W[8J9KS"L?=HKJ/+"%<@S43W+"ACI&LY<N&$1SW$
M-*OJ-R2<IOF.D8V^'C=%I>%+4:.X)EC$9*R-)&$8/LVOO&U]ZD%0IPV?X=N<
M'M5 NH+([IE7W;@T88!B,$LHP>/(\YQ7EK&HL.P?)*QZIV\RS;'#[B=96+6/
M9"\TSU/-.0VK2WI\?4Y$BD::@6#T=SON^W(W00$$@#B3^T2Z]93^BO5!])RV
MVL^LX],@M],FMG0W+27%S#&T,-Y(!;SW:6AN)+,%"YN4BSD X;;?IVR SVUF
M>J[IRP3;&[;Y$&3TV=0"Q&,>179[N3,&NHL8L?&/%!RSB0&'9EO(B,M.O!/(
M8MA8M&3M>]9-"D11Y1$-'/(<$6OD_P"P7TQ^T#T_;^I)O6MWJL\6H7]M/I&F
MW^H#6K^QAM4N)+FZ#MN2-WCN;>*>W4[4DMBRJ"5S-6>V-[ ENT$&+5RS%&BB
MF!&%1B I4N<@.!CD\\8$L>E?&([4BXQ*]VP8VEAN3&9LRPB6Z6L3.7B;)L+-
MNP<??EOMQ&^&S1YP>4-5%%%437V+U-,+A[(+K#ZDAB<.CPF.2Q/6)Z# (JQ]
MBVU"1Y/?CDM?,PN!9M&EM$V6F$,C2-.Q_*Q<D[DQ@D9X/ZU:.SK*FI*\IZZP
M"5%K>U(@F!H:QU<ZEY Q_B"B&V)B*^1XY7G5)9D2 H2"!\O&,X&.>_8?U]C4
MGTO.Z3SV8E,L:KA4\8; ().>0I)Q7.HJK#]^GEB?J?[L[IU$-&WGVQ#L9#$8
M06FGY3'/,D@$2[KC?\047ZE7[RCU+8XQNB;DJ3E3D8Y...<$=^1QS71S?%:&
M7C=/B]-GRRQ.N54L<D9.%X..#CZ=JZ.P],^]H/)%@KC;S1FK7ZH$I6>VT1*)
M.*T8J\(B*\JVWQSQT_?7L<MHAW=$!\$[@.<G]?/]">,5Y!?^G+<]>*P*7!RQ
M C4+O.3P0!CD\'GQV&15S=C]IFMIL:.K=L%M;:QDE/MIZAT"Y))IL$:8'RO8
M905%LB555.?CE-1II>L^[D#L >/M]^#_ 'JCU347U*Y$S($55VHH\#)(S],?
M3OX]IMUJJNII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2H_W#V_HMS,8GXKD
M+1G"FD+C3S?4$B',94RC2X[B)]#L=54P7GA>51?YM9(Y1E8=P?\ ,_?^_;Q6
M^TNY;*X2>%BLBX+$<;ESVP/.<8X/'U%>9V=;%99M?9UM=.S>/.I;F4ZQ7HS'
M,+=6&E1262AF,8?I5!)QM%ZC^VK)+E9?RKAARQQD9]R<''/'G[\&NZM=9M]0
M1BMBWQ"@$R;\ 'N6/@9/(S@@DX[5)E-BV 4U7#K9$@DESW>A9)LNR&EFF/2'
MOIR(K33SOAH!(D1"(1(154745[IBYQR 3P",D#C/MC@GR*YZ?7HEO.E)*S,&
M9=ZD,BD'\A8<?3 (R>?%4^W>P>?0Y%,/$HU.C&4/!67KDQE"<@QGE>;_ %EI
ML11HP1\(\=U.KW#IFT(J(-\:E7%GINLPZ8=4.H)^Y-4M-9L397LUL'O;0AHT
MN.BP^)MG_P#=MY,Q8_.&':\$7QS!A\G(!W @$G^'G R1X!R>!S@FK#X-AD'&
MMOH3S50Q;U=08LVDHWFQ)EU]UU^2U#;+E36.^Z338FJ H"J)YX+6C4-2$MQ/
M+&-G.2".#CN3SQCSSQSFN5O-=$$K06D;RPV;%)Y3*&1F#;2=P;:2K<'D'/&,
MYK'B@TX9N\B+[BH6 C[H>.V*=8.0NV/\C;I&H)R@=1*1=**J<:VNRFW1MOYR
M%7(RI+^"2#P0<X&<@9[&NGO+^*STN.]=/E<X2;@2,Q&5R20=ISQ@8QG[UAVY
M>X6,T4V#&>I8MGBUQB%]DD#),>E?J;QSJ27'KTQT(S9=M^WG2WO:MQU-DVWQ
M0' !$(M2[+3Y9XY4D/PEVEW!:Q6DOX221W$3-UR6P%15!<^X!QP15'IOJ2\D
MN\7<82 G,1BYDDQ^4$* V"?Z>.3C&-GG++$-SKG(,.QRL>>L8E?76C601W7)
M1/QF77498-DU2$+12#1Q@$,'W&4<(NHP/7->IO3J^HY=,N)=3EA&BF\BLK9%
M633G:]N(][W$$B-U)W$12)PZ]-3MXSSTMQ;(S2ZL9$BO-0MXH)EDC)D:WL9,
M6<<4N,0LQ<RR*2"2HJ2;/9&Z;W)M-[<C;8"^L*!JC@5U.RL:#$K5D),E/*3X
MD<N:\XC0B]U(,5H";;%557"W>E+&/TOZ8G]+V=U->)>Z_?>H;J2X=@L=W=(8
MNE8PK\MO"D8626,C\:>1CO8Y%<U'I_Q7J9?4,]Q!\3^ZH]$ALTC B2WC_P")
M6YEE4;[BX>0 $,2JD[3CL<KKLWC6..2*.9+6+455B<B0S):;]XCC9(^)%+3I
M162Z.GE!$N441ZEYU):R"2[&.48B0E>?)) (_B^V#G]<19/2=S'=[)+B.2 S
MB[08P[.&W;  ,X5L=L]L U&V+SX4_,;*PLF(4FP]\W[=R6 B,BF!_P!U&C,N
MN#RW&5S^*!"*HKB<JJ+YU.FZXM=D4KJ#*)-K@@YVE,$'^F?&/&,]%K>G7-UI
M4"6G^L8T:<;MN\1NQ>,D\J6P#@\X[ @5*&;28=I(G'"@0X;UVW"K:^B@&+QN
MSC,1:D&C?(@Z/*M +:D7;>)PQ1154A6L3P[FDP.226.,\ >?_&2!W(JC]-:9
M>:?<S7]VOPULS(JHLH*9#J"9AD 9)SD_Q;<'FO2O!H%O68Q0U]R^+UA#K*YB
M0H@HHAQZZ-'=;7PBJHO"XJ'PJ$O/"\>-:6.6)]R<?;/\_P"=5,K!IYV'9IY6
M7[,S$8[^,^?[UF6L:PII2MI?RKXYX\HB<>51>43SX\\<<K\?.E*A;?3:Z\W=
MP*9A5#N-E6V+T^;!.9DF'E&"Z.MCR>N76-/2VG48;GLH3#K[2"\*&J@8HO.K
M#2;^'3;V.\ELH+]8ED M[@-T2[1LB.P7!;I,0X&<94 \&L67<I&XKGRO?CG'
MV/8_3^50VUZ6Z:CG;;XMCU37O;>4"3K+-;2YF3+#,<HMQBHS7)+F/BX<AF2Z
M;DR>3DEOI, ;!M11$29-JXNX[Z>ZWO>RE%LHD55L[2,M^(8X\?*R* (R%)R2
M<Y.:S1F3 X(P<N?S$^.P'G^A[^*^^!["4^8;=Y#MSO=MO06-=2Y?D4#&G76&
M3.RQ99I/4MJU+C.#,BRW&#$#7N-N@32<HGRN5WJDEO>17FE7DZR2VL)N.2%2
M<H!*@1OD= 1GD8YP.*\8!AA@,$Y/W^XYQ5KJ&G@8_65U)5QEBUM3!8KH+/49
MHU$B-ML,-(XZ1NN*VVV(=9FI$B(JJOA=44DCS3/-)R\K-([X4;G;OD#&#] ,
M?R-.PQXX_IG_ *UP\LQ+',TJQI\II85]5A.@60U]@RC\;WU7+:GU\E6E5!-R
M)-CL2&D+D>XV*D))X7U)9(762)BDBGY64X/S J0#XR"1]N.U>'!5E/9QM(]Q
MWQ_2N]8%$Y3IX04Z4Y3QPG")QRGQPGA/''QQXY7#.6/CWXQDG!X/GCO_ +^
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MK#+MDD4A"@$))2?<RA75U7< "=,%]'(MKN&TS)N8D<1LTLD,8D((.)'B<Q[
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MC1XLEK'*EU'&9DIN>ST/3)[2H*HVK1DC#9)]*])JB&@KK&[N%8=- ,8 &.V
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ML'5FCD53M9G@PW'RH9HQ(1DXX3<6]@.U4KJH/K&:V^R:OR&1EV=75W1;:7\
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M@'O]_/8<UJEDZ:@@;B3CO@#[GV_ES51L=]7.[M7G&53+_#\;O-I/_%+',/\
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MQ]NY&81\\O,AK[^JJUB)?5E?08-=Y8Z]7.R9$.";D8JIP'U><4.PCRQVS<(
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M->/JY!P%5?(KJ5%<[3^(-W!Y/?SC_IY'DCOF_P!.UYK;Y+N,W$9Y,B8^(!\
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M?4+M7%I(3<5RIR>7'L+^ K2"@*Q:SHL>5+%51'7V0<).L4+6$E_>R_GN9O\
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'-*4TI7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>g68105g97b86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g97b86.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[26D4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )8B^E@@X0DE-! 0      $ < 5H  QLE1QP"   "@  < E  "')R,CDT
M,38U' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0)&C6/Q&MV21\,%=N<M2D0#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              0$   )F          $
M                     0             "9@   0$
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   0$     4F=H=&QO;F<
M  )F    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   $!     %)G:'1L;VYG   "9@    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M     #A"24T$$0       0$ .$))3004       $    !#A"24T$#      ;
M*0    $   "@    0P   >   'V@   ;#0 8  '_V/_B#%A)0T-?4%)/1DE,
M10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$  &%C<W!-
M4T94     $E%0R!S4D="               !  #VU@ !     -,M2% @(
M
M$6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M    %')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0
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M
M      !865H@        \U$  0    $6S%A96B
M6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M       DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C
M+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                 &1E<V,
M    +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@
M<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L
M;W5R('-P86-E("T@<U)'0@                            !D97-C
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0                                  =FEE=P
M    $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %
M  !7'^=M96%S          $                        "CP    )S:6<@
M     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #<
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M.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B ^8#Z@/N _(3]A/Z(_XD C0&1
MID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G
M1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+XDPJ3'),
MNDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q4GQ2QU,3
M4U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9&EEI6;A:
M!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV %8%=@JF#\
M84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I:#]H
MEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7 K
M<(9PX'$Z<95Q\')+<J9S 7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M@#FQ$ATB"!T5K=B:M,1(Y3@Y$[3!W[P ,1*\^+/E(RE#"(;%%$I   T(B];
M8-#ZB@&R^KQ$.NAK835<1Z+0P<Q$ 0!!< ?"(QWD#:%B:XFO9.=DFO6$^JA4
M@9.TP8SML5]A,="$3 H[!Y(&,.Q'JDT2Y WU'F QUR^/K*&^H;J1O,YP,P>H
M.>N/5U[AF#T4C #?O? _DU%[0(V=6@-(\0&D2,P3!C"['L9\4N+8GAPLC&DS
M?68\?.;$;Y :W=C+'+%N%GY]2O5[%N&BEY2KB8;,6Q6C)D[AGQI."EGC=BY
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M13N<GI?W+APA;<Z;J8:ZJ'.J17<6%UP[T1) QS8;GZ. ,1,2+TBW:!R!D'K
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M^)+;%PD]*H#M,BB)U&Y%DSZ4(8&QTQ*0VN4@E'0;T'&-7J-J:C=.8 T"L00
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MYO/NKEDWJK=T^3<C&K>:A69;:NZA7+#6:YE"H]['U'E[ZH>&M91)=+?1G#,
MF=X5]2KZ.;"SJ4&#S7F8VDT- IM+JQI"&@!H$XP(!V$[61@_*?!M;F7KJNG.
M64N#B]'9F..H6ZF-C</=I6QCR<A%'3[ZJ7EMK3V.[N@R33!JJT2E38]L:SY.
M63$IFTS%G9KN3QO*-\:=!EK;7C>5U6>UNZSG.#6 YEP) )P"3'49A9FGV+75
M9,@.(D02!(SWCU@SZIA6C<&3^#)YB*Y,>P<%@,EJK\-UTM0G&..+:1O93,[3
M)!G-IK-[^+$C=3=VE:9Q1VVDR-73<0!^198 ,$6VU^:@=4\Z8WSJBV!4J "F
MZCS/Z[<T#:)Z!8VIJEG3OJ5FX/[6I;OJ3S22\/(:)G,M@[Y^'Q3R)P7/'7#T
MA;V3>%:P<.1DAC #VY)</[:Z,WVU<$-:LM]7C[(]X*QC,9FVYNZ$V:+LEX2E
MVQ#EO((O(Z,;L(YVW<TBR^IMNFN;<ON#S37+WFDYD^BU@.QY8F#W&%>U:=&N
MUI<UKJ<!I8X M@XCE,@Y\.NW??G%KGC@^A[&RG?F#X3APNO,%SX4PS:K<?K5
M8^N9%G>\?=V1(C)]QP$.3'=L6<WFE;17@47$Q#VA$MC=^RF&R:D@Q9R:-2VT
M[4GNMVW-6LP4G5W/E]0!P EO/Z7I 8(!D>$&%BK75=.81:BLVER]BYM6G18R
ME3-9W+@!K1/3'K](RN.7BBX&X#+[N<B8OAUG(.[N-?A91NAS<^(+/N9HSX82
MX50@<ZGB6\[;;UM!Q 74W(20<QR2,NA(J!+1BB;L!5JW99WQI&DQU5A\VNZH
MY'N;-=D!C(:6G D@"!TV*SQ- 508:9.70"3@]<_MP( Z8=-D[@3:<-MR0+%3
M!(VDGAS-MOR-AN\<IO.)*8XGI#(MV.\07[:.3#P"TY'X\8V\K8[@K1&XR6LE
M 1%P0<Y!NI:04,:YHC43=4&N-R:CO,R'FI5-#E<UH>'-#N4ESI))F9,R9"IN
M['L@0&]3L-Y.1[XC;$Q.%G1KQ;<#I+Q0C?J,X4OJ-CN)'AZ@&BRV!,>++%X?
MI;#X-\ZR#I^:T_/'YE+Y;($6FGIUIF$>*N%;=<1JRAU!DJ:??N)<VK<3YO7=
MBJ\2ZG=<E$[Q+VC/6!!D01)SLD$@;Q&(P.8XF-SW 1XR%BG+%Z<$;GL][\L>
MVKFQ!=N3VEKVX_L!=A85LV[D&V[@2RVLO*0RDTG9A[Y?"C9JG=!)7!DEU%3,
M>J",=:J I'=!7M6ZD-0H5:K7AM,%M4.<Z'#L09<V0"0<R02#DG96;76EO<5K
M9I8TWDUZ8:&C\,X\SV  #>"7#W[R.@S0@ E+H2CXB(_@^+U?%[:VU5.9IB6@
MGU#QV]GORKBASF7CYJ/Y2B8[0CM,=!L5&:Q#*:Z=#&(;11WO0"'0*D(!<T".
M8$9B3'K[A[3ZRL9>,+:]G<CT6M>^F ,?3!9 C$!T.]>1!.-J0\T64! ![I^K
MSEUT$JB"0@.@WU#EYNN_6/JJO3 +R!B1OB<R(.T^&!$8DJ9[&"[J .P+7FY<
M!L]L[,;<QZ')B%Z^O)0&,V%R<8TF9-U]3YXO$C'SDP&!HK+I.[X<*) .NZ,X
M;M%VAS@32@)+HF-Z)PWHO&CQ-@PY>.UEQWC$ G),' &(C8;++Z6!#SU]F2=S
MCVR>LKV@UHJRZ41*(@^ _P"[Q_!1%Y!/*PH^X#XNX5I-(CH]KH7W=;5T<HG%
MHE-.(%4['GY0%(KCS1%\")E/2,!E"E-L0"MOX1[/M[H&.<4VEA_.!F)#MQ["
M/<K2\/X/VR<?]/W=T+Q11(Z>%,8  I$E1,(]"B'<G#0CK[$!$.GAK>M5O(RY
M\8D. /78CUX(V)[L K"7K1YN1 A[J'-@9)?C<02,&>G>-U+;@&ORU<5<5N%L
MGWS*H0=G6=?T$^N*6==X5!E&G\Z%5<YD/V8 ("()@*8B<I3\P@/@.,U(U765
MS3I N<VF"UQ'-!(C(R8R"1 F""3*FJ<OG5DR (<ZH\0(<*6/2'T7&7-=UAT;
MXCLIL[CKPOE[*Y;$N.W\7X;PKB'Z^=_XX1R HMFUG?V2+ZG8'SE5W.9?MZ^;
M>M0)2$C#.X1(]A3L3&K)KH-(AR^D$7#;$U-,K4+=U6@'/N7NI->VW>ZV:T.I
MR264RV1)DB,DB5E>V94J&6M.<2!ML=Q'V=ZSV\X@.S\C<R0;"S+:X9Y+'%]<
M2V4);*;A[B2T9GW)P/+X-L K5&#?R-IM'-IQX9")<9HQ:W(^ D(2717-!H0[
M5TY;NK2G:ZIV(>\UFN;1:YA%1X+G=L?$'F(@3F>F1"I7%S:4G,<]X::[A;P(
MCM*I#&D>(+@9D$$#*Q-$YAX,'27"S)DN'A6C\/0UY\*[C)&,[HPFC-YV/><!
MD1%UG^;N?("L0F_7QU*PX2;]PTN68N&T):UG$-;L+;4<Y9)J-J_9ZB//&5!=
M&NZDT4'4ZM04FES.4-> 0.<D@'8D[JC9T*-K:VM&F1RV]%[G"  34KDMD 08
M=Z0G.QP0"N-C+B6X*+NQ)F^4R99?#TPOJ0R7EIO.VZK8=HV$E<^%T<;-K7P5
M&8B4A,/W?+1$M%3;&5DY!W9$C9UXRMSO(R<O6=G(Y1TNWIUK34V5;9E*I7J,
M#6OKGM*ABH3+V9<3$  #ND "5=$T7 D\I(&[@TF1$$$#NCNZ'O"D?AGB9X%<
M+1G#$]B+WX?7UUX^R9@%\%\M\36+%7#%6)/8HNVWLO?5$QC\<-YT%H6\GL2>
M2>7=?.09YR^8(W/&C;2'FJ"UO5L]0JNN6EMR6EE8<O:5"W%9H&"8 Y,;;$]Y
M505*3.S<'$%I$D8,1G8'/P&!T6)[ ROPJKQ5N$-=W#%&YFA<49-B_KE7=BZW
MY_"D;?$CQ /)]T>1M<MIJVV[<3>-U72=G'=PBS6)8+M&T<WCU"M#)78M[XM
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MOF\AI,Q) D8_!\N6].]6]E[B,[/J\[8XF)E)+#=X77=M[YEDIIW<<6UC;FO
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M[&%YLG?DHW$,0SY&/XGL-G9JN2BT5=PUZI.19)F5,0%R(PJJ)5S:(*I4E5"
MH4.4Q@ !K81Q72(S9O,R2>V< 23DQ,2K(V+N<.#VPT\S0YI<02WE)!.T@F8Z
M&.I6UYY*5Q(K-V+8O$UA0A&B2A1W%7R '545$RB@ 2#+OT"I &_67>^F@'BN
MC_8ZHS.*A,8V!),]ZEI6%1E6M4-1A[4B1R3AH ;OW&2)V),>/!#R4'B1T'_.
M>PF'KT,-?8B CU\0@];]6PJ<<5V^";*H7-$!Q<PD"3L3F/;'=A53:&3,'QP)
M]D85:6\E6XC1A&L.WXF,*$T[4=O531-]%\X6^P13*)8/F!-)/TB@8-@?8AUJ
M!XLH\Q/F=0R>KA\?7.?<K5NE/-[4NZM8.;YN*5"F ":<[YV!.9+8)!@JC?K4
M#B2'QXG<(C[=Q-]>&]Z'4!KQZC[1Z^-1'%M 0/-*F)C(,>HRKWS0;@Q[!/U#
MKNM_ZT^XDQZ_JG,)]>NPC+[#U" #KW ]@B'X1]M0^^RD3/F+CXFH02/$3CU;
M=RAYF)GF,^LKDL_)0^(5%T@>0XEL+N&B:@G402B[ZYUO1]%#G&#*!2*G H+&
MZ"5,!$FA$:A]]E'8V=3N^ES > !P0.GO\%2JV+W4RRE4#''\YPYB!,X)$B-@
M!OLJ\U\EDXDE;@CI>4XE\,*,F3AJJ1BSB[W(DBV;*"LBU;IGA (1(3\AC^LY
MB@<XB<>>IJ?%=NQE1@L'0\DR*I!SU(G?OR?'&%8U-&J>95;>A6%.XKM_#7$$
M/+W9>0X>ERDDP)[L*XY?R87B4DUYPZ7$CAM DLLKW93L+[.9!JKR$[D0]QP3
M(!2>)"$%,#"82@.^M>GQC:TZ+6&RK!S6@ AU Q C!-,O@20"23#B"<F</:\'
M]E<V%Q<7?:^9L(=3:'!M1T0'.G#G P9(^L*R%/)5.(\\:V9!Q,X6**#ETX.<
MT3>XE.*Y4BZ$/</FV ICZO$PZ /5#[\* ,^8/)B"36/,0.I(($G? &T" <YR
MEI+Z5T^X-<D.938 9D%KG&9Q)$[S)/4*E!Y*)Q)%."A>)W")3 8!#]RK[$V]
M@;8#[@B ]-!L=[#QWXA2/%M(U!4\Q>>4R :[L>&_3<01[%=BR)$&HV',<QQ:
MT9#A$D#Z7C/Q"KL[Y*]Q+S:[917B<PJ (-B-]*15\ 4 ( !L@$@]== (;+T$
M \*J5N,:%4MBSK -.0'G?$Y),GQ/KG98K2.'_N92N6"JU[Z]5SPXL!+6ETP3
M$^R8R1"I"7DI7$JB*O)Q/85YU4@2*(15\@8-*)J!O4&&]=V&N@:UX;U5O]]5
MN7%PM*@$DM]+:>XB8S,QOB1$K*5K'MN3FY2&=( ;F9@;#<[#,D'=<MMY*MQ+
MD!9L\XG<)N6;LX&71/%7V91,XCT<H*&@Q%-QT* @!N10H!WG-TT^^FB2)LGD
M9_TKAC$>C($8VQ"MZFDL/95;<LMZU+T06- !:V?1]$"&[R,@^]4S]:?<1X[$
M.)W"8@(" <T5?7-R"(CRFY8(2^OT@ 1 1V-1'%=O$>9U /ZH,B??GU]5>"T)
M YW-+H'-RM ;/6 ! $[ 8"U#R3_B3$1UQ/83V(@(",5?0]0\!ZP&^GM'6OP5
M-]]EOD>9U"#O/+F.\F9@;3/<%'S3_>]TCX+>'DH/$F7PXGL)B(CX>Y%\CH0-
MS!XP.QT(;#>PWUT ZJ;[[K83-E4SDDD"3WG*>:G^NZ0  >8[#&(/[%6GODK/
M$:]CHMHOQ+X6\ZCA50*N,7? IF:''ODDQ_<,JHF27 X@&A*!1Y0#6JF;Q=;"
M"+!P(!B:KOSB"XC^KS$2X").3$!8ZCI56WN;RHRJTT+LL<*0F:=5L%[^H'.Z
M2[ )DR=XI@>2D\2'*(?JE\)"/B!ABKZWO8CZX/?K'U@ [\.HZC]^%&,V+S__
M #'?O,DS^W,J[\Q?,]HT9)@-P,S@0J@'DJ_$>,<BP/Q,86,"+DZR8A&7N()E
M4( '* ^X8Z$50(;Y/$.E09Q?0:9.GN.(CMG''M=W3W1.(5+[EN[>K7[4?A&-
M:1&Q:" 8  ,28[I/>09:\*WDPUOV1DF%OKB>S/$Y&A+>?LI%O8E@Q3]C%W N
MQ,F=-"?E9I!J[(P.HD3SEJT:F.Y2 R9EDP-NK>[XNKU+=U"UHBCS3^$>0YXF
M8 =Z1@3C,8&%&WTQM+\:\U0)@# $[@ >.#&\[P%ZP8.(CH&.8PT2R;Q\9%,6
ML?',FJ94F[1BS1(W:MD$RAHB**":::90\"E !V/6M.<2\N<\\SG$N<3DN<<D
MDG<D]2LL      !  P .X#H%6:@HI1$HBQ=F'$UA9UQK>F(\GP32YK$OR$?V
M[<D0\+Z#F-D4C(*F14  .V=MQ$JK1ZB)7#1=-)=$Y54P&IZ-:I0JMJTG<M6F
M9:02-\08(,$8<-C[D(D9$@X,Y!\"O(3F#R4BX37P^?X%XEK>:V(X>N'3*'R=
M"R_U01+=17G;QPR%N,GC.5(V)RIB].DP56,43F;D$XD+ME'BP\@%S:-=4:T
M&D\LD@8Y@""20)5G7M&U00TAH,B  ,'H0!MU/>L6-_)3.)- CP XF\*"L]2%
M#G"(OGT2*G 5>;]Q=CS%V'X1WT&JGWUT29-G4$Y(#B<QM,CKUR3CN5K6TZI4
M;;M[5@%NX.@L$$-,MQ_NG('0Y$'*X'ZT]XD!V(\3F$A'U@$1?>]_]QB%1^^V
MW_LE3_BZ^OF^Q79MR29(,G.!B?<?B5683R5;B,B'2KP_$SA=99-NN5F!(F]P
M(FX63[HBBH'@@$0(F)A#DZ@8"F\0W4?OLIQ MZ[1&PJ&#X$ COW/=U*L;S2G
MW;#1-5K*;ZS*E0 02QI$L)&"V)D'!F8RJ.;R3_B5.83FXG<)"8PB81&)OT1V
M)A.([]PA_P H1-\O7QH>+K<F76M4GF#C+I/,/SI+IYAT.ZO1;-:  T>BT-!A
MNS< #& .@Z+?^M/>)/Q_5.83WK6_<V^_7K?_ %#X#H.GQ![*B.+:8'*+)P;,
MP*S@)[X!B5+YD!M4=[_W+0ODGO$D4=FXG,*&T'0?<F^=@ ;T ?N+\8Z^40#Q
M&H#BVEG^25,Q,NW@^C,]W0].D)YD!L['=T/C!!S[5<"?DL7$LP:-6<)Q08>C
M@2.B[=/$&%]MWJ[X@ <.5=O"E,D@U4*4S5,A@)S 50X<X :ICQ9;.DU;.O5E
MO+#Q1?Z)B6@N!P?S@=S.(PK.GI'-="ZNJK:KV_B6!OH4C,R6G![N^)W$!9-N
M'R:OBPNF/MM.Y.+/'MS2T,18'$U=3G)$^^5 _>@1NBZE(YVY%DF*@BDW44*D
MF(!RDZ5);\4VUO5-1EB]H=RRUE8M&-L-<T$C8$_45A+WA6M>W5W6JWP+:Q(I
M-=1:128XSRL; #!&X;@G=8W/Y+)Q(+R;J1<\3&&%!=-UD-!%7N4Q#G1,BGXP
M@EY2@(<P '40]G2KI_&=%SR_S!X.(/;.D1O^=/U^Y7E/ATT=/MM.IUF<E$M=
MS<O*?0J=J(@28<?9GO5N*>2A<29P !XG,*Z#PW%7R( '_<6@$/$/"J3N,:),
M^9U9DQ+SB<&,SM QX+-&S>>;\*/2W] =\^^<_8J^IY+#Q,FMY&!+Q.85*DDO
MWXB6*O<H")C")=\L(!QUOU[T.QUUZS.XQIN9RFR?(C/;O.TYDN.0.N#GKDK%
MC0C]UWZF:K'S0;2:QS>;D<,%S>:0"3,D03WJWOUJ%Q)F]$>)_"NA]01-\=1#
M0AO<'ZM .]^(!ZP#5!_%M*HT-\VJ\O4<YCO[_COUE9;S2,!T9DQ(D]/# Q$0
MN<IY*?Q.E="Z1XI,-)F*L==/]S;['E,8Q3& 2!!&)HX!RF'6S?Y6ZF^^UG]C
MJ'>9KO,SOCF(S GO5F-&MNR-/DIY(/XML>@26=#ALRWNP=U\GWDH_$6].1PG
MQ+X3;JF()G)"1%] B*VQVH@4L((D[WE]),0Y2 (" !X5*.*J VL7 @NC\,[\
M[Z4D$273DG>!,]*EO85:(--]85&'\]X)>,]"[F(B1ZXB=EP_UIYQ*=/^<]A3
MP$ _<F^>@#XA_P!"=-['8>O8[J?[[J(@>9UH$0.U,#E^C$#$=(VZ*MYB(CG,
M=V(^"^I/)0.)0OCQ.83\=A^Y5\=!Z['I!![1WT'>Q^/<?ONI#:P,Q&:SC@&0
M!G:<Q@ YWRIO,QWC/A^Y5F'\E8XC62CQ)WQ,X679OF;AJX32BKXYS"8@BW./
M>P>N9)8I5 , <Q= )>H!J8\7T29\P=/?VKI[H^ED$8R3@#!6.N](?6-(T:K*
M;Z;PYKRV7M[X>!S"<B!OUA4W]:B<2'A^J7PEKV>Y5\A_^R>/QT^_&GUL7?\
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MPW%R,5? ))M"',==,HA!]Z!U3@D!M#HQ  H@)0 *F/%M&!_):N!B78'7?FD
M'/UXF5CJVD^<7%I4JU&]C:]H\L(DU:KI--[AD>BX MD>C&""51P\D_XE0U_S
MH,(Z 0'I$7V'@&NG[A=!UT == J4<7TQ,6U3TB"X!Y](B()]+)$""08@*_\
M-!WC8#;H-AML.@Z+</DG_$D("'ZI_"?7VQ-]?$'74#[  /D  J8<7TQM:51F
M3#H]N(3S-O1Q]1V^)^"W)^2A<1Y#%%3B=PH9,!#O +%7USB4! 1Y>:! O,&O
M1V.@Z5,.+Z4_DU83OZ1$R9,PZ<DDGJCK0P>5S>:/1YA(GI((B)B9[@JT_P#)
M7.)%V5LS;\3.%FD4S'3=H2)O@IE1'157+@Y8+2[M8H=3JB)40 "):#I1O%]-
MAD6U>!(!%02)SZ()C?U[F>L8ZAHIIBK5KUVUKM[BYE=S \4FYAK0_( \(]H@
MF^Y'R8SB,<+M18\1N'&K=I%MV"15&%\E.*B).0R_*E#%*//K8F$HFT&A'I56
MVXQMJ+JCGV=>J73!<*3B)GJX$C&#&ZU\\&5:E)S*NH<Q=<FLXAF2"0XL+A!
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M4F@2T("ERE,F)3%*(#Q=1>3_ "6J1UDGJ9.#C) )&Q(SNJ5?2&.8WLNSIU6
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M$=D^?GO4EJ(M-!UZ!U\>@=?EHB<I>OHAU\>@=?E^<:A [A[D30>P/F"HHM=
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M[U?:%+"B@E$2B)1$HB41*(E$7B>\I(=R1[^5,D)A1:GB&Z?4=$*:V6ABCH1
MN]COITV)A]8UZC\FK#2\F6H5J4]L;FZ(B=_.61D9QM]0V!7EO4WMN/+]=T;B
M.PMM*T=Q)Z VID@QWD;;Q!$PO(I')B90YP+S"&^<-;]HAU_WZ^6K:P9Z1JF,
MS&.N1(C<X]>T;KO5TZ"-P.D8WV]703O]16PL6_EY!!A'ME7;M=3NTT$@YC"(
MCHH  ;,81$0  UL1$ \1JC6M;B^NC;T:!,[$])ZS/?F 9CIA0??6UA9^<W5<
M6U!H)@Y,"<3[#O$=<;2]@>#^1CHUI)Y/O.U\=D>HIN@BY<[^2GQ:J$!1-0+>
MC$#JHBJ7T@+*/8M36N9,Q1!0=QLN#*IH%]5OT6E^2 #RYAQ)$ C$S'7HN5WG
ME;L*M>I1T;3]1U84:K:?:VU.AR,YHESJ];\%RL)EW84JS0 >=PJRN\L>$WA[
MPIP_8UFL3VQ;.327[ ,)-[>\M&H3#R>D7C9,SXA6ST718YFW==ZT)$)\@("D
M)7 JJAWAOE)Q9Y7_ "N7GE>XHX5K_=;A73-!UVXMK+0K*O<4:+[9E?EL]0-2
ME7+;JEJE%O;LCF;4YBV/1,?4_P#@R^3KR=\5Z"S5-4TG3=:U 6?:W5_=&WO!
M:U;BBU]2VYGOHN#F"?SJ3@X3 .%U(\2G#4]GLL0-I\/-@W7==U3,+[H7-8-A
M6])7(2VY(ZAC)HLF<&@_.U%R@7OUV $4%@;93 F/[&'T&X$O]?NN&;.\XH>V
MW>ZF.PN;ES;,/:8R9RPG^N=S&>6%YE\OVD^3KA7C9VG<&WU!UK5I\UUIVFE]
M^:%SVC^8,IVM:XK.?$\U,_0 /<9[@^S=\G4R_DBX;=REQHQ[K&&-&RS>41QC
MYXB:_+J2#D70;S0,U%4[6CEQ "NVZZ@3)T^9$6S$WIU)K_'.GZ>UU/27-O=0
M&U0#FM+=TY>'_P"GJ@;!LTMN8D[\7IV5YJOX-U&YT^P(,UZGH7U<=&T:+O2M
M*??4K-%P)/*QI',O;E8-@6?BRT("P[!M^,M6SK7CFT3!P40T29,&#%J0B2**
M**1"%+R@0!,;8G4-LZAA'8UQBZNKF^N*UW=UG5Z]=Q<YSH'?@1, 3$# Z!;3
M9VEM86U&TM*(H4* +&,9F9GTG'<DG+B<DDDYB<@?)5&/V>/O5RE$2B)1$HB4
M1*(E$2B+$F>O>7R=]YDY^9J41<W#?O:6G]S2?EGHBR=XT1?(P;,0OJ#8^(^
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MF/M.T&!WURKRS95VHV09-#)VH1PU:R[Y\HHH@"3&,=/VH*@FHHH"1C)E0.*
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MH]SW.)<XO<7$N))))).9.<KIE.C2H -I-:UH  Y6A@@ 8Y0!&VT*X2AHH!H
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M.UCO>YAT5UF2#>,2;L(](Y3@5-44VZ*"C@Y2E,DFH]<.E034$0,7G,4;]M*
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MXNQ)).2=SF%W*FRG2I4Z%)C6V])CJ3*+6M:RFPCE%-C&CE:UK!RAK0 T>B
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M*(E$2B)1%$_&WPB\T?;$9^AH6BB-G>K[0I844$HB41*(E$2B)1$HBZ^>(W@
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M<?-( J(*HL%W8)".RM\H&GU+6ZIUM'%&B7$LT^UN7A^H.!EM/4-2<SF;8L<
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MH55<4#H$$5!*F(@!C$. &!(1Y3F "&T U,*A:YQ:8R?2+>8"9$P2)@'KM@]
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M&MZD_)Z;>*E<X-!<[ :))[EU@&[<7LUP#1L_L^H:_>_-_)ZFOC\E;$.$.)"
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M8LD:U_\ +.V__#ZB/)GK1('G%H)/YKY/L$Y3[_=,/^AK_P#"NZ#L]..RVNT
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M #<,LFX@+@8LT15?X@23\REGT8VBI41$OI!$OGHE .8X%+U$H_/S\]%*P!V
M#[0 ?GHBUHB41*(E$2B)1$HB41*(E$2B)1$HB41*(HGXV^$7FC[8C/T-"T41
ML[U?:%+"B@E$2B+B+"H1-4Z1>=4"G,0A3 7O#@!M%,<P"4O.(%*4_*(%$>O0
M*(HFX5RM?<OD"YL97)CR[H<D(24GG=R75/)R!TRO)=5O&1K$&T.W8NV#A I5
MV9F4HZ,U;&*DZ$BH&(4GL]N/VS]2C2SQ:G:W&F20B<?.5(\TTPDT[J=WH_<
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M_F=OJ65L$QV/6D7.N;!>7U(@Z>,$I>1OV+ON,EU3,&0-(UL@2_8J*D%V+!B
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ME:63$VW:C9\(/E483O!NAU-S+IP>.D5C2C6V6C=L*?+,DC5%FX*PP,8]^?\
MKU[^O5/?[C\_)[BI?AX?V_K'Z1^6HHH>YHSC>^/;P?1EN+X^E(]G!)/9*+?-
MYH92TFTF9O'1U\7;.HR[&+;PR$XY(+BSFK!.5D+;CY2XD[D8(-A0$H3F._\
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M5 &Y--X ]<C""XH' JTSTP]ISW0#/SZUDA,Q3D(<A@.4Q0,4Q1 2F*(;*8!
M1 0$-" @(["J2K SD;+R0>53_O"X2/ONR9^B;:K=N"ORF\_4M^+EK?$WY);_
M -X)]G*W/J7C, IM!H=;\ V/K_\ ;^.NDEKR<%H'22%I+1Z(]_V_!-']H_%Z
M7C^.G)5[Q[Q^Q1D]Q^K]J[F.P&_A4>&_?JCLO;_\S=^^-:MQ;(T:XG?SZS]I
M%"#'J*SG#O\ .#AU[.8Z[%?H^!X!\@5RE;ZM:(E$2B)1$HB411/QM\(O-'VQ
M&?H:%HHC9WJ^T*6%%!*(E$2B)1%"!+'F2HB]H>)1LR?F;'MN\W-XVFG]5-C-
M+1B)1R9\0KM^_571OUT@P1D7PMHLD N8BK@Q5GD@D1)1,GS\_/V3-TO-REYP
M*!^4.<"B(E VO2 HB!1$H#O0B4!$.H@ ]*(L3Y$Q1;F1ET'DV\EF2L?;\W#,
MG,8Y;MS1XS$G;,T281%RT=)ED8F3M**>L%%4EF::B:OGS-R01+1%AC,^&L>H
M<-^2&$U Q%^+0-BY;NV.N*\(B"FY4ER7+'SUS3=PL5O<U)K&/GTTY%UWL0U:
M(H_M?S<I0;E "*5\7_B# ?5YBVZ__9FW]0T15*B)1$HB;#>MAOV>NDCO11/X
MY?@9<57\WW+?^P\U5W8?EMI_>:/^8U6]W^35_P!6[X+\M4 $#''J("(>(_\
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M'ZM!H=^SQKT5P#_1?2C_ -I>'ZWYF-MCOM/?!X9Q?_2*\B)Y*4XDR6MC?&<
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M74'+2KJ&;"VL<S)5Q/-ER.WMVFNSSQ)5@HT'NSN#MR$Z^/C^_P!?K^I=F >
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M3G;M08/I=6YIB"F91Y,B=HP8L$7(KJ$20*U9MT6[9%N@ B!=B3YS\A2LBO\
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M *3@#\/U,6YTKT5P'_1G2/UEX?9.ZX;Q?_2&]_5T_@U=;=;LM92B+W7>33_
M<O'_ $W7/^BH2O/'E$_I(_\ NE#X%=KX)_F&A^F__'47HJK1EMJ41*(E$2B)
M1$HBQ+ES%,5EV#90$S(/&4>SE$9!=!N4RB+\J1#%,W<I=ZB!P !YT3&$Y$5B
MIJ]TIRZHBQ?FVRXV&QQ;-K6XJA&I%R%:*<+%23%6X(B2?KRP"C"2#)PJ8%(A
MXL8PN".#G12*&^42@4H._P ?G"=WS."N3PZ1;N%=93C9)S&%EFEX-TY*$@H8
MD) 1"I8THIK13-$1;@C,):>K'3 AA5 053*<!HBDFX7,BBLH"2K@R:1U"I(
M K*\A#* DF!A !44,4"$ 1T(FT(@'6B*)S#B>6=2EOL%[&>,$W#V.:72"\DU
M.YM\EP7S*8]@?-TTA,6364GXTQI$C<P@T9K@XYA HT15J<O"W9SB=Q/"1<D1
MU*6_8N<DI=F"#Q(6APE,0HZ%1=ND@L!54=#YNJJ  (B.RCL2*48"  '7U '4
M0WO6]#\>NOXZ(M=A[0^<*(FP]H?.%$38;UL-^S?7YJ(M:(O(_P"54_O#X2?O
MNR9^B+9K<^"ORR]_4-^)6M<2?DM#]>[X%>,>NFK2F?1'M^)2BF7<SV _\*?P
MY_<K+W]#E^UJG%?\T5_[_:_Y067X>_G$_P!VK?YY7Z/Q? /D#Z*Y4N@K6B)1
M$HB41*(E$43\;?"+S1]L1GZ&A:*(V=ZOM"EA102B)1%3W:2JR#A-(2 L=%8B
M8G 12*=1,Q2'.7H8Q"F, J%*.SE 0 0'K1%%[#O#]+V3>$GD"ZIEE(W*^<2;
M=-)B@[58MHI<1*S29&>NU%&*A"[,MRE7%4INY R*90(!.GCU[OG=8&M6UGK.
MZ<83RDQ!!;KK-MP(QMS-+1*TO&>E2$N$214U,@H+Y:,EBBZ,=58QDC#%M^]1
M)M,09]GS\Q]:>K"[*J(L?9,M5Q?..[XLQ$&_/==J3MO%!XLX;M3A,QKJ/,BZ
M<,RG=)-U"K]VJLW(99)/:B91. %HBBO>N'9:W.$K)-IRMPS%M&@K5RQ<4?&V
M3+"U8L(AY%7.^C[0=/GC)PO+0S)J\12<]X5)=14O,1P)2%,>'M^?#P3Z_G[/
MF5,M+7U/AKK^XH#L?$/W/3Z?A\?P %3-W;ZPH.V/J/P7YPU^?O\ ,B?Z0<@?
M[:3E?0/@S^BW#W_==E_E-7A?C#^DO$7_ 'G>_P",JSR^(?*'TUM;MCZC\%J"
M^A?$/_*A]-4G?F_HC[5.S<^K[0O;1V,'P <7_=V\OTTK7@ORC_TVU[^^5/@Q
M>Y/)_P#T,X>_[NH_%RE7QR_ RXJOYON6_P#8>:K5+#\NL_[S0_S&K:;O\FK_
M *MWP7Y:IOLS_P HOTUZS9]!OZ+?@%YQ?]-WZ3OB5NJ92HE]D7^43Z"U*_Z#
MOT7? JH[Z;?9\2OU,>"/X&?"7_-JP;_1E;%>2+W\KO?[S<?XW+T;;_B:'ZH?
M!JE/5!5THB41*(E$2B+$F>O>7R=]YDY^9J41<W#?O:6G]S2?EGHBR=1$HB#X
M#ZNGC[*(J--Q24W$2<2X5<HMY)BY8JK-%3-G22;I(R)E&RI/225*4XF34*("
M0X 8-"&Q(L7V#ART,70CUI E?BY<-GX/)EX[=.I%R#DRRYU5Q,J)%EDC*#W*
MATSN>7E(*I@*4 (/=\[J).$(%W&7?@)T^N=![!.;8O=2RB,[0MN%E7+9N+1!
MPTN60C'[B27(NT5:RQ^]2[CW0*FF\.1XDD4Y%V/"(:'J&Q =;Z^KQUZPHBHD
MK%Q3]-JZEFC9P2(<&E6IG:15"LG:+5VW%TD)@$"JIMG3I/G]:9Q+X#JB+%N#
M+EQ-==I.)G#K-BVM9>:<]XLP9)LD7DAYNT,HX*4ASB<HM3M"( <2%1;$(W31
M13133 GSW*GX=$/JWXB.H>^RT]?_ -'EDT4K?SOTBL^[#VA[/'U^RDC:<]RF
M6M$2B+38;UL-^S8;]OT"%$6M$7YH_:^_PF'%\/J'* Z'U#_>Q;5>B^ ?Z-:7
MZ[SZG$'W''K7#N+?Y_O?T!]8;"ZWZW5:PE$7NN\FG^ Y>/\ INN?]%PE>>/*
M(1]\C\_^Z4/M7:^"?Y@H?IO_ ,=1>BJM&6VI1$HB41*(E$2B)1%CS)-E%OVU
MI*VQ7;MC/3(*)KNV"<B@19NIWJ0F1.=(R8"(:%9!0CE'8G1.!P :(K1P_C.>
MQRT>M)"4@U&3E05$XJW84T>T(Y.;:L@Y?O5G4L_=K$ J9_.7!DDP#]C  $0H
MBS20H  E O0?#H( &^@?'U'QUKI1%C9;$>.EI6)G%;5C#2L \>/XMX)%"J-7
M3YTJ_7<"4JG(J(/7*[I+ORJ @NN==(I%1$U$^?GX^M63>""27$7A!1-%(JBE
M@YR*J<B9"'5_;V']"J<-"8!Z& !$1$0$>M/MQ\3^U/;WX]<9^I7SDW+F.,,0
M3>Z,H7=$V9;[N30AFLI+G63;KRKQN[=(,4002765<*M6+E<I0(/(DW5.(@1,
MXEKVUK<WM46]G0JW-=P);2H4W5:K@WZ1:QH+C'4@&-U1KW%&UI.K7%6E0I-@
M.J5JC*5,%QAH+WEK02<"3)Z2L$_J]^#X>H9YLO0]0]*5\/\ NVLG][/$!R-$
MU!P.0?-*V0>OXOKNL?\ =[11@ZKIX/4>=T,'J/IK3]7OP>_Y^K*\=?92OCK>
MO^C?'77Y.M/O8XA_V'J'_*5O_P"M/N]HG^UM/_YNC_\ >MZ7'EP@K+MVZ.>+
M),X=+HMT"BK)IB==PJ1!!(%%(XJ9>^54(F G.0NS &]#5.IP]KU%KGU=)OV4
MV@N<Y]K6 :T;EQY8 '4GQ4]/6M(JO;3IZG8O>\@,8RZH.<XG9K6BH7%QZ "?
M;A2\;JI.$$5T3E4163(LDH3J51-0H'(<H^LIBF Q1]8" UB1\P9^M9->2/RJ
M?I87"1OI_?=DSQZ?]46T/T5N?!7Y9>_J&_$K6^)?R:@.O;'_  E>,KE,/0 '
M?LT-=-6DMP #@Y$'><F/<M/_ &_@WK?SB ?*.J0>Y303L"9V\5W,]@.(?W4[
MAS'?08O+P /JW]9R_>GR]0Z?'6J<6?S17/3S^V_^FF ?<<'N.#E9?A[^<B.O
MFU;'7-<D8]6?4OT?0$-!U#P#U_$/]0_,/LKE2Z"MU$2B)1$HB41*(HGXV^$7
MFC[8C/T-"T41L[U?:%+"B@E$2B)1$HBBH7A_F6.1'-WPTY;3)-S*K2WGJEK@
MXFV"KHXF=)L$SN!A4UEDA,@:3\S*_ ISG!3O#&$2*5)0$"E P\P@4 $P^)A
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MW@HU)4KCG*)$_,R<NA'GUO78^!/*JW@O1W:2-)=>S<U[D5.W%)O-6%-NP8[
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,JE1$HB41*(E$7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>g68105g98z25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g98z25.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1CT4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &-B^8V X0DE-! 0      $ < 5H  QLE1QP"   "@  < E  "')R,CDT
M,38U' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0)&C6/Q&MV21\,%=N<M2D0#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              10   )H          $
M                     0             ":    10
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   10     4F=H=&QO;F<
M  )H    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   $4     %)G:'1L;VYG   ":     -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 2 "@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M!JT\OY\(/43NNK98&A@U:2&NU^BX[7,?MV_]-50*7-#&-KT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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ME=KD,BBC8VVFLQRHC45#5L5C%A:-H$&JAL,/R3-49<@+D%EGK*!9JNJ?REW
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MR)4IUMEAI'/=;CCJDH;2"1\RBD<ZJE*E*"4@J4>$I!*C\ ))JA(2"20 .23
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M\^WT_P#OVU@K+7E1JRO@R9TN#!A1)=DMMZQDQXT:._8/LMAEEV:\TR%27$-
M-(4Z7%H0 D*2.VJ$@1/4P/C]"E4+N3@M!FE&IBXDL5C\$.2(=JXXVU\$L@%0
M>6M70MA820LJYZ1RH)Y]9MA?.V;Z5LG=)3O;'B*TS.V!,2"0)Y!CBL%PPA]L
MA8$)RDG@$"03TZ G@XF:C&C9#<&.^AN [76-<^.IJQ8L(X8+"C^[?#3BTK7U
MMD'AME:5\]@KG74?]H+(A1=0^AP [D("@H0.(!/&00!G Q)K3+TIY0D*1M)$
MD">8F)/421$]!FK][68%7XRY*FR[6#=9*E7P<U45Y#S=0DJ\U45 )4ZF0\%(
M<<+R4%EM:FFN0I2W]!JFI.7JD )+5NG*=P(4L< J)QT\SG/(SLK.T;MP0"A2
MX\6V"4GDB>9!Z\8QBKX=2>WS#OV'<=S]!K55.GCUXIU)^H]>/4>OT_7\M*5K
MI2FE*:4II2FE*:4II2FE*:4II2FE* @^A!_3].?["#^ATI6G(^H^OK[?72E.
M1]1[>X]_3^?MI2G(!X) /TY'.E*=2?\ C#^8TI6O(/H1[_U>O\O?2E"0!R2
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M;6"4/TN&QG1:/N$<%(O7:-H I<27>.DR#;VC _3O^T+(_F;=1*0>"E;J@$@
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M8.OLM)EQ:0"0D F"I1F .N8/'.:QUZ-7,;L*Z%/:0ZVW,CM24-OI*'4)>0'
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M;\B.PTX[(>:99:27'777$MM-MH^9:W'%$)0A(!*E*4  #R0-5 W%*4R5*,)
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M_-K4=NQ>8(F,Y..H/'E<DQ.)!$<?,><=9])YJ/>4[I[M4%<G&LHA4[J+1MZ
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M:?9=06W6'FD.M.(4."VI"^I+B#R00M)!!X(X.DJ!!22"#,@D'Y$<?AY<&J$
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MM(,^( @&"-V>(!.?6ME4-=V<8VQQXQH>'R;V=>PI(>F"),G7$8QD)5YS3K:
M^'._!4H)/E* )/8ZYC5DV[K+MO96H<>4F%*:0(&<ROW<'UD9Z"1G:.TRK@B
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M:ST5E92;L^TW102%=P@J0A!)Q"G4R0"?=!.(-?-9CT9 6T2D=*>D!*>>E 2
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M204DH<"T\I(Y!X_CJ>0"((D>56UV&VPV$H2E*$( 2A*0D)2A(X2$@!/3P.Q
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M3M?)K_-2F$VEUEV2J#UA#Q<>\PF*U;:<N^?9<> M2E7</=\WF ()A:P#NW
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M,J=<<=40ZX^94#W:"@C)PDA)GTGJ)R9I*5D4Z9P''E*'?U6KE7/RD!1^4'U
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MG+;J60S&:0F]9%V@W+Q<\^2'H;](V.0T65 !>GL^B;C+R]H21'?^)2LP00S
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M((!/H0>>.0>W!]3V]OKJ1[1$_P!4&8&<9D\#\IQ&<SG[DD**0" DP1$8!XZ
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MT\BZ"GNZ>[IM3G"RXV&Y$<P#$'Q20(K(;K57+FV:5:E#0<;4XXF,H"7-XC.
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MTI32E:$\ D^@!/\ +2E:=:>.?;CD?4CV('J0?;5"8^O/%*T\Q/;U[^G;U_\
MM^?'Y<ZK2M2I(]^_'/'OW_T_EJFX>?GT/03^6:5H7$@\=_UX[?7^K@\Z3F(/
M$_P^-*%Q((!/<\<< ^YX'Y^O;MSP3WXTG,01\L?A-*T+J!SW)(]0!W].??CG
ML?;D#WTD8,\X%*U+B1ZGWX_CSQ^O;W_(@^G?5:5IYJ.0._)_+^_Z_IJD^A_
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MU)41SW.MEJEU<IU*_2W<O(3[8_,.+) "U <D\8Q^>*U]@Q;*M+51:2I1MVE
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MKK+C0 4CNE,@+3F4*0L@B1,R(Q6-G2=/<9(9<4IM(4UO;6)2M3B'I20D$*E
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M&7V4-I@NK#LCE;2N@*X7RH#7(]IO;&5VE\ANU>L;$K=>958KO+U-TN$6UQ:
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M84*:2I*5;>3C-<LYIVK/M!*DPIM%NTE"KU:DNAEM2"5RRH%*R=Q!S( JI_\
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MA2X$B E222"(P1.:P*LK-;S;Z[5DOM$%MSND;D$9"DD'$'(Q(P1Q5W^!RD@
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MH6S(:;>:<0H<%*FW$K0I)'8]2.5?Y7//9)'!BJ@J292HI/F#!^\0?QZ#YT_
MP?#ZJ4J96XKC\&6M06N5$J(##_6#R%AUME*DD=OPI'Y:J23R2?B364W#ZDA!
M><*0( *U1'WU503VXY( (^GH/0#V _@#^G;5*P1SZ\_7I6[2JTTI5N=V]PH.
MU&VF<[E64&190,&QJVR67!AEH2Y<>JANRW&(RGE(:2\Z&BA'6M*0H@J('?6>
MVMU7=PS;(]Y]U#28\UJ"1Y>=8;AX6[#SY$AIM;A'F$))_95K-O\ Q9;([E9H
MG;;&LM;DYRE4^,_1.0)S09LZ>KA7-S5(L'(Z(#]C75\^/*D,1I3BPPI3Z4EM
M*B)EUH]_9LFX>8*6!MA>]!)2I10E11.X!2AMDB)Q-1F-1M;AP,(62\=P4CNU
MP%);#B@%D;50DS@FN"5XGO#]17>>T9RB+&L<,3*G9BN#23W(J9,<QVIJ!/B0
M%Q;>TCE^,S+C1WY$QOK0A:!R.*ITC4WD,.=RX4.[4,!3@20%DE)"2H*0A62#
M 3R>:HO4K%I;R%.)!1"WE;%%. !!5&U2AQMDJ!!!&(JW:_%MX-?+QNM<R/$_
MA\_:AWM;%7BBQ$E"5?#&F;"V:^ZO(KWQ?J36K?M$L/-2G&VW%A;B>J0=(UXJ
M=*F[A1M=[9FYDH2TWWRD,>/QI#8*@EN=Q! !-8?Y2TG]$WWK$/-AUL%H%.U2
MRW*CMVIDF()!SZXK"9XFO"_#N[V-)R[%53,.IWL@M[M-6':RJB5$9EQ8&0MP
MS7BP@Q;..&X#4WXYIJ:EM#(^(Z58/Y)U8--H[IY*;A80EKOO&HN&1+95NVJV
MR5%,8S63^4-,*EK"V993O*^Z, -XE*RF%*&Z$@**LD 1@;,7\3OAFW RS!X&
M,WU/D.8[@&Y<QE,7&IDJZ;5AM@:>W792#7&51JH)L_X)[[T<BF ]-Z$*2F0G
MJ/Z5JMHU<%U#C;-M ?VN@I ?\80G:N%%8'"0KC(E.*-ZAISSC7=K0MUTI[HE
MLDE2#W:2HE!V[28E1$ F>9K;+\0GA=H]T;_:Z7:XM6[B4%W'AWD5>-IC?#Y*
MO&H>X]=$>N!5IAN7DFCE-9'7LIE*G/E#\F&A3[#RDU&GZR]:HN4AUQEUM:FO
M])D%LN+M2I:-^Y"%+0IM6Y,!(GW>+O:M-:N5L*#:76W$[_T!VAPMHN$ +*-B
ME[5I4D!1A6#!!JU%IXV?"U'L, 7CE<UDT_*,@RZDIYU=AACJQVVJ<;>S>U79
MRI=:RY1HMXCK$TRU>2B:B:;12UQFY$E,D:#JZQ<AQ0;#;=NXK>^5)6VZM+32
M0E*B7)!(*1)&4J J,=7TX&W2A)7WBGMA[G:$N(2IQR3M&V5 D*_6C<":JVO\
M7'A2DQZARVR+$*RXKL$A[@*KU5L6<FAK+>B9R69&@V,6&]#5/16ROCI$2O?5
M)>C+5++19<"M8_Y#UF5AMIU;*[I=JE06IL.*;=4TDEMPI5L44@;BD(]:O&J:
M8!N6MA+C;>]R ES9O0%J 4@$$\D09/WUU?\ 9[>&NKE8'6T-O,ET^77UKCS,
MRLQJSAU>-.UE*,DD2;AM<)CX"&_6NB:P_P"4&WFG"^E2FR5BJ=!U5X7#CC2M
M[20LA2T*4N'.YA/B,^(03,"/+-5_E;3VRRVAP)0HE/N*2$JV[P"-N)!D# XC
MFI+;2[V[:[XT<S(]L\A3D-1 L%5DJ2F',A%J8EM+R4%J:PPZI#K*TO,/)26G
MFE)<;6I*@3KKVQNM/=[B[94RX4A>TP1M/!E)((XX/6IMM=V]XV7+=P.("B@G
M((4.1!@_0\Q5U]1*DTTI32E-*4TI32E-*5X64?XLY%_S%;_]GR-9&?YUK_S$
M?YA5CG\VY_N*_P IJT?A@('ASV/)[ ;7X3_W>@ZE:I_WGJ']\?\ \YJ'IO\
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MT_2HS\2.*B7I2&V_$D'VBR,3D?Z:R<CX-J/W=34_4I5V[CCGD?7C@\\@^@)
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MTH-LXKO;>%207"2M(3'A ]WXGCFIJH0HI2#QQQV/;L>#P0D=N.R3QSV/IQW
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M/T/E2O#/A/V&56HJOZ/JE,1I+J60A4E#K/G>0'%LOI=\UIQ28[2?,0H+"$]
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M\UCU>*;G;),5&/8\VYF.6Y!C]C.<JXZ[")7U6V^57D7[KDE/5"=4_2PFGW4
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MJ(16E7P+*0KH<4K@*>=(Y2L<I*@.3Z1:L.("G7U)4^Z/'L)*$CH$%20HXC)
M^&*URBG&V0(S/Q\I..OQJY&IM6TTI32E-*4TI32E-*4TI32E-*5U7XC,EHLO
MMMOLJ'2IIU"%H(/(X*5(4A0"3P 4<_F- 2DR%*!]"1'P(R/D:H0"((!^(D9K
MR(N*X]!?$F%25,1\$GSHT!AAXD]R?,;2%!1/<J'Y]M7J=>4(4\\1Q!=<(^XJ
M(/P(BL:664G<EEH*'!#: 9^(37N!LCT*?5)YX]".>2 03U$'@DJ].?3G6..A
MR/.<_A'WS66N75:4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32
ME-*4TI7C9'_B]??\S6G_ %%_5R/?3_O)_,5:OW3\OS%6S\.W_ -L]_FXQ#_L
M2'J5J'].N_[P[_G-1['^AVO]W9_]M-7EU#J532E-*4TI32E-*4TI32E;5$#C
MD$\]AP.2/Y=QS^6GRG[OVD4K8".1P00>Q225*_7NL@<>_P O/YC2J=/W@_E$
M_A6I')"04DCGDGCE/T "2DC]>>1_'2J#X ?>/S K<.W8@^_!)Y_M)4.?IWX^
MNJ?(_A^^JR)B<^5;M5JM-*5M()/H#P.P)XYYY"@>Q^7C@\<=R._MI2H)>-WP
M+[=^,G!WJ:\2S59C$ANQ:?(BTEQ"F72EPUMLA"0](A*<:2ME8(=C.GS&B.5I
M5O-!UZ[T&Z6\R$O,/M]U<VKA(:>0#*21D!;9\25 2># ,U&N;5NY2 J0M(A#
M@]Y&9('H>H\\\U\G&\WV)OBPV?MY<^DJ(N3XG\>W&BV,&PBR"%3)(CQ4D)<3
M*X4M:4\O1&"D$)X4!U'U[2^WVCW! 6\^PYM*EM.6SJ@G:@J4 6DN(4($).X@
M@C="B0-._:.LID(*@#'Z,@B8F3NVX)P9&3/RE5X:?L._$-?Y#62]XONO!<9C
MR&'YK;TN/-L)#*%A:VFHD=;[JU%/8-O)8;*CRM8XX-=1^U'2[5AQ&G%=U<+;
M*4%#)2$$C!7WJFR""<A(5$8!JB=,N'B@K2$( $A<@\<"$J2<])^?E]5.R6R6
M%["X%58#@L%,6M@-H5*E.!)F6DSH"'9LU;:4)6ZX0.G@ -M@-I! YUXIJFJ7
MFL7:[R]7N<5*4I!.U+<^%,0,QSR)F#Q6\8MVK= 0VF!R2>28R2?KUJ+?BT\$
M-'OW73I5/Y$2SD+<FN0^M,-UFT4CA5M1SRRZU'DRNE/WG63&EU]FXA#Q=A2B
M9!UPGT]8'QGKU_?S67UZ_L^L_&L,-[]GCOI@$V%]X1DO5UAD='C4":]%F+?7
M:9+<QJ2H9D"MC6L-7Q,N7&2IQF:ZE <'?D$:R-MJ=44I(!#;KGB) AEI;JA(
M!R4H(3C*B 2!)&-UP-)"E D%UEO&3+KJ&DG)$ *6"<GP@P"<5DI\,7V?=KB-
MK!R;<EYDR:]Q+T2$E*"RP\ D!^-'!6I^0G@]+\YN.AE)X,-QU(>U9Y'S^^.H
M]#]9K*1R,&#TR,01D'.?+X5EMAUT:OAL0(32&HD9A+##/^2$!/22H\$K4KU*
MCW4223IQQ\OHS^-(G!R(@^9]/G] \5BO\9WV<M=OC)E9CMS*BTF5.+>EOUJU
MB/&>GNI3Y\B ZM!9!F%"?C($EQIAQ:4NM2(SBEE<AM\I 2K* (Q$\SUQR9Z5
MZ'V/[?ZAV:6AEW=<VB(2U,+<MQ^L$AQ24N-J!([M2DI3[P,DBL/=SX O$[A=
MM2UEIA:'/OV]C8[4S&Y"%1Y-E,2\N.V3%,J.WYK<=U1*7WDI*>[I))U/8<;6
MEQ2-P[EE3JM\#PI*08@D[B58F!$Y'%>Q_P#YS=FE--*NRIM]Y:6U(#-RHH6J
M8E3;2VRD 3^C6L"8Z&,E7A8^S1OL?NX.7;SOQ6##6'F:"(\F2\M20. 7&BZA
MGJ_"M\^4^A/);90X?-UB<O\ <A2$!0/'B"8^."1QY2/QKBNTWVM*N[5ZPT9H
MAMTG_2'&]I3NCQM;E%9!'1Q"%)_JS,YJH%?$KH,:O@,-1H41A$>+':0$-L--
M(#;:$(2E X2D>X!/OZDZUN3D\]>N:\1=<<><6\ZLN.NJ*W%J))429))S)JQ6
M[/;=7PR]N/\ =)S+T_S.;@:F6O\ 1M1_N[7_ -]:UK+G^EZ;_>GO_L+FI":A
M)X'P'Y5L*:K2K#[HJ!W!V-/< 9E=^H^F+S_7CGCT]^.Q!/;4ZS,6VH)."IE!
M'R?2?R_'%0;I)+]B1^J^J?FVK\OWGI5]QZ#]!J#4ZL?WCM\*+GB(P5Z9CC <
MS*KKW(K<1#C;2[>O+J9++++CRDM)G5\QL2X0><;:=<Y;==:2>=:76=,1J5N$
MD)#K:DEI1W0!(W!<), ]  >37H?V<]M'.Q^JO%XO*TO4&THO&F@E2TNLGO+6
MY82MQM'>LNA)(6M*5IQR #\J>=[-;I;9Y#/Q_+<4N(CT*0ZUY_W>^67/+5PG
MJZ6UKCJ6. MF5T=:CRCJ3WUY+?:1>V:R.Y6&Y,D DD2>!!F9,9&.G%?</9_M
MKH>O6O?6^H6MPH )W-+;A)\G0I0+2NB@Z$008D<U9M[MQGF96-=5X_C5U9S)
M[S3+"6H,I+:G'%(9X+ZT!KH;4L( 07%^7R0D^FL%OI=_<+"&+9U2C'*8 (/7
MK@1& /*:V^H]J-"TNT<N+O5+9IMIOODRZ@ H R$N*6&BHG/\Y$')B!7T*> ;
MP;7^U*W<XW#A)AVB)+JZRM>3TR'9#*G66)LAKI4MAJ(A;HC>9TK<>>4L(Z$(
M4KT?LWV?]B)N;D)[U).TB3.9$[DIP!@].>:^3?M;^U:U[06YT70G>^MGDM^T
MOI0 TEH'>IMI15O*W5':]*  A( ).*RE7UE0UE7)>R*3"8K%H4W)38*;++R5
MI"5-*:(4A\K2!^Z#3BE<\)!UV2E!(D@QUC/T/E7SM\/NZ5&7,,*?SNIE+PO
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M]@"/UUKP9$^=3:YM5H)Z\^E1\W9_X5O#+_G)S+__  YN!J9:_P!&U'^[M_\
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M<#G=!-?MWL3:KH=9/9L)LIG-LGI<0QV>U%BJ<>-=,O<AJ(BIW1\.P9B%/+0
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ME:!0) [_ (>KOV[=OK^O?Z>^E*CEXGM\(VQNV<[(V@V]D%@H5V.1'%@!V>^
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M9ZF!)'H>0#F")J$6_GAKR7+\ER#(J=YZR@9#%;#\=I]+-E7O)2A@IBH5P)#
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M;8(G*W=I28, H$$S@B)/T@;.[/XSLYB4/&L=:"BEM#EC9.)3\58S"@!QYU0
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M@V/ K61FF&F=^-^4?"NMR8Q_;VP4EF2AQ*BZVTM2FDMK;"F51^@L!I70VV@
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F*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>g68105g99u33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105g99u33.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1NV4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &YJ^<&8X0DE-! 0      $ < 5H  QLE1QP"   "!_\< E  "')R,C,P
M-S(X' (% !]-:6-R;W-O9G0@5V]R9" M(%!U<F5496-H("YD;V-X.$))300E
M       0J7MJ\=LUYD8@43C;<:'V?3A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              P<   8!          $
M                     0             & 0   P<
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   P<     4F=H=&QO;F<
M  8!    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   ,'     %)G:'1L;VYG   & 0    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 40"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M>I/K:VN[(J>WES/MY+]/H[;&[/<[_I_\&JC[>@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0'_P  1" $Q ET# 1$  A$! Q$!_\0 'P !  $$ P$! 0
M          <!!08( @0) PH+_\0 >Q    8! @$%" @.# @%#0X' 0(#! 4&
M!P 1"!(3%"$Q"4%14U24T=,5&%)7D9*3TA87&1HB6&%QEI>8H=76"B,R-55B
M@96QU-?P)"<T0G2#LL$S-Z*SX28H.#E$5F-G<W9WMK<V0T9'2&1F<H2(H[2U
MPL8E>(*'XO'_Q  = 0$  04! 0$              0(#! 4&!P@)_\0 :1$
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M7TWK'_K3QA;3?C%H/BLHOWFI0S-W>ONF%(R78JQ!9BIZ45&DA!:INL28T<+
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MS26L1<(LD^IM"CN02$#2L!D@$X'/ /9SJ_:[;[7WLC16HCN9 A=D@L4=E12
MSX56;"Y&>OF15ILO=W^Z\TI5LWN5V8U)=\>5(Q1M/#]1Z^L]/ S+^MSI6B<K
M4&AG!H6QQ,K7Y8J0'-'3D9(Q3P$7S)RW2N0='6Q5T&:V66=5(#-%J3R %E5U
M!*,0"4=& SS5@>HBJ)MN]K(6Q*T4!;)5)+.)6(#%"1O $@,K+GJWE8=8-8Q]
M<*=U&$>K,]'V_P#0[C+;X?H;Z]7_ !8;)_B]U].G/[,^JK/C#VFY@7%H<?\
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MZ+B7<LT09L7CD#F1;+')B76P6P=E)#!=RM:SW+;EO'-J<D<DK%@F$5F&\0Q
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M61XL=D_Q:Y[.:WTQ!SW'>.0>SUU9\86TR@ W%KE3@MX)&Q)Z\;I"X/9CKQU
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MJ(52R>5_+P 'W0V$$F4VR\JM"8[B%XY8XY'G8E8DBDM[.4L#@,?OEVL:\O\
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M+2VQ)CLH6"7C8FJJQK06^[TG0+F'0+O2M5N!J#W)GY27DMT "D8C42RP6\@
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M.(D<45S+=;X A )=4MTC1GR#O-( N%#'QG$#B([;CU;CR>H!Z@W$  Q@ZQ,
M]0CV@/?UZ!@DGM/6<?)D]9ZR?UUR0W3GD#@L2=W /E'RAU\B>8Y^JJ%Y7*+O
MR@#E%[=P[X=X?[]_1>L?&/VU22N#C&>KD/D/_KU9J?<\B(-\'[#M_B!H7_ZC
M9]:K3/PM3_ZTN/\ NK>LRYYBRSS_ -CX>OG_ )<E0!N/A'X1UM*QL#N'H%-Q
M\(_".E,#N'H%-Q\(_".E,#N'H%-Q\(_".E,#N'H%-Q\(_".E,#N'H%-Q\(_"
M.E,#N'H%-Q\(_".E,#N'H%-Q\(_".E,#N'H%!$>2;K'X1\!M*L3@ +@ <^SX
MJ_I*]PE_[51PI_Z'EW_V]Y2U\M=(7^_'6_\ G;7_ ,!:U]&;#_[V-,_[7_XZ
MYK\OG[)84%/NC<.<!'E)\/&+U2;;!R3%L60]AW'?<0-L8-P$-P#7K?16%;9:
M17&\IU2\#+G&5:"V##(/:#^JO->D@,=H(B"!NZ=;$?'QKD@GOQR] KQ'DL[9
M:F++EFY25VDW=GSK%S$+EJ760C17N<9/6>#N4NS?I)L4FS=*0LM;A)=88U!@
M<CB/132,5N99%3O1IMD(+.V%NAAT]XY+-'9V6W>%72)D\H9*K(_X6\,GMKBV
MN[QI+J83!9+Q'CNF50#,DK*\@<A<^4RJ3C&< 9 &*E0O'%Q5EF(B=#,MA4DH
M6*?1#91U&UE\V?(R#FIO';^PQCV$<1=JL;EW0Z0_6M]H9S-K-(TNHO\ V9Z7
M7(==EA-LYH9611I\2K+)Q& >;(*M(R+$>(3!&#//]ZA*1XD<;I5V%91U?5-Z
M-A>/O1H\2Y4'[VW" WM[>#MB) 6D$CCAH0V1D=@W'9Q9'0:-S9JL@E9VHUS2
M7+&U9.1&?&S6^Y%6<RI($LF_BT[-?KO)HUI^[<5EO]%UD9(1*<?+O6B\#9K0
M@6/L>C;T(MR#),0L(BCA&X#(560)!;J)%"R8C7RQ@9DZSK###7\G*4S9"1;W
M$,DLI)81AB"\TK%&)0EVRI!J+;_Q 9;RC"J5^]VX\_#C;OH[;1YH&KQ;6+M
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MMU6U]:F:0F!%90\/$EE1Y)N8*AB$($\/0+>Q9H[FV>\EM-3B=56XPK26DXB
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M'6X(8GJ50P&/5ZD=RJ3K2,Q,3]6F'[KB 65C:HI<\ZPEA1Q >[Y/@E*U;;2
M!%S<2A7$,9V2)G8?'F/;&XCI!-M*6M-P-KDJQ?DN=MN,\0BF0-IIC:406;Q-
M?M%;N)8HT<-OJ3<1OF:>/R,I%^ &L+!LLL6^\R.7U#>""6>.3P56G7=D95X;
MEE$14)%&VZQ#RDDE)4JS_N;4%7\B8Z;W3$EAK-CG+.Q097-]G>$K#.KK9=X0
M;,FA7G,7.7"Z04M#UN)S<UBYF)MDB:V.*N 2TO88!U&,WV%<1[6S/:7AMM02
MY1(-[@BR:1YHK76X"SK((XB#(]H6!C7"S!@JR  94+;-QBXMQ<VC0RM,(Q*]
MTJQQ-/IV%3=,C@B-+O&&/E+S;=;FC<E]SLA,1PE>;V>"LS6&;5R:"$MRE\6F
MYH8^(@&3F LRD8:/D5XAVT;/"2M0CY!K7C/!<G9QR*_-FU$MEM5<7LTA@N(V
MDFDW7C9!&F_(K<10[%< ^4CE<KN[V5P152W.SL=K'&LD<G"6-MQDE,KC<WW4
M@)EE<^24!(;F#DYJ[J8XX3G>7L+YPI&-ZFTD,[\=DCC>L1$6XO8XAL.$*9F>
MR6?,&;H",NDH[B7=1G,/W6AXJFH0P+5"LSM<R8K$0L \8(-H^M9];-IJ&GW-
MU<E;#1(KR61N&U\M[<6L,5MI]P5'^)'/#/=[P(>2.:%F.' JVUKI/A%G?0P0
M[]YJSP)$K2^#M:Q73O-<QA\'=:VDACW<$(R2@!6%>*6-L5#FG/E5P_CYSR&^
M0LEM*A7I1^)@)&U^8G0:HV.7.IR3(,H6NF4G9A=7D@U9,'BZ@@5(1UZ#=WAL
MM)FOYQNR06/&= "6:;@@JBKUEW<JJ*,DM@ <QGC;:U\+OXK.!P$FN^$IS@+$
M7.\[ X&Y'$&=CDX5#G#86KQQ1Y*A,J9XO]GJ +)8^82#&C8J9K !5([$6-X=
MCC_%T<H0H 0B[:B5ROE>"4H J^Z4N.QE3;TZ+:/9:;;13<[EU:XO&&,/=W;-
M<79SVCC2.J9ZD51V"KFHRK<7UQ+#_@;RPVRL?P;6W18+=2,<CPD5F Y%B?.3
MU.%EC79/B;X=(ZWMXIW4GV=L0L[0UG>9"#<UQSD*NH3B$R+@0;A$K1AW24CS
MP\UT,RW.;EW :M7,JZ3JC0;PF73[QHBGX8D%O)N%.8\H-@K@YSC'.JM/$9O[
M$2@&/PVUW]X97=$\9\H8/DDX#9! !)((%>OSGC9X9JS6^&3 V9<0P5U"/?8^
MF>)2PR$/47<#C2W5CB+O]FNZ:6/F.)&.0I:UFB"1D3;@/E67K4QCR1=51G2#
MOE#J'\]39S5YIM7U>RO9H \4YTV%!*LUU;SZ?;)&RRO=-&D>=\Q[T(D29=[?
M;)KK)-;TN*#3K"XLTE6'A274K<,I#-;W]PTOWM+=97;<\EQQRCPD)N]IY!G+
M"B1H]G;N('A7M7%VK1LSM<<<4$%A$6.#\?)3UTP=(8UK=MB"X'AVJUJ;TVO\
M0,;!V$V*[$6@ER#7HEQ*E,W14@H&F:EPF,6E:U'HW'LS=:3-?!M0NI(X+I+J
M6&3PEOO,LLMK))'Q8Q.8Y#A01O5>':>9$W]0TU]2,%T]MJ4=BHM;;B26[V\<
MBM;!U,<:3J/O,FYQ8UWB5RND'%2I69K M<MCN;QY;+G+<6_$DC7+UC*D(8[K
M%ZQ\A3<(.YF8AZH$!6'L13T;_(2"].9/8"*33=RUN,P9-5%9%(G4Z('BU.:W
M2&[MX4T736FMKVY-S-;W7%N1%&TN\Z<4VQ!F"L20L."PR1H=1,4EC',SVLTQ
MU:^X4]K&(%FA,,#/)PMU&6/B;IB#*I'$;*J/('G-KJZTE;I<,BZ>,,6<2/$<
MXW1F*]2"8%Q2MR=E/IF<0D=/U^>DVBG:5>LX/A<L.D5T@!5A-2E=7 Y#*)[\
M_JX:\O=)TI>:27!U*]7&0;/32LJ(W9B6]-LF"#O() .VMCISB&VU'4!O!X[<
MV%MG('A%\&1VR#UQVBW#9R-UBA/,K6EVP (  ]75L(#WM@[!ZMMN]V;=FP;:
MZ#D.78.[ER\W=Z*UHZN79G'=RZAV]75U'-?H,;<5. N$_$S]FIC6N9(?VVC<
M&KC'E':EHL1&6>D2'"*]')LK?75IQ'D5S8:NYS?+V%&^P=:EZ-;WEI$Z2-OC
M@CETP\M?0M2UR]B<7<MK'!=ZXMU=,)6*3)JZ^#) D=S"4D\"6-H&D22,1EMZ
M/! /<Q:I8:593*+>.X:>UTHPQYA0.@TA!.TS/#*S*]W*RRB-HY=[&ZXQ4%64
M.Y@6%PPG[7+S7L@WN7#QCF<)7YG)LH[D*)9:QP_3^3LMQBCYZ^*60Q8TJ7$%
MBES64VAF3AW=:/+1<-*.X-!0-A;KMC;GA0I]ZX6J7$7A$<;8N4N-0BM[0$LG
MDW?&M;I&9L'@L-\*V#@R#9J0K)-(X<265NVX9.<#V]D;BX&ZI\J%X[FV*D?A
M2QNH9E)&11S;N=+B G<;D=\/%9?S]SX=++<[ =UQ%V^JP2$-(<1+6]5W$MED
M[;7[W*UV0A5<&$N;&0L3!$)>Z7"02GT4:;77]"L,VUHDANBNHRA(=1AMXPEA
M%.RR'3VBFNH>'-"K*QO.&5C)*01J%WG8/>4;.[LEL9+*%I)+*>4L]W+%$5:[
M$\4#YAF<%6LS)O-N%Y#NL GDYIE$."HV,,QT+A^D:;8<;TO#G$9<Y)VT:33U
MY7YFW5_@8<8MZ!/70CNU<@G$0UN-0K+=].2TXQ@C62.=/',>]?/'\67L[X78
M7&J1W$5Y/>Z3"BN JR+ VNQWI98@L>5L'CE?=01N[(1@D;EVX;1O!KN+3FAD
MACM=0FWE!+??(M.6 QE\ON+>(\2@NS!1)O%B.?@F.YA-R2".X!L!>T W+U_R
M!U_WWUZ5WX!/F'9Z>SY:X1N:JK@\RQ[6Y+GF<<^>1U9Y=M;L6,OTHN"FFUD
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M,$8.T<>,$8_$NP=79YJCQI]$.,':/:!AV [+3@=1&<^%J<CX^P?$>0=RFX(
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MVR#[W(C9,;$L0V2Y+ C.*J?2+5HA%'Q(-UIW62/A%PUQ,L\A!DCD'^(BXRN
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M:;Z]_P"H^JFX_N<GS;_PTYI7W!O@TWU[_P!1]5-Q_<Y/FW_AKD1)0!W$IB@
M#N(]0=G9JEV&ZV.9QG'5G'/&3@#Y2!0QN0V4E'DL>2LN?).%)( W6/)AVJ2*
MV7JE%Q;/XV@%WM@BX:Z2DU--9-_(V*NMTXA!NHD$&56+D;U$2*2$F;9NJ^3I
M\U'MTESO74O'(MEC(^5:OK.U-GM1="WMIKK1+>VMI+>WBTZ]E\*:6)A<M#=0
M:;<0F2 DR"-KR*25D$4<4I<"O<=G]G=B-2V.TXWNH:?9[17FJ7:W%U<ZO8P0
MV5G%*&LX9],N-7M9^'<*BP&=-.N$@25KAY8N&73NJ8BP^5-XV^G.S/*,H68D
M5S(IP"T2+IM*6!DP:M'1; 5Q*'52A(]PX9Q23V4<HV>*=Q3)XT;R"R5N/:_:
M\\.9MD7C@ENXK<1N+Y;E8^!:RS2RH;;=B1O"'$4D_"@0VMQ'-(DC0AZYM@.C
MP/-;G;^![J*QDO9)DDL/!#*9[T):P.M\QF*BW!>WMA)</%?PSP1.B7#5EECX
M></PC^SQ7T^X1"8@;(PKI8>3"$;N"F&T/8%^[?/6<Z^8 W%@T)-&!BJ[6KZ+
M@C:RMV"Q' H:^SV_VPNH[.X78JXEM+NTGN?#+=+\QA4LDNH%$;VZ2>7*_!5F
M"I<#R[4S+N[VSU+HJZ.M/DU6WDZ1K6&]M-0M;!-/N)[&.52;^6SNWEN%OI[<
MG@1FZ&X)FLS(8KV.+#!,"MV,\/5MQ#%CLL%L1#VR!9SQ8]M&*ILJM*3-M92$
M@R<QTG*'=24-&5Z*?O4"LSMC%LL:HDH<#IHGWFF;2[7WZW7'V9-D1I5[<6C2
M&Z7?U&"TL9(+=EN((0([FXNY8HM]A(?!9MY0RMCG]:V-V#TQK1K#;!=2SK5C
M!J M3;MP]'N=1OX;AH&M;NY*SV$%A!<3\.$0,=00P,%DQ602],Q*G4;L];I5
MUC;8Y)H,'$164:W:6*;8[6=44D$7+JVU0SUT<&\,99A$(WQZV<..;-$H+.O8
MQCJK;5]L&U70X3+>R:=++)[(3W>S=W8RN!-;?>"D-G?+ L9DG6.YE]CHI(XR
M>-($X\F\O="Z/X]#VIFBBTF+6[: >Q%I:[76%_:KO6UX6N0;F\T\W$\BI;&:
M&'V3EAFFW3!'O>#QYDWQ9PRR]*K:[3)3&*M\U6Z(,LB^L[%$L'8&T:RE,@JJ
M)OC-V/(E"V%G%0C-RZ228R=;G45%4P'9/6W&TW2%9ZQ>)[!7=]IEK?ZPULR:
M;*5NK-II(=*BXD,+RH(1;27$DR*7EBN("=_(SMK/9#HBOMG-,9=J[;3]8O\
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M8.KZ^5ZP>2G5"H.0#D+R(!H'<X>#SM^DP(@( &WTP\F"&P=@!O<>P!Z]NP1
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MTYYG-4ZO '>V#KZ@#L#^3MW'<=^_UCJD\\<V\D84[[Y4<\XRQQD'!'41UB@
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M;2,<OT=_'/V3U%L_CI!FKL5PQ?M6SM(#I*'2!-5,QUQ;W%M*89XS$^Z&R<,
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MCJ SS/4*F#".%+[GF\1M!H$6=Y)/#<](/URJ)Q4!$E4(F[F9=V4I@:LV@'
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MB%\Y%:&QHK&V5K+1"#5J*"YJ['2^[U"ZV8O65F$ X%E:6V]NS"1;>)+I,P)
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M0,_$QLU#+QTK$RS-"0C))@+9TR?L7295VKMHY1$Z2[=PB<BB*J9A(<A@,41
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M.@P&Z2!KB6=U&](L$"OY!OIK(NK<7=,4?!WKB0LHC+@+O!683/KD_@SS+##
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ME*:4II2FE*CNT_OF7_14O]M72E8WI2FE*:4II2FE*:4II2I,KHA[%-^OQO\
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MU=X #O:8'/SXSY\=6:$ XR <=61G'Q=U.B-MA+S"?),  8.3U& H;% P=A@
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M[6S1OA)JOT:U_CI[<O:;X&Z#],OJ?5?LJ>]7C[^=+C^EM/:V:-\)-5^C6O\
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MC>%63)9ZS9!(]6T9Y5,]M(0HX\ WN)/8RNV[%<%0=[[W(%? .WP-D1 ! 5A
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MK;R8WRX>ITI3G6WDQOEP]3I2G.MO)C?+AZG2E9]!E4/'(&14*B0><V(9,%1
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M5;12)*U4)R"[JJ3RD(K'VIVE/I1SPD09T[9O6K;(;2KU2XCB>=8Q&6D4%/\
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M*1FHRHEC3V1VP1$/V\D.G,1RKLI3<X"+@5DR'20<'2NI!-)%),D;-%"T:2R
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M 4RBH\T"P-T?SVVRVACVIVBO];@T^WTV&[<;EM H!*H-U9[AU $MU,/+G<
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MGF I/4W<PYXQSQU@U07COJ$';L0WV'DJ\KK_ )"_[AT-O;YY6\!Y\\0QG_\
M9_N/?V5''N/QB88!)S))S'F.<?KYU3ICL>QVZ$-S!N"@F !*7E#N(%\'9X1
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M\8Y' 8G(SO AP3G(8'-1UTYSY8Z^5'YFLS@6WXO#\U%]75CC77NTWSK_ ,5
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M$\UNIF5'<[N5DWPT9RX(+-R(K5ZY;:9;);)8<-MV:\CEE6X65Y$28F!G7R2
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M/5CGR)P.>2< FAYYR7;LYG?QS!/63C..??CGU542G$HAR0Y'5L  4 +L/84
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MM .2(; 8>LP=\0 >\&IY^;LP<@8QSP,$<B0">\BI.&!RK$D ;V"" !@*-T@
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MN(\C?<0'D[=0[!ML&PL<$=0..78.><C.<9ZCC&1\E00.8W2=[=!."" O5@
M=^>62,@]= ,8! ?L1V'<.4(#MU\K;<1$1#?L 1'8   TR>TY^/G^W^L<NJIP
MH(.#RQRW3@X[^7;VXQFN(\H>^ =0A]B)0ZN5RN]X![/N=N_7J,^K]>?VTP/]
M;/?@Y[0,\NS/+XA7>CY.3B%%UHJ1>1BSI@]BW*L>[59JN(V2;&9R+!95!1-1
M5D_:G4;O6ASF;ND%%$5TU$CB0:71) HD1'"LKJ'1&W70@HZ[P)#(0"K @@\Q
MSYU4K,F2CRJ2I4[I=<JP(93NXRI!P5/(]1&*Z0F,.VX@(  AMN4 V'D;]8"
M]?(#?K\/AU7D_NQV=GJ']&J<*1@@XYC&&[2K=8&>M1V]GQT 3@&P&V#;;;E%
M'O[[[B(CN/?'??3) P#@<OZYYZ^VG?S?![,''+L.5)/5CF2<=M5$Q]MA,!@Z
MQ[2]8COOOV"/AV[ [P:9.,9R/D^/]M4!2P/$WB<]Q/+EYNO.37$"B(AML'6
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M-,]9SV8\YR<Y!QD$=^14;J@Y ;GU\CC/?CD,_(>7*G*-N!AY)C% 0 QN2)@
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M2M.,5NH+_P!SM@,,.9),1"[O/F!R[QS%0'5;+W)6U3-GCV>'.#L8V$R6TQ?
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M5R,'!XV1D<CCK'*I]AM( (]B].P<9'@5M@XZO^+[.SNKA[1;@F^T^X7/R?\
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M/OS'^D%_]73VSO0I[R:O^CEA]KI[8[N2?VB>.?R7N'S^L:>)SI9]^8_T@O\
MZNGMG>A3WDU?]'+#[73VQW<D_M$\<_DO</G]8T\3G2S[\Q_I!?\ U=/;.]"G
MO)J_Z.6'VNGMCNY)_:)XY_)>X?/ZQIXG.EGWYC_2"_\ JZ>V=Z%/>35_T<L/
MM=/;'=R3^T3QS^2]P^?UC3Q.=+/OS'^D%_\ 5T]L[T*>\FK_ *.6'VNGMC^Y
M*!V<"F.0_P#NO\/G]9T\3G2S[\Q_I!?_ %=/;.]"GO)J_P"CEA]KJOMC^Y*[
M"'M%,=;#VA[5_A]V'KWZ_P#"?#U_?Z]/$YTLXQ[,QX'4/N@O\#Y.'3VSG0I[
MQZO^C=A]KJGMCNY)_:)XY_)>X?/ZQIXG.EGWYC_2"_\ JZ>V=Z%/>35_T<L/
MM=/;'=R3^T3QS^2]P^?UC3Q.=+/OS'^D%_\ 5T]L[T*>\FK_ *.6'VNGMCNY
M)_:)XY_)>X?/ZQIXG.EGWYC_ $@O_JZ>V=Z%/>35_P!'+#[73VQW<D_M$\<_
MDO</G]8T\3G2S[\Q_I!?_5T]L[T*>\FK_HY8?:Z>V.[DG]HGCG\E[A\_K&GB
M<Z6??F/](+_ZNGMG>A3WDU?]'+#[73VQW<D_M$\<_DO</G]8T\3G2S[\Q_I!
M?_5T]L[T*>\FK_HY8?:Z>V.[DG]HGCG\E[A\_K&GB<Z6??F/](+_ .KI[9WH
M4]Y-7_1RP^UT]L=W)/[1/'/Y+W#Y_6-/$YTL^_,?Z07_ -73VSO0I[R:O^CE
MA]KI[8[N2?VB>.?R7N'S^L:>)SI9]^8_T@O_ *NGMG>A3WDU?]'+#[73VQW<
MD_M$\<_DO\/G]8T\3G2S[\Q_I!?_ %=/;.="GO'J_P"C=A]KJOMC^Y*=?_6*
M8ZZ^W_K7^'WK^_\ X3IXG.ECG_LS'S!!_P!L%_S!ZP?O?,')R//4>V<Z$_>/
M5OT;T_LZO\[[*#Q']R4'MX%,=#N.X[\+_#Z.X^'_ "GMT\3G2S[\Q\^O_;!?
M\\# _P"+[!R^+E4^V=Z%/>35_P!'+#[75/;'=R3^T3QS^2]P^?UC3Q.=+/OS
M'^D%_P#5T]L[T*>\FK_HY8?:Z>V.[DG]HGCG\E[A\_K&GB<Z6??F/](+_P"K
MI[9WH4]Y-7_1RP^UT]L=W)/[1/'/Y+W#Y_6-/$YTL^_,?Z07_P!73VSO0I[R
M:O\ HY8?:Z>V.[DG]HGCG\E[A\_K&GB<Z6??F/\ 2"_^KI[9WH4]Y-7_ $<L
M/M=/;'=R3^T3QS^2]P^?UC3Q.=+/OS'^D%_]73VSO0I[R:O^CEA]KI[8[N2?
MVB>.?R7N'S^L:>)SI9]^8_T@O_JZ>V=Z%/>35_T<L/M=/;'=R3^T3QS^2]P^
M?UC3Q.=+/OS'^D%_]73VSO0I[R:O^CEA]KI[8[N2?VB>.?R7N'S^L:>)SI9]
M^8_T@O\ ZNGMG>A3WDU?]'+#[73VQW<D_M%,<A_]U[A]_P!S@=/$YTL^_,?Z
M07_U8H/[3G0H?_P35AYSLY8 ?*?"C@=YKT+Q7PU=STS)3(:_4+A6X5)>NS2
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MT$;O(JH4#<& -W(QGDH[ !SQ4CU7][U/])5_V$=0>I?B_>:D=;?'^X5D:O\
MP9OY.W[@AJ#ZOVU->2_$'G+B&A,DYW=U2GY;9X>CL4Y&Q/5KC#,:BM5(_+L/
MC"7R)"7^(;I3[C*:LX:UF7Q<FJ2AK4=20:1"R%@4DCJLS=%86FG/#:+*]LUY
M)<V]S*KN03;M<"V-H^\>#_AA)QY0909-[E@#G+VZOUGN6B29+5;>>%)(USBY
M$)E2=<??,;PDB)"D%C&.TY^5/R!G%QD>&B^'>T6+,.)CH$41GL^2UUK\4M9S
M5"U.;K!L+NEC24L-@AH [:@24*JZB9-@C9YVT0:-GY44I 0MV2&PX+R7\45I
M<*<HMC' P9/"K>-'>/CJB.4XX8H^\8PK,G.K4<][QE6QDENK<_AF^:9-U_!Y
M7=$DX+2,H;A$!T*B0E U8WPTY*RA.W'&19_(V9)K+<E9,2M+WCF;C9UQCYKB
M^3X7,?V2X62;;.ZNG#U9XGD%Y,O6DZUF8B3?WDS>K*](0D7D.O7J<&GQI=<"
M"S2S2&=[>XC9!<FX]D94@B!XK2,C0[@,3!@(AO9!\JHT^YNW:U,TUZUW))!'
M/#()#;B'P..6:5@(EC#[Y($@*YD.Z!@$#V4 =]^H0V\(;?!X=<H#G/F.*ZFJ
MZFE1C9\RXSIL[.5FRVME&3U;QU*Y:FXLZ#YP[C\=PCA=I)6=1)HU7%1H@Y;.
M42-T.=?N3MW -&BX(*B2_':W$J+)'$S(]PEJK J 9W *1Y8CFP(P>KS\JQY+
MJWBD:*254D6!KEE.<\!"0T@P#D+NG(&3YJQBD\2>'\@NV$97K!,MYN2DE8EK
M6[91;]C^U@Z2K[ZTD4<U2^UBM6-C'/8",DI&)F'L6WB)E./>I1+YZX:KI)W9
M["[MBPEB7"#+/%/;SQC#K&RB6"62,LKNJNJN65B P!JW#J%I.%,<IRV,))'+
M#+@H\JG@S)'+NLD;LK;F&"G!.#5EJ?%I@>[V>'J5:MLP]D;![#)P<DXQ_D:*
MITN_L%*C\BP\'&Y!EZFPH;ZSOJ1*,K&G5&MD5LI(Y50ZL4F=LY31JETZ\AC:
M22-0J;V\HF@:50DC1,[0I(TRH)%*ES&$!QEN8JB+4K.9TC25B7"[C&*98V+Q
MB55$S1B(N8V#",.7(/)3@XGU:7C6YU$EWK9!5)L9XJFLNDDHFT(82G<G(H<I
MBMR& 2F6$ 3*(" F =8(RQP%8YQCR6P<]7/&,D<\9SS'*LTLHZV4?&P'ZB<_
MJQ76-9($B9%3RT<1)1L#PBAGK4I#M#&3(#DIS*@46XG53*"P#S0F.0 -N8H#
M.ZV2-UL@XP 2<XS@ #)P 2<9P*;Z'_*7F,YR,>GJ[.KKKJRUNK\(ESL@_ FS
MJ):&2:H.9%TFI-R;6(8++,XY%V[08"\>(B\DUD4XZ+9 XE)-TSC&;QXA*H[_
M (*D_AX)\D'<#%@"VZ"1ND8!))& ":I>5$_"8#FH./*QOD!20N\0IR#O8P!S
M)%7 9N*!4C<7[4JZ@J F@9PB58XI(IN%0*D*@*&%-NJDX. %$2H*$5, )G*8
M:>9&0K8P#G=/:2.[KR,55OIG=WESSY;P[,9[?./37$T]#D:#('DF16 'YOIQ
MG3<&G.<]T?F^DBJ"/+Z0 H"43@8%@%,0Y8<G4X);=W3O8SNXR>H'J'5U]N.=
M-Y=W?R-W.-[( _7C/>?,,U0]@A4Q< I*,$Q: 4SKG';<G1B&,8I5''+5+S*9
MS)J%*=3DE,9-0"B(D-L 8XPK<^0\ELGD3R&,GD"2!S&.>#RJ-].>64;O7D@8
MZN9SU Y&#V]E7)%PBX*4Z)RJ)J% Z:A# <AR& #%.0Y1$IBF*("4P#L(=8"(
M"&H_;G&.T'M!'81VCKJH$'!','F".8(/40>H@]A&0?37VTJ::4II2FE*:4JA
MNP?O#_1I2ORX=T\_[+FZ?^;M(_\ 5QCK[EZ!/^#^S_ZSU3_OA7YA_P!JG_A6
MO_\ J?1?^X>O/?7M=?-=-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E [0_W=O\FE/3\G(_)YZV
M\X4.+*[\,-O+(19U9JAS#EN%QIJJW);R""8<T$G%\Y^UL+"S1,;F'8"5%\4
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M+^XXZR1W7#(C&\V)2TDDL@=Y)&PQ8 H"$#995!8UNSK05O:D&J_O>I_I*O\
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M!^Q 1_\ @XRZNL \'WO!OK[CZ!F"]']KU9&I:F2"1GRIEZ\9QU_^0Y9_,/\
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MLCR3+O'> "E$6*,X!,:+D*"')7##<G?\_7_?X=:+O\YSZ!CY/D^/KK>8'+S
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M V%NXH[AW&3\9-D:'EF"+%R\4K+R\6>3TZ[?I9UPTV<)6FFQ<1A$-K([.VL
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%-*5__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>g68105page144.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page144.jpg
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M P,# P,# P,# P,# P,# P,# __  !$( N4"< ,!$0 "$0$#$0'_Q $1  $
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MQZZ*=F1H;RLM)>SG]EPGS_9C/AB/*6'[I]Y^P.TCUD&G:/Y2W',&XT?:&GR
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MVH24+PE+;?CA]7KV<.KB]8I7=QO^Y@BB. . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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M<ABKQ$@C8]F#P04*.S$DI8:S\,A"%8\R,YSGBLMYHXZ0_P"=O]U3_#IV)_\
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MC*2K&$-MK<P^K_BX>^]8I7=QO^Y@BB. . . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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M<^'_ '2747/CX?ZN.8?6/Q</?/U"E<W&\CF"*(X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
MX X X!J\]ZQB))]J;O#'(3OEL%[44)$LAB*[-S#8SL&D^=_$1E2'9&48_P!B
MG.,YY=8/YW;]]ZS/4/"1L?\ 98<D$?; ZJVV0@*RG951MFVX,6OM&6!D,/MG
M8MRV*$B8:L$XH7;(,"+*SB;AZ3(\)OK>1Q3?DSS:RY6\T7=#:6)$>\Q[N5QB
MR9CA:Q[>WB$(1WX81$9F&"L_6@O!<CD8HZ.=E..2;3)2IJ5(>CLH0C+*$.+?
M6[A]7_%P]]ZQ2N;C?KS!%$< < < < < < < < < < < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
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MU;U^"EPVI V6SZ!(O+0E]MQF$A/Q?A86-"4;EN"5)*G=V^IZID9<Y:_?Q<C
MSKT;EV>-=XEP02@N![*I)N;Z=M(K9MENJV=V$L_7;?'>'8#NM9ELU^*-4$O=
M+A"MTJN"Z**'5IQ+1.VR7Z>1%P6"D\H\S&2W*>=SB(I:TMX=;3F5=E;NW6HN
M4:JKJE39W27I&)JV@:/8O9=K'R.#(C"$H7)RN5O.O#P)[J;:DT1[I676VW6M
M$WAUIYMMYEUNQVUQIUEU"7&G6G$:ERAQIUM6%)4G.<*3G&<9\.>_&I?!R[Z+
M/ZEX*V/4\:O\E=]@8]TQOXX,-<TG:8DZQFAU:K\<E=3@GYU8B[N6!($:\5U?
M"C2C!1_'DCQTK]5Y?V)QG/'C4O@Y=]#ZEX7#*7E/'X8Q;=+-YT2WMT3V+I9(
M*_[NE=M4,7,K^I+&5P8J53O4.)#NEA?*MU&]"(YZG'"0=K5BR@:+8@TMJ3&3
M,98<6TO&<IQG[.0LMO=;ENKO725+G(V-:;5S4K"I.4?Q-VG%%TDDZ4='L=*E
M18]T=W.?#&A;WG.?LQC%@M^<YS_4QC\4?VYY/C4O@Y=]%+ZF8/SIC?DKOL%K
M-]]O+?V0ZX69^KZ6,Q*/%O0\$7O\J[D"5;#6JKS%/3JD6;C:^;E#K"N0I$9+
M4E+"&I+K:7EM)5E:;?+OSN8DUP-1IOJMAG^5>7\#2N9\:7E"S=R^";C:5J[&
M4E*W+:G)<-*5=:[4MAZ!'?#U7/#/CCU%^&<X\/''FSX9\/'/ASFBW'93KY('
M ' ' ' ' ' ' ' ' ' ->_N905E>N8,0@@0%8,[CIHA9$6J(DC!01J]_BXG0
M<$89$:J>/<<3(BYDQI#+4IEMW+:LH3S):3&,\Z,9*L6F6V;>GC8-_)M4[6W8
MN35=JK&#:JNE51C?(]OP)39#[3+)7<H6,^ZVA$N^2M:;#2PVZI*4YE,0Y] L
M,I+6/#Q4T"2XK'WRL>;.4[YY.Q5_U<6N\<+7G#U^\E7([&?\E;G#[E37_2.<
M'KAT[^-C!K;&VMJ^Q2EX98![.M1*J_&2,YPGT0]C=:DTRP94O/@CX E(4KQQ
M][C.?#A8.!TVTGW2)<Z\YT<[.1;NVUTPMVY4]%</$O32+N_R NNF4H7B'?LH
M<0EQM>+Z0RAQM>,*0XVK$7*5H6G/CC./'&<?<Y[\G87P:+3]H7-OZ3'\E;^]
M'\@/KI_N._\ \/2'_P#*\>3L+X-#]H7-OZ3'\E;^](:=T0ZSBX,DF4^LQ@R&
MC+LPB1V/)@#XC>,9SER3-ELLQHZ,8QG[5JQCCR=@_!HF/G!YNE)1CD1<GT*U
M;;[W"6B_DW=6CBEQ]85'<NVI*5J:^8U2XRQ]&8<3GRYS+V-9&154=:3G^NP/
M=(O8QC[&LYRG"O'B."_!MI^IWR\^NO.$-N5EVK*ZI6[;E_$C%R[]%W3#R7U3
M8V#4.Z;EDLYFC0-#!-E#P=4J$@'8I4AP5%VX9AC#UUL5:Q&M C,07"B2E2 O
MQ<EAK+.'T->3PH0P<>7:5BEPO93T*[S9LOG/5\6&D]C<4YY=F,IRE""3;O.#
M?"EL=%LI*BZJU-@6L:@#@>Y7J07%;GMBM1>UH\-UZ*R5(N# #%AWW3:@:>1!
M<D*CS)Y"N4X9%<DO)6]EN&W]]XXYB.9VU;LP7@^P7/FR?:8>?D3H[T\M5=%5
MUBWWJMNFY5=#;3"\,S(F,XQG&9+'CC./'&<>JC[,XS]F<<TXZ8SQK6:8+NW8
M&H:PDVNV4:7<NU@_65SNP0C7XQ.)0+L>TC-?;KS]LK]C BSQ$U9Y2'"C\23+
M<7)6SA>,*RG.W8-N-R]&U<2[)PAT+>UMVTZ2QUW-R=.T7)S\11>39L\44U55
M5-Z5*JAMRS[4.JL9SC/9#M]C./LSC-TTCC.,X_,S_P#<^<V'R7B>Y?V/8.*?
MM.YFZL7\D_OS5CO+K3,UW;*H$KW8WL9F$:[+)U+,R1*:8EOXJ>>Q:=694PZC
M2+&&R_TLKQ^(\,I^+_9?)X?><MIX.-&5%'[:G1UTZC:<'G;6LBU*=Q6*QQNT
M5(?;=CQ^ZW<71U;"E-,:$,7_ *]Z[V@>[&=A4V>U:C8O!1(\AIJ**2;=T9U*
MV*I,2$O2C[C$'%BW:;QAO+JL_#8C-^;Q9RMR(86/*"DX[:=SJB^KNE7,YSUB
MQJ-S%MJQV4;W"JP=:=K?AOXM]+<?3J^DM[M35=KIN]['K<-V+WWFN";Q7:]%
M5-DZ;D$\CRL[W&HTKUIB=,M(7(PWU5JWD7AO'ERJ=]F?B4^C$\+'C*B6RO<_
MA=SN(N,;F[5KV#')FK/:.#?@.E4L/HXO]?/_ */5MV+:2Z,5>R[DBUVQ[[[*
M&:^/_&J2>$2+)J2*P53K][K2Z''$90S2T EB!-1M8LW,^'?CON(RSZ;K2FO,
MJM#3\5SHX[-O5T4[G=-=S?.!S!;P^TM^+QN/LU7L]W'VU6JR:K^#C2J:WU3J
M7;[W=.JOKGK99;KHF+?F[X$NNI'9.5L.[4A_0<G:%4A[)P4I) 7.B$0F:/(G
M?&ON,N(@Q/4D+\$-J5CUD8&+"TYVX)37IE/ECGG7<W7+&)J=^$L2XVFG&W"L
MFGPKBX=[E2BZ7LZ3/3JWU)UM3#8G=(0Y>TD@%S[#5^HTJ09"2->4NL.;>VW4
M1M4J(A%;;+ ZI7P4E34 ?'()B,YPC.4+])K"-$S<B;N7+%(J''T*C=.MG;9O
M:X]%38'S'G@< < < < < < < < < < < < < T;^^5UBT3/Z(=R^S[U!2QO^
MJ:@&O5W9XRUWH(<%N1;+2:VRIJ$%M(^OOXR!_M1>'H;F'6?L7A6?MY?8-ZYV
M\+-?P7%NV'N#=:=!O+]I@H5-]$M<%COROYT0N_8*05P%J$W7XS$[/8#:")"8
MU*(AJ[.K64K1X.QG($3.'L+5AI*58YLY76\T4='HSJ/=]]UV9DA,=8?W9O\
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MLO!&487YLXV=45)^\SC/CG&<>./L_,Y=9GYM/T/71IW(G^+,+W\O]G,F_6Z
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MJ=R_++R$I3GAVG&3HW^-R(RITK=3HV4Z#V1.?A%_JU?[;/.<K<=..') X X
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MG7K,86+5^+FU<@VHU]ML4JNJJFEO17FDNT.AKMKF@5/8^PXM6UGKN'@2Y2G
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M;=RYLC&<W2Y*=$ME'TL]S3N/!QS&?LSA:\9QG\S[[/.?K<;D=?) X X X X
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M8#:4B)/'SXCCT2;!EQW$N-/-+6VXVK"DYRG.,\YQF?G5SWQWZ7A,O/RV/(X
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MMN-J2M"T52OH6A:,X4A:%I'84A:%8QG&<9\<9Y/%+K8*EY /G ' ' ' ' '
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M[L1 F=)6Z)?]5AA]Q^,G"%/(0EUK*\1K'XJ'OGZA2N;C?!S E$< < < < <
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M?NVG&.QM0EXY*$WI[DU&M-LDJ\#=:['X36WAHZ+B1K/M:WX?;/L#6H[LAJN
MN\'0&4$$8SZ8R!-/]=&)MCGPH;2&H3$\]/8;D3W6D)5)?QA;GBKPYA]7_,[Z
MZ-GW#.I<AI/-P;C_ !DL'+J^EI7XI)O?1+8NI;CT+N?A'/U:O]MGG/#KAPX
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MSAM>UF[%>U^(BR-_;/<1%J:X)4[#0)\<Y7AMN9)2RZM;>',^3FS%=;S1;T4
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M=V_?>LSU#PD;)?9"_P T%[=O_5.U3_Q=9YM9<K>:*.@EU:/>\U[N]:8'.M-
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MG.,9SG.,?[Y=1,?9C[F/L3C'_<QS#ZQ^+A[Y^H4KFXWD<P11' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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M*(X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
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MK_BX>^]8IW=WIF_OF"*(X X X X X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
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MD93E5S8Q;N0G*WPT32VM+:]R/2BY;J%^*79AU^IU4O(!DDD%<JX%M(=)."N
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MUP)6::2Z*6H9FI O4G>Y>1$GI=:MWQ.(R'X@MD\%@"G Z$YAN/&<?L6%81C
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M&T2WDI3C#J\* M&]U)ZKOVB!>'NMNAW+F*77G1ML5J6A_4D!VI0H RJNPS>
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MFQW5P/EIII<PB^12T_ZN%2\/*?3S;9RY2T"*P\K&C<R-E>*DY=.U[*1]!4]
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M6RM=3X%K<,[(U7L+L;9]=ZLN-SI,,>VU.W:&I^*@5EJ=BX(LL.3EO)1YWL8
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M:WF^>[G7.Q,C"EXG;LY%AV*V[/!*WCN' K%J:EQ1MP\.*JY=I5N33H;GI?\
ME@\V>EZAAZG;>I7<C$R8Y5+N3VEN]EJ]VTLJ_;E!PN7KC_!S=%%VDHJ*:4C,
M#4VL*UIC7-3U;3G"[E7I8W(@%\]).F"K0[$F1)8C223Z4/2\1,2/2;4OQ5AI
M"<9SG./'/.N8=>S>9M9OZ[J2MK.R9*4^"/#%R45&J57MEPUDZNLFWTG8^3N4
M]+Y&Y:Q.5-%=YZ5A0E"UVLN.:C*<IJ+DE%4CQ<,$DN&"C'H+B<PILPX X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X!8,MVBT&#GV844V4&C$Z=*%P[&.Q%,2)P^48C
MJFQ&4Q8HUY^:IJ A4F5\.EW$&+C+TGTFL>?@%>WG:>O=; A-FN]J&@0)TN(
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MWI/U?Y@_0,[XO>^\+'[-[:>UYMA5>:OG=GJ'.S4RCQ(<W%[;ZI"*]1]I+,V
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M5_F#] SOB][[PS!NGN/>W7I2EPCUR[I]7ZS31TH;58<]6[J&69:E_!9R/'>
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MG+2/ 'O-L'! X X X X X X X X X X X X X X X X X X X X X X X X
MX X X X X X X X X!@GI]^=-+[F Q[6>K &1V%['E=BMU\RZ*5$J0'8MI&1
MB)FQ-74BY1")]=P>^G/@@H=1N4.D)(RU,Q8SW ,A**+EF+=-C4H74=>SC-8^
MHPNGMR2-AR[%;5:A-:WUW9-F6M%G<(OO!:_\BB01!2%%6V4C'62LAS$YU:,
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M"OSL\$K>>=SW7/\ .@^QQ_AIWQ_BMQP'O-KW! X X X X X X X X X X X
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M?7%@,R+733%O([FO;]8L 4(9#UB=3Z?KLJ6C5BTUN-8K%3KK(%ZJ+.!1TTE
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M:_P0. . . . . . . . . . . . . . . . . . . . . . . . . . . .
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MSF2!-5:]KKL^:#!%<E'K-LF$4MXFU)EX@;;O=8N,>ZGHT2H;*%U)3M_FUAR
MPS<(!(J4&P C$&#'>9&NX: AF+A%BP]^M-;V-5;:%XA5B[KK-1%E-GPM8RP0
M"RFMA4RHII(8'8-D;3C:]$N+-?!-LGX:'PK:TM)^7*? CVYDT<3%UZM:SK]+
MM@&/,OU4 W-^&(%%=:S]C *^]O<@]8*8/;L.Z@P@# M96&01(-C94[,)V3'D
MR4.N@2E9X3 "*O=>O4ZC3(=H8#66YUVMVC8>=D7"H.WL$V7%7(-3)L_>%@#
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M!3JK0-CPLI]:C1*Y BT/73-1DG&)^P E6:GWMZN7 4F+M $8%@6KC]1#)KV
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MH#G .ZM!BE;J<>"6VG# 575MRKP6]U01K4E=H^K(A@_$A4_5VK"^P]+S;'8
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MP@TBBXK,4@]LIR;6Z]L"V;+L;EN'#C47Z%D2A5DP]4)T>5+>1@:Q"=<99CY
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M-EZ9'FPI<5X#IFBA]F/@"Z -JI)>VF[4JV3+.1"0X "M7@R^P[6BMAJ.QAS
MH"YEEQYBM";%*L>;*9BSY0QMIEQ/ (*H"J<1L0J!5*P5UE7)\T[1]56=(X_L
M6KV82/I^R35'MVQ#[!LM'<UAC)=B;711A=4Q!*-.CT29CKZ6F@.B7]&W&+NL
M6;;MECF%3Q>CV^U6DV*UB/V,:HQ@I/CZW:L+1QR95-=IM[LV%76['!;^8###
M+ V9*A^O+0!,GZJ[9)X*HW$N6UQ:4Z\M.GV]A4(!<AS *GA8C.Q[ !#;3C[;
MN#6OSM-*!!$)3]JE*8.*&SO@&9$)Y3D8"62S]SVY7*-8K$&V>Y>09$E2-=!,
MQK329-NNHN($,PMIX@1'351HK$6C&+$)/S[ I2"3;*DC&&T$(3;X$::@V,JW
M#MBZ&-IE:BKE;&)[>UG7)=*MMSVE9H]9KT@_JJOAM@'[TW!G!(3>+)D_$7 F
MA(Z675M90_*B@30\>'R-CVU!1&RK3-8U\5?JVUJ[3]DV;7]+8/QP12JL0)<F
MO7^DN6 _$/"C)&P59Y<7$ZMMOR(@R,E*9($C^%K;$JC42!4 TH:F1;+=IVFF
MAXUTOKC80;,"Q6V_;3K]2MC9FX$+22*K,?-VI (8ENRRQQV:Q+G0T. 1#T(=
M=:JFMVO\:I+3=7OYW=58NM=J%MV3F=*BVZ!8 @RQ1KP*.VFYQ 92P*FL9K@-
MT)$3*CLQI"% )SZ@($@'F-4_80J_N5R,"=G+LUA=O,H>>NU)UKK)-;MP2=M:
M'4[<FV7JT"=KD+4_$F@G"27#TX:\EI<-2<N 5 2S&EVBIDXX.];>UM2H@.90
M9=;BE##H,76+=7MAWVW[BL]D?&RWS@$J(#LBJ_#CK/,S!1%B+!G2F9#<8"1N
MR04\;#E2]>6W85**.J8MI"YUR=M2S[.I]A%4^\##WPE7OOU41+ZYIB9M:8$$
MZZ_:IY!;+L6*F-#FJ< G#5BG.2I$ [9QL\;/V!,CS5Z\G2]3Q]>TA^_UN-2[
M'6]DFCKX> (%T@,P_+IH^1(.EBY66XVQAI2FH8$K=I->#@;?8Z .OL6FZRIC
M +4M8L"2IJT4R"<J .I+FJ"[$W*+$AJ89KEO<<1 N L*>9^#*2GI7P^8^, 3
MF6#16A=0'BK4[9*C7 DO6^Q*I8ZY>J0<-_&[!I\ "(J+T**]7Q6AI1-E\% :
MEP70. LU2LG$0L2)>0)?4ATY6-36O7.M+%,%!JC;P! '\_P!?T>+JX>4[$UV
M/HU[V("#5*^WI,,.Z@W,?L(8O-@)*X=9A? RWP.V0>/T^:((Q"-['03EAL88
M1H(+JZZ/K+5B)=&UD;B_5YWTVR(OI2X5LN9;L4>2.JR0LM"51)KI""]( EP6
MI4I5CLE+@T& YJF %:?W$1N :6/FV:^:N=-G!!ZCQ+E!",9LKQZLAWE6J2B0
M++Q8#*(66I8V6N,!45''DR]<;#UY^1J"ZW=<NVKP/G&MG"*XBNV@6?O@)N(F
M_8M)_>D >^5 DRP"0N+\<A#DV"IIV%%D 4=7XD"WUZKNT4==QM_!VIZS5*E;
MOH<8< JQ,Y<Y;%*W+L)YX;29UBN9NON-)D--3Y]M".6)YN0Q$F,R,1P.HD8%
MR1NU]RA26*<(@%LV9N-KI=\,';O=]0085%"D!T_6VS8J=FT*TZVM+;610IF?
M &F(N'R9!M^,]#: K>U#[A)N1S:"*SLO6%S77 DVVKV_BMV?6-.UH/>L0JT4
MJP':D>CA+)6+:*$KFQQ00\:*#+ 2:(NQ&&UJ]0"9!7ZU'F@W0U0C:QBAH%GJ
M%%9=04!!E5X-(M<!ETH7U[;BH4B5^G#J9%)'S3  @Z,*%)S&?%Q;3(%O2K6M
MTR-PG"M9W^0>&346F.61;6Z>/WQ K1FYZC,:I=%WJS1*"P/#+*SX L4:; NG
M0DR*[&3*Q%^/R!5DUALGL8E'G2[#4C>JP ?YL5C:ZMH9YK21.RVN6D-K^VL6
M^S"@]N(W' J'-:,RX1!V$#433"<%RXCR ).P/.V&#3#%X$6VKV.C"$!]1YUY
M+L>O1\,/,"%9$"VQ-;6J77 NC/FP:?.J[N+>]'EM10[X^(YEZ=!?= G(JH%\
ME=>RB4R?4/I>WO6.^%JY5K!F5L.;L"]BX1#Z0'SB>R+V(HI@56X4NT.S9)"#
MD602Z_/BML2UX T-=D3! ][\W3S-AN=,/E0%9ZYCAC0F,6#QGZS*[!7:=3VZ
M:'- VFD$<TV=$FG/E4KY;EQQUQM2<*5#9[!RM_Y5ZYO_ !LON]-.]<E[?,KS
M)M>R]/T/#TC]S/8FY^#7^H5^=GG'S@RWGGA]UV/(Q[G'L:S,L.?"+WGOB%B3
MC&,M8E_BE7*Q'5GQ\V'%1V5KQ]GAX)S]OC]G >\VL\$#@#@#@#@#@#@#@#@#
M@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@&$VG8@F 3V^
M=JC=?FW ?NCLO<+Z:-VJL>OJH#7=R65P1*C [H#(56@#]APQ[[I"SS)&'H;
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M*5^MV:2:EEZJY2+C85U3&]F2%C=EZ[K8YVA$:$(U7)38Z\.TILS7\XI6RX5
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MC"SL+X(9A][$5 %P3127)@AK1+"2;_J5[9-CDCX55@"5$*2+K\M0<[>)"(L
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M^;Q\N/ 'O-LO! X X X X X X X X X X X X X X X X X X X X X X X
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M?M@DS0K%L2.EJ9<2<G9-*:H ?3!Z?LC\9MJ% (EE#Z=/&O(:(/1$RIS9[&(
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MPZG<8[%7CQ>OH&[ ;\8.("6RWZQB2I^KK"+J4P4U)2.F'1;CK[#D.-&1&EY
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MP'O-KW! X X X X X X X X X X X X X X X X X X X X X X X X X X
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MM?.,"8GT+L6F$[ T8 #8L@V-6"DDLO2V9#[K$!8%0QV1R=D+B%;VYI.V7>O
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M;.OS!9D3>QM45B*1B&"D*!JXN_)3#FCXYB9(N!&,!$1C91,!#4I["798$G<
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M95*U*F-(98+N0UEXL*0VE.78S,AN.^M#:W4.*::RV#WFU_@@< < < < < <
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M4?MM]6J+;M,MB:-EYFDYNLV7#Q3 ['M*MJ3[>YV4.!4:?MO"JU1;57<7NB;
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M43.L?;:W_<15];2[3YP[(YA@\VJK1KJE<-1(I!RC"JK,:FX]7#><M+QC^O\
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M?3)B-1I[:ICKR+R9\_7/HV[\H'U>\WWZS7?HF_\ *CJE7GW=F0%L#UOVH];
MB-K5*BR;5GNAK2?8D )ULLI^0-P2F&7R35BC0K&M,<^W*3)04PJ=F/\ :B.V
M\B\F?/USZ-N_*!]7O-]^LUWZ)O\ RHC@NP_=X"SA\O/M;5@Q$IT^=G5X CWB
MU:P#IP*3&&?!""L.)-S#N!D03%I?C'9$=DHAAYZ-E>4OON.O(O)GS]<^C;OR
M@?5[S??K-=^B;_RHE@>T^[&(7'&Q?:HJ4:CQK!$MB:7_ "X-4GG)5J&; D7D
M=8R-SN,FQ6621RE[$)]*,LMN,YRE/E82PPR\B\F?/USZ-N_*!]7O-]^LUWZ)
MO_*B10+1[Q NJV2I'_;GC6&IGR%<N$]13W J=7I]?MXF>-D6J1535<M@DA6-
M?6D8/SA%?:E8C#ICCTEQV=\5);6\B<F?/USZ-N_*!]7?-_79S-=^B;_RLLEJ
MCW,N_5Z*0R-)]ONDF:/:MA"=7O["#;R3;PNK;9MG88<2ZS=KC;A)<F0UQ(-W
M44Q)!#T16/& RL9G Y37DI7=)Y/A:E*UKEV=U1;C'R=>CQ.FQ<3OM1J]E:.F
M^C*%[0^0H69SL<QWKE]1;C#R3?CQ22V1XGDM1J]G$TTJUHZ&?=+M&UL72PZ
ML6OB5@MW6ZY4P#+FUNT[5W-5K*[MS7@BW5.8>OYF!7#^MM<4=^<OUQIH'=(>
M?AFI24NR8<?QPV?I5W3\/!S+DXRAG8TKT4JU@HY%_&<95WMRL2DJ;.&2Z:F
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MR<9./$HM/A;2BVO!3XJ.E'1NH>RW:*X;C8ZZ;RZ1:NT?L6WU4!NX%)L78[:
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M,]%+URT-F8L:O,#,ZL6P0C.P9F2+4UOR.1\L*R[N?FY_QYI/]-AZC.@^:?\
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MF7 +J!!F+:"MC=68VQ7MCM[&N%4A5?:&J)*Z6T<G6+%JK>SK",L#)B8< D8
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MY*L;-M1BXP2I!-W4_H]^_7^F4[#?Y/F@?[F<QGE[ESYAPOC&H?+##_6;E/\
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M$&:+?RY&=VMY5>L.(R&%?U6WE8_-YA/*7(_S1F_2'_!FN^5O-Q\Q:C]*_P#
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MU*N5A.(*I223C666E9R\AE;#:L82M:%+;PL'O-K7! X X X X X X X X X
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M=:PXRTO#4A.4/MX6A*L-O(5G*DNHQGP5C.<YQGQX!W< < < < < < < < <
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MFJ/G_&JFN7>7.'I_W?)^6>LR;?T?E/\ YSG??_+3WI_RGYZ^N>/\R:)^1O\
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MK'>58^XKV[?9:5CQ_P!7J=>\\ W4< < < < < < < < < < < < < < < <
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MS3*1< 0<) UQ.8E0H%BK@.>V_ B8=E.O/Q65 51/N$*-!Q? >R*'LO6]B%L
M$?C2( :/=K*1O=O,UBO 19U4(&_!^DJ(<+11P<@/FDBLB9A,>,EYY?B!WUZ/
M:J03$5>M6FW[7/6&DS*=<0VM2])H<76@JA9@50)L:HTFPWRRURI&(P*R,.,
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M#8*CZ,?Q:J/5[\^(I=O8U-KJ<^/QJN];"&4?731(T3:%)N"13T+X''GQ'::
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MA9>MY>3F948\*G>N3NR4:M\*E-MI5;=*TJVR^W+ Q@X X X X X X X X X
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M[IL]K"XV'07CJ829\#828)KX"J" L_,-927(8?2M#,/TX/)0R_;T]NNV6V.
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M87M-W(Z[+AQD4EL0ULPF2HP"* JC0&'0Q$[7S%BM9(? +PHEAU(7)$P9_)>
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MD,W6J"#VQ)>IZK.LUD:#Q(I@(<M$YXUL\8$89-'&W9HK$D9"C&H;4/+>,@2
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M!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P#FW^$;_5I_VV.
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MW"3:E89\S8(;-PA.TVG;*LXXCK:/K\N%F*UBD0P86^NUVMV>-E1H+8)YZ/\
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MKAVZ 5FDJMMMH+.RQQ@]9C6H(,"KUU-7D-HRZ[ZSBR2\1DH\,X=R!-YON2U
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M@P')*2+[DKX:-P"]C]6CE-B&J50)]J*50'+Q=-K'[B)#VL9L"Z6M,Z]MRAU
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MR%+,[8,"2 N</CV>SFOFWS1#A!N9)\@V0J$!G50_J44NPQ$$-+TV\-QQ$[;
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M'V./\-.^/\5N. ]YM>X(' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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MS'DHDIP!355D0K;7JE*U"6DF#E.AL[6B0 =D49+7H[L(!M'&KMH;0!QKY+G
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M:TTT[JTC&L XQ>;*Y4)B!2S<)\G)@:KTS(LRIT6.BTNFJLH#@4N&1Q&=9<?
MJ*%ZZ;8S?]4:XL"XN!$ROW2[GY@-EZLG&B-<P>UP()7/:VK]B5"O(.46!)]%
MX>\!)^;Q;8\DIM>0*5J4R):!VN[%J2 :L312GCIU-U":"WL*H-6Y^NR+=3PS
MF%?W=8ZI/RB0\Y*GV:<S&AOYBPAD>%(+8:EN 5$) 5>QDI$(0(^,UO/M<JWN
MTJPS7M;VS8>WM:$Z5+ W*K'B=DK5DMUE<MU;(%I-CFCLIL4OY>RX]%9BON*
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MG<]US_.@^QQ_AIWQ_BMQP'O-KW! X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
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M/=<_SH/L<?X:=\?XK<<![S:]P0. . . . . . . . . . . . . . . . .
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MA=L&S2\BCD:U -,WNJ';"A%;VL48, QDLC"CFG$AZJ)=DKDO3')$-0%0!0Y
M$S7JE%MC&TZ1$N)PCL"'&F3H1.)>QD(C>2PXR*<OJ0_S*R7T E)8))?!A [9
MB) AC5094G#8$$^SL*FT;808[L+3%9FR;-;8FPQF+2^:;U/K?8<0A=BNP;%
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M$VZPS) LO$'<DS4=&68Z77DMJ4[E.&FG5H EO]-/U5_YC_<4_P"SZ[%_\FN
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M$QR)66Q!@1(:^M1E3A03 0UF=E3Z6U?:ZWX87AEM]6?,O^M&H?1MWV!]3_\
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MM57 EYM17 ]0:\@B(9AE/096VY"=D(STW5>7_-/CZ=?OZ3S%FY.I0MR=JU+
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M@Y^#7^H5^=G@E;SXS^";_4)_.X#WG9P0. . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M. <'/P:_U"OSL\$K>?&?P3?ZA/YW >\L%;>RNN:)V'U5UKM^#=?NF[J;>+7J
MJP$HD"/1KF3UR^)7;M="3BR>)B]DCP!ELRV,5$3\4(8E2&7%_"2$-W4,.[<Q
M)YENCMVY14E]LN*M)-4\&JI6N^BZ46\LB$,B./*JG.+:?0Z4JJ]>VM.HR!Y:
ME<< < < < < < < < < < < < < < < < < < < < < < < < < < < < <
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M%";B_2=#8+-Q7K,;T=THI]]5+D\HE0< < < < < < < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
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MW.E$NQ6FF[!VNNE:%<O9,1MB,$+F!)DI"J:K'.*P8:8[SJ?66\PUA&?'&,<
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M:Q5ZG$ VQR7'- ,! [ BRO3QB84]@H*Q&1#,N30T##+R76W,N1F<(5C*$>&
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K^=L9^O/QJY I>26^7R/@L5?Y#A3RP&%?%>3)3REO'P]7'P_PN>"52I__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>g68105page145.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page145.jpg
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MOK2SI9\:O!+:2NL(&K,9TKDYF^Y(:4+OQ9\=I!_K $^ZX8:I_P#U9KR6]?\
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M^M*V:%IP@  ["0[;8=O#(CZ^O>CQ0Q.;-FM]KV 2P(>'X=C^!4$;',?BNC0
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M-:141>%Z"S-/#SQ4B;1TO71?';3@(-K+V RRBAP#'1@G-B8@21&;*$R"T<A
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M*4Q(Y)Q$>6O#[CP#61[;Q!GX[^]V:UQ2FJ\;QKXIO+BHI:>,*%65D*RK!@C
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ML8%)66%I93HD"OK(LFQGS[&2&)#@PHPWR)4N9*.\88\6,%KGO(]R-:U%55Z
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MKB$*0CE>0CW.*4KW/>YSW.50$>99CD&87\_5VL)J09T @!;#V((0YD77L20
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MPI%!C\H:BD1M81R#>.PL1.:Z]<CHT9Z0VF+("14&#'KHP8<,(8T2,$,:)$C
M'&BQ(L8301XT:.%K @C@"Q&L8QJ-:U$1$X1.@CW>7EGNJUL,+P^PF5&LZB7)
MJ]@; JI+XL[)YT4JQ[37NO[(780(P.:H;R\ Y%B?>APG_6>\:$!YHZ.KQNKK
MZ.C@PZNFJH,6NK*NOC#B08$*&- QHL2,%&B!'")J(UK4]/TKZ] &,CR.[V==
MV&O< L)--C]-,-7;*V76E1DBL.)O$O \!F*U1ES8PG=EC8LY%0"=VM5T]S6Q
MP,&-8W28E25>.XW71*BBJ(;(=;6PA^W&C :O?]WESWE*0CG/(5ZO*8CG/>YS
MW.<H"3,LRO\ +[Z?J_6,WZ"?7O"+8FQ!#%*BZ\AR1,D#IZ1AQ&A6NS+6$1"1
MHST("I ]LR8U46-&E 3,-PZ@P6@@8]C$)(%3!0[V"<4LB3+E2C$DS[.TL))#
M3;2XM)A7GERY#R'DG>XCW*YW0,3-<TO;:^-K'6!8Z9BL>,?+,L/&9.IM64LX
M;GQK"?')S'MLTM8_+JBH=Z.3^5R^V*UK3@^,+PNBP&A%14 S^RV1)L;*QGR'
MS[J_N9S_ ';6_P AM#?RBUO+61^LD2"+RJ\-:C1M8QH,?/<]MEN0ZYUT*'/V
M/90@S94J<Q\G']=T$DCPMRW+V">%Q2%(Q[:JK:1DFUDC5$4<8<B0$'A@.!5.
MOZ@U? /+L[*SF/M\FR:V>R1D&69!($(<V]O9C&#8:6=HFL&(;!QHD<8X\<8@
M"&-H-S8.P9E-,@89AD&'?[,R"&274U,LA4J,=IT)]-)S?-Y,=&R*[%*TZ*Q@
MVJV5:2D2+%17^X0(0R\6\03$/.WSRCR;FRR6^M-7>$EKD^3VI'_5W]X6K\A(
MQYHX+2O@TE<,$88HL"(T<:)'&UC45>Y[@YNOCFRZDPW]ZH^8:RO76K8IM96L
M4:U&.Y%DI_>6XT";[\/&ZJVF"'V"7[[QM9SPG/*HBAV$IOO6ZHGZ_-$_1_-1
MM;T__@KH%:CV]A>26D6FIGY.6PE^ZHFV. 9_0Q.T(GF(I;2]QBNJXZHQB]J$
M,U7NX:WERHG0$QJ]S47CCG\GK_GHB]!=T HS:ZM:[8FF*J%.+&KLAR#,(MU%
M&C/;L8U?@&06<(,A7-<[LCV$89F]JM^^Q/R<\A]VI=6U*NM_PJ<:#^+[6Q"D
MLO91B_65,Y+)9D$O>U_ZF0H6\]O#O1/7H+MSW-IC^!2K2EFEKK >1X!$9+"C
M%(V-9[!Q:KL HA&O9VRZZ:43N47[KUX]>.@R-S6ME0ZDV??4TTM=<4NO<RMJ
MJ>#L4T&QKL?GRX4L*$:\?NQY FN;W-5.43E%3H'E+,0=')E,=VR&51SM+PG+
M3-@N*TB-_B\H1$7H&GJ"TL+W56L[RWEEGV]SKS";6TG&1B&FV-CC5;,FRS(-
MK!^[)DF<]W#43ER\(B>G0)VDKNUR/6F.W-Y.-96DPM^DF:=&(4R1LFN8<9'H
M-@Q_J8L=C$X1/1J=!6I[JUNX^>DMIQISZO:N?TD!3(SF+4UEQ[%?!&K&M_4Q
M0_=;SRO"^J]!Z8/<6ECG.YZZ=--)@X]F6-0*6,3L]NNAS-983<2HT?M:UWM&
MM+$QU[E<O>1WKQPB!]I+BTD[@V%1'G&)35.$ZSLJZN<@_8B3[FSV."TE"5&(
M3W)H:F,U_+E3@+>$3UY"P]W:MW?68XV:5*,^J[V[+6\,]A]M%RW'8 )RKV^Y
M[PX<P@T^]QVO7TZ"S++JV@[4U)2Q)Y@5-[&V&^X@,0?LV#ZJFJ3UKCJYCB?R
M,QGN;VJWU=Z\]![;'N;2INM0@K9IH8;[:(*6W&+LXGU2X%GUJZ$;N:Y?9=/J
MXY5[>%[A)Z\<HH5MZYM:+%JV;3SS5\HVP=4U93@0:O?776R\6J+:(ON,>WVI
M]9-*%_ISV/7A47A4#YNVYM,=U-L"]HYI:VXJL7LYM=/!V*:)*")'#,)"->/O
M:OV<M5.@<FP)DRMP;,[*N.2+85V)9).@R1(UQ8TR+33#Q9 D>U[5*$XVN;RB
MIRG05@<Z5:83AEE/,LJ=8XICD^;*>B=\F5,IXDB2=Z,1K.\QB.<O"(G*_9T#
M5T7=6V1ZDP&_O9QK.XM<<B3+&>=!H:7)*\O>8B"8,?<J-1/1$3A.@]]27-I>
M4%_+MYI9\F-LG:=3',9&(X592[ R&JJH;4&QC?:A5\08F^G/:Q.55>5Z"M>W
M-I:Y'M^+8S2RXU#L4-13A*C.VOKG8#A%HZ(!6-:Y1.GV1R_>Y7N(OKQPB!KU
M\F-A[+J_(3-EQ_9.9XU5:HK?$2;18M1V;(F*W9=U;GRG"\X;F-*^,8&1C-14
MPF1O=<GTSU5S?7C@-K(VHQJ-155$5W'<O*\*Y5XY7U7CH+^@0LCR.KQ2IEWE
MT24&L@,$^46'6VEO(8TIF 9[5=30K"QDJI"(BH,3U:GJO"(J] +_ .D-JS_Y
M3R?_ 'M-G_[3>@'^V/(#5\K5NRH@K/)%-*U_F8 H_7&RQ,4A,;LF,1Q"X<T0
MV]SDY<Y4:U/5?3H$;QT56Z3T2OW55=6:R7\O*+^R-,JM7@?//^1T','^Z/%;
M1[%^9377/8N*>76/E2-^4+7WN[:)5XY].Y<?1O\ UG0=)GA1VQ-C?(52K]TL
M+SGO[)!>J*V-DOCGXWW8R<+^0TF2=W/V+_D]!/;H,3^R^HUR:Q_)W_ZI5\5/
M_P Q?.[_ (&<"ZJ3JEOM^ZO=B0LRT7K&9%B9/=XQ:TF99W+AI:4.JX&2TTF+
M#))A^X(5YG%D"6TL"I[T00'),EJT'LBE$:*_W5_Q6RWQ3^.C8=1F&0T=_/SG
MS%\C9\9M DWZ: W5>31O':S88LR/'<1UID6G9LX/8-$2%)"CN"=[&AOVSO.K
MF1>-UKK1L.;L&=#!+M[B8'ZW']8X_+<Y@<FR80R"^LM)J,>E/4=[#61F.>Y1
M1!',T'I@F"4NO:-U34NES9,N7(M\@R"V,DS(,JR"8UGXCD.0V'8-9MG-436^
MC6! !@P 8, AC:#4V#L"QK[&'@N"0X=YLR]A_5PH4UQGT6(4CCOC%SC."Q7L
M+%H(Q6.9%B->.7<RV+&CJUC9$B.#BU]KZOP&NFL9-E7V17TM+;+\PMFA6]RN
M\<)H7S[!P&,!&B10L:"#" UD6OB,8 +&L;Z@E[%V&;&7UV,8K6BRC9.3#D+C
M&+NDNCQ0QH[FBFY3E<T3#.H\,HR$:LJ4K7$,161HS"R3#&H9>O=>"PL=I:V=
MD3)\ZRDD>9F>93([8\NXE1FE;#KJ^*TAF4F*40SO%6UHG*.,-SWO<608YRAC
M[$V('$ UM76U9\ESG)32HN%X;"DCC2KV9"8QTN=/EN:1M'BM,TS"65F5JBBB
M<UK6E.4 "A9KK79\8-893E-H+*=D9-'CLR7)TCOC100XY"G@XIBD$Q3NH\,I
M'G?]-&1RD.5SY,EY9!7OZ#.V#L&NP>NB(Z!,O<CO)ZU&'X?4O#^.99>()3M@
M5["N:&-#C!:IITTZLB5\1CS&>UK>%!'UYKZQJ["7GN=385]LR^AI$G3832NI
M,2I%*V2'",(9)1IHM#%D-0DJ4]K9=Q+8DB1VHT (X.;/,[I,!I76ERV=)++E
M1ZFBI:D'UE_E%_.0OX=CN.5Z.8Z?;S7"<J-[FB")CS'>( R$:#*P+!;J9=)L
M[9)(LG/#@D0J6CB&=/H-8X_)5%-C>.R"L8DZZGHUBW-SV,+8%8@A(.&,0N@?
MV:YI0X)0S+_(Y!05X/9CB%&"6796EE.)]-6TE'6QVOEV]Y:RW-#%B@:\IBO1
MJ)]JH XPC"L@R&^C[2V;''$R0##"P?!O?%85VL:B8QPY+RG"YT.TV'>1']EG
M8C[A11*L&&[V$,:6!3RG*J'"Z2PR3); -52U@$/-G'0CVM5Y!QXT8 0L+(F3
MY\HK 1HXF//)D/8(37$>UJ@(<5Q:]V'>5^QMBPI-1%IY"S=::UGH,BXDA1N&
M+,,R"-Y(D[9,R*]R"$BD#CX"N )SY+CG<!GR"_I\6I[#(,@L(E11U$.1/M;6
M>=D:%7PHPU(61),141K$:G"<<N<Y41$551% 'T%#;;=NJW.,WKYM-@]/,%<:
MWUQ:!>&9-F@-[U?L78,$JH]MNURH6FIC)VU**V3):L]6,@@>+*R@TM=*M+:9
M$@5U=%-,L;&=(%#@P8<4+SRYLR7(>P,:)&")SR$>Y&L:BJJ^G01]K:^=O:RA
MY%D<*96:?@3 VV&8?91RQ9VQ9L0@Y%7G.:U\AK"@Q6+($DBDI#M1TAR-G3F(
MY(\<(2)*4<**61((-@HPB&,8I&"&,3$<0I2F*YHQL&Q%<YSE1J(BJO"=!'!&
MF\A9C32!GA:( 9BQ(Q4* ^[9,<G<R5+8J,(#4H2-Y$%R([)5^^]$K6M;."2(
M1MC!1GZMHQ-X8C6M&P8F)]QB-1$8Q@VIPB(B-1$]$1$Z".4V9)\@)AZFLD'@
MZ.BF="N;R*9X)6XI82=LBAQZ6%XI =71S#<*PL!.:^]>BQXKTA(8T@)%0H<>
MNBAA0P@C1(HAQXD2*$<:+%BQQL#'BQHXD:(  !&C6,8B-:U$1$1$1.@CW>7E
MENFVL,,PZQFT^M*F6>KV!L*IDOBSLFFQS?3V.OM>V87L(%@"(X%Y> 7^1JCX
M4-_UBF-! \4='68Y55]%20(572U,*+75=77QV1(-?!AB:"-$B11(@@1PB8B-
M:WT1$Z +Y)D=WLV\L-?8!82J6@I)1J[9>RJTJ,D5<@:-^KP' 9?:X1LV,)W9
M8V+.X5 )RM:KI[FMC@8<:QJDQ&DK,<QNMAT]%3Q&0JRL@C5D>*!CE?\ =5SW
MO*4I'*\I7JXIBN<1[G/<Y5 1YEF5_F%]-UAK&:M?/KWB%L/8HQAE1->1)0FE
M%3TC9 S0+;9EM#,A(T5Z$!5 >V9-:O=&C2P)F&X;0X)00,=QF$V#4P6E>P:D
M-)ERY<HKY$^UM;&44LNUN;265\B7,D/?(DG(YY'N<JKT#%S7-;VVOC:QU@6/
M^V/T\8^6Y:>,RPI=64LX??&GV$=ZI'M,UM0<NJ*=R_>3B7+1L1K6G!\89AE%
M@- &CH1'4+9$FQLK&?(?875_=3WJ6TR#(+4W\HM+VUDK[DB03U5>&M1HVL:T
M&1GN>6ZW ==:X'"L=D6<(,V5)G,?)Q_7>/RB/"S+\N8%XB&<9P2-JJM'CD6T
MD;D111QR) 0=V!8%4Z_IS5\ LJSL[*82WR7)K5[)&099?R!C'+O+V8U@VFEF
M8)HQC&T<>)&8./'&, AC:#>V#L"93S(&%X7 B7^S,AADDU-3+(5M/CE.I?IY
M.;YO(C<&K<5K3M5C&-5LFTEM2+%17J0@06=?Z_AX-#L2%GR,BRG(I(K/,<QL
MQ"9<9/;L$HFF.T7ZBOJ*X*H"NK@=L6OBM08T55>]X1#T>=K_ )"O/:.C7(Z/
MJ3P?5RN3AKD-!\CG-[?7UX[5Y_3T',A\<V:8GA'[U1\P]EE^25&-0)&LK6("
M5<3108\B3^-:!-[#"F5K7%08G.X_,U>@["?Z0NC?]U;!O[8('_OO0*]%N756
M46D:CQO8&*WEQ,]U8M96W$65,.@!..=PPB>Y[D"$;GN7CT1.@)3'(]J.1%1%
M^SGT7CG[?R_;T%W0!38?]U3Q_P#]D^>?\&63]!]W1]NIO[]6#?\ L+?H+]_?
MW,YO^RO67_"AAG09F_/[ANX_[UF?_P#BM:= _9W^MN9_\Q9'^IK^@9&B_P"X
MII_^]9KW_P 4:CH$GQX_N0XI_P#;<E_\;\@Z#[I/_M/9G]^K9O\ JZO0>NNO
M[HWD!_L]Q'_@@UYT%V._W==I_P![S4'^K&V.@\9/_G$T_P#>6R3_ ,><4Z"W
M-O[L^CO_ +DVG_J!3=![;8_UP:*_OR@_X,MG=!]WG_K-J?[Z&E?^%S#.@M\A
M_P"XAM#_ &&W'_N*= ]-B?ZPLV_V'Y/_ *B3>@Q-6_W,]=?[!L1_\7*_H&AX
MX_W#=8?[$Z__ -D;H/?1_P#K8R7^^SN;_A0RGH*U;_KKWM_?7C_\&6NN@UN>
M4*\[\\AOM^[1?'2B^B\>ODEGR\\HBHGV_EXZ#<1T%= D7=_2XW72KC(+6NHZ
MB"T;YMK;S8U=71&&*P WR9DL@HX&.,1K45SD17*B= POY]-*?[KVL?[>\7_[
MJ= /MM;NTU(U7LR/&VSK4YSZ^S00A!SC&R%(4F-6;1C$,=DYY"/?Z(UOWE7[
M/7H&?XZJK=(:)<K%<O\ -7K1W]<G;_WITG*\J->4]/LZ#EV_=DU7&/DT^?77
MZHH4'Y*LNA1E]$8"+NWR*!'5&_:J-!;M1%_-_#T'2GXL,^@\K?DCJ&JG;_/C
MI/(NU/L0F0^+FI&O=^E7)5IS^E.@GWT&)_9?4:Y-0/FH3,I_R8?%+C.&VU;0
M3KC#_/EYL@FPUG2:&(+56L(\RUIX+D=%GW8(DIS8@I/\D0[VE,A&"4!:DZMI
MM!C^(ZIPTP(KVUF/4<6ROKNYM)9)<R45K#6=]D^26\I7R[*TF.823,EF<XA'
M\KZ(B-0C0Q\&'D_A^]/!0^+>,N1U^9Y0/RK\TY.29'(J[']G-646=^4>U-FX
MQDN2@EC@NL;'(,#SFLG4M2-Z%GDD_K7!#'EO$&^W!,$I=>4;JFJ=+FR9<P]O
MD&06QDFY#E603$9^(Y#D-A[8OK+2<X:)PUHP1PM8  Q $,; :NP<_L8%C#P/
M X<.]V9?0OJX4&<XKJ+$J1QWPSYMFY8A&%C4$8S7,BQ6N;*N);%C@[6M/(C@
MX=?Z_K\#KYS&S)5_D=],;;9AF-LT2WN67BA8%\^Q<%C 1HL8+&@A0@-9$@1&
M,"%C6-]02]B;#+C)*S&,6K1Y1LC*&'_9C%UD.CQ110/&&=E653A-*ZCPVB<9
MJRI+FJ0Q%9&C,+)*,:AE:\UV+"QVEK:63\GSO*21YF9YE+CMCRK>5&81L2NK
MHC2%'28I1C,X5;7"<X<82N>]QI!3G*'CL/8@,0#65E96R,FSG)2RHN&89"DL
MC2[V9$:SZJ=.F?K&4F*TC3,+961FJ**)6M:TL@H %#RUUKL^,EL<IRJS'E.R
M,GCQF9-DR!("(")'>0\'%<5@'>9]'AM&\[TC1T<XL@CGR93RR2/?T&?L'8-=
M@]="7Z*=>9'=SUJ,0P^H<'\;RR\:-Q6U\!I2-%%A1@M4\V:=61*^(QYS.:UO
M"@CZ]U]8U=A+SW/)L.^V9?0TB39L-#.I,2HW%;)%A&$BDHA8M%%,QKY4IZ-E
MV\MOU$CM1  C@Y<[SNCP*D=9W'UQS2I4:IHJ6HC_ %E_D^03_<2LQ[':_N8L
M^UGO$Y417,"$3'F.\0!D(T&9@>"WDR[9L_9)(DO.Y$>5$I:.(?Z^@UCC\OM0
MN-XX=XQLG7D]HV+<W/8TT\S$$+VX8Q"0'[F>9T&"4,V^R&26-!C>Q'"*)'+-
MLK.RG%2-64M)61FDF6UW;3'M#%B@8\IBN1K4^U4 =87A=_DE_#VAM"*.-D,5
MITP;!/J13ZW6%;,&\)S&.!Y85QL2XA%[+&Q8KQ0Q.6%"=[/OGE@4,IRF@PNC
ML<BR6P#4TM7&61,FF1[D;W/:&/&C1PM)*G6,V21H8T8#"2))WL$)CR/:U0$>
M+8M?["O*W8^QH1ZF/32?K-;:UG^V1<31XWL%F.9B$\L2?LF;$,YHA(KX]#'(
MH0]TIQY#@,U_D%-BU18Y!D-A$IZ2IAR+"TM9QF1X4"'%9WF/).]41C$;]GVJ
MY?1$5RHB@#J"@N=N7-;G&<0)E1@U-*#:ZXUO;B("=-F1WN)7[#V'!(JK^*HJ
MM-3TQD5M2U6RI+5L%8R$!YLK.OI:^3:6\R'75]?%D3+&QFR!1(,&'$ ^3,F2
MY<A[ QHD8 G$(][D:UC555].@C[6UUAO:QB9'D<2;5ZAKI8K7#<.LHYHDW8L
MV,9LBLS?-ZXZ,*#%HI1M/2TDAJ/.Y&3IS$=]/'"$B3&%#C$DR7C&*,)Y3F(0
M8A"$QJO,8IC.&,0AL:KGN<K6HB*J\)T$<6L/Y"S4*=LF'H@!4)%BE]Z.?=DF
M(]KF2I0W(TD;4H2M11"5&OR1R=[T_#6M;-"1XAMC 8U6C:T#.UG8UC&#&-%:
MQ&HC6#$Q@_3A$1K4_1T$=)DR3Y 3)%3529$+1T202%=7<0Q8TO<,R.1PYF/X
M_+CO88&KXY1N%8V E1UX]'1HSTA(8L@)$0H8*^(&'%CQXT6($<>)$B 9'C18
MT<;11HL:.)K1@  +$8QC41K6HB(B(G'01\N[RSW7;V&&8793*?6M5+-4[ V#
M5R219V33HY5#8:_U[91B-(!H"-<"\NPK_(^70X3_ *SWC0@/%)25F.U,&BIJ
M^#64U3#C5]765\<<6# @1 M#'AQ8HVH,( L8B-:GY/T^O0!;(\CN]G7=AK_7
MMC+I:"FD%KME[+KBHP]8=O;]9@.!RFH01LV,->RPL6(\5 )ZM:KI[FMC@8\;
MQNDQ&DK<;QRLAU%%3Q!PJVNAL5@8P!JYRIR]7D*4Q'*0A".<4I7.>]SGN<Y0
M$699E?9??S-8:PFNKI\!PQ;$V((8)437<24%I1TM,,[30;?9=K#*U\:*]I05
M0'MF3&KS&C2@)N&X=0X)00,<QN"V%4P6F<QBE-+F2I<PRR;"TM+&8\DZVM[2
M84DB7+.]\B2=[GD<KE5>@8F:YI>VMZ;6.L"Q_P!L/8C2,LRR1'9/I=64LX?=
M&L)\8B_3VF:6D=%=3U#E5'>DN6C8K6M.#YPO#*+ : -'0B.H$/(L+*QGR'V%
MW?W4]_NV>07]J9?J+6\M9*J0YR?;Z-:C!M8QH,?/,\N?Q@6NM;#A66QK.&*9
M*DSV/DX]KJ@E/>(>7Y>R.41"J<@2-JZMI!2;:0Q411QQ2) 0=N!8#3Z_ISP(
M!)=G9V4TMQDN36Q!RLARR_D#8R7>7DUHPL-,,P31B$-HX\2.P<<#!@$-C0;^
MP=@3:B;!PS"8$3(-FY#$=(J*B88PZ?'Z="H"1F^;R8KO>K<5KC+V,8U6RK24
MGTL5%?[A @LX!K^'@\.Q*><?(\JR.6.US',K,8FW&46[!(%ACL$B1ZZIK0_J
M*ZNCHD6OBM08T55>]X86Q-B)B+:VDHJU<HV%DZR08AAX9*1G3G1^QLZ[O)J,
M,E%B% AF$L+ C'(-%:$+#2C  0(*^*=!<X_Y^?(&+)<ADY1DMCJWP9M;^V>U
M8M=^(R*?R("2!CE3W$91XU7LC-'$B]Y2(WDABF.0I7A!;QRQW6F#_O%GR59#
M'J\1Q2UO_"+Q)MK:X<.MJ)-O?7U_?Q[RP/),\'U$^V@XO6-E/1>\R0A*_E6(
MO0;]_P!N<*_\+\7_ +8*?^S.@]XN6XM8''#K\AHK&695]J'!N*V7*+VIW/4<
M<$IY7H-B*YW"+PU%5?3H'"U4<U'-_BK]G''"I^=..4]>@NZ"%OEMDV?XWE/C
M$'6,C$H&99=M_),)K;C.*NWO,;HF6&F=E7\RUF4E':T5C:F%#QEX@B;,CM]X
MS7/<K&N:H,+)L6\Q\J_9W\2W/X],_9K*:C+8*QM'9^Q"SJ9LCZ<$KOW _F.3
MZAW>C>'?F5$1>@^Y=C'F5F='(Q^UW-X\ B&L**R]R%HW/TD-/CU[6Y##8BGV
M\9BC)-JF,>BM[O;5>.%]4#VR_'/,G-,5R?$+/<_CO'K<IH+G')YH>CL^26*#
M=5\FMDEBO/N HDD,$=RL[FJWN1.>>@5BQ_-8L0L%^X_&_P!HD1\5[F:+V"BH
MUX4 KT5=Q\-<K55414X_J)T"7B>/^9>'8OC.)UVY?':1 QC'J7'H1IFC=@?4
MGAT=?'K(Q)+P[@8Q9! 145ZM:UO=SPB)Z=!AX;C/F1A&-P,8JMS^/,F'6/L'
MC--T=GSY#_Q"QFVID>X&X!#^Y(FN:U$:GW$3GUY7H+\8Q?S)Q,5Z.MW+X\&;
MD&47V6RUE:.S]_MS\AE),F1P>UN 7;&"7GV^[N=VKPY5^WIP\9I*Q3QFD*IL
M;\R:.ZS&\B;G\>"3,TMJZYLQFT=GR@#(J\<IL7"V%V;?81H"0*,1'=[G*I7N
MXX;PG6_E9[;/F9+/+C]M8_"M4]\<8?8>.>9<+*KS,!;G\=UL<DI<;I)8"Z-S
M]8HHN,2<DE0C1T;M]ID.=V1&0B.<YO#&<(G#NOY5OK$1;,U_@/,F,>93\TC9
MPNY_'?\ %8N+SL4''31V??1N@3K6!<&,]/YX/>^I9)KF-:J.[48J\M55Y2W3
M%DQ9D_+DNTBD\?OT/=XK[/&/,BVR3%LJD;G\>&V&)"R 5>(.CL]2,9N11(<.
M6LI'[@<571Q1$5G:YJ=RKW<IU1=D&,>961S<4FS]T>/ BX=DK<IKDCZ-S]HS
MSQ45_C_LR_=W YSHKHE^9_#%8]'L:O/:CDZ"LIQGS*R^KC5=EN;QW &+?XMD
M0WQ-&Y\A/J\3R*JRBO"_W]OE8Z,6?5#8;A.?:[D:J*O*!]S/&/,C.,6R#$;3
M<WCQ&KLAK)%7+/$T=G[908\I$:\@7&W <2&X^SEJMZ!4N:[S0O*>UII>X_',
M4:WK)]7)4.C=A)(&"PB&AE>)7[B>U"-&95:JHJ<IZHJ>G064%5YG8[1TM!$W
M)XYEB4E36T\-YM&[!4I 5<,4$)#N9N1C7%>*.BN[6M3E?1$3H$O"<6\Q\%Q:
MBP^IW/X]2*['H JV&:;HW/G2B@"KW(IG W (2E[G<)PU$XX_+ZJ%V*XWYD8E
M!G5M=N;QX.&?D&49,8DK1F?JYL[*KZPR"<%B@V^)J1P3+%S1<HKO;[455=T'
MVAQGS*Q^?EEE!W/X[D/F&0#R2Q9(T=GRBCS&4-+C_M1/:V^US0+#HQ.^^YSO
M<5R\\*B- #;DUGLVEK=B[=VMG.&9ADN?Y=X?8B*)@F%7&&T]-3ZZWS&G!.8-
MYD^53)DZQ/F95>Y##8Q@FHC>>>@W")_53U7[?T*O'^3T'WH,.:^$P+_K_IOI
M^&>[]5[*!1%?]Q2*=4&B>XGIS^7H$?W<2_Z+'?\ LZO_ /:Z >;=+BG\U&SV
ML?CR/77>;]G#ZSN[OV9L_P"*B*JK_4Z ,:!<YNAM(*UR(K=2:Z<GW.7-7]CZ
M;CGEKO5%Z#63X(>-6E?&3YH_DHCZOIK"NM?(KQN\9_)W+5L+,]@*+E^>;6\A
M:K/!4:$1GTE)<75)%G)&<A/IC$>T;T&J,:&P;Q^:^%YY_(97JJ(.PJ?#[+6,
M^QROLM99MBA2\?E:Y,'8WG\[..@G]T&)_9?4:Y-8OE)IG8NQ//KX_-B:WRVG
MQ&UT=A7DWE=J3)<=D9'191B&46OC[@^=89[<&SJIE1?6F)7DH]7/1Q1QIT0:
MD$0:O8ZI.J1OE#G=E_-EMW6^!"BVF<2=/Y]8WL^:TTC']=XU(Q"]:"^RCZ9X
MWGL;10O'558WCD3RM<1RBBA,9I'.!^Y@>VGQB[G(B(G=YE; >KE:U'O5=5Z?
M:U7JB)R[MX3E?L3H.I?8&?V4"RAX%@<.)>[+OX?U<*#.<7\#Q*B<5\0^;YL2
M*YIHU#%D-<R+%:YDJXEL^GCJUC3R(X.#7^OJ[ JV<Q)<F_R2^F-M\QS&U:)U
M[EMY[ PNL+!PF-#&C11,0$&$!&1:^(Q@ L:QOJ";L/89<9-5XOB]8S*-CY2P
M_P"S&,?4NC1@Q([Q"GY7E,X3#$I,,HG'8LJ2K'$,5PXT=A9)1C4,C7>O!86&
MTM+:R?E&=906/,S+,Y<=L>3<2HXW,B5U=#1YAT6*4;".%6UHGN'&&KGO<604
MYRAY;"V(#$@UE;50)&29QDI)$7#<,A'2-+O98$8DJ=.F=AF4F*4;3,-9V96*
M**%6M:A9!  *'GKS79\;-993EED'*=D9."*S)<F2.X$./$C*XL+%<4@&<5U%
MAM(0COIXR.<605SY4EY9)7OZ#.V#L*OP>O@JD.=>Y'>37U.(8A4*)+O+;Q!$
M(VNKVF>P46)%$Q3S9IU9$KX@WG.]K&IR"1K[7MA5V,S/,\F0K_9=_"2'-FQ/
M>?28E2*5L@.$X2&4U"Q:&*1$?*E/:V7;RV_42.UK0 C@Y,[SNCP*D6TMUG&/
M(F1JBBI:B-];?9-D$[O_  W'<=K^YBS[:?[;E:WN8((F/,9XPC(1@,S \%O9
MEV/9^RW09F<RHLJ+1T<21^(4.L,?G(SW<=QN0HQ"GW4]HV+<W/8PM@5J"$@X
M8A"Z!^9IFF/X'03;[()9(D**Z/& *)&+-L;*SG%''K*6EK(R.EVMW;S"L!%B
MA:XIBO1$3[50!WAF&7^2W\+:.SXK(]_%8=,%P1TD4ZNUC6S!*$YSE I(5ML6
MWAD5EA8,5XH8GNA0G>RISRP)^4Y5C^%T5GD.2V0:>FJHOU,R:5KW(Q'O0$<$
M< &DE39\N2]@8\<+"'D&>P8V.>YK5 38OB^0;!O:S9.QH)JN+3G^KUMK6>K'
MKBG<U[!YEF0!/-%F;*G1#<"#W$!0!>X05=)><[@,=]?4F+5-E?9!81*:DJ84
MBQM+:<5D:#!AQF]QCR9#U:QB-1?1/5SE]$155$4 ?0T-WMZWKLYSB!.J,(I9
M0+36^N+@1(\Z=,CN4E?L+8U>5.6VS7M::FIRMXJ4[94EJSU8R$!ZLK*NI8,N
MTMI<2MKH$23.L+&:<,2%!@PPOE3)DR5(>,,:)&"QQ"/>Y&M:BJJ]!'VMKK'>
MT^)D.0Q9=;J"LEAL\/P^SCGBS-C38QT/79KG-9):PT?%8SV,/24IVHLAR,GS
MAHY(\<(2(.<$..^5*>,0HXG$D2"/8P8!,;WF,8Q7,8,(VM5SWN5$:U.5]$Z"
M.362/(:6I"_4Q-#QCH6+%+[T>1NJ3&>BCE21+V%CZC"9G(A*C79(].]_^EJ(
MV<$CAC'' -%&)B1QHQJ#:QC!L8G8U!IVL:-C1^G"<(U/3[.@CK,ERO("9)J:
MF3(AZ-B2GPKN[BF-%D[BE12$%/QW'I87-(#6,<@U'86 E1]ZY'Q8SDAH4T@)
M#PX<:OB1XD6-'C1H@1QHL6& 8(\:, ;0QXT4 F#&   L:QC&HC6M:B(B(B)T
M$?;N[M=U6UEA6%6<VGUM4S#U&P-@U<DT29DMA%(X-EKW7MG&<T@/8*QP+R[
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MF<,9B4>&4CS,^JE=CB%*]D>,PLDHQJ'OKS7@<+!9VMO8DRC.\F*&;F69S([
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M-I9S"6^3Y-;E;*R#*\AE,$*9>7LL3&#+**P3!B$-K(T.,QD>.P0!L&T$+/\
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M(-S7M1>@U:Z2UWJ#<V<8UC==;>3]'&=J*SS&YBVWD-MUD"RL@9348M%GXS8
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ML;&:5L:LIJ6LC(2;;W=O,>T$6*!CS',]&M3H!UAF&7^2W\;9^T(C8E]';(7
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MX_X^V6@_&=N3Y+K&WVA69 /?&R%Q9U?2WOX++Q\LE^D!V \B*)A98F*! /C
M)^M[V]B@2_YW//M%<UVD/%%KD:J]J^0&SN>YK4[F._\ (2G9P5[1HJ\-<_E$
M7TZ"[^=SSY5>UND?%'G[B/5?(#9Z-$KN?X[ET.GW%1KG(_CL[4Y[N@L_G>\^
M>$?_ #(^*2,4;2=R[_V<B-[NYS4?SHG[J*)O?W_Q$:Y.5]>@^?SN^?GJG\R'
MBDCT:]SANW]L_N:K43M1>W1*\M(1R#1[4<SO].>@^_SO>?*+ZZ2\44:G\=_\
M_P#L]R,3EK4<O9HEZN&Y>Y4<WN;VM5>>@1=0^6V],SAYRF>Z^U1BF1ZBWGC.
MD-F8I197EU_(=-RFSP1*;)\,MY&.UT>TH+;&-@1+(!)((RM5A $1')WH#YI/
M/;2&UW;6Q?Q\S&NV%LG3V8X/@V=8];8[G&-1<7N<UV6W6,<EF^SQ^%*G#B7,
M:8JBA-,\GTWHJ,(QZAZYYYGXCXY4^;9#Y7Y!B6O<:Q2?KFM#DV(5N=Y762+3
M8Y,KC5M++C1<?EV )D:3BKT<=&?2*I48KVD;VN"MD_('XZ:=PUVU-HYBN(Z?
MM(NJI.'["_9W+KR'?IMO%+O,L<^KJZ3'YEECXC4](Y6/F,$UY7M$O:96C<#Z
M@[JS?8%S9&U,'7DW!XV/Z[R&KO\ *BYB"??P-B8TS*:F3 KJZJ3VG'@R0-'&
M>OU/+G.(C.$:H"[9'GMJSQBI+JU\OLKQG5\.%L&NU[4Y!BU1GV8X[9V]E@]=
MG+8LLM;C4V33R(<"65CW'[0$<%WMO5W+$"26.[*DY?=YA"I6UK:G&9V.Q:^U
M533!7L/(L+QW,HEH'L)$2,%X,A:-K%[U5HT?RG=VM\%[][S[PZ9WC_T/09V%
MNWCIUN:9W&.^^E]TYHB/RY,?&9QQ$1XNKM=KCR;>,M\SYYF=/<5HV5W<F]N:
M3BM$^IAU,M92@.YATLVRU5J#^I;[?LK$_*YW*.^Q..O,+/6?U&R]R;KMB,W3
MHSX=CM\\71MLE*Y;O+=_N:1Q_D^OZ';>2+_S>6OM)"[%N6;"#@+H<!2$PH^7
M_BWZYHT:*]%2-@?2>XOJON^XI/<_)PC?R]=7=>KGJ/LNIV]#F.FY=UDB9MNC
M'?QB)I6D9?O?R^@PS68F?*4"YW8P<\PS#I<*+(9ET'+9?U\=YHZP'XO%J92,
M4!$,V4R:EGV\HYG8K/Z[GT_W/8O??=W4^YK>@=P6].N^9L\^:V<%F2V[S8K\
M5L1,W3,3,QDFM/8^?<[?'BQQ?96FAP95E[\:ML"K&P4EIFN7$Q93*50K6H/&
M,CR+ZWL]MZ2>[\!]KLY;_HO=SZ<+[W$4BDS67-G4U=];>BZ,U7D.R9-%-R>1
M62\;I*;'($@$$][D^9Y3385BM6Z?+18U9$G9%?Q6'E$1S(P'/(K7=O:I$7\P
MW9YTX4["A6GCUXRF+G.:T^"US87DKL@J0+6Y@VD\$BQ<_P :QHD$ JDC2.'W
MN[G-[6N155 LRS>GFWA.1:[Q^_T)XT]^R,BM\9J9E7Y%['F!@SZC#\AS0I+%
MDKQUK7I'/6XT<0T#[I5.YB=G;W.0%N1M#S'GQ9$.5I?QL?&F!?$.+^?K9')0
M2AB&5C7!T/SP\<A416K]Y>WM5?<'W  Y&$>3$O&AX7/P7!IN*)71*?\ 9R=Y
M<;/L:EU-$2%'A0'19/CK(;)CQQL8UB.5[U[&<.<I1=X*5/CWE71UM;34F*8;
M4U%;%B5]=5UWEWLZ+ KH4<4<<>+!BQ_')@6@ ,G:UHV\.:UJLY0H$(#"GZ<\
MB[[/4V#D>#:_OKN)$Q5F-FLO*W94J7C,W&I]I8"LJRR3QW(]2GEW@WL:UJM:
M6*(C%<I@JH<YWR>MV#@OSL? =89SB.$X>&#F&/8Q0BQ+8N2[%=80#[S$ME(R
M"ZR?"\-EBLS3\N*Y>T1VE0O>CT:K4Z#J'\B[S.(/R#_'O'M<4IP8#+S?R#QW
M%LQ@Y!)E7<VVM?&?-;RYIK_&ST\4-4!A,6[XL@,V6V0P*][1.X10V>=!B?V7
MU&N36GY.[6RO6/GAX#4^&:[=L6_W3A?DQJL<8N31<3K<1Q^';>/FQ,XS^WL9
M-=:.G1\:P_#93HM< 2'L9Y0@:\2.<1M2=4Y]@;$'B(*RMKZDN3YIE,@L+#,-
MA'2-.O)<=K7RYTV4YAQT>,432,+9V16N%$$YK6M)(* )2+-=X$3'R3\LRJV#
ME6R<E&(>29,-CA08D6,8Q8N(8C#*0KZ3#*(Y2(",CE+(,KY,IQ))"/Z#/V%L
M&OP:OCH^%*OL@O97X/B&(5*B?>Y;>/"0WX;7,,Y@(T>*!BFFS3N9$KXK7G.]
MK&^H(VOM?6-;82\]SR9$O-FWD5(<R7"0JT6(T:F24/",(%*8P\:BCG:U\N6Y
MK)5Q+']1([6M!'C@Z,[SNFU_2?C-NDF4Z3*!54M)5A2;?Y/D$Y7-J\<QVM1[
M'V%O9/:O8WEHA#8\QGC ,A&@Q\#P*YF73ME;+: F>&C&A45%"/\ 5X_K&@F=
MCY&.X[(<QB65Y8=C?QFY5C"SB-0(D'#&(:@0<TS2BP.BDY%D,OZ>OCD!&&,
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MM0D!-LIL<OO5VQ=@02JCFV+'*TM+2F;Q5M5LJ4U9ZC'! ]6-E"IJZ3:6LR+
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M^-DKLBPRMQ2VO@O\T--,B @YHV^2E)'DNPA[)3WNQR5[K4:BC[6_;W>@1/\
M(_9_EIY.^/>#3[;P!'B6JD\B?&O.,@O;7R<T[FYY=-K#R;P69;X_^PJX]3CM
MI&13:)\ 33RQ1N#-*5WMHYJA*WR,1U?9Z%'$^."<5CM^8:5Q8!/$L0YQOP7+
MQ_@JH;8@7J64C4)W$1L?M%]XC7=J*'KDY;V1Y#>)38_A9,\<:QN?[3=<9E8O
M\=B?B@_Z/^SVP<<C?S3YOE.2M++G.8=>\+8BL Y'N5W8U0)E_J+?<'=N9;AT
M;O'!==NV%@6ML'RG&<ZT=.VFCR:RLL_GT]O36T#;&O#U*3@Y_(')C/#*:Y0L
M(C^[N1X*3,>^0!IRD)Y8Z)4;VA:V,OAQD#&">-SD(1A&^3#B\2&*G*.5_:J)
MV_8C2!>M'Y^MXX\J-"^COO,7P]R1'*U%1%7[ODX[M[NU?L[D3N3CN[?U@-G,
M->><F=8GD^$Y#Y5Z12@S'';O%+QU9XAW\.P2IR&N-3VCX$N5Y)3@1)_T,POL
MO>$[!D<Q7,(UO:8.=_\ ? \=2/\ &CXZ3HJD?^QGEI@M<$Z\*9D:1IS9\%AR
M/;PGN/)6"55^]R]_/KZN<'3/O"Q9?^(&E<M:Y&C'F'AAG*/Y[FH*'M[45\JN
M<OVL<-.'+_T*KT$]^@Q/[+ZC7)K&\G$3_&5_%4OIS^!^=R?:G<K5TW@*JB)]
MJM[D3G\G/'Z.JDZI:^6F94.%^-V[YEV8X_K=5[#IZBOA1#S[6\NK#"K](--2
M5D5A)5E8R4$]Z,&U4&(9"D5@AD>TCF!_<SL*IC_''L+.I@S3[V!Y5;,I*9TV
M2^3!Q^&?7^JR6AJ& J)%K[*[]Q@YDM$=(.  Q*]!-1G0=;^9YGC^"4$Z^R&4
M2) B>P ;(L<LRPL;":1L:LIZ6MBM?,MKJVF/:"+% QYCF<C6HO0#G#,,R#)K
M^%M'9\1D6^B-/^PF!NDBG5^LJZ8)P3R91@.+!M]C7$(JCL)[%>&")SH4%RB^
MHD3 *.493C^%T=ED62V0*>EJHJR9LXR/<UC5<@@@C@"TDF;/ER'M%'C!80\D
M[VC$QY'-:H"3%\7O]AW=;L?8L$]3#II"3-:ZTL.Q[L75S'M%F>:A$0T69LF9
M&,J!"CB1Z".]1"[I;CG4#-?7U-B]18W^06$2GI*F')L;6UGF'&@P(<5GN'D2
MY!%:T;&M_A5R^B(JJB* -H:&YV];UV;9M FU&!TTL-IKG7-P(D>?8S([U)7[
M"V' +ZI8M=VFIJ8S52K:K)<IJSU&.$![L+"#40I%E:2HT"!!C'E3["68,6'!
MAQ@ODRYDN5(>,,:)'")Q"/>Y&L:U7*O"=!'NOKIF][*)D%Y'F5VG*Z2&TQ'%
M+ )XTO9D^.8<BMS3,ZV2C"1<-A%&TU+3&:CIKT;.FL1J1@,"112BAQGR)+V#
M''$\IS/>Q@Q"8BO,4AC.&P8F-:KGN<K6HB<KPG01P1I_(:9WD23#T1'-W@ 1
M31S[LD17HK3F:O:2/J,)4Y8Q4:_)')W._P!+41)P2.$)D8#&*P36QV(P:#8Q
MC!B&BL&UC4:Q@FM'Z<-1&M3T3TZ".TV9*W_,DU%1)D0='PY)(%[?1#%C2]P3
M(Q7#FXWCDR,1A0:SCE&X5E9"5'73T?%BO2(AC'"0T*%'KH8(42-&BQ(811XD
M2& <>+%BQAM%%BQ8XFM''CQ@L1@V-1&L:B(B(GIT$?KR]M=T6]CA6$V<VFUQ
M4RS5&PMA5<DL6;D,^,516&OM>V<4B$ \)&N!>785_D/WHD-_UOO%A =J.CJ\
M<J8%#35T&KI:F''@5577QQQH4"#%$T0(D6,-C1A"%C41J)_"OKRO0!G),DN]
MFWEAK[7MC,I:.G.6OV7LJN(C#U!T1GU>!8))1""/G1A.1L^P:CQ8^)_"=T]S
M&! P8UC5)B%'6XWCE9$IZ*GB#A5M;#8K0QPL5[W<J]7E,8Q7J0I2.>4Q7N(1
MSGN<Y0$F9YG?9;?R]7ZPFNKK."H1["V&P09,+7,.8!IAU%2,S30[?95M"*TD
M2(]I 5D=[9DQJHL:/+ EX9AE%@E#!QW'(3857":<B(0IYDZ9-F%658VEM93'
M%G6UQ:S"//+EG>X\D[W/>JJO0,?-LVO+&\+K#6)(SLW=&C2<GR>1&;84>JZ*
M<U7Q[:VC=R!L\MM(['NIJ95Y.Y/J9/9#8JE!Z89A=)@%"REI62BL63)LK2TL
MI+I][D=[/>C[/(,AM"M::TNK0R(IC.X:C4:,;6"8,;09N>Y]:@N(^O-= A6^
MR;B&R:YTYI3X_@./D>\'[99FL8PB?2N*U[*VM8\<JWE-5@U& <F2 '1@& 56
MOJB1#B'F7%Q:S27.4Y5;O&?(,MOSC8.3<W$D8Q"]US!M%'CB:.+"BL''CC&$
M;&("%L'/YM/-@8;A4"-D.S,BB/D4U-+,8=/15#2H"3FV;28KE-6XG6&=V-:W
MB59R?Y+%17J]X05\ U]#PB)9%D3CY'E>1RQ6F8YG9B$VWR>V&'V1E,,2>Q64
M]8)?8K:X'$6OBHC!HKE(1X8FQ-B-Q!E934=8[*-@90Z1'P_#@2$C$L"1T&DV
MYNIJ,,E#B- TS"6%@1CD$U6B$PTHP %"W7FNW8H2UR/(K)F4;$RI(S\LRM\=
M8S"#BJ5T'',=@O(?\"PVA]][84)KW.5SB2)#S2C&,\/;86PX>&0Z\$:OFY%E
MN0RCU^&895E$*VRFUCB]PPAF([V:REK0O]^QL9'$6!&17D57.&,@8.O->S:&
M7.S+-+&-DNR\BA!B75U'&9E31U(S.E1<+PJ)*Y/5XG6&)W*Y_P#*[.2BRI:N
M(HV"!8S_ #ZFP.F'.L0SI]C86 :?&,:IQCDY!EV0R1D?!H:"(\@F%EF:)Q"D
M(X<:'&&21((( B$:#8P# KE+DFRMD'@VFQ+.&:'"AP2/EX_KK'Y3V%7$<0>8
M07&<=PF/M;5S&2;:2QJJ@HPH\<(/'.,XH<#HCV]Z22C5D1:ZJK*V,Z?=Y%=S
MWH*JQ['*L2H:TO+0Z=@ -X3T<\CF"80C09&#X3?VMX#9^S$COS3VI,7&<7!(
M2;2ZNHI;5#(JZP[6I'MLQM@(U+FY:B>\J?2Q>R&S]<!!S#+\?P6AL,@R.9^'
M5<(8T<48229,J9,*D6OK*R!&:2;:7-G,>P,6* ;SR#/:QC7.7CH&3BV1663T
MR7%M61:*Q-*F@E8\V\@W,ND&"804.KOI-<PL6'DT<:"^LB#<1L>4YPD(9&(1
M0B?F9+)OECE2P-_0M']WCMJ=3-L:K7]@3)2MVANU'E1V?B>0):Q4[2)%3L7W
M45R]R,3H&!C),@;Y';>=_3MQ\3UU%HE'6?[,Z!1)J)E&]T;#[5 HFNKT^^[L
M:CE22G?Z(+D,+"IUP#R$WXA?/''()'8IHYRV)L?T$Q+%OT6P6H-C"1U GT:M
M7GL3_P!L]>>$Z#CWTCY&93XV?O$ORF9[C6UH-[:7-6+$I.=BK\")'R6-;S=2
MRF2 0W5D_&AM_$JZ-&4D?Z4(5=[L@XA,,JATA2,$^5B7I+,=0AQ*<6%DYLUL
M(=BD;Q[6$XF:9U>YJ5IT!:N.@6NMVM]P1']SN7,:UJ-10(>0Q_E9R#/=7YL;
M";L;\ 7,RE Z/X[N.\N5XZRE1L%[+-@7CCO15>IFHKF_9Z]!X8S'^6#',RV7
MF@\&M2RMBV^'V$F(T?CTU8P<8QF'C)$+*?/(PICAAM(-!B&U/XJKSR]09,/
M?E7A:2P'3+,2MEA8(FI2QYZPO'MT>6?6&9XSE@F)%?;.E"&=V,C:)SSD57/_
M %J.;W(X$K=6X?D8TW?XIOK:%-D=)68WB^38 ROJ<;T?E61V<W/\BP62,>/8
M_CII]O=BCGQD2R7#B*L8*J5RL8A.X,O"+;Y<)U!N>;3Z$L,GH]QY?DN38WDE
M)O#P_J:BYI+G!<9P^KMI53.Q2[L*]\EM![A0))<]K.$7@G=R'PM5\P<C"M(8
M>[QFNVMU!>ZNMWG=Y!>'SHTYN!4#ZJ2VK:S!6RF&(5_\G^J5S>U.7^OV@ZQS
M_F"!N"=LMOC'DSQ6>MJ/ C(GD'X:)9!)1Y3DN2,D/8[ /P\D$S;Y!-1C4,UZ
M.5RJWM3H&954'RY5$;&C3/$F;E4G$?(C*]YP*:?Y)^*=+56D;,,QS&TO*.;:
MTV%1KZ#96&*9O.C*6.1(XYKFN[% WL4))Y]Y0^=FM,3O,VS#XU4J<;Q^O//F
M$3S:TE,FR7A&Y(U;60(V(NE6=U-1J!A C#=*DRBHUJ.<Y.@3M7>6GG3M_"*3
M86%?&>L^@R.#%GPVS/-/2D"RA)(BAEK69!3R\1CV%/< 0XFR8D@8I,=K>QRN
M14<H/M=T_(TXJC7XP5]MPN]\EWG#HQSWR/<151P?V717JJJY_N=S7HJ-_-T%
M&W1\C/ZM6?%\UW+VM<C?.+1S7,8J^VTBE=BG)?I8_*L]._W'.=W*O0>G\]/R
M+^WZ_%\+N<W[[/Z;VC7-^ZQ40/"XFC2B=VM9]].Y!HJ=WKR@1_R_*OD3B764
MY]8?';28MC$V^\?=CY.RZ\XM(I&JK70V6EO[VWDV2XP*,T&0XE'APE*]44#X
M G*JL3CH*Q#S<\W<O\BIN7Q_C-N*9_[ 5>I8-9D_EUIJC2PR"82KVW  *5*Q
MU1Q;6SP[)XTJ/ E-!*,%I>UBO"9C <EMD?R3SM'[!T^'XTX#9&=9IMC*A7SO
M-;2CH=8+8.X,AV=!AFB_LVV3(?!BW;(A7-]'%$KV_=5$0"5D6X?DBM=J:\V0
M#XQ (#!L3V;CQ:A?-K1[9%A)SZ7KZ1&DAD+CBA$&O9AA4(U_WG*=O;Z-5% '
M[1R/Y?;W'=^UFG/"*%J#(MQWEODM5FT7RYT%>W6,6@]0X=@&+Q!Q[G#+2J97
MMR3&73[(K8Y93X3F@C.$5SCL!W0LK^2INHO'[7)OC4A"G:7N=-V5A8M\UM*$
MBWK-5BA@EMA#3'/=C+=_1J\32?Z$CT1[E5%50:N<><7F-K7RLP.3F'QWAK;S
M8&LK'6]-3A\Q=03XE5*C7DG.&W&9WT/%WT^&5=G%KWQ8!)[Q-FRT5@UX:YR
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M@,E[?4N+U-C>W]C#IJ6IA2+*TM9QAQ8,&%&;WGDR9!%:,;&-_/ZJOHG*JB=
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MQFQPPW9*N4Y=N>5G-MDB!L;'/;.TTEDT&RL,G[@MC2ARH:?3LB-&R)%AM9&
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M&K]7=6<=QY#D;[0!!V/5IOJ*Z!(YY]^%%-S^?W0#?S^3[>[H+O[+ZC7)JO\
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M1G:C@JC9LUOU/L AA(5R(C5X1$]>?3T]5=RJ_P *JO01SU!_=A\LO[[.O_\
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MB#-G(Z)!)-DO8QQR->T+%<]6N[>U0U\0?+S%_D8^+;4/EUA6)W.#4NXKO#K
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MN/1;Z@F%,$I9,*9"FQB5]Q36]>7V+6BO:DZ-E5%W42444F,5$>-R(OJUS7.
M0ZA7C</EDJ_9_.SK_P!?_P#7G3_^9T#MS[/[<-O'UWKD$.WV-;PQS2DG#(?'
M\!H#E>!V89E[+Q%4+G,>RLK6/9*MY3%8Q1QQR9( <F :_J<$J9$.,6=:VUI.
M=<9/E-R5DC(<NOS"".3=WDD;!C<56":*. 31Q8448X\<8PC8Q 6\LQ+'\WH;
M#&\FKVV539":P\=2FCE$8)628<Z#+CD#*KK6MF"8>++ \<B*=C2">U[45 %6
M)Y7D.$7M?K/9<\M@6S[P:YV-*$$ LY#'$\O[.9)[#!Q*[9E;#$YQ&,:R/= &
MZ5%:U[9,:."%MER+OGQ0X7GG*]L_\#V3_P#/Z E[#V('#A5U540'9-GF2D/%
MQ##HIV1Y%H>,@UF6EI,>PK*/$J-A6ELK(C',CC5HQM+)* !0P]>:\/CI;'*,
MJL&Y+L7)Q@7*,G]E\6.T4=Q%AXSC,!Y3/I<)I4*OT<3N4A2.?)E.++*0B@1;
M.KK[6NG5=C B65=91#P+"NG@'*@SX,H3H\J',BF:\,F-) 1S'L>US7-545%Z
M "5MK/T9:5V*Y-/EV&H;66"LPO,;20^7-U]8RS,C5F!YK8G>0\C')AB-#1W)
MW*X;NV#->I%C&.%GDLJ+CNKE3_".\>T_JIM7'47G]**G0%S.L[H]?TBW%PLN
M2>1*!545%5 2;D&47\WN2MQW':[O&MA;V#V+VM5S1!&UYC/$ 9"L!DX-@][+
MO$V;LQ(DO/I<0T*DHX1UFX_J_'YRC(?'<<.K1MG7<\8F?C%PK&$GE:T8D%$&
M(70&1P!N1>YO=SW<HJ\M7N]%16K]UR*B\<+]J=!'"3&L- 2I5O4QBR-&S9!)
MV08_# 23+U%+D'<:?DN-00M>8^M)1"*:SK0HI*0CWRHK5B>\ (1P^5*?!G^#
MF3SH,R+,A2MT>%<F-,BG%(B2(TKS-\>3QI()(G/"6/( 1KQO:Y6O:Y%1514Z
M"SYCJ!<G^*CY"J5K/<=(\1MX2D9^?\+P:VM%7GA>.WZ/GH-+_P $-NF2?NZG
MCHTW+_V?W))IG)W?Z&"#YM1$-W>OHWZ&>YW'I]U>@Z+?#";(L/$OQODRT1LM
M=+:\%+9SRK)4;&J^+(9S_P!(8#D7^#H)'_V7U&N2(NT+#'<2\H-,;$R2W'45
MN-^.WDE"ER)"\QDCV6<^-9FM8(;"3)=B>97"!& %A"R#%0;&.(]C5J3J<LK6
MT_><.WN-O55C48S=4=W383K9Q6@G8S6Y%4S*21F67>TZ1&/LZ95V!&Q _K8^
M.B>HQ*22\YNB(9_%#X&>/7Q5>'^2:ETYO65MW6A]H[%VID>ULJL\5+"CVA/P
MW%[BH^IQ0I*2*'%(V'#@RD0CC+8A/WM&]WLC"<=+27.X;BKSG.:J=3X%43X]
MGKO7EG'?%G6DV*12UNP]A5Y.',FC=VFIJ4[>*M.V5*:L]1#A >ITV!4PI]A/
MG1*^%!BR;"=-L)0HL.%$C"<:1+ER9#QAC1(XAJ\A'N1K&HJJJ)T$?X4*PWO-
M@W^00#PM-U\J/.Q;%YT<L27M"5$*P\+,,RKY+62(V#QSL:>FIS-:ZP<UDV:Q
M&)'CH$AB$C0Q%*8XHXF#(<QCE8Q@QB8KRF*0BHC1B&WESG+PC4Y5>@C@JS?(
M,K2N:8.AH9^X8D86/)W9(CEY:4C?]&#J4!!\L8O#LE>WE>*WA)P2/""/%:U!
M-8$:,8-@VHP0AL&U&L8P;4:UC!C:C43[$:B(G01VF3IN_94BIICR8NCX,B3$
MOK^"8D:7MZ7%(X$K&L;F@*,H-9A.QPK.R&YK[IS718J_2>^8P2%@P8=;%B1(
M48$*)$C A0X<83(\2'%CC:./$B1A-8&-'CC8C!C8UK6M1$1$1$3H !=WMSN:
MWL<)PBQFU6N*B=)J]A;$J9!(LV^FQ"*&PU[KRSCD:01@E:X%W=A=_(.'0XBK
M.4I8('&CI*;&J>KIJ.NB4E-40P5U950 #B0($,#&@CPXL8;6C"$36HC6M1.5
M]?55YZ /9'DE[LJ]M==Z[M)-314\M:S9>RZQ4:>E,QC73,#P26K7B/GAQNXG
M3T1P<?"].$=/<,80+N.8W18C15F.X[6QJ6CI8S8E=716J,$8#%>YRJKU<4QC
MD>XA2D<\IBO<0CG/<YR@)\RS/(,LR"?JW5LY(=K"2./8.P! %,AZXAS!-.RJ
MJV&:2%:[*MH16OB1"(X%8![9LQKF+'C2P).&89C^#X_"QS'8#H%; 4Q>"G+)
MF39LLKI=C;6T\[R2K:YMIQ7GERSO(>2=[GO<JKT#(S;-KVPO':SUBZ*7-B18
M\K)LFE1VSZ+5E'/;S&M[B/W-'9Y7:B1RTU.KFK)5%DR/;AC<I >>$X30X#2#
MHZ5DES22I-E:6MG)=.O<CO9RH6TR/(K0K6GM+NT*G<8SN$:B-&-K L&-H,S/
ML^MPVL?7>O8T.XV7;0VSU=-80V/X%02"EC_MGF:QB,+])W"(RNKF/9*N)0E&
MQ1@9)D@!TX!@-1K^J/&BR9EM=7$M;;*\KN7C-D&6WYAL'(M[B2-@QJ]!B:*-
M&$UD6#%&R/'&,(V,0$3/M@3:6=7X7AD"-DNRLDC'E4E,=Y65-%4")]/(S7-9
M<7O/68G62.6(C>)5G*1L6*BD<]X@4]?:_A83"F2CV$W(<NR*0RSS3,K48A6V
M3VS1J(3S!%R&LI:L+E!65H52+7Q>&,17*0CPQ]A[$9AZ5E)35KLHV!E2R8^&
MX=&D)&+9$BM']=;W$[VS)18C1(<;["Q>Q[0M>P0F&DE  H>6N]>.Q7\1R3)K
M-,HV/DR ?EF6/ Z()XHKSO@XYCD%Y3K1X71+(>V%"1[G*KG2)#RRBE,\,G86
MPHF%0X,>-!-DN4Y)(?589AE64*6^4W""]\PA%*[V*RFK(B_465B=/IJ^(BD>
MJN48R!@:^U]+HY=CFF:SX^0;,R$ XUU=1AF'445,$JR8>$X5%E\FK<2JR*CG
MN=Q)M)35ERE4BC&$%K/L_J,!J V4]DNSF6<IE1C>-4XF2LARW(93"/@T-!#<
M0:'FF:)SR$(X<>)'821((, B$8#4P' +=;<VQ]EK$G;%L(9(,&#!*^1CVN<?
ME/&<V(XB\PA/.20X0UMK9PQR+:0-%X%&%'CA!ZYQG-'@-$N0713D"Z2"OKJR
MNCNG7>174YWMU>/8Y6"5)%K?6ID[(\=G'/J][F"81[08>$8->VE^W9>SP 3,
M7Q)(,6Q>-);-H]6TUBBLDUE;(8GTUMF=K%[6W-RUO)?6)%[(;/UP$3+\PH,&
MQZ;D=_8C@UE:H1$5!$ERY4F05L6#55D",CYEG<VDTC(\2*!CSR9#VC&U7.3H
M!EB&)7V99#!V=LVO+7S(7O2->Z]*44B'KZ-+$X#KJ\4)2Q+/9EG"*YAY#%("
MHCD=#B.=W29,H"SD614F(4%GD-]:0Z>DHXCIEE96!E9&B1AJU'.(_AY'E(YR
M,&-C7D*1S6,:YSFHH!W'<=O-GW];L+8=/,IL;JI ;+6NMK)GM2*^0)O?#S[8
M,-'/&7-'(O=6UK^X5 -W>[NL'*Z,!KM;6KQ^IL;:TLH%35U$.38V5E9RA18%
M="BC=)E3)TH[V#C1@":Y[WN5&M3U7H +6UEINZR@9=EM9,K-55,Z+98-@ME%
M+$GYK.AF0];G^>5Y^QX:J.5K3T='(;R)49.FM^H^G!$!UXWA--@?[51Z1\M1
MY-FN3[ L_KY02J.\RZP2?<"%VQ/='6/.J. SASA*GJ[C[R! ZW8XGRMQF":8
MZC^.MS.>7F*C6>2Y^U2/:SDK>Q4^\B+RJKZNZ"=:QSM5W\FD\\\(B",O/JOV
M?=_)Q_S_ ,O :^-"8KM:[\S/D2?@6U8&NX<?-?')D^#/UQ7YB2=))H.A>R4R
M787M.:(Q@>&>WV/1>.[GU5.@XOLTH=CX)^\"?)'DV53I%FF'[*TE<Y;D4O':
M[#*6_BV=]J'(*$!9]G++C^'LR"IKR/C2#2O:?&"60KNP9%:'>U@^ZO&Z%=6.
M>9[Y->/UUL:YBD@//%W#@CJ3"J D@<D>%84P]Z$@JUCQL=83G,'*N)8T,9&#
M9'C1@+C?*KQ=:B-3R0T+PB<)_P"5_7OV?VP]!]_I6>+W^$AH7_??U]_MAZ#P
M)Y4^*LUQ:PGD?X_R2'BO(:O=M_71GE@O=[!7EBKD+G$AO<[VW*YJC<J]J_;Q
MT&O_ ,H/(/1^HM)YO18WNC6F;:DGS<+-3T&)Y]B^6YAK"<#8F*3%IZ>@J+B;
M;7^N9(QO^F$ 9#T!$02-=7N:L ).8OO#0^69)%V9L[?FC8=E7O.[7N $V_KZ
M3"UW!DC)'?<6C@Y":#:;)M817,E2F.>&K"]T.&Y461(E <4\H/&9OHGD/HQ/
M7GTVS@/\'_R_^9.@^_THO&?_  B-&?[[6!?]W^@M=Y0>,SOM\B-&>GV*FVL!
MY3]*+^/^B^G011VKO?1&L\;V5D^O-Y:<OL-R7&<OEYWK2DV?@\^R@VLZEL72
M<[UQ5!ONXUM).[W+>E G%FO=*BM^N]P<T&]H/>NB-G:PTK8[#W;I_'-?XIKG
M6S\6UO?[+PRKN<DO:C%J7VLOV32SKH,F""LG!5]10R6(\!&-FSF))]@$,)H)
MY0^,Z(B?TB-&^B<>NVL"5?3\ZK?\JO0??Z47C.B*O](C1G"(JK_Y6L"]$1.5
M7_X__(G0)TGRR\4F?J9/DUX^A<\<<O83<^N!/<*2 ,N,_M?DB*HI,4S",7CA
MXWHY.45%Z 'YGY#>-]+D)]FZN\EO')V4*&,',L.-O+64&HVK4PA(((#&+DC8
ME3GE3&^Y56SN&$:B0YBK&49(H # _/'Q\LL^W^S7V\M+,R+9FP<+M:2RS+8&
M)T=#A]'7Z-U1C]]DV5#GWL3ZE]%>1#P0U4<RR+"S \"/&!AY(0E?@.^O#G J
MD\.-Y2Z&M;>TG.N,HRBXW?K*1?Y;D!AA'(N[N2+(A">9PPL$  VLC0HHQQXX
MQA&QB 2(_E=XMRT*Z+Y*:!DM"H4,L?<>NSH)9#_:CH119&[L4Y?NLYX[G>B<
MKT&3_2B\9_\ "(T9_OM8%_W?Z!MY9O7Q(SBBG8WDN^M%V%18#:TP/YWL& 4)
MPE')A6$&7'R(<NNM:R8$9XDL#QR(T@;2#>U[47H()[&\N,%PO<?C3CDW:>M]
MKV%1DFT_V+SBJV+A#*B\@2]3Y!70!;9O8EF^IU]=5$HXVSIYAMAV@/U\)CY3
MWP&!+O7NWO&S'#V63Y3Y,:+R78N3B#^T^3+M/!8T=@ J1T3%L8A%R,I*+"J-
M2.^DAH]7E(Y\F2XLHI"J!5_I0^,Z(G_T1&C/ZNVL!Y^Q/M_T_P"?5%Z"OZ47
MC/\ X1&C/]]K O\ N_T"7;^1?BK=5UA5VV^=!6E9:0Y%?95D_:6O9<"P@S!*
M"7"FPSWA 28LH#E8]CVJCFJO00&WSY-ZAU)CVN,;'N;!]H:]#OO1MAA$K%M@
M8EF.<8J.KV/33G8-E @Y"25,Q\00HRIOY+D%&$GT]H878.6<)2X/NC0LJ\39
MFSO(C0,K/I<0\&CHH6X,%FT&KZ":K7GQ['#NNA,GW=@@V?B]RK&%GD8T0D'$
M$(70%P?E?XL*^0(?DKH%Y(QO:DC;N/7;B1CJ,9D"=C<B[@E]DK'=KD1W:Y%_
M+ST'K_2L\7O\)#0O^^_K[_;#T'F3RG\6RHB/\D-"JB<^G\[^O>%1R*UR.1<@
M7E%:JHJ?E1>@U*_(KM'4-1XU7.$:?W'IO.L(SG?_ (?LCZVQW:&$VF0X%?IY
MCZ+MBSL#IHMV:3:81;NBO?*I@-4E5)>Z1$:L9Q0A#9;\@M"F4^!OFMC7;[CK
M[Q,\BZH8^'.5Y)NH<O -&M:BN5W>1..$YY^SH.:C]W&M5M?W>6Z"O<O[%[ZV
MHK.Y%X:VHV-@V=*X?/"=K'SE=S]B.1?T]!TS^$<L<SQ?U6@O1E=$RF@:B?Q6
MMQK.<FQ[L]?5/;6LXX_)]G02B_LOJ-<D4L^H\7O?+KQP;>18EA9T6G?(?)L>
MBRRE?]'8Q,G\?JW\=!!5_P!*:76BM%8(Q&/=&>='#[7\.2I.H][,SV@U-K;/
M-EY*;VL<UQAV29M>.0\8!/PG%:B7>3AC-,-'BL,6-"<QBD>QBO<G*HB\]$<Z
MW[MGLZJ\Q?CZI<VL*F52X5J[R?\ )AE)KV25LJ)99?FVX,BWS$S#*I+&#C7D
MC&J[;,6#6P_;2-&G0BS7H4SHJQ0Z5YTZ'4P)UA.FQ84*OBR)\Z9/DAC0X4.,
M-\B3*ER3O$*-%CA8Y[R/<UK6HJN7CE>@C_"A3=\3X-_?U\N!IJ#*C3L7QB='
M+%E;1E0RLDP,QR^!)&R1%PB+*8T]/4&8U]@YK)LUOMI'CH$AWO!#"4A3C"(0
MR',:05K&#&-BN*8I'JU&C8QO+G*O"(GJO01N5\OR#.PI6$!H:(9JM&QI0R=V
M20E1?=>U>#"U''(SEK/XV2O:BJB5J<3@DB$ 8K48)&A$C&,8%J,&(; L1C6B
M8UK48Q@VHB(GHC41$XXZ".LV=-W[*D5%063#TA!/)B7^002FC2]O2XIGQ9F,
MXU,C/0T?6P#,<.RLQ.:ZZ<UT6([Z3WSF"0D"!"K(L6%!C@A0XD6/"APXPA1X
ML2)%&T,:)$C!8,,>. 348P;&HUK41$1$1$Z  WMY<;FM['",)L)E5KFHFR:O
M8>PZ@Y8LZ^G1'N%8:\U[9 <A F&]K@7=V%>("*Z'#>LY2EA <:*CIL:J*NFH
MH$2FIJF#'K:RK@A%$@P(4=C1QX<:.-C&"$%K41J)]OVKRJJO0![),DOME7EI
MKK7EF>IHZ>:M;LO9E:[@U,5C6NEX'@DK[XS9Z83D2?.1'!Q\+_L?/<,80+N-
MXW18C1U>/8[6QJ:CIHR1*ZMBL]L$4"*]7<N?W%,8Q7N(4Q'.*<SG$(YSW.<H
M";,\SR'++^?J[5LYL2UA?3CV#L$( S(FN(,P3"LJZMAT)"M=EVT0B/AQ'M("
ML"YLR:U6.C1Y8$K#<,Q_!Z"#CV.070*V"XQ>"F+*F39LHSI5C:VT^4I)EK<6
MTPCSRY9WO/(,1SWN55Z!DYOF][.O7:RUDZ,7-BQH\G)LFE1TG46K**<BK'M[
M@'<@K3*K07<M-3*Y'2')]3(]N&-RD!Y83A-#@%&RBI&2'M))D65I;6DE9]]D
ME[-=[EKD>16A6L-:7=J3[YC.1$:G:,;1B&,;09F?Y_;@M(VO=>1H=QLNVA-G
M?RQA34&!4,@CP?MGFGTQ6%^D:0;V5]<QXY5Q)&X8U8%DB3'!TX#@-1KZJDQ8
MDF9;7-S,=;Y7E=R09K_+;\PABD7%Q)&,3%>@0L%'CB:.+"BC&".,81M8@(F?
M[ FTLVOPS#:^-DFRLBC&E4E,9YF55%4A-]-)S;-9<57&J\3JS.[41O$JSDHD
M6(UQ%>\(*FOM?PL(AS9);&9D669$<=EF>96H@BM<GM6B]H1"A"GM5=-5@7V*
MVM J1:^*B,8BO4A"!C;#V&S$&UM)2UCLIS_*%D P[#HTA(Q;(D5 _6W%O.]L
MS:+$J+Z@9+"P>Q[0M<P8FFDE  @>6O->NQ5;')<EM$R?8^3MCNRS+"1W1!/%
M&4KH.-XY (0[J+#:-TAZ0H37N<YSGR)#RRBE*\,G86P8V%1(,<%<?)<HR.2Z
MJPW#*LHV7&4V[1>\<0BD<H*NFJX_Z^RL3HD:OC(I"*KE&,@)^OM?2J.78YKF
MMA&R#9F0A&"YNHXB"IZ&G"7ZB'A6%19;?J*O$JLJ]SG.XE6<I'2Y2J]S!A!<
MS[/JG :@=C8"EV4RRDCJ,;QNG$R5D669#*81\&AQ^&I!M/-D-$YY"$<./$CC
M)(D$$ 1"-!IX#@%NMP79.R7QIVQ9\,D"# A$<?'M<X[)>.03$<2>48GG>=XA
MK:VKF#D6T@2+P**./'$#USC.*3 :1U]=E.\#Y$>OKJVMC/L;S(+J>[VZK'\=
MJP+]1;7EJ=.P !IZ^KWJP3'O:##P?!KRUO$V5L\ 4S%\,\;%L6CR6SJ35M)9
M-XEUE<=K?I[7,[:,C6W-RU."\?2Q/;AL53@1<OS"BP:@F9+D%@*#55_ML,]!
M&ERY4F01L6#65<"(TDRTN;.<1D>+$ PAY)WM&-KG.1.@&&(8A?9ED,/9FSH!
M:Z;":8^O=?$*(\37\6:-X'75T\+RQ;/9MG"(YDB0QSP5(".B1'.YD29(%O(\
MBI<0HK'(L@LXE324L9TNSL9Q>P$6*/A%>]4Y(0I'JC!C8CB%(YK&-<]S6J ;
MQW'+O:%]6[ V)43*;'*J4RTUIK>Q&HSU\@7K"V!G\15<PF:%8O?6UK^X= )W
M<1'3W*L<#;:VE;C]3/MK2P@U=741#V%E8V<H<6# @Q6*>7+FRC.8,   :YSG
MN5$1$Y7H +5U5GN^TKLMRVMG5.JZR;&L\%PBQBEAS\TG1"J:MSW/ZX[&D%51
MR,:>DI)#442]LV<SZCZ<$4)"29$6!&E2I<H$6+& >7*DRSC!'BQPC<4\B08K
MF##'"-BN>]RHUK4557H S@6T<0VS4V64X%82;6BAY-D6,.F2*ZQJWDLL7FDJ
MK9T>#.B1Y<JN-(&I02./;D1GB,)581KE" >_O%?4_D7Y>3[+9+-@1K'"O&;7
ML#'YV [5V)K&6.!DFU]N$LH\F;A-_CTBVA224L4K1R'$$,@D<O'VJ"0OQH>,
MOJB6'DDWNX3C^EMY&(K?7A51";%:C?7U3N^Q557\,5G(/W6O@]IW3ILI/K#*
MO(/#9.;SJZRRR7!\CML39N06-1!955<RTGWF16,R4>OK&I'$I")VA:UKD1K1
M]!S)^4]' TY\R'E'30LIV',PR^Q'XZ]P;!_:K,;[,EO\MJ[2TQ2%F&3FM2S9
M]N_%\0 2'!&C5^D YZ,'RY7=!W-PQ4%E$BV%>*GGP9T8,V%-ALA2HDR))&TL
M>7%D@0@9$:0)Z.81CE:]JHJ*J+T&5^&5O_R?!_\ @D?_ -[Z#XM96(G*U\!$
M3\JQ(Z)_[GT&D?RTQVGVE\E^E-88[<UH;(>C'+DM0/\ $$HII(M[L/*:7%,[
M6@E5M@ZEMY50$YHX)(YD9&AEM;RT/>$W]>^.GB_F8;"+)T\W%\RQB2"NS/#;
M#*\S+9XW9R!D)'>.4S(Q"N,?MQ#<:MLP-^FG@Y5.PK"A&!&3PO\ &543_P F
M$5W"(G/[3YJ[T3[/5<E55Z"OZ%WC-_N7Q?[9LU_VR=!7]"[QF_W+XO\ ;-FO
M^V3H*_H7>,W^Y?%_MFS7_;)T '\D?%#0.+:M_&,>P)U/9ILK157];!RW.(\C
M\.O]Z:XHKJ'[HLF:] 6=-8GC&1%3O"9[?L5>@7Y^H_ RNV*#4]C"PR)LF9(A
MQX^'2,WS)EV:59P)-O71/9_:-1MGV-5%)) !7(8H&*]K5;Z] 6&^%_C,K47^
M:^+ZHB_ZYLU_*G/_ (2+T 8\B_%G0^"Z*VOFF(X*Z@RG%<'OL@QR\K\JS4,^
MGNZF&^=664,J9(O9)A3 L(SE%:JMX<BHJHH1F\8]!Z+Q'56J=E9WI/5&78'M
MP#@9GD&3:]Q>ZL,"V5+R>TIJC)IUK8UQY#<*SI!Q:^7WN]JKM6QSIV@ER7!#
M8N/Q&\5WC12>-FBFN7GE&ZKPGT]53CG\$1>>/MZ"]?$7Q6]%=XY:05&_8C]8
M88YC?MYX:ZG5J?QEZ!JYAXZ^&^#4,[),C\?-$PJF$T+%</4F'2YDV9+,R- J
MJJ!$HR3;2XM)9& B18['GD'(QC&JY43H-8OF?XYX1AV+:DW)$U1A.GLJM=M6
M>)XOC.O:&EQ&QP[",AT?N9UM&R&\Q($"1;9KD;(H737CD.BUC1LC1%5S"RY
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M64RRE"J,:QRG$R5D.6Y#+81\*@H(3RB9(F2&B<\A'N'&BQQDD2"" (A&@T\
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M%:P(5G6S(MA7V,2//@3X,@4J%.A2PL/%F0Y('D#)BR0$:\9&.5KV.14547H
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MHBHG*<K]B?E7C[>/S]!!;S3V3/CZ^)@^#8X'.,VA[%\=KV\KW7 Z&DQFI=Y
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M3):I 50".APW*BR),H(@_*/_ '*]*_W^Q_\  ?N[H-FO/^5]OZ.@KH*Z ?[
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M#C;6M?054VXMYT2NJJJ(:=9V=C*%#A0($03C2YTR4=S1!CQQ,5SW.5$1$YZ
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M6%%S^/%!"NJ6:=8-!LW'X;G$%CF2'&PB0;B US_P>X]MY:\KU&1"1"F$H/'
M\[I<^IOQ2H;+AEAR#55[1VP4AY!BU_":+\0QW(J[O(Z!;05*BJB.>(XG,,!Y
M0$&1X"_RW_\ -CWO_>OR[_4F1T#6\&?_ #4-,_\ S M/_&>]Z D[YIL5FZYN
MKG*LBDX@W$'QLNQS,X$=)=QAV6U*N'07%%"8UQK:RDRI7T/X:Q'+<!EO@*Q[
M9*L<#9QJ/4Y?M,DW,;B399CA%)CUGBN"V=!(QJMQB%?4L85IG=36S)4_]H;B
MRLBRJ]]A[I?P5HWU[6B*^066$CN@U>_*Q%^MTWJ2&DN7 67NV1$2?7D8*?!6
M3H?>04FP2E$<0YL17^X)SQD8CVIW-<G**$U\.S>\J<B76>R4CMS!XI<G$<J
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M<OAVCFO3N:Y%\R] (K7(J*BM5%X5.%14]%].@EF2HKOQ,[65%4UKY9FN1E=
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MXB=9$B4[M<XK$8WT5>@#FKYOG_@WCGXZ:AF_'+>!V%X\ZBUGK_'MFXSY=^/
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MOL_BRIU+D-9M[P[J;636(+V\KQDGF5HGV\<R6*01!V$.OGR_JX1D1LJ ?O\
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M4555$1>@CM&CS/("2*?.:>/HV*=DRFII@R D[B.(K21+R]C$1AHVL(I1H^#
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MFK#G[$GPB0:ZO@F?+QW6^/S'C,;$\2>88G2)$E0C=;VSACD6TAB)VBBBCQQ
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M^997%G-(R/%B@80\F0]HQM5SD3H!AB.)7^:9#!V;LZN-728/O2-=Z],41XF
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MZ^U[/&_AV5*BJ.UM1\LHF*HA=UB[^2 9<<QNBQ.DJJ'':R+1TE+#'!K:N$-
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MAIK0E+C6KL>L1_189^R=[!SZPJKC&QV2NACG3EF3ZAJ2'(YX9!%"O+[Y<_F
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M.UI>.:7^-GQHO,"'4UDJOMZSR6Q??HYDF2UZS'FS3!\WU]3Q3,,U6?0NK6F
MB=SBD1R*@1Q3YQOGZ>]6_P"+#\>E=W-8C4RB2B][E5&-Y_GO57*J_D]4Z ]^
M.OS$_.+G&X\+Q?;7QF>.-/KRTF2A91;3-[4.H UL$,&5(26F?99LO,Z2G*PX
MF(UI:R8Z0Y?:8Q'.1[0V56WR(_(1&K+237?'WXHR["/761JR._Y8= R$D3QQ
MC.@ > > PR':64K6JQI1/?\ 8A&*O<@:9;'YO/W@" RPE'^+WQZ!$KF3Y4A[
M<M)+8"+"&<YW-+&W>YLIH0A<J.$B^YQ]U%Y3D&O@?SX_.WL_"\8V)@7QJ^.>
M287FU-&R'&+^'D\X4:WIIO=]/,$*9NJ-+#W.8YKF%$,C'HK7-:Y%3H-D7B3\
MJ7RW[(Q')++>OQO>+^/W5=?"B42V/G9K'Q[E3JY\-I)/.)9O)VA:V8(Y^U&S
MF2(H7JJL03G,5_09_E=\IORS:ZP*INM'?'#XN9#DDG)8]?:#KO/?5F_I4*G)
M EE4S,(PI^L+D BRA-8Z>LR0,'*,<']8TC0U\K\VG[P0K>W_ !7?CYQQQ_KJ
M-_D_W<?M3H/O^.U_>">.%^+OQ[7_ /&HW^9_/ET%+\VO[P3Q_P#4NO'SU<G_
M .%1N.57CA?_ "Y?:J]!;_CM?W@=/3_%=^/B>G"\Y4;[$17?;_/CQ^GH-IWC
M+\E_R8YYK'%[_=_Q[^+^(9=.6V_& D^173>L9S1Q9YPUARZTR6OSN[QUTL+$
MX9)MC.>Q$(C1M>UB!%;Y)_DU^5K4][XWYOXK>&GCO(NHT?,(>4W,#R3P+R'%
M07^>VS<#K<-L?V2R?6\*)!NP-J;6.21'D1TL1!1[NV.0;@@/ISYA?GVUKA@]
M5P/CDT?EQ]<V-E36%C=9!7P;2*:^E$S:%62(M#MVFI!QJ^IRB.*(D2.,+8C!
ML_C,=P!^P;YI/GRM\TQ.IOOB]\<V4=GD%5!N'3-HP<*BLK),T8YQ#Y?<[CLZ
MK&!"C/<Y9TB-(%'X[W")QV.#J3UAY$XUDVOJ3(MGWFD]6[%FPK ]UK>O\D-9
M[ A4<P,N>*!!%GM<2GK;5+&&$)W''"&R.XZL<UWMJK@Y=-B?,_\ /70Y[F=)
MBOQ@^.LC&*C)[FOQ^1%VC"S6/)IHE@8-9*%E]+N2KJ<D9)A,8_ZR-&C!/W=S
M1#3[C09W^.U_>">>4^+OQ\1?]E1E3\OY/Y\O7[>@EYXC_+3\R^R[S,(>]/C3
M\9*.GK:F">DG6GF%@OCBK[0LQ1OB@DYUD.T6Y4TD57N<.+'B+'5J*\KN]&J$
MC][?))\I^+ZDRS)].?&YXQY)F]2."E7!K/D;T[MXZ+)G CS##U]C%+@UYDQ8
MT0KG_3QK6,5J-]S@C6.8X-8J_,_^\0*U%=\4>D>.6\+^+6B<\KW)Z?SU?EYZ
M#Y_CG?WB'O?_ .BCTESRG+?Q:TY:OY/7^>KUZ#U!\R_[Q1*>HXOQ.:9E$1BO
M<.-8W$@B#3E%(K [G>]K$7^NXX3H(X;1RS]X2^8F7*\;]I1<+\&= 7<A:79.
M!:9B,N-BYM4(/WID6UHZ/-\GS_(*$KNT+QVEQBV)D[E;,DJC7]!U0_&;\;OC
MM\1OC<>/&^AQV?'I1S,]S"UG_BM@>9,96MMI-G:1P"2^S++)]=$:<< #8W(8
ME96A44=A)(3XT/BV17649OY ;!J)M#EVSH=/28AB5HSLL==Z>QI\N1BF-68F
MN>.+E&16MI,O;D:.<H9,X<157Z-%Z"2G]E]1KD]P_P"A#_ZAO^9U4G5Z=$?'
M)W(J<\?I_-^7GH(-^0?QW^-7D+E2;2G4>2Z@W_%B_35'DIX]95:::WM7(QK6
MQVSLUQ(D<>:08R,;VP,BBW%<YJ=KHZM544(KXEXL?*EXV1)-/HSS6\?/)7%3
MSK:X?6>9OC[<8]LNSMK)?=?*R/=GCUEF/,R6RE'^Z^?,Q5YAA&(2-<(36= ^
M3YW\ST.D/#?XW_'3?Y(>+('$N*GRL\@*2EKIB@5L:5,Q^X\7K.;8 ;(57J)D
M\;G-;V][57N0$'7UG\L6!PI,4'B+X.V%M>V"6V79?;><.WY-YD]\8802KNX*
M/PR1$8,0FCC1 -;&@Q1CCQV,$QC4 IR\V^6DD:0V)XU_'Z*8X!FQ#2O,+R!D
M1A2'C<T))$<7A?%*>.PBHKV-*-SVHJ(YJ\*@,C A?*MA(+*4;QV\"LARS)#@
ML<RS&P\P]^#M<DM0A]D2J)OA84-515@54-=6@5(T"/\ =9W/<0I ?KLX^6-4
M7CQH\ ^[A>WN\Q]_*WGCTY1/"E%5.@'F$QOE;Q>=<9-;^//@+D^>Y-[3<BRN
M1Y?;_B=T&*8Y*O',?KG^&4Y,>Q*E:=R1X0RD5Y7$D'(:28I7 0WYO\L#VJUW
MC/X"*U?M3^F3OY.41>>/3PH3\W0#C$8ORNT5[=9G?>/7@)D^<7JGAFOB^7N_
MX4>EQILMTFMQ#%JQ?#.:REH8G#"2$:1Y[&:BR9+WN03! 2'9O\L+D5KO&CP$
M5%]%3^F3OY/\M/"CGH!O2Q/E<C9E9Y_D?CUX"9)DYDEU>-D)Y?>0$.MPG$RO
M"YE%CE>_PTFM!.L7QVEM;%7?4V14:U4''"  P)"YQ\L2HJ?T:/ /U14]?,C?
MJIZ_G3^A1T VAQ/E=)G$K/<C\>O 7(;6$AX&"PB^7_D!%JL"I98!,LFU<5?#
M24DO)KTS'+.M7]AGQNR*%@0(1I@)7[<_+%_@T> G_P#V1OW_ )%'0#4L/Y6[
M3. YGDOCSX!W8\?0?[ XZOE[Y 1:;$I1HKP6V0$"OAI(;=998>\\09I&C^@A
M<ACL8XLDI@)7[<_+%_@T> G_ /V1OW_D4= -[F)\K>39A5Y#DOCSX"VM%C"Q
M+#$\.7S \@ U,#+!%,\N873OZ&9$R"VA,<QM6,@Q@K'^X=K7R7#*$".F<?+$
MB(G]&GP$]/\ \\G?R_YOA2J] -\KA_*UF]]32,D\>/ 2;AM&\%J/!D\O=_LK
M[O*HLP<FONLIE+X9O;=5U&T#"0:U0LC-FK]2;WGCCH$"0W./EA:U$7QH\!57
MUY[?,G?OY5Y_KO"A55?X5Z <YO%^5G8$ZHB9#X\> Y\%@N=.NL);Y?;^;'S"
MVCE$2H'DD]/#5$EXO6.8IB5?L>U.DH-9#W@&X! (P\W^5YC>W^C/X#^BKQV^
M9&_.$;^1/O>%;E]$_J= P,_;\K^P05]'9>/W@;%PUY#ORZ@A^8?D"";F,-&-
M^DQZ7= \-1%K\9/(57V,<0E+8#8V.XC ..PP/N%E_P JD&,")'\8O .)%C"$
M"+%C>8F^0QHL<+&C%'C!;X5>V( 6-1K&,:QK&HB(B(G0-//)/ROYS70\??HC
MP;H:"3,=^U@JCS%W]'NK^B^G*TN/5]Y&\.(DG'!6AU8R7* UTI8?N""\#R>\
MP'-5Y)\HU%70:BF\7/C_ *RIK(<:NK*Z%Y?[UAPH$"$%L>)"AQ@^%2ACQHH&
M-:QC$:UJ)Z)T"%FEQ\MN5TRT5=H_P7Q2//E %>6E/YA;Z=D#Z!>Y;.NQ^Q_H
M91TQ^ULA\!;8(TQ8@GO>%K3^V48+>.6_R88C2U>.8YXK^!5-14T(-?6U<#S
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(>?\ [YT'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>g68105page152.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page152.jpg
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M P,# P,# P,# P,# P,# P,# __  !$( 6T"8 ,!$0 "$0$#$0'_Q #U  $
M @(" P$!            !P@&"00% 0,* @L! 0 !!0$!               %
M 0(#! 8'"!    8" 0(" P8+#@\-! @' 0(#! 4&  <($1(3"2$4%3$BDA87
M&$%1L5)R,U/3M=8*87$R(U4V=I97E[<X6'B1)#14E#755K8W=]>8&3F!0M)S
MD[-TU"5UE28GLK19&D-%1J9'*+C8P>%B9,1FF1$  0," P,&" L$"00" P$
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M"LN2I6TCP4ON9/@AA*E/!2^YD^"&$J4\%+[F3X(82I3P4ON9/@AA*E>!20*
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M/\AO3>^2;Z8(5GCA4SZAI-6L(O":OO$L:7-=8W82J:29#;$CO9RD2:D=0/\
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MK.ES]M4VR0O<JN<YS=I"@ =1]P #Z&0&I #480,![//]!<_J8 U"$##^1/\
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M*3D=:)[<%3>FAF4P=XP>:DFVM5EG\LZ"4F+38JZTW8S@'4ZNZ3%91R"*1"F
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M4UIR54D9K+76N:\SEO9;:YI0D/R<U/K6IR]\\I4UJXVVBK5V4VKR',GOJ/\
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MN56D1'C&[[9%>H,"*D225>BLJ<$BBJ<PB<PX_P!4:=\F7H'UE9^IM/\ DR]
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M)IK*Q*2SAB[!%%T51JJDL"O<FH$"0V1A>P4>W,#(@[1NH<^=01#9&%[!1XS
MR(.T;J;0N\N]5HFR*T_J%U0C)NO2*C-=PS&:5C7"+N.=)/HV1C9:'D8^8AY6
M->H$6;.VCA!R@J4#$.4<MC?+$[CCJ'#D^(X'F*MC?)$\/CP</VR.!\*[GR\M
M2474CCSC*YKR*?1M5E^'.CYI160M%GN:LE8'U2YE%L3U:R6^;L4P_?'5!(7
M*.C]IS (@ F]/?\ =V:2>Q+I35PD(R PH*8  +O>[TTDUD72D%PD(R PH*8
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M_F3/F/\ H.4OH/YK'S.^B5OQ=B!W3DZ9BJ$.X6,11,P*)G*90PE,0Y!,4Y3
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M4'-Y;PS5?>5O\5'DI_-[W'_!Q8\(<U\K_P"35?[,F%_RNS/\#VC<YO5?Q?\
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M:[U[FVI]4$;&!E2:D1C'@=H<&C1N1E'@Q(":C0X(* W9 Q3(!3)CV>"4.@@
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M(2#;M*\,1P*1CI=IS77,\CXVQR!C9*DGA:&X; :=--F"NN9WOC:QX8'U)/"
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M]"RLS&QH]5"_TI// ]P140O]MAXP>KM*;ZC>S^MR$^ *_P!MAZP'J[2F^O\
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M72;,F#%,SEX[<*FA^U-!LW2,<YA] %*(Y0WL;1Q%DU!_\;E4:;*X\+9+<N.
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M7)ZH59G-NY6 KK>H:IDC1;0WBMHV)D)E[#^TK,SBHD4FA"OQ53,DV1]X'A)
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M.$M/5\(/6%P K7(M%3ST*AKF_A;"ZT9"6GJ^$'K"X 9Y$"I6T!7[4K_Q2O\
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M5L878]!M+JA2%B>3UEV!R,H#M:C:L@M!V7<-E@YF5XRUMVO)?%W4EJ2(V9.
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M>V'A.(&)&TDC$\HR5KIJZ4L86:_\Z4X1&'E0_777^HB+!QZ/[8^D1'-(1O\
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M788>86H=>JMBMCR3M)?#.#!=\9@R9J"5<XKF2,T/Z'80O@M6QOI6I.&XDD?
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M=H,9ELV/)SDR^6=.E0(!EEU3'-U$1Q[VU/MY>E2D6H7T$38897LA8T!K0:
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M;4^WDZ4]ZZGV\O2O2O7E/5G!6-CV2#SU9P5D"VZ=S @#LR1Q; MTV"000,X
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MB/T,(HEG-'ZQLEGJET>P*Z4U4;RRV;"GAYR9B(9>[L8B<@VEEE8"-?HU^;D
MC+$\(99=L=145>XYC"4!#,VXE:PL!\US>$U K2H-*YC(+,VXE8PL!\TMX34
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M[H7'3^PKU^+&/=NE_P#D=+/(GZ<L/ES=+?JI\U3FA^Z%QT_L*]?BQCW;I?\
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MEK0P.!-3\7A12WEB)A$PB81,(F$3")A%&FY+G8=<ZKOVP:Q PEGE:-59RWC
MV">D*S'2<=6XQU,RC4)J,K]H=-'RK%D<K?\ I)1,RPE YB%ZF"Y@#G!IP!*#
M$T6=Q"\@YB8IS+-V325<QK%Q)-(UVX?QS5^NV25=MV#YVRC73UFBN<Q4E56[
M=10@ 8R9!$2A;S9(NPPB81,(F$3")A%'.R]FQ&K(RORDS 72Q)V:X5^BQ;.C
MP*%@DOC#:7(L8)-VV7DXLC5D^?\ :AXXG$I%#E[NA1$P7-:75H0*"N* 54C
M/4 'H(=2@/00Z&#J #T,'IZ&#KT'\W+43")A$PB81,(F$3"*,5]E*);@::@3
MI%H<JN*&;8:UX2?TTE38PQ9A>O\ JCAFXM"-S5DQF4R(]J,4JCT6*?Q.PIS$
MNX?,XZC.E,?^B4PJI.RU$PB81,(F$3")A%Y#IU#NZ@'4.H@'40#Z/0!$ $>G
MYH811%J6]7&^$V"M:JU5JXA4=F7'7D-\7+3,69:93I<LYB7TS*$E:E5TX<[T
MY$CHMT3/0 #' R@=I>Z][6MI0G$5_;%5(HI<RQ43")A$PB81,(F$6";1M<K0
M]:;!O,)$QT]*4JF66WM826EG4%'RP5F(=S;F/<3#*)G74<+IHQ4*FJ5FXZ*B
M7N+VB(A<P!S@TY$H,3150Y:T;:FZN.\#!P3:4JU]ML+=&:\]J]-U>5=8S%XT
M?LRN5>X11)%I5Y>;:5ZSV"-$ZI&0+)+'!3U<Z9#==[3YHK>ZZQ[J, -#X1NJ
MK7QLEC?$\ L>QS2#D010@TV';R+2CI_RR>;NJUMAJ?/L\Q)<=A75]L*5/4I=
M>J ]MU@4=.K;.3+2QZ=V*BZDYU^J14569V)/>B!TSCVF+T;=9M&U_FOQ-<_\
M)7+7G=6UNA'_ "=-_EL#!Q0/=1H]$"DK, -]>=>_>/EE<T-U47X@R7.+S&%H
M5Y.Q$G-,KA8CV6'?M(8SAZT;^RZSI#7CT[Q&:(T<)'5?G;IB@(F0.IX9TSM9
MM'"G6OIS_P"$)8]U;>RGZ]L.F\8:0.&WD!%<,W3/%*5&5<<QC6TG&WB+RJ@M
MQ5*/V,M?MC,:EQBN<3;.36X$V=8EMB[8O'*_8&T/BL:OD,M8G\A"T*S,3K2J
MC)JS6.D=(O4Y!,?E^\)9J08^W>'/#L:UY<:T6Y>Z*7V,%I9"*-D(IPBK6 8^
MB#4C$Y*VM<X1WB!V7>KX$G4E&UE91"4%&$D'_;7GK@JJM]>-4AB"I-5;I(LX
MYRZ,F83+JM>Y3T^[SKK*X=$V.K:BM<<]VS9B HUV@W[HFQ\451F:G'=LV8TY
MUCG#K75PUGR:WO"7:.2BY*1VWO>?@T45_6T)>DRVO>(SNN6YL[(4J7JL\[6?
MMR-S 5PW-'&%8I?%3Z]#'%U6D1,)!<'XTV&F2Z;3[5]I8LAD(+P<:9+:WFJM
MM,(HXOVSHC7<A0HR3K]UGG>Q[6>F5X*? (3:3>;)"2EC,$XJM)QP1;'V'!OG
M/C?IA>QFH'3O["GN:TNJ13 (!520(=!$.H#T$0ZAZ0'I]$!]'4!RU%XPB81,
M(F$6H[S)N4I*<NOQ:^*/K[G9.LE-F(6=&64(\9QVM[!\;;*S1AS,$F(J)L:R
MW3045?IBHJ],(D*5#JK(V4312Z>Z@:^E*5K4<ZO:/Z7*MI_DRI)H>7SJ1)))
M1$A++M[]+6A4J\H!S;8N)E3'B$4D$D!55,8_B@0/6P-ZP/451,/1,]!O,/$L
MXR6TE3[6?[ WU!RY5&:AIIQ\TNAL%SMI+7< GL"1FFEK>SI4W()N;@TK9Z>W
MNRD+ZS[ &\IU)08OVUZJ$J,=T;"X%$ (!#FOFK\]&^O^:7*OC;Y5- <G=PK6
MP0&UM_+M5#BWBYF7823BEMI Z1BB136VM6LW;CD,/0DDYKYO=4*&89YA!$Z4
M[!\.Q6DT%5MUJM6KU&J];I-2C&\+5:= 1%6K40U(5-M&0, P0BXEBB0O0H$;
M,FI"_FB'7Z.<BYQ<XN=Z1-5K+O<HB81,(L2E*!1)NT05XF:75):Z59%1O6;=
M)5^*?6>NMUE#JK-X.=<M5).*0654$YR(*D*8P]1 1RH<X"@)H466Y1$PB81,
M(F$3")A$PBP"L:RJ=0MEYN\*6Q?&/8Z\8YMKB7NEQL;!VI"IN$(@L9!V"<DX
M2MH1K5T=!)*-;M$RH=J?3L*4H7%Q(#32@RP19_EJ)A$PB81,(F$3")A%A]_H
ME<V;3YVAV].7<5BS,58R=9PEEL=2>R$8Y(9%Y&GFZI*0LXBQD&ZADG"2;@A%
MT3F34 Q#"&5:XM/$W,>%%D47'-XB,CHEH=XHTBV+2.:GD)!]+/SMV2";9 SV
M4DW#N2DG8I)AXB[A55=4_4QSF,(B-,\47.PB81,(F$3")A%B5QH%$V(P91=_
MI=4O$9&R*,Q'1UNK\58V+"7;IJ)-Y5DUEVCM!K)-TUCE(N0I52 8>A@ZY4.<
MW%I(*++0 "@!0  *4 *4 #H %*'0   ]   !T#*(F$3")A$PB81,(F$6(K:_
MHCFY-=C.*75%]@L8T8=E>EJ]%*7!G$"1PF,4ULAVHS"$:)':H"@58$NBIO>^
M^'*\3N'AJ>'<BR[*(F$3")A$PB81,(O(#T$!] ]! ?2 "'H]/I >H"'YF$4?
MT/653UL:TC5"V-,+G9I*XSZ<]=KE<$5;',N5WDM(QR-MG9I*""2=.3'618@W
M0.8"]2>\)VW.<74K3#D 2M5G^6HF$3")A$PB81,(L;N52@[]4['2+.B^<5RV
M0[ZOSS6-F9BO/7D/)HF;2+)&:K[Z,FH\KUJ<R2AFSA)0R1S$[NTP@-02TAPS
M"98KE5R CZK Q%;B3RBD9",48Y@>:FYFR2OJC?J")7L]87TG-RBJ9![04<N%
M5.P +W=   H22:G-%W6$3")A$PBJ'%_QSK'^PJ=_P,X^YO._+6_>GZ*O_P"W
MX5;S-%6)A%B-JU]0[TM!.+M2JG;W%7D1EZRO9Z]%3JU=EC F4TI!JR;5R>)D
M3%1* KH"FH(% .[IE0YS?1)%4J5EXB(B(B(B(B(B(CU$1'TB(B/I$1'*(O&$
M3")A$PBUX^85I36=AT_=]R3%;*\V+5H*HUR&G59.7%JA!O[Y&QKZ/<P /OB\
M_0>1UI?H+"LU.HJBX[3&$$TNS>L99&S-A!_E.)J,-RN836FQ7L\F0IB>7QJ(
MIB>&/QCVV;M]MK6+T'VM<#E,$PO^G.2J%,!BIC_4P"" >A(,Z5GH-YAXEL#)
M;25/M9_L#?4'+E49K"]@W:.UIK>\;&EV[IW$T"DV:[2C1B4AGKJ.JL$^G7K=
MF50Q$S.EFS Q4P,(%$XAU$ PAS7Q_>1^>2Y7/N0WF<;+1\79&^MA62$B&KQ5
M%VZK1+ A6KW; :G3\4C..+7).KU^*3(?N3A8%(IP(=15,(+593Q-MQD!4\I.
M7QK!(?Z*^@[(=8TPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PBI)(VRJTOE].R]RL]=J,2XJTU'(2MHFXRO
MQB\BI1=!N4X])_+NF;11\HW;**%1 XJ&(F8P!T*80D.%SM.:&@D]:<L=BO\
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M4\LB%,F<BA0W!.D$R9RG*!TM0Z025()BB( =)4ABF#W2F*(#T$!#.;U7\7_
M/C6"3TO M_N1RQIA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3"+H9ZJU>U(%:VBM5^RMB%[2-[!#1LR@F'K#5X'AI2+9RFF8KQB@L E
M!*JBF<! Q"B%0XC(D(L:A=1:JKDX:SP&N*3#V8Y"$5L;"MQ:$\N";@CL@N)@
MK;VBY4*[3!4#J*&/XH=_7N].5+WD4)-$JN8&L]<%G6-H+0::6R1@D-'3Y:U$
M!+L#ID032.SD : Y;J))M4RD,4P&*!"@ @ 93B=2E31%G&41>,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB814H\R81#R^N: @/00XX;/$![>[H(0"_0>W_?=!^A]
M',]M^(9\X*K?2"MEY,+.-8>7UJMI$-H=G'IW/=ZB+> D'$I$E5=;IOCM\=L]
M=@5P=5Q(+JJ.$S!T;N3J(E]ZF YUC?1',/$MD9+:8I]K/]@;Z@Y<JC-5]Y6_
MQ4>2?\WO<?\ !Q8\(<U\K7Y-&@@W\L:&3;HI()CN*PKBF@F1(@KNM2Z2=.EA
M(F4I15<NECJJ&_1'4.8QA$PB.<WJOXO^ ?&M>3TE] &1RL3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB8143\T1ZM&^6WSODV_9ZS&\4]T23;Q"B9/UAA39%VAXA
M2B4QD_%1#N ! 1#KZ0S/:XW+!_7'C56^D.=6*\A"]2FS/*WX^WN;(Q3E[#/;
MP4D"QAT58XSB-WIL:$,LR40C8A,[=P6,!0H^K)&]_P"_ Q^XQNM H*#);*W$
MJ?:S_8&^H.551FJ^\K?XJ7)/^;WN/^#BQX0YKY6/R: 70^6)#>N%;$6^66R@
M4&IU3I>JAJG2@,#&,L1,X.3L 2%< #L*L)P()B 4P\WJOXO^ ?&M>3TE] 61
MRL3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB8142\T5NL[\MKGBT;I>.X=<4-UMT
M$.I"^,LO2Y))-+N5,1(OB', =3"!0Z^D0#,]K^)C^>/&JM](<ZEO\G1@%*OY
M0W&*!4!?I'S>_P#U8[@ATU7$>\Y%;5D(IYV* !RI/HQVBNGU .J:A1^CG7+9
M6[E3[6?[ WU!PJC-5]Y6_P 5'DI_-[W'_!Q8\(<U\K_Y-3_LR87_ "NS7\#V
MC<YO5?Q?\ ^-8)/2\"W]Y'+&F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%63D1R-<Z&/7466M9'8SB>9N'
M7JD99F]?>I*?&FGU&-8,&ZT#.>U'DC)W!-0PG,T0;-FRIS*&,)"#FCB:Z)\T
MCPR*, DD$YFFS%6221PQ.FF/#$W,XGDV*NGS_KS_ "/MD_M_@/Q8S!UVG?[E
MGJO\BC_?.E=L/5?]5/G_ %Y_D?;)_;_ ?BQCKM._W+/5?Y$]\Z5VP]5_U4^?
M]>?Y'VR?V_P'XL8Z[3O]RSU7^1/?.E=L/5?]5/G_ %Y_D?;)_;_ ?BQCKM._
MW+/5?Y$]\Z5VP]5_U4^?]>?Y'VR?V_P'XL8Z[3O]RSU7^1/?.E=L/5?]5/G_
M %Y_D?;)_;_ ?BQCKM._W+/5?Y$]\Z5VP]5_U4^?]>?Y'VR?V_P'XL8Z[3O]
MRSU7^1/?.E=L/5?]5<%GYB-H?$1!MQ0N[AZH695<1+78\.XDHIM#7.U43Q9@
MHTQ)FT5DINF/S-TDUES^K$(HIX8J 7,\C;2*-DLD[!'("6GA?B :'9AX5FDU
M&PBC9+)*!'("6FCL0,#D/&N=\_Z\_P C[9/[?X#\6,P==IW^Y9ZK_(L/OG2N
MV'JO^JGS_KS_ "/MD_M_@/Q8QUVG?[EGJO\ (GOG2NV'JO\ JI\_Z\_R/MD_
MM_@/Q8QUVG?[EGJO\B>^=*[8>J_ZJX<CYAUNB8Z1EI#B'LEO'Q3![*2#@;Y!
MJ W81S95X\7%-*K'54!%L@8W:4IC#TZ  CZ,J)=/<0T7+*D_)?Y%4:QI9( F
M%2?DN^JKWZKOBVRJ6TM;F""M.U9BU0CR&),$L"#9W5+3,5==9K,DC887[-^I
M$"X1,9HW4*FJ!3D*<HYEGA,$IB<:EJDR.$T4AYB5$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$5)O,I(53R]^::9R H13C;M$ATS%*8JA#
MUYP4Z9BG 2&*<HB @8!*(#Z?1F>V_$,^<%5N85OO)N00:\ M6-VQ&:;="V[C
M312CX+XM,T2%VY<P!%&#  *R\+]"<2@!'!P,L4 *H 9UC/0',%L#);0E/M9_
ML#?4'+E<,U7WE;_%2Y)_S>]Q_P '%CPAS7RL?DT#5LS\L6&1:()MTC;ELKHR
M:1>T@N7^J=*/WJXA]T=/7*BIQ^B<XC]'.;U7\7_ /C6O)Z2^@+(Y6)A$PB81
M,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81:\^:_Z[M4?81W\-.G,R2?E=U\UGTE'ZM^5S_-'T@HASCUYVF$3")A$P
MB81,(H?H9R!<+,F)R H9C9#%3$Y04,4O(SD4!C%3$>\Q2B/I$ Z!DUJ/Y=8_
M=/\ I*8U#\OLONG_ $E,&0JATPB818;L?_%QL7_)_=_\%Y7+XOM6_.'C"OC^
MT;\X>,+8_P 9O\5"7[/=M_PIV_.VU'\;)SCQ!>IO],J?<TE:F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBI%YEZQ&WEX<VW2@I%3:<9=LN
MU!773;(@FUK#MPIXKE8Q46Z?8F/<H<0*0/2(@ #F>UQN6#^L/&JM](<ZM-Y)
M-IAKOY<FF+;7Y/VS#3MCW&[8203 3Y5R)[@O#1=-.8!LR]=29.VRC<G5(@I%
M2!,0ZD$1ZUHHT#<%LK:\I]K/]@;Z@Y55&:K[RM_BI<D_YO>X_P"#BQX0YKY6
M/R:$[D_EBPQG2";=4-RV0A4TG'K)!;)ZITHFR7%7P4.U1TR(FJ=/M'P3G%/N
M/V]YN;U7\7_ /C6O)Z2^@+(Y6)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81:\^:_Z[M4?81W\-.G,R2?E=
MU\UGTE'ZM^5S_-'T@HASCUYVF$4$;&WJQUG;&\--U&P.JL2'C).>O;#PPAJP
MI,2$FQCTI;UQ)LS%NH$4J<YB.Q62*'>=$$OTS-B*W,K.)KAQUP&TTW=*V([<
MRLXFN''7 ;32F72HP4YJ4,CYJP^3_:8*R+=1U$%5B:VFO,H%=MVJ2L8R)9UG
M2J+@J_B HH5)-$ *"XH]Y!'-[!)2O$S#//#X/VV+-[#)2O$S#//#X%/.L-K5
MO;,?.R5;:RS-*NSJE=D4)E..1=IR*3-L\5(*,?)27JXI%<@0R:XI+ 8O=V=A
MB'/KS0NA(#J8BN"UI87PD!U,17!2;F%8D !,/0 $1'W  .HC_N!A%1^)UB^L
M_,6B;ACI2I%B=0ZPY%4BSL2K.5[HZE-J<C-EN8)CVMDU&#*$BT*LJZ43=*)K
MF4=$,D02")LZ*^F:W1+6 UXGMJ-WFN/PFJZ&]G:W1+6W->)[:C=YKC7PFJM;
ML&TOZ9492PQ5?=VJ4:JQ;2-K[(ZR;B2?R\LQB&J0*-V<@X3235? HH*:"IP3
M(;H41R!C8)'AI-!OYA504;!(\-)H-_PJ 6?+&$F4[3&P&N-B/KK5XZ ?C6'4
M,JW;3OM^VEIB",%-,$9?QS!+E4 H+-43BF05#D33 YR;!LW-H7.:(R3C7*@K
MB,-BV#9N;0N<WJR3C7*@KB,-BXLAS.UI&'(+BL;",R*^80SV71CZP,1'6%YV
M%7KKIXM:D#&EXQ<QD%TTR' 7)!13$ZPE(-182NR+:TKMRWY9*HL93D6USVY;
M\E8C8I@-K?89@[NAM>W4P=Q3$-T-594P=Q#@4Y#=!](" " ^@?3FM%]JWYP\
M86K']HWYP\86R#C-_BH2_9[MO^%.WYVNH_C9.<>(+U-_IE3[FDK4PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$5#/-.*4_EH\^2'Z]I^).\
M2&Z>[VGHTJ4W3\WH/HS8M/Q,?SQXU5OI#G4L?DXS:49>3_QC9S8G&79V+D6U
MD14$14%VVY,;>15%03=!$XB3T_FYUJV5O"4^UG^P-]0<*HS4!<I6[AWQ9Y&M
M&C==V[=:!V^W:M6J*CARY<+Z[L*:+=NW1*=9==90P%(0@"8QA   1'"'-?"G
MY(?F9\;^)7 R+UEMN&W4>QM]@S]A77I^MD)Z'19-*!K6IR3=9T\LT*^0DHFP
MTV1;.4#MBF*9#N*)R'*88:^LKBXGZR,#AX0,318GM+C49+;=#>>WP6L,1%S\
M+%\D9"&FXYE+1+]'3+,B3Z-D6Z;MB[2(O>$5R)N6RI3@!R%. #Z0 ?1FG[KN
M]S>E6=6Y>M3SX."2,ZTK*D=R0)//XE_.LXP=,M!6<0\6\81\@_(H%X%L5)J]
ME&Z9BF.!Q%4!*40 P@]UW>YO2G5N7;!YX7"H1  K_)41$0  ^1R-](CZ #]?
MN/==WN;TIU;EU$#Y\/!&SP\?8(".Y(2<+*H&<QT@CIAJFD[0*LJ@90B;F[H.
M" "R)B]#D*/4ON=.F/==WN;TIU;EY=>?!P292\/ .XWDBA,V!&6<0K VF6@J
MR","DT7F%$CDO!D$P8(OD3'\0Y!,"@=H&$!Z/==WN;TIU;EVP>>%PJ,( %?Y
M*B(CT /D<C?2(^X'IOOT<>Z[O<WI3JW+J('SX>"-GAX^P5^.Y(2D++("YC9!
M'3#5-)VW!51$54TW-W0<$+XJ1B]#D*/H]SICW7=[F]*=6Y>7_GP<$HM_!QDA
M'<D&LA9GSJ-@6I],M#'DW[&+>33MLB9*\*)IG0BH]=<14,0HE3$ $3"!1>Z[
MS<WI3JW+M@\\+A4(@ 5_DJ(B(  ?(Y&^D1] !^OW'NN[W-Z4ZMRZB$\^'@C9
M(\)6"CN2$E'"]E(X':.F6B:?KT))NX:5;=KB[HJ][*48+(F'M[3&3$2B8H@8
M7NN[W-Z4ZMR\RGGP<$H0\0G*QO)%D>?F6M=ABJ:9:'%_-OD';II')"C>%0(L
MNW8+' RG8F )CU, B "]UW>YO2G5N7;?Z\/A3_>_R5_><COQ]Q[KN]S>E.K<
MNIB//@X)3R<@K#QO)%^G%3,I79$Z6F6A :3<(X]5EHY0%[PD)EF+CWAC% R9
MA_0F,'IQ[KN]S>E.K<DQY\'!*OMVKN:CN2$>V?2T1!-%EM,M#E7F)^00BH9@
M4$+PL<%9"1<II$,8 (4Q@$QBEZB#W7=[F]*=6Y=M_KP^%/\ >_R5_><COQ]Q
M[KN]S>E.K<NIC?/@X)3#B;:1D=R0>.:Y+&@IQ)/3+0IHV8*P82AF"PJWA,BB
MH1\HW5[DQ.GVJ@'=W 8 >Z[O<WI3JW+Q.^?#P1K,6XFYZ.Y(1D4U59(N'JVF
M&JB:2LB_:Q;$AB-KNNL(N9!ZDD'0H@!C@(]"]1![KN]S>E.K<NW'SPN%11$I
MJ_R5 Q1$!#Y'(WT" ]!#T7T0] X]UW>YO2G5N74LO/@X)24E.0[&-Y(N9.M+
MQS:>9DTRT*I&+RT>G+1J:QU+P1)07<:L58HIF. %'H80-Z,>Z[O<WI3JW+E2
M'GI\'(IDYD9&'Y)M6+1,%7+D^FF)B(IB<J8&,5*]**" G. >@HCZ<>Z[O<WI
M3JW+F#YX7"HHB4U?Y*@)1$!#Y'(WT" ]!#T7WIZ!Q[KN]S>E.K<NI;^?!P2=
M34I76\=R05G(5C$R4K'%TRT!9DPG3R!(ARHH:\%;G(_/%.0*!#F,7PA[@+U+
MU>Z[O<WI3JW).^>_P2K,+*6*?C>2$9"0K):1E9%;3+11%DQ;%[EW*J;:[KN#
MD3+Z1 A#&^D X]UW>YO2G5N7:_Z\/A3_ 'O\E?I_XG([Z/I_O\Q[KN]S>E.K
M<NJ+Y\'!(T\K6"QO)$9]&%0L2L7\C+3QB0CE^XBT)$5!O'JPHJR+11("@<5
M,01$H%Z"+W7=[F]*=6Y<B3\];@U"QDC,RL3R291<0P>RDF]4TTR.FSCHYLJ\
M?.E"(WE58R;9JB<X@0IC"!?0 CZ,>Z[O<WI3JW+W-//-X0OFC5\TA.2:[1\U
M;O6BY=-L *NU=HD<-EB@>]E.4JR*A3 !@ P /I !]&/==WN;TIU;EP5//?X)
M(SC.LJQO) D\_B7\ZSC!TRT%9Q#Q;Q@PD'Y% NXMBI-7LHW3,4QP4$50$I1
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MB)')(4Y@HX=(*2:75$I 6'WWO [#]MS.ZLK7AW7-P(/HG8>=7-[K2M<'=<W
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G!N%D\=+UHK$41C>JH*%$B^DHXG[#^]+^A-_OQ^D/_P#1A5%*K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>g68105page153.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page153.jpg
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MRM]NT;;]VV_S[:@FKH56?T3?\Q/T:DA[2IH0&@#0!H T : - &@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@&)_B'6WER_^0L"U,(Y8N#!;E4@8RL&
M^KYQ_GK)&-\C5JZ[UD77/QK:]O6Y ID[%D)V13:'52*Y5F*DZR=F?=@DA>@'
M1.(MY43('&G"MW6Y6[DN.CUFQ*4J+7;RN.9=]V5AV$E=.ES[ENF?$@S*[5WY
ML1Q3TE3#7G.$J"$I(&@%*: - &@#0!H T : - &@#0!H T : - &@#0!H T
M: - &@#0!H T : - 4OU_P#5?T]"=W:19_1-_P Q/T:![2IH0&@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@#0!H T : - &@/+S\93!ESYGY/VZWA
M3%V><H9)H6.[3E7E Q_AC%=?QS#@)G7:;-_>;+E8IEQY#LZYEN.2U0O=:1/0
MAL*2T6RZO0#ZG"&R:EC;B3QZL2I6LW9=2M?%MJTFJ6FU3OLH4"8S"'O=.,$T
M*VD,RH\@E+J?<(OM _FTDZ 5EH T : - &@#0!H T : - &@#0!H T : - &
M@#0!H T : - &@#0!H T!2_7_P!5_3T)W=I%G]$W_,3]&@>TJ:$!H T : -
M&@#0!H T : - &@#0$BU*3MVIW'7?H3L>FW0'?;KH"#:^\*Z;%*BDI/UAL ?
M:&YV*@=Q\A&@*F@#0!H T : - &@#0!H T : \ZWQ&*!9T'F54I]P8>M>XZK
MD+$6.*/#R9?MR7TNTK*MVUJK?4V\J],MRP[LM%^4Y2Z*_P"Z0Z0MQVH5NJ5"
M.8RFVF'M .]<)JI<5:XG8"J]TXW@XDKL_'-">J&.:55IE8I]L% 6B%$B5"I3
MJE4W694!#4@(D2'GV0]Y3BU+0HD!5^@#0!H T : - &@#0!H T : - &@#0!
MH T : - &@#0!H T : - &@#0%+]?_5?T]"=W:19_1-_S$_1H'M*FA : - &
M@#0!H T : - &@#0$#N 2/'8[=">NWJ'4Z 25DWF_P 4<.WG7<<Y0Y"8WL2^
M;;MI%V5FUZ[6D1ZW#HSP0XPL1BR4/SY;#B5L06_-G.)4%):4-CH!M'XE&7:7
M5;PP?557?0:SB)6![WS#*QI?-VY@Q;;%V,O7ACNVK>OF;4\=-TZXIU:H";J0
MU'I<Y*&T-S'GUH!1T 65\,9^X8^#LE6?<=ZHO-_&G)?-^.Z:(M;NBZZ1:%&M
M^OQ5T^P[>O*])4RZ+PMVV$SE-0Y\Q?FK94&]@EH:"HXUH T : - &@#0!H T
M : - &@&*/BF5W.EK9-H-1LO,_%#&=A3<:S!-H>;ZCC%J]KBF4V7/=K+U!I5
MX8CR!6ZC!%/?;8:#4AICWA6WE[DD@*IXK90Q?QLX-\6(ET6Y?^-H4[&M*A6K
MC61!K.9\C/O!M53ELM,XPH%6DW!(=3.$L"%%:::8?2D--I1V) 5MBSD/C7+=
M6ET"V*A<M/N2##=J4FTK[L2]<=7:W26)*8*JJNW+ZH5O5;[.<EN)2AY+/EJ*
MAMOXZ [JM1&VQ]?J^30%,N+'H!'K/30%9)W /K .@(Z - &@#0!H T : - &
M@#0!H T : - &@#0!H T : - &@#0%+]?_5?T]"=W:6ZRIN,AT*([0WOMX=I
M*0=P.I\= ]I>Z$!H T : - &@#0!H T : - 0/4$?)H#S)\[HM.IW)K,-<3>
ME-P%=..[IMC,N'J1<T#*=XUCD5E5&*$6D:GCE-LT:KVS;O=01^[Z&HL>I51B
MHA4A;#:5(4L#J?Q$#5KJQ;QFR-E:SG8-$JO'+(DB]K$J,K"U9S?8UY52SJ%5
MWKLJZ<NFAT2Z[3Q@T)<NI-,RX(34VHSKS;G1K0KN;A;7PCFT)X@T^9$J]#JE
M!KV2\DW'9K5-EVO4*_2K+J]?6Y;U+R%/L^GTRBS,A1665BIJ0T5-.;,E:_*[
MCDBM/"G6.?CP'S#6)>MB\A'0D- &@#0!H T : - &@#0#!'Q2'<^8DRO7,R\
M>\)9MO2X[KPS0;*KN0K=LW&.1<7T2FT2Z9[_ -A5&UYN-LH96%3$2N2)TCW6
M+%I+T=G9Q:G0" ,F9&6>+_PWN(%L<>;\S3E:IT&W6[;G9!XZXNMJYJ=7VY2*
MA57J[7K?R?;=8N2V+/C5);D:$S I#TYI1#)90AL  =E^#]4[POK#65\[Y"RQ
M&R5?F=\LKO>[*;_K#%6QG5*58UL6<C'5RTH4*V*32+GHL&W653&*?";BMO%0
M!6HJ60'6ZU78U%@19KJ5.R)LJ+3J?$;V#L^?+=\N-#;*ALE3IW]I6R1MU(T!
MC*K<[M(KE!@OTB6JFUUU5/-=:DQG(T"J%MUR/!J$;M+Z$R%-*0ET'L\S9)V)
M&X&V=ZTN,(0D%*TDN;'HD;;I/4[G?0%WH T : - &@#0!H T : - &@#0!H
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MK<-)N&+%DD$^[27J5*DIC/CM/L.=BSVD[;: W'0!H T : - &@#0!H"E^O\
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M0V5D6Y+BN#DXYQKH'V#0;OK\['<.C.NS"S=MPT&X*9+E^])89:I'>V5R$J<
M ">N5%>LGDKQ7X#WA@BSKVG7KD9J\Z#A/$]^Y)O>Q*A6[4N&SUVWF"V\BYNM
M[(U#KMKT5FS(KP=JO?7_ '^(H>7$=#W<D!UOA58-RXXQ:;6N>CO45R#/C1Z/
M!/(.]^1T6'1H5#ID*-"I]XWRVW4*33X'D>1'IS82TAIH+ '<= +&6@=I.ZAL
M">A^3T]- 6;.SKSR5@$-K[0=U [=B5==CUZG0%\$)&VV_3;8?-X?+H"?0!H
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M;K]K6WG48KC-,6[,F5:F&N8_@V]49N7&[7FR8/E%=VCWE3K9[5>9YJ0 \GH
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MU).3FJ<_=]MQ;=NR[*K+M^KUBJVDA45B;&,@HB;!2>TE0#_\="6VPE V )Z
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MAW$=PW2.IV!'CJVVH*,U/\$APA',P25;C4OQ67_#UY#U_P#):,VX%&/=UD)
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MJ,MC\A25]7Y^\??'JU-S]H@56?HI=HQ3=P6URBY8I)">_(UM/#8[[H.,;!2
M=NJ3[!U]6>[G^Z>7^5/\8\.YAN<&KW8]?QEY(<Z[)22!W#KTW7V)6E"!XK*D
MJ\1X;:[UO.$\<H+_ #:TH4".Y(4%=P )\2A)_&4GTC5_@$^/TESY ?2O<D)(
M2"-^OCZ-N@U98AX>8@_+YC#CX[L/+Z#G=VI",C<54>VK_P"EKA5""DC9LJGU
M0>8K<;D)[MCKJ.LX<J:W+<LO=]!R&C_OZ"W\2])Z$T?53_-'T:^/H>RO(>_Q
M]E>0D?\ T2_F'TC4O=Y49;G\E^9G+,L_]$V4?EQW? __ %9J6M+/^WFOZIZ)
MG8>1_P"^'+[_ -?ROZVV(!PX@*P[BQ123W8^M0C8[?\ WGBCKTUT71OW-D_Z
MM;_%1]=^\/#G_6%_ZEF/UDC<:G3X=0A2($QE,F+-C/1)L9X=S,J')2IF3#=0
M/KL2(SJT*2KN1[1/:=SKE8O<=9A:<]CI]WW=@E617D<<':;1*XXR]B>O5NC4
M#&CL"(X[4+.J-8=:CHLBKNN27Y,ZF)<6IV%).QBQTB.0H)01K7\S"Q)QE7A3
MI5=+V)G:N4-!S/,=S.V<NX2NY.+DXMT?#!/BE&O115776HJ[L;=:4@ME"NWM
M4%I[5 *5VK';N>J%)V/J5N-;-OULO*YTHZEE\PLQ>A?6ZY<CW1_A+SA=TR5R
MC;  2S>-BM(V\>U-DQB"H^D]=;>C?M"\J_$1T_WW_NOEU?ZG>_6#B'H_T?\
M$==CN_0W.T^?(?1KR(; HJ>Z_<]I )(S/<'AX_\ %5#UY_EOI[A]B<7!H.AO
M_P!$RW^.;.ZT@(5WDCP\?P_+K?1-F]CU&(G2HU+@3JD[W^13H,N>\4;%?D0X
M[DAXMH)3WJ"&^@WZZ7+W@6O$>"J7N=[,9W+9&W1SS%U02ZVTEYS4L3Y*M[+=
MCTB_K97-71:VJH"$9L?W64H4V4_"E%<=2U%)3)8*1U]H'<:G*9I9F]!0?JR:
M:[_X"[F[2,WRMKZT#,I1O\#XDGA[/$O@9LE(;9/(;C4ZI"/.;N+*:$'O4%CO
MQ]+W(1OVD=K9]'IU5%?[0V'_ )[-?JF:&9;7NRYSCTZ;H_\ V[^$<$OMOS;,
MKS?F*9[F6OSJ" 4]LN*?%1 '=MM\VNZY7Z*W^CCYCX\WORDM0;_Y<6T]V.[J
MI5SHW=0K9L)^Q?T*DJ*$]^_4G??6U][3 &])\!\P^C5;V@2KS9JLB#Q,SY[D
M8Z)55QW6+:9]]>$>,3=Q9M<MR7#U0AUNKJ! !)3T'4C4 4+9]#:MBU[=MMA*
M$LV]0*+0FPUOY(31Z9%IJ4M)4E)2V$1AV_)H#9M 2H5WC<#;0$V@)%H[^WY%
M _,1U21MXD*'AX: 3#G''%=CURBYXQ/2&ZAF''%&F0?W?;EN0&,H8Z><;EU[
M&TW>0B FK25M>\4*8^A0@U) 25H9??[@.HXIRW:.9; H&1K(D/RZ'76E)+$Q
MLPJK1:K#?,&MV[<,![\_2K@MRK-/0YL9P=[4AE0'<-CH#J&@#0!H T : - 4
MOU_]5_3T)W=I%G]$W_,3]&@>TJ:$!H T : - &@#0&G7ZB"+)O+[0--$)5J7
M()GVTW->I'NBZ3+]Z^U&:9M4G:86@2^B.?/4WW!OVR- ,:<-L2VE=7(3%&3;
M*S=PFH$6PT7$Y+L?C8_EB%D+)$6OVS4(#5N7+0,I7X^]#MVGJEBHK4BE/3//
MAMCS&T)4- )4Y*<P<V7;=O(W#UX9)SO!H:[FY V]3\4VY@F#*I%:B6#ER@6S
MC6P*5?+=C/59E>5;4D/3HU2]Y6([$=7<L[[Z ]2-/4%0(/:TIA*F6#Y*SNMG
M\RESRB=R 6U=.FXZ=-8Q^E[":)P=>@8$QS"_W3=X:6>U.6\R)[BH]XWR?<_L
M@_5 'JVU]H:/5\MY9+VN"/H/G34)..NWDJ4JQ'OQ'<^WUQBX^T?)5@U%JDU,
M9DQI;=;E+HT:MNNVA6*G)-QQ8M/?8D(7,>I\)09*4%27%;@;D$=GRNE2S5+=
MV2\1Q;PP6%*><UIUBJG'Z=SDQ%2\ESKZH5&S-6L?9+Q[1WD.-8LKL&6[=5JU
M6KL051Z9(=\U]"K:E+1(* @B0S[6^PU5DM(G"_=6;<8VXI4HZM[:X]VW<:%V
M]<;]7'L',;<DLUZCTFNQ&IH@UJGQJG$$]E4*:&)K276$RXCG<Y&?1W=JD*)(
M(UKW+<5<X8^R66JR]L4[Q2COQ>0E)4_YKGGXSO)*=EI,6(45VUDO,>7]?O?5
MV*[AT!WUXA[XE&$+"CMHO2>G<DX7E38.Q?\ C'\.O ;GWL]Z/4GT=12/U3\A
M.WW=3=^FMO?4PDO"M/AZ!CJ^X"3R@Y1N,GM4Y>]K..[GQ)QI9NZ@/1T:&OJK
MW;MOD^S+>KDU\)X7S;:C#6I\.^*;[6SDF<JE5;3Q'D^ZJ+.7%J=OV#=-5IKS
M)"7XD^/ ?<C2VUK[T!:%-C;IX:]&R-B.:N0A)T<IQ7>TCK+5$WU""L9<[I:L
M=60NX,*YYNNNMVO2DUVYZ+:1FTJN5 QT&55X,@* =:FN[J04@#M/IUWS-<G3
MR]:9S+U^[^,:-O,3EMH+ZPWD$9;LJ'><>V[ILYB;*FPOL2\(*J97650'RRI]
MZ&K<MLR/K(/JUU+,Y2YD,["W<NV[JH\8+#8]]7W&]9;\2$L,69"[2F%D;BLE
M94XI_EKAIM"CU#>TZIJW5X>E VUT/6$Y<J:W'<\O=]!RFD7)?;T-GM(]"*/J
M)_FCZ-?'T?91]"P=8)]1(]^B7\W^,:SBE*23Z27A%_)?F9S#+"1_"7)IZ[JQ
M[>XV]>]L5+H/EUJZG",+5ZZO:G:X7Y,=G7B<_P D2_VMT%[UG\K^MMB"<,!
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M@A"''#TWT M#0!H T! D ;G?Q Z GQ.W@- 4T/MN**4**BD))]E0 "]^T[D
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MEWHNH-5'W[D'%L:+Y4,,&'3<<XNL. W$5*!)F^16*S/1OX(4DI &H LK0!H
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MO.-CS*F<8%RT6_U"J97JMQ4^11L;7O6H3\.52Z+'CN,3Z5294.2X\8B@?+6
MHCJ>FNE9B"R5Q7K47*2DZQI@TTDL.IGW7E^7X\Q\K<OYK2KEB5RUIL(.,LWE
M[:E*,6I*:G).D-L4]DM@V9R<S?7^%EWLY]XWXLOF^<7Y)N</\GL0R[#NNVHE
M!>;1&D3\\8X74(5-89NJ33T/1JQ&#2XD[RFI3Y0MM2G*'K5Q;<M%?R3CUR-S
M79S586\J[==BU#*4_6B_J+RKPM7+=M6[*/6[AJ=OWQ'ILBU:W"LFZYE-N%VK
M1TOPH%'J$2"] JM4+9\M;,5QU1>0L ;@ZPGJUVX^*.65-GLG;,OR/KF8M*Y>
M^I0N=#S^47;]+L-_9S?: V!I&3-RCO.^)<B ^!/:>^W_ &3Z.ND=3N\27U:F
M/03+D#6:87,@H]+U#*476WXNQ;^HIV1>%.R)R&X\.6K0\@M-6W<-^SJM-KMA
MW?;E.I\.;CJO0FGGJC6Z1%AK5(EK2T@!Q'<5 #?P-MM\6>C=C"EQ3;K2C7$F
MFZ_QMC.O\]:)F]!]SO-62O9O2[F8S2TV,? SN5O3DK>?M7))*U=DZ**;?4.=
M9$>F1[ N(PD*=F-4]AYL*[MU+,V*2/1W*\K<_.-=Y4.&$9126%.Q(^)[U]3S
MURS%4C"*W88UV;NXO);:UWU:<B.'6XCE(N_WI!44-K<+E!\AY31V_.?6ZGKL
M=2ZTZ\"3H.XV\1T^4>O;Z=5 0]P"1*G8.K5[SI;$V1E#.G(?)#,J(CL8<I%>
MS%=T:V&P.I6MBUJ?"0I?7N*3UVU#BY*B="4JL6^=MM^[8>LG;Z=M2O5P8K3:
M13MMT5W#U[[_ (=2]O015/%$VH : - 04E*TJ0H!25)*5)/4%*AL0?D(.@.2
MT.K9%&2+NM^JVO38.-X$&A+L>XH$YUZ=4I#L9?V[#J=/*0W";@22A+*DD]R>
M[7*7[&1EIT+EN;6;:?$ME.BG9YSC%]8^LR;;X*X8[CJQ[N@ZD;@$[[$=1U&_
MJ.N(MP4(TXG)];J<KNQVGG'X25%2,[?#G1(;;9=J4;XOL)I$9M+;';'Y/-3D
MN]C8 #KK,0*4?2I1].^LS$]':#ND$>'4#Y@2!^ : FT : @2 "20 /$D[ ?.
M?1H"EN/.WW&WE;;[C;?S-MM_7OH3N[29G]$W_,3]&@>TJ:$!H T : - &@#0
M$#X'YCZ_\770' Z;.@_W@;KII5,,M>*K6J)C!4INE*AIN>MP@\5J4F$_.$A!
M#A"2MML!*CL=M 9? -0CU3%EM3(JPXRH56.3Y,MCM=B5NIQWFTMS5N2 TVZV
MH()5L4[%.R=M =C4"H[;;#U[^GU;:U\S8\:"X9-33,DTA,G(3AYQJY6TN#0N
M1>#,=9?I-*,]=&1>E A56317JGVHJ$BD2W4IDT]^<VV@+6TI*SV]3K?^TM3R
MN45G)W)<5555HC7GD\I=QN)-^0\]WQ@N/['PW.!;\WAO<6=J#1+\S_BNSJKB
M&G7W>%_"':TMBZ:K7*%B&3);K61;,F5@4QA/ET^>I@,L^7Y24*5K?RN;SN<O
M*%RX_$2VMO#MJ:TLMEH+&TL?(.??!EOJL\@_AWX%R;E6(BX[ZJ=/K]+K=2NZ
MVX35V'[!N"H4J!%N5^92:;-GUF%3XS;;[\B.R^XL?G!W@DQJ'B9>]X:G)RHJ
MXLRLV\LZ\%N->M(<@O/&-H75:]QVJ];E%BL7'0JK0WI<&B4=,R$*I!D0TSXI
M<B=@EPG'4K:WZ>8$D[ '6E'-9B#4HSDI+K?QESLV7@[<>Y' >#\^-5^/UEIG
M4>D0;SL-VN8KN_W1B&JHQ*Q8-4DT"1'JDV/';4]59$>*P],0%%")#JDCZNKK
M]Z[<QDV^**;Q;J^UE:M9>,OFTE*O0+,5N4]/'6FJ)X[#8FI.VTEZQ'8GMZ[;
M>(\=_DUB^HF->&DMIBWZ3"D.%U^%#>61MWOQ8SR]MR0.]UM:NT;^&^VJI3O-
M[)]DDBJ&6R]*W(1<J[U4G;IT=I(;:BQ6FP-NQMAEM)_T6TI&VL*W'M5RGRD9
M_5LK^;AW+XCSP?\ :&KFR7;N*^*%"Q-C.OYQK=S9QN]^HX3IM+NZM4?(-(HF
M(KJ<>DW#2+ D0[HJZ;(E3FJW$9;=1']YA=[R@EM.KX^#%U=BV^Q&+RV6;^CA
MW#B/PE:W=%W_  VN%MQ7Q4*I6;NJF [,5<E1N&0_-K;]6CQ'8<W[2DSW'YSC
M\>0P62EYUUUM+82M:E DE/@FG9MQMIO&F&"V;"MY3+^)"2MPI%]"'$DQ$)*2
M&6PKKNI*4)(W^4#?5EV]>F^&,GP;\3.>7L?68WH0C1>0O4@A(!ZD ;^GK\^L
M/)L-B5&VUL!:>Y)'S>'3P.IBZ.H4G'%8LMW6E*Z!.XWZ[$#?<;'NW^L-O1K"
M?%/#<4RM<4N*,G&CJJ?A%JF E(V2TRD?R0TV /F ]&J)6+O%\U>N1B]R;6/3
MY3)\5VD\TG<OM8MM=V-=A.(0!![&NA'@VC?Q]'3QU"L9G?F+M/E,Q\.SNM8]
MGQ'B"^&G1.13'QZKWRE>]G5ZW<"YDR?SEHF,+QJ"VD.W]4K(JD@5VA5.NMI6
MY=L:V'6AY,1WM;@^6V6>WL4D[4GG91X99R]*'1Q2H5*.3KZEB2ETN46NZA[=
M7J<R]V>9':=2DD]BFV]B2-@>J2 1K"-N2KXLY7*[.)UIY/+L*[V4R.9LN-_+
M6[LE1Q4U&26.-*K# U^E1EM7#<G:AP>8:04*5V]GEI9D)2TA0VZ(/3;T:ER5
MIUM6E5]%%7K.7U"=K,:=D\KEE&W*T_6452GH?8;(AI.Q*64H*S^*D)*QOU!7
M\AUMJY*44YM[,4\:&I=3S?%:ONXK2>#XJI]F[R,F$$^85J[5!0V*0D#T=-]R
M02-:_AY?:X^L5VY9Z$?!E./@1V<*I+^=7#KP+.J42-4X,NGS(<*=!G,.Q)<"
M;'CR8DN-);4Q(C2F)+3K#\=YE:DK0M*DN()21L=8NU8?M0CW(NC&N,KM]/JG
M_ >"+XSG%ZY.*W-+&MB<3(667L*4FST\B:OCBAQ;ENJP.-U1N_+E.I=R759K
M=.=<@XUMRJU"E-26UO!+4!YM2(Q0TMUM<>#E?P$83A=KZN9S235'2XZ;^H]Y
MUM,+FVW0Y<EY3TB91*5)DO**2IY^13X[K[Q*4D%3CJRK<=#OK+AL;."-/(5^
M WA.[?E#>G.J:Z&J;&L&C*L4QN,I*4-;I\5*W;"-P.A*  5$'P]6L5ELJGXB
M7KK9T]YC&%BW+P,OE+-O+3QDXJ*]G&."VX]QK62NUNQ;D6ZIQII$)M2UL[J=
M"42XZBI(1NHG8:M35<=A>G<<FY[-Q4EO.+NNV4-N)\@TBXU.]Z27W@M%'6P4
M+_$*4@E6^I;B9>8YGRBS91.,G';-W(2Z(M2G6[A[&MW9!JT6BQ6Y=6D1K=H<
MF8IF)$>FPF)<A:VT=J5N(3L"=P2-5@XE\,F_J/E'@'Q+O^WJ56Z51;MPO:5=
MI\:Y*<Q2JRZW.C.NKJ,J!'E2V&&ZLZ3)9*75E;3J5'J=2MI*P8N>0VM82 T'
M -]TE02/%/K(!^;P.J[2D[S=W"&[>5W7/A^;2;ZS!6JNX$TZ6;HAQ8,]-9JZ
M(S4&4)K#E';G.MT65YJ665(D2Z8EIQ]HI_,OJ6VE2TI2M6]FG9G=7U?V>!5V
M[=^W[MY%B-V4:324J[J%Y.N>WZ9.I5,J%7@PZC77I$:C09#Z&I54D0VE/RF8
M+"R')+D=A!6L)![4C<ZPMY7,78RG;BY0BJMK%)=+*[^:L9>:A>E23>&U^8SF
MXWV_P^[ZM:YL$= &@+=;[:5%)/M ]0.I]'78==AOU.HC%7JJ+>&#W$J*W4J3
M[^'0]2/3\H]0U4K4+=Q)-\3J2SR:\'>67'JO<Q>(.*QEJRH62.,*_BM(SY;%
M1GQJ$K%D&Y\WKJ%LSKNJ-3=BTV U5H>R@M;H2E1V405 &XQ'[XWQ*?A_22MN
M-S(XZREMK=2M,7*=JR-E-+[70/)J"^[RE'91&X!\= 9$?$7X(*!(Y;X#(!V_
MZ2+<WW]029O<?N: '?B*<$TGL/+? B5]R $_Q)MS=1604I $PE7</0- 4+$Y
MZ<6LMYJMK!&),MV/E"\;CLNZ[UC&P[IHERL4FFVE+I$2I(K$>#+>J$!Z4W7&
MUQG'&2P\M#B.X*3U 6)MT\3OV_LU?6\_Q[.W?N[_ &O5W>G0G=VE\S^B;_F)
M^C0/:5-" T : - &@#0!H"5:0I"DGP4E23OZB"#Z] <O:B0_XKN.+%/,\X]A
MMH0&0*H(#-S/*7NH>R:6J2K<#ZWFDG;;0&N<;)LJHX;M"9.[ERUIK33SRU(6
MMTQ[BJ[ 65(V!!2CH-MP.AWT!W70 >HV]>@&YOB![IK/ Q85(01S]PI[<5D/
MR DVEDH+0$E) 2X!LM1'LIW/HUMY)5OS6'T<MNS9OZBB_@T^LK?#(FNU#C[=
MDAY1*V^1?)"(3WEP+]UR[<K"7"X0DK44-CQ&X\-];.K?M7\E>8HRGM2'#EMA
M?=U(WZ$ D;CL(V)!W ]K?IL=QKBS>$)X>J#F,^4/*'&50C,4:T;C?M//EI3Y
M#[-,HSC]TTPT*_HL4OA*'93-QT8U"H/%7:'9S?3=6MUKBL1EC6E#4_*M8;:B
MS:)=MN7'%]]MRN4>X8(?7%5,H%5@5F,B4A1"XSDBGR)#"'D#Q25=P\-M:<E1
MFX]IGVW?, /:I.Z=]E I4-ST"DE(*21UV/74$%-^4W'*0L+]H$@A*BD=H))4
M0DA*1TW)Z;D#TZ U5.1+$571:HO.TS=)!(ME%R495Q$).RO]R>^"I>R?'\UT
M].@&\>:C*W>7'PRY:)TF$W&RMR5:,1MAY3%4DR.+&0U1Z=*6VDIBH4B.Y(3W
M[=RF"!N=M ;C\)UZ,_\ #MXI*BO!]MK&IB*6!U\^%<==BR4$@!.[<AI23TZD
M;Z <,6X4JV[21MN5 ^&W4[C8G8#U;[GIH"=)) )&Q(WV\=OHT!'0!H T! ]1
MTZ=?H/\ P: \XG%J(B1G3@3/\L*<A\O?B\H2L$*3'$RX*\E]+>Z4EM,A3040
M-]COUU)0MJ?7\1Z. -QT\04G[Q_R:,SM[P#2$J4L) 4LA2SMU44]$[^O;4%A
MKPI,&FU*;5V6Y'OE5>CHEO*?D24]K0*&DM17'3'C-I2=O82"=]SOJ^O%"G0C
M+<;+J@Q)5 G;8[;*!/R@'?;0'GG^(8A8Y+\ZRVLI6OX2UO+2$[;CRN0MP]Q!
M(6.H&Q&VRO3H!^ZPT!-CV>@>";5MU V&W04:$!T]&@-LT!H63^S]P;H\SN[/
MLQ7=VJ[%;><ST"B#L3Z/7H#&S7T,WOC]D.]S3UNW>@I[5E;[@3:OEK60D);*
M4J4#W>O0"<_B'XVJV<^$/)["%NR:; N7+F*;JQI;SE9K-(HD1=7NZ"*5$ J%
M7EQ("'>R0M;:'%I+A;*0"=MP%!8/QO1L.8AQ5B6VV8T:@XSQW:%A4IF(E+<8
M0K3H,&BH#3;82A 28>Z0-T]JCMH#K.@+&;)5&9><2T75-LN.(0%=A<6A"E(:
M"B"$J=4 D=/$ZKMI9O,/)5<,$^);DW2O9M9$G.,>**30DR^;3_CK;V'LL4V/
M)M>LX]NI.0Z:BHTM52K,=N+%EP*O0H<9KW=R2:Y'':%=P0HI;6!ND#7==#U+
M3^2)9[3=3B\U:S.6G9]5U:<UZLZT=''#=7:<#F+-_-WX74DE&2?<Q6<&0F5'
MBR A]'GQ670)2/)DH\UM#OE2&@=D2$!6RT_BJ!UTY;,3GR^T : TV\K9J=R4
M^+%H]S5&U)D:N4.KJJ5,;8<>E1J14F9LFC24/I4A<"KQD*CO_C>6OIUU=8N6
M[+;E%---=^\E&V+(0G=1"0%).Y.WXPZ=#N21X#TZI=&Z[PW4\>N.['X1Y<NB
MS[;M:Q,89X^(Q;_++GE3K9PD_,IL>U_=+DS=<TV;E+EO38<1%1N7&N)Z'2X=
M0AP)BW%5"4IF,PRXM?<T('"^(7P;\Z\/,2IQ5C+F+BAVCRKNN:^)SUQ<(L47
M7-9K5V2V9=8I].JM4N5F>FAMN1T)8962II"=@= *8D<$^9#R.UKFKA2(OO"O
M-C_#[P=W; 'V>V3<4E/4^GQVT!5C<%N7+;JGJMS;Q88K;20&:7\/_C^RZ^[W
M>TZ^Y,J$K8A/@$ ;'KH"KQ@X293QES&NGD#F3*%.RS4:5@6!B?'-Q4#">+\.
MT.+3J[>4JYKSB2J+9,QZHBMM5"FP>Q\H#$F"4I*RM)0D!UKL/F=N_M>1]?;K
MW;[=_P ^^A.[M*K/Z)O^8GZ- ]I4T(#0!H T : - &@#0'&9$J$UFYJ$9,F/
M4I.,4OI<+;9C?9[=W.!U@$MGR92GE[]ZE%/:-@G?0%MQU@.TS$-IPG6'XQ0W
M5'DLS$-MS4-RJW4I+0DMM)2A*NQWH?QAUZ;Z [?H T>" V3\2FXZ+:3/!FXK
MBN"EVM1*=S[P<NI5ZMSHU,I$".[;61V%*J%1F/QH<",[YG877G$-H[MU* UN
M:<T[DKCVNW+X45W(J4:O:F1^%W7:9(XO7/78E4ITJD/\A.3%59J[$Z'*I3E.
M&6[IDN2F:A$6N&[ ;;W5YR5*2IL=X*DG?5^H^O?4GMX4:UGU6^'>=[M[,&>L
MDTV9>^-\96/#Q])83,L(7Y=U1I]VY(IZ7UMJK*85)I<NGV)2Z@RT7('OBYK\
MAI:%N-L;E(T.!=9L<<NH1=E#%]P53//%SD?R6M^EO3KMO*X,,5+%CLF)<%GX
MVH%W4YZX,?4UQ]#;E-J5=IU?H;\FKUL*"7WBRPPEM@#?=M4=MPCMI7K972LN
M)[1?EU<:,538;\^T:(WBN\(["_L>^,;=MHUJDRC[2''DTOW>GU>GK?"528<M
MIZ/*"=EI) (TO:FN+>6<;.)8WY&9AO*I5?#- LNW:WF?%4Y-"S=>=PU"30<>
MV\74*D6_<=/I5-BRZW7YU^4L)J$>E1U1DQ([@6Y(1W(;58[=M/&M&%.74;U7
M;>SCEFY8EFY(8@V!B:B4A<^ZJACF[YHJ&7:X],$>!;;$KW.%<5EV2Q3T+?JC
M:7?>Y2G4,"06DNE5,U%/U=AG%U53I"N,/'611D4=6%<;>X%I"4ENU:4B<A(3
MLDMU=J.BKI4GT*#X5OUWWUB9#7G(JV[FQ)RYX&V_<=XLSL(6MDS-EX6C>>0;
MPBM5VT52^/5]V3*QI7*W6ZBU*NJ,F=<T252Y\EPS(T,NL.N.>3YF@%$?!VJ$
M&=\.3C,FG2*5,BP;7N&FB;1)K51IDQVG7W=,*1+C3F'GV)2'Y#"CWM+6VKZP
M5UV '0_B=5[.%L< ^6]Q<;:U/M[.=!PE=E7QG6Z5,IL"ITJY8#+<IB?#F54I
M@1W(T9EU04Z>SH1X[: ;FPAS=^*%76L2,7I3OA'&V*NBPHMU52)S;OF=D4TJ
MH1Z<BMRVK?7CMBF2+V4TZ5)@^\AE4Q79YFW70'H(02H;[I())24G<%/XIW]>
MV@)] 2DD'4I&$I-.A+W;?3X$GQW.VC5$8J;J>9WA/DFR[@Y+\8L91,@67+R'
M8?,'XK%4N*PX%;@3+KI5#J==JC=+DU6CM/JFTWWQV2IU!<0 4#8;]=H,5N6^
MIZ8@=OND#Z=2S.WO*#2RN2^#X-]J4[>H[[[^.H+"Y[0"3UZG?4UPH34FU! =
M=_D]/^+0'FQ^)KDBQ;%Y8<KZ5>=V6]:U0O[X5](MBQH=<J\.G2KPKZL_UQ]=
M%MZ+)4EZJUA#;B2F.WNI25;]-M"N4FGA0]#]@O(>L:RWFEI<:>M.W'6W$?56
MA=&A*2M.Q^JH'<:FB'&S;]06&DY%_P#4NOJ\MIX(AI6IIY7:TI"),=2^X^@I
M0"1\N@+"7':>O.T*FTB2A0HUU)2-_P#5"TZFWU)6X0I20I26D]I ]KTZ \G/
M_:G+5SOE*;Q"Q?@VCY*NN<B'ES(ES6U8BZZFGL4RUV;=/[X59-#*4QG* GO2
M),G\VTVZ>TA770'I&^'U<%<NW@[Q"N>YZC4JM<=:XYXBG5JJ5M3BJS/J;UD4
ME4V14B[NXJ8\^2IQ2CW%6^YWT L70%!QM*E;J)\!T'K!W!Z@C<;=-:UV[:LR
M<\5=:IAT&:;<.$M?(;:1V,I\E"=@@((;#82%)0EL !*0 K;8;:RRK=QRN/BD
MWOFZ]QK.X[,J04>XL_M.,U48L%YU"9DE+GNZ0%$+2A/>^R%#=/G([.\@['8?
M<UM*S=4>.7LD6[DI.C,[K O#0$-M_7JN5M2VM]Y-2FX/9VV"AW(W[MM@.X>T
M 0=RGQ'IU,8*.QL@\PG"S$F)+;Y@\2,M6[C6R[:R?DW-OQA:7D2^J)0H4"\,
M@1;2S!3C;T*ZZV@(J%:11PLAA+BE)0@>RD)4KNS!Z>V1L@ #;;T#P!V&^PV'
M;U]'KT!5T!*M"7$E*AND[;C<CP.X\-O2- 2(:2A2E J4I0 [E'<[#T;[#IOZ
M^N@#]?\ U7]/0G=VD6?T3?\ ,3]&@>TJ:$!H T : - &@#0 ? Z X(9$5WD(
MNGRG7G2YA1I]<%V*TJ(IHY!>:$E;Y/F>\=W0M[=H2"?$: .,LZ)4,,6F_#\T
MH0Y7XCY>=D/.F;!N6KPYP4N3NYV"0R>ST=NVW30&A\S^:W'_ ($X<F9ZY*W=
M*LW'$.L4NW$3*=2:C<%8JEP5CWER!1J+0:3'D5"HSE0X<B4YVC9N+$=6?JD:
M 0UA'XYW"/DO^\DCCS#Y.9NI%J.P456NXPXQ9;NNFL(JK<E5.<D"!0')\5$Q
M<*0ELOLL$F.K;42]E^0#4GQH/B6\)>4V'*OP:KV#>3]\YJCU6WLSTO$UW8<N
MO&,,4_'H57)DN_)=R5:TJY1K'JE!E/T^7-AK]YB^^AY"5%':;M*G))2QV&%Q
MK@=#J5@XKO3X=W&#%-8R?B[/]W\1;\8MAVA<?L59DA8^NKBSDG-5Q0*''Q+<
M<RFW_;ZLPXVK=4N9N-%JU0KLR1'=[42&0VX"C:OW/%G1>UWFK;33?%L'-<+?
M$6M(87L?(]=XLYLP#QI$2CVK;&3[GJ>)JU;M(4;B@V-1J1(H-HY KUXQ(Z9[
MI0[)73U,QVX[RW%I0@JUKN#K3[XLJJ5W&:N'D9@CG+9=P8QLZ;>=O"':M,Y#
MV#DBMVG*8L^MT_$]\PGG[FMIZ/,<J%<@6]=M$5!J$8-L+>'<A'>E:B=JU&5M
M\;3I@M^\)IX51JU=^*G3V<-71G>Q>,N>,L8)LB.B%=&7*!5\.6ZF-7(4Z%1Z
MU3G+-NZ_J7=C<VFUB8VS([8*FD*6=O922-._%V[E$B=N)1Q/SY@W):5X9XL3
MX>'+EJ!=52N:HWU=M'I^ W&ZU4L;KGVA6')$YW-S$F>U2A:BHH6AI*%I8!;[
MB1WUU9-'MHRK@7XH=W<FZ3<->PQP)Y)77"M290*;6W)5Z<=K?7"D799]$ONB
MH2U6,L0GGTS;3N.%()2@AM3WEJV6E0!NI9#8*%3RNY-@)!^'!R*2-@#VY4XK
MJV&WH_YZDD[#YM09C97Q$,_5?+:,,X9ROP8S)8EXU>ZUWQ9U4O&]<#U&B3;5
MH=6M^WLB6Y4IUH90J]4I+%SL7;3:9Y\1*IK'OGO#>Z8[H4!PC#'/.UOACURT
M>&./\<9"R7B&IR:1:6'L4/UZUX-]\?\ .M299N>^>-56ORO2:;1LC6E28U5%
M1IU88?DOQT..1WUNCRU) 5Y4/B6U;ECP1R+GFU.$MS73Q^NS&N2XU9K>9;YQ
M12<9R:5:\BNVW>#=\TJ/=R[L7:\&HTB2U*3'B*>D1D]S22#H*H\R5+X:7+B_
M-=3Y-9IX(\,[LM'#MZX0*<=6!G2D8NM#%3&7;EH,S#DZY+)LFDOU:\;IO]=6
MANTH5&>M#:T,I<"&UN#0TYW9J3I6B9[,\;<P.1^2;3MB\[.X*7M(M>Y65/PI
M;F=<.M>ZAB9+@RQ+8$Y:NV'*BK0L-%14H=-]#*U.<IT=:'$\U?%"RYA'+]D8
M7N#@Y>U1N>]EV)'A*IN<L;)2S,R=>4^Q+)BI7,BM0I+U5N*GN(652&T1T[%1
MZ[:&T8?DI\4S.?%>W:/<.4?A_P"0J-"K7V[[A]I\@<*)?F_NO0W;FK[4%-#D
MU]<NH0:&RX\VP4->>EI7:H;'4IE,_:.\T?EGSEKE$IE;B?#2K[,6K4V'58HD
M<J\+I=3%G16YD?SD"$.USR74]R=]P=QOOH11]&!Y]OA_XEJ/+CEES,SG@'CG
M3N)67J%=G\?<3\E'[TH5ZW=:F3<D-SX]?P;E*W*1"IT"_<*Y713JA*6VRPF7
M24%P>>71'.HWF.#V,=(PO\6SE#E7--X<:XWP\Z[4,Q8T8N>GWC(I'(2Q:?9E
M4K6.ZA;M"OF?:D^OT&,?L!5:K[1@KDN>>ME801YB5#4EEMIMT%DGD[SX;?V:
M^&=4W6WTJ4Y(_O;X;:+90GN0 TJA+6?,4HCU@#U:@M-2O#G9R8P];\_)7(7@
MI7<288MJG2*G?]_Q.1N+KZJ=NA11'IL6CV31Z<Q4[FF5&HN,Q6T,OQP"Z5G?
M;;0&Y89^([CG.]X8^H-@V/?R[.R36\H6C1\JU:5:<6V8-VXLHL6Y:Q2I]-9K
MLBMML5.W:A'F0I7N_D.QWT*Z$J2DC"XVHU1I-O\ Q ,UY<N[*%L\8>(LC,\?
M#UX3K(OJI71GZQL5NPZHEV0:')I]-E42ZW9D&NPX;[R2XJ.\TTEM2T?G4G4F
MLKEQXJK&3>?=SY Y#\^N*E*S=\.:RH>4L>5>P[$F42YN1MNWK0KXM'/55NI-
MOT"!5:';5 7;-QT"IV?.JL&<A8\AYCRW?,0^E*1E%S?M)U%C\BOB+Y>^#U7[
M5XXY"QM6^6./[CH]4N[ M_G(M"L[(EKXUI]5A4>3CS*"*S1I3%R5*R*C468U
M-K+&RYM.4@24AYHK<@SQP%CPOB2YSF<<+=Y+3N!F2+?Q[<UE6C>L*J5#-F'#
M'3 O=VEQK>;>0U57:Y',Z57(R5%<!LLA7M!/B!>96/S0Y57AA1>2$<%KHA4"
MKT^0\N4O.^*'$Q6$U0TGS8S#R!+E,N26QMWHW[23\P'):K\3G+=O<HZ)Q_N3
MA-D5^\;>@S&*O0+,R7CN[KOEBK6!-R%$:M2E>\4&A5F<NUK8DRO=UU1@J2CR
MT!4@M-.@-O\ Q!L[WGSNR91:YQ!S/-P!0<98[N[%N2KUO:[<78:O^=(R-!CR
M;PQHBTLSU^A2Q0J2U'1!KLAN*Y(I]7B+8*A[!(#ZGPP<N.Y:XC8]3)H#U$J&
M*9%6P557VJG3ZU0;DJ&)4P;9>O2T:W2T-T^MVE=R6DS8,MCO9>0Z2AQ:.Q:@
M'#M 2G;_  !.J;D[,7\XL?(WZ"54Y)D&TKLNV?&ID&Z9%%LRHV]<5&N6#3FS
M$KKLZH(ABBU:BUIM29-.?IQ0\E7803YB2/#7-:9GLC9M.<K?%?33BW5)=*:W
MX&I>KQ4W&]T"AL4:!3X0<>EN0($*GIES'%R)3R(,=,=+S[[NZW9#R4]SBR=U
M*.YUIWLT[V"PC5NGE)LIIU9L6M>F-39#0!H"WD]P944J*5#8IZA()!&R5J(/
M:A1Z$CJ!H#SG\!\//XMYY5:L2LI6_?U,OJ-FVI6MC"P[<R!%M[#%5-<34+KK
MEQK;AVMBZDUF_5S6D>>U1D5&HOQEER2Z4]^@/1C'+I:W? 2X5+)"5=R=NXA.
MQV2!ND#<;>/W] 5] &@#0%+]?_5?T]"=W:19_1-_S$_1H'M*FA : - &@#0!
MH T!!6W:=_#8[^(Z;?)UT!Q;RZ6<^]Z6$BN)PXA)E%:MU4C]^%*]U*/J!(F)
M*BKZQ\#H##\7F6HV&+:8;1(04S[L6Y[S(1)><=<NZMK6^7$$A*7U**@@^TT#
MVJ ((T!J',GA9Q[YZX<G8#Y.6(C(&,YM:H]SM4U%5J%#J-*N6WU2#2*Y2*M2
MWX\V#48R)CS86E12IEU:5)(5H!#^%O@:\)^-,"M4WCO6>4&"J7<;L!^XJ=BC
ME'EJRX57<IB9(@N5*/2*[&;EB$9CJD=^^WF*Z==M )JR1\$;BUDWES5+A.3>
M5]&R7)X[5&!6<IU7,E2R+<MSVW=]:DV76: ]6<HP;Q0(8M^/Y/EL-1U,J6E8
M)Z;[5JYX<*OI**>85[>_PL7\FV)!QQD'G)S3NFU*94[5K=.I4VZ\2-P8U8L2
MM4BX+(G*C,XE09 MFJT*,\AM:BA]:-UC54;SM3<UM9BX.>!EK6^%K;%,QW2,
M*WIR5Y)9-P/1HM1AQ<-714L6Q+4>:JHJB9#=5J-MXVH=T5.&E5;E++*IH0I3
M@W![1JSZXU+B27$]],3'ZO*E#I:?AM<>(]M-6O3#DBWX#%MRK18FT#(-3I-6
MA6Q+O:B7Y(HT"H0VVI$*(JM4!G8-J':PIQL]P6HF]ZC=:QH\%T[EAO*XY2DF
M^EC=5<XG65(XR<Q;11FOD7AS$&$ZWF!>1\(V=5<6U2'=$:TU2<GT^X'KJN+&
M-;NB/4+_ $EBJ*;]Y2F.F8E/:&P4JU;MZ=W&6PW(-)*&\1;\&C/E]<V>*%)X
MS\>.0&0*I3JK-N?)O,'-%S6W%IM3X_T;,-<KU:A<;./C==LRCQKQO2NB3)=G
MW5+AR*;!;=??C(4MUAENDS'@<'?"H7QMIU?HV$N;/+2QZ3<\VB3*W#\[!E?,
MYRU[3HMBVZIR77,.S925TVU;<A10I!07$LA3@4X5*4 GKFME.P>"#%GT[D=\
M2[GLS-R=&NB7;].QSCS$=X7!2:#9D1BH7A?54C6/Q^F3J5:5IPY"%2Y+@"$=
MX[>Y0Z <"XE,<3_B:9.<8C\KOB+71DK 5CTF\*!2<]4:Q\72[BP[F"JTV52<
M@VRW Q7%=K]G7A5["BJB2TOM2V'(>X "U;@,MYQMWA97.:_(6A9>YQ\YL53>
M..=8=!QW6+,X]WWGZ55,O4FC&S+DO"I7U:&-ZA2';RJL6/"C>ZI:"I.[:P"X
M=M#"8[ECO@!AJW/A.7]<6%^8/Q(<E8'D8>S+/IF,;<HE.QY7KQBS:O7VKFI%
M.P+>&+H-UM56JU<2@W%E*;<E+5YJ"&W$[MI51;CS^6SERR<YWTUAFZ^1/Q"Z
M"]E6]N/]&OVULNT?C=B6LWH<.7/;"L6*=BW51K8NNJ-6HJE1FXS\%M3Z$Q]B
M5+4 9(J>P;BOP37<. L?U=7+OF[0')K5P/+HMLYJIM+HM/4FZ:VQY-+IJK*4
M8<5Q*"5 J.Z]SXZ;R:#+7Q:Z3@SA[RGXY4[-G*'F0:==*K4O=_*<ZX:IE2[;
M7HV(ZM5+LD46VJ-0+8IZWZQ6:ZN,F Z^L1J4ZIV2Z%[!.H('3[.X>+^+7B_'
MG)?E1D'+=L8FNNCQ;LXL85QK?,2W'['Q=<UL+HT.Z\J7"BCSY-Y99R+;,M3U
M16DLQJ8U+,9M"E!:]31LEBU8_P .MN)%8B1.:G/:/&B1F8D6,SGNG-M1XT=E
M+#$=H?N.2AMIE 2GJ=@/'449%*G(<7?!JP+A@57^&6<N9=FO5]$9-?F6WR+J
ME EUK[.>F2:<U5'J-0X2IS<&149!C%WO5'#RP.BNDU,?J[*M%^#SAVW[NK5_
MVWR!YDVA>U;:K42HW9;V?'(UQU9FXY$";<,BIUERV7ILB;7)U+BK?>6I;Q$=
M [M@$@66K? VWO-V<^&HQ*;73G><'Q$&F&'T2FWF>3<E$U2WF' MMR2BUT.>
M2@(V2D$)Z>&Y.H+R_@_"]Q=+D409)S]S'SE;U'KM.N!RP\Q<AZ_=N/ZY-I$E
M$RE)N.V! @1ZM$A3&D.I;4L>V@'KH#M,#@;Q:I-K.V32\0TVG6PJ'<,-%*AU
MRX8\6.S==G4W'M?3#+-70]$74;/H\:(MULH= ;"DJ2O=6BVF,_9.2/?"\X[1
M7'D8_N;D5@Z#*>3+J=/PCR*RAC^)<,]#+4=BHW(F!7Y#U7G0HK(884XHAIO<
M)ZK43-"E=9RBJ_!9XJW!D"+DNYLA<O;KNR*BD$U:Y.5>4JE,?>MLU-=M/+J"
MZHBK1Y-N/5B2N"MF0@,E]S8#O5O&PNA[(@#XLWPX^"N .*]\<HLC'E?>U?QG
M3:%9EID\ALM7]6(D_*-Z4&TX)CTJX*G<$^K0:?7I[$]5/BEDS"QY8*.\$#(V
M3X=V.(GQ!>*U@8UH66,[,<!N-K*<06\B['ZGC?D-R+RU8R:?.JES90B/L.S<
M?XKQY,J##=O6R0Z[,=:;?F*[([#9 6+G'X>&-<68$O>70N2/,ZTZ%;U(:7 H
M]-Y(W@Q:\ R*K!CJ":)&;CL+$^;++SB5*W7*<4X5;DG0&H77\-^EV?FJB9#X
M^Y^S%3^4D6V:OD2RK[SO>LS+U+K]RV@Q!M)%N7S#K4;[159U5M2M2:)*<BN"
M9 A3E.15=P[5@=CQ%<?#/.]6OBY>1N!<&8EY4VO/I5G\@;"S/2[#FUJBW"U%
M$V+/MFX;H98BWGCJ[X;)G4>KQ$A-0C[*D(0^AQ"0-N^%'$IE/XM52FT5:';?
MIG)#E/ MA49YB1346NQG6^D6RFD/QD(BKH;5 ]W1!,<",(H0&0&NP !S'0!H
M T : - &@#0%-U)6@I'0JV&_JZCKXCP^3KH!C/@5R$S[0LN4K#62+J:R%@?*
M=\<F+9P!?EPU>\+NS17KQPED2YV\IP\D5:YJLXW:UO6XAI,2@,L":W*@M(4G
MW97YH /ELI2E'LDG<]=R5=0 GZQ]I7U?$DG?0%70!H T!2_7_P!5_3T)W=I%
MG]$W_,3]&@>TJ:$!H T : - &@#0!H#@;R((Y'NI2AY%15@]I!D%X*CIAKR$
M[L@1MDJ\[WHE17W =O3IXZ LN+:FEXCIRF5/K:%S7^A)?4'!NB^;@0LQ'?>)
M*WJ>XM)4PI2D*+9&Z$'< !1.@(*^J?1T/4]0.GJT#V"9,J0JI9=^V;G"A4R;
M5:=0*/5;&RE @H=EU+^'4^3]L1+AI5/;[W)TRT[BC)E/,- R'8,AXH"BVE!N
M@U1QZ37K@=]MVXJ-=-+A5RWZG J]'J<9$RFU*FRVIL.=$<W['V'F24%._0C?
MN2H%*@"#K&<7':9VZ59GNOR?>_X=5EN!14K;N"CL"3ZST._J.XUDG&2;6--O
M89Q4I;MG6,X\RFY..9?/*ALLI70^0'!3)V14I2PEEF/>N.;-KEJ5ME;Z %U&
M=7+=EPUCZRXS,+<;A1ULP\*_D)7X.DK<EATIX? :DG=A?IP^JUMKL-*^$10Z
M=246C(I5.CT^--^'/\/M]]%.;BP:?*GNVA>[LF<Y$BPV$S*C*';YLQ:BXX$A
M)'3?6KZE*U+DY/</C]^_3;KMX;ZCU=M50FD^&M,>@\S/QZFN&%M9 P#?G(KE
MCR&X\Y0NG&V7\"8[L3CQ8="OBZ\T65D]VE1K\M):;GIDBWZ0BHN(BQ_/DRX
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MS%-^4K^(-T.N*"4=%I4EO;8[;$ZU2X]$&^VWRJV\=_I^4: FT : - 4OU_\
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M0&@#0&",IW[9]U[U]BF%*">Y79ON2.GAOMH#.Z - &@(*WV.V^^QVV&YWV]
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M.(NNE2#L5@!0*)*3N.GW1K":;6&VJ\Y*IOV"QJ1BVPK+OFZ<FTJWZ72;NO\
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MEJW4E3MP3*<B#1VFV8+[CD>$AI+;!\O8 #UF( "?3UZG?;<GU[#H-] 3: -
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M (B]+MZ9K,(V,CDM(E))TR\[.;C/UU5MY5M1D]F-=M6*(S@ZX,?)+[)1O?\
MB<]#]9 R+;I4IP'QV'7KKE]2PT^XI8?-Y/\ 7(Z9[MJ?VB7_ /$ZKA_^OOBT
M^7OFQ>,^=JG#>3'FM8]J;;<E7<\REEM]EPN+9V4%=J"K?8;D=->@923=B<?O
M5?GZ#\^812OIK&MB'I-$N5V9(Y6\/'78E/,%_$7(ARGRPZ7)3*10\*[1TM**
M4E55]Y6M2P/S*(B4G]*=[S9.5<?D*9^*'\0YQSN2F7B7AI):4LGL4PW;N2&"
ML;[ #S$$=.FX/JT!N?P_)T*2>:+4>5'><1SUY .*0R\VXKRUP[&"72E"E'RE
MG<)5X$CIH!PS?;QT : - 4_,3_AM_ET!#SD'< C<>/4=/GZZ CYS>^Q6D'U$
MC?;U[;Z E2^TL[)<2H@['M4D['Y=CN- 55$ ;D[#<>)V'B/3L= ><[BS3'*1
MR(P9$>*.]WXHWQ7*DA*5A7YFJVQ=]0;/@.@3)VU%4#T7H\/N]/FZ:)I[ !=;
M!4"X@% !6"M.Z KP*AO[(/HWU(*/OD4*0@R&$K<4I+:2\T%.*0DJ6E">_=:D
M)&Y W(].@*RG6T]O<XA/>=D=RTCO/CLG<^T=O5H"3]?O_P#(_P!/0G=VE!"H
MZVVTN=AZ)0"2/K%0;"=^G4K.P'KT#VE1;$9"5+4TG9(W.R2H_< ZG0@E\N+T
MV:!W*>H;41[1 !)VV'4Z C[JPKJ&6_5[25)/0D>'30"<[+@49S*N1I9A,SJL
MQ?RHBY+K2?>Z-%<LJU)<9F.IU3RQ"DK2IP]A;!4Z>G0Z 4JH!0(4.X'Q!VZ]
M=_3TT!*A"$;]J C?QV &_P![0$5)"NBNJ?Y/KT!2\EH#V64[@=.B?1X?C: 2
M5D*QH]1Y8X1N:H.(GTR9B#-MH3*#)0%P7BFL8ZK[$QQE06EQ:.U3?R: U[AC
MBQ>)V>35H/KI4QB3RLR?>----@N0F8=)R%2+0O.%27&Y$J8^]*H[5:$9QU2]
MG2UW)"4=J4@+2;AQVP &6T]H"4]@VZ#PZ#8#0%UL -@.@'0>CYM )YS9?DRU
MH%M6U9-*IM?RIDFL_NSCR!4D._9,&9'B/SZQ>EQ^[.-RS:MGTQLRI/E]JWE%
MF.@AR0C0&MT3B3BN3VU/+-$@9\O20^Q-K%UY:IT"ZV$5)+24.HM6V*HS-MZS
M*&P5J,:% 9;#/12UNN[N* 4LS3XT6*U'9AQHS+#*(K#$=M#34:(RTEJ/'CMM
M%*&D,,H2A(2  E(]&@&/LHV13+7YA\HJJQ_K2;SI6#ZLY$D]SZHLN#:MPTYW
M=]Q94&Y+;7U4]!OKZ=Y*3_W96GN^M3KT>W:W>D\0YIM?^(9AK8[K,:M5/2V4
M+A,H4XE6S:&]VUHW[%I4G?;8CIUUZ;?C\X_T,#KV6M\,:K88E,>FI)2FF0T#
MM ;6F,SVMC<^RE 9[@>O4[G6K1;S9+]GW=#:4L1FF4A9)2TA+:23MNLI"4C<
MZG876_9.=9"::FW#@EDL-.(7R1PNU)#J5+2IC]Z62E) 6WNE#BD^O6AJC<=,
MS+6WP+GXC-K*_M-O])'\9#_%Y8\L:_Z#-MF_[+M6]+6G!KWVW[MH5*N&AR$Q
M^Y$</4NJQYD-Q<<*)2KRPH [ Z^+5L/=Q.=A4>+B/,B,&4:-&1B:\+!J5\V%
M:KDEQR-CJM6Q6H%.N2T[8BEI+=.L.5$JD6;$BI4$097F--(2R4I0,7[2%9>[
M1$(6CRFO]85YCA [?-6KM2'.T'8=_3P].I2Q*\UC;IN&A./5,HU8C9]8J<*'
M4F4<JN0D-;$EE;B?=Q?$\J8+;JR &T/GIL!KK-W]JG\IGS/K'[[S7Z>?G%,1
MX%,@LM1Z=3XL-EEOL;$9A$=+;21[+00V5'9(]1U;/Z!]GG*X^R7,9Q">QQ+7
M:MM2E-K#CB5%P> V"O3OZ>FM(5,LXEIU)\X!WN4!NZGTK&_:5(4%$;[ZF7T/
M:7Y7Z67R3E4"D)A\L>/EQ^\)73)MK99L^-;ICLJALUIV/1+D-XMR'4&2S4H\
M&D*@A"3LMM\D^&N0TNE4=HY&:6K/RCEJ1ND _P"'77.'N9 MH5X@]/ET!C6D
M-BIS!V[GW2+OOUZ NC;KH"ZD!("?YPZ?Z0Z=>FKK5<?(49QMY9UV<4?QD-MY
M48']ZJZWB6U 8?L5'D*"PI9^W+B'O':%=O0)*>OHUYYJ:7VO#HH_,?9?(KXO
M<WIT6W5:WGNSYJQ@7BB%!20TE&R#L>T$'<;=BR5%20L>H?/J$Z.IBK<;%_C7
MLLU+]U;>+ZGS0Z,ETE0#OV33^_M5U4"Y[NIQ162=R3OK9K.ZJII+8<I+5+ZC
MX5OC<-OM.E?)L,S!B4ZF-^1 IT*$TKVRB-'99;[P=DA3+*6VUJ*?QCUU1/*5
M3DV:=Z6?O)RV+'R]>-3F6>/+?Q\"IIL!%_8G3]57U59%MU*D_7_&!VUQ^NXY
M.?Z/*?KD=S]VJ_VAKN^R=5_^/OC@_("VE7/@W+%!B.L0Y%0LFN-,27F5OM1R
MW&5)]IEIQMQ:%EGM(21X^K7HF4PLRBO95Z?H/SZA3Q8TW6(=V)SJOX_9J.:^
M)V0&U0FDVC9F5[?7!7'<4Y)1?MI6,^MUEX+(0J,]:2 >\G=+OCTUL&P<-PK'
MC_\ 6=\Z?.892!@?AEL5-)ZK*LQMI2#XJ]H!(]1.@-LX ]KO]\=PL1D+B\Z\
M_P!.:<8C1XRDQ&&++<:9<+*$J?*5O*V*M^FV@'!R ?'0  !X: CH"4CI[(2#
M\H^_H" 0@=>Q )\2$@;_ '=MSH +:.[N[$=QV!.PWV_X- 4$KBMO>2D-(?4E
M3H; 0'5H2H)4X$CVU#N/CH"Y5MMU\-TC[Y 'K].H;X55[ >>K!DE,'DWQO:>
M8<:-1^)9\4)EA3B@M2B+ NQ]*DJ'U&E(860#_)U'#&='0'H3;(4"1X;D#YAJ
M5;\-<*!*6D$J5VIW7MW'M3NL#J LD'N"?1ZM2"F8K"NU2X[*U()4C=ML]BE;
MA2FU%(4A2TGVCZ1H"=325=FZ&SY9*D#L2>T[=.TG;M/S;: E[1YO9M[/E;>/
M^?OO\^^A.[M$]T*NY=D<B[\MRJTIEG"4#&V/ZC9-7^QA%?FY G5:Y47C#-?$
M]9J34.E1(2TQ?=D>2M7<7%!8[0>T4-()#*R"H'V=BGZP)6D @#QV/X-"#S5_
M&8K>9XN6K8:QZSR&M.PVL9QZI?&5<,Y7Y9V2(,2GU:H./0*;&Q'CJ[L142IM
MM(4)=5J;CU3;9<24,A+:>X!ZC@G=5(OCA_QZNZ@U*X:Q2+@QI0:A!JEV7M<N
M2+FGM.-+0J37+[O"CV]<UTU);C:O-ES(,1YQ7BT@ #0&S6K(ES,IWTDJ\YB!
MD!<=87(4T([#%AVN^T4[#\^2]5-@P3V[J#@]H: 49H T : - < O5E;N=\&*
M2$A3=HYJ*'2"7&W5Q\>I0XV-^PG?Q"@= 4L(R$/W=R,2@-J#.:6VE26U;F4Z
M,68T#CCJ>Q(0X@I[=@2.F@%": QM1JM/I469-J4V)3H$"+(G3Y\Z6Q#B08,1
MLNRYLR3)<:8BQ(K([ENK4E"0.I&@&_\ &_('$6=N;8H]A7!&N=G'_&^H5>WK
MACT^8BWJV[<F1HM(N6=C^X9D>/ O&E0FJ/$CSI=-+\9EU3:"X>X @.(@;>KK
MU.PVW/K^?0$COU#_ (>@Z 9:SN3_ 'ML[-D[C]T\,J1_FE=*N)!^?Z^OI_D6
M7'[L(+HSLU_]5IGC/-DU9U&Y!JO%<KY#17VAYZU=O<E1!2/Y"0G90_TCUUZ1
MF9TS'A]-F'G9P5R"L15O:Y+;T%HM*5;]K>W;Z^N^_35."*P["E(Z>/JT,XSH
MJ&EW2T/WDPR5I)*.0&&7$!(WV4N]Z>R%N'\1("NA].N/U7#2\R]W@7/Q6;.5
MN?TJUA^4C^,CT-N$EI8"0HE13LHD#JO8DE()&P.^OBX][&^^0F38/%K*<ODQ
MF FI8<58,#&-&ET6:X+CLBN3JS+K4IIVR7UER]W;\J:(T9J33 9=-;CA+["X
MWFR61%,:B1;!J7-[G]F:K.Y6M^ZN'_""P+B4Q LJAU9V#EGE3.IDR-4Z-,G7
M?%BP;ALK%K<-QE<UNG.1W*F4^[H=+2G>Z44YAIQX=V!OO&IHHB9Z9;'8AKE?
MR$;0@)0E"$MWF\VVTGL&^P0!MU/0:ZM>N4S=S#[]^<^:=:7#KF;7^L3\XI4L
M/H4 1T]!])'7T:MG-2LM%,?9*R8RD *Z!/CM\OI_ -:W6.HOW&UJ *#T24K/
MW-^GW=]9*+G;H79>25UK^*<DJ=0$/DMP]II*S)J-P9E=[$()08<+'4CSG'5C
MH@"1)92 ?$ZW,D_!FH[:L[-R)<3UAK^-Z1S@#8;:YX]W(Z Q;?\ QK,_\SC?
M^$[H"N\>_P!G;;VU)'R[;'<?/J^"HJ]1K79.]E[D:4X9Q7EI)8C<.3FC_>VN
MYU22I/\ !:Q4!7=LD*%R7+NGM.^YV'CKSK4W%ZQ'B=%1X]C/L7DFY%^Y;3U%
MT?VYG=U?R5CH,DKMW4-@-QZP?7K->!OG\#+5>A3UN)OY+^(H%M._XO7YO\NK
M81MN/JW4EY&2KR3K!R2^2R0,-J/XO0_YOHUGPQ:HKRKY'\99+-2X&DY-M?@M
M'(<Y[*QXI+2>Y9OS%#G;OML&\D6X2-]O$@:XC7;=U1N9:<:/@RF/_P!Y'=/=
MG]8_M"O$M\+6DZKA5/\ \OO] YEDI/=C7(H]K_U.N0;-D)7_ ,4R5 I4H@#P
MUZ)EX\,)K_/3]!^?MNCN1=<? AZ36T+:34,"A3:BN13Y_8I2DE2%)LQEU14>
MH42E&W3;5QL"'\ LN4_XJ'Q *6[(E3I50PWQ+NOW^0ISRV*;46<AT>F6ZRSY
MI:0Q1':!*?0I(!69Z]QN.H'2OA^K]CF<G;;S.?'(5:2?QDB)8X44^OM6-C\^
M@'"= &@#0!H T : UI-8M]ZOOTE%0H[ER0HR'G:>F=!76XU/?4?+?=IR7#.9
MBNE/LN*0$*]!.K?"?"I=*Z/294-C5OL/G3\OI&M>:;]5&)YJL/+J%9Y,X ID
M&I3Z4\W\5?XI]%;JS18DO4]US"-YRV)<-B2TN/O'=D?FT+! V5X[]+K,E:5)
M+B0/2;!8<BQ&([LA<MUIIMMR2Z$AR0XVA*%O.!("0MU22H@= 3TZ:B<E*54J
M$LNM8D!H T!2_7_U7]/0G=VB;+?N.T'N35_VG'K$%^^8&*,?5ZIVV+->AU*/
M;,RXKHB4ZL.WXMU2;@@O5!EYIJF)0!"=0IS<^8  >T4F\-VRG<;**4JW)&Z5
M* 4D$$'N4#L-"#S _&7N+%MP9_HN/+NLV_:I5Z;C&QZ;2ZS'SS^XMENS\HW9
M7:7;]0IN,;UL>\L356+8E3M]$RX:NZJ%4HD!]"4*="@TL!_?B-,N.?QJPS)N
MZO8\N>YUV+1TUVN8GIT6E8XJ%2;9+<EVT*?"I]*A1J.%I[4!F+'9[@HH;2G8
M: EL!UN1DS+;?NG9[KDMT^>A:4][J<<V"0ZILDE:@'2-^G@/5H!1V@#0!H /
M@= <!OAE3F=,(C=\-"V,RH=\HMI2EIR#8RB7%*"7$*#K:>TI/CX]- 87#4YY
M%_\ )N.&TI2WF6G^[J)!:4MS%6/2M/:V04K/E@[';?KUZ: Q61>5%!MRY7\9
M8OMNK9US0E#R',?6&]'-/M-]#!=9DY8OM]*[9Q=2UK4A*C.6N<H.#R8CRBE*
M@$:7O>V"*A?<*W/B"\L\))O-JKT P>)% ON+;V-[5J-<B-2:73+WHSDYF\,P
MRGX[R'?.KK4:BK*DK$!"%MZ ZUD"RU0N8MLW7BRUZ%+R%BSB?)=LF@-.0[>H
M]9LVKY2$.OX\A2H[(@T.+6FZ?%7$>*3&CRH<=2T^6%G0"TL995MG*E+FSZ 9
M\.?19GV3=%LUR _2+GM&NI:0\]0[CI$M*)$&>VVXE:% *8D-*#C+CC9"M =(
M=^H?\/0= ,LYV"U\P<Z-H\O;]R<,NG=2N[N33;F(\ ?V8U]/<@I/W8*NWZ_+
M\:T>*<Y_O9_+-4&Z@4%.ZSX;#KL.I/S#7HN:_;5^ACZ3BLY[5KY/H*"6=U+^
MJ4G\;KMOOX=-^HUB4$5-)Z K;1L/9W"O:/J'0== <UOY9CU+&4IU;K3<7.6%
M93@9/8ZXB-D&CD-*.Q)#B"2!X[:T]1QT[,=/@7/Q&797#-6OTD?QD.Z93Y+_
M +O7'*Q'ARUV\T9^6T'EV+1JJB+;E@1)*>Z)<69+Q0Q+@V#1BDAQN,I+U5GC
M9,6.O<K3\4K8?0)8XVXTLFYUY4S_ %V)F[,S].D4Z-6)M,$;'6/J547'Q,MC
M$EB2G9T2@0E1U^1*J<@R*Q44IW>?2A7E"09OBNM$7'==L5+E0?1A_)-]8JIS
MM2F+GR?L"UZZJ9:32YRW779:HMK5."TM3BBL.-J2=NW;4HUK]=J$:\>HOD.\
MA8[*F^QKE9G5]1=>;\P*DW0'EN*2E* TA#CQ2E*NJAL==1O_ +9<^6_.?-FM
MX:]F_P"L3\XH1;4QU1;4XP/);#@4%@!?=T[!UZJ3OUU>_HRB/L$R$/+0 7HX
M.Y!W<&WW.OCJCJ"+M3,DI5^?C#9.W1Q/R_*>NKK=.'J,K#7COY)Q&L2$CEEP
MSAAN1(D>\9X>4_#6VXQ$0QC^GA2:F$K[FH\H2=V2=NYU 'XIUL6:^*GUG9^0
M\-8;5/:'2]<^>]!H#%M_\:S/_,XW_A.Z!;2O(.Q2H?BE0^[]S5]O8UU%%^Y&
M.5N4V\2_&0VIE*HL,\O[M8D/-,H&$+'<+DA]IF&%FYKE"2HN  .$G8 JZZ\^
MU"-K[8C*]7PJ.O<Z'V/R+E+K]Q.0S45<DEKN<5+<92G]'8K11J_+1.F\R2JI
M22KK4Z01OXB?"W VVZI\S< J'CJVFEK?+X?B-9*]3"UJ/^BO?Y!274:6#VBJ
MT@K(/8GWV'[1/5.VSI^J!UUBYZ9%\/K5[?B+8J[2O@ZC2N/S5[_((-U*D]2*
MI2".IZ3H77;QV_.[ZF-_3(M23E5/K^(F4,S)<-NSJ'B/96U>I5[*^KLKV'&,
M]U6E_P -%KBSF''DW[B@;,/QU.%!R1;?H*@-O'<^@:X_7]2AF,S=HJ)PRGZX
M]"]U^G<Q+F+AS\)*7V3JM?5:7[OO[]@Z3D5QM&.LC]_<DMVE<B5>P7?9^R)G
M8H)2#W#;7H5I4A)[G=D?GYPVXW5&+]=685\F/\)IZ6U+JF!)!Z(:@S0GH4?I
MK'0@%22.A.WATVU86"0L.H:'Q5.;BFWH:GG.-7$'WJ.B0XY,26ZOF7W=UZ,6
MPB.RI*U!)"E=^W7;;0&0^'3'J#,SG6J:ISR'OB(<AY%+2M:%(^S7:%C;93(3
MNIM EH<'8=C^-Z= .3Z - &@#0$"0" 2 3X#U_-H".@,"U;%O,UV7<[-&IK5
MQ3XS$*=6VX4=-5F0XO=[M$DS_+]Y=C,=WLH*NT>K5GC3X/#KZJ)J9T_+OXCP
M^<;:K(//!QZHC;7(K$\QU+K,F'\7KXBKB$R ILJ%:P!?4E9:3L0XE3:$%)WV
M\= >A\>'W2?DW/4[?)N= 1T!3=<#3:G%$)2G;<GP ) ^YXZ MF)S#\N5#0\R
MM^&EE3["'$*?9#X4IHO-)45M!P(/;W ;[;Z N/U_]5_3T)W=HCRUJ D<U,OW
M8JT*5&E?P$Q!;<>^T7 XNLU*$;IOFHNVO(MA53>9CTZ!)<3*:G"+'4XZZMDK
M=V'8#VBP9+B6F5.+ *4=I/<0E(]H#N43X)3ON?$[> .A R3SML;"\SDC&O#D
M!FCB^BW:GB6@V;9V&>2D7(++%NU*37:PY7;OM06?>MNP955O)QZ)#;6]%7/C
MKA 1W!W]N@')>'5N(M#C7BFV8^0:7E&G46WW(%%O:BNU632:I06:C-%#CT^;
M79E1K=0BTBE%J&F1+?>DO!CO<6I1)(&0L)Z(,J9;@!^.9XO:/476(W>MU$*7
M8EH1HSDQ2VTH;>4]#<'8VI1[ DK]&@%$: - &@#0'!+YGQX^<\%1EE DSJ+F
M)N.%(*BL,4RU'5H0OJ&TGL22-^H&@,'A7L5DGE"VVK=Q&7J(XZ@$=R7%XIL(
M^SU]E2@GH20- <LJO&Z\<.7%<N0.(M:HUL2+QN.KWUD'!%[)E/8IR7=%51YU
M6J]-KL1B=<.++PK$I +DZ(F;3%KW4]!4=UZ 2O1^/W%;D#?^<*3D2S[XPAR6
MS(W6V;TM.\';:BY"H-*N:WK/H>2#Q_OU-)J$"Z[-OFEV;3Q,J%-E3G(7NY<9
M;@.%:  JR@PHU YTP;6ITMQNCT3A!0(,"FO.OR'FHU)S-+IL66_-DN+?D+]V
M92WWJ45N$%2B21H#IW&:*ANDY:JM1>>DW75L]Y><NF94&8\>JEJF7=.HUDQ)
MC3+BRQ!A8Z@4E-/2KM+D M/E(4\HD!2JT]Z=@=M_3\GR: ;ISGPMO/)N8+CR
MC9.<Y>-GKIM^V:'5Z0;"I-U-NJM9-31$DM3*A/BOLE]F>L%*4J&P'77IW*?O
M$GR]IRTV=A7LK&;?!+V6VT^*C35<%CU(ZGJ?*-C4;T\S<N-2DZ]-*G,D?#[S
M:E84>61[NU:3OABVAT6DI5NK[9!'0Z[5?]]UN=U*603=*44DFTOXW"Z)=!UZ
M?(;E>3=^;BNMX?"05\/K,JO)1#Y9/4Y#;#2%H:Q-;K_O,D))<>*WJVMP=X&_
M;Z-8_P"^BR]NF7/]-'_(+%R'!_EI=_\ "8"Y."^4[9HE4N.[N:4*@VW08;]4
MK->K>*[3I-)HM-ALK?ESZA59=>C0H$1II'<XZZL!('3QU8O?3%PI#(*'RI1D
M^_A7=3M-JSR'9X/6O.M1+]E\1LV<H:DRJ@YXO2C<>J;<%-JL;-L_%U'LR\LB
MU:W:K'D1'<.T"<J74XEM)4RH1KFJ:&6)((,2,Z$HD:X74/>[>S%F=F%F,7<A
M*/DXDUCAU[B^WR/9M78W/$?JR3[G4?'Q!B*P,+6VS9N/:"BCTM#CDNI2GWI%
M4K=P5=:0)%?NNXZB])K-QW'/00J1+FO//N;C<I':D>/TI@=X,SD_(ELXFLZJ
M7Q<TD1:73 VA$2(S[Q5ZY4WU!FE6]0(#7Y^IURLS"F/'CM@K6M>_@DZ U/CO
M:%<M'&4/][8D.%>-W5^Z\BW?"AAMQFG7#?\ <50NF71Q+0E)GB@-5)N AY7M
M+;BI'@!H0TGM.5W1P.XH7G<E?NRX\.T:=<%S5N?<5=J*:I<T1=2K=3=\Z?4G
MV(-9C1A)E.=5E* #K0GD(3FYT56ZG 7^4]&S%Z68N6K;NW).3?"MKVFN_P#5
MQ\,=MC@VB;?_ #Y>(_"+@WU/U&/88+D_15LMP[D03\.'A:G?MP90O_QW>*OI
MN#IJ'D(/<B7RAHWYJ'<BI_U<?#$C_H+H)'RUN\!^#]X-6V\G9C&DDJF']EM*
MM.D+-OR\,3H.+.'''#"]T)O+&>*Z):MRHCO0FJM&EUBH2669!6'PPJKU*?[N
M74.*2HH"=TDC5JR]I.J2[B[+:!DLI=\;+6K=N:WQ23^ 5)JTY\- 6:&G!-?>
M(3Y2V64).WM%25+*@?3ML1H"J0.U6X!V4=^F_P!T=/7K--U["N_&*AL5'1OK
M$]Y,XQX0R]<,>Z,B8_I=S5V- 9I;56?D5")+;@1W79,6(I4*;%\QMAUY:D I
M(2I1(VWUJ9G3\EFX.%ZU#Q7]]3'O.^<O>\?G'EG(0RO+NH9G+V;<Y3A;A-QB
MIS2C<DEL4I))2>UI)'/'N!O%&0>Y_$%(>5MV[N52O*.WCMUJOAOKCO[-Y#\&
M/<_C.P_[]_?!_P#EL[_IOX">-P+XH1W&G6</T%"V5%305,K;H2HC8G9=24D[
MC3[!R$/5\.#ZVOC*Y>_3WIR?S^M:C&YT*]*E.QI&3'!_BPD[C#%H;GK_ +-+
M/7Q/C+.I^Q,A^8M=R,'[\?><\'KFIT_33^,RE-X;\:J1,BU"GXAM2+,A2&)4
M9]N*\5-OQG4O,N=CS[K1*'$ C=)V(W&QTEH>1DW+P;2DZ8T5?5=8KL>*Z#C[
MWO>]X-V7$M6U#CX91KXLUZLXN,U@TZ2BW%K8TZ/ Z]DY(;QKD%0[D[V=<7<K
MNW5L*1+Z!7CKDK5J5JJE)M/'MWGG2:G/CX%&5$JTVI;%V;C3BZXFH8%3VE;#
MD!8*NSO/>;+6=U*!Z'8 ^&KC,2%B2$F+\53F=.#R%&I<8>))4TEA*'&?<KBS
M(P$NNG93Q=#VZ=]P@;Z V'X?M,-)K7/:*I_WDK^(+FJ6E80E 9;J-BXDJ:(^
MP_9>^D=.FY/RZ <3T : @? _,?HT6TE;3D.<7\I1<27]+PNQ"F969MF<Y8D*
MIE@T^1<:4I]R:E)ENLQ5-K._1Q:4$^) UOZ'9R"U>,M1FY9"4_63;HECT;%6
MFS$T=05UOYAM/=0V#'"KQF6/9\C([$:)?BK:HSEW1:<XVJGQ[D7":-9:AEE;
MC?D(F=P':I2/0E1 UKZA;RL-7OO(2D\E6D$WLC5T=.M;WBUM-FUQ>$N+VMYO
M^J"P-11+%;02K)2-QX[I'I])&_A\FI!Y%:AQ?Y:4/EUF'GYB/ETU9V&\4<U^
M5M,R78&<),61@3CQ1'\8IM&K9]MNT8L]JHWY>ZXMP^5%I*"P9<UQI+JPV5Z
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MQ"RTYG6U$OMN%MQLF,\R5(=224K0HI(.^V@%XM@ *VZ^VK<GJ21[))Z#KTT
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M&O=VG74@+RCO!]LK ('>M(W'B =TJ'K2M!"@?4?7H!,EIRVQR'S#%##Z /W
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M]Q4'/.6//9?;;J,K'RFGE,/*8<2;9EPP>Y+1;4I+J" 23VG0"GAU /R: CH
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M?\VXK<;G0&_P+"I[2(\*;(K,I;4&,B0^NY;B6N1);\LNR%E-392%/+0I6P2
M-]M 9,6#0$K+K8K;;BEN*]FZ;E""5[[J<0*QLK??IZM 9*':E*A#\TF8I1/M
MKD56K2UD>G9R7-?<!V^70%BNPZ"Y(>?6*NDO$%0:N6Y6DGTG\VW5TMI^XD:
MC^X5OCHDUQ(/4@73<^Q)\2?]\>)T!(; M]1!/VYNC?L'[UW04$D=%+1]K[*.
M_7KOMH"HY95&=2A"VJFA+9&RF;CK[3C@ VW=6U4&G%D'^4I?30$#8-NDK/\
MOP>8CL4!=-SA)'\T5?;?0%*-C^W(=0I]29C3WY5+6IR J=7:[/;B/.,.QG'V
MF9M2D,)6J,^MLGM)V4= (4L:1*'Q6,_P_(=]R;X68'>3*\E 95).4LHM^1[P
M$A?FI;]KLWVV.^@,GP]_]Y[XDQ__ +A\;#[HX^XY/T*&@'$- &@#0!H T :
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M#;#+$"EP(3+,4K5&:9BQ6F&FHZG"IQ3#:$!*"HE12 3UT!E= &@#0!H T :
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MN/B90EJ4M1SIANJ E0*$,U'CW9+3;:$[#M4DT\E7COW#0#CN@#0!H T : -
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M5L[=I!\%'?TD: G2GM"0E*4) ZI \.G0#;8=- 3Z L3_ +<K_P U_IJT!?:
M- &@#0!H T : - -_,)I:OB5UE!<2:\GB+39"D^1%[DT,Y/F-,I$GR1,+?VB
M%J[%.AL*.Z1OOJ2B7M,P7$@E7,OXF9\I2$)RS@)*72H*2ZX, V_YG:GQ1V!0
MW]>^H,H^T_+\8X]H6AH T : - &@#0$J_JGYQ](^0Z \_60'BKDM>*"MU88^
M,EQ,1Y9"BEKSN-U*(*/SBP4*WW5LE.WIT!Z!&R%(!&_I\00>A(.X/7Q&@)]
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MZ$EQ)4%J+5M@K(WVW!Z: KBI6.^T)3>8+Z2P2I(<^V"4;K'\ERWEK]G;Y-M
M6[M6Q]VJ1_&"^%.. /I0*RZVIP(/:-EFW4^6"1N0-M] 5S,L,1E,JRG>KJ24
M*4\*G,6\L-J#Z>QU%"W/>%@'MV"ATT!"HUBP&QW/Y,O..U'2D;MSZFGN[B$@
M+2U;;JEDD^@G;0%*-4\=.#N9R3>^S);:4I%2K96KS"5!PJ70DE8(/H'3;T:
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MHM+H_G-I+*'_ +.ALQ!(#8W#8>$;NV_%[NW0&P!I0&WF+/SK43]P^C0$ RH
MCS'.I)W+BM^OR[;Z YIF7#ED9ZQ=>>'\C1:A.LN_*,JBU^-3*I+H]0+'G,2F
M9,&IPEMRH<Z)+C-NM.).R7$ D'PT!P[CKPHQOQCN>[[IL"_,WUI^^ZO6[ENJ
MCY R?5+OMVKW=<7V6FL7A)I,R*RT;FF,4=AM4H'<H21MN2= +#&_IV^YOH"D
MILEP.!:QL .WN/9Z?Q=B/3H""VBOQ4?N*(^CU: /)VZ^8ZKY%N%23\X].@*"
MX+;AW47/$;@/.I2I(*CV*2E024'NZC;KH#'U"A1Y[#45UQQ+"),.2I'F*5WK
M@OMR8_51W&SK0W_E#IH"[AP/<F3';42A<R9)W/52!+D.R%C<^D+=.WR=- 5U
M0TK3VK4M1"NX++BO,23X]JO$ ^K0%;RR4A).X3X$DD_=/IT %HE'9T ]8)!'
MS'0$GN_0#N5L-MO;5Z/7H"<-;=1M]\Z E\CKOO\ ]\=M 3I:2%=Y&Z@-@=R0
M!\@]!T!2<B-K0^@%:2^' I06HD%UORU=H45!(V] ].@,;#HD:&I;C:U%Q<5F
M&3T2 ACJD )V[=B-_GT!AU6A#4Y=JR^[_P KFW69I22DLAVF(I90V$G;<,)W
M[MM]^N@,A1*"U1X%/IC:U.L4Z"Q 9=4XLK4PPVEM'>>[=2^U&Q.@,V8D=6^Z
M"=]]_P XYUW\?Q] 4C381V_,^'A[;G_CZ NFVD-)[4)V'W3^$Z BIM"CNI()
M]?7_ "Z F "1L!L- "DA0*5#<'Q'X= 2!IL>"!^'0$?+1_)&@$^U#!U&F\D:
M-R+<K=58KU"P]7<-Q;;2U%-%D4FO7?!NR37'G2@R348\F AE" L->6X2H;@:
M&/"JU)K"P):]C9TS5GBE52KR[DSI2<9TNXZ;*4R:12XV+Z/6*-1G:6E#;;X=
MJ#576I\N*6.Y [=M] HI8H4'H9!MUW]/AH T!1,=DG<MC\(^@Z B&&4^#:>O
MSGZ2= 3>6V/! T >6C^2- 2O$I1N-M^Y.V^PW)4 !N=@#H!#%Y<'L<WK=UZW
MA4KFNUJ???(? _(^I16GX9AP+JP%&HT2V*/2V7(^\>B5MNBMF:%*+Y6LD;#P
M 72V=P>@&RB-A]P[[;#;???;0$%--JZJ0"?6?'[^@#RF_P"0G[V@)%QH[FW>
MT@[ @';8C<@G8C8@[I'7QT =H\[;K^CW^7?S-_'QW^7QT)W=I1;^HC_:?JCZ
MOU?#T?)J#)]A(KQ3^G^JYX_,/#Y/7H0^PJ#Q'^T_5]'C]S_-T'<1_M>@[@_M
M>@[B@OZZOTW@CZWUOQ_'Y/5J2'V%+\0?/_H_45X_X>&H)[BY] _VGP5\WI\/
M\>I([BB/K+^O^D3_ #OT:?K?Y_J_S=!NW%3]:C_:/JN?S_K)^K_F^OY=M!W%
M7^UZ@GN#^UZ#N#^UZ#N#^UZ#N#^UZ#N#^UZ#N#^UZ#N#^UZ#N#^UZ#N('T?[
M5XCQ_P 7RZ#N(CT_[5X_XAH.X/[7H.X/[7H.X/[7H.X/[7H.X/[7H.X/[7H.
MX/[7H.X/[7H.X@?JG_:?!7CX>GQ_QZ#N(_VO0=Q*GP_\J\3X>'B?PZ!=A-_:
M]!W!_:]!W!_:]!W!_:]!W!_:]!W!_:]!W!_:]!W!_:]!W%!?UT_I?%7UOK?H
ME>'R^O\ S=20MNX@U^D<_2>)_1_7_%^OH-^XN/[7J">X/[7H.X/[7H.X/[7H
M.X/[7H.X/[7H.X/[7H.X@KP_\I\1];P\1^'_ !Z#N*"?K_K?TB_#ZWUE?]]Z
M]21O*C7Z-/\ M/I^I]7ZQ\-03W%3^UZ#N#^UZ#N#^UZ#N)/UO_E/Z/\ TOK?
'^#H3NW'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>g68105page154.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page154.jpg
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M P,# P,# P,# P,# P,# P,# __  !$( C\!G ,!$0 "$0$#$0'_Q #I  $
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MKD4'\06,V;@FU56)WBI'4,"ZJ2!R-" 4@["J< $>@#N(:"K*SV4OZLG\T/\
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MA T T T T T T T T T T T T T T T T T T T T T T T T T T T T T
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M/B=FA T T T T T T T T T T T T T T T T T T T T T T T T T T T
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MR9@$# 59,H[>W;0%'Q5-2-DQ?C>QS"A5I:P4*GS<JL1,J1%I*6KT<_?*E2(
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M  X#L<H?#U].NJW%Q='Q+HR4E5<"MZ@D: : : : : : : : : : : : : :
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MS6)W,*G6[2!N9B"<^_;Z:E13MN3I2O\ QI\"N<IPFE#[>!DSK2.F- - - -
M- - - - - - - - - - - - - - - - - - - - - 1IF4J0XGR49<RQ$242
MU&.9OQ[Y2A"/>9TN>Q.X4F_'?IN/70%5QIV1QS0!;@<$!I-5[(*<>X"/X$P[
M8*</AY@3;?;IOH"\SEY%$N^PCML.V^P[@(#M[=AT!CU#1T'_ +4%PE_](_:9
M/"M,C3%[+?Y1*"6M]F<ID2==SYLZQGZ B<AB< #80$1T!D1H#'S(+>+'.GC\
M=TXD$Y,"Y?&*0;(-#,'/=J$61^$BLJ8KEOV4 *9'LE-S4^_L&@.5I*/2\H82
M#,5]^*FP%:95(Q"M_P ,&.2R+4FRY51$_P V#_YE=(4P !2!/GN._'0%F9I:
MI//)+Q  ZK@BC62SA(-R)':%2650QH5'MK LNF[,(%="8G8*H(&#<X 7KH#*
M78W+CQ^+;C]X=_UG'N\N/+GM\7IOOH3R^)[$?U2?\@OYM ^)V:$#0#0#0#0#
M0#0#0#0#0#0#0#0AJIUJI@J42B8Q=P]2B "'VAN [&#V#[-%HZAJJH8_YBID
M&FC'6UFG)PUG&:J5>-9*U).Z_,N8^:M,3&*L'SV,5;C(-2).C"D1<J@(F$>'
M$!$!O61-)II-/Q-;\I"M4Y+[OX$K5JD5^I,S,H1LNW(JIWW+A=VX>2#UR(G,
M9R_D72JSMXN83CU.<=@Z!L'354IRD]2^-N,%1%W:Q,QH!H!H!H!H!H!H!H!H
M!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H"+LV=</Y1#EQ_P#Y?V[83"!2\OP)
M_P 0Y"'M'0%5Q9_JQQSOMO\ L'4/0=P_\GX[T'VAH"^Q]/:/4/3J/J&@,?84
MK7_::OAA$_SP8?Q^4FQB]LS+]J+@83"3;GW 7Z;[[;>S0&0>@,8\ER\<GY*>
M,T(=XW+*N6&;I!&.,J4':T>TJ,*@X>)(=3G02<.4R";H "?;0'F=CR\U*X ^
MWQ;NG_K9H0: MC.;!^[\KO"%=HV45:QTOY N)%R3CQ9MS8H(BD*@F*/PN'"A
M4^FP[CH#+W=7??D7]7M[=NUSX[[_ 'N>W7?WZ$\OB>M']4G_ ""_FT#XG9H0
M- - - - - - - - - - - - - 0_FTRA:C&"F4AA#(&+MQ,?CQ V1*V41#V"
M(@.V@)@_]W0#0#0#0#0#<!]/]WMT T T T T T T T T T T T T T T T T
M T T T T T!&.9S"7$V33!_P>/[:J&X (<B0;X2B " AN AH"L8T-SQQC\_^
M-2:H;T /O03 ?0.@>N@+U'\NW4/SAT_=T!CM"@7_ &I+P/(W(,*4 .&WPE*-
MON'H;;J81#0&16@,5,G5N%6\I/&6W&CT1L3* SI6T97<>^2&D:Q791S'"/+;
MY=9ZP25$ #?DF'7;IH#M=?\ ;4KG_P!UNZ?^MJA: [LIN#I>2?BN@5=0@.$\
MZ\FY6XJ)NA1HL0H4%'/_ ()VA^(!_CCTT!DC\/+?XM^WZ\?C^_M^KVVWV]GN
MZZ$\CUH_JD_Y!?S:!\3LT(&@&@&@&@&@&@&@&@&@&@&@&@&@(BS'79ZT5V+C
M*^"9G*5SQ_+N0.X(W (VOWFOSLF.YRG[@BPCE  H  [CZZ EI,=R%';;<-]O
M=OUV#[ T!]Z : : ZS&*&^X]/0?4?78/9^75$OJ9)@KDOR3OE#\G<=8%84AI
M+U_)<=%/&=R%5XX&'<!*R+>?93"#$RBK @1[,AV*IDB("<#%,KT -3#ZD09R
M("'-0-S[E'^-Q !*?8Q!*&XFXAU !'V@.K@>K0#0#0#0#0#0#0#0#0#0#0#0
M#0#0#0#0#0#0#0#0$39W7.AA;+BJ10,JAC*\N$RF]#'1K<B<@"/NW+H#V84>
M*2.&L22"Q0*L^QE0GBI0]"J.:K%+'*'V 8XZ DP?0?7]P-Q_+ML.^@,?X-HY
M/Y+9 DB]PS(F)<>,%#!N+<KTUEN3@I=Q4$ 6,@4>G$!XAU'0&0.@,<<E'*7R
M#\:0$=A,3- @&P[B!*7%\A  #KMOH"CNO^VI7/\ [K=T_P#6U0M >3+CI5+R
MC\16A3&!)XEY!=XH&X@8&^/X50@B'\;B8>GIMZZ RE^+G_E=OUXCOOSWV]^^
M_3?0GD>A']4G_(+^;0/B=FA T T T T T T T T T T T!P([=?]WKJ&Z*H.
MHZY$]N6X;CL =.0_:4H#R-^X&^L/,0(]OSJR&8QA:HFN:0&R5<RQDBD$$HA&
MQQ8V,%SF 2)IG@#.0$N_(QBAMZ:SB^I51C*72Z$BE, @&WH/4.FW0>H=/9L
MZRH1UH^]09C0#0&./E%ENP8-P_8\E5Z+@IJ2A)2L-4F%A"RFC1:3=AC(9XJX
M_9*"L<]R00>G.0$FIR[[<A -QU1+BS))O@:E;9(9GSIY;>#^=8"E'B,192IM
M.?7^9)\BG%1MDK$_:I2/JLLUL,/^W'S#954ZS,[)2+ QC'*L98A0(,Q^I$N+
M2J;\$3<C&-RWY% >([\B[B(@&Q@ P!L/M_@U<8'HT!P(@'KH#G0#0#0#0#0#
M0#0#0#0#0#0#0#0#0#0#0#0#0$59P1.ZP_E=HD3N+.L9WMNB0.(G.HI69,
MA1$.0[_DT P2&V#\-AZ;8JQX&WY*C#AH"4S[<1W]-NOY/;^3IH#'V"FD@\F+
M[7A<%[ZN(,?3)6P+&W,FWM5SCUG'R_$"[$57*3F(\NNVVV@,A- 8YY'>.V^?
MO'!H@R^8:OR9F*]=\MOD>Q38MPW^$0$3?,J!PZ"7;0%&<A_]M.MFW#<?%RZA
MQWZ],LT$=_R== 4_+PF_VJ/$ H<>)D?(7EN&YNF/H/;B/LZ^OV: RJY#W-]N
MNVVVX_UWY-]">7Q.]']4G_(+^;0/B=FA T T T T T T T T T T T!\''8@
MB&W[H[;]=MM_>/L^W6,_I8-8WDMY-Y>QKEC(53K+^.8U^OXOK<K'*JU TT>/
MGK(UMS@';59-RH^O=Q>.:XFVA*NS1;]P!<O7S@&B(EU0#"JC^<'DI-^).+LF
M3-U!QD&W^=GA_A.PJOJ-!5F0AL?92L.+$+K77$#')F8LY"5;S#P>^)ECII//
M@/Q O&ZW]/Q*Y_;\3]!OM_=V_>'5O(P_J^)V:Q+QH!H# 'ZE]YE,=^'67[7$
M6)&H2#!C&)(69S%Q<RE"G=RK1LV>%CYIRUACJG>&333.\43;$4. G. :HEQ9
M= UH8AKM.CLE^"E^<5RW6H)W"&$(R"M32!1#'2#QU8KL\M4Q,6-K!NH.M2;R
M6EFCANV,NT;K&."3=0P\140TDB9?2S]$;<  QQ .O41W P"7<W4 Y!R^(P"8
M?=N&KR@](] $?LT!95=E+0[G+TVGHUJPB(NPLV5,>)B85)F$5K$'(.Y!T KJ
M "B%B=O6@<2D#@@'3?<1 O;0%-EWJ\=&O7S9FK(KM6ZJZ3!#;OO#IEW*W1$P
M@4%%#;  CTT![$%#JD QTQ3-Z"41 =AV#<!V$=A*;<!_)H#NT T T T T T
MT T T T T T T T T!9V06I'E&NK4Y"'*[J-C;"10.1%.[#O2<52["!B !M
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M6RIB5\87)1;-FXN%F+DI^3=,C<QS;IAQ'<;K?#XFCE?[B\*+]Y^M[61>- -
M- - - >=9,3"GP-P$IA'IZ;;=1]W( Z!OZ;Z CC'#FCOBW<M*CDHU5CD.Q-K
MAQ:"U%]>4A:'G)18@'$CA=]W4S&5#8#>[IH"3@#8-@_P_P"'<= <Z : HT\T
M9/XJ28R0$-'.XR0:R)#G%,IF#EHLW=E.< $03,BJ.^W4!#?0'15(V+A*S7X.
M#3!&%A(2*B(A(#BH"<7&L4&<>F!S !C\&B) W$.NV@+@T T T T T T T T
MT T T T T T!;ML 3UNP)E 1.>!F0* >T31KDH 'VB(Z I6,TSHXWQ^DH42J
M)4BJ)J%'U*<D"P*8H_:!@T!>Q@W 0T!#K14AL[RR0&()T\60QC% Q1-LI:9
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M@4H;+E[-IDNZ*V_4"&%8O#[0-ZZ F?0&..2/^T!XV?R<T?\ 4R,T!&)EWO\
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M" J*$3&E[$S<9$ZXQ+%<&[ A7SKXJ2Y<#5+XJJLGOT\,>*,F2#6*3^HG]/\
M<0C5&3D9AJUCW5R\?W3?Y-:4;H*)-S?-G,4" 8I@/S,/,Q@"RW51]M33R?\
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MN9)%2*3"'^>0)\\S.J@9^[^0.45EA:&(F *%'B43 !MNF@.V,AXYC)34FV$
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M(M&K]5H#I!HNHQ<ED61EB H=HY*@LU([; .X@X*1P=,#E$@\51* ]1#0%6;
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M<R%[>X&$>0]0 H  CO\ ;UZ>S5Y!W: HUB5%" FURE QD(B36*4?NF,FQ<&
MIMA =A$.N@-7?BU>:MDCRJRN"K.ZJ77%]/@F"$I.6"+"NFAK(C%L9&,JD"PA
MXV1<Q4<[9$1!1\Y=&:KB/;,(*"8PKC_N,VMCU'W=!Z^[UU/(MY$3P&X9BR0(
M#_\ L7C$PAMN(\7M^W .I=A-J""ERF:&;+,4;AUO 2#N5?0AIY:436;&;-&
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MMI: L]CXG*_AMN83&3[ZT-9/QU9I^R%WOT2Q82=C*Z,^D7*$G9)GYM559QW
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MX,0Y>*GL,(%W1;Q*09HO$%%%F[@A56ZRJ2B!E43E Q#=E5-)9/H.VQR@;?U
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MXK#> :4^CO,A"Z6;1SYZ[M4/!JQ"8F12/-3*THF4S]L1(3J*E9IJN3"3X41
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MUJBA(LP9M*XT2*X:JG6>KKJF*!+(<?8#8ZD04R 43"8?7<P\AZ@'3?8NX%]
MZ!TU8#LT T T T T T T!:=U<_+56U+%*)E$*O/+ !=N0=N+>*EV*(@8XF%/
M8-M^N@*7BIX9YB_&SQ41%1Y0J<Y4W]>;BNQRQA-[0ZGUBYI.@+[5$.V??8=B
MB.PCQ =NO40$!#?;6+FFJ$I:FC?S#9 OY8Y+,5Q9W#]3"V&QKL,U3KSEB]L\
M<]R^\!Y#0[Y3_E&UQ<69149B<+^S55; =^=-1X#?:MF70S6Q].22GW?A_EU]
M814;.I+SM\$W"CMNJ9\S6:A.>,!VR[)[(.TW3F+<$4:IHNQ*)UB+ <I=C[!9
M9A;NRG!W(0G"'725:M>RB95*2C<5I_4U4_7*+U(.1=E!$!'^*/7?J @(CN(=
M?9Z:TK69C7\:>7;DG9C*C]^G\2R4916J9B'^TL?_ +:2%8.ZQ*,@7$<;(I,5
MV2 YG2347M!3.&SP4 62J*Z;<2E*"GQ'25W .F]N-D.?FJ5N<(VN<J4E_P!-
M&_Q*W)UHDS,,BW,1'@8H;>IN/[WWOLUGA94,['\^"E%5:I+CI[JF56WTT=4<
M*E YBF#80* @(=/BW_BF]Y!]H>T0#5CN23IT2?W?Q#T1!EK3D$YZ1J<??8NN
MO;F->>UV#<P3=?MILI8Y\@'264*9.4>V:,-Q(17<6ZA3JFY <=L89-F4NAR2
MFGP?$QKX)DSL&2; B+= I$6S=(B#=NB0J::**9>)$DR$*5,B9"@  4H 4
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MN6HY^XXEB,9-KHG1R:6J?4J4YA8F??JI1Z>&M*%]Y@QSGVG8I\D38M\K&V-
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M:*'FF>IK#(S.O34?!S5:FJX>@O):$<W-.XU:P/&AHULX(\7,)#) )B &M>M
M84_3.\=,-8U\I9G)49]1.A>7EXFL$6&-I&**G'8[KA,78^R%E4^4K-(M8>C6
M"75;1B]PDU$$6+P3&CRJ@D4/AWU9"OP(/T#(<>'PCOZ<NNX[B4!#<.@E$"B'
ML#5@.[0 =8S3<6EQ!TKE R8@8-PZ>S?IN&Y?L VVP^S;4K@@8,^1-.M-OQKD
M6#J6/IO)&0'&1ZK*.JI!9ULWCU+2-::2K$T0Y;9(K"#R90@8R'4'Y]BB3L/-
MG29![NV]LE)TDE\GC[2JXUU4YE*AZAF5&NXIK]6_ \"92B&EP3G(UY9['Y-1
M4;3"O"'CF<S<;6XKEBFU)9X9%=N=T(J-#@HFF(E#<;X6ZVW)K3[M2OJBGQU)
M;BZ7Y;-DC%?YTQA**#Z*J8;>,1#[1(WN9 '6H;)%/D3=?)O .%,B9GD;S0K>
MPQQ7U[0^KU?Q<_2FI"/8*)?B!8X7-N<HF<MV:AU@ 2^B0CUVV'":JM 86LL;
M9Q\[/&6Q9C9>7SQY!Y&KME<TI.!H61L45BC(Q#>5BGR<178:Y5*U603+M>ZW
M?23LR;PGQBGP,4NL.F3!G1X15'-<7@K$A<LSV(9B,3Q'2&T+%8YQ_)U@D8]0
MBVA!<.',M89X'J+EB0#'*5-$_P P<XB(Z=,O %VRU'\NS2C]6$RQ@=C"'?.U
M(QI(89L+N1:LE'"HMD'+UO?FC9RZ(W.4AU"()]PP;@'7;4.+^!*XU-"WFY2?
M-@OE5D8*WF;"L3+FP-A]PP.EB"2=-7UFCCYU/#!5*L^R4W;MK#$P+B3=.K!,
M@$+5F1OG=Q=$23-'M+EP,D_'2#S^VQCE"TMLB^-AZB2?\>CSR%JPQ9\@F?V-
M; 6!6$;+P<DRR# "Y@_F5V2B9E$CJ'.DJKSXJ 4*KFBZN0;2I4M&;K6=D?JJ
MT>)N]KP[+9(<^.V0SU:S5?'LK$4--DK2)0K D]4'-GE96371<)."JD&0(F9
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MG%OC)NO[N1\OLW:RE&;K!-I>XW@PBM\H\/8I[-.3<?JP+-DBH681@_V"B8(
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M!L*6RY5G(MGQ1CVPW^F)D2J-UFZE"2=IK"9'H29"04Z\9K2460DB4'  BH0
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M1W5;3DN!7KL^]7N$O&4/*2TQ*5.7BU&5BK[NPJUET]?(3S]9-5<S%4ABE9G
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M@8^UX=['W"Q:M1RK]).63T7.N2E%VW%)KAT*.I,=ZV2-KSK\O*7^F=$_VO\
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MAZ^8ZK&.?I/8A//-0MU0<XBFI.#8QL\HA&QC_P 8+6HS=IRCR,6C7K505P
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M-. #OVWBF+U"G*X'85.0 .WIJB.#MUV<GFV+4LNOSN4[BDY<VU%I)^Q:$_\
ML_>;;\N*DXQ6C\3UL;'YY@*"TMBSP948%.X=D(PR'D]%;M]WF5-11QBM852&
M0 1$#%'KKSV=L6R/(4ORMCG_ .9=_P"XKN=K;U;MN:A+0M:JJ_4#B$;BDQQ!
MX/($D,BW.>8&L.1\D)@#>8L#B1!HT)'8O.5Q"MR+\&CHBFRR8!LF38=:[V'9
M:ZXMBO\ ]R[^Z1K1V'>I+JC%M->U?N),7L_GGRCT(W$W@<*ZRH-UU'V3\G)I
M+.EB!VRM3-,6E4% % $!!4!, !ZZZ&%M^WX;Z[%B<8UX6JRC]\Y5K[.!9<[>
MW:.&[MR,NNOV1@?,9;\^O'#(.<K/.8$\/)57,V>,=H1#*-R'?0BA36Q9C>@.
M+;$K/:2DD:M0*]:.#TRQ$'AET%RHHJ_HSJ;N9E8UY*/E97+^E>/_ %'<[7].
M][WZ-RZH3=NU&4I>Z,>JGQ7V1E3G;.'U$/':@I7BY^._A'*QIY!&'YUFZY/=
M/TS/DU>#AVFICIFD1  2,!S&.7?<  1$0 =JY>Q\"+I:R:5IHH\__P 7[2CL
M3T\N^K>\/ V;)_(/RY3Z9.E5%\%I/5^'@2=BS(_U+,B4FN7JJ8;\!W<+8X>/
MD6+D,G9<:*E*JF<1;+IHXZ.#9PUV HI_%MU'EJ(RQ<I*;M9+7NC_ -QY_NCM
M>]VKW#D=M949JYC.CN.M)NM/E]G-.B1()Y#ZIZH' ^%? H"&*8!$F6,R J)A
MZ_"H&. V$1]^I>-B/1VLG[H?]QPGAVW_ %O[F8A4?,?G6Q\MK-1,U47Q'H]C
MD:F$/C&:<J9(D(Z+AA=1SF7AHZ>,G%#:$+$\:).B/%TVRK8Z0M2DVW$U,;EG
MSORZM954M/ECJN.GS'TS$](=R7:#[XV;-CF0G#JG9C\TK3X.,HJ-?E?'5NC\
M#8FUC_-D4P*K'>*"ZJ&P@N=ME(IE!'82GXE<[&((>[KKHQQL.4>F[;R.B7'2
M/+7_ %'QJ&1:R//O9=J4=^LM>7X5K1\_]->1&.5IGS9J$EB1HG_LP-T\@Y4A
M*,Z!C'9$.D5)S5+E-J-79G2YE",')H$IC&3 RO,A0#8!'6"AAX[2L6\E/_IC
M_$ZU['EN<+<,Z;BE2J7'X&/41Y,>8DWE"WX73HOCQ5\CQB'<B&E^/?*Y$VY-
MM)*(K/H.18H3*Z+5:-4^92,HW.("02EW%0PIZ=Q+)OT:RHW$M$U%5]VI].W'
MT@NOM*/<FT7)WMN7RRE#51G1-UHO;RX&23>#^H8"!#*4_P -5@[1D]E;CE]8
M-CCL!NM>*3;B'4H  >SV:V+>%CR^IY2?NC_$^08.T7L:]*-ZXY-/3X<.19F0
MI#ZC%*J<Q:$L6>*MI3AV9W8P]:L^5%IQT4AB]P6C16,:,52)(@)@Y& Q2%'8
M1'8-1<QXRKT_FW+W1K_\QZ'8NV<#N[=XX6^Y'Y>])TCK15Y)OE5Z*I;>+,A>
M<>8:XE8Z[4O$AH)@:G5B7]JRTRF&")RD70*NV;0KAKP<!]PP<^)BG W7IJC'
MA&,Y/S;]G3C-0H_8JUU-[NCT_P!X[9W)[=DN:VN*_M3UI)KCK3DJ&.>6_+;R
MLAU,S8X?4C#ZYJ="3.,[7<XBL^2;G%U7N-GIJ(1L+*Y$;5$:K'2K]O:V1$>X
M<I 5=H%$2@;<-OS;Z^G-K'_IAQXJOR^*JO<<>SM]K'2\R;X$ZX6(G)^//T?"
MD+)*G9N<4R!T.Z1(Z/RGC%:6@N'OR)2LUVC4RX !"[$#O$Z;@.IZISGU7)==
MQO66FOW":C&3C!UBGQ\3<@*7(2CW% $OH)3;=-P$0'H(#RVV_)Z:F/U*I!1%
M:Q#KSS.RKM4UYB/BW<.Q>+%!55HQ?NF[QZFB=3D<AG*S1+D(#N($ !WU<05M
M! B!.!-^._MV#V 'H4"E /R  : [M - - >"3 !CI#<=MV#L!^P!04ZZ \59
M$#5V#$!W 8B-V'W_ .A(: KF@/DP;AZ[>@=/M$/W.G[N@(0Q:@".0_(D0.8_
M>R76E1 P$#B(XAQP42@)"E$0^'?KN/7UT!..@(\CWW=R5/1W8,7Y&IUYR+GN
M&,5S\_)392)]@2 1(S3Y0?B 1$>YL/LT! 'D8<Y,V>&' YB<\R6TA^(B '3'
M$]P$Q#!Z"41 !_<T!EQQ_2>S]3OZ?Y7IH3R*;)Q;>:AW\4[YF:2<>LP<E2V*
ML"3A(R:G 3@)1$2FZ"(#L.HY!\2*,HY%KF%,<GL]LKMZM%;B/PV)D8^B42<R
M9/ P$@-1E'U;K<:]E7<6R0;\G:R;=0J9=QV$ VU0#6]A?(.%[5YN0CCP[K-$
M4HF2L-9 4\AY*IX16QI8*#>:U*P4C0+-/6Z3I=??R#RWC(NXIU%JF<&Y(%<<
M" !A-9#C\"#<<@(=L #?X1$NX[[CMMU$1 !-T]O35@.[0#0#0#0#0#0#0'48
M YE$=M@V'KL&P@/3<1]?B$-@]^@(?P'$HQ&(J='ID4 &K>7*7O%4*J'=L$JX
M,!@4,90 $Y]]A$>GV:AQ3X@E]8 !,P@4!$-A#8H&'<!#;8!$-QUC*,4JDKB:
M>O*X\JW\IY1-!%_^%R.&,;,G*P0Z4A#NWJ5ZMIHR(DTFZY9FZ/UW9_\ DZL,
MDP+*O@35?'"/07 :OVERX&M%_M7<8>9E>762(VKUP\'WZJ?RQ62)22"^,59)
M4\,DNZ19.@4;E^:22540.L!BH[)E*4-NW*,L65F7!OA\#EWXN6Y0IQZ5^UG@
MQI*Y%OETP#E*BI1MNE*!3LE8.Q;5KE;W-9K%@>P456[-E^=<6<D;/&AW/XLL
MG'MC?)+G!6 43*!BN!V\_?P;$)MVH]+][?[6?9NW+>?&S%V76+IR_%Z/3Q\#
M=%%ST\6JNE7+)!@NK7W9+/&,WJL[$L5#L5@ED&\J=M".)1@#(5-W!FK<XAU!
M,-=' \VTZQ::X:+^1[/<-JG?P%>RUA+(I6KG.FG*J5*U*]65JD$#$D@7!6\"
M6 AFD01%J=1FK"MHI!"'<,3+&*[61<10(CN/+U]1UTLF$,JW%?U)ZTX_A0U,
M".7#&C25ANO_ )<F_@ZKER/>WC$DP^82>-E";@<@%7$#]L1V #)G HI#L'H.
M^WOUJ?X_G67WO^)V;5ZY7IGU5]Q].44?F#G(0 3.4"; ;U4Z;G,;?XA'?U'1
M8^1;?]IT2]E?VU-^U.Y&VDY?@CL<((HB5$13!42%,F83 H) W "B5( ,*HEW
MZ%#J;T#;5=[&R9:S=7[E_ HNW7.Q*5:+7D>?@@LDLBT;@=%I(2#;DW6;K%0<
MQSI1)<#D:G.FU545$3BF(@H41$I@W#5"QLANE?P7\#E[/<\Z]/\ ,24E7G0^
ME$T=P,/$NX"H4YCCLDIPW*H ;\P."FX[@.L.B49>7/54K]J'4\KS5.U*/5;4
MC7AYFQB$M!X5"0))33E#R3Q@9\C&.13F2"G(*,F[XZ!U-G%:;(.OFGK<!()V
MHIGVUR,ZMF25O1.4?V\OWGTCTQR+V/?RHVK;4(XM^B2^76W*O5QYZKCJ;WI^
MO05BB5H:=C6TI%JD(FLS?)%6:KE(<IR HDH/;.!3% ?BUZF[B6<F75?CU2][
M_9P/P[C;CNVRWH[GMN1<M9\']</E>O'@J(UZS<7/>$MQ-::LR>R7C7;),2SL
M"W,JZ_NLEGKD *[9I<%E"55\L<Q@#<I6BIMCF @@(<?)<MME'R6U9D^'A_(_
M16UYVU^M.Q1V+=)0AZ@6(N6/=>DLMM?[32_JBE715>K1L#JMKA[E 1UD@GB+
MR+DFY'""J!TU#$ Y2F[:P)F.0BJ8F #!N/7TZ===NU+S;=5]7M/SWN_;^Y[%
MNEW9-XC*QNUF3ZH.JTY-=23H_<8G^0.#Z_FK)\ P=F%A9:YC2Q3U0L:1.XM!
M3_[50#9-PHF(\5&CA(W!4NQA O4NQ@ =<[)P6ZWDZ7*5K5\?<>I]/?4G)].-
MS=^Q9_-[=>ETY%MZIIJCYJC5:JGA1Z%*\<<_2A[!,8*S*JG7,JU!?LM$7H$1
M1M$2JHX".D(9T810?-CH)@)%.8F, @4X H4=\L3,I2SDR;O5T\/^![OU,]/5
M:Q+7J%V7=6X=O9MOS+MJ"75B2>KC-12<6FTFFWK[&5/S-R+4,50V!,B7UX:*
MI]0\BZS+6.9/&KR"4 Q)0\D-E)=XFUY*LVK3YC=1SU(B7<3!MK<E<AH]*,^&
M[?A2[CO.W;GY6193?2]*TY5UH82>2WE+X99HH<IDVM7RVQENQJBLO5;K#XWN
M[A648DD1BU!CV[6+!U.T^4E.8 \3 S8BS910P@FDH.M+*MV[MF*E_N1=4]:K
M^1],]-?43>]HW*[V=;A.]L&1)*]&5.ARU54Z_4E[JK0N&E?5[\8J:1]0_(2\
MOL97*HUJJR<DM+UVQ2:;B'GF;5W"R4JXCHETC&/K! N"R:"*AQ579$<*I\RM
MU#:LPKE(4N54OCK[3B^I.'L?;VXO(VF?7;N2;Z8Z]-7]*UX+[S*ZR^=_CI7*
MQ3+6N_NTC"7^<=U&JN*_CBW3YWLRWJY;DW:'C63,\F4LQ75B.&0BEQ<D5( #
MN.L[:MW(]7.M:Z\3P<JWYQW&U6.=_JY_=P_ U7/O./#ZUMF\N^#F7V*K!057
M=FHUZQOD0L \2AF4',6=Q Q@&@G/X.E%6%+\27(J4(J0=-SG(4HG#7%O.[9O
M.YC2:;^I4_C73[M3]*[%W%@]_=MVNU.[91GN4*JQDRG25I)<6DDG))=*4U.J
MXLIMHS;XY7_&WDQE:)SS!,('/=0B\FSCU"EVHE'L.0L%J0%M=5.@3ZAUHZY7
MMM6H)ZW<MHWYERJR7:.#"JDB&W7P\I3K&35?:OP/@N_[)@86]7M@>?.679GH
MTX4DO?1:4XT29E#@*;?*X%^CZX1=+Q2<I_=NF[CET2HJ/BOO&JTN5$!(@F"#
M4B(LP,"9.)1 "[AK::3EU/ZJG#LRDK\[7]$6TEX&[#W?[O9J%&*U1M-ZT.=2
M2- - - - >"3V_#I'??8&#H1V]1#L*^F@*;5C$&MP@I%,1,(>-[93A\10^21
MV =]QT!<.@/DWI_G%_\ A!H"%L9?ZPO(+_TBUK_U2X]#\P: FH?0>F_0>G3K
MT].O3KH"PHY==:^2Z*B9DDVE;@S)G[Z*B2ZCQ[+@L5-JF4%FP-RLR!S.(D4Y
M_" "!MP(,\A(M=WEOQ$D4B'.E$YDGSKF(&X$*\QE;VI#']Q1.;0&5._Z;;8-
MNWP^]_E[?O[^S0GD4]TF==F=%-PLT4.AL1P@HFFX1*(@8ZR*BJ2R?( +L!1#
M;;?TT#XF@W(GU%J]@R*^J30VOE-BXN7\'9?:V_$K*]7*)D7D93[I2J+;YC'\
M/'/5P!=[7)8L\P8M" 8C=<Z"1NH#JGI>M*U(-HN,O/'Q'RSD)IBO'V>Z+<L@
M.:*SORM=KTI^/)LZXX1[ZCN0G8DCVN1KQAL)7#59TFY3,( )/36<4ZZU!F$0
MQ#E Q! 2CL("'H.X (?P#K,'WH!H!H!H!H!H!H#J.8>12 3?[AMQZA^L*4VP
M>P2E'??0$)^.$J>;PG1Y,ZJZYG369W6<F ZZG9L4PW RAPV QMDOWM 38N(@
MD<0'B.W0WP]!W#8?BW+N ^_IK&7TDQXFF7S!@E2^6B4TX504CYOQSC8"0;'5
ME6(#%-[[)-Y4SN?15.QH59?H379DI1L7\?>MA_"HX!5> .J/>7(TFW5#)L+B
M;S%#'3+'D6VCI'P 823*VDM,@NQBCS=&$[J";IO6[ES%QJI6I%(]T O0:K]H
M%4U$C#IURBZ+@8>1*61"\D]6HKVOP7M,XJG@.&\2K!@NEE\A(YPG,N\C%PW2
MK?!7:VUZLJOF#^8O"I_P-G%3C0CYFR=ILEG;AZJ8"G !.H8!U9T0DDY/4^AX
M6[96S2_+9,?+O..D9:/A7[O;_ R/DKSY"2DQDVJX\?8KM^0<:0)#R]70ALMU
M6KM[!9:^XEZ9%,;K)-W\;-*/8L2N7B:2/>8%XIJ);*%W*,(/JM\? ]'9[HRM
MRV1P>-A25*=77<Y^PO\ KTMY<MZU7OVDGL#2$VG4JEWA-5\A-&[AZK$MS2+B
M/: LU6AVJI@$R;<2"8I0 NQ.(EU,+]R+U3^XZ^U8^X7<-7+.+;BE6OERE+_Q
M=7!'AO62,VXZAHFPWAW@=O7Y2VQ%?CW#&HY??R#V3EV[PJ+1Q',3NW7R38C1
M9R\>G K5HV1$ZH@&VK?S4_;I[#GYVXY&)<Z;JE&7MY>T\;+,E@G+Y"XR86G#
M'[;6:HV:\56#+_>@W7EZ]4+,TK5CD6ZSID1HL6)FG@H*-SF YBAWB[E#5\;U
MQP6G(8VZY.116*R==4E4F56'\DU$FCP9#"C 3E(S$70WHQS]H@_I$1(B503E
M. ;<1 PCZ"'KI<N75#JDJ(LO9V:K<X>7)M+54\2!X_(/DMB[%^9,CYT:X1I,
M)7+)DFX.*]4$;I85F,$VGESLUW2T4Q:/+&ZG&C91XF=FD1XL98A/C-R'6M^:
M:J<79]PNXM^4LQ.$=:.6G$[9;,E[!E1'2S^C/5\BV>+H\ E T_,<L6/L4G50
MM[)I8T8Z(7<U**&N*E<*O7G;;-3[)G4 WPZT[T^N]7V'0P^^/R>=+!M1\US?
M5ISKIXHPUS4^\B9UFBM<&N-HR(+Y$P](QJ_HKVY+6\LF[3,=M)W(DY$M&S*.
M4?@!FI4"*F9-D$NXN;GMKA;LI/I<4E\R5?:?I3T:WG'EE9,=SMRA;GC7'*,E
M7Y.EIRX\$N7,VW8V\@\WS:#FI2<;C>"R#0HU:-NT3D>4GV$H\-#)B9W:XL(P
M3MWC!S&(@[4,"93JE PD]! .QCYURV^C)73).GOIS7C4_+?J+V'B;#&WW!V[
M=>;V??\ FADP5;:K_0W14DG5-/@U0M5_YB#.X7FLJV^V^/L;B1!-!A8YJQ1.
M6&K!LTGK67'S,)N/D(QNLG%2=C<%0*J450$A@7']%L.KY].5\TTE"/"O!^P^
M4_G\K$S+63L4YV]RA)3LWUI&U.+KU2:X)I-)T:JTJ<RR&<9G3PKEWMD;)P%M
MP%=A8@UBX0;0Z1Q/(J.!5V=(R+P7[ZN.6ZA#(*D$JI1(*)MBB4=<E9%[;KOS
M+^U7B^'_  YU/T>L[:O7O9,?9]TNVL7U(PX)2R6Z1RTJ:1:7UM\5T+QJ31%6
M#RDO&:*38:A)^.R]'=X5L:\G9/PG([\7,NXM4 :.@F;5O.-2Q@HK)BLLJNY,
ML<A#)=@H@*H=W$REDI23BXTKH^/+^=#X%NNSYG;N[9&W;E9NX^5CW7;=NXDI
M7&J_/%:IIUT==:D$9B&S>1$]/59EDG!]>RWAB;6;M;/%X]S'&N&LB:)EY=_&
M1$VZG0B++#G)77I' @J=NBZ:G(;=0  ='<<:*_N6]+D5I2M3V'I]ZCY?I?E7
M<?*BKVR[FNFYCW>:Y-53Z6N.E$^#Y&(F0_)W)'E/1/'.HC6L7J4>$R*SG_(Q
MQY U"X(.6E%J=%R'\U9%:0@X:K6>L6Q("(M3MS-W3=RHDZ 54QXC1B9<9I1N
MM*55U5Y>WXG;]3?2JYA;&O4OM1M['D24G*VW*$%2LH2HG3HK[J-:UJ>MK=O!
MI]8J]C][4?#R M<[.+U!O2;#X[Y[@9UM8+/'Q#0:[8XU[)D",7GHV7(1))Z!
M47!B.!(;F@MKK=,)33='&GM_<?(\'\QE8JO[5D6K:DJR=57JY\J_O+8\BUL&
M66+D[<W?^-=,ML86'D[/#+82RE&2]T@:.G\C4T;'"VEQ*,W$:$:[3;UB16;*
M)%;O$R-Q["P@&CN"E%?V(MS]FI]%]+NZ.WNUMWDN]\)YV-=3AU<H.2:ZT^J-
M:-JJ\-?8Y$J.?, L*O65K'1,"8KL!KRZFZWC#(.$\NJY'>Y8[$;1%GL37(&9
M*U>V"82<,6C)!N@B55JL@9, 3$HA&'-VH].0NB?@^+.-W]M6V]O;O'_'7H7M
MHO2^2[%U@Z\$G37WF15+QYBE''=DL^-\=^%RE.0M2S6WQ];PADQVK&VFW1-<
M>61.?KK>?%VVD$HM)BI*I"F)FR37]*&Z>MSR+;ZYM+I:T]K/+WMORK5UW;<I
M6YPM]?&C:3Y4?/D:W;OA6I8<L=@K-(QAA#*% =M\IXCIM3:X\DX6E8;R-'TB
MU7=C&LE)!RZG86(;N3K?)RC8IR&0.LVY"42%-QK%F];S-(ORJ\::<>3?+VGW
MZ?<GI+ZG>ETMNS<3_$=\[9%=.1<;3RG%4K%=;JY/ETK7@9G^%@Y%#QF^E*:\
MR=+G4R2^,?V<?U:,L:+K\#7\=+6G_P NEFGCP2R*9B 4#MSBB0H;FVW H>@H
MU%2?!GYCP(W(2E&]K=7'Q-]_^+_N]FH3355P.G+ZD?6A(T!;]K?2$95;-)11
M2FE(^ FGT:4Z)G)#/VD>Y<,BF;D,4[@HN$R[D 0$P= ]= :W?I>>2>;?)3"E
MBO&>+5CNSV:(MYH@)7&81W[,(M5(E@^_!UPC!40:S\.Y>F;/VQUEUVS@HD.)
M?30&T IN6W3;< $/;N Z \,H &CGY?3=B[Z_8+=4/\.@*13B"2JP1!'<2Q+$
M/7?_ ,$2V_@T!<^@.M0#"7X?7IL(AN &W#B82^WB;KH"#<7D'^\#R!$3KIJC
MD:!263.H4Z8B&-:4X;N$.FY>;%5(@E]@I[Z G4-A ! .@^S;V?D^W0$;1150
MRG;U#(]M U3IR3=<0V%P=.0LIG)"[@'($.\3E[A.'OT!&>=Q$,@>,  (AOFE
MR @ B&X?W<7@=AV]0Z: R)V'N>@_=W_<[N@++O\ 5AN5$MM9429/B6"K3<.D
MRE #\,6<OXMVV;)/B\#B=F+A4G<#B;X2[@&X;:$OB6!3,+TUO2*A%7+'F.)J
MRMZA78FY/UJ;7GY)J:C81BQEW)W#R..L^;+OD#G(=41W((;[CT 07Q$8]IT%
M'R414:Q6:BE((BB[&L5R#@!51$0#D)6$<F@OR$!'](D8@"/H.V@)!;)&12!,
MQN6P]/;L&P;]=B[[GW']W0'?H!H!H!H!H!H!H#Y'?D7W!O\ EWZ: QX\45!5
M\?,=J"4""=G/&XAZ!O:IWIH#(1< %(X"'(!+MQZ;&W'T'ETV'V[^S6,OI9,>
M)J0\NH]NMY45IRNJ_%8<+H)P2$?)L!D4+*A>3+-9JNUJ22&//:(F.46.2R2I
MQAJJW SPQ#.01#5!<N&IIWDHX;#A'SE;'3-*2C.=\$Y$)(LM)S9G#:.=T=Z=
M1"PN"#,RY7"$;R%ZX,/S6X&$"@/09V;C_P AB6?Z7D(W"+8VI+N^5S,ZN/Z_
M)96K#)&&KV0'!799RO,FK>81CD(XOS)V+0S<EE?$,L1(JIRKB!C&V+QL56TN
M=#]09O:6TYFZVLG(X.UJGJOI?!>TJ<70(6LV"V3-8J]>JLYDJXN;S?'L*V63
M_:FYR2:31_8IY8@J+24@Z:M42;_#Q(0$P 2%*4,:K2BU,L;;=DVW9I3HNBG#
M[-4_DBG5.2;.DY.?K]X-;$G]GGADH\]A0FWE2? LK'/8!N=NT1=0*<<9L99-
MLN51PD903&.<-@!I6JT^)5LN7M.[8]S#N7G:Z%5-)+CRXZT+,>X@QG?7==F+
M<H[S*^QG,R"-57MUN;6E:B3+D&1Y-M'*0"$=^'RCA)%N9<CXKI04-DA(":J@
M'-+F<3+[*[;W*_6>=+[TO@7_ (OQEC4N8[!D]&=F;[F@*@E2YA_99R$GYZL5
M9G(I/R0;-C#PL*:NL'4BD0%0,F!C;!N(CUUOV^GH7N/)Y/:VQ[3D3\K.TC+_
M %+[:?B2?2GS9M-S"S')TMDMW'OU@1H[VZT^Q(0KA%X<PD&%KD'$S+ &!E03
M %E5N*/PGYJ"!@F?TZZHY.7:P,>$[^-F2G<7].FM=/PK7X&-]LQA3LWSV9<7
MWU\.<*)%62AV\8&V3+"4)4+0YBIM8T,W?4].OO?EH5PJ<46CY5RJCW/TAA-L
M!=5QBVW3B>E[>Q<7<HQADRHE37V>TNZ5Q=7+!/XZGEZQ'+S>(8N1@J#.G=RR
M;^LQTHW0;.6+9!)^DS>$719I$4%R1<#)% @@(!K5O**O42TZ3Z!B=K['A9D<
MF='<4%PX<?O,??*A62AH_"SY1:9:M$?(C$<0X?5]DK,*-UYBR"R;,9".!%R+
M>$>JB4CIX4I>P4Q=SE#?7!W*JG%K@IQ_;X'T?M;=\&U=R[%J.CQ+RI3BNB7.
MOX?$V7>4/C-"9EKSZ981L&-W1A'L Y/+,4W3&Z5*0XFDZ;8TA*)5&+SM@*1^
M(B@I[TSJ%-Z;*PXY/T:7*::?A7]Y^1NQ.\5BW7L?<BE<[9R9_+"K_MMU^:*T
M7/YES6O%(U)^0^?X#&SCPJ\>X</'C U#E,JKJ2F%<LT*PSY+I8*7;8%1PC2$
M(R(F&,;+M_QYPNW15626,[5050.=N3F71P935V6->5.A?CP^XYG>6Q8O;>[P
MVS N1O6;C\R,XO3RI)]*]]>/W>)^@Z:BXFS0SZ#G&"<C&R:"[%\V=(E61=H.
M$SE514(<0 0XCU]WL'IKHY6)"[#6CTIJ>?L[G?[<W"WG84I0R(RZE*/%-?;[
MC3TUR$P\0\G9*H2&0&TK@=S8BPTI#-9AHUR#AY24KT6999^B^5&1&-4=RYG;
M.5[0M1 Y43"' HZ\WC-X%^47_L]5%[#].;?B;=ZZ;%^4C)6_4^W9<K,>"O15
M=::NM$V_ETTXHR+K7CIX@8_Q"2!KUZ0H./<LOUG4C*'R%!55[E5651<-G$!/
MR<FFW/8F@)O' "Q*4% %PIOZCKTD/R^0JIUCX_ _+^[[?G=J9>3M._VY/?,>
M:C?C-:V_F2]B6K7WD>YD\2,)KJ/QPC>*K3,HXXIA&K/%*MNKB55:8_CV0*/H
M&=IA^;^'A';1;N [<!V"=SF(@F<0UR<W;=?-M4JOMJ?8?3_U(N;!G6^U.Y>J
M]V9EJDH4K3JTZEP<DM*I/W:JA3_#R:\+;7 -+&K0\$U3(V*9$S:6LS7]EOEH
M)^U=K,4W2%B%VK%M%OQ*44(FF"W9!1QN@&QP#6&)FR<7"6DXO]GV_@4>IWIN
MNU=V>7L#=[M_)@KMN44_EZZ_(_W<=.)D.[\/O"&Y69Y6PQ9@67E(='\8L=-+
M#P#ZRMW#YXM(P\Q-((O33L6V1<OUC( J0$%/F! H;;!KHP_N?,V?'E.<YN%W
MZT0!Y4^ >/21,/>\.8EQZ]D*4YFYI[CUS7V;D)Q*=4.YM$G7GKHIW32T/ ^-
M4PJE(Y*F4/A.FF;7/N6;]Y>923:?V^/[3[;Z5=W=HV+USL[O>W;G:SH]%B]+
M3R9O1-ZKY/%\53FB:?&"H>+60J"@O2\44*!?M9XUFGJNE#()_A=O=1D3"/Y9
MNW=E%4.\SK[9OR.0#@1J0BFQ@W&W$R'>;LOA!:T]]#QOJ!Z:[_Z<[S>P<F4K
MN'D5E:N<5*#=4DTJ::<-'RJ39?<48ZIF(<P_LO1*I +2-*R!8I)U'PS)%_(3
MYJ;,-@F'<@5(72LJF@H*8+B<3D)\)1 NP:WE1I^)X2S&-C"DX?[M-?>:Z/%%
M!J3Q>^D4LW65,D9CBPR0J%(D94#>/5J3,8Q"@0G+N;^@=0Z^NMN[_P#Q[;]B
M.7M\I7&YS^M\3=25XB/#83;GY"4O$>9N(")@ OJ(E+L80_Q1 ?;K4L?1\3J2
M^I'I(H4XB ;[AZ@/\( (;@(A[=AZ:M)/O0%LW5N#NFVUJ*J"(.:S/-Q6<H*N
M6R0+13M,57#9%PT6<()\MSD(JD8Y0$ .41W #5_])K'T90<+V)G'9UKV>$I>
M5J[UQ(QT/+0,E43-JFRCBUA_%2SUT=C&I R*I&MPY*HH&,"KAX?=<0-LH!L&
MP>@: \4E_P"+W_O^1=__ ) _^_H"D5'<:O![^OX4QW__ $1+0%RZ X'T_=#\
MX: @/&2*2>4O)!T5P918]]I9%68J 8C=-OB6C&2731';MJ.#*F 3?QN >[0$
M]@(\=^H#MO\ %[!^WTT!';-\[6R3(,!$WR+.G13HA#-B<3+R$L_ QTW@'%0>
MU\GL*1BAL @8HCN.P$6YX_U@^+W_ *:G/_JWO.@,C_X__>O^,T)Y?$\KM%ZM
M&.DXYRDUD%&2A&#EPB#E!J\%$P-UU&XB7O)$6$HF+N'(H;;AH'Q-<WG[5O):
M;H7BVZ\?I)PYR-4_+#"<Q>4V:5I3ITI5%6L_"7"5N,759)A.NJ% 2,FG*+L0
M=%24*V(FJ)B".I,^A5+ZP'8O-2P92DI3)EG\0K=@1M7Y: ^>P<[NCFS_ -XL
M+*KA\T*\M(2L;'HJM5/EY.-67549N$"F34'DH4(,6DN!G@4W(!'[1#_W>OO_
M #:&)]: : : : : : : X'J(!O\ :/V["&@,>?%(0-X_8[';B!FDZ.P>S>TS
MO0- 9"G#D40_WNNP[[" ]! ?;K"XZ0;)7$T]>:1W/^TQ# HLW)#N<"-&#EN]
MK[680E).1R>V;PD:#,W*=NT@O,E1-'U-D5).6D")*OEB,T% -J>9+P+K?S/I
M-1GSSUAAOSPL3(7X)OP\ $#PSU9NO,MVSNS5RJV1C+J0J16Q)13@*[D&I/E&
MW,@)F%,P&"^TNN-7IJ;6#9C?WG'L-T4)*=5QK6E/=H;UFBS=!N5NU2.=(2)A
MQ,;D'PE* =0^\8 #K]NJ[L_+^C5H_4LK%S)=K<'-Q<+=%%4H]'QY\RM-U6P(
MHO#BL@HH[!L0J)4Q%(IA IE#E5^#<I1'K[/9UVUNX-A9=KJN?++V?S./E7;L
MMNE8E%='3[3"[&&=K1E7R NN%S8AQ/7ZI6W-[?VJXXPR71IN7%S"VU.$A)JQ
MU.+D74X/XY$.$RRAGS"+<Q\JIV!(JF(*:SP\>&5DW+-Q],(1337/6FI\X[=W
MB[B;M=P7CV[MJ>E92E5:\J4K\:F5$?'PL.I()UV&CXE):36D':T='MHW\0D#
MII)*R+M-DDD1=V=-$A!5, F.4@==MM49MN.,WY?S>\^KV]MV_KA6VO,E33JE
MI[M:G97$(.K3L[:8*!C8RP6=,Y+--142P9S,_P E"K :1D6Z"#MX +$ VZAS
M".W4=:MK-O-]+C!17M=32S>S\3*ORE>A9A:;T?7.M/:N%?<>RCP=%IUJ5M-9
MI%5K$_*.#JR4M$5B$CY21!\N5PN>0DFK)-VL=P<@&.8YS"8P /KKJ6YPG];5
M/8<;/[0VF&#<LV_+4VM))MM:K@GH_P"!>35&J1\E*OZ?4:[7&LE+/).>_9R.
M:Q99V75'=61ERM$4A?R0AN KJ\E# (AOK*<[<?H=4<G;=FQ,&D89%QWO=&A2
M'"QG;HZK5B"9%A#IP'EW2F'H  &PDV$.OKK0NJ-RYU.O53X'L\?+P\*'E9-Z
M3R7JDZ5<>7XU,!?.*XM*/3Z@F63+#W60R%&HU)$KDS-PXL[%BZDVJ;!$!,$R
M^0CD55BM]AW+N8 Y$UY3>+DX-47S=2/M'HKM^W;[NM^SN"A"U.S.*J^-4UJF
M^#-M> <RQF8<852PQ4@24E5XJ/:V8IC((OV4Z2+1&1,\8]P!1Y.2B($)R$_/
M8  0-MZO!OPN6UU.LJ*O[_N/Q)ZI=J9O9'?61VSD173:NRZ9P=86X-MQDI.G
M*FDD:"?KSMUFV5O =2JQB1[L\RPM)MFIXQ/L6G]G)FO2:5;;3+TBT3#6R0^5
M$C%P5,C[D!2D7*4Y4S59T)N_U8T:R6K?BO X>R9NW9>[X6S;IE2GA7+W3+)^
M6L$TU3BHT3:T:-HN5O)*%O\ X795NKU_9Z78X.!*[F&=2(HVN\4M"V.+;/0@
MVLH\A%VTL@X+V3 =82IG'H)R"4#96\B=SY;M(IKVU]VIZ'U/[1Q_3O=[&1FW
M)7]BO./E75TM33X-THJ2T:IRXZU)H\8H.E9D\6,46BWB?)BV1L61*<_=;W4(
M"%OETB7;95LDI;TH_P"<^7E5&A2 X3(Y.0%B[E$/35DL5Y,';2Z8I44N+?*N
MOBCRV#O^1VYO?^7VK)MVLV%WJMW%*C@DZJ,=*2BFOZDZZU,<7#8WAY:(^LY"
MKYK[X[6">#]CYV:K\?,AC:0>&,"#!!H]1=(-#ICL!3IE("J0&.(@<-A\_.UD
M;?GV\234L.XZ.?\ IT]Q^EKN%M/KIM?YK;Y86/ZB6[;<K?7+_P!>XQZI2GQ2
M?2I270DNI4=%J;&8F*ITT4+9&1%9DEI^,*!["WBXAVZE8MVW3)\L^E2M?F7;
M$Z0 44CG,78 *(;=->LL6[%RUTIIZ4KX^U'Y6M6[FW9>3A;A>A_9G*-9.DX2
M3HTE2E$UQ9A5Y.^+RA'".9,#P$#$7ZO-4?Q2HQL'$HPF1(9@Y"0.P>Q8-"QR
MLR@=,IFZ@I@)Q*!3#MTUR,O;YJ#R;"I>A6J\4?=?2/U$V.<7V!ZBY-K_ -IY
MMW^UE)]5^S<<:133I#RGHY:OI>J1-?C1F"H9KK![BA7(BMY!3XPMW:C'L&UD
M5=QBP,^+PZ:0/SM"."<DT5S&%N(<=M@ =9;5<_,6VKE(SKP/*^JGIMNGI_W%
MT*]CY';M]=6/DPDVIQE]*D^E+JI2O+PXF5ZB)U0 16 H%*8NY0*(_$ ARZEW
M 0 ==.L8Q<%'5GS'R;TH]-R,7?7TSUZH^U+A]YK0\A*!8?&FW*>46&8]1U!%
M=]_-^/6Y.",]#.3)$>V&!#91-C(@<I5'!4R@50X <0]=<3*LY6!<>;@6U<E-
MM7$ZT4>-53[<S]1>FNZVO4?8EZ5]V9,/\K3JV_+N43=Y:*S??],.FKMN,7)R
MI%Z,R(-F6GYS\9\C7>BOP>QLAC+(*#ENH)"OX5^E4);O1TDB!A%-VW.(;\>0
M&*(&+N @.MW&OV,JVNETO4U7@^9\.[Y[#[B]/NX;NS;W:E&]"3K5-=<:ND[5
M4JQ;\:,TQ7_R6M'B[]-[Z8V?*SBZ.R,WQY6\<V>QU]:WJ4\K6%B/'2U.%A0=
MFJUC7$[MFP<<0%N3MJ\!-\)^FY-R<(VYJCBCP<)>7E3C:H[?5HUX&F*%^N5]
M1VER5'\F[GEK&>0:+DY[-V%CX^UF%9&Q] 4AJP4N<?7221Z#'6<\Q&TIFLV?
M336:>@C+]LPM@;F.!:8Q4%TIG7\M2AYC>J/V&^"7FO4/-G%YK]#0B%+L38L:
MM.4(;.6W2$$QF6",I!NY&7;04&P!U),W(=Q!,AC(*)F(<1$ $<BLSDT!YGJ
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M"# J$Y7F4HQ@FCE?\<+71=Q2B)"."@ (%[2OQ@H4+IP4,&5U*GS?N.EM/_\
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M\I,K.Y:RY2P!=?'<[9W N&=6NDQ5YP)>/50!19JU"%6.[;?+D .X9PBF(&,
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MKV3&4Q^R-\B/T*9FTR@45463XB*8E%P1$W=*4H* /$->?R=WN3R/,M1:B_\
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ME-9/AX<>'L,]XR;K\NI(A$2L3)+1CDS"63CGS-ZK'/2$!51C(D;*J*,WA2'
MPI*@50 '?;3E3D5]4J4;=%[6=RB+(JH'*BRYF*8@&,BEN&P["7F!!,)3&,&X
M>S;445*<BW\QD4IYDZ?]3_B1GC_Y1^26L;AK,-TKI.O7[&&M";!!Q"IQ39M
M(L8R/*0BR#1ZC#_.@F/)7=P)C=!WTZ8^"^XE964N%VY7_KE_$E$S.-5V*9HS
M..X" &;(F$#;B(&V,F.P[@/74\-5Q)CEY4?INW%[I27[SZ_#F'4/DVNP^O\
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MCFG)P[R\2BEJ8#(.(S( 14&2PQ+YSN0KIB@Z9/(E)0K/=J8QDA*9 1W !ZZ
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M!R'[I3#TWVZ".@+8\?3*&P-A(RQ.TJ;$6-A53Y@IVU/V-AA.3N!T/Q$?7VZ
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MIB(\3E  ^$?\D1]= ^)]MFYFX 0!(!"E I2D+Q  #?;8/8&VW3WAO[="#UZ
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M=$,N .&/R3EIQ$INIC>H]=:;5-'Q/E65CRGB0RGQE&I^@K;T^S?0Y"T5#G4
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M,)ER./P=X[+))NR@0#<^ @!.GKK/H2X%2VFNCG*I[Z)"7V+F)92WW*%LL8[
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M[V3&F.XJ3\="58Z&PFB+157Z5>:2E<E4%RW3PKA1(6@E035!-YV<NJ'*<16
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M6V].J=8J+1V\?LZM7H2N-'L@<JL@[;0<8UC$'3]4A4R*O7";4#JF I0,<PB
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M^F\UJ\-.+/ZSY1^*TI<63!F_(YBJM$XXN36QJ3;=F)#M(V/7<$*Y*M^A3.4
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M[&()1'</0=] >MKV_ED!2*!4S))G(4H; !3E P;!UV#KZ: [] - - - - -
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M)?(.0.HJ(%2*!DC!S4,.W$$_R]=] >MAM\BRV$#!\HWV,'4#!V2;&#UZ#[-
M>O0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0'P8-Q#T
M#J7;?V[#N8/RB : Q@\+I-Q,>,V,))TLNX7=-[08ZSD#%7/PN]E2+W -\0"!
M$P -_8&@,HM - 0]7VW'-^3G7/?OT3%2/;]P(2>2!$WV[@MMH"8/9TV'IT]W
MV?N: @:ZLT5\TX!>K+./F&2>5P0*1%,45OFZO&D5%P<2]Q'M%*'#CMR'UT!=
M5_Y?M%BL04.0/VW5 P%(8Q5 &MS8\#B'W W#U'VZ D/XN]RY#OM_C#PVY<=O
M=PVZ_P .A/+XGI1_5)_R"_FT#XG9H0- - - - - - - - - - - - - 6_9D
MC+PDLW+Q$SB-=(EY@!B@)TCAN8!Z<=]OW= 52/+Q8,B=-R-&Q!VZ!N5$A1V^
MSIH#V: : : ^#*$)]\Y2^H]1]@;B(_D#;0'/,N_'D&^XAM[=P #"'Y0 0T!]
M: : : : : : : : : : : : : : : : : : : : : ZC;=PO01,.WIMT*!N6
MXB/3;I^70&%OT\)8TQX>X=?*<@45)?D5>XDLB(J,LFW)H<2$6^/M<DAXB(CN
M&V@,U] - 1+!@I_?-D<PBGV_V'QGP^ >X4_XCD/F)C[@7@)=M@]^@)9+U*&_
MM*'N]WV=- 0[;@#^]G#?0/\ ^I/_ %?8_P"]H"LWQ9VE-XT*W=LFR2UT[;Q-
MV7=1VA^ S!NPRZ='/,H&_D@.@+\XG[VVP;<?3B;[W+[VWKQ[O7W<=">7Q/4C
M^J3_ )!?S:!\3LT(&@&@&@&@&@&@&@&@&@&@&@&@&@/A0@*$,F;J4Y1*8/\
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M%+R+U#H CH#W]PH@4P?$!N/4HE,  ?T,(@80X_;H#LT T T T T T T T T
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MZV%NS\N9,5<B?-@L)P.#7]F&P<F?#H*OS/; >>X<1'[- 5+)C9960Q6J@<Q
M:Y0BE'  )N)VIZ]9D#E.4#E 0[JB8[COMMZ: DKX>]Z].U]W^+OO]WCMZ?9H
M3R.]']4G_(+^;0/B=FA T T T T T T T T T T T T T T _)ZZ UO_ %%J
MU._W;8XO]5S/C_"K[&.34I>87RI5G]_QSD2D3%:FXO(&/;'0(]XS>7)>1KO>
M>LV*1_FEG,>4J.QQ#4LM35:%<^GC!4)GC6Z62F./%>8?6R[N7MEM7B9C]QC>
MBV!=./:.H=2=K[M_(+ELR$7)E4.J50R*R#A,Y.AAT,9M,V!B4HB!A !$/01
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M&3!07<K:8>38(V2(=/&/843?)+ID<(I(E 0*8H9@_0C*)J&M=2-\XFDF1.Q
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MH[#H"K\OBY_]R[FV_7CRY[;^N_'0GD>E']4G_(+^;0/B=FA T T T T T T
MT T T T T T T T 'T'0A\#4#X]FCR>7WU'DOEUSBCY$8N<G%V<'#=14?&?$
MW<^3$=S)<  2\!^$O3V:RKQ1]#[;MQ?;\I476JZKCQ^WM,SO&>O3]6\=HVIQ
MMZ;Y L=??9'C8FXR39T5DK('MUE=1#223,H+UVQ@5G*318Q3<U4FXB0>H:PB
MTKL%+Z6]?=0\#?;>3K5_.R[K\SES8(GVU_+%/YXE+1-;SUU)XQA'4HDP;_CC
MBOHOE%)%I&'= H+8BQS+ 00 PB.^OD7KAB6\KTLWV%R,9Q6+<:32:6G%5K0V
M-O;_ ,O;A5]#:T^)COG)O7GV%<IH66&8VBM/,?6!&:@'TF$*PGHA2/5*ZBG\
MN!DSQS-\E\!E $"E(;?V:_A)Z69%W#[[VVW8G*V_-@GTMJNO.C1]5R(0ECW:
MI:5I4S7J2+)O5ZRA&-RM8]*O0R;!F03J%0:)1C1)LB"QN0J W; 0G(1^(0W'
M7^B?8'&.QX2BDE*Q;X?]%?VGQV\VO-=$Y*7OYF)?G1"NK5XQ7A@JB+0_SL*9
M4KE<I=VI9=!H4PG Q"I%5%R  ;D @ ^NMO<TG8;7"OVU_<?3O3.QMUGO_&G"
MXI7NAM13T<J52Z:TX^S4UI*U9[7\*O,DX#L#2TT^6J#:O9GQV=(94E5L$E#H
MJ+KF8\B*QQ4!6*X*H E#8?40W$OEFW&TW%Z-ZH_0.3W'9WK?GL?>:>%F6LAO
M&:^3K@Z**5.BM?#4V2> "AG7C-52++G<JA-6,3N#G.5114\LJHIOL4A .0QM
MAXAL'IU]1]!LT[BMUJWQXZGY]]8[<L#O5SE%+)\N/3!:)JCUZ5[-7I\3/#70
M/F8T T T T T T T T T T T T T T T T T!TFW _ION)  1WV#81W !+N/
M+K[=@T!@9AS$L)DW F3,97-.9;L'^>LX+"L148^;BI!CE68F8F0C5B&6(U78
MNRIJH_Q1  V#8=+60K=RO@Z%-^RK]OH9=U=\9+4&5JADW(^:K#DT,>ED1I]<
MD:M$1+*/7D(HL0>37.R=*HN9@S0#@HX(BD90QQ$"DW/SZ<LY/'E;A!)RY\SE
MX^SSLYD,ISETPKI735-<*^TJ]1P#<#Y2:Y0RWDM7([ZI/+27%D$A6(^LPU*C
M)]PHB0S@C)50\U.MX82,P=J;'%(HCN(F$=::G\I%[&G+,\W6E="_SLY%;R%(
M^2&,4BF6'G$>[15(N2<+)/KLQ<L3M3B7Y4\.=FQ7,L&_<*LFEML41WI;J=Q\
M%[C#YKX*V=W]1*S>;4[;Z YKY(>K1%%I X[<O+@P1C\?EJ4W(.[N,\Q8,9-2
M276.W4_#G[DK,W9!9),PE""#.RP%;AD#&O-1)-<0N@HHB?\ 2+",.U,MP #E
MY"F4VYN@[ /LT!3,VK+MZ4S5;K&04"_8M3%0ASICVE\CU9!9,3)F*;@LDH)#
M!OL8IA >@Z E78>__$V[>WI_%Y[;>OK[-">1V(_JD_Y!?S:!\3LT(&@&@&@&
M@&@&@&@&@&@&@&@&@&@&@.!]!_)H0^!ITQ%(8YJ/F#YQC(9&Q^SNEISICB6>
MUEY<X]K*M8IE@B@,H=>09RCU%2./)@S<"*:1.!"I\@ZB.LN9[CMW/Q[6Q3Q9
M.7G4?)M&<GB(ACN/PVSK^+#(+5&L7'(T(B[1F6T\=]*)7::=SDDYD&I$TE%)
M.5>*K$#;<J1B]1#81JN54HS_ *8MU^X\7>=,EK_FJ23G!N5YB;(C,Z9URK5"
M8*+=)3L**_Z.81 BXB4I-R[AO[-]]?._5J"N^F>\12<G=Q9J-%6K:TT-K A*
M.X6\A_[::J0,^,UF(1XU2%JNG)Q"S8HINFHME 50%,!*MR4(3HJ8I^ADO?K_
M #_=F/,V_P!4,7%O8F8G:RE%R5J3A52I\LN:]O ^IW;UEXDY]2I-57C\499P
M/2&A^VL5UVX]BCWP6(N54$FZ:9SBHD/:45YE'<Q?AU_HK[<NQO;!MTM4G8AH
MU1Z0\#Y#?MW8RN)4ZW+37V_P,6?.-^6,\<[P['YI)8YX9-%=H7NJHG;2S5XF
M<I3B"9164;@D(C]T%!'KMMKJ[G+_ --T+A6O#Q/<>EF'C2[[L;O"34[,7+71
M5CP5&]>/@:P)^H3OC_229<Q)88.9JN1\=,8;+%?-(-'XQAI2+4<CW$DUR.03
M9R#KNIK@8%&IA.3]6H8@^:=IJ":HV^7A]O#V:GZ5M7NU_4/?Y2[K=[$WK!R>
MK'E;A6W<M0::K).*3JM:IU3JGX;$?IZ*-5?&>L EN/:L%K%4J9>!2*KRZBW;
M(4NP<")F+U*&W77<VN3L6UU^#7C[3X+Z[WUD=^O=51]%N$8J+JFJ.-73@_91
MF?.NB?*AH!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H")<5423HL=<V<BNW<
MGL64,BWAL9J8Q0387"RNYIBV5$X;_-MFZY2''[OKMK*D*5YF6BU7$ECB #N
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E)P$RAR@7<P@ B*%_[E[VWQ[=KCRV4W^[MRVX[[;?P]=">1__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>g68105page170.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page170.jpg
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MQTMHD#FW'<)PVWC&%_L4_@PUR3KGFJ/?ZW#REAL.NK/!0,''F2\U-2WS%-]
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MOHV7I14)0;I%1418CC[A'+^8)OYS-F@'JC9XL.':5F'>4.Z+:I&-D?/"V<^
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M@FS;+/1VO]&\=J@%-6*15A1TY*C06L 6CY4KMC"GG<*7X)2G&<)2G& 9AB7
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MP7W7/;&GQYVKZAB:5?[3+DVNV!4O2]QD'J^T-(MP'QVN2NMZL])DCB2"HMO
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MNIQA>8?&$Y/]N?$<C)'ZC-\9B?(09NR%\H9CM5HD@@$$VD2-4JS?ZM\IB/\
M!Q?).N,1%J>+ P$'T+&M0WN!@@#7PS_,J7_]2Y_^":NM&M.K,8_:&?\ T3?_
M (F.FFN7IIHZ::.FFCIIJ&U;_G;8'[LFOX%T[IIJ9=--4M:_\<2OZ]TI_#2V
M]--))R\W37M55BDTRQU2:M+')"U[6X_QZXN*Q-1M?E+7<)^5:FK?&^;/KU%
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M8MBR:CI$#+[>2L90,K*GD-^+.<KRK#PV(XF  5*@+!HTNAH1) # +1C4A@:
M:]/E9/\ '9$:21DN(-" ,;0(]2A+U$0+2H+"+"U!JW5\K"104CR1XNTC9MVE
M<ZR@*I$ZX;V"0BZU6_Q=HP* 0/MI:IV5;B&,=F&5M+CGB4D+<6XSWSM\;IXL
M&&YG958B"*('7*!$0&7(%NF%!(BI&LV3*67+F(L0>0AI#;A;'@_N,"2OXJ3
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M.8BX"M!ZHL,]*E*RD6+A(6SW22E9(I2<*4D8$$9;J\XQG.$IS]&>J>1GP\7
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M %_ES !E2!:R5&[(" ;]:'_)EK9T%RWI3AL;6H]3_P I32 B_@($*&^HV.Y
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M4UZ::C=RQWJ%JQV2KO6YS'BO.,(SWC"OH5G/T83G^;W_ )G46FTQ!,==OO\
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M09+F+8)5[EIE?J^6>J_C4#\;'C<CNPLP((!:V6"&Z!7M2P"XJT( 2(N^2RY
M[Y,+%45U1ZDD*Q4$]I/M-QN/8I,O.^MD-:0]-TJN5C9ODI8;PP0XR%'QFU[W
M0WW:[W,D)%D",^%P]:>3_4YR&&FW<+RD09E*<?5RK//(76P@-DGW?B,"#/J9
MJQB9.N-8C!I"8XH*!:Q$?0 =H]"?73&@G@R@8\A&&B2(!;27A#@262PRF5?L
M71R1UN,O-*_F*2K.,]1((W_\34:D"")%1KM]<UW7S@;;Y?UO1(VCJ:9I7?UW
MD"^*F@C#K#K7D4[J^L&1\A44+9BGZDDE#+IHRF,X)(4C^JD90E65)1C&&FJ1
M?^8A0"8Z5B'^+'+-R*G<R"IF,_EE/I E%RY)ALLX:(@Q+#[LJ7($.$KRGR(4
M\O+F5>6>FFM7N+7,32-OT?7+ELZL;$HJY>X[%@Z[&[8D[5R'LB Z@%5'+')D
MWJ+@[(B$A5-S@V$L&/,97V4I/J9\_&MLF-6(;W!"QI^$?SUI&Y)$"NNDL$!K
M:V0* *RQ#$4%?:&),0 #)&F,JG.+BG-5F.F:E=I1VN.M?U @#46W O0&P0P/
MZBH96OQCX\-+Q2.ZW!VV\)SE><^&%*Q:+LJKEJ58 @GT(!$SM0BA@C[CH$@L
MH%5)D#U[B8_>FUC(F3M).KOU5NK6^ZXV5EM;39TX!"G,1LD\=5K;5EL&$"-'
MLMMC6Z"@BBD+$>2OU&4.-X[]LJ[_ $=2;&ZH'80I)'3=:&FX@TK_ ,-1N%Q7
M\0_I(_G!^Z#L1,+XI?YA:3_75T_A[:.H:[I._F(W"S:]I7)^]4N8G*_;*?\
M+UWM9:]-UER:9L,9+0TY$2 1D([7$KGT2C+S&,L9"QDKU.WI?7[=>/\ .Y\G
M'^/\V(LK#D<>8F;3R,084Z%20>D$S2=;_C,2YN8,3Q!3)O$3XV@UI0P:Z:WB
MQ/REKU;J.TSA1QTU9>,G'6?F#9-)R9(R4F*[8)$\J11)I1)).?*(4I[!&,/X
M<SGU,>??KZGY?"O&^6Y7'2VS'R,BBV+85B.VVD4I%(VIKYGX#-DY/P7#Y&5B
MV7)Q<3$F9)9 9,UDS6:SO73/]>=KU]'331TTT=--0J]?\W0G[M:1_"B+Z::F
MO3348N_;[&6[NE*\?9B?[H5]"5X^%%]TJSCZ<)5CZ,]5YJX7]OM/N]NW7Z>O
MTU)/>-]QMO\ =]?37QQ6[3MFM&GK34K/OSBJ\J4T!R1KRBZ/9X&KUF-8MO(.
MLS+$O$TG[)GZY+BJ?'1(]?CCRXTB4)EL/(9)PZM;V<WQN.4X;ERS(O\ MX7T
MEWQ9,^8L%([/U#$#'X@I&-1!B-48&7!\IR<YL3#YOFC%H%JY,&+&$.Q88E!+
MERP)93]EQE:XO<2G>02^1.N*B'<;?S"E\L0FSY.#(KYNVJ9J]F%*AY"AU>MI
M$)I0=>>;!7Z;AY))KS"2,+]1Q;@8<@P<?%Y Q"\ 3(W'R^3D-M"VNI&$J  <
M<%NV5-_SW?R_)QV9$.#D1=V$A?CQQU<@2;L;+>[%B5R7C<7:DTW S4DBT.(Y
M6T"+Q*,<DW<.B<C[XPQ XN=7I%55D4@9EI(*-2EQF< J:]/X8:>X,-@=QQW*
MLBEWXZVN"&P8A-3[_GFS@@_BN /%0BN5 4'Y:VZ\GRY5S,URPG(>1!IX_A!B
MM(C>OZ@@TO[S+]VMH]2M+8XW_+08=(26ZP9I]ATMMUQ]LMQGC7LAMPMLAW&'
M2$$K3ES#B_KKPKR5].<]?0\U@W-S,!:#F<QM$L:0*"-H%!TUH^-4K\=QU+7D
M<?&+IFZ$6LFIG>34[G56_+3VA>]K:XV'*;!LEKM$K5?F&<L->Q9]O<LCT@-6
MZ<[=8V&C(]VSMME.0 +&,H!]MC(&!_%(_P"+QC'67A]_^V_A^6W\;D?'#(Y_
M$6.?.LM/=="@&[N@#I&MW.A/]P_*<?' X^+FA443:JG!A<!9I$N?;VW716=:
MU==U'1TTT=--'337 5_Q8C_T#O\ 2U=--1JA?XC4O]R=<_Z'#Z::EG337S'\
MF*=9CN8N^C\;8X[PT!(\AN,$F'27IMND[%"S36I>8DHVT3=?C6+!:K7LTX=A
M($9(%D 9@P%84QAG*\.9<*,4Q9,I+#'\ASW6L)3XDXQC(@J0AR'-F+AU"E9'
M09_G;LN(*2$QCX_C*"TW%C\HC%Y!N187PX[+9:XF:G2?ZITI;Z5$9D8'D!IL
M,!>JYBM,2,'=ZZB*D&F.:CVY)UX;[O=;U-\ELX Y4"TEMY(;D=A3B&,(PYZN
MO@*>,W%QW!D3+\.88Q<G'^*S()J0/-<'8D,!:IVA-9/E#^H7DC';AS-_J/M+
M4;/S<3$5)/8P;&(AG+&Y@TG5U1];G7)JSB*Y94U3QT7!HPEGD1L(XAA,OS,J
MNQPUM(6TVZ\JQ,IS4&,?5Q)1#&6.^0V?;XI_V_CR8&^+4J,S8\GQEP(KD\/"
MY5P@S=Y0?*UVY2]KH#:W<S)DS<#Y,PBG(/E6#;!!FS<?'((B%PQ^25H7>U+2
M9.C7#D,H3BU\Q=XN\QFPER^RM^3[<Y#6^4O,8 Q-:8KYR*J'/R^$D*&J2W5
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M$^K*Y[1FHYU>6TM9<FM>526<4VAIAE"%+D(HA:L):&;3COG\"$_\&.EQNO\
MQ23/629)^TFIU$HA08R 4!! .P@0(](%!Z#5J5^O0-4A8RMU>%BJ[7H81H"(
M@X, 6*B(L%G'9D./C@FF! Q6L?0EMM"4I_F8ZZS,YEB28 KZ 0/V"FBHB"U
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M0+K0BX3<HC<E@I4R"@1NK$^GL#:R<R^Z6,[-JZ6Q#>46&O.S9">&Q$WC65:
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ME\7UI4)C,:&F/CE3$0/*KCP$Y:4D(%<A@E8@F%#MY]-O*4>2$Y[=TX[<@23
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M!LC@_N&!S6E*1C/=.',=^W6AE9:L")G^0D'^4$:XF;%D=\:,#DQD!@-U) 8
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MNY(1)U[7])C[_7 !U9QAE =JEGJD<>IY.5>IC(+*?YGT]^M.1<"JJX2Q!47
M@ !JT !,@"*F.M-=Q>66O55 8A;3,I^&Z@@[R!('0U.K%7K:!=<R\[K6.=>5
ME65/.:7KKCRLJQV5E3J[6IS.58_#]/T]56KZ#]GJ9/[34^IKOJRU:"! VIM
M@1Z0*#Z4VU6VZ]23=JU):*=2J&<J4."%&B(F,K@VMF\J;/%?4R+;(JS'D5/&
M&D*5@H81YUK./J-Y5GJ.6]RAJ2,N(F211<B,QZS"@]M X["0&D=/L<#W'%D
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M#*27PG$X=9:?<;0VO)\F]G!SY5F51B(+*9&T% SK]J!F'X9,:LX:DYL:'<D
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M177K1N:FCQ3+HGQ=>8@2A1UGK-5SET'+IN4ODB23:LYE_:B)5AS,6*Y%(_\
MF .M9PN*T*D2VQ@7$$'R^$&&8&]"/^RWJ)_Q&!:Q()AI!HP$@?EMD9%?^6U>
M7+GR(FHP@G<LJVB)OKB&KQN_DSNF$5D0R*;QENJ;AUAJRA#NM85G#+@LFZX+
MC&4-(=[K5C?\0/)\"^4U(C<!VJZ_C<KD$_1"#^&%DZS9F(Y@2O\ %(W(%!F_
M" 1 B()@4!)=5NV>M4/@B6DXQ*9F-;+3KL+#L94PH\H/XO8;&"40 ZU>5X#*
M>83C\;C"LK4VC"L=D8SG-D3R(<<LLB)4P1]0>A]#K:IM8- ,'8U!^T>FH5+
MKBJO(,)(L;GPVMWAK!Y4$RB5>Q$W\2-'.)EF[D0_B40*G*,DX:6MG"L^*%XS
MVZAS\D\?/FHIL=NTV 4)[2 Q6.A 8KT!B-.+CM;%ADM!59;N)J!+3%Q/62)]
M1.J[UF<J3(N>,'V@U(@M$6C$CDJT^W0?*0>4K%Q)RE;^'NEBO=GW$>JJ1RM3
MSJ!5+R.G2XA\H].3D&VT+B,#]T":()"DDAV+$+CXKW(ADF>/C-6+;ME$R5$D
MQ5Z%H *@("UD:+=3_+3G1/4D\N!:.V2C(YF'!@Q6W-RTQMA$?#^YD!8G'HBI
M2YEHLCU\-H\DM8:1A=.$RN3Z9R-Y_NL1@&D"LVB1)+72Y5=#&,ZKZX0?I_$R
MB8V)I%TR0 MH"AFTMZGJ>CIIHZ::7O17^,?)'_:$E/\ 17J?IIIA.FFCIIHZ
M::.FFCIIHZ::.FFNI^5]<U+^C7.S^U-_T"?YW7=<.^LB]W/MC:A#?>G#JTPC
MDWS7P_/QA!(<A$,K'Y'H>.$*"L=0,&>8;5G.'&I,)Q'X4N8SC'>CD,J!&8PH
MRH29@0&!,F13UW^PZNX\G)V@%K3 -9,4Z'6@_&_9,9MK2]$N\,HDJ+/AV0@I
MI\^!E![,W$8^%N6:,DJW9;=%G1<V^(MYE>#WW>RLI=SAS"L=>ESL3X^03D%K
MN Y6(*W5 (@#8@BWM*D$4.L/'(LL4R$-L[S&_4F5,JTU#JP.VL5;WL(>0Y$K
MUO'<B-EMSEGVO/Q[]3J<F\/88V.Q+%CN5X?*.5L)*LK2<T(^ \#"NX0T7XK&
M7Y+RUAX"/EXF.P,RG$3/JP#$?O5!"J03!%)%Q(W<W\K)DR9 %098] %D G9:
M6LU8D.%,&U5+*ZZQS)H%2=C*+]][,2.<U8I +;FI =I7<DPN8BAY\<.?MG*Q
MTC,;*"*>>#C1'<HC$84M./P#KU2@?'Y+3@4XP0M#:99P6@DL)(NAK: 7P(R,
M[Y,;! 5S-A:"8HZW!3 ,5"B4D7$@DJ6;3[U?D!/V2V1=9)XW\AJP))D)'7;;
M)7:.+5XQ*LDXP3)O@[ D)1@;&1\=\H$<7C#J/J_2KQJ1;P9(4@=?[-W2?[/]
MJFU=29K=@3/I_: _F-WV ]8!8_J.I:S<X22EJQ;;1%N.6:3I!%7DWPU^Q[U&
MKVB-V]L5,A'+DWMA2"LSMDC)8=]L=BM (2."I;ICRE---SX]IX>6[WCDF"=R
M((91O-I )[E N';4Q#-3D8K3_=&X#I1"C': W<%@,25:2([O=^8M(O1VIJRI
MK8).NTN7 7W,FS\8RQ(!H;Q[J)*1";@TL:K!S"U-MYQ*+PEQ25>BOMA.<XIS
M<)J8)-L3<;D $3!)8@"0U3^V_P ?DXV5=J#NF+1!EB>B@234?;KQ.![-;LS>
MQ;).;%N]OVJF7/AKI0+G<SC@*1#$%,D02!-7.[@W+#4QJ2;$5EEU)K+Y#.,^
M3+?TX5MD?HT\0G&6-S;GR D%2T"*0ULF+IF3 SG*7S'%D7QLH!58CM8"6B9(
MNE02!%MHD*"=&T#CM+4ZVPRVXM/BIQ#2$+4G"E+PE2TIPK*?-><]L_S<YS_-
MZSZLUS=--9R\]H.W6,BBP]$:N;UI+UYMS,6SK\0T^V/98MNBB"F8T..V/J0P
MEIT-IQ)*$V&/PH;+F%9=3W9<HSWSB9 3;F4D1(@3[A([=IW^PZNQ%0,DD G"
MX'K)4@10]W[NU:W+OIJN-]AN]GTK0Y?9$%9:Y>'(MT:R1=LID7KV9;D03B@U
MO.4^&N^QP(40A#*5CH3-2"G&,H<4YY+SC'H\P8_-?C*E756H9@D D'M4 @S(
M A=@2!.L7'#*AQM/:Q )&XZ$222(@2W<2"2 =9'TW7/)VG;('MP0G)V6>8V%
MLZ4]G:Z59[-5<1ZQ;(3677H"=YER,(1%I+(;2%E+.5$9]-'M(]/@XUDXY?#P
M558.7](VXEO):8W/NV$7$$FN0 ZU\B,G(R@0,)Y,TB"MR[%8E!;,P!&R03JW
M6]T_,++ H4:S5-@1L].9.>LLS*</:<1#0XHT="K';/%C^9^<PII4D>[A"4/R
M'DTTZG.$*:2IS5X\;<@(K*,5QDDF(\K**VS'C$DVFA#QW6:S9F=,.0XP3D![
M8@TM,TD7$-!!D U']8:Z13<@U&1S4L2P9*M@B(DBQ1LAC%'H8;280.(IU]0K
M+Q&%*2WE:\H3G&/+/;OU0]MYLHDTZT^W4L98H"WN(^S^37?ZCJ>L4-D3$3':
M<X'Q8.Q-RUJ8O3G'/6UTBM5[JM^NSHNBV;3MMD'KLF)&OM?KR8*N/PC94N6*
M$N00TSZN5.X;]!UIJB8&\R#>I*]FV<@=\7>P7K3V];)5Y;2_)?9Q]T8A['L?
M3\%JNYV.+L%]J,)&6K3\)<)9<R,+ZR&XP5!3C)12O2Z::T'XX67D!6.,FJI+
M7K$-R\.GF(>0D;G==_3$+;78F2I53/>DK/-3U6N4:1:<6%Z0;>CHUJ-CFAL#
MNM-(6\]A,06O@C\NTF?KT$?7UFD:FH0J2QANE-Z'<]*P-CO.G#U;:]MV?$VK
M:.I(W5F!%A8@FP=CQM_=F&W4/^^45\-@H=J*R&XVC",>3WK)<[_5RG..K2$\
M8:[\R32.G0S_ ,/Y=52U\1V1O/7TC_C_ ":MOJ&I:7?BE_F%I/\ 75T_A[:.
MFFD3Y_2\K4MXZKO->OUHH4_7M?(!"(@Y:V-0\N%8MUZT"EX^QUFEI?E[&AP,
M?P'<>8<C8_U75F*0RYE75&7*^/)C5;;7+*TAC(L9J$ VU ,F!2!W%1J;&W@<
MMP!?CP%U-*,K+%!WL*D,N/O8?2=($_M&VZ8,UYM.@[WV3+6$V-N@9#&R9_DK
MN.FD&@VN?IC3D=K04MY>"1X2 &2C,T,Q[XO#A82DM/8=59BY#KFQX<9!QY>#
MB:JEFEKV<C\(%RT!(RIC OF5#82F/)R[R64MS&N 9E60<"VC=50',]JQXV:P
M2/'E*V=+?,DY(!5J%E&-FZKP>=8RHDE3O'C>Y+*A&"F!L(9@A:O\>CS\>>?-
M\G^Q^'/JX<4GLO+$QR9TQF+7%8D&I,6EH7;VAK2XJ+9M',6=V+J]LJ*493[4
M-000:D^TF>GM;75,^9/R6&CY-Q.SM78+#*C1FLD\9^0*2$^\;L.'?<P8E<*)
M?*RY&,^FT,0XE*L+:<<2IUA6;@%.7$G1RH,$$UWC8#[6@*/=)4C6AW/YP2)Q
MKGB.XSCR!5D")H>Y5);(8;$;#(T3XS<B;OM:@R=DO-[03+#7"<AAG*O#5/5\
M;B+!; <#3F"W&*Q:9 C'N5=Y!E" "DY3Z6,*2XG'  >-ARU\F1"6VB0[K0>Y
M1"BCU)DCL*DT<7-DS/E#VVIDM$*PH -RT!CZE1:-I.F(^WKGYYV#]]_'O_U7
M4=:]59NK==CHFLK1;*Q>"F9N''$?"=G#]26J+;RX>*.ZHRNTD5^VR[6&G5=V
M8]"BE9_8X^C/5>1BH6V).7&NQ-&R*IVV,$P3VJ89X0,=#1';JN-V'VJC,) J
M1($A>YA(7N(UG7LSYAO(*OEUEBJ[+U4WB9J<3,$8<TKN78S"Y.0R^PM0Q]/I
M\0W%QZGTI\&#T-&(<_$N83Y)=QJQ(K<M\+W>$9441 -K+QV:&)M<_F/!$ +!
M:&Q95UF;,R8/,W05[6__ *F:5(;\I.RL$,+CY<)UIYC:DHJC_'L729^*JJ>9
M=*LSFC@ALR.8?WJ<YAC6LS C&2?_ -U>_JEM/U%_7QGJ.947*RXYL#&)()B:
M5%#]HH=QJS YR8$R,069020"H,C<!J@'H#4;&NO$(W!8FR"&T721\&Y4H1'>
MP:(4KT&M<LV-O&<I;SA:OCJ\]UX_%Y9[-?MG5>K=1EG?%L5>*U7%WC^Q\M&+
M.+;5+ZC3+J<:J0<HM89Z8Y59% 1*E9PZDHALM6,MH9;7C#RD10ELCH8A44CU
MEF8&9H1 H%)8&2P ()XYM\<?B9@=^B@B(V-:W0"/;)G7%-[[MT57,S#=YPT2
MU&4\Q;DI*:F(C$.2\%*'2JBQ:]'2-@R-@P5OP0,PZ0VCNG*<JSCKI,%1^]D1
M?N9U4Q]8/:3"@P6(4$B0%&/HC'_I4L)^DBL5(D*"T U%<WV$\)^%Q)!V0D>T
MIKV)+)<4.X*\KC9M9;)R#'1RV4/LO9PXE8+2S<JQC(./<>CUE^2!_19E4E38
M1(ND=*>/OG^P;O0C?5G$[\N.X3)$B!6?HT#[FCZQK-X$.*A-8V"("VM?I<P6
MR<>5*F9VQ;OL,G&!.*V3*$/LS9;#-[CG9(IO'NC ,D"!BMI78&'A<,#JW.F)
M^&YDA\65FD,%@KPL)0%H+%9+,5M97)")_B"[+Y_#2<N5<A)#_'LP$N()R,S$
M!S0S:$53YE4-4@0?#<OY%%L^AK^WMXHE%/U@;-234S6.2NPF3</7>V JD7H9
M. XRREO!E.LXC;* ]-XPVR4SGV:!F\9L.=N/FY!6"#Q>.!*LUI.#(@D$$0SL
MI<H1E2/S2V0*VL?'PY<_$XZ,S%!GY+4.4-*9D?NGOM4 *%R'QN"RX386!=+3
M/,!4Y?H.!VM*THB#N@-=C*6/KS0TC7YUZV3H]>(;D;+*W^FNUJMU!U$D[W40
MI&0W,^F^3A0Q'?4%!Y.3B6LN<,\ Q: @R.P.2 KFQ1:5"AF!"AKT UG/D QY
MB/\ #D"[L<DERBH5I07%[P0;% )8!7C1+UZ?_P"<&_\ ;^,O][NJ];-'KT__
M ,X-_P"W\9?[W=--?E;U/\%_7%S]57T9.XR=L_1GZ,]X[MVS_P!GZ.FFL KW
M(.YI6OT#[=M )2+%NOUD"2/)U]KZ)4%$4,MBB CFBCQ GIMM*,<=$<<\\0&$
M8SY8\_C$^'#Y6,'@),7R3Y\TD7"XDB@!C/ ECX BFG*UN;GAC:/U62@,6K9A
MB  1MN<)\5Q(477G54A%$!"55P;<5X PB[/IRLQ/-*!6Z$TP[GV)93[]A*#]
M)@A6?[+-/1+3CB<X\_60ECV^)_G\1@1*;V0?S6W+_EF@@AP  (<MC"EL_/4_
MI^2<DAAA'<JO1BHJ#C:0"U3XP7*S,-=K:O8A, A,+@:69"P1:MALN>C,:B'^
M*#NY&4W'.YJL.ZT8V9X>>6I'T(MST\9\T92VE6)B5Y"_1<U*Q3%D(D5':1-3
M<(G'.0*#H<G].#-2V*LGKDQS4">X2* *9[XQEB(78+Q6[!7QO[/Q8=A(FRIB
M37!9I\)#D1DP]%QH0H)+%2&FGF9ER+?8<",0RPK&.YF&!G/558@G/A(JLBX>
MI;C-D@ T(K<+Z+ #1G"IJ>1HPYALT/!$T"9U2214-LILFXDE)Q2VKY?<K/QV
M>QYA9Q[&X8QCWO'C*<YS3-<X;QCQ"P*KNYA6,X;[9[=_'LOU<]1&IGKJO]).
MCO<<.=;@\C\5;R'<,*-]Z.?E:T<;*BA3.2L QV<^S3C#.$NM8\$MX2VI8V&5
MJYAKQ\!-2<&*OKV+6O<9WEP'.[@-(U6OORU_O\GK3O-/01M"2@V0E8.D0K$N
MV-M*VA?;N8=$DW=K!LUTEG98\4P$+IZ5/8;"8G4'ZC>2.[]=DZ&<%B"EX2F(
M:07EE.(\(K_IF%6EG;C<DDU)E<V, PT95([1#MY&!8X2$)BO. G.Q,IC_P"H
MIN3!N0W*2)2T &VX?IT(%XO'<C!4G(YVM5FT[XN[8@E,J K\.F5YY(80^M%=
MRM180P&:/%D%-M*2XS*N&RB<^2#GE*00IR?')/(R4-@\0KM*C$6@,(_$I)5C
M!)#RP?3Y(6<90IL?QY^C*:Y'@]A9SL0*AH .*,90:O**GWQH'?#+NW;&M,G)
MUGTB7SN3+JX[#-EV$6I445(P[YKC9"$H2LNJMCA90A'N6LCN@(;S8VM^*P2"
M3(J UTE<8%#.4"=SDD0&H"KEI8VL;#D,LHXV8$=Q]T"ZP[D="Q+KNH,&?'<3
MD#4,!G[T[A'$L24^A<D0%S*KY:4EQSCGID+-/LFP0/77GR92<DA,ACZX.0^Z
M6\;L%.5QU,$0012L<C'2#0P*%7(91-SOA#SCX:NK,CFY@S@^\BG'(H6BX F9
M$"2 LYF!7Z!:P_4OLU7O4)8?<^!1/F^L_CME;R_AX_D\K,S&_%\J=5];/NOZ
MI[Y_&_7\NK.9'ZO+ @>1J=M.XT[.W_I[?2D:V<:?T^.3)L7][T'[W=_U=WK7
M7N>O3_\ S@W_ +?QE_O=UFU=K+/D20!]O-^HC[M*P2<2&AW0&P"+/[6,]FD.
M3/)2;IYIFM1R)!D!?KOQ#;S+6&\+G6GV$X'>SR5RJU8_45WV\&18ZB)8>X6R
M0 ?*V-DAF!\F,B0/"TQ/7/A'2E)B" \$LK#&,LK=\NF<=D^0\HJP;>L=V";@
M+D.W$2\ER35'>(C\0.,3ASE?#C:E+*'0CMET5M!2LYS[;R3YYSN^( _T)RPN
M>G<8D2Z_]W\^OT]V\*LC6?-_G !('F-.[TS".WM$4%940!4^-M;(6!VK?:5_
M*'!/#W.K.W]6\=>_CBUV/U_^+@88RK"<X_!CZ,?MW=OPZIUKU![(]6TPDZIL
MD1AQ,-L3*'DGZ(0IES&S1EM/)<C(]9[?ILX\DJ'2I[&<=Q\91]'6?EDCBY2#
M:1C:O<([364EA&_:"W[HF-680#F0$2+Q2E:BE:?MIZTU6NN#84@FZ>ZL")O"
M1Z.IG)$[K\_T%OSD&^^0G[=00&&LR^59*<4+Y//K7ZDAAHC+K>-;^_+2(Y.0
M=*"W%VTH *F$G&)-A+%XP<4DHDM=_A\9W<R;LLMW &M!)C(8%P"C'-IZ#( <
MYH3K($FDEEG2&S%(C42-=*;C$O[HIRL.H#JD<)7@LR2484I0CSV7O3QEW#?B
MUA5.$RF2:QG(ZT'BQ4K6)),+V2Q(-YR :6_CJ.GA%*[^3)6G;])/?0 BP(3I
MKU/4M'331TTTO>BO\8^2/^T)*?Z*]3]--,)TTT=--'331TTT=--'331TTUU/
MROKFI?T:YV?VIO\ H$_SNNZX=]9%3EZU_/G5[6:S[M,V.-Y3<S"IVKZVB9U-
M]5'N"<AUJ159!R/&B7Y=2#V,IPR7E>$N]\9QE*_"K* 5$ACW#V_;U^GKJ>(D
M-(M%#OMK07CD'%QVJH>.A8C;D%&@R$X.-%[N8=8OPV/BQ3JTEI==?RN+RXYG
M(2\+6E0_CG&<_AZV\@$6!F1NS=?[30&^HV Z*%&LN)0I<"ZK37Z@'M^E:_UK
MM8<[;V&Y'[]M 4+O>Q0UG&NDTR-$1>;$T:(TDR3D"A?&*V_%'H':BP2'E.(B
M7FV6&5NNK';QE>,?QS$\;&9E+>X_RF=P#!&]NXK4 Z?DE=7(41^;(%8_O1TM
MD2 #!-0.QJ$=2=V9LBP#@-U'D5OJ1;D=@9@8UZD2&R[%*%R+D!&_#JU&!P/(
M8]F7R4:$0O*64DY4MIY+2'5X7ZVM%NM:TD%<A$;,%N-*&+006->PJ=H.JLCX
MO$]U;0H:U@&6YH(Z?F.;1C]+7F)C6D_!!C8S$WM96PC.3K_N&ZRY6VM]!W\>
M)8C&TGH,:@WKS.R_N9Q$GEQ9*Q&0$9#=&0I#N6_-/$M_1 "+_)68OBT6_6 *
M/6#D!( FM"QYU@9 /&=ZB;JF?V6C>V9)Z:/=4ZTZRGXH[&Q7]H5FCN)O\WFV
MP>Q%,QU>A) ^I5W FU;)Y6&X%X/'!CAVE,Y&9*R.1G"RDM)6CR<1UW@CRX^0
MDU5[I.P$O0']YK0 ($P*F*5\F,>7'DG<!;1N95#)'[J[D_ADTK)N7Y@)YT=J
MN%?CK--54SXX_@>1@ 9D^3]; 2E-8&;@Y:#/2M*\8S]0IM6?P)\L_45G8G]0
MD$^Q]O\ EW^@W.MF  T82I=0?J#=38[_ /@C67U.FMI[7/37]2[>W=&2,U:-
M7,RUDIM9V9.14-#"@2=3GW[H=KS;"B8-F1,4Z;D@K*4".L963@@AM2<^HBL<
MK*5MP^9S)HL%;D56@K-!OVP2H DD>:#;B89&G,W&%#/D$.)(%6N[@*=PW)
M&M;./O'79^N)ER?V?O"_7^1CUX'AA$;!O<G5Y2-)C'63_M15KC(38:I!N6(<
M)%=%=0ME'IMY4K#7=>>_':2%[R6%:@+V6QL;A89.QN:E3K3F#9,Q93& -<H%
M#/?(:*%8987H5D1IR.JM=TE')^[UW6VS=-WNUESX4!6*=MR3D'JT:!'RBTMV
M72#;(N7Y20BP5QQ9#B6RVG'V\/#*6CZ<J[9*?S\2?C?*J ="SRHD=1)Z29B
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MPK'=/EA2U]#1Q<''ZXL94GH27=Y W A@*DF03($*M/&XQP/ER$@G+DNH"($
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MO(7=XBP/0A[[B_I227"L%22\H84P$Z[Z[<.#+?$XE_NL?$Y*P1![^1C:B,6
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MM<B+#R0D:C<KQ-R6NFM;(F&8OV#@R6;$J*U^0DM1]+V-/[)&RM^6-5A)$/\
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M 4_(2P[;3=AQ@M&P>A!="<I6A2Q06\SX]$4LMJB[@0(""9S"]>SWJY()3MQ
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M]24YF7-!\3B)!:F55=2T V![D<-95@"]_)E,5&)B6,90H/+J<C)QHP4SYFJ
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M/+'ED697$:S5=E8PA[^4S1Y9S3&<9;2^UC.4NY_C@@P8DS_PBE2!! [I@&T
ME0PB!=,5N@Z.5ER+G?+A@L"PJ2002I -LL2KKB(()'N)!**P;7B!HZ.OTKL&
MY;*HFK-A:Y]8RD:\+NNJX^/O<5'0+BH_X<Y#3^BM78$@Y"O&H9?6S@T0E0[>
M&,X;2O*]OE8\89LH"<S(_DE"8B]B09-RE712H(NGO)F"<C5Y$8B?!B[8/[UJ
M L*02TN&(,$&-I TXK55K-,AQJ]4*]"5:!#4^L6&KT6%#18[A3RR27&0(]@<
M9MPDAU3CBL)[K6K*E9SG.<]9V9FBXDP(KZ#8:L@23U)D_4_77O=1UW6;'$G9
MVIP#AZJ=25!;41*6&L!W>)U7>Y N4@;#>K=.,1TULAO7@U:"C4R(*LK'9FS1
M6E(:60IAY:6\./WXW&/M)R,&&P-@N!,Q)[F(H0"3:Q+$:CF:W(+ZJ$4@[D%X
M4P*P*()F2!4 ).K+YNWPNC5C6N1-:ZSV1FQ; 8@21]G4_9]UC(,1^,+>>DHN
M)UCK38Y>91S+*6<*D/A0"6UJ6LKNC#:XI:W*7&W7'D,]>T P)H W63-!"L::
MM$A+@2#>O_$SZR "13?<C4WXBV^J6?5;(U9U] :S)AI(UJR5BFZSO.M*0Q,F
M%$/8?K85[HFO9*7P1'ML+*(0#V21G*,JSC"<YO>'QID4DXRH%34-:KL -PMS
MF"0)K/<& QX'N=PP R$W$@&H)*J22!+0D,*Q Z%26EZJUIT=--+W=O\ 62T%
M^X'?G]/U%TTTPG331TTT=--'331TTUC0JU0C&OM$5\K8.V*\;_)MT4*N.H7'
M-K:0<<[.UX-R'-"NRX"6S#V(Q<6\ZXPEQ#K (SA#B4C,J>:::BDG9J)881^O
MR&U-\OU^0BH8 X,C@Y#MC%4X8>2M0=5EGSJ%EG%";K8KY3P#_@*/&OX+=]-)
MK3[[36C?&EFN7;4@*I,^<V*/'3$T"*;M'4D9K>PQPYR8^4<AG:4]"Q;D8,Q@
MIOZ'AVR,]L(>QE;7T<@;]==DQ$T__&/YB1]YTP0M,IX1P$H%5*T))Q028V,D
M18*+'.CHY",-I  +:%00&$EM.$X:;4E&,8[=NW4KF!+ F3O]?M]=1(!B1[9C
MZ3O'I/74EZYKNE=XZR,C#\9(>7AX(RTR\7'[(D8NLQY4>"?8I$&WV\D&"!-E
MB XL,R7):2.TZ2\T.VMS"G%I1C*L--?-[\P?:G,,VH4X#E/ 4[4-J(UU<@9,
M\C5#&TJG? "MV4^;C&D-1#>RJOK/[%4\UF/;=FV"')^1'*(9:] =3).7DFW/
MQ&QP<OD0U($/: P69) 8D*1:Y 6(8P+7=</'YF56MP8\;,&(/L5@0SP;<=!+
M,;E3>9@Z2[:6R;7&Z^T(\WNC7=:!"!V$W*RF>#UEKPM;>7LV8B[/*UHR5UM8
MZC./PTC%BY)(C&HE#9>&VG\DD.,FA7<H)^NQ/A=@&X6(*?:2N0Y'4"^6L;,!
MC1@UKW,X0%#/G<7$B_%Y,&(WJ.45*@K!/BL()6$!2Y6L99JH)M:PT?6MZVW-
M?F6F]WZ.L91I[3K'M>,TM+B66X4Z'B9>4KKR(31<9$!$G18LP=.(?96^I4&R
MD;*/K.E:,V4YN&F,A$56#0H-C8W9@[]TBS'CR'(H47%G*$2S2R<@#.Y#JN+Q
ML P8!KC8>.KB)&3+E4]Q)5;BU3:HM6"Y;\S*A"T&&K?+875M(%9D*W6*55=.
MV8*J+A%2<?'THV%<8X_NQ@#DJX<PQ[,;#+("%K*;&+P_[0'/D7.Q.7)E9LYQ
M(P1C3M$JI>)*/C4@L+B+0%43<M?&_2)Q+$=<7&&>0Z6@'&7*Y&B JVY765@,
MYB6#2KLWK#EW:+=6V)^]_.!VE0[>6N99+H%?X/[#OT.$:W".8$9$G&H@%YW(
M\B-E_(J<MK95G [SRU>1+FK)^G4*N(WLF.YR05_$QEA)!%K()';0 2>XVX^;
MCR*&RG&@#EA:\AT4*6$P)40XF ]LN8J!?-7W%-[).B*M0/G#[^MLZZ)(/ A4
MSY=6U)6S3P <9"2[\VF/%#*<D$QU,ETRRULBX'4MU+ZFE-M^RS7B-[Y"H#%5
M!(Z(%=58Q,PS=A)) O[?PQ>W+XR93A9L8S92X52:SWF$$B; &I4D))V.I!O%
MWD%3-)[:/M_,S>6R8I^GF EP&WOED;DJM+BB')^4<,ES;%(!9A(EF+DVAH]I
M4FV>$T G#:FGWWVS&<?-*CBNIM[\N*TL8L_-2+29!,D0""Q(54*L0VM'%5AR
M$9B610Q98HX\9!5HB%,2T1$L3V]NJ*X\;+V-CEA(KA=F00LTC3"VUS4#\O?:
M5IN[(#%(U,8F2*I53B:K>_A1F'B'G242^8U;P@W<).%Y;7ZF/'D5N>SLX7S'
MMM,7>9Q#1%A%K-#W&XNH@K+87!_1_%J]I 06S2!XGFPD1D!FIQ64,D6@C6FM
MGV;NU,#8O<;HO/M_82S#[/\ ^BJY=AHP-DQ(3Z<'E7I]@5#8;P:,$N)<;;3(
MN$+0XG#: \NM6J-*V+LEV_JD$[UL;EV1!2 C<*Y\K/DDF:^"G:P44DU3:[8B
MW-0[UCBB LCX,2'Z@+:UY\^[Y'$"@Y66K$8PQ](\I0&/WI>VZ8M:R)>8NLMC
M9C$>2T0*SXKHFHMA+K8FY;Y[(]!C9-_;NT%[W=4RW:DLIQ E9^5YR:=M3%03
M1X!$VX"M5P>.,BAH\@,HKV[*&'R26C5-Y%'0%CBVWO9'DL6Z-[9:R[K;==;-
M+KHK.NM;V!X]S63ZP+K?K;%T5B)IJO+5MK8S!D)F7M =SD!Z%!F,Q%U^7=OF
MLX*#:;. ,HI!-FN+BQ:C9)MH*+D9;!&8U&&!W%JPXZT6CB$>9@(#3QZ]>[-"
M2-Y1Q?B!]^3MQPXG1S[%-01F/V6XNZ)WO4E,A%$0EG[#&M$)G$E+\">#N9:!
M&%EI"J41Z8KQZ77@(L\CBOM)V5CSEON$--1\20MQ#KIV"!&FFLK+;>92ZA6;
MY./T6>\@"PR6( ^TE@P'U)5H]"=7\$_GXBHBJQ;)C[+()^EL'TUE9(U8*2X_
M[W+C!M*DQDG+Z=%1*A7/4/V=]="MB^W8L,Z+I^6J\.HEQQ* D3<=+>[>[H"2
M$I+KBKS<OQW%QFD_)*5]&(PXY"TM9U!!M4+E"D,,A4HNO+X.1260%39\=#05
M,7YEM!@+V-XVAC&)BI6P$!A4U;@J[+.U)H.8X]+(KQQGQL8/:6FC'VT$4]B%
M3ZXK>AXIHQ@V=*$2MY+445W<:<4C#*O:M6/F&+%F8-;CR8N0H$PKL6@!H) A
MJGN:U@ X8P=1P9L.'*7RY!C5>6#0J/\ M,4HM&**25N+4_B;$<VO:*Q-2S4-
M##Z#L,P_5GF7HN/V)QX*)?D84J2M=A :'#X_I=FL5ZOJ>.=]=YIG"65+4VPM
M+BGHY,Y3C<GR,#B3!CDL8 3%A?"S1$*N-@K!FE06:P!4.'4/T[A^/D;(R*58
MH 4*L'RI&,&V2N6C$+:&<+C8@D95O2)X_P"R=^AT.RZ5HFN-D5G7U,JU-F).
MD734I@4;8XBNHFWJRP>/QREXL%:R)UA_O%OC OMO8<R,*A66G+LN++BY&7EE
M"58&R1 9UQK@=#,L%M6UQ<ZFT $B$70WBR8\>#'!R+.1UD"T^=\N%^L$H2 P
M(9#*^Z<IOS4>@^9^HKE]O*WQJ$ ]%1;4A28S8])K85Y#?$RB/AK-.5'2\')-
M5>!/D2"1&&BFUL.A#8\'&W',88G\,BT.N0A6)D$ /3*PF'R(C-;W=+=W9A#P
M/8K*MN=((/;=#&[(@:" K.B!I N4EB0R*IV"1'R2ATK=K)33ZF,*<837-K.X
M;=RWW6TEQ-D1ZG@OOC"L8QW_  X[=<8*'(4RLT,13UC_ (:UH7;&#D4+D*B1
M,@&*B:3!I,5U\X>QJS%.5'7GN6=$B-MV_DHE@J9OVB8A<@(5*5SP=1F>TK8U
M.'^B*M<H(A+"XM?U99Z55E*4>?@L_18!*_\ VQ9@@A9Y.2H, %)! R*+&<%1
MB&0'+KO-6OR%IF>4Y-U(;PX;E8/,%3O>6>VUBQ!517HT+6WX2%$9E>/,@@FY
M##QF7]HZ1=:E'05&JS[3%@T"%$%RC@K25K9;;%D,Y1XJ=;]-I3ON<=GS?(\9
M[6.6[$2H#,02Z A1>&;N5E%CK<5/M:NO(^45WXS'):C(]S7,H"*4< ECC=0.
MX &TT802I8#Z )_+<8')XDH=J-]^+M>(CTG0^Q0L&RILC7VPHT'#]FPA^0*4
MVI+3*,N9SE.<92O/T]8F8%R)DDL1ZFT%F/J8568THH+& #KUT%N($B H6?02
M0H'4"6(45@D@"21JM]GFPUA PU&CUF9]2XDV 1*FY5YEV.]Q710YH#-EF9<%
M]3\B$XT&X*A)[IC66PGFR<)4GF,@\K"1NKS3<7X,K)$=W<DLMI!9+FDX@X/,
MI7]/F0D2<9$&/P9<:O,]O8T*UP(5X4@.5BYGX\_$_8,?9@O&4A7#*D?9S:7D
MWWINM\?L<V/W",J\L8^LK/;OWS^%'8-]3.JFT>'@+C;SH'2!'QZ<"71Q(T4V
M$D+.7N.=6<6XWB*0P MYUQ2O6])*5X?\TOY45A]Q?,%.-Q@-AQ\($;1XUBV.
MTK^Z4 QD1XP%@:J0#R9]J\C+Z?OM,Q4-^\'G(#-Y+2=9LUZKX)Y*WLP",U4:
M8!&WHV:##M5&*ND,$C4=W&4[*UK.K@=IQ[X)CB,/L/RY+@B<+6088.VXT[3\
M1*_'%@8P_I\TLI%M; )*4()[2UJJ#0XW-3#. >;A1"/,W/0V]6C*[$0=V !:
MT,,A(IE5KH08^HP;FZ:8\HGC#DE_7M)]%IW;O$A$X>RG-74*4''E<:7KQ* .
M^25#$H,CF7O41D84=;G@U?@N_49B-RF#;?9(D@W":1<#((( 4A0^4:[C)<05
M&/D^XT@97ZY!; V: 0I!5@Y!=IBH",KK]JA+#9>.KILV^^@V"D]Y\>)5$Q)H
M-FJW6%239?&>O9-):GY3 (Y)6''6GU+0XRO*<-YHQNN;@%.&]S'&BK;$!VQ8
M13=0S69*VD.%!  *JM6 XN-EX_*5E3"%(RD0H\8;+DR@E:NOYO'+!2@[E$@>
M1G[R*95ZLMR5;G^,]:L6 4(?&<OO&]"9"TO5&)5*PCTZGC<X3'F6/S21)D*R
MVA++V7F^R,ML]:<A5?/G+_DAG .P7&&#,+B1"XL8&< DF_& 28!&="<BA\B8
M\^1!B2&96&-L:L01*C\R%R(!!2Q&@(*EO.(URWY4+-2]>:CB];WZK@5^SFL:
MBAN1NNA8*>?-$K<N?= ZUJW2U<FVGWF3/BV/:^V#]Y+NK(RM+Z,L:#F\^;(K
MAO!@XZ(J1+8PC$* +X626PJ&88U&-5 %';3##/C:^<;Y.[)*_G%L63(';JQ8
MVS;)*J,DF&36U.NB-E6"L,26R=1(UM:7##VWZK'F[(OK P+)*VXXM5BC9*)#
M>?/%PEU;*&L^@I7AYK[>6<\#QH9_-*2PZ*TF@/XA$&Z%WB*:MX[\AU8\C&,;
M!B!#!I7HU ()ZK6(W.LT>1\(V]M[>:R : ,\X1Q@94Q9YB+K\EA?VI:2&T9&
M76EVZ491)NO>A&ID3LHDB%*8 <C%9=+3Y9CRY(*W?J5.ZR/\'GZ%1!@%O<6M
M5G]B''EJ^7 .% T ?H,_N(41Y\4L"X86@T9E%BL0K8W<AE33Y859CA.44\]'
M_<1)EMN[(8R)K:^\?[O9Q6?AT/C#+]?X_:8UI=A4,I[>NE^8?PSA6,E>HO.$
MI];A,3\>E2P'&.Q)$#+B%" JP/;( 444*9##/S%0?)<>+ ?(I@E 23@SDP&4
MN2223:P,2Q8H"#N_:!W@YV0+*@EC"AYUB6663 ;,&'$%'L]F=?,(=(LF$L,,
M-HSE2W%81XXSV[9QG/5+NF-3DR$*@$DDP /4D[#7JJK,0J@ECL!J#S0),K79
M-4=7,R3$M W_ .'N,06P2!))H[90>1<,/$SI<:0*2A]"DJ<0ZQE*\8=PYC/T
MPYN'(<&;CE3Y2CK:0 9@BTAP5WH0P(_>!$C7>-EQE\>=&!Q$JP8$D1(,@J9(
MBH*F?0ZK_7E'L5:.MN3M>8A6CXVBB,X%K,LTV8=7K4%"2HV<4WX$YGX2^,@5
M'KY<%PVTE$>V*QC#76ERI;*1LW(=QO4,F(75,U*L#=.2G<Q6P+AXN)\80,(M
MXZ*?90J^4QV@;!@>V,=>U0UY:QM'UZ2C>9<M.%UK$.#.Z3VF*!+YBBH]V:>@
M]TTMH]AUV4]:>(S$J/;2E)A+Z6\/=F,-8RYA=&(%5R TNSEAM4>/$LT@;J1W
M2_;5K+%72P)S*X]HPA9IN,F1HK79@:&RM%#7EM)>IZGHZ::.FFE[T5_C'R1_
MVA)3_17J?IIIA.FFCIIHZ::.FFCIIHZ::.FFNI^5]<U+^C7.S^U-_P! G^=U
MW7#OK)/<>6<:OA,OID%,IY5<R5.)BLLID<X2OD2K^I%$)4PES&<=^ZOHQC&?
MIQ^'%.8P<9],V/\ \P_D_P#$C?4D%P=?7&P_:(_\;_8=M/!Q,N-0N>B:4_32
M2W@H 5RL2PQPIPID58XI253403DZ.C/=/ $D^*GF6\L.9^E"E8Z]'EXV1T<P
M4?$A4^JA0OW05(J!ML!K-A8F\.",@<DCTO\ S!78RKJ:3O!,@ZRES(ZMJ/+J
MOSMR<V+5XP+95CN1\O'1?VBBSK3'3UP&A%R\'6JS/V1H4L2%P(DA"1&,#^"W
M5^2$K=Q?%NB858GN7CL%!ZWJ2XD4F 6()J54 2Q&MG/OR9#C+Q^>8B-NR17I
M<P,[BNT4VRU[LBF[3K_VIHLJ],0>) Z*R6_$3<(ZD^.<2T:.H"P1T5(IRPXK
M&,JRUA&<_@SGMGJUD955F':XD?8&*G[*J1!K36<,I=L8]Z-!'H8#?S,#3UU.
M.H:EHZ::P!XJ0VMI/F9B3M0-T>L%;(RNM%%QR9"A-3\S.; :C1P\1S!1HTJI
M(:B,$$J':%=9QY=TO)4NWXUF7C<BTP6S917K 0F#L($GH2"1$D'5?++#)C4R
M$*XS3:@M@^LL5Z4(5I(!AL_FD?"LU#0+,H#?)+!>Z1! PJ!\)Q)/FO5Z5RPD
MYR6:):8CVU-^HIQ+3WIJ1A2DXQCU&\R*&YR U'@SST$6KO\ M@4.]?0VO_EF
M8^P.MW]DAP?2A!(-9&\&-+3P/H?'VYW"28V=KJT1>P_M/%RVNV+I((3E^;BH
M^7E)S(_W7XA*-@R,:%:4YD\5I96<(RWEU7GA/H(?&%? ?\9C+,2 00.R37MB
MXDP-F+$"V#K%D 9[.26*'LK3>ZT&V"0R"06F@63=K>'K'K9HZ::7N[?ZR6@O
MW [\_I^HNFFF$Z::.FFCIIHZ::.FFL97@+<5KS0.8><X]@QBN..F6O;[5WPB
MC3[2B:M#(F'VJ0[K&SQSL*H(5I2/<%/)FSDCM']XL/,>4TUX6878SF64N6KA
M^A*GF2#LL\P"29 @ER2(E#5-'RFCS,E%IFF!5LD&-D**FE.RYS9+PD2$$TTX
M>K=#0&WM84S[RIIC)E&L=I<B$\=N1FP7*"_\<'BW#ACSZ<UKI4\@4I+F6QIE
MJ5,2M63'RWC"R%]  KEQN5CU'VQM/UWU(N3B\/X+PWUE00*[Q6JS!H2) U90
MO#72P=6AZ@P1MWX1!W7[P W7M_[O)F7;+@4T-*Y*?)O[TS+0J&3W.T62^[&>
M6$JRQG*$9P;NLZ!$=1'HXAI]3Z$R5-5(.N E;X_O+9_Y-H_=^ML3 F=,75JW
M&T^NP]7AUR+D7!@LQX*Y>6DIV34.QC.&\FS$P4;*2+_;/TNONN.*_FYSU/)D
M;*U[1, 4 &P %!385]34UU!5""!.Y_E,_P#CTV&J6XI?YA:3_75T_A[:.H:E
MK.?YHV1V[+ /F#31 S>K"<*S!7,^@FMO*V365C=[)$AS$HPRXZUA*FVX\E+G
MX5J;\<>>/DL%S\=C,C+(J158,&AD'8BE"0#61)T\GQW,6H4\9I(F0) E2#VD
M;AH:"**3&D+NK]=EZKHH-R.V<\!=A+D"Z_6]U["AIJ+P[MJ>8FBFK%78=6;"
MB-?;P@)V5&B! \9]$9>4]B5:<F-'YN+ I-J?'X&NH.U'(!93*M+L5<DWNL?E
MQ(.!>1XOC'Y*07;FP0Q) 9L6)RH:V^!%%MLBYG8,0%H>OFU*!D3(Y*-RR,G!
MD6:P02$\FMTY&*LTT%*10M;L<O$4.$@P 20$O$!I84Z0,\TTD9K+B$IZYB\N
M;CC"J1E&*Q=P&).*X$D"64Y  RJ2:.8#EA#*N F[*S+BR,"Y!8E+,;YL;>V;
M,@7NR9*,L@L[JJGF&N0R*[ER2JVR!YRNV@8V$C0.1&U66W*M (+D[#*VLQG5
M4?)>\C$,C^0I(I#S[;SZ,&HQY)78QCQY<D# 3+L*V8B$ *HO:2"Y4+"F0G<6
M,">7C9\V3-Q<?M+'&H&0W>:69T)(( 5N.]I=G4H'8@7*3=^MN,G(W9D03;Z/
MIJU3VN")F38I<^Y\PRX*E[($W(N1A\K/C6*N@RC9 CP7T,DD&I(2WGR6YA65
M.\7%F&-,?*7Q9FQA#!#!0L ,"())(<,8!-"-Q:P9./R7#\<NW'L8%YAOS$';
M::"T/.,BWQF@ BW3::5X)[0>LDQ,;2CMVZL*AHROP]5G*'RQ1L%Z="C@I"..
M8.CI">J34$@A!.'W7$^N^6_XN*4VI'CF6&T8V=P1F;(25,$$,JB"RVD!+!8H
M  +N03VQ:RNY\151BL:'$!D-T"P1^):D[*911#,6;#EO#F0O&S9QA4">L:-K
M:''%-DQ5=-?0.2(GQ^TL/LFX2L0^\E/CDIB+-=1G/?#2NLGR.0>$Y&  .;%0
M&T5S)04-*^W8CM)4$L-O#2Q@@)-N-JFIIC:I)Z_UMP:P30J/QSR,3R^EX(:)
MLKDDC4Z#6D26Q7;3'/--P6LL+<;I\T75J\R6A)"<9.%G5G8SA?F+^.*]#V;2
M$YJ3-G)8&16N;)7W=LQLMXV!:T8BV'*;.)\6K70^,$>X?W+4+$$9"!M(QM%0
M"+@=+K;7I1%4LZE5]Q"4UZ:5E>(NLI\<8C2NZNZ-TOJQVQG/X$+S_P#<Y_!U
M@UITN1D63]\AP68HO!.*@63D;UJS[?V^:*VGUOLWC8BG$O\ =/?WWQ+*,IQA
MGV_GCOTQ5&;Z'#]=QGCTMF#/NN@>VSOYDH</U\WTV\$^L[C]VV3[K^S]#196
M-N44/X45@A^N%/MCI<K+3+C3-!BE+<77U[%RX>\C+R5)+^(#(&PK*%,NK>3A
MJ&,CSY1U&+&?7=W&U(^V3=M"Q)CE,>'ZOD^FR+]MWV=L;R9@5[?A%AFPZ20#
MV,_=/"&Y2/.5:MX]JU'"-K?P@BVV##+^,.)PF24KP%3G*%AN9>3EOB'\]@-[
MN+U_>Y! I%)-")/D'8#C]^F2C8_JG(_DPR?M@5!I9[B']FI7<1\N<).&#61G
M7\-1U0<<'9(# >\!^,^UW'/2.)DAQ8QUK#><I)PZ1D?./40V2I*6G*/E*<+/
MO[&V)7^4!BOW D=).K^#7+BBIE?ZWIT%I/W03TC63M0/"=TCL=P:(N+H8\WI
M9#[;V_;A-&-EB6.Z1GH1DZ!48R7K25N]_74%&G?$DMI9<4,.E#R[P;\''ZJW
MR&*W<S?QS3HQ!" ^,VAB2UZM"Z\GB,+RM0#PG)EIVSJ-F45[C^8U8[;+2S"E
M*_,@X<M[#\#L,?P>."(]WR@WL_EAJ"V+1(IG*6+CJ<9V.R^F15ZR"GB!D_79
M;6XR080Q7CC]&@DD!"TD@DDEEJ:2>T0Q49!)"R+=69",7/Y7' [$S9^K"IX9
MRQ:P.-0"Y"A&<I:K@^4'%JX=,'Q^-BP:$0M[S[T#8SGJ2'([9\^'YXKD[$%L
M8B;'0X2'*0.T.E;:</-$ $]G7,OOMLI=AR 7X7+8R .-F ]PGMR/(>TA3(@-
MB#6K/C1F#!I)D);AL!*IFXRQ4S>;P"0MK&5BURGD!(8J21IO/EE/!VA^WMX
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M]OF+Q[OU.WA_-ZR<XL.,66Z0^,TF8&1"?;4B)D>TB0W:3K1Q5OSA* L& F
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M8B2L?U&3)C9?&0.TB9.-@ PZ /92@+@$-6X'5G5&RIQZ:B]7YT%OBFUF!KP
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M##3^!Q;LW@; [\96)*A4)V.56-P!V!8%5"UM-"3-Q\+!CYP5%Y&10ZJ2\P2
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MJP% %@'Q<%L2;E;#:3S0"'R7G\CQLA[1A&2HT%[^I\$*MF\+&#87]: @-0;
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M8!=B H<!QQ!);P@DH0%)(=,Q5B B%'\:MC6X>;C/Y?(XJ!0X.4E $'YB90K
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MOVH#/]:P)O6VWI&K#;>"T>2P >MES$?\MQ>.EUW6=.WU+7='331TTTO>BO\
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M4#M0.?L967''79"1$K2(:"%<5ESP0V,,TVAM*4_6SC*E,C*[ HH50JB!)F%
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M;:VUJ?0E$,9G-E7TQ8SO,2[B0*6DQ!8DA@+0 5),,IM.'^L[C>)A%,'>Z)D
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MA"L*QNY"A,[H  +S0"T30;28H -R8 $T&L/#89.-CRR2Q05)#$BIJP FI.P
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M<X<M9,GZ=>3BM*%BD$P2RHA8@>X(&>%9EC(%:V&FWIR9&R!<<0<182#0WY%
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M<Y^E3A+*$I[YRM/X>LW)4.,:,8#94'[3%?I74\;! ^1O:J$G[!!T_P!Q-U%
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M?!6YYY$8SZ+B7U?C>K&M.4E9&&7@;F"!8":"5:;B!W T"D5K0QB4.)S6BX[
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M/S(G^/E$$S%N1E@5- ! K,5(!D#!K;6RXYG;.PHE&^=V5V4"V#,%M,C6< 2
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M-G'-KPG,;E*T/)3W_F]=X_=Y6;\Q%D4I822!)K-8!'6/K2/(-IQJ#8[1$UO
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M0A:'TMN-O)<SCLC*?K2(QVF&)8, *;B-]Z$&D??.DM<!';;4SUF(^PBH/W$
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M&Q*R^P6-GQ;1&83W+)Y&'WEN^GZZ,"9&?,EPT!YN1 "&;(0X[H(.?!(8XQ(
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ME';$(D$,F3NM/:F-_#!;&3E#8<65EX@));("N.PU&-<(=KC,IDQEBIJI9$R
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MR,4TG:E87D5,M?8:=J3)Y>4>+*5,8DU=E>R<0K#N>LF>3RN.@(%V0C\,U6*
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M^A^08:1)$8L\*7055=/K8IR)>0;6\RAQTG)&!L+0K&?4ZGDXYLQ\F3;<86V
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M)4/A[&<_RA*\'.RD!@C&25 $=2<@*B/5P0-R#MJ[AQY<4[2NT_3:RO\ T?\
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MY\L^Z[J[XQGSS]/?'EV3Z6>NCIJ1ZZJ?3GNOY.O.K!;###WL+;^*%\?0]/\
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M.Y5BH)CH 08Z21%:VVQS?M;U6HU4RUH>F;_Q+6,B-S5;M5Y>UQXBGXYU&2F
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M^TDQ%>K^+[EQKKK6/+Z.Z_IZNX^08LRY3^$S]XV/W'5/(QG+A;&/Q"/N._\
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M:'LJ]B+XJ<RGPQX]:,QQG(3B]AK$1$B2!4T!D S4"=9\0=<87)5A2=R8H"8
M$D02 (!,:Q&K.SK1QKW-NO8%$T)<[BW.VZPP-L<=KE\CQ&R794J0B9,)^E\1
ML2T['%K&0E#_ ,1,'1E]?=TE26U)I^.-OQ^/B[*P!$T@JJR">T @1;*@M+
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M_B>:&Q]JM2>B@\AS4XR % AFL0H% :8\>/7F\['EY"9 BL6RKC,0206P/O\
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M"-*\@WKR^N+%;P^9@&PP;8;*TJ=R8E26$WYR<? XS+4X><# ]Y'@QB>TS%P
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M-A9*=MTIYL+ F=MMRC1V12EI9^)M N#>IE&&$O9P^KQN%:O 1L@N!QJ!)%5
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M?NT3BC<0V* K- 5BC20Y7%4Q^04#G#-D!.7%SL+@VG=\EL O#^Y%)=OS%$6
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M+\6WENMHCA_RW'(V/&PFFU<:[1VQZ6?EQ'C-L:K3WYMJ<C*.FXR-,Q6?6_\
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M/5:8_-Q_U. ^3&H6\K,8V8L%4DQ4V&# F"![2=;L7+QY'9#"_F6I)$OV+DD
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M2I*4+(V=,1P6H0<DW$FX !P*1 #FPLH$@R22008XEYH*L54 NQ8'(S0KY%,
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M8YV6A;IL*K<$.)5=A(ZU5YJD4&[\(HDG:+U<,8L#DB(F)!V\"-/SX#@ISKQ
MJA@AARVD89>4KZL\-R8,/(Y?<K\APZX_X@Q&UL<*9"E48KD<E@V0&U0!#9L)
M?->!*LN.1*P"ZPC=3(+FY *^($L0:BT:?MOCS7*S'C;:^5Y$W&VGKEB&G-1<
M5=3Q4?&P)(*6H^,F86WV\F7"L+0<$R*1EEYUIQ_ V480M?;$W*J$"@G)'=:0
MPF:$$=+2L[U#D&!3C97 R9+2<0(M41>5@"HF)N#& 958# &K:$Q6G^&LB!'2
MS?$7C#&K/'%E,!GU;2 DD"\62J=4-(#M1+J!Y :1,<R\WA:L(=4XCOE.<XS+
M(GCR-CE6M8B14&#$@]0=QJ6')Y<2Y;60LH-K"&$B88 F"-B)-==E6BN&*FTL
MJXF<4\MI']JE/V=TI] _P]Z*RUC.(7OX*CGU-9_X4]N_TI3G$-6:_;NC^&C[
MF77N)W%-QS*U.>:ZWI)2O-189^5=\PGX?>1[+G_86CO_ #<]VFNMG0O"E*<]
M^(O$SP2A.,IS5M'Y1Z;+4@RA&49@O#*$#R9#>,9QV]-S*?V.,8PTTH\MLWA1
M%CUY;/RMY2;'M4G9X=M<%QTT8<U&CUP:*$3*S;KLJ,@.+LXPPV(92,NOG>EE
M6&T92I752YKE1K7!?$<D$5'>4L/_ *AB\+7L*L2) UW*/#C;)*M9R%P]IF;E
MN\H.WA'M9R1#R+>NIEJ&R<+]NSZ(;'RVXO5Y"PY&:1)[CT'I:E1"78N49+]H
M](-+FFAI,XN=>?$:<PG!#2".V<83X*TA+@Q#+VJIWWEF6!ZLL2R[A65A(F*&
MSV\@8+,ANGNCMH :F9%TT,1(()!@&R)JA\%H,=.'.%''R2;<,E(QY$!K?2\J
MX*W!BBU\R1D<C1*5APK0#S3>2W,X;2TA*E9QE*<]5BKA/6:]!"EJGI,6KZN5
M45(U<:*6WB*#<RP6@ZQ-Q]%#,: Z]LO7?" 9TW+W#_C,M8!,\4\IJE:/6E9,
M!B+L1KS':)3AU3Y"65L?1CU'D*Q]'?/=IK\JUAP;:()$_D=\8LYCQY)U7:E:
M.4QEN*A!BWTLYS$^+BW8VXK9;QV^NK+K?T80G/334GU/48&R4;F=0M3U2I4J
M*G'AZI3JQ6\P<=6(HF=XPZW!CV4XK@BHJ-:R5()];"&EJ;^G.4J_!GHWG36?
M%*X%\C8&RR$R?QUT8*B3V+FZ8D86UI8L3"'0[8+\1DR"I\R$E;<TNQI6X^D!
MN/<S[CL'C"V4M5<!7XGQ^'AF V/!R,9MD)^<A4!5:2$)/Y@9F8K-C(QG4<]^
M7)FR)OESXW[B2;4.(M<1'>1C(0B%4V2I"M=747\M[DY#3JI4/C3Q=0VAB9'&
M=CYZ=@I).) \LH?.?8WMZ(:#S@GS?&0+C&7<K2VM+2_33#'B*8D3L#JJB@)%
M%9:$DM%0 O59N-T'4<F-'6T 6C(6V@P2#1A4-2KUDP8$1J0L?+XY1"GTL\7C
M]QO%748P?(J!RRVG(NP)-FS#3*Z6WL5&1 )+,VYA6'6E$(5E:O47W0ENW)CQ
MG*2E<"XE3&&%548CBM8BA2"8H"06#269FK;C)DQC!D _3EBS*.K>899!D$&1
M)W[H'M50&-$I_P V2,KQ</$U7C0$^&+ @5%QP.&,CH@"-$8#D!Y49R4;-F%%
MI;RH9:2&,C]DI7ZWULYF[9,CMD<@Y&S,QI'89(7^W=NWMB84'5F#&N(>,B,"
MH%4+T(BI)W 60!0S!N'6R*7"?,?&LD2[L2F:GF*>T[E<X'3LT&#LAS6(QUM(
MT:7+/RT: I4QEMY3RT.]AL*;PWYYPYU9."\DAK+3 D>[H28V%#&YVIOJG&G,
M&(#-DQG/*R0A"Q*W  L221< 3$2I(,$%BNV[/T#67^,W17^1_56M6E&WMQJW
MSMJ,VD$/Q]H\DO84;4F V]AVVBS@3+]:)9=R+9A*\U6\E!H6-AT)<>X,0*\Y
MYJ<<S]1- PQE.0V_Q4>D@]JD>Z3#">T@1$J00QTQPF<Y3L>-EQ4WERI$S(*=
MO<(NF"C*0942$^7-R8C7I##_ !HXQX'/M,)8%X L4[AM;46880XX?%2-Z-CY
M"<RDONR]W9&2OSPIC*',XQIQFS)@=IC$P)@P?[SV?NGO$$W?B.]L>;DX3.F1
M8QF_"J5O$D>/W%2#;VF L$=LDRTZDEU3=I9V3DZ1F64_X)J0.K9NF4K1FIRL
MA)J1V8IF6/$]N0PVQC&<8PXC.7<X1X]S&YBWJ=;\:V8U2E !3:@Z3KQI+7^\
MC03A6=,2&'B@[(,VHK9VIL#)5/69JU#9(P)34$^B-EGVQ&6U8<RXK\3E+>/+
MJC.C9,#XUBYD8"9B2"*VD&/6"#&Q!U=C8)D5S,!@:1-#-)D3Z2"/4:\Z UAN
M^)@8J*5I$H90T<*&\/'[5UD^ )EJPC658X#\O4SY=P5G WM6UDOD/J7G"EK4
MCR5UIS.,F5G6;2>L3]\ #]@UGPHR8@KVWC>V8DU,228GU.IGHS4>U(CD=/;3
MM]" IM:(U=9*P.4[=82R3TM-66_P%L9&)C:[%Q\."'# 1KK7JM);RXZOZ?5Q
MX*13C%BN#'=E+4]+,:UF>Z5.T+;;2ZXM-A.0/2!C"_60[M]EL,(D73=)MM ?
M7J6I:.FFOXI*5I4E2<*2K&4J2K&,I4G..V4JQGOC.,XS]..N$ B#4'702#(W
MTJ>LX2'.3R>#,K=;GAHW>\T9&0EA&!Q!>] U#JW,>AY189HL:PE7U,OX95EA
MM2LX3GMVS7R&S+@=^.H?D!#:I-H9@.U2T&T$P"8,"L';7<2XKU3(;<,B2!,"
M:D"DP*Q(G57:1GI*SYN8>^N/W$G5$Y 5Z!FX>$H^V:SM)]]4JW--O?:5XK5U
M&37XW)T*XD4E""L$MI=SE+:FLI5/.^+!\9DYC./U.-GD&F,*N-7!9]PW=W+;
M188$S S\/]9EY2X>5C5,+A8*L68DL0P"0L@"(,U:13?2U<>>>W#S8LQ\&V[:
M?EUTJ2LZJT/JZ'U=OBE[7F+:?*2[-?E S&#==T=L)3$S-0S(:A\E>Y<DLH5A
MO+7==^+$<BIC63S'L(45%N3&KH09DW=UM*H%>EP&N<G.G'S.Y9?].QAP<C&#
M?CR9%8%:@ *@8RTJQ9(-A8VAS"Y!ZHXX36J(2MUS@8HO81E@4:/R"WI2-!%J
MAZZW&KDBJ*@C7EP'NDH)\3;RZ(IT'*<+3G"\]\]L>'*<OR+<+ML7C^0P9R 7
M$3XX!*"*L#(J+3K4V+,<2'CH7SOEL V7=![J]W=18J;1-:4!KGG9J1ZTU4?=
MP_RJ:'2I%4PFV3%*YCT.[V:!]O#'RE?^S-6E=/5'.P,3^6Q<^89#++#1*^RW
M7F%,JU(>,69,KL&\1*VK<6<5L(D%0,:Y'+P0;.P,I#:I9G;(5XP#(<R*A)BY
M,A"H^Q 9G-HQR:@AF!D!KQN9GRK#!V#&.1?"%0!*BFQY)=]TVS%OO 8=5(C,
MR;YK8#A<8VPMPIG#F71FTY6ZE"/IZX58,$/N;8>HDB1ZK(]PD5%>Y9XV7&K!
M&,.54@'>'BVFXNGM!J8,>UH9JKM\8;M7HBVTUK1%LJU@!9DX*R5MJ@3<%,QI
M"?)@^+EHU)()X;R?I2XTXI&?YF>NY,>3"YQY5*N-P1!]=C]*ZDKHX)0@@$@Q
MZJ2K#[0P((Z$$&NIY7*KJ\8[$G4JY0AY('"DXD*Y#UYHX-)3;C*L8+C!TD#X
M(:\TY^MCS3WQ].._4-2U,OROKFI?T:YV?VIO^@3_ #NNZX=]9";V4I&H(MU"
MX%IQCE9S!):>M T<97V713.09+3\F/+P\_%N,L.-86GUPWVDN)2K.,8QYIKR
M,<;XL@(4KF0SZ0TR/0C<&GT(WU9B09+\9!(;$ZQZRI$'U!FHZBD';6G.I;Y7
M=E:^K5MJ]J8NT6: V*JU"CI&&G)&-Q["6/'0R*&$MIZ2'=SA8J,"JS^TYRWX
M];.5C\>9K5*XF-R@S[2>W>NWK7UUEPLS8UO(.4 71!K )J*'?I36$5DLH%<O
M>XK"1'Z!<*JFS;-,Q&'':%!DYEJM8K)=XXRP.VG78?>0:)J*/4R$V8_A_/O,
M*+4/Y/8N+E;#P,&7&8=4$0: V*)6*B/-(H +1VKY#&[E)Y.1GPM/C8U!$DAZ
MD-)BI2#66!($L*OEQPYIT-BGLD;^Y.T.>O<\&/-HJ\;%13;5/BE&2(XK7QRG
M13<?8\RHN&'5/*9'RVM*D>DC.%H3ZF;CC^%QU+.D7-M)*8VM"R?;=,@FZZE
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MOE// V)KCO0U9!&<&F&FQ%1+]@>#+]N0<(ZES*DJS['"585AYSO4T$ +0_\
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M%.RF'*SZ'B0*P 6TTE+*%*0A+Y-:ATY$""R8<2%9-,R8@,@(%1WR2X:226*
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M64XQ&V-K@SI^)L>(D]@!MX/A'J2.)%-C^(L  8$5[X(L+BSMD0H([R6KWHA
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MW"^7+^OWIIH]?47_ "?2/]POER_K]Z::/7U%_P GTC_<+Y<OZ_>FFCU]1?\
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M:.FFCIIHZ::.FFCIIHZ::.FFCIIHZ::0KYAF1<:BJ&3B'A ,7NPY/?']'U4
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MX8>Q2U9F=@Q2)@M(TH\AYK"QR%/9\DM+?PTXC'\:&S\?!AQF#=C61W $H28
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MC[;JR,@79X8=XQN'-VFNKQ282<84@HR/%2,(QA24(82I><Y?C26XV+ S*JY
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M#-D+O6I ZCH3[?I'74<8S*GY]M\MM($ M&_4!2&^JMM$"WZY;*M< WY&I66
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M[K+1YP39)QRP86H44IA)9"FQY,MQ@$!:?<$*PA!#BL>2\X3A><]L=2[K5WL
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M)I^99KF3_+Y?6P4]>]/3N^O9W4KV7:L,I48Y.V#*I*GJPH&Y8RO[4ZGSC/\
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M*#I-#.3VG,$*[/KRZMW+RDM+=4PU'&".-@4T*\?$"-K2$46Q6T+M8"P6+0[
M7&M!^9E,4.?(9C>7)NF>Z[>XA2TR46;0\_4M6:.FFCIIHZ::.FFCIIHZ::.F
MFCIIHZ::.FFCIIHZ::.FFCIII>]%?XQ\D?\ :$E/]%>I^FFF$Z::.FFCIIHZ
M::.FFCIIHZ::ZGY7US4OZ-<[/[4W_0)_G==UP[ZQ4Y.F'O:@376XY84;)[QY
MYG$7P^.A9ZL5J0#7OL0&.E:X?4]D'2IT@P<^6/XUB9$0D%>'FO)3:<YN1W 5
M"E,N!A(D,?+[1 )!%JDF%@-*L&4D7X A8!A<KKD5AZ+XS5I905:;;03,&X1N
M[G#'7,,WKFM;HGZW1%;4O<"^DBV5VG!0AP%-+-8(CJ='2YFO-;7(FO8?CT'+
M:E(T9_WSSJO#PPUV]7DMXR<.(L,;A68;22"PD D0@8JDFX+ ;ONU@QL,\.T,
MN-F"4V/M=A(!!<B6(HQJ*1K).^)F8?<]^-+G]=L14SM&W5-#<GJ?#@\5"7.P
M'0QAS<NQPV/=F[ (<<DG(+LH0 ^\TATLUUI;F%>=P_$>'A3*!:V J8$R5!?:
MG:1VGM 6YK59A77S&=>0^3& %3(2:U+%HW!8R5($@F9W_$+JXRVOBI6*Y$06
MPM'Z:D*G6ZZZ['[&K/&J^&6B;GY%ES+WQ6L0/%^CUR $-A9R0:;PPAMQT7*<
M*:5EY[.-W( N*%!C4JB*@)*P5\9!))B0HD3 %#:+1K+A+8O&,;7LI)9H"P5R
MRA6*4R.3-(,L)J=:$:+VMQ&$MS>M]%5-%+L%B%+6['P.@[]KF((%JS\J-EN1
MFC=?U^N#^S>'*P*T\2E;B<Y4RE2'$J5!!ERXW"F<:0YD]6I(!-20M8D@ 3N-
M2;%BPO>5 R'MD"M+:2.DNL=#6)M,.;U3JS6$VFP* 9O_ %0!LZ1C\Q$_8-CQ
M55JR=)XM>;K:7Y,[VL):K\YH67:AJZ#[;,EAW-O'2DX,1IU649P,W/XX4S4G
M+^9:/:!!DL?;)5;PONFYMR-1YTKBQY"8PA\*L?<98.$%HN@%MV@6@U*R)<;Y
MC#*VM74YQA^ C XZ;LA)1DWK@G8XL:$'0K$[[D6$"T]N-T-P932?QJ01L^GW
M0EQQ:DL.9G)/*#L>[QL9ZSY,1!NBE1Z@DQ )$KKX^!<N$\=10N@"T (M<6D$
M@$;':D;@4*6\)I+5C]OJ&S]G7"3=MX=I(JNLHYOC"=#5PJ L!*ZS4I6+V(=Q
M2T];81PR2*?]TUZJ! U*[OO+87A6/2"'&5Q(6/+RXX>2!W0UH!!AAXT[;HJQ
M6)B[S,A5\8RO_ # @P26 @M<(E8R9 ?[*AY]UN\O6/6K1TTTO=V_UDM!?N!W
MY_3]1=--,)TTT=--'331TTT=--9TZXXJU?<6F- 7&7VIR)IYF=":DBO@^L-X
M7;7]7PU'TV-],K%?@#1X_$B1ZV?6?\?-WQ3Y9^C'334H_D T/]/O,S_>GVC_
M 'TZ::MFN\3-+QE8AZQ<80_=J*[.R5AKL_OZ27N&VP!\J@!!2(2S7-J1E(L/
M'PUI2&F5H2A>,YQ].>N!5#^0 #)$3UBM)]*G]I]==8ED\;5QS,&HFAF/60*_
M0>FO??XO<;BFWV2-#:A=:)=0\2A>O:ME)#S;)0Z7G\?"\>J][<UYO*E=U90Z
MM.<YPK.,RDQ'0?\   ?S #[AZ#7-OV1]UUW_ )B6^TDZL"D:VUYK0(V.UW1Z
MG1H^2+P?(A5*OQ=>%..PTEC!AC$4**T25Z*,)]1>,KSC'X>NEW*A"24!) Z2
MVY^TP)]8U&U;SD@>0A03U(40HGT44 Z"@U5O%+_,+2?ZZNG\/;1U'4M,1TTT
M=--'331TTT=--'331TTT=--'331TTT=--'332"_,1EY2OZAID_"M2KLI";%D
MY83X',OUJ886!I3<9#AT;96/-%<-CF$+(;/>;?&%4UAQYIUK"D*\_P"5RG!\
M?DRAB@%LL&"%074%KB& M!)-#(D"I&IXQ<Q$2;6I6L*3%*_81L8.VL-*QNU&
MRM)WERWWO;5UI\? ZSEC;!<>0TKL-^,EYLVZ+8$BY-O7@T1!$'%ND!_$G8XW
M!PT>RVAAI&/->KF83_IK*RL6',Q(AI>Q\!E;B#!O!E+"S/+@K[=>?\9ESG*<
M&!LF3E'B\@LA<&W\[&%Z+^%D*MMC5["&>HJ6S6?6S<G9(U]O8F)Y,E0 EY<V
M:[ 66 9B-6KF99F/83I@J/JSY7MHYLG#KZ7YIM:#.XK8J6<\;DXCG.9R&Q^?
M.[M-P*W( &DB59AF#)<?$0_>7RF/.X7FQ<7$,GD/(_288G,N0BYH#,RH 2%\
M<$I#*4!QA0K'UHZTT.9K6:J9:MGU0.+,Q)J+!W9)V*63$SK4M64#R$VSI>3>
M)'BHH0DH9CTG#6B6/%+N4.^;EF3CYI&9RX;'C"S(FXXD8F0+@Z>,!7A 3F>Z
MU>U?55T 'Z50V#*IR"Z $*YG*J%,JN+(<I@B0JXT"K<+CUZYMRJ4@60F!;_M
M"MJKH;0PLY'<A)2&LH#+@BA9&,((AM$P4RT8M+6'2!7\/M..)PZCS\&/.6/D
M96#" 'R9%0!&[6*9<48D7M6T'* 2RJ45JE"S,M.%<GGY-H&3&MV,,S0$<(S0
M@L!1F9;B>Z]LCNP90=:2:PW?Q/I+5(ODU\PG=EWCH6(DH8BOW@G?MVJYD\<4
MW$2:KF5 ?#'K!-04UA88;A2V64/H5EIKOC/CK8*<^9^,HR8<Q QD*;;99E.)
M9,%P#U=K5B:$FS#BR%'RYFR*Z-?D0L&&,G\$@"50RL+(-"9E=._0>0&BML3Z
M*AKC9JKA9GZ_(V;$)&ZPY&(*:@8P\>)./.P?;0F8Y#,D8TSZ1"VGW%K^HA6,
M9SBE<61@S*"40(6/0#)-E=I8 D 5BI %=3'*P-:%;N?VB"":$S!$@$*T,8!@
M@$FFL7[;OZ:AF-61[6ZN0L;DF\[S@B@HCDO/5UC)&O"8X5V&?%Q0Y,F5C81X
MKT& 4*'%@6TX20^6K+?E@XAOXV#*SM9D^-.0$D-MR,BAY %S-1/*0%50N,(2
M&<Z>=A"-EY%Q51\HG'M$A/S,./*($E@180,*DL1DR,<@$!&1X&;?D]C;3$@C
MMM;MMI":-;"#Z[=-QV/>(#,B%*UI:O5BJY%:^D29&+&+1Z9PSV&AFWU-.M.9
M=\VO5Q8SXLS.)(PXB"5Z')D%X(,+<(%U4=86%9 6\D^;%\D%SMD6_+EM4Y%M
M*Q0! H%HL8JH8ND&K(TC0N6BW_;V;LU,J[1.Z59_P*VYCZ$25=QES.<WK.&\
M9[_64OR0UGZ'<+SG&<9=>KJ%;8]Q%!%/),L<=[F\S<9EX2$OT"X2F2%JPB@2
M"+%;9 <D.32[Z3X3:<&E-YRVRXEQ:,I)7D8D_>=A'0QBR-!&[1$PI!! 8]BL
M#S(;>/E?:U 9V([T$@FB[Q+ B"0.XJ181$2_\?L"/1F,9P#<\91FD;?QG_$G
M6WT*:5?,OHPOR[9\E*QC';.>Z5-I0&NG7I<%C'#Q-\%NFR<BMS:5?;]Y+ON%
M'.8%T_K8-+:BEOD-O,BX']%K",XPRVWAE>,O-NJ5'&9XV!][N/B:=R;D4R2*
M,3,EE 5CW* I U6AG)E$S;GR+N*6N1  JH$0%:6448E@3I\^I:LT=--'331T
MTT=--'331TTT=--'331TTT=--'331TTT=--<1#BF6'GD,N$+::<<0.SX8>?4
MA&5)9:RZMMK#CN<>*?)24]\_3G&/IZAD9DQLZ*68 D 1)(&PF!)VJ0/74\:A
MW",0JD@$F8$]3$F!O0$Z5?0UH9#C>1]TM@1-+'$V]*V:RQTR\&2756!=,ZHD
MY@64(AR)&/(>AFFW,.K%=?:7Z><MJ7C.,Y[RLF#B)DS9''Z?&I8M! M DF-Z
M#?[-0PA\Y554C(S0 8F9@;$BM#OUKJ.B_,5X+&-0!#/*W2"1K0Y[>!))O40&
M-(G88$*5%-DF/,,-32!CFG%!.*06E"N^6\8QGM:V-UY/Z,C_ !4 A>I!,2O[
MPF!VS$CU&JGSXL8ES LO,S1?WCZ ])B:QL=.:A25I2M"L*0M.%(4G.,I4E6,
M92I.<?1G&<9^CJ)!4E6HP.IHRNH=""A$@C8@[$:_77-2T=--'331TTT=--=3
M\KZYJ7]&N=G]J;_H$_SNNZX=]9 [\2XK3(J62H<)Y7)_F<EDVP1@DS#"/*5R
M(PT4?$GP=E"D6F%YPK#+H!:%JQC&6\_AQ1GG\NTPWFQUB?Q#I_\ BC>1N+N/
M%[725\;S%#%I_P#'_ [:8CB+R.D;,MO3FT+'696_Q0[+-2G8=$D";L2-#KL=
M9IX]ZIHUEK^'IH=3%G1 6<-8=9-0CS0OU,.-I]!P<V,\BOEEBPF3 95O),&6
M9B(*@T!ZP,*%L;!6CQ-%D4J;S8HZA%6;I,S$T!.5&V V8'<MELL8_HH S&Z"
M"GOBE)J6"I U=[6,APB3D] ^)$_Z3F6\.-R<F0IU2?+QSA"U>?PW\?"Q(H!+
MXV%/_:,A0!6;V!A#1C!DVG7RS^;FR3&1,H"D_A_,5JUJ0:U.\'T;5T<4K7L9
ML@;3%;W1KK0QEK<(FXZPZPTW5+(]>;K:X6 -%CK#75ZJK=9K)M-AQ%M#//E-
M.$-80T4,VM"&\>B<>7)_AU)(P@J%D%2$A\CAKB+C56"DBH9=UC*^3%@BY0+V
MM^J7!EQH0!66)R20L%(-&;6Y56C9J'KD+%V.QNV^> CAA9:SOQ<?"O3IS3>$
MOR;L3%(;C8]92\>66F$X;1W[)QVZHR,C.6QK8AV$DQ]YKJU00*F3)_9-!]PI
M]8U[_4-=TEG"FV.25)L50)/'(=J]AFCP0TK(]V#$6"V6M3:7FG*_%CX8<DXT
MI3:FS9)2LY5A2VL82TEC[L)?JN5E)^D*5^^":1L ;FFC)V9@FRMA5A]MSAON
MHO7<D0(.N7FQ?MD:^H=2DM9[$C=:RTA=8V*/G9@((V,5&&8]!]HO$CKO88K2
M&?5]9/XL);BV\(2]];*>JY)Y>+%,8W)!I/I! ZD=!<)V-)(FP4<5\I!O5DC[
MY$'Z$Q)B@K(V/AZNYB:W@M>P@>[=IQKVPHX+"[ :)6K4X_(A$N&$05@/C8B@
M08<0_.PS*"<C,#>@SY>"''/V2M.0X\CCPBUC *[VO:"5DF3 ())BI(BFJ>[&
M&.0BP,8/JLL 3&TE6 B:">L:9[5^X=<[FB)&=UK8OM+$Q,L7!'F8B)V(0S*@
MN*:*%2B=C(MXCTEHS]=M*V\X[9PK.,XSU%L;JH=A"M,?<8/UW_;TUT.I=D'N
M6)^__P =-69U#4M+W=O]9+07[@=^?T_47333"=--'331TTT=--'336 -\^4Z
MCF77=";H7O&,U_ZO&;1E2Q72M-"WEU/V<IS']7_'GMB5E:DF8/QV9]KC#7A^
MS5W^AIJN?_U?%G_K3P?^[2!^N7IIK1CCA\N?&A-.0NI<<C]N-HA;??+5F6T\
MXSI,&:S=PZ\(@:PP+!UX5)DUS$#E01&#&L8R2OR:SV3VXHMR')4RML'85F0/
MWND^FI!HB@H2?MD1!^@W'H:Z88;BX@11+K7(?E,IXH6(86Z3N!\U+;\00$^D
M\80V$(CQ2I%(*6RTMLI'(;<<\FO)Q:LV%R1$#]@_K3^V[[K5MBT:7=ML#=Z]
M>Z/_ "QV>E9F=73KBA_=U7EU_P"V=]O>5R1LDJ=V/8OM/8?(WTNX2)' 8*&X
MT;TOQ+*6\);\E=OP]<+2JK %HCZFI-?4UC[ !TU6JVEC),F:]* 0/I2?M)/7
M5:<4O\PM)_KJZ?P]M'4=2TQ'331TTT=--'331TTT=--'331TTT=--'331TTT
M=--9Y_,IC[%)Z.JXM15,-V;[PI J$?K[ZQ)P8X#3>WSDDQ1K$!;#@CF&QE*;
M=%BI,M*L?B17G/%&?.^59TX#NA(*LA,%@;1D4M[59CVS( [A(E9N$\8N)45)
M1H^VTQU'7:M#T.QPUHY.]Y34<U.9<Y$GY14M6LMN$Q^[7[>S(&E6B,E#((.7
MXYP-G)/>"@3'"7 HMXU8BO,]###S9"?88XAA8YKAB/,P"5'<)Q7.&K>,<&6,
MJEP[RC@:\[X_D9@0J+Y'P\?F.P:[N*YL?C )471W*!5U$C$,JDE/88*W(YLU
MB2:/Y$?9D&>C9HX9P3>Z1UU1N)CJXR/#0I^F"H<F3D)Q;#I$2:7(*<]5]_UD
MX2IOKS\-Z%SR)("Y U28=FRE* +*  !BL,L2"6M8T.SDCCCR%QBQ_OBBKB=V
M)4"YJLI8F7V(6B8^A$WK:Q(68<4/E2Y-YKLS BY9H.[FF'K _&1Q8\C)31W'
M).<##CY<\9%#6"0UIPA>''%/MXTY,3XN)D!*C,BI>2VQQNAR$,)N)&-@IQK9
MFDBRUM;RQ7F>.GD+LRABP4AUSG$#0*$6[&7!8MC@=Q\:W^3*V/?)FN&XN$8Y
M.LR]3!?EI2Q2L-NN,E9H*S9FV:XTW9&^,6)FV%,'13*GPF8]$D&TM;B5IQEG
M#E7.PY3EN!M!QC&0K$ 9!'="@T)E6R B.TE23&LC]_,3(SY#A56=K;RL)%T!
M5"L>Z@-&B%$"G #);X$IDP_(G<H@S4V9C( \F)O=R5PA4.2\]G(P7&./GPHY
MI8JG!UEL20N,O+<6O+RQ_#6Y7*V,X@!9=<)"T;(P  F&< PFU%502+F;5A7.
M,B!1*\=9<NQ*O854LI(G*&*DCN*DQ*%20'0X257;>QMCASI'WLFU+6@DF-?H
MJ_!7.*(.E;;!.OU3 =1W)0->_;9AAKR<?)(/,'CW$I2EI+_[&\LJG+D 1L7=
MA'L[<B,C,0JD "TVWL'8FBO"L30Z90R8"Q.56QNQN)!Q^/(## "X^2PVS:>Y
MB%("%5;F7N;&=2-0YG(EAIZ];]EI-J,"VZ(!\#!,A_@HB/@/'*6;.AXGW'A#
MBF%-AL-?1'*E<]EH\;B#-EXV"+BR_&2Q),EOU.4!FN4$O:(DB^T +C\<.WH<
M]UG+Q%!\S?*X[3;3Q+@4,MX8J$N()0-X6)N;,'N4,UP&QL^R[9$<MS6Z9V/E
M*';I5(=\@YV3CVBDRM8% ]**W-H_5+3!+ S3^6<*,8.:PZ[Z;)++CSC7KX2K
M8,P*H"N#%6DEO*X)W%8 N*CT#HH\;:\@\C-G^3$@+B3+F01Y "(#*2"HQL:M
M!%('Y;D7KK1B7JB\,6;.:O)I\(G=*LYQ1-7?54Q)5S"E9RB9[H0QY8QE2/K-
M]^S6,XRKK)KU=0C;5>.!"*6)!SX#B[W-"O* INOA'5C/#59LT-]<2':7,@/L
M.92^C+(PZFE9\C \94^@E>1A7\)=I]#^5D-=@:@&K*) ()("/S)3CY6&X01Z
MCO04-2-XHK&"1 !++8C]27B>GT?962QA(-S^KFA:K3XX12=;+7Y-8G,-(2A+
MOEW2OOCRQE/UE.=@WUT]8UZ'!1LML/?&#DR>"5;2@%*S+B"!'*;1J#6[ _FT
M'"5UM3#0[*&VE*#;5Z2$IPLA"4$O1Q5XV!C[CQ\1)ZDE%))V))-22J,34HA[
M16AE\HZ#/D ^@#D "@@ 4 !8 ;.X[B^O4M6:.FFCIIHZ::.FFCIIHZ::.FFC
MIIHZ::.FFCIIHZ::.FFCIII>M%XQFQ<DL9QC.,\@Y7&<9QWQG&=5ZG[XSC^;
MC/3?32X<M[OS JEWKT/QRU'%V"A$0 "9NW/5Z&GB(V\'V5HIK+<+B5S.O00U
M4A"02WV8UUMDJ:&<4^TEEQ2>826?(<@HI6RH[B$<LOT#LV(*Q*J"F0%A((YG
M)7"GA%SEOS/IC+(H(G<H/(Q4!S!4A#$%=XC:'S2RH\R7L%2BH.+P9 Q#;0.O
M&)&QC/2,O[NRRB:X.W)RQ496(_#D>T8..<TZXVVI(Y3)")+%]N$8N.2Q.1V
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M !P5OSPTZCU7?.*DJ(6@K_\ $Q9OLN)-W[P)5I4QI:MU\"^09BLJH53/]50
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MVM1WQXSAQDKB(@J* BXM$;48EAZ,S'<F8>##>N2Q?(NQ@2*08/U  ^P#T&K
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MSC"+D<$16A-/[0.YJTS-1L8URQFK^.<:%8Q%\LMLRJYP:MCQYDMH7411=67
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M]X'!S\UM=_Q$ROZO^FD'1]X'!S\UM=_Q$ROZO^FD'1]X'!S\UM=_Q$ROZO\
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%O]&O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>g68105page171.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page171.jpg
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M%!4CTY1506&1,D)28M97E]$S-%34%B9&)PH:&!$  @$# P(#! 8) 0D
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M3U#N,>N2^FTZHS]U1U'(:C(7VYXI:<PO]-VHM5BVJKU25KN8V>OQ=JN"3O\
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M^3F?X_Q1(K&1<K8/$D*C@'Z@*\@OGH=_]<G_  _TR^\/X^O=!+" 0SHIOT+
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JZ4M1XP]Q_NU/EZ4M1XP]Q_NU/EZ4M7$YP[![#?SB?T#_ -<O]GI0"O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>g68105page176.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page176.jpg
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M P,# P,# P,# P,# P,# P,# __  !$( 9<"0@,!$0 "$0$#$0'_Q $"  $
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M53/YNKSA,IC%':EU(>)3"4?^ /<(': \![!JP"']4 '054\?G>L)?BI=2'^
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M$='KVY=V7Y)=YT!:[H!H!H!H#TN/[W7_ %E7](;0'R5H+R<'4M^-';/=/CM
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M5KI?PX_-[/;#QY^FQ9H#Z6.@&@&@&@*I(+RWF2/^5YBC\J;*F@+6] - - -
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M"#R'A#Y8?-T!7)G#R@/2K]I/=C^5!NWT!:KYK+\*OK$^W;1O\8N^@-G'IY_
MLV\?N#3]=Y30$S- - >I?^T+?K2GZ0= 5@=&;R=&"_JUFWW>LFZ M$T T T
MT!5%O:\H1T>O;EW9?DEWG0%KN@&@&@&@/2X_O=?]95_2&T!\E:"\G!U+?C1V
MSW3X[0'TV.FQY/#8K\4+;E[D=2T!-?0#0#0%3W5)^NCIA_\ -'VZ?8?EG0$B
M.G1\#3#'ZQ>O=-NF@)LZ : : : ^7_E#[ZOG$?QBLP_9U?M ;Q702\CKT^OB
M_P )Z\SF@+=M - 1*VT_?$WD?&9'W$,,Z C)UA/@IT/XZ&Q+\K3$N@+4- 1
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M"H?+_EO-D_Q ]ZGNL[8M 6\: : : : K'ZSWDJ]]WQ>;I]+;: UJ8#ZWZ_\
M4&%];&N@.6T!:3_-3:@J^1##=/\ "7SY[;5X]?7>I(7N8%T(/(>$/EA\W0%<
MF</* ]*OVD]V/Y4&[?0%JOFLOPJ^L3[=M&_QB[Z O/Z2VZ^C9:PI"X 2@+?3
MLFX.JJ)9J&M<0JS;V2JNI^3:Q-YJ\@0HM7]?EE1**?,)50*H40 Q1$P 6W:
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M9]W%(VW;==E].R-6[BE7LUS60*A%9(BHE22J%9M9LG6U.(A+0LW [IBO/*N
M!L8I3\P%./#T@\0+A] - - - ?+_ ,H??5\XC^,5F'[.K]H#=/Z,-U7QOT,M
MEE];U:PW=6H;7VU@"IU-J#VRSY(R2G7*T=!LS" .Y)9$ANZ3X\3F#@':.@+/
MMN&X.@[H<053,^-E),*U:$5RBQFH]>,F(:68+&:2\)*,URE%-]&/4S)*<HF*
M(AV#QX@ &<] 1*VT_?$WD?&9'W$,,Z C)UA/@IT/XZ&Q+\K3$N@)5[HMUU.V
MFQ6/K1D2L7*2H]TO+"C35PJ\0I+QF/EI8@EC)NVIH *[:&=O." *$ QN\$
M!$0 0.O[ZW"+O:9D1TW4!5NY<XQ<(*EX@51%;*E%424 #  @!R& >T '0$Q=
M - - 56;7?*F]5/]QFP?W+,F: E-@;=Q1LZY)S5AUO7+C1,H8+L QEKJ=SB%
M6"TC .W3AM W6O/B 9G)5R?\6,9 W,54 $!$G*8IA E;H!H!H#7B\Z9\B[N4
M_='A_P!TNO: U:Z7\./S>SVP\>?IL6: ^@+GW=O2-N&0L*4W(M;N2=?S;8EJ
M=%Y(B8A22I]6MBIVR,)#6M=OS.6!K NY C=0I#@ @(F "E,8 )6: : : JD@
MO+>9(_Y7F*/RILJ: E=CW=O2+UN.RKM==UJY4[)>,F+:?:A98A1O"7RH.11(
M%JJ,HESHNHY)9RF0X*]V83']+S<#< )6Z : : JZZU_DG=_/Q<KO]);Z ^;%
M4?O-].GXQFU7UJ4T!]3O=+NOINTJ'H5LR+5KK)42WW5E2YVY56&/,Q>/%9,"
M%CINWI(CXRVA'3@PI=XF4Y@.' "B(@&@)0MG"+MN@[;* JW=(I.$%0 0!1%8
MA5$E  P 8 .0P#V@ Z ]V@&@*A\O^6\V3_$#WJ>ZSMBT!,[WVU&9[KU-HMAK
MMQK=ZDJ4E>:'99*'5&D9$C$&I',\QKLVB!TRRU<XF!PBL! 'NS<IA$.70$JM
M - - 5C]9[R5>^[XO-T^EMM :U,!];]?^H,+ZV-= <MH"TG^:FU!5\B&&Z?X
M2^?/;:O'KZ[U)"]S NA!Y#PA\L/FZ I(W'[M,65K?OLC>2<;D<Z6W2D;DJ'?
MRQ^/YM^N_FK)GS<9:(]Q1D42@:YPR<=<6I'#MIQ20<$62-Z9(X !-CH ]4/;
M=M-W!=2^WY-KF?Y6,S1E2ISU01QW@RZ7V2:1[!>TBN6U,(%NNO67IO5!/D1<
M@!C\#<!]+H"_W;AUM=@F!<08[QVZIF\"Q6"CU%"J/+DVV594CG<LR;OWDB1
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M#9Q;Z)>\!6+'V]K'-I&0JS:3;R^S#+*[B 6KEIKMK%FYC6[9'T[AK% D4"J
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MG 0Z=."P$. ^K6;?=ZR;H"T/0#0#0#0%46]KRA'1Z]N7=E^29>= 6NZ : :
M: ]+C^]U_P!95_2&T!\E>" ?S<'4M_0W1VSC^A_M/C0^:.@/IK]-CR>&Q7XH
M6W+W(JCH":^@&@&@*G^J0 C9^F'^AU1]NG'_ %/RUH"76RG']MQ;MCQA0[U$
MJ05J@$K866BE%V[D[0TC>[1+,P%9HJNW/WT>_24#E,/ #\![>(: E-H!H!H!
MH#Y?^4/OJ^<1_&*S#]G5^T!O%=!+R.O3Z^+_  GKS.: MVT T!$K;3]\3>1\
M9D?<0PSH",G6$^"G0_CH;$ORM,2Z M0T!&S=W1[1DC;Y>J;3(L\U9)9Y1E(^
M-360;G<$B<AU.9D# JY410+XO&QRRH\3!Q G .(B : DGH!H!H"JS:[Y4WJI
M_N,V#^Y9DS0%J>@&@&@&@->+SIGR+NY3]T>'_=+KV@-6NE_#C\WL]L/'GZ;%
MF@/I8Z : : : JD@O+>9(_Y7F*/RILJ: M;T T T T!5UUK_ "3N_GXN5W^D
MM] ?-YKT!+1^!NF//O&AD8JR;D-LOJ*Z$Z8E>^HS<&4ER$*<5">+.C@0>8 X
MB/9Q#0'UR] - - - 5#Y?\MYLG^('O4]UG;%H"U>RVZITQAZJ7"SUZJ1@F,0
M)&RS4;!,!.4AE#$\<E'+5OS%3*)A#FX@4!'P: Q-[ZK:_P#C(8%_#!CW[8M
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M.^JU4RYGG$%\M]SHT]!-W+\\-'QSS+6:2LU[S#04P"<D2HE5436](97OBD3
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M+Q$![ T!81@_>RGF[(++'X;3=[.(Q?1TG(!=,WX$/0<?M?4QOXP+%[9/91+
MWD7X>D;)BB/?*>EXAH#(A=Q$E+U?<)*P&#,\LYS!QK)'0\/:\<+Q!LQ2T/$O
M'T<XP^4)@QKQ 3#UN1NBX*=IWAS@' O'FT!7U@OJSY"NM)*OESIH]1:C9*B9
M1]#6JN5;;B[L]?;NFZ@';N(N8<VN/6<-W+50HF*)#"F<#!S&#@.@(?\ F]&X
M-*W53/\ CA/"NX:M>J6<;W</9W<<8C!XW8\C2&2"KR-I+-O2M;@<#<X,11'B
M0!$#]F@+RH;<DG,T3+MZ#!6Y&+#$<U/0IJA,8K68WK)8P7#_ ,5Q'7AF%#72
M%F1'@P7!5OXQP[2ET!%D.IJF( /O .IJ'$/ .U$_'^K_ )]>'0&>=OV[XF?[
M3+58-L>[["PQ,&>;]D.?\)J8XJ\F!':#48F)E_9%,E>39N_[P&_(412(8P#V
M<- =>R1NNR.WVP9KS?AW:_G:PY%Q=*2$36\)7['[RJWK)JT+88F-D)&EPB$L
MY<S,#(1+Q=W'.B*D%R5 ?2!X- 50;X^I>MF+IRYY2D=B/4*QY)6_#KI*6>VO
M;@HRJ%4EQ=,"22,I9%+8F)8IC((G2!T+<O.4 -R!QX: DYT3-Q*62-F>** 3
M"&XRB>P6D3TH-TR9BX]4H%P\9OUD$T?1+(6;DBV*3:^,@"J/=(B42'\/+H"?
MJ.Z5); \_G;WO>Z-,L#-/87[CZN(54\[3)F<XW@PDX''@SG/(P[OQCQM%?QH
M@'8D,KP#EY= 1M_.:)_B =37^"B?[>M 2%P/NR3SLG>% VW;L<.^PB)0EA3S
MOAI3'JEM!<CTXQU(+[()<)^60\3X*( *0E%5/M'F[ ,'9\WQ9=Q[MSH^Y7%6
MS/</D6*<9"1@,E82EJ$ZKVXJNTKU1>Q#FUP>.R2;OU0$KQNFJF!UQ(9DN58>
M4O'@!2OUR-^3;+FQ08%+9_ONQX@XR5691*R92V[GJ%9,F:F7TB34912VO!*]
M6([[PJ8I\133./\ 8\! ONVJ[I4\LX;=S0;>=TN- QECVL.ABLMX@4ILW?RH
MU,'H)8S8!.R?LL<+ P[HA .B)EEDB_V?$ .VSVZ]."P'6<]>]PW7S);*^;L0
MPU X;4D,]0(KO'[,75EQT,^B,2R0\0[U147AP*BJD;MY^  1X_.:)_B =37^
M"B?[>M =XG-SZ>9]INZ:Z>]^W08I"DXGR0@>J9FQ&I1[K:@/CZ;>]_28#U=D
M_9 @4 [H1!9+@OZ7]'0'Y\=;GTL:[)MKF4"[?]T%_+:<78OBB8\QKB-2T93@
M/\RV)/5"TU )UEZC1@>(\15%RH'!5/@ \_8!J9YYZ@^*<O5WI!;2SX9W+2LY
MBS?%0\U9;PM*X'8/IZ_U*,O.1)RD#3VI[@=U+R"EB2[A./$B23X3*\YP!N!5
M -HK9#N22L&!-TN7RX+W)PY:IN4SQ,'QE8L4GB\P6(RDNTD_4JITDLXZ]6I<
M@.0;BB#E/@Z(=,1#EXB!)K)^Z]/&.,L=9,][CNNR"&14VZA:!C##:MKR92._
MC0DA)D2JC/1_L740X^+J *ZW*Y](''PZ CO^<T3_ ! .IK_!1/\ ;UH#-:N[
M.PSFU[)V?Z9MDW--+;3&$^A6,%7[$R]=S#=+"P1:)PZ</2$Y]95]!RC^03_N
MDKQ/@@DN?L%/@($;R=06YR6U"*R-DW9-N^A[_<(_(-2MV,<;XD7OTO09>O1"
MA'<M8"K3,(K&UB2!T M%U.8YCD4((#W8G$"FSH/;Y4L5;6<NP8;0]]&2/5#<
MO=)H9C%>WL;=!,?&:+C=J$3(2);<Q\6FT/$>\5;\@\B2J9N8>?@ %QD3U'\O
M$O,LYM.P7=Y&89EJ^+W&[YGB5ROFB3L,0^:1]DA;1B\+ L6);F4>@O'+^.$%
MTT145Y. "!0*V=S.?T\0]>+"EZ'"^X')XR6U*L2!:=A_&A[K>602E3W"-_$Y
M*OC,1@M)"/\ '>=TEWIA1(DH/$>7M EY@+J+HP]XW4N@V,]1N4-.[@S2IVT3
MM?,\<0O#$.*8X(R<3]FY!82X^IXK]R/-_<ZR1^/I^  60!NM3' ;3/7O<]U@
M%=S24*.&QPXK]WIJ969-#C*.\=!/"9*%2Y?&CN =F &?ZIP'^MT!Z-P&[-/
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M08,!V%]2EB#YZT9>/2&U=1O'LO&W";?QM^X+=U1;LFW><ZIP*;D3*(\!X<-
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M=CX8F]GZJYT]WV&T!M\(/6;I1RBV=MG"S-0$G:2"Z2JC540$02<IIG,9!00
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MAX0$0T!KJ90=.4O.0MN[9)=1-N[VRO/&42FX)K]QCG<<HCWI?[+NE!XAZ Z
MMVVT/&ALF[RF(.VQGJ>Y3Q@[(KA$SM- V$<+E!<[4#BLFB8Q@ #"4"B/R= 2
M]T T!$#?G\%7)?\ A^-?=7HV@)?Z : UI-G+A=QYPIOW[Y4ZG<XDM*"7.81Y
M$4D]IX)IE] A 'L#0&RDB]9N5G+=N[:KN&9BD=H(KI*K-3G 1(1RD0YCH&.!
M1X 8 $>&@-=?SDE95#;3MF514,FH7=&RY3D'@8..(\I%'@(>B Z V(2O6;1"
M/([=MFQW?B[9J5PNDB9RY.F'(W;@H<HK+GX=A"\3#Z&@.0T T T T!HI]91W
MW75TQ49RX*DT9]0#IWK&.NJ5)NV2^Y;'J+JG44$J:28 7B8PB   =N@-ZA)9
M)=,BR"J:R*A0,FJD<JB:A1\!B'((E,4?1 = >S0#0#0&KIYR*(^JFPP.W@.3
M+)V?_KW GR- ;02#UFZ4<I-G;9PJR5[AXD@NDLHT7$A5 1<D3.8R"HD,!N4P
M / 0'0'Z= - 1"VH"(S.Z_M'LW99%X?H?YLT30'LP[\*K>3\O;S[F\EH#C&8
M_P#S!IX/D>\]KGNRV+0$S- - - 1*WSU? ESVM90K6YVX/J%@^2+4 NULC'P
MQSZ*!K>ZP]@!0=A&3/=>.V=NR;F_N97F(J(>EX\Q0,>=3D$R]/3=65$W,D&'
M)@J1N/'F3!1B!!X_)YB?^G0$#O-Q%4T.F-"++*$111S_ +EE%553E3223)E6
M=.=10YQ I"$* B(B(  : OC;N&[M%-RU71<MUB\Z2[=4BR*I![.9-5,QB'+Q
M#P@(AH#W: K'ZSWDJ]]WQ>;I]+;: UJ8#ZWZ_P#4&%];&N@.6T!:3_-3:@J^
M1##=/\)?/GMM7CU]=ZDA>Y@70@\AX0^6'S= 9V\W8^&)O9^JN=/=^AM ;*=.
MVFU;'VY[(.YBF7&YPKG+%<:QF1L:!( \H5CL<>H0(^\$9.N\7BY]NT3!$P(&
M*B<#&-R@)S\P' ]//X%FWC]P:?KM*: F9H!H!H"B3H+E*?!.Y(IP Q#[H+R4
MQ1[0,4T;$@("'R0$!T!9=MCVGUG:JXRK'4&YW.3H.1KHI>87'MED E(7&TG(
M%74GV5/=K<S].*FGRW?G15,8$S% "CPT!*W0#0#0%?G55\G;NW]J25_Q^-T!
MC3IM8_J^5>EOAK&UU8GDJG=\?7FN3[)%TNR77C)2[V]LX!!XU43<-')"FYDU
M"& Q#@ Z FGMHP67;=A^M8=;WZWY'BJB=^V@9Z\+MW4^T@EW:B\7 *.6Y"%7
M903<X(-S&#F!(I0\    9[T T T!1+YQ+Y/-Q[;U9^P?)&@+%\J[::1NOVLU
M+$UXD)^"0<56@3U?M55D58RQU*U0D,P<PMAB7"9@3478KB/,BJ!T52&$I@\
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M!0SYM>P:R>PK+4;((%<,9'<;<F+QNH)BD<-'>)\2MW*)A(8IP*JBH)1$! >
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MH#BYSS>FHUZ%EY^2W[[K2QT'%R$P_,@[7<KE91C15ZZ%%NC8S*N%000-RD*
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MIUKV.-3+X$=)J-@>5U5YS)$;I]X\/^I\W$Y@,E_TJG9'_(9[=OV2P_\ Q>=
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M?*V'%&56E>CGD@U:R$X\8X^L,D\:PS1=9-Q).6D>V4<*$0*<R:*9CF "E$0
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MET1 -CG 1#_:':![!^3[/<!]N@-IP/ 'R@T!YT T!$':@/&9W7\?QLLB!_\
MLQ1- 9<I>+5ZGEK->2U)=)XCED<<>+Q1&QDE(;V"5ES7U>]<BH8KKU1.X[PO
M I>0 X=N@,*LQ_\ F#3P?(]Y[6QX?*S+8^'_ *..@)F: : B+NCW,6;;5)X@
ME PS<,DXSNUR+3\BV^E%&2D\7FE%8]G6YMY6VZ*S^7BG[]VH1<Z?(5N5+B)N
M8Q"F _K?3GF/VS[5\H9MDJ%%Y/8TPE/,K1YM9!M%SGJ_>ZO6D@=K.8^41($>
MI,E=$YD%.*B!0#@/I@ C!UFE>^Z=>7E@#E!:2Q@IR\? "F0:R?E'P<0#CH#
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MY,DFF51<QC\H<W#0&ZYH#7+\Y-$0VS;:. B'_%&P\ \/_A)E'0&Q:U_O9O\
MK"7TLN@/?H!H!H!H#27WZL,3O/.-<"!F.^SF,:E]V+$*K>U5B8?5Z7=W-GMR
MKKC'E26E(QLY>*1%ON -8UVV$O<N6[HZ9Q*0YAT!NT: : : \" "' 0 0] >
MT- :L7G+W@V.^V%:/L]P'H#:=#P!\H/F: \Z : B#M/_ ,L[K_C99%^QBB:
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M]GVE)?USB= =<Z)?DT-N7_=R=[KM[T!:QH!H!H!H#7I\YI\FL'M[4?["LF:
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MKS7J!2]Z+*[66E4^44A&62U(K!^%U(J#M4BT51D2PK-X4%A31,43F#M$.P0
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M : K'ZSWDJ]]WQ>;I]+;: UJ8#ZWZ_\ 4&%];&N@.6T!:3_-3:@J^1##=/\
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MNXMRSD3&]B9VJEVG<WG.6@)YBFZ1;R,>\LJ2[9RF@^0:O$B+(G Q043(82B
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MV]Z M8T T T T!KT^<T^36#V]J/]A63- 7LXJ^]?C?\ <%3_ +'H[0'?= -
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M+?AI>)<1F#Z/@^L6^.L4VBJQ)DIA%YYRC9I>98)B59@T5CF)&3P3F4$IN!=
M7S^;R0$+:NBAM&KEBC&4S!S-,OC"3C)%LB\9O&J^2KB4Z2[=P11%0/ (<2CP
M, "': : LGV4O91# L10+ Z,\L6$[/=L'S"QO[,N,K-(U^OJ$ 1$PH.*@C'*
MIF'M.F<IO (: SW9K]5ZU/TZG2D@<EFR(]EHZK1+-!9V^=A#1+B7F9-1- AQ
M90\0S2+XP[5Y4$E5D4Q-SJD*8#3;\WNAV$%U&\V,8Y$J29\#Y8?.E.! 6?23
M_(N 7,C)O#D*0JS^0=',JLIP#G.81X: W6] :Y7G)WP9=M'QHV/N291T!L7-
M?[V;_K"7TLN@/?H!H!H!H#2%ZA^#R;A/.)L 8_4N,512Q^<<)Y)]7)A,BK1<
MV*MOE6OY:^F0[EH7QZS#!>(MQYQ$%ERB!3#Z40-L'&>.-R])W+9@L%GRVRR%
MMJR!'-[#1ZE-MC$M^+KF#M))Y6X9RDF1!:E*L.\43YSJ'!02ARDX"8P$N= -
M - :L/G+W@V.^V%:/L]P'H"^7</CS<U.7_!^0-O&6(VKQM,LX,\LXOMC07-0
MR-0I==IZINDE4$5';.VP3=!3Q$0,DF?OQXJ$$A>($N= - 1!VG_Y9W7_ !LL
MB_8Q1- 2R1CX]L[>OV[%FW?27BXR+U%LBD[?^)I"@T\=<D(59UXJB(D3[P3<
MA>PO - 0_9^4'GOB>USW9;%H"9F@&@&@(=[^]PUHVJ;3<K9YID+!V"RT4M-&
M-B+(#LT*[&Q7^JU5UXZ5BLW=""+*;44)R'+^J%+Q[.("!&OK,JBOTZLN+& "
MBM)8P5$H=H *F0*R<0 1[1 !'0$:_-]8QS-=+-E#,I9[ O);*&X.,:3L;R!(
MPKE_:'[5"68"IZ3QV.55!9+F[.\(''0%IVTVF[C<?8T?4W<OD2$RQ;8&VSK2
MK9#BV9F$G9J"*B2E=>VQMR(HIV<I3J$< F42 4I0YU!XF$"3V@*Q^L]Y*O?=
M\7FZ?2VV@-:F ^M^O_4&%];&N@.6T!:3_-3:@J^1##=/\)?/GMM7CU]=ZDA>
MY@70@\AX0^6'S= 9)\W&^';OW_P[-7N]P.@-R[0$3-BECG[;M&P19+1,R-@L
M$M2DW,I,R[I5])2#GU3D4^_>.US&575%-,H<QA$> !H"6>@&@/4O_:%OUI3]
M(.@-<GS</[S^\GXU\A]@%3T!L=Z : : : K*ZR_DN=[/M*2_KG$Z ZYT2_)H
M;<O^[D[W7;WH"UC0#0#0#0&O3YS3Y-8/;VH_V%9,T!>SBK[U^-_W!4_['H[0
M'?= 5T[H-IF?MU>3256R[BI#%^SM&#BE)G'.)&[JO95R18145":A[=?CF.:-
MIITB$Y$F(<ZP*&*<@"4%!QYN;:F>W3D_PMSD76NT$8W5# BLGF?^TV27TC[=
M&]ZT5/4W&X-Y_P")>!=D+GL)LZ'.>1CKJ5(<CEG-N,7CK>B>S-:6"4]R\15=
M5TW1BM1S7*BJQ*U-V.&,7Y L3WIO;9J?#8]VX;=<73^X3=XXIJ96:TU-Q-6E
MI#$6-9Z;(<\G-S\Y,H)RD@=RLHN*!2F,/I.&K,OL'B<IN.TXVV]!'#MFP5EU
MD-"??5.L$#W=WN>OUOU*JT[]C9C:W*7(.Q>%MP>;7,64N\GSANQMS@]GK=.5
M5MHWIIRF4MHJ)';PV\:K;VWM,:Q)%5&I]53-?09%<,)[I"+B(&+NTLARDX@)
M2%<8LQ6X "@'8 &[WCP]$==[Q6W1+N)B)1K=PW*(B=D31%1$^PQ3Y\R_B;'A
MRZ<Y7S2\.X5SWNJKGO\ Q%]J<Y5ZJY5K55ZJ8NR1:"V[#'19LF3)R7L$_)]1
MNK]Q,R;U\]D7LTW/GIC#>..P.998B(MVZ0=X(D!,@ /8&LLGGN6V;/?\A9YX
M^'WUF?./^M9= 2[T T T!C7,_P!Y[*_M:WK[%Y30%$?FS_P&,G?&8M/N6XBT
M!L3: U$^IQY:G%GM'X<^SR[: O@Q$6I8WR)OVSJM5YJ4FXO-",=93U1NJ_G)
M6J06'<.R9!&$!XV;S+FO)N7*Z0@!G94#*IH\PG!,P$^(.;B++#1-B@)!K+0<
M[',Y>(E&2H+,Y"-D&Z;MD];*E[%$'+=4IRCZ Z UTO.K?)%WGV\<&?90OH#K
M'2:L$[5O-U=ND[6I>0@9IE"M2M)6*=*,W[8KS<P#%V5%RB)5$P<LG*B1^ ^F
M3.8![!T!<95[A 87W%;KH:U/TH*HR]'HNZ C]QQ*Q:LB0S_'&0G8F .U=)UC
MU@J=(@"<3."CP$RA>8"1M4BJO;'4-FP*M)P]LL5!CXEH-F1%"PP=7?+C8 A%
MXXKMXUAG3EVNFH]32-WAU$DRJB(HE H&H/T!?*3YL^+]D[[/\ : W1] :Y7G
M)WP9=M'QHV/N291T!L7-?[V;_K"7TLN@/?H!H!H!H#0"ZV;"4DNMGCQC79MG
M7+P[S-M[0Q9.2DFK%0L5EC[C] 4H3FP*H4C(*KN&6F2%040&-42,=0IE3%2*
M;0%YXXK\Y$XC_P 0>U'PCX)6G@']3CLWX\- >/N5^<B?C![4OV6IW\3C0#[E
M?G(GXP>U+]EJ=_$XT ^Y7YR)^,'M2_9:G?Q.- 4@]96E]5Z"3VWCO2RAAFX@
MZM$@3%B..Y&N]^SFT[_AX9D91VSP%0$H])P51EW:RR$J0.0WZB7MYP+OQQ9Y
MR)\C<'M2X< X?^+4[T/1]YN'$?1T!X^Y7YR)^,'M2_9:G?Q.- /N5^<B?C![
M4OV6IW\3C0$\NE?%[A8;%.>8[=38*Q9\ZH;I\GA>9NFK,5ZR\=FA:69H:*4C
MZ=0V_<E8BF!@]2VP\X#V#X= 2:Q1/SDAN6W8P3^7D'D+7AP5Z@Q3ERHJPAO5
M>@2#R4]3FQA%-KZH.DRJ+<H!SG#B/;H"M/?16.H?9=]U<)L ON+*),--IC8^
M15LFO(ELC)1ZN7Y0()*("5Q!E@#+-W!' J\I&?I3!Q,?L* &'_N5^<B?C![4
MOV6IW\3C0#[E?G(GXP>U+]EJ=_$XT ^Y7YR)^,'M2_9:G?Q.- 07ZE...O3'
M[*LSN\ZYOVV36+$2T(;1&5V4JIYER4^2Z>E$>)E;[6*LN;N9X[510"OT/U,I
MA'G !(8#]N_O'O7"B=K-@D=SN:=NMAP,UL.-%+["5%]6G5D?Q/LOA"MD(I%C
MMHHCHS@) R!A$DLV'E*(\3AV"!BWI-T3K+SVT-C);+\MX'IV!U,I913@H+(,
MI6RV=&91L'=V1RX3?[;<A.$F;R7!0[<AI5P)4Q\! X!H"RW[E?G(GXP>U+]E
MJ=_$XT ^Y7YR)^,'M2_9:G?Q.- 0LZC..NN[&;%MT<CN)S;MOGL'L\3S3C*$
M+6)*LJV*4IQ'#$9IE"ILMK-2<GD56?-W8%E& ^@L0>&@(YP'^0(#AX/4&%X?
ML8UT!RV@+2?YJ;4%7R(8;I_A+Y\]MJ\>OKO4D+W,"Z$'D/"'RP^;H#)/FXWP
M[=^_^'9J]WN!T!LZ4O;YDRA[J,BYGB\XV*;PYE*M-0GL(VDAY1G6+Y'*E39V
M&A27.0D%$.&/.5RS[L>]54$PF$0#0&?L88WJV(*#5\:4EJX952GQH14&U=NE
M'SE!F"ZS@"+.UOU5<_>KF'F'M[= =\T T!ZE_P"T+?K2GZ0= :Y'FXI0-AW>
M64>/ VZZ1*/#L'@./ZH'8/R!T!<)M8V_Y,V\J96K5HS=8,PXWL%U5M.)V-T3
M.\N./(R6\8<SM6?V,YA]6XDLBJ4S(O*0K<@& I2@;E*!+C0#0#0%9767\ESO
M9]I27]<XG0&(>DW1$,G](S$V/',]8:LA<ZUF.O'LE3?A%V6"]4LIW]N65@Y
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M?]PWZ4= ::'0:9(LNI/EONA./C>VG(;U7G-S<%E[_@0#@7L#@3T@< T!N9:
MURO.3O@R[:/C1L?<DRCH#8N:_P![-_UA+Z670'OT T T T!H$=:+R[VV[XX.
MS7[ <;: W/<8XSW*4;<GF*QV;+S+(>V_(C1"PTJG3K58EOQ7< <II.J[ NDB
M@S6I*S'G.4#F,J"O+Z4O 1$"76@&@&@-6'SE[P;'?;"M'V>X#T!?+N#QON6G
MLBX0R'M]RU&56,I5A,TRKC"V-%W-1R-1Y9=KZHK HT*9RUM$,V25!D;BF03+
M<PJ%$@ 8"7.@&@(@[3_\L[K_ (V61?L8HF@)#P6/:S7+E?+[%MG"5CR0-8&T
MN%'*BJ#GV(1*L+" W;&_4VH(,5C ?E_KS#Q'0$:F?E!Y[XGM<]V6Q: F9H!H
M")&Z+&FY*WR&(KEMKRZQH,]CNY%?6^DV=JLZHN4Z9*J,&TS#V$&@&>(OHMD@
MHJP.0"\%E!'G*(%'0$;^M(*Z/3(W3R9$062K]:IEHD2]X"7=Q%8R=29Z9< <
MP&+P:QD>JH/'Y!!T!U_K"O&\CTU\ER#-5-=H^/B1XU71.55)9NZO-570524(
M(D4342. E, \! >(: CQYOO%NISI8M(5C+/(![+Y/W"1C.=CN R$*Z?VA^U;
MRS$#&*47<<JJ"R?$0#G(''0%J.TZE;BL=8R<TO<GD>#RW;(&SS+6LY"C&CAE
M+6.CF435@G-N16(FE[)DN=0BPI%Y.0I XF$!,($G= 5C]9[R5>^[XO-T^EMM
M :U,!];]?^H,+ZV-= <MH"TG^:FU!5\B&&Z?X2^?/;:O'KZ[U)"]S NA!Y#P
MA\L/FZ JXV[SNZG&^X[=Y,[8K[G:LVE&U7F:7@L0X!R_:92T5VX9&DI.3,[L
MM345C58*MOZJ44'H(^++J.%4P-WB)P$"W_:\GU=MVT9>"XWWA;@*Q:J?7K!-
MM(C+N)\Y8OK-E?13E-")J[&_V4B$&PLTZD\;+"S<D(X9HK"94G!,PZ Z5BV<
MZPF1MG=*W:16\G+$NP>SDS 7_'C&LY/+DB!+4)0\->[-1JPJNW=Y@JU4?I*]
MXZ@R&*NW046( %(;@!T]UN&ZB;-C)23C>1O:*PAXJ)G91T39WNA628PL\)P@
MY9QW!E3$CYCNS>*J\!(ORCR"/#0&<, -.K3N1GYF(IF][-5'C486#E:;:<XX
MKSMB: R8\D%9!27KU$<S*3L\[-PD3&*NQ20!3ODPX )  3 !R\76NK?8,6/\
MVUW?/E^;Q]')S"3J C\9YQ7SLH[BK9["5#Q>"6X+W63AAF2G.,DGP9D;I*&$
MPF()- 54;&ENHWBZ&O43CJ];RL=Q=CRGD%C>S4C:9N$EF+&[XR484COYTL =
MR#BU6UI'>-/DN8BD:N445P$_#@!:;@R)ZM6XU]:X_'&]W-\&[QW+ C?H_,6*
M<Y8EFF,$C&R+V0E*C"S_ (P_O4U'NFS9L>':E2=\[]$QA*4P"8#^K%7NK]$[
M>6^X>&WGYOM#!*T.:S9,5L\6YT99OI/,I+(Q$S:L5KI*VR/AY%5@W5,J+;]3
M8O4W9>\2 >($8WNXOJC+,J&XJ&Y/>Y=G%W?-A22B-K&Y8K).MM>[&VVB%E ;
M.6MG:U4%2\R*'=J.1, %$AAX !(G&"/5MR32<QY,?[Q]Q6)*)A^#0D3/LUX9
MSICRR9"EWZSY&'K>.*9(*+3EHDYE1LBF@1 IE?&7B*)DRJ&X: Q'O)QEU.'N
MPB=R)EK=YG:6H&5L;JR5GQ18L#;@#6*NP3>8*C.QN48H"KMZH1@:-.=0'9R$
M6;"14H]VH!M 1EVRW_J7XPV_XX:UO+>\K&^)A2F;2W7A]K6X4*+5J1;$G=^8
M6"%=L15CGL)(2T\+=$A%B<$C>,F/RF H@6!X9BNKIEG%-_R]+;P=RF*8>F6!
MG!0M3R!@W/S?(^1ROJZG8&TA1*;' [>S390H+H\R1SIE.AQ,H '( @?LN4!U
M;<?TBIY!LF];<"\BL@Q["9I=3IV$=P=QRYZC*L3.9J2ON+8E(9_&C>N/!3:+
M#*&(*RRI>Z 0YN & XK.?4PE64"^0W5;[C(VA9XG7E&^S3=!(-I@K4'"X*,'
M\:H[8."*LFYEBB57M( _V0"  95J<SU/+3BC*^>'&_G-U*Q!AVJN;'9[!D+#
MV>*A8I5RUEBQ"D-3*=)F(^MC@KGF(=1JL8$UB"D<H&X: BSU/L%]3WWJ>'[9
MF_/V4LRX8R>\K]KD:RXQ?E6R6+&-DFTV=7IT7E#'J+U=_6Y2397]RLV567(0
MK]D#/@95<@@!VAEG#J<U$4:1-[F-\%4?1+5=I464IM(W,M!M%,J$=')2=K9I
M=WPCD(YL"AUVB@G60(ESG$"& P 2*CC=5F9Q*[R[$;Y<XK-F,9+R08TEL09[
MK6;;$D7G3IPT'&,PFC*7Q&[.$%@1/'JJ"U004<JE\7(*@ JHB57L0GR/?M[^
M0;]4:YEK<SG;(1\;6NM2U/DZOB#,678JN9]0K$98I:G^I=:Y'D3D+&:<V1JY
M775.@5X"B2:8G VL0.3_ #[Y 1J+KVOM]Z*OJV:^5.B?!4@3]3OTGHS"[_9/
M\072R,6#G;E^W<UE4TSX[:L;J.=_31NRLB)3LKH4JO1J'/Y1W"]35EM]N=YO
M6YC>75JJZH5M4L;JS[9-Q#2I1\2^AI1DP.XN:Y2UI5I-++()%5.H1$GC/:81
M*(#E\\YBW7;]NHJZNW_ ;"-QSUPKW>'V'<?%+$TJBY"C*Y-2S6DQ"CX]?LMB
M/7:>UKZZQ3F:+JO$&XMN42FX<.($#*]BS/6ZN\=/+>+N>W(9$A$6V^/'N'\.
M[>J[G)>V77"[JZM\@$L=]RI9T"F]B.;+/!0+&/) ( NA%M"G.5=0[GTH&Q9T
M_"7QAM^W51%7L,A<;S6-W.[Z H\QDV57FW<I)PEU>H5A&W3296CM\@=T1))=
M?@50$N(]HAH"66U'*67LM8ACK!GC$$GA/*L7+2E8MU2>G*M&/9"%,BF-FJK@
M%W"J]6G2K HU%0PG+P,7B< *<P$D] - 8US/]Y[*_M:WK[%Y30%"WFV(/QV#
MY="*%L64'<7<PC3/ .9H#_[DV)O$Q= F(*"V!QR\X%'CR\>';H"X':/E7<!D
MNH6UAN5PTIB+)U!N3^IO%HU875(R!'))IN8ZYT1TJY=.U(9VBKW9RJF,)%B#
MP,(#P #7TZCOE?X+VC-O/NHWK0&P1MI^^)O(^,R/N(89T!^[=\QW)S&*VD#M
M6C*(;*,W;Z^P+;\A"Q7A,90(G<+2F06D0](IZNSD'W296C9,HJ"=43E#TN@-
M>[SC6_V.S]&S*%0R*T/'Y5Q7G_ -1R"<6YV\98W(3/C$/D&MJG103<5F]QX@
M\0Y0 6KCOVAPYVYN('<^DIN-L&WKH/;(I6A5\+5?;$1TRBV:R0J0\+4E]PQX
M*\W2>7YDTDHVOPU@X(I]X51V_7013XB81*!>5O1J+Q3;#DN8HL.T&VXM(QSU
M2XMH",8E*7;$%@99391RSA$A2MPM3RO*,G:_ 3&2>*";CQ'B!Z-F#C<S/8F?
M9!W0V2F2-KR;-+WFH5&A-FYJ[C?'LRP:+5BI)3R/I[0[*S$'"SP_-Q.MR@8P
M!H#6;Z$WE)\H?%=OGN@8'T!LU5W*FX]GNUMF(+OAM!? 4Q4"VO%><JNX,LT9
M/XXK1&;IF0VCAT<S&;=.G!SL#I)D*JDGX#<1, %0WG)WP9=M'QHV/N291T!<
M5NLR%N%Q9B^$O6W;%T?F:<@[-7U+ICLZZS:Q3="6YDIL:6HFLDD:RMCF2%(J
M@*$[L3FY#<O 0)*0$FM-04+,.(Q]".)6*CY)>&DRD))1*SYHBY5C'Y4C'3*]
M8**BDJ!1$H'(/ 1#0'+Z : : T!^N/B>W9&ZK]OLE8R56,4.<373:%<(N[6%
MQ+,0K5BG%, X]CK($A'NVK5HU@1MX.53.!$I4DE#!P,!# !;FAM$ZOHM[X[D
M.J57&R=)C$[,92/?Y%E&LM3I*/6D:_86CY)XWB4 GRM5R-VQG!E/U,#B($4(
M80/R8]VF]8#)$?-N:_U/(M>0C8Y.<CX=)SDM5U+P$@I*M(*0%V==O&QSF5E(
M)ZT.V,LH=FLV-WH@4Q!,!P,+MHZPRM;J$W<>I.SH<G;YN5C4JW.2UX1D86*A
M9$T3*VB:/(R4.5"$CY$Z"*QB%.('>-^7F!4HZ RA;MD_5IH,:RFKIU;:E6HJ
M2DV,)'/)1;)C=.0F9,%31T5'\7_,^DI $3 @@D!E5A+P( CV: K2WF].?J.9
MN7VJ1^7=_6,LCV"W95KE;JM#F).]2%BK3*_'>7*I782^.MY2#AK4;$R+<SCN
M$U$C+ 7M.@H70%@#C9CUNX#'%>OM]ZAT+27:GJ4OD* =6R\2K?&\<Z,8DO(N
M+%'J"PLJ$&/)S T3*9<#\2\H%,( =E<[,>K.A&L9E'JS5V6B)"2CHM*3KQ,H
MV%@W5E43.FKR2=PSUXVBH<K,HKJO7!DVJ"'ZH<Y2B B!UNH;->M5<$7-@0ZD
ME9B\=D4D749>W=ON;YE8*PT;*+,+G#MH=X^:FKDP9$QT55WB ^*"5?M >4 )
M)]+[;=EBRU'=5'YWW;9VNN1*=O$R35Y*X8LRO/U:GV5JC3,;2K&58QBC=TL=
M1=&6X&7.JH*I2EX#R@&@)B8_P9)V?-VX+'<AN+W6D@\7FQ1['56^=9\CU4+K
M3W<Y+ _5%F)5^1ZW#NN !RE'AH"K_>-MPW@$WRV.#VD[U[KC-[4-DD)<YY]G
M?*<^^:6=]*9ELT-6ZPRMQ$VJ-6;.Y5F"8J.051!9R40*(B8- ?GC-DO6S<2D
M!!2O4:A(R9FGTV=5BVM-QECQU5B43"WN)TDI!N\>1LJ],DV3321$Z*RY.]$H
M<> ''V#9CUNH!C7$%NHA#'N5KNXU>!IREGOJ"LE"M7RR\O9T)LHN(XGJ936;
MB8%DJ":BH)>*@H"YR<0/U1&T#K VJ/OYZ9U/8ZR3U!=R;!U6F[J^IO9-TU\<
M]2CLW:<PY8ILK&#)3Q150X=I3%.!#%,!0.FSFR#JJ9.K]_I&0^I15'F()ZF0
MM=L<W9E\@N*-<VN3T).N2M-2<%>GCI B7$[%THDX4*5PMW7I#@&@*Z=QVQKK
MNX@QO5,"_=DN>][:7R55M5;OAF4"\R:-<J*2$U7J19<.S-FJR\A5X%"%(Q3F
MBS)N]!%$3 *I@*($7-B]CZN%4V^Q\=AB WETFD2N0+8%.KF.L;NG%8G)EX_.
MZM!HE1;)[ S=\V<-'2R[8B:H_J*ABCPXB $RIC(77(KS>SRT\YZB<96:]%ED
MTIT^&9IP#TB;=99^5>-:Y16>,2LSD*4#!WYE0-Q*7LX"!)\F,.M+%I;8(RY;
MO\I0=YW'^I24S2X9M9+4[V^.IIJ#R/#-KEO;(YQ#,ED2."^,,VKHH+,G*?#F
M2'B!#3J<UCJS8;QQN4PWF;->X',^*V.+6<W9[E5:E,R>&[10I$(%:S+RLY,W
M=M)Q,57GC[Q"354C%TT50#ASE.&@,@P/^0(#ZA0WK8UT!RN@+2?YJ;4%7R(8
M;I_A+Y\]MJ\>OKO4D+W,"Z$'D/"'RP^;H#+'2SWLQ6W'*^ZLT]M%WPY9;NEJ
MM5X.WX$VB7W+L4<\#D?.3Z<4:6ZO 9N-=?JSC9-$2B4B[MFX+_7(#P L8ANI
M]8XFQTV8<;/.K',,XG)&29BU1,9TV\DT:/ME4NC1VA5EYQK")2 3DWCU/N$$
MC*"B:2X>,+\JR9- 8%VG=1>A+[/\#T.<Z?W5$<PM7K%NBI9I4-A5]MM>O\//
M.;&V=&KM]B3BZB8ZQ*/ <+K,E6ZZ@F.W7$2"?B!G62ZF+R[1_L?G]@G4IJN/
MIF#393%18],W*LS.A#^HS1BPQO*22CKU%?0,$_5=K@]9$;JJ ""21$B@JHH!
MWIAU18*"9M6L!LCZMS.4;LZ0S</Y'IQ97>U<C>O'*A81JU-9/H]A4I.T1IEB
M*J-@!LFHHF?NU>Z$I@.DY,ZH9'\-9PI_3=ZI1GD9)4><QN6J]/[*%-GC'B;1
M'3MD@+!)R1S0[E@[?HJO2IG3!FY YB+)BJ!3F P#MZZF,C5X_*9(78WU5C+6
MW=;N_GE+14=EN3III0XS(%[>SL')2M1516K]EML,_9IL7<:[$%XE1=;L-Z<!
M E3)]42NREAH]MC]@?51K9XDEK+?X4_3,R&^L%Y:6. 3C?$$+<R>-5*R[++Q
M[-VLX0,L#DB!43\H 4Q0./>]4"G-2QM5:]-#JESV,W[*I1LRQ>[#,X(75B\K
M8NG+2Q3%B=N72UN;Q:<7%-$&YU@=<0.<RQTB]V('BN=3. ICZ9;TK9)U?JY4
MYQ[6Y6%IP=."\N*KC-*#*S3L-;JT>BFV<MXR^D(<ZR:9SI,W9E%T1(*G*('Z
MLE=4JO9!C)F!F.GSU=)NH6V*CZT^IY^GQD&//6G"D@NNMD.-GA [YU+P@ @J
MBT*L4 .B4Z7ZIQX@=8REU&*=:ZO<R3>RKJZ6&+D-O-TQ-.UNW]/C)ZE4M!I&
M-.N-NL9#)IQS.0$Z)P<JD033%%4W'E*0H !T7'74MQ],;(\.XML'32ZHN335
MO!6+8-C"-MD>64:C:).MT6#C&$C#6^-(];!"K*HBNS>@DH'=@14J8CRZ R=)
M=3RR.[(X6A-K_5_IE#C(.N04#4HGIJWB9DGY8AFZ&1EW]CL:4BY2DI-PY21
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M'KL\I;IKKEFE(UC:%:9@"T6;IF/:_$*R*$7)%2BGQGE9<@9MR@"90+P[#<
MR7B7JUX_2W%[II]GLMZF,R2R%P8J2*@]D^1)2:ADHZB2+),]@CFKHZL265,!
ME&?>?WRD0QR\0 = =!EMVT+E/?5-9RMW3RZGL]AA7:M6<4FK\WLKOB+&7O\
M"Y?E[TV4G:C)N$QE6\(R<(.8YUS"1L\YQ .?D, &3\M[R\=(8AE\?T+II=5U
M]XV_C9&(CXW:+D=!=HW+98)[+P4;8)&>>.8:%6;-%77B0'*T,N F*4%3 ( =
MV>=1R[2DC;6E1VD]5*@,G$KC!:G/W6P#(UN;QU2IRL8I=H!W$VN59-V4Q?$
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M]5*98O B+E0XAQ$ [!X 3TR'D2L8NK2ULMRDPG#(.FC)0T%6K%;) 7#U04T
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MN#<6*F*SJL8UD5HM8;!4[33GH/$$D5E )&6V'A9%5#NW!>"I$C)&'B &$0$
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MY8LLBY/QY07DF@JZC6EUNM;JSF0;(J DLX8H3DFQ5=H)*B!3'3 Q2F'@(\=
M>JF9DQ#D9^ZBL>Y5QO?)-DU!Z]C:9>:Q:'[1D*@(@[=,X24?.&[45C 3O#E
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MZL-1<WNTO&)7@+0RB@=[&N45"<1']3.70$R;[D"E8=J:,M/&,PC4#LX*N5V
MC3O9F=E%4Q1AZI4*Y&IBXDY5X"7=MVR! *0A1,82)$.<H$,YO;MDG.;I_896
MB;?]MS.;<'D#*DPQC?->='BJH\PO;'9+9&N\:P\@Z_KEFY8V?,7CP\:Y@XZ
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MG']U8&[20,];C#G,J/=@GZ< *(\!'0%Q>@&@(@;\PX[5,EAPX_W?C7LX<?\
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MP6"YQ;*-/QT]LD78'\! V&5J4I38RR8VB*U.W D;"O"O(2(66\43 7"C=,2
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MD.!QUN$V4X]F&=5LM[6M$_@>TS:HI,D\29@M(OLIH0BATE$WEDQ$ZLLR5!D
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M8L9)LHRD6;609K"F*K1ZW1=-E115(ND*B"Y%$CBDLF4Y>(#RF* AV@&@/U:
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M]09M47C_ +@7[M)NDFY>^*IBBV\;7(0JKGQ=$>5/G$W(7L#@&@/U: : : :
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M1O1%]$Z&2-TY_-R?G3XJR?>7*V<21P,8LCM#(7X&25\+6UHD;I?WCF(E'/\
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MO-E;9Y1V+;[#3#X*2/'V;;S\9,ZR65L;/=<KWOB;&L.F-DB^XJ5<O="-G2*
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MWY 9WAM;:&QN9ML-P#X8LCCKJW298+9RMAB?(JJV&-R?4Y[UD8K=+DT[&O4
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M<Y$17HQJNJM5+WM9S/*H: : : : : : : : : : : : : : : : : : : :
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M>B';J%:UWWD13Z1S2PJJQ.<U52BT54JGP6A[M2?,: : : : : : : : : :
M: : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
M: : : : : : : : : : : : K'ZSWDJ]]WQ>;I]+;: UJ8#ZWZ_]087UL:Z
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MN@H.</0/]#4^=T%!SAZ!_H:GSN@H.</0/]#4^=T%!SAZ!_H:GSN@H.</0/\
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I*%E7L"G?_OM,\F/[&/ODXZ_RG_\ >/KJ^M[_ -\?Y(__ !.H)^1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>g68105page177.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page177.jpg
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MN)Q7JFG8<8XZL,MLGN"YE)ZB4^9DEQV'MQ?6D).NQKQZL!0( $!9RJ8_0/8
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MHEWD<I]W>(=  !PLWJW>?S!MG-OL_;/5*"HFYNGN)X2KXBR5986.@L>7W%V
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M5'/5B$EL;=A5G3-%=4$P&BB($]0X]H"(B >SJ/P\ ]/\ K,_ZR'<W_I;&O\
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MK 3TRP57[OL!4-P,6YHMT8RF*J%?NE.B'_RSCO*$&U;F:POO\2^<$"MS=?<
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M#1U9,EV')U :KU/#MB8.?>63M!5)#+-L56;>ADJ!@EP1&KQI&B)TO?@*56Q
MH5<Z7IIHN%0*&?V@ .[9SQ6%^#NV:Q,7KT >G=M7K$'7H(" ].OP#[!X!=CC
MX4&N^&QJ)E$RG4UZUA02$_HIG7.G:=@>A2D3(D0QP3+U[2%   /@  X ZHJ)
ME.1,QR%44[O3()B@<_8'4W841ZF[0]H]/@X!7UKC7:VI&[/R%^72L, GNEEF
M>@:B_8Q3EC&6:N6B/F(1>N)$8H3,I9)*402<$;J+.!.\Z$0( "(& @7QA7_'
M]^TD4JCZ(.QG)2W;7R1JW>H.+82]TB*[GJ_,'EM;0RQ5%)B%CW[]JS,NLD"B
M*Z8)J%*)0Z@1=GQ-P;]GGN!4CE0:)^+YN8_I 3U#G)@J-!)OZ9D3$*U%+NZB
M42F 0  ]G7@%INI9RIZH:S*'$"D)KSADYS"/0"E+C>MB81'Z@  < GIF[*\(
MJHGZ0I%6$B*B3A)P5='TTU"+]4A,"?J ?V%$>[IT$?AX A^Y']-OCL_*XD_S
M=<X\ [&S\F2O;#:VV<UKK=&)5L8[3SBMLMD8E*5Z :-H[#Z+V3DVYGD:N1LV
M9N#CWI.4! P@!C&3$Q# 1O3)99]Y-:VV5BF"!?T?$G-A8(-%@RKEN<V/.M.D
M9&;A8I)^\F(U!5Z)NX)$B2ZIC=Q15* J"!3W^R^?O_(I].$3]U?:+@&REGJM
M76STYLSJ1W#YBVF&KR[4Z/?C!3&0*<DDN$K48>S@LD: >/S&(81[DRNTTS-3
M+($6,J4"*<PV6P7'4^[QFJ,.@XN\Y!$Q13(0C,( N-9VP/&5-D5[9#B=D\JY
M<9,)-5^^; 0KE--G_ D.)TQ,!'6BU.R+J]A"\8:SJSKM7J&"K;+)8WNL5*/E
M*))8?G&;6TPS>-D+(Z4GRJ4N1DGD4X!Z!5!,@GV=Y3%$0)RP9!RX6&YW."C'
MU%P_;"MW=0QW+-U$7SJ<4=N74SD=M$K FI08NUI+)^G"@7N5,4SU9-LNN=(P
M&OOY"C 7]H5\7YAZ] 8U8?8 F'_R+L_[ *4!,(C^X'MX _\ ,N6Z6;=P'"RR
M:*"/DET%7756,1$K9$N(M7E3+KBN)"HD23 3&[^@ !1Z_!P"(]_H9Q6]M_#]
M>W,+;[I<EMYLCQC1P>QP3YU;(577;*+.(FH=DR?Q%%A&C^(!NH(@DR4!!#JX
M,93N.8"TO*+&T1];N3:UV):3?V17*4]37[6NU+W:F5&/HJHEQZ9Z_*$J9Y/,
MD7!UGK8CAR815(!TTR$,(&J9YBR&_15>'93U3]@HQ)/0Z)^F!@U%O1O5 W9Z
MO>(>P>IA+T^  'J(@;H=1_BI6/Y/0OUM;< 76)$*#FB:E\O_ /C"1NLFK$XE
MR6O\6L0T$\$AFF*DV1Q,WI=D.JD)Q<&,(6,W0?5]8@-B@)AMCC';6Z;:4K/^
M+J7&OJ1J(GCP]*A)"3DFULRFKD>;6#8\F/FC%\C * ?%BC")*,QZ?<^;+ C\
M &$!Y<\O(:U)QV-H"*6L.77 )S]-/%OE(E_C)<@F0;9&F[$W367K$3'*B)03
M$IU9<0,T316*=0"@=?9QK+LM,MAF<_*)3DZTUCRTVF9I!@G%H2TJABNP)2$F
MC&I*+)1Z;YV4ZI4"G,5(#=H"(!P#6;\9!RE\&&S91.0IU-W[85(IS  G.&<,
M&F[2AU 3"!0$1 /;T#@&WFT:K-Q$5':BQ12*3T1 /134!150ZJ1E!5==5/4
M.AU3@ %#ITX B^X\@FWR5I29M)*,WKG8*Y1L2LP<0Q)):<<:[9G)'Q\/\N@>
M&6FW+DH$;I.2F2,KT Y>WKP!<<J1[2L>3/4&S5>CU\+M;-7MH6N1;P!JFC?4
M)1HVUX1C93*3%LXATWL'48YNFH5%LZ.<YG*I&: $ QA 8_%KDLMMTVLA[!2[
MD[L>IJ+]6[41BBS@[6R2S(^;0\@449"6!=PA&)IHJ#[TL0IR& G:7H4 ('UI
M(13R^>418':AP0P/X[@$A%" B41A]F4SH*E('0_I&)W!W?&*81]OU. 6R&44
M4!NJU.V40,?N6.8QC 9OV'^,W.F(D$_J=OP_%[>OU> =G@%;.BZ8E\?$"I[V
M*A5*?FT/<S&Z^[&)D;*0>H0._P"(5P!O;\7VB7KU'X  TF_%?^)E0_Y17/Z[
M!P"Q+@!P"TG^ZFY!5\A,-I_QE\^?2U>/KZ[Y)"^I O! RVC$+8IS>7!J52LJ
MM5LK#'VP<I#2(MDG\4X>-J]3$215DC%"@:3KD@5T)7*22B#@HE(JBJFJF0W
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M6ZP\ NVQ[W#OELJ*A"%,&OFLP%[3=_Q/G=L$!#=PD((&.0 $P=/8/LZCTZB
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M??U(0ICJ"/0 $1Z"!"_F,=VU;1# "MQD:+;;1(;NZ,73&M-B69JP_:1 YNK
M1\2Z=R"B)WY&B,BU8J/RQ,>#8IP!9#O'J(%T02%"?V"=Q/D*4@I'*%XJ["Q6
M>/+'39J6LA&+R):^#&*GY67AD7D8UC!.JB18BCT&)EU2 '0I0-<7R8-G+/P>
M"S>22DR[:;V1[9U+*M6S)23<(;D6Y)9\9FR329M?>E"B?TTB@F3KT*'0. ;!
M?CW_ !%=/_R;\._S$A. .%P X < ZC__ (B]_P#!'/\ O)^ :A?@J_H/\OO^
M+(+[B%^X!M284: &$L4%:G]R5<8TQZLHNBFD8YE"U.#(8XE5*=,QE$40((B
M^SV_#P!?-_3RA,-43Y$!B,N;9W58D=\J>\_)H.1SW0^@O3,P%P1 " /M+\!N
MG ( V1H,"PRSHA9ZHP6C89'R$65Z_C;57IMG/,[+;,-9F0FW=-=/W3!*+J<J
M]@EW:A#,G17QG0*-UTDNI3@>YMV:?=;L>/\ =5JT258&JFV>L5J;1=5+:9NU
M5"(H-4<R]2AXPXBX0<64$RH)/$2**I]#>F41'J "JK59O7O/1A&$69PD7$-_
M%AL/(,(VNQ*L0P;04EMO0Y1NS?1[E>0,>2%!T/OYR&*1PX[SD(GW=H 7MKNS
M)HM19I^J9T=$J'5)?T02, *&,L=-,XMB^@ ]HG  [N@#\/ /0X @.A*?H%W/
M Z@''\/78E1142D2 PG-4SB82EZ%+VE$ Z_5Z=1]O (5U#/!P.CZMKRRO7I6
ME1^0LXN:@T94R4D;/%3R6RN74HHPG9NYI>PR SCQ%1D5LP0]V,!CG[PZG*!0
MAY=E0#Q >)1(PJJG5LM-4!;TA A@)K_>NIE#%*"::A_4 0+[!'V] ]@\ W&L
M5?T7XW_D%3_YO1W ,]X < . 0GLM^+EG_P"A/*O\Q9[@&KSXJB&_0J;J*>J8
M"!L=DL@H="=ACBIALQ51-V^H!R  AT P%$!]H"(!P"\#"3"0:[7[_3]<-386
MP/\ *^**HI;;69ZO[BFZURQJXKD:T@VCJ*)8/?+,JGW(&?LU0*(@D8QC]  J
M:\:L&I9-G-@G<.2L)0=R\EWDD<VZ]P+U^$]<D(NLXL381-;7K\FQ>L3,FIB.
M&DB5XY*1,QD01. B;@%GF0*I5&GD)T/R=!I61L[N5+VW1>QEF82))YH5.IUN
M157.UFFXVF/(^>/!#W-0WNB1$4Q022#N[@*F/#A_;2>7W^768?N^M. ;87 #
M@$?W/',)>)O'$]*N)!!YC"Y*7>!(R5230<RBM7L53.A)$415,LS^3K,N8"D$
MAO5*0>[H @($@< U=O/_ -?PGO%5T#K_ .TYB3V?!_\ =6ZP\ NOI::2^^.R
M+5PU,Y07U\UC%3J4AD4C(6W/RZ1E@,<IN@J$#M[0-\8 Z]. .>H\(F\;LA1=
M&.Y275*LFV5.T2!#L[BN'12BB@HIW_$*80$W0>GP< K5P-+4^P2VQ51M<W'+
MDA][K=(UN&JY'3Z[15GC+/6)@TC9V1VSY!K6?6EXXAG1$ 12;/!!18BAR=H$
M->+Q_,,O'ODTM^?1=@ATLG;EOX*L4J+E'EJ9T!QG/+K?W628,'*\O*3LM*MY
M 4/=4D^I!(1,QSE$2@8'FYJR-^SJ61--MVMFOBYBA8(KIG!5HDC@",*U*)5^
MJZ2Z"0 4W</> @(&]O7@%IVHZ:I=6M:SF7$Z1]?,* DCZ9"@CV8WKH*#Z@?'
M4%41 ?;[ Z>SZO )Z4<@H@\[&CE<4#'0.W,EZ)G/Q2]X-S+BFFLF8A_88![1
M$!#KP!!]Q2H,<R^.9)%$4T";<O&Z**"8F!(I]>,W))AV$ >U-/NZF'X"E 1'
MV!P#WL_Q=Q?[9Z@-J4_J$6FM4MJ#VDMJKKRPMI&(5K6,4$$&3-C+0O:_^<!V
M*RBBJIB&:HJI]O<<IB@0]0*U8X'R?$>7DM1>7>;TDNJDE9*A%N(9M8X..V"I
MS:K*R$8Z5=JLGT3%*^ZBF+ET':3N!4W=T*!41^R^?[IY%/IPB?NK[1< VP.
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MBU?D0%=)NH]BEU2][5P*:?JIB ]H< F[@!P#J/\ _B+W_P $<_[R?@&H5X+
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M+48JK-46^5CN23%&0D ;HI0%J244'JQ$ZAA!,X_%Z%$P#4< . ' -6'R$?\
MTPMXOO\ P&J_639_@#UVEY+ERSN4^K;%I,2H^1_01:%CG[Q2':/')\2ZM^FF
M\D!;.E&3<P&[C'! YRE#V%,/0. 8'OO7+%7]IO#LVI=<KE";.-T<CKQM9GF[
MJ5=(VM7 .:#34S8IN)GG0S$?)L2IG9@FH5<I3%]0Q0 $2 6"2K7%^.:-E.&J
M<RQ@XUROF2X# 8^<6:TIR2[FE6Q&[/<H(NVL\:L-2WEG*F1[#,6A7C)%$BIU
MC*(F U@_,$5$/%!X=#H%$J:X1;GVE.4QC.-1+VJ8YRJ=#E,83=1 0 0^#H'P
M< VVLL7K)V--?T;QB/&A<NVZO5^LOAH1)88=_,0B;5G\N&AURMW0NIAG']ZR
M#8""9R8GIEZG,4! E'%]Y^R7CZHWT:W8J<>TPK656JUMCSQ=D@'"P"5S%S#!
M3H=N[:+D,40$ $P !N@=>@ 9YP X O&W?XI^S_Y/&:ON;67@&L%XR&Z1O!IM
M L(&!53=BU-S' YP_@OLYX.'H4 -VD-U,(]P !O\/L#@&X"F0$TR)@8Y@(4I
M0,H<RBA@*'3J=0XB8YA^J(CU'@%?VVE;>3^2]'*[,#$23&9V5N#>R-7J$@LU
MD*V\U]S25]'-0([379O%$#D!-0#]B0E$0#X! !;,OU^M2&_6K$!'O*M\CFUZ
MW$A[Q9%X&PU*"-AMN&OZM?AH&Y(OBQDY(U&%6](99)XX;(""P.$TS""0 ,QB
M.],+_MC&S<;,,K(">J;V#EIB*AI>O1Q)VO9N>Q<FT1AK'V3;5--RD8J8J 8J
MI"@H4PD.41 A;6Q(1\O_ )05O55 ":^^.U(4 $/1.*D=LP<%3E$HF]5,$Q H
M@(!T,/L'@%L2:WJ*KI>DL3T#$**BB8D25[TRJ=4#C_NI2=W0PA[ , A]3@'Q
M3WGUF_I"@#?JK[T"@*"L(=G\#[N)3 0H@I^^[@'XOP>W@%<^C:7_ -[QK"_J
MJ^VH9T2]'O\ X .W)&3S^J"?3_=3=W01Z_  < TE/%?^)E0_Y17/Z[!P"Q+@
M!P"TG^ZFY!5\A,-I_P 9?/GTM7CZ^N^20OJ0+P0<M!V1R#JKLA@S*N,L#7#8
MZS_(V:JQ]CFCM;&\G"QLO5:^\=V,4:M5KA*>X1"L0D18?<_2#W@.Y0@B7J!8
MZIYP]QDBB=3Q+[%E( @ C\WLV&]IA H>PN!C&]HC^YP#]_IO]R?U2NQ?_5_-
M7WA^ 5A[R9RW \C&P>C\X\\?6Q6)6>'<[XO4?*'QQEB<;.X^3S3C"P3$S*2<
MSC6HQ<##5V'JBRJRBBB@F[O@  $0 N^\CCN-30\E9Y!<Y&+'0[6566,@=RFN
MV9%S3G]PX4(=IT=D4!H!C%%+^$ZA\7XW3@$8^:!"]M=2=7G$I)T&>K[O?C0R
M/8VA.&L#*Z3E/<Y<KTG&(*IJBLVBI$LJ1 RP*+*)+-TSG$$W!@* %R+R@55'
M'GHY.=7I*%I>2+1:XIZZMDZYL;5NM;9Y*N^A/TQT%I<P2D=-$(@W47,Z!F8B
M+L3=APX!0#Y"\<Y!R?X9I>NXMH%XR9/M-WW5@4K6/JS+7"T#7H/<2XO)>4;P
M,4BXE7J,8P#U5NTAC@4!$?J\ Q3 'EMW&P)@C#^&5?%CL18?L4XYIN/#6%.I
M9O8)S9JK"LH(DHG'FP:Z49%D/= 4](RBGI]W03#TZ\ F3]-_N3^J5V+_ .K^
M:OO#\ _!?.'N,8YTR^)?8L3I@43E^;V; [>\!$OM' P%'J ?4$>G /W^F_W)
M_5*[%_\ 5_-7WA^ =93S@;B.T7;=/Q-;#G'L6;*=D#FD_I*G2$.Q3MP0/:8O
M> B7V#T_<X! ?A/Q/EBAX \I\]EC$>3L5N+-6XAQ7T\B4NV49*:.RP7<TYU6
M 8VIC$O)5A%OGWH>\F;E$1Z#T#J  !M!X,635PQB8J9A$4<9T!)3J4Q>TXT^
M%6  $Q0 P"FJ4>H=0]O3X0'@"];V+J+8=H"T:9LX5'9S5KT!4.86YSDSW1BG
M(8Z7<8.@E$/9\!OAX!%>V5F*XRYH @\7=0OSOV^J\I!TF2J[B/G&CNNX7V#0
MM,M-339P]C3*+HRD>DBV.9,>Q(5$S+ <WI@>YLFPB%=U=*4YA59"(D:5N"C.
M+!(/6?HQAL855%ZL@Z;.$EXPY&ASCZK<R2A!#O 0, #P!&8]HLT\^^#K+)R:
M,@O/>(O+3X5X>P3UCJ804=LWCM"NNJU\LF.Y1-(0(HKOCID_X6Z.901/U P@
M7U.VS)Z"*;KHH0PG%-$RRB9%P,B8JA%$2G(#@GI&$1*8# 'P].H< [1B=4C)
M)G%(?3%,AR 43)#V]I3% X&*)B?"'4!#]W@"$Z'DZAN<F8QC]=\-A2&/W>F<
M_4M1 3=R79V&']TO3H/P=. +=I9-1-+U)ECY3CGC['<U;<KR<"X^1)^XL8RU
M(;+Y1@6,0#*+A7KA*3"?:M7Z*Z9'!D2E,Y<K($(GV@4Z^3C$V5LL^)+Q81V*
M\;Y#RA)0TQ0I6;B\=TJ?O+Z#B5\*7*&+/2<;6(^0E4XKY4DVZ2JH$-V]_P 4
MHCU 0&CJGFEW(K=6K5=_1.;$NA@*_"PAG1:[FHI')XF-;,%%R$^P282$6.W$
MP%$1$H#T$1$.O /<4\X>XR1#**>);8LI"]!,/S>S8;H B ? 7 PF'VC^YP#]
M_IO]R?U2NQ?_ %?S5]X?@'#^G'W"]X]U_1,[%>\ EZWI?-[-G=Z7=V=_7[ W
M;T[O9\/7@&'Y+\Q^Y60L<9!H)?%%L3&FO%'ME/))'K6;%TX]2S0$A"D?*(%P
M20RZ;0ST%#$ Q1.!>@" CUX!A?CFQGDS&7AAW&B,DX]O^+Y>3V"R3.14+DFF
M3-*G96OKO<5Q\=.IP5@;-)1*)D',>J*2AB%$X$$ Z=!X!<UK_"R [,>12R18
ML%+G'Y&Q=&1/RS,V!C2S&<ZXXN<K#,1+!RJT40]= !]Y.V6=H)=Q4S@4QP,!
M4/XX+/'M\^Y@<F@I:X.JUY8O(\\>L<6*R)FT,UF:CBXL',I,F[V-"S5L&BA
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ME^+\("YZTD*EY>/*4?N4$#X%\=*I@.<QP)TA]F2"5(!Z]B?0G7M#V=PB/U>
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M41[1$ ,).@B >W@#O:]CUPEA\P&=G4)A_%Y#IG Q68F^9<0H M.\ (8YN_\
MA! 1#KT ?@X L?D$>IO<1X4<)]"B.XFJ!%DO435,W73S/6RK-U#)&.GZJ"@"
M4W01Z"' .IN.=-UL%XT3HKB9(=M[><#H*?%.*.KF?P$@B'4#$$Q1*8/]D. 6
M(< K*R&K;&7DKBOFR^91B+G0^W.)VTRJP._F7%,L\U=XO*QU?49JHV ZH-A1
M]V,LV!/U/6$Q^STC@91@BY5V_;K;,VNBE%S!3VN&I<W!6<[ 6T+<&$X\S=+1
M=AAURBFYDX\S%VF@H=0J:J:R)TC '8' +!7#9-XT6:.B@HDY0.@N !T Q52"
M0_: ]W;\/L^'IP"N' DJI+V[)U;J<W.J6*L;Q9JGK1#P,X2.ATZXH9DT<,<B
M&"'FSG;/8Z9]_BV2@-#/W+(#$<%](0$"*/']'6&J>/&1DZG$5"XO6V6MJK/!
M1]@?N:BU91SO.V4AECO+"XC[ +>98F4>*%=E;$2.D8"="AU.($3YW7:N/V=>
MTJ.#-1(\\7\4L@ JD51574P-&.&_NRH@4''0_0R9@ !,  8 #@%HNH(I.M5=
M7Y%%=<R2VN6%BII"8Q&YB'QU6U 6% Q0$%_;TZC_ +7V< 80'8BV(X!H\^,J
M"8H"D4K@A17]$53)&.'1,H?'^'KV>WI]3@"![D^I]F?QW"]630[=PI Y5&ZA
MDB^D77[-XMTE#J_"*P 4B@>P#=P@'P\ ]K8M:;+MGIPRC'\%%1DM4]J(RURT
MI,.8.7BJXXJN-O6DJ:^0172):FDD5L9'U@!$J/JF$P&*7@$?5F647\G4'7)1
M1$EEK.@UF;RS )A2?>$C7&Q-<;UN7DI,[)CZSVQ1D:+E0HD Q%1.4>H !C 3
M#C+XV\NW!#>THX2U& 0_P&E-DP'X/W0X! V#JRZ>;7[]6J&3=)SU*SQAX\0@
ME;'U9@Y.+DM=,9-9UG:DFS9TTD8EBR$7:2*J*AO>&Z?8=+J(\ =U9O:'3*O5
M>!5D[+2780ZB^4VF1F+6V)@E*OI!R8Q&T"=O+-"D8M6IC(K =VDZ4(8I.PRA
M@%!TH5%?0R7%)T7N;36U!%P1[#]3)Y9RN)FZ@F 13/\ '*81#H8!_P!G@$O>
M/Q'U]#].2^LNCVZX855[D%/3.;TZ'!&],P]!ZIGZ=#!]4. 8+Y/5E?P%LV*+
MI>[&][QB7L!0%OX,,SX_*D<3$*  *A0 PA[>WKTZCTX!F^[$:5[CK'C)1K(R
MZ,UL[K+'NHQK*'BUQ9O,NU1@\^3Y!)9HM&'2:*'6%1-4BH&((D,!Q#@%</D%
MCHR5WT\+EYJ-]N4]!2^S62*A&L&T\VG\4Q[JN:^9> MD%J("[<7=PZ5.T5<&
M=* N@U,0X$,43& L=DANZM&M,F5Q2K!9%:S?(C8#OLZTO(49VTQJ_=15<H9F
M[$P1\<M/G0>*Q3L_8W(^4.0YA'O,!7=XTHJ ALEZEIQK8&<U,^*#'MBLC=Z_
M^49[UY+)=;!C[^Y.NZ6",030528)=XHH(D$B12E 0X [N$$^SR'[X )U%>N)
M-*E2^J;O](3M=ARB1+V!Z:8  ] _PC^[P!]W9D"@W,NY,V '2()B"P(@NL?N
M(FV/U]BI51-^\^J(!^YP! ?'PBH> VA<BX6!-+>S;U$6H"4$53K9.,8%U?9W
M&42*D)2>WH '-]4> 2AI"U0-KI1I 2F%W\K979^IZBG;[O\ 9EOJO9Z/?Z/=
MWAU[NWNZ>SKT]G /.\A1% T=VZ6,X4(U3UQRT91%$@@L)TJ?*K"H18@BKT%(
M@D$@%'N ?9[> *-N3DZ&BM(E,57^T1"E_M\-B6P8Y:.U2%F[M3H'+&('9Y]>
M-1@XEE#24<6431.T#N5#TN_N,;O[0+=??8\CWW$%VY7ZQ?6%L4Q?>#E*3V*G
M(7XW;V)] ,/LZ!TX CFY$DZA\CZ82K)[!QKF.SO<WR4A9UUFU<9"VUXS$J9Q
M-N6YB+MXY-,HBH<H]2%]OU. *OFSY_R'D3TQCJ81M!%98_VIMN/K-8\C/I6+
MS,PFW&MEKOD05.-0=2\'78Q@\<),&IO515]T34*D1N01X W,&C:2^0VX*2:$
M.QJI=4(-.IMHT3'?/UELLOW5BFIPXD1(FY7>JIH(H@4W81 R@J'%80( O&M)
MP/Y>_*.!#IF*G@+QTD4*7VG(K\E;,G IA >A?X,P#TZ=?:' +8'*'O")DO67
M0[A(/J-E/26+V'*?H4X /0#=O0?W0$> <2J:"3@)!=8$P30]V %3)%03]58@
M]X&.4#$44-T*/0P ;V ("(!P"N;1Q)<OCWJZQ3]S=6GYV*L114X^DJGD;)GH
MF;H]HI@"@&-Z@B("/0O3ZO -)KQ7_B94/^45S^NP< L2X < M)_NIN05?(3#
M:?\ &7SY]+5X^OKODD+ZD"\$$KZN9SPKKMNAKMDK/F8ZOA"A-X+.<(%JN=AB
M*S6I:>F*G72QE4DY*914;&+)(MUW*:1#H*F59%,50 *8IP+,=*_)=XYL71>R
MD-.[^8&F336X.5[!!3=SS'2@E)R!L+.EG9R*#EN9@U<0;(Y%FS55-+TO1:@7
MO,("80,4T?\ *-X[JOB>>@I;=S7^"L4!E7;*;0H\_D.B0D+:OG]L=E&RTRPL
MI>:*DNNY-!D#L.W= @1G) =P00.B< ,^R#Y3M,9O7G,*5LW<U+7M]RP3E*OS
M%+K6Q='EX2O3#:C6"/J_S&AVT<#Y\_N)W)0?-SR3@K9<$RMS+%[AX!$^SGDQ
M\?5B\7MCQ[%;E:W2%Y6UZQO"DJ3'+-2>S:DFP:TTCN.+'HOQ<'>MP;*>JB!1
M.GV& P!VCT 7;S%;Q^-S,FL= 1Q3LQ@"VVA7=_3*2R&:HVR#6EYRJ53*U65L
M;F3D$4OE"2JM?KY/746:K>[(>CW <#%,' +6I#RR>-==O"PU2W4TZCHN*BF+
MVL7&XY@ISU."DVDDG!NFJ-9DIN,LQY'YM+NA1D3+II&54 BIS@<X' 3/3SR)
M:?0&&&="G]Z==).(N.2-B$LB2L=EZE8QN=&0D,GY!E:_?*A'1IG;^2->EG2)
MU2G==[5)=%9L8R95"B![2_D?T:A_(GBF7?[MX'D\75;13*%-)E&=RS3%95U?
MY;,F*G;AA8Y%LHPBT9AY PJ+ML46C<K@2+&(!P 2D ?XWEQ\8:)$>N^.KJX@
M9-'O+F&F**!W]""LITDR]"A\)Q /8'U. 5O5GR.^/Z6VBW6D76T^CTQ69W+&
MJUFK$IEW+=56K$Y$U[ \= W&:I:389$ZMIISHGIH+&+[N#A0R1U4# )R@2?I
M?Y2?'-67>W?SAW7UMA4[%NEF:VUUQ(Y8J+9O/UF:C:8$9.PZJDD!7\4[.S5*
M1=/JF8R8@ CTX X%@\MOC&7A)MHCOEJTHX7A)4$4RYAIYA.86:I"E+TDA 3F
M.<  O[X1'V / *VM7?)1H/4_&32,.%VJU^"XQNF-E8KL7V7:0A+MK6ZKD^W3
MIDG#-W0S[%^J[?"9,?<A2Z=2]?4Z 8"P7$WE-\<D%A[&#.6W6UNCGD;C:CM7
MZ#[*=9:"U>-ZO%(+-W9U7A2MU4EB]AP-T$I@Z"'4.G %?WE\EOC;R)A&MP+3
M>G7Z0=%S[KW.R!ZIF6L#8H2#BLQ5"6GW\4XA'0O4DX2&:+*G5(0P@DF83=>
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M=:A)9>3S#?\ .N.6]S:622,#5I#14*RCX])-689+'%PZ*=FB5JF1$"+',(E
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MOK$]@*M2-H@LAD\KX_FY*OR,_CJM1Q'][MM<D$*S,2ERDFG:U%NR9 HHD<@
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M]@ZTR,!MYE:$:S5FPABXKM5LSKU 41[&C"JLX]HQ]5<YTTFJ2" ]PF A1,/
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MRP4!BN4#]Z*;EL(HD2]0QA M3PF[0#"V)2.@!$HXWQXT+[P9$2N3N*C#>D!
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M#8^@.U ?3ZB80Z"(B81$1']SIP##/*+U#1C-HE$H&]7&':)P$2 ;[,./^@F
M! 1* _#T]O3@$@[;/S_,O%"Y&SAY[IL]K,NB9F5L(2QRY5K+CLBBF>'*)U5
M],@*G(7U! !-V_&X!5]Y#6\M7-C?#3:9UM:\MY #=7($XV8*0M#J63 AGN \
MI2C&F(-H]W7H-NSK G(15)9[Z+@[<PJJJ&/[0+1=G5J'9*!D,EHC[@]1HV/;
M>XE?DA(\=%P[2X4RQ-'-A>61-5BJQ6JK&+<&<*1[])ZP*L!C$."R7<!6WXV
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M: CP"N'2%VJGX\JD@5DY4*I6\X)"N7TO0*13(.5%#J]P*&.!4/1 #=Y2=1,
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MP"'MQ5'J/A^O:S404=%U<QNK&%2:'=&*L6(I LR&:@X2,_.#D $2 =+U0'M
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M[>@^T '@"':'?O\ <[\O/87_ /I'@"[Z3!4*EJ&ZR<[4@H&8?Y>SO K6#(T
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MZL^K7*U<-'=D72EG=Q\LN\^R!+&:8QCHA^Q8Q,HV(C&+1ABQ"R*:WJBKZ9^
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M-UPEDS'[MPC(WR^65)*J(6JO1ZUY7!E\50D85PHBY_X.<H+?$X!TMR=H\?Y
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M'"I 8YQW?)>TP]9V*S8HA,SD4S6EBS"9)'![B030@8R-.FA&>\I'<+JF,LX
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M6!7)M.I%<<3T?JG7I"+E(&B2-HD8 J+<^"E&""C%]:7G<)$DU_4'M5]J90*
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M>@#\(#\' .%'O*[>%,#L2F]!0BBQDC-?:F)#)- (/J$[!)U.!P]IC=0$0^
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M 7@'=W7(DGY$_"N1 !*B3,VX94@'U.H)AI/D\" /JB*H="_4-[?W> 6Y\ .
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MLE<(9"6L3922>H1$=4:%\GQC=5PJ?W=@R]<_II$ I"=PB =1'@#H4?'])QI
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M+J=5502D3('U1$0#@%M"2J:R::R*A%452%4252.51-1,Y0,11,Y!$IR'*("
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MQ4"948BVL9@(4#2<2_BWR@% 55%1 H@!"--TSM=3MR%T@Y/7C'EL9QKR#9Y
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MN:->]G\-V:L3T"C$3]>FV-C?1T@T6:)IKMG3=6N&*(E$.H&#H=,X 8H@8 $
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M3YC7(UJ,62V^JDBNL4U9L5?%.(7--D&(DNL[U]Y+U'T 52Z=%>H 9P'D4PH
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M#V] Z]. ?GQ(?V?>"?\ &&:/N^Y2X!9!P X < ^&Z]![>G=T'M[NHAUZ>SJ
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M$#,=,OZ&I/Z:MBONZY!X UW #@!P X!KI>'O\>WRG_2J[^[;G;@&Q;P X <
M. ' ->KRQ_C]^,3^7;/\X'7W@&PKP X < . ' $+\HO]GCN%]!=U_P"0AP#$
M_$A_9]X)_P 89H^[[E+@%D' #@!P X JVGO]%EH^GW93[O&0. 5[^8+)+2QZ
M_6S&B46Z:O,:;6^,V5>2JJZ)VLJG?]NL=.&J+5 A060/'!7C@H)Q$#^H7M^
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M@7@#P:9?T-2?TU;%?=UR#P!KN ' #@!P#72\/?X]OE/^E5W]VW.W -BW@!P
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M%E/JG,1LW2)U^H4H!P!"/)_^)NG_ *Y77W\Z*I< LSV$_C'O=_J^ZU_ONVG
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MNW6;04,Q?]CSHZ KX.H=O;P"3-,OZ&I/Z:MBONZY!X UW #@!P X!KI>'O\
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M\8< B0GXO;3\OJ'_ #UV' )2L']).[7T#T7^9N2> >55OXQ>/#Z'KC]QRE\
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M$E"%4343,!TU$S@!B'(<HB4Y#E'J A[!#@'[X < K@\NW]G!M7_(:'_GS5.
M59ZB+)F\*_C'0 1%0NR.K*A@ A^P"CMB<H?PG;Z?=U(/Q>O<'3X. 6D9'_HT
M\EO\IU/S<,.\ GDGXV%!_)GLW\^Z=P!:J/\ B\:?_E:A]T;,/ ,OR/\ Q?\
M);_)%E^;G$< 3TW]O1K'_@\/.4/SD,6< 9ZN_B_81_+>)^<S=> 9I>O^.>1_
MZ&:[]PZW< RF'_I6TS^@;(/\V\8< B0GXO;3\OJ'_/78< E*P?TD[M?0/1?Y
MFY)X!Y56_C%X\/H>N/W'*7P"KSQJ_P!E7)?ZQ3+/_P!$:6X!G6VO]N7XQ?\
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M]P X K>W:1XW&$)D=N0QG>&,GXXRH7L*)E/DJ%L;>'MQ2= $ ]:D3\F0PC[
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MD5-),V#SL;VL[U-/N2*'ID+VB8O0P@8/MK_;E^,7_P"29>_-2VDX!?\ < .
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M0-4;QB))(>6Z$0033101QAL*DBBD0J:229'E9 B::9  I"%#V  !T . ;AG
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MNEM9MDQ7LI.^W5SH>Z:".?M8][&.<C4D1JN5K454542E%)XU0C-:F%]W*<X
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M;2'W8*[P#>MK?\78#_$L7_R%#@";;G3MHK\[J@\I%<^==P<[%!$UN'67]TC
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MG4*4ZQB4ZO*'*D0P@90Q"%$P@'7H =?@X U1B@8!*8 ,4P"4Q3  @8!#H("
M^P0$. *M@X1Q5>+EK@],9.%BDW&1<***#\1;&4])G"6J+8QA$!/C6U.3LTT@
M$13B7;'V ' -+S!7[_8+\L7;/[MUKX!.O #@%I/]U-R"KY"8;3_C+Y\^EJ\?
M7UWR2%]2!>""<=5OQD6/Y+VY7W.:QP#8JB?Z4=&OH&RO_-3"O (DZC]@!_[1
M_'U<_G;!P"8IC^EO<W\GO%WUFS5P!>I3^E_P\?R*RO\ FJL^ (OY/_Q-T_\
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M'\.33'^M;KQ]N"A?Y=X ?AR:8_UK=>/MP4+_ "[P _#DTQ_K6Z\?;@H7^7>
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M=L!]GC65OE^-@7E83NK+,5,92+N#?(^@NRE46MD292_:B $34<I*JI$*4I#
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M=&=@@88DQA>:?9@+:M>SKJ2MB@\>1T>,8G]F0H.V@.*HX]1013$I3$'M'KT
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MF$@R3<9HW<!C B/H?&^'V< YIJR;+OL9[ T]OHUGP93*>=5LC5TQ[=KX1HE
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MNJPIF3,*Z0(@7J!(*OBAT#A;%%UE77"7F94 C(Q@Z>9\O<>[M,&5M'*6Z^!
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MB-*,F4&.E2Z>OTZNE176:L=RLC'KUO[/AG#B:<3;E!9-\#XA4DDC)>@;O[P
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M.][]79):'<O5*ZHXT)*BK6F;UJ1E\F0JS781)5FV1:$%+O*(**I#VG$Q0 .
M?#:W>4MU!MX:8W\UML2K4X.D)B>T22?/DY1%PHZ82Y&H9]2ATW\6N<IFXE;%
M*GZ9?8(]1$#R7VJ/DVD"MVZV]^M2$8$@I.2T;&:,O(4EBLBAT3FL4P\AMC(]
MXN_6%(0<$ X(NBG$JI#%   #@G-1O)1.1M:AQWBUDC8NJE(TBFD;H]+-@;P@
ML0C7-?;+I[*$=,(YZP3(BJ9$Y512(!0, "/4!9\K:E>1V"R?IK%J[XX)695W
M-MUFJ;&(:7%:1\58G>-,F2*[V0%/.1WLE&HQLF\:-V:2S0$P434.HH9/XP#4
MN]6?)C(P,Y7Y'>/6!TWLXK*61TAHN\B7DX[5!,@/Y!6&V,CQ6?)(H(IE5_?B
M1$@"(]/:!VV&M7E"CEHXK7>S5Q**A63=K!02&A!&L?!.$2+H*R$29KL(DX8K
M.FJXI&33,5$J?4"E#J;J!WGFOGE1>"W0-OQK,2&*@_;24";1)5Q&S2#Y'T?0
M? YV(45311[C&[$A*57N$% ,7V< P]74KRDMHFI0-6\B^$Z1#U*R-I]%A7M+
MW*R$PP0<NG9Z?+FG-@99P%274="4&S11J=)),B29RI% G .1AJ!Y'HF17>P^
M[.L,4T>/Y";D:XST:=?->2L\@\B'X6YW"K[#K(EL[!S"I&;.D3(B03*&$ICG
M[@ X;CK)Y)@JUKD)/='5)^_^0+ ^>S!=##-)MT^-57T(YDR2"6P9CMI5>&4.
MU!<I3&(@84^@I]2"!#.M^K/E!<ZC8'J%6\C&(:E7$,38F+7GD;IHC\[H>#AH
MJ%?,X96='-Y63[WZ/;$8O5P8HJ+(&4%/T3F[@ G:;U8\HUA63<RV_P!K.Z=M
MI%XYCW:N@4:Z=,(A^U49OJLDM(9Y>J&@Y!!4Q'/02N7"8BF97M$0$#L*ZK^2
MM_5H2HSVZ^I]BAX *^M&-I?04J[)G)U59H[KDPQB3;"FBF$A R#!!PR,DD4K
M59$ADP#M#@'X?ZL>3B5/7).6WKU?EK?4&T@G5KU)Z%)N;+!/96.4BY&4CCEV
M"18-73]FH)%R)HD;JA[!3Z   ![SG ?EA<,#M">0[7EFY.W:(A*-=&.KQ-9N
MH0[AVFB[V"=L/5?E*)#E,B=,A3")"E'H( 83B?3[R:8>J[^JUS?[7V0:2=SO
M=\?O)C25T=ZO/9$MTQ=)\0!AL*R:ILR2\VL"! 3ZIH@4HF,(=1 41;!?DVO&
MU^RS6M;@ZZCEO!-2URR'5;"&I,A&)V:7L59R_'H4M0QLZNC05>G8MBZCY03*
M.R.R.DE0(BHV3, $N+:G[Z[8)XBSC(;W8'!S4*_D")A8D-*'C%Q 2=Y:1L!=
MH>Q,W.P;I=K:Z;+5P$$Q*9,6KYL8W0X=. ,&\UK\J;N?BIT?(9@--./AI*">
M0?X%<DK!S;22,U4,YD&A]C.Y.5;+-"BFY1,FH!#'3_>', @<<5J[Y,JW$0-?
MIN[^JE'A:Z"#6)CZUH(5NSCH8KDCA["Q[$VPY6S)E(B3^%]+TSB;XP& _P ;
M@&JMK,VG64!F)G:95E.V=IM3LZULDY&1AH2-F; WR]8TIF6CH4[R1/#L9*2(
MJLBU%PX%NF<$Q44[>X0&/X < M)_NIN05?(3#:?\9?/GTM7CZ^N^20OJ0+P0
M,MHNC?%]Y<&IXXD:E%V3['^P0@ZND1+S<+[C\WZ6"Z?N4),0;WWLS@R(D/Z_
M84A3]2F$0X!M(8\:9H;+R8Y6G,:S#<Z2 0Y:%6[+ K(K 8_O)I$\_99\CA,Y
M.WL!,$Q*(#U$?J >3G]?8-KC&;=:P,,22V7VQVR\%$YM>VR,H4HV2,<SZ/>R
ME+0=S<8^=)@!6ZX(+(D./\(02^T *2, >17RS3>RMBP+M_X]&.M54JU?<VEU
MGJC0.1]A\1S<8UD6K))O#3M#?D<G<RX*G%, 05<- ()G#<I> 7FT/-N(\GG4
M;T+(M3LL@@ BZA6,NU)8F':/0Q9*MNCMYZ,4(;V&*X;)F*8! 0Z@/ ,+FHW:
ML\O)GK]OP*V@COG)H=O+T.^NY5"-%0PM$I%TSOK-HY>D1Z H=-),AC>T"@'L
MX!)E ;Y*;1#@F492E2TZ+Y0S1Q186;@XLD:*20)).&L[-SKI1Z"X*"8Y52D$
MHE "@("(@=3(;;+#EK&ABJ8H$.]*X6&64OL!8)YLLU%,H-R1Z<!8(!1NN57J
M)S*&4*)>@  #[> 835X[9Q&?BU+E:\'OJN1P(S+2MTF\1LXNU])0 )&OI*\2
M3%LX]82CW*H*%[0$.G40$ )V7!845@;&2(X%)0$#K$,HB582#Z1E4R'3.=(I
M^@F #%$0^ 0^'@%3>G^W^P^W4EL]5H&RZZUF^:H[-9,UPR54'%+R*_>-UJ=(
M]].N9#C?6ARQ&0JNLD^;AV"5)4JZ '.9$X@!:-4TK8C7XY.\/*^_M)4SA+.Z
MLPD(R"65]504S,&,K(2C]NF"':!@474$3 (@/00  ,$R RSPYEFI\76'%,1!
ME8E*]0O55M<Y**27K*B95LZ@K7!-4F7NXD "&2,?O 1[N@@  <=!99];S*Q\
MG6+$TM7Q8JE0;4>J6V$ERR(J)"BJJ[G+;.,SLRI <#$!$#B80$#  " @2+9T
M[*K 2B=.=0C*SG:F"%=V-D^D8-!YW%[3R3&->QKYRV G7J5)=(W7I[> 0'\E
M;A__ #;:Z?:[R-]\7@#'L@>%9-"R)VRL@#5N#Y1FFJBS4> D0'1VJ*RBRR38
MZ_<)"G.<Q2] $1'V\ A.VQ^RRU@D%*-:<)Q]6,=/Y*:6BEW:4G42 D0%@?OH
MN[1;!<YE^X2BF@F $$ 'J/MX OM.:Y:;;Q0 95F<>RZYM3[_ /) T&O6*!31
M(7,.,A>C)EL%BL N3*=R()"D*0$[3]P#U > .'?$,AN(0J>,Y*GQ5B]\0,9U
M=XB8FX?Y/ #^\IE9P<Q"/ =G'M[#BMV%Z#U*/LX!%,9&;8DD6!IBXX 7B2O&
MQI-&.H.0&\@JP!8@NTV+AQD!PW0=G0[@3.=-0A3]!$HA[. ,7P!<I",VT,_>
MFB[CK\C&&=N#1R+Z@9!7>I,15.+5-XNAD!!!9T1#M!0Y"$(8W40* >S@$M41
M#(+>"!/)<E4)6R^^.3"ZI,3+PL+\GCV>Z)^Y3<O-O?>R!W>H?U^PW4.A0^J!
MXV1&N87/R5]BB;QS#]@NOEOY_5VQSWO &!'W+Y,^0+' >["F(*>KZOJ]W4O3
MMZ#U Q>H1^RB%@8J7NT85D:L45OE)I5:9=8J=5 4C A[D^E;K*L$1*OVB;O0
M/U+U .@^W@'KY!QDZN%SQ7>H^;2C)7%#^[R\4Q=L3O(Z7D+91)JFMDY(4735
MRDRCU)8'!P2'O5!/L 2]>X ,#^2MP^G\=M<^OT=Y&Z=?MC< GZMIV-*!BT[<
MZAGMF(T(6:=5YF]CX1=\ CZBD:RD7LB^;-1#IT*JNJ8/^^X!&U\99_<39#XR
ML>)(JN@R1*HVN]3MTW,#(@=7WA4CN$ML(S*S,F) (041. @/4P]0Z 0I?<1;
M,Y6B(:I7;(.$F550O^+[E-*5C']W2GG#7&^1JMD,L;&KRE]>1[9:67JY&PJJ
MI*@D143 4P@ < R?*0C^%+JD'7V?(VP/L^I_%6I\ :C@!P X < 578@1^R3J
M '4>@["O.H?4'IA3+G3K^[TX U7 %SS'BS(MJO\ B;)6,K138&?QJWO\<NPO
M%=F9^(F(^]Q<2Q4,E\A3\ ]9/8U>'34*(G434*82B4/8/ *W=D\YYRU8S+DC
M..1;Q@(C6CZ@Q[HK-*BW\GSEDG>891I7*I#-1R"+A:?GYA5-LD)3&*4IQ,*?
M0AC\L6R[!8ZOA+C.9!?X$#*HGQ>]>C&-^U7NHB?X_@;6X1XAVCG?E'$<6:@R
MN6RERC72*E66]NSZ[FZE7T;'!"CI'*JHBT1OJY$6:_&AKS?:O5;KMCL4D#G:
M;;-ZTO%Y*NF8#8^HQB%5HN*XA-43J1T=!1ADU%T -_NQBD/U,B \P_C?7[ZU
MMI]KV!*[-EG)+)7_ $47^B@;]B-;153[>B^AV.\U.7]6SF:Q? '$+D;P;Q_"
MZRLU8O3(7Z=+_*2TZ2/GE1S8WK^XBN;TD4<RTQ^S"MAD5:5:<),:J99,8EG9
MJ5=Y.=2;@DD"I9%]%W>+8N%3+@<2BF@D $$ Z=0$1V:=&R*]'JQF>IXCDXO,
MOS81D39%R@_AF4%6K%6WB+*2R5;Y [J21L$Q*&<MY0KI-RR,D5(/=5"]PG$0
M-P!=K8TO</J+N[AZD2%3AY/%%DV'BB$MD5+2S,F-LBUF1S% ),$HF4B%RO"0
MN2"MD%CF403.U.GZ8@3H $PZJXMV:Q/A7 ^/5K]@^<J%,HM*AW3I&@7EA892
M%;1S4ZYD5CWQS'-)-1JH)2'%$Z0& #"0?:' 'SX MSR+VX,[=&87/7M-B+E<
M62;K'^0E72;053BV(Y52R$DDHX*CV@<Q2E*)NH@ ![. 3#1D;ZW@$T\D2-3E
M+.#IR*KNEQ4M#09F8G#W,B;&:EII\5R1/J"AA7$IA^  X!C^1&F9G*D9]BF<
MQM#HD(X^60OU<LL\HNH(I^ZC&F@+) %;$(4#>H"@*"81#ITZ#P#'Z8PV/0L#
M13(%GPS)58I''OS2HTVYQ,\HH*)@:BU?2]SEV"1"+]!4 Z!Q,3J " ^W@'?^
MQB^C\GW_ "Q"3;8L];L;UBCQT7*1ZB\1&/JG(6R4CY1X=J[;O'K9TYLP%61(
M9(P$1^*<!-U #!@BMQ.@=;MKGUZ>T0QWD;IU^KT#[(W7IUX P5?)/)PD8G:7
M$2[L1&:)9ES!-';&'7?@7^'4C6;]V_>-FAC?O"*+*' /A,/ (PO3'81Q.BIC
M6R8ABJU[HW*5K=:C;YJ;]_#O]Z4%["V^%8^ZGZE],GH=Y>@]3#UX!W\>L\XM
MG[\V5)_%TO%F:$",2H=8M,$^2?>L J*/EYZT3R"[44.H%*0B9P/[1,(>S@&8
MW%*XKUY^G07M<CK4;T/DQY;8Z2E8%+HNF+GWUA$242_7[FH' G8X)VJ" CU
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MK[%Y=J]%U:R*^O[_  <-8%+1'L^U=0B'H3:L/ G>"JW IS?\%3[#&$OMZ=1
M3;8R:RE%;3ZH?8^H%7N2?S<SZH<\]?UZ:H1X:NU@BK8A$JC9?413;E(H"GL$
MQC"7M+T[A 8FC6;.<K.E:7_%%*I]>%JX4/,P65G5O?E>$ ONS8L.KC^ND,DN
M(CW*>\AV=/WINO )0GW$TTA9-S78QG-3J#152*B9"3-"LI!Z4O5%JZE2,9,T
M>BJ;V"J#=82_#VCP!?PO&U/U=?L9 /T_/?O1< /GQM3_ %?\9?;]>_>CX LN
M?+ELRKD34TSW!6.&RJ6?G9V2:6=7BX.W X<RF04%3CBI$6J8-CJG]0"K#W$
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M,23Q#(^,ZA28I)F"C)_7\EN+JZ=O15*46JS!6CU@K5$$1$WJ^LH/4 +V>WJ
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MOR*^;3K_  J[ALQQ4GCB]5>7K%P]SB6*]<R$<[:3^29 K<\)VC[D!N\QD^G
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MLV)'.M9V>M5 O![56L#Y"QO,T""H[YI*-O7:3^-+1)Y#BTI&2,J0\:63;K"
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M@!P X < . ' #@$'IZY8>3H-%Q@-226HF.;=%7BJUQT_DG3%I8X2;?62*=O
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M_@;)FA7(LSA5ULZO*6Z4K8,)>]&S^>1+'/I)-"060;2U?;.D_?%0[BOEBF.
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M.P.<LUY&>JQYH'(5?Q+%P:2"ZIY!)Q2&=P0F#/T#($2124/.H^B)5#B< -U
MO0.H%;F?;5F3&]&REJ!A2"NK[,.8,\.CXSE:7(_-:5@,&9ADI#)63,AP]X?D
M3@:K*T<C>QQ#1TZ<(B68.S$@"94G< J&6,XYP_!&95;(=DS_ (HW6P GD#&<
M)#(2627%:RK9J+)T^6J%AC;5BR >5_*><\@XND(P]<923Q:O/YA])@[:K%;K
M^D QD5F'(Z.\U67Q2&>\CEEZGEMMFC!5QEK;7I.H7-I!P$Q4%)MG<8R(PE4,
M4, 0,SKTI"JB]E9-^<#+NT2J>F!K:ZYNG[Z,S<]E(P\))O-L]I74E"J.VT@I
M#R#C,EF6>Q2C]D8[-\>.<G,B*R(BDJ).X@B40X PW #@%I/]U-R"KY"8;3_C
M+Y\^EJ\?7UWR2%]2!>"!Q?'#_: X+^C38?ZS4+@&UGP X < . ' #@!P X <
M . ' #@!P X < . ' ,'5R'6T<DL,4'5>!;Y*CR^0VJ(-#BP-6X2>A*V_5._
MZ^F1X23L#8"HB'<8AC&#V%'@&<< . ' #@!P X < . ' #@!P X < . ' #@
M!P!&O(!MX34+!Q[!789U;\SY*FF^,,!T1@W(\=VK*=C151@B+-3*IF/$Q*@@
MY==.[N*4J7L%4!#"]\VI-3P3KJW;[N8G<D-K$G59)W]&HB?%&_B=]R4^)V;\
M3N 7>0/*L.#S$WY'C?$P/R6>OW*K8[/%VWUSN<_T;),B>S%_OG*_JC%("UAT
M*L&L^%6LJ<6&6,Y9.;OK)MY!W)XB]KV?IVTNW4W,1:J\@BXBX^8IKN26;0SL
MZ0-G*0JI.@]-<#HTZ%JJZK@D@NW>[F[EZS74J]5DG?U=U^+6U[6_LK\3Z^6O
M/C.?>59,K@(?R/&&%MV8S V#4[8[3&6J)'#1G[LLZ-]Z7XHKD9548@U:K#4O
M91^6'O\ CG'%BO,.A%,']!R[1H%*_P  2&=.7T9'G@K,Q.^<1L<]=KG;K,A<
M1YQ5.*2IRJ&$V;'5\G.N8BQ74+C:,AU7'-)KE[NR+1O;[A"5F'C+)94&!4R,
MT9J99M$7\@D@"1.TJAS!U(41]H!T A^PN-7L-&NE<9TZB)V;+KQXYMV-J!3X
MB8NV4Y1^V6;.OENI03,[V9]\0=J$6<R)2,TRK',LJ0ICF$#(L?T&RS=P2S#E
M-BTB[(RBGL!CB@LW:4C'8MJTF+4TIZ[U I64G>[*#)$LD[0 6[9ND1FV.=(%
M5G &+Z:?T)!]*&;_ +L-VX PETML/0JA:+Q83N$X&GU^7LTRHT0,Z=$BX-@O
M)/SMVQ! [A8K5L82D >IC>S@'KQ4DUF8N-EV)CF92K!G),S*$%-0S5\W3=-S
M'3-[2'%)4.H#[0'V< [_   X < . ' #@!P X < . ' #@!P X < . ' #@!
MP X < . ' #@&%0]_KLY=[ICY@J[-8Z%'U.3L*2K4Z31)K=$9=>#%J[$>QT=
M1.$7]0I?:F(%Z_ON <5_K5@L4*):=:5:9:V+IG(Q,V1DC(L7*K!0ZH0MCCE/
M34DZU)@H9-RBFJ@L4# HDH10I1X!$B>QL93%$X;/L"^P_,D.5L6RO4G4MB:?
M5+[#/(#(;-L:.CFZH!ZGNTT6,>(@/:)#@'>($FM\R8A=M0?-<J8X<,A H@[0
MO%95;"!P 2?PY),R?Q@'V>WV\ T4\ .FKY'/+YBY0>,GFWNUKMF\:K)N&KMJ
MYS5:5F[ELX2,=)=NX1.4Y#E$2F*(" B \ GS@!P"TG^ZFY!5\A,-I_QE\^?2
MU>/KZ[Y)"^I O! XOCA_M <%_1IL/]9J%P#:SX < . ' #@!P X < . ' #@
M!P X < . ' #@"FR/X]-._)-R3]V#%/ &RX < . ' #@!P X < . ' #@!P
MX < . ' .G(2#&)8/I23=MV$;&LW,A(/G:I$&K)BS1.X=NW*R@E31;MT$S'.
M8P@!2@(CRB21D4;I951L;4555>B(B)555?L1#D6EI=7]W%864;Y;V>1L<;&(
MKG/>]4:QC6IU5SG*B(B=5541#7;QU8[;N[O9A+>"46<MM;*#G6QX$U1K#YNF
M+6XIL<9Y*DKUFE1LN10 ^4)Z"02CEB]#E!$H%$#("(Z;U6-^_P"V2;Y=HJZ_
M8JZ#',7T>Y.DMU3[U^EB_P"ZT]*N?;RW\1O'RR\3M=>QO+^U1P97<KB-?KMX
M7(C['!=Z>B,:J2W+/BJK7Z9:&QAS<YYFF!7K%F-LG-$660Z+5;D@V X,QL,(
MPDG# 3B!C'C7CA [R.5$Q0'O043-U#KUX!$7X'^ ^GI_-RW@T$>HQ@9@S*$.
M/U.@PP7\(L2=/9V^CV_X. 2U1,4XTQ@V6:X]HM6IY'12E>JP,*Q8/9#L$3%-
M)R"2(/Y-0#"(][A10W4>O7KP"0. *KII_0D'TH9O^[#=N 9EM+^+3L!]#.2_
MYGS' )'QW_1_1?Y'5GZR,> 9CP X < . ' #@!P X < . ' #@!P X < . '
M #@!P X < . ' #@"JXS_&PVE_D;KI];,E< :K@'X52363.DLF15)0HD425(
M51-0A@Z&*<A@$IBF#X0$.@\ C%;!V%7#X)1QA_%R\D"@*A(K8_J:KX%0,)@4
M!V>),X!0##UZ]W7KP#1=P&W0:)Y[:M4$6S5KM_M<W;-FZ1$6[=NAFNU)(H((
MIE*FBBBD4"D*4 *4H  !TX!/? #@%I/]U-R"KY"8;3_C+Y\^EJ\?7UWR2%]2
M!>"!Q?'#_: X+^C38?ZS4+@&UGP X < . ' #@!P X < . ' #@!P X < .
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MO^[#=N 9EM+^+3L!]#.2_P"9\QP"1\=_T?T7^1U9^LC'@&8\ . ' #@!P X
M< . ' #@!P X < . ' #@!P X < . ' #@!P X JN,_QL-I?Y&ZZ?6S)7 &J
MX < . :"6"OW^P7Y8NV?W;K7P"=> ' +2?[J;D%7R$PVG_&7SY]+5X^OKODD
M+ZD"\$#B^.'^T!P7]&FP_P!9J%P#:SX < . ' #@!P X < . ' #@!P X <
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MU\ G7@!P"TG^ZFY!5\A,-I_QE\^?2U>/KZ[Y)"^I O! XOCA_M <%_1IL/\
M6:A< VL^ ' #@!P X < . ' #@!P X < . ' #@!P X < . ' #@!P X < .
M ' #@!P X < . ' #@!P X < . ' #@!P X < . ' #@!P X < . ' #@!P
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MZJ3-D#RI:!XPOS_&MQV1IK*TP\@:)GB1[2PST/7Y(BGI'93=C@H:1@8]PFL
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M%\</]H#@OZ--A_K-0N ;6? #@!P X < . ' #@!P X < . ' #@!P X < .
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M[/DSM?F?.>0-H=CY2)4A&5\O;-A#Q]<CUV1(U<(6!8KO2).?DXHMTC"L"3=
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M$]CRSW3YV[U9SIIW]9)'.ML?(Y7N]557N<Y:^KG*OJILC\[&'B^' #@!P X
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M20OJ0+P0.+XX?[0'!?T:;#_6:A< VL^ ' #@!P X < . ' #@!P X < . '
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MG^P6#(+_ %UM'SAMN1Y9U-5%O,N:JV>5BFR4:>/>0=:5;KF(9LFH(')T*(B
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M'V\ . ' #@!P Z /PAU^K_W?W> ' #@!P X < . ' #@!P X < . ' #@!P
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M,M?]0+-_D[@44LB^Q-E+_P!7%X_LS_F+_%B8_CM_\R/_ !3^,O\ ^A?\8_\
'C>03\C__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>g68105page178.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page178.jpg
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M P,# P,# P,# P,# P,# P,# __  !$( MD!T ,!$0 "$0$#$0'_Q #?  $
M 00# 0$             " (&!PD! P4$"@$!  ,! 0$!              $"
M P0%!@<0   & @$!! 0)!P@%!PD%"0$" P0%!@ '"!$A$A,),4$4%5&Q(G(S
MTY46%V%Q,B-55AB!D:%"DE-4U,%2))0E\&)#LS1T"M'ALF,U174F-O&"D\-E
MHG-DA(5&1QD:$0 " 0($ P4$!@<%!P,%  ,! @ 1 R$Q$@1!46%Q@9$B$Z&Q
M,@7!0G(C,Q3PT5)B@I*BX;)#) ;QPE-S@Y,58Z,TTK/#1 =4)37_V@ , P$
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M=Y2U?^>;%W--DZ7_ %22,'] U)Y5:I';3 X3EN&[M_DOS,5!^8+Z/I=1^8!
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M[O\ \-?]45XZSI!RJV. SXS?>N"=[K*ZO_+6?3I3/0-5./*I^'@3.KB_Y?\
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M1&(C$1B(Q$^&28-I1@[CG:8*M7K=1LNF( 8!36*)##T'UE >H#ZA#KEE-&K
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M2=^U7GUV(C[UVG]Y)W[5>?78B/O7:?WDG?M5Y]=D@$Y1'WKM/[R3OVH\^MR
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M,4#%42537,FJF8H]0,41 0'J&6((;2?BD @C4,I4%KM(]1"R3H@':(^]7G0
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M*G\10!,HH<1,<W9Z1R#AG$O3$1B(Q$8B4*?1G^8;XAQ)&<^<_P#V(W_=S_\
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M^&.YN,NSNW+1+;S3>(7(ZAZ?I@?:J].PSKM)MSOK5NXP&UK9U-F*$W?4)^R
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M7VDP^OQ$?@YL+]BI?:3#Z_$1^#FPOV*E]I,/K\1.!T[L( Z^Y4NS_P#4H_\
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M-V]O'"DH:A]/U:3:#B6C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$35-1;KO:7\R$
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M 5<#2D< ]?I2]TCY$H>CM)W3AT^ <\W=V74ZC2:V3H!#24&<,Z8Q$H4^C/\
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MYEJ7KFMQ5FLVTC-^ZFFK'0$#*QXE==X[M91TW0;D55.4F8O=>V'N7JGT4+,
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MH5IW2MN.L%$T)1!*A'2+,E:-I)#[N'3"PM2)M"-&[Q/J7WRW3;D2 A3>.0I
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M*Y,R\(\B;?;VM):T-2JR-J6CGZT7%JJS9$V#%RY4Z"JN<N13&LM7"DF& ]0
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MMVA5M<5PFM8VIC;(W<E$E]<Q=KA[R\][KO6,VRL\E#*]3-56K=8$1/-K[PN
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MC^Y6:1BMFM:[%7.1E-9;^8Q2[560CHQ:;I\RFZ.T]G9E10.AG;?20N99*FO
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MNR^TU_\ )XB/XAY']UV7VFO_ )/$1_$/(_NNR^TU_P#)XB/XAY']UV7VFO\
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MNOY\!*_ED52PYU8#NK6F<P0/<V:NI/JM<(K3ACPD;J?YOO&"1I9=L2-Z5LE
MV1.V%;34-4JDH6[M*QKK4%.V7MV-NT:\FA.I<];R%E4C7;!$I'Z[U--JW;+K
M'ZCK0.FM13RWS_+< 3P4]^<LH9:*^+5'ODDM%\P93D(TYF+T/5$FDOQAV59-
M64="9FXANGMVQ0FL*_>H]3Q4'BRM;;V"1L39%(JZ9!1:KI&.8%_%32YKC,/E
M2[D?C%6->S+#*:,*;Z[:_P -0*#E-?M+\WY\YU78;Y(UI>S[+J-EXR:?VCQ>
MGM?2FD-WZ.WAO799*%+J6IE;K"YC;5J)$71 @I2-.<[MTD)'"A"J"='T$L^I
MN[=A1\>]T4_<%DW"/Z2:Y]TQN:S9NLF#+:9AT((_7)@WOS4N*&OD]A.9F1N[
MF/UZGOXBLA$UUD\0MLKQ:4KR?("NT[OS")Y*;UQ]XTS*%6*W0?E;.?8U%_!^
M5YZ;BW<VUG=#\,KZK=;;WTM(/:148XSI]/U-T]JW\)])5Z,R,[>.D_1/9D?,
MHT=6BTI6_43?.LF=ZL5'K\*^V)K7[LHK);,OK;7>O; S!:96&>@[/.OFZH#&
M^V.64<N1V[212-U#MM[:ZN[&TN8W$:TC?:N^J5/3RH/"<B;FU<L6]ROX5VW<
MN+]FT:/[99C[S<>(D8]FVLBYV(Q8QC.6>14^\J\>SA[0,3O?^&KV*+%W/-Y*
M->R.XNL>V+)MF0':%,].9-L43YE84O;:XV18$=%<$K_=,UN!DPXAF7O2FK^\
M).?2VXJ7OS6T#M.@*2AZS/N)UD@G-1JT5*-9&M3TE69QFZ:*F.0WLLU$+D37
M1.JU=(@19%0Z2A3#9P!2DHC$YS*>9S2,1'_+LRI95SE2:G0/B,QN.Y=0E6NK
M8VTM>@YUJ*!=C-AM\$#B@&<F*5N6Z(^V^)6#.!.7PP>@CWP$!#J ]<NJLU@[
MH860VGO_ $,S?[K_ "QKZ[>:O3] 9>TE-0\-"/[-+RL;%5R*BG,[*3TD];,8
M>.A6;0S]W+OY%RHFU:1K9B0RRBZABID2*)Q$"AUR6U&A;B)J  *#]#.(6;A;
M)&14U7IB+G(>=BF$["2D0_:R+"7@Y1 CF,F8UTT551>14BW4 Z#A,3)*E'J4
MPY63/3Q$8B,1&(D]]:?_ $%5O_A2/_I'Q$OG$1B)9FPTP5H]I*/[%>B _ )$
MA.'\PER^V8AU;ZU8;(]D@2U4%)RV5#TIN$% _.14AO\ 1GO7/PV^R?=//7XA
MVS9$4W?; ?\ UD0-_:3Z_P"G/GIZ(SG6?_L1O^[G_P"I-B#G/SM>:EHW<?)'
M@AR"TYH4QW&R[3&UMS'UU*32A5+Y!UVZ0-BMNNDY5=9LU9*7JLQ;J.**RB:*
MIEP24,4BAAS%M8>SN&_"%[2>RN4O8IKO6GQ8VJKTZR..]]G\G7;[;$KH;B=?
M(N%IO#>AHZZVE3:']TN1!;_.;"KS2?XX5Z+N@*P+N+I<%&'EGZS9B[!NAWR,
M.KKN&/UN5?=/I'W?JM0=*X#PG.-0L*6^/0*GK3&8%U)9?-'6MVOW=K@MO2=4
MKO*7:-2L.NKA!V.D/9GC]9]T5YUK+9%>V>S&6;2BFM*"F[1=Q5O2%.3KBBA"
M.229"&#*S1/1:]B'N$'J*S2]YS?6S@4M CH:9^,]#S;=9<J=Y[LU_4]3Z'N5
MMA-.:X?[5TA<:]$J2^OMS;$L,H[I^_\ BKR'D49F.5H>O-I:1_V%BY.":*SY
M?O*K!W2D#&VQ:Z;M?N:Y<,)K<4+:%H_C$#'CC);S->G>0OEL2]5W%K'E!$RF
MUH:'@;CK9M%0M7W[JMO+WN& $=>Q,*F9@\A]'III+1 +$.M,1L1XBQ1,X$!Z
M=U;7<W%*/]8<IS[>ZUI&]-*8&0B1KOFF4:-EX-[8+EM6D,K[OE@?D70-9M-7
M\CM]MHOBZ1+B[:-I4IDF#PJ=;W6!(-W)E00)*BR;'>E]@*8QLC0VJG,V+I[Q
M>"@]RX=DVP6]AD+]H=QLER.PG'MF)]7Z=\Q>O[M_$.R:=L:&SKOS6T?LW:,Z
MWJ<%(:TFF\/Y?1]?VJX&?N$GB4=5(_?C5O'JO8_V9RD!EO"-[*<W7KVR#;L4
M;\-[_P P0#I:MJ;0_@))'MK.3=OZR#<#&FV^7O7]Z[<<7#_&  >7"DM'7>O/
M,D1NL]N8D%R(@.0%HX@<8ZCL>][6I5CE:Q;=S:ZVON&][GTX,K1#M[93]:3K
M=VS:1LO76SA-B5VV% %&YEQ#E5DNI:]+FE>9!LEC7M.)[)O<K;O7@WPUN:1R
MI>"BG8,.R?I:TT]N$CJ'5;_8,%,5>^/==TUU=*U8)EK8YVOVEQ ,%9Z&F; R
M;LVDW)QLF=1)=TFBD5=0HF[A>O3.AE4*:3)68MC,E9A-H^5T,!%10.8AR)K@
M7O\ @*'()$UNYT$#^$<P&Z#V#TZ#E+B7'ML+1HX4GPQED*BXNO%2P![S--/
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M1'D)%*&]FD7_ !ZW7K9Y/]X2=)/7DV\9J_*12( 92P58VKKBMMEO5Y54V:>
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M.Y7Y/:+F8IM)U'K^)3B]F3<5'#!:.OL7LC72SV+*DJU/-Q=IB$57+E,$1?D
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M.B@QA0!@S27<JL6LBY36=B4HB1JFH;H/3H,L=0HV(B:!XK6_//BKJ7S1N/\
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M=Z23J/>(*N$C^*LJ)M$965D7\-B213 AR7Q'UAYC2O,\Y0C%6.:Y'E@!ARP
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M)HQ</GFG->UFOW"QWHR,J[C2II-6%JBT6C?J#IV^>I(IE 04,0P*7&M-A=0
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M7UL)6X $FX)([%K5PULG*)BT(UC7K186IRHG#Q\J^X]7<-NF%;MTA3V+<_\
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MJ?W-IL=:;D*^C;'(*Z0D9PFO1IKNU-H5635FM=[ /=NL-?8,9>MJ$7C1>%9
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M8:K%UQCMBG2>OHEG MX!D+">F(]D9RZ:'6%XJN[<+=X4&Q2%KMU_%-\T+);
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MO5*_).CRM(=KT2\T:4?N8TR[MM'BS-'+HG$R*S/HF'?;F !N[4MBZX'I7W*
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MS)+_ '!W]3@>5= ^&(]URG[,DO\ <'?U.(CW7*?LR2_W!W]3B(]URG[,DO\
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ML%(6U+R3J]SL]]ND_)NY:OW*R6>@[JD+(9M,E@73%T<B0(G &I4^Y>X;CC>
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M(C$1B)280 /E=H?E#K_1B.G"0:MMSX+4:I;BV#9S46-JE,Y&5IUNF;2K]@D
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M'V-NJJX571!0WM;)%%DT \V!ZY''O /<)R[EF+K4U*XCH<1AW$CL)EB['J7
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M:N959[#1"CE*3D5D$JB]5,LB %;J EU'Y0]VB&E[=6U__9VB*.T7"U1UIQF
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M+U#5KC_RDW096?M<Q$2"%GXQSE<J5OH4K'H18BP<$D+$LBJ<.^H1=K\DIDS
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MRE.T0_KF]7J#M[,1*?"+\)Q[1'H)S"'HZ=.@CTZ!B)R"12]>AC@ ^KOFZ?R
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MEYJYC+*"4TPW(8!.80'Q"J(@':/J X@'Y!Z9>^/\J1VR;0'JB3U[@?"8/1V
M;L[/0( '8&>).Z<"B40Z=5/2 _2'$>P>O3J(B/3$3L   .@=@!B)SB(Q$8B8
M:W9_].1P^L)A/I_NKG.C;?'W3#<?!WR+"WH/_)GJ?JE.'=/%6]*G_P"['T_#
MD'(S 8G#G],V$59'V>MP*/00\.&C"=!_(S1ZC_..>/<;4Q(RGI&>VI]&?YAO
MB'*0,YUE.!&Y3CZ"I=X?S%+WAZ ':(] Q!SF+C;IH)3&*,D[ 2B("'NMZ/:
M]/2">)$X_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']
MI._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT
M']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'X
MUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1
M'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ
M\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/
MOJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]
ME/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)
MW]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_
MM)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N
M@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]]7B)2
M?<^OU"'3-).Q*H4Q#![K?!V& 2C_ -'\ Y(SD'*0N< GXZW@B!DO&6\(0 2]
M4O$-X9A P (").G9ZL])-Q:"XGWSC%JYRGI0#\L5.0\F?KW&$DS=*= ZB":*
MY#*" =HB()@/9Z\O<W-EK!0-YNPR]NVXN!B,),'\:J '_O-W]E/NS\GT09Y,
MZH_&N@_M)W]E/OJ\1'XUT']I._LI]]7B(_&N@_M)W]E/OJ\1'XUT']I._LI]
M]7B)DB)E&DU',Y5@<RK)\B#ALH=,R1C)&'H43)G^641$![! !Q$Q1NXP_=^*
M( _IS!>H?"!6;D?Z!SHV_P 9[)AN/@D6UO0?^3/4_5*<.Z>4"(KN4D0_Z=9%
M#K^590J8?R]395LCV?1,5S[YL9:(E;M6[<OZ+=!%$/S))E('] 9XL]"=JGT9
M_F&^(<21G/G/_P!B-_W<_P#U)L0<YK?4 3*J= Z_+./\G>'U>G#_ '=D7V_#
M+:>M>R1.#I*)_IIG)\XAB]?S=0#K_P";$3KQ<^[%6RB5%(<X]TA#G$ $>A"F
M,/0.G7L* CZ\/]V-391 %$1  $!$PB   ]1ZAT[.SKV]1QG$Y.FHF( HF=,1
M#J *$,01#X>Z8 'U9(4EPGUB0.\F@D,P52Q^$"L F<0[P$,)>Z)^\!1Z=P!
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M]);PU"G.?5_$WQS&3L,*&]-5#+U-L_>6.-"[08O(EI%3GW7DG*Z(.N\HBPM
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M(]>HY:5RQ&<^D8*!%W[>: @C/Q<E>B_-"QAGPO2 ($>B\%K[2+P@#T!7O>(
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M;&>+"F7IT(*I^[T[YNMER'9+KY<>WVR\PT90@ "E:R)2E  *4LFN4  /0
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MU'A/L30:4CK%OOW8"VU6<AN2.C;02)=US9?(]7?!H^2C5W'MRJD<B#=D/<
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M4-<<JMK:#HM!"A5RS1Z=;T+L)&E6>3V<XFVJUD5MNR BWSMG[ YCV\2Q>LC
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MJJN%1$>HB=0W40_,4.@!\ !GKH J!1RG"3J.KB3/9IE;/9YQ!JH4?8&A2.I
M_:!11(8.XAU]'?<G^3\WKF5Z\+8PSE[2"Y6LEH0A$R%3(4"D(4I"% .@%(4
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MBVU&F1AINP5X*TN9)\H;W3-*^#))=1,5%+J -G90]9V9.G4>SO$ZYZEZV/2
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M$1B(Q$8B,1&(C$3YG8*"V5!(4P5[@^%XPG!+Q?\ H_%%/Y8)][IWA#MZ95B
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MC((2L;,4V?5:*G,UDXAX15LNGU #^&;Q&KQ$P]>J*Y  0]/8(@/: Y[*MZB
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MJODET"2+=%1M[9&R1E&Q*KH+6Q=P/IU%#F:FOA-/-6X;>(UXUX8#].$R_/\
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M2F<V4C\P++<O?++I_*-A:>,NB>1[Z'KU*;;TB-%S<76[E>D8QM$EWFZK982
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M%VI>O-D:T?P$R_7;42=(C&V6L[.G:^F\LT:Y62*^7.91-5%4"*EQL6Q9M+8
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J8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1.!] _F'XL1/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>g68105page179.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page179.jpg
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M P,# P,# P,# P,# P,# P,# __  !$( O(!R ,!$0 "$0$#$0'_Q #F  $
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MYMI6-G;6IM/M#V D+8C6)&5(O8RU*)/X<I;G4#'$>RS"I1RGS5Y1=%)BD8!
MRH"'3"+*=0N%5O\ 682Z4:R0-PJ%EC6LQ7+35Y=A/5V>BGJ?B-9*'F8M=U'2
M3%P3M(JBH<A@^'"*Y,(F$7CR=@A(59FWEI:-C5Y K\T>@]>H-EWX1;%>3D@8
MH*'!5X9A'-E%U@3 PIHD,<W0H".$6-M4\@-+;RU]5]KZ?V=2=BZWNTB^AZ?=
MJM8&$C7;/+QDE(Q#^+@I(JA49)^UDXAVB9)+O& [93L^8.$7V:FWAJ3>T18)
M_3NPJKLB$J=VM&M[-*U&60EV4'?:2]]FVVHR*[?YK:>KS\01=MS=#HG'H;MP
MBRKA$PB81,(F$3")A$PB81<%/JS_ $#?(.%(S5$?JD_H%^3"'-=F%"81,(F$
M3")A$PB81,(F$3"+@?T?DZ]OYLJ3($:>)]B@Z&.OW5^:S5LG,4'_ ,RWRPDN
M1\BS@F.R>"^M(?A#-6Y;V? 3%-@9^L/-PU/7$M+>%&#:&UL2<O)A@S4]<,B'
MCG)X(E-D?"XQAL]Y4<;3O(GF6T6>SW?GXJ-R?\UMO]UZ<A]YQ\VKV=%C'S,8
M#2,KSF\G]OQVMT)1'>Q_,MWM.;&O6LBP3HP[=><?:_ VNS1!YV/EZ;(6P[%@
MP:NG239ZV+*=17*=V54@\FPE,;RKU"!_]JW8?###"6! <%V+CIS5MR#_ -N?
M,?G:._\ $Q'R/P4--.^:SSEOE!X"ZHGM^0$6?>FPO,PU9/\ )RWSFOM7)V#9
M''&=E*_QJK5RO:E+FZ3!/"-G#>8D62,8V7M)$D4"&*F=8%>^F-5XKG$Q%G_:
M*Y=LRXD<3A(:<>1))&"FZL;6R6D2-9^(D$?5B<6PX.6QX!G<JY^7//'S!==S
MG.U@3F8UKMKXQ^4]Q4Y;-F&EXW6%@U;*<CYRWQM<V _JLI<: \LCS5=V!,JX
M1QA1,=.13\(Z9#$*IAN#Z-6YW,07K^([6L O[MD0",#B'+GAAVK.B$;);;:'
M*W8[FPG(O7,MWMDL7\Q?,&Y7Q.G/-5J,]OV/V'$T/@CY<O*_7#&]T+3EAA*S
ML#D)9*&79E1C*N_I;BN6#6SXDWXK6*EFTDLR.5%1-QWP\0V^[H%4K8XF%/Q6
M@#$^Z9N>[#]'5MO*-DZKQ'&[X3:X' Q8"0Y2//JS+:'JSF-O;>W-7DMHV8Y;
MU7B0?B7.\);3JO6]@J]0?0/(?CA<M8H6S=UA&'E1B92XNMD2\B2+B7\(Z!*L
M>KMP10.LJIW[;B-7^<O@Q WNZ! ^B!%HC$N<M3^"QJC(?EZF+3V])!X$ZP^/
M _18]IP*@]HKS4-S;IWKIW68\E8S=VE>37#SS))2^V&2B:?3(JPW71#V[-Z-
M:=?:P(H[O.DXQG7VHQ@1TN]*M.M6QY$S) 1(<W#OMN)_"]X ^K_M$)C'*4AI
M)[6<E=VTGH^([(D##XM.!X^6()B'/!R .:G5Y9+#;E@_\LCJN(XZN5PWA(\'
M=WQ>K%(A8 DR;!7>;-;03>*61/U;SXR1RD:CU Z;LQ![!#-O]0$/(EQ6-E%V
M_P"%4^7'/JN;X,(QD/4]WU[#C_Q)MW9=RN7R?I#B';_(ZXNZGW0YUTXJ<921
MU]N[7MO51;6*+WI&;(E'5FK]DJBG2V--HDV(!7B*/JX2QGAT5DB]3$-G;\3D
M*I"1+'TJV[/3CBPX]SNN?9F4M<6_O9OS?4>?1E%R#\R+G#+[@J\Z_D9)O9K%
MYY%H\N^7XJ%@XI)A%<1X^B'>IW)-J,:%M876(CB!<CVI1UX!T#^&)19=U,,Z
M(1OLV%=DFGN=KO)RQ;2:@6![" &//JMISA WRA[FWW-#%L_4B"W4$DY*/_$/
MS$^:UKV?Y=SVZ<M+1?:]R,\R7GIPXO\ 3)6#U.A N]2ZJ8/5=9RS!W TN+G4
M[S"O!;J-I/UL2+E,FF9$Y3CXO'\/I.YV^RVEY(_,_!K[),2")5QT@YYN..>/
M-+&B=U:!AM?BM4 ^(D+(QD8D<8AS@,L,5';C)RYY Z6X#\;)?6/,2WQ6X-Y^
M>K:-";M?V^6U[?YQI0=C[<O\)-OK)!VN <OF<G.-X=O( N[.D J)?J0(W$4L
MZ=H8[BOX/1-F_P"WZ3]VNP G'$N.)S6V\@/3^(W,S;B)BV&<JW Z<,.!*V&<
MJ^4?/3B7L'E1QVL7*NX3@<1/*POO,?46_+)KO7E6GN2F]C;D<M(AE=(6,K[F
MKV2MZ^@56E85@HE%J+U5T#MP *JM^YR2$1M]SOHX2KW6RI8/CJCB?O9D#QQ6
ME-49;_;[881M%]IQP#/Y2.0S P\ LF>4=L:T[8\W'S,=C;#KS>D[+V#P[\KR
MZW^B%.<CJHW&PZ,=3%HKRK)T8S]H,-+29D3)+=54/FD4^=G=Z0HVN]J'T/BL
M8CL$(^Q<-]AM_P"UVC.?PNTGM.X#/W9=%:7GP.]L;<HMTY$<;V]GE;%Y1>Q-
M;[_JUGK-QH[>C([:J*R5PWE6+Y%.;>PM,B[A=-R;!HB@WCG9B+/7: !WE%2!
MR;>8JOIWT8Z@;)1B!QI=K2Q<.)!NH&'-=\J_7JNV!PE*L$'CB"S'L).*O7DC
MSWVOR:Y >3!"<..6,QQ_U%YEFH>2+ZWR]<@=:W:4@I*LZ?BK35%XV,O<)+-V
M5ZI5T>NHU=,3 0[EL9$Z0J)@(;RI$?B-](.JO1J!?AP.'$ABN2NS_P"WU6R#
M2$])<-T([ 5:FNN8?/"4Y[[YXLSG)#5\(\X8;AX;TYTVW7+5?5J_(WCI8M;&
M-O793#6,33)J<O.QMM65T9]$NX-^V85]XU;LB$*15<RDB5=]'YB+#_-6 @,X
M ! &>3AP&QS&2TM HG^7()!VD""78EP3V'%B7PXYJ*6L/-WY*7/=FGJYK/F)
MK:Y5K??&+S(GP;5VQ$5*E:E;[FX_V*QHZ/V$QU:3VG>=)TZN"@WC7+28=&&P
M,&JDDJP3(8IS\Q'^6F^8VE)[]0!PYGBM# >O")!_ZJT-Q9BP?B!P;YUN^\I3
MDKNK?,)R%H').O;?HW(7C]:M8T/;= V-8]>[#J,/8IS6L?8PNFG-MZ[BXF.N
MU VDV<EG4FKHAG4,#DK<IA0,@ =ET3Z T,)D''JN:J37DG$!E^8'F'S5U_L;
ME-MCS'G4&%CTAJ?D(EP0\QSR^?Q +;<-IT!QYV"6VZ$Y//*N^EF#V=2AMDMU
MY11DS:H1S5%BBU>.%$59%4,-NT&WEAU?!M\1*$@SQW-4<(D#@S8.,"<"2%TW
MUZ0:&(EMHZ7+C4)D@8Y'$^5W)S7Z[],[PI^W_+RMVZ]C\@*MONC3VH=IVZ^[
M2TBG HQ<51WE9F)V4K=65K"AF2UGH-+=%9KJF.#DTJV4%0B)A\$E-_';&BR.
MY<;8Q8_-[65-J6E&4^!Q_3Y<%H-XM,^8?#'9G$KAC;=NZLYQ\)MLZ)Y%S7EX
M<N-=1\=#<G^+E<I?'^RRT1(3*\;Z[#NJL:E336%2E#ED$3.G+8H+)F(DR%OI
MWV?"MZ=^U?QBO:S) +/%@ 68$$EL<W&!EB1- T[G;LQIG> 7?(]OM')\L%AG
MRO\ EKN^/XN>2YQ[@M[VV,UWRH1YSVWD_NY6R5B9MU+V/K*.V3L&CZ=;6R5A
MWR5(D;?+D4L[]*1]8FI(B2I2J W44+G9OF_-VB+,/A5![)>@<1UX]JY9'1JF
M=1/_ '6,3^R2'!'(]C9Y.LC:6Y[^8;R]M/D[ZRE.34_Q5M/.GC5SB3VA9:MK
M[6LF[L,QI"9D8W2>]JI3;[7WC6$DKS$,$I$$$A(P>(K'%ND0/".3#;[>NR5D
MI&6BOX?">9S<9]5.YM_+51MB ]GQ*5;<XD'(<@<.A;BKHO/FA<@-6\P]/ZIK
MG+]GO!M!>:WJ7@KNM64J5&UC4SZWLFIF3.W5!?6;U5W;)6]15\C7,NYOD>,7
M#D?O C&WK2)!(GM\.KJW?Q*,;,-K=^:F,<C"H&#98.1@?G5]S4:MA*$'_,4P
MH!ZZIR=^I 8MP[%>6CN9/F);1V[%V.K[UJFU!U9MGS(WW(S6E%O6B'NLK?1-
M%-)-MQ)U_I6LM2R>VI1]+6>,]0FE&C=%XX!-T+MVF8B)S<.VB-M\+HW5H_!A
M\-E(<S/S &3<0/D'%=-U4;-Y;M*R!;+>[>.> K()+$G EAJYE\%+CR4>6?*O
MEW5]<;LVWO+4FQ*%M#C0PL%YUXRNU>F-O4#DS![-GHR\/FU$K%-@ U5J\U><
MMHD(&3=O'+5_')JIJ'%=8QNW=;6N%1A83C#;SK(R),?,#CQP+@8EPO.C;89"
M<8M*-UM=@.8B)@QSQZ8\,>2LSRT?;],\X/SRC<G'",3M.RS^B[GJB5N;@K5O
M*\-HB&NS2O/:0^EU$VJFO*V/JZ,N#4WJS22 WK7=6$1&NWLVY^%RCY?S,=Y:
M+ V+:089YANW!NJ[+X6CXJ)5/^3.WCIYZ_I9<7;O6EKA3O7D?QAU+PVFH;:U
MRTEPMY">?-NZN4,%WB-;I%@X861&1?LDEY64CTBP>N9VZ,G:L4=LX:-W)A64
M2[P&*?.:$[!L/AE<O>_[+;ZCXD3%A8G#W@#@<V8#!7G7(W761#MNJ=./[3C/
M(X/P.')9EH7F)[RM? SC:%TY@[5D=K;5W%YJ]38PY;(I2YW8D;I.(M[[4;ZQ
M[\82,):M=N-*I)1LC#0#%J^D[FX<(-!;BD!E O=57';PE'WS\/<\WU@>)''-
MN.+K(RB;-W&.4;R!TP!PZ/P&62\9+G;R?W50_+J4LG-/;E//M_R3^86]=S2>
MO-B1M(>VC>6EZW8QH5SDWL8U(:OVY&=AS>L*L09K/%6ITC=0%0HUW(A7;O+0
M/_<:6Y"1)RY$^*ZZH4ZMG.?O?FY ]0(18'GG(X\0LFZCW?>=Y\L?(GW1R WQ
ML5B_V?Y26Z;M,69#9DM1:_:-^,(:):2#IJTBGL? +7F>;DZ3#5N0%WQ$B NF
M)$Q*-Y1$9;_0')V%9;M.+=F?18USU[;;2.7YRT>#,_18"XW;UV9O.A_^6CV3
MR#Y!;-&(N_)3GM7]M7)OL)]KV#6M%3;7*/U$WGW55-!0L;<'#=\I'1_>*D\>
MM'*J"?>\8XFZ=O 1OVPC'_\ YTL.9;KQYG/)<LB!L=V#F/B->/$!Q[/8Z]FE
M\_N4["BZEK\QR"<5C2>TO-D\PGCYM_?MHN$W2HNAPM,CDR<7:I;MHZ[;-;13
M8)]/R*LD5V"B"LXI'$1=.3-17 S9TQG3LF_^"N/-RY=WX\G.#JMEFC=_$#(>
M8;O;^!&+#)N:GBMR0YJZ0YI<((O9W(Q#F5IG94/Q#X_WZ>XYW&3U_;-=[PGA
MF9_WL6/13KPH_:VF.2$,R*\EY@6CGV:R:+>K.6/@^&YQH $S$/[D>+_1'8M;
M#JJU!A^)/(<I'M\%^LT/1V]/Y/1V#Z _-A:*N$3")A$PB81,(F$7!3ZL_P!
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M*0KF0<M(EJU07?+E3*!U3%$YBE* CT ,(K7]QVF?Q/9[N&I=8!=KM%K0=SN
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MJ)6O>#TE0$P?G*3J'^L,(<U!Y3:NP"++%"R.>A5E2@ M8\0 H*&  #JTZ]
M.GQX4+A[U]@]G_U&X]/7_AH_M ?@ZBT$>F!C$S'NC,HJ#M;8(AT&R.?Y&L>
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MZR9<MA:I R;69'I&"H,XU;J^ F^+_>")F[@*  ],SE'290IQTFL2Z>K_ #_
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MID'JZ0D;DP5UB>/KWXGU\].]77=.BU]VS4D#_.$!4'O#EKKIC/=6%H&(D3T
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MO+TV5 5R2+JCC[8]Y/\ =3^+O)Z1<FD)MK6R-%9LJ>X8 A+/73=QXAGJC95
MWJIQ\(QCCW BL4S^*;F[<?\ 27;;<0!9_-9,2@&SQ;/AQ5S.ROX5131_UE6X
MV\VX::X&,\<L'PY\%@>5\M38E(Y/)>ZFGV&/XAUG36J('0=(U_LN+H;/2EQU
M@WV0E;*I:8"T5VP6.VTK<1KZHYD3QCU)66>F$LJ?N))+$YZQ.V-AW'EGZ@T\
M7@*3 99$2P]JO9&N,ZS47CZ9U</.;A,]OE'9P4B>!W"RW\7^#C37MEU^"/)N
MS:85JFY)"/N,O:6E^OD%!6:LU-_^()I^O#HI)P\H@CZPDDU_5% %BF,F7+;\
MRW.PEMJQY_1TCMT51^6)5=I^#OI76?RC&8_>LG(=<B%!VE>5AR%I_E'/^*C>
M"6>\E++4=!U6SUZ>V0><UPQ<:<VZC;7$A2;$^!VVKD'+55943,&Z#<AWY.OA
M@90YQW^(3C?NMI?3CZ-NR,N#"B6JSM89<SDHVP-<-U"SW;=G?"/'SS;2.S-S
MPXKQME^6GYBUQ'9S6F[G5HUKGEN;\A);7"WR:+G<-8Y 3VNY31>JI%&,*K+U
MAMK:"K;R*5<G3!&& I1CS*$<*"5 Q-\[LG\Q_P#J)6>.D@MSP5R1*%E(#M"Q
MNPU1A[9 CLQ5X/\ RS^1E^V=K5YL2H-)'CNIS9VAMJS:/-L!Q&%UYQQNG&V.
MU0O0F:M<>-4I8]GV<@I85XJ-= U:%_7%/ZR<Q0Y]K'UKH0.$#5= /AY[[)>E
MW$1+G*/%5M(.QA(<80'[L(Q/M!'M6_*)K00,3$P43%/&L3!Q<?#1;4$I!?U:
M-BVB+%BV\=V*[I<4&J!"=]4YU#].IC"(B.6E8+K9VQ_EF3#[H$#_ !1/:,>*
M:3&(?B%]_J#_ /87OV1Q_9X1/4'_ .PO?LCC^SPBK[/?^GU%[]D<?V>'!KE;
M]"! /:5$CI9^*I[/?_L+W[(X_L\'!6((+'-="J2B)NXLFHD?H ]Q4AB' ![0
M$2F #  AVAU](9:,3(M'-4,XC-<2E,<P$(43',/0I2AU,81]!2A\(C\60006
M*L[XKZ 8OA]#%[V>G^Z./[/(17716CQ.Z54RC-V0H3C PF.U7*4 *L43"8PI
M@4H 'PB(!A%/O")A%P4^K/\ 0-\@X4C-<4?JD_H%^0,(<UVAV=@>@,*$PB81
M,(F$3")A$PB81,(J"/0/Y0_UB 9!?!N:D*)&\MI7ZC;]X;4NNRS!M4=Q;.V9
M4+_%N(9!X\DHVOZ/O]_@C1\LJL5>&6:3]80%04R'%=(1((E <I6#9O\ T2_I
M?E[)]\-/_I+.VT5;'U0'M.XKAW3,@?DS4=KOSEDJ3SWU;HU[(5<VC+\XG-!N
MWOJK[\3Q/*56MM-ITT7$N*011:;.5!F]KQ$>]XIK&9-/KU'NY7:FVT&$PS R
M!.& ./?CET*TNT0 LBY+@,!SR/L[G6S\HB(!U#H;N@(_D'IVA_(.;<5'!URP
MB81,(F$3")A$PB81,(F$3")A$PBXG[W=-W.Z)P*;N 81*03=![H'$ ,(%Z^G
MH CA%"#2<AR58\D=O5>_;(C]L:59Z_IDLSF/P)!TU?7>ZI6>GS3NKJE(P*:)
M[=4V=()'OES2?K4G&KJHE5=*>LBFE%>,!+@A($M)S4X>F2B81,(F$3")A$PB
M81.@?%Z/1^3")A$Z811+Y2[1OFL9KBPE2I5BP8;+Y34/5-Z:/89O*'E*;9JK
M>Y-ZV8.EEDSPSY-_7FYBN$RG/W>\7H'>ZA4$FZ,!QC(^ =5G(1K).;Q'B6^=
M0MY=[\Y:\7Y7<&SZY>8C:&N*[H+8=MG:,_U]$1\'I.^/KM1ZMH%:*MD45M9+
M0:;93TL[GXZ67<"HVB3.D#,T3D(?&<XR]4"1!>H1[?5B)O\ <U$=6'%:5UF?
MHB0R%AF1R%4S$,?MZ>>!/)>W>^9.U]*43S,T9)!/9%DX3U"CVS7MED8EI'%L
MY]C:5CKHRCK.R@D&$>N%5M@N5W!FQ$!/%+)$,('(*IMIUM5"]V,]_.&GE SA
M&&/98'?+2N2BV<K?1D&;9URD<P9-,3/>8.!U6-0Y@<@AYP(<# MQ034JS;99
MMYA5:X$M[+'CVXN*M'3C/9WX7]=4V0A[1!3U85P@1%MU$X>LY,_4(W=L1'\(
MVZ0>4([=B.;2O;'D>Q=,*P1M_2(-=L8#$XB4S=I?# -5(GE@.*V*\*]WSO)+
MBAH+>MHB$(*R[-UI7;-88QHFJDQ0G'#;P)96.26.HJE&/'[=1=L4QSF*W4(
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M.K?J_P"'V5791[9O MH06@F:FB4XM-(&XIB8ADNZ("/7KFGE^B" P&/0,/8
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M; 2V.7I2+<>BFUQQW;6^2.B=5;XJ#1W'UW:M+A;C'1D@*1W\3[4:E.\B'RB
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M@V#*YTH#5.HZ,9I#P4*2$HE/DIEI$QK"+DIY:#KR,A)/58QH( \D%Q5<.3%
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M+HAL"Q<(W#<VN+/+1#)N-J:6W1-(V9#H6MK MHN,?N*;8+0N1ZHU1:^/')I
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M4=+RT_.ZS692<19&+YB[K$K:Y14JZ)R+N1D'!7!UBJG <ZZHU1,(OH,];/\
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M(_R9[GPC;'7Z\N&2^9^.;[#\K6>WM7HZ]C_ BUGIR]#O5Q[HCZ100ZE)\/\
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M0T[KZW4S;M:G&K]2+DY5W5YVG;$MK79EG0JQX>;380L!?;F@E,R)8@S5"2=
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M:>B>XC76&$AO9=P\U?[@(T\ADMJO'.M<LH/EZYE+##7Y?C'8J []E0^RG,]
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M_*.5TQ;2PT\E8DDN273O!V]H=H]1[0[1_P! R3C$0/N#AP\$<LW!5$P"'03
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M4:2TA6:%(K.FR8BX8@U.FMX:YDDU.3<ZMIM[I'49;6B<SCPC$2_]J/T"Z-O
M6W5UOI$KJPXSQEP6'(+S!==7&D<<I.H4*NM[]?-K<3J)N^D7VE6NDO*35N3=
M/EK)%[ I!K#$Q9[+5G+B%>$B9/\ 7,'96;@ISE52$N>MN*/R^^LV\CY:KMQ
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MF<!!:SIVUZI<M9N):53KI;?9K-7R:OV6E/QJ+<;QZI !)MGD:8C1TT\4/ 3
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MFV%6^S]4N.F7<U>[PK5+]M^4I42K-PS.7<U]9=:+>-5>X*S4^>GOA&W=F!.
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M98HKG$!^ B!3&'\A1ST9G3 R/NLN*()(;$.MBY"%3*4A Z%(4"E /0!2@
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MRLK&DRJN![9Q 'Z>#E?;MORW^1NT]@; N:]OT$R935AM4Q7(QK$7*);NT/\
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M7R]4&0XA_@>X2]3)?N9&K=971.++&J)V&CVFJ;#<2T(^"0CGYDDSNX=LL11
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MNR2XY<=9!%@68UE3'16UGK-DBEI)F*SIM9:LXGG526BWCI87B!X9:RRGJC9
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M.31D(XS=J[9+"(M$ !(RL*RF=A$PB81,(F$3"+B<3%(8Q2"H8I3"4A1* G,
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M9ZNL>QAW *)&5OJ0_O+IQ,^K0$)?)ASS5GV[AAKZ3)M9A9K?<;;&<A&\RGO
MZCRMHM=MQ+C7;/4T'"SAHV!+[):Z\AXP'$4$6HS42EC*.5S*B<4P^HV'I[B@
MSXBXV#I,RC*)'0:8N> "^.^)2W'PW>2-<1^7+1BQ_NRVKA]8$]F*M$.%^N"W
M)OM#\:W-/?'BB+7;IEZY^+SUYKJ\VGC5=**-#A J0"=*<"H< :BI[8.#\Q@5
MZ%S04BN)$_I"3]095Q)Z@F%9',8JM>XG;= 2?T8Z1 =8QM,<.&$K/$<U*O2M
M+J>C*?KW6]#8&AZ-KFMP]-K\69=1RJW@(IF1BD#EVJ/BNWB@)^,LL?J998QC
MCVCE-U6)[<REF/+_ (?X8]D O1VALA8"&T$F7^(?4/MF2LC;FTI6-VN]2.K%
M,3D<.H=O53=M60@G4:@27M50C)V.BV<N$A&R!W,(=I8W!EDFXH+&'NB"I>[G
MS):<A .#$NOH9F4Z9B#-.L1[Q,2^0**T%Y;VB8BA16L7$A.W"!@-51VA(IM>
M&=*M:33247.O+1[N)6+?U<\3.,Y*=<-W3E^Y0&2,XC&2B:Z9VX&-7<&1E.Z/
MN  ']R<?ED%I.4I6 X>:R4AWV0D?9$J7^I]:LM.P:%687B\6.L0]=HU3K$-=
MY>/FOPO%42I1U61*PFCQS6P2[RP)QY7TBXD73U=9Z<YR&3(()AK.>J\0^G-Y
M!95D1V^L^[# ]H66Q>-052;G63*LL4YD$CG("BX)%*97P4Q-WU?"*8!,)0$"
M@/4<J"Y;DM>#\%\4W,1\#$O)>24*BQ9HG66,;N_.  'NI%*(@!U%C]"E#X1'
M+B),M(S4 N'"@%8K*M;Y9Q/J*)'1>&ZLBH'*HW18@ "U1;J)B*9TBICU[Q>P
MPF$?ASW=K3&!,)>]" D>QGP7).R( F<I3,1VNRRQHZJ#*3:UB=)=YE"?-9B<
M!$BLFL40*8/@$&B(B;X>AC%SCW=QTACA+Y%M57*M]3.I>9YBV3")A%P4^K/]
M WR#A2,U1'ZI/Z!?DPAS79A0F$3")A$PB81,(F$3")A%00Z@(8P?%1($Q(&:
MU9[B>US5WF>Z9W!LKU:K:XG>%>Z=9L+_ #318E6'8[7<.J[2TJCV9!!2/CK)
M(4M.068)N#)JO&Z3E)#OB!R#:DQA"T3'GF0S=#+/N(5+(RGZ8!\D07_A_45#
MEUNODKQN;T6C:O*6KZ\J.J./FU5J034(RJUM?[SYV2VN[Q!2,TLQ+*0A4=,V
M).8.@@5&0C5$RN5A*@50AN?5.%$*3_/E8 _!F/Z9+I,!;9*4,";+)8\I$,.W
M-^[@%D2>Y2\GW^P=8PMFL%HJ5=@N;NO*];[GKZK0TUJF_:'N=2Y#.:RV8S(U
M]2UP#E]8JI Q<_ 3#9*4B)8$1*\=-9!L?-)F$1ZN6BG<D\?-"B<H,'X2&'58
M%[(FJ _%-M,<2 ")VQ@?8<7X*,UIY*[;Y.V#1Z+Z[2,'#T/E)Q'V=6=LAJ52
MM26O(C8^NN3U9V ^LU8G63J @XRKVF"C6"K*8<2 Q+UZ5)^X64,0A-/0]*Z5
MP+CTZQS8V[6N3]?,9/PPP3UHV5B$'$Y1L!Z&K<&#]XBXYAER@N2');6FR;1N
M_85>;US8-PT#Q"UWMG9I:%96%/K%.<<DN4U52WQ)U6/@K22!<2U);5N1>-1;
M/D()&?16=)$9IAW<H1T3M(RG9J'9HC''J\5I:=>D0X1;%3*Y82V^;+PJXLSU
MXF1V3 ?YBM!2/-:=TM4+Q7V-YXR,K7*EOD[#4@Z07HE"D'*<&\L35ND)G4"5
M\)$Q:'$@O3%EL=60!_H_3L66DZ#'Z1(_I7D[]KG'-'<?#?;G'*NP[A9YR[H)
M[_.ZFK,LZJ2\#4N.O)0(5<K6M,4JVLNW-.)MG(M!(=911FW7-XHMP#*-EE&]
M%=8\DJK\&R/I1;^JIM$1MQ9/WX$9>WN6)ZOYA/)NQT^XV"N.AO3&K.]-W C*
M/U\UI6UK3K:]:4F[)>B:^K%JCU*6_NU&V#%>)^$GSX)%R@@YATY4TD5,QKT:
MY^I,AH Q8<@81/CB5>R58-0K?S5N7YN5L0XP;TVYL+<.\Z+LV->&B*NL6=US
M9X.*8)Z_FJ9(W6WPD<P767;1URIVT:VA#IL)^O3*3@/$;EDF#M9F\*1/6K3<
M!*/O1D<..2KNCZ)BP+8$GAGDN/$,I4-Y^86@DB]2:'Y50#UD5PC(IM54E^.F
ME49!U%'?%*@NR//-WA#F:B9 '9%@[#@<,RHUCX?&RP>;\U<?NZAI]BK:?_N5
ME8]V6VI\6EJ^93Z+Z/Y1^7- &[RZL"X[,/!<LE2F$3")A$PBX'+WB'*)C% Q
M3%$Q3=PQ0$!#O%,'Z)@^ ?@PBU0\0&G&.1Y;[SO7'R91AC/];0.OK+186&N$
M8E=)FBWJPNK!N_9"TU%,XJ2N4C+S_LB+?*+*RC^/0665,=$Z()17Y-N <@DW
MEVK;#DHF$3")A$PB81,(F$3"*@Y60,HD#- OS;;;U=LS7DARCVEI^OV/<N@N
M1/+-_KGDYHA%-W+JZVN:&QZ%#T/E+J:#E$_#2@XYJ5)C>XQ@'J[Z/*A,( *S
M-UXV,1961K.'J1(;D)Q)!^Z) =6'%6TF4)B+:M$P'YF$A'^(Q)Z LI[Z=Y%\
MD+CO>@52;AA;0\CLKEK1-U:W4J0Q@Z5JVIYATVT)?XRRII(NI*-V7%HQX%5<
M*.6DL6:!5B")6:A,O&F0U53EYY;(F/+U0:(G'EC81Q9N[DNGHJC>')KW8U=:
MY"Y@W-S6_P"R>)#XVXL[4UQI_EGYJ#V]R"]<7MO+K4C:G(#7IQQ(6M)[QOT?
M7 _"#1K%N%)UC^.U7J*ZC0%&Z3_UDRQBF!4V:T^?X9'5_,_-;@?=$HZ?8NBX
M-\0+!H#;4 _MM,R;H08]>843[+R8Y20&C8]?73VNTA>D:!Y);?-6J_Q_9>QY
MV\Z\YLM];P<+[$]6(K%L;WKJ9<OG;1D";QZH(R#90I1,8>C9[F5%@@(DON=G
M62#E7=?*N\_=KQZ NN7XCL(;K;FQ_/Z&]('6&W$H=F+X\U:NS^0') TQNB A
MI=*P7W6M'\QZL:MV;%Z?C&VP6PT/5.G+WJ9]6Y)O$+1+1S*3-B?1WAMD3(3W
MLA$>Z=PW4$?3NLMLE"<P8R)O@0^0KW<H5X\0:JXE^HYKPJ8T0B'SC7MCWG:#
M5_'-_%;BM-31K'I[5<^K/NK6O-:YIDF[LKU%)N\FWSNO1Z[Z1=(HMF2:;EP[
M,<5 !%/Y_7J'7KU]"4H' CRO(^,I2'L*YZI3<2&0C$=\8QB?:/!8=YRZTK_(
MC5VA-3S=SMFNK*[Y*T56D[-H3IW'7C7=N@ZM>)JF7: ?M2'2#V'9V+$SEL\_
M[.D$0]4= 9)<2CX&^I O,J T  2_%?3_  S<1E7*-F)8@!1<TON3E+5-D6YK
MO+6H:.OMNY#U/1O)#D#6JDTF*%)(T3C%)S.OMX:Y-(LWL>WUMNVW(1S8IY--
M4*^_<KQ;CHX!-;//A'U!806KD0P/1@>F8PYA=&J437&P F(+MU)(^7S=<EZ?
M+BW[+VAY?W"?86^*:,%LJ1YC\)['L*'C*Y,I)-8>'Y$0?MZUN*\1.1E*_7YB
MALAEY%LX[R;!DZ417'N$-G0=$=W&Z'\N(;KD7]I6<8R_+2J^E,D],PWL"S=R
M<Y5 ILFBRN@7,#:UJEJWF>5>VK:N>V<:UL*F:(A;]3D*E:'4>DF",C(&0;2#
M1JJ9"6'NM.]XZ8E#&&,CVK:;Z1V*!5BYE<J9^W5VN6/9[:QTM39?%& FXX^F
MHV*:/X;D-QLFKQL919^R:E5(RU;L&.3*R/V>K^,HSD3KF%,Q>_;5Z=KN+Y!S
M#6W-HP$RW:[#F1BRQG(C<41&$9 /_3^F"^+@+L+:M]V/6*W:I!W"UR9X2\7[
M12-5Q=(;4VCQMVEK+M.'V<O6HI.)0<PZ\0I%1*+IB+D1:IJIE%,"=P,]6O\
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MSD*LRFK*WHLO66,"U:^*>,C' **N$#JN4C!2O3.O42UFHAN@9B_5\N"TDXD
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MQ['5*X&$I&1?47'0<E*'*@N 5HF2BXG PE,!# 4XE$"F$O> IA >Z82]2]X
M'X.H=<(M?/'B!MT-R:W"\B>0=RVCIR2HM>CG-<V%=HZX*'W[#6F?4V!/ZK9$
M_O-,HT'7';",DHUH!(@DH)4VZ9%6S@QXAYZ]8_3O27EGH6PC)1,(F$3")A$P
MB81,(F$3")A%"[F#<K=3)SAX-4M<S6D+?S%UM0[8RC'+=!K:ZE/4W9#R1KLP
M19LNHX8+/(=LMW$S)&[Z(#WA#J&5C/3NJJ]+BP6!_JZ:IV.W%S#3P9WZ)9#5
MM;;7QK](M];5?540_!A89\7TMQ<::-^\T.6FO=2J[<I4]9%ME73>OF(ZLNE(
M.J#^%UAK72DO982BW*%K*Z9VL*\U-!52+DA>>'U>JS"JCLRQ7"0%I4#^4I)_
MOJHS?ZA-T8RCUP</A[%%LFOW0 _DV0@,??!KA/5T8S(;')U,;8W(S=.GM?\
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M+(CY#^\5F5.(BWM>)%M$6B,69DBC'IL$T4635JDBF6/!@BW J"+5!$I/"*F
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M")A$PB81,(F$3"+B8H&](B'3XNGQ@/Q?DQCP591$HZ3DZ%*!>P!$?S_G$?\
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MM_FSN*PB7B"L@ZTLWLB5&)<GZ,I=4I4C"( 1N^]"9C=?T2+E#NB/Q],XMS3
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M@^QL_ON$3W^T_P#8K!]C9_?<(GO]I_[%8/L;/[[A$]_M/_8K!]C9_?<(GO\
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MA;/L&KNWT/M"(C]W7K:#NI/K1./)U\5[6;3>K-&U9>>G63@QG+1JW]94043
MX@F8A:TX;<#@HM!.X<YLIR992F$3")A$PB81,(F$3")A$PBPAN2MZ:LDCJ$N
MVWD(A*0>UH2Q:>;2]J>5MRZVU'1<RG!FKS1I*QOXCGV\,ZD!39G(Y(9$RIA2
M$ $P36_K 1ST2^1S[,3R&*G !SE^LL/$L!U(&:BZUUQY?TMN+=T*M:*98]L_
MAZZV3?%!LF]+E8VC&LVF."%NL_9M8V*_/J;"Q:,2<K-P[2C42Q:0E2*9#J4,
MQH?\L(\ 3[2WM. ZX#%9R'X@)R8_K_I4>IC77&.VR%XL5?+ 6ZJDE;<E<9I[
M<YF=CYH)37L92+$CLEU*3!BV!!#6S5JU23F05(QC2HJ( F7NJ#[E3"F(ZZ?O
M L8_M X$9@KG/\R75CW-GV=5B,*GPU_"I9T)NG^S!M!"DO2=[F M@V0-<FK2
M,86W!+!;"E+J0PM ;>-X/X>$3]T$>JF:9/S&?1L2_)@Q/3%9V9]H_7^H^!Y%
M;<.,D#6:[IVK,*6TB8^H)-&Z559P -@@6]98LFK""0A/4S&:#$IQK5,&XI")
M#)=! 1 >H^;NW]5CFP730?P^\J/_ #GURUWA6Z-58^^Q,4-/O:5QG*LM[P6W
MXF]7@)F(C$BVW5-]UY<ZC)0#N6%ZW.C('0753!-P@8@@8F5=!G/)G5K+=$<,
M5%A_H31T09OL.T0T@O;ZVR83EFVW8-A[%//2+RKZ[F]:EMD\[<W!9F=\RU;-
MN8-9ZY*N]<Q)$B.W*YDBJ!Z5>SC7(W$CKW<UA'>&RD4\<5C.D:CX8W@6L-KU
M&GVYY#ZMX]!$$@+W8IN5K6K:$I,37&6<K[L; X?0,=""=^XKDFU,DLH0ZP L
MH43 /7"K;3E;.P><Y^'ZL>Q9SN]*%41^F+?*6[665O\ (UI>ZE72-I<95%[7
M$JD^62D;4R*_@4]D-]OF;2CM";9E>NG6S6Y)QR\5,9VZ??/54.4QBCR1E5"(
MC$@1X8J;B962D<G4F=?<.6=8G)6TQL5&UZ>L<8PAI>:D963L4\K 1,I-3<7
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MTV5@XTR0HN?7#>*"2*!A3+AMXBCTHG&%?Y<]2=N) =T]6./!+HO&TPQLF;B
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M>1U'(/&#F/1>,S@7H0R:A*2CJVM.V/\ =[:=<C]:4H&(F.3'%B_BMM7GNG'
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MF(2;C6$S#2Z$C%R\/+,V\A%RL8_(LT?QLE'NTUFCY@^:JG2525(=-0AA P"
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M*1;P>A->1328GEK1,L&4:Z2C9JPKS9+*K,3$8+XT=*O36)(L@ N$E2E?$*N
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MBH*AMHZ-O#1"/N[).7O"Z%RCD*G#T08^T%=W1Q[=8NJ? ,X]PDY\0CAN@4%
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M5&(FJ?+,D/P_!TADO"O!(:1CG1W(D<"1RJ3)JA#;FN,/[N4Y1?'&=\=Q)_\
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M7 SC7K]^R$9\LP8D?*#@RB9;_,PHFL]=WB;VIJ*T:SV)0]\07'B5U1=KYJ.
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M*8U'>5&0IM5?4!:"<41W7(1Q2UZOZE^&EJHM&M5*\I7_ &< , A3Q)DA:@B
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M!K*GR(1YBCL&KCR/18I5(%3UB4)KTVO4M.JZO&",R]I^VQ?&GE1LHK^()0<
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MB*\;D329R4J_(*7A:RX;NG-MM:FP&CMA%BCZNK)M(H3'=))"HL&]TJZ:*_2
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M81,(F$3")A$PB81,(J#V=1_E_FP5'%89@$O5KVNB;K\UU*E#J'3KWR&4#_\
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M*E2=+O@."37H/W'QG>;7>_E_]57 QA&FJKRL'W==8K!DX/D(:19B<M2_//\
M2/P>_P#TUM]Q_IR7FJGO=S.CBU&XM-GFRQB2P9AS<J$0\P])!_Y@8G$@M*WL
M3;AV!#EM:>P*N72R*2>@#VTI4Z(,-^($^D,F"'0'?0'@>)T[H],^W/\ K#XW
M'_\ 3-?^E);7X<=AZYF=P*I?F0=3L)F>G2^3P=L'7YH/_P!+_P"G9?\ [\'_
M .U;-_\ %9_&Z_/';FZ/Y0'\M^7;TA6):1#S-ZGOXEQ@OS^\F[I9?-=\Z3D#
MQ/YF<V)WAAQXU%=]C:]U75Y&7)"5992@S4?782O1T=.2]=J'XWV2D)YH926\
M<QT?U3<IP\(F<&SVT?@?^FH[K:[2.YW-@B23B[AR<,6'(+].W,K/B/QK\O?N
M8U[4<L"&X8X+](7EV^7O$>2KIOE_R*NW,+9?)73T?1)B]5&MGE73*BP.MM>P
M+ZSJNVE</8K!6W>S)]XB=D5^Q609^K]PH$ZJ'[GQ/QCXG_\ DFZV^UHV\*+I
MD"6D<<L,<O:OHOAVR'PF%]UET[*(8AR_B6^3O7Y^N+''/G__ .99V9M?D;R"
MY.V_0/$&F7-W4JK2:7[0=PC%XHDVED=?T"D-Y6(@'J]=@GK0TQ8)@SQTJX<%
M A5.HE1^M^);OX)_H_:1V=%$;?B$L]8?O)#''@%XFVH^(_ZAF;9V:-J.(S[E
MW<M^)G/;_P MC<]7\I^,/*B[;QXLV.\1E-N5&NH/V<2=\<'$NA1]@TQ63FJP
MI'6^-8.DX^?BQ9/FCM/IW$Q[GB3\)W?PK_6)/P[>40JW0'E-8;$X N7R+/DJ
M[O9_$/@4XW472GMM0?47P!XLR_=?QHWW4.47'_3G(B@BH%/W-KVK[ A$5^\+
MEBA8HQN\7BG8F(EWWD0\.HU5,!0*91$1#LZ9^8[W:7;#?7;.]GJL,0W3FOMJ
M+Q?MX7PRD LYYS+=,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBX*
M?5G^@;Y!PI&:HC]4G] OR80YK\P6T-Q3.DN0O('G6]0 MBK?F!5#0\Q,S]TB
MH2MDXPU=O4>/TI28:MMTIFS2X%LMH>61XLJBV:MI%$%40.('$_W%.T]6B/PE
MP:)[$7@$8BPC4X/L7SD_P]\?B$ ]IL](OC$1!; <)=7[EKR Q#_^<5;*)G*H
M16%\1-0ABG(HF?ATL<AR&*(E,4Y![P" CU*/7/7%<H__ *VU&6/KY?>7FP$_
M_P PE]7TAX,%,CS$:[_Y=;G9R7W+J[DUN6E:<Y5:GC&,3;]X5FW>[DDU(-HI
M4GL%:VK(R&O-E637Q4DT'S%Z@H^;*"#8AC>&<J7D_!Y?ZR^$[&F_:0E;M+"P
MC+S!GP88,XR\5OO_ /\ &MY>:MQ9&&Y!Q(PQXXY''CQYK3AY(M*V=OBW^;3Y
M<.DMRV?</#VV\9]PUW6]UL:LK&59"[J64*KI6\QL/('50IZM_9.'!G[5 B97
M#5MXPI]4@Z?1_P"I3M]C5\/_ -1V1JAN/4B\(!OVG'3Y5YWP:&XWMF\V%4B=
M@V!EC)^#'#ERR[%F7R"O-CU/Y8D/NGR[_,$8SO'B4K>W;';HFZV&L3KQC7;6
M^81D-;J5>XV,8NIN+36<5]!U$22;99FZ37,!C$+X1C<_^KO]/7?'(C_4'P6<
M)TS(&@EY#LR5_P#3_P 5AL1+8[V$H1&1&![_ -/Z+C\_CS@./7F':[UAP"X1
M7&&V0E=-JU:W;#W%952:YU?&!7$WGX;@FEIV!^'DD6Q)5_Z]*R*Q$&K1LT!,
MBBJB@D"?]&_Z:^(_"-W/XMO:9 Q@6#\6?YF"G_4/Q6G>TQVFW<UF0<_)_2OU
MC^5S6]1:XX,\>M):;W;KK?T)HG7M=U;9+_K&UP=OK3F\0\<UD;2T3DH!Z]:H
MF2D94QTT3F*L#91,QBE[W3/SSXU.^SXK=;=5.OU)F7F+G/\ 3Y%]7\,C5#X?
M7547TQ'ZRM@V>:N],(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBX*
M?5G^@;Y!PI&:HC]4G] OR80YK1IMS75IM>R=M\ )*K/'M?W]ROI/+"-MQ'*;
M>.:Z":637NSMMK.0.4 6>1.TJ.\@_#2,99-:<CC*)E2<$4'Z7:[D #XK(X4[
M?T1^V(Z8^SYUXQA"-DMI(%IV&8QYXGN4]?\ [=7#<>78<\?<RP_S6^%X0;9_
M$MS]?!,:D-%[OX?_ !%^$_\ PH(L^OJ'7N?._3 #9Y8^+;__ +9_VG7_ ))]
M6EAGGGG[5V#8;<;T[]C^9,6=RS=F2B+R4\@GRLN5&Q)?:^QN-Z$)?;+)+3%K
MF]8W"VZV1M4JY."CN3G8.KR[*O.9)XKU4<.4VB3APJ8QU#G.83#Z.Q_U5\;^
M'[6&SV]W^7@7B) 2;O(=<6\^ ?"]]>-Q?4/5'$$CQ P4Z.)G"+BUP:H#O6G%
MK3U:U16)1\G*3YHD7TA/VB510]61D[3:)MW)6*?=H(B)41<N5"(%,8$BD P@
M/D?$-_N_B=T;]Y,RE#(91'W1@N_:;/;;(2&WCIU9YE_'YE$3EGQ=\N#F/8SG
MY2<8:OM:X5LDI'!=G-9?0=J;-H(YVYH]2^UB6@YN18E(3H@@J[531[Y![J8F
M <^N^$_!O]2T[<7[&Z$(R; R!'F^R06_1G9?FOQ'_P#8/^DSOI;+<0MEN(PO
M)F($#\*3,#@,CGXLH:(^2SY&[MF9VGPK151 #&%(;_M ZP]UPY:B@**6TCJ
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I?:\)X)]KPG@GVO">"?:\)X)]KPG@N)_T3?\ %?HCZ?1Z!]/Y,)X+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>g68105page181.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page181.jpg
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M 0$! 0$!           )  H(!P4& 0$! 0$                   $"$
M!00! 04%"  $!04    #! 4&!P ! @@)-;=(><F*$1(3%1DA%!;6%QA8F/!A
M(B0Q4;(C=29&-X?'$0$! 0$                  4$Q_]H # ,!  (1 Q$
M/P#2?KEKL?VG7MM9 D?9W=1%4&[N]LO&3;0(RVMER-V4W&/'[P!0VJ@(3/:R
M\20TLHG$ O9_V@L<A,\LLLKWO>A73'TX69_*[D1_O//GYHH+Z<+,_E=R(_WG
MGS\T4%].%F?RNY$?[SSY^:*"^G"S/Y7<B/\ >>?/S107TX69_*[D1_O//GYH
MH"Q_#4C_ +>?G'[J-Q/G7U3?V"_._P!R\F_-_P!!/JA_@;XWW_YQ\?\ 4[\
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L]'WCWOLHN%<E[_Y*>'_F!O\ H#J-SCS>@J"H*@J#U3_VY_\ 5?\ ^J4'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>g68105page188.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page188.jpg
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M<8S:1T;E=U'Q[!L@R8L65"H[5FR9M4BH-FC1JWC4T&[9NB0I")D*4A"@
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M.);&L[[BP5\0BJ2*#>?3R-)0]?26B'U%8PS!O9TE$FCV* 'K==-<R1GJA]E
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M"ACU203,!TS3XG6 "'$=BB&P^(^C0$X#Y1[O@$0 *Y7A$?  _P!GW(_I'_\
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MB*C\0.0DO5%P@ _3%I\Z9?#X1 = 3P_RCO>\4YRA7:\( 8P!_P#H_9''P 1
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MH _WCW>__!RO?]WW(_\ *'0!_O'N]_\ @Y7O^[[D?^4.@#_>/=[_ /!RO?\
M=]R/_*'0!_O'N]_^#E>_[ON1_P"4.@$M9OE&N[(<SX[L3_W49S-6HF86*C-;
M"=X:QS2&DUL62LW)377L92M31813$P**J)%00=&,;U3@.@-O?R>W='E;N4;9
M<^-$]266I#ZE)0B]6@'D 4R-B96!9\F^2=3LX#D4U8E,4C%%/8#& 0'P$ -C
M^@#0'"X<(-&Z[MTNDV:M457#ERNH1%!N@B0RBRZRJ@E32223*)C&,( 4 W'0
M$,C,B5J4=QS1(TNS":,8L$]EH":B(V<,5)1<"1<A(L6[9=59LD95$@F*=PB
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MD# QM;C4HR,2.5$IU7#APX5.X?2#YP<57DE)/%1%9[(/5A$ZJIQ$QC#\
M!F= 4+[TI%DFVFX@\6BK(O.SWO7D6LT8Q?,,64;5<:MGT6F7IB<499>5;JG$
M#  &9$W =P$H%1_D=/[R[AO\,Q1^Y5ST!NLT : 5E4^Z?EG^U4']Q'^@&GH
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MMVMMNC-NW9M,)6)HS:HI-FS9O9<;(MFS9 A4D4$$$K45-)%%(H%*4H !2@
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MF+N!-0SWW5,4V(S/:RN@#I\QCCNDKA62M2O)59C'QR8E]XW"R21Y5R)#*#N
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M*G;I-27CEYJYM:7<GIB \DTU*@\%O6K6MZA%+<@4# @[ "EED4Q.8"N@4*H
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MKI^S*!.DZ<1:M/+'JJ")1/R:@_6X[" ?3!WW\-@,;A+[DU!_BZS_ #^@&EH
MT : 75CR$K6UY$J]$O4BPBT3.'$W&-*Z>),W3;@Y7725>V5BYZ3<@B!Q,D78
MQ1VW#81 5YNZ.DD1774K%]23;"3K"M&5](Q05.*29@(I9RG.114!(4P ("<!
M#TAH#OH=Q]6=$%5K4[TZ3+$>WS';M*NL4L-U%TO:(F);#%!N)VRFP^D0*(@
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M_P#!\:V@,M.0UIEV,=&C)U!5BNU\I;VDM4)*3:SJ*I42.THQ$EO9%AT5TP5
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M7M\HW.@SI(K ZCV4.NW'92Y*H\.8;#OL/PE$! ! !V_&/+?>FRA_S2E_RWT
M?&/+?>FRA_S2E_RWT!U']W<2K)W&R6',D/H]\@JU>,W4?2%VSENL02*HK)*7
M8Q%$U""(" AH" 1N3[%0W+:"GL;95?U5ZY08U>QOD*>L\C'#@YDVM8LSP]W.
M*@"?BFPD5A+Y@3E;KF%P!%' #*^,>6^]-E#_ )I2_P"6^@#XQY;[TV4/^:4O
M^6^@#XQY;[TV4/\ FE+_ );Z C3^\V=6TUV00Q_DYK%L8NR(R,'T*<"DPY>G
M@QCGA$"WCBJ6'*U7 1$!$HN0 /GAT!D.WJ06E<)XUD7$3*02SRKLECQ$T5FG
M*L.1E *B_38/'[1-QQ !,4BR@%WV$=P$- .70!H T : - +RP6"3E)-:FTU8
MB<NF1(UCL1DB.65-9.2 HGLF<#(/K2^0-R9LS;D2((.' =+IIK@2F @(RLQB
M,5%(G3;IG576665.X>OWKDXJO)&1>*B9=](OES"HLLH(G.<1$?@#0%8;1#ND
MK3V\,K+-.K"[8&M:[N;C"%D4WCHEJQZ=BJ[=N45U&\<111-)94 *(; 3D4#;
MZ :V0XYC+WG%,5)M47T=(N;VT?,W! 40<MEJ8^*HBJ0? Q3!_7 0 0\0T!!X
MEZ[I&<RUZQ/EW\$]QM&,*M:7IU%7"2RUPD2,ZS:7A]R^T#B<J4>].(>?X])4
M?- 4SD!P8T 0HU> 0V$&JX" ^ @(/76X"&@,-B;]JK?^%/)_VYRV@&GH T :
M ICWA5J4=4O(EO;V-BRB8/M-[K:_*U91PH22L+FRUFGO8F5:M@^E.&=9&MN"
MKF-XI'?I<?GAT!2'Y'3^\NX;_#,4?N5<] ;K- )S.LNA7J$E/NF[YVU@[QC&
M7=-HQJ=](KMHW(U7=N$V+),04=NC)(CP3+XF'P#0&*Q':HV\62]7"'1DF\78
MXC',HQ;S$>XB95!!>#D=D9",=E(Y8NTS%$#IG#<HAH![@4 $1   3;<A  W'
M8-@W'TCL&@/W0!H T : - =+X?U[^<U!5]!S-OJ!/RWT9M20^9SZ$!H T :
M- &@/*MVI)0:\GW5HV9=VVKBO:IW)ISSE@F"KYO#GN=1+(K,TA35!1TDT$YD
MR\3;F  V'0'JGXE$P'$I>92F*4^P<@*82B8H&](%,) $0^'8/F: 5]P^Z-B'
M_.%T^U%YH"J>-#YJ/W$VX)M58,'HY;O!*>W48UA%,UD/!S*CMR@]:B>T.@\R
M,D0P.3 D42^!"EZ)C@7)OG[51/\ '6@_;G!Z KY 0T78:CVP0DTR1D(N2KDH
MV>-%N0$53-C=\8!*=,Q%D%TE"E.FJF8JB2A2G(8IB@( /*(E)&JR#.J6EXL^
M9O% :U&W.Q 3RH@412K]B6V B=I12(/27'B233*)B@"Y5$Q 8V@#0&I!*SIN
M/E0;KBR2K-0EH"W5HDB_?R4,N[LC99CB&@NTPC))%4A8PJ3B#;"1<P;DYJ%*
M('.F8H%V[462I%\PI"O9)Q*4R:R6]:U]_+O#.9:N3?Q89).WKKV1=*&=S49+
MI ?R*RHJ.D%T^BH=0JB0I@,>1^[+3_P99(^VK%6@->/RF5Z3QNXQ;:E&-0?D
M2Q[GV+63NJ""\.DUE5<1(.5R X7;IE?(D)R3W.!1 # (@&YB@7GM\.>C56>M
M51!T>O)U^5?66F-3+.V"\8:.=.'<O4&2AECQ4PP(<509MN+9\F44@2!<R:A0
M)UBXQ#XSQT=,P'(>BU$Q#E^=.0U?CQ*8/Q# .^@)UH""6"?D74@:HU$R1K 9
M))67EU4@<QU.CG("*;UZD(@F\FGB8"+!B(@*@AU5>*!1$X$+R?7XZMX7N\='
M%5,!HIP[>O7:HN9&5D7+EL9Y*2CPP H\D'APW.<=@   I0*0I2E J7W!XRO<
MQW+4&=CD$$:W.RE-3*==. %&9<5!ZWFW#8\F_ML4]A5H5)NJZ(4L<^4=AZB'
MK"?B!L?*JD8P%*HF8QDP5*4IRB8R0CL"@  [BF(_#Z- +C%'UL2?X0<J_P!)
MELT R1(03%.)2B<G+@82@)B\@ #<3"&Y>0!X[>G0'UH T : ZC]@RE63N-DF
MC=]'OFZK5XS=)$6;.6RQ!351624 2*)J$$0$!#0"X8/WM ?-*_8'3A]4GZZ3
M.KVAZJ9=S%.5S@FTJUH=JB)U!4.8$XZ04$1<>#=<WF.FHY :6@#0"OL ?^EK
M&@_"%7R9_P#AJ'H#YPE]R:@_Q=9_G] -+0!H T : 7<_89*5E%Z93%TR3"14
MALEB%--RSIC-RF55(O2.!D'MI?MC@=FS-N1(A@<. Z733< 2JOU^,K,8C%12
M)TVZ9U5EEEU3N'K]ZX.*KR2DGBHF7?2+Y<PJ++*")SG$1'X T!FM 46: XV[
M6P;O/)DVN/F@*<4A<M2W&D&.U Y"F5 IU"E$P%V Q0$#"!1'0%D[E]TG#G^<
MKM]IK[0'5>QS&7R]*QDFT0?1[[$K-L[:.4RJH.$%+9) =-0A@$! 0_K@/B'C
MH"LN+<KVO!TS7\>YJ=).\6Y!EGB6$LN[+D90KZ0DGBC+#V2'3M=P=G-M"_2X
M:575%.52+TU#@X*("!:?$W[56_\ "GD[[<Y;0#3T : - 4([TTH44YE9==V6
MQ)]G7>TG&-B)@+%6%5J^,33B[A7@(D=MWR,>5$O(.1%51V'CN %2OD=/[R[A
MO\,Q1^Y5ST!NLT @^YEF[D,0R[!A$$L+U[8\?M6D JH**<VX7OU:32B5%BOX
MLR17YS=+D#EN)>6_4)Z0 A_:Z:5-$R7MRO/JE,DJF-T9.M2:+IN_A7K>)ED%
MF3I)Z\D77,AD]P,=PMU"B!P.8# .@+6: - &@#0!H T!TOA_7OYS4%7T',V^
MH$_+?1FU)#YG/H0&@#0!H T : \K_:5"$L$QW50;F1;PC:5[4>YIBO,/PV91
MB2ULJI3O78G41*""/I-N<H?BZ ]3X#N #L(;@ [#Z0W#T#^*&@%?;P$<BXB$
M $0"0NFX[> ;U%YMN/P;Z AE4(;S+/U3?]H+)1O0/SOLR]^MZ/G?#TZ :%[
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MG@EPTCD7#Z1=(]Q<:=)E#D6;M&DLX$*+LFW=R#UN@(".R9UR[F,(@ @8U_\
M*>T24A%PE(_M^>0DD5&(=INNXV)7CW;IRD12:B%!/0A36-'1S@BWH_5!3@
M3TZ XJM\HPA#I'@TTL.V5KY-U-5<ANX CV=1J)4S^RUY1V2ANCR4<HJD8A)
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MFF11(R:9#@8!,8H -+0"RLUEEY666HM%6(G.D31-9K.=$CJ.HD>Z3*JD(I*
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MY9>J53.5.9-?F*TW/*(@NQJ,<YQU0Q26$B@"@_L3U,HBS9CN4@;+N !("$6
M=L# QM;C4XR,34*D515PX<.%3N7T@^<G%5Y)23Q416>R+U81.JJ<1,8P_
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MP[@00 "CN(: C44NDZ@G3I X*-W67\NNFZ@;@"B#BJ9"704 # !@!1)0! !
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M8HB @<]8KL=4J["UB)\Q[,@8UI%L1=+"X<BV9HE13,NL)2]14Q2[F$ *&X^
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MJ@"GSI7IB;GTT'-;:3..); ^>:M>WSL4Q*W<3CC&804$) =).C-K-'MI4B_
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MTKE]TG#G^<KM]IK[0'VG]VQU^"QA]MLEH#,XT^L:O?X*O^S7.@,-B;]JK?\
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M&/V]XI.8%2%35 QZ=%&'JID]1-7<?6*'@4VX!H"X&@%G0OKBR[^$1K_1W0M
M9&RUI^+\ELJ1V[2UM4"-W+=P<R,7:XM$QU"P<X9,BADSIBH863T"'59*F'8#
MHG614 RU6M4;;(]5XP!=LZ9.E8V9AWR8(2T%+MP(+F+E6H&/T7*15"G(8HF2
M71.19(YTE"',!)= &@#0"XQ;'.JU1ZK6YLJ+"=182!SQAW391R)$9%11=1(J
M*J@+I(%?(\S$$Q2"J4#" F#0'0N7W2<.?YRNWVFOM ?:?W;'7X+&'VVR6@,S
MC3ZQJ]_@JW[-<Z BF/I>.@:Q>9:6<D:,6F4,FG65,4YS"92[2B2"""*13KN7
M3I=0J:*293*+*G*0A3&, "!(8>'DK')-;;;&IV@,SF6JE46,0Y8$IR&3"8F
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M$BR:R*0J-6CI,$%$U')C% ]4GR25/6NWR;G:!8\A-;_#VEWB1@T<,#Y%RI$
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M09*WSR3%]TUC>9%O&'.+<J95BJ',!<"<HD#8EFB\BM9B*,FA62 1-XNU>3%
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M-$3)L:OTEF)X9.!4*T;76TM8IRK&HHH(D6?Q**#@ZQ"\'1E17*(@H B!L[T
MLZ%]<67?PB-?Z.Z%H!F: - 0:Q5Q\5^%LJ8MVUH;H)H/&JYQ0C;9&("8Y(>9
M.0IQ271YF%D] IE&:AA#8Z)U4C@9NNV)C96!GC0J[9=NN=E*1;T@(R<-)H@4
M7,;)-P,<$7*(' P"43)JIF*JF8Z1R',!GM 4@BV:+L.V+S#-Z\1:M[F[$C(Y
M$_+*HW2B^6?N]VKE0S-HY,4QP)TQ'< $P$Y;@6)N7W2<.?YRNWVFOM =&3EH
M^#RW)RLJY(T8-,51HK+&*<XB=6X2"*""*293K.'3I<Y4T4DRF455,4A"F,(
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M: M-DZS5:0R-A2UJR,B2O-XVXR";]G#O5#BJQMF-DBE>MEVQ9!HQ47(*9A!
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M:C-K]4K?:,:62L5K*-,B8*5A7U/<VP8=M'O8.5?/7*-CCF4C.H(NA$@' Q5
MW24(")P+5Z - &@#0!H#I?#^O?SFH*OH.9M]0)^6^C-J2'S.?0@- &@#0!H
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MRA>IF$OE)),Y*HE6?$M=?=T:*G8%NLULIOU4B;BJU(LLT55X%,(#\IEHS)&
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MH9XVD8^,?I1+<B[]@(&C7LX\CX]H\G'4:H0BB0JG*05DR*J%45(4X ,/0!H
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MG\))UE])Y!M#YW79E2,5EX-PY.S55BI-6%D9>'4?,3&Z:HM73A#F \%#!XZ
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M5C5WKIC 1C2+:N9%5)9^Y2:)%2!P]5;H-4%'2PAR.)$DR<A'B4H;  $AT :
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M1G+MX]KDG#5GDJXC;)FRD&8CI;,L1(FKSF[3)"-UG[>$)Q 5&H'(0H*>)=]
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MLC&U" ,A(VFNMVLN\5\@V=P*KP6A7JAT&+@#TFY#*8.WZ4*=!JV,%&B0,V9
M ,FY@;1X"@T &[0 ;)#ZJ?TI+U #U"^@ 'IH T F>X:.=RV%<BQK!LZ>.W<
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M[ .SZ#@F3=G%H=OF-'!4$/%)9S*5ME*2;TPB4G-63DGJSA4W$H&45,/$-]@
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MWG'622\SJX+7@7L>N-MT:Y-J+UY<^";_ +!M:G>WG%5DCTC-,:XXA+!#G%W
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M-0W(!CVQC+CZ>1BB8-@T!MGT IF&4GLNFZ=0F+LC2\<WEIR'2DVRF.FS5\M
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M=0G#?YG+?COH#7)FV0KK7&N7W-C2"2KR%([T5YR.:N4TW3^().5D\@S;'!=
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MK&,X4W,0@&'F;Q\1W 661J33)_(^&C3M1K$T9JM<F+8TM Q<B9NR3J;PY&:
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M6HV)C8%ZG5K1+-9:#M#Z0E89S7EX-0C5\W4KT<@W=KLYA/GLON4P_2P53W.
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MQ>\%=T%BD"V%Y36N55VWL584Q8QUT(P1A?>+J^Q"-!G#^8%'H>TS$\.J*!0
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MJBBU:$49[I%,0W/0&RS0!H#5QW/%2-\HOV$=9R+8GN3W/#ON.R@AC\G%(P%
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MVQNUWU7?N$F54M;U4RSABX6,";6K6EVH(F.Y.803CY!0?U9X(+CYK@=T T=
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MI6+MLQY8)FQSO^-HJ1M J+2*\<Y;"9&06,X46E&/GFCTK=ZHLY,H(B!TP/\
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M]J?;-!J^^5@>0;..[D[1,$>R2]+="LPE^6,XDK)NW9'5-UDP<B*A (!-C\M
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M\!$0,4#+=R%UB:A'-WKC(LY7)!.7Q^1O$JQ'FJBW"1O,/'%LDN[9U"0E">R
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M^&CDM/E/+SMOCFS<K(J734U#64EI/75/@UXJ/'Y"^=0R#VV6A/XW'>8(V/\
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M)ZI=QL383R+6$7=.(S$./9&)28%;S;. ]FR*"JC5R5%8K@QCIJJ&,='BIX>
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MW>3?*%:'(1W!NF,.1N45TA,#Q38BFPBF!/<6C]+R#^)E.Z 'XGZJ;#X?UQT
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M.#)O*X%C@T56" "N!7)I154(]R!P3(/!,1,'4\?0.@%IDJ;M+#(V&_8]'7L
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MD3(]!D*K2(YOCQ2!2&VM))^_83REAK[&?:(HPBCQG*Q:B!'1D3F4,J0QDA,
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MO)SLK3,V&3>>!FHXCK4T(GY8'!GY7-JQD11D4P;JM@$OTP52@( !.)]BF$P
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M@GJLZ.D5$7Z[MR:X02[N0?JNWS=Q(R"W3%15RNN=8Q@YF%0P<3 =B'^Z_?\
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MW""QEH)) S8D>8KMP0J94#I(&3!0A04V$H?/[Z EF@/P1 H"8P@   B(B.P
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MRW434 O-,PF244(<!F: - &@#0'2^']>_G-05?0<S;Z@3\M]&;4D/F<^A :
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MV;%*X+X:"KNYF1<2*#Z'NHSQ)16G6!6(3:$3F%8WRQ&IG/F.H(G!8$N&X<M
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M9=2SG[M0(MG^)!5+E##PF(YBKD":J7QHU(%4TU$9@QD5MAY%,)3E]782^.X
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MN:JMC8'(I"0V,5(IZT?Q[R"3C'L4Y(6-B4F[9.19M&J[(Q4DW)DQ B8@5%(
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MVP=4*F]E49IRV<VF25?MVYVJ)O;UNG9Q-N1-0QCF\FE(%1$X@7J"03 4H#Q
M"8XF_:JW_A3R?]N<MH!A2\O&0,8^F9E\WC8N-;J.WSYVH"3=LW2#<ZBAQ_\
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M8Q=XMN-OF[W;SV_)V0JW6I[(EN>+"SBW,JVD["UCH&JQ:YP1A:I6V1A;LD"
M!SD 55?7,(% 6><TYV*L61+S)56O2-86JKF#@+!1GGM*UJ(+Q$:+I2]1DG(-
M6*"2<DT%NS<1X"KT^)%A,00V MBIDEBF03^[EK.( B/3(QC3*;K1AY(2\?:P
M!R0,3RJ@;^J[$$_'Y[0'ZWR7#*/HAB[C)^*&:D'$8T=23)JDR2=(0IYP/.KH
M/W'E$5VZ*J29S@!3.4C)[@/'D!-/;$3_ )4CO^>MO[KH ]L1/^5([_GK;^ZZ
M /;$3_E2._YZV_NN@(Q.7Z'A7;5B1K*S;ATS>/@"!:HOT4$6;ABV,1RY.Z;M
MD7"YWY122$_44(FH8 V((Z Z*V2&*)A*%=M2VRSA'D@QCE"F!"1)'@L41EB[
MH+E/YE,W_":E$^P"''0%3X^L%L\VME'(>(8]KG,MK91\-9*LJHM$)4B/M;FO
M04C*-+-/K09)UK2)5\9RN+0ZZ+%R;H&(<P$* TLAXFI6=;5D2JV453)I4K$T
MM6K-!/ ;6&FVB/L&63QEGJTPW$5HN;BW!2F*<@['+N10#$,)1 B^%KEDUCE0
M,19S;H+7FI46:&MY'9@V9P&9:LO.0 -9Z.C^H56.M\4DQXSC @'315.19,02
M5*  7,T!43NBV]HX[WVVZ-IWY"(%V]HT??D)?6 NWIV\= =?Y/;;_87[1>(D
M$H]O&)Q**9CG3$HTV)XBF93Z89,0^=$WK"'I\= 7#T : - 0&>@9*.DE;?4$
MB'ESIIEGX RI&[*WLFQ (D J'V1965DB'%F\-L50H W7'I<#H 26!GHVQQJ4
MG&*G.B<ZJ"Z"Z1V[U@];G%)Y'2+-4"K,I!DL42*I' #$,'S-A$#,Z - 4ZIU
MB+7E^W'>/<R S=;R9 D\NJV1!F+VS4A07S@[I1(@MFY&P\BE$3F$0 H"/AH"
MXN@#0"9C;S4L:88)>[U.L*U4JQ"O).;FI)04VS-JD]<%#P*!U7#A=4Q4T44R
MG676.5-,ICF*40%-VZ"XR]7E<EV*+E(2LKY(R'8*5CZ?8.8V69.#W28.SLUZ
MCG0!O8"% %8]GL9"/3.1814="4S<"W^@#0!H"J.<)1NEE?'\*:-;J.WV#^Y*
M41F3"7S;)O%.,.-7,8B'3$WEY529255V.4.3-/<IO 2@-O%GU/(/X4[I^R6V
M@&GH!997^MZ!_";B+^E"I: Z]7 GQFY8,H!=DTZ"H GVV()8.0]<!'P*(!\/
MS- 3"+N-7FGQHV*FV+YZ":ZQ$45!'S*#54J#E=BH8I4I!NV7.4BAT#*$(80
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M4^>P[[[Z ^9JOVQ^A%)Q5_?0*S)IT9%PA7Z[(&F'/!$OG5DY!DLFR/R(8>"
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MRXEV(.X@(AN!"H[$;"'9HQL-D/)$7%M>H#&.:V9B9JQ;J+**E:MA<P[AQY9
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MZ!\ 'ZZ?0(Z Z#?!>*6C^0E&D+(-)26\J$M)-KI=&\A*^STC(LO:;U&QD<R
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M!R1-8AA(;8P%, [;"&@.UH T : @,] R4=)*V^H)$/+G(D6?@#*$;LK>R;D
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M)4RD%,ZXV&9ARJE7$P@4$A4$!*/( #;<"(N+O>B(+G;X9MSAP1%4Z"![/C9
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M,I C7 [F7GFSXJ,?'L,I4!&,E8X2-U#R*4G*.XZ1:BF513Z2K'@(BG\]L8!
M#Y')V5U#UMNWP0X1<R8'+/FE<IX^:L:XL5(HE*FK&O)J1FTS. .ER1:$, @
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MI>LMF=V5I'8*> U?9"NSB:E)K(U,CVD'(%4:*!'D1BCV"0E"**;D*LF@4NX
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M5?LD+*.FTM 3;$QA6CI6/7#8Z9_242G()DS%,8#)XF_:JW_A3R?]N<MH!IZ
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M(L=B4QSE4(N0H]*A6B_N2[$5)"'GK\^D$12!R*Y.BVG&Q@,) (;J" "(E,
M92U9JF(B&7=UG"^6[?-F6;MF,(2N$@4%%'*H)B[D9>4<@BPBV11%1PHFDZ<
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M*\B;N:J(2J*YFI)N/;Q5;F'3J9:BO8F"Z[$JAFK84TF#HP*+B<3@!!*(%M-
M&@#0!H T!AYV AK-&K0\_'-I6,<&2.LR=D$Z"AD5"JI&,4!*.Z:A0$/'TAH#
MH^[T+OO[-;?WE[N?.#^T?3V]F>G^]=O@]/XNH*OH,^V^H$_+?1FU)#YG/H0&
M@#0!H T : U]YJ+!'PCGDEH%Z6MFK7=R6?-' 4T@$,,DV"2%B4Y3%%V#/GTP
M$!#GMH#8)H!9P_W7+Y_$7&O[LY*T!F+5^V^/?XY+_:5<= *^W_=5=_Q=PO\
MTRR&@//Y\A:;J2MR,/ 1#O2^41+Z@" !PM5,)Z!*40-L7Q_%T!Z@UO%)4/1]
M+/XCZ ]4?3JJ'UU\Z#*N]M\FM*'D5%H:9A1;XMP4U*E,I,$E79$JW/<7K4&$
MC(D,S6Y>J)S)J;@("0-O';^_L.O#[OW%0R,?(Z\_)D_*<WT-W3]V?77#27[G
MJ7RF/BR<L>&J:]U<]/8OE986SU.M72+-"6N$CY^),NBY,PDVY7+<7" FZ2O
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M,)1,4H@ ^M &@#0!H T : Z7P_KW\YJ"KZ#F;?4"?EOHS:DA\SGT(#0!H T
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M$?1X;:PRHMG*RL;!QKV7EWK:.C(YLJ[?/G:I46[9NB43**JJ&$  H ']41\
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MM&CK0,5'5#(C^5C8:=?^138*2@M$2 D=T@DZ<%1((B?AL!T*1WPH5BX9-O\
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M  AZ! = ?D5E?&DY(M(F'O57DY-^H*+)@RF63AVZ5 AU!30135,=0X)IF-L
M>@!'0&:97.IR,I+PC"QPSR8@"*J3<:W?MU7L4F@<$UCOVY3BHV*DH8 ,)@#8
M= (3"V9\3(XOJ":N1J<0X,G>Y33K !#_ !H_]("J AH#[S3D>OSN,)IYCRT0
M<_.P%DQQ)MR14C$O#-'B>0:Z>-5< [<IQZ*:CM#8#.#D0\!YCQ = 13$&1>N
MXA+?DBX0BTD&+&S&PV%9Q L&/M4^0)M-HV7"&6&&:/#,SH *21O P[" &W#0
M#"QQFC$J5(KY%,CTXIBM5MP&>8 (?JUSZ0%8!#0&-Q%E[%ZM?R"_3OE:,PB,
MPY C))^,DBFQ:2,I9IB18,C/5.#91PZ8E%0H$.;U0'X0$- .:>R+0ZNLT;V*
MW5^$7?M"OV24E*-6BCID<PD(Z0*LH45$#'*( 8/#<- 8+X[,1??(IO\ IZ/_
M +MH#&625A8:W-7-7G80EXEVK=P^HRTFT:*WV*215%NJW054+Y>P-6C4_DGN
MW!0B?07$4@(= "LF8>X'%SK)]'A2V^I-C*8=[DCRX2<@@RL-<G()SB"//6))
MDL8KB+>J'F%?--E0*H"C4GAL "(#VPMDB@3SZ\0\+<JY*RKS)UX6:Q["5:.7
M:Z2*B"ZJB2":@J'(FB03"( (;!OH!N,;Y2Y(TZ6/M$&\-6"+*6(K:1;*C"D;
MF7*N>2 AQ\H5$S50#"?;;@;Y@Z @DUW%8,KS5J]F<J4MDU>2T/!MUS3+=5,T
MI/R3:(B&QQ;BKT2O))XDD"A^*1#' 3F*'CH!7Q&?,4,LAYG/'W>L3<LV:XY*
MS@6,VR]H2CY_#/D(E@T Y^)S23PY42*%Y$*?D ^)3  &2@.X:%D<@3./4+K3
M;9:Z<^BF.2:C7H2RQLA1_;D\VK3)RC-2:KB,G2L9F1;)N4>+=<S=4') *7BD
M<"TN@#0!H T : Z7P_KW\YJ"KZ#F;?4"?EOHS:DA\SGT(#0'&HLDEMU54T^6
M_'J'*3EMZ=N0AOMOH#C\VU_Y2W_XY/\ 1: ^RKH' QB+)' @;G$JA# 0/$=S
M" B!0V#X= ?GF$.'5ZZ/3$>(*=0G 3?D>?+CO^)H"@>892O-<+9W<60AY2OH
MU;N]/,1C-V0CI_'$>)BNT;F!P@(*JD$0+L<HAOZ0T!>@UAATY9O!*OT0E',4
MXF441Y 16/:.VK%RX*OQ\OZCMXF7CRY#RW -@'8"$Q2Z*>6[V"BZ28&HN-3%
M ZI"\O\ '&2O6 IC!N'XN@,M:7C;VOC[BZ;AO<5P'9=(-P&E7'</G_$!^9\.
M@*;]RT!*3'<#A*3CX:=EV]7M6%9&27A95NW2@6\AE=[&%F):$.9-S-L!(JH@
MH8A@(R;JK+&*<0(70&F+Y#5-TF[RT+-]5$)1WWB=_*-=>2M<>2CF+<MLBT]Y
M*BZ=-;=#B=FY8J'*@04S@FH8P@ "83![&%=L,*TMQQ\NRW5\:[ZZUIX<)46/
MVZ\>/#EH6Y*UOW'%+Y4W_91Z4CM\G*$4(G<L>'.*2G$I:5-G$=B"._$N0!$0
M#X=>A#)[/ZU_ ]QYK_\ =T__ -&4-9'YT/\ NO\ PA-8ILS:I)L'<ZRLZS27
MP_A(&#^#I=PL\<LK&5^93DTC.JU#33=BLV5<D$R2YR*<5"FV$!WU;[RZ?YW[
MKTK2/ZRR?WZ9./\ Q>'[B/XD9?*V<I2,JAW6+(&US=I]H-4P9/\ $61W:7D3
M$7%90K9XTJ+=0?,E1(<PO2&21.=0I%3$!,VMEXS$%F3'2MJMH)0U_0GT(RHC
M8WQ,89179."K-I8\8@@4M65%$K+9<#&,FESZ@>)O@ Y;[FE-A4I%[2(B[R%B
M*I&E8(+X>R6\34;*2S)*85;-7D36&3]ZTAC.54$3R#0BJZ92&4* CH#LT_-,
M>[JM?<W&,M\=:EXABK8&++%63@:M)8Z!#/4$2IUV433(FL(AQ*Y<%*/@"J@!
MS$"3#E^G%*4QFU\*4_SAS8GRH!3_ /R##30*?^MOH -EZG)CQ4;7Q,VV_%3$
M^4TS;?-XGIH#MH#Y^.&ECX A>1$?  #%641$1'P   *=N(B.@/OXW:ASZ?E+
M_P!3T]+XI<J]7;;??I^YG/;;\30'Q\<-+_2;S\P0'%640$!#T@(>YW@(: 7F
M2>X[&U:AD6+J/M$U-V=5[%52HO\ %>3S&M\LPB7]A>1#1 ](<%<+-X.'=.SE
M$H[)-SF^#0$IK/<)B^YU^,M=5>W"?K<RU*^BYN-Q9E-Q'O6AS&(1PBX+3 **
M1C$$ $=M]M (:E34I V#*T[$66Q5UO>,DRUB+%SW;OE:QJ=!!A&PC%^Q?L3P
M7%C),(M)0$U$1.0_+QV$  #+XW@%$LTO;H:;L-F<VM6=F[').\67#'%<KP,J
MO4:M#1K92SIK)N7$@$>93CYHZIA P@0"E$= 7(,N@4I3F62*0_B0QE" 4_P^
MJ81V-X?,T!\>;:?\J;_\<G^BT!]F71+PY+)%ZFW3Y*$#J;[;<-Q];??X- *P
MV6F2CZ89QE,OTTG"3$A!.I&+A&)H]61BU00?)M%7DPS6720<;DY],"F,4>(B
M'CH#5=\H]E2TVNU]E=*K6)\J5^8CN^_M[?P]OML?7J_1I]Q*U_([=Y$0-@;6
M>4D0L<6R.H82K,$4"J\0!40WUYV[X65N.UY&!A9-F'E74SA&^M1<ZI2BTIQZ
MDUU1;U3TU36JXE=<HPFI2BI13Y/DS98QD<D1K:+BV..%4F\(BFV;-4;K5"$3
M9()D;MTDT=^1 2;% H<_5 /  V';7YRV;TD]3,3 [6KR.X\J-VV76/(BE4X5
MU2JG&*C[OV]O2E3U6:P3MG*-:K<JWZ]F?ARE>U3'2:6G/B]?VEX\./!<=>)]
M&L.3#)+I!0E ZZP. ,-\J>Q! 1,)%=C<S#R / NQ=@ /Q0M9WH_ZF6]N;SM]
M'<F6\O)W=9&.I>6E.M61D[+IJ*DM6^KR(.$.FF%>O&,HS'<,-75S=,>E5Z/G
MP>G)?2]7QU)$FXL=GA9QO.4WR:_LL[!..-:8-ZM,MG*:@/"$=1X]"-4.403*
M<^VQC;[[;ZW[N'LKN&_<]OR\>2W'*HHQJ;,F^5=4NF&9"[(L\N,-(V.N*E5*
MI*75#RYOIG*1B59-2A.+]R+;:2U?Y.B6NO+7GK\Z/)/0K9W)=I'<=W=5S,W:
MM99LF1>^5CW 8WR!$W^O,QEQON/;#C<:LZ.<7[('MT2JT<]B':H().U55D=R
M*E*4W9I/63?RGGF]/LFE,I'[8NSEC.-,:!5#=ON'S4)*2M=F!O)VA*ILEE$;
M6HC7%VYK,P012/'-A,=JHJ"JR1E%TD^C -@OM#,_3ZOLS$W2WVZGO5:^GOOM
MMS]U..^^@%U2G^84Y_*HECL3@*F0&QC\[1;"!R^+VA_.">J['+T^/B&P<M_@
MV$0&%[4S'_D_$?V66G^2N@.07^:"F(0T7B<#*;"F4;3:P,??T< &J;FW_$T!
M\&DLRD,)3QV)"F+X&*:UVHI@'T[" U0!#P'0 62S*<P%)'8D,8W@4I;7:C&$
M?3L !5!$? - ?97V:3&,0L7B<QR?/D+:;6)B;> \BA5-R[#\W0$)Q].Y%>4V
M"<U>!Q5&P*K=88YBYN%M57;I \<%4*HHK6EU#"9<IS>)S> Z QN3W^85*_#"
M>-Q08J>1\3'W2M%K4$#ADVJ=+EQJNQ2BH ;B/@!=Q\1V 0.)-_E_XX7*WL[%
M(G^+%@43!:+5T>'O;([;*^ZHDWW\-O3OH"#5&:[Q0KT>%?@^UM:$#S@1:TQ?
MLH)2BC('[H&YWZ32BN&R;HR8 )RD.8H#X .@)5AJ1SG[K3BTK%8<3E#Y&R.$
ML+&V7 \861]\I@%DV"[FI$75:E H<!.!3B7TE 0VT VSR&9TQ %(S$Q!,'(H
M'M5K*(E^: &J@;AH#X]J9C_R?B/[++3_ "5T!R"^S2!RIC%8G!0P;E(-IM?,
MP;".Y2^ZG(0V#0%'\TR]\9]RF/VS&'Q?[YR&$,ZGM)FEMM7L^-HJ4CB$DU(2
M;<\$V13MSD"LTH@03.JY(BHFL)6Y .F!>'%;E%0M_(5PDH?XTKIQ(54AS<0<
MMAV H&$=@_&T TBK(FY\54C=/?J<5"#T]M]^>P^IML/IT B^XER_4Q>[1K2Z
M*MC7MF.DJ\@29;PYW$X;(%:&*1+)J%6(RYOBDW4$A^  ([>&@%IB-XH%5OXY
M:&<3D1I5*+=6EG>1KRTE<FAYKSK=RM72-V;A^8Y]F@LR$$P"ET_7$!T!%,=9
M0I5JS)<J!**3AYJA2%46M2CF+KZ#A6?-*(1E(89$FH.OQ[J8E(Y\[;*-2E<+
M,@4415$ZFPB0"]^@#0!H T : Z7P_KW\YJ"KZ#F;?4"?EOHS:DA\SGT(#0$?
MGJG5K25J2SUN!L1&1E3LR3D0PEBM#K@0JQFQ7[=<$#+%3*!A+L)@*&_HT!'/
MBBQ3][.@?8?7OWOT!F(VB4B&:R3&(IU7BV4RAY67:1T!%,FTJV BJ8-Y%!LU
M32>H=-<Y>"@&+L<0V\1T &H='-"DK1J=5C5U-UYU.!- 10PQ'NYC>;)&"T\D
M5SR.(]0"<MQ'Q\= 44N-1JU/HN3;93\38YG;;6D>Z*:K$-*4V$>1TI/1<TR5
MAX]ZU!%H*[9PZ*1,2 JGZIM@,7TZ =-\A*Q&Y:Q;5B5*BJ5A]7IF-&'F:ZU<
M1#$KNR0KDPPL:B@5BTF'BXF*F<Q.&YSB(#OX@3D:/2['EVXC8*C69P8_'N-6
MC 9B"C)(6+7VUDDPMF@O&JWED!,4!X$V+N >&@"T8FQ8G,8^X8VH1!&Y+;B6
MHP!1'C3+><N_%@&_$Y0$/F" #H!29AG<=U7.U:<SK"%<WZSQ>)*]CYJ1C&K6
MV9?M,GS\H_90SEQTUVK%G%HK*.ES*)MT$C^N;<Y2F T9_(60M=D@R<VLE(I$
MV\M?>#W[-9ES*P49..6HPUZI<H@@QD7+)(RI6SL#(\S)AS3WV* COH#TS1^.
MZ! .@E8*CU&%E&R3@&\C%5R'CWR +(G26!%VT9HKI@JD<2FV,'(HB ^&JH?7
M7SH,KKBN#D7T,A5J@SQC5X4N*<3O+ 1_C8\\[M;VS5^3.]/-*L;766KINFFR
MX@19%8QA54$QQY;!L/>/_J[=?Y2R?WZ99Q_T$/W"_$C&Y2QU<J553S=.QW@R
M_P P5^T:E@&>!%&ZHMEP5%5T)F=XDG(E3,F5,.*0E*90#'$J93F#7"\2>KU"
MX&G+[2&YL)Q$&C&T]Y(QC+!RR#:65FVLJ=="9:(9,*SD 9C'E*F)RFV 1_$T
M!V<A4K(,+0%DHB-P_<D()=BK"TH<(2*L8@=]*-VCY\SC6N0)$Z0QS.0<.U"M
M6QUU2$.4A1.?Q ZE2Q'.3M8@)F<JV"*U,2D2Q?2=?<8"(NM#O7+<BKB/45-D
M) YSME#"7<Q"&\/6* [@ $Y=XOM#]A&13Y_AIY%PHB,-&NL'+N&$0(@ ;QC1
M7)AV[$=@#ZD4OHT!\S.++)8W@2-A>87GI $2-P?3.#5I-X#=,3&30!R\R8LM
MT4S',)2[[ (CMZ= 8U'"CYNLDX;M\#(.$%4UT%T< %36162."B2R2A,C@=-5
M)0H&*8! 0$-PT!(/<"\#.!9QGL3#902Z 6'XF'OMP$.B+?HA*_&?YX$O+B).
M/4VX#Q]'AH"/*81>*J**JM<"JJJJ'5554[?B'4554,)U%%#FR.)CG4.81$1\
M1$=] )/-W;J U^-R 4N&6<_BAY*6VJJ1N"D&S?VM*5N9I;D91JK?72$BU+#6
M9R*:9R[$< FIXB0 $!H8V[=WN*,<1F**?)XL0I,8P2C?9;_#KEY[3;('$Z)I
MS;)""$LN3< YJIB.Q0^9H!1P_EG\O=H-2F8QD7]+N$G6'QJMVHS,\R1!NFV>
M1_F7S:^F; _<QKQ)91,AC F50N^PCMH"<XZGX.;M[K& PM#=P"BLLC=JB?!\
MGC=W'V"/B:U88!TZ8S5AFHV9;NXN1*8#@W/Q$I-E2B02B!9Q]0Z/*1\;$R5.
MJTA%PI#)P\:]@(ITPBDSE*0Y(YFNU.W9$,0A0$$RE 0  ^#0&'^*+%/WLZ!]
MA]>_>_0&=>4NGR 0X/ZI7'H5TJ9( '<)&N @R)"@*18CK-C^S2IBV3$H(\-N
MF7;YT-@%'0<>T&PA>92=I-1FY);*&0"+2$K78B1>J@C8'**1573MHLN<$DB
M0H";U2E  ]&@*1]\N%<898;8[K.,B9!QYE'!&;*5E^/OG;QV[0>4I.H6NNP4
MRI"0\XG(,&U:26=M+"F\,W,JNLD0J!E42D63$P"7@,']V\HC8+\W[UN["&G&
MZ,@W?*RW81@"*N<V@PARR1T69#0/M"62>HM4VJ!1/Q5<E(D ;@&@$>^HE^@:
MW)7*[]\&>\<5:*F7E?<3V0OD\NW6JQ2]@;%EDBP;9](50$%9%[+Q)HYL7D!7
M,BJB@0QA5*.@(]VU5WNER+>LF.*OW^Y:C:+-L:!,X0DJ]V,=OT+.7/'M@HCN
M:L,@_=(UI)E-L36VOO2-S-55D@2,V*<04.8I *!=TD)G7&UTI=*S1:*9<HS+
MF28B]LK_ )G[#[=19NOU_ KN1E\;^][;&4W&1*J3.2MR39VWBXY124=%2*8P
MI%.0P'I$[$,/8BMG87VHDG,:4250G.W+$R[Q1Q3XANLY\W3(AR#HG-F5\P<=
M0X*IF Y5VY]A P'+OH"S\/7J]5FS?%ELK=>?5*1><JI(KP,4$--N@,+@D/9(
M\C,D8C<D.ES37%,I)0I!4)Q7*HF '%5Z)2IR<R8WFZ?6)=O$7MJSB492 BWZ
M,8S^+G'P>5CTW354C-OQ2)ZB8%+L4/#P#0$S'$6*1\!QG0! ? 0&G5[Q_P#W
M?H"1.JE57S^*E'M:@'<G!$23A)%S#QZ[Z'30."B!(MVJW,NP(B<-R@D8@%'Q
M#0&+DL;8[F7SB3EZ'3962>'!1W(2-9A7KUTH4A4RG<.G+)1=8Y4R 4!,81
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M8UQ_7*Y<\E56V/KR]1>Y%0:52XN,FY'1"95^+^DKIUV?,WMB:25J;-Q^E+&
MI)1,HF(!52'2 "Q/Q14S],NO\Z.3OY8: /BBIGZ9=?YT<G?RPT ?%%3/TRZ_
MSHY._EAH ^**F?IEU_G1R=_+#0'Z&(Z: @(*77<!W#?*&3A]'X@V_8= +##6
M(:H&,JD5R6[H+E9.P.D?).3FIB#[3?" &0][$^&X#OZ ].@.3*F)J<G7X(2G
MN8B;)6)2>OD[)APXJ9-JA#; >W& #<3#L/I*/B&P@ Z C=HQG6(^_P!O<LG-
MT;N6.#W3YHX)DS)/60=-YN:505(H:V&,(I*I@8 '<NX>C0#CP4NLZPYC1TY5
M.NY=4^%<N5U3"=5=PX:$6765./B=594XF,(^(B(CH#EQ-^U5O_"GD_[<Y;0#
M3T!!K%8GYY *G4P07LRZ":[Y\NF*\94HQ<3%)+2Q"F)YAXXX&!BR Q3NE"B8
MPD1(HH4#-UVNL*TP%DR%==5==1[)23U0%Y.8DUP+YJ3DW7$GF';C@ > %333
M*5-,I$R$(4"LF<G4B&9L<L$E77LE7 7<Z]?-R <61G[1_@QM&.'.Q13*X11?
MNB(B80'950 ^'0#FQ9]3R#^%.Z?LEMH!IZ 665_K>@?PFXB_I0J6@.&J?=/R
MS_:J#^XC_0#3T : - &@#0!H#I?#^O?SFH*OH.9M]0)^6^C-J2'S.?0@- &@
M#0!H T!2&ZQUQE\?Y5B<>LT9"]RC'NNCJ>P<G:IMWMC?2K=M%-5E'JS=FFFN
MZ4*4154(F&_K" : GF4D&ZV<<0IJ*KIG2:'6;)I' A%SM[1 J&37$S5V4R9$
MR<]MB")B@ *$$=Q FCZRLZQDZ\.5T7#YZ^IN,X^%AF!2*2<Y*J2N3%$H^/1.
M<A!/P()U53F*BV1*954Y$RF, $6M*L72I>MY!R!),'MV15LL\>+9.6ZZ\%3Z
M_0K=(2\-2X]ZJU76:H;)>?>\4C/7)DQ6,DD""*0%>\,WB!O=BG8]M#.6;F%8
MXFEWB4DG".D7,??>XF]62O.FSB+?R:"OF(L 5.!Q(8 .0Q>1#E.(&KSY ]6Q
M!'YG)%HM30AN\7OS2LQ@(4IVS)ODBD%A?+@L9$X**R92@?I%. @(_P#!\= >
MEI;ZDK_:S_0CJJ'UU\Z#Y%8.W*9AYI1^K#2T9+IM,5X(9NE(Q^U?D;/$JU/"
MJT<':*JE1<I@8!,F80, "&X>.MK[[P<[ [PW*&=3;3*>?D2BK(2@Y1=T])14
MDM8OP:X,L8LHRQX=+3]U<OF1:/6I%\C<<I8S66R)R"*)*VFU@!KBQ 2ZRSI1
M*1&=*L)53+"5)0K?AS*4/$>._CL!)- &@#0!H T : - 1>Z,Y>0JTVR@9=*!
MF'#,4X^875.@DP7ZB8@N=9,BATP H"&X%'TZ E&@*P]OOU[]S_X='/VD4_0"
MZH?_ &M\J_QC_P#9/0] 7CT H+-G;&U.5G1LTI*P\56'Z478K0ZJMH]SH1^L
MV9.B-Y*V)Q!X!KL210 YS..FF=4"F,!MP #7YGKNEL=CSWV--\ Y((CBO,EP
MB7[RPL;55T8'+U3)/R+*Q5:M4^?I[ZQ3<C&-(DKM:19OV22$>N(@4XG(LF R
MW6=H[!Z^4XJ.<T>O0-:OCM9:"C*>XM%RDI"US]S,I)>Q(V^5)PY3(WK:13'!
M%PY744$XF$/0!2.P_*6S';E'O(1E)X3S?EWN&[MRUW!F,9O-\%BR6=5:^L;0
ML=RY+/3M\/ QU5?4]L1=L;H(QY99/KB0YR%4 B>?>]GY0S)&+G](A.S_ +4Z
M_+S=AQLL^]X^];&^1(1W6V&0*Y/VVO/86GP[IVNO9*C#OF**G("H*.B+[* 3
MB("5RKWJ]U>.Z]CAG_LCQ+O'5DS_  <4QHN/,]3D@:O/[O(6(7DO.3U2P5#7
M6GT%@]?N%G,R,CTF8*$ XJ(&X" B;1WQY)0L]$P-3L+4BL!!J0$;6(&"^43P
M=-0,S/\ O;:+A#K2UHRO19697FHZ7M+P=W:Y2N&ZA2&!<43<0%GA_N3[B;KW
M#S%!P5BQ,LGCV8KMHMU_B,^85R_27F96&0IZ/=4E"U1U+@:^^L#6OMW$@Y6
MSXCA@X:I%%N=)#F!OT^2IA<H7SY/GMEO61,NW8ETNU/G+C.I5V4I$I!ME[3>
MK7/-V46N^JLX[;,V#&021(S4=*GCP3\J.W1X@!L'^+J;^^]E#_Y^/O\ 5]H!
M3UW%"]A?9CAI7)^2W4>ZOC9N[046H?T[_P!']"637(H2A$5;.FZH%,DJD8AT
MCID.00.7EH#*1U6M=:EFM5M69,I+M'ZGEJA;%5,?<9<P%,9.O3R@X^ K>U-T
M2?2E!V3E$B"<FRY54P 8GQ=3?WWLH?\ S\??ZOM 'Q=3?WWLH?\ S\??ZOM
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MM%C8N<05C_9S>73KD^]]FO$%7:3\AC,8U10%2)'2Y&(GOS, : LOH T : -
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M<_5A<8P;[K2*]DJUTFG4L\=K+NR*5J>@V221^J"AEP<DL [F,<!("(  #OX
M2?*_UO0/X3<1?TH5+0"4RSDBRX]SSC=M7J<>VH7IG6Z7/+)*R!%*Q$R%FF5U
M;$*$?&R)W*#0$#=0# 0J8>N8P)E4,0!_XV  H]? !W &S@ 'YH ^=>/AN&@$
MG2991%>]UC'\=$EO4[D[(3VS3_D6YV=8C"VR5:,9VU'0Z2TK+&9I=**CU%.J
MY FXBFU344*!8&K56+J,8,='>875<.%7\M+2"H.9>=EG/'SDQ,/>!!=OW0D
M!$ *FDF4J21$TB$(4"2: - 5AS7[0+D2FF2L2K6,/AKN"0?U,KM9-*<="IBI
M>.GE6)5RH.AK16ZR)5#IG,B,GL4Q>H8# ,O%GU/(/X4[I^R6V@&GH!"]RS^3
MBL1RTI"&7+,QMCH$A$BUBW$VZ]I,[[6W#(K:(:"5S)KG<)E B"8@90P@ : 0
M_;_7W&592I99F;O/N[)7:[27SAW$J/(N#MA92"F&,FA.UV6;]=%<R[9(QC;)
MKI*MP(!SI?/ 7RT : - &@#0!H#I?#^O?SFH*OH.9M]0)^6^C-J2'S.?0@-
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M]BN&DRI"E53D58MPJ@#AN@87*?BJ<A-_6*.P>G0$[:X\I3&)EH)I7(Y"(G5
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MC1E'*MYQJPJ1YR1,?=&1;N49D8=)(G6/P,Q(DN!O4)OU \3? !-- &@#0!H
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M$25Y 4C<R-B<"H7B(F,!!W#CX@-W%GU/(/X4[I^R6V@&GH!!]S#*6DL1R<?
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M*?\ -?=OWGT!+%[4T0G6%?-$V=1Q(H)N$Y!"LS2T$W*H18X)OYU-F:,8+E!
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MO?2^?><LOV58^_E/H!<Q-QO096O*@8?L8G-2,<%,F%LQ]R*4LQDCB80]Y
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M3!C"HWH8T\^F4H+LR"_.]*9Q'F+(ALF0/I1AT!?GAWA_I_;7_P VR?\ ])T
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MO&JY 40<M7,!(HKH+)FW Z:J1Q*8!](#H#%4WMTQ71+[=<E04,]&U7YZRD+
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M19QJ;Q)TK6X9%1@X1>-A2?-'0-2JLWB CZBB8@<!\ WWV$#'?%W4CBT"1H4
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M &^V@+ =O6>J#W-XAJ&;L8*3"M'N[=^YA#S\6>&EA3CI1[$./-QQU5Q0$7;
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M$X8N*.V)X\F4F,PGW7X[9P\4O%DE$II)^PF_:12 9(XQ[MH#='I.BF(=+JF
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MYN1&/3*R<EPE9JHK+NXPQ*M*:(RLZ82ZS)@T>1\Q5JS,N8G'T(O).LIY1>2
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MH,$53Q;Y28KT/ Q52B[$+11@ULJ\?*V"9DY&&:G6<$+6V2\X5HQ,FHH@()*
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M&.L)W=?D$;*FA7TK70DG=<&":+J/7/OE$@#D)L[HKEF &.0W$J1OJ>V^QAV
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MS8 ON7,I&QS8'2N1YE%S"V2%D[XH[5LQ64@%=E*^WC&354$&7FO*N(XI4DV
M)\   &[VL_*F]T,5>+3=&43:[*[45J56R;C:Z35(>H7*\Q%&IL62T+61RR;6
M^,M$;4:T@@MT^DU>%6,)FQETQ=+ ;"9?Y6SNOD)0[J'[:'$#"*NR$1;F$DV=
M&&$I$FL]YE9)BLNI*.>7ZBX%.@'I4,'CH#HQGRLW>&DYC5Y+MJ6=(@K(&DHH
MA4$.HI'$,LA%IR213F#VJ!.)G!4]F@#RXJ[<1 345\IWW(J]Q>2,R6KLA=(,
M*Y5J)'XS<NK<XCF2JEB@O(6= \P+$$' 1[]TLB#A5MLJ)P3 J8\3 !'Y3O\
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M4 A963?/$I\Q$!204($U+<%3''9FR P'*58W?*^+MTEGRU5<4^$?;Q_OY?\
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M4,( 4I0#^OZ \= 0&.8/[L^:V*PM7#"NL5R.ZM5GA#)+N5DQ S:S6=J?82O
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M]YT.24K;&E;F7)UP:A&<H:0/E-WS%YW.?)((U2$3C,=1_=2U:563447\W:'
M73&!Y>>;)+E%5>'=N#E,F_7.9>36,JOL*8D55X7ZL^4NXNUHU)_"K<TD]=7*
M7F4ZOVOCSD^,O:?4#[AF/EP]'O7O)WK(=O<M_85D[JU&*CCQ^&W%54MIKIL4
M>'D0@H8\(QK>D^JN'H$R>FH(2BH$.*1<97M,RH$,*95#OZF8A#'VXE.<J9A
M!'<0*.WH'7?CY&G>Q9]3R#^%.Z?LEMH!IZ 1/<C)2D-BB2F(,AU)N*LV/9*'
M33B'<^=6397ZM.6*)(-@X:O9<ZKA,I0;I*IJ*B/$# /CH",=N$S=K$C-SN2$
M85O>Y:KXU?6A&NLIN.@R2:\+)F,$:PLC=K.LT10X"*;D@'*<1 !,7B80+.Z
MA5!_:1]_&V\_;C.:PL#]#+_*V_ODC9N[/]IU?R?A?ZG0:@:WB'NZ4[H6>9RK
M9I+VQ)YT#HT"=)V_,<P*V21FEZY*9S/",\.HKH88=1)$85=J>82O*M9W?^8$
M@>7'D>-M'=K[G6\ZYO\ -E9WZ*7PJR.MR<)9/2L?58[CI6X^8LET_:=6GNGT
M0WKU#^[U#T,L]-G'MI^N$NUN.?0]_GM"QJZ8Y%6R*^>[N,MYC:YYD+5ARV2.
MY?P3R5)^<D;\HA1,!,L[Y1OF?WF2(/VA)5!&KVF+QKW)3U.-#/\ M\M%!@*:
MG9<>LT::,RGF>:BY\&[4[IV?R IF#J&Z0^)Z@X.PPWW*SM_>3#JE7T3C3F2K
MZ7B3JA7UU+R^KXB4+=(]4O=T?'@=2^Y[W5ZLY/I5L7:GI)7LN5Y-.6\G%MW+
MMRC,5U>_XN??F/&W";S/)>S4Y6 [+554O/ZXOH7F+=M@%DYC**UC7CM:0>1T
M?0V#M^X;OVB[YRRQ%CALN]7:2B2$HU6=*I"H9)R0CA,QA*J4IP, =IV&$JL%
M5S;E.,:DVTTVU12FVI:26O/1K5>/$^8WJUE4YO=5F;C5QIQ[KLZR%<90G&$9
M[MN,HPC.IRJDHIJ*E7)UR2U@W%ICOU[9S Z7P_KW\YJ"KZ#F;?4"?EOHS:DA
M\SGT(#0!H T : - 4>O,A;HG'N59.@2"43>6#7NG<T^46*V.C'V5.<9>QGBI
M7B#IH*;=^)#&ZB2A-@\2B'AH!X7.PC YJQ8B$:XD!GZE?X/F@NT;ECRN;)C!
M8\@X%VLB"J")4-A33Y*G,8 *41T!)8?[KE\_B+C7]V<E: S%J_;?'O\ ')?[
M2KCH##Y9GX6LU9G,S\DUBHUG<:(HLY=*<0,);A"G*@W2*!EW;M8""":*13JJ
M&\"E$= 4ZP]E.L3<-VU3L[D:A,X-W#+$A:>6Y5ATE&M6%$>N&<]8S>T#E/<%
MGB(""9!X1)!,W 3+&64,!=3XU<7_ 'R*%]F%>_?'0!\:N+_OD4+[,*]^^.@#
MXU<7_?(H7V85[]\= 06%S117-\O46ZR=1#Q,9'4U:*0&V5DI45I%"<-)&*H5
M\"IQ6,U2W XCQX^&VX[@3KXU<7_?(H7V85[]\= +:0RAC,<P5%8,BT,4BXUR
M,D8X7"NB!5#VC%IB%-_C'<!.4@B'S=A^9H!D_&KB_P"^10OLPKW[XZ /C5Q?
M]\BA?9A7OWQT ?&KB_[Y%"^S"O?OCH ^-7%_WR*%]F%>_?'0$-O_ '"XMH-4
MDK6>T0EH)&*Q:9X2J6"NRL\Z+)2["*%5E'^UD3.2L0?==8"CR!!(X@ B  (%
M/LH=S%;FZTG=<8ED*C?9^HI/IE.>L53JT8[KB3.'ET&-@D'5A0;JV&-9S'EV
MKI@=PZBY$5&BY3)@ND "ZSI9%,FYFK=JQ](U>4J2C*K0UQ6<W:!9R%=E8"QR
M2[^(6C4WZS=":CG $([,NNW1-'+F,FHNBJ & 6'?;W*#7X?.%&K=\P\C3;,[
M<SLM.R$DXG)J/DH?&] <LC-25V;7(1@=>/2*8#,'*AC\P 2"'(H%&<?6'%-9
MJOR:*<?DNHU\:GW"9QAJY#*Y065?O+.YSA4RO8G(EMK.18E!] -J-&2RRCB*
M>2E3DIMNP;E;.F[D=P+0]G&0:15>\#N(L:,^?V<\S/=*'$Q#FVV1I35&S>8F
MS+6V#D\B6B3I\W)/%W!SR3JKN$8T=TTO+)+!P$#>9\:N+_OD4+[,*]^^.@*5
M]PSAE-,T6U2R=CM&-9WHV0VLVM)0-K58=:%?,[!4',,T7=RY$9QTH*C5X@0R
M*0N#E6X=%'K <U,N^ H&6I+5M(Q=/=72(K=WO=CEEY$&=IDL5PI'Z;4%')G<
M9#%KDFB5R^>N!8HD\NDBF*IUBBF!81CD+'UU?M;#8[[2&5>8+I/:M5G=NKQ5
MG*Z8@HUM%F;C)" /0'8[%B?^\O!58/-"4C8!E?&KB_[Y%"^S"O?OCH ^-7%_
MWR*%]F%>_?'0!\:N+_OD4+[,*]^^.@(-+YHHK?(%*BF^3J(2'D8&\.Y1#WLK
M(D6=1BM3+&',J=\*I!0+(.-@(8 ,!A$P#L&P&C/Y8>7C9/Y/WLOF89XTGHU?
MNFPRX9NH5VTD6L@1.O9$+LP=H+F9.>:A!( @IP$W@(AZ=<1]=9J';VVS?%+>
M<=Z>W2%KT/J-_51QZO6+O2":BWZ;;LNI\HZWX*U>G'1>/R:FZEV:9:2Z%CLL
M:A8\H2@"GCO'[5UU8C'D8[*LBI)S$@W(L@T<*(IG-*S!RB!RD%DQ X>JOU^R
M5BMC<X]6:^$8:ZJ">JU^35)]4^;^K'Q/GE13B78$]MP+9X_:E$8RR\QI*S+L
M@XM0K@W'724H_#8B;4?XSD-/JE7U46TLA(2D#7)I*8OTGQ5R3E5<J2L946:(
M*E+&1K9155BW?,BBL2-A>1TV0<G;T3F,(N+U3C!2JQ9N61-?:6:+2&GY*\$U
M^2EP7.7]M3D3HRH4;GN^/Y/;E/5'!V^,Y>9D.22ZYR24NF6D7EY6D96O[#&2
MBOLL<BWK\E#*PL>]6K>&(9TM[R699XLG)Y1EGB_4?,&$F!B/Y&'DW1S>T)$@
MF<3"QO+-=TN9C0H0E%Z:1PX:]3\;'X\N/'\M\Y\EPU*U?FXV<LW)_A/?=NBH
MQXPC*O;ZHK2N4ZUK7"RN"UQJ>->%&/FY&DXJ"[R[MJLG"VBU1#QM#-!;I8>P
MXP:MTIF1>LSMV\=8)2%3,4H2:8JHF;(*\64 U,"SD2+[F0MSG.W2^Z+C7'ZE
M/B^/"3CRUY=*Y07%E./195*[:=IO5FX6QFL_<7/6N$9:NVJN]ZOH:3\^U-W9
M=FM52E#16=C:PQTR1TNG%VW.=C8JLV:1 77IF*ZZN)'!DG3E, 69Q"7TLRQQ
M!*0L+PI2D!- I0;2Y3JLZ8Z3S)MK3\FN/#5OQTXKGQG+@N'*N*P,C"Z%*S%[
M(QI1E*?"%^?='J24%[RE8WUJ"2E1@U-RFY6RUNB[J&?0ZL\ECR7>*.#)&?YU
MR@NYCX_V^LU1X.V];DW0&CFMS;-"F32.D8D?",B@D<07!+IV.GI3KIFE1KK9
M;+\*TB^"<O#\V"X+BR;K)J5&Y[KCUN_3R]OVR/4XI-IPG;7QL^'4Y]:BTKMP
MMUG)NN4IOL).ZM9:VFXV"M8)KRA6,; B@]0FLES27-<R+R*<![<6AS.^9B,C
MD%]/.MU5@%N(>8R8NB5,813CM\4]%_XGLX<W%\>'"4GSX<Y7ZTP<ZRVB7Q?J
M#D:2LNZXN&WQ<4M5:WY<,F,=%*SJ5.!6U57I?U*J&V61MSB?QK;I=B#VWR;A
MQ[C8I;R#=J%>BC.HQNI.6!RV(Y!K)+(;!)/-A:QR&[1MU%1$R\RLL5D;)K7(
M;]ROGTKVR?)OGK+3AR7RXU6/MTL.[;-JR.CMV.GQVXN,OX3->]"G'32L\K@O
M(QN$\J:^(R)5UQTJSEP\S%)J1<?.-Y7(\K8:*;(>2S)MS0= C4;A#J,XY@W=
MF6;IJQZJHEC(4#B<XF,\>B(F$RJ,I-NNG1Y<I:3F^4--=5[%+3DN#TT;%LL&
MRFO*W&$\?M.B+>'A*2\W+E+W/-G)>])3Z4LC*T2>GD8ZX14<9%1L1:I%\@@]
M<U?"5?:L7E@L$F_5;3>2IE[)NE%GKB66Z3MZ27=*E\R\ YC*F,5NUV..Z%J2
MU3QZVZL>+]^Q\/,?BHM\]7SE^!%R=F95E5[CN52R>ZYZ1Q,6,5Y>'6OJ3LI_
M(G&*4L?&E%*"4KLC72,92>ONFIZ73[+98ETUJ$,Q8(XOQ1',B'G+1(,S)IQ,
MS(P0@F;S"9C)&C8]3BA%)"#IX8JH%!K:BXSBISAI0OT56FCE)/ZTE[5S2_)Y
MO5Z:9T,>^BR[:=JR*[]ZM<GN&XRG]E3&3?FPA>V](OWOB;H]4\J2=./%Q?VV
M2AS2[%^XEGC-G9\T3TC.MJ_"(N#O*QBN$>/1.X6?O$BI^28D*4BKYX8I'DTX
M("#8.B4A4KD:[:KU9+26Y6K1KG"N//1>/3PYOC)\$8#>!DX$L3&E9C]E8TH2
MG<](Y&?=&/!Q3X2GQDZ:='5B5ZSLD['*4^RBW=$7FZU4K$LK*.C&D<MYG>F:
M_P"+S-"KI.(N%=&#V22<;H)JI-FA!,QKC8O-4!6$A%:HSAT.K&EP_P ;;P6G
MMT;X=6G+G&*XOCP)NE&;JW/>L=*I>[MNV1<I*?5T]-EL5[ZID^F4YO2[-G)0
MKT@I2AC01KLM">67*%9P37#N&Z;,X.32F6)-(ZJJVZ("I,R5:<O"J*&+],>6
M1T)C"!FWBYN)4^5T13A@QY\];&_>_"GSU2UE\PJLW"G<?BNOXOU"R7JM.CHP
M(+IAKJOLZK:UI%_5IP81YJQ:4Z:/E55;)(]V/R2DS/D" :/^Z1@2MT;@R\W!
MPS>WXJ*D_FSM^1PFY+D4%&R8^68)ID0*)U 5.;A7JU*RSN7M:RW6$7N4>FK3
MC%>93[TOE?#@N"\3Z;_<%AMN-Z*>O6)@OXFZ'8=CNR]7TW6RQMQ]RKBUY,$N
M%DO?NEU6:1@XQ7H%R4:4"O6(B9$QA34JS&>''AU0E"FC0C2%$3=3IF:'=";8
M!#< W$!VW[^?) ZN+/J>0?PIW3]DMM -/0"4[@80]EQP>NIR+F'4G;GC.(3E
MF1$E'D8>0R+5VQ7[1-P4R!W#45.9 . EY &^@(CV[TZ8QZ:S4>?G$;++U:#H
M,0ZGT&*,826(WCYD6;PS!N1-NU<*,CI]8J90(*P&$O@(: LJ19%0ZB::J9U$
MA %2$4*8Z8COL"A2B)B".WP[: AU!_:1]_&V\_;C.:PL#]#+_*V_ODC9N[/]
MIU?R?A?ZG0:JL39;^4+=]SEPK-3J$]D_M71S8I!A>.X*BP.(9FO8V.6-/9I/
M'MGC9F!LN0W%?LRTHRB&SJGK(/HUFV5-*?3>8<MVK=O4"?<UV-B4V97:ZS>G
MS,JJ./*%/#KE5-2C.UPGUQK4L=J4(Q?F\=3]Y^H'I]]T'']#]NWO?]QQ-C]>
M)=LJ_P""V#.OW:G(W%>8L:K<,:RF_&V^.1C+&NR[*MWA.C)NNK6#]GTD2[^J
M;$L<PV_-Y8'Y2&1O.,\6/7])G\(!1GF :JLTK3N27=006EO*N*S*.5FI0G))
MHT!\4G,I#B0. XG?F'5#=[M[5?<<L[&Q6ZY8WE/%AI!MN/6I.$GI]K.,>KGH
M].!L'W3>X]PRO3K;O3"67Z,4]K;WOL*\VC>OCH;]E*>3"N,;_A951R:HJ3>%
MC6VNAOI<HJ7O&TC ,PXL5$:V%X=51Y/Q]#G':B[CS:ZCN7Q%CB1<J+N^DW\T
MLHNY,)U.F3J&$3<2[[!T_8;I9&"LB>KG9&J3U>KUE12WJ^&KU?/1:GX6]6MN
MIV?NJS:,91CCXEV=1!1CT14*MVW&N*C#673%1BDH]4NE:+5Z:COU[9R\Z7P_
MKW\YJ"KZ#F;?4"?EOHS:DA\SGT(#0$7LJMT2(S]SF%7?*&.M[0"RR\K$D3(!
M4_+BS-%PDR*YS&$_,#@F!0 -A'<=@(IYO-G\'\6?9A;?Y#: ST2OD8[.7-.Q
M=*;2!&V\"E$STZ]9N7G!;<DNN\K<>NR;=4$PYHIN#<1,/'<  0/PR^1_=Y-0
ML521M?G.*K(T_.A7@C^1_IJ<F%:&2,\X<?I8M )N(^OX>(&N;.),U2&"<_L6
M-?QXX>.Z?W<HMT(VS7-:34<*.T^HG'(ITT@JO2G .D'(H&';Q+XZ LAE5&[O
M,B8-<&AZDXLK5K:W3AK[;GR5]HH6V8W)'N499O57DF8IA,F10JC1!,3*"45-
MMMP,A*V7*C+N=<UBHQ&/'\--8.B)ZP*V.:LL7+,YNN7&18,$H92,@I=D[B'#
M>T+]8%TT5P.F0Q1V Q3 8?-62<J8O-2[U=T<)0&-X"9E'%AD'5LOKB>&65JT
M^U@&,"R:48R<DO)'661*V IG*[HZ":11$YM@%LTIF7\N7RBY[S% QM<IT);:
M>ZP]B*1FI9O/X^"4L;*,4NMQBF,<K#S>19Z(>BD""SHJ,&S<*HE*=P*AA <M
MFIV065TQ@WJN-L0H5:N2MI;QZ;9S-,&T9"C4Y2/B4WC6/HRD?#IF(9-,J29C
M)%4$"$$0V'0#9A(JZ*22!;)3\6M(<2K>97A).6D)(A@2.* (-7]0C&JA3+\0
M.)EB\2"(AN(;"!WVL18!2L O:KCQ-9/J^ZI6KIZLD\VZ_1]X#JUM T;R $N7
MEBN]MS;;[!R C7LW*/\  ;"_V06+^0.@([5*W=4[7E62F*3CYK*/(NBIUGRJ
M\HK79$[-O/E>$>2KFJM7:2C8ZY0."#=?B!B;[".P ,!U$VH(*/495+&JEF,L
M<)5HZ?22,$BWW6Z9H^02JJ\@Y6$ 3W*HU1*&YO$=@W 3<A'9-^-RH@-)PP"H
MXXR)Q3"=L7$R?O/B[F<ZGN$ ;E-Q H;#Z3>CPW <KV)M)8N&/'5+&RLT<1]X
M$'KV1;Q;8/#;V,[0JSEV^'T_5T&^@/BP1-M3D +5:CC-[%]!,16L#^3C)#S0
MF/UB WCJI+-^@4O'B;J\A$1W*&P;@8EO&9*%= '5(PX1J*R0.3MYR?57(W%0
MO7,@FI1$DU%BI;B0ICE*)M@$0#QT!*1AY3WD!(*Q1O=#H;F?"HX]Y/,] 1X!
M%>P?9@H>:V#EYSET_'COZN@(HI'9-*LKY>D8;%$%% 0.I/6!-8R/(P)F5(2A
MG*10R>W( ,8 '< $0\= 1NWU#(=HJ%J@']-Q>D,I".4&/L66D'3M62ZJ!VR:
MI9:J1#--J8 -S4%7D78.)1$= ?,Q0[T3VI>8"K8Q9Y&;))-$8-&0D!JN08-J
M F0B+9(N*J@\AY9D9108Z00;.3-#&$AP4;J*I"!66WX<ROW!U3)-0.RP9&XR
MR=8F(WJ#(K?(G)E:<QE>J\!/UE.62A"L(>;VKQ#IN3,E 3(Y!5(%B"DJ<"I]
ML^36R]0Z_P!EF..WEM2FV-NUW)4U>)N*LUXZ3^_1DS;X6R&@;3883&5:DI-N
MV7(\5%,K?INQ!(SP71R[& 7V&\<YG;=WF7+#><(Q$.>0O)XR'O$Y1'U-IM\B
M6&0[E/0DG2Y)A12S"\7 (6!NU= YCS&5*@+\7H@_Z9 -UHQN4?@HV%_Q-[!8
MOY Z S,\A*Q#&+D@K^-6[%JU!U<W<N^>,F\6FD"!W:D*HC6G(/TDR=82BX\J
M)A*0-@Y#Q K]8<-VC(N8*'FY*L5-@PQNPG&F.JY.RCB'<O$+0R4934U<H<M
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MG*GHVNGIP(J/@WTU5WUP6L8ZPKP:X+7HG%^3R.WMX,\@+7:*S C(G<G98DQ
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MH+NID9>6=)LH]CV]+*N'"G(0* Y BDTTTTTRG57<+JG*FDDF4RBJABD(4QA
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MN(0SY^C7KOF[Q97#<[O3R73C1CHL;'^%W&5,>E>[56]7Y5"UDH_;3?59K+T
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MXVWG[<9S6%@?H9?Y6W]\D;-W9_M.K^3\+_4Z":ZS3635):&)G?=3W1&IO9K
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ML7OM2;DG+23;U&+KT33CI?#^O?SFH*OH.9M]0)^6^C-J2'S.?0@- &@#0!H
MT!K[RK T">HV0$\L)&2QBS;=V[JZ3;)1RK.UR',_:M7TS78Q..DT'LPVC'#D
M45#)'4;GV,D4QC> $[RRX:-.[' "S<ME1FE\>Y%8K.8UZ=E#.J^ZR%ADKJ,D
M03 3.U D0;N#(^@R"1^7J[B '7R K>\1YQIDOC^D-+?CF4QUEB1M<'[T##/*
M7**VW$BKVQ5>&)79A>0B'Q5!6DF+<Y3%4*9=NB94RI%0&6_/EB^2E#E(F"HE
M=B81X[N#"UGM+F^QL@J\K<Q6V<<E#1C*HJKM)"-M"SDCQ-\)4SMR%Z9RJ"(
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ME&R[F-7,<BA"I/D4S)F$2F#8WH'0';SKD>1JO=[@2OD8Y*DHN0Q3D23494F
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M']1DK!C-^HY4?O)!Q-NZ4^C%@<1;GKU=ZL]<K+H',@LU7A#',B8!,4QQ*(:
M8.@#0!H"%0YJ^-WNI6 / L)6%2]X!5Y>3%L*,S[#\GN(EY@F#CJ[ 'CQWT!-
M= +*1^[+3_P99(^VK%6@&;H T : - &@(!E27@X#'ENFK-&IR\!&0Z[R6C55
MC-TW;-$R9E4S*D(H<@  <O5*8P[;  B.V@.JQC7]TD6T_8VJS*NQS@CJKU9T
M04UG3E$_)M9[,W. "#LH@!V#$X;,PV66#S/$K8!DZ - 4F[D<:1$YG7MCR<"
M;OWEHSO($.AT^#B.=U^R(5=222DXYP19LN=B\BVZ[98"=9N?GP,4#F'0%V=
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M=%/NB[/Y=DO#F[C,$US"M.%^5U%_&Q35)G);]@=5:15?M0G59MU5Q>@H=83
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MO:K>(Q7-FK+X7@92AU'M>-9* WD8QLC#6D1=NW[FW(UTR(D2*;9)ZH8 .&X
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M#8!V'8!R/;VZ;1D0^;U*4D7DB(@_AFUAH*3Z!#P\9%=];VD6Y =__(W#KT:
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M$)(4VT.(B4!!\DZN[=ZN)0$1'RJ3CT>&_AN_HG].O]TXW]W_ (0_Y@WWSO\
MB#OG^C_Y@Q<C\F#\G<S>KMFG8S2)9ND8H)2#.;BT&SD!(4PG22D<CL7I"E,8
M2CU$B#N [!ML(OZ)_3K_ '3C?W?^$/\ F#??._X@[Y_H_P#F#\8?)A?)WNWC
M=LZ[%Z3%MUC\59!W-Q2S9J7B8W462C\DO'IR;@ ;)I'-N/HVW$']$_IU_NG&
M_N_\(?\ ,&^^=_Q!WS_1_P#,&6;?)9?)PKR$@T5[-,<LVK,HF:2B\D91I+&
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MX=!THG&2E?OKN09@"8ING$6K3RQZIS"05 ,U"06X\3  ]0=P'PV 8&@#0!H
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MY!EG#11*.E8RCHQSLPDZ;M6-;SY'Q$P XG 6QG28&Y 'SX;;Z 8.@#0!H T
M: - &@(1DFO/K71;+78PS<C^6CC-6IG:AD6X*"JD?=50B:IB%V(/B!1T!-]
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MXYE((V:R/7$T#R.>M8!./A .(C"JM$Y$KY<2"<0)[6,LF8-@#?H_#H"2: -
M&@#0!H T : @^26L2]HMF:3LNK Q"\<8C^812.LJP0%5(17(DF4QSB!@ -@
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>g68105page189.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g68105page189.jpg
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MXD%/'L[D2;;H<J.^B=&DQ(LB-,![P2H\EA$AB2E9J5)?9=2H>P1J#+E,AR@
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ME;JTIXCTCR4'EKI RXEN(!;M#GRO:' [J\.U:^_FY&G74Y-((8G.!&TT%?\
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MH]GYQ^EHB*CV?G'Z6B(J/9^<?I:(BH]GYQ^EHBK7R_1X?1T1&B(T1&B+RHD
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M _!QKM!((/\ ?'@01K$*. ((HZOV&BI&^.1KWM<VC"1B:%U#3P\5Z^,4U(^
M>XU0*G]SC- /;]94U6GC+*BH^]7M =;^IJ*5IE_%WY=M%3XQC0'X![C4)H/W
M.,\3[ ]95/9J\1DNRU%>]7!C"X-SQT(P.; X5I7CV(.XQ! .![C5/9^YMKR>
MSZQH-6 589*B@]_N5C<KHG2Y@,OX3@X]PWJOQC'C^X3<7A]5^YQGA[?]\M5R
MFH'% 6$ YFBNW'R_U<$#<51[,#W&\G'X-M4XBM0?6/'5<AH35N':L+9@Y\C
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M:R,Z@ZA;=ZM%)I7)BM"[D/S5]8QM0PB@\.9M..U8IM.TIEM;2B7QRRN:X?E
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M]TBV;<Q%E];YWFHI&<NQV.![#19;NYES;B8+)9PV\SCE[[+4]ECF=5B_>*9
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M^;;5S(2ZIO ^9P)KP!/DUDDT;2R[-'"UIXA7OL[=[<I&!6\/R<%CXTZN^M\
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M %*+'L*=FJ;&MN\NQ-PGA*8DB\YI8&Y!Y4H:N]]Q=[U6@<Q-%O.Q%(2.WF4
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ML%XVFHS'E<JKB0VM</<-FQ;/IFXT^YT.TNM-E-SS+=ADF+<G->UH;GR5=ES
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M3&Z(.E.(A2(^RN+1TK5SK2Q(OK84L_HE<MV'-[%>S1%D?F4]+7Y'<=_5E_\
MVXT1'YE/2U^1W'?U9?\ ]N-$1^93TM?D=QW]67_]N-$1^93TM?D=QW]67_\
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M%M["Z!W_ )(EH=#MJT BO:<=ZZ*&WMWZ.Y[Y*/:[R5&/;QP^Y(_UAN2&=O\
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M$_3>UM;'19K*UU,ZHV.Z=64FN0EK3R^R@QIVI&MO+=E4'K;ZFI<R+=4X;?\
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MI^<CL/6J1_*Y@/:M10D?X?\ *L4]OAHB!U8=+9 (ZD=AZ'EH?C=P"GIDA/\
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M;TR%1X)F6\FOD >LW'YVO%^L&D=(_3YA\\MQ"QO:[,W#[1B<.U>MZ+0ZWU+
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M@-?8UFMVETE!M6&?R*/B^9'9<8A&=>9K<9KE5R-'W1]Y24E7)&820IQ1IY*
M>4C6\;%(Z/*!X@H;07>%NU.=PK</-[QB5BM6#XA(98]50TLW26%N%"762ZMT
ME2&[>VHK6:>Z+(\HUJI(83(3,[*X;O\ DLX$S11H6Q9V5S+(Y/K',,E0E]T
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MHHOI1HEM8V&A07+I38W1N<I-0"YV<CV5HNBF^K.MW5_?Z]/;-A%];>GS 4J
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M\T:E*05JXZU^MM'R:4T%5'N0.4<$N?33^^O?(>;(\.X^0CX)1Z4/L#4#IO\
M]N'?]RC:?BU_]7W+K>I/!<CSW"K-;L7L3&1W"V9C9+T_:7[K%LHEVN(B4W/9
M:N$U"XK3J@\DI"@:D:VE]!-<6YB@($E1B>Q2KF(S19!MJ% WOK\FMO'*W.B[
MM8SM*VVS'C_WQMZ<OLMTE&X-N(]6S(L>WQ"A3;/-1P!22:#@*:YBYT75GM<!
M(TU!'V+6FP?0CL2Y=/'2CU 6;-(F?7/:&"6[.N9(CQI&76BW761>) 6AQ3BI
M[!CL):==4M:%I[VO*I*A37.P](:PW:YJB?*9"G$;Y],^[F]&+7&PW'9Y%O=E
MPWX;4]&Y6**<9\4TMCO5=Q%4\5-E?,2GTCVZZ&RZ?U2%N0R-"E,TZ1K VF(4
M1FWO0UOULMZRQ"?M;)GW2Y70.F0S>XSR)C,.07;>^B>U#\"5EMBH[VH*R 16
M@UK-3Z8UNX.028=Y4:XL7A[>Y3.=#73GN)MG=G,ES?#6<>8OF*W5$MYR_P 2
M[7(S[I*MBHMN6EJ.S/0S!AQ7O='1RE;II6E1O^GM'U#3(.5=/!;39O[%L+*U
M="X/.RB:]U[= >Z^^ESW$N.(X2Q<7+G?;9?\>NS676ZW"Z^K\=LUK5!F6IV.
M[(9D/NP7*APA#BN([::DW>FRS$EM:JZ[M'3&K4SG;CI+WUM$>QX-"VGN*I-I
M2NW*K>FK:TRW.6PFX2W'$Q$-N(7-"7"6Q5'E-*C7%W6@]0W%Q2HHM=Z%REOQ
M? =UMID[,3%;4M6BT[?7^SVV5<8N;XTZF="R*!)QFXMNPF&&7T+GS;FTX5ND
M)0L56==/H&C7.GRE]UC(=IW*7;6+XWB0I_/PIS>I_P!&5S'MY3BZ>/EI_;G$
M>SKJ6LRN<[BMNCX4YO\ DSN7\:\7]^:O1'PHS?\ )G<OXUXO[\T1(WN[B=ZW
M&QR[P;OMQ=8[*X+[P>9OF.W"2U)CLGNG&(\>9WBBXTBA _1 >?1%"=:^GG.M
MN<EN$]W#;U>+;D"%NV*],J8EHG6>='[_ +UEUE<E#;J2Z&E5*2DI/&HUHM8,
MSFY(Q@M5J)F< R,8*0+I^V1RJ1C>1SLBVVGB/D406:.S+N%HCW2VPHSG.)$8
M29$=*$O.)HIE 4%I"55!)K71+1S,S[DD'"FWM6>P@EACK+^*E$S7,^EC/]IM
MSKKD[.&7N[66X2G'[*]&=9ENH7<T*#T!]N.>9*XO-R#CRDJ-> U37)+G)R;<
M$UI]A6.Z!=5N*>3TP;3YY;9]QRF=MW<&XJ;:NQPHDZYV<+=C2J+>>0;@I@PT
M+8X%31*S6G#MTTJ&8LK<"BI;P..W8FX]4G2-E[69P-P+)B-WDX^EQU%YM29%
MOD>KUH*I+,IQN.\M*V)2U]US-\U *DCLULKTRBV<8!5U%+N8W3-H-JS-H=HL
MSS3)H*!M[>F+>A"YDV1,>A18"W8S*F68I+RT52\M(YJD%".(!US>GQWDEU;O
MO@?39SAOVX]JUMI87L.HMN[<@63(G<]IVN>0>61W"B6;-<4WZN%XMF-9Q9H.
M-P(6U6<1+4C%'"[:)#K>0X:FV/SU1Y,F.N]F*B7R!7I]T7"$@<1Z'KT>G%H=
MTP7LU7(?$\G*,,*5[5H.BY>K66]Q%UF8'V?J2X")H!,1P;6FUXH03M7SX=6V
MWL3*M^['MQCMKRK&[3;TL2\^F7+F5'E9!-0RB=<K,M3KK$J$S:DL(%>3E?J*
M:\0T6^ZGLKJ]_NB6*6<5Y>2E!CO WT7HO54VB\FT/3+'0V?_ '0[:<#L]J>)
MT5[9W;;C>+:VT8Q=9CMN7DEX7,@7&0/5+L<8[=VUWN7:X#B%KO#D$J0TIP<J
M5\"=2NF]6FN-9(Q(JN2L;@>IH3@OH&/$\*T]GM^;7C77J!VJ>=JIHJ+TCZM/
MMZ!2+?S'N26_)<_['.#?PVW>_P"5#+]54M2#O?4K_P#LE_UJM5&U%%EL/_))
MA/\ P*?_ )<O&O(=8_W3OZS_ #*XV3]UW]1_FE<.H;]H[E0*FK%55';I3@,5
M1P+VEE=J\NNM,-+??=:99;!4MQU24(0 *U4I5$BO8./;JRZN[/3HO479  XJ
MMA:W=S+Z:V!<5A+NMM;8:DN7"&B/("C&>7)92T^4&BTM+*^4J01Q'#6KEUW1
MH=,SQ/:97OK7"N..U;2+0]8N-4#9&.$;&[-V&'<O9N4 *C)\;%YI@)B)\0T#
M)">%6 5 N5/ 4\NK[_7-);#;03O;SW4-.P[%CL-$U9TUS/ TF!I<"1Q&U7)4
MR+";#TQ]J,US!/>O+2VCG-3R$J/U0'DU+U;4-.LYHY[EP$4C T$\=O\ )0M+
MTO4M0ADM[9KC+&\O('#9C[2O*Y\)I3"79D9I4H%44+?;29/U-.XJKW7F"@13
MR'45NL:(R>.+F-!E<&[>."GMTO6N0]W+)Y;2=G!5$Z'XLP?%QO&I25*B^(:,
MA ">8\S8655IK,.H-*-W\MA>'.K1#T_JGI?F4["&[5H;?_M"=-O\(=S_ /DQ
MO.NVZ5 %PZFS,?=54T4DO>3MJI'J#S#7H5 -BZ%5U5$:(C1%'IL,H?\ 2!=>
M \V&]+1/$&E<8SD &A)!X5^;HBD)YT^?^@?I:(CF3Y_Z!^EHB3O/5#QFWW\/
MK6*T-*FVW>@KV5/DT1*&Y]K<_2*_K3HBA/NW^&;]_P .9_6^(Z*]VP=R7*:N
M G=+IK3(:EJGKV\W%\"ZR\VB&VTG&,1$QN:R4EUXNI6GNBDCD4#6H.BAGS'O
M2K7\$Y1M0.''=;'.T4'%FZ=H'8/8&J%LC@.6: &KNUHVCVK)&V%Y(GKRZ'9Q
MW)R\U[,DYY:XT6RV=["U6Y2[A>7%,BZ1YX2^6V8Z%NAXM%Q*.Q/Z/7!R/ZB=
MUDRZLN4>F&QY7!P',SD4):3B!W+?1LTL:,1FDY^;!M32E<*C95-JZ]<QL6WN
MR.Y&=9-D1Q&PXAT_=0>17;)QM_:=U388-KP^V2';HG;>_@V+.'(JDI*;7._M
M.6KT'B&^90[U:9?')L3T;[P6[=_"]_[WMKDF^69WF_8ED./9_OOM!\F;EAQ>
MQ7*?;KC&5AN&1^J6+C. QT0GP\A-ML?CXSE"@K<0@ B^[7;-*4KW$"13_2=D
MI/LE4:TJK]4KM!&B)3]$1HB0[?\ J<*C@ DF]P@* ]O=2>!/8*^SJ;8_NK#/
M^VF1NW6XQY<5$/&KG<RJ7'3Z$BW,-FKZ *%Z0HTX^84U/N-I*C05SI]<S,=Q
MVO0@;:/<4I"7)%UC/)]$!-2B,10<//K4L9&XG.ZE/M4]<E+S#? A98PF-% )
MH41525 %5!3GFI!X'6=L-N74+Q162.+&%S14KFG\AW[655MEQ8"CS$Q[/#X5
M\@ISFGMZS<BUW."C>HF_*M*_D.^*%\KB<D;_ $MI1V^:K45>J^GMSL(5/43?
ME2,;Q9/O"W:+4[*5D92U<EI]TM)Y:.Q54YCX*IXH-:CLU)@MH.(JK"]SS5V!
M3=%[C;F,M<CL9Y?%5%2;"\5'LK0H0D'YPUM/3PY=JC2R/C(R8E.LV*WOSJ+B
M7AYECCS&8=XGH5_>Z=%7W93'>4GG35M"B7C2HUJ+FU@Q=FQ4MEQ,6>5.L^-!
M?_B&3^\WX:?;S]7_ .*OM7V[^J_H:UG*9Q_'3V<5GYK^'X*^W@E54$ICUY5U
M4 *I^J%:$$:ANB#XR)W')6N!(H*X#!286"25Q8&LD'XJ#W]J:ADK&Z2(^\[F
M4Y)CUVQ"EHEX-9H+,5JZVN.Q>8C\@7<MLMNE2VZ$*45'T376_P!5^7LTNWDL
MF2-F$8#R[,037:">Q<'TJ[73U1>PZGJ=M+#S3RV-9&"UE-AH*GO.*:-O3 R5
M?5+TI7NWO2DXZQ:-_P"T9-%8FH:8==GXMC\NR/38JG6/&)CRK:YRD(=+3I"B
M4I4"?/\ J^-IL8AN+VGV@%=!J-(V/C:*_J>;<=J59O&+O$>F>K<VOMMA39DJ
M8]:X\''%P''9$YZX)+_B;*[)D*CR7>9I3BUJ%$CF*0-<Q#K>HP,$<;P&#_"%
MKHKVYB%&$>X%8YQ.86I<=6335"X1UQ+BZ,=PDO38RPVDMS'W,<4]*31I-.91
M55-:D\=2_P"X]1_.W_TA9?F=Y^8>X*Q%P!F.\7'<@NLWO;A;+A*+T6SMOR3:
M.Y\#$\4W;VW(\%@, I:;*4!554YB=1KS7=2N(?32/:87;1E'\U:[4+IXRN(I
MW!+YTRBF4;X]M?A'AI(J2D%6(1E$))I4#F[>PG76=.X61;N#ON6STIY?&\G;
MF^Y+?N>UXJTX_ 6]+9C7+.,1M\WP4V7;WGH<F[-)?C^*A/1Y*&W4BBN58J-;
M_P!ZVJ2:^8/8HF[NW>/QG<B9LUTQ?.Y<^WIS#*^XDR;:;$W!?=K>2HN1DOKY
M37M-=8C"TFI+O>4&"O8I@]BE[J;KV22[D3]JL</;MVTPG,QRTLPEW.UW61<%
M-?W[YJS'F$J74FI&KVMRFH)]Y5V8]BYS$L.M$S:G/KS*E9,_=+7=-X6($US,
M\N+\9JPW_((MH0VH7L<(#$-M+?FY?9U<"6N+@34]JM.*UF18A:6=D-N<H9?R
M)&0W1[91N==QEV5&;(1D&28C'O2%N*O"J)N#,QU+@ %>;5AC!-:FO>5:6AQJ
M=J27J4L;5AWJV>Q*Q9-DV,6?)=O]U9<Z+ O^X]\NUQN=INF!-6CX-X_9;\PN
M[Y$RU<7D1D2GDPV4NJ4XDZNIC6I]ZN6]VXQ..WL5OG<)D_<,7G$KIN=%LDS)
M-SLAON36M%IQ:VW" B=<+=?5P6IL::\IPQVU+3&6HM@GEU<'$;%4&BS]]\/M
M-EVRVJNEGN&36.ZY)E6&6V[7>W9%FTZZS&;OCUQ>F1XT.%?&W[C<KE*:0&6>
M9M#LGDYR$<VL38VM?G!.;O*HM!%Q=+W1]+R8S<W<S*#XM,"Z9'EU[NU_8G6G
M<<0;:FZ(-XE6B3<F$QFVW:)<1S)(!--9G.+SF=M2N%%(%C5U:OUBM-Y:*5(N
M=OAS.%"4K>80IQ"OZI#E0>SLU;5%O*#S#YPT1%!YA\X:(J*2""*#V>'DKQ'S
M1HBC?#.X%HR/.L)B;HY38K3B&87.'C]EBV+!9D2%CUV;8O=H0Q(N^+7"XJ2&
MKDI +CRZ\O#@ !R&N:S<V<QBBI1M/P@[17>M/>WT\,A8RE!V>U;M,W==  1O
MEG*>%.%BVX X"@X#"^4FGL:U+NIK]S&$TJVM*- X*'\YOI<'9?#LHT+R[*W4
M>"4O;VYJZ$*"DAW']MG %#B%#O,*50@]FG]SZA4.-"1_@"L=?7#C4G[ KB9^
M[*0E*=\LX2E(HE*;#MNE( I1("<+   ' :J>J-1/#_T!7#4;H"@.'<%Y7-W6
M=0MMW>_-G6W!1;;E@VW<0H5)H4JPLBE3_0T9U1J$8HVGM8"KOF=WQ'_I"YO(
MKONMCF.9!>[9O+EZ9EMM,^XLM''-N$QGY$*,I]EN0VSAS*W&W5-\JJ*2H@\"
M-2M/ZBO[K5(('9<KG8^ 4Q]BHW4Y3J$!NW<BW$,GZE*@[=K=A+=W<N*VV^!#
MFY-BEX]N=E.XMQNNW>972Z">I:[+;)LR_81(NUL/?*;6S*B2GD)C -\@9==]
M(5H?5^J1++I;I-7+;73PQV9\;6AX;3!U68U7*?3*WZ=$=Q-HFMRZIJ(O'.,,
MC/"TG<21Y21@-@W+BLAV#VTW=N&22+[ D*D6^]N6_'<DAR#%O"+9X.*_.B/+
M4@)<::O7?) 4D'D"2..OE/I9O3C[V_\ [6OKB^M 3S#-FJWQ?ASXC'@O6OJ)
M+?7#K"35V1V=RWR1QM;23PGS%NS#%;+%-DL$VER;;F3B\*0N[3,S1"FWBX2%
MR9S\88KE"W8Z5$!$=A]QM/>)1P<"17@->A](VT+-2+VCQ57#Z6UK[GQ)X@K4
M #FXTY>ROD'$=GM^37IE%T&1M4U>\=<71_CUYN^.7OJ.VJMU^L%REV6]VN1D
M:/%VR[0'C'FVZ6AJ,ZA$N*^DH6D'@H4I72BM=&XGP[%@)Z^^BI!"U]36TX0D
MA2EC(5* 203Q AI-% <#7M'8=%F@8YI)=P2O?)5S8MSZ*]N;E ?1*@7+*=U+
MC E-A7=RH$_<C*Y<*6WSI2HM2HKZ'$D@52H'RZ*2I$7^"'#Y TYQ\GU"M5&U
M%$UL=D6/1MJ,,9D9!88SS46XMNLR+U;&'6G$WV\ MNM.RD.-N)H:I(!&O*=0
MMI9)WN<T^<_S*XF4R<UP _$?YI5_A3B_XSXU^S]I]^:UW)F.T%6UEX(^%&+_
M (SXU^S]I]^:>GEX%*R\$?"G%O+D^-?L_:??FLD5K.^0,:#F)P6.62:.,O Q
M 6'<+MB5WB+ANY#9)#7,B2MB)?;6Z\^8A[]+*6&I+CC_ 'BD4*0#4:YKJFPL
MGZ--+KS7NC96F5Q9A_TT75]./U2+4H1I65LSZ5S-#L>XI/6+A;5Q+=<(\K$G
MFQ<;W<'+/,OEJ;9AQIS93$;+9>6I#H+7!L)YN=0  .O&+;ICJ.#0+?5([#U]
MC+SGAW.,61C7.Y8H'#-E: #QICM7M+=>T*[UJYTR"YR7</)8_P#2!H]S6\S=
M^;-3AN7BXW2Q7!$^9WEJC/*MEA\#&\7%#T5YNX<\Z/$3SI6ER,@DN)0.9">*
M@-:K4[RWO[2[UJ=DC;K3M&M96@.( >^:1KA2M'8-&WO4W2[233+NVT.U(N;7
M4-9NXG.R $,;#$X-K2HH7$U&VM%TF1WG'KC<+&GUU8IT1M=R=EI1=;=(BMUA
M(2PY**)"VV@I[@@KI57 <=>F?472WON=+LHVS/T^2*2<-9BX9(SE!=MPK[:+
MSCZ<WUYZ?4KV&W(OXIX('N+:AS))VAY#3@*XT(V;EQ2I=L=M[P?FV]R5$QNV
M-6]+LN,7V9B;P5/,14ESO!)3$%5H3Z8;%2*<=>-/==W.C-U2**[CO(=.-P'N
M'A$C;B9@<16F7*QM1LW[UZJ&2?-)+)MO2T=?<EPI_P!HM:2*[0:DX[0MXS<;
M+ZWBR_65H#B,MD.NRO'0@L6M4(-)>=?[T$6]3P"0X3W97PK777Z)91?W59-A
ME(N9]8= ^I)K&(7/ H=AS &HQW+1:]+>MZ:FBE@!8S2F/%&@?K\T G#=D)&7
M9O756.\V>X]1'3<S;KQ:;@^F_P"Z#BV8-SA37D(&V5X!<6W&?=<2CCVD4XZ^
MJ.D+:[8[-.:\32E>U>'V<1BO9>4,L!D=0'&@K@*G@%)>DDUKYZ#VJ#7HQIN6
M[--R]:HJ(T1&B*&7)-VL>V%Z[.J^_P"X6+=11L.?8AL WB=\VBVVSS+K/=)&
M,8_E$>_1I=QQ2V3HZ)$!Z>R.1T@CG('9HB4W\_78;_Q#US_ZB]Y_^+VB(_/U
MV&_\0]<_^HO>?_B]HBHUUX]/*9]MN,O#NM2Z.VB:FXP6;ML#O--AM3$,NL(D
M+BKL"6W%M-O*Y>:M":Z(G>=/O5%MGU-0,ZD;<HS.%+V]OT7&,ML>>X3?<#O]
MGNUQM,>\0F'[-D$:-.[N1;Y:'4KY>4@TT1,9R+:S=.'-R&XJVXRE<!MUV6J6
MEJWADQ8D6PJ=DGGGA:4)]6O4X=B03VZ$T%3L522=NY=1"N</(=P=@IMNMCD]
M%FQ/<>QS;LB4@M66Y1\;Q)+T%Q,21*@R57%0" I2R4=W4!-::H'M=BQ8'@ U
M&U*[D\Z%$RS9N-)?;8DW'=S'&83*U>ZR%-QKDIWN6P>99;"DE1 Y4<PK2HUC
ME-N UUQ.8&AX+2&YN8ZOAB[.8<*[EDMR6O)#<WA.'WIPMQCVA>[EDDO9G.CW
MENPNB/A8=5X*?'(DA5Q>0E10IUOB02#]K&O,+@::_P"HL=[)JSX=6;%E&FY1
ME>*4YA=MK3'#@NCCDE.AN;R!R\WFWCLV;DA?79!WANFS.X%LZ?+5;K[OC<MB
M-^K?M39+O;L<O%JN^<3L7M$:R6ZYVC,%)Q2Z0)C[I;=8N7]INH44N@I-->J+
MGE\[F6?(B]3.$IW2S' ;'TP9S>,&PK9'-]D["]T ]!./W;<S=*??I,G>'#<A
MN,7!8+N'P,-88B.6^XL2&G'EO.*;<4II)41?5QMI]5N#P((W*R,$$4XB+::T
M'9Q/MBNB)3=$1HB1/?QOGP5*_(U>K<I7$CT2'T'^B1J99?O>Q89_(F>P%%$V
M!QH!-AD\:"AD-GCQI36UNFMR9MZBP?N#O4E2**0GL/ >SKGEL%ZY$^:M?(:D
M?.)IHBIW:/Z4#VA3Z%-5J4JO>J(D>WJ3^Y:,L5JF[Q>(KZ)+3X^9PU(MR0_#
M@L;XVNJ3M31Y*U<@/,34J\I]CZ>MNPEQ#2<%"!H[=M3G]@0%XO="L<P-]D?5
M<17P<+@*U'9Y-:^_:&2!K=E%L6^0):^Y9^Y(_NCD^I'U']+V?4^QK7J[X+V.
M$<4I7D32M:5-.WC4#6"7-) X$[#]@*J/')D=Y:)B=];VL@YQU)-6&9DTG<AW
M"$7/+;9+9>791"APH4J(FQE33+3LAY#R I*5K)4NAXZZ+4WS_(HW/R"   8^
M+VA>4=/6735OUQ<B0S#4'U)!-12HQ'M":EOIF&)O;N=(V3#'L[NTNW[A;E8]
M F6C&LA0+-<+WME=XDB%<X+N/NKN#4J1 ,<(0_'4B2E*BI8%-<7U%9W%]9Q-
MM6ESZ@T[*'%>AZA;SNMW"(?H<P4X[Z)PZ<AN%!7;_=4GL(.W62U!!I0DQ!V>
MQPIKC3H&KTPA*T?I9Q^$KU\(;A^3W=7_ %=Y+[TU%^2:S_E'^/8GIIN!6&C,
M7'9<N$S@NZ+LR (_BXZ-O,C+D<S&^]C=\D12I ?:JI/#B!J3\AU=S6GDG!96
MV4Q%>*5#8+(QC=YW5N60XWG=DCY%>\9D6=%PP3*0_,CV['(]OEO!J):Y?=);
ME(*:+*5&E:4UV>B6]S;6[H[EA8[-A7>*+;:; ^"-P?M+ON2V9-ED+*I&(VJP
M6S)ILMO-\<N4I<C%L@M,*!;K3-3-FS9DZ[VV#%;90RV0D)4I:UD #6Z6R61?
MK7<I.\NVUW8@2G;7 Q3/HTZX):)B1)4YRQ>$COO=B'7RPYRCR\AT17L4M=RB
M;M;N721!DLVV[0MN46V:XV4QYJK?:KNU-3'</VPQ''$AS^E*AY]$7-XC9+O$
MVDW"M<BW2F;E/NV\SL*"XT4R)3=XR#))-K6RV>*TSF7T*;_I@H:(M?D%@O;^
MQ&V]D9M4YR[VZ1LBJ;;4LGQD863)<1?NQ=9)!0(#$1Q;G]*E!T1()U<HRVW[
MQ;-9'8L)W0RZS(P/=;'+NK;=M^&TU*O-RP.5;[=E>1P(-RO./6&XMVA_G<@,
MKE2.[+2*<U=$75[2XUD2>G3>ZW/XN+)<\BG[G/V7'[=B]XQ9AYFZ8G;HL!%K
ML]^5ZX=:>E-J;$B0$.27 IPI!531%M^HV#?F]G-K3 QS-;W(LN4X,N\6K"(T
MA>1L0SC\^VS%EZ(AV;;(++TM+4N2PE3[+2U%L%=-$6)A6*Y(UTCV_'%8U+M]
M_7,,AO&D6^5!?C,O;G)NS33<"XJ$]AAJW>Z 2*/]V.9P!51HB6?%,G@X0B^8
ME>H&3,(M.17=ZR2X^,Y!>(=PL-WENW>WNQ9MHMTZ.1$\8N.I!*%-]T!31%UG
MQH8K]SRG^(N:_M!HB/C0Q7[GE/\ $7-?V@T1'QH8K]SRG^(N:_M!HB;+FN+X
MKFFZUPR5=VW:QNU7?%+0U*GXMC&30HTF\6:;,80Q<6)F)SBZ^;;(1RN)2FB4
M 5X:B75A:7;?U6_J<5C?#"\>)M7<59^*S;S\I?4#^P=\_P#=_J-\GL,H;D&"
MP-LK9M3E!)1\5NWGY2^H+]A+Y_[O]/DUA^0*_P!);?D"/BMV\_*7U!?L)?/_
M '?Z?)K#\@3TEM^0(^*W;S\I?4%^PE\_]W^GR:P_($]);?D"P;AM#MK<(DR!
M,W'W]>AS8SD:3'<LM\"7V'DEMUM=,";4$N(44GB.![=7LTVS@+;IK,HA>,>.
M;9[JHV***5MP^)K[=E8PUV(+GBHH/;[T@N-YPQ'WFLN+QML<BVLL]NVTS93M
MCBXU>9#>1+8RG"[78\LF-PK&VL3ID-$AM"E K^JJ#QIV'5')TWP07D-_<& /
M; 6&A+J^!Q)(-*+A?IW=WSK6]M-0T.+07QW[FRNJU[WQBG+E:YH;0.J<,:4V
MXK;6C*TVZ[9<](Q3.%NW'(A*5%LV&WZ="M_=6FWPPR%HB(#*WVXR)"D4K5XG
MRZ^==%M>I-1N[Z[O=*ATV)IP;$ !(,U,:>]>H=86=MZ>T.C78O;0_N.D!+V8
M?A-<,:!;$WJ1DV5[>L0<5SB(W;<K=NUPG7K$KK9[=$@L8SD,5;CTV:VVRE:I
M$QI*4UJHJUW/3NESVL_J)33LHN-LH'6LO,)S!.(: +S7E =;52@KP<!30GF"
M5 @$&AH1V:[);F,\PX8)E_R3>*XQDVT_4+<<EQO'<AN$#K2ZE[7!GWNQVNY3
M(ENCY]*7&@QY,R*\\U%C!T\B J@))X5IHI300**5)W:_;1]LLO;>8,ZT>6K;
MN)6!QL\GU%4*@%)Y/)YM%5=5;K5;;/$:@6FWPK7 8^T0+=%8A0F!4FC,6,VT
MRU4FIY4BIT19RDA5?9%*&M/+VCS&O'1$A4GIAZ=YLN3.F;&;1R9,QYV5+D/;
M?8RZ](E2'%//R7EKMQ+C[SBRI2U$J))/E.L;H+9P\3 2L?(M]N3Q*W^:QTV?
MD$V>_P!76*_M9K'Z2T_RVIR8/R!'YK'39^039[_5UBO[6:>DM/\ +:G)@_($
M?FL=-GY!=GO]76*_M9JYMM;-<'-8T$*A@MR*%@HM!D?23L=<8"6L7VUVZP2]
M,RH\J)DF.X!C$:[0U,+YE(C/-06'&0^CT5%*TJ*32M-<SU9TO#U)HTNEL<V&
M20'Q4K2O94?S6TTF\9I>HQ7[8P[E_AK2OMI]RXM[HBVF?M<5A=EPYN^1[K*N
M3F11MML+9E3$RB%F/-C"W=U)6P\.\:?4>^0[Z8/,-<+-])/7:19Z7?ZC<-]'
M$Y@Y/Z;7 UIF;4[._''BNB'5D46JW&J6UC;L?<.8X@U)!93'-M.:F*WUQZ0M
MM9=PL4V-$M\)%J2V9S7J"SR7KM+IRS+J9SL<2;?>;PS[C-DLGO)+'H+J-8]1
M^CME<VUO:6D[8X&6L<$]6%QF;&\O%2'"A-37;M4JUZ_U2&ZEO)(XG3F=\L-!
ME$3GL#2:8YC@.&P+4JZ-]M)%JNMO:QS!L<?GW^3.2YCFW^+18J[%S#U98KK;
M_ )AWIF!R=ZTM]*BT^>8 D#6WU[Z:#J*XCDN[V6&*&]?+'R?"X0OC>SD.+LP
M(!<'5I2K=BU6G]22Z9:BWM(V@O@A;,?SRQ2,D,@ILS92*8D5K5;>Y=(FW$Z3
M89#,>#!-JY%SEMV&T/2[M+]%,F[*G/L*D0;U/8!8?E-$.NQCW9/(*'F[KZ#Z
M,^&W@M=0OF0PP-B<USFN;(T3/F<'@-&#LY:0*8+:GKS43+/-D;S)IS*#7RD@
M-IVT ]ZNIZ1=JDY(Y=U6''GK(ZSX9>(O8K8G+.Y!"*)LSZE1"](QQIZKR+>K
M^UT/DK KK=__ (GTV/J:VZ@MWM8R#4G77+RG$.C,88#7"E:U(([%'?UG?2Z;
M)I\S<Q>W+G)QR\*4IMQJE0Q/8C9K!+VQDF&;5[=8I?XS,F,Q>L<PRP6:[-1I
MB"B6PW<(,%F4AF2DT6E*@E0X$'7JMO;0VS,D0HW=W+B6MRXFF<[3Q*5K65H(
MK7BKT:N1&B(T1> BA)'E433V2.)/G/F]C1%[T1&B(T11X](''J;^47/E^/?;
ML$^P-GL:IV^8:(GRYQ^\O+B.!&,WT@^8BURB#VCL.L%P*1%PVH30$]BAPVEN
M-H9W.V=LK@N;5UF(W]N$%,/N!:EQH&/[;,3O6',XF1XM9FI4SRI*5$*!U&T]
MSW,?G-?%]RC<SF8@4HGESV&E[F;:O.LQW'F[@T8[KC3:UQW/7MD#Q8><2IU@
MJ0L)4I"DDH%#PUL.7.]KG0-C<8VEYS@D!K=K@,/$T>4[EDB>6$N#Q'X3B14=
MWM3@YDEA.ZMJA_ 54J4[95.HSQ+?,U ;'B?[W%PLJ(YTU%.\_1CAKS:[YK_J
M!:W(T5MS;2P&FH!P:8J#REI!+AW$+IH1._0'/]6RN?\ ;R[<=M:K?9'PW-VR
M'FM6X'ZTQW7I*YY*6.P>T/H:(DUVW^V;A?SEY)^MK5HB4O1$:(DDWM8+^WUR
M4$\P8EVQ]7L)$QI!5_V/>5UGMI.7,.W!89QX/:F2-+"765GL0ZRHBOD;6@GC
M[0UNI'<T%@PHHL/[@[U);$4%L-K2>#C32Q^E4VDI-?9!USQP<1P*V"R=$1HB
M-$24;R@? ^I'9=8)^Q?&LT'G5KO*1V)G<G[6#YE*^@G6YC&&?@M?^).KV$:Y
M,/F.$4#M^EJ0?/R1(;2C\]!UJ[R7FS5I2BV+?*.Y++[[U#5_P5!0QT@BH*4B
MGG[/G:QEKN4YM,233WJK<)J;R$US*7<T?R_=*UN[?VF%@\C;JZ.P=Q(X95>K
MM=_5K9]5/A#OB%,,)YQ52% ]V*'A36]U%NF?V\Q]S<9;O/3EFIH*5S8 [UYW
MHOS"UZYEDFTQTNFTJ;D9* U_;-79R:8X"F/%,7W9^%Z,QZ0[EBL>Y/6^!UCV
MF+EZ8DJ2PPQBM_Q;)&'G;FRR\&Y<$3WF#W;B5);<4D@5-=:9YD:V,P']/)M_
MC%>BND;<2ONX"/2YJ9>!_P""F32.%4FH/&M3QK]'5GZQ.);16U"]<?9^?_\
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MS;;DI]MAV4MF,A2N9]U$=A:U)2"0A)/8#HBS]$6ER!B^2+3+9QN;;[=>UHI
MFW6"[<K?'=K]7)A,2X+LALIJ*)=0:GMT1(T[9>H!+A*LZVRYCQYD;=W_ ).
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M1R%+4&WI4*3*@XASN!,A#C*WF7U%82M*D\W!0(J-><VG_NH__P!!_,+16_\
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MJ3AQ4QDQ&68F2;?,B+'2V&4-0BK!7BRVTTD(352O1'$'CKJ1T_IT#&QMC<9
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M7A?1-,97%F[B9A)9)3SLO;U;_.HYFG$NHJ#D5 6W4!0X\%"O;K-#86S&&8-
MC::5W5^-5A$5N&B8.&2M =U>"ZM>TW2O+<ARWLNW#D+C%<B%)7O3OP5L*D,E
MM;C#@RCG07V%T-.T'4HL>VE0?%L[5F;(QQ-"*MV]BWEKP#I@A)D-R!?<IB3V
M?#O0LZR7=?<6SNLJD,R>5-LR^Y7NUE)DQT+"NZJ%)!KPU4Q/$H@(/..QN\K+
M&Q\D/J& F'\PV)9X&=V^:8N,[889D>7SVPF% @63')UEQ>TH1P3ZQR"Y1K9:
M;/!9'%007%\M>1M1[;7#*]T;L)&"I&\#B5>(92SF93R^.Y.-VNVWFX4B[YIG
M4^'=,]OT5MFYOVYEWU1CECB*<DQ,;L(>*GW(44DN/R%T<E/>D0D )$:YN8[6
M!UTYW@C8Z0@8ES6#,X-&\T5T<$LCJ1AN8[,VQ>\1>M6>9/&W)QO(<@]7-Q9E
MCF8]-:?C6MR7&<2TF6VTXI(;=2E%20%<U1V:\DZ6CCZJUT_4KI^]OH])\4,E
MG.TM:74#2]K3LVU':NIO+C4M-T-NFW$5L,S@X' NH3QW+M,C_E.VR_Q7N!^M
M,=U[&N82ECL'M#Z&B)-=M_MFX7\Y>2?K:U:(E+T1&B(T1&B*A(':::I45#?Q
M%#@*G8F\W)'PES9;"5%33T[PQ\M(< GO.0^1)',>';76S:QT469X(%-ZU[B)
M'G)CW)P320AL)"0D 42GL 2  D4\E$C6O=B5,C!#:%(_NUM^,JM(N=O:I?K2
MVIQ@('I38J?2>ADT)4ZE()9/D5P\NLT,O+=2O@)5A:[@:I,]C\T7;[@K$+H\
M0Q-=<<MO?$A42<UP?A'F(Y4R0*I'D6D^4ZS7;,SRZ'Q1\1W8_:LC31M"G8 @
MD\>S6M:07N VBBO5=9$6)[[U17?!7V?M3?Z1/T-55#M5M^M/J2KAV5H.![2=
M7 9FEM:+#)-)"*Q,S/7+7W'HMP9<G,HAVZ_(MTZ#:<A\#&F7&S/3F2V'H:WD
ME5$.!*RCF"%E(!X:SVUQ+%EAE)= '@Y:X.IN(6KO-(L;X^L=$UFLN8YL<E!F
M8YS30@INL&9NWL]B6W>+3X5VWPO%ZRI^W9-D*2F*FP6>7)1X>:^X&GW7H\9+
M]5*=!J$*%0*:Z+)HW4]Y<37CF:7R+=SF$8![V-) _P"J@:O.-)_O#H;2-+TR
MY+]5U.YU)S)'&IY43WD%U3C1@-<>U;9G)=M[WN/G6$2MJE+N>(V-S()=]DXU
M;F[5=VF6F'#%MDI#?/-G+$D  BI*3YM:J70V16MM=\X?ZHC>=^&*WVE]<6EY
MK^KZ+!IMW;2::'9I7LHRZ#1_V37Q5&Q<$O<[:!&U,#=9>R=Y]73\E7C?J)&+
M0OA"U)2XZCQKL+T4-VY19/I!781PU)'3@^92Z:)69H:^+'+AP]ZT ^I&C'HI
MG4#]-U"&RGU+D<@MI*R4D^)S:X1X>[<NZD7C:J-N?CNV"MJVS/R6Q>OH][&.
M0C88+28LJ48DV6JA;EE,0IY>7ZM0&L)T>ZATB35K:XBC9',(RUQ\1)%:@<*+
MJ?[IM(.MQTD+.X9?>@Y[KDMI !_E-=^<@;*+E8>XFT;^);D9B=G9K4/;:]BS
M38#N*6]NYW=PO)8\19HY!3*BU6#S$CA7S:V$O3VI0ZA;6 O+7_4PNDVU& KC
MP6@T_P"I5C==.ZSK;=(O[>WTV3))&]@:^X%:%\(KXAVX+<3<VVEMR]ID+VH?
M>^-TQ3:NZQBVD6'Q?A"D9#0$PB@2QS<H53E.HT6DZA,+JMW;Y;9KB=GB !)R
M<=G9BIXZ_LQ>:!;-T^\$FKQYH'9<(6D _KXX&A[5GP\NVHEY)NCC@VN*']K;
M:]=+G*<Q6V(AW=IAE;RH]A=^KG2%A% "E(*N%:ZB2Z&V*TMKWFBET1O._>?^
M"OT[KFTOM?U?1XM.N[:73FN+YY&98[FFT0NKXB=@7*R-UMFXVVF,[F.;17-=
MMRG(56"+:6L3M8OD*0E]]CQ$Z+WG=L0E+8)"N<U!'#C34D]-FUU":QYK Z-H
M).)!KP[5H8OJ3HTG0\/5<FF:A#837W)Y!929LF8M#B*^0TKMWUHNZ%[VG5NF
M]M2=MV1>F\:^$J[G\'K9\'O")0ETQD3*A\3@/T):"3Y]0_DF73WZH)&B-LH8
M<3FJZOLI[5U_]U6EOUB[0X[:Y&KBU$AE(I#D+:Y0ZM,U,-FU<%"W;V4E[<Y9
MN<C:>XHM&)WU-CFVM_$[3ZYE2%N,L^(MD0OAJ1$27@2HK20 >%136P;TW,V[
MAM(IHP^X@>\&I%6M%37MHN;L/J=HEKHFK=106>H11V4P9+5A<Y[G&@,8KBRI
MQ.% NED9OM$QD.VF-*VS;,O="TM7>S2O@Q;!#M3#T7Q:6,@=*DN0I2&^"DH2
MY11 U CZ<D?82MYI,<;JG'$[_#Q"W$GU.TINI:/HQ@OZZU$7M_1.4#*"<YW'
M%8\#<'9JX.;K):VR<:^*#O/7RGL6M0%U#7C HV%"7%F:3X,_5AL^DG@*ZON-
M FMHH+ATHI=;,3V;??N6.VZ\T69UY,VUNP=%!97+L&(HW'@%K']T=D6<7VRS
M!6V<HV[=&ZHM-CBMXM:53($AV:N"'+TV'^6*PEQ!55*ED CAY-3?[5GM;J]M
MGRQ<RQ(#C4_B8'^'#@<:T4"X^H&@P_);J6SO#/J.8PEK?#'^H6GFXX8XX@KL
M47[:)>Y&1[8(P"(F^XSCHR6=->QNW>I78"4,++,*8*J=F*$@>B4)[#QX:UYT
M4"WAO'/J+DF@!-:@AM3V"NY;=O6>CW75]UTU-:W3M0CM73R/I^F[E@4R&N)H
MZE:#%<&C=_8B1MA)W65MJZC&XV3*Q54%6)6PWMVX-O,ME]J'SE+L$J= Y@JO
M \-3HNE9)K_Y;'*WG&-SZU.6C6EQ]HI@N</U-Z=GZ2BZJELKTV[KYMN !X@[
MF!C3M\H.WLJN[FY)L[;MQ,*VX<P.&J^9Q8EWZTOHQ6T&T,PQ&>DE$^6I 6U)
MY(Z@$A"J$CCQUK+?09G:?-JXE!;&_+6N/##_ )KI=1ZQTJWZNL](N+6Y=J\\
M0<R5K?T6BF <ZN#N&&U<_$W/V.EV7="^IV^::A;2W'U;DZ7,0LZ9#SX><9*K
M,WR$2V4ELFI*.!'GU+ET":&XBM^:*R"HQPQ%<?>M=<?5;0(=(UO5'C5#;Z5.
M([@"%V:1Q=2L KXFU[L%ZD[D['QH.TES<P)I,?>&5'CXNV,.LQ<C.S'&&61>
MD<H$1)6\"0.>G'5S.F+B5UV.8VMI2N)WC-AA\%6_^HW3Q^275S;WTTNI1M=
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MW-F0X/3->"S7L.IMK+MB.Q8'TS53@-O\F;RS&8%WJD2E($:X-II[G/C@-R.
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9]PU:J8+']U^]_P!T_P!5]5_8ZHKL/L7_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
